<SEC-DOCUMENT>0001213900-26-049412.txt : 20260429
<SEC-HEADER>0001213900-26-049412.hdr.sgml : 20260429
<ACCEPTANCE-DATETIME>20260429171951
ACCESSION NUMBER:		0001213900-26-049412
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		245
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260429
DATE AS OF CHANGE:		20260429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ASCENTAGE PHARMA GROUP INTERNATIONAL
		CENTRAL INDEX KEY:			0002023311
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42484
		FILM NUMBER:		26918112

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		68 XINQING ROAD
		STREET 2:		SUZHOU INDUSTRIAL PARK
		CITY:			SUZHOU , JIANGSU
		PROVINCE COUNTRY:   	F4
		BUSINESS PHONE:		86 512 8555 7777

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		68 XINQING ROAD
		STREET 2:		SUZHOU INDUSTRIAL PARK
		CITY:			SUZHOU , JIANGSU
		PROVINCE COUNTRY:   	F4
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>ea0285148-20f_ascentage.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Wed Apr 29 21:01:00 UTC 2026 -->
<html xmlns:aapg="http://www.ascentage.cn.com/20251231" xmlns:compsci="http://compsciresources.com" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:dtr1="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WASHINGTON,
D.C. 20549</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>FORM
<ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-70339">20-F</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(Mark
One)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentRegistrationStatement" id="ixv-70340">&#9744;</ix:nonNumeric>
<b>REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>OR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="ixv-70341">&#9746;</ix:nonNumeric>
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>For
the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-70342"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-70343">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-70344">2025</ix:nonNumeric></ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="ixv-70345">&#9744;</ix:nonNumeric>
<b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>OR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentShellCompanyReport" id="ixv-70346">&#9744;</ix:nonNumeric>
<b>SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Date
of event requiring this shell company report&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
the transition period from ___________ to ____________</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Commission
file number <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-70347">333-284064</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-116"><b>ASCENTAGE
PHARMA GROUP INTERNATIONAL</b></ix:nonNumeric><br/>
(Exact name of Registrant as specified in its charter)</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not Applicable</b></span></td> <td style="padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; width: 49%; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="ixv-131"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cayman Islands</b></span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Translation of Registrant&#8217;s name into English)</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Jurisdiction of incorporation or organization)</span></td></tr> </table><div>
</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-70348">68 Xinqing Road Suzhou Industrial Park</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2" id="ixv-70349">Suzhou</ix:nonNumeric>,
<ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-70350">Jiangsu</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-70351">China</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName" id="ixv-156"><span style="font-family: Times New Roman, Times, Serif"><b>Thomas
J. Knapp</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Ascentage
Pharma Group Inc.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1" id="ixv-70352">700
King Farm Blvd</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine2" id="ixv-70353">Suite 510</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown" id="ixv-70354">Rockville</ix:nonNumeric>,
<ix:nonNumeric contextRef="c1" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-70355">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode" id="ixv-70356">20850</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="c1" name="dei:CityAreaCode" id="ixv-70357">(301)</ix:nonNumeric>
<ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber" id="ixv-70358">520-1026</ix:nonNumeric><br/>
<ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelEmailAddress" id="ixv-70359">thomas.knapp@ascentage.com</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Name,
Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Securities
registered or to be registered pursuant to Section 12(b) of the Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td> <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle" id="ixv-208"><span style="font-family: Times New Roman, Times, Serif">American depositary shares <br/> (each representing four ordinary shares, no par value per share)</span></ix:nonNumeric></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol" id="ixv-214"><span style="font-family: Times New Roman, Times, Serif">AAPG</span></ix:nonNumeric></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-70360">Nasdaq</ix:nonNumeric> Global Market</span></td></tr> </table><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Securities
registered or to be registered pursuant to Section 12(g) of the Act. <b>None</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Securities
for which there is a reporting obligation pursuant to Section 15(d) of the Act. <b>None</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Indicate
the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered
by the annual report:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-70361">373,322,192</ix:nonFraction>
Ordinary Shares, par value US$0.0001 per share, as of April 1, 2026.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#9744;
Yes &#9746; <ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-70362">No</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">If
this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#9744;
Yes &#9746; <ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-70363">No</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Note
&#8211; Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 from their obligations under those Sections.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#9746;
<ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-70364">Yes</ix:nonNumeric> &#9744; No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: right">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#9746;
<ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-70365">Yes</ix:nonNumeric> &#9744; No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth
company. See definition of &#8220;large accelerated filer, &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221;
in Rule 12b-2 of the Exchange Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</span></td> <td style="width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</span></td> <td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-70366">Non-accelerated filer</ix:nonNumeric> &#9746;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-70367">&#9746;</ix:nonNumeric></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided
pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="ixv-70368">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            term &#8220;new or revised financial accounting standard&#8221; refers to any update issued
                                            by the Financial Accounting Standards Board to its Accounting Standards Codification after
                                            April 5, 2012.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b) by the registered
public accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="ixv-70369">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-70370">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;&#160;240.10D-1(b).
&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. GAAP &#9744;</span></td> <td style="width: 60%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-0">International Financial Reporting Standards</span> as issued by <br/> the International Accounting Standards Board &#9746;</span></td> <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other &#9744;</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If
&#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the
registrant has elected to follow.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Item
17 &#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Item 18 &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If
this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#9744;
Yes <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany" id="ixv-70371">&#9746;</ix:nonNumeric> No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">(APPLICABLE
ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.6in; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#9744;
Yes &#9744; No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>TABLE
OF CONTENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001"><b>INTRODUCTION</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ii</b></span></td></tr>
  <tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002"><b>PART
    I</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003"><b>ITEM
    1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004"><b>ITEM
    2. OFFER STATISTICS AND EXPECTED TIMETABLE</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005"><b>ITEM
    3. KEY INFORMATION</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006"><b>ITEM
    4. INFORMATION ON THE COMPANY</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>85</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007"><b>ITEM
    4A. UNRESOLVED STAFF COMMENTS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>158</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008"><b>ITEM
    5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>158</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009"><b>ITEM
    6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>170</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010"><b>ITEM
    7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>188</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011"><b>ITEM
    8. FINANCIAL INFORMATION</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>191</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012"><b>ITEM
    9. THE OFFER AND LISTING</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>193</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013"><b>ITEM
    10. ADDITIONAL INFORMATION</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>193</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014"><b>ITEM
    11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>202</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_015"><b>ITEM
    12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>204</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016"><b>PART
    II</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>206</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017"><b>ITEM
    13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>206</b></span></td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018"><b>ITEM
    14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>206</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019"><b>ITEM
    15. CONTROLS AND PROCEDURES</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>206</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020"><b>ITEM
    16. [RESERVED]</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>207</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021"><b>ITEM
    16A. AUDIT COMMITTEE FINANCIAL EXPERT</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>207</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022"><b>ITEM
    16B. CODE OF ETHICS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>207</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_023"><b>ITEM
    16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>208</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024"><b>ITEM
    16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>208</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_025"><b>ITEM
    16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><b>208</b></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_026"><b>ITEM
    16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><b>208</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_027"><b>ITEM
    16G. CORPORATE GOVERNANCE</b></a></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>208</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_028"><b>ITEM
    16H. MINE SAFETY DISCLOSURE</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>209</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_029"><b>ITEM
    16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>209</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_030"><b>ITEM
    16J. INSIDER TRADING POLICIES</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>209</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_031"><b>ITEM
    16K. CYBERSECURITY</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>209</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_032"><b>PART
    III</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>211</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_033"><b>ITEM
    17. FINANCIAL STATEMENTS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>211</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_034"><b>ITEM
    18. FINANCIAL STATEMENTS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>211</b></span></td></tr>
  <tr>
    <td style="padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_035"><b>ITEM
    19. EXHIBITS</b></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>211</b></span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTRODUCTION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
where the context otherwise requires or where otherwise indicated in this Annual Report on Form 20-F, all references to &#8220;Ascentage
Pharma,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Ascentage Pharma Group International,
a Cayman Islands exempted company, and its subsidiaries.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRESENTATION
OF FINANCIAL INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our financial
statements included in this Annual Report on Form 20-F are prepared in accordance with the International Financial Reporting Standards
and its interpretations, or IFRS, as issued by the International Accounting Standards Board, or IASB. Our financial statements are presented
in Renminbi, or RMB and none of the financial statements are prepared in accordance with U.S. GAAP. Our fiscal year ends on December&#160;31.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms &#8220;US$,&#8221; &#8220;U.S. dollars&#8221;, &#8220;dollars&#8221; and &#8220;$&#8221; refer to U.S. dollars and the term &#8220;RMB&#8221;
refer to the legal currency of the People&#8217;s Republic of China. Unless otherwise indicated, all references to currency amounts in
this Annual Report on Form 20-F are in RMB. We have made rounding adjustments to some of the figures included in this Annual Report on
Form 20-F. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic aggregation of the figures that preceded
them.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Unless otherwise
noted, all translations from Renminbi to U.S. dollars in this annual report are made at a rate of RMB6.9931to US$1.00, the exchange rate
set forth for cable transfers in the City of New York, as certified by the Federal Reserve Bank of New York, on December 31, 2025. We
make no representation that any Renminbi or U.S. dollar amounts could have been, or could be, converted into U.S. dollars or Renminbi,
as the case may be, at any particular rate, or at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FREQUENTLY
USED TERMS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Business Terms</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated or unless the context otherwise requires in this document:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;ADSs&#8221;
</b>refer to American depositary shares, each of which represents four (4) of our ordinary shares, no par value per share;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;ADRs&#8221;
</b>refer to the American depositary receipts that evidence the ADSs;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;CCASS&#8221;
</b>refers to the Central Clearing and Settlement System established and operated by HKSCC;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;China&#8221;
or &#8220;PRC&#8221; </b>refer to the People&#8217;s Republic of China, and only in the context of describing the PRC laws, rules, regulations,
regulatory authorities, and any PRC entities or citizens under such rules, laws and regulations and other legal or tax matters, excludes,
Taiwan, the Hong Kong Special Administrative Region and the Macau Special Administrative Region;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Ordinary
shares&#8221; </b>refer to our ordinary shares, par value US$0.0001 per share;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;RMB&#8221;
and &#8220;Renminbi&#8221; </b>refer to the legal currency of China;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;HKEx&#8221;
</b>refers to The Stock Exchange of Hong Kong Limited;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;HK$&#8221;
</b>refers to the legal currency of Hong Kong;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;HKSCC&#8221;
</b>refers to Hong Kong Securities Clearing Company Limited;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Hong
Kong Listing Rules&#8221; </b>refer to the Rules Governing the Listing of Securities on HKEx, as amended, supplemented, or otherwise
modified from time to time;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;<i>IFRS</i>&#8221;
</b>means the International Financial Reporting Standards, as issued by the IASB;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#8220;Innovent&#8221;
</b>refers to Innovent Biologics (Suzhou) Co., Ltd., a company with limited liability established under the laws of the PRC;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Nasdaq&#8221;
</b>means Nasdaq Global Market;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#8220;RSU&#8221;
</b>means restricted share units;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;<i>SEC</i>&#8221;
</b>means the U.S. Securities and Exchange Commission;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;SFC&#8221;
</b>refers to the Securities and Futures Commission of Hong Kong; and</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Takeda&#8221;
</b>refers to Takeda Pharmaceuticals International AG; and</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;US$,&#8221;
&#8220;U.S. dollars&#8221;, &#8220;dollars&#8221; and &#8220;<i>$</i>&#8221; </b>means United States dollars, the legal currency of the
United States.<b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;<i>U.S.
GAAP</i>&#8221; </b>means United States generally accepted accounting principles.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDUSTRY
AND MARKET DATA</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Annual Report on Form 20-F includes industry, market and competitive
position data that have been derived from publicly available information, industry publications and other third-party sources, as well
as from our own internal data and estimates. Certain information and data, including statistics, estimates and projections about market
size and future growth, included in this Annual Report on Form 20-F have been derived from an industry report commissioned by use and
independently prepared by Frost &amp; Sullivan, or the F&amp;S Report. Independent consultant reports, industry publications and other
published sources generally state that the information they contain has been obtained from sources believed to be reliable, but that the
accuracy and completeness of such information is not guaranteed. While we have compiled, extracted, and reproduced industry data from
these sources, we have not independently verified the data. Forecasts and other forward-looking information obtained from these sources
are subject to the same qualifications and uncertainties as the other forward-looking statements in this Annual Report on Form 20-F. These
forecasts and forward-looking information are subject to uncertainty and risk due to a variety of factors, including those described under
&#8220;<i>Item 3. Key Information&#8212;D. Risk Factors</i>.&#8221; These and other factors could cause results to differ materially from
those expressed in any forecasts or estimates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRADEMARKS
AND SERVICE MARKS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Ascentage,&#8221;
the Ascentage logo and other trademarks or service marks of Ascentage appearing in this Annual Report on Form 20-F are the property of
Ascentage or its subsidiaries. Solely for convenience, the trademarks, service marks and trade names referred to in this Annual Report
on Form 20-F are listed without the &#174; and &#8482; symbols, but such references should not be construed as any indicator that their
respective owners will not assert, to the fullest extent under applicable law, their right thereto. All other trademarks, trade names
and service marks appearing in this Annual Report on Form 20-F are the property of their respective owners.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Annual Report on Form 20-F contains forward-looking
statements. All statements other than statements of historical facts contained in this Annual Report on Form 20-F may be
forward-looking statements, including statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or
projections regarding future events or future results of operations or financial condition. These forward-looking statements are
subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including Section 27A of the
Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or
the Exchange Act. In some cases, these forward-looking statements can be identified by words or phrases such as &#8220;aim,&#8221;
&#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221;
&#8220;intend,&#8221; &#8220;is likely to&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221;
or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.
These forward-looking statements reflect our current views with respect to future events and are subject to risks and uncertainties,
some of which are beyond our control, or other assumptions and important factors that may cause our actual results, levels of
activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking
statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements in this Annual Report include, but are not limited to, statements about:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations regarding sales, manufacturing and commercialization of Olverembatinib and Lisaftoclax in China;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations regarding the clinical development, regulatory approval and commercialization
                                            of Olverembatinib  and Lisaftoclax outside of China and of our other proprietary product candidates,
                                            including trial initiation, patient enrollment, trial completion, data announcements, regulatory
                                            filings, and timing thereof;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations regarding the potential advantages of our products and product candidates over
                                            existing therapies or therapies currently in development and expectations regarding the status
                                            of current therapies being used or being developed that are or may be competitive to our
                                            product candidates and potential changes to standard of care, and their comparative efficacy,
                                            safety, pharmacokinetics, or PK, pharmacodynamics, or PD, bioavailability and other characteristics;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: left">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: left">our expectations with regard to our ability to create, identify, nominate, select, research and develop additional product candidates and to submit investigational new drug application, or INDs, and/or Clinical Trial Applications, or CTAs, for our pre-clinical product candidates and timing thereof;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations regarding the potential advantages of our proprietary technologies over existing
                                            technology platforms, including drugs and therapies currently in development, and the prospects
                                            for our ongoing and future technology collaborations;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
                                            and projections relating to our competitors and our industry, including competing therapies
                                            and technologies;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            plans to expand our technology platform and the potential benefits of such platform;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations with regard to the willingness and ability of our current and future partners
                                            and collaborators to pursue the development, approval and commercialization of our products
                                            and product candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            and our partners&#8217; product discovery, development and commercialization plans with respect
                                            to our products and product candidates and proprietary technologies;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            potential to enter into new collaborations, including research and similar collaborations
                                            with research institutions and hospitals;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            and our partners and collaborators&#8217; ability to develop, acquire and advance product
                                            candidates into, and successfully complete, clinical trials and commercialize products that
                                            are approved;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations around the potential initiation, timing and success of clinical trials initiated
                                            by third parties, including IIT, of therapies including our products and product candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            initiation, timing, progress and results of our pre-clinical studies and clinical trials,
                                            and our research and development programs;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timing or likelihood of regulatory filings and approvals for our products and product candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to identify, and to negotiate contracts with, suitable contract manufacturing organizations,
                                            or CMOs, contract research organizations, or CROs, and the ability of such CMOs and CROs
                                            to manufacture sufficient quantities of our products and product candidates for clinical
                                            trials or commercialization in compliance with current good manufacturing practices, or cGMPs;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            commercialization and market acceptance of our products and product candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our plans to continue to
                                                                                                                                                                        build our commercialization capabilities and to commercialize and market Olverembatinib, Lisaftoclax or other proprietary product
                                                                                                                                                                        candidates that may be approved;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            pricing of and reimbursement for our approved products in different markets;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            implementation of our business model and strategic plans for our business, products, product
                                            candidates and technologies;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            and our partners&#8217; ability to operate our businesses without infringing the intellectual
                                            property rights and proprietary technology of third parties;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            scope of protection we and our partners are able to establish and maintain for intellectual
                                            property rights covering our products, product candidates and technologies;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            analysis of potential patent infringement claims and our rights with respect to such claims,
                                            and expectations around patent coverage and effectiveness of such coverage for competitive
                                            products and product candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            receipt of future milestone payments, royalties and other payments from our partners, licensors
                                            and other collaborators and the expected timing of such payments;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            impact of regulatory developments, legislative actions and political conditions in the United
                                            States, China, Hong Kong and other jurisdictions, including trade policies and tariffs that
                                            may apply to products that we purchase or sell, or judicial decisions overturning or establishing
                                            new legal precedents;</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to operate in compliance with applicable laws which are complex and have different jurisdictional requirements;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to effectively manage our anticipated growth;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to attract and retain suitably qualified employees and key personnel, particularly
                                            for our commercialization efforts;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations around increase of headcounts and operations in key geographic areas;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timing, receipt of and terms and conditions of any required approvals, licenses or permits
                                            and the failure to renew, or the revocation of, any such approvals, licenses or permits;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            estimates regarding future expenses, capital requirements and needs for additional financing;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectation that the use of proceeds from our public and private financings and the period
                                            over which such proceeds, together with our available cash, will be sufficient to meet our
                                            operating needs; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            future financial performance.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">You should
refer to the section of this Annual Report on Form 20-F titled &#8220;<i>Item 3. Key Information&#8212;D. Risk Factors</i>&#8221; for
a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking
statements. As a result of these factors, you should not rely on these forward-looking statements as predictions of future events.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The forward-looking
statements contained in this Annual Report on Form 20-F are based on our current expectations and beliefs concerning future developments
and their potential effects on us and speak only as of the date of this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We will not,
and do not, undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future
events or otherwise, except as may be required under applicable securities laws. You should therefore not rely on these forward-looking
statements as representing our current expectations and beliefs as of any date subsequent to the date of this Annual Report on Form 20-F.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
I</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
2. OFFER STATISTICS AND EXPECTED TIMETABLE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
3. KEY INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
[Reserved]</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B</b>.
<b>Capitalization and Indebtedness</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Reasons for the Offer and Use of Proceeds</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Risk Factors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of risk factors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Our business
faces significant risks and uncertainties. We are a Cayman Islands exempted company that conducts operations in multiple countries,
primarily through our subsidiaries, with substantive business operations in China and in the United States. Under this holding
company structure, investors in our ADSs hold equity interests in the Cayman Islands exempted company obtaining indirect ownership
interests in our operating companies, including the PRC operating companies. This holding company structure involves certain risks
to investors of our ADSs and ordinary shares. You should carefully consider all of the information set forth in this Annual Report
on Form 20-F and in the other documents we file with or furnish to the SEC, including the following risk factors, before deciding to
invest in or to maintain an investment in our securities. Our business, financial condition or results of operations could be
materially and adversely affected by any of these risks, any of which could have an adverse effect on the trading price of our
securities. Additional risks not presently known to us or that we currently deem immaterial may also impair our business, financial
condition and results of operations. In any such case, the market price of the ADSs could decline significantly, and you may lose
all or part of your investment.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
please find a summary of the principal risks we face, organized under relevant headings.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
related to our financial position and need for additional capital</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred significant net losses in the past, and we intend to continue to invest substantially in our business. As a result, we
may not be able to achieve or sustain profitability in the future despite the commercialization of Olverembatinib and Lisaftoclax in
China.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">We
                                            will need to obtain additional financing to fund our operations, and if we are unable to
                                            obtain such financing, we may be unable to complete the development and commercialization
                                            of our drug candidates, including Olverembatinib and Lisaftoclax.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Raising
                                            additional capital may cause dilution to our shareholders, restrict our operations or require
                                            us to relinquish rights to our current or future products and our drug candidates, including
                                            Olverembatinib and Lisaftoclax.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            credit facility may not be available to us at all or on the same terms as it has in the past.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have a limited history of generating revenues on which to evaluate our potential for future
                                            success and as a result it is difficult to evaluate our current business and predict our
                                            future performance.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 10; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
related to clinical development</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outside
                                            of China, we have not obtained any marketing authorization for any of our drug candidates.
                                            We depend substantially on the success of Olverembatinib, Lisaftoclax and our other drug
                                            candidates, several of which are in clinical development. Clinical development of drug candidates
                                            is inherently uncertain.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            clinical trials of our drug candidates fail to demonstrate safety and efficacy to the satisfaction
                                            of the U.S. Food and Drug Administration, or FDA, NMPA or other comparable regulatory authorities
                                            or do not otherwise produce positive results, we may incur additional costs or experience
                                            delays in completing, or ultimately be unable to complete, the commercialization of Olverembatinib
                                            and Lisaftoclax in the United States or elsewhere or the development and commercialization
                                            of our other drug candidates.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
                                            drug development involves a lengthy and expensive process with uncertain outcomes, and results
                                            of earlier studies and trials may not be predictive of future trial results.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
                                            of our drug candidates are being tested or used by patients who are critically ill, who may
                                            be unfit for certain medical interventions or for whom there are no other treatments or options,
                                            which can result in heightened risk of adverse events, including death.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim,
                                            initial, top-line and preliminary data from our clinical trials that we announce or publish
                                            from time to time may materially change as more patient data become available and are subject
                                            to audit and verification procedures. We may also selectively report data to explore certain
                                            trends that are interesting, but you may not agree with our assessment as to what might be
                                            material or appropriate.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may not be successful in our efforts to identify or discover additional drug candidates.
                                            Due to our limited resources and access to capital, we must, and have in the past decided
                                            to, prioritize development of certain drug candidates; these decisions may prove to be wrong
                                            and may adversely affect our business.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we encounter difficulties enrolling patients in our clinical trials, our clinical development
                                            activities could be delayed or otherwise adversely affected.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
related to obtaining regulatory approval</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            regulatory approval processes of the FDA, NMPA and other comparable regulatory authorities
                                            are lengthy, time consuming and inherently unpredictable, and if we are ultimately unable
                                            to obtain regulatory approval for our drug candidates, our business will be substantially
                                            harmed.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            FDA, NMPA and other comparable foreign regulatory authorities may not accept data from trials
                                            conducted in locations outside of their jurisdiction.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to obtain NMPA approval for our drug candidates to be eligible for an expedited
                                            registration pathway as Category 1 drug candidates, the time and cost we incur to obtain
                                            regulatory approvals may increase. Even if we receive such Category 1 designation, it may
                                            not lead to a faster development, review or approval process.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
                                            appropriate, we plan to secure approval from the FDA or comparable foreign regulatory authorities
                                            through the use of accelerated registration pathways. If we are unable to obtain such approval,
                                            we may be required to conduct additional preclinical studies or clinical trials beyond those
                                            that we contemplate, which could increase the expense of obtaining, and delay the receipt
                                            of, necessary marketing approvals. Even if we receive accelerated approval from the FDA,
                                            if our confirmatory trials do not verify clinical benefit, or if we do not comply with rigorous
                                            post-marketing requirements, the FDA may seek to withdraw accelerated approval.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
related to commercialization</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are substantially dependent on the commercial success of Olverembatinib and Lisaftoclax.
                                            If we are unable to maintain or increase sales of Olverembatinib and Lisaftoclax, our ability
                                            to generate revenue and our financial condition will be adversely affected.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">If
                                            we are not able to obtain, or experience delays in obtaining, required regulatory approvals
                                            for our drug candidates (including Olverembatinib and Lisaftoclax outside of China), we will
                                            not be able to commercialize our drug candidates in the markets that we desire, and our ability
                                            to generate revenue will be materially impaired.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have and may continue to license commercialization or other rights and pursue other forms
                                            of collaboration worldwide, which can expose us to additional risks of conducting business
                                            in additional international markets.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have limited commercialization experience, and we may lack the necessary expertise, personnel
                                            and resources to successfully commercialize any of our other products that receive regulatory
                                            approval on our own or together with collaborators.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
related to our intellectual property</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to protect and defend our proprietary technology or obtain and maintain patent
                                            protection for our drug candidates, our competitors could develop and commercialize technology
                                            and drugs similar or identical to ours, and our ability to successfully commercialize our
                                            technology and drugs may be adversely affected.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
related to our reliance on third parties</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            rely on third parties to manufacture a portion of our drug candidate supplies, and we intend
                                            to rely on third parties for at least a portion of the manufacturing process of our drug
                                            candidates, including Olverembatinib and Lisaftoclax. Our business could be harmed if those
                                            third parties fail to provide us with sufficient quantities of product or fail to do so at
                                            acceptable quality levels or prices.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have entered into collaborations and other relationships with leading biotechnology companies
                                            and research institutions and may form or seek other collaborations or strategic alliances
                                            or enter into additional licensing arrangements in the future, and we may not realize the
                                            benefits of such alliances or licensing arrangements.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            rely on third parties to conduct our preclinical studies and clinical trials and we must
                                            work effectively with collaborators to develop our drug candidates. In many cases, our drug
                                            candidates, including Olverembatinib and Lisaftoclax, are studied in third-party studies,
                                            including in investigator-initiated trials. If these third parties do not successfully carry
                                            out their contractual duties or meet expected deadlines, or fail to design, execute, and
                                            complete appropriate and timely studies of our drug candidates, we may not be able to obtain
                                            regulatory approval for or commercialize our drug candidates and our business could be substantially
                                            harmed.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
related to our industry, business and operations</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            our manufacturing facilities are damaged or destroyed or production at such facilities is
                                            otherwise interrupted, our business and prospects would be negatively affected.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have significantly increased our research, development, manufacturing, and commercial capabilities,
                                            and we may experience difficulties in managing our growth.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            failure to comply with applicable regulations and industry standards or obtain or maintain
                                            various licenses and permits could harm our reputation and our business, results of operations
                                            and prospects.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            tension in international trade, rising political tension and increasing geopolitical risks,
                                            particularly between the United States and China, pose significant challenges that may adversely
                                            impact our business, results of operations and financial condition.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks
related to doing business in the PRC</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are subject to continued approval, filing and other requirements of applicable U.S. securities
                                            laws and Nasdaq listing rules as a U.S. public company, and may be subject to further approval,
                                            filing or other requirements with PRC governmental authorities in connection with future
                                            capital-raising activities.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
                                            greater oversight by the Cyberspace Administration of China, or CAC, over data security,
                                            particularly for companies seeking to list on a foreign exchange, could significantly limit
                                            or completely hinder our ability in capital raising activities and materially and adversely
                                            affect our business and the value of your investment.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    the Public Company Accounting Oversight Board, or PCAOB, is unable to inspect or investigate completely our auditors located in China
    because of a position taken by a foreign authority and the SEC identifies the Company as a Commission-Identified Issuer under the
    Holding Foreign Companies Accountable Act for two consecutive&#160;years, our ADSs will be delisted from Nasdaq and our ordinary
    shares and ADSs will be prohibited from trading on a national securities exchange or in the over-the-counter market in the U.S. under
    the Holding Foreign Companies Accountable Act. The delisting of our ADSs, or the threat of their being delisted, and a prohibition
    from trading, may materially and adversely affect the value of our ordinary shares.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: left">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: left">Existing regulation and future legislative actions in both the U.S. and China may restrict our ability
    to transfer our scientific data abroad.</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Risks related
to our ordinary shares and our ADSs</i></span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dual listing of our ordinary shares and ADSs may adversely affect the liquidity and value of our ADSs and ordinary shares.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    trading prices of our ADSs have been and are likely to be volatile, which could result in substantial losses to you.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we fail to maintain an effective system of internal controls over financial reporting, we may be unable to accurately
    report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence and the market price of
    our ADSs may be materially and adversely affected.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
related to our financial position and need for additional capital</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>We
have incurred significant net losses in the past, and we intend to continue to invest substantially in our business. As a result, we
may not be able to achieve or sustain profitability in the future despite the commercialization of Olverembatinib and Lisaftoclax in
China.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred a net loss of RMB1,243.0 million (US$177.7 million), RMB405.7 million and RMB925.7 million for the years ended December 31,
2025, 2024 and 2023, respectively. As of December 31, 2025, we had accumulated losses of RMB7,013.3 million (US$1,002.9 million). Investment
in pharmaceutical product development is highly speculative because it entails substantial upfront capital expenditures and significant
risk that a drug candidate will fail to gain regulatory approval or become commercially viable. We have devoted significant financial
resources to research and development, including our nonclinical development activities and clinical trials. We continue to incur significant
development and other expenses related to our ongoing operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Although
we have commercialized Olverembatinib and Lisaftoclax in China, we have several other drug candidates in clinical and preclinical development.
In addition, we expect to incur significant expenses related to obtaining regulatory approvals for Olverembatinib and Lisaftoclax in
additional markets, including the United States. Substantially all of our operating losses have resulted from costs incurred in connection
with our research and development programs, selling and distribution expenses associated with commercialization of Olverembatinib and
Lisaftoclax in China and general and administrative expenses associated with our operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We expect
to continue to incur substantial and increasing losses for the foreseeable future, and we expect these losses to increase as we continue
our development of, and seek regulatory approvals for, our drug candidates (including Olverembatinib and Lisaftoclax outside of China),
and commercialize such drug candidates, if approved. Typically, it takes many years to develop one new drug candidate from the time it
is discovered to when it is available for treating patients. We may encounter unforeseen expenses, difficulties, complications, delays,
and other unknown factors that may adversely affect our business. The size of our future net losses will depend, in part, on the rate
of future growth of our expenses, our ability to generate revenues and the timing and amount of milestones and other required payments
to third parties in connection with our potential future arrangements with third parties. If any of our drug candidates (including Olverembatinib
and Lisaftoclax) fail in clinical trials or do not gain regulatory approval for the indications we seek or if approved, fail to achieve
market acceptance, we may never become profitable. Even if we achieve profitability in the future, we may not be able to sustain profitability
in subsequent periods. Our failure to become and remain profitable may decrease the value of our Company and could impair our ability
to maintain or further our research and development efforts, raise additional necessary capital, grow our business and continue our operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We expect
our research and development expenses to continue to be significant in connection with our continued investment in our research and development
platform and our ongoing and planned clinical trials for our drug candidates, including for Olverembatinib and Lisaftoclax. If we obtain
regulatory approval for Olverembatinib and Lisaftoclax and our other drug candidates in the United States or other jurisdictions, we
expect to incur increased sales and marketing and manufacturing and other expenses as we prepare to commercialize the approved drugs.
In addition, we will continue to incur additional costs associated with operating as a U.S. and Hong Kong-listed public company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, if we fail to increase our revenues to offset the increases in our operating expenses, we expect to continue to incur operating
losses for the foreseeable future. Our prior losses and expected future losses have had and will continue to have a material adverse
effect on our financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>We
will need to obtain additional financing to fund our operations, and if we are unable to obtain such financing, we may be unable to complete
the development and commercialization of our drug candidates, including Olverembatinib and Lisaftoclax.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We have funded
our operations primarily through equity financing. We have also received government subsidies that consist of funds from local governments
as compensation for research activities and clinical trials, for which there are no outstanding obligations, as well as tax credits in
China and Australia. Such government subsidies were mainly R&amp;D-related subsidies received from the provincial and municipal governments
of Suzhou and Guangzhou and the local taxation office in Australia for the years ended December 31, 2025 and 2024. Other than Olverembatinib
and Lisaftoclax, which has been commercialized in China, we do not have any products approved for commercial sale in any other jurisdiction.
During the years ended December 31, 2025, 2024 and 2023, we recognized RMB574.1 million (US$82.1million), RMB980.7 million and RMB222.0
million, respectively, in revenue from the sales of pharmaceutical products, commercialization rights income from our agreement with
Innovent, intellectual property income from our agreement with Takeda and management fee income. Our other drug candidates (including
Olverembatinib and Lisaftoclax outside of China) will require the completion of regulatory review, significant marketing efforts and
substantial investment before they can provide us with any product sales revenue. Our operations have consumed substantial amounts of
cash since inception. We expect to continue to spend substantial amounts on drug discovery, advancing the clinical development of our
drug candidates and launching and commercializing any drug candidates for which we receive regulatory approval (including Olverembatinib
and Lisaftoclax), including by building and expanding our own commercial organizations to address certain markets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">As of
December 31, 2025 we had RMB2,470.1 million <b>(</b>US$353.2 million) in cash and bank balances. We believe that our existing cash
and bank balances and our loan facility, will enable us to fund our operating expenses and capital expenditure requirements through
at least the next 12 months from the issuance of the consolidated financial statements included in this Annual Report on Form 20-F
but may not be sufficient for us to fund any of our drug candidates through regulatory approval, which may last several years. We
will need to obtain substantial financing to fund our future operations, including completing the development and commercialization
of our drug candidates, including Olverembatinib and Lisaftoclax in the United States. Even if one or more of the drug candidates
that we develop are approved for commercial sale, we anticipate incurring significant costs associated with sales, marketing,
manufacturing, and distribution activities. Our expenses could increase beyond expectations if we are required by the U.S. Food and
Drug Administration, or the FDA, the NMPA, or other regulatory agencies to perform clinical trials or preclinical studies in
addition to those that we currently anticipate. Other unanticipated costs may also arise. Because the design and outcome of our
planned and anticipated preclinical studies and clinical trials are highly uncertain, we cannot reasonably estimate the actual
amount of resources and funding that will be necessary to successfully complete the development and commercialization of any drug
candidate we develop. We are not permitted to market or promote Olverembatinib and Lisaftoclax in the United States or other
jurisdictions outside of the PRC, or any other drug candidate, before we receive marketing approval from the FDA, NMPA or other
regulatory agencies. Moreover, we expect to increase our headcounts to support our expansion and our fixed expenses such as rent,
interest expense and other contractual commitments are also expected to increase in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cash and financial resources to support our operations involve risks and uncertainties, including the factors discussed elsewhere in
this &#8220;Risk Factors&#8221; section. We could utilize our available capital resources sooner than we currently expect. Our future
funding requirements will depend on many factors, including, but not limited to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            progress, timing, scope and costs of our clinical trials, including the ability to timely
                                            enroll patients in our planned and potential future clinical trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            outcome, timing and cost of regulatory approvals by the FDA, NMPA and comparable regulatory
                                            authorities, including the potential that the FDA, NMPA or comparable regulatory authorities
                                            may require that we perform more studies than those that we currently expect;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            cost and timing of development and completion of commercial-scale internal or outsourced
                                            manufacturing activities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number and characteristics of drug candidates that we may develop (including as a combination
                                            therapy) and the requirements of any future acquisitions, in-licenses or collaborations;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">the
                                            amount of sales and other revenues from Olverembatinib, Lisaftoclax and other drug candidates
                                            that we may commercialize, if any, including the selling prices for such potential products,
                                            if and when approved, and the availability of adequate third-party reimbursement;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount and timing of the milestone, royalty and/or other payments we receive under arrangements
                                            with our licensees, partners and collaborators, such as our collaboration and licensing agreement
                                            with Innovent, or are or may be required to pay under our current and future collaborations,
                                            licensing and other similar arrangements, and the terms of those arrangements;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual
                                            property rights;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">selling
                                            and marketing costs associated with our current and future products, including the cost and
                                            timing of expanding our marketing and sales capabilities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            costs of operating as a public company in both Hong Kong and the United States; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            time and cost necessary to respond to technological and market developments.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
we can generate a sufficient amount of revenue, we may finance future cash needs through public or private equity offerings, license
agreements, debt financings, collaborations, strategic alliances and marketing or distribution arrangements. Additional funds may not
be available when we need them on terms that are acceptable to us, or at all. General market conditions or the market price of our ordinary
shares or ADSs may not support capital raising transactions such as an additional public or private offering of the ADSs or other securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global economy, including credit and financial markets, has experienced volatility and disruptions recently. While the potential economic
impacts of the current U.S. administration, geopolitical conflicts in Russia and Ukraine, Iran and the Middle East and in South America,
and tensions in U.S.-China relations are difficult to assess or predict, these conditions have resulted in, and may continue to result
in, volatility and disruptions in the capital and credit markets, reducing our ability to raise additional capital through equity, equity-linked
or debt financings, which could negatively impact our short-term and long-term liquidity and our ability to operate in accordance with
our operating plan, or at all. In addition, any public health emergencies may also cause extreme volatility and disruptions in the capital
and credit markets. Our results of operations could be adversely affected by general conditions in the global economy and financial markets.
A severe or prolonged economic downturn could result in a variety of risks to our business, including our ability to raise additional
capital when needed on favorable terms, if at all. The Federal Reserve raised interest rates multiple times in the past in response to
concerns about inflation, and it may raise them again or determine not to continue to lower them in a timely manner. Higher interest rates,
coupled with reduced government spending and volatility in financial markets, and recent and potential future disruptions in access to
bank deposits and lending commitments due to bank failures, may increase economic uncertainty and affect consumer spending.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
adequate funds are not available, we may be required to delay or reduce the scope of or eliminate one or more of our research or development
programs or our commercialization efforts. Therefore, our inability to obtain additional funding when we need it could seriously harm
our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Raising
additional capital will cause dilution to our shareholders, restrict our operations or require us to relinquish rights to our current
or future products and our drug candidates, including Olverembatinib and Lisaftoclax.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We may
seek additional funding through a combination of equity offerings, government or private party grants, debt financings,
collaborations, strategic alliances, licensing arrangements, and other marketing or distribution arrangements. To the extent that we
raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the
terms may include liquidation or other preferences that adversely affect your rights as a holder of the ADSs. The incurrence of
indebtedness or the issuance of certain equity securities could result in increased fixed payment obligations and could also result
in certain restrictive covenants, such as limitations on our ability to incur debt, issue additional equity, declare dividends,
acquire or license intellectual property rights, make capital expenditures and other operating restrictions that could adversely
impact our ability to conduct our business. In addition, issuance of additional equity securities, or the possibility of such
issuance, may cause the market price of the ADSs to decline. In the event that we enter into collaborations, strategic alliances or
marketing, distribution or licensing arrangements with third parties in order to raise capital, we may be required to grant licenses
on terms that may not be favorable to us or relinquish valuable rights to our current or future revenue streams or rights to
Olverembatinib, Lisaftoclax or our other drug candidates that we otherwise would seek to develop or commercialize ourselves or
potentially reserve for future potential arrangements when we might be able to achieve more favorable terms. We could also
potentially have to share or relinquish certain rights to our platform or other assets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
credit facility may not be available to us at all or on the same terms as it has in the past.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
credit facility contains restrictive covenants that primarily limit our ability to transfer or dispose of assets, merge with other companies
or consummate certain changes of control, acquire other companies, conduct material investments or related party transactions, issue
bonds, pay dividends, incur additional indebtedness and liens and enter into new businesses. We therefore may not be able to engage in
any of the foregoing transactions unless we obtain the consent of the lender or terminate the credit facility, which may limit our operating
flexibility. In addition, to secure our credit facilities, we may grant security interests from time to time. As of December 31, 2025,
bank loans amounting to RMB600.2 million <b>(</b>US$85.8 million) were secured by the pledge of our buildings with a net carrying amount
of RMB677.0 million (US$96.8 million) and right-of-use assets with a net carrying amount of RMB25.3 million (US$3.6 million). Such loans
were also guaranteed by two of our subsidiaries. Any failure to satisfy our obligations under these bank loans could lead to foreclosure
of the assets that secure these borrowings, disruption to business operations and payment obligations of our relevant subsidiaries, which
could materially and adversely affect our business, results of operations and financial condition. There is no guarantee that we will
be able to make scheduled payments for the principal and interest on any such loans or meet the restrictive covenants on our credit facility.
Furthermore, there is no guarantee that future working capital, borrowings or equity financing will be available to repay or refinance
any such loans. As a result, we would be in default of such loans, and the relevant counterparty could elect to declare the borrowings,
together with accrued and unpaid interest and other fees, immediately due and payable and proceed against security interests under the
loans, if any. If the borrowings were to be accelerated, our business and liquidity could nevertheless be subject to adverse effects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
ability to use our net operating losses to offset future taxable income may be subject to certain limitations.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">As of
December 31, 2025, Ascentage Pharma Group Inc., our U.S. subsidiary located in Rockville, Maryland, had federal and state net
operating loss carryforwards, or NOLs, of US$231.2 million and US$18.4 million, respectively, due to prior period losses. The Tax
Cuts and Jobs Act of 2017, or the TCJA, allows for federal NOLs incurred in tax years beginning after December 31, 2017, to be
carried forward indefinitely. The deductibility of federal NOLs is limited to 80% of the current year&#8217;s taxable income. However, NOLs
generated prior to January 1, 2018, will still have a 20-year carryforward period, but are not subject to the 80% limitation.
Furthermore, our ability to use NOLs is conditioned on Ascentage Pharma Group Inc. achieving and maintaining profitability in the
future and generating U.S. federal taxable income. Since we do not know whether or when Ascentage Pharma Group Inc. will generate
the U.S. federal taxable income necessary to use its remaining NOLs, its NOLs generated prior to January 1, 2018, could expire
unused.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have a limited history of generating revenues on which to evaluate our potential for future success and as a result it is difficult to
evaluate our current business and predict our future performance.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We were founded
in 2009 and did not generate any revenue from product sales until 2021. While we have commercialized Olverembatinib and Lisaftoclax in
China, we have not received regulatory approval for Olverembatinib and Lisaftoclax in the United States or any other market, and we have
no other products approved for commercial sale in any market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently,
any predictions you or we make about our future success or viability are subject to significant uncertainty and may not be as accurate
as they could be if we had a longer operating history. We are focused on discovering, developing and commercializing therapies for hematological
malignancies. Our limited operating history as a revenue generating company, particularly in light of the rapidly evolving cancer treatment
field, may make it difficult to evaluate our current business and predict our future performance. We will encounter risks and difficulties
frequently experienced by clinical-stage companies in rapidly evolving fields. Additionally, as we pursue new indications and enter new
markets, we may also encounter additional and new challenges and risks, including those associated with further expanding our global
footprint and operations. If we do not address these risks and difficulties successfully, our business will suffer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have several drug candidates in clinical development, and their risk of failure is high. We are unable to predict if these drug
candidates or any of our other drug candidates that advance into clinical trials will prove safe or effective in humans or will obtain
marketing approval. Because of the uncertainties and risks associated with clinical development activities, we face a significant risk
of business failure. We can provide investors with no assurance that we will recover all or any portion of our capital investment in
the clinical development of our drug candidates. If we are unsuccessful in addressing these risks, our business will most likely fail,
and our investors could lose all or substantially all of their investments.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
related to clinical development</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Outside
of China, we have not obtained any marketing authorization for any of our drug candidates. We depend substantially on the success of
Olverembatinib, Lisaftoclax and our other drug candidates, several of which are in clinical development. Clinical development of drug
candidates is inherently uncertain.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">To date,
we have obtained regulatory approval in China for (a) Olverembatinib for the treatment of adult patients with chronic myeloid leukemia
in chronic phase, or CML-CP, or chronic myeloid leukemia in accelerated phase, or CML-AP, with the T315I mutation and adult patients
with CML-CP that is resistant or intolerant to first- and second- generation tyrosine kinase inhibitors, or TKIs, from NMPA and (b) Lisaftoclax
for the treatment of adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, or CLL/SLL, who have previously received
at least one systemic therapy including Bruton&#8217;s tyrosine kinase, or BTK, inhibitors. Outside of China, we have not obtained marketing
approval for any drug candidates conducted sales and marketing activities necessary for successful commercialization of any approved
products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We may fail
to or be unable to design and execute clinical trials to support marketing approval of Olverembatinib or Lisaftoclax outside of China,
or any of our other drug candidates. We cannot be certain that our current or planned clinical trials or any other future clinical trials
will be completed on time or be successful. We cannot guarantee that the FDA or foreign regulatory authorities will agree with our study
design, protocol or protocol amendments, or statistical plan, or that they will interpret clinical trial results as we do, and more clinical
trials could be required before we are able to submit applications seeking approval of our drug candidates. To the extent that the results
of the clinical trials are not satisfactory to the FDA or the applicable foreign regulatory authorities for support of a marketing application,
we may be required to expend significant resources, which may not be available to us, to conduct additional clinical trials in support
of potential approval of our drug candidates, including potential confirmatory or Phase 3 registrational trials. Even if regulatory approval
is secured for any of our drug candidates, the terms of such approval may limit the scope and use of our drug candidate, which may also
limit its commercial potential.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our business
and the ability to achieve and maintain profitability will depend on the continued commercialization of Olverembatinib and Lisaftoclax
and the successful development, regulatory approval and commercialization of our drug candidates in key global markets, including Olverembatinib
and Lisaftoclax in the United States and other jurisdictions. We have invested a significant portion of our efforts and financial resources
in expanding the approved indications for Olverembatinib and Lisaftoclax in China, extending regulatory approval of Olverembatinib and
Lisaftoclax to other countries, and the continuing clinical development of our other drug candidates in clinical trials around the world.
The successful clinical development of Olverembatinib and Lisaftoclax in the United States and other jurisdictions and our other drug
candidates will depend on several factors, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">successful
                                            and timely completion of nonclinical and clinical development of our drug candidates and
                                            any future drug candidates, as well as the associated costs, including any unforeseen costs;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                            and maintaining relationships with CROs and clinical sites for the clinical development,
                                            both in the United States and internationally, of our drug candidates and any future drug
                                            candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">timely
                                            submission of application for and receipt of marketing approvals from applicable regulatory
                                            authorities for any drug candidates for which we successfully complete clinical development;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">receipt
                                            of regulatory approvals from the FDA, NMPA and other comparable regulatory authorities for
                                            our drug candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">making
                                            any required post-marketing approval commitments to applicable regulatory authorities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
                                            an efficient and scalable manufacturing process for our drug candidates both in China and
                                            in countries outside of China, including obtaining finished products that are appropriately
                                            packaged for sale;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                            and maintaining commercially viable supply and manufacturing relationships with third parties
                                            that can provide adequate, in both amount and quality, products and services to support clinical
                                            development and meet the market demand for drug candidates that we develop, if approved;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">successful
                                            commercial launch following any marketing approval, including the development of a commercial
                                            infrastructure, whether inhouse or with one or more collaborators;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            continued acceptable safety profile following any marketing approval of our drug candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commercial
                                            acceptance of our drug candidates by patients, the medical community and third-party payors;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying,
                                            assessing and developing new drug candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining,
                                            maintaining and expanding patent protection, trade secret protection and regulatory exclusivity,
                                            in China, the United States and internationally;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">protecting
                                            our rights in our intellectual property portfolio;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">defending
                                            against third-party interference or infringement claims, if any;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">negotiating
                                            favorable terms in any collaboration, licensing or other arrangements that may be necessary
                                            or desirable to develop, test, manufacture or commercialize our drug candidates, including
                                            any rights relating to third- party drug products and therapies used in combination therapies
                                            with our drug candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
                                            coverage and adequate reimbursement by hospitals, government and third-party payors for drug
                                            candidates that we develop;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">addressing
                                            any competing therapies and technological and market developments; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attracting,
                                            hiring and retaining qualified personnel.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If we do
not achieve one or more of these factors in a timely manner or at all, we could experience significant delays in our ability or be unable
to successfully complete the clinical development of our drug candidates or commercialize Olverembatinib and Lisaftoclax in accordance
with the NMPA approval in China, which would materially harm our business and our ability to generate sufficient revenues and cash flows
to continue our operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We may also
experience delays in developing an approvable, sustainable, reproducible and scalable manufacturing process or transferring that process
to commercial partners, which may prevent us from completing our clinical trials or commercializing our drug candidates, including Olverembatinib
and Lisaftoclax in the United States or in other jurisdictions outside of China, on a timely or profitable basis, if at all. If we need
to transfer a portion of our manufacturing process to commercial partners, we are aware of only a limited number of companies on a worldwide
basis who operate manufacturing facilities in which our drug candidates can be manufactured under cGMP regulations. It would take a substantial
period of time for a contract facility that has not been producing small-molecule therapeutics to begin producing such under cGMP. We
cannot be certain that we will be able to contract with any of these companies on acceptable terms, if at all. New manufacturers would
also need to have sufficient rights under applicable intellectual property laws to the method of manufacturing such ingredients.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in the manufacturing process or facilities will require further comparability analysis and approval by the FDA and other relevant regulatory
authorities before implementation, which could delay our clinical trials and drug candidate development, and could require additional
clinical trials, including bridging studies and potential confirmatory or Phase 3 registrational trials, to demonstrate consistent and
continued safety and efficacy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We have not
submitted any new drug application, or NDA, to the FDA for any drug candidate. An NDA or other relevant regulatory filing must include
extensive nonclinical and clinical data and supporting information to establish that the drug candidate is safe and effective for each
desired indication. The NDA or other relevant regulatory filing must also include significant information regarding the chemistry, manufacturing
and controls for the drug product. We cannot be certain that our current or future drug candidates will be successful in clinical trials.
Further, even if they are successful in clinical trials, our drug candidates or any future drug candidates may not receive regulatory
approval. If we do not receive regulatory approvals for current or future drug candidates beyond our NMPA approval for Olverembatinib
and Lisaftoclax, we may not be able to continue our operations. Even if we successfully obtain regulatory approval to market a drug candidate,
our revenue will depend, in part, upon the size of the markets in the territories for which we gain regulatory approval and have commercial
rights, as well as the availability of competitive products and therapies, whether there is sufficient third-party reimbursement and
adoption by physicians.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2024, the U.S. Supreme Court overruled the <i>Chevron </i>doctrine, which gives deference to regulatory agencies&#8217; statutory
interpretations in litigation against federal government agencies, such as the FDA, where the law is ambiguous. This landmark Supreme
Court decision may invite various stakeholders to bring lawsuits against the FDA to challenge longstanding decisions and policies of
the FDA, including the FDA&#8217;s statutory interpretations of market exclusivities and the &#8220;substantial evidence&#8221; requirements
for drug approvals, which could undermine the FDA&#8217;s authority, lead to uncertainty in the industry, and disrupt the FDA&#8217;s
normal operations. Further, changes in the leadership, policies, and funding of FDA and other federal agencies under the current U.S.
administration can have a material impact on FDA&#8217;s operations as well as our manufacturing, clinical and commercial development
plans and timelines.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2025, an executive order was signed asserting greater authority over all federal agencies, including those established by Congress
as independent from direct presidential control. The executive order may lead to delays, if not cancellations, of pending and proposed
regulations at federal agencies and introduces uncertainty as it subjects all significant regulatory actions by the agencies to the President&#8217;s
supervision and control. We cannot predict the impact that such executive order, any future executive orders or legislation implementing
executive orders may have on our business or our results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Aside
from the NMPA approvals that we have obtained to date for Olverembatinib and Lisaftoclax, if clinical trials of our drug candidates fail
to demonstrate safety and efficacy to the satisfaction of the FDA, NMPA or other comparable regulatory authorities or do not otherwise
produce positive results, we may incur additional costs or experience delays in completing, or ultimately be unable to obtain approval
and complete, the commercialization of Olverembatinib and Lisaftoclax in the United States or the development and commercialization of
our other drug candidates.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Before obtaining
regulatory approval for the sale of Olverembatinib and Lisaftoclax in the United States or in other jurisdictions outside of China or
regulatory approval for the sale of other drug candidates, we must conduct extensive clinical trials to demonstrate the safety and efficacy
of our drug candidates in humans. We may experience numerous unexpected events during, or as a result of, clinical trials that could
delay or prevent our ability to receive regulatory approval of or commercialize our drug candidates, including, but not limited to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulators,
                                            or institutional review boards, or IRBs, data safety monitoring boards, or DSMBs, or ethics
                                            committees, or ECs, may not authorize us or our investigators to commence a clinical trial
                                            or conduct a clinical trial at a prospective trial site;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinical
                                            trials of our drug candidates, whether as a monotherapy or a combination therapy, may produce
                                            negative or inconclusive results, and we may decide, or regulators may require us, to conduct
                                            additional clinical trials or abandon drug development programs;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
number of patients required for clinical trials of our drug candidates may be larger than we anticipate, enrollment may be insufficient
or slower than we anticipate, or patients may drop out at a higher rate than we anticipate;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            third-party contractors, including clinical sites and investigators, may fail to comply with
                                            regulatory requirements or meet their contractual obligations to us in a timely manner, or
                                            at all;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            might have to suspend or terminate clinical trials of our drug candidates for various reasons,
                                            including, but not limited to, a finding of a lack of clinical response or a finding that
                                            participants are being exposed to unacceptable health risks;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulators,
                                            IRBs, DSMBs or ECs may require that we or our investigators suspend or terminate clinical
                                            research for various reasons, including noncompliance with regulatory requirements;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            cost of clinical trials of our drug candidates may be greater than we anticipate; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            drug candidates, drugs that may be used in combination with our drug candidates or drug candidates
                                            in the same class as our drug candidates may cause adverse effects, have undesirable side
                                            effects or other unexpected characteristics, causing us or our investigators to suspend or
                                            terminate the trials.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are required to conduct additional clinical trials or other testing of our drug candidates beyond those that we currently contemplate,
if we are unable to successfully complete clinical trials of our drug candidates or other testing, if the results of these trials or
tests are not positive or are only modestly positive or if they raise safety concerns, we may:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            delayed in obtaining regulatory approval for our drug candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                            obtain regulatory approval at all;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
                                            approval for indications that are not as broad as intended;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            the drug removed from the market after obtaining regulatory approval;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            subject to additional post-marketing testing requirements;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            subject to restrictions on how the drug is distributed or used; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            unable to obtain reimbursement for use of the drug.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delays
in testing or approvals may result in increases in our drug development costs. We do not know whether any clinical trials will begin
as planned, will need to be redesigned or will be completed on schedule, or at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Additionally,
as some of our drug candidates represent a novel approach to cancer treatment, they carry inherent development risks that could result
in delays in clinical development, heightened regulatory scrutiny, or delays in our ability to achieve regulatory approval. We may be
required to further develop or modify the protocols related to our drug candidates to demonstrate safety or efficacy, which may delay
clinical programs, regulatory approval or commercialization of our drug candidates, including Olverembatinib and Lisaftoclax in the United
States and other jurisdictions outside of China, if approved. In addition, potential patients and their doctors may be inclined to use
conventional standard-of-care treatments rather than enroll patients in any current or future clinical trial.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
clinical trial delays also could shorten any periods during which we have the exclusive right to commercialize our drug candidates or
allow our competitors to bring drugs to market before we do and impair our ability to commercialize our drug candidates and may harm
our business and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Our
product candidates (including Olverembatinib and Lisaftoclax) may cause or be associated with significant adverse events, toxicities
or other undesirable side effects when used alone or in combination with other approved products or investigational new drugs that may
result in a safety profile that could prevent regulatory approval, prevent market acceptance, limit their commercial potential or result
in significant negative consequences.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our product candidates are associated with undesirable side effects or have unexpected characteristics in preclinical studies or clinical
trials or in post-approval studies when used alone or in combination with other approved products or investigational new drugs we may
need to interrupt, delay or abandon their development or limit development to more narrow uses or subpopulations in which the undesirable
side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective or result in
subsequent regulatory limitations, including black box warnings. Treatment-related side effects or other adverse events, whether treatment
related or not, that may occur while a patient is on the treatment could also affect patient recruitment or the ability of enrolled subjects
to complete the trial or result in potential product liability or other claims. Any of these occurrences may also prevent us from achieving
or maintaining market acceptance of the affected product and may harm our business, financial condition and prospects significantly.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
further significant adverse events or other side effects are observed in any of our current or future clinical trials, we may have difficulty
recruiting patients to the clinical trials, patients may drop out of our trials, we may be unable to enroll a sufficient number of patients
on a timely basis, or we may be required to abandon the trials or our development efforts of that product candidate altogether. We, the
FDA, NMPA, other comparable regulatory authorities or IRBs, DSMBs or ECs may suspend clinical trials of a product candidate at any time
for various reasons, including a belief that subjects in such trials are being exposed to unacceptable health risks or adverse side effects.
Some potential therapeutics developed in the biotechnology industry that initially showed therapeutic promise in early-stage trials have
later been found to cause side effects that prevented their further development. Even if the side effects do not preclude the product
candidate from obtaining or maintaining marketing approval, undesirable side effects may inhibit market acceptance due to its tolerability
versus other therapies. Any of these developments could materially harm our business, financial condition and prospects. Further, if
any of our product candidates obtains marketing approval, toxicities associated with such product candidates previously not seen during
clinical testing may also develop after such approval and lead to a requirement to conduct additional clinical safety trials, additional
contraindications, warnings and precautions being added to the drug label, significant restrictions on the use of the product or the
withdrawal of the product from the market. We cannot predict whether our product candidates will cause toxicities in humans that would
preclude or lead to the revocation of regulatory approval based on preclinical studies or early-stage clinical trials.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
if one or more of our drug candidates receives regulatory approval, and we or others later identify undesirable side effects caused by
such drugs, a number of potentially significant negative consequences could result, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may suspend marketing of the drug;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                            authorities may withdraw approvals or revoke licenses of the drug;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                            authorities may require additional warnings on the label or narrow the proposed indication
                                            for our drug candidate;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may be required to develop a Risk Evaluation and Mitigation Strategy, or REMS, for the drug
                                            or, if a REMS is already in place, to incorporate additional requirements under the REMS,
                                            or to develop a similar strategy as required by a comparable regulatory authority;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may be required to conduct post-market studies;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            could be sued and held liable for harm caused to subjects or patients; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            reputation may suffer.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these events could prevent us from achieving or maintaining market acceptance of the particular drug candidate, if approved, and could
significantly harm our business, results of operations and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Further,
toxicities associated with approved drugs that have not been seen during clinical testing may also develop after such approval and lead
to a requirement to conduct additional clinical safety trials, additional contraindications, warnings and precautions being added to
the drug label, significant restrictions on the use of the drug product or the withdrawal of the drug product from the market. We cannot
predict whether Olverembatinib and Lisaftoclax or our other drug candidates will cause toxicities in humans that would preclude or lead
to the revocation of regulatory approval based on nonclinical studies or early-stage clinical trials.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Many
of our drug candidates are being tested or used by patients who are critically ill, who may be unfit for certain medical interventions
or for whom there are no other treatments or options, which can result in heightened risk of adverse events, including death.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product candidates may be used in populations for which safety concerns may be particularly scrutinized by regulatory agencies. Patients
treated with our product candidates may also be undergoing other treatments, including surgery, radiation, chemotherapy and other regimens,
any of which can individually or together cause side effects or adverse events, including illness, progression of disease and death,
that may not be related to our product candidate but may still impact the success of our clinical trials. Many of our drug candidates
are being tested in or used by patients after having failed or developed intolerance or resistance to other therapies or critically ill
individuals who are unfit for certain medical interventions or for whom there are no other treatments or options are available. The inclusion
of critically ill patients in our clinical trials may result in deaths or other adverse medical events due to other therapies or medications
that such patients may be using or due to the gravity of such patients&#8217; illnesses or weakened condition. Therefore, it is expected
that some of the patients enrolled in our clinical trials or who otherwise receive any approved drugs could die or experience major clinical
events either during or after the course of our clinical trials or receiving treatment, which has occurred in the past.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interim,
initial, top-line and preliminary data from our clinical trials that we announce or publish from time to time may materially change as
more patient data become available and are subject to audit and verification procedures. We may also selectively report data to explore
certain trends that are interesting, but you may not agree with our assessment as to what might be material or appropriate.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may publicly disclose preliminary or top-line data from our preclinical studies and clinical trials, which is based
on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following
a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations
and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate
all data. As a result, the top-line or preliminary results that we report may differ from future results of the same studies, or different
conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Top-line data also
remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary
data we previously published. As a result, top-line data should be viewed with caution until the final data are available.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change
as patient enrollment continues and more patient data become available or as patients from our clinical trials continue other treatments
for their disease. Adverse differences between preliminary or interim data and final data could significantly harm our business prospects.
Further, disclosure of interim data by us or by our competitors could result in volatility in the price of our ADSs representing our
ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses
or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability
or commercialization of the particular drug candidate or drug and our Company in general. In addition, the information we choose to publicly
disclose regarding a particular study or clinical trial is based on what is typically extensive information, and you or others may not
agree with what we determine is material or otherwise appropriate information to include in our disclosure. Hematological malignancies
and  other indications for which we develop drug products are inherently complex and heterogeneous, and the existence of certain mutations
and biomarkers can impact the response rates and risk of adverse events. The pathways that we target can also implicate different diseases
and indications and result in clinical trials where we enroll patients with different diseases. Additionally, these diseases are often
treated with multiple lines of therapies resulting in patient populations with different treatment history and resistance or intolerance
to certain existing drugs or therapies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Therefore,
from time to time, we may also selectively report data for a certain subpopulation of patients that received the study drug in a particular
study, such as patients who received a particular dose or patients who have a specific indication or have specific characteristics such
as a specified mutation, intolerance to certain treatments or other high risk indicators, or combine similar patients across studies.
There is no guarantee that these data cuts will be representative of the indications or subpopulations for which we pursue approval,
and there is risk that such data, being either a smaller subset of patients treated or an amalgamation across multiple studies, and conclusions
and interpretations may not predict future results. If the interim, top-line or other data that we report differ from actual results,
or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize,
our drug candidates may be harmed, which could harm our business, financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Clinical
drug development involves a lengthy and expensive process with uncertain outcomes, and results of earlier studies and trials may not
be predictive of future trial results.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
studies and clinical testing are expensive and can take many years to complete, and its outcome is inherently uncertain. Failure or delay
can occur at any time during the preclinical or clinical trial process. Success in preclinical studies and early clinical trials does
not ensure that later clinical trials will be successful. In some instances, there can be significant variability in safety and/or efficacy
results between different trials of the same drug candidate due to numerous factors, including, but not limited to, changes in trial
procedures set forth in protocols, differences in the size and type of the patient populations, patient adherence to the dosing regimen,
and other trial protocol elements and the rate of dropout among clinical trial participants. In the case of any trials we conduct, results
may differ from earlier trials due to the larger number of clinical trial sites and additional countries and languages involved in such
trials. A number of companies in the biotechnology and pharmaceutical industries have suffered significant setbacks in clinical trials,
even after positive results in earlier preclinical studies or clinical trials.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any potential promising results in earlier studies and trials for any drug candidate, we cannot be certain that we will not face similar
setbacks. In addition, the results of our preclinical animal studies, in vitro or other laboratory testing, may not be predictive of
the results of outcomes in human clinical trials. For example, our drug candidates may demonstrate different chemical, biological, and
pharmacological properties in patients than they do in laboratory studies or may interact with human biological systems in unforeseen
or harmful ways. Drug candidates in clinical trials may fail to show the desired pharmacological properties or safety and efficacy traits
despite having progressed through preclinical studies and initial clinical trials. The failure of clinical trials to demonstrate safety
and efficacy for our desired indications could harm the development of the relevant drug candidate as well as other drug candidates employing
the same technology, which could have a significant impact on our product pipeline and future growth prospects. Even if we are able to
initiate and complete the necessary clinical trials, the results may not be sufficient to obtain regulatory approval for our drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
obtained from preclinical studies and clinical trials are susceptible to varying interpretations, which may delay, limit or prevent regulatory
approval. At each phase of clinical development, we must ask for the appropriate authorization from the relevant authorities in applicable
jurisdictions before we can conduct clinical trials and then present the results of the clinical trials to these authorities. The authorities
may refuse to provide the authorizations necessary for clinical trials or have additional requirements (for example, relating to study
protocols, patient characteristics, treatment durations, post-treatment follow-up, certain differences in interpreting results between
local regulatory agencies), and in some cases may require additional studies. Any refusal or decision by health authorities to require
additional trials or examinations would be likely to result in the discontinuation or delay of the development of the products concerned.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
could also encounter delays if a clinical trial is suspended or terminated by us, by the IRBs, DSMBs or ECs of the institutions in which
such clinical trials are being conducted, by a DSMB for such clinical trial or by the FDA or comparable foreign regulatory authorities.
Clinical trials can be delayed or terminated or fail to meet endpoints for a variety of reasons, including, but not limited to, delays
or failures related to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            FDA or comparable foreign regulatory authorities disagreeing as to the design or implementation
                                            of our clinical trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            FDA or comparable foreign regulatory authorities disagreeing with our clinical development
                                            strategy or statistical plan;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in governmental regulations or administrative actions;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            in our ability to commence a clinical trial;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reaching
                                            agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of
                                            which can be subject to extensive negotiation and may vary significantly among different
                                            CROs and clinical trial sites;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
                                            IRB, DSMB and/or EC approval at each clinical trial site;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recruiting
                                            an adequate number of suitable patients to participate in a clinical trial on a timely basis;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of patients required for clinical trials of our drug candidates may be larger than
                                            we anticipate;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">having
                                            subjects complete a clinical trial or return for post-treatment follow-up;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinical
                                            trial sites deviating from clinical trial protocol or dropping out of a clinical trial;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">protocol
                                            deviations or non-compliance with Good Clinical Practice, or GCP, requirements, or other
                                            data integrity reasons, that cause us or the FDA or other regulatory authorities to exclude
                                            data from non-compliant sites or investigators, which may cause the trial to be underpowered
                                            to meet the endpoints;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            by us or our CROs in qualifying or analyzing patient data at the completion of clinical trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to demonstrate a benefit from using a drug candidate;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">addressing
                                            subject safety concerns that arise during the course of a clinical trial;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adding
                                            a sufficient number of clinical trial sites; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
                                            sufficient supply of drug candidates for use in nonclinical studies or clinical trials from
                                            third-party suppliers.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
conducting clinical trials in foreign countries, as we intend to do for our drug candidates, presents additional risks that may delay
completion of our clinical trials. These risks include, but are not limited to, the failure of enrolled patients in foreign countries
to adhere to clinical protocol as a result of differences in healthcare services or cultural customs, managing additional administrative
burdens associated with foreign regulatory schemes, as well as political and economic risks relevant to such foreign countries.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation
in connection with such services. Under certain circumstances, particularly as we move towards the commercial stage of our drug candidates,
we may be required to report some of these relationships to the FDA, certain national registers or other applicable agencies and comparable
foreign regulatory authorities. The FDA or comparable foreign regulatory authority may conclude that a financial relationship between
us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA or comparable
foreign regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site, and the
utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications
by the FDA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval
of one or more of our drug candidates. If we experience delays in the completion of, or termination of, any clinical trial of our drug
candidates, the commercial prospects of our drug candidates will be harmed, and our ability to generate product revenues from any of
these drug candidates will be delayed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
any delays in completing our clinical trials will increase our costs, slow down our drug candidate development and approval process and
jeopardize our ability to commence product sales and generate revenues.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the results of our current and future clinical trials are inconclusive with respect to the efficacy of our drug candidates, if we do
not meet the clinical endpoints with statistical and clinically meaningful significance, or if there are safety concerns associated with
our drug candidates, we may:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incur
                                            unplanned costs;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            delayed in or prevented from obtaining marketing approval for our drug candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
                                            approval for indications or patient populations that are not as broad as intended or desired;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
                                            approval with labeling that includes significant use or distribution restrictions or safety
                                            warnings including boxed warnings;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            subject to changes in the way the drug candidate is administered;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            required to perform additional clinical trials to support approval or be subject to additional
                                            post-marketing testing requirements;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            regulatory authorities withdraw their approval of the drug product or impose restrictions
                                            on its distribution in the form of a modified REMS;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            subject to the addition of labeling statements, such as warnings or contraindications;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            subject to litigation, investigations, proceedings, or other actions; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">experience
                                            damage to our reputation.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
absence of or delay in therapeutic response could also result in the delay or even discontinuation of the development of our drug candidates.
We cannot guarantee that the development of our drug candidates will ultimately be successful, especially within time frames compatible
with our financial resources or market needs. Any failure or delay in the development of these products would have a material adverse
effect on our business, income, financial condition and outlook.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Many
of our drug candidates are in early stages of clinical trials.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Olverembatinib
and Lisaftoclax are our only drug candidates that have received regulatory approval in any jurisdiction. Each of Olverembatinib and
Lisaftoclax are also in Phase 3 registrational trials for other indications, and we have ongoing clinical trials for Alrizomadlin,
Pelcitoclax, APG-5918, APG-2449, APG-3288, and other product candidates. Regulatory approval generally requires the completion of a
Phase 3 clinical trial to test the safety and efficacy of the drug candidate on a large sample of patients unless an expedited
program or pathway is granted by relevant regulatory authorities. The timeline between a Phase 1 clinical trial and a Phase 3
clinical trial and subsequent filing of an NDA or foreign equivalent can take several years. We will need to commit substantial time
and additional resources to conduct further nonclinical studies and clinical trials before we can submit an NDA or foreign
equivalent with respect to any of our drug candidates. We cannot predict with any certainty if or when we might submit an NDA or
foreign equivalent for regulatory approval for any of our drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be successful in our efforts to identify or discover additional drug candidates. Due to our limited resources and access to capital,
we must, and have in the past decided to prioritize development of certain drug candidates; these decisions may prove to be wrong and
may adversely affect our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future results of operations are dependent on our ability to successfully discover, develop, obtain regulatory approval for and commercialize
drug candidates beyond those we currently have in clinical and nonclinical development. A drug candidate can unexpectedly fail at any
stage of nonclinical and clinical development. The historical failure rate for drug candidates is high due to risks relating to safety,
efficacy, clinical execution, changing standards of medical care, and other unpredictable variables. The results from nonclinical testing
or early clinical trials of a drug candidate may not be predictive of the results that will be obtained in later stage clinical trials
of the drug candidate. If we fail to identify potential drug candidates, our business could be materially harmed. The success of other
future drug candidates we may develop will depend on many factors, including the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">generating
                                            sufficient data to support the initiation or continuation of clinical trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
                                            regulatory permission to initiate clinical trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">contracting
                                            with the necessary parties to conduct clinical trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">successful
                                            enrollment of patients in, and the completion of, clinical trials on a timely basis;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timely manufacture of sufficient quantities of the drug candidate for use in clinical trials;
                                            and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
                                            events in the clinical trials.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
programs to pursue the development of our drug candidates for additional indications and to identify new drug candidates and disease
targets require substantial technical, financial and human resources whether or not we ultimately are successful. Even if we identify
suitable new drug candidates, such drug candidates may not achieve proof of concept in a cost-effective manner or at all. Our research
programs may initially show promise in identifying potential indications and/or drug candidates, yet fail to yield results for clinical
development for a number of reasons, including, but not limited to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            research methodology used may not be successful in identifying potential indications and/or
                                            drug candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                            drug candidates may, after further study, be shown to have harmful adverse effects or other
                                            characteristics that make them unmarketable or unlikely to receive regulatory approval; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            may take greater human and financial resources to identify additional therapeutic opportunities
                                            for our drug candidates or to develop suitable potential drug candidates through internal
                                            research programs than we will possess, thereby limiting our ability to diversify and expand
                                            our drug portfolio.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we have limited financial and managerial resources, we may forego or delay pursuit of opportunities with other drug candidates or for
other indications that later prove to have greater commercial potential or a greater likelihood of success. Decision-making about which
drug candidates or other indications to prioritize involves inherent uncertainty. Our resource allocation decisions may cause us to fail
to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development
programs, therapeutic platforms and drug candidates for specific indications may not yield any commercially viable products. If we do
not accurately evaluate the commercial potential or target market for a particular drug candidate, we may relinquish valuable rights
to that drug candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous
for us to retain sole development and commercialization rights.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
there can be no assurance that we will be able to identify additional therapeutic opportunities for our drug candidates or to develop
suitable potential drug candidates through internal research programs, which could materially adversely affect our future growth and
prospects. We may focus our efforts and resources on potential drug candidates or other potential programs that ultimately prove to be
unsuccessful.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise
adversely affected.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient
number of patients who remain in the trial until its conclusion. We may experience difficulties in patient enrollment in our clinical
trials for a variety of reasons, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            size and nature of the patient population;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            patient eligibility criteria defined in the protocol;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            size of the study population required for analysis of the trial&#8217;s primary endpoints;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            proximity of patients to trial sites;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            design of the trial;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to recruit clinical trial investigators with the appropriate competencies and experience;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competing
                                            clinical trials for similar therapies or other new therapeutics;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinicians&#8217;
                                            and patients&#8217; perceptions as to the potential advantages and side effects of the drug
                                            candidate being studied in relation to other available therapies, including any new drugs
                                            or treatments that may be approved for the indications we are investigating;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to obtain and maintain patient consents;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            risk that patients enrolled in clinical trials will not complete a clinical trial; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            availability of approved therapies that are similar in mechanism to our drug candidates.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
clinical trials will compete with other clinical trials for drug candidates that are in the same therapeutic areas as our drug candidates,
and this competition will reduce the number and types of patients available to us, because some patients who might have opted to enroll
in our trials may instead opt to enroll in a trial being conducted by one of our competitors, or they may fail to meet the enrollment
criteria due to having been on certain treatments previously. Because the number of qualified clinical investigators is limited, we expect
to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number
of patients who are available for our clinical trials at such clinical trial sites. Even if we are able to enroll a sufficient number
of patients in our clinical trials, delays in patient enrollment may result in increased costs or may affect the timing or outcome of
the planned clinical trials, which could prevent completion of these trials and adversely affect our ability to advance the development
of our drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
develop drug candidates in combination with other therapies, which exposes us to additional risks.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
develop drug candidates in combination with one or more other approved or unapproved therapies. Even if any drug candidate we develop
were to receive marketing approval or be commercialized for use in combination with other existing therapies, we would continue to be
subject to the risks that the FDA or comparable foreign regulatory authorities outside of the United States could revoke approval of
the therapy used in combination with our drug product or that safety, efficacy, manufacturing or supply issues could arise with any of
those existing therapies. If the therapies we use in combination with our drug candidates are replaced as the standard of care for the
indications we choose for any of our drug candidates, the FDA or comparable foreign regulatory authorities may require us to conduct
additional clinical trials. The occurrence of any of these risks could result in our own drug products, if approved, being removed from
the market or being less successful commercially.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also may choose to evaluate drug candidates in combination with one or more therapies that have not yet been approved for marketing by
the FDA or comparable foreign regulatory authorities. We will not be able to market and sell any drug candidate we develop in combination
with an unapproved therapy for a combination indication if that unapproved therapy does not ultimately obtain marketing approval either
alone or in combination with our drug product. In addition, unapproved therapies face the same risks described with respect to our drug
candidates currently in development and clinical trials, including the potential for serious adverse effects, delay in their clinical
trials and lack of FDA approval. If the FDA or comparable foreign regulatory authorities do not approve these other drugs or revoke their
approval of, or if safety, efficacy, quality, manufacturing or supply issues arise with, the drugs we choose to evaluate in combination
with our drug candidate we develop, we may be unable to obtain approval of or market such combination therapy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in methods of drug candidate manufacturing or formulation may result in additional costs or delay.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
drug candidates progress through preclinical and clinical trials to marketing approval and commercialization, it is common that various
aspects of the development program, such as manufacturing methods and formulation, are altered along the way in an effort to optimize
yield and manufacturing batch size, minimize costs and achieve consistent quality and results. Such changes carry the risk that they
will not achieve these intended objectives. Any of these changes could cause our drug candidates to perform differently and affect the
results of planned clinical trials or other future clinical trials conducted with the altered materials. This could delay completion
of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical
trial costs, delay approval of our drug candidates and jeopardize our ability to commercialize our drug candidates, if approved, and
generate revenue.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
related to obtaining regulatory approval</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
regulatory approval processes of the FDA, NMPA and other comparable regulatory authorities are lengthy, time consuming and inherently
unpredictable, and if we are ultimately unable to obtain regulatory approval for our drug candidates, our business will be substantially
harmed.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our drug
candidates, including Olverembatinib and Lisaftoclax, and the activities associated with their development and commercialization, including
their research, development, design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising,
promotion, sale, distribution, import and export are subject to comprehensive regulation by the FDA and other regulatory agencies in
the United States and by comparable foreign regulatory authorities. Before we can commercialize and market any of our drug candidates,
we must obtain marketing approval for the desired indication and patient population.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtaining
approval by the FDA and other comparable foreign regulatory authorities is unpredictable, typically takes many years following the commencement
of clinical trials and depends upon numerous factors, including the type, complexity and novelty of the drug candidates involved. In
addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval may change during the course
of a drug candidate&#8217;s clinical development and may vary among jurisdictions, which may cause delays in the approval or the decision
not to approve an application. For example, if the FDA or other regulatory authority requires us to change our study protocol or design,
our clinical trial plans may be delayed. Further, securing regulatory approval also requires the submission of information about the
drug manufacturing process to, and inspection of manufacturing facilities by the relevant regulatory authority. Regulatory authorities
have broad authority in the approval process and may refuse to accept any application or may decide that our data are insufficient for
approval and require additional nonclinical, clinical or other data. Even if we eventually complete clinical testing and receive marketing
approval for our drug candidates, the FDA and other comparable foreign regulatory authorities may approve our drug candidates for a more
limited indication or a narrower patient population than we originally requested or may impose other prescribing limitations or warnings
that limit the drug candidate&#8217;s commercial potential. We have not submitted for, or obtained, marketing approval for any drug candidate
outside of China, and it is possible that none of our drug candidates will ever obtain such regulatory approval. Further, development
of our drug candidates or regulatory approval may be delayed for reasons beyond our control.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We have obtained
NMPA approvals for Olverembatinib for the treatment of adult patients with CML-CP with the T315I mutations, CML-AP with the T315I mutations,
and CML-CP resistant or intolerant to first and second-generation TKIs and for Lisaftoclax for the treatment of adult patients with CLL/SLL
who have previously received at least one systemic therapy including BTK inhibitors. We are authorized to market Olverembatinib and Lisaftoclax
for these approved indications in China. However, in order to market in other regions such as the United States and other jurisdictions,
we must obtain regulatory approvals or clearances in those jurisdictions. None of our other drug candidates have received marketing approval
from any regulatory authority, other than Olverembatinib and Lisaftoclax in China as described above. It is possible that none of our
existing drug candidates or any drug candidates we may discover, in-license or acquire and seek to develop in the future will ever obtain
regulatory approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
drug candidates could fail to receive regulatory approval from the FDA, NMPA or a comparable regulatory authority for many reasons, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            regulatory authority&#8217;s disagreement with the design or implementation of our clinical
                                            trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to demonstrate that a drug candidate is safe and effective for its proposed indication;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            of clinical trial results to meet the level of statistical significance required for approval;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to demonstrate that a drug candidate&#8217;s clinical and other benefits outweigh its safety
                                            risks;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">data
                                            integrity issues related to our clinical trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            regulatory authority&#8217;s disagreement with our interpretation of data from preclinical
                                            studies or clinical trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            insufficiency of data collected from clinical trials of our drug candidates to support the
                                            submission and filing of a NDA or other submission to obtain regulatory approval;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            FDA, NMPA or comparable regulatory authority&#8217;s finding of deficiencies related to the
                                            manufacturing processes or facilities of third-party manufacturers with whom we contract
                                            for clinical and commercial supplies; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in approval policies or regulations that render our preclinical and clinical data insufficient
                                            for approval.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA, NMPA or a comparable regulatory authority may require more information, including additional preclinical or clinical data, to support
approval, which may delay or prevent approval and our commercialization plans, or we may decide to abandon the development program. If
we were to obtain approval, regulatory authorities may approve any of our drug candidates for fewer or more limited indications than
we request, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a drug candidate
with a label that is not desirable for the successful commercialization of that drug candidate. In addition, if our drug candidate produces
undesirable side effects or safety issues, the FDA may approve any of our drug candidates for fewer or more limited indications than
we request, may impose significant limitations in the form of narrow indications, warnings or a REMS. Regulatory authorities may not
approve the price we intend to charge for drug products we may develop, may grant approval contingent on the performance of costly post-marketing
clinical trials, or may approve a drug candidate with a label that does not include the labeling claims necessary or desirable for the
successful commercialization of that drug candidate, or restrict distribution of our drug candidates and impose burdensome implementation
requirements on us. Any of the foregoing scenarios could materially harm the commercial prospects of our drug candidates. Of the large
number of drugs in development, only a small percentage successfully complete the FDA or comparable foreign regulatory approval processes
and are commercialized. The lengthy approval processes as well as the unpredictability of future clinical trial results may result in
our failing to obtain regulatory approval to market our drug candidates, which would significantly harm our business, results of operations
and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
FDA, NMPA and other comparable foreign regulatory authorities may not accept data from trials conducted in locations outside of their
jurisdiction.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acceptance of study data by the FDA, NMPA or other comparable foreign regulatory authority from clinical trials conducted outside of
their respective jurisdictions may be subject to certain conditions. In cases where data from United States clinical trials are intended
to serve as the basis for marketing approval in the foreign countries outside the United States or vice versa, the standards for clinical
trials and approval may be different. There can be no assurance that any United States or foreign regulatory authority would accept data
from trials conducted outside of its applicable jurisdiction. If the FDA, NMPA or any applicable foreign regulatory authority does not
accept such data, there is a risk it would result in the need for additional trials, which would be costly and time-consuming and delay
aspects of our business plan, and which may result in our drug candidates not receiving approval or clearance for commercialization in
the applicable jurisdiction.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncertainty
in the regulatory framework could also result in disruption to the supply and distribution as well as the import/export both of active
pharmaceutical ingredients and finished product. Such a disruption could create supply difficulties for ongoing clinical trials. The
cumulative effects of the disruption to the regulatory framework, uncertainty in future regulation, and changes to existing regulations
may increase our development lead time to marketing authorization and commercialization of products in the United States and/or other
jurisdictions and increase our costs. We cannot predict the impact of such changes and future regulation on our business or the results
of our operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to obtain NMPA approval for our drug candidates to be eligible for an expedited registration pathway as Category 1 drug
candidates, the time and cost we incur to obtain regulatory approvals may increase. Even if we receive such Category 1 designation, it
may not lead to a faster development, review or approval process.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NMPA categorizes domestically manufactured innovative drug applications as Category 1, provided such drug has a new and clearly
defined structure, pharmacological property and apparent clinical value and has not been marketed anywhere in the world.
Domestically developed and manufactured innovative drugs will be attributed to Category 1 for their clinical trial application, or
CTA, and NDA applications. While some multinational pharmaceutical companies may file CTAs with the NMPA prior to approval of a drug
in another country in order to take advantage of Category 1 classification, such drug will most likely be assigned to Category 5 for
NDA approval purposes because, based on historical observations, multinational pharmaceutical companies will typically not
prioritize applying for local manufacturing rights in China, hence subjecting the drug to the imported drug status. The imported
drug registration pathway is more complex and is evolving. Imported drug registration applications in China may only be submitted
after a drug has obtained an NDA approval and received the Certificate of Pharmaceutical Product granted by a major drug regulatory
authority, such as the FDA. A Category 1 designation by the NMPA may not be granted for any of our drug candidates or may not lead
to faster development or regulatory review or approval process. Moreover, a Category 1 designation does not increase the likelihood
that our drug candidates will receive regulatory approval. Further, there have been recent regulatory initiatives in China regarding
clinical trial approvals, the evaluation and approval of certain drugs and medical devices and the simplification and acceleration
of the clinical trial process. For more information, see &#8220;<i>Item 4. Information on the Company&#8212;B. Business
Overview&#8212;Government regulation&#8212;PRC regulation</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
regulatory environment in China has substantially changed in recent years and may change further in the future in unpredictable ways.
Any future policies, or changes to current policies, that NMPA approves might require us to change our planned clinical study design
or otherwise spend additional resources and effort to obtain approval of our drug candidates. In addition, policy changes may contain
significant limitations related to use restrictions for certain age groups, warnings, precautions, or contraindications, or may be subject
to burdensome post-approval study or risk management requirements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Where
appropriate, we plan to pursue approval from the FDA or comparable foreign regulatory authorities through the use of accelerated registration
pathways. If we are unable to obtain such approval, we may be required to conduct additional preclinical studies or clinical trials beyond
those that we contemplate, which could increase the expense of obtaining, and delay the receipt of, necessary marketing approvals. Even
if we receive accelerated approval from the FDA, if our confirmatory trials do not verify clinical benefit, or if we do not comply with
post-marketing requirements or commitments, the FDA may seek to withdraw accelerated approval.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
possible, we plan to pursue accelerated development strategies in areas of high unmet need. We may seek an accelerated approval pathway
for one or more of our drug candidates. Under the accelerated approval provisions in the Federal Food, Drug, and Cosmetic Act of 1938,
or FDCA, and the FDA&#8217;s implementing regulations, the FDA may grant accelerated approval to a drug candidate designed to treat a
serious or life-threatening condition that provides meaningful therapeutic benefit over available therapies upon a determination that
the drug candidate has an effect on a surrogate endpoint or intermediate clinical endpoint that is reasonably likely to predict clinical
benefit. The Food and Drug Omnibus Reform Act made several changes to the FDA&#8217;s authorities and its regulatory framework, including,
among other changes, reforms to the accelerated approval pathway, such as requiring the FDA to specify conditions for post-approval study
requirements and setting forth procedures for the FDA to withdraw a product on an expedited basis for non-compliance with post-approval
requirements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA considers a clinical benefit to be a positive therapeutic effect that is clinically meaningful in the context of a given disease,
such as irreversible morbidity or mortality. For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory
measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit but is not itself a measure
of clinical benefit. An intermediate clinical endpoint is a clinical endpoint that can be measured earlier than an effect on irreversible
morbidity or mortality that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit.
The accelerated approval pathway may be used in cases in which the advantage of a new drug over available therapy may not be a direct
therapeutic advantage but is a clinically important improvement from a patient and public health perspective. If granted, accelerated
approval is usually contingent on the sponsor&#8217;s agreement to conduct, in a diligent manner, additional post-approval confirmatory
studies to verify and describe the drug&#8217;s clinical benefit. If such post-approval studies fail to confirm the drug&#8217;s clinical
benefit, the FDA may withdraw its approval of the drug.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to seeking such accelerated approval, we will seek feedback from the FDA and will otherwise evaluate our ability to seek and receive
such accelerated approval. There can be no assurance that after our evaluation of the feedback and other factors we will decide to pursue
or submit an NDA for accelerated approval or any other form of expedited development, review or approval. Similarly, there can be no
assurance that after subsequent FDA feedback we will continue to pursue or apply for accelerated approval or any other form of expedited
development, review or approval, even if we initially decide to do so. Furthermore, if we decide to submit an application for accelerated
approval or under another expedited regulatory designation (e.g., breakthrough therapy designation), there can be no assurance that such
submission or application will be accepted or that any expedited development, review or approval will be granted on a timely basis, or
at all. The FDA or other comparable foreign regulatory authorities could also require us to conduct further studies prior to considering
our application or granting approval of any type. A failure to obtain accelerated approval or any other form of expedited development,
review or approval for our drug candidate would result in a longer time period to commercialization of such drug candidate, could increase
the cost of development of such drug candidate and could harm our competitive position in the marketplace.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
Fast Track designation by the FDA, even if granted for any of our drug candidates, may not lead to a faster development or regulatory
review or approval process, and does not increase the likelihood that our drug candidates will receive regulatory approval.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Olverembatinib
has been granted Fast Track designation from the FDA for the treatment of CML in patients with certain genetic markers who have failed
to respond to treatments with existing TKIs. In the United States, Fast Track designation is designed to facilitate the development and
expedite the review of therapies for serious conditions and fill an unmet medical need. Programs with Fast Track designation may benefit
from early and frequent communications with the FDA, potential priority review and the ability to submit a rolling application for regulatory
review. Fast Track designation applies to both the drug candidate and the specific indication for which it is being studied. If any of
our drug candidates receive Fast Track designation but do not continue to meet the criteria for Fast Track designation, or if our clinical
trials are delayed, suspended or terminated, or put on clinical hold due to unexpected adverse events or issues with clinical supply,
we will not receive the benefits associated with the Fast Track program. Furthermore, Fast Track designation does not change the standards
for approval. Fast Track designation alone does not guarantee qualification for the FDA&#8217;s priority review procedures.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>To
the extent we obtain orphan drug designation, rare pediatric disease and/or Fast Track designation, we may not be able to maintain or
take advantage of all the benefits associated with such designations for our drug candidates. Further, orphan drug exclusivity may not
prevent the FDA, NMPA or other comparable foreign regulatory authorities from approving competing products.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
authorities in some jurisdictions, including the United States and the European Union, may designate drugs for relatively small patient
populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat
a rare disease or condition, which is generally defined as a disease with a patient population of fewer than 200,000 individuals in the
United States, or that affects more than 200,000 individuals in the United States and for which there is no reasonable expectation that
costs of research and development of the product for the indication can be recovered by sales of the product in the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Generally,
if a drug with an orphan drug designation subsequently receives the first regulatory approval for the indication for which it has such
designation, the drug is entitled to a period of marketing exclusivity, which precludes the FDA or NMPA from approving another marketing
application for the same drug for the same indication during the period of exclusivity. The applicable period is seven years in the United
States and 10 years in the European Union. The European Union exclusivity period can be reduced to six years if a drug no longer meets
the criteria for orphan drug designation or if the drug is sufficiently profitable so that market exclusivity is no longer justified.
Orphan drug exclusivity may be lost if the FDA or NMPA determines that the request for designation was materially defective or if the
manufacturer is unable to assure sufficient quantity of the drug to meet the needs of patients with the rare disease or condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In particular, Olverembatinib was granted orphan drug designation by
FDA for the treatment of CML, acute myeloid leukemia, or AML, acute lymphocytic leukemia, or ALL, and gastrointestinal stromal tumor,
or GIST, and a Fast-Track Designation for the treatment of CML in patients with certain genetic markers who have failed to respond to
treatments with existing TKIs. Lisaftoclax was granted orphan drug designation for the treatment of myelodysplastic syndrome Such designations
may not effectively protect the drug candidate from competition because different drugs can be approved for the same condition and the
same drugs can be approved for a different condition but used off-label for any orphan indication we may obtain. Even after an orphan
drug is approved, the FDA can subsequently approve a drug that is otherwise the same drug for the same condition if the FDA concludes
that the later drug is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In response to the court decision in <i>Catalyst
Pharms., Inc. v. Becerra</i>, 14 F.4th 1299 (11th Cir. 2021), in January 2023, Congress, in an amendment to the Orphan Drug Act in
the Consolidated Appropriations Act of 2026 or CAA, clarified that orphan drug exclusivity applies to the FDA&#8217;s same approved
use or indication within a rare disease, rather than the entire rare disease or condition. The change abrogated the decision in <i>Catalyst
v. Becerra</i> and aligns the statutory text with the FDA&#8217;s longstanding interpretation. This change makes explicit that
orphan drug exclusivity blocks approval of the same drug only for the same approved use or indication, not for all uses within the
broader designated disease. The amendment also applied retroactively. It is unclear how future litigation, legislation, agency
decisions, and administrative actions will impact the scope of the orphan drug exclusivity. Orphan drug designation neither shortens
the development time or regulatory review time of a drug nor gives the drug candidate any advantage in the regulatory review or
approval process or entitles the drug candidate to priority review.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the rare pediatric disease designation and priority review voucher, or PRV, program, a sponsor that receives an approval for a drug product
for a rare pediatric disease may qualify for a voucher that can be redeemed to receive priority review for a different product. The sponsor
may transfer or sell the voucher to another sponsor. FDA awards rare pediatric disease PRVs to sponsors of rare pediatric disease products
that are approved and meet certain criteria. The PRV program was previously subject to a sunset period by which eligibility to receive
a voucher was limited to products that received rare pediatric disease designation by December 20, 2024. However, as of February 3, 2026,
the enactment of the CAA has allowed the program to resume and reauthorizes designations until September 30, 2029. To date, we have received
rare pediatric disease designation for at least one of our drug candidates but not an approval, and changes to the rare pediatric disease
program can impact our ability to realize the full benefits of the designation.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if one or more of our product candidates receive Fast Track designation, we may be unable to obtain or maintain the benefits associated
with the Fast Track designation. Fast Track designation is designed to facilitate the development and expedite the review of therapies
for serious conditions and fill an unmet medical need. Programs with Fast Track designation may benefit from early and frequent communications
with the FDA, potential priority review and the ability to submit a rolling application for regulatory review. Fast Track designation
applies to both the product candidate and the specific indication for which it is being studied. If any of our product candidates receive
Fast Track designation but do not continue to meet the criteria for Fast Track designation, or if our clinical trials are delayed, suspended
or terminated, or put on clinical hold due to unexpected adverse events or issues with clinical supply, we will not receive the benefits
associated with the Fast Track program. Furthermore, Fast Track designation does not change the standards for approval. Fast Track designation
alone does not guarantee qualification for the FDA&#8217;s priority review procedures.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Regulatory
approval may be substantially delayed or may not be obtained for our drug candidates (including Olverembatinib and Lisaftoclax outside
of China) if regulatory authorities require additional time or studies to assess the safety and efficacy of our drug candidates.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
regulatory authorities require additional time or studies to assess the safety or efficacy of our drug candidates, we may not have or
be able to obtain adequate funding to complete the necessary steps for approval for any or all of our drug candidates. Preclinical studies
and clinical trials required to demonstrate the safety and efficacy of our drug candidates are time consuming and expensive and together
take several years or more to complete. Delays in regulatory approvals or rejections of applications for regulatory approval in the United
States, the PRC or other markets may result from many factors, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                            requests for additional analyses, reports, data, nonclinical studies and clinical trials;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><!-- Field: Split-Segment; Name: 1 --><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                            questions regarding interpretations of data and results and the emergence of new information
                                            regarding our drug candidates or other products;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinical
                                            holds, or partial clinical holds, other regulatory objections to commencing or continuing
                                            a clinical trial or the inability to obtain regulatory approval to commence a clinical trial
                                            in countries that require such approvals;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to reach agreement with the FDA, NMPA or other regulators regarding the scope or design of
                                            our clinical trials;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay
                                            or failure in obtaining authorization to commence a trial or inability to comply with conditions
                                            imposed by a regulatory authority regarding the scope or design of a clinical trial;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            inability to enroll a sufficient number of patients who meet the inclusion and exclusion
                                            criteria in a clinical trial;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            inability to conduct a clinical trial in accordance with regulatory requirements or our clinical
                                            trial protocols;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinical
                                            sites and investigators deviating from a trial protocol, failing to conduct the trial in
                                            accordance with regulatory requirements, or dropping out of a trial;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            of our third-party CROs to satisfy their contractual duties or regulatory requirements or
                                            meet expected deadlines;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay
                                            or failure in adding new clinical trial sites;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ambiguous
                                            or negative interim results, or results that are inconsistent with earlier results;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unfavorable
                                            or inconclusive results of clinical trials and supportive nonclinical studies, including
                                            unfavorable results regarding effectiveness of drug candidates during clinical trials;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">feedback
                                            from the FDA, NMPA, an IRB, DSMB, EC or comparable entities, or results from earlier stage
                                            or concurrent preclinical studies and clinical trials, that might require modification to
                                            the protocol;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unacceptable
                                            risk-benefit profile or unforeseen safety issues or adverse side effects;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">decision
                                            by the FDA, NMPA, an IRB, DSMB, EC or comparable entities, or us to suspend or terminate
                                            clinical trials at any time for safety issues or for any other reason;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to demonstrate a benefit from using a drug candidate;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            inability to obtain approval from IRBs, DSMBs, or ECs to conduct clinical trials at their
                                            respective sites;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">manufacturing
                                            issues, including problems with manufacturing or timely obtaining from third parties sufficient
                                            quantities of a drug candidate for use in a clinical trial; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
                                            in maintaining contact with patients after treatment, resulting in incomplete data.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in regulatory requirements and guidance may also occur, and we may need to amend clinical trial protocols submitted to applicable regulatory
authorities to reflect these changes. Amendments may require us to resubmit clinical trial protocols to IRBs, DSMBs, or ECs for re-examination,
which may impact the costs, timing or successful completion of a clinical trial.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are required to conduct additional clinical trials or other studies with respect to any of our drug candidates beyond those that we
initially contemplated, if we are unable to successfully complete our clinical trials or other studies or if the results of these studies
are not positive or are only modestly positive, we may be delayed in obtaining regulatory approval for that drug candidate, we may not
be able to obtain regulatory approval at all or we may obtain approval for indications that are not as broad as intended. Our drug development
costs will also increase if we experience delays in testing or approvals, and we may not have sufficient funding to complete the testing
and approval process. Significant clinical trial delays could allow our competitors to bring drugs to market before we do and impair
our ability to commercialize our drug candidates, if and when approved. If any of this occurs, our business will be materially harmed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Obtaining
and maintaining regulatory approval of our drug candidates in one jurisdiction does not mean that we will be successful in obtaining
regulatory approval of our drug candidates in other jurisdictions.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtaining
and maintaining regulatory approval of our drug candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain
regulatory approval in any other jurisdiction. For example, even if the FDA grants marketing approval of a drug candidate, comparable
regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing and promotion and reimbursement of the
drug candidate in those countries. However, a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative
effect on the regulatory approval process in others. Approval procedures vary among jurisdictions and can involve requirements and administrative
review periods different from those in the United States, including additional nonclinical studies or clinical trials as clinical trials
conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the
United States, a drug candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases,
the price that we intend to charge for our drug products is also subject to approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also submit marketing applications in other countries. Regulatory authorities in jurisdictions outside of the United States have
requirements for approval of drug candidates with which we must comply prior to marketing in those jurisdictions. Obtaining foreign regulatory
approvals and establishing and maintaining compliance with foreign regulatory requirements could result in significant delays, difficulties
and costs for us and could delay or prevent the introduction of our drug products in certain countries. If we or any future collaborator
fail to comply with the regulatory requirements in international markets or fail to receive applicable marketing approvals, our target
market will be reduced and our ability to realize the full market potential of our potential drug candidates will be harmed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Disruptions
at the FDA, the SEC and other government agencies caused by funding shortages, layoffs, changes in regulations or policies or global
health concerns could hinder their ability to hire and retain key leadership and other personnel, or otherwise prevent new or modified
products from being developed, approved or commercialized in a timely manner or at all, or otherwise prevent those agencies from performing
normal business functions on which the operation of our business may rely, which could negatively impact our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the FDA to review and approve new products or other regulatory filings can be affected by a variety of factors, including
government budget and funding levels, government shutdowns, significant layoffs or turnovers, ability to hire and retain key personnel
and accept the payment of user fees, and statutory, regulatory, and policy changes, and other events that may otherwise affect the FDA&#8217;s
ability to perform routine functions. Average review times at the agency have fluctuated in recent years as a result. Layoffs in 2025
at several U.S. health agencies, including the FDA, the Department of Health and Human Services, the Centers for Disease Control and
Prevention and the National Institutes of Health, have impacted the FDA&#8217;s ability to review and approve new medicines and conduct
necessary inspections. Over the last several years, the U.S. government has shut down several times and certain regulatory agencies,
such as the FDA and SEC, have had to furlough employees and experience substantial funding cuts and pause or delay critical activities.
In addition, government funding of the FDA, SEC, and other government agencies on which our operations may rely, including those that
fund research and development activities is subject to the political process, which is inherently fluid and unpredictable, and spending
allocation priorities may undergo significant changes through congressional budgeting and appropriations processes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent the FDA&#8217;s normal operations are disrupted or delayed, for example due to travel restrictions, public health or geopolitical
issues, staffing shortages, layoffs or lack of funding, the FDA may not be able to complete the necessary inspections or provide feedback
in a timely manner during our clinical development or review period. If any such delays or disruptions were to occur, it could significantly
impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could have
a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets
and obtain necessary capital in order to properly capitalize and continue our operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Even
if we receive regulatory approval for our drug candidates, we will be subject to ongoing regulatory obligations and continued regulatory
review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements
or experience unanticipated problems with our drug candidates.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our drug candidates are approved, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage,
advertising, promotion, sampling, record-keeping, conduct of post-marketing studies and submission of safety, efficacy and other post-market
information, including both federal and state requirements in the United States and requirements of comparable regulatory authorities
in China and other jurisdictions. Manufacturers and manufacturers&#8217; facilities are required to comply with extensive FDA, NMPA and
comparable regulatory authority requirements, including, in the United States, ensuring that quality control and manufacturing procedures
conform to cGMP regulations. As such, we and our contract manufacturers will be subject to continual review and inspections to assess
compliance with cGMP and adherence to commitments made in any NDA, other marketing application, and previous responses to any inspection
observations. Accordingly, we and others with whom we work must continue to expend time, money and effort in all areas of regulatory
compliance, including manufacturing, production and quality control.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
regulatory approvals that we receive for our drug candidates may be subject to limitations on the approved indicated uses for which the
drug may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including
Phase 4 clinical trials and surveillance to monitor the safety and efficacy of the drug. The FDA may also require a REMS program as a
condition of approval of our drug candidates, which could entail requirements for long-term patient follow-up, a medication guide, physician
communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other
risk minimization tools. In addition, if the FDA, NMPA or a comparable regulatory authority approves our drug candidates, we will have
to comply with requirements including, for example, submissions of safety and other post-marketing information and reports, registration,
as well as continued compliance with cGMP and GCP for any clinical trials that we conduct post-approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA may seek to impose a consent decree or withdraw marketing approval if compliance with regulatory requirements is not maintained or
if problems occur after the drug reaches the market. Later discovery of previously unknown problems with our drug candidates, including
adverse events, or AEs, of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or
failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition
of post-market studies or clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions
under a REMS program. Other potential consequences include, among other things:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
                                            on the marketing or manufacturing of our drug candidates, withdrawal of the product from
                                            the market or voluntary product recalls;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines,
                                            untitled or warning letters or holds on clinical trials;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
                                            by the FDA to approve pending applications or supplements to approved applications submitted
                                            by us or withdrawal of approvals;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
                                            seizure or detention, or refusal to permit the import or export of our drug candidates; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">injunctions
                                            or the imposition of civil or criminal penalties.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA strictly regulates marketing, labeling, advertising, and promotion of products that are placed on the market. Drugs may be promoted
only for their approved indications and for use in accordance with the provisions of the approved label. The FDA, NMPA and other regulatory
authorities actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have
improperly promoted off-label uses may be subject to significant liability. The policies of the FDA, NMPA and of other regulatory authorities
may change, and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our drug candidates.
We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative
action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption
of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any regulatory approval that we
may have obtained and we may not achieve or sustain profitability.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we were able to obtain accelerated approval of any of our drug candidates, the FDA would require us to conduct a confirmatory
study to verify the predicted clinical benefit and additional safety studies. Other comparable regulatory authorities outside the United
States, such as the NMPA, may have similar requirements. The results from the confirmatory study may not support the clinical benefit,
which would result in the approval being withdrawn. While operating under accelerated approval, we will be subject to certain restrictions
that we would not be subject to upon receiving regular approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
our research operations and manufacturing facilities are in the PRC. The pharmaceutical industry in the PRC is subject to comprehensive
government regulation and supervision, encompassing the approval, registration, manufacturing, packaging, licensing and marketing of
new drugs. See &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Government regulation&#8212;PRC regulation</i>&#8221;
for a discussion of regulatory requirements that are applicable to our current and planned business activities in the PRC. In recent
years, the regulatory framework in the PRC regarding the pharmaceutical industry has undergone significant changes, and we expect that
it will continue to undergo significant changes. Any such changes or amendments may result in increased compliance costs on our business
or cause delays in or prevent the successful development or commercialization of our drug candidates in the PRC and reduce the current
benefits we believe are available to us from developing and manufacturing drugs in the PRC. Chinese authorities have become increasingly
vigilant in enforcing laws in the pharmaceutical industry and any failure by us or our partners to maintain compliance with applicable
laws and regulations or obtain and maintain required licenses and permits may result in the suspension or termination of our business
activities in the PRC. We believe our strategy and approach is aligned with the Chinese government&#8217;s policies, but we cannot ensure
that our strategy and approach will continue to be aligned.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
related to commercialization</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>We
are substantially dependent on the commercial success of Olverembatinib and Lisaftoclax. If we are unable to maintain or increase sales
of Olverembatinib and Lisaftoclax, our ability to generate revenue and our financial condition will be adversely affected.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We are substantially
dependent on the commercial success of Olverembatinib and Lisaftoclax, our only products approved for sale in China. Sales of Olverembatinib
and Lisaftoclax in China accounted for substantially all of our revenues for the years ended December 31, 2024 and 2023, and although
a substantial portion of our revenue for the year ended December 31, 2024 was related to intellectual property income and option payment
received from Takeda under the Takeda Exclusive Option Agreement (as defined below), we expect our revenues to continue to be driven
primarily by sales of Olverembatinib and Lisaftoclax in the near term. Our ability to successfully market Olverembatinib and Lisaftoclax
and our other current and future drug candidates depends on numerous factors, including but not limited to those described elsewhere
in this section, some of which are beyond our control. If we are unable to obtain regulatory approval for Olverembatinib and Lisaftoclax
in the United States, or if we are unable to continue to commercialize Olverembatinib and Lisaftoclax successfully in China or commercialize
our other current and future drug candidates or are unable to obtain a distributor or partner to commercialize them, we may generate
substantially less revenue or may not be able to generate any revenue. This would result in an adverse effect on our business, financial
condition, results of operations and growth prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>If
we are not able to obtain, or experience delays in obtaining, required regulatory approvals for our drug candidates (including Olverembatinib
and Lisaftoclax outside of China), we will not be able to commercialize our drug candidates in the markets that we desire, and our ability
to generate revenue will be materially impaired.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We became
a commercial-stage company in 2021 upon commercialization of Olverembatinib and Lisaftoclax in China. We have not received regulatory
approval to market Olverembatinib and Lisaftoclax in the United States or any market outside of China and, other than Olverembatinib
and Lisaftoclax, do not have any drug candidates that have gained regulatory approval for sale in the United States, the PRC or any other
country, and we cannot guarantee that we will ever have internally developed drugs approved for commercialization outside of China. Our
business is substantially dependent on our ability to complete the development of, obtain regulatory approval for and successfully commercialize
our drug candidates in a timely manner. We cannot commercialize any products or drug candidates without first obtaining regulatory approval
to market each drug from the FDA, NMPA and/or comparable regulatory authorities. We are currently conducting Phase 3 registrational trials
for Olverembatinib and Lisaftoclax in the United States and in other countries outside of China, and certain of our other drug candidates
are also currently undergoing clinical trials. We cannot predict whether these trials and future trials will be successful or whether
regulators will agree with our conclusions regarding the preclinical studies and clinical trials we have conducted to date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
obtaining regulatory approvals for the commercial sale of any drug candidate for a target indication, we must demonstrate in preclinical
studies and well-controlled clinical trials, and, with respect to approval in the United States, to the satisfaction of the FDA, that
the drug candidate is safe and effective for use for that target indication and that the manufacturing facilities, processes and controls
are adequate. Regulatory authorities outside of the United States, such as the NMPA, also have requirements for approval of drugs for
commercial sale with which we must comply prior to marketing in those areas. Regulatory requirements can vary widely from country to
country and could delay or prevent the introduction of our drug candidates. Clinical trials conducted in one country may not be accepted
by regulatory authorities in other countries, and obtaining regulatory approval in one country does not mean that regulatory approval
will be obtained in any other country. Approval processes vary among countries and can involve additional product testing and validation
and additional administrative review periods. Seeking non-U.S. regulatory approval could require additional nonclinical studies or clinical
trials, which could be costly and time consuming. The non-U.S. regulatory approval process may include all of the risks associated with
obtaining FDA approval. For all of these reasons, we may not obtain non-U.S. regulatory approvals on a timely basis, if at all. For details
of requirements to obtain regulatory approvals in the PRC or the United States, please see the section titled &#8220;<i>Item 4. Information
on the Company&#8212;B. Business Overview&#8212;Government regulation.</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The process
to develop, obtain regulatory approval for and commercialize drug candidates is long, complex and costly both inside and outside the
United States and the PRC, and approval is never guaranteed. Even if Olverembatinib and Lisaftoclax and our other drug candidates were
to successfully obtain approval from the relevant regulatory authorities, any approval might significantly limit the approved indications
for use, or require that precautions, contraindications or warnings be included on the product labeling, or require expensive and time-consuming
post- approval clinical trials or surveillance as conditions of approval. Following any approval for commercial sale of our drug candidates,
certain changes to the drug, such as changes in manufacturing processes and additional labeling claims, may be subject to additional
review and approval by the FDA, NMPA and comparable regulatory authorities. Also, regulatory approval for any of our drug candidates
may be withdrawn. If we are unable to obtain regulatory approval for our drug candidates in one or more jurisdictions, or any approval
contains significant limitations, our target market will be reduced and our ability to realize the full market potential of our drug
candidates will be harmed. Furthermore, we may not be able to obtain sufficient funding or generate sufficient revenue and cash flows
to continue the development of any other drug candidate in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have and may continue to license commercialization or other rights and pursue other forms of collaboration worldwide, which can expose
us to additional risks of conducting business in additional international markets.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-U.S.
markets are an important component of our growth strategy. We intend to focus on additional opportunities in the PRC, in particular, but
may also pursue partnerships in other geographies. Our ability to enter into partnerships will depend in large part on whether we are
able to successfully demonstrate that our small-molecule drug candidates are attractive novel therapies for cancer. If we fail to obtain
licenses or enter into collaboration arrangements with third parties in these markets, or if these parties are not successful, our revenue-generating
growth potential will be adversely affected. Moreover, international business relationships subject us to additional risks that may materially
adversely affect our ability to attain or sustain profitable operations, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">efforts
                                            to enter into collaboration or licensing arrangements with third parties in connection with
                                            our international sales, marketing and distribution efforts may increase our expenses or
                                            divert our management&#8217;s attention from the acquisition or development of drug candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in a specific country&#8217;s or region&#8217;s political and cultural climate or economic
                                            condition;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">differing
                                            regulatory requirements for drug approvals and marketing internationally;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
                                            of effective enforcement of contractual provisions in local jurisdictions;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially
                                            reduced protection for intellectual property rights;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                            third-party patent rights;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unexpected
                                            changes in tariffs, trade barriers and regulatory requirements;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">economic
                                            weakness, including inflation or political instability, particularly in non-U.S. economies
                                            and markets;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
                                            with tax, employment, immigration and labor laws for employees traveling abroad;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            effects of applicable non-U.S. tax structures and potentially adverse tax consequences;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency
                                            fluctuations, which could result in increased operating expenses and reduced revenue, and
                                            other obligations incidental to doing business in another country;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">workforce
                                            uncertainty and labor unrest, particularly in non-U.S. countries where labor unrest is more
                                            common than in the United States;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            potential for so-called parallel importing, which is what happens when a local seller, faced
                                            with high or higher local prices, opts to import goods from a non-U.S. market with low or
                                            lower prices rather than buying them locally;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            of our employees, agents, representatives, business partners and third-party intermediaries
                                            to comply with the rules and regulations of the U.S. Treasury Department&#8217;s Office of
                                            Foreign Assets Control, or OFAC, and the Foreign Corrupt Practices Act of 1977, or the FCPA;</span></td>
</tr></table><div>



</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">production
                                            shortages resulting from any events affecting raw material supply or manufacturing capabilities
                                            abroad; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">business
                                            interruptions such as physical damage to our facilities and those of our third-party service
                                            providers, loss or spoilage of inventory, power outages, telecommunications, transportation
                                            or other infrastructure failure, cybersecurity incidents and other business interruptions
                                            resulting from geopolitical events, including war and terrorism, or natural and man-made
                                            disasters, including earthquakes, volcanoes, typhoons, floods, hurricanes, fires, drought,
                                            extreme heat, blizzards and other extreme weather conditions.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
and other risks may materially adversely affect our ability to attain or sustain revenue from international markets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have limited commercialization experience, and we may lack the necessary expertise, personnel and resources to successfully commercialize
any of our other products that receive regulatory approval on our own or together with collaborators.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We have limited
experience as a commercial organization, and we have no commercialization experience in the United States. Although we have commercialized
Olverembatinib and Lisaftoclax in China, we may lack the necessary expertise, personnel and resources to successfully commercialize Olverembatinib
and Lisaftoclax in the United States or any other key global markets, and we may not be successful in commercializing any of our other
products that receive regulatory approval on our own or together with collaborators, if at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors
that may affect our ability to commercialize any of our drug candidates on our own include, but are not limited to, recruiting and retaining
adequate numbers of effective sales and marketing personnel, obtaining access to or persuading adequate numbers of physicians to prescribe
our drug candidates and other unforeseen costs associated with expanding our sales and marketing organization outside of China. Developing
a sales and marketing organization in a new market requires significant investment, is time-consuming and could delay the launch of our
drug candidates. We may not be able to build an effective sales and marketing organization in the United States or other key global markets.
If we are unable to build our own sales and marketing capabilities or to find suitable partners for the commercialization of our drug
candidates, we may have difficulties generating revenue from them.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to, or decide not to, further develop internal sales, marketing and commercial distribution capabilities for any or all
of our drug candidates, we will likely pursue collaborative arrangements regarding the sales and marketing of our drug candidates. However,
there can be no assurance that we will be able to establish or maintain such collaborative arrangements, or whether they will have effective
sales forces. We would have little or no control over the marketing and sales efforts of such third parties, and our revenue from product
sales may be lower than if we had commercialized our drug candidates ourselves. We also face competition in our search for third parties
to assist us with the sales and marketing efforts of our drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that we will be able to further develop and successfully maintain internal sales and commercial distribution capabilities
outside of China or establish or maintain relationships with third-party collaborators to successfully commercialize any product, and
as a result, we may not be able to generate substantial product sales revenue.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
face substantial competition, which may result in others discovering, developing or commercializing competing drugs before or more successfully
than we do.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The development
and commercialization of new drugs is highly competitive and characterized by rapidly advancing technologies, with a strong emphasis
on proprietary products. We face competition with respect to Olverembatinib and Lisaftoclax, our current drug candidates and any future
drugs that we may develop or in-license from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies
worldwide. There are a number of large pharmaceutical and biotechnology companies, including AbbVie, Enliven, Roche, BeOne, Terns, Novartis,
Innocare, Oric, Agios, and Takeda that currently market and sell drugs or are pursuing the development of drugs that are addressing similar
pathways and mechanisms of actions as our drug candidates. See &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Competition</i>.&#8221;
Some of these competitive drugs and therapies are based on scientific approaches that are the same as or similar to our approach, and
others are based on entirely different approaches. Potential competitors also include academic institutions, government agencies and
other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements
for research, development, manufacturing and commercialization.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
beyond companies targeting the same pathways, there are a large number of companies developing or marketing treatments for cancer, including
many major pharmaceutical and biotechnology companies. These new treatments can change the standard of care, and tolerance for safety
and expectations for efficacy and can also impact the addressable patient population, the adoption of our drug candidates, if approved,
by patients and healthcare providers and payors as well as pricing and reimbursement.</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial opportunity could be reduced or eliminated if our competitors develop and commercialize drugs that are safer, more effective,
have fewer or less severe side effects, are more convenient or are less expensive than any drugs that we may develop. Our competitors
also may obtain approval from the FDA, NMPA or other comparable regulatory authorities for their drugs more rapidly than we may obtain
approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market
and or slow our regulatory approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
drug candidates, if approved under an NDA, could face generic competition earlier than expected. The enactment of the Generic Drug User
Fee Amendments of 2012 as part of the Food and Drug Administration Safety and Innovation Act of 2012 established a user fee program to
generate hundreds of millions of dollars in funding for the FDA&#8217;s generic drug review program. Funding from the user fee program,
along with performance goals that the FDA negotiated with the generic drug industry, could significantly decrease the timeframe for FDA
review and approval of generic drug applications. In addition, the pricing of our drug candidates depends, and if and when approved for
marketing, will depend, in part, on the pricing strategies adopted by our competitors. If we or our partners are forced to reduce the
prices of our drug candidates, or if sales of our drug candidates fall, due to competitive pricing, our revenue will be negatively affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the companies against which we are competing or against which we may compete in the future have significantly greater financial resources
and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals
and marketing approved drugs than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even
more resources being concentrated among a smaller number of our competitors. Smaller and other early-stage companies may also prove to
be significant competitors, particularly through collaborative arrangements with large and established companies. Many of these competitors
are active in seeking patent protection and licensing arrangements in anticipation of collecting royalties for use of technology that
they have developed. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing
clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary
for, our programs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market opportunities for our drug candidates may be limited to those patients who are ineligible for or have failed prior treatments
and may be small.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancer
therapies are sometimes characterized as first line, second line or third line, and the FDA often approves new therapies initially only
for third line use. When cancer is detected early enough, first line therapy is sometimes adequate to cure the cancer or prolong life
without a cure. Whenever first line therapy, usually chemotherapy, hormone therapy, surgery or a combination of these, proves unsuccessful;
second line therapy may be administered. Second line therapies often consist of more chemotherapy, radiation, mAb drugs, tumor targeted
small molecules or a combination of these. Third line therapies can include bone marrow transplantation, mAb and small molecule targeted
therapies, more invasive forms of surgery and new technologies. In markets with approved therapies, we expect to initially seek approval
of our drug candidates as a later stage therapy for patients who have failed other approved treatments. Subsequently, for those drugs
that prove to be sufficiently beneficial, if any, we would expect to seek approval as a second line therapy and potentially as a first
line therapy, but there is no guarantee that our drug candidates, even if approved, would be approved for second line or first line therapy.
In addition, we may have to conduct additional clinical trials prior to gaining approval for second line or first line therapy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
projections of both the number of people who have the cancers we are targeting, as well as the subset of people with these cancers in
a position to receive later stage therapy and who have the potential to benefit from treatment with our drug candidates, are based on
our beliefs and estimates. These estimates have been derived from a variety of sources, including scientific literature, surveys of clinics,
patient foundations, or market research, and may prove to be incorrect. Further, new studies may change the estimated incidence or prevalence
of these cancers. The number of patients may turn out to be lower than expected. Additionally, the potentially addressable patient population
for our drug candidates may be limited or may not be amenable to treatment with our drug candidates. Even if we obtain significant market
share for our drug candidates, because the potential target populations are small, we may never achieve profitability without obtaining
regulatory approval for additional indications, including use as a first-or second-line therapy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
market opportunities may also be limited by competitor treatments that may enter the market. See &#8220;&#8212;<i>We face substantial
competition, which may result in others discovering, developing or commercializing competing drugs before or more successfully than we
do</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any
of our drug candidates that receive regulatory approval may fail to achieve the degree of market acceptance by physicians, patients,
third-party payors and others in the medical community necessary for commercial success.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of our drug candidates that receive regulatory approval may fail to gain sufficient market acceptance by physicians, patients, third-party
payors and others in the medical community. For example, current cancer treatments like chemotherapy and radiation therapy are well established
in the medical community, and doctors may continue to rely on these treatments to the exclusion of our drug candidates. In addition,
physicians, patients and third-party payors may prefer other novel products to ours. If our drug candidates do not achieve an adequate
level of acceptance, we may not generate significant product sales revenues and we may not become profitable. The degree of market acceptance
of our drug candidates, if approved for commercial sale, will depend on a number of factors, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            clinical indications for which our drug candidates are approved;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">physicians,
                                            hospitals, cancer treatment centers and patients considering our drug candidates, if approved,
                                            as a safe and effective treatment;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            potential and perceived advantages of our drug candidates over alternative treatments;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            prevalence and severity of any side effects;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
                                            labeling or product insert requirements of the FDA, NMPA or other comparable regulatory authorities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timing of market introduction of our drug candidates as well as competitive drugs;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            cost of treatment in relation to alternative treatments;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount of upfront costs or training required for physicians to administer our drug candidates;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>


</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            availability of adequate coverage, reimbursement and pricing by third-party payors and government
                                            authorities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            willingness of patients to pay out-of-pocket in the absence of coverage and reimbursement
                                            by third-party payors and government authorities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">relative
                                            convenience and ease of administration, including as compared to alternative treatments and
                                            competitive therapies; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            effectiveness of our sales and marketing efforts.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our drug candidates represent a departure from more commonly used methods for cancer treatment, and potential patients and their doctors
may be inclined to use conventional standard-of-care treatments rather than any of our drug candidates, if approved. This may have a
material impact on our ability to generate revenues from our drug candidates. Further, given the novelty of our drug candidates, the
end users and medical personnel may require a substantial amount of education and training.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our drug candidates fail to achieve or maintain market acceptance among physicians, patients, hospitals, cancer treatment centers or
others in the medical community, we will not be able to generate significant revenue. Even if our drug candidates achieve market acceptance,
we may not be able to maintain that market acceptance over time if new products or technologies are introduced that are more favorably
received than our drug candidates, are more cost effective or render our drug candidates obsolete.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
currently manufacture, and intend to continue to manufacture, at least a portion of our drug candidates ourselves. Delays in completing
and receiving regulatory approvals for our manufacturing facility could delay our development plans and thereby limit our revenues and
growth.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Suzhou facility, our global research and development center and manufacturing facility, has more than 200,000 square feet of space, and
the manufacturing capacity for both oral solid tablets and capsules is up to 250 million dosage units per year. We also maintain manufacturing
capability for lyophilized formulations at the Suzhou center, and we lease a facility in China Medical City, Taizhou, Jiangsu Province,
China, where we produce and supply preclinical test articles and clinical trial materials for some of our drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the risks described in &#8220;&#8212;<i>Risks related to our reliance on third parties</i>,&#8221; our manufacturing facilities
will be subject to ongoing, periodic inspection by the FDA, NMPA or other comparable regulatory agencies to ensure compliance with cGMP.
Our failure to follow and document our adherence to such cGMP regulations or other regulatory requirements may lead to significant delays
in the availability of products for clinical or, in the future, commercial use, may result in the termination of or a hold on a clinical
trial, or may delay or prevent filing or approval of marketing applications for our drug candidates. We also may encounter problems with
the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">achieving
                                            adequate or clinical-grade materials that meet FDA, NMPA or other comparable regulatory agency
                                            standards or specifications with consistent and acceptable production yield and costs;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shortages
                                            of qualified personnel, raw materials or key contractors; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ongoing
                                            compliance with cGMP regulations and other requirements of the FDA, NMPA or other comparable
                                            regulatory agencies.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
to comply with applicable regulations could also result in sanctions being imposed on us, including fines, injunctions, civil penalties,
a requirement to suspend or put on hold one or more of our clinical trials, failure of regulatory authorities to grant marketing approval
of our drug candidates, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of our drug candidates,
operating restrictions and criminal prosecutions, any of which could harm our business. Developing advanced manufacturing techniques
and process controls is required to fully utilize our facilities. Advances in manufacturing techniques may render our facilities and
equipment inadequate or obsolete.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
produce our drug candidates in the quantities that we believe will be required to meet anticipated market demand for any of our drug
candidates, if approved, we will need to increase, or &#8220;scale up,&#8221; the production process by a significant factor over the
initial level of production. If we are unable to do so, are delayed, or if the cost of this scale up is not economically feasible for
us or we cannot find a third-party supplier, we may not be able to produce our drug candidates in a sufficient quantity to meet future
demand.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may face difficulties from changes to current regulations and future legislation. Healthcare legislative measures aimed at reducing healthcare
costs may have a material adverse effect on our business and results of operations.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
United States and many foreign jurisdictions have enacted or proposed legislative and regulatory changes affecting the healthcare system
that could prevent or delay marketing approval of our drug candidates or any future drug candidates, restrict or regulate post-approval
activities and affect our ability to profitably sell a drug product for which we obtain marketing approval. Changes in regulations, statutes
or the interpretation of existing regulations could impact our business in the future by requiring, for example:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            to our manufacturing arrangements;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
                                            or modifications to drug product labeling;</span></td>
</tr></table><div>

</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            to reimbursement in government-funded healthcare programs;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            recall or discontinuation of our drug products; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional
                                            record-keeping requirements.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any such changes were to be imposed, they could adversely affect the operation of our business. In the United States, there have been
and continue to be a number of legislative initiatives to contain healthcare costs. For example, the Patient Protection and Affordable
Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively, the ACA, substantially changed
the way healthcare is financed by both governmental and private insurers, and significantly impacted the U.S. pharmaceutical industry.
The ACA contained provisions that may reduce the profitability of drug products through increased rebates for drugs reimbursed by Medicaid
programs, extension of Medicaid rebates to Medicaid managed care plans, mandatory discounts for certain Medicare Part D beneficiaries
and annual fees based on pharmaceutical companies&#8217; share of sales to federal health care programs. In December 2020, the U.S. Centers
for Medicare &amp; Medicaid Services, or CMS, issued a final rule implementing significant manufacturer price reporting changes under
the Medicaid Drug Rebate Program, including regulations that affect manufacturer-sponsored patient assistance programs subject to pharmacy
benefit manager accumulator programs and Best Price reporting related to certain value-based purchasing arrangements. The American Rescue
Plan Act of 2021 eliminated the statutory cap on Medicaid Drug Rebate Program rebates that manufacturers pay to state Medicaid programs.
Elimination of this cap may require pharmaceutical manufacturers to pay more in rebates than it receives on the sale of products, which
could have a material impact on our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2021, the United States Supreme Court held that Texas and other challengers had no legal standing to challenge the ACA, dismissing
the case without specifically ruling on the constitutionality of the ACA. Further, the Inflation Reduction Act of 2022, or the IRA, among
other things, extended enhanced subsidies for individuals purchasing health insurance coverage in ACA marketplaces through plan year
2025. The IRA also eliminates the &#8220;donut hole&#8221; under the Medicare Part D program beginning in 2025 by significantly lowering
the beneficiary maximum out-of-pocket cost through a newly established manufacturer discount program.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bipartisan Budget Act of 2018 also amended the ACA, effective January 1, 2019, by increasing the point-of-sale discount that is owed
by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug plans, commonly
referred to as the &#8220;donut hole.&#8221; CMS published a final rule permitting further collections and payments to and from certain
ACA qualified health plans and health insurance issuers under the ACA risk adjustment program in response to the outcome of federal district
court litigation regarding the method CMS uses to determine this risk adjustment. In addition, CMS has published a final rule to give
states greater flexibility, starting in 2020, in setting benchmarks for insurers in the individual and small group marketplaces, which
may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces. The American
Taxpayer Relief Act of 2012, among other things, reduced Medicare payments to several providers, including hospitals, and increased the
statute of limitations period for the government to recover overpayments to providers from three to five years. Other legislative changes
include aggregate reductions to Medicare payments to providers of up to 2% per fiscal year pursuant to the Budget Control Act of 2011,
which began in 2013 and will remain in effect through 2032, unless Congress takes further action.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
the OBBBA has enacted, among others, changes to eligibility requirements for premium tax credits, which has resulted, and is expected
to result, in less coverage in the ACA&#8217;s health insurance marketplace (&#8220;Marketplace&#8221;) over the next few years and has
made other changes to the enrollment and eligibility requirements for Medicaid. It is possible that the ACA will be subject to judicial
or Congressional challenges in the future. It is unclear how additional challenges and healthcare reform measures under the current U.S.
administration will impact the ACA. For example, the CMS recently proposed two mandatory payment model pilots, the Guarding U.S. Medicare
Against Rising Drug Costs (&#8220;GUARD&#8221;) Model, focused on Part D drugs, and Global Benchmark for Efficient Drug Pricing (&#8220;GLOBE&#8221;),
focused on Part B drugs, which will require pharmaceutical companies to pay additional rebates on certain medicine whose U.S. net-of-discount
prices exceed those in certain other countries. Complying with any new legislation and regulatory requirements could be time-intensive
and expensive, resulting in a material adverse effect on our business. &#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically,
there have been several recent U.S. Congressional inquiries and proposed federal and state legislation designed to, among other things,
bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing
and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. For example, the IRA includes
prescription drug provisions that have significant implications for the pharmaceutical industry and Medicare beneficiaries, such as directing
the federal government to negotiate a maximum fair price for certain higher-cost single source Medicare drugs, imposing penalties and
excise tax for manufacturers that fail to comply with the drug price negotiation requirements, requiring inflation rebates for all Medicare
Part B and Part D drugs, with limited exceptions, if their drug prices increase faster than inflation, and redesigning Medicare Part
D to reduce out- of-pocket prescription drug costs for beneficiaries and impose new required discounts on manufacturers, among other
changes. Various industry stakeholders, including pharmaceutical companies and the Pharmaceutical Research and Manufacturers of America,
have initiated lawsuits against the federal government asserting that the price negotiation provisions of IRA are unconstitutional. The
impact of these judicial challenges as well as other legislative, executive, and administrative actions and any future healthcare measures
and agency rules implemented by the current U.S. administration on us and the pharmaceutical industry as a whole is unclear. The implementation
of cost containment measures or other healthcare reforms, including any potential expansion of government price controls, may prevent
us from being able to generate revenue, attain profitability, or commercialize our drug candidates, if approved.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our drug candidates obtain marketing approval in the United States, the 340B Drug Pricing Program may require us to provide significant
discounts on outpatient drugs to eligible healthcare organizations. The program has expanded substantially in recent years, and further
expansion of the 340B program, the number of covered entities, or contract pharmacy arrangements could negatively impact our revenues
and results of operations. Sales under the 340B program are made at a significant discount to our wholesale acquisition cost. Growth
in 340B-eligible purchases as a percentage of our total U.S. sales could negatively impact our net revenues and gross margins.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control
pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain
product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other
countries and bulk purchasing. In addition, regional health care authorities and individual hospitals are increasingly using bidding
procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other health
care programs. These measures could reduce the ultimate demand for our drug products, once approved, or put pressure on our drug product
pricing. A number of states are considering or have recently enacted state drug price transparency and reporting laws that could substantially
increase our compliance burdens and expose us to greater liability under such state laws once we begin commercialization after obtaining
regulatory approval for any of our drug products. Further, FDA has authorized the state of Florida to develop Section 804 Importation
Programs to import certain prescription drugs from Canada for a limited period of time to help reduce drug costs, provided that Florida&#8217;s
Agency for Health Care Administration meets the requirements set forth by the FDA. Other states may follow Florida, while other states
await FDA approval. We expect that additional state and federal healthcare reform measures may be adopted in the future, any of which
could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced
demand for our drug candidates or additional pricing pressures.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, recent legislative and regulatory proposals in the United States have included &#8220;most favored nation&#8221;, or MFN, drug
pricing policies designed to align the prices in the U.S. with the lower prices in other countries. If enacted, this could affect profitability
for any of our drug candidates that obtain marketing approval in the U.S., if any, as well as in other countries, as a price referencing
policy to the U.S. market could make it commercially unviable to launch in a price constrained market. There are investigations underway
to examine price differentials and consider policy approaches for implementation, including through administrative action. To the extent
that such regulatory and policy changes have a negative impact on us, including through adverse implications in drug pricing and local
market access, such changes could adversely impact our business, results of operations and financial position.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue prospects could be affected by changes in healthcare spending and policy in the United States and abroad. We operate in a highly
regulated industry and new laws, regulations or judicial decisions, or new interpretations of existing laws, regulations or decisions,
related to healthcare availability, the method of delivery or payment for healthcare products and services could negatively impact our
business, operations and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal and state levels directed at
broadening the availability of healthcare and containing or lowering the cost of healthcare. We cannot predict the initiatives that may
be adopted in the future, including repeal, replacement or significant revisions to the ACA, the IRA or new legislation. The continuing
efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce
costs of healthcare or impose price controls may adversely affect:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            demand for our drug candidates, if we obtain regulatory approval;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to set a price that we believe is fair for our drug products;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to obtain coverage and reimbursement approval for a drug product;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to generate revenue and achieve or maintain profitability;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            level of taxes that we are required to pay; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            availability of capital.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors,
which may adversely affect our future profitability.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and
additional downward pressure on the price that we receive for any approved drug product. Any reduction in reimbursement from
Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost
containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or
commercialize our drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legislative
and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for biotechnology
products. We cannot be sure to what extent the trajectory of these legislative and regulatory proposals will be implemented by the federal
and state governments, whether additional legislative changes will be enacted, whether FDA regulations, guidance or interpretations will
be changed, or what the impact of such changes on the marketing approvals of our drug candidates, if any, may be. Further, recent policy
changes affecting the FDA have resulted in significant changes to research, testing, regulatory approval or clearance, manufacturing
and marketing of FDA-regulated products. The FDA has also adopted certain programs, including the PreCheck Program and Commissioner&#8217;s
National Priority Review Voucher Program, designed to increase domestic production of FDA-regulated products and increased enforcement
activities by issuing larger numbers of warning letters to pharmaceutical companies related to violation of regulatory standards governing
direct-to-consumer advertising. In addition, increased scrutiny by Congress of the FDA&#8217;s approval process may significantly delay
or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing testing and other requirements.
Changes to healthcare regulation and policies, agency priorities, enforcement initiatives and focus, and coverage and reimbursement for
healthcare products and services may be sudden and unexpected, and we may experience increased costs to monitor for such changes and
respond to any new requirements affecting our business and operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif">There
is also a great degree of uncertainty regarding how the U.S. Supreme Court decisions, including <i>Loper Bright Enterprises v. Raimondo</i>
and <i>Corner Post, Inc. v. Board of Governors of the Federal Reserve System</i>, will impact enforcement and decision-making authority
of regulatory agencies, including those of the FDA. <i>Loper Bright</i> explicitly overturned Chevron deference, which previously gave
judicial deference to administrative action by agencies in the executive branch. Further, the Supreme Court&#8217;s decision in <i>Corner
Post</i> may result in challenges to FDA decisions by new litigants long into the future, resulting in greater uncertainty about our
continued operations. In February 2025, an executive order was signed asserting greater authority over all federal agencies, including
those established by Congress as independent from direct presidential control. The executive order may lead to delays, if not cancellations,
of pending and proposed regulations at federal agencies and introduces uncertainty as it subjects all significant regulatory actions
by the agencies to the President&#8217;s supervision and control. We cannot predict the impact that such executive order, any future
executive orders or legislation implementing executive orders may have on our business or our results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject, directly or indirectly, to applicable U.S. federal and state anti-kickback, false claims laws, physician payment transparency
laws, fraud and abuse laws or similar healthcare, privacy, and security laws and regulations, which could expose us to criminal sanctions,
civil penalties, contractual damages, reputational harm and diminished profits and future earnings.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
providers and third-party payors play a primary role in the recommendation and prescription of any drug candidates for which we obtain
marketing approval, or for which we may provide contracted promotional services to third parties. Our current and future arrangements
with healthcare professionals, clinical investigators, CROs, third-party payors and customers may expose us to broadly applicable fraud
and abuse and other healthcare laws and regulations (at the federal and state level) that may constrain the business or financial arrangements
and relationships through which we market, sell and distribute our drug products for which we obtain marketing approval. Similarly, our
participation in the federal health care programs and acceptance of federal grant funding may subject us to federal false claims laws,
civil penalties and assessments, criminal prosecution, and other administrative, civil, and criminal remedies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, once our product is approved in the U.S. we may be subject to transparency laws and patient privacy and security regulation
by both the U.S. federal government and the states in which we conduct our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
we have an approved product in the U.S., the laws in the U.S. that may affect our ability to operate include, but are not limited to,
the following examples:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-size: 10pt">The federal Anti-Kickback Statute, or AKS, prohibits, among other things, persons and entities including
pharmaceutical manufacturers from, among other things, knowingly and willfully soliciting, receiving, offering or paying remuneration,
directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual
for or the purchase, lease, or order of, or the arranging for an item or service for which payment may be made, in whole or in part, under
federal healthcare programs such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the
statute or specific intent to violate it in order to have committed a violation. This statute has been interpreted to apply to arrangements
between pharmaceutical manufacturers on the one hand and prescribers, purchasers and formulary managers on the other hand. Although there
are several statutory exceptions and regulatory safe harbors protecting certain common activities from prosecution, they are drawn narrowly,
and practices that involve remuneration intended to induce prescribing, purchasing or recommending or arranging for the prescription or
purchase of any drug product may be subject to scrutiny if they do not qualify for an exception or safe harbor. This law would apply to
our marketing practices, educational programs, pricing policies, and relationships with healthcare providers. We continue to evaluate
what effect, if any, these rules will have on our business.</span></td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-size: 10pt">The federal civil and criminal false claims laws and civil monetary penalty laws impose a range of prohibitions
and compliance considerations. For example, the False Claims Act, or FCA, prohibits individuals or entities from, among other things,
knowingly presenting, or causing to be presented, claims for payment to, or approval by, the federal government that are false, fictitious
or fraudulent or knowingly making, using or causing to be made or used, a false record or statement material to a false or fraudulent
claim to avoid, decrease or conceal an obligation to pay money to the federal government. Claims resulting from a violation of the federal
AKS or the FDCA constitute a false or fraudulent claim for purposes of the FCA. Promotion that is deemed to be &#8220;off label&#8221;
can also be the basis of FCA exposure.</span></td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-size: 10pt">The federal Civil Monetary Penalties law prohibits, among other things, offering or transferring remuneration
to a federal healthcare beneficiary that a person knows or should know is likely to influence the beneficiary&#8217;s decision to order
or receive items or services reimbursable by the government from a particular provider or supplier.</span></td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-size: 10pt">The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended by the
Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and its implementing regulations imposes criminal
and civil liability for fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and
willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private payors. The false
statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false,
fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. A violation
of these statutes is a felony and may result in fines, imprisonment or exclusion from governmental programs. Similar to the federal AKS,
a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a
violation. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from government sponsored programs,
or integrity oversight and reporting obligations to resolve allegations of non-compliance.</span></td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-size: 10pt">Privacy and data security laws may apply to our business. Under Section 5(a) of the Federal Trade Commission
Act, the Federal Trade Commission, or the FTC, expects a company&#8217;s data security measures to be reasonable and appropriate in light
of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools
to improve security and reduce vulnerabilities. Medical data is considered sensitive data that merits stronger safeguards. The FTC&#8217;s
guidance for appropriately securing consumers&#8217; personal information is similar to what is required by the HIPAA Security Rule. States
may also impose requirements, for example the California Consumer Privacy Act created data privacy obligations for covered companies and
providing privacy rights to California residents, including the right to opt out of certain disclosures of their information and other
states have adopted consumer privacy laws and regulations, including those specific to health information. HIPAA, as amended by HITECH
and its implementing regulations, also imposes obligations on certain covered entity healthcare providers, health plans, and healthcare
clearinghouses as well as their business associates that perform certain services involving the use or disclosure of individually identifiable
health information, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually
identifiable health information. HITECH created new tiers of civil monetary penalties, made civil and criminal penalties directly applicable
to business associates, and gave state attorneys authority to file civil actions for damages or injunctions in federal courts to enforce
HIPAA laws and seek attorneys&#8217; fees and costs. While we are not currently a covered entity or a business associate under HIPAA,
our future operations could subject us to HIPAA as a business associate or covered entity, depending on the scope of such operations.</span></td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>The federal physician payment transparency requirements, sometimes referred to as the &#8220;Physician Payments Sunshine Act,&#8221;
requires applicable manufacturers of covered drugs, devices, biologics and medical supplies for which payment is available under government
healthcare programs to annually report to the Centers for Medicare and Medicaid Services, or CMS, information related to certain payments
or other transfers of value made or distributed to physicians, certain non-physician practitioners and teaching hospitals, as well as
ownership and investment interests held by such healthcare provider and their immediate family members. While we are currently not subject
to the Physician Payments Sunshine Act, if our products are approved in the U.S., this may become applicable to us.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif">For both investigational and commercialized products, interactions with or
communications directed to healthcare providers, patients or patient- or disease-advocates or advocacy groups, and payors, are subject
to heightened scrutiny by the FDA. Relative to nonpromotional communications, for example, there are specific and limited FDA accommodations
for nonpromotional, truthful and non-misleading sharing of information regarding products in development and off-label uses including
dissemination of peer-reviewed reprints, support of independent continuing medical education, and healthcare economic discussions with
payors. In a competitive environment, a company&#8217;s communications about products in development may also be subject to heightened
scrutiny.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif">Analogous state laws and regulations, such as state anti-kickback and false
claims laws, may apply to items or services reimbursed by any third-party payor, including commercial insurers, and in some cases may
apply regardless of payor (i.e., even for self-pay scenarios). Some state laws require pharmaceutical companies to comply with the pharmaceutical
industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government in addition
to requiring drug manufacturers to report pricing and marketing information, including, among other things, information related to payments
to physicians and other healthcare providers or marketing expenditures, state and local laws that require the registration of pharmaceutical
sales representatives. Many of these state laws differ from each other in significant ways and may not have the same effect, and may apply
more broadly or be stricter than their federal counterparts, thus complicating compliance efforts; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price reporting laws require the calculation and reporting
of complex pricing metrics to government programs, where such reported prices may be used in the calculation of reimbursements or discounts
on our drug products. Participation in such programs and compliance with their requirements may subject us to increased infrastructure
costs and potentially limit our ability to price our drug products.</span></td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">In addition
to FDA restrictions on the marketing of pharmaceutical products, pharmaceutical manufacturers who obtain FDA approval for any drug candidates
and who begin commercializing those drugs in the United States may be subject to various federal and state laws targeting fraud and abuse
in the healthcare industry. The activities of pharmaceutical manufacturers are also subject to regulation by numerous regulatory authorities
including CMS, other divisions of the Department of Health and Human Services, the Department of Justice, the Drug Enforcement Administration,
the Consumer Product Safety Commission, the Federal Trade Commission, or the FTC, the Occupational Safety &amp; Health Administration,
the Department of Commerce, the Environmental Protection Agency, and state and local governments. These laws may impact, among other
things, our proposed sales, marketing and education programs. In addition, pharmaceutical manufacturers who have approved drug products
on the market may be subject to patient privacy regulation by both the federal government and the states in which they conduct business.
If any of our drug candidates, including Olverembatinib and Lisaftoclax in the United States, are approved, our operations may be subject
to such patient privacy regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we may be subject to state and non-U.S. equivalents of each of the healthcare laws described above, among others, some of which may be
broader in scope and may apply regardless of the payor. Many U.S. states have adopted laws similar to the federal Anti-Kickback Statute,
some of which apply to the referral of patients for healthcare services reimbursed by any source, not just governmental payors, including
private insurers. In addition, some states have passed laws that require pharmaceutical companies to comply with the April 2003 Office
of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers and/or the Pharmaceutical Research and Manufacturers
of America&#8217;s Code on Interactions with Healthcare Professionals. Several states also impose other marketing restrictions or require
pharmaceutical companies to make marketing or price disclosures to the state. There are ambiguities as to what is required to comply
with these state requirements and if we fail to comply with an applicable state law requirement, we could be subject to penalties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the breadth of these laws and regulations, and the narrowness of the statutory exceptions and safe harbors available, it is possible
that some of our business activities could be subject to challenge under one or more of such laws or regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Violations
of fraud and abuse laws may be punishable by criminal and/or civil sanctions, including penalties, fines, disgorgement, imprisonment
and/or exclusion or suspension from federal and state healthcare programs such as Medicare and Medicaid and debarment from contracting
with the U.S. government. In addition, private individuals have the ability to bring actions on behalf of the U.S. government under the
federal False Claims Act as well as the false claims laws of several states.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law
enforcement authorities are increasingly focused on enforcing these laws and regulations, and it is possible that some of our practices
may be challenged under these laws or regulations. Efforts to ensure that our current and future business arrangements with third parties,
and our business generally, will comply with applicable healthcare and other laws and regulations will involve substantial costs. It
is possible that governmental authorities will conclude or perceive that our business practices, including our arrangements with physicians
and other healthcare providers, some of whom receive stock options as compensation for services provided, may not comply with current
or future statutes, regulations, agency guidance or case law involving applicable fraud and abuse, healthcare, or other laws and regulations.
If we fail or are perceived to fail to comply with any such laws or regulations, or any litigation, investigation, proceeding, or other
action is initiated against us, including if we are not successful in defending ourselves or asserting our rights, it could have a significant
impact on our business, including the imposition of civil, criminal and administrative penalties, remedial measures, damages, disgorgement,
monetary fines, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual
damages, reputational and financial harm, diminished profits and future earnings, and curtailment of our operations, any of which could
adversely affect our ability to operate our business and our results of operations. In addition, the approval and commercialization of
any of our drug candidates outside the United States will also likely subject us to non-U.S. equivalents of the healthcare laws mentioned
above, among other non-U.S. laws.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defending
against any such actions can be costly and time-consuming and may require significant financial and personnel resources. Therefore, even
if we are successful in defending against any such actions that may be brought against us, our business may be impaired. If any of the
physicians or other healthcare providers or entities with whom we expect to do business are found to be not in compliance with applicable
laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs,
which may also adversely affect our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to the risk that our employees, independent contractors, consultants, commercial collaborators, principal investigators,
CROs, suppliers and vendors may engage in misconduct or other improper activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when we are subject to these U.S. laws, ensuring that our business arrangements with third parties comply with applicable healthcare
laws and regulations involves substantial costs. The compliance and enforcement landscape, and related risk, is informed by government
enforcement precedent and settlement history, Office of Inspector General advisory opinions, and special fraud alerts. Our approach to
compliance may evolve over time in light of these types of developments. Additionally, the potential safe harbors available under the
federal AKS are subject to change through legislative and regulatory action, and we may decide to adjust our business practices or be
subject to heightened scrutiny as a result. If our operations, including activities to be conducted by our sales team, were to be found
to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant
civil, criminal and administrative penalties, damages, fines, exclusion from government-funded healthcare programs, such as Medicare
and Medicaid, qui tam actions brought by individual whistleblowers in the name of the government, and the curtailment or restructuring
of our operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Misconduct
by these parties could include failures to comply with FDA regulations, provide accurate information to the FDA, comply with federal
and state health care fraud and abuse laws and regulations, accurately report financial information or data or disclose unauthorized
activities to us. In particular, sales, marketing and business arrangements in the health care industry are subject to extensive laws
and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing, and other abusive practices. These laws and regulations
may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs
and other business arrangements. Misconduct by these parties could also involve the improper use of information obtained in the course
of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify
and deter misconduct by these parties, and the precautions we take to detect and prevent this activity may not be effective in controlling
unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from
a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending
ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant
penalties, including civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation
in government funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, contractual damages,
reputational harm, diminished profits and future earnings and the curtailment or restructuring of our operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to stringent and often unsettled laws, regulations, policies and contractual obligations related to privacy, data protection
and information security, and changes in such laws, regulations, policies and contractual obligations could adversely affect our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to privacy, data protection and information security laws and regulations that apply to the collection, transmission, storage
and use of personal information, which among other things, impose certain requirements relating to the privacy, security and transmission
of personal information. The legislative and regulatory landscape for privacy, data protection and information security continues to
evolve in jurisdictions worldwide, and there has been an increasing focus on these issues with the potential to affect our business.
Failure to comply with any of these laws and regulations could result in enforcement action against us, fines, imprisonment of company
officials and public censure, claims for damages by affected individuals, damage to our reputation and loss of goodwill, any of which
could have a material adverse effect on our business, financial condition, results of operations or prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to properly protect the privacy and security of personal information, we could be found to have breached our policies or
contracts. Further, if we fail to comply with applicable privacy and data protection laws and regulations, including in connection with
our clinical trials, we could face significant administrative, civil and criminal penalties. In addition to federal regulators, state
attorneys general are authorized to bring civil actions seeking either injunctions or damages in response to violations that threaten
the privacy or security of the personal information of state residents. We cannot be sure how these regulations will be interpreted,
enforced or applied to our operations. In addition to the risks associated with enforcement activities and potential contractual liabilities,
our ongoing efforts to comply with evolving laws and regulations at the federal and state level may be costly and require ongoing modifications
to our policies, procedures and systems.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Privacy,
data protection and information security regulation is evolving at both the domestic and international level. Laws in all 50 U.S. states
require businesses to provide notice under certain circumstances to governmental authorities and affected individuals in connection with
certain breaches of personal information, and, in the future, we may be required to notify applicable governmental authorities and affected
individuals in the event of a data breach or other data security incident. In addition to data breach notification laws, some states
have enacted statutes and rules requiring businesses to reasonably protect certain types of personal information they hold or to otherwise
comply with certain specified data security requirements for personal information. For example, the California Consumer Privacy Act,
as amended by the California Privacy Rights Act, or CPRA and collectively, CCPA, and approximately one-third of U.S. states have enacted
new data protection and privacy rights, requiring covered companies to grant rights to consumers regarding their personal information
and implement processes to enable consumers to exercise their rights. Certain of these laws provide a private right of action for certain
data breaches or provide for administrative fines, including the CCPA, among others, which provides for administrative fines of up to
US$7,500 per violation and allows private litigants affected by certain data breaches to recover potentially significant statutory damages.
In addition to these omnibus state laws, states have enacted laws and regulations relating to other aspects of privacy and information
security, including certain sector-specific laws, such as Washington&#8217;s My Health, My Data Act. Similar laws are being considered
in several other states, as well as the federal and local levels, reflecting a global trend toward more stringent privacy and information
security legislation. The laws are not consistent, as certain state laws may be more stringent or broader in scope, or offer greater
individual rights, with respect to sensitive and personal information than federal, international, or other state laws, and such laws
may differ from each other, which may complicate compliance efforts. State laws are changing rapidly and there is discussion in Congress
of a new comprehensive federal data protection law to which we may become subject if it is enacted, which may add additional complexity,
variation in requirements, restrictions and potential legal risks, require additional investment of resources in compliance programs,
impact strategies and the availability of previously useful data, and could result in increased compliance costs or changes in business
practices and policies. These laws may apply directly to our business or indirectly by contract when we provide services to other companies.
If we become subject to these new or additional privacy laws, the risk of enforcement actions against us could increase.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt; font-style: normal; font-weight: normal">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the European Union&#8217;s General Data Protection Regulation (EU) 2016/679, or GDPR, went into effect on May 25, 2018 in respect
of processing operations carried out in the context of the activities of an establishment in the European Union and any processing relating
to the offering of goods or services to individuals in the European Union and/or the monitoring of their behavior in the European Union.
Also, notwithstanding the United Kingdom&#8217;s withdrawal from the European Union, by operation of the so-called UK GDPR, the GDPR
continues to apply in substantially equivalent form to processing operations carried out in the context of the activities of an establishment
in the United Kingdom, and any processing relating to the offering of goods or services to individuals in the United Kingdom and/or monitoring
of their behavior in the United Kingdom. Accordingly, where we refer to the GDPR, we are referring to the UK GDPR in the context of processing
operations in the United Kingdom, unless the context requires otherwise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The GDPR provides that European Union member states and the United
Kingdom may make their own further laws and regulations to introduce specific requirements in certain areas, including related to the
processing of special categories of personal data,&#8217; including personal data related to health and genetic data. This may
lead to greater divergence among the laws and regulations that apply to the processing of personal data across the European Union and
United Kingdom, compliance with which, as and where applicable, may increase our costs and could increase our overall compliance risk.
Such laws and regulations could also limit our ability to collect, use, share and otherwise process personal data in the context of our
European Union and/or United Kingdom establishments (regardless of where any such processing occurs), and/or could cause our compliance
costs to increase, ultimately having an adverse impact on our business, and harming our business and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GDPR imposes accountability obligations requiring data controllers and processors to maintain a record of their data processing and policies.
The GDPR imposes certain other onerous obligations, including: obligations for controllers and processors to appoint data protection
officers in certain circumstances; increased transparency obligations to data subjects for controllers; obligations to honor increased
rights for data subjects; obligations to implement certain technical and organizational safeguards to protect the security and confidentiality
of personal data; and the obligation to provide notice of certain significant personal data breaches to the relevant supervisory authorities
and affected individuals. In addition, the GDPR provides an expansive definition of personal data (including, for example, &#8216;pseudonymized&#8217;
and key-coded data).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GDPR also imposes strict rules on the transfer of personal data to countries outside the European Union and United Kingdom, including
the United States, known as &#8216;third countries,&#8217; in respect of which the European Commission or other relevant regulatory body
has not issued a so-called &#8216;adequacy decision&#8217;, unless the parties to the transfer have implemented specific safeguards to
protect the transferred personal data. This is an area of evolving complexity and achieving effective compliance with changing requirements
and guidance in relation to data transfers from the European Union and United Kingdom is challenging. Standard contractual clauses approved
by the European Commission and/or United Kingdom&#8217;s Information Commissioner&#8217;s Office (as applicable) remain, in principle,
a basis on which to effect such transfers, but the standard contractual clauses alone may not suffice in all circumstances. Use of the
standard contractual clauses must be assessed on a case-by-case basis, taking into account the legal regime applicable in the destination
country. If we are unable to implement sufficient safeguards to ensure that any transfers of personal data from the European Union and
United Kingdom are lawful, we may face increased exposure to regulatory action(s), substantial fines and injunctions against processing
personal data from the European Union and United Kingdom. An inability to lawfully transfer personal data out of the European Union and
United Kingdom to the United States or any other jurisdictions may (1) restrict our activities in the European Union and United Kingdom,
(2) limit our ability to conduct clinical trials in the European Union and United Kingdom and/or to work with partners, service providers,
contractors and other companies subject to European data protection laws and regulations and/or (3) require us to increase our data processing
capabilities in the European Union and United Kingdom at significant expense or otherwise cause us to change the geographical location
or segregation of our relevant systems and operations, any or all of which could adversely affect our financial results. Additionally,
other countries outside of the European Union and United Kingdom and Switzerland have passed or are considering passing similar cross-border
data transfer restrictions and laws and regulations requiring local data residency, which could increase the cost and complexity of operating
our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fines
for non-compliance with the GDPR are significant&#8212;the greater of &#8364;20 million or 4% of global turnover (and the higher of &#163;17.5
million or 4% of global turnover in the case of the UK GDPR). A wide variety of other potential enforcement powers are available to competent
supervisory authorities in respect of potential and suspected violations of the GDPR, including extensive audit and inspection rights
and powers to order bans on all or some personal data processing. The GDPR also confers a private right of action on data subjects and
consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting
from violations of the GDPR.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, any actual or alleged breach or violation of privacy, data protection or information security laws or regulations, particularly
those resulting in a significant security incident or breach involving the misappropriation, loss or other unauthorized access to, or
use or disclosure of, sensitive or confidential patient information, could have a material adverse effect on our business, reputation
and financial condition. While we attempt to mitigate these associated risks, there is no assurance that our own privacy, data protection
and information security-related safeguards will protect us from all risks associated with the processing, storage and transmission of
such information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
to comply with the GDPR has required substantial efforts, and we expect that it will continue to be a rigorous and time-intensive process
that may increase our cost of doing business or require us to change our business practices. Despite those efforts, there is a risk that
we may be subject to fines and penalties, litigation, and reputational harm in connection with our activities carried out in the context
of our operations in the European Union and the United Kingdom.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is possible that these laws and regulations may be interpreted and applied in a manner that is inconsistent with our practices and our
compliance efforts may be, or may be alleged to be, unsuccessful. If so, this could result in government-imposed fines or orders requiring
that we change our practices, which could adversely affect our business. We must devote significant resources to understanding and complying
with this changing landscape. Any actual or perceived failure to comply with federal, state or international laws or regulations, policies
or contractual obligations regarding privacy, data protection, or information security could expose us to penalties, imprisonment of
company officials and public censure, claims for damages by affected individuals, damage to our reputation and loss of goodwill, any
of which could have a material adverse effect on our business, financial condition, results of operations or prospects. Even if we are
not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant
resources and generate negative publicity, which could also harm our business, financial condition, results of operations or prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
FDA and other regulatory agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA and other regulatory agencies strictly regulate the promotional claims that may be made about prescription products, such as our
drug candidates, if approved. In particular, a product may not be promoted for uses that are not approved by the FDA or such other regulatory
agencies as reflected in the product&#8217;s approved labeling. If we, or our employees or contractors, are found to have promoted such
off-label uses, we may become subject to significant liability. The U.S. federal government has levied large civil and criminal fines
against companies for alleged improper promotion of off-label use and has enjoined several companies from engaging in off-label promotion.
The FDA has also requested that companies enter into consent decrees or permanent injunctions under which specified promotional conduct
is changed or curtailed. If we cannot successfully manage the promotion of our drug candidates, if approved, we could become subject
to significant liability, which would materially adversely affect our business and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
insurance coverage and reimbursement status of newly-approved products is uncertain. Our drug candidates may become subject to unfavorable
pricing regulations, third-party coverage and reimbursement practices, or healthcare reform initiatives, which would harm our business.
Failure to obtain or maintain adequate coverage and reimbursement for new or current drug products could limit our ability to market
those drug products and decrease our ability to generate revenue.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The regulations
that govern marketing approvals, pricing, coverage and reimbursement for new drugs vary widely from country to country. In the United
States, recently enacted legislation may significantly change the approval requirements in ways that could involve additional costs and
cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries,
the pricing review period begins after marketing or product licensing approval is granted. For example, Olverembatinib was included in
the 2022 National Reimbursement Drug List in China, which became effective March 2023. In some foreign markets, prescription pharmaceutical
pricing remains subject to continuing governmental control even after initial approval is granted. We might obtain marketing approval
for a drug product in a particular country, but then be subject to price regulations that delay our commercial launch of the drug product,
possibly for lengthy time periods, and negatively impact the revenue we are able to generate from the sale of the drug product in that
country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more drug candidates, even if any drug
candidates we may develop obtain marketing approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States and markets in other countries, patients generally rely on third- party payors to reimburse all or part of the costs
associated with their treatment. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid,
and commercial payors is critical to new product acceptance. Our ability to successfully commercialize our drug candidates will depend
in part on the extent to which coverage and adequate reimbursement for these drug products and related treatments will be available from
government health administration authorities, private health insurers and other organizations. Government authorities and third-party
payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish
reimbursement levels. The availability of coverage and extent of reimbursement by governmental and private payors is essential for most
patients to be able to afford treatments such as gene therapy products. Sales of these or other future drug candidates that we may identify
will depend substantially, both domestically and abroad, on the extent to which the costs of our drug candidates will be paid by health
maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration
authorities, private health coverage insurers and other third-party payors. If coverage and adequate reimbursement are not available,
or is available only to limited levels, we may not be able to successfully commercialize our drug candidates. Even if coverage is provided,
the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient
return on our investment. Reimbursement by a third-party payor may depend upon a number of factors, including, but not limited to, the
third-party payor&#8217;s determination that use of a product is:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            covered benefit under its health plan;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">safe,
                                            effective and medically necessary;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appropriate
                                            for the specific patient;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cost-effective;
                                            and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">neither
                                            experimental nor investigational.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is also significant uncertainty related to the insurance coverage and reimbursement of newly approved products and coverage may be more
limited than the purposes for which the medicine is approved by the FDA or comparable foreign regulatory authorities. In the United States,
the principal decisions about reimbursement for new medicines are typically made by CMS. CMS decides whether and to what extent a new
medicine will be covered and reimbursed under Medicare, and private payors tend to follow CMS to a substantial degree. No uniform policy
of coverage and reimbursement for products exists among third-party payors, and coverage and reimbursement levels for products can differ
significantly from payor to payor. A decision by CMS or a third-party payor not to cover any product candidates we may develop could
reduce utilization of such product candidates once approved and have a material adverse effect on our sales, results of operations and
financial condition. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement
rates but also have their own methods and approval process apart from Medicare determinations. As a result, the coverage determination
process is often a time consuming and costly process that may require us to provide scientific and clinical support for the use of our
drug products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained
in the first instance. It is difficult to predict what CMS will decide with respect to reimbursement for fundamentally novel products
such as ours. Reimbursement agencies in the European Union may be more conservative than CMS. Moreover, eligibility for reimbursement
does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture,
sale, and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and
may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used,
may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services.
Our inability to promptly obtain coverage and profitable payment rates from both government-funded and private payors for any approved
drug products we may develop could have a material adverse effect on our financial position, results of operations and our ability to
raise capital needed to commercialize drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by
any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in
the United States. Our inability to promptly obtain coverage and profitable reimbursement rates third-party payors for any approved drug
products that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize
drug products and our overall financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increasingly,
third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the
prices charged for medical products. We cannot be sure that reimbursement will be available for any drug candidate that we commercialize
and, if reimbursement is available, the level of reimbursement. Reimbursement may impact the demand for, or the price of, any drug candidate
for which we obtain marketing approval. In order to obtain reimbursement, physicians may need to show that patients have superior treatment
outcomes with our drug products compared to standard of care drugs, including lower-priced generic versions of standard of care drugs.
We expect to experience pricing pressures in connection with the sale of any of our drug candidates due to the trend toward managed healthcare,
the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare
costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result,
increasingly high barriers are being erected to the entry of new products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
variety of risks associated with testing, manufacturing, marketing and other activities in connection with our drug candidates internationally
may materially adversely affect our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We plan to
eventually seek regulatory approval of our drug candidates (including Olverembatinib and Lisaftoclax) in many jurisdictions in addition
to the PRC, including in the United States and, accordingly, we expect that we will be subject to additional risks related to operating
in foreign countries if we obtain the necessary approvals, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">differing
    regulatory requirements in foreign countries, such as the lack of pathways for accelerated drug approval, may result in foreign regulatory
    approvals taking longer and being more costly;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign
    regulatory authorities may disagree with the design, implementation or results of our clinical trials or our interpretation of data
    from nonclinical studies or clinical trials;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
    policies or regulations of foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient
    for approval;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">impact
    of global health emergencies, including pandemics and epidemics, on our ability to produce our drug candidates and conduct clinical
    trials in foreign countries;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unexpected
    changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">economic
    weakness, including inflation, or political instability in particular foreign economies and markets;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
    with legal requirements applicable to privacy, data protection, information security and other matters;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
    with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign
    taxes, including withholding of payroll taxes;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign
    currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to
    doing business in another country;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    staffing and managing foreign operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">complexities
    associated with managing multiple payor reimbursement regimes and government payors in foreign countries;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">workforce
    uncertainty in countries where labor unrest is more common;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays or restrictions related
    to differing foreign investment laws and regulations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential liability under the
    FCPA or comparable foreign regulations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges enforcing our contractual
    and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights
    to the same extent;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">production shortages resulting
    from any events affecting raw material supply or manufacturing capabilities abroad; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">business interruptions resulting
    from geo-political actions, including war and terrorism.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">These and
other risks associated with international operations may materially adversely affect our ability to attain or maintain profitable operations.
In particular, there is currently significant uncertainty about the future relationship between the United States and various other countries,
most significantly China, with respect to trade policies, treaties, tariffs, taxes and other limitations on cross-border operations.
The U.S. government has made and continues to make significant additional changes in U.S. trade policy and may continue to take future
actions that could negatively impact U.S. trade. For example, the U.S. government has issued a Notice of Request for Public Comments
on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients with comments due within
twenty-one days from the date of publication in the Federal Register, and others in Congress have advocated for the use of existing executive
branch authorities to limit those Chinese service providers&#8217; ability to engage in business in the U.S. We contract with WuXi STA,
a subsidiary of WuXi AppTec, that manufactures certain of our active pharmaceutical ingredients. WuXi had been initially identified as
a &#8216;company of concern&#8217; in the proposed BIOSECURE Act, which may have restricted WuXi&#8217;s business in the U.S. or the
ability of businesses in the U.S. to conduct business with WuXi. The BIOSECURE Act was signed into law on December 18, 2025, and while
WuXi is not currently listed as a &#8216;company of concern&#8217;, such a designation is still under consideration by other governmental
departments.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict what actions may ultimately be taken with respect to trade relations between the United States and China or other countries,
what products and services may be subject to such actions or what actions may be taken by the other countries in retaliation. If we are
unable to obtain or use services from existing service providers or become unable to export or sell our drug candidates to any of our
customers or service providers, we could experience significant delays in the development or commercialization of our product candidates,
and our business, liquidity, financial condition and/or results of operations could be materially and adversely affected. For additional
detail, see &#8220;<i>Risks related to doing business in the PRC&#8212;The tension in international trade, rising political tension and
increasing geopolitical risks, particularly between the United States and China, pose significant challenges that may adversely impact
our business, results of operations and financial condition</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Illegal
and/or parallel imports and counterfeit biopharmaceutical products may reduce demand for our future approved drug candidates and could
have a negative impact on our reputation and business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The illegal
importation of competing products from countries where government price controls or other market dynamics result in lower prices may
adversely affect the demand for drug products for which we have or will obtain regulatory approval (including Olverembatinib and Lisaftoclax)
and may adversely affect our sales and profitability. Unapproved foreign imports of prescription drugs are illegal under the current
laws of the United States, China and other applicable jurisdictions. However, illegal imports occur and may continue to occur or even
increase as the ability of patients and other customers to obtain these lower priced imports continues to grow. Furthermore, cross-border
imports from lower-priced markets, known as parallel imports, into higher-priced markets could harm sales of our future drug products
and exert commercial pressure on pricing within one or more markets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
products distributed or sold in the pharmaceutical market may be manufactured without proper licenses or approvals or be
fraudulently mislabeled with respect to their content or manufacturers. These products are generally referred to as counterfeit
pharmaceutical products. The counterfeit pharmaceutical product control and enforcement system, particularly in developing markets
such as China, may be inadequate to discourage or eliminate the manufacturing and sale of counterfeit pharmaceutical products
imitating our future drug products. Since counterfeit pharmaceutical products in many cases are very similar in appearance to the
authentic pharmaceutical products but are generally sold at lower prices, counterfeits of our products could quickly erode the
demand for our future approved drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, counterfeit pharmaceutical products are unlikely to meet our rigorous manufacturing and testing standards. A patient who receives
a counterfeit pharmaceutical product may be at risk for a number of dangerous health consequences. Our reputation and business could
suffer as a result of counterfeit pharmaceutical products sold under our brand names. In addition, theft of improperly stored inventory
at warehouses or plants or while in transit which are sold through unauthorized channels could also adversely impact patient safety,
our reputation, business, financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
related to our intellectual property</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to protect and defend our proprietary technology or obtain and maintain patent protection for our drug candidates, our
competitors could develop and commercialize technology and drugs similar or identical to ours, and our ability to successfully commercialize
our technology and drugs may be adversely affected.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends in large part on our ability to obtain and maintain patent protection in the United States, the PRC and other countries
with respect to our proprietary technology and drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have sought to protect our proprietary position by filing patent applications in the United States, the PRC and other countries related
to novel technologies and drug candidates that we consider important to our business. The risks associated with patent rights generally
apply to patent rights that we in-license now or in the future, as well as patent rights that we may own now or in the future. This process
is expensive and time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce or license all necessary or
desirable patent applications at a reasonable cost or in a timely manner. We may not be able to obtain or maintain patent applications
and patents due to the subject matter claimed in such patent applications and patents being in disclosures in the public domain. It is
also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain
patent protection. Although we enter into nondisclosure and confidentiality agreements with parties who have access to confidential or
patentable aspects of our research and development output, such as our employees, collaborators, CROs, consultants, advisors and other
third parties, any of these parties may breach these agreements and disclose such output before a patent application is filed, thereby
jeopardizing our ability to seek patent protection. Consequently, we may not be able to prevent any third party from using any of our
technology that is in the public domain to compete with our proprietary technology and drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions
and has in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial
value of our patent rights are highly uncertain. Our pending and future owned and licensed patent applications may not result in patents
being issued which protect our technology or drug candidates or which effectively prevent others from commercializing competitive technologies
and drug candidates. In fact, patent applications may not issue as patents at all. In addition, the coverage claimed in a patent application
can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. Furthermore, changes in
either the patent laws or interpretation of the patent laws in the United States, the PRC and other countries may diminish the value
of our patents or narrow the scope of our patent protection. We may not be aware of all third-party intellectual property rights potentially
relating to our proprietary technologies and drug candidates. Other parties have developed technologies that may be related to or competitive
with our own technologies and such parties may have filed or may file patent applications or may have obtained or may obtain patents
claiming inventions that may overlap or conflict with those claimed in our own or licensed patent applications or issued patents. Additionally,
publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications are typically
not published until 18 months after filing, or in some cases not at all. Therefore, we cannot be certain that we or our licensors were
the first to make the inventions claimed in our owned and licensed patents or pending patent applications, or that we or our licensors
were the first to file for patent protection of such inventions. There is also no assurance that all of the potentially relevant prior
art relating to our owned and licensed patents and patent applications has been found, which could be used by a third party to challenge
the validity or enforceability of our owned and licensed patents and patent applications, should they issue, or prevent a patent application
from issuing. Any of the foregoing could harm our competitive position, business, financial condition, results of operations or prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that our or our licensors&#8217; pending patent applications will result in issued patents in jurisdictions in which
such applications are pending. Even if patents do issue on any of these applications, there can be no assurance that a third party will
not challenge their validity or that we will obtain sufficient claim scope in those patents to prevent a third party from competing successfully
with our drug candidates or otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our patent
rights by developing similar or alternative technologies or drug candidates in a non-infringing manner. If the patent protection provided
by the patents and patent applications we own or license is not sufficiently broad to impede such competition, our ability to successfully
commercialize our proprietary technologies and drug candidates could be negatively affected, which could have a material adverse effect
on our business, financial condition, results of operations and prospects. The issuance of a patent is not conclusive as to its inventorship,
scope, validity or enforceability, and our owned and licensed patents may be challenged, deemed unenforceable or invalidated in the courts
or patent offices. We or our licensors may become involved in interference, inter partes review, post grant review, ex parte reexamination,
derivation, opposition, challenges in judicial court, or other similar proceedings challenging our patent rights or the patent rights
of others. Such challenges may result in patent claims being narrowed, invalidated or held unenforceable, which could limit our ability
to stop or prevent us from stopping others from using or commercializing similar or identical technology and drug candidates, or limit
the duration of the patent protection of our technology and drug candidates. Given the amount of time required for the development, testing
and regulatory review of new drug candidates, patents protecting such candidates might expire before or shortly after such candidates
are commercialized. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing
drug candidates similar or identical to ours. Such challenges also may result in substantial cost and require significant time from our
scientists and management, even if the eventual outcome is favorable to us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our owned and licensed patents and patent applications may be co-owned with third parties. For example, one of our licensed patent
families is co-owned with a third party. If we are unable to obtain an exclusive license to any such third party co-owner&#8217;s interest
in such patents and patent applications, such co-owners may be able to license their rights to other third parties, including our competitors,
and our competitors could market competing products and technology. In addition, we may need the cooperation of any such co-owners of
our owned and licensed patents to enforce such patents against third parties, and such cooperation may not be provided to us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to protect our intellectual property rights throughout the world.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing,
prosecuting, maintaining and defending patents on drug candidates in all countries throughout the world could be prohibitively expensive
for us, and our intellectual property rights in some countries can have a different scope and strength than do those in other jurisdictions.
In some cases, we or our licensors may not be able to obtain patent protection for certain proprietary technologies and drug candidates
outside the United States. In addition, the laws of different jurisdictions provide different degrees of protection of intellectual property
rights.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently,
we may not be able to prevent third parties from practicing our inventions in all countries, or from selling or importing drugs made
using our inventions in and into all countries. We may not be able to prevent third parties from practicing our inventions in all countries,
or from selling or importing drugs made using our inventions in and into all countries. Competitors may use our technologies in jurisdictions
where we have not obtained patent protection to develop their own drugs and, further, may export otherwise infringing drugs to jurisdictions
where we have patent protection, but where enforcement rights are not as strong as those in other jurisdictions. These drugs may compete
with our drug candidates, and our patent rights or other intellectual property rights may not be effective or adequate to prevent them
from competing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
companies have encountered significant problems in protecting and defending intellectual property rights in certain jurisdictions, including
the PRC. The legal systems of some countries do not favor the enforcement of patents, trade secrets and other intellectual property,
particularly those relating to biopharmaceutical products, which could make it difficult in those jurisdictions for us to stop the infringement,
misappropriation or other violation of our patents or other intellectual property rights, or the marketing of competing drugs in violation
of our proprietary rights.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition,
many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent
owner may have limited remedies, which could materially diminish the value of such patents. If we or any of our current or future licensors
are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be
impaired, and our business, financial condition, results of operations and prospects may be adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention
from other aspects of our business. Such proceedings could put our owned or licensed patents at risk of being invalidated, held unenforceable,
or interpreted narrowly, could put our patent applications at risk of not issuing and could provoke third parties to assert claims of
infringement, misappropriation or other intellectual property violation against us. We may not prevail in any lawsuits that we initiate,
and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual
property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we
develop.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the scope of any patent protection we obtain is not sufficiently broad, or if we lose any of our patent protection, our ability to prevent
our competitors from commercializing similar or identical drug candidates would be adversely affected.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent position of biopharmaceutical companies generally is highly uncertain, involves complex legal and factual questions, and has been
the subject of much litigation in recent years. As a result, the issuance, scope, validity, enforceability and commercial value of our
patent rights are highly uncertain. Our pending and future patent applications and those of our licensors may not result in patents being
issued which protect our drug candidates or which effectively prevent others from commercializing competitive drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted
after issuance. Even if patent applications we own or in-license currently or in the future issue as patents, they may not issue in a
form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us, or otherwise
provide us with any competitive advantage. Any patents that we own or in-license may be challenged or circumvented by third parties or
may be narrowed or invalidated as a result of challenges by third parties. Consequently, we do not know whether our drug candidates will
be protectable or remain protected by valid and enforceable patents. Our competitors or other third parties may be able to circumvent
our patents or the patents of our licensors by developing similar or alternative technologies or products in a non-infringing manner
which could materially adversely affect our business, financial condition, results of operations and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents or the patents of our
licensors may be challenged in the courts or patent offices in the United States and abroad. We may be subject to a third-party pre-issuance
submission of prior art to the United States Patent and Trademark Office, or USPTO, or become involved in opposition, derivation, revocation,
reexamination, post-grant review and inter partes review, or other similar proceedings challenging our owned patent rights. An adverse
determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate or render unenforceable, our
patent rights, allow third parties to commercialize our drug candidates and compete directly with us, without payment to us, or result
in our inability to manufacture or commercialize products without infringing third- party patent rights. Moreover, our patents or the
patents of our licensors may become subject to post-grant challenge proceedings, such as oppositions in a foreign patent office, that
challenge our or priority of invention or other features of patentability with respect to our patents and patent applications and those
of our licensors. Such challenges may result in loss of patent rights, loss of exclusivity or in patent claims being narrowed, invalidated
or held unenforceable, which could limit our ability to stop others from using or commercializing similar or identical technology and
products, or limit the duration of the patent protection of our drug candidates. Such proceedings also may result in substantial cost
and require significant time from our scientists and management, even if the eventual outcome is favorable to us. In addition, if the
breadth or strength of protection provided by our patents and patent applications or the patents and patent applications of our licensors
is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize
current or future drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intellectual
property rights do not necessarily address all potential threats to our competitive advantage.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations
and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">others
                                            may be able to develop products that are similar to our drug candidates but that are not
                                            covered by the claims of the patents that we own or license, or may own or license in the
                                            future;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            or our licensors or collaborators might not have been the first to make the inventions covered
                                            by the issued patents or patent application that we own or license, or may own or license
                                            in the future;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>


</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            or our licensors or collaborators might not have been the first to file patent applications
                                            covering certain of our inventions;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">others
                                            may independently develop similar or alternative technologies or duplicate any of our technologies
                                            without infringing our intellectual property rights;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            is possible that the pending patent applications we own or license, or may own or license
                                            in the future, will not lead to issued patents;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued
                                            patents that we own or license, or may own or license in the future, may be held invalid
                                            or unenforceable, as a result of legal challenges by our competitors;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">others
                                            may have access to the same intellectual property rights licensed to us in the future on
                                            a nonexclusive basis;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            competitors might conduct research and development activities in countries where we do not
                                            have patent rights and then use the information learned from such activities to develop competitive
                                            products for sale in our major commercial markets;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may not develop additional proprietary technologies that are patentable;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            patents or other intellectual property rights of others may have an adverse effect on our
                                            business; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may choose not to file a patent in order to maintain certain trade secrets or know-how, and
                                            a third party may subsequently file a patent covering such intellectual property.</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
any of these events occur, it could significantly harm our business, results of operations and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may become involved in lawsuits to protect, enforce or defend our intellectual property, which could be expensive, time consuming and
unsuccessful. Our patent rights relating to our drug candidates could be found invalid or unenforceable if challenged in court or in
patent offices.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitors
may infringe our patent rights or misappropriate or otherwise violate our intellectual property rights. To counter infringement or unauthorized
use, litigation may be necessary in the future to protect, enforce or defend our intellectual property rights, to protect our trade secrets
or to determine the validity and scope of our own intellectual property rights or the proprietary rights of others. This can be expensive
and time consuming. Any claims that we assert against perceived infringers could also provoke these parties to assert counterclaims against
us alleging that we infringe, misappropriate or otherwise violate their intellectual property rights. Many of our current and potential
competitors have the ability to dedicate substantially greater resources to protect, enforce and/or defend their intellectual property
rights than we can. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing upon, misappropriating
or otherwise violating our owned or licensed intellectual property. Proceedings to enforce our patent and other intellectual property
rights could result in substantial costs and diversion of management resources, which could harm our business and financial results.
In addition, in an infringement proceeding, a court may decide that patent rights or other intellectual property rights owned by us are
invalid or unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patent rights
or other intellectual property rights do not cover the technology in question. An adverse result in any litigation proceeding could put
our owned or licensed patents, as well as any patents that may be issued in the future from our owned or licensed pending patent applications,
at risk of being invalidated, held unenforceable or interpreted narrowly. Furthermore, because of the substantial amount of discovery
required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised
by disclosure during this type of litigation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we or one of our licensing partners initiate legal proceedings against a third party to enforce our owned or licensed patents, or any
patents that may be issued in the future from our owned or licensed patent applications that relate to one of our drug candidates, the
defendant could counterclaim that such patent rights are invalid or unenforceable. In patent litigation in the United States and the
PRC, defendant counterclaims alleging invalidity or unenforceability are commonplace, and there are numerous grounds upon which a third
party can assert invalidity or unenforceability of a patent. Third parties may also raise similar claims before administrative bodies,
even outside the context of litigation, through mechanisms such as ex parte re-examination, inter partes review, post-grant review, derivation,
opposition proceedings and equivalent proceedings. Such proceedings could result in revocation or amendment to our owned or licensed
patents in such a way that they no longer cover and protect our drug candidates. The outcome following legal assertions of invalidity
and unenforceability is unpredictable. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we
would lose at least part, and perhaps all, of the patent protection on our drug candidates. Such a loss of patent protection could have
a material adverse impact on our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to prevent misappropriation of our trade secrets or confidential information, particularly in countries where the laws
may not provide extensive protection for those rights. Furthermore, because of the substantial amount of discovery required in connection
with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during
this type of litigation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to claims challenging the inventorship or ownership of our owned and licensed patents and other intellectual property.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we are not currently experiencing any claims challenging the inventorship of our patents or ownership of our intellectual property, we
or our licensors may in the future be subject to claims that former employees, collaborators or other third parties have an interest
in our owned or licensed patents or other intellectual property as inventors or co-inventors. For example, we may have inventorship disputes
arise from conflicting obligations of consultants or others who are involved in developing our drug candidates. Litigation may be necessary
to defend against these and other claims challenging inventorship. If we fail in defending any such claims, in addition to paying monetary
damages, we may lose rights such as exclusive ownership of, or right to use, our patent rights or other owned or licensed intellectual
property. Such an adverse determination may also result in a loss of freedom to operate, or in patent claims or exclusivity rights drugs
being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing
similar technology and drug candidates, without payment to us, or could limit the duration of the patent protection covering our proprietary
technology and drug candidates. Such challenges may also result in our inability to develop, manufacture or commercialize our proprietary
technology and drug candidates without infringing, misappropriating or otherwise violating third-party patent rights. In addition, if
the breadth or strength of protection provided by our owned or licensed patents and patent applications is threatened, it could dissuade
companies from collaborating with us to license, develop or commercialize current or future technologies or drug candidates. Such an
outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation
could result in substantial costs and be a distraction to management and other employees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could
be costly and time consuming and could prevent or delay us from developing or commercializing our drug candidates.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial success depends in part on our avoiding infringement, misappropriation or other violation of the patents and other intellectual
property rights of third parties. There is a substantial amount of litigation involving patent and other intellectual property rights
in the biotechnology and pharmaceutical industries, including inter partes review, post grant review, interference and ex parte reexamination
proceedings and oppositions or other comparable proceedings. Given the vast number of patents in our field of technology, we cannot be
certain or guarantee that we do not infringe existing patents or that we will not infringe patents that may be granted in the future.
Numerous issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing
drug candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our drug
candidates may give rise to claims of infringement of the patent rights of others. For example, we are aware of patents owned by third
parties that have generic composition of matter or method of use claims that may relate to certain of our product candidates. Any challenge
to the validity of these patents may be unsuccessful, and courts or patent offices in the United States, the PRC and elsewhere could
uphold the validity of any such patents. If we were to challenge the validity of any issued United States patent in court, we would need
to overcome a statutory presumption of validity that attaches to every United States patent. This means that in order to prevail, we
would have to present clear and convincing evidence as to the invalidity of the patent claims.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
parties may assert that we are employing their proprietary technology, including patents and other intellectual property, without authorization.
There may be additional third-party patents and patent applications of which we are currently unaware with claims to materials, formulations,
methods of manufacture or methods for treatment related to the current or future use or manufacture of our drug candidates. Given that
patent applications can take around 18 months or longer to be published, there may be currently unpublished patent applications that
could be relevant to the use or manufacture of our drug candidates and give rise to infringement risks if such patent applications become
issued patents. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these
patents. If any such third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of any of
our drug candidates, any molecules formed during the manufacturing process or any final product itself, the holders of any such patents
may be able to prevent us from commercializing such drug candidate unless we obtain a license under the applicable patents, or until
such patents expire or they are finally determined to be held invalid or unenforceable. Similarly, if any such third-party patent were
held by a court of competent jurisdiction to cover aspects of our formulations, processes for manufacture or methods of use, including
combination therapy or patient selection methods, the holders of any such patent may be able to block our ability to develop and commercialize
the applicable drug candidate unless we obtain a license, limit our uses or until such patent expires or is finally determined to be
held invalid or unenforceable. In either case, such a license may not be available on commercially reasonable terms or at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
parties who bring successful claims against us for infringement, misappropriation or other violation of their intellectual property rights
may obtain injunctive or other equitable relief, which could prevent us from developing, manufacturing and commercializing one or more
of our drug candidates or other proprietary technology. Defense of these claims, regardless of their merit, would involve substantial
litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of
infringement, misappropriation or other violation of intellectual property against us, we may have to pay substantial damages, including
treble damages and attorneys&#8217; fees in the case of willful infringement, obtain one or more licenses from third parties, pay royalties
or redesign our infringing drug candidates, which may be impossible or require substantial time and monetary expenditure. In the event
of an adverse result in any such litigation, or even in the absence of litigation, we may need to obtain licenses from third parties
to advance our research or allow commercialization of our drug candidates. We cannot predict whether any required license would be available
at all or whether it would be available on commercially reasonable terms, and we may fail to obtain any of these licenses on commercially
reasonable terms, if at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors and
other third parties access to the same technologies licensed to us, and it could require us to make substantial licensing and royalty
payments. Also, in the event that we are unable to obtain such a license, we would be unable to further develop and commercialize one
or more of our drug candidates, which could harm our business significantly. We may also elect to enter into license agreements in order
to settle patent infringement claims or to resolve disputes prior to litigation, and any such license agreements may require us to pay
royalties and other fees that could significantly harm our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant
expenses, and could distract our technical personnel, management personnel, or both from their normal responsibilities. In addition,
there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities
analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the market price of the ADSs
and our ordinary shares. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available
for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources
to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or
proceedings more effectively than we can because of their greater financial resources.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse
effect on our ability to compete in the marketplace.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intellectual
property litigation may lead to unfavorable publicity that harms our reputation and causes the market price of our ordinary shares to
decline.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the course of any intellectual property litigation, there could be public announcements of the initiation of the litigation as well as
results of hearings, rulings on motions, and other interim proceedings in the litigation. If securities analysts or investors regard
these announcements as negative, the perceived value of our existing products, programs or intellectual property could be diminished.
Accordingly, the market price of the ADSs and ordinary shares may decline. Such announcements could also harm our reputation or the market
for our future products, which could have a material adverse effect on our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivation
proceedings may be necessary to determine priority of inventions, and an unfavorable outcome may require us to cease using the related
technology or to attempt to license rights from the prevailing party.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivation
proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the priority of inventions
with respect to our patents or patent applications or those of our licensors. An unfavorable outcome could require us to cease using
the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing
party does not offer us a license on commercially reasonable terms. Our defense of derivation proceedings may fail and, even if successful,
may result in substantial costs and distract our management and other employees. In addition, the uncertainties associated with such
proceedings could have a material adverse effect on our ability to raise the funds necessary to continue our clinical trials, continue
our research programs, license necessary technology from third parties or enter into development or manufacturing partnerships that would
help us bring our drug candidates to market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent,
which might adversely affect our ability to develop and market our products and drug candidates.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot guarantee that any of our patent searches or analyses, including the identification of relevant patents, the scope of patent claims
or the expiration of relevant patents, are or will be complete or thorough, nor can we be certain that we have identified or will identify
each and every third-party patent and pending patent application in the United States and abroad that is relevant to or necessary for
the commercialization of our current and future products and drug candidates in any jurisdiction. Patent applications in the United States
and elsewhere are not published until approximately 18 months after the earliest filing for which priority is claimed, with such earliest
filing date being commonly referred to as the priority date. Therefore, patent applications covering our drug candidates could have been
filed by others without our knowledge. It is also difficult for industry participants, including us, to identify these third-party patents
and patent applications because patent searching is imperfect due to differences in terminology among patents, incomplete databases and
the difficulty in assessing the meaning of patent claims. Further, the scope of a patent claim is determined by the interpretation of
the law, the words of a patent claim, the written disclosure in a patent and the patent&#8217;s prosecution history. Our interpretation
of the relevance or the scope of a patent or a pending patent application may be incorrect, which may negatively impact our ability to
market our products. We may incorrectly determine that our products or drug candidates are not covered by a third party patent or may
incorrectly predict whether a third party&#8217;s pending patent application will issue with claims of relevant scope. Our determination
of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, and we may incorrectly
conclude that a third-party patent is invalid and unenforceable or not infringed. Our failure to identify and correctly interpret relevant
patents may negatively impact our ability to develop and market our products and drug candidates. If we fail to identify and correctly
interpret relevant patents, we may be subject to infringement claims. Also, because the claims of published patent applications can change
between publication and patent grant, there may be published patent applications that may ultimately issue with claims that we infringe.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the number of competitors in the market grows and the number of patents issued in this area increases, the possibility of patent infringement
claims escalates. Moreover, in recent years, individuals and groups that are non- practicing entities, commonly referred to as &#8220;patent
trolls,&#8221; have purchased patents and other intellectual property assets for the purpose of making claims of infringement in order
to extract settlements. From time to time, we may receive threatening letters, notices or &#8220;invitations to license,&#8221; or may
be the subject of claims that our products and business operations infringe or violate the intellectual property rights of others. We
cannot guarantee that we will be able to successfully settle or otherwise resolve such infringement claims. If we fail in any such dispute,
in addition to being forced to pay damages, we may be temporarily or permanently prohibited from commercializing any of our drug candidates
that are held to be infringing. We might, if possible, also be forced to redesign drug candidates or services so that we no longer infringe
the third-party&#8217;s intellectual property rights. Any of these events, even if we were ultimately to prevail, could require us to divert
substantial financial and management resources that we would otherwise be able to devote to our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in U.S. patent law, or laws in other countries, or their interpretation could diminish the value of patents in general, thereby impairing
our ability to protect our drug candidates.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
is the case with other pharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining
and enforcing patents in the pharmaceutical industry involves a high degree of technological and legal complexity. Therefore, obtaining
and enforcing pharmaceutical patents is costly, time consuming and inherently uncertain. Changes in either the patent laws or in the
interpretations of patent laws in the United States and other countries may diminish the value of our intellectual property and may increase
the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. We cannot
predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. In addition, Congress or other
foreign legislative bodies may pass patent reform legislation that is unfavorable to us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
that other requirements for patentability are met, prior to March 2013, in the United States, the first to invent the claimed invention
was entitled to the patent, while outside the United States, the first to file a patent application was entitled to the patent. After
March 2013, under the Leahy-Smith America Invents Act, or the America Invents Act, enacted in September 2011, the United States transitioned
to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a
patent application would be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed
invention. A third party that files a patent application in the USPTO after March 2013, but before us could therefore be awarded a patent
covering an invention of ours even if we had made the invention before it was made by such third party. This requires us to be cognizant
of the time from invention to filing of a patent application. Since patent applications in the United States and most other countries
are confidential for a period of time after filing or until issuance, we cannot be certain that we or our licensors are the first to
either (1) file any patent application related to our drug candidates and other proprietary technologies we may develop; or (2) invent
any of the inventions claimed in our patents or patent applications.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
America Invents Act also included several significant changes that affect the way patent applications are prosecuted and also affect
patent litigation. These include allowing third party protests and submission of prior art to the USPTO during patent prosecution and
additional procedures to attack the validity of a patent by USPTO- administered post-grant proceedings, including post-grant review,
inter partes review and derivation proceedings.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to
invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a
claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action.
Accordingly, a third party may attempt to use the USPTO procedures to invalidate our owned and in-licensed patent claims that would not
have been invalidated if first challenged by the third party as a defendant in a district court action. An adverse determination in any
such submission or proceeding could reduce the scope or enforceability of, or invalidate, our patent rights, which could adversely affect
our competitive position.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
law relating the patentability of certain inventions in the life sciences industry is uncertain and rapidly changing, which may adversely
impact our existing patents or our ability to obtain patents in the future. The U.S. Supreme Court and federal courts have ruled on several
patent cases in recent years that impact the scope of patentability of certain inventions or discoveries related to the life sciences,
including both narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in
certain situations. The trend of these decisions along with resulting changes in patentability requirements being implemented by the
USPTO could make it increasingly difficult for us to obtain and maintain patents on our products, and could jeopardize or otherwise reduce
patent term, reduce the scope of, or invalidate or render unenforceable our patent rights. In addition to increasing uncertainty with
regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of
patents, once obtained.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, the U.S. Supreme Court held in <i>Amgen v. Sanofi </i>(2023) that a functionally claimed genus was invalid for failing to comply
with the enablement requirement of the U.S. Patent Act, 35 U.S.C. As such, our patent rights with functional claims may be vulnerable
to third party challenges seeking to invalidate these claims for lacking enablement or adequate support in the specification. Additionally,
other decisions in prior years found that patent claims that recite laws of nature are not themselves patentable unless those patent
claims have sufficient additional features that provide practical assurance that the processes are genuine inventive applications of
those laws rather than patent drafting efforts designed to monopolize the law of nature itself. What constitutes a &#8220;sufficient&#8221;
additional feature is uncertain. Depending on future actions and/or decisions by the U.S. Congress, the U.S. federal courts, the USPTO
or similar authorities in foreign jurisdictions, the laws and regulations governing patents could change in unpredictable ways that would
weaken our ability to obtain new patents or to enforce our existing patent and the patents we might obtain or license in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2012, the European Union Patent Package, or the EU Patent Package, regulations were passed with the goal of providing a single
pan-European Unitary Patent and a new European Unified Patent Court, or the UPC, for litigation involving European patents. The EU
Patent Package was implemented on June 1, 2023. As a result, all European patents, including those issued prior to ratification of
the EU Patent Package, now by default automatically fall under the jurisdiction of the UPC. It is uncertain how the UPC will impact
granted European patents in the biotechnology and pharmaceutical industries. Our European patent applications, if issued, could be
challenged in the UPC. During the first seven years of the UPC&#8217;s existence, the UPC legislation allows a patent owner to opt
for its European patents out of the jurisdiction of the UPC. We may decide to opt out our future European patents from the UPC, but
doing so may preclude us from realizing the benefits of the UPC. Moreover, if we do not meet all of the formalities and requirements
for opt-out under the UPC, our future European patents could remain under the jurisdiction of the UPC. The UPC will provide our
competitors with a new forum to centrally revoke our European patents and allow for the possibility of a competitor to obtain a
pan-European injunction. Such a loss of patent protection could have a material adverse impact on our business and our ability to
commercialize our technology and drug candidates due to increased competition and, resultantly, on our business, financial
condition, prospects and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict how decisions by courts or the applicable government entity may impact the value of our owned and licensed patents. Any
similar adverse changes in the patent laws of other jurisdictions could also have a material adverse effect on our business, financial
condition, results of operations and prospects. Depending on future actions by courts and applicable government entities, the laws and
regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio
and our ability to protect and enforce our or licensed intellectual property in the future. Any of the foregoing could have a material
adverse effect on our business, financial condition, results of operations and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Obtaining
and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements
imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Periodic
maintenance fees, renewal fees, annuity fees and various other government fees on our owned and licensed patents and patent applications
are due to be paid to patent agencies in various jurisdictions in several stages over the lifetime of the patent. Various governmental
patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent
application process. We are in some cases dependent on our outside counsel or our licensing partners to take the necessary action to
comply with these requirements with respect to our owned and licensed intellectual property. Although an inadvertent lapse can in many
cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance
can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the
relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include failure
to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal
documents. In any such event, our competitors might be able to enter the market, which would have a material adverse effect on our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
terms of our patents may not be sufficient to effectively protect our drug candidates and business, and we may need to obtain patent
term extensions and equivalent extensions outside of the United States.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
most countries in which we file, the term of an issued patent is generally 20 years from the earliest claimed filing date of a non-provisional
patent application in the applicable country. Although various extensions may be available, the life of a patent and the protection it
affords is limited.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, the Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Amendments, permit a patent extension
term of up to five years as compensation for patent term lost during the FDA regulatory review process based on the first regulatory
approval for a particular drug or biologic. A patent term extension cannot extend the remaining term of a patent beyond a total of 14
years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for
using it or a method for manufacturing it may be extended. In the European Union, supplementary protection certificates are available
to extend a patent term up to five years to compensate for patent term lost during regulatory review, and can be extended for an additional
six months if data from clinical trials is obtained in accordance with an agreed-upon pediatric investigation plan. Although all countries
in the European Union must, in accordance with applicable EU legislation, provide supplementary protection certificates, there is no
unified procedure among countries in the European Union and so supplementary protection certificates must be applied for and granted
on a country-by-country basis. This can lead to a substantial cost to apply for and receive these certificates, which may vary among
countries or not be provided at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be granted any extensions for which we apply in the United States or any other jurisdiction because of, for example, failing
to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing
to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time
period or the scope of patent protection afforded could be less than we request. In addition, to the extent we wish to pursue patent
term extension based on a patent that we in- license from a third party, we would need the cooperation of that third party. If we are
unable to obtain patent term extension, or the foreign equivalent, or if the term of any such extension is less than we request, our
competitors may be able to enter the market sooner, and our revenue could be reduced. Any of the foregoing could have a material adverse
effect on our business, financial condition, results of operations and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if patents covering our drug candidates are obtained, we may be open to competition from other companies as well as generic medications
once the patent life has expired for a drug. Manufacturers of generic drugs may challenge the scope, validity or enforceability of our
owned or licensed patents in court, and we or our licensors may not be successful in enforcing or defending those intellectual property
rights and, as a result, may not be able to develop or market the relevant product exclusively, which would have a material adverse effect
on any potential sales of that product. Upon the expiration of our issued patents, or patents that may issue from our pending patent
applications, we will not be able to assert such patent rights against potential competitors, and our business and results of operations
may be adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><!-- Field: Split-Segment; Name: 2 --><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. We may be subject
to claims that our employees have wrongfully used or disclosed alleged trade secrets or confidential information, including alleged trade
secrets, of their former employers.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive
position and to protect our drug candidates. However, trade secrets can be difficult to protect and some courts inside and outside the
United States are less willing or unwilling to protect trade secrets. We seek to protect these trade secrets, in part, by entering into
non-disclosure and confidentiality agreements with parties that have access to them, such as our employees, corporate collaborators,
outside scientific collaborators, sponsored researchers, contract manufacturers, consultants, advisors and other third parties. We also
enter into confidentiality agreements with our employees and consultants. However, monitoring unauthorized uses and disclosures is difficult,
and we do not know whether the steps we have taken to protect our proprietary technologies will be effective. Any of these parties may
breach such agreements and disclose our proprietary information, and we may not be able to obtain adequate remedies for such breaches.
Further, we cannot guarantee that we have entered into such agreements with each party that may have or has had access to our trade secrets
or proprietary technology and processes. We also seek to preserve the integrity and confidentiality of our data and trade secrets by
maintaining physical security of our premises and physical and electronic security of our information technology systems; however, such
systems and security measures may be breached, and we may not have adequate remedies for any breach. Enforcing a claim that a party illegally
disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming and the outcome is unpredictable. If any of
our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them from
using that technology or information to compete with us and our competitive position would be harmed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
many of our employees, including our senior management, were previously employed at other biotechnology or pharmaceutical companies,
including our competitors or potential competitors. Although we try to ensure that our employees do not use the proprietary information
or know-how of others in their work for us, we may be subject to claims that we or these employees have used or disclosed intellectual
property, including trade secrets or other proprietary information, of any such employee&#8217;s former employer. We are not aware of
any threatened or pending claims related to these matters or concerning the agreements with our senior management, but in the future
litigation may be necessary to defend against such claims. If we fail to defend any such claims, in addition to paying monetary damages,
we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation
could result in substantial costs and be a distraction to management. We may also lose personnel as a result of such claims, and any such
litigation or the threat thereof may adversely affect our ability to hire employees or contract with independent contractors. A loss
of key personnel or their work product could hamper or prevent our ability to commercialize our drug candidates, which would have a material
adverse effect on our business, results of operations, financial condition and prospects. Even if we are successful in defending against
such claims, litigation could result in substantial costs and be a distraction to management.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our trade secrets may otherwise become known or be independently discovered by competitors or other third parties. Competitors
or third parties could purchase our proprietary technologies or drug candidates and attempt to replicate some or all of the competitive
advantages we derive from our development efforts, willfully infringe our intellectual property rights, design around our protected technology
or develop their own competitive technologies that fall outside the scope of our intellectual property rights. If any of our trade secrets
were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them,
or those to whom they communicate such trade secrets, from using that technology or information to compete with us. If our trade secrets
are not adequately protected so as to protect our market against competitors&#8217; products, our business, financial condition, results
of operations and prospects could be materially and adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relatedly,
while we typically require our employees, consultants and contractors who may be involved in the development of intellectual property
to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party
who in fact develops intellectual property that we regard as our own, which may result in claims by or against us related to the ownership
of such intellectual property. Moreover, even when we obtain agreements assigning intellectual property to us, the assignment of intellectual
property rights may not be self-executing or the assignment agreements may be breached, and we may be forced to bring claims against
third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property.
Furthermore, individuals executing agreements with us may have preexisting or competing obligations to a third party, such as an academic
institution, and thus an agreement with us may be ineffective in perfecting ownership of inventions developed by that individual. If
we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property
rights. Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs and be
a distraction to our management and scientific personnel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be successful in obtaining or maintaining necessary rights for our development pipeline through acquisitions and in-licenses.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
our programs may involve additional drug candidates that may require the use of additional intellectual property or proprietary rights
held by third parties, the growth of our business may depend in part on our ability to acquire and maintain licenses or other rights
to use these proprietary rights. We may be unable to acquire or in-license any compositions, methods of use or other third-party intellectual
property rights from third parties that we identify as necessary for our proprietary technology or drug candidates on commercially reasonable
terms or at all. Even if we are able to in-license any such necessary intellectual property, it could be on nonexclusive terms, thereby
giving our competitors and other third parties access to the same intellectual property licensed to us, and it could require us to make
substantial licensing and royalty payments. The licensing and acquisition of third-party intellectual property rights is a competitive
area, and a number of more established companies are also pursuing strategies to license or acquire third-party intellectual property
rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their
size, cash resources, and greater clinical development and commercialization capabilities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to
license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment.
If we are unable to successfully obtain rights to required third-party intellectual property rights, we may be required to expend significant
time and resources to redesign our proprietary technology or drug candidates, or to develop or license replacement technology, and our
business, financial condition and prospects for growth could suffer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
rights to develop and commercialize our technology and drug candidates may be subject, in part, to the terms and conditions of licenses
granted to us by others. If we fail to comply with our obligations in the agreements under which we license intellectual property rights
from third parties or otherwise experience disruptions to our business relationships with our licensors, we could lose license rights
that are important to our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into license agreements with third parties, including the University of Michigan, for rights related to certain of our drug
candidates, and we may enter into additional license agreements in the future with others to advance our research or allow commercialization
of drug candidates. These and other licenses may not provide exclusive rights to use such intellectual property and technology in all
relevant fields of use and in all territories in which we may wish to develop or commercialize our technology and products in the future.
Additionally, our current license agreements impose, and future agreements may impose various development, diligence and other obligations
on us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, subject to the terms of any such license agreements, we may not have the right to control the preparation, filing, prosecution,
maintenance, enforcement or defense of patents and patent applications covering the technology that we license from third parties. In
such an event, we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted, maintained, enforced
and defended in a manner consistent with the best interests of our business or in compliance with applicable laws and regulations, or
will result in valid and enforceable patents and other intellectual property rights. It is possible that our licensors&#8217; infringement
proceedings or defense activities may be less vigorous than had we conducted them ourselves or may not be conducted in accordance with
our best interests. If our licensors fail to prosecute, maintain, enforce and defend such patents, or lose rights to those patents or
patent applications, the rights we have licensed may be reduced or eliminated, and our right to develop and commercialize any of our
products that are subject of such licensed rights could be adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
licensors may have relied on third party consultants or collaborators or on funds from third parties such that our licensors are not
the sole and exclusive owners of the patents we in-licensed. If other third parties have ownership rights to our in-licensed patents,
they may be able to license such patents to our competitors, and our competitors could market competing products and technology. This
could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is possible that we may be unable to obtain additional licenses at a reasonable cost or on reasonable terms, if at all. Even if we are
able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In
that event, we may be required to expend significant time and resources to redesign our technology, drug candidates, or the methods for
manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis.
If we are unable to do so, we may be unable to develop or commercialize the affected drug candidates, which could harm our business,
financial condition, results of operations and prospects significantly. We cannot provide any assurances that third party patents do
not exist which might be enforced against our current technology, manufacturing methods, drug candidates, or future methods or products
resulting in either an injunction prohibiting our manufacture or future sales, or, with respect to our future sales, an obligation on
our part to pay royalties and/or other forms of compensation to third parties, which could be significant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information on the terms of our license agreements with the University of Michigan, see &#8220;<i>Item 4. Information on the Company&#8212;
B. Business Overview&#8212;Agreements with the University of Michigan</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to comply with our obligations in the agreements under which we license intellectual property rights to or from third parties
or otherwise experience disruptions to our business relationships with our licensors or licensees, we could lose license rights that
are important to our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are heavily reliant upon licenses from third parties to certain patent rights and proprietary technology that are important to or necessary
to the development of our technology and drug candidates, including licenses we are granted through our agreements with the University
of Michigan. Disputes may arise between us and our licensors or licensees regarding intellectual property subject to a license agreement,
including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            scope of rights granted under the license agreement and other interpretation-related issues;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            financial or other obligations under the license agreement;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            and the extent to which our technology and processes infringe on intellectual property of
                                            the licensor or licensee that is not subject to the licensing agreement;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            right to sublicense patents and other rights to third parties;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            diligence obligations under the license agreement and what activities satisfy those diligence
                                            obligations;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            right to transfer or assign the license;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            inventorship and ownership of inventions and know-how resulting from the joint creation or
                                            use of intellectual property by our licensors and us and our partners; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            priority of invention of patented technology.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may seek to obtain additional licenses from our licensors and, in connection with obtaining such licenses, we may agree
to amend our existing licenses in a manner that may be more favorable to the licensors, including by agreeing to terms that could enable
third parties, including our competitors, to receive licenses to a portion of the intellectual property that is subject to our existing
licenses and to compete with our proprietary technologies and drug candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreements under which we license intellectual property or technology from third parties are complex, and certain provisions in such
agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise
could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe
to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business,
financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that we have licensed prevent
or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully
develop and commercialize the affected drug candidates, which could have a material adverse effect on our business, financial conditions,
results of operations and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
spite of our best efforts, our counterparties might conclude that we have materially breached our license agreements and might therefore
terminate the license agreements, thereby removing our ability to develop and commercialize products and technology covered by these
license agreements, including our agreements with the University of Michigan. If these licenses are terminated, or if the underlying
patents fail to provide the intended exclusivity, competitors would have the freedom to seek regulatory approval of, and to market, products
identical to ours. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions,
results of operations and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information on the terms of our license agreements with the University of Michigan, see &#8220;<i>Item 4. Information on the Company&#8212;B.
Business Overview&#8212;Agreements with the University of Michigan</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to claims that we or our employees have wrongfully used or disclosed alleged confidential information or trade secrets.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into and may enter in the future into non-disclosure and confidentiality agreements to protect the proprietary positions
of third parties, such as outside scientific collaborators, CROs, third-party manufacturers, consultants, advisors, potential partners,
lessees of shared multi-company property and other third parties. We may become subject to litigation where a third party asserts that
we or our employees inadvertently or otherwise breached the agreements and used or disclosed trade secrets or other information proprietary
to the third parties. The inquiry may progress to a claim that we or our employees inadvertently or otherwise breached the agreement
and used trade secrets or other information proprietary to the third party. Defense of such matters, regardless of their merit, could
involve substantial litigation expense and be a substantial diversion of employee resources from our business. We cannot predict whether
we would prevail in any such actions. Moreover, intellectual property litigation, regardless of its outcome, may cause negative publicity
and could prohibit us from marketing or otherwise commercializing our drug candidates and technology. Failure to defend against any such
claim could subject us to significant liability for monetary damages or prevent or delay our developmental and commercialization efforts,
which could adversely affect our business. Even if we are successful in defending against these claims, litigation could result in substantial
costs and be a distraction to our management team and other employees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
making claims against us may be able to sustain the costs of complex intellectual property litigation more effectively than we can because
they have substantially greater resources. Furthermore, because of the substantial amount of discovery required in connection with intellectual
property litigation, there is a risk that some of our confidential information could be compromised by disclosure. In addition, any uncertainties
resulting from the initiation and continuation of any litigation could have material adverse effect on our ability to raise additional
funds or otherwise have a material adverse effect on our business, operating results, financial condition and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to claims that we have wrongfully hired an employee from a competitor or that we or our employees have wrongfully used
or disclosed alleged confidential information or trade secrets of their former employers.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
is common in the pharmaceutical industry, in addition to our employees, we engage the services of consultants to assist us in the development
of our drug candidates. Many of these consultants, and many of our employees, were previously employed at, or may have previously provided
or may be currently providing consulting services to other pharmaceutical companies including our competitors or potential competitors.
We may become subject to claims that we, our employees or a consultant inadvertently or otherwise used or disclosed trade secrets or
other information proprietary to their former employers or their former or current clients. Litigation may be necessary to defend against
these claims. If we fail to defend any such claims, in addition to paying monetary damages, we may lose valuable intellectual property
rights or personnel, which could adversely affect our business. Even if we are successful in defending against these claims, litigation
could result in substantial costs and be a distraction to our management team and other employees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>
Patent protection and patent prosecution for some of our drug candidates may be dependent on third parties.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we normally seek to obtain the right to control prosecution, maintenance and enforcement of the patents relating to our drug candidates,
there may be times when the filing and prosecution activities for patents relating to our drug candidates are controlled by our licensors
or collaboration partners. If any of our licensors or collaboration partners fail to prosecute, maintain and enforce such patents and
patent applications in a manner consistent with the best interests of our business, including by payment of all applicable fees for patents
covering our drug candidates, we could lose our rights to the intellectual property or our exclusivity with respect to those rights,
our ability to develop and commercialize those drug candidates may be adversely affected and we may not be able to prevent competitors
from making, using and selling competing products. In addition, even where we have the right to control patent prosecution of patents
and patent applications we have licensed to and from third parties, we may still be adversely affected or prejudiced by actions or inactions
of our licensees, our licensors and their counsel that took place prior to the date upon which we assumed control over patent prosecution.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current and future trademark applications in the United States and in foreign jurisdictions may not be allowed or may subsequently be
opposed. Once filed and registered, our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined
to be infringing on other marks. As a means to enforce our trademark rights and prevent infringement, we may be required to file trademark
claims against third parties or initiate trademark opposition proceedings. This can be expensive and time-consuming, particularly for
a company of our size. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition
among potential partners or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to
ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential
trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations
of our registered or unregistered trademarks or trade names. Over the long term, if we are unable to establish name recognition based
on our trademarks and trade names, then we may not be able to compete effectively, and our business may be adversely affected. Our efforts
to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property
may be ineffective and could result in substantial costs and diversion of resources. Any of the foregoing could have a material adverse
effect on our business, financial condition, results of operations and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
related to our reliance on third parties</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>We
rely on third parties to manufacture a portion of our drug candidate supplies, and we intend to rely on third parties for at least a
portion of the manufacturing process of our drug candidates, including Olverembatinib and Lisaftoclax. Our business could be harmed if
those third parties fail to provide us with sufficient quantities of product or fail to do so at acceptable quality levels or prices.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Although
we currently have manufacturing facilities in the PRC that support our clinical and commercial production, we partially rely on outside
vendors to manufacture supplies and process our drug candidates, including Olverembatinib and Lisaftoclax. We have limited experience
in managing the manufacturing process, and our process may be more difficult or expensive than the approaches currently in use. Our anticipated
reliance on a limited number of third-party manufacturers exposes us to the following risks:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may be unable to identify manufacturers on acceptable terms or at all because the number
                                            of potential manufacturers is limited and the FDA, NMPA or other comparable regulatory authorities
                                            must evaluate and/or approve any manufacturers as part of their regulatory oversight of our
                                            drug candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            manufacturers may have little or no experience with manufacturing our drug candidates, and
                                            therefore may require a significant amount of support from us in order to implement and maintain
                                            the infrastructure and processes required to manufacture our drug candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            third-party manufacturers might be unable to timely manufacture our drug candidates or produce
                                            the quantity and quality required to meet our clinical and commercial needs, if any;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">contract
                                            manufacturers may not be able to execute our manufacturing procedures and other logistical
                                            support requirements appropriately;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            future contract manufacturers may not perform as agreed, may not devote sufficient resources
                                            to our drug candidates, or may not remain in the contract manufacturing business for the
                                            time required to supply our clinical trials or to successfully produce, store and distribute
                                            our drug candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may not own, or may have to share, the intellectual property rights to any improvements made
                                            by our third-party manufacturers in the manufacturing process for our drug candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            third-party manufacturers could breach or terminate their agreement with us; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of these and other risks could delay or prevent the completion of our clinical trials or the approval of any of our drug candidates by
the FDA, NMPA or other comparable regulatory authorities, result in higher costs or adversely impact commercialization of our drug candidates.
In addition, we will rely on third parties to perform certain specification tests on our drug candidates prior to delivery to patients.
If these tests are not appropriately done and test data are not reliable, patients could be put at risk of serious harm and the FDA,
NMPA or other comparable regulatory authorities could place significant restrictions on our company until deficiencies are remedied.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
manufacture of drugs is complex and requires significant expertise and capital investment, including the development of advanced manufacturing
techniques and process controls. Many of the third parties with whom we contract may also have relationships with other commercial entities,
some of which may compete with us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturers
of drug often encounter difficulties in production, particularly in scaling up or out, validating the production process, and assuring
high reliability of the manufacturing process (including the absence of contamination). Furthermore, if contaminants are discovered in
our supply of our drug candidates or in the manufacturing facilities, such manufacturing facilities may need to be closed for an extended
period of time to investigate and remedy the contamination. We cannot assure you that any stability failures or other issues relating
to the manufacture of our drug candidates will not occur in the future. Additionally, our manufacturers may experience manufacturing
difficulties due to resource constraints or as a result of labor disputes or unstable political environments. If our manufacturers were
to encounter any of these difficulties, or otherwise fail to comply with their contractual obligations, our ability to provide our drug
candidate to patients in clinical trials would be jeopardized. Any delay or interruption in the supply of clinical trial supplies could
delay the completion of clinical trials, increase the costs associated with maintaining clinical trial programs and, depending upon the
period of delay, require us to begin new clinical trials at additional expense or terminate clinical trials completely.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
third-party manufacturers fail to comply with manufacturing regulations, our financial results and financial condition will be adversely
affected.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
a third party can begin commercial manufacture of our drug candidates, contract manufacturers are subject to regulatory inspections of
their manufacturing facilities, processes and quality systems. Due to the complexity of the processes used to manufacture our drug candidates,
any potential third-party manufacturer may be unable to initially pass federal, state or international regulatory inspections in a cost-effective manner in order for us to obtain regulatory approval of our drug candidates. If our contract manufacturers do not pass their
inspections by the FDA, NMPA or other comparable regulatory authorities, our commercial supply of drug product or substance will be significantly
delayed and may result in significant additional costs, including the delay or denial of any marketing application for our drug candidates.
In addition, drug manufacturing facilities are continuously subject to inspection by the FDA, NMPA and other comparable regulatory authorities,
before and after drug approval, and must comply with cGMPs. In addition, contract manufacturers&#8217; failure to achieve and maintain
high manufacturing standards in accordance with applicable regulatory requirements, or the incidence of manufacturing errors, could result
in patient injury, product liability claims, product shortages, product recalls or withdrawals, delays or failures in product testing
or delivery, cost overruns or other problems that could seriously harm our business. If a third-party manufacturer with whom we contract
is unable to comply with manufacturing regulations, we may also be subject to fines, unanticipated compliance expenses, recall or seizure
of our drug candidates, product liability claims, total or partial suspension of production and/or enforcement actions, including injunctions,
and criminal or civil prosecution. These possible sanctions could materially adversely affect our financial condition and results of
operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furthermore,
changes in the manufacturing process or procedure, including a change in the location where the product is manufactured or a change of
a third-party manufacturer, could require prior review by the FDA, NMPA or other comparable regulatory authorities and/or approval of
the manufacturing process and procedures in accordance with the FDA or NMPA&#8217;s regulations or comparable requirements. This review
may be costly and time-consuming and could delay or prevent the launch of a product. The new facility will also be subject to pre-approval
inspection. In addition, we have to demonstrate that the product made at the new facility is equivalent to the product made at the former
facility by physical and chemical methods, which are costly and time consuming. It is also possible that the FDA, NMPA or other comparable
regulatory authorities may require clinical testing as a way to prove equivalency, which would result in additional costs and delay.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>We are dependent on our suppliers, and the inability or other
failure of suppliers to deliver necessary materials and components of our products at prices and volume and with specifications and performance
characteristics acceptable to us, could materially harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Currently, our drug substance or API for our manufacturing activities
are supplied by a single source supplier. We have agreements for the supply of drug substance with manufacturers that we currently believe
have sufficient capacity to meet our demands. However, raw materials and components used in the manufacturing process, particularly those
for which we have no other source or supplier, may not be available or may not be suitable or acceptable for use due to material or component
defects. There is a risk that, if supplies are interrupted in any manner, including as a result of the BIOSECURE Act, it would materially
harm our business. For additional detail, see <i>&#8220;Risks related to doing business in the PRC&#8212;The tension in international
trade, rising political tension and increasing geopolitical risks, particularly between the United States and China, pose significant
challenges that may adversely impact our business, results of operations and financial condition.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have entered into collaborations and other relationships with leading biotechnology companies and research institutions and may form
or seek other collaborations or strategic alliances or enter into additional licensing arrangements in the future, and we may not realize
the benefits of such alliances or licensing arrangements.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We may form
or seek strategic alliances, create joint ventures or collaborations, or enter into additional licensing arrangements with third parties
that we believe will complement or augment our development and commercialization efforts with respect to Olverembatinib and Lisaftoclax,
our other drug candidates and any future drug candidates that we may develop. Any of these relationships may require us to incur non-recurring
and other charges, increase our near and long-term expenditures, issue securities that dilute our existing shareholders, or disrupt our
management and business. We have also established collaborations and other relationships with leading biotechnology and pharmaceutical
companies around the world, including a collaboration and license agreement with Innovent and clinical collaboration agreements with
AstraZeneca, Merck and Pfizer, and research and development relationships with leading research institutions, such as Dana-Farber Cancer
Institute, Mayo Clinic, MD Anderson Cancer Center, National Cancer Institute and the University of Michigan. See the section titled &#8220;<i>Item
4. Information on the Company&#8212;B. Business Overview&#8212;License, collaboration and agreements</i>&#8221; for more information.
We cannot guarantee you that these third parties (which we refer to in this risk factor as collaborators) will not terminate their collaboration,
or seek to change terms of the collaboration, with us. Additionally, in June 2024, we entered an exclusive option agreement where we
granted Takeda an exclusive option to take an exclusive license (even as to us and our affiliates) to Olverembatinib in the Territory.
We cannot guarantee that Takeda will not terminate the option agreement or seek to change the terms of the exclusive license prior
to exercising the option, nor can we guarantee that Takeda will exercise the option at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face significant competition in seeking appropriate strategic partners, and the negotiation process is time-consuming and complex. Whether
we reach a definitive agreement for a collaboration, partnership, licenses or other arrangement will depend, among other things, upon
our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration, partnership,
licenses or other arrangement and the proposed collaborator&#8217;s evaluation of a number of factors. These factors may include the
design or results of clinical trials, the likelihood of approval by the FDA or applicable foreign regulatory authorities, the potential
market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients,
the potential of competing products and the existence of uncertainty with respect to its ownership of technology, which can exist if
there is a challenge to such ownership without regard to the merits of the challenge and industry and market conditions generally. Moreover,
we may not be successful in our efforts to establishing or maintaining our collaborations, partnerships, licenses or other arrangements
for our drug candidates because they may be deemed to be at too early of a stage of development for collaborative effort and third parties
may not view our drug candidates as having the requisite potential to demonstrate safety and efficacy or commercial potential. If and
when we collaborate with a third party for the development and commercialization of a drug candidate, such as our strategic partnership
with Innovent, we can expect to relinquish some or all of the control over the future success of that drug candidate to the third party.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborations,
partnerships, licenses and other similar arrangements are complex and time-consuming to negotiate and document. In addition, there have
been a significant number of business combinations among large pharmaceutical companies that have resulted in a reduced number of potential
future collaborators.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
collaborations, partnerships, licenses and other similar arrangements involving our drug candidates and are subject to numerous risks,
which may include the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
                                            have significant discretion in determining the efforts and resources that they will apply
                                            to a collaboration;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
                                            may not pursue development and commercialization of our drug candidates or may elect not
                                            to continue or renew development or commercialization programs based on clinical trial results,
                                            changes in their strategic focus due to the acquisition of competitive drugs, availability
                                            of funding or other external factors that diverts resources or creates competing priorities;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
                                            may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical
                                            trial, abandon a drug candidate, repeat or conduct new clinical trials or require a new formulation
                                            of a drug candidate for clinical testing;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
                                            could independently develop, or develop with third parties, drugs that compete directly or
                                            indirectly with our drug candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            collaborator with marketing and distribution rights to one or more drugs may not commit sufficient
                                            resources to their marketing and distribution;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
                                            may not properly maintain, enforce, protect or defend our intellectual property rights or
                                            may use our intellectual property or proprietary information in a way that gives rise to
                                            actual or threatened litigation that could jeopardize or invalidate our intellectual property
                                            or proprietary information or expose us to potential liability;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes
                                            may arise between us and a collaborator that cause the delay or termination of the research,
                                            development or commercialization of our drug candidates, or that result in costly litigation
                                            or arbitration that diverts management attention and resources;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborations
                                            with entities or educational institutions in the United States may be suspended, terminated
                                            or otherwise adversely affected by escalating geopolitical tensions between the United States
                                            and China, which may be exacerbated by recent retaliatory tariff increases; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
                                            may own or co-own intellectual property covering our drug candidates that results from our
                                            collaborating with them, and in such cases, we would not have the exclusive right to commercialize
                                            such intellectual property.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, we may not be able to realize the benefit of current or future collaborations, joint ventures, strategic partnerships or the
license of any third-party drugs if we are unable to successfully integrate such products with our existing operations and company culture,
which could delay our timelines or otherwise adversely affect our business. If our existing collaborations are terminated or suspended,
we may not be able to identify other suitable collaborators or reach agreement with other suitable collaborators on a timely basis, on
acceptable terms or at all. If we are unable to continue our collaborations with our existing collaborators or are unable to identify
or reach agreement with other suitable collaborators, we may have to curtail the development of a drug candidate, reduce or delay its
development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any
sales or marketing activities, increase our expenditures or needs for additional capital to pursue further development or commercialization
of the applicable drug candidates or undertake development or commercialization activities at our own expense. If we fail to enter into
collaborations and do not have sufficient funds or expertise to undertake the necessary development and commercialization activities,
we may not be able to further develop our drug candidates or bring them to market and generate product sales revenue, which would harm
our business prospects, financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely on our current and future partners&#8217; willingness and ability to devote resources to the development and commercialization of
some of our products and product candidates and to otherwise support our business as contemplated in our partnership agreements, which
may be terminated.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We rely on
our current and future partners to support our business, including to assist with, or to conduct, clinical and regulatory development,
manufacturing and/or commercialization of certain of our products and product candidates or to provide access to technologies, skills
and information that we do not possess. For example, we have granted Innovent exclusive rights to develop with us our Olverembatinib
in the PRC, the Hong Kong Special Administrative Region, the Macau Special Administrative Region and Taiwan and exclusive rights to commercialize
Olverembatinib in certain cities within the PRC, the Hong Kong Special Administrative Region, the Macau Special Administrative Region
and Taiwan. Additionally, in June 2024, we granted Takeda an exclusive option to take an exclusive license (even as to us and our affiliates)
to Olverembatinib in the Territory, with potential additional payments and royalties, but we cannot guarantee you that Takeda will not
terminate the option agreement or seek to change the terms of the exclusive license prior to exercising the option, nor can we guarantee
that Takeda will exercise the option at all. If we do not realize the contemplated benefits from our current and expected partnerships,
our business, financial condition and results of operations may be materially harmed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">In particular,
the termination of our current and future partnerships could significantly impact the development and commercialization of our products
and product candidates and impact our financial results and future prospects. For example, Innovent has the right to terminate the collaboration
and license agreement concerning Olverembatinib at any time by providing 180 days&#8217; prior written notice to us; provided, that in
the event we are not able to commercialize the licensed product in the cities which Innovent has exclusive rights to, we have certain
rights and obligations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Additionally,
under our exclusive option agreement with Takeda, Takeda has the right to not elect to exercise the exclusive option and can terminate
the agreement in its sole discretion upon written notice, among other options. Any disruption to our arrangement with Takeda or changes
in Takeda&#8217;s product development or business strategy for Olverembatinib could result in Takeda terminating the option agreement
or seeking to amend the terms of such agreement or seek other changes that could ultimately cause a material decline in our expected
revenue. Any failure by any current or future partner to perform its obligations under our agreements for any reason, including its obligations
to make milestone payments or pay royalties, or modification of termination of such agreements, could have a material adverse effect
on our financial performance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also expect we will continue to rely on certain of our current and future partners to periodically provide us with information about
the status, progress and results of clinical trials and regulatory processes that they are conducting, sponsoring or pursuing with respect
to our partnered products. With certain partners, we may not have direct access to the underlying data or direct communications with
the relevant regulators.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our reliance on our current and future partners could subject us to a number of additional risks, including the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            partners have significant discretion regarding whether and on what timeline to pursue planned
                                            activities;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            cannot control the quantity and nature of the resources our partners may devote to the development,
                                            commercialization, marketing and distribution of products or product candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            partners may not develop products generated using our small-molecule technology as expected;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes
                                            between us and our partners may delay or terminate the research, development or commercialization
                                            of the applicable products and product candidates or result in costly litigation or arbitration
                                            that diverts management&#8217;s attention and resources;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may not receive milestone payments from our partners, at the expected time or at all, if
                                            our partners do not achieve future milestones or if we and our partners disagree about whether
                                            a milestone has been reached;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            respect to collaborations, partnerships or other arrangements under which we have an active
                                            role, we and our partners may have differing opinions or priorities, or we may encounter
                                            challenges in joint decision making, which may delay or terminate the research, development
                                            or commercialization of the applicable products and product candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            partners may delay, terminate or repeat clinical trials or require a new formulation of a
                                            product candidate for clinical testing, or may abandon a product candidate;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            relationships with our partners may divert significant time and effort of our scientific
                                            staff and management team;</span></td>
</tr></table><div>

</div><p style="text-align: left; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            partners may be subject to regulatory sanctions that could adversely affect the development,
                                            approval or commercialization of the applicable products or product candidates;</span></td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            partners may not properly maintain or defend relevant intellectual property rights, or may
                                            infringe the intellectual property rights of third parties, or may use our or third parties&#8217;
                                            proprietary information in such a way as to invite litigation that could jeopardize or invalidate
                                            our proprietary information or expose us to potential litigation;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            partners may develop competing products, therapeutic approaches or technologies;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">business
                                            combinations, financial difficulties or significant changes in a partner&#8217;s business
                                            strategy may adversely affect that partner&#8217;s willingness or ability to continue to
                                            pursue our products or product candidates; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            collaborations, partnerships, licenses or other arrangements that we rely or expect to rely
                                            on may be terminated, breached or allowed to expire, or our partners may reduce the scope
                                            of our agreements with them.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
one or more of the foregoing risks, if realized, could have a material adverse effect on our business, financial condition and results
of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to maintain an effective distribution channel for our drug candidates, our business and sales could be adversely affected.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We have relied
on, and plan to rely on, a number of third-party distributors to distribute Olverembatinib in China, including Innovent, and Lisaftoclax
and we plan to rely on third-party distributors to distribute drug candidates in jurisdictions outside of China, if approved. Our ability
to maintain and grow our business will depend on our ability to maintain an effective distribution channel that ensures the timely delivery
of our drug candidates. However, we have relatively limited control over our distributors which may fail to distribute our drug candidates
in the manner we contemplate. If price controls or other factors substantially reduce the margins our distributors can obtain through
the resale of our drug candidates to hospitals, medical institutions and sub-distributors, they may terminate their relationship with
us. There is a risk that, if the distribution of our drug candidates is interrupted, our sales volumes and business prospects could be
adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>We
rely on third parties to conduct our preclinical studies and clinical trials, and we must work effectively with collaborators to develop
our drug candidates. In many cases, our drug candidates, including Olverembatinib and Lisaftoclax, are studied in third-party studies,
including investigator-initiated trials. If these third parties do not successfully carry out their contractual duties or meet expected
deadlines, or fail to design, execute, and complete appropriate and timely studies of our drug candidates, we may not be able to obtain
regulatory approval for or commercialize our drug candidates and our business could be substantially harmed.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently have the ability to independently conduct clinical trials. We have relied upon and plan to continue to rely upon third-party
CROs to monitor and manage data for our ongoing preclinical and clinical programs. We rely on these parties for execution of our preclinical
studies and clinical trials, and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that
each of our studies is conducted in accordance with the applicable protocol, legal and regulatory requirements and scientific standards,
and our reliance on the CROs does not relieve us of our regulatory responsibilities. We, our CROs for our clinical programs and our clinical
investigators are required to comply with cGCPs, which are regulations and guidelines enforced by the FDA, NMPA and other comparable
regulatory authorities for all of our drug candidates in clinical development. Regulatory authorities enforce these cGCPs through periodic
inspections of trial sponsors, principal investigators and trial sites. If we or any of our CROs or clinical investigators fail to comply
with applicable cGCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA, NMPA or comparable regulatory
authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that
upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials comply with
cGCP regulations. In addition, our clinical trials must be conducted with products produced under cGMP regulations. Our failure to comply
with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
CROs have the right to terminate their agreements with us in the event of an uncured material breach. In addition, some of our CROs have
an ability to terminate their respective agreements with us if it can be reasonably demonstrated that the safety of the subjects participating
in our clinical trials warrants such termination, if we make a general assignment for the benefit of our creditors or if we are liquidated.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of our relationships with these third-party CROs terminate, we may not be able to enter into arrangements with alternative CROs or
to do so on commercially reasonable terms. In addition, our CROs are not our employees, and except for certain restrictions imposed under
our agreements with such CROs, we have limited ability to control whether or not they devote sufficient time and resources to our ongoing
clinical and nonclinical programs. If CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines,
if they need to be replaced or if the quality or accuracy of the clinical data they or our clinical investigators obtain is compromised
due to the failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended,
delayed or terminated and we may not be able to obtain regulatory approval for or successfully commercialize our drug candidates. As
a result, we may need to enter into new arrangements with alternative third parties, our results of operations and the commercial prospects
for our drug candidates may be harmed, our costs could increase and our ability to generate revenues could be delayed. Switching or adding
additional CROs involves additional cost and requires management time and focus. In addition, there is a natural transition period when
a new CRO commences work. As a result, delays occur, which can materially influence our ability to meet our desired clinical development
timelines. Though we carefully manage our relationships with our CROs, there can be no assurance that we will not encounter similar challenges
or delays in the future or that these delays or challenges will not have a material adverse effect on our business, financial condition
and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our future
revenues are dependent on our ability to work effectively with collaborators to develop our drug candidates, including to obtain regulatory
approval, and commercialize our drug candidates, including Olverembatinib and Lisaftoclax in the United States and other jurisdictions.
Our arrangements with collaborators will be critical to successfully bringing products to market and commercializing them. We rely on
collaborators in various respects, including to undertake research and development programs and conduct clinical trials for our licensed
technology, manage or assist with the regulatory filings and approval process and to assist with our commercialization efforts. We do
not control our collaborators; therefore, we cannot ensure that these third parties will adequately and timely perform all of their obligations
to us. If they fail to complete the remaining studies successfully, or at all, it could delay, adversely affect or prevent regulatory
approval. We cannot guarantee the satisfactory performance of any of our collaborators and if any of our collaborators breach or terminate
their agreements with us, we may not be able to successfully commercialize the licensed product which could materially and adversely
affect our business, financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">In many cases,
our drug candidates, including Olverembatinib and Lisaftoclax, are included in preclinical studies and clinical trials, including investigator-initiated
trials, over which we may have no or limited control. If they fail to design, execute, and complete appropriate and timely studies of
our drug candidates or patients may experience AEs not related to our drug candidate that could still impact regulatory approval or market
adoption by patients, healthcare providers and/or payors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
related to our industry, business and operations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our manufacturing facilities are damaged or destroyed or production at such facilities is otherwise interrupted, our business and prospects
would be negatively affected.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">In addition
to the manufacturing risks described in &#8220;&#8212;<i>Risks related to commercialization</i>&#8221; and &#8220;&#8212;<i>Risks related
to our reliance on third parties</i>,&#8221; if our manufacturing facilities or the equipment in them is damaged or destroyed, we may
not be able to quickly or inexpensively replace our manufacturing capacity or replace it at all. In the event of a temporary or protracted
loss of the facilities or equipment, we might not be able to transfer manufacturing to a third party. Even if we could transfer manufacturing
to a third party, the shift would likely be expensive and time- consuming, particularly since the new facility would need to comply with
the necessary regulatory requirements and we would need FDA, NMPA or and other comparable regulatory agency approval before selling any
drugs manufactured at that facility. Such an event could delay our clinical trials or reduce sales of Olverembatinib and Lisaftoclax
in China or our product sales if and when we are able to successfully commercialize one or more of our drug candidates, including Olverembatinib
and Lisaftoclax in the United States and other jurisdictions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
interruption in manufacturing operations at our manufacturing facilities could result in our inability to satisfy the demands of our
clinical trials or commercialization. A number of factors could cause interruptions, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">equipment
                                            or technology malfunctions or failures;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">work
                                            stoppages;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">damage
                                            to or destruction of either facility due to natural disasters;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regional
                                            power shortages;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
                                            tampering; or</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">terrorist
                                            activities.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
disruption that impedes our ability to manufacture our drug candidates in a timely manner could materially harm our business, financial
condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
we maintain insurance coverage against damage to our property and equipment. However, our insurance coverage may not reimburse us, or
may not be sufficient to reimburse us, for any expenses or losses we may suffer. See &#8220;&#8212;<i>We have limited insurance coverage,
and any claims beyond our insurance coverage may result in our incurring substantial costs and a diversion of resources.</i>&#8221; We
may be unable to meet our requirements for our drug candidates if there were a catastrophic event or failure of our manufacturing facilities
or processes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have significantly increased our research, development, manufacturing, and commercial capabilities, and we may experience difficulties
in managing our growth.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since our listing on the HKEx in 2019, we have significantly increased
our research, development, manufacturing and commercial capabilities. As of December 31, 2025, we had approximately 767 full-time employees.
As our development and commercialization plans and strategies develop, and as a result of becoming a Hong Kong and U.S.-listed public
company, we must add a significant number of additional managerial, operational, sales, marketing, financial and other personnel. Future
growth will impose significant added responsibilities on members of management, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying,
                                            recruiting, integrating, maintaining and motivating additional employees;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">managing
                                            our internal development efforts effectively, including the clinical and FDA or other comparable
                                            regulatory authority review process for our drug candidates, while complying with our contractual
                                            obligations to contractors and other third parties; and</span></td>
</tr></table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">improving
                                            our operational, financial and management controls, reporting systems and procedures.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our future
financial performance and our ability to commercialize our drug candidates (including Olverembatinib and Lisaftoclax) will depend, in
part, on our ability to effectively manage any future growth, and our management may also have to divert a disproportionate amount of
its attention away from day-to-day activities in order to devote a substantial amount of time to managing these growth activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent organizations, advisors
and consultants to provide certain services. There can be no assurance that the services of these independent organizations, advisors
and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition,
if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by consultants
is compromised for any reason, our clinical trials may be extended, delayed or terminated and we may not be able to obtain regulatory
approval of our drug candidates or otherwise advance our business. There can be no assurance that we will be able to manage our existing
consultants or find other competent outside contractors and consultants on economically reasonable terms, if at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If we are
not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, we may
not be able to successfully implement the tasks necessary to further develop and commercialize our drug candidates (including Olverembatinib
and Lisaftoclax in the United States and other jurisdictions, if approved) and, accordingly, may not achieve our research, development
and commercialization goals.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
future success depends on our ability to retain our key executives and scientists, and to attract, retain and motivate qualified personnel.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We are highly
dependent on our executive officers, senior management, scientific teams, and scientific advisory board. To induce valuable employees
to remain at our company, in addition to salary and cash incentives, we may provide equity award grants from time to time. The value
to employees of these equity grants that vest over time may be significantly affected by movements in the price of our ordinary shares
and ADSs that are beyond our control and may at any time be insufficient to counteract more lucrative offers from other companies. Except
with regard to Dr. Wang, we do not have formal employment or service agreements with our key management and scientific personnel, and
our executives may terminate their employment with us at any time, with or without notice. We do not maintain &#8220;key person&#8221;
insurance for any of our executives or other employees. In addition, we rely on consultants and advisors, including scientific and clinical
advisors, to assist us in formulating our discovery, preclinical development and commercialization strategy. The loss of the services
of any of these persons could impede the achievement of our research, development and commercialization objectives.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
replacing executive officers and key employees or consultants may be difficult and may take an extended period of time because of the
limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory
approval of and commercialize products. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain
or motivate these key personnel or consultants on acceptable terms given the competition among numerous pharmaceutical and biotechnology
companies for similar personnel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. Our consultants
and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities
that may limit their availability to us. If we are unable to continue to attract and retain high quality personnel, our ability to pursue
our growth strategy will be limited.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we have been, and from time to time may be, involved in labor disputes with our employees. Such disputes may divert our limited
resources and management attention to defend the claims. The claims raised in such labor disputes may have an adverse impact on our reputation
in the industry and/or as an employer. Furthermore, our insurance coverage may not be sufficient for such labor disputes. Therefore,
any such labor disputes may have a material adverse impact on our reputation, business, financial condition, and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
employees, independent contractors, consultants, commercial partners and vendors may engage in misconduct or other improper activities,
including noncompliance with regulatory standards and requirements.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We are exposed
to the risk of fraud, misconduct or other illegal activity by our officers, employees, independent contractors, consultants, commercial
partners, and vendors. Misconduct by these parties could include intentional, reckless and negligent conduct that fails to: comply with
the laws of the FDA and other similar non-U.S. regulatory authorities; provide true, complete and accurate information to the FDA and
other similar non-U.S. regulatory authorities; comply with manufacturing standards we have established; comply with healthcare fraud
and abuse laws in the United States and similar non-U.S. fraudulent misconduct laws; or report financial information or data accurately
or to disclose unauthorized activities to us. If we obtain FDA approval of any of our drug candidates (including Olverembatinib and Lisaftoclax)
and begin commercializing those drugs in the United States, our potential exposure under U.S. laws will increase significantly our costs
associated with compliance with such laws are also likely to increase. These laws may impact, among other things, our current activities
with principal investigators and research patients, as well as future sales, marketing and education programs. In particular, the promotion,
sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject
to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict
or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commission(s), certain customer incentive
programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained
in the course of patient recruitment for clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation.
It is not always possible to identify and deter misconduct by officers, employees and other parties, and the precautions we take to detect
and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us or our officers
or employees from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations.
If any such actions are instituted against us or our key employees, and we are not successful in defending ourselves or asserting our
rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we engage in acquisitions or strategic partnerships, this may increase our capital requirements, dilute our shareholders, cause us to
incur debt or assume contingent liabilities, and subject us to other risks.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may evaluate various acquisitions and strategic partnerships, including licensing or acquiring complementary products, intellectual property
rights, technologies, or businesses. Any completed, in-process or potential acquisition or strategic partnership may entail numerous risks,
including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
                                            operating expenses and cash requirements;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            assumption of additional indebtedness or contingent or unforeseen liabilities;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            issuance of our equity securities;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assimilation
                                            of operations, intellectual property and products of an acquired company, including difficulties
                                            associated with integrating new personnel;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            diversion of our management&#8217;s attention from our existing product programs and initiatives
                                            in pursuing such a strategic merger or acquisition;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">retention
                                            of key employees, the loss of key personnel, and uncertainties in our ability to maintain
                                            key business relationships;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
                                            and uncertainties associated with the other party to such a transaction, including the prospects
                                            of that party and their existing drugs or drug candidates and regulatory approvals; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            inability to generate revenue from acquired technology and/or products sufficient to meet
                                            our objectives in undertaking the acquisition or even to offset the associated acquisition
                                            and maintenance costs.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we undertake acquisitions, we may issue dilutive securities, assume or incur debt obligations, incur large one-time expenses,
and acquire intangible assets that could result in significant future amortization expense. Moreover, we may not be able to locate suitable
acquisition opportunities, and this inability could impair our ability to grow or obtain access to technology or products that may be
important to the development of our business. If we undertake acquisitions of businesses with access to promising markets or technologies,
we may not be able to realize the benefits of such acquisitions, including if we are unable to successfully integrate them with our existing
operations and company culture, or if we encounter difficulties in developing, manufacturing and marketing any new products resulting
from such acquisitions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to various governmental export control, trade sanctions, trade policies and tariffs and foreign investment laws and regulations
that could impair our ability to compete in international markets or subject us to liability if we violate the relevant controls.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some cases, our drug candidates may be subject to export control laws and regulations, including in some limited cases, the Export Administration
Regulations administered by the U.S. Department of Commerce, and some of our activities may be subject to trade and economic sanctions,
including those administered by OFAC, which we collectively refer to as trade controls. As such, in some cases, licenses may be required
to export, import, re-export or transfer our drug candidates to certain countries and end users and for certain end uses. The process
for obtaining necessary licenses and making required notices may be time-consuming or unsuccessful, potentially causing delays in sales
or losses of sales opportunities. Trade controls are complex and dynamic regimes, and monitoring and ensuring compliance can be challenging.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, following the geopolitical conflicts in Russia and Ukraine,
several countries imposed certain economic sanctions and export control restrictions against Russia and Belarus and have continued to
strengthen these controls. These controls include sanctions on certain Russian individuals and entities, including certain Russian banks,
energy companies and defense companies as well as restrictions on the export of certain goods and the provision of certain services to
and on new investment in Russia and Belarus. We currently are sponsoring some clinical trials in Russia through collaborations with CROs.
Although we, and our CROs, have implemented measures designed to ensure our compliance with these controls, monitoring and ensuring compliance
can be challenging. We believe that these clinical trials we are conducting in Russia do not give rise to sanctions or other regulatory
encumbrances. Any or all of these factors could negatively affect our clinical development plans, financial condition and result of operations.
For example, in response to additional restrictions, we could be required to close out clinical trials hosted in Russia. Any failure to
comply with these regimes could subject us to both civil and criminal penalties, including substantial fines, possible incarceration of
responsible individuals for willful violations, possible loss of our export or import privileges and reputational harm. In addition, investigating
or defending against any such allegations, actions or investigations could result in the diversion of management&#8217;s attention and
resources and significant defense costs and other professional fees.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">In addition,
there is currently significant uncertainty about the future relationship between the United States and various other countries, most
significantly China, with respect to trade policies, treaties, tariffs, taxes and other limitations on cross-border operations. For example,
the current U.S. administration has made and continues to make significant changes in U.S. trade policy and may continue to take future
actions that could negatively impact U.S. trade, including imposing new tariffs on certain foreign goods or renegotiating, or potentially
terminating, certain existing bilateral or multi-lateral trade agreements. Changes in U.S. trade policy have resulted in one or more
trading partners adopting responsive or retaliatory trade policies, which may make it more difficult or costly for us to export our products
to those countries. In addition, the U.S. Department of Commerce has initiated national security investigations into the importation
of pharmaceuticals and pharmaceutical ingredients pursuant to Section 232 of the Trade Expansion Act of 1962, which could result in the
imposition of new tariffs on imports within the pharmaceutical industry. Further, the U.S. announced a 100% tariff, on any branded or
patented pharmaceuticals imported into the U.S. from drug manufacturers that do not have, or is not in the process of building, a manufacturing
facility in the U.S., which has been delayed as negotiations with large drug manufacturers continue. The extent of the impact that such
tariffs, trade policies, or new legislation or regulations will have on the company specifically, or on the U.S. market and global economy
generally, are uncertain and in the long term, unpredictable, and could adversely affect our business, financial condition, and results
of operations. In addition, the increased tariffs could impact our ability to commercialize Olverembatinib and Lisaftoclax in the U.S.
or to develop and commercialize other drug candidates for the U.S. market, which is relevant to our ability to generate future revenues
from these activities. Changes in trade policies and tariffs may have adverse implications on drug pricing, drug production levels and
patient access, and may result in supply chain or other operational disruptions. If we are required to change our current manufacturing
partners or suppliers now or in the future in order to avoid such tariffs, the terms of new agreements that we may enter into may not
be favorable to us and related operational disruptions may heighten manufacturing and compliance risks. As a result, the continued impact
of these tariffs and trade policies may impair our plans for further drug developments for the U.S. market as well as our ability to
generate revenues.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Further,
we may also be subject to review and enforcement under domestic and foreign laws that screen foreign investment and acquisitions. As
a result of these laws, information regarding investments by particular investors may need to be submitted to local regulators, which
in turn may impose added costs on our business, impact our operations, and/or limit our ability to engage in strategic transactions that
might otherwise be beneficial to us and our investors. These laws are also regularly changed and updated. For example, the U.S. Outbound
Investment Security Program restricts direct and indirect investment by U.S. persons into companies with specified connections to China
to prevent the transfer of capital and intangible benefits that could be used to accelerate the development of specific technologies
of concern. Additional U.S. legislation has been proposed that would further expand the set of technologies of concern. These rules may
limit our ability to engage in certain kinds of research or to invest or maintain investments in China, Hong Kong, and Macau and may
also limit our ability to raise capital in the U.S. Continuing changes in both U.S. and non-U.S. jurisdictions to foreign investment
laws and rules could adversely affect our strategic initiatives, financial performance, and growth prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to comply with anti-bribery and anti-corruption laws and anti-money laundering laws, and similar laws, our reputation may be
harmed and we could be subject to penalties and significant expenses that have a material adverse effect on our business, financial condition
and results of operations.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, anti-bribery laws in the PRC and possibly
other anti-bribery and anti-corruption laws and anti-money laundering laws in countries outside of the United States where we conduct
our activities. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to
generally prohibit companies, their employees, agents, representatives, business partners, and third-party intermediaries from authorizing,
offering, or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
sometimes leverage third parties to sell our drug candidates and conduct our business abroad. We, our employees, agents, representatives,
business partners and third-party intermediaries may have direct or indirect interactions with officials and employees of government
agencies or state-owned or affiliated entities and we may be held liable for the corrupt or other illegal activities of these employees,
agents, representatives, business partners or third-party intermediaries even if we do not explicitly authorize such activities. We cannot
assure you that all of our employees, agents, representatives, business partners or third-party intermediaries will not take actions
in violation of applicable law for which we may be ultimately held responsible. As we increase our international sales and business,
our risks under these laws may increase.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
laws also require that we keep accurate books and records and maintain internal controls and compliance procedures designed to prevent
any such actions. While we have policies and procedures to address compliance with such laws, we cannot assure you that none of our employees,
agents, representatives, business partners or third- party intermediaries will take actions in violation of our policies and applicable
law, for which we may be ultimately held responsible.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
allegations or violation of the FCPA or other applicable anti-bribery and anti-corruption laws and anti-money laundering laws could result
in whistleblower complaints, sanctions, settlements, prosecution, enforcement actions, fines, damages, adverse media coverage, investigations,
loss of export privileges, severe criminal or civil penalties or suspension or debarment from government contracts, all of which could
have an adverse effect on our reputation, business, including our financial condition, results of operations and prospects. Responding
to any investigation or action will likely result in a materially significant diversion of management&#8217;s attention and resources
and significant defense costs and other professional fees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any
failure to comply with applicable regulations and industry standards or obtain or maintain various licenses and permits could harm our
reputation and our business, results of operations and prospects.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of governmental agencies or industry regulatory bodies in the United States, and in non-U.S. jurisdictions including the PRC,
impose strict rules, regulations and industry standards governing pharmaceutical and biotechnology research and development activities,
which apply to us. Our failure to comply with such regulations could result in the termination of ongoing research, administrative penalties
imposed by regulatory bodies or the disqualification of data for submission to regulatory authorities. This could harm our reputation,
prospects for future work and results of operations. For example, if we were to treat research animals inhumanely or in violation of
international standards set out by the Association for Assessment and Accreditation of Laboratory Animal Care, it could revoke any such
accreditation, and the accuracy of our animal research data could be questioned.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we are required to obtain, maintain and renew various permits, licenses and certificates to develop, manufacture, promote, and
sell our drug candidates. Third parties, such as distributors, third-party promoters and third-party manufacturers, on whom we may rely
to develop, manufacture, promote, sell and distribute our drug candidates may be subject to similar requirements. We and third parties
on whom we rely may be also subject to regular inspections, examinations, inquiries or audits by the regulatory authorities, and an adverse
outcome of such inspections, examinations, inquiries or audits may result in the loss or non-renewal of the relevant permits, licenses
and certificates. Moreover, the criteria used in reviewing applications for, or renewals of permits, licenses and certificates may change
from time to time, and there can be no assurance that we or the parties on whom we rely will be able to meet new criteria that may be
imposed to obtain or renew the necessary permits, licenses and certificates. Many of such permits, licenses and certificates are material
to the operation of our business, and if we or parties on whom we rely fail to maintain or renew material permits, licenses and certificates,
our ability to conduct our business could be materially impaired. Furthermore, if the interpretation or implementation of existing laws
and regulations change, or new regulations come into effect, requiring us or parties on whom we rely to obtain any additional permits,
licenses or certificates that were previously not required to operate our business, there can be no assurance that we or parties on whom
we rely will successfully obtain such permits, licenses or certificates. For example, the Regulations on the Administration of Human
Genetic Resources, promulgated by the State Council in May 2019 and amended in May 2024, require approval from or filing with the Ministry
of Science and Technology of the People&#8217;s Republic of China where human genetic resources, or HGR, are involved in any international
collaborative project and additional approval or filing procedures for any export or cross-border transfer of HGR samples or associated
data. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our practices in relation to
our clinical studies, potentially resulting in confiscation of HGR samples and associated data and administrative fines.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we or our third-party service providers fail to comply with environmental, health and safety laws and regulations, we could become subject
to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
and third parties, such as our CROs or contract manufacturing organizations, or CMOs, are subject to numerous environmental, health and
safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of
hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and radioactive
and biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal
of these materials and waste. We also store certain low level radioactive waste at our facilities until the materials can be properly
disposed of. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting
from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources.
We also could incur significant costs associated with civil or criminal fines and penalties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting
from the use of or exposure to hazardous materials, this insurance may not provide adequate coverage against potential liabilities. Except
with respect to our Suzhou facility, we do not maintain insurance for environmental liability or toxic tort claims that may be asserted
against us in connection with our storage, use or disposal of biological, hazardous or radioactive materials.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may be required to incur substantial costs to comply with current or future environmental, health and safety laws and regulations.
These current or future laws and regulations may impair our research, development or production efforts. Failure to comply with these
laws and regulations also may result in substantial fines, penalties or other sanctions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we face allegations of noncompliance with the law and encounter sanctions, our reputation, revenues and liquidity may suffer, and any
of our drug candidates that we commercialize could be subject to restrictions or withdrawal from the market.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Any government
investigation of alleged violations of law could require us to expend significant time and resources in response and could generate
negative publicity. Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to
commercialize and generate revenues from any of our drug candidates that we are able to commercialize (including Olverembatinib and Lisaftoclax).
If regulatory sanctions are applied or if regulatory approval is withdrawn, the value of our company and our results of operations will
be adversely affected. Additionally, if we are unable to generate revenues from sales of Olverembatinib and Lisaftoclax in China or in
any jurisdictions for which it received marketing approval or any of our drug candidates that we commercialize, our potential for achieving
profitability will be diminished and the capital necessary to fund our operations will be increased.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
or our CROs, contractors, consultants, or other third parties may suffer system failures, security breaches, or other incidents, which
could result in material disruption of our product development programs and adversely impact our business, financial condition or results
of operations.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are increasingly dependent upon information technology systems, infrastructure and data to operate our business. In the ordinary course
of business, we collect, store and transmit confidential information (including but not limited to intellectual property, proprietary
business information and personal information). It is critical that we do so in a secure manner to maintain the confidentiality and integrity
of such confidential information. We have also outsourced elements of our operations to third parties, and as a result we manage a number
of third-party CROs, contractors and consultants who have access to our confidential information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the implementation of security measures, given the size and complexity of our internal information technology systems and those of our
third-party CROs, contractors and consultants and the increasing amounts of confidential information that they maintain, our systems
and those of our CROs and other contractors, consultants, and other third parties may be vulnerable to security breaches, and other incidents,
including breakdowns or other damage or interruption from system failures, natural disasters, terrorism, war and telecommunication and
electrical failures, compromises, disruptions, computer viruses, unauthorized access, cyberattacks and other forms of hacking.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
we may be subject to inadvertent or intentional actions by our employees, contractors, consultants and other third parties, or from cyber-attacks
by malicious third parties, including the deployment of harmful malware, ransomware, denial-of-service attacks, phishing and other social
engineering, and other means to affect reliability and threaten the confidentiality, integrity, and availability of systems or data,
which may compromise our or our third-party CROs, contractors or consultants&#8217; information technology systems or lead to unauthorized
access to, or loss or other processing of, data or other assets, including data that is processed or maintained on our behalf. The risk
of a security breach or disruption, particularly through cyberattacks including supply chain attacks such as SolarWinds or cyber intrusion,
including by computer hackers, foreign governments, and cyber terrorists, has generally increased as the number, intensity, and sophistication
of attempted attacks and intrusions, including attacks generated by AI, from around the world have increased. We may not be able to anticipate
all types of security threats, and we may not be able to implement preventive measures effective against all such security threats. The
techniques used by cyber criminals change frequently, may not be recognized until launched, and can originate from a wide variety of
sources, including outside groups such as third-party service providers, organized crime affiliates, terrorist organizations, or hostile
foreign governments or agencies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
insurance policies may not be adequate to compensate us for the potential losses arising from any such system failure, security breach,
or other incident, including any such event that affects our systems or third-party systems where data important to our business operations
or commercial development is stored or otherwise processed. In addition, such insurance may not be available to us in the future on economically
reasonable terms, or at all. Further, our insurance may not cover all claims made against us and could have high deductibles in any event,
and defending a suit, regardless of its merit, could be costly and divert management attention. If the information technology systems
of our third-party CROs, contractors and other consultants become subject to disruptions or security breaches, we may have insufficient
recourse against such third parties and we may have to expend significant resources to mitigate the impact of such an event and to develop
and implement protections to prevent future events of this nature from occurring.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
to our knowledge we have not experienced any such material system failure, security breach or other incident to date, if such an event
were to or be perceived to occur or cause interruptions in our operations, it could result in a material disruption of our development
programs and our business operations, subject us to financial and reputational harm, compel us to comply with breach notification laws
and subject us to mandatory remedial action, which could have a material adverse effect on our business. We cannot assure you that our
security measures, or those of our CROs, contractors, consultants or other third parties, have prevented or will prevent such failures,
security breaches or other incidents. For example, the loss of clinical trial data from completed or future clinical trials could result
in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Notifications and
follow-up actions related to a system failure, security breach or other incident could also impact our reputation and cause us to incur
significant costs, including legal expenses and remediation costs. We may incur significant costs in an effort to detect and prevent
system failures, security breaches, or other incidents, and we may face increased costs and requirements to expend substantial resources
in the event of an actual or perceived system failure, security breach or other incident. We also partially rely on our third-party research
institution collaborators for research and development of our drug candidates and other third parties for the manufacture of our drug
candidates and to conduct clinical trials, and any similar system failure, security breach or other incident relating to them or affecting
their systems or data could also have a material adverse effect on our business. To the extent that we suffer or are perceived to suffer
any such failure, security breach, or other incident, including any loss of, or damage to, our data or systems, or inappropriate disclosure
of confidential or proprietary information, we may also be subject to litigation, investigations, proceedings, and other actions, incur
liability and the further development and commercialization of our drug candidates could be delayed, which could have a material adverse
effect on our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit commercialization
of our drug candidates.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We face an
inherent risk of product liability as a result of the clinical testing of our drug candidates and commercialization of approved drugs.
We face significant risks arising from commercialization of Olverembatinib and Lisaftoclax in China and will face even greater risks
arising from future commercialization of it in other markets, including in the United States, and future commercialization of our other
drug candidates. For example, we have been involved in and may in the future continue to be involved in, litigation if our drug candidates
cause or are perceived to cause or be associated with injury or are found to be otherwise unsuitable during clinical testing, manufacturing,
marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure
to warn of dangers inherent in the drug, negligence, strict liability or a breach of warranties. Claims could also be asserted under
U.S. consumer protection acts and other applicable laws in relevant jurisdictions where we conduct clinical trials or commercialization
activities. If we cannot successfully defend ourselves against or obtain indemnification from our collaborators for product liability
claims, we may incur substantial liabilities or be required to limit commercialization of our drug candidates. Even successful defense
would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result
in:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">decreased
                                            demand for our drug candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">injury
                                            to our reputation;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdrawal
                                            of clinical trial participants and inability to continue clinical trials;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">initiation
                                            of investigations by regulators;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
                                            to defend the related litigation;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            diversion of management&#8217;s time and our resources;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantial
                                            monetary awards to trial participants or patients;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
                                            recalls, withdrawals or labeling, marketing or promotional restrictions;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">loss
                                            of revenue;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exhaustion
                                            of any available insurance and our capital resources;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">the inability to commercialize Olverembatinib
    and Lisaftoclax in the United States or other jurisdictions for which we receive marketing approval or the inability to commercialize
    any other drug candidate; and</span></td></tr>
  </table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            decline in the price of our ordinary shares and the ADSs.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Although
we have purchased product liability coverage in China and the United States, the amount of such insurance coverage may not be adequate,
we may be unable to maintain such insurance at a reasonable cost or in an amount adequate to satisfy any liability that may arise or
we may not be able to obtain additional or replacement insurance at a reasonable cost, if at all. We may seek to expand our insurance
coverage for products to include the sale of commercial products if we obtain marketing approval for our drug candidates (including Olverembatinib)
and Lisaftoclax or any drugs that we in-license, but we may be unable to obtain commercially reasonable product liability insurance for
any products approved for marketing. Our insurance policies may also have various exclusions, and we may be subject to a product liability
claim for which we have no coverage. We may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our
coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such
amounts. Even if our agreements with any future collaborators entitle us to indemnification against losses, such indemnification may
not be available or adequate should any claim arise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have limited insurance coverage, and any claims beyond our insurance coverage may result in our incurring substantial costs and a diversion
of resources.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain property insurance policies covering physical damage to, or loss of, our buildings and their improvements, equipment, office
furniture and inventory. We hold employer&#8217;s liability insurance generally covering death or work-related injury of employees. We
hold public liability insurance covering certain incidents involving third parties that occur on or in the premises of the company. We
hold director and officer liability insurance. We do not maintain key-man life insurance on any of our senior management or key personnel,
or business interruption insurance. We have some clinical trial related insurance coverage, but it may not cover all situations that
may arise relating to a patient who enrolls in our trials. Our insurance coverage may be insufficient to cover certain claims for product
liability, damage to our fixed assets or employee injuries. Any liability or damage to, or caused by, our facilities or our personnel
beyond our insurance coverage may result in our incurring substantial costs and a diversion of resources.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
to existing tax laws, or challenges to our tax positions, could adversely affect our business and financial conditions.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to income taxes and other taxes in the United States, the PRC and other foreign jurisdictions. Significant judgments and
estimates are required in determining our provision for income taxes and other tax liabilities. Our tax expense may be impacted, for
example, if tax laws change or are clarified to our detriment or if tax authorities successfully challenge the tax positions that we
take, such as, for example, positions relating to the arms- length pricing standards for our intercompany transactions and our state
sales and use tax positions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is uncertainty regarding future legislative and regulatory changes and policies related to matters such as taxation and importation,
and any such proposed or enacted regulations by the current or a future U.S. administration, Congress, or taxing authorities in other
jurisdictions could materially affect our tax obligations and operating results.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, beginning in 2022, the Tax Cuts and Jobs Act of 2017 eliminated the option to deduct research and development expenditures in
the year incurred and instead requires taxpayers to capitalize and subsequently amortize such expenditures over five years for research
activities conducted in the United States and over 15 years for research activities conducted outside the United States. The One Big
Beautiful Bill Act, or OBBBA, reinstates the option to deduct domestic research and development expenditures in the year incurred, commencing
with tax years beginning after December 31, 2024. Foreign research and development expenditures remain subject to the 15-year capitalization
and amortization requirement. The OBBBA also includes other significant provisions, including tax cut extensions and modifications to
the international tax framework. In addition, the IRA, among other things, included a new 15% alternative minimum tax on the adjusted
financial statement income of certain large corporations for tax years beginning in 2023. To the extent that such changes have a negative
impact on us, these changes could adversely impact our business, results of operations and financial position.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the adequacy of income taxes, we assess the likelihood of adverse outcomes that could result if our tax positions were challenged
by the State Administration of Taxation, or SAT, the Internal Revenue Service, or IRS, and other tax authorities. Should the SAT, the
IRS or other tax authorities assess additional taxes as a result of audits or examinations, we may be required to record charges to operations
that could adversely affect our business, financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
global operations and structure subject us to potentially adverse tax consequences.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generally conduct our global operations through subsidiaries and report our taxable income in various jurisdictions worldwide based on
our business operations in those jurisdictions. In particular, our intercompany relationships are subject to complex transfer pricing
regulations administered by taxing authorities in various jurisdictions. Also, our tax expense could be affected depending on the applicability
of withholding and other taxes (including withholding and indirect taxes on software licenses and related intercompany transactions)
under the tax laws of certain jurisdictions in which we have business operations. The relevant revenue and taxing authorities may disagree
with positions we have taken generally, or our determinations as to the value of assets sold or acquired or income and expenses attributable
to specific jurisdictions. If such a disagreement were to occur, and our position were not sustained, we could be required to pay additional
taxes, interest and penalties, which could result in one- time tax charges, higher effective tax rates, reduced cash flows and lower
overall profitability of our operations. The tax laws of certain countries in which we do business could also change on a prospective
or retroactive basis, and any such changes could increase our liabilities for taxes, interest and penalties, and therefore could harm
our business, results of operations and financial condition.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
increasing use of artificial intelligence, or AI, based software (including machine learning) and social media platforms may result in
reputation harm or liability or could otherwise adversely affect our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">AI-based software, including generative AI, is increasingly being used in the biopharmaceutical and global healthcare
industries. As with many developing technologies, AI-based software presents risks and challenges that could affect its further development,
adoption, and use, and therefore our business. For example, algorithms may be flawed; data sets may be insufficient, of poor quality,
or contain biased information or other errors or inadequacies, any of which may not be easily detectable; AI has been known to produce
false or &#8220;hallucinatory&#8221; inferences or outputs; AI can present ethical issues and may subject us to new or heightened legal,
regulatory, ethical or other challenges; and inappropriate or controversial data practices by data scientists, engineers, and end-users
could impair results. We use AI-based software in our business, and the analyses that AI applications assist in producing may be deficient
or inaccurate, which could subject us to competitive harm, potential legal liability, and brand or reputational harm. Furthermore, our
use of AI-based software may lead to the inadvertent release of confidential information which may impact our ability to realize the benefit
of our intellectual property. If we do not have sufficient rights to use the data or other material or content on which any AI solutions
we may use rely, we also may incur liability through the violation of applicable laws, third-party intellectual property, privacy or other
rights, or contracts to which we are a party. No assurance can be provided that our use of AI will enhance our business or operations
or result in our business or operations being more efficient or profitable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, regulation of AI is rapidly evolving worldwide as legislators and regulators are increasingly focused on these powerful emerging
technologies. The technologies underlying AI and its uses are subject to a variety of laws, including intellectual property, privacy,
data protection and cybersecurity, consumer protection, competition, and equal opportunity laws, and are expected to be subject to increased
regulation and new laws or new applications of existing laws. While there is currently no comprehensive federal legislation in the U.S.
that regulates the development or use of AI, AI is the subject of ongoing review by various U.S. governmental and regulatory agencies,
and various U.S. states and other foreign jurisdictions are applying, or are considering applying, their platform moderation, cybersecurity,
and data protection laws to AI or are considering general legal frameworks for AI. For example, the significant increase in companies
that have incorporated the use of AI in their businesses has increased SEC attention on AI-washing as an area of enforcement. European
Union legislators approved the EU Artificial Intelligence Act, or the EU AI Act, which establishes a comprehensive, risk-based governance
framework for AI in the EU market. The EU AI Act, and developing interpretation and application of the GDPR in respect of automated decision
making, together with developing guidance and/or decisions in the impact of AI technology on data privacy, may affect our use of AI technologies
and our ability to provide, improve or commercialize our business, require additional compliance measures and changes to our operations
and processes, and result in increased compliance costs and potential increases in civil claims against us, and could adversely affect
our business, operations and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may not be able to anticipate how to respond to these
rapidly evolving frameworks, and we may need to expend resources to adjust our offerings in certain jurisdictions if the legal
frameworks are inconsistent across jurisdictions. Furthermore, because AI technology itself is highly complex and rapidly
developing, it is not possible to predict all of the legal, operational or technological risks that may arise relating to the use of
AI.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relatedly,
social media platforms are increasingly being used to communicate about our drug candidates and the diseases our drug candidates are
designed to treat. Social media practices in the biopharmaceutical industry continue to evolve and regulations relating to such use are
not always clear and create uncertainty and risk of noncompliance with regulations applicable to our business. For example, patients
may use social media channels to comment on the effectiveness of a product or to report an alleged adverse event. When such disclosures
occur, there is a risk that we may fail to monitor and comply with applicable adverse event reporting obligations. There is also a risk
of negative or inaccurate posts about us on social media, including criticism regarding our drug candidates. The immediacy of social
media precludes us from having real-time control over postings made regarding our Company or drug candidates. Our reputation could be
damaged by negative publicity posted on social media platforms which we may not be able to timely reverse. If any of these events were
to occur or we otherwise fail to comply with applicable regulations, we could incur liability, face restrictive regulatory actions or
incur other harm to our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
face uncertainties with respect to our leased properties.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease real properties from third parties primarily for our offices in China, and the lease agreements for most of these leased properties
have not been registered with the PRC government authorities as required by PRC law. We failed to register these lease agreements with
relevant housing administrative authorities primarily because the registration of a lease agreement requires cooperation between the
lessor and lessee and we have found that lessors are typically unwilling to undertake the administrative burden of registration due to
the low risk of penalty. Failure to complete the registration of lease agreements will not affect the validity of the lease agreements
or the binding effect of the lease agreements over contracting parties or result in us being required to vacate the leased properties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the failure to do so does not in itself invalidate the leases, we may be ordered by the PRC government authorities to rectify such noncompliance
and, if such noncompliance were not rectified within a given period of time, we may be subject to fines imposed by PRC government authorities
ranging from RMB1,000 to RMB10,000 for those of our lease agreements that have not been registered with the relevant PRC government authorities.
As of the date of this Annual Report on Form 20-F, we are not aware of any regulatory or governmental actions, claims or investigations
being contemplated or any challenges by third parties to our use of such leased properties. Moreover, we plan to be more stringent in
the future in terms of requiring our lessors to cooperate with us in registering our lease agreements with relevant housing administrative
authorities. However, we cannot assure you that the government authorities will not impose fines on us due to our failure to register
any of our lease agreements, which may negatively impact our financial condition. Additionally, for some of our leased properties, the
owners have not obtained approvals from or made appropriate filings with applicable local authorities, such as drainage permits for the
properties. As a result of these non-compliance matters, we may be subject to monetary damages, the suspension or disruption of our operations,
interruption of our business, and may be forced to relocate from such properties, which could materially and adversely affect our financial
condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to make adequate contributions to various employee benefit plans as required by PRC regulations or comply with laws and regulations on
other employment practices may subject us to penalties.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
operating in China are required to participate in various government sponsored employee benefit plans, including certain social insurance,
housing funds and other welfare-oriented payment obligations, and contribute to the plans in amounts equal to certain percentages of
salaries, including bonuses and allowances, of our employees up to a maximum amount specified by the local government from time to time
at locations where we operate our businesses. We cannot assure you that our practices will be deemed to be in compliance with the abovementioned
employee benefit plan requirements in all aspects. For example, certain of our PRC subsidiaries engage third-party human resources agencies
to make social insurance and housing fund contributions for some of their employees, and there is no assurance that such third-party
agencies have made or will make such contributions in a full or in a timely manner. The relevant PRC authorities may require us to pay,
or in the case of any shortfalls, to cover, such social insurance and housing fund contributions. We may also become subject to fines
and legal sanctions due to any failure to make social insurance and housing fund contributions for our employees. With respect to the
underpaid employee benefits, we may be required to complete registrations, make up the contributions for these plans as well as to pay
late fees and fines. If we are subject to late fees or fines in relation to the underpaid employee benefits, our financial condition
and results of operations may be adversely affected. We may also be subject to regulatory investigations and other penalties if our other
employment practices are deemed to be in violation of relevant PRC laws and regulations.&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
related to doing business in the PRC</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may be subject to further approval, filing or other requirements with PRC governmental authorities in connection with future capital-raising
activities.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 6, 2021, the General Office of the State Council of the PRC, together with another regulatory authority, jointly promulgated the
Opinions on Strictly Cracking Down Illegal Securities Activities in Accordance with the Law, which calls for enhanced administration
and supervision of overseas-listed China-based companies, proposes to revise the relevant regulation governing the overseas issuance
and listing of shares by such companies, and clarifies the responsibilities of competent domestic industry regulators and government
authorities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CSRC and other PRC government authorities have previously implemented new regulations and guidance to regulate overseas listing of domestic
enterprises. For instance, on February 24, 2023, the CSRC and other relevant government authorities promulgated the Provisions on Strengthening
the Confidentiality and Archives Administration of Overseas Securities Issuance and Listing by Domestic Enterprises, or the Provision
on Confidentiality, effective on March 31, 2023. Pursuant to the Provision on Confidentiality, where a domestic enterprise provides or
publicly discloses documents and materials involving state secrets and working secrets of state organs, or relevant documents and materials,
to the relevant securities companies, securities service institutions, overseas regulatory authorities and other entities and individuals,
or provides or publicly discloses relevant documents and materials through its overseas listing subjects, it shall report to the competent
department with the examination and approval authority for approval in accordance with the law, and submit to the secrecy administration
department of the same level for filing. For details, see &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Government
regulation&#8212;PRC regulation&#8212;PRC regulations on securities offering and listing outside of China.</i>&#8221; As such regulations
relating to overseas listings are newly implemented, there remains substantial uncertainties as to how they may impact our ability to
raise or utilize funds overseas and conduct our business operations. Moreover, as the PRC government strengthens the oversight and control
over overseas securities offerings and/or foreign investment in China-based issuers, new laws and regulations in relation to overseas
listings of China-based issuers may continue to be promulgated and implemented in the future, which may subject us to scrutiny and incur
additional compliance costs. We cannot assure you that we will be able to comply with such regulations in a timely and adequate manner
or at all. The regulatory authorities may impose fines and penalties on our operations in China, limit our ability to pay dividends outside
of China, limit our operating privileges in China, delay or restrict the repatriation of future capital raising activities into China
or take other actions that could materially and adversely affect our business, results of operations and financial condition, as well
as the value of the ADSs and ordinary shares. Our failure to meet such requirements could significantly limit or completely hinder our
ability to offer or continue to offer securities to investors and cause the value of our securities to significantly decline or be worthless.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently,
if you engage in market trading or other activities in anticipation of and prior to settlement and delivery, you do so at the risk that
settlement and delivery may not occur. In addition, if the CSRC or other regulatory authorities later promulgate new rules or explanations
requiring that we complete other procedures for future capital raising activities, we may be unable to obtain a waiver of such requirements,
if and when procedures are established to obtain such a waiver. Such procedures for obtaining the waiver remain unclear. Any uncertainties
or negative publicity regarding such requirements for future capital raising activities could materially and adversely affect our business,
prospects, financial condition, reputation and the value of the ADSs and ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
greater oversight by the CAC over data security, particularly for companies seeking to list on a foreign exchange, could significantly
limit or completely hinder our ability in capital raising activities and materially and adversely affect our business and the value of
your investment.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2021, the CAC and several other PRC government authorities jointly promulgated the Cybersecurity Review Measures, which
took effect on February 15, 2022 and provides that the relevant operators shall apply with the Cybersecurity Review Office of CAC for
a cybersecurity review under certain circumstances such as the purchase of network products and services by &#8220;operator of critical
information infrastructure,&#8221; or CIIO, or any &#8220;online platform operators&#8221; controlling personal information of more than
one million users which seeks to list in a foreign stock exchange. See &#8220;<i>Item 4. Information on the Company&#8212;B. Business
Overview&#8212;Government regulation&#8212;PRC regulation&#8212;PRC regulations on cybersecurity review and data privacy.</i>&#8221;
As of the date of this Annual Report on Form 20-F, we have not been informed by any PRC government agency that we qualify as a CIIO,
and we possess personal information of less than one million users. Further, we have not been involved in any cybersecurity-related investigation
initiated by the CAC or any other PRC government authority and have not received any cybersecurity-related warning or sanction from
the PRC government authorities, or any notice from relevant authorities requesting that we file for the cybersecurity review. Therefore,
based on our understanding of the current PRC laws and regulations, as advised by our PRC data compliance counsel JunHe LLP, we are of
the view that we are unlikely to be subject to such cybersecurity review arising from our offerings of our securities on a U.S. stock
exchange.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">On August
20, 2021, the Standing Committee of the National People&#8217;s Congress, or SCNPC, promulgated the Personal Information Protection Law
of the PRC, or the PIPL, which became effective from November 1, 2021, the PIPL illustrates the basic compliance rules of cross-border
transfer of personal information. On July 7, 2022, CAC issued the Security Assessment Measures for Data Cross-Border Transfers, which
became effective from September 1, 2022. On February 22, 2023, CAC issued the Measures for the Standard Contract for Cross-border Transfer
of Personal Information and the Standard Contract for Cross-border Transfer of Personal Information, or the SCC, which became effective
from June 1, 2023. On March 22, 2024, the CAC enacted the Provisions on Promoting and Regulating Cross-Border Data Flows. On October
14, 2025, the CAC, together with the SAMR, issued the Measures for Certification of Cross-Border Transfer of Personal Information, which
became effective from January 1, 2026. See <i>&#8220;Item 4. Information on the Company&#8212;B. Business Overview&#8212;Government regulation&#8212;PRC
regulation&#8212;PRC regulations on cybersecurity and data privacy.&#8221; </i>Pursuant to above PRC laws and regulations related to
data cross-border transfer, we need to make SCC filing with the local cyberspace administration provincial level or obtain personal information
protection certification conducted by professional institutions recognized by CAC for our cross-border transfer of clinical trial subjects&#8217;
de-identified personal information. As of the date of this Annual Report on Form 20-F, we have completed our SCC filing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
it remains uncertain how the existing regulatory measures will be interpreted or implemented in the future, and whether the PRC regulatory
agencies, including the CAC, may adopt new laws, regulations, rules, or detailed implementation and interpretation related to the measures,
which may have a material adverse effect on our future capital raising activities. If any such new laws, regulations, rules, or implementation
and interpretation comes into effect, we face uncertainty as to whether any review or other required actions can be timely completed,
or at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
such uncertainty, we may be further required to suspend our business, shut down our platforms or face other penalties, which could materially
and adversely affect our business, financial condition and results of operations, or could significantly limit or completely hinder our
ability to offer or continue to offer securities to investors, which could cause the value of the ADSs and ordinary shares to significantly
decline or become worthless.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the PCAOB is unable to inspect or investigate completely our auditors located in China because of a position taken by a foreign authority
and the SEC identifies the Company as a Commission-Identified Issuer under the Holding Foreign Companies Accountable Act for two consecutive
years, the ADSs will be delisted and our ordinary shares and ADSs will be prohibited from trading on a national securities exchange or
in the over-the-counter market under the Holding Foreign Companies Accountable Act. The delisting of the ADSs, or the threat of their
being delisted, and a prohibition from trading, may materially and adversely affect the value of our ordinary shares.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Holding Foreign Companies Accountable Act of 2020, or the HFCAA, if the SEC determines that we have filed audit reports issued
by a registered public accounting firm that the PCAOB has determined that it is unable to inspect or investigate completely because of
an authority in a foreign jurisdiction, it will identify us as a Commission-Identified Issuer. If the SEC determines that we are a Commission-Identified
Issuer for two consecutive years, the SEC will prohibit our ordinary shares and ADSs from being traded on a national securities exchange
or in the over-the-counter trading market in the United States. Our auditor, Ernst &amp; Young Hua Ming LLP, is an independent registered
public accounting firm based in mainland China. On December 2, 2021, the SEC adopted final rules implementing the HFCAA, which include
requirements for a Commission-Identified Foreign Issuer to disclose information, including the auditor&#8217;s name and location, the
percentage of shares of the issuer owned by governmental entities and whether governmental entities in the applicable foreign jurisdiction
with respect to the auditor has a controlling financial interest with respect to the issuer, among others. These amendments also establish
procedures the SEC will follow in identifying issuers and prohibiting trading by certain issuers under the HFCAA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2022, the PCAOB, the CSRC and the Ministry of Finance of the PRC signed the Statement of Protocol, which establishes a specific
and accountable framework for the PCAOB to conduct inspections and investigations of PCAOB-governed accounting firms in mainland China
and Hong Kong. On December 15, 2022, the PCAOB announced that it was able to secure complete access to inspect and investigate PCAOB-registered
public accounting firms headquartered in mainland China and Hong Kong completely in 2022. The PCAOB Board vacated its previous 2021 determination
that the PCAOB was unable to inspect or investigate completely registered public accounting firms headquartered in mainland China and
Hong Kong. However, whether the PCAOB will continue to be able to satisfactorily access and conduct inspections of PCAOB-registered public
accounting firms headquartered in mainland China and Hong Kong are subject to uncertainties and depends on a number of factors out of
our and our auditor&#8217;s control. The PCAOB continues to demand complete access in mainland China and Hong Kong moving forward and
pursue ongoing investigations and initiate new investigations as needed. The PCAOB has also indicated that it will act immediately to
consider the need to issue new determinations with the HFCAA if needed. If the PCAOB determines it is unable to inspect and investigate
completely registered public accounting firms located in China for 2023 and beyond, and our registered public accounting firm is located
in that jurisdiction, the SEC will identify us as a &#8220;Commission-identified Issuer,&#8221; and upon two consecutive years of non-inspection
under the HFCAA, the ADSs will be delisted from Nasdaq and our ordinary shares and ADSs will be prohibited from trading over the counter.
We cannot assure you that we would be able to retain a registered public accounting firm that the PCAOB will be able to inspect or investigate
completely. Delisting of the ADSs would force holders of the ADSs to sell their ADSs or convert them into our ordinary shares. The foregoing
could adversely affect our ability to raise capital. Such a prohibition would also substantially impair your ability to sell or purchase
the ADSs when you wish to do so, and the risk and uncertainty associated with delisting would have a negative impact on the price of
the ADSs and/or ordinary shares. Moreover, the HFCAA or other efforts to increase U.S. regulatory access to audit information could cause
investor uncertainty for affected issuers, including us, and the market price of the ADSs could be adversely affected. The prohibition
would also significantly affect our ability to raise capital on terms acceptable to us, or at all, which would have a material adverse
impact on our business, results of operations and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
PCAOB has historically been unable to inspect our auditor in relation to their audit work and the inability of the PCAOB to conduct inspections
over our auditor deprives our investors of the benefits of such inspections.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
auditor, the independent registered public accounting firm that issues the audit report included elsewhere in this Annual Report on Form
20-F, as an auditor of companies that are traded publicly in the United States and a firm registered with the PCAOB, is subject to laws
in the United States pursuant to which the PCAOB conducts regular inspections to assess its compliance with the applicable professional
standards. Our auditor is located in China, a jurisdiction where the PCAOB was unable to conduct inspections and investigations before
2022. On December 15, 2022, the PCAOB announced that it was able to secure complete access to inspect and investigate PCAOB-registered
public accounting firms headquartered in mainland China and Hong Kong in 2022. However, the inability of the PCAOB to conduct inspections
of auditors in China in the past made it more difficult to evaluate the effectiveness of our independent registered public accounting
firm&#8217;s audit procedures or quality control procedures as compared to auditors outside of China that have been subject to the PCAOB
inspections, which could deprive investors and potential investors in the ADSs of the benefits of such PCAOB inspections, and cause them
to lose confidence in our audit procedures and reported financial information and the quality of our financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be restricted from transferring our scientific data abroad.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2018, the General Office of the State Council promulgated the Measures for the Management of Scientific Data, or the Scientific
Data Measures, which provides a broad definition of scientific data and relevant rules for the management of scientific data. According
to the Scientific Data Measures, enterprises in China must seek governmental approval before any scientific data involving a state secret
may be transferred abroad or to foreign parties. Further, any researcher conducting research funded at least in part by the Chinese government
is required to submit relevant scientific data for management by the entity to which such researcher is affiliated before such data may
be published in any foreign academic journal. Given the term state secret is not clearly defined, if and to the extent our research and
development of drug candidates will be subject to the Scientific Data Measures and any subsequent laws as required by the relevant government
authorities, we cannot assure you that we can always obtain relevant approvals for sending scientific data (such as the results of our
pre-clinical studies or clinical trials conducted within China) abroad or to our foreign partners in China. If we are unable to obtain
necessary approvals in a timely manner, or at all, our research and development of drug candidates may be hindered, which may materially
and adversely affect our business, results of operations, financial condition and prospects. If the relevant government authorities consider
the transmission of our scientific data to be in violation of the requirements under the Scientific Data Measures, we may be subject
to fines and other administrative penalties imposed by those government authorities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in economic, political or social conditions or government policies from where we operate could have a material adverse effect on our
business, results of operations, financial condition, and the value of our securities.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
significant portion of our operations are in the PRC. Accordingly, our business, results of operations and financial condition may be
influenced to a significant degree by the political and social conditions in China in general and China&#8217;s economic growth. The
PRC government has implemented various measures to encourage economic growth and guide the allocation of resources. Some of these measures
may benefit the overall PRC economy, but may also have a negative effect on us, leading to a reduction in demand for our drug candidates
and adversely affecting our competitive position. Any of the foregoing could result in a material adverse change in our business operations
and/or the value of our securities. Our ability to successfully maintain or grow business operations in China depends on various factors,
which are beyond our control. These factors include, among others, macro-economic and other market conditions, political stability, social
conditions, measures to control inflation or deflation, changes in the rate or method of taxation, changes in laws, regulations and administrative
directives or their interpretation, and changes in industry policies. If we fail to take timely and appropriate measures to adapt to
any of the changes or challenges, our business, results of operations and financial condition could be materially and adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
PRC legal system is evolving, and any failure to comply with laws and regulations could have a material adverse effect on our business,
results of operation, financial condition and the value of the ADSs and ordinary shares.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
large portion of our operations are conducted in the PRC through our PRC subsidiaries, and are governed by PRC laws, rules and regulations.
Our PRC subsidiaries are subject to laws, rules and regulations applicable to foreign investment in the PRC. The PRC legal system is
a civil law system based on written statutes. Unlike the common law system, prior court decisions may be cited for reference but have
limited precedential value.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the late 1970s, the PRC government has promulgated laws and regulations dealing with economic matters, such as foreign investment, corporate
organization and governance, commerce taxation and trade, with a view towards developing a comprehensive system of commercial law. For
instance, developments in the pharmaceutical industry and other industries and that we are and will be involved in may lead to changes
in PRC laws, regulations and policies or in the interpretation and application thereof. As a result, we may be required by the regulators
to obtain or renew the licenses, permits, approvals, to complete additional filings or registrations for the products and services we
offer, or to modify business practices that may subject us to various penalties, including criminal penalties for individual and entity.
We cannot assure you that our business operations would not be deemed to violate any existing or future PRC laws or regulations, which
in turn could materially and adversely affect our business operations. In addition, the implementation of new rules, laws and regulations
may significantly affect the industry in which we operate, which could affect the value of our securities, such as causing our securities
to significantly decline in value or become worthless.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, there is a limited volume of published court decisions due to our civil law system, which may be cited for reference but are
not binding on subsequent cases and have limited precedential value unless the Supreme People&#8217;s Court otherwise provides. The PRC
administrative and judicial authorities have certain discretion in interpreting, implementing or enforcing statutory rules and contractual
terms, and it may be difficult to precisely predict the outcome of administrative and judicial proceedings. As a result, we may not be
aware of our violation of any of these policies and rules until sometime after the violation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
evolvements may also affect our decisions on the policies and actions to be taken to comply with PRC laws and regulations, and may affect
our ability to enforce contractual rights, property (including intellectual property) or tort rights. In addition, unmerited legal actions
or threats in an attempt to extract payments or benefits from us could also happen, which may therefore increase the operating expenses
and costs, and materially and adversely affect our business and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in the regions where
we operate against us or our management named in this Annual Report on Form 20-F based on foreign laws.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
large portion of our operations are conducted in the PRC through our PRC subsidiaries, and a substantial portion of our assets are located
in China. We also have senior executive officers who are PRC nationals and reside within China for a significant portion of their time.
The courts of mainland China may recognize and enforce foreign judgments in accordance with the requirements of the PRC Civil Procedures
Law and other applicable laws and regulations based either on treaties between mainland China and the country or the region where the
judgment is made or on principles of reciprocity between jurisdictions. However, China does not have treaties providing for the reciprocal
recognition and enforcement of judgments of courts with the Cayman Islands and many other countries and regions. Even if you are successful
in bringing an action of this kind, PRC laws may render you unable to enforce a judgment against our assets or the assets of our directors
and officers if such enforcement is not in compliance with relevant PRC laws and regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>It
may be difficult for overseas regulators to conduct investigation or collect evidence within the regions where we operate.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
claims or regulatory investigation that are common in the United States generally are difficult to pursue as a matter of law or practicality
in China. For instance, in China, there are significant legal and other obstacles to providing information needed for regulatory investigations
or litigations initiated outside of China. Although the authorities in China may establish a regulatory cooperation mechanism with the
securities regulatory authorities of another country or region to implement cross-border supervision and administration, such cooperation
with the securities regulatory authorities in the Unities States may not be efficient in the absence of mutual and practical cooperation
mechanism. According to Article 177 of the PRC Securities Law, or Article 177, which became effective in March 2020, no overseas securities
regulator is allowed to directly conduct investigation or evidence collection activities within the territory of the PRC. Accordingly,
without the consent of the competent PRC securities regulators and relevant authorities, no organization or individual may provide the
documents and materials relating to securities business activities to overseas parties, which could present significant legal and other
obstacles to obtaining information needed for investigations and litigation conducted outside of China. The Provisions on Strengthening
the Confidentiality and Archives Administration Related to the Overseas Securities Offering and Listing by Domestic Enterprises, which
became effective on March 31, 2023, provides that the investigation and evidence collection in relation to the overseas securities offering
and listing of the PRC domestic companies by the overseas securities regulatory authorities and relevant authorities shall be conducted
through the cross-border cooperation mechanism for supervision and administration and the domestic companies in mainland China shall
obtain the prior consent from the CSRC or relevant authorities before cooperating with such overseas securities regulatory authorities
or relevant authorities in connection with relevant inspections or investigations or providing relevant documents to such overseas securities
regulatory authorities or relevant authorities. The inability for an overseas securities regulator to directly conduct investigation
or evidence collection activities within China may further increase difficulties faced by you in protecting your interests. If the U.S.
securities regulatory agencies are unable to conduct such investigations, there exists a risk that they may determine to suspend or de-register
our registration with the SEC and may also delist our securities from trading market within the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation
and negative publicity surrounding China-based companies listed in the United States may result in increased regulatory scrutiny of us
and negatively impact the trading price of the ADSs.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that litigation and negative publicity surrounding companies with operations in China that are listed in the United States have
negatively impacted stock prices for such companies. Certain politicians in the United States have publicly warned investors to shun
China-based companies listed in the United States. The SEC and the PCAOB also issued a joint statement on April 21, 2020, reiterating
the disclosure, financial reporting and other risks involved in the investments in companies that are based in emerging markets as well
as the limited remedies available to investors who might take legal action against such companies. Furthermore, various equity-based
research organizations have published reports on China-based companies after examining, among other things, their corporate governance
practices, related party transactions, sales practices and financial statements that have led to special investigations and listing suspensions
on U.S. national exchanges. Any similar scrutiny of us, regardless of its lack of merit, could cause the market price of the ADSs to
fall, divert management resources and energy, cause us to incur expenses in defending ourselves against rumors and increase the premiums
we pay for director and officer insurance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
tension in international trade, rising political tension and increasing geopolitical risks, particularly between the United States and
China, pose significant challenges that may adversely impact our business, results of operations and financial condition.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business could be materially and adversely affected by the tensions in international trade in recent years. Changes to international
trade policies, laws, regulations and administrative orders could adversely affect the global economic conditions. In addition, geopolitical
tensions among major economies have escalated due to, among other things, trade disputes, global health emergencies, sanctions imposed
by the U.S. Department of Treasury, and the executive orders issued by the U.S. government that may prohibit transactions with certain
selected Chinese companies as well as their products and services. Rising political tensions could reduce levels of trade, investment,
technological exchange and other economic activities between the two major economies, or result in new tariffs, sanctions, export controls,
or other new laws and regulations. The recent retaliatory tariff increases between the U.S. and China in April 2025 may result in significantly
escalating tensions between the two countries. Such tensions involving China, and any escalation thereof, may negatively affect trading
and business environments, which may, in turn, adversely impacting our business, results of operations and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When it comes to our industry in particular, certain Chinese biotechnology
companies and CMOs may become subject to legislation, trade restrictions, sanctions, and other regulatory requirements by the U.S. government,
which could restrict or even prohibit our ability to work with such entities, thereby potentially disrupting the supply of material to
us. For example, the BIOSECURE Act was signed into law on December 18, 2025, and it targets U.S. government contracts, grants, and loans
for entities that use equipment and services from Chinese biotechnology companies of concern. Though the BIOSECURE Act does not name WuXi
as a &#8216;company of concern&#8217;, such a designation is still under consideration by other governmental departments. We contract
with WuXi STA, a subsidiary of WuXi AppTec, that manufactures certain of our active pharmaceutical ingredients. In addition, U.S. executive
agencies have the ability to designate entities and individuals on various governmental prohibited and restricted parties&#8217; lists. Depending
on the designation, potential consequences can range from a comprehensive prohibition on all transactions or dealings with designated
parties, or a limited prohibition on certain types of activities, such as exports and financing activities, with designated parties. If
any other current or future supplier is included under or otherwise added to the BIOSECURE Act or otherwise designated on any U.S. government
prohibited party lists, such designation could impact and potentially restrict our engagement with such suppliers. While we believe that
our current manufacturing plan will provide us with alternative sources for such supplies, there is a risk that, if supplies are interrupted,
or the quality of ingredients provided by such alternative sources is not to our specification, it would cause delays in our supply chain
and increase the cost of manufacturing our drugs and/or drug candidates, which could materially harm our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
regulatory changes limiting trade with China could affect our research and development activities or business operations, including,
for example, in 2024, Congress passed H.B. 815, which included the Protecting Americans&#8217; Data from Foreign Adversaries Act of 2024.
This law creates certain restrictions for entities that disclose sensitive data (including potential health data) to countries such as
China. Failure to comply with these rules can lead to a potential FTC enforcement action. Additionally, the Department of Justice recently
finalized a rule implementing Executive Order 14117, which creates similar restrictions related to the transfer of sensitive U.S. data
to countries such as China. These data transfer restrictions (and others that may pass in the future) may create operational challenges
and legal risks for our business. In addition, the political landscape in the United States has affected U.S. government&#8217;s attitude
towards China and may increase the likelihood of the imposition of further restrictions on biopharmaceutical companies that have substantial
operations in China, in particular under the current U.S. administration. Companies with substantial operations in China may have to
limit and reduce their research and development and other business activities, or cease conducting transactions with parties, in the
United States and other countries that impose export controls or other restrictions. Given our substantial research and development activities
in the United States and China and our cooperation with certain U.S.-and China-based suppliers, our business is particularly susceptible
to these controls and restrictions, and our financial condition and results of operations could be materially and adversely affected
as a result.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Payment
of dividends is subject to restrictions under the PRC law. Any limitation on the ability of our PRC subsidiaries to make payments to
us could have a material and adverse effect on our ability to conduct our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage
Pharma Group International is a Cayman Islands exempted company, and its ability to declare future dividends will depend on the availability
of dividends, if any, received from our PRC subsidiaries. Under PRC laws and regulations, each of our PRC subsidiaries may pay dividends
only out of its respective accumulated profits as determined in accordance with PRC accounting standards and regulations. In addition,
a foreign-owned enterprise is required to set aside at least 10% of its accumulated after-tax profits each year, if any, to fund a certain
statutory reserve fund, until the aggregate amount of such fund reaches 50% of its registered capital. Such reserve funds cannot be distributed
to us as dividends. For a detailed discussion of applicable PRC regulations governing distribution of dividends, see &#8220;<i>Item 4.
Information on the Company&#8212;B. Business Overview&#8212;Government regulation&#8212;PRC regulation&#8212;PRC regulations relating
to dividend distribution.</i>&#8221; As a result of these laws, rules and regulations, our PRC subsidiaries are restricted in their ability
to transfer a portion of their respective net assets to their shareholders as dividends. Furthermore, if our PRC subsidiaries incur debt
on their own behalf in the future, the instruments governing their debt may restrict their ability to pay dividends or make other distributions
to us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
there are currently no such restrictions on foreign exchange and our ability to transfer cash or assets between Ascentage Pharma Group
International and our Hong Kong subsidiaries, if certain PRC laws and regulations, including existing laws and regulations and those
enacted or promulgated in the future were to become applicable to our Hong Kong subsidiaries in the future, and to the extent our cash
or assets are in Hong Kong or a Hong Kong entity, such funds or assets may not be available due to interventions in or the imposition
of restrictions and limitations on our ability to transfer funds or assets by the PRC government. Furthermore, we cannot assure you that
the PRC government will not intervene or impose restrictions on Ascentage Pharma Group International, its subsidiaries and the affiliated
entities to transfer or distribute cash within the organization, which could result in an inability of or prohibition on making transfers
or distributions to entities outside of mainland China and Hong Kong.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Enterprise Income Tax Law and its implementation rules provide that a withholding tax rate of up to 10% will be applicable
to dividends payable by Chinese companies to non-PRC-resident enterprises unless otherwise exempted or reduced according to treaties
or arrangements between the PRC central government and governments of other countries or regions where the non-PRC-resident enterprises
are incorporated.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
restriction on currency exchange may limit the ability of our PRC subsidiaries to use their Renminbi revenues to pay dividends to us.
Any limitation on the ability of our PRC subsidiaries to pay dividends or make other distributions to us could materially and adversely
limit our ability to grow or make investments that could be beneficial to our business, pay dividends, or otherwise fund and conduct
our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Governmental
regulations of currency conversion may limit our ability to pay dividends and other obligations and affect the value of our ordinary
shares.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The PRC government
imposes regulations on the convertibility of Renminbi into foreign currencies and the remittance of funds out of China. A significant
portion of our revenue is in RMB. We may convert a portion of our revenue into other currencies to meet our foreign currency obligations,
such as payments of dividends declared in respect of the ADSs, if any. Shortages in the availability of foreign currency may affect the
ability of our PRC subsidiaries to remit sufficient foreign currency to pay dividends or other payments to us or otherwise satisfy their
foreign currency denominated obligations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments, and
trade and service-related foreign exchange transactions, can be made in foreign currencies without the prior approval of PRC State Administration
of Foreign Exchange, or SAFE, by complying with certain procedural requirements. However, approval from or registration or filings with
competent government authorities is required where Renminbi is to be converted into foreign currency and remitted out of China to pay
capital expenses such as the repayment of loans denominated in foreign currencies. Pursuant to the Circular on Reforming the Management
Approach regarding the Foreign Exchange Capital Settlement of Foreign-invested Enterprise, or the SAFE Circular 19, a foreign-invested
enterprise may convert up to 100% of the foreign currency in its capital account into Renminbi on a discretionary basis according to
the actual needs. The Circular on Reforming and Regulating Policies on the Control over Foreign Exchange Settlement of Capital Accounts,
or the SAFE Circular 16, provides for an integrated standard for conversion of foreign exchange under capital account items on a discretionary
basis, which applies to all enterprises registered in China. In addition, the SAFE Circular 16 has narrowed the scope of purposes for
which an enterprise must not use the Renminbi funds so converted, which include, among others, (1) directly or indirectly used for payments
for expenditure beyond its business scope or otherwise as prohibited by the applicable laws and regulations, (2) unless otherwise expressly
provided, directly or indirectly used for investment in securities or other financial products (except for financial products with risk
ratings not higher than Level 2 and structured deposits), (3) provision of loans to non-affiliated enterprises, except where it is expressly
permitted in the business scope of the enterprise and (4) construction or purchase of real properties for use by third parties, except
for enterprises engaging in real estate development and real estate leasing. We cannot assure you that additional restrictions on the
convertibility of the RMB into foreign currencies for current account transactions will not be imposed in the future. If we cannot obtain
sufficient foreign currencies to satisfy our foreign currency needs, we may not be able to pay dividends in foreign currencies to our
shareholders. Further, we cannot assure you that new regulations will not be promulgated in the future that would have the effect of
further restricting the remittance of Renminbi into or out of China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>China&#8217;s
M&amp;A Rules and certain other PRC regulations establish complex procedures for some acquisitions of PRC companies by foreign investors,
which could make it difficult for us to pursue growth through acquisitions in China.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or the M&amp;A Rules, and some other regulations
and rules concerning mergers and acquisitions established complex procedures and requirements for the acquisition of Chinese companies
by foreign investors, including requirements in some instances that the Ministry of Commerce of the PRC, or MOFCOM be notified in advance
of any change-of-control transaction in which a foreign investor takes control of a PRC domestic enterprise. Moreover, the Anti-monopoly
Law promulgated by the SCNPC requires that transactions which are deemed concentrations and involve parties with specified turnover thresholds
must be cleared by the anti-monopoly enforcement agency before they can be completed. In addition, the Measures for the Security Review
of Foreign Investment promulgated by the NDRC and MOFCOM in December 2020 specify that foreign investments in the military, national
defense-related areas or in locations in proximity to military facilities, or foreign investments that would result in acquiring the
actual control of assets in certain key sectors, such as critical agricultural products, energy and resources, equipment manufacturing,
infrastructure, transport, cultural products and services, information technology, internet products and services, financial services
and technology sectors, are required to obtain approval from designated government authorities in advance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, we may pursue potential strategic acquisitions that are complementary to our business. Complying with the requirements of
the above-mentioned regulations and other rules to complete such transactions could be time-consuming, and any required approval processes
may delay or inhibit our ability to complete such transactions, which could affect our ability to expand business or maintain market
share. Furthermore, there is a possibility that the PRC regulators may promulgate new rules or explanations requiring that we obtain
the approval of MOFCOM or other PRC government authorities for our mergers and acquisitions. We cannot assure you that we can obtain
such approval from MOFCOM or any other relevant PRC government authorities for our mergers and acquisitions. Any uncertainties regarding
such approval requirements could have a material adverse effect on our business and results of operations and our corporate structure.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PRC
regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion
may delay or prevent us from using the proceeds of our public and private financings to make loans to or make additional capital contributions
to our PRC subsidiaries, which could materially and adversely affect our liquidity and our ability to fund and expand our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
funds we transfer to our PRC subsidiaries, either as a shareholder loan or as an increase in registered capital, are subject to approval
by or registration with relevant governmental authorities in China. According to the relevant PRC regulations on foreign-invested enterprises
in China, capital contributions to our PRC subsidiaries are subject to registration with the State Administration for Market Regulation
or its local counterpart and registration with a local bank authorized by SAFE. In addition, (1) any foreign loan procured by our PRC
subsidiaries is required to be registered with SAFE or its local branches and (2) any of our PRC subsidiaries may not procure loans that
exceed the difference between its total investment amount and registered capital or, as an alternative, they may only procure loans subject
to the calculation approach and limitation as provided by the People&#8217;s Bank of China. SAFE promulgated the SAFE Circular 19, effective
from June 2015, in replacement of a former regulation. According to SAFE Circular 19, the flow and use of the Renminbi capital converted
from foreign currency-denominated registered capital of a foreign-invested enterprise is regulated such that Renminbi capital may not
be used for the issuance of Renminbi entrusted loans, the repayment of inter-enterprise loans or the repayment of bank loans that have
been transferred to a third party. Although SAFE Circular 19 allows Renminbi capital converted from foreign currency- denominated registered
capital of a foreign-invested enterprise to be used for equity investments within China, it also reiterates the principle that Renminbi
converted from the foreign currency-denominated capital of a foreign-invested company may not be directly or indirectly used for purposes
beyond its business scope. Thus, it is unclear whether SAFE will permit such capital to be used for equity investments in China in actual
practice. SAFE promulgated the SAFE Circular 16, effective from June 2016, which reiterates some of the rules set forth in SAFE Circular
19, but changes the prohibition against using Renminbi capital converted from foreign currency-denominated registered capital of a foreign-invested
company to issue Renminbi entrusted loans to a prohibition against using such capital to issue loans to non-associated enterprises. Violations
of SAFE Circular 19 and SAFE Circular 16 could result in administrative penalties. The SAFE Circular 19 and SAFE Circular 16 may significantly
limit our ability to transfer any foreign currency we hold, including the net proceeds from our public and private financings, to our
PRC subsidiaries, which may adversely affect our liquidity and our ability to fund and expand our business in China. On October 23, 2019,
SAFE promulgated the Circular of Further Facilitating Cross-border Trade and Investment, or the SAFE Circular 28, which, among other
things, allows all foreign-invested enterprises to use Renminbi converted from foreign currency-denominated capital for equity investments
in China, as long as the equity investment is genuine, does not violate applicable laws, and complies with the negative list on foreign
investment. On April 10, 2020, the SAFE promulgated the Circular on Optimizing Administration of Foreign Exchange to Support the Development
of Foreign-related Business, or the SAFE Circular 8, under which eligible enterprises are allowed to make domestic payments by using
their capital funds, foreign loans and the income under capital accounts of overseas listing without providing the evidentiary materials
concerning authenticity of each expenditure in advance, provided that their capital use shall be authentic and conforms to the prevailing
administrative regulations on the use of income under capital accounts. On December 4, 2023, SAFE issued the Notice on Further Deepening
the Reform to Facilitate Cross-border Trade and Investment, which releases new foreign exchange management policies and revises some
rules under SAFE Circular 16 and SAFE Circular 28.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the various requirements imposed by PRC regulations on loans to and direct investment in PRC entities by offshore holding companies,
we cannot assure you that we will be able to complete the necessary government registrations or obtain the necessary government approvals
on a timely basis, or at all, with respect to future loans or capital contributions by us to our PRC subsidiaries. If we fail to complete
such registrations or obtain such approvals, our ability to use the proceeds from our public and private financings and to capitalize
or otherwise fund the PRC operations may be negatively affected, which could materially and adversely affect our liquidity and the ability
to fund and expand our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to comply with PRC regulations relating to the establishment of offshore special purpose companies by PRC residents may subject our PRC
resident beneficial owners or our PRC subsidiaries to liability or penalties, limit our ability to inject capital into our PRC subsidiaries,
limit our PRC subsidiaries&#8217; ability to increase its registered capital or distribute profits to us, or may otherwise adversely
affect us.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE
promulgated the Circular on Relevant Issues Concerning Foreign Exchange Control on Domestic Residents&#8217; Offshore Investment and
Financing and Roundtrip Investment Through Special Purpose Vehicles, or the SAFE Circular 37, in July 2014. SAFE Circular 37 requires
PRC residents or entities to register with SAFE or its local branch in connection with their establishment or control of an offshore
entity established for the purpose of overseas investment or financing with such PRC residents or entities&#8217; legally owned assets
or equity interests in domestic enterprises or offshore assets or interests. On February 13, 2015, SAFE issued the Circular on Further
Simplifying and Improving Foreign Exchange Administration Policy on Direct Investment, or the SAFE Circular 13, effective on June 1,
2015, pursuant to which the power to accept SAFE registration was delegated from local SAFE to local qualified banks where the assets
or interest in the domestic entity was located. In addition, such PRC residents or entities must update their SAFE registrations when
the offshore special purpose vehicle undergoes material events relating to any change of basic information (including change of such
PRC citizens or residents, name and operation term), increases or decreases in investment amount, transfers or exchanges of shares, or
mergers or divisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our shareholders who are PRC residents or entities do not complete their registration with the local SAFE branches, our PRC subsidiaries
may be prohibited from distributing their profits and proceeds from any reduction in capital, share transfer or liquidation to us, and
we may be restricted in our ability to contribute additional capital to our PRC subsidiaries. Moreover, failure to comply with the SAFE
registration described above could result in liability under PRC laws for evasion of applicable foreign exchange restrictions. In addition,
our shareholders who are PRC entities shall complete their overseas direct investment filings according to applicable laws and regulations
regarding overseas direct investment by PRC entities, including filings with MOFCOM, the NDRC, or their local branches based on the amount
and industry of the investments or other factors thereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have used our best efforts to notify PRC residents or entities who directly or indirectly hold shares in our Cayman Islands exempted
company and who are known to us as being PRC residents or entities to complete the foreign exchange registrations or overseas direct
investment filings. However, we may not at all times be fully aware or informed of the identities of all the PRC residents or entities
holding direct or indirect interest in our Company, nor can we compel our beneficial owners to comply with SAFE registration requirements.
We also cannot assure you that all shareholders or beneficial owners of ours who are PRC residents or entities will in the future make,
obtain or update any applicable registrations, filings or approvals required by SAFE regulations or other regulations relating to overseas
investment activities issued by MOFCOM and NDRC. Failure by such shareholders or beneficial owners to comply with such regulations, or
failure by us to amend the foreign exchange registrations of our PRC subsidiaries, could subject us to fines or legal sanctions, restrict
our overseas or cross-border investment activities, limit our PRC subsidiaries&#8217; ability to make distributions or pay dividends
to us or affect our ownership structure, which could adversely affect our business, results of operations and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to comply with PRC regulations regarding the registration requirements for employee equity incentive plans or share option plans,
the PRC plan participants or we could be subject to fines and other legal or administrative sanctions.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">In February
2012, SAFE promulgated the Circular on Issues Concerning the Foreign Exchange Administration for Domestic Individuals Participating in
Stock Incentive Plan of Overseas Publicly Listed Company, or the SAFE Circular 7. Pursuant to SAFE Circular 7, directors, supervisors,
senior management and other employees participating in any stock incentive plan of an overseas publicly listed company who are PRC citizens
or who are non-PRC citizens residing in China for a continuous period of not less than one year, are required to register with SAFE through
a domestic qualified agent, which could be the PRC subsidiary of such overseas-listed company, and complete certain other procedures,
unless certain exceptions are available. In addition, an overseas-entrusted institution must be retained to handle matters in connection
with the exercise or sale of stock options and the purchase or sale of shares and interests. We and our executive officers and other
employees who are PRC citizens or non-PRC citizens living in China for a continuous period of not less than one year and have been granted
options are subject to these regulations as our Company has become an overseas-listed company. Failure to complete SAFE registrations
may subject them to fines of up to RMB50,000 for individuals and may also limit our ability to contribute additional capital to our PRC
subsidiaries and our PRC subsidiaries&#8217; ability to distribute dividends to us. We also face regulatory uncertainties that could
restrict our ability to adopt additional incentive plans for our directors, executive officers, and employees under PRC law. See &#8220;<i>Item
4. Information on the Company&#8212;B. Business Overview&#8212;Government regulation&#8212;PRC regulation.</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Ministry of Finance and the State Administration of Taxation, or the SAT, have issued certain circulars concerning employee
share options and restricted shares. Under these circulars, our employees working in China who exercise share options or are granted
restricted shares will be subject to PRC individual income tax. Our PRC subsidiaries have obligations to file documents related to employee
share options or restricted shares with relevant tax authorities and to withhold individual income taxes of those employees who exercise
their share options or are granted restricted shares. If our employees fail to pay or we fail to withhold their income taxes according
to relevant laws and regulations, we may face sanctions imposed by the tax authorities or other PRC government authorities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are classified as a PRC resident enterprise for PRC tax purposes under the EIT Law, such classification could result in unfavorable
tax consequences to us and our non-PRC shareholders or ADS holders.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the PRC Enterprise Income Tax Law and its implementation rules, an enterprise established outside of the PRC with a &#8220;de facto management
body&#8221; within China is considered a &#8220;resident enterprise&#8221; and will be subject to the enterprise income tax on its global
income at the rate of 25%. The implementation rules define the term &#8220;de facto management body&#8221; as the body that exercises
full and substantial control and overall management over the business, productions, personnel, accounts and properties of an enterprise.
In 2009, the SAT issued the Circular on Issues Concerning the Determination of Chinese-Controlled Enterprises Registered Overseas as
Resident Enterprises on the Basis of Their Bodies of Actual Management, or the SAT Circular 82, which provides certain specific criteria
for determining whether the &#8220;de facto management body&#8221; of a PRC-controlled enterprise that is incorporated offshore is located
in China. Although this circular only applies to offshore enterprises controlled by PRC enterprises or PRC enterprise groups, not those
controlled by PRC individuals or foreigners like us, the criteria set forth in the circular may reflect SAT&#8217;s general position
on how the &#8220;de facto management body&#8221; test should be applied in determining the tax resident status of all offshore enterprises.
According to SAT Circular 82, an offshore incorporated enterprise controlled by a PRC enterprise or a PRC enterprise group will be regarded
as a PRC tax resident by virtue of having its &#8220;de facto management body&#8221; in China and will be subject to PRC enterprise income
tax on its global income only if all of the following conditions are met: (1) the primary location of the day-to-day operational management
is in China; (2) decisions relating to the enterprise&#8217;s financial and human resource matters are made or are subject to approval
by organizations or personnel in China; (3) the enterprise&#8217;s primary assets, accounting books and records, company seals, and board
and shareholder resolutions, are located or maintained in China; and (4) at least 50% of voting board members or senior executives habitually
reside in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe none of our entities outside of China is a PRC resident enterprise for PRC tax purposes. However, the tax resident status of
an enterprise is subject to determination by the PRC tax authorities, and uncertainties remain with respect to the interpretation of
the term &#8220;de facto management body.&#8221; If the PRC tax authorities determine that our Cayman Islands exempted company is a resident
enterprise for PRC EIT purposes, a number of unfavorable PRC tax consequences could follow and we may be subject to EIT at a rate of
25% on our worldwide taxable income, as well as to PRC EIT reporting obligations. In addition, non-resident enterprise shareholders (including
the ADS holders) will be subject to PRC tax at a rate of 10% on gains realized on the sale or other disposition of, or dividends paid
on, the ADSs or ordinary shares (which in the case of dividends will be withheld at source) if such gain or income is treated as sourced
from within China. Furthermore, if we are deemed a PRC resident enterprise, dividends paid to our non-PRC individual shareholders (including
the ADS holders) and any gain realized on the transfer of ADSs or our ordinary shares by such shareholders may be subject to PRC tax
at a rate of 20% (which in the case of dividends will be withheld at source) unless a reduced rate is available under an applicable tax
treaty. It is unclear whether non- PRC shareholders (including ADS holders) of our Company would be able to obtain the benefits of any
tax treaties between their country of tax residence and the PRC in the event that we are treated as a PRC resident enterprise. Any such
tax may reduce the returns on your investment in the ADSs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the uncertainty as to the application of the &#8220;resident enterprise&#8221; classification, we cannot assure you that
the PRC government will not amend or revise the taxation laws, rules and regulations to impose stricter tax requirements or higher tax
rates. Any of such changes could materially and adversely affect our business, results of operations and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
face uncertainties with respect to the indirect transfers of equity interests in PRC resident enterprises by their non-PRC holding companies.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2015, the SAT issued the Bulletin on Issues of Enterprise Income Tax on Indirect Transfers of Assets by Non-PRC Resident
Enterprises, or the SAT Bulletin 7. SAT Bulletin 7 applies to transactions through offshore transfer by a foreign company directly or
indirectly holding taxable assets in China. In addition, SAT Bulletin 7 provides certain criteria on how to assess reasonable commercial
purposes and has introduced safe harbors for internal group restructurings and the purchase and sale of equity through a public securities
market. SAT Bulletin 7 also brings challenges to both the foreign transferor and transferee (or other person who is obligated to pay
for the transfer) of taxable assets. On October 17, 2017, the SAT issued the Announcement of the State Administration of Taxation on
Issues Concerning the Withholding of Non-resident Enterprise Income Tax at Source, or the SAT Bulletin 37, which came into effect on
December 1, 2017. SAT Bulletin 37 further clarifies the practice and procedure of the withholding of non-resident enterprise income tax.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
a non-resident enterprise transfers taxable assets indirectly by disposing of the equity interests of an overseas holding company, which
is an indirect transfer, the non-resident enterprise as either transferor or transferee, or the PRC entity that directly owns the taxable
assets, may report such indirect transfer to the relevant tax authority. Using a &#8220;substance over form&#8221; principle, the PRC
tax authority may disregard the existence of the overseas holding company if it lacks a reasonable commercial purpose and was established
for the purpose of reducing, avoiding or deferring PRC tax. As a result, gains derived from such indirect transfer may be subject to
PRC enterprise income tax, and the transferee or other person who is obligated to pay for the transfer is obligated to withhold the applicable
taxes, currently at a rate of 10% for the transfer of equity interests in a PRC resident enterprise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face uncertainties as to the reporting and other implications of certain past and future transactions where PRC taxable assets are
involved, such as offshore restructuring, and sale of the shares in our offshore subsidiaries and investments. For transfer of
shares in our Company by investors who are non-PRC resident enterprises, our PRC subsidiaries may be requested to assist in the
filing under SAT Bulletin 7 and/or SAT Bulletin 37. As a result, we may be required to expend valuable resources to comply with SAT
Bulletin 7 and/or SAT Bulletin 37, or to establish that we and our non-PRC resident investors should not be taxed under these
circulars, which may have a material and adverse effect on our business, results of operations and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
custodians or authorized users of our controlling non-tangible assets, including chops and seals, may fail to fulfill their responsibilities
or misappropriate or misuse these assets.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Under PRC
laws, legal documents for corporate transactions are executed using the chop or seal of the signing entity or with the signature of a
legal representative whose designation is registered and filed with the relevant branch of the State Administration for Market Regulation,
or the SAMR. Although we usually utilize chops to enter into contracts, the designated legal representatives of our PRC subsidiaries
have the apparent authority to enter into binding contracts on behalf of these entities without chops. In order to maintain the physical
security of our chops, we generally have them stored in secure locations accessible only to authorized employees. Although we monitor
such authorized employees, the procedures may not be sufficient to prevent all instances of abuse or negligence. There is a risk that
our employees could abuse their authority, for instance, by entering into a contract not approved by us, or seeking to gain control of
any of our subsidiaries. If any employee obtains, misuses or misappropriates corporate chops and seals or other controlling non-tangible
assets for whatever reason, the business operations of the relevant entities could be disrupted. We may have to take corporate or legal
action to seek the return of the chops, apply for new chops with the relevant authorities, or otherwise seek legal redress for the violation
of the representative&#8217;s fiduciary duties against us, which could involve significant time and resources to resolve and divert management
attention from business operations. In addition, the affected entity may not be able to recover corporate assets that are sold or transferred
out of our control in the event of such a misappropriation if a transferee relies on the apparent authority of the representative and
acts in good faith.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fluctuations
in exchange rates could have a material adverse effect on our results of operations and the value of your investment.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conversion of Renminbi into foreign currencies, including the U.S. dollar, is based on rates set by the People&#8217;s Bank of China.
The value of Renminbi against the U.S. dollar and other currencies is affected by changes in China&#8217;s political and economic conditions
and by China&#8217;s foreign exchange policies, among other things. We cannot assure you that Renminbi will not appreciate or depreciate
significantly in value against the U.S. dollar and other currencies in the future. It is difficult to predict how market forces or PRC,
or U.S. government policy may impact the exchange rate between Renminbi and U.S. dollar in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incur portions of our expenses, and may in the future derive revenues, in currencies other than the RMB, in particular, the U.S. dollar.
Any significant appreciation or depreciation of Renminbi may materially and adversely affect our revenues, earnings and financial condition,
and the value of, and any dividends payable on, the ADSs in U.S. dollars. For example, a significant portion of our clinical trial activities
are conducted outside of the PRC, and associated costs may be incurred in the local currency of the country in which the trial is being
conducted, which costs could be subject to fluctuations in currency exchange rates. A decline in the value of the RMB against currencies
in countries in which we conduct clinical trials could have a negative impact on our research and development costs. Furthermore, to
the extent that we need to convert U.S. dollars we receive into Renminbi to pay our operating expenses, appreciation of Renminbi against
the U.S. dollar would have an adverse effect on the RMB amount we would receive from the conversion. Conversely, a significant depreciation
of RMB against the U.S. dollar may significantly reduce the U.S. dollar equivalent of our earnings, which in turn could adversely affect
the price of the ADSs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently do not engage in hedging transactions to protect against uncertainty in future exchange rates between particular foreign currencies
and the RMB. While we may decide to enter into hedging transactions in the future, the availability and effectiveness of these hedges
may be limited, and we may not be able to adequately hedge our exposure, or at all. In addition, our currency exchange losses may be magnified
by PRC exchange control regulations that restrict our ability to convert Renminbi into foreign currency.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
related to our ordinary shares and the ADSs</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
dual listing of our ordinary shares and the ADSs may adversely affect the liquidity and value of the ADSs and ordinary shares.</i></b></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ADSs are listed on the Nasdaq Global Market, and our ordinary shares are listed on the HKEx. Trading of the ADSs or ordinary shares in
these markets takes place in different currencies (U.S. dollars on Nasdaq and HK$ on the HKEx), and at different times (resulting from
different time zones, different trading days and different public holidays in the United States and Hong Kong). The trading prices of
our ordinary shares and the ADSs representing them may differ due to these and other factors, even allowing for currency differences.
Any decrease in the price of our ordinary shares on the HKEx could cause a decrease in the trading price of the ADSs on Nasdaq. Fluctuations
in the price of ordinary shares due to circumstances peculiar to the HKEx could materially and adversely affect the price of the
ADSs. Because of the different characteristics of the U.S. and Hong Kong equity markets, the historic market prices of our ordinary shares
may not be indicative of the performance of the ADSs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
could seek to sell or buy our ordinary shares to take advantage of any price differences between the markets through a practice referred
to as arbitrage. Any arbitrage activity could create unexpected volatility in both the ADSs on Nasdaq and the ordinary shares available
for trading on the HKEx. In addition, holders of ADSs will not be immediately able to surrender their ADSs and withdraw the underlying
ordinary shares for trading on the other market without effecting necessary procedures with the depositary. See &#8220;&#8212;<i>The
time required for the exchange between our ordinary shares and ADSs might be longer than expected and investors might not be able to
settle or effect any sale of their securities during this period, and the exchange between our ordinary shares and ADSs involves costs.</i>&#8221;
This could result in time delays and additional cost for holders of ADSs. We cannot predict the effect of this dual listing on the value
of our ordinary shares and the ADSs. However, the dual listing of our ordinary shares and the ADSs may reduce the liquidity of these
securities in one or both markets and may adversely affect the development of an active trading market for the ADSs in the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
trading prices of the ADSs are likely to be volatile, which could result in substantial losses to you.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The price and trading volume of the ADSs may be subject to significant
volatility in response to various factors beyond our control, including the general market conditions of the securities in Hong Kong and
elsewhere in the world. Our share price in Hong Kong has fluctuated from a 52-week high of HK$95.35 to a low of HK$38.15, and our price
of our ADSs has fluctuated from a 52-week high of $48.45 to a low of $19.11, each as of April 22, 2026. In addition, the business and
performance and the market price of the shares of other companies engaging in similar business may affect the price and trading volume
of the ADSs. In addition to market and industry factors, the price and trading volume of the ADSs may be highly volatile for specific
business reasons, such as fluctuations in our revenue, earnings, cash flows, investments, expenditures, regulatory developments, relationships
with our suppliers, movements or activities of key personnel, or actions taken by competitors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><!-- Field: Split-Segment; Name: 3 --><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to market and industry factors, the price and trading volume for the ADSs may be highly volatile for specific business reasons,
including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            of regulatory approval or a complete response letter, or specific label indications or patient
                                            populations for its use, or changes or delays in the regulatory review process;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            of therapeutic innovations or new products by us or our competitors;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
                                            actions taken by regulatory agencies with respect to our clinical trials, manufacturing supply
                                            chain or sales and marketing activities;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            adverse changes to our relationship with manufacturers or suppliers;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            results of our testing and clinical trials;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            results of our efforts to acquire or license additional drug candidates;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
                                            in the level of expenses related to our existing drug candidates or preclinical and clinical
                                            development programs;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            intellectual property infringement actions in which we may become involved;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            concerning our competitors or the pharmaceutical industry in general;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">achievement
                                            of expected product sales and profitability;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">manufacture,
                                            supply or distribution shortages;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
                                            in our results of operations;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            about our earnings that are not in line with analyst expectations;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">publication
                                            of operating or industry metrics by third parties, including government statistical agencies,
                                            that differ from expectations of industry or financial analysts;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in financial estimates by securities research analysts;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            made by us or our competitors of new product and service offerings, acquisitions, strategic
                                            relationships, joint ventures or capital commitments;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">press
                                            reports, whether or not true, about our business;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
                                            to or departures of our management;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
                                            of exchange rates between the RMB, the U.S. dollar and other currencies;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">release
                                            or expiry of lock-up or other transfer restrictions on our outstanding ordinary shares or
                                            ADSs;</span></td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
                                            or perceived potential sales of additional ordinary shares or ADSs;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
                                            of our ordinary shares or ADSs by us, our executive officers and directors or our shareholders
                                            in the future;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                            economic and market conditions and overall fluctuations in the U.S. and Hong Kong equity
                                            markets;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in accounting principles; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            or developments in the PRC or global regulatory environment.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these factors may result in large and sudden changes in the volume and trading price of the ADSs. In the past, following periods of
volatility in the market price of a company&#8217;s securities, shareholders have often instituted securities class action litigation
against that company. If we were involved in a class action suit, it could divert the attention of management, and, if adversely determined,
have a material adverse effect on our financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock market, in general, and small pharmaceutical and biotechnology companies have experienced extreme price and volume
fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry
factors may negatively affect the market price of the ADSs, regardless of our actual operating performance and may cause the price of
the ADSs to decline rapidly and unexpectedly.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
time required for the exchange between our ordinary shares and ADSs might be longer than expected and investors might not be able to
settle or effect any sale of their securities during this period, and the exchange between our ordinary shares and ADSs involves costs.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no direct trading or settlement between Nasdaq and the HKEx. In addition, the time differences between New York and Hong Kong, unforeseen
market circumstances, or other factors may delay the deposit of ordinary shares in exchange for the ADSs or the withdrawal of ordinary
shares underlying the ADSs. Investors will be prevented from settling or effecting the sale of their securities during such periods of
delay. In addition, we cannot assure you that any exchange for ordinary shares into ADSs (and vice versa) will be completed in accordance
with the timelines that investors may anticipate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the depositary for the ADSs is entitled to charge holders fees for various services including for the issuance of ADSs upon deposit of
ordinary shares, cancelation of ADSs, distributions of cash dividends or other cash distributions, distributions of ADSs pursuant to
share dividends or other free share distributions, distributions of securities other than ADSs, and annual service fees. As a result,
shareholders who exchange ordinary shares into ADSs, and vice versa, may not achieve the level of economic return the shareholders may
anticipate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Substantial
future sales or perceived potential sales of the ADSs, ordinary shares or other equity securities in the public market could cause the
price of the ADSs to decline significantly.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sales of substantial amounts of the ADSs in the public market, or the
perception that these sales could occur, could adversely affect the market price of the ADSs and could materially impair our ability to
raise capital through equity offerings in the future. The ADSs are freely tradable without restriction or further registration under the
Securities Act, and all other ordinary shares held by our existing shareholders may also be sold in the public market in the future, subject
in certain cases to the restrictions in Rule 144 and Rule 701 under the Securities Act. As of April 1, 2026, there are 928,218 ADSs,
representing 3,712,872 ordinary shares, or 1% of our outstanding ordinary shares. We have registered the offer and sale of all shares
of ordinary shares that we may issue under our equity compensation plans. Ordinary shares issued under our equity compensation plans as
a result of the exercise of stock options or vesting of RSUs outstanding under our equity compensation plans or pursuant to future awards
granted under those plans will become available for sale in the public market to the extent permitted by the provisions of applicable
vesting schedules and Rule 144 under the Securities Act. We cannot predict what effect, if any, market sales of securities held by our
significant shareholders or any other shareholder or the availability of these securities for future sale will have on the market price
of the ADSs and our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
may be subject to limitations on the transfer of the ADSs.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ADSs are transferable on the books of the depositary. However, the depositary may close its books at any time or from time to time when
it deems expedient in connection with the performance of its duties. The depositary may close its books from time to time for a number
of reasons, including in connection with corporate events, such as a rights offering, or &#8220;for record date or processing purposes&#8221;
in emergencies, and on weekends and public holidays. The depositary may refuse to deliver, transfer or register transfers of the ADSs
generally when our share register or the books of the depositary are closed, or at any time if we or the depositary thinks it is advisable
to do so because of any requirement of law or of any government or governmental body, or under any provision of the deposit agreement,
or for any other reason.</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
a United States person is treated as owning at least 10% of our share capital, such person may be subject to adverse U.S. federal income
tax consequences.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a United States person, as defined by the Internal Revenue Code of 1986, as amended, is treated as owning (directly, indirectly or constructively)
at least 10% of the value or voting power of our share capital, such person may be treated as a &#8220;United States shareholder&#8221;
with respect to each non-U.S. corporation in our group that is a &#8220;controlled foreign corporation,&#8221; or CFC, for U.S. federal
income tax purposes. A non-U.S. corporation will be a CFC if United States shareholders, as defined in the immediately preceding sentence,
own directly, indirectly or constructively (through attribution), more than 50% of either the total combined voting power or total value
of the stock of such corporation. No assurances can be provided that we are not a CFC or will not be a CFC. A United States shareholder
that owns our ordinary shares or ADSs directly or indirectly may be required to report annually and include in its U.S. taxable income
its pro rata share of &#8220;Subpart F income,&#8221; &#8220;global intangible low-taxed income&#8221; and investments in U.S. property
by our subsidiary CFCs, regardless of whether we make any distributions. Failure to comply with such reporting requirements could result
in adverse tax effects for United States shareholders and potentially significant monetary penalties. We do not currently expect to assist
investors in determining whether we or any of our non-U.S. subsidiaries is treated as a CFC or furnish to any United States shareholders
information that may be necessary to comply with the aforementioned obligations. A United States investor should consult its advisors
regarding the potential application of these rules to an investment in the ADSs.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b><i>We
previously identified a material weakness in our internal control over financial reporting in connection with the audit of our financial
statements as of and for the years ended December 31, 2022 and 2023, which has been remediated. We may identify additional material weaknesses
in the future. If we fail to maintain an effective system of internal controls over financial reporting in the future, we may be unable
to accurately report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence and the market
price of the ADSs may be materially and adversely affected.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">As defined in
the standards established by the PCAOB, a &#8220;material weakness&#8221; is a deficiency, or a combination of control deficiencies,
in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interim
financial statements will not be prevented or detected on a timely basis.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">As a public company
with securities traded in the United States, we are subject to reporting obligations under the U.S. securities laws, including the Sarbanes-Oxley
Act of 2002. Section 404(a) of the Sarbanes-Oxley Act requires that management assess and report annually on the effectiveness of our
internal control over financial reporting and identify any material weaknesses in our internal control over financial reporting. Our
independent registered public accounting firm has not conducted an audit of our internal control over financial reporting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Once we cease
to be an &#8220;emerging growth company&#8221; as such term is defined in the JOBS Act, our independent registered public accounting
firm must attest to and report on the effectiveness of our internal control over financial reporting. Even if our management concludes
that our internal control over financial reporting is effective, our independent registered public accounting firm, after conducting
its own independent testing, may issue a report that is qualified if it is not satisfied with our internal controls or the level at which
our controls are documented, designed, operated, or reviewed, or if it interprets the relevant requirements differently from us. In addition,
as a public company, reporting obligations may place a significant strain on our management, operational and financial resources and
systems for the foreseeable future. We may be unable to timely complete our evaluation testing and any required remediation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">During the course
of documenting and testing our internal control procedures, in order to satisfy the requirements of Section 404 of the Sarbanes-Oxley
Act, we may identify weaknesses and deficiencies in our internal control over financial reporting. If we fail to maintain the adequacy
of our internal control over financial reporting, as these standards are modified, supplemented, or amended from time to time, we may
not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section
404 of the Sarbanes-Oxley Act and we may not be able to meet our reporting obligations, avoid material misstatements in our financial
statements or comply with applicable financial reporting requirements and related regulatory filings on a timely basis. Additionally,
ineffective internal control over financial reporting could expose us to increased risk of fraud or misuse of corporate assets and subject
us to potential delisting from the stock exchange on which we list, regulatory investigations and civil or criminal sanctions. As a result,
our business, financial condition, results of operations and prospects, as well as the trading price of our ADSs, may be materially and
adversely affected.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations
regarding the ADSs and ordinary shares, the market price for the ADSs or ordinary shares and trading volume could decline.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for the ADSs will be influenced by research or reports that industry or securities analysts publish about our business.
If one or more analysts who cover us downgrade the ADSs or ordinary shares, the market price for the ADSs or ordinary shares would likely
decline. If one or more of these analysts cease to cover us or fail to regularly publish reports on us, we could lose visibility in the
financial markets, which in turn could cause the market price or trading volume for the ADSs or ordinary shares to decline.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Techniques
employed by short sellers may drive down the market price of the ADSs.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short
selling is the practice of selling securities that the seller does not own but rather has borrowed from a third party with the intention
of buying identical securities back at a later date to return to the lender. The short seller hopes to profit from a decline in the value
of the securities between the sale of the borrowed securities and the purchase of the replacement shares, as the short seller expects
to pay less in that purchase than it received in the sale. As it is in the short seller&#8217;s interest for the price of the security
to decline, many short sellers publish, or arrange for the publication of, negative opinions regarding the relevant issuer and its business
prospects in order to create negative market momentum and generate profits for themselves after selling a security short. These short
attacks have, in the past, led to selling of shares in the market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
companies listed in the United States that have a substantial majority of their operations in China have been the subject of short selling.
Much of the scrutiny and negative publicity has centered on allegations of a lack of effective internal control over financial reporting
resulting in financial and accounting irregularities and mistakes, inadequate corporate governance policies or a lack of adherence thereto
and, in many cases, allegations of fraud. As a result, many of these companies are now conducting internal and external investigations
into the allegations and, in the interim, are subject to shareholder lawsuits and/or SEC enforcement actions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be the subject of unfavorable allegations made by short sellers in the future. Any such allegations may be followed by periods of
instability in the market price of our ordinary shares and ADSs and negative publicity. If and when we become the subject of any unfavorable
allegations, whether such allegations are proven to be true or untrue, we could have to expend a significant amount of resources to investigate
such allegations and/or defend ourselves. While we would strongly defend against any such short seller attacks, we may be constrained
in the manner in which we can proceed against the relevant short seller by principles of freedom of speech, applicable federal or state
law or issues of commercial confidentiality. Such a situation could be costly and time-consuming and could distract our management from
growing our business. Even if such allegations are ultimately proven to be groundless, allegations against us could severely impact our
business and shareholders&#8217; equity, and the value of any investment in the ADSs could be greatly reduced or rendered worthless.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have broad discretion in the use of the net proceeds from our public and private financings and may not use them effectively.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our management
will have broad discretion in the application of the net proceeds, including for any of the purposes described in the section of this
Annual Report on Form 20-F titled &#8220;Use of proceeds,&#8221; and you will not have the opportunity as part of your investment decision
to assess whether the net proceeds are being used appropriately. We currently anticipate that we will use the net proceeds from our public
and private financings, together with our existing cash and cash equivalents and our loan facility, as follows: (1) to fund the research
and development of Olverembatinib, including activities related to the various registrational trials and other clinical trials, as well
as pursuing approvals with regulatory authorities in multiple countries; (2) to fund the research and development of Lisaftoclax, including
activities related to the various registrational trials and other clinical trials, as well as pursuing approvals with regulatory authorities
in multiple countries; and (3) to fund the research and development of our other product candidates, and strengthen our technology platforms
and research and development capabilities. We intend to use any remaining net proceeds for working capital and general corporate purposes.
Because of the number and variability of factors that will determine our use of the net proceeds from our public and private financings,
their ultimate use may vary substantially from their currently intended use. The failure by our management to apply these proceeds effectively
could adversely affect our business, financial condition and results of operations. Pending their use, we may invest our net proceeds
in a manner that does not produce income or that loses value. Our investments may not yield a favorable return to our investors and may
negatively impact the price of the ADSs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Insiders
will continue to have significant influence over us, and their interests may not be aligned with the interest of our other shareholders.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 20, 2026, our directors, executive officers, holders of more than 5% of our ordinary shares and their respective affiliates
beneficially own, in the aggregate, approximately 22.56% of our outstanding ordinary shares, Our co-founders &#8212; Dr. Yang, our
Chairman and Chief Executive Officer, Dr. Zhai, our Chief Medical Officer, Dr. Wang, a member of our board of directors and Dr. Guo
&#8212; and their respective affiliates who beneficially own approximately 15.9% of our outstanding ordinary shares as of April 20,
2026, are parties to the Concert Party Confirmation Deed, or the Deed, pursuant to which such parties, amongst other things, agreed
to actively cooperate and communicate with each other to obtain and maintain consolidated control and management of our Company and
agreed to vote unanimously as a group on all matters and resolutions proposed at shareholder meetings of our Company. See
&#8220;<i>Item 7. Major Shareholders and Related Party Transactions&#8212;B. Related Party Transactions&#8212;Concert party
confirmation deed.</i>&#8221; As a result of such ownership and the Deed, such insiders, and in particular our co-founders, will,
through their voting power at our shareholder meetings and their delegates on our board of directors, have significant influence
over our business and affairs, including decisions in respect of mergers or other business combinations, acquisition or disposition
of assets, issuance of additional shares or other equity securities, timing and amount of dividend payments and our management. They
may also have interests that differ from yours and may vote in a way with which you disagree, and which may be adverse to your
interests. In addition, without the consent of such shareholders, we could be prevented from entering into transactions that could
be beneficial to us. This concentration of ownership may also discourage, delay or prevent a change in control of our Company, which
could deprive our shareholders of an opportunity to receive a premium for the shares as part of a sale of our company and may
significantly reduce the price of the ADSs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
can be no assurance that we will not be a passive foreign investment company, or PFIC, for United States federal income tax purposes
for any taxable year, which could subject United States investors in the ADSs or ordinary shares to significant adverse United States
income tax consequences.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-U.S. corporation, such as our Company, will be classified as a &#8220;passive foreign investment company&#8221;, or PFIC, for U.S.
federal income tax purposes for any taxable year, if either (1) 75% or more of its gross income for such year consists of certain types
of &#8220;passive&#8221; income, the &#8220;income test,&#8221; or (2) 50% or more of the amount of its assets (generally determined
on the basis of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive
income, the &#8220;asset test.&#8221; For this purpose, cash and assets readily convertible into cash are categorized as passive assets,
and the Company&#8217;s goodwill and other unbooked intangibles are taken into account. Passive income generally includes, among other
things, dividends, interest, rents, royalties (other than certain royalties treated as derived in an active conduct of a trade or business),
and gains from the disposition of passive assets. We will be treated as owning a proportionate share of the assets and earning a proportionate
share of the income of any other corporation in which we own, directly or indirectly, at least 25% (by value) of the stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the PFIC asset test, the amount of our assets will generally be determined by reference to their value, which may be determined
by reference to our market capitalization. However, if we are considered to be a CFC that is not &#8220;publicly traded&#8221; for purposes
of the PFIC rules during the tested period, the amount of our assets will generally be determined by reference to our adjusted bases
in our assets. Further, for purposes of applying the PFIC asset test to us, if any entity in which we own 25% or more of the total value
of the outstanding shares of such entity is considered to be a CFC that is not publicly traded, the amount of such entity&#8217;s assets
would generally be determined by reference to its adjusted bases in its assets. No assurances can be provided that we or any of our subsidiaries
are not a CFC or will not be a CFC, and consequently, no assurances can be given that the PFIC asset test will not be applied to us based
on the adjusted bases of our non-U.S. subsidiaries in their assets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
that we and our subsidiaries were not, and do not become, CFCs, based on the composition of our income and assets and the estimated value
of our assets, which is based on our current market capitalization, we do not presently expect to be a PFIC for our current fiscal year
or future fiscal years. However, no assurance can be given that we will not be a PFIC for the current fiscal year or future fiscal years
because the determination of whether we will be or become a PFIC for any taxable year is a fact intensive determination made annually
after the close of each taxable year that depends, in part, upon the composition and classification of our income and assets. Fluctuations
in the market price of the ADSs may cause us to be or become classified as a PFIC for the current or future fiscal years because the
value of our assets for purposes of the asset test, including the value of our goodwill and unbooked intangibles, may be determined by
reference to the market price of the shares or ADSs from time to time (which may be volatile). Among other matters, if our market capitalization
is less than anticipated or subsequently declines, we may be or become classified as a PFIC for the current fiscal year or future fiscal
years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC for any taxable year during which a U.S. Holder (as defined in the section of this Annual Report on Form 20-F titled &#8220;<i>Item
10. Additional Information&#8212;E. Taxation&#8212;U.S. federal income tax considerations&#8212;General</i>&#8221;) holds an ADS or an
ordinary share, certain adverse U.S. federal income tax consequences could apply to the U.S. Holder. See the section of this Annual Report
on Form 20-F titled &#8220;<i>Item 10. Additional Information&#8212;E. Taxation&#8212;U.S. federal income tax considerations&#8212;Passive
foreign investment company rules</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
second amended and restated memorandum and articles of association contain anti-takeover provisions that could have a material adverse
effect on the rights of holders of our ordinary shares and ADSs.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
second amended and restated memorandum and articles of association contain provisions which could limit the ability of others to acquire
control of our Company or cause us to engage in change-of-control transactions. These provisions could have the effect of depriving our
shareholders and ADS holders of an opportunity to sell their shares or ADSs at a premium over prevailing market prices by discouraging
third parties from seeking to obtain control of our Company in a tender offer or similar transactions. Our board of directors has the
authority, without further action by our shareholders, to issue preferred shares in one or more series and to fix their designations,
powers, preferences, privileges, and relative participating, optional or special rights and the qualifications, limitations or restrictions,
including dividend rights, conversion rights, voting rights, terms of redemption and liquidation preferences, any or all of which may
be greater than the rights associated with our ordinary shares, in the form of ADS or otherwise. Preferred shares could be issued quickly
with terms calculated to delay or prevent a change in control of our Company or make removal of management more difficult. If our board
of directors decides to issue preferred shares, the price of the ADSs may fall, and the voting and other rights of the holders of our
ordinary shares and ADSs may be materially and adversely affected.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited, because
we are incorporated under Cayman Islands law.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an exempted company incorporated in the Cayman Islands. Our corporate affairs are governed by our second amended and restated memorandum
and articles of association, the Companies Act (as amended) of the Cayman Islands, or the Companies Act, and the common law of the Cayman
Islands. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities
of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law
of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands (as compared to the United
States) as well as from the common law of England, the decisions of whose courts are of persuasive authority, but are not binding, on
a court in the Cayman Islands (except for those decisions handed down from the Judicial Committee of the Privy Council to the extent
that these have been appealed from the Cayman Islands courts). The rights of our shareholders and the fiduciary responsibilities of our
directors under Cayman Islands law are broadly similar to those other common law jurisdictions, but there may be differences in the statutes
or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities
laws than the United States. Some U.S. states, such as Delaware, have more fully developed and judicially interpreted bodies of corporate
law than the Cayman Islands. In addition, if shareholders want to proceed against us outside of the Cayman Islands, they will need to
demonstrate that they have standing to initiate a shareholder derivative action in a federal court of the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
of Cayman Islands exempted companies like us have no general rights under Cayman Islands law to inspect corporate records or to obtain
corporate records (other than the memorandum and articles of association, the register of mortgages and charges and any special resolutions
passed by shareholders) or to obtain copies of lists of shareholders of these companies. Under Cayman Islands law, the names of our current
directors can be obtained from a search conducted at the Registrar of Companies in the Cayman Islands. Our directors have discretion
under our second amended and restated memorandum and articles of association to determine whether or not, and under what conditions,
our corporate records may be inspected by our shareholders but are not obliged to make them available to our shareholders. This may
make it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder&#8217;s motion or to solicit
proxies from other shareholders in connection with a proxy contest.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of all of the above, public shareholders may have more difficulty in protecting their interests in the face of actions taken
by management or members of the board of directors than they would as public shareholders of a company incorporated in the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
judgments obtained against us by our shareholders may not be enforceable.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a Cayman Islands exempted company, and the majority of our assets are located outside of the United States. The majority of our current
operations are conducted in China. Service of court documents on a Cayman Islands company can be effected by serving the documents at
the Company&#8217;s registered office and it may be possible to enforce foreign judgments in the Cayman Islands against a Cayman Islands
company, subject to some exceptions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
if investors wish to serve documents on and/or enforce foreign judgments against our directors and officers, they will need to ensure
that they comply with the rules of the jurisdiction where the directors and officers are located. In addition, the majority of our current
directors are nationals and residents of countries other than the United States. As a result, it may be difficult or impossible for you
to bring an action against us or against these individuals in the United States in the event that you believe that your rights have been
infringed under the U.S. federal securities laws or otherwise. Even if you are successful in bringing an action of this kind, there are
significant legal and other obstacles to obtaining information needed for such actions and the laws in the Cayman Islands, PRC and Hong
Kong may render you unable to enforce a judgment against our assets of our directors and officers, depending on where our directors and
officers are located. For example, in China, according to Article 177 of the PRC Securities Law which became effective in March 2020,
no overseas securities regulator is allowed to directly conduct investigation or evidence collection activities within the territory
of the PRC. Accordingly, without the consent of the competent PRC securities regulators and relevant authorities, no organization or
individual may provide the documents and materials relating to securities business activities to overseas parties. See also &#8220;&#8212;<i>Risks
related to our ordinary shares and the ADSs &#8212;You may face difficulties in protecting your interests, and your ability to protect
your rights through U.S. courts may be limited, because we are incorporated under Cayman Islands law</i>&#8221; for risks associated
with investing in us as a Cayman Islands company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
voting rights of holders of ADSs are limited by the terms of the deposit agreement, and you may not be able to exercise your right to
direct how the ordinary shares which are represented by the ADSs are voted.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders of ADSs do not have the same rights as our registered shareholders.
As a Holder of our ADSs do not have any direct right to attend general meetings of our shareholders or to cast any votes at such meetings.
Instead, holders are only able to exercise the voting rights which are carried by the underlying ordinary shares represented by the ADSs
indirectly by giving voting instructions to the depositary in accordance with the provisions of the deposit agreement. Under the deposit
agreement, holders may vote only by giving voting instructions to the depositary. If we instruct the depositary to ask for holders&#8217; instructions,
then upon receipt of your voting instructions, the depositary will try, as far as is practicable, to vote the underlying ordinary shares
which are represented by the ADSs in accordance with such instructions. If we do not instruct the depositary to ask for holders&#8217;
instructions, the depositary may still vote in accordance with instructions given, but it is not required to do so. Holders of ADSs are
not able to directly exercise their right to vote with respect to the underlying ordinary shares represented by the ADSs unless they
cancel and withdraw such shares and become the registered holder of such shares prior to the record date for the general meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under our second amended and restated memorandum and articles of association,
the minimum notice period required to be given by our Company to our registered shareholders to convene a general meeting, other than
an annual general meeting, is at least 21 days. When a general meeting is convened, holders of ADSs may not receive sufficient advance
notice of the meeting to withdraw the underlying ordinary shares represented by the ADSs and become the registered holder of such shares
to allow attendance at the general meeting and to vote directly with respect to any specific matter or resolution to be considered and
voted upon at the general meeting. In addition, under our second amended and restated memorandum and articles of association, for the
purposes of determining those shareholders who are entitled to attend and vote at any general meeting, our directors may close our register
of members or fix in advance a record date for such meeting, and such closure of our register of members or the setting of such a record
date may prevent holders of ADSs from withdrawing the underlying ordinary shares represented by the ADSs and becoming the registered holder
of such shares prior to the record date, such that they would not be able to attend the general meeting or to vote directly. If we ask
for holders&#8217; instructions, the depositary will notify the holders of the upcoming vote and will arrange to deliver our voting materials
to the holders. We cannot assure holders that they will receive the voting materials in time to ensure that you can instruct the depositary
to vote the underlying ordinary shares represented by the ADSs. In addition, the depositary and its agents are not responsible for failing
to carry out voting instructions or for their manner of carrying out holders&#8217; voting instructions. This means that the holders of
ADSs may not be able to exercise their right to direct how the underlying ordinary shares represented by the ADSs are voted and may have
no legal remedy if the underlying ordinary shares represented by the ADSs are not voted as requested.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The depositary for the ADSs will give us a discretionary proxy
to vote our ordinary shares underlying the ADSs if holders of ADSs do not vote at shareholders&#8217; meetings, which could adversely
affect holders&#8217; interests.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the deposit agreement for the ADSs, if holders of ADSs do not
vote, the depositary may give us a discretionary proxy to vote the ordinary shares underlying the ADSs at shareholders&#8217; meetings
if:</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            have timely provided the depositary with notice of meeting and related voting materials;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            have instructed the depositary that we wish a discretionary proxy to be given;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            have informed the depositary that there is no substantial opposition as to a matter to be
                                            voted on at the meeting; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            matter to be voted on at the meeting would not have a material adverse impact on shareholders.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The effect of this discretionary proxy is that if holders of ADSs do
not vote at shareholders&#8217; meetings, they cannot prevent the ordinary shares underlying the ADSs from being voted, except under the
circumstances described above. This may make it more difficult for shareholders to influence the management of our Company. Holders of
our ordinary shares are not subject to this discretionary proxy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
and the depositary are entitled to amend the deposit agreement and to change the rights of ADS holders under the terms of such agreement,
and we may terminate the deposit agreement, without the prior consent of the ADS holders.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We and the depositary may amend or terminate the deposit agreement
without the consent of the holders of ADSs. Such amendment or termination may be made in favor of our Company. Holders of the ADSs, subject
to the terms of the deposit agreement, shall be given at least 30 days&#8217; notice of any amendment that imposes or increases any fees
or charges (other than stock transfer or other taxes and other governmental charges, transfer or registration fees, SWIFT, cable, telex
or facsimile transmission costs, delivery costs or other such expenses), or otherwise prejudices any substantial existing right of ADS
holders. If you continue to hold the ADSs after an amendment to the deposit agreement, you agree to be bound by the deposit agreement
as amended. The depositary may, and shall at our written direction, terminate the deposit agreement and the ADSs by mailing notice of
such termination to the registered holders of ADSs at least 30 days prior to the date fixed in such notice for such termination. After
instructing its custodian to deliver all ordinary shares to us along with a general stock power that refers to the names set forth on
the ADS register maintained by the depositary and providing us with a copy of the ADS register maintained by the depositary, the depositary
and its agents will perform no further acts under the deposit agreement or the ADSs and shall cease to have any obligations under the
deposit agreement and/or the ADSs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><b><i>Holders of ADSs may not receive dividends
or other distributions on our ordinary shares, and you may not receive any value for them, if it is illegal or impractical to make them
available to such holders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary of the ADSs may agree to distribute, subject to the terms of the deposit agreement, the cash dividends or other distributions
it or the custodian receives on our ordinary shares or other deposited securities underlying the ADSs, after deducting its fees and expenses.
You would receive these distributions in proportion to the number of ordinary shares the ADSs represent. However, the depositary is not
responsible if it decides that it is unlawful or impractical to make a distribution available to any holders of ADSs. For example, it
would be unlawful to make a distribution to a holder of ADSs if it consists of securities that require registration under the Securities
Act but that are not properly registered or distributed under an applicable exemption from registration. The depositary may also determine
that it is not feasible to distribute certain property. Additionally, the value of certain distributions may be less than the cost of
distribution. In these cases, the depositary may determine not to distribute such property. We have no obligation to register under U.S.
securities laws any ADSs, ordinary shares, rights or other securities received through such distributions. We also have no obligation
to take any other action to permit the distribution of ADSs, ordinary shares, rights or anything else to holders of ADSs. This means
that you may not receive distributions we make on our ordinary shares or any value for them if it is illegal or impractical for us to
make them available to you. These restrictions may cause a material decline in the value of the ADSs and ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>ADS holders may experience dilution of their
holdings due to inability to participate in rights offerings.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may, from time to time, distribute rights to our shareholders, including rights to acquire securities. Under the deposit agreement, the
depositary will not distribute rights to holders of ADSs unless the distribution and sale of rights and the securities to which these
rights relate are either exempt from registration under the Securities Act with respect to all holders of ADSs, or are registered under
the provisions of the Securities Act. The depositary may, but is not required to, attempt to sell these undistributed rights to third
parties, and may allow the rights to lapse. We may be unable to establish an exemption from registration under the Securities Act, and
we are under no obligation to file a registration statement with respect to these rights or underlying securities or to endeavor to have
a registration statement declared effective. Accordingly, holders of ADSs may be unable to participate in our rights offerings and may
experience dilution of their holdings as a result.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ADS
holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable
outcomes to the plaintiffs in any such action.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
deposit agreement governing the ADSs representing our ordinary shares provides that, to the fullest extent permitted by law, ADS holders
waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our ordinary shares,
the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable based
on the facts and circumstances of that case in accordance with the applicable state and federal law. To our knowledge, the enforceability
of a contractual pre-dispute jury trial waiver in connection with claims arising under the federal securities laws has not been finally
adjudicated by the U.S. Supreme Court. However, we believe that a pre-dispute contractual waiver of jury trial is generally enforceable,
including under the laws of the State of New York, which govern the deposit agreement, by a federal or state court in the City of New
York, which has non-exclusive jurisdiction over matters arising under the deposit agreement. In determining whether to enforce a pre-
dispute contractual waiver of jury trial, courts will generally consider whether a party knowingly, intelligently and voluntarily waived
the right to a jury trial. We believe that this is the case with respect to the deposit agreement and the ADSs. It is advisable that
you consult legal counsel regarding the jury waiver provision before entering into the deposit agreement. The jury trial waiver provision
may result in increased costs to ADS holders to bring a claim, limited access to information and other imbalances of resources between
our Company and our ADS holders, and such provision could discourage claims or limit our ADS holders&#8217; ability to bring a claim
in a judicial forum that they find favorable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you or any other holders or beneficial owners of ADSs bring a claim against us or the depositary in connection with matters arising under
the deposit agreement or the ADSs, including claims under federal securities laws, you or such other holder or beneficial owner may not
be entitled to a jury trial with respect to such claims, which may have the effect of limiting and discouraging lawsuits against us and
the depositary. If a lawsuit is brought against either or both of us and the depositary under the deposit agreement, it may be heard
only by a judge or justice of the applicable trial court, which would be conducted according to different civil procedures and may result
in different outcomes than a trial by jury would have, including results that could be less favorable to the plaintiffs in any such action.
Nevertheless, if this jury trial waiver provision is not permitted by applicable law, an action could proceed under the terms of the
deposit agreement with a jury trial. No condition, stipulation or provision of the deposit agreement or ADSs serves as a waiver by any
holder or beneficial owner of ADSs or by us or the depositary of compliance with any substantive provision of the U.S. federal securities
laws and the rules and regulations promulgated thereunder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are a foreign private issuer within the meaning of the rules under the Exchange Act, and as such we are exempt from certain provisions
applicable to U.S. domestic public companies.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we are a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the securities rules and regulations
in the United States that are applicable to U.S. domestic issuers, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            rules under the Exchange Act requiring the filing of quarterly reports on Form 10-Q or current
                                            reports on Form 8-K with the SEC;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            sections of the Exchange Act regulating the solicitation of proxies, consents, or authorizations
                                            in respect of a security registered under the Exchange Act; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            selective disclosure rules by issuers of material nonpublic information under Regulation
                                            FD.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will, however, be required to file an Annual Report on Form 20-F within four months of the end of each fiscal year. In addition, we intend
to publish our results on a semi-annual basis through press releases, distributed pursuant to the rules and regulations of Nasdaq. Press
releases relating to financial results and material events will also be furnished to the SEC on Form 6-K.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be
filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or information which would be
made available to you were you investing in a U.S. domestic issuer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, we are a foreign private issuer, and therefore we are not required to comply with all of the periodic disclosure and
current reporting requirements of the Exchange Act. The determination of foreign private issuer status is made annually on the last business
day of an issuer&#8217;s most recently completed second fiscal quarter. We would lose our foreign private issuer status if, for example,
more than 50% of our ordinary shares are directly or indirectly held by residents of the United States and we fail to meet additional
requirements necessary to maintain our foreign private issuer status. If we lose our foreign private issuer status on this date, we will
be required to file with the SEC periodic reports and registration statements on U.S. domestic issuer forms, which are more detailed
and extensive than the forms available to a foreign private issuer. We will also have to mandatorily comply with U.S. federal proxy requirements,
and our officers, directors and principal shareholders will become subject to the short- swing profit disclosure and recovery provisions
of Section 16 of the Exchange Act. In addition, we will lose our ability to rely upon exemptions from certain Nasdaq corporate governance
requirements. As a U.S.-listed public company that is not a foreign private issuer, we would incur significant additional legal, accounting
and other expenses that we will not incur as a foreign private issuer, and accounting, reporting and other expenses in order to maintain
a listing on a U.S. securities exchange.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
currently report our financial results under IFRS, which differs in certain significant respect from U.S. generally accepted accounting
principles, or U.S. GAAP.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently
we report our financial statements under IFRS. There have been and there may in the future be certain significant differences between
IFRS and U.S. GAAP, including differences related to revenue recognition, intangible assets, share-based compensation expense, income
tax and earnings per share. As a result, our financial information and reported earnings for historical or future periods could be significantly
different if they were prepared in accordance with U.S. GAAP. In addition, we do not intend to provide a reconciliation between IFRS
and U.S. GAAP unless it is required under applicable law. As a result, you may not be able to meaningfully compare our financial statements
under IFRS with those companies that prepare financial statements under U.S. GAAP.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are an emerging growth company within the meaning of the Securities Act and may take advantage of certain reduced reporting requirements.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
qualify as an &#8220;emerging growth company&#8221; pursuant to the JOBS Act. An emerging growth company may take advantage of specified
reduced reporting and other requirements compared to those that are otherwise applicable generally to public companies. These provisions
include exemption from the auditor&#8217;s attestation requirement under Section 404 of the Sarbanes-Oxley Act in the assessment of the emerging
growth company&#8217;s internal control over financial reporting. As a result, if we elect not to comply with such auditor attestation
requirements, our investors may not have access to certain information they may deem important.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards
until such date that a private company is otherwise required to comply with such new or revised accounting standards. Pursuant to the
JOBS Act, we have elected to take advantage of the benefits of this extended transition period for complying with new or revised accounting
standards as required when they are adopted for public companies. As a result, our results of operations and financial statements may
not be comparable to the results of operations and financial statements of other companies who have adopted the new or revised accounting
standards.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>We have experienced increased costs as a result of being a public
company in the United States and expect such costs to increase after we cease to qualify as an &#8220;emerging growth company.&#8221;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have incurred additional significant legal, accounting and other
expenses after becoming a public company in the United States. The Sarbanes-Oxley Act of 2002, as well as rules subsequently implemented
by the SEC and Nasdaq, impose various requirements on the corporate governance practices of public companies. For example, as a result
of becoming a public company, we had to increase the number of independent directors and adopt policies regarding internal controls and
disclosure controls and procedures. It may also be more difficult for us to find qualified persons to serve on our board of directors
or as executive officers. We cannot predict or estimate with any degree of certainty the amount of additional costs we may incur or the
timing of such costs.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an emerging growth company, we may take advantage of specified reduced reporting and other requirements compared to those that are otherwise
applicable generally to public companies. These provisions include exemption from the auditor&#8217;s attestation requirement under Section 404
of the Sarbanes-Oxley Act in the assessment of the emerging growth company&#8217;s internal control over financial reporting. We will
remain an emerging growth company until the earliest of (1) the last day of the fiscal year during which we have total annual gross revenues
of at least US$1.235 billion; (2) the last day of our fiscal year following the fifth anniversary of the completion of our U.S. initial
public offering; (3) the date on which we have, during the preceding three-year period, issued more than US$1.0 billion in non- convertible
debt; or (4) the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Securities Exchange Act of 1934,
as amended, or the Exchange Act, which would occur if we have been a public company for at least 12 months and the market value of the
ADSs and ordinary shares that are held by non-affiliates exceeds US$700 million as of the last business day of our most recently completed
second fiscal quarter. After we are no longer an emerging growth company, we expect to incur significant expenses and devote substantial
management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act and the other rules and regulations
of the SEC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
an exempted company incorporated in the Cayman Islands, we are permitted to adopt certain home country practices in relation to corporate
governance matters that differ significantly from the Nasdaq corporate governance standards; these practices may afford less protection
to shareholders than they would enjoy if we comply fully with the Nasdaq corporate governance standards.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are listed on Nasdaq and subject to the Nasdaq corporate governance rules. However, Nasdaq rules permit a foreign private issuer like
us to follow the corporate governance practices of its home country. Certain corporate governance practices in the Cayman Islands, which
is our home country, may differ significantly from the Nasdaq corporate governance standards. Our shareholders may be afforded less protection
than they would otherwise enjoy under the Nasdaq corporate governance standards applicable to U.S. domestic issuers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
4. INFORMATION ON THE COMPANY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
History and Development of the Company</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage
Pharma Group Corp Limited, a company incorporated in Hong Kong with limited liability, or Ascentage Pharma (HK), was established in May
2009. Dr. Yang, Dr. Zhai, Dr. Wang and Dr. Guo, our co-founders, were the initial majority shareholders of Ascentage Pharma (HK).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2010, Jiangsu Ascentage Pharma Co., Ltd, a limited liability company incorporated under the laws of the PRC, or Ascentage Jiangsu,
was established as a wholly-owned subsidiary of Ascentage Pharma (HK).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage
Pharma (HK) went through a series of internal restructurings and equity financings in 2015 and 2016, pursuant to which Ascentage International
Limited, a limited liability company incorporated in Hong Kong, or Ascentage International, Hongkong Sansheng Medical Limited, a company
incorporated in Hong Kong with limited liability, and Shengda Taizhou Investment Centre LLP, or Shengda Taizhou, acquired equity interests
in Ascentage Jiangsu from Ascentage Pharma (HK). Shengda Taizhou held the equity interest in Ascentage Jiangsu for the benefit of Dr.
Yang, Dr. Guo, Dr. Wang and Dr. Zhai.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">In December 2016,
Ascentage Jiangsu entered into a share transfer agreement for the acquisition of the entire equity interest of Guangzhou Healthquest
Pharma Co., Ltd., or Healthquest Pharma from Dr. Zhai and Ren Jing. See &#8220;<i>Item 7. Major Shareholders and Related Party Transactions&#8212;B.
Related Party Transactions&#8212;Healthquest acquisition.</i>&#8221;</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2017, we commenced a reorganization, or the Reorganization, consisting of the following principal steps:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            November 2017, Ascentage Pharma Group International was incorporated as an exempted company
                                            with limited liability under the laws of the Cayman Islands;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            November 2017, Ascentage Pharma Group International acquired all the equity interests in
                                            Ascentage Pharma (HK) from Dr. Yang, Dr. Wang, Dr. Guo and Collected Mind, a business company
                                            incorporated in the British Virgin Islands with limited liability and a wholly-owned subsidiary
                                            of 3SBio Inc. (a company listed on the Main Board of the Hong Kong Stock Exchange (stock
                                            code: 1530)) after which Ascentage Pharma (HK) became a wholly-owned subsidiary of Ascentage
                                            Pharma Group International; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            July 2018, Ascentage Pharma Group International acquired all of the equity interests in Ascentage
                                            International, from each of Dr. Yang, Dr. Wang and Dr. Guo, in exchange for which Ascentage
                                            Pharma Group International issued ordinary shares to Ascentage Limited, a company that was
                                            incorporated in the British Virgin Islands with limited liability which was owned by Dr.
                                            Yang (for himself and as settlor of the Yang Family Trust) as to 45.53%, Dr. Guo (for himself
                                            and as settlor of the Guo Family Trust) as to 27.69% and Dr. Wang (for himself and as settlor
                                            of the Wang Family Trust) as to 26.78%, in an amount calculated with reference to the registered
                                            capital amount owned by Ascentage International in Ascentage Jiangsu immediately preceding
                                            the acquisition, until the dissolution of Ascentage Limited in December 2023.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of the Reorganization, Ascentage Pharma became the top holding company of our company and its subsidiaries. Our daily
operations are conducted primarily through our operating subsidiaries in mainland China, Hong Kong, the United States and Australia.
Ascentage Pharma Group Corp Limited, Ascentage International Limited, Ascentage Investment International and Ascentage Investment Limited
are investment holding intermediaries.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2019, Ascentage Pharma completed its Hong Kong initial public offering in which it offered and sold an aggregate of 14,008,000
ordinary shares. On October 28, 2019, the ordinary shares began trading on the HKEx under the stock code &#8220;6855.&#8221;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">On February
3, 2021, we entered into a placing and subscription agreement with Ascentage Limited, as the Vendor, and J.P. Morgan Securities (Asia
Pacific) Limited and China International Capital Corporation Hong Kong Securities Limited, as placing agents. An aggregate of 26,500,000
existing ordinary shares owned by the Vendor were placed by the placing agents to not less than six placees at a price of HK$44.20 per
share and we subsequently issued to the Vendor the same number of 26,500,000 new ordinary shares at the same price of HK$44.20 per share.
The closing price of our ordinary shares on the HKEx on February 3, 2021, the date on which the terms of the placing were fixed, was
HK$48.80. The net proceeds (after deducting all applicable costs and expenses, including commission and levies) raised were approximately
HK$1,153.64 million.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 23, 2021, Innovent Biologics, Inc. subscribed for 8,823,863 of our ordinary shares at a price of HK$44.00 per share, for a total
consideration of HK$388.25 million. The net proceeds (after deducting all applicable costs and expenses, including commission and levies)
raised from the subscription were approximately HK$388.06 million. The closing price of our ordinary shares on the HKEx on July 14, 2021,
the date on which the terms of the subscription were fixed, was HK$52.95.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">On January 18,
2023, we entered into the 2023 Placing and Subscription Agreement with the Vendor and J.P. Morgan Securities (Asia Pacific) Limited,
China International Capital Corporation Hong Kong Securities Limited and Citigroup Global Markets Limited, or the placing agents. An
aggregate of 22,500,000 existing ordinary shares owned by the Vendor were placed by the placing agents to not less than six placees at
a price of HK$24.45 per share and we subsequently issued to the Vendor the same number of 22,500,000 new ordinary shares of the Company
at the same price of HK$24.45 per share. The closing price of our ordinary shares on the HKEx on January 18, 2023, the date on which
the terms of the top-up placing was fixed, was HK$24.05. The net proceeds (after deducting all applicable costs and expenses, including
commission and levies) raised were HK$543.9 million.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">On June 20, 2024,
pursuant to a Securities Purchase Agreement with Takeda, we issued and sold to Takeda 24,307,322 of our ordinary shares at a price per
share equal to HK$24.09850 (equivalent to approximately US$3.08549), for an aggregate purchase price of US$75 million. In connection
therewith, we entered into a Registration Rights Agreement with Takeda, granting the Takeda certain registration rights. A copy of the
Registration Rights Agreement is filed as Exhibit 4.15 to this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">In January 2025,
Ascentage Pharma completed its U.S. initial public offering in which it offered and sold an aggregate of 8,260,144 ADSs (representing
33,040,576 ordinary shares). On January 24, 2025, the ADSs began trading on the Nasdaq Global Market under the symbol &#8220;AAPG.&#8221;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">On July 14, 2025,
we entered into the 2025 Placing and Subscription Agreement with Dajun Yang Dynasty Trust, a family trust established by Dr. Yang, as
vendor, and J.P. Morgan Securities (Asia Pacific) Limited and Citigroup Global Markets Limited, as placing agents. An aggregate of 22,000,000
existing ordinary shares owned by the vendor were placed by the placing agents to not less than six placees at a price of HK$68.60 per
share and we subsequently issued to the vendor the same number of 22,000,000 new ordinary shares of the Company at the same price of
HK$68.60 per share. The closing price of our ordinary shares on the HKEx on July 14, 2025, the date on which the terms of the top-up
placing was fixed, was HK$74.70. The net proceeds (after deducting all applicable costs and expenses, including commission and levies)
raised were HK$1,492.5 million (US$190.1 million).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In March 2026, the Board approved the transfer of ownership of Ascentage
Pharma Group Inc., Ascentage Pharma Pty Ltd., and Ascentage Pharma Europe Limited from Ascentage Pharma Group Corp Ltd. to Ascentage
Pharma to streamline the organizational structure, which the Company expects will occur in 2<sup>nd</sup> quarter of this year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
corporate headquarters are located at 68 Xinqing Road Suzhou Industrial Park, Suzhou, Jiangsu, China,
and our telephone number is +1 (301) 291-5658. Our agent for service of process in the United States is Ascentage Pharma Group Inc.,
located at 700 King Farm Boulevard, Suite 510, Rockville, MD 20850, and its telephone number is +1 (301) 291-5658. Our registered office
is located at the office of Walkers Corporate Limited, with the registered address of 190 Elgin Avenue, George Town, Grand Cayman KY1-9008,
Cayman Islands. Our corporate website is www.ascentage.com. The information contained on or that can be accessed through our website
is not incorporated by reference into this Annual Report on Form 20-F, and you should not consider information on our website to be part
of this Annual Report on Form 20-F. The SEC maintains an internet site that contains reports, proxy and information statements, and other
information regarding issuers that file electronically with the SEC, such as the Company, at http://www.sec.gov.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Business Overview</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel,
differentiated therapies to address unmet medical needs in cancer. For more than two decades, our founders and team have leveraged their
deep expertise to develop our proprietary drug discovery platform to pursue particularly challenging targets and significant unmet global
medical needs. Our lead assets, Olverembatinib and Lisaftoclax, have global potential to address the major hematological malignancies,
including chronic myeloid leukemia, or CML, acute myeloid leukemia, or AML, chronic lymphocytic leukemia, or CLL, acute lymphocytic leukemia,
or ALL, myelodysplastic syndrome, or MDS, which is expected to exceed US$166 billion in aggregate market size by 2035, according to the
F&amp;S Report.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
first lead asset, Olverembatinib, is a novel, third-generation tyrosine kinase inhibitor, or TKI. Olverembatinib was the first BCR-ABL1
inhibitor approved in China for the treatment of patients with CML in chronic phase, or CML-CP, with T315I mutations, CML in accelerated
phase, or CML-AP, with T315I mutations, and CML-CP that is resistant and/or intolerant to first and second-generation TKIs. We are currently
commercializing Olverembatinib in China. All commercialized indications of Olverembatinib have been included in the National Drug Reimbursement
List, or NRDL, in China beginning January 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">We believe that Olverembatinib, with its real-world patients&#8217; data
in China, where it is approved, has the potential to be a global therapy for CML. The global CML market was around US$12.3 billion in
2023 and is expected to grow to US$14.6 billion by 2035, according to the F&amp;S Report. We are currently conducting a registrational
Phase 3 trial, or POLARIS-2, of Olverembatinib as a monotherapy for CML that is cleared by the U.S. Food and Drug Administration, or FDA,
and European Medicines Agency or EMA. The clinical data obtained in China may not be accepted by the FDA or other foreign regulators to
support ongoing or future clinical trials, and Olverembatinib is approved only in China, such that the outcome of our ongoing clinical
trials is uncertain. We are also pursuing label expansion of Olverembatinib in combination with chemotherapy for the treatment of first-line
Philadelphia chromosome-positive ALL, or frontline Ph+ ALL, in an FDA and EMA cleared registrational Phase 3 trial, or POLARIS-1, and
conducting another registrational Phase 3 trial, or POLARIS-3 evaluating Olverembatinib as a monotherapy for succinate dehydrogenase (SDH),-deficient
gastrointestinal stromal tumor, or GIST.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Our second lead
asset, Lisaftoclax, is a novel Bcl-2 inhibitor that we are developing for the treatment of various hematological malignancies. In November
2024, we announced that our NDA for the treatment of relapsed and/or refractory, or R/R, CLL and small lymphocytic lymphoma, or SLL,
was accepted with Priority Review designation by the Center of Drug Evaluation, or CDE, of China&#8217;s National Medical Products Administration,
or NMPA. We believe this NDA is the second NDA filed in the world for a Bcl-2 inhibitor and the first in China for a Bcl-2 inhibitor
for the treatment of patients with CLL/SLL that are resistant or intolerant to Bruton&#8217;s tyrosine kinase, or BTK, inhibitors. Lisaftoclax
was approved in China by the NMPA for the treatment of adult patients with CLL/SLL who have previously received at least one systemic
therapy including BTK inhibitors in July 2025. We started commercializing in China in July 2025 shortly after receiving approval. We
intend to seek approval in multiple countries outside of China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global CLL/SLL market was around US$9.4 billion in 2023 and is expected to grow to US$38.2 billion by 2035, according to the F&amp;S
Report. We are also conducting an FDA-regulated registrational Phase 3 trial, or GLORA, of Lisaftoclax in combination with BTK inhibitors
for patients with CLL/SLL previously treated with BTK inhibitors for more than 12 months with sub-optimal response and pursuing approval
of Lisaftoclax for frontline CLL/SLL in a registrational Phase 3 trial, or GLORA-2, of Lisaftoclax in combination with acalabrutinib.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that Lisaftoclax, with its short half-life and potential for patient-friendly ramp-up schedule, can serve as a backbone molecule
for combination therapies for many hematological malignancies, including and beyond CLL/ SLL. Therefore, we are also evaluating Lisaftoclax
in combination with azacitidine, or AZA, in two registrational Phase 3 trials, GLORA-3 (EMA and CDE cleared) and GLORA-4 (FDA, EMA and
CDE cleared), for the frontline treatments of elderly, or unfit patients with AML or patients with higher risk, or HR, myelodysplastic
syndrome, or MDS, respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backed
by our strong scientific foundation, knowledge of small molecule discovery and capabilities to conduct clinical trials worldwide, we
use state-of-the-art technologies to develop innovative therapeutic agents to treat cancers and address unmet medical needs within this
patient population. Our initial focus has been to leverage our expertise in chemistry to synthesize inhibitors targeting proteins and
pathways that drive the key hallmarks of cancer. Earlier in our pipeline, we are harnessing our understanding of protein degraders to
develop therapies, such as proteolysis targeting chimera molecules, or PROTACs, that target traditionally undruggable proteins that are
implicated in oncogenesis.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">We are empowered
by our technical expertise in structure-based drug design and our innovative drug discovery engine, which allows us to address unmet
medical needs by targeting key apoptotic pathways and validated tyrosine kinases. These core competencies have allowed us to develop small
molecule and degrader therapies targeted at Bcl-2, Bcl-2/Bcl-xL, IAP and MDM2, in addition to building next-generation cell signaling
inhibitors (i.e., BCR- ABL1, ALK, FAK inhibitors) and epigenome-modifying agents (i.e., PRC2 inhibitor). We are the only Company in the
world with active clinical programs targeting all three known classes of key apoptosis regulators, according to the F&amp;S Report. We
have nine ongoing U.S. and/or international registrational trials, including four that are FDA-cleared, for our two key clinical-stage
assets. Beyond our two lead assets, we have several other clinical-stage assets in U.S. or international clinical trials.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Leveraging our
robust internal research and development capabilities, we have built a portfolio of global intellectual property rights. We have also
established collaborations and other relationships with leading biotechnology and pharmaceutical companies around the world, including
a collaboration and license agreement with Innovent and clinical collaboration agreements with AstraZeneca, Merck, and Pfizer, and research
and development relationships with leading research institutions, including but not limited to Dana-Farber Cancer Institute, Mayo Clinic,
MD Anderson Cancer Center, National Cancer Institute and the University of Michigan. <span style="letter-spacing: 0.2pt">As of December
31, 2025, we had 512 issued patents globally, 374 of which were issued outside of China.</span></span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have assembled a talented, global team with experience in the research and development of innovative drugs, as well as commercial manufacturing,
sales and marketing. Our success is shaped by this global team of approximately 767 employees across the United States, Europe, Australia,
and China, as of December 31, 2025. Together, we are dedicated to continuously strengthening our research and development capabilities
and accelerating the clinical development progress of our product pipeline with the goal of addressing the unmet medical needs of patients
globally.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
pipeline</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a pipeline of seven clinical-stage small-molecule drug candidates. The following table summarizes our pipeline and the development
status of each candidate as of December 31, 2025:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.5pt 0pt 41.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img1.jpg" style="width: 624px; height: 290px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="font: normal 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left">1.</td><td style="font: normal 10pt Times New Roman, Times, Serif; text-align: left">Approved in November 2021 in China for the treatment of adult patients with TKI-resistant CML-CP and CML-AP harboring
the T315I mutation, has been included into the China 2022 NRDL effective March 1, 2023.</td>
</tr></table><div>
</div><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: normal 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left">2.</td><td style="font: normal 10pt Times New Roman, Times, Serif; text-align: left">Approved in November 2023 in China for the treatment of adult patients with CML-CP resistant and / or intolerant
first and second generation TKIs, has been included into the China 2024 NRDL effective January 1, 2025</td>
</tr><tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: normal 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: normal 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
     <tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<td style="font: normal 10pt Times New Roman, Times, Serif; text-align: left">3.</td><td style="font: normal 10pt Times New Roman, Times, Serif; text-align: left">In July 2025, Lisaftoclax was approved by NMPA in China for the treatment of adult patients with CLL/SLL who
have previously received at least one systemic therapy, including BTK inhibitors.</td></tr>
     </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
two lead FDA-cleared Phase 3 trials collectively address all five major hematological malignancies:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
of key completed and ongoing clinical trials for Olverembatinib</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img2.jpg"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: left">Approved in November 2021 in China for the treatment of adult patients with TKI-resistant CML-CP and CML-AP harboring
the T315I mutation, has been included into the China 2022 NRDL effective March 1, 2023.</td>
</tr>
</table><div>

</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2.</span></td><td style="text-align: left">Approved in November 2023 in China for the treatment of adult patients with CML-CP resistant and or intolerant
first and second generation TKIs, has been included into the China 2024 NRDL effective January 1, 2025.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
of key completed and ongoing clinical trials for Lisaftoclax</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img3.jpg"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            July 2025, Lisaftoclax was approved by NMPA in China for the treatment of adult patients
                                            with CLL/SLL who have previously received at least one systemic therapy including BTK inhibitors.</span></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Olverembatinib
(HQP1351),</i></b> our first lead asset, is a novel, third-generation TKI. Olverembatinib is the first BCR-ABL1 inhibitor approved in
China for patients with CML-CP with <i>T315I</i> mutations, CMP-AP with <i>T315I </i>mutations and CML-CP that is resistant and/or intolerant
to first and second-generation TKIs. Since January 2025, all approved indications of Olverembatinib are covered by the China NRDL, which
bolstered the affordability and accessibility of the drug in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olverembatinib
was included as an Emerging Treatment Option in the 2024 National Comprehensive Cancer Network (NCCN) USA guidelines for the management
of CML and in the updated 2025 European LeukemiaNet recommendations. In addition, Olverembatinib has been included in the 2025 edition
of the Chinese Medical Association&#8217;s Guidelines for the Diagnosis and Treatment of Chronic Myeloid Leukemia in China, the 2025
edition of the Chinese Anti-Cancer Association (CACA) Guidelines for Holistic Integrative Management of Cancer, and the 2025 edition
of the Chinese Society of Clinical Oncology (CSCO) Guidelines.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, the FDA has granted four orphan drug designations, or ODD, to Olverembatinib, including for the treatment of CML, ALL, AML and
GIST, and fast track designation, or FTD, for the treatment of CML in patients with certain genetic markers who have failed to respond
to treatments with existing TKIs. Olverembatinib was also granted an Orphan Designation by the European Medicines Agency, or EMA, for
the treatment of CML. Through three registrational Phase 3 trials, we are currently evaluating Olverembatinib as a monotherapy and/or
in combination with existing treatments for patients with CML, first-line patients with frontline Ph+ ALL, and patients with SDH-deficient
GIST. Clinical trials evaluating Olverembatinib are currently taking place in Australia, various European countries, India, Canada, China
and the United States. On February 25, 2025, the CDE of China NMPA granted Olverembatinib the breakthrough therapy designation for patients
with first-line Ph+ ALL.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lisaftoclax
(APG-2575),</i></b> our second lead asset, is a novel Bcl-2 inhibitor that we are developing for the treatment of various hematological
malignancies. To date, the FDA has granted five ODDs to Lisaftoclax, including for the treatment of CLL, AML and MM. In November 2024,
we announced that our NDA was accepted with Priority Review designation by the CDE. On July 10, 2025, Lisaftoclax was approved by China&#8217;s
NMPA for the treatment of adult patients with CLL/SLL who have previously received at least one systemic therapy including BTK inhibitors,
which makes Lisaftoclax the first Bcl-2 inhibitor receiving conditional approval and marketing authorization for the treatment of patients
with CLL/SLL in China, and the second Bcl-2 inhibitor approved globally. Shortly after the approval, we have commenced the commercial
sales of Lisaftoclax in China. According to the F&amp;S Report, this NDA is the second NDA filed in the world for a Bcl-2 inhibitor and
the first in China for a Bcl-2 inhibitor for the treatment of patients with CLL/SLL that are resistant or intolerant to BTK inhibitors.
Through four registrational Phase 3 trials, we are currently evaluating Lisaftoclax as a monotherapy and/or in combination with existing
treatments for patients with CLL/SLL, AML and MDS. We are also evaluating Lisaftoclax in ongoing clinical trials for MM and other hematological
malignancies. Clinical trials evaluating Lisaftoclax are currently taking place in Australia, Belgium, Canada, China, France, Germany,
Hungary, Japan, Poland, Spain, United Kingdom and the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Alrizomadlin
(APG-115)</i></b> is a novel, orally bioavailable, highly selective, small molecule inhibitor of the mouse double minute 2, or MDM2,
homolog, or MDM2-p53. We believe Alrizomadlin has potential to treat a number of serious rare and orphan diseases and address unmet medical
needs in both adult and pediatric indications.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA has granted six ODDs for Alrizomadlin for the treatment of soft-tissue sarcoma, gastric cancer, AML, retinoblastoma, stage IIB-IV
melanoma, and neuroblastoma. In addition, Alrizomadlin has been granted two Rare Pediatric Disease Designations, or RPDD designations
by the FDA for the treatment of neuroblastoma and retinoblastoma.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, the FDA has granted six ODDs and two rare pediatric disease designations, or RPDD, for Alrizomadlin. Clinical trials evaluating
Alrizomadlin are currently taking place in Australia, China and the United States. A Phase I clinical study of Alrizomadlin alone or
in combination with Lisaftoclax in children with solid tumors is ongoing; current data indicates that Alrizomadlin alone or in combination
with Lisaftoclax showed a manageable safety profile, with preliminary antitumor activity in heavily pretreated relapsed/metastatic rhabdomyosarcoma
(RMS) or other soft-tissue sarcomas (STSs).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pelcitoclax
(APG-1252)</i></b> is a novel, highly potent, small molecule drug designed to restore apoptosis through dual inhibition of the Bcl-2
and Bcl-xL proteins. To date, the FDA has granted one ODD to Pelcitoclax for the treatment of small cell lung cancer, or SCLC. We are
currently evaluating Pelcitoclax in two Phase 1b trials and one Phase 1b/2 trial for the treatment of patients with non-small cell lung
cancer, or NSCLC, neuroendocrine tumors or non-Hodgkin&#8217;s lymphoma, or NHL. In October 2023, we presented preliminary results from
the Phase 1b trial of Pelcitoclax in combination with osimertinib in patients with epidermal growth factor receptor-mutant, or EGFR-
mutant, NSCLC at the 2023 Congress for the European Society for Medical Oncology, or ESMO, demonstrating potential therapeutic utility.
Clinical trials evaluating Pelcitoclax are currently taking place in Australia, China and the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>APG-5918</i></b>
is a potent, orally bioavailable, and highly selective inhibitor of the embryonic ectoderm development, or EED, a sub-unit of the Polycomb
Repressive Complex 2, or PRC2. APG-5918 is a PRC2 inhibitor with demonstrated potential for treating patients with anemia, including
beta-thalassemia and chronic kidney disease, or CKD-induced anemia and oncology, including TCLs, Prostate cancer and MM. During 2026,
we will advance the clinical development of APG-5918 in oncology and anemia in the U.S. and China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>APG-2449
</i></b>is a novel, orally active, small-molecule focal adhesion kinase (FAK), the third generation of anaplastic lymphoma kinase (ALK)
and receptor tyrosine kinase C-ros oncogene 1 (ROS1) triple ligase kinase inhibitor (TKI) designed and developed by Ascentage Pharma.
It is the first FAK inhibitor approved by CDE for clinical study in China. In the first-in-human trial, cerebrospinal fluid PK analyses
showed that APG-2449 was brain-penetrant. An updated study of APG-2449 demonstrated preliminary clinical benefit in patients with NSCLC
whose disease was TKI na&#239;ve and resistant to 2G ALK inhibitors, especially in brain metastases. In addition, high pFAK expression
levels in baseline tumor tissue correlated with improved APG-2449 treatment responses in patients with NSCLC resistant to 2G ALK inhibitors,
suggesting that the increase of pFAK may be associated with second-generation ALK TKI resistance. In October 2024, APG-2449 was cleared
by the Center for Drug Evaluation (CDE) of China&#8217;s National Medical Product Administration (NMPA) to enter two registrational Phase
III studies that will separately evaluate APG-2449 in patients with non-small cell lung cancer (NSCLC) who are resistant to or intolerant
of second-generation anaplastic lymphoma kinase (ALK) TKIs; and treatment-na&#239;ve patients with ALK-positive advanced or locally advanced
NSCLC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>APG-3288</i></b>
is the first novel, highly potent and selective BTK degrader developed utilizing Ascentage Pharma&#8217;s proprietary proteolysis-targeting
chimera (PROTAC) technology platform. This candidate induces the formation of a ternary complex consisting of the BTK target, the PROTAC,
and the Cereblon E3 ubiquitin ligase, leading to proteasome-mediated degradation of the BTK target. Unlike conventional BTK inhibitors,
APG-3288 is designed to act through degradation rather than inhibition, inducing rapid, potent, highly selective, and sustained degradation
of both wild-type BTK and multiple BTK mutants associated with resistance to existing BTK inhibitors. Critically, this approach blocks
the BCR-BTK signaling axis at its source, thereby overcoming resistance to BTK inhibitors and potentially providing a novel and differentiated
therapeutic strategy for BTK-targeted treatment. In preclinical studies, compared to other BTK degraders in development, APG-3288 demonstrated
more potent BTK degradation, higher selectivity, and more favorable PK properties that highlighted the drug&#8217;s potential.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
competitive strengths</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our Company is differentiated by several strengths, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.25pt; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global,
                                            integrated biopharmaceutical company with discovery, development, manufacturing and commercialization
                                            capabilities, strategically targeting the global hematological malignancies market, estimated
                                            to be US$67.2 billion in 2023 and rising to US$208.8 billion by 2035 according to the F&amp;S
                                            Report:</span></td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
                                            and well-established in-house discovery team;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integrated
                                            clinical development team working across China, US, UK and Australia;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            200,000 square foot manufacturing facility provides clinical and commercial supply of drug
                                            products, including support of all of our clinical trials; </span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
                                            commercial team comprised of more than 270 members in China together with U.S.-based senior
                                            leadership with significant global commercialization and sales experience;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            two lead FDA-cleared Phase 3 assets that are collectively addressing all five major hematological
                                            malignancies;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    market position with Olverembatinib, a novel third-generation BCR-ABL1 TKI, commercialized in China since 2021 with real- world patient
    data, validating global development and commercialization plans and Lisaftoclax, a novel Bcl-2 inhibitor, commercialized in Chine
    since July 2025 for the treatment of various hematological malignancies globally, including and beyond CLL/SLL;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deep
    expertise and insights in developing small molecule drugs for challenging targets and high unmet medical needs;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    innovative pipelines with global potential and ongoing clinical trials in Australia, Canada, China, various European countries, Japan,
    United Kingdom, India and the United States that are driven by the proprietary drug discovery platform and technologies such as chemical
    synthesis and targeted protein degradation; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dedicated
    science-driven international team with complementary knowledge and skillsets, led by visionary founders working together for more
    than 20 years.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Disease and industry background</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.5pt"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>All the information and data, including
statistics and estimates, for the diseases described in this section and elsewhere in this Annual Report on Form 20-F including the
markets and forecasts regarding the diseases have been derived from the F&amp;S Report.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hematologic
malignancies, or blood cancers, affect the production and function of blood cells. These cancers typically begin in the bone marrow where
blood is produced. Blood cancers, like all cancers, are characterized by the overproduction of an abnormal type of cell. Blood cancer
cells do not form solid tumors, but their uncontrolled growth crowds out normal cells in the blood, bone marrow or plasma, preventing
normal cells from developing and performing important functions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
hematologic malignancy has various subtypes as well. Blood cancers are estimated to account for about 10% of all new cancer diagnoses
globally. Approximately 1.5 million new cases of blood cancer cases were diagnosed globally, and the global incidence is expected to
reach 1.8 million by 2035. Approximately 720,000 people die from blood cancer every year, accounting for more than 7% of cancer deaths.
The global market for hematological malignancies was US$67.2 billion in 2023, representing approximately 30% of the cancer therapy market,
and expected to grow to approximately US$208.8 billion by 2035.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Survival
rates for most hematologic malignancies have improved over time, likely due to the introduction of new and more effective treatments,
include chemotherapy, radiation, targeted therapy, stem cell transplant, immunotherapy and cell or gene therapy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leukemia
is a group of blood cancers characterized by abnormal, uncontrolled white blood cell growth that usually begins in the bone marrow, where
most of the body&#8217;s blood is produced. In some cases, such as acute leukemias, these blood cells are not fully developed. In other
cases, such as chronic leukemias, the mature cells are transformed and become leukemic. Clinically and pathologically, leukemia is subdivided
into a variety of large groups. According to the blood cells affected and disease progression, leukemia is mostly composed of the following
four types: chronic myeloid leukemia, or CML, acute myeloid leukemia, or AML, chronic lymphocytic leukemia, or CLL, and acute lymphocytic
leukemia, or ALL.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chronic
myeloid leukemia (CML)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chronic
myeloid leukemia, or CML, also known as chronic myelogenous leukemia, chronic granulocytic leukemia and chronic myelocytic leukemia,
is a rare cancer that is characterized by the increased and unregulated growth of myeloid cells in the bone marrow and the accumulation
of these cells in blood and other organs. CML is divided into three phases: chronic phase, or CML-CP, accelerated phase, or CML-AP, and
blast crisis phase, or CML-BP. Most patients with CML are diagnosed at the chronic phase. In the chronic phase, less than 10 percent
of blood and bone marrow cells are immature white blood cells, also known as blasts. In the accelerated phase, the number of blast cells
in the blood and bone marrow exceeds normal levels.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Western countries, CML accounts for 15 to 25% of all adult leukemias and 14% of leukemias overall, including the pediatric population
where CML is less common. In 2023, the global incidence of CML was approximately 51.6 thousand with a compound annual growth rate, or
CAGR, of 3.2%, and it is projected that the incidence of CML will continue to grow up to 64.6 thousand in 2035. The global CML market
was around US$12.3 billion in 2023 and is expected to grow to US$14.6 billion by 2035.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acute
lymphocytic leukemia (ALL)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acute
lymphocytic leukemia, or ALL, is a rare cancer characterized by a rapid increase and large numbers of immature or dedifferentiated blood
cells, called lymphoblastic cells. These blood cells never grow up to function as normal cells due to DNA damage.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
incidence rate of ALL is closely related to age and gender. Around 60% of ALL cases are diagnosed before the age of 20, and compared
to females, males are more likely to develop ALL. ALL primarily affects children and is the most common type of childhood cancer. According
to the American Cancer Society, or ACS, it is estimated that in 2024 there will be approximately 6,550 new cases of ALL (3,590 in males
and 2,960 in females) and approximately 1,330 deaths from ALL (640 in males and 690 in females) in the United States. In pediatric patients,
which account for approximately 50% of ALL cases, the chance of cure is approximately 80%. ALL can also occur in adults, though the prognosis
is generally worse in older patients with approximately a 45 to 60% chance of cure and poorer prognosis in patients who are 60 years
or older. According to ACS, about 80% deaths from ALL in the United States occur in adults. According to the F&amp;S Report, the five-year
overall survival rate is 40.0% in adults in the United States and is 17.6% in adults in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were around 120.3 thousand new cases of ALL in 2023 with expected growth to 150.5 thousand in 2035. Since the molecular basis of ALL is
complex, comprising  various genetic and environmental factors, the incidence of ALL will remain relatively stable in the future. The
global drug market of ALL was around US$3.7 billion in 2023 and is expected to grow up to US$26.9 billion by 2035.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philadelphia
Chromosome-Positive Acute Lymphoblastic Leukemia, or Ph+ ALL, is the most common cytogenetic abnormality in adult patients with ALL,
occurring in about 20% to 30% of all cases. It results from a reciprocal translocation between the ABL1 oncogene on the long arm of chromosome
9 and a breakpoint cluster region, or BCR, on the long arm of chromosome 22, resulting in a fusion gene, BCR-ABL1, that encodes an oncogenic
protein with constitutively active tyrosine kinase activity. The incidence of Ph+ ALL increases with age, from less than 5% in younger
children to 20% to 25% in older adults. There were around 18.3 thousand new cases of Ph+ ALL patients in 2023 with expected growth to
23.1 thousand in 2035.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chronic
lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chronic
lymphocytic leukemia, or CLL and small lymphocytic lymphoma, or SLL, are two slow-growing hematological malignancies commonly grouped
together as a type of non-Hodgkin lymphoma. In CLL, the cancer cells start in the bone marrow and slowly progresses to the blood, whereas
in SLL, the cancer cells are primarily found in the lymph nodes and spleen, but both CLL and SLL behave similarly and are treated in
the same way.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the exact causes of CLL and SLL are unknown, it primarily affects older populations and is among the most common leukemia subtypes in
adults, accounting for a quarter of all leukemia cases in Western countries.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advancements
in basic research and targeted therapies have brought significant survival benefits to patients with CLL/SLL. Despite advancements in
new targeted therapies, CLL/SLL still presents major clinical challenges and remains an urgent medical need for new treatment options
that can offer both efficacy and safety.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to ACS, it is estimated that in 2024 there will be approximately 20,700 first-line cases and 4,440 deaths from CLL in the United States.
In China, CLL/SLL is occurring at a rapidly rising incidence rate, with a younger age of onset and higher aggressiveness, thus posing
a serious threat to public health in the country with global incidence expected to increase to 119.5 thousand in 2035. The global CLL/SLL
market was around US$9.4 billion in 2023 and is expected to grow to US$38.2 billion by 2035.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acute
myeloid leukemia (AML)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AML
is a rapidly progressing hematological malignancy that typically affects older patients. According to ACS, it is estimated that in 2024
there will be approximately 20,800 first-line cases and 11,220 deaths from AML in the United States. The average age of diagnosis is
currently at approximately 68 years of age, but it can also occur in children. Variables that are used to predict a patient&#8217;s prognosis
and influence treatment strategies include age, antecedent MDS, and cytogenetic abnormalities. Increasingly, there are also a number
of identified mutations (such as CEBPA, c-KIT, FLT3, IDH1/2, KMT2A-r/MLL-r, and NPM1) that can impact prognosis. According to the F&amp;S
Report, the five-year overall survival rate is 26.0% in adults in the United States and is less than 20.0% in adults in China. The global
incidence of AML is estimated to be 97.6 thousand as of 2023 and is expected to reach 122.1 thousand by the end of 2035.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is estimated that, globally, there were 97.6 thousand new cases of AML in 2023, which is projected to increase to 122.1 thousand in 2035.
The global AML market was US$3.9 billion in 2023 and is expected to grow to US$10.8 billion by the end of 2035.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Myelodysplastic
syndrome (MDS)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Myelodysplastic
syndrome, or MDS, constitutes a broad spectrum of hematological malignancies. MDS results from clonal alterations in the bone marrow
stem cells that can manifest as a variety of hematological abnormalities of varying severity. In some cases, the underlying cause of
MDS is unknown, or primary MDS. More commonly, the condition develops following exposure to high doses of radiation, chemotherapy, or
other toxins that damage the bone marrow stem cells. In about 1 in 3 patients, MDS can progress to AML. The incidence of MDS ranged from
0.22 to 13.2 per 100,000 population across different regions, age groups, genders, and ethnicities, and the incidence rate of it tend
to be higher in more developed regions, such as North America, Europe, and Australia.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2023, there were around 94.9 thousand new cases of MDS worldwide. According to the F&amp;S Report, the five- year overall survival rate
is 31.3% in the United States and 27.0% in China. In Europe, there are an estimated 15,000 to 25,000 new cases diagnosed each year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global incidence of MDS is estimated to be 94.9 thousand as of 2023 and is expected to reach 104.1 thousand by the end of 2035.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Multiple
Myeloma (MM</b>)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple
myeloma, or MM, is a hematologic malignancy that results from an overproduction of plasma cells in the bone marrow. Normally, some B
lineage cells mature into plasma cells whose sole function is to produce immunoglobulins, or Ig. In the case of MM, patients typically
produce excessive amounts of a defective type of Ig called M protein that serves little function in protecting the host. However, these
IgM-producing myeloma cells proliferate quickly and can crowd normal cells out of the marrow. As a result, hematopoietic deficiencies
can develop, leading to anemia, leukopenia, thrombocytopenia, and a dependence on blood or platelet transfusions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is estimated that there are approximately 191.8 thousand new cases of MM globally in 2023, and the number of new cases is projected to
increase to 257.9 thousand in 2035. According to the F&amp;S Report, the five-year overall survival rate is 55% in adults in the United
States and is 33.7% in adults in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global drug market of MM was around US$25.4 billion in 2023 and is expected to grow up to US$75.8 billion by 2035.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our products</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
first lead asset: Olverembatinib</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
first lead asset, Olverembatinib, is a novel, third-generation TKI. Olverembatinib is the first BCR- ABL1 inhibitor approved in China
for the treatment of patients with CML-CP with <i>T315I </i>mutations, CML-AP with <i>T315I </i>mutations and CML-CP that is resistant
or intolerant to first and/or second-generation TKIs. We believe that Olverembatinib, with its real-world patient data in China, where
it is approved, has the potential to be a global drug for CML and Ph+ ALL.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2023, Olverembatinib was included in China&#8217;s 2022 NRDL for the indications of <i>T315I</i>-mutant CML-CP and <i>T315I</i>-mutant
CML-AP. Olverembatinib was included as an Emerging Treatment Option in the 2024 National Comprehensive Cancer Network (NCCN) USA guidelines
for the management of CML and in the updated 2025 European LeukemiaNet recommendations. In addition, Olverembatinib has been included
in the 2025 edition of the Chinese Medical Association&#8217;s Guidelines for the Diagnosis and Treatment of Chronic Myeloid Leukemia
in China, the 2025 edition of the Chinese Anti-Cancer Association (CACA) Guidelines for Holistic Integrative Management of Cancer, and
the 2025 edition of the Chinese Society of Clinical Oncology (CSCO) Guidelines.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2024, Olverembatinib was approved by the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region
of the People&#8217;s Republic of China for the treatment of adult patients with TKI-resistant CML-CP or CML-AP harboring the T315I mutation
and adult patients with CML-CP resistant to and/or intolerant of first- and second-generation TKIs. Starting in 2025, all approved indications
are covered by the NRDL in China, which further bolster the affordability and accessibility of the drug in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, the FDA has granted four ODDs to Olverembatinib, including for CML, ALL, AML and GIST, and FTD for the treatment of CML in patients
with certain genetic markers who have failed to respond to prior TKIs. Olverembatinib was also granted an Orphan Designation by the European
Medicines Agency, or EMA, for the treatment of CML. Previously, Olverembatinib was accepted by the CDE breakthrough therapy designation,
or BTD, for the treatment of patients with SDH-deficient GIST who had received prior frontline treatment as well as first-line Ph+ ALL
patients.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We are
currently conducting an FDA and EMA cleared registrational Phase 3 trial, POLARIS-2, of Olverembatinib as a monotherapy for CML, and
subject to the trial&#8217;s successful completion. We plan to pursue approvals in the US and other key countries. In parallel, we
are pursuing label expansion of Olverembatinib in an FDA and EMA cleared registrational Phase 3 trial, or POLARIS-1, in combination
with chemotherapy for the treatment of frontline Ph+ ALL and a registrational Phase 3 trial, or POLARIS-3, as a monotherapy for
SDH-deficient GIST. We are continuing to enroll and expect to complete the majority of patient enrollment in POLARIS-1 in
2026.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of key completed and ongoing clinical trials for Olverembatinib</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img4.jpg" style="height: 277px; width: 650px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
                                            in November 2021 in China for the treatment of adult patients with TKI-resistant CML-CP and
                                            CML-AP harboring the T315I mutation, has been included into the China 2022 NRDL effective
                                            March 1, 2023</span></td>
</tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2.</span></td><td style="text-align: left">Approved in November 2023 in China for the treatment of adult patients with CML-CP resistant and or intolerant
first and second generation TKIs, has been included into the China 2024 NRDL effective January 1, 2025.</td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current
treatment paradigm and its limitations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the standard of care for CML and ALL was chemotherapy, which involves the use of cytotoxic drugs to kill cancer cells. However, chemotherapy
alone was not curative and had limited effectiveness in controlling the disease. The introduction of TKIs revolutionized the treatment
of CML and ALL. BCR-ABL1 is a leukemia-causing fusion gene that produces a dysfunctional protein called &#8220;BCR-ABL1 tyrosine kinase&#8221;
that is biologically active, leading to the abnormal regulation of cell growth and survival and is associated with CML and certain types
of ALL. TKIs are targeted therapies that are designed to specifically inhibit the BCR-ABL1 tyrosine kinase. Imatinib, or GLEEVEC, the
first TKI approved by the FDA for CML, was highly effective initially but many CML and ALL patients developed resistance or intolerance.
To address this, a number of second-generation TKIs were developed, but many patients also developed resistance or intolerance. Notably,
first and second-generation TKIs have not been able to address patients with CML with <i>T315I </i>mutations, which was associated with
rapid progression and limited survival. Although second-generation TKIs are widely used with an estimated US$5.5 billion in annual sales
in 2023 according to the F&amp;S Report, there remains significant unmet medical need for CML.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">More
recently, third-generation TKIs have been developed to further enhance treatment outcomes. Ponatinib, or ICLUSIG, was approved by the
FDA in December 2012 for the treatment of CML and Ph+ ALL in patients who are resistant or intolerant to prior generations of TKIs, or
in cases where <i>T315I</i> mutations are present. However, ponatinib has been reported to cause severe thrombosis and is currently carrying
a Black Box warning required by the FDA due to the excessive rate of vascular events (&gt;27%), occurrence of heart failure (8%) and
serious liver toxicity. For serious non-hematologic adverse events related to ponatinib, the FDA label recommends modifying the dose
or stopping treatment. Dose modifications include decreasing dose by 15 milligrams (mg) from the recommended starting dose of 45 mg for
each occurrence of an adverse event. A ponatinib dose-ranging study in CML-CP patients showed a dose-dependent reduction in response
and concluded that the benefit/risk of dose reduction should be carefully assessed, especially among patients with <i>T315I </i>mutations.
Despite these safety and efficacy trade-offs, ponatinib remains one of the only two approved drugs in the United States for patients
with CML with <i>T315I</i> mutations and costs more than US$200,000 per person per year. However, the U.S. patent for ponatinib is expected
to expire in December 2026 and EU patent is expected to expire in June 2028.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Asciminib is an ABL1 allosteric inhibitor that was approved by the
FDA in October 2021 for the treatment of CML-CP (following treatment with 2 prior TKIs) and for the treatment of CML-CP with <i>T315I</i>
mutations. It was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed Philadelphia
chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) in October 2024. Asciminib is mechanistically different than
other TKIs in that it binds to the myristoyl pocket of the BCR-ABL1 protein instead of binding to the ATP-binding site of the kinase domain
of the protein similar to other TKIs. However, patients with <i>T315I</i> mutations must receive 200 mg of asciminib twice daily, which
is five times the regular dosage of asciminib for patients with CML without <i>T315I </i>mutations, and costs close to US$1 million per
person per year. Asciminib also has challenges with some specific compound mutations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the availability of ponatinib and asciminib, CML, whether with or without the <i>T315I </i>mutations or multiple and/or compound mutations,
remains stubbornly resistant to approved therapies. Therefore, there remains a significant global unmet medical need and demand for more
safe and effective therapies for patients with CML.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
solution: Olverembatinib</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
first lead asset, Olverembatinib, is a novel third-generation TKI targeting multiple tyrosine kinases, including BCR-ABL1 mutants and
multiple and/or compound mutations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Mechanism
of action</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BCR-ABL1
is a fusion gene that occurs when pieces of chromosomes 9 and 22 break off and trade places, during cell division. Part of the ABL1 gene
on chromosome 9 fuses to part of the BCR gene on chromosome 22. The new shorter chromosome 22 is called a &#8220;Philadelphia chromosome.&#8221;
This abnormal gene produces the BCR-ABL1 protein, which is constantly active, acts upon a number of intracellular signal transduction
pathways, and causes greater cell division and inhibiting apoptosis, which is programmed cell death. Cells with BCR-ABL1 tend to grow
abnormally and divide out of control rather than undergo cell death. As a result, BCR-ABL1 is associated with CML, Ph+ ALL and some cases
of AML.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inhibition
of BCR-ABL1 can block the abnormal cellular proliferation associated with disease and can subsequently trigger cell death. However, some
BCR-ABL1 mutants, such as the <i>T315I </i>mutant type, have or can confer mutations that disrupt the binding of first and second generation
TKIs, leading to resistance and allowing cancerous cells to survive and further proliferate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olverembatinib
has a particularly high binding affinity for BCR-ABL1 and has been demonstrated to inhibit both the wild-type and the <i>T315I </i>mutant
type of BCR-ABL1 triggering apoptosis of cancerous cells. Olverembatinib has also been shown to have a strong binding affinity to a number
of other kinase targets, such as KIT, which has been implicated in SDH-deficient GIST.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.45pt 0pt 41.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mechanism
of Action of Olverembatinib</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.45pt 0pt 41.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="ea028514801_img5.jpg"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.45pt 0pt 41.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
<i>in vitro</i> anti-proliferation assays of common BCR-ABL inhibitors and Olverembatinib demonstrated that Olverembatinib has strong
inhibition of TKI kinase activity for the majority of BCR-ABL mutations, including <i>T315I </i>mutations, as well as multiple compound
mutations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
clinical results</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olverembatinib
has demonstrated a series of clinical data to date, as summarized below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.75pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: left"><b>Strong antileukemic activity in patients with heavily pretreated CML-CP, including T315I mutations, and Ponatinib and/or Asciminib failures, see &#8220;<i>1. Strong antileukemic activity in Heavily Pretreated CML-CP Patients</i>&#8221;</b></td></tr>
  </table><div>


</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: left"><b>Olverembatinib in combination with low-intensity chemotherapy showed efficacy in first-line Ph+ ALL
    Efficacy, see&#8221;<i>2. POLARIS-1 Global Phase III Part 1 Results <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olverembatinib
    + Low-intensity Chemotherapy in first-line Ph+ ALL</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8221;</span></b></td></tr>
  </table><div>


</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: left"><b>72% CCyR and 44% MMR in adult CML-CP patients resistant and/or intolerant to 1L TKIs, see &#8220;<i>3.
    Clinical benefit as a viable 2L Treatment for CML-CP</i>&#8221;</b></td></tr>
  </table><div>


</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: left"><b>76.5% patients achieved CR/CRh/CHR in in MLN-FGFR1 Mutant Patients, see &#8220;<i>4. Olverembatinib
    Efficacy in MLN-FGFR1 Mutant Patients</i>&#8221;</b></td></tr>
  </table><div>


</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><p style="text-align: left; margin: 0pt 0"><b>Deep
                                            Remission and Improvement in allo-HSCT outcomes in BC-CML patients, see &#8220;<i>5. Deep
                                            Remission, Improvement in Allo-HSCT Outcomes in Blast Crisis</i>&#8221;</b></p></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: left"><b>Significantly longer EFS and better tolerability than BAT arm in CML-CP patients in a 4-year follow-up
    study, see &#8220;<i>6. Registrational Phase II Study in CML-CP: 4-Year Follow Up</i>&#8221;</b></td></tr>
  </table><div>


</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: left"><b>Olverembatinib in combination with venetoclax enhances allo-HSCT outcome, see &#8220;7<i>. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olverembatinib
    + Bcl-2i Bridging: Potential for Chemo- or Immunotherapy Free Regimen with Lisaftoclax</span></i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8221;</span></b></td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.75pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">All of the
results presented above and below (other than &#8220;<i>3. Clinical benefit in patients with ponatinib- and asciminib-failed CML-CP and
Ph+ ALL</i>&#8221;) in this section &#8220;<i>Key Clinical Results</i>&#8221; include data from trials conducted outside of the United
States. To the extent the trials were conducted outside of the United States, the FDA may not accept such data, and additional trials
may be required, resulting in additional time and cost.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>1.
Strong antileukemic activity in Heavily Pretreated CML-CP Patients</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Updated
results from a phase 1b randomized clinical trial&#160;of Olverembatinib for the treatment of patients with CML or Philadelphia chromosome-positive
ALL. In this trial, Olverembatinib had a favorable pharmacokinetic profile, was generally well tolerated, and showed strong antileukemic
activity in patients with heavily pretreated chronic-phase CML with or without T315I variants, including prior ponatinib and/or asciminib
failure. Olverembatinib may provide a viable new treatment option for patients after failure of 2 or more TKIs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
multicenter phase 1b randomized clinical trial was conducted from January 28, 2020, to January 2, 2024, with a median (range) follow-up
of 48 (0-166) weeks. Patients with CML or Philadelphia chromosome-positive ALL were enrolled. This bridging study was performed in part
to confirm that there are no racial differences in the pharmacokinetic profile of Olverembatinib. Patients were randomly assigned to
30, 40, or 50 mg of Olverembatinib orally every other day in 28-day cycles.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographic.</i></b><i>
Of 80 included patients, 46 (58%) were male, and the median (range) age was 54.0 (21-80) years. </i>The median (range) time from the
initial diagnosis of CML or advanced Philadelphia chromosome&#8211;positive leukemia to the first dose of Olverembatinib was 5.9 (0.4-24.0)
years. The study population was heavily pretreated: 14 (17.5%), 22 (27.5%), and 43 (53.8%) had received 2, 3, or 4 or more prior TKIs,
respectively. Five patients had prior allogeneic stem cell transplant. A total of 46 patients (58%) had received ponatinib and 25 (31%)
had received asciminib. A total of 11 patients had treatment failure with both ponatinib and asciminib. A total of 25 patients (31%)
had a T315I variant at baseline. Among the 18 patients in the advanced leukemia group, 9 were in accelerated-phase CML, 6 in blast-phase
CML, and 3 had Philadelphia chromosome&#8211;positive ALL.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
antileukemic activity in patients with heavily pretreated CML-CP, including T315I mutations, and Ponatinib and/or Asciminib failures</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="ea028514801_img6.jpg" style="width: 700px; height: 270px"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Efficacy
results.</i></b> Among evaluable patients with chronic-phase CML, CCyR occurred in 61% patients; MMR occurred in 42% of patients. Cytogenetic
and molecular responses were similar in patients with or without T315I variants. A total of 58% of patients with prior ponatinib treatment
achieved CCyR, and 37% achieved MMR. A total of 50% patients with asciminib resistance had CCyR, and 33% had MMR.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Safety results.</i></b> Based on investigators&#8217;
assessments, 75% of patients experienced at least 1 treatment-related adverse event; 40% of patients experienced grade 3 or higher treatment-related
adverse events; and 15% of patients experienced treatment-related serious adverse events, none of which were fatal. Frequently reported
(10% or more) treatment-emergent adverse events included elevated blood creatine phosphokinase (all grades, 31 [39%]; grade 3 or higher,
10 [13%]) and thrombocytopenia (all grades, 23 [29%]; grade 3 or higher, 14 [18%]).</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.
POLARIS-1 Global Phase III Part 1 Results - Olverembatinib + Low-intensity Chemotherapy in first-line Ph+ ALL</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Updated
results from POLARIS-1 (NCT06051409), a global registrational Phase III study designed to evaluate the efficacy and safety of Olverembatinib
combined with low-intensity chemotherapy in patients with first-line Ph+ ALL. The primary endpoint of the study was MRD (BCR-ABL/ABL1
&#8804; 0.01% by qPCR) negativity rate by the end of three induction cycles.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
patients with ND Ph+ ALL, Olverembatinib in combination with chemotherapy demonstrated an MRD-negative CR rate of 64.2% by the end of
the induction therapy and a favorable safety profile.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographic.
</i></b>As of July 18, 2025, a total of 55 patients with first-line Ph+ ALL were enrolled in Part 1, including Olverembatinib 40 mg QOD
(n = 15) and Olverembatinib 30 mg QOD (n = 40). The chemotherapy backbone consisted of 49 patients who received Olverembatinib + VD and
6 patients who received Olverembatinib + VDP. At baseline, the median age of the 55 enrolled patients was 43.0 years (range, 18&#8211;70),
with 63.6% female and 36.4% male patients. Most patients were Asian (90.9%), while 9.1% were White. The BCR::ABL1 subtype distribution
was predominantly P190 (65.5%), followed by P210 (29.1%), with smaller proportions of P190+P210 (3.6%) and P230 (1.8%). The mean treatment
duration of all patients in Part A was 9.6 months.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Primary
Endpoint: MRD Negativity Rate by the End of Three Induction Cycles</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="ea028514801_img7.jpg" style="width: 450px; height: 283px"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Efficacy results.</i></b> As of July 18, 2025, among 53 efficacy-evaluable
patients, 50 (94.3%) achieved a CR or CR with incomplete hematologic recovery by the end of induction therapy. The best MRD negativity
and MRD-negative CR rates were 66.0% and 64.2%, respectively.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IKZF1plus
(particularly with concurrent BTG1 deletion) is a widely recognized high-risk factor associated with poor prognoses in B-cell ALL (B-ALL)
because it can often cause resistance to chemotherapies and a high propensity to relapse. Among the 10 patients in this study who had
this genotype, the molecular response rate at the end of the induction therapy was 90% (9/10).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Safety
results. </i></b>Olverembatinib in combination with low-dose chemotherapy was well tolerated. Common (incidence &gt;15%) grade &#8805;
3 treatment-emergent adverse events (TEAEs) were neutropenia (63.6%), thrombocytopenia (56.4%), leukopenia (54.5%), anemia (49.1%), pneumonia
(30.9%), hypokalemia (20%), and abnormal hepatic function (16.4%).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>3.
Olverembatinib as a viable 2L Treatment for CML-CP</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
was an open-label, single-arm, multicenter investigator-initiated clinical study (ChiCTR2200061655) designed to evaluate the efficacy
and safety of orally administered Olverembatinib at 40 mg every other day (QOD) in Chinese patients with CP-CML resistant/intolerant
to one prior line of TKIs (including imatinib, flumatinib, nilotinib, and dasatinib) without the T315I mutation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographics</i></b><i>.
</i>As of July 24, 2025, the study had enrolled 47 patients with CP-CML without the T315I mutation. (93.6% first-line TKI-resistant,
6.4% first-line TKI-intolerant). The median age was 42.0 years, and 66.0% of patients were men. The median (range) interval from diagnosis
to initial Olverembatinib treatment was 1.03 years. A total of 25.5% of patients had received 1L imatinib, and 74.5% of patients had
been treated with a 1L 2G TKI, including dasatinib (n = 7, 14.9%), nilotinib (n = 13, 27.7%), or flumatinib (n = 15, 31.9%). A total
of 76.6% of patients had no mutations at baseline, while 23.4% had non-T315I BCR::ABL1 kinase domain mutations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72%
CCyR and 44% MMR in efficacy-evaluable patients, increasing response over time</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="ea028514801_img8.jpg" style="width: 450px; height: 174px"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Efficacy
results.</i></b> As of July 24, 2025, 39 (83.0%) patients received at least one efficacy evaluation; 36 (76.6%) at least two efficacy
evaluations; and 34 (72.3%) at least three efficacy evaluations. Two patients had not yet received their first efficacy evaluation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the data cut-off date, 71.8% (28/39) of patients had achieved a CCyR and 43.6% (17/39) MMR. CCyR and MMR rates assessed at the end
of cycles 6, 9, 12, 15, 18, 21, and 24 were 54.3% and 25.7%, 66.7% and 33.3%, 74.2% and 35.5%, 84.6% and 46.2%, 85.7% and 47.6%, 90.0%
and 60.0%, and 89.5% and 57.9%, respectively, suggesting that responses deepened as treatment persisted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Among
39 efficacy-evaluable patients, 30  received second-generation TKIs in first-line treatment. Of them, 76.7% (23/30) achieved a CCyR
and 43.3% (13/30) MMR. Among the 9 patients who were pretreated with imatinib, 55.6% (5/9) achieved a CCyR and 44.4% (4/9) MMR.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Safety
results. </i></b>The median (range) treatment duration was 16.0 (1-18) cycles. A total of 42 (89.4%) patients experienced treatment-related
adverse events (TRAEs) of any grade, including 21 (44.7%) patients who experienced grade &#8805;3 TRAEs and 6 (12.8%) patients who experienced
serious adverse events (SAEs) related to Olverembatinib. Grade &#8805;3 hematologic toxicities included platelet count decreased (42.6%),
neutrophil count decreased (25.5%), and anemia (8.5%). Olverembatinib-related SAEs included platelet count decreased (6.4%) and anemia,
myelosuppression, and pyrexia (2.1% each). No deaths were reported during the study.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>4.
Olverembatinib Efficacy in MLN-FGFR1 Mutant Patients</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
was a phase 2, open-label, multicenter investigator-initiated study that was performed to evaluate the efficacy and safety of
Olverembatinib in adults with first-line or relapsed MLN-FGFR1. In this trial, Olverembatinib was highly effective and well
tolerated in patients with MLN-FGFR1 in both preclinical and clinical settings. Combined chemotherapy was preferable in patients
with BP disease, and allo-HSCT remained an important strategy for extending survival.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographics</i></b><i>.</i>
As of October 30, 2025, 20 patients from 16 centers were enrolled and 17 patients were evaluated for efficacy. Median(range) age was
48(25-81) years old, 7 patients were men,14 had CP disease (10 with EMD, mostly presented as T-LBL) , 5 had BP disease (2 B-ALL, 2 AML
and 1 MPAL) , 1 EMD only, 6 were previously treated 2 had prior alloHSCT,13 had peripheral blood eosinophilia, of whom 11(84.6%) had
CP disease. ZMYM2 (65.0%) was the most observed fusion partner.RUNX1 mutation was detected in 9/16 (56.2%) patients.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img9.jpg" style="width: 350px; height: 281px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Efficacy results.</i></b> 13/17 (76.5%) patients achieved CR/CRh/CHR,
among whom 1 achieved CCyR and 2 achieved CMR at 2 months&#8217; evaluation. Best responses were 5 CMR, 4 CCyR, 8 CR/CHR. With a median (range)
follow-up of 11 (2-38) months, 11 patients were still alive with no detected disease. Among the 5 patients who had received HSCT, 3 were
in CMR to date, 1 relapsed, 1 died of transplant-related infection.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Safety
results. </i></b>Adverse events in 11 CP patients who were treated with Olverembatinib alone were evaluated. 1 patient reported grade
3 platelet count decrease and 1 patient reported grade 3 alanine aminotransferase elevation, hyperpressure cerebral infarction. Rash
and constipation were mostly commonly observed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>5.
Deep Remission, Improvement in Allo-HSCT Outcomes in Blast Crisis</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
real-world practice analysis captured data from consecutively enrolled BC-CML patients aged &#8805;14 years undergoing allo-HSCT at the
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences between November 2021 and January 2025, including
both de novo and chronic phase-transformed cases.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
real-world analysis provides the first clinical evidence supporting the efficacy and safety of Olverembatinib in transplant-eligible
BC-CML. Olverembatinib significantly enhances pre-transplant molecular responses, compared to 1/2G-TKIs, associating with improved survival
and reduced NRM in BC-CML patients receiving allo-HSCT. With a manageable safety profile, Olverembatinib represents a promising bridging
strategy prior to allo-HSCT, potentially redefining frontline management of BC-CML.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographics</i></b><i>.</i>
A total of 64 patients with BC-CML receiving pre-transplant TKIs treatment were included in the study (median age 33 years, range 14&#8211;61).
At BC diagnosis, 43.8% (n=28) exhibited additional cytogenetic abnormality, including 20 complex karyotypes. Twenty patients (31.3%) harbored
ABL1 mutations, predominantly E255K and Y253K. T315I was seen in 5 cases. Thirty (46.9%) patients carried additional genetic mutations,
including myeloid neoplasm-associated mutations (e.g., ASXL1, RUNX1) and IKZF1 deletions. Extramedullary involvement occurred in 11 patients
(17.2%). All patients received TKIs+chemotherapy before transplantation and were stratified by pre-transplant TKIs exposure: 1/2G-TKI
cohort (n=42, imatinib, nilotinib, flumatinib or dasatinib) versus Olverembatinib (n=21, HQP1351), with balanced baseline characteristics<i>.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><img alt="" src="ea028514801_img10.jpg" style="width: 350px; height: 309px"/></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Efficacy
results.</i></b> The Olverembatinib cohort demonstrated advanced pre-transplantation treatment responses: higher hematologic remission
rates (100% vs 81%, p&lt;0.05) and CCyR rate (76.2% vs 55.8%, p=0.17). Notably, Olverembatinib achieved significantly improved molecular
remission at transplantation: MMR 61.9% vs 16.3% (p&lt;0.001) and CMR 23.9% vs 4.7% (p&lt;0.05).&#160;Olverembatinib cohort showed clinically
meaningful improved survival, including trends toward improved two-year OS (87.1% vs 57.2%) and two-year PFS (75.8% vs 52.6%),</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration:underline">Safety
results</span>.</i></b> Safety analysis revealed treatment-related adverse events in Olverembatinib cohort 52.4% (11/21) of patients. Six
(28.6%) developed grade 3/4 neutropenia. Cardiovascular Events were observed in two patients, including deep vein thrombosis (n=1) and
pericardial effusion (n=1).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>6.
Registrational Phase II Study in CML-CP: 4-Year Follow Up</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
was an open-label, randomized controlled, multicenter, pivotal registrational Phase II study (NCT04126681) designed to evaluate the efficacy
and safety of Olverembatinib in patients with CML-CP resistant and/or intolerant to first- and second-generation TKIs. This report features
an update on results released in an oral presentation at ASH 2023. In this trial, Olverembatinib demonstrated a clear therapeutic advantage
over BAT in patients with CML-CP resistant and/or intolerant to first- and second-generation TKIs, including those without the T315I
mutation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographics</i></b><i>.
</i>As of January 13, 2025, a total of 144 patients with CML-CP were enrolled in the study, including 105 patients without the T315I
mutation. In this study, patients were randomized in a 2:1 ratio to the Olverembatinib arm or the control arm with investigators&#8217;
choices of best available treatment (BAT). The primary endpoint was event-free survival (EFS). An event was defined as disease progression;
loss of achieved complete hematologic response (CHR), major cytogenetic response, or complete cytogenetic response (CCyR); treatment
failure; no achieved CHR within 3 cycles; death from any cause; or unacceptable toxicity.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EFS:
All Patients with CML-CP</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img11.jpg" style="width: 400px; height: 243px"/></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Efficacy
results.</i></b> The Olverembatinib arm achieved a significantly longer EFS than the BAT arm: among all patients with CML-CP, the
median EFS of the Olverembatinib arm and the BAT arm were 21.2 months and 2.9 months (P &lt; 0.0001), respectively. Among patients
with CML-CP without the T315I mutation, the median EFS of the Olverembatinib arm and the BAT arm were 11.9 months and 3.1 months (P
= 0.0159), respectively. Other efficacy parameters of the Olverembatinib arm were significantly better than those of the BAT arm:
among all patients with CML-CP, CHR rates of the Olverembatinib arm and the BAT arm were 85% and 35%; CCyR rates were 38% and 19%;
and major molecular response (MMR) rates were 30% and 8%, respectively. Among patients with CML-CP without the T315I mutation
treated in the Olverembatinib arm or the BAT arm, CHR rates were 82% and 50%, CCyR rates 26% and 21%, and MMR rates 16% and 10%,
respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Favorable
Safety Profile</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img12.jpg" style="width: 420px; height: 250px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration:underline">Safety
results</span>.</i></b> Olverembatinib showed a favorable safety profile in patients with CML-CP with/without the T315I mutation, with no
new safety signals. Grade &#8805; 3 adverse events included hematologic toxicities. Notably, the incidence rate of vascular occlusion
in the Olverembatinib arm was 7%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7<i>.
Olverembatinib + Bcl-2i Bridging: Potential for Chemo- or Immunotherapy Free Regimen with Lisaftoclax</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
study aimed to investigate the efficacy and safety of an Olverembatinib-venetoclax regimen before bridging to HSCT in adult Ph/BCR-ABL1+ALL
patients with refractory/relapsed disease or persistent MRD. This study demonstrated that the use of Olverembatinib-venetoclax involved
regimen prior to transplantation is effective and safe. Prompt allo-HSCT bridging post-Olverembatinib-venetoclax treatment significantly
enhances long-term outcomes in high-risk patients. Moreover, the results support the Olverembatinib-venetoclax involved regimen as a
frontline consolidation or induction treatment, which may achieve rapid molecular remission, reduce pre-transplant treatment cycles,
and minimize chemotherapy-related toxicity.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographics</i></b><i>.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
single-center case series included 17 refractory/ relapsed (R/R) (n=2) and minimal residual disease (MRD) persistent positive (n=15)
Ph+ALL patients who were treated with Olverembatinib-related therapy between February 20, 2022, and January 31, 2023, including 2 with
hematology relapse, 9 with persistent positive MRD, and 1 with relapsed MRD. Four patients harbored a T315I mutation. Two patients had
received prior blinatumomab or INO treatment. All patients had previously failed TKI treatment, with four of them who did not respond
to at least two different TKIs. The median number of chemotherapies courses before enrollment was 3 (range: 3&#8211;11). The regimen
included Olverembatinib (40 mg QOD) combined with venetoclax (100 mg d1, 200 mg d2, 400 mg, d3&#8211;28) + prednisone (1 mg/kg, d1 ~
14) + vincristine (1.5 mg/m2, d1, d8) regimen. The last follow-up date was April,2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olverembatinib
+ Venetoclax Combination: High Percentage of Relapse-Free Survival post-HSCT</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img13.jpg" style="width: 450px; height: 290px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Efficacy
results. </i></b>The median number of Olverembatinib + venetoclax regimen cycles was 2 (range, 1&#8211;3 cycles). With a median follow-up
of 856-day post-HSCT, the 2-year overall survival and relapsed free survival rates was 88.2 &#177; 7.8% and 79.4 &#177; 10.9%, respectively.
15 (83.3%) enrolled patients successfully underwent bridged allo-HSCT. Overall, all 2/2 patients with hematological recurrence achieved
CMR, and 10 of the 15 MRD + patients achieved CMR, resulting in an overall CMR rate of 70.6%. Three patients who failed MRD clearance
after one cycle of Olverembatinib and venetoclax regimen proceeded to the CD19 bispecific T-cell Engager (Blinatumomab, BiTE) therapy
and only one attained MRD clearance. Notably, all patients with T315I mutations (4/4) achieved CMR before transplantation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Safety
results. </i></b>Olverembatinib-venetoclax involved regimen demonstrated favorable tolerance and safety. Gastrointestinal symptoms were
observed in one patient, while another experienced dizziness. Nine patients experienced grade 1&#8211;2 neutropenia and thrombocytopenia.
No cardiovascular events, proteinuria, creatine kinase (CK) increase, rash, hypertension, or infection were observed. All patients completed
the treatment, and there were no cases of treatment suspension or discontinuation owing to drug intolerance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Olverembatinib
Registrational Trials</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently conducting an FDA and EMA cleared registrational Phase 3 trial, or POLARIS-2, of Olverembatinib as a monotherapy for CML.
We are also pursuing label expansion of Olverembatinib in an FDA and EMA cleared registrational Phase 3 trial, or POLARIS-1, in combination
with chemotherapy for the treatment of frontline Ph+ ALL and another registrational Phase 3 trial, or POLARIS-3, as a monotherapy for
SDH-deficient GIST.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">POLARIS-1&#8212;Registrational
Phase 3 trial for the treatment of first-line Ph+ ALL</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2023, we received clearance from the CDE to initiate our registrational Phase 3 trial (NCT06051409) of Olverembatinib in combination
with chemotherapy in patients with first-line Ph+ ALL, or POLARIS-1, which may potentially make Olverembatinib the first TKI for frontline
treatment of Ph+ ALL. In December 2025, we received clearance from the FDA and EMA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img14.jpg" style="width: 400px; height: 176px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
POLARIS-1 trial is a global, multicenter, randomized controlled, open-label Phase 3 study designed to evaluate the efficacy and safety
of Olverembatinib in combination with chemotherapy in first-line patients with Ph+ ALL. The POLARIS-1 study was also initiated in China
after it was cleared by the China CDE in 2023. The primary endpoint will be MRD-Negative CR rate at the end of the third 28-day cycle.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We are continuing
to enroll patients in POLARIS-1, and we plan to complete the majority of enrollment in 2026.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">POLARIS-2&#8212;Registrational
Phase 3 trial for the treatment of CML-CP</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2024, we received clearance from the FDA to initiate our registrational Phase 3 trial (NCT06423911) of Olverembatinib in CML-CP,
both with and without <i>T315I</i> mutations, or POLARIS-2, the first registrational Phase 3 trial for Olverembatinib in patients with
CML-CP to be conducted, and we are pursuing clearance in multiple countries. The POLARIS-2 protocol was submitted under an existing IND
that was initially submitted to the FDA on June 10, 2019.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img15.jpg"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><!-- Field: Split-Segment; Name: 4 --><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
multi-center, randomized, open-label, registrational Phase 3 trial has two parts. Part A is a randomized controlled study that evaluates
the efficacy and safety of Olverembatinib (investigational arm) compared to the efficacy and safety of bosutinib (control arm) in patients
with CML-CP previously treated with at least two TKIs. Part B is a single arm study to evaluate the efficacy and safety of Olverembatinib
in patients with CML-CP with <i>T315I</i> mutations previously treated with at least one TKI and without other available effective treatment
options.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary endpoint for both parts is MMR rate at 24 weeks, and the key secondary endpoint is MMR rate at 96 weeks.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We are continuing
to enroll patients in POLARIS-2, and we plan to advance enrollment of POLARIS-2 trial in 2026.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">POLARIS-3&#8212;Registrational
Phase 3 trial for SDH-deficient GIST</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2024, we received clearance from the CDE to initiate our registrational Phase 3 trial of Olverembatinib in patients with SDH-deficient
GIST, or POLARIS-3, and we are pursuing clearance in multiple countries.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img16.jpg"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
multi-center, randomized, open-label, registrational Phase 3 trial evaluates the efficacy and safety of Olverembatinib in patients with
SDH-deficient GIST who have undergone previous treatment. Adult patients will receive 40 mg of Olverembatinib once every other day for
28 days.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary endpoint will be PFS rate at 13 months as evaluated by an independent review committee. Key secondary endpoints include CBR,
overall response rate, time to relapse, duration of response, and OS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
are continuing to enroll patients in the POLARIS-3 trial throughout 2026.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
second lead asset: Lisaftoclax</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
second lead asset, Lisaftoclax, is a novel, oral Bcl-2 inhibitor developed to treat a variety of hematologic malignancies and solid tumors
by selectively blocking Bcl-2 to restore the normal apoptosis process in cancer cells. In July 2025, Lisaftoclax was approved by China&#8217;s
NMPA for the treatment of adult patients with CLL/SLL who have previously received at least one systemic therapy, including BTK inhibitors,
which makes Lisaftoclax the first Bcl-2 inhibitor receiving conditional approval and marketing authorization for the treatment of patients
with CLL/SLL in China as well as the second Bcl-2 inhibitor approved globally. Shortly after the approval, we have commenced the commercial
sales of Lisaftoclax in China. We believe that Lisaftoclax, with its short half-life and potential for patient-friendly ramp-up schedule,
has the potential to serve as a backbone molecule for combination therapies to treat many hematological malignancies, including and beyond
CLL/SLL. Furthermore, FDA has granted five ODDs to Lisaftoclax, including CLL and AML.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the registrational Phase 2 trial for which we have submitted an NDA that was accepted with priority review by the CDE, we
are currently conducting an FDA and EMA cleared registrational Phase 3 trial, or GLORA, of Lisaftoclax in combination with BTK inhibitors
for patients with CLL/SLL previously treated with BTK inhibitors for more than 12 months with suboptimal responses. Also, we are evaluating
Lisaftoclax in combination with AZA in GLORA-4, an FDA and EMA cleared registrational Phase 3 trial, as a frontline treatment for high-risk
MDS. In addition, we are pursuing approval of Lisaftoclax in combination with acalabrutinib as the frontline treatment for CLL/SLL in
an FDA and EMA registrational Phase 3, or GLORA-2, trial. We are also evaluating Lisaftoclax in combination with AZA in GLORA-3, a registrational
Phase 3 trial, as a frontline treatment for AML. Other clinical trials of Lisaftoclax are ongoing for MM and other hematological malignancies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of key completed and ongoing clinical trials for Lisaftoclax</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img17.jpg"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            July 2025, Lisaftoclax was approved by NMPA in China for the treatment of adult patients
                                            with CLL/SLL who have previously received at least one systemic therapy including BTK inhibitors.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"></p><div>


</div><!-- Field: Page; Sequence: 115; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current
treatment paradigm and its limitations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">CLL/SLL</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
treatments for CLL include chemotherapy, anti-CD20 mAb, BTK inhibitors, PI3K inhibitors, and Bcl-2 inhibitors. The frontline standard
of care is either rituximab or an obinutuzumab/chemotherapy combination or ibrutinib, a BTK inhibitor. The FDA approval of idelalisib,
a PI3K inhibitor, and venetoclax, a Bcl-2 inhibitor, have provided new options to treat R/R CLL. In May 2019, the FDA granted approval
on the combination of venetoclax and obinutuzumab for the frontline treatment of patients with CLL/SLL. To date, venetoclax is not approved
for CLL/ SLL in China. CLL/SLL still presents major clinical challenges and urgent medical needs for new treatment options that can offer
both efficacy and safety. There is increasing evidence that a double combination of CD20 or BTK with a Bcl-2 targeted agent may offer
deeper and more durable remission of an MRD negative response.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bcl-2
is highly expressed in all CLL cells in all patients, and a great majority of CLL cells appear dependent on Bcl-2 for survival. Bcl-2
inhibitors are effective as a monotherapy in approximately 60 to 80% of patients with relapsed CLL, and CR, including CR with incomplete
recovery, or CRi, can be expected in 15% to 20% of patients. The rate of response, including CR, is independent of genetic subtypes,
but the negative prognostic genetic markers del17p, TP53 and NOTCH1 mutations are associated with less durable responses per multivariable
analyses. Achieving CR and/or having undetectable MRD in the peripheral blood (achieved in 30% of patients) or bone marrow is associated
with prolonged remissions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">AML</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
frontline treatment for AML generally involves the use of cytarabine and daunorubicin/idarubicin as an induction therapy, followed by
high dose cytarabine as a consolidation therapy. Combination regimens including FLAG-Ida, MEC, or hypomethylating agents are used in
relapse cases. As of the date of this Annual Report on Form 20-F, there are several approved drugs on the market to treat a subset of
AML that has mutations in the IDH2, FLT3 or CD33 genes in addition to several targeted drugs in clinical development for AML.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bcl-2
is variably expressed in AML, and only a minority of patient samples show marked sensitivity. Consistent with this, single agent activity
is evident in patients. Available clinical data reflect that inhibition of Bcl-2 in AML results in a &#8220;hammer-strike&#8221; effect,
with Bcl-2 being a significant target, but not a bullseye. Consequently, combination therapy is essential. In relapsed AML, the CR/CRi
rate appears higher with these combinations than with monotherapy. In October 2020, the FDA granted approval to venetoclax in combination
with AZA, decitabine, or low-dose cytarabine for newly-diagnosed AML in adults who are 75 years or older, or who have co- morbidities
precluding intensive induction chemotherapy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">MDS</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment
for MDS varies depending on the clinical presentation and prognosis, as well as the patient&#8217;s age, health, prior treatments, and
other factors. MDS may be treated with chemotherapy, growth factors (to support hematopoiesis), blood transfusions, and other supportive
therapy, and stem cell transplantation. Lower-risk MDS may require only growth factors and/or transfusions. HR MDS is typically treated
with DNA hypomethylating agents, such as AZA or decitabine. AZA has also been shown to improve survival in certain patients. Since HR
MDS can progress to AML, it is often also treated with drug regimens used in AML. However, all patients eventually progress on these
therapies. HSCT remains the only treatment for MDS with curative potential, but only a fraction of patients are eligible and/or receive
a transplant. More so, HSCT is associated with considerable morbidity and mortality. There are a few advanced-stage clinical trials that
are evaluating the potential of Bcl-2 inhibitor in the treatment of MDS, including the Phase 3 VERONA trial of venetoclax in combination
with AZA to assess change in complete remission and overall survival in first-line patients with HR MDS, but as of the date of this Annual
Report on Form 20-F, venetoclax has not received FDA approval for frontline treatment of patients with first-line HR MDS. Thus, there
remains a great unmet need for more effective drug treatments for MDS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
solution: Lisaftoclax</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
second lead asset, Lisaftoclax, is a novel Bcl-2 inhibitor that we are developing for the treatment of various hematological malignancies.
In July 2025, Lisaftoclax was approved by China&#8217;s NMPA for the treatment of adult patients with CLL/SLL who have previously received
at least one systemic therapy, including BTK inhibitors, which makes Lisaftoclax the first Bcl-2 inhibitor receiving conditional approval
and marketing authorization for the treatment of patients with CLL/SLL in China as well as the second Bcl-2 inhibitor approved globally.
Shortly after the approval, we have commenced the commercial sales of Lisaftoclax in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 116; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
the use of a classic rational design approach to the discovery of this candidate, Lisaftoclax demonstrates unique pharmacokinetic properties
in the inhibition of its target. These properties include potent inhibition at the time of maximum concentration with limited persistence
in plasma. In addition, the short ramp-up period for Lisaftoclax dosing provides potential advantages both for patients and the health
care system.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Mechanism
of action</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
B-cell lymphoma 2, or Bcl-2, family is comprised of proteins that are highly involved in regulating apoptosis. All proteins belonging
to the Bcl-2 family contain at least one more of four domains, called Bcl-2 homology, or BH, domains, and named BH1, BH2, BH3 and BH4,
and some members, such as Bim, contain only a single BH3- domain. The anti-apoptotic proteins, including Bcl-2 and Bcl-x(L), inhibit
cell death; in contrast, the pro-apoptotic proteins such as Bim is, promotes cell death. Lisaftoclax binds to the Bcl-2 and disrupts
the Bcl-2-Bim complex, and therefore, Bim is released from the complex and activates apoptosis. Lisaftoclax also induces cellular apoptosis
by disrupting Bcl-2/BH3 interactions, and indirectly neutralizing MCL-1 functions, leading to downstream caspase activation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mechanism
of Action of Lisaftoclax</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img18.jpg"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
clinical results</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: left"><b>Lisaftoclax shows strong clinical activity in AML and MDS and the potential to overcome Venetoclax
    resistance in AML, see &#8220;<i>1. Lisaftoclax Shows Strong Clinical Activity in AML and MDS as well as in Venetoclax Refractory
    AML</i>&#8221;</b></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: left"><b>Strong ORR (62.5%) in the challenging, BTKi-failed R/R CLL/SLL patients, see &#8220;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
    <i>Monotherapy in a Registrational Phase II Study of BTKi-failed R/R CLL/SLL Patients</i>&#8221;</span></b></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="text-align: left"><b>Strong potential for combination with Olverembatinib in FLT3-ITD mutant AML, combination with Alrizomadlin
    (APG-115) to overcome venetoclax resistance in AML and combination with Alrizomadlin (APG-115) for Diffuse Large B-Cell Lymphoma
    (DLBCL)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, see <i>&#8220;3. Lisaftoclax &#8211; A Potential
    Cornerstone for Combination Drugs Across Multiple Diseases&#8221;</i></span></b></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Lisaftoclax
also has a unique PK profile compatible with a potentially more convenient daily (vs. weekly) dose ramp-up schedule and induced rapid
clinical responses in patients with CLL/SLL or other hematological malignancies. Previous clinical results showed Lisaftoclax achieved
target treatment dose and BTK inhibitor combination in as quickly as approximately one week.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Additionally,
Lisaftoclax in combination with Alrizomadlin has demonstrated further benefit in AML, with potential to overcome venetoclax resistant.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the results presented above and below in this section &#8220;<i>Key Clinical Results</i>&#8221; include data from trials conducted
outside of the United States. To the extent the trials were conducted outside of the United States, the FDA may not accept such data,
and additional trials may be required, resulting in additional cost and time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"></p><div>

</div><!-- Field: Page; Sequence: 117; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>1.
Lisaftoclax Shows Strong Clinical Activity in AML and MDS as well as in Venetoclax Refractory AML</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
was a phase Ib/II study (NCT04964518) designed to evaluate the efficacy and safety of Lisaftoclax in combination with AZA in patients
with ND or relapsed/refractory AML, mixed-phenotype acute leukemia (MPAL), chronic myelomonocytic leukemia (CMML), or higher-risk (HR)
MDS. The first part of this study was the dose-escalation phase, and the second part was the dose-expansion phase. These preliminary clinical
data show that the combination regimen of Lisaftoclax plus AZA holds promise in overcoming venetoclax resistance, therefore potentially
offering a new treatment option to patients with AML/HR MDS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographics.</i></b>
As of July 1, 2025, 103 patients were enrolled, including 63 patients with AML/MPAL (of whom 56 had relapsed/refractory diseases) and
40 patients with HR MDS/CMML (of whom 25 had relapsed/refractory diseases).</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img19.jpg"/></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Efficacy
results.</i></b> In the 44 evaluable patients with R/R AML/MPAL, the ORR was 43.2%, and the CR rate was 31.8% (14/44). In the 22 evaluable
patients with venetoclax&#8211;exposed R/R AML/MPAL, the ORR was 31.8% (7/22), and the CR rate was 22.7% (5/22). In the 15 evaluable
patients with ND HR MDS/CMML, the ORR was 80.0%, including 6 (40.0%) patients who achieved a CR, and 6 (40.0%) who achieved a marrow
CR (mCR).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Median
overall survival (OS) values for patients with R/R AML/MPAL or R/R HR MDS/CMML were 7.6 months and 11.3 months, respectively. The median
OS was 6.3 months in patients with ND AML/MPAL and was not reached in patients with ND HR MDS/CMML.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Safety
results.</i></b> No dose-limiting toxicities (DLTs) were reported in part one for dose-escalation or part two for dose-expansion. Common
grade &#8805;3 treatment-emergent adverse events (TEAEs) included neutropenia (41.7%), febrile neutropenia (35.0%), thrombocytopenia
(26.2%), and anemia (17.5%).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<i>Monotherapy in a Registrational Phase II Study of BTKi-failed R/R CLL/SLL Patients</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
was a pivotal registrational Phase II study (NCT05147467) in patients with CLL/SLL, with the objective response rate (ORR) as its primary
endpoint. Patients in this study were refractory to, relapsed on, or intolerant of both BTK inhibitors and ICTs; or failed prior BTK
inhibitors and were ineligible for ICTs. Lisaftoclax monotherapy demonstrated significant and durable clinical efficacy and a manageable
safety profile in patients with heavily pretreated BTK-refractory R/R CLL/SLL, underscoring its utility as a potential new treatment
option.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographics.</i></b>
A total of 77 patients were enrolled in this study. Among them, 33 (42.9%) had chromosomal complex karyotype, 30 (39%) had del(17p)/TP53
mutation, and 41 (53.2%) had unmutated IGHV. Among patients who had chromosomal complex karyotype, 63.6% had concurrent chromosomal complex
karyotype and 63.6% had concurrent high karyotypic complexity (abnormal chromosome number &#8805; 5).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 118; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monotherapy
in a Registrational Phase II Study of BTKi-failed R/R CLL/SLL Patients</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img20.jpg" style="width: 330px; height: 291px"/>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><img alt="" src="ea028514801_img21.jpg" style="width: 570px; height: 241px"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Efficacy
results.</i></b> As of July 25, 2025, among 72 evaluable patients with R/R CLL/SLL, the ORR as confirmed by the independent review committee
(IRC) was 62.5%, the median progression-free survival (mPFS) was 23.89 months (with a median follow-up of 22.01 months). Among high-risk
patients (those with adverse prognostic genotypes such as del(17p)/TP53 mutation, chromosomal complex karyotype, and unmutated IGHV),
the treatment showed clinically meaningful deep responses. 21.8% of patients achieved minimal residual disease (MRD) negativity in peripheral
blood. In the 11 evaluable patients with bone marrow MRD, 54.5% achieved bone marrow MRD negativity.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisaftoclax
monotherapy demonstrated a median progression-free survival of 23.89 months in patients with heavily pretreated BTK-refractory R/R CLL/SLL,
with no tumor lysis syndrome reported</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Safety
results.</i></b> Lisaftoclax demonstrated a manageable safety profile in BTKi-pretreated patients. Frequent grade &#8805;3 treatment-related
adverse events were hematologic toxicities that included decreased neutrophil count, decreased platelet count, and anemia. Neither tumor
lysis syndrome (TLS) nor treatment-related deaths occurred during the study.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 119; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>3.
Lisaftoclax &#8211; A Potential Cornerstone for Combination Drugs Across Multiple Diseases</i></b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img22.jpg" style="width: 270px; height: 267px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
data from a preclinical study demonstrated that Lisaftoclax in combination with Alrizomadlin overcomes venetoclax resistance mediated
by various mechanisms, including&#160;<i>BCL-2</i>&#160;mutations. In addition, we posit further, putative molecular mechanisms. Our
data rationalize clinical development of this treatment combination in patients with diseases that are insensitive or resistant to venetoclax.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Results.</i></b>
The combination exhibited synergistic antiproliferative and apoptogenic activities in TP53 wild-type AML cell lines in vitro. This synergy
was further exemplified by deep antitumor responses and prolonged survival in AML cell line&#8211;derived and patient-derived xenograft
models. Interestingly, the combination treatment resensitized (to apoptosis) venetoclax-resistant cellular and mouse models established
via chronic drug exposure or genetically engineered with clinically relevant Bcl-2 gene mutations. Synergistic effects in reducing cellular
viability and proliferation were also demonstrated in primary samples of patients with venetoclax-resistant AML treated with Lisaftoclax
and Alrizomadlin ex vivo. Mechanistically, Alrizomadlin likely primes cancer cells to Bcl-2 inhibition-induced cellular apoptosis by
downregulating expression of antiapoptotic proteins myeloid cell leukemia-1 and Bcl&#8211;extra-large and upregulating pro-death Bcl-2&#8211;associated
X protein.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img23.jpg" style="width: 270px; height: 258px"/>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
data from a preclinical study demonstrated that FLT3 inhibition by HQP1351 downregulates MCL-1 and synergizes with Bcl-2 inhibitor APG-2575
to potentiate cellular apoptosis in FLT3-ITD mutant AML. Our findings provide a scientific rationale for further clinical investigation
of HQP1351 combined with APG-2575 in patients with FLT3-ITD mutant AML.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"></p><div>

</div><!-- Field: Page; Sequence: 120; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Results.</i></b>
HQP1351 potently induced apoptosis and inhibited FLT3 signaling in FLT3-ITD mutant AML cell lines MV-4-11 and MOLM-13. HQP1351 monotherapy
also significantly suppressed growth of FLT3-ITD mutant AML xenograft tumors and prolonged survival of tumor-bearing mice. HQP1351 and
APG-2575 synergistically induced apoptosis in FLT3-ITD mutant AML cells and suppressed growth of MV-4-11 xenograft tumors. Combination
therapy improved survival of tumor bearing-mice in a systemic MOLM-13 model and showed synergistic anti-leukemic effects in a patient-derived
FLT3-ITD mutant AML xenograft model. Mechanistically, HQP1351 downregulated expression of myeloid-cell leukemia 1 (MCL-1) by suppressing
FLT3-STAT5 (signal transducer and activator of transcription signaling and thus enhanced APG-2575-induced apoptosis in FLT3-ITD mutant
AML cells.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="ea028514801_img24.jpg" style="width: 450px; height: 170px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Differentiated
trial design.</i></b> Patients with first-line CLL/SLL or R/R CLL/SLL were treated daily with Lisaftoclax alone or in combination with
continuous acalabrutinib or rituximab for six 28-day cycles. Primary objectives were to determine the RP2D, safety and efficacy, including
ORRs of Lisaftoclax alone and combined with acalabrutinib or rituximab. Patients underwent Lisaftoclax daily ramp-up over 4 to 6 days,
with the monitoring of TLS as follows without debulking: 20 mg on day 1; 50 mg on day 2; 100 mg on day 3; 200 mg on day 4; and 400 mg
on day 5. Dose ramp-up was followed by Lisaftoclax target doses of 400, 600 or 800 mg. Patients in the combination groups also completed
the daily ramp-up, as well as an additional 7 days of Lisaftoclax at the target dose, acalabrutinib or rituximab was added on day 8,
and then treated until disease progression or unacceptable toxicity was observed. The daily dose ramp-up is more convenient to healthcare
professionals and patients because the therapeutic dose can be reached earlier, in this trial as early as day 8.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lisaftoclax
registrational trials</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently conducting four pivotal registrational trials for Lisaftoclax as a treatment for patients with CLL/ SLL that do not achieve
CR from treatment with BTK inhibitors, or GLORA, which is cleared by the FDA, first-line CLL/SLL patients, or GLORA-2, first-line or
elderly/unfit patients with AML, or GLORA-3, and first-line patients with HR MDS, or GLORA-4.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
previously completed a registrational Phase 2 trial for the treatment of R/R CLL/SLL in China, and Lisaftoclax was approved by China&#8217;s
NMPA for the treatment of adult patients with CLL/SLL who have previously received at least one systemic therapy including BTK inhibitors
in July 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Completed
registrational Phase 2 trial for the treatment of R/R CLL/SLL in China</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2021, we received clearance from the CDE to initiate our registrational Phase 2 trial (NCT05147467) of Lisaftoclax for the treatment
of patients with R/R CLL/SLL in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.9pt 0pt 68.45pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is a single-arm, open-label, multi-center, registrational Phase 2 trial to evaluate the efficacy and safety of Lisaftoclax as a single
agent in patients with R/R CLL/SLL where we planned to enroll approximately 75 CLL/SLL subjects who have failed or are intolerant to
prior BTK inhibitors and immunochemotherapy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligible
subjects received Lisaftoclax 600 mg, administered orally once daily with repeated 28-day cycles.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 57.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary endpoint of this trial is ORR. Response is evaluated every two 8-week cycles till complete treatment or one month after last
dose. Other endpoints include MRD and Bcl-2 expression.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 121; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">GLORA&#8212;Registrational
Phase 3 trial for the treatment of CLL/SLL with prior BTK inhibitors</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2023, we received clearance from the FDA to initiate a registrational Phase 3 clinical trial (NCT06104566) of Lisaftoclax in combination
with BTK inhibitors for the treatment of patients with CLL/SLL previously treated with BTK inhibitors (GLORA). Since then, we have also
received clearance to proceed with clinical trials in Australia, Canada, EU and UK, and we are pursuing clearance in multiple other countries.
The protocol for this trial was submitted pursuant to an existing IND that was initially submitted to the FDA on December 22, 2017. This
trial is currently being conducted in Australia, Canada, Japan, certain European countries, United Kingdom and the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><img alt="" src="ea028514801_img25.jpg"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
multi-center, randomized, controlled, registrational Phase 3 trial evaluates the efficacy and safety of Lisaftoclax in combination with
a BTK inhibitor in patients with CLL/SLL previously treated with a BTK inhibitor monotherapy for more than 12 months with suboptimal
responses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">In the investigational
arm, patients will be dosed with Lisaftoclax in combination with a BTK inhibitor. In the control arm, patients will be dosed with a BTK
inhibitor as a monotherapy. We are continuing to enroll patients for GLORA throughout 2026 with a target enrollment of 440 patients.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary endpoint of this trial is to evaluate the PFS of Lisaftoclax in combination with BTK inhibitors compared with BTK inhibitors
as a monotherapy in patients with CLL/SLL previously treated with BTK inhibitors as determined by an independent review committee using
the guidelines. The key secondary endpoint is OS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">GLORA-2&#8212;Registrational
Phase 3 trial for frontline treatment in first-line CLL/SLL</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2023, we received clearance from the CDE to initiate our registrational Phase 3 trial (NCT06319456) of Lisaftoclax in combination
with acalabrutinib in patients with first-line CLL/SLL, or GLORA-2, and we are pursuing clearance in multiple countries. This clearance
could potentially pave the way for Lisaftoclax, in this combination regimen, to become a frontline treatment for CLL/SLL.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea028514801_img26.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Our multi-center,
randomized, open-label, registrational Phase 3 confirmatory trial designed evaluates the efficacy and safety of Lisaftoclax combined
with acalabrutinib compared to the efficacy and safety of an immunochemotherapy (or cancer immunotherapy, or CIT) in patients with first-line
CLL/SLL. We are continuing to enroll patients for GLORA-2 throughout 2026 with a target enrollment of 344 patients.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the investigational arm, patients will be dosed with 20 mg to 600 mg of Lisaftoclax once daily with acalabrutinib twice a day for eighteen
28-day cycles. In the control arm, the CIT regimen includes fludarabine, cyclophosphamide, rituximab, and chlorambucil once daily for
six 28-day cycles. The primary endpoint is PFS, which is defined as the time from randomization to disease progression or death from
any cause, as determined by an independent review committee. The key secondary endpoint is investigator-assessed PFS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 122; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">GLORA-3&#8212;Registrational
Phase 3 trial as frontline treatment for elderly/unfit patients with first-line AML</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 55.25pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, we received clearance from the CDE to initiate our registrational Phase 3 trial (NCT06389292) of Lisaftoclax in combination
with AZA in elderly/unfit patients with first-line AML, or GLORA-3, and we are pursuing clearance in multiple countries. This clearance
could potentially pave the way for Lisaftoclax, in this combination regimen, to become a frontline treatment for AML.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea028514801_img27.jpg"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
multi-center, randomized, double-blind, placebo-controlled, registrational Phase 3 trial evaluates the efficacy and safety of Lisaftoclax
in combination with AZA compared to the efficacy and safety of a placebo in combination with AZA in first-line AML patients who are old
or not eligible for standard induction chemotherapy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 57.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the investigational arm, patients will be dosed daily with Lisaftoclax in combination with AZA for the first seven days of a 28-day cycle.
In the control arm, patients will be dosed with placebo in combination with AZA for the first seven days of a 28-day cycle.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary endpoint is OS, defined as the time from the date of randomization to the date of death of any cause. The secondary endpoints
include percentage of participants with ORR and safety evaluation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">We are continuing
to enroll patients for GLORA-3 throughout 2026 with a target enrollment of 486 patients.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">GLORA-4&#8212;Registrational
Phase 3 trial as frontline treatment for first-line patients with HR MDS</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 35.4pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2024 and 2025, we received clearance from the CDE and FDA to initiate our registrational Phase 3 trial (NCT06641414) of Lisaftoclax in
combination with AZA in first-line patients with HR MDS, or GLORA-4, and we are pursuing clearance in multiple countries. This clearance
could potentially pave the way for Lisaftoclax, in this combination regimen, to become a frontline treatment for HR MDS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="ea028514801_img28.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
multi-center, randomized, double-blind, placebo-controlled, registrational Phase 3 trial, evaluates the efficacy and safety of Lisaftoclax
in combination with AZA compared to the efficacy and safety of a placebo in combination with AZA in patients with first-line HR MDS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the investigational arm, patients will be dosed with Lisaftoclax in combination with AZA. In the control arm, patients will be dosed
with placebo in combination with AZA. The primary endpoint is OS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"></p><div>


</div><!-- Field: Page; Sequence: 123; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; letter-spacing: 0.2pt">We
are continuing</span> <span style="font-family: Times New Roman, Times, Serif">to enroll <span style="letter-spacing: 0.2pt">patients
in the GLORA-4 trial throughout 2026.</span><span style="font-size: 10pt">&#160;</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.5pt 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
other clinical candidates</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea028514801_img29.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APG-2449</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-2449
is a novel, orally active, small-molecule focal adhesion kinase (FAK), the third generation of anaplastic lymphoma kinase (ALK) and receptor
tyrosine kinase C-ros oncogene 1 (ROS1) triple ligase kinase inhibitor (TKI) designed and developed by Ascentage Pharma. It is the first
FAK inhibitor approved by CDE for clinical study in China. In the first-in-human trial, cerebrospinal fluid PK analyses showed that APG-2449
was brain-penetrant. An updated study of APG-2449 demonstrated preliminary clinical benefit in patients with NSCLC whose disease was
TKI na&#239;ve and resistant to 2G ALK inhibitors, especially in brain metastases. In addition, high pFAK expression levels in baseline
tumor tissue correlated with improved APG-2449 treatment responses in patients with NSCLC resistant to 2G ALK inhibitors, suggesting
that the increase of pFAK may be associated with second-generation ALK TKI resistance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2024, APG-2449 was cleared by the Center for Drug Evaluation (CDE) of China&#8217;s National Medical Product Administration (NMPA)
to enter two registrational Phase III studies that will separately evaluate APG-2449 in patients with non-small cell lung cancer (NSCLC)
who are resistant to or intolerant of second-generation anaplastic lymphoma kinase (ALK) TKIs; and treatment-na&#239;ve patients with
ALK-positive advanced or locally advanced NSCLC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea028514801_img31.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><img alt="" src="ea028514801_img32.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Phase 1b/2 study of APG-2449 in combination with liposomal doxorubicin hydrochloride in platinum-resistant ovarian cancer is ongoing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 124; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Select
clinical trial results</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-small
cell lung cancer (NSCLC)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
single-arm, multicenter, phase 1 clinical trial included a dose escalation to determine maximum tolerated dose (MTD) and recommended
phase 2 dose (RP2D), followed by a dose-expansion stage at RP2D to evaluate safety. Secondary endpoints included pharmacokinetics, pharmacodynamics,
and preliminary efficacy. APG-2449 was administered once daily in 28-day cycles through a 3 + 3 dose escalation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Demographics. </i></b>144
patients were enrolled from May 27, 2019, to April 2, 2024, and received APG-2449 (150-1500 mg/day). Eligible patients were aged 18
years or older and had advanced ALK or ROS1 fusion gene-positive NSCLC and other solid tumors (during the dose escalation). Patients
with ALK-positive or ROS1-positive NSCLC regardless of previous TKI treatment were enrolled during the dose escalation. After RP2D
was determined, patients with second-generation TKI-treated ALK + NSCLC, TKI-na&#239;ve ALK +, and TKI-na&#239;ve or TKI-treated
ROS1 + NSCLC were enrolled in dose expansion. Eligible patients also had: (1) an Eastern Cooperative Oncology Group performance
status (ECOG PS) score of 1 or less; (2) adequate bone marrow reserve and organ function; and (3) no or stable brain metastases.
This study was registered with ClinicalTrials.gov (NCT03917043). Recruitment is ongoing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea028514801_img33.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Efficacy
Results</i></b>. Of patients with&#160;<i>ALK</i>-positive, TKI-na&#239;ve NSCLC (n = 14) treated at RP2D, the objective response rate
(ORR) was 78.6% (11/14), and median progression-free survival (mPFS) was not reached. Of 22 patients with NSCLC resistant to second-generation
ALK inhibitors (without ALK compound mutations or activation of bypass or downstream signaling pathways), 10 (45.5%) achieved partial
response, with a mPFS of 13.6 months. Intracranial partial response occurred in 9/12 patients at the RP2D (intracranial ORR: 75.0%).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Safety
Results</i></b>. MTD was not reached, and RP2D was 1200 mg. The most common grade &#8805;3 treatment-emergent adverse events (TEAE) were
anaemia [6 (4.2%)], alanine aminotransferase (ALT) increased [6 (4.2%)], electrocardiogram QT prolonged [5 (3.5%)], and pneumonia [5
(3.5%)]. The most common grade &#8805;3 treatment-related adverse events (TRAEs) were ALT increased [5 (3.5%)], QT prolonged [5 (3.5%)],
and vomiting [2 (1.4%)]. There were no treatment-related deaths.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 125; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Development
Highlights</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-indent: 20pt; margin-left: 0pt; margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">In
                                            April 2025, we released updated preclinical data of APG-2449 at AACR 2025, demonstrating
                                            enhanced antitumor activity with chemotherapy in preclinical models of small cell lung cancer,
                                            or SCLC, with activated FAK.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; letter-spacing: 0.2pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">In
                                            October 2025, we released clinical data from the phase 1 trial of APG-2449 in eClinicalMedicine.
                                            APG-2449 demonstrating favorable preliminary safety, pharmacokinetics, and efficacy in TKI-untreated
                                            or second-generation ALK-resistant NSCLC. Higher baseline tumor phosphorylated FAK levels
                                            were associated with greater APG-2449 treatment benefit. Targeting FAK signaling may provide
                                            a feasible strategy for overcoming second-generation ALK TKI resistance.</span></td></tr></table><div>
</div><p style="margin-left: 0pt; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Alrizomadlin
(APG-115)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alrizomadlin
is a novel, orally bioavailable, highly selective, small molecule inhibitor of mouse double minute 2 homolog, MDM2. Alrizomadlin is undergoing
multiple clinical trials as a monotherapy or in combination with immunotherapy or chemotherapy in treating solid tumors and hematologic
malignancies in sites around the world, including United States, China and Australia. We believe Alrizomadlin has potential to treat
a number of serious rare and orphan diseases and address unmet medical needs in both adult and pediatric indications. Compared with adult
tumors, pediatric solid tumors are characterized by low TP53 mutation frequency and high MDM2 amplification frequency. To date, the FDA
has granted us six ODDs, including for soft-tissue sarcoma, gastric cancer and neuroblastoma, and two RPDD, including for neuroblastoma
and retinoblastoma. In addition, we plan to pursue FTD, ODD and RPDD for our late-stage programs for Alrizomadlin in malignant peripheral
nerve sheath tumors, or MPNST, and adenoid cystic carcinoma, or ACC, for which we reported preliminary Phase 2 results in 2022 and 2023,
respectively. We are also developing Alrizomadlin for the treatment of other solid tumors and hematological malignancies, including AML,
MDS, and T-PLL. Clinical trials evaluating Alrizomadlin are currently taking place in Australia, China and the United States. We plan
to discuss with regulatory authorities and explore global registrational trials for Alrizomadlin for ACC or MPNST.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Malignant
peripheral nerve sheath tumor (MPNST)</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malignant
peripheral nerve sheath tumor, or MPNST, is an ultra-rare type of sarcoma that is very aggressive and has no available approved therapies.
The causes of MPNST are not well understood, but it typically originates in the cells that cover and protect peripheral nerves and then
grows quickly to invade other tissues. Chemotherapy and radiation have had limited effect on curbing the cancer, and efforts to develop
targeted therapies that have shown success in other cancer, such as inhibitors of EGFR, mTOR and tyrosine kinase have not been successful
to date. The current standard of care is aggressive surgical resection and, in some cases, amputation. However, surgery is sometimes
not available due to size or location of the tumors, and traces of the cancer can remain and result in recurrence. MPNST remains plagued
with high rates of recurrence and metastasis. The five-year survival rate is estimated to be 50% with median survival to be six years.</span></p><div>

</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Adenoid
cystic carcinoma (ACC)</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 57.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adenoid
cystic carcinoma, or ACC, is a rare form of malignant and persistent neoplasm that arises within secretory glands. It grows slowly
along nerves continuing to recur years after diagnosis and treatment. Approximately four million people globally, and 1,300 in the
United States, are diagnosed with ACC each year, with approximately 33 million people currently living with ACC, of which
approximately 11,000 are in the United States. ACC is initially asymptomatic so it is often diagnosed late after the tumor is
already at an advanced stage and has become metastatic. Currently, there are no NCCN standard treatment guidelines for managing all
ACC. ACC patients are typically treated with surgery and radiation. Conventional chemotherapies are also used, but patients
frequently develop resistance to such therapies, and clinical benefit has remained limited. ACC is characterized by frequent
recurrences and metastases to sites such as the brain, lungs, liver, and bones. Most metastases develop 3 to 10 years after initial
diagnosis, but can develop even later in life, so ACC patients require life-long monitoring.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 126; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Our
Solution: Alrizomadlin</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alrizomadlin
is a MDM2 inhibitor that has a stable chemical structure, high cell permeability, high binding affinity, and favorable PK profile. The
MDM2 protein is an antagonist of the p53 transcription factor, a well-known tumor suppressor. Overexpression and amplification of MDM2
has been associated with various cancers, such as liposarcomas, soft tissue tumors, osteosarcomas, and esophageal carcinomas, and implicated
in disease progression, treatment resistance and poor patient outcomes for other immunotherapies, such as PD-1/PD-L1 checkpoint inhibitors.
Various approaches to inhibit MDM2 have been attempted for more than three decades, with hundreds of small molecule inhibitors evaluated
in preclinical studies and clinical trials, but no MDM2 inhibitors have been approved to date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using
a structure-based approach, we designed a new class of potent, selective, cell permeable, non-peptidic, small molecule inhibitors of
the MDM2, and selected Alrizomadlin as our lead MDM2 inhibitor. Alrizomadlin has been generally well tolerated and has demonstrated clinical
benefit in a number of indications, including in MPNST and ACC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.45pt 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mechanism
of Action of Alrizomadlin (APG-115)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea028514801_img34.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Select
clinical trial results</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adenoid
cystic carcinoma (ACC)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Phase
2 study of novel MDM2-p53 inhibitor Alrizomadlin (APG-115) with or without PD-1 mAb (toripalimab) in patients with ACC or other solid
tumors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the data cutoff date of February 13, 2025, 57 patients with advanced ACC, malignant peripheral nerve sheath tumor (MPNST), liposarcoma
(LPS), biliary-tract cancer (BTC), and other tumors were enrolled. Alrizomadlin monotherapy showed encouraging antitumor activity in
patients with advanced ACC or MPNST. Alrizomadlin in combination with toripalimab was also well tolerated and demonstrated antitumor
activity in patients with MPNST, BTC, and LPS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 127; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Efficacy
Results</i></b>. In the monotherapy arm, 17 patients were efficacy-evaluable. The ORR was 16.7%, and the DCR was 100% in 12 patients
with ACC. The DCR was 80% in 5 patients with MPNST, 4 of whom achieved stable disease (SD). In the combination arm, 29 patients were
efficacy-evaluable. The ORR was 16.7% and the DCR was 100% in 6 patients with BTC. The ORR was also 16.7% and the DCR was 66.7% in 6
patients with LPS. Two patients with MPNST had confirmed partial response (PR) with prolonged progression free survival (PFS) of 60+
weeks and 96+ weeks, respectively. In 27 safety-evaluable patients treated with Alrizomadlin at the 150 mg dose level, 12 (44.4%) experienced
grade 3 or higher TRAEs. Treatment-related SAEs were reported in 8 patients (29.6%). One patient discontinued treatment because of TRAE.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Safety
Results</i></b>. In the monotherapy arm, 24 patients were safety-evaluable, 33.3% reported grade 3 or higher treatment-related adverse
events (TRAEs). Three patients (12.5%) experienced treatment-related serious adverse events (SAEs). One patient discontinued treatment
because of TRAE. In the combination arm, 27 patients are safety-evaluable, patients treated with Alrizomadlin at the 150 mg dose level,
12 (44.4%) experienced grade 3 or higher TRAEs. Treatment-related SAEs were reported in 8 patients (29.6%). One patient discontinued
treatment because of TRAE.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Other
programs</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            believe Alrizomadlin has the potential to treat a number of other solid tumors and hematological
                                            malignancies. In addition to the above-described trials. <span style="color: windowtext; letter-spacing: 0.2pt">We
                                            are currently advancing the following clinical studies of Alrizomadlin in the United States
                                            and/or Australia:</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext; letter-spacing: 0.2pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">A
                                            Phase Ib/II study of Alrizomadlin monotherapy or in combination with pembrolizumab in patients
                                            with unresectable or metastatic melanoma (in collaboration with Merck &amp; Co.) or other
                                            advanced solid tumors.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">A
                                            Phase IIa study evaluating the pharmacokinetics, safety and efficacy of Alrizomadlin as a
                                            single agent or in combination with Lisaftoclax in subjects with relapsed/refractory T-cell
                                            Prolymphocytic Leukemia, or R/R T-PLL, or NHL.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">A
                                            collaborative research study of Alrizomadlin monotherapy or in combination with chemotherapy
                                            in a Phase II study for the treatment of salivary gland cancer.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">In
addition, the CDE has granted approval for the following clinical trials of Alrizomadlin in China:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">A
                                            Phase Ib/II clinical study of Alrizomadlin in combination with anti-PD-1 antibody (JS001)
                                            toripalimab, for the treatment of patients with advanced liposarcoma (LPS) or other advanced
                                            solid tumors.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">A
                                            Phase Ib study of Alrizomadlin as a single agent or in combination with azacitidine or cytarabine
                                            in patients with R/R AML and relapsed/progressed high-/very high-risk MDS.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">A
                                            Phase I clinical study of Alrizomadlin alone or in combination with Lisaftoclax in children
                                            with solid tumors is ongoing, current data indicates that Alrizomadlin alone or in combination
                                            with Lisaftoclax showed a manageable safety profile, with preliminary antitumor activity
                                            in heavily pretreated relapsed/metastatic rhabdomyosarcoma (RMS) or other soft-tissue sarcomas
                                            (STSs). </span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 2.85pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt"><i>Clinical
Development Highlights</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">In
                                            June 2025, we released clinical data from our Phase II study of Alrizomadlin as a single
                                            agent or in combination with PD-1 inhibitor toripalimab in patients with advanced adenoid
                                            cystic carcinoma, or ACC, or other solid tumors in a poster presentation at the 61st ASCO
                                            Annual Meeting. In the monotherapy arm, 17 patients were efficacy-evaluable. The ORR was
                                            16.7%, and the DCR was 100% in 12 patients with ACC. The DCR was 80% in 5 patients with MPNST,
                                            4 of whom achieved stable disease (SD). In the combination arm, 29 patients were efficacy-evaluable.
                                            The ORR was 16.7% and the DCR was 100% in 6 patients with BTC. The ORR was also 16.7% and
                                            the DCR was 66.7% in 6 patients with LPS.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"></p><div>


</div><!-- Field: Page; Sequence: 128; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pelcitoclax
(APG-1252)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-small
cell lung cancer, or NSCLC, represents 80-85% of all lung cancers. A persistent cough is the most common symptom, making early detection
of lung cancer difficult. The majority of lung cancer patients present with either stage 3 locally advanced or stage 3 metastatic disease.
The current standard of care is chemotherapy or checkpoint inhibitors, but some patients who have specific mutations associated with
NSCLC, such as an EGFR or ALK, have been responsive to targeted therapies targeting those mutations. For example, TKIs targeting EGFR
mutants, or EGFR-TKIs, have been approved as frontline therapy for stage 3 or 4 NSCLC after chemotherapy. However, some patients have
disease that remain resistant even to first-, second- and third-generation TKIs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product candidate Pelcitoclax is a novel, highly potent, small molecule drug designed to restore apoptosis through dual inhibition of
the Bcl-2 and Bcl-xL proteins. To date, the FDA has granted one ODD to Pelcitoclax for the treatment of SCLC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
various clinical trials conducted in the United States, Australia and China, patients have been treated with Pelcitoclax as a monotherapy
or in combination with other antitumor agents. Pelcitoclax has been well tolerated in patients to date using either weekly or biweekly
intermittent dosing schedules. Preliminary antitumor activity was observed as a single agent in heavily pretreated patients.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
progress of Pelcitoclax is as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clinical
progress</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pelcitoclax
is currently under investigation in a variety of combination trials, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Phase Ib study of Pelcitoclax plus osimertinib in patients with epidermal growth factor receptor,
                                            or EGFR, mutant NSCLC in China;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Phase Ib/II study of Pelcitoclax as a single agent or in combination with other therapeutic
                                            agents in patients with R/R NHL in China.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            Phase I study of Pelcitoclax in combination with cobimetinib in recurrent ovarian and endometrial
                                            cancers.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Plans
for APG-1252</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan
                                            to initiate a Phase I study in China evaluating the safety and PK of APG-1252 as a monotherapy
                                            and in combination in R/R AML.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple
                                            IIT oncology studies to be conducted outside China.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2021, we entered into a cooperative research and development agreement, or CRADA, with the National Cancer Institute, or NCI, of
the National Institutes of Health, or NIH. Pursuant to the CRADA, the Division of Cancer Treatment and Diagnosis, or DTCD, agreed to
sponsor Phase 1, 2 or 3 clinical trials to evaluate Pelcitoclax, alone or in combination with other compounds, for the treatment of cancer
with our support and funding. We expect to collaborate on a series of clinical trials to evaluate the safety and efficacy of Pelcitoclax
in solid tumors. The NCI may also conduct non-clinical correlative studies that focus on exploring the biologic activity of Pelcitoclax,
as well as combination studies of the compound with other targeted agents. As data from the NCI- sponsored studies and our other trials
emerge, we and the NCI will discuss additional studies to support the development of Pelcitoclax.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 129; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>APG-3288&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-3288
is our first disclosed novel, highly potent and selective BTK degrader developed utilizing Ascentage Pharma&#8217;s proprietary proteolysis-targeting
chimera (PROTAC) technology platform. Unlike conventional BTK inhibitors, APG-3288 is designed to act through degradation rather than
inhibition, inducing rapid, potent, highly selective, and sustained degradation of both wild-type BTK and multiple BTK mutants associated
with resistance to existing BTK inhibitors. Critically, this approach blocks the BCR-BTK signalling axis at its source, thereby overcoming
resistance to BTK inhibitors and potentially providing a novel and differentiated therapeutic strategy for BTK-targeted treatment. In
preclinical studies, compared to other BTK degraders in development, APG-3288 demonstrated more potent BTK degradation, higher selectivity,
and more favorable PK properties that highlighted the drug&#8217;s potential.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-3288
received IND clearance from the U.S. FDA in January 2026 and received IND application clearance from the China CDE in February 2026.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">During 2026, we plan to conduct a global Phase I
study evaluating APG-3288&#8217;s PK, safety, tolerability, efficacy data in patients with relapsed/refractory B-cell malignancies, including
in U.S. and China.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APG-5918</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-5918
is a potent, orally bioavailable, and highly selective EED inhibitor. EED is a subunit of PRC2, which plays a role in regulating transcription
of genes. It is believed that some mutations can activate PRC2 and result in silencing of key genes such as tumor suppressors and thereby
allow the cancer to replicate more quickly. APG-5918 is believed to act upon EED and inhibit the PRC2&#8217;s methyltransferase activity.
We believe APG-5918 has demonstrated potential for treating patients with anemia, including beta-thalassemia and CKD-induced anemia.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea028514801_img30.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
study results from our preclinical models of anemia were presented at the 2023 ASH Annual Meeting demonstrating APG-5918 has potential
to improve CKD-induced hemoglobin, or Hb, insufficiency. This study investigates the effects of APG-5918 on Hb and fetal Hb, or HbF,
<i>in vitro </i>in human CD34+ hematopoietic stem cells, or HSCs, from human cord blood and a CKD-induced anemia rodent model.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the HSCs, the mRNA levels associated with Hb increased in a dose-dependent manner with treatment of APG-5918. Hb and HbF proteins were
also dose-dependently upregulated. In the renal anemic rats, APG-5918 was administered orally and both body weight and hematologic parameters,
such as levels of red blood cells and Hb, improved significantly in a dose-dependent manner compared to the control. Based on these results,
we are currently evaluating APG-5918 in an NMPA-regulated, randomized, double-blind, placebo-controlled, Phase 1 single and multi- dose-escalation
trial (NCT05773586) in anemic subjects. We believe this is the first clinical trial in China of an EED inhibitor amongst products with
active trials.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also initiated an FDA-regulated multi-center, open-label, Phase 1 trial (NCT05415098) of APG-5918 to evaluate the safety, pharmacokinetics
and efficacy of APG-5918 in advanced solid tumors or lymphomas, including non-Hodgkin&#8217;s lymphoma, that have progressed or are intolerant
after treatment with approved therapies or for which there are no standard therapies available. The IND for this trial was submitted
to the FDA on May 26, 2022. This clinical trial is currently taking place in China and the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2026, we will advance the clinical development of APG-5918 in oncology and anemia in the U.S. and China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>


</div><!-- Field: Page; Sequence: 130; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
Publication:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font-size: 10pt; vertical-align: top; text-align: justify">
<td style="font-size: 10pt; width: 0.25in"/><td style="font-size: 10pt; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            December 2025, we released the preclinical results on APG-5918 at ASH 2025, demonstrating
                                            that APG-5918 can overcome immunomodulatory drug (IMiD) resistance as a monotherapy as well
                                            as exhibiting synergistic antitumor activity when combined with IMiDs or cereblon E3 ligase
                                            modulators (CELMoDs) in preclinical MM models.</span></td>
</tr></table><div>

</div><p style="font-size: 10pt; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font-size: 10pt; vertical-align: top; text-align: justify">
<td style="font-size: 10pt; width: 0.25in"/><td style="font-size: 10pt; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            June 2025, we released preclinical results of APG-5918 at EHA 2025, demonstrating potent
                                            antitumor activity and synergistic activity with the histone deacetylase inhibitor tucidinostat
                                            in T-cell lymphoma (TCL) models.</span></td>
</tr></table><div>

</div><p style="font-size: 10pt; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="font-size: 10pt; vertical-align: top; text-align: justify">
<td style="font-size: 10pt; width: 0.25in"/><td style="font-size: 10pt; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            April 2025, we released preclinical data on APG-5918 at AACR 2025, demonstrating that APG-5918
                                            showed potent single-agent antitumor activity and enhanced efficacy in combination with enzalutamide
                                            in preclinical prostate cancer models.</span></td>
</tr></table><div>

</div><p style="font-size: 10pt; text-align: left; margin-left: 0pt; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 2.85pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>APG-3288</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 2.85pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-3288
is our first novel, highly potent and selective BTK degrader developed utilizing Ascentage Pharma&#8217;s proprietary proteolysis-targeting
chimera (PROTAC) technology platform. Unlike conventional BTK inhibitors, APG-3288 is designed to act through degradation rather than
inhibition, inducing rapid, potent, highly selective, and sustained degradation of both wild-type BTK and multiple BTK mutants associated
with resistance to existing BTK inhibitors. Critically, this approach blocks the BCR-BTK signalling axis at its source, thereby overcoming
resistance to BTK inhibitors and potentially providing a novel and differentiated therapeutic strategy for BTK-targeted treatment. In
preclinical studies, compared to other BTK degraders in development, APG-3288 demonstrated more potent BTK degradation, higher selectivity,
and more favorable PK properties that highlighted the drug&#8217;s potential.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-3288
received IND clearance from the FDA in January 2026 and received IND application clearance from the China CDE in February 2026.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">During 2026, we plan to conduct a global Phase
I study evaluating APG-3288&#8217;s PK, safety, tolerability, efficacy data in patients with relapsed/refractory B-cell malignancies,
including in U.S. and China.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Discovery
pipeline: protein degraders</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
deep understanding of heterobifunctional molecules and ligase biology has allowed us to develop protein degraders targeting traditionally
undruggable proteins of interest implicated in key oncologic pathways. We believe we have the ability to develop differentiated protein
degraders with improved PK/PD profiles resulting in less off-target effects than observed with degraders in clinical development by others.
We also believe we can develop cancer therapeutics targeted at resistance mechanisms that have traditionally plagued small molecule inhibitors,
with our protein degrader candidates.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 131; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2026, we announced that APG-3288, our first novel, highly potent and selective BTK degrader, received IND clearance
from the FDA and CDE. In addition, we identified and nominated our targeted protein degrader, or TPD, candidate for pre-clinical development.
This orally bioavailable degrader is targeting the p53-MDM2 pathway. In the last twenty years, many highly potent and orally active MDM2
inhibitors have been developed as a way to activate the p53 tumor suppressor gene, and several are currently in clinical development,
including Alrizomadlin. However, inhibition of p53 often leads to upregulation of MDM2, which, in turn, has limited the efficacy of MDM2
inhibitors evaluated by others to date. Therefore, we believe that a degrader approach has the potential to be a transformative new strategy
against these key oncology targets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also identified several compounds from our protein degrader discovery capability that can rapidly reduce levels of the Bcl-xL
protein in human cancer cell lines and thereby inhibiting their growth due to their dependency on Bcl-xL. Based on our initial
studies, we believe our Bcl-xL protein degrader approach has the potential to demonstrate strong antitumor activity along with low
levels of platelet toxicity. We are in the process of selecting and nominating our first Bcl-xL degrader candidate for pre-clinical
development. The potential candidates exhibit high selectivity for the Bcl-xL target, demonstrating potent cellular and degradation
activity, and showing remarkable in vivo efficacy in xenograft mice models.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Competition</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biotechnology and pharmaceutical industries, and the oncology drug sector specifically, are characterized by rapid change in current
standard of care, evolving understanding of disease etiology, fierce competition and strong defense of intellectual property. While we
believe that our platform and our knowledge, experience and scientific resources provide us with competitive advantages, we face competition
from major pharmaceutical and biotechnology companies, academic institutions, governmental agencies and public and private research institutions,
among others.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of our product candidates are approved for the indications for which we conduct clinical trials, they will compete with currently
marketed drugs, as well as any drugs potentially in development. It is also possible that we will face competition from other pharmaceutical
approaches as well as other types of therapies. The key competitive factors affecting the success of all our programs, if approved, are
likely to be their efficacy, safety, convenience, price, level of generic competition, and availability of reimbursement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to products and product candidates targeting the BCR-ABL1 pathway, we are aware of companies that currently have products or
are developing product candidates that can be competitive, including Novartis and Takeda, which are currently marketing asciminib and
ponatinib, respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to product candidates targeting the Bcl-2 pathway, we are aware of companies that currently have products or are developing product
candidates that can be competitive, including AbbVie, which is currently marketing venetoclax.</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to product candidates targeting the MDM2-p53 pathway, we are aware of companies that are currently developing product candidates
that can be competitive, including Astex, Boehringer Ingelheim, and Kartos.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to product candidates targeting the EED pathway, we are aware of companies that are currently developing product candidates that
can be competitive, including Fulcrum and Oric.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our current or potential competitors, either alone or with their collaboration partners, have significantly greater financial resources
and expertise in research and development, manufacturing, pre-clinical studies, conducting clinical trials and marketing approved products
than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated
among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly
through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining
qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as
well as in acquiring technologies complementary to, or necessary for, our programs. Accordingly, our competitors may be more successful
than we may be in developing, commercializing and achieving widespread market acceptance. In addition, our competitors&#8217; products
may be more effective or more effectively marketed and sold than any treatment we or our development partners may commercialize and may
render our product candidates obsolete or noncompetitive before we can recover the expenses related to developing and commercializing
our product candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 132; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>License,
collaboration and other agreements</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
enter into collaborations with biotechnology, pharmaceutical companies and research institutes to advance the development and commercialization
of our product candidates and to supplement our internal pipeline. We seek collaborations that will allow us to retain significant future
participation in product sales through either profit- sharing or royalties paid on net sales. Below is an overview of some of our collaborations
that have had a significant impact or that we expect may in the near term have a significant impact on our financial results. This is
not a complete list, and we have several other collaborations or other agreements with third parties that could affect our results and
financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agreements
with the University of Michigan</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">License
agreement with the University of Michigan</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><span style="font-family: Times New Roman, Times, Serif">In December 2010, and as amended May 2013, February 2016, May 2017,
June 2017, August 2018, December 2018, January 2019, and November 2020, we entered into a license agreement with the Regents of the University
of Michigan, or the Michigan Agreement and the University of Michigan respectively. Under the Michigan Agreement, the University
of Michigan granted to us an exclusive, sublicensable (subject to certain restrictions) license under certain patent rights relating to
Bcl-2 and/or Bcl-xL, IAP inhibitors and MDM2-p53 inhibitors, or the Patent Rights, to make, have made, import, use, market, offer for
sale and sell products covered by the Patents Rights or manufactured using, or employed to practice, a Licensed Process, as defined further
below, or the Licensed Products, and to practice processes or methods covered by the Patent Rights or using a Licensed Product, or the
Licensed Processes in all the fields worldwide.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 4.5pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
Michigan Agreement was amended in August of 2025 by amending and restating the Michigan Agreement and entering into a new license
agreement or the Michigan 2 Agreement. The amended and restated license agreement terms are substantially the same as the Michigan
Agreement, except it does not apply to any new discoveries. The Michigan 2 Agreement terms are substantially the same as the amended
and restated Michigan Agreement except that it applies to any new discoveries as well as adding annual payments and development and
sales milestones.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
must (i) use commercially reasonable efforts to bring a full scope of Licensed Products to market or one or more Licensed Processes to
commercial use through a program for exploiting the Patent Rights (including using commercially reasonable efforts to advance the clinical
program to reach certain commercial, research and developmental milestones before certain dates), (ii) continue diligent marketing efforts
throughout the life of the Michigan Agreement and (iii) do all that is necessary to obtain and retain any government approvals to manufacture
and/or sell Licensed Products and/or use Licensed Processes for all of our relevant activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the entry into the Michigan Agreement, we paid the University of Michigan an upfront fee of US$15 thousand, agreed to
sponsor a research program for a certain period of time for no less than US$600 thousand, and agreed to reimburse current and future
patent expenses incurred by the University of Michigan. We have agreed to pay the University of Michigan a percentage of net sales of
Licensed Products and uses or licenses of Licensed Processes as a royalty. This royalty ranges from the low to mid-single digits and
is subject to certain reductions. In addition, we agreed to pay the University of Michigan a percentage of the revenue we receive from
sublicensing Patent Rights (as defined therein) under the Michigan Agreement. We are required to pay the University of Michigan minimum
annual royalties, which are creditable against the royalties owed for net sales of Licensed Products and uses or licenses of Licensed
Processes and sublicense revenue. These minimum annual royalties vary by certain periods of time and range from amounts of US$50 thousand
up to US$250 thousand. Our royalty obligations will expire on the date of the last to expire of the Patent Rights or until the Michigan
Agreement is terminated. Upon the achievement of certain regulatory and commercial milestones, we are obligated to make milestone payments
of up to US$1.36 million in the aggregate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 4.5pt; margin-bottom: 0pt">Under
the Michigan 2 Agreement, we paid the University of Michigan an upfront fee of US$30 thousand and will pay an annual fee for
2025-2027 and another annual fee for 2028 to 2033. We have agreed to pay the University of Michigan the same percentage of net sales
of Licensed Products and uses or licenses of Licensed Processes as a royalty. This royalty ranges from the low to mid-single digits
and is subject to certain reductions. In addition, we agreed to pay the University of Michigan a declining percentage of the revenue
we receive from sublicensing Patent Rights (as defined therein) under the Michigan Agreement. We are required to pay the University
of Michigan minimum annual royalties, which are creditable against the royalties owed for net sales of Licensed Products and uses or
licenses of Licensed Processes and sublicense revenue. These minimum annual royalties vary by certain periods of time and range from
amounts of US$50 thousand up to US$250 thousand. Our royalty obligations will expire on the date of the last to expire of the Patent
Rights or until the Michigan Agreement is terminated. Upon the achievement of certain development and commercial milestones, we are
obligated to make milestone payments of up to US$8.140 million in the aggregate.</p><div>

</div><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0">&#160;</p><div>

</div><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Under
the amended and restated Michigan Agreement and the Michigan 2 Agreement, the University of Michigan retains the right to control
all filing, prosecution and maintenance of the Patent Rights, as well as interference and disputes (including litigation) regarding
inventorship, but we agree to reimburse these costs. We have the right to direct and control the enforcement and defend the Patent
Rights worldwide for or all fields but must notify the University of Michigan before filing any suit and adhere to the procedures
set forth in both agreements. Both agreements will continue until the last to expire of the Patent Rights, unless terminated
sooner in accordance with such agreements. Both agreements will terminate if we cease to carry on our business or if we fail to make
payments to the University of Michigan, in each case upon written notice by the University of Michigan. The University of Michigan
has the right to terminate both agreements upon any material breach or default by us upon written notice. We have the right to
terminate both agreements upon written notice if we complete certain procedures described in those agreements, including
suspending the manufacture, use and sale of the Licensed Products and Licensed Processes. After the licenses granted under the
agreements terminate, if we have filed patent applications or obtained patents relating to any modification or improvement to the
Licensed Products or the Licensed Processes within the scope of the Patent Rights, we agree upon request to enter into good faith
negotiations with the University of Michigan for the purpose of granting licensing rights to such modifications or improvements in a
timely fashion and under commercially reasonable terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 133; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">BCL-2
license agreements</span></i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2016, and as amended December 2016, we assumed from a third party, and entered into, a series of related agreements with the
University of Michigan and/or Georgetown University, or collectively, the BCL-2 License Agreements. Among other agreements, we assumed,
and entered into a certain (1) license agreement with the University of Michigan and Georgetown University, dated September 2003, and
as amended June 2006, September 2006, November 2007, May 2010, July 2012 and August 2018, or the Michigan-Georgetown Agreement, and (2)
amended and restated license agreement with the University of Michigan, dated August 2011, initially amended and restated June 2010,
and as amended April 2012, November 2016 and August 2018, or the Michigan-Gossypol Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Michigan-Georgetown Agreement, the University of Michigan and Georgetown University granted to us an exclusive, sublicensable (subject
to certain restrictions) license under certain patent rights relating to Bcl-2 and/or Bcl-xL, or the Michigan/Georgetown Patent Rights)
to make, have made, import, export, use, have used, market, offer for sale and sell products covered by the Michigan/Georgetown Patent
Rights or manufactured using, or employed to practice, a Licensed Process, defined further below, or Michigan/Georgetown Licensed Products,
and to practice processes or methods covered by the Michigan/Georgetown Patent Rights, or the Michigan/ Georgetown Licensed Processes,
in the field of therapeutics for human use (and with respect to the Michigan/ Georgetown Licensed Products, also as a prognostic or diagnostic
reagent, or the use in the development of the same solely for use in clinical trials sponsored by us to develop human therapeutics and
not for sale to third parties), or the Michigan/Georgetown Field of Use, worldwide. Upon our written request, the University of Michigan
will enter into good faith negotiations with us to expand the Michigan/Georgetown Field of Use to include veterinary uses and/or prognostic
or diagnostic products (including reagents) for commercial purposes, and our right to request such negotiation will terminate with respect
to prognostic and/or diagnostic products three years after notice is provided by either party to the other of an invention relating to
such expanded use.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Michigan-Gossypol Agreement, the University of Michigan granted to us an exclusive, sublicensable (subject to certain restrictions)
license under certain patent rights relating to Gossypol co-crystals, or the Gossypol Patent Rights, to make, have made, import, export,
use, have used, market, offer for sale and sell products covered by the Gossypol Patent Rights or manufactured, used, imported, offered
for sale or sold using, or employed to practice, a Gossypol Licensed Process, as defined further below, or the Gossypol Licensed Products,
and to practice processes or methods covered in whole or in part by the Gossypol Patent Rights, or the Gossypol Licensed Processes, for
the treatment, palliation, prevention and diagnosis of all human and/or animal diseases, including the measurement, indication and/or
prediction of the pharmacologic response to any of the foregoing, or the Gossypol Field of Use, worldwide. If the University of Michigan
receives notice from a third party that such third party would like to negotiate for a license to any patent or patent application under
the Gossypol Patent Rights for animal uses, or a Veterinary Use Sublicense, the University of Michigan will promptly notify us (date
of such notification, the Notice Date) and request we enter into good faith negotiations with such third party for a Veterinary Use Sublicense.
If the Gossypol Licensed Product identified as the subject of the Veterinary Use Sublicense, or the Sublicense Product, either would
be directly competitive with any Gossypol Licensed Product (i) then sold or under actual development by us or (ii) scheduled to begin
development or sublicensing by us within 24 months of the Notice Date, then we may decline the request for such sublicense and must notify
the University of Michigan of our decision. Upon certain other prescribed conditions in such agreement, the University of Michigan may
negotiate with the third party on our behalf to grant a Veterinary Use Sublicense.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Michigan-Georgetown Agreement, we must (i) use commercially reasonable efforts to obtain and retain any governmental approvals to
manufacture and/or sell the Michigan/Georgetown Licensed Products and/or use Michigan/Georgetown Licensed Processes for all of our relevant
activities, (ii) use commercially reasonable efforts to bring one or more Michigan/Georgetown Licensed Products to market or one or more
Michigan/ Georgetown Licensed Processes to commercial use through a program for exploiting the Michigan/Georgetown Patent Rights (including
using commercially reasonable efforts to advance the clinical program to reach certain commercial, research and developmental milestones
before certain dates), (iii) continue diligent marketing efforts for one or more Michigan/Georgetown Licensed Products or Michigan/Georgetown
Licensed Processes throughout the life of the Michigan-Georgetown Agreement. Michigan/Georgetown Licensed Products used, leased or sold
in the United States must be manufactured substantially in the United States unless a waiver is granted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 134; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Michigan-Gossypol Agreement, we must (i) use commercially reasonable efforts to obtain and retain any governmental approvals to manufacture
and/or sell the Gossypol Licensed Products and/or use Gossypol Licensed Processes for all of our relevant activities, (ii) use commercially
reasonable efforts to bring one or more Gossypol Licensed Products to market or one or more Gossypol Licensed Processes to commercial
use through a program for exploiting the Gossypol Patent Rights (including using commercially reasonable efforts to advance the clinical
program to reach certain commercial, research and developmental milestones before certain dates), (iii) continue diligent marketing efforts
for one or more Gossypol Licensed Products or Gossypol Licensed Processes throughout the life of the Michigan-Gossypol Agreement. Gossypol
Licensed Products used, leased or sold in the United States must be manufactured substantially in the United States unless a waiver is
granted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Michigan-Georgetown Agreement, we agreed to pay the University of Michigan a percentage of net sales of Michigan/Georgetown Licensed
Products and uses of Michigan/Georgetown Licensed Processes as a royalty. This royalty ranges from the low to mid- single digits and
is subject to certain deductions. In addition, we agreed to pay the University of Michigan a percentage of the revenue we receive from
sublicensing Michigan/Georgetown Patent Rights under the Michigan-Georgetown Agreement. We are required to pay the University of Michigan
minimum annual royalties of US$10,000, which are creditable against the royalties owed for net sales of Michigan/ Georgetown Licensed
Products and uses of Michigan/Georgetown Licensed Processes. Our royalty obligations will expire on the date of the last to expire of
the Michigan/Georgetown Patent Rights or until the Michigan- Georgetown Agreement is terminated. Upon the achievement of certain regulatory
and commercial milestones, on a new chemical entity-by-new chemical entity basis for a certain therapeutic area, and for each new chemical
entity in addition to that certain therapeutic area, we are obligated to make milestone payments of up to US$1.15 million in the aggregate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Michigan-Gossypol Agreement, we agreed to pay the University of Michigan a percentage of net sales of Gossypol Licensed Products
and uses of Gossypol Licensed Processes as a royalty. This royalty ranges from the low to mid-single digit and is subject to certain
deductions. In addition, we agreed to pay the University of Michigan a percentage of the revenue we receive from sublicensing our Gossypol
Patent Rights under the Michigan- Gossypol Agreement. We are required to pay the University of Michigan annual royalties of US$2,500,
which are creditable against the royalties owed for net sales of Gossypol Licensed Products and uses of Gossypol Licensed Processes.
Our royalty obligations will expire on the date of the last to expire of the Gossypol Patent Rights or until the Michigan-Gossypol Agreement
is terminated. Upon the achievement of certain regulatory and commercial milestones, on a new chemical entity-by-new chemical entity
basis for a certain therapeutic area, and for each new chemical entity in addition to that certain therapeutic area, we are obligated
to make milestone payments of up to US$1.15 million in the aggregate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Michigan-Georgetown Agreement, the University of Michigan will retain the right to control all aspects of filing, prosecution and
maintenance of the Michigan/Georgetown Patent Rights, but we agree to reimburse these costs (including for interference proceedings)
and have a right to step in if the University of Michigan declines to perform such activities. We have the first option to enforce or
defend the Michigan/Georgetown Patent Rights worldwide for the Michigan/Georgetown Field of Use but must notify the University of Michigan
before filing any suit and adhere to the procedures set forth in the Michigan-Georgetown Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Michigan-Gossypol Agreement, the parties agree to cooperate full to obtain, protect and defend patents arising out of the Gossypol
Patent Rights, with the University of Michigan having the final say on any disputes (but we have a right to step in if the University
of Michigan declines to perform these activities), and we agree to reimburse the costs related to the filing, prosecution, interference
proceedings, and maintenance of the Gossypol Patent Rights. We have the first option to enforce or defend the Gossypol Patent Rights
worldwide for the Gossypol Field of Use but must notify the University of Michigan before filing any suit and adhere to the procedures
set forth in the Michigan-Gossypol Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Michigan-Georgetown Agreement will continue until the last to expire of the Michigan/Georgetown Patent Rights, unless terminated sooner
in accordance with such agreement. The Michigan-Georgetown Agreement will terminate if we cease to carry on our business or if we fail
to make payments due to the University of Michigan, in each case upon written notice by the University of Michigan. Upon material breach,
the University of Michigan has the right to terminate the rights granted with respect to the Michigan/Georgetown Licensed Product or
Michigan/Georgetown Licensed Process at issue upon written notice. We have the right to terminate the Michigan- Georgetown Agreement
upon written notice if we complete certain procedures described in the Michigan- Georgetown Agreement, including suspending our use of
the Michigan/Georgetown Licensed Products and Michigan/Georgetown Licensed Processes. If the Michigan-Georgetown Agreement is terminated
for reasons other than due to expiration of the term, if we have filed patent applications or obtained patents relating to any modification
or improvement to the Michigan/Georgetown Licensed Products or the Michigan/Georgetown Licensed Processes within the scope of the Michigan/Georgetown
Patent Rights, we agree upon request to consider entering into good faith negotiations with the University of Michigan or its future
licensees for the purpose of granting licensing rights to such modifications or improvements in a timely fashion and under commercially
reasonable terms.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 135; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Michigan-Gossypol Agreement will continue until the last to expire of the Gossypol Patent Rights, unless terminated sooner in accordance
with such agreement. The Michigan-Gossypol Agreement will terminate if we cease to carry on our business or if we fail to make certain
payments or reports due to the University of Michigan, in each case upon written notice by the University of Michigan. Upon material
breach, the University of Michigan has the right to terminate the rights granted with respect to the Gossypol Licensed Product or Gossypol
Licensed Process at issue upon written notice. We have the right to terminate the Michigan-Gossypol Agreement upon written notice if
we complete certain procedures described in the Michigan-Gossypol Agreement, including suspending our use of the Gossypol Licensed Products
and Gossypol Licensed Processes. If the Michigan-Gossypol Agreement is terminated for reasons other than due to expiration of the term,
if we have filed patent applications or obtained patents relating to any modification or improvement to the Gossypol Licensed Products
or the Gossypol Licensed Processes within the scope of the Gossypol Patent Rights, we agree upon request to consider entering into good
faith negotiations with the University of Michigan or its future licensees for the purpose of granting licensing rights to such modifications
or improvements in a timely fashion and under commercially reasonable terms.</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Strategic
partnership with Innovent</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2021, we entered into a strategic partnership with Innovent pursuant to the HQP1351 Collaboration and License Agreement among Ascentage
Pharma Group Corp Limited, Innovent and Guangzhou Healthquest Pharma Corp. Limited. Under the HQP1351 Collaboration and License Agreement,
we granted Innovent development and commercialization rights for Olverembatinib and any finished form product comprising Olverembatinib,
or the Licensed Products. Pursuant to the HQP1351 Collaboration and License Agreement, Innovent paid us an upfront payment of US$30 million,
and upon achievement of certain regulatory and commercial milestones Innovent is obligated to make milestone payments of up to an additional
US$115 million in the aggregate. We and Innovent have also agreed to use commercially reasonable efforts to carry out development and
commercialization of the Licensed Products in the Field and for the Territory (as defined below).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
granted an exclusive (except as to us) license to Innovent to develop the Licensed Products and Olverembatinib for the treatment, palliation,
diagnosis or prevention of human and veterinary oncology diseases, or the Field, in the PRC, the Hong Kong Special Administrative Region,
the Macau Special Administrative Region and Taiwan (each a Region, or collectively, the Territory). We also granted an exclusive (except
as to us) license to Innovent to commercialize the Licensed Products in Innovent&#8217;s Covered Cities (as defined below).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
and Innovent agreed to use commercially reasonable efforts to commercialize any Licensed Products for Olverembatinib in the Territory
after regulatory approval has been obtained. From the total potential market within the Territory, we and Innovent established the essential
target market (the Essential Target Market). We are allocated 40% of the Essential Target Market, and Innovent is allocated 60%. From
the Essential Target Market, we and Innovent each selected cities that we, respectively, will have the exclusive right to commercialize
the Licensed Products in, or, in each case of our Company and Innovent, or the Covered Cities. For the five-year period after the first
commercial sale of the first Licensed Product, we and Innovent, and respective affiliates, are prohibited from commercializing a certain
Competing Product (as defined therein) in the Territory.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
retained the exclusive right, and are obligated, to supply Innovent the Licensed Products for use or sale in Innovent&#8217;s Covered
Cities and must use commercially reasonable efforts to fulfill this obligation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
HQP1351 Collaboration and License Agreement will expire on a Licensed Product-by-Licensed Product and Region-by-Region basis between
us and Innovent with respect to such Licensed Product in such country. The HQP1351 Collaboration and License Agreement may be terminated
by either party in the event of an uncured material breach by the other party or in the event the other party becomes subject to specified
bankruptcy, insolvency or similar circumstances. In addition, on a Region-by-Region basis, the HQP1351 Collaboration and License Agreement
may be terminated by Innovent or by us in the event a Licensed Product or another product containing the Licensed Molecule is withdrawn
from the market by a regulatory authority in such Region, for such Region. Innovent may terminate the HQP1351 Collaboration and License
Agreement at will upon specified written notice; provided, that in the event we are not able to commercialize the Licensed Products in
Innovent&#8217;s Covered Cities by a specified date, we have certain rights and obligations. In the event Innovent terminates the HQP1351
Collaboration and License Agreement for our uncured material breach or our specified bankruptcy, insolvency or similar circumstances,
the commercialization license we granted to Innovent will become fully-paid, irrevocable and royalty-free.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 136; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Takeda
exclusive option agreement</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2024, we entered into an exclusive option agreement with Takeda Pharmaceuticals International AG, or Takeda, and our affiliates,
Guangzhou Healthquest Pharma Co., Ltd., and Ascentage Pharma (Suzhou) Co., Ltd., or the Takeda Exclusive Option Agreement, where we granted
to Takeda an exclusive option to enter into an exclusive license agreement, under which Takeda would have the exclusive right (even as
to us and our affiliates) to research, develop, import, export, make, have made, manufacture, have manufactured, use, commercialize,
and otherwise exploit Olverembatinib, or the Compound, and any product comprising Olverembatinib, or the Product. The rights to be granted
under the exclusive license agreement would be for any therapeutic, prophylactic, preventative or diagnostic use in or for animals and
humans, or the Field, and would be granted worldwide, excluding the PRC, the Hong Kong Special Administrative Region, the Macau Special
Administrative Region, Taiwan and the Russian Federation, or the Territory.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the Takeda Exclusive Option Agreement, we were paid
US$100.0 million by Takeda related to intellectual property income and option payment. In aggregate, under the Takeda Exclusive Option
Agreement and the expected terms of the exclusive license agreement, we are eligible to be paid a one-time option exercise fee and certain
development, commercial and sales milestone payments totaling up to approximately US$1.2 billion and royalties in a range equal to 12-19%
of net sales. In addition, in June 2024, we issued and sold to Takeda 24,307,322 ordinary shares, or the Takeda Shares, for an aggregate
purchase price of US$75 million. In connection therewith, we entered into a Registration Rights Agreement with Takeda, granting Takeda
certain registration rights related to the filing of a resale registration statement covering the Takeda Shares, the filing of an unlimited
number of shelf registration statements if the Company is qualified to make such filings, and granting of certain piggyback registration
rights. Takeda&#8217;s registration
rights will terminate when Takeda no longer owns any Takeda Shares. A complete copy of the Registration Rights Agreement is filed as Exhibit
4.15 to this Annual Report on Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0">&#160;</p><div>

</div><p style="text-align: left; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">During the term of the Takeda Exclusive Option Agreement, we retain
full control and decision-making authority, at our expense, over the development activities and strategy related to any Compound or Product
worldwide, including the Territory, subject to certain obligations. Though we retain the sole right and responsibility, at our expense,
to manufacture or have manufactured the Compound and the Product for the Field anywhere in the world, we also agreed to transition the
technology to manufacture the Compound and Product to a third-party contract manufacturing organization, following which we will be eligible
to receive a development milestone payment in the low double-digit millions.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Takeda Exclusive Option Agreement, we agreed to use commercially reasonable efforts to develop and seek regulatory approval for a
Compound and Product for a certain indication in the Territory. For the term of the Takeda Exclusive Option Agreement, we and our affiliates
are prohibited from developing, manufacturing, commercializing or otherwise exploiting any Competing Product (as defined in the Takeda
Exclusive Option Agreement), and we are obligated in certain situations to take certain actions related to our obligation to not develop,
manufacture, commercialize or otherwise exploit any Competing Products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0">As of the date of this Annual Report, Takeda has not exercised its
option under the Takeda Exclusive Option Agreement, which will expire upon the earliest of: (x) the end of the option initiation period
if no option initiation notice was timely provided; (y) the end of the option exercise period if no option exercise notice was timely
provided; or (z) the effective date of the exclusive license agreement. If at the end of the option initiation period or option exercise
period, Takeda has not timely provided an option initiation notice or option exercise notice, as applicable, due to government investigations
under any antitrust or foreign direct investment laws, then the Takeda Exclusive Option Agreement will not automatically terminate, and
Takeda will have the right to issue an option exercise notice at the closing of such investigations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Takeda Exclusive Option Agreement also may be terminated by Takeda or us in the event the other party becomes subject to specified bankruptcy,
insolvency or similar circumstances. In addition, the Takeda Exclusive Option Agreement may be terminated by Takeda or us in the event
of an uncured material breach by the other party. In the event Takeda has the right to terminate the Takeda Exclusive Option Agreement
for our uncured material breach or fraud, then Takeda may, in lieu of termination, have other rights. Takeda may terminate the Takeda
Exclusive Option Agreement at any time in its sole discretion upon providing 30 days prior written notice.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 137; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intellectual
property</i>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><span style="font-family: Times New Roman, Times, Serif">Intellectual
property rights are fundamental to our business. Through our robust research and development, or R&amp;D, platform and research collaborations,
we have strategically developed a global intellectual property portfolio, which includes exclusive licenses to issued patents and patent
applications worldwide with respect to Olverembatinib, Lisaftoclax and our other drug candidates. For Olverembatinib, Healthquest Pharma,
our wholly owned subsidiary, acquired certain relevant patents from Guangzhou Institutes of Biomedicine and Health, Chinese Academy of
Sciences or GIBH Our comprehensive and growing intellectual property portfolio positions us to capture market potential globally.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proprietary nature of, and protection for, our drug candidates and their methods of use are an important part of our strategy to develop
and commercialize novel medicines. We have obtained or licensed patents relating to certain of our drug candidates and are pursuing additional
patent protection for them and for our other drug candidates and technologies. We also rely on trade secrets to protect aspects of our
business that are not amenable to, or that we do not consider appropriate for, patent protection. Moreover, trade secrets can be difficult
to protect. While we have confidence in the measures we take to protect and preserve our trade secrets, such measures can be breached,
and we may not have adequate remedies for any such breach. In addition, our trade secrets may otherwise become known or be independently
discovered by competitors. For more information on these and other risks related to intellectual property, see &#8220;<i>Item 3. Key
Information&#8212;D. Risk Factors&#8212;Risks related to our intellectual property</i>.&#8221; Additionally, we have registered and unregistered
trademarks, including amongst others, our Company name, as well as domain names incorporating some or all of these trademarks.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success will depend significantly on our ability to obtain and maintain patent and other proprietary protection for commercially important
products, technologies, inventions and know-how related to our business and our ability to defend and enforce our patents and other intellectual
property, preserve the confidentiality of our trade secrets and operate without infringing, misappropriating or otherwise violating the
valid and enforceable patents and proprietary rights of third parties. We also rely on know-how, continuing technological innovation
and in-licensing opportunities to develop, strengthen and maintain the proprietary position of our development programs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2025, patent rights held by us relating to our drug candidates include the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Olverembatinib, our material patents consist of two issued U.S. patents, four issued PRC patents, one pending PRC patent application,
and other international patents and patent applications directed to compositions of matter and processes of manufacturing, as well as
one issued U.S. patent, five pending non-provisional U.S. patent applications, three PRC issued patents, two PRC patent applications,
and other international patents and patent applications directed to methods of treatment, as well as one issued U.S. patent, one pending
non-provisional U.S. patent application, one issued PRC patent, and other international patents and patent applications directed to pharmaceutical
formulations, as well as one pending non- provisional U.S. patent application, one issued PRC patent application, and other international
patents and patent applications directed to polymorphs of Olverembatinib. These patents and patent applications, if issued, are expected
to expire between at least 2030 and 2045, without taking into account any possible patent term adjustments or extensions and assuming
payment of all appropriate maintenance, renewal, annuity or other governmental fees. The following table summarizes our material patents
with respect to Olverembatinib:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Olverembatinib</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Type of patent</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Owned
    or licensed</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of <br/>
patents and<br/>
 non-provisional patent<br/>
 applications <br/> (in the U.S.)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Earliest
    possible expiration date of issued patents and <br/> pending patent applications, if issued (notwithstanding any patent term adjustment
    or patent term extension)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%"><span style="font-family: Times New Roman, Times, Serif">Composition of Matter</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Owned</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 3,
    2031</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Methods of Treatment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">April 26, 2044</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Process</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">February 26,&#160;2040</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Formulation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 9,&#160;2039</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Polymorph</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">July 1, 2041</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 138; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Lisaftoclax, our material patents consist of eight pending non-provisional U.S. patent applications, eight issued U.S. patents,
seven pending PRC patent applications, ten issued PRC patents, and other international patents and patent applications directed to methods
of treatment or processes of manufacturing, as well as one pending non-provisional U.S. patent application, one issued U.S. patent, one
issued PRC patent, and other international patents and patent applications directed to polymorphs of Lisaftoclax. We also have an exclusive
license that covers three issued U.S. patents, two PRC issued patents, and other international patents and patent applications, directed
to compositions of matter and methods of treatment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
patents and patent applications, if issued, are expected to expire between at least 2037 and 2043, without taking into account any possible
patent term adjustments or extensions and assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees.
The following table summarizes our material patents with respect to Lisaftoclax:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisaftoclax</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    of patent</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned
    or licensed</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of patents and non-provisional patent applications (in the U.S.)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earliest
    possible expiration date of issued patents and pending patent applications, if issued (notwithstanding any patent term adjustment
    or patent term extension)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 62%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Composition
    of Matter</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensed</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: center">3</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 4, 2037</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method
    of Treatment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 6, 2043</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 1, 2041</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Polymorph</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 5, 2041</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Alrizomadlin, our material patents consist of five pending non-provisional U.S. patent applications, seven issued U.S. patents,
one pending PRC patent application, eight issued PRC patents, and other international patents and patent applications directed to methods
of treatment or processes of manufacturing, as well as one pending non-provisional U.S. patent application, one issued PRC patent and
other international patents and patent applications directed to polymorphs of Alrizomadlin. We also have an exclusive license that covers
one issued U.S. patent, one issued PRC patent, one pending PRC patent application, as well as other international patents and patent
applications directed to compositions of matter.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
patents and patent applications, if issued, are expected to expire between at least 2035 and 2043, without taking into account any possible
patent term adjustments or extensions and assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees.
The following table summarizes our material patents with respect to Alrizomadlin:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alrizomadlin</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    of patent</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned
    or licensed</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of patents and non-provisional patent applications (in the U.S.)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earliest
    possible expiration date of issued patents and pending patent applications, if issued (notwithstanding any patent term adjustment
    or patent term extension)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Composition of Matter</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensed</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: center">1</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 16, 2035</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method of Treatment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 11, 2043</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 10, 2040</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Polymorph</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 22, 2041</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 139; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Pelcitoclax, our material patents consist of two pending non-provisional U.S. patent applications, three issued U.S. patents,
three pending PRC patent applications, four issued PRC patents and other international patents and patent applications directed to methods
of treatment or processes of manufacturing, as well as one issued U.S. patent directed to polymorphs of Pelcitoclax. We also have an
exclusive license that covers one issued U.S. patent, one issued PRC patent, as well as other international patents and patent applications
directed to compositions of matter. These patents, and patent applications, if issued, are expected to expire between at least 2034 and
2041, without taking into account any possible patent term adjustments or extensions and assuming payment of all appropriate maintenance,
renewal, annuity or other governmental fees. The following table summarizes our material patents with respect to Pelcitoclax:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.5pt 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pelcitoclax</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    of patent</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned
    or licensed</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of patents and non-provisional patent applications (in the U.S.)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earliest
    possible expiration date of issued patents and pending patent applications, if issued (notwithstanding any patent term adjustment
    or patent term extension)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Composition of Matter</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensed</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 15,
    2034</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method of Treatment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 1, 2041</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 3, 2040</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Polymorph</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 12, 2041</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.5pt 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to APG-5918, our material patents consist of one issued U.S. patent, one issued PRC patent, as well as other international patent
applications directed to processes of manufacturing. We also have an exclusive license that covers one issued U.S. patent, one pending
non-provisional U.S. patent application, one issued PRC patent, one PRC patent application, as well as other international patents and
patent applications directed to compositions of matter, as well as two pending non-provisional U.S. patent applications, one PRC issued
patent, one PRC patent application, and other international patents and patent applications directed to methods of treatment, as well
as one pending non-provisional U.S. patent application, one PRC patent application, and other international patents and patent applications
directed to pharmaceutical formulations, as well as one pending non- provisional U.S. patent application, one PRC patent application,
and other international patents and patent applications directed to polymorphs of APG-5918. These patents and patent applications, if
issued, are expected to expire between at least 2040 and 2044, without taking into account any possible patent term adjustments or extensions
and assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees. The following table summarizes our
material patents with respect to APG-5918:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-5918</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    of patent</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned
    or licensed</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of patents and non-provisional patent applications (in the U.S.)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earliest
    possible expiration date of issued patents and pending patent applications, if issued (notwithstanding any patent term adjustment
    or patent term extension)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Composition of Matter</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensed</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 14%; text-align: center"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
                                            16, 2040</span></p></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method of Treatment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 12, 2042</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 10, 2041</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formulation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 6, 2044</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Polymorph</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
                                   29, 2043</span></p></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 140; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to APG-2449, our material patents consist of two pending non-provisional U.S. patent application, one issued U.S. patent, two
pending PRC patent applications, three issued PRC patents, as well as other international patent applications directed to methods of
treatment, as well as one issued PRC patent, one pending PRC patent application, and other international patents and patent applications
directed to processes of manufacturing, as well as one pending non-provisional U.S. patent application, one pending PRC patent application,
and other international patents and patent applications directed to polymorphs of APG-2449 .We also have an exclusive license that covers
two issued U.S. patent applications, two issued PRC patent, as well as other international patents and patent applications directed to
compositions of matter. These patents and patent applications, if issued, are expected to expire between at least 2037 and 2044, without
taking into account any possible patent term adjustments or extensions and assuming payment of all appropriate maintenance, renewal,
annuity or other governmental fees. The following table summarizes our material patents with respect to APG-2449:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APG-2449</b></span></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    of patent</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned
    or licensed</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of patents and non-provisional patent applications (in the U.S.)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earliest
    possible expiration date of issued patents and pending patent applications, if issued (notwithstanding any patent term adjustment
    or patent term extension)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Composition of Matter</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensed</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 28, 2037</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method of Treatment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 22, 2044</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Polymorph</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 25, 2044</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to other compounds, we have an exclusive license to other U.S. and PRC patents and patent applications, with issued and pending
international counterparts which generally relate to our efforts to develop other small molecule drugs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict whether the patent applications we pursue will issue as patents in any particular jurisdiction or whether the claims of
any issued patents will provide any proprietary protection from competitors. Even if our pending patent applications are granted as issued
patents, those patents, as well as any patents we license from third parties, may be challenged, circumvented or invalidated by third
parties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries
in which we file, the patent term is 20 years from the date of filing the application. In certain jurisdictions extensions as compensation
for regulatory delays are available. For example, in the United States, a patent&#8217;s term may be lengthened by patent term adjustment,
which compensates a patentee for administrative delays by the USPTO in granting a patent, or may be shortened if a patent is terminally
disclaimed over an earlier-filed co-owned patent. In addition, in certain instances, a patent term can be extended to recapture a portion
of the term effectively lost as a result of the FDA regulatory review period. However, the restoration period cannot be longer than five
years and the total patent term including the restoration period must not exceed 14 years following FDA approval. In certain foreign
jurisdictions similar extensions as compensation for regulatory delays are also available. The actual protection afforded by a patent
varies on a claim- by-claim and country-to-country basis for each applicable product and depends upon many factors, including the type
of patent, the scope of its coverage, the availability of regulatory related extensions, the availability of legal remedies in a particular
country and the validity and enforceability of the patent.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the patent positions of biotechnology and pharmaceutical products and processes like those we intend to develop and commercialize are
generally uncertain and involve complex legal and factual questions. No consistent policy regarding the breadth of claims allowed in
such patents has emerged to date. Changes in either the patent laws or interpretations of patent laws in the United States, the PRC and
other countries may diminish our ability to protect our inventions, and enforce our intellectual property rights and more generally,
could affect the value of our intellectual property. Accordingly, we cannot predict the breadth of claims that may be allowed or enforced
in our patents or in third-party patents.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 141; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biotechnology and pharmaceutical industries are characterized by extensive litigation regarding patents and other intellectual property
rights. Our ability to maintain and solidify our proprietary position for our drug candidates and technology will depend on our success
in obtaining effective claims and enforcing those claims once granted. We do not know whether any of the patent applications that we
may file or license from third parties will result in the issuance of any patents. The issued patents that we own, or may receive in
the future, may be challenged, invalidated or circumvented, and the rights granted under any issued patents may not provide us with proprietary
protection or competitive advantages against competitors with similar technology. Furthermore, our competitors may be able to independently
develop and commercialize similar drugs or duplicate our technology, business model or strategy without infringing our patents. Because
of the extensive time required for clinical development and regulatory review of a drug we may develop, it is possible that, before any
of our drug candidates can be commercialized, any related patent may expire or remain in force for only a short period following commercialization,
thereby reducing the advantage of any such patent.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
seek to protect our proprietary technology and processes, in part, by entering into confidentiality agreements with our consultants,
scientific advisors and contractors and invention assignment agreements with our employees. We also seek to preserve the integrity and
confidentiality of our data and trade secrets by maintaining physical security of our premises and physical and electronic security of
our information technology systems.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we have confidence in these individuals, organizations and systems, agreements or security measures may be breached and we may not have
adequate remedies for any breach. In addition, our trade secrets may otherwise become known or be independently discovered by competitors.
To the extent that our consultants, contractors or collaborators use intellectual property owned by others in their work for us, disputes
may arise as to the rights in related or resulting know-how and inventions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial success will also depend in part on not infringing the proprietary rights of third parties. It is uncertain whether the issuance
of any third-party patent would require us to alter our development or commercial strategies, or our drug candidates or processes, obtain
licenses or cease certain activities. Our breach of any commercialize our drug candidates may have a material adverse impact on us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, substantial scientific and commercial research has been conducted for many years in the areas in which we have focused our
development efforts, which has resulted in third parties having a number of issued patents and pending patent applications relating to
such areas. Patent applications in the United States and elsewhere are generally published only after 18 months from the priority date.
The publication of discoveries in the scientific or patent literature frequently occurs substantially later than the date on which the
underlying discoveries were made. Therefore, patent applications relating to drugs similar to our current product candidates and any
future drug candidates, discoveries or technologies we might develop may have already been filed by others without our knowledge.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information on these and other risks related to intellectual property, see &#8220;<i>Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks
related to our intellectual property</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commercialization</b>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Ascentage Pharma entered an accelerated commercialization
phase driven by a &#8220;dual-engine&#8221; strategy: the cornerstone product, Olverembatinib, achieved substantial growth following the
implementation of NRDLs, while the newly launched product, Lisaftoclax, rapidly scaled following its initial launch during 2025. Throughout
2025, the Company rapidly expanded its commercial footprint, further strengthened its commercialization capabilities, and continued to
grow its in-house sales team. At the same time, the Company remained focused on enhancing product competitiveness through clinical value
and evidence-based data, laying a solid foundation for sustainable long-term growth.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">on: Our in-house commercial team, which includes
sales, marketing, market access, channel management, sales force effectiveness and sales training, includes more than 270 members, the
vast majority of whom possess extensive professional experience in hematology-oncology field. For our two core products, the Company adopted
a specialized, product-dedicated organizational structure. With the continued expansion of the commercial team and capabilities, we progressed
from single-product commercialization to a &#8220;dual-engine&#8221; parallel strategy, supporting sustained growth of our cornerstone
product, Olverembatinib, and the rapid uptake of the new launched product, Lisaftoclax. In 2025, our commercial team covered more than
1,500 hospitals and over 800 pharmacies for our two commercialized products. We also established strategic partnerships with leading pharmaceutical
distributors, achieving national wide drug distribution coverage.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 142; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Manufacturing
and facilities</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">We
have established our own Suzhou facility as our global R&amp;D center and manufacturing facility. The R&amp;D center and the manufacturing
facility were commissioned into use in the second half of 2021 and the fourth quarter of 2022, respectively. We refer to the global R&amp;D
center and manufacturing facility as the Suzhou Manufacturing Center.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">The
Suzhou Manufacturing Center has more than 200,000 square feet of space, and the manufacturing capacity for both oral solid tablet and
capsule formulations is up to 250 million dosage units per year. We also maintain manufacturing capability at the Suzhou Manufacturing
Center for injectable drug products, including lyophilized formulations. We have the necessary licenses and approvals to manufacture
and supply Olverembatinib oral solid tablets for supply for global clinical trials as well as for commercial sales in the China market.
We completed the drug tablet coating, debossing development, and the GMP production of Olverembatinib tablets, thereby preparing for
future applications to the global regulatory authorities including the FDA.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Global Manufacturing Center and quality management system implemented at the site are compliant with the standards of the EU GMP, marking
the achievement of a major milestone that will pave the way for our continued global expansion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Our Global Manufacturing Center can produce and supply Lisaftoclax
for our global clinical trials. In 2025, Lisaftoclax pre-approval inspections and GMP inspections for both drug substance and drug product
were successfully completed through collaboration of Ascentage Pharma and contract development and manufacturing organizations, or CDMOs,
which facilitated Lisaftoclax&#8217;s NDA approval in China. After the NDA approval in July 2025, the first commercial batch of Lisaftoclax
was successfully manufactured and launched to the market for the first prescriptions issued before the end of July 2025.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we lease a facility with a size of approximately 50,000 square feet for R&amp;D and manufacturing in China Medical City, Taizhou,
Jiangsu Province, China, where we produce and supply preclinical test articles and clinical trial materials for some of our drug candidates.
We believe that the existing facilities are adequate for our current needs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees
and human capital</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2025, we had approximately 767 full-time employees, 447 of whom were engaged in research and development activities.
None of our employees are represented by a labor union or covered under a collective bargaining agreement. Our human capital resources
objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees,
advisors and consultants. The principal purposes of our equity and cash incentive plans are to attract, retain and reward personnel through
the granting of share-based and cash-based compensation awards, in order to increase shareholder value and the success of our Company
by motivating such individuals to perform to the best of their abilities and achieve our objectives. We are committed to supporting employee
health and safety in the workplace through a generous health insurance program, as well as fostering an inclusive work environment that
supports our workforce.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
proceedings</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may be subject to various claims and legal actions that arise in the ordinary course of our business. As of the date
of this Annual Report on Form 20-F, we are not a party to any litigation the outcome of which, we believe, if determined adversely to
us, would individually or taken together have a material adverse effect on our business, operating results, cash flows or financial condition.
Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources
and other factors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Government
regulation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
regulation</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Government
authorities in the United States at the federal, state and local level and in other countries regulate, among other things, the research,
development, testing, manufacture, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution,
post-approval monitoring and reporting, marketing and export and import of drug and biological products and medical devices. Generally,
before a new drug, biologic or device can be marketed, considerable data demonstrating its quality, safety and efficacy must be obtained,
organized into a format specific for each regulatory authority, submitted for review and approved by the regulatory authority.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 143; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
drug development</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">In the United
States, the FDA regulates drugs under the FDCA and the Public Health Service Act. Drugs also are subject to other federal, state and
local statutes and regulations. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal,
state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply
with the applicable U.S. requirements at any time during the product development process, approval process or post-market may subject
an applicant to administrative or judicial sanctions. These sanctions could include, among other actions, the FDA&#8217;s refusal to
approve pending applications, withdrawal of an approval, a clinical hold, untitled or warning letters, product recalls or market withdrawals,
product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution,
disgorgement and civil or criminal penalties. Any agency or judicial enforcement action could have a material adverse effect on us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product candidates are considered small molecule drugs and must be approved by the FDA through the new drug application, or NDA, process
before they may be legally marketed in the United States. The process generally involves the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">completion
                                            of extensive preclinical studies in accordance with applicable regulations, including studies
                                            conducted in accordance with good laboratory practices, or GLPs;</span></td>
</tr></table><div>
</div><p style="margin-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">submission
                                            to the FDA of an IND application, which must become effective before human clinical trials
                                            may begin;</span></td>
</tr></table><div>
</div><p style="margin-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
                                            by an independent IRB, DSMBs, and/or ECs at each clinical trial site before each trial may
                                            be initiated;</span></td>
</tr></table><div>
</div><p style="margin-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">performance
                                            of adequate and well-controlled human clinical trials as designed by the study protocol in
                                            accordance with applicable IND regulations, good clinical practice, or GCP, requirements
                                            and other clinical trial-related regulations to establish substantial evidence of the safety
                                            and efficacy of the investigational product for each proposed indication;</span></td>
</tr></table><div>
</div><p style="margin-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">submission
                                            to the FDA of an NDA;</span></td>
</tr></table><div>
</div><p style="margin-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            determination by the FDA within 60 days of its receipt of an NDA to accept the filing for
                                            review;</span></td>
</tr></table><div>
</div><p style="margin-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfactory
                                            completion of an FDA pre-approval inspection of the manufacturing facility or facilities
                                            where the drug will be produced to assess compliance with cGMP requirements to assure that
                                            the facilities, methods and controls are adequate to preserve the drug&#8217;s identity,
                                            strength, quality and purity;</span></td>
</tr></table><div>
</div><p style="margin-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                            FDA audit of the preclinical study and/or clinical trial sites that generated the data in
                                            support of the NDA filing;</span></td>
</tr></table><div>
</div><p style="margin-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA
                                            review and approval of the NDA, potentially including consideration of the views of any FDA
                                            advisory committee, prior to any commercial marketing or sale of the drug in the United States;
                                            and</span></td>
</tr></table><div>
</div><p style="margin-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
                                            with any post-approval commitments and requirements, including the potential requirement
                                            to implement a REMS and the potential requirement to conduct post-approval studies.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
data required to support an NDA are generated in two distinct developmental stages: preclinical and clinical. The preclinical and clinical
testing and approval process requires substantial time, effort and financial resources, and we cannot be certain that any approvals for
any current and future product candidates will be granted on a timely basis, or at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 144; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The preclinical
developmental stage generally involves laboratory evaluations of drug chemistry, formulation and stability, as well as studies to evaluate
toxicity in animals or models, which support subsequent clinical testing. The sponsor must submit the results of the preclinical studies,
together with manufacturing information, analytical data, any available clinical data or literature and a proposed clinical protocol,
to the FDA as part of the IND application. An IND submission is a request for exemption from premarket approval requirements to enable
the lawful shipment of the investigational product and to administer an investigational product to humans and must become effective
before human clinical trials may begin. Preclinical studies include laboratory evaluation of product chemistry and formulation, as well
as in vitro and animal studies to assess the potential for adverse events and in some cases to establish a rationale for therapeutic
use. The conduct of preclinical studies is subject to federal regulations and requirements, including GLP regulations for safety/toxicology
studies. An IND sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data, any
available clinical data or literature and plans for clinical studies, among other things, to the FDA as part of an IND submission. Some
long-term preclinical testing, such as animal tests of reproductive adverse events and carcinogenicity, may continue after the IND submission
is complete. An IND submission automatically becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises
concerns or questions related to one or more proposed clinical trials and places the trial on clinical hold. In such a case, the IND
sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. As a result, submission of an IND may
not result in the FDA allowing clinical trials to commence. IND sponsors follow a process similar to an IND submission, review and approval
when filing a CTA with regulatory agencies in other countries.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clinical
trials</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The clinical stage of development involves the administration of the
investigational product to healthy volunteers or patients under the supervision of qualified investigators, generally physicians or academicians
not employed by or under the trial sponsor&#8217;s control, in accordance with GCP requirements, which include the requirement that all
research subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols
detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria and the
parameters to be used to monitor subject safety and assess efficacy. Each protocol, and any subsequent amendments to the protocol, must
be submitted to the FDA as part of the IND submission. Furthermore, each clinical trial must be reviewed and approved by an IRB, DSMB,
or EC for each institution at which the clinical trial will be conducted to ensure that the risks to individuals participating in the
clinical trials are minimized and are reasonable in relation to anticipated benefits. The IRB must also approve the informed consent form
that must be provided to each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed.
There also are requirements governing the reporting of ongoing clinical trials and completed clinical trial results to public registries.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">A
sponsor who wishes to conduct a clinical trial outside of the United States may, but need not, obtain FDA authorization to conduct the
clinical trial under an IND submission. If a foreign clinical trial is not conducted under an IND submission, the sponsor may submit
data from the clinical trial to the FDA in support of an NDA. The FDA may accept an adequate well-controlled foreign clinical trial not
conducted under an IND submission if the trial was conducted in accordance with the ethical principles contained in the Declaration of
Helsinki pursuant to 21 CFR 312.120, incorporating the 1989 version of such declaration, or with the laws and regulations of the foreign
regulatory authority where the trial was conducted, such as the European Medicines Agency, or EMA, whichever provides greater protection
of the human subjects, and with GCP and GMP requirements, and the FDA is able to validate the data through an onsite inspection, if deemed
necessary, and the practice of medicine in the foreign country is consistent with the United States.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials in the United States generally are conducted in three sequential phases, known as Phase 1, Phase 2 and Phase 3, and may overlap.
Phase 1 clinical trials generally involve a small number of healthy volunteers or disease-affected patients who are initially exposed
to a single dose and then multiple doses of the product candidate. The primary purpose of these clinical trials is to assess the metabolism,
pharmacologic action, tolerability and safety of the drug. Phase 2 clinical trials involve studies in disease-affected patients to determine
the dose and dosing schedule required to produce the desired benefits. At the same time, safety and further pharmacokinetic and pharmacodynamic
information is collected, possible adverse effects and safety risks are identified, and a preliminary evaluation of efficacy is conducted.
Phase 3 clinical trials generally involve a large number of patients at multiple sites and are designed to provide the data necessary
to demonstrate the effectiveness of the product for its intended use, its safety in use and to establish the overall benefit/risk relationship
of the product and provide an adequate basis for product approval. These trials may include comparisons with placebo and/or other comparator
treatments. The duration of treatment is often extended to mimic the actual use of a product during marketing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.45pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif">Post-approval
trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial marketing approval. These trials are used to
gain additional experience from the treatment of patients in the intended therapeutic indication. In certain instances, the FDA may mandate
the performance of Phase 4 clinical trials as a condition of approval of an NDA, or the sponsor may agree to a commitment to conduct
such trials. Progress reports detailing the results of the clinical trials, among other information, must be submitted to the FDA at
least annually. Sponsor is also responsible for submitting written IND safety reports, including reports of serious and unexpected suspected
adverse events, findings from other studies suggesting a significant risk to humans exposed to the drug, findings from animal or in vitro
testing that suggest a significant risk for human subjects and any clinically significant increase in the rate of a serious suspected
adverse reaction over that listed in the protocol or investigator brochure.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><!-- Field: Page; Sequence: 145; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.45pt"><span style="font-family: Times New Roman, Times, Serif">Phase
1, Phase 2 and Phase 3 clinical trials can potentially not be completed successfully within any specified period, if at all. The FDA
or the sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research subjects
or patients are being exposed to an unacceptable health risk. Similarly, an IRB, DSMB, or EC can suspend or terminate approval of a clinical
trial at its institution if the clinical trial is not being conducted in accordance with the IRB, DSMB, or EC&#8217;s requirements or
if the drug has been associated with unexpected serious harm to patients. Additionally, some clinical trials are overseen by an independent
group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board or committee. This group
provides authorization for whether a trial may move forward at designated checkpoints based on access to certain data from the trial.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with clinical trials, companies usually complete additional animal safety studies and also must develop additional information about
the chemistry and physical characteristics of the drug as well as finalize a process for manufacturing the product in commercial quantities
in accordance with cGMP requirements. The manufacturing process, as performed by the manufacturing facility, must be capable of consistently
producing quality batches of our product candidates. Additionally, appropriate packaging must be selected and tested, and stability studies
must be conducted to demonstrate that our product candidates do not undergo unacceptable deterioration over their labeled shelf life.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NDA
review process</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
completion of the clinical trials, data is analyzed to assess whether the investigational product is safe and effective for the proposed
indicated use or uses. The results of preclinical studies and clinical trials are then submitted to the FDA as part of an NDA, along
with proposed labeling, chemistry and manufacturing information to ensure product quality and other relevant data. In short, the NDA
is a request for approval to market the drug in the United States for one or more specified indications and must contain proof of safety
and efficacy for a drug.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
application must include both negative and ambiguous results of preclinical studies and clinical trials, as well as positive findings.
Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a product&#8217;s use or from a number
of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient
in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of the FDA. FDA approval
of an NDA must be obtained before a drug may be legally marketed in the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Prescription Drug User Fee Act of 1992, as amended, or PDUFA, each NDA must be accompanied by a user fee. FDA adjusts the PDUFA user
fees on an annual basis. PDUFA also imposes an annual program fee for each marketed human drug. Fee waivers or reductions are available
in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally,
no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.
In November 2023, the FDA issued a guidance on Real-Time Oncology Review, which allows applicants to provide the FDA with earlier access
to critical efficacy and safety data, which can help streamline the review process and to potentially enable earlier FDA feedback to
the applicant, including earlier feedback on data quality and potential review issues.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">The
FDA reviews all submitted NDAs before it accepts them for filing and may request additional information rather than accepting the NDA
for filing. The FDA must make a decision on accepting an NDA for filing within 60 days of receipt. Once the submission is accepted for
filing, the FDA begins an in-depth review of the NDA. Under the goals and policies agreed to by the FDA under PDUFA, the FDA has 10 months
from the filing date of a new molecular-entity NDA, and six months from the filing date of a new molecular-entity NDA designated for
priority review, to complete its initial review and respond to the applicant, commonly referred to as the ND&#8217;s &#8220;PUDFA date&#8221;.
The FDA does not always meet its PDUFA goal dates for standard and priority NDAs, and the review process is often extended by FDA requests
for additional information or clarification.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">Before
approving an NDA, the FDA will conduct a pre-approval inspection of the manufacturing facilities for the new product to determine whether
they comply with cGMP requirements. The FDA will not approve the product unless it determines that the manufacturing processes and facilities
are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications.
The FDA also may audit data from clinical trials to ensure compliance with GCP requirements. Additionally, the FDA may refer applications
for novel drug products or drug products which present difficult or controversial questions of safety or efficacy to an advisory committee,
typically a panel that includes clinicians and other experts, for review, evaluation and a recommendation as to whether the application
should be approved and under what conditions, if any. The FDA is not bound by recommendations of an advisory committee, but it considers
such recommendations when making decisions on approval. The FDA likely will reanalyze the clinical trial data, which could result in
extensive discussions between the FDA and the applicant during the review process. After the FDA evaluates an NDA, it will issue an approval
letter or a complete response letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information
for specific indications. A complete response letter indicates that the review cycle of the application is complete, and the application
will not be approved in its present form. A complete response letter usually describes all of the specific deficiencies in the NDA identified
by the FDA. The complete response letter may require additional clinical data, additional pivotal Phase 3 clinical trial(s) and/or other
significant and time- consuming requirements related to clinical trials, preclinical studies and/or manufacturing. If a complete response
letter is issued, the applicant may either resubmit the NDA, addressing all of the deficiencies identified in the letter, or withdraw
the application or request the opportunity for a hearing (although such hearings rarely have been granted by the FDA). Even if such data
and information are submitted, the FDA may decide that the NDA does not satisfy the criteria for approval. Data obtained from clinical
trials are not always conclusive and the FDA may interpret data differently than we interpret the same data.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 146; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><!-- Field: Split-Segment; Name: 5 --><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Orphan
drugs</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">Under
the Orphan Drug Act of 1983, as amended, the FDA may grant orphan designation to a drug or biological product intended to treat a rare
disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the United States, or
more than 200,000 individuals in the United States and for which there is no reasonable expectation that the cost of developing and making
the product available in the United States for this type of disease or condition will be recovered from sales of the product.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Orphan drug
designation must be requested before submitting an NDA. After the FDA grants orphan drug designation, it discloses the identity of the
therapeutic agent and its potential orphan use. Orphan drug designation does not convey any advantage in or shorten the duration of the
regulatory review and approval process. If a product that has orphan designation subsequently receives the first FDA approval for the
disease or condition for which it has such designation, the product is entitled to orphan drug exclusivity, which means that the FDA
may not approve any other applications to market the same drug for the same indication for seven years from the date of such approval,
except in limited circumstances, such as a showing of clinical superiority to the product with orphan exclusivity by means of greater
effectiveness, greater safety or providing a major contribution to patient care or in instances of drug supply issues. However, competitors
may receive approval of either a different product for the same indication or the same product for a different indication, the latter
of which could be used off-label in the orphan indication. Orphan drug exclusivity also could block the approval of one of our products
for seven years if a competitor obtains approval before we do for the same product, as defined by the FDA, for the same indication we
are seeking approval, or if a product candidate is determined to be contained within the scope of the competitor&#8217;s product for
the same indication. In response to the court decision in <i>Catalyst Pharms., Inc. v. Becerra</i>, 14 F.4th 1299 (11th Cir. 2021), Congress,
in an amendment to the Orphan Drug Act in the Consolidated Appropriations Act of 2026 or CAA, clarified that orphan drug exclusivity
applies to the FDA&#8217;s same approved use or indication within a rare disease, rather than the entire rare disease or condition. The change
abrogated the decision in <i>Catalyst v. Becerra</i> and aligns the statutory text with the FDA&#8217;s longstanding interpretation.
This change makes explicit that orphan drug exclusivity blocks approval of the same drug only for the same approved use or indication,
not for all uses within the broader designated disease. The amendment also applied retroactively. It is unclear how future litigation,
legislation, agency decisions, and administrative actions will impact the scope of the orphan drug exclusivity. If one of our products
designated as an orphan drug receives marketing approval for an indication broader than that which is designated, it may not be entitled
to orphan drug exclusivity. Orphan drug status in the European Union, or the EU, has similar, but not identical, requirements and benefits.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2024, the U.S. Supreme Court overruled the <i>Chevron </i>doctrine, which gives deference to regulatory agencies&#8217; statutory
interpretations in litigation against federal government agencies, such as the FDA, where the law is ambiguous. This landmark Supreme
Court decision may invite various stakeholders to bring lawsuits against the FDA to challenge longstanding decisions and policies of
the FDA, including the FDA&#8217;s statutory interpretations of market exclusivities and the &#8220;substantial evidence&#8221; requirements
for drug approvals, which could undermine the FDA&#8217;s authority, lead to uncertainty in the industry, and disrupt the FDA&#8217;s
normal operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif"><i>Pediatric
studies and exclusivity</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">Under
the Pediatric Research Equity Act of 2003, an NDA or supplement thereto must contain data that are adequate to assess the safety and
effectiveness of the drug product for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration
for each pediatric subpopulation for which the product is safe and effective. With enactment of the Food and Drug Administration Safety
and Innovation Act of 2012, sponsors must also submit pediatric study plans prior to the assessment data. Those plans must contain an
outline of the proposed pediatric study or studies the applicant plans to conduct, including study objectives and design, any deferral
or waiver requests, and other information required by regulation. The applicant, the FDA, and the FDA&#8217;s internal review committee
must then review the information submitted, consult with each other, and agree upon a final plan. The FDA or the applicant may request
an amendment to the plan at any time. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission
of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data
requirements. Additional requirements and procedures relating to deferral requests and requests for extension of deferrals are contained
in FDASIA. Unless otherwise required by regulation, the pediatric data requirements do not apply to products with orphan designation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt; text-indent: 16.6pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Under
the Best Pharmaceuticals for Children Act of 2002, pediatric exclusivity is another type of non-patent marketing exclusivity in the United
States and, if granted, provides for the attachment of an additional six months of marketing protection to the term of any existing regulatory
exclusivity, including the non-patent and orphan exclusivity. This six-month exclusivity may be granted if an NDA sponsor submits pediatric
data that fairly respond to a written request from the FDA for such data. The data do not need to show the product to be effective in
the pediatric population studied; rather, if the clinical trial is deemed to fairly respond to the FDA&#8217;s request, the additional
protection is granted. If reports of requested pediatric studies are submitted to and accepted by the FDA within the statutory time limits,
whatever statutory or regulatory periods of exclusivity or patent protection cover the product are extended by six months. This is not
a patent term extension, but it effectively extends the regulatory period during which the FDA cannot approve another application. FDA
may only grant pediatric exclusivity if existing patent or exclusivity protections for the drug would otherwise expire at least 9 months
after the grant of the pediatric exclusivity; FDA has 180 days to make a pediatric exclusivity determination once the NDA sponsor submits
study reports required under the written request.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt; text-indent: 16.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expedited
review programs</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA has a fast-track program that is intended to expedite or facilitate the process of reviewing new drugs that meet certain criteria.
Specifically, new drugs are eligible for fast-track designation if they are intended to treat a serious or life-threatening condition
and preclinical or clinical data demonstrate the potential to address unmet medical needs for the condition. Fast-track designation applies
to both the product and the specific indication for which it is being studied. The sponsor can request the FDA to designate the product
for fast-track status any time before receiving NDA approval, but ideally no later than the pre-NDA meeting with the FDA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
product submitted to the FDA for marketing, including under a fast-track program, may be eligible for other types of FDA programs intended
to expedite development and review, such as priority review and accelerated approval. Any product is eligible for priority review if
it treats a serious or life-threatening condition and, if approved, would provide a significant improvement in safety and effectiveness
compared to available therapies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.05pt"></p><div>

</div><!-- Field: Page; Sequence: 147; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
product may also be eligible for accelerated approval if it treats a serious or life-threatening condition and generally provides a meaningful
advantage over available therapies. In addition, such product must demonstrate an effect on a surrogate endpoint that is reasonably likely
to predict clinical benefit or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, or IMM,
which endpoint is reasonably likely to predict an effect on IMM or other clinical benefit. As a condition of approval, the FDA may require
that a sponsor of a drug receiving accelerated approval perform adequate and well-controlled post-marketing clinical trials. The FDA
may withdraw drug approval or require changes to the labeled indication of the drug if confirmatory post-market trials fail to verify
clinical benefit or do not demonstrate sufficient clinical benefit to justify the risks associated with the drug. If the FDA concludes
that a drug shown to be effective can be safely used only if distribution or use is restricted, it may require such post-marketing restrictions
as it deems necessary to assure safe use of the product. The Food and Drug Omnibus Reform Act made several changes to the FDA&#8217;s
authorities and its regulatory framework, including, among other changes, reforms to the accelerated approval pathway, such as requiring
the FDA to specify conditions for post-approval study requirements and setting forth procedures for the FDA to withdraw a product on
an expedited basis for non-compliance with post-approval requirements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
a drug may be eligible for designation as a breakthrough therapy if (a) the product is intended, alone or in combination with one or
more other drugs or biologics, to treat a serious or life-threatening condition and (b) preliminary clinical evidence indicates that
the product may demonstrate substantial improvement over currently approved therapies on one or more clinically significant endpoints.
The benefits of breakthrough therapy designation include the same benefits as fast-track designation, plus intensive guidance from the
FDA to ensure an efficient drug development program. Fast-track designation, priority review, accelerated approval and breakthrough therapy
designation do not change the standards for approval but may expedite the development or approval process.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Post-approval
requirements and commitments</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
approval of a new product, the manufacturer and the approved product are subject to continuing regulation by the FDA, including, among
other things, monitoring and record-keeping requirements, requirements to report adverse events and comply with promotion and advertising
requirements, which include restrictions on promoting drugs for unapproved uses or patient populations, known as &#8220;off-label promotion,&#8221;
and limitations on industry-sponsored scientific and educational activities. Although physicians may prescribe legally available drugs
for off-label uses, manufacturers may not market or promote such uses. Prescription drug promotional materials must be submitted to the
FDA in conjunction with their first use. Further, if there are any modifications to the drug, including changes in indications, labeling
or manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new NDA or NDA supplement,
which may require the development of additional data or preclinical studies and clinical trials.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA may also place other conditions on approvals, including the requirement for a REMS, to assure the safe use of the product. A REMS
could include medication guides, physician communication plans or elements to assure safe use, such as restricted distribution methods,
patient registries and other risk minimization tools. Any of these limitations on approval or marketing could restrict the commercial
promotion, distribution, prescription or dispensing of products. Product approvals may be withdrawn for noncompliance with regulatory
standards or if problems occur following initial marketing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product
reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity
or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved
labeling to add new safety information, imposition of post-market studies or clinical studies to assess new safety risks or imposition
of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions on the marketing
    or manufacturing of the product, complete withdrawal of the product from the market, or product recalls;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines, warning letters, or
    holds on post-approval clinical studies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal of the FDA to approve
    pending applications or supplements to approved applications;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension or revocation of
    product approvals;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product seizure or detention;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal to permit the import
    or export of products; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">injunctions or the imposition
    of civil or criminal penalties.</span></td></tr>
  </table><div>

</div><p style="margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs may be promoted
only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce
the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label
uses may be subject to significant liability.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 148; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><i>FDA
regulation of medical devices and companion diagnostics</i></span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">A
therapeutic product may rely upon an in vitro companion diagnostic for use in selecting the patients that will be more likely to respond
to that therapy. If an in vitro diagnostic is essential to the safe and effective use of the therapeutic product and if the manufacturer
wishes to market or distribute such diagnostic for use as a companion diagnostic, then the FDA will require separate approval or clearance
of the diagnostic as a companion diagnostic to the therapeutic product. According to FDA guidance, an unapproved or uncleared companion
diagnostic device used to make treatment decisions in clinical trials of a drug generally will be considered an investigational medical
device unless it is employed for an intended use for which the device is already approved or cleared. If used to make critical treatment
decisions, such as patient selection, the diagnostic device generally will be considered a significant risk device under the FDA&#8217;s
Investigational Device Exemption, or IDE, regulations. The sponsor of the diagnostic device will be required to comply with the IDE regulations
for clinical studies involving the investigational diagnostic device. According to the guidance, if a diagnostic device and a drug are
to be studied together to support their respective approvals, both products can be studied in the same clinical trial, if the trial meets
both the requirements of the IDE regulations and the IND regulations. The guidance provides that depending on the details of the clinical
trial protocol, the investigational product(s), and subjects involved, a sponsor may seek to submit an IDE alone (e.g., if the drug has
already been approved by FDA and is used consistent with its approved labeling), or both an IND and an IDE.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">At
a high level, medical devices are classified by FDA into one of three classes based on their risk to users. A Class I device is considered
low risk and is typically exempt from premarket review. A Class II device is considered moderate risk and is typically subject to premarket
review in the form of the 510(k) notification and clearance process. A Class III medical device is considered high risk and is typically
subject to premarket review in the form of the Premarket Approval or PMA process. Pursuing FDA approval/clearance of an in vitro companion
diagnostic would require either a 510(k) PMA, or possibly a de novo classification for that diagnostic if there is not an applicable
predicate device. The review of companion diagnostics involves coordination of review with the FDA&#8217;s Center for Devices and Radiological
Health. In June 2023, the FDA issued guidance on a voluntary pilot program on oncology drug products used with certain in vitro diagnostic
tests, which is intended to provide greater transparency regarding the minimum performance characteristics necessary for certain oncology
diagnostic tests. In April 2024, the FDA published a final rule regarding phasing out its enforcement discretion for most laboratory-developed
tests and to amend the FDA&#8217;s regulations to make explicit that in vitro diagnostics are medical devices under the FDCA, including
when the manufacturer of the diagnostic product is a laboratory. These proposed changes and other regulatory changes pertaining to diagnostic
products can increase the cost and time needed to develop new diagnostic tests and to bring them to the market.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>510(k)
clearance process</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.4pt"><span style="font-family: Times New Roman, Times, Serif">To
obtain 510(k) clearance, a pre-market notification is submitted to the FDA demonstrating that the proposed device is substantially equivalent
to a &#8220;predicate device,&#8221; a previously cleared 510(k) device or a device that was in commercial distribution before May 28,
1976 for which the FDA has not yet required the submission of a PMA application. The FDA&#8217;s 510(k) clearance process may take three
to 12 months from the date the application is submitted and filed with the FDA but may take longer if the FDA requests additional information,
among other reasons. In some cases, the FDA may require clinical data to support substantial equivalence. In reviewing a pre-market notification
submission, the FDA may request additional information, which may significantly prolong the review process. Notwithstanding compliance
with all these requirements, clearance is never assured. After a device receives 510(k) clearance, any subsequent modification of the
device that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, will
require a new 510(k) clearance or require a PMA. In addition, the FDA may make substantial changes to industry requirements, including
which devices are eligible for 510(k) clearance, which may significantly affect the process.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>De
novo classification process</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a new medical device does not qualify for the 510(k) pre-market notification process because no predicate device to which it is substantially
equivalent can be identified, the device is automatically classified into Class III. The Food and Drug Administration Modernization Act
of 1997 established a different route to market for low to moderate risk medical devices that are automatically placed into Class III
due to the absence of a predicate device, called the &#8220;Request for Evaluation of Automatic Class III Designation,&#8221; or the
de novo classification process. This process allows a manufacturer whose novel device is automatically classified into Class III to request
down-classification of its medical device into Class I or Class II on the basis that the device presents low or moderate risk, rather
than requiring the submission and approval of a PMA. If the manufacturer seeks reclassification into Class II, the manufacturer must
include a draft proposal for special controls that are necessary to provide a reasonable assurance of the safety and effectiveness of
the medical device. The FDA may reject the reclassification petition if it identifies a legally marketed predicate device that would
be appropriate for a 510(k) or determines that the device is not low to moderate risk and requires PMA or that general controls would
be inadequate to control the risks and special controls cannot be developed. Obtaining FDA marketing authorization, de novo down-classification,
or approval for medical devices is expensive and uncertain, and may take several years, and generally requires significant scientific
and clinical data.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PMA
process</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PMA process, including the gathering of clinical and nonclinical data and the submission to and review by the FDA, can take several years
or longer. The applicant must prepare and provide the FDA with reasonable assurance of the device&#8217;s safety and effectiveness, including
information about the device and its components regarding, among other things, device design, manufacturing and labeling. PMA applications
are subject to an application fee. In addition, PMAs for medical devices must generally include the results from extensive preclinical
and adequate and well-controlled clinical trials to establish the safety and effectiveness of the device for each indication for which
FDA approval is sought. In particular, for a diagnostic, the applicant must demonstrate that the diagnostic produces reproducible results.
As part of the PMA review, the FDA will typically inspect the manufacturer&#8217;s facilities for compliance with the Quality System
Regulation, which imposes extensive testing, control, documentation, and other quality assurance and GMP requirements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 149; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
U.S. regulatory matters</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Healthcare
providers and third-party payors play a primary role in the recommendation and prescription of any drug candidates for which we obtain
marketing approval, or for which we may provide contracted promotional services to third parties. Our current and future arrangements
with healthcare providers, third-party payors, customers and others may expose us to broadly applicable fraud and abuse and other healthcare
laws and regulations (at the federal and state level), which may constrain the business or financial arrangements and relationships through
which we research, as well as, sell, market and distribute any products for which we obtain marketing approval. In addition, once our
product is approved in the U.S., we may be subject to transparency laws and patient privacy and security regulation by both the federal
government and the states in which we conduct our business. The applicable federal, state and foreign healthcare laws and regulations
that may affect our ability to operate include, but are not limited to:</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: left; font-size: 10pt">The federal Anti-Kickback Statute, or AKS, which prohibits, among other
things, persons and entities, including a prescription drug or medical device manufacturer (or a party acting on its behalf), from knowingly
and willfully soliciting, receiving, offering or paying any remuneration that is intended to induce or reward referrals, including the
purchase, recommendation, order or prescription of a particular drug, for which payment may be made under a federal healthcare program,
such as Medicare or Medicaid. This statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on the one
hand and prescribers, purchasers and formulary managers on the other hand. Although there are several statutory exceptions and regulatory
safe harbors protecting certain common activities from prosecution, they are drawn narrowly, and practices that involve remuneration intended
to induce prescribing, purchasing or recommending or arranging for the prescription or purchase of any drug product may be subject to
scrutiny if they do not qualify for an exception or safe harbor. Moreover, the Affordable Care Act, or the ACA, provides that the government
may assert that a claim including items or services resulting from a violation of the federal AKS constitutes a false or fraudulent claim
for purposes of the civil False Claims Act of 1863, or FCA;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            federal civil and criminal false claims laws and civil monetary penalty laws impose a range
                                            of prohibitions and compliance considerations. For example, the False Claims Act (&#8220;FCA&#8221;)
                                            prohibits individuals or entities from, among other things, knowingly presenting, or causing
                                            to be presented, claims for payment to, or approval by, the federal government that are false,
                                            fictitious or fraudulent or knowingly making, using or causing to be made or used, a false
                                            record or statement material to a false or fraudulent claim to avoid, decrease or conceal
                                            an obligation to pay money to the federal government. This includes the civil FCA that can
                                            be enforced by private citizens through civil whistleblower or qui tam actions. Claims resulting
                                            from a violation of the federal AKS or the FDCA constitute a false or fraudulent claim for
                                            purposes of the FCA. Promotion that is deemed to be &#8220;off label&#8221; can also be the
                                            basis of FCA exposure. The DOJ can impose exclusions from federal health care programs and/or
                                            penalties for parties who engage in such prohibited conduct;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.75pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
                                            law includes provisions established under the Health Insurance Portability and Accountability
                                            Act of 1996&#160;(&#8220;HIPAA&#8221;), as amended by the Health Information Technology for
                                            Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;) and its implementing regulations
                                            addressing healthcare fraud and false statements relating to healthcare matters. The healthcare
                                            fraud statute prohibits knowingly and willfully executing, or attempting to execute, a scheme
                                            to defraud any healthcare benefit program, including private payors. The false statements
                                            statute prohibits knowingly and willfully falsifying, concealing or covering up a material
                                            fact or making any materially false, fictitious or fraudulent statement in connection with
                                            the delivery of or payment for healthcare benefits, items or services.&#160;&#160;A violation
                                            of these statutes is a felony and may result in fines, imprisonment or exclusion from governmental
                                            programs. Similar to the federal AKS, a person or entity does not need to have actual knowledge
                                            of the statute or specific intent to violate it in order to have committed a violation;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HIPAA,
                                            as amended by HITECH and its implementing regulations, also imposes obligations on certain
                                            covered entity healthcare providers,&#160;&#160;health&#160;&#160;plans, and healthcare clearinghouses as
                                            well as their business associates a that perform certain services involving the use or disclosure
                                            of individually identifiable health information, including mandatory contractual terms, with
                                            respect to safeguarding the privacy, security and transmission of individually identifiable
                                            health information. HITECH created new tiers of civil monetary penalties, made civil and
                                            criminal penalties directly applicable to business associates, and gave state attorneys authority
                                            to file civil actions for damages or injunctions in federal courts to enforce HIPAA laws
                                            and seek attorneys&#8217; fees and costs;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.75pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            federal physician payment transparency requirements, sometimes referred to as the &#8220;Physician
                                            Payments Sunshine Act,&#8221; requires applicable manufacturers of covered drugs, devices,
                                            biologics and medical supplies for which payment is available under government healthcare
                                            programs to annually report to the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;)
                                            information related to certain payments or other transfers of value made or distributed to
                                            physicians, certain non-physician practitioners and teaching hospitals, as well as ownership
                                            and investment interests held by such healthcare professionals and their immediate family
                                            members; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.75pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">analogous
                                            state and foreign laws and regulations, such as state anti-kickback and false claims laws
                                            which may apply to sales or marketing arrangements and claims involving healthcare items
                                            or services reimbursed by non- governmental third-party payors, including private insurers,
                                            state laws that require biotechnology companies to comply with the biotechnology industry&#8217;s
                                            voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal
                                            government; state and local laws that require drug manufacturers to report information related
                                            to payments and other transfers of value to physicians and other healthcare providers or
                                            marketing expenditures and require the registration of their sales representatives, state
                                            laws that require biotechnology companies to report information on the pricing of certain
                                            drug products, and state and foreign laws that govern the privacy and security of health
                                            information in some circumstances (such as Washington&#8217;s My Health, My Data Act, which,
                                            among other things, provides for a private right of action), many of which differ from each
                                            other in significant ways and often are not preempted by HIPAA, thus complicating compliance
                                            efforts.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.75pt; text-align: left; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 150; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt">Pricing and rebate programs must also comply with the Medicaid rebate
requirements of the U.S. Omnibus Budget Reconciliation Act of 1990 the Veterans Healthcare Act of 1992 which established the 340B program,
and other rebates or discounts including those required or amended in the Medicare Modernization Act of 2003, the ACA and in the Inflation
Reduction Act. If products are made available to authorized users of the Federal Supply Schedule of the General Services Administration,
additional laws and requirements apply. Manufacturing, sales, promotion and other activities also are potentially subject to federal and
state consumer protection and unfair competition laws. In addition, the distribution of pharmaceutical and/or medical device products
is subject to additional requirements and regulations, including extensive record-keeping, licensing, reporting, storage and security
requirements intended to prevent the unauthorized sale of pharmaceutical and/or medical device products. Products must meet applicable
child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act of 1970 as well as other applicable consumer safety
requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
failure to comply with any of these laws or regulatory requirements subjects firms to possible legal or regulatory action. Depending
on the circumstances, failure to meet applicable regulatory requirements can result in significant civil, criminal and administrative
penalties, including damages, fines, disgorgement, imprisonment, exclusion from participation in government funded healthcare programs,
such as Medicare and Medicaid, integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits
and future earnings, injunctions, requests for recall, seizure of products, total or partial suspension of production, denial or withdrawal
of product approvals or refusal to allow a firm to enter into supply contracts, including government contracts.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif"><i>U.S.
patent-term restoration and regulatory exclusivity</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Patent term
restoration can refer to two processes that may add time to the life of a patent for FDA-regulated products, a Patent Term Adjustment
(PTA) and a Patent Term Extension (PTE). Both mechanisms potentially extend patent exclusivity. PTA is related to the patent prosecution
while PTE is related to regulatory approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">PTA provides
for addition of time to the patent term based on delays by the patent office during the patent examination process. The length of the
PTA is assigned by the patent office at the time of granting of the patent application. The patentee then may request reconsideration
within two (2) months of the determination by the patent office and if the patentee does not agree with the determination they have 180
days to file suit in the Eastern District of Virginia for judicial review. In the future, we may seek reconsideration if a PTA if we
disagree with a PTA determination made by the patent office.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">PTE provides for an extension of a patent&#8217;s term based on the
time taken by FDA for regulatory review. Depending upon the timing, duration and specifics of FDA approval of any future product candidates,
some of our U.S. patents may be eligible for PTE. The Hatch-Waxman Act permits extension of the patent term of up to five years as compensation
for patent term lost during product development and FDA regulatory review process. PTE, however, cannot extend the remaining term of a
patent beyond a total of 14 years from the product&#8217;s approval date. The PTE period is generally one-half the time between the effective
date of an IND or the issue date of the patent, whichever is later, and the submission date of an NDA plus the time between the submission
date of an NDA or the issue date of the patent, whichever is later, and the approval of that application, except that the review period
is reduced by any time during which the applicant failed to exercise due diligence. Only one patent applicable to an approved drug is
eligible for the PTE and the application for the PTE must be submitted prior to the expiration of the patent and within 60 days of FDA
granting &#8220;permission to commercially market&#8221;. The USPTO, in consultation with the FDA, reviews and approves the application
for any PTE. In the future, we may apply for PTE for our currently owned or licensed patents to add patent life beyond its current expiration
date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant NDA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Regulatory
exclusivity provisions under the FDCA also can delay the submission or the approval of certain applications. The FDCA provides a five-year
period of non-patent data exclusivity within the United States to the first applicant to gain approval of an NDA for a new chemical entity.
A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is
the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review
an abbreviated new drug application, or ANDA, or a 505(b)(2) NDA submitted by another company for a generic version of such drug where
the applicant does not own or have a legal right of reference to all the data required for approval, which thus is termed &#8220;data&#8221;
exclusivity because it proscribes the submission of an application based on other&#8217;s data as opposed to the approval of an application.
However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement with
respect to one or more patents listed for the drug in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations
publication. The FDCA also provides three years of marketing exclusivity for a NDA, 505(b)(2) NDA or supplement to an existing NDA if
new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the
FDA to be essential to the approval of the application, for example, new indications, dosages or strengths of an existing drug. This
three-year exclusivity which is termed &#8220;market&#8221; exclusivity because it proscribes the approval of an application which would
lead to market entry as opposed to the submission of an application. This regulatory exclusivity covers only the conditions of use associated
with the new clinical investigations and does not prohibit the FDA from approving ANDAs for drugs containing the original active agent.
Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full
NDA would be required to conduct or obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical
trials necessary to demonstrate safety and effectiveness or generate such data themselves.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></span></p><div>


</div><!-- Field: Page; Sequence: 151; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif"><i>U.S.
coverage and reimbursement</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Sales of our products will depend, in part, on the extent to which
they are covered by third-party payors, such as government health programs, commercial insurance and managed healthcare organizations.
There is uncertainty related to third-party payor coverage and reimbursement of newly approved products. In the United States, government-sponsored
plans, principal decisions about reimbursement for certain new products are typically made by CMS subject to coverage requirements for
federal programs. CMS decides whether and to what extent, a new product will be covered and reimbursed under Medicaid, Medicare, and 340B,
subject to applicable regulations and laws. Private third-party payors often follow CMS&#8217;s decisions regarding coverage and reimbursement
to a substantial degree. Medicare Part B (physician-administered drugs) typically covers drugs deemed reasonable and medically necessary.
Medicare Part D (self-administered drugs) includes requirements to cover certain therapeutic classes of drugs, including all or substantially
all drugs in protected classes, which include oncology. Medicaid typically covers FDA-approved drugs where the manufacturer has a Medicaid
agreement in place. However, plans and plan administrators may use other utilization management tools, including prior authorization,
requirements to try another therapy first (step edits), or cost sharing. Commercial plans and providers have more flexibility, although
may still be subject to minimum coverage requirements. Accordingly, decisions regarding the extent of coverage and amount of reimbursement
to be provided for any of our products will be made on a payor-by-payor basis.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increasingly,
third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the
prices charged for medical products. Further, such payors are increasingly challenging the price, examining the medical necessity and
reviewing the cost effectiveness of medical product candidates. There may be especially significant delays in obtaining coverage and
reimbursement for newly approved drugs. Third-party payors may limit coverage to specific product candidates on an approved list, known
as a formulary, which might not include all FDA-approved drugs for a particular indication. We may need to conduct expensive pharmaco-economic
studies to demonstrate the medical necessity and cost effectiveness of our products. As a result, the coverage determination process
is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products
to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their
companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical
or biological products, will apply to companion diagnostics. In most foreign countries, the proposed pricing for a drug must be approved
before it may be lawfully marketed. The requirements governing drug pricing and reimbursement vary widely from country to country. For
example, the EU provides options for its Member States to restrict the range of medicinal products for which their national health insurance
systems provide reimbursement and to control the prices of medicinal products for human use. A Member State may approve a specific price
for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing
the medicinal product on the market. There can be no assurance that any country that has price controls or reimbursement limitations
for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our products. Historically, products
launched in the EU do not follow price structures of the United States and generally prices tend to be significantly lower.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
healthcare reform</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The United
States government, state legislatures and foreign governments have shown significant interest in implementing cost containment programs
to limit the growth of government-paid healthcare costs, including price- controls, restrictions on reimbursement and requirements for
substitution of generic products for branded prescription drugs. For example, the current U.S. administration is pursuing measures to
reduce the cost of drugs in the United States, such as issuing two Executive Orders (EO) in 2025 directing federal agencies to take action
to reduce the prices of drugs sold in the United States to match the lowest price available for the same drugs in comparably developed
nations. It is currently unclear how, and to what extent, these measures may be implemented, and what impact their implementation would
have on our Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The Medicare
Prescription Drug, Improvement, and Modernization Act of 2003, or the MMA, established the Medicare Part D program to provide a voluntary
prescription drug benefit to Medicare beneficiaries. Coverage requirements, required discounts, penalties, and pricing have later been
amended under the ACA and the Inflation Reduction Act (IRA), passed in 2022. The IRA directs the federal government, through CMS, to
select and set the prices of certain medicines approved by the FDA after 9 years (NDA) or 13 years (BLA), in both Part B and Part D.
It also requires manufacturers of approved drugs to provide discounts on drugs through the Medicare Drug Rebate program in Part D and
imposes penalties on manufacturers for price increases above a certain rate of inflation in Parts B and D. The IRA also limits patient
out-of-pocket costs in total for certain covered drugs and specifically for certain drug types in Part D, including insulin and vaccines
in both Parts B and D.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Under Part
D, Medicare beneficiaries may enroll in private prescription drug plans that cover outpatient, or self-administered, prescription drugs
that cover outpatient, or self-administered prescription drugs. Part D prescription drug plan sponsors can develop its own drug formulary
that identifies which drugs it will cover, the level of cost sharing, and any utilization requirements, such as prior authorization.
However, Part D prescription drug formularies must include drugs within each defined therapeutic category and class of covered Part D
drugs, though not necessarily all the drugs in each category or class. There are six projected classes in Medicare Part D, 1) antidepressants;
2) antipsychotics; 3) anticonvulsants; 4) immunosuppressants for treatment of transplant rejection; 5) antiretrovirals; and 6) antineoplastics,
where Part D plans are required to cover all or substantially all drugs, although the plans can require prior authorization or step therapy
in certain circumstances. Any formulary used by a Part D prescription drug plan must be developed and reviewed by a pharmacy and therapeutic
committee. Federal reimbursement and out-of-pocket limits in the Part D program may increase demand for products for which we receive
marketing approval. However, negotiated prices for our products after rebates and discounts may be lower than the prices we might otherwise
obtain; federal programs require additional rebates and discounts that are not required by commercial payers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Drug coverage in Medicare Part B includes physician-administered drugs
judged reasonable and medically necessary by CMS. Reimbursement is determined by a formula established by CMS, typically drawn from the
drug&#8217;s Average Sales Price reported by the manufacturer. As noted, the IRA also included certain reforms affecting Part B drugs and their
cost-sharing. Drugs used incident to a hospital stay in Medicare are covered in Part A in typically through a bundled payment system established
by CMS. Commercial insurance plans often follow CMS coverage.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></span></p><div>


</div><!-- Field: Page; Sequence: 152; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">Various industry
stakeholders, including pharmaceutical companies and the Pharmaceutical Research and Manufacturers of America, have initiated lawsuits
against the federal government, asserting that the price negotiation provisions of the IRA are unconstitutional. The impact of these
judicial challenges, legislative, executive, and administrative actions and any future healthcare measures and agency rules implemented
by the government on us and the pharmaceutical industry as a whole is unclear. The implementation of cost containment measures or other
healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our product candidates
if approved.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The ACA contains
provisions that may reduce the profitability of drug products through increased rebates for drugs reimbursed by Medicaid programs, extension
of Medicaid rebates to Medicaid managed care plans, mandatory discounts for certain Medicare Part D beneficiaries and annual fees based
on pharmaceutical companies&#8217; share of sales to federal health care programs. The Medicaid Drug Rebate Program requires pharmaceutical
manufacturers to enter into and have in effect a national rebate agreement with t HHS as a condition for states to receive federal matching
funds for the manufacturer&#8217;s outpatient drugs furnished to Medicaid patients. The minimum Medicaid rebate, applied to drug sales
in Medicaid Managed care and fee-for-service, on most branded prescription drugs of 23.1% of AMP with rebate calculation for &#8220;line
extensions.&#8221; Additionally, for a drug product to receive federal reimbursement under the Medicaid or Medicare Part B programs or
to be sold directly to U.S. government agencies, the manufacturer must extend discounts, calculated based on the AMP and Medicaid rebate
amounts, to entities eligible to participate in the 340B drug pricing program. &#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Additionally,
there has been heightened governmental scrutiny recently over the manner in which drug manufacturers set prices for their marketed products,
which has resulted in several Congressional inquiries and proposed and enacted federal and state legislation designed to, among other
things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs and reform
government program reimbursement methodologies for drug products. The American Rescue Plan Act of 2021 eliminated the statutory cap on
Medicaid Drug Rebate Programs rebates that manufacturers pay to state Medicaid programs. Elimination of this cap may require pharmaceutical
manufacturers to pay more in rebates than it receives on the sale of products, which could have material impact on our business. &#160;</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and
biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and
marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk
purchasing. For example, a number of states are considering or have recently enacted state drug price transparency and reporting laws
that could substantially increase our compliance burdens and expose us to greater liability under such state laws once we begin commercialization.
These and other health reform measures that are implemented may have a material adverse effect on our operations. We are unable to predict
the future course of federal or state healthcare legislation in the United States directed at broadening the availability of healthcare
and containing or lowering the cost of healthcare. These and any further changes in the law or regulatory framework that reduce our revenue
or increase our costs could have a material and adverse effect on our business, financial condition and results of operations. The continuing
efforts of the government, insurance companies, managed care organizations, and other payors of healthcare services and medical products
to contain or reduce costs of healthcare and/or impose price controls may adversely affect the demand for our product candidates, if
approved, and our ability to achieve or maintain profitability.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Drug
approval outside of the United States</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to regulations in the United States, we must obtain the requisite approvals from regulatory authorities in countries outside
the U.S. prior to the commencement of clinical studies or marketing of the product in those countries. Certain countries outside the
U.S. have a similar process that requires the submission of a clinical study application much like the IND prior to the commencement
of human clinical studies. The approval process varies from country to country and the time may be longer or shorter than that required
to obtain FDA approval. The requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary
greatly from country to country and may require us to perform additional pre-clinical or clinical testing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC
regulation</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the PRC, we operate in an increasingly complex legal and regulatory environment. We are subject to a variety of PRC laws, rules and regulations
affecting many aspects of our business. This section sets forth a summary of the principal PRC laws, rules and regulations that we believe
are relevant to our business and operations in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 153; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Introduction</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
strictly supervises and regulates the development, approval, manufacturing and distribution of drugs. The specific regulatory requirements
applicable depend on whether the drug is made and finished in China, which is referred to as a domestically manufactured drug, or made
abroad and imported into China in finished form, which is referred to as an imported drug, as well as the approval or &#8220;registration&#8221;
category of the drug. For both imported and domestically manufactured drugs, China typically requires regulatory approval for a CTA to
conduct clinical trials in China and submit China clinical trial data, prior to applying for marketing approval. For a domestically manufactured
drug, there is also a requirement to have a drug manufacturing license for a facility in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2017, the drug regulatory system entered a new and significant period of reform. The General Office of the State Council and the General
Office of the Central Committee of the Communist Party of China jointly issued the Opinion on Deepening the Reform of the Evaluation
and Approval System to Encourage Innovation in Drugs and Medical Devices, or the Innovation Opinion, in October 2017. The expedited programs
and other advantages under this and other recent reforms encourage drug manufacturers to seek marketing approval in China first, manufacture
domestically, and develop drugs in high priority disease areas, such as oncology.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
implement the regulatory reform introduced by the Innovation Opinion, the National People&#8217;s Congress, or the NPC, and the National
Medical Products Administration (formerly the China Food and Drug Administration, or the CFDA), or the NMPA, has been revising the fundamental
laws, regulations and rules regulating pharmaceutical products and the industry, which include the framework law known as the PRC Drug
Administration Law, or Drug Administration Law. The Drug Administration Law was promulgated by the SCNPC on September 20, 1984, and last
amended on August 26, 2019 and took effect as of December 1, 2019. The Drug Administration Law is implemented by a high-level regulation
issued by the State Council of the People&#8217;s Republic of China, or the State Council, referred to as the Implementing Regulations
of the PRC Drug Administration Law. The NMPA has its own set of regulations further implementing Drug Administration Law; the primary
one governing CTAs, marketing approval, and post-approval amendment and renewal is known as the Drug Registration Regulation, or DRR.
The DRR was promulgated by the State Food and Drug Administration (the predecessor of CFDA and NMPA), or the SFDA, on February 28, 2005,
and the latest amendment of DRR promulgated by SAMR, in January 2020 took effect as of July 1, 2020. PRC drug regulation is set to become
increasingly stringent and standardized as the NMPA and other regulatory authorities issue more and more circulars and regulations to
implement reforms.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Principal
regulatory authorities</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the PRC, the principal regulatory authorities for drugs are the NMPA, the National Health Commission (formerly known as the National
Health and Family Planning Commission), or the NHC, and the National Healthcare Security Administration, or the NHSA. The NMPA is the
department in charge of the pharmaceutical industry of China. It is responsible for drafting the laws and regulations related to pharmaceuticals
and medical devices, making policy planning, formulating departmental regulations, organizing the development and issuance of pharmaceutical
and medical device standards, classification, and management systems, such as national formulary, and supervising implementation. The
Center for Drug Evaluation, or the CDE, is the technical evaluation unit for drug registration with NMPA. It is mainly responsible for
conducting technical evaluation on the drugs applying for registration and verifying the relevant drug registrations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NHC is the primary national regulator for public health and family planning management. It is primarily responsible for drafting national
health policies, supervising and regulating public health, healthcare services and health emergency systems, coordinating the reform
of medical and health systems, organizing the formulation of national drug policies and national essential medicine systems, launching
early warning mechanisms for the monitoring of the use and clinical comprehensive evaluation of medicines, as well as drug shortages,
providing suggestions on the pricing policy of national essential medicines and regulating the operation of medical institutions and
practicing of medical personnel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NHSA, a new authority established in May 2018, directly reports to the State Council and is responsible for the management of the healthcare
security system. It is primarily responsible for drafting and implementing policies and standards on medical insurance, maternity insurance,
and medical assistance, supervising and administering the healthcare security funds, formulating a uniform medical insurance catalog
and payment standards on drugs, medical disposables, and healthcare services and formulating and supervising the implementation of the
bidding and tendering policies for drugs and medical disposables.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 154; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-clinical
research and animal experiment</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NMPA requires preclinical data to support registration applications for imported and domestic drugs. Pursuant to the DRR, nonclinical
safety evaluation study for drugs must be carried out by organizations with quality management standard certification for non-clinical
safety evaluation study for drugs and must comply with the quality management standard for non-clinical safety evaluation study for drugs.
On August 6, 2003, the SFDA (the predecessor of CFDA and NMPA) promulgated the Administrative Measures for Good Laboratories Practice
for Non-clinical Drug Research, which was revised on July 27, 2017, to improve the quality of non- clinical research, and began to conduct
the Good Laboratories Practice. Pursuant to the Circular on Administrative Measures for Certification of Good Laboratory Practice for
Non-clinical Laboratory issued by the SFDA on April 16, 2007 and amended on January 19, 2023 by the NMPA, which became effective on July
1, 2023, the NMPA is responsible for the certification of non-clinical research institutions nationwide and local provincial medical
products administrative authorities is in charge of the daily supervision of non-clinical research institution. The NMPA decides whether
an institution is qualified for undertaking pharmaceutical non-clinical research by evaluating such institution&#8217;s organizational
administration, its research personnel, its equipment and facilities and its operation and management of non-clinical pharmaceutical
projects. A Good Laboratory Practice Certification will be issued by the NMPA if all the relevant requirements are satisfied, which will
also be published on the NMPA&#8217;s website.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Regulations for the Administration of Affairs Concerning Experimental Animals promulgated by the State Science and Technology
Commission on November 14, 1988 and amended on January 8, 2011, July 18, 2013 and March 1, 2017, respectively, by the State Council,
the Administrative Measures on Good Practice of Experimental Animals jointly promulgated by the State Science and Technology Commission
and the State Bureau of Quality and Technical Supervision on December 11, 1997, and the Administrative Measures on the Certificate for
Experimental Animals (Trial) promulgated by the Ministry of Science and Technology and other regulatory authorities on December 5, 2001,
using and breeding experimental animals is subject to rules and performing experimentation on animals requires a Certificate for Use
of Laboratory Animals.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registration
categories</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to engaging with the NMPA on research and development and approval, an applicant must determine the registration category for its product
candidate (with such determination to be confirmed with the NMPA), which will determine the application requirements for its clinical
trial and marketing application. Drug marketing registration applications are subject to three categories, namely traditional Chinese
drugs, chemical drugs and biological products. Among them, the registration applications of chemical drugs is categorized by innovative
chemical drugs, improved new chemical drugs, generic chemical drugs and others, and the registration applications of biological products
is categorized by innovative biological products, improved new biological products and biological products on the market (including biological
similar drugs) and others.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registration Category of Biological Products and the Data Requirements for Declaration, issued by NMPA on June 29, 2020 and became effective
on July 1, 2020, replaced the former category of therapeutic biological products and stipulated that the therapeutic biological products
should be classified into three categories: Category I refers to therapeutic biological products that have not been marketed anywhere
in the world; Category II refers to improved new therapeutic biological products; and Category III refers to therapeutic biological products
that have been marketed in China or abroad.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expedited
programs</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NMPA and its predecessors has adopted several expedited review and approval mechanisms since 2009 and created additional expedited programs
in recent years that are intended to encourage innovation. Applications for these expedited programs can be submitted together with the
registration package or after the registration submission is admitted for review by the CDE. The Announcement of Three Documents Including
&#8220;Working Procedures for Review of Breakthrough Therapeutics Drugs (Interim)&#8221; promulgated by the NMPA on July 7, 2020 clarifies
that during clinical trials of drugs, innovative drugs or improved new drugs that are used to prevent and treat severely life threatening
diseases for which there are no available effective prevention and treatment methods or there is sufficient evidence to show such drugs
have obvious clinical advantages compared with existing treatment methods, etc., applicants can apply for breakthrough therapeutic drug
program in Phase 1 and Phase 2 clinical trials, usually no later than the start of Phase 3 clinical trials.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
admitted to one of these expedited programs, an applicant will be entitled to more frequent and timely communication with reviewers at
the CDE, expedited review and approval and more agency resources throughout the review approval process.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NMPA also permits conditional approval of certain medicines based on early phase China clinical trial data or on foreign approval clinical
data. Post-approval, the applicant may need to conduct one or more post-market studies. The agency has done this for drugs that meet
unmet clinical needs for life-threatening illnesses and for drugs that treat orphan indications. In 2018, NMPA and NHC established a
conditional approval program for drugs designated by the CDE that have been approved in the United States, European Union and Japan within
the last 10 years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clinical
trials and marketing approval</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of preclinical studies, a sponsor typically needs to conduct clinical trials in China for registering a new drug. The materials
required for this application and the data requirements are determined by the registration category. The NMPA has taken several steps
to increase efficiency for approving CTAs, and it has also significantly increased monitoring and enforcement of the Administrative Regulations
of Quality of Drug Clinical Practice, or the PRC&#8217;s GCP, to ensure data integrity. The PRC&#8217;s GCP was initially promulgated
by the SFDA on August 6, 2003, and the latest version came into force on July 1, 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 155; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trial
approval</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
clinical trials conducted in China for new drug registration purposes must be approved and conducted at pharmaceutical clinical trial
institutions. In October 2014, the CFDA, the NHC and the National Administration for Chinese Medicine issued an Administration Rule for
the Project of Clinical Trial Conducted by Medical and Healthcare Institution, pursuant to which, clinical trials conducted by medical
and healthcare institutions may only be conducted in projects approved by such medical and healthcare institution, and after the approval
of such clinical trial project, such medical and healthcare institution must file such approval with the medical and healthcare authority
that issues its operating license for records.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 30, 2015, the CFDA promulgated the Notice on Issuing the International Multi-Center Clinical Trial Guidelines (Trial), or the
Multi-Center Clinical Trial Guidelines, which took effect as of March 1, 2015, aiming to provide guidance for the regulation of application,
implementation, and administration of international multi- center clinical trials, or IMCCT, in China. Pursuant to such guidelines, IMCCT
applicants may simultaneously perform clinical trials in different centers using the same clinical trial protocol. Applicants may make
use of the data derived from the international multi-center clinical trials for application to CFDA for approval of an NDA after satisfying
certain requirements under the Guidelines.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 10, 2017, the CFDA promulgated the Decision on Adjusting Items concerning the Administration of Imported Drug Registration, pursuant
to which, if the IMCCT of a drug is conducted in China, the IMCCT drug does not need to be approved or entered into either a Phase II
or III clinical trial in a foreign country, except for vaccines, and the application for drug marketing authorization can be submitted
directly after the completion of the IMCCT. With respect to applications for imported innovative chemical drugs and therapeutic biological
products, the marketing authorization in the country or region where the foreign drug manufacturer is located will not be required.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Drug
clinical trial registration</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015, the CFDA began to issue an umbrella approval for all phases (typically three) of a new drug clinical trial, instead of issuing
approval phase by phase. For certain types of new drug candidates, CTAs may be prioritized over other applications and put in a separate
expedited queue for approval. The NMPA has now adopted a system for clinical trials of new drugs where trials can proceed if, after 60
business days, the applicant has not received any objections from the CDE. China is also expanding the number of trial sites by changing
from a clinical trial site certification procedure into a notification procedure. According to the DRR, after the completion of the pharmaceutical,
pharmacological, and toxicological research of the drug clinical trial, the applicant may submit relevant research materials to CDE for
applying for the approval to conduct drug clinical trial. The CDE will organize pharmaceutical, medical, and other technicians to review
the application and to decide whether to approve the drug clinical trial within 60 days of the date of acceptance of the application.
Once the decision is made, the result will be notified to the applicant through the website of the CDE and, if no notice of decision
is issued within the time limit, the application of clinical trial shall be deemed as approval. In addition, the applicant must, prior
to conducting the drug clinical trial, register the information of the drug clinical trial plan, etc. on the Drug Clinical Trial Information
Platform. During the drug clinical trials, the applicant must update registration information continuously and register information
of the outcome of the drug clinical trial upon completion. The applicant is responsible for the authenticity of the drug clinical trial
information published on the platform. On September 6, 2013, the CFDA released the Announcement on Drug Clinical Trial Information Platform,
pursuant to which, applicants must complete trial pre-registration within one month after obtaining the clinical trial approval to obtain
the trial&#8217;s unique registration number and must complete registration of certain follow-up information before the first subject&#8217;s
enrollment in the trial. If approval of the foregoing pre-registration and registration is not obtained within one year after obtaining
the clinical trial approval, the applicant must submit an explanation, and if the procedure is not completed within three years, the
clinical trial approval will be automatically be annulled.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Human
genetic resources approval</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 2, 2015, the Ministry of Science and Technology issued the Service Guide for Administrative Licensing Items concerning Examination
and Approval of Sampling, Collecting, Trading, Exporting Human Genetic Resources, or Taking Such Resources out of the PRC, which provides
that non-PRC-invested sponsors that sample and collect human genetic resources in clinical trials shall be required to file with the
China Human Genetic Resources Management Office through its online system. On October 26, 2017, the Ministry of Science and Technology
issued the Circular on Optimizing the Administrative Examination and Approval of Human Genetic Resources, which simplified the approval
for sampling and collecting human genetic resources for the purpose of commercializing a drug in the PRC. The State Council issued the
Regulations on the Administration of Human Genetic Resources, or the HGR Regulation, which became effective on July 1, 2019 and was amended
on May 1, 2024. The HGR Regulation regulates the collection, preservation, usage and external provision of China&#8217;s human genetic
resources. According to this regulation, &#8220;human genetic resource&#8221; includes human genetic resource materials and information.
Human genetic resource materials refer to organs, tissues, cells and other genetic materials containing human genome, genes and other
genetic materials. Human genetic resource information refers to information, such as data, generated by human genetic resources materials.
The Ministry of Science and Technology is responsible for the management of human genetic resources at the national level, and the administrative
departments of science and technology under the provincial governments are responsible for the management of human genetic resources
at local level. Non-PRC entities, non-PRC individuals and such entities established or actually controlled thereby are not allowed to
collect or preserve China&#8217;s human genetic resources (including organs, tissues, cells and other genetic materials of human genome
and gene) or provide human genetic resources abroad, while they are prohibited from using China&#8217;s human genetic resources unless
they have obtained an approval from relevant PRC government authority or have filed with relevant government authority for international
cooperation with a Chinese entity. The HGR Regulation formalized the approval requirements pertinent to research collaborations between
Chinese and non-PRC-owned entities. Pursuant to the new rule, a new notification system (as opposed to the advance approval approach
originally in place) is put in place for clinical trials using China&#8217;s human genetic resources at clinical institutions without
involving the export of human genetic resources outside of China. On May 26, 2023, the Ministry of Science and Technology issued the
Implementing Rules of the Administrative Regulations on Human Genetic Resources, effective from July 1, 2023, which further provided
specific provisions on the collection, preservation, utilization and external provision of human genetic resources of the PRC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 156; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trial
exemptions and acceptance of non-PRC data</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NMPA may reduce requirements for clinical trials and data, depending on the drug and the existing data. The NMPA has granted waivers
for all or part of trials and has stated that it will accept data generated abroad (even if not part of a global study), including early
phase data, that meets its requirements. On July 6, 2018, the NMPA issued the Technical Guidance Principles on Accepting Foreign Drug
Clinical Trial Data, or the Guidance Principles, as one of the implementing rules for the Innovation Opinion. According to the Guidance
Principles, the data of non- PRC clinical trials must meet the authenticity, completeness, accuracy and traceability requirements and
such data must be obtained consistent with the relevant requirements under the PRC&#8217;s GCP of the International Conference on Harmonization
of Technical Requirements for Registration of Pharmaceuticals for Human Use, or ICH. Sponsors must be attentive to potentially meaningful
ethnic differences in the subject population.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NMPA now officially permits, and its predecessor agencies have permitted on a case-by-case basis in the past, drugs approved outside
of China to be approved in China on a conditional basis without the need for pre-approval clinical trials inside China. Specifically,
on October 23, 2018, the NMPA and the NHIC issued the Procedures for Reviewing and Approval of Clinical Urgently Needed Overseas New
Drugs, which established a program permitting drugs that have been approved within the last ten years in the United States, European
Union or Japan and that (1) treat orphan diseases, (2) prevent or treat serious life-threatening illnesses for which there is either
no effective therapy or prevention in China, or (3) prevent or treat serious life-threatening illnesses and the non-PRC-approved drug
would have clear clinical advantages. Applicants will be required to establish a risk mitigation plan and may be required to complete
trials in China after the drug is marketed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clinical
trial process and good clinical practices</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the DRR, a clinical trial consists of Phases I, II, III and IV as well as a bioequivalence trial. Based on the characteristics of
drugs and the research objective, the research contents must include clinical pharmacology research, exploratory clinical trial, confirmatory
clinical trial and post-marketing research. The NMPA requires that the different phases of clinical trials in China receive ethics committee
approval and comply with the PRC&#8217;s GCP. The NMPA conducts inspections to assess the PRC&#8217;s GCP compliance and will cancel
the CTA if it finds substantial issues.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
improve the quality of clinical trials, the CFDA promulgated the PRC&#8217;s GCP on August 6, 2003, which was further amended on April
23, 2020 and came into effect on July 1, 2020. To ensure the quality of clinical trials and the safety of human subjects, the PRC&#8217;s
GCP provides comprehensive and substantive requirements on the design and conduct of clinical trials in China. In particular, the PRC&#8217;s
GCP enhances the protection for study subjects and tightens the control over bio-samples collected under clinical trials. The PRC&#8217;s
GCP stipulated that the sponsor will bear the expenses for medical treatment and the corresponding compensation for any human subject
who is harmed or dies due to reasons connected with the clinical trial. The sponsor and investigator will pay the human subject the compensation
or indemnification in a timely manner. Pursuant to the Innovation Opinion, the accreditation of the institutions for drug clinical trials
will be subject to record-filing administration. The conduct of clinical trials must adhere to the PRC&#8217;s GCP, and the protocols
must be approved by the ethics committees of each study site. Pursuant to the newly amended Drug Administration Law, and the Regulations
on the Administration of Drug Clinical Trial Institution jointly promulgated by NMPA and NHC on November 29, 2019, and effective from
December 1, 2019, drug clinical trial institutions must be under filing administration. Entities that only conduct analysis of biological
samples related to clinical trials of drugs do not need to be filed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>New
drug application and approval</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of clinical trials, a sponsor may submit clinical trial data to support marketing approval for the drug. For imported drugs,
this means issuance of an imported drug license. For NDAs in China, sponsors must submit data derived from domestically manufactured
drugs in support of a drug approval. Under the current regime, upon approval of the registration application, the NMPA will first issue
a new drug certificate to the applicant. Only when the applicant is equipped with relevant manufacturing capability will the NMPA issue
a Drug Approval Serial Number, which is effectively the marketing approval allowing the holder to market/ commercialize the drug in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Opinions on the Reform of Evaluation and Approval System for Drugs and Medical Devices and Equipment promulgated on August 9,
2015, the State Council published the policy for carrying out a pilot plan for the drug marketing authorization holder mechanism.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the newly amended Drug Administration Law, under the drug marketing authorization holder mechanism, an enterprise or a research and
development institution which has obtained a drug registration certificate is eligible to be a pharmaceutical marketing authorization
holder, and this pharmaceutical marketing authorization holder shall be responsible for nonclinical laboratory studies, clinical trials,
production and distribution, post-market studies, and the monitoring, reporting, and handling of adverse reactions in connection with
pharmaceuticals in accordance with the provisions of the Drug Administration Law. The pharmaceutical marketing authorization holder may
engage contract manufacturers for manufacturing, provided that the contract manufacturers are licensed and may engage pharmaceutical
distribution enterprises with drug distribution license for the distribution activities. Upon the approval of the medical products administrative
department under the State Council, a drug marketing authorization holder may transfer the drug marketing license and the transferee
will have the capability of quality management, risk prevention and control, and liability compensation to ensure the safety, effectiveness,
and quality controllability of drugs, and fulfill the obligations of the drug marketing license holder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 157; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Manufacturing
and distribution</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the newly amended Drug Administration Law and the implementing measures of the Drug Administration Law, all facilities that manufacture
drugs in China must receive a Drug Manufacturing License with an appropriate &#8220;scope of manufacturing&#8221; from the local drug
regulatory authority. This license must be renewed every five years. Similarly, to conduct sales, importation, shipping and storage,
or distribution activities, a company must obtain a Drug Distribution License with an appropriate &#8220;scope of distribution&#8221;
from the local drug regulatory authority, subject to renewal every five years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
has formed a &#8220;Two Invoice System&#8221; to control distribution of drugs. The &#8220;Two-Invoice System&#8221; generally requires
that no more than two invoices may be issued throughout the distribution chain, with one from the manufacturer to a distributor and another
from the distributor to the end-user hospital. This excludes the sale of products invoiced from the manufacturer to its wholly owned
or controlled distributors, or for imported drugs, to their exclusive distributor, or from a distributor to its wholly owned or controlled
subsidiary (or between the wholly owned or controlled subsidiaries). However, the system still significantly limits the options for companies
to use multiple distributors to reach a larger geographic area in China. Compliance with the Two-Invoice System will become a prerequisite
for pharmaceutical companies to participate in procurement processes with public hospitals, which currently provide most of China&#8217;s
healthcare. Manufacturers and distributors that fail to implement the Two-Invoice System may lose their qualifications to participate
in the bidding process for centralized purchasing, a process used by the NHSA to negotiate the prices of drugs and medical devices with
manufacturers, aiming to reduce costs and ensure consistent access to essential healthcare products across the country. Non-compliant
manufacturers may also be blacklisted from engaging in drug sales to public hospitals in a locality.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Two-Invoice System was first implemented in 11 provinces that are involved in pilot comprehensive medical reforms, but the program has
expanded to nearly all provinces, which have their own individual rules for the program.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Advertising
and promotion of pharmaceutical products</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
has a strict regime for the advertising of approved drugs. No unapproved drugs may be advertised. The definition of an advertisement
is very broad, and it can be any media that directly or indirectly introduces the product to end users. There is no clear line between
advertising and any other type of promotion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
advertisement for drugs requires an approval from a local drug regulatory authority, and the content of an approved advertisement may
not be altered without filing a new application for approval. An enterprise seeking to advertise a prescription drug may do so only in
medical journals jointly designated by NMPA and the NHC, and the advertisement for a prescription drug shall tag &#8220;this advertisement
is for medical and pharmaceutical professionals reading only.&#8221; Drug advertisements are subject to strict content restrictions,
which prohibit recommendations by doctors and hospitals and guarantees of effectiveness. Advertising that includes content that is outside
of the drug&#8217;s approval documentation, off-label content, is prohibited. False advertising can result in civil suits from end users
and administrative liability, including fines. In addition to advertisements, non- promotional websites that convey information about
a drug must go through a separate approval process by a local drug regulatory authority.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Post-marketing
surveillance</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the amended Drug Administration Law, the drug marketing authorization holder is responsible for the monitoring, reporting and handling
of adverse reactions in connection with pharmaceuticals in accordance with the provisions of Drug Administration Law. Marketing authorization
holders, pharmaceutical manufacturer, pharmaceutical distributors, and medical institutions will regularly inspect the quality, efficacy
and adverse reactions of drugs manufactured, distributed and used by them. Cases of suspected adverse reactions will be promptly reported
to the drug administrative authorities and the competent health administrative authority. The drug marketing authorization holder will
stop selling, notify the relevant pharmaceutical distributors and medical institutions to stop sales and use, recall sold drugs, promptly
announce recall information if the drugs have quality issues or other safety hazards.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>National
reimbursement drug list</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 3, 2015, the General Office of the State Council issued the Outline for the Planning of the National Medical and Health Service
System (2015-2020), which aimed to establish a basic medical and healthcare system that covers both rural and urban citizens by 2020.
Participants of the national medical insurance program and their employers, if any, are required to contribute to the insurance program
monthly. Program participants are eligible for full or partial reimbursement of the costs of medicines included in the National Drug
Catalog for Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance, or the National Reimbursement Drug List,
or the NRDL.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 158; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NHSA, the Ministry of Human Resources and Social Security, together with other government authorities, have the power to determine which
medicines are listed in the NRDL. Medicines listed in the NRDL are divided into two parts, List A and List B. List A drugs are widely
used clinical treatments with good efficacy and lower prices compared to similar drugs. Patients purchasing medicines included in List
A will be reimbursed the purchase price through the basic medical insurance program in full. List B drugs are clinical treatments with
good efficacy and slightly higher prices compared to List A drugs. Patients purchasing medicines included in List B are required to pay
a certain percentage of the purchase price and obtain reimbursement for the remainder of the purchase price through the basic medical
insurance program.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NRDL is always linked to centralized purchasing, and is regularly updated to include new drugs, adjust the reimbursement status of existing
drugs, or remove some drugs that are no longer eligible. On December 7, 2023, the NHSA and the Ministry of Human Resources and Social
Security released the 2023 NRDL, the scope of which was expanded to cover 3,088 drugs in total.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
significant PRC regulations affecting our business activities in the PRC</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations of foreign investment</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
establishment, operation and management of corporate entities in China are governed by the Company Law of the PRC, or the PRC Company
Law, which was adopted by the SCNPC in December 1993, implemented in July 1994, and subsequently amended in December 1999, August 2004,
October 2005, December 2013 and October 2018. Under the PRC Company Law, companies are generally classified into two categories: limited
liability companies and companies limited by shares. The PRC Company Law also applies to foreign-invested limited liability companies.
Pursuant to the PRC Company Law, where laws on foreign investment have other stipulations, such stipulations shall prevail. The most
recent amendment of the PRC Company Law was adopted in December 2023 and came into effect on July 1, 2024, which introduced multiple
updates to the current PRC Company Law with regard to, among others, the capital contribution liability, corporate governance structure
and responsibilities of directors, supervisors, senior managers, controlling shareholders and actual controllers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
activities in China by foreign investors are governed by the Guiding Foreign Investment Direction, which was promulgated by the State
Council on February 11, 2002 and came into effect on April 1, 2002, and the latest Special Administrative Measures (Negative List) for
Foreign Investment Access (2021), or the Negative List, which was promulgated by the Ministry of Commerce of the PRC, or MOFCOM, and
the National Development and Reform Commission on December 27, 2021 and took effect on January 1, 2022. The Negative List sets out in
a unified manner the restrictive measures, such as the requirements on shareholding percentages and management, for the access of foreign
investments, and the industries that are prohibited for foreign investment. The Negative List covers 12 industries, and any field not
falling in the Negative List are administered under the principle of equal treatment to domestic and foreign investment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 15, 2019, the NPC promulgated the Foreign Investment Law of the PRC, or FIL, which became effective on January 1, 2020 and replaced
Foreign Investment Enterprise Law of the PRC (1986) (as amended in 2000 and 2016). Pursuant to FIL, the foreign-invested enterprises
are entitled to pre-establishment national treatment and must comply with the special entry administrative measures (as provided in a
negative list). FIL provides the free inward and outward transfer of the contributions, profits, capital gains, etc. of the foreign investor
within the territory of the PRC in RMB or a foreign currency in accordance with the law and a foreign investment information reporting
system and emphasizes the protection of the intellectual property rights of foreign investors and foreign-invested enterprises.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2019, for the purpose of further promoting the foreign investment administration and simplifying the administrative procedures,
the MOFCOM and the SAMR promulgated the Measures on Reporting of Foreign Investment Information, which became effective on January 1,
2020, and suspended the Interim Measures for Record-filing Administration of the Incorporation and Change of Foreign-invested Enterprises
on the same date. Under this regulation, an information reporting system applies to foreign investors&#8217; mergers and acquisitions
of domestic non-foreign-invested enterprises and strategic investments in listed companies, provided that they comply with the implementation
of special access administrative measures prescribed by the PRC regulators and do not involve the mergers and acquisitions of affiliates.
Specifically, under the information reporting system, where a new foreign-invested enterprise is incorporated or a non-foreign invested
enterprise changes to a foreign-invested enterprise through acquisition, merger or other means, such incorporation or change no longer
requires approval or record-filing of MOFCOM, but shall be reported online to the commerce administrative authorities through the Enterprise
Registration System and the National Enterprise Credit Information Publicity System, together with the registration with the relevant
department of the SAMR through the same systems.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations of environment protection</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to Chinese environmental protection laws and regulations promulgated by state and local governments concerning environmental
protection regarding construction projects, the use, discharge and disposal of toxic and hazardous materials, and the discharge and disposal
of wastewater, solid waste and waste gases and industrial noise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Environmental Protection Law of the PRC, or the Environmental Protection Law, which was promulgated by the SCNPC on and became
effective as of December 26, 1989, and amended on April 24, 2014 and came into force on January 1, 2015, all enterprises and institutions
which discharge pollutants must adopt measures to prevent and control pollution and damage to the environment from waste gas, waste water,
waste residues, medical waste, dust, malodorous gases, radioactive substances, noise, vibration, ray radiation and electromagnetic radiation
generated in the course of production, construction or other activities. The relevant authorities are authorized to impose various types
of penalties on the persons or entities in violation of the environmental regulations, including fines, restriction or suspension of
operation, shut-down, detention of office- in-charge, etc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 159; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations of intellectual property rights</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
has made substantial efforts to adopt comprehensive legislation governing intellectual property rights, including patents, trademarks,
copyrights and domain names.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Patents</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PRC Patent Law, most recently amended in December 2008, and its implementation rules, most recently amended in January 2010, patents
in China fall into three categories: invention, utility model and design. An invention patent is granted to a new technical solution
proposed in respect of a product or method or an improvement of a product or method. A utility model is granted to a new technical solution
that is practicable for application and proposed in respect of the shape, structure or a combination of both of a product. A design patent
is granted to the new design of a certain product in shape, pattern or a combination of both and in color, shape and pattern combinations
aesthetically suitable for industrial application. Under the PRC Patent Law, the term of patent protection starts from the date of application.
Patents relating to invention are effective for twenty years, and utility models and designs are effective for ten years from the date
of application. The PRC Patent Law adopts the principle of &#8220;first-to-file&#8221; system, which provides that where more than one
person files a patent application for the same invention, a patent will be granted to the person who files the application first.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing
patents can become narrowed, invalid or unenforceable due to a variety of grounds, including lack of novelty, creativity, and deficiencies
in patent application. In China, a patent must have novelty, creativity and practical applicability. Under the PRC Patent Law, novelty
means that before a patent application is filed, no identical invention or utility model has been publicly disclosed in any publication
in China or overseas or has been publicly used or made known to the public by any other means, whether in or outside of China, nor has
any other person filed with the patent authority an application that describes an identical invention or utility model and is recorded
in patent application documents or patent documents published after the filing date. Creativity means that, compared with existing technology,
an invention has prominent substantial features and represents notable progress, and a utility model has substantial features and represents
any progress. Practical applicability means an invention or utility model can be manufactured or used and may produce positive results.
Patents in China are filed with the China National Intellectual Property Administration, or CNIPA. Normally, the CNIPA publishes an application
for an invention patent within 18 months after the filing date, which may be shortened at the request of applicant. The applicant must
apply to the CNIPA for a substantive examination within three years from the date of application.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
19 of the PRC Patent Law provides that, for an invention or utility model completed in China, any applicant (not just Chinese companies
and individuals), before filing a patent application outside of China, must first submit it to the CNIPA for a confidential examination.
Failure to comply with this requirement will result in the denial of any Chinese patent for the relevant invention. The PRC Patent Law
also sets up the framework and adds the provisions for patent linkage and patent term extension.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Patent
enforcement</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unauthorized
use of patents without consent from owners of patents, forgery of the patents belonging to other persons, or engagement in other patent
infringement acts, will subject the infringers to infringement liability. Serious offences such as forgery of patents may be subject
to criminal penalties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
a dispute arises out of infringement of the patent owner&#8217;s patent right, Chinese law requires that the parties first attempt to
settle the dispute through mutual consultation. However, if the dispute cannot be settled through mutual consultation, the patent owner,
or an interested party who believes the patent is being infringed, may either file a civil legal suit or file an administrative complaint
with the relevant patent administration authority. A Chinese court may issue a preliminary injunction upon the patent owner&#8217;s or
an interested party&#8217;s request before instituting any legal proceedings or during the proceedings. Damages for infringement are
calculated as the loss suffered by the patent holder arising from the infringement, or the benefit gained by the infringer from the infringement.
If it is difficult to ascertain damages in this manner, damages may be determined by using a reasonable multiple of the license fee under
a contractual license. Statutory damages may be awarded in the circumstances where the damages cannot be determined by the calculation
standards referenced above. The damage calculation methods shall be applied in the aforementioned order. Generally, the patent owner
has the burden of proving that the patent is being infringed. However, if the owner of an invention patent for manufacturing process
of a new product alleges infringement of its patent, the alleged infringer has the burden of proof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
most recent amendment to the PRC Patent Law, which was promulgated by the SCNPC in October 2020 and became effective in June 2021, describes
the general principles of linking generic drug applications to pharmaceutical patent protection, also known as Patent Linkage. In July
2021, the NMPA and the CNIPA jointly published the Measures for Implementing an Early-Stage Resolution Mechanism for Pharmaceutical Patent
Disputes (Tentative) providing an operating mechanism for Patent Linkage. Upon notification of generic applications and certifications,
if the patentee or the interested person disagrees, the patentee or the interested person will need to file a claim with the court or
the CNIPA within 45 days after CDE publication and must submit a copy of the case acceptance notification to the CDE within 15 working
days after the case acceptance date. Otherwise, the NMPA can proceed with the technical review and approval. For chemical drugs, the
NMPA would initiate a nine-month approval stay period upon notification. If the patentee or the interested person cannot secure a favorable
court judgment or a decision from the CNIPA within the nine-month period, the NMPA can grant marketing authorization to the generic applicant
after the nine-month period expires.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 160; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trade
secrets</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the PRC Anti-Unfair Competition Law promulgated by the SCNPC on September 2, 1993, as amended on November 4, 2017 and on April 23,
2019, or, collectively, the PRC Anti-Unfair Competition Law, the term &#8220;trade secrets&#8221; refers to technical and business information
that is unknown to the public that has utility and may create business interests or profits for its legal owners or holders, and is maintained
as a secret by its legal owners or holders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the PRC Anti-Unfair Competition Law, business persons are prohibited from infringing others&#8217; trade secrets by: (1) obtaining the
trade secrets from the legal owners or holders by any unfair methods such as theft, bribery, fraud, coercion, electronic intrusion, or
any other illicit means; (2) disclosing, using or permitting others to use the trade secrets obtained illegally under item (1) above;
(3) disclosing, using or permitting others to use the trade secrets, in violation of any contractual agreements or any requirements of
the legal owners or holders to keep such trade secrets in confidence; or (4) instigating, inducing or assisting others to violate confidentiality
obligation or to violate a rights holder&#8217;s requirements on keeping confidentiality of trade secrets, disclosing, using or permitting
others to use the trade secrets of the rights holder. If a third party knows or should have known of such illegal conduct but nevertheless
obtains, uses or discloses trade secrets of others trade secrets, the third party may be deemed to have committed a misappropriation
of the others&#8217; trade secrets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trademarks
and domain names</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Trademark Law of the PRC, promulgated by the SCNPC in August 1982, as amended in February 1993, October 2001, August 2013 and
April 2019 and its implementation rules, or, collectively, the Trademark Law, the Trademark Office of the National Intellectual Property
Administration is responsible for the registration and administration of trademarks throughout China. The Trademark Law has adopted a
&#8220;first-to-file&#8221; principle with respect to trademark registration.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain
names are protected under the Administrative Measures on the Internet Domain Names promulgated by the Ministry of Industry and Information
Technology in August 2017 and effective November 2017. The Ministry of Industry and Information Technology is the main regulatory body
responsible for the administration of Chinese internet domain names.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations on labor contracts and social security</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Labor Law of the PRC, which was promulgated by the SCNPC on July 5, 1994, came into effect on January 1, 1995, and was amended on August
27, 2009 and December 29, 2018, the Labor Contract Law of the PRC that became effective on January 1, 2008, as amended on December 28,
2012, and the Implementation Regulations on Labor Contract Law of the PRC which was promulgated and came into effect on September 18,
2008 by the State Council, seek to clarify the responsibilities of both employers and employees and codifies certain basic rights and
protections of employees. Among others, the Labor Contract Law of the PRC provides that after completing two fixed-term employment contracts,
an employee that desires to continue working for an employer is entitled to require a non-fixed-term employment contract. In addition,
employees who have been employed for more than ten years by the same employer are entitled to require a non-fixed-term contract. The
Labor Contract Law of the PRC also requires that the employees dispatched from human resources outsourcing firms or labor agencies be
limited to temporary, auxiliary or substitute positions. Furthermore, where an employer causes any damage to the dispatched employee,
the labor dispatch entity and the employer shall assume joint and several liabilities. According to the Interim Provisions on Labor Dispatch,
which was promulgated in January 2014 and took effect in March 2014, to implement the provisions of the Labor Contract Law of the PRC
regarding labor dispatch, a company is permitted to use dispatched employees for up to 10% of its labor force and the companies currently
using dispatched employees are given a two-year grace period after March 1, 2014 to comply with this limit.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Individual Income Tax Law of the PRC, which was promulgated on September 10, 1980 by the National People&#8217;s Congress, last
amended by the SCNPC on August 31, 2018 and came into effect on January 1, 2019, companies operating in China are required to withhold
individual income tax on employees&#8217; salaries based on the actual salary of each employee upon payment. According to the Law on
Social Insurance of the PRC, which was promulgated by the SCNPC on October 28, 2010, came into effect on July 1, 2011, and was amended
on December 29, 2018, the Provisional Regulations on the Collection and Payment of Social Insurance Premium, which was promulgated by
the State Council on January 22, 1999 and amended on March 24, 2019, and the Regulations on the Administration of Housing Provident Fund,
which was promulgated by the State Council on April 3, 1999 and came into effect on the same date, and was amended on March 24, 2002
and March 24, 2019, employers are required to contribute, on behalf of their employees, to a number of social security funds, including
funds for basic pension insurance, unemployment insurance, basic medical insurance, occupational injury insurance, maternity insurance
and housing provident funds. Employers who fail to contribute may be fined and ordered to make good the deficit within a stipulated time
limit.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 161; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->152<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations relating to employee stock incentive plan</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2012, the State Administration of Foreign Exchange, or SAFE, promulgated the Notices on Issues Concerning the Foreign Exchange
Administration for Domestic Individuals Participating in Stock Incentive Plans of Overseas Publicly Listed Companies, or the Stock Option
Rules. In accordance with the Stock Option Rules and relevant rules and regulations, Chinese citizens or non-Chinese citizens residing
in China for a continuous period of not less than one year, who participate in any stock incentive plan of an overseas publicly listed
company, subject to a few exceptions, are required to register with SAFE through a domestic qualified agent, which could be a Chinese
subsidiary of such overseas listed company, and complete certain procedures. We and our employees who are Chinese citizens or who reside
in China for a continuous period of not less than one year and who participate in our stock incentive plan are subject to such regulation.
In addition, the State Taxation Administration of the PRC has issued circulars concerning employee stock options or restricted shares.
Under these circulars, employees working in China who exercise stock options, or whose restricted shares vest, will be subject to Chinese
individual income tax, or IIT. The Chinese subsidiaries of an overseas listed company have obligations to file documents related to employee
stock options or restricted shares with relevant tax authorities and to withhold IIT of those employees related to their stock options
or restricted shares. If the employees fail to pay, or the Chinese subsidiaries fail to withhold, their IIT according to relevant laws,
rules and regulations, the Chinese subsidiaries may face sanctions imposed by the tax authorities or other Chinese government authorities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations relating to dividend distribution</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PRC Company Law and Foreign Investment Law, and Regulations on Implementing the Foreign Investment Law of the PRC, foreign investors
may freely remit into or out of China, in RMB or any other foreign currency, their capital contributions, profits, capital gains, income
from asset disposal, intellectual property royalties, lawfully acquired compensation, indemnity or liquidation income and so on within
the territory of China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, SAFE issued the Notice on Improving the Check of Authenticity and Compliance to Further Promote Foreign Exchange Control,
which stipulates several capital control measures with respect to outbound remittance of profits from domestic entities to offshore entities,
including the following: (1) under the principle of genuine transaction, banks must check board resolutions regarding profit distribution,
the original version of tax filing records and audited financial statements; and (2) domestic entities must hold income to account for
previous years&#8217; losses before remitting the profits. Moreover, domestic entities shall provide detailed explanations of the sources
of capital and the utilization arrangements and board resolutions, contracts and other proof when completing the registration procedures
in connection with an outbound investment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations relating to foreign currency exchange</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal regulations governing foreign currency exchange in China are the Foreign Exchange Administration Regulations, most recently
amended in August 2008. Under the Foreign Exchange Administration Regulations, payments of current account items, such as profit distributions
and trade and service-related foreign exchange transactions can be made in foreign currencies without prior approval from SAFE by complying
with certain procedural requirements. However, approval from or registration with appropriate government authorities is required where
RMB is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of foreign currency-denominated
loans.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Circular on Reforming the Management Method regarding the Settlement of Foreign Exchange Capital of Foreign-invested Enterprises, or
Circular 19, promulgated by the SAFE on March 30, 2015 and last amended on March 23, 2023, allows foreign-invested enterprises to make
equity investments by using RMB funds converted from foreign exchange capital. Under Circular 19, the foreign exchange capital in the
capital account of foreign- invested enterprises upon the confirmation of rights and interests of monetary contribution by the local
foreign exchange bureau (or the book-entry registration of monetary contribution by the banks) can be settled at the banks based on the
actual operation needs of the enterprises. The proportion of willingness-based foreign exchange settlement of capital for foreign-invested
enterprises is temporarily set at 100%. The SAFE can adjust such proportion in due time based on the circumstances of the international
balance of payments. However, Circular 19 and the Circular on Reforming and Regulating the Management Policies on the Settlement of Capital
Projects, or Circular 16, promulgated by the SAFE on and effective as of June 9, 2016, continues to prohibit foreign-invested enterprises
from, among other things, using RMB fund converted from its foreign exchange capitals for expenditure beyond its business scope, investment
and financing in securities and other investments except for bank&#8217;s principal-secured products, providing loans to non-affiliated
enterprises or constructing or purchasing real estate not for self-use. Recently, Circular 16 has further been amended by Circular of
the State Administration of Foreign Exchange on Further Deepening Reform and Promoting Cross-border Trade and Investment Facilitation
issued by SAFE on December 4, 2023 to further clarify restrictions on the use of domestic institutions&#8217; income from foreign exchange
receipts under capital account and the RMB funds obtained from the settlement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 162; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->153<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 23, 2019, SAFE promulgated the Circular on Further Promoting the Facilitation of Cross-border Trade and Investment, or Circular
28. Pursuant to Circular 28, on the basis of allowing investment-oriented foreign- invested enterprise (including foreign-invested investment
companies, foreign-invested venture capital enterprises and foreign-invested equity investment enterprises) to use capital funds for
domestic equity investment in accordance with laws and regulations, non-investment foreign-invested enterprises will be allowed to use
capital funds for domestic equity investment in accordance with the laws under the premise of not violating the Negative List and the
authenticity and compliance of their domestic invested projects. Such provisions have recently been replaced by Circular on Further Deepening
Reform and Promoting Cross-border Trade and Investment Facilitation that when non-investing foreign-funded enterprise makes domestic
equity investment with capital funds in the domestic currency, the investee will handle the registration for the acceptance of domestic
reinvestment and open a capital account to receive funds, and no entry registration of cash contribution is further required. The domestic
institution that transfers the equity will, in accordance with the relevant provisions, register the receipt of domestic reinvestment
and open a settlement account under the capital account to receive the consideration for equity transfer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the Circular on Optimizing Administration of Foreign Exchange to Support the Development of Foreign- related Business issued by SAFE
on April 10, 2020, eligible enterprises are allowed to make domestic payments by using their capital funds, foreign credits and the income
under capital accounts of overseas listing, with no need to provide the evidentiary materials concerning authenticity of such capital
for banks in advance, provided that their capital use will be authentic and in line with provisions, and conform to the prevailing administrative
regulations on the use of income under capital accounts. The concerned bank will conduct spot checking in accordance with the relevant
requirements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 25, 2006, the People&#8217;s Bank of China issued the Administration Measures on Individual Foreign Exchange Control and its
Implementation Rules were issued by SAFE on January 5, 2007, both of which became effective on February 1, 2007. The Implementation Rules
was later partly amended on May 29, 2016, and March 23, 2023. Under these regulations, all foreign exchange matters involved in the employee
stock ownership plan, stock option plan and other similar plans, participated by onshore individuals shall be transacted upon approval
from SAFE or its authorized branch. On February 15, 2012, SAFE promulgated the Notice on Relevant Issues Concerning Foreign Exchange
Control on Domestic Individuals Participating in the Stock Incentive Plan of An Overseas Listed Company, or Circular 7, to replace the
Operating Procedures for Administration of Domestic Individuals Participating in the Employee Stock Option Plan or Stock Option Plan
of An Overseas Listed Company. Under Circular 7, the board members, supervisors, officers or other employees, including PRC citizens
and foreigners having lived within the territory of the PRC successively for at least one year of a PRC entity, who participate in stock
incentive plans or equity compensation plans by an overseas publicly listed company, or the PRC participants, are required, through a
PRC agent or PRC subsidiaries of such overseas publicly-listed company, to complete certain foreign exchange registration procedures
with respect to the plans upon the examination by, and approval of, SAFE. We and our PRC participants who have been granted stock options
are subject to Circular 7. If our PRC participants who hold such options or our PRC subsidiary fail to comply with these regulations,
such participants and their PRC employer may be subject to fines and legal sanctions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations of commercial bribery</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to specific provisions in the amended PRC Anti-Unfair Competition Law effective from April 23, 2019, commercial bribery is prohibited.
Both the bribe giver and bribe recipient are subject to civil and criminal liability. Further, pharmaceutical companies involved in a
criminal investigation or administrative proceedings related to bribery are listed in the Adverse Records of Commercial Briberies by
its provincial health and family planning administrative department. Pursuant to the Provisions on the Establishment of Adverse Records
of Commercial Briberies in the Medicine Purchase and Sales Industry, which became effective on March 1, 2014, provincial health and family
planning administrative departments formulate the implementing measures for the establishment of Adverse Records of Commercial Briberies.
If a pharmaceutical company is listed in the Adverse Records of Commercial Briberies for the first time, their production is not required
to be purchased by public medical institutions. A pharmaceutical company will not be penalized by the relevant Chinese government authorities
merely by virtue of having contractual relationships with distributors or third-party promoters who are engaged in bribery activities,
so long as such pharmaceutical company and its employees are not utilizing the distributors or third-party promoters for the implementation
of, or acting in conjunction with them in, the prohibited bribery activities. In addition, a pharmaceutical company is under no legal
obligation to monitor the operating activities of its distributors and third-party promoters, and it will not be subject to penalties
or sanctions by relevant Chinese government authorities as a result of failure to monitor their operating activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations of product liability</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Along
with the strict new drug approval process, certain Chinese laws have been promulgated to protect the rights of consumers and to strengthen
the control of medical products in China. Under current PRC law, manufacturers and vendors of defective products in China may incur liability
for loss and injury caused by such products. Pursuant to the General Principles of the Civil Law of the PRC, or PRC Civil Law, promulgated
on April 12, 1986 and amended on August 27, 2009, a defective product which causes property damage or physical injury to any person may
subject the manufacturer or vendor of such product to civil liability for such damage or injury. The Civil Code of the PRC, or PRC Civil
Code, which was promulgated in May 2020 and became effective on January 1, 2021, amalgamates and replaces a series of specialized laws
in civil law area, including the PRC Civil Law. The rules on product liability in the PRC Civil Code remain consistent with the rules
in the PRC Civil Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 163; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->154<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 1993, the Product Quality Law of the PRC, or Product Quality Law, was promulgated to supplement the PRC Civil Law aiming
to protect the legitimate rights and interests of the end-users and consumers and to strengthen the supervision and control of the quality
of products. The Product Quality Law was revised on July 8, 2000, August 27, 2009 and December 29, 2018 respectively. Pursuant to the
revised Product Quality Law, manufacturers who produce defective products may be subject to civil or criminal liability and have their
business licenses revoked.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Law of the PRC on the Protection of the Rights and Interests of Consumers was promulgated on October 31, 1993 and was amended on August
27, 2009 and October 25, 2013 to protect consumers&#8217; rights when they purchase or use goods and accept services. According to which,
all business operators must comply with this law when they manufacture or sell goods and/or provide services to customers. Under the
amendment on October 25, 2013, all business operators shall pay high attention to protect the customers&#8217; privacy and strictly keep
confidential any consumer information they obtain during the business operation. In addition, in extreme situations, pharmaceutical product
manufacturers and operators may be subject to criminal liability if their goods or services lead to the death or injuries of customers
or other third parties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
tort law</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Tort Law of the PRC, or the Tort Law, which became effective on July 1, 2010, if damages to other persons are caused by defective
products due to the fault of a third party, such as the parties providing transportation or warehousing, the producers and the sellers
of the products have the right to recover their respective losses from such third parties. If defective products are identified after
they have been put into circulation, the producers or the sellers shall take remedial measures such as the issuance of a warning, or
the recall of products in a timely manner. The producers or the sellers shall be liable under tort if they fail to take remedial measures
in a timely manner or have not made efforts to take remedial measures, thus causing damages. If the products are produced or sold with
known defects, causing deaths or severe adverse health issues, the infringed party has the right to claim punitive damages in addition
to compensatory damages. The PRC Civil Code amalgamated and replaced the Tort Law effective January 1, 2021. The rules on tort in the
PRC Civil Code are generally consistent with the Tort Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations on cybersecurity review and data privacy</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">On November
7, 2016, the SCNPC issued the Cyber Security Law of the PRC, with the most recent amendment coming into effect on January 1, 2026. Pursuant
to the Cyber Security Law of the PRC, network operators must not, without users&#8217; consent, collect their personal information, and
may only collect users&#8217; personal information necessary to provide their services. Providers are also obliged to provide security
maintenance for their products and services and shall comply with provisions regarding the protection of personal information as stipulated
under the relevant laws and regulations. In addition, pursuant to the Cyber Security Law of the PRC, personal information and important
data collected and generated by a critical information infrastructure operator, or CIIO, in the course of its operations in China must
be stored in China, and if a CIIO purchases internet products and services that affects or may affect national security, it should be
subject to cybersecurity review by the CAC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2021, the SCNPC promulgated the Data Security Law of the PRC, which took effect in September 2021. The Data Security Law of the
PRC applies to data handling activities carried out within the territory of the PRC. The Data Security Law of the PRC further provides
that data processing activities carried out outside of China, which harm national security, public interest or legal interests of Chinese
citizens and organizations, should be subject to legal liabilities. Pursuant to the Data Security Law of the PRC, those conducting data
handling activities should, in accordance with laws and regulations, establish and perfect a data security management system across their
entire workflow and adopt the corresponding technical measures and other necessary measures to ensure data security.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2021, the State Council promulgated the Regulations on the Security Protection of Critical Information Infrastructure, which came
into effect on September 1, 2021 and further clarified the definition of critical information infrastructure. Under such regulations,
critical information infrastructure refers to the important network facilities and information systems in crucial industries and fields
such as public telecommunications, information services, energy, transportation, water conservancy, finance, public services, e-government
and national defense science, technology and industry, as well as other important network facilities and information systems which, in
case of destruction, loss of function or leak of data, may result in serious damage to national security, national economy, the people&#8217;s
livelihood and public interests. According to such regulations, a CIIO is required to perform certain obligations to protect the critical
information infrastructure&#8217;s security, including but not limited to, conducting network security tests and risk assessments at
least once a year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
security protection departments are responsible for organizing the identification of CIIOs in their respective industries and areas in
accordance with the identification rules and shall inform the identification results to the operators of network facilities and information
systems in a timely manner and in the meanwhile report such results to the public security department of the State Council.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2021, the CAC and related authorities promulgated the Cybersecurity Review Measures, or the Cybersecurity Measures, which took
effect on February 15, 2022. According to the Cybersecurity Measures, a company is subject to cybersecurity review if it affects or may
affect national security and falls under any of the following circumstances: (1) it is a CIIO who purchases network products and service,
or (2) it is a network platform operator who carries out data processing activities. In addition, any network platform operator possessing
over one million users&#8217; personal information must apply for a cybersecurity review before listing abroad. Relevant PRC regulatory
authorities may also initiate cybersecurity review if they determine certain network products, services, or data processing activities
affect or may affect national security.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 164; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->155<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Personal Information Protection Law, or the PIPL, which took effect on November 1, 2021, outlines the main system framework and comprehensive
requirements for personal information processing. The PIPL provides a comprehensive set of data privacy and protection requirements that
apply to the processing of personal information and expands data protection compliance obligations to cover the processing of personal
information of persons by organizations and individuals in China, and the processing of personal information of persons in China outside
of China if such processing is for purposes of providing products and services to, or analyzing and evaluating the behavior of, persons
in China. The PIPL also provides that critical information infrastructure operators and personal information processing entities who
process personal information meeting a volume threshold set by Chinese cyberspace regulators are also required to store in China personal
information generated or collected in China, and to pass a security assessment administered by Chinese cyberspace regulators for any
export of such personal information. Lastly, the PIPL contains proposals for significant fines for serious violations of up to RMB50
million or 5% of annual revenues from the prior year and may also be ordered to suspend any related activity by competent authorities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2024, the CAC enacted the Provisions on Promoting and Regulating Cross-Border Data Flows, or the Cross-Border Data Flows Provisions,
further regulating that a data processor&#8217;s responsibility to conduct cybersecurity review such as applying for the data export
security assessment, submitting the standard contract filing, or obtaining the compliance certification can be exempted under certain
circumstances, including, among others: (1) an individual&#8217;s information must be provided abroad for entering into or performing
a contract which the individual is a contracting party, such as for cross-border shopping, cross-border delivery, cross-border remittance,
cross-border payment, cross-border account opening, air ticket and hotel reservation, visa processing and examination services; (2) an
employee&#8217;s information must be provided abroad for human resource management under the labor-relating rules and regulations and
a collective contract signed in accordance with the law; (3) an individual&#8217;s information that must be provided abroad to protect
the safety of his/her life and property under emergency circumstances; and (4) the cumulative number of the individuals&#8217; information
that a data processor (other than CIIO) transferred abroad in a year since January 1 is smaller than 100,000 individuals and no sensitive
personal information is included.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRC
regulations on securities offering and listing outside of China</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 17, 2023, the China Securities Regulatory Commission promulgated the Trial Measures, and relevant notes and supporting guidelines,
which came into effect on March 31, 2023. The Trial Measures seek to regulate all types of overseas offerings and listings by PRC based
companies, including: (a) direct overseas listings, i.e. overseas listings by joint-stock companies which are established in PRC; and
(b) indirect overseas listings, i.e. overseas listings by PRC based companies in the names of an overseas entity, if such issuers meets
both of the following conditions: (1) more than 50% of its audited financial indicators (either operating revenue, profits, total assets
or net assets) for the most recent accounting year is accounted for by its PRC-based companies, and (2) major business activities or
operations are conducted within the territory of PRC; main places of business are located within the territory of the PRC; or the majority
of senior management staff domicile in the PRC or are Chinese citizens.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meanwhile,
overseas offering and listing would be prohibited under certain circumstances, including but not limited to (1) the offering and listing
are expressly forbidden by the Chinese laws, regulations and relevant rules; (2) the intended overseas securities offering and listing
may endanger national security as reviewed and determined by competent authorities under the State Council in accordance with laws or
(3) there are material disputes with regard to the ownership of the equity held by the domestic company&#8217;s controlling shareholder
or by other shareholders that are controlled by the controlling shareholder and/or actual controller. If a domestic company falls into
the circumstances where overseas offering and listing is prohibited prior to the overseas offering and listing, the domestic company
will postpone or terminate the intended overseas offering and listing, and report to the CSRC and competent authorities under the State
Council in a timely manner. If domestic companies fail to fulfill the above-mentioned filing procedures or offer and list in an overseas
market against the prohibited circumstances, they would be warned and fined up to RMB10 million. The controlling shareholders and actual
controllers of such domestic companies that organize or instruct the aforementioned violations would be fined up to RMB10 million and
directly liable persons-in-charge and other directly liable persons would be each fined up to RMB5 million.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2023, the CSRC, the Ministry of Finance, the National Administration of State Secrets Protection and the National Archives
Administration jointly issued the Provisions on Strengthening Confidentiality and Archives Administration of Overseas Securities Offering
and Listing by Domestic Companies, or the Confidentiality and Archives Provisions, which became effective from March 31,2023. The Confidentiality
and Archives Provisions specify that during the overseas issuance of securities and listing activities of domestic enterprises, domestic
enterprises and securities companies and securities service institutions that provide relevant securities services will, by strictly
abiding by the relevant laws and regulations of the PRC and the requirements therein, establish sound confidentiality and archives management
systems, take necessary measures to implement confidentiality and archives management responsibilities, and will not leak national secrets,
work secrets of governmental agencies and undermine national and public interests. Work manuscripts generated in the PRC by securities
companies and securities service institutions that provide relevant securities services for overseas issuance and listing of securities
by domestic enterprises will be kept in the PRC. Without the approval of relevant competent authorities, it will not be transferred overseas.
Where archives or copies need to be transferred outside of the PRC, it will be subject to the approval procedures in accordance with
relevant PRC regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 165; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->156<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Organizational Structure</b>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following diagram illustrates our corporate structure, including our principal subsidiaries, categorized into onshore entities, which
are organized and registered in the PRC, and offshore entities, which are organized and registered outside of the PRC, as of the date
of this Annual Report on Form 20-F:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><img alt="" src="ea028514801_img35.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently use, and have not used in the past, a variable interest entity structure.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 2026, the Board approved the transfer of ownership by Ascentage
Pharma Group Corp Limited of Ascentage Pharma Group Inc., Ascentage Pharma Pty Ltd. and Ascentage Pharma Europe Limited to Ascentage Pharma
Group International to streamline the organization. Once the transfer is completed, these three subsidiaries will be directly owned by
Ascentage Pharma Group International and thus in the organization chart above will appear directly under Ascentage Pharma Group International
connected by a solid line and arrow.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Property, Plants and Equipment</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our corporate headquarters are located in Suzhou and consists of more
than 200,000 square feet of leased space. This facility currently accommodates half of our executive leadership team and leadership of
our product and technology, marketing, sales and corporate functions, as well as our R&amp;D center and manufacturing facility.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also lease offices in Shanghai, Suzhou, Guangzhou, Taizhou and Beijing in China and Rockville, Maryland in the United States. We believe
that our facilities are adequate to meet our needs for the immediate future, and that, should it be needed, suitable additional space
will be available to accommodate any such expansion of our operations. See &#8220;<i>Item 4. Information on the Company&#8212;B. Business
Overview&#8212;Manufacturing and facilities.</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 166; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->157<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
4A. UNRESOLVED STAFF COMMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read the following discussion and analysis of our financial condition and results of operations together with our financial statements
and the related notes appearing elsewhere in this Annual Report on Form 20-F. This discussion contains forward-looking statements that
reflect our plans, estimates, and beliefs that involve risks and uncertainties. As a result of many factors, such as those set forth
under the &#8220;<i>Item 3. Key Information&#8212;D. Risk Factors</i>&#8221; and &#8220;<i>Cautionary Note Regarding Forward- Looking
Statements</i>&#8221; sections and elsewhere in this Annual Report on Form 20-F, our actual results may differ materially from those
anticipated in these forward-looking statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">For a discussion
of our results in the year ended December 31, 2024 compared to the year ended December 31, 2023 and certain financial information as
of December 31, 2023, please refer to the section titled &#8220;<i>Item 5. Operating and Financial Review and Prospects&#8221; </i>contained
in our Annual Report on Form 20-F for the year ended December 31, 2024, filed with the SEC on April 16, 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Operating Results&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We are a
global, integrated biopharmaceutical company engaged in discovery, development and commercializing therapies to address global unmet
medical needs primarily in hematological malignancies. For more than two decades, our founders and team have leveraged their deep expertise
to develop our proprietary drug discovery platform to pursue particularly challenging targets and significant unmet global medical needs.
Our lead assets, Olverembatinib and Lisaftoclax, have global potential to address the major hematological malignancies, including chronic
myeloid leukemia, or CML, acute myeloid leukemia, or AML, chronic lymphocytic leukemia, or CLL, acute lymphocytic leukemia, or ALL, myelodysplastic
syndrome, or MDS, and multiple myeloma, or MM, which is expected to exceed US$166 billion in aggregate market size by 2035, according
to the F&amp;S Report. According to the F&amp;S Report, we are the only company in the world with active clinical programs targeting
all three known classes of key apoptosis regulators. We have nine ongoing U.S. and/or international registrational trials, including
four that are FDA-regulated, for our two key clinical-stage assets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a research intensive, innovation-focused company, we have also incurred losses and experienced negative operating cash flows since inception.
Our net loss was RMB1,243.0 million (US$177.7 million), RMB405.7 million and RMB 925.7 million for the years ended December 31, 2025,
2024 and 2023, respectively. We expect to continue to incur significant expenses and operating losses for the foreseeable future as we
conduct our ongoing and planned preclinical studies and clinical trials, continue our research and development activities and seek regulatory
approvals for our product candidates, obtain and protect our intellectual property and incur additional costs to establish sales, marketing
and distribution infrastructure for expanding sales or to commercialize any product candidate for which we may obtain regulatory approval
in the future. We will also incur increased audit, legal, regulatory and compliance costs as well as investor and public relations expenses
associated with operating as a public company both in Hong Kong and in the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Strategic
partnership with&#160;Innovent</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July&#160;2021, we entered into a strategic partnership with Innovent pursuant to a collaboration and license agreement among Ascentage
Pharma Group Corp Limited, Innovent and Guangzhou Healthquest Pharma Corp. Limited, or the HQP1351 Collaboration and License Agreement.
Under the HQP1351 Collaboration and License Agreement, we granted to Innovent development and commercialization rights (including branding
rights) for Olverembatinib and any finished form product comprising Olverembatinib, or the Licensed Products. Pursuant to the HQP1351
Collaboration and License Agreement, Innovent paid us an upfront payment of US$30&#160;million, and upon achievement of certain regulatory
and commercial milestones Innovent is obligated to make milestone payments of up to an additional US$115&#160;million in the aggregate.
We and Innovent have also agreed to use commercially reasonable efforts to carry out development and commercialization of the Licensed
Products in the Field and for the Territory. For additional information regarding the HQP1351 Collaboration and License Agreement &#8220;<i>Item
4. Information on the Company&#8212; B. Business Overview&#8212;Strategic partnership with Innovent</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 167; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->158<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Components
of results of operations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
primarily consists of (1)&#160;sales of pharmaceutical products, (2)&#160;income relating to commercialization rights pursuant to
the HQP1351 Collaboration and License Agreement (3)&#160;management fee income of fund and (4)&#160;intellectual property income.
Revenue from sales of pharmaceutical products is generally recognized at the point in time when control of the product is
transferred to the customer, generally on acceptance of the products. Income relating to commercialization rights pursuant to the
HQP1351 Collaboration and License Agreement is recorded under contract liabilities and recognized over time during the expected
commercialization period, after we obtain commercialization authorization from local authorities. Income relating to
commercialization rights includes both a fixed element (the initial payment) and variable elements (including but not limited to
development milestones and commercialization milestones). Milestone payments pursuant to the HQP1351 Collaboration and License
Agreement are recognized as performance obligations are satisfied, once we can conclude that it is highly probable that there will
not be a subsequent reversal of a significant amount of revenue. The intellectual property income is recognized at a point of time
upon the customer obtains the right to use the non-patented intellectual property as there are no ongoing activities that
significantly affect  intellectual property.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of sales</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of sales primarily consists of commissioned processing costs of Olverembatinib and Lisaftoclax, costs relating to the purchase of other
products, product packaging and delivery costs and patent amortization costs for sales-based royalties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
income and gains</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Other income and gains primarily consist of income from government
grants, fair value gain on derivative financial instruments and interest income on term deposit at banks. Income from government grants
is conditioned on use for research and development projects, which grants are intended to compensate expenses arising from research activities
and clinical trials, and incentivize the development of new drugs. Income from government grants is recognized as profit upon our receipt
of acknowledgment of compliance from the relevant governmental body.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Fair value
gain on derivative financial instruments consists of the fair value gain on the warrants issued to Innovent pursuant to the warrant subscription
deed entered into on July 14, 2021. These warrants expired in July 2023 without having been exercised.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income is recognized on an accrual basis using the effective interest method by applying the rate that exactly discounts the estimated
future cash receipts over the expected life of a financial instrument, or a shorter period, when appropriate, to the net carrying amount
of the financial asset.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
expenses</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Selling
and distribution expenses</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and distribution expenses primarily consist of marketing expenses, employee-related expenses, and travel and meeting expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and development expenses</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses primarily consist of internal and external research and development expenses, including clinical trial expenses
incurred to develop our drug candidates, CRO-related expenses, costs of materials to support our clinical trials and preclinical studies
and costs associated with preclinical activities, staff costs, intellectual property expenses, materials, depreciation and amortization
and share option and RSU expenses of research and development employees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 168; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->159<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, we have dedicated significant resources to our research and development activities. For the years ended December 31, 2025
and 2024, our research and development expenses represented 61.0% and 67.5%, respectively, of our total operating expenses. As we initiate
new clinical trials and continue to advance our clinical programs for our drug candidates, we expect our research and development expenses
to continue to increase for the foreseeable future and to remain a significant&#160;percentage of our total operating expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the components of our research and development expenses by nature for the periods indicated.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
    thousands)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internal
    and external research and development expenses</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">634,700</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,761</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">493,766</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee-related
    expenses and share option and RSU expenses related to R&amp;D employees</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">376,412</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,826</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">336,059</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    and amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,868</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,413</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    property, materials expenses and other expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,468</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,653</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,981</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,137,448</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162,653</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">947,245</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the components of our external research and development expenses by compound for the periods indicated.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
    thousands)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-2575 CMC and
    clinical expense</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">395,871</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,123</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">358,565</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HQP1351 CMC and clinical expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,059</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,175</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,571</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-115 CMC and clinical expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,482</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,110</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,702</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-5918 CMC and clinical
    expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,063</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">499</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,639</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APG-1252 CMC and clinical
    expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,720</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,349</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,845</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    pipelines&#8217; CMC and clinical expense</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,083</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,412</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,304</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    external research and development expenses</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">631,278</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,668</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">486,626</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administrative
Expenses</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administrative
expenses consist primarily of share option and RSU expenses, employee-related expenses and depreciation, and amortization.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt">We expect our general and administrative expenses
to increase as we have increased our headcount over the past year and expect to increase our headcount in the immediate future.
However, we will incur increased audit, legal, regulatory and compliance costs as well as investor and public relations expenses
associated with operating as a public company both in Hong Kong and the United States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 169; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->160<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the components of our administrative expenses for the periods indicated.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Share option and RSU expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,017</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">574</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,861</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Employee-related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">94,608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,529</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,081</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,004</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,356</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100,652</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,394</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,827</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">246,281</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">35,218</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">187,125</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Finance
costs</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance
costs primarily consist of interest expenses from bank borrowings and other borrowings.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Expenses</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expenses primarily consist of fair value loss on financial assets
at fair value through profit or loss, or FVTPL, and donations. The loss on fair value of the financial assets at FVTPL was a non-cash
adjustment that represented the change in fair value arising from the common stock of Unity Biotechnology, Inc. held by us. We had entered
into several agreements with Unity, covering the development and commercialization of certain Bcl-2/Bcl-xL inhibitors, including APG-1252
and APG-1197, respectively. Since that time, Unity has ceased operations. Donations primarily consist of the cost of sponsoring academic
events of associations and foundations for public charitable purposes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share
of profit of a joint venture</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
share profits in venture capital investments through our 33.42% equity interest in Suzhou Ascentage Harvest Venture Capital LLP, or Ascentage
Harvest. Ascentage Harvest is a venture capital firm that invests in and incubates unlisted high-quality early stage biomedical innovation
companies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
tax</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to income tax on an entity basis on profits arising in or derived from the jurisdictions in which we and our subsidiaries
are domiciled and operate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cayman
Islands</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the current laws of the Cayman Islands, Ascentage Pharma Group International is not subject to tax on income or capital gain arising
in the Cayman Islands. Additionally, upon payments of dividends by Ascentage Pharma Group International to its shareholders, no Cayman
Islands withholding tax will be imposed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 170; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->161<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong
Kong</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries
incorporated in Hong Kong are subject to income tax at the rate of 16.5% on the estimated assessable profits arising in Hong Kong. For
the years ended December&#160;31, 2025 and 2024, Ascentage Pharma Group International did not make any provisions for Hong Kong profits
tax as there were no assessable profits derived from or earned in Hong Kong for any of the periods presented.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Chinese mainland</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">The Company&#8217;s subsidiaries domiciled
in the PRC are subject to the statutory rate of 25%, in accordance with the Enterprise Income Tax law (the &#8220;EIT Law&#8221;), which
was effective since 1 January 2008, except for the following entities which are eligible for a preferential tax rate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Healthquest Pharma was qualified as
a High and New Technology Enterprise (&#8220;HNTE&#8221;) and was subject to a preferential rate of 15% for three years from 2022 to 2024.
In 2025, Healthquest Pharma was no longer qualified as a HNTE and thus subject to the statutory tax rate of 25%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: 0.6pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Suzhou Yasheng
was recognized as a qualified HNTE under the EIT Law by the relevant government authorities and is subject to a preferential rate of 15%
for three years from 2023 to 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: 0.6pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>United States</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: 0.6pt"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">The subsidiary operating in the United
States is subject to tax at a maximum of 21.61% and 21.36%, respectively, for the years ended 31 December 2025 and 2024. No provision
for income tax has been made as the Group had no assessable profits earned in the United States during the reporting period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">A requirement to capitalize and amortize
previously deductible research and experimental expenses resulting from a change in Section 174 made by the Tax Cuts and Jobs Act of 2017
(the &#8220;TCJA&#8221;) became effective on 1 January 2022. Under the TCJA, the Company is required to capitalize and subsequently amortize
R&amp;D expenses over five years for research activities conducted within the U.S and fifteen years for research activities conducted
outside of the U.S.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">In July 2025, the One Big Beautiful
Bill Act (&#8220;OBBBA&#8221;) was enacted, which reinstated current deductibility of domestic research and experimental expenditures
and provided an election to accelerate the recovery of previously capitalized costs. The Company did not elect to accelerate the deduction
of previously capitalized domestic research and experimental expenditures and will continue to amortize such costs over the remaining
statutory periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of operations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Comparison
of years ended December 31, 2025 and 2024</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">574,120</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">82,098</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">980,650</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(48,938</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,998</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,085</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">525,182</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">951,565</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other income and gains</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,359</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Selling and distribution expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(353,640</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50,570</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(195,998</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,137,448</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(162,653</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(947,245</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(246,281</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,218</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(187,125</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Finance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(54,070</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,732</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(64,455</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(73,599</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,525</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,075</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Share of profit/(loss) of a joint venture</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">314</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,236,047</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(176,753</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(395,255</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,940</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(992</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(10,425</span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss for the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,242,987</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(177,745</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(405,680</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 171; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->162<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>&#160;</b></span></p><div>

</div><p style="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the year ended December 31, 2025, we generated revenue of RMB574.1
million (US$82.1 million) from the sales of pharmaceutical products, commercialization rights income from Innovent and management fee
income compared to RMB980.7 million for the year ended December 31, 2024, representing a decrease of RMB406.6 million, or 41.5%, which
was primarily attributable to the intellectual property income from Takeda in 2024 partially offset by the rise in sales of pharmaceutical
products.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost
of sales</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cost of sales for the year ended December 31, 2025 was RMB48.9 million
(US$7.0 million), compared to RMB29.1 million for the year ended December 31, 2024, representing an increase of RMB19.8 million, or 68.3%,
primarily due to the increase in the production cost of Lisaftoclax and Olverembatinib.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
income and gains</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Other income and gains for the year ended December 31, 2025 was RMB103.5
million (US$14.8 million), compared to RMB 57.4 million for the year ended December 31, 2024, representing an increase of RMB46.1 million,
or 80.4%, which was primarily attributable to (i) the increase in bank interest income to RMB82.1 million (US$11.7 million) for the year
ended December 31, 2025, as compared to RMB37.8 million for the year ended December 31, 2024; (ii) the increase in government grants related
to income to RMB14.5 million (US$2.1 million) for the year ended December 31,2025, as compared with RMB9.1 million for the year ended
December 31,2024; and (iii) the increase in rental income to RMB5.0 million (US$0.7 million) for the year ended December 31, 2025, as
compared with RMB2.3 million for the year ended December 31, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
expenses </b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Selling
and distribution expenses</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2025, the selling and distribution expenses increased by RMB157.6 million or 80.4% to RMB353.6 million (US$50.6
million), as compared to RMB 196.0 million for the year ended December 31, 2024. The increase was attributable to the increase in selling
and distribution expenses incurred in the commercialization of Lisaftoclax and Olverembatinib.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and development expenses</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2025, the research and development expenses increased by RMB190.2 million, or 20.1% to RMB1,137.4 million
(US$162.7 million) from RMB 947.2 million for the year ended December 31, 2024. The increase was attributable to the increase in clinical
research expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administrative
expenses</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2025, the administrative expenses increased by RMB59.2 million, or 31.6% to RMB246.3 million (US$35.2 million)
from RMB 187.1 million for the year ended December 31, 2024. The increase was primarily attributable to the increased staff cost.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 172; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->163<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Finance
Costs</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2025, the finance costs decreased by RMB10.4 million, or 16.1% to RMB54.1 million (US$7.7 million) from RMB
64.5 million for the year ended December 31, 2024. It was due to the decrease of the interest rate incurred in relation to bank borrowings.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -1.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Expenses</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2025, other expenses were RMB73.6 million (US$10.5 million), as compared to other expenses of RMB9.1
million for the year ended December 31, 2024, which represented an increase of RMB64.5 million, or 711.0%. The increase was
primarily attributable to (i) the increase in fair value loss of contingent acquisition consideration related to the acquisition of
Guangzhou Healthquest Pharma Co., Ltd. in December 2016 to RMB29.5 million (US$4.2 million) in 2025, and (ii) the increase in
donations to RMB23.4 million (US$3.3 million) for the year ended December 31, 2025, as compared to RMB6.3 million for the year ended
December 31, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss on fair value of the financial assets at FVTPL was a non-cash adjustment that represented the change in fair value arising from
the common stock of Unity held by us.</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
of profit/(loss) of a joint venture</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif">For
the year ended December 31, 2025, share of profit of a joint venture was RMB0.3 million (US$0.05 million), compared to a loss of RMB0.3
million for the year ended December 31, 2024.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
for the reporting period</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">The loss of
the Company increased by RMB837.3 million, or 206.4%, to RMB1,243.0 million (US$177.7 million) for the year ended December 31, 2025 from
RMB405.7 million for the year ended December 31, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income
tax expense</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -1pt">For the year ended December 31, 2025, income tax expense was RMB6.9
million (US$1.0 million), compared to RMB10.4 million of income tax expense for the year ended December 31, 2024, representing a decrease
of RMB3.5 million, or 33.4%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Liquidity and Capital Resources</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations have historically been financed primarily by capital increases from our founders and investors and net proceeds from our public
and private financings. Although we have commercialized Olverembatinib in the PRC, we have incurred significant net losses in the past,
and we intend to continue to invest substantially in our business. As a result, we may not be able to achieve or sustain profitability
in the future. Until such time as we can generate significant revenue from product sales, we expect to finance our operations through
equity sales, debt financings and other capital sources, including potential collaborations, strategic alliances, licensing arrangements,
and other marketing or distribution arrangements. We may be unable to raise additional funds or enter into other agreements or arrangements
when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as and when needed, we may have
to significantly delay, scale back, or discontinue the development or commercialization of one or more of our product candidates, which
could have a material adverse effect on our business, results of operations or financial condition. In addition, our net losses may fluctuate
significantly from period to period, depending upon the timing of our expenditures on our research and development activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 173; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->164<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">As of December
31, 2025 and 2024, we had cash and bank balances of RMB2,470.1 million (US$353.2 million) and RMB1,261.2 million, respectively. Our principal
sources of liquidity are cash and bank balances and interest-bearing bank and other borrowings. We place cash and cash equivalents (which
are mostly held in U.S. dollars, Hong Kong dollars and RMB) in short term deposits with authorized institutions in Hong Kong and China.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt">Our ordinary shares were listed on the HKEx in 2019, and the net proceeds
from our initial public offering on the HKEx (including shares issued as a result of the full exercise of the over-allotment option) were
approximately HK$369.8 million (US$47.5 million). Since 2024, we have also raised proceeds in the transactions described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">In June 2024,
we entered into an exclusive option agreement, or the Takeda Exclusive Option Agreement, with Takeda Pharmaceuticals International AG,
or Takeda, and our affiliates, Guangzhou Healthquest Pharma Co., Ltd. and Ascentage Pharma (Suzhou) Co., Ltd. Pursuant to the Takeda
Exclusive Option Agreement, Takeda paid us US$100.0 million. In aggregate, under the Takeda Exclusive Option Agreement and the expected
terms of the exclusive license agreement, we are eligible to be paid a one-time option exercise fee and certain development, commercial
and sales milestones up to approximately US$1.2 billion and royalties in a range equal to 12-19% of net sales. In addition, in June 2024,
we issued and sold to Takeda 24,307,322 ordinary shares, or the Takeda Shares, for an aggregate purchase price of US$75 million.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">In
January 2025, we completed our U.S. initial public offering in which we offered and sold an aggregate 7,325,000 ADSs at an offer
price of US$17.25 per ADS, representing 29,300,000 ordinary shares of the Company for gross proceeds of approximately US$126.4
million (equivalent to approximately HK$983.8 million). On February 13,2025, in connection with the underwriters&#8217; exercise of
their over-allotment option, we issued an additional 935,144 ADSs at an offer price of US$17.25 per ADS, representing 3,740,576
ordinary shares of the Company for gross proceeds of approximately US$16.13 million (equivalent to approximately HK$125.6 million).
Each ADS represents 4 ordinary shares. Our ADSs are listed on the Nasdaq Global Market, or the Nasdaq, under the symbol
&#8220;AAPG.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">In 2025,
we entered into the 2025 Placing and Subscription Agreement with Dajun Yang Dynasty Trust, a family trust established by Dr. Yang, as
vendor, and J.P. Morgan Securities (Asia Pacific) Limited and Citigroup Global Markets Limited, as placing agents. An aggregate of 22,000,000
existing ordinary shares owned by the vendor were placed by the placing agents to not less than six placees at a price of HK$68.60 per
share and we subsequently issued to the vendor the same number of 22,000,000 new ordinary shares of the Company at the same price of
HK$68.60 per share. The closing price of our ordinary shares on the HKEx on July 14, 2025, the date on which the terms of the top-up
placing was fixed, was HK$74.70. The net proceeds (after deducting all applicable costs and expenses, including commission and levies)
raised were HK$1,492.5 million (US$190.1 million).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We
believe that our existing cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements
through at least the next 12 months from the issuance of the consolidated financial statements included in this Annual Report on Form
20-F, but may not be sufficient for us to fund any of our drug candidates through regulatory approval, which may last several years.
We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than
we expect. Our present and future funding requirements may change and will depend on many factors. See &#8220;<i>Item 3. Key Information&#8212;D.
&#8212;Risks related to our financial position and need for additional capital&#8212;We will need to obtain additional financing to fund
our operations, and if we are unable to obtain such financing, we may be unable to complete the development and commercialization of
our drug candidates, including Olverembatinib and Lisaftoclax.&#8221;</i></span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the numerous risks and uncertainties associated with product development, we are unable to predict the timing or amount of increased
expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate additional revenue from
product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis,
then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations. See &#8220;<i>Item
3. Key Information&#8212;D. Risk Factors&#8212;Risks related to our financial position and need for additional capital&#8212;We have
incurred significant net losses in the past, and we intend to continue to invest substantially in our business. As a result, we may not
be able to achieve or sustain profitability in the future despite the commercialization of Olverembatinib in China.</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect our operating expenses to increase over the next several years as we expand our research and development activities. Until such
time as we can generate significant revenue from product sales or royalties, if ever, we expect to finance our operations through a combination
of public or private equity and debt financings or other sources, including payments upon achievement of certain development, regulatory
and sales milestone events and royalty payments under our existing strategic agreements, and future collaborations with other third parties.
To the extent that we raise additional capital through the sale of equity or convertible debt securities, our shareholders&#8217; ownership
interest may be diluted, and the terms of any additional securities may include liquidation or other preferences that adversely affect
the rights of our shareholders. Debt financing, if available and on commercially reasonable terms, may involve agreements that include
covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures
or declaring dividends. If we raise funds through additional collaborations, strategic alliances or licensing arrangements with third
parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates
or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings
when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant
rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 174; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->165<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><!-- Field: Split-Segment; Name: 6 --><div>
</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
flows</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
cash used in operating activities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">For the year
ended December 31, 2025, net cash used in operating activities was RMB1,174.1 million (US$167.9 million), which was primarily due to
our loss before tax of RMB1,236.0 million (US$176.8 million), adding back non-cash charges of RMB205.5 million (US$29.4 million), including
depreciation and amortization of assets, share option and RSU expenses and interest expenses from bank borrowings and other borrowings,
and net cash used in changes in our operating assets and liabilities of RMB143.6 million (US$20.5 million).</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">For the year
ended December 31, 2024, net cash used in operating activities was RMB111.4 million, which was primarily due to our loss before tax of
RMB395.3 million, adding back non-cash charges of RMB172.9 million , including depreciation and amortization of assets, share option
and RSU expenses and interest expenses from bank borrowings and other borrowings, and net cash used in changes in our operating assets
and liabilities of RMB111.0 million.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Net cash
used in investing activities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">For the year ended December 31, 2025, net cash used in investing activities
was RMB1,000.1 million (US$143.0 million), which primarily consisted of a net increase in property, plant and equipment and other intangible
assets of RMB27.6 million (US$3.9 million), and payment of contingent consideration in relation to our acquisition of Healthquest Pharma
in December 2016 of RMB43.3 million(US$6.2 million) and the increase in time deposits with original maturity of more than three months
to RMB925.1 million(US$132.3 million).</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2024, net cash used in investing activities was RMB362.0 million, which primarily consisted of a net increase
in property, plant and equipment and other intangible assets of RMB24.3 million, and an increase in time deposits with original maturity
of more than three months of RMB312.2 million, as well as investment in a joint venture of RMB16.0 million.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
cash provided by financing activities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">For the year ended December 31, 2025, net cash inflows from financing
activities of the Group amounted to RMB2,540.1 million (US$363.2 million), which mainly consisted of net proceeds of RMB2,304.9 million
(US$329.6 million) from the U.S.IPO and the 2025 placing; partially offset by payments of interest paid which amounted to RMB51.3 million
(US$7.3 million).</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2024, net cash provided by financing activities was RMB314.8 million, which primarily consisted of net proceeds
of RMB533.9 million from the issuance of shares through our offering of ordinary shares in 2024, partially offset by payments of interest
and lease principal of RMB69.0 million and payments of listing expenses of RMB13.3 million.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 175; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->166<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
obligations and loans</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">As of December
31, 2025 and 2024, we had interest-bearing bank and other borrowings of RMB1,979.7 million (US$283.1 million) of which lease liabilities
comprised RMB22.2 million (US$3.2 million), and RMB 1,668.5 million of which lease liabilities comprised RMB 30.2 million, respectively.
The following table sets forth aggregate information about material contractual obligations and loans as of December 31, 2025 and 2024.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="13" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2025</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="9" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    interest rate per annum</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    interest rate per annum</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(%)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
    thousands)</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in&#160;thousands)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 16%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
    borrowing</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11-2.50
    or 1 year LPR-0.60 to 0.89</span></td><td style="text-align: center; width: 1%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; width: 1%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,040,000</span></td><td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; width: 1%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,718</span></td><td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; width: 1%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.60-2.70
    or 1 year LPR-0.30 to 0.75</span></td><td style="text-align: center; width: 1%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    portion of long term bank loans-unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year
    LPR-0.45 to 0.75</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156,200</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,336</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year
    LPR-0.15 to 0.65 or 1 year LPR+0.65 to 0.85</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,170</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    portion of long term bank loans-unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">358</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80-4.55</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    portion of long-term bank loans-secured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year
    LPR-0.85</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,498</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,359</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year
    LPR-0.85</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00-4.35</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,283</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,041</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00-4.35</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total-current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,222,481</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,812</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">779,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    loans-unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year
    LPR-0.45 to 0.75</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027
                                            - 2028</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,900</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,431</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year
    LPR-0.45 to 0.65 or 1 year LPR+0.70 to 0.85</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026-2028</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">203,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    loans-unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,750</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,256</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80-4.50</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026-2027</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    loans-secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year
    LPR-0.85</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027
                                            - 2038</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">583,675</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,464</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year
    LPR-0.85</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026-2038</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">588,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00-4.35</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027
                                            - 2028</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,913</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,133</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00-4.35</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026-2028</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,793</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total-non-current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,238</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,284</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">889,435</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,979,719</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,096</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,668,497</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:
LPR represents the Loan Prime Rate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025, bank
    loans amounting to RMB600.2 million (US$85.8 million) were secured by the pledge of our buildings with a net carrying amount of RMB677.0 million (US$96.8 million) and right-of-use assets with a net carrying amount of RMB25.3 million (US$3.6 million).
    Such loans were also guaranteed by two of our subsidiaries. As of December 31, 2024, bank loans amounting to RMB599.7 million were
    secured by the pledge of our buildings with a net carrying amount of RMB 731.3 million, and right-of-use assets with a net carrying
    amount of RMB26.5 million. Such loans were also guaranteed by two of our subsidiaries.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 176; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->167<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unsecured bank loans amounting to RMB140.0 million (US20.0 million) and RMB278.1 million were guaranteed by our subsidiaries as of December
31, 2025 and 2024, respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the maturity analysis of our interest-bearing bank and other borrowings as of December 31, 2025 and 2024:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
    thousands)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analyzed into:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within one year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,222,481</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,812</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">779,062</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the second year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,201</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,908</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">242,473</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the third to fifth years,
    inclusive</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,034</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159,355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
    five years</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">456,937</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">487,607</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,979,719</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,096</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,668,497</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Research and Development, Patents and Licenses, etc.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of our research and development activities, see &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview</i>&#8221;
and &#8220;<i>&#8212;A. Operating Results.</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Trend Information </b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of trends, see &#8220;<i>&#8212;A. Operating Results&#8221; </i>and &#8220;<i>&#8212;B. Liquidity and Capital Resources</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as disclosed elsewhere in this Annual Report on Form 20-F, we are not aware of any trends, uncertainties, demands, commitments or
events for the year ended December 31, 2025 that are reasonably likely to have a material and adverse effect on our revenues, income,
profitability, liquidity or capital resources, or that would cause the financial information included in this Annual Report on Form 20-F
to be not necessarily indicative of future results of operations or financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
Critical accounting estimates</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
tax</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax is comprised of current and deferred tax. Income tax relating to items recognized outside profit or loss is recognized outside profit
or loss, either in other comprehensive income or directly in equity.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, based on tax
rates (and tax laws) that have been enacted or substantively enacted by the end of each of the reporting period, taking into consideration
interpretations and practices prevailing in the countries in which us operate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 177; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->168<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax is provided, using the liability method, on all temporary differences at the end of reporting date between the tax bases of assets
and liabilities and their carrying amounts for financial reporting purposes. Deferred tax liabilities are recognized for all taxable
temporary differences, except:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
when the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not
a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss and does
not give rise to equal taxable and deductible temporary differences; and</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
in respect of taxable temporary differences associated with investments in subsidiaries, when the timing of the reversal of the temporary
differences can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognized for all deductible temporary differences, and the carryforward of unused tax credits and any unused tax losses.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which the deductible
temporary differences, and the carryforward of unused tax credits and unused tax losses can be utilized, except:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
when the deferred tax asset relating to the deductible temporary differences arises from the initial recognition of an asset or liability
in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable
profit or loss and does not give rise to equal taxable and deductible temporary differences; and</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
in respect of deductible temporary differences associated with investments in subsidiaries, deferred tax assets are only recognized to
the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available
against which the temporary differences can be utilized.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer
probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized
deferred tax assets are reassessed at the end of each reporting period and are recognized to the extent that it has become probable that
sufficient taxable profit will be available to allow all or part of the deferred tax asset to be recovered.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realized or the liability
is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and deferred tax liabilities are offset if and only if us have a legally enforceable right to set off current tax assets and
current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation authority
on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets on a
net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts of
deferred tax liabilities or assets are expected to be settled or recovered.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
recognition</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from contracts with customers is recognized when control of goods or services is transferred to the customers at an amount that reflects
the consideration to which we expect to be entitled in exchange for those goods or services.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the consideration in a contract includes a variable amount, the amount of consideration is estimated to which us will be entitled in
exchange for transferring the goods or services to the customer. The variable consideration is estimated at contract inception and constrained
until it is highly probable that a significant revenue reversal in the amount of cumulative revenue recognized will not occur when the
associated uncertainty with the variable consideration is subsequently resolved.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the contract contains a financing component which provides the customer with a significant benefit of financing the transfer of goods
or services to the customer for more than one year, revenue is measured at the present value of the amount receivable, discounted using
the discount rate that would be reflected in a separate financing transaction between us and the customer at contract inception. When
the contract contains a financing component which provides us with a significant financial benefit for more than one year, revenue recognized
under the contract includes the interest expense accreted on the contract liability under the effective interest method. For a contract
where the period between the payment by the customer and the transfer of the promised goods or services is one year or less, the transaction
price is not adjusted for the effects of a significant financing component, using the practical expedient in IFRS 15.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Sale of products</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from the sale of products is recognized at the point in time when control of the asset is transferred to the customer, generally on acceptance
of the products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Commercialization rights</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 11pt DengXian; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We provide
commercialization, development and branding rights (collectively, &#8220;Commercialization Rights&#8221;) to customers for an agreed
upon commercialization period ending ten years from the date of the first sale of the product as stipulated in the relevant
agreement. The consideration for Commercialization Rights include upfront payment, development and regulatory milestones payments
and commercialization milestones payments.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 178; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->169<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 11pt DengXian; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
and regulatory milestones payments are fully constrained until the period in which those regulatory approvals are achieved due to the
inherent uncertainty with the approval process and included in the transaction price in the period regulatory approval is obtained. Upfront
payment and development and regulatory milestones payments are recorded under contract liabilities and recognized as revenue over time
during the commercialization period on a straight-line basis.</span></p><div>

</div><p style="font: 11pt DengXian; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 11pt DengXian; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
milestone payments based on the level of sales are recognized at a point in time when the later of the following events occurs: (i) the
related sale occurs, or (ii) the performance obligation to which commercialization milestones payments have been allocated has been satisfied.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Intellectual property income</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
property income is recognized at the point in time at which the non-patented intellectual property is granted to the customer because
we will not undertake activities that affect such intellectual property.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consideration for intellectual property income comprises a fixed element and a variable element. Variable element is recognized as transaction
price when we can conclude that it is highly probable that a significant reversal in the amount of cumulative revenue recognized will
not occur.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Others</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide consulting and promotional services to our customers through contracts. Depending on the contract, revenue is recognized over time
as the service is rendered, or at the point in time as the service is completed and accepted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
estimates</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the critical accounting estimates described above, there are other accounting estimates within our consolidated financial
statements. Management believes the current assumptions and other considerations used to estimate amounts reflected in our consolidated
financial statements are appropriate. However, if actual experience differs from the assumptions and other considerations used in estimating
amounts reflected in our consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated
results of operations or financial condition. See Note 3 to the consolidated financial statements for further information on significant
accounting policies that impact us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Directors and senior management</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information relating to our executive officers and directors as of date of this Annual Report on Form
20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 7%; padding-right: 2.65pt; padding-left: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 61%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position(s)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
    Officers</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajun
    Yang, M.D., Ph.D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman,
    Chief Executive Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yifan
    Zhai, M.D., Ph.D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Veet
    Misra, Ph.D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"/>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Office</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    J. Knapp</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SVP, General Counsel</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Jin Cao</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">39</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Head of Finance, China</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Employee
    Directors</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marina
S. Bozilenko <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marc
    E. Lippman, M.D. <sup>(2)(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon
    Dazhong Lu, Ph.D. <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wei
    Ren <sup>(2)(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Sidransky, M.D. <sup>(2)(4)(5)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shaomeng
    Wang, Ph.D. <sup>(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changqing
    Ye <sup>(1)(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debra
    Yu <sup>(3)(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 1.65pt; padding-left: 2.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member of the audit committee</span></td></tr>
  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member of the nomination committee</span></td></tr>
  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
                                            of the remuneration committee</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify">Member of the research and development committee</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify">Lead Independent Non-Executive Director</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 179; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->170<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Executive
officers</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dajun
Yang, M.D., Ph.D. </i></b>is our co-founder and has served as our Chief Executive Officer since 2009 and as Chairman and a member of
our board of directors since 2017. Prior to co-founding our Company, Dr. Yang co-founded Ascenta Therapeutics, Inc., where he was a Senior
Vice President of Research and Preclinical Development between 2004 and 2008. Prior to that, Dr. Yang was a part-time professor and supervisor
of doctoral students at the Cancer Center at Sun Yat-sen University from 2003 to 2006 and an Associate Professor of Biochemistry and
Molecular Biology, an Associate Professor of Oncology and Senior Investigator at the Lombardi Cancer Center at Georgetown University
from 1995 to 2001. Dr. Yang is also a co-founder of two national magazines in China, &#8220;Chinese Medical Students&#8221; and &#8220;Family
Doctors.&#8221; Dr. Yang received his Bachelor&#8217;s in Medicine and his Master&#8217;s in Oncology from Sun Yat-sen University in
China and his Ph.D. in Genetics from Michigan State University.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Yifan
Zhai, M.D., Ph.D. </i></b>has served as our Chief Medical Officer since July 2013. Dr. Zhai was the President of the Chinese Biopharmaceutical
Association-USA from 2009 to 2010. From 2007 to 2010, Dr. Zhai served as Chief Scientific Officer of Celladon Corporation, a biotechnology
company previously listed on Nasdaq until its merger with Eiger Biopharmaceuticals, Inc. Prior to that, she served as Executive Director
of Anaborex (Shanghai)R&amp;D Co., Ltd. from 2007 to 2008, as Chief Scientific Officer at Oncomax Acquisition Corp. from 2005 to 2007,
as President of HealthQuest Inc. from 2003 to 2005, as Director of the Department of Pharmacology at Exelixis, Inc. (Nasdaq: EXEL) from
2001 to 2003, as a Senior Research Scientist at Bayer Pharmaceuticals Corp. from 1999 to 2001, and as a Scientist at Human Genome Sciences
Inc. (acquired by GSK plc), from 1996 to 1999. Dr. Zhai was a Postdoctoral Fellow at the surgery branch of the National Cancer Institute
from 1993 to 1996. Dr. Zhai received her M.D. from Sun Yat-sen University in China and her Ph.D. in Pharmacology and Toxicology from
Michigan State University.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Veet
Misra, Ph.D. </i></b> has been our Chief Financial Officer since July 2025. Dr.</span> <span style="font-family: Times New Roman, Times, Serif">Misra
has more than 20 years of experience in investment banking. Prior to joining Ascentage Pharma, he was a Managing Director in the Healthcare
Investment Banking group at Cantor Fitzgerald where he covered the biopharmaceutical sector. Before that, he worked in the life sciences
investment banking groups at Houlihan Lokey and RBC Capital Markets. Over the course of his banking career, Dr. Misra advised on deals
spanning equity, equity-linked, debt, and debt restructuring, as well as buy-side/sell-side M&amp;A and corporate strategy, primarily
focusing on the biotechnology sector. Dr. Misra earned a Ph.D. in Molecular Biology, with a focus on the oncology field, from the University
of Toronto and an MBA in Finance &amp; Strategy from the Schulich School of Business in Toronto.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Thomas
J. Knapp, J.D. </i></b>has served as our Senior Vice President, General Counsel since March 2019. He was previously our Senior Vice President
of Legal Affairs from 2018 to March 2019. From 2018 to February 2019, he served as a consultant at SELLAS Life Sciences Group, Inc. (Nasdaq:
SLS), which acquired Galena Biopharma, Inc. in a reverse merger. Prior to that, from 2015 to 2018, Mr. Knapp was the General Counsel
and Corporate Secretary at Galena Biopharma, Inc., a biopharmaceutical company previously listed on Nasdaq. From 2010 to 2015, he was
Executive Vice President, Chief Legal Officer and Corporate Secretary of Sucampo Pharmaceuticals, Inc., a biopharmaceutical company acquired
by Mallinckrodt Pharmaceuticals. From 2009 to 2010, he was a consultant to NorthWestern Energy Corporation (NYSE: NWE) and Of Counsel
at Exemplar Law Partners, LLC, where he advised clients on renewable energy and financing funding. From 2003 to 2008, he was Vice President,
General Counsel and Corporate Secretary at NorthWestern Energy Corporation (NYSE: NWE). From 1996 to 1998 and 1999 to 2002, he was Of
Counsel at Paul Hastings LLP and has also served as Assistant General Counsel of The Boeing Company (NYSE: BA) from 1998 to 1999. Mr.
Knapp was appointed as the Assistant Attorney General of the State of Illinois in 1978. In addition, he was also a mediation panelist
of the American Bar Association from 2015 to 2018. From 2017 to April 2019, Mr. Knapp served on the board of directors of Osiris Therapeutics,
Inc., which was previously listed on Nasdaq (Nasdaq: OSIR) and subsequently acquired by Smith &amp; Nephew plc (NYSE: SNN) in April 2019.
Mr. Knapp received his Bachelor&#8217;s in Political Science and Business from the University of Illinois Urbana-Champaign and his Juris
Doctor from the Loyola University of Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Jin Cao</i></b> has been our Head of Finance, China (acting Principal
Financial and Accounting Officer) since December 2020. Prior to joining our company, he was Deputy Director of Finance of Simcere Pharmaceutical
from 2016 to 2020. Mr. Cao started his career in Huawei Technology South America Division and served as regional Chief Accountant, where
he was in charge of a number of finance and control functions in various operations. Mr. Cao received a Bachelor of Literature from Nanjing
University and is a Certified Public Accountant and Certified Tax Advisor in China and also has Legal Professional Qualification from
the Ministry of Justice of China.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 180; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->171<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-employee
directors</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Marina
S. Bozilenko </i></b>has served as a member of our board of directors since November 2024. Since July 2021, Ms. Bozilenko has served
as President, Chief Executive Officer &amp; Director at Biothea Pharma, Inc. She currently serves as an independent director of Talphera,
Inc. (Nasdaq: TLPH). Previously, Ms. Bozilenko served as a Strategic Advisor at William Blair &amp; Co. LLC from January 2010 to February
2021. Prior to that, Ms. Bozilenko served as a Principal at Kidd &amp; Co. LLC from 2008 to 2010, Senior Managing Director at Bear, Stearns
&amp; Co., Inc. from 2003 to 2008, Managing Director at Banc of America Securities LLC from 2000 to 2003 and MD &amp; Senior MD-West
Coast Healthcare Investment at Prudential Vector Healthcare Group from 1999 to 2000. Prior to that, Ms. Bozilenko was Managing Director
at Vector Securities LLC and Managing Director &amp; Head-West Coast at Vector Securities International, Inc. from 1998 to 1999. She
has previously served as a director of Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) from 2010 to 2020 and as a director of SynAct Pharma
AB (Nasdaq Stockholm: SYNACT) from April 2021 to February 2024. Ms. Bozilenko received her Bachelor&#8217;s degree in Biochemistry and
her Master&#8217;s degree in Social Sciences from The University of Chicago.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Marc
E. Lippman, M.D. </i></b>has served as a member of our board of directors since January 2025. Dr. Lippman has served as a professor
of Oncology and Internal Medicine at Georgetown University Medical Center since 2018. Dr. Lippman previously served as the Kathleen
and Stanley Glaser Professor of Medicine at the University of Miami Leonard M. Miller School of Medicine from 2017 to 2018 and as
deputy director of Sylvester Comprehensive Cancer Center at the University of Miami from 2008 to 2017. He also previously served as
the John G. Searle Professor and Chair of Internal Medicine at the University of Michigan, Ann Arbor. Prior to that, Dr. Lippman was
the Head of the Medical Breast Cancer Section, Medicine Branch, at the National Institutes of Health and was a Senior Investigator
at the National Cancer Institute. Dr. Lippman currently serves on the board of directors of Radiance Biopharma, Inc., a biotech
start-up, and previously served on the board of directors of Seagen Inc., a public company which was acquired by Pfizer Inc. (NYSE:
PFE). Dr. Lippman has published over 500 peer-reviewed articles and is a recipient of the First American Cancer Society Lectureship
and Prize at the American Society of Clinical Oncology Meeting, the American Association for Cancer Research Rosenthal Award and the
Brinker Award for Basic Science of the Komen Foundation. Dr. Lippman is a member of the Association of American Physicians, the
American Society for Clinical Investigation, the American Society of Biological Chemists, the American Association for Cancer
Research and the American Society of Clinical Oncology. Dr. Lippman received his Bachelor&#8217;s in Chemistry from Cornell
University, and his M.D. from Yale Medical School.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Simon
Dazhong Lu, Ph.D. </i></b>has served as a member of our board of directors since 2018. Since 2009, Dr. Lu has served as the Managing
Director and Partner of SDIC Fund Management Company Ltd., a PRC-based private equity fund manager. From 2008 and 2009, Dr. Lu worked
at CEL Partners, a private equity firm that focuses on buy- outs, acquisitions and mergers. From 2002 to 2007, Dr. Lu served as the Investment
Manager and Partner of Shanghai Newmargin Ventures, a venture capital management company based in the PRC. Prior to that, Dr. Lu worked
in a number of financial institutions, including China International Capital Corporation Limited, an investment bank based in the PRC
from 2001 to 2002. Dr. Lu received his Bachelor&#8217;s in Economics from Nankai University in China. He received his Master&#8217;s
in Business Administration from McGill University in Canada, and his Ph.D. in Economics from Nankai University in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Wei
Ren</i></b> has served as a member of our board of directors since June 2019. Mr. Ren has been a lawyer at Jingtian &amp; Gongcheng,
a law firm in the PRC, since 2003, where he has served as a Partner since 2009. Mr. Ren received his Bachelor&#8217;s in Law and his
Bachelor&#8217;s in Economics from Peking University in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>


</div><!-- Field: Page; Sequence: 181; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->172<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>David
Sidransky, M.D. </i></b>has served as a member of our board of directors since March 2021 and our lead independent director since December
2025. Dr. Sidransky currently serves as the director of the Head and Neck Cancer Research Division, Professor of Otolaryngology&#8212;
Head and Neck Surgery, Professor of Cellular and Molecular Medicine, and Professor of Urology and Genetics at The Johns Hopkins University.
Dr. Sidransky also currently serves as Professor of Oncology at the Johns Hopkins Oncology Center. Dr. Sidransky completed a fellowship
in Oncology at The Johns Hopkins University and Hospital in 1992 and was appointed to its faculty that year. Dr. Sidransky is a member
of the American Association of Cancer Research and the American Society of Clinical Oncology and has received certifications from the
American Board of Internal Medicine and the American Board of Medical Oncology. In addition, Dr. Sidransky currently sits on the National
Board of Scientific Advisors of the National Cancer Institute. Dr. Sidransky is a founder of Champions Oncology, Inc. (Nasdaq: CSBR)
and serves as a director of Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD), Orgenesis Inc. (Nasdaq: ORGS) and Ayala Pharmaceuticals, Inc.
(OTCQX: ADXS). He is also Chairman of the Medical Advisory Board of the Flight Attendants Medical Research Foundation and the Adenocystic
Carcinoma Research. Dr. Sidransky has received numerous honors, such as the Israel Cancer Research Fund Osserman Award, the AACR- Richard
and Hinda Rosenthal Foundation Award, the Toby Comet Award Bar Ilan University and the AACR Team Award Theme Circulating DNA. Dr. Sidransky
received his Bachelor&#8217;s in Chemistry from Brandeis University and his M.D. from the Baylor College of Medicine.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shaomeng
Wang, Ph.D. </i></b>is our co-founder and has served as a member of our board of directors since 2017 and as chairman of our Scientific
Advisory Board since 2010. Dr. Wang joined the University of Michigan in 2001 as a tenured faculty and is currently a Warner-Lambert/Parke
Davis Professor in Medicine at the University of Michigan, Ann Arbor, where he also serves as director of the Michigan Center for Therapeutic
Innovation. Prior to that, he served as an Assistant Professor from 1996 to 2000 and as Associate Professor from 2000 to 2001 at the
Georgetown University Medical Center. Dr. Wang received his Bachelor&#8217;s in Chemistry from Peking University in China, his Ph.D.
in Chemistry from Case Western Reserve University and did his postdoctoral training at the National Cancer Institute, National Institutes
of Health. Dr. Wang served as the Editor-in- Chief for the Journal of Medicinal Chemistry, American Chemical Society from 2011 to 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changqing
Ye </i></b>has served as a member of our board of directors since June 2019. From 2011 to 2015, Mr. Ye served as the Managing Director,
Chief Financial Officer and a member of the investment committee at CITIC Private Equity Funds, a PRC-based private equity fund. Prior
to that, from 1993 to 2011, Mr. Ye worked at PricewaterhouseCoopers Zhong Tian LLP, most recently as the Partner and Service Line Leader
of the firm&#8217;s advisory services and transaction services at the firm&#8217;s Shanghai Office. Mr. Ye currently serves as an independent
non-executive director of Baozun Inc. (Nasdaq: BZUN), Niu Technologies (Nasdaq: NIU), Jinxin Fertility Group Limited (HKEX Stock Code:
1951) and Hygeia Healthcare Holdings Co., Limited (HKEX Stock Code: 6078). He previously served as an independent non-executive director
of Luzhou Bank Co., Ltd. (formerly known as Luzhou City Commercial Bank Co., Ltd. (HKEX Stock Code: 1983)), VNET Group, Inc. (Nasdaq:
VNET) and NWTN Inc. (Nasdaq: NWTN). Mr. Ye received his Bachelor&#8217;s in Journalism from Huazhong University of Science and Technology
in China, and his Master&#8217;s in Business Administration from the University of Warwick in the United Kingdom. Mr. Ye has been a Certified
Public Accountant of the PRC since 1994.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Debra
Yu </i></b>has served as a member of our board of directors since November 2024. Ms. Yu has served as Chief Operating Officer and Partner
at Panacea Venture since March 2023. She currently serves as a director of MeiraGTx Holdings PLC (Nasdaq: MGTX) and JW (Cayman) Therapeutics
Co Ltd (HKEX Stock Code: 2126). She served as Chief Strategy Officer, Strategy and President at LianBio and in other positions from October
2019 until December 2022. She previously served as Managing Director and Head of Cross Border Healthcare Investment Banking at China
Renaissance Securities (U.S.), a brokerage firm, from 2016 to 2019. From 2009 to 2016, she served as Managing Director of Labrador Advisors,
LLC. Prior to that, she was Vice President, Strategy at WuXi Apptec between 2008 and 2009, where she helped to architect and co-lead
Pfizer&#8217;s venture capital team, and a member of Pfizer&#8217;s Worldwide Business Development organization between 2005 and 2008.
Prior to that, she was a Bay Area venture investor for several years, serving as General Partner of Delphi Ventures from 1995 to 1998
and Managing Director of Bay City Capital from 1998 to 2001. She has also held positions at McKinsey &amp; Co. in New York and London
between 1992 and 1995, and she began her career as an analyst at Morgan Stanley from 1987 to 1988. She received her Bachelor&#8217;s
degree in Molecular Biology from Princeton University and her M.D. from Harvard Medical School.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 182; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->173<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family
relationships</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Yang and Dr. Zhai are married.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Arrangements
for election of directors and members of management</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">There are
no contracts or other arrangements pursuant to which our executive officers or Directors have been or must be selected.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Compensation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
officer and director compensation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
of chief executive officer</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets out the compensation awarded to Dr. Dajun Yang, our Chairman, Chief Executive Officer and Director, in the fiscal
year ended December 31, 2025</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fees</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fees</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Salaries, allowances and benefits in kind</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Salaries, allowances and benefits in kind</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Share option expenses</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Share option expenses</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Pension scheme contributions(1)</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Pension scheme contributions(1)</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td>
    <td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; width: 30%">Dr. Dajun Yang</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">40,938,595</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">5,854,141</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">617,219</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">88,261</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">219,454</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">31,381</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">41,775,267</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="width: 4%; border-bottom: Black 1.5pt solid; text-align: right">5,973,783</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our PRC subsidiaries are required
    by law to make contributions equal to certain percentages of each employee&#8217;s salary for, among other things, his or her pension
    insurance. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">(2)</td>
    <td style="font-size: 10pt"> A portion of Dr. Dajun Yang&#8217;s &#8220;Salaries, allowances
and benefits&#8221; includes a bonus payment of RMB17,106,000 (USD 2,394,847) which represent the payment for the cancelled RSUs granted
in 2023 and 2024 as his bonus for those years.</td></tr>
  </table><div>

</div><p style="font-size: 10pt; margin-top: 0; margin-bottom: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
of senior management</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets out the aggregate compensation awarded to Dr. Dajun Yang, Dr. Yifan Zhai, and Veet Misra, as a group, in the fiscal year
ended December 31, 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center; font-weight: bold">Short term employee benefits(1)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Short term employee benefits(1)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Equity-settled shares-based payment expenses(2)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Equity-settled shares-based payment expenses(2)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Post-employment benefits(3)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Post-employment benefits(3)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Total</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">(RMB)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">(USD)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">(RMB)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">(USD)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">(RMB)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">(USD)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">(RMB)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">(USD)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 10%; border-bottom: Black 1.5pt solid; text-align: right">55,099,657</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 10%; border-bottom: Black 1.5pt solid; text-align: right">7,879,146</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 10%; border-bottom: Black 1.5pt solid; text-align: right">742,520</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 10%; border-bottom: Black 1.5pt solid; text-align: right">106,179</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 10%; border-bottom: Black 1.5pt solid; text-align: right">711,144</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">101,692</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">56,553,321</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">8,087,017</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relates
                                            to compensation and bonuses to be settled within 12 months of employees rendering services,
                                            recognized as expenses when incurred.</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relates
                                            to awards granted prior to 2025 and settled during 2025, which are disclosed here consistent
                                            with the Company&#8217;s customary practice.</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relates
                                            to amounts contributed by (1) our PRC subsidiaries to statutory PRC post-employment programs,
                                            or (2) our U.S. subsidiary to its defined contribution 401(k) savings plan, as applicable.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 183; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->174<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
of directors</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets out the compensation awarded to our non-executive directors in the fiscal year ended December 31, 2025.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 11pt; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fees</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fees</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Allowances and Benefits in Kind(1)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Allowances and Benefits in Kind(1)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Share Option Expenses</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Share Option Expenses</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RSU Expense(2)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RSU Expense(2)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Pension Scheme Contributions</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Pension Scheme Contributions</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; border-bottom: Black 1.5pt solid">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(RMB)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic">Non-Executive Directors</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 22%; font-weight: bold; text-align: left">Dr. Shaomeng Wang</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">428,573</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">61,285</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">1,181,254</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">168,917</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#8212;</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#8212;</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">294,571</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">42,123</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#8212;</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#8212;</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">1,904,398</td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">272,325</td><td style="width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Dr. Simon Dazhong Lu</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294,571</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294,571</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,123</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left">Independent Non-Executive Directors</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Mr. Changqing Ye</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,285</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">307,521</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,975</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">736,094</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,260</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Mr. Wei Ren</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,285</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">307,521</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,975</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">736,094</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,260</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Dr. David Sidransky</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,285</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">307,521</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,975</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">736,094</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,260</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">238,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,606</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Marc E. Lippman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,285</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294,571</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">723,144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,408</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Marina Bozilenko<sup>(4)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,285</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294,571</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">723,144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,408</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Debra Yu<sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,285</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294,571</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">723,144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,408</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relates to payments to be settled
    within 12 months of Directors rendering services, recognized as expenses when incurred.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"/>
    <td style="font-size: 10pt"/></tr>
  </table><div>


</div><p style="text-align: left; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relates
                                            to awards granted prior to 2025 and settled during 2025, which are disclosed here consistent
                                            with the Company&#8217;s customary practice.</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
incentive plans</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2018
restricted share unit scheme</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
2018 RSU Plan was originally adopted in July 2018.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
2018 RSU Plan allows us to provide RSUs to existing or incoming employees, directors or officers of ours, our subsidiaries and companies
whose financial results have been consolidated and accounted as subsidiaries of Ascentage Pharma by virtue of the contractual arrangements.</span></p><div>


</div><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 184; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->175<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our 2018 RSU Plan, we may issue RSUs covering a maximum of 5,274,657 ordinary shares. As of December 31, 2025, there were 6,294 RSUs
covering ordinary shares outstanding under our 2018 RSU Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purpose
of the 2018 RSU plan</i>. The purpose of our 2018 RSU Plan was to incentivize the existing and incoming directors, senior management
and employees for their contribution to our Company and to attract, motivate and retain skilled and experienced personnel to strive for
the future development and expansion of our Company by providing them with the opportunity to own equity interests in our Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Plan
administration</i>. Our 2018 RSU Plan is administered by our board of Directors or a duly authorized committee of our board of directors,
or the Administrator. The decision of the Administrator as to all matters relating to our 2018 RSU Plan or its interpretation or effect
is final and binding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
appointed a trustee to assist with the administration and vesting of RSUs granted pursuant to our 2018 RSU Plan. All ordinary shares
underlying the RSUs granted and to be granted under the RSU 2018 Plan are or were transferred, allotted or issued to the trustee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Eligibility</i>.
Existing or incoming employees, directors (whether executive or non-executive) or officers of the Company or any member of our Company
were eligible to receive grants of RSUs.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>Restricted
share units</i>. Each RSU represents one underlying ordinary share, and represent a conditional right granted to any participant to obtain
the corresponding economic value of the underlying ordinary shares, less any tax, stamp duty and other charges applicable, as determined
by the Administrator in its absolute discretion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the provisions of our 2018 RSU Plan, the Administrator determines the terms and conditions of RSUs, including the vesting criteria
and the timing of payment. Each award of RSUs is evidenced by a grant letter setting forth the material terms of such award.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Within a
reasonable time after the vesting criteria, conditions and time schedule have been reached, fulfilled, satisfied or waived, the Administrator
will send a vesting notice to each relevant participant confirming the extent to which the vesting criteria, conditions and time schedule
have been reached, fulfilled, satisfied or waived, and the number of ordinary shares (and, if applicable, the cash or non-cash income,
dividends or distributions and/or the sale proceeds of non-cash and non-scrip distributions in respect of those ordinary shares) involved.
RSUs that are vested may be exercised (in whole or in part) by serving an exercise notice in writing on the trustee and copied to the
Company on the terms set forth in the letter of grant, vesting notice or other applicable agreement between the Company and a participant.
Unvested RSUs terminate on a participant&#8217;s termination of employment or service or upon an attempt to transfer or encumber the
RSUs in an impermissible manner under the terms of our 2018 RSU Plan. Additionally, RSUs will be forfeited if a participant breaches
certain restrictive covenants set forth in our 2018 RSU Plan.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator may at its discretion cancel any RSU that has not vested or lapsed, provided that the Company must either (1) cash out
the RSUs, (2) grant a replacement award of equivalent value, or (3) make other arrangements to compensate the applicable participant.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>


</div><!-- Field: Page; Sequence: 185; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->176<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-transferability
of Awards</i>. The RSUs granted under our 2018 RSU Plan are personal to each participant and are not assignable. Participants are prohibited
from selling, transferring, assigning, charging, mortgaging, encumbering, hedging or creating any interest in favor of any other person
over or in relation to any property held by the trustee on trust for the participants, the RSUs, or any interest or benefits therein.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>Certain
adjustments</i>. In the event of any capitalization issue, rights issue, consolidation, sub-division or reduction of the share capital
of the Company, the Administrator may make such equitable adjustments, designed to protect participants&#8217; interests, to the number
of ordinary shares underlying the outstanding RSUs or to the amount of the equivalent value, as it may deem appropriate at its absolute
discretion.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
transactions</i>. If a general offer to acquire the ordinary shares (whether by takeover offer, merger, or otherwise in a like manner)
is made to all of the shareholders of the Company (or shareholders other than the offeror and/or any person controlled by the offeror
and/or any person acting in concert with the offeror) and the general offer to acquire the ordinary shares is approved and the offer
becomes or is declared unconditional in all respects, a participant&#8217;s RSUs will vest immediately, even if the vesting period has
not yet commenced.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If a compromise
or arrangement between the Company and its shareholders or creditors is proposed in connection with a scheme for the reconstruction of
the Company or its amalgamation with any other company or companies and a notice is given by the Company to its shareholders to convene
a general meeting to consider and if thought fit approve such compromise or arrangement and such shareholders&#8217; approval is obtained,
a participant&#8217;s RSUs will vest immediately, even if the vesting period has not yet commenced.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If, prior
to the termination of our 2018 RSU Plan, an effective resolution is passed for the voluntary winding-up of the Company (other than for
the purposes of a reconstruction, amalgamation or scheme of arrangement), all outstanding RSUs shall be treated as having vested immediately.
No ordinary shares will be transferred, and no cash alternative will be paid, to the participant, but the participant will be entitled
to receive out of the assets available in liquidation on an equal basis with the Company&#8217;s shareholders such sum as they would
have received in respect of the RSUs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>Amendment
and termination</i>. Our board of directors may, at any time, terminate or amend our 2018 RSU Plan in any respect, provided that consent
is needed for material amendments to the 2018 RSU Plan or amendment of awards which are materially adverse to a participant.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2021
Restricted Share Unit Scheme</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Our 2021 Restricted
Share Unit Scheme, or 2021 RSU Plan, was adopted in February 2021 and amended in April 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Our 2021 RSU
Plan allows us to provide RSUs to existing or incoming employees, directors or officers of our Company or any member of our group or
a service provider (as defined in the 2021 RSU Plan).</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our 2021 RSU Plan, we may issue RSUs covering a maximum of 3,133,526 ordinary shares. As of December 31, 2025, RSUs covering 443,127
ordinary shares were outstanding under our 2021 RSU Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purpose
of the 2021 RSU plan</i>. The purpose of our 2021 RSU Plan was to incentivize the existing and incoming directors, senior management
and employees for their contribution to our Company and to attract, motivate and retain skilled and experienced personnel to strive for
the future development and expansion of our Company by providing them with the opportunity to own equity interests in the Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Plan
administration</i>. Our 2021 RSU Plan is administered by the plan Administrator (which is similarly defined under the 2021 RSU Plan as
under our 2018 RSU Plan). The decision of the Administrator as to all matters relating to our 2021 RSU Plan or its interpretation or
effect is final and binding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
appointed a trustee to assist with the administration and vesting of RSUs granted pursuant to our 2021 RSU Plan. All ordinary shares
underlying the RSUs granted and to be granted under the RSU 2021 Plan are or were transferred, allotted or issued to the trustee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Eligibility</i>.
Existing or incoming employees, directors (whether executive or non-executive) or officers of the Company or any member of our group
or a service provider (as defined in the 2021 RSU Plan) were eligible to receive grants of RSUs.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
share units</i>. Each RSU represents one underlying ordinary share, and represent a conditional right granted to any participant to obtain
the corresponding economic value of the underlying ordinary shares, less any tax, stamp duty and other charges applicable, as determined
by the Administrator in its absolute discretion. Subject to the provisions of our 2021 RSU Plan, the Administrator determines the terms
and conditions of RSUs, including the vesting criteria and the timing of payment. Each award of RSUs is evidenced by a grant letter setting
forth the material terms of such award.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Within a
reasonable time after the vesting criteria, conditions and time schedule have been reached, fulfilled, satisfied or waived, the Administrator
will send a vesting notice to each relevant participant confirming the extent to which the vesting criteria, conditions and time schedule
have been reached, fulfilled, satisfied or waived, and the number of ordinary shares (and, if applicable, the cash or non-cash income,
dividends or distributions and/or the sale proceeds of non-cash and non-scrip distributions in respect of those ordinary shares) involved.
Unvested RSUs terminate on a participant&#8217;s termination of employment or service or upon an attempt to transfer or encumber the
RSUs in an impermissible manner under the terms of our 2021 RSU Plan, provided that the Administrator may choose to accelerate the vesting
of unvested RSUs within 30 days following a participant&#8217;s termination of service due to death. Additionally, RSUs will be forfeited
if a participant breaches certain restrictive covenants set forth in our 2021 RSU Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>


</div><!-- Field: Page; Sequence: 186; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->177<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator may at its discretion cancel any RSU that has not vested or lapsed, provided that the Company must either (1) cash out
the RSUs, (2) grant a replacement award of equivalent value, or (3) make other arrangements to compensate the applicable participant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Non-transferability
of Awards</i>. The RSUs granted under our 2021 RSU Plan are personal to each participant and are not assignable. Participants are prohibited
from selling, transferring, assigning, charging, mortgaging, encumbering, hedging or creating any interest in favor of any other person
over or in relation to any property held by the trustee on trust for the participants, the RSUs, or any interest or benefits therein.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Certain adjustments</i>.
In the event of any capitalization issue, rights issue, consolidation, sub-division or reduction of the share capital of the Company,
the Administrator may make such equitable adjustments, designed to protect participants&#8217; interests, to the number of ordinary shares
underlying the outstanding RSUs or to the amount of the equivalent value, as it may deem appropriate in accordance with the
guidance of the Hong Kong Stock Exchange issued from time to time and as the auditors or the independent financial adviser of the Company
retained for such purpose shall certify in writing to the Board to be in their opinion fair and reasonable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Corporate
transactions</i>. If a general offer to acquire the ordinary shares (whether by takeover offer, merger, or otherwise in a like manner)
is made to all of the shareholders of the Company (or shareholders other than the offeror and/or any person controlled by the offeror
and/or any person acting in concert with the offeror) and the general offer to acquire the ordinary shares is approved and the offer
becomes or is declared unconditional in all respects, an employee participant&#8217;s RSUs will vest immediately, even if the vesting
period has not yet commenced.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">If a compromise
or arrangement between the Company and its shareholders or creditors is proposed in connection with a scheme for the reconstruction of
the Company or its amalgamation with any other company or companies and a notice is given by the Company to its shareholders to convene
a general meeting to consider and if thought fit approve such compromise or arrangement and such shareholders&#8217; approval is obtained,
an employee participant&#8217;s RSUs will vest immediately, even if the vesting period has not yet commenced.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">If, prior to
the termination of our 2021 RSU Plan, an effective resolution is passed for the voluntary winding-up of the Company (other than for the
purposes of a reconstruction, amalgamation or scheme of arrangement), all outstanding RSUs of an employee participant shall be treated
as having vested immediately. No ordinary shares will be transferred, and no cash alternative will be paid, to the participant, but the
participant will be entitled to receive out of the assets available in liquidation on an equal basis with the Company&#8217;s shareholders
such sum as they would have received in respect of the RSUs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Amendment
and termination</i>. Subject to the 2021 RSU Plan and the compliance with the Hong Kong Listing Rules, save for any alterations to the
2021 RSU Plan which are of a material natural of any alterations to the provisions relating to the matters set out in Rule 17.03 of the
Hong Kong Listing Rule to the advantage of the participants must be approved by the shareholders in general meeting, the Board may amend
any of the provisions of the 2021 RSU Plan (including without limitation to amendments in order to comply with changes in legal or regulatory
requirements and amendments in order to waive any restrictions, imposed by the provisions of the 2021 RSU Plan, which are not found in
Chapter 17 of the Hong Kong Listing Rules) at any time. Subject to compliance with the Hong Kong Listing Rules, any change to the terms
of the awards granted to a participant must be approved by our board of directors, the Remuneration Committee, the independent non-executive
Directors and/or the shareholders of the Company, as the case may be, if the initial grant of the awards was approved by our board of
directors, the Remuneration Committee, the independent non-executive Directors and/or the shareholders of the Company, correspondingly.
This requirement does not apply to the alterations that take effect automatically under the existing terms of the 2021 RSU Plan. The
amended terms of the 2021 RSU Plan must still comply with the applicable provisions of the Hong Kong Listing Rules. Our board of directors
may terminate the 2021 RSU Plan at any time before the expiry of the relevant scheme period.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>2022 restricted
share unit scheme</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Our 2022 Restricted
Share Unit Scheme, or 2022 RSU Plan, was adopted in June 2022 and amended in May 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Our 2022 RSU
Plan allows us to provide RSUs to existing or incoming employees, directors or officers of our Company or any member of our group or
a service provider (as defined in the 2022 RSU Plan).</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our 2022 RSU Plan, we may issue RSUs covering a maximum of the amount equal to 2% of the ordinary shares in issue as of the date of adoption,
or 11,072,695 ordinary shares. As of December 31, 2025, RSUs covering 5,582,518 ordinary shares were outstanding under our 2022 RSU Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purpose
of the 2022 RSU plan</i>. The purpose of our 2022 RSU Plan was to incentivize the existing and incoming directors, senior management
and employees for their contribution to our Company and to attract, motivate and retain skilled and experienced personnel to strive for
the future development and expansion of our Company by providing them with the opportunity to own equity interests in the Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Plan
administration</i>. Our 2022 RSU Plan is administered by the plan Administrator (which is similarly defined under the 2022 RSU Plan as
under our 2018 RSU Plan). The decision of the Administrator as to all matters relating to our 2022 RSU Plan or its interpretation or
effect is final and binding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
appointed a trustee to assist with the administration and vesting of RSUs granted pursuant to our 2022 RSU Plan. All ordinary shares
underlying the RSUs granted and to be granted under the RSU 2022 Plan are or were transferred, allotted or issued to the trustee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Eligibility</i>.
Existing or incoming employees, directors (whether executive or non-executive) or officers of the Company or any member of our group
or a service provider (as defined in the 2022 RSU Plan were eligible to receive grants of RSUs.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>


</div><!-- Field: Page; Sequence: 187; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->178<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
share units</i>. Each RSU represents one underlying Share, and represent a conditional right granted to any participant to obtain the
corresponding economic value of the underlying ordinary shares, less any tax, stamp duty and other charges applicable, as determined
by the Administrator in its absolute discretion. Subject to the provisions of our 2022 RSU Plan, the Administrator determines the terms
and conditions of RSUs, including the vesting criteria and the form and timing of payment. Each award of RSUs is evidenced by a grant
letter setting forth the material terms of such award.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Within a reasonable
time after the vesting criteria, conditions and time schedule have been reached, fulfilled, satisfied or waived, the Administrator will
send a vesting notice to each relevant participant confirming the extent to which the vesting criteria, conditions and time schedule
have been reached, fulfilled, satisfied or waived, and the number of ordinary shares (and, if applicable, the cash or non-cash income,
dividends or distributions and/or the sale proceeds of non-cash and non-scrip distributions in respect of those ordinary shares) involved.
Unvested RSUs terminate on a participant&#8217;s termination of employment or service or upon an attempt to transfer or encumber the
RSUs in an impermissible manner under the terms of our 2022 RSU Plan, provided that unvested RSUs will remain outstanding for 3 months
following termination of employment or service. Additionally, RSUs will be forfeited if a participant breaches certain restrictive covenants
set forth in our 2022 RSU Plan and any shares or consideration previously transferred to a participant in respect of RSUs may be recoverable
by the trustee in accordance with the terms of our 2022 RSU Plan.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator, in its sole discretion, may pay earned RSUs in the form of cash, in shares or in some combination thereof. The Administrator
may at its discretion cancel any RSU that has not vested or lapsed, provided that the Company must either (1) cash out the RSUs, (2)
grant a replacement award of equivalent value, or (3) make other arrangements to compensate the applicable participant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-transferability
of Awards</i>. The RSUs granted under our 2022 RSU Plan are personal to each participant and are not assignable. Participants are prohibited
from selling, transferring, assigning, charging, mortgaging, encumbering, hedging or creating any interest in favor of any other person
over or in relation to any property held by the trustee on trust for the participants, the RSUs, or any interest or benefits therein.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>Certain
adjustments</i>. In the event of any capitalization issue, rights issue, consolidation, sub-division or reduction of the share capital
of the Company, the Administrator may make such equitable adjustments, designed to protect participants&#8217; interests, to the number
of ordinary shares underlying the outstanding RSUs or to the amount of the equivalent value, as it may deem appropriate in accordance
with the guidance of the Hong Kong Stock Exchange issued from time to time and as the auditors or the independent financial adviser of
the Company retained for such purpose shall certify in writing to the Board to be in their opinion fair and reasonable.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
transactions</i>. If a general offer to acquire the ordinary shares (whether by takeover offer, merger, or otherwise in a like manner)
is made to all of the shareholders of the Company (or shareholders other than the offeror and/or any person controlled by the offeror
and/or any person acting in concert with the offeror) and the general offer to acquire the ordinary shares is approved and the offer
becomes or is declared unconditional in all respects, a participant&#8217;s RSUs will vest immediately, even if the vesting period has
not yet commenced.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If a compromise
or arrangement between the Company and its shareholders or creditors is proposed in connection with a scheme for the reconstruction of
the Company or its amalgamation with any other company or companies and a notice is given by the Company to its shareholders to convene
a general meeting to consider and if thought fit approve such compromise or arrangement and such shareholders&#8217; approval is obtained,
an employee participant&#8217;s RSUs will vest immediately, even if the vesting period has not yet commenced.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If, prior
to the termination of our 2022 RSU Plan, an effective resolution is passed for the voluntary winding-up of the Company (other than for
the purposes of a reconstruction, amalgamation or scheme of arrangement), all outstanding RSUs of an employee participant shall be treated
as having vested immediately. No ordinary shares will be transferred, and no cash alternative will be paid, to the participant, but the
participant will be entitled to receive out of the assets available in liquidation on an equal basis with the Company&#8217;s shareholders
such sum as they would have received in respect of the RSUs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>Amendment
and termination</i>. Subject to the 2022 RSU Plan and the compliance with the Hong Kong Listing Rules, save for any alterations to the
2022 RSU Plan which are of a material natural of any alterations to the provisions relating to the matters set out in Rule 17.03 of the
Hong Kong Listing Rule to the advantage of the participants must be approved by the shareholders in general meeting, the Board may amend
any of the provisions of the 2022 RSU Plan (including without limitation to amendments in order to comply with changes in legal or regulatory
requirements and amendments in order to waive any restrictions, imposed by the provisions of the 2022 RSU Plan, which are not found in
Chapter 17 of the Hong Kong Listing Rules) at any time. Subject to compliance with the Hong Kong Listing Rules, any change to the terms
of the awards granted to a participant must be approved by our board of directors, the Remuneration Committee, the independent non-executive
Directors and/or the shareholders of the Company, as the case may be, if the initial grant of the awards was approved by our board of
directors, the Remuneration Committee, the independent non-executive Directors and/or the shareholders of the Company, correspondingly.
This requirement does not apply to the alterations that take effect automatically under the existing terms of the 2022 RSU Plan. The
amended terms of the 2022 RSU Plan must still comply with the applicable provisions of the Hong Kong Listing Rules. Our board of directors
may terminate the 2022 RSU Plan at any time before the expiry of the relevant scheme period.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pre-IPO
share option scheme</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Pre-IPO Share Option Scheme, or Pre-IPO Option Plan, was adopted in July 2018.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Pre-IPO Option Plan allows us to provide options to purchase ordinary shares, or Options, to substantial shareholders, existing or incoming
employees, directors or officers, or any other service providers of our Company. Our Pre-IPO Option Plan was terminated but continues
to govern the terms and conditions of the outstanding awards previously granted under our Pre-IPO Option Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2025, there were no options covering ordinary shares outstanding under our Pre-IPO Option Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 188; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->179<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purpose
of the Pre-IPO Option Plan</i>. The purpose of our Pre-IPO Option Plan was to reward participants who contributed or would contribute
to our Company and to encourage participants to continue to work for our Company towards enhancing the value of the ordinary shares to
benefit our Company and our shareholders as a whole.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Plan
administration</i>. Our Pre-IPO <i>option plan</i> is administered by the plan Administrator (which is similarly defined under the Pre-IPO
Option Plan as under our 2018 RSU Plan). The decision of the Administrator as to all matters relating to our Pre-IPO Option Plan or its
interpretation or effect is final and binding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility</i>.
Substantial shareholders, existing or incoming employees, directors or officers, or any other service providers of our Company were eligible
to receive grants of Options.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options.</i>
Options can be granted under our Pre-IPO Option Plan. The exercise price of Options granted under our Pre-IPO Option Plan is HK$0.01
per ordinary share. The Administrator determined the material terms of Options granted under our Pre-IPO Option Plan, which material
terms were included in an offer letter issued to each participant under our Pre-IPO Option Plan, including (1) the minimum period for
which the Options must be held before they can be exercised; (2) a performance target that must be reached before the Options can be
exercised in whole or in part; and/or (3) any other terms, all of which may be imposed (or not imposed) either on a case-by-case basis
or generally. Options are only considered granted in respect of timely accepted offer letters and on the terms set forth in such offer
letters. Options must be exercised within the exercise period set forth in an applicable offer letter, which will not exceed 10 years
from the date of such offer. Generally, subject to an applicable Option expiration date, a grantee may exercise the then exercisable
portion of an Option for 3 months following termination of service, provided that (1) if a grantee dies before exercising an Option,
his or her legal representative may exercise the Option within 12 months following the grantee&#8217;s death, and (2) Options will automatically
terminate in full if a grantee commits certain acts specified in Section 5(d) of our Pre-IPO Option Plan. Options will also expire upon
the date of commencement of a winding up of the Company, upon the effectiveness of a compromise or arrangement, or, if a grantee is solely
a substantial shareholder, on the date on which such grantee ceases to be a substantial shareholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-transferability
of Options</i>. Options are personal to the grantee and are not assignable or transferable. Options may not be sold, transferred, charged,
mortgaged, or encumbered.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain
adjustments</i>. In the event of an alteration in the capital structure of the Company while any Options remain exercisable by way of
capitalization of profits or reserves, bonus issue, rights issue, open offer, subdivision or consolidation of shares, or reduction of
the share capital of the Company in accordance with legal requirements, corresponding adjustments (if any) will be made to the number
of ordinary shares and exercise price of outstanding Options. Grantees will be notified in writing in the event of any such adjustments.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
transactions</i>. In the event of a general offer being made to all the shareholders, we will make best efforts to ensure that an appropriate
offer is extended to all grantees. Upon such offer becoming or being declared unconditional, the grantee will be entitled to exercise
the Option in full (to the extent not already lapsed or exercised) at any time within 1 month after the date on which the offer becomes
or is declared unconditional.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a compromise or arrangement between the Company and the shareholders or its creditors being proposed in connection with
a scheme for the reconstruction of the Company or its amalgamation with any other company or companies pursuant to the Company&#8217;s
bylaws, the Company will give notice to all grantees and Options (to the extent not already lapsed or exercised) will become exercisable
in whole or in part not later than 2 business days prior to the date of the general meeting directed to be convened by the court for
the purposes of considering such compromise or arrangement, or the Suspension Date. With effect from the Suspension Date, the rights
of all grantees to exercise their respective Options will be suspended and forfeited.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a general meeting is convened to consider a voluntary resolution to wind-up the Company, the Company will provide notice to each grantee
of entitlement to exercise all or any Options (to the extent not already lapsed or exercised) at any time not later than 2 business days
prior to the proposed general meeting of the Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment
and termination</i>. Specific provisions of our Pre-IPO Option Plan which relate to certain listing rules applicable to the Stock Exchange
of Hong Kong Limited cannot be altered to the advantage of participants, and changes to the authority of the Administrator may not be
made without the prior approval of our shareholders. Any alterations to the terms and conditions of our Pre-IPO Option Plan which are
of a material nature, or any change to the terms of Options granted, must also, to be effective, be approved by our shareholders, except
where the alterations take effect automatically under the existing terms of our Pre-IPO Option Plan. As noted above, our Pre-IPO Option
Plan was terminated, and we will not grant any additional awards under our Pre-IPO Option Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Post-IPO
share option scheme</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Our Post-IPO
Share Option Scheme, or Post-IPO Option Plan, was adopted in September 2019 and amended in May 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Our Post-IPO
Option Plan allows us to provide Options to (a) any executive director of, manager of, or other employee holding an executive, managerial,
supervisory or similar position in any member of our Company, any full- time or part-time employee, or a person for the time being seconded
to work full-time or part-time for any member of our Company; (b) a director or proposed director (including an independent non-executive
director) of any member of our Company; and (c) a service provider (as defined in the Post-IPO Share Option Scheme), or Eligible Persons.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment, the maximum aggregate number of ordinary shares which may be issued subject to options under our Post-IPO Option Plan
is </span><span style="font-family: Times New Roman, Times, Serif">14,907,464 <span style="font-size: 10pt">ordinary shares. </span></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2025, there were no options covering ordinary shares outstanding under our Post-IPO Option Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>


</div><!-- Field: Page; Sequence: 189; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->180<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purpose
of the Post-IPO option plan</i>. The purpose of our Post-IPO Option Plan is to enable the Company to grant Options to Eligible Persons
as incentives or rewards for their contribution or potential contribution to our Company and to provide the Eligible Persons an opportunity
to have a personal stake in the Company with the view to motivate the Eligible Persons to optimize their performance efficiency for the
benefit of our Company, attract and retain or otherwise maintain on-going business relationship with the Eligible Persons whose contributions
are or will be beneficial to the long-term growth of our Company, and/or for such purposes as the Administrator (which is similarly defined
under the Post-IPO Option Plan as under our 2018 RSU Plan) shall determine.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Plan administration</i>.
Our Post-IPO Option Plan is administered by the plan Administrator. The decision of the Administrator as to all matters relating to our
Post-IPO Option Plan or its interpretation or effect is final and binding. Notwithstanding the foregoing, subject to the Post-IPO Option
Plan, if the Board determines to make an Offer to a substantial shareholder or an independent non-executive Director (or any of their
respective associates) and that grant would result in the Shares issued and to be issued upon exercise of all options and awards already
granted and to be granted (including options and awards exercised, cancelled and outstanding but excluding any options and awards lapsed
in accordance with the terms of their respective schemes) to such person under this Scheme and the other schemes in the 12-month period
up to and including the Offer Date representing in aggregate over 0.1 per cent, or such other percentage as may be from time to time
provided under the Listing Rules, of the Shares in issue (excluding treasury Shares) on the Offer Date such grant shall be subject to,
in addition to the approval of the independent non-executive Directors as referred to under the Post-IPO Option Plan, the issue of a
circular by the Company to the Shareholders and the approval of the Shareholders in general meeting by way of a poll convened and held
in accordance with the Articles at which the Grantee, his associates and all core connected persons of the Company shall abstain from
voting in favor of the resolution concerning the grant of such Options at the general meeting, and/or such other requirements prescribed
under the Hong Kong Listing Rules from time to time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Eligibility</i>.
Eligible Persons (which consist of (a) any executive director of, manager of, or other employee holding an executive, managerial, supervisory
or similar position in any member of our Company, any full-time or part-time employee, or a person for the time being seconded to work
full-time or part-time for any member of our Company; (b) a director or proposed director (including an independent non-executive director)
of any member of our Company; and (c) a service provider (as defined in the Post-IPO Share Option Scheme) are eligible to receive grants
of Options under our Post-IPO Option Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Options.</i>
Options can be granted under our Post-IPO Option Plan. The exercise price of Options granted under our Post-IPO Option Plan is determined
by the Administrator but generally will not be less than the highest of the closing price of the Shares as stated in the daily quotation
sheets of the Hong Kong Stock Exchange on the Offer Date, and the average of the closing price of the Shares as stated in the daily quotation
sheets of the Stock Exchange for the five Business Days immediately preceding the Offer Date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator determines the material terms of Options granted under our Post-IPO Option Plan, which material terms are included in an
offer letter issued to each participant under our Post-IPO Option Plan, including the number of ordinary shares subject to an Option,
the applicable exercise price, the vesting schedule, expiration date and the method of acceptance. Options must be exercised within the
exercise period set forth in an applicable offer letter, which will not exceed 10 years from the date of such offer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
subject to an applicable Option expiration date, a grantee may exercise the then exercisable portion of an Option for 3 months following
termination of service, provided that (1) if a grantee dies before exercising an Option, his or her legal representative may exercise
the Option within 12 months following the grantee&#8217;s death, and (2) Options will automatically terminate in full if a grantee commits
certain acts specified in Section 8(d) of our Post-IPO Option Plan. Options will also expire upon the date of commencement of a winding
up of the Company, upon the effectiveness of a compromise or arrangement, or, if a grantee is solely a substantial shareholder, on the
date on which such grantee ceases to be a substantial shareholder. Additionally the Administrator may cancel Options if a grantee breaches
the transferability provisions of our Post-IPO Option Plan or other terms or conditions of the grant of an Option, or if a grantee engages
in conduct that is detrimental or prejudicial to the interests of the Company or its subsidiaries, as determined by the Administrator
in its discretion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-transferability
of Options</i>. Options are personal to the grantee and are not assignable or transferable. Options may not be sold, transferred, charged,
mortgaged, or encumbered.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain
adjustments</i>. In the event of any capitalization issue, rights issue, sub-division or consolidation of shares or reduction of capital
of the Company in accordance with applicable laws and regulatory requirements, such corresponding alterations (if any) shall be made
(except on an issue of securities of the Company as consideration in a transaction which shall not be regarded as a circumstance requiring
alteration or adjustment) in the number of ordinary shares subject to any outstanding Options and the Exercise Price of outstanding Options.
The Company will notify affected participants of any such adjustments.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Corporate
transactions</i>. In the event of a general offer being made to all the shareholders, we will make best efforts to ensure that an appropriate
offer is extended to all grantees. Upon such offer becoming or being declared unconditional, the employee participant will be entitled
to exercise the Option in full (to the extent not already lapsed or exercised) at any time within 1 month after the date on which the
offer becomes or is declared unconditional.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">In the event
of a compromise or arrangement between the Company and the shareholders or its creditors being proposed in connection with a scheme for
the reconstruction of the Company or its amalgamation with any other company or companies pursuant to the Company&#8217;s bylaws, the
Company will give notice to all grantees and Options (to the extent not already lapsed or exercised) granted to an employee participant
will become exercisable in whole or in part not later than 2 business days prior to the date of the general meeting directed to be convened
by the court for the purposes of considering such compromise or arrangement, or the Post-IPO Suspension Date. With effect from the Post-IPO
Suspension Date, the rights of all grantees to exercise their respective Options will be suspended and forfeited.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">If a general
meeting is convened to consider a voluntary resolution to wind-up the Company, the Company will provide notice to each employee participant
of entitlement to exercise all or any Options (to the extent not already lapsed or exercised) at any time not later than 2 business days
prior to the proposed general meeting of the Company.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>


</div><!-- Field: Page; Sequence: 190; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->181<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><i>Amendment
and termination</i>. Subject to our Post-IPO Option Plan, and the compliance with the Hong Kong Listing Rules, save for any alternations
to our Post-IPO Option Plan which are of a material natural of any alterations to the provisions relating to the matters set out in Rule
17.03 of the Hong Kong Listing Rules to the advantage of the participants must be approved by the Shareholders in general meeting, the
Board may amend any of the provisions of our Post-IPO Option Plan (including without limitation to amendments in order to comply with
changes in legal or regulatory requirements and amendments in order to waive any restrictions, imposed by the provisions of our Post-IPO
Option Plan, which are not found in Chapter 17 of the Hong Kong Listing Rules) at any time. Subject to compliance with the Hong Kong
Listing Rules, any change to the terms of the Options granted to a participant must be approved by our board of directors, the Remuneration
Committee, the independent non-executive Directors and/or the shareholders of the Company, as the case may be, if the initial grant of
the Options was approved by our board of directors, the Remuneration Committee, the independent non-executive Directors and/or the shareholders
of the Company, correspondingly. This requirement does not apply to the alterations take effect automatically under the existing terms
of our Post-IPO Option Plan. The amended terms of our Post-IPO Option Plan must still comply with the applicable provisions of the Hong
Kong Listing Rules.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes, as of April 20, 2026, the number of ordinary shares underlying outstanding options and RSUs that we have granted
to our directors and executive officers under our equity incentive plans.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Ordinary Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Underlying</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Price</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding Awards</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(US$/Share)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date of Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date of Expiration</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Executive Officers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Dajun Yang, M.D., Ph.D.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">46,972</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 11%; vertical-align: top">19-May-23</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="vertical-align: top; width: 9%; text-align: center"><span style="font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Yifan Zhai, M.D., Ph.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">126,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">19-May-23</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">23-Jun-22</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Veet Misra, Ph.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-Employee Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Simon Dazhong Lu, Ph.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,457</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.013</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">August 15, 2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">26-Nov-25</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">N/A</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Wei Ren</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">23-Jul-21</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,990</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">26-Nov-25</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">N/A</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">David Sidransky, M.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,641</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">17-May-21</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,990</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">26-Nov-25</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">N/A</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Changqing Ye</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">23-Jul-21</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,990</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">26-Nov-25</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">N/A</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Debra Yu, M.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;10,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">26-Nov-25</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">N/A</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Marina S. Bozilenko</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">26-Nov-25</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">N/A</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Marc E. Lippman, M.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; vertical-align: top">26-Nov-25</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">N/A</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shaomeng Wang, Ph.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;&#160;26-Nov-25&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">N/A</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">All directors and executive officers as a group</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,255,070</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#8212;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="vertical-align: top; text-align: center">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
agreements and indemnification agreements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dajun
Yang labor contract</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Dr. Yang&#8217;s
services in China are governed by a Labor Contract with Suzhou Ascentage Pharma Co., Ltd., or the Yang Labor Contract. The Yang Labor
Contract has a term of five years, ending July 31, 2027, and provides for salary, and transportation, meal and communication subsidies.
Other than in connection with a certain enumerated breaches or actions by Dr. Yang or by Suzhou Ascentage Pharma Co., Ltd., the Yang
Labor Contract may only be terminated in accordance with the Labor Contract Law of the People&#8217;s Republic of China. Dr. Yang is
also subject to customary invention assignment and confidentiality provisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yifan
Zhai labor contract</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Zhai&#8217;s services in China are governed by a Labor Contract with Guangzhou Healthquest Pharma Co., Ltd., or the Zhai Labor Contract.
The new Zhai Labor Contract has no fixed term and provides for salary, and transportation, meal and communication subsidies. Other than
in connection with an enumerated breaches or actions by Dr. Zhai or by Guangzhou Healthquest Pharma Co., Ltd., the Zhai Labor Contract
may only be terminated in accordance with the Labor Contract Law of the People&#8217;s Republic of China. Dr. Zhai is also subject to
customary invention assignment and confidentiality provisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 191; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->182<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Veet
Misra offer letter</i></span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">In June
2025, Ascentage Pharma Group Inc. entered into an employment letter agreement with Dr. Misra, our Chief Financial Officer, or the
Misra Employment Letter. The Misra Employment Letter has no specific term and provides for at-will employment. In accordance with
the Misra Employment Letter, Dr. Misra is currently eligible for an annual salary of USD$525,000, and an annual bonus opportunity of
40% of his annual salary, and Dr. Misra is eligible for reimbursement of expenses incurred by him in connection with rendering
services. Also in June 2025, Ascentage Pharma Group International awarded, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
to approval by the board of directors and compliance with the relevant laws and regulations (including the Rules Governing the
Listing of Securities on The Stock Exchange Of Hong Kong Limited or Listing Rules)<span style="text-decoration:underline">,</span></span> sign-on equity incentive RSUs with
a value of $1,500,000 and Options with a value of $500,000 to vest in equal tranches over a four year period beginning with the
first tranche vesting after the first anniversary of the date of employment. He was also awarded an annual performance incentive
RSUs with a fair value of $600,000 and Options with a fair value of $600,000 each of which vest based on the successful attainment
of specific performance measures. Both the sign-on incentive and annual performance incentive awards will be granted on such terms
and provisions as are contained in the 2022 RSU Plan and the Post IPO Option Plan, respectively, Dr. Misra is also subject to
customary invention assignment, confidentiality, and non-solicitation provisions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shaomeng
Wang Service Agreement</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, Ascentage Pharma Group Corp Limited entered into an independent contractor service agreement with Dr. Wang, or the Wang Service
Agreement. The Wang Service Agreement provides (1) for a term of three years ending March 1, 2025, which has been extended to March 1,
2027, (2) for annual compensation during the term in the amount of US$165,375 per year, paid monthly, and (3) that Dr. Wang is eligible
for reimbursement of expenses incurred by him in connection with rendering services to the Company, including related travel and living
expenses. The Wang Service Agreement provides for customary invention assignment, confidentiality, and non-solicitation provisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adoption
of compensation recovery policy </b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2025, we adopted a compensation recovery policy in accordance with Rule 10D-1 promulgated under the Exchange Act and Nasdaq
listing rules. A copy of our Compensation Recovery Policy is filed as Exhibit 97.1 to this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Board Practices</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
of directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors currently consists of nine directors. A director is not required to hold any shares in our Company by way of qualification.
A director may vote with respect to any contract or transaction, or proposed contract or transaction in which he or she is, whether directly
or indirectly, materially interested provided such director, if his or her interest in such contract or transaction is material, has
declared the nature of his or her interest at the earliest meeting of the board at which it is practicable for him or her to do so, either
specifically or by way of a general notice. Our directors may exercise all the powers of the company to borrow money, mortgage or charge
its undertaking, property and assets (present or future) and uncalled capital or any part thereof, and issue debentures, debenture stock,
bonds or other securities whether outright or as collateral security for any obligation of the company or of any third party. None of
our non-employee directors has a service contract with us that provides for benefits upon termination of service.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 192; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->183<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
independence</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">As a foreign private issuer, under the listing requirements and rules
of Nasdaq, we are not required to have a majority of independent directors on our board of directors, except although our Audit Committee
is required to consist solely of independent directors. Our board of directors has undertaken a review of the independence of the directors
and considered whether any director has a relationship with us that could interfere with such director&#8217;s ability to exercise independent
judgment in carrying out the responsibilities of a director. As a result of this review, our board of directors determined that Dr. Simon
Dazhong Lu, Wei Ren, Dr. David Sidransky, Changqing Ye, Debra Yu, Marina Bozilenko, and Dr. Marc E. Lippman, representing seven of our
nine directors, are &#8220;independent directors&#8221; as that term is defined under the applicable rules and regulations of the SEC
and the listing requirements and corporate governance rules of Nasdaq. In making such determination, our board of directors considered
the relationships that each non-employee director has with us and all other facts and circumstances our board of directors deemed relevant
in determining the director&#8217;s independence, including the number of ordinary shares beneficially owned by the director.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
committees</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We have established
three committees under the board of directors: an audit committee, a remuneration committee, a nomination committee, and a research and
development committee. We have adopted terms of reference for each of the four committees. Each committee&#8217;s members and functions
are described below.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">The audit committee is comprised of three members, namely Changqing
Ye, Dr. Simon Dazhong Lu and Marina S. Bozilenko, with Changqing Ye serving as chairman. Our board of directors has determined that each
of Changqing Ye, Dr. Simon Dazhong Lu and Marina S. Bozilenko satisfies the &#8220;independence&#8221; requirements of Rule 10A-3 under
the Exchange Act and the Nasdaq rules. We have determined that each of Changqing Ye, Dr. Simon Dazhong Lu and Marina S. Bozilenko qualifies
as an &#8220;audit committee financial expert.&#8221; The audit committee oversees our accounting and financial reporting processes and
the audits of the financial statements of our Company. The audit committee is responsible for, among other things:</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing,
                                            compensating, retaining, evaluating and overseeing an independent registered public accounting
                                            firm to act as our independent auditor;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ensuring
                                            the independence of our independent auditor;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and discussing our internal controls and the integrity of our audited financial statements;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing,
                                            with our management, procedures with respect to the presentation of our financial information
                                            and reviewing earnings press releases, earnings guidance provided to analysts and rating
                                            agencies and financial information provided to the public, analysts and ratings agencies;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
                                            the design, implementation and performance of our internal audit function;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
                                            our financial reporting system, risk management and internal control systems;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">performing
                                            our corporate governance functions;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">setting
                                            hiring policies with regard to the hiring of employees or former employees of our independent
                                            auditor and oversee compliance with such policies;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
                                            approving and monitoring related party transactions involving directors or executive officers,
                                            including developing and maintaining policies and procedures for reviewing, approving and/or
                                            ratifying such transactions;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
                                            the Company&#8217;s environmental, social and governance issues;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
                                            procedures to address complaints received by us regarding accounting, internal accounting
                                            controls or auditing matters;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and discussing with our management team and our independent auditor the adequacy and effectiveness
                                            of our legal, regulatory and ethical compliance programs and reports regarding compliance
                                            with applicable laws, regulations and internal compliance programs; and</span></td>
</tr></table><div>

</div><p style="font-size: 10pt; text-align: left; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and discussing with management, including our internal audit function, if applicable, and
                                            our independent auditor guidelines and policies to identify, monitor, and address enterprise
                                            risks.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 193; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->184<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remuneration
committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Our remuneration committee consists of Wei Ren, Changqing Ye and Debra
Yu, with Wei Ren serving as chairman. Our board of directors has determined that each of Wei Ren, Changqing Ye and Debra Yu satisfies
the &#8220;independence&#8221; requirements under the Nasdaq rules. The remuneration committee assists the board of directors in reviewing
and approving the remuneration structure, including all forms of remuneration, relating to our directors and executive officers. The remuneration
committee is responsible for, among other things:</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">making
                                            recommendations to the board of directors on all the Company&#8217;s remuneration policy
                                            and structure for all executive officers&#8217; remuneration and on the establishment of formal
                                            and transparent procedures for developing remuneration policy;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving, annually, the corporate goals and objectives applicable to the compensation
                                            of our Chief Executive Officer, evaluating at least annually our Chief Executive Officer&#8217;s
                                            performance in light thereof, and consider factors related to the performance of the Company
                                            in approving the compensation level of our Chief Executive Officer;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
                                            at least annually, and approving or recommend for approval to the board members other than
                                            our Chief Executive Officer, our Chief Executive Officer&#8217;s (i) base salary, (ii) incentive
                                            bonus, including the specific goals and amount, (iii) equity compensation, (iv) any employment
                                            agreement, severance arrangement, transition or consulting agreement, retirement agreement
                                            or change of control protections and (v) any other benefits, compensation or similar arrangements,
                                            if any (including, without limitation, perquisites, pension rights, any benefits in kind,
                                            any compensation payments such as compensation payable for loss or termination of office
                                            or appointment, and any other form of compensation such as a signing bonus or payment of
                                            relocation costs), including any amendments to or terminations of any of the foregoing;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
                                            at least annually, and approving or recommending for approval to the board members other
                                            than our Chief Executive Officers items (i) through (v) above for the other executive officers,
                                            including any prospective or former executive officers, including any amendments to or terminations
                                            of any of the foregoing;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving compensation payable to the executive officers for any loss or termination
                                            of office or appointment to ensure that it is consistent with contractual terms and is otherwise
                                            fair and not excessive;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving, as well as approve amendments to or terminations of, any compensatory contracts
                                            or similar transactions or arrangements with such other employees as our remuneration committee
                                            determines, including employment agreements, severance arrangements, transition or consulting
                                            agreements, retirement agreements and change-in-control agreements or provisions;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving our employee benefit and equity incentive plans and share schemes under Chapter
                                            17 of the Listing Rules of The Stock Exchange of Hong Kong Limited;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing,
                                            and periodically reviewing, our employee compensation plans; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and discussing our compensation policies and practices with management, and also periodically
                                            discuss with the board of directors and/or the nomination committee corporate succession
                                            plans for our executive officers and other key employees.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 194; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->185<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nomination
committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our nomination committee consists of Dr. David Sidransky, Wei Ren,
Debra Yu, and Dr. Marc E. Lippman, with Dr. David Sidransky serving as chairman. Our board of directors has determined that each of Dr.
David Sidransky, Wei Ren, Debra Yu, and Dr. Marc E. Lippman satisfies the &#8220;independence&#8221; requirements under the Nasdaq rules. The nomination committee assists the board of directors in selecting individuals qualified to become our directors and in determining
the composition of the board and its committees. The nomination committee is responsible for, among other things:</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and assessing and making recommendations to the board of directors regarding the desired
                                            qualifications, expertise and characteristics of sought members of the board of directors;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and assessing and making recommendations to the board of directors regarding the structure,
                                            size and composition (including the skills, knowledge and experience) of the board of directors
                                            and making recommendations on any proposed changes to the board of directors to complement
                                            the Company&#8217;s corporate strategy;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and assessing and making recommendations to the board of directors regarding the independence
                                            of independent non-executive directors;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying
                                            individuals suitably qualified to become board members and selecting or making recommendations
                                            to the board of directors on the selection of individuals nominated for directorships;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
                                            the performance of individual members of the board of directors eligible for re-election,
                                            and selecting, or recommending for the selection of the board of directors, the director
                                            nominees for election to the board of directors by the shareholders at the annual general
                                            meeting of the Company or any special meeting of shareholders at which directors are to be
                                            elected;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">considering
                                            the board of directors leadership structure, including the separation of the Chairman and
                                            Chief Executive Officer roles and/or appointment of a lead independent director of the board
                                            of directors, either permanently or for specific purposes, and making such recommendations
                                            to the board of directors as the nomination committee deems appropriate;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
                                            and reviewing periodically the policies and procedures for considering shareholder nominees
                                            for election to the Board;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">considering
                                            director nominee recommendations from shareholders of the Company that are validly made and
                                            in accordance with applicable laws, rules and regulations and the provisions of the Company&#8217;s
                                            memorandum and articles of association;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
                                            and recommending termination of membership of individual directors for cause or for other
                                            appropriate reasons;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
                                            the &#8220;independence&#8221; of directors and director nominees against the independence
                                            requirements of the securities exchange on which the Company&#8217;s securities are listed,
                                            applicable rules and regulations of the SEC and other applicable laws;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
                                            to the board of directors&#8217; nominees to fill vacancies and newly created directorships on the
                                            board of directors and nominees to stand for election as directors;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">periodically
                                            reviewing the structure and composition of each committee of the board of directors and make
                                            recommendations, if any, to the board of directors for changes to the committees of the board
                                            of directors, including changes in the structure, composition or mandate of the committees,
                                            as well as the creation or dissolution of committees; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
                                            the Company&#8217;s director orientation and continuing education, including making recommendations
                                            for continuing education of members of the board of directors and evaluating the participation
                                            of members of the board of directors in accordance with applicable listing standards.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research
and Development Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our research
and development committee consists of Dr. David Sidransky, Dr. Wang Shaomeng, with Dr. Marc E. Lippman serving as chairman. The research
and development committee assists the board of directors to oversee R&amp;D strategy, pipeline, investments, and emerging trends, ensuring
alignment with the business while managing risks. The research and development committee is responsible for, among other things:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">annually
                                            review the Company&#8217;s product development pipeline;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif">reviewing,
                                            evaluating and advising the Board regarding the quality, direction and competitiveness of
                                            the Company&#8217;s R&amp;D programs; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 8.8pt"><span style="font-family: Times New Roman, Times, Serif">reviewing
                                            and making recommendations to the Board regarding scientific merits of the Company&#8217;s
                                            internal and external investments in R&amp;D, including any potential external investments
                                            in R&amp;D (e.g., potential acquisitions, alliances, collaborations, equity investments,
                                            manufacturing, contracts and grants) that are submitted to the Board for approval, reporting
                                            as appropriate to any committees of the Board formed to evaluate and approve potential external
                                            investments.</span></td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 195; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->186<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Duties
of directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Cayman Islands law, our directors have a duty to act honestly, in good faith and with a view to our best interests. Our directors also
have a duty to exercise the care, diligence and skills that a reasonably prudent person would exercise in comparable circumstances. In
fulfilling their duty of care to us, our directors must ensure compliance with our second amended and restated memorandum and articles
of association, as amended and restated from time to time, and the class rights vested thereunder in the holders of the shares. A shareholder
may in certain circumstances have rights to damages if a duty owed by the directors is breached.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has powers necessary for managing, and for directing and supervising, our business affairs. The functions and powers
of our board of directors include, among others:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">convening
                                            shareholders&#8217; annual general meetings and reporting its work to shareholders at such
                                            meetings;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">declaring
                                            dividends and distributions;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing
                                            officers and determining the term of office of the officers;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercising
                                            the borrowing powers of our Company and mortgaging the property of our Company; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
                                            the transfer of shares in our Company, including the registration of such shares in our share
                                            register.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
composition and election of directors and officers</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors will consist of a minimum of two directors. Our officers are elected by and serve at the discretion of our board
of directors. At each annual general meeting, one-third of the then-seated members of the board of directors, or, if the number of the
members of the board of directors then seated is not three or a multiple of three, then the number nearest to, but not less than, one-third
of the members of the board of directors, shall retire from office, provided that each member of the board of directors (including those
appointed for a specific term) shall be subject to retirement by rotation at least once every three years. A retiring director shall
be eligible for re-election at the general meeting at which a director retires. The members of our board of directors to retire by rotation
shall include any member of the board of directors who desires to retire and not to seek re-election to our board of directors. Any member
of the board of directors who has not been subject to retirement by rotation in the three years preceding the annual general meeting
shall retire by rotation at such annual general meeting. Members of our board of directors are not required to retire upon reaching any
particular age. We may from time to time in general meeting by ordinary resolution elect any person to be a director either to fill a
vacancy or as an addition to the existing members of the board of directors. Any director so appointed shall be subject to retirement
by rotation pursuant to our second amended and restated articles of association.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
member of our board of directors may be removed by ordinary resolution before the expiration of his or her term of office (but without
prejudice to any claim which such director may have for damages for any breach of any contract with our Company) and may by ordinary
resolution appoint another individual in his or her place.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
member of our board of directors shall be vacated if: (1) he or she becomes bankrupt or makes any arrangement or composition with his
or her creditors; (2) he or she dies or becomes of unsound mind pursuant to an order made by any competent court or official; (3) he
or she is absent from meetings of the board of directors for six consecutive months without special leave; (4) he or she is prohibited
by law from serving as a member of the board of directors or is removed from office pursuant to our second amended and restated articles
of association; (5) he or she resigns by delivering notice in writing to our Company at our registered office or at our headquarters
or tendered at a meeting of our board of directors; (6) he or she is removed from office by an ordinary resolution of our Company; or
(7) he or she is removed from office in writing signed by no less than three-fourths of the then sitting members of our board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Employees</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2025, 2024 and 2023, we had 767, 567, and 583 full-time employees. We have developed a culture of innovation where employees
seek to proactively solve complex problems and challenges faced by a high growth business. We believe that we maintain a good working
relationship with our employees, and we have not experienced any material labor disputes. None of our employees are represented by a
labor union or party to a collective bargaining agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
Share Ownership</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
regarding the ownership of our ordinary shares by our directors and executive officers is set forth in &#8220;<i>Item 6. Directors, Senior
Management and Employees</i>&#8221; and &#8220;<i>Item 7. Major Shareholders and Related Party Transactions&#8212;A. Major Shareholders</i>.&#8221;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.
Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 196; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->187<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS </b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Major Shareholders</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Except as specifically noted, the following table sets forth information
with respect to the beneficial ownership of our ordinary shares as of April 20, 2026 by:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            of our directors and executive officers;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.75pt; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            person known to us to own beneficially more than 5% of our ordinary shares; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            of our directors and executive officers as a group.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The calculations in the table below are based on 373,322,192 ordinary
shares outstanding as of April 1, 2026.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned
by a person and the percentage ownership of that person, we have included shares that the person has the right to acquire within 60 days,
including through the exercise of any option, warrant or other right or the conversion of any other security. These shares, however,
are not included in the computation of the percentage ownership of any other person.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">To the best of the Company&#8217;s knowledge
after having made reasonable inquiry, as of April 1, 2026, a total of 928,218 ADSs, representing 3,712,872 ordinary shares, or 1% of
our outstanding ordinary shares, are held by one record holder in the United States. The holder is the depositary of our ADS
program.&#160;We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The address for Dajun, Yang and Yifan Zhai listed in the table is
c/o Ascentage Pharma Group International, 68 Xinqing Road Suzhou Industrial Park, Suzhou, Jiangsu, China and the address for Veet Misra, Shaomeng Wang, David Sidransky, Marc E. Lippman, Debra Yu and Marina Bozilenko
listed below is c/o Ascentage Pharma Group Inc., 700 King Farm Boulevard, Suite 510, Rockville, MD 20850. The address for all other persons
and entities listed below are noted below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ordinary shares beneficially
    owned</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Ordinary<br/>
 shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Percentage of<br/>
 beneficial<br/>
 ownership</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name of beneficial owner</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">5% Shareholders</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Edward Ming Guo<sup>(1)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">59,356,611</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15.9</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Takeda Pharmaceuticals International AG <sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,307,322</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Executive Officers and Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Dajun Yang, M.D., Ph.D.<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">59,356,611</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Yifan Zhai, M.D., Ph.D. <sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">59,356,611</p>
</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Veet Misra, Ph.D.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Thomas J. Knapp</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">362,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Jin Cao</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,296</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Marina S. Bozilenko</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Marc E. Lippman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,652</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Simon Dazhong Lu, Ph.D</span>. <span style="font-size: 10pt"><sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in"><span style="font-size: 10pt">Wei Ren <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">David Sidransky, M.D<sup>. (7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,631</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Shaomeng Wang, Ph.D.<sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">59,356,611</p>
</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in"><span style="font-size: 10pt">Changqing Ye <sup>(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Debra Yu</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left">All directors and executive officers as a group (13 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">599,094,15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.1</td><td style="text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    beneficial ownership of voting power of less than 1%.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of (i) 11,011,767
    ordinary shares held by Ming Edward Guo Dynasty Trust (as of March 1, 2025), (ii) 2,222,259 ordinary shares held by Edward Ming Guo
    (as of March 1, 2025), (iii) 8,565,823 ordinary shares and 2,992 options vesting in the next sixty (60) days beneficially owned by
    Shaomeng Wang, Ph.D., a member of our board of directors, (iv) 23,152,125 ordinary shares beneficially owned by Dajun Yang, M.D.,
    Ph.D., our Chief Executive Officer and a member of our board of directors and (v) 14,401,645 ordinary shares beneficially owned by
    Yifan Zhai, M.D., Ph.D., our Chief Medical Officer. The Ming Edward Guo Dynasty Trust is a discretionary family trust established by
    Mr. Guo as settlor for the benefits of Dr. Guo&#8217;s family members, of which South Dakota Trust is a trustee. Mr. Guo shares
    voting and investment control over the shares held by the Ming Edward Guo Dynasty Trust. Mr. Guo, Dr. Wang, Dr. Yang and Dr. Zhai
    are parties to the Concert Party Confirmation Deed, and Mr. Guo may be deemed to share voting power over the ordinary shares
    beneficially owned by parties to the Concert Party Confirmation Deed. See &#8220;<i>Item 7. Major Shareholders and Related Party
    Transactions&#8212;B. Related Party Transactions&#8212;Concert party confirmation deed</i>&#8221; for more information. Mr. Guo
    disclaims beneficial ownership of such shares except to the extent of his pecuniary interests therein.</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 197; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->188<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 24,307,322
    ordinary shares held by Takeda Pharmaceuticals International AG. Takeda Pharmaceuticals International AG is a wholly owned
    subsidiary of Takeda Pharmaceutical Company Limited, a public company with securities listed on the Tokyo Stock Exchange and New
    York Stock Exchange. Voting and investment discretion with regard to these securities is ultimately controlled by the board of
    directors of Takeda Pharmaceutical Company Limited.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of (i) 22,054,131
    ordinary shares held by the Dajun Yang Dynasty Trust, (ii) 1,097,994 ordinary shares held by Dajun Yang, M.D., Ph.D., (iii)
    13,234,026 ordinary shares beneficially owned by Edward Ming Guo (as of March 1, 2025), (iv) 8,565,823 ordinary shares and 2,992
    options vesting in the next sixty (60) days beneficially owned by Shaomeng Wang, Ph.D., a member of our board of directors and (v)
    14,401,645 ordinary shares beneficially owned by Yifan Zhai, M.D., Ph.D., our Chief Medical Officer and Dr. Yang&#8217;s spouse. The
    Dajun Yang Dynasty Trust is a discretionary family trust established by Dr. Yang as settlor for the benefits of Dr. Yang&#8217;s
    family members, of which South Dakota Trust is trustee. Dr. Yang shares voting and investment control over the shares held by the
    Dajun Yang Dynasty Trust. Mr. Guo, Dr. Wang, Dr. Yang and Dr. Zhai are parties to the Concert Party Confirmation Deed, and Dr. Yang
    may be deemed to share voting power over the ordinary shares beneficially owned by parties to the Concert Party Confirmation Deed.
    See &#8220;<i>Item 7. Major Shareholders and Related Party Transactions&#8212;B. Related Party Transactions&#8212;Concert party
    confirmation deed</i>&#8221; for more information. Dr. Yang disclaims beneficial ownership of such shares except to the extent of
    his pecuniary interests therein.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font-size: 10pt">Consists of (i) 14,089,111 ordinary shares held by HealthQuest Pharma Limited,
(ii) 312,534 ordinary shares held by Yifan Zhai, M.D., Ph.D., (iii) 13,234,026 ordinary shares beneficially owned by Edward Ming Guo (as
of March 1, 2025), (iv) 8,565,823 ordinary shares and 2,992 options vesting in the next sixty (60) days beneficially owned by Shaomeng
Wang, Ph.D., and (v) 23,152,125 ordinary shares beneficially owned by Dajun Yang, M.D., Ph.D., our Chief Executive Officer and a member
of our board of directors and Dr. Zhai&#8217;s spouse. HealthQuest Pharma Limited is a company incorporated in the British Virgin Islands
with limited liability and wholly owned by Dr. Zhai. Mr. Guo, Dr. Wang, Dr. Yang and Dr. Zhai are parties to the Concert Party Confirmation
Deed, and Dr. Zhai may be deemed to share voting power over the ordinary shares beneficially owned by parties to the Concert Party Confirmation
Deed. See &#8220;<i>Item 7. Major Shareholders and Related Party Transactions&#8212;B. Related Party Transactions&#8212;Concert party
confirmation deed</i>&#8221; for more information. Dr. Zhai disclaims beneficial ownership of such shares except to the extent of her
pecuniary interests therein.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 48,937 ordinary
shares subject to options and 2,992 options vesting in the next sixty (60) days held by Simon Dazhong Lu, Ph.D.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 16,814 ordinary
    shares and 3,140 options vesting in the next sixty (60) days held by Wei Ren.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 18,491 ordinary shares and 3,140 options, vesting in the next sixty (60) days held by David Sidransky, M.D.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of (i) 2,518,845 ordinary
    shares held by the KEW Trust, (ii) 6,024,066 ordinary shares held by the Shaomeng Wang Dynasty Trust, (iii) 1,193,032 ordinary shares
    held by Shaomeng Wang, Ph.D., (iv) 13,234,026 ordinary shares beneficially owned by Edward Ming Guo (as of March 1, 2025), (v) 23,152,125
    ordinary shares beneficially owned by Dajun Yang, M.D., Ph.D., our Chief Executive Officer and a member of our board of directors
    and (vi) 14,225,367 ordinary shares beneficially owned by Yifan Zhai, M.D., Ph.D., our Chief Medical Officer. The KEW Trust is a
    trust established by Dr. Wang as settlor for the benefit of Dr. Wang&#8217;s children. The Shaomeng Wang Dynasty Trust is a discretionary
    family trust established by Dr. Wang as settlor for the benefits of Dr. Wang&#8217;s family members, of which South Dakota Trust
    is trustee. Dr. Wang shares voting and investment control over the shares held by the KEW Trust and the Shaomeng Wang Dynasty Trust.
    Mr. Guo, Dr. Wang, Dr. Yang and Dr. Zhai are parties to the Concert Party Confirmation Deed, and Dr. Wang may be deemed to share
    voting power over the ordinary shares beneficially owned by parties to the Concert Party Confirmation Deed. See &#8220;<i>Item 7.
    Major Shareholders and Related Party Transactions&#8212;B. Related Party Transactions&#8212;Concert party confirmation deed</i>&#8221;
    for more information. Dr. Wang disclaims beneficial ownership of such shares except to the extent of his pecuniary interests therein.</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of 16,814 ordinary
    shares and 3,140 options vesting in the next sixty (60) days held by Changqing Ye.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 198; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->189<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
rights</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal shareholders do not have different voting rights. We are not aware of any arrangement that may, at a subsequent date, result
in a change of control of our Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholders
in the United States</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2025, we completed our U.S. initial public offering and listed ADSs representing an interest in our ordinary shares on the Nasdaq
Global Market under the symbol &#8220;AAPG.&#8221; As of April 1, 2026, a total of 928,218 ADSs, representing 3,712,872 ordinary shares,
or 1% of our outstanding ordinary shares, are held by one record holder in the United States. The holder is the depositary of our
ADS program.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Related Party Transactions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following includes a summary of transactions, and any currently proposed transactions, to which we were or are expected to be a participant
in which any of our executive officers, directors, or holders of more than 5% of any class of our voting securities, or any affiliate
or member of the immediate family of any of the foregoing persons, had or will have a direct or indirect material interest since January
1, 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Healthquest
acquisition</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2016, pursuant to an agreement between Ascentage Jiangsu and Dr. Zhai, our Chief Medical Officer, and Ms. Ren, or the Healthquest
Acquisition Agreement, we acquired all equity interests in Healthquest Pharma. Prior to our acquisition, Dr. Zhai held 99.6% of the equity
interests in Healthquest Pharma and Ms. Ren held the remaining 0.4%. The fair value of the total purchase consideration on the acquisition
date was RMB80.4 million (US$12.1 million).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the Healthquest Acquisition Agreement, we agreed to pay Dr. Zhai RMB20.0 million upon our obtaining NDA approval for Olverembatinib
in China and four annual deferred milestone payments of RMB20.0 million within the first four years after the commercialization of Olverembatinib
in China, representing a total of RMB80.0 million (US$12.4 million) in the aggregate. Olverembatinib was approved in China during the
year ended December 31, 2021, and we made the associated payment of RMB20.0 million. Olverembatinib was also commercialized in China
during the year ended December 31, 2021, and we have made a total of three such annual deferred milestone payments since the commercialization
of Olverembatinib. The remaining milestone payment of RMB20.0 million (US$2.8 million) was made in June 2025.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
Bonus Payment</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In June 2025, the Company paid Dr. Yang, the Company&#8217;s
Chairman and CEO, a cash bonus payment of US$ 2,394,847 in exchange for the cancellation of an aggregate of 2023 and 2024 bonus RSUs.
The cash payment represented the aggregate share price of the underlying ordinary shares on the date of cancellation in June 2025. In
March 2026, the remuneration committee and board of directors ratified the cash payment to Dr. Yang.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tax Reimbursement Payment</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the July 2025 placing, pursuant to which Dajun
Yang Dynasty Trust, a family trust established by Dr. Yang served as vendor, the trust and/or Dr. Yang incurred certain tax liabilities,
for which Dr. Yang was reimbursed by us in the amount of US$553,648.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private
placements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;<i>Item 4. Information on the Company&#8212;A. History and Development of the Company</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deed
of Non-Competition</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 24, 2019, we entered into a Deed of Non-Competition with Dr.
Dajun Yang, our Chairman and Chief Executive Officer, Dr. Yifan Zhai, our Chief Medical Officer, Dr. Shaomeng Wang, a member of our board
of directors, Dr. Edward Ming Guo, one of our co-founders, Ascentage Limited, and HealthQuest Pharma Limited, a company incorporated in
the British Virgin Islands with limited liability, or HealthQuest Pharma Limited, collectively, the Covenantors. Pursuant to the Deed
of Non-Competition, the Covenantors agreed that, during the period that the Deed of Non-Competition remains effective, they will not develop,
acquire, invest in, participate in, or otherwise be involved in, directly or indirectly, whether as a shareholder, director, employee,
partner, agent or otherwise in any business activity involving development of a drug candidate which carries the same target as any of
Ascentage Pharma&#8217;s drug candidates, or the Restricted Activity. The Deed of Non-Competition does not restrict any of the Covenantors
from acquiring a direct or indirect shareholding interest of not more than 10% in a company engaged in any Restricted Activity, provided
that each Covenantor (individually or together) will not directly or indirectly own more than 10% of the total issued share capital of
such company or control the exercise of more than 10% of the voting rights thereof or control the composition of the board of directors
of such company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Covenantors is offered or otherwise intends to take up any business opportunity which directly or indirectly engages in or
owns the Restricted Activity, or the Competing Business Opportunity, the Covenantor must within 10 business days of identifying the Competing
Business Opportunity refer the same to the Company, or the Offer Notice, and the Covenantor must not invest or participate in the Competing
Business Opportunity unless such Competing Business Opportunity was rejected by the Company or an independent committee of our board
of directors fails to respond within 30 business days of receipt of the Offer Notice.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 199; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->190<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Deed of Non-Competition will cease to be effective on the earliest of (1) the date on which all Covenantors, in the aggregate, cease
to beneficially own 10% of our total issued share capital and (2) with respect to each Covenantor on an individual basis, the non-competition
undertaking will cease two years after termination of such Covenantor&#8217;s employment relationship with Ascentage Pharma.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concert
Party Confirmation Deed</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 11, 2018, each of (1) Dr. Dajun Yang, our Chairman and Chief Executive Officer, (2) Dr. Edward Ming Guo, (3) Dr. Shaomeng Wang,
a member of our board of directors, (4) Dr. Yifan Zhai, our Chief Medical Officer, (5) HealthQuest Pharma Limited and (6) Ascentage Limited,
or (1) through (6), collectively, the Concert Shareholders, entered into a Concert Party Confirmation Deed, or the Deed. Pursuant to
the Deed, among other things, the Concert Shareholders agree and acknowledge that: (1) they have, and will, actively cooperate and communicate
with each other to obtain and maintain consolidated control and management of our Company and adopt a consensus building approach to
achieve decisions on a unanimous basis on major affairs related to our Company, including matters required to be approved by our shareholders,
(2) they have not, and will not, challenge any decisions or resolutions passed in our shareholder meetings without concurrence of the
other Concert Shareholders, nor will any Concert Shareholder attempt to exercise voting rights independently without concurrence of the
other Concert Shareholders for any reason, (3) they have, and will, exercise their respective voting rights unanimously as a group, individually
or through any entity directly or indirectly controlled by such Concert Shareholder, on all matters and resolutions proposed at shareholder
meetings of our Company, and (4) each Concert Shareholder has been, and will be given, sufficient time and information to consider and
discuss all corporate matters to achieve unanimity among the Concert Shareholders. The Deed remains effective unless otherwise terminated
by all parties to the Deed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
agreements and indemnification agreements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the section of this Annual Report on Form 20-F titled &#8220;<i>Item 6. Directors, Senior Management and Employees&#8212;B. Compensation&#8212;Employment
agreements and indemnification agreements.</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
incentive plans and agreements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the section of this Annual Report on Form 20-F titled &#8220;<i>Item 6. Directors, Senior Management and Employees&#8212;B. Compensation&#8212;Equity
incentive plans.</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Interests of Experts and Counsel</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
8. FINANCIAL INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Consolidated Statements and Other Financial Information</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
Statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;<i>Item 18. Financial Statements</i>,&#8221; which contains our financial statements prepared in accordance with IFRS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 200; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->191<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may become involved in actions, claims, suits, and other legal proceedings arising in the ordinary course of its business,
including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related
matters. We are not currently a party to any actions, claims, suits or other legal proceedings the outcome of which management believes,
if determined adversely to us, would individually or in the aggregate have a material adverse effect on our business, financial condition,
and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends
and Dividend Policy</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has never declared or paid any cash dividends. The Company&#8217;s board of directors will consider whether or not to institute
a dividend policy. It is presently intended that the Company will retain its earnings for use in business operations and, accordingly,
it is not anticipated that the Company&#8217;s board of directors will declare dividends in the foreseeable future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a holding company incorporated in the Cayman Islands. In the future, we may rely on dividends from our subsidiaries, including our
PRC and U.S. subsidiaries, for our cash requirements, including any payment of dividends to our shareholders. PRC regulations may restrict
the ability of our PRC subsidiary to pay dividends to us. See &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Government
regulation&#8212;PRC regulation&#8212;PRC regulations relating to dividend distribution</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has discretion as to whether to distribute dividends, subject to certain requirements of Cayman Islands law. In addition,
our shareholders may, subject to the provisions of our second amended and restated memorandum and articles of association, by ordinary
resolution declare a dividend, but no dividend may exceed the amount recommended by our board of directors. If we pay any dividends on
our ordinary shares, we will pay those dividends which are payable in respect of the ordinary shares underlying the ADSs to the depositary,
as the registered holder of such ordinary shares, and the depositary then will pay such amounts to the ADS holders in proportion to the
ordinary shares underlying the ADSs held by such ADS holders, subject to the terms of the deposit agreement, including the fees and expenses
payable thereunder.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Significant Changes</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 201; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->192<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><!-- Field: Split-Segment; Name: 7 --><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
9. THE OFFER AND LISTING</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Offer and Listing Details</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ordinary shares have been listed on the Hong Kong Stock Exchange since October 18, 2019 under the stock code &#8220;6855.&#8221; Our
ADSs have been listed on the Nasdaq Global Market since January 24, 2025 under the symbol &#8220;AAPG.&#8221; Each ADS represents four
ordinary shares, no par value per share.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Plan of Distribution</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Markets</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ordinary shares are listed on the Hong Kong Stock Exchange under the stock code &#8220;6855.&#8221; Our ADSs are listed on the Nasdaq
Global Market under the symbol &#8220;AAPG.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Selling Shareholders</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
Applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
Dilution</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.
Expenses of the Issue</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
10. ADDITIONAL INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Share Capital</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Memorandum and Articles of Association</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a Cayman Islands exempted company incorporated with limited liability and our affairs are governed by our second amended and restated
memorandum and articles of association, the Companies Act (as amended) of the Cayman Islands, or the Companies Act, and Cayman Islands
common law. For more information, see our second amended and restated memorandum and articles of association attached as Exhibit 1.1
to this Annual Report on Form 20-F and &#8220;Description of Securities&#8221; attached as Exhibit 2.4 to this Annual Report on Form
20-F, each incorporated by reference herein.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are summaries of material provisions of our second amended and restated memorandum and articles of association and the Companies
Act, insofar as they relate to the material terms of our ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registered
office and objects</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
registered office in the Cayman Islands is at the office of Walkers Corporate Limited, with the registered address of 190 Elgin Avenue,
George Town, Grand Cayman KY1-9008, Cayman Islands. According to our second amended and restated memorandum and articles of association,
the objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any
object not prohibited by any law as provided by Section&#160;7(4)&#160;of the Companies Act (as amended) of the Cayman Islands.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 202; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->193<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
of directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;<i>Item 6. Directors, Senior Management and Employees</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
shares&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>General.</b>
Our authorized share capital is US$50,000 consisting of 500,000,000 ordinary shares, par value US$0.0001 per share. As of April 1, 2026,
373,322,192 ordinary shares were issued and outstanding.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our issued and outstanding ordinary shares are fully paid and non-assessable. Certificates representing the ordinary shares are issued
in registered form. We may not issue share to bearer. Our shareholders who are non-residents of the Cayman Islands may freely hold and
transfer their ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b>.
The holders of our ordinary shares are entitled to such dividends as may be declared by our board of directors subject to our second
amended and restated memorandum and articles of association and the Companies Act. In addition, our shareholders may, subject to the
provisions of our second amended and restated memorandum and articles of association, by ordinary resolution declare a dividend, but
no dividend may exceed the amount recommended by our directors. Our second amended and restated memorandum and articles of association
provide that dividends may be declared and paid out of our profits, realized or unrealized, or from any reserve set aside from profits
which our board of directors determine is no longer needed. Dividends may also be declared and paid out of share premium account or any
other fund or account which can be authorized for this purpose in accordance with the Companies Act. No dividend may be declared and
paid unless our directors determine that, immediately after the payment, we will be able to pay our debts as they become due in the ordinary
course of business, and we have funds lawfully available for such purpose.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
rights</b>. In respect of all matters subject to a shareholders&#8217; vote, each ordinary share is entitled to one vote for each ordinary
share registered in his or her name on our register of members. Voting at any meeting of shareholders is by poll, except that the chairman
of the meeting may, pursuant to the Hong Kong Listing Rules, allow a resolution to be voted by a show of hands.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum required for a meeting of shareholders consists of two shareholders entitled to vote at general meetings present in person or
by proxy or, if a corporation or other non-natural person, by its duly authorized representative. As a Cayman Islands exempted company,
we are not obliged by the Companies Act to call shareholders&#8217; annual general meetings. Our second amended and restated memorandum
and articles of association provide that in each financial year; we will hold a general meeting as our annual general meeting in addition
to any other meeting in that year and will specify the meeting as such in the notice calling it. We will hold the annual general meeting
within six months after the end of our financial year. Each general meeting, other than an annual general meeting, shall be an extraordinary
general meeting. Shareholders&#8217; annual general meetings and any other general meetings of our shareholders may be called by a majority
of our board of directors or our chairman or upon a requisition of shareholders holding at the date of deposit of the requisition not
less than one-third of the votes attaching to the issued and outstanding shares entitled to vote at general meetings, in which case the
directors are obliged to call such meeting and to put the resolutions so requisitioned to a vote at such meeting; however, our second
amended and restated memorandum and articles of association do not provide our shareholders with any right to put any proposals before
annual general meetings or extraordinary general meetings not called by such shareholders. Advance notice of at least 21 days is required
for the convening of our annual general meeting and other general meetings shall be called by at least 14 days&#8217; notice in writing
in accordance with our second amended and restated memorandum and articles of association.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching
to the ordinary shares cast by those shareholders entitled to vote who are present in person or by proxy at a general meeting, while
a special resolution also requires the affirmative vote of no less than three quarters of the votes attaching to the ordinary shares
cast by those shareholders entitled to vote who are present in person or by proxy at a general meeting. A special resolution will be
required for important matters such as a change of name or making changes to our second amended and restated memorandum and articles
of association.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
of ordinary shares</b>. Subject to the restrictions in our second amended and restated memorandum and articles of association, any of
our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any
other form approved by our board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 203; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->194<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up
or on which we have a lien. Our board of directors may also decline to register any transfer of any ordinary share unless:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the instrument
    of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other evidence
    as our board of directors may reasonably require to show the right of the transferor to make the transfer;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the instrument
    of transfer is in respect of only one class of shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the instrument
    of transfer is properly stamped, if required;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the
    case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed
    four;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the shares
    are free from any lien in favor of the Company; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a fee of such maximum sum as
    the Hong Kong Stock Exchange may determine to be payable or such lesser sum as our directors may from time to time require is paid
    to us in respect thereof.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our directors refuse to register a transfer, they shall, within two months after the date on which the instrument of transfer was lodged,
send to each of the transferor and the transferee notice of such refusal.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration of transfers may be suspended and the register closed at such times and for such periods as our board of directors may from
time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register closed for more
than 30 days in any year as our board may determine.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidation</b>.
On a return of capital on winding up or otherwise (other than on conversion, redemption or purchase of ordinary shares or, on a winding
up, with the sanction of a special resolution of our Company and any other sanction required by the Companies Act and subject to any
special rights, privileges or restrictions as to the distribution of available surplus assets on liquidation attached to any class or
classes of shares), assets available for distribution among the holders of ordinary shares will be distributed among the holders of the
ordinary shares in proportion to the paid up par value of the shares held by them. If our assets available for distribution are insufficient
to repay all of the paid-up capital, the assets will be distributed so that, as nearly as may be, the losses are borne by our shareholders
in proportion to the paid-up par value of the shares held by them. We are an exempted &#8220;limited liability&#8221; company registered
under the Companies Act, and under the Companies Act, the liability of our members is limited to the amount, if any, unpaid on the shares
respectively held by them. Our current second amended and restated memorandum of association contains a declaration that the liability
of our members is so limited.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our Company is wound up (in whatever manner), the liquidator may, with the sanction of a special resolution and any other sanction required
by the Companies Act, divide among our shareholders in specie or kind the whole or any part of the assets of our Company whether the
assets shall consist of property of one kind or shall consist of properties of different kinds and the liquidator may, for such purpose,
set such value as it deems fair upon any one or more class or classes of property to be divided and may determine how such division shall
be carried out as amongst our shareholders. The liquidator may, with the like sanction, vest any part of the assets in trustees upon
such trusts for the benefit of our shareholders as the liquidator, with the like sanction, shall think fit, but so that no shareholder
shall be compelled to accept any of our ordinary shares or other assets upon which there is a liability.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Calls
on ordinary shares and forfeiture of ordinary shares.</b> Our board of directors may from time to time make calls upon shareholders for
any amounts unpaid on their ordinary shares in a notice served to such shareholders at least 14 clear days prior to the specified time
of payment. The ordinary shares that have been called upon and remain unpaid are subject to forfeiture.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption,
repurchase and surrender of ordinary shares</b>. We may issue shares on terms that such shares are subject to redemption, at our option
or at the option of the holders thereof, on such terms and in such manner as may be determined, before the issue of such shares, by our
board of directors or by an ordinary resolution of our shareholders. We have made repurchases of our ordinary shares as part of our 2022
RSU Scheme during the last three years ended December 31, 2025, and we may continue to repurchase any of our ordinary shares in the future,
provided that the manner and terms of such purchase have been approved by our board of directors or by ordinary resolution of our shareholders,
or are otherwise authorized by our second amended and restated memorandum and articles of association. For example, at the annual general
meeting of the shareholders held on May 10, 2025, the shareholders approved a resolution from the board of directors to repurchase no
more than 10% of our total number of shares in issue as of the date of approval, valid until the 2026 annual general meeting of the shareholders.
On March 25, 2026, our board of directors approved a resolution to submit for the approval of the shareholders at the 2026 annual general
meeting, the extension of the resolution until the 2027 annual general meeting of the shareholders. In addition, on April 8, 2025, the
Company announced the repurchase of 50,000 existing shares for the purpose of the 2022 RSU Scheme to satisfy the RSUs upon exercise.
Under the Companies Act, the redemption or repurchase of any share may be paid out of our Company&#8217;s profits or out of the proceeds
of a fresh issue of shares made for the purpose of such redemption or repurchase, or out of capital (including share premium account
and capital redemption reserve) if the Company can, immediately following such payment, pay its debts as they fall due in the ordinary
course of business. In addition, under the Companies Act no such share may be redeemed or repurchased (a) unless it is fully paid up,
(b) if such redemption or repurchase would result in there being no shares outstanding, or (c) if the Company has commenced liquidation.
In addition, our Company may accept the surrender of any fully paid share for no consideration.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 204; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->195<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Variations
of rights of shares</b>. If at any time our share capital is divided into different classes or series of shares, the rights attached
to any class or series of shares (unless otherwise provided by the terms of issue of the shares of that class or series), whether or
not our Company is being wound- up, may be varied with the consent in writing of three fourths of the voting rights of the holders of
that class or series or with the sanction of a special resolution at a separate meeting of the holders of the shares of the class or
series. The rights conferred upon the holders of the shares of any class issued shall not, unless otherwise expressly provided by the
terms of issue of the shares of that class, be deemed to be varied by the creation or issue of further shares ranking pari passu with
such existing class of shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inspection
of books and records</b>. Holders of our ordinary shares have no general right under Cayman Islands law to inspect or obtain copies of
our list of shareholders or our corporate records (other than our current memorandum and articles of association, the register of mortgages
and charges and any special resolutions passed by shareholders). However, under our second amended and restated memorandum and articles
of association, during the period when our shares are listed on the Hong Kong Stock Exchange and except when our register of shareholders
is closed on terms equivalent to Section 632 of the Hong Kong Companies Ordinance, any of our shareholders may inspect during business
hours any register of shareholders maintained in Hong Kong without charge and require the copies of extracts of it. Under Cayman Islands
law, the names of our current directors can be obtained from a search conducted at the Registrar of Companies of the Cayman Islands.
The books of account shall be kept at our headquarters or at such other place or places as our board of directors thinks fit and shall
always be open to the inspection of the members of our board of directors. No shareholder (unless otherwise a member of our board of
directors) or other person shall have any right of inspecting any account or book or document of our Company except as conferred by the
Companies Act or ordered by a court of competent jurisdiction or authorized by our board of directors or our Company at a general meeting
of shareholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance
of additional shares</b>. Our second amended and restated memorandum and articles of association authorizes our board of directors to
issue additional ordinary shares from time to time as our board of directors shall determine, to the extent of available authorized but
unissued shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
second amended and restated memorandum and articles of association also authorizes our board of directors to establish from time to time
one or more series of preferred shares and to determine, with respect to any series of preferred shares, the terms and rights of that
series, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the designation
    of the series;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number
    of shares of the series;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the dividend
    rights, dividend rates, conversion rights, voting rights; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the rights and terms of redemption
    and liquidation preferences.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may issue preferred shares without action by our shareholders to the extent authorized but unissued. Issuance of these
shares may dilute the voting power of holders of ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-takeover
provisions.</b><i>&#160;</i>Some provisions of our second amended and restated memorandum and articles of association may
discourage, delay or prevent a change of control of our Company or management that shareholders may consider favorable, including
provisions that authorize our board of directors to issue preferred shares in one or more series and to designate the price, rights,
preferences, privileges and restrictions of such preferred shares without any further vote or action by our shareholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exempted
company</b>. We are an exempted company with limited liability under the Companies Act. The Companies Act distinguishes between ordinary
resident companies and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside
of the Cayman Islands may apply to be registered as an exempted company. The requirements for an exempted company are essentially the
same as for an ordinary company except that an exempted company:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does not
    have to file an annual return of its shareholders with the Registrar of Companies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is not
    required to open its register of members for inspection;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">does not
    have to hold an annual general meeting;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may issue
    shares with no par value;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may obtain
    an undertaking against the imposition of any future taxation;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may register
    by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may register
    as a limited duration company; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may register
    as a segregated portfolio company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 205; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->196<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Limited
liability&#8221; means that the liability of each shareholder is limited to the amount unpaid by the shareholder on that shareholder&#8217;s
shares of the company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an
illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Register
of members</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Act, we must keep a register of members and there should be entered therein:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the names and addresses of
    our members, a statement of the shares held by each member, and of the amount paid or agreed to be considered as paid, on the shares
    of each member;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which the name
    of any person was entered on the register as a member; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which any person
    ceased to be a member.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Act, the register of members of our Company is prima facie evidence of the matters set out therein (that is, the register
of members will raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register
of members is deemed as a matter of the Companies Act to have legal title to the shares as set against its name in the register of members.
The shareholders recorded in the register of members will be deemed to have legal title to the shares set against their name.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the name of any person is incorrectly entered in or omitted from our register of members, or if there is any default or unnecessary delay
in entering on the register the fact of any person having ceased to be a member of our Company, the person or member aggrieved (or any
member of our Company or our Company itself) may apply to the Grand Court of the Cayman Islands for an order that the register be rectified,
and the Court may either refuse such application or it may, if satisfied of the justice of the case, make an order for the rectification
of the register.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Material Contracts</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not entered into any material contracts other than those described in &#8220;<i>Item 4. Information on the Company,</i>&#8221; &#8220;<i>Item
6. Directors, Senior Management and Employees</i>&#8221; or &#8220;<i>Item 7. Major Shareholders and Related Party Transactions&#8212;B.
Related Party Transactions</i>&#8221; or elsewhere in this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Exchange Controls</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Islands currently have no exchange control regulations or currency restrictions. For exchange control regulations or currency restrictions
in China, see &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Government regulation&#8212;PRC regulation</i>&#8212;<i>PRC
regulations relating to foreign currency exchange</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
Taxation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion of Cayman Islands, PRC and U.S. federal income tax considerations related to the ownership and disposition of the
ADSs or ordinary shares is based upon laws and relevant interpretations thereof in effect as of the date of this Annual Report on Form
20-F and is intended for general information only and does not constitute tax advice. U.S. Holders should consult their tax advisors
as to the U.S. federal, state, local and non-U.S. tax considerations to them of the ownership and disposition of the ADSs and ordinary
shares in their particular circumstances.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cayman
Islands taxation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to Walkers (Hong Kong), our Cayman Islands counsel, the Cayman Islands currently levies no taxes on individuals or corporations based
upon profits, income, gains or appreciation and there is no taxation in the nature of inheritance tax or estate duty. There are no other
taxes likely to be material to us levied by the government of the Cayman Islands except for stamp duties which may be applicable on instruments
executed in, or, after execution, brought within the jurisdiction of the Cayman Islands. The Cayman Islands is not party to any double
tax treaties that are applicable to any payments made to or by our Company. There are no exchange control regulations or currency restrictions
in the Cayman Islands.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
of dividends and capital in respect of our ordinary shares will not be subject to taxation in the Cayman Islands and no withholding will
be required on the payment of a dividend or capital to any holder of our ordinary shares, nor will gains derived from the disposal of
our ordinary shares or ADSs be subject to Cayman Islands income or corporation tax.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 206; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->197<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
People&#8217;s Republic of China taxation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to JunHe LLP, our PRC counsel, under the PRC Enterprise Income Tax Law and its implementation rules, an enterprise established outside
of the PRC with a &#8220;de facto management body&#8221; within the PRC is considered a resident enterprise and will be subject to the
enterprise income tax at the rate of 25% on its global income. The implementation rules define the term &#8220;de facto management body&#8221;
as a managing body that exercises substantive and overall management and control over the production and business, personnel, accounting
books and assets of an enterprise. In April 2009, the SAT issued a circular, known as Circular 82, which provides certain specific criteria
for determining whether the &#8220;de facto management body&#8221; of a PRC-controlled enterprise that is incorporated offshore is located
in China. Although this circular only applies to offshore enterprises controlled by PRC enterprises or PRC enterprise groups, not those
controlled by PRC individuals or foreigners, the criteria set forth in the circular may reflect the SAT&#8217;s general position on how
the &#8220;de facto management body&#8221; test should be applied in determining the tax resident status of all offshore enterprises.
According to Circular 82, an offshore incorporated enterprise controlled by a PRC enterprise or a PRC enterprise group will be regarded
as a PRC tax resident by virtue of having its &#8220;de facto management body&#8221; in China only if all of the following conditions
are met: (1) the primary location of the day-to-day operational management is in the PRC; (2) decisions relating to the enterprise&#8217;s
financial and human resource matters are made or are subject to approval by organizations or personnel in the PRC; (3) the enterprise&#8217;s
primary assets, accounting books and records, company seals, and board and shareholder resolutions, are located or maintained in the
PRC; and (4) at least 50% of voting board members or senior executives habitually reside in the PRC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that Ascentage Pharma is not a PRC resident enterprise for PRC tax purposes. Ascentage Pharma is not controlled by a PRC enterprise
or PRC enterprise group, and we do not believe that Ascentage Pharma meets all of the conditions above. Ascentage Pharma is a company
incorporated outside of the PRC. For similar reasons, we believe our other entities outside of China are not PRC resident enterprises
either. However, the tax resident status of an enterprise is subject to determination by the PRC tax authorities and uncertainties remain
with respect to the interpretation of the term &#8220;de facto management body.&#8221; There can be no assurance that the PRC government
will ultimately take a view that is consistent with us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the PRC tax authorities determine that Ascentage Pharma is a PRC resident enterprise for enterprise income tax purposes or if dividends
we pay to our shareholders are otherwise treated as sourced from within the PRC, we may be required to withhold a 10% withholding tax
from such dividends we pay to our shareholders that are non- resident enterprises, including the holders of the ADSs. In addition, non-resident
enterprise shareholders (including the ADS holders) may be subject to a 10% PRC tax on gains realized on the sale or other disposition
of ADSs or ordinary shares, if such income is treated as sourced from within the PRC. It is unclear whether our non-PRC individual shareholders
(including the ADS holders) would be subject to any PRC tax on dividends or gains obtained by such non-PRC individual shareholders if
we are determined to be a PRC resident enterprise or if such dividends or gains are otherwise treated as sourced from within the PRC.
If any PRC tax were to apply to such dividends or gains, it would generally apply at a rate of 20% unless a reduced rate is available
under an applicable tax treaty (and in the case of dividends will be withheld at source). It is also unclear whether non-PRC shareholders
of Ascentage Pharma would be able to obtain the benefits of any tax treaties between their country of tax residence and the PRC if Ascentage
Pharma is treated as a PRC resident enterprise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
U.S. federal income tax considerations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is a summary of U.S. federal income tax considerations generally applicable to the ownership and disposition of
the ADSs or ordinary shares by a U.S. Holder (as defined below) and holds the ADSs or ordinary shares as &#8220;capital assets&#8221;
(generally, property held for investment) under the U.S. Internal Revenue Code of 1986, as amended, or the Code. This discussion is based
upon existing U.S. federal tax law (including proposed Treasury regulations and the income tax treaty between PRC and the United States,
or the Treaty), which is subject to differing interpretations or change, possibly with retroactive effect. No ruling has been sought
from the Internal Revenue Service, or the IRS, with respect to any U.S. federal income tax considerations described below, and there
can be no assurance that the IRS or a court will not take a contrary position. This discussion, moreover, does not address the U.S. federal
estate, gift, and alternative minimum tax considerations, the Medicare tax on net investment income, or any state, local and non-U.S.
tax considerations, relating to the ownership or disposition of the ADSs or ordinary shares. The following summary does not address all
aspects of U.S. federal income taxation that may be important to particular investors in light of their individual circumstances or to
persons in special tax situations such as:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks and other financial institutions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance companies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pension plans;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cooperatives;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated investment companies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">real estate investment trusts;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 207; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->198<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dealers
                                            or traders in securities that elect to use a mark-to-market method of accounting;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
                                            former U.S. citizens or long-term residents;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
                                            entities (including private foundations);</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            liable for alternative minimum tax;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">holders
                                            who acquire their ADSs or ordinary shares pursuant to any employee share option or otherwise
                                            as compensation;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investors
                                            that will hold their ADSs or ordinary shares as part of a straddle, hedge, conversion, constructive
                                            sale or other integrated transaction for U.S. federal income tax purposes;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investors
                                            that have a functional currency other than the U.S. dollar;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            that actually or constructively own 10% or more of our stock (by vote or value);</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            that hold their ADSs or ordinary shares in connection with a trade or business outside the
                                            United States;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            required to accelerate the recognition of any item of gross income with respect to their
                                            ADSs or ordinary shares as a result of such income being recognized on an applicable financial
                                            statement; or</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
                                            or other entities taxable as partnerships for U.S. federal income tax purposes, or persons
                                            holding ADSs or ordinary shares through such entities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
of whom may be subject to tax rules that differ significantly from those discussed below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
U.S. Holder is urged to consult its tax advisor regarding the application of U.S. federal taxation to its particular circumstances, and
the state, local, non-U.S. and other tax considerations of the ownership and disposition of the ADSs or our ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this discussion, a &#8220;U.S. Holder&#8221; is a beneficial owner of the ADSs or ordinary shares that is, for U.S. federal
income tax purposes:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            individual who is a citizen or resident of the United States;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            corporation (or other entity treated as a corporation for U.S. federal income tax purposes)
                                            created in, or organized under the law of, the United States or any state thereof or the
                                            District of Columbia;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            estate the income of which is includible in gross income for U.S. federal income tax purposes
                                            regardless of its source; or</span></td>
</tr></table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            trust (A) the administration of which is subject to the primary supervision of a U.S. court
                                            and which has one or more U.S. persons who have the authority to control all substantial
                                            decisions of the trust or (B) that has otherwise validly elected to be treated as a U.S.
                                            person under the Code.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) is a beneficial owner of the ADSs or ordinary
shares, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of
the partnership. Partners in a partnerships holding the ADSs or ordinary shares are urged to consult their tax advisors regarding an
investment in the ADSs or ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
U.S. federal income tax purposes, it is generally expected that a U.S. Holder of ADSs will be treated as the beneficial owner of the
underlying shares represented by the ADSs. The remainder of this discussion assumes that a U.S. Holder of the ADSs will be treated in
this manner. Accordingly, deposits or withdrawals of ordinary shares for ADSs will generally not be subject to U.S. federal income tax.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently expect to make distributions on the ADSs or ordinary shares. In the event we do make distributions of cash or other
property subject to the discussion under &#8220;&#8212;Passive foreign investment company rules&#8221; below, any cash distributions
paid on the ADSs or ordinary shares (including the amount of any PRC tax withheld) out of our current or accumulated earnings and profits,
as determined under U.S. federal income tax principles, will generally be includible in the gross income of a U.S. Holder as dividend
income on the day actually or constructively received by the U.S. Holder, in the case of ordinary shares, or by the depositary, in the
case of ADSs. Because we do not intend to determine our earnings and profits on the basis of U.S. federal income tax principles, any
distribution we pay will generally be treated as a &#8220;dividend&#8221; for U.S. federal income tax purposes. Dividends received on
the ADSs or ordinary shares will not be eligible for the dividends received deduction allowed to corporations in respect of dividends
received from U.S. corporations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 208; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->199<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individuals
and other non-corporate U.S. Holders may be subject to tax at the lower capital gain tax rate applicable to &#8220;qualified dividend
income,&#8221; provided that certain conditions are satisfied, including that (1) in the case of U.S. Holders of ADSs, the ADSs shares
with respect to which the dividends are paid are readily tradable on an established securities market in the United States, or, in the
case of U.S. Holders of either ADSs or ordinary shares, if we are deemed to be a PRC resident enterprise under the PRC tax law, we are
eligible for the benefit the Treaty, (2) we are neither a PFIC (as defined below) nor treated as such with respect to a U.S. Holder (as
discussed below) for the fiscal year in which the dividend is paid or the preceding fiscal year and (3) certain holding period and other
requirements are met. We expect that the ADSs will be readily tradable on an established securities market in the United States and that
we will be a qualified foreign corporation with respect to dividends (if any) paid on the ADSs. There can be no assurance that the ADSs
will continue to be considered readily tradable on an established securities market in later years. Because the ordinary shares will
not be listed on a U.S. exchange, dividends received with respect to ordinary shares that are not represented by ADSs may not be treated
as qualified dividends. U.S. Holders are urged to consult their tax advisors regarding the availability of the lower rate for dividends
paid with respect to the ADSs or ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are deemed to be a PRC resident enterprise under the PRC Enterprise Income Tax Law, see the section of this Annual Report on Form
20-F titled &#8220;<i>Item 10. Additional Information&#8212;E. Taxation&#8212;People&#8217;s Republic of China Taxation</i>&#8221;) we
may be eligible for the benefits of the Treaty. If we are eligible for such benefits, dividends we pay on our ordinary shares, regardless
of whether such shares are represented by the ADSs, and regardless of whether the ADSs are readily tradable on an established securities
market in the United States, would be eligible for the reduced rates of taxation described in the preceding paragraph.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
U.S. foreign tax credit purposes, dividends paid on the ADSs or ordinary shares generally will be treated as income from foreign sources
and generally will constitute passive category income. If PRC withholding taxes apply to dividends paid to a U.S. Holder with respect
to the ADSs or ordinary shares, such U.S. Holder may be able to obtain a reduced rate of PRC withholding taxes under the Treaty if certain
requirements are met. In addition, subject to certain conditions and limitations, PRC withholding taxes on dividends that are non-refundable
under the Treaty may be treated as foreign taxes eligible for credit against a U.S. Holder&#8217;s U.S. federal income tax liability.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder who does not elect to claim a foreign tax credit for foreign tax withheld may instead claim a deduction for U.S. federal
income tax purposes, in respect of such withholding, but only for a year in which such holder elects to do so for all creditable foreign
income taxes. The rules governing foreign tax credit are complex. For example, subject to temporary interim relief provided by the
IRS, Treasury regulations provide that, in the absence of an election to apply the benefits of an applicable income tax treaty, in order
for non-U.S. income taxes to be creditable, the relevant non-U.S. income tax rules must be consistent with certain U.S. federal income
tax principles, and we have not determined whether the PRC income tax system meets these requirements. U.S. Holders are urged to consult
their tax advisors regarding the availability of the foreign tax credit under their particular circumstances.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sale
or other disposition</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion under &#8220;&#8212;<i>Passive foreign investment company rules</i>&#8221; below, a U.S. Holder will generally recognize
gain or loss upon the sale or other disposition of ADSs or ordinary shares in an amount equal to the difference between the amount realized
upon the disposition and the holder&#8217;s adjusted tax basis in such ADSs or ordinary shares. The gain or loss will generally be capital
gain or loss. Individuals and other non-corporate U.S. Holders who have held the ADSs or ordinary shares for more than one year will
generally be eligible for reduced tax rates. The deductibility of a capital loss may be subject to limitations. Any such gain or loss
that the U.S. Holder recognizes will generally be treated as U.S. source income or loss for foreign tax credit limitation purposes, which
will generally limit the availability of foreign tax credits. However, if we are deemed to be a PRC resident enterprise under the PRC
Enterprise Income Tax Law and PRC tax were to be imposed on any gain from the disposition of the ADSs or ordinary shares, a U.S. Holder
that is eligible for the benefits of the Treaty may elect to treat such gain as foreign source income and claim a foreign tax credit
in respect of any PRC taxes on disposition gains. Under Treasury regulations, subject to temporary interim relief provided by the IRS,
if a U.S. Holder is not eligible for the benefits of the Treaty or fails to make the election to treat any gain as foreign source, then
such U.S. holder may not be able to use the foreign tax credit arising from any PRC tax imposed on the disposition of the ADSs or ordinary
shares. Additionally, other limitations under the foreign tax credit rules may preclude the U.S. Holder from claiming a foreign tax credit
with respect to such PRC taxes. If a U.S. Holder is precluded from claiming a foreign tax credit, it is possible that any PRC taxes on
disposition gains may either be deductible or reduce the amount realized on the disposition. U.S. Holders are urged to consult their
tax advisors regarding the creditability of any PRC tax.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Passive
foreign investment company rules</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-U.S. corporation, such as our company, will be classified as a &#8220;passive foreign investment company&#8221;, or PFIC, for U.S.
federal income tax purposes for any taxable year, if either (1) 75% or more of its gross income for such year consists of certain types
of &#8220;passive&#8221; income, or the income test, or (2) 50% or more of the amount of its assets (generally determined on the basis
of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive income, or
the asset test. For this purpose, cash and assets readily convertible into cash are categorized as passive assets, and the Company&#8217;s
goodwill and other unbooked intangibles are taken into account. Passive income generally includes, among other things, dividends, interest,
rents, royalties (other than certain royalties treated as derived in an active conduct of a trade or business), and gains from the disposition
of passive assets. We will be treated as owning a proportionate share of the assets and earning a proportionate share of the income of
any other corporation in which we own, directly or indirectly, at least 25% (by value) of the stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the PFIC asset test, the amount of our assets will generally be determined by reference to their value, which may be determined
by reference to our market capitalization. However, if we are considered to be a CFC that is not &#8220;publicly traded&#8221; for purposes
of the PFIC rules during the tested period, the amount of our assets will generally be determined by reference to our adjusted bases
in our assets. Further, for purposes of applying the PFIC asset test to us, if any entity in which we own 25% or more of the total value
of the outstanding shares of such entity is considered to be a CFC that is not publicly traded, the amount of such entity&#8217;s assets
would generally be determined by reference to its adjusted bases in its assets.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 209; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->200<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
assurances can be provided that we or any of our subsidiaries are not a CFC or will not be a CFC, and consequently, no assurances can
be given that the PFIC asset test will not be applied to us based on the adjusted bases of our non-U.S. subsidiaries in their assets.
Provided that we and our subsidiaries were not, and do not become, CFCs, based on the composition of our income and assets and the estimated
value of our assets, which is based on our current market capitalization, we do not presently expect to be a PFIC for our current fiscal
year or future fiscal years. However, no assurance can be given that we will not be a PFIC for the current fiscal year or future fiscal
years because the determination of whether we will be or become a PFIC for any taxable year is a fact intensive determination made annually
after the close of each taxable year that depends, in part, upon the composition and classification of our income and assets. Fluctuations
in the market price of the ADSs may cause us to be or become classified as a PFIC for the current or future fiscal years because the
value of our assets for purposes of the asset test, including the value of our goodwill and unbooked intangibles, may be determined by
reference to the market price of our ordinary shares or ADSs from time to time (which may be volatile). Among other matters, if our market
capitalization is less than anticipated or subsequently declines, we may be or become classified as a PFIC for the current fiscal year
or future fiscal years.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC for any fiscal year during which a U.S. Holder holds the ADSs or ordinary shares, and unless the U.S. Holder makes a mark-to-market
election (as described below), the U.S. Holder will generally be subject to special tax rules on (1) any excess distribution that we
make to the U.S. Holder (which generally means any distribution paid during a fiscal year to a U.S. Holder that is greater than 125%
of the average annual distributions paid in the three preceding fiscal years or, if shorter, the U.S. Holder&#8217;s holding period for
the ADSs or ordinary shares) and (2) any gain realized on the sale or other disposition of ADSs or ordinary shares, or collectively,
the Excess Distribution Rules. Under the Excess Distribution Rules:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            excess distribution or gain will be allocated ratably over the U.S. Holder&#8217;s holding
                                            period for the ADSs or ordinary shares;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount allocated to the current fiscal year and any fiscal years in the U.S. Holder&#8217;s
                                            holding period prior to the first fiscal year in which we are a PFIC, each a pre-PFIC year,
                                            will be taxable as ordinary income; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount allocated to each prior fiscal year, other than a pre-PFIC year, will be subject to
                                            tax at the highest tax rate in effect for individuals or corporations, as appropriate, for
                                            that year, increased by an additional tax equal to the interest on the resulting tax deemed
                                            deferred with respect to each such fiscal year.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC for any taxable year during which a U.S. Holder holds the ADSs or ordinary shares and any of the entities in which we hold
equity interests is also a PFIC, in each case, a lower-tier PFIC, such U.S. Holder would be treated as owning a proportionate amount
(by value) of the shares of the lower-tier PFIC for purposes of the application of these rules. U.S. Holders are urged to consult their
tax advisors regarding the application of the PFIC rules to any of the entities in which we hold equity interests.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC for any taxable year during which a U.S. Holder owns ADSs or ordinary shares, we will generally continue to be treated
as a PFIC with respect to the U.S. Holder for all succeeding years during which the U.S. Holder owns the ADSs or ordinary shares, even
if we cease to meet the threshold requirements for PFIC status, unless the U.S. Holder made a timely &#8220;deemed sale&#8221; election,
in which case any gain on the deemed sale would be taxed under the PFIC rules described above.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an alternative to the Excess Distribution Rules, a U.S. Holder of &#8220;marketable stock&#8221; (as defined below) in a PFIC may make
a mark-to-market election with respect to such stock. If a U.S. Holder makes this election with respect to our ordinary shares or ADSs,
the holder will generally (1) include as ordinary income for each fiscal year that we are a PFIC the excess, if any, of the fair market
value of the ADSs and ordinary shares held at the end of the fiscal year over the adjusted tax basis of such ADSs and (2) deduct as an
ordinary loss in each such fiscal year the excess, if any, of the adjusted tax basis of the ADSs over the fair market value of such ADSs
and ordinary shares held at the end of the fiscal year, but such deduction will only be allowed to the extent of the amount previously
included in income as a result of the mark-to-market election. The U.S. Holder&#8217;s adjusted tax basis in the ADSs would be adjusted
to reflect any income or loss resulting from the mark-to-market election. If a U.S. Holder makes a mark-to-market election in respect
of the ADSs and we cease to be a PFIC, the holder will not be required to take into account the gain or loss described above during any
period that we are not a PFIC. If a U.S. Holder makes a mark-to-market election, any gain such U.S. Holder recognizes upon the sale or
other disposition of the ADSs in a year when we are a PFIC will be treated as ordinary income and any loss will be treated as ordinary
loss, but such loss will only be treated as ordinary loss to the extent of the net amount previously included in income as a result of
the mark-to-market election. If we cease to be a PFIC when you have a mark-to-market election in effect, gain or loss realized by you
on the sale of the ADSs will be a capital gain or loss.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mark-to-market election is available only for &#8220;marketable stock,&#8221; which is stock that is traded in other than de minimis
quantities on at least 15 days during each calendar quarter, or regularly traded, on a qualified exchange or other market, as defined
in applicable United States Treasury regulations. For those purposes, we expect that the ADSs will be treated as marketable stock, and
our ordinary shares may be treated as marketable stock as well. We anticipate that the ADSs should qualify as being regularly traded,
but no assurances may be given in this regard. Once made, the election cannot be revoked without the consent of the IRS unless the ADSs
cease to be marketable stock. If we are a PFIC for any year in which a U.S. holder owns ordinary shares but before a mark-to- market
election is made, the Excess Distribution Rules described above will apply to any mark-to-market gain recognized in the year the election
is made.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
a mark-to-market election cannot be made for any lower-tier PFICs that we may own, a U.S. Holder may continue to be subject to the general
PFIC rules with respect to such U.S. Holder&#8217;s indirect interest in any investments held by us that are treated as an equity interest
in a PFIC for U.S. federal income tax purposes. Another alternative to the Excess Distribution Rules is if a U.S. Holder makes a valid
&#8220;qualifying electing fund,&#8221; or QEF, election.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
QEF election is available only if a U.S. Holder receives an annual information statement from the PFIC setting forth its net ordinary
income and net capital gains, as determined under U.S. federal income tax principles. In the event that we are a PFIC, we cannot provide
assurance that we will perform the necessary calculations or provide you with the information statement necessary to make a QEF election.
Accordingly, you may not be able to make or maintain such an election with respect to your ordinary shares or ADSs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 210; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->201<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a U.S. Holder owns the ADSs or ordinary shares during any fiscal year that we are a PFIC, the holder must generally file an annual IRS
Form 8621. You should consult your tax advisor regarding the U.S. federal income tax considerations of owning and disposing of the ADSs
or ordinary shares if we are or become a PFIC, including the availability and possibility of making a mark-to-market election or qualified
electing fund election.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information
reporting and backup withholding</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Holders may be subject to information reporting to the IRS and U.S. backup withholding with respect to dividends on and proceeds from
the sale or other disposition of the ADSs or ordinary shares that are made within the United States or through certain U.S.-related financial
intermediaries. Backup withholding will not apply, however, to a U.S. Holder who furnishes a correct taxpayer identification number and
makes any other required certification, or who is otherwise exempt from backup withholding and establishes this status if required to
do so.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. Amounts withheld as backup withholding may be credited against a U.S. Holder&#8217;s U.S. federal
income tax liability, and a U.S. Holder generally may obtain a refund of any excess amounts withheld under the backup withholding rules
by filing the appropriate claim for refund with the IRS and furnishing any required information. U.S. Holders should consult their tax
advisors regarding the application of the U.S. information reporting and backup withholding rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information
with respect to foreign financial assets</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S. Holders may be required to report information relating to the ordinary shares or ADSs if the aggregate value of these assets and
certain other foreign financial assets, including equity of foreign entities, exceeds certain threshold amounts, subject to certain exceptions
(including an exception for ordinary shares or ADSs held in accounts maintained by certain U.S. financial institutions). U.S. Holders
should consult their tax advisors regarding their reporting obligations with respect to their ownership and disposition of the ordinary
shares or ADSs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.
Dividends and Paying Agents</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G.
Statement by Experts</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H.
Documents on Display</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to periodic reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers.
Accordingly, we are required to file with the SEC an Annual Report on Form 20-F containing financial statements audited by an independent
registered public accounting firm, as well as reports on Form 6-K. The SEC maintains a website at http://www.sec.gov that contains reports
and other information that we file with or furnish electronically to the SEC. We will also make available, free of charge, such reports
and other information through our corporate website at www.ascentage.com soon as reasonably practicable after they are electronically
filed with, or furnished to, the SEC. The information contained on or that can be accessed through our website is not incorporated by
reference into this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">As a foreign
private issuer, we are exempt from the rules and regulations under the Exchange Act prescribing the furnishing and content of proxy statements. In addition, we are not required to file reports and financial statements with the SEC as frequently or as promptly as U.S. public
companies whose securities are registered under the Exchange Act.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will furnish the depositary of our ADSs with our Annual Reports on Form 20-F, which will include a review of operations and audited consolidated
financial statements, and all notices of shareholders&#8217; meetings and other reports and communications that are made generally available
to our shareholders. The depositary will make such notices, reports and communications available to holders of ADSs and, upon our request,
will mail to all record holders of ADSs the information contained in any notice of a shareholders&#8217; meeting received by the depositary
from us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.
Subsidiary Information</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>J.
Annual Report to Security Holders</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to market risks in the ordinary course of our business. These risks primarily include credit risk and liquidity risk. For
more information about financial risks that we are exposed to, see Note 26 to our audited consolidated financial statements included
elsewhere in this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 211; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->202<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Credit
risk</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Credit risk
refers to the risk that a counterparty will default on its contractual obligations resulting in us incurring a financial loss. Our credit
risk is primarily attributable to our trade and other receivables. We seek to minimize losses due to increased credit risk exposure by
transacting with recognized and creditworthy third parties. All customers that wish to trade on credit terms are subject to our credit
verification procedures. </span>As of December 31, 2025 and 2024, our credit risk for receivables from third parties was RMB252.9 million
(US$36.2 million) and RMB 83.1 million, respectively.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
risk</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
risk is the risk that we will encounter difficulty in meeting financial obligations due to shortage of funds. Our exposure to liquidity
risk arises primarily from mismatches of the maturities of financial assets and liabilities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
manage our liquidity risk by ensuring the availability of funding. Our primary sources of liquidity have been cash and cash equivalents
raised from the issuance of ADSs, preference shares and convertible instruments and drawdown of loans and cash provided by operating
activities. We monitor working capital projections to ensure that we have adequate working capital to meet current requirements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">As of December
31, 2025, we had current liabilities of RMB1,643.4 million (US$235.0 million), as compared to RMB2,944.2 million (US$421.0 million) of
current assets. As of December 31, 2024, we had current liabilities of RMB1,166.6 million, as compared to RMB1,474.2 million of current
assets. We believe that the net proceeds from the revenues from our commercial sales in China, our public and private financings, together
with our existing cash and cash equivalents and our loan facility, will enable us to fund our operating expenses and capital expenditure
requirements through at least the next 12 months from the issuance of the consolidated financial statements included in this Annual Report
on Form 20-F but may not be sufficient for us to fund any of our drug candidates through regulatory approval, which may last several
years.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interest
rate risk</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
exposure to interest rate risk primarily relates to the interest income generated by excess cash, which is mostly held in interest-bearing
bank deposits. We have not used any derivative financial instruments to manage our interest risk exposure. Interest-earning instruments
carry a degree of interest rate risk. We have not been exposed, nor do we anticipate being exposed to material risks due to changes
in interest rates. However, our future interest income may be lower than expected due to changes in market interest rates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inflation
risk</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, inflation in China has not materially impacted our results of operations. Although we have not in the past been materially
affected by inflation since our inception, we can provide no assurance that we will not be affected in the future by higher rates of
inflation in China.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
exchange risk</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a global business enterprise with part of our operations based in the PRC. Most of our transactions are settled in RMB, and our financial
statements are presented in RMB. We do not believe that we currently have any significant direct foreign exchange risk and have not used
any derivative financial instruments to hedge our exposure to such risk. Although, in general, our exposure to foreign exchange risks
should be limited, the value of your investment in the ADSs will be affected by the exchange rate between U.S. dollar and RMB because
the majority of value of our business is effectively denominated in RMB, while the ADSs representing our ordinary shares will be traded
in U.S. dollars.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of the RMB against the U.S. dollar and other currencies is affected by changes in China&#8217;s political and economic conditions
and by China&#8217;s foreign exchange policies, among other things. In recent years, the RMB has fluctuated against the U.S. dollar,
at times significantly and unpredictably, and it is difficult to predict how market forces or PRC or U.S. government policy may impact
the exchange rate between the RMB and the U.S. dollar in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that we need to convert U.S. dollars into RMB for our operations, appreciation of RMB against the U.S. dollar would reduce
the RMB amount we receive from the conversion. Conversely, if we decide to convert RMB into U.S. dollars for the purpose of making payments
for dividends on our ordinary shares or ADSs, servicing our outstanding debt, or for other business purposes, appreciation of the U.S.
dollar against the RMB would reduce the U.S. dollar amounts available to us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><!-- Field: Page; Sequence: 212; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->203<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Debt Securities</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Warrants and Rights</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Other Securities</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
American Depositary Shares</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
and expenses</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary may charge each person to whom ADSs are issued, including, without limitation, issuances against deposits of ordinary shares,
issuances in respect of ordinary share distributions, rights and other distributions, issuances pursuant to a stock dividend or stock
split declared by us or issuances pursuant to a merger, exchange of securities or any other transaction or event affecting the ADSs or
deposited securities, and each person surrendering ADSs for withdrawal of deposited securities or whose ADSs are cancelled or reduced
for any other reason, a fee of up to US$5.00 for each 100 ADSs (or any portion thereof) issued, delivered, reduced, cancelled or surrendered,
or upon which a share distribution or elective distribution is made or offered, as the case may be. The depositary may sell (by public
or private sale) sufficient securities and property received in respect of a share distribution, rights and/or other distribution prior
to such deposit to pay such charge.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following additional fees, charges and expenses shall also be incurred by the ADR holders, the beneficial owners, by any party depositing
or withdrawing ordinary shares or by any party surrendering ADSs and/or to whom ADSs are issued (including, without limitation, issuance
pursuant to a stock dividend or stock split declared by us or an exchange of stock regarding the ADSs or the deposited securities or
a distribution of ADSs), whichever is applicable:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            fee of up to US$0.05 per ADS held for any cash distribution made, or for any elective cash/stock
                                            dividend offered, pursuant to the deposit agreement;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            aggregate fee of up to US$0.05 per ADS per calendar year (or portion thereof) for services
                                            performed by the depositary in administering the ADRs (which fee may be charged on a periodic
                                            basis during each calendar year and shall be assessed against holders of ADRs as of the record
                                            date or record dates set by the depositary during each calendar year and shall be payable
                                            in the manner described in the next succeeding provision);</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            amount for the reimbursement of such fees, charges and expenses as are incurred by the depositary
                                            and/or any of its agents (including, without limitation, the custodian, as well as charges
                                            and expenses incurred on behalf of ADR holders in connection with compliance with foreign
                                            exchange control regulations or any law, rule or regulation relating to foreign investment)
                                            in connection with the servicing of the shares or other deposited securities, the sale of
                                            securities (including, without limitation, deposited securities), the delivery of deposited
                                            securities or otherwise in connection with the depositary&#8217;s or its custodian&#8217;s
                                            compliance with applicable law, rule or regulation (which fees and charges shall be assessed
                                            on a proportionate basis against ADR holders as of the record date or dates set by the depositary
                                            and shall be payable at the sole discretion of the depositary by billing such ADR holders
                                            or by deducting such charge from one or more cash dividends or other cash distributions);</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            fee of up to US$0.05 per ADS held for the direct or indirect distribution of securities (other
                                            than ADSs or rights to purchase additional ADSs) or the net cash proceeds from the public
                                            or private sale of such securities, regardless of whether any such distribution and/or sale
                                            is made by, for, or received from, or (in each case) on behalf of, the depositary, us and/or
                                            any third party (which fee may be assessed against ADR holders as of a record date set by
                                            the depositary);</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock
                                            transfer or other taxes and other governmental charges;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            transaction fee per cancellation request (including any cancellation request made through
                                            SWIFT, facsimile transmission or any other method of communication) as disclosed on the &#8220;Disclosures&#8221;
                                            page (or successor page) of www.adr.com (as updated by the depositary from time to time,
                                            &#8220;ADR.com&#8221;) and any applicable delivery expenses (which are payable by such persons
                                            or ADS holders);</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">transfer
                                            or registration fees for the registration of transfer of deposited securities on any applicable
                                            register in connection with the deposit or withdrawal of deposited securities; and</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fees
                                            of any division, branch or affiliate of the depositary utilized by the depositary to direct,
                                            manage and/or execute any public and/or private sale of securities under the deposit agreement.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 213; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->204<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
facilitate the administration of various depositary receipt transactions, including disbursement of dividends or other cash distributions
and other corporate actions, the depositary may engage the foreign exchange desk within the banking division of the depositary, or the
Bank, and/or its affiliates in order to enter into spot foreign exchange transactions to convert foreign currency into U.S. dollars.
For certain currencies, foreign exchange transactions are entered into with the Bank or an affiliate, as the case may be, acting in a
principal capacity. For other currencies, foreign exchange transactions are routed directly to and managed by an unaffiliated local custodian
(or other third party local liquidity provider), and neither the Bank nor any of its affiliates is a party to such foreign exchange transactions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foreign exchange rate applied to a foreign exchange transaction will be either (a)&#160;a published benchmark rate, or (b)&#160;a rate
determined by a third party local liquidity provider, in each case plus or minus a spread, as applicable. The depositary will disclose
which foreign exchange rate and spread, if any, apply to such currency on the &#8220;Disclosures&#8221; page (or successor page) of ADR.com.
Such applicable foreign exchange rate and spread may (and neither the depositary, the Bank nor any of their affiliates is under any obligation
to ensure that such rate does not) differ from rates and spreads at which comparable transactions are entered into with other customers
or the range of foreign exchange rates and spreads at which the Bank or any of its affiliates enters into foreign exchange transactions
in the relevant currency pair on the date of the foreign exchange transaction. Additionally, the timing of execution of a foreign exchange
transaction varies according to local market dynamics, which may include regulatory requirements, market hours, and liquidity in the foreign
exchange market, or other factors. Furthermore, the Bank and its affiliates may manage the associated risks of their position in the market
in a manner they deem appropriate without regard to the impact of such activities on the depositary, us, ADR holders or beneficial owners.&#160;<i>The
spread applied does not reflect any gains or losses that may be earned or incurred by the Bank and its affiliates as a result of risk
management or other hedging related activity.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, to the extent we provide U.S. dollars to the depositary, neither the Bank nor any of its affiliates will execute a foreign
exchange transaction as set forth herein. In such case, the depositary will distribute the U.S. dollars received from us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Further
details relating to the applicable foreign exchange rate, the applicable spread and the execution of foreign exchange transactions will
be provided by the depositary on ADR.com. Each holder and beneficial owner by holding or owning an ADR or ADS or an interest therein,
and we, each acknowledge and agree that the terms applicable to foreign exchange transactions disclosed from time to time on ADR.com
will apply to any foreign exchange transaction executed pursuant to the deposit agreement.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay all other fees, charges and expenses of the depositary and any agent of the depositary (except the custodian) pursuant to agreements
from time to time between us and the depositary.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right of the depositary to charge and receive payment of fees, charges and expenses survives the termination of the deposit agreement,
and shall extend for those fees, charges and expenses incurred prior to the effectiveness of any resignation or removal of the depositary.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fees and charges described above may be amended from time to time by agreement between us and the depositary.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
depositary anticipates reimbursing us for certain expenses incurred by us that are related to the establishment and maintenance of the
ADR program upon such terms and conditions as we and the depositary may agree from time to time. The depositary may make available to
us a set amount or a portion of the depositary fees charged in respect of the ADR program or otherwise upon such terms and conditions
as we and the depositary may agree from time to time. The depositary may also agree to reduce or waive certain fees that would normally
be charged on ADSs issued to or at the director of, or otherwise held by, us and/or certain holders and beneficial owners and holders
and beneficial owners of ordinary shares of ours. The depositary collects its fees for issuance and cancellation of ADSs directly from
investors depositing ordinary shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary
collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable
property to pay the fees. The depositary may collect its annual fee for depositary services by deduction from cash distributions, or
by directly billing investors, or by charging the book-entry system accounts of participants acting for them. The depositary will generally
set off the amounts owing from distributions made to holders of ADSs. If, however, no distribution exists and payment owing is not timely
received by the depositary, the depositary may refuse to provide any further services to ADR holders that have not paid those fees and
expenses owing until such fees and expenses have been paid. At the discretion of the depositary, all fees and charges owing under the
deposit agreement are due in advance and/or when declared owing by the depositary.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 214; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->205<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</b>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
&#8212; D. Material Modifications to the Rights of Security Holders&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
Use of Proceeds</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following &#8220;Use of Proceeds&#8221; information relates to the registration statement on Form&#160;F-1, as amended (File No.&#160;333-
284064) in relation to our U.S. initial public offering, which was declared effective by the SEC on January 23, 2025. In January 2025,
we completed our U.S. initial public offering in which we issued and sold an aggregate of 8,260,144 ADSs (representing 33,040,576
ordinary shares), at a public offering price of US$17.25 per ADS (equivalent to HK$33.57 per ordinary share), resulting
in net proceeds to us of US$132.5 million (equivalent to HK$1,031.4 million), after deducting underwriting
discounts and commissions. J.P. Morgan Securities LLC and Citigroup Global Markets Inc. acted as joint book-running mangers for our U.S.
initial public offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total expenses incurred in connection with our U.S. initial public offering was US$14.6 million (equivalent to
HK$113.6 million), which included US$10.0&#160;million (equivalent to HK$72.8 million) in underwriting discounts and commissions and US$4.6 million (equivalent to HK$33.5 million) in other offering expenses. None of the net proceeds or transaction
expenses from our U.S. initial public offering were paid, directly or indirectly, to our directors or officers and persons owning
10% or more of our equity securities or our affiliates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">In July 2025,
we completed our 2025 placing, pursuant to which we issued 22,000,000 ordinary shares at a price of HK$68.60 per share. The net proceeds
(after deducting all applicable costs and expenses, including commission and levies of HK$16.7 million (US$2.2 million) raised were HK$1,492.5
million (US$190.1 million).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The net proceeds
received from our U.S. initial public offering and our 2025 placing are continuing to be used &#160;as described in the final prospectus
filed with the SEC on January 24, 2025 and the Form 6-K filed with the SEC on July 25, 2025, respectively. As of the date of this Annual
Report on Form 20-F, we have not yet substantially used the net proceeds received from these offerings.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
15. CONTROLS AND PROCEDURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Disclosure Controls and Procedures</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Evaluation
of Disclosure Controls and Procedures</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain disclosure controls and procedures (as that term is defined in Rules&#160;13a-15(e)&#160;and 15d-15(e)&#160;under the Exchange
Act) that are designed to ensure that information required to be disclosed in the Company&#8217;s reports under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is
accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Head of Finance
(acting Principal Financial and Accounting Officer), as appropriate, to allow timely decisions regarding required disclosures. Any controls
and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives. As required
by Rules 13a-15 and 15d-15 under the Exchange Act, our management, with the participation of our Chief Executive Officer and Head of
Finance, acting as our Principal Financial and Accounting Officer, carried out an evaluation of the effectiveness of the design and operation
of our disclosure controls and procedures as of December&#160;31, 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Management&#8217;s Annual Report on Internal Control over Financial Reporting</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our management is responsible for establishing
and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) and 15d-15(f) promulgated under the Securities
Exchange Act of 1934.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the course of auditing our consolidated financial
statements as of and for the years ended December 31, 2022, 2023 and 2024, we and our independent registered public accounting firm identified
one material weakness in our internal control over financial reporting. As defined in the standards established by the PCAOB, a &#8220;material
weakness&#8221; is a deficiency, or a combination of control deficiencies, in internal control over financial reporting, such that there
is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on
a timely basis</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The material weakness identified relates to our
insufficient accounting and financial reporting personnel with the necessary knowledge and experience with respect to the SEC&#8217;s
rules and regulations and the internal control over financial reporting requirements of the Sarbanes-Oxley Act of 2002.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 215; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->206<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To remedy our material weakness, we have
implemented several measures to improve our internal control over financial reporting, among others: (1) hiring additional financial
reporting personnel with SEC reporting experience, (2) expanding the capabilities of existing financial reporting personnel through
continuous training and education in the accounting and reporting requirements under SEC rules and regulations and (3) establishing
effective monitoring and oversight controls for non-recurring and complex transactions to ensure the accuracy and completeness of
our consolidated financial statements and related disclosures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Because of its inherent limitations, internal control
over financial reporting may not prevent or detect misstatements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our management assessed the effectiveness of our
internal control over financial reporting as of December 31, 2025. In making this assessment, our management used the criteria set forth
by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). As of
December 31, 2025, based on an assessment performed by our management on the performance of the remediation measures described above,
we determined that the material weakness previously identified in our internal control over financial reporting had been remediated and
our internal control over financial reporting is effective based on those criteria.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Attestation Report of Registered Public Accounting Firm</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 20-F does not include an attestation report of the Company&#8217;s independent registered public accounting firm
regarding the effectiveness of our internal control over financial reporting due to an exemption provided by the JOBS Act for emerging
growth companies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Changes in Internal Control over Financial Reporting</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period covered by this Annual Report on Form 20-F, except as disclosed under &#8220;<i>&#8212;A. Disclosure Controls and Procedures</i>&#8221;
and &#8220;<i>&#8212;B. Management&#8217;s Annual Report on Internal Control over Financial Reporting</i>&#8221; above, there were no
changes in our internal control over financial reporting (as such term is defined in Rules&#160;13a-15(f)&#160;and 15d-15(f)&#160;under
the Exchange Act) during the period covered by this Annual Report on Form 20-F that have materially affected, or are reasonably likely
to materially affect, our internal control over financial reporting, other than the changes to remediate the material weakness as described
above.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16.
[RESERVED]</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16A.
AUDIT COMMITTEE FINANCIAL EXPERT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has determined that each of Changqing Ye, Dr. Simon Dazhong Lu and Marina S. Bozilenko, an independent director and
member of our audit committee, qualifies as an &#8220;audit committee financial expert,&#8221; as defined by SEC rules and regulations
and in accordance with applicable Nasdaq corporate governance requirements. For a description of each directors&#8217; experience, see
&#8220;<i>Item 6. Directors, Senior Management and Employees&#8212;A. Directors and Senior Management</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16B.
CODE OF ETHICS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Business Conduct and Ethics that applies to all our directors, officers and employees, including our principal
executive and principal financial officers. Our Code of Business Conduct and Ethics addresses, among other things, conflicts of interest,
confidentiality, competition and fair dealing, financial matters and external reporting, our assets, as well as the process for reporting
violations of the Code of Business Conduct and Ethics and employee misconduct. The Code of Business Conduct and Ethics is available on
our website at&#160;<i>www.ascentage.com</i>. The information contained on or that can be accessed through our website is not incorporated
by reference into this Annual Report on Form 20-F. The Audit Committee of our board of directors is responsible for overseeing the Code
of Business Conduct and Ethics and is required to approve any waivers of the Code of Business Conduct and Ethics. We did not grant any
waivers to the Code of Business Conduct and Ethics during the year ended December 31, 2025. We expect that any amendments to the Code
of Business Conduct and Ethics will be disclosed on our website.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to disclose on our website any amendment to, or waiver from, a provision of our Code of Business Conduct and Ethics that applies
to our directors or executive officers to the extent required under the rules of the SEC or Nasdaq. Our Code of Business Conduct and
Ethics is available on our website at www.ascentage.com. The information contained on our website is not incorporated by reference in
this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 216; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->207<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16C.
PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth the total amount of services rendered by Ernst &amp; Young Hua Ming LLP for services performed in the years ended
December&#160;31, 2025 and 2024, and breaks down these amounts by category of service:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">RMB (in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Audit Fees (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,900</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Audit-Related Fees (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax Fees (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">620</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">592</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">All Other Fees (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">288</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">288</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,008</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,780</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audit
                                            fees&#8221; means the aggregate fees billed for professional services rendered by our independent
                                            registered public accounting firm for the audit of our annual financial statements and other
                                            audit services provided by our independent registered public accounting firm in connection
                                            with regulatory filings to the SEC.</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audit-related
                                            fees&#8221; means the aggregate fees listed for professional services rendered by our independent
                                            registered public accounting firm related to the audit of our financial statements that are
                                            not reported under &#8220;audit fees.&#8221;</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Tax
                                            fees&#8221; means the aggregate fees billed for professional services rendered for tax compliance,
                                            tax advice and tax planning.</span></td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Other
                                            fees&#8221; means the aggregate fees billed for corporate support services provided by our
                                            independent registered public accounting firm.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee&#160;pre-approval&#160;policies and procedures</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our audit committee charter, the audit committee is required to&#160;pre-approve&#160;all audit and non-audit services provided by
the independent auditor, unless the engagement is entered into pursuant to appropriate preapproval policies established by the Committee
or if such service falls within available exceptions under SEC rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16D.
EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_025"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16E.
PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December&#160;31, 2025, no purchases of our equity securities were made by or on behalf of us or any affiliated purchaser.
At the annual general meeting of the shareholders held on May 19, 2025, the shareholders approved a resolution from the board of directors
to repurchase no more than 10% of our total number of shares in issue as of the date of approval, valid until the 2026 annual general
meeting of the shareholders.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>




</div><div><a id="a_026"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16F.
CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16G.
CORPORATE GOVERNANCE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">We are listed on the Nasdaq and subject to the Nasdaq rules. However,
we are a &#8220;foreign private issuer&#8221; as defined by the SEC rules and regulations and, in accordance with Nasdaq Listing Rule
5615(a)(3), we may, in the future, elect to comply with certain home country governance requirements and certain exemptions thereunder
rather than complying with certain of the corporate governance requirements of Nasdaq. Certain corporate governance practices in the Cayman
Islands, which is our home country, may differ significantly from the Nasdaq rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 217; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->208<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In the event we elect to comply with certain home country governance
requirements, our shareholders may be afforded less protection than they otherwise would under the Nasdaq rules applicable to U.S. domestic
issuers. See &#8220;<i>Item 3. Key Information&#8212;D. Risk Factors&#8212; Risks related to our ordinary shares and the ADSs&#8212;As
an exempted company incorporated in the Cayman Islands, we are permitted to adopt certain home country practices in relation to corporate
governance matters that differ significantly from the Nasdaq corporate governance standards; these practices may afford less protection
to shareholders than they would enjoy if we comply fully with the Nasdaq corporate governance standards.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_028"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16H.
MINE SAFETY DISCLOSURE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_029"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16I.
DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_030"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
16J. INSIDER TRADING POLICIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Our
board of directors has&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-70372">adopted</ix:nonNumeric>&#160;an Insider Trading Policy that governs the purchase, sale, and other dispositions of our securities
by directors, senior management, and employees that is reasonably designed to promote compliance with applicable insider trading laws,
rules and regulations, and any listing standards applicable to us. Although the Company is not subject to the policy, the Company complies
with applicable insider trading laws, rules and regulations. A copy of the Company&#8217;s Insider Trading Policy is filed as Exhibit
11.1 to this Annual Report on Form 20-F.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_031"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
16K</b>. <b>CYBERSECURITY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="ixv-25932"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk
Management and Strategy</i></span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="ixv-70373"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" id="ixv-70374">Our
cybersecurity risk management program is designed to protect the confidentiality, integrity, and availability of our critical systems,
information and data.</ix:nonNumeric> The policies, standards, processes and practices of our cybersecurity risk management program are part of our information
security management system, or ISMS, program, which is integrated into our enterprise risk management process.</ix:nonNumeric> Our cybersecurity risk
management program includes a comprehensive set of policies and procedures to prevent accidental or intentional unauthorized modification,
destruction or disclosure of confidential, proprietary, personal or otherwise critical information, including an appropriate level of
security over the equipment, processes and software used to process, store and transmit information.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_3" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="ixv-25948"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
elements of our cybersecurity risk management program include, but are not limited to the following:</span></p></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_4" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_3"><ix:continuation continuedAt="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_2" id="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a cybersecurity
    threat defense system that addresses both internal and external threats;</span></td></tr>
  </table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_5" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_4"><ix:continuation continuedAt="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_3" id="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a cybersecurity incident response
    plan that includes procedures for responding to cybersecurity incidents and risk assessments designed to help identify material cybersecurity
    risks to our critical systems, information, products, services, and our broader enterprise information technology environment;</span></td></tr>
  </table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_6" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_5"><ix:continuation continuedAt="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_4" id="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a security
    team principally responsible for managing our cybersecurity risk assessment processes, our security controls, and our response to
    cybersecurity incidents;</span></td></tr>
  </table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_7" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_6"><ix:continuation continuedAt="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_5" id="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">network,
    host and application security;</span></td></tr>
  </table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 218; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->209<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_8" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_7"><ix:continuation continuedAt="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_6" id="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_5"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sensitive
                                            information protection methods, including technical safeguards, procedural requirements,
                                            and monitoring program on our corporate network;</span></td>
</tr></table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_9" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_8"><ix:continuation continuedAt="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_7" id="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_6"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">continuous
                                            testing of our security posture both internally and with outside vendors;</span></td>
</tr></table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_10" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_9"><ix:continuation continuedAt="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_8" id="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_7"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">security
                                            system effectiveness reviews with reference to applicable security standards; and</span></td>
</tr></table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_11" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_10"><ix:continuation id="_CybersecurityRiskRoleOfManagementTextBlock-c0_cont_8"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regular
                                            cybersecurity training for employees and contractors.</span></td>
</tr></table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_12" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
further improve the effectiveness of our cybersecurity risk management program, we engage <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" id="ixv-70375">third-party</ix:nonNumeric> service providers, where appropriate,
to assess and test the adequacy of our security controls and processes, consult best practices to address new challenges and evolving
risks, or otherwise assist with aspects of our security processes. <ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="ixv-70376">Additionally, our risk monitoring systems are regularly audited by
our internal auditors as well as cybersecurity audit companies. We consider the results of external and internal audits of our risk detection
and monitoring systems and implement modifications as necessary.</ix:nonNumeric></span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_13" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_12"><ix:continuation continuedAt="_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock-c0_cont_2" id="_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also implement third-party risk management processes to identify, assess and monitor material risks from cybersecurity threats associated
with key services providers that have access to our information technology systems or our confidential, proprietary, personal or otherwise
critical information based on our assessment of the potential impact to our operations and respective risk profile.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_14" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_13"><ix:continuation continuedAt="_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock-c0_cont_3" id="_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established and seek to continuously improve effective information security governance. We apply a risk-based approach in line with
our overall risk management framework to address potential gaps in security controls. The processes of our cybersecurity risk management
program are aligned to ISO 27001:2022, an international standard for information security management.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><ix:continuation continuedAt="_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock-c0_cont_4" id="_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock-c0_cont_3"><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_15" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_14"><ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" id="ixv-70379">As of the date of this Annual Report on Form 20-F, we have <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" id="ixv-70380">not experienced</ix:nonNumeric>
any cybersecurity incidents or risks from cybersecurity threats that have materially affected or are currently viewed as reasonably likely
to materially affect, us, our business strategy, results of operations, or financial condition.</ix:nonNumeric> However, the scope and impact of any future
cybersecurity threats cannot be predicted, and there can be no assurance that our cybersecurity risk management program will be effective
in preventing material cybersecurity threats in the future. For a description of the risks from cybersecurity threats that may materially
affect us, including our results of operations and financial condition, see &#8220;</ix:continuation></ix:continuation><i><ix:continuation id="_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock-c0_cont_4"><ix:continuation id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_15">Item 1. Key Information&#8212;D. Risk Factors&#8212;Risks
related to our industry, business and operations&#8212;We or our CROs, contractors, consultants, or other third parties may suffer system
failures, security breaches, or other incidents which may have a material adverse impact to our operations and financial position, which
could result in material disruption of our product development programs and adversely impact our business, financial condition or results
of operations.</ix:continuation></ix:continuation>&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="ixv-26103"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Governance</i></span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_2" id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is responsible for overseeing cybersecurity risk as part of its enterprise risk oversight function and has delegated
to the Audit Committee oversight of cybersecurity and other information technology risks. <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="ixv-70383">The Audit Committee oversees management&#8217;s
implementation of our cybersecurity risk management program.</ix:nonNumeric> Our board of directors receives periodic reports regarding operational,
financial, strategic, regulatory and other risks to the Company, including risks and exposures associated with cybersecurity, information
security and privacy matters and the steps management has taken to monitor and control such exposures. The Audit Committee and our board
of directors receive biannual reports from our Chief Executive Officer regarding management&#8217;s plans to monitor and address cybersecurity
risks and results from our internal audit function and third-party service-providers on their evaluation of the effectiveness of our
cybersecurity risk management program.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><ix:continuation id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cybersecurity management team, led by our head of information technology, <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" id="ixv-70384">is responsible for the day-to-day activities of our information
technology systems and implementing our cybersecurity risk management program, assessing and managing our material risks from cybersecurity
threats and</ix:nonNumeric> supervising both our internal cybersecurity personnel and our external cybersecurity consultants. <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="ixv-70385">Our cybersecurity management
team is informed about and monitors cybersecurity risks and incidents through various means, which may include briefings from internal
security personnel, threat intelligence and other information obtained from governmental, public or private sources, including external
consultants engaged by us, and alerts and reports produced by security tools deployed in the information technology environment.</ix:nonNumeric> Our
head of information technology has more than 10 years of experience in cybersecurity leadership, directing enterprise security strategies,
managing cross-functional teams, and overseeing compliance with frameworks such as ISO27001. In addition, she performs risk assessments,
security related policy development, and incident response coordination, ensuring alignment with business objectives. She has also implemented
advanced security architectures including endpoint/virtual desktop infrastructure security, network security, data security, email security,
and others and led audits for information technology security compliance as well as fostering a security-first culture through staff
training and threat simulations. Based on ongoing communications with our cybersecurity management team and internal and external cybersecurity
personnel, our head of information technology provides updates to our Chief Executive Officer as to our overall security controls, policies
and operations and our Chief Executive Officer informs the Audit Committee and the board of directors regarding the effectiveness of
our cybersecurity risk management program, associated risks and steps taken to reduce our vulnerability and mitigate impacts associated
with cybersecurity threats.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 219; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->210<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_032"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
III</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_033"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;17.
FINANCIAL STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;<i>Item 18. Financial Statements</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_034"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;18.
FINANCIAL STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audited consolidated financial statements as required under Item&#160;18 are attached hereto starting on&#160;page&#160;F-1&#160;of this
Annual Report on Form 20-F. The audit report of Ernst &amp; Young Hua Ming LLP, an independent registered public accounting firm, is
included herein preceding the audited consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_035"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;19.
EXHIBITS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents are filed as part of this Annual Report on Form 20-F or incorporated by reference herein:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font-size: 10pt; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation
    by Reference</b></span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt; border-bottom: black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.&#160;</b></span></td>
    <td style="font-size: 10pt; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; border-bottom: black 1.5pt solid; width: 45%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="font-size: 10pt; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; border-bottom: black 1.5pt solid; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form</b></span></td>
    <td style="font-size: 10pt; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; border-bottom: black 1.5pt solid; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    Number</b></span></td>
    <td style="font-size: 10pt; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; border-bottom: black 1.5pt solid; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="font-size: 10pt; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; border-bottom: black 1.5pt solid; width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Filing
    Date</b></span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex3-1.htm">Second
    Amended and Restated Memorandum and Articles of Association of the Registrant</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1/A</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 21, 2025</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1474274/000119380525000042/e664138_ex99-a.htm">Form
    of Specimen American Depositary Receipt (included in Exhibit&#160;4.3)</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1/A</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 21, 2025</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex4-2.htm">Registrant&#8217;s
    Specimen Certificate for ordinary shares</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1/A</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 21, 2025</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1474274/000119380525000042/e664138_ex99-a.htm">Deposit
    Agreement, among the Registrant, the depositary and all holders and beneficial owners of American Depositary Shares</a> &#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;333-284315</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;a</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 16, 2025</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4*</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex2-4.htm">Description of Securities</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1#</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-12.htm">Form
    of Indemnification Agreement between the Registrant and each of its directors and executive officers</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-1.htm">Concert
    Party Confirmation Deed</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3#</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-2.htm">Pre-IPO
    Share Option Plan</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4#</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-3.htm">Post-IPO
    Share Option Plan</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; ">
    <td style="font-size: 10pt">4.5</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><a href="ea028514801ex4-5.htm">Post-IPO Share Option Plan as amended on May 19, 2025</a></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6#</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-4.htm">2018
    RSU Scheme</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7#</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-5.htm">2021
    RSU Scheme</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">4.8</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><a href="ea028514801ex4-8.htm">2021 RSU Scheme as amended on May 19, 2025</a></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr style="font-size: 10pt; vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9#</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-6.htm">2022
    RSU Scheme</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    27, 2024</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">4.10</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000121390025087798/ea025585801ex10-1_ascentage.htm">2022 RSU Scheme as amended on May 19, 2025</a></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">S-8</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">333-290285</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">10.1</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">September 16, 2025</td></tr>
  <tr style="font-size: 10pt; vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11&#8224;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-7.htm">Collaboration and License Agreement between Ascentage Pharma Group Corp Limited, Guangzhou Healthquest Pharma Corp Limited, and Innovent Biologics (Suzhou) Co., LTD, Dated as of July 14, 2021</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="ea028514801ex4-12.htm">Amended and Restated Amended Patent License Agreement between Ascentage Pharma Group Corp Limited and the Regents of the U2022 RSU Scheme as amended on May 19, 20252</a></p>
</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="font: 10pt Times New Roman, Times, Serif">4.13&#8224;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ea028514801ex4-13.htm">License Agreement between Ascentage Pharma Group Corp Limited and the Regents of the University of Michigan, dated as of December August 12, 2025</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-9.htm">English translation of Guangzhou Shunjian Biomedical Technology Co., Ltd. Share Transfer Agreement, dated as of December&#160;5, 2016</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ea028514801ex4-15.htm">Offer Letter between Ascentage Pharma Group Inc. and Veet Misra</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font-size: 10pt; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16#</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-11.htm">Services Agreement between Ascentage Pharma Group Inc. and Shaomeng Wang</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17#</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-13.htm">Deed
    of non-competition among Dr. Dajun Yang, Dr. Yifan Zhai, Dr. Shaomeng Wang, Dr. Edward Ming Guo, Ascentage Limited and HealthQuest
    Pharma Limited, dated April 24, 2019</a></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 220; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->211<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18&#8224;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-14.htm">Exclusive
    Option Agreement, by and among Ascentage Pharma Group Corp Limited, Guangzhou Healthquest Pharma Co., Ltd., Suzhou Ascentage Pharmaceutical
    Co., Ltd., Ascentage Pharma Group International and Takeda Pharmaceuticals International AG, dated as of June 14, 2024</a></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27,
    2024</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19&#8224;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-15.htm">Registration
    Rights Agreement, dated as of June 20, 2024, by and between Ascentage Pharma Group International and Takeda Pharmaceuticals AG</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20#</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-16.htm">English
    translation of Labor Contract between Suzhou Ascentage Pharma Co., Ltd. and Dr. Dajun Yang</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21#</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-17.htm">English
    translation of Labor Contract between Guangzhou Healthquest Pharma Co., Ltd. and Dr. Yifan Zhai</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.22#</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-19.htm">Offer
    letter between Ascentage Pharma Group Inc. and Thomas J. Knapp, as amended</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.23#</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2023311/000110465924132177/tm2415654d13_ex10-20.htm">English
    translation of Labor Contract between Suzhou Ascentage Pharma Co., Ltd. and Jin Cao</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-284064</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 27, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex8-1.htm">List of subsidiaries
    of the Registrant</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex11-1.htm">English translation
    of Ascentage Pharma Group International Insider Trading Policy</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex12-1.htm">Certification by Principal
    Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex12-2.htm">Certification by Principal
    Financial and Accounting Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex13-1.htm">Certification by Principal
    Executive Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of
    the United States Code</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex13-2.htm">Certification by Principal
    Financial and Accounting Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and Section 1350 of Chapter 63
    of Title 18 of the United States Code</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex15-1.htm">Consent of Ernst &amp;
    Young Hua Ming LLP, independent registered public accounting firm</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex15-2.htm">Consent of Walkers
    (Hong Kong)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex15-3.htm">Consent of JunHe LLP</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.4*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex15-4.htm">Consent of Frost &amp;
    Sullivan</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea028514801ex97-1.htm">Ascentage Pharma Group
    International Compensation Recovery Policy</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.&#160;INS* &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance Document. &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.&#160;SCH* &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.&#160;CAL* &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase
    Document &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.&#160;DEF* &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Definition Linkbase
    Document</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.&#160;LAB* &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document
    &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.&#160;PRE*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase
    Document</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104* &#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL for the cover page of this Annual Report
    on Form 20-F (embedded within the Inline XBRL document)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain portions of this exhibit
    (indicated by asterisks) have been redacted because they are both not material and are the type that the Registrant treats as private
    or confidential.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates a management contract
    or any compensatory plan, contract or arrangement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 221; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->212<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registrant hereby certifies that it meets all of the requirements for filing on Annual Report on Form 20-F and that it has duly caused
and authorized the undersigned to sign this Annual Report on its behalf.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ASCENTAGE PHARMA
    GROUP INTERNATIONAL</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 60%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 29,
    2026</span></td>
    <td style="width: 5%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Dajun Yang</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajun Yang, M.D., Ph.D.</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and Chief Executive Officer </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 222; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->213<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><!-- Field: Split-Segment; Name: 8 --><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ASCENTAGE
PHARMA GROUP INTERNATIONAL</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Index
to consolidated financial statements</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pages</b></span></td></tr> <tr> <td style="padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 91%; padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_001">Report of independent registered public accounting firm (PCAOB ID: <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId" id="ixv-70386">1408</ix:nonNumeric>)</a></span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; width: 8%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr> <tr> <td style="padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_002">Consolidated statements of profit or loss for the years ended December 31, 2023, 2024 and 2025</a></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr> <tr> <td style="padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_003">Consolidated statements of comprehensive loss for the years ended December 31, <span style="font-family: Times New Roman, Times, Serif">2023,
2024 and 2025</span></a></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr> <tr> <td style="padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_004">Consolidated statements of financial position as of December 31, 2024 and 2025</a></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_005">Consolidated statements of changes in equity for the years ended December 31, <span style="font-family: Times New Roman, Times, Serif">2023,
2024 and 2025</span></a></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr> <tr> <td style="padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_006">Consolidated statements of cash flows for the years ended December 31, <span style="font-family: Times New Roman, Times, Serif">2023,
2024 and 2025</span></a></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-10</span></td></tr> <tr> <td style="padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; font-size: 10pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_007">Notes to the consolidated financial statements</a></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-12</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 223; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="f_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Report
of Independent Registered Public Accounting Firm</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.45pt 0pt 70.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholders and the Board of Directors of Ascentage Pharma Group International</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AuditorOpinionTextBlock-c0_cont_1" escape="true" name="dei:AuditorOpinionTextBlock" id="ixv-27586"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_AuditorOpinionTextBlock-c0_cont_1"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">We
have audited the accompanying consolidated statements of financial position of Ascentage Pharma Group International (the
Company) as of December 31, 2025 and 2024, the related consolidated statements of
profit or loss, comprehensive loss, changes in equity and cash flows for each of the three years in the period ended December 31,
2025, and the related notes (collectively referred to as &#8220;the consolidated financial statements&#8221;). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31,
2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31,
2025, in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board.</span></p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
<ix:nonNumeric contextRef="c0" name="dei:AuditorName" id="ixv-70387">Ernst &amp; Young Hua Ming LLP</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2017.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shanghai,
the People&#8217;s Republic of <ix:nonNumeric contextRef="c0" name="dei:AuditorLocation" id="ixv-70388">China</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">April 29,
2026</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 224; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="f_002"></a></div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
statements of profit or loss</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and U.S. dollars (&#8220;US$&#8221;), except for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUE</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    property</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-1; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70389">678,415</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-2; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Products</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70390">193,535</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70391">260,835</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70392">499,272</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-70393">71,395</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70394">28,449</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70395">41,400</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70396">74,848</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-70397">10,703</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70398">221,984</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70399">980,650</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-70400">574,120</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-70401">82,098</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Products</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="cny" id="ixv-70402">29,342</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="cny" id="ixv-70403">27,031</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="cny" id="ixv-70404">46,661</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="usd" id="ixv-70405">6,672</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="cny" id="ixv-70406">1,201</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="cny" id="ixv-70407">2,054</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="cny" id="ixv-70408">2,277</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="usd" id="ixv-70409">326</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    cost of sales</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="cny" id="ixv-70410">30,543</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="cny" id="ixv-70411">29,085</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="cny" id="ixv-70412">48,938</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="usd" id="ixv-70413">6,998</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross profit</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="3" unitRef="cny" id="ixv-70414">191,441</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="3" unitRef="cny" id="ixv-70415">951,565</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="3" unitRef="cny" id="ixv-70416">525,182</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="3" unitRef="usd" id="ixv-70417">75,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income and gains</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIncome" scale="3" unitRef="cny" id="ixv-70418">59,316</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIncome" scale="3" unitRef="cny" id="ixv-70419">57,359</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIncome" scale="3" unitRef="cny" id="ixv-70420">103,495</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIncome" scale="3" unitRef="usd" id="ixv-70421">14,800</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and distribution expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SellingExpense" scale="3" unitRef="cny" id="ixv-70422">195,387</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SellingExpense" scale="3" unitRef="cny" id="ixv-70423">195,998</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SellingExpense" scale="3" unitRef="cny" id="ixv-70424">353,640</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SellingExpense" scale="3" unitRef="usd" id="ixv-70425">50,570</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administrative expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="3" unitRef="cny" id="ixv-70426">181,076</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="3" unitRef="cny" id="ixv-70427">187,125</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="3" unitRef="cny" id="ixv-70428">246,281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="3" unitRef="usd" id="ixv-70429">35,218</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="cny" id="ixv-70430">706,972</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="cny" id="ixv-70431">947,245</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="cny" id="ixv-70432">1,137,448</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-70433">162,653</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="cny" id="ixv-70434">5,203</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="cny" id="ixv-70435">9,075</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="cny" id="ixv-70436">73,599</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="usd" id="ixv-70437">10,525</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.25pt; padding-left: 5.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance
    costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="3" unitRef="cny" id="ixv-70438">96,057</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="3" unitRef="cny" id="ixv-70439">64,455</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="3" unitRef="cny" id="ixv-70440">54,070</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="3" unitRef="usd" id="ixv-70441">7,732</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: 0pt; padding-left: 0pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            of profit/(loss) of a joint venture</span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="3" unitRef="cny" id="ixv-70442">1,076</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="3" sign="-" unitRef="cny" id="ixv-70443">281</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="3" unitRef="cny" id="ixv-70444">314</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="3" unitRef="usd" id="ixv-70445">45</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -5.25pt; padding-left: 5.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS BEFORE TAX</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-70446">932,862</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-70447">395,255</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-70448">1,236,047</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="usd" id="ixv-70449">176,753</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    tax credit/(expense)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" sign="-" unitRef="cny" id="ixv-70450">7,150</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" unitRef="cny" id="ixv-70451">10,425</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" unitRef="cny" id="ixv-70452">6,940</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" unitRef="usd" id="ixv-70453">992</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    FOR THE YEAR</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70454">925,712</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70455">405,680</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70456">1,242,987</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-70457">177,745</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -5.25pt; padding-left: 5.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attributable to:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 5.45pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    equity holders of the Company</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="3" sign="-" unitRef="cny" id="ixv-70458">925,637</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="3" sign="-" unitRef="cny" id="ixv-70459">405,433</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="3" sign="-" unitRef="cny" id="ixv-70460">1,242,769</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="3" sign="-" unitRef="usd" id="ixv-70461">177,714</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 10.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-controlling
    interests</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-70462">75</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-70463">247</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-70464">218</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="3" sign="-" unitRef="usd" id="ixv-70465">31</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 10.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -5.25pt; padding-left: 5.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70466">925,712</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70467">405,680</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70468">1,242,987</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-70469">177,745</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 10.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="cnyPershares" id="ixv-70470"><ix:nonFraction contextRef="c12" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="cnyPershares" id="ixv-70471">3.28</ix:nonFraction></ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="cnyPershares" id="ixv-70472"><ix:nonFraction contextRef="c13" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="cnyPershares" id="ixv-70473">1.34</ix:nonFraction></ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="cnyPershares" id="ixv-70474"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="cnyPershares" id="ixv-70475">3.49</ix:nonFraction></ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-70476"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-70477">0.50</ix:nonFraction></ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11.85pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 225; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="f_003"></a></div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
statements of comprehensive loss</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and U.S. dollars (&#8220;US$&#8221;), except for number of shares and per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    FOR THE YEAR</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70478">925,712</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70479">405,680</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70480">1,242,987</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-70481">177,745</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
    COMPREHENSIVE INCOME/ (LOSS)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income/ (loss) that may be reclassified to profit or loss in subsequent periods, net of tax:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of foreign operations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-70482">20,593</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-70483">2,829</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="cny" id="ixv-70484">41,574</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="usd" id="ixv-70485">5,945</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income/ (loss) that will not be reclassified to profit or loss in subsequent periods, net of tax:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" scale="3" unitRef="cny" id="ixv-70486">5,666</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" scale="3" unitRef="cny" id="ixv-70487">4,120</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" scale="3" sign="-" unitRef="cny" id="ixv-70488">11,441</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" scale="3" sign="-" unitRef="usd" id="ixv-70489">1,636</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
    COMPREHENSIVE INCOME/(LOSS) FOR THE YEAR, NET OF TAX</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" unitRef="cny" id="ixv-70490">26,259</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" unitRef="cny" id="ixv-70491">6,949</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70492">53,015</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" sign="-" unitRef="usd" id="ixv-70493">7,581</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    COMPREHENSIVE LOSS FOR THE YEAR</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70494">899,453</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70495">398,731</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70496">1,296,002</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="usd" id="ixv-70497">185,326</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attributable
    to:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    equity holders of the Company</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" scale="3" sign="-" unitRef="cny" id="ixv-70498">899,378</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" scale="3" sign="-" unitRef="cny" id="ixv-70499">398,484</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" scale="3" sign="-" unitRef="cny" id="ixv-70500">1,295,784</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" scale="3" sign="-" unitRef="usd" id="ixv-70501">185,295</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-controlling
    interests</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-70502">75</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-70503">247</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-70504">218</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="3" sign="-" unitRef="usd" id="ixv-70505">31</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70506">899,453</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70507">398,731</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70508">1,296,002</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="usd" id="ixv-70509">185,326</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 226; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="f_004"></a></div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
statements of financial position</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and U.S. dollars (&#8220;US$&#8221;), except for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant
    and equipment</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-70510">849,450</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-70511">781,235</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-70512">111,715</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13(a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-70513">56,109</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-70514">47,827</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="usd" id="ixv-70515">6,839</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="3" unitRef="cny" id="ixv-70516">24,694</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="3" unitRef="cny" id="ixv-70517">24,694</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="3" unitRef="usd" id="ixv-70518">3,531</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other intangible assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIntangibleAssets" scale="3" unitRef="cny" id="ixv-70519">75,998</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIntangibleAssets" scale="3" unitRef="cny" id="ixv-70520">65,936</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIntangibleAssets" scale="3" unitRef="usd" id="ixv-70521">9,429</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in a joint venture</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" unitRef="cny" id="ixv-70522">32,717</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" unitRef="cny" id="ixv-70523">33,030</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" unitRef="usd" id="ixv-70524">4,723</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -15.75pt; padding-left: 15.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at fair value through profit or loss (&#8220;FVTPL&#8221;)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-70525">1,141</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-70526">4,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-70527">572</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -5.25pt; padding-left: 5.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="cny" id="ixv-70528">44,236</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="cny" id="ixv-70529">31,957</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="usd" id="ixv-70530">4,570</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.25pt; padding-left: 5.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" unitRef="cny" id="ixv-70531">59,303</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" unitRef="cny" id="ixv-70532">30,725</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" unitRef="usd" id="ixv-70533">4,394</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -5.25pt; padding-left: 5.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    non-current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="3" unitRef="cny" id="ixv-70534">1,143,648</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="3" unitRef="cny" id="ixv-70535">1,019,404</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="3" unitRef="usd" id="ixv-70536">145,773</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
    ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -5.25pt; padding-left: 5.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="3" unitRef="cny" id="ixv-70537">6,597</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="3" unitRef="cny" id="ixv-70538">28,618</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="3" unitRef="usd" id="ixv-70539">4,092</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.25pt; padding-left: 5.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    receivables, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTradeReceivables" scale="3" unitRef="cny" id="ixv-70540">83,143</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTradeReceivables" scale="3" unitRef="cny" id="ixv-70541">252,938</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTradeReceivables" scale="3" unitRef="usd" id="ixv-70542">36,170</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments, other receivables
    and other assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" scale="3" unitRef="cny" id="ixv-70543">123,211</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" scale="3" unitRef="cny" id="ixv-70544">192,532</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" scale="3" unitRef="usd" id="ixv-70545">27,532</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-70546">1,261,211</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-70547">2,470,085</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-70548">353,217</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="3" unitRef="cny" id="ixv-70549">1,474,162</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="3" unitRef="cny" id="ixv-70550">2,944,173</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="3" unitRef="usd" id="ixv-70551">421,011</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
    LIABILITIES</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade payables</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-70552">91,966</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-70553">106,740</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" scale="3" unitRef="usd" id="ixv-70554">15,264</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="3" unitRef="cny" id="ixv-70555">258,098</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="3" unitRef="cny" id="ixv-70556">276,666</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="3" unitRef="usd" id="ixv-70557">39,563</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentContractLiabilities" scale="3" unitRef="cny" id="ixv-70558">37,485</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentContractLiabilities" scale="3" unitRef="cny" id="ixv-70559">37,485</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentContractLiabilities" scale="3" unitRef="usd" id="ixv-70560">5,360</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest-bearing
    bank and other borrowings</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Interestbearingbankandotherborrowingscurrent" scale="3" unitRef="cny" id="ixv-70561">779,062</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Interestbearingbankandotherborrowingscurrent" scale="3" unitRef="cny" id="ixv-70562">1,222,481</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Interestbearingbankandotherborrowingscurrent" scale="3" unitRef="usd" id="ixv-70563">174,812</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="3" unitRef="cny" id="ixv-70564">1,166,611</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="3" unitRef="cny" id="ixv-70565">1,643,372</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="3" unitRef="usd" id="ixv-70566">234,999</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    CURRENT ASSETS</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssetsLiabilities" scale="3" unitRef="cny" id="ixv-70567">307,551</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssetsLiabilities" scale="3" unitRef="cny" id="ixv-70568">1,300,801</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssetsLiabilities" scale="3" unitRef="usd" id="ixv-70569">186,012</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    ASSETS LESS CURRENT LIABILITIES</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AssetsLessCurrentLiabilities" scale="3" unitRef="cny" id="ixv-70570">1,451,199</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AssetsLessCurrentLiabilities" scale="3" unitRef="cny" id="ixv-70571">2,320,205</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AssetsLessCurrentLiabilities" scale="3" unitRef="usd" id="ixv-70572">331,785</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 227; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
statements of financial position (continued)</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and U.S. dollars (&#8220;US$&#8221;), except for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT LIABILITIES</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
    liabilities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentContractLiabilities" scale="3" unitRef="cny" id="ixv-70573">248,460</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentContractLiabilities" scale="3" unitRef="cny" id="ixv-70574">210,224</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentContractLiabilities" scale="3" unitRef="usd" id="ixv-70575">30,062</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest-bearing
    bank and other borrowings</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:InterestbearingBankAndOtherBorrowingsNonCurrent" scale="3" unitRef="cny" id="ixv-70576">889,435</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:InterestbearingBankAndOtherBorrowingsNonCurrent" scale="3" unitRef="cny" id="ixv-70577">757,238</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:InterestbearingBankAndOtherBorrowingsNonCurrent" scale="3" unitRef="usd" id="ixv-70578">108,284</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-70579">5,368</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-4; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-5; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeferredIncomeNonCurrent" scale="3" unitRef="cny" id="ixv-70580">27,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeferredIncomeNonCurrent" scale="3" unitRef="cny" id="ixv-70581">6,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeferredIncomeNonCurrent" scale="3" unitRef="usd" id="ixv-70582">929</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentLiabilities" scale="3" unitRef="cny" id="ixv-70583">6,274</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentLiabilities" scale="3" unitRef="cny" id="ixv-70584">12,031</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentLiabilities" scale="3" unitRef="usd" id="ixv-70585">1,720</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    non-current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="3" unitRef="cny" id="ixv-70586">1,177,037</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="3" unitRef="cny" id="ixv-70587">985,993</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="3" unitRef="usd" id="ixv-70588">140,995</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments and contingencies</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33, 34</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-8"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    LIABILITIES</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="3" unitRef="cny" id="ixv-70589">2,343,648</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="3" unitRef="cny" id="ixv-70590">2,629,365</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="3" unitRef="usd" id="ixv-70591">375,994</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    attributable to ordinary equity holders of the Company</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares (par value of US$<ix:nonFraction contextRef="c14" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-70592"><ix:nonFraction contextRef="c15" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-70593"><ix:nonFraction contextRef="c15" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-70594">0.0001</ix:nonFraction></ix:nonFraction></ix:nonFraction> per share as of December 31, 2024 and 2025; <ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesAuthorised" scale="0" unitRef="shares" id="ixv-70595"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-70596"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares" id="ixv-70597">315,224,993</ix:nonFraction></ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesAuthorised" scale="0" unitRef="shares" id="ixv-70598"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesAuthorised" scale="0" unitRef="shares" id="ixv-70599"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-70600"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-70601"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares" id="ixv-70602"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares" id="ixv-70603">373,321,692</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares authorized, issued and outstanding as of December 31, 2024 and 2025, respectively)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="3" unitRef="cny" id="ixv-70604">214</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="3" unitRef="cny" id="ixv-70605">256</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="3" unitRef="usd" id="ixv-70606">37</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury
    shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TreasuryShares" scale="3" unitRef="cny" id="ixv-70607">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TreasuryShares" scale="3" unitRef="cny" id="ixv-70608">2,961</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TreasuryShares" scale="3" unitRef="usd" id="ixv-70609">423</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    premium</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="cny" id="ixv-70610">6,545,129</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="cny" id="ixv-70611">8,916,853</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="usd" id="ixv-70612">1,275,093</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    and reserves</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CapitalAndReserves" scale="3" sign="-" unitRef="cny" id="ixv-70613">384,515</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CapitalAndReserves" scale="3" sign="-" unitRef="cny" id="ixv-70614">397,276</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CapitalAndReserves" scale="3" sign="-" unitRef="usd" id="ixv-70615">56,810</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    fluctuation reserve</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="cny" id="ixv-70616">126,071</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="cny" id="ixv-70617">179,086</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="usd" id="ixv-70618">25,609</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    losses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AccumulatedOtherComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70619">5,770,555</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AccumulatedOtherComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70620">7,013,324</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AccumulatedOtherComprehensiveIncome" scale="3" sign="-" unitRef="usd" id="ixv-70621">1,002,892</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EquityAttributableToOwnersOfParent" scale="3" unitRef="cny" id="ixv-70622">264,194</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EquityAttributableToOwnersOfParent" scale="3" unitRef="cny" id="ixv-70623">1,324,462</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EquityAttributableToOwnersOfParent" scale="3" unitRef="usd" id="ixv-70624">189,396</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-controlling
    interests</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-70625">9,968</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-70626">9,750</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="usd" id="ixv-70627">1,394</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    equity</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70628">274,162</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70629">1,334,212</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-70630">190,790</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 228; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="f_005"></a></div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
statements of changes in equity</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and U.S. dollars (&#8220;US$&#8221;), except for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="26" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attributable
    to ordinary equity holders of the Company</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share<br/>
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury<br/>
    shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share<br/>
    premium</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital<br/>
    and<br/>
    reserves</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange<br/>
    fluctuation<br/>
    reserve</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated<br/>
    losses</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-<br/>
    controlling<br/>
    interests</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total<br/>
    equity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 23.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2023</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70631">180</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70632">26,552</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70633">5,393,029</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70634">359,235</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70635">159,279</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70636">4,439,485</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70637">408,658</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-9; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70638">408,658</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-10; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-11; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-12; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-13; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-14; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70639">925,637</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70640">925,637</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c32" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70641">75</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70642">925,712</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of operations</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-15; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-16; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-17; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-18; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-70643">26,259</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-19; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-70644">26,259</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-20; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-70645">26,259</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive loss for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-21; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-22; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-23; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-24; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" unitRef="cny" id="ixv-70646">26,259</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70647">925,637</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70648">899,378</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c32" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70649">75</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70650">899,453</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    contribution from a non-controlling shareholder of a subsidiary</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-25; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-26; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-27; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-28; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-29; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-30; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-31; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c32" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" scale="3" unitRef="cny" id="ixv-70651">10,290</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" scale="3" unitRef="cny" id="ixv-70652">10,290</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70653">15</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-32; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70654">470,066</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-33; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-34; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-35; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70655">470,081</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-36; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70656">470,081</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase
    of ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-37; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny" id="ixv-70657">5,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-38; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-39; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-40; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-41; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny" id="ixv-70658">5,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-42; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny" id="ixv-70659">5,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    share-based payments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Pre-IPO share option expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-43; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-44; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-45; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" scale="3" unitRef="cny" id="ixv-70660">3,750</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-46; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-47; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" scale="3" unitRef="cny" id="ixv-70661">3,750</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-48; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" scale="3" unitRef="cny" id="ixv-70662">3,750</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Restricted share unit(&#8220;RSU&#8221;) expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-49; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-50; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-51; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" scale="3" unitRef="cny" id="ixv-70663">27,753</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-52; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-53; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" scale="3" unitRef="cny" id="ixv-70664">27,753</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-54; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" scale="3" unitRef="cny" id="ixv-70665">27,753</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Exercise of Pre-IPO share options</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70666">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-55; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70667">18,354</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" sign="-" unitRef="cny" id="ixv-70668">18,347</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-56; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-57; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70669">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70670">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Vesting of RSUs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" unitRef="cny" id="ixv-70671">11,123</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" unitRef="cny" id="ixv-70672">14,239</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" sign="-" unitRef="cny" id="ixv-70673">25,362</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70674">1</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70675">1</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70676">55,466</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70677">55,468</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70678">55,468</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70679">197</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c34" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70680">21,351</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c35" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70681">5,951,154</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c36" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70682">371,441</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70683">133,020</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c38" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70684">5,365,122</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70685">60,417</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70686">10,215</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70687">70,632</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 229; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 311.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
statements of changes in equity (continued)</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and U.S. dollars (&#8220;US$&#8221;), except for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="26" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attributable
    to ordinary equity holders of the Company</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share<br/>
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury<br/>
    shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share<br/>
    premium</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital<br/>
    and<br/>
    reserves</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange<br/>
    fluctuation<br/>
    reserve</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated<br/>
    losses</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-<br/>
    controlling interests</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total<br/>
    equity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 23.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2024</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70688">197</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c34" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70689">21,351</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c35" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70690">5,951,154</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c36" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70691">371,441</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70692">133,020</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c38" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70693">5,365,122</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70694">60,417</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70695">10,215</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70696">70,632</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-70; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-71; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-72; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c47" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70697">405,433</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c48" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70698">405,433</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70699">247</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70700">405,680</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of operations</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-73; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c46" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-70701">6,949</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c48" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-70702">6,949</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-78; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-70703">6,949</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive loss for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-79; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-80; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-81; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-82; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c46" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" unitRef="cny" id="ixv-70704">6,949</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c47" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70705">405,433</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c48" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70706">398,484</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70707">247</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70708">398,731</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c42" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70709">17</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-83; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70710">533,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-84; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c48" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70711">533,940</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70712">533,940</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase
    of ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny" id="ixv-70713">1,959</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-90; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c48" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny" id="ixv-70714">1,959</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny" id="ixv-70715">1,959</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    share-based payments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    RSU expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-95; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-96; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c45" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" scale="3" unitRef="cny" id="ixv-70716">20,924</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-97; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-98; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c48" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" scale="3" unitRef="cny" id="ixv-70717">20,924</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-99; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" scale="3" unitRef="cny" id="ixv-70718">20,924</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Exercise of Pre-IPO share options</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-100; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-101; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70719">11,379</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c45" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" sign="-" unitRef="cny" id="ixv-70720">11,373</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-102; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-103; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c48" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70721">6</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-104; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70722">6</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Vesting of RSUs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-105; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" unitRef="cny" id="ixv-70723">14,671</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" unitRef="cny" id="ixv-70724">7,954</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c45" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" sign="-" unitRef="cny" id="ixv-70725">22,625</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-106; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70726">8,631</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70727">40,719</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c48" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70728">49,350</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-114; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70729">49,350</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70730">214</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c51" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70731">8</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70732">6,545,129</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c53" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70733">384,515</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c54" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70734">126,071</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c55" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70735">5,770,555</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70736">264,194</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c57" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70737">9,968</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70738">274,162</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 230; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
statements of changes in equity (continued)</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and U.S. dollars (&#8220;US$&#8221;), except for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="26" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attributable
    to ordinary equity holders of the Company</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share<br/>
    capital</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury<br/>
    shares</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share<br/>
    premium</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital<br/>
    and<br/> reserves</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange<br/>
    fluctuation<br/> reserve</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated<br/>
    losses</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-<br/>
    controlling<br/> interests</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total<br/>
    equity</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 23.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2025</span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70739">214</ix:nonFraction></span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c51" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70740">8</ix:nonFraction></span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70741">6,545,129</ix:nonFraction></span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c53" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70742">384,515</ix:nonFraction></span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c54" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70743">126,071</ix:nonFraction></span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c55" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70744">5,770,555</ix:nonFraction></span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70745">264,194</ix:nonFraction></span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c57" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70746">9,968</ix:nonFraction></span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70747">274,162</ix:nonFraction></span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-115; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-116; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-117; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-118; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-119; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c63" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70748">1,242,769</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70749">1,242,769</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c65" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70750">218</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-70751">1,242,987</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of operations</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-120; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-121; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-122; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-123; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c62" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="cny" id="ixv-70752">53,015</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-124; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="cny" id="ixv-70753">53,015</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-125; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="cny" id="ixv-70754">53,015</ix:nonFraction></span></td>
    <td style="text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive loss for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-126; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-127; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-128; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c62" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70755">53,015</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c63" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70756">1,242,769</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70757">1,295,784</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c65" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70758">218</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-70759">1,296,002</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70760">40</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-130; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70761">2,279,855</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-131; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-132; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-133; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70762">2,279,895</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-134; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="cny" id="ixv-70763">2,279,895</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-135; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny" id="ixv-70764">3,590</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-136; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-137; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-138; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-139; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny" id="ixv-70765">3,590</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-140; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny" id="ixv-70766">3,590</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    share-based payments</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"/>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"/>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"/>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">- p<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ost-IPO
share option expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueShareOptionExpenses" scale="3" unitRef="cny" id="ixv-70767">2,420</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueShareOptionExpenses" scale="3" unitRef="cny" id="ixv-70768">2,420</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueShareOptionExpenses" scale="3" unitRef="cny" id="ixv-70769">2,420</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    RSU expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-141; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-142; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-143; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" scale="3" unitRef="cny" id="ixv-70770">18,454</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-144; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-145; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" scale="3" unitRef="cny" id="ixv-70771">18,454</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-146; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" scale="3" unitRef="cny" id="ixv-70772">18,454</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Exercise of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-147; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-148; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70773">7,627</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" sign="-" unitRef="cny" id="ixv-70774">7,623</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-149; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-150; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70775">4</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-151; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70776">4</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    Vesting of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" unitRef="cny" id="ixv-70777">1</ix:nonFraction></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" unitRef="cny" id="ixv-70778">637</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" unitRef="cny" id="ixv-70779">25,374</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" scale="3" sign="-" unitRef="cny" id="ixv-70780">26,012</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-152; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-153; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-154; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-155; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-156; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70781">1</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-157; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70782">58,868</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-158; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-159; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-160; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70783">58,869</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-161; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-70784">58,869</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c66" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70785">256</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70786">2,961</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70787">8,916,853</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70788">397,276</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c70" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70789">179,086</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c71" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="cny" id="ixv-70790">7,013,324</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c72" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70791">1,324,462</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70792">9,750</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-70793">1,334,212</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c66" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-70794">37</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="usd" id="ixv-70795">423</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-70796">1,275,093</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="usd" id="ixv-70797">56,810</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c70" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="usd" id="ixv-70798">25,609</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c71" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="usd" id="ixv-70799">1,002,892</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c72" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-70800">189,396</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-70801">1,394</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-70802">190,790</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 231; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 124.65pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="f_006"></a></div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
statements of cash flows</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and U.S. dollars (&#8220;US$&#8221;), except for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    FLOWS FROM OPERATING ACTIVITIES</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    before tax</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-70803">932,862</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-70804">395,255</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-70805">1,236,047</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="usd" id="ixv-70806">176,753</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
    for:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of property, plant and equipment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="cny" id="ixv-70807">55,281</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="cny" id="ixv-70808">71,184</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="cny" id="ixv-70809">65,761</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="usd" id="ixv-70810">9,404</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of investment property</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" scale="3" sign="-" unitRef="cny" id="ixv-70811">15,883</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-162; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-163; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-164; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of right-of-use assets</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForDepreciationOfRightofuseAssets" scale="3" unitRef="cny" id="ixv-70812">11,632</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForDepreciationOfRightofuseAssets" scale="3" unitRef="cny" id="ixv-70813">11,134</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForDepreciationOfRightofuseAssets" scale="3" unitRef="cny" id="ixv-70814">10,657</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForDepreciationOfRightofuseAssets" scale="3" unitRef="usd" id="ixv-70815">1,524</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of intangible assets</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="3" unitRef="cny" id="ixv-70816">10,399</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="3" unitRef="cny" id="ixv-70817">10,851</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="3" unitRef="cny" id="ixv-70818">10,062</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="3" unitRef="usd" id="ixv-70819">1,439</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    share-based payments</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" unitRef="cny" id="ixv-70820">31,503</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" unitRef="cny" id="ixv-70821">20,924</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" unitRef="cny" id="ixv-70822">20,874</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" unitRef="usd" id="ixv-70823">2,985</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Gain)/loss
    on disposal of items of property, plant and equipment</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-70824">4</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-70825">50</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-70826">18</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="3" sign="-" unitRef="usd" id="ixv-70827">3</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    on disposal of leases</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-165; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForGainOnDisposalOfLeases" scale="3" unitRef="cny" id="ixv-70828">85</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForGainOnDisposalOfLeases" scale="3" unitRef="cny" id="ixv-70829">685</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForGainOnDisposalOfLeases" scale="3" unitRef="usd" id="ixv-70830">99</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value loss on financial assets measured at FVTPL</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-70831">699</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-70832">832</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-70833">1,134</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-70834">162</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value loss on financial liabilities measured at FVTPL</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-166; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-167; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" scale="3" sign="-" unitRef="cny" id="ixv-70835">29,533</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" scale="3" sign="-" unitRef="usd" id="ixv-70836">4,223</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value gain on derivative financial instruments</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFairValueGainsLosses" scale="3" sign="-" unitRef="cny" id="ixv-70837">2,822</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-168; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-169; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-170; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance
    costs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFinanceCosts" scale="3" unitRef="cny" id="ixv-70838">96,057</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFinanceCosts" scale="3" unitRef="cny" id="ixv-70839">64,455</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFinanceCosts" scale="3" unitRef="cny" id="ixv-70840">54,070</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFinanceCosts" scale="3" unitRef="usd" id="ixv-70841">7,732</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    of (profit)/loss of a joint venture</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" unitRef="cny" id="ixv-70842">1,076</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" sign="-" unitRef="cny" id="ixv-70843">281</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" unitRef="cny" id="ixv-70844">314</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" unitRef="usd" id="ixv-70845">45</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision
    for inventory write-down</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-171; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-172; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForProvisions" scale="3" unitRef="cny" id="ixv-70846">4,180</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForProvisions" scale="3" unitRef="usd" id="ixv-70847">598</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    exchange (gain)/loss</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="3" sign="-" unitRef="cny" id="ixv-70848">1,621</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="3" sign="-" unitRef="cny" id="ixv-70849">6,694</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="3" unitRef="cny" id="ixv-70850">10,161</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="3" unitRef="usd" id="ixv-70851">1,453</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForReconcileProfitLoss" scale="3" unitRef="cny" id="ixv-70852">716,931</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForReconcileProfitLoss" scale="3" unitRef="cny" id="ixv-70853">222,323</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForReconcileProfitLoss" scale="3" unitRef="cny" id="ixv-70854">1,030,596</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForReconcileProfitLoss" scale="3" unitRef="usd" id="ixv-70855">147,374</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">(Increase)/
    Decrease in restricted cash balances</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" scale="3" sign="-" unitRef="cny" id="ixv-70856">7,936</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" scale="3" sign="-" unitRef="cny" id="ixv-70857">96</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" scale="3" unitRef="cny" id="ixv-70858">18,948</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" scale="3" unitRef="usd" id="ixv-70859">2,710</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Increase)/Decrease
    in inventories</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" sign="-" unitRef="cny" id="ixv-70860">6,719</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" unitRef="cny" id="ixv-70861">9,570</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" sign="-" unitRef="cny" id="ixv-70862">26,201</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" sign="-" unitRef="usd" id="ixv-70863">3,747</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Increase)/Decrease
    in trade receivables</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="3" sign="-" unitRef="cny" id="ixv-70864">91,537</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="3" unitRef="cny" id="ixv-70865">62,750</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="3" sign="-" unitRef="cny" id="ixv-70866">169,795</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="3" sign="-" unitRef="usd" id="ixv-70867">24,281</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in prepayments, other receivables and other assets</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="3" sign="-" unitRef="cny" id="ixv-70868">7,841</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="3" sign="-" unitRef="cny" id="ixv-70869">14,421</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="3" sign="-" unitRef="cny" id="ixv-70870">86,337</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="3" sign="-" unitRef="usd" id="ixv-70871">12,346</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0pt; padding-left: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(Increase)
    /Decrease in other non-current assets</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="3" sign="-" unitRef="cny" id="ixv-70872">3,552</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="3" sign="-" unitRef="cny" id="ixv-70873">48,950</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="3" unitRef="cny" id="ixv-70874">27,784</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="3" unitRef="usd" id="ixv-70875">3,974</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0pt; padding-left: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(Decrease)
    /Increase in trade payables</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" scale="3" sign="-" unitRef="cny" id="ixv-70876">23,114</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" scale="3" unitRef="cny" id="ixv-70877">19,521</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" scale="3" unitRef="cny" id="ixv-70878">14,774</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" scale="3" unitRef="usd" id="ixv-70879">2,113</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in other payables and accruals</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" scale="3" unitRef="cny" id="ixv-70880">48,573</ix:nonFraction></span></td>
    <td style="text-align: left"/>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" scale="3" unitRef="cny" id="ixv-70881">78,506</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" scale="3" unitRef="cny" id="ixv-70882">113,809</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" scale="3" unitRef="usd" id="ixv-70883">16,274</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    /(Decrease) in contract liabilities</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities" scale="3" unitRef="cny" id="ixv-70884">81,620</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities" scale="3" sign="-" unitRef="cny" id="ixv-70885">3,654</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities" scale="3" sign="-" unitRef="cny" id="ixv-70886">37,485</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-70887">5,360</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in deferred income</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" scale="3" unitRef="cny" id="ixv-70888">1,360</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" scale="3" unitRef="cny" id="ixv-70889">7,740</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" scale="3" unitRef="cny" id="ixv-70890">1,000</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" scale="3" unitRef="usd" id="ixv-70891">143</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    tax paid</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-173; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-174; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" scale="3" sign="-" unitRef="cny" id="ixv-70892">29</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-70893">4</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash flows used in operating activities</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" sign="-" unitRef="cny" id="ixv-70894">726,077</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" sign="-" unitRef="cny" id="ixv-70895">111,357</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" sign="-" unitRef="cny" id="ixv-70896">1,174,128</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-70897">167,898</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 232; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 124.65pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
statements of cash flows (continued)</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and U.S. dollars (&#8220;US$&#8221;), except for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    FLOWS FROM INVESTING ACTIVITIES</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
    of property, plant and equipment</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" unitRef="cny" id="ixv-70898">46,108</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" unitRef="cny" id="ixv-70899">24,289</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" unitRef="cny" id="ixv-70900">27,571</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" unitRef="usd" id="ixv-70901">3,942</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from disposal of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" unitRef="cny" id="ixv-70902">14</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-175; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-176; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-177; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    of intangible assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" unitRef="cny" id="ixv-70903">10,736</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-178; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-179; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-180; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of contingent consideration related to acquisition of a subsidiary</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" scale="3" unitRef="cny" id="ixv-70904">20,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" scale="3" unitRef="cny" id="ixv-70905">9,516</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" scale="3" unitRef="cny" id="ixv-70906">43,342</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" scale="3" unitRef="usd" id="ixv-70907">6,198</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity/(Placement)
    in time deposits with original maturity of more than three months</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity" scale="3" sign="-" unitRef="cny" id="ixv-70908">98,752</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity" scale="3" unitRef="cny" id="ixv-70909">312,230</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity" scale="3" unitRef="cny" id="ixv-70910">925,139</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity" scale="3" unitRef="usd" id="ixv-70911">132,294</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    in other financial assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-181; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-182; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:InvestmentInOtherFinancialAssets" scale="3" unitRef="cny" id="ixv-70912">4,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:InvestmentInOtherFinancialAssets" scale="3" unitRef="usd" id="ixv-70913">572</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    in a joint venture</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-183; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:InvestmentInJointVenturesClassifiedAsInvestingActivities" scale="3" unitRef="cny" id="ixv-70914">16,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-184; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-185; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash flows generated from/ (used in) investing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" unitRef="cny" id="ixv-70915">21,922</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" sign="-" unitRef="cny" id="ixv-70916">362,035</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" sign="-" unitRef="cny" id="ixv-70917">1,000,052</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-70918">143,006</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    FLOWS FROM FINANCING ACTIVITIES</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from issue of shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromIssuingShares" scale="3" unitRef="cny" id="ixv-70919">470,081</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromIssuingShares" scale="3" unitRef="cny" id="ixv-70920">533,940</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromIssuingShares" scale="3" unitRef="cny" id="ixv-70921">2,304,905</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromIssuingShares" scale="3" unitRef="usd" id="ixv-70922">329,597</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury
    share purchases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" scale="3" unitRef="cny" id="ixv-70923">5,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-186; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" scale="3" unitRef="cny" id="ixv-70924">9,036</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" scale="3" unitRef="usd" id="ixv-70925">1,292</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from exercise of share options</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70926">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70927">6</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" unitRef="cny" id="ixv-70928">4</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" unitRef="usd" id="ixv-70929">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70930">92,348</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70931">60,556</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70932">51,308</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" unitRef="usd" id="ixv-70933">7,337</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from bank loans</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70934">953,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70935">535,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70936">1,240,970</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="3" unitRef="usd" id="ixv-70937">177,456</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    of bank loans</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70938">956,091</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70939">672,850</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70940">923,990</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="3" unitRef="usd" id="ixv-70941">132,129</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    portion of lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70942">10,766</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70943">8,413</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-70944">9,717</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" unitRef="usd" id="ixv-70945">1,390</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    contribution from non-controlling shareholders of a subsidiary</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests" scale="3" unitRef="cny" id="ixv-70946">10,290</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-187; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-188; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-189; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing
    expense paid</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-190; font-family: Times New Roman, Times, Serif; font-size: 10pt">-&#160;&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ListingExpensePaid" scale="3" unitRef="cny" id="ixv-70947">13,283</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ListingExpensePaid" scale="3" unitRef="cny" id="ixv-70948">11,728</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ListingExpensePaid" scale="3" unitRef="usd" id="ixv-70949">1,677</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash flows generated from financing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="cny" id="ixv-70950">368,751</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="cny" id="ixv-70951">314,767</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="cny" id="ixv-70952">2,540,100</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-70953">363,229</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" sign="-" unitRef="cny" id="ixv-70954">335,404</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" sign="-" unitRef="cny" id="ixv-70955">158,625</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70956">365,920</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" unitRef="usd" id="ixv-70957">52,325</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents at beginning of year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70958">1,345,639</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70959">1,038,048</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70960">893,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="usd" id="ixv-70961">127,712</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of foreign exchange rate changes, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70962">27,813</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70963">13,677</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" sign="-" unitRef="cny" id="ixv-70964">63,236</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" sign="-" unitRef="usd" id="ixv-70965">9,042</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    AND CASH EQUIVALENTS AT END OF YEAR</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70966">1,038,048</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70967">893,100</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70968">1,195,784</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="usd" id="ixv-70969">170,995</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANALYSIS
    OF BALANCES OF CASH AND BANK BALANCES</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents at end of year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70970">1,038,048</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70971">893,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70972">1,195,784</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="usd" id="ixv-70973">170,995</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    bank balances</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70974">24,537</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70975">24,633</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-70976">5,685</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="usd" id="ixv-70977">812</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time
    deposits with original maturity of more than three months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" scale="3" unitRef="cny" id="ixv-70978">31,248</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" scale="3" unitRef="cny" id="ixv-70979">343,478</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" scale="3" unitRef="cny" id="ixv-70980">1,268,616</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" scale="3" unitRef="usd" id="ixv-70981">181,410</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances at end of year</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-70982">1,093,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-70983">1,261,211</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-70984">2,470,085</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-70985">353,217</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 233; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><!-- Field: Split-Segment; Name: 9 --><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="f_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" id="ixv-38776"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORPORATE
                                            AND GROUP INFORMATION</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a limited liability company incorporated in the Cayman Islands on November 17, 2017. The registered office of the Company
is located at the office of Walkers Corporate Limited, with the registered address of 190 Elgin Avenue, George Town, Grand Cayman KY1-9008,
Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an investment holding company. The Company became the holding company of the subsidiaries upon completion of the reorganization
in July 2018. The Company is a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address
global medical needs primarily in hematological malignancies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2019, the Company completed its Hong Kong initial public offering with the Stock Exchange of Hong Kong Limited (the &#8220;Hong
Kong Stock Exchange&#8221;). In January 2025, the Company completed its U.S. initial public offering with the NASDAQ.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" id="ixv-38797"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars
of the Company&#8217;s principal subsidiaries are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place and date of incorporation/ registration and</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="4" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominal value of issued/registered</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentage of equity interests attributable to the Company</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company name</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">place of business</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">share capital</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indirect</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">business</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 35%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suzhou Ascentage Pharma Co., Ltd.*@ <br/> (&#8220;Suzhou Yasheng&#8221;)</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 14%; text-align: center"><ix:nonNumeric contextRef="c74" id="ix_0_fact" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC/Chinese<br/> mainland</span><span style="font-family: Times New Roman, Times, Serif"><br/> June 1, 2016</span></ix:nonNumeric></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c75" decimals="-3" format="ixt:num-dot-decimal" id="ix_1_fact" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="3" unitRef="cny">2,000,000</ix:nonFraction></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-191; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c74" decimals="2" format="ixt:num-dot-decimal" id="ix_2_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 12%; text-align: left"><ix:nonNumeric contextRef="c74" id="ix_3_fact" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical research and development</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guangzhou Healthquest Pharma Co., Ltd.*@ <br/> (&#8220;Healthquest Pharma&#8221;)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c76" id="ix_4_fact" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC/Chinese<br/> mainland<br/> July 3, 2012</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c77" decimals="-3" format="ixt:num-dot-decimal" id="ix_5_fact" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="3" unitRef="cny">150,000</ix:nonFraction></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-192; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c76" decimals="2" format="ixt:num-dot-decimal" id="ix_6_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c76" id="ix_7_fact" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical development and sale of products</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage Pharma Group Inc.</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c78" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-38998"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States of America <br/> (&#8220;United States&#8221;) <br/> November 4, 2015</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="3" unitRef="usd" id="ixv-70990">0.015</ix:nonFraction></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-193; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c78" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure" id="ixv-70991">100</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c78" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary" id="ixv-39027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical trials</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suzhou Shenghe Innovation Works Biotech Co., Ltd.*@</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c80" id="ix_8_fact" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC/Chinese<br/> mainland <br/>September 21, 2022</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c81" decimals="-3" format="ixt:num-dot-decimal" id="ix_9_fact" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="3" unitRef="cny">500</ix:nonFraction></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-194; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c80" decimals="2" format="ixt:num-dot-decimal" id="ix_10_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c80" id="ix_11_fact" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental of buildings to group companies</span></ix:nonNumeric></td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><ix:footnote id="ix_0_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English names of the companies registered in the PRC represent the best efforts made by the management of the Company in directly translating the Chinese names of these companies as no English names have been registered.</span></ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">@</span></td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These entities are limited liability companies established in the PRC.</span></ix:footnote></td>
</tr></table></ix:nonNumeric></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 234; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory" id="ixv-39155"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td><td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" id="ixv-39169"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BASIS OF PREPARATION</span></ix:nonNumeric></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory-c0_cont_2" id="_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements have been prepared in accordance with IFRS Accounting Standards (which include all International Financial Reporting
Standards, International Accounting Standards (&#8220;IASs&#8221;) and interpretations) approved by the International Accounting Standards
Board (the &#8220;IASB&#8221;).</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
have been prepared under the historical cost convention, except for financial assets at FVTPL and derivative financial instruments which
have been measured at fair value.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfBasisOfConsolidationExplanatory" id="ixv-39183"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Basis
of consolidation</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_2" id="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements of the Company and its subsidiaries (collectively referred to as the
&#8220;Group&#8221;) for each of the three years ended December 31, 2025. A subsidiary is an entity (including a structured entity),
directly or indirectly, controlled by the Company. Control is achieved when the Group is exposed, or has rights, to variable returns
from its involvement with the investee and has the ability to affect those returns through its power over the investee (i.e., existing
rights that give the Group the current ability to direct the relevant activities of the investee).</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_3" id="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
there is a presumption that a majority of voting rights results in control. When the Company has less than a majority of the voting or
similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee,
including:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_4" id="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            contractual arrangement with the other vote holders of the investee;</span></td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_5" id="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rights
                                            arising from other contractual arrangements; and</span></td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_6" id="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_5"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Group&#8217;s voting rights and potential voting rights.</span></td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_7" id="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies.
The results of subsidiaries are consolidated from the date on which the Group obtains control and continues to be consolidated until the
date that such control ceases.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_8" id="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Profit
or loss and each component of other comprehensive income are attributed to the owners of the parent of the Group and to the non-controlling
interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity,
income, expenses and cash flows relating to transactions between members of the Group are eliminated in full on consolidation.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_9" id="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group reassesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of
the three elements of control described above. A change in the ownership interest of a subsidiary, without a loss of control, is accounted
for as an equity transaction.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DisclosureOfBasisOfConsolidationExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Group loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, any non-controlling
interest and the exchange fluctuation reserve; and recognizes the fair value of any investment retained and any resulting surplus or
deficit in profit or loss. The Group&#8217;s share of components previously recognized in other comprehensive income is reclassified
to profit or loss or retained profits, as appropriate, on the same basis as would be required if the Group had directly disposed of the
related assets or liabilities.</span></p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 235; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
<tr style="vertical-align: top; text-align: left">
<td style="text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_2" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock-c0_cont_1" escape="true" name="aapg:DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" id="ixv-39301"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGES IN ACCOUNTING POLICIES AND DISCLOSURES</span></ix:nonNumeric></p></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock-c0_cont_2" id="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has adopted amendments to IAS 21 Lack of Exchangeability for the first time for the current year&#8217;s financial statements. The Group
has not early adopted any other standard or amendment that has been issued but is not yet effective.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no new IFRS Accounting Standards, amendments or interpretations that became effective in 2025 that have any impact on the Group&#8217;s
financial statements.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td><td style="text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_1" escape="true" name="aapg:DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" id="ixv-39321"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED BUT NOT YET EFFECTIVE IFRS ACCOUNTING STANDARDS</span></ix:nonNumeric></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_2" id="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has not applied the following new and amended IFRS Accounting Standards, that have been issued but are not yet effective, in these
financial statements. <ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfInitialApplicationOfStandardsOrInterpretations-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations" id="ixv-70994">The Group intends to apply these new and amended IFRS Accounting Standards, if applicable, when they become effective.</ix:nonNumeric></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfInitialApplicationOfStandardsOrInterpretations-c0_cont_1"><ix:continuation continuedAt="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_3" id="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="padding-left: 0.25in; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 18</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 59%"><ix:nonNumeric contextRef="c83" id="ix_15_fact" name="ifrs-full:TitleOfNewIFRS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Presentation and Disclosure in Financial Statements<sup>2</sup></i></span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 19 and its amendments</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><ix:nonNumeric contextRef="c84" id="ix_16_fact" name="ifrs-full:TitleOfNewIFRS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsidiaries without Public Accountability: Disclosures<sup>2</sup></i></span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 9 and IFRS 7</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><ix:nonNumeric contextRef="c85" id="ix_12_fact" name="ifrs-full:TitleOfNewIFRS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendments to the Classification and Measurement of Financial Instruments<sup>1</sup></i></span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 9 and IFRS 7</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><ix:nonNumeric contextRef="c86" id="ix_13_fact" name="ifrs-full:TitleOfNewIFRS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contracts Referencing Nature-dependent Electricity<sup>1</sup></i></span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 10 and IAS 28</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><ix:nonNumeric contextRef="c87" id="ix_18_fact" name="ifrs-full:TitleOfNewIFRS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sale or Contribution of Assets between an Investor and its Associate or Joint Venture<sup>3</sup></i></span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IAS 21</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><ix:nonNumeric contextRef="c88" id="ix_17_fact" name="ifrs-full:TitleOfNewIFRS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation to a Hyperinflationary Presentation Currency<sup>2</sup></i></span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Annual Improvements to IFRS Accounting Standards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8211; Volume 11</i></span></p></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><ix:nonNumeric contextRef="c89" id="ix_14_fact" name="ifrs-full:TitleOfNewIFRS"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 7<sup>1</sup></span></ix:nonNumeric></td></tr> </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_4" id="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:footnote id="ix_2_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">Effective for annual periods beginning on or after January 1, 2026</span></ix:footnote></p></td>
</tr></table></ix:continuation>

<ix:continuation continuedAt="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_5" id="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2</sup></span></td> <td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">Effective for annual/reporting periods beginning on or after January 1, 2027</span></ix:footnote></td></tr> </table></ix:continuation>


<ix:continuation continuedAt="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_6" id="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_5"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>3</sup></span></td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No mandatory effective date yet determined but available for adoption</span></ix:footnote></td>
</tr></table></ix:continuation></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group is in the process of making an assessment of the impact of these new and revised IFRS Accounting Standards upon initial application.
So far, the Group considers that these new and revised IFRS Accounting Standards, except for IFRS 18, are unlikely to have a significant
impact on the Group&#8217;s results of operations and financial position. IFRS 18 is expected to be applicable to the Group. IFRS 18
introduces new requirements on presentation within the statement of profit or loss, including specific totals and subtotals. It also
requires disclosure of management-defined performance measures in a note and introduces new requirements for aggregation and disaggregation
of financial information. The new requirements are expected to impact the Group&#8217;s presentation of the statement of profit or loss
and disclosures of the Group&#8217;s financial performance.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 236; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_3" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForInvestmentsInJointVentures-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForInvestmentsInJointVentures" id="ixv-39503"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Investments
in joint venture</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForInvestmentsInJointVentures-c0_cont_2" id="_DescriptionOfAccountingPolicyForInvestmentsInJointVentures-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
joint venture is a type of joint arrangement whereby the parties that have joint control of the arrangement have rights to the net
assets of the joint venture. Joint control is the contractually agreed upon sharing of control of an arrangement, which exists only
when decisions about the relevant activities require the unanimous consent of the parties sharing control.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.3pt; text-indent: -20.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForInvestmentsInJointVentures-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s investments in joint ventures are stated in the consolidated statement of financial position at the Group&#8217;s share
of net assets under the equity method of accounting, less any impairment losses. Adjustments are made to bring into line any dissimilar
accounting policies that may exist. The Group&#8217;s share of the post-acquisition results and other comprehensive income of joint ventures
is included in the consolidated statement of profit or loss and consolidated other comprehensive income, respectively. In addition, when
there has been a change recognized directly in the equity of the joint venture, the Group recognizes its share of any changes, when applicable,
in the consolidated statement of changes in equity. Unrealized gains and losses resulting from transactions between the Group and its
joint ventures are eliminated to the extent of the Group&#8217;s investments in the joint ventures, except where unrealized losses provide
evidence of an impairment of the assets transferred. Goodwill arising from the acquisition of joint ventures is included as part of the
Group&#8217;s investments in joint ventures.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory" id="ixv-39519"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Goodwill&#160;</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
is initially measured at cost, being the excess of the aggregate of the consideration transferred, the amount recognized for non-controlling
interests and any fair value of the Group&#8217;s previously held equity interests in the acquiree over the identifiable assets acquired
and liabilities assumed. If the sum of this consideration and other items is lower than the fair value of the net assets acquired, the
difference is, after reassessment, recognized in profit or loss as a gain on bargain purchase.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is tested for impairment annually
or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. The Group performs its
annual impairment test of goodwill as at December 31. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Group&#8217;s cash-generating units, or groups of
cash-generating units, that are expected to benefit from the synergies of the combination, irrespective of whether other assets or
liabilities of the Group are assigned to those units or groups of units.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment
is determined by assessing the recoverable amount of the cash-generating unit (group of cash-generating units) to which the goodwill
relates. Where the recoverable amount of the cash-generating unit (group of cash-generating units) is less than the carrying amount,
an impairment loss is recognized. An impairment loss recognized for goodwill is not reversed in a subsequent period.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 61.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
goodwill has been allocated to a cash-generating unit (or group of cash-generating units) and part of the operation within that unit
is disposed of, the goodwill associated with the operation disposed of is included in the carrying amount of the operation when determining
the gain or loss on the disposal. Goodwill disposed of in these circumstances is measured based on the relative value of the operation
disposed of and the portion of the cash-generating unit retained.</span></p></ix:continuation></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt; text-indent: -22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 237; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt; text-indent: -22.4pt"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_4" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" id="ixv-39603"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Fair
value measurement</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group measures its financial assets at FVTPL and derivative financial instruments at fair value at the end of each reporting period. Fair
value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the
liability takes place either in the principal market for the asset or liability, or in the absence of a principal market, in the most
advantageous market for the asset or liability. The principal or the most advantageous market must be accessible by the Group. The fair
value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
fair value measurement of a non-financial asset takes into account a market participant&#8217;s ability to generate economic benefits
by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest
and best use.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair
value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value
hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.75pt; text-indent: -30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8211; based on quoted prices (unadjusted) in active markets for identical assets or liabilities</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8211; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is observable,
either directly or indirectly</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8211; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
assets and liabilities that are recognized in the financial statements on a recurring basis, the Group determines whether transfers have
occurred between levels in the hierarchy by reassessing categorization (based on the lowest level input that is significant to the fair
value measurement as a whole) at the end of each reporting period.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 238; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_5" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" id="ixv-39705"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Impairment
of non-financial assets</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
an indication of impairment exists, or when annual impairment testing for an asset is required (other than inventories, deferred tax
assets and non-current assets), the asset&#8217;s recoverable amount is estimated. An asset&#8217;s recoverable amount is the higher of the asset&#8217;s
or cash-generating unit&#8217;s value in use and its fair value less costs of disposal, and is determined for an individual asset, unless the
asset does not generate cash inflows that are largely independent of those from other assets or groups of assets, in which case the recoverable
amount is determined for the cash-generating unit to which the asset belongs.&#160;</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
testing a cash-generating unit for impairment, a portion of the carrying amount of a corporate asset (e.g., a headquarters building)
is allocated to an individual cash-generating unit if it can be allocated on a reasonable and consistent basis or, otherwise, to the
smallest group of cash-generating units.</span></p></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
impairment loss is recognized only if the carrying amount of an asset exceeds its recoverable amount. In assessing value in use, the
estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments
of the time value of money and the risks specific to the asset. An impairment loss is charged to the statement of profit or loss in the
period in which it arises in those expense categories consistent with the function of the impaired asset.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
assessment is made at the end of each reporting period as to whether there is an indication that previously recognized impairment losses
may no longer exist or may have decreased. If such an indication exists, the recoverable amount is estimated. A previously recognized
impairment loss of an asset other than goodwill is reversed only if there has been a change in the estimates used to determine the recoverable
amount of that asset, but not to an amount higher than the carrying amount that would have been determined (net of any depreciation/amortization)
had no impairment loss been recognized for the asset in prior years. A reversal of such an impairment loss is credited to the statement
of profit or loss in the period in which it arises.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory" id="ixv-39731"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Related
parties</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
party is considered to be related to the Group if:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            party is a person or a close member of that person&#8217;s family and that person:</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                            control or joint control over the Group;</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                            significant influence over the Group; or</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_5"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                            a member of the key management personnel of the Group or of a parent of the Group;</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5pt"></p><div>

</div><!-- Field: Page; Sequence: 239; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in thousands of Renminbi (&#8220;RMB&#8221;)
and US dollars (&#8220;US$&#8221;)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>except for number of shares and per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-size: 10pt">ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">2.4</span></td><td style="text-align: justify"><span style="font-size: 10pt">MATERIAL ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Related parties</span> (continued)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A party is considered to be related to the Group if: (continued)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_6" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_5"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_7"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            party is an entity where any of the following conditions applies:</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_8"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity and the Group are members of the same group;</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_9"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            entity is an associate or joint venture of the other entity (or of a parent, subsidiary or
                                            fellow subsidiary of the other entity);</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_10"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity and the Group are joint ventures of the same third party;</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_11"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            entity is a joint venture of a third entity and the other entity is an associate of the third
                                            entity;</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-indent: -76.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_13" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_12"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity is a post-employment benefit plan for the benefit of employees of either the Group
                                            or an entity related to the Group;</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_14" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_13"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity is controlled or jointly controlled by a person identified in (a);</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_15" id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_14"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            person identified in (a)(i) has significant influence over the entity or is a member of the
                                            key management personnel of the entity (or of a parent of the entity); and</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory-c0_cont_15"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"/><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity, or any member of a group of which it is a part, provides key management personnel
                                            services to the Group or to the parent of the Group.</span></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 240; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_7" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" id="ixv-39996"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Property,
plant and equipment and depreciation</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
plant and equipment, other than construction in progress, are stated at cost less accumulated depreciation and any impairment losses.
The cost of an item of property, plant and equipment comprises its purchase price and any directly attributable costs of bringing the
asset to its working condition and location for its intended use.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditure
incurred after items of property, plant and equipment have been put into operation, such as repairs and maintenance, is normally charged
to the statement of profit or loss in the period in which it is incurred. In situations where the recognition criteria are satisfied,
the expenditure for a major inspection is capitalized in the carrying amount of the asset as a replacement. Where significant parts of
property, plant and equipment are required to be replaced at intervals, the Group recognizes such parts as individual assets with specific
useful lives and depreciates them accordingly.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is calculated on the straight-line basis to write off the cost of each item of property, plant and equipment to its residual value over
its estimated useful life. <ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory-c0_cont_1" escape="true" name="aapg:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" id="ixv-70995">The principal annual rates used for this purpose are as follows:</ix:nonNumeric></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory-c0_cont_1"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 86%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c90" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" scale="-2" unitRef="pure" id="ixv-70996">4.75</ix:nonFraction></span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" scale="-2" unitRef="pure" id="ixv-70997">20</ix:nonFraction>% to <ix:nonFraction contextRef="c92" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" scale="-2" unitRef="pure" id="ixv-70998">33.33</ix:nonFraction></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    and equipment</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c93" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" scale="-2" unitRef="pure" id="ixv-70999">9.5</ix:nonFraction>% to <ix:nonFraction contextRef="c94" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" scale="-2" unitRef="pure" id="ixv-71000">31.67</ix:nonFraction></span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicles</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c95" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" scale="-2" unitRef="pure" id="ixv-71001">23.75</ix:nonFraction></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table></ix:continuation></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
parts of an item of property, plant and equipment have different useful lives, the cost of that item is allocated on a reasonable basis
among the parts and each part is depreciated separately. Residual values, useful lives and the depreciation method are reviewed, and
adjusted if appropriate, at least at each financial year end.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
asset&#8217;s carrying amount is written down immediately to its recoverable amount if the asset&#8217;s carrying amount is greater than
its estimated recoverable amount.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
item of property, plant and equipment including any significant part initially recognized is derecognized upon disposal or when no future
economic benefits are expected from its use or disposal. Any gain or loss on disposal or retirement recognized in the statement of profit
or loss in the year the asset is derecognized is the difference between the net sales proceeds and the carrying amount of the relevant
asset.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
in progress is stated at cost less any impairment losses and is not depreciated. It is reclassified to the appropriate category of property,
plant and equipment when completed and ready for use.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 241; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_8" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_7"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" id="ixv-40143"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Intangible
assets (other than goodwill)</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination
is the fair value at the date of acquisition. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible
assets with finite lives are subsequently amortized over the useful economic life and assessed for impairment whenever there is an indication
that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at each financial year end.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" id="ixv-40154"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are amortized on the straight-line basis over the following useful economic lives:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 87%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c96" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-71002">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c97" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-71003">10</ix:nonNumeric> years</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c98" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-71004">14</ix:nonNumeric> years</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c99" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-71005">20</ix:nonNumeric> years</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
useful lives of software are assessed by the Group considering different purpose and usage of the software, and the authorized period
for use. The useful life of patent is assessed by the Group based on the remaining and foreseeable patent protection period after acquisition.
The useful life of a purchased license is assessed by considering the expected usage of the license by the Group.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" id="ixv-40196"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Research
and development costs</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
research costs are charged to the statement of profit or loss as incurred.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditure
incurred on projects to develop new products is capitalized and deferred only when the Group can demonstrate the technical feasibility
of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or
sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the project and the ability
to measure reliably the expenditure during the development. Product development expenditure which does not meet these criteria is expensed
when incurred. During the reporting period, all expenses incurred for research and development activities were regarded as research expenses
and therefore were expensed when incurred.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" id="ixv-40212"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Leases</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group assesses at contract inception whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract
conveys the right to control the use of an identified asset for a period of time in exchange for consideration.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Group
as a lessee</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets.
The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 242; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Leases</span>
(continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Group
as a lessee</i> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_9" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_8"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
                                            assets</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
assets are recognized at the commencement date of the lease (that is the date the underlying asset is available for use). Right-of-use
assets are measured at cost, less accumulated depreciation and any impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. <ix:nonNumeric contextRef="c0" continuedAt="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory-c0_cont_1" escape="true" name="aapg:DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" id="ixv-71006">Right-of-use assets are depreciated on a straight-line basis
over the shorter of the lease terms and the estimated useful lives of the assets as follows:</ix:nonNumeric></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory-c0_cont_1"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_6"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 87%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold land</span></td>
    <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c100" format="ixt-sec:duryear" name="aapg:RightofuseAssetsOfEstimatedUsefulLives" id="ixv-71007">30</ix:nonNumeric> years</span></td>
    <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c101" format="ixt-sec:duryear" name="aapg:RightofuseAssetsOfEstimatedUsefulLives" id="ixv-71008">2</ix:nonNumeric> to <ix:nonNumeric contextRef="c102" format="ixt-sec:duryear" name="aapg:RightofuseAssetsOfEstimatedUsefulLives" id="ixv-71009">7</ix:nonNumeric> years</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
ownership of the leased asset transfers to the Group by the end of the lease term or the cost reflects the exercise of a purchase option,
depreciation is calculated using the estimated useful life of the asset.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_8"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
                                            liabilities</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are recognized at the commencement date of the lease at the present value of lease payments to be made over the lease term.
The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease
payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also
include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for termination
of a lease, if the lease term reflects the Group exercising the option to terminate the lease. The variable lease payments that do not
depend on an index or a rate are recognized as an expense in the period in which the event or condition that triggers the payment occurs.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
calculating the present value of lease payments, the Group uses its incremental borrowing rate at the lease commencement date because
the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is
increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities
is remeasured if there is a modification, a change in the lease term, a change in lease payments (e.g., a change to future lease payments
resulting from a change in an index or rate) or a change in assessment of an option to purchase the underlying asset.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s lease liabilities are included in interest-bearing bank and other borrowings.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 243; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Leases</span>
(continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Group
as a lessee </i>(continued)</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_10" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_9"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_13" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_12"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
                                            leases and leases of low-value assets</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_14" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (that is those leases that
have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the recognition
exemption for leases of low-value assets to leases of office equipment that are considered to be of low value.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
payments on short-term leases and leases of low-value assets are recognized as an expense on a straight-line basis over the lease term.</span></p></ix:continuation>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" id="ixv-40467"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Investments
and other financial assets</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and measurement</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets are classified, at initial recognition, as subsequently measured at amortized cost and fair value through profit and loss.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics
and the Group&#8217;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Group has applied the practical expedient of not adjusting the effect of a significant financing component,
the Group initially measures a financial asset at its fair value plus in the case of a financial asset not at FVTPL, transaction costs.
Trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are
measured at the transaction price determined under IFRS 15 in accordance with the policies set out for &#8220;Revenue recognition&#8221;
below.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order for a financial asset to be classified and measured at amortized cost, it needs to give rise to cash flows that are solely payments
of principal and interest (&#8220;SPPI&#8221;) on the principal amount outstanding. Financial assets with cash flows that are not SPPI
are classified and measured at fair value through profit or loss, irrespective of the business model.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 244; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Investments
and other financial assets</span> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and measurement</i> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_11" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_10"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash flows.
The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or
both. Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial
assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through other comprehensive
income are held within a business model with the objective of both holding to collect contractual cash flows and selling. Financial assets
which are not held within the aforementioned business models are classified and measured at fair value through profit or loss.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
or sales of financial assets that require delivery of assets within the period generally established by regulation or convention in the
marketplace are recognized on the trade date, that is, the date that the Group commits to purchase or sell the asset.</span></p></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent
measurement</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsequent measurement of financial assets depends on their classification as follows:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
assets at amortized cost (debt instruments)</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment. Gains and losses
are recognized in the statement of profit or loss when the asset is derecognized, modified or impaired.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
assets at FVTPL</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_13" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_12"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets at FVTPL are carried in the statement of financial position at fair value with net changes in fair value recognized in the statement
of profit or loss.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
on the equity investments are also recognized as other income in the statement of profit or loss when the right of payment has been established.&#160;</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" id="ixv-40619"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derecognition
of financial assets</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized
(i.e., removed from the Group&#8217;s consolidated statement of financial position) when:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            rights to receive cash flows from the asset have expired; or</span></td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Group has transferred its rights to receive cash flows from the asset or has assumed an obligation
                                            to pay the received cash flows in full without material delay to a third party under a &#8220;pass-through&#8221;
                                            arrangement; and either (a) the Group has transferred substantially all the risks and rewards
                                            of the asset, or (b) the Group has neither transferred nor retained substantially all the
                                            risks and rewards of the asset, but has transferred control of the asset.</span></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 245; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derecognition
of financial assets</span> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_12" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_11"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Group has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risk and rewards of ownership of the asset. When it has neither transferred nor retained
substantially all the risks and rewards of the asset nor transferred control of the asset, the Group continues to recognize the transferred
asset to the extent of the Group&#8217;s continuing involvement. In that case, the Group also recognizes an associated liability. The
transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Group has retained.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Group could be required to repay.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" id="ixv-40725"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Impairment
of financial assets</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group recognizes an allowance for expected credit losses (&#8220;ECLs&#8221;) for all debt instruments not held at fair value through
profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash
flows that the Group expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows
will include cash flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
approach</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ECLs
are recognized in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition,
ECLs are provided for credit losses that result from default events that are possible within the next 12 months (a 12-month ECL). For
those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is
required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL).</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each reporting date, the Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition.
When making the assessment, the Group compares the risk of a default occurring on the financial instrument as at the reporting date with
the risk of a default occurring on the financial instrument as at the date of initial recognition and considers reasonable and supportable
information that is available without undue cost or effort, including historical and forward-looking information.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group considers a financial asset in default when contractual payments are 120 days past due. However, in certain cases, the Group may
also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive
the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 246; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Impairment
of financial assets</span>&#160;(continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
approach </i>(continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_13" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_12"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets at amortized cost are subject to impairment under the general approach, and they are classified within the following stages for
measurement of ECLs except for trade receivables which apply the simplified approach as detailed below.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_8"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.65in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
                               1 &#8211; </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            instruments for which credit risk has not increased significantly since initial recognition
                                            and for which the loss allowance is measured at an amount equal to 12-month ECLs</span></td>
</tr></table></ix:continuation>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_9"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.65in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
                                            2 &#8211; </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            instruments for which credit risk has increased significantly since initial recognition but
                                            that are not credit-impaired financial assets and for which the loss allowance is measured
                                            at an amount equal to lifetime ECLs</span></td>
</tr></table></ix:continuation>

<p style="text-align: left; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_10"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.65in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
                                            3 &#8211; </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            assets that are credit-impaired at the reporting date (but that are not purchased or originated
                                            credit-impaired) and for which the loss allowance is measured at an amount equal to lifetime
                                            ECLs</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Simplified
approach</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
trade receivables that do not contain a significant financing component or when the Group applies the practical expedient of not adjusting
the effect of a significant financing component, the Group applies the simplified approach in calculating ECLs. Under the simplified
approach, the Group does not track changes in credit risk but instead recognizes a loss allowance based on lifetime ECLs at each reporting
date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking
factors specific to the debtors and the economic environment.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" id="ixv-40880"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Financial
liabilities</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and measurement</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
liabilities are classified, at initial recognition, as financial liabilities at FVTPL, loans and borrowings, or payables, as appropriate.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s financial liabilities include trade payables, financial liabilities included in other payables and accruals, interest-bearing
bank and other borrowings, long-term payables and other current and non-current liabilities.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 247; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Financial
liabilities</span> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_14" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_13"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent
measurement</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsequent measurement of financial liabilities depends on their classification as follows:</span></p></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
liabilities at fair value through profit or loss</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
liabilities at fair value through profit or loss include financial liabilities designated upon initial recognition as at fair value through
profit or loss.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
liabilities designated upon initial recognition as at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied. Gains or losses on liabilities designated at fair value through profit or loss are
recognized in the statement of profit or loss, except for the gains or losses arising from the Group&#8217;s own credit risk which are
presented in other comprehensive income with no subsequent reclassification to the statement of profit or loss. The net fair value gain
or loss recognized in the statement of profit or loss does not include any interest charged on these financial liabilities.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
liabilities at amortized cost (trade and other payables, and borrowings)</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
initial recognition, trade and other payables, and interest-bearing borrowings are subsequently measured at amortized cost, using the
effective interest rate method unless the effect of discounting would be immaterial, in which case they are stated at cost. Gains and
losses are recognized in the statement of profit or loss when the liabilities are derecognized as well as through the effective interest
rate amortization process.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the effective
interest rate. The effective interest rate amortization is included in finance costs in the statement of profit or loss.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock-c0_cont_1" escape="true" name="aapg:DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" id="ixv-41016"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derecognition
of financial liabilities </span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock-c0_cont_2" id="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial liability is derecognized when the obligation under the liability is discharged or cancelled or expires.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing
liability are substantially modified, such an exchange or modification is treated as a derecognition of the original liability and a
recognition of a new liability, and the difference between the respective carrying amounts is recognized in the statement of profit or
loss.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory" id="ixv-41032"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Offsetting
of financial instruments </span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, or to realize the assets
and settle the liabilities simultaneously.&#160;</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" id="ixv-41043"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derivative
financial instruments</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and subsequent measurement</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently
remeasured at fair value. Derivatives are carried as assets when the fair value is positive, and as liabilities when the fair value is
negative.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
gains or losses arising from changes in fair value of derivatives are taken directly to profit or loss.</span></p></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 248; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_15" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_14"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForTreasurySharesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory" id="ixv-41122"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Treasury
shares </span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForTreasurySharesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Own
equity instruments which are reacquired and held by the Company or the Group (treasury shares) are recognized directly in equity at cost.
No gain or loss is recognized in the statement of profit or loss on the purchase, sale, issue or cancellation of the Group&#8217;s own
equity instruments.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories" id="ixv-41133"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Inventories</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are stated at the lower of cost and net realizable value. Cost is determined on the first-in, first-out basis, in the case of work in
progress and finished goods, comprises direct materials, direct labor, contract manufacturing fee and an appropriate proportion of overheads.
Net realizable value is based on estimated selling prices less any estimated costs to be incurred to completion and disposal.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" id="ixv-41144"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Cash
and cash equivalents</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_2" id="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents in the statements of cash flows comprise cash on hand and at banks, and short-term highly liquid deposits with a
maturity of generally within three months that are readily convertible into known amounts of cash, subject to an insignificant risk of
changes in value and held for the purpose of meeting short-term cash commitments.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of the consolidated statements of financial positions, cash and bank balances comprise cash and cash equivalents as defined
above, restricted bank balances and time deposits with original maturity of more than three months as defined above.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForProvisionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" id="ixv-41160"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Provisions
</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForProvisionsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForProvisionsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
provision is recognized when a present obligation (legal or constructive) has arisen as a result of a past event and it is probable that
a future outflow of resources will be required to settle the obligation, provided that a reliable estimate can be made of the amount
of the obligation.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForProvisionsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForProvisionsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Group expects some or all of a provision to be reimbursed, the reimbursement is recognized as a separate asset, but only when the
reimbursement is virtually certain. The expense relating to a provision is presented in the statement of profit or loss net of any reimbursement.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForProvisionsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the effect of discounting is material, the amount recognized for a provision is the present value at the end of the reporting date of
the future expenditures expected to be required to settle the obligation. The increase in the discounted present value amount arising
from the passage of time is included in finance costs in the statement of profit or loss.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" id="ixv-41181"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Income
tax</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax comprises current and deferred tax. Income tax relating to items recognized outside profit or loss is recognized outside profit or
loss, either in other comprehensive income or directly in equity.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, based on tax
rates (and tax laws) that have been enacted or substantively enacted by the end of each of the reporting period, taking into consideration
interpretations and practices prevailing in the countries in which the Group operates.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax is provided, using the liability method, on all temporary differences at the end of reporting date between the tax bases of assets
and liabilities and their carrying amounts for financial reporting purposes.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 249; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Income
tax</span> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_16" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_15"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax liabilities are recognized for all taxable temporary differences, except:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_5"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                            the deferred tax liability arises from the initial recognition of goodwill or an asset or
                                            liability in a transaction that is not a business combination and, at the time of the transaction,
                                            affects neither the accounting profit nor taxable profit or loss and does not give rise to
                                            equal taxable and deductible temporary differences; and</span></td>
</tr></table></ix:continuation>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_6"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            respect of taxable temporary differences associated with investments in subsidiaries, when
                                            the timing of the reversal of the temporary differences can be controlled and it is probable
                                            that the temporary differences will not reverse in the foreseeable future.</span></td>
</tr></table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognized for all deductible temporary differences, and the carryforward of unused tax credits and any unused tax losses.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which the deductible
temporary differences, and the carryforward of unused tax credits and unused tax losses can be utilized, except:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_8"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                            the deferred tax asset relating to the deductible temporary differences arises from the initial
                                            recognition of an asset or liability in a transaction that is not a business combination
                                            and, at the time of the transaction, affects neither the accounting profit nor taxable profit
                                            or loss and does not give rise to equal taxable and deductible temporary differences; and</span></td>
</tr></table></ix:continuation>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_9"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            respect of deductible temporary differences associated with investments in subsidiaries,
                                            deferred tax assets are only recognized to the extent that it is probable that the temporary
                                            differences will reverse in the foreseeable future and taxable profit will be available against
                                            which the temporary differences can be utilized.</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer
probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized
deferred tax assets are reassessed at the end of each reporting period and are recognized to the extent that it has become probable that
sufficient taxable profit will be available to allow all or part of the deferred tax asset to be recovered.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realized or the liability
is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and deferred tax liabilities are offset if and only if the Group has a legally enforceable right to set off current tax assets
and current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation
authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets
on a net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts
of deferred tax liabilities or assets are expected to be settled or recovered.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 250; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-indent: 0.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_17" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_16"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants" id="ixv-41388"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Government
grants</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_2" id="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
grants are recognized at their fair value where there is reasonable assurance that the grant will be received and all attaching conditions
will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the periods that
the costs, for which it is intended to compensate, are expensed.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_3" id="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
government grants whose primary condition is to compensate for research and development projects or other than purchase, construct or
otherwise acquire long-term assets are designated as grants related to income. Some of the grants related to income have future related
costs expected to be incurred and require the Group to comply with conditions attached to the grants and the government to acknowledge
the compliance of these conditions. These grants related to income are recognized as deferred income in the consolidated statement of
financial position and transferred to profit or loss when related costs are subsequently incurred, and the Group received government acknowledge
of compliance.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
government grants related to income that are receivable as compensation for expenses or losses already incurred or for the purpose of
giving immediate financial support to the Group with no future related costs are recognized in profit or loss in the period in which
they become receivable.</span></p></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory" id="ixv-41409"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Revenue
recognition </span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_2" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_3" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from contracts with customers is recognized when control of goods or services is transferred to the customers at an amount that reflects
the consideration to which the Group expects to be entitled in exchange for those goods or services.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_4" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the consideration in a contract includes a variable amount, the amount of consideration is estimated to which the Group will be entitled
in exchange for transferring the goods or services to the customer. The variable consideration is estimated at contract inception and
constrained until it is highly probable that a significant revenue reversal in the amount of cumulative revenue recognized will not occur
when the associated uncertainty with the variable consideration is subsequently resolved.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_5" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the contract contains a financing component which provides the customer with a significant benefit of financing the transfer of goods
or services to the customer for more than one year, revenue is measured at the present value of the amount receivable, discounted using
the discount rate that would be reflected in a separate financing transaction between the Group and the customer at contract inception.
When the contract contains a financing component which provides the Group with a significant financial benefit for more than one year,
revenue recognized under the contract includes the interest expense accreted on the contract liability under the effective interest method.
For a contract where the period between the payment by the customer and the transfer of the promised goods or services is one year or
less, the transaction price is not adjusted for the effects of a significant financing component, using the practical expedient in IFRS
15.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 251; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -42.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Revenue
recognition</span> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers </i>(continued)&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_18" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_17"><ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_6" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_5"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
                                            of products</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_7" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from the sale of products is recognized at the point in time when control of the asset is transferred to the customer, generally on acceptance
of the products.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_8" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_7"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
                                            rights</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_9" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group provides commercialization, development and branding rights (collectively, &#8220;Commercialization Rights&#8221;) to customers
for an agreed upon commercialization period ending ten years from the date of the first sale of the product as stipulated in the relevant
agreement. The consideration for Commercialization Rights includes upfront payment, development and regulatory milestones payments and
commercialization milestones payments.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_10" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
and regulatory milestones payments are fully constrained until the period in which those regulatory approvals are achieved due to the
inherent uncertainty with the approval process and included in the transaction price in the period regulatory approval is obtained. Upfront
payment and development and regulatory milestones payments are recorded under contract liabilities and recognized as revenue over time
during the commercialization period on a straight-line basis.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_11" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
milestone payments based on the level of sales are recognized at a point in time when the later of the following events occurs: (i) the
related sale occurs, or (ii) the performance obligation to which commercialization milestones payments have been allocated has been satisfied.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_12" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_11"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
                                            property income</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_13" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
property income is recognized at the point in time at which the non-patented intellectual property is granted to the customer because
the Company will not undertake activities that affect such intellectual property.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_14" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consideration for intellectual property income comprises a fixed element and a variable element. Variable element is recognized as the
transaction price when the Company can conclude that it is highly probable that a significant reversal in the amount of cumulative revenue
recognized will not occur.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_15" id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_14"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -42.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DisclosureOfRevenueFromContractsWithCustomersExplanatory-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group provides consulting services to its customers through contracts. Depending on the contract, revenue is recognized over time as
the service is rendered, or at the point in time as the service is completed and accepted.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 252; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -42.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Revenue
recognition</span> (continued)</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_19" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_18"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" id="ixv-41653"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
income</i></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income is recognized on an accrual basis using the effective interest method by applying the rate that exactly discounts the estimated
future cash receipts over the expected life of the financial instrument or a shorter period, when appropriate, to the net carrying amount
of the financial asset.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory-c0_cont_1" escape="true" name="aapg:DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" id="ixv-41664"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Contract
liabilities </span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
contract liability is recognized when a payment is received or a payment is due (whichever is earlier) from a customer before the Group
transfers the related goods or services. Contract liabilities are recognized as revenue when the Group performs under the contract (i.e.,
transfers control of the related goods or services to the customer).</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" id="ixv-41675"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Share-based
payments</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates share incentive plans which include the pre-IPO share option scheme, the post-IPO share option scheme, 2018 restricted
share unit scheme (the &#8220;2018 RSU Scheme&#8221;), 2021 restricted share unit scheme (the &#8220;2021 RSU Scheme&#8221;) and 2022
restricted share unit scheme (the &#8220;2022 RSU Scheme&#8221;). Employees (including directors) of the Group receive remuneration in
the form of share-based payments, whereby employees render services in exchange for equity instruments (&#8220;equity-settled transactions&#8221;).</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of equity-settled transactions with employees is measured by reference to the fair value at the date at which they are granted,
further details of which are given in note 31 to the financial statements.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of equity-settled transactions is recognized in employee benefit expense, together with a corresponding increase in equity, over
the period in which the performance and/or service conditions are fulfilled. The cumulative expense recognized for equity-settled transactions
at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group&#8217;s
best estimate of the number of equity instruments that will ultimately vest. The charge or credit to the statement of profit or loss
for a period represents the movement in the cumulative expense recognized as at the beginning and end of that period.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service
and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood
of the conditions being met is assessed as part of the Group&#8217;s best estimate of the number of equity instruments that will ultimately
vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without
an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value
of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
awards that do not ultimately vest because non-market performance and/or service conditions have not been met, no expense is recognized.
Where awards include a market or non-vesting condition, the transactions are treated as vesting irrespective of whether the market or
non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 253; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Share-based
payments</span> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_20" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_19"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
the terms of an equity-settled award are modified, as a minimum an expense is recognized as if the terms had not been modified, if the
original terms of the award are met. In addition, an expense is recognized for any modification that increases the total fair value of
the share-based payments or is otherwise beneficial to the employee as measured at the date of modification. Where an equity-settled
award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognized for the award is
recognized immediately.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dilutive effect of outstanding options is reflected as additional share dilution in the computation of loss per share.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" id="ixv-41781"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Other
employee benefits</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pension
scheme</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
employees of the Group&#8217;s subsidiaries which operate in the Chinese mainland are required to participate in a central pension scheme
operated by the local municipal government. The subsidiaries operating in Chinese mainland are required to contribute a certain percentage
of their payroll costs to the central pension scheme. The contributions are charged to profit or loss as they become payable in accordance
with the rules of the central pension scheme.</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group implemented a safe harbor defined contribution 401(k) savings plan (the &#8220;401(k) Plan&#8221;) for U.S. employees. The 401(k)
Plan covers all U.S. employees and allows participants to defer a portion of their annual compensation on a pre-tax basis. In addition,
the Company implemented a matching contribution to the 401(k) Plan, matching <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="aapg:OtherEmployeeBenefitContributionPercentage" scale="-2" unitRef="pure" id="ixv-71010">100</ix:nonFraction>% of an employee&#8217;s contribution up to a maximum
of <ix:nonFraction contextRef="c82" decimals="2" format="ixt:num-dot-decimal" name="aapg:AnnualBaseSalaryPercentage" scale="-2" unitRef="pure" id="ixv-71011">6</ix:nonFraction>% of the participant&#8217;s annual base salary. Such matching contribution vests when made.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" id="ixv-41804"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Borrowing
costs</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
costs directly attributable to the acquisition, construction or production of qualifying assets, i.e., assets that necessarily take a
substantial period of time to get ready for their intended use or sale, are capitalized as part of the cost of those assets. The capitalization
of such borrowing costs ceases when the assets are substantially ready for their intended use or sale. All other borrowing costs are
expensed in the period in which they are incurred. Borrowing costs consist of interest and other costs that an entity incurs in connection
with the borrowing of funds.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock-c0_cont_1" escape="true" name="aapg:DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" id="ixv-41815"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Events
after the reporting period </span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Group receives information after the reporting period, but prior to the date of authorization for issue, about conditions that existed
at the end of the reporting period, it will assess whether the information affects the amounts that it recognizes in its financial statements.
The Group will adjust the amounts recognized in its financial statements to reflect any adjusting events after the reporting period and
update the disclosures that relate to those conditions in light of the new information. For non-adjusting events after the reporting
period, the Group will not change the amounts recognized in its financial statements but will disclose the nature of the non-adjusting
events and an estimate of their financial effects, or a statement that such an estimate cannot be made, if applicable.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 254; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.55pt; text-indent: -1.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_20"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" id="ixv-41884"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Foreign
currencies</span></span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are presented in RMB. Each entity in the Group determines its own functional currency and items included in the
financial statements of each entity are measured using that functional currency. Foreign currency transactions recorded by the entities
in the Group are initially recorded using their respective functional currency rates prevailing at the dates of the transactions. Monetary
assets and liabilities denominated in foreign currencies are translated at the functional currency rates of exchange ruling at the end
of the reporting period. Differences arising on settlement or translation of monetary items are recognized in profit or loss.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">Non-monetary
items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the
initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the
date when the fair value was measured. The gain or loss arising on translation of a non-monetary item measured at fair value is treated
in line with the recognition of the gain or loss on change in fair value of the item (i.e., translation difference on the item whose
fair value gain or loss is recognized in other comprehensive income or profit or loss is also recognized in other comprehensive income
or profit or loss, respectively).</span></p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the exchange rate on initial recognition of the related asset, expense or income on the derecognition of a non-monetary asset
or non-monetary liability relating to an advance consideration, the date of initial transaction is the date on which the Group initially
recognizes the non-monetary asset or non-monetary liability arising from the advance consideration. If there are multiple payments or
receipts in advance, the Group determines the transaction date for each payment or receipt of the advance consideration.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currencies of certain overseas subsidiaries are currencies other than the RMB. As at the end of the reporting period, the
assets and liabilities of these entities are translated into RMB at the exchange rates prevailing at the end of the reporting period
and their statements of profit or loss are translated into RMB at the exchange rates that approximate to those prevailing at the dates
of the transactions.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
resulting exchange differences are recognized in other comprehensive income and accumulated in the exchange fluctuation reserve, except
to the extent that the differences are attributable to non-controlling interests. On disposal of a foreign operation, the cumulative
amount in the reserve relating to that particular foreign operation is recognized in the statement of profit or loss.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
goodwill arising on the acquisition of a foreign operation and any fair value adjustments to the carrying amounts of assets and liabilities
arising on acquisition are treated as assets and liabilities of the foreign operation and translated at the closing rate.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of the consolidated statements of cash flows, the cash flows of overseas subsidiaries are translated into RMB at the exchange
rates ruling at the dates of the cash flows. Frequently recurring cash flows of overseas subsidiaries which arise throughout the year
are translated into RMB at the exchange rates that approximate to those prevailing at the dates of the transactions.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 255; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory" id="ixv-41960"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNIFICANT
                                            ACCOUNTING JUDGEMENTS AND ESTIMATES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the Group&#8217;s financial statements requires management to make judgements, estimates and assumptions that affect the
reported amounts of expenses, assets and liabilities, and their accompanying disclosures, and the disclosure of contingent liabilities.
Uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amounts
of the assets or liabilities affected in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Judgements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the process of applying the Group&#8217;s accounting policies, management has made the following judgements, apart from those involving
estimations, which have the most significant effect on the amounts recognized in the financial statements:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group applied the following judgements that significantly affect the determination of the amount and timing of revenue from contracts
with customers:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
rights contracts include variable consideration based on future events. In estimating the variable consideration, the Group is required
to use either the expected value method or the most likely amount method based on which method better predicts the amount of consideration
to which it will be entitled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.2pt; text-indent: -1.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
that the payments of certain variable consideration are not within the control of the Group, such as regulatory approvals, relevant consideration
is not considered until relevant approvals are obtained. The Group determines that the most likely amount method is the appropriate method
to estimate the variable consideration. When the Group can conclude that it is highly probable that there will not be a subsequent reversal
of a significant amount of revenue, the variable consideration will be included in the transaction price.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Estimation
uncertainty</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key assumptions concerning the future and other key sources of estimation uncertainty at the end of the reporting period, that have a
significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are
described below.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: left; text-indent: -1.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax assets are recognized for unused tax losses to the extent that it is probable that taxable profit will be available against which
the losses can be utilized. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized,
based upon the likely timing and the level of future taxable profits, together with future tax planning strategies. The Group has carried
forward tax losses of RMB <ix:nonFraction contextRef="c103" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="cny" id="ixv-71012">4,425,237</ix:nonFraction> and RMB<ix:nonFraction contextRef="c104" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="cny" id="ixv-71013">5,347,045</ix:nonFraction> (US$<ix:nonFraction contextRef="c104" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="usd" id="ixv-71014">764,617</ix:nonFraction>) as of December 31, 2024 and 2025, respectively, of which related deferred
tax assets of RMB<ix:nonFraction contextRef="c105" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71015">3,523</ix:nonFraction> and RMB<ix:nonFraction contextRef="c106" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71016">12,373</ix:nonFraction> (US$<ix:nonFraction contextRef="c106" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="usd" id="ixv-71017">1,769</ix:nonFraction>) have been recognized as of December 31, 2024 and 2025, respectively. Deferred tax assets
have not been recognized in respect of losses that have arisen in subsidiaries that have been loss-making for some time, and it is not
considered probable that taxable profits will be available against which the tax losses can be utilized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">If
the Group was able to recognize all unrecognized deferred tax assets, net loss would have decreased and equity would have increased by
RMB<ix:nonFraction contextRef="c107" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71018">1,119,913</ix:nonFraction>, RMB<ix:nonFraction contextRef="c108" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71019">1,321,638</ix:nonFraction> and RMB<ix:nonFraction contextRef="c109" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71020">1,572,664</ix:nonFraction> (US$<ix:nonFraction contextRef="c109" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="usd" id="ixv-71021">224,889</ix:nonFraction>) during the years ended December 31, 2023, 2024 and 2025, respectively. Further
details on taxes are disclosed in Note 9.</span></p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 256; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory" id="ixv-42059"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPERATING
                                            SEGMENT INFORMATION</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">For
management purposes, the Group has only <ix:nonNumeric contextRef="c0" name="ifrs-full:FactorsUsedToIdentifyEntitysReportableSegments" id="ixv-71022">one</ix:nonNumeric> reportable operating segment, which is discovering, developing and commercializing
therapies to address global medical needs primarily in hematological malignancies Management monitors the operating results of the
Group&#8217;s operating segment as a whole for the purpose of making decisions about resource allocation and performance assessment.
Therefore, no analysis by operating segment is presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Geographical
information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfProductsAndServicesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfProductsAndServicesExplanatory" id="ixv-42084"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from external customers</span></ix:nonNumeric></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0; text-indent: 369.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DisclosureOfProductsAndServicesExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese
    mainland</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c110" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71023">221,984</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c111" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71024">302,235</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c112" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71025">574,120</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c112" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71026">82,098</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Switzerland</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-195; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c114" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71027">678,415</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-196; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-197; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71028">221,984</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71029">980,650</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71030">574,120</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71031">82,098</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0; text-indent: 369.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
revenue information above is based on the locations of the customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" id="ixv-42332"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current assets</span></ix:nonNumeric></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese
    mainland</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c116" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71032">1,088,733</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c117" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71033">1,090,914</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71034">978,233</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="usd" id="ixv-71035">139,885</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71036">2,665</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71037">4,474</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71038">4,489</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="usd" id="ixv-71039">642</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c122" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71040">24</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c123" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71041">444</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c124" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71042">35</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c124" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="usd" id="ixv-71043">5</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    non-current assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71044">1,091,422</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71045">1,095,832</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-71046">982,757</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="usd" id="ixv-71047">140,532</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
non-current assets information above is based on the locations of the assets and excludes financial instruments and deferred tax assets.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 257; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPERATING
                                            SEGMENT INFORMATION (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Information
about major customers</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory" id="ixv-42663"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from customers amounting to over 10% of the total revenue of the Group in the reporting period is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the years ended December 31,</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer A</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c125" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="cny" id="ixv-71048">107,323</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c126" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="cny" id="ixv-71049">229,895</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c127" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="cny" id="ixv-71050">436,644</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c127" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="usd" id="ixv-71051">62,439</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 11pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    B</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-198; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c129" decimals="-3" format="ixt:num-dot-decimal" id="ix_19_fact" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="cny">678,415</ix:nonFraction></span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-199; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-200; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 11pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    C</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c131" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="cny" id="ixv-71053">35,021</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-201; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-202; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-203; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 11pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    D</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c134" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="cny" id="ixv-71054">30,623</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-204; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-205; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-206; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="cny" id="ixv-71055">172,967</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="cny" id="ixv-71056">908,310</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="cny" id="ixv-71057">436,644</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" unitRef="usd" id="ixv-71058">62,439</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These customers generated less than 10% of the total revenue of the Group during the years ended December 31, 2023, 2024 and 2025.</span></ix:footnote></td>
</tr></table></ix:nonNumeric></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock-c0_cont_1" escape="true" name="aapg:DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" id="ixv-42993"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUE,
                                            OTHER INCOME AND GAINS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
analysis of revenue is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Revenue
from contracts with customers</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" id="ixv-43016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></ix:nonNumeric></td><td style="text-align: justify"><ix:continuation continuedAt="_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory-c0_cont_2" id="_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory-c0_cont_1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated revenue information</span></ix:continuation></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<ix:continuation id="_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory-c0_cont_2"><table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Types of goods
    or services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intellectual
    property income</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-207; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c138" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71059">678,415</ix:nonFraction></span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-208; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-209; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif">Sales
    of products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c140" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71060">193,535</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c141" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71061">260,835</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c142" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71062">499,272</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c142" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71063">71,395</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif">Commercialization
    rights income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c143" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71064">26,049</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c144" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71065">37,485</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c145" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71066">72,629</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c145" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71067">10,386</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c146" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71068">2,400</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c147" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71069">3,915</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c148" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71070">2,219</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c148" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71071">317</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c149" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71072">221,984</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c150" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71073">980,650</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c151" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71074">574,120</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c151" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71075">82,098</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Timing
    of revenue recognition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">At
    a point in time</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intellectual
    property income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-210; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c153" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71076">678,415</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-211; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-212; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Sales of products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c155" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71077">193,535</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c156" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71078">260,835</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c157" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71079">499,272</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c157" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71080">71,395</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commercialization
rights income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-213; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c160" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71081">35,144</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c160" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71082">5,026</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Over
    time</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commercialization
    rights income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c161" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71083">26,049</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c162" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71084">37,485</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c163" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71085">37,485</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c163" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71086">5,360</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c164" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71087">2,400</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c165" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71088">3,915</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c166" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71089">2,219</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c166" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71090">317</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c167" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71091">221,984</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c168" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71092">980,650</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c169" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71093">574,120</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c169" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71094">82,098</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 258; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUE,
                                            OTHER INCOME AND GAINS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from contracts with customers (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated
                                            revenue information (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock-c0_cont_2" id="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfInvestmentContractsLiabilitiesExplanatory" id="ixv-43777"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the amounts of revenue recognized in the current reporting period that were included in the contract liabilities
at the beginning of the reporting period:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
    rights income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="3" unitRef="cny" id="ixv-71095">26,049</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="3" unitRef="cny" id="ixv-71096">37,485</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="3" unitRef="cny" id="ixv-71097">37,485</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="3" unitRef="usd" id="ixv-71098">5,360</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-indent: 37.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
                                            obligations</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about the Group&#8217;s performance obligations is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -22pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intellectual
property income</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
intellectual property income is recognized at the point of time upon the customer obtains the right to use the non-patented intellectual
property as there are no ongoing activities that significantly affect the intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
performance obligation is satisfied upon acceptance of the products and payment is generally due within 45 to 120 days from the date
of billing.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -11pt"></p><div>

</div><!-- Field: Page; Sequence: 259; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUE,
                                            OTHER INCOME AND GAINS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from contracts with customers (continued)&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
                                            obligations (continued)</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Commercialization
rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
performance obligation is satisfied over time as commercialization rights are granted for an agreed upon commercialization period ending
ten years from the date of the first sale of the product as stipulated in the relevant agreement. Among these, revenue from sales-based
commercialization milestone payments is recognized at a point in time when the related sale occurs. Upfront payment in advance is required,
and the development and regulatory milestones payments and commercialization milestones payments are generally due within 120 days from
the date of billing.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfPerformanceObligationsExplanatory" id="ixv-44019"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of transaction prices allocated to the remaining performance obligations (unsatisfied or partially unsatisfied) as at December
31, 2024 and 2025 are as follows:&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts expected to be recognized as revenue:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    one year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c170" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" unitRef="cny" id="ixv-71099">37,485</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c171" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" unitRef="cny" id="ixv-71100">37,485</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c171" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" unitRef="usd" id="ixv-71101">5,360</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
    one year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c172" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" unitRef="cny" id="ixv-71102">248,460</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c173" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" unitRef="cny" id="ixv-71103">210,224</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c173" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" unitRef="usd" id="ixv-71104">30,062</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" unitRef="cny" id="ixv-71105">285,945</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" unitRef="cny" id="ixv-71106">247,709</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="3" unitRef="usd" id="ixv-71107">35,422</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of transaction prices allocated to the remaining performance obligations which are expected to be recognized mainly related to
commercialization rights, which have been partially recognized during the reporting period (note 26). The amounts disclosed above do
not include variable consideration which is constrained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory" id="ixv-44232"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Other
income and gains</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    interest income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks" scale="3" unitRef="cny" id="ixv-71108">32,409</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks" scale="3" unitRef="cny" id="ixv-71109">37,840</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks" scale="3" unitRef="cny" id="ixv-71110">82,125</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks" scale="3" unitRef="usd" id="ixv-71111">11,744</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants related
    to income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" unitRef="cny" id="ixv-71112">19,358</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" unitRef="cny" id="ixv-71113">9,073</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" unitRef="cny" id="ixv-71114">14,496</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" unitRef="usd" id="ixv-71115">2,073</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange gain, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetForeignExchangeGain" scale="3" unitRef="cny" id="ixv-71116">1,621</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetForeignExchangeGain" scale="3" unitRef="cny" id="ixv-71117">6,694</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RentalIncome" scale="3" unitRef="cny" id="ixv-71118">400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RentalIncome" scale="3" unitRef="cny" id="ixv-71119">2,324</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RentalIncome" scale="3" unitRef="cny" id="ixv-71120">4,989</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RentalIncome" scale="3" unitRef="usd" id="ixv-71121">713</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value gain on derivative
    financial instruments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" scale="3" unitRef="cny" id="ixv-71122">2,822</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    on disposal of items of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71123">4</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherGainsLosses" scale="3" unitRef="cny" id="ixv-71124">2,702</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherGainsLosses" scale="3" unitRef="cny" id="ixv-71125">1,428</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherGainsLosses" scale="3" unitRef="cny" id="ixv-71126">1,885</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherGainsLosses" scale="3" unitRef="usd" id="ixv-71127">270</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other income and gains</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIncome" scale="3" unitRef="cny" id="ixv-71128">59,316</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIncome" scale="3" unitRef="cny" id="ixv-71129">57,359</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIncome" scale="3" unitRef="cny" id="ixv-71130">103,495</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherIncome" scale="3" unitRef="usd" id="ixv-71131">14,800</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"></p><div>

</div><!-- Field: Page; Sequence: 260; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock" id="ixv-44683"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
                                            BEFORE TAX</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" id="ixv-44693"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s loss before tax is arrived at after charging/(crediting):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 40%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    of inventories sold</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" scale="3" unitRef="cny" id="ixv-71132">29,342</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" scale="3" unitRef="cny" id="ixv-71133">27,031</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" scale="3" unitRef="cny" id="ixv-71134">42,481</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" scale="3" unitRef="usd" id="ixv-71135">6,074</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    of services provided</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSalesRoomOccupancyServices" scale="3" unitRef="cny" id="ixv-71136">1,201</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSalesRoomOccupancyServices" scale="3" unitRef="cny" id="ixv-71137">2,054</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSalesRoomOccupancyServices" scale="3" unitRef="cny" id="ixv-71138">2,277</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSalesRoomOccupancyServices" scale="3" unitRef="usd" id="ixv-71139">326</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Write-down
    of inventories to net realizable value</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right">-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InventoryWritedown2011" scale="3" unitRef="cny" id="ixv-71140">4,180</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InventoryWritedown2011" scale="3" unitRef="usd" id="ixv-71141">598</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of property, plant and equipment**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_24_fact" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="cny">55,281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" id="ix_25_fact" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="cny">71,184</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_26_fact" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="cny">65,761</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_27_fact" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="usd">9,404</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of investment property**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_28_fact" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" scale="3" sign="-" unitRef="cny">15,883</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of right-of-use assets**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13(a)</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_29_fact" name="ifrs-full:DepreciationExpense" scale="3" unitRef="cny">11,632</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" id="ix_30_fact" name="ifrs-full:DepreciationExpense" scale="3" unitRef="cny">11,134</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_31_fact" name="ifrs-full:DepreciationExpense" scale="3" unitRef="cny">10,657</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_32_fact" name="ifrs-full:DepreciationExpense" scale="3" unitRef="usd">1,524</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of intangible assets**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_33_fact" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny">10,399</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" id="ix_34_fact" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny">10,851</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_35_fact" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny">10,062</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_36_fact" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="3" unitRef="usd">1,439</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="cny" id="ixv-71155">706,972</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="cny" id="ixv-71156">947,245</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="cny" id="ixv-71157">1,137,448</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-71158">162,653</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    benefit expense (including directors&#8217; remuneration):</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wages
    and salaries</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:WagesAndSalaries" scale="3" unitRef="cny" id="ixv-71159">337,381</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:WagesAndSalaries" scale="3" unitRef="cny" id="ixv-71160">367,008</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:WagesAndSalaries" scale="3" unitRef="cny" id="ixv-71161">404,195</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:WagesAndSalaries" scale="3" unitRef="usd" id="ixv-71162">57,799</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    share-based payment expenses**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_37_fact" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" unitRef="cny">31,503</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" id="ix_38_fact" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" unitRef="cny">20,924</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_39_fact" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" unitRef="cny">20,874</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_40_fact" name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" unitRef="usd">2,985</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pension
    scheme contributions (defined contribution scheme)*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_20_fact" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="3" unitRef="cny">30,705</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" id="ix_21_fact" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="3" unitRef="cny">34,404</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_22_fact" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="3" unitRef="cny">35,234</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_23_fact" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="3" unitRef="usd">5,038</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:LossBeforeTaxArrivedCharingOrCrediting" scale="3" unitRef="cny" id="ixv-71171">399,589</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:LossBeforeTaxArrivedCharingOrCrediting" scale="3" unitRef="cny" id="ixv-71172">422,336</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:LossBeforeTaxArrivedCharingOrCrediting" scale="3" unitRef="cny" id="ixv-71173">460,303</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:LossBeforeTaxArrivedCharingOrCrediting" scale="3" unitRef="usd" id="ixv-71174">65,822</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value (gain)/loss, net:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    financial instruments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" scale="3" unitRef="cny" id="ixv-71175">2,822</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at FVTPL</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:FinancialAssetsAtFVTPL" scale="3" unitRef="cny" id="ixv-71176">699</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:FinancialAssetsAtFVTPL" scale="3" unitRef="cny" id="ixv-71177">832</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:FinancialAssetsAtFVTPL" scale="3" unitRef="cny" id="ixv-71178">1,134</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:FinancialAssetsAtFVTPL" scale="3" unitRef="usd" id="ixv-71179">162</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities at FVTPL</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-231">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:FinancialLiabilitiesAtFVTPL" scale="3" unitRef="cny" id="ixv-71180">29,533</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:FinancialLiabilitiesAtFVTPL" scale="3" unitRef="usd" id="ixv-71181">4,223</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Gain)/Loss
    on disposal of items of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71182">4</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71183">50</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71184">18</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment" scale="3" sign="-" unitRef="usd" id="ixv-71185">3</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    on disposal of items of lease</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForGainOnDisposalOfLeases" scale="3" unitRef="cny" id="ixv-71186">85</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForGainOnDisposalOfLeases" scale="3" unitRef="cny" id="ixv-71187">685</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustmentsForGainOnDisposalOfLeases" scale="3" unitRef="usd" id="ixv-71188">99</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    payments not included in the measurement of lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13(c)</span></td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PenaltyExpense" scale="3" unitRef="cny" id="ixv-71189">181</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PenaltyExpense" scale="3" unitRef="cny" id="ixv-71190">238</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PenaltyExpense" scale="3" unitRef="cny" id="ixv-71191">329</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PenaltyExpense" scale="3" unitRef="usd" id="ixv-71192">47</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
    grants related to income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" unitRef="cny" id="ixv-71193">19,358</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" unitRef="cny" id="ixv-71194">9,073</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" unitRef="cny" id="ixv-71195">14,496</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="3" unitRef="usd" id="ixv-71196">2,073</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    interest income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks" scale="3" unitRef="cny" id="ixv-71197">32,409</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks" scale="3" unitRef="cny" id="ixv-71198">37,840</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks" scale="3" unitRef="cny" id="ixv-71199">82,125</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks" scale="3" unitRef="usd" id="ixv-71200">11,744</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditors&#8217;
    remuneration</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AuditorsRemuneration" scale="3" unitRef="cny" id="ixv-71201">2,550</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AuditorsRemuneration" scale="3" unitRef="cny" id="ixv-71202">7,900</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AuditorsRemuneration" scale="3" unitRef="cny" id="ixv-71203">5,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AuditorsRemuneration" scale="3" unitRef="usd" id="ixv-71204">729</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DonationsAndSubsidiesExpense" scale="3" unitRef="cny" id="ixv-71205">3,988</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DonationsAndSubsidiesExpense" scale="3" unitRef="cny" id="ixv-71206">6,322</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DonationsAndSubsidiesExpense" scale="3" unitRef="cny" id="ixv-71207">23,395</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DonationsAndSubsidiesExpense" scale="3" unitRef="usd" id="ixv-71208">3,345</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Penaltys" scale="3" unitRef="cny" id="ixv-71209">24</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Penaltys" scale="3" unitRef="cny" id="ixv-71210">1,425</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Penaltys" scale="3" unitRef="cny" id="ixv-71211">5,777</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Penaltys" scale="3" unitRef="usd" id="ixv-71212">826</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    exchange (gain)/loss, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="3" sign="-" unitRef="cny" id="ixv-71213">1,621</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="3" sign="-" unitRef="cny" id="ixv-71214">6,694</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="3" unitRef="cny" id="ixv-71215">10,161</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="3" unitRef="usd" id="ixv-71216">1,453</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><ix:footnote id="ix_6_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no forfeited contributions that may be used by the Group as the employer to reduce the existing level of contributions.</span></ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><ix:footnote id="ix_7_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The depreciation of property, plant and equipment, the depreciation of investment property, the depreciation of right-of-use assets, the amortization of intangible assets and the equity-settled share-based payment expenses for the years are included in &#8220;Cost of Sales&#8221;, &#8220;Research and development expenses&#8221;, &#8220;Selling and distribution expenses&#8221; and &#8220;Administrative expenses&#8221; in the consolidated statements of profit or loss.</span></ix:footnote></td></tr> </table></ix:nonNumeric></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 261; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory" id="ixv-45989"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
                                            EXPENSES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfOtherExpensesTableTextBlock" id="ixv-46000"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value loss
    on financial liabilities at FVTPL</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" sign="-" unitRef="cny" id="ixv-71217">29,533</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" sign="-" unitRef="usd" id="ixv-71218">4,223</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DonationsAndSubsidiesExpense" scale="3" unitRef="cny" id="ixv-71219">3,988</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DonationsAndSubsidiesExpense" scale="3" unitRef="cny" id="ixv-71220">6,322</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DonationsAndSubsidiesExpense" scale="3" unitRef="cny" id="ixv-71221">23,395</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DonationsAndSubsidiesExpense" scale="3" unitRef="usd" id="ixv-71222">3,345</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange loss</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ForeignExchangeLoss" scale="3" unitRef="cny" id="ixv-71223">10,161</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ForeignExchangeLoss" scale="3" unitRef="usd" id="ixv-71224">1,453</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-style: normal; text-decoration: none; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-237"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none">2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Penalty" scale="3" unitRef="cny" id="ixv-71225">1,425</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Penalty" scale="3" unitRef="cny" id="ixv-71226">5,777</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:Penalty" scale="3" unitRef="usd" id="ixv-71227">827</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value loss on financial assets at FVTPL</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-71228">699</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-71229">832</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-71230">1,134</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-71231">162</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on disposal of items of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71232">50</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71233">18</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-71234">3</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OthersExpenses" scale="3" unitRef="cny" id="ixv-71235">492</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OthersExpenses" scale="3" unitRef="cny" id="ixv-71236">446</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OthersExpenses" scale="3" unitRef="cny" id="ixv-71237">3,581</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OthersExpenses" scale="3" unitRef="usd" id="ixv-71238">512</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="cny" id="ixv-71239">5,203</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="cny" id="ixv-71240">9,075</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="cny" id="ixv-71241">73,599</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="usd" id="ixv-71242">10,525</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" id="ixv-46413"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8<i>.</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCE
                                            COSTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinanceCostExplanatory" id="ixv-46424"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
analysis of finance costs is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on bank loans and other borrowings</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnBankLoansAndOverdrafts" scale="3" unitRef="cny" id="ixv-71243">91,690</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnBankLoansAndOverdrafts" scale="3" unitRef="cny" id="ixv-71244">61,555</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnBankLoansAndOverdrafts" scale="3" unitRef="cny" id="ixv-71245">51,812</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnBankLoansAndOverdrafts" scale="3" unitRef="usd" id="ixv-71246">7,409</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on lease liabilities (note 13(b))</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestCostsCapitalised" scale="3" unitRef="cny" id="ixv-71247">1,321</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestCostsCapitalised" scale="3" unitRef="cny" id="ixv-71248">1,498</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestCostsCapitalised" scale="3" unitRef="cny" id="ixv-71249">1,118</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestCostsCapitalised" scale="3" unitRef="usd" id="ixv-71250">160</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on long-term payables</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" unitRef="cny" id="ixv-71251">3,046</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" unitRef="cny" id="ixv-71252">1,402</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" unitRef="cny" id="ixv-71253">1,140</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnBorrowings" scale="3" unitRef="usd" id="ixv-71254">163</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="3" unitRef="cny" id="ixv-71255">96,057</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="3" unitRef="cny" id="ixv-71256">64,455</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="3" unitRef="cny" id="ixv-71257">54,070</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="3" unitRef="usd" id="ixv-71258">7,732</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 262; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" id="ixv-46734"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCOME
                                            TAX</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group is subject to income tax on an entity basis on profits arising in or derived from the jurisdictions in which members of the Group
are domiciled and operate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cayman
Islands</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the current laws of the Cayman Islands, the Company and Ascentage Pharma Group International are not subject to tax on income or capital
gain arising in the Cayman Islands. Additionally, upon payments of dividends by these companies to its shareholders, no Cayman Islands
withholding tax will be imposed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong
Kong</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsidiaries incorporated in Hong Kong are subject to income tax at the rate of <ix:nonFraction contextRef="c174" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71259"><ix:nonFraction contextRef="c175" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71260"><ix:nonFraction contextRef="c176" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71261"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71262"><ix:nonFraction contextRef="c175" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71263"><ix:nonFraction contextRef="c176" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71264">16.5</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% on the estimated assessable profits arising in
Hong Kong. For the years ended December 31, 2023, 2024 and 2025, the Company did not make any provisions for Hong Kong profits tax as
there were no assessable profits derived from or earned in Hong Kong for any of the periods presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United
States</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsidiary operating in the United States is subject to tax at a maximum of <ix:nonFraction contextRef="c177" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71265"><ix:nonFraction contextRef="c177" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71266">21.36</ix:nonFraction></ix:nonFraction>% and <ix:nonFraction contextRef="c178" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71267">21.61</ix:nonFraction>%, respectively, for the years ended December
31, 2024 and 2025. No provision for income tax has been made as the Group had no assessable profits earned in the United States during
the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
requirement to capitalize and amortize previously deductible research and experimental expenses resulting from a change in Section 174
made by the Tax Cuts and Jobs Act of 2017 (the &#8220;TCJA&#8221;) became effective on January 1, 2022. Under the TCJA, the Company is
required to capitalize and subsequently amortize R&amp;D expenses over five years for research activities conducted within the U.S. and
fifteen years for research activities conducted outside of the U.S.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2025, the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;) was enacted, which reinstated current deductibility of domestic research
and experimental expenditures and provided an election to accelerate the recovery of previously capitalized costs. The Company did not
elect to accelerate the deduction of previously capitalized domestic research and experimental expenditures and will continue to amortize
such costs over the remaining statutory periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chinese
mainland</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s subsidiaries domiciled in the PRC are subject to the statutory rate of <ix:nonFraction contextRef="c112" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71268">25</ix:nonFraction>%, in accordance with the Enterprise Income
Tax law (the &#8220;EIT Law&#8221;), which was effective since January 1, 2008, except for the following entities which are eligible
for a preferential tax rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthquest
Pharma was qualified as a High and New Technology Enterprise (&#8220;HNTE&#8221;) and was subject to a preferential rate of <ix:nonFraction contextRef="c179" decimals="2" format="ixt:num-dot-decimal" name="aapg:PreferentialRate" scale="-2" unitRef="pure" id="ixv-71269">15</ix:nonFraction>% for three
years from 2022 to 2024. In 2025, Healthquest Pharma was no longer qualified as a HNTE and thus subject to the statutory tax rate of
<ix:nonFraction contextRef="c179" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-71270">25</ix:nonFraction>%.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">Suzhou
Yasheng was recognized as a qualified HNTE under the EIT Law by the relevant government authorities and is subject to a preferential
rate of <ix:nonFraction contextRef="c180" decimals="2" format="ixt:num-dot-decimal" name="aapg:PreferentialRate" scale="-2" unitRef="pure" id="ixv-71271">15</ix:nonFraction>% for three years from 2023 to 2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends,
interest, rent or royalties payable by the Company&#8217;s PRC subsidiaries, to non-PRC resident enterprises, and proceeds from any such
non-resident enterprise investor&#8217;s disposition of assets (after deducting the net value of such assets) shall be subject to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="aapg:WithholdingTax" scale="-2" unitRef="pure" id="ixv-71272">10</ix:nonFraction>%
withholding tax, unless the respective non-PRC resident enterprise&#8217;s jurisdiction of incorporation has a tax treaty or arrangements
with China that provides for a reduced withholding tax rate or an exemption from withholding tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" id="ixv-46807"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current and deferred components of the income tax (credit)/expense are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="3" unitRef="cny" id="ixv-71273">29</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="3" unitRef="usd" id="ixv-71274">4</ix:nonFraction></span></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    (note 18)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncome" scale="3" sign="-" unitRef="cny" id="ixv-71275">7,150</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncome" scale="3" unitRef="cny" id="ixv-71276">10,425</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncome" scale="3" unitRef="cny" id="ixv-71277">6,911</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncome" scale="3" unitRef="usd" id="ixv-71278">988</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            income tax (credit)/expense for the year</span></p></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" sign="-" unitRef="cny" id="ixv-71279">7,150</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" unitRef="cny" id="ixv-71280">10,425</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" unitRef="cny" id="ixv-71281">6,940</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" unitRef="usd" id="ixv-71282">992</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 263; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCOME
                                            TAX (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfIncomeTaxExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" id="ixv-47069"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation
between the income tax expense/(credit) computed by applying the statutory tax rate to loss before income tax and the actual provision
for income tax is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss
    before tax</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-71283">932,862</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-71284">395,255</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-71285">1,236,047</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="usd" id="ixv-71286">176,753</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    tax computed at the statutory tax rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncomeTaxComputedAtTheStatutoryTaxRate" scale="3" unitRef="cny" id="ixv-71287">244,549</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncomeTaxComputedAtTheStatutoryTaxRate" scale="3" unitRef="cny" id="ixv-71288">70,114</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncomeTaxComputedAtTheStatutoryTaxRate" scale="3" unitRef="cny" id="ixv-71289">287,881</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncomeTaxComputedAtTheStatutoryTaxRate" scale="3" unitRef="usd" id="ixv-71290">41,166</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lower
    tax rate for a specific entity</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:LowerTaxRateForASpecificEntity" scale="3" unitRef="cny" id="ixv-71291">59,396</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:LowerTaxRateForASpecificEntity" scale="3" unitRef="cny" id="ixv-71292">7,112</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:LowerTaxRateForASpecificEntity" scale="3" unitRef="cny" id="ixv-71293">59,759</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:LowerTaxRateForASpecificEntity" scale="3" unitRef="usd" id="ixv-71294">8,545</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statutory
    income and expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StatutoryIncomeAndExpense" scale="3" sign="-" unitRef="cny" id="ixv-71295">2,824</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StatutoryIncomeAndExpense" scale="3" unitRef="cny" id="ixv-71296">17,534</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StatutoryIncomeAndExpense" scale="3" unitRef="cny" id="ixv-71297">12,900</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StatutoryIncomeAndExpense" scale="3" unitRef="usd" id="ixv-71298">1,845</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Items
    not subject to tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncomeNotSubjectToTax" scale="3" unitRef="cny" id="ixv-71299">4,093</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncomeNotSubjectToTax" scale="3" unitRef="cny" id="ixv-71300">7,236</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncomeNotSubjectToTax" scale="3" unitRef="cny" id="ixv-71301">7,533</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncomeNotSubjectToTax" scale="3" unitRef="usd" id="ixv-71302">1,076</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Items
    not deductible for tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" unitRef="cny" id="ixv-71303">9,192</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" unitRef="cny" id="ixv-71304">24,045</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" unitRef="cny" id="ixv-71305">49,582</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" unitRef="usd" id="ixv-71306">7,091</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Research
    and development super-deduction</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ResearchAndDevelopmentSuperdeduction" scale="3" unitRef="cny" id="ixv-71307">67,525</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ResearchAndDevelopmentSuperdeduction" scale="3" unitRef="cny" id="ixv-71308">75,135</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ResearchAndDevelopmentSuperdeduction" scale="3" unitRef="cny" id="ixv-71309">48,919</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ResearchAndDevelopmentSuperdeduction" scale="3" unitRef="usd" id="ixv-71310">6,995</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(Gain)/loss
    attributable to joint ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:GainlossAttributableToJointVentures" scale="3" unitRef="cny" id="ixv-71311">269</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:GainlossAttributableToJointVentures" scale="3" sign="-" unitRef="cny" id="ixv-71312">71</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:GainlossAttributableToJointVentures" scale="3" unitRef="cny" id="ixv-71313">78</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:GainlossAttributableToJointVentures" scale="3" unitRef="usd" id="ixv-71314">11</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Provision
    to return</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NewProvisionsReturn" scale="3" sign="-" unitRef="cny" id="ixv-71315">23,311</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NewProvisionsReturn" scale="3" unitRef="cny" id="ixv-71316">35,342</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NewProvisionsReturn" scale="3" sign="-" unitRef="cny" id="ixv-71317">68,391</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NewProvisionsReturn" scale="3" sign="-" unitRef="usd" id="ixv-71318">9,779</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect
    of tax rate changes on deferred taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectFromChangeInTaxRate" scale="3" sign="-" unitRef="cny" id="ixv-71319">56,104</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectFromChangeInTaxRate" scale="3" sign="-" unitRef="cny" id="ixv-71320">10,822</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectFromChangeInTaxRate" scale="3" sign="-" unitRef="cny" id="ixv-71321">71,206</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectFromChangeInTaxRate" scale="3" sign="-" unitRef="usd" id="ixv-71322">10,183</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Uncertain
    tax position</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:UncertainTaxPosition" scale="3" unitRef="cny" id="ixv-71323">23,665</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:UncertainTaxPosition" scale="3" unitRef="cny" id="ixv-71324">14,236</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:UncertainTaxPosition" scale="3" unitRef="usd" id="ixv-71325">2,036</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Effect
    of withholding tax on the interest income of the Group&#8217;s HK subsidiary</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-243; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:EffectOfWithholdingTaxOnTheInterestIncome" scale="3" unitRef="cny" id="ixv-71326">29</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:EffectOfWithholdingTaxOnTheInterestIncome" scale="3" unitRef="usd" id="ixv-71327">4</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Tax
    loss expired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-244; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NetOperatingLossExpired" scale="3" unitRef="cny" id="ixv-71328">31,670</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NetOperatingLossExpired" scale="3" unitRef="cny" id="ixv-71329">29,628</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NetOperatingLossExpired" scale="3" unitRef="usd" id="ixv-71330">4,237</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Deductible
    temporary differences not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeductibleTemporaryDifferencesNotRecognized" scale="3" unitRef="cny" id="ixv-71331">33,235</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeductibleTemporaryDifferencesNotRecognized" scale="3" unitRef="cny" id="ixv-71332">71,465</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeductibleTemporaryDifferencesNotRecognized" scale="3" unitRef="cny" id="ixv-71333">49,919</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeductibleTemporaryDifferencesNotRecognized" scale="3" unitRef="usd" id="ixv-71334">7,138</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Tax
    losses not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="cny" id="ixv-71335">237,432</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="cny" id="ixv-71336">68,580</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="cny" id="ixv-71337">163,913</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="usd" id="ixv-71338">23,438</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax (credit)/expense at the Group&#8217;s effective rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" sign="-" unitRef="cny" id="ixv-71339">7,150</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" unitRef="cny" id="ixv-71340">10,425</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" unitRef="cny" id="ixv-71341">6,940</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" unitRef="usd" id="ixv-71342">992</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</span></td><td style="text-align: justify"><p style="margin: 0pt 0">The disclosure <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">presentation of previous
periods has been adjusted to be in line with the 2025 disclosure presentation of &#8220;Tax loss expired&#8221; to ensure consistency.</span></p></td>
</tr></table></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.25pt"></p><div>

</div><!-- Field: Page; Sequence: 264; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><!-- Field: Split-Segment; Name: 10 --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDividendsExplanatory" id="ixv-47749"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDENDS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
board of directors resolved not to declare any final dividend for the years ended December 31, 2023, 2024 and 2025.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" id="ixv-47765"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
                                            PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The calculation of the basic loss per share amount is based on the loss for the year attributable to ordinary equity holders of the parent, and the weighted average number of ordinary shares of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares" id="ixv-71343">356,130,452</ix:nonFraction> (2024: <ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares" id="ixv-71344">302,062,104</ix:nonFraction>, 2023: <ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares" id="ixv-71345">282,299,269</ix:nonFraction>) outstanding during the year, as adjusted to reflect the rights issued during the year.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
adjustment has been made to the basic loss per share amounts presented for the years ended December 31, 2023, 2024 and 2025 in respect
of a dilution as the impact of the options and RSUs outstanding had an anti-dilutive effect on the basic loss per share amounts presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:EarningsPerShareExplanatory" id="ixv-47783"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of basic loss per share is based on:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Loss</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    attributable to ordinary equity holders of the parent, used in the basic loss per share calculation</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="3" sign="-" unitRef="cny" id="ixv-71346">925,637</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="3" sign="-" unitRef="cny" id="ixv-71347">405,433</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="3" sign="-" unitRef="cny" id="ixv-71348">1,242,769</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="3" sign="-" unitRef="usd" id="ixv-71349">177,714</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Shares</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average number of ordinary shares outstanding during the year used in the basic loss per share calculation#</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" id="ix_41_fact" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">282,299,269</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" id="ix_42_fact" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">302,062,104</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" id="ix_43_fact" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">356,130,452</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td><td style="text-align: justify"><ix:footnote id="ix_8_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average number of shares was after taking into account the effect of treasury shares held.</span></ix:footnote></td>
</tr></table></ix:nonNumeric></ix:nonNumeric><div>
</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 265; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfPropertyPlantAndEquipmentExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" id="ixv-48043"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPERTY,
                                            PLANT AND EQUIPMENT</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" id="ixv-48053"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Buildings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Leasehold<br/> improvements</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Furniture&#160;and<br/> equipment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Motor<br/> vehicles</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Construction<br/> in progress</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">December 31, 2024</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>At January 1, 2024:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in">Cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c181" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71353">834,913</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c182" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71354">29,218</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c183" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71355">179,256</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c184" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71356">609</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c185" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71357">12,650</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71358">1,056,646</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c181" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71359">65,137</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c182" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71360">11,517</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c183" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71361">73,771</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c184" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71362">406</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71363">150,831</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c181" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71364">769,776</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c182" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71365">17,701</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c183" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71366">105,485</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c184" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71367">203</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c185" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71368">12,650</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71369">905,815</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">At January 1, 2024, net of accumulated depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c187" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71370">769,776</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c188" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71371">17,701</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c189" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71372">105,485</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c190" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71373">203</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c191" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71374">12,650</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c192" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71375">905,815</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c195" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71376">2,059</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c197" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71377">12,807</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c198" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71378">14,866</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c195" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71379">50</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c198" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71380">50</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Depreciation provided during the year (note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c193" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71381">39,599</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c194" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71382">6,896</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c195" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71383">24,569</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c196" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71384">120</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c198" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71385">71,184</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Transfers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c193" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71386">1,105</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c194" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71387">15,010</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c195" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71388">2,049</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-254">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c197" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71389">18,164</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-255">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exchange realignment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c195" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71390">3</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c198" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71391">3</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">At December 31, 2024, net of accumulated depreciation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c199" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71392">731,282</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c200" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71393">25,815</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c201" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71394">84,977</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c202" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71395">83</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c203" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71396">7,293</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c204" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71397">849,450</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">At December 31, 2024:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c205" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71398">836,018</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c206" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71399">44,239</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c207" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71400">182,734</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c208" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71401">609</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c209" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71402">7,293</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71403">1,070,893</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c205" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71404">104,736</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c206" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71405">18,424</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c207" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71406">97,757</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c208" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71407">526</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71408">221,443</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c205" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71409">731,282</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c206" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71410">25,815</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c207" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71411">84,977</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c208" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71412">83</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c209" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71413">7,293</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71414">849,450</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 266; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPERTY,
                                            PLANT AND EQUIPMENT (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><ix:continuation id="_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory-c0_cont_1"><ix:continuation id="_DisclosureOfPropertyPlantAndEquipmentExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Buildings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Leasehold improvements</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Furniture and equipment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Motor vehicles</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Construction in progress</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">December 31, 2025</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>At January 1, 2025:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in">Cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c210" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71415">836,018</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c211" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71416">44,239</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c212" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71417">182,734</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c213" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71418">609</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c214" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71419">7,293</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71420">1,070,893</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c210" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71421">104,736</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c211" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71422">18,424</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c212" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71423">97,757</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c213" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71424">526</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71425">221,443</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c210" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71426">731,282</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c211" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71427">25,815</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c212" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71428">84,977</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c213" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71429">83</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c214" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71430">7,293</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71431">849,450</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">At January 1, 2025, net of accumulated depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c199" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71432">731,282</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c200" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71433">25,815</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c201" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71434">84,977</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c202" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71435">83</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c203" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71436">7,293</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c204" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71437">849,450</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c217" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71438">3,270</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c218" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71439">2,635</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c219" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71440">427</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c220" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71441">11,229</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c221" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71442">17,561</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c218" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71443">18</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c221" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71444">18</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Depreciation provided during the year (note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c216" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71445">37,117</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c217" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71446">10,374</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c218" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71447">18,157</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c219" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71448">113</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c221" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71449">65,761</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Transfers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c216" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71450">2,802</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c217" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71451">13,242</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c218" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71452">368</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c220" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71453">16,412</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Deficit on adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c216" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" sign="-" unitRef="cny" id="ixv-71454">19,982</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c221" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" sign="-" unitRef="cny" id="ixv-71455">19,982</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exchange realignment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c218" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71456">15</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c221" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" sign="-" unitRef="cny" id="ixv-71457">15</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">At December 31, 2025, net of accumulated depreciation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c222" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71458">676,985</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c223" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71459">31,953</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c224" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71460">69,790</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c225" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71461">397</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c226" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71462">2,110</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c227" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation" scale="3" unitRef="cny" id="ixv-71463">781,235</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">At December 31, 2025:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c228" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71464">818,838</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c229" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71465">60,734</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c230" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71466">185,546</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c231" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71467">1,036</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c232" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71468">2,110</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PropertyAndEquipmentCost" scale="3" unitRef="cny" id="ixv-71469">1,068,264</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c228" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71470">141,853</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c229" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71471">28,781</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c230" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71472">115,756</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c231" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71473">639</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedDepreciationsCost" scale="3" sign="-" unitRef="cny" id="ixv-71474">287,029</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c228" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71475">676,985</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c229" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71476">31,953</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c230" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71477">69,790</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c231" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71478">397</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c232" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71479">2,110</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-71480">781,235</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount in US$</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c228" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-71481">96,808</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c229" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-71482">4,569</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c230" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-71483">9,980</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c231" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-71484">56</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c232" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-71485">302</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-71486">111,715</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 267; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfLeasesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfLeasesExplanatory" id="ixv-49123"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEASES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">The
Group as a lessee</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has lease contracts for land and buildings. Lump sum payments were made upfront to acquire the leased land from the owners with
lease periods of <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="aapg:TermsOfLandLease" id="ixv-71487">30</ix:nonNumeric> years, and no ongoing payments will be made under the terms of these land leases. Leases of buildings generally have
lease terms between <ix:nonNumeric contextRef="c233" format="ixt-sec:duryear" name="aapg:LeaseTerms" id="ixv-71488">2</ix:nonNumeric> and <ix:nonNumeric contextRef="c234" format="ixt-sec:duryear" name="aapg:LeaseTerms" id="ixv-71489">7</ix:nonNumeric> years. Other leases generally have lease terms of 12 months or less and/or are individually of low value.
Generally, the Group is restricted from assigning and subleasing the leased assets outside the Group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
                                            assets</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" id="ixv-49151"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Group&#8217;s right-of-use assets and the movements during the year are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    land</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at January 1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c235" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-71490">23,654</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c236" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-71491">27,598</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-71492">51,252</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="usd" id="ixv-71493">7,329</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c237" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" unitRef="cny" id="ixv-71494">17,108</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-279; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" unitRef="cny" id="ixv-71495">17,108</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" unitRef="usd" id="ixv-71496">2,446</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation charge (note
    6)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c237" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" unitRef="cny" id="ixv-71497">10,004</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c238" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" unitRef="cny" id="ixv-71498">1,130</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" unitRef="cny" id="ixv-71499">11,134</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" unitRef="usd" id="ixv-71500">1,592</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c237" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsRightofuseAssets" scale="3" unitRef="cny" id="ixv-71501">1,067</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-280; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsRightofuseAssets" scale="3" unitRef="cny" id="ixv-71502">1,067</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsRightofuseAssets" scale="3" unitRef="usd" id="ixv-71503">153</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange realignment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c237" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeRealignmentRightofuseAssets" scale="3" sign="-" unitRef="cny" id="ixv-71504">50</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-281; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeRealignmentRightofuseAssets" scale="3" sign="-" unitRef="cny" id="ixv-71505">50</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeRealignmentRightofuseAssets" scale="3" sign="-" unitRef="usd" id="ixv-71506">7</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2024 and January 1, 2025</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c205" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-71507">29,641</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c239" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-71508">26,468</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-71509">56,109</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="usd" id="ixv-71510">8,023</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c90" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" unitRef="cny" id="ixv-71511">5,047</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-282; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" unitRef="cny" id="ixv-71512">5,047</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" unitRef="usd" id="ixv-71513">722</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation charge (note
    6)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c90" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" unitRef="cny" id="ixv-71514">9,527</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c240" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" unitRef="cny" id="ixv-71515">1,130</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" unitRef="cny" id="ixv-71516">10,657</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" unitRef="usd" id="ixv-71517">1,524</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c90" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsRightofuseAssets" scale="3" unitRef="cny" id="ixv-71518">2,675</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsRightofuseAssets" scale="3" unitRef="cny" id="ixv-71519">2,675</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsRightofuseAssets" scale="3" unitRef="usd" id="ixv-71520">382</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange realignment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c90" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeRealignmentRightofuseAssets" scale="3" unitRef="cny" id="ixv-71521">3</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeRealignmentRightofuseAssets" scale="3" unitRef="cny" id="ixv-71522">3</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c228" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-71523">22,489</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c241" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-71524">25,338</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="cny" id="ixv-71525">47,827</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="usd" id="ixv-71526">6,839</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"></p><div>

</div><!-- Field: Page; Sequence: 268; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEASES
                                            (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">The
Group as a lessee </span>(continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfLeasesExplanatory-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
                                            liabilities</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 35.4pt 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" id="ixv-49725"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of lease liabilities (included under interest-bearing bank and other borrowings) and the movements during the year are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying amount
    at January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-71527">22,681</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-71528">30,232</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="usd" id="ixv-71529">4,323</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New leases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-71530">17,108</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-71531">5,047</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" scale="3" unitRef="usd" id="ixv-71532">722</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion of interest recognized
    during the year (note 8)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71533">1,498</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71534">1,118</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" unitRef="usd" id="ixv-71535">160</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PaymentsofLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71536">9,911</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PaymentsofLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71537">10,835</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PaymentsofLeaseLiabilities" scale="3" unitRef="usd" id="ixv-71538">1,549</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange realignment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeRealignments" scale="3" unitRef="cny" id="ixv-71539">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeRealignments" scale="3" sign="-" unitRef="cny" id="ixv-71540">6</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeRealignments" scale="3" sign="-" unitRef="usd" id="ixv-71541">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DisposalsLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71542">1,152</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DisposalsLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71543">3,360</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DisposalsLeaseLiabilities" scale="3" unitRef="usd" id="ixv-71544">481</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying
    amount at December 31</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-71545">30,232</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-71546">22,196</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="usd" id="ixv-71547">3,174</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analyzed into:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71548">9,439</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71549">7,283</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" unitRef="usd" id="ixv-71550">1,041</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current
    portion</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71551">20,793</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71552">14,913</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="usd" id="ixv-71553">2,133</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maturity analysis of lease liabilities is disclosed in note 39 to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfProfitLossFromOperatingActivitiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory" id="ixv-50139"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts recognized in profit or loss in relation to leases are as follows:</span></ix:nonNumeric></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DisclosureOfProfitLossFromOperatingActivitiesExplanatory-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest on lease
    liabilities (note 8)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71554">1,498</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" unitRef="cny" id="ixv-71555">1,118</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" unitRef="usd" id="ixv-71556">160</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation charge of right-of-use
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DepreciationChargeofRightofuseAssets" scale="3" unitRef="cny" id="ixv-71557">11,134</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DepreciationChargeofRightofuseAssets" scale="3" unitRef="cny" id="ixv-71558">10,657</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DepreciationChargeofRightofuseAssets" scale="3" unitRef="usd" id="ixv-71559">1,524</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense
    relating to short-term leases (included in administrative expenses) (note 6)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" scale="3" unitRef="cny" id="ixv-71560">238</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" scale="3" unitRef="cny" id="ixv-71561">329</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" scale="3" unitRef="usd" id="ixv-71562">47</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total amount recognized in
    profit or loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TotalAmountofRecognizedInProfitOrLoss" scale="3" unitRef="cny" id="ixv-71563">12,870</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TotalAmountofRecognizedInProfitOrLoss" scale="3" unitRef="cny" id="ixv-71564">12,104</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TotalAmountofRecognizedInProfitOrLoss" scale="3" unitRef="usd" id="ixv-71565">1,731</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            total cash outflow for leases and future cash outflows relating to leases that have not yet
                                            commenced are disclosed in notes 32(c) and 33(b), respectively, to the consolidated financial
                                            statements.</span></td>
</tr></table></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 269; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfGoodwillExplanatory" id="ixv-50398"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GOODWILL</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory" id="ixv-50409"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -11pt; padding-left: 11pt">Cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CostGoodwill" scale="3" unitRef="cny" id="ixv-71566">24,694</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CostGoodwill" scale="3" unitRef="cny" id="ixv-71567">24,694</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CostGoodwill" scale="3" unitRef="usd" id="ixv-71568">3,531</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated impairment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="3" unitRef="cny" id="ixv-71569">24,694</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="3" unitRef="cny" id="ixv-71570">24,694</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="3" unitRef="usd" id="ixv-71571">3,531</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of goodwill as at December 31, 2024 and 2025 was allocated to the cash-generating unit (&#8220;CGU&#8221;) of Healthquest
Pharma.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Impairment
testing of goodwill</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverable amount of the cash-generating unit has been determined based on a value in use calculation using cash flow projections
approved by senior management. The cash flows of the unit are projected based on the forecasted sales of the new drug after the
approval of the new drug application (&#8220;NDA&#8221;) and within the patent protection period. No revenue nor cash flow has been
forecasted after the expiration of the patent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
were used in the value in use calculation of the cash-generating unit for the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following describes each key assumption on which management has based its cash flow projections to undertake impairment testing of goodwill:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
rate - The discount rate applied to the cash flow projections was <ix:nonFraction contextRef="c15" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" unitRef="pure" id="ixv-71572">19.40</ix:nonFraction>% as at December 31, 2025 (2024: <ix:nonFraction contextRef="c14" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" unitRef="pure" id="ixv-71573">24.20</ix:nonFraction>%). The discount rate used
is before tax and reflects specific risks relating to the relevant unit.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
revenue &#8211; The revenue is based on the business strategy and management&#8217;s expectation for the market development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
values assigned to the key assumptions are consistent with external information sources. The management believes that any reasonably
possible change in any of the key assumptions on which the recoverable amount is based would not cause the cash-generating unit&#8217;s
recoverable amount to drop lower than its carrying amount.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 270; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory" id="ixv-50577"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
                                            INTANGIBLE ASSET</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" id="ixv-50587"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    at January 1, 2024, net of accumulated amortization</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c242" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71574">10,232</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c243" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71575">48,089</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c244" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71576">27,125</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c245" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71577">85,446</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c246" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71578">1,403</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c249" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71579">1,403</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    provided during the year (note 6)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c246" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="3" unitRef="cny" id="ixv-71580">2,100</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c247" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="3" unitRef="cny" id="ixv-71581">7,251</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c248" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="3" unitRef="cny" id="ixv-71582">1,500</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c249" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="3" unitRef="cny" id="ixv-71583">10,851</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c250" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71584">9,535</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c251" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71585">40,838</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c252" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71586">25,625</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c253" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71587">75,998</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c254" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IntangibleAssetsGross" scale="3" unitRef="cny" id="ixv-71588">18,728</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c255" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IntangibleAssetsGross" scale="3" unitRef="cny" id="ixv-71589">93,050</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c256" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IntangibleAssetsGross" scale="3" unitRef="cny" id="ixv-71590">30,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c257" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IntangibleAssetsGross" scale="3" unitRef="cny" id="ixv-71591">141,778</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c254" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedAmortization" scale="3" sign="-" unitRef="cny" id="ixv-71592">9,193</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c255" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedAmortization" scale="3" sign="-" unitRef="cny" id="ixv-71593">52,212</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c256" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedAmortization" scale="3" sign="-" unitRef="cny" id="ixv-71594">4,375</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c257" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedAmortization" scale="3" sign="-" unitRef="cny" id="ixv-71595">65,780</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    carrying amount</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c254" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71596">9,535</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c255" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71597">40,838</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c256" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71598">25,625</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c257" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71599">75,998</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    at January 1, 2025, net of accumulated amortization</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c250" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71600">9,535</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c251" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71601">40,838</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c252" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71602">25,625</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c253" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71603">75,998</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    provided during the year (note 6)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c258" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="3" unitRef="cny" id="ixv-71604">1,262</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c259" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="3" unitRef="cny" id="ixv-71605">7,300</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c260" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="3" unitRef="cny" id="ixv-71606">1,500</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c261" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="3" unitRef="cny" id="ixv-71607">10,062</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c262" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71608">8,273</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c263" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71609">33,538</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c264" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71610">24,125</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c265" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71611">65,936</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c262" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IntangibleAssetsGross" scale="3" unitRef="cny" id="ixv-71612">18,728</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c263" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IntangibleAssetsGross" scale="3" unitRef="cny" id="ixv-71613">93,050</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c264" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IntangibleAssetsGross" scale="3" unitRef="cny" id="ixv-71614">30,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c265" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IntangibleAssetsGross" scale="3" unitRef="cny" id="ixv-71615">141,778</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c262" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedAmortization" scale="3" sign="-" unitRef="cny" id="ixv-71616">10,455</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c263" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedAmortization" scale="3" sign="-" unitRef="cny" id="ixv-71617">59,512</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c264" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedAmortization" scale="3" sign="-" unitRef="cny" id="ixv-71618">5,875</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c265" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AccumulatedAmortization" scale="3" sign="-" unitRef="cny" id="ixv-71619">75,842</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    carrying amount</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c262" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71620">8,273</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c263" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71621">33,538</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c264" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71622">24,125</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c265" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="cny" id="ixv-71623">65,936</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    carrying amount in US$</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c262" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="usd" id="ixv-71624">1,183</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c263" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="usd" id="ixv-71625">4,796</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c264" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="usd" id="ixv-71626">3,450</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c265" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" unitRef="usd" id="ixv-71627">9,429</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 271; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfJointVenturesExplanatory" id="ixv-51410"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INVESTMENT
                                            IN A JOINT VENTURE</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfInvestmentInAJointVentureTableTextBlock" id="ixv-51420"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 64%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share of
    net assets</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" unitRef="cny" id="ixv-71628">32,717</ix:nonFraction></span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" unitRef="cny" id="ixv-71629">33,030</ix:nonFraction></span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="3" unitRef="usd" id="ixv-71630">4,723</ix:nonFraction></span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock-c0_cont_1" escape="true" name="aapg:ScheduleOfGroupsPrincipalJointVentureTableTextBlock" id="ixv-51509"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars
of the Group&#8217;s principal joint venture are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-indent: -22.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of registration and business</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registered share capital</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of ownership interest</b></span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal activities</b></span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suzhou Ascentage Harvest Venture Capital LLP* (&#8220;Ascentage Harvest&#8221;)</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 9%; text-align: center"><ix:nonNumeric contextRef="c0" id="ix_44_fact" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></ix:nonNumeric></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_45_fact" name="aapg:RegisteredShareCapital" scale="3" unitRef="usd">360,000</ix:nonFraction></span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" id="ix_46_fact" name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" scale="-2" unitRef="pure">33.42</ix:nonFraction></span></td> <td style="white-space: nowrap; vertical-align: top; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%**</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 20%"><ix:nonNumeric contextRef="c0" id="ix_47_fact" name="aapg:PrincipalActivities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in Biotechnology companies</span></ix:nonNumeric></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-indent: -22.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above investment is indirectly held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.25pt; text-indent: -0.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><ix:footnote id="ix_9_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English name of the company registered in the PRC represents the best efforts made by the management of the Company in directly translating the Chinese name of this Company as no English name has been registered.</span></ix:footnote></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left"><ix:footnote id="ix_10_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group holds two of three representatives in the committee that directs the relevant activities of Ascentage Harvest. As a result, the Group has significant influence over the financial and operating policy decisions of Ascentage Harvest.</span></ix:footnote></td>
</tr></table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" id="ixv-51650"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table illustrates the summarized financial information of the Group&#8217;s joint venture:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            of the joint venture&#8217;s (loss)/gain for the year</span></p></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="3" sign="-" unitRef="cny" id="ixv-71633">281</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="3" unitRef="cny" id="ixv-71634">314</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="3" unitRef="usd" id="ixv-71635">45</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                 of the joint venture&#8217;s total comprehensive (loss)/gain for the year</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="3" sign="-" unitRef="cny" id="ixv-71636">281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="3" unitRef="cny" id="ixv-71637">314</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="3" unitRef="usd" id="ixv-71638">45</ix:nonFraction></span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate carrying amount
    of the Group&#8217;s investment in the joint venture</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" scale="3" unitRef="cny" id="ixv-71639">32,717</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" scale="3" unitRef="cny" id="ixv-71640">33,030</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" scale="3" unitRef="usd" id="ixv-71641">4,723</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 272; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" id="ixv-51828"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
                                            ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" id="ixv-51838"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listed
    equity investments, at fair value</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ListedEquityInvestmentsAtFairValue" scale="3" unitRef="cny" id="ixv-71642">1,141</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    unlisted investments, at fair value</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OtherUnlistedInvestmentsAtFairValue" scale="3" unitRef="cny" id="ixv-71643">4,000</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OtherUnlistedInvestmentsAtFairValue" scale="3" unitRef="usd" id="ixv-71644">572</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-71645">1,141</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-71646">4,000</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-71647">572</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above listed equity investments were classified as financial assets at fair value through profit or loss as they were held for trading.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above unlisted investments were classified as financial assets at fair value through profit or loss as they represent investments in
non-trading equity instruments and have not been designated as financial assets at fair value through other comprehensive income.</span></p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfDeferredTaxesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfDeferredTaxesExplanatory" id="ixv-51991"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFERRED
                                            TAX</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory-c0_cont_1" escape="true" name="aapg:ScheduleOfDeferredTaxLiabilitiesExplanatory" id="ixv-52001"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
movements in deferred tax liabilities and assets during the reporting period are as follows:</span></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Deferred
tax liabilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value adjustments arising from acquisition of a subsidiary</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
    assets</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c270" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71648">10,549</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c271" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71649">5,413</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71650">15,962</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 9)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c272" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" sign="-" unitRef="cny" id="ixv-71651">5,181</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c273" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" unitRef="cny" id="ixv-71652">1,300</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" sign="-" unitRef="cny" id="ixv-71653">3,881</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities at December 31, 2024 and January 1, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c274" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71654">5,368</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c275" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71655">6,713</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71656">12,081</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax charged/(credited) to the statement of profit or loss during the year (note 9)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c276" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" unitRef="cny" id="ixv-71657">1,975</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c277" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" sign="-" unitRef="cny" id="ixv-71658">1,241</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" unitRef="cny" id="ixv-71659">734</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities at December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c278" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71660">7,343</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c279" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71661">5,472</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71662">12,815</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities at December 31, 2025 in US$</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c278" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="usd" id="ixv-71663">1,051</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c279" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="usd" id="ixv-71664">782</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="3" unitRef="usd" id="ixv-71665">1,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 273; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFERRED
                                            TAX (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfDeferredTaxesExplanatory-c0_cont_2" id="_DisclosureOfDeferredTaxesExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfDeferredTaxAssetsExplanatory" id="ixv-52265"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Deferred
tax assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
    liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donation
    expenses</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Losses
    Available<br/>
    for Offsetting<br/>
    Against<br/>
    Future<br/>
    Taxable<br/>
    profits</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c280" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71666">43,440</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c281" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71667">5,413</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c283" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71668">16,402</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c284" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71669">65,255</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c285" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" unitRef="cny" id="ixv-71670">5,623</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c286" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" sign="-" unitRef="cny" id="ixv-71671">1,300</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c287" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" sign="-" unitRef="cny" id="ixv-71672">2,896</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c288" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" unitRef="cny" id="ixv-71673">12,879</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" unitRef="cny" id="ixv-71674">14,306</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets at December 31, 2024 and January 1, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c289" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71675">37,817</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c290" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71676">6,713</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c291" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71677">2,896</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c292" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71678">3,523</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c293" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71679">50,949</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c294" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" unitRef="cny" id="ixv-71680">12,582</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c295" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" unitRef="cny" id="ixv-71681">1,241</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c296" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" unitRef="cny" id="ixv-71682">1,204</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c297" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" sign="-" unitRef="cny" id="ixv-71683">8,850</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" scale="3" unitRef="cny" id="ixv-71684">6,177</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets at December 31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c298" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71685">25,235</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c299" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71686">5,472</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c300" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71687">1,692</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c301" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71688">12,373</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71689">44,772</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets at December 31, 2025 in US$</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c298" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="usd" id="ixv-71690">3,609</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c299" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="usd" id="ixv-71691">782</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c300" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="usd" id="ixv-71692">242</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c301" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="usd" id="ixv-71693">1,769</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="3" unitRef="usd" id="ixv-71694">6,402</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
presentation purposes, certain deferred tax assets and liabilities have been offset in the statements of financial position. <ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory-c0_cont_1" escape="true" name="aapg:DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" id="ixv-71695">The following
is an analysis of the deferred tax balances of the Group for financial reporting purposes:</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax offset in the consolidated statements of financial position</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" scale="3" unitRef="cny" id="ixv-71696">6,713</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" scale="3" unitRef="cny" id="ixv-71697">12,815</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" scale="3" unitRef="usd" id="ixv-71698">1,833</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    deferred tax assets recognized in the consolidated statements of financial position</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71699">44,236</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="cny" id="ixv-71700">31,957</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="usd" id="ixv-71701">4,570</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    deferred tax liability recognized in the consolidated statements of financial position</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilities" scale="3" unitRef="cny" id="ixv-71702">5,368</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2024 and 2025, the Group has tax losses arising in Chinese mainland of RMB<ix:nonFraction contextRef="c266" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="cny" id="ixv-71703">2,963,587</ix:nonFraction> and RMB<ix:nonFraction contextRef="c267" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="cny" id="ixv-71704">3,047,076</ix:nonFraction> (US$<ix:nonFraction contextRef="c267" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="usd" id="ixv-71705">435,726</ix:nonFraction>), respectively,
that will expire from 2026 to 2035 for offsetting against future taxable profits. The Group has tax losses arising in other jurisdictions
of RMB<ix:nonFraction contextRef="c268" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="cny" id="ixv-71706">1,438,160</ix:nonFraction> and RMB<ix:nonFraction contextRef="c269" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="cny" id="ixv-71707">2,250,477</ix:nonFraction> (US$<ix:nonFraction contextRef="c269" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" unitRef="usd" id="ixv-71708">321,814</ix:nonFraction>), mainly from the United States that are available indefinitely for offsetting against up
to&#160;<ix:nonFraction contextRef="c15" decimals="2" format="ixt:num-dot-decimal" name="aapg:FutureTaxableProfitsPercentage" scale="-2" unitRef="pure" id="ixv-71709">80</ix:nonFraction>% of future taxable profits of the company in which the losses arose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2024 and 2025, the Group has deductible temporary differences of RMB<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" unitRef="cny" id="ixv-71710">828,668</ix:nonFraction> and RMB<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" unitRef="cny" id="ixv-71711">1,000,310</ix:nonFraction> (US$<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" unitRef="usd" id="ixv-71712">143,042</ix:nonFraction>), respectively.
The Group has the tax credits of RMB<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TaxCredits" scale="3" unitRef="cny" id="ixv-71713">120,606</ix:nonFraction> and RMB<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TaxCredits" scale="3" unitRef="cny" id="ixv-71714">158,931</ix:nonFraction> (US$<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TaxCredits" scale="3" unitRef="usd" id="ixv-71715">22,727</ix:nonFraction>), mainly from the United States that will expire between 2039 and
2045 if not utilized.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
deferred tax assets have not been recognized in respect of above tax losses, deductible temporary differences and tax credits as they
have arisen in entities that have been loss-making and it is not anticipated there will be sufficient taxable income in the foreseeable
future to utilize these items.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024 and 2025, there was <span style="-sec-ix-hidden: hidden-fact-301"><span style="-sec-ix-hidden: hidden-fact-302">no</span></span> unrecognized deferred tax liability for taxes that would be payable on the unremitted earnings
of the Group&#8217;s subsidiaries or joint ventures in the Chinese mainland as these enterprises are still in accumulative losses status.</span></p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 274; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFERRED
                                            TAX (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Deferred
tax assets</span> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfDeferredTaxesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024 and 2025, the Company has uncertain tax position amounts of RMB<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:UnrecognizedTaxBenefit" scale="3" unitRef="cny" id="ixv-71716">23,665</ix:nonFraction> and RMB<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:UnrecognizedTaxBenefit" scale="3" unitRef="cny" id="ixv-71717">37,901</ix:nonFraction> (US$<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:UnrecognizedTaxBenefit" scale="3" unitRef="usd" id="ixv-71718">5,420</ix:nonFraction>), respectively, of
which <span style="-sec-ix-hidden: hidden-fact-297">nil</span> and <span style="-sec-ix-hidden: hidden-fact-298">nil</span> are presented on a net basis against the deferred tax assets related to tax loss carry forwards on the consolidated
balance sheets. As of December 31, 2024 and 2025, the uncertain tax position amounts of RMB<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:UnrecognizedTaxBenefitsRecognized" scale="3" unitRef="cny" id="ixv-71719">23,665</ix:nonFraction> and <span style="-sec-ix-hidden: hidden-fact-299">nil</span> (US <span style="-sec-ix-hidden: hidden-fact-300">nil</span>), respectively, if
ultimately recognized, will impact the effective tax rate.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023, 2024 and 2025, the Company did not record any interest expense and penalty accrued in relation to
the uncertain tax position in income tax expenses.</span></p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory" id="ixv-52888"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
                                            NON-CURRENT ASSETS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfOtherNonCurrentAssetsTableTextBlock" id="ixv-52899"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Contract acquisition costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ContractAcquisitionCosts" scale="3" unitRef="cny" id="ixv-71720">30,529</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ContractAcquisitionCosts" scale="3" unitRef="cny" id="ixv-71721">29,851</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ContractAcquisitionCosts" scale="3" unitRef="usd" id="ixv-71722">4,269</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Value added tax recoverable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentValueAddedTaxReceivables" scale="3" unitRef="cny" id="ixv-71723">26,034</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">Deposit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermDeposits" scale="3" unitRef="cny" id="ixv-71724">2,439</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermDeposits" scale="3" unitRef="cny" id="ixv-71725">690</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermDeposits" scale="3" unitRef="usd" id="ixv-71726">99</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Prepayment for property, plant and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentPrepayments" scale="3" unitRef="cny" id="ixv-71727">301</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentPrepayments" scale="3" unitRef="cny" id="ixv-71728">184</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentPrepayments" scale="3" unitRef="usd" id="ixv-71729">26</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" unitRef="cny" id="ixv-71730">59,303</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" unitRef="cny" id="ixv-71731">30,725</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" unitRef="usd" id="ixv-71732">4,394</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfInventoriesExplanatory" id="ixv-53014"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INVENTORIES</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfDetailedInformationOfInventoriesExplanatory" id="ixv-53023"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work in progress</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:WorkInProgress" scale="3" unitRef="cny" id="ixv-71733">2,736</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:WorkInProgress" scale="3" unitRef="cny" id="ixv-71734">25,371</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:WorkInProgress" scale="3" unitRef="usd" id="ixv-71735">3,628</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinishedGoods" scale="3" unitRef="cny" id="ixv-71736">3,861</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinishedGoods" scale="3" unitRef="cny" id="ixv-71737">7,427</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinishedGoods" scale="3" unitRef="usd" id="ixv-71738">1,062</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    Provision</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisions" scale="3" unitRef="cny" id="ixv-71739">4,180</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisions" scale="3" unitRef="usd" id="ixv-71740">598</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="3" unitRef="cny" id="ixv-71741">6,597</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="3" unitRef="cny" id="ixv-71742">28,618</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="3" unitRef="usd" id="ixv-71743">4,092</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 275; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory" id="ixv-53270"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRADE
                                            RECEIVABLES, NET</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfTradeReceivablesNetTableTextBlock" id="ixv-53280"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade receivables, net</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="cny" id="ixv-71744">83,143</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="cny" id="ixv-71745">252,938</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="usd" id="ixv-71746">36,170</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s trading terms with its customers are mainly on credit. The credit period is generally 45 to 120 days. Each customer has
a maximum credit limit. The Group seeks to maintain strict control over its outstanding receivables and has a credit control department
to minimize credit risk. Overdue balances are reviewed regularly by senior management. The Group does not hold any collateral or other
credit enhancements over its trade receivable balances. Trade receivables are non-interest-bearing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" id="ixv-53393"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
aging analysis of the trade receivables as at the end of the reporting period, based on the invoice date and net of loss allowance, is
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Within 45 days</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c302" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="cny" id="ixv-71747">54,484</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c303" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="cny" id="ixv-71748">252,938</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c303" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="usd" id="ixv-71749">36,170</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">45 to 120 days</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c304" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="cny" id="ixv-71750">28,659</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="cny" id="ixv-71751">83,143</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="cny" id="ixv-71752">252,938</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="usd" id="ixv-71753">36,170</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">An
impairment analysis is performed at each reporting date. The Group has applied the simplified approach to provide for ECLs prescribed
by IFRS 9, which permits the use of the lifetime expected loss provision for all trade receivables. The directors of the Company are
of the opinion that the ECL in respect of the balance of trade receivables is minimal. No loss allowance for impairment of trade receivables
is provided as at December 31, 2025 (2024: nil).</span></p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory" id="ixv-53489"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PREPAYMENTS,
                                            OTHER RECEIVABLES AND OTHER ASSETS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory" id="ixv-53500"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Prepayments for clinical trial expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PrepaymentsForClinicalTrialExpenses" scale="3" unitRef="cny" id="ixv-71754">71,050</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PrepaymentsForClinicalTrialExpenses" scale="3" unitRef="cny" id="ixv-71755">100,769</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PrepaymentsForClinicalTrialExpenses" scale="3" unitRef="usd" id="ixv-71756">14,410</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Prepaid listing expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PrepaidListingExpense" scale="3" unitRef="cny" id="ixv-71757">22,465</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Value added tax recoverable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ValueAddedTaxReceivables" scale="3" unitRef="cny" id="ixv-71758">9,794</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ValueAddedTaxReceivables" scale="3" unitRef="cny" id="ixv-71759">46,748</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ValueAddedTaxReceivables" scale="3" unitRef="usd" id="ixv-71760">6,685</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherReceivables" scale="3" unitRef="cny" id="ixv-71761">6,137</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherReceivables" scale="3" unitRef="cny" id="ixv-71762">1,455</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherReceivables" scale="3" unitRef="usd" id="ixv-71763">208</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DepositsAssetsPrepayments" scale="3" unitRef="cny" id="ixv-71764">5,367</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DepositsAssetsPrepayments" scale="3" unitRef="cny" id="ixv-71765">2,159</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:DepositsAssetsPrepayments" scale="3" unitRef="usd" id="ixv-71766">309</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Prepayment for treasury share purchase fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PrepaymentForTreasurySharePurchaseFees" scale="3" unitRef="cny" id="ixv-71767">4,754</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PrepaymentForTreasurySharePurchaseFees" scale="3" unitRef="cny" id="ixv-71768">8,798</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PrepaymentForTreasurySharePurchaseFees" scale="3" unitRef="usd" id="ixv-71769">1,258</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other prepayments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Prepayments" scale="3" unitRef="cny" id="ixv-71770">3,644</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Prepayments" scale="3" unitRef="cny" id="ixv-71771">32,603</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Prepayments" scale="3" unitRef="usd" id="ixv-71772">4,662</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" scale="3" unitRef="cny" id="ixv-71773">123,211</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" scale="3" unitRef="cny" id="ixv-71774">192,532</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" scale="3" unitRef="usd" id="ixv-71775">27,532</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of financial assets included in prepayments, other receivables and other assets approximate to their fair values.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial assets included in the above balances relate to receivables for which there was no recent history of default or past due amounts.
As at December 31, 2024 and 2025, the loss allowance was assessed to be minimal.</span></p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 276; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory" id="ixv-53699"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
                                            AND BANK BALANCES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfCashAndBankBalancesExplanatory" id="ixv-53709"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents as stated in the consolidated statements of cash flows</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-71776">893,100</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-71777">1,195,784</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="usd" id="ixv-71778">170,995</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    cash</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-71779">24,633</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-71780">5,685</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="usd" id="ixv-71781">812</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time
    deposits with original maturity of more than three months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepositsFromBanks" scale="3" unitRef="cny" id="ixv-71782">343,478</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepositsFromBanks" scale="3" unitRef="cny" id="ixv-71783">1,268,616</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DepositsFromBanks" scale="3" unitRef="usd" id="ixv-71784">181,410</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances as stated in the consolidated statements of financial position</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:BalancesWithBanks" scale="3" unitRef="cny" id="ixv-71785">1,261,211</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:BalancesWithBanks" scale="3" unitRef="cny" id="ixv-71786">2,470,085</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:BalancesWithBanks" scale="3" unitRef="usd" id="ixv-71787">353,217</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominated
    in:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c309" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71788">298,922</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c310" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71789">205,783</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c310" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-71790">29,426</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c311" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71791">947,012</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c312" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71792">2,257,307</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c312" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-71793">322,791</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HK$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c313" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71794">13,812</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c314" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71795">3,827</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c314" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-71796">547</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c315" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71797">1,465</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c316" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71798">3,168</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c316" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-71799">453</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71800">1,261,211</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71801">2,470,085</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-71802">353,217</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the end of the reporting period, the cash and bank balances of the Group denominated in RMB amounted to RMB<ix:nonFraction contextRef="c306" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71803">205,783</ix:nonFraction> (US$<ix:nonFraction contextRef="c307" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-71804">29,426</ix:nonFraction>) (2024:
RMB<ix:nonFraction contextRef="c308" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-71805">298,922</ix:nonFraction>). The RMB is not freely convertible into other currencies, however, under Chinese mainland&#8217;s Foreign Exchange Control Regulations
and Administration of Settlement, and Sale and Payment of Foreign Exchange Regulations, the Group is permitted to exchange RMB for other
currencies through banks authorized to conduct foreign exchange business.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
at banks earn interest at floating rates based on daily bank deposit rates. Time deposits with original maturity of more than three
months earn interest at fixed interest rates for varying periods of between two years and three years. The bank balances are deposited
with creditworthy banks with no recent history of default.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory" id="ixv-54065"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRADE
                                            PAYABLES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfTradePayablesExplanatory" id="ixv-54075"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
aging analysis of the trade payables as at the end of each reporting period, based on the invoice date, is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within 1 month</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c317" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71806">72,506</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c318" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71807">91,119</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c318" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="usd" id="ixv-71808">13,030</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 to 3 months</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c319" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71809">6,288</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c320" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71810">3,648</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c320" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="usd" id="ixv-71811">522</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 6 months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c321" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71812">13,172</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c322" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71813">11,973</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c322" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="usd" id="ixv-71814">1,712</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71815">91,966</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71816">106,740</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="usd" id="ixv-71817">15,264</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trade payables are non-interest-bearing and are normally settled in less than six months.&#160;</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 277; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfOtherPayablesAndAccrualsTextBlock" id="ixv-54303"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
                                            PAYABLES AND ACCRUALS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureofOtherPayablesAndAccrualsExplanatory" id="ixv-54313"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    promotion expenses</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AccrualsClassifiedAsCurrent" scale="3" unitRef="cny" id="ixv-71818">67,009</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AccrualsClassifiedAsCurrent" scale="3" unitRef="cny" id="ixv-71819">121,545</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AccrualsClassifiedAsCurrent" scale="3" unitRef="usd" id="ixv-71820">17,381</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payroll
    payables</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisionsForEmployeeBenefits" scale="3" unitRef="cny" id="ixv-71821">61,848</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisionsForEmployeeBenefits" scale="3" unitRef="cny" id="ixv-71822">78,423</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisionsForEmployeeBenefits" scale="3" unitRef="usd" id="ixv-71823">11,214</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payables
    for construction cost</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CurretPayablesForConstructionCost" scale="3" unitRef="cny" id="ixv-71824">35,381</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CurretPayablesForConstructionCost" scale="3" unitRef="cny" id="ixv-71825">5,888</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CurretPayablesForConstructionCost" scale="3" unitRef="usd" id="ixv-71826">842</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    payables-current portion (note 36)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="3" unitRef="cny" id="ixv-71827">29,344</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="3" unitRef="cny" id="ixv-71828">8,340</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="3" unitRef="usd" id="ixv-71829">1,194</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities-current portion (note 36)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" scale="3" unitRef="cny" id="ixv-71830">1,968</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" scale="3" unitRef="usd" id="ixv-71831">281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    payables</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="cny" id="ixv-71832">23,442</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="cny" id="ixv-71833">21,493</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="usd" id="ixv-71834">3,073</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
    subsidy</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:GovernmentSubsidy" scale="3" unitRef="cny" id="ixv-71835">16,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:GovernmentSubsidy" scale="3" unitRef="cny" id="ixv-71836">22,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:GovernmentSubsidy" scale="3" unitRef="usd" id="ixv-71837">3,232</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    payables other than income tax</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentExciseTaxPayables" scale="3" unitRef="cny" id="ixv-71838">9,627</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentExciseTaxPayables" scale="3" unitRef="cny" id="ixv-71839">13,700</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentExciseTaxPayables" scale="3" unitRef="usd" id="ixv-71840">1,959</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    accrued expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" unitRef="cny" id="ixv-71841">14,847</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" unitRef="cny" id="ixv-71842">2,709</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" unitRef="usd" id="ixv-71843">387</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71844">258,098</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="3" unitRef="cny" id="ixv-71845">276,666</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="3" unitRef="usd" id="ixv-71846">39,563</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
payables are non-interest-bearing.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfContractLiabilitiesTextBlock" id="ixv-54675"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTRACT
                                            LIABILITIES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfContractsLiabilitiesExplanatory" id="ixv-54685"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of contract liabilities as at December 31, 2024 and 2025 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term advances recognized
    from customers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
    rights income</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c328" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="cny" id="ixv-71847">37,485</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c329" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="cny" id="ixv-71848">37,485</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c329" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="usd" id="ixv-71849">5,360</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    advances recognized from customers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
    rights income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c330" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="cny" id="ixv-71850">248,460</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c331" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="cny" id="ixv-71851">210,224</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c331" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="usd" id="ixv-71852">30,062</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="cny" id="ixv-71853">285,945</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="cny" id="ixv-71854">247,709</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="usd" id="ixv-71855">35,422</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
liabilities include long-term and short-term advances related to commercialization rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2021, the Group entered into an agreement with Innovent Biologics (Suzhou) Co., Ltd (&#8220;Innovent&#8221;). Under the agreement,
the Group owns all intellectual property generated in connection with the development and commercialization of HQP1351. Innovent was
granted the commercialization rights of HQP1351 in China and should make a non-refundable payment and milestone payments for such rights
to the Group, which are recorded under contract liabilities and recognized as revenue over time during the commercialization period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the agreement, the Group recognized RMB<ix:nonFraction contextRef="c323" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="cny" id="ixv-71856">349,523</ix:nonFraction> (US$<ix:nonFraction contextRef="c323" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="usd" id="ixv-71857">49,981</ix:nonFraction>) in aggregate as contract liabilities from contract inception
through December 31, 2025 (2024: RMB<ix:nonFraction contextRef="c324" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContractLiabilities" scale="3" unitRef="cny" id="ixv-71858">349,523</ix:nonFraction>). The Group recognized RMB<ix:nonFraction contextRef="c325" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71859">37,485</ix:nonFraction> (US$<ix:nonFraction contextRef="c325" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="usd" id="ixv-71860">5,360</ix:nonFraction>) as revenue during the year ended December 31,
2025 (2024: RMB<ix:nonFraction contextRef="c326" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71861">37,485</ix:nonFraction>; 2023: RMB<ix:nonFraction contextRef="c327" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="cny" id="ixv-71862">26,049</ix:nonFraction>). Milestone payments are recognized as the transaction price when the Group can conclude that
it is highly probable that there will not be a subsequent reversal of a significant amount of revenue.</span></p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 278; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfBorrowingsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfBorrowingsExplanatory" id="ixv-55020"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTEREST-BEARING
                                            BANK AND OTHER BORROWINGS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock-c0_cont_1" escape="true" name="aapg:ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" id="ixv-55030"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective interest rate<br/> per annum (%)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term borrowing</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 25%; text-align: right"><ix:nonNumeric contextRef="c337" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55104"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.60-2.70 or 1 year LPR-0.30 to 0.75</span></ix:nonNumeric></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c338" name="ifrs-full:BorrowingsMaturity" id="ixv-71863"></ix:nonNumeric><ix:nonNumeric contextRef="c337" name="ifrs-full:BorrowingsMaturity" id="ixv-71864"><ix:nonNumeric contextRef="c339" name="ifrs-full:BorrowingsMaturity" id="ixv-71865"></ix:nonNumeric>2025</ix:nonNumeric></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c340" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71866">290,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c341" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55128"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.15 to 0.65 or 1 year LPR+0.65 to 0.85</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c342" name="ifrs-full:BorrowingsMaturity" id="ixv-71867"></ix:nonNumeric><ix:nonNumeric contextRef="c341" name="ifrs-full:BorrowingsMaturity" id="ixv-71868"><ix:nonNumeric contextRef="c343" name="ifrs-full:BorrowingsMaturity" id="ixv-71869"></ix:nonNumeric>2025</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c344" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71870">213,170</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c345" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55152"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80 - 4.55</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c346" name="ifrs-full:BorrowingsMaturity" id="ixv-71871"></ix:nonNumeric><ix:nonNumeric contextRef="c345" name="ifrs-full:BorrowingsMaturity" id="ixv-71872"><ix:nonNumeric contextRef="c347" name="ifrs-full:BorrowingsMaturity" id="ixv-71873"></ix:nonNumeric>2025</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c348" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71874">255,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c349" id="ix_48_fact" name="ifrs-full:BorrowingsInterestRateBasis"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c350" id="ix_49_fact" name="ifrs-full:BorrowingsMaturity"></ix:nonNumeric><ix:nonNumeric contextRef="c349" id="ix_50_fact" name="ifrs-full:BorrowingsMaturity"><ix:nonNumeric contextRef="c351" id="ix_51_fact" name="ifrs-full:BorrowingsMaturity"></ix:nonNumeric>2025</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c352" decimals="-3" format="ixt:num-dot-decimal" id="ix_52_fact" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny">11,453</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c353" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55200"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c354" name="ifrs-full:BorrowingsMaturity" id="ixv-71879"></ix:nonNumeric><ix:nonNumeric contextRef="c353" name="ifrs-full:BorrowingsMaturity" id="ixv-71880"><ix:nonNumeric contextRef="c355" name="ifrs-full:BorrowingsMaturity" id="ixv-71881"></ix:nonNumeric>2025</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c356" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71882">9,439</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71883">779,062</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c357" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55316"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.45 to 0.65 or 1 year LPR+0.70 to 0.85</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c358" name="ifrs-full:BorrowingsMaturity" id="ixv-71884">2026</ix:nonNumeric><ix:nonNumeric contextRef="c357" name="ifrs-full:BorrowingsMaturity" id="ixv-71885"></ix:nonNumeric> - <ix:nonNumeric contextRef="c359" name="ifrs-full:BorrowingsMaturity" id="ixv-71886">2028</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c360" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-71887">203,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c361" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55340"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80-4.50</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c362" name="ifrs-full:BorrowingsMaturity" id="ixv-71888">2026</ix:nonNumeric><ix:nonNumeric contextRef="c361" name="ifrs-full:BorrowingsMaturity" id="ixv-71889"></ix:nonNumeric> - <ix:nonNumeric contextRef="c363" name="ifrs-full:BorrowingsMaturity" id="ixv-71890">2027</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c364" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-71891">77,250</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c365" id="ix_53_fact" name="ifrs-full:BorrowingsInterestRateBasis"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c366" id="ix_54_fact" name="ifrs-full:BorrowingsMaturity">2026</ix:nonNumeric><ix:nonNumeric contextRef="c365" id="ix_55_fact" name="ifrs-full:BorrowingsMaturity"></ix:nonNumeric> - <ix:nonNumeric contextRef="c367" id="ix_56_fact" name="ifrs-full:BorrowingsMaturity">2038</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c368" decimals="-3" format="ixt:num-dot-decimal" id="ix_57_fact" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny">588,292</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c369" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55388"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c370" name="ifrs-full:BorrowingsMaturity" id="ixv-71896">2026</ix:nonNumeric><ix:nonNumeric contextRef="c369" name="ifrs-full:BorrowingsMaturity" id="ixv-71897"></ix:nonNumeric> - <ix:nonNumeric contextRef="c371" name="ifrs-full:BorrowingsMaturity" id="ixv-71898">2028</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c372" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-71899">20,793</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; non-current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-71900">889,435</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71901">1,668,497</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective interest rate<br/> per annum (%)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term borrowing</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 25%; text-align: right"><ix:nonNumeric contextRef="c373" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55585"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11-2.50 or 1 year LPR-0.60 to 0.89</span></ix:nonNumeric></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c374" name="ifrs-full:BorrowingsMaturity" id="ixv-71902"></ix:nonNumeric><ix:nonNumeric contextRef="c373" name="ifrs-full:BorrowingsMaturity" id="ixv-71903"><ix:nonNumeric contextRef="c375" name="ifrs-full:BorrowingsMaturity" id="ixv-71904"></ix:nonNumeric>2026</ix:nonNumeric></span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c376" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71905">1,040,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c376" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="usd" id="ixv-71906">148,718</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c377" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55613"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c378" name="ifrs-full:BorrowingsMaturity" id="ixv-71907"></ix:nonNumeric><ix:nonNumeric contextRef="c377" name="ifrs-full:BorrowingsMaturity" id="ixv-71908"><ix:nonNumeric contextRef="c379" name="ifrs-full:BorrowingsMaturity" id="ixv-71909"></ix:nonNumeric>2026</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c380" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71910">2,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c380" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="usd" id="ixv-71911">358</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c381" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55641"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.45 to 0.75</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c382" name="ifrs-full:BorrowingsMaturity" id="ixv-71912"></ix:nonNumeric><ix:nonNumeric contextRef="c381" name="ifrs-full:BorrowingsMaturity" id="ixv-71913"><ix:nonNumeric contextRef="c383" name="ifrs-full:BorrowingsMaturity" id="ixv-71914"></ix:nonNumeric>2026</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c384" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71915">156,200</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c384" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="usd" id="ixv-71916">22,336</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c385" id="ix_58_fact" name="ifrs-full:BorrowingsInterestRateBasis"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c386" id="ix_59_fact" name="ifrs-full:BorrowingsMaturity"></ix:nonNumeric><ix:nonNumeric contextRef="c385" id="ix_60_fact" name="ifrs-full:BorrowingsMaturity"><ix:nonNumeric contextRef="c387" id="ix_61_fact" name="ifrs-full:BorrowingsMaturity"></ix:nonNumeric>2026</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c388" decimals="-3" format="ixt:num-dot-decimal" id="ix_62_fact" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny">16,498</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c388" decimals="-3" format="ixt:num-dot-decimal" id="ix_63_fact" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="usd">2,359</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c389" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55697"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c390" name="ifrs-full:BorrowingsMaturity" id="ixv-71922"></ix:nonNumeric><ix:nonNumeric contextRef="c389" name="ifrs-full:BorrowingsMaturity" id="ixv-71923"><ix:nonNumeric contextRef="c391" name="ifrs-full:BorrowingsMaturity" id="ixv-71924"></ix:nonNumeric>2026</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c392" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71925">7,283</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c392" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="usd" id="ixv-71926">1,041</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71927">1,222,481</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="usd" id="ixv-71928">174,812</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; font-weight: bold; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c393" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55833"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.45 to 0.75</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c394" name="ifrs-full:BorrowingsMaturity" id="ixv-71929">2027</ix:nonNumeric><ix:nonNumeric contextRef="c393" name="ifrs-full:BorrowingsMaturity" id="ixv-71930"></ix:nonNumeric> &#8211; <ix:nonNumeric contextRef="c395" name="ifrs-full:BorrowingsMaturity" id="ixv-71931">2028</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c396" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-71932">114,900</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c396" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="usd" id="ixv-71933">16,431</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c397" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55861"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c398" name="ifrs-full:BorrowingsMaturity" id="ixv-71934"></ix:nonNumeric><ix:nonNumeric contextRef="c397" name="ifrs-full:BorrowingsMaturity" id="ixv-71935"><ix:nonNumeric contextRef="c399" name="ifrs-full:BorrowingsMaturity" id="ixv-71936"></ix:nonNumeric>2027</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c400" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-71937">43,750</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c400" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="usd" id="ixv-71938">6,256</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><ix:nonNumeric contextRef="c401" id="ix_64_fact" name="ifrs-full:BorrowingsInterestRateBasis"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c402" id="ix_65_fact" name="ifrs-full:BorrowingsMaturity">2027</ix:nonNumeric><ix:nonNumeric contextRef="c401" id="ix_66_fact" name="ifrs-full:BorrowingsMaturity"></ix:nonNumeric> &#8211; <ix:nonNumeric contextRef="c403" id="ix_67_fact" name="ifrs-full:BorrowingsMaturity">2038</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c404" decimals="-3" format="ixt:num-dot-decimal" id="ix_68_fact" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny">583,675</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c404" decimals="-3" format="ixt:num-dot-decimal" id="ix_69_fact" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="usd">83,464</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c405" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-55917"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c406" name="ifrs-full:BorrowingsMaturity" id="ixv-71944">2027</ix:nonNumeric><ix:nonNumeric contextRef="c405" name="ifrs-full:BorrowingsMaturity" id="ixv-71945"></ix:nonNumeric> &#8211; <ix:nonNumeric contextRef="c407" name="ifrs-full:BorrowingsMaturity" id="ixv-71946">2028</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c408" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-71947">14,913</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c408" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="usd" id="ixv-71948">2,133</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; non-current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-71949">757,238</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="usd" id="ixv-71950">108,284</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71951">1,979,719</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="usd" id="ixv-71952">283,096</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table></ix:nonNumeric>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:
LPR represents the Loan Prime Rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:footnote id="ix_11_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The bank loans amounting to RMB<ix:nonFraction contextRef="c332" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71953">600,173</ix:nonFraction> (US$<ix:nonFraction contextRef="c332" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="usd" id="ixv-71954">85,823</ix:nonFraction>) as at December 31, 2025 were secured by the pledge of the Group&#8217;s buildings with a net carrying amount of RMB<ix:nonFraction contextRef="c332" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71955">676,985</ix:nonFraction> (US$<ix:nonFraction contextRef="c332" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="usd" id="ixv-71956">96,808</ix:nonFraction>) and right-of-use assets with a net carrying amount of RMB<ix:nonFraction contextRef="c333" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71957">25,338</ix:nonFraction> (US$<ix:nonFraction contextRef="c333" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="usd" id="ixv-71958">3,623</ix:nonFraction>) as at December 31, 2025. Such loans were also guaranteed by two of the Group&#8217;s subsidiaries.</span></ix:footnote></p></td>
</tr></table></ix:continuation></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 279; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTEREST-BEARING
                                            BANK AND OTHER BORROWINGS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfBorrowingsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
bank loans amounting to RMB<ix:nonFraction contextRef="c334" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="3" unitRef="cny" id="ixv-71959">599,745</ix:nonFraction> as at December 31, 2024 were secured by the pledge of the Group&#8217;s buildings with a net carrying
amount of RMB<ix:nonFraction contextRef="c335" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71960">731,282</ix:nonFraction> and right-of-use assets with a net carrying amount of RMB<ix:nonFraction contextRef="c336" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71961">26,468</ix:nonFraction> as at December 31, 2024. Such loans were also guaranteed
by two of the Group&#8217;s subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unsecured bank loans amounting to RMB<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:UnsecuredBankLoansReceived" scale="3" unitRef="usd" id="ixv-71962">140,000</ix:nonFraction> (US$<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:UnsecuredBankLoansReceived" scale="3" unitRef="cny" id="ixv-71963">20,020</ix:nonFraction>) (2024: RMB<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:UnsecuredBankLoansReceived" scale="3" unitRef="cny" id="ixv-71964">278,070</ix:nonFraction>) were guaranteed by the Group&#8217;s subsidiaries as at December
31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of borrowings are all denominated in RMB. <ix:nonNumeric contextRef="c0" continuedAt="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock-c0_cont_1" escape="true" name="aapg:ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" id="ixv-71965">The weighted average interest rate for the outstanding short-term bank loans
as of December 31, 2024 and 2025, was <ix:nonFraction contextRef="c14" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-71966">2.63</ix:nonFraction>% and <ix:nonFraction contextRef="c15" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-71967">2.18</ix:nonFraction>%, respectively.</ix:nonNumeric></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analyzed into:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    one year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c170" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71968">779,062</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c171" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71969">1,222,481</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c171" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="usd" id="ixv-71970">174,812</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the second year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c409" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71971">242,473</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c410" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71972">160,201</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c410" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="usd" id="ixv-71973">22,908</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the third to fifth years, inclusive</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c411" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71974">159,355</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c412" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71975">140,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c412" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="usd" id="ixv-71976">20,034</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
    five years</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c413" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71977">487,607</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c414" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71978">456,937</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c414" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="usd" id="ixv-71979">65,342</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71980">1,668,497</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="cny" id="ixv-71981">1,979,719</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="3" unitRef="usd" id="ixv-71982">283,096</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 280; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDeferredIncomeExplanatory" id="ixv-56420"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFERRED
                                            INCOME</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfDeferredIncomeTableTextBlock" id="ixv-56430"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentGovernmentGrants" scale="3" unitRef="cny" id="ixv-71983">27,500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentGovernmentGrants" scale="3" unitRef="cny" id="ixv-71984">6,500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentGovernmentGrants" scale="3" unitRef="usd" id="ixv-71985">929</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfGovernmentGrantsExplanatory" id="ixv-56512"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
movements in government grants during the reporting period are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At beginning of
    the year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="3" unitRef="cny" id="ixv-71986">36,360</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="3" unitRef="cny" id="ixv-71987">27,500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="3" unitRef="usd" id="ixv-71988">3,932</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Received during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RecognizedAsIncomeDuringTheYear" scale="3" sign="-" unitRef="cny" id="ixv-71989">7,740</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RecognizedAsIncomeDuringTheYear" scale="3" sign="-" unitRef="cny" id="ixv-71990">1,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RecognizedAsIncomeDuringTheYear" scale="3" sign="-" unitRef="usd" id="ixv-71991">143</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portion
    classified as current liabilities (note 25)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PortionClassifiedAsCurrentLiabilities" scale="3" sign="-" unitRef="cny" id="ixv-71992">16,600</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PortionClassifiedAsCurrentLiabilities" scale="3" sign="-" unitRef="cny" id="ixv-71993">22,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PortionClassifiedAsCurrentLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-71994">3,146</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At end
    of the year</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="3" unitRef="cny" id="ixv-71995">27,500</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="3" unitRef="cny" id="ixv-71996">6,500</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="3" unitRef="usd" id="ixv-71997">929</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" id="ixv-56681"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE
                                            CAPITAL AND TREASURY SHARES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory" id="ixv-56691"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
and fully paid</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
    shares in <br/>
    issue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB
    equivalent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares of US$<ix:nonFraction contextRef="c436" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-71998">0.0001</ix:nonFraction> each</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c436" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-71999">290,196,560</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c436" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-72000">27</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c436" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-72001">197</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
    shares in <br/>
    issue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB
    equivalent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares of US$<ix:nonFraction contextRef="c437" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-72002">0.0001</ix:nonFraction> each</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c437" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72003">315,224,993</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c437" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-72004">29</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c437" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-72005">214</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31, 2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
    shares in <br/>
    issue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB
    equivalent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares of US$<ix:nonFraction contextRef="c438" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-72006">0.0001</ix:nonFraction> each</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c438" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72007">373,321,692</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c438" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-72008">37</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c438" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-72009">256</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 281; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE
                                            CAPITAL AND TREASURY SHARES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory-c0_cont_1" escape="true" name="aapg:DisclosureOfShareCapitalAndTreasurySharesExplanatory" id="ixv-56993"><ix:continuation continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_2" id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">Movements
in the issued share capital and treasury shares from January 1, 2023 to December 31, 2025 were as follows:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury
    shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2023</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c439" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72010">265,185,950</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" unitRef="cny" id="ixv-72011">180</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" sign="-" unitRef="cny" id="ixv-72012">26,552</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" sign="-" unitRef="cny" id="ixv-72013">26,372</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ordinary shares
    (a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c440" decimals="INF" format="ixt:num-dot-decimal" id="ix_70_fact" name="aapg:IssueOfOrdinaryShare" scale="0" unitRef="shares">22,500,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" id="ix_71_fact" name="aapg:IssueOfOrdinaryShares" scale="3" unitRef="cny">15</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_72_fact" name="aapg:IssueOfOrdinaryShares" scale="3" unitRef="cny">15</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the Pre-IPO share option scheme (b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c440" decimals="INF" format="ixt:num-dot-decimal" id="ix_73_fact" name="aapg:IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" scale="0" unitRef="shares">911,062</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" id="ix_74_fact" name="aapg:IssueOfSharesUnderThePreIPOShareOptionScheme" scale="3" unitRef="cny">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_75_fact" name="aapg:IssueOfSharesUnderThePreIPOShareOptionScheme" scale="3" unitRef="cny">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the 2021 RSU scheme (c)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c440" decimals="INF" format="ixt:num-dot-decimal" id="ix_76_fact" name="aapg:IssueOfSharesUnderThe2021RSUSchemeInshares" scale="0" unitRef="shares">71,034</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus (d)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c440" decimals="INF" format="ixt:num-dot-decimal" id="ix_77_fact" name="aapg:IncreaseDecreaseInNumberOfSharesEquitysettledBonus" scale="0" unitRef="shares">1,528,514</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" id="ix_78_fact" name="aapg:StockIssuedDuringPeriodValuesEquitysettledBonus" scale="3" unitRef="cny">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" id="ix_79_fact" name="aapg:StockIssuedDuringPeriodValuesEquitysettledBonus" scale="3" unitRef="cny">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_80_fact" name="aapg:StockIssuedDuringPeriodValuesEquitysettledBonus" scale="3" unitRef="cny">2</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase of ordinary
    shares (e)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" id="ix_81_fact" name="aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny">5,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_82_fact" name="aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny">5,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs (f)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" id="ix_83_fact" name="aapg:VestingOfRestrictedShareUnits" scale="3" unitRef="cny">11,123</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" id="ix_84_fact" name="aapg:VestingOfRestrictedShareUnits" scale="3" unitRef="cny">11,123</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023 and January 1, 2024</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c441" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72029">290,196,560</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" unitRef="cny" id="ixv-72030">197</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c34" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" sign="-" unitRef="cny" id="ixv-72031">21,351</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" sign="-" unitRef="cny" id="ixv-72032">21,154</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ordinary shares
    (g)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c442" decimals="INF" format="ixt:num-dot-decimal" id="ix_85_fact" name="aapg:IssueOfOrdinaryShare" scale="0" unitRef="shares">24,307,322</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c42" decimals="-3" format="ixt:num-dot-decimal" id="ix_86_fact" name="aapg:IssueOfOrdinaryShares" scale="3" unitRef="cny">17</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" id="ix_87_fact" name="aapg:IssueOfOrdinaryShares" scale="3" unitRef="cny">17</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the Pre-IPO share option scheme (h)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c442" decimals="INF" format="ixt:num-dot-decimal" id="ix_88_fact" name="aapg:IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" scale="0" unitRef="shares">656,077</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the 2021 RSU scheme (i)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c442" decimals="INF" format="ixt:num-dot-decimal" id="ix_89_fact" name="aapg:IssueOfSharesUnderThe2021RSUSchemeInshares" scale="0" unitRef="shares">65,034</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus (j)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" id="ix_90_fact" name="aapg:StockIssuedDuringPeriodValuesEquitysettledBonus" scale="3" unitRef="cny">8,631</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" id="ix_91_fact" name="aapg:StockIssuedDuringPeriodValuesEquitysettledBonus" scale="3" unitRef="cny">8,631</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase of ordinary
    shares (k)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" id="ix_92_fact" name="aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny">1,959</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" id="ix_93_fact" name="aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny">1,959</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs (l)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" id="ix_94_fact" name="aapg:VestingOfRestrictedShareUnits" scale="3" unitRef="cny">14,671</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" id="ix_95_fact" name="aapg:VestingOfRestrictedShareUnits" scale="3" unitRef="cny">14,671</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2024 and
    January 1, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c443" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72044">315,224,993</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" unitRef="cny" id="ixv-72045">214</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c51" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" sign="-" unitRef="cny" id="ixv-72046">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" unitRef="cny" id="ixv-72047">206</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ordinary shares
    (m)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c444" decimals="INF" format="ixt:num-dot-decimal" id="ix_96_fact" name="aapg:IssueOfOrdinaryShare" scale="0" unitRef="shares">55,040,576</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" id="ix_97_fact" name="aapg:IssueOfOrdinaryShares" scale="3" unitRef="cny">40</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_98_fact" name="aapg:IssueOfOrdinaryShares" scale="3" unitRef="cny">40</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the Pre-IPO share option scheme (n)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c444" decimals="INF" format="ixt:num-dot-decimal" id="ix_99_fact" name="aapg:IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" scale="0" unitRef="shares">455,263</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-335; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-336; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the 2021 RSU scheme and 2022 RSU scheme (o)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c444" decimals="INF" format="ixt:num-dot-decimal" id="ix_100_fact" name="aapg:IssueOfSharesUnderThe2021RSUSchemeInshares" scale="0" unitRef="shares">1,008,253</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" id="ix_101_fact" name="aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" scale="3" unitRef="cny">2</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-337; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_102_fact" name="aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" scale="3" unitRef="cny">2</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus (p)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c444" decimals="INF" format="ixt:num-dot-decimal" id="ix_103_fact" name="aapg:IncreaseDecreaseInNumberOfSharesEquitysettledBonus" scale="0" unitRef="shares">1,592,607</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-338; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-339; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-340; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase of ordinary
    shares (q)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-341; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-342; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" id="ix_104_fact" name="aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny">3,590</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_105_fact" name="aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" scale="3" sign="-" unitRef="cny">3,590</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs (r)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-343; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-344; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" id="ix_106_fact" name="aapg:VestingOfRestrictedShareUnits" scale="3" unitRef="cny">637</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_107_fact" name="aapg:VestingOfRestrictedShareUnits" scale="3" unitRef="cny">637</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2025</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c445" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72060">373,321,692</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c66" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" unitRef="cny" id="ixv-72061">256</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" sign="-" unitRef="cny" id="ixv-72062">2,961</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" sign="-" unitRef="cny" id="ixv-72063">2,705</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c445" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72064">373,321,692</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c66" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" unitRef="usd" id="ixv-72065">37</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" sign="-" unitRef="usd" id="ixv-72066">423</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IssuedShareCapital" scale="3" sign="-" unitRef="usd" id="ixv-72067">386</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><ix:footnote id="ix_12_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the share placement, <ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" scale="0" unitRef="shares" id="ixv-72068">22,500,000</ix:nonFraction> placing shares of the Company were issued and allotted at a price of HK$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="aapg:IssueOfOrdinaryShare" scale="0" unitRef="shares" id="ixv-72069">24.45</ix:nonFraction> per share on February 1, 2023, and an amount of RMB<ix:nonFraction contextRef="c415" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="3" unitRef="cny" id="ixv-72070">15</ix:nonFraction> was credited as share capital.</span></ix:footnote></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><ix:footnote id="ix_13_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company before December 31, 2023 to those grantees. In connection with the exercised share options, <ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72071">911,062</ix:nonFraction> new shares of the Company were issued with a weighted average exercise price of HK$<ix:nonFraction contextRef="c41" decimals="2" format="ixt:num-dot-decimal" name="aapg:WeightedAverageExercisePrice" scale="0" unitRef="hkdPershares" id="ixv-72072">0.01</ix:nonFraction>, and an amount of RMB<ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="3" unitRef="cny" id="ixv-72073">1</ix:nonFraction> was credited as share capital.</span></ix:footnote></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><ix:footnote id="ix_14_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2023 to those selected persons. In connection with the exercised RSUs, <ix:nonFraction contextRef="c416" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72074">71,034</ix:nonFraction> new shares of the Company were issued, and an amount of RMB<ix:nonFraction contextRef="c417" decimals="-1" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="3" unitRef="cny" id="ixv-72075">0.05</ix:nonFraction> was credited as share capital.</span></ix:footnote></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><ix:footnote id="ix_15_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, <ix:nonFraction contextRef="c416" decimals="0" format="ixt:num-dot-decimal" name="aapg:IssueOfOrdinaryShare" scale="0" unitRef="shares" id="ixv-72076">1,528,514</ix:nonFraction> ordinary shares and <ix:nonFraction contextRef="c417" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfTreasuryShares" scale="0" unitRef="shares" id="ixv-72077">1,237,884</ix:nonFraction> treasury shares, being underlying shares of the RSUs granted under the 2021 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB<ix:nonFraction contextRef="c418" decimals="-3" format="ixt:num-dot-decimal" name="aapg:BonusDueToEmployeesAmount" scale="3" unitRef="cny" id="ixv-72078">1</ix:nonFraction> and RMB<ix:nonFraction contextRef="c419" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfTreasuryShares" scale="0" unitRef="shares" id="ixv-72079">1</ix:nonFraction> were credited as share capital and treasury shares, respectively.</span></ix:footnote></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><ix:footnote id="ix_16_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the Company instructed the trustee to purchase <ix:nonFraction contextRef="c420" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72080">250,000</ix:nonFraction> of its shares on the Hong Kong Stock Exchange at a total consideration of RMB<ix:nonFraction contextRef="c421" decimals="-3" format="ixt:num-dot-decimal" name="aapg:SharesConsiderationAmount" scale="3" unitRef="cny" id="ixv-72081">5,923</ix:nonFraction> for the purpose of the 2022 RSU scheme.</span></ix:footnote></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><ix:footnote id="ix_17_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the exercise of RSUs granted under the 2018 and 2022 RSU Scheme, <ix:nonFraction contextRef="c422" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfTreasuryShares" scale="0" unitRef="shares" id="ixv-72082">1,069,461</ix:nonFraction> treasury shares were allotted to the employees during the year ended December 31,2023.</span></ix:footnote></td></tr> </table></ix:continuation></ix:nonNumeric><div>
</div><p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 282; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE
                                            CAPITAL AND TREASURY SHARES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><ix:continuation id="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory-c0_cont_1"><ix:continuation id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td><td style="text-align: left"><ix:footnote id="ix_18_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="aapg:SubscriptionOfShares" scale="0" unitRef="shares" id="ixv-72083">24,307,322</ix:nonFraction> placing shares of the Company were issued and allotted at a price of HK$<ix:nonFraction contextRef="c423" decimals="2" format="ixt:num-dot-decimal" name="aapg:AllottedSharesPricePerShares" scale="0" unitRef="hkdPershares" id="ixv-72084">24.10</ix:nonFraction> per share on June 20, 2024, and an amount of RMB<ix:nonFraction contextRef="c424" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="3" unitRef="cny" id="ixv-72085">17</ix:nonFraction> was credited as share capital.</span></ix:footnote></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, <ix:nonFraction contextRef="c425" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72086">656,077</ix:nonFraction> new shares of the Company were issued with a weighted average exercise price of HK$<ix:nonFraction contextRef="c426" decimals="2" format="ixt:num-dot-decimal" name="aapg:WeightedAverageExercisePrice" scale="0" unitRef="hkdPershares" id="ixv-72087">0.01</ix:nonFraction>, and an amount of RMB<ix:nonFraction contextRef="c426" decimals="-2" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="3" unitRef="cny" id="ixv-72088">0.5</ix:nonFraction> was credited as share capital.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font-size: 10pt"><ix:footnote id="ix_20_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2024, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2024 to those selected persons. In connection with the exercised RSUs, <ix:nonFraction contextRef="c427" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72089">65,034</ix:nonFraction> new shares of the Company were issued, and an amount of RMB<ix:nonFraction contextRef="c428" decimals="-1" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="3" unitRef="cny" id="ixv-72090">0.05</ix:nonFraction> was credited as share capital.</span></ix:footnote></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td> <td style="font-size: 10pt"><ix:footnote id="ix_21_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2024, <ix:nonFraction contextRef="c429" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfTreasuryShares" scale="0" unitRef="shares" id="ixv-72091">397,949</ix:nonFraction> treasury shares and <ix:nonFraction contextRef="c430" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfTreasuryShares" scale="0" unitRef="shares" id="ixv-72092">2,081,399</ix:nonFraction> treasury shares, being underlying shares of the RSUs granted under the 2022 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB<ix:nonFraction contextRef="c431" decimals="-3" format="ixt:num-dot-decimal" name="aapg:BonusDueToEmployeesAmount" scale="3" unitRef="cny" id="ixv-72093">8,630</ix:nonFraction> and RMB<ix:nonFraction contextRef="c432" decimals="-2" format="ixt:num-dot-decimal" name="aapg:BonusDueToEmployeesAmount" scale="3" unitRef="cny" id="ixv-72094">1.4</ix:nonFraction> were both credited as treasury shares.</span></ix:footnote></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></td> <td style="font-size: 10pt"><ix:footnote id="ix_22_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2024, the Company instructed the trustee to purchase <ix:nonFraction contextRef="c433" decimals="0" format="ixt:num-dot-decimal" name="aapg:StockPurchasedDuringPeriodShares" scale="0" unitRef="shares" id="ixv-72095">100,000</ix:nonFraction> of its shares on the Hong Kong Stock Exchange at a total consideration of RMB<ix:nonFraction contextRef="c434" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="3" unitRef="cny" id="ixv-72096">1,959</ix:nonFraction> for the purpose of the 2022 RSU Scheme.</span></ix:footnote></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><ix:footnote id="ix_23_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of RSUs granted under the 2018 and 2022 RSU Schemes, <ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfTreasuryShares" scale="0" unitRef="shares" id="ixv-72097">939,687</ix:nonFraction> treasury shares were allotted to the employees during the year ended December 31, 2024.</span></ix:footnote></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="font-size: 10pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</span></td> <td style="font-size: 10pt"><ix:footnote id="ix_24_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, 7,325,000 ADS (represents 29,300,000 of the Company&#8217;s ordinary shares) were offered at a price of US$17.25 per ADS on January 23, 2025, followed by an additional 935,144 ADS (represents 3,740,576 of the Company&#8217;s ordinary shares) were offered at the same price on February 13, 2025, and 22,000,000 placing shares of the Company were issued and allotted at a price of HK$68.6 per share on July 17, 2025, amounts of RMB40 (US$6) was credited as share capital.</span></ix:footnote></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2025, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 455,263 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.3 (US$0.04) was credited as share capital.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</span></td> <td style="font-size: 10pt"><ix:footnote id="ix_26_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During June to September 2025, the Company issued ordinary shares with respect to the restricted share units under the 2021 and 2022 RSU Scheme exercised by certain selected persons of the Company before December 31, 2025 to those selected persons. In connection with the exercised restricted share units, 1,008,253 new shares of the Company were issued, and an amount of RMB0.7 (US$0.1) was credited as share capital.</span></ix:footnote></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</span></td> <td style="font-size: 10pt"><ix:footnote id="ix_27_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2025, 775,685 ordinary shares and 816,922 ordinary shares, being underlying shares of the restricted share units granted under the 2021 RSU scheme and the 2022 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB0.5 (US$0.07) and RMB0.6 (US$0.09) credited as share capital.</span></ix:footnote></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</span></td> <td style="font-size: 10pt"><ix:footnote id="ix_28_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2025, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB3,590 (US$513) for the purpose of the 2022 RSU scheme.</span></ix:footnote></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</span></td> <td style="font-size: 10pt"><ix:footnote id="ix_29_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of restricted share units granted under the 2022 RSU Scheme, 17,925 treasury shares were allotted to the employees during the year ended December 31, 2025.</span></ix:footnote></td></tr> </table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 283; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>




</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory" id="ixv-58132"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESERVES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of the Group&#8217;s reserves and the movements therein for the current and prior years are presented in the consolidated statements
of changes in equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the post-IPO share option scheme, the 2021 RSU Scheme, and 2022 RSU
Scheme, expenses amounting to RMB<ix:nonFraction contextRef="c446" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="cny" id="ixv-72098">20,874</ix:nonFraction> (US$<ix:nonFraction contextRef="c446" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="usd" id="ixv-72099">2,985</ix:nonFraction>) (2024: RMB<ix:nonFraction contextRef="c447" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="cny" id="ixv-72100">20,924</ix:nonFraction>; 2023: RMB<ix:nonFraction contextRef="c448" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="cny" id="ixv-72101">31,503</ix:nonFraction>) were recognized and contributed to capital and
reserves during the year ended December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the exercise of the Pre-IPO share option scheme and vesting of restricted share units granted under the 2021 RSU Scheme,
and 2022 RSU Scheme, RMB<ix:nonFraction contextRef="c446" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="cny" id="ixv-72102">33,000</ix:nonFraction> (US$<ix:nonFraction contextRef="c446" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="usd" id="ixv-72103">4,719</ix:nonFraction>) (2024: RMB<ix:nonFraction contextRef="c447" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="cny" id="ixv-72104">19,333</ix:nonFraction>; 2023: RMB<ix:nonFraction contextRef="c448" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="cny" id="ixv-72105">32,593</ix:nonFraction>) was credited to share premium, and RMB<ix:nonFraction contextRef="c449" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TransferredOutFromCapitalAndReserves" scale="3" unitRef="cny" id="ixv-72106">33,635</ix:nonFraction> (US$<ix:nonFraction contextRef="c449" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TransferredOutFromCapitalAndReserves" scale="3" unitRef="usd" id="ixv-72107">4,810</ix:nonFraction>)(2024:
RMB<ix:nonFraction contextRef="c450" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TransferredOutFromCapitalAndReserves" scale="3" unitRef="cny" id="ixv-72108">33,998</ix:nonFraction>; 2023: RMB<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:TransferredOutFromCapitalAndReserves" scale="3" unitRef="cny" id="ixv-72109">43,709</ix:nonFraction>) was transferred out from capital and reserves during the year ended December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
PRC laws and regulations, there are restrictions on the Company&#8217;s PRC subsidiaries with respect to transferring certain of their
net assets to the Company either in the form of dividends, loans, or advances. Amounts of net assets restricted include paid in capital
and reserve funds of the Company&#8217;s PRC subsidiaries, totaling RMB<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CapitalAndReserveFunds" scale="3" unitRef="cny" id="ixv-72110">3,033,545</ix:nonFraction> (US$<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CapitalAndReserveFunds" scale="3" unitRef="usd" id="ixv-72111">433,791</ix:nonFraction>) and RMB<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CapitalAndReserveFunds" scale="3" unitRef="cny" id="ixv-72112">2,702,519</ix:nonFraction> as at December 31, 2025
and 2024, respectively. See note 41 for the statement of financial position of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
connection with the equity-settled bonus, the Company settled the bonus of RMB<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:BonusAmount" scale="3" unitRef="cny" id="ixv-72113">58,869</ix:nonFraction> (US$<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:BonusAmount" scale="3" unitRef="usd" id="ixv-72114">8,418</ix:nonFraction>) (2024: RMB<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:BonusAmount" scale="3" unitRef="cny" id="ixv-72115">49,350</ix:nonFraction>) by issuing <ix:nonFraction contextRef="c451" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72116">1,592,607</ix:nonFraction>
ordinary shares (2024: <ix:nonFraction contextRef="c452" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72117">2,479,348</ix:nonFraction> treasury shares) at a price of HK$<ix:nonFraction contextRef="c451" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="hkdPershares" id="ixv-72118">40.05</ix:nonFraction> (2024: HK$<ix:nonFraction contextRef="c452" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="hkdPershares" id="ixv-72119">21.95</ix:nonFraction>) to employees, among which, RMB<ix:nonFraction contextRef="c451" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="cny" id="ixv-72120">58,868</ix:nonFraction> (US$<ix:nonFraction contextRef="c451" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="usd" id="ixv-72121">8,418</ix:nonFraction>)
(2024: RMB<ix:nonFraction contextRef="c452" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="cny" id="ixv-72122">40,719</ix:nonFraction>) was credited to share premium.</span></p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory" id="ixv-58164"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            option scheme</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
pre-IPO share option scheme</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
July 2018, the Company adopted the pre-IPO share option scheme for the purpose of providing incentives and rewards to eligible participants
who have contributed or will contribute to the Group. Eligible participants of the pre-IPO share option scheme may include any substantial
shareholder, existing or incoming employees, directors (including executive directors, non-executive directors and independent non-executive
directors) and officers, or any other service providers of any member of the Group who the board of directors consider, in its sole discretion,
have contributed or will contribute to the Group. The pre-IPO share option scheme was terminated but continues to govern the terms and
conditions of the outstanding awards previously granted under the Company&#8217;s pre-IPO share option scheme.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
maximum number of shares which may be issued upon the exercise of all pre-IPO share options is <ix:nonFraction contextRef="c453" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72123">12,307,533</ix:nonFraction>. The exercise price for each
share under the pre-IPO share options was HK$<ix:nonFraction contextRef="c453" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72124">0.01</ix:nonFraction>.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 284; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            option scheme (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_2" id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" id="ixv-58254"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following share options were outstanding under the Pre-IPO share option scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise<br/>

price&#160;HK$ </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>per share</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number
of<br/>
 options</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise<br/>
price&#160;HK$ </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>per share</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/>
 options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Outstanding as of January 1</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c41" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72125">0.01</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72126">3,263,648</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c14" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72127">0.01</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72128">2,607,571</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Forfeited during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72129">0.01</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72130">81</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Exercised during the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c13" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72131">0.01</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72132">656,077</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72133">0.01</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72134">455,263</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">Outstanding as of December 31</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c14" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72135">0.01</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72136">2,607,571</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72137">0.01</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72138">2,152,227</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of share options exercisable was <ix:nonFraction contextRef="c454" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72139">2,152,227</ix:nonFraction> as at December 31, 2025 (2024: <ix:nonFraction contextRef="c455" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72140">2,607,571</ix:nonFraction>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average share price at the date of exercise for share options exercised during the year ended December 31, 2025 was HK$<ix:nonFraction contextRef="c456" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72141">58.54</ix:nonFraction>
per share (2024: HK$<ix:nonFraction contextRef="c457" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72142">34.03</ix:nonFraction> per share, 2023: HK$<ix:nonFraction contextRef="c458" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72143">22.98</ix:nonFraction> per share).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" id="ixv-58380"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices and exercise periods of the share options outstanding as at the end of the reporting period are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
    <br/>
Number of<br/>
 options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price<br/>
 HK$<br/>
 per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    period</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c507" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72144">2,360,420</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c507" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72145">0.01</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 68%; text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aug
    15, 2018-Aug 15, 2028</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c508" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72146">232,719</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c508" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72147">0.01</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    15, 2019-May 15, 2029</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c509" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72148">14,432</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c509" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72149">0.01</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept
    16, 2019-Sept 16, 2029</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72150">2,607,571</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025<br/>

    Number of<br/>
 options</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price<br/>
 HK$<br/>
 per share</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    period</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c510" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72151">1,983,383</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c510" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72152">0.01</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 68%; text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">Aug 15, 2018&#8211;Aug 15, 2028</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c511" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72153">159,712</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c511" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72154">0.01</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">May 15, 2019&#8211;May 15, 2029</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c512" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72155">9,132</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c512" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72156">0.01</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">Sept
    16, 2019-Sept 16, 2029</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72157">2,152,227</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Group did not grant any new share options under the Pre-IPO share option scheme during the year ended December 31, 2025 (2024: <span style="-sec-ix-hidden: hidden-fact-352">Nil</span>).
As the share options have been fully unlocked in 2023, the Group has not recognized any share option expense during the year ended December
31, 2025 (2024:<span style="-sec-ix-hidden: hidden-fact-353">Nil</span>, 2023: RMB<ix:nonFraction contextRef="c459" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="3" unitRef="cny" id="ixv-72158">3,750</ix:nonFraction>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
exercise in full of the outstanding share options would, under the present capital structure of the Company, result in the issue of <ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="aapg:AdditionalOrdinaryShares" scale="0" unitRef="shares" id="ixv-72159">2,152,227</ix:nonFraction> additional ordinary shares of the Company and additional share capital and share premium of US$<ix:nonFraction contextRef="c460" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="usd" id="ixv-72160">4,957</ix:nonFraction>, equivalent to RMB<ix:nonFraction contextRef="c460" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="cny" id="ixv-72161">34,662</ix:nonFraction> (before
issue expenses), transferred from capital and other reserves.</span></p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 285; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            option scheme (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_3" id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
post-IPO share option scheme&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 21pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
September 2019, the Company adopted the post-IPO share option scheme for the purpose of providing incentives and rewards to eligible
participants who have contributed or will contribute to the Group.  Eligible participants of the post-IPO share option scheme
include (a) any executive director of, manager of, or other employee holding an executive, managerial, supervisory or similar
position in any member of the Group, any full-time or part-time employee, or a person for the time being seconded to work full-time
or part-time for any member of the Group; (b) a director or proposed director (including an independent non-executive director) of
any member of the Group; (c) any substantial shareholder of any member of the Group; (d) a customer, consultant, business or joint
venture partner, franchisee, contractor, agent or representative of, a supplier of goods or services to, a person or entity that
provides design, research, development or other support or any advisory, consultancy, professional or other services to any member
of the Group; and (e) an associate of any of the persons referred to in paragraphs (a) to (c) above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 21pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
April 2025, the Company amended the post-IPO share option scheme. Under the amendments, eligible participants were restricted to (i)
Employee Participants (as defined under former paragraphs (a) and (b)) and (ii) Service Providers, and the categories previously set
out in former paragraphs (c), (d) and (e) were eliminated. In addition, the maximum number of shares which may be issued upon the exercise
of all Post-IPO share options was reduced from <ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72162">20,707,462</ix:nonFraction> to <ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72163">14,907,462</ix:nonFraction>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 21.7pt; text-align: justify; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">Under the post-IPO share option scheme, the maximum number of shares
issuable upon the exercise of all options granted under this and other Group plans shall not exceed <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfExceedShareCapital" scale="-2" unitRef="pure" id="ixv-72164">10</ix:nonFraction>% of the Company&#8217;s issued
share capital as of the listing date (including any outstanding, cancelled, lapsed, or unexercised options). The Company may, with separate
shareholder approval, grant options exceeding this limit, provided that any excess is granted only to eligible participants. The aggregate
number of shares subject to options granted under the Post-IPO Share Option Scheme and other Group plans shall not exceed <ix:nonFraction contextRef="c454" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfExceedShareCapital" scale="-2" unitRef="pure" id="ixv-72165">30</ix:nonFraction>% of the Group&#8217;s
issued share capital at the time of grant.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to any restriction contained in the post-IPO share option scheme, an option may be exercised in accordance with the terms of the post-IPO
share option scheme.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
November 26, 2025, the Company granted options to 33 grantees to subscribe for an aggregate of <ix:nonFraction contextRef="c463" decimals="0" format="ixt:num-dot-decimal" name="aapg:AggregateShareIssued" scale="0" unitRef="shares" id="ixv-72166">633,243</ix:nonFraction> shares under the post-IPO share
option scheme. Subject to the terms and conditions as set out in the Post-IPO share option scheme, <ix:nonFraction contextRef="c464" decimals="0" format="ixt:num-dot-decimal" name="aapg:SharesGranted" scale="0" unitRef="shares" id="ixv-72167">486,868</ix:nonFraction> shares granted to 25 grantees
are vested in the portions of <ix:nonNumeric contextRef="c465" name="aapg:PercentageOfVestedConditionalShares" id="ixv-72168">25%</ix:nonNumeric>, <ix:nonNumeric contextRef="c466" name="aapg:PercentageOfVestedConditionalShares" id="ixv-72169">25%</ix:nonNumeric>, <ix:nonNumeric contextRef="c467" name="aapg:PercentageOfVestedConditionalShares" id="ixv-72170">25%</ix:nonNumeric> and <ix:nonNumeric contextRef="c468" name="aapg:PercentageOfVestedConditionalShares" id="ixv-72171">25%</ix:nonNumeric> on the first, second, third and fourth anniversaries of the grant date of the options,
and the remaining options granted to eight grantees in respect of <ix:nonFraction contextRef="c469" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72172">146,375</ix:nonFraction> shares are vested in the portion of <ix:nonFraction contextRef="c469" decimals="4" format="ixt:num-dot-decimal" name="aapg:PercentageOfVestingRequirementsForSharebasedPaymentArrangement" scale="-2" unitRef="pure" id="ixv-72173">8.33</ix:nonFraction>% monthly on the 26th
of each month over an 11-month period starting from November 26, 2025, with the remaining <ix:nonFraction contextRef="c470" decimals="4" format="ixt:num-dot-decimal" name="aapg:PercentageOfVestingRequirementsForSharebasedPaymentArrangement" scale="-2" unitRef="pure" id="ixv-72174">8.37</ix:nonFraction>% to be vested on October 26, 2026. The
exercise price for each share under the post-IPO share options is HK$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="hkdPershares" id="ixv-72175">63.35</ix:nonFraction>.&#160;&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no cash settlement alternatives. The Group does not have a past practice of cash settlement for these share options. The Group accounts
for the scheme as an equity-settled plan. Share options do not confer rights on the holders to dividends or to vote at shareholders&#8217;
meetings.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<ix:continuation id="_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following share options were outstanding under the post-IPO share option scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 12pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 12pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c504" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72176">63.35</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-347; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c505" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72177">63.35</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c505" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72178">633,243</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised
    during the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c505" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72179">63.35</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-348; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December
    31</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c506" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72180">63.35</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c506" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72181">633,243</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 286; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            option scheme (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_4" id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices and exercise periods of the share options outstanding as at the end of the reporting period are as follows:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"></p>

<ix:continuation id="_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025
    Number of options</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    period</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 31%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c513" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-72182">633,243</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 31%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c513" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72183">63.35</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 30%; font-size: 10pt; text-align: center"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov
                                            26, 2025&#8211;Nov 26, 2035</span></p></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group granted <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72184">633,243</ix:nonFraction> new shares options under the Post-IPO Scheme during the year ended December 31, 2025 (2024: <span style="-sec-ix-hidden: hidden-fact-354">Nil</span>), and recognized
share option expense of RMB<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" scale="3" unitRef="cny" id="ixv-72185">2,420</ix:nonFraction> (US$<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" scale="3" unitRef="usd" id="ixv-72186">346</ix:nonFraction>) during the year ended December 31, 2025.</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise in full of the outstanding share options would, under the present capital structure of the Company, result in the issue of <ix:nonFraction contextRef="c471" decimals="0" format="ixt:num-dot-decimal" name="aapg:AdditionalOrdinaryShares" scale="0" unitRef="shares" id="ixv-72187">633,243</ix:nonFraction>
additional Ordinary Shares of the Company and additional share capital and share premium of US$<ix:nonFraction contextRef="c471" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="usd" id="ixv-72188">2,902</ix:nonFraction> equivalent to RMB<ix:nonFraction contextRef="c471" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="cny" id="ixv-72189">20,294</ix:nonFraction> (before
issue expenses) transferred from capital and other reserves.</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" id="ixv-58919"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the share options granted was estimated as at the grant date by using the binary tree option pricing model. The following
table lists the key inputs to the fair value model used:</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">At grant dates</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Expected volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-72190">49.65</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-72191">3.09</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life of options (year)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" unitRef="pure" id="ixv-72192">10.00</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Weighted average share price (HKD per share)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-72193">34.98</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs
                                            granted to employees</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 RSU Scheme</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 6, 2018, the Company approved and adopted the 2018 RSU Scheme. The purpose of the 2018 RSU scheme is to incentivize the existing
and incoming directors, senior management and employees for their contribution to the Company, and to attract, motivate and retain skilled
and experienced personnel to strive for the future development and expansion of the Company. Unless otherwise cancelled or amended, the
2018 RSU Scheme will remain in force for <ix:nonNumeric contextRef="c472" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="ixv-72194">10</ix:nonNumeric> years from the date of adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of RSUs that may be granted under the 2018 RSU Scheme in aggregate (excluding RSUs that have lapsed or been cancelled
in accordance with the rules of the 2018 RSU Scheme) shall be <ix:nonFraction contextRef="c472" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72195">5,274,657</ix:nonFraction> ordinary shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 14, 2020, pursuant to the 2018 RSU Scheme, <ix:nonFraction contextRef="c473" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72196">2,590,592</ix:nonFraction> RSUs were granted to 50 selected persons, who are employees of the Company.
The RSUs granted would vest on the third month from the grant date, and in equal tranches over the remaining years of the total vesting
period as <ix:nonNumeric contextRef="c473" format="ixt-sec:durwordsen" name="aapg:SharebasedPaymentVestingPeriod" id="ixv-72197">three years</ix:nonNumeric>, on condition that employees remain in service without any performance requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each RSU under the 2018 RSU Scheme at the grant date was determined by reference to the fair value of the ordinary shares
of the Company issued to its shareholders, using the market approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.4pt; text-align: justify; text-indent: -1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group did not recognize share-base payment expense during the year ended December 31, 2025 (2024: <span style="-sec-ix-hidden: hidden-fact-355">Nil</span>; 2023: RMB<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="0" unitRef="cny" id="ixv-72198">3,169</ix:nonFraction>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2023, all RSUs under the 2018 RSU Scheme had been exercised.</span></p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 287; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs
                                            granted to employees (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_5" id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 RSU Scheme</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">On
February 2, 2021, the Company approved and adopted the 2021 RSU Scheme The purpose of the 2021 RSU scheme is to (i) incentivize the existing
and incoming directors , senior management, and employees for their contribution to the Group; and (ii) attract, motivate, and retain
skilled and experienced personnel to strive for the future development and expansion of the Group by providing them with the opportunity
to own equity interests in the Company. Unless otherwise cancelled or amended, the 2021 RSU Scheme will remain in force for <ix:nonNumeric contextRef="c474" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="ixv-72199">10</ix:nonNumeric> years
from the date of adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
maximum number of RSUs that may be granted under the 2021 RSU Scheme in aggregate (excluding RSUs that have lapsed or been cancelled
in accordance with the 2021 Scheme Rules) shall be <ix:nonFraction contextRef="c475" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72200">3,133,526</ix:nonFraction> shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
April 30, 2025, the Company amended the 2021 RSU Scheme, thereby expanding the eligible participants by adding a service provider as
a new category of eligible participants.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
May 17, 2021, pursuant to the 2021 RSU Scheme, <ix:nonFraction contextRef="c476" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72201">440,490</ix:nonFraction> RSUs were granted to 34 selected persons, which include employees, senior management
of the Group, and a director of the Company. Among the awards, <ix:nonFraction contextRef="c477" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72202">10,641</ix:nonFraction> RSUs were granted to an independent non-executive director and <ix:nonFraction contextRef="c478" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72203">55,157</ix:nonFraction>
RSUs were granted to the Chief Commercial Officer. On July 23, 2021, <ix:nonFraction contextRef="c479" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72204">26,892</ix:nonFraction> RSUs were granted to three independent non-executive directors
of the Company. The RSUs granted were categorized in six types based on the vesting period and the proportion of shares that can be unlocked
upon each of the vesting dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_1" escape="true" name="aapg:DisclosureOfUnlockingDatetextBlock" id="ixv-59072"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant fair<br/> value HK$ <br/> per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of <br/> conditional <br/> shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested <br/>
conditional shares</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c514" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72205">43.80</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c514" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72206">100</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 20%; text-align: center"><ix:nonNumeric contextRef="c514" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59132"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2021-2024</span></ix:nonNumeric></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 19%; text-align: center"><ix:nonNumeric contextRef="c514" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59137"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c515" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72207">43.80</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c515" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72208">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c515" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59163"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2021-2024</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c515" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59168"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c516" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72209">43.80</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c516" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72210">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c516" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59194"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2022&#8211;2025</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c516" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59199"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c517" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72211">43.80</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c517" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72212">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c517" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59225"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2022&#8211;2025</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c517" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59230"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c518" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72213">43.80</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c518" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72214">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c518" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59256"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2022&#8211;2025</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c518" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59261"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c519" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72215">52.00</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c519" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72216">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c519" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59287"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2022&#8211;2025</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c519" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59292"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></ix:nonNumeric></td></tr> </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2025, <ix:nonFraction contextRef="c480" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72217">48,439</ix:nonFraction> RSUs were granted to 34 selected persons of the Commercialization Department.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_2" id="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant fair <br/>
value HK$ <br/>
per share</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of <br/>
conditional shares</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested<br/> conditional shares</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c520" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72218">77.45</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c520" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72219">100</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"><p style="margin: 0pt 0"><ix:nonNumeric contextRef="c520" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59362"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 27, 2025</span></ix:nonNumeric></p></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c520" continuedAt="aapg_PercentageOfVestedConditionalShares-c520_cont_1" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59369"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></ix:nonNumeric></td><td style="width: 1%; font-size: 10pt; text-align: left"><ix:continuation id="aapg_PercentageOfVestedConditionalShares-c520_cont_1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></ix:continuation></td></tr> </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
for the restricted shares granted to employees and senior management, the conditions for releasing the restrictions comprised two parts,
namely the participants have not been terminated with or without cause on or before each relevant vesting date and the participants have
obtained a score of B or above in the annual performance review prior to the applicable vesting date. The percentage of shares in respect
of which the restrictions may be released depends on the achievement of those conditions. For the independent non-executive directors,
the restricted shares would vest on condition that independent non-executive directors remain in service without any performance requirements.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 288; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><!-- Field: Split-Segment; Name: 11 --><div>
</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs
                                            granted to employees (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_6" id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" id="ixv-59441"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following restricted shares were outstanding under the 2021 RSU Scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024<br/>
    Number of<br/>
    RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025<br/>
    Number of<br/>
    RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c541" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72220">108,998</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c542" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72221">41,552</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c481" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72222">48,439</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c482" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72223">2,412</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-350; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    during the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c482" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72224">65,034</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c481" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72225">89,991</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December
    31</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c542" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72226">41,552</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-351; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each RSUs under the 2021 RSU Scheme at the grant date was determined by reference to the fair value of the ordinary shares
of the Company issued to its shareholders, using the market approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average share price at the date of exercise for RSUs exercised during the year was HK$<ix:nonFraction contextRef="c481" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72227">70.48</ix:nonFraction> per share (2024 HK$<ix:nonFraction contextRef="c482" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72228">20.80</ix:nonFraction> per share,
2023 HK$<ix:nonFraction contextRef="c483" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares" id="ixv-72229">19.96</ix:nonFraction> per share).</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized a share-base payment expense of RMB<ix:nonFraction contextRef="c481" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="3" unitRef="cny" id="ixv-72230">3,604</ix:nonFraction> (US$<ix:nonFraction contextRef="c481" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="3" unitRef="usd" id="ixv-72231">515</ix:nonFraction>) during the year ended December 31, 2025 (2024: RMB<ix:nonFraction contextRef="c482" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="3" unitRef="cny" id="ixv-72232">856</ix:nonFraction>; 2023: RMB<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="0" unitRef="usd" id="ixv-72233">1,589</ix:nonFraction>).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise in full of the outstanding RSUs would, under the present capital structure of the Company, result in additional share capital
and share premium of HK$<ix:nonFraction contextRef="c484" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="hkd" id="ixv-72234">1,894</ix:nonFraction>, equivalent to RMB<ix:nonFraction contextRef="c484" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="cny" id="ixv-72235">1,712</ix:nonFraction> (US$<ix:nonFraction contextRef="c484" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="usd" id="ixv-72236">245</ix:nonFraction>), transferred from capital and other reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 RSU Scheme</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
June 23, 2022, the Company approved and adopted the 2022 RSU Scheme. The purpose of the 2022 RSU scheme is to (i) incentivize the
existing and incoming directors, senior management, and employees for their contribution to the Group; and (ii) attract,
motivate, and retain skilled and experienced personnel to strive for the future development and expansion of the Group by providing
them with the opportunity to own equity interests in the Company. Unless otherwise cancelled or amended, the 2022 RSU Scheme will
remain in force for <ix:nonNumeric contextRef="c485" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="ixv-72237">10</ix:nonNumeric> years from the date of adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
maximum number of RSUs that may be granted under the 2022 RSU Scheme in aggregate (excluding RSUs that have lapsed or been cancelled
in accordance with the 2022 Scheme Rules) shall be <ix:nonFraction contextRef="c486" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72238">11,072,695</ix:nonFraction> shares. &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt"><span style="font-family: Times New Roman, Times, Serif">On
April 30, 2025, the Company amended the 2022 RSU Scheme, thereby expanding the eligible participants by adding a service provider as
a new category of eligible participants.</span></p></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 289; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs
                                            granted to employees (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_7" id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
for the restricted shares granted to employees and senior management under the 2022 RSU Scheme, the conditions for releasing the restrictions
comprised two parts, namely the participants having not been terminated with or without cause on or before each relevant vesting date
and the participants having obtained a score of B or above in the annual performance review prior to the applicable vesting date. The
percentage of shares in respect of which the restrictions may be released depends on the achievement of those conditions.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the 2022 RSU Scheme, on June 23, 2022, the Company initially granted an aggregate of <ix:nonFraction contextRef="c487" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72239">1,634,426</ix:nonFraction> RSUs under the 2022 RSU Scheme (the
&#8220;2022 Awards&#8221;), representing <ix:nonFraction contextRef="c487" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72240">1,634,426</ix:nonFraction> shares to a total of 80 selected persons, who are employees of the Group, among which
<ix:nonFraction contextRef="c488" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72241">100,000</ix:nonFraction> RSUs, representing <ix:nonFraction contextRef="c489" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72242">100,000</ix:nonFraction> shares, were granted to Dr. Zhai Yifan (&#8220;Dr. Zhai&#8221;), who is the chief medical officer
and a substantial shareholder of the Company. The RSUs granted were categorized in six types based on the vesting period and the proportion
of shares that can be unlocked upon each vesting date.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation continuedAt="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_3" id="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type of eligible participants</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant fair value HK$ per share</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>% of conditional shares</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting date</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>% of vested conditional shares</b></span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c521" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72243">20.15</ix:nonFraction></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c521" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72244">100</ix:nonFraction></span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c521" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59716"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2021-2024</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c521" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59721"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="width: 31%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 9%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c522" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72245">20.15</ix:nonFraction></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 9%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c522" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72246">100</ix:nonFraction></span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 23%; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c522" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59745"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2023&#8211;2026</span></ix:nonNumeric></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c522" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59750"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c523" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72247">20.15</ix:nonFraction></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c523" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72248">100</ix:nonFraction></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c523" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59774"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2023&#8211;2026</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c523" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59779"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c524" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72249">20.15</ix:nonFraction></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c524" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72250">100</ix:nonFraction></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c524" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59803"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2023&#8211;2024</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c524" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59808"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%, 60%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c525" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72251">20.15</ix:nonFraction></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c525" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72252">100</ix:nonFraction></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c525" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59832"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2023&#8211;2025</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c525" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59837"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%, 30%, 40%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c526" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72253">20.15</ix:nonFraction></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c526" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72254">100</ix:nonFraction></span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c526" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59861"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2023&#8211;2026</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c526" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59866"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23%, 69%, 6%, 2%</span></ix:nonNumeric></td></tr> </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the 2022 RSU Scheme, on May 4, 2023, the Company granted <ix:nonFraction contextRef="c490" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72255">1,379,094</ix:nonFraction> RSUs under the 2022 RSU Scheme, representing <ix:nonFraction contextRef="c491" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72256">1,379,094</ix:nonFraction> shares to
172 selected persons (the &#8220;2022 Further Grant&#8221;), who are employees of the Group. The RSUs granted were categorized in two
types based on the vesting period and the proportion of shares that can be unlocked upon each vesting date.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 290; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs
                                            granted to employees (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_8" id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_7"><ix:continuation continuedAt="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_4" id="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant <br/> fair value<br/> HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of<br/> conditional<br/> shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested conditional shares</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c527" decimals="1" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72257">21.8</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c527" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72258">100</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 23%; text-align: center"><ix:nonNumeric contextRef="c527" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-59987"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 1, 2023&#8211;2024</span></ix:nonNumeric></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 20%; text-align: center"><ix:nonNumeric contextRef="c527" name="aapg:PercentageOfVestedConditionalShares" id="ixv-59992"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%, 60%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c528" decimals="1" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72259">21.8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c528" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72260">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c528" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 1, 2023&#8211;2025</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c528" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%, 30%, 40%</span></ix:nonNumeric></td></tr> </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the 2022 RSU Scheme, on September 2, 2024, the Company granted <ix:nonFraction contextRef="c492" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72261">777,006</ix:nonFraction> RSUs under the 2022 RSU Scheme, representing <ix:nonFraction contextRef="c493" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72262">777,006</ix:nonFraction> shares
to 59 selected persons (the &#8220;2022 Further Grant&#8221;), who are employees of the Group. The RSUs granted were categorized in ten
types based on the vesting period and the proportion of shares that can be unlocked upon each vesting date.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:continuation continuedAt="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_5" id="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_4"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Type of eligible participants</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Grant fair value HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">% of conditional shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Vesting date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">% of vested conditional shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c529" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72263">33.95</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c529" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72264">100</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 20%; text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c529" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60083"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024</span></ix:nonNumeric></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 21%; text-align: center"><ix:nonNumeric contextRef="c529" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60090"><span style="font-family: Times New Roman, Times, Serif">100%</span></ix:nonNumeric></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c530" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72265">33.95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c530" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72266">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c530" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60116"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2025</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><ix:nonNumeric contextRef="c530" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60123"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75%, 25%</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c531" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72267">33.95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c531" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72268">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c531" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60149"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2025</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><ix:nonNumeric contextRef="c531" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60156"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%, 50%</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c532" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72269">33.95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c532" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72270">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c532" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60182"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><ix:nonNumeric contextRef="c532" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60189"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%, 30%, 40%</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c533" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72271">33.95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c533" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72272">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c533" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60215"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><ix:nonNumeric contextRef="c533" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60222"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.5%, 22.5%, 55%</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c534" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72273">33.95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c534" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72274">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c534" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60248"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><ix:nonNumeric contextRef="c534" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60255"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%, 25%, 25</span><span style="font-family: Times New Roman, Times, Serif">%</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">7</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c535" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72275">33.95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c535" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72276">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c535" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60282"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><ix:nonNumeric contextRef="c535" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60289"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 37%, 38</span><span style="font-family: Times New Roman, Times, Serif">%</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">8</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c536" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72277">33.95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c536" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72278">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c536" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60316"><span style="font-family: Times New Roman, Times, Serif">September 16, 2025</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><ix:nonNumeric contextRef="c536" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60323"><span style="font-family: Times New Roman, Times, Serif">100%</span></ix:nonNumeric></td><td style="text-align: left"/></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">9</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c537" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72279">33.95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c537" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72280">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c537" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60348"><span style="font-family: Times New Roman, Times, Serif">September 16, 2025-2026</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><ix:nonNumeric contextRef="c537" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60355"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%, 60</span><span style="font-family: Times New Roman, Times, Serif">%</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c538" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72281">33.95</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c538" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72282">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c538" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60382"><span style="font-family: Times New Roman, Times, Serif">September 16, 2025-2026</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><ix:nonNumeric contextRef="c538" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60389"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%, 50</span><span style="font-family: Times New Roman, Times, Serif">%</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the 2022 RSU Scheme, on November 26, 2025, the Company granted <ix:nonFraction contextRef="c494" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72283">1,177,256</ix:nonFraction> RSUs under the 2022 RSU Scheme, representing <ix:nonFraction contextRef="c463" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72284">1,177,256</ix:nonFraction> shares
to 145 selected persons, who are employees of the Group, among which <ix:nonFraction contextRef="c495" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72285">143,363</ix:nonFraction> RSUs, representing <ix:nonFraction contextRef="c496" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72286">143,363</ix:nonFraction> shares, were granted to Dr. Yang
Dajun (&#8220;Dr. Yang&#8221;), who is the chief executive officer of the Company. The RSUs granted were categorized in six types based
on the vesting period and the proportion of shares that can be unlocked upon each vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DisclosureOfUnlockingDatetextBlock-c0_cont_5"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td> <td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant
fair<br/> value HK$<br/>
per&#160;share</span></td> <td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of <br/> conditional <br/> shares</span></td> <td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested<br/> conditional shares</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c539" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72287">63.35</ix:nonFraction></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c539" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72288">100</ix:nonFraction></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c539" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60457"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 26, 2026-2028</span></ix:nonNumeric></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; width: 19%; font-size: 10pt; text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c539" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60462"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.33%, 33.33%, 33.34%</span></ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c540" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72289">63.35</ix:nonFraction></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c540" decimals="2" format="ixt:num-dot-decimal" name="aapg:PercentageOfConditionalShares" scale="-2" unitRef="pure" id="ixv-72290">100</ix:nonFraction></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c540" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" id="ixv-60488"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 26, 2026-2029</span></ix:nonNumeric></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c540" name="aapg:PercentageOfVestedConditionalShares" id="ixv-60493"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></ix:nonNumeric></td></tr> </table></ix:continuation></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 291; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs
                                            granted to employees (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_8"><ix:continuation id="_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following restricted shares were outstanding under the 2022 RSU Scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024&#160;Number of&#160;RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025&#160;Number of&#160;RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c499" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72291">1,641,974</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c498" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72292">1,436,525</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c501" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72293">777,006</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c500" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72294">1,177,256</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c501" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72295">42,768</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c500" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72296">132,302</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    during the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c501" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72297">939,687</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c500" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72298">936,187</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December
    31</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c498" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72299">1,436,525</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c497" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-72300">1,545,292</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each RSU under the 2022 RSU Scheme at the grant date was determined by reference to the fair value of the ordinary shares
of the Company issued to its shareholders, using the market approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2022 RSU Scheme, the fair value of the RSUs granted during the year ended December 31, 2025 amounted to RMB<ix:nonFraction contextRef="c497" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RSUsGrantedFairValue" scale="3" unitRef="cny" id="ixv-72301">68,327</ix:nonFraction> (US$<ix:nonFraction contextRef="c497" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RSUsGrantedFairValue" scale="3" unitRef="usd" id="ixv-72302">9,771</ix:nonFraction>)
(2024: RMB<ix:nonFraction contextRef="c498" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RSUsGrantedFairValue" scale="3" unitRef="cny" id="ixv-72303">24,078</ix:nonFraction>, 2023: RMB<ix:nonFraction contextRef="c499" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RSUsGrantedFairValue" scale="3" unitRef="cny" id="ixv-72304">27,063</ix:nonFraction>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average share price at the date of exercise for RSUs exercised during the year through the treasury was HK$<ix:nonFraction contextRef="c500" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72305">20.14</ix:nonFraction> per share (2024:
HK$<ix:nonFraction contextRef="c501" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72306">19.24</ix:nonFraction> per share, 2023: HK$<ix:nonFraction contextRef="c502" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72307">18.15</ix:nonFraction> per share) and through the issuance was HK$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" scale="0" unitRef="hkdPershares" id="ixv-72308">79.35</ix:nonFraction> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized a share-base payment expense of RMB<ix:nonFraction contextRef="c500" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="3" unitRef="cny" id="ixv-72309">14,850</ix:nonFraction> (US$<ix:nonFraction contextRef="c500" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="3" unitRef="usd" id="ixv-72310">2,124</ix:nonFraction>) for the year ended December 31, 2025 (2024: RMB<ix:nonFraction contextRef="c501" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="3" unitRef="cny" id="ixv-72311">20,068</ix:nonFraction>, 2023:
RMB<ix:nonFraction contextRef="c502" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ShareGrantExpense" scale="3" unitRef="cny" id="ixv-72312">22,995</ix:nonFraction>).</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise in full of the outstanding RSUs would, under the present capital structure of the Company, result in additional share capital
and share premium of HK$<ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="hkd" id="ixv-72313">85,945</ix:nonFraction>, equivalent to RMB<ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="cny" id="ixv-72314">78,740</ix:nonFraction> (US$<ix:nonFraction contextRef="c503" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="usd" id="ixv-72315">11,260</ix:nonFraction>), transferred from capital and other reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no cash settlement alternatives. The Group does not have a past practice of cash settlement for these RSUs. The Group accounts for
the scheme as an equity-settled plan.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCashFlowStatementExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfCashFlowStatementExplanatory" id="ixv-60699"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
                                            TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
                                            non-cash transactions</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">During the year ended December <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,
2025, the Company granted <ix:nonFraction contextRef="c505" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" unitRef="pure" id="ixv-72316">633,243</ix:nonFraction> options (2024: <span style="-sec-ix-hidden: hidden-fact-377">Nil</span>, 2023: <span style="-sec-ix-hidden: hidden-fact-378">Nil</span>) under the Post-IPO option scheme to <ix:nonFraction contextRef="c506" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfGrantees" scale="0" unitRef="pure" id="ixv-72317">33</ix:nonFraction> grantees. </span></p></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">During the year ended December <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,
2025, the Company issued <ix:nonFraction contextRef="c543" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72318">48,439</ix:nonFraction> RSUs under the 2021 RSU scheme to <ix:nonFraction contextRef="c543" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfGrantees" scale="0" unitRef="pure" id="ixv-72319">34</ix:nonFraction> grantees and <ix:nonFraction contextRef="c544" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72320">1,177,256</ix:nonFraction> RSUs under the 2022 RSU scheme to <ix:nonFraction contextRef="c544" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfGrantees" scale="0" unitRef="pure" id="ixv-72321">145</ix:nonFraction> grantees.
During the year ended December 31, 2024, the Company granted <span style="-sec-ix-hidden: hidden-fact-379">nil</span> RSUs under 2021RSU and granted <ix:nonFraction contextRef="c546" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfGrantees" scale="0" unitRef="pure" id="ixv-72322">777,006</ix:nonFraction> RSUs under the 2022 RSU scheme
to <ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfGrantees" scale="0" unitRef="pure" id="ixv-72323">59</ix:nonFraction> grantees. During the year ended December 31, 2023, the Company granted <span style="-sec-ix-hidden: hidden-fact-380">nil</span> RSUs under 2021RSU and granted <ix:nonFraction contextRef="c548" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72324">1,379,094</ix:nonFraction> RSUs under the
2022 RSU scheme to <ix:nonFraction contextRef="c548" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfGrantees" scale="0" unitRef="pure" id="ixv-72325">172</ix:nonFraction> grantees.</span></p></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">During the year ended December <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,
2025, the Company issued <ix:nonFraction contextRef="c549" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-72326">1,592,607</ix:nonFraction> newly issued shares to employees including <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="aapg:NumberOfNewlyIssuedShares" scale="0" unitRef="shares" id="ixv-72327">176,278</ix:nonFraction> newly issued shares to Dr. Zhai as settlement of
bonus of RMB<ix:nonFraction contextRef="c550" decimals="-3" format="ixt:num-dot-decimal" name="aapg:BonusAmount" scale="3" unitRef="cny" id="ixv-72328">58,869</ix:nonFraction> (US$<ix:nonFraction contextRef="c550" decimals="-3" format="ixt:num-dot-decimal" name="aapg:BonusAmount" scale="3" unitRef="usd" id="ixv-72329">8,418</ix:nonFraction>) (2024: RMB<ix:nonFraction contextRef="c551" decimals="-3" format="ixt:num-dot-decimal" name="aapg:BonusAmount" scale="3" unitRef="cny" id="ixv-72330">49,350</ix:nonFraction>, 2023: RMB<ix:nonFraction contextRef="c552" decimals="-3" format="ixt:num-dot-decimal" name="aapg:BonusAmount" scale="3" unitRef="usd" id="ixv-72331">55,468</ix:nonFraction>).</span></p></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td><td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year ended December 31, 2025, the Group had non-cash additions
to right-of-use assets and lease liabilities of RMB<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" scale="3" unitRef="cny" id="ixv-72332">5,047</ix:nonFraction> (US$<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" scale="3" unitRef="usd" id="ixv-72333">722</ix:nonFraction>) (2024: RMB<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" scale="3" unitRef="cny" id="ixv-72334">17,108</ix:nonFraction>,2023: RMB<ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" scale="3" unitRef="cny" id="ixv-72335">16,194</ix:nonFraction>), and non-cash disposals of RMB<ix:nonFraction contextRef="c553" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashDisposals" scale="3" unitRef="cny" id="ixv-72336">2,675</ix:nonFraction>
(US$<ix:nonFraction contextRef="c553" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashDisposals" scale="3" unitRef="usd" id="ixv-72337">382</ix:nonFraction>) and RMB<ix:nonFraction contextRef="c82" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashDisposals" scale="3" unitRef="cny" id="ixv-72338">3,360</ix:nonFraction> (US$<ix:nonFraction contextRef="c82" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashDisposals" scale="3" unitRef="usd" id="ixv-72339">480</ix:nonFraction>) (2024: RMB<ix:nonFraction contextRef="c554" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashDisposals" scale="3" unitRef="cny" id="ixv-72340">1,067</ix:nonFraction> and RMB<ix:nonFraction contextRef="c555" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashDisposals" scale="3" unitRef="cny" id="ixv-72341">1,152</ix:nonFraction>,2023:<span style="-sec-ix-hidden: hidden-fact-381">Nil</span> and <span style="-sec-ix-hidden: hidden-fact-382">Nil</span>), respectively, in respect of lease arrangements for buildings.</p>
</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td><td style="text-align: left"><p style="margin: 0pt 0">As at December 31, 2025, 2024 and 2023, the Group had non-cash additions to intangible assets of <span style="-sec-ix-hidden: hidden-fact-383">nil</span>, RMB<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NoncashAdditionsToIntangibleAssets" scale="3" unitRef="cny" id="ixv-72342">1,403</ix:nonFraction>,
and RMB<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NoncashAdditionsToIntangibleAssets" scale="3" unitRef="cny" id="ixv-72343">805</ix:nonFraction>, respectively, and non-cash additions to property, plant and equipment of RMB <ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashAdditionsToPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-72344">10,011</ix:nonFraction>(US$<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashAdditionsToPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-72345">1,432</ix:nonFraction>), RMB<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashAdditionsToPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-72346">9,424</ix:nonFraction> and RMB<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:NonCashAdditionsToPropertyPlantAndEquipment" scale="3" unitRef="cny" id="ixv-72347">26,823</ix:nonFraction>, respectively,
included in other payables and accruals.</p></td></tr> </table></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 292; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
                                            TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfCashFlowStatementExplanatory-c0_cont_2" id="_DisclosureOfCashFlowStatementExplanatory-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" id="ixv-60831"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in liabilities arising from financing activities</span></ix:nonNumeric></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other payables</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accruals</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other loans</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2023</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c556" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72348">383</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c557" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72349">1,775,505</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c558" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72350">17,222</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    from financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c559" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72351">91,027</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c560" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72352">2,591</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c561" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72353">10,766</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    leases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-356; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-357; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c561" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72354">16,194</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c559" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="3" unitRef="cny" id="ixv-72355">91,690</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-358; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c561" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="3" unitRef="cny" id="ixv-72356">1,321</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid classified as financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-359; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-360; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c561" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-72357">1,321</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of change in foreign exchange rates</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-361; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-362; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c561" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-72358">31</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c562" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72359">1,046</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c563" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72360">1,772,914</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c564" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72361">22,681</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other payables<br/> and accruals</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other loans</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c565" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72362">1,046</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c566" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72363">1,772,914</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c567" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72364">22,681</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    from financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c568" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72365">59,057</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c569" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72366">136,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c570" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72367">8,413</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    leases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-363; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-364; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c570" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72368">17,108</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c570" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" scale="3" sign="-" unitRef="cny" id="ixv-72369">1,152</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c568" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="3" unitRef="cny" id="ixv-72370">59,276</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c569" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="3" unitRef="cny" id="ixv-72371">2,279</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c570" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="3" unitRef="cny" id="ixv-72372">1,498</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid classified as financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-365; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-366; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c570" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-72373">1,498</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of change in foreign exchange rates</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-367; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-368; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c570" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-72374">8</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c571" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72375">1,265</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c572" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72376">1,638,265</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c573" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72377">30,232</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other payables</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accruals</span></p></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other loans</span></p></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities</span></p></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2025</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c574" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72378">1,265</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c575" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72379">1,638,265</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c576" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72380">30,232</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    from financing cash flows</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c577" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72381">50,190</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c578" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72382">316,980</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c579" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72383">9,717</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    leases</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-369; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-370; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c579" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72384">5,047</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-371; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-372; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c579" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" scale="3" sign="-" unitRef="cny" id="ixv-72385">3,360</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c577" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="3" unitRef="cny" id="ixv-72386">49,534</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c578" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="3" unitRef="cny" id="ixv-72387">2,278</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c579" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="3" unitRef="cny" id="ixv-72388">1,118</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid classified as financing cash flows</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-373; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-374; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c579" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-72389">1,118</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of change in foreign exchange rates</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-375; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-376; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c579" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" sign="-" unitRef="cny" id="ixv-72390">6</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c580" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72391">609</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c581" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72392">1,957,523</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c582" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="cny" id="ixv-72393">22,196</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c580" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="usd" id="ixv-72394">87</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c581" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="usd" id="ixv-72395">279,922</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c582" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="3" unitRef="usd" id="ixv-72396">3,174</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 293; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
                                            TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfCashFlowStatementExplanatory-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            cash outflow for leases</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" id="ixv-61775"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total cash outflow for leases included in the statements of cash flows is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within operating
    activities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" scale="3" unitRef="cny" id="ixv-72397">181</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" scale="3" unitRef="cny" id="ixv-72398">238</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" scale="3" unitRef="cny" id="ixv-72399">329</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" scale="3" unitRef="usd" id="ixv-72400">47</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    financing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-72401">12,087</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-72402">9,911</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="3" unitRef="cny" id="ixv-72403">10,835</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" scale="3" unitRef="usd" id="ixv-72404">1,549</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CashInflowOutflowForLease" scale="3" unitRef="cny" id="ixv-72405">12,268</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CashInflowOutflowForLease" scale="3" unitRef="cny" id="ixv-72406">10,149</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CashInflowOutflowForLease" scale="3" unitRef="cny" id="ixv-72407">11,164</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CashInflowOutflowForLease" scale="3" unitRef="usd" id="ixv-72408">1,596</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfCommitmentsExplanatory" id="ixv-61980"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMITMENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2025, the Group had capital commitments of RMB<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalCommitments" scale="3" unitRef="cny" id="ixv-72409">307</ix:nonFraction> (US$<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalCommitments" scale="3" unitRef="usd" id="ixv-72410">44</ix:nonFraction>) relating to furniture and equipment (2024: RMB<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalCommitments" scale="3" unitRef="cny" id="ixv-72411">4,366</ix:nonFraction>).</span></p></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group has no lease contracts that have not yet commenced as at December 31, 2025.</span></p></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group enters into business agreements with institutions to license intellectual property.
                                            The Group may be obligated to make future research and developmental milestone payments,
                                            regulatory and commercial milestone payments and royalty payments on future sales of specified
                                            products associated with the agreements. Payments under these agreements generally become
                                            due and payable upon achievement of such milestones or sales. These commitments are not recorded
                                            on the consolidated financial statements because the achievement and timing of these milestones
                                            are not fixed and determinable. When the achievement of these milestones or sales has occurred,
                                            the corresponding amounts are recognized in the consolidated financial statements.</span></td>
</tr></table></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfContingentLiabilitiesExplanatory" id="ixv-62021"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTINGENT
                                            LIABILITIES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group had <span style="-sec-ix-hidden: hidden-fact-384">no</span> significant contingent liabilities as at the end of the reporting date.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfPledgeOfAssetsExplanatory" id="ixv-62038"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLEDGE
                                            OF ASSETS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the Group&#8217;s assets pledged for the Group&#8217;s bank loans are included in note 27 to the consolidated financial statements.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 294; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" id="ixv-62090"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">36.</span></td><td style="text-align: justify"><span style="font-size: 10pt">RELATED PARTY TRANSACTIONS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">a)</span></td><td style="text-align: left"><span style="font-size: 10pt">Apart
                                            from the transactions detailed elsewhere in this financial information, the Group had no
                                            transactions with related parties during the years ended December 31, 2023, 2024 and 2025.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">b)</td><td style="text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureofTransactionWithRelatedPartyExplanatory-c0_cont_1" escape="true" name="aapg:DisclosureofTransactionWithRelatedPartyExplanatory" id="ixv-62112"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">T</span>ransaction
with a related party</p></ix:nonNumeric>
</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt">&#160;</p>

<ix:continuation id="aapg_DisclosureofTransactionWithRelatedPartyExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Dr. Zhai Yifan</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c587" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="3" unitRef="cny" id="ixv-72412">29,533</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c587" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="3" unitRef="usd" id="ixv-72413">4,223</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Dr. Yang Dajun</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c589" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="3" unitRef="cny" id="ixv-72414">3,933</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c589" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="3" unitRef="usd" id="ixv-72415">562</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="3" unitRef="cny" id="ixv-72416">33,466</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="3" unitRef="usd" id="ixv-72417">4,785</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in">&#160;</td> <td style="text-align: left"><span style="font-size: 10pt">According to the HealthQuest Pharma Acquisition Agreement, a contingent consideration of RMB<ix:nonFraction contextRef="c583" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" scale="3" unitRef="cny" id="ixv-72418">29,533</ix:nonFraction> (US$<ix:nonFraction contextRef="c583" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" scale="3" unitRef="usd" id="ixv-72419">4,223</ix:nonFraction>) due to Dr. Zhai was recognized during the year ended December 31, 2025.</span></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left"><span style="font-size: 10pt">On 17 July 2025, the Company borrowed <ix:nonFraction contextRef="c584" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72420">22,000,000</ix:nonFraction> ordinary shares of the Company from Dr. Yang to fulfil a placement to designated subscribers within the required timeline. The borrowed shares were returned to Dr. Yang on 29 July 2025 through the issuance of new shares, accompanied by a contractual borrowing cost payment of RMB <ix:nonFraction contextRef="c585" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingCostsIncurred" scale="3" unitRef="cny" id="ixv-72421">3,933</ix:nonFraction>, which was recorded as a reduction in equity in connection with such issuance.</span></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td><span style="font-size: 10pt">c)</span></td> <td style="text-align: left"><ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory-c0_cont_1" escape="true" name="aapg:DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" id="ixv-72422">Outstanding balance with a related party</ix:nonNumeric></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Other payables and accruals</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OtherPayablesAndAccruals" scale="3" unitRef="cny" id="ixv-72423">29,344</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OtherPayablesAndAccruals" scale="3" unitRef="cny" id="ixv-72424">10,308</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OtherPayablesAndAccruals" scale="3" unitRef="usd" id="ixv-72425">1,474</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OutstandingBalanceOtherNoncurrentLiabilities" scale="3" unitRef="cny" id="ixv-72426">6,374</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OutstandingBalanceOtherNoncurrentLiabilities" scale="3" unitRef="usd" id="ixv-72427">911</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total for Dr. Zhai Yifan</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OutstandingBalanceWithRelatedParty" scale="3" unitRef="cny" id="ixv-72428">29,344</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OutstandingBalanceWithRelatedParty" scale="3" unitRef="cny" id="ixv-72429">16,682</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:OutstandingBalanceWithRelatedParty" scale="3" unitRef="usd" id="ixv-72430">2,385</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: left">In accordance with the acquisition agreement, payable to Dr. Zhai Yifan represented the contingent consideration
related to the acquisition of Guangzhou HealthQuest Pharma Co., Ltd.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">d)</span></td><td style="text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" id="ixv-62337"><span style="font-size: 10pt">Compensation of key management
personnel of the Group:</span></ix:nonNumeric></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td colspan="16" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For
                                            the years ended December 31,</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>RMB</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>RMB</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>RMB</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>US$</b></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Short term employee benefits and fees &#160; </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" unitRef="cny" id="ixv-72431">20,118</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" unitRef="cny" id="ixv-72432">19,059</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" unitRef="cny" id="ixv-72433">59,283</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" unitRef="usd" id="ixv-72434">8,477</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Equity-settled share-based payment expenses &#160; </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" unitRef="cny" id="ixv-72435">1,763</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" unitRef="cny" id="ixv-72436">625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" unitRef="cny" id="ixv-72437">3,141</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" unitRef="usd" id="ixv-72438">449</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Post-employment benefits &#160; </td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" unitRef="cny" id="ixv-72439">986</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" unitRef="cny" id="ixv-72440">977</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" unitRef="cny" id="ixv-72441">711</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" unitRef="usd" id="ixv-72442">102</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total &#160; </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" unitRef="cny" id="ixv-72443">22,867</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" unitRef="cny" id="ixv-72444">20,661</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" unitRef="cny" id="ixv-72445">63,135</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" unitRef="usd" id="ixv-72446">9,028</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 295; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in thousands of Renminbi (&#8220;RMB&#8221;)
and US dollars (&#8220;US$&#8221;)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>except for number of shares and per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory" id="ixv-62538"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">37.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">FINANCIAL INSTRUMENTS BY CATEGORY</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" id="ixv-62546"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The carrying amounts of each of the categories of financial
instruments as at the end of each reporting period are as follows:</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory-c0_cont_2" id="_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>assets at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>fair value </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>through </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>profit or </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>loss</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>assets at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>amortized </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>cost</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Financial assets included in prepayments, other receivables and other assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c591" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72447">9,846</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c592" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72448">9,846</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Cash and bank balances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c591" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-72449">1,261,211</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c592" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-72450">1,261,211</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c591" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentReceivables" scale="3" unitRef="cny" id="ixv-72451">83,143</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c592" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentReceivables" scale="3" unitRef="cny" id="ixv-72452">83,143</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Financial assets at FVTPL</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c590" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72453">1,141</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c592" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72454">1,141</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Financial assets included in other non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-393">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c591" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-72455">2,439</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c592" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-72456">2,439</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c590" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72457">1,141</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c591" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72458">1,356,639</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c592" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72459">1,357,780</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>fair value </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>through </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>profit or </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>loss</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>amortized </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>cost</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Interest-bearing bank and other borrowings (current and non-current portions)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c594" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="3" unitRef="cny" id="ixv-72460">1,668,497</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c595" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="3" unitRef="cny" id="ixv-72461">1,668,497</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">&#160;&#160;&#160;&#160;-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c594" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72462">91,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c595" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72463">91,966</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Financial liabilities included in other payables and accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c594" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" unitRef="cny" id="ixv-72464">103,014</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c595" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" unitRef="cny" id="ixv-72465">103,014</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Other non-current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c594" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" scale="3" unitRef="cny" id="ixv-72466">6,274</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c595" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" scale="3" unitRef="cny" id="ixv-72467">6,274</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c594" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="cny" id="ixv-72468">1,869,751</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c595" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="cny" id="ixv-72469">1,869,751</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 296; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in thousands of Renminbi (&#8220;RMB&#8221;)
and US dollars (&#8220;US$&#8221;)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>except for number of shares and per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">37.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">FINANCIAL INSTRUMENTS BY CATEGORY (continued)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/>
 assets at<br/>
 fair value<br/>
 through<br/>
 profit or<br/>
 loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial assets at amortized cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt">Financial assets included in prepayments, other receivables and other assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c597" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72470">3,609</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72471">3,609</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-72472">516</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Cash and bank balances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c597" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-72473">2,470,085</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-72474">2,470,085</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-72475">353,217</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c597" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentReceivables" scale="3" unitRef="cny" id="ixv-72476">252,938</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentReceivables" scale="3" unitRef="cny" id="ixv-72477">252,938</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentReceivables" scale="3" unitRef="usd" id="ixv-72478">36,170</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Financial assets at FVTPL</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c596" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72479">4,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72480">4,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-72481">572</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Financial assets included in other non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c597" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-72482">690</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-72483">690</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="usd" id="ixv-72484">99</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c596" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72485">4,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c597" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72486">2,727,322</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72487">2,731,322</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c598" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="usd" id="ixv-72488">390,574</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>fair value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>through</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>profit or</b></p>

<p style="margin: 0pt 0"><b>loss</b></p>

</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at amortized</b></p>

<p style="margin: 0pt 0"><b>cost</b></p>

</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt">Interest-bearing bank and other borrowings (current and non-current portions)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c600" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="3" unitRef="cny" id="ixv-72489">1,979,719</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c601" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="3" unitRef="cny" id="ixv-72490">1,979,719</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c601" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="3" unitRef="usd" id="ixv-72491">283,096</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c600" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72492">106,740</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c601" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72493">106,740</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c601" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="usd" id="ixv-72494">15,264</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Financial liabilities included in other payables and accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c599" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" unitRef="cny" id="ixv-72495">1,968</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c600" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" unitRef="cny" id="ixv-72496">138,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c601" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" unitRef="cny" id="ixv-72497">140,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">20<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,084</span></div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c599" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="cny" id="ixv-72498">6,374</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c600" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="cny" id="ixv-72499">5,657</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c601" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="cny" id="ixv-72500">12,031</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c601" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="usd" id="ixv-72501">1,720</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c599" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="cny" id="ixv-72502">8,342</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c600" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="cny" id="ixv-72503">2,230,598</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c601" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="cny" id="ixv-72504">2,238,940</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c601" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="usd" id="ixv-72505">320,164</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 297; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory" id="ixv-63303"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-size: 10pt">38.</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" id="ixv-63311"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Group&#8217;s financial instruments, other than those with carrying amounts that reasonably approximate to fair
values, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="22" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Carrying
    amounts</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Fair
    values</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Financial assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial
    assets at FVTPL</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72506">1,141</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72507">4,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-72508">572</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c602" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72509">1,141</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72510">4,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-72511">572</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial
    assets included in other non-current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-72512">2,439</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-72513">690</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="usd" id="ixv-72514">99</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c602" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-72515">2,311</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="cny" id="ixv-72516">624</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="3" unitRef="usd" id="ixv-72517">89</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72518">3,580</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72519">4,690</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="usd" id="ixv-72520">671</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c602" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72521">3,452</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72522">4,624</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="usd" id="ixv-72523">661</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial liabilities
    included in other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-407; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="cny" id="ixv-72524">1,968</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="usd" id="ixv-72525">282</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-408; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="cny" id="ixv-72526">1,968</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="usd" id="ixv-72527">281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Other non-current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="cny" id="ixv-72528">6,274</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="cny" id="ixv-72529">12,031</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="usd" id="ixv-72530">1,720</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c602" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="cny" id="ixv-72531">5,742</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="cny" id="ixv-72532">11,706</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="3" unitRef="usd" id="ixv-72533">1,674</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Non-current
    portion of interest-bearing bank and other borrowings (other than lease liabilities)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-72534">868,642</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-72535">742,325</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="usd" id="ixv-72536">106,151</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c602" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-72537">859,707</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="cny" id="ixv-72538">709,342</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="3" unitRef="usd" id="ixv-72539">101,435</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="cny" id="ixv-72540">874,916</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="cny" id="ixv-72541">756,324</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="usd" id="ixv-72542">108,153</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c602" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="cny" id="ixv-72543">865,449</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="cny" id="ixv-72544">723,016</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="3" unitRef="usd" id="ixv-72545">103,390</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has assessed that the fair values of cash and bank balances, trade receivables, financial assets included in prepayments, deposits and
other receivables, trade payables, the current portion of long-term payables, the current portion of interest-bearing bank and other
borrowings, financial liabilities included in other payables, and accruals approximate to their carrying amounts largely due to the short-term
maturities of these instruments, or the interest rate being approximate to the discount rate of current market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s finance department is responsible for determining the policies and procedures for the fair value measurement of financial
instruments. The finance manager reports directly to the chief financial officer and the audit committee. At each reporting date, the
finance department analyses the movements in the values of financial instruments and determines the major inputs applied in the valuation.
The directors review the results of the fair value measurement of financial instruments periodically for annual financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current
transaction between willing parties, other than in a forced or liquidation sale. The following methods and assumptions were used to estimate
the fair values:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of the financial assets and liabilities included in other non-current assets, and the non-current portion of interest-bearing
bank and other borrowings have been calculated by discounting the expected future cash flows using rates currently available for instruments
with similar terms, credit risk and remaining maturities. The Group&#8217;s own non-performance risk for other non-current assets, and
interest-bearing bank and other borrowings as at December 31, 2025 was assessed to be insignificant.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of listed equity investments are based on quoted market prices. The fair value of the unlisted equity investments designated
at fair value through profit or loss have been estimated using an asset-based valuation technique based on assumptions that are not supported
by observable market prices or rates. The fair value measurement of these financial instruments may involve unobservable inputs. Fair
value change resulting from changes in the unobservable inputs was not significant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Level 3 financial liabilities, the Group adopts the valuation techniques to determine the fair value. Valuation techniques include a
discounted cash flow analysis. The fair value measurement of the financial instruments may involve unobservable inputs such as discount
rate and possibility of payment. The Group periodically reviews all significant unobservable inputs and valuation adjustments used to
measure the fair values of financial assets in Level 3.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 298; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAIR
                                            VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_2" id="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Fair
value hierarchy</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables illustrate the fair value measurement hierarchy of the Group&#8217;s financial instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Assets
measured at fair value</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFairValueMeasurementOfAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory" id="ixv-63993"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">active</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">markets</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unobservable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at FVTPL</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c604" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72546">1,141</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-409; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-410; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72547">1,141</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2025</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 12pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">active</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">markets</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unobservable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at FVTPL</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-411; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;-</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-412; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c608" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72548">4,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c609" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72549">4,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-72550">572</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 299; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FAIR
                                            VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Fair
value hierarchy</span> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liabilities
measured at fair value</i></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="_DisclosureOfFairValueMeasurementOfAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2025</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">active</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">markets</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities included in other payables and accruals</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-414; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c609" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72551">1,968</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72552">1,968</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-72553">281</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-415; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-416; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c609" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72554">6,374</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72555">6,374</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-72556">911</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2023, 2024 and 2025, there were no transfers of fair value measurements between Level 1 and Level 2 and
no transfers into or out of Level 3 for both financial assets and financial liabilities.</span></p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFinancialRiskManagementExplanatory" id="ixv-64659"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
                                            RISK MANAGEMENT OBJECTIVES AND POLICIES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 61.8pt 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s principal financial instruments comprise cash and bank balances and interest-bearing bank and other borrowings. The main
purpose of these financial instruments is to raise finance for the Group&#8217;s operations. The Group has various other financial assets
and liabilities such as trade receivables and trade payables, which arise directly from its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
main risks arising from the Group&#8217;s financial instruments are interest rate risk, foreign currency risk, credit risk,
liquidity risk, and equity price risk. The Directors review and agree on policies for managing each of these risks, and they are
summarized below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
rate risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s exposure to the risk of changes in market interest rates relates primarily to the Group&#8217;s long-term debt obligations
with floating interest rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s policy is to manage its interest cost using a mix of fixed and floating rate debts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2025, the total interest-bearing bank borrowings of RMB<ix:nonFraction contextRef="c610" decimals="-3" format="ixt:num-dot-decimal" name="aapg:InterestBearingBankBorrowings" scale="3" unitRef="cny" id="ixv-72557">1,911,273</ix:nonFraction> (US$<ix:nonFraction contextRef="c610" decimals="-3" format="ixt:num-dot-decimal" name="aapg:InterestBearingBankBorrowings" scale="3" unitRef="usd" id="ixv-72558">273,308</ix:nonFraction>) (2024: RMB<ix:nonFraction contextRef="c611" decimals="-3" format="ixt:num-dot-decimal" name="aapg:InterestBearingBankBorrowings" scale="3" unitRef="cny" id="ixv-72559">1,116,015</ix:nonFraction>) of the Group were
with floating interest rates denominated in RMB.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table demonstrates the sensitivity to a reasonably possible change in the RMB interest rate, with all other variables held
constant, of the Group&#8217;s loss before tax through the impact on floating rate borrowings. <ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureOfInterestRateRiskExplanatory-c0_cont_1" escape="true" name="aapg:DisclosureOfInterestRateRiskExplanatory" id="ixv-72560">This analysis does not include the effect
of interest capitalized.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:continuation id="aapg_DisclosureOfInterestRateRiskExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease)</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in basis points</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease)</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in loss before tax</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c618" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-64763"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></ix:nonNumeric></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c619" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-64772"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,160</span></ix:nonNumeric></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c618" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncreasedecreaseInLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-72561">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c619" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncreasedecreaseInLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-72562">11,160</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><ix:nonNumeric contextRef="c620" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-64822"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><ix:nonNumeric contextRef="c621" name="ifrs-full:BorrowingsInterestRateBasis" id="ixv-64831"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,113</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c620" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncreasedecreaseInLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-72563">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c621" decimals="-3" format="ixt:num-dot-decimal" name="aapg:IncreasedecreaseInLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-72564">19,113</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 300; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
                                            RISK MANAGEMENT OBJECTIVES AND POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_2" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
currency risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has transactional currency exposures. Such exposures arise from sales or purchases by operating units and investing and financing
activities in currencies other than the units&#8217; functional currencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfForeignCurrencyRiskExplanatory" id="ixv-64912"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table demonstrates the sensitivity as at the end of each reporting period to a reasonably possible change in the US$ and HK$
exchange rates, with all other variables held constant, of the Group&#8217;s loss before tax and in other comprehensive income (without
tax) due to changes in the fair values of monetary assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease) in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rate</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease)</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in loss</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">before</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease) in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">comprehensive</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">income</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(without tax)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB weakens
    against US$</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c622" decimals="2" format="ixt:num-dot-decimal" name="aapg:IncreasedecreaseWeakensAgainst" scale="-2" unitRef="pure" id="ixv-72565">5</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c623" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="3" sign="-" unitRef="cny" id="ixv-72566">44</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c623" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="3" unitRef="cny" id="ixv-72567">56,796</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB strengthens against
    US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c624" decimals="2" format="ixt:num-dot-decimal" name="aapg:IncreasedecreaseWeakensAgainst" scale="-2" sign="-" unitRef="pure" id="ixv-72568">5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c625" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="3" unitRef="cny" id="ixv-72569">44</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c625" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="3" sign="-" unitRef="cny" id="ixv-72570">56,796</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB weakens against US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c626" decimals="2" format="ixt:num-dot-decimal" name="aapg:IncreasedecreaseWeakensAgainst" scale="-2" unitRef="pure" id="ixv-72571">5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c627" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="3" sign="-" unitRef="cny" id="ixv-72572">65</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c627" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="3" unitRef="cny" id="ixv-72573">124,210</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB strengthens against
    US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c628" decimals="2" format="ixt:num-dot-decimal" name="aapg:IncreasedecreaseWeakensAgainst" scale="-2" sign="-" unitRef="pure" id="ixv-72574">5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c629" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="3" unitRef="cny" id="ixv-72575">65</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c629" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="3" sign="-" unitRef="cny" id="ixv-72576">124,210</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Credit
risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group trades only with recognized and creditworthy third parties. Concentrations of credit risk are managed by the customer. At the
end of the reporting period, the Group had certain concentrations of credit risk as <ix:nonFraction contextRef="c612" decimals="2" format="ixt:num-dot-decimal" name="aapg:ConcentrationsOfCreditRisk" scale="-2" unitRef="pure" id="ixv-72577">68</ix:nonFraction>% (2024: <ix:nonFraction contextRef="c613" decimals="2" format="ixt:num-dot-decimal" name="aapg:ConcentrationsOfCreditRisk" scale="-2" unitRef="pure" id="ixv-72578">73</ix:nonFraction>%) and <ix:nonFraction contextRef="c614" decimals="2" format="ixt:num-dot-decimal" name="aapg:ConcentrationsOfCreditRisk" scale="-2" unitRef="pure" id="ixv-72579">91</ix:nonFraction>% (2024: <ix:nonFraction contextRef="c615" decimals="2" format="ixt:num-dot-decimal" name="aapg:ConcentrationsOfCreditRisk" scale="-2" unitRef="pure" id="ixv-72580">96</ix:nonFraction>%) of the
Group&#8217;s trade receivables were due from the Group&#8217;s largest customer, respectively. It is the Group&#8217;s policy that
all customers who wish to trade on credit terms are subject to credit verification procedures. In addition, receivable balances are
monitored on an ongoing basis, and the Group&#8217;s exposure to bad debts is not significant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
credit risk of the Group&#8217;s other financial assets, which comprise cash and bank balances, trade receivables, financial assets included
in prepayments, deposits and other receivables and other non-current assets, arises from default of the counterparty, with a maximum
exposure equal to the carrying amounts of these instruments.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 301; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
                                            RISK MANAGEMENT OBJECTIVES AND POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_3" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Maximum
exposure and year-end staging</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tables below show the credit quality and the maximum exposure to credit risk based on the Group&#8217;s credit policy, which is mainly
based on past due information unless other information is available without undue cost or effort, and year-end staging classification.
<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCreditRiskExposureExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfCreditRiskExposureExplanatory" id="ixv-72581">The amounts presented are gross carrying amounts for financial assets.</ix:nonNumeric></span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>As at <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
31, 2024</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfCreditRiskExposureExplanatory-c0_cont_2" id="_DisclosureOfCreditRiskExposureExplanatory-c0_cont_1"><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_4" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_3"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12-month ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lifetime ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage 1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage 2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage 3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simplified approach</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets included in prepayments, other receivables and other assets - Normal**</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c630" decimals="-3" format="ixt:num-dot-decimal" id="ix_113_fact" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny">9,846</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-417; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: hidden-fact-418; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-419; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" id="ix_114_fact" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny">9,846</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and bank balances - Not yet past due</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c630" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CashAndBankBalancesNotYetPastDue" scale="3" unitRef="cny" id="ixv-72584">1,261,211</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-420; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-421; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-422; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CashAndBankBalancesNotYetPastDue" scale="3" unitRef="cny" id="ixv-72585">1,261,211</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade receivables*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-423; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-424; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c633" decimals="-3" format="ixt:num-dot-decimal" id="ix_108_fact" name="ifrs-full:TradeReceivables" scale="3" unitRef="cny">83,143</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" id="ix_109_fact" name="ifrs-full:TradeReceivables" scale="3" unitRef="cny">83,143</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets included in other non-current assets - Normal**</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c630" decimals="-3" format="ixt:num-dot-decimal" id="ix_115_fact" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="cny">2,439</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" id="ix_116_fact" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="cny">2,439</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c630" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72590">1,273,496</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-429; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-430; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c633" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72591">83,143</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72592">1,356,639</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
at December 31, 2025</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfCreditRiskExposureExplanatory-c0_cont_2"><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_5" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_4"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12-month
    ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lifetime
    ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
    1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
    2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
    3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simplified
    approach</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets included in prepayments, other receivables and other assets - Normal**</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c634" decimals="-3" format="ixt:num-dot-decimal" id="ix_117_fact" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny">3,609</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-431; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-432; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-433; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" id="ix_118_fact" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny">3,609</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" id="ix_119_fact" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd">516</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances - Not yet past due</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c634" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CashAndBankBalancesNotYetPastDue" scale="3" unitRef="cny" id="ixv-72596">2,470,085</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-434; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-435; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-436; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CashAndBankBalancesNotYetPastDue" scale="3" unitRef="cny" id="ixv-72597">2,470,085</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="aapg:CashAndBankBalancesNotYetPastDue" scale="3" unitRef="usd" id="ixv-72598">353,217</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    receivables*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-437; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-438; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-439; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c637" decimals="-3" format="ixt:num-dot-decimal" id="ix_110_fact" name="ifrs-full:TradeReceivables" scale="3" unitRef="cny">252,938</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" id="ix_111_fact" name="ifrs-full:TradeReceivables" scale="3" unitRef="cny">252,938</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" id="ix_112_fact" name="ifrs-full:TradeReceivables" scale="3" unitRef="usd">36,170</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets included in other non-current assets - Normal**</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c634" decimals="-3" format="ixt:num-dot-decimal" id="ix_120_fact" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="cny">690</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-440; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-441; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-442; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" id="ix_121_fact" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="cny">690</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" id="ix_122_fact" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="3" unitRef="usd">99</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c634" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72605">2,474,384</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: hidden-fact-443; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: hidden-fact-444; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c637" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72606">252,938</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="cny" id="ixv-72607">2,727,322</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" unitRef="usd" id="ixv-72608">390,002</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><ix:footnote id="ix_30_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For trade receivables to which the Group applies the simplified approach for impairment, information based on provision matrix is disclosed in note 21 to the financial statements.</span></ix:footnote></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left"><ix:footnote id="ix_31_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit quality of the financial assets included in prepayments, other receivables and other assets and financial assets included in other non- current assets is considered to be &#8220;normal&#8221; when they are not past due and there is no information indicating that the financial assets had a significant increase in credit risk since initial recognition. Otherwise, the credit quality of the financial assets is considered to be &#8220;doubtful&#8221;.</span></ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 302; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
                                            RISK MANAGEMENT OBJECTIVES AND POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_6" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidity
risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Group&#8217;s objective is to maintain a balance between continuity of funding and flexibility through the use of bank loans, lease liabilities
and other interest-bearing loans. As at December 31, 2025, <ix:nonFraction contextRef="c616" decimals="2" format="ixt:num-dot-decimal" name="aapg:LiquidityRiskPercentage" scale="-2" unitRef="pure" id="ixv-72609">62</ix:nonFraction>% (2024: <ix:nonFraction contextRef="c617" decimals="2" format="ixt:num-dot-decimal" name="aapg:LiquidityRiskPercentage" scale="-2" unitRef="pure" id="ixv-72610">47</ix:nonFraction>%) of the Group&#8217;s borrowings would mature in less than
one year based on the carrying values of the borrowings.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfLiquidityRiskExplanatory" id="ixv-66037"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maturity profile of the Group&#8217;s financial liabilities as at the end of the reporting period, based on the contractual undiscounted
payments, is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As at December 31, 2024</b></span></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    demand</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than<br/>
    1 year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    to 5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
    <br/>
    5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    payables</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-445; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c639" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72611">91,966</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-446; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-447; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c642" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72612">91,966</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-448; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c644" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-72613">10,674</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c645" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-72614">8,592</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-449; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c647" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-72615">19,266</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest-bearing
    bank and other borrowings (excluding lease liabilities)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-450; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c649" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72616">813,610</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c650" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72617">452,765</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c651" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72618">565,079</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c652" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72619">1,831,454</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities included in other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c653" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72620">73,670</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c654" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72621">29,344</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-451; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-452; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c657" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72622">103,014</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-453; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-454; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c660" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="cny" id="ixv-72623">6,274</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-455; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c662" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="cny" id="ixv-72624">6,274</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c663" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="cny" id="ixv-72625">73,670</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c664" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="cny" id="ixv-72626">945,594</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c665" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="cny" id="ixv-72627">467,631</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c666" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="cny" id="ixv-72628">565,079</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c667" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="cny" id="ixv-72629">2,051,974</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As at December 31, 2025</b></span></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    demand</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1&#160;year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    to 5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
    <br/>
    5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    payables</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-456; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c669" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72630">106,740</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-457; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-458; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c672" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72631">106,740</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c672" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="usd" id="ixv-72632">15,264</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-459; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c674" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-72633">8,262</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c675" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-72634">16,226</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-460; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c677" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="cny" id="ixv-72635">24,488</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c677" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="usd" id="ixv-72636">3,502</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest-bearing
    bank and other borrowings (excluding lease liabilities)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-461; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c679" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72637">1,255,814</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c680" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72638">365,732</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c681" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72639">546,806</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c682" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72640">2,168,352</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c682" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="usd" id="ixv-72641">310,070</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities included in other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c683" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72642">130,142</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c684" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72643">10,308</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-462; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-463; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c687" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="cny" id="ixv-72644">140,450</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c687" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" scale="3" unitRef="usd" id="ixv-72645">20,084</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-464; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-465; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c690" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="cny" id="ixv-72646">12,031</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-466; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c692" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="cny" id="ixv-72647">12,031</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c692" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="usd" id="ixv-72648">1,720</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c693" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="cny" id="ixv-72649">130,142</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c694" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="cny" id="ixv-72650">1,381,124</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c695" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="cny" id="ixv-72651">393,989</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c696" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="cny" id="ixv-72652">546,806</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-467; font-family: Times New Roman, Times, Serif">2,<span style="font-size: 10pt">452,061</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c697" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" scale="3" unitRef="usd" id="ixv-72653">350,640</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
price risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
price risk is the risk that the fair values of equity securities decrease as a result of changes in the levels of equity indices and
the value of individual securities. The Group is exposed to equity price risk arising from individual equity investments included in
financial assets at FVTPL (note 17) as at December 31, 2025. The Group&#8217;s listed investments held in the prior year were listed
on NASDAQ and were valued at the quoted market price at the end of the reporting period, whereas the investments in the current year
don&#8217;t involve publicly traded market quotations.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfEquityPriceRiskExplanatory" id="ixv-67009"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market equity index for the following stock exchange, at the close of business of the nearest trading day in the year to the end of the
reporting period, and its respective highest and lowest points during the year were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High/low</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High/low</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States&#8211;NASDAQ
    index</span></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="aapg:MarketEquityIndex" scale="0" unitRef="shares" id="ixv-72654">19,311</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c555" decimals="0" format="ixt:num-dot-decimal" name="aapg:StockExchangeIndexShare" scale="0" unitRef="shares" id="ixv-72655">20,205</ix:nonFraction>/<ix:nonFraction contextRef="c554" decimals="0" format="ixt:num-dot-decimal" name="aapg:StockExchangeIndexShare" scale="0" unitRef="shares" id="ixv-72656">14,478</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"/><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-468; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-470"><span style="-sec-ix-hidden: hidden-fact-469; font-family: Times New Roman, Times, Serif; font-size: 10pt">-/-</span></div></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 303; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
                                            RISK MANAGEMENT OBJECTIVES AND POLICIES (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
price risk </i>(continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" escape="true" name="aapg:DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" id="ixv-67160"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table demonstrates the sensitivity to every <ix:nonFraction contextRef="c15" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" unitRef="pure" id="ixv-72657">5</ix:nonFraction>% change in the fair values of the equity investments, with all other variables
held constant and before any impact on tax, based on their carrying amounts at the end of the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying<br/> amount of<br/> equity<br/> investments</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Decrease/<br/> (increase)<br/> in loss<br/> before tax</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments listed in:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ - Financial assets at fair value through profit or loss</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c698" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" sign="-" unitRef="cny" id="ixv-72658">1,141</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c699" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="3" sign="-" unitRef="cny" id="ixv-72659">57</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c699" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="3" sign="-" unitRef="cny" id="ixv-72660">57</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments listed in:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ - Financial assets at fair value through profit or loss</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-471; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-472; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ - Financial assets at fair value through profit or loss in USD</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-473; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-474; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capital
management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary objectives of the Group&#8217;s capital management are to safeguard the Group&#8217;s ability to continue as a going concern
and to maintain healthy capital ratios in order to support its business and maximize shareholders&#8217; value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group manages its capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics
of the underlying assets. To maintain or adjust the capital structure, the Group may adjust the dividend payment to shareholders, return
capital to shareholders or issue new shares. No changes were made in the objectives, policies or processes for managing capital during
the reporting year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group monitors capital using a gearing ratio, which is net debt divided by the adjusted capital plus net debt. Net debt includes interest-bearing
bank and other borrowings, trade payables, financial liabilities included in other payables and accruals and long-term payables, less
cash and bank balances. Capital includes equity attributable to owners of the parent. <ix:nonNumeric contextRef="c0" continuedAt="aapg_DisclosureOfCapitalManagementExplanatory-c0_cont_1" escape="true" name="aapg:DisclosureOfCapitalManagementExplanatory" id="ixv-72661">The gearing ratios as at the end of the reporting
periods were as follows:</ix:nonNumeric></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<ix:continuation id="aapg_DisclosureOfCapitalManagementExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2025</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2025</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">RMB</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">RMB</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Interest-bearing bank and other borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c702" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72662">1,668,497</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="cny" id="ixv-72663">1,979,719</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="3" unitRef="usd" id="ixv-72664">283,096</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c702" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72665">91,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="cny" id="ixv-72666">106,740</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="3" unitRef="usd" id="ixv-72667">15,264</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financial liabilities included in other payables and accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c702" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" unitRef="cny" id="ixv-72668">103,014</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" unitRef="cny" id="ixv-72669">140,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" scale="3" unitRef="usd" id="ixv-72670">20,084</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other non-current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c702" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="cny" id="ixv-72671">6,274</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="cny" id="ixv-72672">12,031</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="3" unitRef="usd" id="ixv-72673">1,720</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Cash and bank balances</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c702" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-72674">1,261,211</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-72675">2,470,085</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="3" unitRef="usd" id="ixv-72676">353,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Net debt</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c702" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDebt" scale="3" unitRef="cny" id="ixv-72677">608,540</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDebt" scale="3" sign="-" unitRef="cny" id="ixv-72678">231,145</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetDebt" scale="3" sign="-" unitRef="usd" id="ixv-72679">33,053</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Equity attributable to owners of the parent</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c702" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EquityAttributableToOwnersOfParent" scale="3" unitRef="cny" id="ixv-72680">264,194</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EquityAttributableToOwnersOfParent" scale="3" unitRef="cny" id="ixv-72681">1,324,462</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EquityAttributableToOwnersOfParent" scale="3" unitRef="usd" id="ixv-72682">189,396</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Adjusted capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c702" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustedCapitals" scale="3" unitRef="cny" id="ixv-72683">264,194</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustedCapitals" scale="3" unitRef="cny" id="ixv-72684">1,324,462</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="aapg:AdjustedCapitals" scale="3" unitRef="usd" id="ixv-72685">189,396</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Capital and net debt</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c702" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" unitRef="cny" id="ixv-72686">872,734</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" unitRef="cny" id="ixv-72687">1,093,317</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c703" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" unitRef="usd" id="ixv-72688">156,343</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Gearing ratio</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c704" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure" id="ixv-72689">70</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-475; font-size: 10pt">NA&#160;</span></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-476; font-size: 10pt">NA&#160;</span></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 304; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod" id="ixv-67652"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVENT
                                            AFTER THE REPORTING PERIOD</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at the date of approval of these financial statements, there have been no significant events after the end of the reporting period.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" id="ixv-67668"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDENSED
                                            FINANCIAL INFORMATION OF THE COMPANY</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="ixv-67678"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
of financial position of the Company</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in
    subsidiaries</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiaries" scale="3" unitRef="cny" id="ixv-72690">380,339</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiaries" scale="3" unitRef="cny" id="ixv-72691">448,431</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiaries" scale="3" unitRef="usd" id="ixv-72692">64,125</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current Asset</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" unitRef="cny" id="ixv-72693">30,529</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" unitRef="cny" id="ixv-72694">29,851</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="3" unitRef="usd" id="ixv-72695">4,269</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    non-current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="3" unitRef="cny" id="ixv-72696">410,868</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="3" unitRef="cny" id="ixv-72697">478,282</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="3" unitRef="usd" id="ixv-72698">68,394</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments, other receivables
    and other assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReceivablesDueFromAssociates" scale="3" unitRef="cny" id="ixv-72699">3,986,172</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReceivablesDueFromAssociates" scale="3" unitRef="cny" id="ixv-72700">4,806,759</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ReceivablesDueFromAssociates" scale="3" unitRef="usd" id="ixv-72701">687,358</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-72702">470,170</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="cny" id="ixv-72703">1,841,572</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndBankBalancesAtCentralBanks" scale="3" unitRef="usd" id="ixv-72704">263,341</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="3" unitRef="cny" id="ixv-72705">4,456,342</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="3" unitRef="cny" id="ixv-72706">6,648,331</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="3" unitRef="usd" id="ixv-72707">950,699</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT LIABILITIES</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="3" unitRef="cny" id="ixv-72708">24,187</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="3" unitRef="cny" id="ixv-72709">2,382</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="3" unitRef="usd" id="ixv-72710">341</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="3" unitRef="cny" id="ixv-72711">24,187</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="3" unitRef="cny" id="ixv-72712">2,382</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="3" unitRef="usd" id="ixv-72713">341</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    CURRENT ASSETS</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssetsLiabilities" scale="3" unitRef="cny" id="ixv-72714">4,432,155</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssetsLiabilities" scale="3" unitRef="cny" id="ixv-72715">6,645,949</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssetsLiabilities" scale="3" unitRef="usd" id="ixv-72716">950,358</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    ASSETS LESS CURRENT LIABILITIES</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AssetsLessCurrentLiabilities" scale="3" unitRef="cny" id="ixv-72717">4,843,023</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AssetsLessCurrentLiabilities" scale="3" unitRef="cny" id="ixv-72718">7,124,231</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AssetsLessCurrentLiabilities" scale="3" unitRef="usd" id="ixv-72719">1,018,752</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetAssetsLiabilities" scale="3" unitRef="cny" id="ixv-72720">4,843,023</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetAssetsLiabilities" scale="3" unitRef="cny" id="ixv-72721">7,124,231</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NetAssetsLiabilities" scale="3" unitRef="usd" id="ixv-72722">1,018,752</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share capital</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="3" unitRef="cny" id="ixv-72723">214</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="3" unitRef="cny" id="ixv-72724">256</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="3" unitRef="usd" id="ixv-72725">37</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TreasuryShares" scale="3" unitRef="cny" id="ixv-72726">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TreasuryShares" scale="3" unitRef="cny" id="ixv-72727">2,961</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TreasuryShares" scale="3" unitRef="usd" id="ixv-72728">423</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital and reserves</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherReserves" scale="3" unitRef="cny" id="ixv-72729">5,652,916</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherReserves" scale="3" unitRef="cny" id="ixv-72730">8,011,879</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherReserves" scale="3" unitRef="usd" id="ixv-72731">1,145,683</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange fluctuation reserve</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeFluctuationReserve" scale="3" unitRef="cny" id="ixv-72732">108,598</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeFluctuationReserve" scale="3" sign="-" unitRef="cny" id="ixv-72733">40,959</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ExchangeFluctuationReserve" scale="3" sign="-" unitRef="usd" id="ixv-72734">5,857</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    losses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="3" sign="-" unitRef="cny" id="ixv-72735">918,697</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="3" sign="-" unitRef="cny" id="ixv-72736">843,984</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="3" sign="-" unitRef="usd" id="ixv-72737">120,688</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    equity</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-72738">4,843,023</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="cny" id="ixv-72739">7,124,231</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="usd" id="ixv-72740">1,018,752</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="srt:CondensedStatementOfComprehensiveIncomeTableTextBlock" id="ixv-68298"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
statements of comprehensive income</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income and
    gains</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherGainsLosses" scale="3" unitRef="cny" id="ixv-72741">18,597</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherGainsLosses" scale="3" unitRef="cny" id="ixv-72742">17,925</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherGainsLosses" scale="3" unitRef="cny" id="ixv-72743">102,560</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherGainsLosses" scale="3" unitRef="usd" id="ixv-72744">14,666</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OperatingExpense" scale="3" unitRef="cny" id="ixv-72745">8,118</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OperatingExpense" scale="3" unitRef="cny" id="ixv-72746">9,983</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OperatingExpense" scale="3" unitRef="cny" id="ixv-72747">27,800</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OperatingExpense" scale="3" unitRef="usd" id="ixv-72748">3,975</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="cny" id="ixv-72749">24,741</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="cny" id="ixv-72750">21,585</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="cny" id="ixv-72751">47</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="3" unitRef="usd" id="ixv-72752">7</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    BEFORE TAX</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-72753">14,262</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" sign="-" unitRef="cny" id="ixv-72754">13,643</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" unitRef="cny" id="ixv-72755">74,713</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="3" unitRef="usd" id="ixv-72756">10,684</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    FOR THE YEAR</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-72757">14,262</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-72758">13,643</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" unitRef="cny" id="ixv-72759">74,713</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" unitRef="usd" id="ixv-72760">10,684</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-72761">84,629</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-72762">67,715</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="cny" id="ixv-72763">149,557</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="usd" id="ixv-72764">21,386</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    COMPREHENSIVE INCOME FOR THE YEAR</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" unitRef="cny" id="ixv-72765">70,367</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" unitRef="cny" id="ixv-72766">54,072</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" sign="-" unitRef="cny" id="ixv-72767">74,844</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" sign="-" unitRef="usd" id="ixv-72768">10,702</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 305; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDENSED
                                            FINANCIAL INFORMATION OF THE COMPANY (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory-c0_cont_2" id="_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfCondensedCashFlowStatementsTableTextBlock" id="ixv-68652"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
statements of cash flows</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            cash generated from(used in) operating activities</span></p></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" unitRef="cny" id="ixv-72769">9,727</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72770">41,686</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" unitRef="cny" id="ixv-72771">123,427</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" unitRef="usd" id="ixv-72772">17,650</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash used in investing
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72773">535,395</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72774">589,153</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" sign="-" unitRef="cny" id="ixv-72775">1,850,400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-72776">264,604</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                 cash generated from financing activities</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="cny" id="ixv-72777">464,166</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="cny" id="ixv-72778">531,922</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="cny" id="ixv-72779">2,229,331</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-72780">318,790</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of foreign exchange rate changes, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-72781">1,581</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-72782">9,311</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" sign="-" unitRef="cny" id="ixv-72783">56,093</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" sign="-" unitRef="usd" id="ixv-72784">8,021</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            (decrease)/increase in cash and cash equivalents</span></p></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" sign="-" unitRef="cny" id="ixv-72785">59,921</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" sign="-" unitRef="cny" id="ixv-72786">89,606</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" unitRef="cny" id="ixv-72787">446,265</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" unitRef="usd" id="ixv-72788">63,815</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="aapg:ScheduleOfReservesTableTextBlock" id="ixv-68901"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the Company&#8217;s reserves is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    and<br/> reserves</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange<br/>
    Fluctuation<br/> reserve</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated<br/>
    losses</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 52%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2023</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c711" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72789">4,526,096</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c712" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-72790">43,746</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c713" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-72791">890,792</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c714" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72792">3,591,558</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-477; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-478; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c717" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-72793">14,262</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-72794">14,262</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-479; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c716" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-72795">84,629</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-480; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-72796">84,629</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive income for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-481; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c716" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ComprehensiveIncomeLoss" scale="3" unitRef="cny" id="ixv-72797">84,629</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c717" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ComprehensiveIncomeLoss" scale="3" sign="-" unitRef="cny" id="ixv-72798">14,262</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ComprehensiveIncomeLoss" scale="3" unitRef="cny" id="ixv-72799">70,367</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c715" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72800">470,066</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-482; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-483; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72801">470,066</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Employees
    share-based compensation scheme</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Pre-IPO
    share option expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c718" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PreIPOShareOptionExpenses" scale="3" unitRef="cny" id="ixv-72802">3,750</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-484; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-485; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="aapg:PreIPOShareOptionExpenses" scale="3" unitRef="cny" id="ixv-72803">3,750</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c715" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RestrictedShareUnitExpenses" scale="3" unitRef="cny" id="ixv-72804">27,753</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-486; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-487; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RestrictedShareUnitExpenses" scale="3" unitRef="cny" id="ixv-72805">27,753</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c715" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" scale="3" unitRef="cny" id="ixv-72806">7</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-488; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-489; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" scale="3" unitRef="cny" id="ixv-72807">7</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c715" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" scale="3" sign="-" unitRef="cny" id="ixv-72808">11,123</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-490; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-491; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" scale="3" sign="-" unitRef="cny" id="ixv-72809">11,123</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c715" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-72810">55,466</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-492; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-493; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c708" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-72811">55,466</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023 and January 1, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c721" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72812">5,072,015</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c722" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72813">40,883</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c723" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-72814">905,054</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c724" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72815">4,207,844</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-494; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-495; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c720" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-72816">13,643</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="cny" id="ixv-72817">13,643</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-496; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c719" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-72818">67,715</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-497; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" unitRef="cny" id="ixv-72819">67,715</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive income for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-498; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c719" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ComprehensiveIncomeLoss" scale="3" unitRef="cny" id="ixv-72820">67,715</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c720" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ComprehensiveIncomeLoss" scale="3" sign="-" unitRef="cny" id="ixv-72821">13,643</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ComprehensiveIncomeLoss" scale="3" unitRef="cny" id="ixv-72822">54,072</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c718" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72823">533,923</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-499; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-500; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72824">533,923</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
    share-based compensation scheme</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c718" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RestrictedShareUnitExpenses" scale="3" unitRef="cny" id="ixv-72825">20,924</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-501; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-502; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RestrictedShareUnitExpenses" scale="3" unitRef="cny" id="ixv-72826">20,924</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c718" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" scale="3" unitRef="cny" id="ixv-72827">6</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-503; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-504; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" scale="3" unitRef="cny" id="ixv-72828">6</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c718" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" scale="3" sign="-" unitRef="cny" id="ixv-72829">14,671</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-505; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-506; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" scale="3" sign="-" unitRef="cny" id="ixv-72830">14,671</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c718" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-72831">40,719</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-507; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-508; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c709" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-72832">40,719</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024 and January 1, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c725" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72833">5,652,916</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c726" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72834">108,598</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c727" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-72835">918,697</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c706" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72836">4,842,817</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-509; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-510; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c730" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" unitRef="cny" id="ixv-72837">74,713</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" unitRef="cny" id="ixv-72838">74,713</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-511; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c729" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="cny" id="ixv-72839">149,557</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-512; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" sign="-" unitRef="cny" id="ixv-72840">149,557</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive income for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-513; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c729" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ComprehensiveIncomeLoss" scale="3" sign="-" unitRef="cny" id="ixv-72841">149,557</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c730" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ComprehensiveIncomeLoss" scale="3" unitRef="cny" id="ixv-72842">74,713</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="aapg:ComprehensiveIncomeLoss" scale="3" sign="-" unitRef="cny" id="ixv-72843">74,844</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c728" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72844">2,279,855</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-514; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-515; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-72845">2,279,855</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Employees
    share-based compensation scheme</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Post-IPO
    share option expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c728" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" unitRef="cny" id="ixv-72846">2,420</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-516; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-517; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" unitRef="cny" id="ixv-72847">2,420</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c728" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RestrictedShareUnitExpenses" scale="3" unitRef="cny" id="ixv-72848">18,454</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-518; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-519; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="aapg:RestrictedShareUnitExpenses" scale="3" unitRef="cny" id="ixv-72849">18,454</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c728" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" scale="3" unitRef="cny" id="ixv-72850">4</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-520; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-521; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" scale="3" unitRef="cny" id="ixv-72851">4</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c728" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" scale="3" sign="-" unitRef="cny" id="ixv-72852">638</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-522; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-523; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" scale="3" sign="-" unitRef="cny" id="ixv-72853">638</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c728" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-72854">58,868</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-524; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-525; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c710" decimals="-3" format="ixt:num-dot-decimal" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" scale="3" unitRef="cny" id="ixv-72855">58,868</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c731" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72856">8,011,879</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c732" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-72857">40,959</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c733" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" sign="-" unitRef="cny" id="ixv-72858">843,984</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="cny" id="ixv-72859">7,126,936</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c731" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="usd" id="ixv-72860">1,145,683</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c732" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" sign="-" unitRef="usd" id="ixv-72861">5,857</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c733" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" sign="-" unitRef="usd" id="ixv-72862">120,688</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c707" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="3" unitRef="usd" id="ixv-72863">1,019,138</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 306; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Ascentage
Pharma Group International</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Notes
to THE consolidated financial statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts
in thousands of Renminbi (&#8220;RMB&#8221;) and US dollars (&#8220;US$&#8221;)&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>except
for number of shares and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDENSED
                                            FINANCIAL INFORMATION OF THE COMPANY (continued)</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
                                            of presentation</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
separate condensed financial statements above have been presented on a &#8220;parent company only&#8221; basis. Under a &#8220;parent
company only&#8221; presentation, the Company&#8217;s investment in its subsidiaries is presented at cost. Such investment is presented
on the separate condensed statements of financial position of the Company as &#8220;Investment in subsidiaries&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 68.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsidiaries did not pay any dividends to the Company for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span style="-sec-ix-hidden: hidden-fact-526"><span style="-sec-ix-hidden: hidden-fact-527">no</span></span> indicators of impairment associated with the investment in subsidiaries as of December 31, 2024 and 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 68.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
information and note disclosures normally included in financial statements prepared in accordance with IFRS Accounting Standards have
been condensed or omitted in this parent company only condensed financial information by reference to the Group&#8217;s consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 57.2pt 0pt 68.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have any significant commitments or long-term obligations as of December 31, 2024 and 2025.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory" id="ixv-70317"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPROVAL
                                            OF THE FINANCIAL STATEMENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements were approved and authorized for issue by the board of directors on April 29, 2026.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 307; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><!-- Field: /Page --><div>




</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentAccountingStandard">International Financial Reporting Standards</ix:nonNumeric>
<ix:nonFraction contextRef="c3" id="hidden-fact-1" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-2" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-3" name="ifrs-full:Revenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-4" name="ifrs-full:DeferredTaxLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-5" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-6" name="aapg:CommitmentAndContingencies" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-7" name="aapg:CommitmentAndContingencies" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-8" name="aapg:CommitmentAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-9" name="ifrs-full:Equity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-10" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-11" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-12" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-13" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-14" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-15" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-16" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-17" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-18" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-19" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-20" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-21" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-22" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-23" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-24" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-25" name="aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-26" name="aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-27" name="aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-28" name="aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-29" name="aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-30" name="aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-31" name="aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-32" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-33" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-34" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-35" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-36" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-37" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-38" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-39" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-40" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-41" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-42" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-43" name="aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-44" name="aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-45" name="aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-46" name="aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-47" name="aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-48" name="aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-49" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-50" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-51" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-52" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-53" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-54" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-55" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-56" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-57" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-58" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-59" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-60" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-61" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-62" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-63" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-64" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-65" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-66" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-67" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-68" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-69" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c44" id="hidden-fact-70" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c45" id="hidden-fact-71" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-72" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-73" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-74" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c44" id="hidden-fact-75" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c45" id="hidden-fact-76" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-77" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-78" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-79" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-80" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c44" id="hidden-fact-81" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c45" id="hidden-fact-82" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-83" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c45" id="hidden-fact-84" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-85" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-86" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-87" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-88" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c44" id="hidden-fact-89" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c45" id="hidden-fact-90" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-91" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-92" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-93" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-94" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-95" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c44" id="hidden-fact-96" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-97" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-98" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-99" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-100" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-101" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-102" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-103" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-104" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-105" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-106" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-107" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-108" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-109" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-110" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-111" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-112" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-113" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-114" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-115" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-116" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c60" id="hidden-fact-117" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" id="hidden-fact-118" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-119" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-120" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-121" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c60" id="hidden-fact-122" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" id="hidden-fact-123" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c63" id="hidden-fact-124" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c65" id="hidden-fact-125" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-126" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-127" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c60" id="hidden-fact-128" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" id="hidden-fact-129" name="ifrs-full:ComprehensiveIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-130" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" id="hidden-fact-131" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-132" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c63" id="hidden-fact-133" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c65" id="hidden-fact-134" name="ifrs-full:IssueOfEquity" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-135" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c60" id="hidden-fact-136" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" id="hidden-fact-137" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-138" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c63" id="hidden-fact-139" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c65" id="hidden-fact-140" name="aapg:RepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-141" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-142" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c60" id="hidden-fact-143" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-144" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c63" id="hidden-fact-145" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c65" id="hidden-fact-146" name="aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-147" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-148" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-149" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c63" id="hidden-fact-150" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c65" id="hidden-fact-151" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-152" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c63" id="hidden-fact-153" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c64" id="hidden-fact-154" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c65" id="hidden-fact-155" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-156" name="aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-157" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" id="hidden-fact-158" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-159" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c63" id="hidden-fact-160" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c65" id="hidden-fact-161" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-162" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-163" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-164" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-165" name="aapg:AdjustmentsForGainOnDisposalOfLeases" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-166" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-167" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-168" name="ifrs-full:AdjustmentsForFairValueGainsLosses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-169" name="ifrs-full:AdjustmentsForFairValueGainsLosses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-170" name="ifrs-full:AdjustmentsForFairValueGainsLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-171" name="ifrs-full:AdjustmentsForProvisions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-172" name="ifrs-full:AdjustmentsForProvisions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-173" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-174" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-175" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-176" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-177" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-178" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-179" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-180" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-181" name="aapg:InvestmentInOtherFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-182" name="aapg:InvestmentInOtherFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-183" name="aapg:InvestmentInJointVenturesClassifiedAsInvestingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-184" name="aapg:InvestmentInJointVenturesClassifiedAsInvestingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-185" name="aapg:InvestmentInJointVenturesClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-186" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-187" name="ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-188" name="ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-189" name="ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-190" name="aapg:ListingExpensePaid" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c74" id="hidden-fact-191" name="aapg:PercentageOfEquityInterestsAttributableToTheCompanyDirect" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c76" id="hidden-fact-192" name="aapg:PercentageOfEquityInterestsAttributableToTheCompanyDirect" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c78" id="hidden-fact-193" name="aapg:PercentageOfEquityInterestsAttributableToTheCompanyDirect" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c80" id="hidden-fact-194" name="aapg:PercentageOfEquityInterestsAttributableToTheCompanyDirect" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-195" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c115" id="hidden-fact-196" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c115" id="hidden-fact-197" name="ifrs-full:Revenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c128" id="hidden-fact-198" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c130" id="hidden-fact-199" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c130" id="hidden-fact-200" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c132" id="hidden-fact-201" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c133" id="hidden-fact-202" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c133" id="hidden-fact-203" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c135" id="hidden-fact-204" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-205" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-206" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c137" id="hidden-fact-207" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-208" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-209" name="ifrs-full:Revenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c152" id="hidden-fact-210" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c154" id="hidden-fact-211" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c154" id="hidden-fact-212" name="ifrs-full:Revenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c158" id="hidden-fact-213" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c159" id="hidden-fact-214" name="ifrs-full:Revenue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-215" name="ifrs-full:NetForeignExchangeGain" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-216" name="ifrs-full:NetForeignExchangeGain" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-217" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-218" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-219" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-220" name="ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-221" name="ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-222" name="ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-223" name="ifrs-full:InventoryWritedown2011" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-224" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-225" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-226" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-227" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-228" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-229" name="ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-230" name="aapg:FinancialLiabilitiesAtFVTPL" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-231" name="aapg:FinancialLiabilitiesAtFVTPL" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-232" name="aapg:AdjustmentsForGainOnDisposalOfLeases" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-233" name="ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-234" name="ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-235" name="ifrs-full:ForeignExchangeLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-236" name="ifrs-full:ForeignExchangeLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" decimals="-3" id="hidden-fact-237" name="aapg:Penalty" unitRef="cny">24000</ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-238" name="ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-239" name="ifrs-full:CurrentTaxExpenseIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-240" name="ifrs-full:CurrentTaxExpenseIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-241" name="aapg:UncertainTaxPosition" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-242" name="aapg:EffectOfWithholdingTaxOnTheInterestIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-243" name="aapg:EffectOfWithholdingTaxOnTheInterestIncome" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-244" name="aapg:NetOperatingLossExpired" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c185" id="hidden-fact-245" name="aapg:AccumulatedDepreciationsCost" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c193" id="hidden-fact-246" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c194" id="hidden-fact-247" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-248" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c193" id="hidden-fact-249" name="ifrs-full:DisposalsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c194" id="hidden-fact-250" name="ifrs-full:DisposalsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-251" name="ifrs-full:DisposalsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c197" id="hidden-fact-252" name="ifrs-full:DisposalsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c197" id="hidden-fact-253" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-254" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c198" id="hidden-fact-255" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c193" id="hidden-fact-256" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c194" id="hidden-fact-257" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-258" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c197" id="hidden-fact-259" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c209" id="hidden-fact-260" name="aapg:AccumulatedDepreciationsCost" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c214" id="hidden-fact-261" name="aapg:AccumulatedDepreciationsCost" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c216" id="hidden-fact-262" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c216" id="hidden-fact-263" name="ifrs-full:DisposalsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c217" id="hidden-fact-264" name="ifrs-full:DisposalsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-265" name="ifrs-full:DisposalsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c220" id="hidden-fact-266" name="ifrs-full:DisposalsPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c220" id="hidden-fact-267" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-268" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c221" id="hidden-fact-269" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c217" id="hidden-fact-270" name="ifrs-full:InterestExpenseOnLeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c218" id="hidden-fact-271" name="ifrs-full:InterestExpenseOnLeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-272" name="ifrs-full:InterestExpenseOnLeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c220" id="hidden-fact-273" name="ifrs-full:InterestExpenseOnLeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c216" id="hidden-fact-274" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c217" id="hidden-fact-275" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-276" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c220" id="hidden-fact-277" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c232" id="hidden-fact-278" name="aapg:AccumulatedDepreciationsCost" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c238" id="hidden-fact-279" name="ifrs-full:AdditionsToRightofuseAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c238" id="hidden-fact-280" name="ifrs-full:DisposalsRightofuseAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c238" id="hidden-fact-281" name="aapg:ExchangeRealignmentRightofuseAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c240" id="hidden-fact-282" name="ifrs-full:AdditionsToRightofuseAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c240" id="hidden-fact-283" name="ifrs-full:DisposalsRightofuseAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c240" id="hidden-fact-284" name="aapg:ExchangeRealignmentRightofuseAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-285" name="aapg:ExchangeRealignmentRightofuseAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-286" name="aapg:AccumulatedImpairmentGoodwill" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-287" name="aapg:AccumulatedImpairmentGoodwill" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-288" name="aapg:AccumulatedImpairmentGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c247" id="hidden-fact-289" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c248" id="hidden-fact-290" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-291" name="aapg:ListedEquityInvestmentsAtFairValue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-292" name="aapg:ListedEquityInvestmentsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-293" name="aapg:OtherUnlistedInvestmentsAtFairValue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c282" id="hidden-fact-294" name="ifrs-full:NetDeferredTaxAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-295" name="ifrs-full:DeferredTaxLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-296" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-297" name="aapg:DeferredTaxAssetsTaxLossCarryforwards" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-298" name="aapg:DeferredTaxAssetsTaxLossCarryforwards" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-299" name="aapg:UnrecognizedTaxBenefitsRecognized" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-300" name="aapg:UnrecognizedTaxBenefitsRecognized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-301" name="ifrs-full:DeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-302" name="ifrs-full:DeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-303" name="ifrs-full:NoncurrentValueAddedTaxReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-304" name="ifrs-full:NoncurrentValueAddedTaxReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-305" name="ifrs-full:CurrentProvisions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c305" id="hidden-fact-306" name="ifrs-full:TradeAndOtherCurrentReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c305" id="hidden-fact-307" name="ifrs-full:TradeAndOtherCurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-308" name="aapg:PrepaidListingExpense" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-309" name="aapg:PrepaidListingExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-310" name="ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-311" name="aapg:IssueOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-312" name="aapg:IssueOfSharesUnderThePreIPOShareOptionScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-313" name="aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-314" name="aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-315" name="aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c440" id="hidden-fact-316" name="aapg:RepurchaseOfOrdinaryShare" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-317" name="aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c440" id="hidden-fact-318" name="aapg:VestingOfRestrictedShareUnit" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-319" name="aapg:VestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-320" name="aapg:IssueOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-321" name="aapg:IssueOfSharesUnderThePreIPOShareOptionScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-322" name="aapg:IssueOfSharesUnderThePreIPOShareOptionScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-323" name="aapg:IssueOfSharesUnderThePreIPOShareOptionScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-324" name="aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-325" name="aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-326" name="aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c442" id="hidden-fact-327" name="aapg:IncreaseDecreaseInNumberOfSharesEquitysettledBonus" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-328" name="aapg:StockIssuedDuringPeriodValuesEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c442" id="hidden-fact-329" name="aapg:RepurchaseOfOrdinaryShare" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-330" name="aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c442" id="hidden-fact-331" name="aapg:VestingOfRestrictedShareUnit" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-332" name="aapg:VestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-333" name="aapg:IssueOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-334" name="aapg:IssueOfSharesUnderThePreIPOShareOptionScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-335" name="aapg:IssueOfSharesUnderThePreIPOShareOptionScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-336" name="aapg:IssueOfSharesUnderThePreIPOShareOptionScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-337" name="aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-338" name="aapg:StockIssuedDuringPeriodValuesEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c59" id="hidden-fact-339" name="aapg:StockIssuedDuringPeriodValuesEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-340" name="aapg:StockIssuedDuringPeriodValuesEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c444" id="hidden-fact-341" name="aapg:RepurchaseOfOrdinaryShare" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-342" name="aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c444" id="hidden-fact-343" name="aapg:VestingOfRestrictedShareUnit" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c58" id="hidden-fact-344" name="aapg:VestingOfRestrictedShareUnits" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:footnote id="ix_19_footnote" xml:lang="en-US">During the year ended December 31, 2024, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 656,077 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.5 was credited as share capital.</ix:footnote><!--Text not found in footnote sections assigned to Schedule of Share Capital and Treasury Shares -->
<ix:footnote id="ix_25_footnote" xml:lang="en-US">During the year ended December 31, 2025, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 455,263 new shares of the Company were issued with a weighted average exercise price of HK$ 0.01, and an amount of RMB0.3 (US$0.04) was credited as share capital.</ix:footnote><!--Text not found in footnote sections assigned to Schedule of Share Capital and Treasury Shares -->
<ix:nonFraction contextRef="c13" id="hidden-fact-345" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" unitRef="hkdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-346" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c504" id="hidden-fact-347" name="ifrs-full:NumberOfOutstandingShareOptions" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c505" id="hidden-fact-348" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c482" id="hidden-fact-349" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c481" id="hidden-fact-350" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c484" id="hidden-fact-351" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-352" name="aapg:ShareGrantExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-353" name="aapg:ShareGrantExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-354" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-355" name="aapg:ShareGrantExpense" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-356" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c560" id="hidden-fact-357" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c560" id="hidden-fact-358" name="ifrs-full:InterestExpense" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-359" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c560" id="hidden-fact-360" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-361" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c560" id="hidden-fact-362" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c568" id="hidden-fact-363" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c569" id="hidden-fact-364" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c568" id="hidden-fact-365" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c569" id="hidden-fact-366" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c568" id="hidden-fact-367" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c569" id="hidden-fact-368" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c577" id="hidden-fact-369" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c578" id="hidden-fact-370" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c577" id="hidden-fact-371" name="ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c578" id="hidden-fact-372" name="ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c577" id="hidden-fact-373" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c578" id="hidden-fact-374" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c577" id="hidden-fact-375" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c578" id="hidden-fact-376" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-377" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-378" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c545" id="hidden-fact-379" name="aapg:NumberOfGrantees" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c547" id="hidden-fact-380" name="ifrs-full:NumberOfSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-381" name="aapg:NonCashDisposals" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-382" name="aapg:NonCashDisposals" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-383" name="aapg:NoncashAdditionsToIntangibleAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-384" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c586" id="hidden-fact-385" name="ifrs-full:AmountsPayableRelatedPartyTransactions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c588" id="hidden-fact-386" name="ifrs-full:AmountsPayableRelatedPartyTransactions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-387" name="ifrs-full:AmountsPayableRelatedPartyTransactions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-388" name="aapg:OutstandingBalanceOtherNoncurrentLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c590" id="hidden-fact-389" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c590" id="hidden-fact-390" name="ifrs-full:CashAndBankBalancesAtCentralBanks" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c590" id="hidden-fact-391" name="ifrs-full:NoncurrentReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c591" id="hidden-fact-392" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c590" id="hidden-fact-393" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c593" id="hidden-fact-394" name="ifrs-full:CurrentPortionOfLongtermBorrowings" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c593" id="hidden-fact-395" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c593" id="hidden-fact-396" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c593" id="hidden-fact-397" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c593" id="hidden-fact-398" name="ifrs-full:FinancialLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c596" id="hidden-fact-399" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c596" id="hidden-fact-400" name="ifrs-full:CashAndBankBalancesAtCentralBanks" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c596" id="hidden-fact-401" name="ifrs-full:NoncurrentReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c597" id="hidden-fact-402" name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c596" id="hidden-fact-403" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c599" id="hidden-fact-404" name="ifrs-full:CurrentPortionOfLongtermBorrowings" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c599" id="hidden-fact-405" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c601" decimals="-3" id="hidden-fact-406" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" unitRef="usd">20084000</ix:nonFraction>
<ix:nonFraction contextRef="c186" id="hidden-fact-407" name="ifrs-full:NoncurrentLeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c602" id="hidden-fact-408" name="ifrs-full:NoncurrentLeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c605" id="hidden-fact-409" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c606" id="hidden-fact-410" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-411" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c607" id="hidden-fact-412" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c607" id="hidden-fact-413" name="ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c608" id="hidden-fact-414" name="ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c607" id="hidden-fact-415" name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c608" id="hidden-fact-416" name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c631" id="hidden-fact-417" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c632" id="hidden-fact-418" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c633" id="hidden-fact-419" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c631" id="hidden-fact-420" name="aapg:CashAndBankBalancesNotYetPastDue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c632" id="hidden-fact-421" name="aapg:CashAndBankBalancesNotYetPastDue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c633" id="hidden-fact-422" name="aapg:CashAndBankBalancesNotYetPastDue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c630" id="hidden-fact-423" name="ifrs-full:TradeReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c631" id="hidden-fact-424" name="ifrs-full:TradeReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c632" id="hidden-fact-425" name="ifrs-full:TradeReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c631" id="hidden-fact-426" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c632" id="hidden-fact-427" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c633" id="hidden-fact-428" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c631" id="hidden-fact-429" name="ifrs-full:FinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c632" id="hidden-fact-430" name="ifrs-full:FinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c635" id="hidden-fact-431" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c636" id="hidden-fact-432" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c637" id="hidden-fact-433" name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c635" id="hidden-fact-434" name="aapg:CashAndBankBalancesNotYetPastDue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c636" id="hidden-fact-435" name="aapg:CashAndBankBalancesNotYetPastDue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c637" id="hidden-fact-436" name="aapg:CashAndBankBalancesNotYetPastDue" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c634" id="hidden-fact-437" name="ifrs-full:TradeReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c635" id="hidden-fact-438" name="ifrs-full:TradeReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c636" id="hidden-fact-439" name="ifrs-full:TradeReceivables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c635" id="hidden-fact-440" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c636" id="hidden-fact-441" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c637" id="hidden-fact-442" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c635" id="hidden-fact-443" name="ifrs-full:FinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c636" id="hidden-fact-444" name="ifrs-full:FinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c638" id="hidden-fact-445" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c640" id="hidden-fact-446" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c641" id="hidden-fact-447" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c643" id="hidden-fact-448" name="ifrs-full:LeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c646" id="hidden-fact-449" name="ifrs-full:LeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c648" id="hidden-fact-450" name="ifrs-full:OtherBorrowings" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c655" id="hidden-fact-451" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c656" id="hidden-fact-452" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c658" id="hidden-fact-453" name="ifrs-full:OtherPayables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c659" id="hidden-fact-454" name="ifrs-full:OtherPayables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c661" id="hidden-fact-455" name="ifrs-full:OtherPayables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c668" id="hidden-fact-456" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c670" id="hidden-fact-457" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c671" id="hidden-fact-458" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c673" id="hidden-fact-459" name="ifrs-full:LeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c676" id="hidden-fact-460" name="ifrs-full:LeaseLiabilities" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c678" id="hidden-fact-461" name="ifrs-full:OtherBorrowings" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c685" id="hidden-fact-462" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c686" id="hidden-fact-463" name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c688" id="hidden-fact-464" name="ifrs-full:OtherPayables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c689" id="hidden-fact-465" name="ifrs-full:OtherPayables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c691" id="hidden-fact-466" name="ifrs-full:OtherPayables" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c697" decimals="-3" id="hidden-fact-467" name="ifrs-full:DerivativeFinancialAssetsHeldForHedging" unitRef="cny">2452061000</ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-468" name="aapg:MarketEquityIndex" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c82" id="hidden-fact-469" name="aapg:StockExchangeIndexShare" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c553" id="hidden-fact-470" name="aapg:StockExchangeIndexShare" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c700" id="hidden-fact-471" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c701" id="hidden-fact-472" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c700" id="hidden-fact-473" name="ifrs-full:FinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c701" id="hidden-fact-474" name="ifrs-full:FinancialAssets" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c705" id="hidden-fact-475" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c705" id="hidden-fact-476" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c715" id="hidden-fact-477" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c716" id="hidden-fact-478" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c715" id="hidden-fact-479" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c717" id="hidden-fact-480" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c715" id="hidden-fact-481" name="aapg:ComprehensiveIncomeLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c716" id="hidden-fact-482" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c717" id="hidden-fact-483" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c719" id="hidden-fact-484" name="aapg:PreIPOShareOptionExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c720" id="hidden-fact-485" name="aapg:PreIPOShareOptionExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c716" id="hidden-fact-486" name="aapg:RestrictedShareUnitExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c717" id="hidden-fact-487" name="aapg:RestrictedShareUnitExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c716" id="hidden-fact-488" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c717" id="hidden-fact-489" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c716" id="hidden-fact-490" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c717" id="hidden-fact-491" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c716" id="hidden-fact-492" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c717" id="hidden-fact-493" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c718" id="hidden-fact-494" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c719" id="hidden-fact-495" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c718" id="hidden-fact-496" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c720" id="hidden-fact-497" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c718" id="hidden-fact-498" name="aapg:ComprehensiveIncomeLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c719" id="hidden-fact-499" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c720" id="hidden-fact-500" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c719" id="hidden-fact-501" name="aapg:RestrictedShareUnitExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c720" id="hidden-fact-502" name="aapg:RestrictedShareUnitExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c719" id="hidden-fact-503" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c720" id="hidden-fact-504" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c719" id="hidden-fact-505" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c720" id="hidden-fact-506" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c719" id="hidden-fact-507" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c720" id="hidden-fact-508" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c728" id="hidden-fact-509" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c729" id="hidden-fact-510" name="ifrs-full:ProfitLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c728" id="hidden-fact-511" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c730" id="hidden-fact-512" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c728" id="hidden-fact-513" name="aapg:ComprehensiveIncomeLoss" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c729" id="hidden-fact-514" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c730" id="hidden-fact-515" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c729" id="hidden-fact-516" name="ifrs-full:AdjustmentsForSharebasedPayments" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c730" id="hidden-fact-517" name="ifrs-full:AdjustmentsForSharebasedPayments" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c729" id="hidden-fact-518" name="aapg:RestrictedShareUnitExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c730" id="hidden-fact-519" name="aapg:RestrictedShareUnitExpenses" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c729" id="hidden-fact-520" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c730" id="hidden-fact-521" name="aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c729" id="hidden-fact-522" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c730" id="hidden-fact-523" name="aapg:StockIssuedDuringPeriodValueVestingOfRSUs" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c729" id="hidden-fact-524" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c730" id="hidden-fact-525" name="aapg:StockIssuedDuringPeriodValueEquitysettledBonus" unitRef="cny" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-526" name="ifrs-full:InvestmentIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-527" name="ifrs-full:InvestmentIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-73396">0002023311</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-73397">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-73398">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-73399">00000</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="aapg-20251231.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><ix:relationship xmlns="" fromRefs="ix_0_fact ix_1_fact hidden-fact-191 ix_2_fact ix_3_fact ix_4_fact ix_5_fact hidden-fact-192 ix_6_fact ix_7_fact ix_8_fact ix_9_fact hidden-fact-194 ix_10_fact ix_11_fact" toRefs="ix_0_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_0_fact ix_1_fact hidden-fact-191 ix_2_fact ix_3_fact ix_4_fact ix_5_fact hidden-fact-192 ix_6_fact ix_7_fact ix_8_fact ix_9_fact hidden-fact-194 ix_10_fact ix_11_fact" toRefs="ix_1_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_12_fact ix_13_fact ix_14_fact" toRefs="ix_2_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_15_fact ix_16_fact ix_17_fact" toRefs="ix_3_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_18_fact" toRefs="ix_4_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_19_fact hidden-fact-199" toRefs="ix_5_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_20_fact ix_21_fact ix_22_fact ix_23_fact" toRefs="ix_6_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_24_fact ix_25_fact ix_26_fact ix_27_fact ix_28_fact hidden-fact-224 hidden-fact-225 hidden-fact-226 ix_29_fact ix_30_fact ix_31_fact ix_32_fact ix_33_fact ix_34_fact ix_35_fact ix_36_fact ix_37_fact ix_38_fact ix_39_fact ix_40_fact" toRefs="ix_7_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_41_fact ix_42_fact ix_43_fact" toRefs="ix_8_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_44_fact ix_45_fact ix_46_fact ix_47_fact" toRefs="ix_9_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_46_fact" toRefs="ix_10_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_48_fact ix_49_fact ix_50_fact ix_51_fact ix_52_fact ix_53_fact ix_54_fact ix_55_fact ix_56_fact ix_57_fact ix_58_fact ix_59_fact ix_60_fact ix_61_fact ix_62_fact ix_63_fact ix_64_fact ix_65_fact ix_66_fact ix_67_fact ix_68_fact ix_69_fact" toRefs="ix_11_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_70_fact ix_71_fact hidden-fact-311 ix_72_fact" toRefs="ix_12_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_73_fact ix_74_fact hidden-fact-312 ix_75_fact" toRefs="ix_13_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_76_fact hidden-fact-313 hidden-fact-314 hidden-fact-315" toRefs="ix_14_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_77_fact ix_78_fact ix_79_fact ix_80_fact" toRefs="ix_15_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-316 hidden-fact-317 ix_81_fact ix_82_fact" toRefs="ix_16_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-318 hidden-fact-319 ix_83_fact ix_84_fact" toRefs="ix_17_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_85_fact ix_86_fact hidden-fact-320 ix_87_fact" toRefs="ix_18_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_88_fact hidden-fact-321 hidden-fact-322 hidden-fact-323" toRefs="ix_19_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_89_fact hidden-fact-324 hidden-fact-325 hidden-fact-326" toRefs="ix_20_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-327 hidden-fact-328 ix_90_fact ix_91_fact" toRefs="ix_21_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-329 hidden-fact-330 ix_92_fact ix_93_fact" toRefs="ix_22_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-331 hidden-fact-332 ix_94_fact ix_95_fact" toRefs="ix_23_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_96_fact ix_97_fact hidden-fact-333 ix_98_fact" toRefs="ix_24_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_99_fact hidden-fact-334 hidden-fact-335 hidden-fact-336" toRefs="ix_25_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_100_fact ix_101_fact hidden-fact-337 ix_102_fact" toRefs="ix_26_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_103_fact hidden-fact-338 hidden-fact-339 hidden-fact-340" toRefs="ix_27_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-341 hidden-fact-342 ix_104_fact ix_105_fact" toRefs="ix_28_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-343 hidden-fact-344 ix_106_fact ix_107_fact" toRefs="ix_29_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-423 hidden-fact-424 hidden-fact-425 ix_108_fact ix_109_fact hidden-fact-437 hidden-fact-438 hidden-fact-439 ix_110_fact ix_111_fact ix_112_fact" toRefs="ix_30_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_113_fact hidden-fact-417 hidden-fact-418 hidden-fact-419 ix_114_fact ix_115_fact hidden-fact-426 hidden-fact-427 hidden-fact-428 ix_116_fact ix_117_fact hidden-fact-431 hidden-fact-432 hidden-fact-433 ix_118_fact ix_119_fact ix_120_fact hidden-fact-440 hidden-fact-441 hidden-fact-442 ix_121_fact ix_122_fact" toRefs="ix_31_footnote"/>
<xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2026-04-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectuallPropertyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectuallPropertyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectuallPropertyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:SuzhouAscentagePharmaCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:SuzhouAscentagePharmaCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:GuangzhouHealthquestPharmaCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:GuangzhouHealthquestPharmaCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:AscentagePharmaGroupIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:AscentagePharmaGroupIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:SuzhouShengheInnovationWorksBiotechCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:SuzhouShengheInnovationWorksBiotechCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:IFRSEighteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:IFRSNineteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AmendmentsToIFRSNineAndIFRSSevenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AmendmentsToIFRSNineAndIFRSSevenOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AmendmentsToIFRSTenAndIFRSTwentyEightMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AmendmentsToIASTwentyOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AccountingStandardsVolume11Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:FurnitureAndEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:FurnitureAndEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:OthersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:OthersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:OthersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerDMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerDMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerDMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:HighAndNewTechnologyEnterpriseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:SuzhouYashengMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c192">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c193">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c194">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c195">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c196">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c197">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c198">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c199">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c200">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c201">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c202">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c203">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c204">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c205">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c206">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c207">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c208">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c209">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c210">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c211">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c212">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c213">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c214">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c215">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c216">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c217">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c218">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c219">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c220">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c221">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c222">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c223">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c224">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c225">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c226">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c227">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c228">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c229">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c230">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c231">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c232">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c233">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c234">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c235">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c236">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c237">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c238">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c239">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c240">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c241">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c242">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c243">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c244">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c245">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c246">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c247">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c248">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c249">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c250">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c251">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c252">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c253">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c254">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c255">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c256">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c257">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c258">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c259">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c260">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c261">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c262">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c263">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c264">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c265">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c266">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c267">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c268">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c269">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c270">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c271">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c272">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c273">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c274">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c275">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c276">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c277">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c278">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c279">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c280">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c281">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c282">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c283">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c284">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c285">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c286">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c287">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c288">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c289">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c290">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c291">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c292">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c293">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c294">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c295">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c296">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c297">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c298">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c299">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c300">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c301">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c302">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:FinancialAssetsAgingAxis">aapg:TradeReceivablesWithin45DaysMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c303">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:FinancialAssetsAgingAxis">aapg:TradeReceivablesWithin45DaysMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c304">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:FinancialAssetsAgingAxis">aapg:TradeReceivables45To120DaysMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c305">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:FinancialAssetsAgingAxis">aapg:TradeReceivables45To120DaysMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c306">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c307">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c308">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c309">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c310">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c311">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c312">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c313">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c314">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c315">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">aapg:OthersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c316">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">aapg:OthersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c317">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:WithinOneMonthMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c318">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:WithinOneMonthMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c319">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:OneToThreeMonthsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c320">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:OneToThreeMonthsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c321">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:ThreeToSixMonthsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c322">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:ThreeToSixMonthsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c323">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c324">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c325">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c326">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c327">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c328">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">aapg:ShorttermAdvancesRecognizedFromCustomersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c329">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">aapg:ShorttermAdvancesRecognizedFromCustomersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c330">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">aapg:LongtermAdvancesRecognizedFromCustomersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c331">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">aapg:LongtermAdvancesRecognizedFromCustomersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c332">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c333">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c334">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c335">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c336">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c337">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c338">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c339">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c340">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c341">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c342">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c343">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c344">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c345">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c346">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c347">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c348">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c349">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c350">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c351">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c352">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c353">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c354">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c355">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c356">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c357">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c358">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c359">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c360">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c361">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c362">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c363">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c364">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c365">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c366">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c367">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c368">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c369">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c370">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c371">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c372">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c373">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c374">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c375">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c376">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c377">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c378">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c379">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c380">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c381">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c382">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c383">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c384">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c385">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c386">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c387">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c388">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c389">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c390">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c391">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c392">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c393">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c394">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c395">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c396">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c397">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c398">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c399">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c400">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c401">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c402">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c403">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c404">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c405">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c406">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c407">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c408">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c409">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c410">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c411">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c412">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c413">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c414">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c415">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-02-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c416">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-30</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c417">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c418">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-30</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c419">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c420">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:HongKongStockExchangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c421">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-30</xbrli:startDate>
    <xbrli:endDate>2023-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c422">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c423">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c424">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c425">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:PreIPOShareOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c426">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:PreIPOShareOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c427">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-30</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c428">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c429">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c430">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c431">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">aapg:RestrictedShareUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-30</xbrli:startDate>
    <xbrli:endDate>2024-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c432">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">aapg:RestrictedShareUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-30</xbrli:startDate>
    <xbrli:endDate>2024-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c433">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:HongKongStockExchangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-02-01</xbrli:startDate>
    <xbrli:endDate>2024-02-29</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c434">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:HongKongStockExchangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-02-29</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c435">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c436">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c437">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c438">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c439">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c440">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c441">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c442">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c443">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c444">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c445">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c446">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c447">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c448">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c449">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c450">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c451">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:ReservesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c452">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:ReservesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c453">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PreIPOShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c454">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:ShareOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c455">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:ShareOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c456">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:SpecialOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c457">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:SpecialOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c458">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:SpecialOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c459">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PreIPOShareOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c460">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:ShareOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c461">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c462">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c463">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-11-26</xbrli:startDate>
    <xbrli:endDate>2025-11-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c464">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-11-26</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c465">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:GrantAnniversariesAxis">aapg:FirstAnniversariesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c466">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:GrantAnniversariesAxis">aapg:SecondAnniversaryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c467">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:GrantAnniversariesAxis">aapg:ThirdAnniversaryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c468">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:GrantAnniversariesAxis">aapg:FourthAnniversaryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c469">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-11-26</xbrli:startDate>
    <xbrli:endDate>2025-11-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c470">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">aapg:ForecastMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-10-26</xbrli:startDate>
    <xbrli:endDate>2026-10-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c471">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c472">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandEighteenRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-07-06</xbrli:startDate>
    <xbrli:endDate>2018-07-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c473">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandEighteenRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-09-14</xbrli:startDate>
    <xbrli:endDate>2020-09-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c474">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-02-02</xbrli:startDate>
    <xbrli:endDate>2021-02-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c475">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-02-02</xbrli:startDate>
    <xbrli:endDate>2021-02-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c476">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-05-17</xbrli:startDate>
    <xbrli:endDate>2021-05-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c477">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:NonExecutiveDirectorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-05-17</xbrli:startDate>
    <xbrli:endDate>2021-05-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c478">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:ChiefCommercialOfficerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-05-17</xbrli:startDate>
    <xbrli:endDate>2021-05-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c479">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:NonExecutiveDirectorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-23</xbrli:startDate>
    <xbrli:endDate>2021-07-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c480">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-27</xbrli:startDate>
    <xbrli:endDate>2025-06-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c481">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c482">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c483">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c484">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c485">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-23</xbrli:startDate>
    <xbrli:endDate>2022-06-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c486">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c487">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-23</xbrli:startDate>
    <xbrli:endDate>2022-06-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c488">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-23</xbrli:startDate>
    <xbrli:endDate>2022-06-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c489">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrZhaiYifanMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-23</xbrli:startDate>
    <xbrli:endDate>2022-06-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c490">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-04</xbrli:startDate>
    <xbrli:endDate>2023-05-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c491">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-04</xbrli:startDate>
    <xbrli:endDate>2023-05-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c492">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-02</xbrli:startDate>
    <xbrli:endDate>2024-09-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c493">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-02</xbrli:startDate>
    <xbrli:endDate>2024-09-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c494">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-11-26</xbrli:startDate>
    <xbrli:endDate>2025-11-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c495">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-11-26</xbrli:startDate>
    <xbrli:endDate>2025-11-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c496">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrYangDajunMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-11-26</xbrli:startDate>
    <xbrli:endDate>2025-11-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c497">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c498">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c499">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c500">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c501">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c502">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c503">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c504">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c505">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c506">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c507">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c508">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c509">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c510">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c511">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c512">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c513">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TwentySixNov202526Nov2035Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c514">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c515">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsTwoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c516">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsThreeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c517">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFourMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c518">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFiveMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c519">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsSixMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c520">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants1OneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c521">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c522">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsTwoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c523">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsThreeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c524">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFourMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c525">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFiveMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c526">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsSixMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c527">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants1ThreeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c528">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants2FourMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c529">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c530">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants2ThreeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c531">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsThreeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c532">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFourMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c533">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFiveMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c534">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsSixMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c535">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants7Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c536">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants8Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c537">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants9Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c538">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants10Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c539">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants1TwoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c540">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants2OneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c541">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c542">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c543">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c544">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c545">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c546">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c547">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c548">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c549">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:EmployeeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c550">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:EmployeeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c551">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:EmployeeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c552">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:EmployeeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c553">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c554">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c555">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c556">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c557">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c558">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c559">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c560">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c561">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c562">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c563">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c564">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c565">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c566">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c567">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c568">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c569">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c570">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c571">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c572">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c573">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c574">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c575">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c576">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c577">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c578">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c579">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c580">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c581">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c582">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c583">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aapg:HealthquestPharmaAcquisitionAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c584">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:DrYangMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-17</xbrli:startDate>
    <xbrli:endDate>2025-07-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c585">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:DrYangMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-29</xbrli:startDate>
    <xbrli:endDate>2025-07-29</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c586">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrZhaiYifanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c587">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrZhaiYifanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c588">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrYangDajunMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c589">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrYangDajunMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c590">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c591">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c592">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c593">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:FinancialLiabilitiesAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c594">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesAtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c595">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c596">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c597">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c598">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c599">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c600">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesAtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c601">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c602">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c603">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c604">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c605">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c606">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c607">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c608">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c609">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c610">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c611">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c612">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c613">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c614">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c615">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c616">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c617">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c618">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:IncreasedecreaseInBasisPointsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c619">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:IncreasedecreaseInLossBeforeTaxMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c620">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:IncreasedecreaseInBasisPointsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c621">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:IncreasedecreaseInLossBeforeTaxMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c622">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBWeakensAgainstUSDollarsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c623">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBWeakensAgainstUSDollarsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c624">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBStrengthensAgainstUSDollarsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c625">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBStrengthensAgainstUSDollarsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c626">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBWeakensAgainstUSDollarsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c627">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBWeakensAgainstUSDollarsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c628">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBStrengthensAgainstUSDollarsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c629">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBStrengthensAgainstUSDollarsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c630">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:Stage1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c631">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:StageTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c632">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:StageThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c633">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:SimplifiedApproachMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c634">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:Stage1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c635">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:StageTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c636">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:StageThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c637">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:SimplifiedApproachMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c638">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c639">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c640">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c641">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c642">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c643">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c644">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c645">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c646">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c647">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c648">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c649">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c650">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c651">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c652">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c653">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c654">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c655">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c656">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c657">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c658">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c659">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c660">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c661">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c662">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c663">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c664">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c665">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c666">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c667">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c668">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c669">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c670">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c671">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c672">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c673">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c674">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c675">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c676">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c677">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c678">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c679">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c680">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c681">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c682">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c683">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c684">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c685">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c686">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c687">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c688">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c689">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c690">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c691">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c692">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c693">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c694">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c695">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c696">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c697">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c698">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:CarryingAmountOfEquityInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c699">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:DecreaseincreaseInLossBeforeTaxMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c700">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:CarryingAmountOfEquityInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c701">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:DecreaseincreaseInLossBeforeTaxMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c702">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:CapitalManagementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c703">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:CapitalManagementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c704">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:CapitalManagementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c705">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:CapitalManagementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c706">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c707">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c708">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c709">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c710">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c711">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c712">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c713">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c714">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c715">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c716">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c717">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c718">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c719">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c720">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c721">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c722">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c723">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c724">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c725">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c726">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c727">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c728">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c729">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c730">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c731">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c732">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c733">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0002023311</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="cny">
  <xbrli:measure>iso4217:CNY</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="cnyPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:CNY</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="hkdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:HKD</xbrli:measure>
    </xbrli:unitNumerator>
<!-- [WMV7][6zk2cJUltLJv35QeobyC+52aRQ/cPtdu/HT+pD9ocR4R5dVi6m7wu7wSmjJJ6vlW7z1b8DsenOuYL96j9nXl/ecQ1foPJzmLU9NEyljGc1fy1OjjmRgIovOrA4wLPxUNT3fapBxy5oubUhGc9k3V1VzrhIrn8Txlqb3dm7I+h2NSTX02diInNg0HppjT/hafyBBNB2RTShZaeCTghhhOrVURgGKu6HyePxEONQWcmpQJTbz4m+MkehJFrwWX1Ann3Jiz/RAFTqTNHkliwz9w819ad4LWM8avb5NpTCuW1/m/8FhcJyP2eBbVEA54NoIQRgpL6zCC+r2/aoHfvvcI4GfF0+jV8TEdUjyGt5Zd4/Da5eX7ZiC2Tm5537d0vHMdauAPzYQa5W8rWsqV] CSR-->
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="hkd">
  <xbrli:measure>iso4217:HKD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.4
<SEQUENCE>2
<FILENAME>ea028514801ex2-4.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 2.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF THE REGISTRANT&rsquo;S SECURITIES<BR>
REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>The following description sets forth certain material terms of the
ordinary shares of Ascentage Pharma Group International (&ldquo;Ascentage Pharma,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo;
&ldquo;us,&rdquo; and &ldquo;our&rdquo;) that are registered under Section 12 of the Securities Exchange Act of 1934, as amended (the
&ldquo;Exchange Act&rdquo;), our second amended and restated memorandum and articles of association (the &ldquo;A&amp;R Articles&rdquo;)
and the Companies Act (as amended) of the Cayman Islands (the &ldquo;Companies Act&rdquo;) insofar as they relate to the material terms
of our ordinary shares. The following summary does not purport to be complete and is subject to, and is qualified in its entirety by reference
to, the applicable provisions of the laws of the Cayman Islands and our A&amp;R Articles, a copy of which is filed as an exhibit to the
Annual Report on 20-F of which this exhibit is a part. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a Cayman Islands exempted company incorporated with limited
liability and our affairs are governed by our A&amp;R Articles, the Companies Act, and Cayman Islands common law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our securities include our ordinary shares, par value US$0.0001 per
share, in the form of American Depositary Shares (the &ldquo;ADSs&rdquo;), each representing four ordinary shares, no par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The ADSs are listed on the Nasdaq Global Market (&ldquo;Nasdaq&rdquo;)
under the trading symbol &ldquo;AAPG.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our ordinary shares are listed on the Hong Kong Stock Exchange (&ldquo;HKEx&rdquo;)
under the stock code &ldquo;6855.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is a description of the rights of (i) the holders of
ordinary shares and (ii) ADS holders. The ordinary shares underlying the ADSs are held by JPMorgan Chase Bank, N.A. (&ldquo;JPMorgan&rdquo;),
as depositary, and holders of ADSs will not be treated as holders of the ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Description of ordinary shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>General</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our authorized share capital is US$50,000 consisting of 500,000,000
shares, par value US$0.0001 per share. As of April 1, 2026, 373,322,192 ordinary shares were issued and outstanding. Certificates representing
the ordinary shares are issued in registered form. We may not issue share to bearer. Our shareholders who are non-residents of the Cayman
Islands may freely hold and transfer their ordinary shares.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Dividends</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The holders of our ordinary shares are entitled to such dividends as
may be declared by our board of directors subject to our A&amp;R Articles and the Companies Act. In addition, our shareholders may, subject
to the provisions of our A&amp;R Articles, by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended
by our directors. Our A&amp;R Articles provide that dividends may be declared and paid out of our profits, realized or unrealized, or
from any reserve set aside from profits which our board of directors determine is no longer needed. Dividends may also be declared and
paid out of share premium account or any other fund or account which can be authorized for this purpose in accordance with the Companies
Act. No dividend may be declared and paid unless our directors determine that, immediately after the payment, we will be able to pay our
debts as they become due in the ordinary course of business and we have funds lawfully available for such purpose.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Voting rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In respect of all matters subject to a shareholders&rsquo; vote, each
ordinary share is entitled to one vote for each ordinary share registered in his or her name on our register of members. Voting at any
meeting of shareholders is by poll, except that the chairman of the meeting may, pursuant to Hong Kong Listing Rules, allow a resolution to be voted by a show of hands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A quorum required for a meeting of shareholders consists of two
shareholders entitled to vote at general meetings present in person or by proxy or, if a corporation or other non-natural person, by
its duly authorized representative. As a Cayman Islands exempted company, we are not obliged by the Companies Act to call
shareholders&rsquo; annual general meetings. Our A&amp;R Articles provide that in each financial year, we will hold a general
meeting as our annual general meeting in addition to any other meeting in that year and will specify the meeting as such in the
notice calling it. We will hold the annual general meeting within six months after the end of our financial year. Each general
meeting, other than an annual general meeting, shall be an extraordinary general meeting. Shareholders&rsquo; annual general
meetings and any other general meetings of our shareholders may be called by a majority of our board of directors or our chairman or
upon a requisition of shareholders holding at the date of deposit of the requisition not less than one-third of the votes attaching
to the issued and outstanding shares entitled to vote at general meetings, in which case the directors are obliged to call such
meeting and to put the resolutions so requisitioned to a vote at such meeting; however, our A&amp;R Articles do not provide our
shareholders with any right to put any proposals before annual general meetings or extraordinary general meetings not called by such
shareholders. Advance notice of at least 21 days is required for the convening of our annual general meeting and other general
meetings shall be called by at least 14 days&rsquo; notice in writing in accordance with our A&amp;R Articles.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An ordinary resolution to be passed at a meeting by the shareholders
requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast by those shareholders entitled to
vote who are present in person or by proxy at a general meeting, while a special resolution also requires the affirmative vote of no less
than three quarters of the votes attaching to the ordinary shares cast by those shareholders entitled to vote who are present in person
or by proxy at a general meeting. A special resolution will be required for important matters such as a change of name or making changes
to our A&amp;R Articles.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Transfer of ordinary shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to the restrictions in our A&amp;R Articles, any of our shareholders
may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any other form approved
by our board of directors.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our board of directors may, in its absolute discretion, decline to
register any transfer of any ordinary share which is not fully paid up or on which we have a lien. Our board of directors may also decline
to register any transfer of any ordinary share unless:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the instrument of transfer is lodged with us, accompanied by the certificate
for the ordinary shares to which it relates and such other evidence as our board of directors may reasonably require to show the right
of the transferor to make the transfer;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the instrument of transfer is in respect of only one class of shares;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the instrument of transfer is properly stamped, if required;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">in the case of a transfer to joint holders, the number of joint holders to
whom the ordinary share is to be transferred does not exceed four;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the shares are free from any lien in favor of the Company; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">a fee of such maximum sum as the Hong Kong Stock Exchange may determine to
be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our directors refuse to register a transfer they shall, within two
months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such
refusal.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The registration of transfers may be suspended and the register closed
at such times and for such periods as our board of directors may from time to time determine, <I>provided, however,</I> that the registration
of transfers shall not be suspended nor the register closed for more than 30 days in any year as our board may determine.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Liquidation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On a return of capital on winding up or otherwise (other than on conversion,
redemption or purchase of ordinary shares or, on a winding up, with the sanction of a special resolution of our company and any other
sanction required by the Companies Act and subject to any special rights, privileges or restrictions as to the distribution of available
surplus assets on liquidation attached to any class or classes of shares), assets available for distribution among the holders of ordinary
shares will be distributed among the holders of the ordinary shares in proportion to the paid up par value of the shares held by them.
If our assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that,
as nearly as may be, the losses are borne by our shareholders in proportion to the paid up par value of the shares held by them. We are
an exempted &ldquo;limited liability&rdquo; company registered under the Companies Act, and under the Companies Act, the liability of
our members is limited to the amount, if any, unpaid on the shares respectively held by them. Our current A&amp;R Articles contain a declaration
that the liability of our members is so limited.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our Company is wound up (in whatever manner), the liquidator may,
with the sanction of a special resolution and any other sanction required by the Companies Act, divide among our shareholders in specie
or kind the whole or any part of the assets of our Company whether the assets shall consist of property of one kind or shall consist of
properties of different kinds and the liquidator may, for such purpose, set such value as it deems fair upon any one or more class or
classes of property to be divided and may determine how such division shall be carried out as amongst our shareholders. The liquidator
may, with the like sanction, vest any part of the assets in trustees upon such trusts for the benefit of our shareholders as the liquidator,
with the like sanction, shall think fit, but so that no shareholder shall be compelled to accept any of our ordinary shares or other assets
upon which there is a liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Calls on ordinary shares and forfeiture of ordinary shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our board of directors may from time to time make calls upon shareholders
for any amounts unpaid on their ordinary shares in a notice served to such shareholders at least 14 clear days prior to the specified
time of payment. The ordinary shares that have been called upon and remain unpaid are subject to forfeiture.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Redemption, repurchase and surrender of ordinary shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may issue shares on terms that such shares are subject to redemption,
at our option or at the option of the holders thereof, on such terms and in such manner as may be determined, before the issue of such
shares, by our board of directors or by an ordinary resolution of our shareholders. Our company may also repurchase any of our ordinary
shares provided that the manner and terms of such purchase have been approved by our board of directors or by ordinary resolution of our
shareholders or are otherwise authorized by our A&amp;R Articles. Under the Companies Act, the redemption or repurchase of any share
may be paid out of our company&rsquo;s profits or out of the proceeds of a fresh issue of shares made for the purpose of such redemption
or repurchase, or out of capital (including share premium account and capital redemption reserve) if the company can, immediately following
such payment, pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Act no such share may
be redeemed or repurchased (a) unless it is fully paid up, (b) if such redemption or repurchase would result in there being no shares
outstanding, or (c) if the company has commenced liquidation. In addition, our company may accept the surrender of any fully paid share
for no consideration.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Variations of rights of shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If at any time our share capital is divided into different classes
or series of shares, the rights attached to any class or series of shares (unless otherwise provided by the terms of issue of the shares
of that class or series), whether or not our company is being wound- up, may be varied with the consent in writing of three fourths of
the voting rights of the holders of that class or series or with the sanction of a special resolution at a separate meeting of the holders
of the shares of the class or series. The rights conferred upon the holders of the shares of any class issued shall not, unless otherwise
expressly provided by the terms of issue of the shares of that class, be deemed to be varied by the creation or issue of further shares
ranking pari passu with such existing class of shares.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Anti-Takeover Provisions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Some provisions of our A&amp;R Articles may discourage, delay or prevent
a change in control of our company or management that shareholders may consider favorable, including provisions that authorize our board
of directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions
of such preferred shares without any further vote or action by our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">However, under Cayman Islands law, our directors may only exercise
the rights and powers granted to them under our A&amp;R Articles, as amended and restated from time to time, for a proper purpose and
for what they believe in good faith to be in the best interests of our company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Rights of Non-resident or Foreign Shareholders</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no limitations imposed by our A&amp;R Articles on the rights
of non-resident or foreign shareholders to hold or exercise voting rights on our ordinary shares. In addition, there are no provisions
in our A&amp;R Articles governing the ownership threshold above which shareholder ownership must be disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Inspection of books and records</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders of our ordinary shares have no general right under Cayman Islands
law to inspect or obtain copies of our list of shareholders or our corporate records (other than our A&amp;R Articles, the register of
mortgages and charges and any special resolutions passed by shareholders). However, under our A&amp;R Articles, during the period when
our shares are listed on the Hong Kong Stock Exchange and except when our register of shareholders is closed on terms equivalent to Section
632 of the Hong Kong Companies Ordinance, any of our shareholders may inspect during business hours any register of shareholders maintained
in Hong Kong without charge and require the copies of extracts of it. Under Cayman Islands law, the names of our current directors can
be obtained from a search conducted at the Registrar of Companies of the Cayman Islands. The books of account shall be kept at our headquarters
or at such other place or places as our board of directors thinks fit and shall always be open to the inspection of the members of our
board of directors. No shareholder (unless otherwise a member of our board of directors) or other person shall have any right of inspecting
any account or book or document of our Company except as conferred by the Companies Act or ordered by a court of competent jurisdiction
or authorized by our board of directors or our Company at a general meeting of shareholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Issuance of additional shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our A&amp;R Articles authorize our board of directors to issue additional
ordinary shares from time to time as our board of directors shall determine, to the extent of available authorized but unissued shares.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our A&amp;R Articles also authorize our board of directors to establish
from time to time one or more series of preferred shares and to determine, with respect to any series of preferred shares, the terms and
rights of that series, including:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the designation of the series;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the number of shares of the series;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the dividend rights, dividend rates, conversion rights, voting rights; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the rights and terms of redemption and liquidation preferences.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our board of directors may issue preferred shares without action by
our shareholders to the extent authorized but unissued. Issuance of these shares may dilute the voting power of holders of ordinary shares.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Exempted company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are an exempted company with limited liability under the Companies
Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that is registered in the
Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The requirements
for an exempted company are essentially the same as for an ordinary company except that an exempted company:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">does not have to file an annual return of its shareholders with the Registrar
of Companies;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">is not required to open its register of members for inspection;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">does not have to hold an annual general meeting;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">may issue shares with no par value;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">may obtain an undertaking against the imposition of any future taxation;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">may register by way of continuation in another jurisdiction and be deregistered
in the Cayman Islands;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">may register as a limited duration company; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">may register as a segregated portfolio company.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Limited liability&rdquo; means that the liability of each shareholder
is limited to the amount unpaid by the shareholder on that shareholder&rsquo;s shares of the company (except in exceptional circumstances,
such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which
a court may be prepared to pierce or lift the corporate veil).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Register of members&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the Companies Act, we must keep a register of members and there
should be entered therein:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the names and addresses of our members, a statement of the shares held by
each member, and of the amount paid or agreed to be considered as paid, on the shares of each member;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the date on which the name of any person was entered on the register as a
member; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the date on which any person ceased to be a member.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the Companies Act, the register of members of our company is
prima facie evidence of the matters set out therein (that is, the register of members will raise a presumption of fact on the matters
referred to above unless rebutted) and a member registered in the register of members is deemed as a matter of the Companies Act to have
legal title to the shares as set against its name in the register of members. The shareholders recorded in the register of members will
be deemed to have legal title to the shares set against their name.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the name of any person is incorrectly entered in or omitted from
our register of members, or if there is any default or unnecessary delay in entering on the register the fact of any person having ceased
to be a member of our company, the person or member aggrieved (or any member of our company or our company itself) may apply to the Grand
Court of the Cayman Islands for an order that the register be rectified, and the Court may either refuse such application or it may, if
satisfied of the justice of the case, make an order for the rectification of the register.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Differences in corporate law&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Companies Act differs from laws applicable to corporations incorporated
in the State of Delaware and their stockholders. Set forth below is a summary of the significant differences between the provisions of
the Companies Act applicable to us and the laws applicable to companies incorporated in the State of Delaware and their stockholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1.5pt; width: 32%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
  <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; width: 32%"><B>Cayman Islands</B></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
  <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; width: 32%"><B>Delaware</B></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Title of Organizational Documents</I></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Memorandum and Articles of Association</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Incorporation and Bylaws</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Duties of Directors</I></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a matter of Cayman Islands law, a director of a Cayman Islands company
    is in the position of a fiduciary with respect to the company and therefore it is considered that he owes the following duties to the
    company-a duty to act in good faith in the best interests of the company, a duty not to make a personal profit based on his position as
    director (unless the company permits him to do so), a duty not to put himself in a position where the interests of the company conflict
    with his personal interest or his duty to a third party and a duty to exercise powers for the purpose for which such powers were intended.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A director of a Cayman Islands company owes to the company a duty to
    act with skill and care. It was previously considered that a director need not exhibit in the performance of his duties a greater degree
    of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth courts have
    moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in the
    Cayman Islands.</P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Under Delaware law, the business and affairs of a corporation are managed by or under the direction of its board of directors. In exercising their powers, directors are charged with a fiduciary duty of care to protect the interests of the corporation and a fiduciary duty of loyalty to act in the best interests of the company and its stockholders. The duty of care requires that directors act in an informed and deliberative manner and inform themselves, prior to making a business decision, of all material information reasonably available to them. The duty of care also requires that directors exercise care in overseeing and investigating the conduct of the corporation&rsquo;s employees. The duty of loyalty may be summarized as the duty to act in good faith, not out of self-interest, and in a manner which the director reasonably believes to be in the best interests of the stockholders. </FONT></TD>
    </TR>

</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Limitations on Personal Liability of Directors and Officers</I></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Companies Act has no equivalent provision to Delaware law regarding the limitation of director&rsquo;s liability. However, any provision which seeks to limit the liability of directors or officers to the extent that the liability is a consequence of the director or officer&rsquo;s own fraud, dishonesty or willful default is unlikely to be enforceable as a matter of common law. </FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subject to the limitations described below, a certificate of incorporation may provide for the elimination or limitation of the personal liability of a director to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director. Such provision cannot limit liability for breach of the fiduciary duty of loyalty, acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, a transaction from which the director derived an improper personal benefit, unlawful payment of dividends or unlawful stock repurchase or redemption. Similarly, a certificate of incorporation may provide for the elimination or limitation of the personal liability of specified officers to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as an officer. Such provision cannot limit liability for breach of loyalty, acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, a transaction from which the officer derived an improper personal benefit, or with respect to actions by or in the right of the corporation. In addition, an exculpatory provision with terms described above cannot limit liability for any act or omission occurring prior to the date when such provision becomes effective. </FONT></TD>
    </TR>

</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Indemnification of Directors, Officers, Agents and Others</I></B></P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cayman Islands law does not limit the extent to which a company&rsquo;s
    articles of association may provide for indemnification of directors and officers, except to the extent any such provision may be held
    by the Cayman Islands Court to be contrary to public policy, such as to provide indemnification against the consequences of committing
    a crime, or against the indemnified person&rsquo;s own fraud, dishonesty or willful default.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our A&amp;R Articles provide that we will indemnify each director,
    managing director, alternate director, auditor, secretary and other officer  of the company and the trustees (if any)
    for the time being acting in relation to any of our affairs, and their respective executors or administrators against all actions, proceedings,
    costs, charges, expenses, losses, damages or liabilities incurred or sustained by such person by reason of any act done, concurred in
    or omitted in or about the execution of their duty or supposed duty in their respective offices or trusts, other than by reason of such
    person&rsquo;s own dishonesty or fraud. In addition, we have entered into indemnification agreements with our directors and executive
    officers that provide such persons with additional indemnification beyond that provided in our A&amp;R Articles.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Insofar as indemnification for liabilities arising under the Securities
    Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that in
    the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">A corporation has the power to indemnify any director, officer, employee, or agent of the corporation who was, is or is threatened to be made a party to an action, suit or proceeding who acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation, and if with respect to a criminal proceeding (other than an action by or in the right of the corporation), had no reasonable cause to believe his or her conduct would be unlawful, against amounts actually and reasonably incurred. A corporation also has the power to indemnify any director, officer, employee, or agent of the corporation who was, is or is threatened to be made a party to an action or suit by or in the right of the corporation to procure a judgment in the corporation&rsquo;s favor against expenses (including legal fees) actually and reasonably incurred if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and only if the person is not found liable, unless a court determines the person is fairly and reasonably entitled to the indemnification. Additionally, under the Delaware General Corporation Law, a Delaware corporation must indemnify its present or former directors and officers against expenses (including attorneys&rsquo; fees) actually and reasonably incurred to the extent that the officer or director has been successful on the merits or otherwise in defense of any action, suit or proceeding brought against him or her by reason of the fact that he or she is or was a director or officer of the corporation.</FONT></TD>
    </TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%">

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Interested Directors</I></B></P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under our A&amp;R Articles, directors who are in any way, whether directly or indirectly, interested in a contract or proposed contract with our company must declare the nature of their interest at a meeting of the board of directors. Following such declaration, a director may vote in respect of any certain contract or proposed contract notwithstanding his or her interest, provided that in exercising any such vote, such director&rsquo;s duties remain as described above. </FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under Delaware law, a transaction in which a director has an interest is not void or voidable solely because of such interest or solely because such interested director is present at or participates in the meeting that authorizes the transaction if: (1) the material facts as to such interested director&rsquo;s relationship or interests and as to the transaction are disclosed or are known to the board of directors or committee thereof and the board or committee in good faith authorizes the transaction by the affirmative vote of a majority of the disinterested directors, even though the disinterested directors are less than a quorum; (2) such material facts are disclosed or are known to the stockholders entitled to vote on such transaction and the transaction is specifically approved in good faith by vote of the stockholders; or (3) the transaction is fair as to the corporation as of the time it is authorized, approved or ratified by the board of directors, a committee of the board, or the stockholders. Under Delaware law, a director or officer could be held liable for any transaction in which such director or officer derived an improper personal benefit. </FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Voting Requirements</I></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a matter of Cayman Islands law, certain matters must be approved
    by special resolution of the shareholders, including amending or adopting memorandum or articles of association of a Cayman Islands company,
    reduction of share capital, change of name, authorization of a plan of merger, voluntary winding up of the company or the recalling of
    the voluntary liquidation of the company.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Companies Act requires that a special resolution be passed by a
    majority of at least two-thirds or such higher percentage as set forth in the articles of association, of shareholders being entitled
    to vote and do vote in person or by proxy at a general meeting, or by unanimous written consent of shareholders entitled to vote at a
    general meeting.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Companies Act defines &ldquo;special resolutions&rdquo; only. A
    company&rsquo;s articles of association can therefore tailor the definition of &ldquo;ordinary resolutions&rdquo; as a whole, or with
    respect to specific provisions. Our A&amp;R Articles provide that an ordinary resolution is a resolution (1) passed by a simple majority
    of such shareholders as, being entitled to do so, vote in person (or, where proxies are allowed, by proxy) at a general meeting and regard
    shall be had in computing a majority to the number of votes to which each shareholder is entitled or (2) approved in writing by all of
    the shareholders entitled to vote at a general meeting in one or more instruments each signed by one or more of the shareholders and the
    effective date of the resolution so adopted shall be the date on which the instrument (or the last of such instruments, if more than one)
    is executed.</P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under Delaware law, each stockholder is entitled to one vote for each
    share of capital stock held by such stockholder as of the applicable record date, unless otherwise provided in a corporation&rsquo;s certificate
    of incorporation. Except as otherwise provided under the Delaware General Corporation Law or by the corporation&rsquo;s certificate of
    incorporation or bylaws, under Delaware law, all matters brought before a meeting of stockholders at which a quorum is present (other
    than the election of directors) require the affirmative vote of the majority of the shares present in person or represented by proxy and
    entitled to vote on the subject matter. Certain matters for stockholder approval, including the approval of certain merger agreements,
    the statutory conversion or domestication of the corporation, certain amendments to the certificate of incorporation, and the sale, lease,
    or exchange of all or substantially all of the corporation&rsquo;s assets will require approval of the holders of a majority of the outstanding
    capital stock. The certificate of incorporation may also include a provision requiring supermajority approval by the directors or stockholders
    for any corporate action.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, under Delaware law, certain business combinations involving
    certain interested stockholders of publicly traded corporations may require approval by a supermajority of the non-interested stockholders.</P></TD>
    </TR>

</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Voting for Directors</I></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our A&amp;R Articles provide that our directors may be appointed by a resolution of our board of directors to fill a casual vacancy on the board of directors or as an addition to the board of directors or by an ordinary resolution of our shareholders. </FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under Delaware law, unless otherwise specified in the certificate of incorporation or bylaws of the corporation, directors shall be elected by a plurality of the votes of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. </FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Cumulative Voting</I></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no prohibitions in relation to cumulative voting under the
    laws of the Cayman Islands.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our A&amp;R Articles do not provide for cumulative voting on the election
    of the directors as described above.</P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">There is no cumulative voting for the election of directors unless provided for in the certificate of incorporation.</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Directors&rsquo; Powers Regarding Bylaws</I></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Our A&amp;R Articles may only be amended by a special resolution of the shareholders of our company. </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The certificate of incorporation may grant the directors the power to adopt, amend or repeal bylaws. </FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Nomination and Removal of Directors and Filling Vacancies on Board</I></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nomination and removal of directors and filling of board vacancies
    are governed by the terms of the articles of association. Our A&amp;R Articles provide that our shareholders may by ordinary resolution
    remove any of our director (including a managing director or other executive director) before the expiration of his or her term of office
    notwithstanding anything in our A&amp;R Articles or in any agreement between our Company and such director (but without prejudice to any
    claim which such director may have for damages for any breach of any contract between him/her and our Company) and may by ordinary resolution
    elect another person in his or her stead. At each annual general meeting one-third of our directors for the time being, or, if their number
    is not three or a multiple of three, then the number nearest to but not less than one-third, shall retire from office by rotation provided
    that every director (including those appointed for a specific term) shall be subject to retirement by rotation at least once every three
    years. A retiring Director shall be eligible for re-election.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, a director&rsquo;s office shall be vacated if the director
    (1) becomes bankrupt or makes any arrangement or composition with his creditors; (2) dies or is found to be or becomes of unsound mind;
    (3) is absent from our board meetings during a continuous period of six (6) months, without special leave of our board, and his or her
    alternate director (if any) has not attended in his or her stead during the period; (4) is prohibited by law from acting as a director;
    (5) has been validly required by the relevant stock exchange to cease to be a director; (6) resigns his office by notice in writing to
    the company; or (7) is removed from office pursuant to any other provisions of our A&amp;R Articles.</P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stockholders may generally nominate directors if they comply with any
    applicable advance notice provisions and other procedural requirements in the corporation&rsquo;s bylaws.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders of a majority of the shares then entitled to vote at an election
    of directors may remove a director with or without cause, except in certain cases involving a classified board or if the company uses
    cumulative voting. Unless otherwise provided for in the certificate of incorporation or bylaws, directorship vacancies and newly created
    directorships may be filled by a majority of the directors elected or then in office, or by the stockholders.</P></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Mergers and Similar Arrangements</I></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Companies Act permits mergers and consolidations between Cayman
    Islands companies and between Cayman Islands companies and non-Cayman Islands companies. For these purposes, (1) &ldquo;merger&rdquo;
    means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies
    as the surviving company, and (2) a &ldquo;consolidation&rdquo; means the combination of two or more constituent companies into a combined
    company and the vesting of the undertaking, property and liabilities of such companies to the combined company. In order to effect such
    a merger or consolidation, the directors of each constituent company must approve a written plan of merger or consolidation, which must
    then be authorized by (1) a special resolution of the shareholders of each constituent company, and (2) such other authorization, if any,
    as may be specified in such constituent company&rsquo;s articles of association. The plan must be filed with the Registrar of Companies
    of the Cayman Islands together with a declaration as to the solvency of the consolidated or surviving company, a list of the assets and
    liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to
    the members and creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman
    Islands Gazette. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory procedures.
    Dissenting shareholders have the right to be paid the fair value of their shares (which, if not agreed between the parties, will be determined
    by the Cayman Islands court) if they follow the required procedures, subject to certain exceptions.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, there are statutory provisions that facilitate, compromises
    or arrangements between a Cayman Islands company and its members (or any class of them).</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under Delaware law, with certain exceptions, a merger, a consolidation,
    a statutory conversion or domestication of the corporation, or a sale, lease or exchange of all or substantially all the assets of a corporation
    must be approved by the board of directors and a majority of the outstanding shares entitled to vote thereon. However, unless required
    by its certificate of incorporation, approval is not required by the holders of the outstanding stock of a constituent corporation surviving
    a merger if:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.25in; text-align: justify">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">the
merger agreement does not amend in any respect its certificate of incorporation;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.25in; text-align: justify">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">each
share of its stock outstanding prior to the merger will be an identical share of stock following the merger; and</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="text-indent: -0.25in; margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">either no shares of the surviving corporation&rsquo;s common stock and no shares,
securities or obligations convertible into such stock will be issued or delivered pursuant to the merger, or the authorized unissued
shares or treasury shares of the surviving corporation&rsquo;s common stock to be issued or delivered pursuant to the merger plus those
initially issuable upon conversion of any other shares, securities or obligations to be issued or delivered pursuant to the merger do
not exceed 20% of the shares of the surviving corporation&rsquo;s common stock outstanding immediately prior to the effective date of
the merger.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A merger between a parent entity and its Delaware subsidiary does not
    require authorization by a resolution of the board of directors or stockholders of that subsidiary if the board of directors of the parent
    corporation approves the terms of such merger and a certificate of ownership and merger is filed. For this purpose a company is a &ldquo;parent&rdquo;
    of a subsidiary if it holds at least 90% of the outstanding shares of each class of the stock of the subsidiary that has voting power.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    </TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%"><P STYLE="margin-top: 0; margin-bottom: 0">Following amendments to the Companies Act that became effective
on August 31, 2022, the majority-in-number &ldquo;headcount test&rdquo; in relation to the approval of members&rsquo; schemes of arrangement
has been abolished.</P>
                           <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                           <P STYLE="margin-top: 0; margin-bottom: 0">Section 86(2A) of the Companies Act provides that, if 75% in value of the members (or class of members) of
a Cayman Islands company agree to any compromise or arrangement, such compromise or arrangement shall, if sanctioned by the Cayman Court,
be binding on all members (or class of members) of such company and on the company itself. Where a Cayman Islands company is in the course
of being wound up, such compromise or arrangement would be binding on the liquidator and contributories of the company. In contrast,
section 86(2) of the Companies Act continues to require (a) approval by a majority in number representing 75% in value; and (b) the sanction
of the Grand Court of the Cayman Islands, in relation to any compromise or arrangement between a company and its creditors (or any class
of them). At the initial directions hearing, the Cayman Islands court will make orders for (amongst other things) the convening of the
meetings of creditors or members (or classes of them, as applicable). While a dissenting shareholder or creditor has the right to express
to the court the view that the transaction ought not to be approved, the court would nevertheless be likely to approve the arrangement
if it determines that: &nbsp;</P>
        <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
        <P STYLE="text-indent: -0.25in; margin-left: 0.25in; margin-top: 0; margin-bottom: 0">&#9679;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">
        &nbsp;&nbsp;&nbsp;the company has complied with the directions set down by the Cayman Islands court; &nbsp;</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%">Under the Delaware General Corporation Law, a stockholder of record
    or beneficial owner of capital stock of a Delaware corporation generally has the right to dissent from and request payment of the fair
    value (excluding value arising from the accomplishment or expectation of the transaction) for such person&rsquo;s shares upon a merger,
    consolidation, statutory conversion or domestication in which the Delaware corporation is participating, subject to specified procedural
    requirements, including that such person does not vote in favor of the transaction. However, the Delaware General Corporation Law does
    not confer appraisal rights in certain circumstances, including if the dissenting stockholder or beneficial owner owns shares traded on
    a national securities exchange and will receive publicly traded shares in the transaction. Under the Delaware General Corporation Law,
    a person asserting appraisal rights does not receive any payment for their shares until a court determines the fair value of the shares.
    The costs of the proceeding may be determined by the court and assessed against the parties as the court deems equitable under the circumstances.</TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
        <P STYLE="text-indent: -0.25in; margin-left: 0.25in; margin-top: 0; margin-bottom: 0">&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;the meeting was properly
held and the statutory provisions as to the required majority vote have been met;</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="text-indent: -0.25in; margin-left: 0.25in; margin-top: 0; margin-bottom: 0">&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;the shareholders
have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority
to promote interests adverse to those of the class; and</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="text-indent: -0.25in; margin-left: 0.25in; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT>&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;the
arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his/her interest.</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT>  If a compromise or arrangement of a Cayman Islands company is approved by the members in the context of a members&rsquo;
scheme and the Cayman Islands court subsequently sanctions such scheme (as described above), a dissenting shareholder would have no rights
comparable to the appraisal rights which it would have if the company in question were a Delaware corporation (being the right to receive
payment in cash for the judicially determined value of its shares). This is because such scheme will be binding on all members (or class
of members), regardless of whether all the members (or class of members) approved the scheme, upon the sanction order being made. Having
said that, a dissenting shareholder would have the right to appeal the making of the sanction order to the Cayman Islands Court of Appeal,
if there were grounds for doing so.</P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Shareholder Suits</I></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In principle, we will normally be the proper plaintiff to sue for a
    wrong done to us as a company, and as a general rule a derivative action may not be brought by a minority shareholder. However, based
    on English authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, the Cayman Islands court can be
    expected to follow and apply the common law principles so that a non-controlling shareholder may be permitted to commence a class action
    against or derivative actions in the name of the company to challenge actions where:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.25in; text-align: justify">&#9679;
<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;a company acts or proposes to act illegally or ultra vires;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.25in; text-align: justify">&#9679;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;the
act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not
been obtained; and</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.25in; text-align: justify">&#9679;
<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;those who control the company are perpetrating a &ldquo;fraud on the minority.&rdquo;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A&nbsp;shareholder may also (subject to meeting
    the relevant requirements in the Companies Act) file winding up proceedings against our company on just and equitable grounds, based on
    similar factual circumstances. It is possible for the shareholder to seek alternative remedies to a winding up within the winding up petition,
    depending on the circumstances. Such alternative remedies include seeking a share buyout order from our company or seeking an order regulating
    the conduct of our company&rsquo;s affairs in the future.</P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Class actions and derivative actions generally are available to stockholders who satisfy certain procedural requirements under Delaware law for, among other things, breach of fiduciary duty, corporate waste and actions not taken in accordance with applicable law. In such actions, the court generally has discretion to permit a winning plaintiff to recover attorneys&rsquo; fees incurred in connection with such action. </FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Inspection of Corporate Records</I></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholders of a Cayman Islands exempted company have no general right under Cayman Islands law to inspect or obtain copies of the register of members or other corporate records (other than the memorandum and articles of association and the register of mortgages and charges) of the company. However, these rights may be provided in the company&rsquo;s articles of association. </FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under Delaware law, stockholders of a Delaware corporation have the right during normal business hours to inspect for any proper purpose, and to obtain copies of lists of stockholders and other books and records of the corporation and its subsidiaries, if any, to the extent the books and records of such subsidiaries are available to the corporation. A complete list of the stockholders entitled to vote at a stockholders&rsquo; meeting generally must be available for stockholder inspection for a purpose germane to the meeting at least ten days before the meeting. </FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Shareholder Proposals and Calling of Special Shareholder Meetings</I></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Companies Act provide shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company&rsquo;s articles of association. Our A&amp;R Articles allow our shareholders holding in aggregate not less than one tenth or more of the paid up capital of the Company having the right of voting at general meetings, on a one vote per share basis, in the share capital of the Company, permitted to be exercised at any such meeting to requisition an extraordinary general meeting of our shareholders, in which case our board is obliged to convene an extraordinary general meeting and to put the resolutions so requisitioned to a vote at such meeting. Other than this right to requisition a shareholders&rsquo; meeting, our A&amp;R Articles do not provide our shareholders with any other right to put proposals before annual general meetings or extraordinary general meetings. As an exempted Cayman Islands company, we are not obliged by law to call shareholders&rsquo; annual general meetings, but our A&amp;R Articles provide that we will do so for so long as our ordinary shares are traded on the HKEx.</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unless provided in the corporation&rsquo;s certificate of incorporation
    or bylaws, Delaware law does not include a provision restricting the manner in which stockholders may bring business before a meeting.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Delaware law permits the board of directors or any person who is authorized
    under a corporation&rsquo;s certificate of incorporation or bylaws to call a special meeting of stockholders.</P></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Approval of Corporate Matters by Written Consent</I></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Companies Act provide that shareholders may approve corporate matters by way of unanimous written resolutions signed by or on behalf of each shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held (if authorized by the articles of association). </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Delaware law provides that, unless otherwise provided in the certificate of incorporation, stockholders may take action by written consent signed by the holders of outstanding shares having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting of stockholders at which all shares entitled to vote thereon were present and voted. </FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Dissolution; Winding Up</I></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they fall due, by an ordinary resolution of its members. Further, the Grand Court of the Cayman Islands has authority to order winding up in a number of specified circumstances including where it is, in the opinion of the Court, just and equitable to do so. </FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under Delaware law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by stockholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated and approved by the board of directors may it be approved by a simple majority of the corporation&rsquo;s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board. A Delaware corporation may also be dissolved by decree or judgment of a Delaware court in certain circumstances. </FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Variation of Rights of Shares</I></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Under Cayman Islands law and our A&amp;R Articles, whenever our share capital is divided into more than one class of shares (and as otherwise determined by the directors), subject to any rights or restrictions for the time being attached to any shares, we may materially adversely vary the rights attached to any class with the written consent of the holders of not less than three-fourths of the voting rights of the holders of such class or with the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class by a majority of two-thirds of the votes cast at such meeting. The necessary quorum (other than at an adjourned meeting) of such meeting shall be not less than persons holding (or, in the case of a shareholder being a corporation, by its duly authorized representative) or representing by proxy holding one-third of the issued shares of such class, that the quorum for any meeting adjourned for want of quorum shall be two shareholders present in person (or in the case of the shareholder being a corporation, by its duly authorized representative) or by proxy (whatever the number of shares held by them) and that any holder of shares of the class present in person (or in the case of the shareholder being a corporation, by its duly authorized representative) or by proxy may demand a poll.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Under Delaware law, a corporation may vary the rights of a class of shares with the approval of both a majority of the outstanding shares of capital stock of the corporation and a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under Delaware law, a corporation may also vary the rights of a series of a class of shares, but not the entire class, with the approval of both a majority of the outstanding shares of capital stock of the corporation and a majority of the outstanding shares of such series, unless the certificate of incorporation provides otherwise. </FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Dividends and Stock Repurchases</I></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to any rights and restrictions for the time being attached
    to any shares, or as otherwise provided for in the Companies Act and our A&amp;R Articles, our directors may from time to time declare
    dividends (including interim dividends) and other distributions on shares in issue and authorize payment of the same.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to any rights and restrictions for the time being attached
    to any shares, our Company by ordinary resolution may declare dividends, but no dividend shall exceed the amount recommended by our directors.</P></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Delaware General Corporation Law provides that, subject to any restrictions in a corporation&rsquo;s certificate of incorporation, dividends may be declared from the corporation&rsquo;s surplus, or, if there is no surplus, from its net profits for the fiscal year in which the dividend is declared and for the preceding fiscal year, and Delaware common law also imposes a solvency requirement with respect to the payment of dividends. Dividends may not be declared out of net profits, however, if the corporation&rsquo;s capital has been diminished to an amount less than the aggregate amount of all capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets until the deficiency in the amount of capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets is repaired. Furthermore, applicable Delaware statutory and common law generally provides that a corporation may redeem or repurchase its shares only if the redemption or repurchase would not impair the capital of the corporation and only if the corporation is solvent at the time of the redemption or repurchase, and the redemption or repurchase would not render the corporation insolvent. </FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Anti-Takeover Provisions</I></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Some provisions of our A&amp;R Articles may discourage, delay or prevent
    a change in control of our company or management that shareholders may consider favorable, including provisions that authorize our board
    of directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions
    of such preferred shares without any further vote or action by our shareholders.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">However, under Cayman Islands law, our directors may only exercise
    the rights and powers granted to them under our A&amp;R Articles, as amended and restated from time to time, for a proper purpose and
    for what they believe in good faith to be in the best interests of our company.</P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Unless a corporation opts out of the provisions of Section 203 of the Delaware General Corporation Law, Section 203 generally prohibits a public Delaware corporation from engaging in a &ldquo;business combination&rdquo; with a holder of 15% or more of the corporation&rsquo;s voting stock (as defined in Section 203), referred to as an interested stockholder, for a period of three years after the date of the transaction in which the interested stockholder became an interested stockholder, except as otherwise provided in Section 203. For these purposes, the term &ldquo;business combination&rdquo; includes mergers, assets sales and other similar transactions with an interested stockholder. </FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Rights of Non-resident or Foreign Shareholders</I></B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">There are no limitations imposed by our A&amp;R Articles on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our ordinary shares. In addition, there are no provisions in our A&amp;R Articles governing the ownership threshold above which shareholder ownership must be disclosed. </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">There are no limitations in the Delaware General Corporation Law related to rights of non-resident or foreign stockholders to hold or exercise voting rights of a Delaware corporation.</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Description of American depositary shares&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>American depositary receipts&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">JPMorgan, as depositary, is the issuer of the ADSs. Each ADS represents
an ownership interest in a designated number or percentage of ordinary shares that we have deposited with the custodian, as agent of the
depositary, under the deposit agreement among ourselves, the depositary, and all holders and beneficial owners from time to time of American
depositary receipts issued thereunder.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary&rsquo;s office is located at 383 Madison Avenue, Floor
11, New York, NY 10179.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The ADS-to-share ratio is subject to amendment as provided in the form
of ADR (which may give rise to fees contemplated by the form of ADR). In the future, each ADS will also represent any securities, cash
or other property deposited with the depositary but which they have not distributed directly to you.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A beneficial owner is any person or entity having a beneficial ownership
interest in ADSs. A beneficial owner need not be the holder of the ADR evidencing such ADS. If a beneficial owner of ADSs is not an ADR
holder, it must rely on the holder of the ADR(s) evidencing such ADSs in order to assert any rights or receive any benefits under the
deposit agreement. A beneficial owner shall only be able to exercise any right or receive any benefit under the deposit agreement solely
through the holder of the ADR(s) evidencing the ADSs owned by such beneficial owner. The arrangements between a beneficial owner of ADSs
and the holder of the corresponding ADRs may affect the beneficial owner&rsquo;s ability to exercise any rights it may have.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An ADR holder shall be deemed to have all requisite authority to act
on behalf of any and all beneficial owners of the ADSs evidenced by the ADRs registered in such ADR holder&rsquo;s name for all purposes
under the deposit agreement and ADRs. The depositary&rsquo;s only notification obligations under the deposit agreement and the ADRs is
to registered ADR holders. Notice to an ADR holder shall be deemed, for all purposes of the deposit agreement and the ADRs, to constitute
notice to any and all beneficial owners of the ADSs evidenced by such ADR holder&rsquo;s ADRs.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unless certificated ADRs are specifically requested, all ADSs will
be issued on the books of our depositary in book-entry form and periodic statements will be mailed to you which reflect your ownership
interest in such ADSs. In our description, references to American depositary receipts or ADRs shall include the statements you will receive
that reflect your ownership of ADSs.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You may hold ADSs either directly or indirectly through your broker
or other financial institution. If you hold ADSs directly, by having an ADS registered in your name on the books of the depositary, you
are an ADR holder. This description assumes you hold your ADSs directly. If you hold the ADSs through your broker or financial institution
nominee, you must rely on the procedures of such broker or financial institution to assert the rights of an ADR holder described in this
section. You should consult with your broker or financial institution to find out what those procedures are.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As an ADR holder or beneficial owner, you are not treated as a shareholder
of ours and you do not have any shareholder rights. Cayman Island law governs shareholder rights. Because the depositary or its nominee
is the shareholder of record for the ordinary shares represented by all outstanding ADSs, shareholder rights rest with such record holder.
Your rights are those of an ADR holder or of a beneficial owner. Such rights derive from the terms of the deposit agreement entered into
among us, the depositary and all holders and beneficial owners from time to time of ADRs issued under the deposit agreement and, in the
case of a beneficial owner, from the arrangements between the beneficial owner and the holder of the corresponding ADRs. The obligations
of us and the depositary and its agents are also set out in the deposit agreement. Because the depositary or its nominee is actually the
registered owner of the ordinary shares, you must rely on it to exercise the rights of a shareholder on your behalf.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The deposit agreement, the ADRs and the ADSs are governed by and construed
in accordance with the internal laws of the State of New York without giving effect to the application of the conflict of law principles
thereof. Any claim brought against us by any holder or beneficial owner or on behalf of our company with regard to the internal affairs
of our company, including the ability to bring such a claim, shall be governed by and construed in accordance with the laws of the Cayman
Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is a summary of what we believe to be the material terms
of the deposit agreement. Notwithstanding this, because it is a summary, it may not contain all the information that you may otherwise
deem important. For more complete information, you should read the entire deposit agreement and the form of ADR that contains the terms
of your ADSs. You can read a copy of the deposit agreement, which is filed as an exhibit to our most recent Annual Report on Form 20-F
filed with the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Distributions on deposited securities, sales&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>How will I receive dividends and other distributions on the ordinary
shares underlying my ADSs?&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may make various types of distributions with respect to our securities.
The depositary has agreed that, to the extent practicable, it will pay to you the cash dividends or other distributions it or the custodian
receives on ordinary shares or other deposited securities, after converting any cash received into U.S. dollars (if it determines such
conversion may be made on a reasonable basis) and, in all cases, making any necessary deductions provided for in the deposit agreement.
The depositary may utilize a division, branch or affiliate of JPMorgan to direct, manage and/or execute any public and/or private sale
of securities and/or property under the deposit agreement. Such division, branch and/or affiliate may charge the depositary a fee in connection
with such sales, which fee is considered an expense of the depositary chargeable to holders of ADSs. All sales of securities will be handled
by the depositary in accordance with its then current policies. You will receive these distributions in proportion to the number of underlying
securities that your ADSs represent. In all instances where the deposit agreement or an ADR refers to a &ldquo;sale&rdquo; (or
words of similar import) of securities or property, the depositary may, but shall not be obligated, to effect any such sale unless the
securities to be sold are listed and publicly traded on a securities exchange or there is a public market for the property to be sold.
To the extent the securities are not so listed and publicly traded or there is no public market for the property so distributed by us:
(1) the depositary shall, in the event the deposit agreement is terminated and the depositary holds deposited securities that are not
listed and publicly traded after the termination date of the deposit agreement, act in accordance with the termination provisions of the
deposit agreement and form of ADR in respect of such securities and property; and (2) in the event the depositary or its custodian receives
a distribution other than cash, our ordinary shares and/or rights to acquire our ordinary shares, and such distribution consists of securities
or property that are not distributed by the depositary the depositary will be deemed to have sold the aggregate number of securities and/or
property so received for nominal value and shall have no obligation to distribute such securities or any proceeds from the deemed sale
thereof to the ADR holders. Furthermore, in the event the depositary endeavors to make a sale of ordinary shares, other securities or
property, such securities and/or property may be sold in a block sale or single lot transaction.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Except as stated below, the depositary will distribute as soon as reasonably
practical such distributions to ADR holders in proportion to their interests in the following manner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Cash.</I>
The depositary will distribute any U.S. dollars available to it resulting from a cash dividend or other cash distribution or the net
proceeds of sales of any other distribution or portion thereof (to the extent applicable), on an averaged or other practicable basis,
subject to (1) appropriate adjustments for taxes withheld, (2) such distribution being permissible or practicable with respect to certain
registered ADR holders, and (3) deduction of the depositary&rsquo;s and/or its agents&rsquo; fees and expenses in (A) converting any
foreign currency to U.S. dollars to the extent that it determines that such conversion may be made on a reasonable basis, (B) transferring
foreign currency or U.S. dollars to the United States by such means as the depositary may determine to the extent that it determines
that such transfer may be made on a reasonable basis, (C) obtaining any approval or license of any governmental authority required for
such conversion or transfer, which is obtainable at a reasonable cost and within a reasonable time and (D) making any sale by public
or private means in any commercially reasonable manner. To the extent that any of the deposited securities is not or shall not be entitled,
by reason of its date of issuance, or otherwise, to receive the full amount of such cash dividend, distribution, or net proceeds of sales,
the depositary shall make appropriate adjustments in the amounts distributed to the ADR holders issued in respect of such deposited securities.
To the extent we or the depositary shall be required to withhold and do withhold from any cash dividend, distribution or net proceeds
from sales in respect of any deposited securities an amount on account of taxes, the amount distributed on the ADSs issued in respect
of such deposited securities shall be reduced accordingly.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">To the extent the depositary determines in its reasonable discretion that it would not be permitted by
                                                                                applicable law, rule or regulation, or it would not otherwise be practicable, to convert foreign currency into U.S. dollars and
                                                                                distribute such U.S. dollars to some or all of the ADR holders entitled thereto, the depositary may in its discretion distribute
                                                                                some or all of the foreign currency received by the depositary as it deems permissible and practicable to, or retain and hold such
                                                                                foreign currency uninvested and without liability for interest thereon for the respective accounts of, the ADR holders entitled to
                                                                                receive the same. To the extent the depositary retains and holds any cash, foreign currency, securities or other property as
                                                                                permitted under the deposit agreement, any and all fees, charges and expenses related to, or arising from, the holding thereof shall
                                                                                be paid from such cash, foreign currency, securities or other property, or the net proceeds from the sale thereof, thereby reducing
                                                                                the amount so held. <I>If exchange rates fluctuate during a time when the depositary cannot convert a foreign currency, you may lose
                                                                                some or all of the value of the distribution.</I></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Shares.</I> In the case of a distribution in ordinary shares, the depositary
will issue additional ADRs to evidence the number of ADSs representing such ordinary shares. Only whole ADSs will be issued. Any ordinary
shares that would result in fractional ADSs will be sold and the net proceeds of the public or private sales of such will be distributed
in the same manner as cash to the ADR holders entitled thereto.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Rights to receive additional shares.</I> In the case of a distribution
of rights to subscribe for additional ordinary shares or other rights, if we timely provide evidence satisfactory to the depositary that
it may lawfully distribute such rights, the depositary will distribute warrants or other instruments in the discretion of the depositary
representing such rights. However, if we do not timely furnish such evidence, the depositary may:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 36pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 36pt">(i)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">sell such rights if practicable and distribute the net proceeds of the public or private sales of such rights in the same manner as
cash to the ADR holders entitled thereto; or&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 36pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 36pt">(ii)</TD><TD STYLE="font-family: Times New Roman, Times, Serif">if it is not practicable to sell such rights by reason of the non-transferability of the rights, limited markets therefor, their short
duration or otherwise, do nothing and allow such rights to lapse, in which case ADR holders will receive nothing and the rights may lapse.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">We have no obligation to file a registration statement under
the Securities Act in order to make any rights available to ADR holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other distributions.</I> In the case of a distribution of securities or
property other than those described above, the depositary may either (1) distribute such securities or property in any manner it deems
equitable and practicable or (2) to the extent the depositary deems distribution of such securities or property not to be equitable and
practicable, sell such securities or property and distribute any net proceeds of public or private sales in the same way it distributes
cash.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Elective distributions</I>. In the case of a dividend payable at the election
of our shareholders in cash or in additional ordinary shares, we will notify the depositary at least 30 days prior to the proposed distribution
stating whether or not we wish such elective distribution to be made available to ADR holders. The depositary shall make such elective
distribution available to ADR holders only if (1) we shall have timely requested that the elective distribution is available to ADR holders,
(2) the depositary shall have determined that such distribution is reasonably practicable and (3) the depositary shall have received satisfactory
documentation within the terms of the deposit agreement including any legal opinions of counsel that the depositary in its reasonable
discretion may request. If the above conditions are not satisfied, the depositary shall, to the extent permitted by law, distribute to
the ADR holders, on the basis of the same determination as is made in the local market in respect of the ordinary shares for which no
election is made, either (x) cash or (y) additional ADSs representing such additional ordinary shares. If the above conditions are satisfied,
the depositary shall establish procedures to enable ADR holders to elect the receipt of the proposed dividend in cash or in additional
ADSs. There can be no assurance that ADR holders or beneficial owners of ADSs generally, or any ADR holder or beneficial owner of ADSs
in particular, will be given the opportunity to receive elective distributions on the same terms and conditions as the holders of ordinary
shares.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the depositary determines in its reasonable discretion that any
distribution described above is not practicable with respect to any or all ADR holders, the depositary may choose any method of distribution
that it deems practicable for such ADR holder, including the distribution of some or all of any cash, foreign currency, securities or
other property (or appropriate documents evidencing the right to receive some or all of any such cash, foreign currency, security or other
property), and/or it may retain some or all of such items, without paying interest on or investing them, on behalf of the ADR holder as
deposited securities, in which case the ADSs will also represent the retained items. To the extent the depositary does not reasonably
believe it will be permitted by applicable law, rule or regulation to convert foreign currency into U.S. dollars and distribute such U.S.
dollars to some or all of the ADR holders, the depositary may in its discretion distribute some or all of the foreign currency received
by the depositary to, or hold such foreign currency uninvested and without liability for interest thereon for the respective accounts
of, the ADR holders entitled to receive the same. To the extent the depositary holds such foreign currency, any and all costs and expenses
related to, or arising from, the holding of such foreign currency shall be paid from such foreign currency thereby reducing the amount
so held.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any U.S. dollars will be paid via wire transfer and/or distributed
by checks drawn on a bank in the United States for whole dollars and cents. Fractional cents will be withheld without liability and dealt
with by the depositary in accordance with its then current practices.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>The depositary is not responsible if it fails to determine that
any distribution or action is lawful or reasonably practicable.</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>There can be no assurance that the depositary will be able to convert
any currency at a specified exchange rate or sell any property, rights, ordinary shares or other securities at a specified price, nor
that any of such transactions can be completed within a specified time period. All purchases and sales of securities will be handled by
the depositary in accordance with its then current policies, which are currently set forth on the &ldquo;Disclosures&rdquo; page (or successor
page) of www.adr.com (as updated by the depositary from time to time, &ldquo;ADR.com&rdquo;).</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Deposit, withdrawal and cancellation&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>How does the depositary issue ADSs?&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary will issue ADSs if you or your broker deposit ordinary
shares or evidence of rights to receive ordinary shares with the custodian and pay the fees and expenses owing to the depositary in connection
with such issuance.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ordinary shares deposited in the future with the custodian must be
accompanied by certain delivery documentation and shall, at the time of such deposit, be registered in the name of &ldquo;JPMorgan Chase
Bank, N.A., as depositary for the benefit of holders of ADRs&rdquo; or in such other name as the depositary shall direct.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The custodian will hold all deposited ordinary shares for the account
and to the order of the depositary, in each case for the benefit of ADR holders, to the extent not prohibited by law. ADR holders and
beneficial owners thus have no direct ownership interest in the ordinary shares and only have such rights as are contained in the deposit
agreement. The custodian will also hold any additional securities, property and cash received on or in substitution for the deposited
ordinary shares. The deposited ordinary shares and any such additional items are referred to as &ldquo;deposited securities.&rdquo;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deposited securities are not intended to, and shall not, constitute
proprietary assets of the depositary, the custodian or their nominees. Beneficial ownership in deposited securities is intended to be,
and shall at all times during the term of the deposit agreement continue to be, vested in the beneficial owners of the ADSs representing
such deposited securities. Notwithstanding anything else contained herein, in the deposit agreement, in the form of ADR and/or in any
outstanding ADSs, the depositary, the custodian and their respective nominees are intended to be, and shall at all times during the term
of the deposit agreement be, the record holder(s) only of the deposited securities represented by the ADSs for the benefit of the ADR
holders. The depositary, on its own behalf and on behalf of the custodian and their respective nominees, disclaims any beneficial ownership
interest in the deposited securities held on behalf of the ADR holders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon each deposit of ordinary shares, receipt of related delivery documentation
and compliance with the other provisions of the deposit agreement, including the payment of the fees and charges of the depositary and
any taxes or other fees or charges owing, the depositary will issue an ADR or ADRs in the name or upon the order of the person entitled
thereto evidencing the number of ADSs to which such person is entitled. All of the ADSs issued will, unless specifically requested to
the contrary, be part of the depositary&rsquo;s direct registration system, and a registered holder will receive periodic statements from
the depositary which will show the number of ADSs registered in such ADR holder&rsquo;s name. An ADR holder can request that the ADSs
not be held through the depositary&rsquo;s direct registration system and that a certificated ADR be issued.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>How do ADR holders cancel an ADS and obtain deposited securities?</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When you turn in your ADR certificate at the depositary&rsquo;s office,
or when you provide proper instructions and documentation in the case of direct registration ADSs, subject to the provisions of or governing
our ordinary shares (including, without limitation, our governing documents and all applicable laws, rules and regulations), the depositary
will, upon payment of certain applicable fees, charges and taxes, deliver the underlying ordinary shares to you or upon your written order.
Delivery of deposited securities in certificated form will be made at the custodian&rsquo;s office (or from the custodian to the extent
dematerialized). At your risk, expense and request, the depositary may deliver deposited securities (including any certificates therefor)
at such other place as you may request.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary may only restrict the withdrawal of deposited securities
in connection with:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">temporary delays caused by closing our transfer books or those of the depositary
or the deposit of ordinary shares in connection with voting at a shareholders&rsquo; meeting, or the payment of dividends;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">the payment of fees, taxes and similar charges; or&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">compliance with any U.S. or foreign laws or governmental regulations relating
to the ADRs or to the withdrawal of deposited securities.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This right of withdrawal may not be limited by any other provision
of the deposit agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Record dates&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary may, after consultation with us if practicable, fix
record dates (which, to the extent applicable, shall be as near as practicable to any corresponding record dates set by us) for the determination
of the registered ADR holders who will be entitled (or obligated, as the case may be):&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">to receive any distribution on or in respect of deposited securities,&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">to give instructions for the exercise of voting rights,&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">to pay any fees assessed by, or owing to, the depositary for administration
of the ADR program and for any expenses as provided for in the ADR, or&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">to receive any notice or to act or be obligated in respect of other matters,&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">all subject to the provisions of the deposit agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Voting rights&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>How do I vote?&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you are an ADR holder and the depositary asks you to provide it
with voting instructions, you may instruct the depositary how to exercise the voting rights for the ordinary shares which underlie your
ADSs. As soon as practicable after receipt from us of notice of any meeting at which the holders of ordinary shares are entitled to vote,
or of our solicitation of consents or proxies from holders of ordinary shares, the depositary shall fix the ADS record date in accordance
with the provisions of the deposit agreement, provided that if the depositary receives a written request from us in a timely manner and
at least thirty (30) days prior to the date of such vote or meeting, the depositary shall, at our expense, distribute to the registered
ADR holders a &ldquo;voting notice&rdquo; stating (1) final information particular to such vote and meeting and any solicitation materials,
(2) that each ADR holder on the record date set by the depositary will, subject to any applicable provisions of the laws of the Cayman
Islands, be entitled to instruct the depositary as to the exercise of the voting rights, if any, pertaining to the deposited securities
represented by the ADSs evidenced by such ADR holder&rsquo;s ADRs and (3) the manner in which such instructions may be given or deemed
given in accordance with the applicable provisions of deposit agreement, including instructions for giving a discretionary proxy to a
person designated by us. Each ADR holder shall be solely responsible for the forwarding of voting notices to the beneficial owners of
ADSs registered in such ADR holder&rsquo;s name. There is no guarantee that ADR holders and beneficial owners generally or any holder
or beneficial owner in particular will receive the notice described above with sufficient time to enable such ADR holder or beneficial
owner to return any voting instructions to the depositary in a timely manner.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following actual receipt by the ADR department responsible for proxies
and voting of ADR holders&rsquo; instructions (including, without limitation, instructions of any entity or entities acting on behalf
of the nominee for The Depository Trust Company, or DTC), the depositary shall, in the manner and on or before the time established by
the depositary for such purpose, endeavor to vote or cause to be voted the deposited securities represented by the ADSs evidenced by such
ADR holders&rsquo; ADRs in accordance with such instructions insofar as practicable and permitted under the provisions of or governing
deposited securities.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent that (A) we have provided the depositary with at least
35 days&rsquo; notice of the proposed meeting, (B) the voting notice will be received by all holders and beneficial owners no less than
10 days prior to the date of the meeting and/or the cut-off date for the solicitation of consents, and (C) the depositary does not receive
instructions on a particular agenda item from a holder (including, without limitation, any entity or entities acting on behalf of the
nominee for DTC) in a timely manner, such holder shall be deemed, and, pursuant to the deposit agreement, the depositary is instructed
to deem such holder, to have instructed the depositary to give a discretionary proxy for such agenda item(s) to a person designated by
us to vote the deposited securities represented by the ADSs for which actual instructions were not so given by all such holders on such
agenda item(s), provided that no such instruction shall be deemed given and no discretionary proxy shall be given unless (1) we inform
the depositary in writing that (a) we wish such proxy to be given with respect to such agenda item(s), (b) there is no substantial opposition
existing with respect to such agenda item(s) and (c) such agenda item(s), if approved, would not materially or adversely affect the rights
of holders of ordinary shares, and (2) the depositary has obtained an opinion of counsel, in form and substance satisfactory to the depositary,
confirming that (i) the granting of such discretionary proxy does not subject the depositary to any reporting obligations in the Cayman
Islands, (ii) the granting of such proxy will not result in a violation of the laws, rules, regulations or permits of the Cayman Islands,
(iii) the voting arrangement and deemed instruction as contemplated in the deposit agreement will be given effect under the laws, rules
and regulations of the Cayman Islands, and (iv) the granting of such discretionary proxy will not under any circumstances result in the
ordinary shares represented by the ADSs being treated as assets of the depositary under the laws, rules or regulations of the Cayman Islands.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary may from time to time access information available to
it to consider whether any of the circumstances described in 1(b) or 1(c) the paragraph above exist, or request additional information
from us in respect thereto. By taking any such action, the depositary shall not in any way be deemed or inferred to have been required,
or have had any duty or responsibility (contractual or otherwise), to monitor or inquire whether any of the circumstances described above
existed. In addition to the limitations provided for in the deposit agreement, holders and beneficial owners are advised and agree that
(a) the depositary will rely fully and exclusively on us to inform it of any of the circumstances set forth above, and (b) neither the
depositary, the custodian nor any of their respective agents shall be obliged to inquire or investigate whether any of the circumstances
described in 1(b) or 1(c) the paragraph above exist and/or whether we complied with our obligation to timely inform the depositary of
such circumstances. Neither the depositary, the custodian nor any of their respective agents shall incur any liability to holders or beneficial
owners (i) as a result of our failure to determine that any of the circumstances described in 1(b) or 1(c) the paragraph above exist or
our failure to timely notify the depositary of any such circumstances or (ii) if any agenda item which is approved at a meeting has, or
is claimed to have, a material or adverse effect on the rights of holders of ordinary shares. Because there is no guarantee that holders
and beneficial owners will receive the notices described above with sufficient time to enable such holders or beneficial owners to return
any voting instructions to the depositary in a timely manner, holders and beneficial owners may be deemed to have instructed the depositary
to give a discretionary proxy to a person designated by us in such circumstances, and neither the depositary, the custodian nor any of
their respective agents shall incur any liability to holders or beneficial owners in such circumstances.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under Cayman Islands law and our A&amp;R Articles, each as currently
in effect, voting at any meeting of our shareholders is by show of hands unless a poll is (before or on the declaration of the results
of the show of hands or on the withdrawal of any other demand for a poll) demanded. In the event that voting on any resolution or matter
is conducted on a show of hands basis, the depositary will refrain from voting and the voting instructions received by the depositary
shall lapse. The depositary will not demand a poll or join in demanding a poll, whether or not requested to do so.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ADR holders are strongly encouraged to forward their voting instructions
to the depositary as soon as possible. For instructions to be valid, the ADR department of the depositary that is responsible for proxies
and voting must receive them in the manner and on or before the time specified, notwithstanding that such instructions may have been physically
received by the depositary prior to such time. The depositary will not itself exercise any voting discretion in respect of deposited securities.
The depositary and its agents will not be responsible for any failure to carry out any instructions to vote any of the deposited securities,
for the manner in which any voting instructions are given or deemed to be given in accordance with the applicable provisions of the deposit
agreement, including instructions to give a discretionary proxy to a person designated by us, for the manner in which any vote is cast,
including, without limitation, any vote cast by a person to whom the depositary is instructed to grant a discretionary proxy or deemed
to have been instructed to grant a discretionary proxy pursuant to the applicable provisions of the deposit agreement, or for the effect
of any such vote.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding anything contained in the deposit agreement or any
ADR, the depositary may, to the extent not prohibited by any law, rule or regulation, or by the rules, regulations or requirements of
any stock exchange on which the ADSs are listed, in lieu of distribution of the materials provided to the depositary in connection with
any meeting of or solicitation of consents or proxies from holders of deposited securities, distribute to the registered holders of ADRs
a notice that provides such ADR holders with or otherwise publicizes to such ADR holders instructions on how to retrieve such materials
or receive such materials upon request (<I>i.e.</I>, by reference to a website containing the materials for retrieval or a contact for
requesting copies of the materials).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There is no guarantee that you will receive voting materials in time
to instruct the depositary to vote and it is possible that you, or persons who hold their ADSs through brokers, dealers or other third
parties, will not have the opportunity to exercise a right to vote.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Reports and other communications&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Will ADR holders be able to view our reports?&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The deposit agreement, the provisions of or governing deposited securities,
and any written communications from us which are both received by the custodian or its nominee as a holder of deposited securities and
made generally available to the holders of deposited securities, are available for inspection by ADR holders at the offices of the depositary
in the United States, on the SEC&rsquo;s internet website or upon request to the depositary (which request may be refused by the depositary
at its discretion).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, if we make (i) any communications available to holders
of our ordinary shares or any securities regulatory authority or stock exchange that could require, or result in, the depositary taking
or planning to take any action pursuant to the deposit agreement or (ii) any communication that reasonably could require the depositary
to take, or plan to take, action pursuant to the deposit agreement, we will furnish copies thereof (or English translations or summaries)
to the depositary and the depositary will distribute the same to registered ADR holders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fees and expenses&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What fees and expenses will I be responsible for paying?&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary may charge each person to whom ADSs are issued, including,
without limitation, issuances against deposits of ordinary shares, issuances in respect of ordinary share distributions, rights and other
distributions, issuances pursuant to a stock dividend or stock split declared by us or issuances pursuant to a merger, exchange of securities
or any other transaction or event affecting the ADSs or deposited securities, and each person surrendering ADSs for withdrawal of deposited
securities or whose ADSs are cancelled or reduced for any other reason, a fee of up to US$5.00 for each 100 ADSs (or any portion thereof)
issued, delivered, reduced, cancelled or surrendered, or upon which a share distribution or elective distribution is made or offered,
as the case may be. The depositary may sell (by public or private sale) sufficient securities and property received in respect of a share
distribution, rights and/or other distribution prior to such deposit to pay such charge.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following additional fees, charges and expenses shall also be incurred
by the ADR holders, the beneficial owners, by any party depositing or withdrawing ordinary shares or by any party surrendering ADSs and/or
to whom ADSs are issued (including, without limitation, issuance pursuant to a stock dividend or stock split declared by us or an exchange
of stock regarding the ADSs or the deposited securities or a distribution of ADSs), whichever is applicable:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">a fee of up to US$0.05 per ADS held for any cash distribution made, or for
any elective cash/stock dividend offered, pursuant to the deposit agreement;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">an aggregate fee of up to US$0.05 per ADS per calendar year (or portion thereof)
for services performed by the depositary in administering the ADRs (which fee may be charged on a periodic basis during each calendar
year and shall be assessed against holders of ADRs as of the record date or record dates set by the depositary during each calendar year
and shall be payable in the manner described in the next succeeding provision);&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">an amount for the reimbursement of such fees, charges and expenses as are
incurred by the depositary and/or any of its agents (including, without limitation, the custodian, as well as charges and expenses incurred
on behalf of ADR holders in connection with compliance with foreign exchange control regulations or any law, rule or regulation relating
to foreign investment) in connection with the servicing of the shares or other deposited securities, the sale of securities (including,
without limitation, deposited securities), the delivery of deposited securities or otherwise in connection with the depositary&rsquo;s
or its custodian&rsquo;s compliance with applicable law, rule or regulation (which fees and charges shall be assessed on a proportionate
basis against ADR holders as of the record date or dates set by the depositary and shall be payable at the sole discretion of the depositary
by billing such ADR holders or by deducting such charge from one or more cash dividends or other cash distributions);&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">a fee of up to US$0.05 per ADS held for the direct or indirect distribution
of securities (other than ADSs or rights to purchase additional ADSs) or the net cash proceeds from the public or private sale of such
securities, regardless of whether any such distribution and/or sale is made by, for, or received from, or (in each case) on behalf of,
the depositary, us and/or any third party (which fee may be assessed against ADR holders as of a record date set by the depositary);&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">stock transfer or other taxes and other governmental charges;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">a transaction fee per cancellation request (including any cancellation request
made through SWIFT, facsimile transmission or any other method of communication) as disclosed on the &ldquo;Disclosures&rdquo; page (or
successor page) of www.adr.com (as updated by the depositary from time to time, &ldquo;ADR.com&rdquo;) and any applicable delivery expenses
(which are payable by such persons or ADR holders);&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">transfer or registration fees for the registration of transfer of deposited
securities on any applicable register in connection with the deposit or withdrawal of deposited securities; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">fees of any division, branch or affiliate of the depositary utilized by the
depositary to direct, manage and/or execute any public and/or private sale of securities under the deposit agreement.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To facilitate the administration of various depositary receipt transactions,
including disbursement of dividends or other cash distributions and other corporate actions, the depositary may engage the foreign exchange
desk within the banking division of the depositary, or the Bank, and/or its affiliates in order to enter into spot foreign exchange transactions
to convert foreign currency into U.S. dollars. For certain currencies, foreign exchange transactions are entered into with the Bank or
an affiliate, as the case may be, acting in a principal capacity. For other currencies, foreign exchange transactions are routed directly
to and managed by an unaffiliated local custodian (or other third party local liquidity provider), and neither the Bank nor any of its
affiliates is a party to such foreign exchange transactions.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foreign exchange rate applied to a foreign exchange transaction
will be either (a) a published benchmark rate, or (b) a rate determined by a third party local liquidity provider, in each case plus or
minus a spread, as applicable. The depositary will disclose which foreign exchange rate and spread, if any, apply to such currency on
the &ldquo;Disclosures&rdquo; page (or successor page) of ADR.com. Such applicable foreign exchange rate and spread may (and neither the
depositary, the Bank nor any of their affiliates is under any obligation to ensure that such rate does not) differ from rates and spreads
at which comparable transactions are entered into with other customers or the range of foreign exchange rates and spreads at which the
Bank or any of its affiliates enters into foreign exchange transactions in the relevant currency pair on the date of the foreign exchange
transaction. Additionally, the timing of execution of a foreign exchange transaction varies according to local market dynamics, which
may include regulatory requirements, market hours and liquidity in the foreign exchange market or other factors. Furthermore, the Bank
and its affiliates may manage the associated risks of their position in the market in a manner they deem appropriate without regard to
the impact of such activities on the depositary, us, ADR holders or beneficial owners. <I>The spread applied does not reflect any gains
or losses that may be earned or incurred by the Bank and its affiliates as a result of risk management or other hedging related activity.</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding the foregoing, to the extent we provide U.S. dollars
to the depositary, neither the Bank nor any of its affiliates will execute a foreign exchange transaction as set forth herein. In such
case, the depositary will distribute the U.S. dollars received from us.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Further details relating to the applicable foreign exchange rate,
the applicable spread and the execution of foreign exchange transactions will be provided by the depositary on ADR.com. Each holder and
beneficial owner by holding or owning an ADR or ADS or an interest therein, and we, each acknowledge and agree that the terms applicable
to foreign exchange transactions disclosed from time to time on ADR.com will apply to any foreign exchange transaction executed pursuant
to the deposit agreement.</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will pay all other fees, charges and expenses of the depositary
and any agent of the depositary (except the custodian) pursuant to agreements from time to time between us and the depositary.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The right of the depositary to charge and receive payment of fees,
charges and expenses survives the termination of the deposit agreement, and shall extend for those fees, charges and expenses incurred
prior to the effectiveness of any resignation or removal of the depositary.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fees and charges described above may be amended from time to time
by agreement between us and the depositary.&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary anticipates reimbursing us for certain expenses incurred
by us that are related to the establishment and maintenance of the ADR program upon such terms and conditions as we and the depositary
may agree from time to time. The depositary may make available to us a set amount or a portion of the depositary fees charged in respect
of the ADR program or otherwise upon such terms and conditions as we and the depositary may agree from time to time. The depositary may
also agree to reduce or waive certain fees that would normally be charged on ADSs issued to or at the director of, or otherwise held by,
us and/or certain holders and beneficial owners and holders and beneficial owners of ordinary shares of ours. The depositary collects
its fees for issuance and cancellation of ADSs directly from investors depositing ordinary shares or surrendering ADSs for the purpose
of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting
those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect
its annual fee for depositary services by deduction from cash distributions, or by directly billing investors, or by charging the book-entry
system accounts of participants acting for them. The depositary will generally set off the amounts owing from distributions made to holders
of ADSs. If, however, no distribution exists and payment owing is not timely received by the depositary, the depositary may refuse to
provide any further services to ADR holders that have not paid those fees and expenses owing until such fees and expenses have been paid.
At the discretion of the depositary, all fees and charges owing under the deposit agreement are due in advance and/or when declared owing
by the depositary.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Payment of taxes&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ADR holders and/or beneficial owners must pay any tax or other governmental
charge payable by the custodian or the depositary on any ADS or ADR, deposited security or distribution. If any taxes or other governmental
charges (including any penalties and/or interest) shall become payable by or on behalf of the custodian or the depositary with respect
to any ADR, any deposited securities represented by the ADSs evidenced thereby or any distribution thereon such tax or other governmental
charge shall be paid by the ADR holder thereof to the depositary and by holding or owning, or having held or owned, an ADR or any ADSs
evidenced thereby, the ADR holder and all beneficial owners thereof, and all prior ADR holders and beneficial owners thereof, jointly
and severally, agree to indemnify, defend and save harmless each of the depositary and its agents in respect of such tax or other governmental
charge. Notwithstanding the depositary&rsquo;s right to seek payment from current or former ADR holders and beneficial owners, each ADR
holder and beneficial owner, and each prior ADR holder and beneficial owner, by holding or owning, or having held or owned, an ADR or
an interest in ADSs acknowledges and agrees that the depositary has no obligation to seek payment of amounts owing from any current or
prior beneficial owner. If an ADR holder owes any tax or other governmental charge, the depositary may (1) deduct the amount thereof from
any cash distributions, or (2) sell deposited securities (by public or private sale) and deduct the amount owing from the net proceeds
of such sale. In either case, the ADR holder remains liable for any shortfall. If any tax or governmental charge is unpaid, the depositary
may also refuse to effect any registration, registration of transfer, split-up or combination of ADRs or withdrawal of deposited securities
until such payment is made. If any tax or governmental charge is required to be withheld on any cash distribution, the depositary may
deduct the amount required to be withheld from any cash distribution or, in the case of a non-cash distribution, sell the distributed
property or securities (by public or private sale) in such amounts and in such manner as the depositary deems necessary and practicable
to pay such taxes and distribute any remaining net proceeds or the balance of any such property after deduction of such taxes to the ADR
holders entitled thereto. Neither we nor the depositary nor any of the depositary&rsquo;s or our respective agents shall be liable to
holders or beneficial owners of the ADSs and ADRs for failure of any holders or beneficial owners to comply with applicable tax laws,
rules and/or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent not prohibited by law, rule, regulation, fiduciary duty,
contractual or confidential obligation or otherwise, the depositary will forward to us such information in the depositary&rsquo;s possession
from the transfer records maintained by the depositary in accordance with the depositary&rsquo;s policies and procedures as we may reasonably
request in writing to enable us to file any reports required to be filed by us with governmental authorities or agencies to comply with
applicable laws; provided, however, that the depositary will have no liability for the accuracy of any such information and will, in connection
with any such accuracy and inaccuracy, not be required to incur or become subject to any liability, cost or expense and will be indemnified
by us in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As an ADR holder or beneficial owner, you will be agreeing to indemnify
us, the depositary, its custodian and any of our or their respective officers, directors, employees, agents and affiliates against, and
hold each of them harmless from, any claims by any governmental authority with respect to taxes, additions to tax, penalties or interest
arising out of any refund of taxes, reduced rate of withholding at source or other tax benefit obtained, which obligations shall survive
any transfer or surrender of ADSs or the termination of the deposit agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Reclassifications, recapitalizations and mergers&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we take certain actions that affect the deposited securities, including
(1) any change in par value, split-up, consolidation, cancellation or other reclassification of deposited securities or (2) any distributions
of ordinary shares or other property not made to holders of ADRs or (3) any recapitalization, reorganization, merger, consolidation, liquidation,
receivership, bankruptcy or sale of all or substantially all of our assets, then the depositary may choose to, and shall if reasonably
requested by us:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">amend the form of ADR;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">distribute additional or amended ADRs;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">distribute cash, securities or other property it has received in connection
with such actions;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">sell by public or private sale any securities or property received and distribute
the proceeds as cash; or&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">none of the above.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the depositary does not choose any of the above options, any of
the cash, securities or other property it receives will constitute part of the deposited securities and each ADS will then represent a
proportionate interest in such property.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Amendment and termination&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>How may the deposit agreement be amended?&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may agree with the depositary to amend the deposit agreement and
the ADSs without your consent for any reason. ADR holders must be given at least 30 days&rsquo; notice of any amendment that imposes or
increases any fees on a per ADS basis, charges or expenses (other than stock transfer or other taxes and other governmental charges, transfer
or registration fees, a transaction fee per cancellation request (including any cancellation request made through SWIFT, facsimile transmission
or any other method of communication), applicable delivery expenses or other such fees, charges or expenses), or otherwise prejudices
any substantial existing right of ADR holders or beneficial owners. If an ADR holder or beneficial owner continues to hold an ADR or ADRs,
or an interest therein, after being so notified, such ADR holder and any beneficial owner are deemed to agree to such amendment and to
be bound by the deposit agreement as so amended. No amendment, however, will impair your right to surrender your ADSs and receive the
underlying securities, except in order to comply with mandatory provisions of applicable law.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any amendments or supplements that (1) are reasonably necessary (as
agreed by us and the depositary) in order for (A) the ADSs to be registered on Form F-6 under the Securities Act, or (B) the ADSs or ordinary
shares to be traded solely in electronic book-entry form and (2) do not in either such case impose or increase any fees or charges to
be borne by ADR holders, shall be deemed not to prejudice any substantial rights of ADR holders or beneficial owners. Notwithstanding
the foregoing, if any governmental body or regulatory body should adopt new laws, rules or regulations that would require amendment or
supplement of the deposit agreement or the form of ADR to ensure compliance therewith, we and the depositary may amend or supplement the
deposit agreement and the form of ADR (and all outstanding ADRs) at any time in accordance with such changed laws, rules or regulations.
Such amendment or supplement to the deposit agreement in such circumstances may become effective before a notice of such amendment or
supplement is given to ADR holders or within any other period of time as required for compliance.&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notice of any amendment to the deposit agreement or form of ADR shall
not need to describe in detail the specific amendments effectuated thereby, and failure to describe the specific amendments in any such
notice shall not render such notice invalid, provided, however, that, in each such case, the notice given to the ADR holders identifies
a means for ADR holders and beneficial owners to retrieve or receive the text of such amendment (<I>i.e.</I>, upon retrieval from the
SEC&rsquo;s, the depositary&rsquo;s or our website or upon request from the depositary).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>How may the deposit agreement be terminated?</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary may at any time, and shall at our written direction,
terminate the deposit agreement and the ADRs by mailing notice of such termination to the registered holders of ADRs at least 30 days
prior to the date fixed in such notice for such termination; provided, however, if the depositary shall have (1) resigned as depositary
under the deposit agreement, notice of such termination by the depositary shall not be provided to registered ADR holders unless a successor
depositary shall not be operating under the deposit agreement within 60 days of the date of such resignation, and (2) been removed as
depositary under the deposit agreement, notice of such termination by the depositary shall not be provided to registered holders of ADRs
unless a successor depositary shall not be operating under the deposit agreement on the 60th day after our notice of removal was first
provided to the depositary. Notwithstanding anything to the contrary in the deposit agreement, the depositary may terminate the deposit
agreement (A) without notifying us, but subject to giving 30 days&rsquo; notice to the ADR holders, under the following circumstances:
(i) in the event of our bankruptcy, liquidation proceedings or insolvency, (ii) if the ADRs are delisted from a &ldquo;national securities
exchange&rdquo;  (that has registered with the Commission under Section 6 of the Exchange Act), (iii) if
we effect (or will effect) a redemption of all or substantially all of the deposited securities, or a cash or share distribution representing
a return of all or substantially all of the value of the deposited securities, (iv) there are no deposited securities with respect to
ADSs remaining, including if the deposited securities are cancelled, or the deposit securities have been deemed to have no value, or (v)
there occurs a merger, consolidation, sale of assets or other transaction as a result of which securities or other property are delivered
in exchange for or in lieu of deposited securities, and (B) immediately without prior notice to us, any ADR holder or beneficial owner
or any other person if (i) required by any law, rule or regulation relating to sanctions by any governmental authority or body, (ii) the
depositary would be subject to liability under or pursuant to any law, rule or regulation, or (iii) required by any governmental authority
or body, in each case under (b) as determined by the depositary in its reasonable discretion.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our ordinary shares are not listed and publicly traded on a stock
exchange or in a securities market as of the date so fixed for termination or if, for any reason, the depositary does not sell the deposited
securities, then after such date fixed for termination, the depositary shall use its reasonable efforts to ensure that the ADSs cease
to be eligible for settlement within DTC and that neither DTC nor any of its nominees shall thereafter be an ADR holder. At such time
as the ADSs cease to be DTC eligible and/or neither DTC nor any of its nominees is an ADR holder, to the extent we are not, to the depositary&rsquo;s
knowledge, insolvent or in bankruptcy or liquidation, the depositary shall (A) cancel all outstanding ADRs; (B) request DTC to provide
the depositary with information on those holding ADSs through DTC and, upon receipt thereof, revise the ADR register to reflect the information
provided by DTC; (C) instruct its custodian to deliver all deposited securities to us, a subsidiary or affiliate of ours (the company
representative) or an independent trust company engaged by us (the trustee) to hold those deposited securities in trust for the beneficial
owners of the ADRs if we are not permitted to hold any of the deposited securities under applicable law and/or we have directed the depositary
to deliver such deposited securities to the company representative or trustee along with a stock transfer form and/or such other instruments
of transfer covering such deposited securities as are needed under applicable law, in either case referring to the names set forth on
the ADR register and (D) provide us with a copy of the ADR register.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon receipt of any instrument of transfer covering such deposited
securities and the ADR Register, we have agreed that we will, to the extent not prohibited by any law, rule or regulation, approve the
transfer of the deposited securities previously represented by their ADRs to the persons listed on the ADR register (as applicable), procure
the relevant updates to our register of members to reflect the transfer of the deposited securities previously represented by their ADRs
to the persons listed on the ADR register (as applicable) and provide the depositary with a certified copy of the updated register of
our shareholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent the depositary reasonably believes that we are insolvent,
or if we are in receivership, have filed for bankruptcy and/or are otherwise in restructuring, administration or liquidation, and in any
such case the deposited securities are not listed and publicly traded on a securities exchange after the termination date, or if, for
any reason, the depositary believes it is not able to or cannot practicably sell the deposited securities promptly and without undue effort,
the deposited securities shall be deemed to have no value (and such holder shall be deemed to have instructed the depositary that the
deposited securities have no value). The depositary may (and, by holding an ADR or an interest therein, all holders irrevocably consent
and agree that the depositary may) instruct its custodian to deliver all deposited securities to us (acting, as applicable by an administrator,
receiver, administrative receiver, liquidator, provisional liquidator, restructuring officer, interim restructuring officer, trustee,
controller or other entity overseeing the bankruptcy, insolvency, administration, restructuring or liquidation process) and notify us
that the deposited ordinary shares are surrendered for no consideration. The deposit agreement requires us, subject to applicable law,
to promptly accept the surrender of the deposited ordinary shares for no consideration and deliver to the depositary a written notice
confirming (A) the acceptance of the surrender of the deposited securities for no consideration and (B) the cancellation of such deposited
ordinary shares. Promptly after notifying us that the deposited ordinary shares are surrendered for no consideration and irrespective
of whether we haves complied with the immediately preceding sentence, the depositary shall notify ADR holders that their ADSs have been
cancelled with no consideration being payable to such ADR holders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon the depositary&rsquo;s compliance with the provisions of any of
the above three paragraphs, the depositary and its agents shall be discharged from all, and cease to have any, obligations under the deposit
agreement and the ADRs.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding anything to the contrary, in connection with any termination
in accordance with the provisions in this section, the depositary may, in its sole discretion and without notice to us, establish an unsponsored
American depositary share program (on such terms as the depositary may determine) for our ordinary shares and make available to ADR holders
a means to withdraw the ordinary shares represented by the ADSs issued under the deposit agreement and to direct the deposit of such ordinary
shares into such unsponsored American depositary share program, subject, in each case, to receipt by the depositary, at its discretion,
of the fees, charges and expenses provided for in the ADR and the fees, charges and expenses applicable to the unsponsored American depositary
share program; provided that the depositary agrees that we will have no liability for the establishment of such unsponsored American depositary
share program.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our ordinary shares are listed and publicly traded on a securities
exchange and the depositary believes that it is able, permissible and practicable to sell the deposited securities without undue effort,
then the depositary may endeavor to publicly or privately sell (as long as it may lawfully do so) the deposited securities, which sale
may be effected in a block sale/single lot transaction and, after the settlement of such sale(s), to the extent legally permissible and
practicable, distribute or hold in an account (which may be a segregated or unsegregated account) the net proceeds of such sale(s), less
any amounts owing to the depositary (including, without limitation, cancellation fees), together with any other cash then held by it under
the deposit agreement, in trust, without liability for interest, for the pro rata benefit of the holders entitled thereto. After making
such sale, the depositary shall be discharged from all obligations in respect of the deposit agreement and the ADRs, except to account
for such net proceeds and other cash.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Limitations on obligations and liability&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Limits on our obligations and the obligations of the depositary;
limits on liability to ADR holders, beneficial owners and others&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to the issue, registration, registration of transfer, split-up,
combination, or cancellation of any ADRs, or the delivery of any distribution in respect thereof, and from time to time in the case of
the production of proofs, we or the depositary or its custodian may require:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">payment with respect thereto of (1) any stock transfer or other tax or other
governmental charge, (2) any stock transfer or registration fees in effect for the registration of transfers of ordinary shares or other
deposited securities upon any applicable register and (3) any applicable fees and expenses described in the deposit agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">the production of proof satisfactory to it of (1) the identity of any signatory
and genuineness of any signature and (2) such other information, including without limitation, information as to citizenship, residence,
exchange control approval, beneficial or other ownership of, or interest in, any securities, compliance with applicable law, regulations,
provisions of or governing deposited securities and terms of the deposit agreement and the ADRs, as it may deem necessary or proper; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">compliance with such regulations as the depositary may establish consistent
with the deposit agreement or as the depositary believes are required, necessary or advisable in order to comply with applicable laws,
rules and regulations.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The issuance of ADRs, the acceptance of deposits of ordinary shares,
the registration, registration of transfer, split-up or combination of ADRs or the withdrawal of ordinary shares, may be suspended, generally
or in particular instances, when the ADR register or any register for deposited securities is closed or when any such action is deemed
required, necessary or advisable by the depositary for any reason provided that the ability to withdraw ordinary shares may only be limited
under the following circumstances: (1) temporary delays caused by closing transfer books of the depositary or our transfer books or the
deposit of ordinary shares in connection with voting at a shareholders&rsquo; meeting, or the payment of dividends, (2) the payment of
fees, taxes, and similar charges, and (3) compliance with any laws or governmental regulations relating to ADRs or to the withdrawal of
deposited securities. The depositary may close the ADR register (and/or any portion thereof) at any time or from time to time when deemed
expedient by it. Additionally, at our reasonable request, the depositary may close the issuance book portion of the ADR register solely
in order to enable us to comply with applicable law; provided that the depositary will have no liability and will be indemnified by us
in such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The deposit agreement expressly limits the obligations and liability
of the depositary, the depositary&rsquo;s custodian or ourselves and each of our and their respective directors, officers, employees,
agents and affiliates, provided, however, that no provision of the deposit agreement is intended to constitute a waiver or limitation
of any rights that ADR holders or beneficial owners may have under the Securities Act or the Exchange Act, to the extent applicable.
The deposit agreement provides that each of us, the depositary and our respective directors, officers, employees, agents and affiliates
will:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">incur or assume no liability (including, without limitation, to ADR holders
or beneficial owners) if any present or future law, rule, regulation, fiat, order or decree of the United States, the Cayman Islands,
the PRC or any other country or jurisdiction, or of any governmental or regulatory authority or any securities exchange or market or automated
quotation system, the provisions of or governing any deposited securities, any present or future provision of our memorandum and articles
of association, any act of God, war, terrorism, epidemic, pandemic, nationalization, expropriation, currency restrictions, extraordinary
market conditions, work stoppage, strike, civil unrest, revolutions, rebellions, explosions, cyber, ransomware or malware attack, computer
failure or circumstance our, the depositary&rsquo;s or our respective directors&rsquo;, officers&rsquo;, employees&rsquo;, agents&rsquo;
or affiliates&rsquo; direct and immediate control shall prevent or delay, or shall cause any of them to be subject to any civil or criminal
penalty in connection with, any act which the deposit agreement or the ADRs provide shall be done or performed by any such party (including,
without limitation, voting);&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">incur or assume no liability (including, without limitation, to ADR holders
or beneficial owners) by reason of any non-performance or delay, caused as aforesaid, in the performance of any act or things which by
the terms of the deposit agreement it is provided shall or may be done or performed or any exercise or failure to exercise discretion
under the deposit agreement or the ADRs including, without limitation, any failure to determine that any distribution or action may be
lawful or reasonably practicable;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">incur or assume no liability (including, without limitation, to holders or
beneficial owners) if it performs its obligations specifically set forth in the deposit agreement and ADRs without gross negligence or
willful misconduct;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">in the case of the depositary and its agents, be under no obligation to appear
in, prosecute or defend any action, suit or other proceeding in respect of any deposited securities the ADSs or the ADRs;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">in the case of us and our agents, be under no obligation to appear in, prosecute
or defend any action, suit or other proceeding in respect of any deposited securities the ADSs or the ADRs, which in our or our agents&rsquo;
opinion, as the case may be, may involve us in expense or liability, unless indemnity satisfactory to us or our agent, as the case may
be, against all expense (including fees and disbursements of counsel) and liability is furnished as often as may be requested;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">not be liable (including, without limitation, to ADR holders or beneficial
owners) for any action or inaction by it in reliance upon the advice of or information from any legal counsel, any accountant, any person
presenting ordinary shares for deposit, any registered holder of ADRs, or any other person believed by it to be competent to give such
advice or information and/or, in the case of the depositary, from us; or&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">be able to rely and shall be protected in acting upon any written notice,
request, direction, instruction or document believed by it to be genuine and to have been signed, presented or given by the proper party
or parties.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary shall not be a fiduciary or have any fiduciary duty
to ADR holders or beneficial owners.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary and its agents may fully respond to any and all demands
or requests for information maintained by or on its behalf in connection with the deposit agreement, any registered holder or holders
of ADRs, any ADRs or otherwise related to the deposit agreement or ADRs to the extent such information is requested or required by or
pursuant to any lawful authority, including without limitation laws, rules, regulations, administrative or judicial process, banking,
securities or other regulators. The depositary shall not be liable for the acts or omissions made by, or the insolvency of, any securities
depository, clearing agency or settlement system. Furthermore, the depositary shall not be responsible for, and shall incur no liability
in connection with or arising from, the insolvency of any custodian that is not a branch or affiliate of JPMorgan. Notwithstanding anything
to the contrary contained in the deposit agreement or any ADRs, the depositary shall not be responsible for, and shall incur no liability
in connection with or arising from, any act or omission to act on the part of the custodian except to the extent that any registered ADR
holder has incurred liability directly as a result of the custodian having (1) committed fraud or willful misconduct in the provision
of custodial services to the depositary or (2) failed to use reasonable care in the provision of custodial services to the depositary
as determined in accordance with the standards prevailing in the jurisdiction in which the custodian is located. The depositary and the
custodian(s) may use third party delivery services and providers of information regarding matters such as, but not limited to, pricing,
proxy voting, corporate actions, class action litigation and other services in connection with the ADRs and the deposit agreement, and
use local agents to provide services such as, but not limited to, attendance at any meetings of security holders of our company. Although
the depositary and the custodian will use reasonable care (and cause their agents to use reasonable care) in the selection and retention
of such third-party providers and local agents, they will not be responsible for any errors or omissions made by them in providing the
relevant information or services.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary has no obligation to inform ADR holders or beneficial
owners about the requirements of the laws, rules or regulations or any changes therein or thereto of the Cayman Islands, the PRC, the
United States or any other country or jurisdiction or of any governmental or regulatory authority or any securities exchange or market
or automated quotation system.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, none of the depositary, the custodian or us, or any of
their or our respective directors, officers, employees, agents or affiliates shall be liable for the failure by any registered holder
of ADRs or beneficial owner to obtain the benefits of credits or refunds of non-U.S. tax paid against such ADR holder&rsquo;s or beneficial
owner&rsquo;s income tax liability. The depositary is under no obligation to provide the ADR holders and beneficial owners, or any of
them, with any information about our tax status. None of us, the depositary, the custodian or any of our or their respective directors,
officers, employees, agents or affiliates shall incur any liability for any tax or tax consequences that may be incurred by registered
ADR holders or beneficial owners on account of their ownership or disposition of ADRs or ADSs.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Neither the depositary nor its agents will be responsible for any failure
to carry out any instructions to vote any of the deposited securities, for the manner in which any voting instructions are given, including
instructions to give a discretionary proxy to a person designated by us, for the manner in which any vote is cast, including, without
limitation, any vote cast by a person to whom the depositary is instructed to grant a discretionary proxy pursuant to the terms of the
deposit agreement, or for the effect of any such vote. The depositary shall endeavor to effect any sale of securities or other property
and any conversion of currency, securities or other property, in each case as is referred to or contemplated in the deposit agreement
or the form of ADR, in accordance with the depositary&rsquo;s normal practices and procedures under the circumstances applicable to such
sale or conversion, but shall have no liability (in the absence of its own willful default or gross negligence or that of its agents,
officers, directors or employees) with respect to the terms of any such sale or conversion, including the price at which such sale or
conversion is effected, or if such sale or conversion shall not be practicable, or shall not be believed, deemed or determined to be practicable
by the depositary. Specifically, the depositary shall not have any liability for the price received in connection with any public or private
sale of securities (including, without limitation, for any sale made at a nominal price), the timing thereof or any delay in action or
omission to act nor shall it be responsible for any error or delay in action, omission to act, default or negligence on the part of the
party so retained in connection with any such sale or proposed sale. The depositary shall not incur any liability in connection with or
arising from any failure, inability or refusal by us or any other party, including any share registrar, transfer agent or other agent
appointed by us, the depositary or any other party, to process any transfer, delivery or distribution of cash, ordinary shares, other
securities or other property, including without limitation upon the termination of the deposit agreement, or otherwise to comply with
any provisions of the deposit agreement that are applicable to it. The depositary may rely upon instructions from us or our counsel in
respect of any approval or license required for any currency conversion, transfer or distribution. The depositary shall not incur any
liability for the content of any information submitted to it by us or on our behalf for distribution to ADR holders or for any inaccuracy
of any translation thereof, for any investment risk associated with acquiring an interest in the deposited securities, for the validity
or worth of the deposited securities, for the credit-worthiness of any third party, for allowing any rights to lapse upon the terms of
the deposit agreement or for the failure or timeliness of any notice from us. The depositary shall not be liable for any acts or omissions
made by a successor depositary whether in connection with a previous act or omission of the depositary or in connection with any matter
arising wholly after the removal or resignation of the depositary. Neither the depositary nor us, nor any of their or our respective agents
shall be liable to the other for any indirect, special, punitive or consequential damages (excluding reasonable fees and expenses of counsel)
or lost profits, in any form, or Special Damages, incurred by any of them or us, or liable to any other person or entity (including, without
limitation, holders and beneficial owners) for any Special Damages, or any fees or expenses of counsel in connection therewith, whether
or not foreseeable and regardless of the type of action in which such a claim may be brought; provided, however, that (i) notwithstanding
the foregoing, the depositary and its agents will be entitled to legal fees and expenses in defending against any claim for Special Damages
and (ii) to the extent Special Damages arise from or out of a claim brought by a third party (including, without limitation, holders and
beneficial owners) against the depositary or any of its agents, the depositary and its agents shall be entitled to full indemnification
from us for all such Special Damages, and reasonable fees and expenses of counsel in connection therewith, unless such Special Damages
are found to have been a direct result of the gross negligence or willful misconduct of the depositary.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary and its agents may own and deal in any class of securities
of ours and our affiliates and in ADSs.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Disclosure of interest in ADSs</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent that the provisions of or governing any deposited securities
may require disclosure of or impose limits on beneficial or other ownership of, or interest in, deposited securities, other shares and
other securities and may provide for blocking transfer, voting or other rights to enforce such disclosure or limits, you as ADR holders
or beneficial owners agree to comply with all such disclosure requirements and ownership limitations and to comply with any reasonable
instructions we may provide in respect thereof.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Books of depositary&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary or its agent maintains a register for the registration,
registration of transfer, combination, split-up, substitution and cancellation of ADRs, which register shall include the depositary&rsquo;s
direct registration system. Registered holders of ADRs may inspect such records at the depositary&rsquo;s office at all reasonable times,
but solely for the purpose of communicating with other ADR holders in the interest of our business or a matter relating to the deposit
agreement. Such register (and/or any portion thereof) may be closed at any time or from time to time, when deemed expedient by the depositary.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary will maintain facilities for the delivery and receipt
of ADRs.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Appointment&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the deposit agreement, each registered holder of ADRs and each beneficial
owner, upon acceptance of any ADSs or ADRs (or any interest in any of them) issued in accordance with the terms and conditions of the
deposit agreement will be deemed for all purposes to:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">be a party to and bound by the terms of the deposit agreement and the applicable
ADR or ADRs,&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">appoint the depositary its attorney-in-fact, with full power to delegate,
to act on its behalf and to take any and all actions contemplated in the deposit agreement and the applicable ADR or ADRs, to adopt any
and all procedures necessary to comply with applicable laws and to take such action as the depositary in its sole discretion may deem
necessary or appropriate to carry out the purposes of the deposit agreement and the applicable ADR and ADRs, the taking of such actions
to be the conclusive determinant of the necessity and appropriateness thereof; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">acknowledge and agree that (1) nothing in the deposit agreement or any ADR
shall give rise to a partnership or joint venture among the parties thereto, nor establish a fiduciary or similar relationship among such
parties, (2) the depositary, its divisions, branches and affiliates, and their respective agents, may from time to time be in the possession
of non-public information about us, ADR holders, beneficial owners and/or their respective affiliates, (3) the depositary and its divisions,
branches and affiliates may at any time have multiple banking relationships with us, ADR holders, beneficial owners and/or the affiliates
of any of them, (4) the depositary and its divisions, branches and affiliates may, from time to time, be engaged in transactions in which
parties adverse to us, ADR holders, or beneficial owners may have interests, (5) nothing contained in the deposit agreement or any ADR(s)
shall (A) preclude the depositary or any of its divisions, branches or affiliates from engaging in any such transactions or establishing
or maintaining any such relationships, or (B) obligate the depositary or any of its divisions, branches or affiliates to disclose any
such transactions or relationships or to account for any profit made or payment received in any such transactions or relationships, (6)
the depositary shall not be deemed to have knowledge of any information held by any branch, division or affiliate of the depositary and
(7) notice to an ADR holder shall be deemed, for all purposes of the deposit agreement and the ADRs, to constitute notice to any and all
beneficial owners of the ADSs evidenced by such ADR holder&rsquo;s ADRs. For all purposes under the deposit agreement and the ADRs, the
ADR holders thereof shall be deemed to have all requisite authority to act on behalf of any and all beneficial owners of the ADSs evidenced
by such ADRs.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Consent to jurisdiction&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the deposit agreement, we have appointed an agent for service of
process on our behalf. Any action based on the deposit agreement, the ADSs, the ADRs or the transactions contemplated therein or thereby
may be instituted by the depositary against us in the state or federal courts in New York, New York or any competent court in the Cayman
Islands, the United States and/or any other court of competent jurisdiction.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the deposit agreement, by holding or owning an ADR or ADS or
an interest therein, holders and beneficial owners each irrevocably agree that (1) any legal suit, action or proceeding against or involving
holders or beneficial owners brought by us or the depositary, arising out of or based upon the deposit agreement, the ADSs, the ADRs or
the transactions contemplated therein or thereby, may be instituted in a state or federal court in New York, New York, and by holding
or owning an ADR or ADS or an interest therein each irrevocably waives any objection that it may now or hereafter have to the laying of
venue of any such proceeding, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such suit, action or proceeding
and (2) any legal suit, action or proceeding against or involving us and/or the depositary brought by holders or beneficial owners, arising
out of or based upon the deposit agreement, the ADSs, the ADRs or the transactions contemplated therein or thereby, including, without
limitation, claims under the Securities Act and the Exchange Act, may only be instituted only in the United States District Court for
the Southern District of New York (or in the state courts of New York County in New York if either (a) the United States District Court
for the Southern District of New York lacks subject matter jurisdiction over the particular dispute or (b) the designation of the United
States District Court for the Southern District of New York as the exclusive forum for the particular dispute is, or becomes, invalid,
illegal or unenforceable). In the deposit agreement each holder and beneficial owner irrevocably waives any objection which it may at
any time have to the laying of venue of any such proceeding, and irrevocably submits to the jurisdiction of such courts in any such suit,
action or proceeding. Additionally, by holding or owning an ADR or ADS or an interest therein, holders and beneficial owners acknowledge
and agree that they will not be able to commence or pursue any legal suit, action or proceeding against the depositary or its agents in
any jurisdiction other than as described in this paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding anything in the deposit agreement to the contrary,
by directly or indirectly holding or owing an ADR or ADS or an interest therein, holders and beneficial owners each agree that the depositary
may, in its sole discretion, elect to institute any dispute, suit, action, controversy, claim or proceeding directly or indirectly based
on, arising out of or relating to the deposit agreement, the ADSs, the ADRs or the transactions contemplated therein or thereby, including
without limitation any question regarding its or their existence, validity, interpretation, performance or termination against any other
party or parties, by having such dispute referred to and finally resolved by an arbitration; provided, however, to the extent there are
specific federal securities law violation aspects to any claims against us and/or the depositary, such specific, and only such specific,
claims may be brought by any holder or beneficial owner in the United States District Court for the Southern District of New York (or
in the state courts of New York County in New York if either (i) the United States District Court for the Southern District of New York
lacks subject matter jurisdiction over the particular dispute or (ii) the designation of the United States District Court for the Southern
District of New York as the exclusive forum for the particular dispute is, or becomes, invalid, illegal or unenforceable) and all other
aspects, claims, disputes, legal suits, actions and/or proceedings brought by such holder or beneficial owner, including those brought
along with, or in addition to, federal securities law violation claims, would be referred to, or remain in arbitration. Any such arbitration
shall, at the depositary&rsquo;s election, be conducted either in New York, New York in accordance with the Commercial Arbitration Rules
of the American Arbitration Association or in Hong Kong following the arbitration rules of the United Nations Commission on International
Trade Law (UNCITRAL) with the Hong Kong International Arbitration Centre serving as the appointing authority and the language of any such
arbitration shall be English. In all cases, the fees of the arbitrators and other costs incurred by the parties in connection with such
arbitration shall be paid by the party (or parties) that is (or are) unsuccessful in such arbitration. Holders and beneficial owners shall
not be entitled to join or consolidate disputes by or against others in any arbitration, or to include in any arbitration any dispute
as a representative or member of a class, or act in any arbitration in the interest of the general public or in a private attorney general
capacity.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Jury trial waiver&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the deposit agreement, each party thereto (including, for the avoidance
of doubt, each holder and beneficial owner of, and/or holder of interests in, ADSs or ADRs) irrevocably waives, to the fullest extent
permitted by applicable law, any right it may have to a trial by jury in any suit, action or proceeding against the depositary and/or
us directly or indirectly arising out of, based on or relating in any way to the ordinary shares or other deposited securities, the ADSs
or the ADRs, the deposit agreement or any transaction contemplated therein, or the breach thereof (whether based on contract, tort, common
law or any other theory), including any claim under the U.S. federal securities laws.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we or the depositary were to oppose a jury trial demand based on
such waiver, the court would determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with
applicable state and federal law, including whether a party knowingly, intelligently and voluntarily waived the right to a trial by jury.
The waiver to right to a trial by jury in the deposit agreement is not intended to be deemed a waiver by any holder or beneficial owner
of our or the depositary&rsquo;s compliance with any provisions of U.S. federal securities laws or the rules and regulations promulgated
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Conversion between ordinary shares and ADSs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dealings and settlement of ordinary shares in Hong Kong</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dealings in our ordinary shares on the HKEx are conducted in Hong Kong
dollars. Our ordinary shares are traded on the HKEx in board lots of 100 ordinary shares. The transaction costs of dealings in our ordinary
shares on the HKEx include:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hong Kong Stock Exchange trading fee of 0.005% of the consideration of the
transaction, charged to each of the buyer and seller;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">SFC transaction levy of 0.0027% of the consideration of the transaction,
charged to each of the buyer and seller;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounting and Financial Reporting Council transaction levy of 0.00015% of
the consideration of the transaction, charged to each of the buyer and seller;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trading tariff of HK$0.50 on each and every purchase or sale transaction.
The decision on whether or not to pass the trading tariff onto investors is at the discretion of brokers;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transfer deed stamp duty of HK$5.00 per transfer deed (if applicable), payable
by the seller;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ad valorem stamp duty at a total rate of 0.2% of the value of the transaction,
with 0.1% payable by each of the buyer and the seller;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock settlement fee, which is currently 0.002% of the gross transaction
value, subject to a minimum fee of HK$2.00 and a maximum fee of HK$100.00 per side per trade;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Brokerage commission, which is freely negotiable with the broker (other than
brokerage commissions for IPO transactions which are currently set at 1% of the subscription or purchase price and will be payable by
the person subscribing for or purchasing the securities); and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Charge by the Hong Kong share registrar between HK$2.50 to HK$20, depending
on the speed of service (or such higher fee as may from time to time be permitted under the Hong Kong Listing Rules), for each transfer
of ordinary shares from one registered owner to another, each share certificate canceled or issued by it and any applicable fee as stated
in the share transfer forms used in Hong Kong.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investors must settle their trades executed on the HKEx through their
brokers directly or through custodians. For an investor who has deposited his/her ordinary shares in his/her stock account or in his/her
designated CCASS (&ldquo;Central Clearing and Settlement System&rdquo;) Participant&rsquo;s stock account maintained with CCASS, settlement
will be effected in CCASS in accordance with the General Rules of CCASS and CCASS Operational Procedures in effect from time to time.
For an investor who holds the physical certificates, settlement certificates and the duly executed transfer forms must be delivered to
his/her broker or custodian before the settlement date.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An investor may arrange with his/her broker or custodian on a settlement
date in respect of his/her trades executed on the HKEx. Under the Hong Kong Listing Rules and the General Rules of CCASS and CCASS Operational
Procedures in effect from time to time, the date of settlement must be the second business day (a day on which the settlement services
of CCASS are open for use by CCASS Participants) following the trade date (T+2). For trades settled under CCASS, the General Rules of
CCASS and CCASS Operational Procedures in effect from time to time provided that the defaulting broker may be compelled to compulsorily
buy-in by HKSCC the day after the date of settlement (T+3), or if it is not practicable to do so on T+3, at any time thereafter. HKSCC
may also impose fines from T+2 onwards.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The ADSs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The ADSs trade on Nasdaq. Dealings in the ADSs are conducted in U.S.
Dollars. ADSs may be held either:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Directly: (1) by having an ADR which is a certificate evidencing a specific
number of ADSs, registered in the holder&rsquo;s name; or (2) by having uncertified ADSs in the direct registration system, which is a
system administered by the DTC; or&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indirectly, through a broker or other financial institution.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary for the ADSs is JPMorgan Chase Bank, N.A., whose principal
executive office is located at 383 Madison Avenue, Floor 11, New York, NY 10179.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Depositing ordinary shares trading in Hong Kong for delivery of
ADSs&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An investor who holds ordinary shares registered in Hong Kong and who
wishes to receive delivery of ADSs to trade on Nasdaq must deposit or have his or her broker deposit the ordinary shares with the Depositary&rsquo;s
Hong Kong custodian in exchange for ADSs. A deposit of ordinary shares trading in Hong Kong in exchange for ADSs involves the following
procedures:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">If ordinary shares have been deposited with CCASS, the investor must transfer
ordinary shares to the depositary&rsquo;s account with the custodian within CCASS by following the CCASS procedures for transfer and submit
and deliver a duly completed and signed letter of transmittal to the custodian via his or her broker.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">If ordinary shares are held outside CCASS, the investor must arrange to deposit
his or her ordinary shares into the CCASS for delivery to the depositary&rsquo;s account with the custodian within CCASS, and must submit
and deliver a duly completed and signed letter of transmittal to the custodian via his or her broker.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon payment of its fees and expenses, payment or net of the depositary&rsquo;s
fees and expenses, and payment of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, if applicable, and subject
in all cases to the terms of the deposit agreement, the depositary will register the corresponding number of ADSs in the name(s) requested
by an investor and will deliver the ADSs to the designated DTC account of the person(s) designated by an investor or his or her broker
if such ADSs are to be held in book-entry form through DTC&rsquo;s &ldquo;Direct Registration System.&rdquo;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For ordinary shares deposited in CCASS, under normal circumstances,
the above steps generally require two business days, provided that the investor has provided timely and complete instructions. For ordinary
shares held outside CCASS in physical form, the above steps may take 14 business days, or more, to complete. Temporary delays may arise.
For example, the transfer books of the depositary may from time to time be closed to ADS issuances. The investor will be unable to trade
the ADSs until the procedures are completed.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Surrender of ADSs for delivery of ordinary shares trading in Hong
Kong&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An investor who holds ADSs and who wishes to receive ordinary shares
that trade on the HKEx must cancel the ADSs the investor holds, withdraw ordinary shares from the ADS program and cause his or her broker
or other financial institution to trade such ordinary shares on the HKEx.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An investor that holds ADSs indirectly through a broker or other financial
institution should follow the procedure of the broker or financial institution and instruct the broker to arrange for cancelation of the
ADSs and transfer of the underlying ordinary shares from the depositary&rsquo;s account with the custodian within the CCASS system to
the investor&rsquo;s Hong Kong stock account. For investors holding ADSs directly, the following steps must be taken:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">To withdraw ordinary shares from the ADS program, an investor who holds ADSs
may turn in such ADSs at the office of the depositary (and the applicable ADR(s) if the ADSs are held in certificated form), and send
an instruction to cancel such ADSs to the depositary.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon payment or net of its fees, payment of CCASS&rsquo; fees and expenses,
and payment of expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, if applicable, and subject in
all cases to the terms of the deposit agreement, the depositary will instruct the custodian to deliver ordinary shares underlying the
canceled ADSs to the CCASS account designated by an investor.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">If an investor prefers to receive ordinary shares outside CCASS, he or she
must receive ordinary shares in CCASS first and then arrange for withdrawal from CCASS. Investors can then obtain a transfer form signed
by HKSCC Nominees Limited (as the transferor) and register ordinary shares in their own names with the Hong Kong share registrar.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For ordinary shares to be received in CCASS, under normal circumstances,
the above steps generally require two business days, provided that the investor has provided timely and complete instructions.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For ordinary shares to be received outside CCASS in physical form,
the above steps may take 14 business days, or more, to complete. The investor will be unable to trade the ordinary shares on the HKEx
until the procedures are completed.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Temporary delays may arise. For example, the transfer books of the
depositary may from time to time be closed to ADS cancelations. In addition, completion of the above steps and procedures for delivery
for ordinary shares in a CCASS account is subject to there being a sufficient number of ordinary shares on the Hong Kong share register
to facilitate a withdrawal from the ADS program directly into the CCASS. We are not under any obligation to maintain or increase the number
of ordinary shares on the Hong Kong share register to facilitate such withdrawals.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Depositary requirements&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Before the depositary delivers ADSs or permits withdrawal of ordinary
shares, the depositary may require:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">payment of all amounts required pursuant to the deposit agreement, including
the issuance and cancellation fees therein, any stock transfer or other tax or other governmental charges and any stock transfer or registration
fees in effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">production of satisfactory proof of the identity and genuineness of any signature
or other information it deems necessary; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18pt">&#9679;</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">compliance with procedures it may establish, from time to time, consistent
with the deposit agreement, including completion and presentation of transfer documents.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depositary may refuse to deliver, transfer, or register issuances,
transfers, and cancellations of ADSs generally when the transfer books of the depositary or our Hong Kong share registrar or Cayman Islands
share registrar are closed or at any time if the depositary or we determine it advisable to do so, subject to such refusal complying with
U.S. federal securities laws.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All costs attributable to the transfer of ordinary shares to effect
a withdrawal from or deposit of ordinary shares into the ADS program will be borne by the investor requesting the transfer. In particular,
holders of ordinary shares and ADSs should note that the Hong Kong share registrar will charge between HK$2.50 to HK$20, depending on
the speed of service (or such higher fee as may from time to time be permitted under the Hong Kong Listing Rules), for each transfer of
ordinary shares from one registered owner to another, each share certificate canceled or issued by it and any applicable fee as stated
in the share transfer forms used in Hong Kong. In addition, holders of ordinary shares and ADSs must pay up to US$5.00 per 100 ADSs (or
portion thereof) for each issuance of ADSs and each cancelation of ADSs, as the case may be, in connection with the deposit of ordinary
shares into, or withdrawal of ordinary shares from, the ADS program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">39</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>3
<FILENAME>ea028514801ex4-5.htm
<DESCRIPTION>POST-IPO SHARE OPTION PLAN AS AMENDED ON MAY 19, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.5</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Ascentage Pharma Group International</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(incorporation in the Cayman
Islands with limited liability)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>POST IPO SHARE OPTION SCHEME</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Adopted on September 28, 2019
and amended on May 19, 2025)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Table of Contents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">Page</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 5%">1.</TD>
    <TD STYLE="width: 86%">DEFINITIONS</TD>
    <TD STYLE="text-align: center; width: 9%">1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>2.</TD>
    <TD>CONDITIONS</TD>
    <TD STYLE="text-align: center">5</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>3.</TD>
    <TD>PURPOSE, DURATION AND CONTROL OF SCHEME</TD>
    <TD STYLE="text-align: center">6</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>4.</TD>
    <TD>OPTIONS</TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>5.</TD>
    <TD>OPTIONS TO CONNECTED PERSONS</TD>
    <TD STYLE="text-align: center">10</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>6.</TD>
    <TD>EXERCISE PRICE</TD>
    <TD STYLE="text-align: center">12</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>7.</TD>
    <TD>EXERCISE OF OPTIONS</TD>
    <TD STYLE="text-align: center">12</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>8.</TD>
    <TD>LAPSE OF OPTION</TD>
    <TD STYLE="text-align: center">16</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>9.</TD>
    <TD>MAXIMUM NUMBER OF SHARES AVAILABLE FOR SUBSCRIPTION</TD>
    <TD STYLE="text-align: center">17</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>10.</TD>
    <TD>CAPITAL RESTRUCTURING</TD>
    <TD STYLE="text-align: center">19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>11.</TD>
    <TD>SUFFICIENT SHARE CAPITAL</TD>
    <TD STYLE="text-align: center">21</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>12.</TD>
    <TD>DISPUTES</TD>
    <TD STYLE="text-align: center">21</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>13.</TD>
    <TD>ALTERATION OF THIS SCHEME</TD>
    <TD STYLE="text-align: center">22</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>14.</TD>
    <TD>TERMINATION</TD>
    <TD STYLE="text-align: center">22</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>15.</TD>
    <TD>CLAWBACK MECHANISM &ndash; CANCELLATION OF OPTIONS</TD>
    <TD STYLE="text-align: center">22</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>16.</TD>
    <TD>DISCLOSURE IN ANNUAL AND INTERIM REPORTS</TD>
    <TD STYLE="text-align: center">23</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>17.</TD>
    <TD>GENERAL</TD>
    <TD STYLE="text-align: center">23</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>18.</TD>
    <TD>GOVERNING LAW</TD>
    <TD STYLE="text-align: center">24</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 63.4pt 0pt 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 55.95pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Ascentage Pharma Group International</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Incorporated in the Cayman
Islands with limited liability)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>POST IPO SHARE OPTION SCHEME</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: left">DEFINITIONS</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>1.1</B></TD><TD STYLE="text-align: left">In this Scheme, except where the context otherwise requires,
the following words and expressions have the following meanings:&ndash;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Acceptance
Date&rdquo; </B>means the date upon which an Offer must be accepted by the relevant Eligible Participant, being a date not later than
28 days after the Offer Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Adoption
Date&rdquo;</B> means September 28, 2019, the date on which this Scheme is conditionally adopted by an ordinary resolution of the Shareholders,
and not being the Amendment Date for the avoidance of doubt;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Amendment
Date&rdquo;</B> means May 19, 2025, being the date on which the amended and restated Scheme is adopted and approved by the shareholders
of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;approved
independent financial adviser&rdquo; </B>means such independent financial adviser as approved by the Board;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Articles&rdquo;</B>
means the articles of association of the Company as amended from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;associate(s)&rdquo;</B> shall have the meaning
ascribed to it in the Listing Rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Auditors&rdquo;</B> means the auditors for the
time being of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Board&rdquo;
</B>means the board of Directors from time to time or a duly authorised committee thereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Business
Day&rdquo;</B> means a day on which the Stock Exchange is open for the business of dealing in securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Cancelled
Shares&rdquo;</B> means those Shares which were the subject of options which had been granted and accepted under this Scheme or any of
the other schemes but subsequently cancelled. For the avoidance of doubt, <B>&ldquo;Cancelled Shares&rdquo;</B> shall exclude <B>&ldquo;Lapsed
Shares&rdquo;</B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Company&rdquo;</B>
means Ascentage Pharma Group International, a company incorporated in the Cayman Islands with limited liability on November 17, 2017;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Companies
Law&rdquo; </B>means the Companies Law (as revised) of the Cayman Islands, as amended, supplemented or otherwise modified from time to
time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;close associate(s)&rdquo;</B> shall have the meaning
ascribed to it in the Listing Rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;connected person(s)&rdquo;</B> has the meaning ascribed
to it in the Listing Rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;core connected person(s)&rdquo;</B> shall have the
meaning ascribed to it in the Listing Rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Director&rdquo;</B> means any director of the Company
from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Eligible
Participant&rdquo;</B> means (a) any executive director of, manager of, or other employee holding an executive, managerial, supervisory
or similar position in any member of the Group, any full-time or part-time employee, or a person for the time being seconded to work full-time
or part-time for any member of the Group; (b) a director or proposed director (including an independent non-executive director) of any
member of the Group ((a) and (b) collectively, the <B>&ldquo;Employee Participant&rdquo;</B>); and (c) a Service Provider;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Exercise
Date&rdquo;</B> means the date of the notice given by the Grantee in respect of the exercise of the Option in accordance with paragraph
7.1;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Exercise
Price&rdquo; </B>means the price per Share, determined by the Board, at which a Grantee may subscribe for Shares on the exercise of an
Option in accordance with paragraph 6;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Expiry
Date&rdquo;</B> means, in respect of an Option, the date of the expiry of the Option as may be determined by the Board which shall not
be later than the last day of the Option Period in respect of such Option;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Global
Offering&rdquo;</B> means offering of a total of 12,180,900 Shares (subject to reallocation and Over-allotment Option (as defined in the
Prospectus)) for subscription, details of which are described in the section headed &ldquo;Structure and Conditions of the Global Offering&rdquo;
in the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Grantee&rdquo;</B>
means any Eligible Participant who accepts an Offer in accordance with the rules of this Scheme;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Group&rdquo;</B> means the Company and its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;HK$&rdquo;</B> means Hong Kong dollars, the lawful
currency of Hong Kong;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Hong
Kong&rdquo;</B> means the Hong Kong Special Administrative Region of the People&rsquo;s Republic of China;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Lapsed
Shares&rdquo; </B>means those Shares which were the subject of options which had been granted and accepted under this Scheme or any of
the other schemes but subsequently lapsed. For the avoidance of doubt, <B>&ldquo;Lapsed Shares&rdquo;</B> shall exclude <B>&ldquo;Cancelled
Shares&rdquo;</B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Listing
Date&rdquo;</B> means the date on which the Shares commence listing on the Main Board of the Stock Exchange;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Listing
Rules&rdquo;</B> means the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, as amended from time
to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Offer&rdquo;
</B>means an offer of the grant of an Option or Options made in accordance with the Scheme;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Offer
Date&rdquo; </B>means in respect of an Option, the date on which such Option is offered in writing to an Eligible Participant which must
be a Business Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Option&rdquo;</B>
means a right granted by the Company under the Scheme, which right permits (but does not obligate) a Grantee to subscribe for Shares in
accordance with the terms of this Scheme;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Option
Period&rdquo;</B> means in respect of an Option, the period to be notified by the Board to each Grantee within which the Option may be
exercisable provided that such period of time shall not exceed a period of ten years commencing on the Offer Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;other
schemes&rdquo;</B> means other than this Scheme, all the schemes involving the grant by the Company of options or awards over Shares or
other securities of the Company to, or for the benefit of, specified participants of such schemes or any arrangement involving the grant
of options or awards to participants over Shares or other securities of the Company which, in the opinion of the Stock Exchange, is analogous
to a share scheme as described in Chapter 17 of the Listing Rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Personal
Representative(s)&rdquo;</B> means a person or persons who, in accordance with the laws of succession applicable in respect of the death
of such Grantee is or are entitled to exercise the Option accepted by such Grantee (to the extent not already exercised) in consequence
of the death of such Grantee;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Prospectus&rdquo;</B> means the prospectus of
the Company in respect of the Global Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Remuneration
Committee&rdquo;</B> means the remuneration committee of the Company established pursuant to the Listing Rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Scheme&rdquo;</B>
means the share option scheme, the rules of which are set out in this document in its present or any amended form;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Scheme Mandate Limit&rdquo;</B> has the meaning
ascribed to it in paragraph 9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Scheme Limit&rdquo;</B> has the meaning ascribed
to it in paragraph 9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Scheme
Period&rdquo;</B> means a period commencing on the Listing Date and ending on the tenth anniversary of the Listing Date (both dates inclusive);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Service
Provider(s)&rdquo;</B> means any person who provides services to the Group on a continuing or recurring basis in its ordinary and usual
course of business which are in the interests of the long term growth of the Group, including: (a) supplier of goods or services to any
member of the Group; and (b) a person or entity that provides design, research, development or other support or any advisory, consultancy,
professional or other services to any member of the Group, provided that any placing agents or financial advisers providing advisory services
to the Group for fundraising, mergers or acquisitions and professional services providers such as auditors or valuers who provide assurance
or are required to perform their services with impartiality and objectivity should not be Service Providers for the purpose of the Scheme;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Service Provider Sublimit&rdquo;</B> has the meaning
scribed to it in paragraph 9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Shares&rdquo;</B>
means ordinary shares of US$0.0001 each in the capital of the Company or, if there has been a capitalisation issue, rights issue, sub-division
or consolidation of shares or reduction of capital in the share capital of the Company, shares forming part of the ordinary equity share
capital of the Company of such other nominal amount as shall result from any such capitalisation issue, rights issue, sub-division or
consolidation of shares or reduction of capital in the share capital of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Shareholders&rdquo;</B> means the shareholders of
the Company from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Special
Resolution&rdquo; </B>means a resolution passed at a meeting of the Grantees (being only those Grantees holding Options, all or any part
of which is unexercised as at the time of the meeting at which the resolution is proposed) duly convened and held and carried by a majority
consisting of not less than three-fourths of the votes cast upon a show of hands or if a poll is duly demanded, by a majority consisting
of not less than three-fourths of the votes cast on a poll;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Stock
Exchange&rdquo;</B> means The Stock Exchange of Hong Kong Limited or (if applicable) such other stock exchange on which the issued share
capital of the Company is primarily listed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Subsidiary&rdquo;</B>
means an entity, including but not limited to such associate(s) as set forth in the accountants&rsquo; report of the Company from time
to time, which is a subsidiary for the time being of the Company within the meaning of the Companies (Winding Up and Miscellaneous Provisions)
Ordinance (Chapter 32 of the Laws of Hong Kong) and <B>&ldquo;Subsidiaries&rdquo; </B>shall be construed accordingly;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;substantial shareholder&rdquo;</B> has the meaning
ascribed to it in the Listing Rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;treasury Shares&rdquo;</B> has the meaning ascribed
to it in the Listing Rules; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Vesting
Period&rdquo; </B>means in respect of any particular Option, the period between the Offer Date and the day on which such Option vests
and becomes exercisable, both days inclusive, and such period shall not be less than 12 months or such other period as the Listing Rules
may prescribe or permit except otherwise permitted under this Scheme and/or the Listing Rules in respect of any particular Option granted
to an Employee Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>1.2</B></TD><TD STYLE="text-align: left">In this Scheme, unless the context otherwise requires:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">paragraph headings are inserted for convenience of reference
only and shall not affect the interpretation of this Scheme;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">references to paragraphs are to paragraphs of this Scheme;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">the singular includes the plural and vice versa;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">references to one gender shall include both genders and the
neuter;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: left">any reference to any statute or statutory provision shall
include any statute or statutory provision which amends or replaces, or has amended or replaced it, and shall include any subordinate
legislation made under the relevant statute; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: left">a reference to a &ldquo;person&rdquo; shall be construed so
as to include any individual, firm, business, company, body corporate or unincorporated or other juridical person, government, federation,
state or agency thereof or any joint venture, association, partnership or trust (whether or not having separate legal personality).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: left">CONDITIONS</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><B>2.1</B></TD><TD STYLE="text-align: left">This Scheme shall take effect subject to and is conditional
upon:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the passing of the necessary resolutions by the Shareholders
to approve and adopt the rules of this Scheme and to authorise the Board to grant Options under this Scheme and to allot and issue Shares
pursuant to exercise of any Options;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the Listing Committee of the Stock Exchange granting the listing
of, and permission to deal in, the Shares falling to be issued pursuant to the exercise of Options under this Scheme;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">the obligations of the Underwriters (as defined in the Prospectus)
under the Underwriting Agreements (as defined in the Prospectus) becoming unconditional and not being terminated in accordance with its
terms or otherwise; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">the listing of the Shares on the Stock Exchange.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Since the
Amendment Date, the previous share option scheme adopted on September 28, 2019 shall be replaced in its entirety with this Scheme, provided
that the options granted before the Amendment Date shall continue to be effective and exercisable in accordance with the terms and conditions
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: left">PURPOSE, DURATION AND CONTROL OF SCHEME</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>3.1</B></TD><TD STYLE="text-align: left">The purpose of this Scheme is to enable the Company to grant
Options to Eligible Participants as incentives or rewards for their contribution or potential contribution to the Group and to provide
the Eligible Participants an opportunity to have a personal stake in the Company with the view to achieving the following objectives:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">motivate the Eligible Participants to optimise their performance
efficiency for the benefit of the Group;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">attract and retain or otherwise maintain on-going business
relationship with the Eligible Participants whose contributions are or will be beneficial to the long-term growth of the Group; and/or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">for such purposes as the Board may approve from time to time.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>3.2</B></TD><TD STYLE="text-align: left">The Board may, at its absolute discretion, invite the Eligible Participant to
take up Options to subscribe for Shares. The basis of eligibility of any Eligible Participant to the grant of any Options shall be determined
by the Board (or as the case may be, where required under the Listing Rules, the independent non-executive directors) from time to time
on the basis of the Eligible Participant&rsquo;s contribution or potential contribution to the development and growth of the Group.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Eligible Participants under the
Scheme include (i) any executive director of, manager of, or other employee holding an executive, managerial, supervisory or similar position
in any member of the Group, any full-time or part-time employee, or a person for the time being seconded to work full-time or part-time
for any member of the Group; (ii) a director or proposed director (including an independent non-executive director) of any member of the
Group; ((i) and (ii) collectively, the &ldquo;<B>Employee Participant</B>&rdquo;); or (iii) a Service Provider. The basis of eligibility
of any Eligible Participant to the grant of any Options shall be determined by the Board (or as the case may be, where required under
the Listing Rules, the independent non-executive directors) from time to time on the basis of the Eligible Participant&rsquo;s contribution
or potential contribution to the development and growth of the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">In
determining eligibility of existing or incoming employees, directors (whether executive or non-executive) or officers of the Company
or any member of the Group, the Board may take into account factors including, among others, (i) his/her skill, knowledge,
experience, expertise and other relevant personal qualities, (ii) educational and professional qualifications, and knowledge in the
industry, (iii) performance, length of employment with the Group, nature of duties and position within the Group, (iv) his/her
adherence to the Group&rsquo;s culture and values, or (v) the contribution and potential contribution to the development of the
Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Service Providers include any consultant
who are experts in research and development, clinical trials and academia who provides consultancy services and/or other professional
services to any member of the Group in connection with drug development and clinical trials in the ordinary and usual course of business
of the Group which is in the interests of the long term growth of the Group, provided that any placing agents or financial advisers providing
advisory services to the Group for fundraising, mergers or acquisitions and professional services providers such as auditors or valuers
who provide assurance or are required to perform their services with impartiality and objectivity should not be Service Providers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">In determining the eligibility
for such consultant to be a participant of the Scheme, the Board shall, in its absolute discretion, take into account, among others, (i)
the skill, knowledge and expertise of the relevant consultant including his or her capability and technical know-how; (ii) his or her
experience and network in the pharmaceutical industry and the academia; (iii) his or her research and development capability as well as
his or her capability and know-how as to the conduct of clinical trials; (iv) the frequency of collaboration and length of business relationship
with the Group; (v) the materiality and nature of the business relationship with the Group (such as whether they relate to the core business
of the Group and whether such business dealings could be readily replaced by third parties and the relevant replacement costs); (vi) the
background, reputation and track record of the relevant consultant; (vii) the potential and/or actual contribution to the business affairs
of the Group, and in particular, whether such consultant could bring positive impacts to the Group&rsquo;s business, such as drug development
and/or commercialization, an increase in revenue or profits or a reduction in costs attributable to or brought by services provided by
such consultant; and (viii) other factors, including but not limited to the synergy between the relevant consultant and the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>3.3</B></TD><TD STYLE="text-align: left">Subject to paragraph 14 and fulfilment of the conditions in paragraph 2.1, this Scheme shall be valid
and effective for the Scheme Period after which no further Options shall be offered but the provisions of this Scheme shall in all other
respects remain in full force and effect to the extent necessary to give effect to the exercise of any Options granted prior thereto or
otherwise as may be required in accordance with the provisions of this Scheme and Options granted prior thereto but not yet exercised
shall continue to be valid and exercisable in accordance with this Scheme.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>3.4</B></TD><TD STYLE="text-align: left">This Scheme shall be subject to the administration of the Board whose decision
as to all matters arising in relation to this Scheme or its interpretation or effect (save as otherwise provided herein) shall be final
and binding on all parties.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: left">OPTIONS</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>4.1</B></TD><TD STYLE="text-align: left">The Board shall, subject to and in accordance with the provisions of this Scheme
and the Listing Rules, be entitled to but shall not be bound, at any time on any Business Day during the Scheme Period, make an Offer
to any Eligible Participant whom the Board may in its absolute discretion select and subject to such conditions (including, without limitation,
any minimum period for which an Option must be held before it can be exercised and/or any performance targets which must be achieved before
an Option can be exercised) as it may think fit, provided that the maximum number of Shares in respect of which Options may be granted
under this Scheme to any Eligible Participant shall not result in the Shares issued and to be issued in respect of all options granted
to such Eligible Participant (excluding any options lapsed in accordance with the terms of the respective schemes) in the 12-month period
up to and including the Offer Date representing in aggregate over 1% of the total Shares in issue (excluding treasury shares).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>4.2</B></TD><TD STYLE="text-align: left">If the Board determines to make an Offer to an Eligible Participant which exceed the limit set out in
paragraph 4.1:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">that grant shall be subject to (i) the issue of a circular
by the Company to the Shareholders which shall comply with, and containing the information specified in, Rules 17.03D(2) and 17.06 of
the Listing Rules and or such other requirements as prescribed under the Listing Rules from time to time; and (ii) the separate approval
of the Shareholders, in the manner prescribed by the relevant provisions of the Listing Rules, in general meeting at which that Eligible
Participant and his close associates (or his associates if the Eligible Participant is a connected person) shall abstain from voting;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">unless provided otherwise in the Listing Rules, the date of
the Board meeting at which the Board resolves to grant the proposed Options to that Eligible Participant shall be taken as the Offer
Date for the purpose of calculating the Exercise Price; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">the number and terms (including the Exercise Price) of such
Options are fixed before the general meeting of the Company at which the same are approved.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>4.3</B></TD><TD STYLE="text-align: left">If the Board determines to make an Offer to an Eligible Participant
in accordance with paragraph 4.1, the Board shall forward to the relevant Eligible Participant an offer document in such form as the
Board may from time to time determine which states (or, alternatively, documents accompanying the offer document which state), among
others:&ndash;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the Eligible Participant&rsquo;s name, address and occupation/position;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the Offer Date;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">the Acceptance Date;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">the date of commencement of the Option Period;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: left">the number of Shares in respect of which the Option is offered;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: left">the Exercise Price and the manner of payment of the Exercise
Price for the Shares on and in consequence of the exercise of the Option;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(g)</TD><TD STYLE="text-align: left">the Expiry Date in relation to that Option;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(h)</TD><TD STYLE="text-align: left">the method of acceptance of the Option which shall, unless
the Board otherwise determines, be as set out in paragraph 4.4; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: left">such other terms, conditions, restrictions or limitations
including (without prejudice to the generality of the foregoing) qualifying and/or continuing criteria, conditions, restrictions or limitations
relating to the achievement of performance, operating or financial targets, the satisfactory performance or maintenance of certain conditions
or obligations or the time or period before the Option can be exercised or any of the Shares shall be vested provided that such terms
or conditions shall not be inconsistent with this Scheme. For the avoidance of doubt, subject to such terms and conditions as the Board
may determine as aforesaid (including such terms and conditions in relation to their vesting, exercise or otherwise) there is no minimum
period for which an Option must be held before it can be exercised and no performance target which need to be achieved by the Grantee
before the Option can be exercised.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>4.4</B></TD><TD STYLE="text-align: left">An Option shall be deemed to have been granted and accepted by the Grantee and
to have taken effect when the duplicate offer document constituting acceptance of the Option duly signed by the Grantee, together with
a remittance in favour of the Company of HK$1.00 by way of consideration for the grant thereof is received by the Company on or before
the relevant Acceptance Date. Such remittance shall in no circumstances be refundable and shall be deemed as part payment of the Exercise
Price.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>4.5</B></TD><TD STYLE="text-align: left">Any Offer may be accepted in respect of less than the number of Shares for which it is offered provided
that it must be accepted in respect of a board lot for dealing in Shares on the Stock Exchange or an integral multiple thereof and such
number is clearly stated in the duplicate offer document constituting acceptance of the Option in the manner as set out in paragraph 4.4.
To the extent that the Offer is not accepted by the Acceptance Date, it shall be deemed to have been irrevocably declined.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>4.6</B></TD><TD>The Options shall not be listed or dealt in on the Stock Exchange.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>4.7</B></TD><TD STYLE="text-align: left">An Option and an Offer shall be personal to the Grantee and shall not be transferable or assignable
                                                                    and no Grantee shall in any way sell, transfer, charge, mortgage, encumber or create any interest (legal or beneficial) in favour of
                                                                    any third party over or in relation to any Option held by him or any Offer made to him or attempt to do so (save that the Grantee may nominate a nominee in
whose name the Shares issued pursuant to this Scheme may be registered). Any breach of the foregoing shall entitle the Company to cancel
any outstanding Options or any part thereof granted to such Grantee.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>4.8</B></TD><TD STYLE="text-align: left">No offer of grant of Option shall be made after inside information has come to the knowledge of the Company
until (and including) the trading day after such inside information has been published in accordance with the Listing Rules. In particular,
no option may be granted during the period commencing 30 days immediately preceding the earlier of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the date of the Board meeting (as such date is first notified
to the Stock Exchange in accordance with the Listing Rules) for the approval of the Company&rsquo;s results for any year, half-year,
quarterly or any other interim period (whether or not required under the Listing Rules); and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the deadline for the Company to announce its results for any
year or half-year under the Listing Rules, or quarterly or any other interim period (whether or not required under the Listing Rules),
and ending on the date of the results announcement. The period during which no Option may be granted will cover any period of delay in
the publication of a results announcement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">No grant of
Option to a Director shall be allowed during the period prohibited by the Model Code for Securities Transactions by Directors of Listed
Issuers of the Listing Rules. If any Option is proposed to be granted to a Director, it shall not be granted, accepted or vested on any
day on which the financial results of the Company are published and during the period of: (i) 60 days immediately preceding the publication
date of the annual results or, if shorter, the period from the end of the relevant financial year up to the publication date of the results;
and (ii) 30 days immediately preceding the publication date of the quarterly results (if any) and half-year results or, if shorter, the
period from the end of the relevant quarterly or half-year period up to the publication date of the results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">5.</TD><TD>OPTIONS TO CONNECTED PERSONS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>5.1</B></TD><TD STYLE="text-align: left">Subject to paragraphs 4.2, 5.2, 9.2 and 9.3, if the Board determines to make an Offer to a Director, chief
executive or substantial shareholder of the Company or any of their respective associates, such grant shall be subject to the approval
by the independent non-executive Directors (and in the event that the Board makes an Offer to an independent non-executive Director, the
vote of such independent non-executive Director shall not be counted for the purposes of approving such grant). Each grant of Options
to a Director, the chief executive or a senior management of the Company or any of their respective associates (as defined in the Listing
Rules) under this Scheme or any other share schemes of the Company or any of its subsidiaries shall be subject to the approval of the
Remuneration Committee.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>5.2</B></TD><TD STYLE="text-align: left">If the Board determines to make an Offer to a substantial shareholder or an independent non-executive
Director (or any of their respective associates) and that grant would result in the Shares issued and to be issued upon exercise of all
options and awards already granted and to be granted (including options and awards exercised, cancelled and outstanding but excluding
any options and awards lapsed in accordance with the terms of their respective schemes) to such person under this Scheme and the other
schemes in the 12-month period up to and including the Offer Date, representing in aggregate over 0.1 per cent, or such other percentage
as may be from time to time provided under the Listing Rules, of the Shares in issue (excluding treasury Shares) on the Offer Date; and,
such grant shall be subject to, in addition to the approval of the independent non-executive Directors as referred to under paragraph
5.1, the issue of a circular by the Company to the Shareholders and the approval of the Shareholders in general meeting by way of a poll
convened and held in accordance with the Articles at which the Grantee, his associates and all core connected persons of the Company shall
abstain from voting in favour of the resolution concerning the grant of such Options at the general meeting, and/or such other requirements
prescribed under the Listing Rules from time to time. Unless provided otherwise in the Listing Rules, the date of the Board meeting at
which the Board proposes to grant the proposed Options to that Eligible Participant shall be taken as the Offer Date for the purpose of
calculating the Exercise Price. If grant of Options involves Director(s), the relevant Director(s) should abstain from voting at the Board
meeting or the Remuneration Committee meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>5.3</B></TD><TD STYLE="text-align: left">The circular to be issued by the Company to the Shareholders pursuant to paragraph 5.2 shall contain the
following information:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the details of the number and terms (including the Exercise
Price) of the Options to be granted to each Eligible Participant which must be fixed before the Shareholders&rsquo; meeting and the Offer
Date (which shall be the date of the Board meeting at which the Board proposes to grant the proposed Options to that Eligible Participant);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the views of the independent non-executive Directors (excluding
any independent non-executive Director who is the relevant Grantee) as to whether the terms of the grant are fair and reasonable and
whether such grant is in the interests of the issuer and its shareholders as a whole, and their recommendation to the independent Shareholders
as to voting;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">the information required under Rules 17.02(2)(c) of the Listing
Rules; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">the information required under Rule 2.17 of the Listing Rules.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>5.4</B></TD><TD STYLE="text-align: left">The requirements in this paragraph 5 do not apply where the Eligible Participant is only a proposed director
or chief executive of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 23.95pt">6.</TD><TD>EXERCISE PRICE</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Exercise
Price in relation to each Option offered to an Eligible Participant shall, subject to the adjustments referred to in paragraph 10, be
determined by the Board in its absolute discretion but in any event shall not be less than the highest of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the closing price of the Shares as stated in the daily quotation
sheets of the Stock Exchange on the Offer Date; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the average of the closing price of the Shares as stated in
the daily quotation sheets of the Stock Exchange for the five Business Days immediately preceding the Offer Date.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Without prejudice
to the generality of the foregoing, the Board (or any duly authorized committee or person by the Board) may grant Options in respect of
which the Exercise Price is fixed at different prices for different periods during the Option Period provided that the Exercise Price
for Shares for each of the different period shall not be less than the Exercise Price determined in the manner set out in this paragraph
6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 23.95pt">7.</TD><TD>EXERCISE OF OPTIONS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>7.1</B></TD><TD STYLE="text-align: left">Subject to paragraph 7.3, an Option shall be exercised in whole or in part and,
other than where it is exercised to the full extent outstanding, shall be exercised in integral multiples of such number of Shares as
shall represent one board lot for dealing in Shares on the Stock Exchange for the time being, by the Grantee by giving notice in writing
to the Company stating that the Option is thereby exercised and the number of Shares in respect of which it is exercised. Each such notice
must be accompanied by a remittance for the full amount of the Exercise Price for the Shares in respect of which the notice is given.
Within 30 days after receipt of the notice and the remittance of the Exercise Price and, where appropriate, receipt of the certificate
by the Auditors or the approved independent financial adviser as the case may be pursuant to paragraph 10, the Company shall allot and
issue the relevant number of Shares to the Grantee (or, as the case may be, his or her Personal Representative(s)) credited as fully paid
and issue to the Grantee (or, as the case may be, his or her Personal Representative(s)) certificates in respect of the Shares so allotted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>7.2</B></TD><TD STYLE="text-align: left">The exercise of any Option may be subject to a vesting schedule to be determined by the Board in its absolute
discretion which shall be specified in the offer letter. The exercise of any Option shall be subject to the Shareholders in general meeting
approving any necessary increase in the authorised share capital of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>7.3</B></TD><TD STYLE="text-align: left">Subject as hereinafter provided and to the extent as allowed by the relevant laws and regulations, as
determinate otherwise by the Board, an Option may be exercised by a Grantee at any time or times during the Option Period provided that:&ndash;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">in the event that the Employee Participant dies before exercising
the Option in full, his/her legal personal representative(s) may exercise the Option up to the Employee Participant&rsquo;s entitlement
(to the extent which has become exercisable and not already exercised) within the period of 12 months following his/her death provided
that where any of the events set out in paragraph 7.3(d), (e) and (f) occurs prior to his/her death or within such 12-month period following
his/her death, then his/her legal personal representative(s) may so exercise the Option within such of the various periods respectively
set out in such paragraphs instead of the period referred to in this paragraph 7.3(a) and provided further that if within a period of
3 years prior to the Employee Participant&rsquo;s death, the Employee Participant had committed any of the acts as specified in paragraph
8.1(d) which would have entitled the Company to terminate his/her employment prior to his/her death, the Board may at any time forthwith
terminate the Option of the Employee Participant (to the extent not already lapsed or exercised) by written notice to his/her legal personal
representatives and the Option (to the extent not already exercised) shall lapse on the date of the relevant Board resolution;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">in the event that the Grantee is an employee of the Group
when an Offer is made to him/her and he/she subsequently ceases to be an employee of the Group for any reason other than (i) his/her
death or (ii) the termination of his/her employment on one or more of the grounds specified in paragraph 8.1(d), the Option (to the extent
not already lapsed or exercised) shall lapse on the expiry of 3 months after the date of cessation of such employment (which date will
be the last actual working day on which the Grantee was physically at work with the Company or the relevant member of the Group whether
salary is paid in lieu of notice or not);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">in the event that the Grantee is an employee of the Group
when an Offer is made to him/her and he/she subsequently ceases to be an employee by reason of a termination of his/her employment on
one or more of the grounds specified in paragraph 8.1(d) and the Grantee has exercised the Option in whole or in part pursuant to paragraph
7.2, but Shares have not been allotted to him/her, the Grantee shall, unless the Board determines otherwise, be deemed not to have so
exercised such Option and the Company shall return to the Grantee the amount of the Exercise Price for the Shares in respect of the purported
exercise of such Option;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">in the event of a general offer (whether by way of takeover
offer or scheme of arrangement or otherwise in like manner) being made to all the Shareholders (or all such holders other than the offeror
and/or any persons controlled by the offeror and/or any person acting in association or concert with the offeror) the Company shall use
its best endeavours to procure that an appropriate offer is extended to all the Grantee (on comparable terms, mutatis mutandis, and assuming
that they will become, by the exercise in full of the Options granted to them, as Shareholders). If such offer becoming or being declared
unconditional, the Employee Participant (or, as the case may be, his/her legal personal representative(s)) shall, notwithstanding any
terms on which his/her Options were granted, be entitled to exercise the Option in full (to the extent not already lapsed or exercised)
at any time within 1 month after the date on which the offer becomes or is declared unconditional;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: left">in the event of a compromise or arrangement between the Company
and the Shareholders or its creditors being proposed in connection with a scheme for the reconstruction of the Company or its amalgamation
with any other company or companies pursuant to the Companies Law, the Company shall give notice thereof to all the Grantees on the same
day as it gives notice of the meeting to the Shareholders or its creditors to consider such a compromise or arrangement and the Options
(to the extent not already lapsed or exercised) granted to an Employee Participant shall become exercisable in whole or in part not later
than 2 Business Days prior to the date of the general meeting directed to be convened by the court for the purposes of considering such
compromise or arrangement (the <B>&ldquo;Suspension Date&rdquo;</B>), by giving notice in writing to the Company in accordance with paragraph
7.2, accompanied by a remittance for the full amount of the aggregate Exercise Price for the Shares in respect of which the notice is
given whereupon the Company shall as soon as practicable and, in any event, no later than 3:00 p.m. on the Business Day immediately prior
to the date of the proposed general meeting, allot and issue the relevant Shares to the Employee Participant credited as fully paid.
With effect from the Suspension Date, the rights of all Grantees to exercise their respective Options shall forthwith be suspended. Upon
such compromise or arrangement becoming effective, all Options shall, to the extent that they have not been exercised, lapse and determine.
The Board shall endeavour to procure that the Shares issued as a result of the exercise of Options under this paragraph 7.3(e) shall
for the purposes of such compromise or arrangement form part of the issued share capital of the Company on the effective date thereof
and that such Shares shall in all respects be subject to such compromise or arrangement. If for any reason such compromise or arrangement
is not approved by the court (whether upon the terms presented to the court or upon any other terms as may be approved by such court),
the rights of Employee Participants to exercise their respective Options shall with effect from the date of the making of the order by
the court be restored in full but only up to the extent not already exercised and shall thereupon become exercisable (but subject to
the other terms of this Scheme) as if such compromise or arrangement had not been proposed by the Company and no claim shall lie against
the Company or any of its officers for any loss or damage sustained by any Employee Participant as a result of such proposal, unless
any such loss or damage shall have been caused by the act, neglect, fraud or wilful default on the part of the Company or any of its
officers;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: left">in the event a notice is given by the Company to its members
to convene a general meeting for the purposes of considering, and if thought fit, approving a resolution to voluntarily wind-up the Company,
the Company shall on the same date as or soon after it despatches such notice to each member of the Company give notice thereof to all
Grantees and thereupon, each Employee Participant shall be entitled to exercise all or any of his Options (to the extent not already
lapsed or exercised) at any time not later than 2 Business Days prior to the proposed general meeting of the Company by giving notice
in writing to the Company in accordance with paragraph 7.1, accompanied by a remittance for the full amount of the aggregate Exercise
Price of the Shares in respect of which the notice is given whereupon the Company shall as soon as possible and, in any event, no later
than the Business Day immediately prior to the date of the proposed general meeting referred to above, allot the relevant Shares to the
Employee Participant credited as fully paid.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>7.4</B></TD><TD STYLE="text-align: left; padding-right: auto">The Shares to be allotted upon the exercise of an Option will be subject to all
the provisions of the memorandum of association and the Articles and the laws of the Cayman Islands from time to time and shall rank pari
passu in all respects with the then existing fully paid Shares in issue on the allotment date or, if that date falls on a day when the
register of members of the Company is closed, the first date of the re-opening of the register of members, and accordingly will entitle
the holders to participate in all dividends or other distributions paid or made on or after the allotment date or, if that date falls
on a day when the register of members of the Company is closed, the first day of the re-opening of the register of members, other than
any dividend or other distribution previously declared or recommended or resolved to be paid or made if the record date therefore shall
be before the allotment date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>7.5</B></TD><TD STYLE="text-align: left">A Share issued upon the exercise of an Option shall not carry rights until the registration of the Grantee
(or any other person) as the holder thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>7.6</B></TD><TD STYLE="text-align: left">There is no general requirement for any performance target that has to be achieved before any Option can
become vested and exercisable except as otherwise imposed by the Board (or any duly authorized committee or person by the Board) and stated
in the offer of grant of an Option.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>7.7</B></TD><TD STYLE="text-align: left">The Options may be vested over such period as determined by the Board (or any duly authorized committee
or person by the Board) in its absolute discretion. The periods over which the Options will vest shall not be less than 12 months or such
other minimum vesting periods prescribed from time to time by any laws, regulations or rules to which this Scheme may be subject, including
the Listing Rules or regulations of any stock exchange on which the Shares may be listed and quoted. Furthermore the Shares to be issued
and allotted to a Grantee pursuant to the exercise of any Option under this Scheme may or may not, at the discretion of the Board (or
any duly authorized committee or person by the Board), be subject to any retention period. An Option granted to an Employee Participant
may be subject to a shorter Vesting Period under specific circumstances which include but not limited to those as set out below:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">grants of &ldquo;make-whole&rdquo; Options to an Employee
Participant (who is a new joiner) to replace the options he forfeited when leaving his previous employer(s). In such case, the Vesting
Period may be shorter to reflect the remaining vesting period in respect of the forfeited options;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">grants of &ldquo;make-whole&rdquo; Options to an Employee
Participant who is an existing key personnel of a newly acquired Subsidiary of the Company to replace the options he forfeited upon the
acquisition of the Subsidiary by the Company. In such case, the Vesting Period may be shorter to reflect the remaining vesting period
in respect of the forfeited options;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">grants to an Employee Participant whose employment is terminated
due to retirement, death, disability, or reasons other than resignation or Cause. In such circumstance(s), the vesting of an Option may
accelerate;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">grants of Options with performance-based vesting condition(s),
in lieu of time-based vesting criteria;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: left">grants that are made in batches during a year for administrative
and compliance reasons, which may include Options that should have been granted earlier but had to wait for a subsequent batch. In such
cases, the vesting periods may be shorter to reflect the time from which an Option would have been granted;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: left">grants of Options with a mixed or accelerated vesting schedule
such as where such Options may vest evenly over a period of 12 months;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(g)</TD><TD STYLE="text-align: left">grants of Options with a total Vesting Period and holding
period of more than 12 months; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(h)</TD><TD STYLE="text-align: left">grants of Options as the year-end bonus of such Employee Participant.<SUP>1</SUP></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>8.</B></TD><TD><B>CLAWBACK MECHANISM &ndash; LAPSE OF OPTION</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>8.1</B></TD><TD STYLE="padding-right: 63.05pt">The Company can clawback an Option by treating it as lapsed automatically and not be exercisable (to
the extent not already exercised) on the earliest of &ndash;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the expiry of the Option Period;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the expiry of any of the periods referred to in paragraphs
7.3(a), (b), (d) or (f);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">subject to paragraph 7.3 (f), the date of the commencement
of the winding-up of the Company;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">in the event that the Grantee is an employee of the Group
when an Offer is made to him/her and he/she subsequently ceases to be an employee of the Group on any one or more of the grounds that
he/she has been guilty of serious misconduct, or has</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: left">The Directors and the Remuneration Committee are of the view
that the vesting period (including the circumstances in which a shorter vesting period may apply), as detailed above, enables the Company
to offer competitive remuneration and reward packages to Employee Participants, on an ad hoc basis, in such circumstances that would
be justified and reasonable, which is also consistent with the Listing Rules and the former practice of the Company and peer companies
in the Group&rsquo;s industry. In particular, Options granted as year-end bonuses to Employee Participants may have a shorter vesting
period as, despite year-end bonuses being a reward for satisfactory past performance in nature, providing year-end bonuses in the form
of Options as opposed to cash would link the value of the year-end bonuses to the future performance of the Group as well, there by encouraging
and incentivizing Employee Participants to continue committing and contributing to the development and expansion of the Group and its
business. Accordingly, the above vesting period is considered appropriate and aligns with the purpose of the Scheme. committed an act of bankruptcy
or has become insolvent or has made any arrangement or composition with his/her creditors generally, or has been convicted of any criminal
offence involving his/her integrity or honesty or (if so determined by the Board) on any other ground on which an employer would be entitled
to terminate his/her employment at common law or pursuant to any applicable laws or under the Grantee&rsquo;s service contract with the
Group, the date of cessation of his/her employment with the Group. A resolution of the Board or the board of directors of the relevant
member of the Group to the effect that employment of a Grantee has or has not been terminated on one or more of the grounds specified
in this paragraph 8.1(d) shall be conclusive and binding on the Grantee;


</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: left">the date on which the Board exercises the Company&rsquo;s
right to cancel, revoke or terminate the Option on the ground that the Grantee commits a breach of paragraph 7.1 in respect of that or
any other Option;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: left">where the Grantee is only a substantial shareholder of any
member of the Group, the date on which the Grantee ceases to be a substantial shareholder of such member of the Group;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(g)</TD><TD STYLE="text-align: left">subject to the compromise or arrangement as referred to in
paragraph 7.3(e) becoming effective, the date on which such compromise or arrangement becomes effective; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(h)</TD><TD STYLE="text-align: left">unless otherwise determined by the Board (or any duly authorized
committee or person by the Board), the performance target in relation to the exercise of any Option cannot be achieved.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>8.2</B></TD><TD STYLE="text-align: left">No compensation shall be payable upon the lapse of any Option, provided that the Board shall be entitled
in its discretion to pay such compensation to the Grantee in such manner as it may consider appropriate in any particular case.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">9.</TD><TD>MAXIMUM NUMBER OF SHARES AVAILABLE FOR SUBSCRIPTION</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Unless further approval has been obtained
pursuant to paragraphs 9.4 and subject to paragraphs 9.2, 9.5 and 9.6, the maximum number of Shares in respect of which Options under
the Scheme may be granted and yet to be exercised (including options that have been cancelled but excluding those lapsed in accordance
with the terms of the respective share schemes) is 14,907,462 Shares, representing 4.2783% of the total Shares in issue (excluding treasury
Shares) as at the Amendment Date (the <B>&ldquo;Scheme Limit&rdquo;</B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>9.1</B></TD><TD STYLE="text-align: left">The Shares which may be issued in respect of all options and awards to be granted
under this Scheme and any other share schemes of the Company (including options or awards that have been cancelled but excluding those
lapsed in accordance with the terms of the respective share schemes) shall not exceed 29,113,683 Shares (representing 10% of the number
of Shares in issue (excluding treasury Shares) on the Amendment Date) (the <B>&ldquo;Scheme Mandate Limit&rdquo;</B>).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>9.2</B></TD><TD STYLE="text-align: left">Subject to the Scheme Limit and the Scheme Mandate Limit, the maximum number of
Shares in respect of which Options under the Scheme may be granted to the Service Providers and yet to be exercised (including options
or awards have been cancelled but excluding those lapsed in accordance with the terms of the respective share schemes) is 3,483,089 Shares,
representing one per cent (1%) of the Shares in issue (excluding treasury Shares) as at the Amendment Date (the <B>&ldquo;Service Provider
Sublimit&rdquo;</B>).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>9.3</B></TD><TD STYLE="text-align: left">Subject to paragraphs 9.1 and 9.2, the Company may seek approval of the Shareholders
in general meeting for refreshing the Scheme Limit, the Scheme Mandate Limit and/or the Service Provider Sublimit every three years after
the Amendment Date or the shareholder approval date of the last refreshment, as the case may be. However, the Scheme Mandate Limit as
refreshed shall not exceed 10% of the total number of Shares in issue (excluding treasury Shares) as at the date of approval of the refreshed
scheme mandate. Any refreshment within any three year period must be approved by Shareholders subject to the following or other terms
under the applicable listing rules and laws and regulations: (i) any controlling shareholders (as defined in the Listing Rules) and their
associates (or if there is no controlling shareholders, Directors (excluding the independent non-executive Directors) and the chief executive
of the Company and their respective associates) must abstain from voting in favor of the relevant resolutions at the general meeting;
and (ii) the Company must comply with the requirement of independent shareholder approval. A circular containing the information required
under the Listing Rules shall be sent to the Shareholders in connection with the meeting at which their approval will be sought.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Thereafter, as at the Offer Date
of any proposed grant of Options, the maximum number of Shares in respect of which Options may be granted is the Scheme Limit as refreshed
less the aggregate of the following Shares as at that Offer Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the number of Shares which would be issued on the exercise
in full of the Options and options under the other schemes granted on or after the date of approval of the refreshed scheme mandate but
not cancelled, lapsed or exercised;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the number of Shares which have been issued and allotted pursuant
to the exercise of any Options or options under the other schemes granted on or after the</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">the number of Cancelled Shares, the subject of Options or
options under the other schemes granted on or after the date of approval of the refreshed scheme mandate.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>9.4</B></TD><TD STYLE="text-align: left">The Company may seek separate approval by the Shareholders in
general meeting for granting Options beyond the Scheme Limit PROVIDED THAT:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the Grantee(s) of such Option(s) must be specifically identified
by the Company before such approval is sought;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">a circular containing a generic description of the specified
Grantees who may be granted such Options, the number and terms of the Options to be granted, the purpose of granting such Options to
the Grantees with an explanation as to how the terms of Options serve such purpose and other information required by the Listing Rules
shall be sent to the Shareholders;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">the number and terms of such Options are fixed before the
general meeting of the Company at which the same are approved; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">unless provided otherwise in the Listing Rules, the date of
the Board meeting at which the Board resolves to grant the proposed Options to that Eligible Participant shall be taken as the Offer
Date for the purpose of calculating the Exercise Price.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>9.5</B></TD><TD STYLE="text-align: left">The Scheme Limit, Service Provider Sublimit and Scheme Mandate Limit referred
to in paragraphs 9.1, 9.2 and 9.3 (or as refreshed in accordance with paragraphs 9.4, as the case may be) shall be adjusted, in such manner
as the Auditors or the approved independent financial adviser shall certify to be appropriate, fair and reasonable in the event of any
alteration in the capital structure of the Company in accordance with paragraph 10 whether by way of capitalisation issue, rights issue,
sub-division or consolidation of shares or reduction of share capital of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">10.</TD><TD>CAPITAL RESTRUCTURING</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>10.1</B></TD><TD STYLE="text-align: left">In the event of any capitalisation issue, rights issue, sub-division or consolidation of shares or reduction
of capital of the Company in accordance with applicable laws and regulatory requirements, such corresponding alterations (if any) shall
be made (except on an issue of securities of the Company as consideration in a transaction which shall not be regarded as a circumstance
requiring alteration or adjustment) in:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the number of Shares subject to any outstanding Options; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the Exercise Price,</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">as
the Auditors shall certify in writing or the approved independent financial adviser shall confirm in writing (as the case may be) to
the Board to be in their opinion fair and reasonable and in compliance with the relevant provisions of the Listing Rules (or any
guideline or supplementary guidance as may be issued by the Stock Exchange from time to time) (no such certification or confirmation
is required in case of adjustment made on a capitalisation issue), provided that any such alteration shall give a Grantee as near as
possible the same proportion of the issued share capital of the Company (rounded to the nearest whole share) as (but in any event
shall not be greater than) that to which he/she/it was previously entitled and any such adjustments shall be made on the basis that
the aggregate Exercise Price payable by a Grantee on the full exercise of any Option shall remain as nearly as possible the same
(but shall not be greater than, except upon any consolidation of the Shares pursuant to this paragraph 10) it was before such event,
but no adjustment shall be made to the effect of which would be to enable a Share to be issued at less than its nominal value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The capacity
of the Auditors or the approved independent financial adviser (as the case may be) in this paragraph 10 is that of experts and not of
arbitrators and their certification or confirmation shall, in the absence of manifest error, be final, conclusive and binding on the Company
and the Grantees. The costs of the Auditors or the approved independent financial adviser (as the case may be) shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Subject to
the above principles and certification procedures, and any further or updated guidance or interpretation of the Listing Rules from time
to time, the default method of adjustment shall be made in accordance with FAQ13 &ndash; No. 1-20 and its appendix (Supplementary Guidance
on Main Board Listing Rule 17.03(13) and the Note to the Rule) (the &ldquo;<B>Supplementary Guidance</B>&rdquo;) published by the Stock
Exchange, which for the ease of reference, has been set out below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: left">In the case of a capitalization issue, bonus issue, rights
issue or open offer of shares, the Company would calculate the adjusted number of Options and adjusted exercise price by applying the
formula prescribed (and as updated from time to time) by the Stock Exchange in section I of the Supplementary Guidance, set out below:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">New number of Options = Existing Options x F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">New Exercise Price = Existing Exercise Price x 1/F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">Where</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">F =</TD><TD STYLE="text-align: center; border-bottom: Black 1pt solid; width: 0.5in">CUM</TD>
    <TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: center">TEEP</TD>
    <TD>&nbsp;</TD></TR>
                                                                                                                       </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">CUM = Closing price as shown in the Daily Quotation
Sheet of the Exchange on the last day of trading before going Ex-Entitlement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 2.5in; text-align: left">TEEP (Theoretical Ex Entitlement Price) =</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1in; text-align: center">CUM + M x R</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1 + M</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">M = Entitlement per existing Share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">R = Subscription
Price</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: left">In the case of a sub-division of shares or reduction of the
share capital, the Company would calculate the adjusted number of Options and adjusted exercise price by applying the formula prescribed
(as updated from time to time) by the Stock Exchange in section II of the Supplementary Guidance set out below:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">New number of Options = Existing Options
x F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">New Exercise Price = Existing
Exercise Price x 1/F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Where F = Subdivision or Consolidation Factor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Upon any
adjustment pursuant to paragraph 10.1, the Company shall notify the Grantees in writing the adjustments that have been made. If there
has been any alteration in the capital structure of the Company, and if the Company has not yet informed the Grantees of any necessary
adjustments to be made to their Options in accordance with the certificate of the Auditors or the confirmation of the approved independent
financial adviser (as the case may be), the Company shall, upon receipt of a notice from a Grantee in accordance with paragraph 7.1, inform
the Grantee of such alteration and shall either inform the Grantee of the adjustment to be made in accordance with the aforesaid certificate
or confirmation obtained by the Company for such purpose or, if no such certificate or confirmation has yet been obtained, inform the
Grantee of such fact and instruct the Auditors or the approved independent financial adviser as soon as practicable thereafter to issue
a certificate or provide a written confirmation in that regard in accordance with paragraph 10.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">11.</TD><TD>SUFFICIENT SHARE CAPITAL</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Subject to
paragraph 7.2, the Board shall at all times set aside for the purposes of this Scheme, out of the authorised but unissued share capital
of the Company, such number of Shares as the Board may from time to time determine to be sufficient to meet subsisting requirements for
the exercise of outstanding Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">12.</TD><TD>DISPUTES</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Any dispute
arising in connection with this Scheme (whether as to the number of Shares subject to an Option, the amount of the Exercise Price or otherwise)
shall be referred to the Auditors or the approved independent financial advisor to the Company who shall act as experts and not as arbitrators
and whose decision shall, in the absence of manifest error, be final, conclusive and binding on all persons who may be affected thereby.
The costs of the Auditors or the approved independent financial advisor to the Company shall be borne equally by the Company and the relevant
Grantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">13.</TD><TD>ALTERATION OF THIS SCHEME</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>13.1</B></TD><TD STYLE="text-align: left">Subject to paragraph 13.2 below, and the compliance with the Listing Rules, save for any alternations
to this Scheme which are of a material natural of any alterations to the provisions relating to the matters set out in Rule 17.03 of the
Listing Rule to the advantage of the Eligible Participants must be approved by the Shareholders in general meeting, the Board may amend
any of the provisions of the Scheme (including without limitation to amendments in order to comply with changes in legal or regulatory
requirements and amendments in order to waive any restrictions, imposed by the provisions of this Scheme, which are not found in Chapter
17 of the Listing Rules) at any time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>13.2</B></TD><TD STYLE="text-align: left">Subject to compliance with the Listing Rules, any change to the terms of the Options granted to a Grantee
must be approved by the Board, the Remuneration Committee, the independent non-executive Directors and/or the shareholders of the Company,
as the case may be, if the initial grant of the Options was approved by the Board, the Remuneration Committee, the independent non-executive
Directors and/or the shareholders of the Company, correspondingly. This requirement does not apply to the alterations take effect automatically
under the existing terms of this Scheme. The amended terms of this Scheme must still comply with the applicable provisions of the Listing
Rules.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>13.3</B></TD><TD STYLE="text-align: left">Notwithstanding anything to the contrary contained in paragraphs 13.1, 13.2, 13.3 and 13.4, the Board
may at any time alter or modify the Scheme in any way to the extent necessary to cause the Scheme to comply with any statutory provisions
or the regulations of any regulatory or other relevant authority. Any amendment to any terms of the Scheme or the options granted shall
comply with the relevant requirements of Chapter 17 of the Listing Rules.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">14.</TD><TD>TERMINATION</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>14.1</B></TD><TD STYLE="text-align: left">The Company by resolution in general meeting or the Board may at any time resolve to terminate the operation
of this Scheme and in such event no further Offers shall be made but the provisions of this Scheme shall remain in force to the extent
necessary to give effect to the exercise of any Option granted prior to the termination or otherwise as may be required in accordance
with the provisions of this Scheme and Options granted prior to such termination shall continue to be valid and exercisable in accordance
with this Scheme.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">15.</TD><TD>CLAWBACK MECHANISM &ndash; CANCELLATION OF OPTIONS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>15.1</B></TD><TD STYLE="text-align: left; padding-right: 0pt">Any cancellation of Options granted but not exercised may be effected on such
terms as may be agreed with the relevant Grantee, as the Board may in its absolute discretion sees fit and in a manner that complies with
all applicable legal requirements for such cancellation. Where the Company cancels Options and issues new ones to the same Grantee, the
issue of such new Options may only be made under this Scheme with available unissued Options (excluding
the cancelled Options) and in compliance with the terms of this Scheme, in particular within the limit approved by the Shareholders and,
subject to the maximum number of Shares available for subscription referred to in paragraphs 9.1, 9.2, 9.3 and 9.4.


</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>15.2</B></TD><TD STYLE="text-align: left">The Board shall be entitled for the following causes to clawback any Option by cancelling the same in
whole or in part by giving notice in writing to the Grantee stating that such Option is thereby cancelled with effect from the date specified
in such notice (the <B>&ldquo;Cancellation Date&rdquo;</B>):&ndash;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the Grantee commits or permits or attempts to commit or permit
a breach of the restriction on transferability of Option or any terms or conditions attached to the grant of the Option;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the Grantee makes a written request to the Board for the Option
to be cancelled; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">if the Grantee has, in the opinion of the Board, conducted
himself in any manner whatsoever to the detriment of or prejudicial to the interests of the Company or its Subsidiary.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>15.3</B></TD><TD STYLE="text-align: left">The Option shall be deemed to have been cancelled with effect from the Cancellation Date in respect of
any part of the Option which has not been exercised as of the Cancellation Date. No compensation shall be payable upon any such cancellation,
provided that the Board shall be entitled in its discretion to pay such compensation to the Grantee in such manner as it may consider
appropriate in any particular case.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>15.4</B></TD><TD STYLE="text-align: left">Cancelled Options will be regarded as utilized for the purpose of calculating the Scheme Mandate Limit
and the Service Provider Sublimit. Where the Company cancels Options and issues new ones to the same Grantee, the issue of such new Options
may only be made under a scheme with available unissued Options within the limit as mentioned in paragraph 9.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">16.</TD><TD>DISCLOSURE IN ANNUAL AND INTERIM REPORTS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Board
shall procure that details of this Scheme and other schemes of the Group including such details as required under the Listing Rules are
disclosed in the annual reports and interim reports of the Company in compliance with the Listing Rules in force from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">17.</TD><TD>GENERAL</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.1</B></TD><TD STYLE="text-align: left">The Company shall bear the costs of establishing and administering this Scheme (including the costs of
the Auditors or the approved independent financial advisor, as the case may be, in relation to the preparation of any certificate or the
provision of any other services in relation to this Scheme).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.2</B></TD><TD STYLE="text-align: left">A Grantee shall be entitled to inspect copies of all notices and other documents sent by the Company to
Shareholders at the same time or within a reasonable time of any such notices or documents being sent, which shall be made available to
him, during normal office hours at the Company&rsquo;s principal place of business in Hong Kong.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.3</B></TD><TD STYLE="text-align: left">Any notices, documents or other communication between the Company and a Grantee shall be in writing and
may be given by sending the same by prepaid post or by personal delivery to, in the case of the Company, its principal place of business
in Hong Kong and, in the case of the Grantee, his address in Hong Kong as notified to the Company from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.4</B></TD><TD>Any notice or other communication served:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">by the Company shall be deemed to have been served 48 hours
after the same was put in the post or if delivered by hand, when delivered; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">by the Grantee shall not be deemed to have been received until
the same shall have been received by the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.5</B></TD><TD STYLE="text-align: left">All allotments and issues of Shares pursuant to this Scheme shall be subject to any necessary consents
under the relevant laws, enactments or regulations for the time being to which the Company is subject. A Grantee shall be responsible
for obtaining any governmental or other official consent that may be required by any country or jurisdiction for, or in connection with
the grant or exercise of an Option. The Company shall not be responsible for any failure by a Grantee to obtain any such consent or for
any tax or other liability to which a Grantee may become subject as a result of his participation in this Scheme.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.6</B></TD><TD STYLE="text-align: left">This Scheme shall not confer on any person any legal or equitable rights (other than those constituting
the Options themselves) against the Company directly or indirectly or give rise to any cause of action at law or in equity against the
Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.7</B></TD><TD STYLE="text-align: left">This Scheme shall not form part of any contract of employment between the Group
and any Eligible Participant who is an employee of the Group and the rights and obligations of any Eligible Participant under the terms
of his office or employment shall not be affected by his participation in it and this Scheme shall afford such an Eligible Participant
no additional rights to compensation or damages in consequence of the termination of such office or employment for any reason.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.8</B></TD><TD STYLE="text-align: left">The Company shall maintain all necessary books of account and records relating to the Scheme.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.9</B></TD><TD STYLE="text-align: left">This Scheme shall in all respects be administered by the Board which (a) shall administer the Scheme in
accordance with the provisions hereof and all applicable requirements of the Listing Rules and (b) may make such rules not being inconsistent
with the terms and conditions hereof and the Listing Rules for the conduct of the Scheme and the determination and terms of each entitlement
under an Option as the Board thinks fit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B>17.10</B></TD><TD STYLE="text-align: left">A Grantee who is a member of the Board may, subject to and in accordance with the Articles, notwithstanding
his interest, vote on any Board resolution concerning the Scheme (other than in respect of his own participation therein) and may retain
any benefit under the Scheme. The Options do not carry any right to vote in the general meetings of the Company, or any right to dividend,
or transfer rights or any other rights whether or not arising on the liquidation of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">18.</TD><TD>GOVERNING LAW</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">This Scheme and all Options granted
hereunder are governed by and shall be construed in accordance with the laws of Hong Kong.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">-24-</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>4
<FILENAME>ea028514801ex4-8.htm
<DESCRIPTION>2021 RSU SCHEME AS AMENDED ON MAY 19, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 4.8</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RULES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ASCENTAGE PHARMA GROUP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>INTERNATIONAL</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RESTRICTED SHARE UNIT SCHEME
2021</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Adopted
on February 2, 2021 and amended on May 19, 2025</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>RULES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ASCENTAGE PHARMA GROUP INTERNATIONAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RESTRICTED SHARE UNIT SCHEME</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: left">Purpose</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The purpose
of this Scheme is to incentivize the existing and incoming directors, senior management and employees for their contribution to our Group,
to attract, motivate and retain skilled and experienced personnel to strive for the future development and expansion of the Group by providing
them with the opportunity to own equity interests in the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: left">Definitions and interpretation</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">2.1</TD><TD STYLE="text-align: left">Defined Terms</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">In these
Rules, except where the context otherwise requires, the following expressions shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Adoption
Date&rdquo; </B>means the date of the adoption of this Scheme by the Board of the Company on February 2, 2021, and not being the Amendment
Date for the avoidance of doubt;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Amendment
Date&rdquo;</B> means May 19, 2025 (the date on which amendment to this Scheme is duly conditionally approved and adopted by the Company);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Articles&rdquo;</B>
means the articles of association of the Company (as amended from time to time);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Award(s)&rdquo;</B>
means award(s) of RSUs granted to a Selected Person pursuant to this Scheme;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Award
Period&rdquo; </B>means the period during which the Award can be vested, which will be notified by the Board to each Selected Person at
the time of making an offer of any Award, which shall not be longer than ten (10) years from the Grant Date of the Award;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Auditors&rdquo;</B> means the auditors of the
Company, as appointed from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Board&rdquo;
</B>means the board of directors of the Company or a duly authorized committee thereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 23.9pt">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&ldquo;<B>Board Lot</B>&rdquo; means 100 Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Business
Day&rdquo;</B> a day (other than a Saturday or Sunday or days on which a tropical cyclone warning number 8 or above or a &ldquo;black&rdquo;
rain warning signal is hoisted in Hong Kong at any time between 9 am and 5 pm) on which the Stock Exchange is open for trading and clearing
banks in Hong Kong and the PRC are open for transactions of normal banking business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Company&rdquo;</B>
means Ascentage Pharma Group International, a company incorporated under the laws of the Cayman Islands with limited liability on November
17, 2017;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Directors&rdquo;
</B>means the directors of the Company and &ldquo;Director&rdquo; shall be construed accordingly;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Eligible
Persons&rdquo; </B>means persons eligible to receive RSUs under this Scheme, who are existing or incoming employees, directors (whether
executive or non-executive) or officers of the Company or any member of the Group or a Service Provider;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Grant
Date&rdquo;</B> means the date on which RSUs, are granted under this Scheme pursuant to a Grant Letter, as described in Rule 5.4;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Grant
Letter&rdquo;</B> means the letter pursuant to which RSUs are granted to a Selected Person, as described in Rule 5.3;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Group&rdquo;</B>
means the Company, its subsidiaries and companies whose financial results have been consolidated and accounted as the subsidiaries of
the Company by virtue of the contractual arrangements; a &ldquo;<B>member of the Group</B>&rdquo; shall mean any of the aforesaid companies;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Hong
Kong&rdquo;</B> means the Hong Kong Special Administrative Region of the People&rsquo;s Republic of China;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Listing
Date&rdquo; </B>means October 28, 2019, on which the Shares were listed and from which dealings therein were permitted to take place on
the Stock Exchange;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Listing
Rules&rdquo;</B> means the Rules Governing the Listing of Securities on the Stock Exchange, as amended from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Participant(s)&rdquo;
</B>means a Selected Person who accepts the offer of the grant of RSUs in accordance with the terms of this Scheme;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;PRC&rdquo;</B>
means the People&rsquo;s Republic of China, and for the purpose of this Scheme, exclude Hong Kong, the Macau Special Administrative Region
of the PRC and Taiwan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 23.9pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Remuneration
Committee&rdquo; </B>the remuneration committee of the Company established pursuant to the Listing Rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;RSUs&rdquo;
</B>means restricted share units, each restricted share unit represents one underlying Share, and represent a conditional right granted
to any Selected Person under this Scheme to obtain the corresponding economic value of the underlying Shares, less any tax, stamp duty
and other charges applicable, as determined by the Board in its absolute discretion;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Rules&rdquo;</B> means the rules of this Scheme
as amended from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Scheme&rdquo;</B>
means the restricted share unit scheme constituted and governed by the rules in this document, as amended from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Scheme
Period&rdquo;</B> means the period of ten (10) years commencing from the Adoption Date, or until this Scheme is terminated pursuant to
Rule 17, whichever is earlier;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Selected
Person(s)&rdquo;</B> means Eligible Persons selected by the Board to be granted RSUs under this Scheme at its discretion;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Service
Provider(s)&rdquo;</B> means any person who provides services to the Group on a continuing or recurring basis in its ordinary and usual
course of business which are in the interests of the long term growth of the Group, including: (a) supplier of goods or services to any
member of the Group; and (b) a person or entity that provides design, research, development or other support or any advisory, consultancy,
professional or other services to any member of the Group, provided that any placing agents or financial advisers providing advisory services
to the Group for fundraising, mergers or acquisitions and professional services providers such as auditors or valuers who provide assurance
or are required to perform their services with impartiality and objectivity should not be Service Providers for the purpose of the Scheme;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Service Provider Sublimit&rdquo;</B> has the
meaning scribed to it in Rule 13;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;SFO&rdquo;</B>
means the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong), as amended from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Shareholders&rdquo;</B> means the shareholders
of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Shares&rdquo;
</B>means Ordinary Shares of US$0.0001 each in the issued share capital of the Company (or of such other nominal amount as shall result
from other sub-division or a consolidation of the share capital of the Company from time to time);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Stock Exchange&rdquo;</B> means The Stock Exchange
of Hong Kong Limited;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Trustee&rdquo;</B>
means the trustee(s) to be appointed by the Board to hold Shares for the purpose of this Scheme;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Vesting
Date&rdquo;</B> means any Share held by the Trustee on behalf of a Participant pursuant to the provisions of the Rules vests in such Participant
in accordance with the vesting schedule (if any) as set out in the grant letter; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><B>&ldquo;Vesting
Notice&rdquo; </B>means a notice to be sent by the Company to each of the relevant Participants after the vesting criteria, conditions
and time schedule have been reached, fulfilled, satisfied or waived, as described in Rule 6.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>2.2</I></B></TD><TD STYLE="text-align: left">Headings are inserted for reference only and shall be ignored
in the interpretation of these Rules. Unless the context otherwise requires, references herein to Rules are to provisions of these Rules,
references to persons includes corporations and vice versa, singular includes the plural and vice versa and references to a gender shall
include all genders.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>2.3</I></B></TD><TD STYLE="text-align: left">References to any document in these Rules are to that document
as amended, consolidated, supplemented, novated or replaced from time to time.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>2.4</I></B></TD><TD STYLE="text-align: left">References to statutes, statutory provisions or the Listing
Rules shall be construed as references to those statutes, provisions or rules as respectively amended or re-enacted or as their application
is modified from time to time by other provisions (whether before or after the date of this Scheme).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: left">Duration and administration</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">3.1</TD><TD STYLE="text-align: left">Term of this Scheme</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Subject
to Rule 17, this Scheme shall be valid and effective for a period of ten (10) years, commencing on the Adoption Date, after which period
no further Awards shall be granted or accepted, but the provisions of this Scheme shall remain in full force and effect in order to give
effect to the vesting of Awards granted and accepted prior to the expiration of the Scheme Period. Awards granted hereunder shall continue
to be exercisable subject to the terms of this Scheme and in accordance with their terms of grant after the end of the ten (10) year period
until the end of the Award Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">3.2</TD><TD STYLE="text-align: left">Administration of Scheme</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Board
has the power to administer this Scheme, including the power to construe and interpret these Rules and the terms of the RSUs granted under
it. The Board may delegate the authority to administer this Scheme to a committee of the Board. The Board may also appoint one or more
independent third-party contractors to assist in the administration of this Scheme and delegate such powers and/or functions relating
to the administration of this Scheme as the Board thinks fit (the &ldquo;<B>RSU Administrator</B>&rdquo;). The Board&rsquo;s determinations
under this Scheme need not be uniform and may be made by it selectively with respect to persons who are granted, or are eligible to be
granted, RSUs under it. If a director is a Participant he may, notwithstanding his/her own interest and subject to the Articles, vote
on any Board resolution concerning this Scheme (other than in respect of his/her own participation in it), and may retain RSUs under it.
Each Participant waives any right to contest, amongst other things, the value and number of RSUs or Shares or equivalent value of cash
underlying the RSUs or Shares and the Board&rsquo;s administration of this Scheme.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">3.3</TD><TD STYLE="text-align: left">Interpretation of Scheme</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The decision
of the Board as to all matters relating to this Scheme or its interpretation or effect shall be final and binding. In particular, the
Board shall finally determine whether a person is eligible to participate in this Scheme.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">3.4</TD><TD STYLE="text-align: left">Trustee</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Company
may appoint trustee to assist with the administration and vesting of RSUs granted pursuant to this Scheme. The Company may (i) allot and
issue Shares under its available Scheme Mandate Limit to the Trustee to be held by the Trustee and which will be used to satisfy the RSUs
upon vesting and/or (ii) direct and procure the Trustee to receive existing Shares from any shareholder of the Company or purchase existing
Shares on-market to satisfy the RSUs upon vesting. The Company shall procure that sufficient funds are provided to the Trustee by whatever
means as the Board may in its absolute discretion determine to enable the Trustee to satisfy its obligations in connection with the administration
of this Scheme. All Shares underlying the RSUs granted and to be granted under the Scheme will be transferred, allotted or issued to the
Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Trustee
holding unvested Shares of the Scheme, whether directly or indirectly, shall abstain from voting on matters that require shareholders&rsquo;
approval under the Listing Rules, unless otherwise required by law to vote in accordance with the beneficial owner&rsquo;s direction and
such a direction is given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: left">Assignment of RSUs</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The RSUs
granted pursuant to this Scheme are personal to each Participant and are not assignable. Participants are prohibited from selling, transferring,
assigning, charging, mortgaging, encumbering, hedging or creating any interest in favor of any other person over or in relation to any
property held by the Trustee on trust for the Participants, the RSUs, or any interest or benefits therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.</TD><TD STYLE="text-align: left">Grant of RSUs</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.1</TD><TD STYLE="text-align: left">Basis of eligibility for RSUs</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Subject
to Rules 5.2 and 5.6, the Board may select any Eligible Person for participation in this Scheme as a Selected Person. Unless so selected,
no Eligible Person shall be entitled to participate in this Scheme. The basis of eligibility of any Selected Person for the grant of RSUs
shall be determined by the Board from time to time on the basis of their contribution to the development and growth of the Group or such
other factors as the Board may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Eligible
participants under the Scheme include (i) existing or incoming employees, directors (whether executive or non-executive) or officers of
the Company or any member of the Group, or (ii) a Service Provider. The basis of eligibility of any Selected Person for the grant of RSUs
shall be determined by the Board from time to time on the basis of their contribution to the development and growth of the Group or such
other factors as the Board may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">In determining
eligibility of existing or incoming employees, directors (whether executive or non-executive) or officers of the Company or any member
of the Group, the Board may take into account factors including, among others, (i) his/her skill, knowledge, experience, expertise and
other relevant personal qualities, (ii) educational and professional qualifications, and knowledge in the industry, (iii) performance,
length of employment with the Group, nature of duties and position within the Group, (iv) his/her adherence to the Group&rsquo;s culture
and values, or (v) the contribution and potential contribution to the development of the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Service
Providers include any consultant who are experts in research and development, clinical trials and academia who provides consultancy services
and/or other professional services to any member of the Group in connection with drug development and clinical trials in the ordinary
and usual course of business of the Group which is in the interests of the long term growth of the Group, provided that any placing agents
or financial advisers providing advisory services to the Group for fundraising, mergers or acquisitions and professional services providers
such as auditors or valuers who provide assurance or are required to perform their services with impartiality and objectivity should not
be Service Providers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">In
determining the eligibility for such consultant to be a participant of the Scheme, the Board shall, in its absolute discretion, take
into account, among others, (i) the skill, knowledge and expertise of the relevant consultant including his or her capability and
technical know-how; (ii) his or her experience and network in the pharmaceutical industry and the academia; (iii) his or her
research and development capability as well as his or her capability and know-how as to the conduct of clinical trials; (iv) the
frequency of collaboration and length of business relationship with the Group; (v) the materiality and nature of the business
relationship with the Group (such as whether they relate to the core business of the Group and whether such business dealings could
be readily replaced by third parties and the relevant replacement costs); (vi) the background, reputation and track record of the
relevant consultant; (vii) the potential and/or actual contribution to the business affairs of the Group, and in particular, whether
such consultant could bring positive impacts to the Group&rsquo;s business, such as drug development and/or commercialization, an
increase in revenue or profits or a reduction in costs attributable to or brought by services provided by such consultant; and
(viii) other factors, including but not limited to the synergy between the relevant consultant and the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.2</TD><TD STYLE="text-align: left">Offer of grant of RSUs</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Subject
to the limitations and conditions of this Scheme, the Board may, at its sole and absolute discretion, grant RSUs to any Selected Person
on such terms and conditions as the Board thinks fit, provided that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">no RSUs shall be granted after the expiry of the term of this
Scheme or after the earlier termination of this Scheme in accordance with Rule 17; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">RSUs that have lapsed in accordance with Rule 10 or for any
other reasons can be re-granted by the Board.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.3</TD><TD STYLE="text-align: left">Contents of the Grant Letter</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Upon the
grant of RSUs, a Grant Letter should be provided to the Selected Person and such Grant Letter shall address, among other things, the following
matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the Selected Person&rsquo;s name;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the manner of acceptance of the RSU;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">the number of RSUs granted and the number of underlying shares
represented by the RSUs;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">the vesting criteria and conditions;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: left">the vesting schedule; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: left">such other terms and conditions as the Board shall determine
and are not inconsistent with this Scheme.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Grant
Letter will require the Selected Person to undertake to hold the RSU on the terms on which it is granted and to be bound by the provisions
of the Scheme.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Grant
Letter shall serve as evidence of the grant of the RSUs and no further certificate shall be issued to the Selected Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.4</TD><TD STYLE="text-align: left">Acceptance of RSUs</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">A Selected
Person may accept an offer of the grant of RSUs in such manner as set out in the Grant Letter. Once accepted, the RSUs are deemed granted
from the date of the Grant Letter. Upon acceptance, the Selected Person becomes a Participant in this Scheme.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.5</TD><TD STYLE="text-align: left">Information to the Trustee</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Board
shall, after any RSUs have been granted and duly accepted by the Participant(s), inform the Trustee of the name(s) of the Participant(s),
the number of RSUs and the number of underlying Shares that can be acquired by each Participant upon vesting of the RSUs granted to each
such Participant, the vesting schedule of RSUs (if any) and other terms and conditions (if any) that RSUs are subject to as determined
by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.6</TD><TD STYLE="text-align: left">Restriction on grant of RSUs</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Board
may not grant any RSUs to any Selected Persons in any of the following circumstances:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">in any other circumstances where dealings by Selected Persons
are prohibited under the Listing Rules, SFO or any other applicable law or regulation or where the requisite approval from any applicable
regulatory authorities has not been granted, or where granting the RSUs would result in a breach by the Company, any member of our Group
or any of their directors of any applicable law or regulation;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">where such grant of RSUs would result in breach of the Scheme
Limit, the Scheme Mandate Limit or other rules of this Scheme as set out in Rule 13;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">after inside information (as defined under the Securities
and Futures Ordinance (Chapter 571 of the Laws of Hong Kong)) has come to the Company&rsquo;s knowledge until (and including) the trading
day after the Company has announced such information. In particular, during the period commencing 30 days immediately proceeding the
earlier of:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: left">the date of the meeting of the Board (as such date is first
notified to the Stock Exchange in accordance with the Listing Rules) for the approval of the Company&rsquo;s results for any year, half-year,
quarterly or any other interim period (whether or not required under the Listing Rules); and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: left">the deadline for the Company to publish an announcement of
its results for any year or half-year under the Listing Rules, or quarterly or any other interim period (whether or not required under
the Listing Rules),</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">and ending on the date of the
results announcement. The period during which no Award may be granted will cover any period of delay in the publication of a results announcement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">No grant
of Award to a Director shall be allowed during the period prohibited by the Model Code for Securities Transactions by Directors of Listed
Issuers of the Listing Rules. If any Award is proposed to be granted to a Director, it shall not be granted, accepted or vested on any
day on which the financial results of the Company are published and during the period of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: left">60 days immediately preceding the publication date of the
annual results or, if shorter, the period from the end of the relevant financial year up to the publication date of the results; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: left">30 days immediately preceding the publication date of the
quarterly results (if any) and half-year results or, if shorter, the period from the end of the relevant quarterly or half-year period
up to the publication date of the results.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.7</TD><TD STYLE="text-align: left">Grant to Directors, the Senior Management and Substantial Shareholders</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Each grant
of Awards to a Director, the chief executive or a substantial shareholder of the Company or any of their respective associates (as defined
in the Listing Rules) under this Scheme or any other share scheme of the Company or any of its subsidiaries shall be subject to approval
by the independent non-executive Directors (excluding independent non-executive Director who is a proposed recipient of the grant of Awards);
and each grant of Awards to a Director, the chief executive or a senior management of the Company or any of their respective associates
(as defined in the Listing Rules) under this Scheme or any other share scheme of the Company or any of its subsidiaries shall be subject
to the approval of the Remuneration Committee (excluding the member of the Remuneration Committee who is a proposed recipient of the grant
of Awards).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">Where any grant of Awards to the following person falls into
any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">any grant of awards to a substantial shareholder or an independent
non-executive Director or any of their respective associates would result in the Shares issued and to be issued in respect of all awards
granted (including awards that been cancelled but excluding any awards lapsed in accordance with the terms of the scheme) to such person
in the Relevant Period representing in aggregate over 0.1% (or such other percentage as may from time to time be specified by the Stock
Exchange) of the Shares in issue (excluding treasury Shares); or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">any grant of awards to a Director (other than an independent
non-executive director) or chief executive of the Company, or any of their associates would result in the Shares issued and to be issued
in respect of all awards granted (including awards that been cancelled but excluding any awards lapsed in accordance with the terms of
the scheme) to such person in the Relevant Period representing in aggregate over 0.1% (or such other percentage as may from time to time
be specified by the Stock Exchange) of the Shares in issue (excluding treasury Shares), </TD>
</TR></TABLE>








<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">such further grant of awards, as the case may
be, must be approved by the Shareholders in such manner as required under the Listing Rules. A circular containing the information required
under the Listing Rules shall be sent to the Shareholders in connection with the meeting at which their approval will be sought. The
Grantee, his or her associates and all core connected persons (as defined in the Listing Rules) of the Company must abstain from voting
in favour at such general meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">6.</TD><TD STYLE="text-align: left">Vesting of RSUs</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>6.1</I></B></TD><TD STYLE="text-align: left">The Board may determine the vesting criteria, conditions and
time schedule when the RSUs will vest and such criteria, conditions and time schedule shall be stated in the Grant Letter. The periods
over which the Awards will vest shall not be less than 12 months or such other may exceed any minimum vesting periods prescribed from
time to time by any laws, regulations or rules to which this Scheme may be subject, including the Listing Rules or regulations of any
stock exchange on which the Shares may be listed and quoted. Furthermore, the Shares to be issued and allotted to a Selected Person pursuant
to the vesting of any Award under this Scheme may or may not, at the discretion of the Board (or any duly authorized committee or person
by the Board), be subject to any retention period.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The vesting period of
Awards granted to Employee Participants (as defined under Chapter 17 of the Listing Rules) may, at the discretion of the Board (or
any duly authorized committee or person by the Board), be shorter under the following circumstances: (i) grants of
&ldquo;make-whole&rdquo; awards to new joinders to replace the share awards they forfeited when leaving their previous employers,
(ii) grant to a participant whose employment is terminated due to death or disability or occurrence of any out of control event;
(iii) grants of awards with performance-based vesting conditions, in lieu of time-based vesting criteria; (iv) grants that are made
in batches during a year for administrative and compliance reason (may include share awards that should have been granted earlier
but had to wait for a subsequent batch); (v) grant of awards with a mixed or accelerated vesting schedule such as where the awards
may vest evenly over a period of 12 months; (vi) grants of awards with a total vesting and holding period of more than 12 months;
and (vii) grant of awards as the year-end bonus of such Employee Participants.<SUP>1</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: left">The Directors and the Remuneration Committee are of the view
that the vesting period (including the circumstances in which a shorter vesting period may apply), as detailed above, enables the Company
to offer competitive remuneration and reward packages to Employee Participants, on an ad hoc basis, in such circumstances that would
be justified and reasonable, which is also consistent with the Listing Rules and the former practice of the Company and peer companies
in the Group&rsquo;s industry. In particular, Awards granted as year-end bonuses to Employee Participants may have a shorter vesting
period as, despite year-end bonuses being a reward for satisfactory past performance in nature, providing year-end bonuses in the form
of Awards as opposed to cash would link the value of the year-end bonuses to the future performance of the Group as well, thereby encouraging
and incentivizing Employee Participants to continue committing and contributing to the development and expansion of the Group and its
business. Accordingly, the above vesting period is considered appropriate and aligns with the purpose of the Scheme.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">There is no general requirement
for any performance target that has to be achieved before the vesting of any Award except as otherwise imposed by the Board (or any duly
authorized committee or person by the Board) and stated in the offer of grant of an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>6.2</I></B></TD><TD STYLE="text-align: left">Within a reasonable time after the vesting criteria, conditions
and time schedule have been reached, fulfilled, satisfied or waived, the Board shall send the Vesting Notice to each of the relevant
Participants. The Vesting Notice will confirm the extent to which the vesting criteria, conditions and time schedule have been reached,
fulfilled, satisfied or waived, and the number of Shares (and, if applicable, the cash or non-cash income, dividends or distributions
and/or the sale proceeds of non-cash and non-scrip distributions in respect of those Shares) involved.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">7.</TD><TD STYLE="text-align: left">Rights of Participants</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>7.1</I></B></TD><TD STYLE="text-align: left">An Award gives the Participant a conditional right upon vesting
of the Award to obtain (i) the number of Shares underlying such Award held by the Trustee; or (ii) an equivalent value in cash with reference
to the value of the Shares underlying such Award held by the Trustee on a date of sale (&ldquo;<B>Date of Sale</B>&rdquo;) (being a date
that the RSU Administrator determines to conduct on-market sale of such Shares once every financial year pursuant to the Scheme), less
any tax, fees, levies, stamp duty and other applicable charges.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">7.2</TD><TD STYLE="text-align: left">Rights on a takeover</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">If a general
offer to acquire the Shares (whether by takeover offer, merger, or otherwise in a like manner) is made to all of the shareholders of the
Company (or shareholders other than the offeror and/or any person controlled by the offeror and/or any person acting in concert with the
offeror) and the general offer to acquire the Shares is approved and the offer becomes or is declared unconditional in all respects, an
Employee Participant&rsquo;s RSUs will vest immediately, even if the vesting period has not yet commenced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">7.3</TD><TD STYLE="text-align: left">Rights on a compromise or arrangement</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">If a compromise
or arrangement between the Company and its shareholders or creditors is proposed in connection with a scheme for the reconstruction of
the Company or its amalgamation with any other company or companies and a notice is given by the Company to its shareholders to convene
a general meeting to consider and if thought fit approve such compromise or arrangement and such shareholders&rsquo; approval is obtained,
an Employee Participant&rsquo;s RSUs will vest immediately, even if the vesting period has not yet commenced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">7.4</TD><TD STYLE="text-align: left">Rights on voluntary winding-up</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">If
an effective resolution is passed during the Scheme Period for the voluntary winding-up of the Company (other than for the purposes of
a reconstruction, amalgamation or scheme of arrangement), all outstanding RSUs of an Employee Participant shall be treated as having
vested immediately. No Shares will be transferred, and no cash alternative will be paid, to the Participant, but the Participant will
be entitled to receive out of the assets available in liquidation on an equal basis with the Company&rsquo;s shareholders such sum as
they would have received in respect of the RSUs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">8.</TD><TD STYLE="text-align: left">Restrictive Covenants</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>8.1</I></B></TD><TD STYLE="text-align: left">By accepting any RSUs granted hereunder, a Participant shall
be deemed to have made the Restrictive Covenants set forth in this Rule 8 (including the Non-Competition Undertaking) to and for the
benefit of the Group.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>8.2</I></B></TD><TD STYLE="text-align: left">The Participant hereby undertakes to the Group that he will
not at any time whilst an employee, director, shareholder or otherwise interested in the Group (save in so far as is reasonably necessary
to fulfil his duties to the Group) or at any time thereafter, directly or indirectly use or disclose or communicate to any person any
information concerning the affairs, business methods, processes, systems, inventions, plans or research and development of the Group
or those of its customers, clients or suppliers and which may be reasonably regarded as being confidential to the Group or to such persons
(other than information which he is required to disclose by law or which is for the relevant time being in the public domain other than
by reason of wrongful disclosure of the same by him) and will use his best endeavours to prevent the publication or disclosure of any
such information by any third party.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>8.3</I></B></TD><TD STYLE="text-align: left">The Participant undertakes to the Group that he will not, except
with the prior written approval of the Company, be directly or indirectly concerned with or engaged or interested in any other business
which is in any respect in competition with or similar to the business of the Group during his employment with the Group, save that this
restriction shall not apply to any holding of Shares or other securities in the Company (the &ldquo;<B>Non-Competition Undertaking</B>&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">8.4</TD><TD STYLE="text-align: left">The Participant undertakes to the Group that, so far as permitted
under the laws of the applicable jurisdiction(s) in which the Participant is employed:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">for so long as he is employed by the Company or any other
member within the Group he will devote his full time and attention to the business of the Group and will use his best endeavours to develop
the business and interests of the Group and will not be concerned with any other (competitive or other) business; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">upon his ceasing (for any reason) to be employed by the Group
he will not for a period of two (2) years from the date he ceases to be so employed, whether on his own account or on behalf of any other
person, firm or company;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">solicit (in connection with any business of a type then carried
on by the Group) interfere with or endeavour to entice away from any member within the Group any person, firm or company who at any time
during the period of one year immediately preceding such cessation, was to his knowledge a material customer, client, supplier, agent,
distributor, or an employee (not being a junior employee) or consultant (by whatever title called) of a member within the Group;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">seek to interfere with the continuance of the supply of goods
or services to any member within the Group or the terms of any such supply; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: left">carry on, engage in or be concerned or interested either as
principal or agent or as a shareholder, partner or employee of any other person in any business or activity which involves the offer,
sale or supply of products or services to customers in the PRC or any other territory in which the Group offers such sale or supply for
the relevant time being, competes with the business in which any member within the Group is or was engaged in the twelve months prior
to the date he ceases to be employed by the Group; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: left">use or allow the use by any third party of any name, logo
or other intellectual property rights used by any member within the Group or any name or logo likely to be confused therewith otherwise
than in the conduct of the business of the Group; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(g)</TD><TD STYLE="text-align: left">deal in the Shares which would violate (i) any applicable
laws, regulations and rules in any relevant jurisdictions including, without limitation, the Securities and Futures Ordinance (Chapter
571 of the Laws of Hong Kong), other Hong Kong securities laws, and the U.S. Securities Act of 1933, as amended from time to time, and
(ii) any internal policy of the Company in connection with dealing in the Shares.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>8.5</I></B></TD><TD STYLE="text-align: left">The Participant undertakes to the Group that he shall not, during
either the course of his employment by the Group or for a period of two (2) years from the date he ceases to be employed by the Group,
make, publish, or otherwise transmit any disparaging or defamatory statements, whether written or oral, regarding the Group or its employees,
products, operations, procedures, policies, business or services.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">9.</TD><TD STYLE="text-align: left">Rights attached to RSUs and Shares</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">9.1</TD><TD STYLE="text-align: left">Rights attached to RSUs</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">A Participant
does not have any contingent interest in any Shares underlying the RSUs unless and until such Award is granted to the Participant. Further,
a Participant may not exercise voting rights in respect of the Shares underlying the RSUs prior to their vesting and, unless otherwise
specified by the Board in its entire discretion in the Grant Letter to the Participant, nor do they have any rights to any cash or non-cash
income, dividends or distributions and/or the sale proceeds of non-cash and non-scrip distributions from any Shares underlying the RSUs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">9.2</TD><TD STYLE="text-align: left">Rights attached to Shares</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Any Shares
transferred to a Participant in respect of any RSUs will be subject to all the provisions of the Articles and will rank <I>pari passu</I>
with the fully paid Shares in issue on the date of the transfer or, if that date falls on a day when the register of members of the Company
is closed, the first day of the reopening of the register of members, and accordingly will entitle the holders to participate in all dividends
or other distributions paid or made on or after the date of transfer or, if that date falls on a day when the register of members of the
Company closed, the first day of the reopening of the register of members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">10.</TD><TD STYLE="text-align: left">Clawback mechanism &ndash; Lapse of RSUs</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>10.1</I></B></TD><TD STYLE="text-align: left">The Company can clawback any unvested RSUs by treating them
as automatically lapsed immediately where:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">such Participant&rsquo;s employment or service terminates
for any reason;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">such Participant breaches any restrictive covenant set out
in Rule 8 (including but not limited to the Non-Competition Undertaking);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">the Participant makes any attempt or takes any action to sell,
transfer, assign, charge, mortgage, encumber, hedge or create any interest in favour of any other person over or in relation to any RSUs
or any interests or benefits pursuant to the RSUs; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: left">unless otherwise determined by the Board (or any duly authorized
committee or person by the Board), the performance target in relation to the vesting of any Award cannot be achieved.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">10.2</TD><TD STYLE="text-align: left">If at any time, a Participant:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">ceases to be an employee;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">fails, during the course of his employment, to devote the
whole of his time and attention to the business of the Group or to use his best endeavours to develop the business and interests of the
Group;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">is concerned during the course of his employment with the
Group (without the prior written consent of the Company) with any (competitive or other) business other than that of the Group; and/or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.25in">(d)</TD><TD STYLE="text-align: left">is in breach of his contract of employment with or any other obligation to the Group (including
                                                                                  without limitation the restrictive covenants set out in Rule 8 (including the Non-Competition Undertaking)),</TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> then the Company can clawback all
vested and unvested RSUs by treating them as automatically lapsed and such Participant shall have no claim whatsoever in respect of the
RSUs or the underlying Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">PROVIDED THAT:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: left">vested RSUs of Participants who ceased to be an employee shall
remain exercisable for three months from the date on which the cessation of their employment took effect; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: left">in the event of the automatic lapse of vested RSUs as a result
of the breach of the Non-Competition Undertaking by the Participant or any other breach of his contract of employment with or any other
obligation to the Group (the existence of such breach shall be determined by the Board at its absolute discretion), and either (a) the
number of Shares underlying such Award have already been transferred to the Participant by the Trustee; or (b) an equivalent value in
cash with reference to the value of the Shares underlying such Award held by the Trustee on the Date of Sale has already been transferred
to the Participant by the Trustee, the Trustee shall have the right to repurchase such Shares (x) at nil consideration for the underlying
Shares which are newly allotted and issued; or (y) at cost price (to be borne by the Participant and to be paid by the Trustee for and
on behalf of the Participant) for the underlying Shares transferred which are received form any shareholder of the company or purchased
by the Trustee on-market (with the cost price being the subscription price or purchase price actually paid by the Trustee), or upon the
written instruction of the Company demand the return by the Participant of the sum of the cash equivalent so transferred to him (as the
case may be). For the avoidance of doubt, the Company shall procure that sufficient funds are provided to the Trustee by whatever means
as the Board may in its absolute discretion determine to enable the Trustee to satisfy its obligations in connection with the administration
of this Scheme, including but not limited to conducting the repurchase in accordance with this Rule, and the Trustee shall have no liability
whatsoever to anyone, including but not limited to the Company and/or any Participant in the event of the Company&rsquo;s failure to
do so. The Trustee is under no obligation to conduct such repurchase unless and until the Trustee received the full price and all the
costs and expenses in connection with or arising out of such repurchase from the Company and/or the Participants.</TD>
</TR></TABLE>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">11.</TD><TD STYLE="text-align: left">Death of a Participant</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">In respect
of a Participant who dies at any time prior to or on the Vesting Date, all the unvested RSUs of the relevant Participant shall be automatically
cancelled with effect from the date on which the Participant dies. The Board may however, in its absolute discretion, determine, within
thirty (30) calendar days after the date of death, that the unvested RSUs of the relevant Employee Participant shall be vested on an accelerated
basis on terms determined by the Board. In such event, subject to the Rules, the Trustee shall hold the vested RSUs upon trust and, as
instructed by the Company, to transfer the same to the legal personal representatives of the Employee Participant (i) within three years
of the death of the Employee Participant; or (ii) within 6 months after the date the grant of representation is obtained from relevant
court (whichever is shorter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">12.</TD><TD>Clawback mechanism &ndash; Cancellation of RSUs</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>12.1</I></B></TD><TD STYLE="text-align: left">The Board shall be entitled for the following causes to clawback
any RSU by cancelling the same in whole or in part by giving notice in writing to the Participant stating that such RSU is thereby cancelled
with effect from the date specified in such notice (the &ldquo;<B>Cancellation Date</B>&rdquo;):&ndash;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: left">the Participant commits or permits or attempts to commit or
permit a breach of the restriction on transferability of RSU or any terms or conditions attached to the grant of the RSU;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: left">the Participant makes a written request to the Board for the
RSU to be cancelled; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: left">if the Participant has, in the opinion of the Board, conducted
himself in any manner whatsoever to the detriment of or prejudicial to the interests of the Company or its Subsidiary.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>12.2</I></B></TD><TD STYLE="text-align: left">The Awards shall be deemed to have been cancelled with effect
from the Cancellation Date in respect of any part of the Award which has not been vested as of the Cancellation Date. No compensation
shall be payable upon any such cancellation, provided that the Board shall be entitled in its discretion to pay such compensation to
the Participant in such manner as it may consider appropriate in any particular case.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in"><B><I>12.3</I></B></TD><TD STYLE="text-align: left">Cancelled Awards will be regarded as utilized for the purpose of calculating the
Scheme Mandate Limit and the Service Provider Sublimit. Where the Company cancels Awards and issues new ones to the same Selected Person,
the issue of such new Awards may only be made under a scheme with available unissued Awards within the limit as mentioned in Rule 13.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">13.</TD><TD STYLE="text-align: left">Maximum number of RSUs granted under this Scheme</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">13.1</TD><TD STYLE="text-align: left">Scheme Limit</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Subject
to Rule 13.2 below, no Award shall be granted pursuant to this Scheme if as a result of such grant (assumed accepted), the aggregate number
of Shares underlying all grants made pursuant to the Scheme (including Awards that been cancelled but excluding Awards that have lapsed
in accordance with the rules of the Scheme) will exceed in total 3,133,526 Shares, representing 0.8993% of the total number of Shares
in issue (excluding treasury Shares) on the Amendment Date (the &ldquo;<B>Scheme Limit</B>&rdquo;). For the avoidance of doubt, the Shares
underlying the Awards under the Scheme Limit may involve existing Shares and new Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Company
may seek separate approval by the Shareholders in general meeting for granting Awards beyond the Scheme Limit (as refreshed) PROVIDED
THAT the Selected Person(s) of such Awards must be specifically identified by the Company before such approval is sought. A circular containing
a generic description of the specified Selected Persons who may be granted such Awards, the number and terms of the Awards to be granted,
the purpose of granting such Awards to the Selected Persons with an explanation as to how the terms of Awards serve such purpose and other
information required by the Listing Rules shall be sent to the Shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">13.2</TD><TD STYLE="text-align: left">Scheme Mandate Limit</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Shares
which may be issued in respect of all Awards to be granted under this Scheme and other share schemes of the Company (including options
or awards have been cancelled but excluding those lapsed in accordance with the terms of the respective share schemes) shall not exceed
29,113,683 Shares (representing 8.3553% of the number of Shares in issue (excluding treasury Shares) on the Amendment Date) (the &ldquo;<B>Scheme
Mandate Limit</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">13.3</TD><TD STYLE="text-align: left">Service Provider Sublimit</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Subject
to the Scheme Limit and the Scheme Mandate Limit, the maximum number of Shares in respect of which Awards under the Scheme may be granted
to the Service Providers and yet to be vested (including options or awards have been cancelled but excluding those lapsed in accordance
with the terms of the respective share schemes) is 3,483,089 Shares, representing one per cent (1%) of the Shares in issue (excluding
treasury Shares) as at the Amendment Date (the &ldquo;<B>Service Provider Sublimit</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">13.4</TD><TD STYLE="text-align: left">Renewal of Scheme Limit, Scheme Mandate Limit and/or Service
Provider Sublimit</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Subject
to Rules 13.1, 13.2 and 13.3 the Company may seek approval of the Shareholders in general meeting for refreshing the Scheme Limit, the
Scheme Mandate Limit and/or the Service Provider Sublimit every three years after the Amendment Date or the shareholder approval date
of the last refreshment, as the case may be. However, the Scheme Mandate Limit as refreshed shall not exceed 10% of the total number of
Shares in issue (excluding treasury Shares) as at the Amendment Date. Any refreshment within any three year period must be approved by
shareholders of the Company subject to the following or other terms under the applicable listing rules and laws and regulations: (i) any
controlling shareholders (as defined in the Listing Rules) and their associates (or if there is no controlling shareholders, Directors
(excluding the independent non-executive Directors) and the chief executive of the Company and their respective associates) must abstain
from voting in favor of the relevant resolutions at the general meeting; and (ii) the Company must comply with the requirement of independent
shareholder approval. A circular containing the information required under the Listing Rules shall be sent to the Shareholders in connection
with the meeting at which their approval will be sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The maximum
number of Shares referred to in this Rule 13 shall be adjusted in the event of any alteration in the capital structure of the Company
in accordance with Rule 14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">13.5</TD><TD STYLE="text-align: left">Individual Limit</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The total
number of Shares issued and to be issued in respect of all the Awards granted to each Eligible Person under the Scheme and any other share
schemes of the Group (including Awards that been cancelled but excluding any Awards lapsed in accordance with the terms of Scheme or any
other share schemes of the Group) in any twelve (12) month period up to and including the date of such grant (the &ldquo;<B>Relevant Period</B>&rdquo;)
shall not exceed 1% of the Shares in issue (excluding treasury Shares) (the &ldquo;<B>Individual Limit</B>&rdquo;) from time to time.
Any further grant to a Selected Person which would result in the Shares issued and to be issued exceeding the Individual Limit shall be
subject to the Shareholders&rsquo; approval in general meeting with such Selected Persons and his or her close associates (as defined
under the Listing Rules, or his or her associate if the Selected Person is a connected person) abstaining from voting. A circular containing
the information required under the Listing Rules shall be sent to the Shareholders. The number and terms (including the subscription price)
of the Awards to be granted to such Selected Person must be fixed before the Shareholders&rsquo; approval is sought and the date of the
meeting of the Board for proposing such further grant of Awards should be taken as the Grant Date for the purpose of calculating the subscription
price, as applicable.</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">14.</TD><TD STYLE="text-align: left">Reorganization of capital structure</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">In the event
of any capitalization issue, bonus issue, rights issue, consolidation, sub-division of shares or reduction of the share capital of the
Company, the Board may make such equitable adjustments, designed to protect the Participants&rsquo; interests, to the number of Shares
underlying the outstanding RSUs or to the amount of the equivalent value, as it may deem appropriate in accordance with the guidance of
the Stock Exchange issued from time to time and as the auditors or the independent financial adviser of the Company retained for such
purpose shall certify in writing to the Board to be in their opinion fair and reasonable, PROVIDED THAT any alteration shall be made on
the basis that the proportion of the issued share capital of the Company to which a Selected Person is entitled after such alteration
shall remain the same, rounded to the nearest whole Share, as that to which he or she was entitled before such alteration, and that the
aggregate subscription price (if any) payable by a Selected Person on the full vesting of any Awards after such alteration shall remain
as nearly as possible the same (but shall not be greater than) as it was before such event, but no such alteration shall be made the effect
of which would be to enable any Share to be issued at less than its nominal value, or to give the advantage of Selected Person without
specific prior Shareholders&rsquo; approval. No adjustment will be required in circumstances where there is an issue of Shares or other
securities of the Group as consideration in a transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">In addition,
in respect of any such alteration as provided in this Rule 14 after the Amendment Date other than any made on a capitalization issue,
the auditors or the independent financial adviser of the Company retained for such purpose must confirm in writing to the Board that the
alteration satisfy the requirements of the relevant provision of the Listing Rules and any guidance letter issued by the Stock Exchange
from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The capacity
of the auditors or the independent financial adviser of the Company (as the case may be) in this Clause 14 is that of experts and not
of arbitrators and their certification shall, in the absence of manifest error, be final and binding on the Company and the Grantees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The costs
of the auditors or the independent financial adviser of the Company (as the case may be) shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">To the
extent not otherwise determined by the Board, the method of adjustment of the number of Awards to the extent outstanding is set out as
below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in">Capitalization issue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Q=Q<SUB>0</SUB>
&times; (1 + n) Where: &ldquo;Q<SUB>0</SUB>&rdquo; represents the number of Awards before the adjustment; &ldquo;n&rdquo; represents the
ratio per Share resulting from the capitalization issue; &ldquo;Q&rdquo; represents the number of Awards after the adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 23.9pt">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in">Rights issue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">Q=Q<SUB>0</SUB> &times; P<SUB>1</SUB> &times; (1 + n) &divide;
(P<SUB>1</SUB> + P<SUB>2</SUB> &times; n)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Where: &ldquo;Q<SUB>0</SUB>&rdquo;
represents the number of Awards before the adjustment; &ldquo;P<SUB>1</SUB>&rdquo; represents the closing price of the Shares as at the
record date; &ldquo;P<SUB>2</SUB>&rdquo; represents the subscription price of the rights issue; &ldquo;n&rdquo; represents the ratio of
the rights issue allotment; &ldquo;Q&rdquo; represents the number of Awards after the adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in">Consolidation of Shares or share
subdivision or reduction of the share capital</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">Q=Q<SUB>0</SUB> &times; n</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Where: &ldquo;Q<SUB>0</SUB>&rdquo;
represents the number of Awards before the adjustment; &ldquo;n&rdquo; represents the ratio of share consolidation or share subdivision
or reduction of share capital; &ldquo;Q&rdquo; represents the number of Awards after the adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">No price
adjustment shall be made to the Awards in the event of any capitalization issue, bonus issue, rights issue, consolidation, sub-division
of shares or reduction of the share capital of the Company as no price is payable for the grant of Awards and the Awards also have no
exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">15.</TD><TD STYLE="text-align: left">Disputes</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Board
shall determine any question of interpretation and settle any dispute arising under or in connection with this Scheme. In such matters,
the Board&rsquo;s decision shall be final.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">16.</TD><TD>Amendment of this Scheme</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>16.1</I></B></TD><TD STYLE="text-align: left">Subject to Rule 16.2 below and the compliance with the Listing
Rules, save for any alterations to this Scheme which are of a material natural of any alterations to the provisions relating to the matters
set out in Rule 17.03 of the Listing Rule to the advantage of the Selected Persons must be approved by the Shareholders in general meeting,
the Board may amend any of the provisions of the Scheme (including without limitation to amendments in order to comply with changes in
legal or regulatory requirements and amendments in order to waive any restrictions, imposed by the provisions of this Scheme, which are
not found in Chapter 17 of the Listing Rules) at any time.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B><I>16.2</I></B></TD><TD STYLE="text-align: left">Subject to compliance with the Listing Rules, any change to
the terms of the Awards granted to a Selected Person must be approved by the Board, the Remuneration Committee, the independent non-executive
Directors and/or the shareholders of the Company, as the case may be, if the initial grant of the Awards was approved by the Board, the
Remuneration Committee, the independent non-executive Directors and/or the shareholders of the Company, correspondingly. This requirement
does not apply to the alterations take effect automatically under the existing terms of this Scheme. The amended terms of this Scheme
must still comply with the applicable provisions of the Listing Rules.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">17.</TD><TD>Termination of this Scheme</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Board
may terminate this Scheme at any time before the expiry of the Scheme Period. The provisions of this Scheme shall remain in full force
and effect in respect of RSUs which are granted pursuant to these Rules prior to the termination of the operation of this Scheme. No further
Award shall be granted after such termination; however, all Awards granted prior to such termination and not vested on the date of termination
shall remain valid. The Company or relevant member of the Group shall notify the Trustee and all Participants of such termination and
of how any property held by the Trustee on trust for the Participants (including, but not limited to, any Shares held) and the outstanding
RSUs shall be dealt with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">18.</TD><TD>Miscellaneous</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">18.1</TD><TD STYLE="text-align: left">Costs of this Scheme</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Company
shall bear the costs of establishing and administering this Scheme. For the avoidance of doubt, all stamp duty and/or transfer tax or
duty and any other charges payable upon the transfer of the Shares to the Participant upon vesting of the RSUs shall be borne by the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">18.2</TD><TD STYLE="text-align: left">Notices</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: left">Any notice or other document which has to be given to a Selected
Person or a Participant under or in connection with this Scheme may be delivered to the Selected Person or the Participant or sent by
post or facsimile transmission or e-mail to him at his home postal address, home or work e-mail address or facsimile number according
to the records of his employing company or such other address as the Company reasonably considers appropriate.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: left">Any notice or other document which has to be given to the
Company under or in connection with this Scheme may be delivered or sent by post to it at its registered office (or such other place
as the Board may from time to time decide and notify to the Participants and/or the Trustee) or by facsimile transmission to the central
facsimile number of the Company or by e-mail.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -23.95pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(iii)</TD><TD STYLE="text-align: left">Any notice or other document which has to be given to the
Trustee under or in connection with this Scheme may be delivered or sent by post to it at its registered office (or such other place
as the Trustee may from time to time decide and notify to the Company and/or the Participants) or by facsimile transmission to the central
facsimile number of the Trustee or the work e-mail address of a designated person of the Trustee as notified by the Trustee to the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(iv)</TD><TD STYLE="text-align: left">Any notice or other document if given by a Selected Person
or a Participant shall be irrevocable and shall not be effective until actual receipt by the Trustee or the Company (as the case may
be).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(v)</TD><TD STYLE="text-align: left">Notices sent by post will be deemed to have been given by
the Company or the Trustee on the first day after the date of posting, and by the Participant on the date of receipt by the Board or
the Trustee (as the case may be). Notices served by hand will be deemed to be served when delivered.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">18.3</TD><TD STYLE="text-align: left">Responsibility for obtaining consents</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">A Participant
shall be responsible for obtaining any governmental or other official consent that may be required in order to permit the acceptance or
vesting of the RSUs. The Company and the Trustee shall not be responsible for any failure by a Participant to obtain any such consent
and shall not be liable for any cost incurred in obtaining such consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">18.4</TD><TD>Responsibility for tax etc.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Subject
to Rule 18.1, the Company and the Trustee shall not be liable for any tax or other liability to which a Participant may become subject
as a result of his or her participation in this Scheme.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">18.5</TD><TD>No other rights</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">This Scheme
shall not confer on any person any legal or equitable rights against the Company directly or indirectly or give rise to any cause of action
at law or in equity against the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">18.6</TD><TD>Discretionary Scheme</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">This Scheme
is discretionary and shall not form part of any contract (whether a contract of employment or otherwise) between the Company or any member
of the Group and any Eligible Person and/or Selected Person. The rights and obligations of any Eligible Person under the terms of his/her
office or employment shall not be affected by his participation in this Scheme. This Scheme shall give an Eligible Person no additional
rights to compensation or damages in consequence of the termination of his/her office or employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">18.7</TD><TD>Power to adopt operational rules</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Board
may from time to time adopt such operational rules as it may deem fit for the purpose of giving effect to or implementing this Scheme
(including but not limited to formulating rules which restrict the vesting of the RSUs granted or to be granted or otherwise impose restrictions
on the Participant), provided that such rules do not conflict with these Rules or contravene any of the applicable laws or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">18.8</TD><TD>Governing law and jurisdiction</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">This Scheme
and all RSUs granted under it shall be governed by and construed in accordance with Hong Kong law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">The Hong
Kong courts shall have the exclusive jurisdiction to determine any claim, dispute or difference arising out of or in connection with this
Scheme or any RSUs granted under it.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">- 23 -</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.12
<SEQUENCE>5
<FILENAME>ea028514801ex4-12.htm
<DESCRIPTION>AMENDED AND RESTATED AMENDED PATENT LICENSE AGREEMENT BETWEEN ASCENTAGE PHARMA GROUP CORP LIMITED AND THE REGENTS OF THE U2022 RSU SCHEME AS AMENDED ON MAY 19, 20252
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 4.12</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN
REDACTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES
THAT INFORMATION HAS BEEN REDACTED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">AMENDED AND RESTATED LICENSE AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">This Amended and Restated Patent License Agreement
(&ldquo;Agreement&rdquo;) is effective as of August 12, 2025 (the &ldquo;Effective Date&rdquo;), between Ascentage Pharma Group (&ldquo;LICENSEE&rdquo;)
having the address in Article 13 below, and the Regents of the University of Michigan, a constitutional corporation of the state of Michigan
(&ldquo;MICHIGAN&rdquo;). This Agreement replaces and supersedes the License Agreement- University of Michigan Files [***] between LICENSEE
and MICHIGAN with an effective date of December 1, 2010 and amended May 30, 2013, February 2, 2016, May 10, 2017, June 1, 2017, August
9, 2018, December 17, 2018, January 10, 2019 and November 30, 2020. LICENSEE and MICHIGAN agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
1 - DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.1
&ldquo;CHINA&rdquo; means mainland China, Hong Kong, Macau and Taiwan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.2
&ldquo;FIELD OF USE&rdquo; means all fields.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.3 &ldquo;FIRST
COMMERCIAL SALE&rdquo; the first invoiced sale for monetary value for use or consumption by the end user of such LICENSED PRODUCT after
regulatory approval for such LICENSED PRODUCT has been obtained in the TERRITORY and where the sale results in a recordable NET SALES
in accordance with applicable accounting standard of LICENSEE, provided that (a) any indigent patient, clinical trial or any compassionate
or named patient, charitable or humanitarian programs shall not be considered a FIRST COMMERCIAL SALE and (b) sale of a LICENSED PRODUCT
under this Agreement by a by or on behalf of LICENSEE or its Affiliates or its or their sublicensees (&ldquo;LICENSEE Party&rdquo; to
another LICENSEE PARTY shall not be considered a FIRST COMMERCIAL SALE unless such LICENSEE Party is the end user of such LICENSED PRODUCT
and such sale results in a recordable NET SALES..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.4 &ldquo;GROSS
SUBLICENSING REVENUES&rdquo; means all revenue or consideration due to LICENSEE from a SUBLICENSEE in consideration for rights under or
relating to the PATENT RIGHTS (including, but not limited to, license issue fees, maintenance or annual minimum fees, amounts based on
product sales, milestone payments, other royalties) whether received in cash or equity. GROSS SUBLICENSING REVENUES shall not include
amounts that a SUBLICENSEE pays to LICENSEE that are specifically identified for research and development, any indigent patient, or any
compassionate or named patient, charitable or humanitarian programs or where LICENSEE is the end user of such LICENSED PRODUCT and such
sale is not a recordable NET SALES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.5 &ldquo;LICENSED
PROCESS(ES)&rdquo; means any process or method that, but for this Agreement, comprises an infringement of (including contributory or inducement),
or is covered by, an issued, unexpired claim or a pending claim contained in the PATENT RIGHTS or uses a LICENSED PRODUCT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.6 &ldquo;LICENSED
PRODUCT(S)&rdquo; means any product that: (a) but for this Agreement comprises an infringement of (including contributory or inducement),
or is covered by, an issued, unexpired claim or a pending claim contained in the PATENT RIGHTS in the country in which any such product
or product part is made, used, imported, offered for sale or sold; or (b) is manufactured by using a LICENSED PROCESS or is employed to
practice a LICENSED PROCESS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">1.7 &ldquo;NCE&rdquo;
means a drug that contains no active moiety that has been approved by FDA in any other application submitted under section 505(b) of the
Federal Food, Drug, and Cosmetic Act as defined in 21 CFR 314.108.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.8 &ldquo;NET
SALES&rdquo; means the amount billed or invoiced, and if any amount is not billed or invoiced, the amounts received, on sales, rental or
lease, however characterized, by LICENSEE of LICENSED PRODUCTS and uses or licenses of LICENSED PROCESSES, less the following deductions
(but only to the extent such sums are otherwise included in NET SALES and are not obtained in view of other consideration received by
LICENSEE):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(a) cash
discounts actually granted to customers in such invoices for sales or lease of LICENSED PRODUCTS, but only in amounts customary in the
trade;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(b) sales,
tariff duties and/or use taxes separately stated in such bills or invoices with reference to particular sales and actually paid by LICENSEE
to a governmental unit;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(c) actual freight
expenses between LICENSEE and customers, to the extent such expenses are not charged to or reimbursed by customers; or</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">(d)
amounts actually refunded or credited on returns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Where LICENSEE receives any consideration
other than cash for such transactions, fair market cash value for such consideration, to be agreed upon by the parties hereto, shall be
included in NET SALES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.9 &ldquo;PATENT
RIGHTS&rdquo; means MICHIGAN&rsquo;S legal rights under the patent laws of the United States or relevant foreign countries for all of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: left">(a) the following
United States and foreign patent(s) and/or patent application(s), and divisionals, continuations (except continuations-in-part), and foreign
counterparts of the same:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">[***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: left">United
States and foreign patent(s) and/or patent application(s) (and divisionals, continuations, (except continuations-in-part), and
foreign counterparts (including, for the sake of clarity, all foreign national cases claiming priority to the identified PCT
applications of the same) which are directed to inventions disclosed to the MICHIGAN Innovation Partnerships and specifically
described and enabled in the invention reports of Innovation Partnerships designated by</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: left">(b)
United States and foreign patents issued from the applications listed in subparagraph 1.7(a) above, including any reissued or reexamined
patents based upon the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.10 ROYALTY PERIOD(S)&rdquo;
means the six-month periods ending on the last days of June and December each year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1.11 &ldquo;ROYALTY
TERM&rdquo; means until the expiration of the last to expire of the PATENT RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">1.12
&ldquo;SUBLICENSEE(S)&rdquo; means any person or entity sublicensed, or granted an option for a sublicense, by LICENSEE under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">1.13
&ldquo;TERRITORY&rdquo; means worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
2 - GRANT OF LICENSE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2.1 MICHIGAN hereby
grants to LICENSEE an exclusive license under the PATENT RIGHTS, with the right to grant sublicenses, both subject to the terms and conditions
of this Agreement, in the FIELD OF USE and the TERRITORY to make, have made, import, use, market, offer for sale and sell LICENSED PRODUCTS
and to practice LICENSED PROCESSES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2.2 Without
limiting any other rights it may have, MICHIGAN specifically reserves the right to practice the PATENT RIGHTS for research, public service,
internal (including clinical) and/or educational purposes, and the right to grant the same limited rights to other non-profit research
institutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2.3 LICENSEE agrees
that LICENSED PRODUCTS used, leased or sold in the United States shall be manufactured substantially in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2.4 The
licenses granted in this Agreement are subject to any rights required to be granted under prior research or sponsorship agreements, or
retained by the U.S. government, for example in accordance with Chapter 18 or Title 35 of U.S.C. 200-212 and the regulations thereunder
(37 CFR Part 401), when applicable. LICENSEE agrees to comply in all respects, and shall provide MICHIGAN with all reasonably requested
information and cooperation for MICHIGAN to comply with applicable provisions of the same and any requirements of any contracts between
MICHIGAN and any agency of the U.S. government that provided funding for the subject matter covered by the PATENT RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
3 - CONSIDERATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">3.1
LICENSEE shall pay royalties to MICHIGAN as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">(a)
Omitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.75in; text-indent: 0in; text-align: left">Royalty rate on Total Annual NET SALES of LICENSED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.75in; text-indent: 0in; text-align: left">PRODUCTS
on each NCE in CHINA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 40%">Annual NET SALES up to [***]</TD>
    <TD>[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES of [***]</TD>
    <TD>[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES over [***]</TD>
    <TD>[***] </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.75in; text-indent: 0in; text-align: left">Royalty rate on Total Annual NET
SALES of LICENSED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.75in; text-indent: 0in; text-align: left">PRODUCTS on each [***] in all other territories:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 40%">Annual NET SALES up to [***]</TD>
    <TD>[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES of [***]</TD>
    <TD>[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES of [ ***]</TD>
    <TD>[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES over [***]</TD>
    <TD>[***]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">LICENSEE shall pay Royalties to MICHIGAN
during the entire Royalty Term, on a LICENSED PRODUCT-by-LICENSED PRODUCT and country-by-country basis and this provision shall survive
any termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">If LICENSEE makes any NET SALES to
any party affiliated with LICENSEE, or in any way directly or indirectly related to or under the common control with LICENSEE, at a price
less than the regular price charged to other parties, the Royalties payable to MICHIGAN shall be only apply if those sales are booked
at NET SALES by LICENSEE and the Royalty shall be computed on the basis of the price paid by commercial payors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(b) LICENSEE
shall pay the following percentage of GROSS SUBLICENSING REVENUES to MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt">(1) [***] if the
sublicense agreement is signed before the FDA, or foreign equivalent, approves the LICENSEE or SUBLICENSEE&rsquo;s IND on a LICENSED PRODUCT
included in such sublicense agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt">(2) [***] if the
sublicense agreement is signed after IND but before dosing the first patient in a Phase II clinical trial conducted by LICENSEE or SUBLICENSEE
on a LICENSED PRODUCT in such sublicense agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt">(3) [***] if the
sublicense agreement is signed after dosing the first patient in a Phase II clinical trial conducted by LICENSEE or SUBLICENSEE on a LICENSED
PRODUCT in such sublicense agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">In the event that GROSS SUBLICENSING
REVENUES includes non-cash consideration (i.e., that LICENSEE enters into a sublicense in which a SUBLICENSEE is to pay LICENSEE
consideration other than cash), MICHIGAN shall receive its percentage according to the following. In each such instance, LICENSEE
shall direct and require SUBLICENSEE to directly transfer to MICHIGAN its share of the total non-cash consideration to be otherwise
transferred to LICENSEE within ten (10) days after said SUBLICENSEE transfers said non-cash consideration to LICENSEE. For example,
if a SUBLICENSEE agrees to provide consideration in the form of stock in one or more tranches, LICENSEE shall direct and require
SUBLICENSEE to directly transfer to MICHIGAN those number of shares of stock representing the appropriate percentage above by said
deadline. LICENSEE shall make such transfer pursuant to and subject in substance to the terms of the form of Stock Transfer
Agreement attached hereto as Appendix A (the &ldquo;EQUITY TRANSFER AGREEMENT&rdquo;).</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(c) LICENSEE
shall pay to MICHIGAN annual license maintenance fee (&ldquo;Annual Fee&rdquo;). This Annual Fee is accrued on June 30 of the years specified
below, and is payable with the semi-annual report for the ROYALTY PERIOD in which the Annual Fee accrues. This Annual Fee is non-creditable
and non-refundable. The Annual Fees are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD>Beginning in 2018 or in the calendar year of completion of [***] clinical trial for [***], whichever is earlier: [***];</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD>Beginning one year after [***] or 2020, whichever is earlier: [***];</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(d)
LICENSEE shall pay milestone payments as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify">[***] upon initiation of [***] trials for each [***];</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD STYLE="text-align: justify">[***] upon [***] for each [***];</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD STYLE="text-align: justify">[***] upon completion of [***] trials for each [***] in a country other than [***];</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(iv)</TD><TD STYLE="text-align: justify">[***] upon completion of [***] clinical trial for each [***] in a country other than [***]; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(v)</TD><TD STYLE="text-align: justify">[***] upon registration of each [***] in the first major geographic market other than [***].</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Milestone payments, except for registration
payment, are non-refundable and non- creditable against future royalties, with the exception that the registration payment is fully creditable
against future royalties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.2 LICENSEE shall be responsible for the
payment of all taxes, duties, levies, and other charges imposed by any taxing authority with respect to the royalties payable to
MICHIGAN under this agreement. Should LICENSEE be required under any law or regulation of any government entity or authority to
withhold or deduct any portion of the payments on royalties due to MICHIGAN, then the sum payable to MICHIGAN shall be increased by
the amount necessary to yield to MICHIGAN an amount equal to the sum it would have received had no withholdings or deductions been
made. MICHIGAN shall cooperate reasonably with LICENSEE in the event LICENSEE elects to assert, at its own expense, MICHIGAN&rsquo;s
exemption from any such tax or deduction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.3 LICENSEE
is not obligated to pay multiple Royalties if any LICENSED PRODUCT or LICENSED PROCESS is covered by more than one claim of PATENT RIGHTS
or the same LICENSED PRODUCT is covered by claims in two or more countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.4 Royalty
payments shall be made to &ldquo;The Regents of the University of Michigan&rdquo; in United States dollars. Payments drawn directly on a
U.S. bank may be made by either check to the address in Article 13 or by wire transfer. Any payment drawn on a foreign bank or foreign
branch of a U.S. bank shall be made only by wire transfer. Wire transfers shall be made in accordance with the following or any other
instructions as may be specified by [***]. In computing Royalties, LICENSEE shall convert any revenues it receives in foreign currency
into its equivalent in United States dollars at the most recent exchange rate published in the Wall Street Journal on the last business
day of the ROYALTY PERIOD during which such payments are received by LICENSEE, or at such other exchange rate as the parties may agree
to in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.5 Royalty
payments shall be made on a semi-annual basis with submission of the reports required by Article 4. All amounts due under this Agreement,
including amounts due for the payment of patent expenses, shall, if overdue, be subject to a charge of interest compounded monthly until
payment, at a per annum rate of five percent (5%) above the prime rate in effect at the JP Morgan Chase Bank, N.A. or its successor bank
on the due date (or at the highest allowed rate if a lower rate is required by law) or $250, whichever is greater. The payment of such
interest shall not foreclose MICHIGAN from exercising any other rights it may have resulting from any late payment. LICENSEE shall reimburse
MICHIGAN for the costs, including reasonable attorney fees, for expenses paid in order to collect any amounts overdue more than 120 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.6.1
Omitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.6.2
Omitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
4- REPORTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.1 Until
the FIRST COMMERCIAL SALE, LICENSEE shall provide to MICHIGAN a written annual report on or before July 30 of each year. The annual report
shall include: reports of progress on research and development, regulatory approvals, manufacturing, sublicensing, marketing and sales
during the preceding twelve (12) months, and plans for the coming year. LICENSEE also shall report to MICHIGAN the date of first sale
or lease of LICENSED PRODUCTS (or results of LICENSED PROCESSES) in each country within thirty (30) days of occurrence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.2 After the FIRST COMMERCIAL SALE,
LICENSEE shall provide semi-annual reports to MICHIGAN. By each July 30 and January 31 (i.e., within one month after each ROYALTY
PERIOD closes, including the close of the ROYALTY PERIOD immediately following any termination of this Agreement), LICENSEE shall
report to MICHIGAN for that ROYALTY PERIOD:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">(a)
number of LICENSED PRODUCTS sold, leased, or distributed, however characterized, by LICENSEE and each SUBLICENSEE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: left">(b)
NET SALES, excluding the deductions provided therefor, of LICENSED PRODUCTS sold, distributed, used, rented, leased, or licensed,
however characterized, by LICENSEE and all SUBLICENSEES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">(c) accounting for all
LICENSED PROCESSES used, sold, or licensed, however characterized, by LICENSEE and all SUBLICENSEES included in NET SALES, excluding
the deductions therefor. (d) deductions applicable as provided in the definition for NET SALES above.</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-align: left; margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(e) amounts
due on payments from SUBLICENSEE under Paragraph 3.1 above, including supporting documentation, including but not limited to any non-cash
consideration owed by SUBLICENSEE to LICENSEE.</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">(f)
foreign currency conversion rate and calculations (if applicable) and total royalties due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: left">(g)
names, addresses, and U.S.P.T.O. Entity Status (as discussed in Paragraph 4.5) of all SUBLICENSEES having a sublicense or option
therefor any time during the particular ROYALTY PERIOD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-align: left; margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(h) for
each sublicense or amendment thereto completed in the particular ROYALTY PERIOD (including agreements under which LICENSEE will have LICENSED
PRODUCTS made by a third party), the date of each agreement and amendment, the territory of the sublicense, the scope of the sublicense,
and the nature, timing and amounts of all fees and royalties to be paid thereunder.</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: left">(i)
any milestone (under Article 3 or Article 5) that has been achieved, and any milestone that was due during the ROYALTY PERIOD but not
achieved, specifying each milestone and whether or not it was achieved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">LICENSEE shall include the amount of
all payments due, and the various calculations used to arrive at those amounts, including the quantity, description (nomenclature and
type designation as described in Paragraph 4.3 below), country of manufacture and country of sale or use of LICENSED PRODUCTS and LICENSED
PROCESSES. LICENSEE shall direct its authorized representative to certify that reports required hereunder are correct to the best of LICENSEE&rsquo;s
knowledge and information. Failure to provide reports as required under this Article 4 shall be a material breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">If no payment is due, LICENSEE shall so report to MICHIGAN
that no payment is due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.3 LICENSEE
shall promptly establish and consistently employ a system of specific nomenclature and type designations for LICENSED PRODUCTS and LICENSED
PROCESSES to permit identification and segregation of various types where necessary. LICENSEE shall consistently employ, and shall require
SUBLICENSEES to consistently employ, the system when rendering invoices thereon and shall inform MICHIGAN, or its auditors, when requested,
as to the details concerning such nomenclature system, all additions thereto and changes therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.4 LICENSEE
shall keep, and shall require SUBLICENSEES to keep, true and accurate records containing data reasonably required for the computation
and verification of payments due under this Agreement. LICENSEE shall, and it shall require all SUBLICENSEES and those making LICENSED
PRODUCTS, to: (a) open such records for inspection upon reasonable notice during business hours, and no more than once per year, by either
MICHIGAN auditor(s) or an independent certified accountant selected by MICHIGAN, for the purpose of verifying the amount of payments due;
and (b) retain such records for six (6) years from date of origination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The terms of this Article shall survive
any termination of this Agreement. MICHIGAN is responsible for all expenses of such inspection, except that if any inspection reveals
an underpayment greater than five percent (5%) of royalties due MICHIGAN, then LICENSEE shall pay all expenses of that inspection and
the amount of the underpayment and interest to MICHIGAN within twenty-one (21) days of written notice thereof. LICENSEE shall also reimburse
MICHIGAN for reasonable expenses required to collect the amount underpaid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.5 So
that MICHIGAN may pay the proper U.S. Patent and Trademark Office fees relating to the PATENT RIGHTS, if LICENSEE, any company related
to LICENSEE or SUBLICENSEE (including optionees) does not qualify as a &ldquo;Small Entity&rdquo; under U.S. patent laws, LICENSEE shall
notify MICHIGAN immediately. The parties understand that the changes to LICENSEE&rsquo;s, SUBLICENSEE&rsquo;s, or optionees&rsquo; businesses that might
affect entity status include: acquisitions, mergers, hiring of a total of more than 500 total employees, sublicense agreements, and sublicense
options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.6
Affordable Access Plan. Within three (3) months of receiving FDA (or its foreign equivalent&rsquo;s) approval of a LICENSED PRODUCT,
LICENSEE will provide MICHIGAN with either (a) an Affordable Access Plan (defined below), or (b) a written explanation as to why
such an Affordable Access Plan is not needed or infeasible. In the case of (b), LICENSEE agrees to discuss such reasoning with
MICHIGAN in good faith within one (1) month thereafter (&ldquo;Initial Discussion&rdquo;) and, if following such Initial Discussion
MICHIGAN concludes an Affordable Access Plan is reasonable and desired, to provide an Affordable Access Plan to MICHIGAN within
three (3) months of such Initial Discussion. The &ldquo;Affordable Access Plan&rdquo; means LICENSEE&rsquo;S and/or its
SUBLICENSEES&rsquo; plans (including strategies and timelines) reasonably intended to support affordable access in a) Low and Middle
Income Countries as defined by the World Bank Group (&ldquo;LMICs&rdquo;), and b) vulnerable, underserved, and special needs
populations in the U.S., as defined by the Department of Health and Human Services, such as through licensing or partnerships
including with non-profit organizations. To the extent such Affordable Access Plan includes Proprietary Information, LICENSEE will
also provide a non-confidential version or statement of such Plan that MICHIGAN can make available to third parties: (a) A specified
set of (&ldquo;LMICs&rdquo;) in which the LICENSEE does not intend to commercialize the LICENSED PRODUCTS (the
&ldquo;Non-Commercialized Territory&rdquo;); (b) LICENSEE&rsquo;S and/or its SUBLICENSEES&rsquo; plans (including strategies and
timelines) reasonably intended to support affordable access in LMICs and Non-Commercialized Territories, such as through licensing
or partnerships including with non-profit organizations; and (c) LICENSEE&rsquo;S and/or its SUBLICENSEE&rsquo; plans (including
strategies and timelines) reasonably intended to support affordable access for the vulnerable, underserved and special needs
populations in the U.S. Within thirty (30) days of MICHIGAN&rsquo;s request (but no more often than once annually), LICENSEE agrees
to confer with MICHIGAN to review LICENSEE&rsquo;S progress, and to consider in good faith any modifications suggested by MICHIGAN,
with respect to its Affordable Access Plan (&ldquo;Progress Discussions&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
5 - DILIGENCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">5.1 LICENSEE
shall use commercially reasonable efforts to bring a full scope of LICENSED PRODUCTS to market or one or more LICENSED PROCESSES to commercial
use through a thorough, vigorous and diligent program for exploiting the PATENT RIGHTS and to continue active, diligent marketing efforts
throughout the life of this Agreement. LICENSEE has the responsibility to do all that is necessary to obtain and retain any governmental
approvals to manufacture and/or sell LICENSED PRODUCTS and/or use LICENSED PROCESSES for all relevant activities of LICENSEE and SUBLICENSEES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">5.2 With
respect to each Invention Report identified below and/or in any future amendment to this Agreement, LICENSEE agrees to reach the following
commercialization and research and development milestones with respect to LICENSED PRODUCTS that are covered by PATENT RIGHTS that are
added to this Agreement on or after January 1, 2024 (together the &ldquo;MILESTONES&rdquo;) by the following dates:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1. Nominate
clinical development lead compound [***] including non-GMP scale-up production, pre-formulation, non-GLP preclinical toxicity and pharmacokinetic
studies of the lead compounds completed for such selection within thirty-six (36) months after the date the of the PATENT RIGHTS covering
such [***] is added into this Agreement.</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2. IND
filing with US FDA or equivalent regulatory agency of foreign countries such as NMPA in CHINA for each NCE project, including GMP scale-up
production and GLP toxicology studies of the lead compounds completed for such selection with eighteen (18) months of selection of the
clinical development lead compounds.</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">3.
Initiate [***] trials for each [***] within twelve (12) months of [***] filing with appropriate regulatory agency.</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4. Initiate
[***] clinical trials for each [***] within twelve (12) months of successful completion of [***] trials.</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">5. Initiate
[***] clinical trials for each [***] with twelve (12) months of successful completion of [***].</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">For clarity this
Section 5.2 does not apply to any LICENSED PRODUCT associated only with a PATENT RIGHT that was included in this Agreement prior to
January 1, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">5.3 LICENSEE
must achieve each MILESTONE on or before the deadline dates indicated and MICHIGAN shall have the sole discretion to determine the validity
of a MILESTONE being reached. LICENSEE shall notify MICHIGAN within ten (10) days after each such deadline as to whether or not such MILESTONE
was met. If LICENSEE fails to meet any MILESTONE under this Article by the date of any MILESTONE deadline, LICENSEE will be deemed to
be in material breach of this Agreement, and MICHIGAN may terminate the Agreement effective on thirty (30) days notice, unless LICENSEE
achieves the MILESTONE within this thirty day period. Notwithstanding, MICHIGAN may terminate this Agreement immediately if LICENSEE fails
to achieve a MILESTONE by the indicated date and does not provide the notice to MICHIGAN referred to above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
6 - SUBLICENSING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6.1 LICENSEE
shall notify MICHIGAN in writing of every sublicense agreement and each amendment thereto within thirty (30) days after their execution,
and indicate the name of the SUBLICENSEE and its number of employees, the territory of the sublicense, the scope of the sublicense, and
the nature, timing and amounts of all fees and royalties to be paid thereunder. Upon request, LICENSEE shall provide MICHIGAN with a copy
of sublicense agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6.2 LICENSEE
shall not receive from SUBLICENSEES anything of value other than cash payments in consideration for any sublicense under this Agreement,
without the express prior written permission of MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6.3 Each
sublicense granted by LICENSEE under this Agreement shall provide for its termination upon termination of this Agreement. Each sublicense
shall terminate upon termination of this Agreement unless LICENSEE has previously assigned its rights under the sublicense to MICHIGAN
and MICHIGAN has agreed at its sole discretion in writing to such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">6.4
LICENSEE shall require that all sublicenses:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">(1)
be consistent with the terms and conditions of this Agreement;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: left">(2)
contain the SUBLICENSEE&rsquo;S acknowledgment of the disclaimer of warranty and limitation on MICHIGAN&rsquo;s liability, as provided
by Article 9 below; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(3) contain
provisions under which the SUBLICENSEE accepts duties at least equivalent to those accepted by the LICENSEE in the following Paragraphs:
4.4 (duty to keep records); 4.5 (duty regarding Patent Office fees); 9.4 (duty to avoid improper representations or responsibilities);
10.1 (duty to defend, hold harmless, and indemnify MICHIGAN); 10.3 (duty to maintain insurance); 14.5 (duty to properly mark LICENSED
PRODUCTS with patent notices); 14.7 (duty to restrict the use of MICHIGAN&rsquo;s name); 14.8 (duty to control exports).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-underline-style: thick">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
7 -PATENT APPLICATIONS AND MAINTENANCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">7.1 MICHIGAN has
the right to control all aspects of filing, prosecuting, and maintaining all of the patents and patent applications that form the basis
for the PATENT RIGHTS, interferences, and disputes (including litigation) regarding inventorship. LICENSEE shall fully cooperate in such
activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">7.2 MICHIGAN
shall notify LICENSEE of all information received by MICHIGAN relating to the filing, prosecution and maintenance of the patents and patent
applications which form the basis of the PATENT RIGHTS, and shall make reasonable efforts to allow LICENSEE to review, comment, and advise
upon such information. LICENSEE agrees to hold such information confidential and to use the information provided by MICHIGAN only for
the purpose of advancing MICHIGAN&rsquo;s PATENT RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">7.3 LICENSEE
shall reimburse MICHIGAN for all fees and costs relating to the activities described in this Article. Such reimbursement shall be made
within thirty (30) days of receipt of MICHIGAN&rsquo;s invoice and shall be subject to the interest and other requirements specified in Paragraph
3.5 above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
8 &ndash; ENFORCEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.1
Each party shall promptly advise the other in writing of any acts of potential infringement of the PATENT RIGHTS by a third party
(the &ldquo;Notice&rdquo;), and provide any evidence thereof at the request of the other party. After the Notice, LICENSEE shall use
diligent efforts to eliminate such infringement without litigation, including, if reasonable, by attempting communications with such
third party after consulting MICHIGAN. MICHIGAN&rsquo;s Innovation Partnerships shall provide reasonable assistance to advance such
efforts. Beginning at the time of the Notice, each party shall reasonably consider and discuss entering into a common interest
agreement and/or joint legal representation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.2 To the extent the described activities
do not result in the elimination of such infringement, LICENSEE shall share with MICHIGAN, subject to appropriate confidentiality
and joint privilege/common interest agreement(s) to be negotiated in good faith between the parties, the complete results of the
LICENSEE&rsquo;s diligence related to the potential infringement identified above (including, but not limited to, a detailed
infringement analysis), as may be updated from time to time. The parties shall jointly identify a strategy with respect to
addressing the infringement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.3 Subject to the other terms in this
Article and LICENSEE being in compliance with the other terms of this Agreement (unless otherwise agreed to by MICHIGAN), LICENSEE
has the right to direct that the parties enforce the PATENT RIGHTS against infringement by other parties within the TERRITORY and
the FIELD OF USE, including those prior to the EFFECTIVE DATE. LICENSEE&rsquo;s right begins upon the earlier of (a) the FIRST
COMMERCIAL SALE or (b) LICENSEE making a bona fide Investigational Device Exemption or Investigational New Drug Application (or
equivalent) filing with the United States Food and Drug Administration or equivalent agency in Europe, China, or Japan (to the
extent included within the TERRITORY). If MICHIGAN is a necessary or indispensible party under applicable law in order for a given
reasonable lawsuit to enforce the PATENT RIGHTS within the LICENSED TERRITORY and FIELD OF USE to proceed, MICHIGAN shall join in
such lawsuit, subject to the other terms of this Article. Each party may grant or delegate to third parties the right to enforce
hereunder, and within the LICENSED TERRITORY and FIELD OF USE, only with the express written permission of the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">8.4 With
respect to the filing and prosecution of infringement lawsuits, the parties agree to negotiate in good faith to jointly select lead counsel
(to be a large, nationally recognized litigation firm) and local counsel (if lead counsel does not have an office in the location of the
suit) that would represent both parties in the infringement lawsuit, each counsel to have demonstrated significant experience in the applicable
legal work. LICENSEE </FONT>shall reimburse <FONT STYLE="font-size: 10pt">MICHIGAN </FONT>for <FONT STYLE="font-size: 10pt">out-of-pocket
expenses incurred in connection with MICHIGAN&rsquo;s activities under this Article, including but not limited to outside counsel expenses
incurred prior to, during, and in the settlement of such litigation, within 30 days after receiving an invoice from MICHIGAN therefor.
Upon the determination to file suit or retain of counsel in accordance with this Article, or at any other time requested by a party, the
parties shall negotiate in good faith a written agreement consistent with the foregoing and this Agreement specifying any further reasonable
details. LICENSEE shall indemnify and hold harmless MICHIGAN with respect to any claims asserted by an alleged infringer reasonably related
to the enforcement of the PATENT RIGHTS under this Article including but not limited to antitrust counterclaims and claims for recovery
of attorney fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.5 Notwithstanding
the foregoing, LICENSEE shall not file or continue any suit without LICENSEE (a) having first performed a thorough, diligent investigation
of the merits of such suit, including with respect to the validity and enforceability of the PATENT RIGHTS; (b) having reasonable, supportable
legal and economic bases for doing so; (c) receiving notice from MICHIGAN that MICHIGAN agrees that LICENSEE&rsquo;s diligence has satisfied
MICHIGAN&rsquo;s own legal and business diligence requirements that the suit is reasonable; and (d) jointly addressing the legal representation
issues in Section 8.4 with MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.6 Each party shall diligently cooperate
with the other in litigation proceedings and other activities related to this Article. Except as provided herein, the parties shall
jointly control and consult one another with respect to any filed litigation and any counterclaims related thereto, and are
generally expected to make joint filings. The parties shall meet and confer in good faith with respect to any action, and shall
reasonably consider the other party&rsquo;s input. If there is any disagreement on strategy that is not resolved with the mediation
of outside counsel, the parties agree that, so long as lead outside counsel agrees that a position both is not unreasonable and is
allowable under court and legal rules, that: (a) LICENSEE shall have the right to control ultimate decisions on strategy matters
that are primary infringement issues, and (b) MICHIGAN shall have the right to control ultimate decisions on strategy matters that
are primarily validity and inequitable conduct issues. LICENSEE shall make any settlement only with the advice and consent of
MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.7 If there is litigation to enforce the
PATENT RIGHTS and damages are recovered in litigation or settlement thereof, the award shall be applied first to satisfy
MICHIGAN&rsquo;s and LICENSEE&rsquo;s reasonable expenses and legal fees therefor. The remaining balance shall be divided equally
between LICENSEE and MICHIGAN. (Provided, however, that if any amounts of any type whatsoever are outstanding under this Agreement
at the time of such recovery, they shall be paid directly to, or retained by, MICHIGAN from the amounts otherwise payable to
LICENSEE under the prior sentence.) For clarity, the damages, expenses, and legal fees are only those that are for the PATENT
RIGHTS, but not other patents. The parties hereto agree to negotiate a resolution in good faith should any such damages or
recoveries be related to patents other than the PATENT RIGHTS. This provision shall control the division of revenues where a
sublicense, covenant not to sue, or assignment of rights is granted as part of a settlement of such lawsuit (including prospective
rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-decoration: underline solid">ARTICLE 9-NO
WARRANTIES; LIMITATION ON MICHIGAN&rsquo;S LIABILITY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">9.1 MICHIGAN,
including its Regents, fellows, officers, employees and agents, makes no representations or warranties that PATENT RIGHTS are or will
be held valid or enforceable, or that the manufacture, importation, use, offer for sale, sale or other distribution of any LICENSED PRODUCTS
or LICENSED PROCESSES will not infringe upon any patent or other rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">9.2 MICHIGAN<B>,
</B>INCLUDING ITS REGENTS, FELLOWS, OFFICERS, EMPLOYEES AND AGENTS, MAKES NO REPRESENTATIONS, EXTENDS NO WARRANTIES OF ANY KIND, EITHER
EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, AND ASSUMES
NO RESPONSIBILITIES WHATEVER WITH RESPECT TO DESIGN, DEVELOPMENT, MANUFACTURE, USE, SALE OR OTHER DISPOSITION BY LICENSEE OR SUBLICENSEES
OF LICENSED PRODUCTS OR LICENSED PROCESSES<B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: left">9.3
LICENSEE AND SUBLICENSEES ASSUME THE ENTIRE RISK AS TO PERFORMANCE OF LICENSED PRODUCTS AND LICENSED PROCESSES<B>.</B> In no event
shall MICHIGAN, including its Regents, fellows, officers, employees and agents, be responsible or liable for any direct, indirect,
special, incidental, or consequential damages or lost profits or other economic loss or damage with respect to LICENSED PRODUCTS or
LICENSED PROCESSES, to LICENSEE, SUBLICENSEES or any other individual or entity regardless of legal or equitable theory. The above
limitations on liability apply even though MICHIGAN, its Regents, fellows, officers, employees or agents may have been advised of
the possibility of such damage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">9.4 LICENSEE
shall not, and shall require that its SUBLICENSEES do not, make any statements, representations or warranties whatsoever to any person
or entity, or accept any liabilities or responsibilities whatsoever from any person or entity that are inconsistent with any disclaimer
or limitation included in this Article 9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
10 - INDEMNITY; INSURANCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">10.1 LICENSEE shall defend, indemnify and
hold harmless and shall require SUBLICENSEES to defend, indemnify and hold harmless MICHIGAN, including its Regents, fellows,
officers, employees, students, and agents, for and against any and all claims, demands, damages, losses, and expenses of any nature
(including attorneys&rsquo; fees and other litigation expenses), resulting from, but not limited to, death, personal injury,
illness, property damage, economic loss or products liability arising from or in connection with, any of the following: (1) Any
manufacture, use, sale or other disposition by LICENSEE, SUBLICENSEES or transferees of LICENSED PRODUCTS or LICENSED PROCESSES; (2)
The use by any person of LICENSED PRODUCTS made, used, sold or otherwise distributed by LICENSEE or SUBLICENSEES; and (3) The use or
practice by LICENSEE or SUBLICENSEES of any invention or computer software related to the PATENT RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">10.2 MICHIGAN
is entitled to participate at its option and expense through counsel of its own selection, and may join in any legal actions related to
any such claims, demands, damages, losses and expenses under Paragraph 10.1 above. LICENSEE shall not settle any such legal action with
an admission of liability of MICHIGAN without MICHIGAN&rsquo;s written approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">10.3 Prior to any distribution or
commercial use of any LICENSED PRODUCT or use of any LICENSED PROCESS by LICENSEE, LICENSEE shall purchase and maintain in effect
commercial general liability insurance, including product liability insurance and errors and omissions insurance which shall protect
LICENSEE and MICHIGAN with respect the events covered by Paragraph 10.1. Prior to any distribution or use of any LICENSED PRODUCT or
use of any LICENSED PROCESS by a SUBLICENSEE, LICENSEE shall require that the SUBLICENSEE purchase and maintain in effect commercial
general liability insurance, including product liability insurance and errors and omissions insurance which shall protect LICENSEE,
SUBLICENSEE, and MICHIGAN with respect to the events covered by Paragraph 10.1. Each such insurance policy must provide reasonable
coverage for all claims with respect to any LICENSED PROCESS used and any LICENSED PRODUCTS manufactured, used, sold, licensed or
otherwise distributed by LICENSEE -- or, in the case of a SUBLICENSEE&rsquo;s policy, by said SUBLICENSEE -- and must specify
MICHIGAN, including its Regents, fellows, officers and employees, as an additional insured. LICENSEE shall furnish certificate(s) of
such insurance to MICHIGAN, upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: left">10.4
In no event shall either party hereunder be liable to the other for any special, indirect, or consequential damages of any kind whatsoever
resulting from any breach or default of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
11 -TERM AND TERMINATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.1 If
LICENSEE ceases to carry on its business, this Agreement shall terminate upon written notice by MICHIGAN attempted to be delivered to
the address for notices provided in Article 13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.2 If
LICENSEE fails to make any payment due to MICHIGAN, upon ten (10) days&rsquo; written notice by MICHIGAN, this Agreement shall automatically
terminate unless MICHIGAN specifically extends such date in writing. Such termination shall not foreclose MICHIGAN from collection of
any amounts remaining unpaid or seeking other legal relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.3 Upon any material breach or default of
this Agreement by LICENSEE (other than as specifically provided herein, the terms of which shall take precedence over the handling
of any other material breach or default under this Paragraph), MICHIGAN has the right to terminate this Agreement effective on
thirty (30) days&rsquo; written notice to LICENSEE. Such termination shall become automatically effective upon expiration of the
thirty day period unless LICENSEE cures the material breach or default before the period expires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.4 LICENSEE
has the right to terminate this Agreement at any time on ninety (90) days&rsquo; written notice to MICHIGAN if LICENSEE first:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">(a)
pays all amounts due MICHIGAN through the effective date of the termination;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">(b)
submits a final report of the type described in Paragraph 4.2;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(c) returns
any patent documentation (including that exchanged under Article 7) and any other confidential or trade-secret materials provided to LICENSEE
by MICHIGAN in connection with this Agreement, or, with prior approval by MICHIGAN, destroys such materials, and certifies in writing
that such materials have all been returned or destroyed;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(d) suspends
its manufacture, use and sale of the LICENSED PROCESS(ES) AND LICENSED PRODUCT(S);</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(e) provides
MICHIGAN with all data and know-how developed by LICENSEE in the course of LICENSEE&rsquo;s efforts to develop LICENSED PRODUCTS and LICENSED
PROCESSES; MICHIGAN shall have the right to use such data and know-how for any purpose whatsoever, including the right to transfer same
to future licensees; and</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: left">(f)
provides MICHIGAN access to any regulatory information filed with any U.S. or foreign government agency with respect to LICENSED
PRODUCTS and LICENSED PROCESSES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Upon notice of intent to terminate,
MICHIGAN may elect to immediately terminate this Agreement upon written notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.5 Upon
any termination of this Agreement, and except as provided herein to the contrary, all rights and obligations of the parties hereunder
shall cease, except any previously accrued rights and obligations and further as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(1) obligations
to pay royalties and other sums, or to transfer equity or other consideration, accruing hereunder up to the day of such termination, whether
or not this Agreement provides for a number of days before which actual payment is due and such date is after the day of termination;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: left; margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(2) MICHIGAN&rsquo;s
rights to inspect books and records as described in Article 4, and LICENSEE&rsquo;s obligations to keep such records for the required time;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: left">(3)
any cause of action or claim of LICENSEE or MICHIGAN accrued or to accrue because of any breach or default by the other party
hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0pt; text-align: justify">(4)
the provisions of Articles I, 9, 10, and 14; and</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(5) all other terms,
provisions, representations, rights and obligations contained in this Agreement that by their sense and context are intended to survive
until performance thereof by either or both parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.6 After
the license(s) granted herein terminate, if LICENSEE has filed patent applications or obtained patents to any modification or improvement
to LICENSED PRODUCTS or LICENSED PROCESSES within the scope of the PATENT RIGHTS, LICENSEE agrees upon request to enter into good faith
negotiations with MICHIGAN or MICHIGAN&rsquo;s future licensee(s) for the purpose of granting licensing rights to said modifications or improvements
in a timely fashion and under commercially reasonable terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.7 If
LICENSEE asserts the invalidity or unenforceability of any claim included in the PATENT RIGHTS, including by way of litigation or administrative
proceedings, either directly or through any other party, then MICHIGAN shall have the right to immediately terminate this Agreement upon
written notice to LICENSEE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
12 - REGISTRATION AND RECORDATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">12.1 If
the terms of this Agreement, or any assignment or license under this Agreement are or become such as to require that the Agreement or
license or any part thereof be registered with or reported to a national or supranational agency, LICENSEE will, at its expense, undertake
such registration or report. Prompt notice and appropriate verification of the act of registration or report or any agency ruling resulting
from it will be supplied by LICENSEE to MICHIGAN upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">12.2 LICENSEE
shall also carry out, at its expense, any formal recordation of this Agreement or any license herein granted that the law of any country
requires as a prerequisite to enforceability of the Agreement or license in the courts of any such country or for other reasons, and shall
promptly furnish to MICHIGAN appropriately verified proof of recordation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
13 - NOTICES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">13.1 Any notice, request, or report
required or permitted to be given or made under this Agreement by either party is effective when mailed if sent by recognized overnight
carrier, certified or registered mail, or electronic mail followed by confirmation by U.S. mail, to the address set forth below or such
other address as such party specifies by written notice given in conformity herewith. Any notice, request, or report not so given is not
effective until actually received by the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%">
  <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 46%; text-align: left">To MICHIGAN:</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify">To LICENSEE:</TD></TR>
  <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><P STYLE="margin-top: 0; margin-bottom: 0">The University of Michigan</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">Innovation Partnerships &nbsp;</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">1600 Huron Parkway</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">Building 520 2<SUP>nd</SUP> Floor</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">Ann Arbor, MI 48109</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">Attn: [***]</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">Ascentage Pharma Group Corp. Ltd.</P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0">Unit B,17/F., United Centre, 95 Queensway,</P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0">Admiralty, Hong
Kong</P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0">Attn: Dajun Yang, President and CEO</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
14 - MISCELLANEOUS PROVISIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.1 This
Agreement shall be construed, governed, interpreted and applied according to United States and state of Michigan law, except that questions
affecting the construction and effect of any patent shall be determined by the law of the country in which the patent was granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.2 The
parties hereby consent to the jurisdiction of the courts in the state of Michigan over any dispute concerning this Agreement or the relationship
between the parties. Should LICENSEE bring any claim, demand or other action against MICHIGAN, its Regents, fellows, officers, employees
or agents, arising out of this Agreement or the relationship between the parties, LICENSEE agrees to bring said action only in the Michigan
Court of Claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.3 MICHIGAN
and LICENSEE agree that this Agreement sets forth their entire understanding concerning the subject matter of this Agreement. The parties
may amend this Agreement from time to time, but no modification will be effective unless both MICHIGAN and LICENSEE agree to it in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.4 If a court
of competent jurisdiction finds any term of this Agreement invalid, illegal or unenforceable, that term will be curtailed, limited or
deleted, but only to the extent necessary to remove the invalidity, illegality or unenforceability, and without in any way affecting or
impairing the remaining terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.5 LICENSEE
agrees to mark the LICENSED PRODUCTS sold in the United States with all applicable United States patent numbers. All LICENSED PRODUCTS
shipped to or sold in other countries shall be marked to comply with the patent laws and practices of the countries of manufacture, use
and sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.6 No
waiver by either party of any breach of this Agreement, no matter how long continuing or how often repeated, is a waiver of any subsequent
breach thereof, nor is any delay or omission on the part of either party to exercise or insist on any right, power, or privilege hereunder
a waiver of such right, power or privilege. In no event shall any waiver be deemed valid unless it is in writing and signed by an authorized
representative of each party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.7 LICENSEE
agrees to refrain from using and to require SUBLICENSEES to refrain from using the name of MICHIGAN in publicity or advertising without
the prior written approval of MICHIGAN. Reports in scientific literature and presentations of joint research and development work are
not publicity. Notwithstanding this provision, without prior written approval of MICHIGAN, LICENSEE and SUBLICENSEES may state publicly
that LICENSED PRODUCTS and PROCESSES were developed by LICENSEE based upon an invention(s) developed at the University of Michigan and/or
that the PATENT RIGHTS were licensed from the University of Michigan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.8 LICENSEE
agrees to comply with all applicable laws and regulations. In particular, LICENSEE understands and acknowledges that the transfer of certain
commodities and technical data is subject to United States laws and regulations controlling the export of such commodities and technical
data, including all Export Administration Regulations of the United States Department of Commerce. These laws and regulations prohibit
or require a license for the export of certain types of technical data to certain specified countries. LICENSEE agrees to comply with
all United States laws and regulations controlling the export of commodities and technical data, to be solely responsible for any violation
of such laws and regulations by LICENSEE or its SUBLICENSEES, and to defend, indemnify and hold harmless MICHIGAN and its Regents, fellows,
officers, employees and agents if any legal action of any nature results from the violation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.9 The
relationship between the parties is that of independent contractor and contractee. Neither party is an agent of the other in connection
with the exercise of any rights hereunder, and neither has any right or authority to assume or create any obligation or responsibility
on behalf of the other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.10 LICENSEE
may not assign this Agreement without the prior written consent of MICHIGAN and shall not pledge any of the license rights granted in
this Agreement as security for any creditor. Any attempted pledge of any of the rights under this Agreement or assignment of this Agreement
without the prior consent of MICHIGAN will be void from the beginning. No assignment by LICENSEE will be effective until the intended
assignee agrees in writing to accept all of the terms and conditions of this Agreement, and such writing is provided to MICHIGAN. Notwithstanding,
LICENSEE may, without MICHIGAN&rsquo;s consent, assign its rights under this Agreement to a purchaser of all or substantially all of LICENSEE&rsquo;s
business relating to the subject matter of this Agreement, so long as such assignee provides a statement in writing to MICHIGAN that it
agrees to accept all the terms and conditions of this Agreement in the place of LICENSEE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.11 If
during the term of this Agreement, LICENSEE makes or attempts to make an assignment for the benefit of creditors, or if proceedings in
voluntary or involuntary bankruptcy or insolvency are instituted on behalf of or against LICENSEE, or if a receiver or trustee is appointed
for the property of LICENSEE, this Agreement shall automatically terminate. LICENSEE shall notify MICHIGAN of any such event mentioned
in this Paragraph as soon as reasonably practicable, and in any event within five (5) days after any such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-decoration: underline solid">ARTICLE
15 - CONFLICT OF INTEREST MANAGEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">15.1 This
Agreement and the licenses granted hereunder are subject to approval by a two- thirds majority vote of the Regents of the University of
Michigan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">15.2 Unless MICHIGAN provides appropriate formal
approvals, continuing development of LICENSED PRODUCTS and LICENSED PROCESSES will take place without the use of MICHIGAN funds, facilities,
or other resources of or funds administered by MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">15.3 LICENSEE shall
cooperate with MICHIGAN in developing and implementing appropriate plans for management of potential conflicts of interest and conflicts
of commitment of MICHIGAN employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">IN WI1NESS WHEREOF, the parties hereto
have executed this Agreement in duplicate originals by their duly authorized officers or representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">For:</TD>
    <TD STYLE="width: 35%">LICENSEE</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 5%">For:</TD>
    <TD STYLE="width: 35%">The Regents of the University of Michigan</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/S/ Dajun Yang, M.D., Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/S/ Bryce Pilz</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(authorized representative)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"></TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Chairman &amp; CEO</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>Date:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Date:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">[***]</TD><TD STYLE="text-align: right; width: 50%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>APPENDIX A TO LICENSE <BR>
AGREEMENT</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EQUITY TRANSFER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AGREEMENT BETWEEN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>[NAME OF LICENSEE]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AND THE REGENTS OF THE UNIVERSITY OF MICHIGAN</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.13
<SEQUENCE>6
<FILENAME>ea028514801ex4-13.htm
<DESCRIPTION>LICENSE AGREEMENT BETWEEN ASCENTAGE PHARMA GROUP CORP LIMITED AND THE REGENTS OF THE UNIVERSITY OF MICHIGAN, DATED AS OF DECEMBER AUGUST 12, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-align: right; text-indent: 0pt"><B>Exhibit 4.13</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-align: right; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-indent: 0pt"><B>CERTAIN INFORMATION
IN THIS EXHIBIT HAS BEEN REDACTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
[***] INDICATES THAT INFORMATION HAS BEEN REDACTED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; text-align: center">LICENSE AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-indent: 0pt">This License Agreement (&ldquo;Agreement&rdquo;)
is effective as of August 12, 2025 (the &ldquo;Effective Date&rdquo;), between Ascentage Pharma Group (&ldquo;LICENSEE&rdquo;) having the
address in Article 13 below, and the Regents of the University of Michigan, a constitutional corporation of the state of Michigan (&ldquo;MICHIGAN&rdquo;).
MICHIGAN and the LICENSEE are collectively</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt">referred to herein as the &ldquo;PARTIES&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-indent: 0pt">WHEREAS, the LICENSEE wishes to acquire
rights to PATENT RIGHTS directed to inventions listed in Exhibit A, including the right to provide such licenses to third parties;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-indent: 0pt">WHEREAS, the PARTIES discussed differing
structures for the payment of royalties hereunder, however for the convenience of the parties in measuring the value of the licenses granted
herein, the PARTIES have negotiated the combination of fees and percentage of net sales (including the royalty base and rate provided
below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 3.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">NOW THEREFORE, in consideration of
the mutual covenants contained herein, and for other good and valuable consideration, the amount and sufficiency of which are hereby acknowledged,
the PARTIES hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 3.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
1 - DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.75pt; text-indent: -35.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.1
&ldquo;CHINA&rdquo; means mainland China, Hong Kong, Macau and Taiwan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.2
&ldquo;FIELD OF USE&rdquo; means all fields.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.3 &ldquo;FIRST
COMMERCIAL SALE&rdquo; the first invoiced sale for monetary value for use or consumption by the end user of such LICENSED PRODUCT after
regulatory approval for such LICENSED PRODUCT has been obtained in the TERRITORY and where the sale results in a recordable NET SALES
in accordance with applicable accounting standard of LICENSEE, provided that (a) any indigent patient, clinical trial or any compassionate
or named patient, charitable or humanitarian programs shall not be considered a FIRST COMMERCIAL SALE and (b) sale of a LICENSED PRODUCT
under this Agreement by or on behalf of LICENSEE or its Affiliates or its or their sublicensees (&ldquo;LICENSEE PARTY&rdquo; to another
LICENSEE PARTY shall not be considered a FIRST COMMERCIAL SALE unless such LICENSEE Party is the end user of such LICENSED PRODUCT and
such sale results in a recordable NET SALES..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.4 &ldquo;GROSS SUBLICENSING
REVENUES&rdquo; means all revenue or consideration due to LICENSEE from a SUBLICENSEE in consideration for rights under or relating
to the PATENT RIGHTS (including, but not limited to, license issue fees, maintenance or annual minimum fees, amounts based on
product sales, milestone payments, other royalties) whether received in cash or equity. GROSS SUBLICENSING REVENUES shall not
include amounts that a SUBLICENSEE pays to LICENSEE that are specifically identified for research and development, any indigent
patient, or any compassionate or named patient, charitable or humanitarian programs or where LICENSEE is the end user of such
LICENSED PRODUCT and such sale is not a recordable NET SALES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.5 &ldquo;LICENSED
PROCESS(ES)&rdquo; means any process or method that, but for this Agreement, comprises an infringement of (including contributory or inducement),
or is covered by, an issued, unexpired claim or a pending claim contained in the PATENT RIGHTS or uses a LICENSED PRODUCT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.6 &ldquo;LICENSED
PRODUCT(S)&rdquo; means any product that: (a) but for this Agreement comprises an infringement of (including contributory or inducement),
or is covered by, an issued, unexpired claim or a pending claim contained in the PATENT RIGHTS in the country in which any such product
or product part is made, used, imported, offered for sale or sold; or (b) is manufactured by using a LICENSED PROCESS or is employed to
practice a LICENSED PROCESS; or (c) is not a &ldquo;LICENSED PRODUCT&rdquo; under subparagraph (a) or (b) of this Paragraph 1.6, but is
covered by an issued, but expired, claim in PATENT RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.7 &ldquo;NCE&rdquo;
means a drug that contains no active moiety that has been approved by FDA in any other application submitted under section 505(b) of the
Federal Food, Drug, and Cosmetic Act as defined in 21 CFR 314.108.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.3pt; text-indent: 0.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.8 &ldquo;NET
SALES&rdquo; means the amount billed or invoiced, and if any amount is not billed or invoiced, the amounts received, on sales, rental or
lease, however characterized, by LICENSEE of LICENSED PRODUCTS and uses or licenses of LICENSED PROCESSES, less the following deductions
(but only to the extent such sums are otherwise included in NET SALES and are not obtained in view of other consideration received by
LICENSEE):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">(a) cash
discounts actually granted to customers in such invoices for sales or lease of LICENSED PRODUCTS, but only in amounts customary in the
trade;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">(b) sales,
tariff duties and/or use taxes separately stated in such bills or invoices with reference to particular sales and actually paid by LICENSEE
to a governmental unit;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">(c) actual freight
expenses between LICENSEE and customers, to the extent such expenses are not charged to or reimbursed by customers; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">(d)
amounts actually refunded or credited on returns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">Where LICENSEE receives any consideration
other than cash for such transactions, fair market cash value for such consideration, to be agreed upon by the parties hereto, shall be
included in NET SALES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.9 &ldquo;PATENT
RIGHTS&rdquo; means MICHIGAN&rsquo;S legal rights under the patent laws of the United States or relevant foreign countries for all of the following:</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.65pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">(a) the following
United States and foreign patent(s) and/or patent application(s) as listed in Exhibit A, and divisionals, continuations (except continuations-in-part),
and foreign counterparts of the same:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.65pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">United States and foreign patent(s)
and/or patent application(s) (and divisionals, continuations, (except continuations-in-part), and foreign counterparts (including, for
the sake of clarity, all foreign national cases claiming priority to the identified PCT applications of the same) which are directed to
inventions disclosed to the MICHIGAN Innovation Partnerships and specifically described and enabled in the invention reports of Innovation
Partnerships as listed in Exhibit A;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">(b)
United States and foreign patents issued from the applications listed in subparagraph 1.7(a) above, including any reissued or reexamined
patents based upon the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.10 ROYALTY PERIOD(S)&rdquo;
means the six-month periods ending on the last days of June and December each year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.11 &ldquo;ROYALTY
TERM&rdquo; means until the later of (a) expiration of the last to expire of the PATENT RIGHTS; or (b) the tenth (10th) anniversary of
the FIRST COMMERCIAL SALE of a LICENSED PRODUCT unless sooner terminated as provided in another specific article of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54.35pt; text-indent: -0.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.12
&ldquo;SUBLICENSEE(S)&rdquo; means any person or entity sublicensed, or granted an option for a sublicense, by LICENSEE under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">1.13
&ldquo;TERRITORY&rdquo; means worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.25pt; text-align: center"><FONT STYLE="text-underline-style: thick">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
2 - GRANT OF LICENSE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">2.1 MICHIGAN
hereby grants to LICENSEE an exclusive license under the PATENT RIGHTS, with the right to grant sublicenses, both subject to the terms
and conditions of this Agreement, in the FIELD OF USE and the TERRITORY to make, have made, import, use, market, offer for sale and sell
LICENSED PRODUCTS and to practice LICENSED PROCESSES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.9pt; text-indent: 3.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">2.2 Without
limiting any other rights it may have, MICHIGAN specifically reserves the right to practice the PATENT RIGHTS for research, public service,
internal (including clinical) and/or educational purposes, and the right to grant the same limited rights to other non-profit research
institutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">2.3 LICENSEE agrees
that LICENSED PRODUCTS used, leased or sold in the United States shall be manufactured substantially in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">2.4 The
licenses granted in this Agreement are subject to any rights required to be granted under prior research or sponsorship agreements, or
retained by the U.S. government, for example in accordance with Chapter 18 or Title 35 of U.S.C. 200-212 and the regulations thereunder
(37 CFR Part 401), when applicable. LICENSEE agrees to comply in all respects, and shall provide MICHIGAN with all reasonably requested
information and cooperation for MICHIGAN to comply with applicable provisions of the same and any requirements of any contracts between
MICHIGAN and any agency of the U.S. government that provided funding for the subject matter covered by the PATENT RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
3 - CONSIDERATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0in; text-indent: 0in; text-align: left">3.1
LICENSEE shall pay royalties to MICHIGAN as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">(a)
Upfront payment of [***] within 30 days of the EFFECTIVE DATE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">(b)
Running Royalties shall be paid according to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.75in; text-indent: 0in; text-align: left">Royalty rate on Total Annual NET SALES of LICENSED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.75in; text-indent: 0in; text-align: left">PRODUCTS
on each NCE in CHINA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.5in; text-indent: 0in; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 40%">Annual NET SALES up to [***]</TD>
    <TD>[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES of [***]</TD>
    <TD>[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES over [***]</TD>
    <TD>[***] </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.75in; text-indent: 0in; text-align: left">Royalty rate on Total Annual NET SALES of LICENSED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; margin-left: 0.75in; text-indent: 0in; text-align: left">PRODUCTS on each NCE in all other territories:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 40%">Annual NET SALES up to [***]</TD>
    <TD>[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES of [***]</TD>
    <TD>[***] </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES of [ ***]</TD>
    <TD>[***]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Annual NET SALES over [***]</TD>
    <TD>[***]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">For NET SALES for LICENSED PRODUCTS
under Paragraph 1.6 (a) or (b), the above royalty rates shall apply. For NET SALES for LICENSED PRODUCTS only under Paragraph 1.6 (c),
royalty rates shall be [***] of the above rates.</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">LICENSEE shall pay Royalties to MICHIGAN
during the entire Royalty Term, on a LICENSED PRODUCT-by-LICENSED PRODUCT and country-by-country basis and this provision shall survive
any termination of this Agreement.</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">If LICENSEE makes any NET SALES to
any party affiliated with LICENSEE, or in any way directly or indirectly related to or under the common control with LICENSEE, at a price
less than the regular price charged to other parties, the Royalties payable to MICHIGAN shall be only apply if those sales are booked
at NET SALES by LICENSEE and the Royalty shall be computed on the basis of the price paid by commercial payors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.15pt">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.2pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(c) LICENSEE
shall pay the following percentage of GROSS SUBLICENSING REVENUES to MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.75in; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(1) [***] if the
sublicense agreement is signed before the FDA, or foreign equivalent, approves the LICENSEE or SUBLICENSEE&rsquo;s IND on a LICENSED PRODUCT
included in such sublicense agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt">(2) [***] if the
sublicense agreement is signed after IND but before dosing the first patient in a Phase II clinical trial conducted by LICENSEE or SUBLICENSEE
on a LICENSED PRODUCT included in such sublicense agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 19.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt">(3) [***]
if the sublicense agreement is signed after dosing the first patient in a Phase II clinical trial conducted by LICENSEE or SUBLICENSEE
on a LICENSED PRODUCT included in such sublicense agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">In
the event that GROSS SUBLICENSING REVENUES includes non-cash consideration (i.e., that LICENSEE enters into a sublicense in which a
SUBLICENSEE is to pay LICENSEE consideration other than cash), MICHIGAN shall receive its percentage according to the following. In
each such instance, LICENSEE shall direct and require SUBLICENSEE to directly transfer to MICHIGAN its share of the total non-cash
consideration to be otherwise transferred to LICENSEE within ten (10) days after said SUBLICENSEE transfers said non-cash
consideration to LICENSEE. For example, if a SUBLICENSEE agrees to provide consideration in the form of stock in one or more
tranches, LICENSEE shall direct and require SUBLICENSEE to directly transfer to MICHIGAN those number of shares of stock
representing the appropriate percentage above by said deadline. LICENSEE shall make such transfer pursuant to and subject in
substance to the terms of the form of Stock Transfer Agreement attached hereto as Appendix A (the &ldquo;EQUITY TRANSFER
AGREEMENT&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(d) LICENSEE
shall pay to MICHIGAN minimum annual royalties (&ldquo;Annual Fee&rdquo;). This Annual Fee is accrued on June 30 of the years specified
below, and is payable with the semi-annual report for the ROYALTY PERIOD in which the Annual Fee accrues. This Annual Fee is non-creditable
and non-refundable. The Annual Fees are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -36.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD>For 2025-2027: [***];</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD>For 2028-2033: [***];</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD><FONT STYLE="font-size: 10pt">Beginning the year of FIRST COMMERCIAL SALE in [***] or 2034, whichever is earlier: [***]</FONT>; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -15.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(e)
LICENSEE shall pay milestone payments as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -36.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD>[***] upon enrollment of the [***] patient of the first [***] safety trial for each [***] with a distinct target;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD>[***] upon enrollment of the [***] patient of the first [***] clinical trial for each [***] with a distinct target;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD>[***] upon enrollment of the [***] patient of the first [***] clinical trial for each [***] with a distinct target;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(iv)</TD><TD>[***] upon FIRST COMMERCIAL SALE in the US and for each [***] with a distinct target, and [***] upon FIRST COMMERCIAL
SALE for such [***] in each of the [***];</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(v)</TD><TD>[***] upon first time achieving NET SALES in a calendar year over [***] for each [***] with a distinct target; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(vi)</TD><TD>[***] upon first time achieving NET SALES in a calendar year over [***] for each [***] with a distinct target.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">Milestone payments are non-refundable
and non-creditable against future royalties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.2 LICENSEE
shall be responsible for the payment of all taxes, duties, levies, and other charges imposed by any taxing authority with respect to the
royalties payable to MICHIGAN under this agreement. Should LICENSEE be required under any law or regulation of any government entity or
authority to withhold or deduct any portion of the payments on royalties due to MICHIGAN, then the sum payable to MICHIGAN shall be increased
by the amount necessary to yield to MICHIGAN an amount equal to the sum it would have received had no withholdings or deductions been
made. MICHIGAN shall cooperate reasonably with LICENSEE in the event LICENSEE elects to assert, at its own expense, MICHIGAN&rsquo;s exemption
from any such tax or deduction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.3 LICENSEE
is not obligated to pay multiple Royalties if any LICENSED PRODUCT or LICENSED PROCESS is covered by more than one claim of PATENT RIGHTS
or the same LICENSED PRODUCT is covered by claims in two or more countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.4 Royalty
payments shall be made to &ldquo;The Regents of the University of Michigan&rdquo; in United States dollars. Payments drawn directly on a
U.S. bank may be made by either check to the address in Article 13 or by wire transfer. Any payment drawn on a foreign bank or foreign
branch of a U.S. bank shall be made only by wire transfer. Wire transfers shall be made in accordance with the following or any other
instructions as may be specified by [***]. In computing Royalties, LICENSEE shall convert any revenues it receives in foreign currency
into its equivalent in United States dollars at the most recent exchange rate published in the Wall Street Journal on the last business
day of the ROYALTY PERIOD during which such payments are received by LICENSEE, or at such other exchange rate as the parties may agree
to in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3.5 Royalty
payments shall be made on a semi-annual basis with submission of the reports required by Article 4. All amounts due under this Agreement,
including amounts due for the payment of patent expenses, shall, if overdue, be subject to a charge of interest compounded monthly until
payment, at a per annum rate of five percent (5%) above the prime rate in effect at the JP Morgan Chase Bank, N.A. or its successor bank
on the due date (or at the highest allowed rate if a lower rate is required by law) or $250, whichever is greater. The payment of such
interest shall not foreclose MICHIGAN from exercising any other rights it may have resulting from any late payment. LICENSEE shall reimburse
MICHIGAN for the costs, including reasonable attorney fees, for expenses paid in order to collect any amounts overdue more than 120 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-underline-style: thick">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
4- REPORTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.1 Until
the FIRST COMMERCIAL SALE, LICENSEE shall provide to MICHIGAN a written annual report on or before July 30 of each year. The annual report
shall include reports of progress on research and development, regulatory approvals, manufacturing, sublicensing, marketing and sales
during the preceding twelve (12) months, and plans for the coming year. LICENSEE also shall report to MICHIGAN the date of first sale
or lease of LICENSED PRODUCTS (or results of LICENSED PROCESSES) in each country within thirty (30) days of occurrence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.2 After
the FIRST COMMERCIAL SALE, LICENSEE shall provide semi-annual reports to MICHIGAN. By each July 30 and January 31 (i.e., within one month
after each ROYALTY PERIOD closes, including the close of the ROYALTY PERIOD immediately following any termination of this Agreement),
LICENSEE shall report to MICHIGAN for that ROYALTY PERIOD:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(a)
number of LICENSED PRODUCTS sold, leased, or distributed, however characterized, by LICENSEE and each SUBLICENSEE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(b)
NET SALES, excluding the deductions provided therefor, of LICENSED PRODUCTS sold, distributed, used, rented, leased, or licensed,
however characterized, by LICENSEE and all SUBLICENSEES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(c) accounting for all
LICENSED PROCESSES used, sold, or licensed, however characterized, by LICENSEE and all SUBLICENSEES included in NET SALES, excluding
the deductions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(d)
deductions applicable as provided in the definition for NET SALES above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(e)
amounts due on payments from SUBLICENSEE under Paragraph 3.1 above, including supporting documentation, including but not limited to
any non-cash consideration owed by SUBLICENSEE to LICENSEE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(f)
foreign currency conversion rate and calculations (if applicable) and total royalties due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(g)
names, addresses, and U.S.P.T.O. Entity Status (as discussed in Paragraph 4.5) of all SUBLICENSEES having a sublicense or option
therefor any time during the particular ROYALTY PERIOD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(h) for each sublicense
or amendment thereto completed in the particular ROYALTY PERIOD (including agreements under which LICENSEE will have LICENSED PRODUCTS
made by a third party), the date of each agreement and amendment, the territory of the sublicense, the scope of the sublicense, and the
nature, timing and amounts of all fees and royalties to be paid thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt">(i)
any milestone (under Article 3 or Article 5) that has been achieved, and any milestone that was due during the ROYALTY PERIOD but not
achieved, specifying each milestone and whether or not it was achieved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">LICENSEE shall include
the amount of all payments due, and the various calculations used to arrive at those amounts, including the quantity, description
(nomenclature and type designation as described in Paragraph 4.3 below), country of manufacture and country of sale or use of
LICENSED PRODUCTS and LICENSED PROCESSES. LICENSEE shall direct its authorized representative to certify that reports required
hereunder are correct to the best of LICENSEE&rsquo;s knowledge and information. Failure to provide reports as required under this
Article 4 shall be a material breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">If no payment is due, LICENSEE shall so report to MICHIGAN
that no payment is due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.3 LICENSEE
shall promptly establish and consistently employ a system of specific nomenclature and type designations for LICENSED PRODUCTS and LICENSED
PROCESSES to permit identification and segregation of various types where necessary. LICENSEE shall consistently employ, and shall require
SUBLICENSEES to consistently employ, the system when rendering invoices thereon and shall inform MICHIGAN, or its auditors, when requested,
as to the details concerning such nomenclature system, all additions thereto and changes therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.4 LICENSEE
shall keep, and shall require SUBLICENSEES to keep, true and accurate records containing data reasonably required for the computation
and verification of payments due under this Agreement. LICENSEE shall, and it shall require all SUBLICENSEES and those making LICENSED
PRODUCTS, to: (a) open such records for inspection upon reasonable notice during business hours, and no more than once per year, by either
MICHIGAN auditor(s) or an independent certified accountant selected by MICHIGAN, for the purpose of verifying the amount of payments due;
and (b) retain such records for six (6) years from date of origination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The terms of this Article shall survive
any termination of this Agreement. MICHIGAN is responsible for all expenses of such inspection, except that if any inspection reveals
an underpayment greater than five percent (5%) of royalties due MICHIGAN, then LICENSEE shall pay all expenses of that inspection and
the amount of the underpayment and interest to MICHIGAN within twenty-one (21) days of written notice thereof. LICENSEE shall also reimburse
MICHIGAN for reasonable expenses required to collect the amount underpaid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.5 So
that MICHIGAN may pay the proper U.S. Patent and Trademark Office fees relating to the PATENT RIGHTS, if LICENSEE, any company related
to LICENSEE or SUBLICENSEE (including optionees) does not qualify as a &ldquo;Small Entity&rdquo; under U.S. patent laws, LICENSEE shall
notify MICHIGAN immediately. The parties understand that the changes to LICENSEE&rsquo;s, SUBLICENSEE&rsquo;s, or optionees&rsquo; businesses that might
affect entity status include: acquisitions, mergers, hiring of a total of more than 500 total employees, sublicense agreements, and sublicense
options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4.6
Affordable Access Plan. Within three (3) months of receiving FDA (or its foreign equivalent&rsquo;s) approval of a LICENSED PRODUCT,
LICENSEE will provide MICHIGAN with either (a) an Affordable Access Plan (defined below), or (b) a written explanation as to why
such an Affordable Access Plan is not needed or infeasible. In the case of (b), LICENSEE agrees to discuss such reasoning with
MICHIGAN in good faith within one (1) month thereafter (&ldquo;Initial Discussion&rdquo;) and, if following such Initial Discussion
MICHIGAN concludes an Affordable Access Plan is reasonable and desired, to provide an Affordable Access Plan to MICHIGAN within
three (3) months of such Initial Discussion. The &ldquo;Affordable Access Plan&rdquo; means LICENSEE&rsquo;S and/or its
SUBLICENSEES&rsquo; plans (including strategies and timelines) reasonably intended to support affordable access in a) Low and Middle
Income Countries as defined by the World Bank Group (&ldquo;LMICs&rdquo;), and b) vulnerable, underserved, and special needs
populations in the U.S., as defined by the Department of Health and Human Services, such as through licensing or partnerships
including with non-profit organizations. To the extent such Affordable Access Plan includes Proprietary Information, LICENSEE will
also provide a non-confidential version or statement of such Plan that MICHIGAN can make available to third parties: (a) A specified
set of (&ldquo;LMICs&rdquo;) in which the LICENSEE does not intend to commercialize the LICENSED PRODUCTS (the
&ldquo;Non-Commercialized Territory&rdquo;); (b) LICENSEE&rsquo;S and/or its SUBLICENSEES&rsquo; plans (including strategies and
timelines) reasonably intended to support affordable access in LMICs and Non-Commercialized Territories, such as through licensing
or partnerships including with non-profit organizations; and (c) LICENSEE&rsquo;S and/or its SUBLICENSEE&rsquo; plans (including
strategies and timelines) reasonably intended to support affordable access for the vulnerable, underserved and special needs
populations in the U.S. Within thirty (30) days of MICHIGAN&rsquo;s request (but no more often than once annually), LICENSEE agrees
to confer with MICHIGAN to review LICENSEE&rsquo;S progress, and to consider in good faith any modifications suggested by MICHIGAN,
with respect to its Affordable Access Plan (&ldquo;Progress Discussions&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
5 - DILIGENCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">5.1 LICENSEE
shall use commercially reasonable efforts to bring a full scope of LICENSED PRODUCTS to market or one or more LICENSED PROCESSES to commercial
use through a thorough, vigorous and diligent program for exploiting the PATENT RIGHTS and to continue active, diligent marketing efforts
throughout the life of this Agreement. LICENSEE has the responsibility to do all that is necessary to obtain and retain any governmental
approvals to manufacture and/or sell LICENSED PRODUCTS and/or use LICENSED PROCESSES for all relevant activities of LICENSEE and SUBLICENSEES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">5.2 With
respect to each Invention Report in Exhibit A and/or in any future amendment to this Agreement, LICENSEE agrees to reach the following
commercialization and research and development milestones with respect to LICENSED PRODUCTS that are covered by PATENT RIGHTS (together
the &ldquo;MILESTONES&rdquo;) by the following dates:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1. Nominate
clinical development lead compound [***] including non-GMP scale-up production, pre-formulation, non-GLP preclinical toxicity and pharmacokinetic
studies of the lead compounds completed for such selection within thirty-six (36) months after the date the of the PATENT RIGHTS covering
such [***] is added into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">2.
IND filing with US FDA or equivalent regulatory agency of foreign countries such as NMPA in CHINA for each NCE project, including
GMP scale-up production and GLP toxicology studies of the lead compounds completed for such selection with eighteen (18) months of
selection of the clinical development lead compounds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">3.
Initiate [***] trials for each [***] within twelve (12) months of [***] filing with appropriate regulatory agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">4. Initiate
[***] clinical trials for each [***] within twelve (12) months of successful completion of [***] trials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">5. Initiate
[***] clinical trials for each [***] with twelve (12) months of successful completion of [***].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">5.3 LICENSEE
must achieve each MILESTONE on or before the deadline dates indicated and MICHIGAN shall have the sole discretion to determine the validity
of a MILESTONE being reached. LICENSEE shall notify MICHIGAN within ten (10) days after each such deadline as to whether or not such MILESTONE
was met. If LICENSEE fails to meet any MILESTONE under this Article by the date of any MILESTONE deadline, LICENSEE will be deemed to
be in material breach of this Agreement, and MICHIGAN may terminate the Agreement effective on thirty (30) days&rsquo; notice, unless
LICENSEE achieves the MILESTONE within this thirty day period. Notwithstanding, MICHIGAN may terminate this Agreement immediately if LICENSEE
fails to achieve a MILESTONE by the indicated date and does not provide the notice to MICHIGAN referred to above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
6 - SUBLICENSING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6.1 LICENSEE
shall notify MICHIGAN in writing of every sublicense agreement and each amendment thereto within thirty (30) days after their execution,
and indicate the name of the SUBLICENSEE and its number of employees, the territory of the sublicense, the scope of the sublicense, and
the nature, timing and amounts of all fees and royalties to be paid thereunder. Upon request, LICENSEE shall provide MICHIGAN with a copy
of sublicense agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6.2 LICENSEE
shall not receive from SUBLICENSEES anything of value other than cash payments in consideration for any sublicense under this Agreement,
without the express prior written permission of MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6.3 Each
sublicense granted by LICENSEE under this Agreement shall provide for its termination upon termination of this Agreement. Each sublicense
shall terminate upon termination of this Agreement unless LICENSEE has previously assigned its rights under the sublicense to MICHIGAN
and MICHIGAN has agreed at its sole discretion in writing to such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">6.4
LICENSEE shall require that all sublicenses:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(1)
be consistent with the terms and conditions of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(2)
contain the SUBLICENSEE&rsquo;S acknowledgment of the disclaimer of warranty and limitation on MICHIGAN&rsquo;s liability, as provided
by Article 9 below; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(3) contain
provisions under which the SUBLICENSEE accepts duties at least equivalent to those accepted by the LICENSEE in the following Paragraphs:
4.4 (duty to keep records); 4.5 (duty regarding Patent Office fees); 9.4 (duty to avoid improper representations or responsibilities);
10.1 (duty to defend, hold harmless, and indemnify MICHIGAN); 10.3 (duty to maintain insurance); 14.5 (duty to properly mark LICENSED
PRODUCTS with patent notices); 14.7 (duty to restrict the use of MICHIGAN&rsquo;s name); 14.8 (duty to control exports).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
7 -PATENT APPLICATIONS AND MAINTENANCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">7.1 MICHIGAN has
the right to control all aspects of filing, prosecuting, and maintaining all of the patents and patent applications that form the basis
for the PATENT RIGHTS, interferences, and disputes (including litigation) regarding inventorship. LICENSEE shall fully cooperate in such
activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">7.2 MICHIGAN
shall notify LICENSEE of all information received by MICHIGAN relating to the filing, prosecution and maintenance of the patents and patent
applications which form the basis of the PATENT RIGHTS, and shall make reasonable efforts to allow LICENSEE to review, comment, and advise
upon such information. LICENSEE agrees to hold such information confidential and to use the information provided by MICHIGAN only for
the purpose of advancing MICHIGAN&rsquo;s PATENT RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">7.3 LICENSEE
shall reimburse MICHIGAN for all fees and costs relating to the activities described in this Article. Such reimbursement shall be made
within thirty (30) days of receipt of MICHIGAN&rsquo;s invoice and shall be subject to the interest and other requirements specified in Paragraph
3.5 above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
8 &ndash; ENFORCEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.1
Each party shall promptly advise the other in writing of any acts of potential infringement of the PATENT RIGHTS by a third party
(the &ldquo;Notice&rdquo;), and provide any evidence thereof at the request of the other party. After the Notice, LICENSEE shall use
diligent efforts to eliminate such infringement without litigation, including, if reasonable, by attempting communications with such
third party after consulting MICHIGAN. MICHIGAN&rsquo;s Innovation Partnerships shall provide reasonable assistance to advance such
efforts. Beginning at the time of the Notice, each party shall reasonably consider and discuss entering into a common interest
agreement and/or joint legal representation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.2
To the extent the described activities do not result in the elimination of such infringement, LICENSEE shall share with MICHIGAN,
subject to appropriate confidentiality and joint privilege/common interest agreement(s) to be negotiated in good faith between the
parties, the complete results of the LICENSEE&rsquo;s diligence related to the potential infringement identified above (including,
but not limited to, a detailed infringement analysis), as may be updated from time to time. The parties shall jointly identify a
strategy with respect to addressing the infringement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.3 Subject to the
other terms in this Article and LICENSEE being in compliance with the other terms of this Agreement (unless otherwise agreed to by
MICHIGAN), LICENSEE has the right to direct that the parties enforce the PATENT RIGHTS against infringement by other parties within
the TERRITORY and the FIELD OF USE, including those prior to the EFFECTIVE DATE. LICENSEE&rsquo;s right begins upon the earlier of
(a) the FIRST COMMERCIAL SALE or (b) LICENSEE making a bona fide Investigational Device Exemption or Investigational New Drug
Application (or equivalent) filing with the United States Food and Drug Administration or equivalent agency in Europe, China, or
Japan (to the extent included within the TERRITORY). If MICHIGAN is a necessary or indispensable party under applicable law in order
for a given reasonable lawsuit to enforce the PATENT RIGHTS within the LICENSED TERRITORY and FIELD OF USE to proceed, MICHIGAN
shall join in such lawsuit, subject to the other terms of this Article. Each party may grant or delegate to third parties the right
to enforce hereunder, and within the LICENSED TERRITORY and FIELD OF USE, only with the express written permission of the other
party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.4 With respect
to the filing and prosecution of infringement lawsuits, the parties agree to negotiate in good faith to jointly select lead counsel (to
be a large, nationally recognized litigation firm) and local counsel (if lead counsel does not have an office in the location of the suit)
that would represent both parties in the infringement lawsuit, each counsel to have demonstrated significant experience in the applicable
legal work. LICENSEE shall reimburse MICHIGAN for out-of-pocket expenses incurred in connection with MICHIGAN&rsquo;s activities under
this Article, including but not limited to outside counsel expenses incurred prior to, during, and in the settlement of such litigation,
within 30 days after receiving an invoice from MICHIGAN thereof. Upon the determination to file suit or retain counsel in accordance with
this Article, or at any other time requested by a party, the parties shall negotiate in good faith a written agreement consistent with
the foregoing and this Agreement specifying any further reasonable details. LICENSEE shall indemnify and hold harmless MICHIGAN with respect
to any claims asserted by an alleged infringer reasonably related to the enforcement of the PATENT RIGHTS under this Article including
but not limited to antitrust counterclaims and claims for recovery of attorney fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.5 Notwithstanding
the foregoing, LICENSEE shall not file or continue any suit without LICENSEE (a) having first performed a thorough, diligent investigation
of the merits of such suit, including with respect to the validity and enforceability of the PATENT RIGHTS; (b) having reasonable, supportable
legal and economic bases for doing so; (c) receiving notice from MICHIGAN that MICHIGAN agrees that LICENSEE&rsquo;s diligence has satisfied
MICHIGAN&rsquo;s own legal and business diligence requirements that the suit is reasonable; and (d) jointly addressing the legal representation
issues in Section 8.4 with MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.6 Each party shall
diligently cooperate with the other in litigation proceedings and other activities related to this Article. Except as provided
herein, the parties shall jointly control and consult one another with respect to any filed litigation and any counterclaims related
thereto, and are generally expected to make joint filings. The parties shall meet and confer in good faith with respect to any
action, and shall reasonably consider the other party&rsquo;s input. If there is any disagreement on strategy that is not resolved
with the mediation of outside counsel, the parties agree that, so long as lead outside counsel agrees that a position both is not
unreasonable and is allowable under court and legal rules, that: (a) LICENSEE shall have the right to control ultimate decisions on
strategy matters that are primary infringement issues, and (b) MICHIGAN shall have the right to control ultimate decisions on
strategy matters that are primarily validity and inequitable conduct issues. LICENSEE shall make any settlement only with the advice
and consent of MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8.7 If there is
litigation to enforce the PATENT RIGHTS and damages are recovered in litigation or settlement thereof, the award shall be applied first
to satisfy MICHIGAN&rsquo;s and LICENSEE&rsquo;s reasonable expenses and legal fees thereof. The remaining balance shall be divided equally
between LICENSEE and MICHIGAN. (Provided, however, that if any amounts of any type whatsoever are outstanding under this Agreement at
the time of such recovery, they shall be paid directly to, or retained by, MICHIGAN from the amounts otherwise payable to LICENSEE under
the prior sentence.) For clarity, the damages, expenses, and legal fees are only those that are for the PATENT RIGHTS, but not other patents.
The parties hereto agree to negotiate a resolution in good faith should any such damages or recoveries be related to patents other than
the PATENT RIGHTS. This provision shall control the division of revenues where a sublicense, covenant not to sue, or assignment of rights
is granted as part of a settlement of such lawsuit (including prospective rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-decoration: underline solid">ARTICLE 9
- NO WARRANTIES; LIMITATION ON MICHIGAN&rsquo;S LIABILITY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">9.1 MICHIGAN,
including its Regents, fellows, officers, employees and agents, makes no representations or warranties that PATENT RIGHTS are or will
be held valid or enforceable, or that the manufacture, importation, use, offer for sale, sale or other distribution of any LICENSED PRODUCTS
or LICENSED PROCESSES will not infringe upon any patent or other rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">9.2 <B>MICHIGAN,
</B>INCLUDING ITS REGENTS, FELLOWS, OFFICERS, EMPLOYEES AND AGENTS, MAKES NO REPRESENTATIONS, EXTENDS NO WARRANTIES OF ANY KIND, EITHER
EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, AND ASSUMES
NO RESPONSIBILITIES WHATEVER WITH RESPECT TO DESIGN, DEVELOPMENT, MANUFACTURE, USE, SALE OR OTHER DISPOSITION BY <B>LICENSEE OR SUBLICENSEES
OF LICENSED PRODUCTS OR LICENSED PROCESSES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">9.3 <B>LICENSEE
</B>AND <B>SUBLICENSEES</B> ASSUME THE ENTIRE RISK AS TO PERFORMANCE OF <B>LICENSED PRODUCTS</B> AND <B>LICENSED PROCESSES.</B> In no
event shall MICHIGAN, including its Regents, fellows, officers, employees and agents, be responsible or liable for any direct, indirect,
special, incidental, or consequential damages or lost profits or other economic loss or damage with respect to LICENSED PRODUCTS or LICENSED
PROCESSES, to LICENSEE, SUBLICENSEES or any other individual or entity regardless of legal or equitable theory. The above limitations
on liability apply even though MICHIGAN, its Regents, fellows, officers, employees or agents may have been advised of the possibility
of such damage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">9.4 LICENSEE shall not, and shall require
that its SUBLICENSEES do not, make any statements, representations or warranties whatsoever to any person or entity, or accept any
liabilities or responsibilities whatsoever from any person or entity that are inconsistent with any disclaimer or limitation
included in this Article 9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
10 - INDEMNITY; INSURANCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">10.1 LICENSEE shall
defend, indemnify and hold harmless and shall require SUBLICENSEES to defend, indemnify and hold harmless MICHIGAN, including its
Regents, fellows, officers, employees, students, and agents, for and against any and all claims, demands, damages, losses, and
expenses of any nature (including attorneys&rsquo; fees and other litigation expenses), resulting from, but not limited to, death,
personal injury, illness, property damage, economic loss or products liability arising from or in connection with, any of the
following: (1) Any manufacture, use, sale or other disposition by LICENSEE, SUBLICENSEES or transferees of LICENSED PRODUCTS or
LICENSED PROCESSES; (2) The use by any person of LICENSED PRODUCTS made, used, sold or otherwise distributed by LICENSEE or
SUBLICENSEES; and (3) The use or practice by LICENSEE or SUBLICENSEES of any invention or computer software related to the PATENT
RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">10.2 MICHIGAN
is entitled to participate at its option and expense through counsel of its own selection, and may join in any legal actions related to
any such claims, demands, damages, losses and expenses under Paragraph 10.1 above. LICENSEE shall not settle any such legal action with
an admission of liability of MICHIGAN without MICHIGAN&rsquo;s written approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">10.3 Prior to any distribution or
commercial use of any LICENSED PRODUCT or use of any LICENSED PROCESS by LICENSEE, LICENSEE shall purchase and maintain in effect
commercial general liability insurance, including product liability insurance and errors and omissions insurance which shall protect
LICENSEE and MICHIGAN with respect the events covered by Paragraph 10.1. Prior to any distribution or use of any LICENSED PRODUCT or
use of any LICENSED PROCESS by a SUBLICENSEE, LICENSEE shall require that the SUBLICENSEE purchase and maintain in effect commercial
general liability insurance, including product liability insurance and errors and omissions insurance which shall protect LICENSEE,
SUBLICENSEE, and MICHIGAN with respect to the events covered by Paragraph 10.1. Each such insurance policy must provide reasonable
coverage for all claims with respect to any LICENSED PROCESS used and any LICENSED PRODUCTS manufactured, used, sold, licensed or
otherwise distributed by LICENSEE -- or, in the case of a SUBLICENSEE&rsquo;s policy, by said SUBLICENSEE -- and must specify
MICHIGAN, including its Regents, fellows, officers and employees, as an additional insured. LICENSEE shall furnish certificate(s) of
such insurance to MICHIGAN, upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.25pt">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">10.4
In no event shall either party hereunder be liable to the other for any special, indirect, or consequential damages of any kind whatsoever
resulting from any breach or default of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-underline-style: thick">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
11 -TERM AND TERMINATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.1 If
LICENSEE ceases to carry on its business, this Agreement shall terminate upon written notice by MICHIGAN attempted to be delivered to
the address for notices provided in Article 13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.2 If
LICENSEE fails to make any payment due to MICHIGAN, upon ten (10) days&rsquo; written notice by MICHIGAN, this Agreement shall automatically
terminate unless MICHIGAN specifically extends such date in writing. Such termination shall not foreclose MICHIGAN from collection of
any amounts remaining unpaid or seeking other legal relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.3 Upon
any material breach or default of this Agreement by LICENSEE (other than as specifically provided herein, the terms of which shall take
precedence over the handling of any other material breach or default under this Paragraph), MICHIGAN has the right to terminate this Agreement
effective on thirty (30) days&rsquo; written notice to LICENSEE. Such termination shall become automatically effective upon expiration of the
thirty day period unless LICENSEE cures the material breach or default before the period expires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.4 LICENSEE
has the right to terminate this Agreement at any time on ninety (90) days&rsquo; written notice to MICHIGAN if LICENSEE first:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -19.35pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(a)
pays all amounts due MICHIGAN through the effective date of the termination;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(b)
submits a final report of the type described in Paragraph 4.2;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(c) returns
any patent documentation (including that exchanged under Article 7) and any other confidential or trade-secret materials provided to LICENSEE
by MICHIGAN in connection with this Agreement, or, with prior approval by MICHIGAN, destroys such materials, and certifies in writing
that such materials have all been returned or destroyed;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(d) suspends
its manufacture, use and sale of the LICENSED PROCESS(ES) AND LICENSED PRODUCT(S);</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(e) provides
MICHIGAN with all data and know-how developed by LICENSEE in the course of LICENSEE&rsquo;s efforts to develop LICENSED PRODUCTS and LICENSED
PROCESSES; MICHIGAN shall have the right to use such data and know-how for any purpose whatsoever, including the right to transfer same
to future licensees; and</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(f)
provides MICHIGAN access to any regulatory information filed with any U.S. or foreign government agency with respect to LICENSED
PRODUCTS and LICENSED PROCESSES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.35pt">Upon notice of intent to terminate,
MICHIGAN may elect to immediately terminate this Agreement upon written notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.35pt">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">11.5 Upon
any termination of this Agreement, and except as provided herein to the contrary, all rights and obligations of the parties hereunder
shall cease, except any previously accrued rights and obligations and further as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(1) obligations
to pay royalties and other sums, or to transfer equity or other consideration, accruing hereunder up to the day of such termination, whether
or not this Agreement provides for a number of days before which actual payment is due and such date is after the day of termination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(2) MICHIGAN&rsquo;s
rights to inspect books and records as described in Article 4, and LICENSEE&rsquo;s obligations to keep such records for the required time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(3)
any cause of action or claim of LICENSEE or MICHIGAN accrued or to accrue because of any breach or default by the other party hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(4)
the provisions of Articles I, 9, 10, and 14; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt">(5) all other terms,
provisions, representations, rights and obligations contained in this Agreement that by their sense and context are intended to survive
until performance thereof by either or both parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.6 After
the license(s) granted herein terminate, if LICENSEE has filed patent applications or obtained patents to any modification or improvement
to LICENSED PRODUCTS or LICENSED PROCESSES within the scope of the PATENT RIGHTS, LICENSEE agrees upon request to enter into good faith
negotiations with MICHIGAN or MICHIGAN&rsquo;s future licensee(s) for the purpose of granting licensing rights to said modifications or improvements
in a timely fashion and under commercially reasonable terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11.7 If
LICENSEE asserts the invalidity or unenforceability of any claim included in the PATENT RIGHTS, including by way of litigation or administrative
proceedings, either directly or through any other party, then MICHIGAN shall have the right to immediately terminate this Agreement upon
written notice to LICENSEE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
12 - REGISTRATION AND RECORDATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">12.1 If
the terms of this Agreement, or any assignment or license under this Agreement are or become such as to require that the Agreement or
license or any part thereof be registered with or reported to a national or supranational agency, LICENSEE will, at its expense, undertake
such registration or report. Prompt notice and appropriate verification of the act of registration or report or any agency ruling resulting
from it will be supplied by LICENSEE to MICHIGAN upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">12.2 LICENSEE
shall also carry out, at its expense, any formal recordation of this Agreement or any license herein granted that the law of any country
requires as a prerequisite to enforceability of the Agreement or license in the courts of any such country or for other reasons, and shall
promptly furnish to MICHIGAN appropriately verified proof of recordation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-underline-style: thick">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
13 - NOTICES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">13.1 Any notice,
request, or report required or permitted to be given or made under this Agreement by either party is effective when mailed if sent
by recognized overnight carrier, certified or registered mail, or electronic mail followed by confirmation by U.S. mail, to the
address set forth below or such other address as such party specifies by written notice given in conformity herewith. Any notice,
request, or report not so given is not effective until actually received by the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
  <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 46%; text-align: left">To MICHIGAN:</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify">To LICENSEE:</TD></TR>
  <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><P STYLE="margin-top: 0; margin-bottom: 0">The University of Michigan</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">Innovation Partnerships &nbsp;</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">1600 Huron Parkway</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">Building 520 2<SUP>nd</SUP> Floor</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">Ann Arbor, MI 48109</P>
                                 <P STYLE="margin-top: 0; margin-bottom: 0">Attn: [***]</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">Ascentage Pharma Group Corp. Ltd.</P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0">Unit B,17/F., United Centre, 95</P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0">Queensway, Admiralty, Hong Kong</P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0">Attn: Dajun Yang, President and CEO</P></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">ARTICLE
14 - MISCELLANEOUS PROVISIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">14.1 This
Agreement shall be construed, governed, interpreted and applied according to United States and state of Michigan law, except that questions
affecting the construction and effect of any patent shall be determined by the law of the country in which the patent was granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.1pt">14.2 The
parties hereby consent to the jurisdiction of the courts in the state of Michigan over any dispute concerning this Agreement or the relationship
between the parties. Should LICENSEE bring any claim, demand or other action against MICHIGAN, its Regents, fellows, officers, employees
or agents, arising out of this Agreement or the relationship between the parties, LICENSEE agrees to bring said action only in the Michigan
Court of Claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.3 MICHIGAN
and LICENSEE agree that this Agreement sets forth their entire understanding concerning the subject matter of this Agreement. The parties
may amend this Agreement from time to time, but no modification will be effective unless both MICHIGAN and LICENSEE agree to it in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.4 If a court
of competent jurisdiction finds any term of this Agreement invalid, illegal or unenforceable, that term will be curtailed, limited or
deleted, but only to the extent necessary to remove the invalidity, illegality or unenforceability, and without in any way affecting or
impairing the remaining terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.5 LICENSEE
agrees to mark the LICENSED PRODUCTS sold in the United States with all applicable United States patent numbers. All LICENSED PRODUCTS
shipped to or sold in other countries shall be marked to comply with the patent laws and practices of the countries of manufacture, use
and sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.6 No
waiver by either party of any breach of this Agreement, no matter how long continuing or how often repeated, is a waiver of any subsequent
breach thereof, nor is any delay or omission on the part of either party to exercise or insist on any right, power, or privilege hereunder
a waiver of such right, power or privilege. In no event shall any waiver be deemed valid unless it is in writing and signed by an authorized
representative of each party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.7 LICENSEE
agrees to refrain from using and to require SUBLICENSEES to refrain from using the name of MICHIGAN in publicity or advertising without
the prior written approval of MICHIGAN. Reports in scientific literature and presentations of joint research and development work are
not publicity. Notwithstanding this provision, without prior written approval of MICHIGAN, LICENSEE and SUBLICENSEES may state publicly
that LICENSED PRODUCTS and PROCESSES were developed by LICENSEE based upon an invention(s) developed at the University of Michigan and/or
that the PATENT RIGHTS were licensed from the University of Michigan.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.8 LICENSEE
agrees to comply with all applicable laws and regulations. In particular, LICENSEE understands and acknowledges that the transfer of certain
commodities and technical data is subject to United States laws and regulations controlling the export of such commodities and technical
data, including all Export Administration Regulations of the United States Department of Commerce. These laws and regulations prohibit
or require a license for the export of certain types of technical data to certain specified countries. LICENSEE agrees to comply with
all United States laws and regulations controlling the export of commodities and technical data, to be solely responsible for any violation
of such laws and regulations by LICENSEE or its SUBLICENSEES, and to defend, indemnify and hold harmless MICHIGAN and its Regents, fellows,
officers, employees and agents if any legal action of any nature results from the violation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.9 The
relationship between the parties is that of independent contractor. Neither party is an agent of the other in connection with the exercise
of any rights hereunder, and neither has any right or authority to assume or create any obligation or responsibility on behalf of the
other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.10 LICENSEE
may not assign this Agreement without the prior written consent of MICHIGAN and shall not pledge any of the license rights granted in
this Agreement as security for any creditor. Any attempted pledge of any of the rights under this Agreement or assignment of this Agreement
without the prior consent of MICHIGAN will be void from the beginning. No assignment by LICENSEE will be effective until the intended
assignee agrees in writing to accept all of the terms and conditions of this Agreement, and such writing is provided to MICHIGAN. Notwithstanding,
LICENSEE may, without MICHIGAN&rsquo;s consent, assign its rights under this Agreement to a purchaser of all or substantially all of LICENSEE&rsquo;s
business relating to the subject matter of this Agreement, so long as such assignee provides a statement in writing to MICHIGAN that it
agrees to accept all the terms and conditions of this Agreement in the place of LICENSEE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14.11 If
during the term of this Agreement, LICENSEE makes or attempts to make an assignment for the benefit of creditors, or if proceedings in
voluntary or involuntary bankruptcy or insolvency are instituted on behalf of or against LICENSEE, or if a receiver or trustee is appointed
for the property of LICENSEE, this Agreement shall automatically terminate. LICENSEE shall notify MICHIGAN of any such event mentioned
in this Paragraph as soon as reasonably practicable, and in any event within five (5) days after any such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-decoration: underline solid">ARTICLE
15 - CONFLICT OF INTEREST MANAGEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">15.1 This
Agreement and the licenses granted hereunder are subject to approval by a two- thirds majority vote of the Regents of the University of
Michigan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">15.2
Unless MICHIGAN provides appropriate formal approvals, continuing development of LICENSED PRODUCTS and LICENSED PROCESSES will take place
without the use of MICHIGAN funds, facilities, or other resources of or funds administered by MICHIGAN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">15.3 LICENSEE shall
cooperate with MICHIGAN in developing and implementing appropriate plans for management of potential conflicts of interest and conflicts
of commitment of MICHIGAN employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">IN WI1NESS WHEREOF, the parties hereto
have executed this Agreement in duplicate originals by their duly authorized officers or representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">For:</TD>
    <TD STYLE="width: 35%">LICENSEE</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 5%">For:</TD>
    <TD STYLE="width: 35%">The Regents of the University of Michigan</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/S/ Dajun Yang, M.D., Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/S/ Bryce Pilz</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(authorized representative)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>Dajun Yang, M.D., Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Chairman &amp; CEO</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>Date:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Date:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[***]</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B></B></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.15
<SEQUENCE>7
<FILENAME>ea028514801ex4-15.htm
<DESCRIPTION>OFFER LETTER BETWEEN ASCENTAGE PHARMA GROUP INC. AND VEET MISRA
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 4.15</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><IMG SRC="ea028514801_ex4-15img1.jpg" ALT="" STYLE="height: 59px; width: 250px">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 50%"><P STYLE="margin-top: 0; margin-bottom: 0">Ascentage Pharma Group Inc.</P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0">700 King Farm Boulevard</P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0">Suite 510</P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0">Rockville, Maryland 20850 USA</P></TD></TR>
  </TABLE>


<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 30, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 402.15pt 0pt 0">Veet Misra, PhD</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 402.15pt 0pt 0">2260 North Point</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suite 1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Francisco, 94123</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0 0pt 372.85pt"><I><U>Via Electronic Mail</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Veet,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">It gives us great pleasure to extend
our offer of employment to you as our <B>Chief Financial Officer</B> for Ascentage Pharma Group Inc. (the &ldquo;Company&rdquo;) on the
terms set forth or referred to in this offer letter (&ldquo;Offer Letter&rdquo;). This Offer Letter supersedes any previous offer made
to you by the Company whether in writing, orally or in any other form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">Please return a signed copy of this
Offer Letter within 48 hours, <FONT STYLE="text-decoration: underline solid"><B>on or before July 2, 2025</B></FONT> to indicate your
interest and that you accepted the offer. Please note that your acceptance of this Offer Letter is conditional on you signing the Employee
Confidentiality and Proprietary Information Agreement and completion of a customary background check satisfactory to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">If you accept our Offer Letter, your
employment will commence on <B>July 7, 2025 (</B><U>or another mutually agreed upon date</U>) (&ldquo;Date of Employment&rdquo;), until
such time it is terminated as provided below in this Offer Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">COMPENSATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">Your compensation and employee benefits will be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>During the term of your employment by the Company, you will be entitled to a <I>semi-monthly</I> (15<SUP>th</SUP>
&amp; 30<SUP>th</SUP> of each month) salary of <B>$21,875 USD</B> (prorated for any period of less than a full month), payable in accordance
with our standard payroll practices and subject to deductions for applicable federal, state, and local withholding.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>According to the terms of the Company&rsquo;s short-term incentive program, you will be eligible for
an annual performance bonus, at the target percentage of <B>40% </B>of your annual base salary. The bonus is based on your performance
measured against your specific individual goals and departmental goals, and the Company&rsquo;s performance of the annual corporate goals
as determined by the Board of Directors of the Ascentage Pharma Group International (&ldquo;Board&rdquo;).
If employed with the Company at the time of the annual bonus distribution, the Company will pay the annual performance bonus, subject
to your performance appraisal results, and the Board&rsquo;s determination of the Company&rsquo;s performance of the yearly corporate
goals.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.65pt 0pt 36.05pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>You will be granted under the following equity awards:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.05pt">Sign-on Incentive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.05pt"></TD><TD STYLE="width: 18pt">a.</TD><TD>Under the 2022 Restricted Share Unit Scheme, amended, of Ascentage Pharma Group International (the
&ldquo;Plan&rdquo;), <B>$1,500,000 </B>of restricted share units (RSUs) to vest in equal tranches over a four year period beginning with
the first tranche vesting after the first anniversary of the Date of Employment and subject to specific approval from the Board of Directors
and compliance with the relevant laws and regulations (including the Rules Governing The Listing Of Securities On The Stock Exchange Of
Hong Kong Limited), on such terms and provisions as are contained in the RSU grant letter and the Plan;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.05pt"></TD><TD STYLE="width: 18pt">b.</TD><TD>Under the Post IPO Share Option Scheme, as amended, of Ascentage Pharma Group International (the &ldquo;Plan&rdquo;),
<B>$500,000 </B>of Share Options to vest in equal tranches over a four year period beginning with the first tranche vesting after the
first anniversary on or about the Date of Employment, and subject to specific approval from the Board of Directors and compliance with
the relevant laws and regulations (including the Rules Governing The Listing Of Securities On The Stock Exchange Of Hong Kong Limited),
on such terms and provisions as are contained in the Post IPO grant letter and the Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.05pt">Annual Performance Incentive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.05pt"></TD><TD STYLE="width: 18pt">c.</TD><TD>Under the 2022 Restricted Share Unit Scheme, as amended, of Ascentage Pharma Group International (the
&ldquo;Plan&rdquo;), <B>$600,000 </B>of restricted share units (RSUs) to vest based on the successful attainment of specific performance
measures, and subject to specific approval from the Board of Directors and compliance with the relevant laws and regulations (including
the Rules Governing The Listing Of Securities On The Stock Exchange Of Hong Kong Limited), on such terms and provisions as are contained
in the RSU grant letter and the Plan; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.05pt"></TD><TD STYLE="width: 18pt">d.</TD><TD>Under the Post IPO Share Option Scheme, as amended, of Ascentage Pharma Group International (the &ldquo;Plan&rdquo;),
<B>$600,000</B> of Share Options to vest based on the successful attainment of specific performance measures, and subject to specific
approval from the Board of Directors and compliance with the relevant laws and regulations (including the Rules Governing The Listing
Of Securities On The Stock Exchange Of Hong Kong Limited), on such terms and provisions as are contained in the RSU grant letter and the
Plan.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><B>2</B><!-- Field: /Sequence --> | Page</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">EMPLOYEE BENEFIT PLANS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 26.7pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">During your employment with the Company, you
will be eligible to receive <B>paid time off (PTO) of 22 </B>days in accordance with our standard policies and to participate in all
group benefits plans made available generally to employees of the Company. You are also eligible to receive <B>two (2) floating
holidays </B>according to company policy to use as you deem appropriate. The Company presently intends to match 401(k) employee
contributions up <B>to 6% of your base salary</B>. The Company reserves the right to amend, modify, or terminate its policies and
benefit plans at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">EXCLUSIVE SERVICE AND REPORTING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">During your employment by the Company,
you will devote all your business and professional time, energy, business judgment, knowledge, skill, and best efforts to the performance
of your employment duties with the Company. You will report to <B>Dajun Yang, </B>President at Ascentage Pharma Group Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">EMPLOYEE HANDBOOK AND OTHER POLICIES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">You will be bound by the employment
terms contained in the Company&rsquo;s Employee Handbook and other written policies of the Company in effect from time to time and be
required to sign the Company&rsquo;s standard acknowledgment form as verification of acceptance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">RIGHT TO WORK STATUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">Under the Immigration Reform and Control
Act, the Company is required to verify the identity and work authorization of all newly hired employees. Therefore, you will be required
to complete the I-9 Form upon your first day of employment. Within three business days of beginning your employment, you also will need
to supply acceptable documentation (as noted on the I-9 Form) of your identity and work authorization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">BACKGROUND CHECK AND EMPLOYEE CONFIDENTIALITY AND
PROPRIETARY INFORMATION AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">This offer is subject to our completion
of a customary background check satisfactory to us as well as your execution of the Company&rsquo;s Employee Confidentiality and Proprietary
Information Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">NATURE OF &ldquo;AT WILL&rdquo; EMPLOYMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">If you accept this offer, your employment
will be &ldquo;at will,&rdquo; which means that either you or the Company may terminate your employment relationship at any time, with
or without cause. This means, among other things, that upon the termination of your employment relationship, the Company&rsquo;s sole
obligation to you will be to pay you any accrued and unpaid salary, plus any unreimbursed business expenses and accrued but unused paid
time off as provided herein, through the termination date and any benefits in accordance with the Company&rsquo;s employee benefit plans
in which you are then participating as provided therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">* * * * * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">If you require further clarification or information, please
contact Lily Cheng, Human</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><B>3</B><!-- Field: /Sequence --> | Page</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Resources at <U STYLE="text-decoration: none">lily.cheng@ascentage.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">If the terms of employment outlined
in this Offer Letter are acceptable to you, please sign and date a copy of this Offer Letter where indicated below and return it to Lily
Cheng. You can email it to Lily Cheng at <U STYLE="text-decoration: none">lily.cheng@ascentage.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">Upon execution by you, this Offer Letter
will replace any prior or contemporaneous oral or written understanding or agreement concerning the terms of employment between you and
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">This Offer Letter
and any dispute concerning the validity, enforceability, or interpretation of this Offer Letter or the terms of your employment will be
governed by the internal laws of the State of Maryland without regard to conflict-of-law principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">We look forward to you joining our team and to a mutually
rewarding relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt">Sincerely,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">/<U STYLE="text-decoration: none">S/ Dajun Yang</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Dajun Yang, Ph.D.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">President</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Ascentage Pharma Group Inc.</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><B>4</B><!-- Field: /Sequence --> | Page</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17.55pt 0pt 0; text-align: center"><FONT STYLE="text-decoration: underline solid"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17.55pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17.55pt 0pt 0; text-align: center"><FONT STYLE="text-decoration: underline solid"><B>Acknowledgment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">I hereby accept the offer on
the terms set forth above and acknowledge this agreement with the Company and that no other terms, conditions, or representations
other than those contained herein form part of this agreement. I understand that my employment relationship is on an
&ldquo;at-will&rdquo; basis and can be terminated by either the Company or myself at any time, with or without cause. I hereby
represent and warrant to the Company that (a) I have the legal right to accept this offer of employment and to perform my employment
obligations hereunder and (b) am not a party to any agreement or understanding, and am not subject to any restriction, which, in
either case, could prevent me from entering into this agreement or performing my employment duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">July 3, 2025</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>DATE</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">Veetshok Misra</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>PRINT FULL NAME</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">/S/ Veetshok Misra</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>FULL SIGNATURE</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-top: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><B>5</B><!-- Field: /Sequence --> | Page</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>8
<FILENAME>ea028514801ex8-1.htm
<DESCRIPTION>LIST OF SUBSIDIARIES OF THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>Exhibit 8.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7pt; text-align: center"><B>Subsidiaries of registrant*</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%"><FONT STYLE="font-size: 10pt"><B>Name of Subsidiary</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%"><FONT STYLE="font-size: 10pt"><B>Jurisdiction of Incorporation</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Ascentage Pharma Group Corp Limited</TD>
    <TD>&nbsp;</TD>
    <TD>Hong Kong</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Jiangsu Ascentage Pharma Co., Limited</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Guangzhou Healthquest Pharma Co., Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Ascentage International Limited</TD>
    <TD>&nbsp;</TD>
    <TD>Hong Kong</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Ascentage Pharma Group Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>United States</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Shanghai Yasheng Pharmaceutical Technology Co., Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Ascentage Pharma Pty. Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>Australia</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Suzhou Ascentage Pharma Co., Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Ascentage Investment International</TD>
    <TD>&nbsp;</TD>
    <TD>Cayman Islands</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Ascentage Investment Limited</TD>
    <TD>&nbsp;</TD>
    <TD>Hong Kong</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Suzhou Ascentage Grains Valley Venture Capital Co., Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Shanghai UUBiopharma Co., Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Ascentage Pharma Europe Limited</TD>
    <TD>&nbsp;</TD>
    <TD>Ireland</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Shanghai Centagen Pharma Co., Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Suzhou Shenghe Innovation Works Biotech Co., Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Suzhou Gsun No. 8 Equity Investment Partnership (Limited Partnership)</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Suzhou Shenghe Innovation Space Development Co., Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>People&rsquo;s Republic of China</TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: left">The English names of the companies registered in the People&rsquo;s
Republic of China represent the best efforts made by the management of the registrant in directly translating the Chinese names of these
companies as no English names have been registered.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.1
<SEQUENCE>9
<FILENAME>ea028514801ex11-1.htm
<DESCRIPTION>ENGLISH TRANSLATION OF ASCENTAGE PHARMA GROUP INTERNATIONAL INSIDER TRADING POLICY
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
11.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASCENTAGE
PHARMA GROUP INTERNATIONAL</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INSIDER
TRADING POLICY</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage
Pharma Group International (6855.HK) (the &ldquo;<B>Company</B>&rdquo;) and its subsidiaries and affiliates (together, the &ldquo;<B>Group</B>&rdquo;)
are committed to ensuring that all of its shareholders and potential shareholders can buy and sell the Company&rsquo;s securities fairly.
Shareholders and potential shareholders must have confidence that Company&rsquo;s board of directors (&ldquo;<B>Directors</B>&rdquo;),
officers, employees, and agents, as well as the board of directors, officers, employees, and agents of any member of the Group, cannot
derive an unfair advantage as a result of their access to Inside Information. Accordingly, all directors, officers, employees and agents
are required to deal in shares and handle Inside Information in accordance with this Insider Trading Policy (&ldquo;<B>Policy</B>&rdquo;).
This Policy also serves to protect the reputation of Company and help protect its and its affiliates directors, officers, employees,
and agents and Company from civil and criminal liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy provides guidelines to the directors, officers, employees and agents of any member of the Group with respect to transactions in
the Company&rsquo;s securities and codifies the Company&rsquo;s standards on trading and enabling the trading of securities of the Company
or other publicly-traded companies while in possession of Inside Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
basis for this Policy and all actions by the directors, officers, employees and agents of any member of the Group must be in compliance
with laws applicable to the trading of the Company&rsquo;s securities. Specifically, it is the policy of the Company to observe fully
the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the &ldquo;<B>SFO</B>&rdquo;) and the Rules Governing the
Listing of Securities on The Stock Exchange of Hong Kong Limited (the &ldquo;<B>Listing Rules</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scope
                                            of Policy</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
provisions of this Policy apply to all directors, officers, employees, consultants and contractors of the Company, each of whom and all
Associates of such persons (collectively, &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
Persons<FONT STYLE="font-weight: normal">&rdquo;), will agree to be bound by such provisions upon being notified of the most recent copy
of this Policy.</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
provisions of this Policy apply to all transactions in the Company&rsquo;s securities, including common or preferred stock, options and
warrants to purchase common stock, notes, restricted share unit, bonds, convertible securities and any other debt or equity securities
that the Company may issue from time to time (collectively, &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
Securities<FONT STYLE="font-weight: normal">&rdquo;).</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exceptions
                                            for certain Transactions</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
Policy does not apply to all transactions involving the Company Securities. The following exceptions are intended to facilitate several
common types of transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
                                            Option Exercises</U>. This Policy does not apply to the mere exercise of a stock option for
                                            cash under the Company&rsquo;s stock option plans. This Policy <U>does</U> apply, however,
                                            to:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 1in"></TD><TD STYLE="text-align: left; width: 17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            sale of stock as part of a broker-assisted &ldquo;cashless&rdquo; exercise of an option (<I>i.e.</I>,
                                            any market sale for the purpose of generating the cash needed to pay the exercise price of
                                            an option); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 1in"></TD><TD STYLE="text-align: left; width: 17.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            sale of shares of Company stock received upon exercise of an option.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Net
                                            Settlement upon Vesting of Restricted Stock</U>. This Policy does not apply to a surrender
                                            of shares to the Company or the retention and withholding from delivery to the applicable
                                            officer, director or employee of shares by the Company (<I>i.e.</I>, a so-called &ldquo;net
                                            settlement&rdquo;) upon vesting of restricted stock in satisfaction of any tax withholding
                                            obligations in a manner permitted by the applicable grant letter or the Company plan pursuant
                                            to which the restricted stock was granted.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
                                            Prohibition</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Insider
trading occurs when a person in possession of Inside Information obtained through involvement with the Company (1) uses that information
to make decisions to purchase, sell, or otherwise trade in securities of the Company or another company, or (2) provides that information
to others to enable such trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
directors, officers, employees, consultants and contractors of any member of the Group</U>:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            purchase or sell any Company Securities while in possession of Inside Information about the
                                            Company, its customers, suppliers, consultants or other companies with which the Company
                                            has contractual relationships or may be negotiating transactions;</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            communicate any Inside Information about the Company to any other person;</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            purchase or sell any security of any other company, whether or not issued by the Company,
                                            while in possession of Inside Information about that company that was obtained in the course
                                            of his or her involvement with the Company;</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">should
                                            ever trade, tip or recommend securities (or otherwise cause the purchase or sale of securities)
                                            while in possession of information that he or she has reason to believe is Inside Information.
                                            Every director, officer, employee, consultant and contractor of any member of the Group must
                                            consult with the Compliance Representative to trade in Company Securities.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Other
trading prohibitions</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers it improper and inappropriate for directors, officers, employees, consultants and contractors of any member of the
Group to engage in short-term or speculative transactions in the Company&rsquo;s securities or in other transactions that may lead to
inadvertent violations of the insider trading laws. Accordingly, trading in the Company&rsquo;s securities by directors, officers, employees,
consultants and contractors of any member of the Group is subject to the following additional restrictions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Short
                                            sales</U>. No directors, officers, employees, consultants and contractors of any member of
                                            the Group may sell the Company Securities short (sale of stock that the seller does not own
                                            or a sale that is completed by delivery of borrowed stock).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Options
                                            trading</U>. No directors, officers, employees, consultants and contractors of any member
                                            of the Group may buy or sell puts or calls or other derivative securities on the Company
                                            Securities.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Trading
                                            on margin; Pledging</U>. No directors, officers, employees, consultants and contractors of
                                            any member of the Group may hold Company Securities in a margin account or pledge Company
                                            Securities as collateral for a loan.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Hedging</U>.
                                            No directors, officers, employees, consultants and contractors of any member of the Group
                                            may enter into hedging, monetization transactions, or similar arrangements with respect to
                                            Company Securities.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Blackout
                                            Periods</B></FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">All
directors, officers, employees and agents of any member of the Group are prohibited from trading in the Company&rsquo;s securities during
the following Blackout Periods:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Announcement
                                            of annual and interim financial results</U>: on any day on which the financial results are
                                            published and (a) during the period of 60 days immediately preceding the publication date
                                            of annual results or, if shorter, the period from the end of the relevant financial year
                                            up to the publication date of the results or (b) during the period of 30 days immediately
                                            preceding the publication date of the quarterly results (if any) and half-year results or,
                                            if shorter, the period from the end of the relevant quarterly or half-year period up to the
                                            publication date of the results;</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Special
                                            Blackout Periods</U>. From time to time, while the following material non-public information
                                            is pending, the Company may impose special blackout periods to those persons who may have
                                            material non-public information regarding the Company (such as negotiation of mergers, acquisitions
                                            or dispositions, new product developments, read-outs from clinical trials, or other material
                                            events) that may be pending and not yet publicly disclosed. Before or during the Special
                                            Blackout Periods, the Company may also require such persons to execute acknowledgment letter
                                            or such other documents as may be necessary to comply with the applicable laws or the Listing
                                            Rules; and</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                            you are in possession of Inside Information.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Clearance
                                            Requirements</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Directors,
officers and employees of the Company with the title of vice president or higher must obtain prior clearance from the Compliance Representative
(as defined below) before they or their Associate makes any purchases or sales of the Company Securities. A detailed procedure and requirement
for pre-clearance is attached as <U>Exhibit A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
addition, employees of the Company with the title of Chief Officer (including CEO, CFO, CBO, CCO, CMO, etc., hereinafter referred to
as &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C-level Employees<FONT STYLE="font-weight: normal">&rdquo;),
must obtain prior approval from the CFO and CEO of the Company (in the case of the CEO, prior <FONT STYLE="font-style: normal">approval
must first be obtained from the Compliance Representative followed by the CFO; and in the case of the CFO, prior approval must first
be obtained from the Compliance Representative followed by the CEO), before they or their Associates can make any purchases or sales
of the Company Securities, and shall notify the Secretary of the Board of Directors to file any necessary filings as required by applicable
law or the Listing Rules.</FONT></FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Violations
                                            of Insider Trading Laws</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Penalties
for trading on or communicating Inside Information can be severe, both for the Company and the directors, officers, employees and agents
of any members of the Group. Given the severity of the potential penalties, compliance with this Policy is absolutely mandatory. A summary
of the consequences of violating this Policy is attached as <U>Exhibit B</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Individuals
who violate this Policy may be subject to disciplinary action by the Company, up to and including dismissal for cause. Any exemptions
from strict compliance with the Policy, if permitted, may only be granted by the Compliance Representative in writing and must be provided
before any activity contrary to the above requirements takes place.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
                                            Representative</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
Company has appointed its Compliance Representative for this Policy. The duties of the Compliance Representative include, but are not
limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting
                                            with the implementation of this Policy;</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">circulating
                                            this Policy to all Company and its affiliates directors, officers, employees, and agents
                                            of the Company and ensuring that this Policy is amended as necessary to remain up-to-date
                                            with insider trading laws; and</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-clearing
                                            all trading in securities of the Company by employees of the Company with the title of vice
                                            president or higher (except for C-level Employees) in accordance with the procedures set
                                            forth in Section 5 of this Policy.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
the event that the Compliance Representative is unavailable, the Company shall designate another appropriate person to assume the responsibilities
during the time of the Compliance Representative&rsquo;s unavailability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Questions
                                            About the Policy</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Any
question about this Policy or any related processes should be directed to the Compliance Representative. Violations of this Policy must
be reported to the Compliance Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Associate</B>.
                                            In relation to a person, means the person&rsquo;s spouse or reputed spouse, any person cohabiting
                                            with the person as a spouse, the person&rsquo;s brother, sister, parent, step-parent, child
                                            (natural or adopted) or step child; and any corporation of which the person is a director,
                                            or any employee or partner of the person, and to transactions by entities over which such
                                            person is a director, employee or partner, or can exercises control over such entities, and
                                            such other person as defined as Associate by Part XIV the SFO (as amended from time to time).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compliance
                                            Representative</B>. Means any senior officer, designated from time to time by the Company.
                                            The Company hereby appointed Thomas J. Knapp as the Compliance Representative dealing with
                                            all the compliance issue for the Company&rsquo;s affiliate company located in US, Australia
                                            and European countries, and Jun Yan as the Compliance Representative dealing with all the
                                            compliance issue for the Company&rsquo;s affiliate company located in Cayman Islands, Hong
                                            Kong SAR and Mainland China.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inside
                                            Information. </B>Means specific information that (a) is about the Company, any shareholder
                                            or officer of the company, or the listed securities of the company or their derivatives and
                                            (b) is not generally known to the persons who are accustomed or would be likely to deal in
                                            the Company securities but would if generally known to them be likely to materially affect
                                            the price of the Company securities. A detailed guideline for determining Inside Information
                                            is attached as <U>Exhibit C</U><B>. </B></FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
Policy shall come into force with effect from the date as executed by the CEO of the Company and replace the previous insider trading
policy as adopted on June 21, 2018. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
Policy is written in both Chinese and English, in case of any conflict between the Chinese version and the English version, the English
version shall prevail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
Policy may be amended from time to time. Any amendments to this Policy shall be approved by the Company and will be communicated to directors,
officers, employees, consultants and contractors of any member of the Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>Title:</TD>
    <TD></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage Pharma Group International</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASCENTAGE
PHARMA GROUP INTERNATIONAL </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRADING
POLICY PROCEDURES FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Ascentage Pharma Group International&rsquo;s Insider Trading Policy, before trading in any securities of Ascentage Pharma
Group International (&ldquo;<B>Company</B>&rdquo;), you are required to follow the following pre-clearance procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company requires all Directors, officers and employees of the Company with the title of vice
                                            president or higher (the &ldquo;<B>Pre-Clearance Applicant</B>&rdquo;) to obtain prior clearance
                                            from the Compliance Representative before they or any of their Associate makes any purchases
                                            or sales of the Company Securities. </FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Pre-Clearance Applicant shall submit the application with all the required information attached
                                            and the executed Trading Notification Form (see below for the format) to the Compliance Representative
                                            through the OA system of the Company, or other method acceptable to the Company. Such application
                                            shall be initiated at least 3 trading days before the date that the Applicant desires to
                                            trade the Company Securities, and the Compliance Representative shall approve, or reject
                                            the application (if he believes the trading as proposed by such application will be a violation
                                            of the applicable laws) within 2 trading days.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            revoked, a grant of permission will normally remain valid for five (5) trading days. If the
                                            transaction does not occur during that specified time period, pre-clearance of the transaction
                                            must be re-requested.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may impose a volume restriction on the number of Company Securities that may be traded
                                            by the directors, officers, employees, consultants and contractors of any member of the Group.
                                            In such an event, the Company will notify all the directors, officers, employees, consultants
                                            and contractors of any member of the Group who will be subject to such restriction, of such
                                            volume restriction and the length of time such volume restriction will be in effect.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
Notification Form </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Version:
March 2021 </B></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise defined, capitalized terms used in this form shall have the same meanings as those defined in the Insider Trading Policy of
Ascentage Pharma Group International (the &ldquo;<I>Company</I>&rdquo;).</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Company&rsquo;s Insider Trading Policy, before dealing in any Company Securities, you are required to provide written
notification of your intent to trade through OA. You will receive a notification in OA or Human Resources if the proposed trading transaction
has been cleared and the period of time the clearance is effective.</FONT></P>

<P STYLE="text-align: left; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
individual wishing to trade shares must complete and submit the form below for pre- clearance/approval:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name&#65306;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
No.&#65306;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail&#65306;</FONT></P>



<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____
(please initial) I hereby provide written notification of my intent to trade in the following Company Securities, which are held or proposed
to be held by myself personally and/or by an Associate as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 3pt; border: Black 1pt solid; text-align: left; width: 32%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Name (Stock Code)</FONT></TD>
    <TD STYLE="padding-left: 3pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 35%"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
                                            of Securities/Derivatives</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="padding-left: 3pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
                                            of Transaction (Disposal, Acquisition, Acceptance, Exercise)</FONT></P>
                                                                                                                       <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage
                                            Pharma Group Intl (6855.HK)</FONT></P>
                                                                                                            <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="padding-left: 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____
(<I>please initial</I>) I have read the Insider Trading Policy and confirm that I am in compliance with such policy for trading the abovementioned
Company Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____(<I>please
initial</I>) I confirm that I will not trade, through myself or through my Associate in the Company Securities: on any day on which the
financial results are published and (a) during the period of 60 days immediately preceding the publication date of annual results or,
if shorter, the period from the end of the relevant financial year up to the publication date of the results or (b) during the period
of 30 days immediately preceding the publication date of the quarterly results (if any) and half-year results or, if shorter, the period
from the end of the relevant quarterly or half-year period up to the publication date of the results;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______
(<I>please initial</I>) I confirm that I will not deal, through myself or through Associate of mine, in the Company Securities during
the Special Blackout Periods, (ii) when I am in possession of inside information; and (iii) where clearance to trade has not yet received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -0.05pt">______
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>please
initial</I>) I confirm that I am not aware of any confidential, Inside Information that is likely to materially affect the Company&rsquo;s
stock price during the clearance time period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in">______
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>please
initial</I>) I understand that acknowledgement of this written notification will not necessarily provide to me or the Associate any defense
against any statutory liability and/or any charge of insider dealing or market misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed: _______________________</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: _______________________</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
Name:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>______________________________________________________________________________________________&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Acknowledgment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______
(please initial) I acknowledge that the required information has been provided above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______
(please initial) Each written acknowledgment is valid for a specified period following the date of the acknowledgment, and the trading
must be completed in that clearance time period. After this time, a new written notification must be submitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed: _______________________</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: _______________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Name:</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
of Insider Dealing and Market Misconduct Provisions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Types
                                            of Market Misconduct</B></FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are six types of market misconduct relating to dealings in securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insider
                                            dealing</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">false
                                            trading</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
                                            rigging</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosure
                                            of information about prohibited transactions</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosure
                                            of false or misleading information inducing transactions</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock
                                            market manipulation</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                            Prohibition on Insider Dealing</B></FONT></TD></TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company&rsquo;s substantial shareholders, directors and employees, plus its advisers are
                                            prohibited from dealing in the Company&rsquo;s shares (or in those of a related corporation)
                                            at a time when:</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">they
                                            possess information which is not known to people who would be likely to deal in those shares
                                            if they knew it; and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">which
                                            information (if known) would be likely to affect the price of the shares materially. (<I><U>Section
                                            270, SFO</U></I>)</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            offence extends to asking or encouraging another person to deal, and to giving them information,
                                            knowing or having reasonable cause to believe that the other person will deal.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is not only individuals that can be accused of insider dealing. Corporations are imputed
                                            with the knowledge of their directors and employees. Therefore, in certain circumstances,
                                            if the Company deals in another listed company&rsquo;s shares at a time when one of its directors
                                            or employees is in possession of Inside Information, the Company may be guilty of insider
                                            dealing too.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                            Market Misconduct</B></FONT></TD></TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">False
                                            trading takes place where a person does anything with the intention that it creates a false
                                            or misleading appearance of:</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">active
                                            trading in securities;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            market for securities; or</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            price for dealing in securities;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
being reckless as to whether it would have that effect. <I>(<U>Sections 274 and 295, SFO</U>)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                            rigging occurs when a person enters into an artificial transaction which has the effect of
                                            maintaining, increasing, reducing, stabilizing or causing fluctuations in the price of securities.
                                            <I>(<U>Sections 275 and 296, SFO</U>)</I></FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            offence of disclosing information about prohibited transactions takes place when a person
                                            discloses, or authorizes or is concerned in the disclosure of, information about a transaction
                                            which constitutes market misconduct and where he (or his associate) carried out the market
                                            misconduct or expects to benefit as a result of the disclosure. <I>(<U>Sections 276 and 297,
                                            SFO</U>)</I></FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            offence of disclosing false or misleading information takes place when a person discloses
                                            false or misleading information which is likely either to induce others to invest, or to
                                            affect the price of securities and the person knows that or is reckless or negligent as to
                                            whether the information is false or misleading. <I>(<U>Sections 277 and 298, SFO</U>)</I></FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                            market manipulation occurs when a person carries out two or more transactions in relation
                                            to securities of a corporation that by themselves, or in conjunction with other transactions,
                                            increase, reduce, maintain or stabilize (or are likely to do so) the price of any traded
                                            securities, with the intention of inducing another person to purchase or sell (or refrain
                                            from purchasing or selling) securities of that corporation. <I>(<U>Sections 278 and 299,
                                            SFO</U>)</I></FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Examples
                                            of activities that will usually amount to false trading, price rigging and/or market manipulation
                                            are wash sales (where a person uses a nominee to buy and sell shares without the beneficial
                                            owner changing) and matched orders (where a person agrees to buy shares at the same price
                                            as he has agreed to sell the same number of shares).</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            activities set out in paragraphs 3.1 to 3.6 above are, like insider dealing, both criminal
                                            and civil offences in Hong Kong. There are some additional types of misconduct that are only
                                            criminal offences. These are:</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offences
                                            involving fraudulent or deceptive devices in transactions in securities, futures contracts
                                            or leveraged foreign exchange trading (<I><U>Section 300, SFO</U></I>);</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offences
                                            of disclosure of false or misleading information inducing others to enter into leveraged
                                            foreign exchange contracts (<I><U>Section 301, SFO</U></I>); and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offences
                                            of falsely representing dealings in futures contracts on behalf of others (<I><U>Section
                                            302, SFO</U></I>).</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consequences
                                            of Breach</B></FONT></TD></TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            six types of market misconduct are criminal offences, punishable in court by a fine of up
                                            to HK$10 million and imprisonment for up to 10 years. Most are also civil offences and will
                                            be investigated by the Market Misconduct Tribunal in Hong Kong (&ldquo;<B>MMT</B>&rdquo;).</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            MMT was established to make it easier to prosecute market participants for behavior which
                                            now constitutes market misconduct. The MMT has wide-ranging powers to investigate and obtain
                                            evidence in relation to misconduct. Although the penalties for breaches prosecuted by the
                                            MMT (rather than through the courts) are less severe, it is generally considerably easier
                                            for a person to be called to account than it was in the past.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            MMT has the power to make the following orders:</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            &ldquo;disqualification order&rdquo;, preventing the person from being a director, liquidator,
                                            receiver or otherwise being involved in the management of the listed company for a period
                                            of up to 5 years without the approval of the court&#65307;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            &ldquo;cold shoulder order&rdquo;, preventing that person from acquiring, disposing or otherwise
                                            dealing in securities, futures, leveraged foreign exchange contracts or collective investment
                                            schemes for a period of up to 5 years without the approval of the court;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            &ldquo;cease and desist order&rdquo;, preventing that person from being involved in any further
                                            market misconduct;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            &ldquo;disgorgement order&rdquo;, requiring the person to pay to the Government an amount
                                            up to the profit obtained;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            &ldquo;costs order&rdquo;, requiring the person to pay to the investigating authority an
                                            amount considered to be appropriate to compensate for the costs of the investigation; and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            &ldquo;disciplinary referral order&rdquo;, requiring that disciplinary action be taken against
                                            the person.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            person who commits market misconduct may also be liable to compensate a person who suffers
                                            loss as a result of the misconduct.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Obligation
                                            to Take Steps to Prevent Market Misconduct</B></FONT></TD></TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
directors, managers, secretary and senior management of the Company are required to take all reasonable measures to ensure that proper
safeguards exist to prevent the Company from acting in a way which would constitute market misconduct. (<I><U>Section 279, SFO</U></I>)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Takeovers
                                            and Insider Dealing</B></FONT></TD></TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that the Company is considering making a takeover offer for a Hong Kong listed corporation will be Inside Information under the
Hong Kong legislation. If the Company decides, as part of the lead-up to the takeover offer, to build a strategic stake in the target,
this will be permitted, provided that the purpose of the dealing is for the takeover offer, and not to affect the price of the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Guideline
for Determining Inside Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Public
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
is considered unpublished if it has not been formally announced by Company by way of an announcement published on HKSE website, Company&rsquo;s
official website or official WeChat account (or announcement in other form recognized by the Listing Rules). Information will continue
to be considered unpublished until the day after the announcement has been published. Statements by the Company&rsquo;s or its affiliates
executives are not considered formal announcements that would qualify as publication under the Listing Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Questions
Checklist for Determining Inside Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
determine whether information is Inside Information, an individual should ask the following questions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Would
                                            a member of the public consider the information necessary to value an investment in the Company
                                            or any of its affiliated companies?</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Would
                                            the information be necessary to avoid speculation or manipulation of the Company&rsquo;s
                                            securities (creation of a false market)?</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Would
                                            it be reasonable to expect that the information would affect the price of or market activity
                                            in the Company&rsquo;s securities or market activity?</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the answer to any of these questions is &ldquo;<U>yes</U>,&rdquo; the information is Inside Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Examples
of Inside Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: -6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
dealing with the following subjects is reasonably likely to be found as Inside Information:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regularly
                                            recurring matters (such as financial results and dividends);</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exceptional
                                            matters (such as acquisitions, connected transactions, strategic alliances, licensing arrangements,
                                            collaborations, etc.);</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">signing
                                            an important contract (including significant joint venture agreements);</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fund-raising
                                            exercises;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comments
                                            on the prospects for future earnings or dividends;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">release
                                            of any projected profits of the Company by Company or its directors;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">entering
                                            into an agreement for the issue of options convertible into securities;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            large foreign exchange loss;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">major
                                            market upheaval in the industries, countries or regions where the company has significant
                                            operations or transactions;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">premature
                                            removal of auditors before end of their term in office;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancellation
                                            of an agreement which was previously the subject of an announcement;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">removal
                                            or resignation of the chief executive officer;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company being aware that its auditors will issue a qualified report on its results;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            change of accounting policy that may gave a significant impact on the accounts; or</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">events
                                            beyond the control of the Company and is of material significance to the Company&rsquo;s
                                            business, operations or financial performance;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            timelines or the results of preclinical studies or clinical trials;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">scientific,
                                            medical or financial data relating to the Company&rsquo;s products or products under development;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
                                            regarding significant litigation or government agency investigations;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">impending
                                            bankruptcy or liquidity problems;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in earnings estimates or unusual gains or losses in major operations;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">major
                                            changes in management;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            determination to declare a dividend;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">extraordinary
                                            borrowings; and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions
                                            of regulatory and health agencies, particularly the China and U.S. Food and Drug Administrations.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Uncertainty</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
with questions of Inside Information, if you are not sure whether information is considered as Inside Information, you should either
consult with the Compliance Representative or assume that the information is Inside Information and treat it as Inside Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>10
<FILENAME>ea028514801ex12-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
12.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>pursuant to Rule 13a-14(a) of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Dajun Yang, MD, PhD, principal executive officer of Ascentage Pharma Group International (&ldquo;Ascentage Pharma&rdquo;), certify that:</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this Annual Report on Form 20-F for the year ended December 31, 2025 of Ascentage Pharma;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge,
                                                                                                                                                                   this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of Ascentage Pharma as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left">Ascentage
Pharma&rsquo;s <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for Ascentage Pharma and have:</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to Ascentage Pharma, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">statements
for external purposes in accordance with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluated
the effectiveness of Ascentage Pharma&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosed
in this report any change in Ascentage Pharma&rsquo;s internal control over financial reporting that occurred during the period covered
by the annual report that has materially affected, or is reasonably likely to materially affect, Ascentage Pharma&rsquo;s internal control
over financial reporting; and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left">Ascentage Pharma&rsquo;s
other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to
Ascentage Pharma&rsquo;s auditors and the audit committee of Ascentage Pharma&rsquo;s board of directors (or persons performing the equivalent
functions):</TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect Ascentage Pharma&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any fraud, whether or not
                                                                                                                                                                                      material, that involves management or other employees who have a significant role in Ascentage Pharma&rsquo;s internal control over
                                                                                                                                                                                      financial reporting.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt">Date: April 29, 2026</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; font-size: 10pt">/s/ Dajun Yang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Dajun Yang, MD, PhD<BR>
 Chairman of the Board of Directors and Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>11
<FILENAME>ea028514801ex12-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
12.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Financial and Accounting
Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>pursuant to Rule 13a-14(a) of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Jin Cao, acting principal financial and accounting officer of Ascentage Pharma Group International (&ldquo;Ascentage Pharma&rdquo;),
certify</FONT> that:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this Annual
                                                                                                                                    Report on Form 20-F for the year ended December 31, 2025 of Ascentage Pharma;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge,
                                                                                                                                                                   this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of Ascentage Pharma as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left">Ascentage Pharma&rsquo;s other certifying officers and I are responsible for establishing and maintaining
                                                                                                                                    disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
                                                                                                                                    reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for Ascentage Pharma and have:</TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to Ascentage Pharma, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">statements
for external purposes in accordance with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluated
the effectiveness of Ascentage Pharma&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosed
in this report any change in Ascentage Pharma&rsquo;s internal control over financial reporting that occurred during the period covered
by the annual report that has materially affected, or is reasonably likely to materially affect, Ascentage Pharma&rsquo;s internal control
over financial reporting; and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage
Pharma&rsquo;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to Ascentage Pharma&rsquo;s auditors and the audit committee of Ascentage Pharma&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect Ascentage Pharma&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
fraud, whether or not material, that involves management or other employees who have a significant role in Ascentage Pharma&rsquo;s internal
control over financial reporting.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt">Date: April 29, 2026</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; font-size: 10pt">/s/ Veet Misra</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Veet Misra, <BR> Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>12
<FILENAME>ea028514801ex13-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 13.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Certification of Principal
Executive Officer</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934
and</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Section 1350 of Chapter 63 of Title 18 of the United States Code</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended,
and Section 1350 of Chapter 63 of Title 18 of the United States Code, Dajun Yang, MD, PhD, Chief Executive Officer (Principal Executive Officer)
of Ascentage Pharma Group International (the &ldquo;Company&rdquo;), hereby certifies that, to the best of his knowledge:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: justify">1.</TD><TD STYLE="text-align: left">Our Annual Report on Form 20-F for the year ended December
31, 2025, to which this Certification is attached as Exhibit 13.1 (the &ldquo;Report&rdquo;), fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and</TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: justify">2.</TD><TD STYLE="text-align: left">The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">Date: April 29, 2026</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">/s/ Dajun Yang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Dajun Yang, MD, PhD, Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><I>(Principal Executive Officer)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><I>This certification accompanies
this Annual Report on Form 20-F pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and Section 1350 of Chapter
63 of Title 18 of the United States Code and shall not, except to the extent required by such Act, be deemed filed by the Company for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Such certification will not
be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to
the extent that the Company specifically incorporates it by reference.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>13
<FILENAME>ea028514801ex13-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
13.2</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -1.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification
of Principal Financial and Accounting Officer</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -1.95pt">Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934
and</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -1.95pt">Section 1350 of Chapter 63 of Title 18 of the United States Code</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -1.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0">Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934,
as amended, and Section 1350 of Chapter 63 of Title 18 of the United States Code, <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jin
Cao, Acting Financial and Accounting Officer of Ascentage Pharma Group International (the &ldquo;Company&rdquo;),
hereby certifies that, to the best of his knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Annual Report on Form
                                                                                                                                                                  20-F for the year ended December 31, 2025, to which this Certification is attached as Exhibit 13.2 (the &ldquo;Report&rdquo;), fully
                                                                                                                                                                  complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 29, 2026</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Veet Misra</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Veet Misra, Chief Financial Officer</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
certification accompanies this Annual Report on Form 20-F pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended,
and Section 1350 of Chapter 63 of Title 18 of the United States Code and shall not, except to the extent required by such Act, be deemed
filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;).
Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or
the Exchange Act, except to the extent that the Company specifically incorporates it by reference.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>14
<FILENAME>ea028514801ex15-1.htm
<DESCRIPTION>CONSENT OF ERNST & YOUNG HUA MING LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 15.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Consent of Independent Registered Public Accounting Firm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We consent to the incorporation by reference in the following Registration
Statements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Registration Statement (Form S-8 No. 333-284445) pertaining to the Pre-IPO Share Option Scheme, Post-IPO Share Option Scheme, 2018
Restricted Share Unit Scheme, 2021 Restricted Share Unit Scheme and 2022 Restricted Share Unit Scheme of Ascentage Pharma Group International,</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                                        </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Registration Statement (Form S-8 No. 333-284064) pertaining to the 2022 Restricted Share Unit Scheme of Ascentage Pharma Group International,
and</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
             </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>Registration Statement (Form S-8 No. 333-290285) pertaining to the 2022 Restricted Share Unit Scheme of Ascentage Pharma Group International;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">of our report dated April 29, 2026, with respect to the consolidated
financial statements of Ascentage Pharma Group International included in this Annual Report (Form 20-F) of Ascentage Pharma Group International
for the year ended December 31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Ernst &amp; Young Hua Ming LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shanghai, the People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 29, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.2
<SEQUENCE>15
<FILENAME>ea028514801ex15-2.htm
<DESCRIPTION>CONSENT OF WALKERS (HONG KONG)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Exhibit 15.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ea028514801_ex15-2img1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 20%"><B>Partners:</B></TD>
  <TD STYLE="width: 39%">28 April 2026</TD>
  <TD STYLE="text-align: right; width: 41%">Our Ref: MRC/BLUI/A6519-H26578</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Paul Aherne **</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brett Basdeo ***</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John Cartwright *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John Crook *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mark Cummings *****</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Natalie Curtis ****</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">James Gaden ****</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kevin Ho ****</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kristen Kwok **</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wing Lam *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Thomas Pugh *****</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Andrew Randall **</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Victoria Raymond *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wei Ching Teo ******</P>

</TD>
  <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Ascentage Pharma Group International</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#20126;&#30427;&#37291;&#34277;&#38598;&#22296;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Walkers Corporate Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">190 Elgin Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">George Town</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Grand Cayman KY1-9008, Cayman Islands</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sir or Madam</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ASCENTAGE PHARMA GROUP INTERNATIONAL </B>&#20126;&#30427;&#37291;&#34277;&#38598;&#22296;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We consent to the reference to our firm under the heading &ldquo;Item
10. Additional Information&mdash;E. Taxation&mdash;Cayman Islands taxation&rdquo; in the Annual Report on Form 20-F of Ascentage
Pharma Group International for the fiscal year ended December 31, 2025 (the &ldquo;<B>Annual Report</B>&rdquo;), which was filed with
the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) under the U.S. Securities Exchange Act of 1934, as
amended (the &ldquo;<B>Exchange Act</B>&rdquo;) in the month of April 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, we also consent to the inclusion of our opinion as discussed in the heading  &ldquo;Item 10. Additional Information&mdash;E. Taxation&mdash;Cayman Islands taxation&rdquo; in the Annual  Report and further consent to our opinion as set forth in this Annual Report being  incorporated by reference into the Registration Statement on Form S-8 (No. 333-284445). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In giving such consent, we do not thereby admit that we come within the category of  persons whose consent is required under the Exchange Act, or the rules and regulations  of the Commission promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yours faithfully</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ WALKERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WALKERS (HONG KONG)</B></P>

 </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Walkers (Hong Kong)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0">&#36984;&#22025;&#20553;&#24107;&#20107;&#21209;&#25152;(<FONT STYLE="font-family: Times New Roman, Times, Serif">&#39321;&#28207;</FONT>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0">15th Floor, Alexandra House, 18 Chater Road,
Central, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>T</B> +852 2284 4566 <B>F</B> +852 2284 4560</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0">Bermuda | British Virgin Islands | Cayman
Islands | Dubai | Guernsey | Hong Kong | Ireland | Jersey | London | Singapore</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">*England and Wales; **BVI; ***Cayman
Islands; ****New South Wales (Australia); *****Bermuda, ******Singapore</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.3
<SEQUENCE>16
<FILENAME>ea028514801ex15-3.htm
<DESCRIPTION>CONSENT OF JUNHE LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 15.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">26/F HKRI Centre One, HKRI Taikoo Hui,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">288 Shimen Road (No. 1),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Shanghai 200041, P.R. China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">T: (86-21) 5298-5488</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">F: (86-21) 5298-5492</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">junhesh@junhe.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">April 28, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>To:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Ascentage Pharma Group International (the &ldquo;Company&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">190 Elgin Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">George Town</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Grand Cayman KY1-9008</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cayman Islands</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">68 Xinqing Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suzhou Industrial Park</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suzhou, Jiangsu</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sir/Madam,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We consent to the references to our firm under the headings &ldquo;Item
3. Key Information&mdash;&mdash;C. Risk Factors&mdash;Risks related to doing business in the PRC&rdquo; and &ldquo;Item 10. Additional
Information&mdash;E. Taxation&mdash;Material People&rsquo;s Republic of China taxation&rdquo; in the Company&rsquo;s Annual Report on
Form 20-F for the year ended December 31, 2025 (the &ldquo;<B>Annual Report</B>&rdquo;), which will be filed with the U.S. Securities
and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) under the U.S. Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;) on April 28, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under the Exchange
Act, or the rules and regulations of the promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yours faithfully,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/<B> JunHe LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>JunHe LLP</B>&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.4
<SEQUENCE>17
<FILENAME>ea028514801ex15-4.htm
<DESCRIPTION>CONSENT OF FROST & SULLIVAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 15.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028514801_ex15-4img1.jpg" ALT="" STYLE="width: 593px; height: 160px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 27, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Ascentage Pharma Group International</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">68 Xinqing Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suzhou Industrial Park</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suzhou, Jiangsu</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Re: Ascentage Pharma Group International</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We consent to the references to our firm under the headings &ldquo;Industry
and Market Data,&rdquo; &ldquo;Item 4. Information on the Company&mdash;B. Business Overview&rdquo; and &ldquo;Item 5. Operating and Financial
Review and Prospects&mdash;A. Operating Results&rdquo; in Ascentage Pharma Group International&rsquo;s Annual Report on Form 20-F for
the year ended December 31, 2025 (the &ldquo;Annual Report&rdquo;), which will be filed with the U.S. Securities and Exchange Commission
(the &ldquo;Commission&rdquo;) under the U.S. Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) on April 28,
2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, we also consent to the inclusion of our opinion as discussed
in the headings &ldquo;Industry and Market Data,&rdquo; &ldquo;Item 4. Information on the Company&mdash;B. Business Overview&rdquo; and
&ldquo;Item 5. Operating and Financial Review and Prospects&mdash;A. Operating Results&rdquo; in the Annual Report and further consent
to our opinion as set forth in this Annual Report being incorporated by reference into the Registration Statement on Form S-8 (No. 333-284445).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In giving such consent, we do not thereby admit that we come within
the category of persons whose consent is required under the Exchange Act, or the rules and regulations of the Commission promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yours faithfully,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For and on behalf of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Frost &amp; Sullivan (Beijing) Inc., Shanghai Branch Co.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%">Signature:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 34%">/s/ Tracy Wang</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>Tracy Wang</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Consulting Manager</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>18
<FILENAME>ea028514801ex97-1.htm
<DESCRIPTION>ASCENTAGE PHARMA GROUP INTERNATIONAL COMPENSATION RECOVERY POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
97.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASCENTAGE
PHARMA GROUP INTERNATIONAL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPENSATION
RECOVERY POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
adopted on February 10, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage
Pharma Group International (the &ldquo;<B>Company</B>&rdquo;) is committed to strong corporate governance. As part of this commitment,
the Company&rsquo;s Board of Directors (the &ldquo;<B>Board</B>&rdquo;) has adopted this clawback policy called the Compensation Recovery
Policy (the &ldquo;<B>Policy</B>&rdquo;). The Policy is intended to further the Company&rsquo;s pay-for-performance philosophy and to
comply with applicable laws by providing rules relating to the reasonably prompt recovery of certain compensation received by Covered
Executives in the event of an Accounting Restatement. The application of the Policy to Covered Executives is not discretionary, except
to the limited extent provided below, and applies without regard to whether a Covered Executive was at fault. Capitalized terms used
in the Policy are defined below, and the definitions have substantive impact on its application so reviewing them carefully is important
to your understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Policy is intended to comply with, and will be interpreted in a manner consistent with, Section 10D of the Securities Exchange Act of
1934 (the &ldquo;<B>Exchange Act</B>&rdquo;), with Exchange Act Rule 10D-1 and with the listing standards of the national securities
exchange (the &ldquo;<B>Exchange</B>&rdquo;) on which the securities of the Company are listed, including any official interpretive guidance.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Persons
Covered by the Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Policy is binding and enforceable against all &ldquo;<B>Covered Executives.</B>&rdquo; A Covered Executive is each individual who is
or was ever designated as an &ldquo;executive officer&rdquo; by the Board (as defined in Item 401(b) of Regulation S-K under the Exchange
Act) (an &ldquo;<B>Executive Officer</B>&rdquo;). The Committee may (but is not obligated to) request or require a Covered Executive
to sign and return to the Company an acknowledgement that such Covered Executive will be bound by the terms and comply with the Policy.
The Policy is binding on each Covered Executive whether or not the Covered Executive signs and/or returns any acknowledgment.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Administration
of the Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Remuneration Committee (the &ldquo;<B>Committee</B>&rdquo;) of the Board has full delegated authority to administer the Policy. The Committee
is authorized to interpret and construe the Policy and to make all determinations necessary, appropriate, or advisable for the administration
of the Policy. In addition, if determined in the discretion of the Board, the Policy may be administered by the independent members of
the Board or another committee of the Board made up of independent members of the Board, in which case all references to the Committee
will be deemed to refer to the independent members of the Board or the other Board committee. All determinations of the Committee will
be final and binding and will be given the maximum deference permitted by law.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounting
Restatements Requiring Application of the Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is required to prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting
requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial
statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error
were corrected in the current period or left uncorrected in the current period (an &ldquo;<B>Accounting Restatement</B>&rdquo;), then
the Committee must determine the Excess Compensation, if any, that must be recovered. The Company&rsquo;s obligation to recover Excess
Compensation is not dependent on if or when restated financial statements are filed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Covered by the Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Policy applies to certain <B>Incentive-Based Compensation </B>(certain terms used in this Section are defined below) that is <B>Received
</B>on or after October 2, 2023 (the &ldquo;<B>Effective Date</B>&rdquo;), during the <B>Covered Period </B>while the Company has a class
of securities listed on a national securities exchange. Such Incentive-Based Compensation is considered &ldquo;<B>Clawback Eligible Incentive-Based
Compensation</B>&rdquo; if the Incentive-Based Compensation is Received by a person after such person became an Executive Officer and
the person served as an Executive Officer at any time during the performance period for the Incentive-Based Compensation. &ldquo;<B>Excess
Compensation</B>&rdquo; means the amount of Clawback Eligible Incentive-Based Compensation that exceeds the amount of Clawback Eligible
Incentive-Based Compensation that otherwise would have been Received had such Clawback Eligible Incentive-Based Compensation been determined
based on the restated amounts. Excess Compensation must be computed without regard to any taxes paid and is referred to in the listings
standards as &ldquo;erroneously awarded compensation&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
determine the amount of Excess Compensation for Incentive-Based Compensation based on stock price or total shareholder return, where
it is not subject to mathematical recalculation directly from the information in an Accounting Restatement, the amount must be based
on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total shareholder return upon which the Incentive-Based
Compensation was Received and the Company must maintain documentation of the determination of that reasonable estimate and provide that
documentation to the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Incentive-Based
Compensation</B>&rdquo; means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial
Reporting Measure. For the avoidance of doubt, no compensation that is potentially subject to recovery under the Policy will be earned
until the Company&rsquo;s right to recover under the Policy has lapsed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Financial
Reporting Measures</B>&rdquo; are measures that are determined and presented in accordance with the accounting principles used in preparing
the Company&rsquo;s financial statements, and any measures that are derived wholly or in part from such measures. Stock price and total
shareholder return are also Financial Reporting Measures. A Financial Reporting Measure need not be presented within the financial statements
or included in a filing with the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive-Based
Compensation is &ldquo;<B>Received</B>&rdquo; under the Policy in the Company&rsquo;s fiscal period during which the Financial Reporting
Measure specified in the Incentive-Based Compensation award is attained, even if the payment, vesting, settlement or grant of the Incentive-Based
Compensation occurs after the end of that period. For the avoidance of doubt, the Policy does not apply to Incentive-Based Compensation
for which the Financial Reporting Measure is attained prior to the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Covered
Period</B>&rdquo; means the three completed fiscal years immediately preceding the Accounting Restatement Determination Date. In addition,
Covered Period can include certain transition periods resulting from a change in the Company&rsquo;s fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Accounting
Restatement Determination Date</B>&rdquo; means the earliest to occur of: (a) the date the Board, a committee of the Board, or one or
more of the officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have
concluded, that the Company is required to prepare an Accounting Restatement; and (b) the date a court, regulator, or other legally authorized
body directs the Company to prepare an Accounting Restatement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Repayment
of Excess Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must recover Excess Compensation reasonably promptly and Covered Executives are required to repay Excess Compensation to the
Company. Subject to applicable law, the Company may recover Excess Compensation by requiring the Covered Executive to repay such amount
to the Company by direct payment to the Company or such other means or combination of means as the Committee determines to be appropriate
(these determinations do not need to be identical as to each Covered Executive). These means include (but are not limited to):</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring
reimbursement of cash Incentive-Based Compensation previously paid;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">seeking
recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards (including,
but not limited to, time-based vesting awards), without regard to whether such awards are Incentive-Based Compensation or vest based
on the achievement of performance goals;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offsetting
the amount to be recovered from any unpaid or future compensation to be paid by the Company or any affiliate of the Company to the Covered
Executive, including (but not limited to) payments of severance that might otherwise be due in connection with a Covered Executive&rsquo;s
termination of employment and without regard to whether such amounts are Incentive-Based Compensation;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancelling
outstanding vested or unvested equity awards (including, but not limited to, time-based vesting awards), without regard to whether such
awards are Incentive-Based Compensation; and/or</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">taking
any other remedial and recovery action permitted by law, as determined by the Committee.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
repayment of Excess Compensation must be made by a Covered Executive notwithstanding any Covered Executive&rsquo;s belief (whether or
not legitimate) that the Excess Compensation had been previously earned under applicable law and therefore is not subject to clawback.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to its rights to recovery under the Policy, the Company or any affiliate of the Company may take any legal actions it determines
appropriate to enforce a Covered Executive&rsquo;s obligations to the Company or to discipline a Covered Executive. Failure of a Covered
Executive to comply with their obligations under the Policy may result in (without limitation) termination of that Covered Executive&rsquo;s
employment, institution of civil proceedings, reporting of misconduct to appropriate governmental authorities, reduction of future compensation
opportunities or change in role. The decision to take any actions described in the preceding sentence will not be subject to the approval
of the Committee and can be made by the Board, any committee of the Board, or any duly authorized officer of the Company or of any applicable
affiliate of the Company. For avoidance of doubt, any decisions of the Company or the Covered Executive&rsquo;s employer to discipline
a Covered Executive or terminate the employment of a Covered Executive are independent of determinations under this Policy. For example,
if a Covered Executive was involved in activities that led to an Accounting Restatement, the Company&rsquo;s decision as to whether to
not to terminate such Covered Executive&rsquo;s employment would be made under its employment arrangements with such Covered Executive
and the requirement to apply this no-fault and non-discretionary clawback policy will not be determinative of whether any such termination
is for cause, although failure to comply with the Policy might be something that could result in a termination for cause depending on
the terms of such arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limited
Exceptions to the Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must recover the Excess Compensation in accordance with the Policy except to the limited extent that any of the conditions set
forth below is met, and the Committee determines that recovery of the Excess Compensation would be impracticable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered. Before reaching this
conclusion, the Company must make a reasonable attempt to recover such Excess Compensation, document such reasonable attempt(s) to recover,
and provide that documentation to the Exchange;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovery
would violate a law in the country where the Company was incorporated that was adopted prior to the date that the Policy was initially
adopted. Before making this determination, the Company must obtain an opinion of home country counsel, acceptable to the Exchange, that
recovery would result in such a violation, and must provide such opinion to the Exchange; or</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovery
would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company,
to fail to meet the legal requirements as such.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Important Information in the Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Policy is in addition to the requirements of Section 304 of the Sarbanes-Oxley Act of 2002 that are applicable to the Company&rsquo;s
Chief Executive Officer and Chief Financial Officer, as well as any other applicable laws, regulatory requirements, rules, or pursuant
to the terms of any existing Company policy or agreement providing for the recovery of compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the terms of any of the Company&rsquo;s organizational documents (including, but not limited to, the Company&rsquo;s bylaws), any corporate
policy or any contract (including, but not limited to, any indemnification agreement), neither the Company nor any affiliate of the Company
will indemnify or provide advancement for any Covered Executive against any loss of Excess Compensation. Neither the Company nor any
affiliate of the Company will pay for or reimburse insurance premiums for an insurance policy that covers potential recovery obligations.
In the event that the Company is required to recover Excess Compensation pursuant to the Policy from a Covered Executive who is no longer
an employee, the Company will be entitled to seek recovery in order to comply with applicable law, regardless of the terms of any release
of claims or separation agreement that individual may have signed.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee or Board may review and modify the Policy from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any provision of the Policy or the application of any such provision to any Covered Executive is adjudicated to be invalid, illegal or
unenforceable in any respect, such invalidity, illegality or unenforceability will not affect any other provisions of the Policy or the
application of such provision to another Covered Executive, and the invalid, illegal or unenforceable provisions will be deemed amended
to the minimum extent necessary to render any such provision or application enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Policy will terminate and no longer be enforceable when the Company ceases to be listed issuer within the meaning of Section 10D of the
Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
acknowledge that I have received and read the Compensation Recovery Policy (the &ldquo;<B>Policy</B>&rdquo;) of Ascentage Pharma Group
International (the &ldquo;<B>Company</B>&rdquo;).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: left; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
understand and acknowledge that the Policy applies to me, and all of my beneficiaries, heirs, executors, administrators or other legal
representatives and that the Company&rsquo;s right to recovery in order to comply with applicable law will apply, regardless of the terms of
any release of claims or separation agreement I have signed or will sign in the future.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: left; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
agree to be bound by and to comply with the Policy and understand that determinations of the Committee (as such term is used in the Policy)
will be final and binding and will be given the maximum deference permitted by law.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: left; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
understand and agree that my current indemnification rights, whether in an individual agreement or the Company&rsquo;s organizational documents,
exclude the right to be indemnified for amounts required to be recovered under the Policy.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: left; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
understand that my failure to comply in all respects with the Policy is a basis for termination of my employment with the Company and
any affiliate of the Company as well as any other appropriate discipline.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: left; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
understand that neither the Policy, nor the application of the Policy to me, gives rise to a resignation for good reason (or similar
concept) by me under any applicable employment agreement or arrangement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: left; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
acknowledge that if I have questions concerning the meaning or application of the Policy, it is my responsibility to seek guidance from
the Legal Department, Human Resources or my own personal advisers.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: left; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
acknowledge that neither this Acknowledgement nor the Policy is meant to constitute an employment contract.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
review, sign and return this form to Human Resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Covered
Executive</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Dajun Yang</TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(print name)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Dajun Yang</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(signature)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>April 29, 2026</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(date)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ea028514801_img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $B G # 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBO.?\
MA M6_P"BH_$;_O\ >"__ )BJ3_A ]5'7XH_$4?\ ;;P5_P#,55\L?^?B_P#
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M'^9Z/17G'_"!ZI_T5+XB_P#?[P5_\Q5'_"!ZK_T5+XB_]_O!7_S%4<D?Y_\
MRG4_R#F?\O\ Y/#_ #/1Z*\X_P"$#U3_ **E\1?^_P!X*_\ F*H_X0/5/^BI
M?$7_ +_>"O\ YBJ.2/\ /_Y3J?Y!S/\ E_\ )X?YGH]%><?\('JG_14OB+_W
M^\%?_,51_P ('JG_ $5+XB_]_O!7_P Q5')'^?\ \IU/\@YG_+_Y/#_,]'HK
MSC_A ]4_Z*E\1?\ O]X*_P#F*H_X0/5/^BI?$7_O]X*_^8JCDC_/_P"4ZG^0
M<S_E_P#)X?YGH]%><?\ "!ZK_P!%2^(O_?[P5_\ ,51_P@>J?]%2^(O_ '^\
M%?\ S%4<D?Y__*=3_(.9_P O_D\/\ST>BO./^$#U3_HJ7Q%_[_>"O_F*H_X0
M/5/^BI?$7_O]X*_^8JCDC_/_ .4ZG^0<S_E_\GA_F>CT5YQ_P@>J_P#14OB+
M_P!_O!7_ ,Q5'_"!ZI_T5+XB_P#?[P5_\Q5')'^?_P IU/\ (.9_R_\ D\/\
MST>BO./^$#U3_HJ7Q%_[_>"O_F*H_P"$#U3_ **E\1?^_P!X*_\ F*HY(_S_
M /E.I_D',_Y?_)X?YGH]%><?\('JG_14OB+_ -_O!7_S%4?\('JG_14OB+_W
M^\%?_,51R1_G_P#*=3_(.9_R_P#D\/\ ,]'HKSC_ (0/5/\ HJ7Q%_[_ '@K
M_P"8JC_A ]4_Z*E\1?\ O]X*_P#F*HY(_P __E.I_D',_P"7_P GA_F>CT5Y
MQ_P@>J?]%2^(O_?[P5_\Q5'_  @>J?\ 14OB+_W^\%?_ #%4<D?Y_P#RG4_R
M#F?\O_D\/\ST>BO./^$#U3_HJ7Q%_P"_W@K_ .8JC_A ]4_Z*E\1?^_W@K_Y
MBJ.2/\__ )3J?Y!S/^7_ ,GA_F>CT5YQ_P ('JG_ $5+XB_]_O!7_P Q5'_"
M!ZI_T5+XB_\ ?[P5_P#,51R1_G_\IU/\@YG_ "_^3P_S/1Z*\X_X0/5?^BI?
M$7_O]X*_^8JC_A ]4_Z*E\1?^_W@K_YBJ.2/\_\ Y3J?Y!S/^7_R>'^9Z/17
MG'_"!ZI_T5+XB_\ ?[P5_P#,51_P@>J?]%2^(O\ W^\%?_,51R1_G_\ *=3_
M "#F?\O_ )/#_,]'HKSC_A ]4_Z*E\1?^_W@K_YBJ/\ A ]4_P"BI?$7_O\
M>"O_ )BJ.2/\_P#Y3J?Y!S/^7_R>'^9Z/17G'_"!ZI_T5+XB_P#?[P5_\Q5'
M_"!ZI_T5+XB_]_O!7_S%4<D?Y_\ RG4_R#F?\O\ Y/#_ #/1Z*\X_P"$#U3_
M **E\1?^_P!X*_\ F*H_X0/5/^BI?$7_ +_>"O\ YBJ.2/\ /_Y3J?Y!S/\
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MUE"".2ZO$LH83-*T<CQV\9+R2B(;WVA%P6W+ZY7S5^TY_P DVU#_ +#^B_\
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MKN4:4<LE.44E)WC%RDH2=.G5C.C+$_TV_P##4'C+_H7O"O\ X#W7_P >I/\
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M6M35.,Y7;ARR_I._X:@\9?\ 0O>%O_ >Z_\ CU)_PU!XR_Z%[PK_ . UU_\
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MW[5C^(-1TF#P]<>$M/\ "_B?4]6UCPA?VNB+=:K:30I>:7;/+"^FR>.^'/\
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MW'GIU)S^[-9^.5S8?#70?&MIH=FVIZ_?3Z9'83K%]AM+FQ:=;V=Y8X5GF@Q
M#;1@QNQE D<"-BWD_P#PU!XRQC_A'O"O_@-=8S_W^KF?$7_)"?AY_P!C5XD_
M]#O*\1KCR3A+AVK0QLJV5T*\H9QFU"$JT\1.4*.&QGL:%*+6(A:-.G[JNI2>
M\IR>IZO$_B!QC0Q>61PV>XK"PJ\-\.XRK##4\)2C4Q6-RQ8G%5YIX2JW.K6]
MYV<817NPIPCH?2O_  U!XR_Z%[PK_P" ]U_\>H_X:@\9=/\ A'O"V/3[/=?_
M !ZOY^?VW_VC?&?PU_: N? OB3]J?7?V+_A-I/[+TWQ5^%7CK0?A3X>^)LWQ
MW^/Z^/-9T/6/AG<:;XB\,^)+CQF/!'AJP\+:A!\$? DWAOX@_$8^-I+C2-=B
MCTT-!X+XO_X*$_'WX5^(_B]=WT5U\1]6^&/CG]L._M/AUJVE77P\TI_"?P\^
M!G[/OCCX1Z-XI\.VOAC5?&&F:3K>L>-?&&I^'IVUQ-9L"=1LKVY\5-IOV:TQ
MKY?P5AJV(HU<AHKZO5G2G.*J3?-3A&I.7LHX]UXQ<9-T7.G'ZQ&$YT>:$7)7
MA<Z\2\;A\-7P_%6+E]:H4L12IR=.FG&M4G2IQ6)J93'!5)J<5'$JE7FL%.I3
MHXOV=6:IO^H#_AJ'QG_T+_A;_P ![K_X]2?\-0>,NO\ PCWA7/K]GNO_ (]7
M\T_CW_@H]^T%\/\ 7_$+^(_A1X>OO$7PEM_VL/"OBOP]X&UWQ<WP>\0ZE\,_
M$/[)=OX,^)&M3:QX,O/'UMX8\,>'?CWK&O>+;C3[^T>PTSPEXKN++3]4BN;:
M?0]WQ#_P51\6^'/&_P"S[X-L/"OP1^*$?Q+\5^'_  ]XN\3?"W6_B9<>%O$&
MC^*?VB9_@/IOC/X*:QXPT?PS_;NBZ?:VUQXOUA(++QY!;20K9R:I;^&[W3O%
MUZG@N XRE&>3T:<HRA%J6'Q:=YUJ>'2:^N7YE5FXSC'VG*J<VY:PC-K-?%64
M82I\0XJK&=.I44J>,RUQY:6'J8J3Y_[-Y+/#P52G*4J7M/:TXPINU6I1_H[_
M .&H/&7_ $+WA7_P'NN_7_EMWI?^&H/&?_0O>%O_  'NO_CU?S.^(_VE?VK/
M&O['_P#P3WUKX=^,_B/K'QL^.'[0?C?X3_&*;X66_P '?"WQ%U>Z\(^$?V@-
M0N_"Z7/QB\.7?PP\"ZAHVO\ @3PP=>.O:7I[FSTRYTR"5-2U2 S>4_$S]J[]
MM_X5-XV\,_&[X_Z?\-?VK/A!\*/V5+KX'?LZ^ /AIX5\1^!OVYOB;\0(K?\
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MD\-2P:'X@@L-6\8^$?L]KIW@6UBMO#3:;KOBQYH1XK6ZM[_PM:OZKP'R<_\
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M\T\5HZKB'$SB^91:QN6P=2<.5.G3A5RV%251RDXP@XPG)Q?/##\U&-?^C/\
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MRO0Q6'PE/&.A.MAI1G3GB<5AI1CB894\-&=+ZI4K5/:-)4I4TE[:7L5_1O\
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M_!3C]K?]FWPG^T3JGQV\'>"/%/Q4TO\ :+^)!\+_  JU5-0L/#WPU^&?A?\
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M/N[%F;2;)F9CDDF!"22>I-?ST?\ !2[_ )2-_L _]DS^+O\ Z7W=?T*^#?\
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M%1]G%0BXMU'*4^9*/P__ ,,__%;_ *%ZW_\ !QIO_P ?H_X9_P#BM_T+UO\
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M80^7Q'Y.H:/#Y8QMQ'Y<B[!L 0A<9C C/R */ONBE_Q$?/\ _GQE/_A)7_\
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MAAXNU;Q5XCU2Q@TN:RU#6M1O+24ZUI\9DM[BYDDB<HTH9"RL"589'?FODO\
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MPC_:!]_^)?X"X_\ +PJ0?\'!'[)AZ?"3]H'_ ,%W@+_YL:/]6_'?_HW>)_\
M"+#_ /T1D/,OHTK?Q2@O^ZC7_P#H2^7]6/LC_A4'C8DM]AT;)=I-PUC2<^8V
M=\H(DR)7).^48D?<VYCN;+O^%0^."T3FRT=G@,AMY&UG2FEMS*NV4V\K2&2
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MZLZN&JJK2C5=;),'SPE.%G&%52G%3Y6N5N/X9_\ !2[_ )2-_L _]DS^+O\
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M&NOF660/Y[F6O>ZUBY->\K/7_@?\'\-#-VOI=KSW)[;_ %R?1_\ T6U?E?\
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M'/4?]1^OZMO^'CG_  3I_P"CIOA3_P"#+Q=_\J:7_AXU_P $Z_\ HZ3X5?\
M@Q\7?_*BJ_XC_P"-]K?\0II_^(WQ[V7_ %#>1RS^B[]'N2L_&'$+I_R57A[^
MN(/Y4U_X)E?M]C&?V6/B:,8_Y9^'NWTUXU;3_@F=^WQ@ _LM?$P?6/P]ZG_J
M/5_5&/\ @HO_ ,$[3T_:C^%?_@Q\7_\ RII__#Q/_@G@>G[4/PK/_<1\7?\
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M%_P;X_\ 1G_B?_P@/$?_ ,]6C_B*V=_]&<\5/_#=D'_S]#_B$.0?]'J\*O\
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MX)W_ +$,VG6<TO[-G@%Y9(BSN;GQ9ECYCKDX\2@= !TK2'_!.S]AX'(_9J\
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M.:KX2\5>&M8BQF]\.^*/#NL7>G:S8!HC.$LYTECEM8R?MO\ X1'P'_T*0_\
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M\?7^C7WCS1K;P3?7=A86D^IZ;J>K3W>HR?I!YL7_ #[)_P!_)O\ XNCS8O\
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M?S+[I?Y$%.7J?]U__0&J7S8O^?9/^_DW_P 74<\D9@G"VJLWD38423Y)\I\
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M; 'PZ[\J(\:'_"WOV!?^BV_L;_\ @Y_9_P#_ (FA?2<S/_HT'%W5?QL9Z?\
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M0P<\LPF&RRA@LTSFC:E2G6>,Q,LPK5J^)DJ<HT:6&ITGITJ]1]1_.LO[%?\
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M>"/@U\<?#GQ,\/\ P8\53_V;;?%'Q+XW_8&\8^.M3\)>)=$^'OPL7Q'?>'?
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M/Q1\(%#$8W&5X*7',%)0KXK$UH*265-*2A5@I)-I232;23?\T_EQ_P#/-/\
MOE?\*/+C_P">:?\ ?*_X5_2Q_9O_  ;<_P#06^)__@1^T-_\AT?V;_P;<_\
M06^)_P#X$?M#?_(=='_$8(?]&S\7O_$(G_\ /4Y?^(-5/^CI>#W_ (G4?_G4
M?S3^7'_SS3_OE?\ "CRX_P#GFG_?*_X5_2T-+_X-NV^[JOQ//_;Q^T,/_;.I
M5T3_ (-P6Z:G\3OQN_VA>_\ VY4?\1@A_P!&S\7O_$(G_P#/4E^#DX_%XI^#
MJ]>.X+_WE'\T'EQ_\\T_[Y7_  JS#%&0,QH>#U1?7Z5_2XOAW_@W%;IJ/Q-_
M&\_:$'_MG[U83PQ_P;EG[NH?$PCT-[^T%]>]F*?_ !&"/_1L_%__ ,0BI_\
M/4QGX01M9^+'@RO7CZFO_>4?S4PQ1GK&G4_P+Z?2KD<48/$:=/[B^H]J_I33
MPO\ \&Z9QLOOB8<_]/O[0!R<>]I_GM5I/"?_  ;MG[MY\2_3_C]^/_UY'V7
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MK?\ 0H/YOXD3/W%ZK_"/?VJZD:9^XG3^Z/4>U?T>IX&_X( '[MQ\1SGGF_\
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MCY5[_P (]3[5_6^/^"37["XQCX9^*>/^JF^,O_DZI!_P2?\ V&AP/AIXI_\
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M\J@Q;_WYO^_2?_'JRE%3>JGIRO1/O+3?J5%N*T<=>9:N+W4>^Q^/'BWX)_\
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M2^ASQ.Y2?^O'#.LF_P#D69]U;_OG^=)O3^\O_?0_QHWI_>7_ +Z'^-?Z+?\
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M\[6?^?'3?_!A<_\ R#2>=K/_ #XZ;_X,+G_Y!HOY/[F%O-?>C4K-U+_F'?\
M88T[_P!&M2>=K/\ SXZ=_P"!]S_\@U2O)-2:33!<VME%%_:^G[GAO)Y9 ?,?
M&U'M(E()P"2ZX!R <5,G[KT?3H_YHC2UW77JNS/PM_X*7?\ *1O]@'_LF?Q=
M_P#2^[K^A7P;_P BIX>_[!%C_P"B$K^>K_@I=_RD;_8!_P"R9_%W_P!+[NOZ
M%?!O_(J>'O\ L$6/_HA*^L\0/^15X9?]F_A_ZV'&A\EX??\ (V\4/^SA2_\
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MKH\LI*,JDI)R53FA!J23C%0=C]./V$/^1&\?_P#8X:;_ .F-*^YJ^&?V$/\
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M]59?]A?2O_2R.M.LS5?]59?]A?2O_2R.M.DOBE_V[^3'T7J_T"BBBF(****
M"BBB@ HHHH *5>H^H_G24J]1]1_.@#*T3_D$V'_7$_\ HV2M2LO1/^038?\
M7$_^C9*U*4?AC_A7Y(<OBE_B?YL****8@HHHH **** "LW4O^8=_V&-._P#1
MK5I5FZE_S#O^PQIW_HUJF?POY?\ I41K=?/\F?@__P %+O\ E(W^P#_V3/XN
M_P#I?=U_0KX-_P"14\/?]@BQ_P#1"5_/5_P4N_Y2-_L _P#9,_B[_P"E]W7]
M"O@W_D5/#W_8(L?_ $0E?5^('_(J\,O^S?P_];#C0^3\/O\ D;>*'_9PI?\
MK'<&'2U\K?M??\D'^(O_ %[:9_Z>_#-?5-?,/[6%F;_X)>/[-;JPLVG@TY1<
MZI>1V%A$5UCPY)FXO)OW<"L$*(7X:1D0<L*^&RR$ZF-H4Z<)U*DZD(0IPC*<
MYSE.,8PA"$93G.4FHQC&,I2;2C%MI/Z;C&RX6S]MI)9/F5W*48Q2^HXB[E*<
MH0BENY2G"*5W*44FU^&M<#\5_#NN>+_A7\3/"?AF]&G>(_%'P^\9>'M OFE,
M"VVLZQX>U'3]-=IQS K7=Q%&\_\ RQ5VE/"FO;_^$+N.?^*H^'W_ (6FE\_Y
M]\4?\(7<?]#1\/O_  M-+_SS_P#KQ7Z \FS=IIY3FUFFG;+,QO9II_\ ,#YL
M_B2G7ITJE.I'$8+FIU*=2/-C<ME'FISA4CS1>96E'FIQYHO1JZ>[/R=\;_L@
M?%GXA'QO\0=*\::%X1\2?%+P#XD^$5S\.M7T2VM=+\)?!'7OA+I_@OPMX4G\
M1V&GWNMR^)O WBW1]+\;'2MEWX6CUN]\3"Q>7[8MQ<>PZW^S-K/A'Q=I_P 3
MOA9J=UXR\>76B>-?#_C*^^)OBZSTOQ#J3^+/#7@GPQI/BSPIXEL/A_KGAGPY
MKW@O2O UGH5I9R_#^:RU;PWK.M07<TE])B[_ $ _X0NY_P"AH^'_ /X6FETO
M_"%W'_0T?#[_ ,+32_\ "LED&9J[_LC-KNSO_9N974KM\R3P+2;;ULFK6222
M/4EG^*E&$'B\N5*$94_9+$94H3H.$:<:%:4<RC4JTZ<(Q4.:I&?-S5)RJSD[
M?!%[^S?XU\1_ ;2OAE\0O&OA7QWXCT6W^$VH^'89O!'AOP]X+\#>,/A]KNE:
MIJ6N^%O^$>T'2]1NFO;6VO8=*?5--B32[EXI=*T_1XI6BM^=^(_[*>L:K>_$
M6_\ AY:>"]$F\5_&;7/BOX79/$_C3P+=>%?$/B3X':1\,+CQY-?>$;&^.N^*
MM-\36VJ^)+S1-8M;[2O$VEWILI]0L+J1MOZ,_P#"%W'_ $-/P^_\+32_\*/^
M$+N/^AH^'W_A::7_ (4WD.:-6>49MLE?^S<Q<K)-+5X%N]G^5DK*V<,[Q%.;
ME#&8!*56I6=-8G+(T>>K4C5G:C#-(4U%SBFXI.]Y\\INI4E/YE^#?A7Q/X;G
M^+%YXD:=5\4_%"36='CN+>VLY;ZVTSP)X&\'ZSXO?3[-Y+?3#\0?%7AG7O&B
M:;&P%O!J\$KI'-<2H/::['_A"[C_ *&CX??^%II='_"%W'_0T?#[_P +32ZT
MCDV;Q22RG-G:^^69CU;?_0#W9PUL33KU)595\$I2Y+J..RY12A3ITE9?VE_+
M2BWW;?2R7Z$_L(?\B-X__P"QPTW_ -,:5]S5\9?L1:+)I?@KQW&^J>'[\R^+
M-.D$FC:S;:K#'C1579/+;C;%*<;EC;DI\PXK[4\@_P#/6#_OZ*^7QM.IA\7B
M*->G5H5H56ITJU*K1JP;A3DE.G5ITZD&XRBTI0BVFG:S3?\ 5WA^K\&\/N+C
M.+P=2TJ<Z=2#_P!MQ_PSI5:M.2Z7C4DKIJ]TTJ^%R&*(S#HS(C,O(;Y2RDK\
MRJW!'SHC?>12(DMK2.66>.SLH[B>%;>>XCL[:.XGMU(9;>>=(EEFMU8 K!([
M1 @$(,"KOD'_ )ZP?]_11Y!_YZP?]_17+>+ZK[G_ )'V/*^S_#_Y(H7%G8WB
M>7>6&GWD?_/.\L+2[CSSSLN(9%!R2<XSDL<Y))S(O#7AV'Q,_C2+0],C\7OX
M?MO"C>)4M8UUD>&;/4+S5K704O0/,BTR#4M0OKV.VBV*)[N=B2K[1T7D'_GK
M!_W]%'D'_GK!_P!_12;@][/U3>W_ &Z%I=G_ %_V\5ECB00B.&",6ZRI;"."
M&,6R3_\ 'PML$11;K<?\MUA\L3?\M0].J?R#_P ]8/\ OZ*/(/\ SU@_[^BF
MG%;67HFO_;0L^S_#_,+;_7)]'_\ 1;5^/?CS]D[]MWXF:O\ &;4O#?QXU/X-
M:5K7QJ\>ZAH6C-\5O']U>?$KX=/XQU&\\""ZG;P]XOT;X):7X2T>:TF\-6/P
M^T36I_%=LGV'Q=!HA2(P?L5;PD2J?,A/#\"12?\ 5M]*A\@_\]8/^_JUG)1G
M)WDU9+:^NK?;I;^M2DY16D4[M[I.UN7N_P"O)I,_''5/V$?VNIO'FH?$&S_:
M&\+ZAXYM?!^M>&-/^)7B7QC\7+SQ'XM_M.3QK>Z.=7\,Z?IMCX>^&4'A3_A(
M=!T.V/PQO(FU]?#<7B[4(;/69CI@H>&O^">?[3$%SK.H>+OV@+'5=4UWP)XL
M\,WFJV_Q(^,,MY*]GI_[0]M\%O#VM(--TFS\3^%?AY?_ !<\$:I>3:C;P2:@
M_@26UFT'4K=M/0?L[Y!_YZP?]_11Y!_YZP?]_11R0_F:WVTWWM:.@^:?;M]E
M=/G^&WRLE^>EI^S5^T7'\&OV@/ -W\85?QY\1WL_^$1^(]C\4/BE#J-S/;^,
M=6UVXU?4+?5=%UO2O@_)<^$;S2/AXWAKX9:#KV@3Z9X?2_OS<I?KI]AX%?\
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MX.\ #@YU8_\ @W[UM!C_ (:NT$]_^2/ZKUS_ -C]7]%,>I1_VM=-]CU;G3K
M8_LV?<,7.I')7.0IW84GAB& ^Z:T?[3B_P"?+5__  63_P"-"^D9XOV=^*Z6
M[_YD'#^R>G_,N,)_1*\!)_%P/7=TG_R5'%*W6O\ S-3^=!/^" NMIC/[5>@G
M&.?^%0:KVQQC_A/?:KB?\$#M:3_FZC0CZ_\ %HM5'U_YGP]?TK^B/^TXO^?+
M5_\ P63_ .-']IQ?\^6K_P#@LG_QJO\ B8SQ?_Z*NC_XC_#_ /\ .XYI?1 ^
MC[/XN!,0_P#NZN*U^6;(_GF3_@@SK28_XRCT,@8_YI)J@SC'/_(]Y[5;C_X(
M1ZTG7]J#0SZ?\6FU/MT_YGKMS7]!W]IQ?\^6K_\ @LG_ ,:/[3B_Y\M7_P#!
M9/\ XT_^)CO%_P#Z*NC_ .(_P_\ _.XYY?0V^CM/XN <0_\ N[.+5^6;G\_J
M?\$+=93'_&3NB$C_ *I1J8]_^AY/>OIC]E+_ ().Z'^SQ\8_#WQA\7?%J/XE
M7G@S[1?>$] T_P '2^&+*U\136TUG;ZUJES=:]K4MXNEPW$L^GV=O'; :AY%
MU-,RVZQ/^M7]IQ?\^6K_ /@LG_QH_M.+_GRU?_P63_XUP9KX]^*N=99C\HS#
MBKGP&986O@L;3H91DV$JU<+B8.EB*,<3AL!#$4E6I2G2J2HSA-TJE6"G%5),
M]#(?HD^ /#6>95Q'E' /L\VR3'X;-,MK8KB'B7,:%#'X*K&OA,1+!8[-:N#Q
M$L/B(4L12AB*52G&O1H5'3G*C!&C16=_:<7_ #Y:O_X+)_\ &C^TXO\ GRU?
M_P %D_\ C7Y!S1[_ )_Y']'6?9_A_F-U7_567_87TK_TLCK3KG-4U*,Q6>+/
M51C5=,8[M-F4$+=QG R>7;HJCECP.:TO[3B_Y\M7_P#!9/\ XU*E'FEK_+W[
M/R'9V6CW?;R\S1HK._M.+_GRU?\ \%D_^-']IQ?\^6K_ /@LG_QJN:/?\_\
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M (T?VG%_SY:O_P""R?\ QJN:/?\ /_(5GV?X?YFC16=_:<7_ #Y:O_X+)_\
M&C^TXO\ GRU?_P %D_\ C1S1[_G_ )!9]G^'^9HT5G?VG%_SY:O_ ."R?_&C
M^TXO^?+5_P#P63_XT<T>_P"?^06?9_A_F:-9NI?\P[_L,:=_Z-:E_M.+_GRU
M?_P63_XU1O;Y)I-,C6UU&,MJ^GG?<6,L$0VR,?FD?Y03T4'J>!4RDG%Z]N_\
MT?(:3OL^O;L_,_"S_@I=_P I&_V ?^R9_%W_ -+[NOZ%?!O_ "*GA[_L$6/_
M *(2OYZO^"EW_*1O]@'_ +)G\7?_ $ONZ_H5\&_\BIX>_P"P18_^B$KZSQ _
MY%7AE_V;^'_K8<:'R7A]_P C;Q0_[.%+_P!8[@PZ6OE/]L+_ )(-\1?^O?3/
M_3UX:KZLKY3_ &PO^2#?$7_KWTS_ -/7AJOG.#?^2JX>_P"QUE7_ *GX<]?Q
M&_Y(+C'_ +)C/O\ U4XX_#NH+F[M+.(SWMY9V, (4SWUW;V4 8Y(7SKJ6*+>
MP!*KOW$ D @'$]?&7[:W[.GB3]IGPO\ !/P7H+^&H-,\,?M!>$?'WC>\\5^'
MO"WC/2[#P9HWA;QKIFH78\"^-+6]\,^-[I=0UK2XX?#NJ6TL,RR27NTFR /]
MP8ZM7P^$KU\+AGC,13C%T<+&3@ZTY5:%/EYTFXJ,:LZDI=(T9W:5VO\ +K*\
M-A,9F&%PV.QL<NP=6<UB,;*"J+#TX4,36Y_9MI3E.="G1A&^M3$4TE)VC+[+
M>2..,S22PQP!5<W#RQI;B-@I63SV80^6X92DF_8P92K$,"1G1&B5Y(XVN)!#
M;K)(D;7$S!F6& .RF:9E1V6*(/(R([!2J,1^)GBK]B+]L?1+#QQ\ _A[\1M<
M\8?LT:;\";'X9_#+2O%_C30+6PUJQM/#?AI5T/Q?H\EU;2Z)XPB^)-MXA\6V
M?BS1_#:Z?:>&9-.\+1:XNDQ0:):]7\2/V9_VWOB=X(\5>$]:U;79O$%Q\3?%
MFLW/CG4?CEH=SX9U7P_J'AC]H;0O"=Y\'O",/AH:O\%XM'T7QA\)?#FJPV^L
MVFM7MQ8ZG/#9[-.U/7M;\%Y_F2512X9S15:=.:45*G4IU,11<54ITJU.$HSH
MU&V\-B'&FJM.+JS44XTI?6+A+))2H2CQOD;H5JM-N<H5:5:A@\1&4J-;$8:K
M4C.GB:245C<)&=:5"K-4(.34\13_ &+P?J,XR.03[$<'\*:&0R&$/&9E57:
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MX=:_<>+?%FG>&KK0?#3/8B^NBDEP]OZ%X6_:I^%?CU_&\7@%O$?C&X\&>$]
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MFIDD9EBEC! ,D,J GD M&P!('.,GFK>S]'^3$MUZK\T5M._Y!VG_ /7C9_\
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MQ^+Q"R9?]R^=?IDC/Z#J*_GZ3_@X2^!;XQ^SE\7L$X_Y&SP5_P#&L?K5I/\
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M#D!AGAAG1_MR/_H-0_\ @TB_^2*:^F!C'?\ XP' [M?\E-B^CW_Y$^S.&K]
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M$_Y!-A_UQ/\ Z-DK4J8I<L=%\*Z+LO(<OBE_B?5]WYD/V:V_Y];7_P !H/\
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MX!\6>'/!7AO3M?\ #7B'PIXJ:S6VOIO#U]I,^H/)']M>;[K^?_UZ/-]U_/\
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M[7XS6>H7FBPZ/:V6AZK\+;2[^'?C"+P[J7P[OK>_^,/@L>,E_P"%B>(?'@\
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M\9J_\N/R5?GDS/XJK7_@DI_P4#B \SX 7:^O_%;_  \. 0 3QXJ/3%=+:_\
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MKZW/^=?^ 8?_ .9SVO\ X7IXZ_Y]_A__ .&P\ ?_ "@H_P"%Z>.O^??X?_\
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MMK_X"VW_ ,;K\BO^"3$A7X1_%[KD_$W1L<^GA*+OVZFOU6\T^X]26P .Y)/
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MM6$XM?4G9QE"46M;.+5]#]A?L</_ #\7W_@RO/\ X]1]CA_Y^+[_ ,&5Y_\
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M 'T?\*/-/O\ ]]'_  H^JP_E7W_\$?UVI_S\G]\?_D2?['#_ ,][[_P97?\
M\>I19PY'[^^ZC_F)7GZ?OOY57\T^_P#WT?\ "E$I!'7J/XC_ (4+"PNO=6ZZ
M^?J+Z[4_Y^3^^/\ \B5=+M(3IUJ3/>C,;9"ZA=HO^MD^ZHEP/PXSD]<UH?8X
M?^>]]_X,KO\ ^/5E:9*?[/M0,\1MWQ_RT<_UJ]YI]_\ OH_X5%/"P<(/E6L(
M/_R6/F:UL9-5JJ]I/2K46\>DY+^7R)_L</\ SWOO_!E=_P#QZC['#_SWOO\
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M>'M*,HZ48)QNK.46M5+LVW;2R5E?3\U?[_ZFE\P?WC^M9?FCV_.CS1[>W/\
MG/Z5T>Q?9_\ @*.;ZUY_D:GFC.-YSZ9.:3S5_O\ ZFLSS1[?GW_SV_6CS1[>
MW/\ G^E'L?)_^ H/K7FOP-3S1UWG'KDT>:/[Y_,UE^:/;_OH4>:,?PY^O'Y?
M_7H]B^W_ )*@^M>?Y&IYH_OG\S3XI1O7#$]>A/<$5D>:/;\Z9)+B*0@C(CDY
M!Y^XW3T^O;K2E1?++3[,NB_EDBH8KWX.^TX?^EP9_G/?%.:+_A:'Q,_>Q_\
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M3DHJ3_WV^JC&^KV6BZ_@;_P^'T#_ *,Y_:P_\)6R_P :/^'P^@?]&<_M8?\
MA*V7^-?OG_PSY\)^?^*5M.>/O2?_ !7?WSZ=*/\ AGSX3_\ 0JVG_?4G]& _
M+'\Z?_$2>$O^C8X7_P 3CBO_ .8A?\0AXF_Z.ECO_$'X2_\ FX_ S_A\/H'_
M $9S^UA_X2ME_C1_P^'T#_HSG]K#_P )6R_QK]\_^&?/A/\ ]"K:?]]2>N?[
MW^12?\,]_"?_ *%6TX_VGSV'][VH_P"(D\)?]&QPO_B<<5__ #$'_$(>)O\
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M7_\ ,0?\0AXF_P"CI8[_ ,0?A+_YN/P,_P"'P^@?]&<_M8?^$K9?XT?\/A]
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M -&TI?\ B?<7_P#S$'_$)^*/^CGU_P#Q7_!G_P UGX#?\/A=(_Z,_P#VK/\
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MBMI]=TF>W^U[8I#^SW\)S@_\(K:9 QG=)_\ %4?\1%X1_P"C:4O_ !/N+_\
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M+_\ YB#_ (A/Q1_T<_$?^*_X,_\ FL_ ?_A\+I'_ $9_^U9_X1MC_P#':/\
MA\+I'_1G_P"U9_X1MC_\=K]^3^SY\*#_ ,RM:#Z-)_\ %?Y^F,'_  SY\*,_
M\BK:<YXW28Y_X%Q1_P 1%X2_Z-I2_P#$^XO_ /F(7_$)^*/^CGU__%?\&?\
MS6?@%%_P6!T:*-8U_8__ &K2JY )\&V.>I/_ #U[9J3_ (?"Z1_T9_\ M6?^
M$;8__':_?C_AGOX3XQ_PBMIUS]Z3_P"*Q_6C_AGOX3]_"MI_WU)W[?>Z?2DO
M$3A&*27AG22222_U^XOLDE9+_<NB5MRI>%/%4I2E+Q0Q#E)N4F_#_@R[E)MM
MO_:UJVVWZGX#_P##X72/^C/_ -JS_P (VQ_^.T?\/A=(_P"C/_VK/_"-L?\
MX[7[\?\ #/?PGX_XI6TXZ?,_'3_:QV_QH/[/GPG(P?"MIUS]Z3_XK'Z4_P#B
M(O"/_1M*7_B?<7__ #$+_B$_%'_1S\1_XK_@S_YK/P'_ .'PND?]&?\ [5G_
M (1MC_\ ':/^'PND?]&?_M6?^$;8_P#QVOWY_P"&?/A1Q_Q2UIP,?>D_,_-U
MH_X9\^$^"/\ A%;3DYZO]?[U'_$1>$?^C:4O_$^XO_\ F(/^(3\4?]'/Q'_B
MO^#/_FL_ ;_A\+I'_1G_ .U9_P"$;8__ !VC_A\+I'_1G_[5G_A&V/\ \=K]
M^/\ AGOX3G'_ !2MIQ_M2?\ Q7\J/^&?/A/_ -"K:?\ ?4GY_>ZT?\1%X1_Z
M-I2_\3[B_P#^8@_XA/Q1_P!'/Q'_ (K_ (,_^:S\!_\ A\+I'_1G_P"U9_X1
MMC_\=IK?\%@M%=HS)^Q]^U:RQR)(57P=8J6*9(&[S&P,X)X/3'?-?OU_PSY\
M)S_S*UI_WU)^7WL?I1_PSW\)_P#H5;3_ +ZD_/[WIQ]*3\1.$7OX9T6M'9\>
M\7-.S35U]2UUBG;R!>%'%*U7BAB8NS5X\ <&)J\91=FL7=.TI*ZU5[K6UOY6
M?B1^TNG[5/[<'[&7C&R^$GQ/^%%OX?\ #GQ0\-IIGQ-TJ/3-2UF2:'4-3&HZ
M3'%E;C3D7SK5I1_R\VMR@SY3[?Z[/!P(\*^'@001I%CD'@C]PG:O/Q^SY\&&
MU+1-;N?AQX4U#7_#,5U!X;\0ZCHUC?:]X>M[XNU];:)J]U#+?Z7;7IDE-W!9
MSPQ7)EE\Y7\QL^P0PQV\4<$*".*)%CC11A511A5 [  8 KYOCKBW <6UN'ZF
M79-/(L/DG#\,E^I2S"KF=/GAF^<9DZE#%XBE2Q<Z3CFBA;%Q]NJD*FOLO8I?
M7^'O!F.X+PO$&'S#.X9]6SGB&IG4<<LOI9955.>49/EJI8C"X>K5PD:RGEDY
MWP<O8.E.DK>V59N2BBBOA3]!"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ea028514801_img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $* G # 2(  A$! Q$!_\0
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M'_$L_C'_ -$W@O\ Q(LB_P#FD/\ B:3P5_Z*;'_^(UG_ /\ ,I_7'17XM_\
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M /-'1_Q*]XP_]";)?_$HR?\ ^0#_ (FM\%_^AUGG_B*9S_\ +#^Q*BOX[?\
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M;BQT=M#TBSI']K+]B?[3K<<G[.TD'AR_U+1]&G\,^$?"^B^"H?%7PUT?XE?
M;QI%H7BV;2O$,<6JZS+9>#/BI#-J-^MS-</XBTJQ>[BM9%FTG"/%?$<95(SX
M&SBMR^S<*N%J4J=.M&7*W*%+,:F&Q,93CS\E.JJ4Z$N18QQ4IJ'3+A#AI\DH
M<>Y-14G54J>*IU:E2DXN48JI5RZGB<,XP:A*=2DZL:\7/ZI%N,7/\G5!=E1
M7=R%1$!9W9B JHJ@LS,2 JJ"22  2:L"RO6AN+A;*]:WLV"7EPMI<-!9NS!
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M^BZZ]S<VC:?;:I+:Y%U^R;^U ?#NF^(/#\^N:SHE]X?T;XDQ0R^-[+0K^_\
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M+[*XTK0].'CGX(2^(_#6O1'QO=#XA^,[3P;X;^-L]M\6[A-'NM2F\=:)H_\
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M,ACAZ6%<)9DJ2^M5:J3Q$<.J4ZEJ>&DXQYJDHU)M3?)R14GY7$609=DL,++
M\297G\L36Q4:D,M=1O"4:3?U:==U84[SQ,8RERTXNG3O!.7/)Q7[7_\ ! 3_
M )2#:!_V2WXE_P#IKM*_.+]LS_D[G]J#_LX/XR_^K%\25^CO_! /_E(-H'_9
M+?B7_P"FNTK\XOVS/^3NOVH/^S@_C+_ZL7Q)7PV5?\GTXS_[-GP1_P"M#Q"?
M=9M_R83@G_LZ?'G_ *S?#1\U4445^NGXZ:4&C:Q<BQ-MI&JW(U/[8-,-OIM[
M.-2.GKNU :>8H'%[]@4%K[[+YOV11NN/+'-9J_.RHGSNSK&J)\[-(Y 1%5<E
MG<D!% +,2 H)(K]2_P!G?_@HM!\"?AW^S[\,T\$QZSHWPT'QQ;Q9KEUH>BW_
M (NTF7XM2Z]!<M\)-:NM2MWT)?$F@:EIWAWQ\-3C0W6FZ>!HWD71-U*77[87
M[*VB_"[P=X?\ _L^?V=\2O"_PWT_P?'XXU_X??"?4IH-4%Y\#KK4=52XQ-_:
M6IP2>"OBO-HWBRYTBS\16<OCZS*&&9=0NT^&J<1\54<97P\^!\9B,.\95P^"
MQF#S3!2ISP\,1C*5/'8Z->-.>"I5*5'"U?8TXXNORXB4XWC[*F??PX9X1K8&
MAB8<>X*AB5@J.)QV"QF58V-6GB9X?!U:F P,J#J0QE:G6K8JDJU26$P]\/&$
MFI^UF_RXN(I;2>:UNXI;6ZMY7@N+6YC>WN8)XR5D@G@F5)89HV!62*1%D1@5
M90014;?(Q1\HXR"C@JX*_>!1L,".X(&.]?L#X\_;J_9$\8:C\;_$D'[+ZIXA
M^)FGW\^@'Q#X2\"^)?[(\032_$.6YN+O7;G6+;7?M/BSQ)XE\,?$[6_%$TNM
M:UI'B'19_!=A:ZEX-L-#$-CQ/^WI^R7XRO\ QIXB\:_LP0^.?$?C'XH^$?'6
MJW.N>"_AWIESJ>A:;!\*5NO"PUCP_J-B_A^+PLG@[QOI>DRZ?I-_:^/-.\9M
M-XMLM,N'OHSST^+>*'&E*IX<Y[%N%!5H1S+)G4C7J4L/4J1IJ5?V<J-"<\12
ME5J5HRE4I4^6/).I4I]%3@_A-3JQI^)6022J5_83EEN<^SE0I5L13I2JRCA_
M:QK5X0P]:-*G0E&-.K4YYJI"G2J?C[-;7-NMNUQ;7%NEW;I=VCSP2PK=VDCR
M1QW=JTB*MQ:R212QI<0EX7>*1%<M&X$%?6O[8?QW\'?'WQM\.=9\#V&N6.C>
M O@YX:^&+R:]X5\$^!IM2O="\3^-M<DU*P\'?#RXN/"/AS3)K;Q/:00:9I!B
MBCGMKF5HMTQDD^2J^QRK%8O&Y=A,7CL#/+,77IRG7P%2?M*F%E[?$PA3G.T>
M:3HTL/6?NQL\1RN*<&E\5F^$P>!S/&83+\PAFN"H5(0P^84Z?LJ>*BZ&&J3J
M0A>7+&-:KB**M*2?U=R4I*:;*_J,_P"#9_\ Y&O]KG_L7?@Y_P"G/XC5_+G7
M]1G_  ;/_P#(U_M=?]B[\'/_ $Y_$:OR;Z1'_)F^-?\ L&RK_P!7^3GZ]]&[
M_D]G O\ V%9O_P"LYG1_691117^5!_K@%%%% '^>M_P5LT?5[G_@HK^U)/;:
M5J=Q!)XZTTQS06%W-%(%\&^&48I)'"R.%=64E6(#*5/((K\YO[ U[_H":Q_X
M*[[_ .,5_J,7W@3P1J=W/?ZEX-\*ZA?73B2YO;[P]I%W=W#A50//<W%G)-*X
M154-([$*JKG  JI_PK7X=?\ 0@^"O_"5T+_Y K^Q\@^EK4R/(LDR1<!T\2LG
MRC+,J6)?$=2D\1_9V PN"]NZ2RBHJ7MOJWM/9JI-0Y^3GER\S_BOB'Z'M+/L
M_P ]SU\?U<*\ZSG-<W>&7#=.LL,\SQ^*QWL%5><4W55'ZS[+VCIP]IR<_)'F
MY5_EY?V!KW_0$UC_ ,%=]_\ &*/[ U[_ * FL?\ @KOO_C%?ZAO_  K7X=?]
M"#X*_P#"5T+_ .0*/^%:_#K_ *$'P5_X2NA?_(%>M_Q.34_Z-[3_ /$FJ?\
MSE/'_P")**/_ $<:M_XB]+_Y]G^7E_8&O?\ 0$UC_P %=]_\8H_L#7O^@)K'
M_@KOO_C%?ZAO_"M?AU_T(/@K_P )70O_ ) H_P"%:_#K_H0?!7_A*Z%_\@4?
M\3DU/^C>T_\ Q)JG_P Y0_XDHH_]'&K?^(O2_P#GV?Y>7]@:]_T!-8_\%=]_
M\8H_L#7O^@)K'_@KOO\ XQ7^H;_PK7X=?]"#X*_\)70O_D"C_A6OPZ_Z$'P5
M_P"$KH7_ ,@4?\3DU/\ HWM/_P 2:I_\Y0_XDHH_]'&K?^(O2_\ GV?Y>7]@
M:]_T!-8_\%=]_P#&*/[ U[_H":Q_X*[[_P",5_J&_P#"M?AU_P!"#X*_\)70
MO_D"C_A6OPZ_Z$'P5_X2NA?_ "!1_P 3DU/^C>T__$FJ?_.4/^)**/\ T<:M
M_P"(O2_^?9_(%_P;H0S:-^U;\7Y=8BDTF*7X!:ND4FJ(VGI*X^('P])CB>[$
M*RR!?F*1EG"!G*[58C\(?B+HFM2^/_&TL6CZK+%)XKU]XY(].O'CD1]4NF1T
M=82KHRD,K*2K @@D&O\ 3?C^'?P_A):'P+X.B8C:6C\,Z)&2O7!*V()&0#@\
M<5&?AM\.B23X!\%$GDD^%M"R3ZG_ $"OD<M^D_4R_C3BKB__ %+IU7Q-E7#&
M6/+_ .WIP6"_U;IYE3598G^RY.O]<_M"[INC2]A[*RE5Y[Q^RS/Z*M+,N".$
MN#7QO4HKA;-N*<T68+(*<WC7Q-4RRHZ+PW]JQ6'6#_LY)5%6J^W]M=QI<EI?
MY>7]@:]_T!-8_P#!7??_ !BC^P->_P"@)K'_ (*[[_XQ7^H;_P *U^'7_0@^
M"O\ PE="_P#D"C_A6OPZ_P"A!\%?^$KH7_R!7UW_ !.34_Z-[3_\2:I_\Y3X
MW_B2BC_T<:M_XB]+_P"?9_EY?V!KW_0$UC_P5WW_ ,8H_L#7O^@)K'_@KOO_
M (Q7^H;_ ,*U^'7_ $(/@K_PE="_^0*/^%:_#K_H0?!7_A*Z%_\ (%'_ !.3
M4_Z-[3_\2:I_\Y0_XDHH_P#1QJW_ (B]+_Y]G^7E_8&O?] 36/\ P5WW_P 8
MH_L#7O\ H":Q_P""N^_^,5_J&_\ "M?AU_T(/@K_ ,)70O\ Y H_X5K\.O\
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M?\244?\ HXU;_P 1>E_\^S_+R_L#7O\ H":Q_P""N^_^,4?V!KW_ $!-8_\
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M_0@^"O\ PE="_P#D"C_A6OPZ_P"A!\%?^$KH7_R!1_Q.34_Z-[3_ /$FJ?\
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M#_B2C"_]'&Q/_B+X?_Y]'^75_8&N_P#0%U;_ ,%UY_\ &:/[ UW_ * NK?\
M@NO/_C-?ZBO_  @/@3_H2O"7_A.:/_\ (='_  @/@3_H2O"7_A.:/_\ (='_
M !.3B?\ HWN&_P#$FQ/_ ,Y@_P")*,+_ -'&Q/\ XB^'_P#GT?Y=7]@:[_T!
M=6_\%UY_\9H_L#7?^@+JW_@NO/\ XS7^HK_P@/@3_H2O"7_A.:/_ /(='_"
M^!/^A*\)?^$YH_\ \AT?\3DXG_HWN&_\2;$__.8/^)*,+_T<;$_^(OA__GT?
MY=7]@:[_ - 75O\ P77G_P 9H_L#7?\ H"ZM_P""Z\_^,U_J*_\ " ^!/^A*
M\)?^$YH__P AT?\ " ^!/^A*\)?^$YH__P AT?\ $Y.)_P"C>X;_ ,2;$_\
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M#?\ $-_H\Z?\;QS#7;_C'(:VWM_PFZVZVO;K8^^_XB9]([7_ (T5E7NVYO\
MC)JWNW5US?\ "A[MUJN:UUJKK4_I[_X;=_8X/3]JC]GP_P#=7O ?_P O:4?M
MM_L<GI^U/^SY_P"'>\!__+VOYFU_X-L?C^H'_&3OPDX.?^1/\:^N?^?RI?\
MB&U^/_\ T<Y\)/\ PD/&O_R92_XAQ]'C_H^6/_\ $>I__.X3\2_I)*]O ;*W
MV_XR:OK_ .7Q_3#_ ,-L?L=_]'3?L^_^'>\!_P#R]I?^&U_V/#T_:E_9^/\
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M<S=ZKU6O,HWO9<S/%?U/E@N;-?X=)*"YK)1I)1I2M!*U".C;CR.?+;FERH]
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M,/BKQ)=P^%?#VD^&_#7Q@O/$U[XC\6^$/"1TR;P_H]M\(]=URQ\0?#?X?:1
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M ,P53K_P0;_:_4Y_X2SX('C'_(W^*?\ Y@Z_7_\ B-WA%_T</AG_ ,*\5_\
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M>UW_ *$C6_\ P9^%O_E]0!U=%<I_;VN_]"1K?_@S\+?_ "^H_M[7?^A(UO\
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MK?\ X,_"W_R^H_M[7?\ H2-;_P#!GX6_^7U '5T5RG]O:[_T)&M_^#/PM_\
M+ZC^WM=_Z$C6_P#P9^%O_E]0!U=%<I_;VN_]"1K?_@S\+?\ R^H_M[7?^A(U
MO_P9^%O_ )?4 =717*?V]KO_ $)&M_\ @S\+?_+ZC^WM=_Z$C6__  9^%O\
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M_P!"1K?_ (,_"W_R^H_M[7?^A(UO_P &?A;_ .7U '5T5RG]O:[_ -"1K?\
MX,_"W_R^H_M[7?\ H2-;_P#!GX6_^7U '5T5RG]O:[_T)&M_^#/PM_\ +ZC^
MWM=_Z$C6_P#P9^%O_E]0!U=%<I_;VN_]"1K?_@S\+?\ R^H_M[7?^A(UO_P9
M^%O_ )?4 =717*?V]KO_ $)&M_\ @S\+?_+ZC^WM=_Z$C6__  9^%O\ Y?4
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M*;U[]F'4M+_8V^(?P#USX@ZQ\-_$?P<^&OP_?PH+7XM:+IV@_$[0_&'PSO\
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M8:]I>EZS8VMJL4%GJFF:;?6T<5Q86<D/+Z_XI\5^*WTV3Q3XB\0>))-'T_\
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M"UWP%\$P_#BV\'_L%:=X<@^$&B^(/#OPOATCXA:-9Q^!-"\5BQ7Q)I7AI(?
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M_B1+96^N^,_V;_$UA\,;W5]>@^&WBZR^"]U/<:K8_$W0=.M\ZAJ4-]/9>*O
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MX=_^0Z</^">7[# Z?LG? ?\ \-SX=_\ D.OLBBC_ %QXO_Z*SBC_ ,23/_\
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MPG_\S-=510!RO_"/ZO\ ]#MXD_\  3PG_P#,S1_PC^K_ /0[>)/_  $\)_\
MS,UU5% '*_\ "/ZO_P!#MXD_\!/"?_S,T?\ "/ZO_P!#MXD_\!/"?_S,UU5%
M '*_\(_J_P#T.WB3_P !/"?_ ,S-'_"/ZO\ ]#MXD_\  3PG_P#,S7544 <K
M_P (_J__ $.WB3_P$\)__,S1_P (_J__ $.WB3_P$\)__,S7544 <K_PC^K_
M /0[>)/_  $\)_\ S,T?\(_J_P#T.WB3_P !/"?_ ,S-=510!RO_  C^K_\
M0[>)/_ 3PG_\S-'_  C^K_\ 0[>)/_ 3PG_\S-=510!RO_"/ZO\ ]#MXD_\
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M_P#T.WB3_P !/"?_ ,S-=510!RO_  C^K_\ 0[>)/_ 3PG_\S-'_  C^K_\
M0[>)/_ 3PG_\S-=510!RO_"/ZO\ ]#MXD_\  3PG_P#,S1_PC^K_ /0[>)/_
M  $\)_\ S,UU5% '*_\ "/ZO_P!#MXD_\!/"?_S,T?\ "/ZO_P!#MXD_\!/"
M?_S,UU5% '*_\(_J_P#T.WB3_P !/"?_ ,S-'_"/ZO\ ]#MXD_\  3PG_P#,
MS7544 <K_P (_J__ $.WB3_P$\)__,S1_P (_J__ $.WB3_P$\)__,S7544
M<K_PC^K_ /0[>)/_  $\)_\ S,T?\(_J_P#T.WB3_P !/"?_ ,S-=510!RO_
M  C^K_\ 0[>)/_ 3PG_\S-:FF:=>6)F-UKFIZP) @1=0ATB(0%2Q9HO[+TO3
MBQDW*'\XR@!%V!"7+:U% !1110 4444 %%?!G_!3KXQ?$GX _L*?M _%SX0^
M(;KPI\2/"&B>%'\*Z_8Z9X>UG4+"]UKXB>$/#EP=.TSQ99:CX:N]2NM/U>\L
M]/36[*?3DO;B"6Y540NOYD_\+N_;W\*^*/@;\$/VF/CSXV_94^%_QZ^.OQP_
MX1#]H[XJZ/\ LL6_[0MO\-?AG\'_  7XC\&?"OQOJ'A#0O$'[,7@OQC\1OB+
M?_$'4?#NJ+X?NO$6J^ ? QT:&RM-=U!KA/I,KX9Q6:X'Z_3QF!H4_K.*PZH5
MYUY8NJL%A(XW%U<-A:%*M6Q?L</)3]AAJ=3$3UY5&S4N2MC(4*GLG3JS?)";
ME%15./M)NG!3G.48T^:2:YIM076]]/Z*:*_ +]BC_@HIX[\7_&_X7^&OVB?V
MA/APOPKU?X ?M62>&OB#KZ^ /AIX9_:#UCX-?ME:-\'?A;\<_#]W=_V?'%<^
M.OA>NH7,VA^%M4_X1'5[HZCXCT+28M-DTW[)P<W_  52^*NH?ME_M Z'I>OZ
MO;_LO>(_#/[1?P+_ &;==N/A+JUIX%L?VA_V;?AM<>,O^%@:5\<K_P *)X#^
M(L7Q4\4>'OC7X*T?P)I?C'7;NPN/A'I,\FB6W]NR_:NU\#YY]:Q>%4*$G@\#
M#'SK)XB-"K">*GAHX>A4J8>G[7%KV6(KSPZ3J4J6&Q,:L*=>C.BL_P"TL-R4
MYMR7M*CIJ/NN46H*;E)*;M3]Z,5/:4IP<6XR4C^CFBOY)?A'_P %!_V\[/X8
MZSK'CWXR>,],UN?X(_\ !.OXJ6^D?&WPS^SE_P +"\4W/[3G[2OPJ\)^*/B-
M^S[:?"#P1I'AC5_V==>^'OB#Q'X/OQXW.O\ Q%\$^,]3T>POWT#6XO,E^O?V
M5?V\_C';?M3^.] ^-'QL\0_'?PMXB\,_M1>,/!G@GX%^%/A7\6O"FLZ5\&OB
MOI&CZ/8^ ?"'PZT?PS^TS\%?'/@?PKK$/@[QA\/?CEX?\;P_$+Q1!?ZGX6\8
MPWNG&SNNG&< 9O@X8V?UK+\1]2ISJ<N&GB:DL1[.5-3C1E*A&BFE-SYJF*4.
M6+O-.-6.$BGF="HZ:Y*L/:-+WU!*',G9R]YRUM:RA>[6FL7/^AVBOS-^%7[0
M'Q^\7?\ !1+6/A?XMU'1=%^ 7B?]BO1OCS\*/AHOA#4_#_Q!T2[OOB?HGA>Y
MUCXN3>*+&V\0Z=XZ<76IZ7/X.TX6>@^'+&VMH+VWOO$/VZ^7],J^3Q^ K9=4
MH4ZTZ,Y8C!8;&Q=";J1C3Q2KN-.<G""]M2EAZM.M&'/"-2+C"K52]I+NI58U
M5)Q4DHU)TWS*S;ARWDE=^[)23C>S:=W&+T11117":!117P/\5_B3\=X?VI-4
M\$>"[_Q%:_"SP-\#_!'Q+\2_\(Y9_"OR(]5USQ3\6[.__P"$GG\=V5_XJO\
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MJJ/^"U?_  4F) _X:)N.2/\ FG7PF_\ F#KO_#O_  5:_P""N'BS3UU;PO\
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MA\+3H1454ESU*]:4H4U&%*I)_P .Z?\ !3+_ (+('[WB#XQ=._[.7AL<\?\
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MT)II75\:^%:5)U7X!^&DHJ"G:'L)5'%M1=J?]@J7-%-SG&W-&$92:26O/2\
M^+L165"/TD/%JE)U)4N:I+%0I*2BY)NK_K&X<DWRPIS4N6=2<(1=Y:?@.O\
MP4C_ ."O)ZZ]\7/?/[/7AP'_ -5=BIT_X*0?\%=6 )U_XN=._P"SWX; Z_\
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M/$?ASQ7\'=8TS3K;5QIMUXF\9^)/!4.I+/X*U&XDI?M$_M9_M=?"W]NSX6?
MKPYKUEJ'P\O=&_9)L_$6E6?PZM=3U;QK>_%7Q_\ $SP;\9O$7AR!-#N=0U%O
M">EZ!X:\2S+I7BSP]I'PZT]I]<\367B+2KA=.DB/C=PI)J+\ O#2+E2G7CS/
M#/FIPA&;?N9#/E<E)*,9\LKMJ48V=E4^CEQMRRE'Z4'C%)1KT\-/E>,CR5JE
M25-1?M.)*?-RRC)RE3YXV2<93NK_ )")_P %$/\ @K$0<Z]\5CS_ -$#\.^W
M_5,JLI_P4-_X*OG&==^*V#GK\!/#OOZ?#(5^A'Q*_:L_;=^%&FV(\5?M%WVG
M0ZA\>_VVOASI_BF]_95T?6_M=O\ LZZ7JD'P/\/1^'O"^EFYOW^,VO6]FMSJ
M-FUK<ZV[C3_!MUISS1S-]IV/[:WQU\.? _XT>._&'POTN\\<?#SXM_!;P->6
MMQ'K>G>#?AG:_%[X6?!/QWXQE^(MQX9TOQ3XDDT7X Z_\3-?T/QI?:+HU_J\
MEAH=E]MM[6Y&IZA"3\;N$HJ,H^ ?AG44Y*,>545=N48+X^'HZ<TDG:]G9-.3
MC&6,?HV\<U)5(R^E%XRT94X2G/GJ8B5DH2F_X7%,W?EBW%-)25VFHQG*/X6+
M_P %"_\ @JV<YUWXJ_C\!?#P]?\ JF@_K5D?\%"/^"K!(_XGGQ4ZC_F@_A__
M .=K7ZT:)_P4C_:&TKXW6/@'6_V?-3\;>"_&GQ(6+1?%VCZ1XS\.V&F>"_\
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MFTV-=A"5^TD&;:2N_'%=1113;;W;?JV_S;$HI;)+T27Y)=W]X4444AA1110
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M[;XBZ+XLM-"M8["RUCQY\.=)\1^*)K2! D$>J:__ *#=ZQ-#& GV_4Q=:E.
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M GG6_A^>1T^%^G<?^3IK^PG^S--_Z!UC_P" EO\ _&Z/[,TW_H'6/_@);_\
MQNG_ ,1O\*K6_P")>.$O_"_#_P#SI,9?1K\=7>WTMN.H^F3XG3_S/'\?Z_\
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MW<+:QY;VVND]';1Z]%9?V3@O>_=U/>:;_?5+Z24[7U=FUJKV:;3W=_R'M_\
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MR\(?]#5X;_\ !YI?_P E4?\ "9>$/^AJ\-_^#S2__DJMK[#9?\^=K_X#Q?\
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MFE__ "51_P )EX0_Z&KPW_X/-+_^2JVOL-E_SYVO_@/%_P#$4?8;+_GSM?\
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MR\(?]#5X;_\ !YI?_P E4?\ "9>$/^AJ\-_^#S2__DJMK[#9?\^=K_X#Q?\
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MFE__ "51_P )EX0_Z&KPW_X/-+_^2JVOL-E_SYVO_@/%_P#$4?8;+_GSM?\
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MR\(?]#5X;_\ !YI?_P E4?\ "9>$/^AJ\-_^#S2__DJMK[#9?\^=K_X#Q?\
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MFE__ "51_P )EX0_Z&KPW_X/-+_^2JVOL-E_SYVO_@/%_P#$4?8;+_GSM?\
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MR\(?]#5X;_\ !YI?_P E4?\ "9>$/^AJ\-_^#S2__DJMK[#9?\^=K_X#Q?\
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MFE__ "51_P )EX0_Z&KPW_X/-+_^2JVOL-E_SYVO_@/%_P#$4?8;+_GSM?\
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MA_X)K?\ 1R-M_P"&T^,'_P P%.'_  6>_P"";!Z?M(6Q_P"Z:_%__P"8&O\
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M4L[&V7G)DN+B*, $EP :_*7QU_P06\1Z9X8U*^^''[0%EXF\5V=M-<:;X?\
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M]G+XJ_$3XX^$OB'\.=+\'0"/2_ASHNI>*-<U^WN=/AT[P/\ $:[\;7NE^/\
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MZ8_Y))=?_/&I_P"H?T;>OC5Q%;_LDWW_ .Q7KH8R\4OIFKX?HU\(/_N_H?\
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M+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\
ME30!V-%<=_:_C+_H3K+_ ,*F#_Y4T?VOXR_Z$ZR_\*F#_P"5- '8T5QW]K^,
MO^A.LO\ PJ8/_E31_:_C+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^
M5-']K^,O^A.LO_"I@_\ E30!V-%<=_:_C+_H3K+_ ,*F#_Y4T?VOXR_Z$ZR_
M\*F#_P"5- '8T5QW]K^,O^A.LO\ PJ8/_E31_:_C+_H3K+_PJ8/_ )4T =C1
M7'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\ E30!V-%<=_:_C+_H3K+_
M ,*F#_Y4T?VOXR_Z$ZR_\*F#_P"5- '8T5QW]K^,O^A.LO\ PJ8/_E31_:_C
M+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\
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M+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\
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M+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ea028514801_img3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $( G # 2(  A$! Q$!_\0
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MIA/_ ) _LPHK^,__ (B4_P!IW_H@WP'_ .^/B#_\VE'_ !$I_M._]$&^ _\
MWQ\0?_FTH_U%XC_Z!\+_ .%V'_\ D0_XA;QA_P! F!_\.F$_^0/[,**_C/\
M^(E/]IW_ *(-\!_^^/B#_P#-I1_Q$I_M._\ 1!O@/_WQ\0?_ )M*/]1>(_\
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MB#? ?_OCX@__ #:4?\1*?[3O_1!O@/\ ]\?$'_YM*/\ 47B/_H'PO_A=A_\
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MTX5UB[^R<954Z,8J/M/;1E!TTXN1_2117\9__$2G^T[_ -$&^ __ 'Q\0?\
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MXB4_VG?^B#? ?_OCX@__ #:4?ZB\1_\ 0/A?_"[#_P#R(?\ $+>,/^@3 _\
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MXB4_VG?^B#? ?_OCX@__ #:4?ZB\1_\ 0/A?_"[#_P#R(?\ $+>,/^@3 _\
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M_P#-I1_J+Q'_ - ^%_\ "[#_ /R(?\0MXP_Z!,#_ .'3"?\ R!_9A17\9_\
MQ$I_M._]$&^ _P#WQ\0?_FTH_P"(E/\ :=_Z(-\!_P#OCX@__-I1_J+Q'_T#
MX7_PNP__ ,B'_$+>,/\ H$P/_ATPG_R!_9A17X<?\$N/^"PJ?MV^.O$7P9^)
M7P\T?X=_%+3O#UYXN\.7?A6^U&[\*^*M%TNXL;;6;$6NKR76H:/K>FC4+>^A
MB?4M2M]3T]+^97L9-.$5Y\3_ +=/_!?SXG?![]H+Q]\'/V<OAO\ #G4?#WPN
M\2ZQX)U[Q;\1[/Q'K-[XB\3^';R72M??2-.T+Q'X9M]*T>PUBUO=/LWN)M4N
M-3BMEU'?91W*V<7!2X6SJKF%;+(X:$<5AZ,,15YZ].-&-&H[4ZBK^]":J2O&
M"C%R<HS3C'DDSRZ' O$M?-\1DD<%3AC<)AZ>+KNIBJ$,-'#5GRT:T<2N>G4C
M6FI0IJ$'-SA4C*$/9S:_J?HK^);_ (B//VVO^B=_LY?^$=X__P#GH4?\1'G[
M;7_1._V<O_".\?\ _P ]"O1_U#XA_P"?6#_\+:?_ ,J/8_XA5Q=_SYRS_P .
ME'_YG/[::*_B6_XB//VVO^B=_LY?^$=X_P#_ )Z%'_$1Y^VU_P!$[_9R_P#"
M.\?_ /ST*/\ 4/B'_GU@_P#PMI__ "H/^(5<7?\ /G+/_#I1_P#F<_MIHK^)
M;_B(\_;:_P"B=_LY?^$=X_\ _GH4?\1'G[;7_1._V<O_  CO'_\ \]"C_4/B
M'_GU@_\ PMI__*@_XA5Q=_SYRS_PZ4?_ )G/[::*_B6_XB//VVO^B=_LY?\
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M]\7/VV?V8M#^)GA^T\.>#M'^+7@S1]:D\3S^(?"WPY\":6;6SB^#]MX'\#>
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M\:NG_92/$M??/_!!/_E(Y\-?^Q+^*?\ Z@.NU\#?MN?\GD?M5_\ 9Q?QJ_\
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M>88J#J+#4*5!5'&.&:BYJDI.*;47)I-I)O\ RTO^%6_$S_HG?CG_ ,)/7O\
MY H_X5;\3/\ HG?CG_PD]>_^0*_U+?LEI_S[6_\ WYC_ /B:/LEI_P ^UO\
M]^8__B:Z/^(D8C_H48?_ ,+,1_\ *#K_ .(RXK_HGL)_X<L7_P#,I_EI?\*M
M^)G_ $3OQS_X2>O?_(%'_"K?B9_T3OQS_P"$GKW_ ,@5_J6_9+3_ )]K?_OS
M'_\ $T?9+3_GVM_^_,?_ ,31_P 1(Q'_ $*,/_X68C_Y0'_$9<5_T3V$_P##
MEB__ )E/\M+_ (5;\3/^B=^.?_"3U[_Y H_X5;\3/^B=^.?_  D]>_\ D"O]
M2W[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\ B:/^(D8C_H48?_PLQ'_R@/\
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MD7*Y7=O\M+_A5OQ,_P"B=^.?_"3U[_Y H_X5;\3/^B=^.?\ PD]>_P#D"O\
M4M^R6G_/M;_]^8__ (FC[):?\^UO_P!^8_\ XFN__B)&(_Z%&'_\+,1_\H/6
M_P"(RXK_ *)["?\ ARQ?_P RG^6E_P *M^)G_1._'/\ X2>O?_(%'_"K?B9_
MT3OQS_X2>O?_ "!7^I;]DM/^?:W_ ._,?_Q-'V2T_P"?:W_[\Q__ !-'_$2,
M1_T*,/\ ^%F(_P#E ?\ $9<5_P!$]A/_  Y8O_YE/\M+_A5OQ,_Z)WXY_P#"
M3U[_ .0*/^%6_$S_ *)WXY_\)/7O_D"O]2W[):?\^UO_ -^8_P#XFC[):?\
M/M;_ /?F/_XFC_B)&(_Z%&'_ /"S$?\ R@/^(RXK_HGL)_X<L7_\RG^6E_PJ
MWXF?]$[\<_\ A)Z]_P#(%'_"K?B9_P!$[\<_^$GKW_R!7^I;]DM/^?:W_P"_
M,?\ \31]DM/^?:W_ ._,?_Q-'_$2,1_T*,/_ .%F(_\ E ?\1EQ7_1/83_PY
M8O\ ^93_ "TO^%6_$S_HG?CG_P )/7O_ ) H_P"%6_$S_HG?CG_PD]>_^0*_
MU+?LEI_S[6__ 'YC_P#B:/LEI_S[6_\ WYC_ /B:/^(D8C_H48?_ ,+,1_\
M* _XC+BO^B>PG_ARQ?\ \RG^6E_PJWXF?]$[\<_^$GKW_P @4?\ "K?B9_T3
MOQS_ .$GKW_R!7^I;]DM/^?:W_[\Q_\ Q-'V2T_Y]K?_ +\Q_P#Q-'_$2,1_
MT*,/_P"%F(_^4!_Q&7%?]$]A/_#EB_\ YE/\M+_A5OQ,_P"B=^.?_"3U[_Y
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MD]Q/,++4=3U*\LT@GU"\>;_3:^R6G_/M;_\ ?F/_ .)H^R6G_/M;_P#?F/\
M^)J%Q_9\RR' *2;:DJTE*[<VWS+")W;J5&W>[=2;;;G)RS7BW:7.N%,K4TW)
M36)FI*3=23DI++E+F<JM5N7-=NK5;;=2;E_FL:C\8OVXM9U:XUO6?$WQSU;4
M-0GBGUM[O1-92'Q*L4.L6S6WBBWL]'M(O$=I<6OB+Q!;7,&KK=K-'K>I2$BX
MN//7HO%O[1?[?/C'QUXI^(=[XM^.NDZ[XM>Z6_M/#FG>*](T"PTZYUK4?$":
M)H>BBVN+?2])LM5U?4[FQCC:2]B-]=++?3_:)S)_I"_9+3_GVM_^_,?_ ,31
M]DM/^?:W_P"_,?\ \34?Z]PNG_J]EMU%P7[R6D&XMQ2^IV2O&.EOLI)J*43+
M_B*M*ZE_JAD]XP=./[^6E-N$G!+^SN51;IPTY?L12:BE _S0-(^(O[:.@:C!
MJ^B^)/CYI>J6UP;N"^M+/Q/'/%=G0O#_ (86Z0G3V3[3%X?\)>%M*MIRAEM;
M?PYHCVK0W&FVL\=>'QU^V5;Z1J^@0^(OV@(]%U_3-(T76M,">,#:ZEI6@I+%
MI-E<AK0N8K6">>U=XW2:]LII+'4);NS=H#_IC_9+3_GVM_\ OS'_ /$T?9+3
M_GVM_P#OS'_\35_Z_P"M_P"P,OOIK[65_==XZ_4[^ZTFM='JK/4T_P"(LJ]_
M]4\J;]UW>(FW>+4HZO+F_=DE*.ONM)QLU<_S!?&5G^T5\1)[:Z\>:7\6?%]S
M9WOB34K2?7]"\17\EOJ'C'7KKQ3XKO(6DL,I<>(O$E[>:YJT@YN]3NIKE_G>
MN,_X5;\3/^B=^.?_  D]>_\ D"O]2W[):?\ /M;_ /?F/_XFC[):?\^UO_WY
MC_\ B:UCXC5H1489-A816T8XNO&*](QPZ2^21M#QBQ%.*A3X<P4(1TC"&88F
M$8K>RC#!QBM==(H_@\_X(B^%O$W@W_@HC\(]>\7>'-=\+:';>'OBE%<ZUXBT
MC4-$TFVDN?ACXMM[9+C4=2M[:S@:XN)([> 2S*9IY8X8]TDB*?E[_@H;X%\;
MZ_\ MQ_M6ZUH7@[Q5K.CZG\>?B?>Z;JNE>'M6U#3=0L[CQ?JTEO>6-]:6DMM
M=VMQ$RRP7%O+)#-$RR1NR,"?]&)["QD4I)9VDB'&5>WA93@Y&59"#@\CC@TJ
MV5FBA5M+954 *JP1*J@=  $  '8 8K@CQQ7CFE;-/[-HN5; 4<"Z/UJMRQC1
MQ%3$*JI^RYG*3J<KBXI)*Z;;L>7#Q0Q$,\Q&=_V+AG.OE6&RIX;Z]B5",<-C
M*V,5=5?J_.Y3E6=-TW!12BI*3;:7^6G_ ,*M^)G_ $3OQS_X2>O?_(%'_"K?
MB9_T3OQS_P"$GKW_ ,@5_J6_9+3_ )]K?_OS'_\ $T?9+3_GVM_^_,?_ ,37
MH?\ $2,1_P!"C#_^%F(_^4'K?\1EQ7_1/83_ ,.6+_\ F4_RTO\ A5OQ,_Z)
MWXY_\)/7O_D"C_A5OQ,_Z)WXY_\ "3U[_P"0*_U+?LEI_P ^UO\ ]^8__B:/
MLEI_S[6__?F/_P")H_XB1B/^A1A__"S$?_* _P"(RXK_ *)["?\ ARQ?_P R
MG^6E_P *M^)G_1._'/\ X2>O?_(%'_"K?B9_T3OQS_X2>O?_ "!7^I;]DM/^
M?:W_ ._,?_Q-'V2T_P"?:W_[\Q__ !-'_$2,1_T*,/\ ^%F(_P#E ?\ $9<5
M_P!$]A/_  Y8O_YE/\M+_A5OQ,_Z)WXY_P#"3U[_ .0*/^%6_$S_ *)WXY_\
M)/7O_D"O]2W[):?\^UO_ -^8_P#XFC[):?\ /M;_ /?F/_XFC_B)&(_Z%&'_
M /"S$?\ R@/^(RXK_HGL)_X<L7_\RG^6E_PJWXF?]$[\<_\ A)Z]_P#(%'_"
MK?B9_P!$[\<_^$GKW_R!7^I;]DM/^?:W_P"_,?\ \31]DM/^?:W_ ._,?_Q-
M'_$2,1_T*,/_ .%F(_\ E ?\1EQ7_1/83_PY8O\ ^93^$W_@AOX8\2^#/^"A
M'PZUSQ?X>USPKHD/A#XFP3:QXCTF_P!$TJ&:Y\#:W#;Q3:AJ=O;6D4EQ,R0P
M(\RM+*Z11AG=5/PQ^V7\/_'FL?M<?M/ZKI/@CQ=J>F:C^T%\8[W3]1L/#>LW
M=C?V5U\1/$<UK>6=U!92075I=0/'/;7,$CPW$$D<T3O&ZL?])9["QE79)96D
MBY!VO;0NN1T.&0C([<4Y;*S4!5M+954 *JP1  #@  )@ #@ <"N"''->&9U\
MR_LV@Y5\%A\$Z/UJLHQCAZ]:LJBG[+F<INLXN+BDE%--MM+RJ?BCB:>=XK.?
M[%PSEBLLP>6O#_7L2H0CA,5B,4JRJ_5^>4JCQ#@X."C%04E)MM+_ "T_^%6_
M$S_HG?CG_P )/7O_ ) H_P"%6_$S_HG?CG_PD]>_^0*_U+?LEI_S[6__ 'YC
M_P#B:/LEI_S[6_\ WYC_ /B:[_\ B)&(_P"A1A__  LQ'_R@]7_B,N*_Z)["
M?^'+%_\ S*?Y:7_"K?B9_P!$[\<_^$GKW_R!1_PJWXF?]$[\<_\ A)Z]_P#(
M%?ZEOV2T_P"?:W_[\Q__ !-'V2T_Y]K?_OS'_P#$T?\ $2,1_P!"C#_^%F(_
M^4!_Q&7%?]$]A/\ PY8O_P"93_+2_P"%6_$S_HG?CG_PD]>_^0*/^%6_$S_H
MG?CG_P )/7O_ ) K_4M^R6G_ #[6_P#WYC_^)H^R6G_/M;_]^8__ (FC_B)&
M(_Z%&'_\+,1_\H#_ (C+BO\ HGL)_P"'+%__ #*?Y:7_  JWXF?]$[\<_P#A
M)Z]_\@4?\*M^)G_1._'/_A)Z]_\ (%?ZEOV2T_Y]K?\ [\Q__$T?9+3_ )]K
M?_OS'_\ $T?\1(Q'_0HP_P#X68C_ .4!_P 1EQ7_ $3V$_\ #EB__F4_RTO^
M%6_$S_HG?CG_ ,)/7O\ Y H_X5;\3/\ HG?CG_PD]>_^0*_U+?LEI_S[6_\
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M )45UU% '(_\(K<?]#=XN_\  [3?_E11_P (K<?]#=XN_P# [3?_ )45UU%
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M7>4)(#A<[MI*L V,$J>>#3Z .1_X16X_Z&[Q=_X':;_\J*/^$5N/^AN\7?\
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M$R?#+_HU3QK_ .'0T7_YC*?^I_$G_0KJ?^#L)_\ -(_^(=\9?]"2K_X5Y?\
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M*MI_P5)\1,<']CKXUKSW@U__ .8#_.*I<$<3O;+J7_ASR?\ ^>P_^(=\7_\
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MXT_Z$=;_ ,*LO_\ FTU_XA9Q[_T3U?\ \+,L_P#G@?JG_P (K<?]#=XN_P#
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MA[]I30]$UGP;-JWQ7TUKF*PN?B'X-O=1TKQI'X2U*WMKR4V-E=W6ESPQ=_\
MM1^%_P!O_P 0_%ZS\0?LY7NN:+X'U'X&ZSI3:!JOC'X=:!X?\*?$:[\+?$>Z
MM[^<^=K^JZSXO'BB;X>:1#!+H&M>$XXX&U>P\>^'+*QUW2_%/C/C+]K_ /X*
M%> /&&I>$[+]GR#XO7.A:;\=-)T1_"OPC^(?AZ'XC>(? =W\21X&\57-]?\
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M/B%Y->T?6OBA\0O$6I+=V/A:YCMO1OV=/CO^W'KGQ!^&%EXS\ >-O%%QX8^
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MIKNV6&XC^W2V(MWU*31Y['5(+62TU"SDE]H\3_L >(O OB+QKX;\<_&GX?\
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MN)MRRII*'-RII0J)R4Y7FT^67-'WEYEX]^$7Q'^$I\+Q?$CPO<>$;SQAH?\
MPDN@Z5J6H:/+K4VA-<2646HZAHUAJ-YJ>@QW%U!<P6L.O6NFW=R]K=&&W=;>
M4IR,/4?4_P JWO'/Q(\;_%36K'Q)\0=?N/$VOV'A[1_"\.KWL5O'?2Z-H,4Z
M:;%>S6\41OKM#=7$EQJ%R)+R[FF>6YED<YK!AZCZG^5>U1]K[*/MW3=;7VGL
ME)4^;FEI#G;FXJ/(KRU;YFTM$OH*'M_8T_K+I/$6?M?8*:HJ3E.RI^T;J.*A
M[-7G:4I<S:C=)>U_ 3X=P?%[XU_!_P"%%WJ+Z19_$OXF^!_ U]JD959M/L/$
MWB+3M*OKNW+?+]JBM+F9K3=P;KR0<YP?]'OX5?"CX>?!+P'X>^&GPM\*:1X-
M\%^%]/M].TG1='M(K:%4@B2-[N\D11+J&IWC(;C4=4O7FOM0NWENKN>6:1W/
M^:%X?U?5?#^KZ1X@T+4+G2==T'5--US1-5LW\N[TS6-(O+?4-,U"U?!"W%E?
M6\%S"2"/,C7<",@_UH?L_?\ !P=\';SP)I%C^TG\./B%H'Q)TZQMK36M:^&^
MCZ1XF\(>*+N&,1RZS96=WKNBZIX>EOV GFT::WO[:SF:5+;4I;<1 ?"<>91G
M&9T\OGEU*KB\/0595\)1DN=5IR@Z>(=)U*:JKV:E2NG*5)W:BHU'(_+?%;A_
MB'.H934RBA7Q^$PRQ$<3@<-).HL34G3='%.A*K25:*HJ=!23G*@[M04:LIGT
MQ^T=_P %0OB3\$_BS^VWX,\/_L_Z/XK\%_L8_"CPOX[U3Q9JGB/XDZ1'XS\0
M>,_ASHWC;1?#K^(M*^$/B'X9>"UBO=>LM.N;7Q%X\7Q5?Z;#=ZQH7AG4E1+9
M_)OB[_P6_P!%_9W;0/"OQM^&'P^T7XD:!^U=XE^ OQNM/#OQPM]0\#^&_A9X
M%\+?!;Q=XW^.OPS\1:UX)T#5OB&^B:;^T/\ "ZQ?X:7GA_POKHUV'X@:9)JJ
MQ>"[B^O*/B#_ (+%?\$OO&.G_$G2?%'P9\>^(],^,ME9:=\6M/UOX&^#M3L_
MB9I^FZ1%X?T^R\=6]WXEFB\4VUCH<$&CVD.M+>1V^FPQ64*K;QK&.7\,_P#!
M3K_@D+X3\/R^%?"G[,NH>'_#-SX+\1_#FXT#2?V</AW8:1=> ?&&J2:UXN\&
MW6GV^M);7/AOQ5K,TFJ^)-(GCDLM=U%S>ZI#=7&)!^;_ .JG$G_0DS'_ ,$1
M_P#EY^,?ZC<8_P#1-YM_X31_^:C](?V^_P!M#Q7^R+X8^!%]\./A9#\9O$OQ
MT^.,7P;TS2+>Y\:W1TG'PU^)'Q&N]=@T;X:>!/B3XR\2RV\'P]ETYM*T3PY+
M)"-0?4KNYM[33Y]_Y^#_ (+F/IG[5>G?LE>)_P!GJTTOQI_PU=\._@=K_B0?
M$F>T\/:3\'O$WPPT+7_&7Q]>WUOP5I>J6]OX(^+'B/2/A9<^#-5@T^[:2^CU
M;4M7TFXBGTE.3U7_ (*+_P#!(#Q-X @^%?BK]F_Q-XQ^'5IX]\0?%"P\'>,O
M@?X4\5:#IOC_ ,3W^M7^L^*=+T_7O$]_!I>K7$OB+6H(KFP6V:UL=1NK"V\J
MSE>%KK?\%#O^"/%S"\,O[*J3)+9C3Y3/^S7\-I99+$+IX^R232:L\SVY&E:9
MF)I"C'3[(L";:$HUPGQ,]LCS%_\ <"/_ ,O'_J+QC_T36;_^$T?_ )I/O+_@
MFC_P4K\#?\%&O!WQ9\1:!H.A>#-7^&_Q"L]+L_#NE>/-/\=RZQ\+?'?ARU\<
M?!GQ_?WECIFDKH>M^,_"%Q='Q)X(D@N[OP5XHT'Q#X<O-2OI]+FF'F6H_P#!
M;;]D6TOOBEI>F^&/CEXJU+X1^+?$_ASQ';^$?"'@_7[;4-%\'> /'OQ.\2?$
M/P[K=I\0_P#A'=6\#Z7X-^&'CK49IQJ\'B/[5H,FC_\ "-C6+NQL+CPK_AYY
M_P $NV\=>"/B7:?!;QUIGCOX=6=EIO@[Q/HOP@\.:+JFCZ3I7ASQ3X3T;1DN
M-*\3VC7.BZ%X>\;>+=-T+1[OS],T>+7]3;3K6VEN'>L?3_\ @H%_P2)L)-=E
MTW]EN.PD\4/K[^(WM/V</AQ:G7&\6:5X@T+Q+_:OD:HGVY=>T3Q7XGT?55N/
M,2]TOQ#K5A.'M=3O(IFN$>)WMD69/_N!'_YH'_J)QD]N&<W_ /":/_S4?6WA
MO_@JS\.O&OC+X_0^$OA9\0-3^%?P(_9A^-'[1D?Q#N?[(LM0^*D?P(^)WC3X
M6>.?#_PY\&0WU_K3V4?B;P!XETG3=6\7#PKJ.HZM9HMGX=FT:ZL]:N?'/$/_
M  4\_:%\.:%\*+0_!;]E;Q'\1/BO_P )-XML-)\.?M=W%[X/\,_#C0/V8-4_
M:?CM_&GB.U^$5_J?A;QU?Z)I-SX7T9-2\/+X2\21/:^/=*UQ/#DT]G9X7A'_
M (*:_P#!,3P-XO\ %OQ \#_ C7/"'CGQ]:&P\;^+_#7P(\#Z'XB\76,DJ7+V
M7B/5]-UFWOM8M);J,7<MM?S3PRWC2W<B-<S32OYM<?M<_P#!&/4?"UGX'N?V
M,_"\W@RP\8W_ ,0K/PHW[+7PK7PY;^.=5L'TK4O%<>BI=+IPUV^TAFT:ZU V
MYN)M&VZ0[MIRK:K7^I_%/_0@S/\ \$1_^:!_ZA\9O_FF<X_\)H__ #4?6G[$
M_P#P4J\:?MJ?'+QEX3\-_ 6[\%?!?PQ8>&+FU^(&NM\1;S6KZY\6? ?X,_&V
MPTZ]O;+X:#X1Z5K5M'\8K+0KOPRWQ2NO$+0:+<Z];6$UE>6\8YSX@_\ !9_X
M'^!-%^%'Q(N?AI\3HO@O\3-0^(\&G>,M7M_#5EXC\3:3X7T+3[CP)XD^'/@O
M3/$6MW>J:/\ $WQ7J5MX3TI?B'?_  OU31)3)JOB#3=.TZ&:9/,]!_X* _\
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M=:5/$<N(]K*$8X=4I.-3GJ\DO K?I^']%K;@ZK_G^(5B6_3\/Z+6W!U7_/\
M$*_H%;H_I?MZ?HS8@ZK_ )_B%;D'1?\ /\(K#@ZK_G^(5N0=%_S_  BNB/3T
M7Y&RW7JOS1]<?L=?$W5_AG\>/ =U8W5PFG>(=?TWPIKEC&28;_3/$=]::5,D
M\?0BUEGM]4B(*D7FFV;LQ2,HW]-5?SI?L*? S7?B?\8?#_B:;39E\&> =5L?
M$>MZK-"RVAO]-EBU'1=)@D;"37U_J$-H[6ZDE-+2]NW*E+=+C^BVOYN\9JV
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M\&_@;X'G\.^'(?"IU;Q'XA^%OQ$^('CNYAU+7M<\%:MXJ\,Z''<:YX>-G>^
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MN6^EZ?I7ASPQX'U?6?!.M:?X4TOP_I\6JIH$MAX@T[Q%%H>EG74\-^,_V_\
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M96C^T?&O_0KZ%_X5UU_\RM '6T5R7]H^-?\ H5]"_P#"NNO_ )E:/[1\:_\
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MK#2HY'.6^RV,OB&ZCLXQT6"U,5N@X2):PO\ APS_ ,$WO^B7^-O_  ['CO\
M^6]?K'_:/C7_ *%?0O\ PKKK_P"96C^T?&O_ $*^A?\ A777_P RM>JL^SM)
M)9OF*25DOK=9Z+S;;?S;?FSWEQ9Q/%**X@SA)))+Z_B'HM%K)RD_5R;[MGY.
M?\.&?^";W_1+_&W_ (=CQW_\MZ/^'#/_  3>_P"B7^-O_#L>._\ Y;U^L?\
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MY'^FW?\ X$S?WO\ ?KZ__B"^"_Z*'&?^&["?_-1]M_Q 3 ?]%-CM?^I7@O\
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MZS9>/+ZQBO8,_NY6LM9\-Z;?6LI'WX7AD5&!"S2##'%_XA\O^"@G_/A\(O\
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M^S;XCU,>*53Q='#XJU:3Q=X"^->IVDNM/,A@\6:);;H(IECT;L!_P;Y?\%!
M0?L'PBX.?^2C0?\ RKJY#_P;\_\ !0%,;K#X1_\ AQH/?_J%^]#K\*R4XSSR
M$E4BXU'+-:C<TX\KYG[.TGRVBN:+22TBFW)OZYP+.-6-3BBE-5HRA5<\^K.5
M12AR/G?L;3;A:*YHR22]V,6Y2E^:'[07C#X6^.?B%9ZY\)/#B>'M C\%^%-+
MU^:'PII_@*T\4^.=/LYU\3^,+'P)I.KZ]IGA"UUB66TA&DV>K72336$VK2>1
M-J4L$?D</4?4_P J_9V+_@@'^WV@&;'X2\>GQ$@],?\ 0,K1C_X(&?M[+C-C
M\)^I/'Q"@/48_P"@:/YU[-'/^'J-*%*.=8!QIQ48NIBU.;2O9RDZ=Y/7=[)1
M2LHQ2]^AQ9PE0HTJ$.),KE&E!0C*KF"J5&ES.\YRI7D_>>KV2C%6C"*7Y>_
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M$/\ H-0_^ ][_P#(U=A10!Q__"?>$/\ H-0_^ ][_P#(U'_"?>$/^@U#_P"
M][_\C5V%% ''_P#"?>$/^@U#_P" ][_\C4?\)]X0_P"@U#_X#WO_ ,C5V%%
M''_\)]X0_P"@U#_X#WO_ ,C4?\)]X0_Z#4/_ (#WO_R-7844 <?_ ,)]X0_Z
M#4/_ (#WO_R-1_PGWA#_ *#4/_@/>_\ R-7844 <?_PGWA#_ *#4/_@/>_\
MR-1_PGWA#_H-0_\ @/>__(U=A10!Q_\ PGWA#_H-0_\ @/>__(U'_"?>$/\
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MHGA&&TUVVTS2K;[59>(6TN33S)_;EU86S>$ZI\=_^"C]_9W=U)X4^.O@B_\
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MXZ=1_P S_KO_ ,E5?@_X*7_M]-C=^UM\<S]?'^N_[7_3W7L.F_LL?L32>"/
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ME>A].T445QGH!1110 4444 %%%% !1110 4Q(TC79&B1KN=MJ*$7=([2.V%
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MS1N\4J9VR1N\;AD9E/\ I8T52\2L5_T*,*_^YO$__*65_P 1GQO_ $3^"_\
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M[>X3_P"B#PO_ (DO$/\ D?CP/^"FOQ$=8T;]@3XUA(YI+B-6-\5CGE:226=
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M$'P4^,61GX5?$8?7P1XF'<?]0NO["**^F7C1C?\ HG\%_P"'#&?_ #.?6?\
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M'_/UXD_\+#Q9_P#+JNJHH Y7_A#M(_Y^O$G_ (6'BS_Y=4?\(=I'_/UXD_\
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M^@/ _P#AUP?_ ,B?UI?\(=I'_/UXD_\ "P\6?_+JC_A#M(_Y^O$G_A8>+/\
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MV#PRQ"Q6!PTE[18FI.FZ.*="56DJ\514Z"DG.5!W:@HU93/I3]HW_@JGXO\
M@?\ &?\ ;-^&^C? '3/%_AW]COX0^'?B/K'B.^\7_$;1+GQKJ_BSX?Z-XST;
M0+74]-^"'B3X5>$[>.\U_3])O$\4?%.S\875JEYK.@>"]:MX%AD\_P#BU_P6
MS\.?L]/H'A7XX_"?PGX7^)NA_M5:_P#L_P#QRT;1_CAH^H>#_!'P\\%>%/@O
MXP\;_';X?^*->\(^&-5^)NGZ!I?[0_PGMW^'K>%O"OBQM7NO&>G2M$G@R\O;
MOC_$G_!7[_@EQXWTWXIZ/XK^#'Q"\1Z5\<+&QTWXP:?K'P4\-7UK\3-/TO18
M/#>G6GC6&?Q,Z>(8+#0+6VT>T341.+?3X(;6';%&BCBO#_\ P4>_X(Y>&] F
M\+>'_P!EK4M,\.W?@SQ/\.[O1[?]G;P1]AO?!'C74SK/C+PS?12:XXO=*\6:
MN1J?B6"Z,QUV^2*ZU-KJ:&)T_-_]5.)7_P R3,?_  1'_P"7GXQ_J-QA_P!$
MWFW_ (31_P#FD_4/]O7]LSQ-^R%X;^!=WX#^%,?QC\4?'7XVP?!O1=%&H^.8
M8-)F;X;_ !$^(UQKLEA\,/AE\7_'6NI#:?#ZXT_^SO#W@C4)HVU!=0O)[2PL
MKF4? J_\%Q[#3OVJ-/\ V2/%'[/4VD_$$_M7_#KX!:[JZ?$9H?#^D?##Q5\,
M=$\2>+/CVT>O>"-"UB+2/ _Q/\0:5\*KWPGJ^G:1J+WE_;:GJ6H:+=B?0XO-
M]:_X*(_\$AO%OP_LOA;XN_9^^('C'P#IGQ!\0?%/2/#?BWX56'B&RT7Q]XEO
M-=N]5\2Z(VJ^,KFXT>^9?$NMV-J=-FMDLM*U"XTNU2*RD> K)^WO_P $:[SS
M3<_LI7-S+/9?V=/=W?[//@NXOY[+_B6EK:?4)M<DOIHW.CZ4\@DN&,CZ?:2.
M6>!&5_ZI\3/;(\R_\$1_^7C_ -1>,GMPUF__ (31_P#FD_1?_@F[_P %(? /
M_!1;P;\5O$_A70-,\':C\-OB!::1;^'[/QYHOCV?6?ACXW\.V?C;X-_$>[O=
M$M;.#0;[Q[X/O)KC5O!5TMQJG@OQ%HVO^&M4N[B]TN=QYIJO_!:?]CS3;_XF
M:5:Z=\:/$>J_"CQ;XE\->)[+PKX T_Q D^E^$/ GCOXE^)/'VB:I8>*7T/4_
M VE>"_AEXYUBYOEU2'6P_A^?2UT!M8NM/L+OYKL_^"EG_!+6R\=>"_B5HGP4
M\?>'/&W@"RTW2_#&O>&/A/HOAJYM=(T3PWXL\(Z!HUXFB>*+&#5M&\/:!XX\
M5V/A_2M4BO+#11K5W-IT%M,RR+S^F_MT?\$>M+D\0RZ3^RH=,?Q<_B.3Q-_9
M_P"SSX'LDUMO&&C^)/#WB<:C%;:Q''<)KN@^,?%>C:E&Z&.YTSQ%K%BZ_9K^
MYCD:X1XG>V0YE_X(C_\ - _]1.,WMPSF_P#X31_^:C[8T+_@JI\*O%GC#X]V
M_A7X<_$/5?A7\!_V9?C-^T?)\4)K.TT^/XGV7P(^)7C+X7^/M"^&/AB6:35]
M5MK/Q+X"\2Z5::UKW_".RWVK6206FCSZ9=6FL3^/:_\ \%./VA_#FD_"O3[C
M]FS]G[6/B5\5W\3>+=*\,^'?VQ;75?#6A_"O0/V:M8_:<CO/%OBBU^#4^H^%
M_'=_X9T:Y\-Z;I6L>%H/!NN731>+=$\;7GA-IKJVX7P9_P %(_\ @ES\/_&?
MC+XA^ _@%KO@_P <_$2PDTOQUXK\.? SPCH^M^+M-GN?MT]AX@OK#6H9M3LK
MF_\ ,U&ZMKHR0W.HSW6H7"27EW=3R^9W/[4W_!%S4?"MGX'N/V-M';P=8>+[
MWQ]:>%X_V;_ =MH4?C#4='_X1R]UXZ9;:G%:2WESX:5?#$JS120'PS'%X<$(
MT6*.P2O]3^*?^A!F?_@B/_S0/_4/C/\ Z)G./_"6/_S4?9_[%O\ P4K\3?MJ
M?&_QCX1\(? :\\)?!CPOI_AFZM_B/X@N_B7<:]J%QXL^!?P<^-FF6=RFG_!V
M7X-:7J,-O\8=/T&]\/S?'";Q2IT>YUJVT*YTZ\M"<3X@?\%DO@-X"TGX4?$&
M^^'OQ4M_@S\4;[XB0Z+X_P!:T.UTG4/%.D^%]#L;GP1XD^&/A2*]U&\\6Z)\
M3_%&HVGA'0Y/$5[X%O='O)!J'B&RT[3@TZ^*^&_V]O\ @EKX4^+-_P#'3PI\
M ?$?AOXOZM'Y>I_$'0_A!H>E>(K]1X>T_P (J;RZL?$4*W#IX7TK2_#T<LL3
M21Z/IUCI\;K:VD$:9"?M?_\ !(QH/$%JG[*5F+;Q9JWBC7?$D _9[\"K%K6L
M>--/&E^*=1OT&I!9KK6M/'V>[E(!VEGB\N5F<M<'<5/;A_,__">/_P T#7 /
M&KVX7SC_ ,)8_P#S4?16K_\ !;#]C+2+W2M,DL_C7>ZMKOPUT#XBZ+HVG?#,
MW.MWUSXC\7>"/ ]E\.)M%;78M5T;XE)XA^(7A>%]$\0VFCZ3=Z?>G6=*U_4M
M($5[+6\8_P#!:/\ 9FT;2?B[:>$/ OQR\<?$GX8:E\2/#>G?#JV\!1Z3/XX\
M4_"?PO\ &;Q%\1;/0_%%[K!\+P:1\/IO@)\3-+\;:A>ZE%J-C)H O?#VB>)[
M'5O#\^K^!)^U=_P2,.L:?X@C_91L8M<TO2?#>@Z?JT7[/_@B"_M='\'/HDOA
M?3X[J+4TE,&A2>&?#;Z:'9FMF\/:&4;_ (E.G_9]?Q)^UI_P2>\;V_CJT\6?
MLMV/B.V^)WBBU\:_$&WUGX >![^/QAXNM(=4@B\1Z^D^H2"_UAHM>\01W-]-
MNGO1XB\1_;'N#X@U@WK_ -2^+'MP]FG_ (3Q_P#F@?\ J!QK_P!$OG/_ (2P
M_P#FH_:?X6^-8_B?\+OAS\1O[-&EQ?$/P#X0\:_V0UR+]=.C\6^'=/UW^S6N
M_(MEO1:+J'V4W/V: 7 C\WR(@_EK_/\ ?\%3_@;X)^%GQ8\&>,_ ^F6/A^W^
M*6E:W=^(-!TV**UL$\1>'[NP2?6K*QA5(;-=7M=5@%_'!&D,E_:/=[1/>3EO
MMZS_ ."LO[)OAWP_9Z/X5\(?%&&QT+2[32M \/6'@K1])L+6PTVVCL]-TNS+
M^(8[/3[.UM88K:W0*L5O!$J(F%5:_&_]J?\ ::\4?M4?$W_A.-:TU?#VA:/8
M?V'X+\*Q7'VP:'HK7+74TE[>"*%;[6=4N2MQJ=VD44/[JUL[=!;V<3-^A>&W
M#/%&6<01QN,P>+RS+X8;$4\7'$N-)8QU*=J%&-!5JCJRA6Y:WM7!*@H2:GS5
M.27Z;X4\(\7Y3Q*LPQV QN499#"8JEC8XMQHK'.K24<-0AAXUZKK2IU^7$*K
M*G&-!4Y<M3FJ^SE\_P!OT_#^BUMP=5_S_$*Q;<''0]/0^BUMP Y7@_D?[PK^
M@5NC^E^WI^C->#JO^?XA6Y!T7_/\(K$@!RO!_(_WA6];1NY541V8]%52Q/RC
MH "371#IZ+\C9;KU7YH^E_V5?&NK>!?CS\,M5TF6=3>>+]#T.]@BE9$N].\0
M7]OH>H03H#LG5['4+@1I(K!9_*F0":*)E_J(K\#_ -@3]FOQ-XU^(>B_%77]
M+GT_P'X+OX]5L[N]@:-?$'B"Q9)]+LM+$J@7,-A?K!?ZE>1[X+?[&--D_P!)
MO#]F_?"OYK\8\=E^+XAP-#"3I5<5@,OEA\PJ4G&2A5GBI5J&&J3BVG5P])S<
MXN3E1]O&E+EES0C_ "AXXYAEN,XER_#X.=*MB\NRR6&S.K1<9<E:IBY5\/A:
MLX-IUL-1<W4@Y.5'ZQ&E/DGS4X? GQI_9N^-^O\ C[XG^(O@[XX\(^&[/XV)
M\)6\2ZYK\U[%XE\#7?PJ_M"PC72M(_X17Q3H/Q$\(ZSI&I2W$G@K7)_"26/B
M5KO4$UZ:WUFXCL?F?Q1_P3B^,.M^%]>\(1?$;P'<V>J'5+A=8U*^^)-O=WGA
MJ\^TR1_ ?4=$TJ_M]&@^%$WB"<?$.[U_3?*\71^,"YMK/S NLUUGQU_90^-O
MC']IOQI\</#NF:#J'AJS\<?LJ:EH]@MIX<MOB;JWAWX>7U_>^-Y?AG\3+_7(
MK[X:MI.KSZ5?>*_#D^F6]K\2?"-IXG\+V=_;:CXAMK^U\$\8^//^"AWPL\(K
M_P +?\3_ !!_M_Q,FL:?X)L?A=HOPTO=?U/XYQ:9X<6S2W=[#Q-IMY\"+_4[
MKQ =*\+O'HGC^Z864MCI;V%E>KI_YY1=9QI*ABL+S<M/FC.$544DHVBW>\W3
MBDF[Q24&WK%V_G/$*ASUWB<#C>3GK*,X5).DX.<^:23BE356;;BDIR;G%+W9
M*_I/B[_@GC^T3XGNM'CM_B_X%T/0+.P\<6%OH-E=>.KFW\+>&/'MG\8++4?A
M/IMUJ4%[>^(_A]ID'C_PM!I;RW'A1'M?"\MMJGAK4(X_#8\/_8_B[]CW1OB5
M\7K[QQ\0?$NO7W@.Z^$OP=\ 7?PXT#Q'K.@:!XLU;X7>-?'_ (Q^U^/K"Q\E
M/$>A_:_%&CG2--:]A5#9ZM;ZC!=66H&%OC35OA5^WW>IJ_@^=?%\7@*;1]-U
M/^SO!GBWX8>#'TR[T'XP^'O&+6'A/5;*[DU#5=<\5:#9:];ZA!J[>%+6V@OY
M;"_U[6=/O+73K+8\7^!?^"C.HV'@'PSIFM>-[N/7_"6K)\3M=N/&GPGL[>TO
MO&S_ !0T[Q#HUK'IFG:3J.B7'@W3KGX:2^$=7T>YU^>.0SW5A)!?Z9KMSJ:D
MZTN3_;<)&T:D4XJ,7&,U&4FY*[YWR65_>4OAE>;DG!4*:F_[-Q\U*5.3C-SJ
M*4X.4(I1=E[-<]VOA<?CARPC$RO$G_!-SXRVOPOTWX;_  R^*O@_PM:OX3\)
MG799+WQXC0_%W0?"/BK1;SXJ^&Y9WURWTK4+O6M6T+4IK:VTFSU&:#1+,Z1K
MGA6]L(KB[?XM_P"">/[1_B&/QM!:?'K3M.TKQ#\2]3\<V^AV_B+Q>MSJMUK&
MD^.[%/$.O>+M0T'6M4BU'PEJ'B3P]K?@_0WT[7M2T^]T!TM_B/I\5OX3'A.W
MX;\#?\%!O#'AF+3?#4'C#2-5:"TG\$)?^(?@U?Z7;7)N[F'Q[=?'^>X>_P!8
M\3>(=6\+0:/#\-]1\&:A/'#XOCN[_P 5S6UK-->3;'BCPS_P4B\/S>$M!\(:
MMXM\966F>*/!>N77BS7?$OP:%SJ=A?:5\#[CXD>&?%>EPZ3X>2[T>QOYOCI'
MX<NK*2-X8XM/TRWL;Z7_ (1;5[>O:XCFLL9@F^:4DYQ@V]7)R;:DM[):MWNH
MWY.:4>PPG+=Y?F45RQBXPG5M%645&,4XRM:\G:/+:SE;VBA'Z#^+_P"R7XM^
M(_Q$\+^,K7QOHXAT'P7\(_#5[)KUMJ-SK.JWGPY\4^.M>U35KB>#=$7UF+Q9
M;",N[.EY#=R3G9)&3]3_  9\#WOPR^#_ ,*/AMJ5[::EJ/P^^&O@7P/?ZC81
MRPV-_>^$_"^EZ#=7ME%/^_BM+J>PDGMHYOWJ0R(LGSAJ^*O$/[*-UXU^$G[#
MV@>-_AKX=\6^+?@[XH^%L7Q(?Q)/HNM7FE^#M%\"^(;#Q98S:K?7,W_"06#^
M)#H$MYIMK<WZ:K=V]K?F"Z^QK-'X/XG\ _\ !1[P]X)MI/!5QXEUSXE>(_ /
M@VXU[Q,_B?X.6U[I?Q%T6#XUZBGAB:TDTO3=,O? 5IJ^K_#ZRCM[>]MK:QM9
MKB6[N?$5O/K5M'RN'MX0I/%T4H3G&*FHTXKEG.$9*2DWRRA>?O):22BG:YVJ
MI]6J5*ZP.(DZE.G*3IRG5D^>G3JR@X2@DIQJ6I^[*6L9.;C>Q^R]%>"?LT^%
M?&W@WX366C_$2U:R\6S^,_BIX@U&V;4+?5!'!XL^*/C#Q1I7EW5K=7ENL+Z3
MJ]B\%I%<,NGPLE@4B-L8D][K@G%1G**DI*,FE);22ZK?1]#U*<G.G";BX.45
M)PE\46[^Z]%JM+Z+<****DL**** "BBB@ HHHH **** "BN7O!XT^U3_ -GM
MX7%EO_T87B:L;H1[5_UY@D$)?=N_U8"[=O?-5L?$#^]X._[]ZW_\<H [&BN.
MQ\0/[W@[_OWK?_QRC'Q _O>#O^_>M_\ QR@#L:*X['Q _O>#O^_>M_\ QRC'
MQ _O>#O^_>M__'* .QHKCL?$#^]X._[]ZW_\<HQ\0/[W@[_OWK?_ ,<H [&B
MN.Q\0/[W@[_OWK?_ ,<HQ\0/[W@[_OWK?_QR@#L:*X['Q _O>#O^_>M__'*,
M?$#^]X._[]ZW_P#'* .QHKCL?$#^]X._[]ZW_P#'*,?$#^]X._[]ZW_\<H [
M&BN.Q\0/[W@[_OWK?_QRC'Q _O>#O^_>M_\ QR@#L:*X['Q _O>#O^_>M_\
MQRC'Q _O>#O^_>M__'* .QHKCL?$#^]X._[]ZW_\<HQ\0/[W@[_OWK?_ ,<H
M [&BN.Q\0/[W@[_OWK?_ ,<HQ\0/[W@[_OWK?_QR@#L:*X['Q _O>#O^_>M_
M_'*,?$#^]X._[]ZW_P#'* .QHKCL?$#^]X._[]ZW_P#'*,?$#^]X._[]ZW_\
M<H [&HIX(+J":UNH8KFVN8I(+BWGC2:">"9&CEAFBD5HY8I8V9)(W5D=&964
MJ2*Y/'Q _O>#O^_>M_\ QRC'Q _O>#O^_>M__'* /FCQ'_P3R_89\6:O>:]K
MW[)_P(O=6OY#->WD?PZ\/6+7,S?>FFBTZSM('F<Y:24Q>9(Q+.S,23A_\.S_
M -@'_HT;X&_^$1IO_P 37UGCX@?WO!W_ '[UO_XY1CX@?WO!W_?O6_\ XY7:
MLRS&*48YACXQ2LDL;BTDELDEB;)+LCTHYSG$8J,<VS2,8I1C%9ECTHI*R22Q
MMDDM$EHEL?)G_#L_]@'_ *-&^!O_ (1&F_\ Q-'_  [/_8!_Z-&^!O\ X1&F
M_P#Q-?6>/B!_>\'?]^];_P#CE&/B!_>\'?\ ?O6__CE/^U,S_P"ACF'_ (78
MO_YI'_;><_\ 0XS7_P .>8?_ #:?)G_#L_\ 8!_Z-&^!O_A$:;_\33U_X)I_
ML"+]W]DCX'CZ>"=-_P#B:^L,?$#^]X._[]ZW_P#'*,?$#^]X._[]ZW_\<H_M
M3,_^ACF'_A=B_P#YI#^V\Z_Z'&;?^'/,/_FT^5!_P39_8)7[O[)GP1&/^I)T
MWZ?W*D'_  3?_8.'3]D_X)CZ>"]._P#B:^I\?$#^]X._[]ZW_P#'*,?$#^]X
M._[]ZW_\<H_M3,_^AEF'_A=C/_FH?]MYU_T.<V_\.>8__-I\N#_@G)^PFOW?
MV4_@L/IX-T__ .)J4?\ !.O]AE?N_LK_  8'T\':>/\ V6OI['Q _O>#O^_>
MM_\ QRC'Q _O>#O^_>M__'*?]JYI_P!#+,?_  OQG_S4']N9W_T.<W_\.F8_
M_-Q\RC_@GC^PZ.G[+?P;'T\'V';I_#4@_P"">W[$2\K^R_\ !T'U'A&Q_P *
M^EL?$#^]X._[]ZW_ /'*,?$#^]X._P"_>M__ !RG_:V:_P#0SS'_ ,+\;_\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ea028514801_img4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $* G # 2(  A$! Q$!_\0
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M'_$L_C'_ -$W@O\ Q(LB_P#FD/\ B:3P5_Z*;'_^(UG_ /\ ,I_7'17XM_\
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M /-'1_Q*]XP_]";)?_$HR?\ ^0#_ (FM\%_^AUGG_B*9S_\ +#^Q*BOX[?\
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M;BQT=M#TBSI']K+]B?[3K<<G[.TD'AR_U+1]&G\,^$?"^B^"H?%7PUT?XE?
M;QI%H7BV;2O$,<6JZS+9>#/BI#-J-^MS-</XBTJQ>[BM9%FTG"/%?$<95(SX
M&SBMR^S<*N%J4J=.M&7*W*%+,:F&Q,93CS\E.JJ4Z$N18QQ4IJ'3+A#AI\DH
M<>Y-14G54J>*IU:E2DXN48JI5RZGB<,XP:A*=2DZL:\7/ZI%N,7/\G5!=E1
M7=R%1$!9W9B JHJ@LS,2 JJ"22  2:L"RO6AN+A;*]:WLV"7EPMI<-!9NS!
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M^BZZ]S<VC:?;:I+:Y%U^R;^U ?#NF^(/#\^N:SHE]X?T;XDQ0R^-[+0K^_\
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M+[*XTK0].'CGX(2^(_#6O1'QO=#XA^,[3P;X;^-L]M\6[A-'NM2F\=:)H_\
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M,ACAZ6%<)9DJ2^M5:J3Q$<.J4ZEJ>&DXQYJDHU)M3?)R14GY7$609=DL,++
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M"#X*_P#"5T+_ .0*/^%:_#K_ *$'P5_X2NA?_(%>M_Q.34_Z-[3_ /$FJ?\
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MH_L#7O\ H":Q_P""N^_^,5_J&_\ "M?AU_T(/@K_ ,)70O\ Y H_X5K\.O\
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M?\244?\ HXU;_P 1>E_\^S_+R_L#7O\ H":Q_P""N^_^,4?V!KW_ $!-8_\
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M_0@^"O\ PE="_P#D"C_A6OPZ_P"A!\%?^$KH7_R!1_Q.34_Z-[3_ /$FJ?\
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M#_B2C"_]'&Q/_B+X?_Y]'^75_8&N_P#0%U;_ ,%UY_\ &:/[ UW_ * NK?\
M@NO/_C-?ZBO_  @/@3_H2O"7_A.:/_\ (='_  @/@3_H2O"7_A.:/_\ (='_
M !.3B?\ HWN&_P#$FQ/_ ,Y@_P")*,+_ -'&Q/\ XB^'_P#GT?Y=7]@:[_T!
M=6_\%UY_\9H_L#7?^@+JW_@NO/\ XS7^HK_P@/@3_H2O"7_A.:/_ /(='_"
M^!/^A*\)?^$YH_\ \AT?\3DXG_HWN&_\2;$__.8/^)*,+_T<;$_^(OA__GT?
MY=7]@:[_ - 75O\ P77G_P 9H_L#7?\ H"ZM_P""Z\_^,U_J*_\ " ^!/^A*
M\)?^$YH__P AT?\ " ^!/^A*\)?^$YH__P AT?\ $Y.)_P"C>X;_ ,2;$_\
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M#?\ $-_H\Z?\;QS#7;_C'(:VWM_PFZVZVO;K8^^_XB9]([7_ (T5E7NVYO\
MC)JWNW5US?\ "A[MUJN:UUJKK4_I[_X;=_8X/3]JC]GP_P#=7O ?_P O:4?M
MM_L<GI^U/^SY_P"'>\!__+VOYFU_X-L?C^H'_&3OPDX.?^1/\:^N?^?RI?\
MB&U^/_\ T<Y\)/\ PD/&O_R92_XAQ]'C_H^6/_\ $>I__.X3\2_I)*]O ;*W
MV_XR:OK_ .7Q_3#_ ,-L?L=_]'3?L^_^'>\!_P#R]I?^&U_V/#T_:E_9^/\
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M<S=ZKU6O,HWO9<S/%?U/E@N;-?X=)*"YK)1I)1I2M!*U".C;CR.?+;FERH]
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M,/BKQ)=P^%?#VD^&_#7Q@O/$U[XC\6^$/"1TR;P_H]M\(]=URQ\0?#?X?:1
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M ,P53K_P0;_:_4Y_X2SX('C'_(W^*?\ Y@Z_7_\ B-WA%_T</AG_ ,*\5_\
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M>UW_ *$C6_\ P9^%O_E]0!U=%<I_;VN_]"1K?_@S\+?_ "^H_M[7?^A(UO\
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MK?\ X,_"W_R^H_M[7?\ H2-;_P#!GX6_^7U '5T5RG]O:[_T)&M_^#/PM_\
M+ZC^WM=_Z$C6_P#P9^%O_E]0!U=%<I_;VN_]"1K?_@S\+?\ R^H_M[7?^A(U
MO_P9^%O_ )?4 =717*?V]KO_ $)&M_\ @S\+?_+ZC^WM=_Z$C6__  9^%O\
MY?4 =717*?V]KO\ T)&M_P#@S\+?_+ZC^WM=_P"A(UO_ ,&?A;_Y?4 =717*
M?V]KO_0D:W_X,_"W_P OJ/[>UW_H2-;_ /!GX6_^7U '5T5RG]O:[_T)&M_^
M#/PM_P#+ZC^WM=_Z$C6__!GX6_\ E]0!U=%<I_;VN_\ 0D:W_P"#/PM_\OJ/
M[>UW_H2-;_\ !GX6_P#E]0!U=%<I_;VN_P#0D:W_ .#/PM_\OJ/[>UW_ *$C
M6_\ P9^%O_E]0!U=%<I_;VN_]"1K?_@S\+?_ "^H_M[7?^A(UO\ \&?A;_Y?
M4 =717*?V]KO_0D:W_X,_"W_ ,OJ/[>UW_H2-;_\&?A;_P"7U '5T5RG]O:[
M_P!"1K?_ (,_"W_R^H_M[7?^A(UO_P &?A;_ .7U '5T5RG]O:[_ -"1K?\
MX,_"W_R^H_M[7?\ H2-;_P#!GX6_^7U '5T5RG]O:[_T)&M_^#/PM_\ +ZC^
MWM=_Z$C6_P#P9^%O_E]0!U=%<I_;VN_]"1K?_@S\+?\ R^H_M[7?^A(UO_P9
M^%O_ )?4 =717*?V]KO_ $)&M_\ @S\+?_+ZC^WM=_Z$C6__  9^%O\ Y?4
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M*;U[]F'4M+_8V^(?P#USX@ZQ\-_$?P<^&OP_?PH+7XM:+IV@_$[0_&'PSO\
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M8:]I>EZS8VMJL4%GJFF:;?6T<5Q86<D/+Z_XI\5^*WTV3Q3XB\0>))-'T_\
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M"UWP%\$P_#BV\'_L%:=X<@^$&B^(/#OPOATCXA:-9Q^!-"\5BQ7Q)I7AI(?
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M_B1+96^N^,_V;_$UA\,;W5]>@^&WBZR^"]U/<:K8_$W0=.M\ZAJ4-]/9>*O
M.KZ?/)_9?BSPQX8DUVSU/0H-1T>_^,O&?[&'[6OP[\(+HEMXD\2?M ZMXM75
M] L[>V^(?C#2=&\.^/;K2?#MAIW[1NN:G!J?@^_T3QW>W%IKEU>:2UOXF\+6
M:ZA?/JOB6]O39/?_ ,U4IIPI1IY@J<E&'-"=.*M-)7M)QBFJ<=%*<WI%Q3;L
MG_;=>#4\1*ME,JT'.IRSIU9OF@Y22YH*<Y)U96DXTX+WIJ;25VOH?Q!_P3L^
M&?C6"U\8ZM^T3XMGT&YUGQ'XCUB[MX_!VG>&+SQ]XNO/BGH_B75]%AM[>WT/
M0;/5-5^*NL6B:"UOJ<EGJ>EZ5!IVIP276N1:U]CZO^S#\'=2^+"_'/QYHFA^
M*]<\/_#GP)X+T1_&.E:-?Z7X/M/AMKWC#Q5:^*--EO[=ELM5FOO%)NKN\F8Q
M6#Z%I=[9&UGADF;X2UG_ ()]?'+6M6UEM8^)O@[Q7X>U70]-COM"\7ZYX^U;
M3]:U+PY\4O#7Q%\,Z9'8-9'_ (133+=_#Q34=2LM0UZSGNKQKFP\%:=JGV_7
M=47Q-_P3W^-^LP_#C1+'XH^$K/P_HOAG4=.\?3W&N?$2^U?Q-JWB^?XI1?$A
M+H7YODUW0O%FD^-/"]DMB]YX9C@A\,SV6I6VKVA\/C0)E*,^5/,U91G'2FX\
ML)QBY1O",&Y2Y%!]':*NH\R=PA*GSN.32NY4Y^]54^>I"4E";52=2-H>TE-/
M>-YNSER-=SKW_!.7X6?$GP+:^$O"GQI\5Z;X=L_A_H'PC\12>%;;PI+:^(;3
MPKX4\5>&5U/59-.L[5G\4>1XRN-2,S74VDO<!/[3T75K>:)8&>)?^"6GP[\2
M?\) ]Y\4_&D$.I^)]>U_3M*MM-T>Q\+Z-9>+M(\:Z)XSMO\ A&],.G:=<ZIX
MAT[QUJBW6IPC3]*-Q96%W=>&[V>\\3MXCY&R_8*_:$L]!M-(LOBKX4T.ZCTV
MQLO#>I:-XM^*<)^"4.F7=W/JNF?#33X18Z;XCTWXEZ-+9>"_%;^*[6QD\.Z#
MIUO<Z-!JTJ6^GVC_ !-^P/\ 'Z&7PAI/PX^+WA_P]X1\+>*_!/C#3K>_\3_$
MVYU[1-;TC3O@9'XXN=,U.]FUTW5IXVU#P!\2+B\L&.F71N/'KWUUK-Q:ZCXB
MT&\I5I)VCFD4KR:;IWMNVVU!ZMNRTNUS6:AR<T/#P:;EDLY/EC%J-:U[\L;*
M+JKW8I.3ULGRWC*;J<GK?QL\(?LHCQ'\,/&?CC]H?PW\/[35?!/PST#X;VMW
MXJ\)6VF>+= ^'>M>)-<T&\T&\U#<VMMJ@\7O;S/ILLJ36MM:S6:*6F=OM;X6
M^'= ^'G@?P5\(]%UPZR?AA\/? GA=)+N6U_MF;1=)T0>'="UC5+:U6.*"368
M_#M[*KQ0Q6TMQ;7BVR!(&5?"+7]G/Q#;?"S]DGP"NN:"+S]GCQE\,_$GB"[2
M"^%CK=GX'\#>)?"M[:Z#'Y/G03W=UK<%Q9&^2&-+:"99BDA13\9>+?\ @GS^
MT%/\.=.\%>"/C%X9TV\G\%>'['Q+J^J^(OB8^I7'Q-TFU^+\LGQ)TO5Y9-9G
MCO?[;\>>%]0:&XL!?SQ>'(TTG5?"MSI^GW,W/:C6C"G/&.,8SFDZD5**2G.,
M)KD@I+FIOF:;DVY.W*==\1AYSK4\ JDITZ;:I2<9MRIPG.F_:5'!\M9<B<5!
M*,+M2;9^O&DZSI&O69U#1-3L-7L5O-1T]KS3;N"]M1?Z1J%SI.JV1GMWDB%U
MINJ65YIU]!N\RUO;6XM9U2:&1%TJ\7_9_P#AMK?PF^&5CX,\1ZK8:WK4?B?X
MA^([_5--6Y%K=2^-_B%XH\:*V;R.*X>YCBU](KV1T EO4N)$+1LK'VBN&:C&
M<HPESQ4FHRVYDK6?SU/2IRE*G"4X\DY13E#?ED[WCN]M.K"BBBI+"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *CEBBGBD@GCCFAFC>*:&5%DBEBD4I)')&X*/&
MZ$JZ,"K*2K @D5)11>VJT:U36C36J::LTTTFFFFFDTP:OH]4]&GJFGHTT[II
MIM-----IH^2/$G[ _P"Q/XOU:ZUWQ)^RG\ ]4U>]<R7=]+\,/"<4US*Q+/-/
M]FTR!))I&)>69D,LLC-)([.Q8X/_  [A_8*_Z-#^ '_AM?#?_P A5]JT5]!#
MBWBNG"-.GQ3Q-3IPBH0A#B+/8PA&*2C&,8YRHQC%))1222222227SE3@[A"K
M.=2KPGPM4J5).<ZE3AKA^<YSDVY2G.62.4I2;;E*3;;;;;;;?Q5_P[A_8*_Z
M-#^ '_AM?#?_ ,A4?\.X?V"O^C0_@!_X;7PW_P#(5?:M%7_KAQ=_T5G%'_B1
MY]_\^2/]2^#?^B0X4_\ $8X>_P#G&?%7_#N']@K_ *-#^ '_ (;7PW_\A4?\
M.X?V"O\ HT/X ?\ AM?#?_R%7VK11_KAQ=_T5G%'_B1Y]_\ /D/]2^#?^B0X
M4_\ $8X>_P#G&?%7_#N']@K_ *-#^ '_ (;7PW_\A4H_X)Q?L%CI^R)\ 1]/
MAMX<'_ME7VI11_KCQ?\ ]%9Q1_XDF?\ _P ^@_U*X,_Z(_A/_P 1CA[_ .<9
M\7#_ ()R_L'#@?LC? +_ ,-MX;_^0J7_ (=S_L'_ /1H_P  _P#PV_AS_P"0
MJ^T**/\ 7'B__HK.*/\ Q),__P#GT+_4G@O_ *([A+_Q%^'/_G$?&/\ P[J_
M82_Z-*^ O_AN/#O_ ,ATH_X)V?L*#I^R7\!A_P!TY\.__(=?9M%'^N/%_P#T
M5G%'_B29_P#_ #Z%_J/P3_T1G"/_ (BW#?\ \X3XU_X=W_L+?]&F_ ?_ ,-S
MX=_^0Z</^">7[# Z?LG? ?\ \-SX=_\ D.OLBBC_ %QXO_Z*SBC_ ,23/_\
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MPG_\S-=510!RO_"/ZO\ ]#MXD_\  3PG_P#,S1_PC^K_ /0[>)/_  $\)_\
MS,UU5% '*_\ "/ZO_P!#MXD_\!/"?_S,T?\ "/ZO_P!#MXD_\!/"?_S,UU5%
M '*_\(_J_P#T.WB3_P !/"?_ ,S-'_"/ZO\ ]#MXD_\  3PG_P#,S7544 <K
M_P (_J__ $.WB3_P$\)__,S1_P (_J__ $.WB3_P$\)__,S7544 <K_PC^K_
M /0[>)/_  $\)_\ S,T?\(_J_P#T.WB3_P !/"?_ ,S-=510!RO_  C^K_\
M0[>)/_ 3PG_\S-'_  C^K_\ 0[>)/_ 3PG_\S-=510!RO_"/ZO\ ]#MXD_\
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M_P#T.WB3_P !/"?_ ,S-=510!RO_  C^K_\ 0[>)/_ 3PG_\S-'_  C^K_\
M0[>)/_ 3PG_\S-=510!RO_"/ZO\ ]#MXD_\  3PG_P#,S1_PC^K_ /0[>)/_
M  $\)_\ S,UU5% '*_\ "/ZO_P!#MXD_\!/"?_S,T?\ "/ZO_P!#MXD_\!/"
M?_S,UU5% '*_\(_J_P#T.WB3_P !/"?_ ,S-'_"/ZO\ ]#MXD_\  3PG_P#,
MS7544 <K_P (_J__ $.WB3_P$\)__,S1_P (_J__ $.WB3_P$\)__,S7544
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M\$>"[_Q%:_"SP-\#_!'Q+\2_\(Y9_"OR(]5USQ3\6[.__P"$GG\=V5_XJO\
M3;S3? FF6EE:> (X;VPD:]N+R0R75GMTI4G5E**<8\L)3;D[*T>567FW.*2Z
MM_?C6K1H1C*49RYJD::4%=WDIN[OM&*A)R?1+YK[XHK\G=&_X**^,(-.^%-W
MKWPJT1-%^(OBB3P-9^)KGQW<OK7]HZ99_#33+G6-5\&Z-X&EO4&K^*OB+&EK
M%X?34]*L++1Y#K5_H*ZUI\MI6O?VY/BE_P *L_9P\67.@/I^M^,M*T:[^)>J
M:'X=,G@+Q)J.L>$H=3DM/ACXDUO[8MU%X?UR1K+Q+%-9-=:;<07>CNZW*)=)
MT_4,2FDXQ5Y.*?/%W<5-O:_\C5M^9I6M>4>19I@VFU.;Y8QFU[.::4W!1WMO
M[123T3BI-.]HR_6NBOR)\3?\%.?%O@S1_#%WXB_9ZC?4O%WAW0?B#I$6B?$4
MWFB)X'\0^!Y_&NE:+J.O:IX.T6&R^*&KI:7.D:1X8%O-H][<QSW47B%X;"ZC
MKV'XJ?$G]J;5OVEM4\ _!%-2'A[PKX#_ &=_&%UI^I:+\-4\!VT?C[XA?$NS
M^(A^)NL^(-3A^)22+X'\%!?"]E\,;6[FM]:MV.I%TN@IGZE7B_?]G33C.:G.
MI'D:IN,9:Q<K>]))76Z>CM9TLRPTDW2]K6DITH.$*4^=.K&4H^[-1O[L')I-
MM*VJO>/Z*T5^6_PQ_;._:-U[X6^"+V?]G-OB;\1+T?LS:CXA_P"%=>+-*%BW
M@3X\1)+/XSU*R\1VWA%/#^K:1;:?K,^J:39S:QX?T.22QNK[7DT>&_N;?IOV
M@OVOO&GPQ_:0\#>#]#TC4G^#WA'3/#5I^T3XA@\&7FO:9X5U_P"-UY>^'_A=
M)JGC.VE&F^$4\#:IIFEZ]XIM9UNTUGPYX[TRX66S6R264^I5_:.G:#DE5>E2
M$DU2M>UG=.;:C33C%U)/EBFTQ_VCAO9*M>HH-T8^]1J1:=:]K\T5%JFDY5G&
M4E2BN:;2:;_2*BOS<^&'[:.E>((_V,KKQ/\ %[X2167Q7^"/BK7?C%>#Q#X4
ML;2R^*VF>%/A%J^FZ!]J;6/(\,:K]K\4^*I&\+3.-0GBA*" +IDA'Z1@@@$$
M$$9!'((/0@]P:QJT:E%I35K\UG:5GR3G3=FXQOK!O2_NN+=N9&]#$4L1%RI2
M4DN2^L6USTJ=6-U&<[>[42UM[T9Q5^5A11161N%%%% !1110 5^17_!3W_@J
MGX0_8+TK3/ _A/1=.^(/[0'BW2QK&C>%]0NI8O#W@_0)9Y[6V\3^,C8RQ:A<
M+?7-K=0Z)X?LI[*YU/[)>75SJ6F6D-NU_P#KK7^=Q_P5B\2>)/$O_!0K]J*Z
M\2RW4UWIOQ&O/#^FQ7,CL(/#_AS3[#1/#D5NLA*PVSZ'I^GRQ)&%C;S3-@M*
M[-^]?1X\/,F\0^-\1A^(8/$Y/D.52SC$Y<JDZ2S.M+&T,#A,+7G2G3JK!QK5
M9XC&1I5*<ZU.G2P_M:<*U63_ )\^DCXD9WX<<"8;$<-S6%SGB'-XY+ALS=.G
M5>5T8X&OC\9BZ%.K"I1>-E1I0P^#G6IU*="I5JXGV56I1HP7KWB'_@N)_P %
M'M=U6ZU&T^-FF^&K:>1FAT;0/AM\-DTNQ0XQ#;'5O"FK:G)&N/E>^U*]N,'#
MSOUK$_X?6?\ !2;_ *.)N/\ PW7PF_\ F#KY]T3X(?LU'QU^R)I=[^T;I_B'
MPY\8+O0S\>%L]'U#PM+\(DN_%^I:3=Z?<ZYK=M]@L1-IUI:6[7M^DDFF-/)X
MGFA?P_<:<TGT]!^R/\%O%D/C/1O'?AN#]F#XDRM\-]/\&^&M ^-/AWXPZ5HF
MH^((/CKJ$NH>,8-3U]+W1M'UW3O /A'[?;-KVMZO8QW]EXDT>"UT_P 66.D6
M_P#;N+RCP?RSZO3J^'>1JC.C.<9?ZDX.-2G2P^95LIJ2>$Q>%IYEB(4J^&JU
MZU:A0Q*IX+V&-JSG3QV"^M?PI@\V\9LT^L5:?B5GSK0KTZ;BN.L=.G4JXC+*
M6;TX_6\%C*F68:=6CB*5"C1KUL-*ICG6P5*G"I@<;]4P_P#A]9_P4F_Z.)N/
M_#=?";_Y@Z/^'UG_  4F_P"CB;C_ ,-U\)O_ )@ZZ4?\$Z/@-9W^AVVI_M7K
M<VFL:%X%E2^T#P]X2NH+G5?&EGXKN[?Q!I=QJ?C/3+>[\ [?#,B6]QN.M1SR
M&WO8XGEA>O(/B)^Q7\+?"7PQ^)WQ$T'X]+K8\)Z+I_B;PU:W=GX.@MFAU/PS
M\)?$NB?#[QH+#Q?>:S9_$_Q;;?$_48_#-MX9TC6?#;_\*]\3G4=1MI%N(=*R
MPV'\$,56HT:/!7#SGB*M"A2E/P_=*G.KB,3'"TX>TJY1!)JK*//S1CR0ES-2
M<:E.EKB*_CKAJ-:M5XZXBY</1Q%>M&'B*ZE2%+#89XNI-PIYS*Z=*,O9\LY>
MTG'E32E3J5>Z_P"'UG_!2;_HXFX_\-U\)O\ Y@Z/^'UG_!2;_HXFX_\ #=?"
M;_Y@Z_*NBOM_^(9^'/\ T07!W_B-Y1_\R'P7_$4/$O\ Z.#QM_XE&<__ #8?
MJJ/^"U?_  4F) _X:)N.2/\ FG7PF_\ F#KO_#O_  5:_P""N'BS3UU;PO\
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MA\+3H1454ESU*]:4H4U&%*I)_P .Z?\ !3+_ (+('[WB#XQ=._[.7AL<\?\
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MT)II75\:^%:5)U7X!^&DHJ"G:'L)5'%M1=J?]@J7-%-SG&W-&$92:26O/2\
M^+L165"/TD/%JE)U)4N:I+%0I*2BY)NK_K&X<DWRPIS4N6=2<(1=Y:?@.O\
MP4C_ ."O)ZZ]\7/?/[/7AP'_ -5=BIT_X*0?\%=6 )U_XN=._P"SWX; Z_\
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M/$?ASQ7\'=8TS3K;5QIMUXF\9^)/!4.I+/X*U&XDI?M$_M9_M=?"W]NSX6?
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M .=K7ZT:)_P4C_:&TKXW6/@'6_V?-3\;>"_&GQ(6+1?%VCZ1XS\.V&F>"_\
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MFTV-=A"5^TD&;:2N_'%=1113;;W;?JV_S;$HI;)+T27Y)=W]X4444AA1110
M4444 %?S(_\ !:G_ ()4?$/XR^,KG]K/]FWP[/XO\4WVDZ?8_%SX:Z/#&_B'
M6)=#M(M-TWQOX4LE"2ZY?'1K:RTK7M!M#)JDJZ98:CI-GJ$]UJBQ?TW45]IP
M#QWGGASQ'AN),AE1EB*5*KA<7@\5&<\%F6 Q#IO$8+%QIRA44)NE3JTJU&4:
M^&Q%*EB*+<HSIU?A_$/P_P A\2^&<5PQQ!&O'#U:M+%X/&X24(8[+,QPZJ+#
M8["2JPG2<X*K5I5J%:,J&*PU:MAZR49PJ4?\L_7/!'C'PUJ-SHWB/PKXAT#5
MK1VCN]+UK1[_ $O4;:13M:.YL;ZW@N8)%(VNDL2.I!5E!!%8PT+40-HTJY Y
MX%J^.<9XV8YP,^N!Z"O]3Z?3["Y?S+FRM+B3 'F3VT,KX'0;I$9L#L,X%0_V
M/I/_ $"]._\  *V_^-5_5</IDRY(^T\/8NIRKG]GQ/)4W*WO."J9*YJ-[\JF
MW)+1MN[?\D3^A1[\O9>),U3YFX*IPM%U.6[Y>=TL]C3<TK)N$5&]^5).R_RQ
M_P"PM1Y_XE5SSDG_ $5^2>I/R<YP,YZXYH&AZD"&&EW0(S@BU<$9))P=F1DD
MDXZDDGJ:_P!3C^Q])_Z!>G?^ 5M_\:H_L?2?^@7IW_@%;?\ QJJ_XG*7_1O'
M_P")/_\ @07_ !)1/_HY/_FK2]/^A_VT/\LK^Q]5_P"@=>?^ \G_ ,31_8^J
M_P#0.O/_  'D_P#B:_U-?['TG_H%Z=_X!6W_ ,:H_L?2?^@7IW_@%;?_ !JC
M_B<E?]&\?_B3K_YR$_\ $D\O^CD+_P 13_\ #Q_EFQZ5K$4D<L5EJ$4L4B2Q
M2Q13QRQ2QN'CEBDC"O'+&ZJ\<B,KHZJR,& (_7+X??\ !:7_ (*3> /"6C>#
M[;XBZ+XLM-"M8["RUCQY\.=)\1^*)K2! D$>J:__ *#=ZQ-#& GV_4Q=:E.
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M GG6_A^>1T^%^G<?^3IK^PG^S--_Z!UC_P" EO\ _&Z/[,TW_H'6/_@);_\
MQNG_ ,1O\*K6_P")>.$O_"_#_P#SI,9?1K\=7>WTMN.H^F3XG3_S/'\?Z_\
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MW<+:QY;VVND]';1Z]%9?V3@O>_=U/>:;_?5+Z24[7U=FUJKV:;3W=_R'M_\
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MR\(?]#5X;_\ !YI?_P E4?\ "9>$/^AJ\-_^#S2__DJMK[#9?\^=K_X#Q?\
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MFE__ "51_P )EX0_Z&KPW_X/-+_^2JVOL-E_SYVO_@/%_P#$4?8;+_GSM?\
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MR\(?]#5X;_\ !YI?_P E4?\ "9>$/^AJ\-_^#S2__DJMK[#9?\^=K_X#Q?\
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MFE__ "51_P )EX0_Z&KPW_X/-+_^2JVOL-E_SYVO_@/%_P#$4?8;+_GSM?\
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MR\(?]#5X;_\ !YI?_P E4?\ "9>$/^AJ\-_^#S2__DJMK[#9?\^=K_X#Q?\
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MFE__ "51_P )EX0_Z&KPW_X/-+_^2JVOL-E_SYVO_@/%_P#$4?8;+_GSM?\
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MR\(?]#5X;_\ !YI?_P E4?\ "9>$/^AJ\-_^#S2__DJMK[#9?\^=K_X#Q?\
MQ%'V&R_Y\[7_ ,!XO_B* ,7_ (3+PA_T-7AO_P 'FE__ "51_P )EX0_Z&KP
MW_X/-+_^2JVOL-E_SYVO_@/%_P#$4?8;+_GSM?\ P'B_^(H Q?\ A,O"'_0U
M>&__  >:7_\ )5'_  F7A#_H:O#?_@\TO_Y*K:^PV7_/G:_^ \7_ ,11]ALO
M^?.U_P# >+_XB@#%_P"$R\(?]#5X;_\ !YI?_P E4?\ "9>$/^AJ\-_^#S2_
M_DJMK[#9?\^=K_X#Q?\ Q%'V&R_Y\[7_ ,!XO_B* ,7_ (3+PA_T-7AO_P '
MFE__ "51_P )EX0_Z&KPW_X/-+_^2JVOL-E_SYVO_@/%_P#$4?8;+_GSM?\
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MA_X)K?\ 1R-M_P"&T^,'_P P%.'_  6>_P"";!Z?M(6Q_P"Z:_%__P"8&O\
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M4L[&V7G)DN+B*, $EP :_*7QU_P06\1Z9X8U*^^''[0%EXF\5V=M-<:;X?\
M%/@@>'-,UB:&-G33_P"W+#Q%JSZ9/=.!%#=7&GW5JDC(+@0Q%YXOP2UG1-7\
M,ZUK/AOQ!I]SI&O>']6U#1-:TJ\3R[O3=6TJZEL=0L;E,D+/:W<$L,@!*[D)
M5F4@G[W@WP&\ _$.CF$N#^.N+<RJY:J:QE)U,!A<5A5B%-8>O4P6/R#"U:F'
MJ3ISA"M!SHRJ0E1E4I5+1E^0>)7TK?I8>#U?*EXA^%OA[D^'SCVTLNQ$:.;X
MW X]X3V<L7A:68Y5Q;CJ%'%T:=6G4J4*L:>(A1J0Q$*5:C><?]"+PUXG\-^,
MM$T_Q+X1U[1_$_AW5H!<Z9KF@:E::MI.H0$E?-M-0L9I[6= P9&,<K;'5D;#
MJRC<K^0?_@E7^UGXL^"OQ]\*?##4]9NKKX6?%S7++PKJ^AW=R[V6E>)=9E33
M?#7B33(I-R6M^NKRV&FZF\1B2\T:ZN/M:W,^GZ4;3^OBOYO\7_"W'>%'%$<D
MKXQ9GEN/PG]I9)FGL5AZF*P7MYX:K2Q6'C.I"CC<'B(>PQ,*52="HIT,10:I
M5O9TO[-^CMX[95X_<"SXGPN6O(\ZRC,7DO$V1?6'C*6 S+ZK3QN'KX'%SITJ
MN)RS,L'4^M8*=>E3Q5%T\5@\5&5?#*KB"BOQO_:QU?\ ;1TWXI?M2Z-\(+GX
MU-X0^)WPE\'^!OAAJWA/1KG4--^$'C?PEX(\6?$?Q/\ $+P9<#3;@6VI>,=!
MMM=\!^;";M)OB7;_  WTM(DO]2B1Z7Q9^.W[:WBSP[#X3\!^"_B;X)\9^#-$
M^(5[XC\1:'\)_%TRMXJTW3_CUI?@?3(+C6H'\.^.+'5/#FE_#?Q;+:Z//?6T
MWB;5M!)NH;FZ31(_SB.!G.-.4:U"TU%N]1)TU*$97FF[Z2?LVDK\RNERM'[1
M/,X4Y58RP^*O2<HKEIN2JRC4E"U-J-M81]JFW;D:3?,G;]G:*_)K2_CW^V=H
MA\0:W9?#W6O%7@KP]K5U!9:1=_![Q]?^.O'EGXEU?]H.XM_%.D2W_BO16TNR
MT.S\%?"V[M_!W]G0PQVGC'^Q7U31([W07M/+]._:'_;RUS4].\23_#GQCJ;:
M<WB/2_#G@&P^&/C'P;H'Q#N?#OBC1M5TGQ9K'B&259O#_P!NT+68M#DTO4;Q
M/#7B&RMKRZL4ENK6[EMA8"H[_O<.DEUK1O=JZC:ZL^[;M'>3TDHMYI17*O8X
MIRDWHJ$VN5.SE=)IK1\J2YIO2,;N+E^VM%?E-I'[1'[:E_K4L^F>"8?$W@'P
MJWA34%\13_L^_$CP9KOQBLM>\<_"[PUXIT?1_"NO^+8]4^'NH> [/Q=X_>.Z
MU*#6O^$B3P';Z^EI:Z!+?W,^U^R]\:_VJ/B]\:M,/Q8\#^+O!?@31-&^(!MY
MIOA]XE\!:-KQUWP]\&]9T6V\2Z?K-WK%I_;G@W7IO'7AK3&L]9N@&BUJSGGO
MKNRN+N6)8*I&,YNI0M"/,TJL7+:ZBHZ2YGII:\;^]JI)7',:,YTZ<:6)YJDU
M"+E1E&'9R<]8\BU]ZZ4K>[>,HR?Z?T5^*GPV\ _M]Z1X-^ _C>7XE>+?#VK^
M,[[P99^,O#/B;4/B;\;[V&\B\)_%+Q)KOC+XB>&/&/\ PAK?#Z&Z>+P]X4N/
M 7A+5;?PM%K]_H]W<7TDVD:7:7>KJG[8'[<MSJ.LQ:5\#+W1+5/ .E:G=OKW
MP7^)?V3PIXHM9_A VL16=[I-WK\NMV>NV7C'X@RZ#+J%G;&T;PE;S:MI]C9Z
M;KEQ=:/ 2<FJ=?#U$N9-^T4+.,N1KW][N]G%R3MW:OFLT@HJ5;#8NDY*+C'V
M+J.2E#VB=X?#9-*2FH--]D[?LM17YQ_L[_M#_M8_$?XX6_A;XG_!.;P!\.KG
MP8-6N)-8\'>)O#^LZ9(G@[P)JVE:]/K$E_KWA<7?B;Q9KGC/P]=>!1K5WJWA
MR'PS"LEY=75AJT]YYM^SEK'[5]U\1_@Y%\19OC$WAR?5/#(\8CQ-I6J6^EM:
MO\%OVD;C4O[<DN-/AC@B_P"$TM?AP;LRR1!==3PQ"Q6:XMHI\W@YQ]IS5:*<
M(*=E4C/F4HU))1<7;F7LVFM=91[FBS"G/V7)1Q$HU:DJ5Y4I4^5QE3CS2C./
M-ROVB:E9749;6/UEHHHKD.\**** "BBB@ HHHH **** /AG_ (*5? WXA_M*
M?L1?'?X(?"C3+'5_B!X^TKPA8>';'4KW2+"R:;3?B+X/UZ^N+BXU^2+1F6PT
MO2KZ_6TU)_LNH26R6$BR?:1&WY^>)O\ @FQXX_9T^)WP4^/GPS\'?\-M7.C?
M&CXT_%3X\_"37A\%?@W#K_BWXH_!WP/\)/!?Q*^$_@5]+\$_ K0=7^%^A^ (
M])N=.U.;3=9UJR\:>)M?@\076O-]FN/WIHKZ'+>)LSRO!K+\,Z+P4J^+K8BA
M.,XO%+&X6&$JTJM>C4I8FG"%."G1EA:V'JTJ[=;VDVE Y:V#HUI^UGS>T481
MA)-/D]G-S4HQDI0;;=I*<9QE'W;):G\\G[,W[,/[97['?Q;^%7Q=T_\ 94MO
MB;I.J?!K]JGPMK/PI^%GQB^$7AVP_9V/Q\_:_P!-_:"\%_"O0K_XA^(/!VG>
M(_#'@'P?:/I%U/X3A&BQ>()KRUT&W.BQV,S\XW[#W_!0R\_:3^*'[8FJ^'OA
MA-J?[2<_[3'P<^)'P?LO%VSXB>&?V<O'/PT;P-\ M*U[QG<^)W^%>OVGPT\0
M?##X>^-GTGPEI]IKRW7Q1\?I)J^J20O!;?T?45Z+XWS%U\1BOJ.5?6<7A(X#
M%UI4,54E7P4,15Q5/#\E3&RA2Y*TZ,W7I?[15EA,-4KSJ58U:M7'^SJ7+"'M
M*_)3FZL(\T$HU'!0E*ZIIRO%27++W8JI-12BXJ/\J_@__@DU^UE\/? ]AX<N
M_#6E_%'Q+K/[.G_!/OPKX;\7OKGP9\ GX'WWP)_:-^#WQ1^/'P%U_0?!>C^#
MM+^*^G0_\(K>^,OAQ\9=4'B7Q5<VGA^^\%:OJD][J6GZQK7T_P#LQ?L:_MB_
M"?\ :>\6>)O WPF\#_ KPG:>%/VI;73?%WQ6USX9_M"^ -%\;_%WXLZ3X[\+
MZE^SH_@QOA[^TY:?#[QK=PZIXQ^+/PZ^./C.RLM,UF;3].\'WI.FPW<O]!-%
M:8KCW.L92Q=+$T<NJK&4JE.MS8>MR?O9J3DL/'$QPSY4N6,'35.\JM2495,1
MB8UU#+,/3E3<)58^S:<;2C?16MS\CGJ]6^9R=HQNHQAR_C5\.?V8OVA;;_@I
M%X(^/GB7X#?"[P?H7@_X?_%CP[\5?CKX.UGP;9^%OCWK'Q#\)_"Y+'Q[X5^'
M=H)_C-X1^*]WXG\')X;\6Z=\2_$OC/P#HGPQ\*:-8^$-;U+Q!J$VHG]E:**^
M;S/-*^:SPLZ].C3>#P5' THT55471H3K3BY>VKXB2?-7J*,(SC2I4U3HT80H
MTJ<8==&C&BIJ+D_:5)59.7+?FDHI_#&*VBKMKFD[RDW)MLHHHKS38*_/7]I7
M]G+XJ_$3XX^$OB'\.=+\'0"/2_ASHNI>*-<U^WN=/AT[P/\ $:[\;7NE^/\
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MZ8_Y))=?_/&I_P"H?T;>OC5Q%;_LDWW_ .Q7KH8R\4OIFKX?HU\(/_N_H?\
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M+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\
ME30!V-%<=_:_C+_H3K+_ ,*F#_Y4T?VOXR_Z$ZR_\*F#_P"5- '8T5QW]K^,
MO^A.LO\ PJ8/_E31_:_C+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^
M5-']K^,O^A.LO_"I@_\ E30!V-%<=_:_C+_H3K+_ ,*F#_Y4T?VOXR_Z$ZR_
M\*F#_P"5- '8T5QW]K^,O^A.LO\ PJ8/_E31_:_C+_H3K+_PJ8/_ )4T =C1
M7'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\ E30!V-%<=_:_C+_H3K+_
M ,*F#_Y4T?VOXR_Z$ZR_\*F#_P"5- '8T5QW]K^,O^A.LO\ PJ8/_E31_:_C
M+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\
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M+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\
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M+_H3K+_PJ8/_ )4T =C17'?VOXR_Z$ZR_P#"I@_^5-']K^,O^A.LO_"I@_\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ea028514801_img5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %D ;4# 2(  A$! Q$!_\0
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MOC-\3O /PI\)V2R/<>(OB!XITCPMIFR)=SB";6+NT-W+DHBV]JL\[LX$<;G
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M/]CCX_\ AJ>2RD;5;CPOXJ\!>+(;>_3/E6]A:7%UH5Q=Q3;5!N99(FA#9<,
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MF:2XN;_4M8U&:XU"^N99I"V^[GF*(/+5MN,4!;N<G&<DDF1F+DG^\Q)R!V
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MPA_GT_X*Q_\ !P7^TE_P4,O/%/P=^#E[K/P _9#FO9]/B\+Z3?2P_$CXM:-
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M6$_:Q_X)9^,UD^%6L-\0/@7K.NQZE\2/V>?%UY*WA#Q"+N56OM8\*W\@GN/
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MJY%1J4IWQ$)SF[UVVUS--Z/GNE;37J*OQ+/,:L)2G"*AJG!*[MTNK.R>BT_
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M-I*[=DMVSYS_ &]/VV_A'_P3^_9L^(?[2WQHOUB\-^";!AHGARUFA7Q#X_\
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M 3@G#@=N=Q#XQD94D_=->#F&(PN71=*5-;Q_AJ\I.,[))*[?,TD^Z?0^SRW
M8K,^6SJ5?:0=JEFXPO!-/FLHIQO>[ZKU/6SK(9HULT:XNR^Q+6%#/,[NA<&"
M&"-I9B%4EL?-'C)]#]&_LE>&?!?Q+^(GC?\ X3V^^(.BZ]X)\(76L_#NW\%Q
M6D,I^(,#H^B2>)TU _;(M"M9%\^_M[:!9IT"H)2I*OTG_!-?X)^%?BU\2%\9
M>,O&M]X=N_"FHZ?%X(\+:=_HFH>*M>O+EEF@OM9OUDMM#T*VT^.35+O4H8S_
M *##+\T;E0?T(_X**:+X7\4_$GP_\4?AK\-=.TGXB6&@^#_#EQJ'P_US2_\
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M\\G_ (.D/^"P%_\ %;X@:Q_P30^ .O6S_"WP!JFC7_[2_C#0M1,P\;^/]/\
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M>N8SUANM!UA;W3Y(20,H(53'RJJ@YKLQ\:?ASXGA$?CWP3;^&-0N[H1-XO\
MA.Z:--;B4YFNKSP%>/-H.J DYFM[.XTB2[/S1/%C!^"O[</V@!-D;A3&ZE Y
M8C:2=^<D]#GDY.?2KYO_ #55C(K/F5,CY<)Y1;85]-PW,#D$X.#7GRR/+ZTY
M0=*4$_>YJ=:I3E=]+0DHV6ENMMSNH8_&8:I><H5HV3Y)4:<XVMNW4BY<UM];
M*WNGUWXR\#ZI_9^I^+?AYJNG?%3P!9!6N=?\*Q31ZWI"R#<@\5^!IU/B3PTJ
M ?O=4GLKO13)E4OE4F0?&&OZGYAU.2(LUO>PQ&XD@DD$;A'( *12-'D,-LQ.
M=BY*.Z8:MGP[XZUKPQJ2ZIH>MWOA[6[*7S[+6=)NI[6\61V6-K(SV[H\MO+C
M?,D[/:S(662)D)5N[N_'WP]^,HU32O&-]I'PK^+,RLNG>.M)M+;2OAA\1M3>
M1H[?3?B)IUM';6G@#4[J<P0P^--"@BTBX9BOB'1%25Y5NA5QN4_N\PA/%8;F
MC"G5AK*GSNT4^?>^SM:UGJ36=#'IO"3CA\9RN<T[*$U"[G91:UM9+SL?%^LW
MB^8\<5D54.6#PW$KY_>9&TL3@<#:Q4G'8'%<?>7'F.\QM2K[MY>7S)6/& ,X
M(P!GJ!UQ6]X\T[Q#X$\3ZWX5\5:/>>'->T66/[=I%YY8N(XIXQ+!>136[26M
M_I=W RW5EJ=A+/I]Y;O'/;S&*1<\!<ZD)X\B3EE+; W4$ @XSR",'D8Z\U]/
M26&K04J<TVZ?M.6RYDG?W?\ %IZ:GR]7%U:=2I#$MTW3ORRDFXSM?2-M=;:7
M?74P=4N&2162>5AN)>+8 F=PR ",X'OGH>>0:\UUJ:)GD=F<#85/! P6W9'0
MYXZ<<?6NQU&\49 D491NIP-V, G)SUQW^O/!\XU2?S7<.R,.2.<Y.<<9X/3D
M^O'->9F/+*E)*26D6D[Z6<79KOI;33R-\LQ.(G6@[_NW)OK\+4G'\T9<D%G/
M&7%PBG_II\^2,<;20!TQD<XYX[\]>7GV8M!%&-^W)<,P&T<-R.YP,<X/ZTZY
ME\@-C[IRV.W'<\\#.>OM62;I&D8D*^4*\X; ..>?3V_'W^9Q5:%2<K.UTEWV
M5KZ=.W4^VP;JQO/GTNM-;[/Y=2%Y@2&+D%AN()/&2?S^IJ%YY&;<K*O0 !B<
M#OUSR1D9[9..U0W)7!*X'('&..3QQ6><8)7&[U7KUYZ<UXM2-^>/,U?F2E&Z
M:OM*-]FKW7FCW*=:K4C[LN5I:-ZZKT.@L]<N--D)D(DMI"-T.W?M RIVMRP)
M_,<X(KLH)K'6+.2...*_MY]T<VFS,"T<<@PP4N"RX&  /NXX)KS-C\J@'KR0
M/7 Z_K6AI[FTG6YMY2) BLYV'<#DDHK#VZ<]/I7IY?FWU%*CC81QF!E:G.G5
M7-4LW9.$I*44TGK?I>W8^EP^9U:4*=1R:=*,$M=VK7?I\OQ/-/B3\+(K2VEU
MC0+9WMH@[7MKCS)[=SAAU))CSD#(' /2OE74+?:2NT':Q'(PV>XQUR""".Q'
M; K],+&]MK^%Y01(6&V[CD V2 @J1(O.XMR/F[#L2,_&_P 7O!Z^&]?::W3.
MG:K&+FR(5-@GRS7*$X&$3.W&>#MP> *^1\0N$,''#T\]RJA"6"KQ<JSI*[@^
M6W([:)PD^5[)N.FEC];X4SZ=2$,/.HW4J^]S-I145)-+>[;2MII^1\YW<"E7
M+#[NUEZ8RK!ANSG/J""K!@&!)!!_=7_@@7_P5JUW_@FM^U-I/@CXA:_+_P ,
MB?M">)=(T;XPZ5J#M/8>!?%=X'TGPW\8M*$CXTXZ+>-##XR\A535O#INW=3<
MZ5%)7X;Z@C D%6V^A!]SZ=N,>F*YF[ACFA>*>+?%(K+)'MRSAAL*J,<9  .!
MD#) ^8D_S+FN M.3Y>CTL_S^]G[QDF/C.G&3;Y;I6NKIOKN]+'^ZKH^JV^K6
M%EJ=G>V6IZ;J%K!?:?J=A-'<65]97D27%E>V5Q SPW-G>6TT,]O<0N\<D<BE
M6QBMJOY$?^#5G_@J-J_[4G[/VM?L2?&+6[6Z^+O[*>A:0?ASJEY<Q+K/CKX"
MSS'2]%@N8"0][K'PWU.&/PY>75L9?/T"[T"YNMMRMVQ_KL1@R@J01@#CUQ7Q
MTX\DI1MRV;T?Y_.Q]?=-)K9I?UH.HHHJ0"BBB@ HHHH **** "BBB@ )P"?0
M9K.U.\MK*TN+JZNH+.VM8)KBZN[F98(+.VAB>>:[EFD9(XHK:&)[F:21U1(8
MI&8@<C0;.#C@X.#[XK^;G_@YQ_;['[%__!//Q5X \(^(;G3/C5^US-=?!7P'
M;VID^W:=X.>&*X^+OBNWFMI;>6RET_PI<+HEC<B820ZKKMI+ "%D($KM)]U^
M8F[)OR/X6/\ @N?_ ,%'_$/_  4E_;L\?>([+7UO_P!GWX&ZYXB^%7[.FF64
M+P:;)X5T_4DAUWQG- [L+[5O&FM6$MY)J+E!-H<6F6<7^CQX;\E]/B("X7DX
M '4G<W(!]@"V0!G!!]:Y?2H8XHH1"I78JJI9A+PB[%92,J4V*NS(#; -P#$U
M] ?"/P+/XUU^&W*D:=:;;W5)"P$45HI4+$IXD\V9B20&WJ#QCBOO.$<JJ9MF
M6$P%!-SJUJ;^%R7)%I2V3[[W5M]$?'\19A2P&%KXFM-/EHU8QI*R<Y.]KN]U
M9VT^U<^H/@=X<DT?PK=W\R/'/KDUOY"LA0M;0L-I(;UR2.G!!'7)]E,*RW;J
MWSHFT*.FT\9ZYSR.""/QHA"P0I;PHD-O"BV]G&H4+%'$BQICJ<E5#$LV3D9)
M)S6AID+,2TJ!F9CN8$YP/8'CH#T& ,U_9>*PE+*\ERW):4?:3C0I1K)R;5.R
M?,TV]TI73O?HMD?R?G6-6+K8FO*+4JLZLTKNT7*]K?<OZ;OTEA:K&L14E.F1
M@'/& <D9XY]/I73VPC8-GJ@.3C))'?@9))YR.,\#N*R8EP(B!\J@DJ!U ZG/
MT&#5KSEC1B@PS%LCJ2<G@ D^W0=>]5E^%E",8PM96Z7M\W<_-\T?-"7,]5S2
M6MM;6[]O(;>7 *E,\@L2WJ. !CGD'/<Y]!BN3E;S6V&51N#$*<[N.,A.K#CK
MD5O2Q22G=EANSD],9QU],]!GG]*8MI:Q0M;%5DNG)F:1E/F0(G*M$<Y97.%8
M<K@GC.:]RKAGR*2:YNK5M4O+;9;]?F?'*O43Y>96N]TMF_/7J<V^SR55003N
MW$@\L" 6P>Q-:5D-B!2<Y1F)]@V.GOFGM"'@,S!2D,A5HA@%V?/3!5L[CDX.
M.">E7(H(PB2+@F-=IBR<2#.6#'.5[$X(]:XK/L_N?^1T2C&=HO6+:O9VT]4<
MWXBNIE1XDPD1D?+!0>=HQ@<$9Z'VKS3X>^!_B!\5OC5\-/AS\*M5CT?XC^*/
M&>E6G@W5Y=1BTE=+UZWNEN[745O9&06[V?D_:$\R0>:T0BA#2D ^H>(P$@EQ
M#\AE;RY&E5V<@?+^["@D@\<#ZU\G^/KG4M*N(]3TJYGL=0L;N"ZL[ZRGDM[N
MRN;9Q+#/;SPLLL%Q;RKOCE1A)$^<, 2*^.XOFH8>E*5W3IRYJBBVG*-_AO'5
M:7U6OYGZ+P;1JU\0Z=+EIS=&=&A6<8U(1<U::E2DG3GNKN:NUH?WK>*_#\GC
M#]GM+73-;N_#OQ0^&&BOXFU7Q1BT\1ZSXF\=:3X7N_"WC/5-3L=1^UPW=MXH
MO'F6![F!&5'86RHR #^7CX*7?QED^ 7QZUW5;R6[?X0?$%+S0KFVU>T$VBR^
M+UO)[J\&@SC8]B=0DA47$-M'#&'N(,$IE:O[+_\ P57^%'@[X.?#[X0?M :?
M\2;GQ4/BO OQ+^*^CZE=:I>:U\(;F/\ =Z/L;55WZE97+?:)-]HY:)!-'F=F
M8_M=^R!^S?\ L<_&.Q^/?CGX8V^N?$3P)XZO-/T7P/H^G:K>KJ\VA6^ERZG8
MZIXKN)(DTV /?/-%=6T\@>W6%I,J3NKQJ6,RW%KV>%S6O[&,*=-89R=^>NH4
MOCDXR]V<G9MV7+OT>5; 9YPA6J+-LLHXJ&(JSJ8'-Z%&$'45*<ZTH\E&#C!J
MD[--1<HZ24EM^"'[!G[>/Q@_9O\ %WQ&\$ZEK%EK'PA\67M]?>/-"O+"#4KT
M'6+/4;:;4M'FC$,HT^VN;F-M7TJWF%K=!E8Q*H.?KO\ X*"^'?"7QOL_V'--
M\$:UXQ\&>#[3P59:;\7-9DLM9L].\+66O7EO<VSV&J:DK6EE<ZTI:*P4?NH!
M/;P%W$; _+'CW]G34[;]HAOAMX/\"6NJ2^"/$>N>*/$GAZROX&TN;07O+98=
M&O-3@=I)I+DPKIT-DI:2>YD\U T>\U^WW[4,OA+XW_LW:MX4T[Q3>_#'Q9J/
MPX_LSPI\+[FRMM-@NW\"2:;./#FH:]<P+!=1Z;+;O$M_ T%W#=+#&&!<LWM\
M/91BIX*>$S)UJM.CCZD97J5(NK2O>F[KWN6,'96:3NW?H>5Q1Q'E64\9<(YO
M@:-#ZSF-.EA<8ITJ=54:53E=2O[.HG",X5&Y<UD[Q79W_);PA:ZQ^R[\5=5O
M/V1M(^)7Q7^'5MH2+?66L7\NHFRN)IH8-:UQ+2\OHHK.&YD3=?S6RL;7:+C"
MQOLK^PF[\5:_H_P6\ ^-OC%X]\/ZCK[Z!X47Q;X6N'L(-#@CU>*UCF:XNI ;
MF^N]*6Y,9U *(+B6"::.,P@25_&-X?\ 'OA+6- U&UO?$<6D^(H-1TVTN-$9
M6LM8N[VZM_L&MZ=975NPC?2)H[=;@R3.]M<L3+M!&!]5_LN:+X]\"^-I_%WQ
M-\3ZWX_^!7C37? _AWXK^&M6\72ZI?:?\/[+Q-H]J=9-[JDTDD5G8V7DV%_)
MI 6W32%N%:5<ECOQGP-A*>!>?Y-5@X8&DZF*P\%><72CS2ASWE*]W93TD_-M
MGZ)GF"P]>G_:2S&A468VH4:L)U8NK&K.BHS^K1BJ$IVM>*BTGH[61^N+Z/J7
MQG_X+2? [X7_  >3P=XY^$?P5^%R_%/XP7'V*T\1^#-#:6WO8?#L&JR:=+/I
MYUC4#)#<0V4PN)@L<9N;==Z&OOBYT_\ 8Y_;<^+'Q9\/R>'=!\1V'PO>P\'^
M*?%'@;PA::5JOARZTBXEG:"RU>VTZROQ:VMY;78$]G#>0*(H[>U'VLQBL?\
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M=NY$8$%0C!BV?EV]!FJNGAT.\, 44$$XX/7/(_ICMWKT"/-[;".3#)?VQLI
M^,,"&W%C@ #!.2,=L$5]#ED5F.39GDS;?MO?C&3NDK2E+E3=X]?AMU/J\@QD
MJ-:E*,FIPE&*>C7*Y15K/39ZM^MS\T=3M2LK1NNUE^8D]B!PH!P1D'Z#' YK
MC[N L05Z+G(]3GD^W X_H :]@\;6*V>L:G;F,J8;B5!D,I(620*<'G&  #T(
MYYSFO++O*)D#:Q&3QSD\]QQSVZ5_+W$N E@JE:$E[RQ.(I]=*=-M0TMM96YG
MOW9_2608MSHPC&5G=2MY7[>?1[=GU/8_V0OVJ/BA^P]^TY\(OVH_A)JDVG>+
MOA3XJLM7>S5RFG^)/"DKI9^*_!^LQAU%SH_B/0'NK&[MFWJ+B5)XU\U4K_:$
M_9V^.'P__:4^!_PM^/GPKUBVU[X?_%WP5H/CKPMJ5I,)8Y=/UNPAN9+20 GR
M+W2KQKG2=2M6_>6FH65S!( \; ?X>%V08W9L%PI(+ $*5YWLA!#>7MWJN,[U
M7;SBO[XO^#/3_@H FO?#_P"+_P#P3M\>^(I)=?\ A[>7OQD^ EMJ#L9+OP7K
MEP(/B+X3TIII&W#P]X@6V\1VNG1^7#%;Z]>SQ?()%C_)\7%7G.UI<TEV5D]-
M-O\ /4_4<)4E*,4W=<J[=N^^OJ?W+ Y /J,T4U&W(K<9*@D Y )&2,^QXIU<
M2V7HOR.X**** "BBB@ HHHH **** ()Q*0%1003AN<''H>G!^H_#@U_DF_\
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M32[W:XR'QBUF D"[B%(9V8$KC.#DL.^>O;\JX'Q;\57L8I#=7OEA4W*DDH5
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M8 )<J5Y4]".^>FKX8\5W_@_Q+H_B2QC@N)-.N&$MG.Q$.HZ9=P2V6J:/<*F
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MO'O$OP:_9NU^Q_:#N/!6M^)O$C_#CPUHFK?#]-.:WU#PDEO=ZGHMAKM@WBR
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MM^T?^SQ??#;6OB7X<L89/%W[,UA\,;;PSX:\'_##QAXAT-KR/P!XQTBR_LF
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M)E:%.XCD/S GUW<GMCI5&0NK'S3E69E4@8Z@X(XQCUQGM4T>/(NA$Q=Q'YC
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M':3RI;(0^NX9/<XY ]:\DN+EO(FD(.Z>;?,1)GYE8E2JDC/T/3G'%7;KQ!"
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ML_AI^V/^SE#\7OAW?6R'4O#FI67BCPM)<Q2ZUX*\56^ESKJOAS5XD8&.6SE
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M!!P6&0#GW'7]:DCLV,1CW $=R.."/?V]_P!#5V!%VJ&*'DX.[..>>G<Y'?\
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MMI^GZMX/MM)LK9/#_AF_M]1N([#PWA8=-M%MC+-=-"V?S \0.QN6A8 X@C&
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MVVDY==VM+I:_T3D'#U/+Z%"M/E]HXW<$HV3=FM5KVOY^9+$B1J%2,(N6.T
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M=,'/F?BGQ;I'AR/^T/$FN6^G1X)6UEN&EOYT;.'BB7<2IQPC 9Q@@5\^:_\
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M"^&$7@;]G_P>EUXQU:VMA\1/C3XHBL[[XH?$B^B5"\VKZPENJZ/H:2AO[/\
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M..V3R>1P,L>P)JG+-$06692J'@?<9FQ)QMDV[<,A7#LCOG]VK-P?]+7X&_\
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MP/2B@T&"->20"22<XP>3D#WQZ]3WI]%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %0*@9&R6&YL$JS(?O=F0JW?U]NG%%% %5)7&.3]^
M13DL<A#\I.XGG'!/< >E7=O&[<V<9^\<9Z].F/:BB@"M-*Z+@<[@W)+ C XP
M58$=?Y595=RJ6)/"GG&,X';&*** )**** "BBB@ HHHH **** "BBB@ HHHH
? **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ea028514801_img6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (&!2L# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI6FWWA#4[JWL+1HYQY:?LQ\1]>N_V-/^"W_[._B/PE+-IGP7_P""K/PG\5>
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MOB".\.B?V9XATG4$UE+!Y8[UM*:TNY?[46RECEBNS8^?]F>)UE:-E<#\F_\
M@NE^T)\1O@C^PY%X#^#/B";PG\8?VQ/CI\&_V*?AWXSM)Q%?>!]3_:"\12>'
MM;\7:> /,:[T?PE::^MK-"T<ME>W5M?QS1RVR9_!;_@L3^RK\;_AE^V;_P $
MC/V=?^"<OB";X;?%+]FC]ECXM>-_@3X?MM3U"+2_%^M? F;2-<N?!VK*MRBZ
MM>_$33;/6-+OY=36=];O=4DM+QS_ &C,X /[9M2UC2=$ABN]:U33=(MKF[MM
M/M[C5;^UL+>XU"[D\JTLX9;N6*.6[NI/W=I!$QGN&PD<;,,5I(3N(YX]3D@=
MB3CDGDG/W>%!K^03_@H1^W]X/_X*$?\ !*#]A7]H;P*]]X-\6O\ \%.?V+/
M7QJ^')NYK+7_ (8_%WPYX[O].\?> ->MT>WNXHK34EDN]--W$B7^D7%A=[-Y
M(3]9?CQ^W[_P4<^&_P 9/B+X!^%G_!(3XJ_&[X=>%/$=QI7A#XN:/\>/A9X;
MTKQ]I$,%O)%X@L="UEAJFG07$DLL*6MYB=&A8M0!^S;?=/7_ (#U_ Y&#[YX
MK*CU2PGU2XTB/4=/.JVMK;7UWI*7MO+J5M9W,DL5M=S622FYM[6X>&5;>YDA
M6*>2%T1V\MP/SD^%O[0_[?GQW_9>^/?B@_L8VO[*'[3VAV&JZ1\!_A]\<_B1
MH'C'PEXKU^;2@^D>)/$>M^!@XL/#UCJ4NR]L@/M=RMNP3:DP(_'_ /X(W?#;
M]H[X1?\ !83_ (*?>"_VKOV@)_VD?CC=? []F_QEXZ\?66G7?A[P=;ZGXKO-
M6OH?"G@'PI<3-'H/@[PC9);:)HMM%;6K/!;27$T1>8R2 ']2=]XC\/V.IV6@
M7NO:+8:YJL;2:9H]WJEA;ZMJ"*[(9+#39YTN[V-71U+00R+N0KD$'$K:]HD&
MN6_AJ76-)A\07MA=:M9:#)J5DFM7>E6DT,%WJ=KI33+J$UA;W5S!!<W<<#VT
M$TL4<DJ/-&I_S5_VF_B-^RMI1_X*VV7[8TW[2GQ2_P""J6A_M1?$^Q_97_:%
M^$WC'Q[K/PH^&.FW<NF2?LZZ+HOQ%\(ZW:?#_P"%NE>$KJXAM_B%X?UX6MTV
MG6L6BOF_L;EXOZ4/^"CC?&S]G;_@G7_P3Y_X*9^(/$-IXH_:\_8#M?V;O$GQ
MB\5>%M9M]0M/C#\.OBU8^!_AA^TS\/;S7-,EDTGQ'X<\7-KL'B>35HS/8-J/
MAZ'7M(,+3I)0!_3C16;I.IVFLZ9INL:?-'<Z?J]A9ZG8W,+^;%<6=_;17=K/
M%(/E:*6&161APRE".O.E0 4444 %%%% !112'IUQ[^E  3@$], G)Z<>O3^8
MKDM+\<>#M:72)-'\7>%]277SJ4>@'3_$&DWZ:XVC3S6NK+I+6EY,NIMI=S;S
MPZD+ SM87$%Q;W9C>)@/RI_X+B_M(_$S]GG]@OQ3I7P.U9-#^.'[27Q#^&O[
M*OPJUY;I[6[\.:]\=?%-IX.U7Q1I<\8,D>K^&_"UWKFKZ/+&K-#JEM:7!!6(
MU^!?_!:#]C_XS_#G]I__ ((8?LB_\$[/%UY\._BO\"_@E^UWXG^!3F_O;2'Q
M=XR_9W\"?#SXJ16'B(1745IJ6L?%C5_"NH6>O7VK^=:WNI^*=2GU/S+>_NE<
M _MCU+6-'T2&*XU?5=.TFVEN+>TBN=2OK6P@ENKMO+MK=)KN6&*6XN'41P0H
MSS2N<(C,:OJ22IW9X&0>#@J,EE'R[MV,$<!2#R.3_'C^W[_P4*\-_P#!1#_@
MCY^RA\?_  I'?> /B/IO_!1/]DGX9?M _#$7M_IOB+X2_&GPMX]EL/'_ (%U
MJR62UU2WL3?!=5T:+48T-[H%_ILES']L6>*+]>OCQ^WI_P %%/A9\6O&/@'X
M1_\ !(_XI?'OX<>&[RVL?"_Q<T+X[?"[PSI?C>Q?3[24:K9:)KC#4].A69Y;
M9X+P>;NAWYPU '[,G@'Z'T]/?C\^/6L31O$>@>(8[R70M>T778[&Y>SO7T;5
M++5([*ZC!+VEXUC/.+>Z3!\R"78XQR@Z5_,A_P %0/VEOV\?C3_P1Q_;$\;^
M-/V?/%?_  3O\9^"?$O@B#6M)\1_&GP9<>*_B3\"8;W1]3^)5K\/O&WAR>&T
M\/\ BG6;&:\\/:59O*FH:A);75K:Y^V+7YQ?\$S_ !C^ROKW_!7+]D'3O^"3
MFE_'/X&?"6+]F+QCK7[;OA+X]WOCGPEHOQ9M);2WM?"5_P"'O!WQ-U>>_P#'
M7Q*'B=H=1U7QSX4MKC3[FU@GGCF,$5PY /[C-#\0Z!XFLAJ/AO7-)U_3%NKJ
MS_M'1-5L=5L?MUA<2VE]8F[T^>XMS<V5U%+;7EMYOFVUQ&T,T:2*P&Y7X _L
MIZG??L?_ /!9S]K/]B/3)I;?X#_M;?"/3OV\O@SX7>Y>2S\#_$U-<7P=^T!I
M_ARU?;#IN@>*=;-CXJ;3-/3R(=6EO+E51KF;/[_4 %%%'2@#$U/7M#T6YTJV
MU;7-'TNZUZ_&EZ);ZGJ-G87.LZBL$UV=,TF*YFB?4;X6MO=77V2S2:X$$,LI
MB\F)W632M9TC78)+W1=6TW6;5;B:T>XTJ^M-1MX[FU8)<6S7%G++$MQ"SA9H
M7830EMKJ.*_!CX9:SJ7[9G_!;7]K#7O%,DES\*?^"47P?\"_"?X3>$IIF?2S
M^T9^U!X/O/&GCOXM)!&YM+O6-*^&-F/A[9"ZCEFT-;^]GMC!<WDC5_/K_P $
M1?VM/C?_ ,$[/B5HOCKX_>)M0\0?\$[?^"BO[5/QO^$%GXUU>_NKRP_9J_:O
M\%?$/7=%\+?VY=WUQ+'HWA3XJ:%]ATN[OEEBLII].34[@0)X9NI+P _OQM=8
MTF\O;_3+75=.N=4TEK?^U=.MM0M;F^TPWB>=:)J%I'(]Q9_:(_GMQ<QQ^;'F
M2+<@S6O7\R7[*?Q"^)/@#_@J_P#\'%WB[X;_  [\0_&_QMX-TO\ 8,U7P/\
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MM_0O[<'AC^VM)/B4:7_;G_".?VE9_P!O?V)]L^P_VS_9(F_M#^R_MW^AF_\
ML_V/[7_H_G>< E;5?@I_P6VO-5_9>E_9!_X*=_#NX;2/&G[*G[0O@7X:_%^1
M;B2SL/'G[)_[0GB&S\"_%#P9XE\K:FHQ:+K]SX7\5^$EOR;70]?MYM1C*M-)
MYG[Q6=U%?6EK>P'=!>6T%U"V0<Q7$2RQG(X.4<'(XH LT444 %%%% !1110
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M3SQV/4?6G4 ?AEJO_!,?QY^PK^S+^U3K'_!,WXF_%OQ[^U-X]\$>&%\#:/\
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M/_;=_P"">/A+X#R_!OX@>&/ ]A#\2_VT/ WQ"T;4;B;1?B3JWC;Q/J]OK?Q
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M^*=)$2Q21_$"_P!$M-:^(][=H"2+_5O'FJ>(M5OU)<Q7-W)&78*#7VN !P
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MY_9)TCX4M9R6Q2Z\<WVK^!+?PU;:(($V2:H=7CN%M8[-?M)F24*%96-?K?\
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M **** "BBB@ HHHH *0  D@ $]2 ,GIU/?H/R'I2T4 &!Z=.GM1110 4444
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M)X?U#61;6*C6[&\LX(YHX#<$ ^J:*0'(^AQC@D8['!/([\TM !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$/XF:19W=KH=@I-M8:CHFE2R^ ]1O=/5#-8V<5IYLEK%:A?H'_@G1:P^#O\
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MSM_P1>_:.^%?QG_9@\&>.OV@/A=XA_8F_8?_ &H/B_\ M8_L^:+H'@O7]/\
MCWXK\:?%.?Q1>:-X,^*&M7>JS^#XO#7P_NO%VM30:EH.F0ZEK_G0+>&'R5*
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M3[83^A[EUW_QGV8[_P#0AP"_#^T7^;%_Q-WF7_1#Y;_X>\U_^=9_IJ/^T3\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %8/B XMM/Q_T'M!'YZK:@_I6]7/>)"1:Z;@X_P"*A\/#
M\#J]H"/Q% '0T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5A3D_P#"2Z:.QT76,_A>Z-C^=;M<].?^*ITP9X_L
M+63CZ7VB#/ZTU^C Z&BBBD 4444 %%%% !1110 4444 %%%% !1110 4444
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MJRDBO-)UFQM[Z2ZTO4;25+BSOHH+B)U>-37>T4 ?RW2_\$>/^"IGBW]G=/\
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M_P"";?\ P2F^$GAGQS^VY\3[.XU3XY_$G1/#EAI'P>_9(\.>+84T^_\ BO\
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M **8=Q+#&  .<CG).2.I! [$ 9/!ZT@9R6X& 0H'(.[J<YP" ",%21NW#G%
M$E%1JQR?FW ^H( *@*P5@N"-V.N",,1D#B3KTH *\ZUS_DIOP^_[%SXA?^CO
M!=>BUYSKI/\ PL_X>CU\.?$//X3>"Z /1J*** "BBB@ K^>+_@XY_P"36_@?
M_P!E]@_]5SXZK^AVOYXO^#CG_DUOX'_]E]@_]5SXZK]'\'O^3H\$?]E!A/\
MTWB#\T\8/^38\:?]B7%?^G*)_')1117^M3W9_E4%%%%(!#T;WV#\RPK_ $1O
M^"7O'_!/?]D0>GP2\(_^B)J_SN3T/UC_ )M7^B-_P2]_Y1[_ +(G_9$O"/\
MZ(FK^/OI?/\ XQSA-?\ 4^QG_JGIG]8_1*_Y*CBS_LGL#_ZMZA]YT445_!ZV
M7HOR1_=X4444P"BBB@ HHHH **** "L_5CC2M2(ZC3[P_P#DM)6A6=J__()U
M3_L'7O\ Z32T 4O"K%O"_AMB<EM!T=B?4G3[<Y_&MZN>\(G/A3PP?7P]HI_/
M3;8UT--[OU?YL HHHI %%%% '\R7_!RQ%%+\-/V2_,C23;\2OB25WHK;2?!^
MDY(W XR.#CJ.#Q7\EOV6V_Y]X/\ OS'_ /$U_6M_P<J_\DT_9,_[*3\2/_4/
MTFOY,*_TS^C3"$O"+(W*$)/^T^(M90A)_P#(V?64)/\ $_S7^DA4J1\6<[4:
ME2*_LWA_2-2I%?\ (J72,XK\"#[+;?\ /O!_WYC_ /B:/LMJ>MM ?^V,?_Q-
M3T5^]>SI_P#/NG_X+I__ "L_"O:U?^?M7_P;5_\ EI7^R6O_ #[6X^D,8_DM
M0SV5IY$W^BVY_=28S#&<?(1P2N>>_KSVJ]44_P#J)O\ KE)_Z U-4Z:32ITT
MJC<)I4Z:YX.$DXR_=^]%IV:=T1*I4;NZE1N,VXOVM6\6J<9)Q?M;IJ2335K-
M)[G^D]^Q*B)^QS^RJJ*J*O[._P &U55 4*H^'WAX!0!@!0         *^GZ^
M8OV)_P#DSK]E;_LWCX-_^J^\/U].U_C)G:2SO.DDDO[9S;1)):9IF*6UMDDO
M1);)'^Q60?\ (AR/_L2Y0_F\LR]M_-MM]VV]VPHHHKS#U@HHHH **** "BBB
M@ HHHH **** "BBB@ I"0 23@#O2TAS@XX..N<?K@X_(T ?#7_!2[XS:K^SW
M_P $_?VROC+H<UU%XB^'_P"SI\5=;\+_ &%)WOI?%(\):C:^&8+,6JM<1W-S
MKD]G# \:DQ/()FDC6,L/XY/^";>F_P#!+/PX_P"P'<?M1>"?^"G'PE^,WQ+'
MP>N?!G[2OQR\6?'3P;^S)\6?VCITTK7G\-:%J.H^(7T8Z%-XIWZ3I+:UIMEX
M>\06L, 6::SO/./]J_[:\7[2,W[+?QJ;]D/2?AQXA_:,L_!M[J?PN\-?%O1C
MK_@'Q5K^FO'>_P#"+ZSIYU7182VOVEO/I.GW%WJ5K8V.IWMI=WKM;12@_P T
MG[6GQ<_;'_X+(_LZ?LZ_L!6O_!-?]J+]FWXJ:E\7?@=XJ_:G^-'QN^&L?PY^
M!O[/UA\'M5T_7O&_B#X5>+[S4+H>*=0\17EC=P?#C2=*6/4+_P *WEQ:RE;R
M>.WD /5?A=^S!X)_X+-_M]_\%1?%O[7OB/XH:S\*_P!D7XK:/^QU^R]\./ ?
MQ1\;?#?1/A;J?A?P[<ZI\0/BS8Q^$=8L(M3^)&M^)-1L]1T;Q'J,5R-(MHFT
MY[2_M(K-;;[D_P"" WQX^+7Q9_8R\;_"WXW^-=9^)GQ$_8\_:7^-/[)5[\2O
M$UR]YXD\;:'\+/$$1\(ZIXAN)29KS5[3PMJ>D:+=7]S+<7E^VFK?7<LEU+,[
M_)6F>,_VAO\ @D-^W)_P4-UD_L3?M1?M8_LZ?MI^*_"/[1OP-\8_LN_#T?$6
M]TKXP)X/M_#/Q!^%_P 2+*ROD;PC<:]X@MK:[\-ZU?*+6XT^"XO9T/FE8O6O
M^"?'@_\ :._X)?\ _!/;3?B+\5/V7_B_\=_VD?VMOVMM=^,_QD^!WP#T:'Q-
MXH^$5[^T7XEO+];KQ#&\RQQZ)\,?#6F:'#X_U 22PZ=K%S-:132V\0NJ /)_
M&_P<\,?\%7_^"S7[9'[/'[3NK^/-7_9<_P""?7P.^!>F?#SX->$O'GB_P#X<
M\5?%GX]:5J/BCQ'\3/&,W@[7-(O=9\0>%8]*_LOPOYUREOIMNEG,(-XN5G_.
MSQ!XN_:9LO\ @G?_ ,%*/V$8O%GQE^./P[_X)_?\%*/AA\(_&7B"TU+Q)XE^
M.NO?\$\KWQAX>\;^/O#\FIZ/<CQ;XEOM \(?:M-N3ILTNLW?A=[BUC>8!$7]
M0OC'??'+_@FI_P %7OVD/VUM,_9-_:"_:C_9A_;T^!'P8T7Q//\ LS>!&^(G
MCSX-?&SX!:;>^'=.TCQ/X,L[ZWN_[!\=:+J$EXWB:016RZW>6]B)I/L5Z8OI
M+_@BK^SY\=? _A[]LC]K;]I#X=ZA\&?BK_P4%_:F\5_M&1_!'Q BKXN^$?@!
MK2'P[X \*>- LLGV;Q//H]HVL:IIIV3:6;Z*QN8Q<P2B@#\1/V?OVB-4^!/P
M3_;S\$_\$Z_#_P 1/"7P=_;I_:I^%_[,?_!)WP7X^L/'6F6^E^,_%WPRAL/V
MC?BW\.?"WQ)N8_%>C?"'X4VJZOXWU>XN5ALQXDL%>+RWN&4_U<_L.?"7X*?L
MY?LU_"_]FOX'^./#GCK1/@=X8T[P7KNL:3XJT[Q5J^H^+XU:Z\5Z[XMO;*]O
MKN/Q%XD\1SZKK6H#4W%X)[QHFPL2 ?B?\1/A;^TU^WW\5/\ @I!^V-X%\,^(
M_#%_^SW\ /CE^Q)_P30T'Q1I]]HM[K/CS5O#=Y;_ !U_: T.RO!:307WCG6U
MMOAY\/M8FMX;N'2])FN+*Y\J\1J^?/\ @BM\'M'TO]MKX7^-OV5_V5/C9^RA
M\$OAU_P3L\*?!?\ ;<B^*?PW\7?#&Q^*'[8.G^(]-GAB%IXLF*^.?&_A1XO$
M=_K_ ([TR*>.^L]8AB:_GCD** ?UYT444 %%%% !1110 4444 %%%% !7*^+
M219Z3COXJ\*C\#KMB*ZJN1\9,5LM&]_%_A%?P;7[ >] '74444 %%%% !7B/
M[0_[/OPB_:H^#OQ ^ 7QU\'V'CSX5_$O0I_#_BWPWJ+2Q)<6<I2:&XLKVU>*
M\TW5-.NHH-1TW4K66.YLKR&*:%P0RM[=49X#8Y;YBO4<CD@GT'IT_I,G)6<6
MM'=IJ[E'JEUND[K3IT$];+:[2O>UGT^]Z?@?B[^SM_P0U_9$_9]^+/PJ^+VH
M_$?]JS]HC5?@$+@_L]^%OVF_CUK'Q8^'_P $KN:)88-4\!>%+C3-*M;;6].M
ME:PTC5=2?49M-TQ;:RLTC2QM7C\:U+_@W _8ZNOB?\7/C!H/[3'_  47^'_C
M7XY^.-8^(7Q,OOAM^USK7@F'Q+XCUG4[[5#+J"Z+X3M[B_M=+?4)[/0XM2N;
MZ33-.$=G;S"-.?TL_:A_X*"?LK_L;^)/"OA3]H#QQJGA'7O&^B7OB+P_;:;X
M+\6^)TOM*TS4(M,N[B2[\.Z1J=O:R17L\<0M[J2*9U/FQQM$"X^:U_X+D?\
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M_P#%5W#:^/OB'XL^+5[)+<ZLVHV4+)H[^#M-BT32/ ]I:+)8^';?P]ILEM:
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M=K;S_D]JE[\=O^"NO_!1/_@GA\8-,_8G_:2_93_9S_83NOBY\3_BC\3/VJ_
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M/TI_%.J>);,:CXDUC4K6^77+=I(I[:*>5YS\P:Q^TQ>?M;?L$?\ !'WXQ?\
M!1'2OB=\7/V.?AY\9?VB_A%^WGJWA'3/B!K]OXM^(WPITK7?AU\&?&'Q9T;X
M8"W\0ZEX6UCQ!ILUZX@@D"^+EMKRYW/*JM]I_##Q[^UE_P $B+__ (*$_LJZ
M9^P?^U/^TUH/QR^.?Q8^.O[$?Q,_9[^'1\:_#[6YOCI:O*_@SXG:Y8ZC'%X
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MXC./IJOAG_$TU^C ZZBBBD 4444 %%%% !1110 4444 %%%% !1110 4444
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M%:ZEI7EP?V9J#ZW<WKWVF^5%]@NFEM=B>5A0#Z@KSC7?^2G_  \_[%SXA_\
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MY9QC)?\ ,U4EH].9)]C^_4#'K^))_F:-HR#CD9Q@D=>O (!]LYQU&#7\!?\
MP^?_ ."E?_1Q[_\ ALOA/[_]25]/U].3_A\__P %*_\ HX]__#9?"?W_ .I*
M^GZ^G)_Q*?XE?]##A;_PXXW_ .=0?\35^'?_ $*N+O\ PWX'_P">Q_?F5!()
M'(.0<G()&#@YX!'4#CVI>#CH><COR.X]Z_@$NO\ @M%_P4LCMKF1?VD75H[>
M9U8?#+X3':R1NRG!\$D<$ X(([$8Z_W:_";7=3\1_"OX9>(M8NOMNL>(/A]X
M.UO5[ORHH3=ZIJOAO3=0O[KR8(X[>'S[NXFE\F".*%-^V*-(PJC\P\1O";B;
MPQ64OB#$976_MF6*CA7EV)KXA1^J*E*LJOML)AN6356'L^53YES7Y;*_Z;X=
M>*_#OB8\U60X;-<-_9$</+%1S6A0H3FL3[3V;HJCBL4I17LIJ;FX6?+:]VUZ
M."#R**C#@;>."#G'0'(_SCT-25^9)MZZ?+R;3_(_3DU]ZO\ )A1113&%%%%
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M4YGZNROWLC_9+#_P<-W>'HIOORX>A;[KNWJ244P%OXL!AR0O(P3P.<-G X)
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M*_X?/_\ !2O_ *./?_PV7PG_ /F*^O\ D\'_  ^?_P""E?\ T<>__ALOA/\
M_,5]?\GC]F_XE/\ $K_H/X6_\..-_P#G4?CO_$U?AW_T*N+O_#?@/_GL?WZ
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M,D9&#TYR1^&>*4E@0,$Y/..,+ZY)P>>O(;'13B@!U%!X!/H/\^G\Q3 S?,2
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M@N@#T6BBB@ HHHH *_GB_P"#CG_DUOX'_P#9?8/_ %7/CJOZ':_GB_X..?\
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MND"A5"X %?R/_P#$2!^TS_T;S\"__![\0/?_ *??\Y^N%_XB0/VF1@_\,\?
MSJ/^8[\0.?SO<=/\]<>C_P 2X^+JU_L#"-+5_P#"UE.R_P"XYQ_\3$>%/_0]
MQ:_[HV:?_*#^O3Q-X7\.>,_#VM>$_%VB:9XD\+^(M/N=*U[P_K5G!J.D:QI=
M[&T5[IVI6%RDEO>65W$QCN;6>-X9HV=)$96(.7J7P]\!:SX*?X<:OX+\+:K\
M/IM&M_#LG@?4- TR]\)-H-M"EO;:.?#US:R:7_9EM;QQQ6]G]E\B!(XECC0(
MN/Y'W_X.0OVEPFX?L]? P$=1_;?C_CC_ *_1GGMU^E?5W[$'_!;_ .._[4?[
M4?PA^ _BSX*_";PUH'Q%UC6],U37?#VL>+[C6],72_"FO>((9;&#4;J6PD,M
MWI"6LIG!0P2NT0WJ*\O-/ ;Q/R;+<?FV89)AZ&#RS!UL;BZCS?+:GL\/3YIS
MJ>SIU93J.,8OEA!.4K+E6J._+/'7PVSG,\+E&7YSBJ^-QLZ4,/3_ +)S&FIR
MK3A2IIU)TE"%YSBFY-**;<K),_H\\&>!_!GPZ\-:5X-\ >%/#G@GPEH< M=&
M\,^%-&T_P_H.EVX);RK'2=*M[6QME9RSOY4"F21F=RSLS'J***_(C]@"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R@_X*F_MK>./V<O
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M=?&"/68UBUE?B1/X T!_&)UN) %AUMM=:^;5X$ 2'4C<QK\J"@#ZBKSK7/\
MDIOP^_[%SXA?^CO!=>B#H/H.O7\:\ZUP_P#%SOAZ/7PY\0_TF\%T >C4444
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M;^!__9?8/_5<^.J_H=K^>+_@XY_Y-;^!_P#V7V#_ -5SXZK]'\'O^3H\$?\
M9083_P!-X@_-/&#_ )-CQI_V)<5_Z<HG\<E%%%?ZU/=G^504444@$/1O8*?Q
M&\BO]$7_ ()><_\ !/;]D0_]41\(_P#HB:O\[H]'^B_R>O\ 1%_X)>?\H]OV
M0_\ LB/A#_T1-7\@?2_2_P!6N$O^Q]C?_5/ _K'Z)7_)4<6?]D]@?_5O5/&_
M^"RW_)E&N^WQ&^&W_I\<?UK^05OE0D>K'\]M?U\_\%EN/V)]>/\ U47X;?\
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M=2W_ -<_&/\ 8&_X*"_ O]J*\_:._P""9?[1'PBT[P=X\^#GP^^#GQ&_9?\
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MM=W>R&^M-28'XA_L/_LV^+_VX_V4/^"\_P"R!KZ6O[+?_!03X_\ Q]L_B?\
M%O\ 9E_L*\TCX6_ >[U;4].\7_""#PYJENYM?%_AOXL6O@B[B\5>*]-VI=6%
M_ ]S:K!)!'+Z!\8]"_X*%>"_BE\3O&7Q5\$?"?\ 9L_;=_X*C_#WX*?\$W_V
M<?A+\'_B''\3K?X>_"WX966M^(/VB_VN_&GC"VLM*L8M-^'?@#6M6G\)Z6GE
M7^@W%QH\4\YNWB$G[9?\$X?^"??QE_9Q^,'[5?[9O[87Q<\&_&/]LW]LC4?
M=O\ $6^^%'A_5?#WP?\ AY\/_A9I<WAWX?> /A[I^NJOB"\M=/TR:+^U];UJ
M*WO+YK&SC>*1[2:_OK^A?L,?$OXN_MN_M<_M5_M+ZII-MHVL_!FZ_9$_8U\.
M>&-3;4KWX9?!#Q)HTU[\5OB5=R?N+:R^(7Q1\8WT<VQ56^T70?#>G:6][)!-
MA0#S?_@F1_P4%_X)S:Y9_"?_ ()_?LEZA\0]"TSX;_#'5=&^"FH>._A5XO\
M ?@SXZ>%/A+>Q>$_'/BSX4>-O$%E;Z;\1YK/7TN+_P 17]C.UU>S7DNL*;NW
MF^U']M>E?S4_L+?\$N?VXOAQ\:/V$K']J#Q)^S_!\!?^"6OP^^,?P_\ V>M=
M^$FJ>++WXB_'V?XGVMGX<TCQ-\0M+UG2[#3?!]IX:\%Z?;V>LZ5%>ZA-K'B0
M#58B\4\S0?TJCD ^H'^>] "T444 %>"_M"2-'X=^'I7^+X]? >,_[LGQ2\,H
M?T/_ .NO>J^>_P!H]S'X:^&Y&,M^T)^SZG.>C_%KPLIZ=\$X[>M 'T)1110
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M^ M6U+2]5\*^./!NKVVO^')=332KRQNM7\+W]]:+IOB;1?/"ZAI%W=*@^T)
MR_Y]_2Y_Y+CAE?\ 5)O_ -7>,/[X^B=_R0_$#ZOB=7?5_P#"/@T?SK_M$Z[\
M2=%_X+8_\$QT_:M_9@\._L2?LR?!?XB_$OX2_L7?%[X7W>D^.I/C]XU\7Z38
M^#OAO\*_'.M^%K:TM?A#X:UG2K2ZU2W\&:G%='[+(\5[=6PN+H1_8'_!2_\
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M/QK\&U.?^_G%>\5\]:ZQ'[5'PR3L?@3\:&_$>._@A_\ %4 ?0M%%% !1110
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M7Y(_D%_X.2O^2]_LQ_\ 9(?'7_J9Z57\X-?T??\ !R5_R7O]F/\ [)#XZ_\
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M)?#2C8=?T48P,#5; 8X ('^D @=1P>!T.,8_E*_X+97$UM^V'HQBGD3?\&?
MYQNZ :[XR'!ZC))W '#<$\JI'Y'275P)%4W#$,@=<N3R?KQ@C&,=\XX%?SK@
M^'IXNA2Q"KJ"JQE**:?V6T]+/9>>NYS<9_2@P_!_%G$?"U3A.MBZF09C2P,\
M5',Z,(U?:T*,X3Y)4[PO*HU9M[73U5O]";_A)O#.2?[?T7)()_XFUAC(& <?
M:<9 [X[#T%(?$OA@_P#,?T;GK_Q-K'!SU!!N2I!'!!&,=J_SV?M$P_Y>"?\
M@6.OT/H1^?TROVJX[7&/^!D_SSW/Z^_/5_JM/_H)7_@#_P#D3YO_ (G!PO\
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MAQS0![-1110 4444 %%%%3+I_B7YDR_27Y'\@O\ P<E?\E[_ &8_^R0^.O\
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M?_DS/%O_ &*<MOZ_VADA_-X.)$'H7_E_]:FCJ_\ OM_.E4YD0GU?^1I!U?\
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MO^TII<G[</\ P7Z_9?\ V;=>B^V_!;_@G'\"KC]LCQ?HDA@N++7/C=\1[_\
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MR:7@'_LGL/\ ^I&/"BBBO./U,*Y[Q:,^%?$HZ@^']:!_'3;G\/;GUKH:PO%
MSX9\1#UT+5Q^>GW% '.?"9=GPL^&B]-OP_\ !J_]\^'--']*] KA?A>H7X:?
M#Q1G"^!O"0&?0:!IX'\OSKNJ "BBB@ HHHH _F6_X.5?^2:?LF?]E)^)'_J'
MZ37\F%?UG_\ !RK_ ,DT_9,_[*3\2/\ U#])K^3"O]-OHT?\FAR/_L9\1?\
MJV9_FK])'_D[6=_]BWA__P!52"BBBOWH_"0J*?\ U$_O#*/S1A4M13_ZB;_K
ME)_Z U'\O^/_ -LD0^O^*7_II'^E!^Q/_P F=_LKG_JWCX-_I\/M _QKX)_X
M+C<_LA>%1_U73P4?^^?#?C8__J_6OO;]B?\ Y,Z_96_[-X^#?_JOO#]?!/\
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M^HAHU?YBM_\ \>-[_P!>ES_Z)>O].KX"?\D-^#7_ &2KX>?^HAHU?Q1],/\
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MORT_]*8JAJ:V_P"/JS_Z_+3_ -*8JPQ7^[8G_L'Q'_J/B#HPFN,P2[XW!?\
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MI_A^%WQ(C]B'\4_#-OKG]V,?4_AZY7ENI*#\:/![=Q\-?B O3^]XE^'1Z_\
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MR8/_ .7']'G_  _L\._]&U>(,^G_  LG3L_^H?0O_!>WPV2!_P ,V:]R<?\
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MO5DTKP+\/([0:]XL\9:A;9MO"NAW&H7]IH>AWNIF--9UV4:78^;<+($^B^M
M!7G&N_\ )3_AY_V+GQ#_ /1O@NO1Z\YUP?\ %SOA\?3PY\0OUF\%T >C4444
M %%%% !7\\7_  <<_P#)K?P/_P"R^P?^JY\=5_0[7\\7_!QS_P FM_ __LOL
M'_JN?'5?H_@]_P G1X(_[*#"?^F\0?FGC!_R;'C3_L2XK_TY1/XY****_P!:
MGNS_ "J"BBBD AZ-[!3^(WD5_HB_\$O.?^">W[(A_P"J(^$?_1$U?YW1Z/\
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M_P#(K?LQGT\5_$O_ -,GAA/Y.3]0!7[Y^'>/#^A#TT?3/_2*"OP+_P""]O\
MR*O[,?\ V-GQ+_\ 3/X5K_&O+?\ D;4G_P!1%3\9UD?Z8>.__)F>+?/*<MOZ
M_P!H9(?S>#B1!Z%_Y?\ UJ:.K_[[?SI5.9$)]7_D:0=7_P!]OYU^BO>?_;G_
M *5(_P J?^7<?^OU3_TS2%H7D3?[H_0$T4+TF_W1_P"@M2^S+_"O_2H#AK./
MI4_],UBO/S!<G_IRE'Y(:_OM_9LY_9U^ A]?@Q\+_P#U"=$K^!&7F&Y';[))
M^J&O[[_V;./V=?@*/3X,_##_ -0G1*^4XI;?U1-])/[XH_LSZ&O_ ",^.?\
ML69-_P"K+%?\$]JHHHKY$_O(**** "BBB@ HHHH *:_W3^'\Q3J:_P!T_A_,
M4GL_1_D ZOX&?^"UW_*2K]H'VL?A5_ZJOPB?ZU_?-7\#/_!:[_E)5^T%_P!>
M/PI_]55X1K^G/HG_ /)RLQ_[)/-?_4S*#^:/I4_\FZR__LJ<M_\ 4/,C\K:*
M**_T5/\ /8****:W7JOS&M;_ .&?_I$W^A]N?\$U1G_@H%^Q][?'+PN?R@U"
MO]%H\ D?YZ"O\Z;_ ()J?\I OV/O^RX^%_\ T3J%?Z++_=/X?S%?Y]_2Y_Y+
MCAE=/]5-O^ZYB_\ ,_OGZ)J_XPCB!]7Q.KOO_P (^#7Y'\EG_!;/YOVQ]-3L
MWP7\%#/IG7O&(K\A$&(\?W7(_(5^O?\ P6R_Y/*TK_LC'@G_ -/WC&OR$7[C
M?]=#_(5^,Y5_R+,'_AC^4E^1_'7C:E_Q%OCR5M?[<QT+_P!UX?+:C7_@?O?A
MMH%%%%>B?E05ZC\#?^2W_!?_ +*[\,_U\;:&/Y&O+J]0^!W_ "6_X+>_Q>^&
M7_J;:&?Z5CB?]WK_ /7FK_Z1(]CAW_DH,A_['F3_ /JURT_O^'5A]/U'_P!:
MG4T?>;_@/\J=7Y7'>7^)_DC_ &FZQ]9?DPHHHJB@KS344S\7_"<F>5^'GCI,
M>S>(? +?S2O2Z\[OU_XNMX7;/(\!^-5Q_O:[X'.?PVC\Z/\ )@>B4444 %%%
M% !2-T/T/\J6D;H?H?Y4+=>J_,3V?H_R9_GF_P#!5;_E(A^UI_V4^#_U#/"E
M?GU7Z"_\%5O^4B'[6G_93X/_ %#/"E?GU7^O/AA_R;K@;_LF<J_]0J)_DKXD
MZ\?\7W_Z*;-/_4G$L****^W/BAK<;?\ >'ZDFOTH_P""061_P4?_ &73U_XJ
M?QCQ]/AEXTSS7YKM_#_O#^M?I1_P2#_Y2/?LN_\ 8S>,O_58^-*^ \4V_P#B
M&O&[ZOAW.[_^$K/M/#/_ ).'P=_V461?^I;/]!$<@=LC\?SK^/#_ (+ Y7]N
M3QV0<X\&?#0\]R?#VTY_#IZ5_8>O0?0?RK^/'_@L$,_MR>//^Q*^&I_+P]G^
ME?Y6<.V_M!7_ .?<_OL[']M_2EBGX757U6=979W:ZUM[-76NST/R_P#DX^3I
MC^(CIGTX[FC"8QL[8^\?;_ ?E245]S9>?WO_ #/\T;^4/_ (?_(#=B^GZG_&
MFLJA6('(4GJ?3ZU)3).$;Z']>*I;KU7YHRG&/)/W8_!+[,?Y9?W3Z9_8RR?V
ML?V9\DG_ (O5\.,>W_%4::?\!^%?W<+V_P!U?ZU_"1^QC_R=?^S0?^JV_#E?
MP'BFQ&?_ !P?F:_NW7M_NK_6OB>)?]YH?X9_FS_0WZ(5_P#4SB"[;_X6L):[
M;_YE6'ZMM]NHZBBBOG#^MPHHHH **** "BBB@ HHHH **** /RN_:N^'W_!/
MK]D+XR>,?^"NW[4^LIX<\>>!_@U!\&+3Q5XRUR;7-)T[PO\ VH-4L?"_PM^'
MEQ%,)OB!XKUEEL[)- B;6=6FOKB%#%;7=](_X%_#_P %_M!> ?\ @FY_P79_
MX*AQ?#7Q!^RW_P -T^#/%WQ)^ 7P $ T+Q'X,^&.F>%KKPQI_P 1_%6AVL<$
M6A^._B!I&KWFO726L=O/%:21W!CAEFB"_?/_  4M_P""77_!2']K[]O;X6_M
M0?";XW_L7W7P5_9\\/:?#\"?@#^T_P" _B;X^\(Z#\0[NP63Q/\ %3Q/X.\/
M6Z>&O$/CF/6'NHO"6LW=Y<KHVA6NG0"Q6[CGD?[R^!?[.W_!0/XI_"?]HWX)
M_P#!4?XH_LF_%_X>_&'X?77P\\.6/[,OP\\>^"+S2-/\1Z7K.C^++KQ'-XXO
M;F&_D^SWFFSZ MA!&;&]M)I9Y)$>*.( _&;_ (*#? KX7?#/_@V%^#5]X&T/
M1=*UCX _"?\ 99^-OPG\0V5A:0ZSIGQ3M=>\&:XWB+3]2C@%XNNZ[JFIWIU>
M]$JW6JF>1+Z:;<:_:_\ ;W^*WQ%\-?\ !(;]I/XO^&[V^L_B?!^Q%XD\76^H
MV7[K4+?Q-J7PN2ZO+JW:+8(;J.>^NI4:$(T3@/$R,BE?RST3_@C?_P %%O''
MPG^!'_!/W]I/]K+]GOQU_P $U_@)\0?"&N9\(>#/'FD?M3?%WX9?"S6FUKX8
M?"CQ[J^HO-X'L+6PN+;3[3Q7JVFR7,FKZ?;6D4"++ Y;]G] ^ G[17C7Q'^U
M[\-OVE?&_P '?&W['?Q7\/6G@']GWX6^"/!^K:-XW\ > =0\)S>'/%VE?$+6
M[X+INOW%V\YDTAM-\U;..)6DF7<L$ !_/?\ M3_ 7X2>#O\ @U*\!R>']"T.
MRO?A=^S=\#_V@?!/B&*SMH]:M?C /$7ACQQ+XJM=72W&H#Q'K'B&\NH=1U))
MUO=3MYI;*ZN)+9VC/&>/_P#@G[^W)XZ^&?QC\/>*+WX&6'[$/[:GQ2_97_X*
M,?M!?MB>.?B#<:3\9?@E8_#'P9\*OB-\3_!S_#X::T/B75Y]5^' M_"_B:'5
M;;1M%T'5[B&ZB$MNL:?3&G?\$9/^"B_B3X&?"_\ X)L_&']K?X!^*O\ @F+\
M,OB!X>OI;O0/!WCK2?VMOB'\$_!'BY?&/@KX,^*=8N/,\!VB0WUM::7KFNV$
MCF]T"&VLXH\020R_K+_P4>_9-^+7[6?P-^&/[(GPEU+0/A_\!?'?Q(\":#^U
M-JO]HSZ7X@@_9=\(O#J?B7X;_#BUMH91+JGCT:/I7@N]%VJV5KX5O]9$CAY(
MA0!^*O[-O_!2W]G;X&?%WXP_\%%_VQ-$^-E]\8_VZ_!T_P 0_@OX*^'7PB\4
M_$W4_P!E[_@EY\(/$=SX:^$_C'XEPZ)!YGPX\._%#77U7XL>+;BZ$O\ :<U]
M87UM#)%IT@7^KGP5XT\+?$7P=X4^(/@?7+#Q/X+\<^'-#\7>$O$>E3"XTS7O
M#/B73K;5]"UG3YP )K+4],O+:\MI, O%,A(!.!^!_P"W9_P36_;"UO\ : ^)
MOQ4_8-U3]G73?"'[2O[!=G_P3S^)W@CXSGQ3H]I\&/!&DZKKLWAKXE_"^+PM
MIVI6VMIHGAWQ+J.BW/@.^2RLKF2UTRYBE<).%_9[]EKX&6'[,G[-7P!_9TTW
M6;CQ'8? OX-_#?X2VVOW<(M[C7$\ >$M)\,MK,UNK.ELVIOIAO?LJ,R6HF$"
M,40&@#WD9(Y&#Z=<?E7G>N?\E-^'W_8N?$+_ -'>"Z]%KSG7#CXG?#T>OASX
MA_I-X+H ]&HHHH **** "OYXO^#CG_DUOX'_ /9?8/\ U7/CJOZ':_GB_P"#
MCG_DUOX'_P#9?8/_ %7/CJOT?P>_Y.CP1_V4&$_]-X@_-/&#_DV/&G_8EQ7_
M *<HG\<E%%%?ZU/=G^504444@$/1O?:/SWBO]$7_ ()><?\ !/?]D0>GP1\(
M_P#HB:O\[H]#]8_YM7^B-_P2]_Y1[_LB?]D2\(_^B)J_C[Z7S?\ JYPFNBS[
M&?CD\#^L?HE?\E1Q9_V3V!_]6]0\9_X++_\ )D^O>_Q&^&P_/76']:_D&VC:
MZ9X$CKGOA2!G\<?A[U_7S_P66_Y,GUT>OQ'^&OZ:ZQ_I7\@XYW'UDD/YD'^M
M?R-PU_N57_K]'_TEV/F?I:I/C[*T^O#5-/S7UBM_FQQ]NF%Q^0I*4]?P7^0I
M*^B/Y7J?'+U7Y1"BBB@@_J;_ ."%?_)M'Q2_[+?J?_J%>#*_;6OQ*_X(5_\
M)M'Q2_[+?J?_ *A7@ROVUK\XS;_D98S_ *_/_P!)@?ZV^"7_ ":7@'_LGL/_
M .I&/"BBBO./U,*R=>&=#UH'OI.HC\[.85K5F:T-VC:L#T.F7X_.UE% &1X$
M79X(\&H#G9X5\/+GUVZ19C/XXKJJYGP4-O@WPDO7;X9T$9^FE6@KIJ'N 444
M4 %%%% '\RW_  <J_P#)-/V3/^RD_$C_ -0_2:_DPK^L_P#X.5?^2:?LF?\
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M HHHJ9=/\2_,E[I=U+\D?R"_\')7_)>_V8_^R0^.O_4STJOYP:_H^_X.2O\
MDO?[,?\ V2'QU_ZF>E5_.#7^I_T?O^3/\%_]@F8_^KK-3_+_ ,>W?Q=XROTQ
M&5I?/*,"W^(4445^QGY"%36W_'U9_P#7Y:?^E,50U-;?\?5G_P!?EI_Z4Q5A
MBO\ =L3_ -@^(_\ 4?$'1A-<9@ET>-P7_J9AC_4:\/?\@#0_^P/IG_I%!7X%
M_P#!>[CPM^S&/^IK^)9_\H?AE_YICOP?45^^GA[_ ) &A_\ 8'TS_P!(H*_
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MVOYXO^#CG_DUOX'_ /9?8/\ U7/CJOT?P>_Y.CP1_P!E!A/_ $WB#\T\8/\
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M\ _]D]A__4C'A1117G'ZF%9VL#.DZH/73KT?G;2UHU0U49TO4AZV%X/SMY*
M,SP@NWPGX77.=OAW1%SZXTVV&?TKHJP?"HV^&/#B_P!W0=''ITT^W'3M6]3>
M[]7^; ****0!1110!_,M_P '*O\ R33]DS_LI/Q(_P#4/TFOY,*_K/\ ^#E7
M_DFG[)G_ &4GXD?^H?I-?R85_IM]&C_DT.1_]C/B+_U;,_S5^DC_ ,G:SO\
M[%O#_P#ZJD%%%%?O1^$A44_^HG]H93^4;'^E2U%/_J)_^N$W_HIZ'HH_X_\
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MSO\ DQ/]F[_L2+K_ -2;7J^;XG_W7"?]?ZG_ *;/ZV^AY_R6W&'_ &2N#_\
M5U ^Z:***^*6[]?T1_H2MOF_S84444QA1110 4444 %%%% !7\J7_!RI_P A
M7]D3_KR^,_\ Z.^&E?U6U_*E_P '*G_(5_9$_P"O+XS_ /H[X:5^P> G_)V^
M#_\ L+Q7_JOQI^.^/G_)J>*O^P?#?^IF'/Y=1U_!OY&DI1U_!OY&DK_5%[OY
M?J?Y@]/F_P H!1112 J7_P#QXWO_ %Z7/_HEZ_TZO@)_R0WX-?\ 9*OAY_ZB
M&C5_F*W_ /QXWO\ UZ7/_HEZ_P!.KX"?\D-^#7_9*OAY_P"HAHU?Q1],/^'P
M'_U^SO\ ](P!_9?T1OXW&_\ UZR3_P!.8X_(;_@NR<?!7X(#'7XL:F/_ "Q]
M;_QK^8&OZ?O^"[(S\%/@B<_=^+&I'ZY\$:T/ZU_,#7\Q<._\BR'_ %]J?E'_
M #/R3Z4O_)T<3_V*<I_]1I!1117N'\WA26_^K'U'_H9I:2W_ -6/J/\ T,T?
MS?\ 7NI^0Z7^\T?G_P"ET3^Y[]A(8_8X_9F'I\&_! _\HEK7UG7R9^PH<?L<
M?LSGT^#?@D_^42VKZS!R ?49K\LK_P 6K_U\J?\ I<C_ &BX9_Y)[(_^Q+D_
M_JKP(4445D>Z%<=XU0/8Z("<;?&/@]_Q3Q#8,!^.,5V-<IXN7=9Z./3Q7X5;
M_OG7;)OZ4 =71110 4444 %%%%3+I_B7YDRZ/RE^1_(+_P ')7_)>_V8_P#L
MD/CK_P!3/2J_G!K^C[_@Y*_Y+W^S'_V2'QU_ZF>E5_.#7^IWT?O^3/\ !?\
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M2/\ 6O[Y:_@9_P""UW_*2K]H+_KQ^%/_ *JKPC7].?1/_P"3E9C_ -DGFO\
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MQ\2>(8&T_P />.KNRN+'4Y);>.*V%V;BTMO0/C3_ ,%O?"?P;_:$^)/@J?\
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M?7AJ"?FOK%9?DV./& .P7^0I*4]?P7^0I*^B/Y7J?'+U7_I,0HHHH(/ZF_\
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M_JQ]1_Z&:/YO^O=3\ATO]YH_/_TNB?W/?L*#/[''[,X]?@WX)'_E$MJ^LP,
M#T&*^3/V$CG]CC]F8^OP;\$'_P HEK7UG7Y97_C5?^OE3_TMG^T7#'_)/9'_
M -B7*/\ U5X$****R/="N8\5#-II7MXG\,$?AK=G73US?B==UKI@SC'B3PVW
MK]W6;,X_'% '24444 %%%% !1114RZ?XE^9+W2[J7Y(_D%_X.2O^2]_LQ_\
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M .B?]@C3?_2*&M>LG0!C0M%'II.G#\K.$5K4WN_5_FP"BBBD 4444 ?S+?\
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M[!\-_P"IF'/Y=1U_!OY&DI1U_!OY&DK_ %1>[^7ZG^8/3YO\H!1112 J7_\
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M2_(_D%_X.2O^2]_LQ_\ 9(?'7_J9Z57\X-?T??\ !R5_R7O]F/\ [)#XZ_\
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M#_L=86W_ (:\..HHHKYP_K<**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *\ZUS_DIOP^_[%SXA?^CO!=>BUYSKAQ\3OAZ/7PY\0_TF\%T
M>C4444 %%%% !7\\7_!QS_R:W\#_ /LOL'_JN?'5?T.U_/%_P<<_\FM_ _\
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MCB@"AH8QHNCCTTO3Q^5I#6I56QMS:65G:,P=K6UM[<NH*JYAA2,L%)) 8KD
MDD XS5J@ HHHH **** /YEO^#E7_ ))I^R9_V4GXD?\ J'Z37\F%?UG_ /!R
MK_R33]DS_LI/Q(_]0_2:_DPK_3;Z-'_)H<C_ .QGQ%_ZMF?YJ_21_P"3M9W_
M -BWA_\ ]52"BBBOWH_"0J*?_43^\,H_.-A_6I:BG_U$W_7*3_T!J-^7_'_[
M9(A]?\4O_32/])_]B?\ Y,[_ &5S_P!6[_!O]/A_H'^-?!7_  7&&?V0O"H[
M_P#"]?!1_P"^?#GC8U][?L3_ /)G7[*W_9O'P;_]5]X?KX)_X+B_\FB>%/\
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MI^_X+L#/P4^"/M\6-3/Y>!M<K^8&OYBX=_Y%L/\ K[/\HGY)]*7_ ).CB?\
ML4Y5_P"HT_T"BBBO</YO"DM_]6/J/_0S2TEO_JQ]1_Z&:/YO^O=3\ATO]YH_
M/_TNB?W/?L*#/[''[,X]?@WX)'_E$MJ^LP, #T&*^3/V$CG]CC]F8^OP;\$'
M_P HEK7UG7Y97_C5?^OE3_TMG^T7#'_)/9'_ -B7*/\ U5X$****R/="L/7_
M /CWT_\ [#FA_P#ISMZW*H:A9F]CMT5PA@O["\)8$AA9W45PR#!&"ZQE5)R
M2"00,4 7Z*** "BBB@ HHHJ9=/\ $OS)>Z7=2_)'\@O_  <E?\E[_9C_ .R0
M^.O_ %,]*K^<&OZ/O^#DK_DO?[,?_9(?'7_J9Z57\X-?ZG?1^_Y,_P %_P#8
M)F/_ *NLU/\ ,#Q[=_%WC*_3$98E\\HP+?XA1117[(?D 5-;?\?5G_U^6G_I
M3%4-36W_ !]6?_7Y:?\ I3%6&*_W;$_]@^(_]1\0=&$UQF"71XW!?^IF&/\
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MBDL&UN^=?)1C8_LWZ&O_ ",^./\ L69-_P"K+%GM5%%%?'']Y!1110 4444
M%%%% !37^Z?P_F*=37^Z?P_F*3V?H_R =7\#/_!:[_E)5^T%_P!>/PI_]55X
M1K^^:OX&O^"UP_XV5?M ^]A\*C_YBOPD/Z5_3GT3_P#DY68_]DGFO_J9E!_-
M'TJ?^3=9?_V5.6_^H>9'Y64445_HJ?Y[!11136Z]5^87LI/^[/\ ](DOU/MS
M_@FJ<?\ !0+]CWW^.7A<?^0-0_K7^BVPR"*_SH_^":W_ "D"_8]_[+GX6_\
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M Y/7VSC_ #S3=R_WA^O^'U_+W&8UBM!,[021B89ZDG ;!.5&< ^H/6IPLO\
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M?AYG^TG#2MP]D:O!VR;*5>#NG;+,"NNVVGEYA11161[@4444 %%%% !1110
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MZO\ NMZ?KJ?Y4N%2$(P<:DINK4DFJ&CC[&E_U$J_FW;6]EU$W+_>'Y-_\32
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M>5OFS^./'!1I^+?'#:G[2MGN-ITU"=&HI1=#+ZC3I\\)I\T;V4E+I:P_<O\
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MZ$_B/!GA/^>?Y5^?7'J*_03_ (*K!C_P43_:S&Y"H^)EN?E.6 ;P;X5SN7J
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M7^\.WKW_  ^G^0<(Q4AAN'*GU]#[?YS['#\2?\](/R;_  ]S^=#+,%8B2 D
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MO)>QZ#I=II4-Y-!'HLD<$ES':">2%'D2*1_+1W50Y]QW#.WN1G'3CH.N.IX
MZT;QQP>2!QS@GCMV'.3TX/-?(\5\?<6<;1P<>)\VJ9I_9[K/!NK2HTY4?K"@
MJRBZ487C4Y(-J2>L4TUK?ZOA?@/A3@QXQ\-931RMX]4EB_93JS5;V#DZ3:JR
MG9P<I6<6M)--/I^<W[:G[&_Q"_;0\%^#?!NN^+/!O@"'P?XIF\417VCQ:QK\
MFH22Z->Z.+*6#4+"P2WCC6]-REQ$[R>9$B[-K,:_./\ X</:O_T7W3__  E[
MG^ER/?\ 3TY_HU#9 SP>XR#@>IP<8_Q%(7P<$$#&=QQ@>@."2,]CT)XZXS\S
M0QV*PT/9T:KA'>R2?YGF\1^%O O%F92S;B'(:&98^5*E1]M6JUDHTZ,>2$80
MIRA&-HZ-ZM[L_G+_ .'#VK?]%]T[_P )*;W_ .GGW_0>E'_#A_6/^B^Z=_X2
MMS_\DU_1J6YP%8]1GH,X! YQP<]>F1C.>*=6W]K9ATQ,UZ)(\/\ X@1X4?\
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M?_!UXH_^4%>E44C8\U\[XP_] [X:_P#@Z\4?_*"CSOC#_P! [X:_^#KQ1_\
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M1R1G_9..OS#) Z@=<=* /.A+\72Z[].^&X3<@8KK/BAF"$_O"JG0E4N!]S)
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MX7B\66&DI;VNNZE::Q<+?2ZWJ:7.KW]Q8V4FH7=W):VKQ ']!7Q<_:\_96^
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ML_\ B3X-?&OX+?M)_"/X]^._$_Q4\#>-+/QC<:!X@^$DNGPV.B:5>>&M1O\
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M"ZU6>V_<U]' 8S[G/4GZXS_3 [XSG*T4 %%%% !1110 4444 %%%% !1110
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MT6 6VF6!U77+[4=:O_L\*A#<ZEJ%Y=3*#YTTC'</4J* /@^P_P"":'[%NG?
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MMT? *;Q5\6+'2]1\"::GBF4PZK;:W<SV>E+?:I]A_LCPU=WMS;2P1:=XHO\
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M3Q!%XHN!NO?$'PZCN-936OM9M[69Y;M8[2.V\A #^BW]C[]C']G7]A#X0?\
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M;4IB$9@-VT@<#(!^CGB7P[X?\8>'M;\)^*]&T[Q#X9\3Z3J&@^(- UBTAO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *_F7_X.>/"L?CK]GK]A_P $2Z]K_A=/&'_!0KX!>&7\2^%;
M[^R_$^@1ZS=:A:/JOAW4@KM8:U8B07.FWJH[6UTD<HY08_IHKQWXP_L^?!+]
MH*S\):=\;_A;X*^*>G^ O&>B_$3P59^-M"LM=M_"_CKP[(TNA^+-%CO(Y!8Z
MYI4KM)8W\6)X'),;+UH _C3_ ."L'_!,/6/V$KSX%?M>?&+XW_MC?\%'/^">
MGP\^)/A^/]KO]FCX_?&SQEXJN_"^AZCJ-O:^'?BSH[^&[C1(?$GAKPMK4MK<
M>(?"GB33[_3;ES -1NAH]Q=QVVQ^T?JWB_XD?\%X/A'X]^ 'QO\ V/OA?\/]
M8_X)I?#O7/V%?%/[5'@G4_%7P%U_PCJVMR6_BG2_@Q:0ZYX=T#1_B3;Z+,1?
M0Q3K>6WA>%M+DLX+M=/B']H_CGP+X2^)?A'Q1\/OB#X9T+QKX$\:Z)?^&_%G
MA+Q-IUMJV@>(- U6WDL]2TC5M-NXY;>_L;ZVFDBN+>X1XVC^4 $Y'R1XU_X)
MG_L"?$?X+> ?V=?'7[)'P.\2?!'X476HWGPN^'6H>"=.;0OAW<ZM<7UWJ<_@
ML1+'>>&Y+Z[U*^N+DZ3=6HEEN'9@=L>P _FB_8U^&GPNTKP3_P '!VI?&_\
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M/A_I%CKFD7^I12PW][HA\I[70[N\2>4W5SI%O933R.TLKM*0X /Y$/BGX*^
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M4=,^+?V72?&*:^;<:FNIZ19V=O:Z9.ET#9VJ-! J!Y _W7^V/K?@?0_VNO\
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MTJ"RCENI=7M=.:9[%+=99$NT18_,<@G]5_"__!*G_@G'X*^,\7[1'A3]BO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF@_K>'0?0?YYY_.@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTD:UTS3/!^I/;73W-C/:OI]O/+##<,#^K>BBB@ HHHH **** "BBB@ HHHH
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M YSD'// P>V21R,&G*, #T'?&?QP /R% "T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ","5(&02
M#C!P<_7M]:XWP[\/_!?@Z[\1ZAX0\&^$?"E]XOU'^V_%5[X9\.:1H%YXEUPH
M8SK'B&\TNSM;C6=2$;R1C4-1-U>%)'4R@$ANSHH XSQ!\/O _B[4O#.L^*_!
M7A'Q-J_@S4DUOP;JWB/PYH^N:IX1UN-H6BU?PU?ZG9W5UH>J1>3'MU#2Y[6Z
M#0Q.)=P!7A]3_9Q_9^UWQY;_ !0U[X$?!K6?B59S1W5G\1=5^&7@K4O'-M=0
M3)/!=0^*KS1)==CNH)T2:"Y2_$\,JLT;HS;F]KHH \V^)/P?^%/QDTRUT/XN
M_"[X=_%/0[&=[NRTCXB^"_#GC;3+2[DVH;JSL?$NFZC;6EUY<:"2>"..5@J#
MS"$4"5?A-\+8]'\)>'8_AE\/T\.^ +^TU7P)H"^#O#:Z+X*U33S*]AJ?A#2Q
MIHL?#>HV3SS&UO='@LKBW:1S#(F]B?1** .*T_X;_#[2=.\4:-I7@3P9INC^
M.+W5M2\::58>%M"LM-\7:AKT'V;7;[Q38VMC%:^(+W6H"8-6N]5BNY]0A/DW
M;S1D@U9_A9\,[SPSX?\ !=Y\.? MSX-\)W&CWGA7P?<>$?#T_A?PS>>'G\S0
M+OP_H$FGMI.C7>A2#?I%QIMI;2::V&LG@85W]% 'F<_P:^$EV+Y;OX5_#:Z&
MI^,(/B#J0N? _AB<:GX\M>;7QQJ DTIOM?C&UP/L_B:?S-9AQF.^'0=)J7@K
MPAK'B'0?%VK>%/#.J>*_"R7L?AGQ/J.@Z7?>(?#L6IQK#J<.A:U=6LVI:/'J
M,2)%?+IUS;"ZC54N%D4 5U%% 'FEW\&OA%?IK<5]\*OAO?0^)/$EEXR\00WG
M@;PM<)KOB_3E"6/BG6DETEUU3Q%8HJ+9ZY??:=5ME4+!=1J !6^'_P #O@Q\
M);W7=1^%7PA^%WPSU#Q/.MSXDO\ X?\ @'PKX.O/$$X<R>;K=SX=TG39M3D\
MS]Z'O'G;SF>4Y=V<^J44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  >01ZT
MT*  ,9_QX_PIU%'GL]K]4)I/?7R>WW"'I@<=OIQ0!CN3]:6BIY;V;;;77;\$
MTAVL(<\8&?7GI_C2T450!1110 4444 %%%% FKJP4444!;;RV$.>PS^E+111
MIVU[A;7?Y::?J%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ea028514801_img7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 'U QP# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH.A:3+!K=\T_C#6GU.W&@M#I7A^]UB2-K><_V5+8S@,+J$'\_/CK_P '*O\
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MUU.P\/>'K/Q?%/9>'+?5M B3[-J%KDZT+630D"R".&3$\(_#'P%X+_X(1?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#Y7^.'[%'[(?[2VN:/XG_ &@?V:/@G\8O$^A10V^DZ_\
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MX;\5ZEI-L\PN'M],U/5;"YO[.TEG_>/:PW$<,C<O$V2#MW_[,'[-NI?!N/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;]?_ *U'F>WZ_P#UJCHH EWCT/Z?XTGF>WZ__6J.B@"3S/;]?_K4>9[?K_\
M6J.B@"7>/0_I_C2>9[?K_P#6J.B@"3S/;]?_ *U'F>WZ_P#UJCHH EWCT/Z?
MXTGF>WZ__6J.B@"3S/;]?_K4>9[?K_\ 6J.B@"7>/0_I_C2>9[?K_P#6J.B@
M"3S/;]?_ *U'F>WZ_P#UJCHH EWCT/Z?XTGF>WZ__6J.B@"3S/;]?_K4>9[?
MK_\ 6J.B@"7>/0_I_C2>9[?K_P#6J.B@"3S/;]?_ *U'F>WZ_P#UJCHH EWC
MT/Z?XTGF>WZ__6J.B@"3S/;]?_K4>9[?K_\ 6J.B@"7>/0_I_C2>9[?K_P#6
MJ.B@"3S/;]?_ *U'F>WZ_P#UJCHH EWCT/Z?XTGF>WZ__6J.B@"3S/;]?_K4
M>9[?K_\ 6J.B@"7>/0_I_C2>9[?K_P#6J.B@"3S/;]?_ *U'F>WZ_P#UJCHH
M EWCT/Z?XTGF>WZ__6J.B@"3S/;]?_K4>9[?K_\ 6J.B@"7>/0_I_C2>9[?K
M_P#6J.B@"3S/;]?_ *U'F>WZ_P#UJCHH EWCT/Z?XTGF>WZU'10!)YGM^O\
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M#IG!@?W?Y<]>O//X^WX?S"?\1*OA7_HS_P 5?^'DT/\ ^8.C_B)5\*_]&?\
MBK_P\FA__,'1_P 0"\7_ /HB<P_\.&4__/,/^(]^$?\ T6F"_P#"?-O_ )@/
MZ>\#^[_+W]^A].G//>C _NC\A[_Y_'ZX_F$_XB5?"O\ T9_XJ_\ #R:'_P#,
M'1_Q$K^%O^C/O%/_ (>/0_?_ *D#V_SD4?\ $ O%_P#Z(G,/_#AE/_SS#_B/
M?A%UXTP2_P"Y;-W^67L_I[//4$X]3G^9[X'7V].%!(&!G'IGC^?MT]Q[X_F#
M_P"(E7PK_P!&?^*O_#R:'_\ ,'1_Q$J^%?\ HS_Q5_X>30__ )@Z/^(!>+__
M $1./_\ #AE/_P \Q?\ $>O"/_HL\%_X39M_\[S^GK _N_R_+KT]NF2#USA<
M#^[_ "]_4_YS]<?S"?\ $2KX5_Z,_P#%7_AY-#_^8.C_ (B5_"W_ $9]XI_\
M/'H?O_U('M_G(H_X@%XO_P#1$8__ ,.&4_\ SS'_ ,1[\(NO&F"7_<MF[_++
MV?T]X']T?D/?_/X_7!@?W?T'YU_,)_Q$J^%?^C/_ !5_X>30_P#Y@Z/^(E7P
MK_T9_P"*O_#R:'_\P='_ ! +Q?\ ^B(Q_P#X<,I_^>8?\1[\(_\ HM,%_P"$
M^;?_ # ?T[D%FSRI QU'()_EGCMS]<TO/10>/?&.!U!&,_3W-?S!G_@Y5\+[
M&V?L>^*@?5OC)H9 'K_R(H[=^G3FOVO_ &$_VOK/]M_]G_2OCU8^!+WX;6VH
M^*_%_A4>&;_Q!;^)KF)_"NI"P>_.IVFEZ1$4OR?,6V^R*UL/D>68C(^<XG\+
M>.^#,OAFW$_#>)RC+*^-6 =:KB<#B(2QLHRE"DOJ>-Q4DW&C*2_=QC[KO)'T
M/#'BAP/QIF-3*>&<_H9ECJ. GF2I4L+CL.U@8S5.<^;&X.E%I3:32DY:I\MM
M3[1HH'3CIVR<G\3W^O>BOA#[U:I/ND_O2"BBB@84444 %%%% !1110 4444
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M@HHHH"R[+[E_D%%%% 679?<O\@[8[?XX_P !7]PO_! WG_@GAX9_[*[\8/\
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M ?13/,3^\*;YR>_Y4 ?._P"U[_R:3^TY_P!F^?&3_P!5QK]?YKMK_P >UO\
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M4 /HIGF)_>%(94!ZD_04 244P2H?X@/KUH\Q/[PH ?13/,3^\*0RH#U)^@H
MDHI@E0_Q ?7K1YB?WA0 ^BF>8G]X4AE0'J3]!0!)13!*A_B ^O6FFX"G 16
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MT6?^3E8O_LF<Y_\ 4O+3]F&ZGZG^=)117^<Q_H:%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %/ !&2)3_
M +J$C\#W]_>F4N3ZG\Z $HJ'>WK^@_PHWMZ_H/\ "@":BH=[>OZ#_"C>WK^@
M_P * )J*AWMZ_H/\*-[>OZ#_  H \"_:[_Y-,_:>_P"S>OC+_P"H!K]?YLEO
M_P >\'_7&+_T!:_TE?VN3G]D_P#:<SW_ &>OC,/_ #'_ (@-?YM5O_Q[P?\
M7&+_ - 6O[G^B!_R+>./^PG)?_4/%G\.?2W_ .1OP9_V+\W_ /4N@34445_9
M)_(04444 %%%% !1110 4444 %%%% !1110 5_<!_P $%/\ E'?X9_[*Y\8/
M_4ECK^'^O[??^""S?\:\?"PW8Q\7/C#QGT\31?RS^'T%?S/]*U?\:VP7_95Y
M/_Z@YNS^D_HL_P#)RL7_ -DSG/\ ZE9:?LW141=LGGN?2DWMZ_H/\*_SG/\
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M^OZ'_"C>OK^A_P *AHH FWKZ_H?\*-Z^OZ'_  J&B@#P/]KB1#^R?^TSZ?\
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MEOC).-IZDY)^I))/N:/(F_YYO_WR>W2EK_2?^0N:/\T?_ H?_)G@'[5GPO\
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MY-!AF/)C<GU*FC^MG_D'-'^:/_@</_DQ=Z^OZ'_"C>OK^A_PI/(F_P">;_\
M?)H\B;_GF_\ WR:/ZV?^0<T?YH_^!0_^3%WKZ_H?\*-Z^OZ'_"D\B;_GF_\
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MI&HZ;H<^F7W]M7NELD#S:;?7=SJ-L[7,C3M_6G^SS_P2S_X)U_LG_$,_%?\
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MO^BB>/?_  LO$?\ \LJ/^%C?$;_HHGCW_P ++Q'_ /+*N.HH_LC*/^A1E/\
MX:LL_P#G<'^LW$O_ $4G$/\ X?\ ._\ Y[G8_P#"QOB-_P!%$\>_^%EXC_\
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MJ_-[B_OB'QI^#0 _XNW\,3Q_T4#PF/T.JTG_  N?X.'G_A;/PR_#X@>$\?\
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MDG'_  GWA(C)/)_Y"IY)Y/O7\$)AM%)#1H#W!CC_ /B!VR/Q-&RS_P"><?\
MW[C_ /B:/]6%TQG_ )*O\S-_3'Q*;3X.P\6KWB\^FG%]FOJVC7X']\:_&CX-
M  ?\+;^&)QG!/Q \) \G)X_M7C)Y/KUH_P"%T?!T]/BS\,\9SQ\0/">"1T/&
ML 9'KC(K^![[/ >5A0CL1''_ /&S_.C[-#_SP7_OW'_\;H_U8CUQL?N5_P#T
MHT_XG$QC2_XP6$EW6=56I>:_V1:/=>I_>Z?C1\&<\_%SX8@]Q_PG_A/(^N=6
MZ^M)_P +F^#1Y'Q=^&7X>/O"7_RU-?P0F*T4X:*,'OF.//I_<'ZBC99?\\X_
M^_<?_P 32_U873&:>45_F9OZ8^)3:?!V'@U]EY]43CY-?5M&?WQK\:/@T !_
MPMOX8GW/Q \)#]/[5I/^%S_!P\_\+9^&7X?$#PGC_P!/ _E7\#_V> \K"A'8
MB./_ .-G^='V:'_GBO\ W[C_ /C=/_5B'7&P^Y7_ #-/^)Q,8TO^,%A)=UG=
M5J7FG]5V>^_4_ORT3XF_#?Q)JD6C^'/B#X'U_5IDDE@TK1?%V@ZIJ-Q';1M<
M7$D5G8:E<74J00HTLQBB(A@669^ :[?(.<G&?4]NF.<#<N,%L98C=WK^/S_@
MD>H3]O/X7(((E'_"(_%"0.L**_R>!]5# L%!^[QP<MWXSC^P,[<DG/.>W &<
M ]R.@[]Z\+,L&L#7C1YE*\$U):\R?-;;NHMZ_>?TIX1^(W_$3^&*V?5<MGE=
M2AG6+RE4IU'4Y9X6C@:[Y:G+#VD?]NBHS<;R2U?0C(P2./PS_6DI2,''7&/Y
M4E>?:VG;3OL?J;;;;;NV[M]_/YA1110(**** "BBB@ IP QT;\!Q3:* "BBB
ML+ON_O8!1111S2[O^OD 44447?=_>P/GK]K9F_X91_:9]/\ AGGXR\=>3\/=
M?_,\GG^5?YNUM_Q[P?\ 7&+CT^1:_P!(C]K?_DU+]IS_ +-]^,O_ *@&OU_F
M[V__ ![P?]<8O_0%K^[_ *(/_(LXV_["<F_#"XL_ASZ6_P#R-^#?^Q?F_P#Z
MET":BBBO[(/Y""BBB@ HHHH **** "BBB@ HHHH **** "O[=/\ @@XV/^">
M7A8?]5<^,(_\N6'_ !_2OXBZ_MR_X(.?\H\_"O\ V5SXP_\ J36]?S/]*[_D
MVN$_[*K)_P#U S<_I/Z+/_)RL5_V3><?^I67_P"1^RU%%%?YP-N[U>[Z^;/]
M#0HHHHYI=V 44447?=_> 4444<TN[ ****+ON_O ****.:7=@%%%%%WW?W@(
M6.X].0,_]] ?TK\;/^"V3%OV=OA6#_T6B(9] /!WB(]._7I7[(G[WX+_ .AB
MOQM_X+9?\FZ?"K_LM,7_ *AOB2OUKP.O_P 1<\/O^RDA_P"H.8K\D?@?TI/^
M4>_%K_LD*_\ ZG92?S.4445_K:?\^84444 %%%% !1110 4444 %%%% !111
M0 V?_70_]<T_]!%7]._Y#%A_UWB_]"6J$_\ KH?^N<?_ *"*OZ=_R&+#_KO%
M_P"A+7-F?_(KS3_L78K_ -0,6>UD"_XRK*_+BSAM_P#E]E/^9_>MH/\ R M#
M_P"P-I7_ *06]:M96@_\@+0_^P-I7_I!;UJU_B3BVUBL39O_ 'BOU_Z>U#_I
M?RK_ )%>6_\ 8OP7_J)APHHHKGYI=V=X44447?=_> 4444<TN[ ****+ON_O
M ****.:7=@%%%%%WW?W@%%%%'-+NP/YI_P#@ND2?C)\ .N1\*_%(&.O_ ".,
M?IZXY]?I7X<1D[V!/4,Q'^UOQD^]?N/_ ,%T/^2Q_ +_ +)7XI_]3*.OPWC_
M -8?]UO_ $.OT?(]<JH_XI?^EL_RI\?V_P#B,O%^K_Y&.#6[V>3Y:FM]FM&M
MFDDTTDAJDD DDGU/)ZTZFI]T?C_,TZO9:5WHMWT7?T/Q2+?+'5_"NK[+S$P#
MU /X48'H/R%+12'_ %T_R"BBBBR[+[E_D%WW?WL3 /4 _A1@>@_(4M% ?UT_
MR"BBBBR[+[E_D%WW?WL3 /4 _A1@>@_(4M% ?UT_R"BBBBR[+[E_D%WW?WL_
M2C_@D82?V[?AODD[?"OQ. ]@? NJY ]CDU_7N&(;@_PY_6OY"/\ @D7_ ,GV
M?#G_ +%?XF?^H)JU?U[?Q_\  ?ZU\-Q)_P C&/\ V#T__39_I']$QW\+,3W_
M -:L\U\_99>D_DDDO));)).!)Y//)_0D44@Z?BW\S2U\RI2LM7LOR1_3SW84
M444<S[O[Q!1111S2[L HHHHYGW?W@%(7P<94?5<G\Z6BJ4VM[L HIN]?7]#_
M (4;U]?T/^%39]G]S =13=Z^OZ'_  HWKZ_H?\*+/L_N8#J*;O7U_0_X4;U]
M?T/^%%GV?W,#Y[_:V_Y-/_:9/?\ X9_^,G_JOO$%?YN]O_Q[P?\ 7&+_ - 6
MO](/]K<I_P ,H?M,Y&#_ ,*!^,G.?^J?>(/Y^F.G2O\ -\M_^/>#_KC%_P"@
M+7]X?1"_Y%G&W_81DO\ ZB8H_AKZ7'_(WX5\L!G-O_"VC^G;H34445_8Y_(:
MV7HOR04444#"BBB@ HHHH **** "BBB@ HHHH *_MT_X(/\ _*/+PG_V5SXO
M_P#J215_$77]N?\ P0;(_P"'>?A;U'Q<^,(_/Q)!_B*_F?Z5O_)M<)_V564+
M_P L<W/Z3^BP_P#C9>*_[)O-_P ,5E[_ !/V5HINY1W_ $/^%&]?7]#_ (5_
MG!9]G]S/]#1U%-WKZ_H?\*-Z^OZ'_"BS[/[F ZBF[U]?T/\ A1O7U_0_X46?
M9_<P'44W>OK^A_PHWKZ_H?\ "BS[/[F ZBF[U]?T/^%&]?7]#_A19]G]S =1
M3=Z^OZ'_  HWKZ_H?\*+/L_N8#J*;O7U_0_X4;U]?T/^%%GV?W,!!]]OI_A7
MXV_\%LO^3=/A5_V6F+_U#?$E?LAO7>W/;W]O:OQO_P""V+9_9U^%>.G_  NB
M/GV'@[Q%_B/RK];\#_\ D[GA[_V4=/\ ]0<R/P+Z4?\ RCUXM?\ 9(5__4W*
M#^9RBBBO];#_ )] HHHH **** "BBB@ HHHH **** "BBB@!DW^MA_W%_E5[
M3#G5K G_ )[Q_P#H8JC-_K8?]Q?Y5>TS_D+:?_UWC_\ 0Q7'FG_(JS/_ +%N
M+_\ 4'%GL\.Z\5Y5_P!E5PX__+[*O\S^]C0?^0%H?_8&TK_T@MZU:RM#8#1-
M%!//]CZ7V/\ SX6]:>]?7]#_ (5_B9BTWBL2[/7$5WMWK5#_ *8,JTRO+5_U
M+\%_ZB88=13=Z^OZ'_"C>OK^A_PKGL^S^YG>.HIN]?7]#_A1O7U_0_X46?9_
M<P'44W>OK^A_PHWKZ_H?\*+/L_N8#J*;O7U_0_X4;U]?T/\ A19]G]S =13=
MZ^OZ'_"C>OK^A_PHL^S^Y@.HIN]?7]#_ (4;U]?T/^%%GV?W,!U%-WKZ_H?\
M*-Z^OZ'_  HL^S^Y@?S4?\%T?^2Q_ '_ +)9XI_]3%*_#>/_ %@^C?\ H1K]
MR?\ @ND0?C'\ "/^B6^)_P#U+A7X:Q??7_=/\S7Z3D:ME5#_ +>_]*9_E/\
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M1110 4444 %%%% !1110 4444 1OU/\ NC_T(5^.7_!:_P#Y-W^%7_998O\
MU#O$%?L:_4_[H_\ 0A7XY?\ !:__ )-W^%7_ &66+_U#O$%?JO@9_P G<\/_
M /LHU_ZA9@?@?THO^4>_%?\ [)*K_P"IN4'\T%%%%?ZUG_/F%%%% !1110 4
M444 %%%% !1110 4444 -G_UT/\ US3_ -!%:&G_ /(5M/\ KM%_Z$*SY_\
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MF%%%% !1110 4444 %%%% !1110 4444 ,F_UL/^XO\ *K^F$G5;#_KXB_\
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M/4_"SQ1G'_8W#/YGGZU^&\7WU_W3_,U^A9)_R+*7K+_TIG^4WT@?^3R\8?\
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MOB=_Z@>K5_7(GWC]/\*^(XC_ .1C_P!R]/\ ]-G^D/T2U_QJW%?]E3G?_IO
MDM%5Z*^=6R]%^1_4#W?J_P RQ15>BF(L457HH L457HH L457I<GU/YT )11
M10 4444 %%%% '@?[67_ ":G^TQ_V;[\8_T^'^OX_+MZ5_G&6O\ Q[6__7"+
M_P!%K7^CI^UE_P FK_M,#M_PS]\9>.W_ "(.O5_G&6__ ![P?]<8O_0%K^ZO
MHA?\BOC7_L)R?_U%Q1_#OTM_^1OP;YX#-_\ U*H$U%%%?V,?R"%%%% !1110
M 4444 %%%% !1110 4444 %?VR?\$)_^4>GA/_LKWQA_]2."OXFZ_MD_X(3_
M /*/3PG_ -E>^,/_ *D<%?S1]*W_ )-KA?\ LJLG_P#4+-S^DOHM?\G+Q/\
MV3><?^I.7G["4445_G,?Z'!1110 4444 %%%% !1110 4444 %%%% #VZM]!
M_-:_'O\ X+4?\F[_  M_[++#_P"H=XAK]A&ZM]!_-:_'O_@M1_R;O\+?^RRP
M_P#J'>(:_5? Y_\ &V_#_P#[*2'_ *@9@?@GTHO^4?/%C_LDJW_J=E!_-111
M17^M9_SY!1110 4444 %%%% !1110 4444 %%%% #9_]=#_USC_]!%:.G?\
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MIN4'\U]%%%?ZU'_/H%%%% !1110 4444 %%%% !1110 4444 ,F_UL/^XO\
M*K^F$G5;')Z2K_.J$W^MA_W%_E5[3/\ D*V/_75?YUQYI_R*<T_[%F+_ /4'
M%GL\/?\ )5Y3_P!E7PW_ .IV5G]WFBD_V+HO3_D#Z5V'_/A;^U:-9NB_\@71
M?^P/I7_I!;UI5_B=C)-8S%)?]!%?I_T]J'_3!E7_ "*\L_[%^!_]1,,+D^WY
M#_"C)]OR'^%)17-SR[_@CO%R?;\A_A2444<\N_X(!<GV_(?X49/M^0_PI**.
M>7?\$ N3[?D/\*2BBCGEW_! +D^WY#_"C)]OR'^%)11SR[_@@%R?;\A_A244
M4<\N_P"" 7)]OR'^%&3[?D/\*2BCGEW_  0'\WO_  7&);XO? !1Q_Q:SQ6<
MCCIXQ((X] .V>>U?B!&-KJ,Y^4\^O)/-?M]_P7$_Y+#^S\.W_"K/%7'U\9-G
M\^_K7XA)_K1_NG^M?I&1ZY71\W)_^3,_RE^D _\ C<?&'_8QPG_JJR[_ "&I
M]T?C_,TZFI]T?C_,TZO7>[]7^9^+Q^&/^%?D@HHHI%!1110 4444 %%%% !1
M110 4444 ?I%_P $E3C]N;X<' /_ !2WQ.!^G_"#:I_]?\Z_K?1QG//*@C@=
M#BOY'?\ @DO_ ,GS_#C_ +%3XG?^H/JE?UNI_#_US7^E?#\1O_A0C_V#P7_D
MES_2'Z)?_)K,5_V56>?^FL 2 _3OU ['Z4N3[?D/\*:.GXM_,TM?,*4K+7HN
MB[']0/=^HN3[?D/\*2BBGSR[_@A"Y^GY#_"C)]OR'^%)11SR[_@@%R?;\A_A
M2444<\N_X(!<_3\A_A2444<[ZO\ !?\   **3(]1^8I:D HI,CU'YBC(]1^8
MIV?8!:*3(]1^8I:0'S[^UC_R:O\ M*_]F_\ QA_]5]K_ /B:_P Y.W_X]X/^
MN,7_ * M?Z-G[6!'_#*W[2O/_-OOQ@Z]>?A_KWZ]?UK_ #D[?_CW@_ZXQ?\
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M_2,C_P"17179O\9,_P I_'[_ )/)Q?\ ]C+"+[LJR\8GW1^/\S3J:GW1^/\
M,TZO8>[]7^9^*Q^&/^%?D@HHHI%!1110 4444 %%%% !1110 4444 ?I#_P2
M7_Y/E^''_8K?$[_U!M4K^MM/X?\ KFO]*_DB_P""3#8_;E^'0_ZE7XEGZ?\
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MA7^*N,_WS%_]A6(_]/5#_I>RG_D5Y9_V+\#_ .HF&"BBBN8] *7)]3^9I**
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M/0$@4FFUH[ -HHHI<T>Z_KY %%%%'-'NOZ^0!1111S1[K^OD!X/^UC_R:O\
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MBBBCFCW7]?( HHHHYH]U_7R _G)_X+??\E<_9_\ ^R4^+?\ U,WK\1D_UG_
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MIV^5B:BBBO[$/Y$6R]%^2"BBB@84444 %%%% !1110 4444 %%%% !7]J_\
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M_P#R^RI?J?W5Z+_R!=%_[ ^E?^D%O6E6=H__ "!M'_[!&E_^D%O6C7^)V/\
M]]QG_857_P#3M0_Z7\I_Y%>6?]B_ _\ J)A@HHHKD/0"BBB@ HHHH **** "
MBBB@ HHHH **** /YQO^"WY/_"V_@!R?^26>*Q^'_":GCZ5^)"<2 #@;3P.!
MUK]MO^"W_P#R5OX ?]DM\5_^IJ:_$E/]:/\ =/\ 6OTK(_\ D5T?67_I3/\
M*;Z0'_)X^+_^QCA?_57EXU/NC\?YFG4U/NC\?YFG5Z[W?J_S/Q:/PQ_PK\D%
M%%%(H**** "BBB@ HHHH **** "BBB@#]'/^"3G_ "?%\._^Q5^)?_J$:I7]
M:7\?_ ?ZU_)5_P $G2?^&X?A[S_S*WQ+_P#4(U.OZU?X_P#@/]:^&XD_Y&,/
M^P>/_I*_S/\ 2'Z)G_)K,5_V56>?^F\ *.GXM_,TM(.GXM_,TM?+K9>B_)']
M0/=A1113$%%%% !1110 4TM@XVL?HI(_,4ZBFK=5< HJCO?^\W_?1_QHWO\
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M_C1[-]U^(%ZBJ.]_[S?]]'_&C>_]YO\ OH_XT>S?=?B!>HJCO?\ O-_WT?\
M&C>_]YO^^C_C1[-]U^(%ZBJ.]_[S?]]'_&C>_P#>;_OH_P"-'LWW7X@6FZG_
M '1_Z$*_(/\ X+-?\F^?##_LLD7_ *B6NU^NC,V6Y/0=SZK7Y#?\%EB3^SS\
M+R23_P 7FCR2>W_"(Z]ZU^M>!J_XVWX?_P#91I??@<>?@GTH_P#E'OQ8_P"R
M2K_^IF5'\WE%%%?ZUG_/FW=M]VW][;_4****!!1110 4444 %%%% !1110 4
M444 -G_UT/\ US3_ -!%7]/_ .0O9?\ 75?Z50G_ -=#_P!<T_\ 015_3_\
MD+V7_75:Y<T_Y%>9_P#8NQ7_ *@8L]KA_P#Y*K+/^RKX;_\ 4[*#^ZG1O^0+
MHW_8'TK_ -(+>M*L+268:1HX#,!_9&E< G_H'VWO5_>_]YO^^C_C7^)^.@WC
M<9JO]ZQ'?I6J(_Z7LI_Y%>6?]B_ _P#J)AB]15'>_P#>;_OH_P"-&]_[S?\
M?1_QKD]F^Z_$] O451WO_>;_ +Z/^-&]_P"\W_?1_P :/9ONOQ O451WO_>;
M_OH_XT;W_O-_WT?\:/9ONOQ O451WO\ WF_[Z/\ C1O?^\W_ 'T?\:/9ONOQ
M O451WO_ 'F_[Z/^-&]_[S?]]'_&CV;[K\0+U%4=[_WF_P"^C_C1O?\ O-_W
MT?\ &CV;[K\0+U%4=[_WF_[Z/^-&]_[S?]]'_&CV;[K\0/YUO^"WH'_"W/@#
MQ_S2SQ/^OC9L_GW]:_$:/_6'_=;_ -#Q_*OVU_X+<$GXM? '))/_  JWQ/U.
M3_R.S>M?B5%]\GMM;_T.OT;)-,KI+M)_^E'^4WC]_P GEXN_[&.%_P#59EXU
M/NC\?YFG4U/NC\?YFG5[#W?J_P S\6C\,?\ "OR04444B@HHHH **** "BBB
M@ HHHH **** /T<_X). ?\-Q?#OC_F5?B7_ZA&J5_6E_'_P'^M?R5_\ !)_C
M]M[X>$<'_A%?B;R.O_(D:GWK^LI6;</F;OW/H:^'XC7_  H1=]L/#\8_\ _T
MA^B7_P FLQ7_ &56>?\ IO %L=/Q;^9I:H[W_O-_WT?\:-[_ -YO^^C_ (U\
MTH.RU6R[]C^H'N_4O451WO\ WF_[Z/\ C1O?^\W_ 'T?\:/9ONOQ$7J*H[W_
M +S?]]'_ !HWO_>;_OH_XT>S?=?B!>HJCO?^\W_?1_QHWO\ WF_[Z/\ C1[-
M]U^(%ZBJ.]_[S?\ ?1_QHWO_ 'F_[Z/^-'LWW7X@-HK'^SZ[_P!!;3__  2O
M_P#+6C[/KO\ T%M/_P#!*_\ \M:U V**QOLVO_\ 07T[_P $<G_RWH^S:_\
M]!?3O_!')_\ +>@#9HK'^SZ[_P!!;3__  2O_P#+6C[/KO\ T%]/_P#!(_\
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MCC@@@#V..1P21_\ 7]^WY%_\%DA"?V?/AD)%F=/^%P1N1%M+ #P9XBR26!4
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MV_MG1^.O&?[+[8_GZ<U_Q-9X4?\ /WB7_P 1Q_\ SQ7Y(2^@)X\O[/!2\O\
M6VI_\XS^:?YO[T?_ (][?X_J/Q/F_O1_DWM_C^H_'^EC_ASK^S5_T.'Q/_\
M!OH_;/\ U#/8T?\ #G7]FK_H</B?_P"#?1_?_J&>QJ?^)KO"?_G[Q-_XCU7_
M .:W^;'_ ,2#>/'_ #ZX+_\ $NJ?_.0_FFR>F5/N <?P\CGI\U&X^W;L>^WW
M_P!K]*_I8/\ P1U_9MZ#Q;\3< D9_MK2!G'&<'2^.Y_ ]NJ_\.=/V;._B_XG
M#V_MG1^.O&?[+[8_GZ<U_P 36>%'_/WB7_Q''_\ /%?DA+Z GCR[>[P4O+_6
MVI_\XS^:?YO[T?\ X][?X_J/Q/F_O1_DWM_C^H_'^EC_ (<Z_LU?]#A\3_\
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M^',G[,W_ $.WQ9_\'.B?_*"C_6'+^T_P_P#DBO\ B57Q8?\ RZR+_P /L?\
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M.JC*FG9?<O\ (#^P:G!F' 9@/0$_XU_)AXN_X+D?\%//V(/C#\ ]!_X*E?\
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M;ZS?-J\5TH^?O^#FC5E\4_M7?\$H/V>?C]XMU7P9^P?\3OBM+??&RXM=9O\
M2- \0>(M/\7Z)ICV?BZXM)[&WCTK2_#E]9I;W]S<Q7'ART\0:WJ]I+;7$'VQ
M?Z+_ -GW_@G!^Q7^RM\;/BE^T5^SS\$+#X4_%?XSC59?B?K?A?Q?\0&\/>)1
MK>K2Z]=+)X O?%%U\/--+ZI/<7UA_97AJP.DR7-TNE?98[F=7]8_:9_90_9R
M_;)^&5W\'?VG?A)X6^+_ ,-[J\BU2+0?$:7L=SI^K01R0QZIH&M:3>:;K>@Z
MO#%-+$^IZ)J-E?21RO$)\,PHOK_7]:>7Y ?R!?#OX<_LY?L=?\'-7[+7P?\
M^"66I:9IOP6^*7PDFLOVJ_AO\+?%VI>.?AKHVD-X?\7:B_V_4[C5_$;+']GL
M/ _B5[NYN5?2M9U<VUB]C'JLPEK^(/V#OV=_^"@/_!T+^V=\*_VH?"5UX_\
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M=2U]KS4]9GT[7[RY6S?4=&MWLX-+G9O+M+>*18Q].7_["O[)&H_LIW7[#K_
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M)X[2V14EOKZZ9[S4=2NGN-0U&_EEO;VYN;J5YF.X'J(Z>OX,/T8EA]"<TM
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M_BKP3#I'Q%^(BSQ3>&K/3_#-EH7A==<%X)=,T6^,-O):Q7.\?W\?#;_@FO\
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MXM:OX'\.:C\2O"^D2QW44NE^'_&UWI\OB+1].DBOKV-[.PU""W9+RZ4QE9Y
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MS9S-=6:ZM9S^'#:W4%A>O)J-C#+')%:74C3VZQN=Q^S-R^OZ'_"DWKG..?7
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MN:??BPENHM\5[Y"H+B$E)BZ9%>T[U]?T/^%(77(/)(Z'N/H3R.I'YTF!XAX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
0* "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ea028514801_img8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )X!F8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BC(XY'/3WXSQZ\<_2B@ HHZ]** "BC
M^O2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDR.#D8/0YZ
M_2ER#T.>WX^E !111D=,\CJ/3/2@ HHHR/6@ HHHH **.G6B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHH) Y)P/4T %%%% !1110 4444 %%%'7I0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&,0?$/P1_P %%?!/AW1;ZU15U9]-\2Z>D]]9VTQ#/Y&_28I)(A\C>;O<?*,
M']6%%1C!;U*DY/H#G ]""!T'0YZ&I* "BBB@ HHHH **** "BBB@ HHHH :^
M-O.<'@D9X![Y'(QZ]J_ [6OVKOC1^UW_ ,%I-)_8S^ 'Q1U;P#^SE_P3_P#
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MD>KVMSX>9;BZ@U&]73]2T_6%FL;>)I$@:56_%#_@W9E\8_L4_M1?M]?\$?\
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M*CEDTCQ=X72WAGLC=:AJFLWEU=7FFZ5X?D-[TG['G[77[=W[&_\ P4Q\)_\
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MH/86=C;:E<_"S6+#44\-2K ^H7'A_1O$-WJ,Q2*TCC_>^,$;E(XR2I .-I/
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MM*NEU'67\1:IJ%E+=SF&%C\,_P#!VWJ>L7/_  3M^!7PSL[ZYTW0OC7^W;\
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M4_"*%]5U_P --)+9:-I,S:GYVJ:#8'R+K6[1A^]'_!5G]H7XVV/[6'_!+?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:)$BD1!^3_PI_P""-G_!7;]A[P/\0_V5_P#@GA_P4G^$W@/]CSQ?XA\6ZOX
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M_.%\(_\ @D1^VS\=OVSO@3^V=_P5A_:\^'?Q\N?V5+@:_P#L\? 7X"> -1\
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MN@:G:>'-0,L_EP7<&CZM' TEQ:%%_I?89QUYXR#TZ]<<\Y^F0N>*^=5_92^
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M&NJ?V:WCC6=)F1K/4+/0K=93;VU[&;"75;G3TNXYK5I(9/P"_:]C_P""J/\
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M!['-+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !36
M^Z?\]Z=0>0?\_P L'\B* $R,XR,XSC/./7Z>]&1G&1G&<9&<>OT]^E?QS_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%O/H/U_P :-Y]!^O\
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M(;>SL-)O-:OEAL[:&WW,L2 ,5UW_ "/J[_@D+_P2DT__ ()Y^%_B)\4_B_\
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MB^%O#0LO#\<-K"T%M?IJ>HK(O^D:E.L8C4']_P!S/QR_X.)CG]K;_@@.<?\
M.2/0AD]1_P 3_P"$_ ]0<9STX%?T>?'OX#_!S]IOX4^+_@C\?/AUX:^*?PJ\
M<6<5AXF\&>+-.CU'2=1C@N8KRSN(PS1S66J:=>P07^DZK8SVVH:7J$%O>6-Q
M%<Q(X^7_ -LW_@G5\%OVY/B#^R#\3/BMXE^)6@:]^Q=\:K/XZ_"ZV\!ZQH&F
M:=K?BRTO/#MY'I_CB'7?#6OW.H^'S+X:L%EM-%O-#U,PR72IJ:-*AB^^&SDO
MM#8=2  5+#KE<[0IWD[@QS@EBY "D"Y_('^VW^Q)^RY\/_B-\"?^"%O_  3C
M^%>E?!:^_;F\4:1\;OV__'/A74]>\1^-_#G[%WPBUA+^^LO$WCGQ3JVM>*F;
MX@:]!)X8\&Z9?ZQ-HZ2+J.CO91VOB=I)/ _&G[4O_!2WQMX$_P""G_[6_P"R
M3^U=X:_97_9@_P""/?Q:\5_LY?!7]C+3_A%X1\2>#_B1X$_9;MK/1_%R>-_$
MFL+_ &U9R>*-"TV(>'8DM[PV1N%TZP;2FM5N9/Z9_P!F#_@GUX<_9^_:R_;$
M_;2\4_$?6/C#\<_VM?$.@VHUW7]"M-'M_A)\'/!D"V_@[X,^"K:VOM08Z)IZ
MK;W.M:HMQ:/XCU+3]/O;K3H[BU+O^>7[1G_!O1\+?CC\:?C]XP\'_M<?M*_
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MZ_XT;SZ#]?\ &F44 /WGT'Z_XT;SZ#]?\:910 _>?0?K_C1O/H/U_P :910
M_>?0?K_C1O/H/U_QIE% #]Y]!^O^-&\^@_7_ !IE% #]Y]!^O^-&\^@_7_&F
M44 /WGT'Z_XT;SZ#]?\ &F44 /WGT'Z_XT;SZ#]?\:910 _>?0?K_C1O/H/U
M_P :910 _>?0?K_C1O/H/U_QIE% #]Y]!^O^-&\^@_7_ !IE% #]Y]!^O^-&
M\^@_7_&F44 /WGT'Z_XT;SZ#]?\ &F44 /WGT'Z_XT;SZ#]?\:910 _>?0?K
M_C1O/H/U_P :910 _>?0?K_C1O/H/U_QIE% #]Y]!^O^-&\^@_7_ !IE% #]
MY]!^O^-&\^@_7_&F44 /WGT'Z_XT>8?;KC\>..O7D?F*97S#^V;^T7I7[(7[
M*/[1'[4>N:+/XETWX#?"3QK\37\.6=Q]GGU^?POHT^H66BK<R/'% ^J7T=K9
MC>52,3>8S@%L 'U!YG0_+@]#Z\9XYYXY^G/2E,A'7 [\\<>O6OY#U^/'_!<S
MX2_L-:)_P6+^*'[5OP;\<_#Z/PAH7[1GCS_@G=IOP'\(>&O!NG_LW>(I;/6&
MM/"_QYMYIOB*/B#9>"-1MO$%G!J+WUD+IA8WM]?E9(G^R_VPO^"A?[1/[1'Q
ME_8!_8I_X)Q?$'0/@7\3OVW/@JO[6'C3]H7QEX)T+XDWOP,_9OA\+6OB"*/2
M? FM7#^'M;\>:U>7\5E#;ZN7TE);*6Q2:VN)TN8 #^B0R8.#M!R!@\')Z#KU
M/8=^U+YASCY<XSCOC.,]>F>/KQ7X%_L!_M:_M?\ PU_;^^-__!*W]OKXJ^#_
M -H?X@^&_A#X?_:*_9S_ &EO#7P_L?A5JWQ6^&6J7QT;Q)X=\;?#_P /I-X4
MTOQ5X9U"*2;S-#E-L+.*07$MU)=6LB?9W_!5S]N2\_X)Y_L4?$G]H7P[X67Q
MQ\23J7A;X:_!GP=<[AIVN_%WXFZLGASP+9ZVQN(FBT>UU&=]0OS#*KR6UHT
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MU70[Z\<74T:L4EF>*,KLBCCR17]$F\J>22"<<8XS[9QUY_SS_)7_ ,%>&/\
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M'H?T_P :-X]#^G^- #Z*9O'H?T_QHWCT/Z?XT /HIF\>A_3_ !HWCT/Z?XT
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M #Z*:6QU5A]1C^=)O&0,'). .,D^@YY/TH ?136;;C<K#)"C(ZD]!^/:E!W
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M10VP=OTQ612 02P8Y3Y0#@Y*C QT'L.E $M%,\Q3Z\$@].HX(ZT;QZ']/\:
M'U\P?MJ:#\%/%'[)'[2OA[]I%=6;X ZO\$OB-8_&(:%INM:QK</PZN/#.H+X
MHOM&TSPW::AKU]J=CI:W%U96VD:??:G+=6\"6=K+*5CD^G-X]#^G^-4KVUM=
M0M;JQOK2VOK&^M[BQOK.\@BNK2\L;N!H+BUN;2;?#<07$;O#<12QM'+ \D4B
M^6Q- '\"/[47PH^.W@O_ ((>>.(M-_X+%^&OCA_P3AU#X8)H7[(W@[PS\&H?
M#'[2/QSN-0UEM'^$_P"SWX\UK5KV/7++P[I'B:WM['Q)HEIIMYXGN=-T*]T/
M4$TW2H5L;?[O^ O@>Y_8Y_X*X?\ !&J7XURIX,L_B?\ \$B+']G'1=3\3RQZ
M;91?&OP5X?TG7]3\ F[NS%%9^([@ZF^FV^GSR1W5[<0Q0PQ.2M?LI\.?^"$G
M_!)[X3_&NP^/O@?]C;P+IGC_ $7Q(_C/PY;76N^-]:\!^%?%D\@FE\0^&_AG
MK/B>_P# 6F7PF6*6&&'P^]KI;V]K_8]G9"UMS%]E?M<_L5?LN?MU_#RT^%O[
M5OP=\-_%[PCI.LP>(O#L6J3:MHVN^%O$-LCQQZ[X5\6^&M4T?Q)X=OUC8)-_
M9>L6D>H0*+74([FW)@HO;<-]M?34_$K2M0T[XV?\'/NJ^+OA[J&FZ]X3_9)_
MX)XWOA+XS>*M&N[:^T;P]XO^)WB%[S1/"FL:I9RS6=MK=GIJQZE/IEW*ES;V
MTID,8^S3B/LO^#BK7O#WQ,_X)?Z5\9_AGK.F?$OP!\#?VN?V:_BYXWUSP!J%
MGXLT;3_!_P //B9#9^-K^ZGTB>[MI;?P\NHQG48EE+6L@*RJARH_6']E#]@'
M]D']B'X8^+OA)^S)\&=%^&W@_P"(=[=:E\1%AU3Q%KOB#Q]J=]9W.FW-]XK\
M5^)=8U;Q)JUP;2[NH8!-JJQ64-S.--CMO-D9]_X+?L0_LG?L]?L^ZS^RI\)O
M@EX1\-?L[^(KGQ?=Z_\ ":^GUOQGX6UM_'MQ-=>*SJB^.-3\1W]];ZS<2L\M
ME<W;V=F1"EC%!##$%.B?1NR?1N]K)[-WZ7"]Y."^**O*/VHI[-QW2\VDC\1?
M^#@;XM_#S]H/]EC]@7X._"+Q'IWC_P =_M6_MR_LH>*_A!H'A*Y@\0ZIK_@[
MP[J;^*_$GBBTM=+FGFATK0M#U2UN]0U%T6"WA>9)9(_*.WZ]_P""D7["/_!+
M?PQI_P 3O^"E?[8'P4LO$.N_ SP'HWC/QI?Q^,O&_AW0OBG>_"Y8Y?A=HWCG
MP;H6N6?A;Q_KR>)GTS0_"A\1Z1J;-?ZC9V=\MY9QK OM7[+O_!&K_@FO^QG\
M75^.O[.W[+_A_P $_%"QL]3TSPWXBOO%?CWQFO@C2=8+OJ^G^!=-\:>*=?TK
MPJE])-.'ETJUMKU$N;J&"[@M)Y;>3ZE_:C_9)^#O[8GA#P;\/?CIIFM^(/ _
M@SXJ^!OC!#X4TS7)-'T3Q)XJ^'6IMK/A:U\9P0QS-KWAJSU0PWU[X>E=-/U6
MX@A>\2Y6!(@!OMJNY_*Q\&]+_;V\*?%7]E7X,>%_C/I?['W[9G_!7Z;XV_MS
M_M4_M%ZE\+_"GQ1\5?#;P)X"T;2K?X(?LM?#GP?X[E3PM!;>!_!]]I6GZOI3
M28M8Q?7&CG3728W?[V?\$:_VNOB[^VC^Q#H?Q-^/%QH&J_%OP5\5_C'\$/&?
MC#PIIQT7PU\1+_X->.=7\$Q>/=(T^*4VEA'XJM-,@U#4+33&.GVVIM=I:Q1P
M(L2>[_MF_P#!/7]F#]O+1_ &G_'[PEXB?6/A/K%_K/PP\?\ PX\:>)/AE\1_
M 5UK.FII.OP>&/%WA.^T[4[+2];TF)--U;3W:6TO;<*JPQ28:O;_ -G3]G/X
M,_LF?!OP3\ /V?O FF?#OX3?#VPGL?#'A;2Y+FX$7VV_EU#5-2U/4=2N+S4M
M6UO6M4NKS5]7U;4;NYO]2U"ZN+N]E+2$4N:.R:[633>GXAMOH>ZH %4#H .V
M/TPO\A]*=48<  8QCL,8_#VI=X]#^G^-.S[/[G_D*Z6[7WCZ\I^-GQ \(_"7
MX0?%7XH^/%#^!OA]\/?&'C+Q?$%=Q-X<T#0;[4=9MPD(+.]U86L\&TY"[UD"
M.ZFO4]X]#^G^-<UXO\+^'_'?A?Q+X)\6:3;ZWX5\7Z#JWAKQ)I%VN;35-%UW
M3[C3-5LKI"3OBN+&:6!RHWKO1H\$9)9]G]S_ ,AG^?%\+?V#O^"FOQ3_ ."-
MGQ>^+?P#^/'ASX3_ /!.?XNWGQ&_:-\-_P#!-DZK9:KX[O?V=(?$VH:]XP^&
MFG?M(W'@!M3\,77BFTT*^N-(T%[*XT:&$V2:G=VDU[JD%Q^H5]IWQ:N/''_!
M*;_@L]_P34_9NE_:#^%.F_L26_[.'C/]CV#QOHND_%_PQ\)XK5-$T_4/AS<Z
MZT"^*-6\#ZEI^JZ'J\NGVD=WJTNDVEWJ%LFFW][=:9],V?\ P0+_ &C/!GPL
M\4?L;_"#_@K-\=/AY_P3L\6:AKL$G[.,GP>\!^)O'_ACX>>)]5N-1\2_";PE
M\=-2UE?$FG>&-;^W7T7VY+"%K"*ZD$6E7'G:F=1^IOVD/^"+GA/Q1HO[&6N?
ML2?'WQM^PW\=/V"O ^I?"SX!_%3PYX9T3XE6-Q\,->TR*Q\3>#?B!X0\0W&F
MZ9XEA\2R++?7^I2Y,6H:AJ\HTR6*^,<,\T?YH_>M_O#<_*']G3XF_M6_'7_@
MYE^$/Q3^/_P"?]E]K_\ 8#^)46B?!"^\9Z/XW^(GASX7VU]+!X=\3_%N]\,Q
MG1-"UWQCXNO+Q])\.&\OY])MM'$-R4N9"[_NK_P64_9ZU_\ :O\ ^"?7QH_9
MNT'XX_##]G6X^,%[X*\'W/Q&^,&K3:3X(&F7'BO3+V]\.SW=OMNI=3\0+9I8
MZ59*C"[U I'AD=B,O]@3_@F7+^R/\4_C-^U1\=_VA_''[9'[:'[0&F:)X9^(
M?QZ\<>']+\&V&B^ /#96;0OAO\-OAYH-Q>:-X.\+VD\=O<7D5G*YU&>SMIQ;
MV;&ZBN><\9?\$H4^/O[&?[0?[''[9W[4?Q4_:@T?XT?%?7_BGX-^)FJ:+I_@
MSQI\#YI-9AU[P!H?@M;36=?M=0M_AQJ5N#I\^I-#!J=I<W-H=-M()$2"GIOI
M;OH"UM;6^UM;^EC\??VKOA=^W_\ \$1OAW^S/^UYX<_X*2_%S]K#X?:-\5/@
M7\!OC]^SG\8O#7AJV^&OBCPGXV>R\$Z;-\(=-T"U\WP0/#MO:QKI=GINV_EC
M@L[ZXN[H?;;27[0_;,_X(ZZG\5?%W[77Q6\(_MO:O^S7^QK^VWI?@;XF_M[_
M  <U#X5Z)XDO_$FG_"S1['4->USPA\0M2UJSU#X>?\)5X1T2'3/%[)IE[)IL
M-K<7%AYSW$EL-'P1_P $0/CIXZ\8? "#]O[_ (*4_%/]MGX!?LL^*M#\8_"+
M]GV\^$7@GX1Z%KOBCP;%;0^ ]>^+_B7PSK.I:MX^;PK';QI%IVH+,]\\*74^
MM">ZU$7OZ6?\%'/V5/B/^V[^S;J?[,W@CXHV7PE\*?$_QGX,L/CKKYM-1GU_
MQ#\"=.UJWU3X@?#_ ,)26(SI.N^.]/M(O#[:U-<PI8:9/?+Y<S7314OQN!_-
MS^S-^V%\1/"'QP\/?M>_"3]E#6/VG?VJO^"CEIKOPD_X)V_L[ZS\1] ^$?A_
MX._\$U_V4+&#3](\;^)_B)XLTW6K/PK<?%;4H3XN<V.F;/$L\^FIJ<E@4M_/
M_I<_X)[?ML^&/^"@'[,_AW]H/0/!GB#X:ZJ_B3QK\./B+\,O$]Y9ZAJ_P^^)
MWPV\077A7QSX6FU2P*V>K6VF:S83?V;JJ1VZ:MISPW9M+661X%^8?VRO^":7
MC7XC^,/V0OCA^Q#\8/"?[+/Q]_8L\->*?AK\+KGQ/\.X_'OPNUKX0>,= L?#
M>J> O$OABRO]'O(8-.CTRQU31[O2[D%;Z$K<QM!(S#Z)_P""<O[#^E_\$_OV
M7]!^ L7CS4_BMXLO/&7CSXI_$_XG:II5GH-SXY^)_P 3?$U]XM\7Z['HEC-<
M)I&E?VI?M::+IJW-U/:Z5;6\=Q-+/YDA8'WQ_GM_3C\N*D3O^']:@WCODGO_
M ))S^=/B;<S#C(&<=\$__6ZT 6**** ,^BBB@ HHHH ****:W7JOS0UNO5?F
MB,_>/^\G\C7\E_\ P5S('[9?B4'@GP/X# !]?[(N*_K0/WC_ +R?R-?R6_\
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M$ ')QP?Y4M-;&#D9X/\ *@:W7S_)C,@R<$'\?:OT<_8)_P"0=\2_^PKX?_\
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M_P#CO7'KCVST/H: %HH[!NS %3ZANA'?!['I10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M=C^XOTJE5V/[B_2@!]%%% !1110 4444 %%%% !1110 5!<_ZH_5?YU/4-P"
M8R!R21@=S@Y- %7\,^V<9]L]OKVK\;/^"I__  4)^.7[,'B[]EK]DS]C;X=^
M"?B7^VG^VIXRUKPO\*T^)M_?V7PR^'/A;PK9+?>*/B3XX@TR2SO]7TS1D?$>
MEV5[9RSI;WDGVHSBSM+S]D_R'N1D#ZCN/4=^E?S_ /\ P67_ &?+WQ[\<O\
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M ()H_M;?&#Q3\%?!/@__ (*#_L@?M Z1^QC\2OA-/J]]J'PHM_C=XJ\<>'/
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M_M_ZQ\3KJ3XG^,/%?Q%CECU+Q6_A_3[BX\0Z1\/KV_GD73+73XU22S^SPO\
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M DX.>G!_7@^E?RD_\)S_ ,'(?7_A"K+KD?\ $B\"Y]>?]-'(SC.!G&?44_\
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MX_NG\Q1YX_NG\Q5:B@"SYX_NG\Q1YT98%U)4<E=N[)/ /IQ_NDC.> ":K44
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MJZ8S7%YH>D7EQ+P#+<W6G6T]Q*P&%#22NSMM&,MQTP/YJ/\ @Y^\,^&?"?\
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MB#XZU5&WPS^*-:M8K&6,VDK7&=/\'6NO:O"8)_LBR":$%HFGDPI\@R>;V?\
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M&<MKI:?%?Q7I:B34?!FC-JK*/!OAN5H+B735?4K\SM=Q^3WOB+XX_P#!0?\
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MU)>L6FFNEG<6BE,L79'S[D4WS$/\)'N23BOYQ/[+%HIN]?7]#_A2AT!YR1W
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MMVU$Y13BG**<DY13:3E%.SDDVKI/1M:7T/Q__P""D'_!,SQA^WO^TK_P3O\
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M)[D$ ?K0 44&2//"-CW//\Z;O4^WMR<4 .HIN]?7]#_A3A)$!RK$]R" /UH
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MX2\&ZC.OB7X@Z!X,%T9]5UO1+B*U2""625K:V5YE /Z% "2 !DD CW# $8_
MAB.H7YC@ FD[$\8'7D>@/Y$$8/0YP,FO//A+\6/A]\=OA9\/?C-\+->MO%OP
MW^*?A#1/''@?Q-:&5(-7\.^(;"+4=,ND1PLT+O;2)$]O+^\MY4N()01&37YC
M?M??\%8Y?@/^TQ!^QQ^S)^R-\9_V\_VD]$^'L/Q7^*_@'X+:_P"$O"]E\'O
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MJMK:WVG2PRK<0QG!//91T3;2ZMMM_-Z]>IUWOK;E\K)6Z6LM%MT_4]I(*XW
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MOQ!CT+Q'\+;K6?$FE_&/]O;Q=X8OFN6O=<OM!T2\A\*_L\VVHVBK!IEOJ/\
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MP5Q_Y/(\2?\ 8D> O_35/7]8*?>'X_R-?R??\%<?^3R/$@_ZDCP#_P"FJ?\
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M1W'T/]/\* %H!!Y%%&>1[_S_ ,Y_*@ _K37Z'_/<?XTIZCZD_A@C^HI&&1]
M?Y@_T- I*\6EJVG^3&M][_@)_0-7Z)_L*<Z9\22.AU/P[^EIJE?G8QPW']T@
M_B&_Q%?HG^PF,:3\2/\ L*>'L^V;35"/Z]*_(O&W_DWN9?\ 89EEO_"R7_ /
MU_P/=_$;)TMU0S*_E_LT/\T??-%%%?PX?WT%%%% !1110 4444 %*.O^1_\
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MJ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGBJQCN+:\OM,N)HS/!<_9Y$=^U)^S5^UWX!^+&N?"?XN_M/>"?BW_P %%O\
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M43-^8O[>_P"P%^TI?_M,^'/VZ/V&?CQ\$/@%\0-+_9)\2_L:?%'2OC_X5O\
M5_AM:_!/4_$O_"7Z%XW\.76EZGI2^'_&'@'5)99(8=0=](U&RALK*>6WM%O(
M[GY&^%/_  4E_87_ ."3'[('PF_8L^"7B_Q#^UEXS^"'A&\T6]\0>$=/CT'P
M5X@\;7VIW6O^+M9OO%-X\]OIVG:GXEUG4KW3+/1+;Q!;_8D%H^K.ZK</ZF6Y
M1F>:UO999@ZV)FK>UE&C*=.FGIS5)M1IPBEJY3FDDF]KGBYOG^39#1=?.,=A
M\/&5_8TIUZ<:U:27PTJ7,ZE2;NK*,&[M=78_IW&6^ZC#D@E5/U(S@ $#!Y[,
M&'!!/YB_MA?\%:_V0/V/8[_1==\:1_$_XGVJNL/PO^&MU9ZUJ<-S&698O$NN
MQO+H_AJ!9(Q#<-/-=W]K(5$^E,N:_$VQC_X+%_\ !6ZZGF;4;W]ES]F;6]UJ
MYC75? OA+4M"N'AF4)9*\7C?XDOL\BXBFGN+;1)9%<:?JMNK%5_33]DW_@A1
M^R7^S_?:=XQ^*K:G^TE\1X1!=75YX\BC@\"V>K)N:34-*\'(9Q>MY@ADA_X2
M>^UR\@D1I%O23M/U#R+(LF;?$6:_7L1%)O(\E=-^_924,5F%W2HWLE*%*3DM
M4^62T^,CQ-Q/Q"^7A#(_[.PM1N,L_P")(UHPITEI*>!RZ:C5KRTO"4TH-V:;
MBS\VO$'[<_\ P5I_X*87-QX,_9)^#&L_L_\ P@UVZ>$>.].2\TJ:;0[]3Y<N
MM?%O7K:UM'CA"7$%_/\ #O3Y(Y$?RI+1)3&#]<_LN_\ !OK\$?"$D?CS]KWQ
MOKGQ_P#B'>R0ZKJVD6FKZKHW@6UNBXGNAJ^HM<_V_P"+T#F6&^DU>\BTJ>W'
MF+IT(S7]#-A86&E6-IIFF6=EIFFV,(ALM.TRVBL;"SA3"PPVUC:I#;1"-0%5
M%C"*HR.2<?G+_P %@?CCXB_9Q_X)A_MN_&'P?K%QH/C+PU\ _&=EX.U:RBWW
M.F>*O$UH/#FB:A <,J-;7.J>>[L$2(1Y#J0&'+BN+L5##O!\/X7#\/8%KV<X
MX+WL;7@FT_K.,K+VTIM73<'&.MXNUCIP?A[@JF*I9CQ1BL7Q;CXR<Z6(S&JE
M@<'4;NXX?*X3IT803MR.5*JTE=V=RC\,?VYO^">7P?\ V5?BS\=?!6O>$_@9
M^R+^SW\2/$_P>U3XA2^$_P#A%O GB;Q7X(U*'0=73X;+IR7NJ_$BT;Q$\_AW
M2M6L-+FEU_6+:^CTJ*YBM9KJK7[('_!6_P#8;_;?^).H?!SX)_$7Q)8?%VV\
M.'QEIWPP^+'PZ\8_"GQEXF\&(%SXQ\)Z9XTTJQ3Q1H*1LKO>V$T\WV?-T(#:
MJ\R^5?"/_@GU^QYK_P#P3(_8>^"W[0?ANRN_@I^S5\,O@E\>%36?&NI>&/"=
MCXZ\/^%;/QSJOC#QE?VFH:;9:YH]MXBUK6];OX/$,USIEP)WFO8[@L2?@OX3
MZFG_  5\_P""J_P;_;,^!/@G5/"G["__  3^\'_%OX:>&/VDI](D\*:A^UI\
M3/B'ITOAC6_#WPO98;34[KX0>#(_-<:](#8W5^AFLFM[R6.*#Y"K.I7DY5)3
MG>3DW4JRJU)2>LG.<Y.<FY7U;;2LE[J27W]&E0PT5"A1A1BHJ*ITXJ-.$4M%
M%1C&*2[**2=TU=-O[F\=_P#!>W_@EU\./BOK_P )O$/Q^U*5O!OB^/X>^./B
MAX?^&_C[Q#\"_ /C>2Z6R3PIXL^+NDZ#=>%-.OH+YUM+ADN+FUCE9MUVL<,Q
MC^]?VB/VM?@O^S%\.? 'Q5^(VJZK>^$_BK\3OA1\(?AZ_@;3$\5W_BWQK\:-
M8M](\!VVB6MK<VL-SI>H/.=3N-1AN6CAT>WFU!E*0%3_ #]_M_V?[-7P+_9U
M\0?\$&_^":_P0L_BO^TM^U3;>(DU[X?)=W?C?1?V??"?Q*UT:SXX_:#_ &@_
M'7B&;5;K2KBP:>34/#>F:SJ3:Q<3_8Y+86\,>F6U[[GXO^#<D'[;O_!%?_@F
MY!XCU3QCX;_86^"/B+]K[XM:]=N=0M?$&K?"SPG9_!/X.C6X9 [1377C35_$
MOB/P^+O]\D6FV]PA9X%=T]7?T_!6_0M*R^_\W_F?5/QB_P""[G_!,GX'?%SQ
M=\'/'7QTUFXU;X;>(XO"'Q7\:^%/AC\0?&OPI^%'B2:X^PIHGQ ^)/AWP_>>
M'=#OH[IS%.(I[U4N8Y;=I3/#+"GV3^T;^W7^RC^RC\%/#_[1'QL^,/AS0_A9
MXTG\/VOP]UK1(KKQ9??$_5/%%L+OPYI/PZT'PM;ZAK/C+4-6M9H[BRBT>SE4
M1R1274T*.&K\1_VZ-3_9>_8H^ WQ"_X(_?\ !/7X"6'QL_;)_;NB^)^H6_P/
MFO+OQ\_@>+XVW%Z/&_[0O[1/C/Q%/JMWX4\*>&(]8GU7PG#KFHK<PW%II3:-
M%;:;%:F[^'_VEO@K^TO^S-^W1_P0=_8%^!_A[X8_'WXE?L]?L1?$*W^'&N_'
M2\U>'X)^#_BWIBV7A?Q3\<-<T72G?6-<D\#>%O#-U#X3T*P:WOI=4U'PW$EQ
M:V\-R8@9_1S\ /\ @J?^Q]^U'\)?CK\5_@;XH\<>-Y_V;-#U+7/C-\(9/AUX
MB\._'OP?9Z5I-YKB6]]\+?$\.B:_>WFM:;I-[+H,=NS)J4]G/IMM+_:(EMH_
ML/X*_&3X<?M#_"7X>?'#X0>)K/QA\,_BCX5TGQCX,\16+?N[_1M8@6> 7,1.
M^RU.V=GM=4TRX"W>F:A%<6%XB7-O**_#[_@G1\5OB+I'_!4+]K;]F3]MKX%?
ML\:7^W;'\"OAU\2;7]J[]GGP_KOA_0?VD?V?S=V^C6=CXLT#7KJXFLM:\"ZQ
M=66DJT)E@>2.XLSYJV"7FH]'_P $-;[_ (5YXA_X*D_L::;<3-X(_93_ ."B
M/Q<L_@[HFX2V'@_X3_%R&Q^(&B^$[!U+Q11Z9XGU'Q/=?90P:W-[Y3I&5 9
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M/9M(\:W$J5^@>J?\$I?VWO@+\3OVG+W_ ()Q?M\^"OV=/@5^USXVUWXH>/\
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M_P *-Z^OZ'_"H:*:W7JOS0UNO5?FBPCKN'/KV/H?:OY0/^"N(/\ PV3XD]_
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M"" 01WR.O'6@$'@'DXP.[9 (VCJW!_ASC!S]TX_F-_9^_P""FO\ P6#\2?\
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MX5#10!-O7U_0_P"%&]?7]#_A4-% $V]?7]#_ (4;U]?T/^%0T4 3;U]?T/\
MA1O7U_0_X5#10!-O7U_0_P"%&]?7]#_A4-% $V]?7]#_ (4;U]?T/^%0T4 3
M;U]?T/\ A1O7U_0_X5#10!-O7U_0_P"%&]?7]#_A4-% $V]?7]#_ (4;U]?T
M/^%0T4 3;U]?T/\ A6AIK SR8/6+W[.*R:TM+_U[?]<S_P"A+1_7Y@;U%%%
M''T444 %%%% !11136Z]5^:&MUZK\T.3[P_'^1K^4?\ X*X_\GD^(_\ L1_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX<^&/CWQ%X-\,[Y64FYD30](M$$\BM-+$,-+(%0M\W?\$P](M/B__P %G_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"M+2_P#7M_US/_H2UFUI:8?](8=_*)_#<!2?3U_S WJ***8''T445S@%%%%
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MD7C;_P FZS)=L5EO_J5,_6_ [_DY.5OHZ.96\_\ 9J1][T445_"A_?@4444
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M.6W-A]Y8,PP>?D" AD49)P3@FG5,W=KT ****@ HHHH **** "BBB@ HHHH
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M/$>A>(=5D\8ZSXNU[5K=(H'OTNY[R\L+O4Y(HKRUOY;C2CIJFVU!9=.1UK]
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M\%!-2N/V4O\ @J!_P3"_:X\)2PZ+IO[3?CK7O^">W[0^GJ7@M?'^C>/--O\
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M3U'QEX.T?6M*\-ZQXO\ "ND>(]=#-HGA_5/$6CZ?KFL*APS:9I-Y>0WU\H/
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MLR#:P$?W/ZFN0KK-/_X\K?\ ZYC^9JHQY7>]P+E%%%4 4444 %%%% !1110
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M$/PQ<Z#X3^".GZ-KFGZ9?>-+W2=26\G5GAG@LEUO5+V"1!H]K+=?K)_P5_\
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M>I_%I?A/_P %6O!K-+8_$Q/$UI"S16UH?&VBZKNA& C"UNM*M957##Y9+AW
MSER1FH)?'W_!5_P>PCN/!:>*8$/FRSQ^&?#FM*L:?Z28S<C4;21"5/E[DB8=
MQGK51\7*U!O^TO#OQ RFUU*I6R"&.5UNU]0Q=24N;5IO5K7=M"GX'TL1!/*/
M%?PBSM-I0A#/YY74DF^6//\ VG@\%&,TG%2C>2Y[QC)V4I?M8<DG!5AQR/F
MSTR0".#GOZ\]Z0X4@,44GD  Y.!D]%;&!R<XQP<U^*C_ +;O[=GA8HWB?]G.
M&]C@65)U/A3Q!$TKVPQ*[2:,;ORF8YVK"KQG)\O/%:-E_P %2?BAI"?\5M^S
M/?Z?-NWR+8'Q3IT8ABD:61P->TY2&2!D<,[",R%O-_<;354O'#@>[6/6>8"S
MM+ZUPIGU*SZW:R^I&Z=[KFEJFTY+WG-;Z./B6K?4Z?"6<0<.>']E\;\-U6X-
M*46H?VK2G[T6N7W=FE)QD[+]F^A.[@ [.0.I&<87.>PZ8STY&*;QP0&.U7PP
M.6)57*H<DJF!+O3*;?D"R<XK\A]'_P""NWPXEN(X-=^$OBS3#&["YFM=>T:^
M6"2.1BZBT5(KIYHU(#$N$#%EVC!KUO1?^"IG[,6HK$-47XB:+.75&#^%3J5N
MB%B#+-<6=VD:)M !9HV()R%(.:]:CXP>&>)Y;\997037_,UI5<#&.B?*_;X>
M@TULU))IZ2LTSQ,1X#>+N"37^H.?XB%W?ZA*EG*E=KWJ<<'C*_-!WO%QTY6F
MM+-_I$7D\SS593,D30+,ZJ\IMI&#O;+-Q.(2T<;F(R&+>-RKGD$;RQ'=$[1D
MJRDAY,X<89CM=<OG:RXP 5!;+"OBK2?^"A7[)FK-"O\ PLQ-)\Y2RG7-(O[%
M443"#]ZT<=RL9WD$@]$^?I7J&D?M8?LW:_;BYTKXS>!KB%L*KOJIM<LS,B@)
M=PP2<LI&=F!P20",_183C7@['J^"XHR'$K=.CFF#:::TLI5J;M9II6T5O,^4
MQ_AWQ[EDW#,.#.*,'+5VKY'F4$E=KXHX6K!/1Z<]]-CZ"ZC#8)'W<A<+@L0"
M /FW$G<.<C\BXRRNRM)*Q>,C:[/([1LK;D+/G>$.3A8E)#JI+;<FN%L?B;\-
M=2B,VG_$/P+>H(I)Y/LWBW0)IHX8PYDEDMX[]KA44(Y.8LX4A0Q*@_GP_P#P
M50^"EO\ $:?PG<>&?%H\&0ZC+HX^(*BQDM/,AN3;OJ:Z I_M*+1EG!D^TFY\
MR2S'VXH8W$59Y[QOPCP]'+*F=9]E6&IYG45'#S_M'"VKS;248^QK5]4G%MRY
M$KKWKW+R#P\XWXF>8T<@X8SS&ULCI/$8]0RO%MJG:3]Y5J.'<M8SC&%-5:DG
M"7+3:BV_U!4%1( J*)I99IP@55N+A]G^DS*B+YDQ"J-\A=P5!W$!<9VH:/I6
MJ/9R:GI>FZJVGW$5[IQU/3K'4!IM_""L=YI_VV"=K&["%E^UVC17*%MR2?>!
ML6EY;7UG:7]G/'=6>H6EM?V-U"P,-[9WD,=Q;7-LQV[XIX)8YHS@9C=3@'BK
M@7(ZJ/8GG\:^IC.G.,:D'>$XQG!IW3A.,9P=U=.\)1::T=[W=SXR490E*,X\
MLXRE&<6G%QG&4HSBXM)IQE&46FDTXM-)II9FI:7INLV,VF:SIFG:SIMP8WN-
M.UBPL]7L;AH9!+!YUCJ,,]H[V\@#PR&-C&45D*NQ(O;<+&BHB1Q1)%&D0$2I
M'&"J1HL85515(18@!$D0*(!M11+M_P!I?SHV_P"TOYT[KO\ @_\ (D:.@_IT
M_"M/2N;T^UL_ZO$!^J-_DUG;?]I?SK0T<@WC8_Y]C_Z,!_DP_6G=/^O^ !TU
M%%%,#SC)]3^9HR?4_F:2B@!<GU/YFC)]3^9I** %R?4_F:,GU/YFDHIK=>J_
M-#6Z]5^:'+RPS_GBOY6?^"M))_;#\09.?^*&\"G\?['D&?KBOZID^\/Q_D:_
ME8_X*T\?MAZ^?^I'\"#\3H\O^%?TA]%3_DZM+_L39O\ ^FJ1_&'T[?\ DQTO
M^RKRS_TN1^9:]!]!2TT9PN,=!GZ4ZO\ 3<_Q%6R]%^0'@$^E(3@9H/((]0:#
MS^8_0@TM=?3\0%'/M]:*0YXQCKS]/:EI@!X!/I2$X&:#R"/4&@\_F/T(-+77
MT_$!1S[?6@\ GTI#GC&.O/T]J1C@'WX_.FKW\]/FQ-I)MM))7;>R2ZGZ:_\
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M_(Z>+2?XO%7B'_T\WO\ @:YY>&/N3C\,G^M=%XT'_%:>+/;Q5XB_]/-\*YP
M[AZ;FY_#_P"L:_THR'3(\F_[%F7K_P M,/;\#_,#/-<WS>VO_"MC_N^LU?T)
M* <^H^O6@Y[8Z\Y]/\:3N/?^?7^A_2O6/)%]/?\ P)_I1WQ]?TQ_C2'J/Q/Z
M8_J*.X/L?UQ_A0 M .?4?7K1_DTG<>_\^O\ 0_I0 OI[_P"!/]*:_0C_ #U'
M^-*>H_$_IC^HI&''X'^8/]/\B@33::6[32^YC6!+#']UB?H%:OT&_8@(_LGX
MCXSG^T_#?/3 ^R:KQU-?GPWWOH#G_OD_XBOT&_8@(.D?$CC!_M3PY^7V751C
M\Z_)/&S_ )-[F7_87ENW_85/?NC]?\#VGXC9.ENJ.8W7;_9H?=NKGW1D^I_,
MT9/J?S-)17\-']]"Y/J?S-&3ZG\S244 +D^I_,T9/J?S-)10 N3ZG\S1D^I_
M,TE% "Y/J?S-*"<'D]/7W%-I1T;Z?U%/O_AE^0GT]5^9\G_MZ$_\,2?M:#/!
M_9\^)Y_'_A%;[G]:_P [ZO\ 1 _;T_Y,D_:T_P"S>_BA_P"HK?5_G?U_=?T0
MO^1+QC_V,LN_]1*Q_#'TL_\ D>\*_P#8LQ?_ *?@%%%%?V(?R.%%%% !1110
M 4444 %*.C?3^HI*4?Q#V'ZL/\*.DEWC9>O- B?PO_#/_P!-U#^[;_@C<2/^
M"</[.V#C]U\1O_5H^,:_3K)]3^9K\Q?^"-__ "CB_9V'_3+XB_\ JT?&/^%?
MIS7^/O'VG'/&2Z_ZR9Q_ZL<6C_7'P[_Y(/@__LG<I_\ 4.D+D^I_,T9/J?S-
M)17R)]D+D^I_,T9/J?S-)10 N3ZG\S1D^I_,TE% "Y/J?S-&3ZG\S244 +D^
MI_,T9/J?S-)10 N3ZG\S1D^I_,TE% "Y/J?S-&3ZG\S244 +D^I_,T9/J?S-
M)10 N3ZG\S1D^I_,TE% "Y/J?S-&3ZG\S244 +D^I_,T9/J?S-)10 N3ZG\S
M1D^I_,TE% "Y/J?S-&3ZG\S244 +D^I_,T9/J?S-)10 N3ZG\S7<:7_R#[3_
M *Y#^9KAJ[G2_P#D'VG_ %R'\S0!?HHHH **** "BBB@ HHHH **** "L#7R
M1#;8_P">S#_R&:WZY_Q!_J+<^DKD_01M0!S&3ZG^?Z'K5+5--TK7=-OM&UW2
M]+UO1]5MY+;5=(UK3K/5M*U&VFQYUM>Z9?Q7%A=P2%59X+FWEA=U5RFY01<H
MI6 X[P3\.OAU\---N-(^&WP^\#?#K2[J<W-WIG@7PCX?\)65[.6D837<&@6%
MA'<2J\LC;[A9B S>658C&?KOPB^$/BOQ7I?CWQ7\)_AGXF\=Z(Z2:1XU\0^
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MVZ;^GQ?A8._EKL_SM9^B;?=(;D^I_,T9/J?S-+L/X\' !)PQ8 D@;0N5())
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M^I_,UN:'G[4?0VS<]\JT*G]16%^ON.A^E;FAL#=;>XMYL_C+#_C0_+^M5?\
M #K****8'F]%09/J?S-&3ZG\S0!/14&3ZG\S1D^I_,T 3T5!D^I_,T9/J?S-
M-;KU7YH:W7JOS193[P_'^1K^5;_@K4?^,PM>'KX)\!_IH\U?U1*6W#D]?4U_
M*]_P5K&[]L37B. /!'@5OP_L>8?UK^D/HJ_\G5I?]B?-_P#TU2/XP^G9_P F
M.E_V5>6?^ER_4_,Q>@^@_E2TB]!]!_*EK_3<_P 1%LO1?D@HHHH&%%%% !11
M10 5'(<+D^H_K4E,D4LI ^OY4XZ23[-?FB*J<J<XI7;BTDNI^G?_  22_P"3
MOM!_[$/QY_Z:+6OZH*_E<_X)(N&_:_T5!D%/ 7CX$GIE=)M@0,<\8SFOZG@2
M.23R#C)/7]>?R^M?YC?2I7_&U)KK_8>4:>7LL4[^EC_;[Z"+C+P)H.+3C+B+
M-XQ?1NG.A&:7G&49)^:>Z):*@R?4_F:,GU/YFOYO/[-)Z*@R?4_F:,GU/YF@
M">BH,GU/YFC)]3^9H GHJ#)]3^9HR?4_F: )ZEA&94/]UE8_16!-4\GU/YFI
M86;S% )R2 .3CDCK[>M5#XX?XX?^E1,ZO\&M_P!>JO\ Z:J'X<^-/^1T\6'U
M\4^(3_Y6KZN=SC'4_,W3K_%70^,O^1R\6>WBGQ"#]1K-X3_.N=!R2/[K']=U
M?Z49'KD>36U7]F9=]RP>&/\ ,'.M,WS?_L:YA_ZD5D.!SV(^HQ0>WL?Z$?UI
M:*]8\D3N#[']<?X4$X[$_3FEHH 0'/8CZC%![>Q_H1_6EHH 3N#[']<?X4C'
M"G@G@].>QIU(W0_0T#32=WHE?\F1$Y<\$<'J,?PU^@O[#_\ R"?B1_V$_#G_
M *3:K7Y]OPQ)]#_(BOT!_8C)72?B.O(/]I^'#Q_UZZMQ7Y)XU?\ )O,R77ZU
MENG_ '-2/UOP.37B1E;>TJ.96??_ &:EM]S/NRBH,GU/YFC)]3^9K^&C^_">
MBH,GU/YFC)]3^9H GHJ#)]3^9HR?4_F: )Z*@R?4_F:,GU/YF@">E'1OI_45
M7R?4_F:<"=K<GMW/K1W_ ,,OR#M_BC^:/E3]O3_DR3]K3_LWOXH?^HK?5_G?
MU_H=_MXDG]B7]K7G/_&/7Q0QDG&?^$6O:_SQ/\FO[M^B%_R)>,//,LN_]1*Q
M_"_TL_\ D>\*_P#8LQ?_ *?@%%%%?V&?R.%%%% !1110 4444 % ZM_NK_Z%
M12@<M_NC]#FA[/T_]NB3/X7Z2_\ 3=3_ (!_=K_P1N_Y1Q?L[_\ 7'XB_P#J
MT?&5?IU7YA?\$<LC_@G'^SL,D$0_$7.#_P!50\8G^M?IPQ/R\G[H[_6O\?O$
M#_DNN,?^RCSC\<RQ;_(_UQ\//^2#X/??AW*?PP=']="6BH,GU/YFC)]3^9KY
M ^Q)Z*@R?4_F:,GU/YF@">BH,GU/YFC)]3^9H GHJ#)]3^9HR?4_F: )Z*@R
M?4_F:,GU/YF@">BH,GU/YFL3Q-XH\->"?#FM^,?&GB70/!WA#PSIMUK/B7Q7
MXJUK3_#WAOP]H]C'YMYJNN:YJUS::9I6G6L0,EQ>WMS#;PHK,\BJI( .BHKG
MO#/B?PWXV\/:1XN\%^)-#\8>%/$.GP:OX?\ $_A;5K+7O#NNZ3=1&>VU/1]<
MTR:YTO4;">W4SQ75K=2Q20C>C$$9\M\*_M,_LW>//&U_\-/ O[1'P-\:_$?2
MYI+;4O 'A/XM>!/$'C73[F%I%EM[[POI>O7.M6D\;12J\5Q91R*T<BLH,;A0
M#W.BH-Q[,2/7)_$<X((/!!'!%8OB/Q-X=\':'J?B?Q?XAT3PGX:T6W^V:QXB
M\2ZO8:%H>E6G(%UJ.K:G<6MA90$C:)+BXC!;Y>M '0T5Y'\+?CS\#?CE::MJ
M'P2^-GPE^,EAH$\=MKM[\*?B1X0^(EIHUS(6"V^IW'A'6-7BLIRR.OE7#1N6
MC<*"5-<OXZ_:O_9?^&'Q+T'X,_$C]H_X&^ ?BYXH6Q?P_P##/QC\5?!7ASQS
MJZ:JVW2&LO#.K:U:ZM*-9;"Z1_HH.IO^[LA-("@ /H2BN-^('CWP5\*/!OB;
MXB_$[Q=X?\ > ?!FF2:SXM\9>+M5M=!\-^'-*BEB@>_UC5M1D@M+"U$L\,8F
MN)$C>26.-&:1T1M#PSXGT#QGX<T+Q?X2UJP\1>%O$^E6>N>'?$&D727FE:WH
MVHPK<6&IZ;=Q,T5U97D#+-;SQL4DC8,I(- '145!D^I_,T9/J?S- $]%09/J
M?S-&3ZG\S0!/14&3ZG\S1D^I_,T 3T5!D^I_,T9/J?S- $]=SI?.GVO_ %R_
MDS"O/\GU/YFN^TG_ )!UI_UR_P#9FH T:*** "BBB@ HHHH **** "BBB@ K
M \0?ZB >LC@?4QM6_7.^(R1!;8X_?L/_ "&U ',_Y_SFE(]P3V4,I9AG 8+G
M.TX)!(&0"<<&JX)SR3CO@G/X8R?R!/H#7XT?\%KOVR?VA/V4O@Q^SGX5_9/\
M6^$O G[1'[47[4WP]^"/@KQ;XU\.Z)XJ\->'?#US!?:CX[UG5]$U^.73I+;3
M='^R:E?7L@@>RL+6Y9)89I4*K6Z _: *6Z8& 2V[Y<#. ?F W!CT*;ACYFPN
M#33@ DD9! *DX89&0><#!&#D$_*RL<+DC\8/V)M+_P""F-M\2[WXF_M,?\%*
M_P!C[]JW]F'P;X?\7KXVT+X _"#P=X=U2UUBPL!<Z=JMQXR\+ZKJ*:<ND6UI
M>7E]ILL@DGA#0R1G:LB_G-X0_:^_X+-?MK_ ;]HG_@IA^R#\<O@;\'OV9?A;
MXJ^+$O[/7[(/CKX&:%XW\0_'_P"&/P*N[\>,-8\;_%F2\@\2>#/$GBB+0=:3
M1[7PT'T^ZFBMK>QETL7D5PAK_7]?,#^KHJ02"1QR3U  ;9N) ( +<*"=SCYD
M#+\U-'.<=L=?ESD*>"V!_%C)(!8$ DXS\D?L'?M8>&OVY/V0_@#^U5X7TXZ!
M9?&3P+I^OZOX8%S+>-X4\60&33_%WA7[;M0W@T#Q#;W^GK(T322)&-[>80X_
M*?XN_M/?\%!?VV_^"A'[0?[$O_!.OX]?#C]DKX??L1^"O!%[\?OCQ\0O@SX>
M^.&J^.?C!\2H[G4_#_PQ\*>&?$-Q::/I7AO2--L[F#7]6M[B'6+75K2_<&YL
M[NQC0O>X']"&,8R0,\C)'3D9SG ^92F"0P8<@+\U*5VD@D KC=GC:#C).0,J
M"R@E=P!=>N>/Y5-5_P""SG[6_AG_ ()G_MP:CX\T?X;^'?\ @HK^Q1^TIX9_
M8V\=^)--TPS_  FNM?\ 'OCOPYX,\*?M#VWAR^!LXM!O-.UK4]4M]%FBCT:^
MUO1X'N+"+2;V*P/TY^S!^VK^T)^R9^T;^WG^S+_P4%_:6T#]I/P#^R?^RY\.
M_P!L*P_:+L_AKX=^%FN:-X5\3:=J7_"4_#OQ)X=\*;=+O[IM3L;:[\$KSJ]S
M97 L0UTLEK' KM?U^/XH#^@\J5)!X8*&*D$$ D+U("G!(Z,=W1-QXIM?F[_P
M2S\:?M2_%_\ 9;LOVBOVK];N(?&/[2GB_P 3?&?X;?"N;3-,TK_A1/P"\5W'
MG?!_X:.UC:65UJ^KIX/M['Q%KNJZJ)M3>[UZ:SNPDEF ?T;R?4_F::?X 3T5
M!D^I_,T9/J?S-,">BH06)QD\].3U[#\>G\Z7#\[CMQC[SCDL2 JE68.VX;2J
M%BK<-BB]@):48[^AXSC)P< D<@$]<<XSCFH!DX!8J6X"G=N.!EL*H)(7@,1D
M<\$C)!\V2-WS X9=V2 !EGXR"BG"EE+ L<+NP<*Z \K^//P3\"_M'_!OXB?
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MK,SR+HVE/NM-*0NW%Q%&]Y,JXN;B;AA]EDD[>@"C(!083  4)R!@*!@'.T
M9P!58N21C@?UXYZ^HSP .P '%*'.!EB>O49Q^/'7\?J.WZID?#F0\.9=3R?)
M<KPV"P%"TJ:I0C2E/D5HRJSM*K6J.UYJ55N3;NW<_%>(N*>(>+,UK9MQ'G>.
MS'&UU-U*V)J2Q5%2DY-TZ&%]Q8.BG*U&&#A1A2A:+AI<_!W_ (+2W=IXT^._
M_!&G]G3Q#%)-X ^,/_!27P#KGQ T^ZD9= \3:3\,_#FL^)-%\(ZQ$&$=TUYX
ME33M3L+:3!2^L+66#$@R?IW_ (*L_LD_LY?&C]G;XX?M$_%?X5>'/B%\7/@%
M^RU\?[3X.>(O$\<^L6WP^N?$GAV74M4U[0= N9Y='B\5_:].M&L?$<EH=8TZ
MW66WL+B**:8-R?\ P64_9I^(WQP_9R^'/QK^!&E3^(?VC_V#_C?X*_;"^"WA
M2TC:6Y\>WWPWDEE\:_#^S@@9)[C5?$W@U]4@T.V6:%9]=BTX-N(4'[IU:R\)
M?MF_LIZCI-]!XQ\$>"_VG_@DUEJ-I=Z6^A>/_!FA_$SPLHU'3;W1_$6GYT[Q
M9X=&H36%W9ZIIGE1:I9.9K:6( /[%T]4K+LERV7^&[LM-KNVVI\\E96O>VE]
M=;====?-GP=_P3C\!_ _XE?\$5/V*O#O[27ACX>^+_@O#^RE\-O$?CG3/BS;
MZ7?_  _AL/#-M/K*:SXG767&F)8Z%<6RWZ7%V1'"Z!B2X05\,VFI^)_^"Y?[
M5W[.VL?"3P%?>!?^"4G[ _Q>M/B9H/QFUS3;C0]5_:X^-W@%#HOAC0/@OH\\
M<-Q9_!KPE)$J2^)D"1WHMRD,I=H[*U_2OXH_\$OOA?\ $_\ X)M>&?\ @F#_
M ,+J^.O@?X->'? O@GX:W7Q$\%:EX/L/BMXF\%>";X7R:#X@NKOPQ>>%9['Q
M*R16_B>VM_#L%O>VD*0P0V^79OFCX-?\$5/%?P)D^'%GX&_X*Z_\%4%\&?"O
M^PX?"OPNOOB[\/4^&G]D^'3'_9WAB^\+:?\ #ZSLY?#$D<,=M?:7"(1=6N]&
MDWL' !C?LE> OA1^VK^U?_P6-_:C^/?A3P7X^^ &N^.?"W["GA^P\?I8:G\,
M/$?P=_9;TA/$'Q&U+5(=7D72UTA/BCJ.IWVL2SO%:PS:*MW=M&;<&/YU\6>*
MM:_X+D?'GX)?!O\ 9F\,3>#O^"37[#?QY\$_$CQU^T9<Z2VE6'[1GQ8^!9DA
M\#_"G]F[3KNWB9OAMX0O!Y&K>+HUBM+RU,D$.$CL[*OTCA_X)5?"R#_@G1XV
M_P""<&G_ !B^,'A;P+\3M0\;ZQ\2/B]X,G\,:7\5?%.K?$KQ[>_$'Q]<S37V
MBZCX?@A\5ZA>-I6J6Z:24?2$-M'M664'YF^"'_!#34_V?-+^&'A/X;?\%:_^
M"J>C_#+X277AT>%?A':?&+X?:7\.!X?\.:C;:A#X-N_#VC_#ZQA/A?4D@DT[
M5M.MVA6[TZZN;<D;RQ (O^"5403_ (*G?\%VY-=E2?Q]+^TQ\'C;>=(O]IK\
M+S\/H'\$A7/^E+H\,IU&.SC)-J9!.D R)5/QU_P3;^'_ (5^*'_!+K_@N!\/
M-6M["X^"OB;]J+_@H38^ DG"'PY:>&X/!EW?0ZEI6W-E'9:+XSM+C5Q<6>8(
M=0M4ERLT+D_JG^U7_P $I_"?[0GQ]US]J'X2_M2_M-_L5_''Q[\.]-^$OQC\
M6_LU>)/#NEV_QB\ Z-&;70K7QGI/BG0]>M/^$B\,6#RV?ASQ+I@LM1L8G(>2
M4K&4\;_:^^ ,7[$G_!*N/_@G_P#L'_#3Q-X@\5_'N)?V2OAS*VG:CXAN[?6/
MC\^HV?QA^/OQH\0:7; V=I8^$KOQGXN\6^*+PV,%QKLEA#:H[W-G;.?UY:?T
MP/HW_@BW\3]<^,'_  2F_81\;^*9KZ^U[_AGWP9X:UC4]4GDN;_7[OP19+X4
MDU^YNY&DEF;68M-2^>>5B\RR!SC=@?IN<Y.<@YYSUSWKP/\ 98^ 7A?]D[]F
MWX%?LT>#9Y;SPQ\#?A;X/^&>GWKX2;5QX8T>UTV]UJ\<*/-O-8NHIKZYEV(7
M>7<1N)->Z;CZG\S0NH$]%09/J?S-&3ZG\S3 _%C]J'QQXJ_:7_X*T_LH_L"Z
M1K6MZ'\'?V=OA/<?\%"/VE8-'U.YTF3XAW^G>*5\"_L[> =1N[!XWO?"-O\
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M?XBK9>B_(#P"?2D)P,T'D$>H-!Y_,?H0:6NOI^("CGV^M%(<\8QUY^GM2TP
M\ GTI"<#-!Y!'J#0>?S'Z$&EKKZ?B HY]OK2-T/T/\J#GC&.O/T]J1B IS]/
MSIK73KHO5L3:2;;LDKMOHD?IE_P2._Y/"TGW\"_$+_TTVXK^J(_=7_@7\Z_E
M@_X)(J5_;!T8GHW@+X@,"/\ :TJV.#TY /O7]3_4 ?W03_GI_7Z5_F1]*IK_
M (BM-]/[!RA7\_88E6^_0_VX^@9&4? 7"1::<>)^()23W2G74HOTE&46NZ=Q
MM%%%?S<?VB%%%% !1110 4444 %2P?ZZ+_?7^=15+#Q*A[!E)^F1FJA\</\
M%'_TI$5?X57_ *]5?_354_#GQGQXR\6#U\5^(O\ T\7G_P 2?TKG5X8^Y./P
MR?ZUT7C0?\5GXJ/KXI\0M^!UF^_QKG0#G/\ M-^H/^%?Z49#ID>3?]BS+U_Y
M:8>WX'^8&>:YOF]M?^%;'_<L35_0?0#GU'UZT'/;'7G/I_C2=Q[_ ,^O]#^E
M>L>2+Z>_^!/]*.^/K^F/\:0]1^)_3']11W!]C^N/\* %H!SZCZ]:/\FD[CW_
M )]?Z']* %]/?_ G^E-?H1_GJ/\ &E/4?B?TQ_44C#(/L#_,'^E FFTTMVFE
M]S&.I8X&!E3UZ< G^E?H#^Q+_P @OXCGLVI>',?^ VJ]:_/]C\W'92#^*M_C
M^E?H%^Q*0=)^(A'&=2\.C'^[;:H#_G%?DGC6O^->YF_^HK+?_4J9^O\ @>T_
M$;)UUC1S&Z[?[-"]_O1]Q4445_#1_?04444 %%%% !1110 4X?=;_@/\Z;3A
M]UO^ _SHZ/T?Y,.J_P 4?_2D?*'[>/\ R9-^UK_V;U\4/_46O:_SQ*_T._V\
M?^3)OVM?^S>OBA_ZBU[7^>)Z>_\ B1_2O[M^B%_R).,/^QEEW_J)7/X7^EI_
MR/>%/^Q9B_\ T_ ****_L,_D<**** "BBB@ HHHH *<O&[_=/ZD"FTHYW#_9
MS^O_ -:A[2]/UB3+X7WY96]>2=C^[+_@CGS_ ,$Y/V=SZQ?$7_U:'C ?TK]-
MV_A_W1_6OS&_X(XG/_!./]G;VB^(H/\ X=#Q@?ZU^G+?P_[H_K7^/W'_ /R7
M/&*>_P#K'F__ *L<6C_7'P\7_&!<'?\ 9.Y5_P"HE)_D-HHHKY ^Q"BBB@ H
MHHH **** "BBB@!0NXA5(+$X"C.<D@8 QEF^93M3<VT@XK^+C_@X6_:H^,'[
M<OA_]K3]AS]D+Q NG_L__L)_!O6_C]_P4#^,%B)KG1-<\7^&K2;4_AU^S-I.
MH6<\<-YJ-SK-N-0\3VJ7)C@O["?[5$X\*:QI5_\ UA_M:6OQ]U#]F+X[Z=^R
MQ=Z-8?M&ZK\,?%6D?!;4-?N+>WTO3/'VH:9<VNAZE<7%V'LX)-.N+@WMDUW&
M\'VF#,\5Q$WEC^'CQK^S#_P6^_8"_P""1G[8WP \7?LN?L6V_P "O&7@/XM^
M/_VI/CN?B3XD\5_M$>.I?%:W-YXJ\=ZMJ7_"9/INN^+K#3I(=/TB,Z0;4062
MNUG++<74TZZ^FWEW_!@?T _ K]G;XZ_M9_\ !O)^S)^SI^SG\:++]G[X@_%3
M]E/X/^'9/B7<V6JWSZ7X0D2PG\9Z+8/I%]I]_I]UXGT 7N@+J5M(SV4=]-<6
MZ>9'NK\,_P#@K/\ LE_\$E_V$OV8_A=^S!^QU/I]M_P6+^&GCOX%6/PKOO@I
MKOBK5?VD_$'Q5U'5/#UUXAUSXCW>B37+V=OXEM+^YU[2/#^OSVTMD=3T9?#&
MG0I':8_0W_@GU_P4'_:M_8"_X(F^!_VG?VR_V;O"_B;]GWX7^!?V>?#'[/"?
ML]:N+WQYKWPD\6PWNAWGCWXN1:]KE[:Z9<Z/>S^'S<QZ99VXA2^O9GLUABC:
M'M_^"V7PR_X))?'3_@E]\</^"@%QH_P TSXP_$WX::3\5OV?_P!I+P4_AK1?
MCAXU^-QT#2H_AGX?_P"$M\.SQ>*O$M_%)IVG>'-:\/ZC<W$>BVFDS0WGV*33
M7DA/^#_3[@?TF?!T^/6^#_PD;XK+&GQ3/PM^'A^)RPE3$OQ%/@_1CXX6(K\I
MC'B?^U C+E67!!(.:_DY_P""W?QH^!/QN_X*A_ +]BC]M[XW-\$/^">/[.'P
M(7]K3]I&S37]:TR#XS>)]<OK^V\!?#ZYTOPV&\1:]?74VEC2['2?#]M?ZPUK
MJE[>6%J;V.&6+]J_^"<_[2S?#W_@EM^P9\2?V^/C'X1^%/Q(\??"3P=H6H^)
M_CEXQTGP1?>+_$5]/J4?@BREU#Q7=Z<^K^+M=\$0^&]0FA+S:EJ4]T]W(US-
M-+,WXF?MZ?"CX%^!/^#H3]C7XU_ME:)X27]GSXS_ +.MIH'PP\1_$I(+CX>M
M\?\ P!IOB31_"\6M'5-^C6CZ9XAU30)-+CUGR=,&I7EC>.CQJ68\@-3_ ()Y
M_#+_ ()(?M _\%+_ (+_ +2?_!&_]K'PQ^S9J/PF\(ZYI/[1G['EO\-_B#X:
M;]HOX>H'LWU30=(\::QX7L(([*Q=+_6]2T31_%=]!);:?K.M65G.999_RS_:
M.3]C*Q\#_P#!PII?[=-AX!NO^"E.I?M)S-^RLWCG21=_&^[TJ\&C1_"9_@!=
MO9W&K0Z>\Q4:F?"\R0-IABCOLZ?]E4_L5_P5&TGX-ZC_ ,%T/^"-</[,?_"'
MVO[7T?C_ %#4OC9=_#B.T:\M_@)9Q&>RN_BN_A0-$;%M.368],'B-6>71I'B
MMD;3I4B;]\/VS8/V-?@=X"^(/[=G[2'P7^#_ (DU']FWP)K/C;2_B3XO^'_A
MC5OB!I":+"3H.@>%/%%[I%SKFGZMKNL2:=HVF-83[HKJ^1@@4.P/U^\#\$_C
MM>?%W]O=_P#@E]_P1F\3W.JOJ0^!?P3_ &J/^"HFMJ]Q)?:+\*? F@Z+J7@S
MX3>)[HJ7M]<^)6M_83JND7]PMQJ.F21RJ%N=/D1?ZL]-TC3]$TO2]&T33[/2
M]#T?3K/2-$TS34C2QTW1M)M8+#3[*TCB)CBM;&UA@M54$;-@5@"1G^%_XHZ7
M^U3\'/V$/A]^U+XV\<^+_@=^U5_P70_;Y^#^F_'[XP^%;W_A'/B-\#/V6_&V
MM"+X<?"KPEK[V=O=^#?*\)7-M>.L0B6TFN)((VCM99V;]5_^";]A\0/V,O\
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M63]ESQ[H7Q-^ \>F>(O$W@^Q\ >,_#4>GQZ)J5OIGA+5]&L-;L--CTC388-
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MW:6=Q!J=Y)+_ $Q?LZ_LZ_!3]DWX/^#?@)^SS\/]&^&/PG\!6D]KX9\)Z/\
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MJWCG4Q=>-?BAI=@EHM[)\0?$&D06'A;^U;B[ECTW0;-K6PAB:ZN)'^L**+(
M_P \=/PS6_H'_'ZY];>4_P#D2&L"M_P__P ?C#TMY1_Y%AH?ZH#L:***8'E]
M%%%8<TN[_KY %%%%'-+N_P"OD 4444U*5UJ]U^:&MUZK\T-#$/CCO]>1]:_E
MA_X*S9/[86OXQC_A!_ 9.>N/[%DR/3T_^MW_ *G/^6G^?[M?RQ_\%9?^3P=?
M_P"Q%\!_^F5Z_ICZ*G_)TZ3_ .I1FW_IFF?Q?].W_DQ[_P"RJRW_ -+9^9R]
M!]!_*EI%Z#Z#^5+7^FQ_B*MEZ+\D%%%% PHHHH **** "HI<;.<XR.G6I:8Z
M[U(SCI^E..DH^J_-$5$Y4YI:MQ:2\S].?^"29S^U[H7I_P (%X^'OD:3; ^V
M.*_J:5C\W3J5_#C]:_EB_P""2#@_M>Z*N#\O@/X@DGUQI5N2/R[^O&.]?U-C
M [_>.1U[_P"17^8OTJ[KQ2J)7YO[#RAVZV]EBG?TLTS_ &]^@C+F\"J$HNZE
MQ%FT4^\J<Z,:B7^%Q:?II<=1117\T\TN[_KY']G!1111S2[O^OD 4444<TN[
M_KY %%%%'-+N_P"OD 4Y?O+_ +P_G3:<IPR_[R_JP%:4G)U:2NW>I3T_[?B9
MU?X56V_LJO\ Z:JGX=^,B3XQ\5D_]#1XA'L,:U>\#V]*Y_.,=3\S=.O\5;_C
M'CQCXK_[&GQ#^NM7QKGP<DC^ZQ_7=7^EN1_\B3)_^Q;EW_J)AS_,+.],WS?_
M +&N8?\ J160X'/8CZC%![>Q_H1_6EHKUCR!.X/L?UQ_A03CL3].:6B@! <]
MB/J,4'M['^A']:6B@!.X/L?UQ_A2,<*>">#TY[&G4C=#]#0--)W>B5_R9&#N
MDQ@C/J..E?H!^Q+_ ,@KXAD'Y3J6@+@]<BVU-L\?4#K^%? /W9 3TZ\>@'_U
MJ^_OV)/^01\0O^PIH)_\E=3']*_)/&NZ\.\TZ6Q&7??]:F?K?@<FO$G*WT=+
M,K/O_LM+_(^Y:***_A/FEW?]?(_OP****.:7=_U\@"BBBCFEW?\ 7R ****.
M:7=_U\@"C) (]2O\Z*0]/Q7^8JE)N^K^&7_I+#MZK\SY0_;Q8C]B7]K4^G[/
MGQ1'_EJWV/UZU_GCU_H;_MXC/[$O[6H_ZM]^*/\ ZBM]7^>17]X_1!_Y$G&'
M_8RR[_U$K'\+_2SO_;O"O_8LQ?XUX!1117]B'\CA1110 4444 %%%% !2KP7
M/^Q_C24H&=_NA'\_\:'L_3]8B?\ G_Z14/[KO^"..1_P3E_9X'_3'XBG\_B?
MXOK].B<X]ABOS%_X(Y?\HYOV>/\ KA\1/T^)_B\']17Z<U_CWXAO_C.^,[/_
M )J+-?QS+&7/]</#Q_\ &!\']O\ 5W*?_4.B@HHHKXSFEW?]?(^Q"BBBCFEW
M?]?( HHHHYI=W_7R ****.:7=_U\@"BBJ-[J>F:9$)]5U+3M*MVE^SQW&J7]
MGIT$L^Q7$,<MY-#&\K*VX1JQDV@MMVD$U'VDY*$%*4I.RC%-MZ-]$^B>KT)G
M*,(2J3E&$(*\I3E&,8JZ5VY-+=I=]=B\,A@=S =059MR-E<%5SY;*%#Y1U.6
M<_, >/,OC1\'/AO^T-\*?B!\#OC'X;3QE\*_BIX8U/P;X^\*/J6KZ+%KOAS5
M[=[:_P!/_M+P_?Z5K-A]HBD93<Z;J-E>PX5K>ZC8$UU1\9>#0/F\9^#%[8_X
M2[PZ6!'4$#4N".X/3O2_\)AX-/\ S.?@W_PK?#H_0ZF#6OL,5H_85]=OW%7H
M_*EO?[_-&7UG#<W+]9P_-92M[>CL]G?VMM?4\S\(?LX?!'P1\ -%_97T/X;^
M'9/V>M!\ 0_"RP^%7B&.Z\8>&#\/H+%M.3POJ,/BJXU:YUS3VM',,S:Y<ZC<
MW"JLDT[S?O1^7G@+_@W9_P""/?PX^*5C\7/#_P"R!H5YKVD:RGB'0?#?BCQU
M\1O%WPZT768YC<"[M_A_XD\4ZGX6O8FG(E73-7TO4-%MC!:I::9!'!&J?L?_
M ,)CX-_Z'3P9_P"%=X<]O^HG[_YR,I_PF7@W_H<_!I^GBWPX1^?]IT>PQ3_Y
M<5__  357_N-#^LX?_H(P_\ X/H__+3YX_:J_8D_9>_;:\'^!? '[3_PKLOB
MAX-^&?CC2_B/X%T"3Q!XL\(6OA_QAHUC<:7IVIV\O@?7?#UY/!:Z;<RV<>E7
M=S/I7DN$>T<1)5G]K#]B_P#9?_;D^&B_"+]JSX.>%OC#X#MKZ+5M*L-;%_IV
MK^']6AB,,>H^&/%/AZ[TCQ+X9N_)/V>XGT35+.6]M"UK=O);LT;>_?\ "8^#
M?^AT\%CV/B_PX#^(_M(TH\8>#3_S.G@S\/%WAPC_ -.8_P @^V6Z&*7_ "XK
M?*C4?X*GH'UG#_\ 01A__!]'_P"6GP?^Q1_P2C_8(_X)ZZGKOB/]E/X Z)X
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M??ZQA]+?\OZ/5V7_ "][G19)Y/4\GKU[XR6./3)_+I17/#QAX.)P?&7@X-D
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M>CWWC2+5/AWX\\!G2K77KFXM-*DB/C70M%&H_:9[6=2NGFX:$)F8(&&?H?\
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M9MW275N*3\DVTI/RCS,<4Y1E)+W8WYI/2*L[:N3BDKZ)WLY>ZFWH+2$XR3T
M'.1R20  "<D\YZ8P*8Q)QLRV/O!#N(XR?NYR5Q\P&2H^8@ $CS?XD_%OX;_"
M'2'USXC^,=%\,6@C9K>.\NHY-0O7VDB/3M.A=[V\E(Y1+>"0R'Y5RQQ7-BL9
MA<!AZF,Q^-PV#PM&,IU:^)Q%&A2A&*N[U*E2$+I:\JDY]%!O0[LORS'YKB:.
M#RW!XK'8O$24*.%PF'KXBO4D[I*-*C2J5'M=OD44M92BO>/2PS ]..01@9P
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M_2X_YD5-*=5_].JO_IJJ?B+XSX\9^*U/7_A*/$'T_P"0S>USR\,?<G'X9/\
M6NA\9<^,O%>>?^*H\0?^GF]KG@.<_P"TWZ@_X5_I7D3_ .$3)^G_  F9>O7_
M &3#_I8_S SS7-\WMK_PK9A]WUFL_P A] .?4?7K0<]L=><^G^-)W'O_ #Z_
MT/Z5ZQY(OI[_ .!/]*.^/K^F/\:0]1^)_3']11W!]C^N/\* %H!SZCZ]:/\
M)I.X]_Y]?Z']* %]/?\ P)_I37Z$?YZC_&E/4?B?TQ_44C#(/L#_ #!_I0)I
MM-+=II?<QK<M_P !_GD?UR?;-??_ .Q)_P @CXA'_J)Z!^MIJ;?R8?CFO@ \
MN!Z8_P :^^_V*F9-*^(>#S_:?A_CJ/\ CUU(>W/'>OR3QKN_#W-.SQ&7V_\
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MJ.1]U^/^0%NOYM_^#I%%E_X)W?#M73<O_#6?PV!5B-AV_#[XK$-@ MO_ 'A
M8Y"A5( :OZ/?.?V_*OYP?^#HQV;_ ()V?#HG!S^UE\. ..W_  K_ .*>3[=1
M_AUS]-P=!?ZS9/&=W">+A&:24KQM)ZIJUKVMOJ?/\4OER#,9*"FU1NKS<.1\
MR]^ZUT[>9_ :+>$\>2BY^Z.3@=AN;<S8&!N)R>IZ@!1;Q]HTQ[#CDCT&._/T
M-29!('UZD]SQZ],@\^GUR%N3C('U/?/H<=_T'OG^J/84YVM3HTX1<XPB\/1<
MFN;XK\KTNOO/YU=?$MU.:K=7I\K5:JW;E>C]Y;/2Z?9:D)MHR<^6O/\ LCV]
M5/K^A]*<+6'',()]00OZ;>/?WI^X^I_,^_O_ )Q]<FX^I_,__7_S^K^JTOY*
M'SP]'_Y$GVM?_G])>E:LO_;R/[+%VA7'OM)_/C-+]G3_ )Y+^0I^X^K?G_GW
M_P CDW'U;\_\^_\ D<CPU+^3#KTP]&__ *2/VM=[UI/UK5O_ ),B-JA.?+7\
MD_J#3OLL/>$$]R&4#\MO%/W'U;\_\^_^1R;CZM^=+ZK2_DH/UP]'_P"1#VM?
M_G]+_P '5O\ Y,C^S1=H4Q[A2?SXS^5.\B':,1(>#_".,=_KU[\]P>E.W'U;
M\_K_ /6_7UX48ZGJ"=N>N?4X_P >Y^M5["@KJ5&E)-2BN3#T5JT[7]WJ]%Y]
MA2K5U"7[V4GS4[)UJVK4U_>^93N;: P7.$0;H7VC:-B$*%8J<;B9!NZ_ZMW+
M+O"A!_L/>"\?\(3X(QT_X0KPCCZ?\(YIGL/Y"O\ 'HN!BWF. -T4GX E3QCI
MWSZ_H/\ 8.\'2,G@SP4HQ@>"_"&,C_J6],K\6\6:4(1R.-.,8KDK[0A"[2BI
M? E>TM/+5K=GZIX:U)5*F:RDI7O!:U)SM:2T7-)VWWZ]SK:*J><_M^5'G/[?
ME7XQR/NOQ_R/U@MT54\Y_;\J/.?V_*CD?=?C_D!;HJIYS^WY4><_M^5'(^Z_
M'_("W7?Z3_R#;3_KE_[,U>:^<_M^5>DZ.=VF69]81_Z$U5&+BW>P&E1115@%
M%%% !1110 4444 %%%% !7-^)!^YM.G$[_7_ %3=*Z2N8\3ML@M#U_?N/SB:
MD]4T!RWX$^P&2?8#N?052U+4]-T;3-2UK6-2LM&T?1;&\U76M9U*YBLM-T72
M]/M9KV_U34KZ=EM[.QL+2VN+J[N97$=O# \DA %.$SDX_D.?P]_2OYA?^#@;
M]N_PUX0\6_ ;_@G)XQ\4_$KX-?!+]H:.V\<?MB_'KP!\.?&_C76+']GW2=4E
M\[X.>![7P9I>IZJWB3XHWFF2Z;X@U.T(CT;1)84N'D%S<6TT*'?\^GW ?=/_
M  3&_P""PO@?_@IY\>OVT/AW\)OA[;Z#\'/V8=5\,V?@#XO7'B.[DU+XQ:/K
MU_JNG7GB>]\,W&EV%IX:T.631WOM!EAUC57O-,DBNIQ:/(47Y?\ %7_!;[]I
M/Q+9_M#?M _LF?\ !./5_P!I'_@GW^S'XSU[P=\2/VD+;XT:3X+\?^,[;X?2
MF/XF>+?@O\(-1TU[GQOX8\(Q1SWHO5U2'S8+74/[2-A]ANW7\M?^"6O[:_[&
M$_\ P4,_X*I?"']F@^*_#7A;]I;X*^"?AI^QQX8L?@YX\\+:?%%\+?@IXNMU
MT_6+>\T&W_X5^]D]HLEC<>+8-(;6KMGGM6DNITB;]0?^"'%SX9MO^#>^S:_D
MM!I>F_#[]M6V\?RS/#Y"ZA:ZG\1'\:G4?-*H)F9+J:Y6Z&71I'F^0 FP/WD^
M GQN^'7[2WP1^%G[0/PHU,:U\-OC#X(T+Q]X1OI%*7/]CZ]:1W2V]];.2]IJ
M-E(TEIJ-B[;K:[AFBD(4;C^8O[4'_!3KX]Z#^UUKO[#W_!/S]C[3_P!M7X\_
M"GX>Z5\3_P!HF;Q+\8M,^"/P_P#A'H_B5/-\'>%]0\7ZGIVI0:A\0O$MH(+W
M3]",$*-8WBR12S-:7L</'_\ !MU;ZY%_P1P_92&J0W0$EQ\6;K1O/CF+KX4N
M_B?XCG\,R1*0I%F=&$!MF'^CRP!1&=C<>1_\$E[=;#_@K'_P7RM-5D5_&<_Q
MY^!>HDR?\?Z> =2\.^(+CP6H,NZ;[*L;W@L8SFV"EV@5 5RN_7^OO^Y >GV7
M_!<KX=WG_!.#XX?MMM\#?&6B_&C]G[XG1?LX?$O]D?Q#J<.G>,O#O[3]SXGT
M7P3IOPZU#7H(I88?#M[J^OV.J'Q&MB]Q'HINRUA)J=I-8CVG]BO_ (*(_&3X
ME?&G]H[]EW]NGX%>!/V6_CY^SE\,O!GQ]U.;X?\ Q27XE_"GQ'\$/&=CJ%V_
MB>U\57-AHYTG4/!EW93Z1XBLKN&2S#+'<6EU*3>"'\@/V7/V/_ G[?7[0/\
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M_:*\4?\ !5/]H;X9?%/]L#5OA#\&8/A?\/?V3+7P+X?^+?AG3AJVI>3<:]X
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M4/"6E'6_%,6AZ?"LDTT?A_2E-[JEPX2"UB,8>3=(@/K/((#*5/.1P0"" 5#
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MX'\4V]MXF=+2\^'.HVLR:-XLM-/+W%K!;ZC.YF>6TBG^F/V$K[P;_P $M?\
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M6G:)96]C;;4 7S66.+=)=N PEN;AKF60,VYR2370^9QT '(51R%'IN)R1GD
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M$%N/AYK-QIOA2SU/4)#!HO@G0;B.,:/X:TNUM[6!E1Y9+B6*)X_KK4O!-_\
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MC9?BG9V]E=:EJGB*;4[;4M$ET586DMK2RTZ]@OF8"=X1T^$/VR/!&I?MQ_\
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M#[USGG/[?E70^&\_VA+GDB";_P!&19QZ9-.,>5Z]>WW?J!W5%%%: >/T444
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M^//L@HHHH **** "BBB@ K^</_@Z*_Y1V?#G_L[+X=?^J_\ BC7]'E?SA_\
M!T5_RCL^'/\ V=E\.O\ U /BE7TG"'_)2Y.N^,A^4F?/\5?\D]FO_8,__2D?
MP*+U'U'\Z2E'KZ<_7!'^-)7]5K51:Z<Z?KS7_4_G#O\ ]N_DPHHHIB"BBB@
MHHHH *7L/J?Y+24O8?4_R6FNG^*'YL3V7^.G_P"EC+K_ (]I?^N+?R6O]@KP
MA_R)O@O_ +$OPA_ZC>EU_CZW/_'M)_UQ;^2U_L%>$/\ D3?!?_8E^$/_ %&]
M+K\5\6]LC_PXS_TN)^K^&7QYM_BC_P"E1.@HHHK\8/UH**** "BBB@ KTS1?
M^059?]<1_P"A-7F=>F:+_P @JR_ZXC_T)J -2BBB@ HHHH **** "BBB@ HH
MHH *Y7Q5_P >UI_U\-_Z*:NJKE?%7_'M:?\ 7PW_ **:@#B?\\$@_F,$?4$'
MTJM<V&G7K![W3-.OG"[!)>V5K=2)& HV(]Q!+(B.02\2R"/OAB239HI6Z@?!
M/[._[ _@W]G;]LG]LO\ ;'T;QWJWB37_ -L>X^'ESJ_@._\ "V@Z3H?PVD^'
MUC-90#PUK=A/-J>KKK F+WPU"UL@@&Q1(I-?F_X\_P"""VK2W/QS^&?[/O\
MP4._:+_9I_8O_:=\:Z_XX^-W[(_@WPEX+U_P[=7GC"6*?QSHGP^\;ZQ.FO\
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M^R_HGBK_ (6]^W3\0[3X!7?Q)T32[R?1_@9\&M8B2^^.7Q:U[58A%::0=.\
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MAF'6O/\ 6/C=\&O#XD;6?BGX$L1$2)=WB/3KAD*@%U*VDTY+(&!8+N&#PQ/
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M ()+(5_:\T8D_?\  /Q (^K:1;\'Z;NM?U'C#8/.%QCUS[_I^M?YD?2KDO\
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M?P+C[I_'^:4VE'IZ]/J2.OY4E?U=%6C9]93:]+[G\X=)>L7^ 44450@HHHH
M**** "E[#ZG^2TE+V'U/\EIKI_BA^;$]E_CI_P#I8RXYM9CGI%)@>I[#VZ8K
M_8)\'G/@SP5_V)?A#]/#FF5_C[77_'M+_P!<6_DM?[!'@[_D3/!7_8E^$?\
MU'-,K\3\7M(Y&U_+B]?^WU?^O(_5_#+XLV_QQ_.!TFYAW_0?X4WK117XGS2[
MO^OD?K04444<TN[_ *^0#MS#O^@_PIO6BBCFEW?]?( KTO0SG2;$^L/_ +.P
MKS2O2]#&-)L1Z0_^SL:N#;;N[Z?J!JT445H 4444 %%%% !1110 4444 %<I
MXK.(++WN'_2)C75URGBL9M[,^EP_ZQ-2>B8'&;V]?T'^%-HZU\C?MF?MR_LW
M_L#_  LL_BY^TGXRO?#>A:YK]KX2\&>'?#FBW7BSQ_\ $3Q?>*'MO"O@'PAI
MKK>>(];>)DF>WAGAAMXG1KJ>!I(5ER3D]FP/KFCI7Y[?L6?\%/\ ]E#]O'Q)
MXX^'_P &]3^)7A#XN?#>SL=5\9_!+X[_  TUSX/_ !>TK0-3$8L/$D7@W7Y)
MYM2\/SO+%&VH6%U/]G>6$W$4<<L<C?.OQI_X+R?\$\_@1\7O'OPC\7>(?C7K
M\7PD\6V/@/XQ?&+X<?!'Q3X\_9^^$7B^]NX+(Z#\0?BOH\ITK1[S3[FYAAU3
M[/:7T5I(717G9,%^_P"?X ?LKN8]_P!!_A3:P_#GB;P]XP\.:#XO\)ZQI_B3
MPMXIT>P\1>&O$.BW4-_H^OZ!JULE[I6L:5>PNT=W9:C:R1S6LJ<2!MO#*P'Y
MZ_ME?\%7/V2_V'?B+X5^#GQ0/QB^(GQD\6^%KOQW:_";]G7X3:Y\:O'VB^ K
M*Y:SN?&WBK0_#]S:OX?\.K<QSHEU=RF:5;>29;<0M#)*>_Y_>@/TFHZ5^?MK
M_P %1/V)M1_8AUW_ (*':3\78]7_ &8/#>F376M>(=/T:]D\7:?KL6J6N@+\
M/[GP3*8-5@^(MQXDOK'P_;>%9I([B?4+RV=+@V$R7C2_L2_\%(/@'^W7J7Q+
M\)?#WP_\8/A3\4_A!#X8U'XA_!O]H/X=W_PM^)>A>'/&UI+J'A#Q@F@:A<W9
MO_"NOV<$[V^J6\V;:>&2WO8(&:W><]_S_ #[_P!S'O\ H/\ "FU\I_LG?M@_
M"_\ ;.\-_$WQQ\&M/\62^ ?AQ\8O''P5M?&_B#2H].\/_$;7OAU?1Z3XH\2_
M#FYBN+G_ (2'P-%K#3Z5IOB1?*M]3N[&^6!%6V<CZLI-R6[8!2@D'(I**7-+
MN_Z^0"M(P4DY/'0 ?Y ]3V'-4=2U+3]&L+_5M9O['2-(TNRN=2U+5M3O;:PT
MS3M-L87N;[4-1OKR6"UL;*TMT>>:YN98X5B4R,ZJ,U<(R, $^P4,3_P$D _0
MD5\L_MJ_LL:/^VS^S#\5OV6?$?Q#\;_"KPQ\7]$M= \4>+OARNF/XK@T"/5;
M34+S1[1]8BFL$M-<6TCL=3AE1]]D\D(RCNK7%MJ[;WW[;>7R^?D!Y)\*?^"K
M?_!-OXY_%:#X'?"+]M3X#>//BS>7USI>F^"](\47-O>ZOJ=G(\5Q8:+J.KZ9
MINAZS=K(ICBM]*U2\FNI/DM$G8J&]$_:1_X* ?L4_L<^(O#GA/\ :G_:;^%'
MP&\3>+]%N/$?A;1/B%K=SIM_KF@VFH2Z3<ZK916VGWH-K#J<%Q8MYS12&>"4
M*A5"P_G7_P""QWPA_9,?PS^Q%_P23_8H^#OP\U']NVP^*7P2UKX:7OPN\'^'
MM.\:?LU_#/X975G>>+/BK\2?%?A^SBN_#IU^QM9+^:TUN]\V_E:ZU&ZC1IM/
M-QF?M<^"OVP?&7_!;;XB^,O ?_!.2']O30OA!^Q;\+_@_P""=5^-DFF>"OV?
M[75]7@M_$?Q%\8C7_%.E7]AKFMWNO"\T?1K+0%DU&SOI]1FO/LL-P)UK?J_O
M_P" !_33^S=^V+^RY^V)H?B7Q+^RU\>/A[\>/#_@_5K70?$^K_#W4[C4[+0]
M8O+)-0M].U&6XLK/R;F:SDCGB5!*KQNIW!@RKF_M+?MM?LD?L;6_@^Z_:J_:
M$^&OP$M_B#-J\'@B7XB:M=:8OB>3P_%ITVN+I?V:PO?,.E)K&E&\\WR1&;^W
M&27Q7PU_P2,_:\^"7[1GASX^?##PS^R1I/["W[27[/'CZS\(_M0_LTV&D^';
M!M%\1RP/;Z+XIL=4\.6=E::[H.L?8[K3K&\F22YMY+&6"WNKZR^S7DWZ6_%/
MX+? OXNV>GS_ !O^%GPS^)&F^$8M3O\ 3IOB5X7T+Q/9^&(;F*"76[ZPDUVV
MGCTJ.Z@LH9-3G+11NEG;^:?+ME(.^_YO;^OSV ^3/A3_ ,%:?^"9OQS^(/A;
MX4?![]MSX#?$7XD^-]271_"'@KPSXBU&[UWQ%JK6\]TFGZ;;2Z/!')<M!:W$
MH1Y8QLB9B1P#U6H?\%+_ -@K1_VFH_V.=3_:D^&%C^TJ^MVOA9OA=-?:C_:$
M'C"^@%S9>";G6ETUO#%OXSO+<F2U\-3ZU'J4S@6JQ"^9;4_AY_P1\^ /P:_;
MG_;6^/G_  5QA^"GP_\ AS\&OA3XU\1_LS_\$]_ ?A'P1H_A71K;PUX&FO-*
M\;_'[48=+M+>WU7Q?XIO=1U32]/U&?,FA23:_I,8,%O9,GRMX_\ V(OVQ+:Z
M^._[#4_[&OB3?\2_^"LEO^WEIW_!1ZXU/P-:_"OPE^S^OC+1?B#J7C+6?$]U
M=KXYT_X@>&=&TBZT!O#,20VJW=PUO;O$@>[D.N[Z=?7R _KF\??M&?!OX9?%
M;X.? WQOXXL-(^+7[0%SXKM_A%X$2"[O]<\8IX&TM-:\77UO#902I8:9H&G.
MD]_J.I26EJK/'!%)+<2+$?: 00>"""!@C'=U8C)SA77:./F#!A\N:_EY_9L_
M;A_9'O?VG_B__P %;/VWOV@OAY\#_ _Q<N-;_9&_X)HZ-\1;S4H+JX_9L^%'
MB(V7Q,^,6AZ58:9J>IZ>GQJ^)"7%_-K=]8V45AX?TNTLFU22QN$9/Z;] \0:
M%XKT31O$_AC6-,\1>&O$>F6.N>'_ !#HU[;ZII.MZ1J=I#>Z9JFEZG:23VNH
M:;>Z?<P75M=V\[Q213PE2WF A\LG>SV6[DHQ32[RLOQN&G=7[-J_R5[M>9L4
MH)'2FEN<#D^G3MGK@TF3NQE0,]R1QSSGG./0#D^E1%3G?E::5[M23BK=Y?"O
MFUW#;5M13VE-J$9/>T93<5*5M>6+<K="0L3P3^@IM(N68  X/?VYP0"1G.#[
MY/MR@)()P21MRJ_,=S?PX7G<!SR ,9Y&*:C5=[*6FNVC7\T6TE*/:47)/HPZ
MI;N7PI:N7=12NY-:723<4TY))W'9Q^/'?GOV^F:-Y!/& .2V.!S@''3J0,\9
M.*\R^(/QD^%GPKMI;GXA^/?"_A98?*,EMJ&IQ/J.V;F%DTJT%QJ;K(055_L:
MQLW&_ )K\_\ XD?\%2/AWILL^C_"+P/X@^(6L2++%9W^JJVB:.UR)1'$T>GV
MXNM:U&TE.&6:S,$Z[@IAW';7QV>^(/!_#$6L\XBP.%JK^'E]&I'%9I4J-M14
M,#0C7Q#YY1Y8-T4G)-=[?>\,^%_'W&<H4\AX6S+,,'=SGC*E)X++:"24IU:N
M8XEX7#*,%9R2Q$N5)MI'Z>:WK=AH&CZMKNKS_8]+T+3+_5M4NRK?Z-8:;:RW
M=W/A1N#PV\3S*H!>0J$53N(K\@=+_P""L2W'Q%-MJ?PMM;7X7S:DMK#?V>L7
M$GBZUL'NEA@UN[A=/[,N)$MB=0EL;94,\2I;6V)I3CF[G4/^"BO[5-M=V-MI
MO_"KOA]JAOK>YMI($\(Z5/93P!;K3]1NKR.YU[6;:ZBE,4;W%O%Y@9@'5<DV
M/"W_  2<UI=7TT^,OBYHJ: MO'/JUEX;\/7JZXDY1D>SL+W4;E[+RD=(]MW+
M$Y-L1Y*QR ,?Q3BKCCQ7XOS#)7X59'G>6Y10QD*F98W/,MPF >9P5O8^QP^,
MKX>M# *+:KUE152I&HG2C)P:C_1'!7AYX)\#9=GT?&KBK),?GF)P2H97@>%\
MQQ^;U,GI2A4EB(UJV H5L%/-U5C3CAJ%3$SHTW&<*SCSJ4OT9U3]L7]F'18H
MY;WXT>"(VF ,=M;W%Y<7K,ZQR2*;:WLY1"Z^:LDB/(J;CM5V9<5YCK7_  46
M_97T8S>7XQUG6O*&XMH/AJ_O5D!;;^Y,S6QD!.6)(79&K,3D;&Y?1O\ @F7^
MS!IRI_:%CXWUN9'67SI_%MYIZ,RNS!);:QC6&6-E(1U?DC(X 2O4M&_86_94
MT6-(T^$6BZH$D,N_7[J_UB5RQ9O+EDN)U:2"(D-;Q'A".2PXK[J-;QVQ48QJ
M4N ,H@XQ4FJN8XZK&5ESR>&5.G33DVY<L:UKMKJC\ZKP^C9A'*<,=XLY[7U<
M83PF09/A'%.?LXPJT:E9\J@H+VE3#^T;;<DTD?/VJ_\ !5?X"V.TZ7X7\=ZN
M=Q&9+:QT=05\S(_TMY-_"K@\ B4L<>60?.]0_P""K+:G&8O _P !?$5]<23Q
M_9_[6U==00PB11,=N@6LDLDF[;'&T:E8W.6  K](=&^ OP3\/[O['^$_@.P+
M\.8_#]C,74E"QS<QS;69HHV8K@_( ."5/H%IX;\.V!C-CX=\.Z>8]I5K#0M*
MM65P0Y*>3:1[ 7!& >5()RZ@TO\ 5OQ@QEXXSQ(R/ T)/6AEG!].,X-VYI1Q
M5?&SD[[ZTWRM=27QGX#X%+ZEX4\1YE6C%_O<UXVG]6G=WCS87#8*G[RLE-PG
M'1Z-GX]K_P % ?VM/$\C)X1_9UBMUDEBMK5AX?\ &-\%>2=EAW-J5I:VLCR
MGS90YC1U#JPP!5U?BY_P5,\5NPTKX80^'K>,",RCP9H-D)64LK.+V[U.2<)B
M4,(1"L<>PNIW%@?V24LBA$)1. 8D)6(*-W C7:,Y=G!X(<*>F149#]SOQP.2
MG ''"Y!8G&XG((]#1_Q#/B3$:9EXK<8M3O[2.3/+\L4MK*3EA:S4?*/*[:<V
MA,/&#@[ I+)_!#P^ISIN]*IG4LVS?EWM)J6+I7J);N49Q;UY6KGXU/\ #7_@
MJ3XN?9J/Q 3PO;W!\V9QXKT;2#!'(-K(MO!IER91&&W&!)0W&X/P 8Y?V%?V
MR_&.ZZ\:?M'0V%Q<M )T;Q%XFO$819*B0:+<Z>JF+Y0Q@ 9RP(& 17[-;<E&
M/#(<@J2"1CH<Y!!Z$$=.^:,JH)(0 @YR-VYL8#%F/#DX)VX+$ >]./@IPY6:
M_M//^-,W>TWBN*<PA&I_BHX:>'A&ZO=P:YFVU:RL+Z0W$^&E4>3\,^'^0RE;
MD67\#Y/B8T[*VE7&PJU'T:=13Y;+1]?Q_M/^"6NM:IN3QU^T+KVI$#]TEC8W
M]ZH21@+H.FO7MQA'&1"492^!YX>N_P!!_P""4WP/TX@ZUXU\>>(P'=MJ)H^A
M H6R(MVG0N1A3M!!!&,\U]\>-OC#\+_ASXE^&/@OQWXXT/PUXN^-/BJY\$_"
M?PSJ,\QUGQYXJL-,DUB^T;P_9V<-U+-)9:7!+?WUS<_9M.L;=-UW>0NT:O/X
MT^+'PQ^'.N_#KPOX]\=^&_"'B3XO>*6\$?"W0-;U.*SU7Q]XN2RDU&70?"]B
M0\^IWL-C#)<SF)/(MT4+/-'(Z(WHX?P5\-<,U-<.4L;._P#$S3%9CF5277WU
MB\?5A)*UDG%I+2UM#S<7](;Q?Q:M_K?6R];*CDN793E>'2?6$<'EM*49/>7+
M*/O7U>Z^5M'_ ."</[*^DB$R>%O$NKRQL&9M7\6WUW'(0IC*M;".*/R60EFB
M#@-*0Y;M7":=_P $P_@?IOQ#M/%D?B'Q=/X5L=0M]3@^'UU):7-B]S:RB>&T
MN=;>,ZA/I9E2-IK-DS- );-V\IV8_HIK&L:3X?T;5]?UW4['1M!\/Z7>ZYKF
MLZC=1VFF:/HVEVDM_J.J:G>SF."RL;"RAEN[NXF=5AMXGDD*@#.!\//B!X'^
M+/@CPM\2?AAXJT;QUX \<:3;Z_X1\7>&[EKW1O$6BW+O'#JFD7)CC:ZM)7CD
M".(P6"NZJ5"EO2EX5>'-26%G/@W)*4\%B(8S"RPF!P^'A#%4FG3E7I)2C55T
MG[SEKJTWOX]+QM\6J<<9&7B'Q15^OT*F"J^WQ]3%*.$K*2K4Z2J13PLI\TN2
MO1?M*2=J3AJCL81'!&EO##'#;V\<<-M#& D=M#&HC2*)>5$0"X1" $7"KD=5
M\X\X"KT&5W %1T!4@@$<DX&#P.PKYDU?]LW]DSPYX%^(OQ.\2_M%_"7PW\._
MA)\0-9^$_P 1?&?B+Q3;Z'X>\+_$SP\XCUOP/+J&JQVD6J>(M.DR+BQT$:HQ
MV2E"X@G\KTSX2?&KX/?M ^"[/XC? OXG^!?B]X#OIY;:V\6?#SQ'IOB?23=0
M*C3V5Q/ILTWV*_A66*673[X6UZD$B3M (G1F_0*<5"*ITE##Q@K:<K322M"/
M+"*C"*2C"*2459*]C\O<X2Q'M9_6JTFY/VF)J^UESMMNI)MOFYY-RYN5.5[M
M)MGJ!8L>>HQQZ9&>N![^M%><S?%WX76WQ5LO@7-X^\+1_&?4O!%[\2;3X8-J
MD)\93^ --U.TT6^\9KHZ[KB/PY!JU_96 U"<0B:XF*012>5*0W0_C!\+_$WQ
M)\=_!W0/'&@ZG\5/ACI?AC7/'W@&*XEB\1^%]%\9PW,_A;6;^TN((DGTC6H[
M*\^S:GITM]91S6\EK=S6]X#;JI.;=_RM9V25UIL]R;R;;D^9MO7ROI^!Z12@
MD=#3 V>H(("D@XS\RAOQ&"!D<$@@$X-.J.:2ZL!22>II***7-+N_Z^0!2AB.
MA_E244<TN[_KY *23U-)111S2[O^OD 4H8CH?Y4E%'-+N_Z^0"DD]:2BBCFE
MW?\ 7R *4,1T/\J2BCFEW?\ 7R 4DGK2444<TN[_ *^0!3@Q' /Z"FT4<TN[
M_KY *23UI***.:7=_P!?( IP8C@']!3:*.:7=_U\@%)).32444<TN[_KY %.
M#$< _H*;11S2[O\ KY *22<FDHHHYI=W_7R *=N8=_T'^%-HHYI=W_7R 4DD
MY-)111S2[O\ KY %.W,._P"@_P *;11S2[O^OD I))R:2BBCFEW?]?( IVYA
MW_0?X4VBCFEW?]?( ZT444<TN[_KY %.W,._Z#_"FT4<TN[_ *^0!UHHHHYI
M=W_7R *=O;U_0?X4VBCFEW?]?( ZT444<TN[_KY %='X9;.HR ]3;3-G_MI#
MG^=<Y70^&?\ D)-_UZ3?^C8*J+N]7Z>H'?T445J!X_15?S_]C_Q[_P"QH\__
M &/_ ![_ .QK'DEV_% 6**K^?_L?^/?_ &-'G_['_CW_ -C1R2[?B@+%%5_/
M_P!C_P >_P#L://_ -C_ ,>_^QIJ,KK3JNJ[H:W7JOS1(1ER/48_\=K^6_\
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MDEV_% 6**K^?_L?^/?\ V-'G_P"Q_P"/?_8T<DNWXH"Q3D^^O^\O\Q57S_\
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M7J_^Y_4TE*O5C_L?X_XT/9^E_P 8B?\ G_Z14/[HO^".W_*.G]GG_KA\1/\
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MM<G-M./[L1'URH-?[ 7@^;'@WP4-O_,E^$/XO^I<TSVK\4\7E>.1I?RXI_\
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MB@LC>6UL\:W[V%M).DTL:N/M/PM^R_\ M/\ [&'[/W[!_P"RU_P3ZF^#%_\
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M+1[R:S<W?]6IN,DG9U)/WO4_2HDFVK:Z>7<">BJ_G_['_CW_ -C1Y_\ L?\
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MMF]UOW_/^MP/SC_9"_9 US]D+_@X?\/Z;X]_:!^)?[3WQ@^+_P#P2O\ B?\
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M\>_^QHY)=OQ0%BBJ_G_['_CW_P!C1Y_^Q_X]_P#8T<DNWXH"Q15?S_\ 8_\
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MO_L:.27;\4!8HJOY_P#L?^/?_8T>?_L?^/?_ &-')+M^* L457\__8_\>_\
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M-53\6O&(QXQ\5#T\4>(!_P"5F]KGE.&/NQ'TQS_6N@\8'=XP\5'IGQ1X@_\
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M6$#F*81/>7]S;6IN&AE2U65KB2*1(64_E;\+_P#@J9JE_P"-EM/BWX(T/0_
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M$KEE<L <H'\Q=^ -FXD[,FDHI60#PYW;S][*G<  ?E! ]CU/4<C@\4F[&=H
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MZ<?M?:V_IX'\ <?[V@,.OMGTYK^H,G$GX@?F,5_+Y_P5=&?VN]<_[$7P ?\
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M&?;/I_.L$<DC^Z3^N[-?Z49)KDN46_Z%N7_AA,/<_P P,Z:6;YLGUS7,;?\
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M_J98'_U&K'\+_2S_ .1_PM_V*\7_ .GX?YA1117]@G\D!1110 4444 %%%%
M!2KU?_<_J:2E7J_^Y_4T/9^GZQ$_\_\ TBH?W,?\$?"/^'=?[/2]Q%\1!]0/
MB?XO&?\ ZU?I?7YG?\$?/^4=W[/G_7+XB_\ JT/%]?IC7^0'B'_R7O&*_P"J
M@S1_?F&+_P C_6_P[_Y(/@__ +)S*?\ U#I!1117QQ]D%%%% !1110 4444
M%?SD?\'01!_X)X?#Q?3]K#X;D]^#X!^*?;_ZXS7]&]?SC?\ !T$1_P .\OAZ
M,?\ -U_PW).>W_" _%/CI_C7TO!__)39/YXN-O7ED?/\5?\ )/9K_P!@S_\
M2D?P1'_6-_UT;_T,TVG'[SL.SO\ F'_KG/Z4VOZJ6J373G3]>:_Y,_G#O_VZ
MOP84444Q!1110 4444 %+V'U/\EI*7L/J?Y+373_ !0_-B>R_P =/_TLCN3F
MWG']V(CZY4'\*_U^_")SX.\&'_J3/"/_ *CFF5_D!W'_ ![W/_7,?^@"O]?O
MPA_R)O@O_L3/"/\ ZCFF5^+>+=K9)Z8K\9*_XGZMX8MN>;=N>/X2B=#1117X
MN?K84444 %%%% !7K.@_\@?3_P#K@/\ T)J\FKUG0?\ D#Z?_P!<!_Z$U &O
M1110 4444 %%%% !1110 4444 %<=XQ_X];+_KY?_P!$M78UQWC'_CULO^OE
M_P#T2U ' ?YX&3^7?Z4QI8HU=I)8XHXD$DLTLD<,$*,0 TTLSQB,!CL9F&Q&
MPKNI-/X[YQWQR<=\#!R?P/T-?E9_P4D_87^,/[?6M?LS?"6+XOO\._V.M%^(
M&H^*?VP_ 7AGQ7XJ\'?$;XX>&8;()X:\ Z%JOAO3[A$T(7J&;6K&]U?2'N$N
M[B6'S9[>R>% ?J9;W5K=Q":UNK:\BRJO)97%O>1Q,P9E61[>5T5F",47=N(!
M+*E-:\LTE2VEO;&*ZE"F"UEO;6&YN59 X>WMIYHKF1"#D,85##&W<2!7\DGP
M[^&GP3_X)O?\%M/"?P-_X)Q7WC#3O@3:?LD?&'XO?M]?L]VWQ%\7^/\ X7?#
M>7PAI&I:]X%U1IO%.K>()O#?CO4[73]-2"SNM3FU**+462-[;[1-8IY7^R=_
MP3J\!_\ !4+_ ()Z_'O_ (*B?M'>+/BO?_MX?&[4_P!H?XH_ OXQ>%_B;X[\
M+3_L[V7PKO\ 7#\(_"OPS\.Z)K]EX;L/#1;0+0ZAIT^E7SV]K?W"Z?+:W$-M
M-$:]_P#/T _LX)P2""&!"A2/F9RS *%SN!.UL;@,E67J &AGNK.T4/>WEI9(
M^WRGO+JUM$D+,0J[KJ:':YRHV<L6;:H;@M^:7_!'3]J/QK^V1_P38_9:^/'Q
M)NWU3XFZSX1U+P;\0M=DV&7Q'XO^'6O7W@KQ!X@N%A2*!9];O-(^V7,*Q8BN
M6?=E6)/Y,Z3^SQ\-/^"R_P#P5<_X*$>%OVRH/%GCK]F;_@G];_#OX!_ ?X':
M-XY\9>"?"W_"P_%-IJ6I_$#XGZZW@G6=#OM1\8VNHVA'A^_FO/(CL;RWLKFV
MN(]*LBIK_7]?\$#^I9Y8HXS+))&D(C,IG:6(6XC5#(\IN/,\D0QQ O)(7P!@
M@,#FJ&DZSI&OVPO=!U73=<L6EF@6^T>_L]4LVEMVV3Q"XT^>YB$D+!A*F[Y.
M"Q +%/XA_$/C+]I;PA_P38_X+/?\$\M!\=?%WXIZ%^P5^U#\-_!WA_Q99:KJ
MVO?&)OV&_'OCG0M6\0^#3K%M&=9U;_A'/ ND>(DU.>.3(\,7M[I-O -,M8(D
M]-_94_:U_9E_8=\?_P#!3G]H[_@GSH6OZG^P)H7P#_9P\,?!_P "6UOX^A\#
M_$K_ (* >,8)O#OAKP7\+;+QJLNMW6NZN;O0K?XCR:#')+:^6;O5Q)]GA!-?
M7M_P0/[*K'6]&U2?4+;2]6T[4KC2;G[#JMO87UI=W&E7X".UCJ<%O/))8WBP
MR13-;3 3)&ZF1$#*6TZ_.G_@EY^RIJ/[(W[+&@^#_B)X@TWQ7^TK\5M>UW]H
M+]JWQ.FI6E]K/B'X\_%:YA\0^,A<PP7,LD&E^$VFL_!^B>7;6UB-)T&WG@AC
M-T2GZ+4)WN 4444P"BBB@ HH/^<D ?B20 /4D@#O7B'_  TA\$Q\8?''P%;Q
M_I*?%#X8?#'3/C)\3-$=;A-/^'GPXUJ>]BT?Q%XT\1O"OA_PVNJ1:=?7UEI^
MJZC:ZE/IMK+J*6ALPDS@'M_XD=>00#R/4@CZ\<CBG[\AL@98CD8  R6(( Y)
M=BV<CTQ7PW^S_P#\%*_V"_VI_B%J/PF_9^_:I^$/Q/\ B38+>R0>#] \1QKJ
MWB&VTL ZIJ/@Y+Z.UC\8:5INY3?:AX<?48+565[@QJRD^_\ Q!^/WPE^%GQ!
M^"WPK\=>+8-$^('[1'B+Q-X5^#?AHV5_>WGC/6O!OAR;Q=XHBA:RMIX=-M-%
M\/0MJ%[J.IO:V,0:*W,WVF6*)T[?,#V*BO@GP#_P5'_X)Z?%'XX2?LX> /VN
M?@QXI^,G]LWGARP\):9XIMW77?$>G^>+[P[X:UN14T/Q)KUD;2\%WI.AZA?W
MEN;:57CW*P'7?M)?\%"/V*?V/?%'A[P5^T[^T=\-_@MXK\5Z&WB;PYX?\::M
M]BU75O#@OY]+&MVMG%'/*=-;4;2\LQ<L%3[1:RQDY RP/LBBOBW2O^"B/[&&
MO? #4OVJ/#OQZ\)^)?V>M%\;:5\/->^*_AR/5-<\*^'O%FM:MHVB6%EK]YIU
MA.='L5U/Q#H\&HZU?+%I&DQWJ7.I7EO;I+(GV?'(DL<<T;I)#-%%-#+$WFQR
MQ3(LD<L<J Q/#*C;H95<I,@WQEE="5?_ " ?1113 */\GW'<<@]O48SC((R"
M44 <+X@^&'PY\5^-? 7Q*\2^"?#>M?$/X6_V^OPY\::AI5I<^(O!47BBUCL/
M$5OX=U26)KO3;;7;*&*#5K2"5;2]*+(\ 95V]X6;#C/W@,K\Q0MDY+J6_>!L
MG*N2.3G(( ;12L@';L  #(4':KDLH.&"D8P5PI"':1\JKL\LC)-Q^7H0K%QD
M+N#$Y&&V]%^ZJD% I;"[SO#:*+(!P8#/RCG!88!#$$MN8L&<DMM)&\ !5"A<
M9I2Y/\3C#!DPP^4A40D*RLF2L:YPH4E58J6&2RBBR =N&TKM49'\("8;).Y2
MH#*=Q+95@P8DHRYQ7 ^%/A=\.? GB3XA>,?!G@CPOX9\6?%C6['Q)\2_$FD:
M/:6FN>.]>TK2+;0=)U+Q3J<<8N]7GTO1K*UTZP:ZE=K6TC,$#1Q$(O>4460#
MB<_48 8_>*@84.0 &*@!58!?E !!(S3:**8!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %=1X2_Y"<G_7G+_P"C8*Y>NH\)?\A.3_KSE_\ 1L% 'I%%%% '
MA]%-WI_>7_OH?XT;T_O+_P!]#_&@!U%-WI_>7_OH?XT;T_O+_P!]#_&@!U%-
MWI_>7_OH?XT;T_O+_P!]#_&FMUZK\T-;KU7YH:1F3\0?R&:_E\_X*NG'[7>N
M?]B+X '_ 'UH;-G\.E?U!;E\S[P_,>E?R^_\%7,']KO7,G _X0?P!S]-!?'Y
MD5_27T5/^3I0_P"Q/FW_ *:IG\7?3M_Y,BO^RJR[_P!+/S57H/H*6F@$A><<
M#/O[4ZO]-3_$=;+T7Y"$X!/H,T$X&<9]OQH(R"/48H(S^8/Y'-+77T_$!1[\
M44A!..<<\^_M2TP$)P"?09H)P,XS[?C01D$>HQ01G\P?R.:6NOI^("CWXHI"
M"<<XYY]_:FNVQ2<9[4UNEYKYZH3:BG)Z)*[?D?I5_P $E_\ D[C3?^Q$^('_
M *:(*_J&[I]#_(5_+]_P2;C"?M<Z3SP_@'Q\_/&W=H\!Z]P 1Z=_K7]0 9./
MF V\#YASQC/^%?YE?2J:_P"(J7Z+(LJ7S=#$)?BC_;?Z!L7#P(PL9*SAQ+GL
MI>2JU^:#OL^:,XO3:^MB2BF[T_O+_P!]#_&C>G]Y?^^A_C7\V']I#J*;O3^\
MO_?0_P :-Z?WE_[Z'^- #J*;O3^\O_?0_P :-Z?WE_[Z'^- #J*;O3^\O_?0
M_P :-Z?WE_[Z'^- #J<GWU_WE_F*CWI_>7_OH?XTJR*'3YE.74<$>OZU=/\
MB4_^OE/_ -.0_0SK?P:W_7FK_P"FJA^+GB\?\5;XIYZ^)_$ _/6+P_UKGU.&
M(]2?TS70>+SGQ=XG]_$NO-_WUJ]V?\^M<^!\V?4G^N?Y?_JK_2?(],ERG_L7
M8'\<-0_2Q_E]GD9/.<U?19KF-]O^@BJ24#/<8]NM!SV..?S'I2'J/?(_3/\
M3]:]8\P7/3W./T)_I1GG'L3^6/\ &D/4?B?RX_K2XYS[$?GC_"@ H&>XQ[=:
M*0]1[Y'Z9_I^M "YZ>YQ^A/]*:YX(]1G\B/\:4]1^)_+C^M(PR#[ _T/]*!-
M-II;M-+[F-89;'^R3^08_P!*^[OV-/\ D&^/_?4= /T_T34#_P"S?I7PB1N?
M'3 ./?((_P#9OTK[L_8T8?V7X^).#_:&@=3@8-GJ []^/_K5^3>-+_XU]FG_
M %_P'_J2S]>\$'?Q&RA+>-+,;^5L-"_YH^V**;O3^\O_ 'T/\:-Z?WE_[Z'^
M-?PP?WV.HIN]/[R_]]#_ !HWI_>7_OH?XT .HIN]/[R_]]#_ !HWI_>7_OH?
MXT .HIN]/[R_]]#_ !HWI_>7_OH?XT .I#T_%?YBDWI_>7_OH?XTA9<?>7JO
M<>H]Z3VE_AE_Z2Q/IZK\SY6_;J&?V+/VL/;X _$\_EX5OJ_SXR,<>@ _(8S^
M.*_T&_VZ67_ABS]K#D'_ (L!\3^A!_YE6^Y^GO7^?*W4_4_SK^\?HAW_ +"X
MM[?VE@?_ %&K'\+_ $L_^1_PM_V+,5_Z?A_D)1117]@'\D!1110 4444 %%%
M% !2KU?_ '/ZFDI5ZO\ [G]30]GZ?K$3_P __2*A_<M_P1[_ .4=O[/9]8?B
M*?\ S*'C#_"OTQK\S/\ @CVP_P"'=G[/0) Q#\1!R0,_\7/\7GO]?TK],=Z?
MWE_[Z'^-?Y >(G_)?<8_]C_,_P#U88L_UO\ #S_D@^#_ /LG,I_]0Z0ZBF[T
M_O+_ -]#_&C>G]Y?^^A_C7QQ]D.HIN]/[R_]]#_&C>G]Y?\ OH?XT .HIN]/
M[R_]]#_&C>G]Y?\ OH?XT .HIN]/[R_]]#_&C>G]Y?\ OH?XT .K^<;_ (.@
MA_QKR^'Q_P"KK_AN/R\ _%+_ !K^C?>G]Y?^^A_C7\X__!T$5/\ P3Q^'V".
M/VK?APW4<_\ % _%,8'/MU]>,<5]+P?_ ,E/DW_89#_TF1\_Q5_R3V:_]@S_
M /2D?P2'^/\ WY/_ $,4RG9R&.,99SCZNIIM?U3#X7_CG^:/YO6TO\2_])"B
MBBJ **** "BBB@ I>P^I_DM)2]A]3_)::Z?XH?FQ/9?XZ?\ Z617'_'O<_\
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M !H =13=Z?WE_P"^A_C1O3^\O_?0_P : '44W>G]Y?\ OH?XT;T_O+_WT/\
M&@!U%-WI_>7_ +Z'^-&]/[R_]]#_ !H =13=Z?WE_P"^A_C1O3^\O_?0_P :
M '44W>G]Y?\ OH?XT;T_O+_WT/\ &@!U%-WI_>7_ +Z'^-&]/[R_]]#_ !H
M=13=Z?WE_P"^A_C1O3^\O_?0_P : '44W>G]Y?\ OH?XT;T_O+_WT/\ &@!U
M%-WI_>7_ +Z'^-&]/[R_]]#_ !H =13=Z?WE_P"^A_C1O3^\O_?0_P : '44
MW>G]Y?\ OH?XT;T_O+_WT/\ &@!U%-WI_>7_ +Z'^-&]/[R_]]#_ !H =13=
MZ?WE_P"^A_C1O3^\O_?0_P : '44W>G]Y?\ OH?XT;T_O+_WT/\ &@!U%-WI
M_>7_ +Z'^-&]/[R_]]#_ !H =13=Z?WE_P"^A_C1O3^\O_?0_P : '44W>G]
MY?\ OH?XT;T_O+_WT/\ &@!U%-WI_>7_ +Z'^-&]/[R_]]#_ !H =74>$O\
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MH **** "BBB@ KB/''_'G8_]?;?^B)*[>N)\<#-E9'TNV_6&2@#S6BBC_/\
MG% !11P "V02<;>A./[N3\Q=?G0>A"L0U*>,="2K, &7(4' +#J#_>4C=W&5
M.: $HIP'3A^OSG;A8U )8NQX&W,8R!M8MA3FF]"N\[-RJV&!#*I0'+=@A?(6
M7[FW&<$D  **=M]#UQC((.6Y"D<D%5/SGD @D97D(591\PPX6-BG.XJX?!&0
M,!F0JF[&XD X)&2X"44XJ1MR&^921QD-M^\RD  (/N\DL724X"!26T %%%%
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MHOR$)P"?09H)P,XS[?C2GD$>M!Y_3]#FC7\/Q 09[]:6D(]\?U_S^M+0 A.
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M7_!5?_D[G7?^Q$^'_P#Z8Y*_IT4C<.1W[^QK^8K_ (*KG_C+C7".A\"?#_\
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M>C67_3JK_P"FJA^-WB[_ )&WQ,?^ICUS]=6N_P#"L+GC&,[FZ_\  JW?%O\
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M3:</NG\?YI3:_JF'P_\ ;\_S1_."VE_B7_I(44450!1110 4444 %+V'U/\
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M;4[KN@/5Z*** /G>BBBN< HHHH ****:W7JOS0UNO5?FB(\2?B/U %?S(?\
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M]OZC_&G'J/Q/\A_4TC#@^P/]#_2@33::6[37X,:X!;G^ZW_H+#^M?<7['_\
MR#?'?_80T'_TCOZ^'&Y?!^GX$$']":^XOV/3G3/'F?\ H(Z&/RM=0 _05^3>
M-6OAYFK6WML%^.(9^O>![OXC90EO&EF/-\L-#[]T?9=%%%?P@?WV%%%% !11
M10 4444 %(>GXK_,4M(>GXK_ #%..[_PS_\ 26)]/5?F?+'[<G_)F'[5O_9
M_B;_ .HO>U_G[C[B_C_):_T"/VY/^3,/VK?^R!_$W_U%[VO\_<?<7\?Y+7]\
M?1#_ .2?XK_[&6"_],53^%OI9_\ (^X6_P"Q9BO_ $_ ****_K\_DD**** "
MBBB@ HHHH *3&=__ %SS^632T#_EI_US/]:'L_3]8B>OX_\ I,_\C^X7_@D'
M_P H\_V?O^N7Q#_]6=XNK]*Z_-3_ ()!_P#*//\ 9^_ZY?$/_P!6=XNK]*Z_
MQ^\1_P#DO>,_^R@S'_U.Q)_K?X>?\D)P?_V3F4_^H=$****^(/L@HHHH ***
M* "BBB@ K^<__@YWX_X)[> /^SK/AO\ KX!^*8K^C"OYT/\ @YWY_P"">W@#
M_LZOX;_IX!^*9KZC@O\ Y*C)O^PN/_I,CY[BO_DGLU_[!O\ V^)_!B1C</0L
M/R*TRGDY#$]RQ_,K3*_JZ'P_]OS_ #1_."VE_B7_ *2%%%%4 4444 %%%% !
M2]A]3_):2E[#ZG^2TUT_Q0_-B>R_QT__ $LBN5 MYCZQ,?R517^O)X0_Y$WP
M7_V)?A#_ -1O2Z_R';K_ (]I?^N+?R6O]>+PA_R)O@O_ +$OPA_ZC>EU^*>+
MO\+)?7$_^EL_5O#+X\U_Q1_&<&=!1117XB?K84444 %%%% !7MGAK_D!:9_U
M[_\ L[UXG7MGAK_D!:9_U[_^SO5T]WZ?J!N4445J 4444 %%%% !1110 444
M4 %<'X]7=9:>,D?Z8QX]H'_G7>5P?CTXLM/][QA^<#TI?"_0#S.BBBL "FJ2
MV<@@9XSP2/IVJ1(WE=(XQNDD9411U9V(50, G)) & 23T!/%?SHZ]_P5%_X*
M*_M#>*?VJ_B)_P $VOV6OV=?B_\ LD?L=>+O$7@#Q;XQ^-?C;Q_X8^)_Q]\7
M?#_3&U;XA67P!TSP[]GT)X-,BCEL]+E\3PF.]O$2 2M?R'3HZBKWV]7T]/,#
M^BLG )/0 G\J,D@%<$'!Y_NGT]^_/TKY0_8B_:Y\ _MT_LM?"/\ :D^&UC>Z
M3X>^*&B75Q>^&=5D2;5?"/BG0[VYT3QAX0U.:*-(KC4/#'B&QO=*O9(XDC8Q
M)*,&3RU^$_VMO^"@/[5<G[9VD?\ !/3_ ()P?"#X(?%K]HSP]\+5^-?QW\9?
MM(>(O&7A?X+_  C\%ZC/;1>$O#][=^!WBUV]\9^+8[F"_L+>&:2"+3[NSE>V
ME'V\Z>^1^7WZ ?LX<X..O;Z]JC6121\RE2JD.".26.Y2@8[-J YW.#N'"XK\
M /"W_!;#Q#HG[%O_  4 ^*G[07P$T[X<_M??\$YM6A\$_&OX!Z)XCN=6\'ZW
MXI\7W\&B_"7Q9X5UZ;.KGX;^.M5O(BMS=%]3@L-/U2YBED187/I_[%W[>'[8
M=W^UEKW[&O\ P4,\%_L\>$_'6J_L?Z%^V_X!^(7[/VI^*%\$:?\ #>\\36_A
MKQ=X+\<6WC6_NYD\2^%=3N4FLM6LYK?3+G1K:XNKA_M$JQ0.,=[V?]= /VR+
M?-M'J,DD' *[@.#DEQR"P3;@J0S8RZOS?_X)O?M7?%W]MKP3\8_VC/$GAWP[
MX6_9U\3?&;Q5X7_8[@L]/U.W\6^,_@SX#O)O#5Y\5_&%Y?7,D4\?Q"\566HW
M_ABRMK*T%CH]G&SO=+<QW)_2"IDDFK?, HHH.>V,^]3UMU8!13<L.N"/;.?P
MHW?[+?E3Y7W7WV_-#M?9I^C3_5#J*;N_V6_*C=_LM^5%O./WA9]OQ7^8ZBF[
MO]EORHW?[+?E1;SC]X6?;\5_F.HIN[_9;\J-W^RWY46\X_>%GV_%?YCJ*;N_
MV6_*C=_LM^5%O./WA9]OQ7^8ZBF[O]EORHW?[+?E1;SC]X6?;\5_F.HIN[_9
M;\J-W^RWY46\X_>%GV_%?YCJ*;N_V6_*C=_LM^5%O./WA9]OQ7^8ZBF[O]EO
MRHW?[+?E1;SC]X6?;\5_F.HIN[_9;\J-W^RWY46\X_>%GV_%?YCJ*;N_V6_*
MC=_LM^5%O./WA9]OQ7^8ZBF[O]EORHW?[+?E1;SC]X6?;\5_F.HIN[_9;\J-
MW^RWY46\X_>%GV_%?YCJ*;N_V6_*C=_LM^5%O./WA9]OQ7^8ZBF[O]EORHW?
M[+?E1;SC]X6?;\5_F.HIN[_9;\J-W^RWY46\X_>%GV_%?YCJ*;N_V6_*C=_L
MM^5%O./WA9]OQ7^8ZBF[O]EORHW?[+?E1;SC]X6?;\5_F.HIN[_9;\J-W^RW
MY46\X_>%GV_%?YCJ*;N_V6_*C=_LM^5%O./WA9]OQ7^8ZBF[O]EORHW?[+?E
M1;SC]X6?;\5_F.HIN[_9;\J-W^RWY46\X_>%GV_%?YCJ*;N_V6_*C=_LM^5%
MO./WA9]OQ7^8ZBF[O]EORHW?[+?E1;SC]X6?;\5_F.HIN[_9;\J-W^RWY46\
MX_>%GV_%?YCJ*;N_V6_*C=_LM^5%O./WA9]OQ7^8ZBF[O]EORHW?[+?E1;SC
M]X6?;\5_F.HIN[_9;\J-W^RWY46\X_>%GV_%?YCJ*;N_V6_*C=_LM^5%O./W
MA9]OQ7^8ZBF[O]EORHW?[+?E1;SC]X6?;\5_F.HIN[_9;\J-W^RWY46\X_>%
MGV_%?YCJ*;N_V6_*C=_LM^5%O./WA9]OQ7^8ZBF[O]EORHW?[+?E1;SC]X6?
M;\5_F.HIN[_9;\J-W^RWY46\X_>%GV_%?YCJ*;N_V6_*C=_LM^5%O./WA9]O
MQ7^8ZBF[O]EORHW?[+?E1;SC]X6?;\5_F.HIN[_9;\J-W^RWY46\X_>%GV_%
M?YCJ*;N_V6_*C=_LM^5%O./WA9]OQ7^8ZBF[O]EORHW?[+?E1;SC]X6?;\5_
MF.HIN[_9;\J-W^RWY46\U]__   L^WXK_,=13=W^RWY4;O\ 9;\J+><?O"S[
M?BO\QU=AX')_MF<=<:?*<_6X@X_  "N.R/4#\1_C77^!B#K4X'_0.DY[<7$'
M^-5%6:?SVDOS@N_<2N^CT[JQZU1116H'SO16?28/J?T_PK/V?G^'_! T:*SL
M'U/Z?X48/J?T_P */9^?X?\ ! T:*SZ3!]3^G^%-0U6O5=/->8UNO5?FBZ?]
M9^(_ES7\QO\ P55.?VMM9]_ O@'\AHCL/U)S[?G7],ZCYAR>N>W;GTK^9?\
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M **7XM/<'UK])6!^7YC]T?W??_9K_(#Q&C?CWC+7?B#,OPQV)_S/]<?#Q?\
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M7\6^_P#U:3_G ]>?KK ]_P#OIO?W_P X^N3 ]_\ OIO?W_SCZY/K+_Z!<O\
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M?KK ]_\ OIO?W_SCZY,#W_[Z;W]_\X^N3ZR_^@7+_P#PFG_\O%]77_034_\
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M^?H<?77'I^I_Q^OY^PP<>GZM_0_YS[#!]9?_ $"Y?_X33_\ EX?5U_T$U/\
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M_-M+S_ ]BHHHK$U/F>BBB@ HHHH ****:W7JOS0UNO5?FAR?>'X_R-?S+?\
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M/]"?Z4=P/8_IC_&@]1^)_D/ZFE[Y^OZX_P * "@9[XS[44AZCWR/TS_3^=
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M[R^B+_R(.*_^QEA/_3%0_A7Z6?\ R/\ A;_L68O_ -/TPHHHK^OC^20HHHH
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MM7:O!!4[1]TL"4/S*0WS444 (!A57G"C ],9R 5&$.#R#MW ]#2T44 %%%%
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MTE% "Y/J?S-&3ZG\S244UNO5?FAK=>J_-#U)W#D]^Y]#7\S7_!5+_D[;6/\
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M)G]NW_!(MC_P[T_9^YQB'X@CC/\ T4OQ;7Z1[F_O'\S7YM_\$BO^4>G[/_\
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M&3ZG\S244 +D^I_,T9/J?S-)10 N3ZG\S1D^I_,TE% "Y/J?S-&3ZG\S244
M?GA_P57_ &.O'?[?7["GQF_94^&WBOPAX*\9?$H^$SI7B3QXVM+X7L%\/^);
M#6[M=1;P_INL:NK7-M:/;VK6NFW(6YDB,RK%N<?/W_!6C]A3]L3]MO\ 8Z^%
MO[)W[,/QK^$_PBT]&\*V7[0=W\2+WXAZ98_$;PEX(\*Z/I6E>"-+N? .A:SJ
MS^'=;\0VU[>^*-.U"*P34K"#2(%N$DCN8U_9#L1W['G(R"..<=^X-* 255 2
MYP$V8+EB5'"D_O'; 5?<J"0N* /PC_95_9K_ ."W7P!D^"_PMNOBC_P2G\,?
MLP?#B_\ #VC:W\./@S\(?CGH6OK\/[.YA_MZQ\'RZEI-MI4?BK4;/[5)#K6K
MW#-+JTQO[Z>=BP?]WF926\EF$.3Y8+ G;QL)(.6_=A%W=/E*@G&:\N^&GQM^
M#_QDN/']M\)/B;X.^(]Q\)_&U[\,?B7;^$M9CUB3P#\0M(@BN-3\%>)O+5#I
MOB*QBDBGO-.<.T6\?O.,#T[^O7DDGDXR223M!"@G)VJHR<4 +D^I_,T9/J?S
M-)10 N3ZG\S1D^I_,TE% "Y/J?S-&3ZG\S244 +D^I_,T9/J?S-)10!\=_\
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MC)]3^9I** %R?4_F:,GU/YFDHH 7)]3^9HR?4_F:2B@!<GU/YFC)]3^9I**
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MP[X6E\)2?$>Z\0F_OX=?CU+485MDTR58$N[)6B_0/X&?LW?MN?&.P\?>#?\
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ME%%%59^7WK_,=O-??_P HHHHL_+[U_F%O-??_P  ****+/R^]?YA;S7W_P#
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M]K?3_P!F_P#;P^#GP@^*GPP\>> -0\;>#OVM/V2_"OBK0OAAX \0:7+)#/\
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MOO#.JR)F%]3T2[FETZ]:%FB-U:7*HQ" G^'K]IS]F']H+]HGP9\2OA_\:?\
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M=^._V O@C_PQYXCN_!ND_"_]KB^UQ/C'^U%K.EZ6FIS:K\.)%O-(T;P[X?\
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M(4 9WV74AS_:^?;^S+49_'S:<MOJ(8'^U!P01G3K7K^,A'KZ?6K^!Z#\A2@
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M/U'^&* ,W[-J)Z:P/_!;:G_VH,4HM=2YSK'!P"?[+M?Q_P"6I_#!_E6B0O\
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MWO\ M?\ 3A[_ ,_:OU^R/[B?]\BC(_N)_P!\BC_B+?B=_P!%SQ'_ .'.O_\
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MB@ HHHH *\V^)?\ R#M-_P"O]O\ T0]>DUYM\2_^0=IO_7^W_HAZ /(****
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M@ 94'''*44 .W'#*.%88=1PKC!&''1NQ!/(*C! R"WC)( &>2%  X  X' P
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M@ .?F.2"V<D$YY[@YSQV&<#TI22< DD*  &^8#:2RD;MV"K$D;<#).01244
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M4;V]?T'^%-HH =O;U_0?X4A=L'!&<'&< ?B<<#U/:DHX[X [D@D8[Y R2/8
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M6&]U!2[)^KA2=9/*>-UF4E?*V$,['=Y956PQ67;]P[)(V(5R"0#\6?%_P_\
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M@VNH>(+Y/[*NFGMK,P1F(N9H_P"4;]O3X9>)F_X*'?\ !:;]L/X96C-\8/\
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M3RRT%VR1E0<!@%.XA2 /FST.]9%Q@?=R,@BOY4/^"DWP4_:S_P""6G[-VO\
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M@WLNU=VT,V6("YW.,?A%_P '$WQ=_:1^#'[ W@S5OV4/BGXZ^#_QI\;?M=_
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M/0_Z)J.L:!XD^(F@Z)//<M),8O#NE;3!Y)C/:?L5_!W]K'_@HE^T#_P4TO\
MQ5_P54_X*"_ ;0/V>/VZOB[\'?AWX#^"GQ-T:S\(Z5X(T_Q'J\NE:7!:>(K*
M^_L^/1X#!I6FVUFT%G!IUHBLLDBL] ']8P8@X)!!P-Q&P@G@*Q.5C+$[59MX
M\S:K!=W+=[9(SP#C)&"<#G<"HVL#E6'(R"0<$ ?S2?LE?&?]I3]E/_@L/9?\
M$V_%O[;OC;_@H#\&/BI^SUKOQ@'B3XJW&B^)OBS^S]XK\*6NHZC::+XM\1Z!
MF"VM/$%KI;V9TJZ> 33Z[HUP^GV\S6UQ<?TL[0O SC V[F#,01D%F 4%CU;
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MH/\ "N^^'#$Z[/G_ *!D_P"EU /Y"O/Z] ^''&O7'_8-N/\ TKAH ]PHHHH
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M.3D _.K]E+]@O5?V9/VS/^"A7[65W\5=-\:6G[<WB'X.^(-,\!V/A6]T*_\
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M)9))(V=I:A,C9Z9X SWP!@#);/ &![4;V/M^7_UZ )J*A\QAVS^7^(I?,;T
M_P ^Q- $M%0^8WIG_/N11O8^WY?_ %Z )J*A\QAVS^7^(I?,;T _S[$T 2T5
M#YC>F?\ /N11O8^WM@?_ %_YT 345#YC#MGWX_Q'\J7S&]!_G\: ):*A\QO[
MO\O_ (JC>Q]O; _^O_.@":BH?,8=L^_'^(_E2^8WH/\ /XT ?F3\._\ @FY8
M>&OVLO\ @I?^T/XV\>:/X]\"_P#!1CPG\._".J_"@^$[W3I? FD>"OADGPWU
M.VUGQ%/J][9^*H_$**U_$+;1]+CT\.EJ[7<ADD7X]_9+_P""&5K^RU_P3O\
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M"G2HTXN<Y.,*=.$8Q:BEIK_+'KGP_P##7PG_ &TO^#B'X5>#;&RTKPA\-/\
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MQT   /=**** /D8<@?04M%% !1110 @Y ^@I:** "D/ /T-%% "T444 %(>
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8?K]J@7/_ 'RBCTXSU))** /=J*** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ea028514801_img9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" -P!$@# 2(  A$! Q$!_\0
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M9/A;+;VU<:N-Y-+?"W&6G;WGZG^D#_PWQ^Q9_P!'.?!3_P +[P[^/_+]]?\
M(Y/^&^OV+1Q_PT]\%!_W/_AT>F?^7[Z_I7^;X;: Y_=P]_\ EFG'7_Z_Z]LB
MC[/!_P \X?\ OVG^>P_+ZYS?T.N'$W;BW/&K[_5\O7SW+_XFMX@_Z)7+_P#P
M;C/\C_2"_P"&^OV+#U_:>^"9_P"Y_P##OM_T_?7]/>C_ (;Z_8L_Z.=^"?\
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M_P#8G_Z.C^"/_APO#O\ \G4G_#?_ .Q-_P!'2?!#_P .%X<_^3J_S7_LMO\
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M_5]>/0?3FL_^)9<A_P"B@SS_ ,$X#_(K_B/N=_\ 0ERS_P #QO\ F?Z<C?\
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M)W;=V #CJ,<<_7\3Z]J*_"4K7V^*6VS]YZ]-6?L"OU<6[O6'P[]/U\S^7O\
MX.4?^0?^Q_\ ]A/XT?\ I#\.J_EB4D%L'&3C]!_G/6OZG?\ @Y1_Y!_['_\
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MXVKA<1C*>&G/ X1\F-J\LFHU9ZTUS6M&ZLDI<K;OH>9G/4_3GKZ_E_C24#D
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M-Q3Y4K-MMJ/=GD>[@!L Y'8 _H.<]<]!TJ"7C=CCITX]*>WW>,E3@A@,9 ;
M+YY#8#J .V"1GDQ3 [NG^<"M&DK>[&$K)SC!W@I;OD=W>/5.^QR17P/5.6LH
M:WA);P:=G=:)WZD6YO4_Y_\ U_YP*-S>I_SG_'_.!28/H:,'TI&]WW?WO_,7
M<?4_G2$D]>:,'T_R.M(W3J1@CE?O<$9Q[]@.YXH!-WW?WO\ S%HR<YR<^O>I
M;2UO+^Z2RT^TO-1OYA)Y-AI]G=:A?2QQ*TTSQV%E%/<3B&,&2YF6,I!&K.^U
M 2(.I(RH52!M+ E2.B XVJ2/G(7E@,'!!KG52DZSI-Q]HTI*-TVE:UVD]+M.
MUTKV=KM.V]JC3:ORK6[3L[*]KNWEHO\ *Z\CW'N>?Y<_B<U%D[NI^]_6INE0
M_P 7_ OZU<[[-*U]--U;6_HPCRI^XY:M-W?>VR3=EN34C=#]#_(TN1ZTTD$'
M!!X/3Z5%EV7W+_(Z;ON_O?\ F19/J?S_ ,^I_.@=?P/\C245G#9^7^1<+M2U
M?;=_YA11169I=]W][_S"J]6*KUG4Z?/]!W?=_>_\PHHHK,+ON_O?^844F1ZB
MEH"[[O[W_F%&3ZG_ #_^H?E1164_B^2"[[O[W_F,<G Y/7^G_P!8?D*CR?4_
MF:?(1QSZG\..:CJ#6#?+N^O5]_47)]3^9HR?4_F:2B@J_G^/_!''HI[\\_C3
M:**BI:W3?R\SKIWTO?X>M_+N%0OG)(&>GMV]:FKVKX3_ +,'[1WQZAO+_P""
MGP0^)/Q1L+*6:"ZO_"'AVYO;"*6%0]S;_P!I2FVL9)85P9(X9Y9(Y-T;A7!4
M<&+QF"P%%XC'X["9=AT[2Q6,Q6'P=*+>J2J8B=.G*;LVH*7,[-I:,Z\/AL3B
MZT</A<-C,54J.SA@J$\15C#K.4(1DU3CIS3M9-I:7/#"<<G(SVY[=QQW]>XQ
M3'Q@8]\8Z5V_C_X;?$+X4^)KCP?\3/!7B3P#XLM(X[F[\.^*M+ETK5+:&8?N
MKHVLW+02\^7*K-%(#N3(-<.Y!.5! (&,]?J?J<_SHI5:>(HPQ%*<*M"LN;#5
MZ4J-6EBJ6_M85J4YJ22:LU=.^^@2IU:5>K0K4YTJF'?LW&MAYT:WI)RM9WW3
MBGILAJ]1]1_.EDSEO9>/R_Q_6D7J/J/YTDI /(7@%LEMNW &&8D@;1S@#J:'
MK**;A%-.\IJ\(*^LI/[*76>T=S=+F4%>S;5E_.];0]9;+^D1 ^N<$ \YQVY[
M^G!Y!Z8YX>N.< C/.2.O^?RKUJ?]G[XYP> Q\5)O@_\ $2'X;_8$U4>.Y/#=
M\/#*Z9+*;=-2;42H@^S--F(/]W+ @]#7DBXYP-HP-J<_* ,8R>>2">>:Y:>,
MPN+E6C0Q6"Q4L)/V<Y8*M#$Q@V[.-2I3E*,)*VL)VE=6LK'15H8F@XJOAYX1
M.*E"G-2O4B]IKF4;Q>Z:YEKOL1MU/U/\Z!W^G]10W4_4_P Z.,=><D?Y^G/Z
M^E:&17;J?J?YTE!.>M%3/X7\OS KU  3T%/?''/K@>O2FY)7'H1C\F)J96;M
M;1)[6U_R_$Z!"".HI*5B!U..%_D*2H?6VQM'X5_74*,X_E133DXP1@'G\#TK
MF&DM-.BOMV!B K$],&JXP<GT/] /\YJ64J$<MGH=O3J< #WW$\#J:]/^''P*
M^-/Q@AU6[^%'PL\<_$:UT"X@M-;N_!OA^[UBWTNZNXYI;47K6ZE8IYXK:62*
M-F*E8F^7%8XK$87!T_:XJM2HTTUSU*\HPI1NXI.<I2A%)R<4DY+5I:W*HT:V
M)GR8>G*M4L^6E%-N?+=M)13;LDV[)Z(\K;(5CG)VGT ^O^/-5F/''L3CT/O]
M?QK0U*POM)O[W2-4LKG3=4TJ[N+#4],O89+:^T[4K*:2TOK*]@D_>17-O<0-
M#/$_,<D;#&<UG,#@YQGKQG../TX'/M[U7M%-NI&I.K2J4DZ4Z'O4;.S4I25[
M1\[OIJK@TE*4.3V52&E2FVV[IM6_KMUL,R?4_G3&R67DYYY[]/?-.P>>#QU]
MOK29''?/I_/Z=OK4+71O1[^A<$W?779)O?9]_(6H6QO(8D# Q[GDGG'Z>F1C
M'2Y:V=YJ5W#I^G65]J5_<>8T%AIEI=7]_.D"&6=X;2QBGNY(X(E:6XDBB<0P
MJ\DFV-68=!X*\ ^-_B9XDM?!OPZ\(:]XW\67L5]>6?AWPSILVKZQ<6>F0&XU
M*6*QM,RM;V4"-<W$J@B)%0L=I85SU,5AJ4*U6M4I4Z5"$JE2=:48TH0CO*K+
MF]VFENW96OJ=%*E6JU:5.E1=6K*<5"E_S\D](P23;?-K9*[TVU.0P,#!.,?Y
MZYS[4AR<C';K]1_CQUKMO'WPU^(/PHUU/"WQ-\%^)? 7B:33[;5ET'Q5I<^D
MZM)I=[)-'9:D+2X =;2Y>UN4B<#:TD,Z]4(KB6.5)'^>:BA5H8F$:].>&Q&'
MJ6=.I@YJI3:>SYHRDGYM-^NZ-JE&K2J.#H_5Z\6W4HN]VKZQ]YIWW5K7M=]"
M(J<'!&.YSQG'X'OQCZ9'-)D#ZGC\_P"F,TF3D@E@ 1EE(##N6&>"5Z@=3T[U
M[#\._P!GOX[?%_3-0UKX4?![XA?$32M)U Z1J>I>#?#E[K=A8ZL;:*^73;JX
MM@R)=O97$%SM;I!-$^,.*Y\7C,-A:,L5C,71PM)3]E!59PITVV^6*G.;C%)N
MUY-W6KL[,NEA*^-FX8'#S=1^[44>:4E?=P2N[VN]M.[/&R6 'U//YX'4]L^O
M8#FFD$8)XW9QQC@'CITZ#Z'BO4?A]\#_ (Q?%W4=>TKX7?##QU\0=1\,,%\2
M67A#0+O6+W0B]S+9I'J<%NI-J7N[>>U7S #Y]O+&02K5P_B+PYKW@_7-5\*^
M*M%U/PYXCT*\ET_6= UFUDL=6T;48,>?I^I6TP\R&ZA#JQC8!OG&>,5G]8PE
M2O5P5'$X1XBG1I8C$TWC*<JE"G42E2E5BFWR5^9*A[J4W*"7-S:]%2AB50GB
MJM+'1P\YK#8*4H6C[6BU'$<SY4FERRNE=KJUI?GW)SU/3_&D!)(&3S[_ )TA
MZGZG^= ..<9Z\'IT[TFKMV45?:Z5EZZ:+OV5S%.R76R[[];;]0?@*2Q(Z_S_
M "STY]P.<880&YSGZ'_/7!'Y^U>T:5^SI\??$'@!OBIH?P;^(FL?#*'2M4UB
M7QYI_AB_NO"JZ5HC7,>M:M_:T:?9TM-)DLKR*]G<^7 8+HM_J3CQ90 -P.0P
MR.>".""/7@@\=CGI6%#%8+$NI'"5L#C)X>7+BZM.I%_5*ETO9249-*3>B4DG
M<[Y4,315*->@_J^*A[2$O>7*TFXZM*ZT3TT\W9CFZ'Z'^505*_0?7^AJ*NF=
MKI)*Z79/TTMKMMUV.>G>U[NU]=]$NK^0F1[CZ]S[9Y^@_I4. <#UXY(/YX'^
M>:F8J%)) 4*<L>  ,DL<=@,YYZ>]?0_AW]CW]JSQ?HFF>)O"?[.'QC\1>']<
MMK:[T36]*\%ZA=:9J5E=-F*]LKJ- );214S'+@A@<YP37G8S%X3!TXU,;B\!
MAVWMBJD,"VWLHJK*";[)7N[75KL]##8?$8JHZ>$P[Q<7:3<5*\4M;KE3?KYV
M\CYR4L2#@$]/7GW..V#_ (C%,E(.!@CN>N<'OGT[#IC@]^-;5M'U70=6U'0-
M;TR\T?7=&U"[T?5M'U*W>UU"PU:RG^QW=A>VK@217EM=0-%)$5#!OEQDD5]
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M!ZY]HO/V9_VC+7P WQ3F^!OQ1C^&BZ.OB*7QY)X1U(>%?[$P2NN-JGEE/L3
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MDL;VTGF*K;RHLZJMQ9SB1)H+R$M;2Q$3(Y1L#])-:_X(H?\ !0/1YO"$-O\
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MUCQ5:^!->CUK6_#UC;QM+?7<FDLL=SJ=GIL*R75_=::)88+9'N'Q&C5]S?\
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MRIIUSJ>GEHM,UF9(FEM]+U'R;J:W_>H&(-?%GRC.3T&>OK[G&.>V..G..?\
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M'Q&0U*<U!0Q>$ITZE6A57+^\=9<M.*;4HVDXM.Z?\H_[)G[&/QZ_;9\<^(/
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MGC55!,BD+^Z>J_\ !6[]LRU_X*MWNE+\2M5'PFTW]IVY^",GP:M[>P;PG<^
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M'!OC;\;_ -O,6UX+[0/A5\:-%^$.@2!PZ1KX2^'6AOXCMP 2$:W\8:AX@B=
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M]GFFC@FDA,C%8I'7GXP_X*<?\$N_^":_PK_X)N_%7]IC]FOX"^&-"\0'P;X
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M\%>&=6%Q%XBU;5?%%G.UEJ7B?4H+C4W@CLYKR6WU2[^VW\%M;I#!)_+UX/\
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M5?Z=XANB72TT?7;-;8PZM,BVNGSV %[)%;W,MW#^ !2)B2T:,649(1<G8"5
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MT\#PV<ENEW;I$/,EDR2?SOXP#R6R0O\ "5!Z[3PPR,@X(R,_B@C100H"Y))
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M PQ'"N44LJPM!8J?U;%X*%"5)UYU?^7=7WE)TXZ)VCJM3]^M _:._8I\/_\
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M\5ZI\/C:'2?!?PTU=H(M/\16GAJ]EL[[6;W3#_9MJ\&FVMD]W'+*8OS1M?\
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M.ZG'?Q>(?%N@P6&AZ/80VTD"Q1W_ ),MNB8N;B:0[C^4NO?\%#=!^%,>G/\
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M7K5\ACEDL!&5+B"AQ$J^!IUX91'$8G+GBL*L7##U)5G0_3#]MCXG_#CXR_\
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M97BCS,5BIXS&XK%M>SJ8C$XC$R4&[0EB*]:O*$)7NHPE5<4[ZJ*;UN?V1?\
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MLB^7J&DZM83W-GJ%G.0S1W-M,\,G.S &!\'LV>F<8Z4]\*BHH55"A5"@ !0
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M_P!G9=JTY?\ "[EVMN_[I7/Y705!SMY]<_\ UL^G/M]:7*C.%QGK@_\ UO\
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M47*.T^6R2:O[K2NNC1_(00.!EACI@=.W4 G]:3 ]7_7_  K^OG_B&X_9_/\
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MF^:[5DEK?338_D:."2,'!+\$G&'.6SSCDX/\NAP'G(.2&# Y/4-][.3SGO\
M2OZXS_P;3_#_ /A^-_QL/J!I?PT;^>G8'?\ R!33_P &T_@#O\</C:O_ '"?
MAD<_^4\U$O'[PR;L\XS*_?\ L3,;]6]7'3?5:7OYC?@QQ_M_9.$MU3S;+[/U
M5W^*OJ?R/'GD@YP1G/8XR.OY_0^V48 \XR><<9/(P<\'_(]*_KB_XAI_A_\
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M.T797Y4KZ)Z)NUC^/G QC<,8Q]Y*3:.?G'/JZG^9Q7]@?_$,9\./^BY?'/\
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MA_A2$ G) _(444AB8'H/R%+113N^[^]_YCN^[^]_YA1C!SZ^Y^G3I112$
M '0# ^G7^M%%%.[[O[V%WW?WL****+ON_O?^8[ON_O?^89/3/'I1112$! /4
M _6C '0 4447?=_>_P#,+ON_O?\ F+G'I^(!_G03GT_(#^5)11Y@! /4 _6D
MP/0?D*6B@ ''0#\A_A2Y/M^0_P *2BBR 7)]OR'^%&<^GY ?R%)10 N3C';Z
M _S%&<^GY ?R%)10 4444 '^?\_G1110 4444"LM[*X8'I_G_('Y4444#"C
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M0/QI<@]#FJI')Q(6&>"# H([<.X)/J< $\@ 8H 8,,9<'C:6CR!RQ=?+)R5
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M^@,;Z9\./&GBQ](DFT76Y+-K_5!;+<1V%O:W%Q.]M&@\#_X-M/C%^SY\!/\
M@EK_ ,%@/BW^U9X+7XE? 'PEJG@";XA_#XV\-V_CRTU73%T32O"4<-Q<6MN\
MFO\ B+4=&TY)&N%6W:Z^U,=L05RS[,#]A/'W_!YA_P $\/"WB[7]#\$_ +]K
M+XJ^#M OYK!_B3X<\.?#_1]!U*&-_+AU+2]/\3>.-*UI+2X)8P_VY9Z-<.H1
MA X<&OUV\/?\%NOV,O'/_!.'X@_\%-?AQ=>-?'GP9^%5FB_$'P)H^D:=9?%G
MPKXD6_TS3KKPCJN@ZSJVGZ5%J\,VKVEU%=?VR-'OM-<7VG:C=V[*U?QJ_"_X
MJ_MW_M:?\$\OVN-2_P""=W_!-K]AK]B3_@FGJFD_%G5_BIXX\9WLWC'QKXD7
MPYH\FJ>*--TGQAXV\07>MZQK>FPVEI8:$]EX#M]&T76FM-/T34+&5)(X_%?^
M"9#R-_P;-_\ !:J-I)/)3XL?#PQ+N)17;1? #2  #Y0^V/=T5F"Y[Y /Z3/&
MG_!XA_P33\.?#WP3XR\.?#O]I/X@>(_%,.HWGB#X;^'/#/@N'Q!\.=.L;_[%
M;W7B_5M1\8VWA>.XU:,/>6.GZ7K6I3QP*AU 6+31!OVD_82_X*P?L:_\%"?V
M;_%?[3GP3^(;:+X+^&<%U)\9M$^(=O#X;\4?!V:RTNYUF=/&]F;BXL8;%]+M
MKF_LM;TK4-3T74K>UN!8W\KVURD7\]'_  :8?L]?L>?$+_@E5\8M:\;_  Y^
M$OC3QMXR^+7Q.\)?'^_\6:'X=\0ZW;^ [+0M(;PKH^LOK$%Y/H_AP:+/J>JV
M4:);V\UZ+C4 LD]J)H_Q8_X-\OAA\//B/^TW_P %K?V6[?XD6_P\_9(^(W[+
M'QZ^'5_X^N_$R6'A?PGX1O/C):>"OAWXTDU6^O;?2GGLO#>L72VNH7=[%)/I
M]S>M'=%7>@#]_OB3_P 'D'_!/3PGXPU_1/A]\!OVL/C1X+\.ZI-83?%/P?X5
M\%Z/X6U2V@;8=2TFT\7^+]#UWR)?OQIK>F:&[QF.1"4D!K][/V!/^"EG[)__
M  4D^!&I_M!_LW^/);KPGX7U"[T;XA:'XMM5\,^*_AIK&GZ>NJW5EXQTR[DD
MBL(#IDJZG:ZS#<W.B:A8*\]G?RBVN G^>O\  S]GK_@N)_P34^&OQR\-?L11
M_!#]OG]AOQ!XK\16/Q7C^ T'PE_:U^"WQ!U'3-&M;36;/Q7X7T=[GXL:!JUM
MX8FT^76="M3IC64%PCK+=-&MV/O;]C;_ (*4?"7]H3_@B'_P5N\!_L\_L;_"
M3]C?]HSX2? '1;SXD2?L_:;>Z+X<^*_@OQGJ5YX2U+Q.LUVU[XQTW4?"NAR>
M*[.]TC7?$7B*"SM-3CGLM5"ZA>VUJ ?KM\=/^#OW_@FO\)/BSXB^&W@OP%^T
M3\?O#WA349=+U[XM?"WPSX1B\!B:UF>UO;O16\6>+O#^L:QIEO=(\<6JQ:=%
MI^HQ(;K3+F\A>!I?WZ_8F_;G_9O_ ."@_P #-"_:%_9B\>0^,_ >KW,NE:E:
MW-M+I7B7PAXHLX8I-0\*^+-"O!'>:1K-FLT<I@D5H+RV>&^L+FXLIX9G_P Y
MC_@A[IG_  4[N?V&/VD-$_8K_8%_8F_:3^!_Q)\5>+O"7QP^*/QW\0^#;#Q[
M:9\$Z5#=^%-3FUSXJ^$[[2?"WAW0KN/Q%H\<^CP6-M>ZE=:Y;SO<.]S7WW_P
M17_9^_X*B_\ !/\ _8O_ ."JGC#X$:5\-/'?Q \0> _A-XJ_9L\)?!#XN?"?
M]I?2KWXL6?C^?0?&,<7A#X;^-O%H%_;^ KM8HIM8CM_.BTI(A<W3V<L<19]F
M!_=)^U?^T9X-_9%_9R^,G[3/Q$TKQ'K?@GX)^"-2\?\ B?1O"5G:7OB34]*T
M7R#<6VB6=]>6-K<WLIF58XKJ[MX9#D&XB"Y'^1IX<_:1_8O_ &Q/^"H7QQ_:
M&_X*%>'OVH/B-\$?C7X[\7WWA'PU\,M6T&T^*&GW7B378=,^'ECX@O=4U4V%
MAH?A/0YH([O3M%O)UC:TBM[&.>)?*E_KC_X)Y_MC_P#!R-\;?VRO@3\*OVZO
MV6M6TW]DWQIXGN=+^-U]XF_9PTC2- B\)/HFI2!M3U&>:ZMK>V?5+?3XSYEO
M+&S2<QL&X_/W_@@)\.OA]XB_X.&?V]/#7B#P%X+UKPWH=U^T?+H?A[5?#.AZ
MIH6COI_Q3CCTZ72M,NK*;3[)[.$*MK):P1M IQ&5-.SZZ>7X_H!^XWB[_@YB
M_P""9?[!'B'Q=^Q-?_#?]HS0XOV0O 'AKX;^&%L?#?@[5K#Q;'X1\(^&K+PQ
MX8\/7L/BN.Z?5[W2I[);C5]?T[1=/2Y@O[N_GMH_G;ZD^'/_  <B?L#^+OV"
M-;_X*#>/=/\ BM\%?AC9_$W5_@UX8\#^.=#T6\^)'Q+^)6BZ+8Z_>>'OAQI?
MAC7=:TWQ%%!INHVD]_K!U&VTO1XFF;7+G3#;2@?RM_ ']GCX3_M(_P#!WC\:
M/AW\8O!'AWQ[\/M%^,?QI\?7'@OQ+IEGJGA?5-3^'WPBFU[PO;ZOH=Y%+IFJ
M:7::[::;<3:7J%M<:==16_DW-M+"60M_X.Z? >C_  M_:]_8;^!OPD^%W@'P
M!\%;#X;^(/%WA#X<>&]*TGP!\,=3\?\ CCXF0Q>.;F\TG1/[ T'37UA--\-P
MZ_K"2V4[VURTEQ>VZH):+/;^NP']"_[+?_!VU_P3>_:+^,'A;X1>+O"'QV_9
ML?QUJ]OHO@_Q]\9=#\)Q_#_4+W4)UMM&&JZUX3\4^(I_#]OJ5R\=N=0U*TCT
M:TDEB^U:I&C-(G[+?\%"O^"EW[*?_!,OX)VOQM_:9\;7&FZ9X@O9-'^'_@_P
MS:#7?'/Q)UR*"*]DTWP?I"20Q7*6UG/#=ZGJ]]<66B:9:SVTE[J%N;FW$O\
M"K_P5>_9+_X+#?MC?"S]G#P-^TI^PW_P3H_9$T?X<W]QI'P2\3>!OCA\"_@]
MJ>NZ;=Z%I]M-\.]&N/%?QLGL=8T6*WMM.U>WT+3K=CIUQ"+B#R1<RFX^?/\
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M!_$FE>&=.T[4IX=>TFYO-,UJ*XFMC,FJ65W<P7N\SK/)O+%I7=M@/I&E49<
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M6AB\-W/EZCX4C\+^&W'AP:44F\86%[XD\4Z5XKUA?*^UKY"/91[?_!#;X.^
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M&N;82K(O[)?\&JW_  4<_:9_;]_9%^-'A[]I_P 0ZM\1?%W[.7C[PIX2\/\
MQ;UZ(-X@\<>&O&>B:MJD&F>(]54*->UWPK/HDRW&K31_VE<6>L6']H7=Q+^]
M7\:_V@?^#8__ (+ >*_@=XF&I_\ !3FW^.NDP^$W\1K\)_&/C#XM:9HOB1=-
MTTZE#H\L^LZ[K>D1R&)&AMY+VP>R\T1F1HXB73@_^"%W_!4C5OA-_P $G_\
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MEUI<NHZ5H>B?VG<6T]CJVE*(89G7-ZZ_U_5K ?;G_!M/_P %HM2_;/N?C?\
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M4O&T]RFH:O>S2SW$G]LF.<DDG(().<88-@9[9 ./8>@HVJ"" -P! ;N"0 S
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M_  _D*_9U_X(E?MP?M!?\$@_'O\ P2O_ ."DVJ_#KPS/\)?%OA_QW^Q/\>/
MWCM/BCJ7@V]LAK<T'A3Q5H9TO29SX;\.+J6L>'K>X6[>[F\'>.KW3-.%G-X:
MTN27\\[/_@E'_P '2.@_LR:)_P $W="^/'PETK]E+1]1LH-'\::#\6-.TGQ#
MHW@[2?$$>H:?X>M_'-IH5G\3K'PUI]Q'!?6O@FTF%O$EO'IL$QLH]M?Z &3T
MZ YW*/NMG.[<#G.[<<^QQT P[>W)[E0F><A1P .>,9//?)SGC#Y)>7W_ /
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MLKC1O'_B+7+W1=/TCPU:VE_X>U&^T;1?"_A_38['2S=RW,MPPBM8D^0/ _\
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MX->#_CW_ &OX@U\?%:R_:#M)O&1UWQ6E\OB+5CJ=]X1O7;4M434+U[J\9/M
M>Y::&5)!N7^G+_@BY^RG_P %Y/@3^TGX[\3?\%1/VE$^,WP+U+X0ZQHWA/P\
M?C3;_$1].^)DGB?PK=Z7JJZ+%X:TI[=4\/VWB*U:_%[MA-PL36\GV@21?TP[
MVQM)+#R_+.[G*'J#GN><GKRPZ$BC<V "20,XZ<$L69A@ [FSACT("\<9I\DO
M+[_^ !>HJAD^I_,T9/J?S-')+R^\"_15$,P(.3QZY(IQE<@@XY]J.27E]X%R
MBJ&3ZG\S1D^I_,T<DO+[P+]%40S @Y/!SU-/\YSZ?E1R2\OO MGH<].^.OX=
M?Y&OY /^#C[_ ((Q_MV?\%,_VC_V7/B_^R%#\+5T[X+?"O4O#>L:AXY^(L?@
MS4['Q9)X[F\4:7<:7:3:+J(N[:W@^SS"ZWIBY5H3#^[W-_7AD^I_,TI=B23@
ML2#N(&00 H(/8@#'XGO1R2\OO_X '\$OBW_@F_\ \'>_C[PIJW@'Q)^VOX5'
MAC7]&NO#^L6=I^T7IVEM?Z+?6CV%]IT][I'@&+4U@N[*62WN?(EC>6%W1G.]
M@WZP_P#!%[_@W:\*?L$?LZ?M->$/VI_$NA?%WXM?MD?#G4_@_P#%>R\)F\3P
MCX3^$6KZ=+!J7@C1;Z^ABO-;U75+Z_GU/7-=FAM;9FT_1K:QM4$-S-<_T\AF
M  SP/SQ[M]XY[\TOF-QSD C@YP=K,P!YY +=.X50<XHY'Y?>!_!/\+O^",/_
M  <)_P#!*SQ%\>?A+_P3 _:#^%7C7]G/XRZFRVFK^(]>\,Z-XGTW[38W-C8^
M*G\+^+=(O(/!'C_3-)DM])U/Q=X4O7CO+BQLKJV2&&VT]+?]</\ @FI_P1*_
M:D^"O[!W[3WP-_;-_;:^,_BCXT_M7>$H/#\-UX)^*?B_Q/HW[-<>G/+J>CZM
MX$UW7KX7FI^+;GQ/<)J'BK5;)-/TS5-"T^PT&*%8C=7$_P#31O;.<\XP#@ @
M8PH##YB$'W Q.*0LQZDYSG/?. #D]3NV@D'()[=J.27E]_\ P /X*/ '_!+S
M_@YZ_8Y\"_%+]E'X&?%OX ?M _L]?$OQ!XBE3Q1\6/$?A?Q[);#7](&D:KK^
MEV?Q?TO6_$/P_DU6T9KBXLK.;488M3#:E$6OF:<_I9_P23_X-X?%G[%?[$G[
M9WPW^.?Q,\-ZE^T?^W)\+-2^'?BBY\&-=7_@?X8:6NBZY'X<TJ*_FAM)?$L\
M'B;7+C4]8U2VL-/@DM#'8V4*^69G_JLWOG)8D@Y4G&4!X95..%8<,O((I-QS
MQ@#&-H VXQCODGL>3U /:ER2\OO_ . !_$__ ,$*/^"4'_!;G_@F3^TQ:^!/
M&>N?!_2_V'=:\>WGBKXR:=HGC[0]=N?&UQ%X8O\ 1-!UGPM:G1!XABE#QZ9+
M=Z;+/ID4>P"[$LT(5O[;0<@$#&0" <9'L<<<>W%4M[8P3D#: #T 4'C QP2=
MS#H6YQ29/J?SI\DO+[_^ !?HJAD^I_,U()7  R.!CI1R2\OO MT51+,23D\G
M/4TF3ZG\S1R2\OO OT50R?4_F:>)7  &./:CDEY?>!<II8 X)Y/08_EZD_S_
M "JF68DG)Y],@4\!WP$!?&21SN/!P!T)^;@X/"$GJ*:IR?\ +;1-OHFUJMK/
MSN*37+*[:7+)OE5Y-QCS)1=]'S):)/F5X:7N9/B.\UJQ\/>(+_PWI]MJ_B*T
MT;5)] TJ^OAI%AJ>M0Z?/+IFG7VK/%<+IEK>7JVT,]^;>9+".3[28Y,,A_C'
M_P""27_! 3]H?P1^WC^T;^WG_P %7/#_ .S[\3H?B'HOC7Q7X7T2S\7:3\5?
M#&K^/OBAXFF\0^*_&.L17^CV6FV%IX7T2VFM-'N[@2V[0:_<31B#[ KK_:-<
M0&9)K6?<8I8Y8W&67]U<Q&*4,<_(I4A0?5N@QD?F1-^PS\61?3_ ^V^,E]!^
MPU<:A+XEN_AY)+>R?$H023^?-\(+;QH',T?PCN;AI+^YMO-_M VC_P!AQSK8
M"2O.S+$8O"2A]7P-?'>UM3I1PSI1Y*DM8SKSJU(0IX=.RJU(JK.FGS1HU$TC
MZSA?),BSG^T(Y[Q9@>&YY?3PF.2QF Q5:&9Y;R5)9A'+I8-592SVBU2CE^35
MUA\/F3G5Y\VP$L/4]KXQ_P %#_\ @C[^R%^UG^PW\>/A%\&O@7^SU\,_B1XO
M\!7.L_"+XEZ!X.\,^&X-#\::!Y6O>';^3Q7HUF!:Z%JCV<FD:KJ:/<65OI&I
MW-ZT=P(%"_S\?!#_ ((I?\%5])_X(E_M3_\ !.'Q\G[/^HW?BOXL?#?XO_LY
M:Q8?''3M1\)6>AOK*ZG\4]+U/6(?#;0Z79XT^'Q)I%\)+JVOKF\U"U9K.-!<
M'^FD_L+_ !3L[QO@)X9^,U]I?[#>H72ZWJ/PZ22_?XEZ? TBFY^#V@^,&<SV
M/PEU24&\O+=I&U2WM'_L6WG6SDD%.G_85^*FBWC? OP+\8;[PS^Q!K=RNMZ[
M\/VDOY/B3H:),K7GPJ\&^+WD>;3?AGX@DC%SJ4#RO?VMN\NFV,R6UQ**\MYG
MG:2YN',39/V$O9XO"3J_6VURRA3<H*65Z>]CW.-6"<F\"^62?UKX(X"E?V?B
MEED?:P6;8=U,ES907#T4Y5,-BI1C.5#C;E4O8<+TX8C 8B4>1<44G6HRC^%G
MCC_@C#^VAXW_ .#<KX:_\$X= /P8O?VB-"^+NA_$2[N8OBC:R_#2?PEIWC;7
M/$$E]8^.XM)>TNYO[+NX)C#'9>2'6:-+E_*#2?06H?\ !"2X_:M_X(.?LJ_\
M$_/CEXU\'^!?VB?V>-&UKQ7\/?BCX,UA?B!\/M \=2>,?'FH1FXU73DL8_$?
M@SQ#X5\2#2=<>S$4VGW,SW-FTUUI4;2?J;<_L+?$WP[>R_ WX8?&:_\ "'[%
M/BB8ZOXJ^'R37LWQ'\-1AE;4OAO\._%CRM-HO@#Q>X,FL0R3/<Z;!Y]OIDL<
M=W)B>Z_84^*?A>ZG^"_P6^,5]X$_8T\8RIJ/C3P"LE[=>/\ PG%&5;5? WPL
M\52L\V@^$/&X 374D>2XTQ#='2Y(GO9#1_:>=1UJ<.XKEC^XJ^RQ>%G4^M2_
MASH0E*"J9=M[3'2G3J4^:3>"J>RFI/\ U(X!FFZ7BEET7B(+-<"\9D>:X>E'
M(:6N(P^:5*4:\L'QFU&I]2X9P\,;@<<Z:BN)<*\7A73_ )$=*_X)*_\ !SAK
MW[,,7_!/.P_:,^$-]^Q;<VP\-P>(;+XR:#?Z9>?#!M1$3^&K3Q)9Z!+XXO/!
MRP>8S>"%G^R&&.72'<6("U_6Q_P1W_X)H_"C_@EI^Q]X?^!7P\\7V7Q/\4^)
M]<OO'_Q8^+^G+!%8_$#QW?PV^G3OHUK#<7B6?A?0=-TVST#1;+[5/<1V]C-=
MWLKZC=W9.I>?L,?%'P5=3?!SX%?&6^^''[(_CMOM7CWP,9;^[\=^#5B(CUCP
MY\'_ !)</)<>&]#\=1;H=:65WETH^?<Z2T<U[\JWW["7Q4\"7,_PH_9W^+][
M\+_V5/B"ZR_$KP4SZAJ7C7P7L^?7+7X-^(;AY9/#EKX^A\RS\1F5W;3IY)]3
MT@)<7;;4\SSM2@I\.U>2%14<2XX[#RDZL[\L\-%).K@;<KJ8N7LJE*4FGA*G
MLZC8N!^ J[OA_%7*J/UJG_:>6?7<DS:C".34$_KF%SN=&.)>6\63Y:JRS(<)
M#,\%F$J5-?V_@/KV#=/]/K6\M[V"*\LI[>\M;I5GMKNTFBGMKFWD&8IX)X&:
M&6-TPRR(S K@Y/:VN[))Z=AQ^?L?7Z^U<AX-\&Z/X \(^'O WAFPDL/#?A'1
MM/\ #^A6>;B866D:1;16=G;^;,SSW!BMXU5979GF*!I&+,QKIMSQC&>>F&!!
MP  K8)R-P )&."<'GI]!3A)PA)KV<I13E34_;03<5)VK-<SL][PI6VL]C\HK
MQI1Q&(>&K3K8?ZS5HT9SH>QYZ%)R]A6<).<J=6K34)5H*4H1J2G3C4J*GSRM
MT529V;J>GIQ3<GU/YFM>27E]Y)?HJAD^I_,TY9&7.#U]>>E')+R^\"[15)I&
M;&3T]..M-R?4_F:.27E]X%^BJ&3ZG\S3E=ES@]?7FCDEY?>!=HJDTC-U/3TX
MIN3ZG\S0H.ZO:W74">ZE$%O/.=VV"">=@F"S+#"\C*%(PY95("' )QN^7(/^
M9KX4_:L_X*D_\'"7[?\ \;/@?\-OVY=/_8N^%'A=O$-QX1^&$_CS5_ VCVO@
MO2/%D_AW2-/TWPSX?NM.U[XE_$2>"[@N?$US]N-ZBAW2.#3[<+#_ *5OB#Q#
MHOA/0-<\5>)M3M-&\-^&M(U#7?$&L:@Q2PTO1-+MI+S5-0O7VN5M;2RAFN+@
M[6_<QOD8S7\!G[1?_!!G]BS_ (*>_'KXV?M)_P#!$_\ X*!?"B+QUH_B1?'7
MQ7^%6GW^OW'A/P5XJ\>MK&H6>H>!?'?AN"#5/#EMXNUBP\1RV]G<6MUIFFM:
MW-O:7Z0DQ0J4;.WW 8OP3U__ (+L?\$6/^"EOPC_ &<?B;XR^-G[<'[+OQ U
MKP.OB?4=,T'XA?$OX;W_ ,./&6O1^%=0\8Z5J6I:?K%[\-O&7@F_CGO[^RDU
M1)[BQT<0W9FTS4H;F/[%_P""PO\ P<*^-?A!_P %(O@#^QW^S=\>OAQX&_9Y
M\(_$WX;#]K#XJ^'X;BZ\6:3=6_CJ"'Q_\/?$.M:A82P^&=)T'1;-FUW_ (1Z
MUGU"\BO)[6XO%\E[5OR*\$_MS?\ !;'_ (-YOVL?@M\&?VX/'NM?$S]GOQ;/
M8/<^#_'7CK_A:/@/Q#\-+O6X-(\0^*OA]XZ,ESXBT+Q/X8C*ZAY%Q<!HY((M
M-U73'MKQF7%_X+B?L@_LTV7_  7B_9G\&^$?!TUI\.OVO]?^"'Q-^+>FKKM\
MS^*=7^,GCT/XKO$G)>711K5I= O'9,8H7GDG@";@HGN!_HHW'[<'[(5M^SC:
M?M?W7[1'PMTW]F;4K%]3T[XSZCXB@T_P9J5HD\UJJZ;=WHM[G4+MYK:XBBT^
MUM)KZ5K>;R;:01LU?+/PH_X+=?\ !*#XW_$'P_\ "WX8_MT? _Q'X\\5ZG'H
MOAOP_-J&O>'GUK5)\FVL=-U'Q-HFCZ5<7=QS%! ;Y'GE'EPAG*[OP[_X+[?L
MG?\ !(G]F[]C/]E#]GW]HOXV?'GX!_"3X,ZKXJ?]G_\ 9\^ <FG^,O%/C^[O
MKL7_ (BU74M$\4LUI+#8^;)HB>,M<ODA\/IK+16HGNKHP2_QW?\ !4_5OV7/
M%'PT_9Q^(_[&/_!,GXX_L*_#/1;R\\)V_P ;_BGJNMO?_'75K+3+;4=-NI/.
M!TJ7Q):6]D==?6='N1YR3RO$BP-$4/O _L$_X.4?^"\/Q2_8C\6?"_\ 9*_8
MN^*_P^T+XH^)_P"W)_VC?%5E!+K/Q.^"NGV\GA"Y\*:-9VUY"=%\/W7C31/$
M.J:LFK"&^U>UM]$'V)K03B>7]\=&_P""M/\ P3JT[]FWP-^TGXC_ &R_@W#\
M'O$'B*+X6P?%.[UK41X=U;XK:7X8L]<\0^%?M+:6MR=>M;)FU*YMGMHBELVY
MF#-M3^!7_@Y6^ GPQT'_ (=*_M%:=H-U%\8?VQ?V5?!WBO\ :&\576J7MY<>
M._$'A7X<?LZZ#HNIW45S)(EM?PZ?K.J17ES P>^DG2:XW21!V_0C_@YC_8N_
M9Y_83_X)(?L;?!W]F?P;)X%\ :_^UF_Q*U/2)M7U'79KSQGXE^!NKVNMZK)?
MZB\DH::WTS3X5AC*1(D0\N-$8+0!_<GXJ_:D_9^\$_L\C]K#Q9\6O"&@?LWO
MX*\.?$-/C)?WLJ>#6\%>,3IO_",>)4NTMI+C^S=8;6](2P=K8R2&]@WQAI#M
MR_A#^V%^S#\>_@K>_M'_  B^.OPY\:_ ;3;C6H-2^+&G:_!9^!]+?PW<_9-<
M&I:[K2Z9;62:;,/+NIKGRHQ.XCC9LH&_G:_;FGB_XA%M'G#JT$G_  3P_8K
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M3>!O%?B#3=*@$^JW?AA&OM2TK7_[.@=+RZM;#4'OH[-9IS:^7;736_\ */\
M\%;?^";O_!13X _\%=_BC_P49_8;\ ?#7]KZS\<7I\;Q^ KC3? _QM\5>![D
M^"+'P5XPT#X@? OQ#>S:UJVC:.FGBZT;Q#IFFW-KI%I>Z;;I-IVH:07'!_\
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M'\W\^G[<G_!2[_@GA_P5C_X)#_MH^)?!WQO^/?P7^ 7PU\8?!3PW\2?C5;_
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M\>V/>BD !SUX8X/?M^%%0!0OCB2/'_/-Q^9 /Z&JVP>I_3_"K%]_K(_]QO\
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M\.ZI?ZGI9NO#6IR2FXU"R@-E<F-2HN$94_LMQN SQD'=C W C&U@ !MVEDP
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MM;?X9^*_"GC_ ,37EQKNI72/$;2?2?$^@O"]Y=-<!;BR9)$F5?+=?ZJ_A_\
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MFP>I_3_"F)]X?C_(U-03-M/1VT(R@ )YX!]/\*CJ=NA^A_E4% X-M.[OK^@
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MX/B^+7A1M6?7I+K[(FC(6OULVU);D^0]F+DSJ<.Z(IS7\@__  6*_P""<GP
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MPN?A=;)9QR^+] \,7U_XQ^'_ (W\&Z9!::7?3V.B:A)+8V%J+W2HKJS:\?\
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M[O@9P 3CD@9P&.?F'(X.0=J@@@8H#$$' X!'3J"<XYY ]=I7>.'W#BH<?O\
M4#^3K_@LA_P;R_'+]LO]M3PO_P %"_V'/VDM!^ G[15A:>#&\36GB^Z\0Z5#
M#XG^'UC9:+X1\9^ O$OAC2]4N-)U/^Q;2SLM8TS5[46%]]B^T1W+-?7-G+\.
M_'#_ (-7O^"A'[1?Q%^$'[1OQ[_X*,^ OCI^TAIGBG2]4^+?B'XDV/CM?#EE
MX?\ "6L:7<^%?#?PSBTCPT9&@BTVRN&U07^D>%[1]3E4VEMAY[E_[IPVTC
M );:,@%B,;FP0S$#A<M@=,8 P\D )\N,@80 R#F4J6"EO4A\D$*W(] .*[?C
M_G_7F!_+]_P6$_X(3_'[_@I#^V)^Q_\ M'_#'XV_![P%X9_9R\/>"M'\1Z!X
M[MO&LFOZU<>%_'EAXKO+O0SX=T#5=/:*[M+3[/;IJ-Y8NMSCS'6(EX_Z@R5=
MY) &*ECO4A3'R_RJYP5,4RF6-F(P,G)(*FH&49*YR!\IX'.W@GE0<YZ]ST.5
MX+MQXQ\N"Q&.@W *05.59<#A6#!<X4 8 ?+O;9_Y6_RL!_%GXG_X-.[K7?\
M@K%<?M@CXL_"!/V.M2_:/T_X]ZG\"I]/\7S_ !"O(9KZT\9>(/ \D:Z&WA!=
M%UGQ]]NB&W64@B\)WHM(HH[B-(A_0]_P5^_8?\>?\%&_V OC-^R'\,/&/@[P
M!XQ^)5]\/+C2O%'CN/69_"^GQ>#_ !_X=\6W<5\GAVRU+5-UUIFAW%E9R6UE
M.$O9[>2:,VXD(_3) ,!@ &_A( &S 91L &%&#R -I(&1UR!0 !QA<;?E48P
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M!W7=?>O\RT",#D=!W%+D>H_,54W/_=_0T;G_ +OZ&@CD7\WY?YE@N<G&.O\
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MOTK4/"T6H003Q6UW</=75U_H8AB, 1X .<?/SQC!.<_= &00<[FSN=B3>XW
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M"0561U_A."&! W*&#8SD*0,Y (/48QTXI<C[Z_+^NWZA==U]Z_S/XJOVG_\
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MVH!(;>&96\PN2I())*[LD<Y95".?XEZ\@$#@[OWOZZ?=T%SQ\_N/\W;]O/\
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MBKIWLA[>@KU7>_\ >;_OH_XTY9&!Y=AQZGV^M/YK^OD4YQ:?4\K/Q7MU&?\
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M?\*:97R><^Y)R?<\TB+Q_E_%GE?_  M>V/\ S*?BD>QLP2/Q Q33\5[3)/\
MPB/BG.,!OL63URP.00R/@ I@# &#CBO5-[_WF_,_XT;W_O-_WT?\:?S7]?(=
MX=G^/^9Y:/BM;D9'A/Q3SG_EQ'KST&.OI2'XL6X./^$0\5''?[*@_0C(KU=9
M&  ,CCKW/K]*3S6^8_,0H!9B1TSV7(9SV 52WJ,4A7C=^[^+/*A\6+8C/_")
M^*1[&S!(_$#%)_PMFU''_")>*C[BR&/Y5ZH78G(9AT[GT^O'X\^H!XI-[YZN
M>"<*3DD8^7).T$@Y&X@GL/5_<.\.S_'_ #/+A\5[<\CPEXJP?6RY_E33\6+<
M''_"(^*C[_9%'Z$9KU=9&P,O(AP,JQY!/)'&0?8@X(YI#*V?O$^Y)R?Y?RI"
MO'^73U9Y4/BO:D#/A+Q0I!S_ ,>:DDXQ\Q PRD=0?IG %!^+-J#SX2\5$GDD
M68QGIZ>U>IEW)^\P^A/^-)O?^\W_ 'T?\:?S7]?(=X=G^/\ F>6CXKVS<CPE
MXJ';FR']!2'XL6ZG'_"(^*CWS]D5?T(S^->K+(P!S(XYZ9/H/8T&5L\,6]R3
MGZ=J7W"O&_PZ>K/)_P#A:ULW)\)^*5[8-HI_'@>](?BK:C_F4_%1^ED#_2O5
MS(Y_B(^A(_K2;W_O-_WT?\:/FOZ^1:G%);KRW/+%^*UMCCPGXJZ][(>WH*#\
M6+=?^91\5'_MT5?YBO5ED8#F1QSZGV]C096SPQ;W).?IVH^XAN+;]V_S:/*1
M\6+8_P#,I>*5^MHIS^0KHO"WCV'7]9@TU- UVP:2*>3[3?6PCMU$:%]K/_>;
M;@#\:[(R,>Y'T)'Y^OZ5/:.QN8E))'SX)P2"8V7()R1C<>. ?RI3?NO^GN5'
ME;T5GZLW%8L,C:<%@<'NI(P#]1SFBD^]QGL#CZD]1GV]>N:*P-#)U'_7Q_\
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M63(Z3>*X-+T:'Q-.)%*2F;7$B74F>57E69S<EI$D*N2023D;>G+_ .!+_/\
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MYZ\KR<_>]@/3VI=P[D?GG_"O*?\ A)OB9_T(EE_X,F_^2J4>)_B:.G@6R_\
M!DW_ ,E4<K[K[T/G:ZK\#U3(&<%3DYY..P'OZ4;O=?\ OK_ZU>5GQ/\ $TG)
M\"69[<:@Y'Z7-)_PDWQ,_P"A$LQ]=1<?SN11RONOO0F[ZM[]3U7=_N_]]?\
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M=SKGPB\)ZY=:<2^G7.MVFE:O/I\F]9 ]E/J"7$UJ1*BR_N'CS*/,/S@&MO\
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M^)G_ $(EF/KJ+C^=R*/^$F^)G_0B67_@R;_Y*HY7W7WH2=GND_D>J[AW*_\
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M&Z=8X8Y)\&1H8(D+905/LGW^_P#X<UV/X/\ XD_!#]B3_@F]_P %E/VWI?\
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MW?[O_?7_ -:ER/4?F*\I_P"$F^)G_0B67_@R;_Y*IW_"4?$[_H1;+_P8M_\
M)-'*^Z^]#YW_ #+\#U/=[K_WU_\ 6HW>Z_\ ?7_UJ\J_X27XF_\ 0AVG_@PD
M_P#DFC_A)OB9_P!")9?CJ3 _C_I5'*^Z^]"/5=W^[_WU_P#6I<CU'YBO*?\
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M=1DV[XY.?)(X' SE %);(VL5./F&00:_FT_X.A_CW\<_V>O^"?7@;QA^S_\
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M%&1[_D?\* %HI,CW_(_X49'O^1_PH 6BDR/?\C_A1D>_Y'_"@!:*3(]_R/\
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M+]A+]F/]@[]B[P7X5_9?^(<OQO\ "_QA6U^,GB3X_7+VJWGQ@U;Q'I\'V;Q
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M76]/\.F&'Q5+J:W.E'1_$"7!U/3UFL K:;<(IF#,\:@NO]?'[%'PZ\8?!_\
M8^_9A^%'Q#TI-"\>?#?X&_#GP7XRT6&]LM4BTGQ)X?\ #MGI^KZ<FI:9/=:=
M?K:7<,D(O+&YGM;C;YL$KQLK'^=#_@J[^QI_P57G_P""O7[/G_!0_P#X)]?L
MU^!_CMI_P;^"ECX-1/'?Q.^'/@_19?$=R?$%KJ>G7FC^)_'7@_Q#*EO8ZC%<
M0WUB'MFD<*LZNF##@NB>[ZO_ "-(R;=K_P!:?U_P37?_ ()K?\',Y0K_ ,/Q
MOA4"(2?E^$\/R[0<L9!\(68.#][<">YC(&*_7#XW^%/@1X?_ ."=_A;]G/\
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M@)2,((]D<<(0%"K$0B-057<HE,M7?]?-_P!:FL%IZW/Y3?\ @F-^W*_[;/\
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M?$-]KOB'X^?''X]_!OQ/XZT"WUB66YUS1/!US;_&VUM?#^G:U))%#?2V<0U
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MMWXBLI[NTLXC>Z;%:M<3M<+%7P#^RC;?\'&/_!+7X+1?L+> _P!ASX(_ML>
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M^W:UKNG^%8-2AM[>WU;5;?Q!XEU_5=4O[!9-&@EU :;I,E[:VO\ :-[^[0(
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M/_P%_P#N6C^R_BI_T,FA_P#@+_\ <M>G44!S/LON1YC_ &7\5/\ H9-#_P#
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MVC((8D&VPS8"!7(W*BA.BY9?[+^*G_0R:'_X"_\ W+7IQP"5R"1C(&>.HQR
M#@@@E<@'C-% <[\ON1YC_9?Q4_Z&30__  %_^Y:/[+^*G_0R:'_X"_\ W+7I
MU% <S[+[D>8_V7\5/^ADT/\ \!?_ +EH_LOXJ?\ 0R:'_P" O_W+7IU% <S[
M+[D>8_V7\5/^ADT/_P !?_N6C^R_BI_T,FA_^ O_ -RUZ=10',^R^Y'F/]E_
M%3_H9-#_ / 7_P"Y:/[+^*G_ $,FA_\ @+_]RUZ=10',^R^Y'F/]E_%3_H9-
M#_\  7_[EH_LOXJ?]#)H?_@+_P#<M>G44!S/LON1YC_9?Q4_Z&30_P#P%_\
MN6C^R_BI_P!#)H?_ ("__<M>G44!S/LON1YC_9?Q4_Z&30__  %_^Y:/[+^*
MG_0R:'_X"_\ W+7IU% <S[+[D>8_V7\5._B30R.X^R]?;_CV'7U[4ATSXI
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M3-%9ZMI5P6EUW2HY]0\U=1*ABU^&O_!03X$WD_QST_QWIW[27C/QJ)/^%M_
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M<%F&;2I*<<5&*S&K=XZ4G*>+FY0DY5E)N<8Z852;;P;UBLUXVYO)5/\ C%^
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M;2;5IO$$44MK>W^A^,-,M;"U\.0>)/#J:OHL%O'K%RK?BU_P2=_X)6?LK_\
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M>MZC':NL@M]3ATU_$4T2QR0QM=2S6\0Q$!^?7QN_8*T3]A+_ (*H?!7X._\
M!;3XM_'+]K']B+XNZA#>? [XW7_Q(\86?@F'Q';ZC;6]HGQ1T2^U"]2SCT:Y
MFM]%\?:3IMQ!.^DW\.K6UQ+HDLZ1_M9_P=F>"O!TO['_ /P3K^'?A_3=(L?A
MY<_MD^!?!^AZ1H"6T7ARU\&W/@&;2-,T_2DM2+;^RTT-XH[!K=O*>TVRJ[*X
M=EKK:R\G?MKY?TKW!I?\-\OZ^\^Z)O\ @Z&_X)-M\38?!LGCCXUVO@W5O&5Y
MX,TGX_7?P;U:W^ NJZQ:W\MI//IWC>34X[ZYT5!&;H:F= S!8J9Y;>*+)']
M^DZMI6OZ3I>O:%J5CK.AZYIMCK.B:QIES%>Z9K&CZG:PWVFZKIE[ SP7FG:A
M9W$%U97<#O#<V\L<T+O&ZL?P,_X+W_LW? SP1_P0]_::^&GA;X7>!=#\)_!7
MX;>"V^'&G:5X9TK31X6O/!6KZ/:Z)J.EO96D4]KJ"Q6$9N;H3>=?+-+]JDFB
MN91)]X_\$CM0NM2_X)@_L%WE_</<7+_LN?".W\Z9R\C06'A>TL;9%=B28[>U
M@@MU#'*+&BJ-@4"XWV>NBM:_R_ B:2LUU/T2HI,CU'YBC(]1^8JK/L_N?^1
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MES1B[.UMK6MO=;+I9'\J^L_L&_ C_@H]_P '1?\ P4M^ W[2Z?$?6/ASX0^
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MW3;.58F6)$)O\FM_3I]_W@XI)[['ZS_L=?\ !?K_ ()X?MI_'/2OV;? FO\
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MV\1?]_'_ /DJC_A7]]_T.WB+_OX__P E4G3OU77OU^8)Q6R?WK_(_F3\*_\
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MBT_X33X9>-[%ICX:\::")]X@NH\7=O)9W*):>(-*;4M)GE6UN+AT_ 3X=_\
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M#?5<SY=[_@JK_P $]/A7_P %2?V3?B%^RMXJUWP[H/Q'L!I_C7X5^,)UAO\
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M]G+XV:%8^+OAW\5?"=_X>\6>$[BYCM]2NM%OE,,FJZ9@_:K&\TV\$%Y9:U9
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M/_@F-^PWX(_9#^)?Q(\"_$7QGH/COXF^-5U[P,FLV&F:I9^+M:AU."#3]/\
M$=I9:W)-I$2>3J-TMG':++(BQR,Q85^J;(^YLHP.3QM([^G./ID_6OAGX)_L
MP?$_3O$VL_&G]H'XOW7CCX\^(],C\-37OA>"ZT?P)X+\(Z?/NM/#W@K0FN4^
MR1:E*@U76[V>,75[?3R"28QQQJOTP/A]?  #QKXC  P 96) '8D76"?<<'M7
MO9=7Q6(H*IB<'4P4IWG2IUFE5='11=:DFW1JN2;]GS3M!QYI.=S\VXERS*LG
MS+ZAEF<TL_A1H4UB\PP="O1R^6.O)8FEEM7$PI5L9@J+]G"GC:V'PD\1-U)P
MPU*E&GS>F;'_ +K?]\G_  HV/_=;_OD_X5YG_P *_OO^AV\1?]_'_P#DJC_A
M7]]_T.WB+_OX_P#\E5Z'O=X_<_\ ,^?]WM+[U_D>F;'_ +K?]\G_  HV/_=;
M_OD_X5YG_P *_OO^AV\1?]_'_P#DJC_A7]]_T.WB+_OX_P#\E4>]WC]S_P P
M]WM+[U_D>F;'_NM_WR?\*-C_ -UO^^3_ (5YG_PK^^_Z';Q%_P!_'_\ DJC_
M (5_??\ 0[>(O^_C_P#R51[W>/W/_,/=[2^]?Y'IFQ_[K?\ ?)_PHV/_ '6_
M[Y/^%>9_\*_OO^AV\1?]_'_^2J/^%?WW_0[>(O\ OX__ ,E4>]WC]S_S#W>T
MOO7^1Z9L?^ZW_?)_PKQ/]IGX5:M\=/V:OVA_@=H6I:?H.N?&;X&_%OX4Z-KV
MLP7USI&B:O\ $3P%KOA#3M9U6VL0UY/IVGW6KPW5_;V2-<2VELX@1KDQD]!_
MPK^^_P"AV\1?]_'_ /DJC_A7]]_T.WB+_OX__P E5+C*2LVON92<4[I/[T?$
MG_!(G]AOQQ_P3C_8,^$G[(OQ#\<>%?B1XJ^'6M_$?5+[Q?X*T_6[+PY>V_C3
MQIJ_B?3[>RM/$-O:ZH+BPM=0BL[N:>".)YTE>WC\MU"?E#_P5<_X-S;3]NC]
MMSX._MN_L^_$KX>_!+QOI?B+P;K/Q_T3Q?H'B.ZT_P")-[X'\0Z1J>D>+M$;
MPQ978MO%EWH]A)HVN_VE'#!JLEOIU\]Y%,MSYG]'/_"O[[_H=O$7_?Q__DJC
M_A7]]_T.WB+_ +^/_P#)51[+2UUIKU\O\A^T79_@?(?_  4U_P"":7[/W_!4
MKX#S_!7XWQ:QX<U;0]8D\5?"CXK^%8K<>-/A9XS6VD@AUS2&N-D6I:?=Q.+7
M7/#UU)#::A !)'/;W<-O=1_B1X<_X)F_\'(/PE\&1? /X4_\%;_A+JGPBT^S
M'A_PI\0O&GA7Q+>?%/PMX5LPUKI5K_:6H^$M9U634K2P$<7V@:AK$H>)2FHX
M5"G].?\ PK^^_P"AV\1?]_'_ /DJC_A7]]_T.WB+_OX__P E4_9>?Y_U^ .:
M?1_>C\K_ /@D]_P1C^%G_!-";X@_%KQ)\1O%/[27[8'QLC6/XM_M$>-DG:_D
MLI;E-0O?#_A"SU&:]OK+2KO4TBO-4U+4;R75]<:RTN.Y2UM=.AM&_9YE<D9!
M/'\*%5&23@+C@9)..@S@< 5YC_PK^^_Z';Q%_P!_'_\ DJC_ (5_??\ 0[>(
MO^_C_P#R55*#CM;33J3>+_F^]?Y'IFQ_[K?]\G_"C8_]UO\ OD_X5YG_ ,*_
MOO\ H=O$7_?Q_P#Y*H_X5_??]#MXB_[^/_\ )55[W>/W/_,7N]I?>O\ (],V
M/_=;_OD_X4;'_NM_WR?\*\S_ .%?WW_0[>(O^_C_ /R51_PK^^_Z';Q%_P!_
M'_\ DJCWN\?N?^8>[VE]Z_R/3-C_ -UO^^3_ (5YI\:? 6H_%'X-?%OX9:7?
MVND:I\1?AMXR\#Z=JNHP7$^G:;?>)]"O-)M;^_AM5:ZDM+.:Z2XN([93<211
MM''\S"D_X5_??]#MXB_[^/\ _)5'_"O[[_H=O$7_ '\?_P"2J34FK77R3_S&
MG%=&_6S7Y'\DG[+/_!#7_@N[^Q5\)K;X%_LS?\%8/@-\,/A99Z]K?B2T\+:9
MX \<7EO;:QXAE6;5KR*?5/A_?7:M=2I'*T9NC&KHN!A17V)^RK_P;]_$23]K
M'P/^V]_P5)_;2\4_M]_&_P"%,MG>_"_PO=:/?:/\,?#6MZ3+!=^']=GL]1^R
M2S/X=OX3?Z;HFFZ-I6ES:FMEJNH275S80Q5_0O\ \*_OO^AV\1?]_'_^2J/^
M%?WW_0[>(O\ OX__ ,E5FJ5NM_4KG7\OY'Y5?\%9/^"1MS_P4#\0_!+]HSX%
M?&[4?V7OVX?V8[Z>]^#'QQL]-N;W3;FPGOVU1/"WC"#3A+J":7IVHW%_J&FZ
MCI]K>W,,NHZAIT]E<Z5>S15^>7C_ /X(O_\ !4O_ (*$>/\ X3:)_P %9?V[
M_A7XX_99^$'BNP\5W'P7_9W\&ZQX6NOBKK.A[8['4O$4MSH^EZ?;3ZI:FZLK
MW4[Z:XOM/MK^\?3=+MKN;[0G],7_  K^^_Z';Q%_W\?_ .2J/^%?WW_0[>(O
M^_C_ /R51[+S7XV#VB[/[T?@]_P4#_X(W_M)^./VV_@M_P %'?\ @FK^T)X)
M_9V_:,^%'PNT;X.W_@[XH:#J&M_#W7/ GAO1[SPWHNF:2NGV&IB&&3PW?S:'
MKFE:O&MG>V4%K/:WUM=QL)OBG]K_ /X-_?\ @IU_P4';P3\:?VM?^"C?PG\0
M?M&?"[QGX=U/X4?#[PO\-?%&@_LT> O"MI=6NK:Z(M-T^Q3Q#/XUOM6M+,_;
MX=.FL[BRM/L<NI+'Y,@_JW_X5_??]#MXB_[^/_\ )5'_  K^^_Z';Q%_W\?_
M .2J'2WUW]?R#VB[/\#\6/\ @K3_ ,$H/VH/VW?C!^Q=^UM^RI^T=X&_9[_:
MO_9'76(H-9\3Z#KVJ^#-9D\0G2;F]O\ 1I;+3-4U*W;3K_3KN*VL=5TQK?4-
M$U>YANG@O88MVG\+/^"6G[4=I_P5%_9V_P""DGQT^//PD\<:_P##C]C#P[^S
MY\6M&\+>'_&6GZSXY^+%II=_:^)?B!X>6^T^WT73O#.MZK>_VI;Z9=S07EE&
M9;=;8DQ;/V4_X5_??]#MXB_[^/\ _)5'_"O[[_H=O$7_ '\?_P"2J?LM;W6Z
M;WZ?UT!S335GKYH_+O\ X*K_ /!,KXE_\%!/B[_P3G^)'@'XG^ OAW8?L5?M
M&7?QL\9:?XRTSQ->WWC/1KG6OAAJK:-X9FT.TN((-5%MX$U*UDFU=K>U\V_L
M98Y&B@N$?\[/VZM/'[ ?_!PI^QE_P4!U>"33/@+^W+X$N/V0/BSXGDF\C2O"
M_P 2FL[30O"IU-8_DCDU.QT_PA-9W<NTRSQZH$+&UE+_ -*__"OK[K_PF_B,
M;?F&)"22.@!:X8+S@[L9&..M?-G[6O[!'P=_;;^"/B#]G_\ :!U7Q;XA\!:[
M?:1K-O<Z-?PZ1XK\+>(] NUO-%\5>#_$,T%^VA>)=-G\T6NH)97"1V]S<Q20
MSB78LRINZ=]5JM';;KI_PS^X2E%*UG^!\<_\%-O^"6_Q1_;H_:O_ .">_P"T
M)X)^*/P^\":!^QE\1Y_&7C#PYXJTSQ1?ZSXO@;Q+H^L&U\+W6BVEQIUO<-;:
M;-#$VKR01&:>&9G,*2(^WXO_ ."9_P 1_$O_  6_^&W_  53A^)G@BV^%W@K
M]F_6/@C?_"F?3/$C?$.\U?5/#/C;05UFRU**U/AA-,2X\46=TT,]Z+E8;.[5
M8GFN(?+_ $@\*?!Z?PCX6\->$[7XD>/-8M?"_A_1_#MKJOB+41J>O:C::)86
M^F6=QK&I1FT6_P!1-I:PFZOC;0/>3>9/)&DDC [W_"O[[_H=O$7_ '\?_P"2
MJ?L[ZWL_GZVUZ!S*UK/\#\P/^"J'_!-#XE_M_P#Q3_8#^(/@/XF^!? %E^R!
M^T)I/QC\6Z=XQTKQ)>WGB_2-.U32+^;2O##Z#:SV]KJ4T%A/;H^K26UHL\D,
MS2&*-XW?\>O^":7Q*^+G_!9/]C3_ (*8Z3\2_ ND?#;]F;X2^,/AWXD^&FHZ
M5XCD^(/B34/$OAKXH:'!J.@:E:VS^&K>RMKCQUI,\B:C<Q3+:Z;J<:1237=L
MT?Z>?\*_OO\ H=O$7_?Q_P#Y*H_X5_??]#MXB_[^/_\ )5/V5[ZK7U!325DG
M]Z/Q'_;Y_P""-_QK^(_[9^@?\%*?^"<?[3&F?LE_ME1^'['PA\2XO%F@:EK?
MPL^,7ARPLDL4/B2UTFWU"\34;O3+#0]#U*RNM,N=*U.TT?3[V2>QU"RANCY#
M\%O^",/[:GQ\_;6^$7[;W_!7S]K/P+^T'J7[.LZZU\!_@'\&/#.I^'?AQX9\
M5+=B_BU;5UO[#3;6&TM=4MM/UDVVDQ7U]J6H:;IJWNI1V-C%9U_0M_PK^^_Z
M';Q%_P!_'_\ DJC_ (5_??\ 0[>(O^_C_P#R52]EK>_YC]HNS_ _$#]MS_@C
M[^T5K7[;]O\ \%+/^"9/[3/AC]EO]JC7/#L?A;XS>$_B'X9O_$7P@^,VEV=D
MD$5WJUCI=E>RQZKJ8L]+@UB#4K"6SN9]/MM4M[_3[UKF25G[%W_!(7]I;_AM
MW_AY#_P5(_:4\)_M+_M(^&/"5WX*^"?@7X7>'+_PU\)_@WI.JV,]A?W^EV^H
MV%F_]KVEM?ZLNDQ:7:_9X;W5+G5+O4;VY2W6+]PO^%?WW_0[>(O^_C__ "51
M_P *_OO^AV\1?]_'_P#DJCV76Z_&W]>=[A[1=G^!_.;^QO\ \$5_V^OV+OBU
M^U7X(\!_MD?"3Q!^PC^TO-\>=<OOA+K_ (0\4+XZM/%7Q5\(>)=&\)ZK<7-M
MH[6=A>^$M<U72+O6)=-UJXLM:TO1\0VB7MP(X/I;]EG_ ((C>'/"7_!'?5O^
M"4W[6OC3P_\ $VRU_5?&>LR_$+X8:=JUA#X7UO5O$D7B3P3XG\,P^*[>TO'U
MWP;J5G8W\L=Y;Q6&I20M:LOV:61:_9S_ (5_??\ 0[>(O^_C_P#R51_PK^^_
MZ';Q%_W\?_Y*H]EYK[@YUV?X'\P5G_P27_X+V^%?@#+^PCX._P""HWP0'[)+
MZ)=?#[3O'E_\/_%D'QVT+X/EGTN'P';:O'HT]Y;A_"KG0UM['5)+>VM&%I;:
MY:1K'+#[[^UA_P &]OA7Q;_P2-\ _P#!+_\ 9 \>^&_AK-X7^,OA#XR^+_BI
M\6K+7=1F^)7BO3-+\16?BKQ%KL/A2RU"ZM]8UJYUJT32K.&V;3M&T;3+;1XY
M6C@AF;^@#_A7]]_T.WB+_OX__P E4?\ "O[[_H=O$7_?Q_\ Y*H]EY^74/:+
ML_O1XG^US^SAXF_:*_8?^,_[*OASQ-HGAOQ1\3/@5<_"C3/%>NV>J7/AK3=7
M?0M/TE-9U&STY&U:33S)922&.UC:\\B6-&0,CBOFG]FKP5#_ ,$=_P#@DMH'
MASXY>._"/B9/V,_@5XLUKQ3XTT&+5;#PMK]_HQU'5-#L]+@U>"UU53J6IW>F
M:(@N;=)Y+JY*I$L<@"_H%_PK^^_Z'7Q$?;S9!GVR+K(SZCGTKY>_:[_8 ^%?
M[;_PG@^"'QY\;?%&]^&/_"9^%_&VM^&/"?B5/#]MXUO/"%[_ &CI>@^,6DL]
M0_M?PE=79+:OHZ?9'O@$(N(I8XIXQP:V>MK;/N3>/][>^ZW/R[_X-F/V:_&?
MPU_8E^(G[4_Q.TN_TGXF?\%!/C;XH_:-O+#4)9I;JV\"WMYJ<?@0R,R">)M1
M@U+5M66SD"9MKFRE'RR*%_HQV/\ W6_[Y/\ A7D>E?":U\/Z3IF@:!XDU;1M
M"T32[+1-%T;2XA9:=I.CZ5:PV>DZ;IUM%<B.WLM.M+>*VM855/+BC5?FP6;0
M_P"%?WW_ $.WB+_OX_\ \E545)*UUTW3_K^NX-Q;O[VOFO\ (],V/_=;_OD_
MX4;'_NM_WR?\*\S_ .%?WW_0[>(O^_C_ /R51_PK^^_Z';Q%_P!_'_\ DJK]
M[O'[G_F+W>TOO7^1Z9L?^ZW_ 'R?\*-C_P!UO^^3_A7F?_"O[[_H=O$7_?Q_
M_DJC_A7]]_T.WB+_ +^/_P#)5'O=X_<_\P]WM+[U_D>F;'_NM_WR?\*-C_W6
M_P"^3_A7F?\ PK^^_P"AV\1?]_'_ /DJC_A7]]_T.WB+_OX__P E4>]WC]S_
M ,P]WM+[U_D>F;'_ +K?]\G_  HV/_=;_OD_X5YG_P *_OO^AV\1?]_'_P#D
MJC_A7]]_T.WB+_OX_P#\E4>]WC]S_P P]WM+[U_D>F;'_NM_WR?\*-C_ -UO
M^^3_ (5YG_PK^^_Z';Q%_P!_'_\ DJC_ (5_??\ 0[>(O^_C_P#R51[W>/W/
M_,/=[2^]?Y'IFQ_[K?\ ?)_PHV/_ '6_[Y/^%>9_\*_OO^AV\1?]_'_^2J/^
M%?WW_0[>(O\ OX__ ,E4>]WC]S_S#W>TOO7^1Z9L?^ZW_?)_PKE_'W@3PK\4
M/ ?C'X9^.]%M_$'@CX@>%];\'>+=#NXV,&K>'_$-C-IVJV,H(9=LUK,ZI( &
MCE\M@"JL:YO_ (5_??\ 0[>(O^_C_P#R51_PK^^_Z';Q%_W\?_Y*I-2>[7?9
MA[O:7WK_ "/YE?A+_P $=?\ @L/_ ,$_]*^)/[/_ /P34_X*&?!K0_V1?'OB
MG7M>\&Z%\?? 6N:Y\2?@F/$4874)O#6I6>BZO917^TQ1OJ&CRRIJ%S9KJTNC
M6%_=71G_ %)_X)(_\$H?"7_!,3X>?$NYU?XCZQ\=_P!I?]HGQ1;>//VC?CQK
MUI/!<^,O$4,E_=P:1HMG>2SWL6@:9JNLZ]JMM>ZE+_:U_?ZW?WE\BM)%;6_Z
M0_\ "O[[_H=O$7_?Q_\ Y*H_X5_??]#MXB_[^/\ _)50J5G>_P"93DFK6?WH
M]-9&X 4X"JO"MCY0!D;AN.<9RW/K2;'_ +K?]\G_  KS/_A7]]_T.WB+_OX_
M_P E4?\ "O[[_H=O$7_?Q_\ Y*JTI+2\?N?^9/N]I?>O\CTS8_\ =;_OD_X4
M;'_NM_WR?\*\S_X5_??]#MXB_P"_C_\ R51_PK^^_P"AV\1?]_'_ /DJG[W>
M/W/_ ##W>TOO7^1Z9L?^ZW_?)_PHV/\ W6_[Y/\ A7F?_"O[[_H=O$7_ '\?
M_P"2J/\ A7]]_P!#MXB_[^/_ /)5'O=X_<_\P]WM+[U_D>F;'_NM_P!\G_"C
M8_\ =;_OD_X5YG_PK^^_Z';Q%_W\?_Y*H_X5_??]#MXB_P"_C_\ R51[W>/W
M/_,/=[2^]?Y'IFQ_[K?]\G_"C8_]UO\ OD_X5YG_ ,*_OO\ H=O$7_?Q_P#Y
M*H_X5_??]#MXB_[^/_\ )5'O=X_<_P#,/=[2^]?Y'IFQ_P"ZW_?)_P *TM(#
M+?PY!7B0\@CI&V?T_GSQ7D'_  KZ]/7QKXA/_;1__DJNK\&^$+K2-<@OI?$N
MK:I&(;F$V5ZQ,+>;"Z^:29)"&C&2,$9)'!QD14O[-[7TOZ7UM\AQMS*VWGZ'
MLR$$=^X.1CE3M/ZK^7/<44U P R  23QT Z+C.#R "<CJ317&;'+Z_\ \?<7
M_7NO_HR6L.MW7@3=PX[P*/Q,DN*PJ[:+M&+LGI^K,9_$PHHHK?FC_+^")/"/
MVB?VG_V??V2O EO\3_VD_BSX0^#OP_N]9M?#UOXK\9:BNG:5-K=ZDDEKIB3$
M-NNYHXI'2/&2J%N@KX=M_P#@N7_P2'NIHX(_^"@7[.B22LJJUSXUM+6)2Q '
MF3S[(HAD\EW  Y) !K\P_P#@[HMXKO\ X)H?#&&XB2:WE_:J^&T-Q')C8T4]
MM?Q2*Z%FVHR,T15RY96+;4! 'Z(_#C_@BO\ \$F=>^#OPWU#Q%^PE^S?.VJ?
M"KP7J&N:I/X4TJPNI[B_\(:==ZKJ4FK126UY#*XFFN[C4#<0RVLFZZ C($M<
M[K2NTHPT[I^?GY&O(N[V/T^^%'Q@^$WQW\%Z;\1O@G\2_ WQ:\ ZNWEZ;XP^
M'GB;2O%GAZ[FV1O]GCU/1[FZMA<A98\V[NLP+ %,YKI- \7^$O%=SXAL_"WB
MGP[XEN_".NGPOXKM] UFPU:7PUXF%G9Z@WA[7$L9YCIFLI8:CI][)IUUY=U'
M;7UI,\82>,M_")_P2B\>ZE^PW_P4[_X+,?!G_@G1X+\6?M??LG?"WX5W/C/X
M;_!CP5X\ TS7OB'9^*/ASHT&B^&?&>IKK>EC4?#L?BSXF>'$U>9KJZUG2/!_
M[VZNYK2*:N-_X($?\%!?VA_V<O\ @GQ_P45U&P_9<\;ZAX'\.^(_VI/VB)_V
MLK_Q=I=[X0\&?'*Q^$_@^#PU\*_$7A6^T\ZKK&K2:Q#I6I76M1WPM+FWOGAD
MM?.C>H^LO^2/G[O_  0Y%Y_U\C^RCXT?\%-_^">?[.GQ)C^#_P <OVR_V?/A
MA\3?-BAOO!OBOXC^'].U?09)P3"/$\4EYM\-"91OB.M-9AT9&7(=2?L[PYXC
M\.>,?#^B>+?!_B#1?%?A3Q+I]MJ_ASQ-X<U.SUG0->TJ]C$MIJ>D:M82SV6H
M6%S&0\-U;320NI!#<BOY-/\ @@I_P22_8W_:1_X)L6/[2/[9OP.\#_M(?';]
MM77OB1XV\?\ Q*^*6G/XG\::;H^J^)-2TW2$\'>)M7DFU7PGJK6,9UF?7=!N
M+/5)-;NY)?MSQQ1*GHW_  ;:>+/%WP6^)W_!3/\ X);:WXEUGQ5X:_8A_:)U
M"/X1W.M7\VH7.@>!O$/B'5] ?PQ;M.)&73VU+23J'RNL2SW-P0D417;:K2TO
M&%GY;?CV^7YD22L^5ZKNKJ_X?U^/]+GQ9^+/PT^!'PX\5?%[XQ^-_#OPX^&7
M@C3CJOBOQKXJU&#3-"T6Q$T=NLUU=S,J;I9Y8X8(4WRSRL$B1FXJU\-/B5X#
M^,?@#PE\4_A?XHTKQM\//'>C0>(?!_BW0YQ=:1X@T6Z>2.WU+3K@ ":VE>&5
M5? R48=J_AV_X+Z?M)?%;_@J7IW[8WP8_9@\3+IG["W_  3!\#7_ ,2_VEOB
MEIR7%[X=^-7[1VFZA#HWA?X6Z/>6L\.GZI8>%;FXNTMI/M-XD-]9:AKYM#]F
MLUE_J$_X(JJ1_P $F_V 1M"@_L[^&$ & N?[3UD8'"@8R"W "YRQ YIPK7G9
MQC:SUM;[M?S&XI13ZV5^U[*Y^GM%'^ (]P1D$>H(((/0@Y%%:\RZ*-NFG0@*
M***KFCUC^" ****GF[1C]P!1115*4>L=?)( IRJ6(51EB<!1U/OCTS@$],D#
MJ13:_"O_ (.+_P!N;Q]^P9_P3(^(GCGX2:O=>'/BO\8/%V@? 3P3XITZ4Q:K
MX0;QMI>OZEXD\4:7('1[74K'PMX>UBPTG4H6^T:9JNIV=];@3V\3I$I\J;48
MV7==/O!*[2[GUM^T5_P5Z_X)G_LH>,;KX=_'C]L?X/\ A#Q]ITWV;6/!=AK;
M>+?$WA^Z\P1FU\1Z1X5BU:\T"Z4D,]OJD=M*D1\UU"<U],_LY?M9_LS?M>^#
M[CQ[^S)\<?AQ\;/"MC,MMJFH> _$NGZQ-HEVX#)9Z]IT,QU#1;N12&CM]1MK
M>5P<JI%?CI_P2W_X(+_L'_L]_LL_#'6?CU^SK\,/VE?VC_BEX*T#Q]\:/B1\
M??"FF?%*[E\6>+=/CU^]TOPY8>,;35+'0-*TUM0^RQRV-E!K6H,OVS6-1O[R
M6::N*\*_\$._&7[(W_!6#X6?ML_\$W/$_P /OV??V8_$>ASZ3^UI^SO?:_XF
ML=#\30W$MU#=V/P\\*V.D:AH\6FZE%)8:Q:PZCJ>G67A7Q':R2:!:16EU-;U
ME[6>CY8:^6WXZ^?X%M13MKIZ?U_PQ^HWQS_X*J_\$Z/V9?B/K7P@^/W[77P@
M^%?Q.\.+9R:[X+\6>($T_6],34+=;NQ-W;LI,7VBV99XP>3&RMP#D\#X8_X+
M6?\ !)GQ?J]KH6B?\% ?V9O[2O9XK>TCU7XDZ+H4$T\SK''$MYJMQ:6N^5V6
M-091\S*.IY_G3G^%W[)OQ;_X.E?VR/#G[7_@_P""/C/X:0?L_6>H6.D_':W\
M+W/A(>);?PWX<2RN+>+Q?(NFOJZQM,(2ADG,9D,(  5?MK_@I]^R)_P;N>$O
MV,/CUK/BKPA^Q5\+?$>E_#?Q#>_#K6?@5K/@#0?B_P#\)W]@?_A$F\':3X&U
M%-9\1WTNMM:QR:1<:=J6C3P/(NKP+9^8RS[63UY8*S[/K\_PV+BK/F3O=6M*
MSC9JS3A;EEW3DG)=&C^H>PU"PU6PL=5TN^L]4TO4[.VU#3-1L+J&\T^_L+R%
M+BTOK*ZMVD@NK2ZMY(Y[>>%VCEBD1T)5E)\(\._M3_ 'QA^T3X__ &4?"OQ&
MTWQ!\?OA3X0T?QU\2? >E6>HWC>"?#GB"2W30IO$.N16KZ%IVI:K'=6]W8:)
M/J"ZO<6#_;TLVM5:4?SF_P#!#/\ :K^)'[+?_!NCKW[4W[1(US5M%^ .E_'S
MQ7\&[+7I98]0\2?#;PQ$D_@'1M+N]057ELK[QR=>T+0)FDEMA##:6=LXMX8X
MH^Z_X(I6FH_LJ?\ !([]I#_@JA\<X1XQ_:&_:ATSXW_MN_%OQ!J+I-K.N:!X
M1T_Q)J'PX\%6US.SRQZ-_9>E/J?A_2UN!#I+>+IK* 0Q0Q+$N>3E&>FFME&,
M6X:/V?/%<Z@YI3DE).35I-QNC.%"G!<L4^7GG42N[J51.,K2^+E:D[4V_9Q;
MYHQ4K-?N%^U%^WM^QG^Q59:?<_M3_M'_  L^#%SJ\!N]&T#Q7XFLHO%FM6H9
MXVN](\)VKS^(-1LTDC='N+2PDB5L M\PSQ?[+7_!3C]@/]M76I_#'[,7[4_P
MI^*/B^U@>[D\%6&N)I'C62SC)$E[;>$]=73]<NK2$_ZVYM[*6.(,I=@"N?YH
M/^"!/_!.7X2_\%'_  1\2?\ @KG_ ,%'_#5C^U=\9OVA/B]X]M?AKX>^*UL_
MB/X<>"_"G@_7+W0;_P"S^!]09_#^H*FO6^HZ+HFF7=M=Z%X;T#2M.M-'T^VN
M&OIKC[O_ ."FO_!OG\._C%>?!S]H#_@EYX=^#_[#_P"V?\'/B5X<\0:3XN\'
M)>_"3X::YX7M&EDOAK&A^ -%O;>WU[2;B"T?3[C2]$@EUNUO=4T?6[R73[I!
M )V?M(PBO>;T5GR.7-[/G^+DYDG92NDE"_+[HG"$962TOS:ZM3Y'"[G?GDG%
MN\&W#G?/R\ZN?TJ7EW9Z;97FI:E<V^G:=IUK/?:AJ%_<16=C8V-M$T]S>7EW
M<-'!:VUK CS7$\KI'#&A>1E%?E'XQ_X+J?\ !(GP+XUG\ :_^WA\#V\0VM[)
MIUW+H>M7/B3PW9WD)VS0W7BW0K6_\.P>3)NCEDEU%4CD5HV8,A%?CC_P<*?&
M#]HSXQ_$;_@FQ_P1W\+^.I_!?BO]MC4/#&H?M+>,O EU<6-OXBTBPU2'POJ>
M@6#J([Z+P_J&JZ=XE\53Z/<0_8]0$.F6NK07%I$T3?LO\+_^"&__  2>^%'P
M?M/@A8_L0? ?QMH,&A#0]3\8?$7P/H_C'XJ>(IWMDAOM=U#XCZU:S>+[+5M2
ME,E\CZ)JNEPZ7-*!I,-A!%;PHFY2FI7^&5]4KQ@VFZ,)I>TC3;46TI)V7+?E
MNFN5*S:TNI+J^:,'3YN=OG:<7*\&^1R?.TY)-?I'\-?B;\.?C)X)T#XD_"/Q
MWX2^)GP_\56J7OASQKX'U[3O$OAG6;=PI+:?JNE3W-I,\998[B(2>;!*?*E1
M'!%=P!GY> V2,$@,N" 2X."B@YRS8P%))VBOYHOV&_\ @G+^U/\ \$5O%W_!
M1GXB_!G7M&^//[!^H^"?%/Q9_9O_ &2SX[\1#XJ1>._#EM;Z\NDIJ5]X:N-%
M\,W#Z=#K'A.2]M9==NM>TZWT#4-<CDU'3VFF_5?_ ()=_P#!0SP#_P %/_V1
M/!O[57@;PQ/\/O[7\0>*O!WC#P!>Z[%XEN_ ?BKPIJ#)<:1=:Q!I^EQZJDF@
MW>C:_#<'3;$+IVLPQ20O+#Y[N^O-%N#O)\L9S4;2^)).5DFM%RV<4VHM78TN
M5WC\*4ERM73<Z3I7DVW)N*<I1NVE)]59+ZT^-/QK^%/[.GPQ\4_&?XX^.M"^
M&?PK\$Q:=/XL\;^)[G[%H>@1:OJ]EH&F/J%R5(@%_K6IV&G6P8 RW-U$BYR#
M7YWC_@NE_P $A"<?\/ /V>P<XP_BV%,' )!W(,8S@YQ@@CJ#C\0/^"H__!4'
M1_\ @HC_ ,$L?^"VW@'X=?!O4?#?PG_8_P#'?P8^$FG?'2Y\86VM:+\9?%=M
M^TGX*TW5?^$:\/IHMH='M--M]'AU;[0=6U*6YTS7=%F81M<,H^L_^"9_['__
M  1<\4?\$W_V'?%GQE^"O[ &J?$_Q!^RK\&=;^)>M>/M/^#P\8ZCXRO?!&ES
M^(=0\77.J2?VL=>DU%YYM5FU(B\-VTAFC5W>J]JTW90;;YFW'=[='9:16RZ7
MW;;<*<5%+5625E;9))=-[):[G[H?LZ_MI_LC?M<PZI)^S'^TC\'/CG-H<,5Q
MKFF_#CQUH7B/6M$MYV*0W&KZ+8W<FIZ?!*PQ'+<VT<;=0V.:W/#_ .U+\!/$
M_P"T1X]_9-TCXAZ>_P"T1\-/!^A?$#Q=\,+VRU+3-:MO!?B0C^R/$FE3:A:6
M]CXATR4%7N9]#N;\6$;QR7OD*ZD_Q+Z_X/\ V-O@I_P<I_L&>'/^".]]X72T
MUW3+JV_:M\-? GQ!=^(_@UI=O??\)%-XATR6_P!%N-1\.66COX/M=(U/Q3I6
ME7<GA_3==CTA9%LM7E>TC_7+_@X6CUG]CCQ]^PW_ ,%A/A'"FF^-?V7OC3H_
MP>^-5S:W4]B?'?[/_P 5+IK63PIK]O;2K)K%JEW%JL-N+MIHK6*\MH8Q$L:!
MG[:5K\L='9Z:?U^/W XI.U]UI_7Y'].Q!&>A 8J2"",KC/(XQR,'H>V<'"5A
M^%/%.B^.O"?A;QOX;F-SX=\9^&/#OB_0+ERGG3:'XGTBRUS1Y954.%=M.O[=
MG5)3'N?*NXP*W*VA--7E%7OT2M;[R0HHHIN2Z17S0!1110I1ZQ7R2 ****')
M=(KYH HHHH4H]8KY) %%%%#DND5\T HZCIU[]/QKSWXK?%WX4_ GP-JWQ-^-
M7Q)\$?";X=: @;6?&OQ \2:7X5\,V!=28HIM5U>ZMK7[1<89+6W20SW,G[N%
M'<@5Z$HRRCKD@8/ .3CKVK^*KXM_#P?\%S_^"_\ \8_V4OCWK/B>Z_89_P""
M:_AVXDU'X0:-KU]HVD>/?&MG<Z;I5SJ&LS:7/$UP?$WBK46LKW4(Y;/68/#V
MF?V3I=]:6]Q<F3&K.2Y%%N#4E)<ME=JZW=^C>RNNC5QJG"::FHO6#O9*=H35
M3E516G&$I)*<8R49Q]V2:;/WZ^'_ /P7*_X))_%#QQ;?#GPC^W3\$Y?%&H7\
M&F:;'K>L77A?1M3U"XD$-M:Z;XB\0VNG:'>RW$Q$< M[Z02N\:IEG7/Z'?%O
MXU?"GX$?#+Q!\9OB_P"/?#O@'X5>%M.M-7\0>.]<OH[?P]INDWLT,%EJ,E^A
M>)[.ZEN85M[B/?%*)HW1V5@:_,3]IW_@A%_P3 _:&_9[\6?!31_V0/@7\'-9
MN?#%Y8> OBA\*/A]X=\"_$3P=XGM[!H] UT^*]"T^VU37(K:^6!]2L_$<VKV
MNJ0FX&H07;,-WY*?M/?LK_M>_L5?\&RO[6'[-G[97Q6\$_&+QI\-M&M-.^'W
MB;P7K'B/Q#'I?PMN/%_AMO#/A+5=6\2Z9H^HWLGAV9-0CTJ5[4Q66E75GH\#
M26^FP22Q*34N:4$Y<RFI2YG:44^5I2;Y6KNTHV>MF]$7R0DY2:C*<W>=1*,9
M2M*3@GR)*U.,G""M9025G8_IW_9R_:E_9W_:\\#7WQ-_9F^+O@WXT^ M,\0W
MOA/4O$W@C5(]4TZP\2:?:6&H7FC7DD>&M[Z&PU73KTQ2JI:UO(9ERC;JZ+XY
M_'KX-_LS?#77/C#\>_B+X9^%?PP\-R:?%K7C7Q;?QZ=HUE+JUY;Z?IT#3ODR
M37MY=V\$,,(=W9\A<*Y'\3'_  :M^,_$W[(/[5/Q*_82^(6JR2^%_P!K;]EK
MX+?MG? NYO"MM;ZMJ,_A>QE\36FDPLI'VJYLM8URPN9(]TD]K\-994DC<[)/
MJK_@ZI\>^+?C[+^SO_P35^%^HFVU76/ 7QV_;>^-1AA>2+1_A]^SU\+_ !UK
MW@E]8$+NR6.OZEH7C&TQ=L(QJL6@W+++(\3)/.[2=E=N4FDDDIRM[ZT^-:.,
M]9+=/:Q[.':Z=N9-NTFKZR2:YF[MN]TW9M:(_I+U3_@HC^Q#H?[.'A_]K_5_
MVEOAE8?LS>*?$Q\&^'OC--K:#P9JWBH7>JV#:';:@%.Z_%WH>KPF!E!+:?=$
M$*A(^;5_X+H_\$@V=5'_  4 _9X#%@BE_&$"(K'^)G8!57^\[$ <Y(&<_P 9
M?QS7_CC;_93) &/VW;IA@ 8SXY_:!&3T&3DYP >1G)W%OZPOAS^Q3_P0@F^#
M?PUU3Q;\#/\ @F];WEW\+O =[XAU'5[/X)V%XNHR^$-&GU.YU34)KJ*2*]>\
M>:2\GE:"9KAI3.YF\P@523E'9J"5XV]V<XZQJ5$OBG&]TWIY:*T2H0E#E=]5
M"\K1<Y2A/GC4;<6U4NDG.-G:*M:Q^K/P!_:E_9K_ &K/#=]XN_9J^.WPK^.G
MAW2[B&QUC4OAEXTT3Q;'HM[/'YL%EK46E7=Q/I5W-&-\=M?1Q2,"" 20#[MU
M_P X_G7\)'_!/+0/V<OA=_P<\^*_ ?\ P2EU>UU3]D*]^!'B(?'K3_ASKNL>
M)/@UIVMQ^&+F^\2:=HVN![O2KW0]&\8+H/\ PB;Q7MYI,/B*2[L-"OYK<&-/
M[M_\_=V_^.\[?]W/'2MJ,E[_ #)R<IN3;;D^9Z67,WRQ22Y81M&.R75U.,59
MV3FVW.HTO:5')J4G.6\KRUMM':*2;3****U<H](KYI$!1110I+K%?) %%%%#
ME'I%?-( HHHI<W]V/W >:_&+XQ?#+]G[X:^*?C%\9O&&E_#_ .&'@BTMM0\6
M^,]<:2/1] L+N_M],AO=1FB21H+7[;=0123,OEPJYEE9(E9Q2^!_QU^#O[2W
MPTT/XQ_ +XC>%OBS\+_$KZA%HGC7P9J<&KZ+?3Z5?2Z9J=LMQ;LWEW5AJ$$U
MG=VTH2:"XB>-T!4UV'CCP3X/^)?@KQ7\.?B#X=TSQ=X%\=Z#JWA7QAX8UBUB
MO=+UWPWKEA-INL:5?6<RF*Y@U"RN);=A(1LW!U*D9/\ %U^POXT\2_\ !O1_
MP53\<_\ !.;X[^*IH?\ @GE^V;K5Q\1/V7/BGXKU!+;PO\//$U])/!ID&H:M
M>LEEIUQ)Y$/P[\=K,T(;5M/\)^)(K2TL]<NKJ3.522?PQM>U^5_+K\O4:5[]
M_P ^Y_7=^T;^U3^SG^R'X(L/B/\ M,_&+P1\%_!.J:Y;^&]+U_QOJ\&EVVI:
M[<P3746F6$;L9[NY%O!)/*D$3^3&%>4H'3=X1\:O^"HG_!/G]G'4/".D_';]
MJWX5?"S5/'O@[2/B#X0T_P 8:S_95YKG@O7XS-HOB*U@GC$BZ=J40\RUEE5/
M-3YE!%?S8_#?PSK7_!Q?_P %7]3^.GC"SU&?_@E1_P $XO%DWAKX4Z)?BYM]
M!^//Q9TJ]M[BXOI8-L45]%XCU.SM?$'B!W*O:>#;?PSX?DFO%O\ 4(QB?\%5
MO!O[+OBS_@Y/_8C\*?M9V'PA_P"&>9_V;K&#Q5IWQ@OO#^@?#&&VL[3Q0VCV
MNI3Z_<Z=H5K;07<=NFG6\UQ'$)%2.-=V%,NN^D86O9:/]'_7W#4;NS[-Z?@?
MO]_P_3_X)!\8_P""@'[/9R0!_P 5;#U/ S\G ]2>G4\5^@OP3^//P;_:/^&6
MC?&?X&_$7PS\2OA5XA34I-&\>>'+^*X\/7\>CSRVNJR17[E(A'I]Q#+%=2.5
M2%HVWL,5^,+_ +*G_!M HD:3P]_P2QW*=[ _$GX'+A"0\A+'Q0I+^608P%"@
M[MRJ #6#_P %D_A3'X%_X(/?M >!?^"97A_0M"^'@T#POK.C:3^SR([[0]3^
M#.H^.++4?BS<>#I_"DE[;ZCIVJ^'?[7?69M,>X%U8-?!)%<!XW[625W&#TZ)
MW_,32O97WMK8^Q_&W_!;[_@DM\//'#_#KQ1^WA\!8?%$%_<Z7?)I/B=?$&B:
M5J-G,]M=V>L>)=%CO=!TF>UN(Y(+A+^_@,4J.CX92*_13X8_%+X9_&OP-H7Q
M-^#OQ \'?%'X=>)X'N/#WC?P'XATSQ/X8UB&*0PS-8ZOI5Q<VDK03*T,Z"0/
M#*CQR*K*0/Y%_P#@D?>_\&RWQ@_8[^"_PHU?P7^QW:_'&Y^&GA_3OC5I'[46
MB>'-,^+=Y\39M(MK;QM=:1\1OB7;69ODU/Q ;JY\*Q^"->,5KID\$%G:V=Q:
MFWB_33_@DE_P2E^)O_!-/]H[]K_5?AK\:?#'BK_@G?\ 'ZXT[Q;\ O@U9^*/
M$/B35_A_K*W<=XM_YM]#-HD$ T[5M4\/OJ&FZM?WOB#2-*\-3:W=75Q:B5$J
MTK_#!KR6WX_U^5.*4;ZW\S]\2".H(X'!!!![@YZ,IX93RI!! (I*>^XD%A@D
M E@&4/\ [05BV 1[DGJS,V6+*W4DX)VC?JK+N0%%%%"DKZQ5O) %%%%-RCTB
MK^:0!11124E?6*MY( HHHIN4>D5?S2 ****E276,;>2 ***4 DX')/0<<_3^
M9]!D] 35.4;/1?-*P"=P,@$YQD@9(4M@9ZD@' ')Z 5\N)^VS^R7)^TF_P"Q
MXGQ]^'+?M/1VPNG^"W]NVX\:[&TN/6_*&G$Y:[&DRI?M9*QNEMP[M$!&^WV+
MXM?%/PE\#?A5\2OC1X]NX;+P5\*/ 7BGXB>*;B65(R-%\)Z)>ZY=6\6]@C7E
M_'9?8;&!P[37=Q#%'%),R(?\T)/AG^T)%^SU;?\ !S%&^N'XRK_P4TU3X@W%
MO;O='[7^S[>77_".2K'I,ZK:6%I;^(K75?#']I K;2:'K5I# BV\2O%A.JT[
M)1LU?;\FG_6I48WOY;>I_IO^+?%/A[P'X6\1>-O&.K6?A[PEX2T2_P#$GB37
M]2D\G3M'T+2[>2ZU'4[V<Y$=M:6\4DLS\[54\9KY<O\ _@H#^Q=I7[/7AS]K
M#4?VC?AO9_LY>+M=M?#/AOXNSZPB>$M7U^]U!]*MM*M;TKEKN348Y+0QL@*3
M(ZOMVFO._P!IOXM>#/V@O^"6?QX^-WP^U"WU/P1\7OV,_&GQ \.WEI<?:+8Z
M=XH\!7&I+#YBJ _V*YDGT^78%!FM)0N%.:_ER^ WQ@_9I^"/_!K]^R=XR_:L
M_9BC_:R^%K?'FRTE?A6/'NL?#9AXCU#XGZE'HWB?_A)-&M[J[9M#G4W1TLV_
MV75<FTNI$AD=ZGVC36D=KZWZ=]?ZZ7%;UW2M_P .?W$:;?V6KZ;I^L:9=0WF
ME:K8V>I:??PN#;75A?P1W5G=12G"F&XMIHIT;./*D1C@,*N;6P3@@#J3Q@\D
M@YQR%4LP[+ACA3FOQN\0_P#!5KPM\$/V^OV+_P#@GKXP^ FI^"O W[6'P-\*
M>*?@=\=Y?',5QH$.N/X8O6LOA2WA>70_[1FU"PO++1/#AU5=?D6YO-?T6:6S
M*--&GH?_  53_P""H?AW_@F1X'^!6H1?"/5?C]\6/VB_C1I/P8^%GP?T+Q3#
MX1UK6M0U2(FZUY-0GTG6(Y+73M0?1M&E2/3_ -_J>N:;$\D*2R2QU[9]H:/M
MWVZA9]G]Q^IY1@2I'*XW=]H(SN.,X49 9NBD@'!I,'&['RG&&_A.1D8/0\<\
M$X[XK\'?VVO^"WMO^SS^TEHG[#?[+'[)/Q)_;I_;6D\,6'BOQY\(_ACXBA\/
M^%?A-I^H:18:G';^+O'UQHVLQPW-K:ZG9/=R76E6FF6,%_I45]JUE>ZI!9ON
M_L%?\%J-/_:>_:4UO]A_]JC]EGXE_L%_MG:?H4_BCP[\)OB3K%IXG\/_ !(\
M.VMJEY=3>"/&L.E^'X]1OH83<7T.FQ:9<6=_86UU=:5JE])9:E%:M57>UH[Z
M^[HOGM?Y[!9G[B44NTY(QG&X\8((4[6((R&4'C<"1[XI*T4T^D7Z(044457-
M'^7\$ 4445/-_=C]P!1115<T?Y?P0!1114\W]V/W %%%%5S0_E_! %%%%3S?
MW8_< 44457-'^7\$ 4445/-_=C]P!1115<T?Y?P0!1114\W]V/W ."L0#@X.
M<$\ D8R 3U/(X&2>P-?#OQR_X*7_ /!/K]FCXAP_";X^?MB_ #X5?$EWMTN_
M!GBWXBZ!I^N:*+L9M9?$EHUV7\.6]PF9(;C6?L<4D8,BL5!-?9WB"TU>_P##
MGB&P\.:G#HGB._T#5[#0M>GMWNK;1-;OM.NK;2-2GM$D@EN5TV]DAOI($N[4
MSO B)*A;S%_EV^ __!)W_@F7_P $S/@1\9OB%_P6#\?_ ++O[0?QK^/?CCXA
M>*_%_P >_P!H+3]+DUKQ)H-Y;K>IH7PI\->-K[5?$%KXS@,FK:GJ4_@1;K7I
M+N\LTAD%M9VZ192JR3=HPW>MNWS7D5%)[NW;^K']/'@OQCX0^)'A?0O&_P .
M_%?ASQYX,\4VD6H>&O%GA#6;#Q#X=\06$V_RKW1]7TN>YLM0M7V-B>WF>/Y3
MDBOBSXC_ /!4W_@F_P#"#XHR?!;XG?MN?LW>"/B?;7O]FZIX4U_XH>&K.[T#
M4L*?[.\2W#WWV/P]?$.@6UU:>UF9F5 FY@#_ #V_\&Y'P]^/_CC]A;_@IMX,
M^!7C+Q?\(/V<OB?\9OBEH'_!.'XA^/M,\2:E-X$\.Z[!XNTI?&VBZ3J%]I]]
M>Z5HMI-X#O9);&_B27Q7I>NI)/)?QW>SO_#_ /P3#_X(Q?\ !*?]@KQ1\/\
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MNS-Z-KS8VBBBJYNT8_<(****I2CUCKY) %%%%2Y+I&-O- %%%%4I1ZQ5_)(
MK3T?_C_B^DG_ * U9E:FC_\ '_%_NR_^BVK*J[PE9626A4/B7S_([%3QR,<
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MK_VU5QM/)IT,NQV(AFW]FRJ0S".6>RP4I8^IA)4YO$QPL:WU:,)^W]FXI/\
M63]EO_@L3X,_;&_X*3_M*?L"?![X0R>/OA7^SSX3O;_QE^U#HWC>RO?!E_>V
M?V#1-6\+Q: FCO\ VA'?>(-:/A>QOK3Q&WFW.CZS=FTN;. 3-_-&O[5VI?\
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MVF0W_AF[@VWVFZG)+=1S(Z0;!)_RM/NU]W3_ (/0J5M[WUVN?)?Q"_X(D_\
M!%W_ (*8_#SP[^T'X6_9\\$V=G\7M"M/&?A_XM_LU^()?A_/J%UXAMA?7.I:
MM9>![R/PQJOB+3[BZG@UJSUVQO9+?7+>6RU&VCN8&6+\D_\ @BE;_$K]@/\
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M;HJI_:%A_P _UE_X%V__ ,<H_M"P_P"?ZR_\"[?_ ..4:^?X@6Z*J?VA8?\
M/]9?^!=O_P#'*/[0L/\ G^LO_ NW_P#CE%WW?WL"W153^T+#_G^LO_ NW_\
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M,=.\!V47@G1&UW5?[<U6":ZM3)9"2-4L5BAD+SLX+2;4&6917Y#0_P#!UO\
M\$T3Y,]SX'_:PL[ J)7U%_@EK4EO:6[+O-XY0[980@\P&/@H"=Q'S5DYM.W-
M_7W"2;U2^[8_HC'PS\(=K2[ P#Q?W! ';GL/3.*>/AGX/Q_QY79YQ_R$9^2
M">,]@1G' Z=017S+^Q!_P4,_9(_X**?#34_BC^R?\5K'Q]HF@7UMIOBW1;[3
M[OPWXT\$ZE>0/=06_BGPGJ>S4=*CN[=)'M;Z19;.[$4AM9F"&O2_V<_VK_V>
M_P!KK2_B/KO[-_Q(T?XL>'/A5\2]0^$?B_Q'X<CN7T&'X@Z-HVE:YJ6D:7JD
ML<<6M6^FV>O:?YU[8EK47C2V^^62VF%/F;MJ[>OZK_@B/3/^%9>#B3C3KDGK
MSJ$X)YQGD>O&.N::?AGX-'73KD<9YOY^F=N3@':-V!EL#) K\5_C[_P<B?\
M!,+X _%[Q9\'-2\:_%+XH7_PUU2[TCXI^-O@]\,-?\??#_P%J&GR20:C!?\
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M**<4W>[DOP_0$[=$_4X#_A6?@_\ Y\KT^QO[C!]CQT--_P"%9>#_ /H&W/\
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M:O0**(J3O=R7X?H"=NB?J<!_PK3P?_SYWO\ X'7'^%-_X5EX//)TZZ;W.H3
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M9:(\D.AZ7 FS4=8N2MI:W%Q:P,6DF05X]JG_  4/^ FD?M^Z'_P3=NU\9?\
M#0WB#X63?&&PF307;P2GA4"]!6YUXLJKJP_L^</%'&50K%N8;TW4W'I*5_/O
MV*;NG[J^2V/JT?#+P<0"-.N"&&X?\3";.,D9((!'((Y /X8I1\,O"'.-/NEX
M)RM_.3@<D8'/O^%=Z"-[G@>N3\Q.XX=VR0S%<+@?=V'.,U\@?MS?MM_!S]@#
M]G[6_P!H/XRG6]4TRUUO0?"/@WP+X0C@N_'GQ-\?^)[Y+#0/ _@?3)Y(TU#7
M=0)GN DC+;P6UM))<R1JR$RY275_U\O0D^@_^%9^$!R;2ZQEA_R$)P,KC<,Y
MQD9'%!^&G@\C_CQNVZ<'4+CG\^WH>GXU\0?M"_\ !3SX!_LK^.OV.?AC\;O#
M/Q)\,>/_ -M:ZTO3OAOX:L] @UB;POJVJ2Z;$NE^.KRUF-GIM_I]UJUK9ZE'
M;&;RITN3DK;.P_1UT:&5H6)#1L\;C(8'8Y &>2"&&0,#N/3(FWO)_)_?_7_
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M  834?\ "LO!XY_LZZ&.<C4)R1CG.!R<=:] ) QDXSG&>/NG#=>F#P<]#02
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M?^?.\_\  VXI?^%:>#_^?.]_\#KC_P")KOZ*KE_O2^\KF7\L3S[_ (5EX/\
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MY0PT.C0-XBUJU1OW+:I):23PL]I$U?U,_!CX!?!O]FKX6^'_ (%?!+X>>%/
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MJ)^Q_I'Q!U2#2_#/[0/PHN+/X<?M"> ;)5L8M(\5V5J8]*\7Z3I*,LEAX?\
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MU(W_  R?^TXO&3\ OBP02,XQX*UC@CA2#GD'DXXZ5]!U\\_M=_\ )I_[3?\
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MH$'AF+0X-+\.Z[H":KXSN[V"XU<6UJEO/^,/_!:_]F/X+_L=?$[]B[X=7_\
MP4C_ &COVZOVJ=1_:#\(^*?B!H_Q=^+2>-/!WPQ^'EEJ=K9QW47@Z&[U^V\#
M>(M6\0301Z>DOB9)+C1;?5?(THQ)+<Q.[WOM;LNJ[;ARQ[(_0[_@LO<_\%)(
M/^"_7[ K?#B+]FQ_%5O+XM'["!\06&KG2IM"?1;$>,/^%]QPZBDESJ::T=6&
ME-I#6<"Z>+%%\QP['F_VZOCC^W!\"O\ @X5_9@UOX1_!?P!\=_V[?''[!?P]
M^&$W@+3=1O=$^%-I\6/%.F^*'\:^*K6ZN96NH_A_X0ETS6-<2+5-1M(QHUGF
MZU*W1"Y^^?\ @L5XO\+_  ^_X+]?\$1O&7CGQ#HOA'PE867Q,BO_ !+XCU&U
MT;0K%KF2UT^-KS5+^6&RMU-]?6UL&DF4&>>&/[\BAK7BVYT+Q+_P=K? O7-+
MN].UW3+G]@677?#^MZ?<6^H6-Y#=P>*A9:UI-[ TD%Q!=Z==R/:W=M(Z36L[
M&-VCDR3J_.2_(&DDW9:+\#9\,?\ !4[_ (*U?L0?MM_LL?LV?\%9_A3^S=KO
MPF_;'UYO!OPT^*G[-ME<V#>%O'=S>Z=IATV]^T:YJ,.K_P!BZQK&B6&KZ=/;
MV<TFGZM:ZG9:EJ"* US]JW71^W9_P<B_LG_L7>(Y;?4?@E_P3Y^%6H_M1>*/
M#=U;I?Z)XG^+-YHVEZU83:E$Z/"UYI<&L>%+.S0JWV.;1[B2.7SI+A5R?^#D
M]@O[4?\ P09<L1(/V\=3^?;DG/BS]GP2$L@W#S7^;RQRH8Y'-'[-=M%X!_X.
MP?V\?#?B=2=<^)G[*ND^+O US=QR+)-HB^&_!>HWL.ER!?)FA2W?[++ABP:R
MF1?G@E535R46]&UKVV_4(J,K.RU?;Y,Y[_@X3=W_ ."F/_!#623+._QXO6=L
MIM8_\)WH&YL*SY+[BP_>$+T 5F->S_\ !2G_ (+$?MZ?LV?\%8/#'_!._P#9
M&^ /PQ^/&I?&/X&>%]:^&.@^)(;G1M9TSXK>-+KQ"@\4>*_&!U:WTV'P#X3M
M-%.K:SI]Q9VZRV4,JRZS:*=X\3_X.$21_P %*?\ @ADP[?'6\Z<\_P#"<^'N
M/K77?%>&&X_X/!O@$)HHY?L_[ _BFYCWHK-%*GPW^+ BGBW*=LL;9,<@^9&R
M5((H>DI*^BDU^-O2_P"78'%*^BTO;[RMH7_!57_@KA^PY^W?^RO^S9_P5?\
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MW&LZ;?V5U?:J;J-M:T31;.SUC4)M12UL?!;_ (*A_P#!1;]E#]N'X/?L0?\
M!8GX4?!/2K#]J:6;3?V=OVIOV?(]0TCX?ZMXOM1'$/"WB?3-3OKUOM=UJ,T%
MA/YPTK5=/OM4T66+2IM/U5+N/\//B#^RMX;\1_\ !QE^W%\%_P!HG]M;]HS]
M@?4OCSIND>/_ (!_%7X1?$J?X2Q?%BPU73O#]SI_@*_\5I=Z;;ZG:>4MW8:'
M8?:3"VL>%-4L&4W\,,1]?^/?[$W[!7P2_P""@'[!WP!^)'_!2+_@I!^W-^TG
M<_'#PMXQ^&'P^T[XH>$_COI/P@U[0O%?AW6?M_C_ /X2KQ')<>";'Q&/#Z3Z
MS_PCT4^N2^']"N+^]LA:6UG*Q=W]';?3?:WG?3S&XJST[L_7S]M;_@JC^W5X
MV_X*!ZG_ ,$O_P#@E!\'?A;XJ^,OPY\,V?B_]H/X[_'47EU\,_AO:7MK:7<F
ME0Z9;7VGLSZ;;WEK%)?37USJ&H:Y*=/TG1=2BMKF:'P;P!_P4W_X+&^$/C]\
M8O\ @FC^UE\$_P!G?2_VQO&WP0\2>.OV0OV@/"6A^)#^SKXKU2STJ:ZAT3Q]
M;6>I72O9ZSI-GKEO!>KJFE7ND>)DL-+UK2;*VODN9>&_X)_?$CPI^R?_ ,''
MO_!7?X3?M'>)M.^'GBS]K63PSXY_9^U7QMJ5MHFG>-/#4/B&\\6:?H>BZQJ=
MQ!I\L][H.JPPZ)ID+O/J#Z)=VT*B6VF1/U[^(W_!6GX06G_!17X;?\$SOA-X
M1E^.GQ$^(7PW\8^(_B?X]\ >)=$U+0O@1:V&D:K?O:^,?LJR273)I<$-_J=M
M;W0N;![VQMYK?SIT!?FW\NFO3NO6]_*Q&S22NN_SW/YP/^#<3QC^W]X$^ _[
M<?C--*_9NU/]DGPEXS_:>\3_ !5TS6-'U2^^)6H?M Z-X(U#4-*L=&L3J"Z/
M=_#&?7+>VM]6TZ^M)+B32)+F%+@%SG]7?V,?^"QNB_#O_@A5-_P4J_:'^&OP
MQ\(S^&_$/C3PYH_PD_9^\%V/PX\(>*?&+^*8?"W@KPWH?ARTGO(M(G\0:K>6
M7]NZNTTT6GV*W6HSQM%"17PK_P $#_B+X"A_X)U?\%:?A;<>,_"L/Q+7XS_M
M4:TG@.;7]-A\83:2/!NNM)JEKH$DXU2;3XA9W+37<=L8$6WF+NOEL:_,K5/A
M;XR^('_!HS\*_%/A#3-6URR^"_[66I?%#QSI6D0O-(W@VT\:SZ)J>H7MO%NE
METS17U.'5=0N'0VUC;V\E_</'#:LZRFU:W9_)W_3_AS3E3Z+^OF?L_HW[;/_
M  <V>,_V>!^WCX8_9H_8PL_@A?\ AE_BSX?_ &8+S3]=N/CKJOP>DM(]<M]0
MMM0?Q):O/K=SX=47FEPR6UIKNH63V\T7A:>[F@MG[[]IO_@X9UUO^"-OPW_X
M*;?LH>#O"%AXYU/]HGP/\"_BY\*_B387/BNU^'FLRV?B>]\;>&[:2TU'0)KV
M\GM](TW5/"VJW,B,VBZM:7E[8HSM;Q?K3\)_^"E7[$D__!/WPC^U_P#\+U^&
MFC_!C1?@?H^JZR#XIT#^UO#FK:;X.@M]0^&<WA^2_2^7QK::E"WAVU\,QPK=
MWFHJEI"EQ+-&!_ %K_@3QIH?_!LK\;?BAXBT#5/"WA'X_P#_  5N\/?$GX6:
M1?6LUI9WW@Y?AIK'AZ37-(BN(5E;3SK6CZCH\%PLCV\Z:6)(7D$NYFW;9[I[
MZ[?(7+'LC^BOXU?\%*_^#BWX>?LV/_P4@_X9:_9$\&?LD6>EZ+\1[_X#ZNU_
MK?QVTKX-ZU=V,=GXB\3ZI%X@LIK*^O8[VWN;F*TTC^V- AOC=:CH$XMI5K^A
M3X-_$'X9_P#!5?\ X)V>&?&5YX7@TOX=_MF_L]W^GZMX/UI%UB/PQ>>+]$N]
M(U'2KIY8@FH/X7\2,MY;7014NFL;6X2/> !Y/_P4YM+>'_@CW^U990P0PV=O
M^QA+%%:I'&+6&&+P;H)@6&$?+MCD3"JJ@(=CCH#7 _\ !O=N;_@D!^P;S@I\
M-A@="%/B"^^?Z=RWX]:?7=[7U];?TNJ(NM^5;I=>JOW/BS_@V%_:#\5^*_V0
M?C;^QUX^U275O%/_  3]_: \5_ C2=2O"1>7OPYEU36I_#$)M_E*V6CWFE:O
M96CJ90L=Q;1,B11PLW]+.3ZG\S7\G/\ P;>1V_BO]JG_ (+5_%[PU"\7P_U_
M]KL>%]"2V4C3;W5+36?%U[>36+L 7D6*%I))T+*$NX_,QYBY_K%JHNUG;O\
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M -!NT_\  >;_ .1:U_\ A'/#W_0"TO\ \!8?_C5'_".>'O\ H!:7_P" L/\
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M%B5'RDGKC/(YI?\ A._!_P#T&K7_ +\W"_\ H,<?Z@_7TUO^$<\/?] +2_\
MP%A_^-4O_".>'A_S M*_&T@/\XJ;Y>E[^=K$*W7;R,C_ (3KP?VUJU_[\7#?
MJ89/R!'TI1X[\(#_ )C=NO\ NPR+GZ[K89_#\>U:O_".^'_^@%I?_@%;G^:+
M_+\:/^$<\/GKH6E_^ <"_P D/]/\%IUOZZ?E;]0=NC;^7_!,D^._!YZZY;'_
M 'H9#^6VV/Z_XUSWB[4?AAX[\)^)_ _BN]M-4\+>,] U;PMXDTO=J-E_:.AZ
M[8SZ=JEF;RRCANK475G/+;^?:207<)D$D-S"RY/;_P#".>'O^@%I?_@+#_\
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M#GARP;2M&\'RZ/KFNWVB:R]A922P1:YJ.EWFL^6X<ZFS1IM_0S_A'/#_ /T
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M'IG_  G?@_\ Z#=I^,$N?QQ:XS].*U_^$<\/?] +2_\ P%A_^-4?\(YX>_Z
M6E_^ L/_ ,:I^[_>_ DR?^$Z\'_]!JU_[]7(_3:,?D/H*/\ A.O"'_09M?\
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M_P )UX0/_,:M?^_$[?J8)#_X]^'KK_\ ".>'Q_S M*_\!(#_ #BI/^$=\/\
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M[-.O?L<?L,?LM_LO>*]8M]>\5?!CX2Z)X5\4:I93/<Z?-XDFN+W7]=MM.O)
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MDB#< :_FN_X*>?L$?LX?\$Z?^"!_[=/P*_9=\/\ BOPS\.=2MK'QU>:;XO\
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MGM]E):;/O?4IQD_^7C7[U5+1C3CI'F<:<'&G'DA>3YTOXB<HSYE)GZ >//\
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MU[]B_P#:BUF\\#?ME?!SPB4L+#3/&&OBZU/4;FUA1?[+TJ'Q5?Q-XW\&ZA/
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M  '@'_M0TU?K)_<@/1:*\Z_X6+#_ -"OXE_\!X/_ (Y1_P +%A_Z%?Q+_P"
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M>B45YU_PL6'_ *%?Q+_X#P?_ !RC_A8L/_0K^)?_  '@_P#CE)N71W_\!_S
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M11A)Y)6::LFK.S_X:_ST*3BG>[Z]._S/PE_9S_X.A?\ @EW\5_@=H]S^T?\
M$+7_ (&?%:U\+VMI\8/@YX\^&WB#6K-/%5K;)::]!HBVUE>Z+XGTG4K^%[S3
M].\IM0M;":&UU"S@NXYU3\_?^"+7AGP[^U3_ ,%Q/VP?^"C?[&/P/\1_ C_@
MGK>?"[6OAWI&JWOAB?P3X7^*/Q#U:/P"UY/H'A6..WLM.&M:GH.K^.;W3-.B
ME@\.1/9QWZ6-[K,UE%_37XV_9D_8H^)/B:V\9^/OV(?@CXQ\6P7MQJ1\0^(/
M@7\,]0U6^OII"\][K%Y<:*LVLR23,UT?[6-^"SL3&Q9MWT3X8UWPAX+T.P\+
M^#/AI+X/\,Z2CQ:7X;\*>&M%\-^'],C=VED33M&T>*QTRRBEE=YBEI:01DO]
MS<"2U!W3EHEV[[:Z^H2DFFE^1[",XR5QNY]B>,D \@9Z*P# 8R :6O.O^%BP
M=O"_B7_P'@'_ +4-'_"Q8?\ H5_$O_@/!_\ '*TV32=^VVGXF9Z+17G7_"Q8
M?^A7\2_^ \'_ ,<I?^%BP=_"_B;_ ,!X#_[5%).5]79?+_,#T2BO.S\18.WA
M?Q-^-O /_:II/^%BP_\ 0K^)?_ >#_XY3;=M)-OT0'HM%>=?\+%A_P"A7\2_
M^ \'_P <I?\ A8L'?POXF_\  > _^U123E?5V7_;O^8'HE%>=GXBP=O"_B;\
M;> ?^U32?\+%A_Z%?Q+_ . \'_QRFV[:2;?H@/1:*\Z_X6+#_P!"OXE_\!X/
M_CE'_"Q8._A?Q+_X#P'_ -J"DG*^KLO^W?\ ,#T6D/0\[3C@]2#V('0D'G!X
M !/4"O//^%BP=O#'B;_P&MQ_[5-(?B+!CGPQXC X^]!  2""HSYR]6"CD[2"
M0PP33=[:2=_1?HP/Y4O^#CWQQJW[7G[3'_!._P#X(R?#'5IVU;]H7XM:#\7/
MCI9Z1<*;W2O .E7.JZ;H*3N"YM[[3O#>G?$GQ4(;J,PW,=GH=RZ'"N/K#_B%
M7_X)416::*^I?M?2Z0D(L! G[2>I?86M8E\IU_LT>%1;0PLH,AMRHME+&%"
M @_;F;2/@Y=>/[?XMW?P"\-W7Q8L[*/3;'XKW7PX\'3?$ZTTY+?[&EA;>/&T
MM_%=M9QVC?9UM(-56W,#M!&GDM)CT$_$>'(_XI7Q,S!I'(:RMBJ2?-O#A;@Q
MS#<"=N54?*BKN4UGR-MM_?L[)>OS*4N7ITU]?ZT/X;/^";_C77?V#H/^"W__
M  19^*>M7"P>!/A9\=_B_P#L\MKMU(&U;0M-\'WCZ['HAECA@FCUGP/<Z%XL
MN;B%42_N;"_EA0;=@\3^+,T2_P#!H]^R=(TL2HO[5/AP%F=0H:+XH:H9 6)
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M_D.-.[E>5N6VMKWO\S]R?-3U_4?XT[>OK^A_PK^/_P")G_!;S]L[PG_P;V?
MS_@IMI,/PK'[1OQ!_:5N/A1K\<WA*YN/ P\+)XE^*NEEK;P\=8BN+;5'@\&:
M1_I0U&;8QN&5<RAA[9X?U+_@ZX\0^&/#OB_2KK_@F5/IWB+P[HGBG3;>:X\:
MQ7UQIFOZ7::Q96]S VB""*Y%G>Q+<1+<*J3"14GE #M"<'>R>FO6_P!U_3ON
M2XVZKYZ?YG]2>\>A_3_&C>/0_I_C7\U7_!-S_@K[^V)XO_;R\6_\$OO^"H/P
M \"?!C]IZS\(7?C?X:^+/A;)?Q^#?'&D:=ITFK&WO;.]UWQ#$\'B#1H;K5?#
M7B#2]1MH;N6SETJ^T:PN%+5_2@"2 3G)Y.>N>^<]_6J2A)72_/1]5\O\B6K$
MGFIZ_P O\:=O7U_0U#13Y(]OQ8$N\>_^?QHWCT/Z?XU%11R1[?BP)/-3U_E_
MC3@ZGG/^?PS4-%')'M^+ EWK[T;QZ']/\:BHHY(]OQ8$GF+_ )Q_C3@ZGG/^
M?PS4-> ?M7_$GQ)\&?V6OVEOC!X/%@?%_P )_P!GWXS?$OPH-5M7O-,;Q#X&
M^'?B'Q-HRZE:QNAO-.;4M+MQ>6^8R8/-C$\8FX.2/;N^O35]>UP/H3>OO1O'
MH?T_QK^6_P#X-[_^"\VO?\%-YOB/^S_^U!_PA?AK]J3PE%/XT\!R>%=.?0?#
M_P 2_A[MCAU6&RTJYU&\>/Q-X1NY(SJ4$$I6[T>\M;ZV26YBNE@^N/\ @N5_
MP4.^/W_!/3PI^Q5K'P"3P:U[\?/VJM'^#OCL^,]"EUR$>$;JVTB>==)CAO[0
MV=\[WLZ+=2S2.L95MF]0*E*$HJ2TN[=6UOTO_P ,.SO;J?NOYBCKQ^7^-*'4
M]_\ /X9K\L?^"M7_  5)^%__  2O^"FC>.=?\+7_ ,5OB_\ %+Q#+X&^ GP3
MT*\^S:UXY\6^6HCN=1F2'4+O3?"^GSSVZ7M_:Z?>W=Y=S0:/8&;4;J*,?D;H
MGB?_ (.TOBYX6M/CGI'AC]A7X&Z?<Z?_ ,)!IG[-'BZ._A\>ZA:39N+71+Z&
M]M/%J:=K,MOLC:TO_B%H5S#-,(KT:?/'+#:B@KV;N[7:2V]==WT6[[=0MUT^
M\_K WK[G_/OBC>/0_I_C7X'?\$F/^"RGB#]M/XE?%3]C+]L#X,M^RU_P4 ^
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M5'101SS>O-+[VB3?CC'OU]>?3MFCS/;]?_K5'104JLTK7^])O[Q_F'L!_/\
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M!;:9<>&8M*\4!_-OO#4W@BPO;N>.PU?5-3\3:OJVI-?ZK+!;*D4O]>_F$\X
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M&A>$IKS6+2)K6^UWQ%XS591-<W5O$:WM=^\]];+77R[:>;$FM&^FEN]]OU_
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M79?<<$==\?=O"ED?;[=(/_9:;_;WCX=?"5EC_K_?_ 5W]!QWQCWI7EW7W/\
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MG99'.?M[G@?0?I7?_6D^7L1SZ$#^5%Y=_P '_P#)!9=E]QP?]N^/?^A4LO\
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MXBUW3;;4;Z7QA8)J+Z-8WLMK#?V$-I<2)]GEO;5Y(Y!^KW_!$?\ X*!>,/\
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M#X7@\,6_AZR@LO$5U;/8*MLT]I=1>*F\0+J+[]2L-4L478 C?TO_ /!?W]M
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MYO4_G29)ZG-%%5=]W][_ ,S*[[O[W_F&2.AQ3LG'WCG/3GIZYIM%%WW?WO\
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M $'M*_\  "#V_P"F/M^I]:.;R_K[@]BO^?D?Z^9W]*#CL#]1FO/_ +%\0?\
MH/:5_P""^W_^,4?8OB#_ -![2O\ P7V__P 8HYO+\?\ @![%?\_(_P!?]O'H
M!.>P'T&*2N ^Q?$'_H/:5_X+[?\ ^,4?8OB#_P!![2O_  7V_P#\8HYO+\?^
M 'L5_P _(_U_V\=_[=CU'KU'\B1^)K\L?^"OO_!,WPW_ ,%1_P!DO4O@H?$=
MKX!^+/@K7[7XC_ GXCW,,TEMX6^(6EV]S;1VFKM:/%>CPWXBL;NYTS5GM)?M
M%A+)9:W#!=W&E0VTGZ(?8_B!_P!!W2?_   @_P#C-)]B^('/_$]TKD$'_0(.
M02<C_4]#3O?IH_-?Y%*FERN-11DMVNNMUIS=/Q['\N'PV_;'_P"#ES]F/P!I
MWP"^)O\ P3(\%?M9>-_"=C!X/\#?M#Z#\3?#>F:-XVM;&V2STK6_%UI;^*M+
MDU1U6-(IM0GM/A_/<Q1L+NU@G+7,GO\ _P $EO\ @EW^USI/[8_Q,_X*R?\
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M_P"Q?$#_ *#VE?\ @!![?],?;]3ZT?8OB!_T'M*_\ (/;UA]OU-%[=/Q_P"
M3[%?\_(_U\ST G/8#Z#%)7 ?8OB#_P!![2O_  7V_P#\8H^Q?$'_ *#VE?\
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MFS6R[W3OY=C>-H145*$K=VTK^5I?(_E__91_X)M_\%%?V[/^"A'P[_X*9_\
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M%?\ /R/]?,[^G;O]E?RKS[[%\0/^@]I7_@!![?\ 3'V_4^M'V+X@?]![2O\
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MHYO+\?\ @&?L5_S\C_7_ &\=_2@X[ _49KS_ .Q?$'_H/:5_X 6_](*/L7Q
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M >>^<'J<45P)W^]K[FU^AZ)YQXRYU2V'K9I_Z/EKD%8D?>)_'GKQFNQ\8_\
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M;<Z+=:E'JK7#$C"I:*58[2,\5U,B20R%)E:)EVAXY0\;*S#.7W E.,DJ0B*
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M?^.I_P#%4N1]U^/^0>RGV_/_ ")J*A^?_GIG\%_HX_S^-'S?W_T'_P <]_\
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M)^)=K^QC_P '1&A>!_\ A06D_P#!17]EG5/!XTJ3PY8_'76M-\3-\6K'PY#
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M*"?\F#_MPCL?V0?VE2?<CX,^-,9^E?6OS_\ /3_QU/\ XJO$/VF_A?KOQO\
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MF_OC\A_\<I/G_P">F/P0_P W--P_O1?_ (%_D'LI]OS)J*A^?_GI_P".I_\
M%4?/_P ]/_'4_P#BO\]Z2@^Z7W_Y![*?;\_\B:BH?F_YZ?HO_P 7]/R]SD^?
M_GI^B'^;G_/7FFZ?:<7Y6E^J#V4^WX,FJU98-[9Y .+NW/(!&1*N#@\=S6?\
M_P#ST_\ '4_^*J>UE\BY@GD9FCAFCE<*(P=L;JQXW9;('  ))[KUI*-G>ZV>
MU^S\AQI2YETLT^O1I]O(_DO_ ."!!Q_P4^_X+BKD8/QJL.'&[<1XVUTJ,G+
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MOAV\LFOH7N=.N9+N&Y%_;V]R/QU^(/\ P3D_X.*/CW\$$_8G^-'[?/[+%O\
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MWVS:>]L5PJD?C%\,_P#@@I^U-^T%^TC\-_VD?^"Q?[=4?[8__"F]2M=7\ _
M_P #Z)>Z%\+I=2LKA+K35U61M)\(VD.E6NI)%/J-II'A&/4?$EO#'9ZEK]M
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MS_\ /3_QU/\ XJER/NG]_P#D'LI]OS_R)J*A^?\ YZ?H@_DP_P ^^*/F_O\
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ME[):NSW7JWU^6F_SN<52I.$V]+::6\_OZ/KIIH[Z<+_PAUU_T,VN_P#@4?\
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M^[];N_\ 7R#V\^T?N?\ F<(?!MT/^9GUQOI<N/YN*3_A#+H_\S1KB_6YD_\
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MT/I1D^WY#_"EML9>WGVC]S_S.#_X0NZ//_"4ZV,]OM,O'MP^/RXI?^$,NO\
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M?V^3X.?\)-IC>/4MVLDU2/&@^<UR9FTN2*^^S &Y6V<SO&B*15<S;Z?<M?\
M@_B5&K4E>T8NRN]']V^[Z(]%'@V[(Q_PD^O+\H4$W;\!3D %9-PYYX(YY/-!
M\&7;$D^*=;R=V2+F8$[R"V2'YZ#!/(&0#@G/1^)?$OA_P?X<USQ=XIU:P\/^
M&O#.EWVM>(->U&Y2VTK1])L(&N;W4+^\>,QVUG96Z/)//(P10IWG&!7SW>_M
MJ?LFZ=\$]%_:1O\ ]H7X86?P%\1ZO:>']!^*\_B:S7P3JVNWEXUA:Z39ZUYW
MD7%]/>(ULT,8RDZLAV;2:')OHEW5OZ?8/:5;7Y-._+(]A_X0R[X_XJK6\ 8
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M'7X=3AO^$,NC_P S3K8_[>90?ID./Q['Z4?\(== G;XIUL'.<)<RKU'0#>%
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M ($2?_%5W>3ZG\S1D^I_,T^9]W][_P P]O/M'[G_ )G!_P#"'77_ $,VN_\
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M0VZ'_,S:X?<7+ '\WS2CP;=X/_%5:Z,XR#=S$@!E8#B3  *@[1\O48P3GN2
M>2 3ZD5QGQ(^)7@+X/> O%/Q/^*/C#0? 7P^\$Z7-K7BSQCXGU"'2M!\/Z9$
M #=ZA>3'9$I<A8XU$EQ<N1';6\KY%$G=+79;Z=/5M>?0:K3DTHI-OI9_YD1\
M%W###>*=<(/\/VF4H,8VX4O@;<#;Q\N %P.*3_A$+H$[O%6M,?FSON)G^]@G
M[S$8..G3!8=&8';\(^+?#?Q \*>&?'/@S6['Q#X1\9:#I?BCPMXATN;[1IFO
M>']>T^+5-(U;3Y]S>;9WVG3PWEC(0IGBFA!#,2*^8M>_X*#_ +!GAG6]8\-^
M(OVT_P!EK0/$.@ZE>Z-K6@ZO\?/AEINJZ+JVG7,EI?Z7JME>^*(+FQU&PNHI
MK.^MKBW66UNX)(IHT=642E'5R;M;K;3\NY4)SE.49:K6Z2T5G;YI[:W>WF?0
M/_"'79Q_Q4^NMVW?:GY_%GW<=.?Y8H_X0RZ//_"4:X/8W,G_ +*^*Q/A'\>O
M@?\ '_2-4\0? GXP?#+XS:#HFI?V-K&M?#/QQX;\>:;I&JO;0WD>FZK?^&=2
MU&VL=0-E/#>_9KEX9&MY8Y8XGC8-7J^3P1N (! ("D9'(^5B",\AAMW YV+T
MIW_E;2Z6[?BB9591DXI1M%M+1[+YG"?\(9=?]#3K7_@1+_\ %4?\(9=_]#3K
M7_@1)_\ %5W>3ZG\S1D^I_,T^9]WZW?^?Z"]O/M'[G_F<'_PAMT/^9GUP^XN
M6 _5\T?\(9='G_A*-<7V-S)^?ROC^M=YD_7Z@'^=&3ZX^G'\J+ONUYW#V\^T
M?N?^9PG_  A=T/\ F:=:_P# B4_S>C_A#+O_ *&G6O\ P(D_^*KN\GU/YFC)
M]3^9HYGW?K=W_KY![>?:/W/_ #.$/@VZ'_,SZXWTN7'\W%)_PAET?^9HUQ?K
M<R?^ROBN\R?K]0#_ #HR?7'TX_E1=]VO.X>WGVC]S_S.$'@RZ''_  E.M<\\
MW$IZ?\#KL_ /AR;3/$]C=/KFJ7ZB&\0V]Q*[Q,6MG()!)'&#C(].G6K&3ZG\
MS70>%\G6[;))_=7)ZGKY+#U]":B2O&2N]4VVWU2^[;_ARHUIN4%9;I?GZV_K
M=:'KBJJ\# QD@#C:&)., XY.?\XHH&%'7')'KG!(&>YQ]?K17 E96UW;UUW=
MST-]]SS/QK_R%;/_ *]!_P"CI:XQ/NC\?YFNN\;N5U.V/'&GJPX_B\^7],#\
MN]<>K<X. /Y=?7U]S7H4HMTH_?ZZRV^\\^M[TW9/9/;S>GK[RT]22BH=S#O^
M@_PIOFMZ-_WR*TY'W7X_Y&7(_+^OD?S!_P#!VG;0WO\ P3=^&EK<0K<0R?M4
M?#J"2+&]&2>TO(9(<X&QGAD>,JID++(V2.17W)\.O^"#O_!)WQ#\(_AYJ>N?
ML)?"IY];^&/@W4M=UD:=J%C=FYU+PII]SJ&I'5(9HFM9YII[BZDOU,)M95^T
M.X"!Z^$_^#M:#^T/^":OP[L6DDA6[_:?^'UHTT3 SPQSVMW$LD62!G]X94<$
M;98PC$ BN#^&_P#P:Z?!/Q-X$^'^N^(_^"B7_!0/4].\0>"?">MZEX3/C;0X
M=%,.L:!8:@VEHL4GG6^FVHNC;6Z(':.W54^;&6P<)\ST4M%Y_P WD[=>OF==
M.T:2BY).[U3T[M:-=['P?_P2K^(NI?\ !/7_ (*2_P#!8/\ 9S_8L\._$G]K
M_P#9)^"_PQNO'O@#X1^ /%]MK%U>>/M/\3?#O1;;1O#'B/43JND3ZYH*>-/'
M/AO4=37S;O7M/\$37,LMU/8F0^[_ /!I[^U3\6=9\(_'+X&ZS^SC\6]:\(_$
M#]I7XI?%KQ5^U;?>(;&]\#>%O%9\'^![)_ACXEBO;1]9OO%QABCU$7<5\+=X
MKF!6M5)+U_1S^P1_P31_9._X)H_#7Q;X)_9C\%WVF:CXTMY-1^(/Q$\5ZI+X
M@\?>/[RPL]42P_MC7)PK1:99G4[P:9HEDL-I;/>7D^'DF+#\</\ @TJ,P_8+
M_:J&U_+'[?'Q0\U3O:-)A\/?AP3%<JG'VC!BD7YQ(J!'R!Y>7&G.$XQ?6[=K
M-:ZVO\U;3[BFXRC)M)K3=:Z75^W3N?C5_P %^? '_!7C]H/]G3XJ_M5_MG:A
MX6_9S_9(^$OQQT7P/\!/V4M"NS=:[XX77-8U_1]&^)WC*+2[^^B:\;1=,BU6
MRU'Q+JNHS;M5NM/T?1M$@M5>;^]CX B,_ ?X$EB!$/@Q\*_,*<+&D?@'0,B/
M"\&0D .RO$C@KECD5^"'_!U@[G_@C_X^YX/QR^"F1D,/^/WQ!SN'#$#.&YX)
MZYK][/@-*?\ A0OP*).3_P *6^%0Q@# _P"$#T$8'RXP.H7& 3G&<FJ4)*<N
MMTOE[TK?<KZ?J9U+.G%-.U_=LMO=6^O7J]3^!_\ X+G?#C_@KC\?/@CJ?[8/
M[=^J^%_V??V<_AW^T?X:\!?L]_L=: S7%]JEMX@\5ZGH%K\2O&(TW5;^V.I3
M:)ID&I6FK>(]3UJ_O+757L]-L_#UNC02?WX_!PC_ (4[\'QTQ\)?AEQQC'_"
M#:#C;@D;<8V\GC')ZG^??_@ZJ<G_ ():VG;_ (RA^!7N<_VMJ!ZX]A^0K^@'
MX.G_ (L[\'CD_P#))/AB<@9))\"Z 2<#U/)[<_A50AK-.^MG??7WOEIVT5OO
M'-*5.*DU&RT]4DMNOGNSTVBH=Y/0\?3'Z')HWMZ_H/\ "JY'W7X_Y'+R/NOQ
M_P B:BH=[>OZ#_"D,C _Q'Z 4<C[K\?\@Y'W7X_Y$]%0AV/<CZ@9HWMZ_H/\
M*.1]U^/^0<C[K\?\B:BH=[>OZ#_"D,C#U/T -'(^Z_'_ "#D?=?C_D3T5 '8
M^H^H I=[>OZ#_"CD?=?C_D'(^Z_'_(FHJ'>WK^@_PI#(P]3] #1R/NOQ_P @
MY'W7X_Y$]%0"1CZCZ@"EWMZ_H/\ "CD?=?C_ )!R/NOQ_P B<=^ V 3@D@$#
MJ..<^GT-?S'?\','[6OQH^'7PG_98_85_9R\57_@?XI?\%"OBXGPKU/QGI4]
MQ9ZII/@*TUKPIX;U70X+^QDCU#3!XI\1^-O#=M?SV#)<W7AZUUS3TE1;E\_T
MV!R1@E1C+ L=N&VE1S_P+OT.#VK^1#_@Z&TK7OA!\7/^"3W[>\-A>7/@#]FG
M]IFTMOB7>6ME-?)I/G^+OAWX[T)YXHPT:QZAI_@/Q7:K++L^T7<MC9I()I($
M>91:4KI]-5LE=7:>FROKTZ>6E&*4U>[EKRZ:7LWJ_P#@'ZF?LY?\&_'_  2O
M^ ?P9T;X7>(_V3?AI\>/$ZZ);Q^-OBQ\9_#T7C'X@^)?$<]A&NN:O8:O?.6\
M++/?&:6RTS0TM[33)7'V94" UXE_P3:_X)*_M"_\$R_^"B?QVUCX">//#[?\
M$NOC%H<&K:7\&?$GCC6=;\?^#OB/<P6%U:3Z)H,VFM9P6/A2_DU72(_$$VL2
M:CK_ (=;38]3$L]C%(/WP\#^,?#7Q6\'^%OB3\/M9T[QEX*\>Z/IOB;PMXE\
M-W2ZKHFKZ;JMO%<6ESIU]8-/#(BO,+650S30RL8ID1TD _+7P?\ \%=?AQX[
M_P""KE]_P2_^%?POUKXH:SX+\'MXK^(_QQ\*>+M&F\$_#;4M(LDOO$>@>(=+
M^S3SW\_A^2\TO1-4-AJ4!@UR\-FD4XM9UAGV=-)7<4^EGKL[=.W1KSWM?HO4
MN[6:WLV[Z6ZNZO?RV/YVO^"1O[*O["G[2G[>_P#P6%_X;*^%'P#^)4GAC]H:
M\_X0<_&6;P[&VE"_\8:\-4/AXZ[?V>&N0D0O)(?,+$*&.X\^B_\ !?7]A?\
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M&N6H7[3X<O\ Q@7/B'Q)92$,(]<T/0(;J?0V5'C74)8VE7:AKYS_ ."8O_!
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M;+81K%!(Z1;4_GP_X*Y_\$/?A;_P2W\6?"#]OKX*?#W7?VJOV./ _C/1=/\
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M>)*'YAP1C!/6OXV_VB/'.B?\% /^#G_]D#P-\#=4MO&_@O\ 8.\"7'B#XO\
MC;P](FJ>%=%\1Z)!J_B/6],CUW39);2_M?[5N?!?A@2"Z$4FOZI?:6K>;9W(
M7^R%Y'9F8L"69BVTY 8L2R@')"J<JF0,H%;'.3I!<R=ME)V]--/D[I=M5Y+.
MLFX)=?=;_']+#Z*@,C#U/T - =CZCZ@"JY'W7X_Y'+R/NOQ_R)Z*AWMZ_H/\
M*-[>OZ#_  HY'W7X_P"0<C[K\?\ (FHJ R,/4_0 T"1CZCZ@"CD?=?C_ )!R
M/NOQ_P B>BH=[>OZ#_"C>WK^@_PHY'W7X_Y!R/NOQ_R)J*@,C#U/T - D8^H
M^H HY'W7X_Y!R/NOQ_R)Z*AWMZ_H/\*-[>OZ#_"CD?=?C_D'(^Z_'_(FHJ N
MP]3] #1YA.<[@,9Z#<0.2$'0OM!P#QC)Z@4<C[H%3;>Z7]>AQOQ-^)/A3X.?
M#?X@?%GQS>+8>#/AEX+\3>/?%-XTL47DZ#X3T>\UO4UC>8A#<3VEE+;6T7+S
MW$T4,:M)(JG_ #7!X3_:%A^%,?\ P<OQG63\25_X*:ZAXFN;2TDNO*O?@->%
M=!86^D3@K86<.JVNK^$/[0>3[*NE:I8Q+B.)"G]/W_!SY^TMXE\#_L8?#S]C
M'X3R-??&O]O[XK^'O@[H&D64NVZO?!6G:SH]QXAB=@PELX=<\3ZCX+T6"\QY
M$UI<:O;RY$4ZCXF3]@7_ (.*7_8%@_X)OR?"O_@G0/V>?^%26?PB;2IO']@O
MBN33+>XM]076Y]37327\8)K4%O?W&K&%G;5(/- 8_O#A5;4DDG:*WM=*3NTW
M]U[>>VIVTXJ,;)IW>KOOT??K^2/Z0OVIOB?X0^.'_!,CX]_&7P%?V^J>"_BK
M^QQXQ^(/AB\L[B*ZM7T;Q5X%GU*.,7(W)<26-Q/-ILXY'FV4Q;)6OY>/@9\1
M?V4OA=_P;&?LI^)?VP_V?O$O[2WPC;X]0:=#\-O"7C^?X::K'XOO/B;>G1=?
M/B*U@FN'M=/?S);K3MA@U*-FM)FC25F'>_\ !&S]I_Q7XA_X(\?\%'?V ?C-
M)-IGQQ_8,^'OQO\ !TFAWURTNH_\*VUG3-;@MK6-&2/9I/A/Q99ZEHEDZAA-
M!J-K*K+%(@KX6^*[%O\ @TM_9.W'Y1^U+X:C' RH'Q.OVW XSNY(SUP<=.*3
MG)IOEVA+=;>\KZ7OO^1=ELWIS>>JL^O^7ZG]6>J_\%2OAO\ !S]N;]DC_@GI
MXI^"?BWP9HO[3OP.\*^,O@A\;KKQ9I4G@EKB3PM?7>G_  OFT*724U2Y\2:7
M)IVE>&Y=0BU1H9M2UC2G-F!=MGT#_@IW_P %-O W_!,[P+\&M?\ $'PO\4?&
M[Q[\>_BUHWP?^&/PC\$:YI_A[Q5XAUC4XIVGU>"ZU:QU2!;"QNUT_2WA%G*\
MVJ:OI]IYEOYZ2#\H?^#@#X#>+-4_X)W_ +(G[=_PD@G@^.'_  3SU7X(?&71
M]8T^ S:LOP^N]+\)1>)H4D&/*T_1]3MM#\7:K*V5CM-$D5EV.Y/SU\+/B[X<
M_P""V_\ P77_ &7OB9X4$.M?LM?\$]/V9? 7QYN[)))+_0T^/?Q8T/0?%=GH
MQO1F)M<T/Q'JOA07-N<2PZM\*-?M225GJG.2DHN*O+6.FEK:WU6UGIUN1[.F
ME>T+6;>FFB[VMU7D?J]^VK_P6S\"?LP?'SPW^QY\%?V:_BU^VA^V3J_AS3_$
MGBCX&?!K4;&TL_AC9:CI5IJMNOC/QM/I6KVT5S';WUK+>P+I5M:VT5S8R7.I
MV+:A:P';_8._X+-> /VN/V@/$G['GQI_9[^+7[$_[7WA[1Y?$-C\$OC+/9ZA
M'XVT"SMH;F_U'P5XLM].T2WU>ZBBE:YCTE--+75E!<76FW^H"WO([3^;7]B'
MPK_P4K\:?\%F/^"S[?L4?'C]G?X*_'.V^-WB.3QDOQX^'>F?$'Q'XE^&#_$O
MQO'X;/P\76]/O[_3/#^EZ6/#K^)6LUC@N;*^\'BZ5X[>R"?7OQ#_ &5_V[+G
M_@K#_P $\OBW_P %!?\ @H/^PJO[2/PZUJ.Y^$'PS\'> K[P!\4OB9\.IK[6
MH-;TC2K'PEX=CAU5)FGUY=(?7[FVB@DEOVM0T(G0)3FY+W?=<N7;1)OEWO>^
M[_#43IPY791ORMI^=KJW2VJ_,_LLP><]FP&'*E0>"3CAI,\KT!''>BFS3$33
M;1Y:-)(@1\;T8R-(NY5!3 4^6ISNW*21@U'O;U_0?X5OR/NOQ_R./D?=?C_D
M345#O;U_0?X4WS&]&_[Y%'(^Z_'_ "#D?=?C_D6**AWMZ_H/\*-[>OZ#_"CD
M?=?C_D'(^Z_'_(FHJ'>WK^@_PIOF-Z-_WR*.1]U^/^0<C[K\?\BQ14.]O7]!
M_A1O;U_0?X4<C[K\?\@Y'W7X_P"1-14.]O7]!_A3?-;T;_OD4<C[K\?\@Y'W
M7X_Y%BBH=[>OZ#_"C>WK^@_PHY'W7X_Y!R/NOQ_R)J*AWMZ_H/\ "F^8WHW_
M 'R*.1]U^/\ D'(^Z_'_ "+%%0[V]?T'^%&]O7]!_A1R/NOQ_P @Y'W7X_Y$
MU%0[V]?T'^%-\QO1O^^11R/NOQ_R#D?=?C_D6**AWMZ_H/\ "C>WK^@_PHY'
MW7X_Y!R/NOQ_R+<2H\BK(XACWQ&28JS+'&S;7+;6+$D',:J@W%2"X )K^$?_
M (+\^ O^"NW[37P-_:S^,OQXU#PO^S)_P3[_ &9_&UA9?"3X+:;<FY\5_M'2
M?\)?8^'-!\?>)ETG4+RXN-/F6[;7-.E\2ZC%IFE7,"VNE>%X[F1]3K^ZW<<J
M< $,'! (^9<X8X(R1DC/X5^'?_!R&Y/_  1I_:Z/3Y/AD.W3_A8&B*!TZ <@
M= <'M4U(-0E>^S;MZ.RMH[==_OV?102B^\GUZ)77GN^]CZ\_8M\>:/\ ##_@
ME#^R[\2M<F6#0?AY^P5\*/%^IW*%85MM.\/_  ,T.]N<2/\ NEQY # ",*P#
M,X4<_P )W_!,+Q[_ ,$"9OV?O%'Q!_X*I"T\?_M5?&S]H3XE>-KVVL=+^(M_
M+X#\&:Q<64>GV^MS>'EM--MX;_7$UWQ*DEM-JVH-;ZI&LJ1D(H_M6^$?B7X'
M^$O^"(GP<U_]IE-6G_9YM?\ @G9\*[7XUV^@VVH7FKM\,]1^"F@V/BH6EKI3
MQ:CM.E2W1EGM)(Y854W"N#"Q$7_!-[]E'_@E!XL_8K\.:K^Q9^SW\-?%G[+O
MQNM?$UU<7OQ#\'6?BOQCXN!U'4M&\1V/C?5O%$6H>);6^TZ6UN=%73VO[>XT
MRSM(+>/"1Q3/G*/,HVE!6CM+>]DOE_F7&4.::2=W)W:TU3=[OU>BWMY(]B_X
M)G_!?_@GK\+?@%+XI_X)J67@N/X"_%_7%\;7FL>!_$6J>(--UOQ-::7:Z(TV
MI?VO*VJ:#JEEIUI;V=[HVIVEC>67EM]IL(FFY_0TXZA2JG!52<X4C@#@ #T
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ML'Q3TSPAKEAKGA:T\86^LZAIYAO-#^R/I-IK-F\]U)I=RMI<V\WV.V<?L8?
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M!4/_ ,=I!/:#I=6P]Q<P'^<E<O\ \(+X:_Y\G_[_ !_^)H_X07PU_P ^3_\
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MAGM"2?M-KS_T]0__ !RN8_X07PU_SY/_ -_C_P#$T?\ ""^&O^?)_P#O\?\
MXFCGETM]R%[2EV?_ (#_ /;'4_:+7_G\MQ[?:+;C\Y*/M-K_ ,_5K_X$P?\
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MULK&UVV.E6%M:V5H&CA\Q_LXW-L.EU:MSWN;8?H'Q_CWKE_^$%\-?\^+=O\
MEJ0./8* ,^V .PH_X07PU_SXM_W^;/\ +Z_G["J4W'1*-E\*5UHMKZ?D*4Z5
MVFY*6M]+Z]>O>YU7VJV/)N;3)_Z>H/Z2 4TW%H3DW-K_ .!4/_QVN7_X07PU
M_P ^3_\ ?X__ !-'_""^&O\ GR?_ +_'_P")H=23N_T7YB52DE:S_P# ?^#8
MZD3V@Z7=L/4"XMSS^,F>F*/M%K_S]VQ^MS;C^4E<M_P@OAK_ )\G_P"_S?\
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MEY?>')+R^\EHJ'S".NT?Y^M*),]@?H?_ -=')+R^\.27E]Y+149D/8#\>?\
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M,&J^/O@->0-&/#]E'J=I=:8VHSO?3RN)DGTM8'EN9G-N%,K*I_FT_P""&_\
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M)5@3_&39_#+0/^"0O_!R!\%_ /[.UNW@?]EK_@HYX#N(/%7P=TF9K;PGX?\
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MX7ZM=6%F][HT%IHNM:;>?:+&^O8[%7_MR_U-M76ZTVQT34TT;5KVVW_V/?\
M@JQ^V)X8_;@\.?\ !-__ (*O_ +X;?!7X]?%;PW/XJ_9Z^+OP8U'5I_A#\78
MK2WG>?1+6TUB^UJ^M]3NETW5?(U$ZJODZAIUWIFK:1I<PLI+Z>97Y=;WML[7
MVM?U=A_5ZEF_=T5[<VNU^Q_0M12$@$KGD,1@?, /=@0!@=3CKVYI"P )R. >
MXJ[/L_N?^1C9]G]S_P AU%0^;[K^?_UZ=YGM^O\ ]:JY)>7WCY)>7WDE%1;S
MZ#]?\:/,/M^O^-')+R^\.27E]Y+14/F^Z_G_ /7IWF>WZ_\ UJ.27E]X<DO+
M[R2BHMY]!^O^-&\^@_7_ !HY)>7WAR2\OO):*A\WW7\__KT[S/;]?_K4<DO+
M[PY)>7WDE%1;SZ#]?\:-Y]!^O^-')+R^\.27E]Y+14/F^Z_G_P#7IWF>WZ__
M %J.27E]X<DO+[R2BHMY]!^O^-&\^@_7_&CDEY?>')+R^\EHJ'S?=?\ /XT[
MS/;]?_K4<DO+[PY)>7WDE%1;SZ#]?\:-Y]!^O^-')+R^\.27E]Y-@G  )8\8
M^4J#GY<;69RS#)8%%" 9+<BOFC]KO]KCX%?L._ ?Q=^T7^T3XOA\'?#OPC$B
M9""YUSQ/K,[K#8>%_">E!EEUOQ#J=PZ1VEC9F1U5S+<&*%&D'TM$8S) DVX1
M2NHE52S>9&9%9@%R'#LH,8C3 ?/REONG^&+_ (+R?\$Q?VJ?&?P(_;+_ ."@
M7[:W[6^J^-]%^%?B72X/V0OV:_A^\\?P\^'G@K7_ !KI^@V%_P"+1>:986!\
M0OX?N+B"_@T?1VU66_GBFU'Q?=6<::?!%2,E%N*O9-WNE:R;;\U=-:;^1M1I
M<SO-*VJ2O?6]M5IT^X_M8^$GQ2\)?&KX3?#?XU>"Y[K_ (0;XI^ O"WQ(\+W
M.KP'3;M?"_B_0K/Q#I=SJMM<%7L)H].O[>2[B8/Y#[TD*[<G\8_BW_P<E_\
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M77G]S_R(Y)=OQ1_,_P#\'9UO!>_\$V_AS97"![>X_:C^'=K<(&=6:"[M+U6
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M3&2 22'#R*K[6 7>&)9_VO\ "/Q&\#?!_P#9%\!_%GXE^(--\*?#WX<_LV^
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M]/M+>61YH5LYHI(II/,A9),8\N^*7PZ?_@V4_P""F/@CXY_#7PD?$G_!-/\
M;)OE\)>*[?4M.MM7\2? [6Y+AAJVDZ!XGOH9=8TJ\\*0W;>(-!VZ@7\1^$DU
M+2=09Y;:WC/]7_['G[)O[(_[!?P]\1_"O]F#2-2\%>"/%GC+4?'^N:9KOB_Q
M5XWNKKQ1JL2PW]Y%JGB66\OK:VG1!BPAD6V0Y*KDDGI?VK_V>/V6?VWO@IK_
M .SW^TQX<LOB%\+/$>H:5J][H\6HZOX?U6QU;0[@76EZKH7B+2A!JVAZC:2
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MTZTW;_M-^=8'_"6^&?\ H+VW_D;_ .,4?\);X9_Z#%L/?$Y_009-%UY_<_\
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MEK^OR,73?,VMFEOY'0TW;_M-^=8'_"6^&?\ H+VQ_P"_P_0P<?2C_A+?#/\
MT%[;_P C?_&*+KS^Y_Y!R2[?BC?V_P"TWYTNT>@/N0,GZUS_ /PEOAC_ *#-
ML/\ @%P?U$//UH_X2WPQ_P!!JV_[]W/_ ,9HNO/[G_D')+R^\Z&D*Y/5A]#7
M/_\ "6^&?^@O;'_O\/T,''TH_P"$M\,_]!>V_P#(W_QBBZ\_N?\ D')+M^*-
M_;_M-^=+M'IGW/)KG_\ A+?#'_09MA[;+@_J(<&C_A+?#'_0:MO^_=S_ /&:
M+KS^Y_Y!R2\OO.AKY*_;_!/[!?[;P &X_L@_M*!%);G'P<\9$L1LX3:656!(
M:0%"R$8/TI_PEOAG_H,6Q]\3C]#!D5QGQ'TSX7_%KX=^/OA5X[N1JG@?XG>"
M?%7P\\9Z;::AJ.E7>H>%/&FA7_ASQ#96FJV"17^EW%WI.I74,-_8RQ7-I*R7
M,#K-&K ;3C-:W<6E[KW8*,E*+MM)-ZK;J?SW?\$+OV;_ (5_M??\&\'PQ_9O
M^,VC1ZY\//BI/^T+X>U2$11SZAI%[)\4-<;2_%6AEL"UUSPSJJ6NJZ5>,RB.
MYM?LTK-!<RQO_)I^U3XD_:<_9.\5_L[?\$;OVF+34_$-G^R7^W7X.^*/[/7Q
M,NI;B2WUSX.^/=8T.PTS3]'-PJRW/AJ_/EZ]HOEN$T:XEU'0HK:VBMU6O](?
M]E+X!?LT_L3_  +\*?LW?LYV=WX1^$/@F^\1ZEX<T#6_$?B'QCJ5I>^*]6N=
M<UJ:;Q%K[76JW:SZG=SW%O!/.T-FK""W18T51XC^UY_P3S_8!_;K\>?"+XH?
MM+_#YO%_Q!^!ES;W/PX\6:!XN\6^"-7TY+36;;Q!::=J]SX:FLW\0Z1:ZQ:Q
M7UKIFK&>VMI7N1 (UNIE;GE3;A!)/FBE%Z:.+MS+;UUW^]G3SWEKM;3NFK6^
M_KTT/PM_X+LP>*OV"?\ @JG^P#_P5_3PMK/BKX#^&I=-^"7QZN]'ADEG\+P6
MUQJ&GV4,_E12R6\6L^%M:U&XT^ZO/W-SJE@-'B+7EU$A_I0\"?ML?L??$[X7
MZ;\:O W[37P-UCX5:GI,&OIXPF^)/A/1;'3=/F@,D?\ ;\&L:I8W_ARZBCW+
M=:3JUO8ZI;2AH+BR>=1O](^(VE_!WXP>#/%?PZ^*FB>$?B)X!\<:9<Z-XM\'
M^+M&BUKP]KVDW@_?V%_IM]:2P20L^)8V55DAD5'BD1D!K\)/$/\ P;7?\$7-
M?\3WFNQ?#;XD^'-&U*\GO]2\">&OCA\1M+\(7%Q<2F5TM;..]\[2K.,G9;V5
MA+%!;1!(H5544"_>@VX1NI+5/W;-I)ZVV=EI:Z>SL[&27-;VBUC+1K6Z\];Z
M7M^+ZW_.OP'\2M*_X+(_\'%_PP^-W[/J7?BG]D#_ ()U> DBU+XO0VUU;^'O
M%7BJUMO$,^GW^BR7T%MY9\1>,=4TVPTNVD07=YHG@W5_$$,DEB]K*O\ :"V6
M8EUP^3NSC.22W*X^4@,!MRQXR6))KYC_ &;O@5^RO^R#\-=-^$'[-G@'P1\)
M/A[ILS7?]A^&=+>*75M1D55EUCQ%JC0-J&OZS/L4W&I:G<3W,Q!+-\S ^]?\
M);X9P =;@.!U9;IR3DDG+1$\L2VWHN<#@"JII)-ROSMW:47RZZ:/LDDD%5.4
MH\OPI==+/TUOZW^1T. .@Q2$9[D?0XKG_P#A+?#/;6+8_A.OZ&']:/\ A+?#
M/_07MO\ R-_\8J[KS^Y_Y&?)+M^*-_;_ +3?G2[1WR?KSCZ5S_\ PEOAGOK-
ML/\ @-PWZB']*/\ A+?#'_0:MO\ OW<__&:+KS^Y_P"0<DO+[SH< = !2$9[
MD?0XKG_^$M\,]M8MC_P&=?YP\T?\);X9_P"@O;?^1O\ XQ1=>?W/_(.27;\4
M;^W_ &F_.EVCOD_7G'TKG_\ A+?#/?6+8?\  9V_E#Q1_P );X8_Z#5M_P!^
M[G_XS1=>?W/_ "#DEY?>=#@#H *0C/<CZ'%<_P#\);X9[:Q;'_@,Z_SAYH_X
M2WPS_P!!>V_\C?\ QBBZ\_N?^0<DNWXHW]O^TWYT;1W)/L>16!_PEOAGOK%L
M/PG;]!#^M'_"6^&/^@U;?]^[G_XS1=>?W/\ R#DEY?>=!@#H /PIW3J"1E<X
M!) W+N/ )SC.,*Q)P,<USO\ PEOAGMK-L?\ @-POZF']*#XM\-$$?VQ;#_O]
MG(Y4@^1E2K!6R.N-IRK,*+KS^Y_Y!R2[?BC^87_@YT^-?BSQM\//V3_^"8/P
M>OW'Q9_;L^,WAFU\0P6+R3W.G?##P_K]IIMI<ZCI\31RW&@ZIXLO5U.^RZ!8
M_ -^1*BQL6YU/^#?'_@I+%\"8?V6)O\ @MYKD?P$MO 4'PMD^%B?LY7,G@Z'
MP/!&EO\ \(NL!^)8$NC6TR8MWE(D=HDGC"/AA^X_C']B']BOX@_MD?#[]OGQ
MGX>UG7_VG_A3H=MX<^'7BZ^\?>,9?"_A/2;6QUC3H8=*^'@N/^$3@N%M=?U=
MOMHL/M!O+V6_9S=[)%^UAXN\,YR=:M]V<Y5+E.H"D$+#R2 1N.3SP>E9I:R;
M3L]$K/:W^;;:?D;7:BK+5);VU>GZ*Q_%#_P2"^-'C;X0_L,_\%@O^"2WQOOI
M$^*O[&W@OX[Z]X'MKR-[62[\#ZKIM_H_BR&VAN9[B5HHM;CTWQ%96J2$:=H^
ML;,[5:5OE_XKX/\ P:9?LF9&/^,H_#PX.=X_X6C>]=KYC(YP=I8XY5<AC_7;
MXR_X)K_\$^/'7[2WQ/\ VO-;\%ZY:_'OXS?#WQ)\+?B;XH\.?$?QUX:T;Q=X
M,\7^&1X0\266I^$M*N[?0)=0U;0UCCN=8-M]O-[!;ZD)!>P1RC,UG_@E_P#\
M$Z]?_8Z\'_L$:GX'\13?LO> O%UOXZ\+^"X_BEX^AUZQ\36NJS:U#>S>.([P
M>);VW74;B68V%Q>-:E2D014C0#)4YM2C):<LHQWO:ZY;^B2W[>93:6L59W3E
MTOT?X'P)_P %W_V6-9^//_!(KX>?&KX=6\T?QF_8G\/_  A_:;\ ZOI9,6K1
MZ-X4\)Z)%XZ"7=J#>&*V\-M=ZU:6L6?M>KZ7I[N@F@CD7X0_X)I_&.Y_X+8_
M\%E/#7[>.MZ5=CX)?L#?LJ_"O0?"^G7MM*NC)^T=\2/"GF>*)H-.N(_+#Z;X
M@U7XA)%>JC@IX'\)ZL(\36KC^N&6T^%]SX$?X9WITZ_\#S>$3X#NM#U 3WL5
M[X4.C+H#:5>R2PM)=)+I:BWFEE+22-^]<E\FOEW]B/\ 8H_8I_X)U_#SQ1\+
M_P!DGPK/\/\ PEXT\5-XT\4)K?BKQ3XYUK5O$']F6.CV\LVO^)Y;W4DT^PL;
M",:?I,<RV-G<W%]>11BXO9W?24;SC))M):II[I:/Y7?W+Y*^EON^>_Y(_CC_
M &</V3_$GQ$_X+8?\%7/V>O&?_!0K]HO_@GI\8O&_P 9=<^)OPZC^$_CD_#F
M?]H/PIXC\:^+?%VG6FH7LEY86^M3>'_#?BOP_K/A73;>>26YM-9UJYL+1(M.
MN_)^L)_V1?V9/A3_ ,%;_P!AWX4?$_\ X*G?MU_ML_M?^%_$B^+_ (9>'-4N
M_"_QF\,_#NVMI=8O]0\/?$3Q;J?B>74/A[!KEIIFHZA?:5I]O<7,=A)!=7RV
MYO+7SOZ'OVW/^"9'_!.O_@H5JV@>+/VE?AO'JWQ%\*V3:=X>^*7@;Q+XD^'G
MQ%M+%5E%KIU_XH\-/9WNN:1ISW%U<:=I&KO<V5G/<S/ BDJ%S?V'?^"6O_!.
M?_@GGXAUWQU^SA\/'M?B?XET^72M9^*OC_Q3X@^('CXZ7<& WFFZ1K?B-KN7
MP]8:A]FMO[1M='^S)?&"-K@N0<Q[-\T7;::DW[VW-S-6[W;UO:UNH-NSLW=I
MJW3:VY^J,Q$D\SX"AY9G4QG:H+2,X7:2A6+!(A=D#2C[J #)CV^['V)X/UK
M_P"$M\,=]6M<9)&1,VS//RX@S_GFC_A+?#'_ $&K;_OW<_\ QFNBZ\_N?^1A
MR2[?B=!@>@_(4M<]_P );X8_Z#-L?^ 7 _4P\?6C_A+?#/\ T%[;_P C?_&*
M+KS^Y_Y!R2[?BC?V_P"TWYT;?=C[$\'ZU@?\);X9_P"@O;#_ +_']!!S]*/^
M$M\,?]!JV_[]W/\ \9HNO/[G_D')+M^)T&!Z#\A2USW_  EOAC_H,VQ_X!<#
M]3#Q]:/^$M\,_P#07MO_ "-_\8HNO/[G_D')+M^*-_;_ +3?G1M_VF_.L#_A
M+?#/_07MO_(W_P 8H_X2WPQ_T&K;_OW<_P#QFBZ\_N?^0<DNWXHZ# ]!^0I:
MY[_A+?#'_0:MO^_=S_\ &:/^$M\,_P#07MO_ "-_\8HNO/[G_D')+M^*-_;_
M +3?G1M_VF_.L#_A+?#/_07MO_(W_P 8H_X2WPQ_T&K;_OW<_P#QFBZ\_N?^
M0<DNWXHZ# ]!^0I:Y[_A+?#'_0:MO^_=S_\ &:/^$M\,_P#07MC_ -_A^A@X
M^E%UY_<_\@Y)=OQ-_;_M-^=&W_:;\ZP/^$M\,_\ 07MO_(W_ ,8H_P"$M\,?
M]!FV'_ +@_J(>?K1=>?W/_(.27;\4=!M'H#[D#)^M+7/?\);X8_Z#5M_W[N?
M_C-'_"6^&?\ H+VQ_P"_P_0P<?2BZ\_N?^0<DNWXF_M_VF_.C;_M-^=8'_"6
M^&?^@O;?^1O_ (Q1_P );X8_Z#-L/^ 7!_40\_6BZ\_N?^0<DNWXHZ' .,@?
M=V,0 "R;@Q#X #D$ JSY9#RI%?A]_P ''XQ_P1J_:ZQN4;/AH1L5L!3\0=$R
M"F%RQ<JLDH5PBA=[D\I^T'_"6^&/^@U;?]^[C_XS7@?[3_P1_9U_;'^"'C+]
MG3]H"VNO%7PD\?G2SXIT+1O$6O>$=2OO[&U&WU;3_L^OZ&UMJU@L5]:PR2I:
MSHEU&K0SAHW8%2LXR6MVFDN5VU3Z^K+@G%Z[;Z.^M_\ ASQ3]BGXD>!_@_\
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MVKW.HWKD(+30].EN'N;K&'CM6D129$4FO,XWUBKM7>B935=+FOIZQ]>QU_\
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M_3_&CS/;]?\ ZU'+/S^__@AS5>[_ /)?\BG_ &3I7_0.L_\ OPM']DZ5_P!
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M9.E?] ZS_P"_"?X4?V3I7_0.L_\ OPM7/,]OU_\ K4>9[?K_ /6I\L_/[_\
M@AS5>[_\E_R*?]DZ5_T#;'_P&C_PH_LG2O\ H&6/_@-'_A5W>/0_I_C2>9[?
MK1RR_I_\$?-5_F_+_(I_V3I7_0.LA]($'Z 4?V3I7_0.L_\ OPM7/,]OU_\
MK4>9[?K_ /6HY9^?W_\ !%S5>[_\E_R*?]DZ5_T#;$_6WC)_,BC^R=*_Z!EC
M_P" T?\ A5W>/0UY5\>/BG;_  .^!GQH^-MUI,OB"T^#OPF^(WQ4N- MIUM;
MG6X?A[X0U;Q9+HL-U(##:3:HFEK90W4O[J%[A9'X4BCEG]VNX^:KI[V[MNO\
MCTC^R=*_Z!UD/I @_0"C^R=*_P"@=9_]^%K\AO\ @D/_ ,%DO@I_P5J\#_$6
M_P#!WA6[^$_Q6^%6K6D?B_X2:UK=GK.JMX4U@,NA>-]$NX1"U_HES>1S:7J
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MN)7MTNIXH0MIK6AR7<,]@NLZ>JP0:I$^EWD=M>(4;],2^.F&! ((X'(SCIR
M<@,.".:I*4H\R=T[=>]^E[]").M&7*V[_+I\BE_9.E?] VR/UMXS_,4?V3I7
M_0,L?_ :/_"KOF#N#_/_  I/,'8?T_QI\LOZ?_!#FJ_S?E_D4_[)TK_H&V0^
MD"#^0H_LG2O^@=9_]^%JYYGM^O\ ]:CS/;]?_K4<L_/[_P#@BYJO=_\ DO\
MD4_[)TK_ *!MD?K;H?Y@T?V3I7_0,L?_  &C_P *N^8.X/\ /_"@R#L#^/'^
M-'++^G_P1\U7^;\O\BE_9.E?] VR'TMT'\@*/[)TK_H'6?\ WX6KGF>WZ_\
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M\BC_ &3I7_0-LA]+>,?R%']DZ5_T#K/_ +\+5SS.<;2VTMN5,.Q"KN^7'!)
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M_P"@98_^ T?^%7/,]OU_^M2[QZ']/\:?++^G_P $?-5_F_+_ "*7]DZ5_P!
MRQ_\!H_\*/[)TK_H'6?_ 'X6KGF>WZ__ %J/,]OU_P#K4<L_/[_^"+FJ]W_Y
M+_D4_P"R=*_Z!UG_ -^%H_LG2O\ H&6/_@-'_A5SS/;]?_K4N\>A_3_&CEE_
M3_X(^:K_ #?E_D4O[)TK_H&6/_@-'_A1_9.E?] ZS_[\+5SS/;]?_K4>9[?K
M_P#6HY9^?W_\$7-5[O\ \E_R*?\ 9.E?] ZS_P"_"T?V3I7_ $#;'_P&C_PJ
MYYGM^O\ ]:EWCT/Z?XT<L_Z?_!'S5?YOR_R*7]DZ5_T#+'_P&C_PH_LG2O\
MH'6?_?A/\*N>9[?K_P#6H\SV_7_ZU'+/S^__ ((N:KW?_DO^13_LG2O^@=9_
M]^%H_LG2O^@;8_\ @-'_ (5<\SV_7_ZU+O'H?T_QHY9_T_\ @CYJO\WY?Y%+
M^R=*_P"@98_^ T?^%']DZ5_T#K/_ +\)_A5SS/;]?_K4>9[?K_\ 6HY9^?W_
M /!%S5>[_P#)?\BG_9.E?] ZS_[\+1_9.E?] VQ/UMXR?S(JYYGM^O\ ]:G;
ML8R54!3)))(ZQPQ1*>6DD;A<*'=F("JJ,S$*"0<LO3Y_\%C3K/9_^D_Y%'^R
M=*_Z!EC_ . T?^%']DZ5_P! ZR'T@0?H!7\\_P 3/^#@K2=9^,?Q:^#W["7[
M#'[1_P"WJGP!U">Q^,/Q.^%=K#:_#[0I],GOH=>LM(F%K=W^HR:8^FWL<.IR
M&/3]4,+3Z?'-; 2M^C'_  3>_P""E_P#_P""F_P7UCXL?!BT\1^$M=\$:^WA
M#XK?"?QS%#;^./AMXK$"W,.FZHEL!;W]E?Q"8Z?JEJJ0SS075FT:7=A>1QYJ
M2D[*3N]M]?1[%-5TKMZ+SC^5NO3N?H!_9.E?] ZS_P"_"T?V3I7_ $#;$_6W
MC)_,BK@DX!P.0#PV>OT'7U':EWCT-:<LOZ?_  2>:K_-^7^12_LG2O\ H&6/
M_@-'_A1_9.E?] VR'T@0?R%7/,]OUH\SV_7_ .M1RS\_O_X(<U7N_P#R7_(I
M_P!DZ5_T#K/_ +\+1_9.E?\ 0-LC];>,_P Q5SS/;]?_ *U+Y@[@_P _\*.6
M?G]__!#FJ]W^'^12_LG2O^@98_\ @-'_ (4?V3I7_0-LA]($'\A5SS!V']/\
M:/,]OU_^M1RS\_O_ ."'-5[O_P E_P BG_9.E?\ 0.L_^_"T?V3I7_0-LC];
M>,_S%7/,]OU_^M2^8.X/\_\ "CEGY_?_ ,$.:KW?X?Y%+^R=*_Z!MC_X#1_X
M5UG@JPL+?Q%9R06=O!)Y=V \,2(X!MI ?F4 X]1W]#BL'<,$@=/_ *WU]:Z7
MP=(/^$@L@1R8[LC\+:3^9/2IJ1DH2;Z1EU\BK2DZ75K63T[W\NBZ'M6T$GKD
M8Y_/MTZ<'CFBG =2>"<?_6S[^M%>:G?;NU]SLST#R/Q^<ZK;KZZ>IS_VWD%<
M%AO[W_CHKO/'W_(4MW_ZAZ\?]MY#U_2N%KT\/_"C\SAJ23J-*]]>C[WWM;JA
MNQ?3]3_C3J=A?[W_ (Z:,+_>_P#'36MUY_<_\B+KS^Y_Y'\P'_!V;=PV?_!-
MOX<W=RS+;V7[4/P\N)W0,[1PVUI>2S/M3'F909& 7W*J9!P*]:\ ?\'-?_!'
MOPC\,OAYI5_^TC\0[G7/#7@#P=HUUI.E? KXI7MZVL:-X<L+2YT^!UT<6\D@
MO+:2T@O3)';@E7>3[/M<^5?\'9'E_P##N'X91SA7BE_:H^'0F2=4:&2)[6Z9
MHD$FY0A1&\Q6!79O&T(S@_M=\%_V0?V2(?A=\)=7B_98_9JBU63X:^ +V34H
M_@/\+$OVNY_">DS37/VY?"@N_/FE9Y9KCSC/)*[.90S9.,E>HY6:M&*^&3WO
MK;3SM?1_B;J<%22;?56L[[._1]U]_J?RE_\ !+[X8?M&?M]_MV_\%8_^"B?[
M)[>-/V%/A3^T!\.+OX=? KXGZMX/M;BY/C34-<\ ZAJ?BG2_#FJ6DND>(+V?
M2_AQXAU7Q0\$=U!H^J_$"..2X>Z,I/<?\&F?P?\ VE?^$!^,_P 74_:>U"/]
MF_P_^T9\4? _C']F0>$M)-AXX^*?_"(> [M?BR_BIK7^U[.=+&2WL%T>SN$T
MYGM(S)$9-X/]FMMING:/HK:1HFGV&E:=8Z5=V>GZ9I-I;Z;I=C''97 BL[*Q
MM8XK>P6-3&T,:(MO\@PI,C"OY"O^#5;]IOX'^#/AG^TM^Q;XM\?6/A_]I[5?
MVQOBQX]T+X1:Q;WMMXBUGPEIWA'P9I6H:KI;26XLW-AJ.D:Q#?6;2)>0/82W
M#6_DNCE*"52%Y-MW=VFE>]^FBZV7EZE.4G'2%[*/5+2W5_=T6Y\H_P#!=+_@
MC=\"OV1_V#?VD?VR/%?Q ^)7[1O[5_Q1_:)\!3/\6?B?JMR@\$>%_%?B'Q->
M3^#?".@0:C?0I9VMJ;;2AJ.IWMVSZ=8V=OI^GZ1%"8G_ +(_#?PR\$?&G]D#
MP)\)/B3HO_"1?#_XC?LY_#OPEXS\/RWNH6*ZUX=U;P%X>AOK$WVF7%K>VZ3A
M44R6EQ#,N"DCK%(RM^+/_!U9*B_\$@?'H=U'_%]/@F@8R1_.SW_B'RPHW LS
M,&5E"[@ "5^; _6WQ5XF^,_@O_@GU%XR_9O\,Z%XS^/'A7]D_P %^)OA-X1\
M5075SH?B;Q5HOP]\/7J:/J-I9W5M=7D6H6<-Y;6NG07-K+>Z@UE#%+OE3-QM
M&K4?*[."L^5ZN\KO:^KZNXVFX;J]GI==EIJ[>A^8G[<?[5WA3_@B+^RUX;_9
M?_8Z_8.^,WQE\,O\'?B1KGA6\\$V%UK'PF^&2:KJNH:+K5Y\8/$5O;:AKUSJ
M5]<W\FM.D5A<F_TZ&"'4+D(Q:/DO^#7SPG\._#7_  3<EUOP=\8_"7Q7\4_$
MSXT>,/B1\4=%\&"_TVP^$OBGQ%9Z4EK\-=3\-ZK;VD^@ZW8VEI+?W,]O:)I^
MJ07%M'I5S<06 <ZO["7_  <5_L5_%/\ 9-M?B/\ ML_&OX8_L\?M+?#N#7=!
M_:!^!^LV%]X6UC4M<T:YNTF/PU^'FKSZEK'B;3M>T]8K Z!;W.LZE8:@MU9:
MN(F;8OS!_P &Q7@'Q3KNJ_\ !1[]KO0?!&L?"[]FO]IW]H1M0^ /A74[%M+L
MM<TO2-:\6ZM>^)]*TUDC-O9Z/:ZU8:27A@2RAN]2N;+3Y9H=,<B/=]I!IIQ<
M7=62Y=$KV7G[NJ\DM[0^94I*:=TM=4[^;OH^^F]N]C^KH!L#+YP .0">!CD]
M\8QGO1AO[W_CHJ0@9.6.<GJ5<D=LLGRYQU Z'(X(Q1A?[W_CIKIMVM;IJMNA
MSIZ*][V5[)M?)VU(]H/7D]ST_04X #@4X <Y;'/H>1ZT87^]_P".FIOZ_<_\
MAW7G]S_R&$'/#8]L TF&_O?^.BG@#G)QZ<'G_"EPO][_ ,=-5;T^]?YA?U^Y
M_P"1'M!^]R?7IQ^%* !TIP YR<>G!Y_PI<+_ 'O_ !TU+=M-?DF_Q07]?N?^
M0P@]CC\ :3#?WO\ QT5)@9/S?0X/-&%_O?\ CIJDKZZ?-I?@PNO/[G_D1[0?
MO<GUZ<?A2@ =*?@9/S?0X/-&%_O?^.FDW9VU^2;_ !6@77G]S_R&$$]#C\,T
MF&_O?^.BI,#/WN,=<'KZ8HPO][_QTTTKZZ?-I?@]0NO/[G_D-"Y5MQSTQVQS
M[5_*I_P>"LL/_!,WX+2;0 O[:OP^=G(8D!/A%\:#C /([D;2> !CH?ZKU (8
M YSCG&/6OY4?^#P5D7_@F=\%/,,>T_MK_#T$.!A@/A%\:F89)&!L5BZY^902
M<!2:QJO]W4CK=VM9-K9=5I:^YI23Y^:VCO\ /1=-^CW_ %/J>V_X.??^".FB
M>&])V_M'_$74-2TSP[HUFFDZ1\#/BG<7MWJ5AHMK ;*TD_LB.")WN+=X([F>
M5($=D,L^QO,K\UO^"*>A^-/VEOVX/^"M/_!3WPG\)?%?P/\ V6/CIX)^(V@_
M#32?$5C_ &')\0-9U:WU;4KK4H[!56WNKK3K>U.NZS>Z8ITFTU;6YK&UGDN$
MG1/ZC_"G['W[(ECI'A?4[#]E+]FNQO\ _A&?#-Q%J-O\!OA7!>+.^AZ=*UTM
MQ#X6643S2_OI9LB9I"6W(Q;/L/CNQT[2OA1X\TO2K2STK2]/^&GC>UL-+TVS
MM]/TJPLX/">K>79V5C:Q16UE;I@%(+=(H<AAM .*3BWRW5U':*B[MV:U;N^K
M[%N<8W3O?KHWV?1-?CIZG\&W_!#/_@ME^RU_P3K_ &;?C;\%OC9X'^/7B+Q%
MK?[1GC7QO;:C\-/ TOB7PY!I%P@LUBN[])HC!J"20/(8F#*D861S@E:],_X*
M*?\ !1+6?^#B;PE\,_V&/^"=?[)'Q?\ $MEHWQ?\/^-OB9\=/B3INB66C_#.
MSC6:T@U&UO[&\O(O!^FW-F;R?7-5UN?3;J]AMTTG3K:\>?RJ_2;_ (-1;+3-
M0_8,_:'BO+#3-0CN/VM?'T,T5]:0745Q!+ID0>VD26.:*>":(D&!@4D#%&1D
M?)^3/^"H/P;^('_!"[]N#X<_\%8/V)?#KZ1^RK\9/%6G^!?VQ?@1X:$UEX&M
MM2UB[22_F&A6:'3M&TSQG9M=7_A6]$$"^&_'-JL&FY34IA67+^[A>_)>\ER-
M-)^=WIHKZ)I7:U1:MS2M>[>C>S:5MK7]-[Z=#^PWX8^#I/AU\,?AG\.GU(:P
M_P /?ASX$\"?VR$=!JG_  AOA72?#+:ELFCCG#:BVEB\<2C>#*-ZQNS+7;X;
M^]_XZ*\S^"GQD^&W[1'PD^'7QR^$/B&R\5?#7XI>%-+\8^$M>T^2&:&XTS6(
M!,MM<^3++]GU739UGTG6;)W:2SU73KVW<YBQ7J&%_O?^.FNM*Z36WFTOP;.9
M^Z[-->5K]^UR/:3]XY'IC'/X4H4#H/YT_ R/F^IP>*,+_>_\=-#=M/R5_P 5
M<5UY_<_\AASV./PS28;^]_XZ*>0.,'/KP>/\:7"_WO\ QTT)7U_-V_!V"_K]
MS_R(\$]3D=QC'ZBE"@'('ZFG$#C!SZ\'C_&EPO\ >_\ '30]/^!K^5POZ_<_
M\AISV./?K3<-_>_\=%2$#LV>?0\#UHPO][_QTT+7_@Z?G8+KS^Y_Y$>">IR.
MXQC]12A0#D#]33R!V;//H>!ZT87^]_XZ:'I_P-?RN%UY_<_\AM-PW][_ ,=%
M2$#LV?;!%&%_O?\ CIH6NWXZ?G8+KS^Y_P"1'@]VR.XP.11M4=OU/^-2$#LV
M?;!%&%_O?^.FAZ;_ (:_E<+KS^Y_Y"#J/J*:P8E@7/<=.@YZ$<C\.1VYJ0!0
M0=W0YZ&E;:0<MD<G!#'L>/ER2/906/;DBE>/6][:>ZW?R\@NK7L[W[.]O+2V
M_H?R%?\ !R?+J'QN_; _X)'?L-ZQ>K;_  G^+GQC7Q[XVTZ:6:UTWQ"I\8:/
MX4:PUF42QQR!-!L]3MM/MV4M:RZS=7,+"6YP/ZY-*T+0_!FEZ1X2\(Z59>&?
M#'A"QM_#?A30=(M4TW3="T31(4L])TJPL;98H[6TLK6&(1"WC@1I%>8MO>0M
M_--_P<I_LC?%SX@_"O\ 9I_;H_9W\*WOCGXJ_L#?%*V^(7B;PEH\=U=ZMK_P
MQCU31?$=U<V-I9QSW<MIX8UK0WN=>2&.:Z.B:M=2VUK.MC/CZ1^"7_!R!_P2
ME^,/P?T[XK>.?VBM'^"/B_\ L2"\\>_"/Q_I&MV7C?PSXF%L)M:T'1--M;.\
M_P"$NLH=2%PNDW7AJ?4H[BW>&.?R)S)"F,9)5)N6E[.#>EXI6=K^=V^NNJU-
MKN4(^SZ74M+--VW37W;WU/L[PS_P3E_9:^#W[9GQ?_X*3> O#GBWP_\ M#^/
M/ ?B&S\8V^G^(A:_#/76MO#KR:AJ%UX#LM*MH9]6UB32=/O+^ZNM3N()]0M;
M74(+>"[EGFG_  1_X-=/"EA\:?'O_!27]OCX@06?B3XY_$W]HR_\&:=XKU,)
M=^)?"WAB]N=:\1Z]HFGRW9FN]%LM7.H:%IB^5+%G2_#T&E,[6,$T+^\?\$SO
MV[/VPO\ @J=_P4N^.7[07PYUGXB> /\ @DI\-/!=[\.-"\#>)]!T:QT_XS^+
MY=)N='T;4[2XU'2)=?TW7K^74+KQ3K%MI6K"RT[2K#2M*U)K74+Z2R3X)_8X
M_:#\/_\ !O+_ ,%%OVS?V6/VSM(\1>$/V3/VN/B##\8?@#^T#IOAO6-;\(:4
M(=2\02Z397(T^"ZNI-,BTGQ;_P (MXJ>SCN;O1]9T#1M3U.RL](OA=J2FN:G
M)+]W>5WRV5W9*2\GK9^KTNFZ7.H36\K+E6FZO=7VT_X8_KP_:H_9@^#_ .V;
M\ _B%^S5\>="N/$?PQ^)6F1Z;K%M875O8ZUI=S974=S8:WX6U&YLM0.C>)=#
MO[<7NGW]M9S/;R*GF0W%M,\4O\]__!4'Q5\;_P#@B/\ "K_@FOXE_9%^*7Q'
MT7]@OX-_%K3?@E^T3\*/%%Q8>.)=<\#Z[JR:WIE]JOB/4M#_ +;EEBT.#QGI
MEA'87&E6EC<:=X6LX+<1KY<G0_\ !3+_ (.(?V4/"7[._BGX8?\ !/WXOG]H
MS]L7XRZ8W@7X.67P=T?4_$R>"-=\4;-*@\9W>H_V=>Z5-X@T!;Q;GPWX=2/4
MK_4=?73X9=,^PP7T]O\ 7%Y^Q1^TU^UW_P $2=8_99_;I\:7OQ-_:\^)WP2U
M?Q-KNNZY;>&[34_#OQ=MKY_''PL\,RR>&["QTB"Y\(W]MX<\(:]J-C&SZB_]
MJ233RK/+%3E*,W+DOHOB2[NZBVK]KM:Z:W3M<B^6$?:.SN^9-Z=-5_GZ&1_P
M76_X* _$?]E+]BWX;G]DGQBVC?M+_MA_$WX>?"W]G+6M'73K_4[6W\1RZ9K>
MM>(=$34;34M+FO;:VU'P_H'VF[M;R OXGEPFZ(-'^%O[>G[25K_P3X_X+H_\
M$_?C+^U+JWQ$^,.K?"K]C#P)I_Q<\2^&-"L]6\>>,/&NJ>'M<M->UG^Q-+BM
M;)K@ZW=31W,-G;6T,<5N&2)>:\E_X(R^)OBQ_P %2OVYOV%_!_QRT'5H_A__
M ,$<?V=]6T3Q;9ZNK7NF^(/B=I/B;7/#GP_O]9MYO-N!K=[;QV%M-<W$45VE
MYX"@.UT'FM^HG[4#+<?\'6'[#PG6.9W_ &<G=HYD$GFM)HWBLAY(W9U9I &<
M @("I(4$$5#;FN972<HI:-JZNV^FMW96[6W+5FVDTVD[ZJ^NRZ[K7T=R_P#$
MW_@[ _8VGT;5/ ?P:_9R_:A^*?QF\;:/J'A?P!\.=;\)Z;X>MM;\1^(;2XTG
M1K#6XK^]_M"\T?4+FY$=Y;:+I][?7\0>VBMY7?;7T!_P;<_L.?'_ /8^_96^
M-_C3]I'P5)\*/'G[57QL_P"%L6?P9O(/[/U#X<>&-/T_4+/2K?4M$C"OH$NL
M2:W<F/0F$=_IVFZ?IRWEO;-*(Z^@_P#@M!_P2G\)?\%!_P!G/5O$?POT+3?!
MO[97P6MI?'_[/7Q1\.VPT+Q3=ZWX?)U!OA_JFOZ3&FH3Z?KTEJ$T>6>6YN-$
MUY+*\TU$,CI7F/\ P0*_X*E:Q^WY^SOKOP@^/U^^G_MJ?LLW4?@3XT:'JK?V
M?K_BSP]IMY-H.B_$.?2Y!'<G6H;ZSE\-^-UCB*V?B.W@NWQ+JQ"5&_M$Y7V?
M(^7E3T7,FG?WE9.UVK:K6XIJ\6E9WW5T^MUY6O\ C\C]]T."/< =AUQZ<?@.
M/3BF,&W-\W<]AZU(<9&25*\893N!'9N3\P/!]Z3 /);!/7@ULDG)M=K:Z7U\
MSDZMV>UGH]TWY$>&_O?^.BC:.XR>YYY/YU)A?[W_ (Z: !W;'M@FF]-_PU_*
MX[KS^Y_Y#>E(0<\-CVP#3\+_ 'O_ !TT@ [G'X$T+7;\=/SL%_7[G_D,PW][
M_P =%&T'KR>YZ?H*DPO][_QTT #G+8Y]#R/6AZ?\#7\KA=>?W/\ R&@ <"OD
MG]O\'_A@O]MYN 5_9"_:4PW.[:_P<\8A@/FP"2@R=IRO&,@-7UQA?[W_ (Z:
M^2?^"@#1C]@K]M\,ZJ/^&0OVD0&8A1D_!OQLQW,V%3 0MERH8$*A=]P692=M
M+ZZ/1[:@I6E'1_%&^CT5U?H?Y]?[(OP:^,O_  3L_8K_ &"_^"ZW[*=EK6OV
M.C>,/B?\+OVV/AQ;W4UQ8>(_A]'\3-5\/:7K%S:;S]G\/:QH45OH&J2E5M-$
M\5:=X=UJ6:.+4)HJ_;__ (.&/C]\+OVI?V4O^"//[0?P;\0P>)/AO\5OVTO"
M'BOPW?1NCSV:7FE>%QJ.D:I$H$EKJ^A7ZSZ3JEL_E21W-JV4570'[N_X-TO
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MJNU>SDW%6>SMKIT;3:^]:/6*KC[M[\W+MJW;JG:ZT=B, #I00>QQ^ -/PO\
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MGK7ZV_\ !;7]G[X>?M(?\$O?VP?#OQ(TJQU6;X>?!KQC\6OA_K.HB'[3X/\
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M-5_;8F_X*T_"']H#XB_"_P -O\6/BU^R3JEG\-I_AY?^#M$MCK_B;PKX;O\
M35L+S6]0\,Z697GMK9=);4H+*:/3]0O)Y;6&X^4?^"NW_!+OQU^S;_P14_X)
MO^&9/"6H_%6R_8;\;VOB;]J3PQX;N)OM3Z1\6[W4?$_Q+FBN-,$DD^F:'XMU
MN/P=:Z]; M8:*8M6?R[6.:8>2?&+P;_P:A^ /V4[G]H;X<Z9=_%SXCZEX1@U
M'P-^S5I_QG^(NG_%/6/'-W;01V_A#Q;H\5Q>7_@>RM]2N=NJ:_J=H]E%8VES
M/IJZC,;>VGS4IVY9:6BK<TG&[MNK:7OIJGT3CK=NR?2Z;=U9/KHK>G]:'[F?
M&W_@HY^WA^UG_P $\_V+OC1_P2S^!^J7?Q3_ &P-8AT#XG?$A_#<GBSPG^R=
M8Z+>V_A_X@ZYJL\BK#;VMCXH>_CM/$=S!=VUCI6AZI(]A=75Q:0M^=7_  4'
MUS_@L#_P2:^%?AK]L*Y_X+&>$_VM;CP[XU\*Z1\2OV=_&GAWP)8:?XOM]7\R
M&Y.@Z3I,;7VJ:!IUPCI>&$^']5M89[.^@23R9K=OD3]N7XG^._@#^Q/_ ,$@
M/V;-#\-_&;_@EM^PY^TIXK\;>//CYIWA#QQXK\5>,_!FG>+O'=EK/]B:U\0-
M1L= \4P1R^'M>E\;W?AR]M=.BL#X@E_M/3=4MM':U;Y2_P""N_P?_P""$?P%
M_95U'PI^P1XZUS]K_P#:W\9^(/#&L7/QB7XL>(?C,OPU^&^DSR3^*=?\8:]X
M<FTGP1I6IZ]+=Z7HEMINHZ3?7EM*\VZ#3U2.:1RE*STM)13^.UGRWO&*LW??
M5-.UOLL2A&Z]U;NSY5WZOI\G^A^C_P#P<EZ9\?/C+X8_X)5_M':)\>[SPE\)
MOCQ\3O@W%\._@D?#&G3VWPD^-.O^#_#VN:E\7;?7Y;9]1UQ_-U5+:+1KZ:2R
M6"RCDCM@\\P%'_@MMX9_;>_9S_:M_P""&N@6_P 9M*_:L_;@\%^+OBE_PA'Q
M7\;>%--\.:1XW^(5W\7O"R^$9==\.Z1_9VGP:7HL]U:PNL'D*\5N\A5^C]Q_
MP7"\3Z*/^"7'_!";XO1W2WGP]\&?&3X'>*?$OB33TEU'3=+T#3?AMX:26]GF
MLDF/E!]+OX(E+M+)<6\EM &EPE>X_P#!2_\ :+^"7[5W_!6K_@W9^.7[/_Q
MT/XI?"OQE\?/%4>A>+M&&ZQU&YTSXQ^"K6\MY(+JWM[FUN+&XEB@N+2^ABN8
M9>)X$; :5)-RYD[RY7\+TUCKK=;IJ[6NP[Z*RO;FTT5[)Z:]_N.!_;5\>_\
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M (*W_P#!37P;_P %J;+X5_\ !*W_ ()>:5XR^.1^+/Q2\)^*OC3\59O!&O\
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M!''#;P1(D442)'&JHH [ D,<(B$EB@!2,'< <;OD(&>>=QSA3CGA2Z*#E8\
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M=>[N^KN]?P#VT//[CDSXVL#UTG7N/6SC'\YQZ4G_  FNG_\ 0(UW_P !(O\
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M@OX1:7?-$]_8?#7X<^%/!%G>- @2)KFW\.VMC#,R( D;21N8\ Q[6YK\K?\
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M^?WR][_(/;0[O[CDO^$WM/\ H%:S_P" B?\ QZG_ /";6/\ T"=>_P# %/\
MX]74X_V8O^_*?X4O']R/_OW'_P#$U/N>GS?^0>VAY_<<E_PFNGG_ )A&N_\
M@)%_\DT?\)KIX_YA&N_^ D7_ ,DUUN?;\<G_  ]_T]SAWR^A_P Y]^V?T]SB
MKR_Y^_\ I7^0>VAY_A_F<A_PF]I_T"M9_P# 5/\ X]3_ /A-K'_H$Z]_X I_
M\>KJ<?[,7_?E/\*7Y?[D?_?N/_XFI]S^F_\ (/;0\_N.2_X373SS_9&N\\_\
M>D7_ ,D4?\)KI_\ T"-=_P# 2+_Y)KK.>P'MSC^GU_ST=Q[_ )?_ %ZJ[_Y_
M+T][_(/;0[O[CD?^$WM.VE:S_P" J?\ QZGCQM8XYTG7<]\62$?@?.Y'I74X
M']V/\8D)_$XY/J:7 _N1_P#?J/\ ^)J?<_IO_(/;0\_N.3/C73R>=(UW/_7I
M$/T^T#'Y4G_":Z?_ - C7?\ P$B_^2:ZW/\ LC\\#Z  8 XQQZ].!E>/3_/'
M^'Z^PS5W_P _;+M[VGX![:'G^'^9R/\ PF]GVTK6L>]H@/X_OC^AQ3AXVLL<
MZ3KN?:R0C\#YW-=5C_9C/)Y,2$]>YQDFEP/[D?\ WZC_ /B:GW/^#=Z_AU#V
MT//[CD6\:61)/]DZ[^-G$#T]#.#3?^$TL@5(TO7/E.[FSAR&SP!BX"E1SPZO
MR<C!45V&X X" D<X&U1U!X & ,<8QW- =2 -I+DX"]B,##;\;1R,."04!W-A
M3D6HRZ5(KLN5W2Z?\.2_8WNZ,FWK?W.NJ?=7Z7/B3XU_LD_L1_M'^)+?QE\>
M_P!D'X/?%[QC:BV6+Q?X^^$WA'7O%4L-H"MM:7NO7%F=1OM/MU)$&G7-S)8H
M7E?[.6DROT;X2G\$> _#FC>#O!7@4>#_  CX=LH=.\/^%_"GAS3] \/:'I\
M*Q6&C:3I/V2PTVSC&!'!9V\**H,;!E)SZ2)4*[]D9!RRX6-V9>I8%EP5 (R2
MP/4*&*\R%!NPRHI(! \M5RN<,Z@Q_< (Q_$Y((0*0U+17YK7[_S6ZV6OW[;
MJ\4^7E:2T5[[+3M;[OQ.3'C6PP VDZZ6'5OL<8+$G)9MUSN+-U9FY8\^E'_"
M:Z?_ - C7?\ P$B_^2:ZLML)0I@J2,<)C!.> N._IFCS%_NM^8_PJK2>JJ63
MV6NB]$C3VBTNGJKJUMG\U^2.4_X3:R'"Z3K6/]JTCS^DQ!_.G#QM98YTG7,_
M[-DA'Y^=UKJ1SD[4(/3=&K-Z<DCVXZ_A3L#ND?\ WZC'_LIJ'RW=W=]7=ZO[
MB?;07?[CDSXUT\GG2==/_;G&/T-P/Y4G_":Z?_T"-=_\!(O_ ))KK>!T5?H
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MX;'M@&DPW][_ ,=%.HH ;AO[W_CHI1GN<_ABEHH 0@]CC\ :3#?WO_'13J*
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MSB8+7V?_ ,$H?^"O'C+]L3XQ?%?]B/\ ;'^"B_LQ_MZ? N&ZN/%?P]M)KO\
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M)OL+"DCRI&A+/(P1 %!.]B F!@YR^T-G"A2Q8A037\C,7_!Q5\2$_P""K*?
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MZOH&M7VKW5\7GTW3+SPMINE1LTFI3CJOV-OVO_@O^P3_ ,%6OV?OV9OV+/\
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M8Z>&XO\ P+?^B ?I1_;/B,\_\(U&?I=O_6,_SJ>9+O\ ^ R_R%[-]U]S.O)
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MLUOQ-X)D0ZEH=L5N;K4M%DU/P\D,L,X4?T5R^(_%LZHD^AR2K& (UEOI9%0
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M2W;4KF.XU-[6TEO)(E_4[_A(O%0A:W&A,(9"'EB&HR+"9 JC<(!%Y?# X#9
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MK'B3MX;1?7_2FY_\A4E)/17OZ-?BU8/9ONON9UXP>A'YB@Y']W\6'],UQ_\
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M]'9Z-^FOWDMM1=E=VT]>WST1_%)\1_AEX(_X)*?\%7_VO?BM^VI^Q+=?M/\
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M[:\0_P#0M1_^!;?_ !H50_9ONON9UV<_W?\ OK_ZU/P?;\Q_C7'_ -M^(_\
MH6XO_ N3_P")H_MCQ%_T+*?^!;?_ !JIYX^?_@,O_D1>S?=?<SKLCU'YBG8/
MM^8_QKCO[8\3?]"ZO_@4W_QJC^VO$/\ T+4?_@8W_P :JA^S\U]S.NW?[O\
MWU_]:GX/M^8_QKC_ .V_$?\ T+<7_@7)_P#$T?VQXB_Z%E/_  +;_P"-5//'
MS_\  9?_ "(O9ONOQ.NR/4?F*=@^WYC_ !KCO[9\3?\ 0N+_ .!3?_&J/[9\
M1=_#<>>_^EMU_P"_54/V?FON?^9UV[_=_P"^O_K4\ D \<_[0_QKC_[;\1_]
M"W%_X&2?_$T?VSXC//\ PC*<_P#3VW_QH_S-3SQ\_P#P&7_R(O9ONON9UV0.
MX_,4[&?3\Q_C7'?VQXE[>'% [#[4W'_D*C^V?$7?PW'GO_I;=?\ OU5#]GYK
M[F=>3@X^7_OK_P"M3@,C/'YC_$5Q_P#;?B,=/#<7_@7)_1!_*C^V?$9Y_P"$
M93G_ *>W_K$?YFIYEY_^ R_^1%[-]U]S.P(QR2/S''UK\4_^#B+1]8\1?\$@
M/VL-&\/:1JOB#6+R/X:)::5H>FWNKZE<,OC[16<0V.GP7%U((XPTLK1PLL4:
MEY61 7'Z^G6O$F,#PVH'I]K? Q_P 'GKP,=13H]?\4P3+-#H+1/&$"O'J$L4
MBD$[L.B!E5D9@0I5SD@OAC1+WH24G9--+=NS7:S[^6Q5.$TVVM.CO'5736G-
M?;R/R\\%?M&W?[%G_!%'X)?M"W?@;Q)XN\1_"+]AOX&7>C_#G3M&U677=;\<
MW'PQ\*Z+X6\/7^D06DFK6J3>(KRV@UL-:)+IEG%<S7,<203%?XU?V ?V]_@?
MX1_:1\<?M_\ _!3G]FC]LO\ :[_;7\0>*+F^^'DUO\-C/\(/@QHD#-_9;^$/
M#&NVX5M:TY':RT*W:V32?"NFHDVGK<ZY?7^I#_1N7Q#XI659UT)UF7.9EU&5
M9I'+ ^>\JHKB0YD<A2&W2LIF*8Q>'C#QP2S'3;PEB/F&K76XC>2QR=WSLIP2
M/X@?4UE*+O3:>D8V5XWUTL[;WT[:-E?!S246Y-W=G9[MV5[K=M_YGYP_\$Y_
M^"I7PS_X*7I\7)OA[\$OCS\'?^%3)X7EUI_C;X;B\/GQ&/%4FJBU'AZ>WC6.
M\>Q;1YVU.$.SVT<]HS(J3H6_3SDDYP#GD<+CO@#.0![\^O-<S-XF\77+(T^A
M23!&=D^TZC<7)BW* #&K@(K JK$X()+@8W$FJ=9\19.?#:'GC=>,6 [!F,67
M('!=OF;J:VC>ROO;?:_RZ$.#DV[VN[V>K5^C:T;OVT['7$X./E_[Z_P!I1DC
M/'_?0_KBN0_MOQ&.GAN+_P "W_H@'Z4?VSXC//\ PC49^EV_]8S_ #I<R7?_
M ,!E_D+V;[K[F=>2!P2/S% YZ$?F/\:X_P#MCQ+V\.*!Z?:F_P#C5']L^(_X
MO#:$^]VPX_[]4T[^G]=+#]F^Z^Y_YG7DX./E_P"^A_3-*.1GC_OH?UQ7(?VW
MXB'3PW%_X%O_ $0?RH_MGQ&>?^$:C/TNW_K&?YTG)+37[I?HA>S?=?B=><#J
M1^8H'/0C\Q_C7('6/$G;PV@_[>F_^-4G]L^(_P"+PVA],W;#_P!I4T[Z]/ZZ
M-)C]F^Z^Y_YG8'@?PY]V _+K^/X5U7@GGQ%9'CB.[Z'(_P"/:0\G@#@=^O:O
M)AK7B(=/#<7XWCC]0@_K7<?#K4]8N?%EA'?:-%8VYM[XFX^T22$,+63"!"H4
MEL=ST':IJ_PY_P"%_D"BN:"?5_BM;_UV/I4Y/0\<'V8'T(Z44B9YX '8]"1S
MS@< >G?U'2BO(CM_V]+_ -*9V'C/Q'+?VS: $\:<O&2H_P"/B?N,GG//'8"N
M"96 SD_0R-^G S7>_$; UJU)SC^SESCK_KYO6N!))ZDGZUZU!KV4?=UMOYW=
MW\SDK:U4T[))7\[?Y"'=D\GJ?XV]:;@^G_C[?X5(=A)/S<_2CY/]K]*N_D_N
M_P""9<S_ +WX_P"9&H+'"@L<J"%9V*EFV@,%!93WP0/E^;H1F0>: N8F7/"[
MB_S$ 8P1D?-R%)(!(/;&?P!_X.//VH/V@_V4/V$O!GQ _9G^*>N?"/XA:W\?
MO!_@^?Q3X?CT^>^&B:O;W FM)$U"RO+6"*>8)*\R0AY5B,0E&37RSX5_X)L?
M\%[-?\(>&O&&D?\ !;*W6]\2^%M#\2Z?I6J?!_26LXY-=T6VU>WT^\N7@NHY
M(X7N8;>XN8K*YV+YDIM7'R&7*[<5"4G%)M*UU=/NUVUU-.2+CS>T5N]WIW[;
M']41W@GKD8R!(Q()WG! R5VA"7W8" J6(S48.X@("Y8MC#, P4_,RL<*^%PS
M*I+KG:1ORM?S*_\ !)O_ (*G?M/GX^?MB_L ?\%5/%/PSTKXX_L=>&9/'%Q\
M=Y[S0/ GAG7_  C:7>@:=<_\)'?M;^'/#:)?1^+O"&LZ#KD&GZ#<:AI>M-:7
MNG1W<)W?0O\ P0S_ ."I_B'_ (*-_#?X[:Y\=/B)\&;+XQ6?[27C7PY\,?@]
MX2UC2-(UW3?@KH7A/PC>Z9J&C>%IM7N_$^N:.^KWNIM<^++C[9;7.H3W4(FM
MX4M;:W(U(R:2>NJY>J:W37=>K!TY)7<M.^MK=.O8_>< MC:K$D@ 9?<22 1M
MQD8SQD#>1B/=E<F[!*Y(PI8?,_W5;:21U4=2 P!(!(!K^+#_ (+6_P#!Q=X@
MTWPM\3/V?/\ @FI%X_FUCX<^*]/\,_'S]KK3O"]];^&/AS>PZE=:?#X(\%7=
MWITD5MJNLZQIMYIEQXHUN#3XI_L&H:?X<75HW:_@_L"^%OBK'P0^&7COQ?>M
M=@_!WP9XY\57\NV*2Z6U\!Z?K_B/49) 1'#<3*E[/,T(106),10L U.+E*.M
MXJ[T]5;U5M?NWO8Y'9/F5I;?%KU_%:H]. E.<(YP"QPY("AMH)(.,MD,%SNP
M<XI 6)) (QU+.4/<'"MAV *X) (Y'/4#^+G]BCQ-_P %_P#_ (*>>#_B]^TC
M\ O^"CG@3X*_!BS^/?Q'\ _#OPWXL^$7PXU&>XT?0-;E-JFDW\/PWO99;+2]
M-NM-LO,O;Z:ZN)06>1Y&.?Z0/^"=WP>_;[^#'P\\?Z/_ ,% _P!J'PG^U)\0
M=6\76%_X&\4^$/".C^$8?"WA.+39(;_1+B#1?#GAV&]N=0U(I?"2YL[EHTB,
M*S_.!2A-3?P2Y>C=K-=]V]5JM/4)PDM.=7:LD[[V^[JN_G<_0DH>Y7.!G]XW
M7'(SCG'3(R#U!((-&UO[P_[^-_A2>_'/S#'3#?, !DX4 _*,\# P,8!6EUV_
M%_Y&5I+3F>FG3I\U^0'<#U)^DC4W!_R[?X5(-O?=GVQ1\G^U^E3?R?W?\$.9
M_P![\?\ ,8%)[@?5V']*=M8=& _[:-_A0<9XSCWZTE5==OQ8_>_F:_KU [@>
MI/TD:F\GKS_P-O\ "GC;WS^&/ZTOR?[7Z5+?D_NO^H<S_O/[_P#,8%)[@?5V
M']*=M8=& _[:-_A0<=L_C_\ 6I*I-=OQ:%>7\S7E;_@@=P[Y^DC'^E-Y/7G_
M (&W^%/&WOG\,?UI?D_VOTI-^3_/]0N_[S\_Z8P*3Z#ZNP_I3MI'1E'_ &T;
M_"@X[9_'']*2FFNWXM!=OJUY6_X([:YZ,#_VT?\ PIF&) PS'C@,['!(!( '
M;.2.N 2 <4[)'0D5_.__ ,',G[6'[17[''[!?PO^)W[,GQ3UWX1>/M>_:G\&
M^!-4\3>'8]/EO[SPMJ7PV^*6L7FC2#4[&^@2UN-4T/2;V1XXEGWV,2HX5I!4
MSE&,7)II+?6]^R7_  2H*4I<KEO;EW3\[Z_<?T/F.0#)BD  +'B3< "0<H 6
M# #)7&X#.X#!PTY7<"&5EP&3<V\'<JX*C)'+#D\8YS7\N-O_ ,$PO^"^3Z59
MZSH__!;>TO-3O-&LM7L;'5?@]IL=D9;^PAO;:VO+L6VI&*%&E2"6<V-RL:&5
MXH9\[&[/_@DE_P %)_VR_B9\2OVZO^"?G[?L_A?4/VL?V._"GB[6=#^*GA*Q
MT_2(_&NG:-INJV=[)=6.G6.G:/=2:=<Q:=XCTSQ#IFFZ1:ZCINHV]O>:-'=V
M\MS-*GMS1E&][7L]DW:ZO9M)M76OKH;>R[37WV/Z7]DORX25BY"H!YI#L<Y4
M-C;\I!!).WC()'-,8.!\P8?-@99\$C/0XP3D$  EB<@"OX??^"8?@K_@LS_P
M5"^$'Q.^._AG_@K_ .,?@CI7@WXQ^)/AC;^$M0^$OAOQI+-%I@>YCU*/48;O
M0Q;VRPRK;B$V<I0*K-<DG;7I'[8WQ%_X+A?\$2[?X5_M.?%;]N/PA^W1^RQ>
M?$70O WQ-\'>*/AUX>\):S;1ZJ[2QCRK:R?7[."ZMHKFWTW6=#\8^;;:OY,>
MIZ+/I[M(J]HN7GY9<N]]'I>U]'>RZZ?+<3IN_*IIM;K7KZ)?BS^SM5W+D'C@
M@EG ((SD9'8[EYQDJV,@$T;2.C*/^VC?X5RG@3Q?I?Q$\#^"/B)H<<\6A^/_
M  9X5\<:%'=\7B:+XPT#3O$FE17BC CG@L=2@C=!&B[@[(7!9CU=:W7;\6C%
MJ46US/=OH[7Z;_\ ! AA_%GZ2,?Z4GS'KD_\#:G#'?/X?_7I?D_VOTI-^3^6
MO^0KM?S/S7_#C "3V'U=O\*78?[R_P#?QO\ "E.WMG\<?TI*$UV^]M?YCNWU
M:]?^' AA_%GZ2,?Z4GS>_P#WVU.&,\YQ[=:7Y/\ :_2AOR?RU_R"[763]/\
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M77XL8=XZ9/."?,8*!G&YF;"JN< %B 6*J#E@"[#["X#L.!P9 03M..0 3U!
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MI_X^W^%2?)_M?I1\G^U^E3?R?W?\$.9_WOQ_S&[#ZK_W\;_"EVM_>'_?UO\
M"DHJKKM^+#WOYG]W_!$RWJ?^^VI,'_+M_A4GR?[7Z4?)_M?I4W\G]W_!#F?]
M[\?\QNP^J_\ ?QO\*7:W]X?]_&_PI/I1577;\6'O?S/[O^")\WJ?^_C4F#_E
MV_PJ3Y>^[]*/D_VOTJ;^3^[_ ((<S_O?C_F-"D]U'U=L_P J7:W]X?\ ?QO\
M*3Z455UV_%C][^9_=_P0(8?Q9^DC'^E-WGYAL)(&1DL6?K]T=2.,!CA3T!XJ
M549Y(XT4LTKQQH 5),DAVJN <@EN.G!(R:_D,_X+9_\ !PC/\*/#WQM_96_X
M)ZZ5XY\5?''X>LNC_'K]HK2O"VHR>#/V=K2/5(M'U&UT:\GL)5N/%L^J31Z%
M_P )%J5O:^'-&OYD33-0U?4!):1Q.48QYFM%?1.[=K[;?UJ]-1J,I;-2[^]:
MW37^OT/Z\&4AB",8/3<X_0C(/<@@,#P0#D4B[R=JAB<_=#/NV[7<LJ@;F&(V
M V@EWQ&@9R!7RU^PUXS\3?$3]BC]DGXA^.-;N?$'C'QK^S5\&/%_B_Q#J&U;
MS6O$6N?#O0-6U[6+QD2.$W5]?7-S>W7EJI#2.YC12*_DM_X+4?\ !QOXLG\.
M>-O@C_P3-;XA6-A\//'>G>%_C;^V'9>%;ZS\-^'M<M=1NUM? ?@*\U/3IH;.
MZUO4-(N[:YU_6X=.EU.RTW4;3P]9W]I,VJ0*52,8W_NW25VWI?3]>BZLVC9O
ME33<;)Z[6TU?KYL_MW^;OD'H07<%2."I&."#D$=B,4F#_EV_PKG/ ]W/?^!O
M ^HWLCS7FH^#?"VH7<[! ]Q=7VAV-U<7#[0JF2>:5YG8 !F<G%=/\G^U^E5?
MR;^7_!,9-W?Q;OOW]1@4GN!]78?TIVUAT8#_ +:-_A0<9XSCWZTE5==OQ8O>
M_F:_KU [@>I/TD:F\GKS_P #;_"GC;WS^&/ZTOR?[7Z5+?D_NO\ J',_[S^_
M_,8%)[@?5V']*=M8=& _[:-_A0<=L_C_ /6I*I-=OQ:%>7\S7E;_ (('<.^?
MI(Q_I3>3UY_X&W^%/&WOG\,?UI?D_P!K]*3?D_S_ %"[_O/S_IC,' X[G^-O
M;V^M=;X&W?\ "26..@CO,@L3UM9 , @<C)[]S7*'';/XX_I75^!_^1EL?^N=
MW_Z325G5?[N?^%[HM2=XOLTM=]7KW/>@#NSD'@;O7O@8Q@ 9SUYR:*7D$\<'
MTZ\#OW/MC-%>4K6T=]7]]W=?)W1W'BOQ(.-9M??3E'_D>>N!R/4?F*[WXD<Z
MS:XR<:=$>AZ-<3@=L9R.?3(KSNO4H?PH>GZLXJC3G9.[_P""_P#-?>6**BP_
MO^?_ ->C#^__ 'U_]>MK/M^*_P R+/L_N?\ D?S%_P#!V5)>1_\ !-SX>2V<
M*7%VO[3GP]>SM)<8FN([2],$0='C\N*2;9%*J,F/-4[D;+UQOP]_;/\ ^#F:
MX^'_ (!T+PG_ ,$J/V<;#2AX'\*V'A[Q=KWCJ6XLQID/A^QM]'UZ_P!.M_C<
MMPL\U@MM>/"UNT6\^7<6SQ9@KZZ_X.*?V5/VBOVP?V(/ OPR_9E^$GB7XQ^/
MM(_:"\$>,-0\+^%CI,=_!X:TN"Y%]K!_MG4M+MO*A<I%*$N6=MX<Q!59Q^VW
MPQTS4-$^&GPXT75K2>PU31OA]X*T?5-.F*-/8ZGIGAG3+*_LY98RR"2TO()H
M)%A9X@R$1NR8-8N$I5:KYW"+BDGHDWKWZKR-E5@J3NE=W7+I?[KW_)[^5OYU
M/^"<?_!&+XLQ^,OVSOVLO^"L]Q\/OC3\??VU_"DOA'QK\+=%SJ?@WP[X%BO]
M*U^32M7NX;>RL[B[>?P;X(M=,TK28A#H&E^&(+4ZCJ;WKSI\Q?\ !IS^S%\!
M&^ _QZ_:8;X9>'9/CQX*_:K^)_PH\)?$UH2_B71/AT?!?@&\/A*SE.XK8-=S
MSW*K%&LN^20\J<5_7Y,K/!=1 M']HM+NW5MPP'N;9H@77GY Y3S& WF,-CGB
MOY5O^"%/PB_X*,_\$]?C#\:/V&OC7^QCK/\ PSEX_P#C[\3OB_8?M<Z5KNG7
M'A6P%SX?TO2]#2TM5U(-J7A_Q'#X7LVLI_L$6KV.IZG]FO;86J.T9[+DG!QB
MWHU=:W;2=[ZV?Q:NR]"5-SIR3M%VV:Z:Z)=K)*U];KI>W9?\'*GP;^$GP2_X
M(V_$[PY\'_AMX+^&.BZQ^T5\)O$>LZ?X'\.Z7X>AUSQ#JNK^([G5-;UI]-@B
M?5=1O[J26:YN[UYYY)3OWY+Y_<J]\%>-_B3^P9'\-?AKJ>EZ+X]^(G[(>B>!
M_"FK:W]I&CV.K>+_ (1:?X>CNM3:RC>X6"U@U":0M;Q><K*KA),&OSR_X.$_
MV8_CY^U[_P $V/%WP5_9J^%WB#XN_%74OBU\+/$%GX(\+MID6K3:)HE[K<NK
M:E&=8O\ 2K(P6$5Q \R+<B=O,58()6#*/T$^(G[/^L?&[]A34_V9=1\2Z_\
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M8T[XU330>-;CQT(6-RND?\22[LUT^>R\B&V^U:E;)]I)5MBDO3OAC9?ML_\
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M[#/'L*4AR21G!Z<X_K6J5WIKIW7?U.=:O373IKU\KDM,+@$CGCZ?XTW:_O\
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M_%?YA=/;4FI"P7&<\U'A_?\ [Z_^O2%6[\_B#_4__7X]119]OQ7^8;?U_P
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M(!AAWN.<CBGR1-$Y2171UP'5D(*,3A4<$@JS<;0>H(/<4<OG'[T4YI;QDO\
MMVQRHC\8C_E^TK\+5!_6CR_&/_/]I?\ X#)_C748'<XZ$94YP0",^G!Z487^
M]_XZ:AQA=WY[W=[*ZOY$<\/Y+^?*M?P.6,7C$G_C^TG\;1"?_0J3R?&/_/\
M:3_X")_\57587^]_XZ:,+_>_\=-'+#O4^YC]K'^5_=_P#EQ'XQ'_ "_:5^%J
M@_K1Y?C'_G^TO_P&3_&NHPO][_QTT87^]_XZ:.6GWG]PN>#WA_Y+_P  Y8Q>
M,3_R_:5^-HA_]F%)Y/C'_G^TG_P$3_XJNJPO][_QTT87^]_XZ:.6'>I]S'[2
M/\K^[_@'+"/QB/\ E^TK\+5!_4TOE^,?^?[2_P#P&3_&NHPO][_QTT87^]_X
MZ:.6GWG]PN>#WA?_ +=_X!RQB\8G_E^TK\;1#_[,*3R?&/\ S_:3_P" B?\
MQ5=5A?[W_CIHPO\ >_\ '31RP[U/N'[2*T46OE_P#EA%XQ'_ "_:5^%H@_J?
M\_6E\OQC_P _VE_^ R?XUU&%_O?^.FC"_P![_P =-'+3[U/N$YP>KA=^<?\
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M'_UZ.6G>R=2[Z6W%[2"VBU?LK?H<GY7C$?\ +]I/_@(G_P 52A/&2'Y+_3%
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M=*.5.!]F38'VG#-'G#EAB)R6&(S\@R6)ZG"_WO\ QTTTE &9G1%7)+R,L:
M%B6=RJJ H+,6(54!9F !IJ,>CE_V_HOQZ@ZD'\2?S77YHYD1^, ,+>:4!_UZ
MQ\G')&<D GH#SZT>5XOW;OMNEE@"1_HR@!^@. 0""N0<<CGUKI(Y;>9$E@N(
M+F&0D1S6LT-S!*58JPCF@DDBD*,"KA7)5@5.&XI)IK:WVFYN;>V#L$C-S/#;
MB21L!8HC-)&))3D8B3=(<C"Y(JN7SC]Z&I13=H-.UW:-G;JW:VFWD<UY7B\
M 7>EJ%)VA8 57_9VDY,7&2HRS$\]!3_^*U"E1?Z:5)+%# OS,< %SGYU4#Y0
MPR%XZUU(3.,$DD@;0/G^8[5.W.?F/"X&2>,9K-N]7T/3[Q=-O]?T"PU)SA-.
MO];TJQU%SG "6%U>17CL2<!5@+9XQ0XVWY5?NUJ-33NTI.VC:3T?F8HB\8<Y
MO=+)SRS6R$MGG//(Z[<-SQZ8H\KQAVO=)_\  1#_ %%=7*AA9HYEDBD7;E)(
MV5_F *_+U((*D'[IW+SR,M&TD\XP<=/\/\FDTFKM^[IK%W?EMY@YV5W&7W'+
M>3XQ_P"?[2?_  $3_P"*I1'XQ'_+]I7X6J#^IKJ<+_>_\=-&%_O?^.FIY:?>
MI]Q+J1>CBWZJ_P"AR_E^,?\ G^TO_P !D_QI#%XQ/_+]I7XVJ'^HKJ<+_>_\
M=-&%_O?^.FCEI]ZGW"4X+50:](V_0Y7R?&/_ #_:3_X")_\ %4HB\8C_ )?M
M*_"U0?U-=3A?[W_CIHPO][_QTT<M/O4^X;J1>CBVO-?\ Y?R_&/_ #_:7_X#
M)_C2&+QB?^7[2OQM4/\ 45U.%_O?^.FC"_WO_'31RT^]3[A*<%JH6?E'_@'*
M^3XQ_P"?[2?_  $3_P"*I1%XQ'_+]I7X6B#^IKJ<+_>_\=-&%_O?^.FCEI]Z
MGW,?M(O1Q;^7_ .7\OQC_P _VE_^ R?XTAC\8G_E^TK\;5#_ %%=3A?[W_CI
MHPO][_QTT<M/O/[A<\%M"W_;O_ .5\GQC_S_ &D_^ B?_%4"+QD""+_2E(/5
M;2//((/4E3P3D,,8Z?-BNJPO][_QTTA ]<^O'3\S3487T<[_ -Y67S*]I%Z6
M?W?YHY<)XR 7%WI*G=N^2UC3:-P(C5AEO+ + \;R!C.#D&SQBR!&OM+7JK.+
M5"7PI59)%4X.=JC8N,*22=V374D*%W%L#OQT[GOV')] ":C$D!F-L+FW-TJ[
MVM/M%O\ :UBP&\XVOF^?Y!4AEE$91@<@XQFG"UK\JOM=I I0M=1=EU4%I;SM
MYG,>5XQ[7NF8!&%^SH=H VE=S9+H06 5ONK_ 'G -.\OQET-_I9"EM@-LI S
M@(P5CA5521C)<X&X]*Z<E57<S;%P26DVHJJ/XW=F"*AZ[RV, DX )J$W5BL/
MVDZA8?9=P070O;7[*Q9BJ[+GSA!('8%4V2$L> ,\4<NMO=O:]KK;JP]I%QNE
M)Q>E[71SQC\8GG[;IA/.=T.2X VA'YVLCY+8&&& C94TA3QB<G[9IF<#:#;1
MG!P"7<DX=RX38/NQ[#U5A7497CDC.2O PX! +(0V'7D?,I*GL>12\>I_(?XT
M<B_N_>@YX;\NW]U+\DCF%C\8JRLE]I:D-DLMLJ.=K-B0,OS"5D*@Y 4$=!08
M_&+'<VH::S!B=[6X9F!S@EF.X$?Q Y5NHP<"NG^4=6P/4C@?K1\I^Z<@8R0.
M!GD<YZD<@=2 2*''1ZKSLU</:1?1_-?\$YCR_&/_ #_:7_X#)_C1Y?C'_G^T
MO_P%3_&NHPO][_QTT87^]_XZ:CEI_P!_[B>>'\G_ )*O\CE?)\8_\_VD_P#@
M(G_Q5'E>,?\ G^TG_P !$_\ BJZK"_WO_'31A?[W_CIHY8=ZGW,?M5VE]W_
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MCEI_W_N%SP_D_P#)5_\ (G*^5XQ_Y_M)_P# 1/\ XJCR?&/_ #_:3_X")_\
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M'_"H:* )MZ^OZ'_"FLYS\IXQZ=_Q%1T4 2JXQ\QYSZ=OP%+O7U_0_P"%0T4
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MI<2>"=!U/Q(-(UJ33O\ A%KO38=8@TZ33[?48+RXDM[J[MB;*XBEDCK]#_\
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MX_Q%"OUW'Z<?X"HZ* )MZ^OZ'_"C>OK^A_PJ&B@"1GZ;3]>/\10K]=Q^G'^
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M=RVLDJ1RR6TEQ:R/;R2QQR/$4:2-')43_P!@ZAWU[4/^_P"P_3?Q1_8.H?\
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M?Q2_V#J'_0>U#_O^W_Q= <L/YOQ1TF3W7 [G(X%+E6XSUXZ?T/6N:_L'4/\
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MGWYH#EA_-^*_R.ER/4?F*,CU'YBN9_L'4NWB"_QV_>=OQ;/YTO\ 8.H]]?U
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M6C:XD>;5;3Q5>F=4>ZUB\E!F/]/G]@ZB>GB&_/K^]/7\6&/ITI1H&I8R=>U
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M@ZEW\07_ /W]Q^N_B@.6'\WXHZ;([$$]AD<TF3W7 [G(X%<W_8.H?]![4/\
MO^W_ ,71_8.H?]![4/\ O^W_ ,70'+#^;\5_D=*&![C^7\Z,CU'YBN9.A:AG
M_D8+\>@\T\G\&/'L<"C^P=2[^(+_ /[^X_7?Q0'+#^;\4=-D>H_,4F6_N_\
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M!!@9RQ("@=LMD;>?FZ#->'^%?VF/V=O'GQ(U_P"#G@OXX_##Q9\5_"O]J?\
M"2_#K0/%NE:GXNT(Z).MKK(U31K6=[JT?2KEUM]0250]I,?+F5'R!QG[0W[5
MGP^^"7['/Q/_ &RDO$O/A_X4^ MW\:/#5Q#<(D^KZ;JOA+^W_!EOIS*3$^K:
MG_:6F"VMU8SR7#+  "Y _AH_X-T_ WQ.\*?\%B)O&7QD<2?$?X\?LB_$W]HG
M6FDA$-W&/C/KUMXGM+F=I=V9=>L)K;Q"3&=JPZO!"=S0%BYS<9123?-:^FR:
M=NCU;7YBA#GBY.4E9R25EK9V3U5]5J^A_;?JW_!1#]@O0M3U+1=8_;$_9XTS
M6-'OKO3-5TR]^)OAZ"\T[4;"YEL[VRNX6NMT5S:W4,MO/$>8Y$8-P,UV_P .
MOVR?V2/B]K5IX8^%_P"TY\!O'?B2^E,.G>'O#OQ2\'WFNZE./^7?3-(;58M0
MU*X(.Y;>QMKB9E#,J%58C^/S_@A1^PK^P?\ M9^-/^"F.N_M=?!GX3?$S7?!
MO[7GBO2/!MW\1-;72KK2-'OM7\1W-Y;:? =;T@RVT]Z!++-LD\N1#EAD@[__
M  7^_P""?G_!*/\ 9!_9*L/CM^S#_P (1^SG^U?X8^(OA6'X1:5\&?B?]KU;
MQ3(;WS=?M[[PU8ZYJ5]:?V+81G6;7Q:KV$NGS6D-G"\RWTR5*J2Y>;W+*[LY
M-2LK^5KZ:=]BO9ZV4F_-J.C:ZI-.WW/?<_L>^)WQV^#?P3U+X=Z3\7?B5X6^
M'&H?%OQ:/ 7PT@\67DFFIXS\:O''-%X7TF[:![)=7G22/[-;WUQ9BY>1(;=Y
M9F$=>M2+(C.D@*LCE'5@ RNI.58=0P(.0>1BOQ0^/O[/GC?_ (*&?\$1_".@
M_&G3YK/]I2[_ &6O ?QV\.:Y/"UCXE\'?M!^ /"0\5Z+J^FRJ(+JPUB_BLKG
M2&$+PR2-K0EEW,D;+[#_ ,$8?VS]7_;K_P"">GP7^+?C:YEE^+7A*"^^#?QC
M^V"-=0N?'_PU>+1KO7;J"-CY">(=/^QWZM*?.DNA>;RQR:TYFI6:T:NFO+?3
MYI^FQDU*.K2:O9VNTE:Z:=K^MUH[;7/U*I<G!'8_I_G'O2458Q02#D4I8G@G
M]!3:* "ER<$=C^G^<>])10 =*=N8]_T'^%-HH *4$C.._!I** #I3MS'O^@_
MPIM% !TK#\4^*_"_@70-3\6^-_$_ASP9X5T6#[3J_B;Q;KNE^'/#^F6YR5DO
M]9UF[LM/M?-P1 DMPDEPX,=NDLGR5O*"64+U)&.,\_3C/T[U_'9^TCX<\1?\
M%MO^"V7Q)_8*^(?C?QEX<_82_8&T*XU3XG> ?!VL7.B/\3_'6FR6%G?W&IW5
MFX5WU_Q-J-OH-AJDB2S>'=$L9O[)C2[N6F$RFHV5KRD[15[7[W>R26K?EH7"
M"E>[M;M9V3_'79=#^CCP1_P4I_X)\?$CQE#\/O W[9W[/7B'QG<7:V%KH-O\
M0M+LI[J^=@D=I:7>JFPTRZN)7(2&.WOI&FD*QQ;W95/UCXZ^(7@CX7^%-8\?
M_$CQ?X?\"^"?#]O'=ZYXK\4:E;:3H&E6LLB017%]J=RR6\$,LLD:1NS;79UV
MD@YK\7OVDO\ @WD_X)A_&+X#^)OAK\,_V:_!GP#^)$'AZY?X>?&#X:RZSIWC
M31O&-C9,?#U[KEW>:I=VNO6#:A%;?VM;W,$27*S371>(Q@#X"_:0^#7[</[/
M7_!MG^U)\$OV^_$'A3QE\5?AWI&FZ)X/\2>'/&B>/+B[^&-MXH\.+X.L?$GB
M+R8I+[6] *ZCIUM,_F2G1TTJVNI7NK-Y'ERFHR4E=<KDG%Z:)W3OM?IOI?JA
M^S@_MMWTWA>SMM;1W_X8_I]^%/QI^$/QV\-3>-O@I\2_!?Q6\(6VJW.A7/B3
MP)KUEXBT>WUJSM[:YN]*GO;&22.'4+:VO;2XFM9-LJ075O,5\N:-FU/B+\3/
MA]\'_"&J?$+XJ^-O#/P[\#:*+7^U_%OC'5K70]!T_P"VW,%G9BZU"]DCB1KJ
M[N;:W@4$M)+-&JCYLU_%Y_P:R^//%'[,_P >?C+^PE\2-1(TOX__  '^#W[9
MGP4EFWV]CK']K>%])B\5)HT4C;IK^\TW7[/3;J1 7=/AUJDJ?NXB!]1?\'27
MQ%\6_%CPM\ /^"=WPMO ?%'Q T?XO_M:?%56>5AIWPR_9Q^&_B_Q3HHU)XLE
M=.U[4M&\5&%;@1VXUOP[H[*69H10JC5)2MJD_=UO?MW[;^H>SBI**FNBU:;:
MOTLU:VO1G]+5]^U9^S+IGPFTSX]ZC\>_A5:?!#6M6.@:1\5Y_&.E1^ ]2UP3
MWMJ=(L_$/G?8IM1%SIVH0?9%D\WS+*Z7;^Y?'E*_\%)?^"?SLJK^VC^S<2[A
M$S\4_#2[F/(&6N@!D<Y8A1W-?Q&_&U4'_!H#^RS^Y1&_X;:OI%8!03GQE\>U
M+[0 %D<F0NXR[JR[N"QK^H;X?_\ !&[_ ((N:I\*OAMJVO?LL?LSK?:Q\+_
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M2Y'J/S%+47F1>J#_ ($G_P 53RZ8/[R,_P#;1/\ XJBZ[K[U_F'++^67W/\
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MC8ZCITT0,5YI]_:M+8W]G)&PFBECE>)U1)%D(!-?*G[:'[&_[//[?7P5\0_
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M3_GI'_W\3_XJF>:OJG_?Q?\ &BZ[K[U_F'++^67W/_(EI,CU'YBHO-']Z/\
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M<<<,$*V\$"+!#!&@6.&&%5BABC5%"A(XT55  P ,@'-?EK\+?^"8WA;X<?\
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MVZGMK:>Y%K-*;J*ZM8FE%[*+OV47?TT8<\_/[F=__P (SI&=I@FW#J/.D!'
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M\(UHW_/&;_O_ "?_ !5;E%'*OZM_\B'-5_G_ /)I_P"1A_\ "-:/_P \9O\
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MW&>WK6_]U7D9ECCB1Y997(6*&.)2\LLKL0D<<2 O([LJH@+,0HS7X??M)?\
M!Q)_P2M_9G\=:I\-O$'QPU?XF^+-!O9=,\0VWP;\(ZIX]TC0+^WE:*ZL;GQ+
M&]CX;U">UD1SJ TC4]1^S!'M6VS(P![L=VE?NTK^FBO^)<'6=]9/;X7)_G8_
M:+_A&])SCR9,G.!Y\N3@X/&[L>#Z'K2_\(UHX /E3X/0^>W/W3QSSPR_]]#U
M%?%W[$G_  4K_8O_ ."A>BZSJ/[+GQATSQGJ_AF!;CQ5X$U:POO"_P 0/#EE
M-.EK;W5YX8UJVM;VXTJ222,KK.F"^T:WED2VDO!>L(C\Y?M6_P#!='_@G/\
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M4'!'<'T(['V/-'*OZM_\B'-5_G_\FG_D8?\ PC6C?\\9O^_\G_Q5'_"-:/\
M\\9O^_\ )_\ %5N44<J_JW_R(<U7^?\ \FG_ )&%_P (UH__ #RG_P"_[_XT
MO_"-:-_SQF_[_P G_P 56Y11RK^K?_(AS5?Y_P#R:?\ D8?_  C6C?\ /&;_
M +_R?_%4?\(UH_\ SQF_[_R?_%5N44<J_JW_ ,B'-5_G_P#)I_Y&%_PC6C_\
M\I_^_P"_^-+_ ,(UHW_/&;_O_)_\56Y11RK^K?\ R(<U7^?_ ,FG_D8?_"-:
M-_SQF_[_ ,G_ ,51_P (UHW_ #QF_P"_\G_Q5;E%'*OZM_\ (AS5?Y__ ":?
M^1A?\(UH_P#SRG_[_-_C2_\ "-:-_P \9O\ O_)_\56Y11RK^K?_ "(<U7^?
M_P FG_D8?_"-:-_SQF_[_P G_P 51_PC6C?\\9O^_P#)_P#%5N44<J_JW_R(
M<U7^?_R:?^1A?\(UH_\ SRG_ ._S?XTO_"-:/_SQF_[_ ,G_ ,56Y11RK^K?
M_(AS5?Y__)I_Y&'_ ,(UHW_/&;_O_)_\51_PC6C?\\9O^_\ )_\ %5N44<J_
MJW_R(<U7^?\ \FG_ )&%_P (UH__ #RG_P"_[_XTO_"-:/\ \\9O^_\ )_\
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M>UM+>ZBNK"[NX1%K,Z06S6\SVUX)]$DN+NUMY+@;^3_X(._LN_\ !-#XD_\
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MP.A); W' R:^JMK>A_*OE+]O7/\ PPE^VNNWG_AD;]I+)[_\D?\ %IZ8]/\
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MT$DNF7FGWVG:7>);M>_@A^RI^S9\8OB'_P %F_\ @K+\"=._X*&_&3_@G_\
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MR?\ BF]*_P# &/\ QJ8>"O"6!CP[I'_@%#_\35_6_P"Y^/\ P ^KQ_FG]_\
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M%>$0#CPYI(^MC%_4'^='UK^Y_P"3?\ ?U>/\T_O_ . ?):ZUHW.=3@_";/\
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MY\C?VWHW_00M_P ;DY_'"XS].*/[9T?MJ4..W[X]*^N?^$+\)?\ 0NZ1_P"
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M_@'R4=9T7!_XF</_ ']Q^NWCZTS^V]%/348,]O\ 2#7UQ_PA?A+_ *%W2/\
MP"A_^)I#X*\)8/\ Q3ND=#_RY0_T4?S%'UK^Y_Y-_P !!]7C_-/[_P#@'R/_
M &SH_P#T$H?^_P :!K6C9'_$S@Z_\]Z^LQX)\(Y'_%-Z5_X Q_\ U_Y&IO\
MA"_"7_0NZ1_X!0__ !-'UK^Y_P"3?\ /J\?YI_?_ , ^2O[9T7_H)P_]_/\
M[&F?VWHG_01@_P# @U]<?\(7X2_Z%W2/_ *'_P")H_X0KPD?^9=TC_P"A_\
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M]<9;[O/4@YR <G)XYHI4QR.X.TD]21SDGOU]\<\T5S&H^BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :#C ]2WZ$T4*V
([/&,44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ea028514801_img10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *^ QP# 2(  A$! Q$!_\0
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M_< Y<4<1Z?\ "YGC],=BU_[>OR9^M_\ P_5_X*L_]'77?_AJ/@M[_P#5.?\
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M_#/A?_E%A?ZV<3_]#WB"W_8;BW^B/UL7_@N;_P %4>=W[5-[_P"&J^"X]/\
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MW;MC\;]S]YGZQK_P7#_X*C=_VI+L'T_X59\'/SX\ ]_KQZ4X?\%P?^"HV?\
MDZ2Z_#X7?!S/_J!5^38!R.%Z^I_P]S^9J;;[C_Q[_P"*K7_B'W W_1&\*_\
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M'^E&1P,C/U&35Q\-_#UNSX$X3_\ #-EC>NVGLNO3\+F?^OG&MD_];N(=>O\
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MEOY9YC[?^2XBQ^HZ_P#!9[_@I@P_Y.7O.O\ T33X0@?G_P (0<=NV.?:G_\
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MV6\.F?:+8"06\\*RR(?E -B+!SR3G(Z^G..N>N0<@BCD?-N!+8YR"2!TZ\#
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MY)B:TL^S%1>*S#B6LZO)ALODW&56C3Q4J-Z$5+V,?=T47;\FO^"3W_!)N/\
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M.*,=CH/'YQ#ZQA<%A*;JN>&I85Q<*4G2A[/E5FG*,IRDE%'[6?\ !2?_ ()
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MDBJ.6I3YE9Z-=7]^H5-O7U_0_P"%0T].I^G]10<1+4D??\/ZU'16D)='\O\
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MX#\17_B/QSIWAV_OO"F@VFA6&A1//9RZI'8:7IVA:6EI&EG)%8V?V:)4$?\
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MU76/@[\1=,@T'XA:9I5O!<ZKIDMG()=&\4Z5 [QM<RZ1*\L=]:(_FWNGR/!
MK7*HS_NA\9/V>/\ @BI^VAX\N_VB=4_:.\,>$M:UR.TU[QU9>%/BWX=\#Q:W
M(8X6:^\7>&O$6G7.J:1JL\"1VFH/ -+E**P>)+O=./X\\%@ 2!CJ2.N.?U/3
MCV([4.B;2I0'\.<_F>3US_CQGQGX-T.)N):W&61<6YWP/Q!7P=' 9IF.3.,*
M.9T*45"E1JT6X\V(A'EC]83:;A"<DI0C,_.>&O%+%Y%D?^JF;\.9+Q=D6#J+
M&93A<ZC+VN'QE:7-5=&:4F\-%MN479J+FKM2:/ZDO^"CW_!2_P#9G^'?[,#_
M +$/["^IZ7K&F7WAFQ\&:CXG\'@W7@?PAX#WDZAI&A:U.9&USQ!K489)]1M)
M;F&S6:YNIKJ2ZF6*N4_9Z_:5_9_\/?\ !#[XG?!76OC'\-M&^+FH>#?BII^E
M_#/4/%>D6OC:_N]2UV&;38+7PZ]RNJ7,U[$#+;!(&>=1O&5#;?YFU54"X&!G
MIU&,9)&!UZ?Y%*=K,#M[\9 Z]..>/KSUYKAH> /#^%X:R?(,+G&/C6P7&F5\
M;9MFF*A3QF/SK,<NJ*?)7G/EC3IUY>XI1<I4HU)R3G.4IRZ<1XTY_7XAS//:
MV7X*$<9PAF/!V"R;"N<,NRO"8^*7UG#\EG*=!<U3E:BI\L8M<L5$_;__ ((;
M_MD^$/V:OCGXX^&_Q;\8Z-X+^$?Q>\+_ &FZUWQ7J=MI/AC0O&OAM,V%QJ-W
M>LEI#+KNF3S:2)+EDA)A17;++GO?^"['[:_@/]H'QW\*?@U\%?&_ASQ]\,?A
MYI$_B[6-?\'ZO:ZOX=U/QGKRR6%E86^H:7-+8W?]B:+"\=U:M*[6-[<+B.)B
M#7X#\<D=<]?<<#O_ (4J_*2IY.<YZ '@=>1V''08Z5]#/P<R"IXI4/%26)<\
M?#!S7]ERI4_J$LR]C+ X;-I3TJ+%4L)*I#E<9)U80J\R:L>*O%+/:7AQ5\-Z
M+]A@JF-IPI9U"4O;4< ZT<7_ &7"-FK2Q,?:0DVK74+)-G]8O["W[;O[,_[1
M'[!^G?L=_'+X^:G^S3\3_!OAFT\&6/C6V\8W'P[U/4K+3KPR^&O$GA+Q:EW8
M6EU?I&$M=9T"XGA$Z+(HMYK>1+J/A_VR_''["O[.G[(6L_"[P]^TA\0OVH/V
MCM;TC4-"T?Q%9_M!?$S7;J74M3E'VK6/'&E^'?&\_@W3?#VG63NMMH&H6%U=
M7ZJD"K>!IYT_ES +E@0NT@\>QY&!['K_ "%(J'+ +@+D+CG..P_/]<8ZU\O#
MZ.V2T.*GGV!XCSS"Y-5X@_UGJ<-T:>6*E5S7VCK3A#,XTI8^.62K-U*F$G)P
MG'FIJS:J0]^/CIFU?AO#9/B>&LLQN9+))\,T\ZQ,LPG.6"H^[.=7+IU%@WB_
M8QYJ>+C:4:ZC.-[*+_II^*7[2_P!O_\ @AC\//@?I?QC^'5[\7=-^%OP]T:^
M^&5MXJT>7QM;:A8:UYE_8W?AN.Z?4()[: ?:)X'MU6WC +$@*3\R?\$3_P!O
MGX:_LE^.OB)\-/C9JG_",_#KXOSZ+J5CXSFCEETWPYXMTJWDT\/XADAW&TTG
M4]-\F!;^-/)T^XM_,NV2&59!^%Y#H QVD;N@ZY]\8Z^OJ/7.9E#2."H&, ;>
M<-P01SC&,<]!]:^APG@;P]'@_C'@K&YCF&,R_B[/<;Q!/%>RH4<1E.+Q.*CB
MZ'U91YJ<X86<4U4J>]5A%JIHY'S];QBSZMQ3POQ/@L!1P6:<-9/@\DH9;452
MM2Q^&CAZU"I5JQYHSE&K"*<Z4)IP;]RTK7_LQM=(_P""=/P7O/BK\9_B+^WW
MXV^,G@CQE%?ZGX,^'9_:7\:7[^%8YKNZU"ZL/!-EX%\<V&MZ]?W,\ZV5H9T\
MFRM8H83%'&CW ^)O^"/?[5W[//A']I_]MCXC_$#XEZ'\(/!OQ-'A:\^'UM\8
M/B 6UB\TVU\1>)9(K&7Q1XNU*?4_$FK66GO9S:C/<ZA>7$:W,2NVP!C_ #3L
MA)SWZ;>PZD\\?KC'0>\@^4 D*".1CG&1G(]" ??O7S^&^CE@GD'%V18[C#.\
MQQ'$^!RO+%F]3"Y9AZ&"P>58[!XZA3PV5X.G3P_M)K!Q^M8JM-5:UN?EE4O.
M?M8OQ]QBS[AW.L)PGEV H</8_-<QE@IXK,:DL7B\UPE3"XO$U\5.I*7LXJK4
MGAL+R2C0NHW4=OW]_P""87Q[^"?PV_X*3?M*_$;X@_%+P/X,\!>([3XDKX=\
M8>)/$>EZ/X<UHZEXNL[G34T[5KJXCL;J2^MD>YLTBDQ-;J\D><%38^!'Q_\
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M<_\ AS7XEJM-+/\ KML7****ZS$5>H^H_G5^L^K4;CR_=>,?R_SS50^)?/\
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M/YU?K/J[']Q?I6XB1>H^H_G3V^^OX?S-,7J/J/YT]OOK^'\S5P^+Y,A_$O\
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MC-*N7UE3J4L*H<LXTWBH_5(PIM.5&FI14WJ?K!X^_P"#<'XQ:/X/U+5?AO\
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M@S;)*.8X*EC,!DM'&XK-WA*N(IT\1'"K%4:-*C#V?-SWG'DIR;BVTD_H=/\
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M?#]JW;6_X&<6XR3BYJ2:LZ;M43Z<CNK2[:V+*8WY<$*&&\H<%<D#<"#U4X(
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MW/AFPD ^W+XL\.R6\K&!I193:?=07#AMN?PRU3XJ?%'6_"MIX$USXE?$'6/
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M .$"^(7_ $3WXB?^$'XO]_\ J#>WZCUK_6\HI_\ $R&-_P"B1P?_ (><7_\
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M0\_\!J9?!'CS'_(@>/@,]?\ A!O%>/;_ )@_8''X?2O]5NBJ_P")K\Q_Z(C
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M#_XFWS/_ *(?+_\ P]8[I_W3SG?T9<"]^+\7I_U),'T_[G3_ "M?^$'\=_\
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M_3\A3AX$\>8'_% ^/?P\$>*/T_XE0_SZU_J#T4U]-3,T[KP_RS3;_C),R_\
MG:8/Z(67O?CW,/\ Q'LO_P#GD?Y?7_""^/?^A!\??^$/XH]O^H5["C_A!?'O
M_0@^/N.G_%#^*/;_ *A7M_G)K_4%HJ_^)U\U_P"B RS_ ,23,O\ YW"_XE!R
M_P#Z+W,==_\ C'\!KZ_\*6OS/\OK_A!?'O\ T(/C[_PA_%'Z_P#$J]OY^IIR
M^!?'F"/^$!\>D>A\$^*!_P"XK\__ *]?Z@=%"^FOFJ:?_$/\LTM_S4F9+;_N
MG:?+;H#^B!EST?'N8_\ B/Y?^N9,_P O[_A!O'O_ $('CW_PBO$__P JJ/\
MA!O'G_0@>/?_  BO$_\ \JJ_U :*T_XG:S1O7P\RJ7D^)<T=_*SRYK\!?\2@
M9=TX^S)>F0X%?EF:/\P)? GCS )\ ^/N_/\ PA?B8=S_ -0JC_A!?'9_YD+Q
M]^/@KQ.3Q[_V5TR?Y_4?Z?M'XG]/?V_SCZYU_P")W<UM;_B&^5+_ +N7,_\
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M;:/8:=\.O&4_@#5(T\2P[-#O+#7K;PS)YVJ7%B-+T>T(TYHMEI& ?Z<O^?\
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MG3;&6Y>U@ /[1Z*_SCOVAOV5?^"KWPE_X)5_!;_@M;=_\%5/C_J_QGT#X??
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M?L#1117OGYF%%%% !7\J_AS_ ()6_MDZ9_P<T>(_^"G5UX/\(1_LD:EX8O\
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M_P %B_V;_P#@NA\<O^"@_P"PIX/^!WC_ .%'[26I:#:^(]>^(_BOP_;3>'O
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M4329'J/S% '\D?\ P2[_ ."0'[>?[-?[67_!8+XF?$+6]+_9^T?]L\?%>/\
M9T^-/PV\:>$/&GC+PGJ_BWXM>+/%WAGQ<OA9[;5(=-OM)TO4]-U9[77+.:)K
ME)M/FMF= 3^;OQU_X);?\'!WQ7^%?QB_97^._P"SG^PQ^VG<>/M=UIO#'[<7
MQ)N_AOI_QO\ #>G7KQ1)J^B>,8IO"WB_3GLEC.H^'M/\0:/?7>BW%Q<0_9M8
MMH[2UA_O_I,KW(QWY']>/SH _P ^'_@L;_P3ZUS_ ()D_P#!N#^SW^RQXO\
M&MM\0/&^C_M3Z5XU\<:UI3W)\.VGBGQK#XAU/4-%\+_;8X;LZ%I$*6UE;S3P
M0O=77VR]$,<=RB"_X@_X)U_\'$7[<O[#W[*G_!/_ ,5>)_V<;W]A/5O"'P.\
M=:=^T!%KEA:>,+OX:2>'?#WC#P5I/CO2[K4&\8ZI-\.TUB&SAT32/#=G<:W<
M>']-)OYK*T%U)_9G^WC_ ,$^OV;_ /@I!\';+X$?M0:#XEU[X?Z?XKTWQI:V
MGA3Q/>^%-3BU_2K>ZM+.Z74K&*25XTM[N9)8&0*2YZ\8^I?AQX#\-_"KX?>
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M3:-IK36>G732B5W$1CB24J\N%_K4I,CU'YB@#^2#PM_P2)_;;TK_ (-F-?\
M^"8UWX,\%#]K;4-9UN\MO"P^(OAYO";6E_\ M2+\4+=SXY26305E_P"$*4WW
MDF51]M"Z<[QSN7'E?[4O_!O7^TG^TS_P1Y_X)Z_ VPU?P7\/?VZ/V#?#FL?V
M)H.H>(M.U?P)XM_X22]L[W6_"EUXNL[:^TV&\AN]!\/ZGH&IRPW.C6\Z:G9W
MP>"],R?V:4F1ZC\Q0!_&W^S;^PQ_P7Q^.7[6GP#\4_M4:%^R'^Q3^SI\&GT+
M_A:.G? 7X>_ +7M1^."^'M3L=2U6UCT:'P]XRNK34_&?V*VTG^VXM1\/Z9X8
MTB6ZGT-'U55#?4_[2'_!+O\ ; ^)/_!Q?^R=_P %&_"?A'PC<_LK_"/P7I&B
M>,/$MQX\T"S\4VFH6GPW^)WA:[BM?!4[IK-]$NH^)-&CADLTE62*:XEVQ);2
M,_\ 3]29'J/S% '\PO[37_!+_P#:]^*'_!Q5^R1_P4:\)>$_"%U^RS\'_ NB
MZ)XS\2W/CS0;3Q79ZC8^!_BEH-W%:>"IV76;^--1\3:+'%-:B82QW%P^(EM6
M9OD/]JW_ ()B_P#!8+X+_P#!<OXC?\%*_P#@GAX0^!OQ#\(?&?0O#N@ZA>_$
M[Q3H%C%X9T6^\+>#O#?Q$T/6/#VL:UHNI"_67P>=0\/Z[I$MY$8;Z"W^RR74
M4MNW]F])D>H_,4 5;?[1+:P&< 79MD-T$(*?:&MMLIB;E6 E!"JN%92DA[9_
MF-_X-^?^"7O[7W_!/G]H/_@IE\0_VFO"'A'PUX:_:<^(G@+Q)\)+OPUX]T#Q
ME=:II>@^,OCAJ^I-JMIH[M/HC#3_ !QX<EBCO_*DGEGNH5C#V<A/]/M)D>H_
M,4 ?QC_ML?\ !%__ (*!?L__ /!4;XE_\%+O^"9W@7]G;]HC1OV@=+U^?XK?
M /\ :(M_##VFBZ]XCMM"F\6RV-MXQ>STW5[3Q#XCT:T\6Z-J.DZC9Z[HFIMJ
M.D3PW&ES)]J^_?\ @DQ^P1_P5%\ ^$_VK?B'^WW\=/ OPU^*7Q[\.>+O"7P;
M\ ? 'P+\&;:#]FR7Q;=ZIJ-QXXT+Q'X6\'V\%U/HE]<:%_PA'@JZUKQ+H6FV
M>A8UP:A>R0.G]'E)D>H_,4 ?P.?''_@F-_P<)^,_ OQY_9H^-OP'_8>_X*#V
M'Q1U+Q!;^"?VR?C"WPTLOC+X*L-1TRUTN+5_"_B=Y/!_C+PXNFQ0#6/#>CZW
M:WL>B:_)<S0C5;06]@F#_P %,O\ @G%XM_X)<?\ !L+8_LT?$+QMI_CKXBZA
M^UCX%^*OC^\T)KB;PMH'B;QEJ(MY/"OAB6[CAN)],T;3-(T^&[OV@B34-<;5
MKVWC2UNH2?\ 0!/0]^#P<8/USQ^?'KQ7QW^W%^PO^SU_P4.^!E[^SQ^TSHWB
M#7_AG>^)=#\636/AKQ%>^&=5_MKP]-+-I5S'JEE').L4)F;?&$(8 @Y'--(#
M^(KPS^P=_P '$/[97_!,O]E7]@O1M=_9SUK]@?XI_#3X%?$'1?C1<^)-,TCQ
MYIGPCUFT\+?$WPMX#\=V]U?#Q1?VWPTOM1M+==*T7PU->:U#X:TS3;359]-L
MV9_V8_X*)_\ !N?;_'O_ ()S_L5_LZ?LR?$VW\*?M$_\$\?"QM_@GXU\2/)I
M^A>/]2UYM%UKXD6>M7-I%-/X7NO%GC+1K/Q;X?U***\@T/5(+33[K=I\]Y=1
M_P!*?P8^$_@_X#?"/X7_  /^'-G=:?\ #[X.^ _"GPS\%:?J%X^I7MGX6\$:
M#8^'=!@N]3F59+VXM]+L;6*6ZE59;B1'EDQ(V#Z=D>H_,4-6 _AA^,7_  2X
M_P"#A'_@KGKO[/OP _X*@>)/@%\'/V5O@EXPL?%/B[Q/\,]8\-:GXH^(FJ:;
MIT6DW&O-H_AS6=:N-;\7ZAX:O=6T[1KZ[3P[X9TG4M5UB_N-/667[-#]^_\
M!3G_ ()&?M/_ !V_X*3?\$C/C?\ LR>"/!\_[-_[#UU\)M%\;3ZYX^T/P]K/
MAOP?\/OB9X1U9+?2M$U C4M??3O!^@DVT=A$[75U"EJ%A>42'^J*DR/4?F*0
M'\P__!7[_@E]^UY^V!_P5,_X)>_M3_ [PIX0UOX/?LM^,?"6L_%[5=<\>>'_
M  WJ^DZ?I?Q>\+^+-3FTK0-2<7^N/#H.EW5Q#%81RM<72)9_NGD5S3_X*K?L
M=?\ !:'6/VN-'_:!_8S\9_"/]K[]EO5-.B'B3]@_]I_3/AQ<_#;POJB>'HM
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M]>D/U'T_QIE 'GO_  FOB#_HG'BC_O[I/_R33/\ A,O$?_1./$__ (%:3_\
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M<>*,_P#7;21^OVGBF?\ "9^(_P#HG'B?\+K2<_A^_'\Q7HM% 'G?_":>)/\
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M<>)\?]?.DG]//&?SKT2BO?/RH\]/C3Q"1@?#CQ1G_KMI(_7[3Q3/^$S\1_\
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M>]EFN*GA:M%9?A</0GC<)/'8M5</3G7HX65&4\1&:_3D^-?$8!/_  KCQ4<
MG'VG2/F(Y"\7)Y8X ]SU Y'H.GW$UW96US<6DUA-/$DDEE<-&T]LS#F*5HF:
M-G4]2C%>>#4E6*]H_.PHHHH JS_ZR'_>)_##<U#3KGE_3]TP_ D<_A3:VALO
MZZLGGCY_<PHHHJA<\?/[@HHHH#GCY_<!Z'^G7\*\%_:4_:6^#'[('P7\7?M
M_M >,8O OPG\!KI'_"2^*+BRNK^*P.L:I::'IRK9Z?#<7-P]UJ>H6MHNR)_W
MDQ;&"S#WJOP._P"#FH9_X(K?M@X[6GPN/Y?%?PF3_+'UJ7:V_P"*_KH6?N1X
M(\7Z!\1O!O@_XA>#[Z/6/"/C[POH/C/PQJD:2Q1:MX;\6:39ZWH>J!)%66$W
MFG7EI=%'572.?RRH(('AOP)_; _9]_:3^(?[0'PL^#7CV#Q?XX_9?\8:1X ^
M-NAQV%]92>#O%&N6^LS:;IS3W=O##?&Y;0=57S;-YHXWLIXV8$BOYV?V7O\
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MOA"=1ENKCX?Z^[[2=5T^:>[6.!+4R;27'T)\;_V]_P#@H3^U=^WM\=/V"/\
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M OY'J/S%&1ZC\Q5"BG[-=W^ %_(]1^8J/SD]_P JJX/H?R-&#Z'\C1[-=W^
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M\Q1D>H_,50HH]FN[_ 9>+* 22./0BFB5"0,GGU&*J8/H?R-&#Z'\C1[-=W^
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M[IK;3[B_[J_R%>W.-G=;,_/1U%%%0!F7W^LC_P!QO_0EJE5V_($D>2!\C?\
MH0JE6L'=6[?B 44W=_LM^5&[_9;\J?,NS^YBNNZ^]?YEG(]1^8IP!)  ))Z
M<D\$\ => 3QV!]*I[U]#^G^-?G1_P6"\2ZYX2_X)7?\ !03Q/X5UW5_#7B70
M/V3_ (RZOH6O:%?76DZSHVI6OA"]DL[[2M2L98;RTN[>94*7MO-#/!,KM$P/
M('->?S31'LUW?W'Z0,)5&6C90,9+(P R<#D\<D@#WI=LW_/)_P#OAZ_C/_8,
M_9R^)?[%/_!..3_@N7\7/VNOVE_V@?VB-,_83\<?$Q/@U\0_B!>7_P $+F*3
MP7+IGPFT.ZT'$MY>MH&@V.AHFI7#O(-8O=0U28EE1I/QT\!?M _LR_&+]EZ]
M_:2^.?[>G_!6)_\ @JAXUT36/B5X:^(GPX^'WQS7X*?#[QWF[O?!'P^\.>$?
M#NC_ /"$ZYX V6>D:5JFK6\NPPWEQ+HXB@LK*V"YU_297+'LOZ^9_I<@R-G:
MA;;]["L<=>N.G0]?0^E*1,,9B89.!E&&3Z#U/M7\)W[:O[;/[;'[5W_!*?\
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M(HW'QA_9C_X*0?\ !3K_ ()C:S\;/B7\</V>OV=M*^&'Q0^!EW\7_$=YXO\
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MY_:J\'S^#O!/P.\)2_LL?\$^_!&I:A8ZI-:>"=662\^,?[036=K<7,.EZ_\
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M*C=_LM^5',NS^YE77=?>O\RSD>H_,4Y22Z!6 8NN#UYSQT.<>OMGM5/>/?\
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MXEUBQ#)H\MS:I=WT5\\'DM+J.HNDUK>&RN[7S3]GC]B'_@H;^UE_P4=^$O\
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M[CZX_P :7</7/L.31S+L_N9*@D[W>FO06G+]X?C_ "-1[O\ 9;\J-WLWY?\
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MC/<WC:7>ZD;2[CFMH9)OZ2\CU'YBC(]1^8I<D0YW_+^?^1_'#^T3_P $\O\
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MV-DURZK+=_9+@QH,^0V,'ZRR/4?F*,CU'YBJY=+>GX&?._Y?S_R/P_\ "_\
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MAQ^-0U)$I>1$#%"S !P 2I)X89R,CJ,@C/IU ]G?L_R9N_)V??MMKW/YVO\
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M>&.&5&$*N7TZ6%J+%T(8?,:BI4KPEF$X5&J]+$3G'2KU'U'\Z2E'4?4?SKZ
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M_P!##X:_\$\G_P 57H61ZC\Q1D>H_,4&?._Y?S_R//?L?Q1_Z&'PU_X)Y/\
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ML?Q1_P"AA\-?^">3_P"*H^Q_%'_H8?#7_@GD_P#BJ]#_ *\#ZGH/QI#TSVW
M?B",CZCTH,U-MI66K\SSX6?Q0SSXA\,D=\Z-(?T+C/YTIL_B=CCQ!X9![?\
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M/U$AQ^5>@T4%MJSZOU///L?Q1_Z&'PU_X)Y/_BJ/LGQ07D^(?#..ASH\G/\
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MD>;3_".JW4@%]JWE07-Q;6\ME!9ZC#:W7]GWTUS&UNW[:5_%+^SK\9?V@_\
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MNC^'O#UA<ZIJ]_)%;I)<2K:6%K<7,B1122.D>(XWD*H?'_V6_P!I;X6_MB?
MGX?_ +1_P0O-9U/X4_$ZUU&^\&ZEKVBOHFI7]CI6M:CX?FOFT::XFEMH;Z\T
MV:6R$\BR2631S310R.85_E@_X)\?M6_M0_\ !33_ (([_P#!2SX=_$#]KWQ3
MJ'C3]F+Q/\3?!7A+]KGX<Z+IVE^,/C1\)]"\#ZQXNL;;7K+6]+@/]F>.M'LK
MC2-4O+S3[;Q*N@ZRUO<3"[LHI:\=_8Q_:9^+W_!)O_@V[\+_ +:&E_''Q?\
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MZ#]?\:!\TN[):#R"/6H_,]OU_P#K4>9[?K_]:@1)14?F>WZ__6I-Y]!^O^-
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MF<),=.O;-KA/,==[DQLZQHU.+O>[^7R?]?(SFMM.C_K]3\Z/V_/^"O7[._[
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M)QZ9XR"< @'!Y/ ]^.M%>0_ KX[?"7]I?X1^!OCM\#/&VD_$3X5?$G18M?\
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ML\&_MK>-?VI--^%7@7Q#;_"[]FSXPW?P-L_C7>ZG9S>$/C'X[\.VD4OCG_A
M+.W@-Q<>'?">H31Z8VN37UW;:A?FXC@6![>1*^ZLC.,\X)QWP.IQZ#N:_GA_
M81_X*&?\$J?V)K/X,?\ !*WX=?&G4)_%OPPUU/@=K?Q:E\!^)Q\&O'_[4FHW
M+:AX_P!!O/C+%:+X8U'XF^*_&MUJE[/9"X>"[N[N*."[FA-ON_H<8E,KC[CL
MK+T ;<P8J.1N+!S*V<-\A08.:I:^MM?Z[&,EJ].K'45'YGM^O_UJ/,]OU_\
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M\.7FMZ'JND6?B+19%AUC0+O4;&>SMM:TJ5@5BU+2YIDO;*1@0ES!&QX%;-%
M^:7=_P!?(_E<^"O[0_\ P7V_8@^&7Q$_9.^*/["7Q!_X*+_%C1O$_CN+X!?M
MLZ?\:O!UGX.\9^'O$UW?:CX9OOBU:>*+J/Q-''X4DO@JZ:ESHTMMH\-OX;AE
MN#IT&K7?:_ G_@D?^W5^S3_P1K^+/[/GP,_:5D^$7_!1_P",/Q9U[]K+Q;\2
M?AWX@N?#OABX^+7B+4=&N=4^%D/B.VLC<Q:!J_A#1+3PC>:Y'9I:CQ#&=5%@
M-)"VE?TW@D @$@'J 3@_4=Z2E8?.S^2']J#QU_P6O_X*<_LI0_\ !.G7?^":
M.H_LI>*/BQ#X-\$_M3?M:_$OXJ>"=;^$>E>%M%N[#4_%VO\ PZ\,:!=W7B&^
MNO%[:(C6MF+O6#!#?3:7]HM)KF#5[/\ :7Q)=?M1?L9-_P $XOV3?V1?V8_^
M%^?LXZ3HFA_!'X_?%[5_$^F>']1^ GPQ^&6C>!?"?A+Q=_8\NNZ1_;M_K&G2
M^(;^6RL=.UI8(_#906\<ES;Q3_IT68@ DD#H"20/H.@_"DHM\Q\[O^A_,E\?
M/@1^WI_P3V_X*S?'_P#X*1?LG?LLWG[=/P#_ &U/AKX'\*?'/X3^"/&F@^"/
MC#\-?%OPU\/Z7H&D>(?#T_B=S9ZIH%S9^'-/NO)CCOI-0N]4U*RGT[3QIFGZ
MJ.Y_8+_9E_;5_:-_X*D?%+_@KA^VE\ [/]D'2K7]G:U_9@_9W_9ON_%>D^,/
MB0?#'_"1CQ%?^,_B9K'AQO['613<:G%81QLD]W)JT%N^F:9%X=B>^_HU!(((
M)!'0@X(^A%(2222<D\DGJ3ZFA*W7^OZW#G?;\3\2O^"PG@7X[?M=W?[-'_!-
M[X3^$O'6G_"3]J+XC1:_^V7\<]'L+RW\+?#O]F?X8W-MXE\4?#U?$T1CBL/&
M'Q?OK>T\,:181_:8KVP.J65]%]BO#)7R;^VC\-_C+^PI_P %2?AG^W-\)/V*
M_B-^U?\ LU:K_P $Z)/V#M%^'OP%TO0=3\2_!7Q9X5\;7'BCP;(OAS5I8X[#
MP=XDT.6V\)I?V,3V^EV:ZR^HO]G2WM;W^FD.X4H&8(3DH&.TGCDKG!/ Y([#
MTH1WC)*.R$C!*,5)'7!((.,]J=EVUZ:^G]6].PN:7=_U\C\A/^"&/[*?QC_8
MZ_X)P_"#X3_'S0(?!/Q2U?Q+\2_BCXC^&]O=PWT'PS7XD^-=;\3:5X'CN;.:
MXM3-HVE7UI_:5O;3R6EKJ=W>6\;3M#)</^O-'7K10'-+NPHHHH%S2[L****!
M!1110/FEW84444""BBB@?-+NPJ2%@LT3%MH66,EO0!U)/'/3/3OZ]#'4L S/
M ./]=%U&?XU]CW]B/6A[/?;H[/Y-Z(E[=7Y+?=;6:=_1GXS_ /!)C]D/XX?L
MK>)OVZM3^,?AS3]!LOC9^T?>_$+X>R6.LV^L'5/"LVH^,)DO;I+>-6L+@1ZO
M9!K>9V8>:P_@./V07ZC//8#C\.G//?V[U_/G_P $+/&/BGQ9XT_X*7Q>*/$^
MO^)O[%_:^U/3M'CUK5[W5%T>PBU/X@(EGI_VZ69;&TABBB1;.U$<1\I 5)1"
M/Z#%QG'J21VX/UQ^@QTQT)'SO"DZ$L@P[P2]C2E4Q/L:>)3J5%3CF.-6)C>V
MDI5E4E%V27-'31R?ZWXYT\YI>)W$JX@Q67XS,G3X853%99AJ^$P$W_JIPVX*
ME1Q%?$2IS6">7T9N<ZO/B:&+J4U3C5@H/HHHKZ(_)0HHHH'S2[L****!!111
M0/FEW?\ 7R/.OC!/XTM?A%\6+GX;:=<:O\18/AC\0)?A_I-I-;V]WJGCB/PE
MK#>$M-M+B[GMK2"ZOM?&GVUO-=7-M;Q2RI)-/#&K2+^2W_! /]CWXO?L8?\
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MUI_T+'C'_P $[?\ R71_PGMG_P!"QXQ_\$Y_^2Z[3)]3^9HR?4_F:+Q_E?\
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MNC_A/K3_ *%CQC_X)V_^2Z[0,3T8G()&#G@=3QV'?THR?4_F:+Q_E?W_ /
MXO\ X3ZT_P"A8\8_^"=O_DNC_A/K3_H6/&/_ ()V_P#DNNTR?4_F:,MZG\S1
M>/\ *_\ P+_@ <7_ ,)]:?\ 0L>,?_!.W_R71_PGUI_T+'C'_P $[?\ R779
MA\D@-DC.0&R1CKD9[=Z7)]3^9H]W^5_?_P  #B_^$^M/^A8\8_\ @G;_ .2Z
M/^$^M/\ H6/&/_@G;_Y+KM,MZG\S2_-_M<8SU_B.%_[Z/ ]3THO'^5_^!?\
M  XK_A/K3_H6/&/_ ()V_P#DNC_A/K3_ *%CQC_X)V_^2Z[3<<XW'/7&><8!
MSCZ$'Z$'H:,GU/YFB\?Y7_X%_P  #B_^$^M/^A8\8_\ @G;_ .2Z/^$^M/\
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M4_F:,GU/YFB\?Y7_ .!?\ #B_P#A/K3_ *%CQC_X)V_^2Z/^$^M/^A8\8_\
M@G;_ .2Z[3)]3^9HR?4_F:+Q_E?_ (%_P .+_P"$^M/^A8\8_P#@G;_Y+H_X
M3ZT_Z%CQC_X)V_\ DNNTR?4_F:,GU/YFB\?Y7_X%_P  #B_^$^M/^A8\8_\
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M^E:!X<L9+BY\5>+=1F2!;L+;ZAJ5I\]_#W_@XD_;F_9F_:+^"7P=_P""R?\
MP3^T/]DWP#^T5-8P> _BSX!O-8-GH$6IZA86=OKGB/3=1\7?$2QU33M&NM2M
M$\8Z;::UHWBG0(+Z/4+[0V2!;"=N2[_G_7]:AR2_IH_L"R/4=N_KT_/MZ]J7
M(]1V_P#'@2O_ 'T 2/4 XZ5_-A_P60_X+H_%7_@EU^UQ^RW\!_!G[.OA_P"/
MGA+XZ^&G\1:[:V.H^((_B9>7,_B2VT*PT/X?1Z=<MI$^JZG+=B.S?4].U!)9
MI86CA(PA^:O@I_P7]_;]\ _\%'/@/^PU_P %*O\ @G_X)_9BM?VG=6\*Z/\
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MU^\/<?SKL;/_ (]+;_KA%_Z M<1YVX@;<99><^C ^@]*[>S_ ./2V_ZX1?\
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M72YK_1?L+&PTNUM[#3+'3],L;,*+:RTRRM["PMXP"S16]I9K#%&X:- KJ@[
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MK \@D?)*;Y&( P^3UL[7TUVVO\M=.NE@YW^?X]^]C^)O_@N;X>M=$_X+J_\
M!"KPL\\VJ6>BZU\%_#YN;U6EGOX-*^,_A/35NKO>'1Y;M;83RDDOO=C,%;-=
M'_P7X23_ (?W_P#!$QBI#MXX^'PW#>\A(^.7AAMK';N.UF)_NJSN#MPQK^U*
M;3],NIXKJ[TW2[J\MFC:TO;S3;&^N;1@PE06EQ<0?:;=8'4.#$\3"X_?*[,,
ME+C3M+NYHKF\TS2[RYM3_HUU=Z987=[;D2!@UK>W%N]Q$1(!(C1F,ICS-QE
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MC453$T*5&E..$JRK8*%J:5)991H2<JE.4Y-HHHKZ(_,@HHHH **** "BBB@
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M )G]\?T8'0?VGIO_ $$;'_P+M_\ XY1_:>F_]!&Q_P# NW_^.5@?\(/X3_Z
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M $!;?\[C_P".533_ )G]\?T8'0?VGIO_ $$;'_P+M_\ XY1_:>F_]!&Q_P#
MNW_^.5@?\(/X3/!T6VY_Z[#]=_%'_"">$1R-#MN/]J4_IOYJ;_WI?@_U8&__
M &GIO_01L?\ P+M__CE']IZ;_P!!&Q_\"[?_ ..5@?\ "#^$_P#H"VWY3_\
MQ=)_P@WA/_H"V_YW'_QRJ:?\S^^/Z,#H/[3TW_H(V/\ X%V__P <H_M/3?\
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ME']IZ;_T$;'_ ,"[?_XY6!_P@_A/_H"VW_D?_P"+I/\ A!O"?_0%M_\ R/\
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MM)*AL':6'4!NA(P<@'(H"LP8A20O#$ D*>N&(X''K7\.OP%_;*_;]T;X(?\
M!.'_ (*Q^*OVUO'/Q+_X;S_;Z@_9Q^)7[%%_9>&9/@KX:^$_BOXC?$3P1I?A
M_P"&VE6EHFLZ;XU\(V7@Z/4[?4S*MY="^LI-4>5K6[_M?]R-2^-_Q=_;"_X+
M Z;\ _@I\1?%7@[]E3_@G)X1C\9?M7:GX+U:XT_3?C)^T;\4M/S\,_@1KM_:
M%8]4T+P!H-O+XO\ $&F0SRV=U>3W.C:O9QW5M#)0FGY:I?UJ/DEY?>?N#14/
MF$D\C(/(&.">0,#ID<@>G2EWGV_S^-:<B_F_+_,DEHJ'>WK^@_PHWMZ_H/\
M"G[-=W^ $U%0[V]?T%+O/M_G\:/9KN_P EHJ'>WK^@_PHWMZ_H/\*/9KN_P
MFHJ'>WK^@I=Y]O\ /XT>S7=_@!+14.]O7]!_A1O;U_0?X4>S7=_@!-4D,BQ3
M0RMNVQRQR-L(#$(X;"Y9<DXP!N&<XYS@U=[>OZ"K5DY^V6HXYN(0<9Z&10>A
MSTZXY I.%D[/6SM>V]F%D])7:>Z6KM=7LKJ[^:/RA_X)F_L7^*?V1M?_ &QM
M5\4?$#X?>.H_CU\?-0^)FB0>!K^ZOI/"MC->^*;G^Q_$2W,$"VVL?\3N%!';
M(\0:WN"TF8U)_57/TQG(Q@<]>Q_#.3]">G\\O_!!]KQ?&/\ P4Z%P+O8W[8.
MHF);H7"+Y0U/XA)$T2W+,S84 E594^YB,@@#^A;<Q;.X]N".F>2/KTSV&>]?
M/\*N#R3"?5Z'LH3^LNC&4>64*2Q^,5>/*U%WE4YIQ;7O)JUU:_ZSXXPS*AXF
M9TLXS2CGF-7]@NOF%##X+ X;&0?"G#ZHTY4,)+$THO!4*F$P_)0J2C6K8.56
MNXUY5%"S14.]O7]!2[S[?Y_&OH?9KN_P/R8EHJ'>WK^@_P *-[>OZ#_"CV:[
MO\ )J*AWMZ_H*7>WM1[-=W^ $M'7I4.]O7]!_A1O/?!!X8'IM/#'@9R 21CG
M(&.:7(N[_ ";(]1U _$C('U(Y'J.:4JP&2"!UR00,8SG)XZ<_3GI7Y8_\%?/
MV[?&'[ W['E_\1/A'X=TOQ=^T3\5/B#X+^ O[.GAO6K476C77Q7^)NI+I>CZ
MIK-H]W8I>Z?H,&_4)+22ZBAN=1?3X;AFMQ/$_P"69^"__!<_]F?Q)\#/B_X#
M_P""@.F?\%"OB[-X\\&V?[8W[$E_X?\ @UX.\/>%O!7B=%F\1WG@.^CUS1KC
M2(?!$9GLI+JV?0;C6+R.SU&&RNK'[5IKY^0TF]?Z_P"!\S^I@D X) ((!!."
M">@QUR>P[T[!]#]T-_P$G ;_ '200#T)Z5^2'_!4'_@I!\0OV,M"\"?"[]G'
M]F7XF?M-?M>?M!Z!XEG^"_P[\*:4)_!O@Y=%M1'JWC;XK^(T=[/3?#_A2^N$
MFN(,QV>JRVDL-YJFC:<YU$^3_P#!O-^T5\?_ -J3_@FOX?\ B[^TWXYU?XA?
M&.^^/O[0.@>(O$&M/:SW%M#H'C9K2TT'3S8A;"WTC109=/T^WM1-%#;11)#,
M8PKN:7MK?TT]/7[_ ,@MI?\ K^OZ1^XU&#MWX^3@;OX<MPHW=/F/ YY[5\\?
MM7_'W2_V6?V9?CU^T?K>G_VQIWP4^%GB[XA/H_F>0NKWNA:9++I&DR3J5:"#
M4M8>PLKFX0F2"WGEFC5W14;^8KX0>&/^"XW[0?[$$_\ P5EL_P#@I%8_#[XB
M>(OAWX@_:7^$O[&NG?"#PEJ'[/\ /\&="L[_ ,6V'P]\4:G.L>L/J?B;PKIE
MVD>JRVMQK&FSR6]N^KSW,HU:U/+J"3?WV_K_ #/Z_.X'=L!1W8GH .^>V.M*
MP*MM8%6(R%8$,1US@X.,$<U_,-^U3_P5F^*GQW_X(\_L<_M0_LP:Y_PH#XC?
MMQ?M&? 7]EWQ5XYM+:W\0/\  ?5_'GBK5O"WQ6U3P[-J:1V5Q>Z3J&AW-OX<
MU'48K=X=.FN)6$=Y!%,GH/[%'[0_Q6_8F_;4_P""CW[%G[4W[5_CK]J']G;]
MD;]G/X5?M5:'\=/C)'HLWQ-\"Z1XI\/W>M^-O!_BKQ%IBV=MKL=PL(G\*V5U
M&MW-<3VEO;MFYAMH2ZNEKZV'R.U]/O/Z.,' ;!VMRK8X(]0>A_"DK\?/^"//
MB;]I7X\_!_XH_MR?M)^*O&,2_ME_$G4_B3^S[\$=;U2Y?PS\#/V:K.:73OA9
MI>@:"S"TL-5\9:3$/%VN:DD46H7R:E9P:FHFMLG]??,/3C)Y'KC&<CGT(/T.
M:T4$^OY?YDDU%0[V]?T'^%&]O7]!_A3]FN[_   FHJ'>WK^@I=[>U'LUW?X
M2T5#O;U_0?X4;V]?T'^%'LUW?X 34A.!D\=/Y^U1;V]?T%#.Q'''/;KZ=\CO
MW_3J#D[2L^C?1_>OS0X_$KNVJU>P_')  //.2P"YSAC@\@=2 1TP2!\P_)WX
M6_ME?%#Q=_P5L_:(_8RU/1_!,?PK^&GP8T;QOX?U>ST*>W\<W&MWFD?#"^G3
M5==-YY%WIHD\7:DJ6_V)9@J6:,ZM;R^9^KF\G'((R<;AN'UVY0L%ZG+#&.I
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M[-964/G_ %^)^=0W?I^J+5%%%8&IQ?B'_C]7_KW@_P#1UQ6'6YXA_P"/U?\
MKW@_]&W%8==4/X7]>1C/XG\OR"BBBMB0HHHH **** "BBB@ HHH_S_G'/Y4
M?S*_\',+K'X)_P""5+,B2*O_  5"^$N^*10Z2*/#'B+?%(A!#HZY1T((96*D
M$'%?G%\5OVG=:_X(_P#CS_@NE^POH=Y/H^N?'^]\-?'[]@C16NHI+J[\6_M>
M:V/AGXALO#FG*5:4:?XEU^ZU&YL[9'6TT;PKYJ&V1'CA_JB_;B_8 ^#/[?\
MI7P%T?XS^(/B/X?M?V<_CIX;_:$\#O\ #G5]"TB?4_&WAJPO=.L-.\3MKGA[
MQ$E]X:DAO)6O++3H=-U!G$134X0LBR><_M9?\$I_V5OVS/VM/V8?VS?C!;^,
MQ\5?V5-234/"&D^&[SP[:>"O''V#7;3Q+HEG\2]-U7PYJ^L^(--T/4K,'2[/
M2M:\/-&ES<V\\\\<F4YFI=G^.WW?UH7%JZ]&K^?0_ S]CC]E_3OV+O\ @O'_
M ,$T/V9+"R6RNOA-_P $CO$6C^)G_=&6\\<ZA8>)M?\ '6H7#P(OVN2;Q;JN
MKQ1S2*9&M(K:(EEMT%?%'Q+_ &;]9^/_ (1_X.._%/@2VFE^,/[*G[<_P._:
MM^$MY##-<:M!KGPGT?Q=J^O66DP6CF5;W6?#B7MF)XW5EC4<KS&W]C&M_L$?
M![7?^"@G@G_@I+>^(?B$/CMX#^"VL_ W2/#<6JZ&/AE<^%M=BOTO+_4]&D\/
M2^(9_$*KJ$HCN[?Q3;:?N$?F:?*8V+9_[.__  3X^"'[-7Q _;/^(G@[5?B!
MXDU#]N[QA#XV^-6B^.-2\/ZCX?LKR+0->\-RZ3X-L](\/Z3<V&CW6G^(K])[
M;7+S79VD%O(L\<,1!:B^J^Y:;6[?\#J'/YO^G_D?SH:;^T5H/_!9/]KK1?VA
M="N[+Q!\$OV /^"57CCXO:I):QWC:2O[9'[1'PQUK3]2TAXCNMK?7_AX;;5;
MO3V4![>TMGVB*&3R[GAOAKS_ ,&;/B['./@GX[)]A_PN23D^U?T*?L/_ /!(
M[]E'_@G[\"/VA?V>?@%+\1?^$._:9U'Q'??$76_&&M:!J7BRVMM;\/:AX7M-
M%\/ZEI7A;2+&'2/#>DZOJ,7AF#4=*U*6TEN);C4;B^E=MUG0_P#@E!^SEH'_
M  37U#_@EG:>+?B]-^SUJ?A;5_"4_BFZU[PL?BTNFZSXD?Q5=RPZ['X-'A>.
M[34&,-J[^$'@2T_=/ 9#YE+E?6^S5M>MK=!<R^YI_<?SIQ_\$9/V_/$?_!,'
MX5?&7]D+_@K'^W7<?$JZ_9L\#?$'PW^SGK'Q:\4:/\/]8TBX\)VVLW/PQ\#W
M/AO7M+N_#<EO:&6P\)172ZC;W)BATR2TA6X20?I7_P &SE]^Q+J_[$?B?4?V
M9?!/BGP'\>K;QJ=)_;;T3XI>([CQ=\81\:M.^UP-J?BKQ#J%OIEW=>'-8/\
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M ,DT<S\O_)O_ )$#K]_^U^M+YG^T/S%<?_8_BS_H<1_X(K3_ .2:/['\6?\
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M +7ZTOF?[0_,5Q_]C^+/^AQ'_@BM/_DFC^Q_%G_0XC_P16G_ ,DT<_\ A_\
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M7]!_A2[SZ#]?\:/9KN_P EHJ'>WK^@_PHWMZ_H/\*.1=W^ $U'8GL#M)]SG
M^O!X]C7/^(_$N@^$/#VN>+/%FMZ;X<\+^&='U'Q!XB\0:Q<Q66E:-H>DVTEW
MJ6J:A=S,D5O:6=M$\DTKL ,!1EV4'^=FV_X+^_$+X\ZKXOU3_@G=_P $O_VK
M/VV?@AX'U[4?#.I_'K2XH/ ?@KQ7?:.8CJB?#>*ZM]0O_$+^3($M["YAT[66
M<Q9MHDN+>62]-KJ_;J^^F^GI^(=+]._3[]OQ/Z1ASC'.>F.<]>GKT/Y'TI 0
M>A!Z_HVP_DQ"G_:('4U^:'_!.[_@J/\  7_@H[X&^(FJ?#S0O&OPO^+OP4U&
M[T+XX?L\?%C3%\/_ !2^&FNV<=PJ?VAIL4K6]QHUS=65]8V^IQ2,]O>0M8ZO
M%8Z@4@KYC_X)B_\ !<WX.?\ !3#]H3]H7]FOP[\*_$_PD\>_ FVU?5(SXGUW
M2]6@\=:1H'B]_!VLW.A+ISB>"\T^X:UU"XMIT8_V?)YQ^6VF9<-FO-JWZ_=\
MAV>NFVY^YF<;B?X<[O; R<^F >?2DR.F1G./Q///I7Y:?\%8_P#@J=\+?^"3
MOP \)_''XD>#-8^)>H>.OB':?#WPAX!\.:I::3JVL72:=<:QK=]_:&H?N+:R
MT;2;=;F92I^TRS+;Y5G6O)_VS?\ @LCX6_9"_8S_ &0OVO/^% ^.OBE_PV)K
M?@7PYX)^%GA?6-)L_$6FZYXZ\*IXGT*PFN+H_8]3NY)9(=(6.V/^DW<D90\U
MLY15[M:;ZZK?IOTVW^]7+/L_N/VD[9[#K29 SGL<'V/'7\Q7\YOBG_@N%^UY
M\-]"UGQK\4O^"&O[?WACP/X7T^ZU7Q9XCTS3M#UZ30=(TY6EU/5+JTAEB,%G
M8V\<T\MQ<7"6T:1%II8XPTB_L9^QM^V'\%?V\/V>? ?[3?[/NNWVL_#GQW]M
MM8[?5K%M,U[P_P"(-'=+;Q%X1\1Z:[LFGZ]H-XP@OH[:YGLKA3'=VLUU9S0R
MMDE[1V;MIVW^7^5_U%TOT[GU/14.]O7]!_A2[SZ#]?\ &K]FN[_ "6BH=[>O
MZ#_"C>WK^@_PH]FN[_ ":BH=[>OZ"EWGV_S^-'LUW?X 2T5#O;U_0?X4;V]?
MT'^%'LUW?X 345#O;U_04N\^W^?QH]FN[_ "6BH=[>OZ#_"C>WK^@_PH]FN[
M_ ":BH=[>OZ"EWGV_P _C1[-=W^ $M%0[V]?T'^%&]O7]!_A1[-=W^ $U%0[
MV]?T%+O/M_G\:/9KN_P EHJ'>WK^@_PHWMZ_H/\ "CV:[O\  ":BH=[>OZ"E
MWGV_S^-'LUW?X 2T5#O;U_0?X4;F]?T'^%'(N[_ ":CU]NOMC.0?<;3D=L'/
M2H2[*"3R!G(P#G! (Z'N0.G>OR@_X*5_\%>?@-_P34\1?L[_  Z\<:1J_P 2
M_B]^TA\1-&\(^%/AQX5U+3K35M!\*:EJ]MHNH?$OQ"VHR!+/0;76;^STVS@*
M_;-:O9;\6/GQZ;?S07=+=I>H'ZR_U&1[C&<_3'/TYI,C.,]RO_ @,D?4#K5=
M96=$<,%\Z*"15PS!4D@$J1A.(1)$)465P=LA4X.*_*C]N?\ X*8?$G]C;XL:
M%\,_"'_!.?\ ;:_:[TO6_ 6F>-)_B-^S?\.U\6^!-'N]2UGQ'I,G@?5-4$T,
MEOXHTJ'0[76-0LS"8X],UO1949FN)<#M9Z].S??LG_78-S]8<'T]3^1(/Y$$
M'T((I.RGLQ(7W(7<0/<+SCTK^>;]G3_@O_IOQY_;9^&'["7B;_@GI^V=\ OC
M+\4()-7%O\8/#'A_0)_"7@^WTO5;_P#X37Q/HC:HNO6/A;_B3W5L=36P-M)-
M)&F)6=5=GQ?_ ."_OAWX9?$CXY:IHG['/QD^(7[%7[+WQ_TW]F3]HW]L_0-;
M\-P>'? GQ<NM7TSP_JT&F^ [FY?6O%'AKPIKNLZ?IVO:W#/;RV]S=0/;64WV
M_2%O,%;3LW;^OEJ%G>W7>UU?\S^AS(P#D8)P#V)YX'OP?R/I1D>O^>O\N:_/
M3]M#]OG1OV6];_90^'7@+P ?CM\;/VROC!H_PU^#GPVTOQ#_ &!O\,/9IK7C
MKXM:SK)LM2:S\"?#SPY-#J.M77]G7+,U[IREX(Y)[I/T$RZD@LK.@"RE$,89
MF=P77#!#&6RHQYDDH2.:4LL@*:>S7=_@!/14.]O7]!2[S[?Y_&CV:[O\ ):*
MAWMZ_H/\*-[>OZ#_  H]FN[_   FHJ'>WK^@I=Y]O\_C1[-=W^ $M%0[V]?T
M'^%&]O7]!_A1[-=W^ $U%0[V]?T%+O/M_G\:/9KN_P  ):*AWMZ_H/\ "C>W
MK^@_PH]FN[_ ":I;?S/M$'DE5E\^(1%QE1(74(6'(VAB"<@\>G45-[>OZ"K%
MM<>3<V\K ;8IXI&PNX[4D5FP"1DX!P,]:3@DF^9JR>NFFCUZ[>@)<S4;.5VE
MRIM-W:5DTTTVVDK-/LT?DO\ \$PO&?['WB[7_P!L^W_90^%7Q#^&6IZ!^T'>
MZ=\<I?'NH6NHQ>,_B,+[Q8L^O^&/LOB775L='$T.LL+9UTXF.ZM<6.$<)^L7
M3"]>F0 >O'?CZYSQP.*_(W_@EM^R!\5OV4=?_;7U/XG77A&ZM_CA^T)>?$3P
M5_PB^OP:U+#X=FU#Q=<1C6HH4C&G:HJZS:(;21BY!GP#Y;"OUM#L<$]3TX'3
MC/U!Y]QG(S7A<,+$2R/"K%82GA*M\3?#TVN3E^O8MTYKLZU-QQ$E?XYMO63M
M^F>,/]C+Q$SR619OC,YP,L-D:P&89AF.*S.M5MD621QU6MBL91P\Z\:>*CC<
M!2=:DI8=86A0H<\*%.I*S14.]O7]!2[S[?Y_&O>]FN[_  /S,EHJ'>WK^@_P
MHWMZ_H/\*/9KN_P FHJ'>WK^@I=[>U'LUW?X 2T?TY/T'4_A4.]O7]!_A0';
M(Y&>V1P#V)P.0#@D=#T;@FA02:=WIZ 3$A=I/ 8J%/9BWW<>N[MZT@(+,H(+
M*,LN>0,XR1UQG^M?)G[:?[:'P1_8%_9W\8_M+?'W5;[3_ GA673]'M=+T*T%
M]XM\9^,->DEB\/\ @KPIISS6ZWOB+69H;EHHI98K"&WM[BXFFBB@>1?R>\,_
M\%]8?#/C3X.6?[8G_!/K]KW]BGX-_M!>(]&\+?"'X^_%SP_I%UX#DU?Q*L3>
M'K/QU'IEX]]X1N-8@N+6>)&^V&"SN%U"YCBL(;BYCMM:J]G;;K=Z+[VU;U"S
M?0_H5[D=QC(QZC(_,<CVI,C.,\Y(Q[CJ/K_^NOR4_;X_X*V_#O\ 8P^*_P +
MOV9/A]\#_C!^V)^UI\8-$G\5^#/V?_V?],LM8UG3?!<32G_A+/%NI7$XAT71
M;UK>9K!TBNKB:QB.KR1)I(6]/7?\$_/^"H_PQ_;U\1?&+X3R_"KXP?LU?M-?
ML]SZ5'\9OV=/CSX>@T#Q[X=M-6<V]AX@TV6QGN=/U?PY-=H]O#,#;ZBBM%=S
MV<%I=V\LV"W5^Z'9[V9^GQ(').!ZFCL3V7&3V&1D9/ICG/3%<[XG\4:!X+\-
M>(?&7BW6+'P]X5\(Z'JOBCQ+KVJ2K;Z=HN@:!8SZKJ^JWT[#$5K86%I/<S.0
M<)&<*QPI_G6@_P"#CCP?KNC>)?CQX#_X)_?MJ>/_ -@WP-XGO/#OBO\ ;1T'
MP7I$G@NULK'55TO5?&VF>%9[X:OJ'@72IV$VL7OF'4M.CW1M8IJ!6R;9V2=W
M;1]^WZ=6[ DWLKG])?\ 3K[4>W?I^.<8_/CZU^=G[7'_  4H^!O[+G['?A+]
ML;18=2^/?A'XM:I\-_"G[/7AGX636=_JOQJ\9?%V=H_AYX=\-75Q.EC;?VD\
M=U-J%Y<-YUB+.:)H'O!!:-R'[!?_  4;UC]K?XG?'3]F[XV?LW>-OV0_VK_V
M>=.\$>*OB)\%O&NNZ+XML[KP/\1;5[SP?XQ\)^,M$E2QURPNK=734K5[:UN-
M.N71W:2*1)'Q6Z]4%GV/U!R/4=<?CC./KCFEK\__ -B']NRV_;F\0_M.ZOX
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M7*KT [\\=^I[5W4OX2_K^8X:TTJB=]$UV?\ ,G\[?H3[QZ'\O_KT;QZ']/\
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M4AAUBWU6YN?[XOVC_P!F3X$?M=?"C6/@;^TA\.-*^*OPFU^_TS5-7\&ZS?\
MB#2[*\O="U&/4M)O'OO#>IZ'K$4UGJ%M!=QB"]B:1E7SHWC)-?S8_P#!3[_@
MV_\ V6O%7P?^#%G_ ,$\/V)?A]H7Q2L_VG?A?J_Q7N(?BIXDT$W/[/-M#X@_
MX63I[77Q*^)+Z5<+<3R:$5T_257Q$RB0Z1+LA9&SJ:M6M]_6Z=_\NWS.BG6B
MT^9I->:LU9[7???Y']4OAGQ/X;\7>'M'\1^%-?T;Q/X=U*SA.G:YH&I6FKZ1
M?K#$MM.;/4+&6:UN!%/!-!*8I6\N:&2-\,C <+\??C?X._9N^!_Q>^/GQ"U
MZ?X+^#?P\\7?$3Q)/Y@5I-.\*:+<ZM)86RL-DU_?/##965J"9+NZN8;:(-)(
MJGXA^-'PR_:&_8G_ &6/@E\&?^"0_P"S3\)==A\(?%+0M"U?X5>/?&K:+X6\
M$_!C7H_%&O\ Q!\3Z#K?C?Q=87>K>)#XON]/D2TFUK4KQHM:U"6UL;R.U,47
MFG_!=+]FG]J3]L;_ ()P?$S]FC]DSPMIGBKXF_%3Q-\*]/U_2=2\7>&O T$'
M@K0/%VC^*?$TJ:YXEU+2]*:/S=&BM)[%+LW%Y9W-PD-K<@[9+;5GZ/KY/;YD
M*NVXWY$F[7;V5UJ]=--3Y(_X-X_@9XV\=_#?XP_\%8OVEK.;5?VJ/^"B'CK7
M?&.FZEJN^:3P/^SQI6KO9?#_ ,"^'HKS]]I?AK4O[.&I6(BD47WAJV\#F1G:
MP,\GS3\9O^"0_P#P4-_L']M?]A[X6^,_V=-,_P"">7[;_P"U_J/[7WQ"^-WC
M'5M=B^-GP;T;7_%OA?QO\1_ &G>$ULI=,URX>X\&:?:Z!K!N)+"'3()#J6H6
M<^J2R:;_ %$_![X=:3\(/A!\+?A)H,$-MH/PR^'7@OX?Z;;00B&UAL/!_A_3
M=!LXH+="52)(K +$J*(45FEV1G._\]_^"N^D_M5_$_\ 9;M_V9/V0_"GB*Y\
M=_M7^.?#_P "O'WQ7TN%4TK]GSX&^*9W3XM_$[7KM;FV<./"HN?#NCQ:<Z:J
M+K6?M=D3-I]2TN1+32SW6_7J][_\-8J-5>VD[Q2:M=M6]W:VJ75_=H?B7\&O
MVYOV?]#_ &F_%?\ P59^.&E?$GQS\/\ 4=2U#_@G5_P1[^!OPP\'7WQ"^)WQ
M-^'WPI(T_P"-/QI\!>&+5HUG;Q_K]I)IL'C RZ<T&BQ/X:U"0O-91O\ TG?L
M8?ML_ G]O/X/R?&?X#ZEKDNC:5XMU[X?^-/"GB_0+OPEX\^&_P 0_#$EL/$'
M@;QKX;U%5NM*UW2OM=K+-"3)!=Q3QW5K*P.:_)#]MK]B#XL_LN_$3_@D=^TA
M^PI^SS<?M"^"O^"8&F?%;X5:S^SAH.MZ/H?C;Q+\//BO\/M)\$3>.O"<VL-:
M:?JWB[2;K1WUG4HXV^VZUK.IQ:I=%5BO;Q?H?_@C9^S+^T!\&/"_[8GQV_:6
M\ 6_P=^)?[;?[6WC[]HNW^"$&M:=K]S\*?"&N1P6WAW1?$6K:49-/NO%M_"M
MS>:W]E55799BZ:"_EFM8%"3^%_?\N[>W9?D7.K!+FYE)O9*2;_/16UO\C]GM
MX]#^G^-&\>A_3_&H\'T/Y&@<$?45I==U]Z_S,/K#[1^]DF\>A_3_ !HWCT/Z
M?XU&.OX$?F"!28/3'/I1==U]Z_S(]K/^=_>B7>/0_I_C1O'H?T_QJ/!]#^1H
M'!'U%%UW7WK_ #+^L/M'[V2;QZ']/\:-X]#^G^-1CK^!'Y@@4F#TQSZ477=?
M>O\ ,A59W^._E=:^1+O'H?T_QHWCT/Z?XU'@^A_(T#@CZBBZ[K[U_F6\0[/2
M*\[[>9)O'H?T_P :-X]#^G^-1CK^!'Y@@4F#TQSZ477=?>O\R%5G?X[^5UKY
M$N\>A_3_ !JS92A;RS(R"+JW_69 0<9X(X/!X//%4L'T/Y&I;9#)<VT8=HS)
M<0Q^8F-R;Y%!9<@C*@DC([4GJFE9NSLFU9NST?DS18E)IRBG%-.24K-JZND[
MK7MJM3^??_@A?JNJ:AXP_P""F)U2_P!2U$VW[7M_%;1ZA<W%RMI FJ>/UV6X
MNY98X88T"+''9[$(0 IPN/Z!/,&1P><<\<@]P.,>X^F,<&ORT_X)K_M:V'[4
MFO\ [8^G6/P1^'WP=;X*?'N[^'MQ=>!(;:W?X@/#>^*H/^$H\3"'1]*:36I%
MTGS',KWTA>]N2+D$/N_450W //3'J/3@YZ?0$GU'%>!PE&A#(,'[+$U<93<\
M:E7J\SFY?VAC'4A&Z=HT)WI12>D(7>C3/U_QSQ.8S\3>('F&0SX;Q3P_#[JY
M?2KX/'4L(UPUP\J<:E?!TJ-.5/%894,8OJ])SHU,:X8CF<*E5V=X]#^G^-&\
M>A_+_P"O4>#Z'\C2J0""?\\5]!==U]Z_S/Q]XAV>D5YWV\Q^\>A_+_Z]&\>A
M_3_&F*>ON"!]33<'ICGTHNNZ^]?YD*K._P =_*ZU\B7>/0_I_C1O'H?R_P#K
MU'@^A_*E4@$$_P">*+KNOO7^9;Q#L](KSOMYC]X]#^7_ ->D9P5(QG(Y#8VD
M=P>>A&0>_H">*:O?W4@4@X/.>.3@$GCG& 5)]P#D]!D\477=?>O\R%5E=7FV
MKJZNM5V/!?VA?V7/@%^U?X=\)>$?VAOAMIWQ.\-^!/'GA[XG^%=)U?5O$&F6
MND^-O"5S'>^'?$N="U?0FG_LN:,,]IJLMQI<\!FBO[&:SFG1_P";[_@IO\>V
M_P""SG[0/P]_X)*_L36T'Q$^'7PP^-O@?XO?MP_M2:7%)>?##X1:;\,M3NI;
M7P/X7\2V@BT_4_%4MQ/J-E+_ &3-<-=ZP;72-(\RWT[6I;7]*_\ @N)\._\
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M.O"'A"<W"VBS>(;[2Y)=,TU[I@T<$>M75LNBR32CR$2_8SLL0D9?Y:_V:?\
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MKJ.SET2WAC3Q)$$NY!;QO-^IR'D C)X Y^]E@..,GIC/YU^'7P6^%/Q-TO\
MX+N?M9_%?4OA]XNL/ACXA_9W\/Z/H/Q#NM#O(/!^M:K#X>^"<,VF:;KKQBRN
M[^.73-1BDMHI6D5[&[0KF%P/G.(I<E;AOGPJQ2GQ#1<:LU)SHWP.,A[6U%2A
M'V<].:=H1D^5M2LE^O\ A="6)P/BG4CGE?(X4_"_,9*A2GA80SV-//\ (92R
M6HL<X3JT,7*<,=4A@G/%^VP%-TXO#QJ-?N;O'H?T_P :]7TXYT^R/K:6Y_\
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M[_XG\S1AO1/U]_\ $_F:XK_A)M5_Z$[6O^^K;W_Z:^QH_P"$FU7_ *$[6O\
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MUHRW^S^35Q?_  DNK?\ 0G:W_P!]6WO_ --?;_.11_PDNK?]"=K?_?5M[_\
M37V_SD477\B_\ #WO^?6&_\ )?\ ,[3Y_P#9_6CY_P#9_6N+_P"$EU;_ *$[
M6_\ OJV]_P#IK[?YR*/^$EU;_H3M;_[ZMO?_ *:^W^<BBZ_D7_@ >]_SZPW_
M )+_ )G:?/\ [/ZT9;_9_)JXO_A)=6_Z$[6_^^K;W_Z:^W^<BC_A)=6_Z$[6
M_P#OJV]_^FOM_G(HNOY%_P" ![W_ #ZPW_DO^9VGS_[/ZT?/_L_K7%_\)+JW
M_0G:W_WU;>__ $U]O\Y%'_"2ZM_T)VM_]]6WO_TU]O\ .11=?R+_ , #WO\
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M_P"^K;W_ .FOM_G(H_X275O^A.UO_OJV]_\ IK[?YR*+K^1?^ ![W_/K#?\
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MH:+K^1?^ ![W_/K#?^2_YG:?/_L_K1ENGR_DW\^E<7_PDNK?]"=K?_?5M_\
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M_7_ZU'F>WZ__ %J )**9O'H?T_QI/,]OU_\ K4 245'YGM^O_P!:CS/;]?\
MZU $E%,WCT/Z?XTGF>WZ_P#UJ )**C\SV_7_ .M1YGM^O_UJ )**9O'H?T_Q
MI/,]OU_^M0!)14?F>WZ__6H\SV_7_P"M0!)13-X]#^G^-)YGM^O_ -:@"2BH
M_,]OU_\ K4>9[?K_ /6H DHIF\>A_3_&D\SV_7_ZU $E%1^9[?K_ /6H\SV_
M7_ZU $E%,WCT/Z?XTGF>WZ__ %J )**C\SV_7_ZU'F>WZ_\ UJ )**9O'H?T
M_P :3S/;]?\ ZU $E%1^9[?K_P#6H\SV_7_ZU $E%,WCT/Z?XTGF>WZ__6H
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MW_M">&?BAXU^ GQE\(_ [QW-\+?C5XB^&'C+1_A-\0[>*RN)?!GQ&N]$O/\
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MR$2>Q\7ZC8[S9O=L'>I%*I>[TNK?S:+97[*VVI-Z-1NDU;E=[O;W7TN]7O\
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M"B6,L0E)2@[-ZSOH_3MOIV6O0F<4HXA])<MO/1:Z[W;Z']$__!2']OSX7?\
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MI<U[9Z9(FA7$Y34)HY9ID_>;_@H7_P %G?VI?^"=/[)?[(F@_%SX#>"/$O\
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MY&DJ0R(0?F'0U%D>H_,46?9_<QV?9_<Q:*3(]1^8I00""2,9]?0T6?9_<_\
M(5GV?W/_ "%P?0_D:2I#(A!^8=#461ZC\Q19]G]S'9]G]S%HI,CU'YBE! ()
M(QGU]#19]G]S_P A6?9_<_\ (7!]#^1I*D,B$'YAT-19'J/S%%GV?W,=GV?W
M,6BDR/4?F*4$ @DC&?7T-%GV?W/_ "%9]G]S_P A<'T/Y&I[218KJVE<X2*X
M@D8XW85)58G'.< <XY]*C,B$'YAT-36 #WUDOR$-=VX*L RLIE0,"O.01D8[
M_2BS6Z>S[]F-*S3E#G2:;@]%-77NM]%+;IN?CK_P2H_92^.O[,'B']N/4OC7
MX.C\)VOQJ_:/U#Q_\.7_ +7T[5F\0^%I=0\83#5"-/D9K!HTU73W%I>JLVV9
M0/N/7Z^C);  XZ'KQTX/?Z?49SS7X._\$3?'OC;QQXK_ ."C\7C#QSXN\:1^
M&_VLM1TCP]%XL\5:YXHB\/:3_:7CQ1I>@KK6H:@-%L0MO;(=/TX6=K_HT:^2
M?)3;^\0^5D)SR>"0.![]#P>.OTZXKYG@^IAY\/4'@X?5:4JN)>'IUDZTJ,(Y
MCC(8A3E9W]M5Y_9QO[CE&5E:Y^S^/E+-*7BEQ)#/L9EN+Q]*APPZ^+RG#XK"
MX6I3J\+9!*A2HT<;B,36451E@J5:-2=64J^'Q%6A*G0G&$9,'T/Y&DJ0R(0?
MF'0U%D>H_,5]-9]G]S/QBS[/[F+129'J/S%*" 021C/KZ&BS[/[G_D*S[/[G
M_D+@^A_*DJ1G0@@,/\FHLCU'YBBS[/[F.S[/[F+129'J/S%.5E!!) _'V-%G
MV?W/_(+/L_N?^08/H?RI*D9T((##_)J+(]1^8HL^S^YA9]G]S%HI,CU'YBG*
MR@@D@?C[&BS[/[G_ )!9]G]S_P @P?0_E25(SH00&'^3461ZC\Q19]G]S"S[
M/[F+129'J/S%.5E!!) _'V-%GV?W/_(+/L_N?^08/H?RI*D9T((##_)J+(]1
M^8HL^S^YA9]G]S%HI,CU'YBG*R@@D@?C[&BS[/[G_D%GV?W/_(,'T/Y4E2,Z
M$$!A_DU%D>H_,46?9_<PL^S^YBT4F1ZC\Q3E90020/Q]C19]G]S_ ,@L^S^Y
M_P"08/H?RIC=,\<=<^F"..O-3,Z$$!A_DU"S#'!S]"/UZ\?UP.AIQ4U*/+&\
MKKEBTK-]$^;W==M=.X>[%WJ<R@M9M1;:BMVE9W:Z*PT@GL ?X1U^8?=SP !N
MSR#D9#=N/S)^&O[2OP]\2?\ !4GX_?LQZ?\  3PCH7Q%\#?"#2?%NM_M VOV
M'_A-/&&G3Z3\-;J+PQJODZ7'>-8P1^([*$>?J<BA=$LR(%#A8_TV'++DMP>B
MDAL=_P"(8; X.< X)P!S^7/PO_9DT7PS_P %6_V@_P!J*#XW?#S6=8\>_!K1
M_"-U\"]/N)#\1_"<%OH_PPM(O$VNPL1$NF72>&HYH@N^98=:TTN<L]?/9Y+%
M*MD*P<;WSA0QD7]63IT?9XF=:HEB7%^TC)*C;#)U52<G!-:GZKX;0R66#\3G
MG\<?"NO#W&OA^OAZV.BL9G*S;)G0CCJ65J5'V%/"?VDY+,E' >Y3]K-5UAHR
M_4O!]#^1KVG3/^0;8?\ 7G;?^B4KQHLIRH(S@\?AG^5>R:7_ ,@S3_\ KRMO
M_1*5[&(VCZNWW'YIA=Y^B_-E^BBBN8[3R[QJQ&JVZCO:1'Z_O9NWMUKCD9B<
MX&!UZ]P?>ND\>:C86NM6J75[:V[FQB<)-,B,5,\ZAL$YP6XS7$#6M&4#_B:6
M&>^+B,]_KV__ %5Z%-VHQMVU?FVT[]M+?>CAK<W,THMW6EDWU=^G8U[@1W/V
M4W*1W9LI5GT]KJ&&X:RG5-K36WG(S64@3]W%)!Y<HZ>9@<S27$T[$S3/(SXR
M\CO*PS\I,IE#>=L0;,%E+C]X1D\8O]LZ1_T$['_P(C_^*_S@^V3^V=(_Z"=C
M_P"!$?\ \5_G!]LAA[.I_)/_ ,!?^1KB1A*LVXK<1PFT2==IE%F^WS+<RE5D
M-N"L16T+F(^7ET<C-3/>W<KQRS75R[0@-$SSS2/%@QD"!Q()HI696+G)504:
M/)#@X7]LZ1_T$['_ ,"(_P#XK_.#[9/[9TC_ *"=C_X$1_\ Q7^<'VR[O^K?
MUKU[EVK]JGW2_P C;FN)+AVFGEEFD(4!YG,DA"C?'&96WR(BLQX&V,-D.6)I
MT5W/ CQ07%Q#'*,ND;M&CKG8JRI&VSD-(TJ(NXIM4MN+$87]LZ1_T$['_P "
M(_\ XK_.#[9/[9TC_H)V/_@1'_\ %?YP?;*MZ?@1[.I_)/\ \!E_D;44\L$@
MF@>2"4JV7AF:-MK+M9!M<,IRH<+\@<NRO@$D-DF>61II)&DF<EM[YW-( &8M
M(09(][*JY!9/W>\ &0FL;^V]'_Z"=C_X$1_X^X_/ZX/[;T?_ *"=C_X$1_X^
MX_/ZX=GV#V=3^2?_ (#+_(WY[RXN&C::YNIRH?:)YRPCW*JL$;<[K&9-K+&&
M#,H9I&!5<UB49[9I$662SFDN[&21%+V5S*-CW%L_[PV\TB_*SQ.DX'[QG+$U
MD_VWH_\ T$['_P "(_\ 'W'Y_7!_;>C_ /03L?\ P(C_ ,?<?G]<"373^OZN
M'LZG\D__  &7^1NO?7<D:PR75S) !GR3+(R;MPW2*'D*I(6.X*%5&P[NP#L2
MV6[NKE8Q<3RS*I*(MQ*\BPHQ"GJ?,)?"LP11&D8VH<J*Q/[;T?\ Z"=C_P"!
M$?\ C[C\_K@_MO1_^@G8_P#@1'_C[C\_K@:?16MZ;]_4N:JS:_=S26R49?CI
MO^70V/,],Y[9P!GMDYX&>]+YKBXFN][_ &F:V%M/= C[7<6\+%HK6>Y8"XE@
MCD+&"(2&) V0E8W]MZ/_ -!.Q_\  B/_ !]Q^?UP?VWH_P#T$['_ ,"(_P#'
MW'Y_7!9]OP06K]JGW2_R-A)9(F1XG>%T)*M&PS'&RD9!!.]@"4=-RM(#N9<]
M'VES-8QQPV<CV4-NKQ0PVDDEO !)*9Y%2&W>()%)(\DDN2B>:V] YW5B?VWH
M_P#T$['_ ,"(_P#'W'Y_7!_;>C_]!.Q_\"(_\?<?G]</WGO^*7ZA:OVJ?<_\
MC5E$<\<D$Z+<V]RQ$\%PB3V\JC$G[^VF!26)7P84<&0S R,6^4BQ]IG$PE6>
M1)@4"S1R%9$B">2JLY<F0^4<$*Q5(P$0HP-87]MZ/_T$['_P(C_Q]Q^?UP?V
MWH__ $$['_P(C_Q]Q^?UPK/L1[.I_)/_ ,!E_D:D BMHF@MUCMH997N98;2%
M8+>2X8@/*\"K'&9IC\\LLL;-(22TAR32[@\$UK*BS6ESA;FUD(>UN(WRTBW$
M$BM'*!( X1HY$'&TDXK*_MO1_P#H)V/_ ($1_P"/N/S^N#^V]'_Z"=C_ .!$
M?^/N/S^N'[WF5:OVJ?=+_(V))9'(\UV?9&L0!)E552/$?D\[514VI'$-J(%"
MM$"*GDN[B810S7$TD44@:-9)GGCC3;L(56< H1@B-@I490!4 -<__;>C_P#0
M3L?_  (C_P ?<?G]<+_;>C_]!.Q_\"(_?W]C^1]LJS[$^SJ?R3_\!E_D;LMY
M<SA/-N+B4H5:-I9WE>(EMI:,RL1&YVABB!8D0#OMRDEW<W+1O<2R7 0[0MQ*
MSLJALC;O+J%#C)B9O+\L[@=]8?\ ;>C_ /03L?\ P(C]_?V/Y'VR?VWH_P#T
M$['_ ,"(_?W]C^1]LEGV#V=3^2?_ (#+_(V"X^TB^&6OG@^R->OM%V;9"3Y#
MW!!F-KR?*MY)?+3&!& V*>)G4,B.=C(T<D;.1&Z.#NB9<*KJ^<,<% ,HQVG%
M8G]MZ/\ ]!.Q_P# B/W]_8_D?;)_;6D?]!.R_P# B/\ Q]C^7TR).Z^0U3J7
M7N3W7V9=UY&C L=K;+9VL<%M:0NS16MI"D%D@X?]S:0;($E9V)>4(&8Y.Y^\
MN\G@XP>N.N/;FL==9TA1SJ=B.?\ GXC]/KZ G_Z]._MO1_\ H)V/_@1'[^_L
M?R/MEM:Z:[6:*J4ZG/)J$]U]E]EY&K\G^U^E&%YZ\ X.1SCIV[UE?VWH_P#T
M$['_ ,"(_?W]C^1]LG]MZ/\ ]!.Q_P# B/W]_8_D?;)>?=D\M;^6?_@+_P C
M3H^M9G]MZ/\ ]!.Q_P# B/W]_8_D?;)_;>C_ /03L?\ P(C]_?V/Y'VR7GW8
M<M;^6?\ X"_\C5^3_:_2C"\]> <'(YQT[=ZRO[;T?_H)V/\ X$1^_O['\C[9
M/[;T?_H)V/\ X$1^_O['\C[9+S[L.6M_+/\ \!?^1IT?6LS^V]'_ .@G8_\
M@1'[^_L?R/MD_MK2#_S$[+_P(C_^*]01^'I@T7EW?X#Y:W\L_P#P%_Y&K\G^
MU^E&%YZ\ X.1SCIV[UE_VSI'_03L?_ B/W_VO\Y^N#^V=(_Z"=C_ .!$?O\
M[7^<_7!S2[O\!<M;^6?_ ("_\C2H^M9O]LZ1_P!!.Q_\"(_?_:_SGZX/[9TC
M_H)V/_@1'[_[7^<_7!S2[O\  .6M_+/_ ,!?^1J?)_M?I1A>>O .#D<XZ=N]
M9?\ ;.D?]!.Q_P# B/W_ -K_ #GZX/[9TC_H)V/_ ($1^_\ M?YS]<'-+N_P
M#EK?RS_\!?\ D:5'UK-_MG2/^@G8_P#@1'[_ .U_G/UP?VSI'_03L?\ P(C]
M_P#:_P Y^N#FEW?X!RUOY9_^ O\ R-3Y/]K]*,+SUX!P<CG'3MWK+_MG2/\
MH)V/_@1'[_[7^<_7!_;.D?\ 03L?_ B/W_VO\Y^N#FEW?X!RUOY9_P#@+_R-
M*CZUF_VSI'_03L?_  (C]_\ :_SGZX/[9TC_ *"=C_X$1^_^U_G/UP<TN[_
M.6M_+/\ \!?^1J?)_M?I1A>>O .#D<XZ=N]9?]LZ1_T$['_P(C]_]K_.?K@_
MMG2/^@G8_P#@1'[_ .U_G/UP<TN[_ .6M_+/_P !?^1I4?6LW^V=(_Z"=C_X
M$1^_^U_G/UP?VSI'_03L?_ B/W_VO\Y^N#FEW?X!RUOY9_\ @+_R-3Y/]K]*
M,+SUX!P<CG'3MWK+_MG2/^@G8_\ @1'[_P"U_G/UP?VSI'_03L?_  (C]_\
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M;XX?':[^(DMOX,NP\W@.66\\4W#>&_$;/+(JZM$=7:'9%Y:YLKH,G *_IO\
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M^V]'_P"@G8_^!$?^/N/S^N#^V]'_ .@G8_\ @1'_ (^X_/ZX+S[L.6M_+/\
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M^6?_ ("_\C2HR1TY]?\ /UQUX]:S?[9TC_H)V/\ X$1__%?YP?;+6UG2"/\
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M_P#P'3_&KV]_[R_]]'_&EWMZ/^O^-%I?S+[F'/5_G7W?\$H?\([H7_0+L_\
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MPCNA?] NS_\  =/\:/\ A'="_P"@79_^ Z?XU>WO_>!]@3D_3GKZ4N]NV_\
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M#$P\-Q7OBV"--=D@OKO^W-4:/1K)SJ5QY#!S<$0GSR!^L!8G(VD'!R<\#UR
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M?W..IR/8G/X4;V_VA[MD#\>?\FBTOYE]S#GJ_P Z^[_@E#_A'="_Z!=G_P"
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MD? VE?\ !PE_P2BUCX@VG@6V^/\ XHCTW4?%'_"%Z?\ &2_^$OCG3OV?+SQ
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MKQU<:@8M<T_4_#\^N0+!?>'KG3]6TE["\F6Z$5O,K?(O[8G_  1!_9^_8>^
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MX 7EW?W?\ 0( 0>>"#V['Z5_+?\ \%9?V@_BMXP_X*E?LX_L6^%?^"@GB/\
MX)]?!7PY^RAXU_: ^/7Q@\/:SX8TZWAFU3Q1<^'_  C8ZA;^)KBPL]1U=;W1
M=/L[6QAO4N(=-UZ\O8[>Y6,E/ZD V[(!VG'!(R!VS@=<9SCO7X%^-/V7/^".
M?[97_!7SXM>&/C)X)\4?&;]O+X8_![P=J'B/X2?%N+5Y/@>_@A-&\/W?A[Q%
M\.O#UP+/3/%6L:/IVK:?/J"6EY>V]I?:EJEY-8&2&XEMYE[3NK:73T=MWJM=
MD_NL=-"]I<U]]-/+[MSWC_@FE^SGXM\&:EXI^-5C_P %<?BA_P %(/AGXM\(
M7'A'1M)\0)X"N_!OA/Q!<WEK?Q>*(-1\+ZQJM[;>(+:RAEAM;"\2QBDMK^>2
M6.61(7C_ #)_;E_8O_:(_80_9B^+7[4_Q=_X+S_MT1^$_AOHQN=,T.V\"_#F
M#6/&7B[59?L7A+P-H8/B**(ZIXCUFZBTZW=8A:Z="\]_<1PV=M-LA_9-^%GP
MU_8Z_P"#D#XP?LS?L36T'A/]G7Q_^QA#\3/VD?@KX4U.^N_AM\+OB]:Z_86V
MD26FER7%W#H&MI8'0;NWTYITN;0>-]6LUC2WCCM[7T+_ (*S6Q_;U_X*Q_\
M!-O_ ():3S!_A'X":^_;I_:3L)"L]EXAT7P=-K&G>!O"NHQ19#K?3:/KVAZE
M92#8MIXXL;_!>&-A',M5JFVXK65KO1:J5WNM[VLP2:K2?V7'F;Y59*RZVTVZ
M/7K<^V/^"%?PX_;B\*_L3Z'\2?V^/C;X^^+'Q9^/NHVGQ,\->%O'KI=:U\*/
MAUJ.CVTGA;P[?SFWM9?[8UJU$GB;7-,,971[C4;737_TJSNU'J7_  5B\0?\
M%!?^%._"OX5_\$Z?#NN6OQ3^.'QH\)?#;XC_ !VT?2['58OV;/@[J,F/%/Q5
M>.]E$*S:?)_9T'VX6MX]KH_]JSP0&[CMR/U"O;[3]+LI[V^O].T;2[",-<7V
MHWMKIFGV%C"0L<MQ>WLMO9V440$,9:62)0FXRM^\ 'Q[^W'^WC\ _P!@#]FW
MQ'^TY\:=;2^\(V4EKI/@KP_X3N;+5]?^*7C368WG\->"_!*V\LUC?7NK>7//
M)J*2-I]AI%K=ZW<N8;1@=5&:6LK6BU>]FN^M[NZ;UM^(JEW.$DKK6]E=;[::
M?+[]+W_GT_:\\+_M@_\ !$OQO^QE\>/!_P#P43^/O[7GA#X\_M0^"/V>?C5^
MSU^T)'H6K+X]@\:6]Q+J/BKX<0Z4)+W2;[3H-.G@MK6U91IE]?:,\<]RD]Q!
M)V'[;U_\5?VM_P#@I!^W!\#_ !3^V3\8/V1OAA^PK^Q1X<^-WP,T3X4>.[/X
M<0>*_B1X@TZY\0:A\4?%[RO;S>+=#T2YMX/#M]H,LDU@RVZ1.8)&N#)ZI^Q=
M^QQ^T=^WU^TU\/?^"IW_  5'DT7P6O@'=K/[#G[#%KJUE-H/P7TO4BEWH7Q'
M^)EE+<F6]\?7$,<&HZ?I]W"-2;5H=/UW65M!9:5I47ZE?MF?\$ROV"/VS_$.
MD_%W]K#X1:=XC\0?#[PQ>6-UX^MO%&O>"=0O?AYI[RZU?^&_'%_X>U#3XO$7
M@N +=7CZ/JP:VBEN;N1IEBE<#.\VGJM[I7>R36N]K[VOYNSVIRIJ2O#6Z5^1
M6O=;;)V[KY-K4_&#6_\ @H-^U'^TK_P2?_X)O? WP7XEO=/_ ."A/_!4K34^
M%4/CC3%;3==\$_"?P7K.I:-\<?VEKQ=.\B72Y/\ A7^CQ:C_ &K:+:NFL>)[
M;5M(3;:E!_3I\-O 6G?##X>>!/AKI&JZ[KVG_#_PGX=\(6FM^)]3N]:\2:]#
MX>TBUTS^W?$&KW<DUUJ6M:I]E_M'5;Z65Q>WD\]PP3.*_C%UCX_?$7PW\,/C
M;_P5W_9_\+>%? $OQ<^)OPL_X)=?\$F=/USP^O\ P@GP$_9;TWQJ/!?B'XU:
M;X7F5(H7^(&M:?J\^BRSQB]M%L?L%_+J%FRB3]G?V"?CE^V5\+O^"BO[1/\
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M$8?#7@S2I(8XK;2/#^GJ(GN;>-7?4+BSL[JX83PY?]%]I]#^1]_;_.?KA""
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MIQU7^\YKOW=++7K9Z=VMEZ&/_8VI_P#0U:M_X"V?^-._L?5?^AIU#_OQ:?\
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M:,'.WO@G'T"MCZD,N%^\<X )!%'LX^7W(MSE:^B7>SM]YA?V%J/_ $-.L?\
M?FT_^)I1H.I'IXIU@X_Z96?]5K;IIWCD,Q^ISCZ$T>S7E_X"B+U/^?DC)_L;
M4_\ H:M6_P# 6S_QI3H^JX/_ !5.H=#T@M,_A\M:]%'LX^7W(OGEY?<_\S#_
M +"U'_H:=8_[\VG_ ,32C0=2/3Q3K!Q_TRL__B:VZ:=XY#,?J<X^A-'LUY?^
M HB]3_GY(R?[&U/_ *&K5O\ P%L_\:4Z/JN#_P 53J'0](+3/X?+6O@^E'7'
MN0/;)!(R>@! /)XXZTW26C:7K:WZ%\\GM;Y)_P";,/\ L+4?^AIUC_OS:?\
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MQ3K&!S_J;,].>FT9^G?I6W^GN.H^E-^<$88D'KD\X],GM[4>S7E_X"B+U/\
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MCM_VRM8_X)*?'W3_ /@GW=+%K/\ PO1?'WA:X\<6OP_EU/["GQ0O? *0>?\
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MO9;[]];P2<O^SW\:/^"Z'B/XU_#?1?VE_P!C3]C'P!\!]4\3VEM\4O&GP_\
MC-XGU_QKX:\+-',;S5O#NB7>J75OJFIQ2B$6UI<0R12[V4[!^\3QK_@H'^P3
M^T%\3?VV?#G[>G_!,;]J+X._#?\ ;V^%GPGB^%/Q,^$?Q*U/PWX@T#QS\,;K
MS;31(/%^AQR:KJ?A2WD+"P>X\2Z%%IFHQPV4^G7,.HVI:6N::I_:O=:2C9I=
M;+KZ[I(A1A?10MY:K\W_ %8U?@W_ ,%C?C?X2_:0^#G[+/\ P4M_8.\:?L.>
M+_VB;^?0O@C\3]/\6V7Q ^#?B_Q;$\/D>%[K68V>XTBXO3<16PGN;N22VOF0
M2V(M;F"X;][65D9D<%61BK*1@JRD@@CL0001ZU_*+XE_X*'_ +1WPT^,O[-W
MP=_X+S?\$V?A;;^!=1^+.AVWP'_:W^&8F\=?#OPO\<+Z:WT[1O$T>F_VI<:?
MH\YG33[=KS3)M(FM+-S??8;NVL9V7^KZZ8^;,SS)++O9GE1Q*DQ9S^^25<I)
M'(V765,HZD,#@@U<);IMO72Z::OJDU^3UZJ[L34BE9Z*^^N[\OUZD)('7N<?
MC1408G.3T&1QW[=/Z\4@<YP3T(SQV/X?RK0R)J*?F+U'YFD+18.",X..34\W
M]V7W$<Z[2^X:2!U[G'XT5$&)SD]!D<=^W3^O%('.<$]",\=C^'\JHLFHI^8O
M4?F:0M%@X(S@XY-3S?W9?<1SKM+[AI('7N<?C1408G.3T&1QW[=/Z\4*Y+ $
M\ C=QV/X>GI5%DM%/S%ZC\S2,T>#@C.#CD]<<5/-_=E]Q/.NTON&D@=>YQ^-
M%1!B<Y/09''?MT_KQ0KDL 3P"-W'8_AZ>E442T4_,7J/S-(S1X.",X..3UQQ
M4\W]V7W$\Z[2^X:2!U[G'XT=:B#$YR>@R.._;I_7BA7.X9/0C/ Z9^GI5%$W
M(R!U.1U _#/0?7/'K7Y ?\% ?^"IGBW]CG]HOX!_LI_!?]D7X@_MA_&_X\^"
M?&OQ!TOP+\.?%6D^&]:T;PUX.>&W>ZG@U:UNH[W[9%%K$AN0]M!##HEP@+27
M,<1_7YF7)(<>N<[<?B>F/7MUK^<']L?_ ()J?\%.?CW_ ,%:(/VQOV=_CK\,
M/V6?A-H?[+FE_ 7P7\:M3L(?B+\0=,M&UT>*O%FF>%_AW<64:>']>U36=6U.
MTMO%+ZC+';:5%<0.)%U VT>=1RY%:^KBO-7:;:3[6-:2T=U:^NJ:V7WGZ'_L
M4?MH?M;?M)^/O%GA+]H7_@FO\:?V+/#&B>#9/$.E?$'XE>+_  WK^B>(]7AU
M.QM/^$8MK;2%BO8]2GM+R;5%N]CP?9;"Y65TQ$LOQ+??\%JOCQ\:/'7QJLO^
M">'_  3>^*O[:/P7_9Z\;ZSX!^(GQWL/'>@^ _#_ (F\4^&(\^(]-^%NEZ@A
MO_$,EG&))-/F#W?VVP\B[6"WBO;*&;+_ &#_ -KC]N+X)_\ !1KQ[_P2C_X*
M"_$KPI^T1K>J_ ^/]H/]G7]I/P]X=@\)ZOXP\'1WRZ-JV@>-- A15DO[B>+7
M1%+=AI[.Y\.WVR>>SU&P$'MO[9_[:'[(_P#P1S^#NG? 7]EOX)^%KW]I'XU:
MUKD_[._[&_P1TF9]6\8?$KQA)Y,_CSQ7HUA->7NA^%1>+#<ZKKEUY=YKK6QM
MM*C(CN+JR5VHMWT5[W23YEM&RNMVMKMZ66II;6UM[=[6Z]O/TU/M'_@GS^WI
M\(?^"C7[.NF_M"_"+3/$GA2.#Q+J_@'XB?#GQE;I#XP^&'Q)\,K:SZ]X-\01
MP1QP37]G%?6-_%?1QH+G3;ZQG,5O//);0]'^W1^VU\&O^"??[.'B[]I7XW/J
MUUX<T"\TO0/#OA;PU;BY\5_$'QMK]PMGX;\$^%[6241OJ6I73322W+!TTS2[
M2[UF[CE@LW2OD'_@BK^PS\3OV&/V0M6TGX^ZO:ZA^T;^TA\7_&/[3?Q[MM-\
MB+3/"_C_ .)%OI;R>$;":U)MY_[&TO3-/&L-;G[/%XCDU6"V+V)M=OYL_P#!
MR[XQ^)NA>-_^"1NC?"WP#H/Q+\4WO[;.F>(?!O@'QA<3+X)\5?%?0QI&E?#7
M0_%2QD;]*N]7\0W,EW'+N6XM%O06-M,XI.I)4U)KWG9/1NUVE>WSU5UKI<S2
M;J.-O<O*W:R5U9[:MM;_ )'TKX._X+;?&#P/\8/V>_!7[>?_  3H^*_[%/PE
M_:U\6:;X+^!/QF\6>-= \5:4/%?B#R3X9T/XC:;IL<-WX=OM8\^WE<$V%Q86
ME[;7]Q8/!9ZDEKZQ^V7_ ,%4_CG\(OVF?B1^R_\ L=?L<I^U=XO_ &;_ ((V
MW[0O[4&LZU\1HOA[IO@?P5J4LLFE>%?!D;0S3^(OB#>Z/;_VI!IL^-.N8I[>
M-'#Q7!KX"_:C^-W_  5/_P"";?C']F?XZ?\ !0GXJ_LL?MV_LG?%GX\>#? 7
MQ5\&:+\"-%\):G^SMXX\6Q-;Z-XS^'MSJMK>2R_\(U"VKBVUBR>WCNKB!-/N
M[91JD-U']F?MA_\ !.S]N"[_ &N/CA^U)_P3[^,?P/\ !D_[8OP#T+X ?M">
M&_CIH>K:G+H$>B12Z?H_Q4^'M]IC%)_$-CX>O5L?[ O (WG@=_F6Y547/)JR
M4[W7V%>S3OUY7\NE[]"W&*UM']-_O^_=V/H'XK_\%9OA%X1_X)B>$?\ @H_X
M"\+ZGXM@^,'A[PE8? CX,W]T(O$_CKXU^/M3/A;0/@\\FG*TES>:=XPBOK77
MK[2(FGCTO0=7U6T@$<0 _2_X;ZAXZU;X>^!M8^)_A_1_"7Q(U;PEX?U'QYX4
M\/WEQJFA>&?%U_I%E>Z_X>TO4KS_ $B]L=$U&>YTVVO2W^E?9S,5.]L?QS>'
M=9_9]_9I^(/PZTKXB^)_$/Q!_P""?'_!OSX6\/\ @'3[S0-$.JW7[4'_  4]
M^+VH3R2V7A+P_'*;;5+OX::IXBU,Z?:3NUWX+\0:E-;:COLW>9OZ*_V'O^"F
M/PX_;5\:_%;X/7?P?^,_[,W[0_P<TK0/%'C?X$_'S0[;1?&O_"#>, '\,^.M
M#GTR6;3-6T.\F*6NHF +_9=S?6EG,S2SLL.D9?9;UZ+TWZ=[V]"90NKZZ7UZ
M=_Z]3](B0.O<X_&BH@Q.<GH,CCOVZ?UXH5R6 )X!&[CL?P]/2K,26BGYB]1^
M9I&:/!P1G!QR>N.*GF_NR^XGG7:7W#20.O<X_&BH@Q.<GH,CCOVZ?UXH5\L
MQX!&>/7\*HHEHI^8O4?F::S1[3M(SCCD]:GF\I?<3S)]']PA('7N<?C1408G
M.3T&1QW[=/Z\4*^6 8\ C/'K^%442U/:QK+<V\;EE22>%'97$;*KR*K%7) 4
M@$X.1S@=ZCS%ZC\S4]M(8[FV>W19IEN(6CB)XE=9%81DG(&\C:"00&(-)32:
M<HRY5J].B3;)4TG%\LI6E%\JLF[2B[)RLDWLKZ7WT/RY_P"";O[8GBG]K'7/
MVP-.\2?#SX>^ E^!?Q[O/AMHTG@"PDT]O$^FPWOBJW&M>*%:*+[3K132+<M<
M NK-<767Y4U^H QUZ= N>G?!..Y.?IR?2ORM_P"":?PI_9M^%VN_MDW'[/G[
M14'Q[OO&_P"T!>>)/BI91:7_ &<WPM\:/>^*Y)/!<[&QLOMSI<7FHP?:LW 4
MZ6P$N),G]2PYW8R#CKP<+G.<CT[$^G-?/\+1Q7]BX=9A.C/$N>*E4G&I"K&F
MOK^+GA*:GA93I.+P_LTU3D^6K>%9)J2/U'QECDE+Q"SB/#^68W*<J]EDDL+@
M\QPF.P6)P-2KD&4RJ5:N%S&4L;"&.Q*S"=%2C*%6%:E7C.%&IA^9]%/S%ZC\
MS36:/:=I&<<<GK7O\WE+[C\NYD^C^X0D#KW./QHJ(,3G)Z#(X[]NG]>*%?+
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MV#_^"@/Q1_:&^-/Q_P#V2?VKOV=+/]E7]K7]G'P]X&\<^+_!6D>/K+QY\/\
MQ-\./B1;->Z!XH\+>+'%O=>9:1Q^3KEGJ"*EFTBR).H$BQ?F#^S;^RC\$?\
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M*Z)9QV.BZ#X=T6SALM,TFPLXL1K:VL4(#B0,\I+3NS232LQRWG=K1+3?6_\
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M4M,X&"",DC=R.G?OCKZ?A3LCU'YB@!:0 Y8^N,?@*,CU'YB@D8.",XXY'6@
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M^%_[3E[X/^'T6L-"4\,^&(]0\9Q+H]@(HXPEK&-/L?\ 6%F=K6(,PQ7['EN
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MTJ\MKZ*2.YBG\X_9Z_8>_;H_:-_X*!?#?_@HS_P4LLO@I\,+S]F[P9JOA?\
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MC'.>1^'4_P J=D>H_,4 +2*",Y[L3^%&1ZC\Q2$\'!&>W(_K0 H(/0TX=?\
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MVKK7_0NR_P#@:E;_ !_L_P#C]'&<?+GT^?-'*_ZDO\Q\Z[2^Y_Y&!_:NM?\
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M^!J4?VKK7_0NR_\ @:E;_'^S_P"/T<?[/_C]'*_ZDO\ ,7M(^?W&!_:NM?\
M0NR_^!J4?VKK7_0NR_\ @:E;_'^S_P"/TF5Y^[QU^_1RO^I+_,/:1\_N,'^U
M=:_Z%V7_ ,#4H_M76O\ H79?_ U*WLKQRGS#*\M@C:&R#T( (R>@)"D@G%&Y
M< @H0<X(WD'!P<$9'!X/H>.M'*_ZDO\ ,/:1\_N,'^U=:_Z%V7_P-2C^U=:_
MZ%V7_P #4K?X_P!G_P ?H&"2!MR.OW_3/\J.1_U)?YA[2/G]Q@?VKK7_ $+L
MO_@:E']JZU_T+LO_ (&I6_Q_L_\ C]''^S_X_1RO^I+_ ##VD?/[C _M76O^
MA=E_\#4H_M76O^A=E_\  U*W^/\ 9_\ 'Z,KDCY>.OW^]'*_ZDO\P]I'S^XP
M/[5UK_H79?\ P-2C^U=:_P"A=E_\#4K?X_V?_'Z./]G_ ,?HY7_4E_F'M(^?
MW&!_:NM?]"[+_P"!J4?VKK7_ $+LO_@:E;_'^S_X_1E<D?+QU^_WHY7_ %)?
MYA[2/G]Q@?VKK7_0NR_^!J4?VKK7_0NR_P#@:E;_ !_L_P#C]''^S_X_1RO^
MI+_,/:1\_N,#^U=:_P"A=E_\#4H_M76O^A=E_P# U*W^/]G_ ,?HRN2/EXZ_
M?[T<K_J2_P P]I'S^XP/[5UK_H79?_ U*/[5UK_H79?_  -2M\E0"3MP.3]^
MDRO3Y2<$@ .2<<G ')X.> ?>CE?]27^8_:+L_N,'^U=:_P"A=E_\#4H_M76O
M^A=E_P# U*W^/]G@@$C>0">@+#(!.>A-'')R@ )4Y+#E1DCGT'-'*_ZDO\Q>
MTCY_<8']JZU_T+LO_@:E']JZU_T+LO\ X&I6]E<X^7OSA]I(." _W2W((4$L
M1R 1S2DJ.25 ]3NHY7_4E_F'M(^?W&!_:NM?]"[+_P"!J4?VKK7_ $+LO_@:
ME;_&<?*3[!V[XXQG/)QQ0<#D[0,$Y.\# + D'H0"C D<9!%'*_ZDO\Q^TCV?
MW&!_:NM?]"[+_P"!J4?VKK7_ $+LO_@:E;_!QC!SQP'(!]"1D*W^R<'VYI,K
MQ]W+$A1A\DA2YP.N H+%L;0.2>11RO\ J2_S%[2/G]Q@_P!JZU_T+LO_ (&I
M1_:NM?\ 0NR_^!J5O\?[/_C]&5R1\O'7[_>CE?\ 4E_F'M(^?W&!_:NM?]"[
M+_X&I1_:NM?]"[+_ .!J5O\ '^S_ ./T<?[/_C]'*_ZDO\P]I'S^XP/[5UK_
M *%V7_P-2C^U=:_Z%V7_ ,#4K?X_V?\ Q^C*Y(^7CK]_O1RO^I+_ ##VD?/[
MC _M76O^A=E_\#4H_M76O^A=E_\  U*W^/\ 9_\ 'Z./]G_Q^CE?]27^8>TC
MY_<8']JZU_T+LO\ X&I1_:NM?]"[+_X&I6_Q_L_^/T97)'R\=?O]Z.5_U)?Y
MA[2/G]Q@?VKK7_0NR_\ @:E6;/5=?-U;"#P\5G\^+R6EO4\M9?,41E_]D.5)
MZ_0]*UN/]G_Q^I[62.&ZMII&V)%<0RNR LRI'(KL0K$*> <@GD9 R<"E*+Y9
M7O;E=[.[M9WLD[M]DM6[%1DI2C%:.4HQ3EHDW**5VVK+N[KU/RK_ ."=7C;]
ME77M:_:[7]DOX5^-/"6H:7\=+FR^.\GBS5)94USXE_;O$XFO]#2ZN[L)I;7$
M>N2 V[6\)6:V!@)"A/TP_M;6B,'P])QSQ>Q@$].HX_G[GCC\Q/\ @F/^R!\:
M_P!E+7_VS]3^,FEZ%IEK\<?VA+WXB_#S^QM:;66OO"]Q>^++H75ZILK,Z?/M
MUC3@UF6N "\@,BF,[OU8!SGIVXP?J#Q@\ ]>>#W/%>!PQ3QCR3"_6\-3P=9/
M$/V,%R04'C<4J4M$ES5:7+4DO^?DW?5GZ;XRULFEXBYK5R#.L3Q)ESP>2QH9
MEB\;B,PK5N3)<HAB74Q->5.I*6&QGUK!4[T[4Z6#ITH*4(1D\#^U=:_Z%V7_
M ,#4H_M76O\ H79?_ U*W^/]G_Q^CC_9_P#'Z^@Y7_4E_F?F'M(^?W&!_:NM
M?]"[+_X&I1_:NM?]"[+_ .!J5O\ '^S_ ./T97)'R\=?O]Z.5_U)?YA[2/G]
MQ@?VKK7_ $+LO_@:E']JZU_T+LO_ (&I6_Q_L_\ C]''^S_X_1RO^I+_ ##V
MD?/[C _M76O^A=E_\#4H_M76O^A=E_\  U*W^/\ 9_\ 'Z 5.<;>#C^/K1RO
M^I+_ #'[2/9_<8']JZU_T+LO_@:E']JZU_T+LO\ X&I6^=HZE!@XY+=<X_GQ
M]:7'.WY=P)4KEL@KU#9/R_\  L9[4<K_ *DO\Q>UBM[KIKH<_P#VKK7_ $+L
MO_@:E']JZU_T+LO_ (&I6^,$@  EAE1A^1ST_(^]&5]4],9;/Y=:.5_U)?YC
M]HFKI2:[I.WWF!_:NM?]"[+_ .!J4?VKK7_0NR_^!J5O\#^[_P"/T$J,G*<#
M<>6)"\_,0.0.#R>/>CE?]27^8>TCV?W&!_:NM?\ 0NR_^!J4?VKK7_0NR_\
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M?%7]H+]HCXG_  W^$W[&OPV^'EA;^$_"W@OQEXQTK5]7\::=\8]>AM_#R_\
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M?*_78R<965DUJD[*]F^^B^;5UNMS])V"CC< <XPQ"D\9[XXQ@YZ8(YP0:C)
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MCQ/X8LVU/6X9]3U=H;>32M/M\[[ZWD,=Q.!!$)+AA#7Y-_&'5[;Q/_P<5?\
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MZC\Q4%)D]@<]NG7\Z!V?9_<6-P/?OCOUI.A8GIQ^@YJ#)SCM_7M_7FE_S^5
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MZKI^9_4!\?OVKOV>_P!F7X!ZM^T_\8_B7H/AWX(:?IV@ZM!XVM)6UZQ\1?\
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M<ZEINO>)ET7P[!IVBBW;4[F_75W2T2V;3S<_4_["/PZ^(OAO_@W0\(?#+7O
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MWM?S[WWU_,_ _P#X.(OV*?B;^UW^S+\)/&/P?^&-K\=_%/[+7Q^TKXT:_P#
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M\.Z()?W9U/6'LK%7BD/G#RVQG_\ !1KX=?$/Q/\ \%H/^"*7CCPQX"\:>)?
M_@;Q'\9F\<^-= \)^(=;\'^#!?0W0LKGQ?XGT_3KG1?"ZWJN4M'UJ_L!<.1Y
M!<D9_?-)9H5=(I)4CD#)*$=E>9&Y99"C(2&SD$L1N4;E.,TL<T\<<D*22I#*
M%\V/<Q28*1M\Q P61E&0-XW'.2^:OV;NWKJXO5:>ZK?H)5E9:Q>]G=)N^O\
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M-^1GIGGITIQX!^AIV?9_<+VB?VT_^WE_F+TQU/;_ .N:*AWMZ_H/\*-S'O\
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M/_B*/LUI_P \8O\ OTG_ ,16P7AY?=_P"O\ VSI?_/\ 0?\ ?1_PH_MG2_\
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M^^<]*7[-8_\ /M#_ -^T_P#B*";P_E?]?]O%;^V=+_Y_H/\ OH_X4?VSI?\
MS_0?]]'_  JQ]FM/^>,7_?I/_B*/LUI_SQB_[])_\105>'E]W_ *_P#;.E_\
M_P!!_P!]'_"C^V=*_P"?V#_OH_X58^SV>W'V6'.<_P"KCQG_ +YSTI?LUC_S
M[0_]^T_^(H)O#^5_U_V\5O[9TO\ Y_H/^^C_ (4?VSI?_/\ 0?\ ?1_PJQ]F
MM/\ GC%_WZ3_ .(H^S6G_/&+_OTG_P 105>'E]W_  "O_;.E_P#/]!_WT?\
M"C^V=*_Y_8/^^C_A5C[/9[<?98<YS_JX\9_[YSTI?LUC_P ^T/\ W[3_ .(H
M)O#^5_U_V\5O[9TO_G^@_P"^C_A1_;.E?\_L'_?1_P *L?9K3_GC%_WZ3_XB
MC[-:?\\8C[>4G/M]SO05>'E]W_ *_P#;.E_\_P!!_P!]'_"C^V=+_P"?Z#_O
MH_X58^SV9 'V6'CK^[CP,]<?+FE^S6/_ #[0C_MFG_Q%!-X?RO\ KYE;^V=+
M_P"?Z#_OH_X4?VSI7_/[!_WT?\*L?9K3_GC%_P!^D_\ B*/LUI_SQB/MY2<^
MWW.]!5X>7W?\ K_VSI?_ #_0?]]'_"C^V=+_ .?Z#_OH_P"%6/L]F0!]EAXZ
M_NX\#/7'RYI?LUC_ ,^T(_[9I_\ $4$WA_*_Z^96_MG2_P#G^@_[Z/\ A1_;
M.E?\_L'_ 'T?\*L?9K3_ )XQ?]^D_P#B*/LUI_SQB/MY2<^WW.]!5X>7W?\
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M]GLR /LL/'7]W'@9ZX^7-+]FL>UM"#V/EIQ_XY03>'\K_KYE;^V=+_Y_H/\
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M[==PY9=GTZ/K_7^1^TR@N,J"P"[B0.%'/WCT4@C!#8(. 1DC(002IP"#@Y(
M';.<XVYXW9VYXSGBOXWO^"M?_!=O]GO]H/\ X)\_$OP7^SZO[6_P+^)'CKQ%
M\/\ 4_@;\2/'_P *?%?PH\._%_1-#\6Q/XEO?A1\1-,U34K;4[=],.^Z2];1
MUELV59(C,3$?Z"?C_P#\%$OV;OV#_P!GW]G?Q1^T-XG\3W_BGXH_#OX::?\
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M8J]3%?8^?Y'YIA_BE_AC^;-FBBBN,ZCP'XH_\C#;?]@F#_THO*\WWMZ_H/\
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MWUI ESI6LCPAHOBEM$1@?$UG<W>CN]K=^=JIMY+"(1-<-: _G]\$_@O^TUX
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MN_#.E7P%V--N=6LM0DFM3/\ 88X+0RR#^1_7++5+O_@A/^VA=-;S7W@'0O\
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M10 [>WK^@_PHW,>_Z#_"FT4 '2G;V]?T'^%-HH =O;U_0?X4;F/?]!_A3:*
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M?%LS>'42'6]T_P#9.F7\3R>&;N([-.6&-]*G@6$ <1\8?V0/V9_'/[7WP/\
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M .GCV_4>M'_"OO%__0(_\G;'W_Z>/;]1ZT_:4_\ GY#_ ,#C_F'++^67W/\
MR.3WKZ_H:<LIV&/<1$'WE [J"22 RHN=TBC.YI)"C+(8]@49KJO^%?>+_P#H
M$?\ D[8^_P#T\>WZCUH_X5]XO_Z!'_D[8^__ $\>WZCUH]I3_P"?E/\ \#C_
M )ARR_EE]S_R.3WKZ_H?\*-Z^OZ'_"NL_P"%?>+_ /H$?^3MC[_]/'M^H]:/
M^%?>+_\ H$?^3MC[_P#3Q[?J/6CVE/\ Y^0_\#C_ )ARR_EE]S_R.3WKZ_H?
M\*-Z^OZ'_"NL_P"%?>+_ /H$?^3MC[_]/'M^H]:/^%?>+_\ H$?^3MC[_P#3
MQ[?J/6CVE/\ Y^0_\#C_ )ARR_EE]S_R.3WKZ_H?\*-Z^OZ'_"NL_P"%?>+_
M /H$?^3MC[_]/'M^H]:/^%?>+_\ H$?^3MC[_P#3Q[?J/6CVE/\ Y^0_\#C_
M )ARR_EE]S_R.3WKZ_H?\*-Z^OZ'_"NL_P"%?>+_ /H$?^3MC[_]/'M^H]:/
M^%?>+_\ H$?^3MC[_P#3Q[?J/6CVE/\ Y^0_\#C_ )ARR_EE]S_R.3WKZ_H?
M\*-Z^OZ'_"NL_P"%?>+_ /H$?^3MC[_]/'M^H]:/^%?>+_\ H$?^3MC[_P#3
MQ[?J/6CVE/\ Y^0_\#C_ )ARR_EE]S_R.3WKZ_H?\*-Z^OZ'_"NL_P"%?>+_
M /H$?^3MC[_]/'M^H]:/^%?>+_\ H$?^3MC[?]/'O^A]*/:4_P#GY#_P./\
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M_P#3S[#\_:C_ (5_XN_Z!!_\#+'W_P"GGV'Y^U'M*?\ S\A_X$@Y9?RR_P#
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MO_%W_0(/_@98^_\ T\^P_/VH_P"%?^+^VD'K_P _EB.YY_X^/H?Q]J/:4_\
MGY#_ ,"0<LOY9?\ @+_R.3WKZ_H?\*-Z^OZ'_"NL_P"%?>+_ /H$?^3MC[?]
M/'O^A]*/^%?>+_\ H$?^3MC[?]/'O^A]*?M*?_/R'_@<?\PY9?RR^Y_Y')[U
M]?T/^%&]?7]#_A76?\*^\7_] C_R=L?;_IX]_P!#Z4?\*^\7_P#0(_\ )VQ]
MO^GCW_0^E'M*?_/R'_@<?\PY9?RR^Y_Y')[U]?T/^%&]?7]#_A76?\*^\7_]
M C_R=L?;_IX]_P!#Z4?\*^\7_P#0(_\ )VQ]O^GCW_0^E'M*?_/R'_@<?\PY
M9?RR^Y_Y')[U]?T/^%7=.=?[0L<GC[9;<8)S^_3C' .>^2*W_P#A7WB__H$?
M^3MC[?\ 3Q[_ *'TJ:W^'WBKSX!<:45@:6-9F6]L=RQ%E$A'[Y^=A('RMST&
M<&DZE-)OVE/9[N,EL]XW]Y=X_:6G4.66CY9.S3M9K:47O;3;?IOT/Y_/^"*F
MEZSI7B;_ (*0?VMIFHZ;'??M;ZA=V+:C:W-I]LB;5?'^;BR:X@B^UVK1MM1H
MLJ 1M<@DU^Z?F*>C;N2G +#</O*2 0&'3!(.1@\_*?P0_93_ ."P%WXN_:4\
M??LS_'GP'J)\7Z_^T3JWPB^"M]\,O!=G9:#;Z7I?B+Q%X?EG^(E]K/B19/[0
MEGTS3Q]OTVSNXUA,\@02O&A^@OVA?^"RG[,W[-OQM^)'P&\=> /CUJ7C#X7>
M(!X9\07WA3PIX<O_  ]<7ITS3M4W:5J%WXSLKB\M!:ZE @GGL;:87'G@KD)G
MX+AOB'A_*N''#^UJ;HX?$XJGB*F*H8BA5HUJF/Q525*M&,)*$G*_LH3?O44F
MGRZK^HO&'PM\5>,/%+&RH\"4Z.9YMD.0Y]A,MRC'X/%4,?E%#),CP%/'8+$0
MQ.%IO#JM[!UYUHTY4ZU6M25&4E[5_K?D!N#P"P(!&=R@;P.<G;QN(Z#.:0O'
MP"<<AAC.TAB,$'H1VRN1GH<5^;7B_P#X*@? 7P/^RG\,?VP-7\#?&6;X7_%C
MQ5J7@[PUI6F>&O#\GC.RU72[>Z>5]9TF7Q6MG;6$KVLI@G359YY-H\RW^9:@
M_8\_X*C_  (_;9^+$OP:^$O@CXRZ1XL@\+:SXQ^U>.?#7A[1M#&F:'%$UW"F
MH67BW5;AKV1IE%K ]M%;Y8JTB<FOI%Q/P^\5A,(\SH.IC:,:U*G]7K.=2$X\
MRE3CRWG%I.5X_9U6VOY-/P:\2J.4YQGE7@_%K).'\1C,%Q!F#EAUA<LQV!G3
MI8S#8J+S+FE5P]6O1IU9J,HTYUJ5V^9'Z6=.22N!G)7L,G)'L!EB>G\1P02*
MRD=>/E.2#C&?O [<8). QRIZ9K\0?$G_  7N_9 \*Z]XE\/:A\,?VDC<^%M:
MUS0M1>Q\$>$YK=K[0=0O--U![4S>-T,D%S=6<A@DD6!I+=DROS$5]-?M1?\
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MM?$7AKP[I^N7MC.A=+3PQ:P>*[^'4+S:K&5+J\T\L$.V3.U6\ ^'_P#P7/\
MV3/B5X[\%?#S0OAQ^T7#KGCCQ)HOA?1;C5?!?A6"PM=0UV]BL;5]1N(O&\DT
M-C%--')/*(FDCC!V1NXVD?%W#?+02S?#1EB)0A3<J-5<[E-4E[.\$I/G:C9:
MJ6G4QAX$^+%27$"7!>84\5PU.4<[C4]A.GED(X)YA)8FG_:$O92_L_\ VR,)
M*;E0<)VM*Q^T8=6) (8 9)7[@P2,DX*$9X+ [0<Y. 31O4=SD9)RK''&?F.#
M@ <CU'/'6OR[_:Q_X*Q_L]?L<_&_Q#\ _BGX&^->J^-/#.FZ%K&H7W@KPUX<
MUGPY-;^(K62]L!:W>H>*].GE9(HV:Y$MA!Y4CA4=@,UN#_@J'\!W_8YF_;?_
M .$%^,J_":'XH6_PE&BGPWH3>.F\1SWD]C'<KH;^*VL6T>&XMW,E_+JHG%LR
MXMB <:_ZTY!*KB<+'-<.J^"A5J8A>PK<T(X=7KN:Y4XJGHJC?P72GJT8S\&/
M%".5Y/G<^%L=#*.(L3EF$R/'5%@987,,1GK;R:E1A'%*498Q8>LJ;;CS/E=U
MRGZ4Y)&02  #DG .0#D$D9!'(QD'G'?"%@HW,0%^;YF; )C(W*&. 64C[H._
MD=<C/Y9?LM?\%:_V<_VN?C5X8^!'PR\!_'+2_&GBZWU2YTZ^\9>%_#>DZ!''
MH]J;VZEO]2L?&&H7*JT6[[+%%8RJW"<$EE\B\;_\%UOV2? 'C/Q?X'UGX;_M
M'7.M^"_$6M>&M9ELO!?A:XL9K_0;R?3[V:QNF\:K)+;/<0R"&7R(&>!T$VQC
MM&$^,N&H485O[7PJC-J*DZ-51D[1=E+E2D[23LM;-,[J'T?_ !=J9KC<FI\!
MYG5S? X.GF.-P,Y8>,Z&!K8BKA*6+<)YBU2P];%4:N'IUI<T'6A*%KQU_:LN
M,GG) PW!PH/(S\OR\9/S \<\@&@,IV\X#'"D\J6)(Z8 'KS@#KC'7\[/C_\
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ME1J5\OJ<W]I7@JE&G4J0DW-5(4IR2:3/W,R.^3C )(&022!@^Y'R\D$D ')
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/[/EY6XVC>Q)1115%'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ea028514801_img11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %M E@# 2(  A$! Q$!_\0
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M>:>;D$@1KOXRV.B]0/3DG@9QP<G I1=18!8[6QRN.0>A'YTWIT?I9W^ZU_P
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M3P2%.,'IDDJH]%7/53A_)Z^3_P @'K"0^28]N "%0AL[AMYW$ !P2>.>"3@
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M8\$CKD< 8R>F<2_:H>[#WQSS[="1[XQZXR*F_2TGZ1;_ "3U\@%*$JFT8 W
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MMC9)@C)SD#)_A)&<X/..H!^]D BIA<Q< MR3@<$=<8Z]P",_H,$4[/L_N?\
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M;O?J7"B2<XW#8W&>H<G*L#Q@@* "..>N ::8HE);8HQM52#@>7@ A>H'!88
M';IG-5A=./X23W)')^I_ =N,4OVQOE_=MQR>,?A^7ZC/4 U%ZS=G2BUT]]7_
M !5MKKU>NQ;O:RW>E_U_K4E$<:[AA"7 &Y_3;M!.=Q; . 2,LNT9.*BV_P"D
M0,I<KY\0P"I*@R#@\YV*>AP>,BFFX."-@XR <<C((R">@ Z=,=\@TR&13/ ,
MMN::/*D< !U*D'T)ZC/7! %*HVN6].W-\5I>[RI6DY2BO=2C4=E)>\URMK<%
M&4FTVI1=[Q?/'2-I)J4&I73BGNHNW+)--I_R#_\ !#OQ_P"&=,_X+:_\%O\
MX8WFNI;^,/''B?3O&/AC00EPK:IHOPY^)'BS2O&6J+<+$;>*;0[KXC>$86CE
M=9[E=7,D EBMIVC_ *I?C7\+]-^-_P '_B;\']9OY],TOXD^"]>\'W6I10PW
M5S8QZWILMH;R&WN1Y$TT9E28*^(RP".1@X_AO_8<U3XJ?L]?\'#'B/XXZ5HW
MA:_^&7[;_P"UM^W)^Q-/=:O=R+K&GQ_#?Q9X8^(/C/4]/MH&0VFJ6^N^&?!M
MGHL]V)K?4;*YU"S\D-+$T?\ >\YV#:H=B&$1.>-BDQDY&3EPC%@>A'I@5^O>
M-6$H9AF'!'$3G0Q>!X[\)^ <94A3QL,9['&Y1D];@WB# 5DJ%"6&>"S+*HX6
M6%J.K**J\ZJ.$DCER3&8S+\33Q&!KRPV8Y5GBQ&"KQ2@\/B<-B:>;83%TVKW
MJ1GAZ:BDG3;@G*+YG?\ F[_X).?M+>+_ -EGXL^+_P#@EA^UAK+:1XR^'VI%
M_P!G_P 1>-_&L6I^)O''@_5+B1/"WAOP_P"']-L;BQTNU&D6DFI6ULVL/*HD
MDC>%2FY?Z1T"D;6.< A_-&X'86W!E4 (P' (/.,+G!%?@%_P70^ ?AB#X9_#
M']L#PEJE[\._C3\'?B[\/M*L/%O@NPTS2/$'B>Q\6>(=/T5[7Q%XH@MUUF>V
MTNT:5;&)IY5C$CH J-@?NQX6O);KPQX<NKAY9[RY\.Z),\\S[IKB>32;626>
M5C]Z2:0LTDASN=L]217\]<+T\9E]3,.',34J5\/E#PTLMK3<?;?V;C56JX6E
M52<IRG@94IX955)*I1C2ERQE&Q^]>,V(R;C/ \(^+N3X9Y5FG'^(SO!<9Y'"
MFJ6783Q X9CE;SK/<EG&,/8Y7Q%A<PHYU7P<XJ6'S:OF6&O[*=.9V,!VEAC;
MM)!^9 #AON[0 "XC."<<,% /.#(&4<87C:>2IS_#P0,D +A2<G@@L<C%))O+
MSA68G//! RRD@]\C  ],EABG"[X*CR\Q(LDH\V,-%$P+*\Z%\PQ. S*\@1"%
M8ACAB/J?::W<&M9)MRBK-6OM%K[2=KZ*776WX9K)7IRY8RUBI)MI.<TWJV]7
M3G*S;:4X=%KH+AAG ]>0!P>1]>.,]\9I"R DY QD'L,^A..V/3\:H)=@NL:2
M0/+*@FCC6YMWFFB<$I+%$)#))$ZC*21JR.HWJQ7HHN"S86/+%E1L##9R,KCZ
MGKZCU.1<I))M6EY76J=KZV:VNS2S>VCZ-]'W+A=.VT]2>F,C)XST))*GW.[N
MP#E,;#C'88Q@@GG'3@_RK/2\1O,*21R^3-]GN5BFBE^RSJN]HKD0NS6\R1$,
MT<P1QN4E>!N<MRK.80R-.D0E>W6:'[4L1("2/;!S.$."0[(%('4BHE5T]V#7
M9MIKNG9)-^G3[R4FG=R;_K[B\<!02HZ@$XXX(R1GGY?4],\_-TC61!D<84GY
M<C( W8.&YR0/7)X  VD5B2>)-'@U33-$NM6TNVUS68;R?1]#N-0M8=7UBVTX
M+_:,^G:=+(MU>P6(EB-Y/!$\5N&'FLN1F\+N%H1,DMJUJ2R"X2[MC;,ZLR.J
MW'F^3YBO\I3S-X<$%>#DC4?VHJ[[2T7_ ($KN_R:N$DW9)\KO?9-6Z[_ .:+
MZNK$C"GL2HR.0S 9P<$@=."-RXP>:<P  P 3N!/ '4D]L8!/'3&#T/2J*W2$
MPA)(&>Y61[<+<P/]K,67F-JJR$W(B4AI3")#&0"Y48%(MZKM*JF.5X6\F9(I
M(Y7MYVC$BP3I&S-#/Y;+((90KA'1MN&JU--=NEFU^/DM==@BFE9RYGZ):=%9
M%UF(QD  C&<>XP<9Z 'D9/\ &OHU)O .  1R0 %RP !P,#CHPSR,=N!FL;I0
M98V>#?;A6GB>YMUDMQ)PCS1^8&@1Q]PRA%8$8)R,LDNTBCDEEDCBAB$;33W$
ML4%O%O954//*R1 R2,J*'<;_ )2N=P CVNZ]GJN;[:2D[V5_=NKJSNGU\M)<
M97TG97VM?K?1-V^_;IJ7@RL1\HR5&1@<%@I /H/;OR0#M-#,%&.,D@G!VC&0
MI/&>>P!SD@9QVJ&619&3R\,@8N#A0B;4=GD9CL5 &!W%MJ@MR &-,%VCQ).A
MCFB<'RIX9(YX9.<$Q2Q,Z.1RK8;(;/>E&<U\48)=E/F:2VL^OGITU+>VC=[;
MVU3_ *_#S+H=3G)4G!Y&"<#GI@' S^9XR*53NSA5QR1C&1U 'ODC[V,?>&.!
MFB;P*T:LT2RSEHK>.26&*2Z=$WO%;I*ZR7$B)\S)$'91G<.13C>"-2\C0VZ9
M +SR1P)DY&W?,R+NP,A<[L#/K1[5O:"73F<DU\HQ47Z7T[IDI23UDGHU9*WI
MWV+3.JY; (4D$ ?[:K^!&0P#<[3C.X,* RD\L&(]<9X9MV0/[H/  R!SG!-8
M*>(M#DU>;P\FKZ-+XA32(-?FT*+5+*764\/WEY-96NN'38YFNQHUQ?PSVL6H
MB(V;W<4L E,B[1IBZPN$B;C(Q@$<$CCTZ 'GGG/'%4IM[1<K=G;I?=IK_@?>
M-IO52:\NC_7[GMN6F(^\@)5 ,[0 AVDDA2><] 1CD9'4"I2% P N,$8(!&!D
MXQQP!G@8).!T)K/^TD[LHWS=?UQ_/_)YI3='H$;&1VYP""1]#CG&"?7/-#E4
MNN6G%+K>5WONVM/DE^@TFKW=_DBUY@W,NX8WE,$XX!(;'56.21C& J]S1N#<
M#&3D8099,G@X/!&.YP5XQG))J?: ,E8F4D<GDX ZGM@X/H#E<D\8I?M&'$A1
MUW'D9&"!TW$\GKCTY!X IWDM73L]+OGBE9;WTNK7;[MVNR>5V:YVKNZT3:\E
M>ZMIUTWOH70N-H. -I'0 9R!DG<PW#C(]RQ.,X8KY90 JE\G&,!<%@.3]XEA
MD9Q@!N>>:.5 9@'#-E A&<[CC@==O(.W .2!GY<TOF#+J#$HPK8,L7F*P&,$
M%_DV[@%48*C&0<FB4N5M.-2;;YER1YK0LO>;V:;:]UV;>SMJDW=I*4;-64G)
M7E/=)*Z=[7<FFWOHDB\2  ?E&$!SP0"!CH2"01D#+8)P <YPH92JL0O/3.WJ
M!U&,]3CC.1D<=<42^1SY9YVG]Y#@G!) PX) RI'<8[$D4&0D_,4&"2")(5ZX
MR,&0<@Y&<Y[G).:/:1:UA55M7>%UZ:7NUVM;LPBI=91Z_:VVLM9-W[MNUK.R
MZWO,48.%R2 H!4$DY!'..@Y)X&UN3PV%+9!&02"./4[BP4KGD@!<_4,!D$52
M+D\%UVYX+2PY).\;FRQX ;!R.0%&,9I-W/.P'JOSP9R"2Q4;OX_EP,<!1C!R
M:.>UE[.K)N]G&&BV5G=I.U]=K>?1M/=2BFKI+FT^>O:]TMMM5<N Y(7;SU!^
M7  7'?)SGC..6ZY4'+R5&-VW!Z>I(ZC@ >OX\XQP*!8D?>4 J1E9H589! QA
M^I.#@@]2.AH9^#DC)QSYL.W &< %CM&XKR!NR<\8%-RMROV=75)6Y%I>^FC<
M5:VJMIZ.XTFDKS@V][-M*][:W5K;-/6VM]DKH<'+$KP2K'G& Q7Y1@*!@!C@
M#((ZD4AD3 /&=RC'RY^8D#@8SO&-HZ<J0!50OZF,[0!CS8%."<J2-^T[ & .
M!\S<Y6C?G^YG)Y$L&0" #M^?(^;<!V V@=,5+J66M*HK=>3_ (/:WI=>3)L[
MZS6_?2WW^OR\T7<$EAL&<XR"H.!TP!WYY! YX'3!0.,LN5YXP/4C Z#IQM).
M23@@8.!1SD#LW4GSXO8Y.'&3C &3C)]!2^8PP=R%N<$RP>N3@[LC( !Z] >I
M--R6ZA6=NG(TV]]%=II>=K:+6Q4D[)*4-[[N[73[3??MZ6- L,Y.#\V#G&<<
M_=S@D?*0V26!.<GDU$LB$ [1DXR#LSR 0-RDKSGIUR.,*.:BRD'(,>!G;^\@
M)55&%W9<$L,*<Y.2Q/0 4%FSPXQ@D@30@'J<@J_7)P,<L.3@DDM2;:7)5CZQ
MTUZ>[?[GI>VUM%%2N[RC:W=VW]?PW[[EUBO=1N)!51\I;U*J,$<9X(!8YSUP
M#+8  7:IX+$G@9V]><GH2>F-P)'2CNSG!4@8_P"6L.=H&1R6+,>F1D@#/K3O
M-P00R=^#+!G)P!D @DAMQ!QD8 Z9RG)Q=E"K)\O-\*6E[):O26_N]+VZ@T]U
M.-NR>J=K=7UMNO-;;WB5VY &!G) 4 = ,CT .[Z+@G)!*%E !*@9!./EQQG@
MDXP0,%AS[9Y%4O.<K@F-SE6_UD')!![2#=]V,J!TR5.>#2>802-T?W<+F2#:
M<@A3@/DD9'/8*.H-'.U_R[J_**^:^2UO:VCZV0>]IK#3>\GT[).]K][WM;HR
MR) S8!!0<9Y Z<X0CH!GL&.0,@$J'*P+!< [P0.G7#$XXP$.,;B=PRN23C%/
M>,[MRX  ;=+  1C& 0P) R?4]<=:-^2N2 ,YVB:,!2> J$OD= & _@W8^]1*
MHN9+V=3EY?C4=%*VB<;<SU<=59=-%J"O?64=+ZIMQU=UO).]MW\*TLM-;VY2
M0,*"0"0<$X(4;>O#?.,].",\-F@N Q"E<J?FXVD)E>!S@MSGG&/FY &31#\G
MYEVG;RTT1( '3(8')^7)R,Y<= *-[9!#+D#(R\!"X(X&7!.5R,9XR0 #0Y6U
M]G5[?"]_=OIV3=D[V71M.XY)VLG%6Z\WE?\ FMTZZ;KJF7>0,DJ.C8('RJ!D
MC/&=W&!P HZGJ5#+Z#( !8$%=PR2#V4C!R2"IR%.#C%(R<C$B'))SYEN#T&"
M26(S][&1G)]J4MN.04.  X\Z#!*  @@,!@!3D$';@XP2"!3O>].JK)N[IK7=
MV5GMI97?R;T$E)*[E%^[M>RO=-/5WU5UJ[;+L6RP_=LH!+?= *@<L.6)'&,8
MR.>21P,T[<O +98CG)^Z2./EX'?&#CIR0<FJ)<YW$K\I)P)82N<MP 6P  0,
M @%0#D9Y0RG#8\O!))_>0\@]5)+X(Q@ $#GMFCG:6E*JV];<M]+[:OHNF_>X
M.[^W&UK:273HM;VU>_6Y>#J21@!E!)3CG'.5."2&Z#CY<\[NH:K9!8C;A@".
M#@-CYP<<C+$@$] , #)JF74KD&/G&,2P;%Y SG=SC/J0<8[4NX@$Y'(/_+:'
M [;L[NWR8QC!4\D4U+5IPJ+1/6.UUJK[)I-O9NZ2N"O;64>;;5RL[Z/1-WM>
MZNT]-++4M^;D95<$@+@Y& 3@8(X  &>O#%MAP> -DJ,+D\$@ [@6YP3T &3@
M'.2,  <4BP9B&96#=?WJ=/0*'V[@1D,>1RH '1B.H.001D,J>8C8"L,G8C$C
M@\'G)SDYY,*?O.,J;C;D;E/1)3YK-2<6I.,E"\4_M\R:LT2O:6<E)-<L))<O
MO2E[1PE!14VHQ23GS.[Y6E;=FF&4C.T#!QR,X^[DD^V3D].G/7#6<*=N0IRK
M-E> G)Z@8Y*Y.<% Q!X&33%Q@ *K,H);)ZDYP"2.,@<>V!@\TTS[B6,9)/4X
M/3 &.O3BCFJ<W\.\5H_>7-S==ULM;7>NEK==&FUH[?+;MK^=_D7N,$Y1<]3@
M-\^,\G )&7.03P0,8&13PR'!XY.%& "QXXP>I]#QU_$TC=-G.PDCH<=P1S[]
M._'--^U'()C.0VX'!R#CDC'4\#\NE.4JFG+37G>HNWE'7\!1C).[ES>B:5OG
MUMU21H,0J[@%SQC/'4@9]>AYHJ@;INA7'0 $=>N![=^?8BBA2J-:P2?^)+]&
M#BV[\]O+7]!O_?RCIU\RH?M0_P">3?\ ?R'_ ..T[SR21Y+\=?FAXSZ_O../
M7%:#L^[_  _R)/\ OY1_W\J#SRH&Z*;CC*A9"3@_>1)">G)R>201C ROVG<-
MPBDVX!!;8N[)4XVLZG!X*D9!..O0@6?=_A_D3?\ ?RC_ +^?_J&3^G-1"X8\
MB"3_ +ZB_P#CG3N#T(P1D$&@SMC_ %$G!ZEH^/7[K.QX[!23T&.M 6?=_A_D
M2_\ ?RC_ +^5"+CTBF.,Y+($7&2?E9R@PN>C ,<[N,8I?M/!/E-@=?GAXS_V
MUH"S[O\ #_(E_P"_G_ZZ/^_G_P"NHO/?!_<OG_>B!';.#(QP2#@X((Z9QDM%
MT /FBG!&<_NB0.>>0>@]5&".B@$  6?=_A_D3_\ ?S_/^?\ /-'_ '\J 7&.
M?*8$\D"2'&2 <\R ^X) SGV&'?:&(X@DR< 9,0P3C&09 <D'@=22!P#D#=E?
MMW=OQU_)^CV99_S/\/\ (EP#_P ],GC/OG&,\8Y_6F0@"Z@V#K,F\GK_ *Q>
M?J!\H[8'8D4SS^>8G ."@RI+$$L3PS*HQZ$L03D!5R6P2,+J$>7(4:>#$C#;
M\QD4$D.P8<8&T*<'!! ! SG[T9QMI;5QFHR46USRM*W.H^XW%:MRTUC<36FL
MG=V4;.*2=T];K6\4U;[KO;_/F_:F\0:!\%-7^ _[8/B/2/',WA7]F#_@Y._:
MY\:?$S7?!>F7VL3:-\)?#_Q2^#OCGQC#/%;/;V:7.L0^'I=-TRWU"^L+?6))
MY]&:XQ=8K^^?X=^/-"^)WP_\!_$[PN;M_#'Q+\$^%/B#X>-[;FUOAH'C71+'
MQ+I(O;0NXMKLV.J6PN;<2.8I3(A8X4G^:GX&?LL^-OVWO^">'_!;#]E+X;>)
M?"GA;QW\:/\ @I3^UMX9\/:]X[AUM?!^GW=C\7/!'B6Z.LR^'K'5-7M8+RPT
M.[LH+^QTJ]DLKZ>"[.GW\<$MO-]N?\&_G[1_Q6_:A_X)??!KX@?&G6]$U_Q3
MX7\3>./@WI.HZ#H5KX>LI? _PCU"#P9X0MI;32[:WMIKJWTG288YM2EL[2>_
M^66XC2X?<WZOF:P_$7A#POFU*IAGG'AIQ'F_!N9X:KFV)J8O$\/<=8ROQ=PQ
MB,+E=3+X87#PPV<X'/\ +)5Z695)NG1H\^#IJI"L^"/-2S#$4^12I8ZG'$1]
MQ14:M"E/#U_WD9\W/RRH5*=H6YG+EDFVGL_\%YXRO_!-WXDWR+=F72?'WPMU
M2W:T'SP2P>+[!EG88)6.(8;(Y4X(.<&OU/\ A5=_VG\-OAMJ&6<7/P]\&W2N
MWWW\WP]I[>8Q8!BS.[>8.N2>*^$/^"Q'AF;Q9_P38_:KLX)DMY=-\!GQ&DDD
MT=NF_1[^UNU#R.D@BR5!7$2."%VN,AJ^3OV,O^"U'_!.JY^#_P"S1\&-=_::
MCU#XSW'@OX<_#C4?#T'P_P#B5?W3>/+RST_08M(GU*W\-W6G"6XU26&W34/M
M\NG(S RWT>'"?SS+,<)EO%V+CC<5A,(L;D66+#RQ%:5.<IT<QQU*<5*HI4*E
M1*O2?)&JJFJC)6<9']$T.$>)>,/ ?ANOPQD>;\0XKAKQ.XVPV:X?)L'5S#%8
M+ 9QP?PYF<,9C:5&K"<,'"GE6/E"I&E44Y4,3=\T)4U^\99OWN"%# @9(R,*
M1@'//<Y((W<9X./X\/\ @H_\9?VS/!_[=W_!;?1?V<;?P;XF\!Z#_P $O_@_
MK'Q*E\?_ !1\3^#9_A+ID_@CXEN_B_X4Z7HZ36MYXNN(#>7<ZS-IL3W=EI2W
M-_'%<%A_89&LK9(@E18E#;RCH6S&H&7;RMJC#JLDA"L.2?XVXZ]^'/PYU;4/
M%NJ:K\/?!>IZKX_\.VWA+QYJFJ^%=&N]2\:^$K.*YM;7PSXKNY;*277= M8+
MV[AM]*U)[BRBCN)52+9.]?85%S*Z5H*_-.I.$$K\L5I%N2NTK-I:2MNDW^!P
ME&3:IJ\(0YI5'.DJ:BI5(I+EES\UN6\5&?+=*4T?Y[_[2OC#XN1?%/P-\4-#
M\4_$/1O#?PI_89_X(O7WBG]I32_C5XKT>Z_9>T_XBZ%!9>)?B%=?#*QO1I?Q
M%T_Q>^_2?%%SJ\;'38I4O)GF#LR?T$?$+_@H+_P4$M/C=\;?AC\.[+6/%?@+
M0_@Q\>M4^%GBG3/V1/B,D7B?7O"?P(U_Q5\.=?T[XO?V]-X4OI-8\26=CJ-C
M.FF2V>K3O'IL=L_G"-OZ /\ A2GP5DT[6=*?X.?#&32/$GACPOX+U^PE\#^%
MFM=>\'>"K?[+X-\+:K;/IQMK[PYX6M56W\/:/<1266C1*JZ?;PCA?3+.'^S;
M2TL-/MX-/LK""*UL+&PC2WL+*SMXQ%:6L-K$B10VUM&B0QQ6\!01HL>U4#"I
MY)WUM^%[_)6\[K?UU*YX]W]WYV^7W[G\5?\ P2%_:B^!GP3_ &EOA;\6;3]K
M6[UCX"^-/^"'/PS_ &D?^"DOC'QU\6]9\=?#;P/^V_K?[1WA_P .'Q+\1=7U
M;4-4T_P/\:I]9\5>.O -M\.U.BZ@/"EI:SVN@7L,MKJMQZ)\8_B+X*^'G_!P
M+^RSK?PH^,.DZUH'Q8^+NN^&_B#8?!_]I?Q%\5/BGX@UW5? L-_;^%?BY\ ;
MN9M&^&?PNT..:RO++4["T2.2&X6X6X=I,U_5/IW[-/[.&BZ1\0/#VC_L]?!?
M2/#7Q;U&RU3XJ>'],^%O@VTTKXD7^G3F^TV\\=:=::.EMXEOM-U%I[[3I]7B
MNDL)KF6X@ O7+-HZ7\#/@;X>^(>H_%[P_P#!?X3:)\5=8@B@U7XF:1\//"VG
M>.[Z%;:*SACOO%5OIR:S*HLH(;5P]WQ!''"I,2( N26FWGKTV_JP*2EM?YIK
M\T?S5_\ !1B#XL_%3_@I-_P4(\(^!?B[H/P'\??!;_@CGIB_LV_%7Q[XNE\#
M^ OAUJWQ=^+<47Q3\3WGBB7S-.\*OKFA:.W@N?Q9-;33:')J-O>JZ>5D?D)\
M.-(\;_&/X+?MR_"/PO\ 'WX/_LZ?LS_"O]L7]B;6O"-A\6_VW/$&K? +QQX]
M\+?!O5KW]I+X.?#[]J[3+NWGU6;XB7B6WB/5]+\/7LEEHVHN+2/,R8;^W#Q]
M^P_\"OBG^TUX9_:T\5:+K6I?$+1O@EXT_9T\2^&99])N_AG\5_A5XTU"WU:?
MP[\4_!&J:?>6GBM-!U.%KK09)KA#:-<RI.D\3PK%Z'=_LO?LPW7PVLO@M>?L
MY? Z?X0Z3JJZSIWPLN/A1X.D\!V.O+O(UFT\*2:&-'M=3CCDF,FI168O,.VV
M5XV >;/5+6W,EHW?EW]5?;17>G6Y1_%IJ?C3XR_$;X)_\$O_ -M_]C_Q+JWP
MZ\1@ZG\!?V7_ -B/7/B#\0/B'X@\6?%/X0?%CXC:C\3?BEX#UZ^NT/Q,^"'C
M;PR#K'Q)\5^.+6ZATCP5H^CV-C+%>:K91R?L5_P17_;$T?XU?L/_ +7\'P@T
MGX@>)OVBOA,GBOXP_$;XB^,_%MK\1IOC9\>?C3X&\6>-M+UW26T\O:^$ULM;
M\.IX8M/A"BPS^!]&L- TZ>VCGO6>3]^=,^%'POTS5?!FOZ+\,O NGZS\-- U
M+PI\.]3T[PEX>LKGX>^%]:2VM]2\.^#+F"RM8]"TC6H;2V@U'3]'FM4N8XHK
M>2.:.$*+'@+X6_#CX56FKV7PQ^&W@KX<V6NZ_>>)=>L/ 7A/1?"5OKGB.[ _
MM#6=5@T:WM1JFISL<S:C)#+/M&UG4,&(MKR?GS76B=M+:2NFWI9+ML!_!]X>
M\<_LJWW_  2'^*7[3^C_ +</Q$\1_P#!4[Q]\(-6U;]HWP;J?Q_\2Q>.]!\7
M7/Q6TBV\;:!K'P@?4$7P78>"&(T[0;@:7IB16*J()YS*57]>O^"F7C/P/XD^
M+O\ P10^!W[77Q=UKX4_L ?&/X6?M&^*OVB/%]U\2-8^$G@[Q7\2_ /[,NA:
MO\'M'^(7Q:T[5M#;14M[S4/$?B'0+2YUNP;7/$5M:)$]U=0V\-?T*+^S#^S@
MFM>+?$T?[.?P2C\1>/XA#XXUY?A7X'&L^,X9KA+AH_%%^NDQWFK)=744<XCU
M&2??<(CR%I!N'2_$3X/?"GXM>%K?P'\5_A3\/OB+X&L[BPN;'P9\0O!GA_Q?
MX:LI[(?8[*XL]'UBROM.M+BPAD^SVOV>-7M[9YXW*(V*KD?=>7O)Q;;TLTV[
M_P U[6O9+9 ?SD_L$?M>?"GQC_P0@^#_ (1_X*6?M"^+O"?Q0@_8I\4?'CXO
M62^)=9\*_'_5/V2[7X^_$;X;_ GXD6.H6"Q^(+NP^(?@CP_X)T+PWXGBN)-3
M\8OJ%KJ\EW.^HRW\FM_P;_\ QJ^#W@#]E[Q?XB\3_M6^#)O /[1O[2NI+^RU
M\#O%'QQ@^+/CGX0>&-9A=?!7PP\4:U<7E_J=K\0/$=E:MKUWX:NY/,T_SA"Q
M9@VW^A;6O@C\%?$YOI?$/P:^%_B ZMX#TOX6ZI_;7@'PIJ$FH_#'1[_^V-%^
M'5\)M,:*?P7I6K-<:MIWA:8?V-97\PN[2TA=)C7@6I_\$]_V-=0^(WP;^*-M
M\ /!'AK7_@)XJU;QU\.=*\#Z-IO@GP99^.]8TTZ4?&6L>$/#%O8:5XD\1Z=I
M[/!I&J:O!?3:4DCO:"-B&#]G._31[\T==.E[:;;W77L3SQ[O[F?RR?\ !;OX
MM75O^UY_P473XD_'/QW\*_BG^S%^Q_\ L@>-?^"6WA/P]X\UGP+K'BCXQ>/?
MB5'%\1]3^&7@G2KFU_X77XCU3Q:FD^$/$D7]G>*)-%T=[FS:UL[:VN;B#]#O
M^"N7CKP9^U1^R-\&--TG]KW]FKP-XU_9Y^-_AF3]J3X?_%']HC4_@'H?BKXA
M>$?A(_B7QY\!=6\<>%[JSU+1?&<,NH)J9T&*7S?-$=N\32!HA_0CXM^#OP@^
M('BOPCX\\?\ PH^'7C?QQX F:;P-XT\5^ M"\1>*O!TAG^U"3PQKNM:;=ZGH
MLJ7?^E1M8W<2I<GSU"R+&1S_ (P_9N_9T^(.F:UHWCO]G_X->-=)\1^+SX_U
M[3?%GPR\':S9ZUX[GB2TD\9ZQ:7^E7$>H>));9(;6?7+E)-0EC4123F,,$7)
M)7O9;6U6O1]%\O\ A@YX]_P9_,)^Q#\<- ^('[8G_!OC\;_@]\//&GP8T#]J
M?]A']OC]G[X@^ ?%'BO7O&-]=_"K]G4^'_'GPYEO/$?B*8ZGXHT*+X@G5/$7
MA3Q7JD:ZIJ.F:_ GFO"^U_ZY4"LBM\W0Y'3&#ELCH?FW8/)ZBODB+]B_X(Q_
MM<>#_P!LE++Q OQ)^&W[.5Y^S'\,?!\%YI=G\*/AKX%U;Q9+XI\1Z[X'\&V6
MFQKH7C?Q)'%I_AK4M:L[V.U;PIIEIHT=C%''/(WUFLYVIB%^0,?/&H8[<G.Y
MPQ!)[!FR<DDX"W!-7O\ =^HTT]G]VA8*+C/S''& 1US@^QQS_,>Z;5]'_(=J
MA%R/^><O_ E6(#H>"Y56XRI&00>5!4#8X7.<XB<XZX>'CZ_O/8_E5CU[M?,>
M5&<G<$ );. 3QP!P?Q_+O43;<,"7#[> .BC/'3'U;." 5//&5:X."IB8$\ %
MX><G;P!*"><CCOQG-1>8@4MB3*AR5?@G(&5+ L0Q <X(!.<X"D&FK--.VNEI
M:)JVD;].:5DWV^8M>[>]KR:N[.RVM9M*[W6_D6;=\SQ8!VD,&7DN),,5)'.!
MDESU'RCKQ7\&/Q\_:W_:9TGX[?'#1],^,OC"PTK2OBKXTTW3[>+4YTBM+.#6
MKB*"UA7S0 L$1"1XP,!.%/ _O+MI,W"DEB,YZ9(5$?"L2PD0H6 8JIVK@%B=
MS5_G7_M%17,O[0W[0+BTO3&WQD\>-'(MG=&)MNLW 'EE()4E4E<<;5(!\O>[
M(#_1OT;<OR_,,[XH>9X+ XQ4\FPCH1Q-/#UH4JCS*=)RI+$+EFU32B[)S2OL
ME9?SU](+&YA@\HX?AE^(S'#5*F:5_;K+)5*<HJ.!C6BJ]>C*,E#GFW?[3<(O
M>SZK_AL+]J4;0/CGX^(5",_VQ<#</F#9^?ALJ/ESG@DG')1_VQ?VH(T=W^.G
MCP1HKN\C:O<A(XT!:1F_>$X5=S,<XQR!Q7SIY,AR?L=]&0P5@=-NR/EP #MM
MF&Y5RNU>6"L7^_NJIJ$-W)9:A#'97\KR6-Y#&1:W2O+));RK''M^R=2Y5%W,
M"6(&0"17];O(.&TU;)\GNTW:679:U+E2]WGE3Y8)N]G>_P#*I2:O_+7]M\0P
MM&6;<01YY*$9?6\TG>4F]7[&<K*"3G.4E&,5>+DFU;[[U_QW_P %&_"OPM;X
MY>)M;^-6@?!Y;71M0;XAZM=M;^'%T[7K^#3=$N_-:[-Q);ZKJ-W:65J\=NRO
M/+$I.'!KQ&?]M3]I6VE>.Y_:!\8Q2P.B3(^O3$H6 8#*RD,<+N)7(5).I# C
M]9O$?[77P<\->'/V!_'OA[X@?LD_$'3/V?=&^!.A?'#X=:W??%#6_P!J2]\.
MZC<W7PW^+?AGPO\ "Z/1G^&7B;1O!7@[Q]K/Q!CM?$$=KK-O?^#(=4L[B;4-
M,TEG]H^&/QX_X)L_!OQ[XF^#WPS\2_L\^(_"7P;^$EEI?P0^,'Q>O;:P^&_C
M[6O'GQ.\5^,?'WA74?C+IOP[\>12ZAX1\'W'AOP=:W;^&]?FU+2X+>72]0@N
M9KN*Q_ Z/B"J5'&SS#PDI8R=&KFRHU,GP6$ITJ.'P&84L#!9A#,,HE6C7_>T
M*]\-]9C7PN(=>"E]5JTU^TU>":]>>$CA?$^M@U.EE_M:>/S+'5ZM>IBLKJYA
M*>'GA\PA2ITTZ&)HRA75.=*M0A3<H/$0<OPMD_;:_:.1_+?]H3Q8&95DV-X@
MF#,&7<K<387<"/F/R8 QZ5T&L_M5_M>^'+W^S?$?Q8^*/A[4CI]AJZ:;K-UJ
M%C>/I6KHKZ3J4=M*ZRO9ZI"R2Z?. $N8V#IVK]>KK]J?]CVT\#WO@#2-1_8]
MTCPYXD\"_M ZQXFTO0O#=]XT73?B/#J*7_PETOPQXU\1?#[P[KLVGZG=(;C0
M+2\TC3QJD3!'MH(RD8\ _;0_:J_9Z^)/C+X-?$W7K;0_VC+G2_@[X"_X4^/@
MWKL?PXU[]GCXF:!8Z(GC*3]H[P;>Z!)%XUT.Z\3PVFK>%_"L\TJVVA:1K6D1
M:/80WUOJEY[.!XRP^-Q]'!T_"2K3I5X9E4IU9X3*YXBI]5R^IBL/&E3GE>6X
M-2G7IR6)6(QM)PPM.3PD\1BJE+!UO*Q?"^*PN#J8B?B7B*DJ53!<T:>)S.-&
M%/%8R.&JSJ.68XK&2H0IRBZ5>C@&WC*E.GB84<+&MBZ?Q[\7?C'^W3\!=1\*
M:'\7_BCXV\#ZYXU\,6_C/PUHM[XNMK_5+OPS>&,6E]?VEE=2RZ1+*MQ'(MCJ
M*PW1BD64)L!(\F7]MC]I%A(__#0GBUTA(660:].-F?E0G$@(#N"B[=Q+L0"<
M"OVH_:9_;\^#'B"R^.FJZ-XY_9_^+&KZU\4_V=?!FC7EI\*=-\4>)]4_9UFT
M'26^/MYX1M[S1+.ZU6XL)WU2Q.HS7;76@K&UG8M'=P:>&]>\6?M0?\$WKWXZ
M?"S4)[O]C6\\$>&](^(5K\%_'/AWQ!KNH7O@?4;[PK;6_@VR^.'AA?@=IWA[
MX:>'X;N*:TTO4]=O?B+J>CZ])#)<V^V2XDA\BAQ[]4P.#EFWA)+%8JJLSE6J
MY5@LNIT)?4</3Q,5##8C)JE>C2E];PZ;JMU:M##8S$TG*<98)>CB.#Y8G$5X
MY5XJ?4Z5-9?3I4,YQ^:TZ\JN(KU,/4:KX?,/95KRH5FO9*-*G6JT*$VJ$HXL
M_ )OVS?VEUMDNS\??&2VLB!EN/[?G\I\ESM\P28#A@J'(R&&W&< HO[:?[2K
M(&3X_>,"HV!F&O3D[F;Y  90>3][./ND''?]#]-^,7P"'_!4?2_BO/%^QYH_
MPTB^'^G6?BGQ /B-XDU?]G/5/& TB6TU37?#?CJX^!VFZ</B=; QS0077PVM
M/"%_>QQ)]L^US321>\'XE_L%W^H7OB'_ (:5_9^U.'P%J?[3$$EO\0/AR_A7
MQ7\6IOB#X5^R_#VZ\*6^D>%;#0-4T_2-4+PZ;JB6*&7RDN+:QMI92%]K'<;Y
M#@%EJJ^&4ZSS+)<NSARPN!RZK'#5,?/%TZ6 J2IY'42JJIA8*4I*-UBZ;>&P
MBI5>;R\)PCG6-GC_ &/B%"G'!YOC\LBJN:9I"=:G@H8*H\?&5?,J,/8.&)Q$
MY)*44L-)4:^*E.,7^.47[:_[2$CE(OV@_%\K^9+'L77IFE+Q7 B>, 2?,ZDP
MRD(,;/,R0?E/9ZC^T?\ MDZ/X)\)?$;4_B_XYM?!/CG4-6TOPGKW_"3))!K.
MI:%A=4M(+>*Y>XA:S:149YXXXG&3&S"OU+U?]J7]CGXJ?'K7OV7OBKXF^!NC
M_L,^-?V0OAUI&C?&/P1X'T'PS?\ @K]HOPIK&C>*O%4^H?$<^&K?7+J^\6"W
M7PU=:*@M+;1[CPAH5E%%%K/BV_,'9:/^V!^PO\7;FU\(_&'5/A1X+^%WQ'^)
MWQVM=5L+7PR=$N_A9X*TBZTJ'X4^)XF3PHJ^'(?'=OI!N87!2X(OS'?16[L\
M:>;B..8T)8&H_!_V=&O##9C7]C1R['?\)&+HXZ5.-%QRB$Z>9PJ8'$+&86M2
MO@Y0HT/WKQE"I'NPW"/MOK%./BNJM6%3%993B\9F.'4<YP53#2Q"J2JX^5.>
M$G0QN&>$JPFH5H2G7]I%TITH?B:W[;'[2*$#_AH+QBLC/%"D?]OS&1I[AUBM
MXQB3&9I2L:9P&+'.0,UZ5\3_ (Z_MP?!KQWJWPT^)WQ2\?\ ACQUH5EHNHZK
MH3^(A?26UGXCTBVUW19Q=65S);3K>:5>VEX!"SE$<(V#D5^NF@_M&_L&^+/A
M%^TA:^)?BM\ -'TCQMI'Q=\+^%?@[XD\+Z+X2UNUO-(TR*T^$>M^%%A^'<_B
MKQI>^(KRPMM4M]8;Q5I$>G3R0);:/?-+(T/Y)?\ !0GXB^"_C!^UY\1/B'\,
M?%%IX\\$ZSX.^"FF:?XJ\.07]]HU]J'A?X7>'O#WB"SCNI+.)GGTG5["]TZ]
M54>,S)+&LI,9*^UPOQ)@N*.*)Y+4\.L-D6#PF79E/%5\QRS"3J5L=0CEM7"4
MZ599;@Z%./L\3B:=:DY5IU*D85*52U.I%>+Q'DN/X?X?CFL>.L=G%>KB,OC3
MP^7X_%1=/"3J8^CBI5Z7]HXFM[2O.GA*U!QA"-*G&HIQYZT)+SP_MA?M2D*1
M\<O'G)PH&KW(&[;N.,OQR5[X!  YQ4J_MA_M3*=X^-WCP;@/E&JW#=% );,A
MQSG:1GYL\8R*^;62YZ_9;T'?N^:UNU!Z@A$-K(H0%5*.Y488H0RJQ9XCNW+E
M;6_9E 8,-/U(J/D!<9:W"EA@@_.^S8< [L+^K1R#AO1K)LG5G:_]G98TU9*,
MDG!:5%:7:W3O^=K.N(4DI9IQ'4FE:4HX[')73=W95G9)WBKW5UMI<^K]4_;
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MT9Z_:"?]J_\ 96\4?&G6_%'Q5_:._9@\8>#O%?QG^ /BG2(=/T#4-.%A\/\
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M\%'/+BBA@M?^"LG[8@CAMHHH85C_ .$FL5"PPPJD4:J&R$544!2 !TK\]/\
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MO!#?$G]J+XM?'30_^"CGP5^%O_!)F'_@G-H@^)OQ$\,>*-=\$?$KQ:]IX_\
M%-I\/--U.WT'XD>(/B+9QZ9;_%K7?%&D:YJEWIXFEU5X9%-U%_H4ZM^SW\!?
M$7A6R\%Z_P#!#X2ZMX,L?$E[XQT_PEJG@3P]=Z!8^+M3OI[_ %+Q'::=/9-:
MP:SJ-]<37FHWR(L]Y-))),\CLS5N:O\ "+X3Z_XO\*?$+7?A=\.-9\=^!+1+
M#P3XQU'PCH-UXC\(V,7S0VGA[59;-KO2[2U)+VD-K)'':.SO $)-'LWY?-Z[
M==-;65WOV#VD>M_N_P C^)/]COQ?J'B']M#]G3Q_>?'_ .-V@?MQ?%S]IO\
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M+9PI'TR0?E[@](_(?.0J $%64)@X9B"V"3R%(*=.%.0=QP;IE!W,O\* Y]2
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MW-O\/_#3075M>6T5U!=0[;)D,-U%,LJ]GQ(<Y.YOXK? O_!-']M;X%?LX?\
M!4J'5?@I'XGUK]HW]BS7?@#X&^'O@G4-7\<:_P#$OXO^*_B2+BQ\4_#RTU:Q
MTRP^%/PP\-Z+JTWB.?P;/>"%+[3VN8F\^%,_V*_!WQGHOP^^#WPB\!^(KKQ;
MJ/B#P-\*_AUX.\0ZG'X*\2SK>ZUX7\)Z3HFKWGF_9-S?:[ZQFF+D-@[CEN27
M&OG"=GB\V:<4E_MV8::+X5'-5R;M-Q:M:UNS]ADG*VL+E+O>[>'P2B]4W=O
M>\[Z^]%W:Z\JD>@_\*(^!62Y^"7PD!9R\A7X>^&R&95"Y/\ H8#-T"DAOE[X
MKHO#OPS^&G@Z^EU7P=\.O WA/59K:6V?4_#GA71M(U&6WEP9+1KRRMX[AH),
M#?%O\OHP&X#& OQ<\&AL"+Q<>5VH? OB3.>N&'V;TP<]>A(QP-OP_P"//#_B
M:^;3]+77EN(H6NF_M+PWJ^DVIC5@-J7-]!'#N/ 6(,6;TP#2G7S"I"<*^)S:
MI3FGSQJ8G%2@X1ES6DIYA74H)I.49QG&5G>/,KCITLGHSC.E1R^G44W*E*CA
M,'&<9U-'RSIX2$N:3>LXN,Y?:::U[Q8BVUMNW' "Y.Y%_@.23Y9X^4D$]S@
M!QAR"TI<GE4P2"H'W<@=>F21]XDDYW4T328QN4?P@9 VD9(&#@XVC_V8YQ0'
MFP,.IY"D YY9MH).>,GGTPWH*Y/Z_7]?ZL>@Y-:;:]'J]^]]'WU^?2R8EP"
M1P3@'!&5(P, #*\*">W3I5;RPK >6FW (?#9&"-I#;@=Q')/3///90TY&0R\
M^I/3/7Z$=/6F-(YYW(5) +9  &20",\<CH1QWP,T$\S[M^M_TL.<-E9% 7#J
M03]XECY!8<X $;G;CH7W$9%%-+.V%9E*R#:,$!E;#%6!SC@HAY]5XYHH-$U)
M7E:_H]OE</)7_GG%_P!^VIRIM(*J@.,?*C*2.>,YXZ]>W'IBH29L']X/P1\_
MSH\RY[K&/QZ]1_,8^M._I]QEKU=1>KE_\B_F6V&1CI^';H<>AYR".A [9J)X
MMQ)(C( P-RYP!C'.>W/M@X[ U$9+D=H^OKCOC/./KZGH!GBDW3MR65. #P2,
M')W=1@]1@\Y7MFD"\B00@'K&"5*E53' 8%25W \./F)[9')J4+L15[(H4'C/
MRA1DD\ '!;\ "<U7\R<9/[L8S@G !YYR<_+GJ!SZ$[NK1+<.,@1X)(Z]<$@]
MO;Z\^QP#;;>MRRZA^#@].&4$<DX)!(QNVXP3@'&<<FH!"I!&R/<<G'E@#TP?
MFSR,C.,9'3T86F9@"R(V"P(.3@94 J<=3)\OJ1CGI3MTR D,CG' VXP/9B<;
M3@<#H0I.!DD!7>BO:VR>GS5M?6_R98CC$8/" GCY%VC'8$9ZY[GMC/ IKQ^8
M20^T%2",=200K9ZX!SP,!@,Y(JNTTPR'$6,9Y((ZX Z')SU&./4'HWSY "<?
MP;FP5#'!.Y@2 <A2&"'!4#^$#!&GV>JNO-?+781.T(R3MA.!R!'D_4Y.3ZGN
M>@[4X1XR%C49![ <YP.1DD#DXX&,#L,U3-(#@R CYNB,3N'RXQGA@&W YXP6
M&0,F42W!Y CP>1\V< \@;L*Q !&"0"1@D EJ:>G37JUK\NJ'=OJ_2^C]5;_+
MU+#1H%("+T^4'GE1\HYZGO\ GSP*6)<7-L0O)G@W_,03EP02,8.,'()SP>F:
MK%[@\%8R..A(/7UQQCKFGV\DOVFV#@*/M-NN!C&=^..F!R<9ZX."PQA:;OI^
M.DM/UMI>WR'&]]/G_3_I?,_%[_@C" ?#W_!256Z-_P %8/VQL[02<?\ "3Z>
M=PV\D@?PC!?.W[QKY=\>>'=+\'_\'2/[.NO:1X4T;2YOC#_P3:\:2^*-=TVT
M@LKSQ-XI\.ZSX_@F\1:V]LBOJFLV?AW0O"OAE+N]_?KHUMIULLS0V4$:_4/_
M  1B)_X1O_@I"RCI_P %8/VQ64<C)3Q+I[Y&".=P7<G.1E!]X&OSV_X.-/A,
MGP9UG]EW_@J-X2^.'Q,^%'Q%^#7CSX8?L]ZA:^"YA9Z9<?"GQ;XOU#6?&U]=
M7-E =9-S)I5UJ-E<:9#*++4K6=;>2&>8P%?UGP/P:SGC/%<(K'K 5N/>"N->
M \OK5:6-KX>><\0Y)A_[&H8BA@JM.<HUL9DU6$*U6-6CAZU:A6<.:HI/CS1S
MAAH8CEYU@\50QG*G%>[2E*-35IZ>SJ*377EMNKK^J"(#='\Y8K'EMV,%LD#?
M@\\'.TGUZ'%63C/"@%0_ Z@J#G W$%>@SW."1G%>-_ ?XY?##]I+X0> /CK\
M%O$J>+_AE\0]"CU7PGXE%A>Z<=5M+8_8II9+#4HK>\M9DN[>995D@1S*&.YQ
MM8^M-,RX8X*!OE.-GW,9;@?=8N6ZD@*>,'-?E=7"XG!5Z^"QE"MAL9A<1B</
MBL/BZ,L/B:&(PN(K4\11J8>HH3I5:-6A5IU>>"<90DG[]TNMR2BJD9\T9I2B
MU*'++VD59IQOS*[M'X=T[66KCPY"MAMI R3\A*C@94<1C/4#+KC.2,_S2_\
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MIMOY?/;\0U>]W9+5Z[_)7=VM4K:KKHKC(&!4!>N06&X=-O3//RDK[ =\U#Y
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M_"?6K$:O_P )'I?CTSMX=U)M(T.2UU[Q!#:W23:3H]];7]X889F,?XM^*_\
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MQO?^#OAS;> M"U+QYHGBJ_,$,6IR6:7&HZ5HNGPPQZ8ZVIE:XB\YODOX!_\
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MS+D=1&!W.3P/4\=!U--WSL ^]1D JF.#CD '(SNXSG. <4A+<D\I0X)51C&
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MP0")EE\^>$F&-D*R^85"$-@U_ !\=?#WQ _;7^+?Q@^#?P[^'7[17C7]E/\
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M-+A8(H2SRR8^NO$O_!9'QO\ #VZ\*7/Q8_8#^._PK\)>,/&VA>"K3Q?XMO\
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M;L_G)QE!3<J<[PER2B^5-U(35-P2<HJ4I-2E'WES0BW9)6>B,$YP"5^7Y3@
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MMC_P<"?$GQ;K7P%\ ^!OV7/V?[#XG>./BA\9_@U\8[?XM?MM>"OAI\+?"_Q
M^"WC?3?">LVWP2^+%YX6O/#?QQT;Q'8WTFN^&;VPDTG4-36 65OI<HD6YKZJ
M\??\$V/C+XQ^-W_!4CXAZ7XG^'^D>&?^"BUO^PAKUGX>\:>#O"_Q8T/P'XM_
M9;\-W?@3XF:+XG^'_B?3GT3Q'X<^)7A>VT"\T/6DODU?1M>M;FZ2*VFM+"6O
M#-;_ ."&IN/V9?A]^QUX6^*%OX8_9^M/$7B/QM\;M%N/AK\,M9\2_%GQIXN\
M76WB[7-=\'>(;W2Y;KX06TTMG;:1I>F>%'MXM*TN&..!@P)I+!5'K^XB]5;V
M]"+NGO;F;W?DV[*_4/KU!.TEB7=.W^RXBR;UL[T-%O[J6KMK\0VU_P""]7B+
M4/B]\<_V?+/]E30-(^-VE>/_  I\-/V6?"/BWXWMH=E\6=<OM7O;/X@:S\7M
M;G\&"V^#W@?X7^'--OO'VN^*;!?&5C>^&[C0HK OJNK0V0_1?]O3]NWQI^RB
M_P"S9\)O@U\!XOVG?VMOVNO%>K^$O@E\(+7XD:7\.?A_<'P5X3/C+XB^+_%/
MQ2UVTN%T/P=I&CPR+H,IT>>]US4;C3(?L]F)YI+?XY_:C_X(]P?M8Q_$K4_'
M.OBV\9ZW'X(\*?!G6]3LM*\1:%\'OA#X,\!>(/ 5S\-#X?E:U'BJ+QE%XDN?
M%'BG6K^=KN[\3Z7X=OG<Q:3#&/4_CK_P30UKXH?"+]BSP9\,/B)\0/@C\9/^
M"?\ ;:);_LY_M&Q:WI7CKQ<D-CX(@\!>(-/\>:5KT4EOXJT[Q=HULJZK;W,Q
M(F6.16/(9K!U4GK0?=.KAUJHIII\[LTW:Z]Y)6V6H\=0=N58I6U=\-6O)Z\R
MNJ%KM._+IW/FWXO_ /!9?]I7X.1?'S3_ (H_L?>!_A!XQ_8VTO\ 80^)/[4'
MA?4OC1%\5(K?X6?M1?$*^^'WQ3@\!ZQX-TS2]+FU?X=I=>&O$OA?5)KB_;7M
M+EU2VU30]-NH45_Z)'E2<++:W&^TG2.ZLY1EC+:W2)<6\@\QE8))%*K*, @8
M0JC?*/YW/V@_^"/7QH^-'P[_ &I=.U3X[7/COXL?MF?#_P#9 ^$'QR^('CRS
MTO1[>_\ A]^SA\2K?QIXPU/1--\/1K!8>(O&VD0'0M+@2/[)IP3?(S;LU^[T
M6L>/K.&&TL?A]8"RM(+:SLD;Q/$9$L[&VCMK8.?)(P(84; ZLQ)YR:(82HI:
MK#-JZ;=7#3Z:-.4FFTTVK]-+:ZS+'4GHGBDV[-PPU:[LDTD_J[T2?DKJS;9Z
M"58KM+RY)R-K$?=Y^X)N#D C  '.>% IV9CC$K$ , I122 NX@ N2QR6'. .
M03TKSYO$7Q%'RKX!TTGC<#XFBP"<@@'R00 N3@^_I0/$'Q%5LCX?Z655@5)\
M30D[SYK8(\K*E"N\D<;2V 1P-?JTDT^7#IMO2^$:OK'WI*2T:WM;L[LAXZG+
M>>.T3B_]GK:[7N_JN[N[MJ_9Z6>_XQ\7^&OA]X2\3_$#QOKMGX<\&^"- U7Q
M1XJUZ_ECM['2/#^BV4M_?WUS(TB!42WADD0,2TC/&IR[%1_/)X'_ ."W7[5/
MQT_9N_:._:1^ G[ 7@>\\+_LY?$W6K/Q/9?'+]J^P^!\Z? "W\'W7C#PU\9-
M4;Q1X$!L-4\464%O)8^#X3<!K/4+6:SU6]GECM9?VI^-GPX/[17PB^('P,^+
MOPDLO$?PS^*/AJZ\)^-= M?'$VC7.K:)>",W5G'J=BB75GYNW >(@[,JP*D@
M_CO8_P#!"?X>>&/A'^TI\#_ ?C'XH^&_AC^U/\6?A+XX^(N@ZOX]E\63CX=?
M"=M/:U^#-O>ZJS2RZ'KXTZ"TOM5D_P!*32PNG(OV6-$&<\+4E+_F&M96Y:F'
MAZ[3M=-.R:;U2;=G:HYA24?CQ33:NOJU5[6]W3#1NEW;NU9O75^__$K_ (*9
M_&#PU_P2Z_9[_;)/P)\-?#W]IG]KKQ=^SS\(O@=\!?&?BC6_$G@^R^*?[1GQ
M&TWPMX.7Q1XFTVPT76)O#MIX*?5O'<RKI=E<W)L8]*#H;M;E/,?'G_!;+7?@
M/^UY^TY^SO\ M!_LY>$-,\ ? 7X)?'+XY6/C?X+?M'^"OB]\39O"7P972'TQ
M_B]\*-'M$;X+W/QA.KVT7@/2O$?B6XU73[JXAM];@M(X;V[@^K?V^/V2/B/^
MUM\"/@[\,?AYH7A3X;^*/V=/VF/V8/VC?A%J&L:R+CPIINI_LY^,]-U*+0-0
MLK*%9_L>I^#?[<T>P%OB."]N+1Y5\M?E^1_C;_P1G;]IO]HWXM_';]H7XDZC
MXVTOQQX"^-7PY\ ^$?!GA;P3\+-3\*>'/C(T,B-\1/%'A2TM+_XP3> S!:1^
M%1XR^WE8K>-92<9J/J=65U_LZY4G?VV'O?5+[33E9WM+3K+HBUCZ*U_VK7F7
M^ZU].5]5['KNM[I^3M]F?\$Q/VZO&'_!0#X+^*_B_P"*_!/P$\!'3/$FD:?X
M=\/_  ,_:=\._M(RV6A:UX<M=<A@^)MUX>T70T^'_CJT-ZUA>^&)5OT6>TGE
M6]*I(B_/OQ/_ ."IWQCT#_@IKX@_X)[?#;X _ 7Q%9^%?#'@3Q!J?CKXK?M?
M>&_@U\0?$K>.]$U75+2#X;_"3Q!X8O;WQU]@O[*WTFZ70M4NIXGNC-.EN8EB
MEX7]F7_@F!^TC^R5XV\)^-OA=\?K*Y\0>.?CU\./B'^V+XCC\'^#/!9^-7P2
M^!OPFU+X:?"7X!^&?"'AS3(/#F@PO-=P:OXR\8+!'K&LW2&YEN)925?UK]HW
M_@G+X^_:H_:H^&7QZ^+GCZTO/AA\(/B+X)^+7@?X&Z=X&\ 6GB+2O'O@&TEB
MTQYOC5'I@\<7/AB74)?[2N]!>]\B1U-N5,1(%?4ZJ;BGATH[_OL.KIV:BYJ2
M<E]II^ZM+.X?7J7Q7Q.K22>&J^[JDI)>PZVW?-HTK<MCXQ\<?\%EOV]_ NF?
MM\Z=\1/V#_@K\,O'?[ OPB^'7Q]\<PZ%^TTOQXT'6_!.K^/M*M_%WP_OKOPC
MX;\/6_A+XEW'PJ.N^,_#EOJ%\QL)+"W.L:<EO=QX_H]\,^)]+\;>&/#'C7P]
M<M<:!XT\-^'_ !?H-Q(5W3Z/XGTFPUC3I' QM=K"[CE9OE#,=HW/)*S?BGX[
M_P""7_Q'N?V,_P#@HE^S[X"\76>H?''_ (*(>(/&?B#XB_'?X@W5O(MBGCS4
M+'3[[07TZP1KF;1/#?@1+_P[X=MHIHML]S'.2H#U^KG@#3/&7PW\ ^ ?ASH/
M@2QFT3X?^!?!_@;29;KQ+#]I?3O"&A:?X=LI9SY(S(\&F1RG/S[&RS$C-.&%
MJ1D^:.&D^5K6KAFM7%I.4Y6LVGK9;:;W$\=1M;FQ*O922P]5-:V>L\,[+5-N
M.NJZ;>VAW )W2JQ&<N25(^[C9O*X( &%(4#E:12S/&Y93L8DB3+%AU*[=QPZ
M?P;,8!Y!(%>>?\)!\1@%#> --"8 ##Q-%C[JC!'E8R0,<@X.,\FM71M6\8W-
M[Y6N>%+31; QR.EW#K,>H2F0$;86B5$)##.'Z@ 5;PDUK+ZO-)WNWA7+2[5K
M3NVNBUNU%ZWM*(XZG5:NL5%N2BE[.HDU?D]ZV'BE'F3<Y.22NW&RBSN%52O)
M8CEACY"2"H((7&20 3U.20>IP+C#$C:,<[B<J S* .^[Y0-W) &U<C!,"L3A
M=V,9( &#U^8,3G+'@Y]B2<=%82$DAOH#D'@[U [9R"0V/E8#J#@XZM:WOU;T
M\VK6WV;O\M$K=3TT33]+Z+R;Z=[:/35IIET'/;K^(Y /\C^./PJ+8,\$'/\
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MCY>_8&T?X^Z1^SUH^J?'G]KVU_;>_P"$XNM/^(?P5^.MU\"M#_9_\67/P/\
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MS]6M'MH_0EW'$;EUVD94JX*LW+,A9B 1DG YX'!P#0X)(W #<-_).0,?-SP
M$."Q)R.01@8IOG7/]R ]#\S2D@Y)ZL"1@DA>?E'"A1Q49,SMN;RH\#YO+&2Y
M)!);>A' )QA<Y) *@FK4&K=(V^S+WKW3CJU>RM9K[2T\R5=6LW=6:DU&3C):
MQE:2<'*,DG%N+2E[RU2)4:=/,\MF7*!059L817<JQ# DO(SX 8_(DA&YU /Y
MT?\ !5#]FKQ3^U/^R'XP\&^#?$=WH7C/P/J>E_%;PO-8^&;OQ9?ZGK?@;?K%
MCHFFZ-:M]KNM2OKJ*.*V2VAN+@RD*L,C'97Z(9F!R9I<H=V62 @9 +X!@ R"
MJJ=I&_"MAD15"I)*FTKY;%2-LC%_-!QQAX^-P.0&&S@#IG=7#F.6TLSR_&9?
MB>6=+&T*N'KR2=.4H5(\J:5-JSARTY0;G=2IJ3:3:7N\)9_F'!G$_#_%F32I
MPS/AS-L)F^"5>G1Q%*M6H8F6)K8?%QQ*G]8H8JE7QN&J4Y0M'#XVO%*=H17\
MQ'@[_@K[^VEX5^$7[-'A>]_8/_;3\9?$WP[K>CV7[3WB?Q+^R?\ % V_B?P1
M90WD&H2?#-+'PS9FR\13$6)LY]4MUM8H89?,+22HR_9GA#_@N1^SS=_%/PA\
M*?C#\ ?VLOV9M3\=7,%AX7U3XW_"S4O"4-_>7]]!I^G_ /$GU."QU5=-NKJX
M2.76K>&;3[(C%U<1[U8_MA]OOPKMY\XQV^U7*EC@$')9^1D'Y6Y*D$,*^)OV
MG/\ @GK^QK^V;XFT#QK^TW\%T^*/BSPOX?G\,^'=7G\<?$+PZ;'0+F\:^FT]
M+'POXLT>PG+7DTDYFN;=I_,RRRK\H'R];).+,!0HO*^)J&-K4JV HPP^=8#"
M4\/'#T*$:$H4\1A'/%TZU6,8RG5M5=6HN>3AR<K_ &O#\?> G$N9U5QUX.8_
MA/*\31XCQ.*SCPZX[XAQ>>4LUS.MB,RP>)H9-Q'##</XK!9?BY^QH9=4J8>&
M"RE+!8.51NG5C]BV.M:+JEQ+:Z1XB\/:Q<PPI,]CH^M:=JEXMKDXN#!8W,\\
M,$S%\3SA4)'EYW;<ZJ-LY5U8?.RMR %+8.>GS(Z^6PP "X'#96OY=OVD?V"?
MC3_P2U\;_&7]MS_@F#X;^ /PT^%?A_X#Z-X;\5_#3QCIWQ#^+/C/5KR+Q-:S
MZU=>'M'U;5[J\:ZO;V;3BD3>*7#06SLMFHWL/H7Q]_P7E^%^@? ?2M9^&/PK
M^*7Q2_:171_ XUKP'KWPI^(G@/P5?Z[>-80_$&ZM]=M])U 6EMH\)U"\TZP!
MDAN!#;VHNG;]X;I\7T<)4Q&$XEP[R7'8?FK1O*>(P..PE/$*BL1@,4Z/M*T]
M)U)8=T:$Z:2A)^_&3QK> .<<24,CSOP;QZ\2^',^KX+ 8JHZ.6Y%Q#PQQ#B,
M']<QN5\:90\R_LW(UAZ,L-.CF=+,LSR_&4JBJN6&J1JX<_H)9@S')( &,+M9
M2,?-T)P2=V"V!V.#G#,\(%PP42*NX%?,(#* 1V#&09+8"['(.#S\H_LC_M=?
M";]M'X6?\+;^#UWJ4VB6.L2>%=?L=>T>\T:^TGQ9IUK;3:UID=GJ*)<RVUC<
M2-:QW[QQ2SK'O:,@/CZA>:3.XLQ9%5G&[<K#.Z--Y!+'S40A\@Q *X(? 7ZG
M!XFCC:-#$X.M'%T,3"G5HSP_-5ISIUE/V=3F34(TVU=N\I1CS.4?<<3\/SC)
M\VX>S3,\FSO+\3E6:Y-B*V$S7+\=35#&8'$8:K4H5J-:G**BZM.I&G)*G*O&
MI2KT*U-N-:G:X1N4 LID#%2 2<ML0G8 ?G4HBE2%RWF$LJ$,%=O;@(V[8I#;
MOE#8SC &2>3M& <E1G@U5:=P?E1$7Y.KS<@+]T&/:N%66-MNT$EL/ND1R6F>
M1RHP@QR0,G 'R[@S@?+QP!NSURI(QT64=6DXRDEI=VW:<HJ*U2OU5M'I?3S;
MN*F[7Y8RDTG"3;C%M05JK=W*UFK6BVUK=N]N&T')#,WEC;@KD=3G/& Q.P\D
MDC)6HRQ8/YQ6- (\%6;<&(R4<@;U8JNW&,EE()8X!J22,3_K&W*[$,4C:/8"
MK8? &X1EQA2,1\'/!-2+-(&1"4)  #$L#A?O *I" !0",!6"L<%G^8-TY:.*
M7*V[7;7*N]I*\DUM:S5TK/XAI-^S;E37M*5.?+[1.<9RNYTW!-JU-Z<\=_M*
M/6^GJ/F )P0K#<C!=I(P=P8 L7&5)4 'GF8D=..>.>G7'(ZXR0#@'&:RC+(V
M0%M@=I8$&0LH8$,ZH5*HQ& ^T9;&U\\$"RR<*;F9F..HASVSC$1X3(SR2!G)
M..14WMHK7[ZKY:*W;=W\A6:5^G?7S_.VEOSN6Y"3*@5E(9TRI8*Z] 3MX+<'
M<W(VE02"!BFQ>6K*5D+KSN(Y"MM8A78G";E\V0!L;A"Q&63%5LSJP8,)1N&X
M2*%P^1B0&)%#C/\ %A,#/)7*ES2SD%BL&3T8O,W!P3C.1@[(V92I5L-N!!8N
M>SEI;E::=_>Y6G;3=/SO\K=@L][?E_G_ %^)H%NN<\'!QC@]<?>#9/ !QSU'
M#9J-FVJ2O)W!54L-KG!!3(R5!+$[L<#&3P0*2M-G/FNHQGRX]K(BX V@R(6X
MVG(R"HX;<V6+7DD&2)G;"D'F+&UL'EE0$9(QUR&P>F:3@XW;:LDG=1DWUOM>
M[26RLGHUJ-]+V2OO>UNBM9WO=WONDDW=,G]_NL(]Q0D!264R,%+$;A@Y+*#A
M2",9%>1?M!?';X9_LQ? [XJ_M$_&+5X] ^&/P;\%ZWXY\9ZF0SW)TW2K8M!I
M.FQC8+K6=>U)[;0]%LE=9+K4[RVMXCO=<^HS/=%&\N.#SA&Y@2<NL,MRL/R&
M:3+LB/*%61PNZ-7:50>$KY%\?Z!^T+\4_"/B7X=?$[]G/]CKXG?#KQ3 ^F>)
M? GQ#\9ZAXR\%>*-(CNQ<6]MXD\(>)O 6K:#JL FMXKK[+?V5S##<QKY9)C$
MM;4,/4Q7.HXG+J3C&*OC<=3PDI1DU_R[JX>M=[IJ-2\6E>R>G)B,3'!U8S='
M&8B_PK"8:IB'!--/E=.O33<K7::324K-NR/YN=<_X+N_MNZ5^S!\1OB!XRT[
M]F[X:?$O1O\ @H=X<_9VUZ;P3I&A_M ZO\&/@IX^^"L7QA\")X7^$_AKXEZ'
MK?[0OQ N<3^&M7?PC=W,EC;VGCC6Y[.TL/"FH7&F_J)\-O\ @MS^S_I'[#/P
MS^/7QV\<_!GQI^U#JOPO\'^._&G[*O[,'Q7\!>.OBI?P^,/$47A[0M0\/^!G
M\22WFG7^IM=:=<ZQX<U"]5/#-]>R:9J&J1M;M(?,-8_X(C?"!X/%4OPU_9N\
M)_LO^*?$GQVTW]H[1OB/^R#^USJ?[.OQ ^%'Q&T[P.?AL=(^#6K^#/@(--\!
M_"^?PG>^)HS\/VT37+>SU3QMXLU32=6TFYOK<6WTR?\ @GQ#'^RUHW[&5A^S
M5\']&^ >@7>CZG:6NC_M4?$:#XLWVL:1XPB\?'7?$7QBO? %_P"*-<U+7?&2
M2ZUXHEND$6L/=W=FD%G9O%##LLKJJ3Y<=DM[73EFV'Y=M$K4IOF33?+RQ:OS
M<_O66/\ ;$+)_4,\WVCEE:]U9[/%1TLU;WG?6+2LG+S7X(?\%S?AE\4OBYX-
M^&7Q&_9#_:K_ &9/#>L?$+XX?!3Q]\8_C=+\(;/X;?"?XW_ KX-Z]^T3XD^'
M/BB3PO\ $+6M>OO-^#/A.Z\1W?B/3-+.EZ3JVH:9H*?;0-?U/0?/[?\ X.%/
M@M8^!?\ A,/'W[&_[7OPXUGQY\)OAC^T+^R]\.M;@^$>J>-?VG_V>?BY\0[#
MX:^"?'_@V+POX\UGPYX5UN76M=T&YU3P'XNUZRU*RTC7-#U:QO\ 4]&U.SU*
M?W"T_P""<"V/B>P\6V_P#\"7=_:?M3_$K]LFYTCQ#^UKXM\3^$]>^,_Q=^">
MJ_L_>/=-\3>&M<^$-[;:M\(M:^'.L36;?#F*YLE.HQ#[3K5UH>J:[H.I?/W@
M_P#X(C_#3PA9R6LWPE\7_$)K*S^&WA;X?:[\7/\ @HY\6_B+XE^!7P?^#OC_
M $?XD?#+]G/X#:UJOPEMS\/_ ( >'/$_A[2C)X'^RZK?:YHUI9Z;JFO-+:I<
M(GEE:-E_:&1RNY;9MA5%.SUD_9*=FF[6C*\FXOD?O%+-J;3DL%G,7LT\MKIM
M;I*/UF6K=^9W5HI-.5[*[K/_  7$\8^(_&?[,O@GX0_L/?%XZA\:O'/[3GP?
M^+&A?$7Q#\.=#^(/P.^*W[/GA:XUG4]*@MX_&4WAC7XM B>U\4^);MK\V=UH
M$=QI^ARWNMB.UD[W_@D)_P %8/%/[;=A\-/@7^T+\)_B1\//VB_$G[/=W^T!
MX<^)NOZ9X/L/AG^T5\/M)^)6J_#GQ)XV^&FF^&=<N]7T'1M&UR+3;"VMO%&G
M:;?ZK;2/J$5OY3PM)>\2_P#!+"Q\2:E8:_;?"S4_ GBK3?C_ /%/]I.R\;?#
M']O[XH^#?&D'Q ^-^EIHOQ;\-P^((/A/>M!\+?'&DQ)IVH^!8K0&.T$EO#K8
M@GN(Y?1_@#^P)JW[,'C?X+_$?X-_ _P%IOC#]G[]G36OV4OAC+XL_:X\>>,-
M(L?@KX@\?O\ $W4M/\0Z9=?"VP/B/Q=+XQ>6XM_%<]Q:26VEE-,6P81"8O\
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MU76=!L_BSIUA\+[.[\1^._ FM:_K>M?#WQ[HUYX=U#PQK-_::FMK=76DZ<T
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M-/A/\8]&\":\1H7Q4\#W]IX,^(_PX\3?#FZM)8-)N-4M_$]Y>:C;C1^)U_\
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MQ3X0O['PAK?AO2= UJPOM-LKWPC=6FHWD5G8:;KMYJHTW5;FRMM/F^=_&/\
MP2;TGXH_%OXA_&'XZ_#7Q1^TMJ7CO3/BAH.A> ?VF?\ @HU\:?C%\*O@%H'Q
MHM5LOB7I_P"S5X/U?X::?<?"6X\064-K9Z1J=KK>J7O@RVL--@\)S:7%I6F)
M:0\KK))+'9')N^D<WPTHQL_M2C1B[23=I*%2_*U:,I1D5'-J;O?!9U'9N^65
M[]7[J>)<6[VTYHI<VK=FCVG_ ()'_MI_$#]L?X8_%.Y^-?Q.\.>*OCK\/]>\
M#ZEXZ^$-A^S#\4?V5O%_P#T+XD>#;?Q7X6\.>(O!_P 6-0U+7?'.BZO;I=W_
M (1^)^GM:Z9XCT>!KN&UMSDKX-\>OV]/VK_A?_P4\?\ 9U\4>+? O[,_[)VL
MP_"_PI\%/B)\7OV/?CGXW\&?M'?%OX@:/J-QJO@;PY^TWX<N[+X6^$/$VAZJ
MNGPQ:1KWGIJ&9],2\CU$>5'-\+?^"6/Q*^!WB/X:^)/A-XK^)FB:AX1^-OA?
MX\?%GQ'XZ_;F^(_Q/^*_[5NI?#7P-J7P_P#@M\'?CA\7[WP/X:UF7]GKX1:)
MJ &A?"2#0M:\,:S;6<.FZM:GS[V_G]2^)?\ P3]\=_&;]HG0?VD/B[HOC7XB
M:CX4\1^%?'GA;]GSQ'_P42^-,W[&/A?XF^!H!!X3^)OA_P#9K7X?_P!C:5XH
MT90;NTM(?$#^&1JDESJLFA&\O+QY[_LRLX1;QN0N[:47G&&YDG*R]HI4FE%6
M;=IUDE**E&3?+%O-J:E;ZEG4M-7'+<19)]+_ %A*36B2M#3FM:VOYQ_$G_@H
M!_P55^'.G_\ !6?2=0^*W[,?Q&7_ ()S?!_X>_%>U^)WP=^#>L^"-)N/B'I_
MB[3?&OCWX!^(K7Q3XH\6)J1G^#%KJ]CKNJV?D7>DZU+:_9[>.5BJ_P!//P_\
M::5\2/ '@#XD:-"L&D_$;P)X1\>:3 \@8P:=XP\.Z5XDM8MRJ!(T,6IDED+I
MM !?#8C_ !P\9_\ !-'QWK?[(7[6'[''P\\.^&OA+X:_;0\1>)_%GQR^,5W^
MT3K_ ,9?C)KGB+QUKNGZKXWOCJ7C;P+H^FW<&OZ-I\G@ZQL9S;VOA[0+V=K:
M*^N8E+?H1X9C_:L\&>&?#?@WPK\'_P!G#3O"W@_PYH'A'PUIK_&'Q;.^G^'/
M#6F6FC:+8O-_PB"^>+2SMDB#,?F>.-B6E42FHY77@N98_AYMW4H2SG#QLFE[
MSMA)-*U_==[+=N+5X>;TY:O Y_%[7AEE?FW=EKB^7E?5IMO33=+ZV8%G901M
MW'<-F<'=AER,C()!/ P.P0*28."1MR V!N +!<)SP,;.<D# /J 37S&/$'[9
M!!!^%_[-V H! ^+OBX!F '&T^$6"ENN3G( )+9..S\!ZO^T#=:V8OBCX'^#_
M (=\.K8RM'J7@CX@ZYXFU@WX_P!7;'2=5T#3;5;9P/WDZSLZ<!4&!B:F KQI
MN?UC(Y-/F<*694:E1J/Q>SA##QG.HX_ ER-VLN5JX4\RA5JQI/!9[3BTX1E4
MRVO3HMR:7[QO$RC"-Y)SE>2C%2=G%M'MBE _;=M=HU!R[ @*2$W8=<;G!SD@
M]!N4&:(KM4[M_P#=8<AMS,%PQP,$Y7G R >%*DTEGF8,!%"R\"179\%P%8J-
MJ\H&)()!ZG 8'!7?<.26D\KIQ$ 0P[L?,#X).4('("XR< UR.G*[VMYN[OOM
M:^S5W\NEWZ-K+II[MEMIVTVTT>UFK;HT>N"",$ @D'WQQQP<@GH?E'X0$L4D
M$H"_/\N'QN!)5"&; 4LP& 0 V3@\Y%;,W'^D2^_$7IV'E>O8D?6FAIP2=L#-
MC')D"L<8+LH4KN8$[L]..3P"O9ONOO F9PB2.SOG*9)1OER=N' W8#$M$6 ^
MZHQD[22F"6X&"(K8$<9!DZ#' ^7C[H#8X8*H((444_9OO'_P)?Y@+1113]HN
MS_  H_S^?6BBCVB[/\ "BBD/^><9_$<C_(H]HNS_   7'&.GTXII7*L!@$J0
M#CIG./P&>!G@4O0<_P"./Q/)Z$_H.U(6&2O).!GZ$@?F,@GV.1D\4>T79_@!
ME7UU-IVG:OJ%LMQ)=Z=I&J7UM%;0O=SRWME82W%G';VBXDNY//BC1;>,AYS^
MZ0[F!K^![X\ZU\1_$WQ3^)'QBT[_ ()D?##Q5\3/%T>K7'Q%\2_$S_@EU\7_
M !I'XB\6Z%>:H^GZ]H]LNMG2@;Z"*R?4;R& '5[@--<!T.*_OEO7MTM[_P"U
MW"VUD]C?)>7QNDLUL[22UECO)I+UF1+!+6W>2X^VR21K;%?/:1?+X_A/_P""
MD7BSX%:/\<?BOX$_9?\ BUX(^('PX_95^!H^)OQ3\7?%#_@K[X_\":[\8[#7
M3K^MZW\.O@#H_P /?%&JZ;J7Q$TA+74-)CLM1,NIPZM/I.G2:8IN[2*3"N^;
M9VT6C[JSM>W,FKW>Z:=K6+AO^#_KY']O7PIOM7U7X3?"W4M>TV'2=;U'X9^!
MK_6=)MM!D\+6^EZA<^%M/:\T^U\+S'S/#=K93,MO!HDK%]/2%;<@F+!]$CW%
M$) ^Z#G/.2!S_P "SEO4KU&XX\:^ &NZ7XE^ ?P-\0Z%I'B?P_H'B#X/?#/6
M='T+QMJC:_XST+3=4\(:1<:?I/BK7);BYEUGQ!:VLBPWVIRW$LM_-&U]([2R
MR5[.@VJ%ZA0%R.GR\?\ UCZ$'VK6$TJ:5M;K[K?IYDO=^K_,:$;') 8]2,<X
M4 #IVYY(SGIQQ4EL6^VV*$ @7ED0PQVN$)QGU/7&,@'OBFL" WO_ %/4^RCK
MCDCTP*EMMPN[$<?\?MGG/3F=.!CC( ^G0CGFKYTU/2UHR=_-IKIK^FM@W=]-
M6M$C\9?^"-94>%O^"D8P23_P5>_;(7ID9?Q!8@GGU.=QS@?R_9%AD D?,&&_
M&0-VW! /;@[E]<GN:_&O_@C8=OA?_@I)P"!_P5A_;*QG.&*Z[;2;2.A!*J"!
M][)!P"37[* G#!B  ^T'KD G:3C R%)!/.,')SG&--I4X;W;J7V6T:BZ^J2L
M]4G<IW4FUI:SO\XJ_GO_ %8_!_\ X.1[<G_@DW\6M3CNA9_\(W\4_@MKZS,I
M(!L?&EC('Q@@&)@9N@4A"#TY_93X0:Y:^)?@]\(?$%A?P:I9:[\)?AWJ=MJ-
MLVZ&^%QX4TR1KF(C@QR.'<# '.#Z5^:__!>/2[#4O^"17[;BZA9V]ZME\-K3
M5;-+B-91;:C9:U926EY""/W=S _SPR !E8Y7W^R_V)69OV,_V2U.Y)&_9V^$
MQV,/FPWA+3MP.%&,?*^,+T., \?JV:0IXCP1X.Q2YY5L#XL<<9?&*Y5&=/,>
M#>%,S<N:UU[*KA%%[MPG*Z_AM<,';,:\9)>]@\-4ZI>TI5\1"#NMHI2ULGS6
M7FSZHW R94$XA"L><,<H!CL. 0,<9SGH35@=!_3I^%5(B5Z8P0>%.<&-MI7?
MZ<'I\VW)&"I-65SSSGG(]>F.?3ICZ@U^6QG!1BHMR5M):)/WZS>F_P 525KK
MX8Q[L[&O39:*^]DFK-MI_?NM;"@8S_G_ #Z?0 =LTO\ ]8_ES12$>_3\OQ'>
MG[1=G^ OZU_K]&-"D;CG.<8'88SC\22<GOSTSBD923D$],XZCWXQWSCWYJ2F
M$D'@G/7!&=WH!S@>GO\ 6A5/*W?;^ONZE*6^R^32Z=%Z:JVMVGIH0N/F8 $K
M@ $ D<\CC .,9[Y.?FQR*BV*.<?O"RE6QR. <$<  %>W'4]QBV#N.<$' )]"
M.< @],@Y]2/I2.,?,.BX.WH#@Y)R.<;2P/X\4.<7ND[*RO&+:WLU*2;6KV3L
M[7EJ)6NF[7332Y(22DE**E%R3<9.$Y4Y.-N:&_O),J21)(NR6.*:$[&:&:))
MXG4.,I)'*KI( X#!71AG[P':);'3BQ5M)TE\F0NS:7IP8APP=,BWR(R,<<Y'
MWB<X-U@0F0?F&.>..A.?<D;GQRQ+ <D4U^1M/ R"0<YV]@Q&<?3//OFLY4Z=
M1P<X<THR;<G&DFU9J4)*,5%PFY*4TU[TX0FW>*9JJU:FO<Q.+IPO%*,<7BH1
MA&G.E+E@HXJ$6G[*,9N2DY1;O.US^;/XC_L7?M)?\$\/VG+S]I;]A?P7XA^-
M'PBNO"?Q*\;_ !<\!?$GXH-HWA;3_%GB*\N-5U&^TK2;5$@8V5JCO;,+226)
M=L8E.P-7K%M_P7X_9CT#]D30?CQXU&B:U\<)+S2=-\3_ +-O@#7A-XETZXU+
M5+C3+^YLKW5H8[>XL]&LX7O[\NX9H=L: LT>[]Y;NV@O8+BQO(+>ZLKN"XM;
MJTGC2>WN[:X0QW$-U!(S1S0S1%D='4JZM@ALX/A"_LK?LOI(\W_#.7P41V;<
M\X^''AIY7<DB1B38$L74R;L'?SWR!7Q3X;S/+:U=\,YI1P."Q/UJK++,PP=:
MM@L+C\35C*GB<#3HU:4Z-**C.\*DY8:<ZTYTHTW)G]!?\1=X'XQR[**?C1P+
MG/%'$?#[RC!X/C+AG.,'D7$N?\/91A*\*F2<0XO,*.,P6.G*-?#3PN;83 8;
M.*=/+\/0Q.-QG+S'SK<_\%:_^";T%U/!_P -:_#600%X_,2:]EBG",X?RY!:
M@-('7<SA0 P*EF!&8!_P5J_X)NMQ_P -:_#=5.3\TE[P5XX)MAS[  9Z"OI%
M/V4OV6P I_9P^!Y 9]P'PV\,\LX<.V/[.(!9E 89*C&#R<TQOV4?V6G;=_PS
M=\#B0X(+?#7PVC'C';3\#[NW!!]<=*]6-/C%)7Q601?6V79F^5N+CI&6,=VK
MV;=M'=IV1\C]=\!O:3E#(O&!M12;CQ+P'S.4=K0CPZH-2?1)6BG%M1W^&?C?
M_P %L/V!?A1\*_$OQ!\(_%_0/C3XAT.72XM/^&O@J]-MXH\1"^U6UTZX:QDO
MX5M0FFV=U-J5S([#_1X)%96<I7V3^SG^VA^S-^U;+>Z?\"/BIH/CS7M%\.Z3
MXG\3>'=&:6:]\,V>M)$([?491&L9EMKN7[#/L)W7$>T\\5T _93_ &8.)(_V
M<?@>)!E48?#CPNC#=M+ 8T[:2 ,@\[F5.N:_.+XE_P#!*3X@C]I7QY^T#^R9
M^UM??L=1_$;PQX=\,:SX(^&?PP\.OIHM]$#%Y?,=X+=C>7#M=2 6\0CD!VEB
MH%<TGQI@Z]#$.EE6<X:5:G1Q6%R^C6P6*HX>2DI8FG6Q^*GAI.G)14J4DFX<
MS@XRNG[6%H_1ZS[)L?EE#%\;>'?$.%I9GCLMXCXQQF7\39+CJ\ZN!CA,BQF3
M<'</_P!K811HQQV*AFU"<Z.)JU*.&Q,*=*$)1_:$B:)41PRNQW?,I.W[IP,J
M#M!X!'4_*W)P4#D8?(W;#Q@<'+9' P,X3./3KU%?S:_L_P#[=O[77[&^N_M*
M_"K]J_X%_MI_MCQ^$OBKJ,?PZ^-'A7X>:;;>'G^&^@:3$D]['+=SV4$%E?7*
M76JO<0&X@\A$"NK!U'[=?LH?M+>$/VO?V?/AY^T9X#T+Q#X7\*_$>UU*XTO0
M?%+6<FN:>ND:I=:3.MZ^GR3VAWS6DCH8Y"54@-R37H9/Q+@,Y4*5"53#8UTZ
MM6O@L7"5+$86A2K5*-2<X3HTH5&ITTE["=:G+VE)J:C**?S?'_A+Q;P%"68X
MFGA,[X6K8S*\#EO%V28K XC(<RJ9MEKSG!2PSAF>)S3#U\3@75C]1S?+<LQ-
M*M@\9!T^?#U(OZ28L&4#LV6P=O!/ !'&01C'&3W(&*&))"+]Y64# ^7<=Q<#
MT*/'L .00V,8((KAB,%6!!( )V@')QR3C'7@8[!LC'*_.PQ&&=D7>\2@L  ?
M*,KD*2B;GWNYR"R+MW#>1[SJJ"C4DK4W*,(3<K.?.[4Y\M_=4M7.,K<BO*[4
M6E^7RYJ:<JBE.,FY*JU"C2A3O24*DW[)RC"HI\M.4X^_[SIM\MI3HX.W/*GN
M>B@@_+QU.!R2,DD'-,^7E$7&2 !NZCE<''8Y)'3)Z]33"V2Q8@A@Q!!W%MV=
MH## QR3@=B.*,XRRL"R@XPP52S$#DG(P"1G^Z>.N,MR7,X*SFW;1QY'*VBO[
M1*UVKM:<KYGW;DFHN3C)Z-MPC5<=)->ZO81JN-M%+E4FGS*.JO*-PXS@E6=@
M2<?,0ORD=#P2>?X0<=:8RKE2$8'<2Q(P,  (<CG/4Y(((!P3VB5I%5&965"6
M$;;6"3>6VTLCE0)5 QO*\(&1CP<TI;:PVL2S+C*DXSDD]VW# Z$8Y(4845*J
MQM).4:2A+V3C&HVG45FDG3G%>]]F^_\ -:Z;:Z4U"TYJ,'!4JU)VG*-G4EA7
M5YHR2C:$>:%^:I:,IDI4@'D_+NR2,C*DY^A//W>I8DY IBJ1M) QU'J,#)4C
M!)Z@\X]B%I%+.^Q2Y#9<H@+.Y RQC499RF\%U8!L,".X"E6#,K#E3\Z-N63/
M!*LK8*L!V."N /JU5;NWSQC=?\OWS^]>[Y%6O%/HT[)[J*:9FFFYT^5PJTFH
M5*4J=!U.9I<TXQIX1N-))N+;E?F]V]TD@+ALY!(/&<\L6D QUP0J8W=B?2G@
M <D#Y0N#@ _.L9WC [,C#!Z J>]1.P49/RKM);A@VS'+  ,P9@0!CD,QVJ6V
M[I)8+R)5WVUVOE?>D,,J0YV@,ZO)&$VD?.OSG&0!EAP<[>JG4BE&4Y3Y?:04
M59.*?M)3YU=-PCJXR<M;)"DN6TJGLZ4&W3=6O1C&$'*#5*47"A[24G5<8\JI
M5;I^_%1=VUAD8)/#=3GE6'!XPW7CN,#!. 04.  <@'EA\N=JJ,D,V  >3C(.
M< < TU&+$AOF"@!F)[ \*!V7N1QD\'&,B0_,3C!'\0 .UF.0, 9(!VGMC&>>
M.7&JVN>4VN:S7+*<5R/X6XSE"47:[<;;R6NU[Y)*,(NDTTHJ3C0@XS=O?J+F
MP?-&,I6DKI2L[2BK-) K<C 4$!E&,XR0 %!X.0@/H #WXIRQ,7*Y 8$*Q/*
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M9QC^\YJ<;S0R'IN&3N)PHSMP<CD]\?3@Y'3*!&&T@YPN0?<'![=U&.>21MI
M75W#%U8<;2"'7(Y4!L-D=<%20Q'RD U;&5XW#."1T'7L>F2%( .,-U/.13E.
M5VI.M"46U9SG=I2:OI4:LX[N[YDTTM;*W&V]NG*_94%>.MFH^RG[K5K.[37O
M)M:NOL/EA2H&[(:1>22/0XR3@ 9/8,.XI"K!2"&)/7"@')!'!_N[<?*!@'ZY
MJTH)4<XX('<C)R.<]<8SD?EF@(1WQS]>!P/RYXZ8P*A."U_>.5[ZU*K5[]G5
MMZIW3[62!V;N[7O_ "4UM:U[136W1;JU[6LY.5!QC<-Q'N>O^13L<Y_SV_P'
MY<=3E ",Y/T_SVSZ=!VI:?.NS_004?Y_S^0_(>@HHH]HNS^] %%%%+FB]X_E
M_P  "+S!OQD;?+$F><\MC\CQCOGUSQ+5'9-@#S1@8PNWY>.GR]..HXSGO@
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M"^2=HSN& 6R-IR#P"0OWB.,D \= Q8CD@, 8P^TX.%9SRQQG=C;QMY#I@Y
M!MG_ .>O;&<'/XG.3^>>O/-((WW;FDY^7H.#@YY!SWR?4EFR><!V5T[*ZCR+
M2_N;N.O-I?5)W2>J2V#1<MOLJI%:RTC4?-4CHXI\[M=R<[6M'D3LGLCACRH4
MD$#A<;R0<LN.2V2 %(R 6R004\@\A@K<AN23R"#G)(X],Y[CZ,,<I !D! QC
M(/!7@'[W7KSV))&#2[9N?W@/7L0>>N/F R??^5"44^:RYGU2L]=]?/9Z:][B
M<82MS)7NWI[1*[:N]*\6_OU_-S1M@Y*X)9 ><AGW$X/X$XVGA>H*MEAMR"S!
MEV[?F+;F)'( )/JI(89(!*D *31L=N&DR 2.GS'Y2IYSQPV. N1VP0::V]$_
MUC!23OR,M@DC=M&..GL#\WI322:E%)./PZ):O=V<91NU>[Y'][NW%*+;BW'F
MO=Q=:$FY<M[N&,H2V@DX^UY+:<B;N\WQ18W6O>%_%/A\322_VWX8\0:)!'+<
M2);F75=(O;"U5I%R8H?-G57E;&Q&!.U0 /YKOV(?V5O^"W?["GPYUCX2_#CP
MW^R]X\\"3Z]?:CX<T/XE_&#4[VP\%VTU_?2_9?"\5GIR"T@U.&>"ZU& A6^V
M EB[*'/],#9"/ETQD(P'"%GV#=LY&< * <C(R.342Y8X8 *#@,0.3V=>#@-@
M?(0>#QR.?G\TX>PF:8W!XYXS,L!C<%0Q5&A7RZO["HJ6*J4YUXRFZ59.,I4X
M*,7",8K513^']%X,\2LSX)R/B7A>AP_P;Q#D/%^)RC%YEEG%O#_]OT)9ED$<
M;4RW$X52Q^"J8.O2CC,7S5Z>,G7J*:I2G.BI0E^.[>+O^"^ &!\#?V!T& P9
M?B?X@&T$@DG=9ON!/#%@^> !@'/C7Q?\'_\ !??XKS_"R>VT/]E?X6R_#'XH
M:7\2KF/X:_&?7M.A^)=OI5A=Z>OP^\>6\EFL=[X-U'[9)=W=M$AW74-NYA+Q
M1N/WM7>6.%5</R6X"HHZKAB,D#KP0>GS84(-X0$E3@X?Y=V44 R1MS\L@(8X
MPP8[@"!\M<E3AM54X5.)N*)0<E>']H2:<H-2C=1RY--58QE;FBG;ENTY*?NY
M;XR+*L3ALSRSPF\$\/BJ*FZ-6/AW*I*G&MA,1@JL73Q'%.+H353"XC$4$JE"
MK!*HYTU1K0I5J7X\-XR_X+WEV/\ PHO]@2-69CY;?%#Q 64,Q(4,]B'8["!\
MP&T@["JXIA\8?\%[VRH^"'[ H+?*<_$[7R-A*KM8+9%L@%F4C<YVA<CJ?V,!
M!PS<@IMQY:D H2%R3\Y88R=Q/)&,Y&4\O)P=I)4MRN0V,\L,8+ @?F0<<&M5
MPS4:N^*.*;M75LSHI+35V>7\R6BO=)Z)-='R/Q3PEI/_ (@_X*I<MDO]0L2U
MRJ#]U)\9.:23:]Z2EK\3:CR_@GX(\(?\%^/!_P 7?C'\4[G1/V7/&%I\68?"
M/]F?#/Q9\:M<O/AU\*AX5BOK69_AUIL5CYMH?$:W2/K;W!VS36T+LCN@Q['_
M ,)A_P %\0>?@9^P26P,;OB=K?RDD9"_\2_=N(X/+*2" !D-7[% G. W/&2J
M!1GS,JNT#<"&82=U?.>3R4X+C<P!7:&RJA<@Y;"@\D$# P,Y<C'1<Z?#,J*5
M.'$G$MG-R<?[3DXN4N:;E=Y:])SG*4E=._PV227;C?&-9EB5B<=X3^"52O'!
M8.A&HO#R=)JA@,-2P.#HJ%#BFA3M0P]"E1=14_:SY54Q%?$UISK5/Q(\?2_\
M%]O''@OQ3X1M_AK^Q9X'N?$VB7^B0^*?!?Q:URQ\5^');V"2$ZUH-[+9;8-4
ML\K/:D;?+D 8,"*B^'1_X+[> / GA/P1<?#?]C#Q]<>%="L=$E\:^./BWK>H
M^+O$TEG&(WU;Q!=Q6>R?5+L@O<RKEGD))?' _;P@@,#($)&2KCG*L2&&TKAA
M\P; +$ !\\8.0HX5P/XC@,, #(Y!((  R, 9X/!HCPJU6==\2\3NM*FJ?,LS
MCS>S<N?E?M,O4'!-:<J]IMS<R;1'_$8K9:LK_P"(2>""P/UYYA*C/P_E1;QB
MH/#*O+$/BI8B;=!RC[%8ET6KU)4?:)53\>(_&W_!>Z.6.1O@3^P,5C(<'_A:
M?B",*R8*L\D=BQCPV,$;E)7YHY.,? GP._9"_P""_P!\$_BW:?%.[^+/@KXM
MQV<_BF4_#KXJ_M'^(-8^&]U_PE4D\LD<^D+!,&AT)I\:!;^7_P 2^..-;80*
M-H_J"Y=2$CC.XX/5@W4J!D@$N_E KD@LY/JM(6++CCS&"2/M(RP</@E6X5F5
MW)PWR[> 0<CGQ7!N'Q53#5<3Q!Q75JX6HZN%D\UE'V-2Z:J*.&PM*$FFERNL
MJJDG\&[/4R7Q[Q_#^"SO 9;X6^!6$PO$F#_L[-:,O#FCCJN+P\>=4Z=*KC.(
ML;4P=HU:B]I@:^!Q+<VY8B24(P_'<^+_ /@O>N!_PHS]@;;M"D_\+/UT1DC/
M\)L0>1@?>!'7G%(?&7_!>W./^%%?L"M\IY'Q0UT'(7"!0++)W,3R<8QU )Q^
MQ0SC<1DL%ZC& .YP>I 'W01UX)XI0P!^Z#]U=P7:0-VTM@ +QP?E&23T)S78
MN&JDDI+B?BS:3_Y&5"[>EV_:9>WK963LEJXW2/G_ /B*N%LTO"#P1]VRM5X(
MKTYN47:7,GQDY).3LI-MS2;O9,_"#XW>'_\ @OS\:/AGXD^&]CX8_9,^#]SX
MD%FJ?$7X4?&+6M*\=^'UTZ_M[XC1KN2Q\N,WODFQO)=PE%K/)&Q*GCTBP\0_
M\%[[&PT_3Y/@S^PEJ7V'3;"R-WJ7Q7\1S7U^;2"&W.H7\Z62O)>WAA:>XD1Q
M$\LDA"D\G]E&.0""J,=H"KQNP"6))]5.6YQ\O/3E4)!'* <@ KL!W?,,_<X'
MEE6 +;<$$<X&2X6?M)5EQ'Q.IU$J-23S.TYQC=TU[N76DXWERR22U?O27P]M
M7QBCB<NHY74\)O!"664,5BL73C+P\G)4\5BZ-"CC)_6%Q5[>K&I3PU&BH5,1
M5HTU23H4<.YU*E7^=S]J?X,_\%]/VG?!F@>#5E^ 'P!.@>)4\1/XA^ 'Q]\3
M>#O$NK^7;36T>D:O=VT=HUSI \W[3]F9G62YB1I8GP*]S\%7G_!?#P7X.\+^
M$V^%W[$OBR3PQHNGZ+)XI\6?%SQ!J'BC7FL85MQJWB"]-D?/U2\V>=>.-YDF
M+G)8D5^V(8CY54*!M5<J""NXEF+8.X[AN^8EN<%C0Q8!@H0@@D,L8(.=V3D]
M<YVD_*,,..!65/A&C3Q5;&1XBXG6*Q$84)UI9G)RE3IV<(>_@GAXJ&MG&G"3
M=U*<[*W;7\<L;B,DP'#F)\*_!"IE&68['9E@L/#PZC&I"OF$*5/%UI8N/$M+
M'5E65*@O88G'U\-15-?5\/1DFY?CH?&/_!? 9'_"COV!< C /Q/UTDC:5W<V
M1!W*!%V42 MCRU8&1?%__!?$C#? S]@9E+$?\E.U_8Y/7:18AP<GD%CD'!K]
MA6#8/S-@'R^(\#:79F#G)')/F<Y"X5<8 RX A% "XSD?*%WE25 ^<D#C@C')
MX.1@CKEPY4@D_P#6;B=M::YG!*[;=TZ>72DFD[7T3VNG8\G_ (BGA.65O"'P
M6B[/?@#$>\VK."4>,M&U[VNNJ]Y72/P.^(7A+_@OWX\^(?P=\>6VB?LM>"(?
MA/KVL:[>^!/!7QJUJQ\%_%%-5T\Z>-(^)%@]ANU+2]+!^W6$<>\Q78#*%8EZ
MV?C1H?\ P7T^,'PN\:?#.'P=^R1\+)/&6EMI<7C[X6_&7Q!HWCOPLIFBD-WX
M;U0V:2VMX5C6,SK*)5CDDV.#(V_]V"KL1\RDJHV%5!/ )"K@G!"MCT)/0GFE
MVELX92V"P( &<@_,>%; 8[><;L@CG('*^$Z4HXBG/B/B:<,=+_:(/,:G-5C&
MG[&TG_9]HKE25XNEI=I\_OGHTO&^M1JY+.'A/X)4WD$4\N2\-X\N'A]?>9IU
M*;XEE#%N&/\ ]I_V^./4:EJ3<J%L*?AE\*K+_@OE\+?AQX*^'DOP_P#V.OB1
M+X/T2WT2;QW\1/C#XAU?QSXG6VD?&J>)+^2U?[9J,JL!+<N7E<KGS% 1!Z /
M&7_!>[@'X%_L#C:?N_\ "SM=)YR?EQ9D$X.=V.J\'YN/V*R$#M\LAV8WX("E
M@Q([E2Q&"1QRJJ 3N#SPPRJC&XC"@8^]@J0HY*A%+?,?FP<8K>CPM*E"%*GQ
M-Q7[.E&,()9E1Y8PC%0C32J8!R48Q2BN9N5EK*2=WPXSQ?IX[%8S'XGPB\#J
MN*QN*Q&.Q%1\"SP[KXC%UY8BK5E1H\5T:5)U95)5'"E0HTH)I4J%.FHP7XZC
MQ?\ \%[Q][X'?L"KN&=K?$[7>>,YR=/+-G@\GZY'-(?&'_!? 9(^"'[ F G/
M_%SM=&&&"Q5C8<?*0Q)7:#&P(Y4U^Q'/RY &\98[ =OJ ^2"HX!Z-P1R"<*$
M7J=Q&\\%1L"$@MR3DE8S,<$C)(Z9W"WPU4LVN)^*;I:?\*F':OT3ME[>K5G;
M6U[+5(SCXJ86ROX0>"J6EW'@*NX)*R=I?ZXIRLHNUMU9NU]/QU/BO_@O@P;=
M\#OV"E78Y&WXHZ^K,[$A)&86&5D5B&C9"$.TAT+-BO(/@UX4_P""_GP@T;Q'
MI%]X?_93^*S^(?&.M^*XM7^)_P 8]9U34M!AUBX:<>&-&D2R(B\/:2#Y.F0'
M)BB"@*G)K]ZR2 -VW&U0<@,0)0P4-E@3M7R06)R-HSC<:3;P.F[+8 4$J%!*
MJ3G@-PV6'S8'7-8RX8C.K3J3XEXH=6GS^S:S)+D4E:23EET:=I+1MIV5FN5M
M)=E'QC=#!YAE]+PG\$U@\RG@Y8R"\.Y.5>I@*M:M@Y2JU.*9XBG[&K7KS3I8
MBBI.IRUHUJ2C"G^.Q\7_ /!>_&/^%(?L"]OE_P"%FZ]T!!V ?8CP06P3EONG
MKDD/B[_@ODWW/@?^P2I"@;H_B=KN7(8\/OL7.&*E/EY.W&X#./V)VY;<<C)&
MX(@.X],A%(R#@(QV@')P,<T?..%<LN&+9W;V"KM ?!P0VW>,'D*%!VG(U?#E
M2*_Y*?B>S3YE+,J,DHO5OW,N<FDUNXO1JWO6:X_^(IX6/*UX1>"B;:23X!Q#
M=^S3XPY6U:^L6U)\RDM&?@E:>$O^"_5E\>-=^.)T']EG4-.UGX=6?@-?@I<?
M&;7!\(])N+'5;?4U\<:=IXLDN8_%=Q]F_L^>[60,UG--$TG+&3CKKX*?\%^=
M9U#XYQW/BKX$>'K#]H'4=!,=WIWQJUJ<?L^V=A;06=V_P>M18B2P6ZB62_NK
M8-&US<L<-ECG^AQ\J&#%2"!@$A2V[G<V5 S\BE@1T; YY("6&&*JP!;  ^8G
MN&;@N5SP,L/<UQ3X/H5G33S_ (GG[.K5K-O,I.E>K06'K1G_ +)2TJTFZ;2O
M[DFH.#M5C[E/Q[S'#3]IAO"OP0I8A99EV64*O_$.,.HO!Y3C(XK+:$7B>(*M
M-8C XA.MAZSHU*U?WL-F.(Q^%DZ+Y7X<^'O$'A'X>^"_"WBOQ--XR\3>&_"N
MC:3XB\8W1,D_B76K&RBAU#6;AILS,]W<+)(7D;S'R&P2V#WQPS9SD?,')*\;
M48@*,E2PR,C<H)YQPV,^,E1P#P/F!!!0+C)7G)&,D;064]AG(L*) 2!(.22=
MJD!F.5)SG)R5/H=P(RJC*_74Z%.C2I4H-RA3IQIPE/F<G&G%0BY.3YFW&*W;
M>B=WJW^)8K$U,9B<1C*K@ZV,Q%?%5O94J&'IQJUZU:M4IPH8?]Q1C3J5IP4*
M/+1A&-.%.$:=.,5;0'G)&<\X[DEC^7('8Y4J>F*>QP"?0$]"1GC&<9..I./3
MTJD4F;AI?E[X!SP<]SC\3R.!R.B>4R_,LK C/49XP<\#!S5\L>R_KYG.75+'
MKCGIMR1C YS]>V.1R.ARIX^G?/;Z^V,_CCMFJ0$Y _>^O8Y[#'WL<8[<$DG)
MSFC;/_SV_0__ !5'+'LOZ^8%W.1D?X?S]#U'7&1P:0[MP^[MQSG.[// '3T_
M(^U5&C9L;I7.!CMCW.#GK]?3TINV8 ?OL  #H<=NP/)X&/3DT<L>R_KY@6I'
M:,9"%\L  O7&W.3R.X(_$<=Z*J,LQ5OF63IA2#C.1\W7J 3CV/<'!*.6/9?U
M\P+%%9_S[MOF'.W?C'.W./IGMCUI3'(< R'&><=ZGV:[O\ +I89 !'/X]P.W
M;G\\=LTN!_A[<8S]<<?3ZG-+RF'W7;/OT_&D(<$9EQDA1GN3TQ^N/QH]FN[_
M   OTF1ZC\ZI;)?^>E!B)!^=LG\L_P#ZZ/9KNP+QSV_S_P#7],\9ZU&Q;H0,
M \CL0 #^ )RH[$]>,U4*R#'SD\CCH,D_+D],9X/MUZT .1GS3MP,$@ X(R">
MPSD$Y)QGGIBCV:W=VMN@!*R,2,D# DZ':<Y5"P'.T *,J<X.[H>/Y3_^"GG[
M"_BC]K+]N;]JG2O@Y\/OV%_VP_B/\2?V8_ 'PR\2^$?VH_BCXI\#_%O]@B#5
M+'4[/P[\6OAII5I#=:=J_AG4;R8^,;:Z\-#3/%$?B#1XK.?57MKI[.Y_JL1@
MSRF4NUO'#-=S1H KB"VMY+EXP>F\1Q%$ /)8#H!7\&/C/]KC]@S]M/\ X*'W
M?Q'_ ."ADWP2^&'PQ^,\7QM^ NE^./A?^T1X^^&OQP^"ND?L_&X@T5/V@-.\
M/R65F-$\>6YO1X<F,DC0:@(T3YG&<ZL;1CRI^[T=KI/9K;2Z[V22LN]T]WZ?
MJ?W%_"'P/K'PS^$?PH^&WB'Q=>?$#7_AY\-_ _@G6?'FI@C4/&FK>%_#NFZ)
MJ'B:^53M$NJ7MDUTDH(\R%U<[WS(USXN_$/3/A'\*_B9\7-;T;6_$6C_  J^
M'OB[XD:AX:\-6DVI>)/$=KX1T*]UQ_#_ (?L($DEU#6=8DM(]-TZT5&,MS<Q
MG!. 7?#B'P?9?#OX?V?P[U$:QX L_ GA&V\#ZP-4N-:_M?P7!H5E#X;U)]8O
M"]WJOV[3$M[IKZZ8W-UO\V7YV..T1Y4Y5F5C& '"AL!TP<*RE2 I =2&#XVX
MP:M4TXZ/5QLI7O:ZOHU:R6NUK+O8F]I7\_U9_GW^ /\ @IO^U;/:_P#!4[XE
MM^UU\9-:^+_Q?_8X^!'QN_X1(:5X^\)^#OV,=<^('QY7P]\1/AU\+-%\;:7%
MHWAB\^!'P1UCPSX=G\?V^BZ5:>*?%2ZWJUJVK75I#?M^XG_!/GXG_M=_#/4/
M^"@GP(_8S\2ZI_P4-\*_ +XJ? R3X!WO[6G[2ESJ<UM#X_\ !.G^(_B7HTG[
M0B>'=9O=>&E:M<R7^EZ//97$=@98]-C,<48B;]YO$/[.WP"\7>(?B3XM\4_!
MKX?>(O$GQG^'.D?"'XM:GK7AVSOIOB)\,-!GU.ZT3P9XECDC-O=:'IUWK6I7
M=O"L:2K-.TOF;DB\N]^SY^SY\#/V8O"FF?#+]GGX2^"_@]X &NPZF_AOP5I0
MTVRN]4N+B%9-0OY&:6ZO;P1A42:ZFD,<82)"JC%9JC);VTC+JWTNM-];/KI>
M[[%.=]NZ^Z_Y]?P\S\HO^"%6H?$'5O@W^W3JGQ7\*^'_  +\5-1_X*>_M6W_
M ,0O!?A3Q&?%_A+PEXQDU72Y]:T/P_XO\BU?Q%HNG7RLEIK?V.T.I6L;226D
M3N8T_< +\BJ#M78J'(Y7:I5<C^\P W#)^;&/?\</^".;G_A&?^"DB8()_P""
ML/[9 7!'#-K=M@'!/8[AGN"O<U^Q1CZG>VXY"G..Y([\_P![')&#[U4(*4(O
M5;-6?V;1?7;X5_5A/XG\[=K[/];>9X5^U-;76H?LO?M+6%G;SWEY>_ 'XM6=
MG:PQO-<WES/X-U:&&VBAB1I+B>:4K%$D2M+(S*@!SBOQ=_X-P?VI/AU\4OV#
M_!O[*6DZ5X^\/?%W]CKP[I^B?&32/&?A:ZT&&RO_ !QK^OZEHXT66[*37B^3
M!(LUO/;P7$">4[1E)48_T)H'22)G 8))O((5ED7(\Q75@5963(*N"I)(*D#C
M^=OQM_P3B_X*C?#O]M7]L3]IG]B?]JSX!?"GPE^UEXL\-^(-4\-^./!%UX@U
M:QMO"FE&PTB L EM:S1--<HSVZ_O4<,Q+EB?US@FMP[F_!7'/!&=YSE7#.-Q
M>)R#BWA3B'.L9F6&RZCQ!D]6MDV(RK&4<NR[,)8O#8SA_-<RQ5-RIT_88S"T
M+U'&4H2X<0L13Q.&Q%",ZBBJN'K4Z<(RDZ-:/M.=<\HV<:L(1ERW;C)JRNK?
MT0JI)8 G=AB!M^Z6. Q<!3N<DL=HPKG!)4$&4;5V@8&64ET4G@A0T8. 6VJ
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M&T$<D%2H&2:<3(1\JKD9QN,@&>.^P#H3Q\W8X& :K>1%_<'Z_P"--:&%03L
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M+P%Y09!W$\IU<]$+[3D JP4Y.2,XF"FX0<6DN77X6V_GJK66WY6&_B>FS?\
MFGZ:KR[DQ:;'^K3 Y8!IFR.AP'1<C/)#.% X) )PTLZ@XCR#M.#&!Y:E0BAV
M(.7>4Y Y.00<@9J$&,X7<[#A3E@0W!;TXRP.-NW/< <!&A3IAN,KA6.3D-M*
MMDD*06.,MDX4@XP;BJFEY)6NVVEK=/3W4GN]/Q%HWVMWN[N]];6U[?+2R/F#
M]JS]C#]F']MGPIX9\"?M2?"K2OBSX5\%>([CQ5X4TC5K[5+"+1]?N-.DTN74
M+>72YK>>6233[B>WDC$K0R0/NY&VOYL_BA^SU9_\$A?^"MG@'X[?L1?\$O\
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MW[)\T9)K?W5=V^5MGMIZ!9_U^GD6]K* (\ 912Q5F)5<C/8ABNQ1N 4,')4
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M8'MD\?J?Q[>E'D1?W!^9_P :/WEOB5^]HO\ #81(S."S+Y&T@$^8[(P;)SN
M0@+\P10<,<%G +^6KAYF<OL/7"IDJ,Y!R=A<G(89 "L0<A2,&KE(V*B1E*#Y
M=I'[K)R,!E93]\E2X+*7;:RJB+2+'&W.-P/1B2>5VX!8G&,'Y@,!0I Z%BDJ
MVMYQ?I""_)78%X$ Y"GH!]U^@SC^#\__ *U,8N.8O+#%AD2,P!!.>FP,"?FV
MD9!)8D$C!A$,7]P#VYX]NO;_ "!4;I''S_JU/RL02-Q/2/KT)RS#@D[1DC !
M:KTG;U4'^:'==OQ9-'Y@))\G:<-CSBQ)# 9W,% V=,*'9MO.>66;=\H7:"N
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M'(Y)Z'((SGMG)[=L 4S>W_/"3_OX/\*#(W&89/\ OZ/8>GT'KTHNUUC\K?\
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MP3VY(_802': S,!MVL.&!Y'(XP0?O%CR01GH:_'G_@CM(!X>_P""D#_(<?\
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M(#Z?3VHT7\KZ:J+_ !<=>N][[%)1ZXB6VMJ<UO:_VV]?/\]21I"?E!)4!?E
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MYP0"?[" W;F8;B>IPQP&)4_\'#O_  1U&"/VP(VD)[?"GXDG'KPV@  =3D9
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M -NR7X<W]?,L><O>9R._3H 2?T!)]@3VIH$"G<I96!X(SD'U].*B64E0#$_
MX'F@$AL%< Y) 5CEN-PR<XXI//R=JJY;)'$N23@#&X<#KO+9P5W8)P12U5[/
M37HV]-U\/Z@U#_G]/YPGYOI+\=BSYF?^6SY[_CSD_6@RX)S+(,#))Z<D <Y[
MDC'KFJOGYQF-B20"0X&2.A(![9*D],@'KDES3M\A,3_,P&#*"3D-C&"!P3[C
MH,'BE9_\'7_Y'^O70/=T_>SUZ\D[:;V][7[NVY*3&^6+.6*X!((/4XS@\]C]
M,4[S%4<2,JX.%X/]X=^<YW<>N>M1>:W7RY,'DXE&,XW9.!QP,^F"/44TS88+
MY3[B#C]ZI^Z3GMT!R3VZC.<BJUZV>W1?K%:6WZ][ E!_\OJG_@NI\MY;>9/Y
MP_Y[O^G^-(TB$$&5FR!P>!N X)QSQR,]>OK4)EV#(C9-I')D4@MU(VX /)S@
MCIU%+YI')B;/.?WB@>_!S1OY)^2^[9]T.T.M:HO^W)__ "7I]Y('C7(61E![
M#'Z\\]>_\J?YO_3:2H1(3TA?IG_6CGG'& ?Z=".O4\QNODR$>OF@C'J#CICI
M[4K>:\M4_P DQ-1Z5YKUIS?_ +>2F08YD<Y90<]#ZC\0/S'O2 Q##*Q#=FQG
MTSCL.<9[8X[BH][?\\9#_P!M!_A1O;_GC)_W]'^%'SC^'_R(DEN\1)ORIS7_
M +D9+YH'69Q2^9_TUD_*H=[?\\)/^_@_PHWM_P \)/\ OX/\*->\?P_R'[G_
M #_E_P" 3_\ DB4M&W+,['ID]>.GY#BE\Q1@+)(H P!UP/0>@Z<>U0[V_P">
M$G_?P?X4;V_YX2?]_!_A2MYK[_\ @!:'_/\ E_X!4_\ DR;S/^FLGY4A=6&&
MD=E/4$<'KC\L\5%O;_GA)_W\'^%&]O\ GA)_W\'^%/K>\?P_*U@]W_G_ "_\
M J?_ "1*&1>$=DZ$@#V[GJ1QQV]!2^9_TUD_*H=[?\\9/^_H_P *-[?\\)/^
M_@_PIW_P_AIZ60FD]L3+YTIO_P!R(E:08&Z5RK<<]"._\B/K4>8 00<$9YZG
MV//7WSU^F:3>W_/"3CI^\'^%&]O^>$G_ '\'^%)2?2WX6^>@UR+?$3OY4YK_
M -O)O,Y/[V3GJ<=??_\ 71YAP?WLAXZ8[@COZ=NG?-0[V_YXR?\ ?T?X4;V_
MYXR?]_1_A3OY0_KY$VU_WEV[.E/\_:(>6B8Y9BS==PQG^6._Z"E5]HVI*V!C
M"YQ@<YQGL!C&>?6H_,8?\L9!_P!M0/?^F?PIID8](G( RW[U<XZ?@/?\J'KI
M=?A?\(EWC:WMY-):+DGOU^WM\R?)=D1G<J[%6![@12/P>Q!53R/YT5 9&) 9
M)$)W,&#!B-N21DMM!:+S$W8R" <C((*4M]%]U_\ Y%%0HSJ)N%24DFU?EG':
MSVYI='O<F)!&<G&TG.<<$9R!U)X[<KWQFF>:O'RN >Y [=3USQWXX[\U1\Z;
M!^:-AAP<C[JC:6(#_>W*ZNJ@8=6W=0I+@)$VLKJ2<!?DQA2&_NY^8\Y(X)P3
MC -2<Q>+J <\$#=M.,D#.3@G! ((;GL>Q!*(X8D9^[MR#U^8#;T.,'G!Y+$X
MXP,TSYK %I!WP .I_P!K/0 XQUP>1UX:9'0_*Z;@%;&W8V7)50".G#$D>[\9
MH N"5>V3_P!\^N/[W<@G/?#'DD4X."-^>,$\'L#C!/0G/  ZDGYBJ\T@DA)#
M%5.]E*[5;:02#M;GY0%PN3GH>A "GS]I!="  &.SDKT)YX/')ZA2V>IY +@D
M!XZ$8Z\;N<$J,DGH?EQG/%*9%!QUX#<8^Z=W.20,?*<^W/KB@2R$L)(U8<DE
M!CYLY).0W;)P< ;APO 3=(YC)*#?O*$*K$X(WLZX)38V$(#':\@7##E0"_O#
M9 X.,G.!@$XW$@D 9/USVIOFKQP3W^4# R1CJ<@ D 9XZ$=JJ@2J<(RC//*X
MX&W&0.!]T CG!48Q058X&Y06/.$'0@9 &<' )P>@7@<9% %T.K(&S@$=?0D>
MX_+(YXXY%<7X_N?"5EX#\?WWQ EF@^']GX!\9W/CR>TCU6>Y7P5;^&-5F\7O
M9P:%'+K$U[_8 U 64>E1MJ4EP818@S&.NF:61<@LA 7YB$4@*25'RY <AFP0
M -H((S]T-+O"V02-V4+>6K%B[%-SJX:/*996#JZ,NX$,-JD>J:VNFKVO9M66
MFA=.2C.+>R:;>NEM;Z>GXG^?IX)'P/\ B=\%?^"QWQF_8?\ ">J? .S^*'P8
M^''PT^'G["/@3P'\6M)^(4'[)7P<^*'PY7XO?M*_$Z=_#JZ%>_%#XCZ7:ZE<
M6'A_PGXFU3Q%#X0UG7O[:.I:C)=:C-^S7_!*OX>^-_&9_P""@EU_P2R\>:=^
MRS^S)XK^+GP%D_9O\8>.?@QXHUKX9/JND^!=)A^+,/@;X7^.FT"_^SZEJRR6
MVI:A&MK92ZMY[F1F=IQ_3TM]<QEIHQ;6TSC)DM-/T^UD:,8!C=X;-'EMV5=A
M@D9HY"Q>567:HLZ;/,^I:1$!;PV\.H6"16UM!;6T,*M>0LVRWMXHH8=SD[A%
M$N^0Y/7%91I2A>3=[QDGJW:2N[-;--6O?6]]^G?&K&;M%WM[UK.Z5^5MZ*S4
MM%T:=[WT/Q!_X(9:3XYT3X-_MVZ)\3_%.F>/_B1I?_!3_P#:OT[QSXXT31E\
M+Z)XN\3PZ[I8U+6-,\-[R-!L=3N4$MOIOF7)TZ)3 ;B<DR/^VJR 1X+[AE@?
ME)8H?N%AG@E-I8'!V[@#N4D_CW_P1\9ET'_@I H8KC_@K)^UY*2H8%G_ .$D
ML?+#<X .P@Y&%60D\ U^O".P0*NT;552H4Y"IR,Y!('SD MGY&1<MM8#6GK3
MA>R?+%W3OHUU5[)62::T2=NARXE14T[V<UK?1>[RP23V[::M[][:*."2.!DD
MCIU)Z'!/)!'')SNQP!09 N,G)(W8']TX ;YB.ISP!P3C. M9Z,W52JGT9!MQ
MDC!!'7#$9&3P2..*>7D<J6VC"DD[ -Z98\@G/WE8CIQSG) %<K^[T:TWUO;[
MKG.]';Y=_P -_G9)=7U+ZR*QP,Y_ YY /W2>F1G/3.>F::94Z]2" =I! ;.,
M8)!.#@;L8Z<\<4T+@X4QC<<'<BCY6QP.0<''()YQD'T;ND.')&Y\;L(,@8R"
M<YX8)@#G))SG)%*S\_\ @#VZ_P!/[O3;<O"567<#@=,L=O8GUZ$ @-P-W!]2
MX,I)4'D8YX^;(.<8X/&00  !P !C%!7EVX'EML3^Z 1'DC*+@F3L2N%R-HQ@
MX NY '#(.=H)0#DDG+8&[. 5P-O&YB< BBV_E^HOZ_KYZ%TE4(R<GHH&,X7"
MXY('&X+CK]TX/(IF\8)!/RD# &3\P#8W+GJ,DXR$R=@X&:F^1P&+JB+@Y*C(
MR%(4Y+##!ARI)W*JM]TJ#,H/E?*^5!(955>Y7DMC:..@8L6QG'-%^KV7HO2Z
M_-[W!WU]'U_7:_KM?YDSN&7HP#.HW8 ^7# ,=IP 1U!P>&) ) J'DYZD@9X;
MH&PA0$@ MPHY7@/D@]D7+#(?;R =R@ ,>RGG )X./O CCN5,CR$*S  9.1&!
MG<,< M@E@W!;###C@@&J3T:OHU:4?=U49*3]YPYTYI<C<91YH2DK:W5*3223
M:?-&>FW-&Z5GHU'EW2=MV]&D9>M>'O#WB?3Y-'\6>&_#GBW199(9Y]%\5Z)I
MOB/2)KFVE/V6[?2M5M[JR-Q;F1GAE>%I8#(PB9<NQXW_ (4K\$F((^!/P,DV
M\AF^$7@+(<JI8*#H?8[F+ C)(/(X'HNYU,BAD&T@'*;01R3M*X)V@DL#A20O
M4XH&^0[OE!(0@*JD8.0"0>!]UMZY.,##$BNFEC<=ATH8?'X["4_:>T5#"8[,
ML'1NVKWI8+-L%3=U^[<Y4I57!<LJ\URJ(IVYFTI2DV_?Y923=OA;@VFU:[N_
M\*W/._\ A37P/)*GX#_ X>I'PC\ GTQDG1.F>AZ<\XSFG/\ !?X';?\ DA'P
M0 56QGX1^ ARJE^0-%;*MM 4CC<%SC 5O0]S*=H:,[AUV]5[@D?R)!XZ<<&&
M89W !2PR5) ;"X4DD?+G(Z[2N<#=BKCF>:JW_"QG&BW><9_S-:WU_P!9;W5]
M-O=2ZO5J5DHN$6DGJZ5*4GOK*3IIN7G:S\V>=_\ "F/@B>3\!O@?U8$'X2>
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ML\R2'AF0('"Y #%68D*51LE5?!9&!R1@ !OE5^)4R0R?,!D%!RP]<=>YYZD
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MYGVA@&8;EQC)R&4;@5Z88$]<"J9W.H.Q70-E-O\ #_LG!XP!TQD<YQUJ6,2
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MPO8D8!HBUNYR5[IIRJ]5OKC.]]K?D3'E:?,TK-I)**WM[WP-O9:7V;6Y<0*
M0QQ\HR3SSP, \\XX/;H:0QYW!?FRN[@@;?F(( '/) ^F!@\\0@%1N$>W<VP
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M<*SJPR#F23.#U4$[3G'+)MSS@_S0>(/V6O\ @L-^SC_P4I_;<_:R_8U^&7P
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MLW%636FKOHH+5)[+HEOJ!=6Y>61U'&UV,@P#\BC<PV#(+;0S# P23FCS(QM
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M0.^>2U!=6OR\^K[ Z<%IRU$UN[Q=ONC9KSN(CQ+N*[O3!'0(>@))+," <LQ
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ML,9XF.XGD]0<$-@]@2QRH)&%=>2.,9(D$T8SLW98JI.."0,#"Y &0,#A<_4
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M !+[O(SP().>IQP/[HS^./<ATW5\8^P7>"0,_9Y#UQDCC)V]2/RR.:7+'O\
MU]X_90UO&I_X%'TM\-[W_#7R#S4&2I(X Z9(5,D84-QM!)/7(X8<%G17B7)#
M-SP!\F%1OFV<<D9PQ);<,C:RC(I_]E:KE0MC=D[1@&VD^\K X)VX"JI/(Z8'
M7)-(=-U<@;-.NV).&/D2@XR=AP5& 0<X&2<CN*?(NZ]7?3??71=ONL3[.DM6
MII><HJ_I^[W7;_@(<LT2@ 9  X&>G/3YB,^S=P>, XI3/'G[V/?L#E1G/0 \
M$'@@H#C=@%C:=JZG:=.NSP3_ ,>\OX,.!G'7&??C@@33-4(W/87J<8 %M*20
MI!)!QDG!VX'3@]30X+NK=UU^]]?/Y#]G323Y:COTYH][.ZY%I=V^3OJ'F*2'
M8L,%2J[@R$D$*05  D'(:,-M!# 9/S4HGC'=CR220OO@9X&!V P.G&5RS1IN
MK!MPL+H@A%.8)!N /#<+\I(QD#!))Q[ATW5^2=.N@ ?^>,I 'T*]3SQR,<9-
M+ECT?Z_JAJA'2\:CZ_%!:;]GI;J2_:(_4_I_CW__ %XIDDT;#&">AQD#.1@Y
M(S_"6!X.?X2#@TW^S]4(^:QO(P Q9OL\A^;/RDY&%4?+ENBXP?O"J#,R#*AB
M2Q4@@#:1QMZY)' !' &1V&7R*_37;IW?65MD2X4]DIWT5^>-KM]^5)^71_GI
M&X3C/&0,[<-QUX..=N<C.%)Y!('+&N4!.7)S@<K]TG@[B1DF,<$-PW3H":H>
M9(,DXRHST//!*@ ]2PSP>1GG/% $I!(C4#);^$ $9'(QT )P.N<=Z%%+73^O
MG?\ S02A32M>47=IMRCZI?"][=.]K[FB)@&Y8GD*"R8Z[0!NSC .T'') <G[
MBT5GG<H8$E6P<;@I#9& ",#C?@$XX!S@$"BERWU37RV#DI/6\_\ MUP?WZ1L
M_*WF:&]/[R_]]#_&D+K@X9<X..0?TSS5/[/'_=3_ +X6C[/'_=3_ +X%/V<>
M[^[_ .V)]G#^:7_@*_S)VPS(=R8.-P)'(&3@@'J25!('!!'1A2+D&0G: &VK
MR,A 5SR3C&PG'/!4'H33/)C_ +JGVP,?7'KV![?6D,40&=B=LY'&,\Y]L=3V
M%"AY_AZ>8>SCWE_Y*OQ_4L*T>W[RYP0<,,]3T&>,]0.PXIC[=H(*G_O@$L%)
MQG.06[GV&.]5_)C[*HZ=%&>,9(Q@@\\C@\X'K3O)3KM4<]UXQG@D<[>.O7CW
MIN"Z-V\]-/D/V<5]J:]+67W.[_44*00<K]TDA6&,#)(<=7W$<$8Q@^G$V0F>
M<YX&67) [GIC!R1QDXSZ57$*#HH/0?,.0#DGW.<GC.!@CC(R&%,_="_\ ''I
MDD?CCL3@TE#^]^#V^5W_ , %3A_-/UM%W]%NF^[+(9<9)';@E2>0"3SGN2>N
M,]>2: 8?FY0%B3@E0> ,XY]#U]Z@$4?=%^I7'X8]O7I^5(88L_ZI#QR=H_S^
M'OVQR^1=7ITM?\F)TX[)ROY\MOG:UWYE@2)C(.<=,$ <?0XZD_GBH9-A#?,@
M& H.Y1\VS.?4!<D ')"KR":3R8N@C4?0 ?7'OCI[U$T(.,;1@@," "0>&!'L
M-H')#;@1]U32Y$GU:_3[M&/DA;XII][1:Z/;1V=OQ/SD_P""NO[/_P 6?VH?
M^"=W[0_P7^!OA^7QG\4-<@\#^)-!\!0:CINF77CZ#P1XUT?Q-J_@FTNM3F@T
MQ+SQ#ING3V5G'J$L5G-<21Q3ND;$CXC_ &,?V+_C1\</$7[=GQ9^,O@#X^?\
M$XO"O[3GQ+^!]]\.OA_X?\6^%?"_QJT?3?A1X-TGP_K_ (DU&7P+=:QH&D:7
MKFHVLL<,4$DEY>6L2W$D*\9_?58W7Y=VS+H0RG W8V$$;2&(4AH_E;R\L$92
M*Y[Q5XE\->"O"WBWQUXSUFR\/>$O WA[6_&/C#Q)J,H6ST+PUX<T^;4M9U:]
MD)\QX[*QMW<AO,9VQ'$F6%2Z.KGSNRBXMW2OO9ZZ.R>ETWZO?2G)QCROWK2N
MFN9NSZ36KE9V5XJUK)K2Y_.%^PC_ ,$=?B'I6F_M:1_%K]HW]O+X%SZE^VU\
M=-5^'MGI?Q7L-)/Q0^&-SJEM=^$_C%?'3)]2_M+4_',%N]Q/J]]]@O+B10\]
MC N_'W=_PZ*TG'_*0'_@H23\V-OQL]!@$E;;'S#&T G*H&_O8]F_8S_X*:?L
MT?MW>,O'_P //@_I_P 9?"GCCP!X%\,?%*+PS\;/AUJ_PWN_B)\%_'$LVF^%
M/C%\,O[1D=O$OP^UFYC-O;7Z&(PK<V,\D<22Q9_0A5&!@;B2YW;5X!=\@J1P
M !MVKT&5&3R2,%RWC+GULWS-[.S?NM;[+EMZ6LBJDIMI-N-GS/EY9736GQ+W
M5'WGIOK?N?D@/^"1.D'EO^"@7_!0CN5!^-G)).<#_1>,X&"..HZFE_X=$Z0>
MO_!0#_@H2#C _P"+V=^!D'[,,@9]_7'>OUQ$//S(".&Y&XD M\N1@$G@[>>2
M6SMS4GDQY/[M,<8^4>B\ X'3#>W(YX(%\D7;F<].EV[I7ZRG\T[;MW;$JDDN
M7>_5V3^:BK?I;?5'Y%_\.BM(Z?\ #P#_ (*$D$<_\7M R?EV_P#+L.V!CKTS
MU!KYS_:[_P""6GQE\"_LN?'SQE^RU^V7_P %!OB1^TAX<^'>I:M\%_!#?&."
M^_X23QG'=V<5AI?]GW@L[:^$D37+M!-=Q1NL;,K^8B(_[\LD:E\!58J,<84<
M'=GM_L?>7EL'J2?E?]K/]L7X-?L6^!_!WC7XLVWCSQ-K/Q-\?:;\)_@]\)?A
M+X7OO'/Q;^+GQ'U6"6\MO"W@/PI92Q37<UO80/=7MU<RV^G6$#;[JXC>1 T2
MI12;C.<4GRQ>B?1OEULETT^5GM2J2<K)7=DE>5EIKIIJNOFUY'Q#X<_X)(F]
M\.^%]0\0_MY_\%!]*\17GA;PO<^(=)3XY)*=/\2W'AW2Y_$6G.\5O)%YEGK<
MFH0/!'-)';2QR6D4LR0JYUC_ ,$B=)  7_@H#_P4)!+8(/QL( )P 2!;9&,8
M]QR..GZ7?"SQ[%\6/AGX$^*4/@KX@?#F+Q[H']MIX&^+'AJX\(?$SPF%OKFS
M?1O&WAF629M'UVWDMGEE7S)?M%I):W*2R12*3Z'L&X?(KJPQ\RL2V "%#;02
M&*_)U#9^\" ::@GKS.6BM=?$[V=_NOHKVM;1E.<K6:2:=KJSY?=OLTUK>RYG
M:[M;M^1Y_P""1&DDC_C8!_P4)P<#(^-I )5L*23:Y .XQGC&[ S\QPJ_\$B=
M)P%;_@H#_P %".K8Q\;, G&6Y^R\]!T.>W!!K]=3"I!R"P92"6S_ '3R!V;E
M@I&,97& .(9(XU*\8XW!3DJ1NV<#/)WGDGJ4)Q\P85R1ZZ?CLGWW\S.$I+[4
MI*R5G&"]Z[][W5;5-1Y;63U35S\D#_P2(T@G _X* ?\ !0IR_P H'_"[CEC@
MX7'V0D9PPSC&>N*^4O&__!+W]H'3_P!M#]G7P%X._; _X*$:O^R1XL^$/QGU
MWX]_$U/C%93)X/\ B;X?N-+3X5:(]^SQW^GR>(H9M4+6UI8WD$[0PF6>%6?R
M_P!\O&GC+PS\.?!GB[XB>-M5&B>"? 'A[5?%7C#6([*^U&?3M#T: 7-]=V^E
MZ=#<:IJ5XBJL=M8:?;2WMW<2PPVR.S@5^<7AS_@KO^R[X[_8YL/VWOAMX$_:
M>^)_PIUOXH^*_A#HG@GX?_!?6/%/QCU'Q-X->[_MZ_;P3ILT\UAX>L;/3[C5
M9]4U2YMQ90*ZZA'!=*T59SC%>ZZG+K>Z:3:2NT^MDEJKZ6NVC15)NZ4)2M:]
MFD]4[6TMLGUU\G8Y6/\ X)$:7@EO^"@7_!0IB0G_ #6W&, ELYMNH=B,X&!A
M1]W-._X=$Z0>3_P4!_X*$]3D'XV[2>IQ_P >V/3OWR/;[K_93_:<^#?[:/[/
M_P .OVG?V?\ 6+[7_A+\3X=7?0+C7-+?2=?T_4/#VJ7.B>(= U[2G:9K#5]&
MU:RN[2Y5)9H9'CWQR."K5]#-%&2"456(SC*A2P'(*@#<-Q '?(/&#S48Q:NY
M2D][IQEH[O5V2T6R5VDK/42F[[--VTG>^GPI66FB=[VNVGHEK^1@_P""16D
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MKC_@H%_P4'6!Y81*_P#PN_RT"&10\CN+5F6./+$MM)&TE4< X_6TQJ58E5!
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MI-[236NKB[_))=+6U6HVY)V<)+2]DKZ=7=-+Y;ZZZGY&G_@D3I.#_P ; ?\
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M[V2N[I*[>BTV:*C.<MDWOU:75/I%]-O)KR+9_P""1.CYQ_P\!_X*$8(#;?\
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M9"G! R"ER+N#I-M\DZB7E!/7K>R>I!Y5Q_?8_P# 1S]>>GKZU)NN_1?\_P#
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M(!P"245./+)WC>ZMI:VJMHW>_1Z=^B%%\LN;XFG=7TZ6MUT\]_DCXG_X)O?
M7XW_ +,7[$GP$^!?[1WQ#?XD?&7P3H_B23Q7J;^(]5\:6OABW\0^)M1US0OA
MWIOCG7'?6O&EA\/]*N8?#\/B#4F>>\1&6/\ T6*$C[;$DA+1A!E5&TCA6P22
M1D $;@2=N#T[9PP0IRF2<# /"E2.%;@<'G!]5+<9)IPB[$YQP!W7KNVMUR20
M .>2=P.32C%0BHIW5M+J[3O>_,]7Y+97]$#NY3?,ESVDU9R2=E9_%%/:S7+K
MO=;CSYS@*< !B0RD9(V.,=L*6968<DE %*]3$5D&<.<J-V"5SMX4<8QE@#QT
M)P=H!X<8>!EB3T^\0,\Y)7GN#U)[_,>M)]G4Y))[$_,<<C&0HX. !D]R#V%5
M;SM\F[/RU_JVW0>EMXM^<);V6_OVO?6^WYF#XKU;QAX=\+>)_$7P\\+Z7XY^
M(/A_0[_5/!'@G6=?3PMI/C#Q3:('TC0-3\336=_#X?@O;DG?K4EA>I8.L<HM
MI=N*_F8^$7[*/_!;SX)?\$SOC[^R-\(OA/\  #X5_'3XR_M&?%+Q^_Q'TK]H
MZQU*\TKX2_'W6M5\5_$:Q\,7[^'39Z#XWT6YN8O"6C:VQGD6PG?7;:W35+9(
MF_J%,(/&YMHXP<-Q_$/NY!4G.X8&3E<$"FB%6PWKM.0  ISNZC' VCY3\K%Q
MTQFLYTHS=VW)J,HIJR6OEKUOO?T=[#A.4>9<T6FDK.-N72R^%Z][6W=KI:GQ
MI_P3Q^$'B?\ 9\_8R^"'P)\4? +P7^S'JGPHTS4O"5M\(O 7Q+?XQ:-:Z9!?
M/=0^-+_XCRZ7I,FO^+/'UQ<77B7Q09K,2V>I7IMRY6--OV@%F5B0H)ZY;@J,
M$$!1C ;.1D@ YR-V"S!"HY+-DD<Y  .2<X'7@_,V<O\ *S'@"@Q@$ %N01DN
MW ;C)YX)89.#D8Y/>JA%0BHWTBDDFK^KT:!MR;;E:6]^3:VFEI:)]FF[WNVG
M8D8W!P< $8"X/W<@@@@!1[GE3@8W#&:C*R(=Y;Y$89) +'!7&V,;@264$#:W
MS!0V0[4IB.,AB?X@0S9P1UP<C&>,8/'XY0Q <DX[G#'(VH=S+Z%6&1@_*P4@
M ;@U:];;-;='OMUMUNVO,BUTTY1L]K4VFE;:_-J[ZWLNB[M_E7_P6/\ @9^U
M?^U-^QGK'[-/[)?PE^&OQ*\0_%7Q3H,?C;6_B/\ $VT^'$/PX\,^#=8TWQA8
MZQH,]SIE\?$=]XFU?2#X=OK&WDLQ;:==?;?,GBP$_([]M'_@EY_P4L_:P_:W
M^'O[2,?P@^"'A3Q3!HG[-(\)^+-+_:">TT;]FO4/A)J^GW7C_3_&W@<^&KC3
M/VB5UBRLYSX8OM9M8GT[[0D$(A6($?UC^0I)+*"6[ !%&,#(5< %8PL2@<%(
MP3G)RTPC)PY&>@R,CKG)SEMH/ R #@9XQ63I1;O]R:ND[WNO/:_>R^=PGR+E
M2TYF]--]^^[U=[[NVMATAED$1EF\R=;:W2XGBB6*&>[6$"\GMXONI%<3K)-'
M$-J0K(+?:%4*(X_.;)!(/4M@ 9CQGKGJS-S@A6"D9"XI?*4  .<@8('!Y)QM
M)Y5R6 8@_,2N1BG)"!R&89R  =HYRS8[^6=Q.TC!RHR<9K1+1*ZTV7+YWZ6Z
M_F[MB?O.3YM).Z]UOEZ63YO>5]==NF[LX&0(ZD*!M(8 L#QM5CN')QA<!C@[
M=V% 4 #PO/&MRWDPR.OFLJAG56=0[(IVAV"%@H!/(QC.6#1!ACAFSUR6/.>H
MW#YB"<DY^;.<84 4"$+@#[H)!5@I7D ')QNQCH",]#G)-5?YW=[6LM5YMMV>
MNO6SZ$^]=-S32<G91<>JY7=-W?Q-6LDW=-6L_P  _BU^S5_P5!^,O_!3JS_:
M#\?_  @^#VM_LX_";0/%OPN_8U\5Z7\?+71=3_9:M_B'X?O_  YXI_:I;X5R
M^';Y/B-\;$L[J,Z'IVKWEK'HXB6'3[B-HHKE*/\ P3;_ ."3G[3'[ G[?&J?
M$36_C]X4^+O[*NA_L"67[.?AS7HOA_X:\#^/?B'XZN/C)K'Q/NM(\7:387-[
MK1U;PMKVM>*?'6N_%35=3NM7\:W'B>QT>\:ZDMY_[/\ Z"1!'G(SW &3C!/R
M]\X(^\HQSD\%5%.\C)Z].!D#E1M R!Q@J@W#H03GYG=CS^PBI2E=MR?,^G6Z
M6E[J/V=-+NUM&:^U=K)I+;WE*3VWW[WW;=^MM$X>8^]L*S%L%ASM1<8P&(('
MS X8?>#!BQP:9Y<W&6?UYV=_J22,XP"?3T%#1!0"2"=P.26SD8.<YSEL#=G*
M@#( II 1FW.Y/# ;B-I)'?)7&<!1C!.5"\L#LD^K7;2_1=E;RU_X)E=]XMMW
M?N/RZN7X#L3("=S'CHP!'( !.TD\9!]\<$'!'E/QW3X@W?P7^*=G\*_!VB^/
M_B'JG@S4=,\,>"==\;ZE\-M)\57.HJEK?://X_TB*;5O!]S<V+SG3O$-C&T]
MA>>3+\IY3U8P7&0N,Y8H0K1.P?:=J. [&.4H78I(%89&  ,5%)$Z$[E5CM#
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M(WVAQ@[5!_B4_-G.<G@?,Q],#+!@ <5!M<#NCKAFRX.Q2^T$@L /F'!VE0"
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MEQ?2((WU"ZM[6VM[C4I($ CCDO;B*2[>)<".2X*<D M"($Y#9//!9BK +\N
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MJB[K1)75[/>W7KOHK]&HRG!W3B[[W7=WMTO9_@WT>GX<_P#!-?\ 9T_X*$^
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ML99@6(4"JYB.2,D9^\ S<_=SG.><XPPP3@@'&<.,0)QR06!!+,WN<J3]T_Q
MYW<8P <EM+7WNF_6_P#G_5@5U?WDFFFI*-V]+VTD^6_71WW=NG\G[_\ !%3]
ML=/VV?CCJ/A/5O#_ ,./@E\9/VQ_CK^T5XI_:Y\-_'WQO8^)/%_P&^-/PNU[
MPU=?LR^+/V8[65?#&LWC^+-5MY]4\:WY>5["R5K<(!'&/KK_ ()?_L _MJ_"
M#X__  !^*7[7GA/X1_#;P]^Q1^P%;?L#?!B#X;?$:X^(>I_&^V3QC<:Q=_%S
M75?3=.3P;IMQHR::EIX;=KN[M[YYRTD<02&/^@;R%WDEGP3NVC .<Y/S ;F7
M(R ?N[N, XH\E2PQG).2 % VX*A1P2H0@;64@@[2 6!-9JA3BXM7O';MT3TT
M6R^_=MNY3JS?,KIIQMLD]K:V=FDF[]_EJC*Y.X,V,8W*PP#DH-@Q@A0I#$9.
M &ZDX )SAD8]F!/+$,,X( 7 VD#(+;06(QD&G&$<X.-QS@,^U<Y.U0"   W.
M,9R3CO2>5C 7=R""N\@<8XP<D# ]>_Y:)-*U]?3Y:.]E]VNQFE:R4T[=73V6
M]K*7O/IS/5+O9#W>0 &38(PP8XQP1M0#) 7YI&^O4 =!144B;$9B&P /E4EV
M(W*/E# J, C@J3D9SGD%*S_F?R2!\U]*DDO[MXK[N;\[C_M2>A_S^%--PK'
M!)P. 2"0#S[8Y'7CDYH=3M;8!NQQP.OXX_STJHRS;LLRJP7^ ?.5ST!'"AF.
M"1EAD<8&30%HSD<!&'3!(Y(!SC/H>G''I2_:%P%<'=CCW'R\\=^F1G.#[@U2
M2/S5 8R AG4X<G'W5;#95L9 )VYQGC! )G2-4P-V<G.2=Q?)+  GJ%"%PH.X
MCG 0J2?._G9K\RMGLNZ:4E^#U6NVOGZS-<Q8RV< ]1GOQV''/?C'J*;Y@R=J
M-\OX9Y XZ#'3_.0(&68LX_=D'@)QNZ G'0X(&X$X Y&XMP&_/(SQL&VJ"I*O
MN.Y0FX* %QG.1\Q(VG@<X3OT^8):;QOM[T92M_X#Z_\ #:EP7 4?.K#D8SG/
M(STQGH,_3F@W*Y'7'<8]CUXX[<?@>>*K1P!2C[FPI/!;^$=,\D Y W#)/7)Z
MBG.L@VB(KR7!)7=D@* ,X(!7:P)) )(!.X@-73I\N:_Y6%L^C]-+^E]OF3-<
M @%58CJ2.@&<9;TY!'//M2&5NP;@\YSMZ<Y)&,8^N/PJBY*.@<%FD.?D(1<!
M1E=F"<D$%@ZI]T'/((D$2.P8.Y5F+@JQ"X7!92 WR#)V@=,@Y'0TAK:WNMOR
ME=?.]M-7\BXMRF,X)_SQVYP#U'!.2.](;@'E48D#)!R/E! )QC/#$>GOQ30"
M$^4#N!D +G/ Z=1R #R!C(&&Q4*2_,S.O&&+1J5#$#NPR0K;HPJA7W%B<%E<
M!I)[M+Y-W\M/U$EK:^E]79[=[*[^[4NF8GG:_88R!_$V0,]6 *\<=1ZYK/NM
M:T73Y;:TU7Q#X6T6\U"58M-M-=\2Z'HE[J4DGRI%IUIJE[:SWLCL0JI;HYWG
M8,G I0JLJ')+L)&&R0%L,S*K;2 &4^5Q( H3KGD ?RD?\%E_@!X__:Y_X*??
M!S]F3X3_  \^#OQ/^)/C;]A+Q_-X//QO^,/B[X5^&?@=KLWBB&WM/CWH!\'"
MYU?Q)XR\&/MN=*T:TLIGN63=(3$K"HF^6/,G?;11;;UUMLK].PTFY<K<$EK=
M)KW;;MN5]=U=*VMUL?U@R,(F:WE5HY%E6,JRD8=C%!Y8"@AI"9!A0<LKAU!4
MYJIJ^LZ/H&I:3I/B'6=$T#5_$ET=/\.:1K>L:=IFJ>)=1^SFY.G>'+*YN4GU
MO44M;>6XDLM.6XG2WB,KHH4Y_D9\6_\ !1G]IK]F?_@HI^R/^QSX&_;#\?>.
M(_A[^V7^QY_P3I_: ^&GQ)N_V=_#^AZ]I?Q6\'Z-HOB[XD?"OX)3:-K_ .TC
MXN@T/5M3TWQ-HW[3'CC68/!;>+;S0/"E_P"'=4L]51)_EW]@?]HCX@^$OA?_
M ,$K/#>M?M"G]K7XZ^&?^"F'[8>@^-_@]\3M%TK5?BE\ /$FC>&_C3<>&?"=
MI<:A$_CS1=7^,VJ:/%X\MFU?5=4*77B2\\+>';B)=)U*PML%B5*7*H/KK=ZV
M]4K+5:V?7?2^OL-]7MIIK\TF[^BU>ENR_N1:X0H #]TLQ4' VC.#V)4L#R.
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ME]X=LO$&AW?B+2XX;G5?#EGK%C=>(=)@O%)LKC5=&BF?4+"WN_O6LMS!&DX
M:,LI-?SAP?MA_$CX._\ !NK\*/VD?@3^VA#\8/B_HG@/X/>$8OVC]9TGPUJ]
M_P" /%FO:UX:\->(?A-K>@2:=;"74_@\NH+X8(\5V\_B/4PMOJE]=7<%[!<R
M?*OQC_:!_:J_9K^*G_!0'POH/[;'[/NG_M(^$_@]^QG=:C^TC\=KKX6?LV>(
M_BIHGBWPMJ_C'QQ\._!_Q)U30=9^'7@7XK^(- LKK3OA1>>+M,GTJWNK:-<2
M7)*,W77+&T+2:<KW<MD[IV7*ME:[OKU6J(T6W\2T>W++6U[]MO)Z:7??^MVW
M\7>%M0\2:]X*L/%'A^_\:^$M&\*^*/%G@ZRU6VF\3^%O#7CR76;7P+X@\1:/
M'(;O2](\7W.@:];>'[JYC2/49M#U".'<8) NZLR[]S'(;. ,X*\%6/4C.1A<
M<9.>,8_B2\'_ +?/QCLOVL="^/O@_P >_%7X0_LS_M0_L_?\$:=,_;;_ &_O
MBCX7\*ZI\=/V?/"UW;_'RP\)+\1/"5GIN@?#[PQHO[5/C;0+?PGKOQ]C\(-\
M//"O@+4_"WCJPMY9?B/X?&K_ -NM\GE:AJ*?9$LA]HF9+1)!-'' WSP/!<$_
MZ1;SPM'/#-A%G299E4!@JJC5]KS7BXR6JVLU;>]T][]']]KJ=/D5[IIZ.ZUO
MNK;I:;I:ZW(3,I*@#()V@>K'C'7OQGCKT&>B^=@#.3D8R 1U.!G('#'  [9Y
MXJJ!.PSE"OWB=A#8R6!"MA@>3MXP6YY7BD"K)YB-O"I@ [V);:Q7T!5OD8X)
M.=V&/0KKL0KO9+R3BWYZ<NOWW^Y%KSU!&]6 )XZ8.,C!QU&[[OT QQ3O/B/4
M$X&#GK@DGGCO_3ZYK+;A7!WDL/F +''L,$]-RY.T=!S@[<C^:6(78%.-H>/<
M2>""7X4'HFP988)(6,_*R>OZ+3_/\2R9N25&<KD>H!PI/;N.@Z$$]Z:9L*7*
MM@<N>N$!RW&.XW9QU!YJHP*NA;+;@"Q1L!2'XV<=R1O52?8XQ4GV8'=RS ')
M5F.&)Y:,KG@9 4DC!!.% SN!WLM+._>,M-.CT3^6Q:%TGHQQD'@GH<'/'7/'
MUI/.#$LB],AB>I)4[1SP1SDCU'O4+!UCVH!N#$DLF[[Q)8[5SN&2&PH(#, ,
M&,L82)0-V%;H, ;#N+<@C+#&X8S\P # 9^Z 7_ WVW6]M?NU[:LN>;U C!Y
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MWS5U\TK?@6S-NX,;'V7KV. #W)VGL#ZG-,,Z[BK9#+@E3VW,">F.3R".HZ5
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MQ#IUAK>@ZYI5PEYINLZ-JUI'>:?JNGW41,=S97MM*DUO,IP8R@.&# ;<>-@
MQ@$X !^7G[HZG@GY?;!!..7;2ZOOV=OOM;?;6[1+W^?_  /PM9#C/*/F:$
M9R<8X/7[W8_K[@8K_:#NR@4-)AB2[,-N1G@G$8X.64]=H R15IPI4@@;3DMG
M@8ZY/OG'///:J3!>,( K$@L/F;H!N7L<D@#(X].E%K[)O^ON[B)O.R2ZKB,*
MZ[ 3M8@%AQP""J\-\I+ $\**D^U-V5=H )P<<$H  <X'+[0>1E6_NFOD;Q/^
MW/\ L=^"?VA-#_9-\8?M!>#?#G[1/B:]L=+T/X:ZK!K$-W>:UJ5O]JTS0?[=
M-C_PCL>OW]J3+::*VH_;KJ/"K%EU!]$L_P!I#X"ZM^T=XJ_9"TOXK^%]1_:>
M\$> (/BOXQ^#%G-)/XG\,^ KHZ:_]MZBR1FQMW$&OZ#>?V6UQ_:$-GK>G7$]
MND=Y$6CGC>U]4^5^N_X]'L^Y?(^52V3:772[:6U]--6]M%U/<#(I<$HN0P_Y
M:E>58CYHUPH*D#:')8 #<2.0\3RL4&,D9,B *<K@ #?QAL]0/N@C!Q@&!%7=
MN<(0%#AN 6!4E2,<!FR=WOG)R35A(PDF5'RD,2WNQSQZ\8'/0#BJL]/-77FM
M;/\  CT_$?YTO&8CP1T."PQ\PSGY<C/S#D$8 (;(BDF9L*Z,JDC.&"+N+*?E
M8?/G8VUL'!&?F)&&L-TX )[9]>0/SZ?CZ5Q/COQMX/\ AMX/\4_$+XB^)-/\
M'^!? ^B7OB/Q?XHU4R_V=H>B68_TF]G$$<MPWEEQ&D4,4DL\C+'"C.0I-%JW
M:V[U_3RNGTUUL-)MI+=['7"X$85RJ[ H55S\R$  @MCLN 3SRHYPS('+.R[L
M*)#D9<' PQR,CC.%[$Y7#<X(%?!FE?\ !37_ ()^ZY\!_&G[3>E_M4^ )O@?
M\//&VC_#CQSXQN+/7[6]\,>/?$.T^'O"6I^$+C34\60ZUKT<A?2(&TI1J2+)
M/"2MG-M^GOA!\9/A-^T'\.?#_P 6O@?X_P##WQ-^&?BM)W\/>,/"]P\^G7_V
M5S'<P2K*L<UG>6D@*7-E=1QW$+_+(M*,H2V=[IM66VMM;ZZ;.]FK[;7J5.45
M=JRO;=7U5_N/5C,64LT8"XVY)4C##:JL6W(QW,I;<"NW.5=7*F%95W%E( (9
MV+,6W!R7D18R2J;NVUBPP,DL6Q(BJ8RK@XRQ<D]60J2<_P!W&TCU!XZ&H"(_
MF(4$8!SZ1R(CJ2!U!!W'TY&.*9!*MPQ8..5/"*<?(0"#EAM5<CJN"2.A!P:?
M]I8?+Y:G&1@YX*[ACGN0A5?7 '4Y+(H'N)DMH8F9Y942-5&<.PR,=!]T-D=
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MCLM4L)[K,EM#>VDTI;$C-%%<(\P1,$D!5((XYR,XR#_)/\ /V>O^"CG[/O\
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M?JK:Y:E]->2 0NW](3,'D+(P(8@$L ,%02 IQR ",E@2P# !LU\F?%;]O_\
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M')8Y  )/&Y@ .]6?M4/]_P#2M6V]6[]+O7;_ ",VK/M]^WSU^\B)53Y9=BH
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M #J. !G/7.#W[8VGLQ/)-!MX(&"!@\1R"./:3\N$ ^7!SD#OP*3$W]V7_O\
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M.XBI^\)8 2'!Z><<XSC)_' /N0*<!*, I*%SD@2^F#W!Z>_'/KS35WH1UO\
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MT\E;^MR6ETM;7U_X*>KOW=M4KEUI(PI/R=!QE3G. !Z<DG'J%8]P:<00<@9
M_B7:K9!YQD<# P.VT$$<@"CM;YOEB!&269,DL2P^\.IR%^;^]N&"%IO[S.T^
M:"2.//W-CG)R.&([^I_&D*_I\_\ AR[$EH)MNHQ/<:>BSW5]:Q00W4M]9VUM
M-<7&F06TX\BZN=4AA_L^UL[@&.YN[J*)R S,/R1_X);_  0^,UIX@_;4_;O_
M &I/A?J7P<_:0_;Q^.]O#I7PF\2Z;IFF^(?@E^R/\ K,^!_V?/AO>:=:3W<&
MAZOK-E)<^(O$IT>>&S\4V]IX>U35(Y;Z -%^L161A]V0,&)#%\A2.CJ!T<'
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MH#"W!65P0<Y8!\8Y&!P 0><XSVZ$@IY(ZDG<QR[*=NYN26(YY(R#@XZ'H *
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MZU&(% P&D_[[/^<>PX'84AA49(:0'!!(<Y*\$KD@XZ<$#(///2@+DZ [TRN
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8",':[ ]BV' YY^5N#D<8/'0XR 04 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ea028514801_img12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img12.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &@ KP# 2(  A$! Q$!_\0
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M"FH?^!MW_P#'Z!JVKY'_ !--2Y(&/M]W@9(&?]=C')P,<<<=:HTJC++[9)_
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M\T7#V<=TT=M)=B/[.ES-#;O*LT@0?R,V/["O[6OCS]IO_@EU\8OA[\%?B_\
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MZ7HKR9_,,>H2R^5(\$@BNS(8IXF*302;)6$<\4@*2POB2-AL9034_P!HNO\
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M\\5M=>5/+%<6\D<;+,F?YMO^"97PW_X*E_#/]JCX#^!?CS>_'7X;_LQ?#/\
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M\_,W_?V7_P".4GG7/_/U/_W]D_\ BZ914.-K+37R7>W8"3S[G_GXF_[^R_\
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M)K*3%Q<_Z1^\&S\5/VCOV)OBK^TA^WQ^TIX6O?#?B:T^#'Q+^,7_  34^/\
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MY!.<'&?\^V,Y).<C)QD_SK_LH?LM_MK?"_\ :%_X)R>%OC_9^,M4T[X/^/\
M]M3XLZ:NI?%;4_VFM)_9U_9YD_8M^&?[-?AOX+Z_^TG<_#[X<Z5X@U3XH?'O
MQ1JOQ(^&_P /X]#CN_"/@"UN-"T^XU.P\$7UQ8?T3CC\R&]!@G.,@<9R02.G
M'<8F+<]6N5]M5\]4OPO^2.>K",6G"2:?123L_*S>CL[>=UV&=)6/;:!GW)
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MACXML-+M+AO!_CGX<_LR?#N#2O$^C:1/X9M?!_AP_P#"+C*TW]F7_@HOX/\
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M-6JX2CBL9+#U\7]3PU2K1C6Q:PV&:KXAX:G.K7EAJ#CB,1"BZ-"2J5()XOQ
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MCQ^S+^RM\0-4T77;WQS\.?%/Q2TG]H#XE7OA_1O!7Q0N/"?@S2_'5WH?P]\
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M,BDVVHZ?:W<926!7!]VSWO;9[V3=O1-]AK=?IN?BSXM_X)-_LX0^&/B)X/\
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M[\-!/ T\TSOIWV/_ ,.B?^"5W3_AW=^Q_P <<?!;PJ/_ &TSV[\BD_X=$_\
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M(XQUQ@$8HQQC_/\ D=O3 I:0]#]#65VWZF "&8A[A(I#"NV-Y1&QB1WQM1I
M-HD8 E8R0S $@<4F"#DD=,Y'4+CTYX&<X/4XYYK^>S_@K)^V7XR_8?\ V[OV
M*?BQX4\,V7CN&]_90_:\\,:CX)USQ%K&A>';UM5^*'[.4EOKURNEK,MSJFBB
MQEM].DN+61HH-3OA%-"6"R?*[?\ !QE\7,%E_9>^%6 S A?B)XP/W2%+#.E
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M?7D=>N1UIE(H 2,>DJC\OZ]ZF2O;U7ZB:OR_XE^";_0EC)8H3P<$G R2 QZ
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MV>?B<TGEQZ3HTLF5\NW7Q=X7\UF9@HP6U-8W ;((#=P#D@Y^IQ_P2:_X*,.
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M7'OZY''4G/ Q4H"[2Q+$Y/R@\]3C X[8/N.>_+ .A^OYGZ\Y'0]SW[Y7 /4
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M?FR2V,XP*P?ZO\P,>Z/S'/78I![L1DY/)SR.IXXQWYY*_)*L/O9D(;Z* &)
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MD#_H1O# )XR?^8.><@CH.2!GT>/@[\(O^B4_#7_PA_"Y'7WT?V_+ZU_,J?\
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MT)4(9D;L2!C.#@$YY&?KT.#BOQ]_X)R?!/X.>/M _;H\0^.OA1\./&>O2?\
M!67_ (*3V3ZWXF\%:!KFJR6EE^T9KJ65N]_J>GW5TUO:1-LAA,OEPCY(U5>%
M_8%>' VX ("G( P3SW'4GL1CKV-?R,_#+_@KQK7[$_Q-_;O^!]G\ M*^)5O;
M_P#!3;_@H%XQ/B2Z^(M[X6G/_"3_ +0?B&YDLGTR'PAK42BQDB\E)Q?;IU*L
M\43L ?F.+LVX9R;+*>+XKIX:ME<\53H*GBLNCFE-XJ<*LJ'^RRPN+7-+V4XP
MJ>RO"6G/"]S]/\)O 3CWZ1_%$_#KPXX3P'&G$,<MQ?$$\ES+%9!@\,\NRCV+
MQN*=?B64<KYZ"QN'4*;OB)RK?N=5(_IX7]F']FX$8_9^^# /J/AIX0R.?O*H
MTD!F!&X;F  R "QKVT*J[5Q@*%10IX4*-JJN.,* ,8QC@8 XK^7@?\'&FO\
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ME.,X^_+V4K.:/O\ Q7\#>,?H]\:8OP_X_P"%LLX2XK669/GN,RS+<3D6,C+
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M^O ?VF*_5'3MW]HV7K]KM>,_]/$7 Y'4#/U!."*_EQ_X([?\%(HM+\3^!/\
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M)^8\XP,$MCL"<UR.H$%21D%GVC!Z KM X)4C)/0]5(S\U=;=;268$<+GO\P
MW!AD9R 2/O D=UY)Y._!*,1N)#]2-QW'CG+'!!&,DG&.C;N*A^L=>VK_ *_
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MK;Z?XPN;_P .Z_9ZKX<UFWMM3TV5&_H+T_\ X)Z_L::2? S67P,T;;\-=/\
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M C[Q/RX/]9?F!D70X(R<%1D].N 2%(RO!/7H,@\<5R6H?ZMP#D,Y[X)R,Y!
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MO!_@CQAXNAT^>=[:'4)O"_AO5->AT^6XC262WBOI-/6VEN8X9I+>.1Y4BE9
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M\U&5)[ZX5KV>XG#W,BHS R,F1A%4 D]XH!//Y'GOU'; SCCCO@5_/5_Q$/?
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MR#].1ZT\_>7_ (%_*JZOT:^Y'7)-4==^5=;[M/?T:]-N@ZDZ\$=0#]01P?\
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MX("D\#;GKYQ=X6=@V5. <*%(]SDG)R<DD\DUZ-JN3N/S#)*_,>NYL[MN ,D
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MSXPATS3M-2\\:WPCN%NIES:<J6ZO?:U]?G;8J/+KS7VTM:W7\>_R6QW.C_\
M!4O]A+7?AEJ'QCT'XW7VM_#71?$=KX=\2^*M(^$7QOU&S\(+J'A3PWXXT_Q;
MXUM;7X</J/@SX9ZCX/\ %_A;Q'IGQ1\3VFF> -2TG7+"YT[Q!<I(SQ]'XI_X
M*3?L2>#-6^*>B>)/CQI5AJ/P;UE/#WCA(O"/Q&U*W.KK\4+#X(ZE:>#;[2O!
M][9_$S_A'/C+JFF?"OQ;-\.)?%4?A3Q]J-AX8U[^SM5NHK9OE+XM_P#!$7]E
MCXS>&;3PKXC^)_[1NG:3#H7PO\-W%MIGB/X4ZA:W^F_"7]F[P/\ LO>%[R?2
M?%WP=\3:);>+4\$?#W1M<B\>Z=I5GXO\.>*]6\72^"-6\*:%XIU'1&]+\+_\
M$D_V:_!WQ"^(7Q!\-^(?B'I,WQ"^.WAK]HB?2K+1?@9;7N@>/- _:3\*?M77
M^FZ=\2K3X+V_QGUSP)XG^+GA#3[G4/!GC/XD^)M(T;P]=7.D^%$T*YL/#VJ:
M&)SUNHI=-;OY_P# &_9Z6YK]=CI- _X*I?LA_$Z+PJ/@1\2M!^*UYKGQ;^ /
MPSURPU./Q_\ "V?0-(_: \4^)O!VC^+M+'B_X:R2^-+SP_XD\'^)O#.I^$]'
MM;=8_&6BZKX0UOQ-X7U?3Y8C^2W_  6__:!^%/[4O[-?[+C?!#6M?\47_@O_
M (*%>'O!OBSPUKWP^^('PZ\::#KVL_L>?'SQKX?M]5\$?$?PUX4\5V5IXG\&
MZ[HOBWPUJ<ND?V;K_A[4[75-.NIK:4,?U0L?^"47[/&GW?P^O(O'?QY\[X;S
M?#V7098_&?A.SN6?X;_M'?&7]I[0GFO['P!;7]K/<?$'XY>*]-OKW1[K3+U/
M#&F^&TTJ;2]?L[_7]2_'']O_ /8#^$O_  3V^ _[(WA3X.^+?B3XPB^)'_!1
M+X>^)/$>J_$J7X>C5&U+P!^PE^T+\-M&G@_X5M\//AWIT]]J'A[P]IVH>*]?
MUG3M7\4>+_%DNI>+/$6NZAK.JZE/<_*<=UIX;@GC#$6A+ZOPQGU=)\RO*CE6
M-K16GO:NDD^6[MS>1Z.4>(E?PAS7+?%C Y;1SG&^&&883Q#PF3XNO7PN$S;$
M<%5UQ/1RS%8G!IXRA0Q\\DCA*M;"QE7I0K.I3C.4%%_C'8_L_P#Q[UVV%]HG
MP7^*>M:>R"T%_I7@/Q-J%K-+;F+=&9],TR>V>>#]V&@\Z22,!3*<]?ZRO^"&
M/@CQKX"_9/\ B!HWCOPCXE\&:Q/\<=9N[?2O%7A[4O#>H36'_")>%HHKN*QU
M.UM97@DE22,3Q1O"\D;J96D1Z^C?^"4M_=C]CKPYF>X3=X]^(A"K-*%V_P!L
M0@'<'!8D'(9N6&22#Q7Z,2S23D-++)*5 &Z1W<[03\H9V) ZD+GO7Y%X*<"T
MEE7"/B*\UK2KYUP[''RRKZHJ='#K.,%!*G'$3K2JR]BH-M<D8OF2<9*,9']X
M^,O[5;C/Z;/T:N'>$L_\&^$N ,/QA'@OCFOCLBXIXDSBO@,5ET\7F-/+Z%'.
M<OPE/$X6NL94HSQ%7V.(I\E+V=)QG+E8IZ<<8(_(]3SQUZ>_<=%?[C?[K?R-
M-Z-QP?<8&/?IC\,@G'3I0Q)5N5^ZW3D]#7]%'^?;5]=/O7FR5?OK]3_Z"U3U
M /O+]3_Z"WU_D:DR>?F3V_SQ_6@$K]OF[?F/HIH)SVQZCH?3G],#H>Y&10&!
M[X^O'XT"L.H1SL3C^+9@YXW+SD<9(R1VZ<8R:9DDG'0?K^/;V]:>HRN,C(<2
M8[XZ8/7:<]0>G>E+IZIO\?\ @!):1;VYD_SU[Z.P]-JL$R>!QQ][=D\8.<?-
MSCDXP 2>/\[CX[> ?'/B[]L;]NY_"7@[Q%XJ%S_P40_;7LH8-"T*^UBXN[R/
MX\^*7:SMHK&">XN)OO;XK=7D $BL/3_1*0YD3GT(X!.<YXY'/&/KT':OY!OV
M-+BZC_X*G_&80RR1I'_P5F_;D+;)FC),OQE\?@LJ#;D1F$%L8.XH"<@8_#O'
MZLZ?"O#>&C&[S;C_ (4R.4E&3E3AG.-GELZT%"49.=&.(E4CS245R-VM=K]/
M\'OIH9]]!/Q!X>\8^'N \G\1,;G^9Y1X2ULBSS.,TR/!X; >(N=Y7E^+SNGC
M,EPN*QT\;E%/+57PV$J4_JN*YZE.=6C*,9/[^_X(#^ _'7P_^%?[2EEX]\#^
M+? MUJ7Q*\#76G6GBSPUJWAR6[MH_"^L)+-9Q:K96374,,LJ12M LJP%ECD9
M6*[OWXX).#]/4D<D\'IGD<D\#DXYGEN)IB#++)*54JID=W*C/(^9F*XR"0"
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MU"SX'-W:^Y \^,'T(R#VR :_*S_@C&[G_@G]X20LS(O[3/\ P4& 5F)5<?\
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M:N*=U%M*ZU48JR%I5X<>^1^F?_9?UI*5?O+]3_Z"U4]GZ,">BBBLDVMOT_4
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M> _&GQ.\<>)/$-AX4\3?$'5K;PUX)^'^B:[XEU)/#?@+P/XQ\>>(M0CLUL-
M\*>%]8U?4KB)+-5FIIN-U-MWWO&ROU=M%ZJWY#G.6B=+K:TES=%9JSO=ZI/5
M:6W/RO\ V8_VM/\ @L?^U;\(+'XT_#S]G[_@F)I'A:_\=_&'X>PV/B_X\_M0
MV&NKK7P3^+GC;X,>*KF2WTKX2:Q8C3K[Q/X#U>^T25+YY[G1KBQN+NWL+N6;
M3[7V_5_'?_!;[1='UG6KKX&_\$I9+/1-'U76KN.V_:$_:R:XDMM(TZZU*XC@
M1O@HB//)#:NL4;R0J[_(TT0;>ONGP'_;4_83\1_$W0OV7_V>?%?ARRUSQ!H^
MI?$3PCHO@7X4^*?!GPF\3:EXO\#^&OVE?%FE>%O'%OX.T7X9:K\5[KX?_%KP
M]\;_ !_X&L-5?QU;:/XUE\4^(]/749M5-OV/CG]NS]D?P'X]_:!^$?CSXK:9
MI7BG]FCX(P_'3X_Z9J/ACQ;=Z+X-^%>M&VL8/MFL1>'[C1?$^OZQ'JVEQ#P#
MX8FU_P 474?B'2+ Z.;G6+2TGFUMY/IK=?+SOY[L7-)3Y8TDTKVM&TFE;JUT
MVN=-^Q3\>M6_:F_9 _9E_:5\1:!I'A77?CU\#_AY\5]7\,:#<WE]HN@ZCXU\
M/VFL7>E:5=:BS7]Q86,UR(;6:[9KAXMK2,2Y)^3_ /@MLLDG_!*#]N"*V6U,
M\WPN\.P1)>RS06<C3?%CX<PA;J6 ">&!WDV32P#S4B8O$-\>#T/PX_X*4?\
M!/72;3X)_"CX>>+;OP'9>*]3MOA5X.^&EA^S_P#%#P!8_ _4].^*8_9]\/\
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M>@ZGX.;PSX@L_$F@:GI=MKNC:QH>I:9=627=LT9\K_8C_:;^ '[2GP\\7S?
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M=\*ZWKWCO1]$M+:WM/$.M:S'+JK67A^]M-,ORO)?LG_MM_LP?'CQUXT_9S^
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M@GQ?IEU8ZQJEM>:/XGT^1IH+O[3:6N?];O\ S[?>O0+_ -U?<?E?\>/VH_\
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MA#6_AYHDMUH&BW-Y8>--#\7Q3:%>WFFZC9^*;;4S<-?75[''A_M4?M:?!O\
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M^([I_''Q \*?#K2CIT.L_##1M,=;;6O%VG7=Z;K4[7&GP7;6_GW0@MIOO_\
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MY8W$5SYQGA@]=OP DF2Y8/R 1EE+,>?]X =<9(4#J ;AOIY?K_7D0<!JN,,
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M'5O&/AG4-6^+OC/Q)%X:M+O2])L+K^B]>'!SW.><<X)Y(Z<\GU)YZ5/M&",
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M]?8?-R!C&,YS[\YYYI)+56WW^6W?;H1[6?-&3UM=6Y;*S=VM/3\#\)?V8_\
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M SSR>W5N">C6T=-^U[?/_(Z?:35+FOKR_+>VBV6CZ6UU/G;X9?L^)\'OV1_
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MT;Q%/\1_%][\'=8\.6OQ+70?BO<V-IXZ3XI1>%](U+3(_AY>76H)+[?\*O\
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MVF^%-"\!Z=M&H_%JY&VP\$>%O"WA&S0@QVOASPSX>T>&-+'0]*AM-NU_8_\
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M0OMGP^\)#P%X$N1I-[\6)[!9/!O@0#P5X9Q;A=%\(9\-6"P:*S61\?\ !_\
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M-IOP"\2_!+Q)?ZYI/Q2\,_#KQ;JWQ^T"UUCQ#X'U7Q'I7PB^*GAGXW_"_3/
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M_'2&;XJ_ SX:0?!PWGP2^#L?A[P9_P *^U3Q-'=OXPU=O#*'7O-;;]BKX0_
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M_97RP'[-/P" &"/^+1>!1G(ST.A CH>N<DC''-2?\,G?LL'C_AFGX!8/(/\
MPJ+P)D\]?^0'D#KCMT'>JED'BZF[\<\/W_[$#?XQIM:>5T^C:/.?BU^SEO\
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MV#GIS2_\1'WP([?LS_%<?]SYX.]>A_XE'3K[<],\C]K(_P!D?]E%P2?V9/@
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M'"K[2*=U3G%JTKG[;X&9OX/Y-Q-FF)\9_"SC7Q9X;JY/4I9?D/ W%.*X2S3
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M^'/%4/A7XE:CXAO[K1["M:?M2?\ !4.Y_:,^ WBP_!3X@>)/@9'KGQD^$_Q
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M&_WC^I)'Z$5:^#Y_JBU_#_K^9$@"KZ9]S_G\_P .G%.I5(&<@\G/W<\87O\
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M:C''U:%"O5A45&G5B_Z!_P#@G_\ \$;(_P!A/]H%?CK'^T<GQ3V^!_%7@O\
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M?A\!A\/0>*QV+KT<.Y5*\Z1_2LK'(7C/(ZYSQG//)XYXX((QQ@U,OWU^I_\
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M?_A7OQ;\&Z%?:CXQT[P;)X%^(VG7_P "?B!JOC?QSX?\+^,=%TB#X8?%S2?
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M-GDV5YG@,JQ%:BL17G+"T\=3C/#0A@X44X5G>5:-2,&^:-_3XI^A%]+WP/\
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MWZWML_P.[\/?\$&/V9?#WPSN/A=9_%+XJ_V4/"/B[X=Z=XCBT?X?Q^-#\/\
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MF^L@2!U/GQ8P1@]",_3CCI_,S_P3(_X);_L<?M,?L@:'\:OB_P" _%VO>/\
MQ9\?/VUK?6M3TSXA>)] L)H?#7[:7[0'A?25@TG3+B*RM?)TC1K**9HD+7%P
MDD\K&:5S7YUXJ<%RXZR# Y1_8N1YXL/F=+'_ %7B'$X["X.DZ.'Q%*.(I5,N
MQ6&JRQ$/KDHTH5*T(NE5Q$ITW*G32^]X"X!^BOXD9CB,A^EYE_B)FGAGA\ \
MPRK#^&KP$\\AQ?1KN&75JL<?C,NHPRZ&"KYK'$IU)556G0]E[2$JDH]S^QW^
MUE_P32_9 UKQGK&B_MD^)?'!\8Z%INARVFJ?!OQCH:62Z?JC:FMU'<V,>I/<
M,[2F$Q2PP)&,NLI8%6_5WX!?\%!/V3_VI_'-Q\/?@E\4)_&WC&ST#4/$UUID
MOA3Q1I CT72[FSMKV\:^UK3+2V/DW%];)'!YPEE6=Y(U8!POS"W_  0^_P""
M=2_?^%?CPKG!_P"+N^.!GD<G%Z,=NH(Z''I[_P#LV?\ !.']DS]DKX@77Q.^
M!_@SQ1X?\7WWAO4?"EQ>ZQ\0/$WBBT;0M6N+.YO;9=/U>YFM4E:>PMFCN%03
M1K'@-R-OS_ O#/'7!V'RKA[ 93P/E'">%Q<ZF(P>5ULPK5J-'$5)5\8\++%8
MK$5(U)2C2<:;J2A>I?D5/F1_0N<<&_LS^"?"[/>'_ >I]*/+^)\!EN,J\$Y7
MQ7A.#_\ 5%9[B:^%E!9WB,/F6+S:& JQCBY5O8SJ55-4(PC"E4J2E]VKQ@8[
M?_K]QU_GZ<NIH'?CVQ^OYX'X<#@9+J_9GO\ F?Q[^?7UZC'."I )// Z]/Z5
M+#T;MDYP>Q.21^#$@^AX[5&?O+_P+^52Q#&X?[6?SRW]:M?PWZ_JC3_EV_Z^
MTB4%AG:<9ZY&>>GX4#@ >E)D#J0/QI:S,PY'(.#R/48/4$=Z6,GSXN<L9$_A
M&!R #@D ^AR0,=P1FDR!U.*(_P#71D#=F6,8 W9)90 !ZD\<%<D\LO!+CO\
MY>J&M]VO-*+?R4O=O_BT[Z7/XV?A7^SUX>^*/Q+_ &Z/$6H_M6?LV?!2\3_@
MH_\ MD:<_A/XK>,H=!\6O!:_$2 PZJ=/DC9SIE\)6;3V/,BHQ&&64-[9_P ,
M8>$\D_\ #PS]B0X Z?$>T)X]O).2!G.#CG@\U'^S;_P2+^%7[;OC#]NCXV^,
M_C%\1_ VKQ_\%*OVU/!L>B>%=#\+:CI0M/#WQ#L_+OVFUF-KMKF\%^WGH6$2
ME$")]YY/IY?^#<;]GCH?VD/C:#R<KX7^'ZCTY!@.>W(/IC';^/\ B_P)AQ#Q
M5Q!G3\/Z.83S3-,5CGC9>(.;8%XWVLZ<8XI9=1FZ6#C4A2BO84H12<)MPO>4
M_P"BLA^B-^SBXTR?*N*?$_Z6WTL>#O$3B'!8;'\7<*<&93XA5>%L@SV=.5/%
MY5D%7*N.,IRRKEV'A1H3IU,)@Z%&52MB.2"46Y_K/^Q3\(_#GPS_ &=/A5I5
MOK?PS^)&K:;;>*;JW^+'@"UTW5-)\16>O>,?$FIVUUH_BA;&&_O+>&POXM)F
M=9FC5[2XLD=H(CCZ]#$KM&W#8SCG'MGKE3S_ #Z$GQ7]G/X(:+^SA\"_AE\"
M?#^NZMXFT3X9^'CX=T_7M<MK&UU?5(&U/4-2^T7UOIR+91RE[XQ*ELBJ4BW$
M?,^[VI=HSD\Y)YQW_J,\^ISU(S7]2\,951R/AS(LHHX.&!AEF49=EZP=.N\5
M'#QPF"H4E1GBYI5,9.E-2I/$RYI5U3564FZEE^$9OEN1Y)C\5D7"^=YWQ'PK
MD.(Q63<*YWQ)4QM3/LSX:R[$U\+D>89J\PQ6-QL,=C\NH8+&XRCB\35Q5'%8
MBO"O.I5A*I.Q&20Q/7=]/X5_S_ATH4L?++##$'(].*2(Y4]?O<Y]0%'3M3S]
MY?\ @7\J]M;OTE^1S235'7?E7XNZU]&OZ0Z@'H1P001^&&!^AX/T]#12=.OH
M!^ &!^)Z_4XI'(2(6+<X("GH,8Y''X\G\_>I"/T_R>._&>._UQB.,@[AGT'!
MYYSSD=/;N,9[BI#V^HZ_E_(\>],[:7P1]'^<BUIN/[2LB2!_I=KT;CFX0#IC
M!8D#&#GOR21_/G_P1B^,G['/AG_@F?\ LUZ%\3?B1^S?HGCK3;KX\Q>(=*\<
M:W\/;7Q59W$G[2WQDN+-=6M];8:I%*VG36<L"W63]D>W=,(5K^@O3/\ D(60
M&!_IEJ2 <G N4(QCL3C)X&#S@DX_S2_V=/@MX,\5_!CPCKVL?\)D+W4=8^*S
M.VE7NEP:>3:_&'XD1K'"ESX9U&<,5@C5BUP^6<X0!55OR3Q?\1*7AKDF7YU5
MR[#9C#&9K1RQTJ]'$XA0G5P>)KPG&&'IU*JG:E&*M%1Y:DOCY;'VG!G%_P!&
MO@W,,5F7THO%OQ!\'.!,3AW@LHXD\-O#W-?$?-\;Q1*K"KA,IQ^3Y17H5<'E
MM?+*&.Q<LTJU(T*6+P]#"M\U>#7]]!_:"_X)_G:#\7?V0",YS_PD7PF&>0,#
MYCDCL,_,<8Y&:^B?AMJWPN\2>&[?Q1\(;SP%J_@_79KAK;7_ (<#P_+X=U>X
MTZXN-.NFCU#PVBV5]+8W4%Q92LTDTEM/#/;,8V5U/\EG["W_  1W^"W[7_@3
MQQXQU[XJ_%WX>S>$_%]IX:M]-TW3O"&K"^@N-#M]6%[/)J&C:<T3B2X, CBB
MD4!-P=B?E_J$_9,_9O\ #_[)'P&\$_ 'POXHUSQEHG@F3Q)/:>(O$=KIUCK-
M^?$GB75/$EP+NUTI?L,8MKC4Y+: 6Y!>&W223]XYH\-.+>(.-L)@N(:_#64Y
M=PYF67UL7EF8X:I.&.G6CBOJSH3P6(ITZ^'I3C2QDJCJTX5%*E32;C4@S];\
M2(_1$S3PTX9XS^C;](3Q>\6L9Q#FE)SR?Q!\,,P\/<'2X<J4,?&KFJEF&;8Z
MO/&4\PP>'H4\NKX3#SE0K?6X22^+Z2I5X=??(_#!/\U%)TI5^^OU/_H+5^LR
MV?HS^='NR>BBBLHIN]OSL(****(_$K[W_P P'+]\9[ D?7@?R)X_'M7@W[5_
M/[+'[3PZ[OV<OCLH ZDCX4^+N!P2>O;D'C!YS[POWU^I_P#06KP?]JTA?V6/
MVG21G;^SG\=2>I'/PJ\7,0?E/'']UOH>E:35XO72SYM4M&FNO2[U[*[Z"DY*
M$W&*E*,)RBI/EBY1A.45)V=HN48J3>BBY7T3/SD_X)Q_'3]AS2?^">?[!^E^
M+?BG^RSIWBK2_P!C;]F6P\3V/B#Q#\,8->L=?M?@SX-@U:UUJ"_87T6K07\=
MQ%?1WFVZ6Y203KYFZOMK3/VFOV#M#NQJ&B?'7]E31+\1RQ+>Z/XR^&6F7HAF
M*^=$+NPN;>X$4H5?,B$@CD"@2(P K^>3]B3_ (("_ WXS_L7?LB_%[6?VA/C
M!HNJ_%7]E[X!?$/4M%TWP[X(GTW2M0\8?"WPMK\^FV,MW";J>SL9K^2UM);A
MC*\**['>S$?3(_X-M_V>^G_#2OQLY]/"G@+(P, Y, ]#D@'W/:OR>69>)\*]
M9X?@3A:K2A6JK#UY9S"G5E252I&E4FN22A4J4HTJM14W3?--W7.G)_Z Y9X<
M_L_L5D^6RSKZ7GC]@<SKY7@)9MEF#\#*^.R_!YC5R[+ZN99=1K/B"=/%X7!Y
MA5QF"H5IX>$,5A<+AL1[!*NT?T&>"/B#X%^)OA^#Q;\./&?A;Q[X5NKF[L[7
MQ'X1UK3_ !!HEQ>V$IAOK6+4M,FN+5[FTGQ%<Q)*9(7 5PK8QV:G..^1Z\@C
M.<CMSD<<9 'T^4OV,_V4_#G[&7P)T;X$>$O%_B/QQH^C>(O%'B.'Q%XKL]-L
MM9N)O%.H+J$]K/;Z2J6:Q6;?N;=QF:1 &D9FZ_5R\8 YXZCH,=OSSSCGWY-?
MI&6U<PKY?@:^:8:A@\QK8>A/'87#UWB:.'Q/*O:4:-?:K1C-^[.24V]O</XF
MXSP?"^7<7<39;P-GF8<2\&8#/,QPO#'$&;Y<LGS7.<CIU8?V;F.892G*.68K
M%4'4E6P*G*6'E%0G*3:DW4445ZC3M=[:=3Y@****D!C$YQ@XP<$$#!QCJ00O
M7(+9&1CH>(9!GKV&4^7YAD8Q@[L="!E&;[V>-M3G&>>I.%Q[#.?PY]NF:AGX
M 7/&UCC/).#R?QZ<=?H*P?ZO\P,>YQ\Q]%R1GMMX;H,\?*>AR.!R17)7X)C8
MC/#YY&X@]/4<Y_O'C!SEBIKKKD<8[%=H( P=V%R#W^4G (' P.%R.3U#(1U&
M?F=CP?FR 6^49Y^;@+CT.3T-0W\[K_@_<M?4#@-6; <$XQM*^I!+9)R,?=&<
M98 <EB<UYO=DK,P)*' )'S]3R3P0#SGD #L  ,#T;5<9<C!#$ \ #).%P1N.
M,9*@KS&QR02:\\N07F<[5;I@DYP" V.O0%B![55X=E_X#_74NT[=?O/1Z$/S
M#/H.G^T8R/YX/X^N** /F4#U'Y#!Q^2C'N![UUG(6**** "C!) &.<CGIT)_
MI12CAE/OC\P0/U(H D(Q&1Z(1^2XIV><?Y_SR/S^M'#!AVZ'\0#Q^!H QWS]
M>O0#D]^F1TY)]: %I",C\\?B"/Z_X<TM% 'FGQJ^+O@SX ?!KXJ?'7XC7SZ;
MX!^#OP^\5_$?Q==Q[3<+H?A'1[K5KBTLE=E275-3:UCTK2;;=NN]3O;2V4%Y
M *^)/V?/^"C?@K]I#4?V:?#>C_!GQ-H'Q'^-=C^VJFK^"=>\5>#=7U'X#_%G
M]A[4OAWX8^(/PV\4:[H]OJ&EZEJ_B>Y^*NE_\(WXQ\,21Z9:^'KAM4N8;BTU
M.*V/W'\5?A'\-OCEX'OOAK\7?!VE^/\ X?ZOJ/AC6-8\(:Y)J T36K[P?XFT
M;QCX>CUFTT^ZLSJVF6GB/0M)U*ZT6_>YT35Q9"PUW3]2TZ:2RE^>;O\ X)X_
ML6W'C&T\?6'P%T'P?XMT[QKK7Q#TW4_ACXK^)7PBMM.\8>)_#GP\\(^*-6T[
M0_A5XU\&>'K*U\5>'?A-\-M,\5Z%::/%X?\ %$?A#2[C7=*O[UKN[NTU)R5F
MDM+W2WOKKNE;MM;9MEQ<4G=:[JV[OH^N^WKY'!_!+]N[3_%7PK_:I^,_QS^#
M,7[*?PG_ &2_B#\6/A]\4/%>J_%#PU\3K:X\;?!G6KW3/C%+9Z3X%\*:3J?V
M#2M5_LP:+K#VM[J7Q O=8BAL=-BO($2?RY/^"QW['ESK6FZE;>)KIO@Q-\)?
MBIXUUOXI7=IK]CXAT'XI?#/]HWX'?LXQ_ 9OA0_AJ37M3\5^*/$OQST36=-U
MVUUV/2K;3[!)&LKW2-0N?$.C_>4O[.7P)N/ 'QD^%-Y\,/#>H?#?]H7Q7\3?
M''QL\%ZFNIZGHGQ$\6?&:[;4?B?K6N07VI3RP3>+-12*]GM]&N-+L]+N8K:7
M0;737A0P^,>*_P!A[]C%_" 7XC?#RTU'P[X/\%:QX<7QE\3?C!\6]9U?PCX1
MN?B-X"^,MW>1?%#QG\2;GQ+X8ET3XE?"[X?^-=#\6Q>);#6?!FH^%=.7PYK&
MCZ9+J%K<)*I:/PWM>3NDD[ZJSZ66_F'/'6\)>3OJM79W>J[V6QQ7@_\ X*F_
ML0^/M/T"]\%?%3Q!XHD\6R^!U\+Z1HOPO^(M_P")O$2>/_A_\:/B7I%SHOAN
M#P\^KZI::3X8_9W^-$?C"[L;2X@\)>(? &K^'-<>UU5K2"X\RUO_ (+!?LNO
MI&GZK\-M"^+?Q+MM3^'?[7GCAM8M_AOXP\/^$/!^L_L8^&/#OBGXF^$/BCK_
M /PCVOZEX,\VS\5Z T?BC3O#?BW1M,TW5M-U*[CNO[8T2RU/Z M_V,OV%/CG
M:^'/B9'\,OAY\=[?3/@5\1?V7-&^)\_C[Q1\7?[1^!WCZ[U>V^(_PZO_ !_-
MXX\1'Q8-1N]4\16-]K^N:MJ_C#17U?Q!8Z5K^D1ZEJ5O+S^D?L#?\$_]00_"
M?1?A=X5U?4/"=E\0O&NK>&+#XO\ Q,U?QQ'H?[5_@F'X>_$37?&5VGQ)NO&N
MN>$/CKX.\#6VG2Q^*M0U'PQXBE\&PZQHL":OH;:A;EJFRY+WTO);:=.R[W0*
M5-Z-37HG+U;44[?-:_@<UJG_  5<_8M\-V.M7/C3X@>*?#\?A;PSKNK>(-;M
M?A7\5M>\ 3^(_!&B>!];^*'PY\!_$.V\$VFB_$CQ_P##.W^(.@MXJ\+>'(F\
M06]L=0G_ +(2YTO5K&P_&_\ X*"_MV>,;C]MC]E'X]?L2ZSJUEXJL?V7?VU?
M@=XML_B3\*;_ ,.^)O">M^"/VD/@;I/Q)\%^+_AY\4M#L=5\+^(M$\0Z%IB/
M_:.F6]T8?L[6K26M^[']UM4_X)M?L0ZSJ/B[4=5_9S\.7D_CC1]5T7Q%93^(
MOB.^B&+Q);^#+#Q1J.A>&U\71>'_  GXL\;6WPZ\$Z?XU\:^$=*T+QCXS@\-
MV=MXEUS68)[V.]_&?_@ICX-_9"^!W_!1/]GFY^,-IX\^&_PT^('[,_[:_P 5
M?%LWPHTT^(O$.O\ QR^*'[1O[/?B'Q#XDU*Q\3:C-'9VWB>ZM]5OM1ATQK;3
M[.^BL8-*TRVM9Y(Z^.\0:F:4.".**N48G#X+-:>4UY9=B\1B7@\/0QGM<-&C
M.OBX-3PM*\Y0G6@U*/.K;W/L?#_%<88/C3AK%>'?AED'C7QU0S6A5X4\)>+J
M&-Q/#7B%G488A83A;.\-E\J>-K9=F7M*_MX8>7MDL'3G%7@,_9"_X*1_MT>)
M?VC_ (5Z)^TUX_\  FA? 75-4UH?$/6KSP+X"\*V-II<7A77[K2GGU^PTVUN
MM,CE\0V^CQ)-;3 S2-'9R.\=PR-_2;X)\?\ @;XEZ$/$WP]\5Z!XT\.M>7.G
MC6_#>H1:GIC7]D(VO+1;F F,SP+<0&1 0561>1SC^<']FKX;_P#!,K]K#XI6
M?PE^$/Q'_:@N/&%UH6M^*(8O$WAGPEH.D#3_  [#!=:B9+T"^=+@QS*MO;FT
M87+^9&9(@"5_?G]GCX >$_V:?APGPQ\%ZGKVK:#%K^K>(([OQ'-92ZDMSK*6
MJSV_F6%I9P-;H+)##F'S1O979@%-?D?@=F/BUB)8FCQ=_JWG'#=26+DL_P O
MXKQ6?9C0S3#T<(H9=3HXBE"G'"2C4J5*DU.5:,W%.+C+F=>.'$WTF<X\8,OP
M7CC]#_P:^B)AL'P1AD^$/#"KQ!@*N9U*F8X_$91Q%B\CSBDE;-$\?@)XU5N:
M-+*</3C"4?:->[ 8[Y[_ )_X_EZ"D?[C?[K?R-(HY)[Y/'IS_P#J_GWI7^XW
M^ZW\C7]'GQ3W'K]]?J?_ $%JGJ!?OK]3^>T\_EGCCKGMBIZ!!1110 4J/\BG
M'WB5QGNZGGIT&[)_3(((2D0$JI& #('Z_P /3J?3!SGV[FIE;2_=?J)VTO\
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MT QT ',RG#CW!'\C_P"RFH%CV\YS@ <=#_%@>O/&XG)VY[DU,OWU^I_] /\
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M.?V9O@?X]\+?LY_&_P"(>C:A_9?[/'P3_;-\)ZMX\LM7^)VI_#ZYT>S^+/Q
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M]JIT/95)2O92FXQ]V,4OC_%3*O#S(N/N(<J\*>+LVX[X PN(PZX=XLS[A_\
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M<C;EF*]N!@#DD$ ';D5YQ='$S9&3A>C[>BA>A'7C/XXZBO2-6(^<$XZ,IYP
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MO5C&$+N/08R1DX.>> K=,XYZ>QYS4J( Z^OS#'89&<X&.G3KCD]SP@7!!!/
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M*>YDF2*-$F<[2Q^_?A??_P#!?3XW^#CX[^$_QO\ B)XU\)OJ6HZ-#K-AX_\
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M%5<VQ*SEX?$YG2K5:$*>+H5,+4NZD)1/K/!QG.T@Y7H <\]B<#)[GT!)!J0
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M^9J22H'_ (*-?\$\7C:1?V]_V+'BB*>8Z_M3_ \I'OX4R.OC8A S?=#$9.
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M\$8)-"_X9WC\,_ C]JGX_?LY^'/#_@S]H#Q#!\5/$C_%1O%U@)='O_%'Q3\
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M-IVH:?J,,+V-]:32_/OQG_X)F_\ !%*X^(&EZ?'XX^!OP(O_ -DOQ3:_%_\
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MZ;PU/\)?BAJ'Q-B^(OB#7Y_'NB3:'<_\)EH;_#SQ1<>)[/Q%I/ZTMT^C*3]
MP)/T Y-+@9SZ?ISGTSU.>N#GT-)QC)6ETLUIU7]>?H--J]NS7I?3^OZ3\?\
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M[XY^(VO6T3>#_A+HFJZ_J>I^++E]3\3:MJ<UI9Z=IL%K:C[&7Y@IW'HIQ[@
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M\=?#WQAA^'/[*W@W]BGX(6'AKX2ZE\,;K2/@7X)^+_C7XQ:?K/Q4O]2^)7Q
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MPAXI@TSXE?9_$.I6VI:-+>:!=_?F>W^?\_\ UO6BAQ4G9W=WKIIIKW_0+O\
MRV_R/YR_#_\ P0R^+_AJS\ >(],_:]^$,WQ<^$GP4\&?LJ_#W5=0_94\2R?"
MVY_9U\&_LP_'S]EZ"\\=^ (?VAH];UWX[WOA[X^ZWXND\8:5XRT?P9'>:%%X
M33P<=%\2:U>Q_J5\8/V)(O&_[#GPV_8X\ _$?_A%;KX)Z=^R._PO^(GC?PO+
MXYTZZ\1_L:>/?A-\1?AW/\1_!VF>(?"5QXE\-^+M8^$>D:=XXTG2?$VBWQT[
M5]0GT?4H;ZUM'/W6OWU^I_\ 06J>K=-._I:VEO3;_._6X-MZOR_ ^6OV/?V=
MM1_9@^"G_"M?$'C+2_B#XMU_XK_'GXW>._%'A_PK<^!/"MSX]_:&^,WC;XU^
M+]/\&>#KWQ'XQO\ PYX-T/6O&]UH7AK3]2\4:YJQT[3XM0U/4I]0O+E%^-?V
MU/\ @G!\3OVU?C1J'B+QQ\>?AKI_P A_9[^.'P1^'_PJE^"GBB^\<?"?Q7^T
M5\'?$7P=^*7[0.@>/=*^,/A_P]XM^+%SX:UR/PQX37QQX)U7PMX.^'BZSX:T
M'0K+Q%XDU7QK-^M^!_G_ #Q[^M%2XI)*3?DEJE\GHM>UOU"[[O\ )?<K(^'O
MV(/V4/&G[,.G_&O7/BC\2O!?Q2^*'Q\^)7@CQ_XRU#X;_#35_A1\-M(MOAK\
M"/A5^S[X1T+PWX.U[Q[\2=;\^?PO\*;'7O%&L:AXI8:AK>MW=CINE:?INFV6
M_P#/7Q=_P10\2M\>_B5^T+\//VRO$DGBOQEX^^"'QUT[2/C1\&_!7C>RO_CO
M\#_VO;7]JGP[??$SQ%\.KGX3>+?''PRM+'3=+^$/A7PW#JVD^+/!GA&PTB.U
M\8ZMHWA/PCX;T?\ >NBFX:+KK^=EY_/O9 FULSXR_9M_9$A^ W[&%C^R-J?Q
M!NO%,]UX5^-.E>*_B1X=\.#P6)O$?Q\\7?$3QUXUUKP9X1GUOQ+_ ,(MH^B^
M(?B5J\?@O0;OQ%KD^G:5INEP:AK&H78N[Z3\@=-_X(3?'?3O@WX?^&A_;M\-
MZG>>&O@M\:?V6_#FF>+O@C\6/B/\)_!'P!_: _9A\"_LT_$Z\^'O@WXA?M1>
M(/%7A7XJZROP_P!-^)MI:6/CN/X+Z/K>I:OX/T7X9Z=X>U+4+V]_I+HJY44T
MGT225GKK\O-]M_)#4FK];_>?%_[7'[(S_M&_L7>*OV0_"/CV#P"FJ>%?A;X4
MT+QQXM\,7/CUK?3_ (6^)O!6NVJZK9:7XB\&Z[9:KKUCX.73(_&_@WQ/X;\<
M^!]7U)?&_@G6=-\3:'I-PGYF_";_ ((H>/?AMKWPUDU#]JSPEXE\&VGCG]F;
MXB_&/1I_@1XB?QIK>M?LB?M>?'O]K[X1Z-\+?B9JWQIU;6=*L]?\2?'>[\(?
M%OQK\8+#XL?$KQY!X;N_'&H>)9?%?CC76L?Z J*GV<?/[_\ A_PL',^[_KY'
MY7_MF_\ !/+QU^UU\=+WQVOQ>^&/PW^%_B3]C;]JK]CCQEHMG\&/$.M?&76O
M#O[6OA'PYX:\7^-8OB=#\5-"\.-J_@.;P/X3G^'>D:OX U6QM=.NO&&DZG/<
M?VOIEYI7Q+\0O^"(GQA^);?$[Q?XE_:V^$.G_%/]H?X9?&3]G[X\W?AW]EKQ
M/;_#.#X'?&#X'?L@? >YE^"W@O4/VA;C6/!WQB\/^&OV/?#VM1>,/%?BCQ=X
M8U;5O'&JV5SX4MM*\.:7%>?T49(;'7<<^@4!>YY !(XZ=3UQ4,W.!R"4(&<#
M[P.1G.>< -CD8&.I(S<5O;JU\E_6OWAS2[F)+'%##'!")1!:VT-M!YSF:4P6
M]ND47GS, 9;CRXQYLSJ#*Y:1ER2!RU\"8WP ,/@X(7!)QUP!QC+%0">,$!3G
MK;G'J/N\Y/S$$@L6&<9*@EB!]":Y'4/N/SG<^,$<,=I^A4ECSUVG/ (S50WM
MYK]23@-5)_><'&0P.,$$LS8SR<A>,[<\A<'J?.;P,)V!&3@<J1C/0_Q)SGK\
MH_&O1M6Y+,-PR>^>0S;L\_+T&Y@.%.0!S7G=P<3/R5Z<8;'W1G& 1R<_YY-<
M\>S^Y%\DNZ^=STBA"0P/7@?^/F/^6[CZ44 991_M9_++?KC'XUUG(6**** "
MC&2%SC)(SU[$]_I12@X93_M ?]]?+^F<T 2$8C(]$(_)<4^DX.1Z<'\0#_(T
M  =/I_G\ !^'UR +01D'_/X_A110!,IRH.,=1@=.#CCVXXIU-3[B_P"ZO\A3
MJ "BBB@"2,87ZLQ_(X_D!4E,C^X/JW_H1I] #7^XW^ZW\C3J:W0?[R?^AK3J
M 'HN0^2<'Y?H,9./Q8U+4*G ?V^;CN-N,?FN?T]:FH *:_W&_P!UOY&G4U_N
M-_NM_(T /7[Z_4_^@M4]0+]]?J?_ $%JGH **** "A'.Q.F68 _1P<GV^\0/
MIFBA%RB-T&X./9<<+^F!VR:F5M+_ ,R_43MI?^9??K;\;?@2(57]WSD>O?.2
M<>N/H*DHHJAC6<+C/?//88QU].M.!R,CH>1110 J,?F7 PI&/?@D@]@ '//3
M J8=!QQ_G!_'KZU"@Y9NQ#C\0C#/Z?D!ZU..*QE;F=OZ?4QG\3MY7];:D<7W
M%/?G_P!"-.#@Y'(P3G/^SP2/49__ %4)]Q?]T?J.:=6QL%21]&_WO_95J)C@
M$GD $G\JDA&%(]"!^2**F?P_-$S^%_+\R6B@\ \9]J9O]L@<$@YY]!T[@C_"
MLK-W:5[=DV_DENWT6[V29DDVTE:\FE%7UDWLHK5MOHEKHW:R=FC_ %S?[G]1
M4A[<?Y_S^H'U$8!;)X!+1C'4DJV>#ZX]N?3KAWW>^0P[ ^G.#G' XX'!&.,$
MC=)I*ZZ?EH]F[?.U^E[.V\=4EU48Z=;:I2M9/E;37,KI2M%V;2)(B3@'HP#X
M]#T(^GS&IZK)G.X<<=\<DD''T/)X  YZ9J16;G ')Z<D_E_/J3UR<'&4E=MI
MKIU6_7J9R5VVFNG5;]>OH2TAQ_C]!Z^W_P!>F;F]!^.1_,]/?I1N8@_='7@D
M@_A_CZU-GY?>B>5]U_X$O\R6TC6XNK:*3(665%;#'< 9%3ANH)#$?0]P2#_+
MQ^S?_P %H_VX+GX.^/OVG_C=^RK;?&']G:ST#2].\-:Y\+/A7XQ_9E2U^/\
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M /P%OYK4U11GYB/50?\ OD__ &0J6LJFZ^9H%%% &/\ /^>/2B/-I_+Z^O0
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M;EV\C "C>O7&><$<'SRZ^>9R0QZ8P2."-P!XZC/Y8QQ5>YY=>_\ PQ?[SS_
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M,\0WOB/Q!HOPJ\2>'?"4IU/^B/5O@EH'B*+Q3!XB\%_#GQ#!XX?1Y/&\&O\
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MF6[?7_+J/EEV?]?,Y2YR"1VV#'0J"N<DCE1C R 5'0EN<-R&H#Y![2=>>P&
MN"Q.0/EY)('&,5Z)<Z1>'.U[<Y' +L.0%R1^X!';DGY<J>>HY6_T6[VL ]N1
MDGY9I,NN"PQF$9W8 )W8)9>N,54916\H[KJO-ARR[/\ KYGE.JA<''&UANZ=
M!E0>X!].!QR*\WN@#,Y)(R<_+N(P22"2K("<8S\HQTQQ7KVJZ+>#>-\!)X.'
M<#(9AD_N2?OE6SZ<8QBO-[G2+OSW"FWP#C_7'L./O6['IC')&,8/>B]/NW\T
&7[_9'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ea028514801_img13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %" ?0# 2(  A$! Q$!_\0
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M@2(RG&?!Q&<'C*MC@D'FI/\ A[-I:!57X$:T %"@GXBV /'&./"#=ADG@9.
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M[1!-#N'Q#L<J)$*<'_A#^VX]0>,\]!5AO^"M&EDY_P"%$:N3W ^(EET[<?\
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MM'_4]_#(9]SGQIU]\8Z8Z<?TQ[5]!^0HP/0?D*7^I.56M[;,/7ZVK_\ J/\
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M' 8G&RJT<5552C3@EAL-5Q#CRU927.J<6U%IM1?PWO&Z=SX+CO(L=GF$P%+
M5,/">'Q5:K4>(Q,,-%PG0C!*,I:3ES+6-T[*^I_/#\*&W?%#X6EB2P^*'PV.
M>?E'_";Z*,X''&%('&2!TY-?TD_MG:'H5U^T9XMO_CY\-?VI/B5\.Y?V=OA[
M%^R'#^S3X>^->NZMH'[2&F>.OC/>?&"31_$'P?CBT3X2?&/6]*O/V<8?A_\
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M9QCK9)'\WMEX(_:^C^(T/P\D\,_M+K\/[3_@JC:_MO)XLO%^)%S9+X(\0?\
M!0^[_9YOOV?4FBLIK1_A;8>!WU[]J^ZTJVO!X+T[X?-IWBM($\":MI-U'Z__
M ,$FO@/\</@/XK^#@^,7AW6O"</Q$_X)\_"'Q%:GP;X$^-'AGPUXM^)<EM\/
M+SXM:?\ M81_$WXF_$N'0/VK/A7J<VE6OA*\^P?#B[^(GASXC?%^Y_LG5KWP
M1JV@_#S]P=-^)GPQU;Q%;>$-)^(G@;5/%E[I-MKUGX6T_P 7Z#?>(;O0[VP@
MU&TUJWT.VU&74;C2KO3+BWO[?48[5[.>QGANXIFMY4D;1\)^-O _CS3[C5O
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MK1XVM[2%XH[>4QD*OT6?V1_V43U_9C_9Z/7K\%_AOWZ_\RUW[^M?0FT9S_\
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M<Q_TA1I%$JJ@1$"JL:*%5%1!@*BC"JH!.%4  '  %2#'.#TZ\YQUZ_K_ )%
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M-UX,=8OL,5^:WXPIS_H=OSR#]/PHK![O5;OH^[ ],HHHK< KP#QM^R[^S_\
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M'\3QKB.'\/A<#+B# UL=1GB:JPT*%1P<*JHQYY2Y:U)R3IZ;R2ZI-W?[0?\
M#BC5<_\ )TNED^_P.OB1^'_"XR0.G0J3R<YZ'_#BO5?^CI-)]/\ DAVH?_/E
M_7KU]:_,D_MZ_MG9_P"3D_B:!QC_ $W2.G?&='Y]NG^ ?V]?VS^W[2GQ,(]?
MMND<_P#E(_SWYKZKZCQC_P!#?!_^"E_\H1^?+,_#E;</8^R_Z>MK\<9=^I^F
MW_#BG53S_P -2Z3_ .&-OCC\_C*3_(=L9Y*_\.*M6/\ S='I)]_^%&7_ /\
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M222WID\XR"3DDN QGDG( Y.>G''N>_K3 _"#QKXP_;U^U:Q<6EKXQTCX6O\
MMU?&"SMK_P "ZU\0O$G[2NE^#HOA+\3[K1- T'P/KGA5OA%KW@?2/&L.EP^"
M;#5/&%S\-M:U"Q\+K<@O>FWA^:?@O\2O$UKIN@:7\3?BO\>=9_92\/?%?X41
M_'W]H[X<?&O]N;_A!]2B/P2_:"L]-MO&5[\<M0U#]JO]DC5]+^+/A/X1']K/
MX6:7\?OB5X#\&>)=7^$VG_$#QAX<N?&'[0FAZW_3M_G':DV].3P>N>?H3W'U
M_I0!^+/P^^$ND>/OV@/V)?%6@^,O^"@NH?"J_P#A-^U-K%Q)\6_VB_VK_ QU
M\_!CXR_!4?LY:O\ $[P-X;^)'A+PIK=CJGA37_&#^"Y?B_X4N/B/\;?A3=Z9
M?_M KX\\90^(KF/]I@, #T'^?I]!P.U*!C_Z_4_4]S10!YKKO_(7OO\ >M__
M $CMJ*-=_P"0O??[UO\ ^D=M17.WJ_5]^[\@/2J***Z #^M>!_$S]ES]G/XQ
MZ=XIT?XJ?!/X9_$#3O&WB30O&/BVU\5>$='U<:]XK\,>'(O!WA_Q'J$ES;//
M+K.E^#HSX/AU%95NF\)37OAF:271+^]L9_>G4L, X.?7'L><'GGCCKCJ.#^&
M?Q_^/WQ5\"M^VAHWQ)_:W\3^"[OP]^UA\,_ WP&\/?!WPQ\&/A]X[\46WC?]
MDK1_B)X&_9F^&WBGXTS>+O!GAO5;GQ>\OQ:^*/QK^*-QJ.C6_A#PE\4M6U>T
M^&'PD5QX% /V]TK2M.T/3=-T;1K"RTK1]*L[73M+TO3;6"RT[3-.LH$MK+3]
M.LK:.*VLK"SMHX[6SL[:**VM+:**WMXHH8TC'\XW[$O_  1V^!_Q*_8R_9$^
M(VJ?%7XR:;JGCW]E_P" 7C+4=/TR3P(-.L;_ ,3_  I\*:U>VE@MWX,NKE;*
MWN+V2*S%U<W$ZVZ1^;-+)N=OZ ?A#-XMN/A1\+Y_B!XB\*^+O'<_P]\%S^-O
M%G@4D>"/%/C&;P[ILGB7Q'X-S' #X4US6C?ZGX>/E1YTB[LF6-5*J/X(_P!G
MWXJ?%:Q^ GP/L;#XJ_%*QL-/^#_PRM+&RT_XD>-;"QL;*V\%:'#:V5G9VNOQ
MVMI:V]NL<-O;VL,4%O"D<44*1(B#Z'AS"X[%5L5' Y@\OE"E3=6:O^\3J2Y8
M:..J:Y]^MM3XCC7,<IR_"X&6;90LVIU<35C0I2FH>RG"C&4ZB;=K2A+EM=;7
MUL?T[G_@B%^S^HR?C%\<0!W\[X>HH'O_ ,4,!R?4C.0#QC#5_P""(O[/DG"?
M&3XX-CG"W/P[;'8Y4>!CV)'0\@C'&#^)O[/WQ7^+$WQ8TA;GXK?%&[BB\(_%
MJ^6*_P#B-XRU*U%YIWP>\>ZAI]T]E?ZW=6D[V-_:VU]:F6V?R+JWAN(OW\$9
M'U+!\8_BYX@\!^-)-6^*/CV]DT_6_A\UC<#Q7K=M<6AO5\;?;A#<6EY:RJ+A
M+>#SXVF6.3[/;;AF)67^:O%_Z3.=>$WCCP-X-3RO%Y\^,\OR3,%G]#.G@OJ$
M<XS#.< J7]G3R_%.N\,\FJ5'5EB:5*M[50A)5(.+]KA?@GAKBCPYXM\1*.2X
M'!X;A/$/#ULLK0J5<1CYJ.7RYJ.(A75&DK8]/]Y3E_!J6W5OT.'_  1!_9^.
M"/C!\<F_[:_#HX) (!'_  @HQP>X..F>@"C_ ((@?L_OG;\8?C@N/67X<]\^
MO@3'&/\ ZWI_,7_P<B?'W7?B#_P40_X(_?V-X/\ V@?A%:V7BS3M,U/3OBCX
M5U?X:/XD2;X\?"AFFT^R76+F/6;>$0JE_(S%(3-8KOD\Q3'_ *$. 1@]/_KY
MK^BO[>SGKF6+;[^TUM;_  >:UTUOHME@N$N&6DUDN!5TGI"II=)V_CK:Z5UH
M[=C\3Y?^"(G[/\,4LO\ PN'XX-Y,4DA7SOAUSY:,Q''@1?O8P,DX]1DFFP?\
M$1/V?I88I?\ A<'QPC,L4<O^L^')QO16(/\ Q0; GYNO3@X]3^U-Z!]DNSW^
MRSCJ1_RR?THLU!L[0D<_9H.Y_P">2T?V_G%[/,L7KM^\_#X&EWZ>H_\ 5'AG
M_H2X#U]G._W^UYOGS;:;'XN'_@B#^SZ!_P EC^.#>PE^'.<X)SD> E/.,8SC
MVYR#_AR!^S_@_P#%X/CBO^T9?AT<>_\ R(C'V QU(XZU^U>Q?3]3_C2@ =!1
M_;V<_P#0RQ7_ (,7_P @'^J/#/\ T)<%_P" 5/\ YH/Q4'_!#_X 8S_PN+XX
MGDD 2_#D>@[> \^X.0>#CC@M/_!$']GX'GXP_'$9[F7X=GOUY\"GIUY[?B*_
M:ZBC^WLY_P"AEBO_  8O_D/S0?ZH\,_]"7!?^ 5?_EY^)D__  1#_9_A@GG'
MQB^.)\F&27:)OAV,E$9L CP*!DX '(Z]>N)$_P""(7[/[J''QA^.0#*& \[X
M=_+O ;C/@4@=<X!(ZCGO^T=^ +"]'I:7./\ OS)_C5B'_51?]<T_]!%']O9S
M_P!#+%_^#+?E!#_U1X9_Z$F ;[NG-NWK*K)K771K]3\6/^''WP!P,_&3XX=?
M^>WPYZYX/_(AGGW'KGCM]N_L@_L5> _V-;3Q]8>!?&'C7Q7#\0;WP_?:C_PF
M4F@.]A-X=M=4MK5-.&@Z+HJ+'<)JDS7)N4G<F* 1,BAPWV=0,]SGWZ5AB,US
M+%TI4,3C<16HR<92ISG>,G%\T6URIZ/S1T83AW),!B(8K!99A<-B::G&%>G"
M2JPC4BXS492JU+*46TU;7KL@^M9D&CZ9;:E?:Q#I]E#JNIP65MJ.IPVT,6H:
MA;Z8]T^FV]_>(BW%Y!IQOKTV$-Q))%9&\N_LJ0BZG$FG17 >T4=3XTS4/^O&
M[_\ 2>2K<?\ JX_]Q?\ T$54U3_D&ZC_ ->-W_Z3R5;C_P!7'_N+_P"@B@!]
M%%% !1110!E:[_R!=6_[!UY_Z3R5JUE:[_R!=6_[!UY_Z3R5JT %%%% !111
M0!EZU_R"KW_KB?\ T):U*R]:_P"05>_]<3_Z$M:E+J_E^H!1113 **** ,[5
MO^0==?[B_P#HQ*T:SM6_Y!UU_N+_ .C$K1H *\<^,&#HVG*QR/[77AF(( LK
MCD$ X)S\O'<YR#7L=<OXBTG1=9AAMM;1&ABN!-"'G-N#,8BGRLDL;-A68D,3
MC@X!7-?AWTD^ <U\4O GQ1\.\DS/*\FS;C#A7$Y+E^:YUC*^7Y3@<36QF3UX
M5\?C<,U6PV'Y<%5INK#52JPA_P O6>CE&)A@\SP.*JTYU:>'KQJ3IPBISFHQ
MG[L8M-2EU2L]MCR7X0 "\UOD@BWM!SW4R7!P0!D8^<\XW9SQTK\UOVN6_:QT
M?]M[Q)J/P?C^.FI_#GXI?LJ_ K]E>WM?"H\<7WPR^'?Q(^.WQ/\ VJ[R]_:9
MM[+3YHO#.A^*?@'I?@'PFGCKQA8W%CK6G>'?B/X&MM>NVMI?"0A_7G0-$\.Z
M3-<OH\:+-.D8NREVURRK&6,0*M-+M^9W /RD\A2VT&NMC((X.0 .O)&?4\XZ
M< GI["OE_HA>%6>>"G@#P-X:<19WDG$>;\-K/:>+SGA[,*V:95C'CN(<RS+#
MRP^,KRJ5)^SPF+HT*D)3G&C4I.E3:A"$5OG^/IYEFN)QE*E4HTZWLW&G6@J=
M1<M*$6Y1Y8VYG9_"MUYV_EO\'I^T/X6U_P"%-Z\7[3WC;XRZM^SG\)?#5QX5
M\>V?[7/A/XU?#]Y?^"?WA_0/$OC7P?\ $>P\7^)?V?\ XU? ^R^) U'Q7\6?
MAW\9O"WPO^+&C_M5KK/B6?Q3XN^-%E^S[X3U3[1_85OOBAH7BW3+C]G_ ,%_
MM$^,OAEJ'P#_ &9M+^.-E^UQ\0_VI/ VAZ%\=Y=4\5V_Q,\4?"AOVJO!_C;X
MAZSXQT/P:EE<?$CPWX/MM"^'7B2:7P&)O$%GXNCU>X/[A\>OY?7^ISGUYHQZ
M\^G'2OZ9/'/YHO%6C?MS7'PE_96@^*_CSXY:;X,N_P#@G]\0#XUU/X4?!W]I
M#Q3XY\+^-(?VG/\ @F1/;_\ #5'AG3_C9HOCCXGZ[>?#F'XQZ?\ $2T^'VM_
M#?XZR_!&7]J27X-R1^(;IK."WX'O$O/#7@X?M/>#?VI])_9VT?P%^T9I7P0@
M_9X\0?MH:_X;\5_&NV^)VD7>B>-/A'"HL_CKX*U'7O"%[8Q_L1^#?B5>7&@?
M#34-)\::/^S[XFN_#=IX-UZ\_I2P.O'/7CKTP<^V.*./;W_S^- 'YE? 3X#3
M:1^W%\5_B5J=A^T=IFD/^RS^RIXT\/67Q*^-7Q@\2^";'XT_$CQQ^V5I_P ?
MK!O"</Q%UKX"77CJU\-:/\';?QEH?@O2;GPWX1">#]1\*V>CZ?J.A7EU^FHR
M  >H S]<4N .@Z\GW/K10 4444 %%%% !1110 4444 %%%% 'FNN_P#(7OO]
MZW_]([:BDU[/]KWV /O6_?'_ "YV_L:*YWN]MWW[O^Z_S ]+HHHKH *Y?7O!
MW@_Q/;S67B;PMX<\06EQ>07\UKKFA:7J]K/J-M;&QMM0EM]0M+F&:]M[-S90
M73H\\-LS6T;I$S(>EDW;#MQD<X)(! Y(W#)&?4 ^G?-?C-\6_ _[0L?@+_@J
M]9Z)\:OVIK?5[7QMX=^(7PAUK1)].37Y=)@_9E^'&L'X._!"/3? /V+PU\-?
M^$LMI?#6H#X::5;_ !*O[X^)KZ_^(LWQ.U_7/&<@!^Q]G9VEA:6EA86MO96%
ME#;6ME9V<$5M:6=G:QK!;6MK;P(D$$%O&B1P0PHL4,2JD:K&B@?@1^PW_P $
MY_V"?&7[$W['7B_QAI]P/%OBG]E?]GWQ'XFV_&WQ;I:MX@UOX2>$=3UATTN'
MQ7;V^G"34;BXD^PP6UO#9\01PQ)$(U_?X$@X'*EV.<Y.3(21T P.01C@8^8G
M)/\ G.? K3M.?X'?!IWL+1B_PF^&[G_18-Y+^#M&8EF:/<VX-G<22>I^9LCZ
M'AS!8G'5<5'#8^K@)4J=.4IT.=RJ1G4E%1:AK:+C*3[72ZGQ'&N:X'*L+@JF
M.R?#9Q&MB:L(4\4Z:C1G3HQ;J0]K"2;E&7*VK-)/7H?V5^%/^"=O[ /@CQ#8
M^*/#MDB:K80:O:1R:C\;/$NK64EGKNB:CX<U2UNM-U+Q5=6%U!=:/JU]:&.:
M$^7YPFC*3Q12)Z+?_L@_L5ZAI-UH@TOPQI.GW]WI]]>IH/Q#N-%N+JXTN/4(
M]/$MU8Z\EP]M:C4KQDMO.2!Y)/,ECD9%Q_' =,TW!QIMD<\_-:VY.>QYC'0<
M#/<>G-!TW3>ITRP/'(^S0=.>3\G4\\DM^&!7E\0> W!/%G$^5<:<295E.><6
M9)1P]#*.(,SRQXG-,NH82MB<3AJ6%Q-3$TG2IT*^,Q=:E'V<G&>(JN[YK+Y;
M!^*\LMRW&9+@,E>"R?,)<^.RS"XWV. QD[4TI8C#4:<:5>25*G:4U)KD34KI
M']'/_!2O_@D5^SW_ ,%+OC_^R1\?_''[3FL?##5OV1KV&\\,>'_"+> ]9TSQ
M6T/CCPMXV0:S=ZU>BZLR9O#$&GLUFC Q7#W 7?&(Y/VS_P"$[\%]/^$O\+'D
MY(\1:/@ '@\WF>G7CKZ"OX%/[-TW_H%V70 $VUOD@$^L>1CGCD<^O-(NE:<3
M@:?9 $$_+:QL2!@G.V/!R .N!UQ@=/LEP.FDEF3D]K_5X+>^LFZB27=W6MK;
MB_XBMLHY(G9))?7E%65DM7!I)+5Z:1BWT/[]?^$@T;4=/NI[#5]+OX##<1B:
MRO[6[B+K&0R++;RRQEE8A64,65N"!D57A\5^&[>"""X\0Z#;S100)+%/K&G1
M21N(5W(\;W2R(ZG@AE!QSC&#7\?7A+5K_0?@!\'K?2=5O]#CF7XMS-;:7J=S
MI$+R?\)_J*).8[*XME:<8C#2,C.(_+7<JE0?2OB]'#/\1]<N)XH+F:>P\(2R
MW4\:SSW+R>!?"[M--<3B22:>9V>669W:67.]V/4?P5PU])+,,Y\<_$WP@K\*
M8*AA/#[%Y]AZ&>TLVQDL3F?]CYQ@<KI_6<%6PT</0EB88V>(E]7JU*5+V4*<
M:U1U$S]FXM@N%_#?@?Q"4HXR/&GLG3RR7^SRP,:F$Q6*O+$R;5;3"RC&,:<7
M+G@[=#^KX^,?"V?^1G\. <]-<TKGIZW?KFC_ (3+PMC)\4>'1Z_\3S2<?G]K
M%?Q]&RL#EC:63'&<>3&O!&<<#:,=,<8YXP0::;*S./\ 0K0 ]C A/T.#R3CT
M&.F17[FN/DU=Y;373_>O_M3\DCXH0:N\I@O^YQ/\5$_L&_X3+PL>GBCPY_X/
M=*Q[]+HTO_"8^%^?^*H\-GC/&N:7Q]?])[]J_CY^Q6)7FRM 3G!\I >O^ VC
MKG&2!P:06%D/F^QVJXR>(X3D#G !VXY]![CK0^/5TRVG_P"%2M_Z3\O\V#\4
M(+_F51ZO3%77K\/WG]?U[XP\+M9WBKXH\-L6M;A57^W-+R28G"X_TI<9/'/'
MOZ31^,/"ZQQ@^)_#@PB#_D.:7V49&3=D=>F!CWP<U_'X+*Q(/^AVAP<EO+CR
M,^HP03D 8![<G&*#:6#')LK(\X&Z%0#D=L >G;Z#W?\ KY?599%JSO;$M[=[
M0=M->@O^(H1;]W*(22W_ -L2MZIQVM=W7;<_L%_X3+PKC/\ PE'AS'<_VYI/
M!]/^/O'ZTO\ PF/A<]/$_APCU&NZ5CG_ +>:_CZ%A8,?^/.Q7IR((SQZX8C(
M(Y[Y[8I/L-D>!969_P!Z.-,>@&,#Z\X QQG&5_K\O^A;!?\ <TO_ )$%XHP=
M[Y3!6[8Q2ZO?W=-OS/[!?^$S\*]_%/AP?]QW2?7_ *^Q_CZ@4?\ "8^%NWB?
MPX1US_;NE?\ R3^'IGO7\?8L; GFRL1_VQC/3ZD=\#()Z\<4GV*Q.2+*T.,]
M8H@.#_"".02.#O)&.F<D'^OR_P"A9!?]S2_6(O\ B*,.N4TUZ8Q2_*.G](_K
M[O\ Q=X8DL;Y!XF\.DM9W2C_ (GFE<EH) O_ "]C +$<G''7':RGC#PL(T7_
M (2CP]N"H#_Q.])QG:.XO#GOTP"1Q@$5_'ZEG9 #%E:J3_T[HW.>3N(P!V)7
MH, $<$(;2R( ^QVA[$&VA4'&,'. 0 >1P-PQGGFC_7Y:?\)D;/K]9M?6VEXK
M_@C_ .(G]LFC9=\9;?5;PMJM;7^]:G]@A\9>%@<'Q1X<SZ?V[I0^F,W63G\*
M7_A,?"W;Q1X<_P#!YI63[<7)_G7\?8L;'O960 (R/)3<.O/7&3Q@[3P#Z4TV
M-BQ(%G: 8Q@QQC(Z'&5(]<9]O6F^/5TRV"_[FE_\C^0_^(GPM_R*8KTQ5W]W
M+\M/D?V#?\)AX7'7Q/X=_P#!YI7ZYNA_6C_A,?"W_0T>',?]AS2LCZC[3CK[
M]Z_CY%E8A0?LEN "Q($,14@9ZD')R,8X) SG'4!LK $;;*U/'&V&(9R>^5QP
M.@X]3DXH7'J>G]FT[_\ 87'IOT%_Q%"/_0HC;O\ 6U=_]N\MT_)G]>FL>+O"
M\NDZG&OBCPVS/87:*/[<TLG<8'^7_CZY)&?7/IQSI'QCX6Y_XJCP[_X/-*_K
M=Y_K7\?*V5D./LMJH. !Y"'<."5)5&W$G'R\<X(SR:46-@<G[)8MG!W>2G/4
MDYRV<_ADD'/6I_U^L[?V93?_ '-+3M]GK<7_ !%"-[+*(/I_OJ3^YQTMY[JQ
M_8+_ ,)CX6[^)_#O_@\TG_Y*%*OC'PKGYO$_AO&."-<TO)/8?\?AZ@'\?:OX
M^A8V8ZV]GC'&+>(8QCC=\N<#CGCIWIIL;(9(L;0GU^SQG(*G)8 DY.00,G.3
MD8X#_P!?;Z?V9#KJL4NB;_E?;\=!_P#$3T]/['CZK&J^S>EX6Z']CNGZOI6K
M"1M+U&QU%(6"2O87EM>)&Y4.$=[:654<JP8*Q#%>0".:T?K7X"_L#^,OVJ/"
M/A7XB6G[/G[./P<^+GAV[\5:7=:]KOQ _:;UGX'ZIIFN#0HH5T>R\+Z/^SA\
M7XM4L(]/CMK_ /M^X\1Z?-//?RZ<NC11Z7]NO?OL_%__ (*3XS_PPW^S#T_Z
M2 >,!@=R"?V&>PY']*^VR[%_7\#A<9R*FL32C5Y$W+ENY+EYFE>SCO;4_1<H
MQ[S3+<'F#I>Q>+HJK[+G53DO.<5'G22EI%>]9)WTT/NO6O\ D%7O_7$_^A+6
MI7YZ?L__ !:_X*!^.?C!\>_"W[4?[)?P9^!WP,\,:7X:G^#OQ+^'G[25[\6]
M=\;:S?\ AOPI=:_X?N/#-Y\+O!%W>Z;I6MWGB;[9XWU&U^'8TVXL=.\*Z5X/
M\;1&_P#',7Z%UVGI!1110 4444 9VK?\@ZZ_W%_]&)6C6=JW_(.NO]Q?_1B5
MHT %?GM_P4ON+BT_9DU>>VN;BUF3QAX,59X)FMI5676+9'"2HT;+E,AB'4\X
MSUK]":XSQCX,\)>/=..A>,?#NC^*-)%U!='3-<LH-2T][BWRT$LUG=))!))
MS.\+/&YB+;DVDEA^6^-/!>9^(GA;QMP3DU; X?-.),EGEV"Q&95,12P%&O\
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M5^#]2N=9\)>)]8\!>%=3\1>%]8O=>E\4WFK>'=;O=)FU/1-3N_$TTWB*YO\
M3;JVNKC799=8FE?49'N6[N;1-'N-3M-:N-*TZXU>PL=1TRQU2>QM9M1L].UB
M73Y]6L+2_DA:[MK+5)M)TN74;2"9+:^ETVPDNHI7L[9HOV\^:/YL?!G_  4
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MFM?5X1.UNJC+YV:/Z#IM$_X)?K!,8[G]F$R>3((Q_P )+X=YD*$HO.J@'<V
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M* /-==_Y"]]_O6__ *1VU%-U]U76+T$@'=;GG_KSMZ*YV]7ON^GFP/3*\/\
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M_"#?& 8/4:+X-'_H/CP9'Y^V*_(__AEG]IC_ *(5\3^/^I5OO7\C_+'M3O\
MAEK]I;H?@/\ %(G@9'AB[ ..IY( S[\YXZ#-+^W^*/\ H7R?_=/Q-_\ TA?J
M/_6OCC_H6U5ZY)5L_NO_ %J?K/=?\%4/@%-;7$(\%?%]3/!- "-%\',5,L3(
M"0?'JCY=VX_,IP,!@34P_P""JOP# "CP-\83MP,_V'X+(.T 9_Y'K(SC.#Z\
MBOR0;]EO]I4*Q/P(^*8 5B2?"]T1@*2> 23P. .2< <D4A_99_:4))_X4/\
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MCJSN[V.;PG\0O!]@=?TKQ/\ HTHPH'!QUQG&>_4D_F2?6O7/>,S6O^05>_\
M7$_^A+6I67K7_(*O?^N)_P#0EK4I=7\OU ****8!1110!G:M_P @ZZ_W%_\
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MQ,ZVC75RULLHA:XF9/,;^HH#;MYW?O&SG&<L2V20 .#AAP,<8["OXA?V8/\
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MZDD_Z7D?:A_X*TZ;D@? ;4NF<CXEV>,'."<^#<=CZ_K2?\/:M/''_"B-5!.
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MMP0V#SC Q\Q)IP_X**_M8\ >,?"O  '_ !;[P_MP%'3H,8''.,\#L*^D)_\
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M&4.=RDC[CC(R"".7'_@HQ^UEQ_Q67A?/)R?A]H(') R"8QSGKZY]LGZ.NO\
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M** "BBB@ HHHH **** "BBB@#S37AG6+WDCYK?H<?\N=O12Z[_R%[[_>M_\
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M""VMUDFD=8HU$DI;+G^[Q5"*J*0$CVJHZ\ !0IR2Q/.-Q8G/+9-?S6_L5?\
M!'/X0_$S]C/]D?XC7_QA^*VF7_C[]F#X">-+_3K"P\$26-C>>*?A5X3URZL[
M%KKP[-<FTMY[UXK8W$\UPT*1M/-+(6<_0</8W+,#5Q4\SHPK0J4X1I*6'CB.
M6<:C;:C)-1O3;3:6JTUZ?%\8Y;G^98;!0R#$3P]:EB*T\0X8UX%SI2HJ,$ZB
M3<TJBOR-;M2NK6?F?P8_;E_:NB^$>O\ B*_^,OB#Q)KK?%C3?#\%]XIT_0]8
MDM-(;P1-JTEE91G3+>"W2:^Q/*XC>>38J^9Y2F-NY\9?M?\ [3E[#X*U:W^,
MOBO2)M;\%0:IJ%MH::+I^GO?1^*_%VE?:$MO[+F2*22QTVPBF"$([0APN]WS
M^AG@;_@DO\&O!WA'4O!EU\0OB5XCTW4/%5OXN6XO#X;TN\M+^#1)-"-O')I6
MB01R6LMK)YK*\?G"91^]VA0F[KG_  2X^%NKG1HH/B1\1-*L=!T6+0K"T@B\
M.7C&UCU;5]9:6XNK[2)99)Y+S6;I<((H(H4@CBA0(2?X(GX;^-<_I9<><>4*
MV;4?"G-*F<3R*G/B^4<K]GB,DX<PV"ITN%H9E)8)QQN#S)P?U"FJ<I.JE2=1
M5)_>9M*C7\%.'.&<'%Q\0<)F5.MF^914J=6O@EB,PFZ,LW552Q"4*N%NHQA[
M1)1=E3=_RC/[7G[48./^%^?$$\=?M.A^I)X_L,8.,'ID<]!C*C]KK]J09W?'
MSXA '!!-WH7OP,Z'T^G/3D<9_3[_ (=/?"_K_P +9^)_T%IX07^6AC/3C/0<
M=S3/^'4/PM0_\E:^)XR<<V?A =>^Z30\'KC ^8GH,XK^BI9'Q7&+E/'5(K>4
MWF5115WWE65DKVZ+:UM+_AZX9X[>G]H5[OI_:]1M6O\ WDU_X,Z]M%^8;_M=
M_M1XPOQZ^(#@AE;-UH>,$$$?+H@.0"6!SP!GG' G[7?[48&#\>OB"J@84FZT
M,@8P,#.B,".#_$6Z\]Q^G,G_  2B^%RQRR+\6?B;*84DD %GX0.XHA;8"-#R
M-PRN!@_,1T-.A_X)0?"Z2&*4?%CXG!I8HY&S9>#@W[Q Q!VZ""",\J6.#CDD
M9I1R3BF<?=QU22:=IK,:K35VM&JNMG%K32ZWTU/]5N.]WF%?M_R.*B:Z[<[?
MG;G3]%H?F(W[7G[48!(^/GQ!;V%WH?'&>O\ 8G(SQR.IS0/VN_VI"0?^%]_$
M(+@_-]JT+@X."<Z'ST' QGJ<#&?T_'_!)WX7]_BW\3N,?\NGA$'CW70S[@^N
M>I[!_P""3OPN[?%KXGY['[+X1/\ /0_\_4FJ_L'BM*WUVKK?7^T*O7_N(VK=
M[_(%PQQW;3,*_I_;$[_C*3^Z:?:Q^8#?M>?M1C)'Q\^(+<CI=Z%QZ\?V(/0]
M^/3 -(/VO/VI."/CW\0L$_\ /UH1P,<D_P#$DZ C)_G7Z@#_ ()/?"_//Q:^
M)Y'0_P"B>$1USW_L/@_RX[XH_P"'3OPN.?\ B[/Q.Z?\^OA$_P ]#//;IW/L
M0+(>+$FOKM;7K_:-6VUMO:/^M]P7#''>O_"A7ZZ?VQ/_ -NE)^6DEY6>I^8#
M?M>?M0X)/Q]^(##:05^TZ&0WRD=%T13SZ*0>,YI!^UY^U&>#\>?B+D=A/HH(
MXSR'T9SSD8Y'&!U(-?IW/_P2B^&$,$\P^+'Q/?RH9)1&;/PB2YC0ML&-#!R^
M-HP1UX(/-2+_ ,$G?A<5!_X6U\3_ )@&Q]C\'1D9&=I4:"HSZCG!ZGGE+(.*
MUI]=J^3_ +1K>?\ T]_%_(/]5^.VK_VA6WM>6<5%YZ)SE^#5OR_,/_AKS]J$
M<_\ "_?B"?;[5H8&/?&B ^P.>I&23S7ZE_ S_@IA^QGX>^$O@71/CM^VQ^SW
MHGQ@TO1([/XAZ3XX^,'@31?%^F^)X+BY2]L_$.D76JV=UI^J0*L<<]G<VUO-
M#M"201D%*H_\.G?AAP?^%M_$TD8X:R\('/3/_,"Q@X__ %]_T5^$WP[LOA)\
M-?!GPUTO4]5UK3_!>BVVB6>J:N(/[2O;>V,ACDNQ;10VRR8D$86&)(TC1%4
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MFOZ??^'3'["HSM\*^*/EX)/Q:\7 +US_ ,Q8YQP<D=^P%5Y/^"4?[!<;;)]
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MJ@D#(_X6GK'' X_Y"H&.V0!P.@XJ?]5L\NY?7Z*YM_\ ;<4]EM:Z:5OTZB7
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M_#OG]C?G%IJI/49^*FL?3&/[488Z8R#^'</_  3Y_8WQ@V>J_C\4]9P<=/\
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M,[K6SY] 1Y X(SCL"/P/]%1_9R_X)Z C'ASX6CK_ ,SOKAZXZ$>*!@=?KQT
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M /KT XX!IOV+3\$"TL"<9V?9;8\Y'^P1QZ>@( R>?Z!=8^$7_!,KP[>)I_B
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M8/\ V3.G_"E_#Y&,#_B;^+<_B?\ A(<G/<9_$]:7^H^8_P#0PPJ_[=Q/^?Z
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M^PJ0@'K0U?\ KY@,4ALX' 9N_P#$KG)P/4G<,]L$^W\VG[&;*O[&_P"R&BR
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M@+JHQUZ?\9=-[=,8P*7^O^$V_LBIZ+$4+_>Z/YA_JV_^@NEZ?5Y?GSV/D3S
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MH<C/KD# ).,^X[YH%U#VF&/:2/;UY/WQCWP!_6OZ 3^R+^TOG_DLG[%9]_\
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M'PM_;[!S_P -A?L[Y/7_ (PD\5?_ $8E?;'Z0?96I9_LN_SU^P76>G7[/)Z
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M3>^X)^:W]/\ GSM_4BBEUW_D+WW^];_^D=M17.]WZOOW?F!Z511170 4444
M?,7[9'Q*\6_"3]G7QWXT\#:SI/AGQ0M_X \):9XMUS3;?6-*\$#XC_$KP?\
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M+8^#=+OK7PY:2,6M]-C9CD ]04Y4'U'?]>.V#P1U!%.IB[548;Y>H)V@ 'D
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M&GQ(^%?@KXP:IX?\8>'/A9XJ^"GC.X?1;._^.VJ>"O%GP=^/^H>$OV<?B\/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#S37F4:Q? L =UOP2!_RYVU%>BM;6[L7D@A=CC+
M/$C,<  98J2>G<^U%9\GG^'_  0)J***T **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ea028514801_img14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img14.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $3 G # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^];PA_P B
MEX7_ .Q=T3_TV6M=%7.^$/\ D4O"_P#V+NB?^FRUJUXBN]0L/#^N7VDVWVS5
M;/1]3N],LRC.+K4+>RGFLK8HA#/Y]RD<6Q2&;=A2"0:J$7.<()I.<X03DU&*
M<Y1@G*3TC%.2<I/2,4Y/1,F<E"$YM-J$)S:BG*34(RFU&*UE)J#48K64G&*U
M:-4R1B01&1!*REEC+J)&4=6"9W%1@Y(&!CK2B1&9D5T+IC>@8%DW<KN4'*Y'
M(R!GM7\<MEH?P8\1_L8Z-^W?\3OB#^TS\0?VL-4\8^,?%'QB^*OPG^/?A#PM
MXU_9G\1^$O%5^UGX7M?A3\0?'?A?1KG1DL;2STG3/"VG:%K.JW,4QFM88+!H
M;>OK+6OVM_''P2_::_;7^)WPVM[/5/&7QFMO^":_PS\ 7_Q.EN5\&>"]7^-W
M@6]B3QQ\0++1;NWM;6VTR"22^U*QT:>RM+[66BMTN%L\AOW#%>">,Y\9ALLS
MFIC,9@9YCE]>.,R:IE.#J9UE6:9)E^-P^&QE?,\74GEBH9KB<QHYAB,!A<36
MP>71Q-++L1A\SRZ=3\-P_C;@U#!8G,\FIX/!X^.7XZA+!9S3S;&4LFS3*L[S
M#!U\3A*&6X6G',W7RK#9=6R_#X_$X>CC,Q>'JYA0KY=F$:7],[R1Q@-(Z1J6
M"@NRJ"S'"J"Q +$\ =2>E/K^8']MO]HK]HK7? OQ6_9C^,'B;X5>(OBQ^SI^
MU/\ L0>(-#^,O@.RUSP/\/-?T_XL>(+^^TC2/'OA^37M7N_#.H^&=0L"?$-I
M:ZY/%J/A^07D:6\D9DF^K;W]O#]H[X;ZY^T;^S[\7?B1\#&^+_PQ^*7[._A#
MP%\4O GPM\>^)X?&UK^T!8:CJ\?@'PI\$M$U[6-8UWXQZ-:Z1=VNA:/>^)K#
MP_="X@U'Q#J5K:0EKKQJGA!GW]G8'%X7,,IQF)Q<ZU9X2C7Q,N;*/:9%'!YY
M@JJRYSQF K4L_P +6Q5.=# X[ P3Y\#6C#$5L+[4/&'A]9AC<)BL!FV#PV%C
M1H1QE:AAHI9NJ>>RQF1XRF\Q4,)CZ%3(,71PU2%;&X'&R<>3'4YSP]#$_N>S
MHA4.ZH78(@9@I=SDA5R1N8@'"C).#Q3)9X(=OG311;L[?-D2/=CKMWD9QD9Q
MTSS7\U6I_M/?%C]I&Q_8SO\ XK6XTGQ?\)_^"QUI\#+NXL=#N? NH^(=$\)>
M%=<O+"Z\8>#H->U^T\/^)0FI_8O$.@6FM:II4%Y9CRI"P<5Z=_P6.\,MXV_:
M8_81\)R_!'QQ^TEI^HZ%^TO>WWP0^'_Q'O\ X6^(?&,>C>%_"&II=6?BFPN[
M26%_#9@.N-91LUSJL5G+IELK2781ZP_A3B89_DF09KF]#!5\SPG%V+Q=;#4\
M+BJ.#CPK"E62HXC&9EE6!Q$<QPV(PU:G7Q6-RW#X1UG'$UTJ<ZI&(\6<+/(,
M\S_*<HKX[#Y7B^$,)A*6)J8K"UL;/BNI6H7K8?"9=FF.P\LNQ.&Q-*I0PV"S
M'$XI4N;#T'*I"D?T%(Z.H=&5T895D8,K#U# D$>X-.K^43]EK]I'XK?LS?LM
M:EXG^!]C'H6D?M6?MO:?\'?@?\*/%NO^-OVB-7_91L+/P]=Q>.-)\7Z$9M#\
M4ZW\1+V_T.232?ALUWIEW=SS6E]<SE)\W'VS8_MQ_MTZVG[/OP"U/P?X(^#O
MQX^,OQ_^+GPTL?C-\4?AGXIT?P-XB^&OPH\(6?C*R\<Z)\)[WQ39ZYIGBCQF
ME\/#[^$M3\2[M(U/3;Y1(3<0FTUS7P:S[!8W%T\)F>38C 8?'8["QQ6.QU++
M<7[#*L']9SC&U\M7U^M]7RBM3Q6!QSR^IFS>(PLJ^"AB\OQ&%QU;/*O&?A_&
MX/"3QF79SA\PQ&!P&*EA,#@:^983V^;8OZMD^"H9E)8"C]8S>E4PN,P,<PAE
M25'%1H8R>$Q]#$X.C^[[2(A0.Z(9&VH&8*7;&=J D%FP"<#)QVI]?S?:)^V#
M\9OC+JO[*NL?%7PI\$?'7Q T'_@IM\<_@+H=_H.E^(++PYIMK\-_AV\NAZGX
M'U0>*#]GO-5U9Y[8^)-?AUNV72;Q7ETH36YG;T'X<_MB?MC^-H?B=\,?CC\2
M/AU\$_C%XS^ 'QI\2^ /A7J_[/7Q#\,:WH'BWP;I.HZK)=_"_P"*,/CO6_ '
MQH\+^'O#L#WFI:OIVK:3K >:WU&TL(X[&X\[GQ/A#G^&IMU,?D\:F'566.@\
M9*M*-.EFF%P%3%8&AA,%7QN,P6'H8NGC,9BZN#PE'#0C*G.5-RIS?3A_%_A_
M$SBJ>!SB5/$^R6!G]3C14JE7*\5F%/"X^MBL91P6#QN(K82I@\'A*6,Q=7$3
M:J053EG _H _S^76BOYL_P!D'X\_MLP>$_\ @F_^SKX-^+_PHCM?CM^SEX]^
M+^M^/?'7PUUOQ3K?ASP?X,U/P[=6&DS2-X\LY?%7C%["\U2QU3Q'J-YI]G?W
M>I'5IK&-].$5[Z]X1_X*#?M#^/?V@?A9\/\ P=XV\">+/AM^TH?VH?"W@;XB
M6'P-\:>&OAQX0USX1Z'JMWX3UWX<>,_$_BBQU[XVQ:+>:?':_$=I_#'AOP\^
MI2RVOAO5&A1)*6.\(<_PN,S'#X?,LCQE'+Z&:8V6(CBL91OE^69AGF!EB*L*
MF6>SP]?$0X;SO%T,#+%5L54H9=B?9TZC]C.J8/Q?X?KX3+L1B<MSS!ULPKY7
M@H8>6%P=:V89G@,DQL<-1E3S-U,11P\^(LEPF(QRPU#"4J^8X=5*M->UA#][
M&D165&=%9R0BLP#.0,D*I.6(')P#@<FG5_*S^S/\:/B=\//A3_P2Y\=?%J?P
MG\<D\1>)?VU?''AO5+[P[XEF^*?A#0_ ?@_QGKNM:78>)I?&MU;^(O%7BWQ)
MIFJNVM:OHUQ!::%?6>BV^E)-I[:G<_8OP<_;X_:UFOOV3?''Q7U+X!^*/AW^
MW9X2^*&M?#[P3\--#U^S\:? [4_"?@76/'OA[^V=5U#Q%J<'Q!T*&TT]-$\:
MWS:=H4NC:SN2+**(YM\X\'<\R^IBHX/,<KS"CA:V<X:.(E7E@UF&)R7&YY2Q
M>'RVA/#5JTJU++^'\RS*O#'RP$(1PU7#T,3BZLL,L3SY-XR9%F-+#3QF79KE
M];$T<FQ%3#QP\<9_9V&SK Y)6PE?,:\,31H*E5QW$&6Y?0G@%F$YO$TL17PN
M$IQQ/U;]X:1F5%+NRJJ@EF8A54#DDDX  '4DX%?SU?L^_P#!1G]KB6#]CKXE
M?M >(OV>F^$O[67PL_:+UP6^D^$_%OA:\^&6J_ +PYJNOIXP\5>(VUS7([[1
MM>72W?7-,TK11_9%D98]-%[=I%+-YWXO_;B^//Q<^&G[67P<\?ZG8>*/!?C3
M_@F;\4OVD_!?Q LO@_XH^!TIO!'>Z"K?#W3_ !#XGUCQ%XJ^%>JVE\EQX8\9
M>)=.\,>([^:R-R-.%M+S,?!GBF./GA:^)R;V&'KTJ6*QF$QM3%4E&&?0X?S.
M.%<\#@X8G%Y3BO;3Q&"]I2J5:=)3PTJE&:Q2J?C3PH\!#%T<-G*Q&(H5*F%P
M6,P,,)6E*ID-3B#*Y8E0QV-GA<'FV%5&&'QKA4I4JE;V>(C"O!X4_I7:6)(_
M-:2-8L!O,9U$>UL8;>2%P<C!S@Y&*:MQ \;2K/"T29WR+(C1I@ G<X8JN 03
MDC ()X-?A5^W%<WB?\$,O#$\-Q?M>2_ G]DQ3);W]S:ZA=O<ZG\*HI8%U&.5
M;F.>_$CVS7+2EMTY>4L-V?@>W_9?^./PD^%O[=GQ:L/V>/B)^QO^SM<?L-?$
M7PGJ'PK\:_M$S_&S6/'OQ2G\C4=(\<:7)'JE^_AT:%ID5U ;AY;>5&F:WM=R
MW]Y#;:Y'X68+-LKQ6.Q7%>&RK$4^+,QX5P.&Q.%PC685\NS;(\K;H1GG.'S&
MKB\8LY=;#87!97CZ%)X*K#,,;@:=6C7EEGOBIC,IS3"X'#<)XO-<//A/+>*L
M=BL+B<7?+\/F.4YWFB5>4,GKY=2PN#_L;V.)Q.-S3 5ZRQE&67X/&U*=:A#^
MM$$, RD%2 000001D$$<$$<@C@BEK^>;X5_ML?M&_LY>%H/AI\;_ !_^SS9^
M&[?_ ()R_##]I/X1>-[CPE\1(-)^'D\NK^'OAGH_@_Q]#I>IZ]XF^)-Y>-?6
M%WYOA^PTO4]<UUH[&SM[.WN9I8.@T#]O#]N?6O#_ .UYX"\&^"+3QW\4O@7X
ME_9SD\,:SXJ^#EU\./'D7P]^,FG7%_XQ\0ZC\")OB#,^O:WX7MK1-3\%>$X/
M%FDZ_P")-+U&'^T+**^B-HW%6\(>)8U,4Z.,R&K@:%;!*CF53,_JN"Q.$Q^8
M3RVEC88C%8*A1A3PV)5.EF-&4W6PE2=N6=*6&KXSLH^,/#$Z6$5;!Y]1QV(H
MXUULLIY7];QN&QF RZGF=;!3P^%QE>K*>(PTJE7+ZRBJ&,IPNI1JQQ-#!_OS
M17\_&L?\%*?CUI7PB\#>$O#?CGX??$?]H#Q_^U(OP"U#Q!9_LY_%?PEKWPAT
MQ_"D_C!(/''[.FN>(5\3:Q\3M3L;.5/#N@Z'XA'A[4[>=WAU*[N-/NF/Z4_L
M<_&?XT_%;X">+M>_:>\&W?PK\9>"O%GCSPCJ'B4:!JG@#3_&7@WP[#'<:3\6
M=%\.:]>ZIJW@Z+4]+N9)+W1]2O+N?0]8TO4(7;;&L,?CYYX=<0</9;+-<QGE
ML<-_:7]G4Z-+&MYAB4\13PD<=A<MKX?"8W$8&>)J1HPJ4Z,JSO"NZ*PE?#8S
M$>UDGB-P]Q!F<<IRZ.92Q3RW^TJE6K@G'+\/;#5,7+!8K,J%?%X+#XV.&INM
M*G4K1I*TZ*K/%T,1A,/]N*Z,6"LK%&VN%8$HQ4,%8 Y5BK*V#@[2#T(J*2ZM
MHF*2W$$;@ E9)HT8 ]"59@<'MQS7\_/[(7A;X?\ P/\ ^"CW@_3/A7XMU#5/
M@?\ M%_LU^.-<^$7B[PW\8-<^-<?[1NL^%/$FE>(?&7Q0^..IZ_?&'0?%FAR
M:AJ&B>#[GPWI\UA?64<]A=ZG%=I/IXZO_@KQ^R'\#?$VK? OXXZMHGB<_$7X
MF_M4?LS_  ,\9:KIOQ \;Z18ZE\-?$.MZAH^L:+#H>FZ[;Z)IUU=Z=&L/]LV
M&GV^K1.!/'>"4%CZT?#_ "R'%V3<.8KB#'TL%GV34<SR_,X</.6)CB*E'.9U
M,#C,KK9OAWAIX:KD&9X7%R6+G6PF+A3P6(PRQ5/&^P\F?B#FDN$,ZXDPW#V
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MB(X?%8M4L!*=:.']MS2E3J1J5J]&A@X2Q1^_]%?SF?#+]N?]NOXA>%/V>O\
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MH6M-$U'4/"T6G)HIBN"JZBQ;5/.B1:G^&/[0'[1G[.?QO_:X^-7CS4O#E_\
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MCIX>T0,K. RG^S+4X(/L:W_[1L/^?N#_ +^+5<D_Y)_^ R_^1(]I3_Y^0_\
M X?_ "1=HJE_:-A_S]P?]_%H_M&P_P"?N#_OXM/V<_Y)_P#@$O\ Y$/:4_\
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M2+M%4O[1L/\ G[@_[^+1_:-A_P _<'_?Q:/9S_DG_P" 2_\ D0]I3_Y^4_\
MP.'_ ,D7:*I?VC8?\_<'_?Q:/[1L/^?N#_OXM'LY_P D_P#P"7_R(>TI_P#/
MRG_X'#_Y(NT52_M&P_Y^X/\ OXM']HV'_/W!_P!_%H]G/^2?_@$O_D0]I3_Y
M^4__  .'_P D7:*I?VC8?\_<'_?Q:/[1L/\ G[@_[^+1[.?\D_\ P"7_ ,B'
MM*?_ #\I_P#@</\ Y(NT52_M&P_Y^X/^_BT?VC8?\_<'_?Q:/9S_ ))_^ 2_
M^1#VE/\ Y^4__ X?_)%VBJ7]HV'_ #]P?]_%H_M&P_Y^X/\ OXM'LY_R3_\
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M#?X1_P#"IT#_ .6-'++^6?\ X!/_ .5A\U]\?_DC>HK!_P"$K\)?]#?X1_\
M"IT#_P"6-'_"5^$O^AO\(_\ A4Z!_P#+&CEE_+/_ , G_P#*P^:^^/\ \D;U
M%8/_  E?A+_H;_"/_A4Z!_\ +&C_ (2OPE_T-_A'_P *G0/_ )8T<LOY9_\
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M_#__ .4-'_#N7]@3_HS']F3_ ,,K\/\ _P"4-?9]%']MYU_T.<W_ /#KF?\
M\\ ^KX?_ )\4/_!-'_Y4?&'_  [E_8$_Z,Q_9D_\,K\/_P#Y0T?\.Y?V!/\
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M31_^5'QA_P .Y?V!/^C,?V9/_#*_#_\ ^4-'_#N7]@3_ *,Q_9D_\,K\/_\
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M +_2_P#Q=1446C_+'_P&/_R(7E_-+_P*7_R1+Y\__/>?_O\ 2_\ Q='GS_\
M/>?_ +_2_P#Q=1446C_+'_P&/_R(7E_-+_P*7_R1+Y\__/>?_O\ 2_\ Q='G
MS_\ />?_ +_2_P#Q=1446C_+'_P&/_R(7E_-+_P*7_R1+Y\__/>?_O\ 2_\
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M(?8G *6:XRC]5Y%@?]CH5\-1]IE&2UKTL1_$^L>WRJM]<K?\^L3COK>*P_\
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M%_W7#?\ 8/1_]-Q"BBBLS<R]#_Y >A_]@/1?_359UJ5EZ'_R ]#_ .P'HO\
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MI_Z*K\'/_#!>!_\ "C_B)4_X*T_]%5^#G_A@O _^%'_$#^-?^?N0?^'2M_\
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MV#I_\*,K91C(>WIUNF70YO85J7VLPJ8>K]@^D?#O_((MOK-_Z.DK;K$\._\
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MM(2BU)N%D[N,;RC9.[NMKN^CB? M%??.F_\ !+O]O'6-:^)'AS3O@%>SZ_\
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M.OAG&K*BIU(/V4ZD:<:KC2K*]*M^[E&IS4ISBX/FO:YK6W0?5OY5OVW;_/\
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M?^#9?_*SXP^W_P#!43_H/_\ !/K_ ,)?]I3_ .:2C[?_ ,%1/^@__P $^O\
MPE_VE/\ YI*^SZ*/K=+_ *%61_\ AJA_\WA]9K_\_JW_ (-E_P#*SXP^W_\
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MGE<*E?#4XJM3KN3KRR]S4KWJUG452$Z,XTZWB/BS_@KG\6O&?[,GBG]G:_\
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M;ZS?^CI*VZQ/#O\ R"+;ZS?^CI*VZ^5K?QJW_7VI_P"EL^@PO^ZX;_L'H_\
MIN(4445F;F7H?_(#T/\ [ >B_P#IJLZU*R]#_P"0'H?_ & ]%_\ 359UJ5%/
M^'3_ ,$/_28EU/XE3_KY/_TN05^.'_!P%_RB'_; _P"P5\+_ /U;W@FOV/K\
M</\ @X!_Y1#_ +8'_8*^&'Z?%[P23^E?1\)_\E5PS_V4&3?^K'"GG9G_ ,B[
M&_\ 8-/_ -*H'^8]1117]\'RH4444 ,:-'.67)"E<Y(.TD$H2""5) )4G:2
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M'J>H6*:/ID^E^ -?GO\ 4/#^MZEIWB9T\.>(=2T_2+W1;2'49E_9Q_8E\/\
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M^VOXS\0_M'_LP>*_#WP2_:,\1%[_ ,>^&?$5G<+\)_B]JZQ*@UZ^ETF":_\
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M4_7^AKH+?H/J/YFOT>@_X(N?\%2$/S?L>>.AW_Y&;X<'MTX\95L0_P#!&?\
MX*@J/F_8_P#'8Y'_ #,?PZ/<GMXQ/K7K4>/N!8I*7&?"JU3UX@RK_P":SX/,
M.$N*ZE^3ACB&?^'),T?3RP1^==MT'U;^5;]MV_S_ 'J_0V'_ ((Y_P#!3E
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MW_!06_"75W^VG\#= N9%!FTO0/V,4U+2K>0\LEK>:_\ 'N74Y8U)V(UPV]E
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M4?\ YI/K^BOD#_A07[?W_1]OPF_\0CT/_P"?O1_PH+]O[_H^WX3?^(1Z'_\
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M#T/_ + >B_\ IJLZU*BG_#I_X(?^DQ+J?Q*G_7R?_I<@HHHJR I,#T'Y4M%
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M4_X=/_!#_P!)B74_B5/^OD__ $N044459 4444 %%%% !1110 4444 %%%%
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MO0_^0'H?_8#T7_TU6=:E13_AT_\ !#_TF)=3^)4_Z^3_ /2Y!1115D!1110
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M;_=;^1KIQ7\/+_\ L393_P"H^*/)Q7\:I_U\K?\ I:/&FZGZG^=)2MU/U/\
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M@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?:;C_GJ_YU!S_=;_ +Y;_"CG^ZW_ 'RW^%%H]H_@%GV?W/\ R)_M-Q_SU?\
M.C[3<?\ /5_SJ#G^ZW_?+?X4<_W6_P"^6_PHM'M'\ L^S^Y_Y$_VFX_YZO\
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M^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D***
M# ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D
M*** # ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP
M/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!
M^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D***
M# ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D*** # ]!^0HP/0?D
>*** # ]!^0HP/0?D*** # ]!^0HP/0?D*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ea028514801_img15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img15.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #! <(# 2(  A$! Q$!_\0
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MC#H_BK3O"L.LR^(?#W@7Q?IF_2)K?(\9?LZ_\%!I]<\-_$#3/!O[4+_%&3X
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M^''[5WBW2_@W^V?\#/B-I_B+QK\;H+?XN^,?#O\ PAWB'P]\1O$-YX%'QO\
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M$J5&6/Q>!5.%2&7UZ4\74=+#UX4I-4J5.IB/K=6E&A1KXS^EQ6 #=1\JC[N
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MM_91PW@^R3M=6\217)^SR%9<(?5!UZ <'I@Y.1G)ZY!Z^IZGU_#_ /X)[_\
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MP].I";J)N49\NCTMRJ73KKYGG8O$U:52,:<K)P3:<8MWYFMW=ZI+3R^9U_\
MPD*_\^DW_?R'_"C_ (2%?^?2;_OY#_A7- Y&?J#GU!P>F1U'8XI:Z/JE#^5_
M^!2_S.7Z]B?YU_X!'_(Z3_A(5_Y])O\ OY#_ (4?\)"O_/I-_P!_(?\ "N;H
MH^J4/Y7_ .!2_P P^O8G^=?^ 1_R.D_X2%?^?2;_ +^0_P"%'_"0K_SZ3?\
M?R'_  KFZ*/JE#^5_P#@4O\ ,/KV)_G7_@$?\CI/^$A7_GTF_P"_D/\ A1_P
MD*_\^DW_ '\A_P *YNBCZI0_E?\ X%+_ ##Z]B?YU_X!'_(Z3_A(5_Y])O\
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M:9?1(O+.Z;% Z<M(J*.3D<Y) &.21\A#_@GI^RV1D>'?BQ@X(_XRB_:EZ?\
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M/_8<U;_TON**%A*#2?++5)_'+JD^_F'U[$_SQ_\ !</\CZDT:?9X9\.CH?[
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M>6S%&5L$?C'H'_!*+P?8KX<L?&'QJOOBQX5\#>&]4^&GPY\#?$;Q'HEWX9\
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MJ_BS3O#L@!O+73IH?G*[_P""2'[$OPS^&WQ'UGQG^UGX*_X4_P#!RU^$NO\
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M0A5G.<IR45&,(J<I.3:2BHMMM:63:]"ZCK)Q26K;<4DENW?E225W>_0^)?\
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MJG[/S2:S/\2/A9\8_AIKVA_$+Q3\(KZ_E\+_  ]\8VR?%'2K?XAZMX3^$?\
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M'%UJ'Q$MK'QB;?QY:W<'C/3;+5M.TQ-+TK6['2]*TG2]%LK"PM?\GK]I(_\
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M'Q&&JTI<DJ-:C.$:E.K%M.49KF3DM%'E3^&O^%7_ +>><#]HK]F?(Z?\8O\
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ML3;%>TC27U%_E1\0?A/^P9\0CX0^.WQ \)#6;*'2]!^$GA?5CX6^/<%@^C>
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MZ[/A&S,<,1&M^3;,K6T7VZ],5LR9VO;1E-D#)D[&C5" 2 1T,@\*V_FM/O\
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MHU!Y7S)D5]I'R%UP0K8V?+QWSC)%<UITI3PWX94'C^PM%;C'0VELO..< $'
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M^'_+J_X-$!_Z'U_'Z8YR>TA_-'_P*/Y7$U\_1/\ R*]%6?L-]_SZO_WW%_\
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MA<CH-$T<=OFW6EN3SSCHH'.<'M@U\?\ _!2CP$WQ.^$'PP\"0?M!:!^SS?\
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MFU:_NZ]TNOLB/-3G^%/T9L_S_P XKJ[,Y*GU>$_I_(]O;%<=:2QI)&6DC0$
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M-7_!$?\ 93\9_'3]K_P)\7QHFI6_PB_9WU@^._$_C.2QN(M"OO&EC:31^"_
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MSP__ ,%4/@%XJ\4:GX7T/P'\;)IF^,_B#]GKP5J6H>%=,TVP^)'QDT3Q_;>
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M%OX;OQ=G@':!GQ)C(.>0/FQ@<CFS'_P1S_X)BQ@"/]COX8K@DC;=^+P"1D#
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M,:E0%V*57: ,=J;EE3M^]G9):>WE=VY4TW+!M7<%9OEMSN4^7EDJ,1>S4O\
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M***@ HHHJH_$O7_, HHHK8 HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M****P?Q2]?\ ,RGU_P"W?R844455/9_UT1E]GYR_]-,0]/Q7^8I:**U>S-.D
MO5?J%%%%+K]__MI"V^<O_2@HHHHCM\W^;-(;_P#;S_4*<GWA^/\ (T45+Z_]
MO?\ I*&OB7H_SB-HHHIKKZR_-$2Z>O\ [:PHHHI=?E'_ -+9"Z?+_P!*D%%%
M%*/PR_KH:T]Y>B_-A3EZ_E_Z$M%%7+X7Z?Y&I\F>*_\ D:?$O_8?UC_TXW-%
0%%8+9>B_) ]WZO\ -G__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>ea028514801_img16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img16.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "O <(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^]CPG_P B
MOX<_[ >E?^D,%;CL00H&>"02>^&XQCV[D9S[&L/PG_R*_AS_ + >E?\ I#!6
MXX.<^HQ[_*LAX^N<?3([T?U^*$W9-KLSC_'7B"Z\+^&-2UJSMX;FYLVLRD5R
M7$3?:;R*!@YC97&Q9205/WE!]J\!_P"%[>)?^@/HI_X'?_\ R17L7Q?_ .1!
MUW@\MI>>>G_$SM,#@_7I7QJ ",D \GG'7DU]OPQEF QN7U:V+PE*O5CBYTU.
M;J<R@J-&2@N6K!63E)K2^N]K(_,N,<ZS7+LUHT<%CJV&I3P5*HZ=-TU%S=:O
M&4GS4:DFW&,5\:5HJT=6SVC_ (7MXE_Z ^B_]]W_ /\ )%'_  O;Q+_T!]%_
M[[O_ /Y(KQC ]!^0HP/0?D*^C_L')O\ H74/OK?_ "\^3_UIX@_Z&V)_\"H_
M_,Q[/_PO;Q+_ - ?1?\ ON__ /C]9VL?M&WOA[2-6\0:_%X4T30M"TR^UG7-
M;U:]N+#2M'TG3+9[K4-2U.^N;A(+.SL[:)YKBXF=4C1.3D@'R@X';\ .O?I[
M8X]*\\^*GPZTCXM_#?QK\,?$%U?6&D>.- N-'N-1TU+5[_2IUN+?4--U6S@O
MHI]/N[C2]6LK+4%L-1@N-.U!8#8W\$EG/,AUH</Y#*M0C7P%*GAY5J4:]2G&
MK4J4Z+K4U7J4Z;Q"52I3HNI4A3;2G*,8MZVEC7XJXEC0KRH9EB*F(C2JO#TZ
ME2C"E4K*E-TJ=2HL*W"G.JH0G.SY8R;TWCZCX,_;L^''Q!LK#4/!/CCX9>(K
M+5&\6I:7-IJM];1E_ 5IH=]XT2Y&IBP;3F\-:?XI\.7^K#4ELO)L-=TJ]C,M
MK>PR'L++]JS3M1U7Q'HEEJ_P_N-9\)6VG7GB?3%UZ-;O0[/5=,M]:TW4KY)+
MU%73+S2;JSU"#5HWDT\VMU!(]TGF)N_-&Y_8KU37?)U?Q]^T+XY^)'C"/QUX
MO^(3ZSXN\)Z+J'AE]7\2R?"J>S\,0^!;C6+BPC^&MC+\)]._MCP++JD]AXA&
MNZI:B?1[*TTNTM^*MO\ @G)X>LTFM]/^+^MVD7]G"&"\C^'7A%==74W\.-X8
MO]+NM?74$O9?A3>V-YJ,=O\ "2S6QT31X&T>'2M4M9?#NGW3?0_ZG^'KG5B\
MPE3C&-J4_P"R,?7BZBQ$4WSREAZM:G]6<I0D\/A)5*G*_945&I2G\Q_KQXF0
MA1;P<:LN9NK%9K@:#4/92Y4H*&(ITZGM[<R>(Q,(4FUS5)2C.G^M-O\ M36E
MU=:]:6VH>!);CPM;:)?>) -89+?1+/Q+9-JGAZ]U&_DNETZ&TUK3Q]LTVY6\
M:"ZAP5DW.JMH2_M'S1V]Q=2S>!8K2RFL[:^NY?$%K%:V=QJ,45QIUK>W3ZDM
MO:7-_;SPSV,%S+%+=P2QS6Z212*]?F5X1_8B\,>%/@WXW^#$GCK4-:T'QO9?
M"?2[B[O_  EHY@T[2_A3XKMO$NG:;'H<VIWEG>Z9JL5LFBS6EU.8[#3]@A6<
MH8V\6\:_L%ZK-:^/W\#V&A76I^+_ !SXK\16'_"::[H&HZ/:Z)XRMOBE;W6G
M^(=#U/2M2T3Q7-X9E^*>I7?@2X.F>'+[PI#I.E1V<EWJ-N\USR2X8X$C6JTI
MXG$*#J0IX7$4\CQE>E6C[/#>TJUE#$NI@8.I5Q/*JL*T(QPT(-U9UN:/IX7B
MGQ)Q=+GIT\OA4A0E5Q%'&<4Y/EDH3=7%1I8?#/&X>G3Q\XTZ>&566'J1FGB)
M56J5.G9_L&W[6FCQZ9J^LSZW\.[32- ;Q4-:U*_U]-/M=/C\#HS^,+B:2_N[
M9FLO#4:/+JVI6Z36%M$IE-RT8#'0T_\ :?M]62PDTS4OAW?IJ4=C)I_V3Q/8
MS-?#5;/^T=-%O&NI[Y)+[3R;ZUAVB>6US<+$8D9U_&R+_@GU*;6WMKS4YV^T
M>"_C-X(\07%MJOA5;S6M$^,6@^)='O=*DN+_ $K4+2/1O"]YXIO-8TN(Z/-J
MUQ>647EZG8Q3W,-QKWG["=[?V?@&%[G3[2[\(?$>^^)VKSZ3#X$TJ'Q3K=S-
M\+IM,:>TLM-2?2KKP[;?#,Z+HUR=4UBRM]%\7>);0Z8LT6DWE$N'O#GVD(QQ
M6:*G*:4ZSX5S62I4_98IM^S]JJM5^UH8>*E"5/FCC8-TX^PJ3.J&<>*SASU)
M<+J?L4_9+Q#X44I5G4PZ454YITZ<52JUN=2C-JIA9<DIJM3B?K+X;_:\T#QC
M;->^%/$/PY\1:>MQI%JNHZ9KXGTV>[U];N30[2RU%KM;+4;O51IU^;&TL9KF
MXG^RSHL?F1,E="O[24A\W_2? 16"_ATRXD/B*T"6^JW3,EKIEQ(VI%(-0N)$
M=(+&<Q74TD4BQQ%D8+^-5E^P'<66FZ5I:Z@IMM'N+*TLX%;P&FG0^'[?PUJ'
MA1VM-(?29-/T[XB6VF745QX=^*-DMOK?A;6!J5YING2PZ]J$=MG>(/\ @G<V
ML^&+KPM:ZM<:18:JFM_V\8[OP/<KXCO]7\=?&/QW#XBUP#2K2ZOO%.A77Q::
MUT+7;B]:>,^$]%N]1BN8KF[TNP3X>\.G6Y8XO,J=&4DE.7">;UG2@H)RG4Y*
M]%U&YMPIQI4XQDTY2=.E%N;CF_BFH+GEPS.IR2;C'Q%X3I1G-N:A&$9^U<(I
M*+G*=2;49-14YZ+]E-,_:IL=7TN'6]-U/P'<:--KFK^'(=4EUHV-E+XA\/ZS
M=^'M;T6&XU&ZLTEU+2M=L;O2KRTBWR+>6\D2JP4$MTK]J_3-;L]6O])UGX>W
MUGH6M7?A[6[I=?CACT;7['4;C2;K2-5-W?6[:=?)J=E=V,<%V(#<SVMPEFUP
M(RP_+SQO^R!XA\<^!?A/\-I-8\,Z9I/A3XD_M&>+?%VM^)[;0?&^JOI'Q\\+
M>/\ 3/.\*>')K&VTF?Q#H^O>.38:-?7E[9WFDFQM_$<<M]>)_8]UQ'B/_@GQ
M\-?B%X;\<:%X>^-<MOINH:'J_P //']S;>&O"/B%M0OK+XA?$'QJMY\0;M=8
MT^XU3Q3X6?X@2Z/::CJUW!/;OH=I=F9X+B]TD].&X2X"KQ56KBZV'I5,1*,:
MCR3&UI8;"1QM?#0K8S#NI"O3KXNA2]OA</-PJ<]2$9)TW*+\C&\:^(^#Q$\-
M&AAL55H44JGL<_RQT<5B_J%#$SIY?BJ=.KAL3A\+6K2H5\31]I32I5'&2J)2
MC^R;_M&W<#7L<S>"H9--NK2QU..76X(GTR^OVVV%CJ2R:@GV"^OF94L[2\$5
MQ=/E+:.5N*Y^Z_:TTJS\>Z-\,+O4O!=I\1_$.G7NIZ#X+N+S4(M=UBPL+:\O
M[V>QM21#*]O8:9J6H-:^>M[)8:7J5]#:R6FG7DL/Y.>,_P!@/X=>)O$'BS0-
M:^,$UCJ7Q1\1V?Q%A^'[^'M.M].UJ7PYIVN^'O&.N7FA+XKL=8\47E__ ,+
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M'5K\-;BTTR\MO&R:O=7FA7<.M-;Q:0EE+8/=7-W?:G+>6T-GI=O:R:I///'
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M@OJ6K7UG?Z(L;;-$"7FDZE(<V]D;MB9=&N<,'>RNF1IXXHMQ@Q,Z@%8<?/\
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M ,NTS'!Z9/E9'RYZXSTYSR"*8C(@N <\9MI<D\A3D19 )Y."!@\A<@5]Y?\
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MB+:?^>C_ /?)_P *-I_YZ/\ ]\G_  J6BC^ME_D'.^R^Y?Y$6T_\]'_[Y/\
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M8[$?^&O&?K-,_J.Y]1^1_P :.?4?D?\ &OY<?^'_ !\</^C:_@Y_X</X@_\
MRLH_X?\ 'QP_Z-K^#G_AP_B#_P#*RC_4WB/_ * \/_X<<!_\F'^N_#'_ $'X
MC_PUXS_Y,_J.Y]1^1_QHY]1^1_QK^7'_ (?\?'#_ *-K^#G_ (</X@__ "LH
M_P"'_'QP_P"C:_@Y_P"'#^(/_P K*/\ 4WB/_H#P_P#X<<!_\F'^N_#'_0?B
M/_#7C/\ Y,_J.Y]1^1_QHY]1^1_QK^7'_A_Q\</^C:_@Y_X</X@__*RC_A_Q
M\</^C:_@Y_X</X@__*RC_4WB/_H#P_\ X<<!_P#)A_KOPQ_T'XC_ ,->,_\
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M:9_PJSP?_P ^^H?^#S5/_DFC_A5G@_\ Y]]0_P#!YJG_ ,DT?VGCO^@##?\
MA>__ )WA]4S?_H!P7_AVJ_\ SL'F.7&/*FYX($<G.>,<+N.?ND#!() ;)X;Y
M<W&(YSM^Z!$X+ CG#!<)G#$ #) QFD_X59X/'_+OJ'_@\U0_SN:/^%6>#_\
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M6_B+4X+:UT*[NOB3>Z5X<\.Z-X>NKCQOXL/B_P 2VVB".:Z73IUQ8)Q_@_\
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M.WFHZ,VL_:_AOIVN76O0>*M,U#Q\FFVMSX5MKV\$@DB8CVKQ'^RW_P %(/\
MA'-)\8^-/V@=0MTUGP9\3OBYXBLO%?QI\9V>K^#O!EQX;FT[XS>-/%$6KZ?!
M#)HTWA:_T+3O%=]HD^IVNNZ;XV\.P6<=]9ZO<RIB7_P._P""@&D?')O@#K/[
M3FHV'C7PU\)M.^/KZI8?%_XB^*-(T/2+GXH>'8!IK_\ "':/KGB7_A,-,^+4
M^BZA/:)HUSIMC=V2>*XM2C\/P?;JUI9ABVJLGQ+PM5Y,,YM4\+C%3I+#24:^
M(;4G*I&4ZU"-10G&-I)X>$>:4EG6R[!1=&'^I_&=%U,13@I3QV!=6J\93E+#
MX:,&E"E*,:-:I0G*FYWC*.-J3<80//-+_P"">7[4UY>:K;:[HOP[\#VNB>&O
M%GBW5M3\4?%?P3);6>A^$8_B%&=2EM/#NJ:YJJ:3XFUGX7^,?#OA7Q%)8IX<
MU'5-,,D^J6FG>;>1Y7PK_8I^(GQ;\+_#C7]"\?\ @73-6^)GA[P[XXTSP?J/
MACXMZC=:#\._%>O>*_#'A[Q?XE\9>'_ ^J?#S3KF^USP9K$3>#I?$4>O6U@;
M*]FF%Y=1:.WO'_#)?[?.BWGBW7[K]J?PMH.L>"M6^%WP\\>7U_\ 'KQ98W&@
M>)/BV=9^(/A/P3=ZI)I']GZQ;);?%O4O&E]=:5<ZAX2CN/B?K,%M?W&JW/B&
MSM,SP]^R3^WAX,\!:5X0\%_'74O!NG>#Y=:.L_#;3OBCXETO0/!'Q3T9=6U2
M[^&=M_PCL>IZ9IGB/P\FE>-;?QIKOB!M"^%WA;QKH.H:+-XIEUK5-*EOB>:5
M71G?B?AN%7VM/EE#"8J-&%)4INKS1Q$:M67-*K0E&2Y82]RBJE-U+U4LKA&M
M!?ZH<6SH^RKJ4:N.P,ZU2O*O35%4Y8>I0HQ]G3I8BG4I^]4B_:571JTZ450\
MJM?V)M=27X;+X@^/'PG\.V?Q/_9]\9?M#Z)J]MX*^-7C/2K#1?ASX#MOB?\
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M\";>17C-]K/CK:K*5+>5X8@?'(P0,-P3D$,Q SSX6=R2P$TI)WQ.!@TI1O\
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M  ORJ 8[1)'VW4JE9KN>T<J<@PPK<1BVMRN2,HC-)(.<7$DQ('RY2Y)FEBM
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M,]N][;>"-/\ $&K:9I$_C"[M8[NRDFL_#1NXM:OQ'>6TT5C:W%S',DD"FO\
M2+_;7Q_PQA^V)T_Y-3_:)QZ\_"?Q0?7WQTZ#MW_S@?@)X:\*>//C'\!/ GC[
M5CHG@+QW\7/A#X*\=:TMQ'9G2?!OBOQIX=\/^*+Y;V17BL&BT2_O -0F1X-.
M+"^FC:*!PO[OX13Y<IXJGS3@H8K"U'.$%5J04,GS"7/3I24E4J1Y>:$&FJDH
MQIM.-22/Y8^D%!U.(."8*,*GM,#C*:IU*DJ5.HYY[E\>2I5BXSI0J*3A.K%J
M5.$Y5(-3IP9^PN@_\$^_@W8>(=6\'_$3]O.W^(WB>ZUGPA:%O@[\4/#0L)+C
M6_!/[2MQ<Z#/JOCCQ@VEZ]J7_"7_  VUK26U%[^R&E^'_%D4L5M>GXI!HOGB
M^_91\+>)_P!J,?#OP=^V!/J'A?Q'\._&GB_P]\1?$7BK0W\?7.E_#OXWZQ\(
MK#X9W6H:M\4="\.ZM?Z1IOA>+XKVIO?&6@VUW\+M"F\9>'O#(N+?2M-?HO'G
MP/\ ^"7UEX#M=0U/XAZIX(\>P^,_A;X0^)/PPT#Q/?7NN?#Z]M_!_P :M8^)
MUYX8U6X^'7QG3Q'X6U/Q%#\(O"&M1WO@2ZU+P;XQ\$:M:C4;+2_%-A<3/\.?
M K_@E]!\)-$U35OCKX7\9>+;SP'\;M:\46^J^+O%GA.\T;6+/6OA_=^!(TT"
M\\%>%(=4\3?#OP)?:_IWANW71].A^+7C>TUJ[@\,G1[/3]*TWZ##YABJ5*IB
MJF8\2UO:QK8.G"?"&!A3A6]A":Q=.G1HO#1@N2$HR59TL3&<8M5*:@Z/R>*R
MC UJM'!TLIX/P\</4HX^K.GQ[F-7$U<,Z]2D\)4JUL0\75JS56I&<'0]OAIT
MIW=*I&4,1KZ-^PGX4\;6*6MU_P %%O!.H1:3\)TUO5[*^U^36M,NH/%'@GP/
MXZD\._#R"\^*9D\2?#NRL/%,=Y\2KR]LM!_L33?#&HWU_P"&[J?29X;&+X3?
M 7PO+\%[#XJ0?MQMX3^(7CCX9_$C1/BQXF\%?%6S\8RW/PN\(2_$?Q''\./#
M&B>*+OP-\1'OM:TCX1^$-#M]'NM6T>./Q'JNFV^C7%QH^HV]K<_GI^U!\./
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M8>(_#.HZ5KFF2%XT5I;'4+9YH3-!([PRR(?S=\T8_P!9&?3"XR>PSNK],_\
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M-[8:5<>$-4\3_$"RLO$CZOJ5U9Z@^H^)5LI/#.GV,EU:6E_J:I:7,>G^+?\
M@HQIL&MR^*O#G@KP_P"$_!]I?:E!K4'AC1/BAXR\5:3X6^$>H7=IH8T3P9XI
MO_$6O:[XY^*>EZ982ZOH_A?_ (2*"UUZ^>WT%8HH[B#M;C]O_P"'5I=6MA<?
M"WXPB^?X@ZA\,]0TVUM_ MSJVBZ_H+/!XEO[_2CXOAO'\-V5S&\'A;Q% 'L?
MB4]KJK>!CJ1TF[C'(P_\%)/",+^*KC5_@5\7="TWPI\.[?XF33W>L> 6U0:5
M_9?A2^U"ROM/BUXV=MJ#ZAX_\$Z#X;72-4UR/7-2U#Q&+N318O"=\USO'BS"
M>SJ47P]PI*-9QM4IY/B%6HR7)[U"3QE2E3DZ5-T.:M3Q$>2<JDJ4\1_M#P?!
MN-52%9<3\8*=*#BHU,WP\H5=:CM6Y<+2JSA[>M&LX4'AYN5.-.->&'7L(=9X
MGB_:X\6V7[*OB>33?%6A_P!J:+XL\3_M!>!_AWXETSP5+X1U+Q1?^$];^'_@
MK5H-1\7^&=5U^X^'^@7&L^%==O;;4[N&^URRU/4-4T!_MUI:P<%XEU'_ (*7
MWWA[2]/72/!5O=:E<?##7M9UGP+9>!=%\0>'Y!XN\-:G\0O 8-_X[O()?#&F
M>%-/\16EQXGT6RUCQ3XDN=230]+TIH+L7EI/H/\ P4P\ :LFH2W_ ,&_BY9L
M;Z]_L'3-,B\,ZEJVK:&?%.I^&O#-Y*;W7M(AF\3>((K72_$.O>#-)M[JY^&W
MA[4[G6O$.K:CH.GMK,WK?A[]MSP#K^A?$O6&\ _$G0I/A;IW@6\UG2=>'@ZT
MEO)O''CJR^&,B1ZO!XDG\/Z+H?@_QK>3V_C#QAXFU+2=!TSPSI6I^.T>7PK!
M;W]U-'BNA3]FUDG#%6%&I4G0IXC*Z]14U4QV(QZI7>(A.2I1Q*P4'.=:<L%0
MPM*KSSI^T'B.#:]155_K!Q1AYUZ=&->KALRHTI59T<%A< ZLTJ4XR=:>&6*G
M"$</3IXO$XJ=!QC4Y#QC0OB%_P %)/$W@SP]K<GPW\#:4WB9=4G:#6="T#P)
MXLL(-7TSPFEKI_B'0;GQ[)J/@.UTJ:^\;S^"]3T^#4_'-WK^E^%[#QUX<T'3
M);N]?1O9?^"CL%MX>%M'X0M[+2I]%U!K.PTWP'/J,DNE:GXJ\/KX9\3:AJ'C
MA6\6:/XETN;PCXS\3WMK<Z/JT%Y:75AIE\)9[JR'U1\ OC'??'SP==>/9_"%
MYX'TO_A/_&.B^&-)U>[-SX@U'POX8&DV>C^)?$$&6MM.U77;[4-2N?[*L7N;
M*WL;.Q>WO;WSVN7]QN"9+FSM\]#)>..,^7!LCB#%N/WMQ,NT'"D0MG<0PK>/
M$E-N-2CPWPO3@JU2O3@\JJS7+.%2DJ4_K&,FW&$)74E3I3E)*?)"$O8PPEPE
M5Y'2K<5<75*BITZ4ZBS:E3O*FZ<Y2BJ&#@HJ=2#DZ?M9QA?E52<H>UGX9\ =
M3^.-SX$TV;]H'1;;0?'-OHK'6;'2+7PDFB76H0>(O$42:E8S^&O$?B">/4]:
MT*+0[_5-$G>73M&N+M(+#5+^[FU&*S]TM4\BWW3$"8[[BY?KMG?]Y-VP4A+K
M#&.H6-#EB,EMT?,EMK0 LK-]JF!X!@LR&C4@D9\VXD@!R<,$89[%+O$OE6@.
M&NW(=CC*VD/[VZ(./O2_+9*5Q^\NBWRD%*\7$UUB<17Q"P^'PJK5)U(X;"0E
M2PN'4I75+#TYU*LX48*T:<)U:LXQ23JU+<S^DPF'EA<-1P\L3B<9*E!0EBL9
M.-3%5VO^7E>I"%.$ZDMYSC3IJ3NU3A?E%L065[E^)+QQ-C^)8AB*T@4')"QP
MXXSEI9IGX9S20'S[A[H<QB:&VM3D8,,=TGGRK[3SQD(>\,"8&'-27;O';K''
MA9[AEM83@ QO+E3( <\6\7F3#AN8USUS0[)96T)BB+B(VT=M"21YCF6&."(L
M1D>9)L5VP=H+L<[2:Y^_^&7_ *3(Z%NO5?FCWUQY^H3%L>38O*D9!)#7<^X3
M/CD$V]LQBC/\#33GDC*IS<7VW&(K "3&<;KR=2L9(ZG[-:N\A5A_K+N-L@QK
M4S!-/@G,CF;R3-)+(!AKB=G9IY%4]&GG8[%Z*'CC'0YCMU-K;,TYPY,MU=29
MP/.;,DNT$'<$*[$S@&)%Z@ 'Y9.Z3[I/[TG^I]2W=M]VW^++V6'1>.W(HKF?
MLNO7'^D1ZK]FCG_?);?98Y/LZ2_.L'F$9D\I6$>\\OMW'K13$:6A_P#(&T3_
M + NE_\ I#;UJ-SD>NW_ -"-9>A_\@;1/^P+I?\ Z0V]:;=3W^[_ .S'^7L>
M>QJ:?\.'^"/_ *2BY_Q)_P#7V?\ Z>F?,O[:_'[%W[8W;/[*?[17XY^$_BH'
MZ<9]3D>E?YDEK*GV*V5]A1K.W0A@2"#;QHP_ND%00<GKQC K_4^^)'@>P^)_
MPX^(OPSU9ECTOXE> ?&OP^U)I-K1K8^-?#>I^'+EY0>#'$FHEGX/[N/C=\N?
M\N+QUX"\6?"/QIXQ^%/CS3KC1_&WPT\2ZUX%\5Z;=P212VVM>&;Z;2;TE'Y,
M%R;9+VSF"E;BRN;:>)FBE1J_=?!K$4E2XBPG.E7=?+L7&%US.A[#$X1S6J;C
M&ORPE:]I3@G;F5_Y>^D3@Z\L1PIF'LV\*L-FN!E45^6&)^MX7&QIR;NKU,.W
M.$=&U"?+K'3'64(JJ"H7'R@*>!QCN>&/?.<*N1TIQG4YQ@$XY*DXP<@YR#_,
MCM6=YX!QYA'H-ISC. 22.<\<D\CJ<"CSU_Y[?H?SZ?\ U^>0*_;.9]G?R=[;
MZ?&N_>VNU[M_S5RQ>ZT[:;O5NS@TKZ:\JE9:R[74>.-52,(B*,! AVX)+-Q_
MM,3N(R6RQ;)/,GGD# =./]ANV,'&,=NW3CTYSO/7_GM^AH\]?^>WZ&FG?I;U
M7;TT_KIL'+'N^[][J^KOK?U;^;U-'SSC!="..-C=OJ#_ /KYH\X>J?\ ?!_^
M)K.\]?\ GM^AH\]?^>WZ&C^MG_D')#O]\KFAYPZ#9@D' 5L=.O\ +/!S@@@@
MT"4#/*9/7Y&QU)Z8..2?K6?YZ_\ /;]#1YZ_\]OT-'];/_(.6/?3MS?/\]31
M\X?WD_[X/_Q-'G#U3_O@_P#Q-9WGK_SV_0T>>O\ SV_0T[ON_P 0Y(?TT:/G
M#^\G_?!_^)H\X?WD_P"^#_\ $UG>>O\ SV_0T>>O_/;]#2N_/[W]P>SAV_+_
M "- S>Z'_@!]^.@/T],_E^G/_!&:3=_P4Z_9. P<^+/%71=N,?#[Q2V,$X[Y
MXSGDX&1G\MO.YXDR,*<[1G[W'!&3SW]<#Z?NE_P;W? O7?BC^W?'\6DT^63P
M;^S?X$UOQ5X@UHPL;.T\6^/;#4/"'@'13.08QJ.JHOB?5;>W +_8/#]_<$!%
M1F^;XOQ5+"\+<05:\U"#R?'T8\TDG*MBJ$L)0I*[UG4K8BG&"5W)\R2=M/KN
M <!6QW&W"N'PL)3J_P!O99B))<S4,/@\5#&XFM+E3Y:=+#X6K4J2:Y8Q46VN
M97_NE0X ZCE.0#V3)SGM@=NQZ5*O3\O_ $%:BZ,%'&&'7[Q4849')((;H<<*
M<=ZD'! S_GG'Y@#'I@CCO_(2M=VV;;^]MWOLT]&K;;;G^@R2M?9O6V_17_&_
MW=;7'T444Q!1110 4444 1]#R.F,?11GZ?-@_2OA+]N[3/&GAGPS\(/VF/A[
MX:U+QEXB_9,^*4?Q2\1>"]$B:YUSQ7\(]8T"]\*_%C3]!M$4_:]=T[P_=P>(
M]/M1@W(T:X@5E:0&OO$_3/M46YT=7C8JR@$.A(8-DY"GD[F& >F0.>,BN+,<
M%',,'7PDJDJ3JQBZ=:"C*=&M2J4ZU"K&,O=FZ5:C2GR2TFE*#:4M.;&X58W"
M5\*ZDZ#JJ#A7I*+J4*]&K1Q.'Q$(S_=SG0Q.&P]54ZGN5%&=.34:DI1H?"'X
MS?#3X]?#;PG\7_A%XOT;QO\ #[QII5EK'A_Q#HUREQ#-;7<$5R;.\B4^=IFK
M6&_[/JFCW\<&HZ;>I+97MO!/&ZKZ7]O'8H>!GJ.?\?7I]!W_ "D\??\ !,/X
M#ZUXW\3?$WX(_$']H7]C/X@>-M1GU?QWJ7[)7Q:USX5^%_'6LWDDMS>Z[XJ^
M&4/VOX=ZEKE_>2O>ZAJMOH-I<7]^TVH7?F7MQ<W$O&_\.U/B3G_E*A_P4L/'
M7_A;WA,<CC 7_A%,\G/;KTP, ?.K^W:2]G6R:.(J1NI5\)F6"I8>K;15*=+&
MPA7HJ6_LINIR-N*JU(QC)U3SO/*4(T\1D%/%UH*T\3@,[RW"X:OT56GA<TH0
MQN&51+G="K.NJ+;IPQ%>$(U9?L;]N'^Q^M>)#]G?]G=9+J6/X&_".*6]E\0S
MW4L7@#PQ#+//XK2VB\1SR2Q:8DC7&LQ65I#?S[A+-%;0Q,XCC51^;_\ P[4^
M)/\ TE/_ ."EH]C\7_"0/X@^%<]>*=_P[2^)/_25#_@I9_X=_P *?_,I0ZN<
M+?(:_P#X=<H?Y)FG]OYM_P!$Q7_\2'AS]*;/O[Q[^RO^SG\1_!LW@'7?A-X,
MTWPO<7%G-<6/A'1=/\'2SV]K=:)=3:5+>>'+73[DZ-J8\.:%:ZQIB2+:ZE::
M3IT-PC?8+)K?J=<^!?P9\1^*="\::M\//"]QXDT#6-(UZWU-=,M(IM0U3P[X
M9UOPAX<N-?9(0^O_ /".Z!XAU2RT*/5'N4TSSH9+94>UMC%^;'_#M+XD_P#2
M5#_@I9_X=_PI_P#,I1_P[2^)/_25#_@I9_X=_P *?_,I2]MF_P#T(<1_X=,I
M_P#D0_M_-O\ HF*__B0\._\ RH_3?PU\&?@OX-O](U;PC\*?AUX7U70OM7]D
M:EH'A'1-)O[ W]E;:9>-!>V-E!<AKC3K*SL)&9W<V=K!;AEBAC1?5/MP_P!C
M]:_'3_AVE\2?^DJ'_!2S_P ._P"%/_F4H_X=I?$G_I*A_P %+/\ P[_A3_YE
M*/;9O_T(<1_X=,I_^1#^W\V_Z)BO_P")#P[_ /*C]B_MP/=.!Q@D]>F1D<?Y
M%?.7[4_[4GPQ_9.^$VJ_%;XEZHB-$5TKP1X.L"MSXM^)7CG4&%KX<\"^"]%1
MC>ZWKNNZG+;6D<-G#(+.*9[V[>&U@DD'P"/^":?Q(R W_!4[_@I:1_$/^%P>
M%%++W&Y?"N5)&0&7!'4<C->N? __ ()U_ +X.?$6P^-?B+5OBY^TI\?-)AEM
M= ^-W[4OQ,\0?&?QKX-AF,B3#X=VOB*9_#?@":2!S:?;O"^DV.HQ6CRVUO>0
M6\\\4M.&>XA>QI97# 3G[KQF+S#!XFGAXMI.JL/@X.I7J03<J5*4Z-*510]M
M44.92RK9OG^)I5*.%R>EE=:HN18_'9MEN84L)&2Y95XX++*/M\56I)J="A5K
M87#3JQIK$5XTE.%3O?V'_A;XY^$_[.'A+3?BI EI\6?'FO>-_C-\4M/BE,T6
MA^-/BYXIU/QE>^&0S1H&E\+6&HZ=X?O"A>-M2L+LPL\9C:O7O%O.N3Y_Y];(
M'_OQT[\>V<9SCBO52K'DG)ZX/S'.<DDL3C!.#G&>K8W,1Y5XM'_$]FY/_'I8
M?3_CV'\\Y_*OL\BPE/ 0P^#HRE*GAL(Z4)3E><^7V?-.;LDYU)RG.6B]Z<DD
ME:W%6PU/!9=A,)1<G2PL:%"$JCYJDXTZ<U[2I-)<U6I*52K5DDHNK6JN*47%
M1\ ^,GC#XF>"?#-AJWPL^']O\1]=G\2:=I^H:%=&_:*/1)K:]GED\K3+[3KR
M,ZIJ=KIOATZR+E[+PFFLR>*]4L-5T_2+C3+KY&T_XY_\%"-)\/\ ABRU#]F/
MPGXCUJTTV!=?\3:MK&HZ=)XAUQM(M]9T^TLO#_A1[Z'PW/;B]NM$U'6I/^)#
M9^)_#%S:6D-K9^)['4]-^H?CY\;;+X"^&?#WC+5?"VL>*-!U#QKIGAWQ0^@S
M(=2\(^$FT7Q)XA\3?$$::+>XN_$.G>"]&\/W.M:WH>F1OJT^C1WUUIL5S<V:
MVEQ\X^'/^"C7P2U_1_!%S:^%/BCJWB'Q5X(\)^-M9T#PGI_@O5K;PA9^*-7\
M'>%HA=Z[KGCGPQ:ZII\WB[QSX:T[1+ZPA>XUW0=3B\90Z?;^'H[VYM_:JRI^
MTM*O4IRC&+Y4O=LV[-7C)-OJU>25U=1.2G&;@FJ$:D7)WD[MII;-J:Y4ET=D
M[WU?+>]_PNK]O9M5U+3%_9X^%XM=*U:2W_M::7Q_=6^L6D7B3P/X>2YTZU7Q
M'9V]L=4\.^)/%?Q!M[VVUK5FT_3_  U=>"-0MH]3\W6I_-KG]H'_ (*)6G@^
MSTW3/V;+&_\ &FK6OBLS^+;[P=>P6O@_4VTSQ9<:58:CX;C\?V</BJZ\&K:>
M"+*'Q!8O8Z#\4]/UV;1K5/#NK>%]2N-5Z[1/^"E'P.O["QDU'P?\88-7O=.\
M3^)(-,\.^$]*\96W_"&:3K>JZ)X=\4R:UHOB)],TM?%MS8P6Y\,^))] \6>#
M;B[.H>-]$T/PN+7Q'?\ L?B3]JKPYI'QB\$? G2O!7C#5?'OBKXB_#[X?ZQ)
M>W7A72] \(2>,O!.@?$O5KJ\NXO$=UJ^L3>$?!/B[PG=R7.E:-/X3\1ZYK-]
MX9\)^*=;USPGXLLM)R<Z+3D\;4W:EM=:K=*%TU%6;L[1][9HODJ<RC]4@FTW
M9J>JBM7>52W*G=K6TG[K;1X9K'QM_;[:U\)M:_ C2-!@N/%EI)K>L0>&-5\;
MZCHW@K1/$=G977_"4^$HO$VEWWB&[\3:+<7>JZ1#X.OO#&J>$[<3QI=7]ZLL
MC_H/X;U3Q#J/ASPUJ/B724\->)-1\-Z%?^)O"\>HPZU!X<\1WVDVEUKOAI-7
M2&*+5[?1-5GO=-BOUA2&\\AKD1*9L5\-0_\ !2#]G:XO_"&CV^C_ !9NM=\=
M^(;3PMX6\/6&D> KO6M3U?6]2MM,\(++#:_$E]/TNS\87-S)'8ZCK>I:7;>'
M)[*]T[QLWAC5;>2Q7-T7_@H]\(;_ ,#ZIXUU7P5\1M!3PU=Z/I_C'21_P@FJ
MW'A?4M?U>?2]&\.I/!XYLQXIU34([#4;N37O"EMJO@/PY]E6S\7>*/#UW=V\
M,FD*N'BY26(YE+EC:;3C=)N]U%VDT_AN_=MY(B5*K-+EP_):^L8M-WT2LYNZ
MO%V:TYF^K:/T0%U<D!C.YR6;( W[G'ELP( *M)%^Z9AAVC/E.6085IDF<DE]
MP8$2 JN908S#ME.,31&(F+9,)%\EGBV[&9#\%P_\%&/V?9_$[>#+;1OBM?>)
M8-)FUK4]*TS1/ VI_P!B6NCG4/\ A,HM5U*Q^(<VAI/X+_LV6:_6PU74(_%.
MGWFDZS\/F\6Z)K&EZA>ZWAG]O7X.ZQ\,_$?Q.UWP_P#$;PC8^"='^$6J>,]"
MN]*\/:_K.EQ_&W2-+O? \NCP^'O$EX/$^BWVOZWI'@"V\1Z>D>FWWC74K;2K
M?"PZI+I^GUG#W:]K#9MZV3LDM^6S:3VU=KVV(]A6_P"?4U=I)):WELK)MZV=
MG:VFZW/M*.26>YN[B5VD8-'91L_),-NA+'/./](GF4D9X0 *2 !'; M->3@Y
M#2I;( ,_N[$.H7J>'N;B[8X[*O''/YZ^'/\ @HY\*]<\7Z-H.C?#[XEW_@K4
MX;#4+SXEO!X6T^#1['7]2U72[#6KSP3J'B2W\57>B6NIVVFC4[_3+6[O7T_Q
M!I\^CZ3JEQ9:C;0]A=_MY_"GPGJ_B+PQXQ\$?%K0M2\)?$;Q/\,]2O[+0?#?
MBSP[)KOA<>(]3U'56U30/%%R^E:-;>'M"@\3ZO>^(K/1;32K#7;&TDN[F\T[
MQ$FC/ZS0_P"?L%JTM)):*[LW'5):W6CNK.^@>PJWM[.7-R\UE:]K]E+2VNCU
MTV/MJ ^9<7<Q4D*_V5>A79:Y$A'()_TEIHR2,GRP=HQMI(1YEW=W&#MC*VD1
MX(PAWS$9Q@F<@-D_>A&<*2P_/;P[_P %*/@MK"ZC'I'P^^,NJV6C23Z?_:>G
MV?PVF\_5-*\1ZCX0\2_;+:^^(^F2P:=9>,+6"QL=6M6U&R\26>JQZYI1.F6E
MU-'<N?\ @H[\#K;PSJ>M>&_!GQK\4VFEV]__ &??W'@S2O!6B:_>M)XCA\/?
M9]4\9^)-%O8(/'.M>&M:TS3;@Z1<MH%PEI/XWB\.6-Y;W5'UBAI:K%WVWUTO
M=)QNUMJNZO:Z']7K:_NY732>FW36TM'?O;MN??R_OKR5SPEDC0]]IN;E!+<D
M$\#R+<P0YYQ)/..N:'/FW\*8#)9RV\\G4CSY90MJF"!\T<7FS$$<;XSR6 &;
MX>UG1]9T"RUW2+^'4-*O[>:]34($G6.5EEF6_8>?#!,S07,=Q;EO*6*26W+P
M/+$897T[1!'&DD[".2:=+NX9S@1DS1NX9L?=MK6.*-AC*I$0N>^J::NGHX-I
M]+.#:?3H[_U8QV?FG^*?^:/H"[_?7RVQ#;(96OKC^Z2LC+8P]#P\P>[D&1G[
M+&IW"0@-O/WKP6)P?M#-)/@'BTMRDD@SG@S2^1;JN""LC;0%0BI+57?S;EU9
M)+RXDN<.-LD4;'%O"Z] R0!=P8X1WD48)-0VH$KSW:YQ,RQ6^!@&UMBR1L#M
M&U9IS+<(O *O$6  ^7Y=*R2[)+[CZF6DGZO\V:6Y1P3R.#@''X<45S\NM1K)
M(J:7>7"*[A)XXHC'.H8A9HRSAMDHPZ[@&VL,@&B@1<T/_D#:)_V!=+_](;>M
M0\G\O_9O\_2LO0_^0-HG_8%TO_TAMZU#]X?A_)ZFG_#I_P""/Y(N?\2I_P!?
M*G_IVH-=>,?@O/(). /ID@9P<#//2OP+_P""M_\ P1MM_P!L^_N?VA_V=[K0
MO"7[3EIHT&G>*O#FNW,>C^#?CEINC0O%HXU'5C')!X9^(^G6>=+TOQ/>Q'2=
M?L$TW2?$=Q9QV5GJMG^_&*AVX) /!;/O\V,8Y/RXVC)!!&>"" /4RK-\PR3&
MTLQRS$/#XJBG&_+&=*K2G;VE#$4I-1K4*JC'GA)IJ2A4ISI580J+Q<]R'*N)
M<LKY1G.%6*P5=QFXJ3IUJ-:G=TL3AJT4YT,12<I<E2*DFI3IU:=6C4J4I?Y=
MOQ<_9>_:7^ VNW/AKXS_  "^+_PXU>TD>!QXB\"ZZ^DWC1N8S-I/B33+34?#
M.N6;,"8[W1=8O[2X4AXIGC937C_]@>).1_PCGB<X.0?^$:UKJ??^S@O3ZG Q
M7^KJS2/%Y$K":W!R+>=$FB#*>OESB2-2#EN(QUQG YB^S6W_ #Y:?]/[/T_G
MK_TZ?C_DU^ITO&/&*$%7R+"SJI)3E1S'$4J4GWC3JX2K.">KY74FHWLFTC\+
MQ'T=\NE5J2PW%..IT&VX0Q.586M6@F[\LZM+&4:<VE9<ZI0YK7E%.Z7^4=_8
M/B7_ *%SQ/\ ^$WK/_ROH_L'Q+_T+GB?_P )O6?_ )7U_JX_9[;_ )\-./TT
M^PX]<_Z-_*C[/;?\^&G_ /@OT_\ ^1JU?C+73M_J_1^6:57OK_T &/\ Q+MA
M>G%N(^62T;?AF!_E'?V#XE_Z%SQ/_P"$WK/_ ,KZ/[!\2_\ 0N>)_P#PF]9_
M^5]?ZN/V>V_Y\-/_ /!?I_\ \C4?9[;_ )\-/_\ !?I__P C4O\ B,M?_HGZ
M7_ASJ_\ S '_ !+MAO\ HK<3_P"&6C_\\#_*._L'Q+_T+GB?_P )O6?_ )7T
M?V#XE_Z%SQ/_ .$WK/\ \KZ_U<?L]M_SX:?_ ."_3_\ Y&H^SVW_ #X:?_X+
M]/\ _D:C_B,M?_HGZ7_ASJ__ # '_$NV&_Z*W$_^&6C_ // _P H[^P?$O\
MT+GB?_PF]9_^5]']@^)?^A<\3_\ A-ZS_P#*^O\ 5Q^SVW_/AI__ (+]/_\
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MNA_\@;1/^P+I?_I#;UJ'[P_#^3UEZ'_R!M$_[ NE_P#I#;UJ'[P_#^3U-/\
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M;Q$9(.03D@D_[6<L3VRH]67>#DGF$2* H 8'C(((.[#)@9Z,@4$,0 0&SM)
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MRG)QN5?-F&<G[IFC3H#E"A"C& !$!>[NW&/W:6]HH/\ >Q+</VSAC<)N/ R
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MZFG_  Z?^"/Y(N?\2I_U\J?^G*@ZBBBJ("BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AEC5ADCD<@C
MJ/7'8Y&>#P>>/F)J:B@"@8IHFROS)DC@_, 2V!@ X4DX/)P&)^7:&#$N0V Y
MVR+T4@@@@=,>N0>&/''S'< -''.?\]_\>?7 ]*KR6\<P82(">@8?*X!)Z,,'
M&T@D'J2PZ8  %#] && 4!P21@,0<-SGMSD;@WHIQ8!!Z=QG\#TK*>UNX6)MI
M%E5N?*EPH&,M@,N,#&Y>G"G [U%!J2&06KHUO<MTB/[Q3R2"CIN0*1G ?:0
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J10%1<*. **)/$&G1221,96:)VC+"'()1BI()=202,@E5)'50>** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>ea028514801_img17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img17.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "^ <(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BFMT[]^
M!]#_ )_I3J_ #_@XK^*/Q!^'O['?PRT/P-XLUKPG9?$GX\Z7X5\;-H-_<Z9=
MZ_X6M/AW\0_$(\.W=Y:217 TBZUO2=(U"_M8G07KZ7:V]PSV;7-O<=V68"69
MYAA,!"I&C+%5E3]K*+E&FN6I.4G&+3E:-.5HIKFDXJZ3;7JY'E4\[S; 933K
M0P\\=B%15><)5(TDH5:LZCA!QE-QA1GRP4H\TW%.44W)?OSSSR>WKSCD=NPY
M[<>U'S_[7ZU_E1'7-90$G6]65 H.3JM\%49 Y/VC "\XZ@4+KVL-PNMZLQ]M
M6OCD8!R0+G@8(;/<=.<5^@?\0VE_T.H_^$%3?U^MV/UE^#,^O$4//_A'J63[
M7^OVO\_.Q_JN_/\ [7ZT?/\ [7ZU_E1C7-;(R-:U8@\C&JZ@01D#(;[3@^YZ
M=^E(-?U@ML&N:H7*AU4:O?%F0\A@!=9*D#@@8.1VH_XAK/\ Z'4?_""I_P#-
M8?\ $&9?]%%#_P ,]3\?]OT^9_JN_/\ [7ZT?/\ [7ZU_E2?VWK?3^V=8Z$C
M_B::B <8('_'P>H_7MQR?VWKG?6=8_#5-0X/'7_2.P.>GXT?\0VE_P!#J'_A
M!4_^:Q?\09E_T44/_#1/_P">']:'^JV-V1G=QVYY_0__ *LT]N.!Z9Z<#)SG
MC)&,''_UJ_RLM)\<>-_#&IV'B+PWXR\5^'M?T:YCU#2-;T3Q'J^FZKIE_;$R
M6]Y87UI>1W%M<1. R2PR*W!5B59E/[N_\%Q?V@/C#XQ;]ASPSK/CS71X=\4_
ML;?"[XT^)-"TN[DT;2=<^)7CBXU:WUWQ)J=AIK6UM=SB'1K6/3()HWM](66]
M_L^.#[;<;^&OP#6HXW 8..:4IQQRQC=5X6K!TOJ=&G7E:G[:?M/:1JQC%^TA
MRR4G)-)7\S%>%.(P^9Y3E\,[H5(9FLQO7E@*U.6'>7X:CB96HK$S5;VL:\(1
M?M:7))3<KQ47+^VWY_\ :_6CY_\ :_6O\J7^VM<[:UJ_ISJNH9XX[7'>C^VM
M<_Z#6K?^#74/_DBN[_B&TO\ H=1_\(*G_P UGI_\0:E_T44/_#1/_P">!_JM
M?/\ [7ZT?/\ [7ZU_E2_VUKG_0:U;_P:ZA_\D4T:YK>X*=:U;)#%?^)M?Y(7
M@G'VG. 2,GMD#OP?\0VE_P!#J'_A!4_^:@_X@S)_\U%#_P -$_\ YX'^JY\_
M^U^M'S_[7ZU_E1_V[K6=HUK5M_)*_P!JW^=HYW8-R& 'J1CW[4'7-:! ;6M7
M&?75;_OT 'VD$L3P!P"2 #UP?\0VE_T.H_\ A!4_^:P_X@S+_HHH?^&B?K?_
M )&&WGMYVU/]5SY_]K]:/G_VOUK_ "I/[<US_H,ZN#GOJNH?_)'3/?.!D9]:
M4:UKAY_MK5O_  :ZA_\ )%'_ !#:7_0ZA_X05/\ YK#_ (@S+_HHH?\ AHG_
M // _P!5KY_]K]:/G_VOUK_*E_MK7/\ H-:M_P"#74/_ )(H_MK7/^@UJW_@
MUU#_ .2*/^(;2_Z'4/\ P@J?_-8?\09E_P!%%#_PT3_^>!_JMKG/.?J>W!XR
M>G7-#$G!&1^?U]._L3P*_@M_X(4?%GXD^'/^"B7PC\$:5XT\0P^#OB?I/Q,T
M/QSX8FU6^NM#U^ST;X8^+O%VD376G7,\EJNHZ9KWAO2;NQU..-;ZWBCN;))_
ML5[=V\WYD?&[XP?%#XL?%OXB?$#X@^.O$WB;Q7XC\8>(KO4-1O\ 6+]MH.K7
MBV]C8P+<+;Z=I6GPK'::;I=G'#96%G%%;6L,<<:K7%#@&K/,,1@7FE*,*&$P
MV)5?ZK5<I_6:N(I*FZ/MTH\DL--N?M9*490M%/G2\VEX45ZF;XO+'G=&-/"X
M#!8Z.)67UI3J_7:^,P\:+P_UI*G[.6"JN4_;S4HRI\L$W-1_U"/G_P!K]:/G
M_P!K]:_S#/A9\'OB[\9=(\4ZSX&UBQEC\*:EH>A/INM>.)=$UGQ/XG\2>'/'
MGBW0_"?@K3[IW'B'Q)J?A[X9^-=0M--%Q9>=_8_V2*>2_O;&UGZN+]E;]L">
M2UBB^$GQ3E>]U:PT.U,5VDL,NJZA8ZKJ/V/[3'KC6Z-IEOH.O1>)97D6'PAJ
M.A:WH_BN31M6TC4;*VUEP!0A.5.?$6%A.%N>,\+[.4;QYE=5,;#>+4M'));M
M/0Z)>$^$A.I2J<78*G4I6]I"K@(4I0YH*HN95<SIZ<C4KIR232DXR]U?Z9'S
M_P"U^M'S_P"U^M?YGNF_LL?M0ZSX5T/Q5I/AS7]1?Q!XQ^(_@6R\(0:[J,?C
MBVU_X1C4_P#A8RZMHEV+:QTBU\*G1]02^-]K<5]*8"]I83PYE6#PU^R[^U5X
MKU*UTO3/ WC"W>8^##>WNJ>(K:RL/#T?Q N_L7A6;Q2ZZS<7?AP7]TT,5U:Z
MG91:CHINK)];L=/BOK-YT^ \,N:_$F$7*Y*7-AN7E<7:5U+&IZ/2Z4HMZ1E)
MZ$OPJP24V^,,!%4W.-3FP-./*X/EFFI9I%^[+2\5*+>D)3>A_ID_/_M?K1\_
M^U^M?YH5E^R=^UG?>&[7Q2O@7Q7;6&I1:)-H5A=>)[3_ (2/Q*OB2&UET(>'
MO#5IK-WK.HQZ@]T+,7IM(-,L]2M[S2]3OK#4;:2UK%U+]F_]IO0K9=1\2^$?
M%'A;13;>*KZ3Q%KWB:TAT"WT[P?X4\6^--2U2XU"QUK4!'HVIZ!X&\3W'A'7
MA$VA>-9M.\CPKJ6K--&Q%P%AFVEQ)A&TW&RPZ;YH[I)8YN35MHJ3OIOH->%.
M"DVH\89?)J3@U'!4I/FC?FBDLU;E*-FFH*;335N9.*_TU_F[[OUI^>#P1EN1
MCD=,G_Z^.I'%?Y4"ZYK; '^V-8 (4D'5-05@'&1D&YX(S@CJ#Q[U_05X4_:8
M^/47_! ?X@3Q?%/Q@FIZ;^UK9? K3O$ UF]_X2:Q^%%UH7@?QC/X.M/$1F_M
MBVTZ34]1OK!C!>),/#EU<>'%E&D2O;5CC^ JN"6$Y<SI5GBL?A<"U+"U:7L_
MK4ZD%53]M5Y^1TI.4+1<ER\LUK;GS3PIQ&7+ .EG5'$/&YK@,L:G@*N']B\=
M4K4HUTXXFNJBIRH3YJ5H.2Y>6:N[?VI?,.F<>V<4?/\ [7ZU_E2G6M<R<:UJ
MYR2>=5U#.2<G)^T\DGDD\DDFD.MZX!DZUJV.?^8KJ QP3DDW.,#'-=__ !#:
M7_0ZA_X05/\ YK/3_P"(,R_Z**'_ (:)^7_4P\S_ %6_G_VOUH^?_:_6O\J)
M->UA\!-<U5\@D;=7O6RN#\V%NN1D8R,CKQQ2C7-:/(UK5R,D<:KJ'4$@C(N"
M-PP<@X]#CG!_Q#6?_0ZC_P"&^HO_ ';'_P 09FO^:BA\\GJ+\\>C_5<^?_:_
M6CY_]K]:_P J$Z_JX(!UW5,L&V+_ &O?9;;][ -R"VT@A@.5/!%(/$&KG8%U
M[56+@[/^)M>GS"/O;,71W;>^WIC+8&<'_$-9_P#0YC_X;ZO_ ,U>7_#:V/\
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M=.%++Z.7585Z>!G*=?\ M"EB*L8SH3Q,8T516%J1DU5J\[E3<>5<UO\ 5/\
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MQM9V$-KX5T58;"+3M,\/:9;Z'>6<MPL/C6/7+K^S*=W^U-\!I/#_ (N\'O\
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M.)'Z;W"L&8*.!N.3C'&1@#O^TW_!9S_D/?\ !/[_ +1Q_L__ /I=XLKZK?\
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M_%WB".WN-7L_C!8-JVLR:CJOA/P]%::_/?#0?!7AF^L],\275UK$26'Z<?\
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M,_B?KRZOJ4=EJUMK=S:ZF-1_XJJQM]:T/7-">PLH!^H/_$-%^T1_T<Q\$O\
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MH Z:DP.W&/3T&<#Z<US7]G>*?^AEL?\ PG5_^6U']G>*?^AEL?\ PG5_^6U
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MP_YF6P ]_#B?S_M?^E+_ %QXF6V9S?\ W+X/]<&"\1>-=O[;KZ?]0F6_+_F
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M.U_S/\0O7!Y5_P#.UGXFQ_\ !$7PK&?^3AO$3'.<_P#"N--_'IXPQSBKB?\
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M?%VR^%%MX.A3PCXM^('BKXB>+)_!7@7P-X(;PI#XA\2:]9>#O%OQ U*&"_\
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M$6G_ !6O/ .M>+;7Q_\ #>#P%K/Q4O;714\'?#VZ36+GXF^/(?"?@W1?%^K
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MAK5K2"_TG7M3TO0=,FL_#]KJ]G<07FG6%WJ4^LFUD274K'2Y62W/N=M\/?\
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MAK%IX=TBXL?HW]ER/]D?]G+XN^*/B[J?_!0"+XTZSXA^#GP]^#MN/B3XGO\
M6-5TO2O!!ANY[A/$.L>(->O+BRO]7%W?Z;I:6UI<:<NI7O\ ;FL>+=3D&L*U
MBN(+?\DIEK[?\89!_P#NN'UOB=7_ .,+RG_Q H/OT^JZ_P##;GGO[17[4_\
MP4,_9>\4:7X=^).N?#2^L_$5M>7?A?Q9X9\(65WX=\00Z<]JNHP0M?6=C?V&
MJZ;]MLVU#3+ZV1HX[N"YM+B]M)!<+X?!_P %//VL9,!O$/@[J03_ ,(5I [J
M!@!?]KO75_\ !2O]K/X8?'N[^'WP^^$^I+XIT;P-J>L>(=<\9PVLUOI-[JFH
MV,.EV&C^'I;N."YOX+6W:^N=7OQ;I823OID-A<7OE7;0?F9:]1_O?^S1U^Y<
M+\.95F&18#%YWPGDN#S*M"JZ]'^RZ>';A&M*-"M+#SJ.5"5>CRU71;3@VFHP
M52,(_P!#<(<*Y-F?#F78[B#@K(,#FM>%1XBA_8]/#-PC7G##UY86=5SPT\3A
MU"O*@[<CDI*%.-6-.'Z00?\ !3#]JF3:6U_PC\P!'_%&:2,9(7^Y[^O?KCKU
MF@_\%+OVE;.^M[G4I? ^O6<;CS],O/"RV<-Q&'02*+G2+W3[R&4C<(Y5E>.-
MB'D@N OEM^:MMTB_W5_]"0_RYKIK7@#/J_;L9%]?45]-'@OA&:Y9<.9-:47&
M5L%3C*S6MI0JQG%ZZ2BXR6C33LSZI\!\$S3A+A7(>62E%VR^E&5FI+2<*T*D
M7:UI0E&2=G%IV9_5=^SS\>/#7[0?P[M/''A^VGTVXANY='\0Z'<RI-<Z+KEO
M!;W,UKYRA%NK2:WNK>ZLKQ403P2[)$BN8+F"++^,W[0VD?![6]$T2Y\/W6M2
MW'AK6?'_ (HU"36]"\-:3X3^''AGQ#X3\,:_XBN=3U^YMK:^U"VU7QMHGV32
M%:TLC91ZK>ZUK^A16]@-4^1O^"7_ (*U_1/ACXV\7ZI!<VFD^,_$>G)X>AN(
MY(Q>6OA^SNX+S5;=74*]E<7>HM9PW,?$MQIUZGS+%&[^A?M?^.M2T7Q_\&_#
M3_ /PU\8O#"K-XRUO7O$O@R'Q39^ 7MOB1\+O!']IR7\^M:?+X:LTTKQMJNL
MWFIZ/X?\?ZF#H%LUUX331(-2UO3/Y=XFRK 99Q5F^5Y>_:X+"XRI3HQ]M&4J
M2]C0JSP[KR?[R6%K5:N&O*?/)THQFW4IU%+^,?$# 8#(.),_R[*:U\#@LP5'
M#-N6*=)3AAZE3"RG'VDZGU2M6JX651\T[4'[1^TC4DNBT_\ ;\^!=W-X%2Y_
MX3'3K;QE!KMQ=ZI<^%=7ET?PI;>'+X:!K&HZYJMK:SV5QH6E>,$N/!6N>(M&
MFU'1/#WBF!M-UV]L/,BE=EY^W?\ "_4O!FM^,_AUI.O^/=/TGQ?X+\"0[()O
M#PO/$_B[Q%XE\,R:=)!J=E)K=L="O_"U]]N9="NC>I<Z=+I"W]O</<0_*%O^
MUG\ ];NO#.IQ_L33:?XE\0>(;;5K/2?$'@+X?#QW=:EH6EZW##K>B:"ZP7%X
M^@^%]#U;P=XA\0OJ=FGP^\<SCPM>6^IZ3%<ZT_0^%OVP_ ?A/PKXIUK0?V0H
M?#O@_P ,Z1X/^(.D6GA?1K?3M1U"ZU32_"MSI<":0G@*P1_%(\4^)/&^G>&M
M6MIIM(O[?04U!=<T^7Q&MO!Y3PL4DUA*W-=)1EB*"BTYM<MU)2;:<8IQE9I.
M5[_#\-]>DVU]>P_+RRO*.$Q#E']VO>LXN-HRC.<E*-]81V5Y?2VA?M\_ NZT
MO3[KQG%X_P#A=K6H>-+7P&OA/QSX%UZ'Q!%KNH>+=:\#::GE:':ZS9W=O<^*
M] O_  [=3:=>7HT?7T.C:P+&^'E5M:/^W/\ L\>*])\97O@KQ1J/BG5/!7PL
M\5_%K4_#UMX>US2=2;0?!VFPZEK6E&XUZPTS2['Q-:PWVE>?H.I7UIJ%LNK6
MDUQ#'"EX]M\I?\-1^!O$TB3^+?V,HO$?BBW\3ZB/#UC'X2T.ZEDUS4O$=[>:
M?/I^J^(M MY[RZTSQ#=/XB^,VK?8M-B^&.J^(]*OPGC.XOQJI[[X0_&SX?>.
MOBO+\'? W[,.G_#NYG\$1:+XHU_7O -I'H%OHOB#PAXJ\27_ (,O4L-)TB#4
MK2V\7:;;1:KI\MY+H_BS1]6M]8COH+Z\AM(YEAH*,W]7K1<(N;?UBA*$5%P;
M>WM'&W,DTG)MI;IWN&,JRG!?6L/*,G&"7U3%0JRE)222O^Z4K\K:?NI1E>W,
MK?7GP1^._A_XZ:?XIU#0-%UK1HO"NOCP]>QZTVF,]S<-9PWGGVW]F7U^GD!)
ME3$[13;P?W>W#'W.ORP\/?M?^)/A5X D\0^+/V?K2TN9;;3M5UM_A?X/U7PI
MH^LZ]K]SJ]OI&DQZ=<IK6J6<MAIVC0_VGXEULR6ESJ6J:;H\%I91.^H1_>_P
M4^(E_P#%7X<:+X]U#P_>>&)-=U+Q>MIH>H6US9ZG::-I'C+Q!HGA^74K6[_>
M6^I7^A:;IVH:A"C26L=[=3K8SSV0MYI.:O0G3;J*')1<^2'[R-3WN5NW,G=Z
M1D[N$=TG9V3Z\+B8U5&FZG/65/GG^ZG2T<K)M27*G[T8V4Y:QDUHKGK%%'^?
M_P!5%<YV!1110 4444 %%%% !116?J.FP:E''%/-J$*Q2>8K:=J>HZ7(S;&3
M;)+IUS;22QX<GRI6>,.%DV[T5@ 7\ ]0/RHP/0>G3MZ5S(\+Z>3C[=XEQD@'
M_A+?$W./^XK2'PQIX)'V[Q+QW_X2WQ-_\M>.>/K2O_7K\_ZT'9G3X Z #\!_
MGL*6N8'A?3SC_3O$HSG_ )FWQ-VQ_P!17WI1X6T\DC[=XEX[_P#"6^)OR_Y"
MO^<4Q?=]Z_S.FHKFO^$5T_\ Y_\ Q+_X5OB;_P"6M'_"*Z?_ ,__ (E_\*WQ
M-_\ +6@#I:" <9 .#D9['U'H>37-?\(KI_\ S_\ B7_PK?$W_P M:/\ A%=/
M_P"?_P 2_P#A6^)O_EK0!9O_  SX=U2XT2ZU+0M(OKGPUJ,.K^'I[O3[6>70
M]4M],U71K?4-*>2)FL;RWTG7=9TZ"XMC')#9ZK?P1,L=U,KZY@@,;PF&(PR>
M;YD1C0QR?:"[3[T*[6\YI)&EW ^89'+[BS9Y_P#X173_ /G_ /$O_A6^)O\
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MP1:_X)[I]WX4>+OQ^,7Q7..H[^+C_P#KYZU;3_@C-_P3_CQM^%/BWCIGXO\
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MXF[$@?\ ,5[X_P#UTO\ PBNG_P#/_P")?_"M\3?_ "UH&=+17-?\(KI__/\
M^)?_  K?$W_RUI/^$6T\X_T[Q+R,_P#(V^)O;_J*^] '345S7_"*Z?\ \_\
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M)XQ_MF_;5_!GA:YO+Z\_L.P$7K-GXK_X(ZVGPI\2?![3/VI_VIH/"GC/X]^
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M2/$=MJWBB^U+3?#.EW?PYT"UU'Q'J.CV5[J.K:=H5E+\5EN=8O=*T_3=1O\
M4;33HKB>RL]/O;FZCC@M+ATZI/V./VOU^]_P48\?OZ9^$=D.G/7_ (66>P/7
M_P"L?ST^!$G_  26_9^^*7PX^+/@7XX?&K4/$GPQNO%U]H47B_P_XP\36US=
M^*M.^(6BRS75]J/PU?Q%9_9]$^)OB*UO[?0-;T6R\8ZC;Z'XF\=6OB7Q/I%M
MJ]?IDO\ P5'_ &+)/N_%'5F] /AU\0^3TY_XID8'/)]"3D &M$_$#IP]6?\
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MXQ48MW44VU%::7>KZ_>>G!2C",93<Y)6E-I)R>NK2T3U2LM- HHHJ2@HHHH
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M?^?VT_\  F'_ .+K._X1CPU_T+VA_P#@IL/_ )'H_P"$8\-?]"]H?_@IL/\
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MG'?_ "T]/^U,_P#^ACG?_A9FO_R_S/G/_AVU_P $Z/\ HT']FO\ \-QX3_\
MD3C\*5?^";G_  3J7[O[(?[-@[\?#GPG_P#(E?17_"??L]_]#K\&O_"C\$?_
M "92CQ[^SX>GC3X-GZ>(_!)_]O*/KV;?]!F9_P#A3CO_ ):']J9^MLQSM?\
M<[FG_P O/GM?^"<W_!/-/N_LE?LXCKT^'GA7OSS_ *+SSSSWYJ9?^"=W_!/E
M/N_LG_LZ+]/A]X5'\K7_ #D^IKW_ /X3O]G[_H<O@Y_X47@KMU_Y?*</'/P
M/3QA\'C]/$'@OV_Z>_<?F*:Q^<=,;FGRQ./_ $JC_M7B#_H99W_X6YK_ /+S
MP1?^">O[ "?=_94_9X7KT\ >%P>>O/V;/^':IU_X)_\ [!"?<_9;_9]7K]WP
M'X9'7KTMN^*]V_X3;X!]?^$N^$&/7^W_  9_\ET[_A-/@+_T-GPA_P#!]X,_
M^2J/[0SC_H.S7_PJS#_Y<']J\0_]#+/+_P#8;FM__3YX:/V!_P!A!>5_9@^
M*_3P+X9'Y8M^/PJ9?V#_ -A=!A?V9O@,OT\$^'!T]Q!GN?SKVT>,O@.>GBKX
M1GZ:YX-/_MU3AXP^!)Z>*/A*?IK?@X_RNJ:S#.5MCLV7IB\Q7_N8?]J\0_\
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MZ];7VN0ZC%XCM[VTOUU-9H]47]Y-/90)>0D&VOK,SV%Y!/8W5U;S 'B6N_\
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M2RI]?.HBO[6\:=/]IS_Y+)?UK+7;HUWZGXV?MD_L8ZY^R3K?A:XM/%5QXU\
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MC?7[[MK/\T=C;W,B+A3\[HJ9PN[<R@WJ* .=_P"$ITCTU;_PG?$/_P JZ/\
MA*=(]-6_\)WQ#_\ *NNBHH YW_A*=(]-6_\ "=\0_P#RKH_X2G2/35O_  G?
M$/\ \JZZ*B@#G?\ A*=(]-6_\)WQ#_\ *NC_ (2G2/35O_"=\0__ "KKHJ*
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MC5NA'_(N^(NAZ_\ ,*II\3Z3V_M?@8S_ ,(]XBSWX_Y!6/?GT["ND/ZXX_\
MU?Y/I7RA^TO^V[^RY^R);Z8_[0'QA\->!-3UJ W6A^%F:ZUKQGK%GYLT!U*Q
M\)Z%;:CKATA)[>XMSK-Q90:0+F*2T-]]JVP'6C0K8FI&AAZ-6O5G\-*C3G5J
M2M=OEA",Y.RU;M9+5M+4WPV%Q.-KPPV#P]?%8BHW[.AAJ-2O6G97ERTJ5.I.
M5EJWR\L5K*44KGT4?$^E=CJX^OA[Q%D?^4HBC_A)]+]=6_\ ">\1?_*JORH'
M_!=+_@FQC/\ PN_6.G_1-/'V?Q']@_ICZ<$4O_#]'_@FQ_T6[6/_  VGC[_Y
M05Z/]@9YUR?,_P#PBQ'Z4F>S_JGQ._\ FGL[7_=-Q3_]PGZK?\)/I?KJW_A/
M>(O_ )54?\)/I?KJW_A/>(O_ )55^5)_X+I?\$V!_P UNUG_ ,-IX^/\M J1
M/^"YG_!-M_N_&W63QG_DFGC[I@G_ * '8#GTX]11_8.>;+)\S_\ "+$?K27X
MB_U3XHO_ ,D]G;],LQ/_ ,J/U2_X2?2_75O_  GO$7_RJH_X2?2_75O_  GO
M$7_RJK\MD_X+@_\ !.-_N_&K6#_W3;QX/YZ$/\?:K2?\%M?^"=4GW/C1JQ_[
MISXY'\]#'^%5_J]GW3)\T?E]1Q%W_P"4DA_ZI<4?]$[G;\O[,Q7_ ,I/T_\
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M7_RJH_X2?2_75O\ PGO$7_RJKX77_@J;^Q4YPOQ4G/\ W*OB+\L_81S5E/\
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M6@ZUK7_0HZH?^XAX=_KJPKJZ*+/^:7WAKW?WO_,Y/^VM;_Z%#5/_  8>'/\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>ea028514801_img18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img18.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #V 5H# 2(  A$! Q$!_\0
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MD<8</\,NH\\]I/DCRJ<Z<;*ZE*$>:$'>[]8F^ W[-G@_X:?"?X@?'?X_>-O
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M[#3=8\[\_P!./?CC]!7DT.FBSNKBQOH+FVN+7_C\QD=^?7_.>]=S9P^3^/\
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MVG.\LO?7>_7U\SWB'6/^6$_U&/\ #^9^HQ6A#K';_/KC_'CTSZUX/>>))_\
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M<%)/FTV[/J?<8KA7%.+Q^3YNG"*YG+F32BDVVWS-+W4]VC^#_7O@GKEG^_\
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M%&O:QJF=)N_^8#I>A<=/YX]OK7X'_LQ_$C^P=>T>?S\_9;ST&<CU_P G]:]
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M$]1U/2-4T;QSXK\/_P#$R&MZ85*G^P@ /^$?)!.=Q."3@X)%?RE:S\;?VBO
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MX:E<>WVSIR,_3I^ KZ1_X5+XXF^$MQ\:8+&VNOA]:>)/^$+O-6^V_P#,4/\
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M7V?:[[^2V/H,LX1DY133NVDU9[MI=N[+'G3WEUI]C!!]IN+K_0K//MP,=O\
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M  Y]<> _&T^CW5O[YZG_ !'Z=/;K7Z(?#WXS>%M>MM(L?''ASPWXVM]+O/\
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MUC[9?W$_MZY_D<_4^WO7D]Y-W^G_ -8$?R.?ZU8U+6/.E/\ /'_UN_ZBN?\
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MTQ_BI\!_B;\&=4T>Q^(VAVVFV^OV?]M>&]6TG6-&\2>&M>TL?\A[^P]<\/\
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M/\5?3[T?R%F.&RK*<WS3)\9S-KJKO5/H]5TZ,_&?Q)_P3-_:V\-^$M(\1_\
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M%OXQ>"?!.L?M?>&_%.M?$CX>ZMX;\9:EXGO_ /A.]%&@_LW_ /$\\/\ AO\
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MV]L=J]C%9ED^NU]>U^O8\?"\%YQA<4G)S5TFVN:ZNE>W2]F[>:1^M&@_MR>
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MZ]]/P/@.-:&$^IWO>VNCOT;UU[^9^U'QX\-S>)/A[\8)X(/M-OKWP'.M6?\
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MWUYXA^Q_\?\ S_;VNZS^G_"+]>#7P_\ '+1Y]9\6ZA/;P?\ +YJA[=_T]/\
M)K]6/AYX#TKPW^SQ;ZY/]FMO%'Q&O#_I?>PTO0O^0%HO;Z_3KUKX_P#$GP?O
MM2BU#S_[-TVX%YB\^UWGIW_6O"S+#?6\)?KOM:^KO_7H??\ "F983"XQIMO^
MQ&]6])-MZZVNM>M][GYOS:;./L\\,%R;C_IT^G?\_:M^'3;ZSNOW]O=6W?\
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MQ?\ VQX.\?ZY\8]-^(%MXD^/'A>S^(6D6?PU\-_ W0?%'P,&OC0M%_XN ?\
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MN7O]H3Z'X<MM$^U<?\>?^?\ A'_I^5?"&I> ]<TVYU";Q'8W-S]EO/L7VO\
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M/B=K%CJ6O7%C8P?9M'TNS^Q:/:?\^&E]O\YYQCM7A\L/DQ>3/!_I%U_RZ?\
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MH6BG^PCKO?Q!\._%F>>U>^LKT6NZ7XI'BXK,H1Q7O-126K;2O9:[M>=CX_\
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M)3:4E*[=1.R;:U4FTVW=/5L\7\;?#V?39;G7/#D N=/NO^/S2?\ GPSV]?\
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M^WZ?_7JQYW[K_..GTST[?KFL_P CW_7_ .M5BO/^L^?X_P#!/Y]+'G^WZ?\
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MW'PK\&^./B-KGVGPW<6O@_5++1[2[_Y"=_JFNZ+_ &#_ &+_ %]O3 !KP?\
M9O\ A[]C^+_A?5?%4&I6WA\?VI_;%W]L_M+4_P#D"_V#H7^<9/;M71_9RPG^
MRZ:ZMJW7WGMV5^I\^_$C"9G_ &IBWE;M%:7>KMIHFUT6MD<_/X4^#L/B/X+Z
M[_8?A+1-.NOA7XH\,>)/[7O-9\1Z9_PN30M:U_\ L+6O'&A_]"[_ ,@3CTZ5
M]$> _"O@;^U/'%C\.+'6[;1M?_X0/6KS5O@Y_P 2W[?JFA:+GQUX+T,>(/\
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MW;\G_0[PZEV_S[>OO[_X;_:H_9"FT6XOH/CO]F^U6?\ R+_BSP?K.IZG8?\
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MZ?R/ICZ>GK6C7T&&;Q>N+^[OY?/;YGS^)PZPFF#<5==TK)WUW6FN^VFY[?\
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MS_M>S_LWQ-Q_R'1H>A\>_P"5?3%W^P3KL.J:=_95CX2U+3_['_L6\TFTO/\
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MW<$TN93MOT3MTV/B?X>:;]CO]'GGU;6]$N-4O/L5G]CM-9SS_+_.:_9#X??
M'X5_ VZT?XC>*M<TSQ_XH^Q_;='\/6EG_9OAFP_YCW_A1=OTYK\__!,VE?\
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M\^>C:;]O\+_]@/T_(<]?3X.^)'A4Z%K/A_QCX'US6[;POXRL_P"VKRT\/?\
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MPYQS^G8?_7_SUKOKZ?5-6L_#D.O7QU$>&_"?]GZ)D$"RT/\ Z!:YQ\G^T/\
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=%\/,F]AFN*A[3,,W<WSN3DU7C;6;D].BO9=C_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>ea028514801_img19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img19.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #L G # 2(  A$! Q$!_\0
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MX?X_"T<;@N&>'\3A:\%4HU\/AHUJ,XO23A4C749J$U.G)I*TZ<U96:7Q%?Q
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M6/\ Q40PHR-S=!D9/(K]NOVFH/V,E\*_MC>/O!\?P9?XB?&[X::WX!;2K!_
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MJG2:G-5).C\<'_@X=_X*?@9_X2OX)GMS\&;48/U_X2+D YSQVXS4)_X.(?\
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MP7-Q)9VM\?@=MLKN]B5&EL[:]_M[[-<7D2R1F2TAE>X0.A>,!US8G_X."_\
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MC8_\+-/WHXU5B"/#_0D>V>O>O[;?!?\ R*7AO_L"Z=_Z2QUYU^T9K'Q \.?
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MF)')K^Z:BI?THO%A_P#,7P\O3AS":]K_ .V=/D5_Q+AX;;<G$-MO^1[5V_\
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MAXFO>OD'_B/X5?EBREX!\!1VEQ#_ .'NI_\ ,7Z'\()_X-XO^"A9_P"7+X)
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MK_\ G1N6O [PH6W!F7K_ +FLW_\ GOY'\PI_X-H/A]S_ ,9>?$'YA@Y^%7A
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MZ#]?\:-[>Q_S[8HY)>7W@6-Y]!^O^-&\^@_7_&J^]O;Z?YY_6C>WM1R2\OO
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M-TFZFFO3^5_U_P!O"]_HX_<?IEJ#%=.O55$55LYU55X55$+ *J@ *JC 51@
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M<>'?AOX%^)5WK?B[Q=?G3="TJ7POXCLH[V\$$USY+W5Y8I;0#R;>5M\SJF5
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MU_QHWGV_7_&@+ON]=]2<OG&<>W7].:-Y Q@8Y]>A_&H-Y]OU_P :-Y]!^O\
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M:[N[+)8$Y*_J:\:_:/D/_#._Q\P,'_A2OQ2.<YZ>!]<]J]=WGT%>-?M'2?\
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MZ()[KT[^9:\^88Q*XP,##$8'' P>.@Z4P,02<\DY9B 2Q!R"Q(RQ! 8%B2K
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MD9S[_2JY7VZ77H(M[_8CMU)_'!Z_Y%>-?M&N#^SS\>L@_P#)%_BCW/!/@C7
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M_/Y<T<COMIZ_\ "]N;U_0?RXHW-Z_P JI><_M^5()7'I^0_IQ1R.VVOK_P
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M_7_ZU=MH9W:="<8^:3OG_EHWL*YZMW%-N_O=[]&;0W?I^J+6H<6-V?2WE_\
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MY3SSG([\T[O2S7;>.WW: 35XY^T40/V>_CSG//P8^* X_P"Q)UL_TKU[S/\
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MTZ4>.N$IRJ3I6A&$>(,KE*3?M'I%)MM)V2V/[,ED&  I.,C.0._XGTI?,/\
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MB9[E-6%',LIX7QV-P56I1IXBG3Q%*MET82G0JITJT;5IITYJSNNJ1\'>!?\
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M2,0J1QHI9W8A54%B0 :[WS!_M?\ U^W?M7C?[1<F?V>_CP,G_DC/Q/Z\C/\
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M6;7=6T']C[4-0T74+C3;\?%;X;0K=6[;9A!-<:R)8P6##:X0!@1@@<$=_K>
ML)''<:\+8.482CBL\P-"2JKFIM5)5TU.-FW%J-FK/H]TCX;Q-S59+X><:YPE
M7BLMX;S+&IX>HEB$Z$,.TZ+E)*-1.;Y9-I;W>MCYL^#%_P#%WXJW'BR6W\1G
M3M)\->'-5O;F;2_#NGWE_J.K_P!D:G?Z)H$5G$B'[+J4VFR?VE?S*;2QM4)8
MO<SVL<FAX$\0^)/$W@"?Q/KOQ'GTK48M8N9]5T6'2-&BATOP1H5WX<LM:\8W
M<%]I['51I7]M2C[+8W N+2*WAF,,T;M&OX.6'QB^*>EW"W>F^/?$>GW:Q7,
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M_P"Y"U^O9PZ=V/H>.V<\?_JKQ#]II@?V;/VA@#R?@;\60.O4^ M?Q7?E2?\
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M!P?^+,_$_KQT\$ZWZBO5_,&.A_S_ )]/PKQ[]H9\_L__ !U[?\6:^)YY[_\
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M5X-.?#]F?5I__1\E<^)5J:^+XU\2?9]SIPR2D[7VZZ?<:>N_\@;5/^O"Z_\
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M;E55(Q8WK[_Y_&CE7\LMOZZF?*K_  RV7Z^98WCT/Z?XT;QZ']/\:K[U]_\
M/XT;QZ']/\:.5?RR_#_,.5?RR_#_ #+&\>A_3_&C>/0_I_C5?>OO_G\:-Z^_
M^?QHY5_++\/\PY5_++\/\S1LV!N[0\\75OU _P">J_X=:_AK^*Q_XNE\4RJ[
ML_$OX@X4D -_Q6&LG!).,$^IQ]*_N,LW_P!+M,9_X^K<D<<CS%K^'7XJ_P#)
M5/BE_P!E,^('?_J;]9[]?QK^H_HQI+,>,+)K_A.R7??_ )&./]?^"?PO].%+
M^Q?#A6:7]K\3*SM_T*,KWNFNO5-=TUH_N/X>_L Z=\0[-[W1OC3'>VC?L]>'
M/C59W^F^![Y['4/$?B35_'6DP_#_ $\ZCJ.FWMR+2;P)J$2:A':-JNKSM</I
M&BSVEE+<-YG\'OV7?A_X^^%GAWXH_$;XTWWP<TK5/B5;> -3G\2^ +G_ (1V
M(WEM=W0C\/>(+G5[1_$>OV<,%C>:S;QZ9!H.BVNJV%O?:V-3N8K)_FS1OBS\
M4O#EM-9>'_B+XTT.TN/"Q\#SVVD^(=1L(9?!S7-[>?\ ",-';3QK_8RW>HZC
M<I9@!(IK^\DC*-<S%]2]^.GQHU+1X/#NH_%/QS?Z!:ZQ8>(;;1+S7KNYTJ#7
MM+N+:[T[6(K"5GMEU"SNK.TN(;CR]XEMH6;=Y:X_?)Y/QT_K5%<5X;V5;&8*
M>'Q4,'3IXW!X*C3S2.,HPA/+L1@ZU;&3Q.633JP5.D\OE9\M3DJ_R+#B'POB
ML#7EP-C'7P^79G2QF"J9E6K99F698BKD<\NKU*L<WPV9X;#8"G@\ZI5(8>I*
MMB8YM&,X_NG.AVO[1O[.GBC]G;Q%H>C:U_:6IZ5KNE-=:;XJETU-/T36=2LY
MW36+#076\NIKN'18I],AOYKR.SN$U*>[MX[=K>WCN)_UF_X(G<Z9^T4,C_D(
M> #]<6NN?XU^'_B?X@^._&MKH]CXP\8>(O%%GX>_M3^PK77-4N=1AT@ZW?R:
MIJYL5G9O);4M1EDO+M@2TLS=0@55_;S_ ((H$C3?VBL<?Z?X![<8^R:W_7K^
M'O7R/BU1S.CX0YO1SK%8;'9E3GE4<5B\)2J4*.(:SRBZ554:OO4IRI.E[:$?
MW4:D6J3=-*4OT?Z/5?)<3](CAS$<.X+&9=D]6.?5,'@,?7H8G$X2,N&,4JU&
M5?#ODK4X8A570J2M6G1E%UTJMTOW:WCT/Z?XT;QZ']/\:K[UZ\_Y]LXHWJ?7
M^7\C7\'<J_EE^'^9_JWRK^67X?YEC>/0_I_C1O'H?T_QJOO'H?T_QHWJ/7^?
M\S1RK^67X?YARK^67X?YEC>/0_I_C1O'H?T_QJOO7KS_ )]LXHWK[_Y_&CE7
M\LOP_P PY5_++\/\RQO'H?T_QHWCT/Z?XU7WCT/^?QHWK[_Y_&CE7\LOP_S#
ME7\LOP_S)V<8/!Z'T]/K7M['_BFG/7_B2.?K_H)].?RKPAG7!Z]#_GK7NQQ_
MPC#9Z?V&^?I]@-<V)248636KW]$=.&23G9-:+?U9G>&/^1&T7_L7+7_TA6O$
MQ(NU<G&%'7ZG_&O;/#'_ "(VC8_Z%RU_](5KPE9%VKC)P .WI]:>$VJ>L?R9
M5=.\=>C_ #1=3]XRI&"[L=JJ@+,S>B@ DGV'-.*.HRR.HRRY967YD)#@Y P5
M((8'D'@UXG\<]#UGQ-\/IM+T72]1\0QCQ1X&U'Q/X4TC4;?2M5\8^!=*\7:1
MJ'C?PEIU]<ZAI-M'=:_X;M[^QCAN-5TV&]#FQDOK9+AI!\60?!KX^> H?!_C
M7PU:>(_&GBA=*\.ZEXP\#^)/$,%YH<+Z%K]U;^ _!T-Y;>(-*O-<E\':,NF:
MGKPEUG^S+2[LVN;6?7H[W4+.;K;:?5[:I)[^5K_=MU,5&Z^*V^EET5]^B/TU
MN'7R)QGK#+Z_W&J4,H&">@'/:J&YYK91,@BGEMT\^)'\V.&X>)3-$DVU/.CB
ME+QK,$3S542!5W8">9<] MMQP?WDI_\ :0Q1KW_!?U^ NB5^_1>5OZL:.]#T
M8'\Z\0_:;D0?LU?M$C/7X%?%L?GX"UX#K]:]?\RX ^[;Y/3,DH&?8>5S^8KB
M?B7X1F^(WPV^(?P[DU"#1T\?>!O%G@IM72&2]?2E\4Z#?Z&=16R9K9;QK(7W
MVE;4W-N+@Q>49H@Y=>S+ZD*&/P-:K)QIT,=@JU25K\M.CC,)5J22C=RY:=*<
MK)7?+9)MI/SLVH5<5E.;86A'GKXK*\SPU"#<8*=;$9;F&'HPYI-1BIUJ]*/-
M)J,>;FDU&,FOX ?"GBK7O"D.K2>']0;3I/$GA/5O!VL.D$,K77A[Q#:Q6VKV
M(:56,7VJ&)%$\6R>(J&BD0\UZYXE_:4^,7C&\T2_\2>(-(U.\\/2P7FF7$WA
M'PNLL>N0ZKX>UR;Q=<-;Z5 ;SQGJNH>%M"37O%5R9-9UO3].33=0NIK.6>*3
M]M8O^"!%K'&D?_#55R=B*F[_ (5'"-VT 9Q_PG+8SUQDXS4G_#@JU_Z.IN?_
M  TD/_S<5_8U?Q0\+<166(KYC0K5U=*O/),RE5BG!TFE4>#4[.DW3M?6#<;)
M2DI?YK8?P%\><)AWA,-DM;#X5N,I8>CQ1DU.C*2K+$*3I1S!PO[=*MS*-W-1
ME>7+!0_"_P %_'KXK?#_ ,6>(_'?A?Q'#:>+_%WB*W\3^)=<N]*T_4;S5[^W
MUF\\0/9WDEW"_F:+J6L7LUYK6CJ%L=6:.S6[C=;&W"?4G_!/SQ1KGC3_ (**
M_ KQEXGOO[3\1>*?BIJ>OZY?""*U6YU+4=%UF6X>.V@58(8]Q"Q0Q*L<,2I'
M&H51G]+/^'!5K_T=3<_^&CA_^;BO;OV;O^".%O\ L\?'3X;?&N/]H:?Q=)\.
M]=;6T\-R?#=-%35BUA>6/V9M43Q7J+60 NS+YHLKCF,)Y9W9'E9YXD^&^)RC
M/88#,**S+'Y%C\MHSIY-F%*K64\%5HX7"NM+"1Y:,:BHQA"4XTH*,;VBG?W^
M$_ _QKP/$?"=;-LHK/)<HXJRG.J].KQ+E.)H8;V69X?$9ACH86&.FYXF=!8F
M52<(5*]6[4>:;C;]PF=>,G&  <_SXSQS]?:DWJ>AS^=9YDN3C MN@_Y:2GMT
MXB[=_?L*#)/T"V^>V9)?Y>3S^?\ +G^0W?>_KHNQ_HT]]^KVM;=_>NSUNM5H
M7]Z=-PSZ4I=!U8#ZYK/$EP!DK;]?^>DH&/KY7% DN<_=M\>SRDX[<^5@T:]_
MR#7S^Y&AO7U_G_A7Y*_\%KY$/["VI\G'_"Y?A0"1@X!N-?&>OZ'%?JT9+CLM
MMQG.9)3^GE<>_)KY0_;2_9@/[8?P,NO@K<^-5^'J7/C'PIXN/B2#1&\2-&WA
M>2_D6Q_LR2_TA6%Z;TAKC[:#;^4"(90^%^CX/Q^%RKBGA_,L?5='!8'-L'B<
M555.=1TJ%*55SFJ=*,ZD^7FB^6$7)J]D[,^+\1\HS'/^ .,<DRFBL3F>;</9
MC@,!AY5:5"-;%5XT%2I.M6E"C24W3DN>K.,$[<THW3?\J?[#7P1^$OQJOOB?
M9?$ZS:6+0++PE<#6[W4_$>E:1X-\):A+XC'C+Q:LWAAG>/Q)I*V6BRZ!=>*H
M9/ =I$-3'B*1)KG38YO//AMX)^$>E_#CXI:Q\8O!_C*?Q;\./B#\ M6O9+;7
MH=-2^^$7CG7I3K^EZ1X:A$%S=>(O$&@K%JBZE/JGE6-C<V%O816-U/-?5^OQ
M_P""!-H<_P#&55T"RE"1\)(AE&QN1O\ BN,,C$*2K94E5.,@4?\ #@BTP ?V
MJ;DX)//PDBYSV./' X7 VXQCWXQ_3=7Q(X(JXO,*[XVQ]/#8VIELZ6&I99G5
M-X-8&ZQ$,/6A0TCCX3G&M%0C%-4JC4ZE+FG_  MA_!#Q3P^7Y3AEX9915QF6
MT<ZI5L;7SSAJO3S">:*^#JXO#5<1>=3*ZD:56A.56<I06(H1=.EB>2'YL_M>
M?LY?#_P'X%T3XM?"&UL=*\&WOBZXT;Q#HNJZMJUQXRT7Q'XCTZTUC3?!_P#9
MMQ<ZUI6FV7A/2H%EO-*D\4ZUXLM+S79DU>:XL;""^E^SO^""S!?CM\>5(.1\
M)M)'UQXNM3GMQ\PKUL_\$#86W%_VK[^3?(\KB3X5*ZO*X"M*ZOXZ8-+L54$A
M&\*H4L0 *^X_V$?^";Z?L1^.?'/C6W^,#?$IO&GA&T\*G39_!8\*C3EM-6CU
M7[:MW'K^MFZ:0Q"#[.;> *&$@F.-I^<XFX^X5Q7 6=\/T.)Z^=YGB:/)A*E?
M*\RP]:I#Z[@:].C6K8BG*$Y4:5&LOK%6I3]I"--.$)1ES_;<">$'B!EWBYPQ
MQAB^",)POD>"Q#J9E2PN>9+C</0J/+,TPM3$X?#8.K"I3IXFMB<,WAJ-*LJ-
M5U9*K.E4BZ/ZD^8G]X4N]1U./SK.$ESGD6WX/+GK_P!<O\FCS+D]%ML?]=)3
MS_WZ%?S)KW_(_N?7N_N1H;U['/TKW#P40?#MD0<_-<C_ ,F)*\$21^DFS.>!
M&6((QWW!3G/H",5[SX'(;PW8D?WKGK_U\25S8K^''_'_ .VLWH?$_0U]>_Y
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MS*;E\& M;U_M7?Y'XYO]T_A_,5^]7_!!Q@/'?[3F>W@7X:C_ ,N7Q,:\B/\
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MR05]X_X?U9<C#RL$BCDD<Y(2-"[$ $DA5R3@ D\< $FA@ZJ&:.158$JS*0"
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M>*_%<_[0OCNRG\5^)_$7BBXLH?!GA^2"TG\0ZS>:Q-:0ROJ.^2&VDO6MXY)
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MJ/O_  #[_P "[O'H?T_QHWCT/Z?XU6\SV_7_ .M1YGM^O_UJ=O-_U\@MYO\
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M^--WGU/TP#^N!_*J)]"QO/H/U_QHWGT'Z_XU7WGN3]<#^6/ZTF\^O'T _H:
M+.\^@_7_ !HWGT'Z_P"-5RY[$_B!_D_I1O/J1^ .?T&/UH G9S@\#H?7T^M?
M1RG_ (I;)_Z ))_\ #Z_UKYI+D DDXP>F.F.>W^%?2L?/A11_P!0#_W'UR8O
M:'K+\D;T/BEZ+\V9_AO_ )$/2/\ L6K?_P!-XKYP1CM7GLI_(#_ 5]'^&_\
MD0](_P"Q:M__ $WBOF52-J\C[H[^U+";5/6/Y,*_Q1]'^9\U2?L>? N7QOX-
M^(\FAZVWC3P%\9OB!\=_#6O?VZZW=KXV^)RQ_P#"76%PRVBF\\&W<\,%Y9>&
M93Y6GWT$=U!=F3?O^@_"VA#PMX=TGPZNN>)O$B:1;M;+KOC/69?$?BK4]T\L
MYN-;UV>*&;4[P&7R1<211D6\4$.W$8)U,CU'YBC(]1^8KL22V27HK&+;>[;+
M63Q[=.!1D_GQT'O_ (FJN1ZC\Q1D>H_,4"+:AF(5068D!55<LQ)&  !DDG&!
MR2:S==UG2/"^G7.L^*-7TKPUI%HL;7FK>(M0LM$TRU6600Q-<:AJ<UK:0"65
MEBB\R93)*1&FYR!7!_%WPIKOCWX4_$KP-X5\12>$?$_C'P-XF\,^'O%4-Q>V
MTOAO6=9TJXLM.UR.YTR6'4H'TRYECNUFL)HKN,Q;K=UD"D?#WP&_9'^.OP=^
M%OA?0_'GQ5T7]H;QOX-^.]S\6;&'X@:_XOF\/ZWX>O? $O@@>&KC6O$=KXLU
M/2=2T*[O;KQ7X<NQI&J:5:ZLB%[)99WNH?2I8+"3RG%X^>:8>ECJ&+PV'H9/
M*CB98K&4*T)2K8VE7A'ZK3I8648PJ4ZLE6J.:=)<JDSQ:V99A3X@R_*:>18R
MOE>+R_'8O%\1PQ6"A@LNQ6&J4X8;+:^#J3^OUJ^/A.=6E7P].6'HQI..(E&4
MX)_H&GC_ ,!RZIIFAQ^//!$FMZU;6E_HNB)XN\./K&LV5_&\UA>Z3I:ZD;_4
M[2_A226QN;*WG@O(D>2V>5$8CR7Q)^S#\*O%7QFTCXZZI%XH3QCI=WX5U.YT
MFP\37=EX(\1Z_P"!+75[+P+XF\4>%HX3;ZOK_A"UUW5(-$OC=6Z1I-#]J@NC
M:6YC\(/[*GC&Z\2V_C>ZU;P-I%U;^)_@AXAE^&7A)+[1/AAJ5G\.9M1FU?2+
MC&C2^(]/O-*NM0M=8\):KIE[;V.J:OHR+K^AVVEZI<V4'WRDB"X60GS$$P9L
MA073?N(*\J"R@Y'('(R17F)7T<;ZZ+?7ITWO;OO;70]M^[\,M]/2[2L]-=_+
M;=*[3;^Y@TRTN-0U2YM]-L+2"6ZO+_4IX;"RM+6%#)/<W5[=M#;6UM#'F26>
M:5(HD^9W51D<:?B?\,_(T:[;XE_#M;;Q&77P[<R>./"J0>(#'<"TD70Y7U58
M]7:.\9;20:>;AH[MEMG"SL(S\&_#S]CWXW>%O"WQETCQK\:[/XH7/CCQ3X)\
M6>#M%\6:GXQU3PQ9IX+\<#Q?)X3U^+6+C4Y+;0/$MI%;Z)J1TFTF6&...9[&
M\@@%H_6>.OV7/'/Q.N?%&OZC=?#WX8W^N>#O$^CP>#_AZ;F7PSJ5YJ_C'P]X
M@.B>/M4N/#-A?ZYIOB73-%NM/\6>)O#%EX3UNWEU&&72+1Y=-%U=^GG&"PF7
MYA6PF7YIAL[PM.&'E3S+"T<3AJ%>57#TZM:$*.+C&O%X:K.>&FYI*<Z4IP;I
MRB>'PWF>8YSE&'S#-\AQG#&.K3Q<:N38_%X'&XO"PH8NOA\/5J8C+IU,)4AC
M*%*EC*2I3<J5.O&C6?MX5$OO:WN[:\C:6TNK:[A66:!I;6>&YB$]M(T%Q 98
M7=!-;S1O!<1;O,AF1XI561&46@LAR54D#J57(''<@8[_ *_2O+_A9X9UOPAX
M/CT7Q'=6-SJAU_Q7JQ_LZ]O+^RM+'7?$6HZMIFEV]YJ%M9W=PFDV%W;Z<));
M:+=]GRHVD5P_CSX6^./%'Q8\">.]#\>SZ%X8\,1Z6NM>%H[[688]<:RU6]O;
MEGM[*XCTV;[3;7$5J?M<3EQ"%D)C" 1E^%PV+K5*>*Q]'+:<<-B:T<17I5JT
M)UJ-&52CA5'#QE-5,542HTYM*G"4N:;44SJS3&8K X>G5PF6U\UJSQ>$P\L-
MAJV'H3IT:]>-*MC'/$RA3=+"4VZ]6"?M)PBXP3D>KCXA?#]I]=MAX_\  AN?
M"T4UQXIMQXQ\-?:/#$%O((;B?Q)#_:?FZ!#;SLL-Q+JRV<<$S"&5DD(4[&B>
M(=!\3Z?'JWAG7]#\2Z3))+!%JOA[5]-UW3))H&V3PIJ&E7-W9O-"V%EB$QDB
M) =5)&?B76/V.QJ_@_XBQW'B8S^.O%>L_%27PO))<V=MX2\):)\3/BG!XUU!
M8$L?#,&M7NL3Z)9V,%Q+K\_B*UL=:20Z:B6C"0>_?!OX8ZA\+6^)MC?:R/$U
MOXL^).I>-=*\47UP6\4ZMINJ:1I%A;6?B^SMK#3M"M=5\.PZ7%H5G=>';>&R
MU?1[.PU"^M;?5Y+YI_/5^JMY-ZK>R:Z.UK_,]+W=;-OMIHU=Z][-:JZ6_:Q[
MF-QS@$CH<#CN>O0=36-+XD\.VZWSW'B/P];II6HVVCZH\^N:3"NEZQ>"![+2
M-2:2[5;#5;U;FU:STV\,-[=+<VS002+<1%^7\6>&]8UZ\T2YTO76TF+37D-W
M"L]W$+T//;2!66UD17VI$Z8F5@/,(!"E@?BGX@_L>>-O%_CKXB:Y8>*?"5EX
M3^(?Q5T#XN:QH%T=6-S>^+O B^%=*\ ZI=O#8/ LVG>'8?%-OJ,(\Y9;VR\)
M&*1D^URV>]6E3A1P]2G6A6J58U'5HQC.,\.X3Y8J<I+EG[2/OKD=DK)ZW,*5
M6I.MB*=2A.C3I."I5I2IRCB5."E*5.,7SP5.5X2YU=R5XZ6O]XZYXQ\%Z!I-
MOJWB?Q?X0T'0=746]GJWB'Q+H6CZ+JJW5K)*L-CJ>IW]K87XN;+S9XUM+B4S
M6@>>/="K./C>S_8B_8+U+Q/XWL-+^&WPLO=<\8^&_#YU'P;I6MZ3='PUINFV
M.JP:7XJ\)>&;2[EO?#%[?P^([B^F\00Q2V]]-)I]W'MB""??T_X$^//$OA?]
MGWPKX\G\/^$[?X'/+93ZG\/?%]]K&I^(M.A^%6J> [6\L7UWP'I=MH\UUJEW
M;3W^E36]^BZ09UAU0W4:12['AGX)>+O#_P ?KSXB6\GA6R\&W.K>*M:O1;ZI
M?:GJ.N2Z_P"&-)\/VKP^&-4\/.G@KQ3')I-J_B7Q)X:\:C1/$^FV5M:OX/M+
MF5Y[?G:NU>*:O]I7LK.^EFM_336]]#=.VS:;BUHVDWS*ROL]%?7TN>__  U^
M'?A3X1?#_P (?##P)82:9X/\#Z'9^'M LIKAKNYCL+-"JR7EVZ1M=WUS(TES
M>W1CC-Q<RRRB- ^T=OG_ #@=_?K57(]1^8HR/4?F*H6^^I:R<Y[_ $%&3C';
M_ 8_E57(]1^8HR/4?F* +63_ ) ]_;W-?17P].?"U@3_ ,]+K_TIDKYKR/4?
MF*^DOAV,>%+ ?]-+O_TID_S]*Y\5_#7?G5ON9M0?OM=>5O\ %&WXFX\/:W_V
M"[W_ -)Y*^726^Z?RX^O6OJ'Q0<>'-<_[!5]_P"D\E?*A8$YR/S%+"?!/_$O
M_21U[\T?\+O]Z,;Q?X<M?&7A#Q;X-OKFXL['QAX6\1^$[V\LEA-Y9V?B71KW
M1;J[M!.CP-=VT%])/;"=)(3-&@E1XRRGY-\ ?L0>!OA+XSU_X@_"WQ[XV\#>
M+?$_PG^&7PHUC4--L/"=_;SQ_#:Y\.^;XTBTK5]'O-,M_%?CO2?#=IHOC%X[
M4V$\5Q/JEC!:ZPL%Y']E9'J/S%&1ZC\Q70TG9M)M;/JO0Q4FDTFTGJTBX[[V
M9@H0%F8(N2J G.T%LL0.@+$D@<DG--R?Y]AWQG^0JKD>H_,49'J/S%,1:S_G
M [^_6C)SGO\ 055R/4?F*,CU'YB@"UDD8)X]_8 ?7IC^=?/'CK]GO2/%GBSX
MK?$"+X@>*_!OB/XG_#KX7_#N?4])B\,SV_A*#X5>*?$OBGPWK6DV_B'2]0L;
M^]U'4O%%U9ZSINN07FEW=C!!#;003RR3'>^/V@_%#Q3\&?B!X>^"GB9?!_Q5
MU715M_!/B8Z@-+71]6^V6TANCJ!MKP6N;2.YB\S[+-GS-FWYB1\C>!?@I^TG
M:_"WX2VG[2,.E_M0>*O"'BWXFWGCCP?JGC'1);+Q+IGBG1HM-\":NM]XFM-*
M\-:M=>")DO433=6BB:S@UJYU32Y)=4T^U1O267T)915S+^TL L13Q]+!QR>4
MJW]I5:52BZDLPIQ5)X=X.DU[&I>K&M[1KEIN.K\66;XF'$-#)%DN:O"5\IKY
MC/B&,,-_8M"O1Q4*$<JJS=?ZW_:->#>(I1CAY4/81;E4C+W3['^"/PDT#X%^
M K?X=Z#K6HZ\PU[Q9XQUK6=;72;75M<\3^-]>O/$GB?67TG1K:QTK2+:\U6^
MF>VTG2+"VTS3;81P6T2HI9O6\DX[X&.@Z"OSO\+_ +,_Q"T;XI^%?BC=:;X3
ML8=*^)W@_5[WP?H=_I5WJVG>$]-^%6C^$5ETGXK:Q9-XXU71O"WB"WNH]3^'
M^K7D%EXTTB(WJ-%=/%!=?;OCRR\1ZIX)\9:;X,U)=)\7ZAX:UJS\+:MYXM1I
MVOW%E-%I5]]H,<WV<6UXT4OF^3+Y>W=Y;8Q7#AZ:K5J-&52GAXU:U&DZU5R]
MC0C5JTZ<JU7DC*?LJ*FZM3DA*2ITY\L9248R]3%UI8?#8G$TZ-;&3H8;$8B&
M%PZ@\3BJE##UZT,+0524*;Q&)G1AA\.JDX0=:O152<(.<X]GDG]!T';I33(J
M&-7DCC::010J[QQM-*!N$40<J99=HW>6FY]H+8P":_/CPE\*OVS+3X+Z9X6\
M;_&#5=2^)\?CCQQK5_XMT#QG8V]Z_AJ3X<7MKX"T-M7O-&C2:PA^(RZ?>ZEI
MZVF!:-(]U++8O<PLV7X*_%YO$FJ:CX_\%Z9^T%;W&G'P[\/KSQQ\1=.M;[X8
M/;^)[?Q&GBF[U%H[35(UU%KR6-M4\&QR^-]-M_"FE:'#&=+OXI(NO-L%2RW,
M\;E]#'X/-J.$Q$Z%+,\NE5E@,=""@UB<*Z]*C7=&ISM0=6E3E>$[Q2Y6_.X?
MS.OG>297F^*RC,N'<3F.#IXJKD>=1P\<VRNI4E53P68PP=;$X6&*IJG&4U0Q
M%:FHUJ5JC?.H_H2)$+NBRQ-*@#/&LD;2HK?=9XPQ=%)(P2H&2!G-.)/?MSV[
M\_CGTKX8\)?L\^-O#G[0$/Q?NFT*]TK4?BK\9-;U.PTZ#PWHOB+3]$\8Z:EM
MX2\1W_BVWLO^$B\;:+LBN;&_^&^L7RIHMY?:9KMAYK:0]L?L#Q3;:S?>'M5M
M/#EZNGZY<6RKIEYYP@6VG\^%V<RE)/+/DI(H;8W#8P0V1R48*K4A3E4A14ZD
M(.K4;]G3C.2BZE1Q3:A!/FE9-VB[+8].O-T:4ZD:<Z[A3G45*CRNK5E"$I>S
MIJ3C'GJ./)#F:7-*-SI7E2/:))8H]YV())(X]S'^!0Y7<Y[*N6.>!0)4WM$L
ML1E5=SQ"2,S*IQ\S1AO-5<D?,5 R1STKXM^)O[.?BSXPZC\,[;QIK^E#3=!\
M'_%+1O%&OW6A^'_&.JQ7_BRY\-QZ))X<M=?2./2=:@L+#4'LO%UA ][X?N8H
M6@1FN,UA>%/V;O&/A3XY:3\4%FTS4]$@^+/C74;FSSX<LO&2^$M5^'^F^%O"
M_BG5O'Z61\3>+[*"ZM+Y-?\ AIJM[%;27=[9>([+-SI8M9RO35&M5I1J0KQI
MU)TU6I-NE5C%M*I3YE&3A*UXW2=N@4*GMJ%*K*G.A.I3C4E1JI*I2E))NE4<
M7**G!WC))M)I:V/O(,0V[J>_N/3]*^)]4_8XU/4/B#\=OB19_M-?&71/$'QY
M\-7G@[4KC3M$^'#ZCX \,/$EMH^A_#CQ+=>&YO$?AW3/#EN;HZ=8V^H):W>H
MW]SK6J17>JB&ZC^S<CU'YBC(]1^8K)I/=7MYM=&NC71LT3:V=ON_R9Y+\ ?@
M]!\ ?A9X?^$^G^+]6\9Z/X6-Q!H>IZUH/A3P]>VNES&-X=+:R\':5H^EW)@G
M^TWD^KW5M-K6KWU]=WFKWUW<R"2O9 2.G\A57(]1^8HR/4?F*>R2Z+1>2!N[
M;>[W9:)).3S^ _ETH+$C&>/H*JY'J/S%&1ZC\Q0!:#$=./P'^%?3?A#GPUHW
M_7FO_H;U\M@@]QT)ZCL,U]1>#>?"^B'ULD/YLY_2N7%_!#_'_P"VLWH/WI+^
MZOS(?')QX4U@YQ^Y@Y_[>[>OFO?_ +7_ (]_]>OI+QX<>$M9)X_<P?K>6PKY
MCWKZ_H?\*>%^"7^/_P!M0JV\?\/ZLM;_ /:_\>_^O7DWBSX$_!OQV_B:3QE\
M//#7B.3QCK?@CQ)XFDU2WEG?5M?^&^W_ (035Y7$P:"_\,*H33+BT-NZ1EXY
MC*CLI]/WKZ_H?\*-Z^OZ'_"NG?3_ (/YF/IH8FC^$/#6@:_XS\4:1IT=EKWQ
M"U/3]9\9:DMU>S/K>IZ7IRZ587<L-Q<36]JUOIZ+;"/3X+2&0#S9HY)B9#TN
M_P#VO_'O_KU5WKZ_H?\ "C>OK^A_PH O1I++GRDDDVC+>6K/@>IV@X'!Y-<Y
M>>+_  GIVLQ^'-1\6^&-/\136,VJ0^'[_P 1:19:Y+I=O')-<:E'I%S>Q:@^
MGP0PS33WJVYMHH8999)5CBD9?BK]MK]F;XS_ +2,7PC7X/?'.]^"K> O$&NZ
MKXH:SU?QAI1\66&IKH L]/E_X1.^L3=+9'3+XA-3,L"?;F,(7?,&ZKQ3\#O'
M.HZW\3K33=+^$FM:-\2]:A\5#QWXQ35[KQWX3O8?AK%X&;P_H^G0Z+-&ZPW=
MJL_A_P 2)XDM4T/2M5UB&X\.:G<LHN/0Q.$PM' 9=BJ.94,5BL6\4L7EU.CB
M(5\M]A5C"@Z]:I%8>LL9!NM2^KRE[*,90K\LVD>1@<PQ^)S;.<OQ&2XK 8'+
MEE[R_.:V)P=7"YX\7AY5L6L)AJ,WB\+_ &;5BL-7^N0A[>I.,\-S4TV?5?A_
MQ=X4\76T]YX2\6>&?%EG:S"WNKOPOXBT?Q%:VMPR"58+FYT:]O8;>=HF$BQ3
M.DC(0ZJ5.:W]_P#M?^/>GXU\P? ;X'ZM\&];\67-]XA3Q;9>)/!_PNTFVUC4
MKASXCTFZ\$:%=:/J'A5;>RTG2]%NO"%M>3W.L^&=5\B'Q%_Q-K[3=;%W%9Z?
M<K],1R(KHQ^8*RL5(ZA2"1@C!R!C!X/2O/5VNS[;V>O;?IL>N[)O73OY:7?Y
MLGG?[+!)<W3K:VT44D\MS<NMO;PP0QF6:>:>8I%%!#$&EEFD=8XXU:1V5%)'
M"M\5?A<FG6&L2?%#X<1Z1JMU<V.EZM+X]\*1:9J=]9-&M[9:?J$FKK:7MY9-
M+$+NVM9I9[;S8O.1!+&6^'/"'[(?QETV+]IZU\8_'0^,]+^->D?8O VBZO?>
M,-4TCP=-!XT?Q5'9:A8ZI?7%O'HVJV$<'A?68M$BAD?1Y[N%$DBV0MU?C;]F
MGQY\5+V^UC4Y_A[\%[VZ\+?$K1;>P^$RMJ(:^\6:%X-T?3)/%6I:OX3TVV\3
M6-^?#E[;:Y_9VC^&]3TWP_-IEAIE_=:A:MJ*>GF^"P>7XV6&P&:8?.<,J&$J
MQQ^&H8K#49U<1AJ=:OAE2Q<85O:8*K.6%K3M[*K4IRG1?(U?Q.'<SS'-\MAC
M,VR'&<,XR6,S'#SRG'XO XS%4Z&$QE;#87%NME\ZF&=/,</3I8^A3YO;4:.(
MA2Q"5924?KCQYX'^'WQC\&>(?A]X]TC2?''@C7&CT[Q)X>N;MY],OWT^Z@O1
MI^I'3KN*3=;7<-M<2V;S(P=(O.C*D ^.VO[&/[+]KJ?A+6;7X1:0FL>!(_)\
M':F-<\6R7^@VYUO_ (2)K.SN9/$#SR6,FN8U"2PN'GM)I4CCD@>"*.%.Y^#'
M@O7? /A._P!%\1/HR7-UXFU/5]/T[P_J&KZKI&@Z-=6>EVNG^'[&_P!;MK74
MKBVTH6,L%O)<Q&1[<PR2R/.\I';>,M*OO$7A'Q+H.DZD=&U36-&O=.T_5EDN
M(GTZ[N83'#>+):F.Z0POA]\#K*O\!!.:X*-.%6K2IU)PHPG4IPG6G%RC1A.I
M&,JLHQ3G*-*,I5'&"YG&#C'WG$]>O.I2HUZE&G/$5*=*K4IT:<U"5>=.G.<*
M4)3:A&5648TXRF^6,JG-+W8R-7Q'XH\.>$;1=3\7^)?#_A/3YK@6R:CXHUW2
MO#MA+=RAY%MHKS6+NRMI+F14D=+>.0RNJ.RH55B*'_"=^!_[7L/#_P#PG/@S
M_A(-5M[6\TK0/^$M\/\ ]N:K:7T+7%E=Z9H_]H_VEJ%K>VZM<6=Q9VTT-U;J
M9X'DB!>ODVR_9I\<7/AOX>>'O%?Q1N]4N?"GQ3U/QSJ/B2WE;4=;31;OP-K?
MA>+2M%_X3+2/%-A]I-]JD4LZWMD+=+)KE[6:*\$9;*G_ &0WTCQ/IVK^#=?C
M@\,^%_$_P(U#0? >L:E<MH_B#0/A38W%KJ">*]4M]%DUZV\1VFH7,7B/PK>Z
M3J)TJXU'3H-,UW3/[)NYX8M\PP]'"8W$X;"XREF.&HU7"CCZ$*M*EBH)1?MJ
M=*O&-6$)-N*51*5XRNCGRW$U\;@,+BL7@JN5XJO152OE^(J4JU;!U&Y+V-6M
MAW*A4E%13<J4G&TXV;LT?=V__:_\>_\ KTX;F&021Z@Y_#Z^W6JK.I9B&)!8
MD$C!()/) R 3W . >E<1X@\/:MJOB#0-5L-<?3K'2S$;ZQ26[07WE7GVELI"
MZ0ONB_<_O@>F#\O SPU*E6J\E;$0PT.2I+VM2,YQYH0<H4[4TY<U624(NUE)
MIRT-,35JT::G1P\\3-U*</90E"$N6<U&52\VHVI1?M)*_,XQ:C=V.DE\4^&(
M+=KN?Q3X;AM$U.YT1[N;Q#I$5JFMV2RR7NBO</>K"FL6<<$\EWI3.+^UC@G>
M>WC2&0K6U[QMX,\*Q6$_BGQGX2\+P:J2NE3^)/%&AZ##JC!$D(TR75K^TCU
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MFF:)';J@^J]Z^OZ'_"GZIK??U_4E[]_^&7ZW^XM;_P#:_P#'O_KT;_\ :_\
M'O\ Z]5=Z^OZ'_"C>OK^A_PH LL_!^;L?XO;ZU]/Q_\ (IIW_P"*?'X_\2[W
M_K7RLSK@\]CV/I]*^J83_P 4FA_ZE\'_ ,IWO_6N3%[0]9?DC>AO+T7YLK^$
M8EF\&^'X7SLET*QC< D$I)9HC $<@X)P1R#62/AEX3  %M=X P,W]R>GOOK:
M\%_\BEX;_P"P+IW_ *2QUTU<D9RC?EE*-][.U_4Z'%2W2=NZN<!_PK/PI_S[
M7?\ X'7'_P 51_PK/PI_S[7?_@=<?_%5W]%5[6I_S\G_ .!,GDA_+'[C@/\
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MU/\ GY/_ ,"8<D/Y8_<<!_PK/PI_S[7?_@=<?_%4?\*S\*?\^UW_ .!UQ_\
M%5W]%'M:G_/R?_@3#DA_+'[C@/\ A6?A3_GVN_\ P.N/_BJZW2=*L]%L8M/L
M%D2VA+E%EE>9P9'+MF1R6.68GD\9P.*TJ*ESG)6E*36]F[ZC48IW44GW2U*>
MHV4>I6%YI\SR1Q7MM-;2/$5$BI,AC9D+*RA@&."RL,]01Q7G?_"J-!P!]NU7
MC_II9C]!9C_ZU>H44XU)PNHR<;ZNW7\&#A&3O**?37M]YY?_ ,*HT'O?:M_W
M]M!_[:&D_P"%4:#_ ,_VJ_\ ?RT_^1*]1HJO;UO^?DOO7_R(O9P_DC]W_!/+
MS\*-![7VK?C+:'_VT%'_  JC0?\ G^U;/_76T_E]C_K7J%%'MZW_ #\E]Z_^
M1#V</Y(_=_P3R[_A5&@][[5?^_MH/_;0T?\ "J-!_P"?[5?^_EI_\B5ZC11[
M>M_S\E]Z_P#D0]G#^2/W?\$\O_X51H/:^U8?]M;3_P"1!0/A1H/>^U4_]M;0
M?^VE>H44>WK;>UG;M=6^ZP>SI_R1^Y?UU?WGEW_"J-!_Y_M5_P"_EI_\B4?\
M*HT'M?:K_P!_;0_^V@KU&BCV];_GY+[U_P#(A[.'\D?N_P"">7GX4:"1_P ?
MVJ@_]=;3\_\ CT_K_6C_ (51H/>^U;_O[:#_ -M#7J%%'MZW_/R7WK_Y$/9T
M_P"2/W?\$\N_X51H/_/]JO\ W\M/_D2E/PHT'M?ZM[YEM#TZ?\N@Z5ZA11[>
MM_S\E]Z_^1#V=/\ DC]QY?\ \*HT'_G^U;/_ %UM/P_Y=/ZTG_"J-![WVJ_]
M_;0?^VAKU&BCV];_ )^2^]?_ "(>SI_R1^X\N_X51H/_ #_:K_W\M/\ Y$I?
M^%4:#VOM6_[^VA_]LQ7J%%'MZW_/R7WK_P"1#V=/^2/W?\$\O_X51H/>^U;_
M +^V@_\ ;,TG_"J-!_Y_M5_[^6G_ ,B5ZC11[>M_S\E]Z_\ D0]G#^2/W?\
M!/+O^%4:#VOM5_[^VA_]M!2_\*HT'_G^U;/_ %UM/Y?8_P"M>H44>WK?\_)?
M>O\ Y$/9T_Y(_=_P3R\?"C0?^?[5OPEM!_[:&O0-+TZ+2=/M--@>22&SB$,3
MRE3(R*207**BEN>2JJ.!A16A14RJ3G93DY).ZO;?[D-0C%WC%)M6T[;E:[M+
M:_MY+2\ACN+:8 2PRC<D@5E=0PSR RAA[@'M6)_PA_AC_H!Z?_WX'^-=)14J
M4EM)KT;7Y-#LGND_5)_FCF_^$/\ #'_0#T__ +\#_&C_ (0_PQ_T ]/_ ._
M_P :Z2BGSS_GE_X%+_,++LON7^1S?_"'^&/^@'I__?@?XT?\(?X8_P"@'I__
M 'X'^-=)11SS_GE_X%+_ #"R[+[E_D<W_P (?X8_Z >G_P#?@?XT?\(?X8_Z
M >G_ /?@?XUTE%'//^>7_@4O\PLNR^Y?Y'-_\(?X8_Z >G_]^!_C1_PA_AC_
M * >G_\ ?@?XUTE%'//^:7_@4O\ ,.6/\J^Y?Y'-_P#"'^&/^@'I_P#WX'^-
M'_"'^&/^@'I__?@?XUTE%'//^>7_ (%+_,.6/\L=-%HO\CF_^$/\,?\ 0#T_
M_OP/\:/^$/\ #'_0#T__ +\#_&NDHHYY_P TO_ I?YARQ_E7W+_(YO\ X0_P
MO_T ]/\ ^_ _QH_X0_PQ_P! /3_^_ _QKI**.>?\\O\ P*7^8<L>R^Y?Y'-_
M\(?X8_Z >G_]^!_C1_PA_AC_ * >G_\ ?@?XUTE%'//^>7_@4O\ ,.5=E]R_
MR.;_ .$/\,?] /3_ /OP/\:/^$/\,?\ 0#T__OP/\:Z2BCGG_/+_ ,"E_F%E
MV7W+_(YO_A#_  Q_T ]/_P"_ _QH_P"$/\,?] /3_P#OP/\ &NDHHYY_SR_\
M"E_F%EV7W+_(YO\ X0_PQ_T ]/\ ^_ _QH_X0_PQ_P! /3_^_ _QKI**.>?\
M\O\ P*7^8679?<O\CF_^$/\ "_\ T ]/_P"_ _QK1U"*.'1[Z&)!'%%IMU'&
MBCY4C2UD544>BJ  /08K3K/U;_D%:G_V#[S_ -)I:3DWNV_5M_FV"26R2]$E
%^21__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>ea028514801_img20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img20.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +* RH# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2*_XB-B>F74[K>]2IIYO2Z5_0_U3O^'GG_!.C_H]_P#99_\ #V> ?_EU0/\
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MVX/V62/;XV^ ?_EX<U_E8^6HS\J<=>%XZ=?S_P X-'EKUVI^2_RZTO\ B$F
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M^=M;=['^J;_P\\_X)T?]'O?LL_\ A[? /_RYH'_!3S_@G5SC]M_]ED?]UM\
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MW\NMC_5-_P"'GG_!.C_H][]EG_P]G@'_ .75 _X*>?\ !.KM^V_^RP/^ZV^
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M.J+_ -\C_"E_Q"3 7_Y'6,_\$4__ )(;\1L2]LNHK_'4J<OSLK^GG8_U3?\
MAYY_P3H_Z/>_99_\/;X!_P#ES2C_ (*>?\$ZNW[<'[+ _P"ZV^ ?_EV/;U_3
MG_*PV)_=7_OD?X4NQ3C"+[_*/?G^0I_\0DP/_0YQO_A/3_S$O$;%]<OP;77D
MJ5^;Y75OOZ'^J<?^"GG_  3K'_-\/[+!Z_\ -;? /OCIKA]OY>F3_AY[_P $
MZL\_MP?LLX_[+=X!Y.2!G_B=^GZ_AG_*Q*=?W2=_X5_VO_K8_#TY"B]T0=>
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MM/$>LZ\VDZ?;VVC'2-8N[Z6UF=]^IS2PO?W4SRR&,\_^UW_P4Y\*?L _M^_
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M.36M0;;TAT_3H[BZG?K'!$SC&*_IJ_X+-?MP:#\"_P#@L-^Q'J%Y:C6/A_\
ML<:/X2\3>+-(TB.%[FU_X6#KIF\5:?IMDS) NJV7@_0_#MW8!W18C<01@A1F
MIS[,\SHYWE."R^K)5U@\VS'%8=<MJD*=&I'#4973:4Z[I-*\;N-KHSR?!8%Y
M7F>,Q\?JZ6)R_ 4:Z3;IJHXRG.*6KM!.,G%2TG=JZ+?P\_X-=O 7AOPQHNK?
MM._MIP^%/$^JV,2W?AWPEX<\/:9X>T_6)$#_ &33O%?BOQ!8WFNFW>7RI571
MK59F#>2X602M\'?\%*_^" GQ(_8B^$>H?M%_"/XL+\??@]X:CM+GQU#>>'5\
M.>-_!VG7\XBC\2VUMIVI:QH^L^$[7S+7^UM0CU&"[LX[@7OV&/3X;BY7^ES]
ML3]A3]BS_@MYX ^&'Q/\*?M%:G)=^%-$U1? /B_X8^)-+\1Z/:6>OO;W%_#X
MH^'6HW,2_P!KV-S:Q12"XFT;5;1ENK&\,@V)%^6G[?/P:_X*Z_L'_L$^(/@A
MH/Q-^%7[3_[%FA_#O6_AGXRUU_AWJLGQO\)_#36EO$GU#QI)J.NW$<^D:7!?
M#3;35] CU"/PUI5O:K?1P6MI#-7PN4<3YW6QV7NIQ#46.J8U8?,<FS/ K!1I
MTW6Y']3K.G^\J.FVX<TJ<F_<7/S:_8YAD.5TL'B_9Y'2>$HX"I7P68TL:\5.
M6)C3<XRG3YG[.+:]Z23LF]$C\Q/^"='_  1-TW]O3]CGQQ^U?=?M%ZK\,+KP
M?XM^)OA>'P/9?#?3O%%KJ"_#KP]I6M)>_P!MS^*=(FLY-7;4_LDT":?=+;I;
M^>DDQE\M/P-MYC<003D!?M$$4V!G[SHA<\J&!!(&PX"CD!BY*_WF?\&[H'_#
MH#XU@<;/BW^TJFW.[!7P#X33!;NV%RW?<>23\S?P7Z>"-/L^>/L\'; _U*8/
M'K_+IQ7W/#6:8S'9UQ7A:^*E/"Y=F,:. ARI*G0G?GBN57:^)MSNVW>^MCX_
M.L#AL+EO#N,PV&4)8[+IUL2TV^;%1G'V<FGM9<RLE;NKNY^D_P#P2]_8$M?^
M"C?[16I_ >\^)]]\)8-,\!:QXV/BC3_"UMXNGE?3+B"V33#I=WJVBQ+%<M<9
MDN#>AD5<+&Y.*\O_ ."@'[)5O^P]^U7\1_V:[3QU<?$BW\"P^'9HO%]YH</A
MNZU1=;TF/4F$VC6^HZK;VAMFE\@&*]G$H7<2A^6OU@_X-BB/^'A7BH$\'X#^
M*OK_ ,A.Q)_+&._2OF7_ (+[#_C:9^T%QUT[X??B?^$6MOZ8Z4Z.:XR?'.+R
MN6(<LOIY/"KAZ/*K>T<X^_?EYKOWD[Z62>F[5;+L.N%:&9*BECZN:3IXFI=W
M5-1=HV3:25XO776Q^-M%'3KQ1_7D?3UK[2S[/[G_ )'S-];=>W7[MPHHHI %
M%%% !1110 4444 %!^ZW^>Q_P'Y"B@_<;\/Y-0]G_78'L_1_DS^C;_@U[_Y2
M(^._?]E/XA9]_P#BXOPGZ^M?Z "_Q?[QK_/_ /\ @U[_ .4B/CO_ +-3^(7_
M *L7X3U_H!5_./B3_P E;B?^P3"_^FV?M_ O_)/X?_KY5_.(4445\*?8A111
M0 P??;Z?X5_G[_\ !T!_RD:\(?\ 9K'PV_\ 4^^+-?Z!(!WD]B.OY5_GZ?\
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M(_&C]B__ (*2^(?V=-.L4D7Q-!X'\2:?$=>\-ZE+!<:GIGB?PG=:IIU]X?\
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M=2G4IJ,9.=.I!*:O!N<)P7-Y)R3?H5!I3@^91M.$N9VLN6<)7W[)KYG]Y?\
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MBKZ-2C!-1?9Z\NOSKXR\)>)_ 'BWQ+X%\;:/>>'?&/@W7M3\,^)M#OH7@O\
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M\/Y-10?NL.YQ_)J3V?\ 78'L_1_DS^C;_@U[_P"4B/CO_LU/XA?^K%^$]?Z
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MC_1NOI3O^(<K_@JW_P!$H^$9_P"ZZ^$__D6O]&ZBC_B*?$W_ #ZRY>F E_\
M-8?ZA9'_ #8[_P 'T?\ YD/\X_\ XAR?^"KO'_%I_A!QZ?'7PIQ]/]&ZT[_B
M'*_X*N?]$H^$1^OQU\)X_'_1>E?Z-O/M^?T]OK^GKPO/^3_];Z_YZ'_$4^)O
M^?67_P#AOE_\UA_J%D?\V._\'T?_ )D/\Y#_ (ARO^"KN1_Q:?X0<=Q\=?"F
M1]/]&[=J7_B'*_X*N?\ 1*?A'^/QV\)X_'%K7^C=11_Q%+B7_GUEW_AOE_\
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M?;_./_K_ *4?\13XF_Y]9>O^Z?+\?]K#_4+(]N;'?^#Z/Y?5+'^<A_Q#E?\
M!5W.3\)_A!]1\=?"F?PS;4O_ !#E?\%7/^B4?"/\?CMX3Q^.+6O]&W(]1Z]>
MWK2T?\12XF_Y]9=_X02_^:P_U"R/^;'?^#Z/_P R'^<A_P 0Y7_!5WO\)_A#
MCV^.WA7/ZVV*7_B'*_X*N?\ 1*/A$?K\=?">/Q_T7I7^C=S[?G_];Z_Y/!S_
M )/_ -;Z_P">A_Q%/B;_ )]9?_X;Y?\ S6'^H61_S8[_ ,'T?_F0_P Y ?\
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M9_#-MBE_XARO^"KG;X4?"+/O\=O">/TM<U_HW4?2C_B*?$W_ #ZR[T^H2_\
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M1^OQV\)X_2U%?Z-U(3[CMU],_P"<>]'_ !%/B;_GUE_I]0E;_P!2P_U"R/\
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M4?"(_7X[>$\?I:BO]&ZBC_B*7$W_ #ZR[_P@E_\ -8?ZA9'_ #8[_P 'T?\
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M^+-5\,:!J7BCPW;W)O;?0/$=_I%K<:YHD5X0OVN'2=3ENK"&Y**;@0+*RKO
MKKJ_F!_X+@^._BM^PM^VA_P33_X*6>%/&OQ M?@1X=^+UO\ LU_M6^!-,UO6
MYO!5YX ^)<LMOI/C#5O#(O4\.+?6%O<^(=/M=6N[(W*ZO/H2),DD<>6_\%%_
MB;\0_P!L;_@LS_P3K_X)S?!GXA>+_#?PU^#-I<?MI_M7:CX"\2:WH4&L>$--
M!_X03P?K.M^&KZV-QI/B2UL[W3WTV]>6TFF\4:+<^6Q,$@ /Z@*X?XF^+9O
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M)XO$6D>'6L=%NVDTR.REU;2[N6:\_P!)CFD_LKHH _BP^&7_  23_;/^*/\
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M>D^&_#5A+_9GAK2(II8;&W:Z93NNG"@'Z,4444 %%%% !1110 4444 %%%%
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M ?U]?\,B?"S&?[:^*N.>?^%M>-,<=1G^T\9'<=NIXIW_  R%\+,$_P!M?%;
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M[D6EKXJ\+ZD[S6L5^MI<-8W-G<WUG(]M<6DEU%=036T/PU\=_P#@XT_X)O?
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M(OB>;M(1</:CXO>,#<I;L[1K.T U8RK"TBM&)"FPNK("6!%?FW^S)_P<+?\
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MDD_%CQI@#U.-4/'O7\XW_!;_ /:L\'?L?_\ !87_ ((Y?&7XP_$W7OAW\!?
M_A_]H7Q'\4);*_\ $3Z-?V5MX2UVRTF&_P##.CO*/$%]<ZO=Z?I>DPW5C.QO
MKZ&,RV\$DLT7Z@?LA_\ !=[]@G]LCXZ:9^S;X2U'XR_!OXV>*=)?7?A[X%_:
M3^$VK?!_4?B=I)AO+Z*\\!2ZG>:A::RMU965Y?V,$TNGWFH6EG<FS@N9(GA!
MI_2_X<#[X/[(?PK[:W\52>F/^%L>-A[\DZEQQSSVI#^R)\+1P=9^*H/8'XL^
M-03] =2R?P]1ZUYQ^S1_P4._9Q_:O^.W[4_[-7PLU#Q?:?&/]CKQ?;>"/C-X
M4\9^&)O#%S;7U[?:UIMAJWAF2XOKE?$OAR]NO#^H-#K%OY4<ENUA*4$.H6LD
MNAH?[?O[._B']NGQ;_P3N\.ZEXKUW]H[P!\*;/XS>.K/3?#,DO@GP?X0U*31
M?[.M->\6_:EM['Q!>P>)-#NK/1#:O<W%KJMK=%RK2/$77]) =N/V1/A8<?\
M$Z^*I!.!CXM>-#DYQQ_Q,^>2!UZG'7BG_P##(/PM_P"@S\5^.O\ Q=CQJ<?@
M-4)_2OF/_@L%^V.W[#'_  3\_:.^-FCR^/-/^(,OPT\>>#_A'X@\!^"KOQO=
M^$_BYKG@+Q--\/\ Q1XCLK<-;:+X4T#7+*TO]>\4:JK:5I$"K->!E*12?RZ?
M$K_@HEKG[6'_  :K?'K4%\:_M!W7[1?P0\,?LT6OQH^+WCS2/%7A"^\8>,/'
MW[3?AZZ;6O WQ%DN(6\>6$MAIMY8ZQJ6BW$:6T$UOIUY&([H(YIY_=_P?Z]
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MG.,9YSUQCUQSCK2NNZ^]?YL9\NG]D/X6=M:^*Q_[JQXV'_N2I/\ AD3X6_\
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M[N(_#G_!!'PO_P %H%_X)V^&M3_84\+_ /!,KQ!\'?'?C;XFWWBS6/C?J?Q
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MH>#V\*>$;[1C=M#;^#4TK1K'5Q;2?;&6X&NZGJTI6./RGC?S&:G^S7_P3G^
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M/V$"X'G?\,G_  31CG.6_P"$!T8 (.A#E7((Y*A>HK\5=<_X-@_@)X_^&:?
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M'B[PMXTTBU\1>#/$N@>+_#U\@DLM=\-:OIVN:3=H?XK74-*N;FTF4 @$)(S
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M6&?V-/V>EY;P-? 9QD^+/% YZXYU7KCFF_\ #&_[.XQGP1>#GOXM\3]C@_\
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M^%;XI_\ EI7U%13O'HG]S_R(]_NOP_R/ES_AC;]GG_H1[W_PK?$__P M:/\
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MJZ7I>K>(+:RU#Q'XB\0V5I;MXKM[G1-6O(VNOM#7'JWBM4G=>I\7^\[K\/\
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M],L0\>GZ1X[\,0ZEH$GB*UTZ.>>"RN;'6]'O'L)I=.U"YO=,_P!!KX:\0_\
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M.9=G]S(=[_WF_P"^C_C1O?\ O-_WT?\ &I/*ST#?E_\ 6IQ@8<E) /4J?\*
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M^Q;\6_'_ ,>/^"A7_!/CXS^#M1\2> _VH/'?AS6/$7BW]GKQ)9"^:+2?B?\
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M_P#6H%==U]Z_S/EK_AE9#_S</^TW^/Q.4C\0-%R1ZXYH_P"&5(Q_S<3^TO\
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M  RK&/\ FXC]ID_[GQ-"_GNT8_I7U(6)]OID?UI0S<XR?KDXH ^6C^RM&?\
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M?8PZ,9FN-4OO"NLZ=J]YX3O9M8TWQ#:2:9JVEQ_U?W/[)?P(_9\_X+%>)O\
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M36*[3\R?]]KZ_6@Q2=UH]UT??T(J<GWA^/\ (TWC^\O_ 'TO^-.4C</F7O\
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M)Q<+_P!<AV)_B/I5P^+Y,#Y*_P"&1?AY_P!#?\9O_#H:U_\ $TO_  R1\/\
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MKU'8^H]J"[KNOO7^9\L_\,C?#SMXP^,V>W_%S]:_^)I?^&1_A\>#XQ^,O/\
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M^%!;>CV^\^6/^&1OAX.1XP^,P/\ V4_6C_[+2G]D?X?'@^,?C-CV^)VL@_\
MH)_E7U/100INZT_/_(^5O^&1/AY_T./QG_\ #GZQ_P#$4?\ #(OP\_Z'#XS_
M /AS]9_^(KZHR/?\C_A1GZ_D?\*"V]'M]Y\L?\,C?#P<CQA\9@?^RGZT?_9:
M4_LC_#X\'QC\9L>WQ.UD'_T$_P J^IZ*"%-W6GY_Y'RM_P ,B?#S_H<?C/\
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M\<$:L\BJ?R _X(/V/QM^-'[/_P 2?^"C7[2'B;Q7J/Q<_P""A?Q&U/XI>'/
ME_XAUJX\(_!GX$^&;[4/"_P<^'W@CPS>7!TC1;>;0[6?Q)=ZYI&G6ESXFM-8
MTF]U>*XOK:2:X"8MM6=[^A^F"_LA_#YSM3Q?\:';;NPGQ.UECM]<+&>/Z\=:
M\Y^*/_!.?]FSXV>&H_!/Q?L_'_Q(\(1:SI/B >%_&/CO4=:T)M;T*[CO]%U&
MYTN\AEL[B?3+Z**[M3=03K#<1I-&@F1&'\MG_!RQ_P %7_C[J-QXR_9*_8-\
M4^-O#/@C]E[Q#\,/$O[<7[0_PN\2ZAX3D\+>+_&GB_3=!^&7P,T7Q=H=]I^H
MP:A/JM_'K'C#3M$O$O+Y;)=.NUDTW2?$T"_O1_P4X^+G[>_@/_@G!X&;_@GI
M\.?&?Q(_:F^+%A\(O =IXO\ "FAGQCKOPMT+Q3X?M+GQ?\6;K3+I;NVDGT^V
M@GLK74M2BO+73=7U.'5;JWNHX3"ZYD[[??\ U^!9][#]D#P&JY_X2OXT( 2
M/^%E:VBB/CR\KY:Q)L&8U2,+M0)O4L=QB'[(_P /7R/^$R^,I(42;1\4-8#;
M.?G"D%B@P<L!A<<D=_Y9_P!OK]@C]LW_ ()-_L>ZK_P40^%G_!73]K+XB?M
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MVFMEI;^OZ_/R)E=ORZ:/_(NT'D$>M4OM]G_S^V'_ (&VW_QZE^WV7_/[8_\
M@=:__':8K/L_N?\ D6\'U/Z?X48/J?T_PJI_:%E_S^V/_@=:_P#QVD_M&Q[7
MUA_X'6O_ ,=H'>7=_=_P"[15+[?9_P#/[8?^!MM_\>I?M]E_S^V/_@=:_P#Q
MV@5GV?W/_(MX/J?T_P *,'U/Z?X54_M"R_Y_;'_P.M?_ ([2?VC8]KZP_P#
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M]W_ +M!&?\^G-4OM]G_S^V'_ (&VO_QZE^WV7_/[8_\ @=:__':!6?9_<_\
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M%VD(S[8__5W^M4_M]G_S^V'_ (&VO_QZE^WV7_/[8_\ @=:__':!:KH_N?\
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M? [MI?BK/;/C#7L?C_I%)_PQ_P#!#OI?B<CO_P 5CKW3O_R\U].[O]EORIU
MN:7=GS!_PQ]\"_\ H$^*?_"Q\0?_ "51_P ,?? SMI/BG_PL=?\ _DJOIW=_
MLM^5.H^?Y#Y_+\7_ )GS#_PR!\#NVE^*L]L^,->Q^/\ I%)_PQ_\$.^E^)R.
M_P#Q6.O=._\ R\U].[O]EORIU N:7=GS!_PQ]\"_^@3XI_\ "Q\0?_)5'_#'
MWP,[:3XI_P#"QU__ .2J^G=W^RWY4ZCY_D/G\OQ?^9\P_P##('P.[:7XJSVS
MXPU['X_Z12?\,?\ P0[Z7XG([_\ %8Z]T[_\O-?3N[_9;\J=0+FEW9\P?\,?
M? O_ *!/BG_PL?$'_P E4?\ #'WP,[:3XISQ_P SCX@_^2ORKZ=W?[+?E3J/
MG^0^=]OQ?^9\P_\ #('P.[:7XJSVSXPU['X_Z12?\,?_  0[Z7XG([_\5CKW
M3O\ \O-?3N[_ &6_*G4"YI=V?,'_  Q]\"_^@3XI_P#"Q\0?_)5'_#'WP,[:
M3XISQ_S./B#_ .2ORKZ=W?[+?E3J/G^0^=]OQ?\ F?,/_#('P.[:7XJSVSXP
MU['X_P"D4G_#'_P0[Z7XG([_ /%8Z]T[_P#+S7T[N_V6_*G4"YI=V?,'_#'W
MP+_Z!/BG_P +'Q!_\E4?\,?_  ,'32O%(/K_ ,)CK_\ 6Y(KZ>#9/1A]12DX
M]3].M'S_ "'SOM^+_P SYA_X9 ^!W;2_%.??QAKV/_2BD_X8_P#@AWTOQ.1W
M'_"8Z]_2YS7T\&R>C#ZBE)QZGZ=:!<TN[/F#_AC[X%_] GQ3_P"%CX@_^2J/
M^&/_ (&#II7BD'U_X3'7_P"MR17T\&R>C#ZBE)QZGZ=:/G^0^=]OQ?\ F?,/
M_#('P.[:7XIS[^,->Q_Z44G_  Q_\$.^E^)R.X_X3'7OZ7.:^G@V3T8?44I.
M/4_3K0+FEW9\P?\ #'WP+_Z!/BG_ ,+'Q!_\E4?\,?\ P,'32O%(/K_PF.O_
M -;DBOIX-D]&'U%*3CU/TZT?/\A\[[?B_P#,^8?^&0/@=VTOQ3GW\8:]C_TH
MI/\ AC_X'_Q:7XH([@>,=>S^ESGK7T\&R>C#ZBE)QZGZ=:!<TN[/F#_AC[X%
M_P#0)\4_^%CX@_\ DJC_ (8_^!@Z:5XI!]?^$QU_^MR17T\&R>C#ZBE)QZGZ
M=:/G^0^=]OQ?^9\P_P##('P.[:7XIS[^,->Q_P"E%)_PQ_\  _\ BTOQ01W
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MWM_%?C?3M5M?V>]*EUJ^%RFG>!/ G@ZZTKQ%H&A3&2RTI]9OM/A @\E4;?\
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MU_T,OAS_ ,'^D?\ R91_PDGAK_H9?#G_ (/M(_\ DR@+/L_N?^1O;QZ']/\
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MW/\ R-WS/;]:7>/0_I_C6#_PDGAK_H9?#G_@_P!(_P#DRC_A)/#7_0R^'/\
MP?:1_P#)E 6?9_<_\C>WCT-)YGM^O_UJP?\ A)?#7_0R>'?_  >Z3_\ )E+_
M ,))X:_Z&7PY_P"#_2/_ ),H"S[/[G_D;OF>WZTN\>A_3_&L'_A)/#7_ $,O
MAS_P?Z1_\F4?\))X:_Z&7PY_X/M(_P#DR@+/L_N?^1O;QZ&D\SV_7_ZU8/\
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MA#Q/@:]X1U6>2XDMM:T6_=KFXABGV'39[_46M_EO;@'Z$_8C_9)_9F_X)_?
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M]WT?^1N^8.X_K_A2[QZ']/\ &L'_ (23PU_T,OAS_P '^D?_ "90?$GAH?\
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M@[_P'O?_ ).KW+SQ_=/YBCSQ_=/YBCEDOL_U]X<TN[/#?^&8/V>_^B/>#O\
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MSQ!OV8?V><<?![P;GVM[_P#KJ!'Z4S_AF']GK_HC_@T<@<P7@Y)  YONI)
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M_P#Z/2_9&_\ $EO@M_\ -M1SQ_FC]Z"S[,^I:*^6O^&Y_P!A_P#Z/2_9&_\
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MW_B2WP6_^;:CGA_-'[T%GV?W'U+17RU_PW/^P_\ ]'I?LC?^)+?!;_YMJ/\
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M_P!'I?LC?^)+?!;_ .;:MH2BHI.2OKI==6WM<AIW>C^X^I:*^6O^&Y_V'_\
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M0:_0[<N P964J'#(RNI0@$,&0D$,K!E(."IW#(YH) '.<_W<$MGC(* ;@02
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M?\PN_P"DO\C\\?\ AT7_ ,$L?^D>/[(G_AE?"'_R#1_PZ+_X)8_](\?V1/\
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M?LA_^&4\(?\ R!1_PZ*_X)8?](\/V0__  RGA#_Y!K]$**+1_E7X_P"87?\
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MA_\ AE/"'_R!1_PZ*_X)8#I_P3Q_9#'_ '13PA_\@U^B%%%H_P J_'_,+O\
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MV1#_ -T4\(?_ "#7Z'T4:?RK\?\ ,.9]W_7R/SO_ .'17_!*_P#Z1X?LA_\
MAE/"'_R!1_PZ*_X)8#I_P3Q_9#'_ '13PA_\@U^B%%%H_P J_'_,+O\ JW^1
M^=[?\$B?^"5[*0W_  3Q_9#(P2 ?@GX0(+#E<_Z$,8;!)]L#!((ED_X))?\
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M$ $CS "N6K^FRY93/<=_WTO'(S\[<9 R,^HZ5<$TW>^EUJO)>02M?3KU^?\
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M*O'O@A/#W@#2?&/QB3^T9)? VEZ-K.MZG!&-+M(1KTC)IPM[)KN7]M_^"O\
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MIRMXCN?$FKZ5KMS:WOA/PO<V\G]E[=?66_>_\/VVKW5FEQ?20?GE\??VT?\
M@M7_ ,$R/A[X,_;*_:C_ &I?V+OVV/@18^(?!MC^T;^SY\*_"/@KP3XU^%VD
M>-=6TSP^VH?#CQ;X8AM-=\8+HNJZE!!]OU"&2R6]6WN=1T>;3)+^6'XY_P""
M@G[*O[<7[0?_  1+_P""5W[1G[5WPH^)7[0'Q=_9.^(#?$']J7X.3S^)+'XN
M>+_V>/$7B._@TZXUV'25'BJW\70^ -+\'VGBS4;>.VU[0H=4U36K]HKRQOY:
M^5?CIX@_X-O_ !C\/OAIX4_X)T?L2_%K]M3]KCXRZ_X9T7P[^S;??$;]KKPU
M+X1&J7-M)KP^(&HW?B7^S6OM&A$UG$?"VI:WI=M>M!JM_JT&F65U<%NZ>S6B
MM=-:VUTMKZ+[EN)1TZ=;[/\ X;0_=_\ X*4?\%7OV@[;]L7]BO\ 8L_8W^/?
MP&_8^\+?M5? '3/VCKO]LS]I3PUH&M^%(/"OBO3M8O\ P7X/\-:9XO;_ (1.
M+7[VSTI5NH=7G26?4-=T2UM-0T]O,6\^M/V _BG_ ,%>?!O[0GQ/^"W[>6B?
M#3]J+]G6S^$]Q\2_@]^W;\!]#\'>#?"_B;4[*+[0O@'6O#>A:K;0W%WK5I;:
MDL4FF>'+Z33=0M[!I-3GL=4!@_-;_@JO\0_V/?@AXQ_8<_8]_P""I/\ P3[T
M!O\ @G[#^S3X2\-^#_VJ/".I?$7Q5XJ_9X^)^@>%8O#VH_"'2/&_A4Q^+O[
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M^FW<=O<WYTFZ$D8)T_RY(Y3=-6NM=I)>;[>OEOU%+5NWWF;_ ,%8/VB?B?\
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M,')QC(QUR,CCK@YZ<TU%MV2;?9?\.-TZB5W3J)+JZ<TOO<$A:*:'4G .2#C
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M-/&\MG*0 C2V_ER':"6;@U;W#KD'VR.?S!'/N"/4&OF#_A5_[3'_ $=!9_\
MAGO"W_R51_PJ_P#:8_Z.@L__  SWA;_Y*I<S[O[V'+_>C]Y]*1V.G0S3W4%C
MI]M=W+1M=WMK9VEO>WQC#"/[9>0P175V(]QVK<S.B\%(QP!9(3!Z?G_^O^1K
MYB_X5?\ M,?]'06?_AGO"W_R51_PJ_\ :8_Z.@L__#/>%O\ Y*JO:/L@Y?[T
M?O/HR\T?1-2=9-3T30-3E$8B$VJZ)I>J3K&J_+&)KRWEF6- "BQB4H-V[:2T
MFY;/2-&TV59]-T3P_IDP.5GTS1-'L;E% VB-+BVLHIDS@!L2%BO"RJ.!\Y?\
M*O\ VF/^CH+/_P ,]X6_^2J/^%7_ +3'_1T%G_X9[PM_\E5-WO?\_P#,D^G1
M@$ ,$ SM(&WDC<"S1NK*,M("<2,[[2Y*DL<;7O#GAOQ5ITNC^*/#V@>)M(N"
MWG:5XBTG3M9TUNVXV6H6]Q 9&!(9PH<J2 Z E#\]_P#"K_VF/^CH+/\ \,]X
M6_\ DJC_ (5?^TQ_T=!9_P#AGO"W_P E5?M)=E^/^97+_>C]Y]"6OASPS8Z=
M9Z-9^&O#=IHU@4:TTFUT/1H-.M)(XE$-Q:64=@MI;W*KMA>:.+S%\H^6QC8J
MT7B/PKX5\8Z:=(\8^&?#?BS2CM+:;XET32M>LS(&C<M#;ZK:74< W*,A"#B-
M!AMB&O /^%7_ +3'_1T%G_X9[PM_\E4?\*O_ &F/^CH+/_PSWA;_ .2JGF?=
M]&]>W]/[R3Z1TW3-+T:RATW1-/TW1=.MMJPV&E6%GI=G'&$54"6VFQ6T E0P
MQ,9EB1LJJ!=@79S\_@+X?W7B!?%MSX$\%7'B<1FWB\1W'A+P]/X@2%AN=)-3
MDLC=,"1Y9E6<.P;YDQDUX=_PJ_\ :8_Z.@L__#/>%O\ Y*H_X5?^TQ_T=!9_
M^&>\+?\ R53]I'^5_=_P.^H'T\VTB0.5E$D961&V&.0. 'BDC 1'A,>8W5N7
M).\N-SMRVE>"/ ^@ZO>>(="\$>#-%U_43NU'6=(\-Z+I>J7S?>5I]1LK"*[W
M1MA0RR@E=VX2'YCX5_PJ_P#:8_Z.@L__  SWA;_Y*H_X5?\ M,?]'06?_AGO
M"W_R52YI=W][ ^B]9T30?$EA/H_B+1M'\0Z/=#;<Z9KVEZ;K%A/GS.&L]1MK
MF'"AU3S!EV1?+9&7FH]#\/\ AWPSIL6C>&M"T/PWI,$<4<6E^'](T_1;!!$K
M>4!;Z9#:Q%8<O%&K(7C29RDV"T<GSQ_PJ_\ :8_Z.@L__#/>%O\ Y*H_X5?^
MTQ_T=!9_^&>\+?\ R52YI=V![EJG@/P%KFKV'B'6_ _@K6?$.F%CI^O:KX3T
M"_UBS+(4(M]1N;22]B38 A1;CYB <A J)T=S:V-W;_9;JPL+RS(C'V"]L[.\
MLRMN0( ;:YMY;2/RB?-B$<!"%$1"FW<?FK_A5_[3'_1T%G_X9[PM_P#)5'_"
MK_VF/^CH+/\ \,]X6_\ DJGS2[O7?5@?2EQ9:?=PFTN[+3[NT)0M:7FG65W8
ME8F#6ZBSGCDMF-NZ+)!YD!,)V[""D85UQ::==6[6EWIUC>6)\DFQN[2SN[%C
M" 83]AN89+8_9I%5XMR9B'$+C:FWYI_X5?\ M,?]'06?_AGO"W_R51_PJ_\
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MVM_*V8.WE237S3_PJ_\ :8_Z.@L__#/>%O\ Y*H_X5?^TQ_T=!9_^&>\+?\
MR53]H^R^[_@E<O\ >C]Y],6\%I:0QV]G;6MC;1;EBM;*VM[2VC4G($-O J10
MH!G<J+DD_>/)J?(]1^8KY@_X5?\ M,?]'06?_AGO"W_R51_PJ_\ :8_Z.@L_
M_#/>%O\ Y*I<\N_X(.7SC]Y]/DJ>"1^=( @.01^?_P!>OF'_ (5?^TQ_T=!9
M_P#AGO"W_P E4?\ "K_VF/\ HZ"S_P##/>%O_DJGSOR)/I_(]1^8HR/4?F*^
M8/\ A5_[3'_1T%G_ .&>\+?_ "51_P *O_:8_P"CH+/_ ,,]X6_^2J7/+O\
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M<(MNT8W$8 Z3#&8V?-&AEU1<J;:KU\+1Y8[)SC2=2R]%)=+!+(>%J#?UWCC
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M7E*)^K!P<9.,C.,']0<'('K\Q'.*5=@/##.,'D<]\XS^6/QYK\?_ (4_M/\
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M^9OR".?I1<\Y&,' X &,9XY).,X).,D'  KFG\3^1M#X5\_S'4445)04444
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ME+36!XQ_GH?0]P/;U]0XRE=75O.S$[V?+%2ETC)\L6_-]+;_ "7<3)Z@<\9
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MP_LI? "'0VWHP;2$^&'AI-/)C1O+(DM$C$;HX$B_.-Z*,]S^U7^S]X5_:O\
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M?F8?6*2=G2::W7,[K\3P;_AK#X$_]#=>?^$SXB_^5U+_ ,-9? K_ *&^]_\
M":\1?_*ZO>!IVFG!&FZ:<D 8LK8\L&(Z1\9",>>V#W%..G:7S_Q+].RO4?8+
M?_XW_*E>/\OXO_,7UFC_ ,^G_P"!/_,\"_X:R^ __0WWG_A,^(O_ )6T_P#X
M:R^!7_0WWO\ X37B+_Y75[R--L &/]G:<V Q(-I!D;>I'[GL2,]L\'D&@Z=I
MP!8Z9IRJ!DDV-L!C&<Y\OIV^O'6B\?Y?Q?\ F'UFE_SZ?_@3_P SP7_AK#X$
M_P#0W7G_ (3/B+_Y74O_  UE\"O^AOO?_":\1?\ RNKWG^SM.P3_ &9IPP S
M9LK7Y0<?>_=\'!!P><<].:7^SM,_Z!^G?^ %O_\ &Z+Q_E_%_P"8WB*2T=&2
M]6U^IX'_ ,-9? C./^$OO,^WAGQ%_/\ LZG?\-8_ K_H;[W_ ,)KQ%_\KJ]Z
M&G:>-X_L[3GVY#C[+ 2FW!;(\GC .>>""#3?[/TW_H&Z=_X VW_QNB\?Y?S_
M ,Q?6:7_ #Z?_@3_ ,SP;_AK#X$_]#=>?^$SXB_^5U+_ ,-9? KOXOO?_":\
M1?\ RNKWC^S]-[Z;IP'<_8;;C_R'3FTW3%SG3]. Y^;[#;@=N0WEGJ2 #TS]
M*+Q_E_%_YA]9I?\ /I_^!/\ S/ _^&LO@/GCQ?>9S_T+/B+K_P""VG?\-8_
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MM_\ &Z+Q_E_%_P"8?6:7_/I_^!/_ #/!O^&L/@3_ -#=>?\ A,^(O_E=2_\
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MF@Z=I>#BPTT'#$'[%;+]TA2<^6< $@'CG.!1>/\ +^+_ ,P^LTO^?3_\"?\
MF>"#]K+X$9X\7WF?^Q9\1_\ RMIW_#6/P*_Z&^]_\)KQ%_\ *ZO>AIVG@,#I
MVFL5VAO]$MRRE@2,@PC/3D'D<=*;_9^F_P#0-T[_ , ;;_XW1>/\OXO_ ##Z
MS2_Y]/\ \"?^9X-_PUA\"?\ H;KS_P )KQ%_\KJ4_M9? KOXOO<>_AKQ%_\
M*ZO>1IVFYYTW3A[_ &&V/_M.E.G:9CC3].SVQ8VX_7RCC\J+Q_E_%_YA]9I?
M\^G_ .!/_,\#'[67P(SQXOO,_P#8L^(__E;3O^&L?@5_T-][_P"$UXB_^5U>
M\C3]. P=.TYO?[' 2._0P@'^E)_9^F_] W3O_ &V_P#C=%X_R_B_\P^LTO\
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M#<6VCW_AKX3MI%WI<-_&(=1CL;RTT"*\LX]0C51J MYP;M0QE$KX%?89L+#
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MC;I^G#U_T*!?Y0G/Z47C_+^+_P P^LTO^?3_ / G_F>"C]K+X$G./%][[_\
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M>'](\1V<5IJ/F3JUM;07B+))@C$^TD^6[:M%/2_FWU\G^/ROV<+NRANUJO\
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MNX?4=<O[*VM+B)M41=3N(5NKG18M/NI]HK/1Z=K>EWKIYKH/ZO#366O=_P#
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M?E(8 @Y8#!QSGT-3BRO2GF?8[KR]F\R&WEV!>I);;M&,<G.!T)SQ7\L7@_\
M:V_:8_X)O?\ !%/]J[]I3QE^V9\&O^"B"> /$DFA?L9_'/P9XCN_&>IRZ#X^
M\0:-\/? =M\6[NYM+*/5]4\):UK$'BRXTIKF^OA976H:9?:G)%!9W$OXF:5\
M6OV9]<_99A_:;\3?\'#?[1.F_P#!3G4O!)^,EMH=EX_\5P_!'P]\2KC3G\36
MWP4O/A?'9+X>N+.#477P]J>I1VYT>+53/=VV@7EG%;P3MU(I+1WW>L=OO^Y?
M?V#ZO%]9=K_TOS/]$F-'E94B1I'<D(B*6=P-_P RH 69#L.& VGC!.1F6:UN
MK=0T]M<1*QP"\,B@OE_W8)4 R 1NQ4$D*,GJ,_Q'_M??\%4?VO\ ]IC_ ((<
M_L-_M/>%/$GQ'^$^C_$_XWV?P?\ ^"@OQD_9YTBXN?B#X*\)>#+[5M UOQ'X
M6CLFBF\,Q>-&L-/\12S07EA#::QJ%AX=M[N*&_1G]-_X)UZ?\,=>_;#_ &=_
M'_\ P2Q_X+1^,/CA\)=8FN8_VHOV1OVX?BMXR\1?%+Q5X,B-D]W<_#;PIXDT
MI=2M/$DUNVJWUG'Y6E2V>MV6D">^O-.?486/:1OL_G9;[:7^_L+ZMU<MGV73
M[[7Z']D4-O<7 8V\$UP$(#&"-Y0"21R4# ?,K*<D?,K#J#37BECD,4D4B2@@
M&)T99,L%Q^[(#\E@ =N"V0,D&OXB/^"H_P"T3;7/_!8CXD? W_@I7^UI^V1^
MQ5^PIX=^%OA8_LEZO^S)J'BCP9X6^(7B;7+32I=9\3>-O%WA6SGN)ECU6?Q3
M;7SWT>HV]G+H&G6TD>D0S-<W/Z&?L&VWQM^&?[#?_!1C4?"__!2WP9_P4 _9
M<T;X:>.M5_9+^*VB^/=6\4_M"?"^XL?".J7.HZ3\0O$,MNMS8WHFEM/)AN]8
MU#4[/6-'N+NQFCL;V6VM5[17:L_+:_SUT7],KZO"V[N]OG\NG5'].(L;T^9_
MHES^Y;9+^XE/EML$A#84X(0JQST#*3U%-CM+J92T-O/*%R&\N)Y-K+]Y&V*P
M$B@Y9#\P[BOX'_V5?V)_VX_VP/\ @CM/_P %"?B3_P %/?VNM!^+GPT^%?Q$
M\3?LS>"O!WQ)UK1O!>G^&OA+K6M742?%&^@U.UU7QMKGBS7;+7+.^U;5YK^Z
MTK14TZU#WUMNLJ],^%O[,O[<'_!1'_@E!K__  5$^.O_  4D_:>\*?'?P]\(
M_%/BOX"^ ?@SXGN/AO\ "31?#_P0AET6R;QOH7AJ[TV3Q9XL\=ZKX<U34_%&
MMW;;K66X!M4NH[J6S1>U_NO6SWZ:?YZ?\.+ZLO\ GXON]=#^XT G: "2V, #
M)Y(&".QR<8.#G@<U8DL[N)2\EM<1Q@X,DD,B)V ^=E"\Y&WGYAR,U_&K^T__
M ,%E/VF/AG_P0)_X)_?'.Q^(MOX5_:G_ &U=1LO@GX@_: U.QT^0^ M-\-:Q
MXDTGQG\54T@6\MH^J7'AG0;,F\BLG_L_6;J]U*"TD?RHU_.;XZ_M'?LU?L1?
M"S0/VG?V"?\ @O!\>OVC_P!L7X9:IX>U/Q]\*OB_X\\7>./A-^T;876IVO\
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MJ:RF:VO8K75+2:PN)+*Y4EK>Z6&X<P7"@M!)ME4,R*I_B\_X*._\$Z?V2/\
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MFT;X@_\ "KO@O\%[#P/X)M++1YIF>/\ X3W6$TTD.8AJ6K>%YM5DA6:\#O\
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M<+C RO4<K6:A&R3DG;;5)7_&_P#F:SJSO[M-KNY)NZ\ETT_X8_DZ_P""9/\
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M%=2\(:6J3Q2ZM=#7=3T7Q!!X?RQOCIB7=JAN[&T5OWB:&?@*DH!SNVJ<9/\
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M1?57YKWOZ:?A^(_;3=ER_9Y=G>[35T^F_P#P2$$@Y%.#G(R>._'^ IWD3?\
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M 3CZV^&?QC^$_P 9]%BU_P"$WQ&\'?$/2ILL+CPOK=EJ-RAZ$75@DBZC:,K
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MT?\ -2_C)_X7NH#]=G%?2E%*Z_EC]R_R)]M/^[]W_!/FO_AF/P]_T4KXS?\
MA?Z@?T\L9I/^&8?#O_12OC+_ .%[?_\ Q-?2F!Z#\A1@>@_(4[1[?A$IUJO>
ME\N7]$CYL_X9A\._]%,^,G_A>:A_\11_PS#X='_-2_C)_P"%[J _79Q7TI12
MNOY8_<O\B?;3_N_=_P $^:_^&8_#W_12OC-_X7^H']/+&:3_ (9B\._]%*^,
MO_A>W_\ 1:^E,#T'Y"C ]!^55:/;\(E.M5ZNE\N7_)'S9_PS#X=_Z*9\9/\
MPO-0_P#B*/\ AF'PZ.?^%E_&0_\ <^ZB/UV<5]*45-U_+'[E_D2JT_[OS7_!
M/FL_LQ^'C_S4KXS?CX_U _IY8_G2?\,Q>'?^BE?&7_PO;_\ HM?2F!Z#\A1@
M>@_*JM'M^$2G6J]72^7+_DCYL_X9A\._]%,^,G_A>:A_\11_PS#X='/_  LO
MXR'_ +GW41^NSBOI2BINOY8_<O\ (E5I_P!WYK_@GS7_ ,,Q^'O^BE?&;_PO
M]0/Z>6/YT@_9A\._]%*^,OX^/=0_HM?2F!Z#\A1@>@_*G[O;\(E.M5ZNE\N7
M_)'S9_PS#X=_Z*9\9/\ PO-0_P#B*/\ AF'PZ.1\2_C(3[>/=0'Z[.*^E**5
MU_+'[E_D2JT[_9^[_@GS7_PS'X>_Z*5\9O\ PO\ 4#^GEC^=(/V8?#O_ $4K
MXR_CX]U#^BU]*8'H/R%&!Z#\J?N]OPB4ZU7JZ7RY?\D?-G_#,/AW_HIGQD_\
M+S4/_B*/^&8?#HY'Q+^,I^GCW4 ?SV5]*44KK^6/W+_(E5IW5N7YK3YZGS7_
M ,,Q^'C_ ,U*^,W_ (7^H']/+'\Z3_AF'P[_ -%+^,O_ (7E_P#_ !-?2F!Z
M#\A1@>@_*G[O;\(E.M5ZNE\N6_RLD?-G_#,/AW_HIGQD_P#"\U#_ .(H_P"&
M8?#HY'Q+^,I^GCW4 ?SV5]*44KK^6/W+_(E5IW5N7YK3YZGS7_PS'X>/_-2O
MC-_X7^H']/+'\Z3_ (9A\._]%+^,O_A>7_\ \37TI@>@_(48'H/RI^[V_")3
MK5>KI?+EO\K)'S9_PS#X=_Z*9\9/_"\U#_XBC_AF'PZ.1\2_C*?IX]U '\]E
M?2E%*Z_EC]R_R)5:=U;E^:T^>I\U_P##,?AX_P#-2OC-_P"%_J!_3RQ_.D_X
M9A\._P#12OC+_P"%[J']%KZ4P/0?D*,#T'Y4_=[?A$IUJO5TOERW^5DM3YL_
MX9A\._\ 13/C)_X7FH?_ !%'_#,7AT<CXE_&0GV\>Z@#^>ROI2BE=?RQ^Y?Y
M$JM.ZMRW\UI\[NQ\UG]F/P\?^:E?&;\?'^H']/+'\Z3_ (9A\._]%*^,O_A>
MZA_1:^E,#T'Y"C '0 ?A3]WM]ZB4ZU76[I?+EO\ *R1\V?\ #,/AW_HIGQD_
M\+S4/_B*#^S%X= X^)7QD)_['W4!C/!_@[Y_#KFOI2D;H?;GGVYI:/1I)/2Z
M23UTTLKWNU;U,Y59R37=6]U>]\M=SYJ_X9E\/DA?^%D_&4C.W_D?;\D'G'&P
M$]L8Y.< $9PO_#,?AXY(^)/QC<+GE?'E^ 6499,@<R+SE!C&#]*^DMH9MH3>
MQ884@DLYR $ P0X^\IR.A .2 ?B3XA?'?QY\2?BSKW[,_P"S%>Z-IGC3P=86
MFI?&OXR^(M..N>&_@_IVL9.EZ5X>T9GCMO%_Q+U>-)+BQL+F6+3-&MT%YJ!8
MXB/-7JT<-RP5-U*]9SITJ4VX^UJ4U>=/77W4USV^%6;:1]!DV3X_.\37IX-T
ML+E^782&-S''XFG+ZOA,-*<*3Q.*J1C+V='VE2$(Z.=:I.%*C"I5G&S/B3X'
M^ _P?L8K_P")O[0_Q!\(1SC_ $.SU'XE:C+K>H.?NQZ3H%A!=ZWJ4[9 5+&Q
MF'(RZ@DCPM]-^('Q C=_@+\-_P!HO5K-E"VGC3XY?$R_^#_A2\WC,-Y9:-<I
M=^+-7TYXV659+.TMY)U RB'"C[3^%/[.'P^^%TB>(KF.?XB_$ZXE:[UCXL^/
MXK?6_&]_J#C$L^FWDZ2P^&+.1LO#IF@I:6UJA,*F10*^@'9G<M([N[$NSG+%
MG))))9BQ&<XYZDG;6"AB\0I<^(GE\$FZE.@DZJB[7Y)RA42=K>]R35[^Z]+>
MM+'\-9'.?U'+8\4XF$HPEF.=^TPF2.JDVHX;*<#7HXNO1<VU3G7Q^'QD%%2J
M4^631^8>D?L5?M)>)'6Y^(?[7GB;P/:\,?#GPBMM0U%K;S,&2W/B[QC<IJ-R
M$Y1)Q8(PP&5>.>@O/^"8OP5\02-<^.?BQ^U!\0;N52ER?$_QP\4BPN@2-V_2
M-*EL; 1M@D0&)D4<;N@K]'20PZDD_>ZXP#D$]3P"!@<DD].V;J>JZ1H]N+S6
M-7TG1K1G2(7>KZG8Z7:M*Z[DB%Q?SV\+2.%(2-7,CLK (<&IGEN6I3GBN?%*
M*BYRQTI))3MR\]1UJ=-*=GK*G!7TLEH:T>.^*I5*6'R65'+JG*IT<+P_E&78
M*M&UUSX2O0P57,ZLXO2$IXRM4TYK\UV_A;P__P $U_V7/"Z7:Z'X:O[8WRQ)
M?37+:;J]W?BWP;=KJ\UO3M0N)"A.<B0-D Y.:]2T?]D;X?\ A^..'P_XJ^(_
MA^*'<(X]"\11Z/"FX89HH].L[?RB^$R@PN%!(.!CZ"MO&/@N]G@M+/QKX.O;
MJY?RK6ULO%6@W=U=.3Q%!;6VH23S2$@D1QQLS9X]:Z;:0RKM.]V"H!MRQ/ (
M&2/F8[%SSN91QD5I0H993M+#4,#",6KNC##UW%WLK5HSJ\DKM6YFGKLMUY.;
M9UQ37FGGN.SN53$PE*"S2OG'MI0C4C2G*-'&4Z<9<M2<*=J4&I3DHQN[(^;W
M_9JT.0 2?$WXRMM5>)/'VIOGYOF=@=V\@9VY(ZGIUJ$?LR>'NWQ*^,?\()_X
M3S40Q)QN8 #"C)884G/&>#Q[MI?BOPCKM]J>DZ#XM\*>(-5T9E76M+T+Q)H>
MLZGHLK.\2IJ^G:;?W-[ICF:.2$)?00'S8I8S\R,!O+CD\<#N!^&,$\CV _/%
M=BY)QO"?M*,W.*4)8><9.G+DJ13IJ5W":Y9).Z:UZGCUXX_#U53Q%&K2F[/E
MQ6'Q6'Q"BX2G&2C6I4:B4H1<HS<8)I.4)R33?S:?V8O#A) ^)7QG4< -_P )
M_J! &"7P-N0QZ=3P3V!P']F/PX,D?$GXSEF&!_Q7U[T)'3*#@C)'N!GO7N=]
MXO\ "&F7,EGJOB[PCIEY'M\VTU+Q/H5A=Q,ZAT2:UN]0BN(G*,'Q)&OR,K#(
M8$W=.UO0=8BEN-'US0M7MX-WVFXTG6=,U.WM2J-(?M4MC=7$=J-BE\SF,>7\
M_P!W)J.?"IRA&M1C.#<9PA6H\\&H.<HSA&KS1M33DVTE&*;DUJ:/!9LJ4,5_
M9-?ZO-P5/%ULOS2,6ZEE3=*M5PL:,Y57)*G:I/VCDE3]HVD_ 3^S'X>P/^+D
M_&3W!\>ZCQ@=@%QD],?KS3?^&9-! )7XE?&7=D;=WC[4,8[G.TD'&>W>O9?#
M7Q$^'OC.[U"P\&^/?!/BZ_TG/]J6/A?Q9H'B"\TT+M#&]M=)U"[GM55F6-I)
M8UB$K"(.9,K4VN>./!7AC5= T'Q+XN\,^'M<\63M:^%]%UK6M.TW5?$5S')$
MCP:+I]U.ESJ4T;W%NKQVL;N&N(EQO<!8IU<)*G]8IU:$H1G&$<1"K0<54G\,
M?:.HZ:G*^D6[N]E&]D;RR_/*=9X6I@\WHXOV;J_4WA,72J^QC3]HZD\/6H4Z
MJHJDG4E4GA_9J"YW-))KQ?\ X9F\/G)/Q*^,HQ@J3X^U%<X.X@87@[@#R!G
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M ,,Q^'CU^)7QF_\ "^OS_P"R"@?LP^'?^BE_&0?7QYJ']%-?2>!Z#\A2X Z
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MK+*].3S+*,GQU11EFF9XYQE2Q>8890R^A"I4H85595:E1:+ _=.2 <Y!#9)
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MXKB:34_%5_:16-I::?JVIL;VTL+>*S23RPQ/SRO_  6W^(H_YQ#_ /!2H_\
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M?^'W/Q%_Z1#?\%*O_""\-?\ R;2YE_-_Z5_D/V57^67W_P#VQ^\E'UK\&_\
MA]S\11_SB&_X*5?^$%X:_P#DVF_\/N_B'_TB'_X*5?\ A ^&S^GVT9I\_P#>
M?_DW^0O9U/Y9?U_V\?O-M3T_\='^-)@>@_(5^#?_  ^Y^(O_ $B'_P""E?\
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M ,/N_B'_ -(A_P#@I5_X0/AL_I]M&:?.OY_Q?^0>RJ_RR^__ .V/WFVIZ?\
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M#?\ P^Y^(O\ TB'_ ."E?_AO_#8_7[><4O\ P^Y^(O\ TB&_X*5?^$%X:_\
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MNY2G&>683#T92<4ER\D%R1I)M*,8K]E/^"0OQ7OOBQ_P3Z/[*_[9G@^S\/\
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M*XFN=(-I>7<]G;0627%R8((T* E>UIZ.[L]K7?GLG?\ RZE^SDNNW=M?F_\
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MY5WK@;P#D!AU'-'VZ[ RTMQU&")I._ _B]?_ ->*_/?_ (* ?&G]N[X(^"/
M.J_L'?LA^'?VO/&FL^)[G3/&_A;Q%XWM/!$/A7PY#I<DMEKL%W>:_H2WDMU?
MK#;-''<RJ(IS*T3&-F3\ OVJ/^"ZG_!9#]BW3?AW?_M)?\$G?A#\/&^+/C*W
M\ ?#72%^,USXJ\3^-?%EQ&DD>D^'O"O@_P 9:UXEOY&\R"U-U;Z:UK%?7EC9
M23K<W]I%,G**UMMY/\+7Z[JR&HRE:VU]7S_\'7T/[!OMUR#CSKEB< *LLK,2
M<< +N)()"D <,>> 2&G4+@[MLUS\N,L+@E><@ .6"'+84$-C<0I(-?BW_P %
M)?\ @IK\8_V!?V)_V9_CH?V>_#_BS]IS]H;QQ\'?A7;_ +/VIZ]?6^E:/\5O
MB#X/N?%'B?PI!JVEW?VNZ;P]J>G:GH=K>SWHMI[CR/,N LD;GQ;X/?ML_P#!
M>;Q7\6?AIX8^+_\ P1^^'_PT^%>N>-_#NB?$7X@6OQNTC5+KP/X-O[^UM/$?
MB6WTV/QY=R7<NBZ=+-?Q6JVERT\D85(I'9&!SQ3L[WT[]=NI7LY6W_\ )I+]
M3^@TWMV,XFN#MVY)F<KEB0 "IY((&<94;EYYX%OKMB/W\WS9V 3R L0%.%!8
M'D-QD 9!Y]:Y50S*,X9LHLBL5<L#\[@,#A<(513&ZLJ^8 "17\WW_!4[_@N]
MJG_!,;_@H%^SE^S;XU^%?@[Q)^SE\3_!GA;QC\5?B*UQXB7XF^"K'Q%XDU+0
M+_4_#-K:ZI;^&;RQ\/16,&J3Z?J&E3SZA;)<01W-O+L9ZE*$5>326F[?5V[]
MR5%O1.[UTYFW^?E^A_24;ZX RTUR.F!Y\@)S@@KAB'!!SA2Q ^\%. 0WUQC(
MGN0..3/(3ST 5OF)R<<#K7@WQ5^,.G^%OV<OB)\?_A[<Z'XVTS0/@]K_ ,6_
M!%Y%=FY\-^+-.L_#$OB;0+I+RP:*231M;M3:2&:TDCN#97 $<D<B@C\H/A-_
MP56^+?Q"_P""'OC3_@J?J?PR^&5A\6_"_P )?B9X]MOAM92>*A\-;G5/!7BJ
M]\/:?:R&?7G\6+I^H6\27.H00^(%N?-S';7D2?-4.=-=5=)O2_3^O4:A)[/9
MV=I/1[ZZ^:/W8%[=DX6><G.!F=B&_P!TJV"<C!&<KU8*I#%JW]T<9GF&02 )
MI"21@D<,5!YX)(5B#M8@9K^7OX"?\%"O^#A']I'X,?#CX_?"K_@G3^POK'PW
M^*WABT\8>#;R]^*OQ(TG5;W1KR2XMH)+BSG\?+)87$LEE<".&<JX4H2S)G/U
M;_P3I_X*U?&#]H/]JKXD?L ?MV?LL3?LC?MF>!?",OQ'TGPMHFN'7O _Q#\!
M6J>?=ZAX=U&[O=1NH[BWTYH]4L[F'4=:TK5[".[99+2]L+BV#YX.R:>NUT[/
MK;<;IN*;<M%J_>?EY^9^[0OK@_\ +>X(R1D3R#IWSG)!YVD @X//')]MN.T]
MR/K<2'^=?E/\&/VZ?B#%_P %(_V@?^"=_P"TKH/A'P[XEB\(:?\ '/\ 8Z\<
M>$X-4M=-^,'P+EMR/$FCZZ-2O+Z$?$;P3?QW,VHVVES0V<FFVUTT=J)5C#?J
M<01@GHPRIR.1D@Y7.Y2, X95R"",@TTZ;U5M/5/_ #(DG%:RY;K1\S?9Z*^N
MC+)O;OM<3GZS2?I@BE6]NN=T\_MMFD_7)JI2$@=>]5>+T3U\F[D*[=O:7^]/
M[^9_D7_MTW>>Z_[_ +#^IIK7LY^[/<CUS.QJCO7U_0_X4H(.<'T_K19+5MV\
MV[%-63?.U_V\W^&GYELWMWVN)S]9I/TP12K>W7.Z>?VVS2?KDU4I"0.O>B\7
MHGKY-W)5V[>TO]Z?W\S_ "+_ -NF[SW7_?\ 8?U--:]N#C;/<CUS.Q^E4=Z^
MOZ'_  I00>AHLEJV[>;=BFK)OG:_[>;_  T_,MF]N^UQ.?K-)^F"*?'>W7S9
MN)ATZ32>_7)JE1G! YY_ISS2;BU9-?>WMJ]_(C?1SNO1]->LG^1V_@^XFFU6
M16ED?_0I<"21VQF6 %AEBH*CGE23T&.:]0&<<\G_ #G'MGIUX[UY1X)P=7E'
M<V,X]N9;?_/>O6*\_$6=71WLHOYV:_4[Z3O'[M>^G]?>%%%%8FH4444 %>4>
M-F UF,<Y^PV[?@)KG]>:]7KR3QN<:TA["PA'_D:?_$5K1_B)=TU^1AB$W3:2
MOJONW.2HIF\>A_3_ !HWCT/Z?XUV\LNS_KYGG\LNS_KYCL#T'Y"C ]!^0IN\
M>A_3_&C>/0_I_C1:79_?_P $=I=G]_\ P1]%,WCT/Z?XT;QZ']/\:.679_U\
MQ<K6K3LM?NU' ;1Q_@3^/\CVK^/3]M/X!_$C]M+_ (./]6_9(_X:)^,GP8^
MWB;]A[X7^,_C/I'PJ\7:GX=U/QKX0\(:/J6KR^"+.ZMKA8=''BG5KBV@U75[
M=%N?L2S[C,YB5?["@QQD@KU.?3'N>GX\5^'%E^R-^T7;?\'#'B/]M2X^&6H1
M?LNZG^PGX>^$=A\6#K/A<Z?=?$.UTXVTWAM- 76SXP^T1SG8UY_PC_\ 9S?+
MY5Y(IR(J-QM?FW;=KWVM>RUM?=VM;MHSJPT9.,I*,FI051-QE\%[*=FDU%OX
M7))2WCS+4_"WX??\$]/'?@/_ (+&?%G_ ((V?#_]LG]I_P *_L!^-_@IX9_:
ME\?>#+/XA7,WC75=+LM"_M.S^'&G^,Y8SJWAW3M1U.\?3M;U/2+BVO-4T6)(
M[XW5P8YH_O/_ ()@?"K4_P#@GE_P78_:7_X)R_"SXJ?%#QG^RYXI_9G\%?M!
M^&?!WQ.\5WWB]O!/B>_ATG5P=)GU*2:2&YB%U=Z5/J4;+>:EIQA&J2W31(4^
MX;']D+]H[3?^#AGQG^V?>?"_48?V9-9_88\,_"/3OBJNM^&)=/OOB'9Z7!;7
M?AE-!CUP^+DO(IT,+7$V@1:<67"WK9%7_"G[)'[16A?\'$/Q!_;3U7X9W]I^
MS'KG[$_@;X6:3\5FUKPO+IM_X_TW2])M;_PY#H$&MR>+5N+:X@FADN;CP_#I
MY>,A+IPRYQ2?[NTH^^YN/[R-G&*=VO?^%6?9>IU.%1*?-":Y>6,KP:M*35D[
MI6;NK=7?34^-/^#;7_D>_P#@L6ZD+C]O_51YH0DA1:^(RP;9G:C#!;&W) );
M'%;_ /P=>V>BVW_!,CP9XT%I _Q)\ _M9_!74/A1?>67U73=7U*+Q2VM0:;*
MS+/!;7]OI>F33I;&-GEM;+>S$[Q\7_LD>"/^"Y?_  32^,'[=UM\&_\ @E5#
M^T!X*_:7_:;\2_%_0/%^O?'#X5>&$.CK=ZO::&;"PM/B+%>-:ZE97UO>R17D
M5G?PLWD2V\3@@>[:O^PI_P %;/\ @K5^TO\ L\>+_P#@J3\./A1^R%^Q]^S9
MXPMOB5IW[-_P\\51>,_%?Q1\;6<EE=V2ZU<:?K?B:RO(KV2SM]-U35;S7(M/
MTK2XK_3M,\/R7&IRWJ5S1<(P4ES23LFXK12DW)-R47RQN]'JEI=7,W1JQJ2J
M._*M'%\V[2BDUYMI+1OWNYC?\%5Y8?BE_P %7_\ @WH^%'Q@LX+CX7:WHND?
M$SQ+8:NC7NA3_$S^S+"[2*YM)\V\MTNI^'_#ZJ9-TBNZ%T.2'_K9F>;[1+)(
MP60.[O@\+\^S"F/YT"MA"\ 161$7?A78_D5_P6*_X)@:A_P4.^"WP[3X6>+[
M/X,?M4_LT>,K;XI_LP_$$)+#I6E^(K1;%SX,U:33_-DMM U*72-&.G7D-OJ#
MZ!J6F1W(L;N*2^M)?@*Q_;L_X.,/ ?A.#X.>,_\ @D5X1^*'QWLK!?#UA\?M
M!^,_A"P^$_BVYAC^Q1>/;[PRGB2"XWWLB1ZI>6,&M^'C(!-''HEB)_LRW%JG
M/WG&?M(N4&I1ES)*S^"<K6W;LEZ6=ATJDZ=E3E!P:C*+BXN+;347S):NZLFM
M4UO>YY]\!-)L/A[_ ,';O[37ACX;1I8^&?B;^Q=8>.OBOH&EHECIR^+;OPK\
M+]5FUF]M[9%M[K5I=2NEU8&6-)([CQ!>J2TI?/YH?\$EOVA_^"I_P:\2_P#!
M2:P_8'_85^'O[67@2_\ VVOB'J_CCQ!XL^),/@C5M"\80QO:P>&-+L[CQ5X?
MCOX9]'BL[X7$@V"XNO):Y4;D3^A?_@D#_P $P/C?^RGX_P#CW^VO^W9X\T3X
MI?M[?M=ZK!J'Q OO#:K>>$?ACX.-ZFH#P5X<OHX;>&YN+JZ:&&_&DQV>CV.F
M:7I.A6%M=#3AJ$_._P#!"K]C+]IK]CRW_P""@EG^TC\+M1^&-Y\:_P!M#Q9\
M4OA=!=ZWX1U\>+_ .IZ5;6UAXBLW\*:WKRV<$TP>%;+59=.U&)PPELE.'K-0
MDW"UES\\XKGA\*3N[\[[/1V;^RG9EN,ES7C*\7&#3C)>\VK*S2=WS1LMVFGU
M3/Q&^%7C[]LO_@XC_;%\)_ ;]KV_^!_[%_@;_@GS\5=,^*OQ+_97T2S\91?'
M?QYX@\.ZO8I-<#3_ !A>7TE[I<26B^'-4\06&LP:?X=MM0COH]!G.KZ;J4O]
MT0ABB2.*!-D$*1V\2!BNR&VC2"&,D@F0K"(Q\I(D">;N)SC^;'_@LG_P37_:
MBF_:?_9P_P""HO\ P3)\$R:[^VQ\'_%>C:)\4/AWIFM:!X;C^-WPQ6&2VM[G
M5=0U[5="T*^DM=):]\&>)5O=02]U#PSJ.FRV(&I^';8U]E_M8_MZ_M:? ?XZ
M?\$R/ NA_LU>%-'\$_MH^-+/X??'6T^(.NP:I\1O@OXXN=&MM=N?!OARU\(>
M-VTW6;C1M+M?$=]J>N16/B[PU:1Z=;!]5@EN;9I]8-*RYDY:6UOSIJZY5%N]
MD]5'F2>NSTQK4ZDFHKGIR4Y0Y)1E%\ZLW%72;D^BN[J]D^5M?L*J\A1W('0'
MKQD@\'\>#WK^*?X;_L;>)/\ @I!_P6R_X*S? SXK_M(?'WP=^RK\+?$/PW\4
M^,?A#\,_B#KGAJ'Q_P")=5T6ZTGP)8S7T-T_]D>'O#]J?%5]J%CIJVS:IJ5[
M8&1A;120M_:T61)RH)*+*5#8R=JOC=@=>!G Z]J_"7_@GK^R5^T5\%O^"K__
M  5V_:*^*'PSO_"7P6_:0U3X'R_!#QQ<ZUX8OK/QY#X/M/$T/B!K33-*UN^U
M[2&TUM1LEE7Q!I>DFX:XC-G]I!.*:E;X6[M_^DO=WVO^-C.B^53YG9NS5^OI
MN?AI_P $_O\ @GSX^_:+_;9_;]_X)<_&?]L;]IO7/V#?V&/B!#XC\(_#+1/B
M-?:+XG\9ZG\3HI['P-9>+?&UFL.M'P]X5\+:'=O>^'-.N;?29?$MQ]LLK:WB
MN]22[^C/^":OQZ^('_!-^S_X+^? 1_'GC+XR?"3_ ()OV$/Q._9TTOXE:Q<^
M(]0TM]:\+_$76[?PS?WTK^<=.U!]$\+6]W!:-;6T%Y;ZGJ$"Q2WTN[]/?^"=
M_P"R1^T5\$_^"K'_  5Y_:(^*'PQU#PC\&OVDO$'P2NO@CXWN-:\,:A:>.K?
MPK8^(HO$,]MI6E:Y?:YI7]F2ZC8K)'XATS2'N3<@6:W 60KY#^S1_P $X?C)
MKO[8_P#P7LB_:%^'&M> ?V=?^"@NA>#?A]\+_'T6M>%+Z3Q=X=O?!_C?PWXJ
MU;1-,T[6-4U?1KS0'U^QGMSXETO2I'GEB:TCN LA3-4ZBMH_M7U>VMNKTO9K
M]#?GCK[RM9/YZ7Z;[GQ9^P/_ ,$;;#_@I7^QWX8_;M_;<_:M_:@\3?M<_M1Z
M3KOQ)\&>.?!GQ7UOPUHOP-TS4-1U"U\!V?A;PU93G1YUM;:WL[^;3;VVDTRT
M@GBT73K2"*R\R7]%O^#??]K+X]_';X!?M%_L^_M/^,KCXG?&S]A7]H_QK^S7
MK/Q0O9+BYUCQUX;\-7UQ9:#J.O7MRTLE[J5G?:1KFG1:C<W+W5WI-MI9O)+B
M[62>;XE_98\7_P#!<W_@F-^SNG[!&B?\$X]'_;)@^&$GB'PG^S#^T[X+^-7A
M/PIX";PUJUW?ZMH4GCSPCK5Q:^)+R+P])J^9+6:^\(2VUK;1:.M]J7V"/5)O
MM'_@GO\ L.?M;?\ !,C_ ()X_M+^,M#T7PS^TG_P4=^/?B3QE^TQXH\"R7L-
MCX*U_P",7B>VMY]*^'*ZN^L^%K6YMK*[FU*;5=935]#BFU?5]4BM+BUT^WM)
M%(J5K<LEH[NTM[:*SO?6]K:*_:R,ZG).-G*-]X6M?KIMHNC3MWMHV?OZR@D
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MD&A>$[&Y>+2YFC%]>/963-#"QN*ZKXR_''_@JK_P11^/7[+GC+]K#]L?2_\
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M]F']JKXU?#+X%6?P3_:._9X'QRTG4;K]E7Q;\:OAA_P@WPX^/&B>'4>%-/\
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MVNVDMKJEE=Z'J<M_:SZ9K]K?"*/PW]I_P[_P6T_X+.Z!X?\ V2_'/['FF?\
M!-/]C_7?$6B:M^T%\1O&/Q-T/QUX]\7Z1X?U1+R3PQX:MM$NDO)H#*BWEEHL
MWAZUL-5O(K675/$4VGV:V$L)24*D>65W-M*S]Y<U[IVMMU;7H-RC.I3DI*,5
M%IINS3M\+6[:^:\SVK_@YNT_PGI?_!-C]G+2_!%KH5EX*T[]K[]GZP\)6GAH
MVK>'K;P]%%K8T^'0O[/F?3SHT%L$@L5LB81"B+'A &/Z&?\ !8CX2Z5\:?\
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M?]?,?13-X]#^G^-&\>A_3_&CEEV?]?,.679_U\QV!Z#\A1@>@_*F[QZ']/\
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M4IU'X+:9_P $^OB__P +]_M\^ +[P)X=TR&/PJ;,>*)?%]U;63>#X_#[7_\
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M\:/*D'.W/ME?\?SK\(_^'"_PR_Z2(?\ !5+_ ,2SU/\ ^4E!_P"""WPR(/\
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M6^&O0?\ !1#_ (*IJ!]TK^UGJ&4SD,5W:"VW=D,P^;)&T$ DD/\ P05^&6T
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M57'X2_\ #A?X9?\ 21#_ (*I?^)9ZG_\I*/^'"WPR_Z2(?\ !5+_ ,2SU/\
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MO\AWH_S?G_D?NYY4G]W]5_QH\J3^[^J_XU^$?_#A?X9?])$/^"J7_B6>I_\
MRDH_X<+_  R_Z2(?\%4O_$L]3_\ E)1SOLO_  )"O1_F_/\ R/W<\J3^[^J_
MXTODOCH/ID9_P_6OPB_X<+_#+_I(A_P52_\ $L]3_P#E)1_PX6^&77_AXA_P
M52SZ_P##6>I__*.CG\O_ "9?Y#O1_F_/_(_=SRI/[OZK_C1Y4G]W]5_QK\(_
M^'"_PR_Z2(?\%4O_ !+/4_\ Y24?\.%_AE_TD0_X*I?^)9ZG_P#*2CG?9?\
M@2%>C_-^?^1^[GE2?W?U7_&E\E\=!],C/^'ZU^$7_#A?X9?])$/^"J7_ (EG
MJ?\ \I*/^'"WPRZ_\/$/^"J6?7_AK/4__E'1S^7_ ),O\AWH_P WY_Y'[N>5
M)_=_5?\ &CRI/[OZK_C7X1_\.%_AE_TD0_X*I?\ B6>I_P#RDH_X<+_#+_I(
MA_P52_\ $L]3_P#E)1SOLO\ P)"O1_F_/_(_=SRI/[OZK_C2^2^.@^F1G_#]
M:_"+_APO\,O^DB'_  52_P#$L]3_ /E)1_PX6^&77_AXA_P52SZ_\-9ZG_\
M*.CG\O\ R9?Y#O1_F_/_ "/W<\J3^[^J_P"-'ER+CY>IP1N'(YROWAUQCG(]
M0<\?A'_PX7^&7_21#_@JE_XEGJ?_ ,I*0_\ !!CX9C&/^"B'_!5+J!_R=GJ?
MKW_XD?3_ .MP::G+[*5^EWI?S)E*DHMJHXM6::3NFFG=75G;MUVZG[M!)44*
MJY"@;0<*H);+@#<2F5!&Y6P>ZXYIWE$Y*1X)<GA@"01S(X7&Z6-<*&W ,IP1
MGK^$)_X(,_#,]?\ @H?_ ,%41@<C_AK+4>0".H_L+GKWQ]:5O^"#/PS)'_&Q
M'_@JCG@$K^UGJ(XQ_P!@'H,?XXH=24&G"$(5+-REK%3LFY>\H>\[-[.5NVZ'
M*:7MZDL1*G&M5A[T,/["I/D2YN5UFX1LVKJG3C&>M^;I^[Q69AMR2,*W7!9N
MY<EBH& -AB6)E(ZGI0$E(/'Y,1NSCS2"KJ%:7DR.04D(VO&>"/P@/_!!GX9C
MK_P40_X*I'CJ?VL]3'KC@Z%P>.![=Z3_ (<,?#,<G_@HA_P52QT'_&6>I\<=
M_P#B0Y'Z=N,<T1<I0=&E2IQA-JI.2K>[-R;:3?LU%7?25G?>VP)QCSR4DI6D
MI<U.*ERIQYFFY3E*:NF_9S3U_AVV_>'9(!G:3R"1A0'YQPF3Y6P *HC*X0;5
M*AF--*-DY7<&R68;/-!!R-K,65=I& ^TML)3)%?A#_PX9^&8'/\ P4/_ ."J
M61U_XRTU/Z<?\2,]?R]Z4?\ !!GX9 Y_X>'_ /!5')[G]K/4OQY.A=AW''H:
M)3E6?M)T?>4?9<T*S4XI*]TU2NOALG]UP<%%N%+$5*$4X^VJ3C"I"7,[*$W&
M"I3NU;V;<9[.]EK^[923<K;0A7[A#<J?O%BH<8#' *(47O@#*LXHX!SN;YV;
M)\LEBP!+?+M"'/!(!WKMST!/X0_\.%_AF3_RD0_X*H^@S^UGJ8*YZ$YT+WX
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M 2<G =FX.3N^;DXP%%?A+_PX7^&7_21#_@JE_P")9ZG_ /*.D'_!!;X9=?\
MAX?_ ,%4<^W[6>I_S_L,4N=II.VOI^?05Z/\_P"?^1^[GE39)QDC&P HO(&5
M;D,$='Q(K -RN.,Y!Y#9X4JN&3:K C81D%=Q;8P;&/O % 2&W8'X2?\ #A?X
M9?\ 21#_ (*I?^)9ZG_\I*/^'"_PR_Z2(?\ !5+_ ,2SU/\ ^4E/G\OQ3_0:
M]DTVI.R5WOHMC]VO(D&!L5E&,*6&5^8E@&8MN'=BV7<'R]R(BBD-O*1P%! .
MW)W#<Q5V;:"@3E1'MC*H55692!LK\)O^'"_PR_Z2(?\ !5+_ ,2SU/\ ^4E'
M_#A;X9=?^'B'_!5+/K_PUGJ?_P HZ7/+R_ 5Z/\ /^?^1^[9ADRQ"\%B1&&V
M( W#@D-N.X ,H^ZC%@N-S$NCB96!=7?@*[K(J2L-Q)\M\'[.BC;LCB !()8E
MCFOPB_X<+_#+_I(A_P %4O\ Q+/4_P#Y24'_ ((+_#/M_P %$/\ @JE^/[6F
MIC_W!FCGDNB?E=#4J2=^?\'_ )'W?\!OV#?"GP?_ &M?VG_VUO%'C+7?BO\
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M^'"_PR_Z2(?\%4O_ !+/4_\ Y24?\.%_AE_TD0_X*I?^)9ZG_P#*2CG?9?\
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MCK_ASX6W_AO4]1U'P[INI3R:5#K6L:OHVCW.JP?9KG4+42Q2MGS4?YE][_\
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M]C<^$]9^./P\L=;L=1MF,<^FW]E/KRRV=^LH\I+6=4EFE#)")&1POYI_M3_
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M(^?WD^\>A_3_ !HWCT/Z?XU!\_\ L_K1\_\ L_K1R1\_O#DCY_>3[QZ']/\
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M_#B+2)_B%X T3Q1HVI^,_ T'B"W-UH4WB[PW9WDVK>'8]9ME-QIAU:UM3>1
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M^U#4;Z=EMK.QLX$>>ZNYY$@AA1Y'D"(Y7S+3/V@?@/K7PDN/C]HWQI^%FK?
MFTTR\UNZ^-&G>.O#EU\*[;1M-E,&IZO<^/(M0;PW;Z;IDZM#J%[-J*6]I*#'
M,ZMQ7Y"_LM?\%&/#/_!2?_@D?^T!\5YXK?P]\;_ OP(^*'PZ_:1^'+J;._\
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MV)=VW'V"?&,Y_P!=;YSG],5[!7G5U:JUZ6^Y_I<[J6D$O3\D%%%%9&@4444
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MJ2TUO7Y+ZZGNK0(L4=O("Y\4_;=_X)9_L@_\% /$'@CQI\=_#GC'3OB)\/\
M2=1\.:#\2?A9XYUOX<^-G\(:N6_M3P5JNJZ',HU?PQ?))-'-::A%/=)'<W4-
MM>6]O<S0O,X\^JO%K:]UIU6BZO7Y+RLZ=5?:]W;=/]$]O2^I\[_\$$OCU\6_
MC[_P3YL-0^,WCG5_BAXF^%/Q\^.'P$T+XJ:]+]MUWQ_X'^%GB"PT[PEKNL:D
MTL\NMZN;*]DM[_6I7E-Z(;=II'E5Y3P__!QK^S1X^_:9_P""6/Q7M_A9IE[K
M?C[X+>+/!WQYTG3-*MY;[5-1T;P)=WA\7Q:/86ZO-?:G;:5=#4HH(()IVCT^
M?$)C4FOUQ^ 'P ^$'[+?P?\  _P&^ O@O3?A[\*OAYI/]D>&O#&G37=SY,<D
MTES>7^H:G?SW6IZOJ^I7<LM]J.JZC<W%[>7,G[Z9HH88T]E+(0RD*RR*ZR*_
MENKJR&,12*Z,DL90E9,HC2 LK[E)!TLN10;;TY6TGVWU73]/4GGBJG-?3G;V
M>BU\NNO3J?F%_P $Y?\ @I7^R=^U_P#L??"+XF^%_C9\.]+\0>&_A?X/\._%
MWP=XL\7Z+X=\8?#OQAX3\-Z=HVOP>*=+U&_AN;"PGNM/FU6QU-!)I>HV%W'<
MVEU*D<@C^?/V6/\ @K=KG[:O_!4;XL_LJ_LO^#O!/Q._8O\ @1\.$U'XA_M0
MZ5=ZFT0^*&(X4\/>%-2@:3PYKVB:MK32Z5HMQ$5.H+I]_J:7"0)$DW8?&G_@
M@%_P20^/7C_4_B=XX_9'\.:;XNUS4WU;Q!+\/_%_CKX=:+K]].YENKB^\,^#
M_$>D>'+26ZF9YKJ71])TZXO)9&EN)S*2Y_0_]FO]EC]G7]CKX<VGPG_9A^$7
M@_X.^ K:Y.H3Z/X4M)4NM5U38L0U?Q%KE_+?Z[XGU40JL U'Q!J.H7JVZI!]
MH,*[#,.>Z4IKE6M[.\K+K=:7>O?L6ZE.ZY5=Z6M&R5FK.]MT[6\]?(_ G_@A
M_A_^"EW_  7= &]7_:7T_#;6VD_\)#K9((^5@R9SM.TDKQG!%:'[;MG)XL_X
M.6/^"15KX5?S]8\!?L]?$[Q/\1OL4?GRV_A9]6^)'V,:GY*A;:!O[1M[F.=]
MT:07-M'O(*&OW.^#7[)/[-/[-_Q"^.WQD^$/PVL_ 'CO]HG76\;?'3Q7!KOB
MS6Y_&>MVDMSJ<FKW-CK>L:KI^CI#//=W36/A?3=*@DWM&L+951^3G_!-#X0_
M$/\ :1_;X_;+_P""MOQI\$^*? -CXSN+G]E[]COP9XXT>ZT+Q9I?P'^'TD.D
M:UX[U+1[D^=ID'CRYT^ 6*SV]LU[ DU_"SPS*QG[*CU]KS;/X>9N^W;3U%[W
M-5=FDXNS](I)K?K=_<?OX3CU/TZT@;)Z,/J*"1V*Y]S2 G/)3'L>:WNN_P"#
M_P C*Z[_ (/_ "'$X]3].M(&R>C#ZB@D=BN?<T@)SR4Q['FBZ[_@_P#(+KO^
M#_R'$X]3].M(&R>C#ZB@D=BN?<T@)SR4Q['FBZ[_ (/_ ""Z[_@_\AQ./4_3
MK2!LGHP^HH)'8KGW-("<\E,>QYHNN_X/_(+KO^#_ ,AQ./4_3K2!LGHP^HH)
M'8KGW-("<\E,>QYHNN_X/_(+KO\ @_\ (<3CU/TZT@;)Z,/J*"1V*Y]S2 G/
M)3'L>:+KO^#_ ,@NN_X/_(<3CU/TZT@;)Z,/J*"1V*Y]S2 G/)3'L>:+KO\
M@_\ (+KO^#_R'$X]3].M(&R>C#ZB@D=BN?<T@)SR4Q['FBZ[_@_\@NN_X/\
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M$/CPL@/SAE+>9M+;FC*L<,R@@+7]*A<[E<.=ZL26=_,+YVD.68&1"'#,$#D
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M6E!W]/FT['QY_P +ZUO_ *-Z^/O_ (2^G?\ RTIW_"^=9_Z-]^/O_A+:?_\
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M.6?_ #\A_P" O_,OFCW3/G,_'O6B% _9X^/8"<I_Q2VG<$_>SC5!NSVSRHP
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M_P"$6T\?^Y2OHG<HY7<W*@9"A6+#A<E,;B0 %/)) [FG;E)* J7#!"BE-^[
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M^];'_-O7Q\_'POIY'Y?VH*7_ (7YKA_YMZ^/?X>%M/!_/^U37T9\OJ_Y)_\
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M!>WNBW5AK6BV/ANZU&)%@@CU&V73EUB2XTZUU'47L)G?]6?^"57_  43MO\
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M_"GA#Q[X[\2^+O$<5EK?C:'1[B$ZG_PB.G6)N=#M@JR+=ZI+(;JW\@+/]O\
M_!&/X>S?L6?\%3O^"GW_  3N^&OC;QMKG[+WPX\,_"KXF?"GP3XUU^X\12>
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M"?A^6V@\0^+/"OAV6\V?9(O$/BC0="FN_,+"-K2#5;^TFN8Y&5D2:"-XF92
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MI-S<0[)&T^X,,K(Z99-VX?:__!0+]N#]L'X/>(O^"?W[('[-_A_X,Z-^V_\
MMOZA-IFN>*_B?#K'B'X/_!ZU\*^&H-4^(>HV^E^'IO[1UV(ZPNIV6DRK<SQP
M6EE;W%M;ZE)=)"?RS_:?_81_X*F?\$W?V2+O]M;X4_\ !5OXH?%GXC_LQ> _
M!_B'XE_ WQEX)T33?@5K'P^\)VVBZ'J/A/P9I%M=SI<V>DV?V>T1+S1=&O\
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MW7]CZ1=Z5J6C:IJ-M-;/:RRZ7>Z=#<E[:.?;(?DKXN:)^T3XW_X+C?'/P7\
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M9;JRVWO9CFDHRLEIVWW2[=7]WWGZ9_MFZ_\ M<>&_P!G[Q+J_P"PQX,^&OQ
M_:2M]=\)IX5\+?%S5[?0O MYX?GU=(_&%UJ6H76H:5$MW8Z,7GTZ#[=$\]R
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MEF69AC;* -Q4",$*Y(PV&0KL&&)B*E2S$YR,A?+ERV(I!D<,4;=NR&SN()5
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M52%K=;<UTFFK];/2W>]S^6W5_P!A7_@JY_P5-_: _9S\8?\ !3?0/@;^R_\
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M"XBA.2A7P]7#5*M*M1FU&I2G**=[-?S3>$/^"?O_  46_;'_ &B_@?\ $O\
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MSQ9J%P]O=6OA.UL-=TS/AM=,B,NIWDDOF1>29!<I(Q_5S9)P3&[/@9)C?+$
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MVR@D8)$;IN  "J0"0 /GR$"\NS99]K*NR0-G9(?G5U8QMN# Y(8,&1N5C!X
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M\ZZ,-I53[)_H9U6E!W]/ONE^)\<_\,W:%_T4;XN?^%M?4G_#-^B_]%&^+?\
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MWT;?==NAY1_PSAH?_11/BW_X6][_ /$4G_#.&B?]%%^+7_A:WO\ \37R4/\
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MYE1FAGD )%.5E[S23WO9:;=M-S-*3ERZMWVOVLW]QTG_  SAH?\ T47XM_\
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M?8ZSX@\>ZCX8M(=<UC3/,EMM-%W%Y-LT<EL;CMOA1_P7A_;1_;4^#MU\3?\
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M] !13?G_ -G]:/G_ -G]: '44@W9YVX]LYI3GMC/O0 44WY_]G]:/G_V?UH
M=12#=GG;CVSF@Y[8_'_ZU "T4WY_]G]:/G_V?UH =12#=WQ^&?ZT'/;'X_\
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MA_C_ +'&^'\[>G'Q5^TES_Q:GP#CO_Q6=ST_[\ _D*GG[JWJU^6YCS^7X_\
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M+/ >3USXPOB/_2:CF5W=;/W7:_3==OP[#5.?6R5]+<W3:^BO_7J;7P)_9U^
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MEX>T2WT7P_>7_AW3KTVEI:I8M-IEK<SSSH6OI&N297E3BW97OKI_AT?W._\
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M2_$U]ENN976ZMJOQ/Z-#(< Y R3@L5"[>-K%UWJN_*[5)S\PST;:I=@2"0I
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M4ZGI5I<W2J&D:WMYI91&CN%.Q@#F5F[.R=GMH]NY7+/^5_?'_,]#WMZ_H/\
M"@NPYR?P )_ 8YKDO"'C;P1\0] M?%?P]\8>%/'WA6_>2.P\3>"/$FC>+/#M
M[+"$::.TUO0;_4-,NGMTDC>X6WNI3 )(A(%:10>G16D=8XHV:21@B*I8LS,<
M!5 Y+$G  Y)(%._D_P /\]?D*TDTG%J_FN]NC)=[$,0257&6 P!N4LF"=JO]
MU@XC9]A!!SSANYP>64C( (8$'H6W,6V1E0>DC*6Y"[J_&;X+?MI?%/\ :J_X
M*2_M,^'?AGXTT[PY^P;_ ,$]_!.H^#OC%J%EHNE:Q>_&S]H?5--O=8OH+'7)
M!)?:/H'POT+2M7NC!I<EI/J&L:3/9:HKI=6\H_/[X"?ME_\ !:G_ (*J2_%W
M]HG]@C7OV:/V:/V2_!GCGQ'X ^"6F_&'P19^-_%OQ]U;PG*#+-J^K:G97TGA
MNTU43V8U#5],.FV>D7^HP:59VUXUI=WSIS2Z-ZNR2U?+N^FB[OY7NC7V3[[=
MUW/ZG#(PXR"W&1P!SG!!(!9#CY652&ZC@@D\PY(!SC;QA=Q5L894SO*YR"<8
M!'/6OQY_X)Y_\%.M5_:O_9+_ &D_B+\9O VE_"3]HW]BN^^)/@G]I/P%87-U
M)X5M?&G@+PUK^MZ7KWAZ;4I7O5T'Q0V@W'DV-Q<7:6-Y'-!;WUS9W%LJ_EC^
MQ]\??^#E#]NK]G[PE^U)\%O%G["/A3X5_$>_\1S>"M)^(_A>32?%B:)I6LW-
M@EW>6]CX4U.TEM9)$>*UNOMTDETMNTCQQL2E'.G:UWS*ZMVV\NNGJ)PMO)+5
M+5=7MUZ_TS^M1F?.T$;B<!3]\]&)VJ#E-AW*ZDJ3E21@FD#/U)&-Q4'<O)!&
MX#+XRHRQ#8&P9R 17XJ?MJ_M>_MH?L'?\$M/#7Q6^)D7PE\8_MX>)?%?PT^"
M$NI>&(/-^#>F?%;XK^)]0T?2O%]I8_V;81ZAH.@:9;Q3MIEU806M]J)$,UL]
MJ)=WGG['?[1'_!0'X*?\%&=%_P""=O[=OQA^&W[3C?&C]F6__:-^%?Q=\"?#
MC2_A3J7@W6/#<Z+XR^'>J>']'C-GK6EO<M/;:7K%RRS37%G%/"MK97 LHDYI
M.S3V3;Z*][)ZWN[.VX>S=FT[[Z6WM\[=C][Q(3CDD$9!"G#*1E&!*@;6'3..
M!D;E()<'.>3Z]O;CH,]:_'?]D3]JGXV_MG_\% _VK_$'P]\8067_  3[_91M
MD_9W\.V-GH>EW2_'3]H_<ESXZ\7VGBF>$:NOA[P*L;VFG0Z=+'8SS$6EVAER
M!^OY*X8A2-K!7R2&3<<*S+S\IZY!/I5)WLTFTW9;:ZV[WMY^3,GV::OH]M&_
MU5UT989V[$9XQCN<CCDCD] .,GCO3!*W.6SMSN"J">F0BY(W2GG,0Y!&,G.1
M^</_  5"_P""B/@O_@FI^S/=_&K6_#5S\0OB%XK\16?PZ^"/PIT^XDMM0^(?
MQ'UA6%G:M+!%<746A:-%C4=;DLX9=1F3[+IEE"EWJ5O/'^8/ASX>?\'-GQ=\
M"0?'$_M-?LB_L_>*]=T=?%'@_P#9:N_A1X7UVSTJSU2U6^TOPEXQ\:ZAH6MS
MV6M&)XX+TZA=^(YM/N)64ZDSQGRYE**E:S;WLE>RUZM^6FMWT1<::C%<T]W9
M-K5M[;)?EIU9_2\7<-M.,@X) )4@'!:,[ 95!^7*J/G#*<84L>80Q#';CD[@
M5(4!"6 *\A=X4\X5AM8J:_%[_@E)_P %,?B'^V_\,?VB/ 7Q_P#A=;_!?]L7
M]CWQ!JW@/X[^"]*AO1X7O-4LK?5(=(\2Z/%=RW<=BTVH:5>6&O>'C?W:P7=M
M]HM@FEWMJ#X?_P $N_VKOVXO^"D'_!,/]HGQ[=_%_P /^%/VK(_B)\7/A_\
M!KXCZ%\/?!^DZ)X?U+PD]OJ'@ZTU/PI;:?%H%_:7UY$=!U6^O+62Y32M1FO7
MDEO[:*XIJ:=K7U3:TM\.^]M>GKZ%.F]==O+_ (.WF?T(EG_VE!P%++@DX!.
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M2Y4G)5E5EVG\#?V5?^"COQ8MO^">_P"U+_P5G_:^U%-+^"7B'6/&'CC]E_X
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M4LX2HQM9M>]SMWL[V;:WWL^VWEJ/VD=KZ<JZ2MT\M_\ @]C\:_\ @E/^Q?\
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MOQ%\,Z)JFF:O83J;JXL;:]M;U4FTR>.SUJSO;2VTV&#X4^+_ .UU_P %PO\
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M?BCXJ>/_ -K/Q3XDUZRU2Y75;^?7K;Q#/H^A7]__ &-;?VOK$.GIIVM0:%8
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M+6RUG2OC%\!_$$,GA+XMZ+:VT:Z7]JGDOX9=1TVV064[3W_DRP7$L<D?R/\
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MO)?C[\7M'^ ?P2^*GQIUK+:?\-?!.M^*6A=LK<WUE:E-+M@N-SBYU.2UCDA
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M^?4<MECX9'Q'GV18C"QJ9%P9@)8>A2P6#IX:DY4\+2HT< X*<J2<Y)+\O?\
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M+<W_ (E33U@>&T\<:O$FMZK=:;$9-.URUTW5$M;N'3UT^;Y2^)G[ G_!8?\
MX*0CX+_ K_@I;X[_ &2OAU^R?\,?'GAWQO\ %F+]F>_\6:M\1/VD=6\(1F72
MX=6C\0Z?:Z3HFEZA=NPO/[-M]$LX+F<WZZ ][I^FR6XXR=])<S4+-7232BFW
MK%=&[M-6=K="U4AW5ENFG=IOI[OX75M[ZG]+?AKQ#9>+O#/AKQ5IJ3II_BCP
MYHWB+3EN$*O'9:SI\&HVBS(2"&6&:),RA95D,RR<E,\/XL^#GPH\1^,;'XP>
M(_AKX,UWXI^#O!WBO0/!GQ"UOP[I^H^+?"FBZQ9/<ZQIGA[6+F&2?2K:^N[2
MSN+I;%HW>XMH9&8-%&[_ "]^UOX6_P""@6K?$?\ 9,'[$GCOX.^!/A)X9^(=
MB?VM-#^)5EILWB#Q=\(+;5_#$(T3X;";P=XG:WU]O#%KXKMD-CJ'ABY6^N=-
M8:C'L5XONF^3SK34H(%0M>6=[9V^1M)-U9R6T +!<*B2W#%P%R8]DF#RQW6U
MG_773^M#&#L[M_S>;W=KG\Y?_!KD?^->WQ=) _Y/<_:#;"*H9L:9X$<(,E5)
MRA$2[E4%R!RQKMO$W_!Q+^SAX9^(WB'X:WG[(W[?%[J/A[QQJW@:[UC3/@(E
MUH5S>Z3K\WA^35-/O1XB62?3)[F$W=G<" /):O"XCW2;:^E/^"+?[#/QG_X)
MY_LJ>.O@G\=-3\ :OXO\2?M(?%#XLV%S\-?$6I^(M 'ACQG9^%4TB"XU'5-!
M\.W*:LDFD78OK6*QFM[8>4$O)V=@GZU+#:&02&PTYI0V]"=/LF=YR^0Q9H<L
MQ.P'>6W"-=VXY)SC&22Z/E2V3VOYK]0;C[5RW5HZZK:]]+-O==#^/KXJ^!?V
MA_\ @HO_ ,%N_P!H#Q!_P3H\>:?^Q%XE_8T\$Z5\'_VC?VMYY]:\8W?QFU;6
M$+Z-X0O/A''J%GX;UJTL+BVU/3H!=^1/<0^'7U6_O[EK+1+.*Y_P3NT;XJ_L
M+?\ !3G]N3]D_P#;(-I\<OVV?VJOV;/'/QE^&G[9\7B#7+C_ (6K\._#/@K6
M]6B\#:MX7U2:6S\'1VT7A/4-0@MM+\N]L)O#5IHEU]ML%T:>#[?^,_\ P3P_
MX*!_LN?MW?&3]N__ ():>,_@)XATO]J+3],/[0O[-/[2<GB?2/"M[XIT2)8+
M3Q'X4USP[$=0::\N8DO+:UBN]#O=*NKW6HI]4U#3]2BL[?TC]A[_ ()T_M83
M_MM^-?\ @IC_ ,%*O'GPD\4?M$7_ ,,[OX+_  A^#/P1&JW7PH^#OPRU*&]L
M]2LEUK68[34]6N+O2-5UK2187,5W/"VM:Q=7FLZI++8M99*$KQO&5U4<F]>7
ME?,DTKVO:W2][LU]I"WQ*UET=[Z>5[7^5NQ^$W_!"#]@[]J[]NK]@^?4[O\
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MTI2Z^Y_#_'%:DCJ*C+^@_/\ ^L:/,/<#^7^- $E%,#@]>/U_I2EU]S^'^.*
M'45&7]!^?_UC1YA[@?R_QH DHI@<'KQ^O]*4NON?P_QQ0)IM)+O%ZNVS3?X(
M]*^%W_(Q7'_8)N?_ $JLJ^@*^??A8P/B.X !_P"03<]?3[59?7VKZ"KSL3_%
M]%&__@+_ ,SMI)J%GW84445@:!1110 #/<Y]^E?/7Q2)'B: [2%72;3+$87!
MN;[.#T++P=O4YZU]"U&T4;\LB$X R44G@Y R<\#GCWX([Z49^RGS*[WW??\
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M )]O_P "7^0>P7\Q\:?*2<KP<D@$$N21]\L#N ^\%Q\KDE2JG;2Y0X.P!@
M0S=5W .0>K%6(;.03@@# K[*\F+_ )Y1_P#?"_X4>3%_SRC_ .^%_P *?US_
M *=K[X__ "(?5U_,_O9\;AU!SY2$9) ;)*@MG 8$$*,M\HPK;VW @X#58*%
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ME((4@JK8&&*@;\Y8=03<O]W!^;.#G=GCYRP9GP ,*S% 1PN*^R?)B_YY1_\
M?"_X4>3%_P \H_\ OA?\*?US_IVOOC_\B'U=?S/[V?&Y<9R%YR#R['YE14&T
M_>13M+%58 L<\8Y8=H.57^$)DX#%0V[DHJXP23A0 W'F!^:^R_)B_P">4?\
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M<;"N,T%AGHQ'<L[%LG[P_NX8@9)#.0 "QQ7V5Y,7_/*/_OA?\*/)B_YY1_\
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M4?\ WPO^%'UM?\^W_P"!+_(/8+^8^,Z*^S/)B_YY1_\ ?"_X4>3%_P \H_\
MOA?\*/K:_P"?;_\  E_D'L%_,?&G'H?S_P#K4E?9GDQ?\\H_^^%_PH\F+_GE
M'_WPO^%'UM?\^W_X$O\ (/8+^8^,Z*^S/)B_YY1_]\+_ (4>3%_SRC_[X7_"
MCZVO^?;_ / E_D'L%_,?&G'H?S_^M25]F>3%_P \H_\ OA?\*/)B_P">4?\
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MVA<\$GA1DD[MP#*5(I"P_A#J"2Q^<YW,JJS;L;F)"J 7+,H'!W88?9/DQ?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>ea028514801_img21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img21.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +8!K@# 2(  A$! Q$!_\0
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M0?\ /&/_ +Y7_P")_P Y/M@\J#_GBG_?*?\ Q-'_ !+GEO\ T468?^&S!?\
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MLM7_ *!5_P"!2_R/]<__ (>@?\$X_P#H^W]DC_P__P ,O_FD^O\ D<G_  ]
M_P""<7_1]O[)/_A_OAD?T_X20>_?^7/^1AY4'_/%/^^4_P#B*/*@_P">*?\
M?*?_ !%'_$N66_\ 119A_P"&S __ "\7^LE;_H%7_@<O\C_7/_X>@?\ !.#_
M */P_9)_\2 ^%_\ \TE'_#T#_@G#_P!'X?LD_P#B0'PO/Z#Q)D_AS7^1AY4'
M_/%/^^4_^(H\J#_GBG_?*?\ Q%'_ !+GE_\ T4>8?^&S _\ S0/_ %EJ_P#0
M*O\ P*7^1_KG_P##T#_@G'_T?;^R1_X?_P"&7O\ ]3)]/U]>#_AZ!_P3B[_M
MV_LDCW_X7_\ #+C\_$F/SX[^U?Y&'E0?\\4_[Y3_ .(H\J#_ )XI_P!\I_\
M$4?\2Y9;_P!%%F'_ (;,#_\ +Q?ZR5O^@5?^!R_R/]<__AZ!_P $X/\ H_#]
MDG_Q(#X7_P#S24?\/0/^"</_ $?A^R3_ .) ?"\_H/$F3^'-?Y&'E0?\\4_[
MY3_XBCRH/^>*?]\I_P#$4?\ $N>7_P#11YA_X;,#_P#- _\ 66K_ - J_P#
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M?MX?LDD]A_PT!\+^?R\29_+FO\C#RH/^>*?]\I_\11Y4'_/%/^^4_P#B*/\
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MD<?K]Q?;V^G^15F..((!Y<><D<QKZCO@8_7IVJO^)<,L_P"BIQ__ (;,%_\
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MN;P=_P#5K+-'K_PHX^UOE"R^:/\ 2S_X>!?L,]!^U]^S>._'Q@\"?_+PT?\
M#P+]AO\ Z.__ &<?_#P>!/\ Y=U_FI!(2>(T)P?X0./R]3FI0D(.1&O_ 'RO
MO_\ J^GZ[0^B7E#7_):X[_PTY>_Q]N<LOI+9NII?ZL97;37^TL?K_P"4[+YG
M^E2/^"@/[#AX'[7W[.1/H/B_X$/_ +FZ4_M__L.]_P!KS]G/J/\ FK_@8=>.
MVM@]Z_S6T2)B/W:?]\@'/./\CTX[U*(X_F_=IG(XVCT]^GH..WM5KZ)64/\
MYK;'+_NDY?\ G[=&$_I-YO#_ )IC++I72>98_O;^34_TGU_;_P#V'2>/VNOV
M="?0?%_P.?3M_;I_O#]:=_PW[^P^>O[7'[.N!S_R5SP.<=!WUIO7'3KGFO\
M-D1(\J!&F?\ =3KS_LYZY[U:6)><QI_WRO3G/;W'_P"KI:^B-E+M_P 9MCW?
M:V58#7_RN8/Z4.<I-_ZK96[?]3''K[W[--'^DBO[??[#Y.%_:X_9WSCM\7/
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M[OV21_W7_P"&(_5O$F/PQ[^U?Y&'E0?\\4_[Y3_XBCRH/^>*?]\I_P#$4?\
M$N67?]%%F'_ALP/_ ,O%_K)6_P"@5?\ @<O\C_7/_P"'H'_!.#_H_#]DG_Q(
M#X7_ /S24?\ #T#_ ()P]OV[_P!DD_\ =?\ X8'_ -!\2?S_ *<_Y&'E0?\
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M0/\ @G'_ -'V_LD?^'_^&7_S2?7_ ".3_AZ!_P $X>_[=_[)(_[K_P## ?\
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M_P#B?\Y/M@_XESR[_HH\P_\ #9@O_F@/]9*O_0*O_ Y?Y'^N?_P] _X)P?\
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M/_B0'PO_ /FDH_X>@?\ !.'M^W=^R2W_ '7_ .&!Q_WSXD^O7_&O\C#RH/\
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M\=O^+R> #^IUWFO\RX11JH'EISGG8N>OZ?S_  JQ%%"028T'3DJH!]<8&/\
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M?& ?T%?8>'T83XYX64]GG&&B]+^ZY54^C6Z71[^1PYI_R+\5W]GI_P"!1/\
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MY"JCL_5_F<%;XWZ1_)EJ#O\ C_2K2?>'X_R-58._X_TJRO4?4?SKIC\*]/\
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M^!/BKQ;XSMO ]SXN\2>-_!EUX5T72M-^)_C;1YY= %YI]VUK-KMU;?9M-O\
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M@'F]K;7=[=6ME8VMUJ%[>2I!:V%C;3WE[=SR,JI#;6UM')//+([*HCB1F)/
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M[Q+K_@?Q!I6AW4.!LN%U"\TY+983D$2S2IPP.<D9_P!1_P#:^_:'^#/[)?\
MP3N\*?M-_&GX<:=\5[/X'^"?A)XX^'O@S4+:UEEOOBT/"]IHG@FXTNZOK6]M
MM)O[.;6;V;^W#:7-QI%D+Z]M()KZ*VC;P_\ X).?\%*?#7_!8[X ?'"'XK?
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MQX<NE*KYH2"+4+>!)BP&YP'DD4;F*A:XV*-Y9(HHHY9YII$A@@MXY)YYYY"
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M+1]0TB6Z6-E20V\>I6\1G3S2I=H6(0$;CDC/]B__  6K^&WA/]@C]LS]B_\
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M%KWA70-4O]1\6>*)TBABFN8&OM6O&N+ZZN%@@6(_+O\ P4Z_9L\-_P#!3O\
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MP6*"2=@!SC%<SXS^'OC_ .&NJ+H/Q&\#^+? >L!';^S?%OAW4_#]](@^8O\
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M3X_U'XE:KY:[D2^B\1W,WAF256/VC3_#NGR$+Q5G_@X;_:3\0_L@_P#!4/\
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M?*W?XK6TLG]J]KG\HK,L:M*S*@12[2DX2)%4EI'7DA8P-VX<AE"@9-?VW?\
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ML/$OA_P] H2&'2]9TH31:!H\"1BT:"XMXMT21H,*_BKQ!E<\XRS.>$:F"SS
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MX13 .!D]2 3MP!U/.![U\7_^#;+]AW]H_P"/'QB^,VN_'OXT2>)?B)\0]?\
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MQ.+P>)R["U,#3K5Z>&C1@HU.:*<(RNH:>\GS2LK+;SY#XF?#KQ1\'_B3X_\
MA/XWM!8>,OAIXPU_P/XHLU;?'#K7AO4)M,O5B9208G>#S$ =R%<*SLP-<C4F
MH:GJ6M7MYJVLWU[JNK:G=37VI:KJ5U<7VHZC>7$ADGN[^_NWDNKV[F<EI[JY
MDDN)G.^>1Y-S&/\ S_G\J_H_#QJ1PM#VM13FZ-.-6:_Y?8J$8JO4]FV_JZ<D
MY1BF[II-MJ[^"KJ/-5E9T^>IS0IZ646W^6_Z+K*G0_7^@JTO0?0?RJJG0_7^
M@JTO0?0?RKHI[OT_4XJFR]?T'M_#_NC^M7JHM_#_ +H_K5ZK6WW_ )L\ZI\<
MO7]$6(._X_TJRO2/Z#^9JM!W_'^E65ZCZC^==$?A7I_F>9B/XK7=09-W/T'\
MVJQ'T7Z_UJOW/T'\VJ>+[J?A_.F<LOXD_3]$6JL1=4_WA_Z%5>IUZ#Z#^5;P
M?N?]O?I_P3FM[TO3\]#1HIJ?<7_=7^0IU:?8?^)'+6^!_P")?FS0JU!]P_[Q
M_D*J<Y[8P,>N><_ATQ^-6X/N'_>./R%0<,_A^:)ST7Z?U-2I]T?C_,U$>B_3
M^IJ5/NC\?YFMX_"O3_,YY_#\T6X^J_3^E3GH?^ _^AK5=/X?^ _TJQ3.:>C3
M\FOS7ZDZ]!]!_*I8^_X?UJ.I(^_X?UK:C\?_ &Z_T/.K_!_V\OU+2?='X_S-
M3G[GX+_2H$^Z/Q_F:G/W/P7^E=1Q3^"?^&7_ *2R2/JOT_I5R+JWT/\ )JIQ
M]5^G]*N1=6^A_DU!YD_B7I_F64^Z/Q_F:L0_>_SZ&JZ?='X_S-6(?O?Y]#6Z
MV7HOR,WL_1_D6JM1_>;_ #V6JM6H_O-_GLM7'XEZ_P"9R3Z?UU193J?I_45+
M4*?>'X_R-35LNOK_ )'G8CXI>B_)$B_<;\?Y"GKT'T'\J8OW&_'^0IZ]!]!_
M*MZ'Q2_P_J>77WB2Q]_P_K5M>@^@_E52/O\ A_6K:]!]!_*NDY*FR]?T%J=>
M@^@_E4%3KT'T'\J[*7P(XOM3_P ;_0L+T'T'\JG3[H_'^9JLF<#ICMC.<YJR
MN<#.<^_7K3GLO7]&<^*_AQ_QK\F.K^H'_@VU_P"/C]LC'7[+\#^G_7;XE?CG
MIBOY?J_J"_X-M/\ CY_;'_Z]?@?_ .C_ (E5^'?2(_Y-#Q3_ -?,C_\ 5Y@3
M]0\!/^3J\+OLLV_')\:?T]3XPF?O8?=]/GQ[>N??/;%%-E!VC.T@A\;_ +O5
ML_CTY/Y\<%?Y@UG9T];?NU^;/]',9_$C_A?_ *6ST:OY9?\ @[5_Y1]? _\
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M'_!PK_P6J/;^QO!V23T(U#P-GCGZ_AT Q7WO_P $]OV./V@?V%I/VA/VFO\
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MXUU6"9?#WBBQTK6O$%E+XAO[?0K'6'LEU&673[*XLI)EA74HQ)\[77_!?O\
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MO'GA[P?K?Q.O+)M4L? MOKM_;Z<?$-]I[W5BK6>GW%PKW3SWEK:VD2-.;B(
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MC)]9TSP@D.@V,\NJ>&$LH=9M]0O8?$5O8W)-K+IEM'(]PC5XU_P=0G_C-_\
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M(I=7TAY4DC2^TP?L?VFF?;+?>H#Q?;M-OK5I(V96EM95SE&5?FS_ (.V%/\
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M-:I4=ZV88Z4J>WP0DYR?W::]7H]S\@'Z] &"X=1SS@?-GN6SN(SCUQ7^G?\
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MJR]HUK!.*3DFG.+LSP<LQ]/+\76E5BYPG3J4TH)7YJBY4W=I6TUL[]3^MO\
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MQ_,BBB4G:G4@!OGVA<_+_?R3@?=YQROM17^8LVK0_P "_4_T<QG\2/\ A?\
MZ6ST:OY9_P#@[5P?^"?GP0Y_YN[\%$8[X^%7Q@//MWK^IBOYH?\ @ZG^'^K>
M+O\ @FQX?\4:>$^P_"K]HGX=>,O$&Z6&,#3=7T+QC\/;<#SG1WW:KXSTX*EM
M'+.6P1&(A,Z?9^'TH0XXX6<_A6<8:3=TE92JZ7;2W:ZJ^V[2)S3_ )%^*\Z=
MK;_:CT/\Z6BDR/44M?Z%?U^I^;!1@>E%% !1110 4$9X-%%']7#^K#&48^4[
M<9P0>1GI@D\$=O>O2OAY\:/C'\'YKJX^$OQ<^*'PNEU"2.74I_AQX_\ %7@A
M]0EB7]R^H'PQK&G1W;J,Y^U(^>_&17F? ']X'OTQCT]_RZ4*1_>.!ZCTZ>N.
MN,_J.*YL3AJ&+I.CB\-#&X9KX)QA*]]+.,XS3[:Q=U>^AO&3IJ\6U;31/?RW
M:W_$]P^)'[2O[1OQATHZ+\6OC[\:OB9H?F1S-X?\?_$_QSXLT$S0#SH+L:-K
M>M7FDR2X&0ZVJLK8(YKQ'&5'J3WYX!/7IG'TY]/1<HW1><YSTSC&>!@=QCCU
MSUI .ZM@'MC/\ZG"8+"8"BJ.$PM/ Q6O)2A3A'75Z4X0CJVV_=5W=O744I5*
MG\6\GI9/FZ+SOKU6K[=A^!Z4445UF(4F!Z"EHH 3 ]!2T44 %%%% !1110%W
MW848!ZC-%% "8'H/RI:** $P/04M%% "8'7 SZXI<#TZ=*** "C ]*** "BB
MB@ P.N.?6C ]*** $P/04M%% !1110 8'I1@#H*** N%%%% !1@>G7K110 8
M Z#%%%%%@"E7J/J/YTE*O4?4?SI/9^C_ " LK_%_NG^E68^57///?_=JI5B+
MC;GW_K5TW[J_PG#7OS+?XGW[ED<GGG@]>>QJ>(XV\@#/.[.W&?XL*QV_WCM;
M R<$5$G1_I_C3T/R_4$?K_\ 6IP3;:2N[.R[OI^)A-7:2ZJR^]G>> /B)X^^
M%?B:T\9?#+QKXK^'?C*QM[R"T\4^"O$&J^%?$5G;WD?D7=M%J^C3VVH06=_&
MN+J.)U@N8T0NNX8,7B_QGXO^(?B35?&GC[Q3XA\;>+M?N#=ZWXJ\5:Q?Z]K^
MJ72QI&);[5=2FGU"^=518O-N9=HB6, < 5R8XP1SZ@]B,'L?>I0>!GOG'4CU
MQ[8]*;PV#>(CCEAH1Q:H^PG4Y8\_+_*YJ"J.*EJHN;@I6?+?WC&4ZDKP;=HW
M=M;)=TN:VWE?HW;>U4\?1?K_ %J"IX^B_7^M;PW^7ZG!5Z_XO\RW']\_[H_F
M:DB[?[W^%1Q_?/\ NC^9IZ=#]?\ "MJG7_''\F<T_A^:+R=3]/ZBK"=3]/ZB
MH(^_X?UJ9?O#_/:K2]Q_,Y)OWGY)?E^!*O\ K5^A_D?\!79>"O&WC'X<^)M+
M\9^ /%7B#P1XMT22XFTCQ1X5U>_T#Q!I,EU:7%A=RZ;J^F7%I?V<MS8W=U93
M/;7$;RVUS/ Y:.5T;C5_UBGM@\]NC=^E6EP3UXQSWS^AS_\ 6SVH=&EB*4J%
M:G&K1K0E2JTI*,HU*<TXSA*,E*+4HMIJ46FFTTUH^"4W&HYQ:YHSYHN_VD[K
M6^FO6Z:WT.V\:>/?&_Q,\27WC7XC^,?$OC[Q=J<=I%J?BOQ=K6I>(M?U&.QM
M(;.PCN]7U6YO+^ZBL[2&.UMDGF*6T$<5M'@1**YA<8)'3VXZY'Y9Z]ZA3!4'
M!;TQG/4_0<>@Z?K4X(VMS_=_GC_]?IWK2E2HX:%/"TJ,<)AZ22HTZ<5&"Y=(
M02C%12ULHJ,8KHEH>?7J3E4G4J-7E?JWS-W5]]]='KUUW9.G\/X?TJP,Y?O\
MHX^C'^55U_A_"K"Y);J, $'^?Y#]:Z4VG=-IK9K=>:\UN>?O&:<N6[:YNVCU
M^1IV-Y=Z=>VM_IUY<Z??V-S%=V.H64\MI>V-U;2+-;WEI=V[Q7%K=6\B++!<
MP213P2*LL4B.BL/:_%W[2'[17Q#T.3PMX]_:!^-?C?PU-''!-X=\6_%;QSKN
MA74*L#$ESI&K:]>V5^ RKMDN;5W3Y624, :\+!R5&!UZ\YY.?\]:MQ'YAD\8
M_#/;]:FM@L!B9T:V(PF6XBOAYJ=&MB:-.>)I3334J$Y4YRIU+Q7PR@V_BNMH
MAB*M*$Z<*\E"<90E%.:4D]'=*44[]FFMRRB@(,=%(!4[5P67*F.(@LD<83RE
M(/.>?2K4?^M?_@7_ *$*K9!Z$&K,?^M?_@7_ *$*ZWLOR[?=_DCSZ_V?G^A8
MK0BZ1_[H_P#0:SZT(NB?[H_]!J3DJ;+U_0<WWC_GM5A?O#\?Y&J[?>/X?R%6
M$^\/Q_D:W6R]$<U3I\RVG0_7_"IX^_X?UJO'W_#^M6$[_A_6F<=7[6M]O/MZ
MDHZK]1_.K"]1]1_.JV0>AS5A/X?P_I6]#=^AYU?>/H_S1;3J?I_44U>H^H_G
M3DZGZ?U%-7J/J/YUTGFXGXJ?S_-%M?OM^/\ ,5=AZ#Z'^=44ZGZ?U%6XNW^]
M_A3C\2]3G3M)_P"%?Y%JK,'1OJ/Y57'1OI_45/#GG^[W_(_IGT]\UN8R=U)]
M[EI/O#\?Y&K:=#]?Z"JB?>'^>QJVG0_7^@JX;OT_5''-Z_+]66$Z'Z_T%3)T
M/U7^=0(0 <D#GU^E3(1@\CJO?T/-:)['EU=W_B?YL>/OM]/\*?3!]\_3_"I!
MG/'6NRC\'_;S_0\NI\3_ *[EB/JOT_I4PZM]?Z"H4/()X]<\=CZ]O2I@02V#
MW_H*U7Z,YJNS_P *_,>GWA^/\C5J/O\ A_6JJ?>'X_R-6H^_X?UKLI_#_79'
M _X<_P#M[\RVO0?0?RI::.B_A_Z":E0#G/8@_EFM&E+1[/?[T_T//J[:*[O"
MR_[B1]=KWV#H6&.<'D=N,_ESC\!Q7^CA_P $[/\ DQ']D+_LWKX7?^HIIE?Y
MQSX D9CA0C,6+;5"A2S$M[ < =>AXR:_THOV+O!][\/OV2OV;? ^I.[ZAX6^
M"GPZT6\9[5K-S<6/AG3H92]J^6MGW*=T+'*'Y>PK^1/I>UJ;R'@RDI)36>9I
M+E;2DTLIH1NHMIN-W;F2:OI>^A_4'T3:=1<1<8SDGR_V/A8\UFE_R.JLDKVL
MW9-M7O9WM9W/IRBBBOX2/[E"BBB@ HHHH **** "BBB@ KD/B#_R(?C7_L4O
M$O\ Z9;ZNOKG_%EA-JOA?Q%I5O\ \?&IZ%K&G0?='[Z]TZYMHLEBJ ;Y5R79
M5'\1 YJH-*I3;V]I3_\ 2X$R^&7H_P C_%>MR5CB&."F!]#Q^."/_KU8'?ZG
M/YFNH\;>#=2^'?C?QO\ #[6MO]K^ /&'BGP1JX5XI%35_!^N7_A_4@98I)(G
M8WMA<,WV=Y+=6!V2%=A;EE/7W9B/?! /Y'@^E?Z59?*G4P.$=/X5A<(]+-->
MQAV;T5]]MO(_+ZJ:K8AZ_'+H^[3;'4445V679?<C$**** $P/04M%% !@'J,
MT444 %'K[]??Z^M%%%@"BBB@ P/2BBB@ I,#T'Y4M% 7"DP,YP,^O>EHH"[[
MO[V%)@>@_*EHH ,#ICCTI, = !^%+10 4F!Z#\J6B@ HHHH **** "DP/04M
M% !1110 5ZI\,/CK\:_@B^N2_!SXN_$KX4OXC@@A\1-\._&GB#PC_;MO:+,+
M>/64T+4;'^U(K59IQ;QW4<ZQM,ZKL61PWE=(W3M]3SCZ#H<]/Y5AB,/A\52E
M1Q6'ABJ$G%RHU(PG"3C)2BW&<91?+)*6L7LNRM<)2C).+L^]VM]'^#8^YFFN
MIYKFYEDFFGGFGN+B:5YIYKB9S)-+/)(6DDGE=R\\KL[RSM([DDU&H ' Y'4X
M(SW'!_S^E-&#QDG/U X[>W\N*<""3C/'K_GV_4UJN51C'E]DEI"GO=>;UV6M
MF[;;L<DG>3UDEO9]7]_S?RL+@>@_*C ]!^0I:*HS$P!T %-?@9(XS@GTW'KU
MSC@Y_+//+Z:3CJ.._P!#D=._3G^M%FVK*]FI-=U'5_@5"]]#U[X<_'WXZ?"#
M1O$GAOX4?&/XF?#30?&!C;Q7HG@3QOXA\)Z5XGQ93Z:@U^RT74K.WU5DT^XN
M;%#?0SA;6:2W#"*5E/D"*B#9&&55^4!BQ"@ 8 !R%PI VAFVXPQR*"% )QT[
M<C/3_/I3P<\BN:GA,)2Q%?%4,/3IU<6TZ\XPA&4Y05DYRC",YM)<J=24VEI%
MJ.A<I2:LY.RZ-Z)^6K76]DHKUU# '08I,#T'Y4M%=)E=]W][$P!T %=[\._B
MI\3_ (0ZY+XG^$_Q)\>?"_Q%+:FQGU[X>^+_ !#X+U>ZL6;>VGW6H>&]2TRY
MO+$OB1K"ZG>V+_O/*+ $<'2;@IY /&><<C/(&1_^NL,11HUZ,Z.(P\<52JKD
MG1G&,H34M%S1G&49)/6THR7D7"<X2YH-J2V=WUT=O.W7<]!^(WQ;^+/Q@U&W
MUCXM_%/XB_%'6;.*6*SU/XB^-_$GC>[TVWF.9H-,NO$VH:C)IL4GRF9(#%'R
M=J.?GKS[NW0@X)*D%2Q&&";0%V+@!2H ;DD9--'S$L>I/Y'U_EP<]/>G#/<Y
M_#%*AAZ.$I4<-AX0H4J*:5&$8QAJM%%0C"*4>B22[+HG)RE>4[N75MW=[[MZ
MMZ6Z_P"99B_A_'^M3Q@9DXZ X]NM01?P_C_6IX^LGT/\S6\/M^K_ /26<.(^
M*/I_[>BTOW!_N#_T*K*@8!QSY><^^3S58?='^X/_ $*K"$;1R/\ 5XZ]\GBK
M?Q?]O?J<<NG^%?D21_<7Z5/'W_#^M0I]T?C_ #-3)W_#^M;'-5^*%O.]O7K_
M ,$M)]T?C_,U-'W_  _K4*?='X_S-2IU/T_J*:W7JOS1SSWE\_R+:?='X_S-
M6JK+T'T'\JLUU3VCZ?HCCGM\T2IT/U_H*M+T'T'\JJIT/U_PJT.@^@IT]WZ?
MJ<U39>OZ#V_A_P!T?UJ]5$\[<<_*.G-7L@]#FK6W]=V>=4^.?K^B+$'?\?Z5
M97I']!_,U6@[_C_2K(ZCZC^==$?A7I_F>9B'^]?6Z@3=S]!_-JL1]%^O]:K@
M@DX.>!_,U8B!VIP>,9X]Z9RR_B3]/T19JQ%U3_>'_H55ZG7H/H/Y5O!^Y;^]
M^G_!.:WO2_P_GH:-%,0C:HR,[1QWZ4^K^P_\2.6M\#7]Y?FS0JU!]P_[Q_D*
MJ<Y]L#\^<_TJW!]P_P"\<?D*DX9_#\T3GHOT_J:E3[H_'^9J(]%^G]34J?='
MX_S-;Q^%>G^9SS^'YHMQ]5^G]*G/0_\  ?\ T-:KI_#_ ,!_I5BF<T]&GY-?
MFOU)UZ#Z#^52Q]_P_K461ZBI8^_X?UK:C\?_ &Z_T/.KOW/^WD_S+2?='X_S
M-3G[GX+_ $J!/NC\?YFIR1LQGG X_*NHXIZ0G?3W9;Z?99)'U7Z?TJY%U;Z'
M^353CZK]/Z5<BZGZ?T:@\R?Q?+_,LI]T?C_,U8A^]_GT-5U^Z/Q_F:L0]2>W
MK^!_Q'YUNMEZ+\C-[/T?Y%JK4?WF_P ]EJK5J/[Q]^GY+5Q^)>O^9R3?]?-%
ME.I^G]14M0K]X?C_ "-2Y!Z$'\:U[^O^1YU?XI>B_(E7[C?C_(4]>@^@_E4:
MD;6Y'?\ E4J@X'!Z#M[5O0^*7^']3RZ^\22/O^']:MKT'T'\JJ(",Y!'3K^-
M6UZ#Z"NHY)[+U_06IUZ#Z#^505.H.!QV'\O_ *Q_*NNDTH*[7WK_ #.+[4_\
M;_0L+T'T'\JG3[H_'^9JNF[CI[=<YS5A3P,GGKSUQGK53U2MKKTUZ/M<YL4U
MR15U\:TOKL^@ZOZ@/^#;4_Z3^V1W_P!$^")P/^NWQ)_$]N?< ]J_E^) ZD#Z
M^W7\J_JM_P"#<'PE>VG@O]J?QZ\DG]G:[XF^'GA2W3[.SHMYX5T[Q#JEX4E&
M//D>+Q591O:CA$Q+]]XR/PKZ1E2G3\(^)8U&E[2MDT%%M*3DLVPTVHQNI-\J
M;:2;Y4W:R;7ZMX 4:E7Q5X;=.]Z5+-YS=G:,?[*Q4;R>T5S2BDY65VEO8_I1
MN !L'?+;O3&YB/;IG..^>V**)P=V&V@%F&TY*J02"H!YZ\9X[XP ,%?YJ04;
MSY;--Q:^=.'=+_AS_17&1YIP<KWY)+[IR\CT.O$OV@?@1\-_VG/@O\2/@#\7
MM!C\0?#KXH>&=1\+>([%EB^TQ0WR;K35=*GN8;A;'7-"U!+36-!U..*2;3-8
ML+6]A"R6Z8]K9MN.,YI<Y&1Z9_S_ )/M6%.I.C7HXBC5E0KX>49PE!M2A*,H
MSA.,E9QE"4(RA):J23Z6?;.*FG%K1IW[=5;\?FC_ "8_^"@G_!+[]J+_ ()Y
M_%;Q)X1^(W@#QCXC^%*^([O3_AG\=-'\.WEYX%\>Z)(PO-'GDOM-CO(]&\20
M6$D8U[P]<RJ=/U1A DLD$ELS_FF^HV".4>]M(WC9DD62ZB216!P5E1G5XV7H
M58 @]0.@_P!J[5-'TGQ#IUUI'B#2]/UO2+S8+O2]7L+74=-NA%-'<1+<V%[#
M/;3K%-%%/")H6\N:!)AAPI'@$_[&7['MQ--<7'[*/[-5Q/<RO-///\"?A=)-
M<RRDO+-+-)X5+332M\TCN2S-EB2<5_1N3_2%QF&P&'P^:Y#1S'$TTHRQ^%QT
M\-+%I12C*I"=.HE+W?>47RZ.UEHOF:W#=.51NAB)0UNTTI;WNMUI?NK^7;_'
M-_M/3?\ G^L?_ J+_P".?YS]<']I:;_S_P!A_P"!47O_ --/\Y^N/]C'_ABK
M]CG_ *--_9F_\,+\*_\ YE:/^&*OV.?^C3?V9O\ PPOPK_\ F5KU/^)C:'_1
M*UO_  [4?_F0R_U9J?\ 09_Y(_\ ,_QSO[2TW_G_ +#_ ,"HO?\ Z:?YS]<+
M_:6F_P#/_8?^!47_ ,<K_8Q_X8K_ &.O^C3OV9__  PWPL_^96D_X8J_8X_Z
M--_9FQ_V0;X5_P _^$4_I3_XF-P__1*UO_#M1_\ F07^K53_ *"W_P" /_Y(
M_P <_P#M+3?^?^P_\"H__CE']I:;_P _]A_X%1__ !RO]C#_ (8J_8Y_Z--_
M9F_\,+\*_P#YE:/^&*OV.?\ HTW]F;_PPOPK_P#F5I?\3&T/^B5K?^':C_\
M,@_]69_]!G_DC_S/\<_^TM-_Z"%A_P"!4?\ \<I?[3T[_H(6/_@7'_\ '*_V
M,/\ ABO]CK_HT[]F?_PPWPL_^96D_P"&*OV.?^C3?V9O_##?"O\ ^96G_P 3
M&X?_ *)6M_X=J/\ \R"_U:J?]!;^<'_\D?XZ']IZ<>NH6)_[>X__ (Y2?VEI
MO_/_ &'_ (%1_P#QRO\ 8P_X8J_8Y_Z--_9F_P##"_"O_P"96C_ABK]CG_HT
MW]F;_P ,+\*__F5I?\3&T/\ HE:W_AVH_P#S(/\ U9G_ -!G_DC_ ,S_ !S_
M .TM-_Y_[#_P*C_^.4?VEIO_ #_V'_@5'_\ '*_V,?\ ABO]CK_HT[]F?_PP
MWPL_^96D_P"&*OV.?^C3?V9O_##?"O\ ^96G_P 3&X?_ *)6M_X=J/\ \R"_
MU:J?]!;_ / '_P#)'^.?_:6F_P#/_8?^!4?_ ,<H_M+3?^?^P_\  J/_ ..5
M_L8?\,5?L<_]&F_LS?\ AA?A7_\ ,K1_PQ5^QS_T:;^S-_X87X5__,K2_P")
MC:'_ $2M;_P[4?\ YD'_ *LS_P"@S_R1_P"9_CG_ -I:;_S_ -A_X%1__'*/
M[2TW_G_L/_ J/_XY7^QC_P ,5_L=?]&G?LS_ /AAOA9_\RM)_P ,5?L<_P#1
MIO[,W_AAOA7_ /,K3_XF-P__ $2M;_P[4?\ YD%_JU4_Z"W_ . /_P"2/\<_
M^TM-_P"?^P_\"H__ (Y1_:6F_P#/_8?^!4?_ ,<K_8P_X8J_8Y_Z--_9F_\
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M_P#1IO[,W_AA?A7_ /,K2_XF-H?]$K6_\.U'_P"9!_ZLS_Z#/_)'_F?XY_\
M:6F_\_\ 8?\ @5'_ /'*/[2TW_G_ +#_ ,"H_P#XY7^QC_PQ7^QU_P!&G?LS
M_P#AAOA9_P#,K2?\,5?L<_\ 1IO[,W_AA?A7_P#,K3_XF-P__1*UO_#M1_\
MF07^K53_ *"W\X/_ .2/\<_^TM-_Y_[#_P "HO\ XY2?VEIO_/\ V'_@5%_\
M<_S@^V?]C'_ABK]CG_HTW]F;_P ,+\*__F5H_P"&*OV.?^C3?V9O_#"_"O\
M^96E_P 3&T/^B5K?^':C_P#,@_\ 5FI_T&?^2/\ S/\ '._M+3?^?^P_\"HO
M_CG^<'VR?VEIO_/_ &'_ (%1?_'/\X/MG_8R_P"&*_V.N_[)W[,__AAOA9_\
MRM'_  Q5^QQ_T:;^S-_X8;X5_P#S*4_^)C</_P!$K6_\.U'_ .9!?ZM5/^@M
M_P#@'_VQ_CF_VEIO_/\ V'_@5%_\<_S@^V3^TM-_Y_[#_P "HO\ XY_G!]L_
M[&/_  Q5^QS_ -&F_LS?^&%^%?\ \RM'_#%7['/_ $:;^S-_X87X5_\ S*TO
M^)C:'_1*UO\ P[4?_F0?^K-3_H,_\D?^9_CG?VEIO_/_ &'_ (%1?_'/\X/M
MD_M+3?\ G_L/_ J+_P".?YP?;/\ L9?\,5_L==_V3OV9_P#PPWPL_P#F5H_X
M8J_8X_Z--_9F_P###?"O_P"92G_Q,;A_^B5K?^':C_\ ,@O]6JG_ $%O_P
M_P#MC_'-_M+3?^?^P_\  J+_ ..?YP?;)_:6F_\ /_8?^!47_P <_P X/MG_
M &,?^&*OV.?^C3?V9O\ PPOPK_\ F5H_X8J_8Y_Z--_9F_\ #"_"O_YE:7_$
MQM#_ *)6M_X=J/\ \R#_ -6:G_09_P"2/_,_QSO[2TW_ )_[#_P*B_\ CG^<
M'VR?VEIO_/\ V'_@5%_\<_S@^V?]C+_ABO\ 8Z[_ +)W[,__ (8;X6?_ #*T
M?\,5?L<?]&F_LS?^&&^%?_S*4_\ B8W#_P#1*UO_  [4?_F07^K53_H+?_@'
M_P!L?XYO]I:;_P _]A_X%1?_ !S_ #@^V3^TM-_Y_P"P_P# J+_XY_G!]L_[
M&/\ PQ5^QS_T:;^S-_X87X5__,K1_P ,5?L<_P#1IO[,W_AA?A7_ /,K2_XF
M-H?]$K6_\.U'_P"9!_ZLU/\ H,_\D?\ F?XYW]I:;_S_ -A_X%1?_'/\X/ME
M?[2TW_G_ +#_ ,"H_P#XY7^QC_PQ7^QUW_9._9G_ /##?"S_ .96D_X8J_8Y
M_P"C3?V9O_##?"O_ .96G_Q,;A_^B5K?^':C_P#,@O\ 5JI_T%O_ , ?_P D
M?XY_]I:;_P _]A_X%1__ !RC^TM-_P"?^P_\"H__ (Y7^QA_PQ5^QS_T:;^S
M-_X87X5__,K1_P ,5?L<_P#1IO[,W_AA?A7_ /,K2_XF-P__ $2M;_P[4?\
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M\.A^O_".9'\J%]*K!77_ !AM=OM_;6'=_*RP9$OH_P",Y7;B?#-VV>5S5_\
MMY5KKU1_EQ+J.G[1_I]J/87$/K_O5,-0TXK_ ,?]H3SP;B'U]F!^G;IFO]13
M_ADW]EC_ *-I^ 7_ (9[X=__ #.?YP?0X5?V3/V6,Y_X9I^ 0/K_ ,*=^'1/
M_J.?YQCJ*U7TJ\(M?]2:OSS>A_\ ,?\ P##_ (E]QST?$F$7FL!6;7R=:S]#
M_+S34+#Y<7ED>/\ GYA Z=OGSZ?KZ\6DU"Q"Y-Y:#GH+F$_C]_L/3MVXS7^H
M/_PR=^RU_P!&V? /_P ,[\.__F<H_P"&3_V6QR/V;/@'G_LCWP[&?;(\.52^
ME?@U_P T54^6;X=?C]3,I_1WQLD_^,HPVV[RJ6GRC64G\FO4_P OU=0T_!)O
M+4\X_P"/B'^K^O\ +'J*F74-/VG%Y;>P%Q#Z^S\_7\S7^GX?V4?V73_S;7\!
M/_#0?#O^OATT@_90_9=!R/V;/@+_ .&A^'G_ ,SM7_Q-A@[?\D35_P##UAO_
M )C.2I]''&S=O]:,)JT]<GQ+_#ZU;H?YABWU@<8O+4<=?/BS]/OCGIGZU+]N
MT_\ Y_+;_O\ P^_^U^IZ<=.:_P!/'_AE3]F#I_PS;\!<=<?\*A^'O7U_Y%ZC
M_AE7]F =/V;?@,/<?"'X>Y_]1VM8_2VPD5;_ %(J/_NM89?^Z1S2^C1C9:/B
MS"6>C7]BXC7_ ,NO^ ?YBBWUA\N+NV[?\O,/\MW]?QJ8WUES_IEJ/^WB'^KX
M_/U_+_3E_P"&5?V8O^C;_@/_ .&B^'G_ ,SM!_96_9B[_LX? C\/A%\/?Z>'
M?\FJ7TN,)=6X'J7_ .QWAO\ YB,9?1BQ<EIQ7A4[67_"-B?_ )LT/\R!+ZQW
M#%]9D]L3P>X[.?\ (JTM]9\XO+<\=YXNF3T&[_/'I7^FH/V5OV80<C]G#X$J
M?7_A4?P_'Z_\(Z*<O[+'[,1.!^SG\"A[_P#"I/A__P#,]6R^EUA5=O@:LVNJ
MSO#:?^639SOZ+F.<7'_6["*__4FQ2_+%-?C]Q_F7K?V6,?:K?//_ "VB]SP-
M_P#];IVJ_:C[>XBT\27T^5416*&[E+2':B[(!(VYSGRUVEY6(2,,Q K_ $PV
M_98_9D49'[.OP+SV/_"I/  Q@$]O#V>W]:T-*_9X^ 'AZX2^T#X&_"#1;Y)+
M>=+G2?AMX,TRX6>U<2VDGVBRT2&82VL@#VTRN&ADPZ$'FE+Z7N'<7[/@:ISV
MM%O.Z25U9ZN&$C-+37E:=KZ[IY+Z*F+E)>UXPPJIM^\Z>48B$U%Z/EG+%.,9
M)/2332=KIH_D _X)4?\ !*;XF?'CXD^"OC5\>O ,V@?LY:!.VN)I/C"VN--U
M+XI7EK%,NE:;8Z),(]030(]3^SWNHZG=1P6U[#8/IL*RBXE\O^UZSMX;6""W
MMX8X(+>)888H^$BBC58XXXP,#RT1%1!_"J@"GHF<#L!GD8('&%)'RL00<GC
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M ,RM/_B8W#_]$K6_\.U'_P"9!+AJH_\ F+:]8/\ ^2/\<_\ M+3?^?\ L/\
MP*C_ /CE']I:;_S_ -A_X%1__'*_V,/^&*OV.?\ HTW]F;_PPOPK_P#F5I?^
M&*OV.AT_9._9F'_=!OA9_P#,K2_XF-P__1*UO_#M1_\ F0?^K4_^@Q_^ /\
MS/\ '._M+3?^?^P_\"H__CE']I:;_P _]A_X%1?_ !RO]C$_L5?L='K^R=^S
M,?K\!OA9_P#,K2?\,5?L<_\ 1IO[,W_AA?A7_P#,K3_XF-P__1*UO_#M1_\
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M%7[')Z_LG?LSG_N@WPL_^97Z4G_#%7[''_1IO[,W_AAOA7_\RE/_ (F-P_\
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M^@A8?^!<?_QRO]C$_L5?L='K^R=^S,?K\!OA9_\ ,K2?\,5?L<_]&F_LS?\
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M*_V'C^Q7^QR,#_ADS]F<CKQ\!OA8!^/_ !29_0Y_JX?L6?L<X_Y-,_9G'T^
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M_P!&G_LTCZ? GX6?_,IWH_X8O_8]'3]E#]FK'_9"OA:/;MX4]*K_ (F1PO\
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M *^?(_RJ5U"PX_TZRXQ_R]0>W;S/T]CZ'$XU"P_Y_P"S_P# F ?^U*_U4/\
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MC.:7@+C9[\34+;ZX&I45_P##*HE\]T?Y9Z7UAD$7UGG_ *^X<]/=OZU9CO\
M3RPW7UIG/_/S"0>O4[R/;VQ7^I3_ ,,D_LJ?]&R_L]_^&;^'7_S-4A_9+_96
M'3]F?X 8]O@[\.@!]/\ BFQQ_P#7]#3C]*K!WTX-KR?9YSAVON6#,)_1_P :
MUIQ-A9.ZT>6U(6WZQK7^1_ER+?:<0/\ 3K,?2Z@]?]^I5U&P!P+^SR!U-Q">
M/P8BO]1;_ADS]E@?\VT? (?]T>^'0_\ =;_S@^AQ(/V3/V6 !C]FOX!#O_R1
MWX=']?\ A'.:N7TK,(E=\%UH^:SBBOSP9G_Q+[C9)I\2X57W?]GUIO[G62^9
M_EW+J-CM&;RR/7DW$/K_ +XJTNH6&X?Z;:=_^7F'T_WZ_P!0G_AD[]EH=/V;
M/@&/^Z._#O\ ^9R@?LG_ ++8Z?LV_ ,9ZX^#OP[Y_P#+<I0^E=@T[_ZFUI>7
M]LX?OOK@S*?T=\8UIQ/A-^N4U7_Z1B%+[VUW/\OU=0T_G-[:G'I<0_S+^_;U
MSUP:D74-/SQ>VO3O<0?T?_/X#'^G]_PRC^R[C'_#-?P#ZGG_ (4_\.__ )G,
M<_3- _91_9= _P"3:_@)GG_FD'P\R/3G_A'?\:V_XFPP?_1$U?\ P\X;_P"8
M['++Z.6,DVWQ1A;-:_\ "1B?31+%:_\ #G^8.M_8=[NU/_;Q#C_T/_/3UJP+
M[3R/^/RV_"XA_+EQ^(.>G6O]/$?LI_LOC_FVSX"G_ND/P\]NF/#HQTS]>:7_
M (94_9?_ .C;/@+_ .&A^'O_ ,SU:0^EG@X/_DB*C_[K6&_^8F<E3Z-&,J.[
MXIP:6]O[&Q+_ /=M'^8@E]8<XN[;MUN81Z_[1JTM]9$#_3+7I_S\0]N/[]?Z
M<O\ PRK^S#V_9N^ P]A\(OA[_P#,[2']E7]F'O\ LW_ G\/A%\/L?IX=Q6B^
MEOA/^B'J?^'K#?\ S$C*7T8L:U:'%F$36O\ R)L2M/+_ &O?8_S(!>V1'_'W
M:9XY\^$GH,\;OS],GTYL+?V05?\ 2[<\#I/#CMQ]_MT(['/M7^FO_P ,J_LQ
M8X_9P^!(_P"Z1_#[^7_"/"E'[*_[,@'_ ";C\",#U^$GP_'\M %:+Z76$VEP
M/5=NG]MX9?C]2,']%_&MN_%F%?\ W1<2]?\ PKU]3_,L6^L\ _:K8_6>+/4?
M[?M^IJ:.[M9"L27$+R.=J*DL;NS,<!456+,Q.,*!DG&.U?Z9A_99_9E'/_#.
MGP*.?3X2_#_MZ?\ $@_E^-1?\,P?LU03136_[/?P/MYX9EECDM_A+X#%Q'*H
M+120R1Z"#%*IC)5U8$#80>@)+Z76"Y917!%6',K<ZSNB^5[WO#!J47=64DU9
MM;-D2^BWC9.,EQ7A7RRYG%9+6BY))JT95,3RJ6MT]U8_SV/V:_V/_P!H#]K+
MQO:^"O@YX UC6I";:76?%%_:3:7X/\,:9+<"WEU36=?O(HK*.*$B91:VTEQ?
M74J-!;V[3@*W][O['_[+G@S]CSX!>"_@SX.L[5I])L;34?&NNV4<D#^,_'<]
MG90^)/%,ZSDSQ3ZA=01"VM9"WV+3X8+)&*6Z-7TSHWA[0O"NG1Z-X9T+1O#N
MCV[R30Z/H6FZ?HVFP232M)),MG8P6\"74Y;SI2D2[Y&9FW-EC/(N\MG+ <C<
M!E1_#P3UV@9.><\U^&>*7C/GGB:\/AG@:&49/@:G/1R[#XF>+K5JW)*G'%YA
M6GR^TK1A*4:"4%&$9R:7.[K]E\,O!S)/#EU\9]<Q&;YOC(.%7,:V'IT:>'HN
M<9O!T7&\HISC&7Q-RY=7RI)XT_WBRN#\S<J3AN?O@GG+_?P>F3CI13[G/RXR
M5#'YL <Y.!N//'*\C^'OBBOQ=+ETD[/5O5K\-#]D<E+5;6LCT2BBBK$%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444679?<@"BBBE9=E]R_R ****=@"BBBBR[+[D 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M9YQWZT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#^M%+<$G;U*AC\Q4#)!P1N^]A3E03@<>P-%+32[_ !:VT[@>BT4450!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5"_WC^'\A4U0M]X_A_(4 0OCCU[_ /U_Z?C529@%8Y)"X5T( R6'RX(^
M8X!!Z8&?05;D[?C_ $JM(,#<3C)XR\: X'8E2W7U]^V* ,^5#P#C8 "V&W<-
MDKRW7Y< ]AC XJJ>,^N!SMR",<8/4X'I[#Z6)<'<> -B8^??_$>C8&X8]N.G
M:J[;ANSPN>"3QGZ=AD?CU%2_Z_X;K_PX&3<XPF<Y^8DD!>,G P.!@?X]Z*)^
MBDE"#GM\HPS @+V]#GOFBG\F_2WZL#T6D)P"?2EIK_=/X?S%, WKZ_H?\*-Z
M^OZ'_"H:* )MZ^OZ'_"C>OK^A_PJ&B@";>OK^A_PHWKZ_H?\*AHH FWKZ_H?
M\*-Z^OZ'_"H:* )MZ^OZ'_"C>OK^A_PJ&B@";>OK^A_PHWKZ_H?\*AI,C.,C
M/IGGOV_ _D: )]Z^OZ'_  HWKZ_H?\*@R.>1QG//3&,Y^F1GZCUI?K^.<=L9
MSGCN,Y]>: )?,3^\.WZ]/S[>O:EWKZ_H?\*^8OCA^U]^SG^SAXY^"7PW^-/Q
M.TKP-XU_:)\7R> _@YH>H07TD_C7Q1$;;=I=D]G:7,$$L9O+.)9[V6WA\RYB
M17W.!7TN>#@\'WH_K] _+N3;U]?T/^%&]?7]#_A4-&1ZC@@'V)Z9],^] $V]
M?7]#_A1O7U_0_P"%0Y!Z'-)D'H0?QI76FJUVU6O33774"?>OK^A_PHWKZ_H?
M\*AHI@3;U]?T/^%&]?7]#_A4-% $V]?7]#_A1O7U_0_X5#10!-O7U_0_X4;U
M]?T/^%0T4 3;U]?T/^%&]?7]#_A4-% $V]?7]#_A1O7U_0_X5#10!-O7U_0_
MX4;U]?T/^%0T4 3;U]?T/^%&]?7]#_A4-% $V]?7]#_A1O7U_0_X5#10!-O7
MU_0_X4;U]?T/^%0T4 3;U]?T/^%&]?7]#_A4-% $V]?7]#_A1O7U_0_X5#10
M!-O7U_0_X4;U]?T/^%0T4 3;U]?T/^%&]?7]#_A4-% $V]?7]#_A1O7U_0_X
M5#10!-O7U_0_X4;U]?T/^%0T4 3;U]?T/^%&]?7]#_A4-% $V]?7]#_A1O7U
M_0_X5#10!-O7U_0_X4;U]?T/^%0T4 3;U]?T/^%&]?7]#_A4-% $V]?7]#_A
M1O7U_0_X5#10!-O7U_0_X4;U]?T/^%0T4 3;U]?T/^%&]?7]#_A4-% $V]?7
M]#_A1O7U_0_X5#10!-O7U_0_X4;U]?T/^%0T4 3;U]?T/^%&]?7]#_A4-% $
MV]?7]#_A1O7U_0_X5#10!-O7U_0_X4;U]?T/^%0T4 3;U]?T/^%&]?7]#_A4
M-% $V]?7]#_A1O7U_0_X5#10!-O7U_0_X4;U]?T/^%0T4 3;U]?T/^%&]?7]
M#_A4-% $V]?7]#_A1O7U_0_X5#10!-O7U_0_X4;U]?T/^%0T4 3;U]?T/^%&
M]?7]#_A4-% $V]?7]#_A1O7U_0_X5#10!-O7U_0_X4;U]?T/^%0T4 3;U]?T
M/^%&]?7]#_A4-% $V]?7]#_A1O7U_0_X5#10!-O7U_GQ[TZJ]3KT'T'\J %H
MHHH **** "BBB@ HHHH **** "BBB@!N]?7]#_A1O7U_0_X5$W4_4_SI* )M
MZ^OZ'_"C>OK^A_PJ&B@";>OK^A_PHWKZ_H?\*AHH FWKZ_H?\*-Z^OZ'_"H:
M* )MZ^OZ'_"C>OK^A_PJ&B@";>OK^A_PHWKZ^OKVZ]NW>H:@N)8X(S/-+'##
M"&DFDE,:1QQ(C,\LDDC*D44:J7D=B%"CYB!S0!=WKZ]L]#T]>G3WH#J3@')Z
MX&2<>M?.GPI_:L_9J^.2_%=O@_\ '#X:_$BW^!7B"?PO\7-1\)^*=/U;1_A]
MK=OILFKSV7B+6()3I5L8-+AGOKB=+V>RBB@F=YP8I%7S/X/_ /!0[]AGX^Z!
M\5/%7P>_:L^"/Q#\._!""ZN?BUKOA_QSI3:=X TZR$K3:KXCN)Y+9++2P;>6
M-=50R:9/*HA@N99'52 ?:^]>!GD]!SS]/6@.AY# CU&>YP/S/'UKY>_9K_;#
M_9;_ &QO#&L^,?V7/CM\./CIX;\-ZL="UO4OAWXCMM:CT753$MPEGJ<"K#=V
M4L\+K/;/<01P3J?W$DRKFOS4_:7_ &]/VA/A;_P6S_83_81\)7WA"+X _M _
ML_\ CWXC_$6QU/PK'?>+)_$7AW5_&MG8-HGB<WT,FDV?D:%IGG6:V4X:5+DL
MY-PIA /W,W*<X.<9!X/!'4'CMW]*-R^OZ'_"J@ 3<S,<!69LG"J%R6.3@LHQ
MN/7/WB3G%<UX4\;^"O'=E<ZKX(\8^%?&FG6M[<:;=:EX2\0:5XBL+:_M'*W&
MG7%UI%Y>6T%]:L=MQ:O(MQ$V1)&IXK2-*K.E4K1I5)4:3A&I6A3J3I4Y57)4
MHU*L:<J5.57EE[.-2K3E4Y9*FJCC+E/+KVZ_=O\ @=AO7U_0_P"%&]?7]#_A
M4&1ZC\Q1D>H_.LP)]Z^OZ'_"C>OK^A_PJ'(/0YI,C.._''UZ4 3[U]?T/^%&
M]?7]#_A4.1DC(R.H[CZCM10!-O7U_0_X4;U]?T/^%0T4KK:ZOVOK_6J^\";>
MOK^A_P *-Z^OZ'_"H:*8$V]?7]#_ (4;U]?T/^%0T4 3;U]?T/\ A1O7U_0_
MX5#10!-O7U_0_P"%&]?7]#_A4-% $V]?7]#_ (4;U]?T/^%0T4 3;U]?T/\
MA1O7U_0_X5#10!-O7U_0_P"%&]?7]#_A4-% $V]?7]#_ (4;U]?T/^%0T4 3
M;U]?T/\ A1O7U_0_X5#10!-O7U_0_P"%&]?7]#_A4-% $V]?7]#_ (4;U]?T
M/^%0T4 3;U]?T/\ A1O7U_0_X5#10!-O7U_0_P"%&]?7]#_A4-% $V]?7]#_
M (4;U]?T/^%0T4 3;U]?T/\ A1O7U_0_X5#10!-O7U_0_P"%&]?7]#_A4-%
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MVG1B&0;X]^TJ]?IU\"_^#I#X:W'Q5_:#B_:$^$?QETWX0P^,(/\ AFRZ\ _
M_P 57_B[4?!)\P73_$:WN;B.WL=:5EB$2VKM&0TJ./E5V[;_ (+Q>&/"NF?M
MX_\ !"F'3O#?AW3HK_\ ;-OXK^WMM TFWAO8##X=4QWJ6]HBW<#DMB"=9(6W
M,^Q69L_U"/\ #_P-O8GP3X/.6)R?#&B%B"Q)&38$DXSDY)[X)K]?X$XP\)\A
MX8SS*>-?"S,N-\ZS:K"A0XBPW&-7(:^3X*CCL'C*<LLPE'*<52HX^JJ5?!8K
M'S^L*K@,1.$:%.I%58^?BZ&-JUJ,L/CZF$P\5K!8:$[NS^)N2M':ZLMM?/\
MGN/_  =#_P#!/0X'_"N/VPB2<*/^&?=<R<\<8U G/;!&">YK],/^">O_  4M
M_9U_X*9>#_B5XX_9UM_B%9:5\*O&&G^!_%=M\1?"C>$]2CUG4=(76[=;.T^V
M7K21I:-LF:0QR0SKY+1A2&/W!_P@G@-65O\ A"_"'R,&W#PWH>X;6!)&+ $$
M <$$'N#D U_*5\+/^"07_!9O]E7XC_M+:W^QU^VQ^SC\*OA_^T+\;O$WQAO_
M  [JG@/5-:O(KC5;R^72()7N=-N(K-[#1[BWLYH;%OLTDD"ND:@!5^KR[ >
MG'&0\187+*.(\*.*,O63XC(LTXUX[S#B'(,Q]IF5:AG>"JX7 \*TL31Q%/+8
MT<1A*LG*FIN2=FXMY3GF>&J49RYL=0?.I+#X6C3Y?<7(_>Q&SDVFK:*[Z:_U
MP '@*0HR,C_ $]^_KGVJ3@#..>XQ]1QZ#T/<=>:_D T;X[_\%E?V0?\ @J/_
M ,$\?V6?VO\ ]KOX7?&GX??M5^+?$3:UI'P^\ 66C0GP_P"'='UX7-C>W][I
M]M?V]Q-?VUG<V\EBP5O*:)F W(W]?89=W).>!R>"3@8SZ>W?GZ5^8<?< U^
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MSH 6BF[U]?T- <$]Q]<?XT .HI,CU'YBC<OJ/SH 6BF[U]?T- <$]Q]<?XT
M.HI,CU'YBC<OJ/SH 6BF[U]?T- <$]Q]<?XT .HI,CU'YBC<OJ/SH 6BF[U]
M?T- <$]Q]<?XT .HI,CU'YBC<OJ/SH 6BF[U]?T- <$]Q]<?XT .HI,CU'YB
MC<OJ/SH 6BF[U]?T- <$]Q]<?XT .HI,CU'YBC<OJ/SH 6BF[U]?T- <$]Q]
M<?XT .HI,CU'YBC<OJ/SH 6BF[U]?T- <$]Q]<?XT .HI,CU'YBC<OJ/SH 6
MBF[U]?T- <'V^N!_6@!U%)D>H_,4;E'<?S_E0 M%-WK]?P_QQ0'!]OK@?UH
M=129'J/S%&Y1W'\_Y4 +13=Z_7\/\<4!P?;ZX']: '44F1ZC\Q1N4=Q_/^5
M"U.O0?0?RJJS @@')_'UJTO0?0?RH 6BBB@ HHHH **** "BBB@ HHHH ***
M* (6!R>#U--H+@D\\=>O'T!]1FDW*.X_G_*@!:*;O7Z_A_CB@.#[?7 _K0 Z
MBDR/4?F*-RCN/Y_RH 6BF[U^OX?XXH#@^WUP/ZT .HI,CU'YBC<H[C^?\J %
MKC_B%!X0NO ?C6W^(3V$?P_G\(^)H?'3ZK<26FE+X.FT2^C\3OJ5Y#+!-:6*
M:(U\UW<131/#;B61)$=%8==O7Z_A_CBJ5_;6>HVEQ87]I;7UC>PS6E]97L45
MQ:7EE<QM!=6MW:SI)#=6MQ#(T-Q;RHR31.R.K(S @'^?]\&OB5^R]<_LK?\
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M9O7W/^??%*&![X^N!0 ZBDR/4?F*3<H[_P!?Y4 .HIF]?<_Y]\4H8'OCZX%
M#J*3(]1^8I-RCO\ U_E0 ZBF;U]S_GWQ2A@>^/K@4 .HI,CU'YBDW*._]?Y4
M .HIF]?<_P"??%*&![X^N!0 ZBDR/4?F*3<H[_U_E0 ZBF;U]S_GWQ2A@>^/
MK@4 .HI,CU'YBDW*._\ 7^5 #J*9O7W/^??%*&![X^N!0 ZBDR/4?F*3<H[_
M -?Y4 .HIF]?<_Y]\4H8'OCZX% #J*3(]1^8I-RCO_7^5 #J*9O7W/\ GWQ2
MA@>^/K@4 .HI,CU'YBDW*._]?Y4 .HIF]?<_Y]\4X,#W ^I&: %HI,CU'YBD
MW+Z_SH =13-Z^].# ]P/J1F@!:*3(]1^8I-R^O\ .@!U%,WK[TX,#W ^I&:
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M@B&#1[[5)M7N4N[/2T:*]N/M<[.E]+MG\EA$,(&!_4?'X>XQ_4&FL!@9Y.<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.[M;A%FM[JUN(GAN+>>*0%)89X7:*6-U*/&S(P*L:^:V_8K_ &/2\C']EWX
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M/S%4** +^1ZC\Q1D>H_,50HH OY'J/S%&1ZC\Q5"B@"_D>H_,49'J/S%4**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M5?O+[$D_3:W-;4'^IB_W%_E6,O4_[K_^@-6S!_J8O]Q?Y4 2T444 %%%% !1
M110 4444 %%%% !1110!B2=!_OR?S%15+)T'^_)_,5%0 4444 %%%% !1110
M 4444 %%%% !10.3@<G!.!UP.IQZ#(S2X.<8.>3C'.!P3CKP>OIWH 2OY>OV
MV_\ E9X_X)1?]FD?%G_U(OB57]0OI[C(]QC.1ZC'/TK^7K]MO_E9X_X)1?\
M9H_Q8/X'Q#\2B#]".GK0!_4-_ OU?_T(TE+_  +]7_\ 0C24 %%%% !1110
M4444 %%%% !1110 4444 *&8=&(^A(I=[_WF_P"^C_C3:* ';W_O-_WT?\:-
M[_WF_P"^C_C3:* ';W_O-_WT?\:^5OVV/V3_  A^W'^S'\4?V7?'_B3Q)X2\
M(_%/2[/3=9\1^$UT^37]-AL-2M-5C?3TU2"YLFDEFLHXG\^"13$TBA0S*P^I
MZ4=_I].XZ=>?2N_*\TS#),RP&<Y5BJN S/*L7A\QP&.H*G*K@\9@ZL<1A\53
M56%2FY4*M.%1*=.I&\=833<7,Z=.K"=.K",Z<H24HRYU%JVS]FU+RLGKL]-#
M^6>Q_P"#63X,:796VFZ9_P %"?V]M-TZPM8+*QT^P^(&DV=C8VEM%'#;6=I9
MVUK%;VUM;VZ0PP6\$<<44:(D:JBA1^6/[77[.O@K_@@K_P %#/\ @G/\6=0_
M::_;*^./P1UK4/B)X]^,-KXMU_4/&EQ8Z7X%N?#6E6-KIN@:;J&D:3J<-U_P
MD\TU[9ZQ-M4V=O-!)PR+_?.0<\,03U/<#WZ]^WTS7RU^VG^SV?VGOV7OCU\%
M=(A\*6_C3XF?"/QW\/\ PAXF\4Z3:ZE;>&]5\5:+/80:@T[P2WMK;07#17,Q
ML98Y2\,<BGS8D9?Z%X,^D;QAB>),/1\3,VEQ;P;G>%S/*,_RQX+AG**T\!Q%
MA*N4XG-X9K@^"Z>(HXS)Y9A//:%2$_:3Q&7QC.5JC;\?$Y1AXX3GPL5AZZG&
MI3J8>6)J5DZ<U4Y%3JUN1JHH*G+F:7+/3RZC]ES]I3X<?M?_ +/_ ,,?VE_A
M$GB-?AM\6]$NO$/A,^+])30O$1T^VUK4M$E;4])CO-0CT^?^T-+O%B@2\N4:
MV%O.LA$P1/?L;C@$G@$@<DX' QSSD],D].V ?Y+/@!_P3)_X.#/V8?@[X ^
MGP8_X*#_ +./A7X8?#31[C0_!^@/\.%U-].T^YU34-8EA-_?:1+>W;_;]2NY
M=]U*?+681J66-=N+^RU_P45_;$_8U_X*>^/OV1O^"M?[<GP@UCX<>'_V?;+Q
M[I?B4^'-'\%>$[GQ=XDU&V/A^P@U.VTR#4VOH;"VU1Y;:7,4Q52"IC"OAFO@
M-@<XQO&>)\,/$/@OCC#9%ALXS[+>',GQ7$&;\4XGAC!XU+"-Y='(*,<3F%/
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MOA;5_&?C3Q-J1D-EHOA[0K5[S4+Z58P[2O'"A6&%8W>>9TACVNX8?E7\(/\
M@O-_P3Y^+'AGXV>+;[Q)\7?@MI?P+^$NG_'GQ%%\?OA!XD^&-_XK^#>M7T6E
M:#\0_AEI-_/?WOC?0-<U2:SL-#>P6.ZO+K4;5EMOL[221?5?_!36S\::C_P3
MW_;'T[X>?!NR_:#\::E\ ?'NF^'_ (-:C:W-_:^/+O4--^QR:6VG64UO>ZC/
M:V<USJ]GI]G,EW>WFFP6UL3/*@/\ G@/]E']I_XB?!#]I?PU\!?AS^UC^U'X
M4\._L9?LG:U\0/'?[37P'\:?#3XK^ _%OP#^)%AXBU_]D?X!_P#"5PQWGC7X
M<2Z6FI?9?#>D6U[''8Z/"\BW%Y/;),@/[W_V(?\ @IS^R]^WXOQ*MO@W>?$C
MP?XP^$ T2X^(GPV^//P_U;X0?$;PUH'BS3_[2\)^++SPQXAE+'PGXEL]\^D:
MXLX@NU7.U003^./[9&K:7J__  <Z_P#!*>?2M5TS5H(OV2?BI%)/I>H6>H0Q
MR?V]\23Y;RV<TR(Y!5@C,&*LK ;6!-?]A[X4K_P4A_;"_P""FG[0>M?"?]H+
MX-?LE_M%_L<?LS_LB:=J_P 1?!GB+X&_$;Q3XK\%>'(A\0K[PGHNN1VOB&VM
M/#1D32-.\3B(02RJXMI<1/''\(>"/^";/P'_ ."9W_!QE_P3?^%_P$\0?%#Q
M#H7C_P#9]^*/CG7;KXI^,+CQCJT.L13>.- 2+3KNXCB^QZ>;+38&:TC79]I,
MLO\ '3 _N(W,0 21@MCJ,@L?S^M&3ZG\S0>B_3^II* %R?4_F:,GU/YFDHH
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MFDHH 7)]3^9J%R=QY/;N?05+4+?>/X?R% "'.>>?QS^M12-V_A .Y3@@Y Y
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MT'Z_XT;SZ#]?\: ):*BWGT'Z_P"-&\^@_7_&@"6BHMY]!^O^-&\^@_7_ !H
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M?/\ -@%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ IRXR/7(^F.E-IRD \X^I[?\
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MIU5[K<N7D>VLK7>G+:%K:'\P@_X+/_\ !5++9_X(9?&TY.<GX@19SDDY/]A
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MKMC=3S[?.V(Z;-H_H3@7#\,\2^$G$?!N9\?<+<&9E_Q$?)>)<-'BB>:PH8W
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MHYY>7W %%%%'/+R^X HHHHYY>7W %%%%'/+R^X HHHHYY>7W %%%%'/+R^X
MHHHHYY>7W %%%%'/+R^X HHHHYY>7W %%%%'/+R^X HHHHYY>7W %%%%'/+R
M^X HHHHYY>7W %%%%'/+R^X J-F )[G"<#_>/\NI]!DXJ2H7^\?P_D*J+<G9
M^NP#'E0$[B<C.%'M^?48(X&:K2.A!"^9N<CY,'.1@8(XZCGCN!STI\H!(W%
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MM/V>7[6H\N<(WRY!!S7UH/\ @X^O\';_ ,$H_P#@HHK;6VL?A'KB[6PVS/\
MQ3O0-C/;'7O5Y]]%_P 5L)GF;Y=DW#-',LJPN<9K@LDQ];B?@N?U[**&88FE
ME^.JN'&=",:F)P\,-B)*<::7MFFH\KC&89W@YT*,JF(=&O[-^TC#!8CWDX>]
M!OZORIMWAS:]_,_IKRHYW  '&3C /0J#D 'CG ZYY[4HX.&ZC/)SV//7@$'
M/3G ^O\ &?\  S_@X(_;DT'X:?&S2OCW^P=^V'X\^)^N^)O&\_P*\3^$OV;M
M:T'1? WA34(;X^!M.\5::/"D":]J.@W$UD-7N6@E^WPVC L[2'=]N?\ !"3_
M (*S_M ?MA:QXY_9._;/\'^.K/\ :M^'&CZ[\4M>\8^)/A]H_P *M,E^'U[J
MF@:9X8\-OX(M-%T&_LM5M)KF\F%[/I-M%J%I)$[33/ 9'[N,/HG>+?!G#?&?
M&&:TN&<9DG!=;*,/F2R;B[AS-Z^(PV:4(3EGN4X/+\WQ6+Q>39;7JT<!FN)J
M87#RP>/K0I*GB(OZP%'/<%B<12PT8XB$<9%1?/0K4XJ5!)P4IS@HQ<G&\8N5
MY*]GT/Z5Z*8)$/ ="?0,/\:=N7U'YBOY?LWLG]S_ ,CV-MQ:*0$$$@Y &21T
M R1DGIC((Z]0?2C(R1D9&,C(R,\#/ID\#/7M2ZM=8_$NJ]5NOFD'GTT=^EG:
MS^=U;O=6W0M%-WI_>7_OH?XT;T_O+_WT/\:+/L_N?^0[/L_N?^0ZBDW+_>'Y
MBDWK_>'O@YQ]<=/QI\LOY9;VV>]KVVWMK;>VNPEJW%:R2NXK5I+=M*[M\AU%
M-WI_>7_OH?XT;T_O+_WT/\:5GV?W/_(=GV?W/_(=130ZG.&''?/'Y]*-RCJR
MC\1_C3Y9)<W*[-73L[-7M=.UK7TO??3<+-;IKY/_ "'44W>G]Y?^^A_C1O3^
M\O\ WT/\:5F%GV?W/_(=132RCJP_.EW*>X_E_.BSU=G:-K^5W97[7>BO:[T6
MH6=KV=N]G;[[6_$6BDR/4?F*,CU'YBBS[/[G_D(6BDR/4?F*,CU'YBBS[/[G
M_D M%)D>H_,49'J/S%%GV?W/_(!:*3(]1^8HR/4?F*+/L_N?^0"T4F1ZC\Q1
MD>H_,46?9_<_\@%HI,CU'YBC(]1^8HL^S^Y_Y +129'J/S%&1ZC\Q19]G]S_
M ,@%HI,CU'YBC(]1^8HL^S^Y_P"0"T4F1ZC\Q1D>H_,46?9_<_\ (!:*3(]1
M^8HR/4?F*+/L_N?^0"T4F1ZC\Q1D>H_,46?9_<_\@%HI,CU'YBC(]1^8HL^S
M^Y_Y +129'J/S%&1ZC\Q19]G]S_R 6BDR/4?F*,CU'YBBS[/[G_D M%)D>H_
M,49'J/S%%GV?W/\ R 6BDR/4?F*,CU'YBBS[/[G_ ) +129'J/S%&1ZC\Q19
M]G]S_P @!NA^A_E756O_ ![0?]<D_P#017*$C!Y'0]QZ5U=K_P >T'_7)/\
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M?\$I3V_X9*^*@S[CQ%\2 1]0>#Z5]7?L;?\ !4GXS7'Q)_;!^!/_  4L\"_
MWX#?$7]D+X-?"K]I/Q1X_P#@9KWCKQ+\(KKX(_%72$U.UGGL_$EK?^+(?$7A
M-F%KKHM+>XLYIF(TZTE"&63\H?$'[<O[)W[=O_!R1_P3+\??LD_&C0OC9X2\
M'?LW?%'PGXIUS0M+\3Z3#I'B26_\>ZQ%I-S#XIT70[R6Z_LJ]L[II;>VD@V3
M*AD$JO&MI<J[@?V7#I^+?S-+300.I Y;J?<TN1ZC\Q6<EJ]_N\D-_HA:*3(]
M1^8HR/4?F*FS[/[G_D(6BDR/4?F*,CU'YBBS[/[G_D M%)D>H_,49'J/S%%G
MV?W/_(!:*3(]1^8HR/4?F*+/L_N?^0"T4F1ZC\Q1D>H_,46?9_<_\@%HI,CU
M'YBC(]1^8HL^S^Y_Y +129'J/S%&1ZC\Q19]G]S_ ,@%HI,CU'YBC(]1^8HL
M^S^Y_P"0"T4F1ZC\Q1D>H_,46?9_<_\ (!:*3(]1^8HR/4?F*+/L_N?^0"T4
MF1ZC\Q1D>H_,46?9_<_\@%HI,CU'YBC(]1^8HL^S^Y_Y +129'J/S%&1ZC\Q
M19]G]S_R 6BDR/4?F*,CU'YBBS[/[G_D M%)D>H_,49'J/S%%GV?W/\ R 6B
MDR/4?F*,CU'YBBS[/[G_ ) +129'J/S%&1ZC\Q19]G]S_P @%HI,CU'YBC(]
M1^8HL^S^Y_Y +129'J/S%&1ZC\Q19]G]S_R 6BDR/4?F*,CU'YBBS[/[G_D
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M*** "BBB@ HHHH */K@_4 C\000?R-%%&JU3::V<=))]&GW73SL N%_NQ?\
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M^?7[#\J0_M$_\'1X_P";'_V$1]?$_B#_ .?8/0?E7QW_ ! G..OB)X+VZ_\
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MW9-MQ2\VUJEW:U072U=DEJV]M.YQ'Q8O+C3_ (5?$R_M;9[VYL?A]XUO(K-
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M]\_C4;L0I&3M!_YZ/@$\C*J..OKSD'@FH;W77\[@02;L8'"J!E<;,Y/4*3G
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M#X*I?WEVJ_M511>)/%IMO#MK_P (S,\LWP)F;0C+XFN%\9+;V\<7C0Z#;?\
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MNHXC?XMJHS7W[3BZ?^T(+?0O@LVJ6=Y,/V5DE\2>+/LGB"P3PQ9R6S?'*8:
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M_AOG]DSGCCXV>!,D^@QJV?RK^;?^(<>(3T_U&XN]?]4^)O\ YP^AZ_UC#?\
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MR5('J013 2BE )Z GZ#/\J"K#JI'U!'\Z $[K_O+_P"A"N]L/^/*U_ZX1_\
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MXC9!RCAAW*G;TR'5@#7].XZ_@W\C7\Q?[9__ "LY?\$HO^S3OBC_ .I%\1Z
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MZC'\Z+>>O?\ 4#R^W\(_$F/XK>.?&$WQ=O)_AIXB\!^'_#?A#X0GPIX?AM/
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MQQ%O12EQ7Q$TGLFTLX;M?>R;["_L_ -V^J8&5_LJA!.5^B?LU9OO=6/XUO\
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MS2;V]?T'^%-HH =O;U_0?X4;V^OX?X8IM% #][>P_P ^^:3>WK^@_P *;10
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M'^%+O;V/^?;%,HH =O;Z?A_CFC>WK^@_PIM% #M[>OZ#_"EWM['_ #[8IE%
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M!XB_X\X?^OE?_14M;]8'B(XLXO\ KY7IW_=3'&!R?I3VU XZBBBIYH]U_7R
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M%%'-'NOZ^0!1111S1[K^OD 4444<T>Z_KY %%%%'-'NOZ^0!1111S1[K^OD
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MY+S,QJT:&-RRI4M&"G74ZDHS<*;E@%:4W%2M&]^S<O=6NA_<K@^B_K[^WO\
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M'_KU@_\ 1:UY[_7I7H6F?\@ZQ_Z]8/\ T6M:P>C7;]0+U%%%6 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHTTO^O\ F!Z)7-^*/^/"+_KZ3_T5-725S?BC_CPB_P"OI/\ T5-3 X.BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#^9+_ (+QD']NK_@A3@]/VP[X'V.[
M1.*_ITNO^/FX_P"N\W_HQJ_F(_X+P?\ )]7_  0L_P"SQK_^>A5_3O=?\?-Q
M_P!=YO\ T8U)?Y_F!!1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXG?^I%\1:G[3] /Z:C]U?^!?SIM.)!5<$'&[/MSWIM-;+Y_FP"BBBF 4444
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ML=3U&"_.DW&G:5?:9=6>HZG;ZJI5M+FL+.:>[AU,,#I\L*7@_P!33U[O\?\
M,">SU;1]1FN;;3=9T;5+FRD\J^M=+U?3M2N;&7<4\N^M[&YN)K-]X*;+E(FW
M@IC<"*?::CIFH?:/[.U32M3-G+]GO!IFIV&I&RN 2#;WHL;BX-G.""##<B*4
M$'*\&OX'+#P-X/\ A-\2/^"J/[9?_!*'Q)XX^'?[)'[,7[!WQ?\ @G=?$'4_
MBSXE\7:A^U!^U1=::;#Q+\2?"MAXEU_4-6\1#X?)>SZ_>^/([.&R76;.UN],
M2RDU"%)/M?\ X)O> /"G[-'_  46_9(\$_L8>)+_ %K2?VE_^".E]\>?VA=
MU#XB^(?'/AKQ=^T*FFZ;JOA?XD^.?[8\0:G;:;XH\2>,KN73M1N0VG+-:0/;
M0P6ZI=;].1=&P/J?_@O"0/VZ?^"%9R,']L74"#V(5M#!YZ<'@CJ#7]/%U_Q\
MW'_7>;_T8U?P5?MC>+O^"POB+_@H7_P2"A_X*>_"[]FOX=^&[3]K>S?X13?
M36=*U:\U/4GN],371XB73_&/B<PP16/V)K1IH+'?,TI+/)O1/[U;K_CYN/\
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M_P"&_AMXP^!_Q9\,_&3Q#+X3^$FL> O$5M\3/$L/B:X\&2:+X(2R>Y\17_\
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M_P"\:/9^8%VBJ7F/_>-'F/\ WC1[/S NT52\Q_[QH\Q_[QH]GY@7:*I>8_\
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M_1,],#SFBBB@ HHHH **** "BBB@ HHHH **** "BBB@#^93_@O!_P GU?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O7](_Y!
M>G_]>D'_ *+6O(*]?TC_ )!>G_\ 7I!_Z+6@#1HHHH **** "BBB@ HHHH *
M*** "F2?ZN3_ '&_]!-/IDG^KD_W&_\ 030!XE1110 4444 %%%% !1110 4
M444 %%%% !1110 %BN".YQ_/\Z_F9_;*.?\ @YH_X)5<<?\ #*OQ-Q[C_A(_
MB)S7],;]/Q_H:_F<_;*_Y69_^"5'_9J?Q,_]2/XBT ?TSYR ..,_KZTE-7^+
M_>/]*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !5>25@Q4<8QS]1^56*IR\R-[!2?88
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MSP-0_P#1FB5_3O=?\?-Q_P!=YO\ T8U?S!?\%V;BWD_;G_X(8[+BU?R_VO\
M4"^R[MV"KOT4[G*RL(T[;V(4'@G<"*_IQNK^S^TW'^EV/^OF_P"7^S_YZ-_T
MWH EHJE_:%G_ ,_=E_X'6G_QZD&HV1.!>6.3P/\ 3[/_ ./4 7J*I?VA9<_Z
M98?* 3_Q,++H3@?\M^<G@ <TXWUH#@W=D/N];^SYW E<?ON20.@Y]: +=%4O
M[0L_^?NR_P# ZT_^/4G]HV7_ #^6/_@?9_\ QZ@"]15+^T+/_G[LO_ ZT_\
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MX'6G_P >I3?V@ZW=EU8?\?\ 9]5.&'^NZCN.M %RBJ7]H6?_ #]V7_@=:?\
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ME-0!<HJD-0LR0!=V1)Z?Z=:=@2<_ON  "23@"E^WV8_Y>[+H#_Q_V?1LD?\
M+;N!^'>@"Y15+^T+,_\ +W9?^!]F/YS4OV^S'_+W8_\ @?9G^4U %RBJ7]H6
M9_Y>[+N?^/ZS[#)_Y;>G/TJ1+J&0$Q20S*K%6:"XAG4, "5+1.XR%(;&<[2&
MZ$&@"S14'GC^Z?S%'GC^Z?S% $]%0>>/[I_,4>>/[I_,4 3$@#)X KV#2/\
MD%Z?_P!>D'_HM:\9,ZX/RGH<#@Y/I7LNC'.DZ<0,9L[<X],QJ<?A0!I4444
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MY]+G_OS)_P#$T )12^7<_P#/I<_]^9/_ (FD*7 QFUN!GIF*09Y P/EY))
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M[D]+2Y/TB<_^RT )12^7<_\ /I<_]^9/_B::5G4X-K< ]>89/_B: %HI LY
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M3_\ R33/^(7K]F$<G]M+]O;CGCXP7&>/3]_UK^F>CISZ>O(_'%,#^2;]I_\
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M&<C\?](--'_!KS^S#D ?MI?MZ GC)^,-P ,\9)^T# '7).T=6^4&OZ9P"3@
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M)T^WM+'3[./D6]K:6MO#$F-L8#5<H0'\P?\ PX\_X*7_ /2=C]I#_P )^_\
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M:O<2/YL[I;QO+*S2S%I&9CJ]\'@X!P>#@YP<'G!P<?0T ?S!_P##CS_@I?\
M])V/VD/_  G[_P#^7-*/^"'O_!2\"1A_P79_:/!2&23!\/7YW")"^T?\3D[2
MQ&U6/0D$U_3WV)[#&>?4X&!U/) P,U-'#<2B3R8'E,($LA6"2=4C.5+2+$I(
M0$[B7(C4*Q;IBE^/]?,#^$'_ ()??LH?\%,O^"B_@K]HCQ8W_!9#]HKX;?\
M"A_VC/&GP&%E$;WQ%_;R>%)'6+Q$\R:A;?8FU")$E%F1(41U82%2"?T\_P"'
M'G_!2_\ Z3L?M(?^$_?_ /RYK^F/PQX"\+^$[74D\#>!/#'A.SU'4+G5M;7P
M5X2T?PW9:IK$Y+W>LZK'X?TVPM]0U.Z+-+/J5ZLU_.')GF.*V>1U!!(!P00<
M'H<'!P<''T-,#^8/_AQY_P %+_\ I.Q^TA_X3]__ /+FE7_@AU_P4O9U'_#]
MC]I#YSY?_(OW^.2/O*=9VE!U8M@#'TK^GNI88IIF9((I)7V%BL2N\@1 266.
M,%G"'#,&79C&23@4 ?PA?L9_LG_\%+_VM/VOOV^OV5W_ ."QW[1?@]?V)_'6
MB>#4\5HMYJK^.8]8EFC.HS:4NH0OHR0S6SJ4:6=6D1@7!4D?IZ?^"'G_  4P
M)+'_ (+L_M('<Q(/]@:@20<<G.L\$]P,XXK^F#1O _A/1M7UK5_#/@CPMHGB
M;Q3/%<^)];\.^%=$TOQ!XHN[<+_I7B?4]*TZVU/Q#/&!A)]:N;R8$N0RG<:W
M61XR4<;2K/E#OW*VXAE(<!E"X"JO\.TC)QFE\@/Y@?\ AQY_P4O_ .D['[2'
M_A/W_P#\N:7_ (<>?\%,,''_  79_:/!8A/F\/Z@ <Y/WO[9_=].'..<#//'
M]/=2Q1O*PBB5WFD8)'''&9'=CR-B $L5(W'8"57YG^44/8#^$7X4?LE_\%,_
MB7_P5#_:2_X)RC_@L?\ M$Z7%^S]\)O#/Q/3XE*UY<3>(9/$<>DO)I#Z"NH*
MU@UHNJ1[[DW,@V[&8 2#/Z<_\.._^"EH V_\%V/VD/?_ (I^_P"W&1_Q.>5.
M/E;D,.1Q7],%GX(\*VOBC4?%=AX)\+6GCK5K6/3M7\66'A31+?QMJUG <6^G
M:OXCM=-C\0ZI9VYC!2TN[VXMX@J;8D1%QT$L4D,C1S))%,N!)%(C1M'QE4*L
M!C"G.%RO/'H#J!_+_P#\.//^"E__ $G8_:0_\)^__P#ES0?^"'O_  4OQ@_\
M%V/VC]NY2=WA_4".O)5?[9.64#.!ST'>OZ?*<@+L%"[R""J!0S,[?*A'5E"N
M%RR#=\P SG%,#^$CQ_\ LG_\%,?!/_!5#X(_\$VO^'R'[1E]'\7?@;KGQDD^
M)S"]2;0WTBYU:W70D\.?V@TEPUS'I,DGVC[5'Y8\P%"(F:OTY_X<>?\ !2__
M *3L?M( @E2/^$?OS@KQC/\ ;.", 8(XQTX%?TQS>!?#%UXKM/%EUX&\+WGQ
M!TRRGTO3/%D_A32)_'.GZ=(6:?3K'Q.VFMXFL=-D+[I+.WOH+:?>Y>-_,<MO
MSP36TGDSQR1.BK\DL+P.%89!,;JN-V2?EX/6DNG]?U_PX'\OO_#CS_@I?_TG
M8_:0_P#"?O\ _P"7-(?^"'G_  4N[_\ !=?]I _]R]J!_P#<R:_I]IRJSL%1
M2[,=JJH+,202 %&3EL$*,?,1M7)XI@?P?_MI_LJ_\%,?V1OVM?V!_P!F!/\
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M24P/YAH?^"''_!2^:6.)?^"['[1ZEY84R?#]^I(DD"$J3K ^92?]7DM(#P,
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M;O(H<(#=+*"1N!P2,C.#@XR..AZBDWKZ_H?\*AHI@2EUP><<'D9S_*OXL/\
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M_P!%N7"R2*61G5G#NA&TE'(9@PY=7?)7C:02 <\5YII?PE^$NC^,;_XB:/\
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M##$JI!%#"D,4<42JD,*6Z!8[:**)4BACB5(XT0(B!0,+[P)]Z^OZ'_"OG/\
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M%NO#/CWP?X3\=^&K_!O/#_C?PWHOBK1;AXF_<RMI6OV6H:<+B%LO;W#V_FQ
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M_FI=+6Z+_+\/Z[@;X=0@&.,#YC(20>I4)M)V+]U2S$FA63.2> .>.H;Y"!G
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M]?7]#_A1O7U_0_X5#10!-O7U_0_X4;U]?T/^%0T4 6H=KS1KO"[F" M@(-Q
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MU+4-/B,2S2$JQ_;[_@C_ /%[X0?&3]A#X=Z[\$_#'QF\#>#O"/C+XF?"[4/
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M &Y?C-\8;?\ X*D?M _$*Q^-'QYMOA]\,_V]_P!F'X=:)^VYX#^(_P 0;?\
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M_&_B3Q+INJ23:A-+:WEFT5EIUM-+:1EH;OXY_;#^(7Q$_:K\4?\ !2_XWO\
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MPL_;#^.]YX,\1ZGJD/P;_8T^+P^#/B_Q-?:OX?N=/TOQ'X\\0)<V>H:OX/\
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MW^T#>?'+01(-#^)Z?%^<'7K7Q+I<4DMO:W<40A%I*]JT3.QN2?U_7^0',_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*[\.?^"G'[8NJ_MR_L@W7[1?Q+3X)_LG_M0>%?@1:?!;2/AC\/?AQ\1_AO\
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M'5O&NCOJFN^$(O!&L7)U>>#0K@3:=_;UQ:"*XO-*OO)O+F"2U9K<--W^ ']
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MD%JB?8KJ?^EY0 Y.WYB#\P4CAFZ%@?+?<5,FY<[6;8,K@UHX))ZO8"2CL3Z
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M>.AQV_B2X\&:)\8;[XC&[%C/=:EXAMY%NO"L=DVGVUE%]H!4/$$N,4UU_KY
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M.>AX.#7S9X*_:D^%FN>#I==\?ZSI?P2\:>'_ (4:1\8?BW\)?BAXAT"Q\>?
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M>UBF_50*5>0$DD%58]5=E4!I(V)),;'A%/**H4ECDD<4E?4!Q(&W) W$A02
M6(&XA1U) &<"C<..>2,@8.3QG@8R2!R1C('.*1F )SD?*26^4E5[[-PPLA^Z
M'W# )ZU^8?[5G_!2:?X"?M!Z!^R9\"_V4/C9^VK^TG>_#F+XP^,?AM\&]8\'
M^$+?X:?#&_U(Z3I/B7Q7XL\=2Q:1'>>(KY'M]!T2,B^U-U_=LNY%84;J^O\
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ME3?,?^\:E0EY?>!^&O[)/_!+3]ICX8?MM^,?V_\ ]I']H+X ^+/C4_[/5_\
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MQKX&^('QS_:9^)-K\1?BEK7PH^'5G\)?A'X=MM"TM]"\)>!/AE\/[5I7\/\
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M2M7TK3]8U%K.77#;W(CU'3K5M.G_ '4Q-?I"97/<#Z#FF^8_]XTE&2[?._\
MPP'\_P!K'_!)?]LG6O@)^ROX=/[5/[,'@O\ :&_8&^,]E\1/V-?%GPD_9IU?
MP5\$/!_@&7P+8>#_ !7\-?'WPW?7I]4\27?B5[!=1?Q-;:C#<))/-]I,MQ(T
MP_0;_@G#^P]JW[#7PB^(?A[QO\3+3XQ_&OX[?&GQI^T%\>_B;I6@OX5\/>*?
MB/XWE0W">&/#4TD]QI&@Z)I\-MI>GP74\ES(D3S3-E@!]^F5SW ^@YIOF/\
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M7PWJ=MK.GFYGU*>.[^TVKF!(XW*NOQW^U?\ \$Q_V_\ ]JK_ ()P^ ?^"?\
MK_[9/[,NBP_V-;>$OCCX]M_V?/&2VGC?PCX"\5^#?$OP3L/ .G0>(SJ'@_5/
M#,7A".T\;ZK>2WB^*);IGMH+-&D%?O*97/<#Z#FD$K@_>)^M5[_:/WL#Q_\
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M$TG/7^S[7/U\I:J,6KW UZ***L HHHH **** "BBB@ HHHH *9)_JY/]QO\
MT$T^F2_ZN3_<?_T$T/9^C_)@?.H'R*"H8;R2.>/F8A@RD,I4X8%3UX.17\_O
M_!<[X$:I^T-X=^'O@ZQ_X)T?M ?M7^+-+\*^--3^"W[2'[,OQ/\ "OP\^(W[
M.'Q?N9+:WT+3M1GUJ_TN^?PCX@N6AUW41;RW5G,=)$<MNMVT$T?[]^:< *<
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MT/@'PKI7B77M/T^UT)I$N;C5[2VTN)1 TT,:O>312?U6(I7@\$\D9#X/<B3
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M?&7P'_8J^!VN_!>3X;WOB7XV^'-!^"GB3P-XBUW1O WQ<\1>)]*\,0:+I?Q
MLM4\>>.=2CL8;[QQH^B0V$LGVB2)9O[)/A?IWCC1_AOX!TGXFZYHOB;XC:9X
M-\-6'CSQ%X;T:;P]X=UWQ=9Z3:VVO:MHFAW$]U/I&FW]_%+/::;+<3&S@:.'
MS&*LQZ\2-T 4*5!VD#"]<1@@?,%]3U)H$L@&XLI+?P@?=QQ^O7O1)-II):_U
MMT M,"2O!.UMP&1MW@83*D$%<D[R00%R "37\AO_  68_P""=O[0?Q5_;O\
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ML@B4(A_9TR.S%LL.3MRV]E ;.XD@?,P&-H& I(/7D$CKGD,22=Q&&(R=H8
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M8]SZU*BT^9V_X('\EO[1W[*W[67QW_X*N_L_?M!_ /\ 87_:C^ WQ(^$O[6
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M"<$YP.5(/%%%[:6_KYL#T2N$^(/_ ""+7_L(P_\ HBXKNZX7X@ G2+4 9/\
M:,/_ *)N*8'D-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% #EZG_=?_P! :O?] _Y FE?]>%K_
M .BEKP!>I_W7_P#0&KW_ $#_ ) FE?\ 7A:_^BEI=7\OU'T^?Z,UZ***8@HH
MHH **** "BBB@ HHHH *CE_U4O\ US?_ -!-24R7_5R?[C_^@F@#YH48 !X/
M/'X__7IU!.6R.1\W/XC_  HH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[$]@,D]L9QP>AYXXS10 [S&_NX_+_P"*-&]O7^7^%-SCUY&0,$DXZX &21W
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MG(ZC'7(')&.!R>.: '^9[?K_ /JIOF-_=_E_\530,G'KQ1^>< D $D98J-P
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M]^/\3_*E#G///MP/Z4RB@"0R'L/U_P#U?SIOF-_=_E_\53:* '>8Q[8]^/\
M$_RI0YSSS[<#^E,HH D,A[#]?_U?SIOF-_=_E_\ %4VB@!WF,>V/?C_$_P J
M4.<\\^W _I3** )#(>P_7_\ 5_.F^8W]W^7_ ,53:* '>8Q[8]^/\3_*E#GO
MS^0_I3** 'F0]E_7_P#52>8W]W^7_P 53:* '>8Q[8_+_$TH<]^?R']*910
M\R'LOZ__ *J3S&_N_P O_BJ;10 [S&/;'Y?XFE#GOS^0_I3** 'F0]E_7_\
M52>8W]W^7_Q5-HH =YI'4$<-R/\ =/'4]:^AO#W_ " ](_[!]K_Z)6OG8@GI
M[_\ H)KZ)\/?\@/2/^P?:_\ HE: -BBBB@ HHHH **** "BBB@ HHHH *CF_
MU4O_ %S?_P!!-25'-_JI?^N;_P#H)H ^90Y  V^OIZ\=Q_G]3S&_N_R_^*IM
M% #O,8]L?E_B:4.>_/Y#^E,HH >9#V7]?_U4GF-_=_E_\5320.20  3D\#CW
M/?T'4G@9-'K[#=G/&.Y!Z';_ !8SM_BQ0 [S&/;'Y?XFE#GOS^0_I3.N2.0
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M^E,HH >9#V7_ #^8I/,;^[_+_P"*IOKR!@ DD@ 98*,L< 98A1D\D@#DT$@
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ME_\ %4VB@!V]C[?E_P#7I0Y[C/Z?TIE% #S(>R_R_P 12>8W]W^7_P 53:*
M';V/M^7_ ->E#GN,_I_2F44 /,A[+_+_ !%)YC?W?Y?_ !5-HH =O8^WY?\
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M%<V^B2_#"'3OLEU/%::5JKW>L7]GI-Y<:EKMMJ>I+-0!_IFK\QXY 8*V.JG
M//\ =X.<M@>IX./@+]IK_@I+^SG^R7^TM^R[^RA\5[;XDS_%3]K[4DTKX2W?
MA+PCIFM>$;2Z;Q%9^%A)XPU6\\4Z/=Z) =0U&V+RZ=HVL^5:K/=, !Y;_P \
MW_!0;_@L)^UM\<O@'_P2+^%7[$GB6V^ 7QI_X*>^'['7/%WQ'L)(WU'P->67
MBVT^&.IZ!X7NIX+F;0]/NO&S:WK::A9.=8ATG3+?2?/6:XFN#\'?M9?L_P#[
M;/[,_P#P6E_X([?"[]L']KB;]L_2[/XF^#]8^$7Q:U_PU_PCOC6"QU/XE:*/
M'/AGQ0UU>:KJNK0Z;KEK83Z'J6IZO>,UE>2Q11V_ERF8_(#^P/P[_P %+_V;
M?$__  4%\7?\$T=,L_B8/VD?!7A#4O&^MWEUX4T^V^&#Z/IF@67B&Z2R\7+X
MIEU>:[73[^T2&%O#-O;SW#26XG C,C?H'UZ8(P3N!!08ZY?[H([@G([@5_,;
M\+?VI?CWJO\ P<[?'']E^\\>:EJ/P*T'X!>*==TKX<RZ?I-O81:Q9?#W2]5L
M[B+4X=/;6!G4;EY'F:\(97XAVQH#^+/_  4-_;5_;4^&GCW]JSQIX[_X+H^"
M_AQ\9/A_XNU1O@%^QA^QHOC[X@>%=6T/2[^^:+PSX^\4^'M'\.^!?!7B#2+)
M(].UQ=?O/%]XVH6^H7>I,BH;6-?UW _T&<$] 3SC !SGGDC&0#@X8C:<'!.#
M1M;:6P=H&2>W3/XG'( Y.#@<&OXF?VPO^"K_ .VS??\ ! 7]B+]LWP;\6]6^
M'G[1?C?XW/X"^(/C7P.EMH<GCBU\(RZM:++J=A;*EE -;6SL6UJWM8H8+NY-
MS(D<'GNQX+]JKXX_\%E?^";7Q'_X)U_M3_&+_@H)+\>_#O[8_BGP!IWC[]GJ
M+PB?#_PG\$VGB2#PKK%QX/M- :YN-,OY!X5\0E%\6:79:+JMOK<<MR/M"L))
M&!_=-%&TLT4$9423.D<98_+O=@J[FP0 "1G.3CL:_G,^,W_!T3_P3+^!'Q9^
M(WP;\;Z%^U1-XR^%?C#6_!?B>;1?A%X.U#1#K/A^^ETS4%TV^O/BKI]S+IS7
MD+-;74FG6K3Q;2+=!(,_T?)Y4>K1QP;C;#4Q'&IY=8ENML).!G+(%+'W(-?Y
MQ'[&_P"WCKG["G_!5W_@J[XGT']A/XK_ +=,_P 1/'OB'PW+X6^%NA2Z[?>
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M_E-AH_\ PDFC:'%>W!@M@\5[-' W[PD%6*'A@<$'U 8XST)PK' )Z5_ED_\
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M-!TVW<'[/D']?\.!_6O14?F>WZ__ %J-X/4<?G_2F!+CZ?F/\:2H]RCHO/T
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M/YU'YGM^O_UJ-X/4?U_GB@"7&/3\P?Y&DJ/>HZ+_ "'\LT>9[?K_ /6H E!
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MK?##QAK<^E0/>>(O EZ\LC'0]582W5K!+YDMM;S-%*JNCHJ ]MP>>F 2"<C
M(P#N.<*!E=Q) &],D;URA^7J1P,G!!VC!.6QG:, G+8XYZ$&OY'?^"M_[57_
M  43T7_@M9^QO^Q=^Q?^TI>?!C1_CY\!=%BO--UK3H->^'^E:UXAU_XTZ7XG
M^(VJ>&9D_P")SK?AKPMH,>N:#;Q7-J'UWP_HVV2V=3+'1_X)W_M%_P#!0?\
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M-XEL_ VO6?BC6KG6;Z"#S-0AL[_2M%N+S38+FZLUGEC: >K:U_P4B_9X\/\
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MQGT_,#^9J+S/;]?_ *U&]3U7^1_GB@"3&/\ ]8/\J*CW@=!_3^6:/,]OU_\
MK4 24N,^GY@?S-1>9[?K_P#6HWJ>J_R/\\4 28Q_^L'^5%1[P.@_I_+-'F>W
MZ_\ UJ )*7&?3\P/YFHO,]OU_P#K4;U/5?Y'^>* ),8__6#_ "HJ/>!T']/Y
M9H\SV_7_ .M0!)2XSZ?F!_,U%YGM^O\ ]:C>IZK_ "/\\4 28Q_^L'^5%1[P
M.@_I_+-'F>WZ_P#UJ )*7&?3\P/YFHO,]OU_^M1O4]5_D?YXH DQC_\ 6#_*
MBH]X'0?T_EFCS/;]?_K4 24N,^GY@?S-1>9[?K_]:C>IZK_(_P \4 28Q_\
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M==U6&'2[Z_?6KZP\0WJ><?[(#\I*M\K!=Q5OE;;QD[3AN,C=@97(W8R*<58
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M<L-&U?Q_\6/$EI%XWT^]\+:#;:)J4>E>-=%$\&GWFK0I=I?1),Z6\;S_ +Y
M$D@!MRG:5VG<&[*5QNW'J!C)'(!%(V4^^"O"$ @@L'^X5'5@W)&T'@$] 2 #
M^8__ ()S_P#!'7]MW]D_]CW_ (* _ K4_P!H3PE\ OC5^TI\5+7XA? SXU?
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M:>!M<TVPTOPD(5O+JYLK'1]-U8Q7%RLT,G] 'S!L N6564D+O9E7"L'XSG+
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M9U&6\O'DO;R]U35+NZNKJZOI[BY)8#S&5@(P#VNBBB@ HHHH **** "BBB@
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M*O&VMZ,+^3P?/X'?4SX!6S\(ZI_PD*M'X=U(VK7PT%IV-JCB(3.\7D?[5?\
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M 9]QC&<C*8.X*1AB0-K?*PW#<"RG!4$8 9@%W$+G<0" ?CU_P6+_ ."6S?\
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M:2WECA#L4B_*R#_@A[_P5=_8J\5?M0?#G_@G/\0OV0_$?[.7[3.OR:OH>O\
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MHSD#')'<@#URN/O#)M;!8*Q 4,2%9N#C!& <_>4X&2 03P0: $HI0"5W 97
M((Y!R<#!'4@_> R5P=P&#A.H![$9!]1_GCZY'6@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP]T"2^FT'P%X3\.^#=$DU.X>YOWTKPQH]CH>G7&H70*B\U%[:PMY[F62/YY
MQW%FKK* /SI_X*=_MV^,_P!@;X&>$/'/PK_9Y\9_M._&+XN_$NT^#_PA^%W@
MFUOKEKCQQJ?AS6/$5KJ_B0Z7I^J:I-X>TR#1KB>\M[*T$US*\4,]_I\,DMY;
M?B+_ ,&T_P"U?^V/^TM\>_\ @I/:?MF_%'XA>*/%G@3Q]X6L;SX=>*/$UYJ_
MACX1>)V\8?$&Q\7>$_ V@S:EJ&C>'M.T6_TUM#ALM(N);)[?2K-&FNUC-Q+_
M %M:='&=3TR22*&1[?4+2:U9HXR]M/YZJ)8I&C9HI(E9BDL'DR@#87PQK^0'
M_@W 0S?\% ?^"X: @O+^U3XE17>;8H#?&_XT!W+'DE0P8NW"J2S$'F@#+_:8
M^!7_  7E_:6^+G[<?Q^^(W[6_P 0?^"8W[-/[-NC>,_%W[.7AKPUXKM(O"?Q
M.\&^$Y]6FT.]U2?X9^/XKFQ?6-%T6VU_7/$/CH:M>Z??>(;;2K71Q:0-%#^I
M/_!O3^VY\>OV\_\ @G;HWQ5_:.NAXB^)'@KXH^-/A'+\0%L+72YOB#HOA?3O
M#6KZ=K>JP644=O=>)+./Q'_9.KZA;06T>HSV5K>W,<VHSW<A_FZ_X+)?\%<?
M#/[>G[8EY_P3@B_:*L_V1?V!OAMX]U'PQ^T5\;I="\7>)M9^*.O>"-0DA\46
M4.@^"-*UW6-2T/2]4L;G0_!WAN6"/2M7UV"37O$FH&Q6TA7]Y/ _AWP_^T=_
MP2V\'?!'_@WL_:;\-_#:R^"_Q T;P2GQ7\3:?XP\'SW;:8D.O^.(?$=YXF\"
M_P!L:AXI\42:U;ZSJ>HQ^'C8W)NEL[:Y@MK>"V@ /U-_;N_X*!?LY?\ !.3X
M9^#OBU^TSJ/BO2/!/C?Q_:_#C0[OPIX<7Q#>PZ_=Z9=:NLMY9"\T]K?38+*T
MNY;_ %%9IL*#B%GVQ/\ G/X6_P"#F#_@DIXF^)VK_#JX^,OC+PGIVDZ9J^JZ
M?\4?&/PVUK2/ACXG&D074TT7A?6TN+W7;ZXNFLY++2WO_"]E97VH(4M;AR5-
M?SV?\%H?V?O^"BOP/_X)I?#SP]_P4C_:-\)_M)>+/%/[=O@:Y^'.L>&-2N=2
MMO#?A*'X5^+;/Q%HMW)=^%_#!C;4]1N+.^C$-O<H$MY 9.<+]"?\%P/A)\,?
M^&O?^#>/X?1^"?#-MX-O_!WA/PKJ'AZQT;3;/3]2T"U\6?"*.VTN]@M8(X[V
MVB\R=3'<^8)/MDXVQF:8.K ?T(?L*?\ !;S]@G_@H=\6]=^!/P&\6^.]*^*.
MD:1JVO:?X5^)_@N7P7?>--!T<1W&HZOX-QJNJ)JBV6ERKJLME>MI&J+8J]V-
M/:%'8._;P_X+=?\ !/\ _P""=GCJV^%GQV^('B3Q!\6Y+&TU6^^&_P )?#'_
M  G7BWPW8WY8V=SXEWZGI&B:-/<0))<C2[_6(=5^RD7 L/*EC9_R$^,&CZ%X
M;_X.^OV?!H>CZ=H5I??LKZ#J.H6FCV-KI4%S<S_#?XB6UU-/#8K#$\DUI;00
M2.8P[P0Q1/'A *^5_P!CSXY_LY?L!?\ !>W_ (*=ZK_P4KUO0_ 'BWXCIJNI
M?!/XO?%3P=>ZGX=N/#VM^(+'62="NY-&U1;&U\0^!H8M$L=>L8I[;43HU_X?
MCG-RSQ%@?U"_ ;_@JA^QA^TW^RQ\3_VPO@S\2;KQ=\+?@IX>U+7OBOI@T6:Q
M^(G@,:383:C)IFN>"[MK>Y%W/8123:8UM<RZ7J,8=K+4+EX9=GYS:U_P=)?\
M$F=(TKP;JL/C;XU:]%XJ$+ZC;^'_ (47-]<_#J.>]:RMY?'S2ZU86.G23+'-
M>06>CW?B34WMEWS68EV(_P"#?[!<>B?%/Q9_P<<_M0?LU^&-2\+?L2>,_P!G
M7XH:#X"F&COHGAC6O$FH^([37=,ATG3I#;K:7BV%GKWB8(EG'<V6F:M#:72V
M,MZUN/3?V5_AE\/5_P"#1;]IK7SX0\-2Z_K.M?%/Q=J6NSZ/ITNN7>O^&_'W
MA#3= O9-2:V-\9-#MC+;Z8PG)M8KB6./RD=RX!^HW_!=O_@MQ_PR7^Q]\!]?
M_8G^(VG77Q/_ &PM 7Q[\)?BC;^%H?$FB6WP=MG^PZ]XHT*?5F6STOQ8U]=6
MVFVD6MZ+?W-F%NY!%;7=HFWX<_X*I_\ !7+Q!\1_V"/^"5G[4G[(_P"T/\;_
M (0^%O&/[1EY\+_CQXJTG6-?^&NM^+M1^&/@KX<K\3H?%UIH.IRRZ_X;CUZ[
MUK5;(3-+:WL-Y<S_ -G(\BH?EK_@H'9S7O\ P:E?\$U]1%@EY_97B+PM;RZI
M]F66;3+2Z\4_$I(;4W?DR/:V]Q<C9Y7VB%)I57]U(Z@KZM_P7;^,/[/W[4W[
M 7_!&37O@MXJ\+?$;X8R?'_0/A5XHO/#MG+::.OBOPU\)_A-X?\ B#X9O+6Y
MTW37DO=,N[B2QU*;[/+#.S_NKJ[CQ)0!^^G[-O\ P<&?\$V_VHOVCO#'[+7P
MY\?_ ! T[QYXQO(]$^'_ (D\:_#Z_P#"OP]^)&KBUD^R6WA3Q#<WDVH*=2>T
MNH]+N?$6DZ%87\RE([@S2Q(_[?6H4W=LD@&#<PHZGT,JJRD=0<9!'4?6OXS?
M^"\_@_PKX%_X*7?\$+8/"?A[1/#7]E:OH/ABS;0M*L-))T/0OB5X6LM*LC]A
MMX%EM]/A;R+82;FC620#ES7]G&<:[D#IJV0 ">EYT !!_ '/H: /X%?V6/ W
M_!3C_@J#_P %!O\ @I%\&OAW_P %;?VG?V7?#/[-'Q UK5?#FFVGB_XE>+]!
MN-(U_P")&N^&=/\ #^E:)HGQ)\&0:#8:);Z<C1"W%U')"T< B@$;2M]>_P#!
M&3]N/]N+1/VR_P#@H)_P37_:=_:+O/VL[;X _#/XS:_X,_: 76IO$^H:3XG^
M&MC=6\EUH_C*XDN=8U32_$"75J]AIVIW][/HFJZ7<+:W1:*7/Y@?L%?\$L_A
M1_P5!_X*<?\ !6+PA\4_C)\<_@[I_P (OB#K/BG3+CX(:WX:T:]U^;Q+\6_$
M.B7EAXD_X2+0-?@NM.LXH$FM(K:.!XKF5WEDE3$9_K;_ &*O^"0W[(G_  2Z
M^#O[01_9_MO&_BGQY\1/AEXTM?&'Q;^*&J:?K/CW5]+LO#.MW=IH:/HUAH^B
M:1I$%R[W4MOI&D6KW]TRS7SW,D:%0#^4+_@F1H/[?7_!1SP3\<?B)XQ_X+^_
M&?\ 9%G^&/QDG^&^G>#?'_Q@\6ZC?>)-)N-(774\0:6U[\:O S6^FV<LQTM[
M:WTV[M4E@+"[A;;;U^[WQ[\8_MA_\$G_ /@BQ^T/\5]$_;:\0?\ !0;XUW?C
M/1Y? G[2VM"[\6Q?#WPOXXU.T\.7FJ6@U_QA\0K:_L?"WE2BUNI-8NM-MM9U
M6TNELT:-0OX<?\&_G_!';]B;_@I#\$_VL/BA^T_X;\?:YXL^'O[3?_" ^&;C
MPA\0/$/A"Q@\/ZAX4C\0SQ75EH]Q!!>W+ZE/+(EQ,/-6$")6"@"OZ6?VZI]+
M_P""/W_!)K4_#_[+O[,^C_M&_!7X4W%OX1\6_"/XO:CK?B[2[?X6>.KO5/\
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MBA[VX\7:OX:$\L/@[6/$DFIB._DUC4O#D=I/?R:BK7:,T+;F,QDH P_VW_\
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M1VR(,@&1II%10< GOR* /Y7_ -F/]O?XK_M!?M4_\%C?^"DK^)?&&H?LP_\
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MFDN7\-6?B_3I-)E57#3:6\/VL+(QC&__ ,$<="_:8\9_M)2_%2X_X+H^'?\
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M8/#$/CAO!^G^(X?B=/XP6_NDDO=>U=;2'3+VUO/&G_"+3_#J"&[N[BQM!=+
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MCU'YBJ^,>OYD_P S2_AG\OZD4 3Y'J/S%&1ZC\Q5?/L1^7]":7&?_P!9'\J
M)\CU'YBC(]1^8JOC'K^9/\S2_AG\OZD4 3Y'J/S%&1ZC\Q5?/L1^7]":7&?_
M -9'\J )\CU'YBC(]1^8JOC'K^9/\S2_AG\OZD4 3[AR,CD,!WY(('Z_A7TA
MX=YT'1S_ -0ZT_\ 1*5\T X()! R/3U'H37TMX;(.@:,1_T#;/\ ]$)0!M44
M44 %%%% !1110 4444 %%%% !4<W^JE_ZYO_ .@FI*BG_P!1-_URD_\ 0&H
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MWXONM9\1'2]/?5[^]\*>(OA]8^%Y+C4I(/MHDT>TU"^M["-9\1Q7<IC +D$
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M"?"GB#1/"D,^LIK-O%9W=KJ6H6NMWFC>*[C0Y0]Z^FVZZI!!<0V9(0']$_[
MG_!9_P#8-_X*0^*=9^'7[/WCKQ/HWQ1T2PN=9?X5_%/PP/!?C;4O#]B$:_UG
MP_#]MUK1]8AT_>DE_P#8M;N=3M(G6XN=/AM7,M>._'3_ (.$?^";?[.OQ3_:
M$^"?Q,\8_$JQ^*/[.7BA?"'BCP=I7PXGU;4/&?B-+F:VOK'X9I;:DEMKJZ9'
M$]QK%[J$^@VUI9NMR+B12%'X>^/OBY\!OV[/^#E;]A'XA?\ !.>YTOQWIOPG
M\/Z1K7[2'QC^'7AV33?!E_8:'#XAEU75-5F:QT=-6M-&\/:AIWAB_NVLVBOK
MZZ@M;5[QX)&B]_\ ^"4'@;P;XG_X.4?^"Q/B/Q!X7T+7=9\(:YXL3PU=ZOI-
MEK#Z,GB/QSIFE:^UC'?1S)&=0T^-;6[>,;W@!CR%;%,#]:M#_P""X?[%GQ3_
M & /VC?V[O@EXH\3:YX9^ &AZCIOB+P7XD\'7FG^-_#OQ%UG3)4^&VG^*/#T
M&KF.X\/ZWX@N=)CO=3T'7;RRBT_[4!>I?Q-$GX@_L*_\%N/BE^V)_P $RO\
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M8A5 49*CY6!^1O\ P60_;O\ VX/B-^WY\!/^"/?_  3K\;-\%_BE\2M%\/\
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M_H$.DWOQ!CF\-_M.&T\;VWA1P\FDWVLSR6>IFPMT\S39+VVMQATC*L#]MO\
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MNH6^OZ-8ZAI_A7P_IV@:-:+HVJSZ;XGM=.\*7NA^*D.G:-X,M;:\L8XF4W8
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M_FI'X4E !1110 C %64JKAU9"LBAXF5U*.LB$X='1F1E(8%205()%?'.@?\
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MP#\>?A+\._C+X(EN%O6\*?$SPCHOC+0A>Q ^3=QZ?K=K=P6]TI/RW%JL+QL
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M,>!O!^E6FA>$_!GA_1_"OAC1;&%(+32?#_A^P@TK1M-MXXU55ALM/M;>WC4
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M_P"2* .5WMZ_H/\ "DR?4_F:ZO\ X0;Q5_T"O_)RR_\ DBC_ (0;Q5_T"O\
MR<LO_DB@#E,GU/YFC)]3^9KJ_P#A!O%7_0*_\G++_P"2*/\ A!O%7_0*_P#)
MRR_^2* .5WMZ_H/\*3)]3^9KJ_\ A!O%7_0*_P#)RR_^2*/^$&\5?] K_P G
M++_Y(H Y3)]3^9HR?4_F:ZO_ (0;Q5_T"O\ R<LO_DBC_A!O%7_0*_\ )RR_
M^2* .5WMZ_H/\*3)]3^9KJ_^$&\5?] K_P G++_Y(H_X0;Q5_P! K_R<LO\
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MKN8]_P"G\J3)]3^9KJ_^$&\5?] K_P G++_Y(H_X0;Q5_P! K_R<LO\ Y(H
MY3)]3^9HW,.Y_G_.NK_X0;Q5_P! K_R<LO\ Y(H_X0;Q5_T"O_)RR_\ DB@#
ME=S'O_3^5)D^I_,UU?\ P@WBK_H%?^3EE_\ )%'_  @WBK_H%?\ DY9?_)%
M'*9/J?S-&YAW/\_YUU?_  @WBK_H%?\ DY9?_)%'_"#>*O\ H%?^3EE_\D4
M<KN8XQSR/0=QUZ5]->&?^1>T7_L&VG_HE*\17P-XI!YTO'3_ )?+(_Q _P#/
MQZ9KW70K::ST;2[6Y3R[BWL;:&:/<K[)(XE5UW(65L$$95B#V- &K1110 44
M44 %%%% !1110 4444 %1S<0R_\ 7.3_ -!-25'*I:*55&6:-U X&25( R<
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ME_\ )%'_  @WBK_H%?\ DY9?_)% '*9/J?S-+N8=S^//\ZZK_A!O%7_0*_\
M)RR_^2*/^$&\5?\ 0*_\G++_ .2* .5+,>Y_E_*DR?4_F:ZO_A!O%7_0*_\
M)RR_^2*/^$&\5?\ 0*_\G++_ .2* .4R?4_F:7<P[G\>?YUU7_"#>*O^@5_Y
M.67_ ,D4?\(-XJ_Z!7_DY9?_ "10!RI9CW/\OY4F3ZG\S75_\(-XJ_Z!7_DY
M9?\ R11_P@WBK_H%?^3EE_\ )% '*9/J?S-+N8=S^//\ZZK_ (0;Q5_T"O\
MR<LO_DBC_A!O%7_0*_\ )RR_^2* .5+,>Y_E_*DR?4_F:ZO_ (0;Q5_T"O\
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M%?\ DY9?_)%'_"#>*O\ H%?^3EE_\D4 <ID^I_,TNYAW/X\_SKJO^$&\5?\
M0*_\G++_ .2*/^$&\5?] K_R<LO_ )(H Y4LQ[G^7\J3)]3^9KJ_^$&\5?\
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M*_\ )RR_^2*/^$&\5?\ 0*_\G++_ .2* .4W,>Y_E_*C)]3^9KJ_^$&\5?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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H\?7J,=/THHI;_>!DW7RA5( V!F."6&"3G)(R2,=^3]!DE%%"V0'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>ea028514801_img22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img22.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,N S@# 2(  A$! Q$!_\0
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MUE7#N5XS.LZQM++\IR^DZV89A6?+2H4XVBZE1I-J";7-*S23]6?6F$]OS_\
MKT83V_/_ .O7XL?\/O?V?_\ HF/Q5_\ +-]_^IE_SCZY!_P6]_9_)P/AC\5
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M^N/!@_7_ (284X_\%N_@)_T2_P"*OX'P;_3Q/1_Q!?Q8V_U#SW_PE7_R\/\
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M%Q?@&IQ_PJOXLGC/W?!G_P U%"_\%Q/@$>OPL^+ ^H\&?_-1_G%'_$%O%?\
MZ(+/?_"6/_R\K_B8;P6_Z.1PY_X5?_<3]M:*_$L_\%Q/@"/^:6_%G\%\&'_W
M:*:?^"XOP" R/A7\6S_VS\'8_/\ X2?%'_$%O%?_ *(+/?\ PEC_ /+T/_B8
M;P6_Z.1PY_X5/_Y2?MM17XC?\/Q?V?\ O\)_BR3Z[/!G_P TIH_X?B_L_?\
M1)_BS_WQX+_^:6E_Q!?Q7_Z(+//_  EC_P#- _\ B87P5_Z.1PY_X5/_ .4'
M[<T5^(I_X+B_ #M\)OBSC_KGX+_^:84G_#\7X ?]$F^+/_?OP5_\T]'_ !!?
MQ7_Z(///_"6/_P T"_XF&\%?^CD<._\ A2__ )2?MW17XA_\/QO@!_T2;XM?
M]^O!G_S34X?\%R?@"!@?";XNX]D\%@?@/^$GI_\ $%O%?_H@L\^6%C^N(#_B
M87P6_P"CC\.KUQ+2_P#3!^W5%?B(?^"YGP !P?A/\7O^^/!G_P TU)_P_-^
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M_P"'Y_P _P"B2_&#_OWX,_\ FGH_X@QXJ_\ 1!YY_P"$T/\ YH%_Q,'X,?\
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M^(,>*O\ T0>>?^$T/TQ U]('P:E\/B)P\_\ N:DOSPZ/W'HK\-?^'[?[/O\
MT2+XQ?EX&_\ FKI/^'[G[/O_ $2'XQ_]\^!__FJH_P"(,>*O_1!YY_X31_\
MF@K_ (C]X.?]'"X?_P#"I_\ S.?N717X9-_P7?\ V?%_YI#\8SUZ+X&[9_ZF
MOZ?G]:;_ ,/X/V?/^B0?&3_OGP/[_P#4U>P_/VH_X@QXJ_\ 1!YY_P"$T/\
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M_E!^ZE%?A2?^"]'[/0./^%0?&7/IM\#$GW'_ !5?0=S3?^']/[/7_1'?C/\
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MT/\ YH#_ (CQX0?]%]P__P"%4O\ Y2?N]17X/_\ #_+]G;./^%._&G.,XV>
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M\YPA_P"#@C]F\8S\&?C<?]U?A^1V_P"IO/OW]/6G_P 09\5/^B#SS_PEC_\
M- ?\1Q\)?^B]R'_PI?\ \SL_?2BOP)/_  <%?LWC_FB_QO/?D?#X'\/^*O'H
M>Q_I49_X.#_V; <'X,_&[(X/'P__ !_YG#Z_Y')_Q!GQ5_Z(//?_  EC_P#-
M O\ B.?A)_T7N0_^%3_^4'[]45^ 9_X.#OV:CU^#/QNZ?W?A\>Q]?%S>_?N!
MWS0?^#@_]FM>1\%_C<WN!\/1T/3_ )&]<\9(_#UH_P"(,^*O_1!YY_X2QO\
M^I ?\1S\(_\ HO\ (/\ PK_^X7/W\HK\ /\ B(3_ &;/^B+_ !O_ /,>^W_4
MX_7]*:W_  <+?LU*<'X,?&X'T_XM[Z>WC'U_3WH_X@SXJ_\ 1!9[_P"$L?\
MY>+_ (CIX1?]' X?_P#"O_[B?T T5\Q?LA_M1^$?VQ/@GI'QP\$>'_$7AGP_
MK&N>)-"@TKQ3_98U>.X\,ZK/I%W-+_8]_J5CY%Q/ TMMLNFD\EE\U(WRH^G:
M^ QV!QF68S%9=F&'J83'8'$5<)C,+57+5P^)H3=.M1J1N[3IS3C)7=FGJS]-
MR[,,%FV P>:9=B:>,R_,,-1QF"Q=%\U+$X6O!5*->G*RYJ=6#4HNRNFG9!11
M17*=H5^*W_!;D#_A0?PRX_YJG_[IGBBOVIK\5O\ @MS_ ,D#^&7_ &5,_P#J
M%^**_3?!;_D[' ?_ &/L+^5<_$?I&_\ )C_$S_LF,?\ ^D4S^8"BBBO]>S_G
ME"BBB@ HHHH **** "BC_/\ A10=%*G]J2_PI_G_ ,!^H4444'0%%%% !111
M0 4444&D(]7\E^H4444&@4449 ZG%)NR;'%<TE%=78***0D#J0/K6+;;N=L(
M*$;+7JWW?];"T4W.2,$>_/;_ #_2@D#/J!GTS^/Z46*!L]01QDGW_P _A41<
ML<>F<X.,?7U_IWIK2$G')'<#M_CC'?\ .D#+R<CW[?SJXI+=JZ?]6>SUWWMY
M&L8VW2N.HI,Y/!!'?U]J3"DY[CK_ $)_+\*N_P"?]6+'5$Q'0>N3UZ\YI6;/
M _$^OT_S^E1U$Y=%]_\ 7XA9ZOMO\PHHHK,>LFENW9?H@HI <Y]CBEH.JG3Y
M-6]6DFNBUOH^H445"3U';)/UH-;-[)OTU_(&/)'^T?Q)-&QO3]12$$=?3-2I
M]T<]SQZ#_P#7FE)V5_TO^J-J-/GDU)-)1;O?E[=6K?(4< ?05!*V"?7C'^?S
MITCG'RD=^A'..N.>W?-5V;<<_3K416M^]_7<Z:TDU[/71Q;U3BU:ZZ^:Z=-;
M;#:4 DX _P FC!/0$_A5J/:JCH"1SSSGWJI2LN[)I4G5E;5*S;=F]%9::6Z]
MQR+M4#&#W^M/I!WZ8[8_7-(-H!8=/RZ=AT_^N:Q/2C%1BHK9)):?GMJ]WIO<
M4D#.?_UY_P G_P#541;=].WT[4,Q/T[?_7IN0.IQ0;1C;5[_ )?\$*8[8X'7
M^0_Q_P ^E#. .,']<8^E19SSZ\_G0$Y=%\PHIORKGWY]S_G_ #WJ-FSQCO00
MHM[;=Q6;/&.AIE%-+!?K[=J#5*RLAU5Z.<^_ZYI3E#R0/Y&@8E1.^[^9S0[[
MOYG-,H *".JGW']#BBDR#T(- "U$[9X'3^9_P_SZ4K-V&#D<U'1<+!1116<I
M75NO77:WYG30H\S<F[)6MI\5_79:?U</I36;;]307"\=\?YSS_D5$22<FLSO
M DDY_P _K3&; XZG]*1F'(Y/!Z<X^M14 +@D$^G4T%C&#[XSCKZ_Y_3M32^T
M;?7G''\^O:H2<DG_ #Q03*5M%N#')S^ IISVQGWHR.>1QUYZ?6C@CU!H-*%)
MS?/)NT9;:ZO?7RO;9=UH!QWQWQG]?_KU$S9/L.G^-(Y5> #GVSVZX_R*;QPW
MIWZ<'_\ 70=,I-Z:>=OZU_KL+4+')]NU*SY.T=#_ $[^F.E1G'?MR/J/2@@4
MG')J!CD^W:E9B?IVH7 RQZ 9_$8[?Y% TFW^H@8)\QZ'C\>#TJ%W9LDYVYR!
MV]OQI3ND)/H#@'IC(X';.#GWIF3C;GC.<>_/^-!LE96$HHIH8$D#/ !SVY]_
M6@8C$Y 7!/5@?3Z],_Y[TX*H)( !/)(Z\GMU!.?7WH)(!P,GL/\ ]>*0#G)^
M\>O^'7M4RE9;ZF]&DYR3DO<6KO=7[)?K;IU5QU122;<;<'.>_3&,?SIC3_W1
MZ]?YX_G58D#J0/K4Q@WK+_A_4[9225H_@K)>G07IU('U-5)7W-CLI('OZG\<
M<4CN9"..F<=SSC_"HBVWCHW8DXQCKGZ_TK0YI2OHMOS D#K4))/6@G)Y^\.O
M\A[=B.*3<5XYPW!]/Q]*"8J[\NX4A. 3Z4$[1D_A[U 6W$^QVGZ]?ZT&RT27
MR%+;C]../S_K_3K4$KE<KC[R]<^N0>/I[]Z)9,#:,'<#SGIGCI_]>JQR %((
MP2>00><#OVX_G5QC>S?R7Z_)D2ET7S?Z?<2H"%)/ S_0'/TJ!YL@J!CJ"<\_
MABFF?<I7J!\N3U&.<?AGW_I59W.,(1NQG.>QXP.V?Z'GM77#X5_5MSEG471Z
M?B_3R"1P@_VCT']?I54R;1D$EV)R>^., ?7N1T&!0T@("YP!RP)ZL>2>W7KZ
M YJ(_/TX [XZY_\ U?K6;7O.^R>IRSFWMN]$EWZ_/S/[>?\ @A=G_AWIX$SU
M_P"%A?%@]<]?&FH=_7U]Z_8*OQ]_X(7G/_!/3P(?^JA?%@?EXTU ?TK]@J_R
M!\4O^3E<>_\ 979]_P"K"H?[=>$'_)JO#G_LB^'?_5;2"BBBO@S]&"OQ6_X+
M<_\ ) _AE_V5,_\ J%^**_:FOQ6_X+<_\D#^&7_94S_ZA?BBOTSP5_Y.OP%_
MV/<+^5<_$?I&_P#)C_$S_LF,?_Z12/Y@****_P!?#_GE"BBB@ HHHH *7Z>G
M/O\ Y_F..:2B@Z:5/[4O5)[>K7?LGMN%%%%!N%%%% !1110 4444&D8VU>_3
M_@_\'8****#0**** 2OT?R"D.>, 'GOZ?Y^M .?4?7K2X)S@$X&3@9P!U)QT
M [GH.]8SE=]++Y7>W?N[+_@G92I\J6EYOHE=KR5K]-[?DAHQD\GZ'.!^?Z?C
MVZ*0#U%!(!QD9],C/\Z7J&(YV@EL=L>OI^-)WC=N\;;MZ6Z:MVMOUMOWWTC[
MTN6/O2O)*,?>E>$>:22C=WC'WI*UXQ]Z5EJ-X4$@?Y_I41)/)I'9\XQV!/'&
M&Z=.WUS_ #I #W.3Z8Z&JBTF[R3=[-\RTT3M>^]FG;>S71J^T82B[23YGLK/
MFWMM:^^FBWT\@ P2?7_Z]! /4 _6E(QG/&.OX]*7! !QP>E:)QV36KT5T[M]
M$KO7R+Y9>]H_<UGH_=5[7EI[JOI>5EYC< = !3';H ?K@\4K'. "#G.0"/U]
M,\XZ9[5$00<'@BIFVKQ2:[Z6ZV^Z^C??02LU?=;73TO9VU5]=&[=;/L[%%%'
M3.<#'J0/YUD%OZ]=M=OQ"BBCMGMZ]OSI-I;M+U:7YM'72I<JYK7=KNR;45UU
M5U;:[>GF%'UZ?YS29'J*:V#C+ #.!W&?SH;2MY[>?IW^5S91<NR23ES2:C%)
M6U<I62^):WZK7571GZ@?B?\ "E3H?K_04TJ <%P#C/;ITSUZ9.*<N!E<@D'D
M=^PQCKU_/-*5VK)-O1VY7MWVV.FC'V<^:<H*/O0NZD?CLFXZM>\EJUNEJTE9
MCZK2N2=JG'')SC/MG/('\\^]3DC;DD;>Y]N_T]_3GIVK2?.YV\\ ?CZ'/0_6
MLX-7;NK*Z;NK)]F]E\V=-9*4(I-.4G&48IIN46I6DHK5IVT:33Z-V(J,$] 3
M2E2#@CFK*#8A)&&_H3QG]?\ .*MSBE=.+U2^)6U^9E2HNI)QUBEN[/1]M;).
MVMG;1-]!\:[5 (YYS^9Q^E.P/0?E35<,!\P)SMX/<G@?7H!ZGCK3LC(&1D]!
MGD]N/7D@?C6;NVT]]VNJZ[;K[MCT(\L8KE:<$K*2:<7;322=G=I[/5WZAP/3
M'^<U$QR2,Y';\J';D@$<]/?@?GBF=!R?7D\?YQD?I2;25VTEW>BWMN]-]-]]
M-S:"U[O16W:;V75\WE:^HN1ZU&Y&.HZ_XTLA*<'*],YXQN^Z.>A;MW/:H\$]
MCGOU-+FC:]U;:]U;:_?MKZ:[%M2;<$FY:JVJ>[3TM=M---6T:L[/02BFEL=0
MW7'2HV;/T_SUIII[-/T:9GR2Z[7LW_77R%<@G@YX_J:9129'J/S%!HM$E?;N
M(S8';/\ GFHAE@6[^F.?3IZ?G2YW9.<8S@'@XR?\_E2$%2,>V#TY(S@^A]0>
MWM0VENTO5V&M=M?37\KB=!DD#GUYSUS4+,6_GZ\TC-G&2!Z=J3MGMZ]J.E^C
MV?3[Q75VKJZW5]5ZK=!3=W^RWY4ZC!]*-M]+[7TO]]BDF]$FWOHF]/DF%1,0
M,;2!USC\.N*<[$$ ?6H20.I ^M)NWEI?71?>%O)Z.S[KY?\  %HH_KZ?_6_G
M16<Y=.G=];;V_(Z*%*[YI.R73:]_7TZ7"F.>!ZYS_.AVVXZ9/K_GO49)8_IQ
M47.]:Z+6VZ6MNVBO;0:3]3D_Y)I&8 'GD#ZG\J5L@=.Q[]/P_P _K42J7) Z
M^O\ ^NES+75:;ZK3UUT^=AM--)IIR^%--.7HG9OY"9/)]>#^--) SR,@=,TK
M?(<,,GG '/\ GGMUJ Y).>*::>S3OM9IW]+7N/DFT[)73L^9J+3M=:2L!.3D
M]Z2BE(( )& 3@9]?3ZT%4\.[\U1K1IV333\V]DF[+SV&X !]#USC'T^F>E0L
MV"<'Z ?3L/SISEQD;6(SC@9'KG.,=.1S_4U&2!@MQCIGCJ/?V[4DT]FGZ-/\
MFSHJ7IJ\HNFE]J2<%Z7DHK6]]_E:S&D\@X( SU&"<^GK[TQFR3S@>G^?>D9L
MG/;M[4F#@G!P.I )IF:U=EJ][+5V[V5W;S_$0D#K4+'))_*AFR>OT!(SCZ=_
M?_ZU)D+\QY ZCOS_ /7ZT[-:M-+O9_Y!&TG9-:.SU6CW:>NCM;1ZZK0<IQ\Q
MX [_ (=!ZFH&<L2<D \8]O3]*'<L3R=N>!3*1NE96#)QCMG./?\ R:**:S@'
M'4YY Y*C'4@<XZ9^OX$&!89*]]I/X=/SID/W,9P022.^"<9 /7\>.M/8 '<
M-Q&T=L\C^7'TH YR>IZ_X?A4RE9;ZF]&DYR3DO<6KO=7[)=[];:6OKKHZH9)
M-N I4DYSSG&,>_7Z^G2B23:!M*DY(/.<?D?YU4) ZD#ZFHC&^KV_/U.V4DE9
M6T^Y+I;H+5>?^#_@7_LM,:5B>#@#T[^YJ)W./F)..@K4YY2332O^@%@ 1G#'
MD'TP#G\\C\JA9L]>2,Y/KS]/\_C32<\FB@A)MKMWL%(>.2>.F..3_/I^%!(
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MA+%4,ME.GF.>9GA:<:U3*LMIP5%XKV<JE.+G5Q"I8.E\256IS.+46?SO^/\
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M#%,9D'GHP?/SQ^SA_P $T?VH_P!IMM?F\/\ AFR\":5X6UB\\/:CXA^(YO\
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M[)OT3?Z,*0Y[8_'_ .M0#D="/K2UG*5WY+\3JI0Y%=KWGOULNW^8G?OT_P"
M_A[_ .>M+@'J,T45!J)P.0/R'-3Z:6.J:;CJ=2T\8/\ U^0<>W^3Z@T'=NV2
M3SC!P!_G_P"OUJYIF[^U-+QRYU/3RJ@=2+R$X'KQZ].M8XU)8+&7N_\ 9:]V
MDWR_N:CO?>RW=MDFVTD[>AEZY<=@F]?]LP>S7,D\5AD^5R4ES)-N*L[R44KM
MQ/[B_'/PY^'GQ:_9LL/A_P#%B^;3?!'B/P/X6M-:O4U6'198$33M/DMY8M0N
M%>""83)&L9F1XV)",C!L'X=\(?L"?\$V?ACJ5CXBNM<T779M+U+3[_3_ /A-
MOB=97VGV=]:3K-;,EM:3:7!,LERBR2VUTMS%-(NS8(R4/I?[?+D_\$[_ !8W
MW#_PK_P5\Q"MAECT@#*DA2N0"P) ].E?R#),P"32I$X V_)&AV-M(.W"[UV\
MLO)"MROS#G_/_P &/#7B3CC).+*N6^(&>\)93'B/,L)BLORMIX?'8B;Q4Y5:
MT8UJ4UST)NE*;NO9RLF^:Q_JC](7Q=X/\.>)^!Z&;^%O#''&<O@_*LPP6>Y]
M0J2Q678.C4P$?8PJ1]I.$88B,,1%1P]1>V2O%-77]'O_  4R_P""@_PKF^%O
MB+X ?!KQ+#XLU_Q=;0:-XGUWPE>QKH7A[0X)HGN=-BU&%'BOKR^$2V<EKITL
M?V.W#QS7"<P/SW_!$?X+:))I'Q+^.6L^'XI=4@U:V\%^#=4U"V#36-K9V?V[
M7KO2F>$)%)<37\>E7%U!-)+ML7MU\M#)YO\ .X'B7CR_NDL=I'\3<+UW$?>8
MO]\.3MXK^C;_ ((C?&CP]<>$_B7\#]0NH['Q'8ZQ#XVT2WNKN,?VOI5]:Q6&
MI1Z9;LP9Y=+NK2.YU 1!MD>HV\CC)=A^D>)WAY'PO\"L]R7A&MF6,IXO-LNK
M\2YC54*6)QN&GB*5*M.<</*\<,H+#TZD8\U"-).,K^TKM_DG@OXN5?&;Z2W#
M_$G&_P#8N"GALAS;!\(9-0P\JV#R[$0H5<1"*Q68T546+E4C5JTG!PDYJ$Z5
MI1IJ/R?^V!_P4]_:)E_: \::/\(/&-]\/OAYX'UN;P[HNG6NDZ1<7>JW.E/'
M;W^KZO)J5G>&Y_M"^ADFL;(^1#:6;)!/O9I7D_7S]ECXHV?_  4%_8RURP^+
M6D6S:GJL6O?#OQO_ &<((8KK5;&RMKFSU_2T=+E=.U K?:;?HDD3QVFI1,]N
MC6ZP[_QS_;1_X)O?M&:=\>_&.M_"SX>ZS\1_ OCOQ#J/BC1K[PY$L[Z'_;-[
M<7L^B:VLLT<L/V*0LJWI\R.Y1XR%4R87]@?V3OAK;?\ !/C]BO6]7^+^I6UE
MK-K'KOQ(\:V]K<1,MKK%SIEO:V'AK3)'DV7NIO8Z7IEDL4)V7&KR3QVY>';*
MWYSXD4_"^/AMX?5?#V&5+C2>99##!2RG$.IQ#[2EAZ3Q"Q].A.6(6*EF3C.I
M.O2C.>(5-4.:$+GZWX2S\98^+OBO0\4<3G6(\.5E/$U?,GQ%@84N&:%/$5\3
M+#PRFI7I4\+4P=/+/]GHQH5:E.&%A.IB7&I4L_RF_P""7/Q#^*WPP_:]MOV6
M(O%DL/PZ&N_%>3Q7X9BT_3#:ZMXB\+Z!JEO%J/V][.;4[;R[C2+6=8[748K=
MOLXB*N"Z-]4_\%?OVGOCE\$O%/PW\&?#/QW/X9\.>.? GBI?%&E1:5H.H1:N
MXO;2P):XU72KZ^MMME=S1DVDL*-&[$[9=A'Y]_\ !-/Q@_C;_@I#X7\<:A(\
M,WBNZ^,.NR+=2*T[W>O^'?$%VL4\J!4FN&DNBA8*$9P2O2OOK_@L'^S5\;_C
M)XR^%'B_X8>!;[Q?X>\+>#/%=KXFU*RDM=NB_P"GV6IFXOQ.RM!;M9VD[K,B
M,,QLN ^VOJ.(\LR#"_2,X17%F$R*A#&<'X+-,ZCF$:.%RW%\2O"8IJIB9XAT
MJ<L3+%4<-3ISG+F=:EAD[S44_C.%\XXGQ?T2./?]1<7Q'C'@>.LQR7A^643Q
M&-S/!\)+'8"+A@L/A%5Q$<)2P-7&5:U-0M+#RQE1WA-S/</^"0WPJTOX>_LE
M7/Q+LM(>]\8?$K4-;\02R1(8[B_TS0HY;+P[I%HTJ Q+*8)T<0M]FFN94F55
M=,U\DV.K_P#!7Y?C/;?$-O#7CG_A&+KQ='=2> YG\.IX<'A*75U+^'Y+*0;+
M=_[($=O_ &G'(M[;W(>[,Y!:-OL+_@D?\6]*^(_[),OPYTK5&TWQ7\+[G5O#
MDR%('FTZTUS[1?>'=9LX&51/;1RS7! E#'[1;F*5CY@!^)[^U_X+(VWQGC^%
MT?C+XC3:5=>)'MK;XAP^'_!$W@U/#+ZBBMKXU5-":VC2TTN1+B73))/M2W*F
MRRTC;J^'C_:%3Q)\8(9E2X 6,KX[,'47B16KQJ8?)V\3.A+(I<LJ4IT\%+ U
M4Z+=>--8;ZM&4')'Z97_ ++I>%'@1+*)^)=7 T<ORSV<O"G#T9T,3GM.>"C6
MCQ%!RIXA0K8^GF5*2Q#AAIU'B_KDDU21]2?\%GOA3H_BW]FCPQ\8+G2FT_QK
M\/?$VC6;RH5D>#0O%$4D>LZ?=W"+^]BLKZ*W-I*2((IWF?;F<8[#_@C$R)^R
M%=RC#;?B+XHD9% V@J+8JH7D@\*#D@[\GTKX"_X*0^"_VL_@U\+]*TKXQ?M<
MV/Q;\(>/-;M=-L_ ESX:T_2=;U2YTL-?7FJ[[#0;2UBT[12;69\:@LTTD\*1
M0S!)@/OK_@C6S#]CV_ 2,2_\+!\5LR1Y8!)%M2#N.=QQN9CDLN-K9(P(SG!5
M,)]&JCA?[8PN<X-\?49Y?C,OGC_JN'PL\0HU<#'^T<+A:RC3Q"JRINE#V5ZT
M^6<I.?+.28^EC?I>XG,%D.*X=S"'A7C(9I@LQP^!^O8O'4,+*K1Q]6658[&8
M-U:V&EAZ<X2BZTEAXQGRQA!R_)G]H[_@I9^TW-^TGXBUGP7X[U#P5X/\$^+K
MS0O#W@^S^QSZ+)I>F7R6<K:W"(6&K7&J):&XU"2>>9K9IY8-+DM4RU?M5_P4
M*%A\5/\ @GCXP\7R6]I/]K\(>"OB#ITTD>X6=S]HT;51<:?+"[R13202S0Q/
M%*$:&9X)':"5PW\EOQ))/CKQSO/F2GQCKS'!)W,^K7?(.26RS %LX);& 17]
M8'[2D@;_ ()5W1^[_P 8^>  R\9!70] !_'Y23@\G)S7W7B?PGP_POB_H_XG
MA[*,/E&(KYWDN'Q6)PT%"MBX3H9%BY/%U(J,JU7VV)Q+<IRE+][.+TDXO\X\
M'.,^)^,\-]*/+.)\]QN=8*?#&<9GA,#F%9XBG@*_UKB/+5#"P?-0P=*%+ 8*
M2P]%I7A"I))V:^,?^"*/QO\ B=XPU/QI\'/$/B>?4/AU\-_ %E?>#/#;:?I4
M-MHL]_XF$EY+'?6]E%JMYYLE_=@M>WL\2>>1''L2/'SK_P %5_VH/C?;_'CX
MH?L^0^.+N/X1W>D^&6?P<NE^'A;$W-G'>O(=5.EMK49DNHQ.V-1&WY1&5&5K
MLO\ @A7-'_PN'XV1OY:N_P -M(1,N@DD"^);,,%3(<H-P\QL8!\L9!:N!_X*
MN_LW?&Z3]H3XE_&ZT^'NKW7PH@\/^&+N?QO;^1+I-JD-K]@ECG=3YL$\-RH2
M:)T(C66%MVV0 =6%RSA'!?2?SS#YGEN48'#2R7!XO+L-BJN%PV&7$5>GA,1#
M%X9UITJ<\PKXBI4KQC3<J\ZU2?+&4^9'-B<\XYS3Z&O#&-R3-,ZS+%KB''9;
MFV+P-#%8S&OA?!U\;A:N$Q4</3K5:.6T<+1C3G5JJ-"%&E&\U#ED?JK_ ,$]
MP(_^":NE%< -X,^)I.% &3!JV<':A;D'#/N9LY+MUK^;K]EK]HOQ+^S)\77^
M(WA7P/X;\<^(FL]6\/:39:U!?RW5C<ZO>1XNM+%DWF->3"#[(%\B6012L(9;
M8--YW](?_!/; _X)HZ47.%_X0OXG/EB3@"+5L%CGJ>IQQR<5^8__  1:^'?@
M3Q=\??BIXF\66.E:GXB\#>&-,O/!=EJ<"7,EI<ZOK=]#J>MV,4X:W%W916UI
M''<1HU[9BX\Q'B29&?P^&,WR[(X?29S#-\L6>9?3SB%/%8%NM'ZY[;-L5AJ=
M*5:A4IU*%&4ZL/;5TY1ITHMRB^:-_H>,,CS?B-?1!R?A[.9<-YGB>&*<L%F=
M/V+67K#Y7AL94K.E7I5:-:MRX6=/#8>2INM6FHQG>,D>\>)/%'_!6G]J7QMI
MGBOX<^#]=_9T\!,FBV]MHVJ:OIFC06DD$$,M[XBDDUG2X/$.NV5[-/\ ;%@@
MTQXOLH-A#!=R0M*?TY^._A7QS/\ L"_$[P]\8M2T?Q+\0=/^!'B2X\8:OIUI
M&VE:GXCT/PW=:E+?6<$\%LD1EOK**>&5;:#[-<8G@BB,<:C\U_\ @HIXS_X*
M%ZE^T'/\*O@G9?$/2OA7JND>&T\,77P[LXU37+B[.W4[W5/$T%O]NTJ>TU-7
MCD@34+-8;2!)I5E@D<M^C_BCP;XS\ _\$[O&O@OX@ZQ>>(?'6@?LS>+[#Q5J
M][J%QJ]U?:]'X$U,ZD[ZE<O+<WY6Z,L:W4KM)<*HD(&[:/R_B=RIY;X89M0A
MX?930Q6:Y77RO)>%H2Q6?87!T<5@IJOQ!FE:M4KU*TIU%"K1Q,?:/$W;E>FX
MP_:.#Z;J9IXQY5B*GB;G5:ADV=8?-<]XQJ4\)PYB,?\ 4\91J8;AO)J-"G3I
MT&J+J4,30G*C+#? G&IS2_$7_@AME?VG/B"#]YO@KJ;$@Y&3XQ\)-Z#/.>V.
MA''3@?\ @LQQ^V7<?]DV\''WQ]IUOG\AGZ<UWW_!#D@_M0?$'!^[\%=1![8)
M\8>$L<'![CC&0>"!7 ?\%F1G]LRY8$$+\-/!X;D?*?.UP<CMSQS7]$Y;-S^E
M9FM2;2E4X+P\Y7>TIY5@;+7JVU9/5MK=L_E;,Z<8_0OR>C2]Z-'Q"Q5.'*D^
M:-/-<;SR7+NH\LG)I6BD[I<KM^3K=/Q /_?0R*_I&_X(F?&SXG^-8O'?PI\3
M^*9]6\ ?"_P=H$'@3P[+8:9!%X>CN]8O/M"0W=I90W]ZD_FNP.H7=V\>2JL
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MD*6>GZA=Z[K,UX6N+N66_EN+".SD>&SBM;1L12F5B?M7XK_#CQU^TW_P3?\
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MUI4C2ESQ52+E&:NU)JS'?Y_SC'^>M0R2;?ND9S@^U$DFT?*1N!P1^>?UJHS
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M;G_D@?PR_P"RIG_U"_%%?IO@M_R=C@/_ +'V%_*N?B7TC?\ DQ_B7_V3&/\
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M+K&0P)0 !J_/)Y'<$ED(+?PC;GCD[?X?0],GD#!P'RR>9(%! 4-@,.F.Q[#
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MHX62<I2C*&'5G:,)1M%K]5S_ ,;_ !;XKR.KD.?^(/$6997B<&Y9GAJ^(A'
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M^OZ7XY\&Z<EPFG:/X]M[O6;W3XYE5((['Q ]X-2ALK)@##ILIGA6("*)XHP
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MVH'*Y/!],'UI#G!P.>W3\^O^?2LSOH45!*;UDULTK1OV\_-_@?W'?\$),?\
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M"@FZ]:%*M6ISE2HJ+=6HHN$+/FDK,\[+^&N(LVPU7&Y7D6;YEA*&)P^#KXG
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MJNMZ#!JMEY1NXD2>\LX;RPU:RN4$T"74,+QNWEG'^?\ _%#P!X@^$WQ-\?\
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M<27;"(Q^(M+62^\->3*8V/FWLSW.CPVYE5;F2]B9V\V&!)?HS_@MA\&IM/\
M&GPL^->DV<EQ%XM@E\ ZWMF0[M6T]WO?#\$=LRHZM>VEQJ$+2!VA_P!#A#QK
M+MD/XA^#/%.I>"O&OA?QIX>NVL=;\,:_H^OZ7>"-6^R7VCWL%]!.$ES&Y22'
M<%8C<!@<FO[4-<\'_#[]LSX(?#?5-6MU?P[K-[\.OB;IR7EA;7EU"=,O=/\
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M8ACU?6->\0:A#;I>:UJNIK%;WMYHFAB]N=3EL[5[6.+1[2YBM4ADD:5_F/\
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M+;)&;>YNA9V$HO$S<&>.2<R!L%OUG_X)W?M2Z#^VG\ M>^!/QJGT_P 0>/M
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M++4;>:X@E\5Z;K=S-:WD(,GV>*YTRR:ZU&SGNX7W7$,1C;[4('/[+_ME2_\
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M6-G+#_7ZU2E6YJ%%.=2KA&U&#A3_ !+'\5_2#S?,O%[)Y976SO(,-4S2AFN
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MV;?AGXXL'DF#6J:AX2\1>)=)NK9("I99KVQ\1B=I_-C5H]->.82,T!3\#_\
M@@7 \?[8OCPR%EG'P \4+-#(&#03KXT\!++&H(R(UD5TVN ZE/+(!0BOK_\
M:W^*T7P:_P""V/[//C"[D:/2K_P7X(\&ZQ+]H\B&#3/'%UXJ\+W%[<DQR+);
MZ:-16_F@9-S>0 CPN4E3U/%G)(\4^,W'&6PE]9K+PMAC<"HTN63Q66Y=1QN'
MC3@DW*SP]=4Y13<XU(N%[IKS_!G.JG"W@;P+FGLOJU+_ (BR\/F$7755?4\T
MS.6"Q-2K/F2BI0Q6&E6A*RIRISC.*:D=9^R]^R$_@W_@L5^T5XE:R,/A/P+X
M?U'XG>%Y)TMXEN+_ .+\,5L8+>TB5 T5I?7OB)K>YCA*1'3H_.E-S(F[[G_9
MR^+8^*/_  4#_;/TZUU""_T;X7>$?AC\.;#[+S;PWEB+O5M:VN)9DGN&O=76
MWO98O*C2:S%O]GCDBD,GW-KECX)\!2^/_C'/:Z=IVLS>#K1/%/B:X=U-SH'@
MBWUS4]&M;MWE,,%KIIUG59<0I$TS7KM-(YCA6'\"/^"'/CK4?B9\<OVV/B/J
M]R]U>>/->L?%:S.AC;[/J^NZG=6END(:3RTL[62WM8XVEFECCAC1VRIS^6?7
ML;QUP[QMQ?FOM92X7X$X3X5PDZB<N;&2S'!82O44[6]I5P^"]M.'Q6?/*_NS
M?ZXL#@> .)^ N#<JA3]CQ7Q]Q=Q3C'3Y4J>$CEF88_!0FE*_)]8QM2A1DTXR
ME%QCU2_&+_@I02/^"@W[2J<;1\7[?W_Y@GA<>N>WH.Q[U_45_P %,>/^"6GQ
M+/8?"SX?$_07?A@G]!7\N'_!2IMO_!07]I0'Y9/^%P6S '(9T_L7PQ\RC@E.
MH) QE<=:_JW_ &_/ OC3XE_\$VO''@CX>^%M=\:>,=;^&/@*WTCPSX;TZXU3
M6M2FCD\.7$L=G86RM/.T<$4LKB-6(C1B>AK]BX[KT,-E_P!%K$8FM3P^'H2R
MJK7KUIQI4:5*@N'9UJM2I4<(0ITX7G.<I1C&*;;LC\6\-Z&(Q&:_2PPU"$\3
MB:]+'T</AZ,75K3JUI<41H8:%.GS2=5R<(*G%<SE.*M=G\)!;$<C 9_?2=>!
MU/)SC\AR3P/6JGF% Q'4X^;OUYP?<D9/MZXQ]>M^P+^VY@1']E+X\9,DC\?#
MGQ!CYC\H(^R\'![^I[=?-_B9^RW^T?\ !K0X/$_Q9^"'Q,^'/AJYU.WT6#7/
M&/A/5-#TV?5[N"[NK338[R\ACB:\N(+&[FA@#;W2WE8#"G']@8;C/@_&8BAA
M,)Q3P]BL3B)*%##8?.,NK5Z\VY6A2I4\7.<YRMI&,7)ZVB[.W\-8W@CC3!X:
MKB\5PGQ%A<-A*4?K.)KY/CZ5##VB^:56K4P\804;ZR<FEWZ'@JGN3RW].WX?
MY]3)V'/U'IZ?6F*.,@@KG  ()!'7(ZC((9<]596'!%-D<(/<@XXXR,?XU],T
MV[I.WH_NVZ;?YGSE*GR)2G=2L]'I:_7=W<EJK]&M$Q&DV[MPVG!V \Y^N,XY
M]Q54LS9+$G!XR?7DD#H!T';V&!F@LS'DD^A)S]<>E0N0<8/K_2MH1;26W?3;
M?<4Y_P# 7?S!F/0C'?US^/\ 2H68#('7I]/_ *]#-CCN?TJ$GMW_ !]^IQ[5
MHWRKE5K]7_74PUD]$VWLMV+_ (9_I0I&/F&3]2,<#COGZT@'!)(SP  #T'O^
M)_*@YP<#GM_G-9G?0I*"4W\;3T>T4]+6[V6M_DD#L!T&#Z<G\:AW'&,]>3_G
M\.U#9S\W7_/I320 3D<$C'/7_/O0=.K$9@/KC@5%\QR<Y Z\_P!/\*=AGYXX
MX_S^?TI">  <CZ8[FDWT5K_E_70VC%)7:_X?LOU/[EO^"#V/^'=G@,@YS\1O
MBX?Q/C;4*_9"OQM_X(.?\HZO ?\ V4;XN?\ J;:A7[)5_C[XI_\ )RN/?^RN
MS[_U85#_ &A\)U;PP\/DMO\ 4_A__P!5](****^"/T *_%3_ (+=_P#) _AA
M_P!E5'_J%^**_:NOQ4_X+=_\D#^&'_951_ZA?BBOTWP7_P"3L\!?]C[#?E7/
MQ+Z1G_)D/$S_ +)G'?E2/Y@J***_U[/^?0****#2,>KWZ>04444&@4444FTM
MVEV&DWLF^]E<*0Y[''OUH&><C'I[TM92E=^2_JYU4H<BN_B?X+M_G]W0;CD9
M&<=^GZ9Y_P X]*>%#'!;;GO_ (4E!P>"< ]3Z4D]5K;7=:VUW2VTWL;*UU>"
MJ+K3E)PC-7ORN2:<4]FTU8;(<-@$C;]V0%AT'R\J,@CK\I." >HY_6W]D_\
MX*JZY^S+\(-)^$VH?#<_$"TT+4M2N-'U2Z\3/IK6&FZA(MTNEP0+IMTQ2WNW
MO)O,>8^8UVV B@(GY'.2YVDX7ID<X4-G\3W_ $SC%/5U1&B,:R(2IW'((*]
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MOARA5PN49A1Q%:A"A32M0@\#AJM'#SA34I1@W2LM-&K*/YUEWB-QIE/"W$'
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M<074$Z'$BSVLL<]M*IW*$:">**97PQW(AV@C-5U)=0N?7ICMGKP>OX4]?,#
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M5[J NA?&TM65YFO @"P;HO)]>*^)'\LOYBR.')^>+;\J],[23C@\9QR#]:K
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MWOIV \ U"23R:4L2,9Z_Y_S^-,)P"?04'0*3CDU#@G<1T!)_S[TF6/<GV_\
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M![=<X_(&C^OZ=P33:2<6WLN:-W_Y,*>0<]*KL23M!.WUSZ=/IT].]*^2VW<
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M.2!G '/U] ??^?3J-V3M?[G_ )&E.*<XJ5E&^K;5MGO[W>PY1M&,YYS44K8
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MXHNNZ^]?YFL>5:N4;O\ O1T_\F%ICMC@=3WIID4@X.#]1_C48(YY'M@]O?\
M&BZ[K[U_F.4M+)IW\X_YAGG&#TSGM2G@$^E-+ >_T_S_ )R*B+$_3TI77=?>
MO\R%&[MM\[M^B3?^2%9LGC(&.E-HI&.!G\OK1==U]Z_S-E&VB3^Y_P"0A8*<
M'/3/'^141.23Z^M!)."2#_,8]:#@ '/.,G'^>OM_DNZ[K[U_F.S[/[G_ ) P
MV]P>,\5 S$YP3CTH9B<^GI28/H?RHNO^&U_*X6?9_<_\A*#VP/K^?7\J7!]#
M^1IN><8/UQQTS2NOZ3_R%9]G]S_R%J-V[#\?\_Y_Q5B>@!]SC@BH]IQG'%',
MN_X/_(I1D]%%M^C_ ,E^8E%%&#C."1[#TK.4M+?C9I6Z+5;G31P[E*\HR22T
M76][=+Z/^F%-<X'!Y/0C]?\ "D9B ,9R<'IV/_ZQ_G%,VL><=>>H[UG==U\]
M/SLOQ.]4Y=(NRTV^76W8:23U)/UIC,!D#.>F?Y^_Z4]@PP .21Z=*A*MDY!S
MDYX---/;7TU_*X.$EO%KY?Y7$')&3]2?\_A2,RJ.,[LG![8Y]^G3WI&)49QC
MTR#46"W/]"?RP#Q1\G]S_P B6I;1A)OT>GY"$D]324I&'"=2>^#M^O3.!WP*
M,=<\?4,,_3CFB_K]S_R*I47*3=525K63TN^S]%TTW(]V.BM^(/\ /FHW?/.#
M@=A_,_YX_.GRMM!P1QC.,@]<8Z<>M1@'')&?QY]^E'R?W/\ R.J3;]U:VWLG
M_P $*A9L_3L/\:';/0YX[Y S33Q_]:CY/[G_ )$6?9_<_P#(3(QD\>QX-0DD
MG^0]*<V6/0X'3BFXQC(('TY_S_*DVEO=?)_Y#4)2VC*RW=GI]Z0'Y1N/'<>Y
M[#U_'TJ)BTA)X&T9QGL.3CUIS9D<9X4$#N.,\\XZ_I087!.,$=CG'%+F7?\
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M"4VGSM/H]+]ER[VZ]F*[^@ ..PXZG]:BR?4\]?Y?CP!2[6/0%O<?-^HS32"
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M^#SPG_\ ,?1_PY$_9D_Z*%\:O_!YX3_^8^C_ (FM\)?^?_%/_AAG_P#-I?\
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M ,4?^(]+_P";AQ^@WXZK_F#X/^7$N!7XK*4?RV$DD$[,CH=TG^'O2[F_V?\
MOJ3_  K^I/\ X<?_ +,/_10/C5_X//"G_P R'M_/U-'_  Y _9A_Z*#\:O\
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MCT]?J<_CZ<_UH_\ #@W]E#_HI7QX'N-?\%?_ ##4A_X(&?LH'K\3/CU_X/\
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M_P#!NI^QZ?\ FJW[18'H/$G@''UY^'9.:;_Q#I?L>_\ 15OVBC]?$7@ ^O\
MU3OW_/ZD4?\ $T_A,]/;\2>O^K^(_P#G@_R-H_1-\6XZRI\/R\EQ%22?G?ZF
MMOG<_C2Y]6_#GU]&]C^5-W9Z%CUZ@_XGU_#Z@X_LO_XATOV.R.?BK^T5]1XC
M\ C_ -YV?\_2D_XAT/V.O^BJ_M%_^%)X _\ G=5+^E-X3],1Q+_X8,1_\\#>
M/T4O%K1RI9!Z?ZQ4?S^IZG\9Q)P<=>G(/YX Y_E[TSG^\W0GC/&/J1_+N/6O
M[,O^(<_]CK.1\5OVBQ]/$G@#^OPZ(Q^%*?\ @W0_8[(P?BO^T9C_ +&3X?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1112=^BN 4444DY7U5EZ@%%%%4 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444C':
MI/' )Y.T<>I/ ^IH 6BO&/CE^T3\"OV9O UU\2_V@_BW\/O@WX#LW$4GB?XA
M^*=*\,Z=-=;'D:QL3J-Q%+J>H^4CRKIVFQW=Z\<<LBP%(I&7D/V:_P!LC]EG
M]L3PS>^+_P!E[X]?##XXZ!I=RUIJ]U\/O%5AK5UHT^YD1-8TE7BUC2A.Z,MN
M^HZ?:Q7)23[.\HBDV@'TM17RE\9?VZ?V-?V=_''AGX9_'3]I_P"!WPG^(/C"
M:"'P_P"#O'GQ'\,^'/$%W]JVFUFN--U#4(KC2[2Z#C[+?:LEC97.',-P_ER;
M/I4Z_HJ:,_B.36-*C\.II1UQ]??4+1=&315M#?MK#ZHTPL5TI; &];4?M'V+
M[(#<>?Y(WT ;%%?%7P+_ ."C7["O[37Q&\0_"/X!?M7_  -^*_Q+\+37,&L>
M"?!_CO2=0U_=:&?[2^DV9EB;Q%!:+;3O=W7A_P#M.VMXXVEEE2,;C[1\=?VD
M?@-^S#X+D^(W[1'Q?^'GP8\#QS"U7Q)\1/%.E>&;"ZNSL/V+3O[1N(9M2O0K
M;S9Z=%=W/DAIS&L2LX /;:*\O^#_ ,;/A#^T%X&TWXF? [XF>!_BS\/M7DEA
MT_QA\/\ Q+I7BG0)[FW2)[BR.H:3<W,,%_;+/"UU87#17EJ)8OM$$?F)GU"@
M HHHH **** "BBB@ HI"<8Z9/09 SQGC\!V_ES7GWB_XM?"WX?:OX5\/^/OB
M5\/_  /K_CF^.E^"="\8>,_#OAK6/&&JK+!"VF^%M.UG4;*\\0WRS75M$;32
M8+NY\RYMT,0::,, >A45&SE=W  &,$GJ3V*CG.>F.N>.G/ 1_%KX93?$.Y^$
M<7Q"\$S?%6QT-/$VH?#6W\4:-<>.].\.3%!!KVH>%8+M];L='N&DC%OJ=Y90
M6=QO402R%AD ]#HIB/O!/'&/Y9Z=O8Y((P0<&O-/B=\:?A-\&+?PI<_%?XB>
M$?A[#X[\8Z)\/?!C^+-;L]'_ .$H\<>))S;:#X6T-+J1)-2UK5;C$5I8VJR2
MR,0,#(R >G44QF*CIGG&!D<#DGH>@!/N< ')S7'2_$;P#!XZM?AA/XV\(0_$
MF^\/R^++#X?3>)-'B\;WWA:"Z:QF\26GA5[M=<N-!AODDLY]7AL7L(KJ-H'F
M$GR@ [2BFJ<YZ@@]",=R!W(.<9&#T(X%<+\2/BC\./@]X6N/''Q6\=^$_ASX
M.M+W3=-NO%'C37=.\.:%!J&L7D6G:38R:IJMQ:VB7>I:A<065C;M+YMU=31P
M0J\KJI .\HJ"UN8;N"&YMY8YH+B*.>"6)@\<L$R"2*:-P2&CEC97C88RI!YJ
M>@ HHHH **** "BBB@ HK&O=?T73]3TS0[S6=(LM;UP7;:'I-[J-I;ZGK(T^
M))]0.EZ?),EYJ L('6:\:SAF%K$RR3F-""=@'(!]?QH 6BBFDMG"@$\9!."
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX4LII))[R?QKJT=G;:;H^G>7%?:Q803W+1JT\L/Y6>.OC!\4/V,?V?OVWO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?I!S@[H_#/A5QV(QQ^?I7],/?/U_7'^% #2N01DC/.5P#[]N_?.?;!Q31$@
M ' &W!.<KSE23DL#DY#$YJ2B@"&.W@B7;##'"N[?MB18ANYRV$"\G)R>_.>I
MS(J*N=O'H., 8 P..G QG..@P.*=10 4A4-C.>#D8/?IG'0X[9! /(Y -+10
M!\F>+/V%_P!E#QU^U1X!_;7\7?!CPQKW[3OPP\+W'@[P+\5;]]3?5=!T"X&H
M!+>'3%OTT"ZN[$:MJ?\ 9.JW^E76JZ0;^[.F7EJ9F)^I[[3K'5+*[TW4[2VU
M'3K^VN+*_L+ZW@N[.^LKN*2"ZL[RUGC>"YM;F"62">":-XYHG>.165V#7**
M/QQO/^#?S_@CY??$X?%FX_8?^&7_  D8UQ?$;:'#JOCFV^&<NK++YYGG^$-O
MXJB^%L\+S?O);&;P@]C*Y)DMFK[[^-W[(/[.?[1EM\&K+XQ?#'1_%VG_ +/O
MQ&\+?%CX/:=]JU;1--\$>//!/E_\(IK6FZ?X=O\ 2;.=-#6*-+'3+^&[TE$C
M1&LF15 ^DZ* / OVDOV7O@3^UY\-)?@]^T7\/].^)OPVF\1>'_%<WA;5KW5K
M*REU_P +7PU/0=0>?1K_ $Z]+Z??!;B.(70@=E"3121DH6WG[+GP&U#]H'PI
M^U/>?#S2YOC]X'^&M[\'_"_Q(-WJJ:OI?PVU#4;C5KOPHEK'?)I,^GRZC=37
MA:ZT^>Y69@RS@HN/?Z* /S _:O\ ^"-'_!-K]MGXG+\9_P!HG]F?0O%/Q2EL
M(-+UGQOX9\6_$'X9:[XMTRV@2TMK'QQ=_#/Q7X2/C6"WLXHK*#_A*%U66*PB
MBL8Y%LT6 >X^)/\ @GG^QAXJ_9=TG]B[4_V?_!%O^S!H5WX<U#2OA#H46H^&
MO#EIJ/A3Q!;>*M$U)9?#]_INJRZE!XBLX-8NM0FU"2\U.^5YM2FNVEEW_9U%
M 'R_^TC^Q=^RY^U[\*;7X)_M*?!;P7\7OAOIJVIT71/%=C)->>&[JRM!86NI
M^%_$5I-:>)/#.LPV0%LFLZ%JVGZGY.4-T0S!O!OV//\ @DK_ ,$\_P!@GQ-J
MOC?]EG]FCPE\._'>L64VEW/C[4=6\6_$+QW;:1<F,W6CZ3XQ^)/B#Q=XBT32
M+PQ1&\TS1]1L;*[,<?VB"38N/T9HH :% ]3V&<' [@$C<0>^2?; K\Q/VP/^
M"-O_  3D_;J\?6WQ5_:-_9RTCQ!\3X[.'3+[XA^#?%?CGX5^,?$6DP0K;1Z5
MXMU[X9^)/"E]XLLH[-18P+XADU&:SLO]&LIK:(*H_3VB@#YO^ G[(/[,O[,'
MP53]G;X#_!3P%\.?@NUMJ5KJ/@'1]$@GT?Q"-:M19:Y<^+#J?VZ\\6ZAKEH!
M;:UJ?B2YU34-5AQ'?7,Z!0/@_P /?\$#O^"1'A;XMV'QJT;]B3X8P^,=*U<:
M]I.F76H>,]2^&^EZNDXN8+W3OA%J7B>[^%MG)9W*I/8+!X02*PECB:T2'RT"
M_L!10!\W?'[]D;]GK]J"Z^#M[\<OAY:>.+GX!?$O2_B_\)))M7\0:1_PAWQ$
MT6UGLM*\16:Z#JNEK=R65M<RQPV6HK>:;@@O9L54C<_:#_9I^"'[5/@:Q^&W
MQ^\ Z9\1_!.F^,O"GQ L=!U>?4+>VMO&'@C4TUCPOKB2Z9>6-R;G2=1C6XAC
M>9K:3!BFADA)C/NM% 'Q;^V%_P $[_V,OV^=+\*:3^UM\!_"OQ@C\#75W=^#
M]1U6XUO1/$'AU[\1B^ATKQ+X6U70]?M;.\,,375DFI"TFDC21X2XW'KO _[%
MO[-'PV^/NO\ [4'@KX966A?'3Q/\,?!_P;USQY#K/B.YNK_X;^ K*RT[PIX:
M?2[W5[G0HX=*LM.LK=+V'3(]2N$MXS=WD[@L?J2B@#Y<_:K_ &*OV6?VWO 5
MO\-/VJ?@KX,^,WA.PNI-0T6#Q-931:QX:U*:,0SZGX4\3Z1/IOB7PMJ,\*I#
M/>^']6TZXFA1(Y9'50*\[_8__P"":G[#O[!2:_+^RA^SSX,^%.M^*8/LGB/Q
ME!)K7BKQ_K=@LPN8M*U+Q_XUU7Q'XQN]'@N56X@T>;6VTR*=5E2U$BAA]ST4
M ?(O@?\ 8S_9]^!WC+]IWXP_!+X1>'-'^,7[51_MKXS:KJ.N>)'L/BGXETG3
M]>CT%?$WV^[UVTT;3A+X@U*TN9-"T:%([6_N!]AN3'!#7E__  2X_8LN/V _
MV+?AI^S?JUQX4N?$FC:O\0/&?BV/P);WEMX$TWQ%\2/'?B#QK=^'O!<&I0V^
MH+X6\+6NLV?AC19;Z""[N[+2([V>WMI+DV\7Z$%0>>>H/7TQ^70<C!]"*<!@
M #H!@=^GN>3^- 'A'[0_[,_P0_:N^'\/PM_: \"67Q&\!6_B[PCX[A\.ZE?Z
MQI]JGBKP)K,.O^%=6\[1-0TR[,FE:M;PW:0&X-K<F,1WD%Q"6C9/VD_V9O@I
M^UW\'/%WP _:%\&1_$'X2^.X;*#Q3X2GU?7-$CU2/3KZ#4K+.J^'-2TG6[5H
M+VV@G1K/4K=MT8#$J6!]XHH P?#/AG1/!_AOP_X1\.V2Z=X>\*Z'I/AO0=.6
M26:/3]%T.P@TS2K*.2X>6:5;2QMH;=99Y)9W5-TLKN2QW N.Y/ &"% X&/X5
M'7'/Y=.*=10!\3?MD_\ !.G]C+]O[0-#T']K#X%^&?B@_A5KA_"/B9KG6?"W
MCSP@;ITEN4\+^/\ P?J6@^,=#M[F>.*XNK*PUJ&RNYHT>ZMYL8./^Q5_P3+_
M &(?^">FG^([3]DKX$Z!\,M3\8^0OC#QC<:GXA\:?$#Q1#;.TUO9:WX]\<ZM
MXC\5W6EP7+-=P:.NK1Z3!='SX+&-^:^\:* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#S3XT6_CJ[^#WQ8M/A?J5KHWQ,NOAIX[M_AUJ]]-;6UEI7CJ;POJL?A+
M4KRXO5>S@M;'7VT^ZN)KN-[:**)Y)U:)6!_CD_X)&?L+?\$5OVCOV:[_ ,0_
MMVV'PN^,_P#P4'T?XA>.]-_;/U;]IWXU:A!\3--^,=IXEU&UU2RAW>/](TK5
M?!_V:UMY?#/B#24U"WU:R=II-2G*K#;_ -H?C"#PS=>$O%-MXT:Q'@ZX\.:W
M!XL;5+C[)IB^&I=,NH]>.HW7F0_9K$:6UV;RX\Z+R;?S)/,CV[A_!-XE\=?\
M&X_B/Q%XHLOV;O\ @BE^TI^UEX'\,^(=5\.2_%_X&_#'XM7WP[UW6=+O9K;4
MH_#VMWWCR!-4M([B)C:3QQQ+-9207,<44$T&X _IS_8[_8'_ ."+7P&^/.F_
M$#]BOX:_LR^'_P!H#1_#_B"TTW4/A;\4;GQ=XJL_#NH1067B)HM%_P"$\\00
M?8WBEM[>[OGTUFMUFC19X?-&[]B:_DO_ .".>H?\$YC^VA:P?LM?\$:OVJOV
M)OB5)\,?'"'X\?%[P=XIT'PA:>'M^BOJGA9KK7/%>L6PU+Q!,MK%9QI:&>06
M,A$JJ6S_ %H4F[?>E]X!1113 **** "BBB@ HHHH _F>_P""MCLO_!9[_@@.
M <!OBS\?P?Q\->%%_4''I7],-?S)_P#!7%U7_@M-_P $ E8X#?%;X_ #/5SH
M'@]4Q[DGIWK^FAV8 E1DA@,=\<$X'<^@H$W97?Y-_@KLDHJ,.S<@ @9[$;CC
MH#R,9XS7Y'_\%'_^"Q_[//\ P3%\9?"GP9\<_!'Q4\377Q;\/^(/$.AWWP]T
M.RUBVL+?P]?PZ?=6^I)<WMI(DTLDZ20F+S!Y?+[003Z&493FF?9EALHR; 8C
M,<RQ<:LJ&#PT8RK5/8P52I&*E."<E!\W*I7:3M>S,<3B:&#HU,1BJL:%&FXJ
M=2=[+FLD]%)VN[7MIUL?KI17\W?PQ_X.?_V"/BG\1_AW\,-$\!_M$V6O_$OQ
MUX0^'VA3ZC\/[9-.M];\:>(-.\.:5+J-S%J\AM[%+_4[=KJX5',4.]]C$8/]
M'X=NC#YO8'&<],]N,')Z#J"00._B#A;B/A2MAL/Q'DV.R>OC*-6OAJ6-IPA.
MM2HU%1J3BHU:BM&K)0LW%MO1-)R,L)F&"Q\)SPF(IUXTYQA-PYK*4E=)WC'2
MW78EK"\1>)_#?A+3O[7\5>(="\,:4+FVM#JGB+5K#1=.%U>2K!:VWVW4;BVM
MOM-U,RQ6T'F^9/*RQQJSD"MH,<'<O/7 QP.V>>#C&??/89K^;3_@ZLDC_P"'
M5%W&Z(_G?M.?LU(N]<E<?$6R=MG/!9 R,><HS+WS7SZ:;:UNM]';7SMR_<V=
MC:3LVKO;S/Z2$E#HCH5D20*4=&!5U;)$BD$AHRN&##(*_,N1@US^H^,O">D:
MUH_AS5?%7AS2_$/B S?V#H&H:UIMGK>NBV&ZY&C:3<W4=]J9@',IL8)Q$.7P
M*C\&(!X/\)%4  \-:#\@PH4?V5:* HQA0%&W:,#;D8S7X@_MZ>(_V3-._P""
MOW_!)+PW\6_@IX_\9_M$:XGQQG_9Z^*OAWQ]::!X.^%SZ=HL+>(8_&/@V:VE
MN?&*:U%((;#[/<VXTV4"0K(/EI@?O,K;N0., @]CD9X]1C']0#3J_"+X@_\
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M6U]IVHV,UQ9WMG<1LLD%S;320S(0\;E2#7\]7B7_ (*;>$?V[/V'_P#@JI\
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M#_AXG]A&P*Z-+KTJ_9TUC5$O0VG6A??,8)P 2C&OV*J9)M)+NG]SU ****H
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M:X<Z#J-]97U[HDT=K<Z7-;3VL,B^^:O_ ,$?_P!B36_V3O@'^Q1J'A'Q[/\
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M?V'7[@174-]I>F73N7AFDF\N_P""/?[(7C/]CK]ESQOX4\?>#M-^&GB3XO\
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M^;O4/VKO^"_4GB/Q#;Z-^RAX"&@V_B'7[/1)]2^'M]#)/I%MJ]];Z/=22/\
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M-_V@/B>TD>HV-M>QO'8>'K'5K9'2XCD5TM]0L[:^A1@5CNK>&= )8T8>G_\
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M&_\ #NG76M1RP*J+!(FI2W*O"JJL; H% 7 [^@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH%?R;^[]6%%%%
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M"GP_\6Z=JO\ :G_"!Z'''I9#>"+NX$;36UP7O(KF(W<,T,LDA;]\=B8 *@@
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M/B#7_AIX-\(VVC6?A#7$UVRTJP.E:S9-;^99:;IMMHUM#80:0L AMB]NBB+
M'Z-!5 (  R,'WP,<^IQQGK1M!QD=.A[CZ'J/P/M0!\"_M'_L _#+]I[]J']C
MG]JKQGXK\7Z1XM_8J\6>*?%WP]T#0WL8=#\1ZIXHTR/3;A?$OVF":ZDMK:!1
MY,5D\#NQ=7DVN5JQ^TY^P3\/_P!J7]HK]C#]I#Q=XQ\7Z#XF_8H^(GB/XE>
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MD_'3X+^!_@GXC\*WDEDWA#2] \!ZK%JVFZKI*I NHC4+I[:"&Z2>62!09GA
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M:7>IZI?V>G:;86\UY>WU]<P6EE96ELC27%U=W5P\<%M;P1@R3332)'&BLSN
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MH_*#$.2"!\+-_P '"W_!& *W_&P3X-@_PD:?\0'*Y ;H/!GS<=<CAB4SN!%
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M'_;!C_94_P""F7_!%[QWXJ^/6J?"O]FC7-5_:<N?C-)!XJN[#X=>)=$3PKX
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M4LM,M5L+*QO/^$BU*PGD_LJVGMYY)3[]\7?VH_V3?VH?CA_P20^-OAK]L?\
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M "#M<&?\]/QK^G.@ HHHH **** "BBB@ HHHH **** "BBB@ H/0_P#ZJ**
M/RM_X*'_ /!*OX8?M\^(/A1\7-.^+WQB_9<_:C^!(U:T^$G[3'P \1Q>'/B%
MX=T?71(=8\*:DTJ/#K7AO4))99WL3)9WEO+/<FUOH8KNZBGS?V(_^"57@O\
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MU7PUK]B^D6"M<Z5K-I/9W<<,RP+);7.V<R6MW RW%K=+%<P,DT2.OQ6<\/\
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MH:MI?@_Q$]CH>FRW$\;DV5A%?WKQ6D3"$RW5Q,ZF21C5C_@WM\-^#;3XJ_\
M!<'X9Z7X>T>#X?VO_!17QA8P>#5L;9_#::/KOABXM-2TT:-)$;$V%_';R07=
MJ;?R)X3Y,J-'A:_6;_@FC_P3^M?^"=7PE^*WPKL_BC/\5X?B7^T5\6?CU_;5
MSX5A\)2Z._Q0UM=6/A?[!#KGB!;P:&B1VQU;[7 VHMYERNG6*LMLGS]\$O\
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MEG?W=S<:?(AL)9I'MBQM_P#!3C_@GOIO_!2+X/?"KX/ZM\3+WX56GPR_:/\
MA3^T(FNZ?X:M_%<^KW/PP?6FB\,/I]QJ^BK:0:RNMRK)J@N9GL_LRL+68.P
M!^;'_!RW\-?AQX:_X(F^/M)T;P7X:TG2?A'XV_973X8V&GZ39V4'@<V/QH^'
M?A2TB\+I!"@T=4\-ZE?:'ML/)#Z9>75HY,4KJ>[_ &]O$/Q2MOBC\/I_!_\
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M(Z''&?;/IDXZ9/6OQ>_8V_X)+>(?A%^U%K'[=W[9W[5OC;]NC]L.3PC)X \
M>.O$?@[1?A=\-?@KX(O58:MHWPO^%GAC4-1T/3-0U9/W-_KLTGFS1O<SI:0Z
MEJ&H7MU^T0Z#Z?Y[#^0^E !1110 4444 %%%% !1110 4444 %%%% !1110
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M< 8/))Z@8YSU/RD$8R",9'\_O_!5/_@L+XA^!OCW1?\ @GY_P3R\)V?[2_\
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M[_9^N8'TK^G>OYBO^": _P".@S_@N8W;_A$/V6Q^/]G:X>??&*_IUH ****
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MT\\TBQ0PPQ*7EEEE=D2.*-%9Y)'=51%+,P S7\U7QR\?^.O^"TW[1VH?LC_
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MO^"&1V_\%'/^#A"#^Y^W+X4EP.G[ZU^)1)^I*9.>I]\FOZ<:_F*_X(8MYO\
MP4B_X.%)NQ_;A\(0XQC_ %%O\3X_IVP3WQGO7].M3#X5;^MAO<***0GD#US^
ME4(_F-_X)FG/_!P-_P %SR>H\,_LNKSZ#2]:Q[XZU_3G7\QO_!--/^.@C_@N
M7(.%_P"$3_990@=-W]FZVQ)QWP<'/.*_IRH **** "BBB@ HHHH **** "BB
MB@ HHHH **** .5\=>,M!^'/@CQC\0?%%Q+:>&/ GA7Q#XR\174$+W,UMH7A
MC2+S6]7N(;=#YD\L.GV-Q)'"A#RNH1>6%?RA?!C_ (*.?\'"G_!0'PM<_M)?
ML0_L;?LJ^ _V5_%WB+7(/@Q=?'OQS=Z;XU\7>#-)U2YTZP\530RZA;O<1ZG'
M;NT]U9V%MIINXKJ'3#<V\"W$W]5_Q.T"#Q5\-?B%X7NO#\7BRU\2>!_%F@7/
MA6>\;3H/$T&L:#J&G3>'YM07#6$6LQW#:=)>*0UJER9QS&*_D7_8/D_X./\
M]@W]G?1_V;O"/[ '[.'Q3^%G@'7?%2_!^V\>_'U[+QCX#^'6J:_J.L:#\/+K
M4M+U5(?$-AX8BOFT_1M2OTCU7[ D,%W)*(H]@!^N7[#GCC_@NKKGQTTW2_V^
MO@9^Q[X)^ #^'=?EU3Q3\&/B)?Z[XX@\3011'P[;6VD3S7$4NG7]QYJW[D(8
M(8T8.K91OVNK\0?V&OVJO^"S?Q5_:(L/ G[;O_!/3X0?L[_ B;PEXCU&]^*_
M@+XKOXTU"W\5:<;/_A']$729M?O'^S:P7O1+<'3W\E8H6\]"<-^WU !1110
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M$$5_!#?^%/\ @IM^T)^Q3^RW_P %/_BK_P %5_VI/AO'^V9^V/\ "OX;:O\
M"KX.>)Y/"WPT^!OP/^-7Q&UCX>>']=T2PTJ>ULK36- U6/09+BP%C#ID5MJC
MPWLL][#-J$W^@EK&DZ;KVD:KH>LV<&HZ/K6G7VDZMI]TH>UOM-U&VEL[ZSN4
M/#P75K-+!,IX:-V!ZU_+Q??LB?L9?LA_L[_'_P#X(]?M#?\ !1CP+IWP_P#V
MJOBK::I^P[\*=2.DV?[1'[.NJ>/?&6G>)O!&B6$6EZC?:CXJTW2OC';Z?JWA
M'5M1TCPS:S6S7&CK=6D5Q)+" <#^Q)^S=^V#_P $_O\ @LI\.O@E^UW_ ,%
MOVF?VKOA3\?_ -G_ .+/B3]E+4?&/CO4)?".L>-? <NB/\2_!'Q4\#:Q<ZV\
M_BO0/"VI:?XF\(^(/#VI6&EO"+H7EM]HF2VM/ZUJ_G*_X)\_L3?'GQY^VA_P
MU;^V_P#\%(/@[^W5\7_V)?#OC+]F?X7_  W^ OASPEX.T/X&^)O$)2Q^(FN_
M&+0_#LSWUE\7]:T6TATNZTS5+&RN+6UDG%Q>ZC;PZ5#I_P#1K0 4444 %%%%
M !1110 444=: /YIO^"M3A?^"RO_  0)  W'XO\ Q]&>"=K>%?#*D>O4CVR#
MW%?TL9YQ]"?QS_A7\Q__  5QDQ_P6K_X( KDX;XI?M \=L_V)X,0''KR><<9
MZU_3C0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/^"A'_!P4&_UG_#>.C!NA^7;\22G/T8_YS7]/-?S%_\ !# E/^"CO_!PA#C
M7]N+PE(/3]Y:_$S^B@_EUK^G2@;5G8*0@$@^F?U]:6@\ GTH$?S%?\$W)<_\
M'#/_  6^3U^'O[+Q_P"_5IJJ_P#M3_/?^G6OYD/^"<$ 3_@X7_X+>2?]4Z_9
M9.?3S[/6'Q^/EC]:_IO]??\ P _I0 4444 %%%% !1110 4444 %%%% !111
M0 444'H>_MZT ?GI^W#_ ,$P/V,/^"A$.@7G[2?PMFUCQ[X)T^?3OAY\8/!_
MB/6_ WQ9^'44]V=0,WA+QEX?N;>YM&M[W=?VL6HVNJ6$%W(\\=HLTKL?RSU_
M_@GA_P %.OV)=/G\6?LN?M__  I_:=^#?A&T>2;X(?\ !2CX?>%YAIOANPN2
M]MIVG?M(^&;&V\2IJAMREE+XG\:M]G4JD]U%*YDCN.1_X+P_\%A_VS/V"?BS
M\(?V=OV2?@,^MS_%#P/:>-/%'[1VI?#/Q[\8M-^&=I-XNOM!GLM.^'OA"P2R
MUW5(;#3;B_FAU'5TF"W%FL6G2K*)*_!"?]HK]EKX\7T?B[_@IO\ %#_@L]_P
M4$UII(9)/@_X8_9T\<?L\?LP6A@U$ZE+I=M\/O#%[:7_ (BT.:5DMH[3Q%);
MW=O;1A);BXEN+B:4 _I/_P""8'_!9+X:?M??M8>-/V)_%7[,_@GX5_M1?"[P
M;KWB?Q?XX_9^\9_#WXW?LZ:CINC7>CVUU9>&_B[X-AM+U+NY.K6W_$JU*P@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1D>HH_2HP0!]\.>W()]1T/.<#&/3-)NW23]%>W
MKV%KV=K.[[>5M]1^0,\].M(&4KD$8/3..>WK@^G6H#*6!!R@ )W>@ Y/T]<<
M]Z\'_:,_:'^%O[+'P<\:?''XQ>(+70/!'@K2Y+R\E>55O=8U%T9-*\/:#:NR
M/J.N:S>;;33[.#+,[27$VRV@FFCSJSA1BZM6<:=.$92E.3M&"C%R<JDG91BD
MK7;NY-12;:.>MB\/0P];$U:]&E2H0J5:LZ\O90ITJ47.I5G*6T(1B[O=OEC%
M.4HQ?A_[?7[<?P^_82^"=_\ $KQ5&VO^,M>FD\.?"KX=:>[3:W\0/&]Q&!9:
M996L&^\;3;.::WGUFZM(998;>:.VB5KR]M$;Y(_X)G_L2^/]&\3>*/V_?VS(
MX_$_[9WQ\M([VVM-3B2:+X$?#F\B5]&\ >&[60M%HVHR:6+6#65L0C6%K!!H
M7G2/'J,UUX=^PS\ /B3_ ,% ?CM9_P#!3G]LKPW<:9X6TV0Q?L8? 37(9_[-
M\#>$8YY);3XBZWI-ZBH^LW\K"[T::6+S+VY>779\0KI$%K^NW[8/[87P!_84
M^ WC/]HW]I+QU8>!_AKX*LV>660QW.O>)]:G5QI'A'P=HHECN_$7BW7;I1::
M5I%IRW[^]OYK/3;2\O+?RZ%-YC4I8ZJG"G2DZF#I5(N\E)VCBJM-M6]I%7P]
M-J].%JC2FT?*951J\0XZ'$&84IQRZ@Y/(<OQ$'%3C)Z9MB*,_AK3C%?4:<HN
M5*A.%>7+6J+EU_VHOVG?@E^QS\#?'O[1/[1'C;3O /PM^'>ES:CK>K7K*UWJ
M,^'_ +.\.>'-,$B76O>*M?N-NGZ+HMB'N;^^95'EVT<T\7\OGP)_9>_:)_X.
M(/C7X0_;A_;XT+Q)\&/^"9'PV\1'7?V./V+)Y[O3M2^.L=C?.VG?%KXOP%(6
MF\/Z]8K&TDRC?X@MF;1_#?V/PDMSJ>O[7[,7[*_[2/\ P7R^.7@C_@H3_P %
M(/"FJ_"O_@GY\/M7/B3]BC]@74;FX6/X@1Q31G3/BW\;H56S&M6.K-;+>^7?
MVBGQ9"8].TZVT_P%%Y7B7^N:QLK33;6TTW3K*"PTZPMK:QT^RL;>*TL;&SM(
M1#;6MI:V^R&UM+>!([>"WAACCBC1(D18U&WV>K????>WZ]>_R/LU%*[5[MW;
M;;;]6]_P*FB:)I/AW2M*T'0-*T_0=!T2PM-)T;1=&LK?3M*TG2]/@CM[+3K"
MQM8X+:RLK2&)+:VM;:&."&&...)$0 5M444#"BBB@ HHHH **** "BBB@ HH
MHH **** "C_/Y444 ?SN?\$7;AKC]NO_ (+Y,Q'_ "?]X9?(Z<_#FXC_ /08
ME^E?T19&,Y&/7/'/3GWK^<S_ ((HN#^V]_P7P?(VK^W[X<.XD@ 1^ +W)) )
MP N6 '3CI7]!OA/Q;X8\=^&]*\6^"]=TGQ7X7UR$W.C^(-!U*UU72-3MTFEM
MI+BRU"TEGMKB&*X@F@+0RR!98GC.&5@ ;5G8Z;(YY''7D<<9Y]..?IS2\'G]
M:Y/P9XR\+?$+PMH_C3P1KVF>*?"GB&T^W:'X@T2Y6[TS5K,R20_:K2Z3<)8_
M,BEBW*?OQLO!P*D\'>,O"?C_ ,/6/BSP1XCT7Q9X9U0W']G:_P"']0M]4TB_
M-I=365U]DOK626"?R+NWGMIO+D8)/#)&<.K  C^:K_@A<#_P\I_X.&&P=O\
MPVUX*4-CY2RI\6-R@],KD9&<C(R!D5_3[7\RG_!#R 6O_!27_@X1@ P&_;:\
M#W6,$?\ 'YIOQ(N<C/4-YA(/<$'H17]-= WN%%%(<=^QSWZ_A0(_F7_X)RE?
M^(A;_@MR%/\ S3;]E7(SGYOL6M;OR)/';/O7]--?S&_\$U<O_P '!W_!<B1L
M9C\%?LLP*#][;_9^MMG'7:<#!Z$BOZ<J "BBB@ HHHH **** "BBB@ HHHH
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M(2L:,ZJ\C ;B$4D%B%Y(4$@<GB@"2BBB@ HHHH **** "BBB@ HHHH ****
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MP60_X( R(2N[XW_&Z!B#C*S>&_# =??*@\>G3GI_3-GG'L3^6/\ &@ HHHH
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MM_9W36O]<M !1110 4444 %%%% !112'.#CK@X^O:@#^:/\ X*YHLW_!8O\
MX("J<Y7XW_'*8#'>+POX;(S^/\OR_I=[_0?S_P#U5_,W_P %<)<?\%F_^" L
M)(&[XO\ Q[DQW.WPYX50'TP/, ]<FOZ9/7\C_/\ K0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 49'6BHF?D8P?O#/.1U[< \<>U)MI7LY6Z15V[[6$V
MEUL]?/;=V6MEN[;+>P_<O/(X&3]*8TBA=Q954$!B6''?DYXXY(]/8&L3Q%XD
MT'P?H6J^)O%6LZ9X>\.Z%8W&J:UKVL7MOINE:9IUJADN+R_OKMXK>VMXESOD
ME=4!PO4@'^;_ .-/[5G[5_\ P5J\>>)?V8/^"<4VJ_"C]E31=5E\,_'O]N35
M+>ZTR#7[$.;37_!_P>@=(+^_EO;*>:%+ZU$=Y=B)GNKK2K#<DO)B<5"A[D;5
M,3+^%0C[U1MZ7:5VHIV<I>ZHQ3N[I)^3F>;TLN]E0C"6,S'%1F\#@,.U[3$\
MEN:HV^;V&'IN4?:8BKRTXINW-*T#WO\ ;'_X*;_$+Q[\4[G]AW_@F-HMA\:O
MVHM1DFTOQ[\4HL7OPC_9WTL2_9=2UKQ!KJK)I&H>(;*/[2L-J9S::=<0E76_
MOC#:#T3X&_LM?L??\$B/A'XY_:L_:D^+VBZO\7-3M'U_XY_M7?&34XYM?UW7
MKRWE%[H7@6*^$VHVEG=/)-I^E>'M AFUW6K<+'.C1,+6W^-?C)^VK^P!_P $
M%?A;H?[&_P"RKX"U3]IC]MGQLUO#HWP$^&N/%?QE^)/Q"U6T\JT\8_&_7])A
MO[OPWI4\D8OTT8QOJD>DJPT718()9=5/DO[./_!'/]JG_@H[\4?#G[;/_!>'
MQ=)XIETZ]3Q%\$_^">/A>^%G\&/A!IEW''-;6OQ%LM,NI+?6-<AMX[2VU/1H
M+R_N;VY.H'Q/K^I&?^SX.>C@'4K1Q>.C"KB(W]E%7E0H1E\2I1GK[5JRE6DG
M-6M!P3UXL%DLZN+AFN<RIXO,(.4L+AXWG@LL52W-##0G?VE>T8J>+FG-N/[A
M4HMW\[UG]L?_ (*<_P#!>SQ-J_PU_P""=>E>*OV$?^":[:EJ?AKQ]^W#XZTB
M_P!(^,/Q@T.%HUU&R^#6EK-!>Z3%JFF 6L4>AR+=6BZXDFO>*-)DLIM,/[V_
M\$]O^"7O[)7_  37^'[^$?V>? J/XR\01+-\2OC;XR,>O_&'XH:Q<2_:]2U/
MQ/XNN(_MJ6=WJ(-XF@:<]KHUKB)S;7%TANW^_/#GAG0?"&@Z1X7\*:%HOAGP
MWX?L(-+T/P_X?TVTTC1-'T^S41V=CI>EV$5O96%G;Q#9%:V\,<2  *-M?.G[
M96K_ +7F@_ K7M3_ &'/!7PE\?\ [0R:QX=B\/>'?C9XAU'POX GT.?5(8_$
MUUJ&JZ3&]ZE]8:.9Y],@0*EQ=JD<C;6*'TG%W5GRQ6T8I67W[^;=V^I])_5_
MZ_K[C\<O@D\M_P#\'.W[;32N6&A_\$Y_V?-.M-XW%+>\\4P7\B1L.B&[NY9'
M4D;I&)QP#7]&P=3T.>,]#TSM]/48K^/7P/\ LR_\'&/@S]OWXO?\%![;]GO_
M ()XW/Q*^,GP/\#_  ,\0^$+SXX>-T\'V6A>!+R&]T[6-/:TT5M6&K7<L*+=
MB>[DMO)7RXD7 S_4I^S7J?[0NM?!/P!J?[5?A3X=^"_C_=:9*_Q%\-?"?7-2
M\1_#_2=5^V7*Q1>'M:UB.+4+ZVDL$M)9FN(\QW4DT4;/'&DC4![Q1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_.M_P $5TV_MU_\
M%\CSD_M^>%UR1C[OP\O3CZC?S^%?T4U_/-_P1F@$'[=G_!?%1C_E(#X:X[\_
M#/S/?C,IQSV-?T,T%2W84444$G\O?_!"N1#_ ,%+O^#AE5.?^,UO!!_$'XN(
M?;A@0>:_J$K^7C_@A%%M_P""D/\ P<+.QRY_;@\*KG_IF)OBX\9YYP5D^7V%
M?U#T#ENPI"0 2>E+2,"00/\ /- C^9O_ ()W1K#_ ,'#?_!:]5Z3?"K]E:=A
MZNUIJHSCOU//O7],M?S0_P#!.\;O^#A;_@MBXY$?PL_9-C)]"]AK;8_'83^%
M?TO4 %%%% !1110 4444 %%%% !1110 4444 %(> 3P>#U.!^)YP/4XI:0YP
M<8S@XSR,^X[CUH _!W]O[_@K+\9?V7/CQXP_9L\-?\$G?VM/VPO DG@G0[R^
M^*/PJMQ<_#SQ-;>.-&D;6O"XC?P?JUM,^EPS3:3JT<FI.SR/*K6T,;*S_@XO
MQ/\ V/\ 42]Q_P 0A'Q;D,A,TTC?";P9"Y+.WF,0_@.)C(9.B$*TFXL0!C=_
M<IX]\::+\-/ ?C;XB>)WN4\.> /"/B7QMXAEM8_/NH]$\+:/?:]JKVL.]#/.
MMC87!AB+(9'"H9%S7\L_P,^'/_!87_@LMX%T?]M.Y_X* >)?^";7[-/Q*N-9
MUC]F;X!_L^>%+/5/'>I?#"/5+BQ\+>._BIXZN=6L9+W4/%-K9KJ\>C2K>PFS
MNX98K?0HI/[.H ]U_P""0_[7W@V_^-US^S+\)?\ @AO\9?\ @FQX*\2^'/$?
MC37?B=K/@32?"G@:\U/P^-/-GHFJWNF>!]$^W:EJQNI6TV&;69%CDMIWAMG:
M65U_I5K^=O\ 8E_:8_;R_93_ ."@ME_P2T_X*)?%/PO^T_:?%;X-ZQ\:OV0_
MVL]!\)VG@/Q)XKTGP/>#3_&GPW^*GAC3I);-_%.G1)=:G9ZFEQ>74D%B+F\U
M/4(M;LX-)_HDH **** "BBB@ HHHH ***#_G% '\R?\ P5TC;_A]%_P0!EP=
M@^+?Q[BW=M[:!X0<#\51C[8.>U?TUCO[G^@K^9S_ (*Z3HG_  66_P"" D1Q
MO?XS?'5AQD[?^$;\+1'G&/O2#T(K^F2@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "D!!Z>N.AZTM1F1 "2_')R<E1CKSC&,\=>O .:F3:UW2W23;\O))=6]D)
M_K;YO9>O;N/+!>2<=!^)Z >N>V*^<_VF/VH/@C^R/\*];^+_ ,>/&MAX,\):
M0)$MQ,RS:SK^J&)GMM"\-:2F+K6M8O0N(;2V7$:DSW,MO;K),GS[^W=_P41^
M$'[#7AO1H-:LM6^*'QP^($QTOX1_L_> XFU;X@^/]8FD^SVTJ6-I'<7&CZ!'
M<O'#=ZS<6CKN+064%W<JR)_.U^T[\>OAI^SYXM\*?MD_\%F]6'QC_:M\1BQN
M_P!C?_@E!\'ROBF]\'2:E<P_\(P?$GAF!]3MYM?NM2^QQW&M>($N+-+\^796
MGBS6X%TV#BJ8N];ZOAVJF)Y7SR@W*CAE-/DG7G&\6Y-/DA%\[:U48W9\[C\W
MQ,\1/*LDC2KYPE>=2HG4P66TIZ+$XNK3O%UHJ\J6 C/VU>4;24:=Y'U)XEL/
MCM_P5.T?4/VBOVW/%,O["?\ P2I\!B7Q58_#7Q!XDC\'>,OC)H.GNSV_B?XD
M^);R73UT+P[?PB(643(K32W)M- TV>\<:C=>$Q_\% /VJ/\ @H1)/^P]_P &
M^OP>L/V?OV3/ 1C\"^-_^"BOC/PO=^&/ 'A72%673=5A^!/AV^T^.YUGQ*D:
M7MS::RZ7_BZ[N[:TOIX?"?VR#5GU_AS_ ,$T/V\?^"T/C/PQ^T9_P60US6OV
M>OV3]&O[;7_@C_P3-^%^L7OAV"72X7+Z/J?QVU.VDCNX]2N;63==6TS'Q<T?
MDVB'P79)+H)_JH^%/PF^&_P/^'_AGX5?"'P+X7^&OPX\%:5:Z'X2\$^#=(L]
M#\.Z%I5E&(H+:PTZRCCBC*QJOF3L6GN909YY'E=V*P6 6$4IU*CQ.+J2<JF+
MFDYR4GS*G%+W84XII1BDK+>\KF^59%A\L=:O5JSQ^9XKEJ8[,ZW\:O/?V=*,
M7[/!X6#;5/ T%"$$DZGM*C<C\WO^";7_  1^_9B_X)PZ'?>(_#5EJ/QD_:;\
M;@ZC\7_VJ_BHP\1_%;QWK]X-VIM8ZAJ4E[-X4\//.3]GT;2+E))8W>75+W4;
MMY)W_64* =V,L1@GN0.P[ 9YZG\>H?17H?/3MI9=WWU^X]Q))6222Z)?U]VR
MZ)!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% '\]'_!&N3/[>W_  7UCSD+^WWX2D''_/3X92+_ "B _#WK^A>OYY/^
M"-((_;Y_X+[Y'_-_'@X?E\-+D_UK^AN@<M_DOR"BBB@1_,)_P0O0K_P4G_X.
M%B1M#?MM>"B%^L7Q5<'';<'!_P#U5_3W7\QW_!#G'_#RK_@X4Q_T>OX$/X&Q
M^)Q!_'GW'>OZ<:!O<*.E%(<=^_'YT"/YH_\ @G4VW_@X/_X+<*W5_AK^R4ZY
MSG TWQ G'MEA],^E?TNU_-#_ ,$\04_X.&/^"URGH_PH_9/DZCM8ZR!T_P!X
M]>:_I>H **** "BBB@ HHHH **** "BBB@ HHHH **** .(^)FE>#->^''Q
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MW97?^2"BBBF,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _GL_X(V(!^WA_P %\I.[?\% ?#"'Z1_#!6'Y>8:_H3K^
M>W_@C4<_MT_\%[NQ'_!07P]^7_"L(0#GWP3CM7]"5 Y;L*#GMZC\L\_D***!
M'\P?_!#!S)_P4J_X.%W_ (/^&U_ R _[44/Q7C<8Z\!5!/0]NAK^GROY@/\
M@A3@_P#!2+_@X6P>?^&X/"0/X?\ "UA].N>GIZ8K^G^ACENPHHHR,@>O3\*!
M'\S?_!.N0R_\'#'_  6S)_Y9_"[]E.('T"V6L8'Z'IQQ7],E?S.?\$Z$*?\
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M'W'_ &W/!L0/^W"/BQO'X>8O<_X_T_4#;N[A02!U[G'XT44"/YJ?^">RHO\
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M(0&6TM[J9;N^D7J8K&"XE !)3 -?C_\ $#_@N#\-/%FOZE\/_P!A/X$_%_\
M;;^(,1EM+6_\ >'[S1OAC!?$-Y$E[XTU6"*UFM4=7>9%-A.8@?*9P0U?F+^T
M5X<_X(?_ + FL6GB7_@HQ^UOXW_;N_:32ZENV^'6M>,M2^,7B?4-;6X2"XTU
M/A)X/U'_ (1?0+J/49$2VMO&>HZ/J$JR0_ZY YK1\ ?MH?\ !9+]M[2+7PC_
M ,$JO^"=?P^_X)Q_LW3WEOIUO^T-^U'H6GZ-XCNM&L+O[%<WWAOX:-HMFLSO
MI<R:CIXF\*:VLK^5#:>*%^:Z9+^U<1?W\-@:4E9-?[3BDK=7[F'A)7OS152*
M?<S4.+\T2=5Y?PUAVVY483AFF;^SLU>-22A@<-+57FJ5=PDDDV]']C^.O ?_
M  5:^/>@S_$3]LS]JOX,?\$W?V<XK$R^(_"WP]US3O\ A)[72[^!FFLM9\?^
M(KFSTRUU P1R+]DN[\R0SNZ6?FR)7Y+P?M9?\$A?@I\0I_A]^Q!^S5^T!_P6
M>_:VAFLU3Q3IFEZ_XX\ V'B"XCN&L+K5/&VLV4NC6MC%J$0BU-8=(OK&8@K!
MJC[PZ?IE\.?^#</PQ\6M>7XE_P#!57]LG]H?_@HC\17NK"^/A77O%VN?#SX%
M:5<:9?-=VMO8> =&U.6ZO;#!%JUE>ZBE@EK%%';64"A_,_H#^"7[.WP+_9P\
M'Z;X#^ 7PB^'?P=\'Z9:1V-IH'P]\*:/X:L5MH,F!9SIMI!<7[1$X$E]-<2'
M.2_R@4XY1@G*%3%4Y9A7IRYH8G&R]M.$MER65.G%1WC%4G%-M^]N],/P=DL*
MRQF.IXC/,:KI8S/,1+,I1=T_W6'JQC@:5FO==/ J4=E/O_-3X?\ V2_^"^7_
M  42TK2X/VB?CQ\.O^"2W[,6L6;F3]GG]E+3+34OC?)X>UK2G@N]!UWQ= R6
MF@ZA!((_M$2:R%M-[_9[(2/(J?I9^QE_P0>_X)R_L6:A9>-O#'P8MOC'\;%E
MDOM6^/'[0EV_Q7^)&I:S<VL$-_JEO/XB2XT71Y+FXA-W"MAI:W%I*RNEZ\JB
M6OV2 ./0]?4C)R1D]?KCWI1G'(P?3.:]/E79:*RLDM%LM$M%KI;JSZE)1BH1
MC&$$DE"$5&"2V4812C':R48Q26B2*D5OY2HBJ@2*/RX8U 6.-0-H1$'R+$J!
M56-0%4#"@*J@6P. #Z?Y]Z6BBRUMI=6LM%ZVU5^E[7MH"22M;1-O5MZOU;$"
MJ.@I:**$DE9#"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI^J6]M>RRZ??+%(UI=I#<+&YC"G^=FW_ .#73]AF+'G_ +2__!2*^()">?\
MM;WL8C!+%0OV?P1#CRPV <X8@$YRV0#ZV_8DC_X+?P_'FV'[?7CS_@GCKGP!
M/A/Q 9=-_9HT[XH6WQ+F\8[[!?#DB'QD?[.70HD_M"34BA>X#"!4!4DI^S5?
MQ_\ [(G[!?PO_P""5?\ P7:^#WP?L/C3\=OCQX<_:=_97^+/BKX)R_%WXLZO
MXB\5?"'Q)X-U6WC\8:#XET.&"/1/&/AWQAX=LY+S0/%ES8>'KS2-7TB^TR.T
MU#YKI?[ * "BBB@ HHHH **** "BBB@#^9/_ (*]0%_^"S/_  ;_ ,RD!D^-
M'QS0]<E/^$?\)RL/3!$?YX[9K^FL=_8_T%?S._\ !70A?^"RG_! ,MT/QH^.
MJC_>;PUX7V_J*_IC_P B@ HHHH **** "BBB@ HHIK-MQP3G/3'&,XSGL<=>
M@ZGB@!U)GIP>?;I]:Q/$/B?PYX1TBZU_Q7KVC>&="L8S+>ZUX@U.RT;2K.-5
M9B]SJ&HSV]I NU6.9)5R%)' S7X4_M4_\''_ /P36_9W\0_\*Y^'GCGQ7^V)
M\9Y=\=A\*OV3/#S_ !3U&XOX[@6CZ9>>*+.6'P?IU_%<%4GLI-:DOH5)9K;*
M[""?K;SM?^K['[W.5("GJW 7.TD]3@CG( )^4YQDC/&?X9O^"K?_  =Q>-_V
M7OVJ_B3^S+^QM\"_AUXYLO@9XPU?P#\1?BA\7;SQ%=V/B7QGX;NCIOBC2O!O
MAOPOJ>AR6.DZ%J]O?Z.=?U35[R75;JVFFMM+M[)+>XN_NB/]K'_@XT_X*&0F
MU_9A_9 ^%W_!,;X/ZKJ36J?&;]J?4I?$OQ;;1)E2:QUG2/A[>Z4MQ:3RPXW$
M^!M?TZ9Y([>'4E1FNZ_D#_X+#_\ !!+_ (*&_LG_ +0>I_$O5(]>_;!\(?M$
M?$32IX_C]X*\.:;I&H^*OC?\5]6AEUGPWXL\":3<N?"FMZ[X^U74(M -K FA
M:O:30364EG)'>:?8S)J.KDDGKK9)*ZO=M]NNWG?<<XQ3G-PA3C;FG4J*$%=J
M*NVU;5I+75M+9W/[#OV*_P#@['_X)T?&O]G:7XB?M6>)S^RQ\:?#6HVVA^*_
MA,ND>,/B6WB.YEL_/M/$OPQD\)^&[_5M=\/7TL5S;RV5U80:EX?O%2WU%Y;:
MYLM2O96_X.>O#7QEUS5?"W["/_!-/]OC]L#5K21X].UO1?AJ?"'@W4P,^5</
MJ2'Q-KND64BA97GU3P[:2018::V&<KX/_P $(?\ @BY\._\ @E1\$/B%^TW_
M ,%-9/@!IWQ=^)\/AV?1_"WQ*L? GB/3/@'X4T)+F[18_%/B*"^B'Q \0WVH
MHVO1^%G%MH]GIMAI_P!OO[R>^2R_0GQW_P %H-3^)FMR?!W_ ()??LN^./VI
MO%%I<C2&^(;:!=^#O@9X63<;)-2:]^SP7-YI-I<&%C<S#1-"FM59H]74%,X5
ML7AZ&E6HXRTLHQE4DV]HJ$(RDW+9:)7T<EJSR,SS[*<IY(8K&0>(JM*A@Z*=
M;&UWUC3P=)5<1))6?/RTZ<4^:I.,4SYME_:Q_P"#FW]HV:2[^'/[#/[('_!/
M_P"'<T$DLOC3]J;XI/X_UO1K9T;;-<:?X>UC3=6@O((P9)#>?#C[,D@"N, H
M?R@^._BC_@I3\5O%#?#'QU_P7&\:_&3XHWVI_P!D6_P7_P""9_P:?3O#EI>_
M-'=:?>?&+0H/AY<1O"VZ*XMX(?%6J*Z,LUC&J&1?VRT;_@E-^V]^VUJUMXQ_
MX*E_M<:V_@LZD=1M/V7OV?-2/A[P3;VTDC2_V/XBU>T4:7/':.$2%UA\8W4L
M!D5=>MI?F'[8?L\_LB?LZ?LL>&(_"?P$^$G@SX<::L8BN;S1],$GB'5E!!\S
M6_%&HR7GB+69,@.@U'5+F*)BP@BAB"Q#S:D\TQMXT*5/+J-TO:XQ0J8BHOYJ
M5",G"FWK9U*DY1T:BFM?(J8CB;.:=LNI1X<PTG;ZYCU2Q6.G3YM94,/2DZ&'
ME.-XJ5>I5J0;4E34D?Q\_ 3_ (-??'W[0'B/3_B3^V3\4?BA<0WDR37MQ\:/
MBEK?QE^,=_8X221OL;36?A3P_+J"'RT&MWFN7VELC+=:%)(*_I _9F_X(B?\
M$Q/V6=)L;;P-^R-\)/%?B2QEAN'\?_%GPGHGQ,\:7%]$RN+ZWO\ Q/I]Y8^'
MY-RJT=MX6TW0[")ANCM5)8']6X(EC!VJJDX!VG@D  ' PHX SA1DY8C)R9ZZ
ML)E\<-K5JU\95;YG6Q-65;E>EU3C)1C3B]DH1LE97L>GE.24\LBYUL;C\VQK
ME*4L=F>+GBZT7/XHT$XTJ-"D]4H4Z%TM.>QE:;HVF:+9P:?HVG:?I5C;1QP6
M]GIMG:Z?;001 +'#!!9P0PPQ1J J1I%L"@ !:T/+/&2'(!&6&"1G(!QR0.V2
M3G)Z'%2T5Z+UWUWM\U;^KW/;Y4M5[K=KN*2NETLERZ];13?5O0A:(LP;=GKE
M3G'/7!'\/^R003@\8Y7:XR5;)QC:Q(7&<YXSAB<DL5;^Z !S4M%*R7JM+];?
M)+\@22V7Y_JW^2$48&/KZ_U)/ZTM%%,84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)D
M^A_3_&JUY>6=A;R75_=6]G:Q@>;<W4\5M!&&(4&2:=TB0$D %F&20!DD \W-
MX[\%Q9\WQ?X7B4#)9_$.CHI&,D[GO  .V3CWI.-5ING3JU=ERTZ<I6;ZN2A*
MUNJ?W&<ZE.#2G4IP;V4Y1BWZ*4HO7:Z1UH.1GU]:6L[3M4L-7MH;[2KVSU+3
MYP6M[[3[JWO;.=5)5C!<VTLD,H5U9&,;,%964\@XT:A2TU;BTY1DI1LU*$G"
M2::BU:47T1I^71IIIKOI<**3(]>/K29!QZYP!N[>IP<?ASZ4<ZO\<'ZNS_.U
MOD'R_%"LP7&<\G  Y.:89.,A6;G'"GW&?IQUZ=.>1ELQ&!RH;. 2"0I8%<\<
M@C\/3(!-?B/_ ,%+/V5=0^,7Q+C^)^@?\%0OCK^R!JGA#X.W<0^!?PT^(7AC
MPYH7C"XT*Z\2:Y8>+Y=&U?6+#4%U+4Y+@Z)=WD-I=17UMI5I#&5EMY$?U,GP
M']K9AA\![:6'^L5(4_;PP>+QZI\TJ<>=T<'"=:4(NHO:34;4UJVK77%CL7'!
MX>K6DX2<$G&FZM.G-NST3JM0;=O=3=WT/VY,H'5).V<(Q ![D@8P/XO[O).%
M&:42 DKALC&>!CG.!D$CMGZ?CC^13_@C_P# OXI_M$?#_P#8O_;!^)__  6$
M_:,U7QKXFU)O'_B']DK6/B5X3O\ 2/%?_"+^,O$6C1^"M4T^76X/$5_H^M6.
MD6U[?P-HKW,T4[*L?E*KG^NE%Y!*[3@9QC''3L.@[# !R ,5T\1Y/_8.9ULM
MIXQX^=&4H5*KR_'9=&$Z5>5*IR4LPITZU6'N2Y*L4Z=1>]"3MJ8#&1QM!5?9
MRIMQC[KJ4JC3>MW*C*4/>6JCHTMTC^?#_@C?)N_;Y_X+[*.B_M]>#R!GN?AA
M(A/T/EC'K7]"M?SR?\$;4>+_ (* ?\%^HW!##]O'P+)SGE9OAC=R(V>F60JQ
M4<J" <9%?T-UXUT]5MT\UT?H]T=K=]?)?D%(QP/Q4?FP']?\.:6B@#^93_@B
M)D?\%-O^#A93_P!'E_#1OP?2/B81^F#7]-=?S*_\$3W5?^"H_P#P<+P*.!^U
MW\)9B1C;F30?B4"..X8-D8X]2<U_356<-7)]7;^O(;"BBDSR!ZY_2M!'\T?_
M  3V)/\ P<.?\%I\]OA!^RB/P%IJV/TK^EVOYIO^">ZY_P"#AG_@M2W]WX1?
MLF+_ -]6.LG_ -E'?\^W]+- !1110 4444 %%%% !1110 4444 %%%% !112
M'H?H>V?T[_3O0!\73_M<? WXK_M(?'C_ ()[^%O'OBGPY^TIX ^"VF>.?%#6
M'AO4K6/PKX8^)FE-9^&O%'AKQ-=0#0]3UO2Y-2M-16QAG>2TN4A$ZD+*$_):
MV_X(J?\ !02Q4QV7_!?K]MJ*+S&8+-\+_AU=N$Y$:^9-XB9MZI@.ZA5D8%A$
MF0!^<?[5?[2/[7_[+?\ P<9?M3>+/V-OV,M4_;4\<^+?V'_@%:>)? >C^*;?
MPK=^%_#UL\<:>)FN[ETCNHC?6MMIKQA92OVE-H#;67ZO;_@KM_P7H)PG_! ;
MQKG_ &_C!IH'YC _7W^@!^B/[ __  1Q\ _L>_'3Q;^UQ\7OVB/C=^VS^U_X
ML\-3^!4^//QWU",3^$/ =Y=6]W=>%O ?@^QNK[2?#%M>74'FW\L%W/F.2:.R
M@L!>ZHVH?LO7X+_L)_\ !03_ (*Q?M _M%>&?AK^U/\ \$E]>_90^"^I:/XF
MU#7OC-JGQ+L?$4.BZCIFFRW6AZ:-)A?S;B36[]8[$/@^2'\S[H%?O10 4444
M %%%% !1110 4444 ?S-_P#!79#)_P %D_\ @@&H.-OQI^.<I)Z$1^&O##$#
MW(X].>:_IDK^9+_@L!<&W_X+(?\ !OZPS^]^.OQIMB1C_EX\/^%X\$'L<\_3
MU//]-@&.!TY_S_.COZ_Y +102!U[G'XTUFVC/4\ #.,D]LG\Z!-I)M[(=2$@
M8SGDXXY]3^7%-WCI@EL$[1U('7'N.,CL2 >M?G)^V+_P5F_X)Z_L):=JTO[1
M_P"TY\//"_B32;6[N1\-]!U>'QC\3M1GL=HETRS\#^&SJ&KQZDVY0EKJ4>G9
M!R9$7#5.MW[R5]DU?\$TW\OF#YMXQYO+F4;_ '[6WU['Z.%P#CGW]NOX\D8_
M7IS5>\OK33[>>\OKF"SLK2"6YN[V[FCM[2T@A0R2S7-Q,R0P0QHK/)+*ZI&J
MDLP'-?RKW?\ P7"_X*)?MK7T&A_\$F_^"7'Q-\2^"M6N9M+MOVF?VLQ-\,?A
MC;)=V8N-+\1:?I+W%BEUI05E8O/J]\)V)5;<HCRCY/\ BQ^Q%^T;\;?/\3?\
M%UO^"VWA[X7>"[G4+;4KO]D[]ECQ?I_@OPG8(J/#JNAZU=::L>H2:?<6V(H2
MV@:RQ;,LET\JJD6=6O0HQYZM:C1A%>_4JU(4X1UMKSRB[7:5EJKJ_9X8C%87
M!4YUL;BJ&$HQ5W5Q52EAZ,%IK*K5JPARW:]YM7;22U1^\'[7?_!=W_@F)^QG
M?W/A?XC?M(^'/&_Q)A=+>'X4_!.WN/BYX]N+ZYB9["RDT[P@M_9:?+>RA8(G
MU&_MDCD;]]Y:JS#\PS_P4X_X+@?\%$8-.A_X)O\ _!/&V_91^#_B&6U-M^TU
M^VQ?P6=_-HD\]SI^HZCX>^'X>P6=[/"W]M)91^)IY)$%O%:2A))6\M_9B^*W
M_!%']C+4;?0?^";/_!/?XA_M6?$_2((=$C^*FA?#&_\ &FMZY=6UQYUI?#XK
M_$"TU&PL[R6<@_;=,L_#S"/*QIMDD6OT>M_VD?\ @M]^T-;7'_"J/V-/@W^R
MAH$]RJV7BC]H3QH_B#QI9POEEN/^$'L6:PO%12'&V\BP0,)@[:X7F^";2H2J
MXR3LDL)0K55)];2<(TDO.=>&B;3;M%_.3XQR>3E# +'YU5@^7DR3+<9F"G*]
MFHXA4Z&"T3O?ZYRVC)\S?NOY-\/_ /!N/XY_:3U"3QM_P5M_X**_M*?MFZU?
M-:7=]\+/ ?B2\^%?P)L+S3KA9K;[/H5NKPWUK'&HMQ]F\-^&ITAC3%R64,OZ
M<_#[PE_P1\_X)1^%8(O -C^RS^S1;6D-W:#6K.XT*_\ B/J+2(!?6M_XFN9M
M>\?ZD]TQ!FM;K4F@>21T6!$R*^:(/^"57[<'Q\M9W_;4_P""F'Q5UBPU"Z%W
M<^ /V?[(_#OPI'%*V9["&\C:RU>VMPO[I?L]Q*@P6&\<'Z8^$W_!$S_@G3\)
MY8M0?X&Q?%'Q+'-%.?%GQD\0:OX]\02W,;%VGFNKZ>"*4NY9F2>"8'A6)4&E
M+$YG6LL/E\:,9+2MC*\8N.SN\+152K)VTM&M%W:;NDT83S+B_&V_LS(L#EU*
M;M]8XCQ[C5IQW4_[/RF-:M=Z+DJXRFTWJ[J4#Q7QC_P7A_9\U6^M]!_9A^#/
MQ]_:H\07\[V=HWP_\":AI7AY[DMY=L%U[68(X+V.=RFU;17<QL&PI.!_.W_P
M4^_X*!?M(?M4_$;PGX-^(7P]NOV<KG]G[Q%<:KIWP\T[Q!>:IJVF^-;NUL+B
MV\0>+Y6C@M3XA\.6YAL[6SM8Y8]$-[J<3/))>3*G]X'A?X=>"? VF+HG@?PC
MX5\&:0J>6-/\*:!I?AVV"*GEIB'2+6TBWJF")&1GW*"6)Y'YHZI_P12_8 US
M6M8\0:W\-?$NM:UKVLZGK^L:EJ?CWQ%>WFH:SK5[<:AJ>HW5Q/,\LT]Y>7=Q
M<3%W8&1A\N ,>+GF59UF>&5&EF+PTIRBY0P]*A"G[DHU$O:S4L4E>+NHR2>B
MDFKV^!X\X,\3>(\ICA,MXPRZ%>M5I5,70I8.GE>!A3I5858TZ551Q68S<9Q]
MV;KQYN5<Z:?N_E3_ ,$S_P!@[X*?\%'? 5A^U=^V/\=OC%^U9\1=(\6:AI?B
M7X4>//$#:1X)^'OB72Y$E339]#T.XB34M/UC2;C2M=L+C3(O#MI-%<R6A2YD
MLKE8_P"H3P'\._ GPS\-V?A#X=>#_#/@CPMIZH+/0?"NB:=H6DQ%8UC,OV+3
MK>&&6>18HQ-=3*]S.T8DFFDD)8_.?[,'["O[.O['M[XQOO@-X1O_  E-X^@T
M>#Q6LWB'5-6MM4&@F].E3/:WLK0175J+^[C6ZBC69H9VB=BBH%^P4 &[!!Y_
MA/ &.XZ Y)X'&,5[>5X*6%P6%A6;GBJ<.6O5DY2<Y<K3E>:;7-=-ZVO==3]"
MX/X>_L/)L%1QN%P3SB-*,,QQU&4L34Q=91M.M+$8F$Z[]JUS2BITX7<ER6=A
M%C"@CCKG*J%^@(Y!QT!.>">!3BO/08QSQSGVQ^'>G45Z7+'LOZT^7RL?7>5E
M;LDDON2LON$"@'C\NU+113M;OZ7T^X-@HHHI@%%%% !1110 4444 %%%% !1
M110 4F1ZC\Q1GG!X/;W'K_\ 6ZTS)#,=IZ=<C''^1^53+F7P\OGS2Y4EW\_2
MZ$VE:]]7;1-_DG;U'Y'J/S%)N!X&"?J/?WZ^WYTW<G'RYSG. #MQ_>QTX[?7
MTKG_ !3K]MX5\->(/$UQ!)<6_A[0]6UZ>VA95FN8=)L9KZ2")Y"$6698'CC9
M_D#$%B%IQC4J2A3IKGJ5:M.E2C3<;SG4J1@H7DW&\I2BMT];W6ZF<U3BZDW&
M-.*;G*?,N5)-WVTLDV[]$=%O7('<XX],^M*3CU_#_/M7\DMI_P ':7[.5[#Y
MW_#(/Q[@WC[DGB[X<*XR2,';>_*0!T)XX!K]>/\ @EQ_P5A^'?\ P5$T[XXW
M_@'X1^/?A5_PHW7? NAZQ!XVU7P]K']NMX[TG7-6L+G2IO#TTR0I8Q:%/%>Q
M7863S9X?+++N(^SSGPYX\X>RIYYG?#6/RW*G*A&.-KO"RHJ.)LL/-^RQ56HW
M6D[1C[)6[W/(P?$.38_$SP>$S&A7Q<&^>C!5%**7^.$4]GLW9:['ZP[N3P<
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M5]P689E-VADU:"V4Z^*H4X^3<8>UDU?1J,HR25VNA_03XJ_:-_9_\#V=U?\
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METC7,S1VR*QE(K^+G[9K\AV77B#Q+>!9$3R+OQ+KMXC@X$BYGOF0XDC5"I#
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ML%_P0'O?#GB7P[K\&G_'SXP+</HNMZ9JP@EE\,^'[JV6<V%U<>2UPEK*;?S
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M65DDH];7NW];_86 ;DVL4N:3DU]<K63?9+1)]K/U/YA(?^"'/_!1.U_X]_\
M@N!^U;T&=]OCIC^[J1QG!_R36M#_ ,$8/^"F]F5^R?\ !<7]IU5'43:<LGIZ
MWQ]!_P#6K^F:BIGXB\4U=*E?*YKM+A_(W]]\N=_F1+A[+9_%]<TOMCL3'??X
M9(_FAN/^".G_  5.<8@_X+C?M&1XZ;]$##]-0'3GZ]ZR&_X(S_\ !59S\W_!
M<C]H8 \?+I%R/_<GC_)SG-?TZT5$?$#B2.TLF_\ $<R#_P"=A/\ JWEG;&/U
MS#%O_P!O/YE8O^"-'_!4J)3C_@N7^TDK 9!710P!'(^_J#'@^_3\J_+[_@L7
M_P $^?VW_P!E[]ACQE\7OVB?^"I/QI_:D^%NA^/OA99ZM\(O'.G0Z?X:U&_U
M?Q=:6&CZU>W/VF0J?#VHW,>JQQ@!9FA1'Y1*_NKK"U_PSX>\6:>^D>*-!T3Q
M+I$LD$\NE>(-)L=8TZ2XM9!-:W#V.HP7-L\]O*!)#(T6^*0*\95E!KORGQ/S
M_+,XRG-,1A\HQE++LQPV.J4(9#D>'JU88>?,Z=/$TLNC4H2FO=52+<H-\\5S
M15\L5POEN(PM?#IXJ#K4Y14Y8S$SY6U:_*ZB36NJV>Q_C4)XGT616FCU*TFB
M.2LD<Z,,C)&5+ XXR0>>WL/[>/\ @G=_P05_9I_:2_8P_9J^-GQ;_:$_;!UR
MV^*/PI\.^*[CX<^%OCOXC\%^ /#Z:NLTTNB>'=+\/2P+;:);N7^QV[[F0.[-
M\S%5_JT'P@^$RH4B^&'PZ4'/RCP1X:"D'.05&F*"#SGCZ]:[73M)T_2+&UTS
M2;*STO3K")8++3]-M(+&PM88R=L%K9VR1V\$*@E5BABCC&<A<U^C^)/TBL[X
MVP.6X/)\MQ'#-3!YE6Q]?$TL?AL9/%0JX=T(4USY;'V,J";E3DO?O+1I*QX/
M#? 6!R+%5<56KPS",XU(THU*3BZ#E)-VDIMSYE[KYN:W2Q^$'@O_ (-G_P#@
MD!X1U0:M??LY:K\0KQ7$DK?$[XD^-?&274F=S27GVW4HWN))&YDWNP;G&!U^
M^OAC_P $N_\ @GI\%C ?AA^QK^SWX4,&-LEO\.]&U"1=H&QB^KQ:@\KA@"[2
M[F8 Y.237WH%.,9P2<GUQT[=?_KU)7X;C.+.+,P<7BN)<[Q-DX.,\SQ481CN
MHRA0J86,K)V]Y3LMK+?[.&6Y?&,4L#A;)N45*C&?*W?6*J.HH-WW@HOY:'GO
MASX7?#KP@\;>$OA[X&\*F('RF\,^$O#^A-'N !,3Z;IMLT1QR"C YQSQ7<I
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M]0/\:G1OWHP;_N^\_FFK)?CT&TK+5I+LVK^KUNOP8O..>OM_^O/Z_E2!<?\
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M9_+H_0&F[I:.SL[7L_1[^2OK:P;@OS'Y0V.,9(R>!CJ"?^^?TI6)X(^I4'D
MYY],G/)XQD?C%N5 S.A09 W88D\]1UR!WZ$TJNI<=0V K+SD9&4RN-PR.26
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M?^"I/_!;"-S')_P0=\8L.I:#]I+PDZ$\DX;^PL$9! (QD8..0!5D_P""J?\
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MGC&DG;6R3[,W?C;Q=536(R?PVK*47%RJ^%W FM]O@R.BX^4DTU?0[X?LX?\
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MV<PVGA\ QXX&&?PS?]<%NKY[XQBFO^SW_P ' ]T"$_;&_9SL-V #)X<$I7)
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M]C3_ (+SL0\__!2;X5#/WDB\(VX"YY^7'P= .![=.XYKC3_P5-_X+;J&5?\
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M%_ EC;:EXMOM)T\K)J<NDZ=>75C%?3V-EYU\]JEP+B:"WD6WCEF*1M^)T/\
MP<>_L92*'?X?_'"&+YP\AT3PP_EE<'+JGB-B$*9D$HS$ I#.IV[OPUF\)_\
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M+3;R[LHI-.L7A+WT@G#HK1B-'=U4_@V__!VS^S<O3]@;_@H*W+<K\*=#  &
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M\#-_P<-_\$UTUNXD'BGXXR?"*R\3R>$Y_P!J:W_9W^*ES^RRFI0WPTRYN/\
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MB%XBT_3+O6]1TSPOI#3&\U.6QTFPO+Z^EAB^SV<,.;B5&>)'];H **** "D
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MAH.A:7X\^'OAZ\LP'9=$\57WB+7KB\N)"+0ZU\3=%BCB^UZ?*Z@'[\?M-?\
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MET+4+>XBNM2\'^*9]#OB;:WOIGM6M94MM3O+*ZT^^G_DI_X)T_LV_P#!)_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>ea028514801_img23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img23.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,Q U<# 2(  A$! Q$!_\0
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M_K_I[5_/%_Q$L_L,_P#1-?VE/_"0^'WO_P!5-^GZ^G)_Q$L_L,_]$U_:4_\
M"0^'WO\ ]5-^GZ^G)_K)D/\ T-<#_P"!O_Y ?^OO!G_139/_ .%E/_(_H>RG
M^S^7U_P_SD493_9_+Z_X?YR*_G@_XB6OV&O^B9_M+_\ A'?#_P#^>=2_\1+/
M[#/_ $37]I3_ ,)#X?>__53?I^OIR?ZR9#_T-<#_ .!O_P"0%_K[P6_^:GR9
M_P#<Y3_R/Z'?D]O\Y_\ K_I[4?)[?YS_ /7_ $]J_GB_XB6?V&?^B:_M*?\
MA(?#[W_ZJ;]/U].3_B)9_89_Z)K^TI_X2'P^]_\ JIOT_7TY/]9,A_Z&N!_\
M#?\ \@/_ %]X,_Z*;)__  LI_P"1_0]E/]G\OK_A_G(HRG^S^7U_P_SD5_.^
M?^#EO]AD?\TS_:7_ /".^'W_ ,\[/Y9I/^(ES]AG_HF?[2__ (1_P]_^>?1_
MK)D/_0UP/_@;_P#D!?Z^<%_]%-DW_A;3_P C^B#Y/;_.?_K_ *>U'R>W^<__
M %_T]J_G?_XB7/V&?^B9_M+_ /A'_#W_ .>?2?\ $2]^PQ_T3/\ :8_\(SP#
M[_\ 53/I^OIR?ZQY#_T-<#_X&_\ Y ?^OO!?_13Y-_X64_\ (_HA^3V_SG_Z
M_P"GM1\GM_G/_P!?]/:OYWO^(EW]AG_HF7[3'_A&_#[_ .>=2_\ $2Y^PS_T
M3/\ :7_\(_X>_P#SSZ/]8\A_Z&N!_P# W_\ (!_KYP9_T4^3?^%M/_(_H@^3
MV_SG_P"O^GM1\GM_G/\ ]?\ 3VK^=_\ XB7/V&?^B9_M+_\ A'_#W_YY])_Q
M$O?L,?\ 1,_VF/\ PC/ /O\ ]5,^GZ^G)_K'D/\ T-<#_P"!O_Y /]?>"_\
MHILF_P#"RG_D?T0_)[?YS_\ 7_3VH^3V_P Y_P#K_I[5_.]_Q$N_L,_]$R_:
M8_\ "-^'W_SSJ3_B)?\ V&?^B9?M,_\ A&^ /?\ ZJ;]/U].3_63(?\ H:X+
M_P #?_R _P#7O@U?\U+E'_A7#_Y$_HC^3_9_R3Z_YZ=L4?)_L_I7\[O_ !$N
M_L,_]$R_:8_\(WX??_/.I?\ B)=_89_Z)G^TO_X1W@#W_P"JF_3]?3D_UCR'
M_H:X'_P-_P#R ?Z]\&_]%+E'_A7'_P"1/Z(?D_V?TH^3_9_2OYW?^(EW]AG_
M *)E^TQ_X1OP^_\ GG4G_$2_^PS_ -$R_:9_\(WP![_]5-^GZ^G)_K)D/_0U
MP3])O_Y /]>^#?\ HI<H_P#"N'_R)_1'\G^S^E'R?[/Z5_.U_P 1,/[#'_1,
MOVF?_".^'WO_ -5.^GZ^G)_Q$P_L,?\ 1,OVF?\ PCOA][_]5.^GZ^G*_P!9
M>'_^AM@?_ W_ /(#_P!>N#O^BDRG_P *H_\ R!_1+\G^S^E'R?[/Z5_.U_Q$
MP_L,?]$R_:9_\([X?>__ %4[Z?KZ<K_Q$O\ [#/_ $3']IK_ ,(WX??_ #SO
MI_D<BXER![9K@G_V]+_Y 7^O7!W_ $4F4?\ A7'_ .1/Z)/D_P!G]*/D_P!G
M]*_G;_XB8/V%_P#HF?[3'_A&_#__ .>=2?\ $3#^PM_T3/\ :9_\(OP!_P#/
M-I?ZR\/_ /0VP/\ X&__ ) O_7;A%?\ -195_P"%4?\ Y$_HDX]4_(?XT<>J
M?D/\:_G<'_!S!^PN>GPS_:9_\(SP!_\ /-I/^(F']A;_ *)G^TS_ .$7X _^
M>;1_K+P__P!#7 _^!O\ ^0#_ %WX1_Z*+*O_  JC_P#(G]$OR?[/Z4?)_L_I
M7\[1_P"#F']A<<_\*S_:9_\ "-^'W_SSJ;_Q$Q_L+?\ 1,?VF_\ PBO '_SS
MJ?\ K+P__P!#; _^!O\ ^0!\;<(K?B+*O_"J/_R)_1/\G^S^E'R?[/Z5_.Q_
MQ$Q_L+?]$Q_:;_\ "*\ ?_/.H_XB8_V%O^B8_M-_^$5X _\ GG4O]9>'_P#H
M;8'_ ,#?_P @'^N_"/\ T465?^%4?_D3^B?Y/]G]*/D_V?TK^=C_ (B8_P!A
M;_HF/[3?_A%> /\ YYU'_$3'^PM_T3']IO\ \(KP!_\ /.I_ZRY!_P!#7!?^
M!2_^0#_7?A'_ **+*O\ PJC_ /(G]$_R?[/Z4?)_L_I7\Z__ !$Q_L+_ /1,
MOVF/_".^'_\ \\VD/_!S+^PJ.OPQ_:;_  \%> /_ )YU"XER![9K@G_V\_\
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M*_G3_P"(FC]A7_HE_P"T]_X1/@#_ .>?2?\ $33^PI_T2_\ :?\ _"'\ _\
MSSJ/]8,E_P"AI@O_  +_ .U'_KMPE_T4.5_^%*_^1/Z+MR^H_P Y_P /\Y%&
MY?4?YS_A_G(K^='_ (B:OV%/^B8?M._^$5\/_P#YY]-_XB;/V%/^B7_M/_\
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MIH_M_)?^AI@?_!B_R#_6SAO_ *'>7/TK7_*+/Z100>G3Z'_#_/X&ES]?R/\
MGO\ S]#7\W'_ !%!?L&?]$L_:G_\(?X<?_/5H_XB@OV#/^B6?M3_ /A$?#?_
M .>K1_;^1_\ 0SP7_@Q?Y!_K;PS_ -#O+_\ P=_]H?TB93V_+_ZU&4]OR_\
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M?_JOV*?^OOX[_P#I+\+J_DK7HOU/_LU?A'&'_)2YCJ_^87K_ -0M$_BKQ?\
M^2^SOK:EE-KZV_V##[=O.UB*BBBOEC\T"I/W7_33_P =J.BDU?J_DP3MT7S0
M4444P"AV12<$X]^I]^@P/K_]8#LBDX)Q[]3[]!@?7_ZPKT>>H>6@4445T'.%
M.^3_ &OTIM%<YO9=E]R_R"BBBN@P"K$<71F'T']?3_/YQ@9R[G"C]>O YZ__
M *S5SI7'.71?/_+_ #/3P]%?Q)Q73D32_P# K6_\!^^VS$P/0?D*,#T'Y"EH
MK,[1,#T'Y"C ]!^0I:* $P/0?D*A;#8^4#'L/\*"2>M)6T8\O74!,#T'Y"C
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M[7Z7[7VOY7OY!113M[>OZ#_"@!M6(HL?,WX#_/4'_/O&%SEWR%_4]>!SU_\
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MMSCW]*SE+=+YOL;4Z?+J]7VMMVO_ %V%I&Z'Z'^5+4!8MZ<>E9V?9FP$Y^@
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MC9O,J%.>6)6TJX^A%2C!7=E*O*,O=2>O4^(/^#<BXN+[_@H1XNO[J0RW=_\
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M+&A^,KO1=-DCAO-4&D>'EN$TZ">X'EPM=S>7%)-(D@MD9IECE*"*3KRSV?\
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MV$FM#6_%WBNSMS%,?#XO;:PTFQTCPP+B&,O!8V4EQ>FWB\VZ$)-JGX*JJO\
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MQOI>G:;>/XIM]4@M=0&ERZ%=72+;OJ*O=6XF<B.-B)E)X_G,P4!#8[= /R'
MY_STJ(DDAMPX[#/?TXX]SGVK&/$.:?7:V8TJL5BL1!4\7:$5%P45%67+9:)>
M\M;I*]T80XTXAIYK7SR->FL?C:2P^8<M' J*HQ2C%<JO%-12?-;FE97NUILZ
M1JYTOQ)I&OF#SETKQ%IVO-9K,$\\6.K0ZI]C%P8W$?F>2;=9C#,(2PD\O;A:
M_H)_X*#?\%OO!'[:O[(5Y^S3HGP#\4>!-7OM1\!WQ\3:IXSTO7-/ME\)D/<Q
MM8P:!8RRM<LI6!Q<@*"&<\&OYW"0".>HQT[D8/Y9ZT<#GUZ]3TZ9'3\L^]<F
M&S3&X*CB<-AJR]CC4UCO=3?))M.S:;3]YZQU[^7!EW$&9Y5A\VP>!Q$/89JI
M_P!JWA!M0J\W,X2Y?=?+.2O%;==$?I3_ ,$R?^"C'B?_ ()S_&37O'=KX./Q
M#\#>/=#L?#?C[P6FM2:%=SVEC>&ZTS6]#U#R+VRAUK2I)9OEO-.O$O+=GLUF
MM"PN$_5#_@HO_P %U?@+^U_^RY\0?@'X)^ /CO3M>^(%AI5NGBWQ/K&A:=#X
M8O\ 3]1M[\WRPZ?!?W6O1PF!K>.UDNM/2ZBN&E=5\H1O_,,?\/?M_GZ=*8W"
MGZ_EDYZ=O0'UZ5M0S_,\-@*^64JT7AI*:UC&3Y9OWDFXMI/>RZW::;=_0P'&
M.>8#*<3D5"O3E@IQG&+E3A-PC52<U&4U*R>CWT;;33;;_HT_8]_X+G^"_P!F
M']B?1?V4=7_9^\2^*=6TCPCXW\,GQ=IWCC3-,TR\;Q3#J4=M?#2I?#MU<VAM
MSJ >:U-RS%(CB5&D '\YEQ-YUS/.R[?.FGF"YSM6:5Y=H(VY"A]N>-Q&<#.!
M'C(&<Y)XYZX/4Y]#CN,_J7AL\'! ZGL>,],>Q/;IU]9Q.98W,J&&P^,K*V#7
MN>[%/ELK+1:V44KOLMM;\F9Y]F6=83!8/,L3%PRZW]FJ,:<6FHI*\DG*>D4O
M>UM?JQ"N0",?AP"/\?J:_:O_ ()-?\%7_"?_  3;\,?&;0/$GP?U_P"*$WQ4
M\4>&]<MKC1/$VG^&X=)BT'1I-*>WNA=Z5J0NYIV?S4D1(=N-C,1S7XI%@>!V
MP/? Z?X]L\<#%-K+ YA6P&)CB<*H_68MVNDX[-72Y4FVGY)>=B,HS''9)C%F
M6 K1PN-2:]Z"FI*2LVXRCRR33;L_7S/J_P#;4_:7A_:E_:N^*W[2GAO0=4^'
MD/Q \46'B;1M)EU<7^L^'KG3K.Q@L;B+6K&VL?\ 3H[FQCN[::UMXA;7"131
M2%TS7[W?LL?\'*>L>#/AAI'PV_:M^!MU\5]3T#1(-%3XB^%->MXM1\66MC;1
M6ULWC3PUXBL[ZWU#6[F-#-J^O6VI6-K=M^\316E>65_Y7V(Z9Q^&?3C_ /5Z
M5'@DX]/Z<?Y_PKIP>=YI@\7B,91JKFQKDYQ<8N,I2DY-\K3C?FD[7CITTT/8
MR_BK/<LS#&YC@\1&4LRE*5>,J<73G.4Y3E/V<ERIJ<Y-6BG%.R;CH_ZR/VAO
M^#EG3W^'NK>!_P!D+]GJ?X>ZW>6+:9I'C;QO=Z/;6/A>"ZLV2XOM&\$^'[$V
MLVJ6-R['3FO-3>Q1HTN;BQD9_(3^5K7_ !EXL\2>+]3\?:]XCU35O'6K>(G\
M6:IXKO+QI]:O/$SWJZG_ &])=LJ;;U-02.XC=5#121Q"$!(E%<W@XSVSC\:;
MD#'OTX//?^OZU689MF6:N#Q=;EC#2,4E",=KM17*D]-[)M):V20LXXCSG/IT
MI9CB8QITM:=.$8PA%Z)N,(J,4W:W,E>UE=))']<G[,O_  <Q^']!^$_AGP7^
MU'\#/%?BWQSX?TRQT'5/&W@;5-'O=-\96ME:B%-;U7P]K,=F^FZPYA@2_ACO
M=0@OY3+?J;-B+5O*9?\ @Y.\1K^T7X1\4Z+\!QX2_9B\'Z-XTM9_A#X9US2[
M'Q7X[\2^(+*"UT7Q%XGUXZ,NCV=GH%RMQJ%OHNGZ2K>?<M+-J%],JNO\N61Z
M^_Y<\>OX578;@<<?B?R/7_\ 7^&/1_UJSJ%.A26+AS8=Q][V<'*48I*/-)QO
M+W4M+ZNSE?6_M1X^XJ5'#PCCZ2>#Y+R=&DYRA!14%4DXN4TXQC>\ES->_P S
M;O\ II_P58_;W\._\%%OC?X2^+?AOX>ZQ\,X/#WPZ7P/>:+K6M6?B"::5=3F
MOQ?07]I8:>K0$2['C^SQL#QYA)R/T1UC_@NYX%U?_@GG<_L5G]G?Q1;^(+KX
M")\'5\:IX\TI]&2]CL8]/76AIQ\-17)LRD7V@VAN ^XF'SW*^:?YO%.WWZ=>
MX]^_ITQ2?_7_ %_P[5PT\[S"GB,;BHUU[3,XNGC?=7P6<;I6M&\6[6M;HSAH
M\39Q1Q>98ZEB(^VSRDZ697ITVN24'%N$6K1]V4DG'9/3:Y]T_P#!.G]N/QA_
MP3]_:1\/_&W0+"3Q-X7GTRY\*?$[P1%>'3AXR\&WVZ0VMO=#?%9ZKI.HI;ZC
MHEW=P7MO:7>]I["59%KZG_X*N_\ !2'X#_\ !1L_#KQ=X;^ 'BOX3_&#P&+S
M1;OQ;J/BK3->L?%'@B__ '[>'=7M;32=,S=:7J:)>Z5J<AN+B&"2[L(S';7$
MBC\;BP7KWJ$\DGU)HI9KC(Y=/+XU4\+*3;4HIVO*]TVG*.J^S9W;[LQIY_F5
M+*:F11Q$98"K*4FI0C)Q<I*;Y)--PU2?NVL^;;F:?]!O_!./_@O=\1OV.OAE
MHOP&^,_P\N_CG\+/#TZVGA'5K3Q#;Z/XR\#>%Y%E,WA^);_3M2L_%&FVEQ)Y
MVEV5Y<6$MO:R26HOHH50#[[^(7_!SI\*?#/A/4;+]F_]DS4-/\6ZA;/<PW'C
M34=$T#PI8:_<W#&XDU'2_"5H;_Q!"JL+AI$U31;F[E=DW)LWM_'L<C@ ]!P"
M /49Y_\ U5 <@G/&><?Y_3TKOI<39OAL.J%/%QDXI1@Y0C*48V224W&^BLEK
MHK6>BM[&$XVXDPV$CA*6.C)0BH4YRI4YU(PBE&*C4<>:T8J*3;;22UTC;V3X
M]?'KXH?M*_&#Q?\ '7XP>(7\3?$'QOK::KK%WY2VUA:6]O(K:;HFAVJ9CTG0
MM)M433].M%+"*%9'D:6YGN))?WB_:W_X+N> /VF?V%=>_9!LOV??%_A#6=6^
M'?@KP?#XSN?&NE:KIL-]X3MM(B>XDTR'0+&Z:VO#ILK)_I2/$KA2),'/\W!/
M&>I]/_K_ $[#)X/XQ9 .1W.3SG'7MQ[XYZ=<9%<.&S;'8?Z]"%=.ICH6QUTG
M>,N9WBVG9^\[M/KKW/-P>>YIA/[3A1Q%XYI!K-)2A&4IPES-M2E=Q;=25W%W
MN_2WZ$?\$ROVU]%_8#_:AL_V@M=\!:C\1-.M? _BSP@/#FC:U;:#=B?Q!:K%
M#>17MU87Z-%;%"98S:1EM^X2<9KN_P#@JS_P4&\-_P#!1?XU>!?BYX:^'>L_
M#*/PO\/I/!5YHVMZS9Z_-<R_VLU^+V"]M-/L5,!\P(]M]F1T)+F0\$?EWD\D
M9"_RSV_Q _&E!  SZGZXQV].<>E"S+&1RV67*LOJDY.37+&Z<G?>W7[F3#.\
MPIY;+(H5XO U*CJ<KA&]Y23UER\VNC:;>WDC^B'_ ()=_P#!;OP-_P $^/V7
M9OV>/$/P#\5?$C4)?B/X[\>CQ)HGC73= L$A\8+I MK!+&\T34KAGLSITH>Z
M%RJR&0%8T +G\BO@3^TCIGP?_;A^'_[6MQX9OM;T3P7^T'?_ !HF\&6U];V.
MJ:AI]YXCUK7!H,6K2VL]K#=B/58X7OI()E,D+_N7$NU/DTMSSP!D*.3QGC\N
MW%-P ,GA1DYSDM^&/;I]?>JGF^/J4\!2J58\F52A4P;48WYH6MSI*SM:RYKW
M5UU-ZN?YI6I971J5X.&1SA4RYJ"NITW'DY]/?MRI+GO=7O=L_<S_ (*X_P#!
M7CP=_P %*_ 7P=\(>&?@QXF^%ES\+_&FN>*;J]USQ1IGB*'6;;6/#LVBI:0Q
MV>EZ6;>6*1S.S-YX4H<*:^?O^"9?_!5KXQ_\$W_%FK0:/I(^)7P.\871U/QQ
M\'K_ %--(,VM16_V:U\3>$_$#:=J4OAW6XU(2]9+.[L-9B5%O;"26WM[BW_*
M]L<D_@!GJ,X]?4]>*82I&>01@#U]O;KZ>E:SS;,IYA'-'64<1%16GNII12LX
MI)--*UG=-/5,Z9Y]FU3-:><SQ*6:1C!044HP<%%)1<5:#3BK.+33N^:]S^V;
M4_\ @Z/_ &:X='76=(_9<^*5[XYED6&73[S6/"FFV4=CY(S/_P );';WE[-Y
M4Q:!K/\ L6.,PKYHND)\@?S*?\%!?^"C/QU_X*)_$RU\:?%2:#P[X0\,I<0?
M#SX4Z#=7#>%/!MI= 1SWJ-<.TFK>)]00>7JNN7966>)3;V,=I:XME^ >6/KR
M<>P'4<GIQSZT8 )SUZ9_'C]?SKIQF?9EF-*5#$5HK#2^*-.*CS.^JERJ-UNV
MGU\]3KS+BK/,WH/#8RO&GA)/][&G"-/FE?>2@ESV:>CNKW>KU1G)/0\GIT(R
M<$>@.,X[5Z?\%_C1\3/V=_BAX2^,_P 'O%M_X+^(G@;4%U/0]<L78$J0(;_2
MM2M780ZIHVM6K-8:IILRSV]WI\DT5PB@H1Y<=HZ[?T/7_/X5$WS<  J,]L]^
M2,=._/:O(ISG3JQJ4G;EVDG9Z6M9W33T[[]3Q*,ZE"K&M2D_K$&N22;V5N5Q
M:;U5D]&FGV>I_9-\./\ @Z!^#WB;P=H>C_M+?LEZW>^);+[ NLW7@_5/#OBK
MPKJ-]:())]=T;0O%-K:WFD_Z2B26VESZC?SVP4N=3*QJH^%O^"A7_!P[\4/V
MI_AEJWP0_9[^'=W^S]X#\46<VE^-O$]UXACUCQ]KNAR%DN= TB73K'3;#PQI
M&JVI6#4S;QWNJ2QF6W@O(86E\S^;\X4<#OQUZX_KT_R:8=N.G)Y/?J#_ (YQ
MQGC'2O<GQ)F^(H2P[JQ5XJ#FH*,N716<DD]8K7WNZZZ_4UN+^(,5A7AJN-A"
MC."ISE&$(U'%)1<9245-O2TM=7>]U=/ZT_84_:5L/V//VK?@_P#M&ZEX3N/&
MVE_#+6;S4;OPQ8:I;Z/=ZI;WUC-I[QVFJ7-C?16S0>>K!&M9?,QPT(P!]T?\
M%=_^"JOA?_@IA<?!&7PU\(/$'PJ3X2P^,1>G7?%-AXC?5V\3-I)C%N;+2=*-
MDMH-,*S,[3^9YX CP!G\8F8<*#VY'7]>G;/&,]>]-/'7CZUR4LRQ4,%4RY5E
M]7JRYJETK\V[;?*WO?9HX</FN,IY?5RJ.(7U2O)RJ>[%-MOFNY<O,GU:YDOU
M_6K_ ()'?\%*_#O_  31^)OQ;\=^)/A9KGQ3M?B1X%TOPC;:;H7B6P\.3:5<
M:=K]KK#7,LE[I.IBXB>.'RU&RWQYBDGD@?/_ /P4D_;"T3]NG]J[Q=^T;X=\
M%ZGX!T[Q3H/A;2SX6UC4[76=0L)O#UG)832/J=G;6MM<QW,>R=(Q;P>2&VL9
M""3\(,P/ /.>1SSTZ_3@ '\.!4;':"3Q_/T/^?:G+,<3++Z67-KZK0FYO1-N
M[OK*UW\7=[E/,L7++*65/$+ZGAJCJ-<JW=V[M6ELV][:W1^WW_!+W_@MS\9/
M^">VDR_"CQCH%]\=/V=S)<7&A> Y->AT+Q!\.M2OKD7-_?>#M?N]-U;&B3,\
MES=>%IX?[-:ZFDFL'TVZO)Y9/V/\0?\ !T7^S?H&F:MJ_P +OV/?&<GC_51>
M->/K.J^$O"VGSWB6RQ:5=:KK6DZ9J6HZM'),HCO(FBM9;>"(".Z+./+_ (K2
MQ)R.V0/IGG/]?I[4TG))]>?SKLP_$>9X6A["G5BTM(.48R<8VT2<DVK*R5G9
M*Z\EZN#XJSK!X:.%I8V$E#^$YPA-PC]E1E*,FK1M9)JW2VQ]9?MF?MI?'']N
MOXT:K\:?C=K45UJDL;Z?X5\*:3Y\7A3P%X<:5I(/#GAFPGDG-K:AE6;5+N2:
M>\U2Z7[7J,MQ(80GW)_P3"_X+._&G_@G!INM?#T^%+?XS? W7]9BUQ?AUJ>O
M2>']1\*ZM-<VBZYJ_@_7EL]1CLCK&FQ21W-A<65WISWL$%X8-ZR._P",[-M_
M'/\ ]>H>I_,_3J>/UKAHYCCH8KZ]3Q-\6Y-OK>^Z:O9IWU36O7H<&'S/,,/C
M'F5+%-XQRDV[OWN9N4N9.ZDI7U4M&M+)6M_;3XM_X.IO@'9:+>:A\/?V4/B+
MJ?C2[6^C5/$/B+PUX>TM?+MP^FW-YJUC8ZE?W\<EX=M]IY@LY8H(R\=T6E&S
M^5C]N#]N/XY?M^?&VZ^-?QOU*Q2]M["/0O!_@SP['-:^$/ ?AJ&1ICHOA^RN
MY[NYD%W.?MNLZAJ%S?7VIWA#7$YM[2RCM_CPGKSS@GU_/_Z]1YXSG'// ))/
M4CICKT'2N[&9WF6/C[+$U8TX*UXQCRQ;LM7&*LWO:Z?7U/0Q^?9KF=+V&,KJ
M-.5I.$%&,&VOB:A&-WKHW=K6Q_2Q_P $L/\ @O\ :?\ L.?L[:1^S+\:O@YX
MB^)/@WP->:Q<_#3Q1X)UO3[/5-,T;7-6?6K[PGJVAZG9+#=6MMJ6H:QJEEJ\
M%]%,LUU-875FT;QW-O\ &O\ P6/_ ."FWPX_X*6?$7X1:]\-/A!XB^%^B_"+
M1?'&A#4_$VM:7=:KXUMO%VH>'KZ">\\/Z591VOAY]';1;E61-7UM]1.IJ?M=
MNMIMF_&R1R"".^2,^F3Q_//H*B#!\G)';'OW!P.1GIZ\'MBJGG.85<!3P5:K
M'ZJWR<W+%R48MVUUDK+3T>NFA=3.\SJY?_9]6O&6%Y8PUA%RY8644I-.2T26
M^VEVM"0\$MR 3RO3;DYQP2/E/! X_"OWL_X)%?\ !9OP=_P3.^&'Q1^'/BGX
M%>)?BK+X_P#'.G^,+35]#\8Z9X9CL8K32SITEC<VEYH.J%W0GSDN_M.QU8(8
MHSEF_ IW(.R,X#*"QP#DMUQGGD$#MCIUINX@@'L,$8R#^N!GZ\^]8X'$5\NJ
MK%8;6R>^NFJV=U9K=+J^G3DP.+Q&78B&*P;7UB"M"ZB[Q:Y=8R3336Z\^^I]
MU6W[86E1?\%(M+_;NF\$ZF-!T[]JJP_:+;X?_P!L6XU.73;3QM_PE1\,IK9L
M5LX;YX?*MI-1;2O+CE)F^R@+D?I'_P %=?\ @MEX)_X*8_ 3X>?!OPS\!O%7
MPHO? _Q>T_XFW&N>(?&&E>)+;4+6P\'^,?#+:5'96&B:7);S/)XD6Y-TUQ+M
M%H8# QG#C^>TL"2H!P2<]N<]^>1GU.2<=ZC/4CZ@\Y__ %_B/PK>GFF*I4<7
M122H8]SY]$WS3YF_35OY>IUTLVQ^'P^,PT*R]CF+FZRY$VJE1MSLVN9:SE'?
M1;>?Z=_\$H?^"@?AW_@F]^TCXD^._B;X<:U\4;+5_AAK7P_A\-^']>L]!O8;
MW4]9T74UOI+R_L=3C,<::;Y C\A2!/CS3@&JW_!6;_@H#X?_ ."D'[37A_X_
M>&_ASJ_PNT[0_A!X:^&,GAW7?$%EXBOIKKP]XD\9Z]/JRWECIVGP)!=6_BM+
M5;9H6,36;7!FF5@B_F0V,CCYN@/0_7CCJ!Z=O2D)PN"!T_0KUY_(GIVJ5C\2
MLOIX"%EAY3M+1;IVNG;F^6B[7)68XN.70RQUE]5G/FDFHMIJ6]][7UT:N^MK
MHCD<#);E<X X.0>WWG'0<_.P/]YNIKEP[# PH7 ''J,].G88SV]Z;*Y8XX 4
MX&.^.,GDCMQ]334Z_4<5S*%DUUU2UZ;+YV7Z')"T9Q2=U%V3[I72^\EIK,$&
M3GKCCKFD=]@SC/. .GZ_AZ55=RYR1C'3_/%7"%[I/72[M]WX=+^9TJ\WV2_K
M[Q7<MQ@ 9R.,$CG!/7U/3C)-1T=:CDD"#U)' [?4]\>GK@CBMTK*R'[*#W5_
MF_\ ,M::V-7T@'OK6D@?CJ4'_P!<\_G7^S;IO_(.L/\ KRM?_1$?^-?XQVE[
M?[6T?=U&KZ..>H(U&WR!GGZX[9K_ &<--_Y!^G_]>-M_Z(BK['A3^'BKJWO1
MT_\  _Z]3] X(^#,-+>_2_#F7Z%X#  ]!BBBBOL#[Q;+T7Y!1110 4444 ?R
M4?\ !T;T_8G_ .OGX\_^DWPLK^21>L/_  +_ -"-?UM_\'1WW?V)_P#K[^//
M_I)\+J_DE5C^ZR>#NST]2*_!>-/^2BS/TPOX86@C^,/%M?\ &?YOMJ\IOZ?4
M,(M?+U(****^9/RX***=O;U_0?X4 -JQ%%CYF_ ?YZ@_Y]XP,Y=SA1^O7@<]
M?_UFKG2LYRZ+Y_Y?YG9AZ/\ R\FNW(G_ .E6_P#2?OMLQ, = !00",'D&EHK
M,[! H7H /I2!5!)"@$]>/K_B?SIU%'Z[^?KW^8K)6LEIMHM/333Y6&A$!R%'
M^?;IWJ)R'X(&.>.O6@DGK25M&/+Z_EZ!96:LK/=65GZJUG\TQ  !@#CTH(!&
M"./2EHJ@LK6LK6M:VENUMK>5K>0@  P!@4UB%.0!D_YY_'\_6AFQ]T]?H<#_
M #[>M14#[>6WEZ=OE8*3 '0 4]/O#\?Y&FT>?7N'6_7OU^_?\0I"0.M!('6H
M* $(R 0>"3D8]#@YR.>,8/3VZ4 ,V0%9L<\*S=L\@#KR<=_ZG;)Y^8_HW]./
MPK^IO_@U_P!+TK5/B)^V)'J.FZ?J(A\%?!AHEO[.VO!$QU[XCAC']HBE\LN%
M3=L*[]J;LE5*^GDV7_VOF5' .L\,L4I7=N:W)&4[\MU?X+)7ZW:TL?3\+9"N
M)<_P>42Q4LOCC8MRFH\\G[/ U*BY8\R4FW"^LMKOHS^6/@_+M?IP/+DST[97
MM^G>G8VY)20\\_NY!GC_ '!W]NN>G%?Z)G[67_!5?]AK]C#XN7OP4^,>A>)_
M^$WL-%TCQ!=Q>%?AKHFLZ5'I^N6JWMB%OIM1TYY+HP21M-$L)VY&"<YKYM;_
M (.!O^"8C)D:%\2R1U!^#^A$#GH,^(.Y[=<_I]35X3RO#5*M+$<38"%=-Q:E
MAFG"VEI+ZQ>_RO?IL?HE7PTX:P=>OAL3QSE=/&X1M3A5P5*-2E;7EG3EC;MI
M6OI\E<_A% )PB@Y; Q@@\>V,C@DCCM3BK1_*5(R,<CJ!QG)'OVYYZ8S7[/\
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MV SB>68_B>G@95<HCFD,=4R]0U]IR2IJ3Q3C>G!\[T3<5IT1_',SE,$H_(R
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MVE!2.6X<JQ)D3>ZG^B+]M;_@I%^QS^P+XV\#^!?CSX>U]->^('A?4/%^A_\
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MK23FTDG&2D[VV5DW=OHG>VUS/5ADYQN/3GD\9QCIQCK_ ),32!_E*\ ^IYY
M[8]?_P!5?UF_\%*/^"2?[+O[ ?\ P2V\;>/? ^FZGX]^-.J>-_@38:E\7?&S
MQ7.M:=:ZQXWTI-6T_P (Z5!%!IGA33+Z&=[*]_L^U_M?4=.D^R:IJ-ZF0/Y+
ME=,;02<'G.3@@XY)&3TXXYQSWKOS++,3E4Z-#$.+J5J4:L.6[2C.]HN5DG))
M*Z5]U=MW/9SC(<7D=;#T,6XRK8BA"O!PNXQC43Y8.7*H\Z5G)+1<R6K38I=0
MO7/&._TST]>U1=LCGCC^G%*^YOE'S=3V&!GJ>F,X[^]:.@>']=\5ZWHWA+PS
MIMQJWB;Q-K&F^'?#^DV4#3SWVLZQ=1V6FVB0V\-Q*7>YFC)GA1C%$9&9=BR5
MR0IV:C#XGI:]W>5K:=[N]ODCSZ5)^UC2IW<G966KYG9-*V[3>EMWLC*9P%(8
M'/3 5B.W3&?4=^*C_/G'7_/^?SK_ %/OV(_V5_!G[+/[*WP(^ UUX<\(1^(O
M!_@;2[3Q),FFV%S+JGC6YMVU?Q=="\O1=WFK3)JMS=QF\>>5I+.VBDC$%I'#
M#!_"A_P75_90'[+G[>_C^\T:**+P)\>H&^,7@^*&V2WATNYUBX%CXOT**..)
M%=-.U^)KY)@?]5J\<) \H9^GS7AFIE> HXSV[Q+7(ZD''EY)3BI6OS._*VXM
MM*W+KY?<Y]P14R7+:&8+%2Q<UR.K2<.7V4JD5/DOS2;Y9.4&VDUR[7T7XX%L
M#G@<?I_DG\S3 X'7=S_L-QD?0@>Q_4GDZ&B ?V[H0/.=>T(8.&R/[5LP0>/F
M&#@GHPYYK_6?^&7ASPA#\,?AG+<^'_#$?VGP1X)A$L^D:5&9KFY\/Z:L42NU
MJ!)//(P2*,99W;"@GBLLBR)9TL1;%O"?5G%Z04VW*[ZM)+3L[Z::HYN%>%UQ
M,L5?'O!+!<ME&"G=S<MDY144K7UNG>RUW_R3"23GJ.0.&')ZD@]#^6/?-1[]
M@W')))P,$D8//0'MZ\=OI^XO_!PE^S_:?!#_ (**^,_$NC:;)I_AKX[>$?#'
MQ/L0$\BQ_M^.W3PQXG@TR..PLK*WMH)-$TRYGM[>>[>.XOI)[R6-[R&.OVY_
MX-B?V>]!\/\ [+GQI_:&\7:+8O<_%/XF_P#"+:+=^(]/MO*M?#/PZL8HKB[T
M[[?IT:1Z7K&JZR7>^6^O+:YN=+$<8MFMG2183(:F(SBME?MG06&4INIRW;BG
MI/ENE[]XNU].9+HRL!PK6Q7$%?(OK+PT<'4Q4Y5E'F<H*FK5+-[3<HM)M)<^
MCTT_A]#;CWR=V?E(R!SR3P,].O3U%-D8I@ $9_X%T^@^OM7^@Q_P<@:#H>F_
M\$S_ !3<:=H>CV%R?B[\(H_M%EI=E:SB)_%,68Q-#;QRJK#&]0X##Y6!Z5^:
M'_!K%X*\'>+4_;(E\5>%/#GB5[#4/A-!9R>(-$TW63:K<Z=XFDDCMFOK6811
MR&$-*%P25&XG%=E;AV-+-J65QQ%U5@I\SC:Z:<FVM7NK7_!'?7X2]AG^'R18
M]U/;4HU%C90Y7!\DI<O(F]?=T:>K>MC^1)CD*1[\X(YX]>>N>O/>E8Y7@YQC
M/ZCO[U^M/_!<K2M*T+_@I[^TGI6C:=8:-I=K<^"4M=.TNRM["RMEE\#:'+(+
M6RLDBCB\UR6E98T4DDXSR?R0SM4$\' R.^?3GG\^:\#%X?ZKB\3A[I^SE*%[
M:/DDXW777EOKWZGSV-PCP>-QN%YN=TG.DY6MS.G4G#FMTYW#FMTYNMA20!DU
M$V2"QX Z9]/7_'_"D+9(/''3\#]3_.DSGGUY_.N4YULO1?D'6D8[1GK3"=I(
MQG)SZ=>W?TJ,G))]3FH<K*RWV]!@3DD^IS11G/\ *D) &36U.GRZWNVNVU]=
M/6YTTZ=K2>[V7X@2 ,FH3R2?4FE+MDX/';@4WK6IN%02R8^53SWQ^H_&B63&
M5'7_ /7SZ=>W\JJ\#)/<DD_7_/ K2$;ZOY+N_P"MO,N,>KV_K\!3QG/;K4#$
MDGGC^F>/\F@G)S^7TJ-VQP.O\A_C_GTKI245=[_UH:@S8X!Y_E_@?\^E14A8
M(-Q. .^,]>/?UI&8!=S=&&1_M!NG'OZ?G@5#;EKKO;R_X<!'<(,XR2< 9Q]?
MP'T/./6JC,7() S@ 8^ON3ZTKMO;@ #[J@<<9..^,\_2I%& /U^M6ERVTO)_
MA_7XO0N$>:]W9+=]_)>?Y+4C"L"..X[C_&G. 4;/92?QP:=GKGC&?7IZ]*JR
M/N)'H3SZ@=!CT[\Y/3I6D8N7ZM&ME3N_>2379O7:VRV_K<86R /3'XXIM&<_
MRJ%Y0O"\MG!R#@8Z^F?;'USZ[G0M4GW2?WI Q"98C)+':,X[YSGT'T/./6JQ
M.22>Y)_.G^;)_>Q^ _J*82223G)YY]^GX8Z=L=*(QZ+J)M)79H:9QJFD>^LZ
M+_Z7P#^=?[..F?\ (.L?^O.T_P#2>*O\8G37/]J:2#T_MK1P,=L:A;8_F<]\
MU_L[:9_R#K'_ *\[3_TGBK['A3^%BO\ '!/Y<[_4_0>"XVHXM]Y0_.?W[V+U
M%%%?7GW 4444 %%%% '\DG_!TE_J_P!BG_KY^/'_ *3_  KK^2@[-J9W_P 6
M,8SC<?US^E?UK_\ !TE_J_V)_P#K[^//_I%\+Z_DE;[D?T;_ -"-?A'&'_)2
MYC_W*_\ J+1/XI\8%;CW/7WI93_Z@8=#****^>/RT*L118^9OP'^>H/^?>,#
M.7<X4?KUX'/7_P#6:N=*XYRZ+Y_Y?YGJ8>C_ ,O)KMR)_P#I5O\ TG[[;,**
M**S.P**** "H6;=CC&*0DGK25M&/+ZL HHHJ@"FLVWZFAFV_4U#0 4444 %(
M2!UI6;J3_GV%0_>;TS0 G+'W_D/\/\]:2BB@!.Y^@_F:_JJ_X-;_ /DH_P"V
M7_V)7P3_ /3Y\2:_E6[Y^GZ9_P :_JH_X-;L?\+%_;,Y&?\ A#/@I]1G7?B7
M_P#6KZ?@_P#Y*'*WVGB/_4?$GZ-X71_XS;(GU3Q]_3ZEBDNO3H?<7_!23_@B
M!\0_V[?VH]8^/^@?'GPC\/M*U+PIX3\.1>'-8\&ZKKE]&WA[25L)[F34+/6[
M&)UN98UD5!;EU4 ,V>3^7/QL_P"#<?XJ?!3X0_$SXNW7[3?@37K3X;^"?$?C
M6[T6T^'NNV5QJEOX<TJ;5+FQM[RYU^Z6WDN4M&1;AX)PORC9VKU#_@M9_P %
M$/VS_P!G+]N;7OA9\%OCIXB\ >!+#X?> M6M?#VCV^FBW2^U?1EN]0N9)I;6
M2X9I[@NQ$K;0!@87BOQP\9_\%5_^"@?Q \(>)/ 7C']I?QKK7A?Q=I%]X?\
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MP^+'_)7/BW_V5CXH?^IWKU?WG_\ !NO_ ,HQ_ 7_ &5?XV?^I[J-?P7_ !8
M'Q9^+@)_YJQ\3QZ=?'?B _\ ZJOB;_DGN$?^O'_NG3-.._\ DB_#Q=\*O_59
M0U_X/F?LS_P;H?\ *3#0/^R$_&'_ -"\(U]-_P#!T;_R<_\ LM^O_"AO&7Z?
M$)<?EVKY@_X-S23_ ,%,=!Y_YH3\8<CWW>$/Z5]/_P#!T:0/VG_V6@2!_P 6
M&\9=2!U^(2^M;837@/$VW^N?C[:G=_\ !^=SJP*:\(,:K-O^T9O1-Z_7*#OM
M?Y_B?S6>$/%FH^ O%WA+QQHVH2Z5K'@KQ+H?BO3=3@>6*:PN]!U6VU1+J.>+
M]\JH+8K.MM^]EM3+;]9,'_0^_P""L>@6OQE_X)(_'+6]1L(M:U:/X*^%/BEH
MK1;8%3Q-9+H.LV^HP"<9C")>7CHKX81NRDJW7_/J^"_PK\4_'3XM_#CX0>"=
M$NO$OB/XA^,O#WAJSTJSA^T/+!?:C;IJES<)LF$>GV.EB]O-1NF1TALK:5FB
MD ,3_P!^W_!9CQ]H?P"_X)4_%SPEJ&I0Z=J_B[P#X0^"'A".UOS:7=UK=^=*
ML%&FI%;-)<Q6]GI=U+<*L%K ;,DSS6D9 8X54_[)XBG436&_L_>5TN98?%Z1
MOHY*'LMM=FW=J[\.X5*?#O&-7%1:R]Y39<ZDH\ZP6/<N52M'F]DZ'PJ]W%N3
MND?YW:D$ @Y! P21S[Y'!SZC@]1Q7I?P2@MKSXW?!2RNXHKBRO?C-\*K6_M9
MXXY;6[LKKX@^&X+BUN[:0&*>WGMY)+>XMYP5ECD*X()%>8Y VJH '' & !P>
M,8XQUXQBO4/@4 ?CS\"O0_'#X09^A^(_AD?3\Z^'P4?]HPFB_P!]I:-7NFX=
M^EO7<_-,O47C<NT]UYEA[)I/W7.DM4T]+-7T:[G^AE^WU^SW_P $Z/AY\'H/
MCA^TQ\)/!VE?#3X)^)K7QQ)HOA'PEINEOXU\3B.2UT#PSJ5IHEG97?B&*^OF
M AT&YO(=%OKC;_;"R6L94><_L+?MZ?L/_P#!3ZV^*7P0\)? 6U\.Z=\.?#VA
M7C^ OB%X.\++:ZMX)U2.;1[34M+M-,AGL],?2[Q9],:PBGDNK)#'=02I#*A'
MD/\ P<G:A+9_\$YSI\:KLU;X\?"E9I#(RRHMG?:E>KY2 @2*9$59MWRB,D]3
MQ^0'_!KRO_&6?[1C=0?@1H.#W!/C?&<Y)R1WZ8XK]>Q68/#\1X3*J&%P7L<8
MH+'7A!3<70JM67):RBH>[RI.[O=V:_H;,,W>#XTR[(<)@LL>&S&%)9G? P]J
MXO#XAQ][V=G%0C327+R_%S)MIK]!?BAJ/_!+?_@@W\0YY++X.>*/BC\9_C1)
MXF\:>&+&./2O%6K?#;P&MS#:Z?X4T_5O$U\8O"OA\W<L]I97$=O/K>K1 ->R
M7-O;1M']D_M;?LX_LE?\%2?^"?-[\?\ PEX2T31]6UOX0ZG\6_A+\2;?18-&
M\6^&=9T'0+^]33==.F&W?4K6!;"^T/4-%U0W-B WGQPB1(G'\S/_  <5WDTW
M_!3KQ;:W%Q-+;Z?\%?@V+2WED+6\ N=/UZ:=+=/^6*W$JB2X?H71"?4?TU?\
M$U2K_P#!$+X;HHP/^&7?BGN&<D;M*\:<Y_B//J,CDXK#!8A8G,L\R2>$P,<N
MPT,2\/RPAS*3I^\Y7BVVI2;O>\;147:R?-EF,IXW.>)^%ZN!RN&2X.GBJ>"P
M5.E",Y2PU.,ZDY6C>\IU')2<N:F^7EE:-G_)U_P0<\*>$?B/_P %'_A%HOC?
MPMH7B[0+[P'\2M1E\/\ B72[;5])>XM_#MO<6%S)87\4UM<75A)(\D<I4A9&
M/&1Q]O?\',7PY\ _#;X__LKZ?\/_  3X5\#Z?J7P;^(-UJ.G^%/#VG:%:WUW
M#XXTB*WN+V+2;6W2>2"&22)9I<O$LA 8*2!\?_\ !O+_ ,I+O@>"/N_#+XG^
M_!\*6G/YXZ9_2OO_ /X.FK*]'Q]_9+U;R6&GGX/_ !&TY9]\(5M0/C31;K[,
M4;$KL;9'D^0'&.<'K\_AJ,5P;C](\RQL?>Y8\R2J)64G'F2LNZ5MU;?Y+ 8:
MA_Q#C.ZGLX7CF:L^2'-32KTURJ?*YI)72M-*VKO>[]"_X-EOA)\+/B;X+_:V
MN_B'\.? _CB_TGQG\.[+2KSQ9X8TKQ!<:;87'AJ]GN+:SN-4L[AH(KBY59VC
M3&YTSG&37R/_ ,+M_9?_ &.?^"YG[6GBKXY?"\>(_A-8^.?$'@?PSX-\)^ ?
M#7B6'1_$/B7P_P"!X-'N;'PWJ^H:'I5C8VES))-<7-K*TEJ)6FAMVD; _0?_
M (-8+"^3X8_M?ZK);3+IEQ\1?A]:079!$$MU;>$KJ6:" XW2>5%+$6,1V0%_
M+E_>DX_ +_@J6?\ C;#^U8>X_:6\/@>H/V'P&"0>V0.?4<5U3G/!\-</XF%.
M'UB.+BUS4XNZ_>V4KQNXV6S;3:OT.ZM5_L[@OA#'0HTGBZ>/A.'M*5-\Z?M[
M*:<%SP:=[-N+:3U<5;^^?]LW]HK]GK]GO]ES4/CA^T'X%U3QU\&K"3P7+-X3
MTWPCH?BZ_>7Q!-;1^'&C\,ZYJ6EZ.3I\MQ&TC27R&T*LT/F%%W?P[6&M_L)?
MMK_\%4/$GCWXA>*H/V?OV./$6KP^)K72?$^G1^!=3U&T\/:+I\5KX&AT[PK!
MX@TKP_'KFJV]P^H2C4[>V72VF>VO?M<QB']1'_!<\+_PZ(\6'@$Q_!'!YSD:
MEI&T'MT)Q^M?QY?\$R?V!=8_X*(?M'1?"*W\2-X0\%>&-%B\:?$SQ+;VLM]J
M=CX4BU!+)K#1(&M)M/CUG5KLBSL)-7>&W0[YHQ<^483W<28C%ULRRG 4L+@\
M4ZGLJKC4C:;DUK%R5G[/=M7M:[;1Z7&^*QV*SS(<HP^!P&-^L+#9BX5HI3<J
M<6I0E-6DJ+2YG%-1LI2MNS^J[XQ_\%>O^"5'[ -YX<^#WP*^#WA7XD:9<>&-
M'\3>?^SKX<^'<O@?2M-UV9VAL[_Q&ER5N?%#0VTE_J.DR0R7\,XB76)+.YN%
M)]K_ &EOV<_V,_\ @K5_P3_U']H?X=^#M&\-:UK?P[\0_$3X7_$R/POI?A[X
M@>&/$/A.PU*6;0O%D>E&0WUD\VFSZ9JVCW%W=P/$\-U"5D6-J^%/VCHO^"(O
M_!';Q%HOP\NOV6&^/'Q^/A^R\8V>D:Q'9_$:]TB=;BW72]3\7:WXVU6_T[P)
M?ZP\4VH:0NA^%[R)?(GFAL;&%D<_LS^SG^TOHO[7W_!/#6OC[X8^%;?!KP]X
MU^%GQ=_L?P)_:%CJ4-A8:;H_B*QBNX+S3='T*REAU&2%KD"'38A%(9(B\Q0R
MMZM!O$5,=EV/Q.6U4\%-/+<%A+RP:Y7'G>+Y4E)=%:+3U2T/I,&Y8VMF64YK
MB\EKQ>6SODV78"\\O3@X\[Q_(DIJZM&T9Q=I16CO_%K_ ,&_GA/PI\1O^"DW
MPST+QIX:T+Q7X>O_ (0_&*_O-!\1:5:ZSI$]Q'X6LY;.=[#4H)[:>>VDD)25
MHP\3="IYK^FW_@H]HO\ P3'_ & O&?@?]KWXX? 32O''CK7]+?X3_"WX1^&O
M#?A?_A&Y);?S]=UGQ-)X3EBLM&2[M;6-$G\4ZQ#J;6#+;6VF01WMPK-_-;_P
M;C$C_@IW\(1T ^"OQFQ@_P#4H:=T.!Q].._7@?<O_!U!J1G_ &C?V3]+VR(F
MG?!OXA79=Y-\$S:CXTT$*4@SA)(18E#.PSB4(#@8/@Y;5AE_"V)QD,/3E7IX
MZ:IN4(3;M5IPBWS1DFE%-V;<;MZ7L?)9/B*66\!XW,(82C+$T<TKQI.I3IS?
M,JU*G"3<J<N91IIM1DW"[^'8_?+]E[XT_L*?\%DOV=/&4H^".E7&D>'[^;P!
MXW\$>./"7AZW\2^"-3U73GGT^\\/ZUI4<KVL5WIX%[HFMZ?)87,,ULVZV@,
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MMRWBG$Y5A'EU/"X+%T%.<O\ :VU\;3::U@U'ELERO1]=&>[D/'>.R'*%D]+
M99C\+&<Y_P#"BVKNHX-PE&TH2C%QTYH/1ZZI6_O6T3_@I9_P0N_9(E\3:]\
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M5B5F-K8V-G<74L2J\NV-C# [\'SW)Y R<XX///<X]<]#U_&HU^\PZCW]>_\
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MTY[M2TO9-WM97Z:WL74XBQ5?)L!D<Z<5'"5O:JHKJ?VN6+^S9*71)[7=M_\
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M1^A<':4,7_CA^<O\B]1117U9]F%%%% !1110!_)+_P '2 W)^Q0/6Z^/ _\
M)?X5U_)0O2$^[?J?_K5_6Q_P='@X_8FX_P"7OX\_^DOPLK^2M@%,8' #?TK\
M$XT=N)<P7?ZF_P#RUI)_H?QMXKTHKCS.YOK2RK?^[@L)RV]+.^MW=+H2T445
M\D? !1110 5"S;L<8Q2$D]:2MHQY?5@%%%%4 4UFV_4T,VWZFH: "BBB@ I"
M0.M*S=2?\^PJ'[S>F: $Y8^_\A_A_GK2444 %%%%!M&/+ZL***8[[?YG-=!:
M3;LA';JOYFHZ**(QZ)?UW9O&/1?/_-A3&;' ^O-#-C@=3^E14&<(]7\O\_\
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M -3[[G\Z:W_!%_\ X*@]5_9%\8Y_['3X3CG/_8_\=31_8N:_]"S'?^$>+_\
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M4_\ @J9_T9[XT!SS_P 5O\'R.WI\0/;MZ#'M$?\ @BC_ ,%33G/['GC/'/\
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M_P"A;B__  CQG_R)?^KV>_\ 0FS+_P (,9_\K/RTR_M_X[[_ .!_*DR_J/\
MQWW_ ,#^1K]2C_P1._X*I9/_ !ASXQ_'QK\'\_C_ ,7'IO\ PY,_X*I?]&=^
M,_\ PMO@_P#_ #QZ/[)S;_H7XW_PCQ?_ ,B'^KV>_P#0FS+_ ,(,;_\ ('Y;
M;F]?Y5&TC'C&>?3KU]/H>_:OU+/_  1,_P""J7_1G?C3GT\<?"'^0^(Q'^>E
M(/\ @B7_ ,%4O^C.O&?_ (7'PAS_ .K&]S^9JO[)S/\ Z%V/_P#"3$__ "!:
MX<SS?^Q\S7:V Q?ZQ/RR\SU*CZY_H:C<9;)(Z X],9(]#T_QK]3O^')?_!53
M./\ ACCQEUZGQQ\(< ?^'%'Y]Z0_\$2_^"J>?^3-_&1]_P#A-OA#[_\ 51\]
M_P"?XU'*<SO_ ,B['-[ZX3$_A>/G_FC>'#N<V7-E&8M[ZX'&II_^ 6]&M3\L
M"X'5AQ['_'%1$@DG(ZG^O^!_(U^J9_X(D?\ !5(Y_P",.?&0Z\?\)O\ "+WQ
M_P U$_W?U]!EC?\ !$?_ (*I]5_8W\99SU;QO\(>V<'(^(F?3Z<]<<W_ &9F
M7_0NS#_PDQ/_ ,@4L@SM?\RC,'_W)8__ .5GY7EN,D\ ?@,4#D ^M?J9_P .
M1_\ @JL/^;-_&?\ X77PBY_\R+WQ_P"/'T&6G_@B/_P57_Z,W\9_AXY^$''7
MU^(_N/UI?V9F?_0NQ_\ X28G_P"1-%D.<?\ 0HS'_P (<=_\K/RO8D\>F>A(
MS[]::2 ,DCZ#.?ITQ7ZH_P##D7_@JK_T9MXT_P#"Z^$(]?3XCX].GKQTJ/\
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MI'X+_P#$]!QG\?3F LV3R1R?X1QU_P /Y^E?J_\ \.._^"L!_P";,/&P]O\
MA//@R,?A_P +'^GUQ[\1?\.-O^"K^<_\,8^-_P#POO@UC_U9%4LJS'_H#QO_
M (13_P C=93FG_0KS#_PAJ__ "/YGY3$$]CG'4X]#V[=1^7MRQR0-JDCKV/
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MGA+?/KVN:+ 9GI; 8U?]R/3;NC\CV<,=N"5!XQ[< ]?\_C4;,HXV-T]/K_\
M7].WMC]<&_X(.?\ !7@DD?L3>-N>W_"??!0<9]OB<?UY[TW_ (<-_P#!7@]?
MV)?'!Q_U4+X*#TZ _$_C_/I4?4,5>[P>.?5_['97\O*Y<,MQSWP.-3_[ O\
M-_UT/R9T[']J:1CI_;>D=\G!U"T/Y$C)(_'M7^TSIO\ R#K#_KRM?_2>.O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%!Z'C/MZ^U>*3?$/XG1M,$^".KS+'(51E\8Z /.4' D0&+(!!W!6Y'3
MJ* /:Z*:A9D4LNQBJEDR&VL0"5W#@[3D9'!QFG4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !_G_/Z4444 %%%% !1110 4444
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M^,;C2K:>.VFU)/"^@W^N-I\,\PDCMI;U+%K>.9XWCCDE61U= 10!W5%?%O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;QO'H6FW/BKPQ?KLO_#FN:?J4L'V]_\ A'_$%KI^LQV"W<<%X++[#*!%<S9
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MB\+Z_;:?8M;6&JP%4O;>"&W:X#7-M>1W(M]/D@TO&?P5_P""N+^+O%LF@_\
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MZ[/XH\0^&-&N+5(X;C3?#LMQ#I23PKY<MQ;W$L;RQNCM^KHZ#_/^% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44?I
M_G\:* "BBB@ HHHH **** "BBB@ HHHH **** $SC )Y/K_G'IQQ^?6 LH!
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M/_M9_MG?\%)_VFOV0/%7Q?TNQ\<_"O\ 9@_9"N=$^'W@OX'^"]9B.H^#M/\
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MGWUO<:;>V6_3&@NC$6F6T>0 _I2HK^0JW\,_MO?MV_\ !9K_ (*9?LU>#O\
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M^<!8_P!M#]EAVQ@Y^/?PO3)'4C=XF4=>G&/PK\_/^"FG[<_QA74/V-OV0O\
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M2_'&N? CX6Z)\/=4\6Z)IUWI>D>(+W23.SW]AI]_-<7MI;R"8;8KF5I,*22
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M/@SPSIH86^G:+I, AA\R9LSW>H73^;?:EJ%R\MWJ.H3W5[>RO//([ 'Y<_\
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MBQ+ *N!DY)X0*OS$MCW]:E^M?R?ZEHOQ*_X+O?\ !0_]JCX/ZY\<OB%\,O\
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M]2T+Q%H.JPM#?Z;J5A<*T-Q;O$WRMA)H)U2X@DCGCBD7^?6/_@WBE^%TVO\
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M0?B'XIXR> P! V]20,5_-1>>*?\ @B/>?LE^/KFQ_:J_;-^%VDZ]HWC6<?\
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MK4O$O@68R-JWPJ\>:1K]I/IGB'P1J_GW,1LYD6>U@O\ 4(+9XDO)10!^GH
M P!TXXZ_AQ7\X?\ P7'@V?MF?\$$[_&=G_!2G0+;!Y^]H-M+R/\ @/Z?2OZ.
MTSM7.,X&=N=H.!G&><9SC/..M? G[97[!W@S]LKXE_L8?$KQ5X_\5>"M2_8N
M_:)TO]H;P?9^'+#2+NT\9:YIUB-/7PUXB?4XI9K/2KA0A:YTPQWH&\*REE=
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M_P" _AUX4A30X?&.NQ-&=2\77OF:E%ON%LD@,IEH ^?/@JI/_!S3^VH_9?\
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MG7]7EAO++^QDU"9?V=7=@[A@Y.!G('H,]\>OY<8H _F-_P"#>WPYX=@^/_\
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M$7AB6.3PGXD^*[^&(DU+XEZKH<:&W6VUN=[*\BR+PS"XNTN/Z$%555550JJ
MJJH 55 P%4#      & .!0 M%%% !1110 4444 %%%% !1110 4444 %%%%
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MZS_C7]G5?Q@_\&@4JOI?_!4:#N/VP)9_^ O!K:XSP>3'_/WR ?V?4'H>]%%
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MFM-#\*?V?-%N]1N]2EUO6A?27,-GJ-P4L])T2"\^S6R:;I4%J/&_''_!4_\
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M"@ _J;&.PQGGTY/K[^M+7XA?M6?\%+_VE4_;&U?_ ()__P#!.+]F;P9^T?\
MM#_#OP%HOQ2^/OC;XP_$.[^'/P-^#'AGQ2DS>$]%UG6=#L]2US5_&'B5$CFL
MM+LHHA:1R[9%F:&[-IN?L5?\%/\ XD?%3X^?&/\ 8=_;2_9^L/V7_P!N#X0>
M 1\5]/\ !WAOQHWC[X2_&GX9S1R'_A-OA1XQ>TL=0O+33)WLK77M+U"W^UV4
MMPWSF6UNH80#]H,#T'7/3OZ_7WI<#(.!D=#W&>N/K7\L?[/O_!8K_@K%^WE\
M'];^*?[#7_!.'X.:MI'PO\3>/O!_Q*\5?&WXSZQX6\->.O%W@_6]1BC\(_ ;
M3K"WAUGQ+?V^C6=K#X@U77+BSTNU\1W\6EVQ(5G7]F?^"9O[=^A_\%&OV2?!
MO[2FF>!=7^&&MW.N^+?A[\1_AWK<\=[=>#/B=\/-7E\/^--#M-2B"Q:II4&I
MP^?IE^T<4TMI<1QW$27,<JT ?H'@>@Z8_#T^E&!SP.>OO]?6D'0?0>WZ=J_
M+]H7_@J]^U;X?_X*,_&__@FO^RW^R)X7^./QB\-_!+X4_%GX3>+/$WCK4_!'
MP[TJW\5QW%W\0-7^.GB+['=1Z!X;\.6AT^U\*V'AR&XUSQ7K-Y'IL9A;?)$
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M/QS[9^AQUI(XP.,\Y^]QN. ,9QUZ  '.!@#C%3E$"D'H2,GW_#\:^_PF$PV
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M#X0_:E_X)R?#G5OV!_C7^Q)^R;\$O@SX(\-_'SQ+=R>(-$\5QZK)X$\.W_Q
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M=-=EO\[DQC;5[^NF[ =!]/K1114E!1110 4444 %%%% !1110 4444 %%%%
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M!P2 2.AQT^GI2T4 &!Z=>OO1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y)_\%$?^"L'[+/[%
M5OJGPD\87^N_$3XS^*O#.H*OPO\ AY#;W^J^&]+UK3KJVL-:\=:K/*NE>#;#
M4%:3^S1J#S7]\T<31:>()X;A_P!7KZ:>VM+RYAB\^:WM+J:&!2Q,TT43R1Q
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEO\ @E[X0).?^+]_M.X!)('_ !>SQ:<#.<#))P.Y)ZFF6?K9^TMX"^+GQ/\
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MV.>]?VE5_%Y_P: ;?L?_  5'('_-W&/P\G7^/7KF@#^T.BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML5NKZ2XA_M755^\.<C@GGACN[\\GDYZGD\TIOW&UV_5?EOW < H V@ 8&,
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MOAO?:I%'XM\;67@NP74_%-[HVE(LD[V6B6#FXN;N=8()!%+';R336\T:\_\
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M^ZL%56WWMI;SVB%<-."1G\'_ /@M=#IO[2?_  4'_P""/7_!(?41J=C^S?\
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MX:^*WP%^(*7UKXAT'Q5X?T=;31KU[73]"N=)2:33Y)[M-?6]N99+W1M,N+8
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M'%;6EG:6Z)!;6UO%'!!"BQQ(B *+R[< J!C Q@8&,#&/08 X]A2T679?<O\
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M^QUOI)+P:9]K^Q"Z=[@0><S.>@H **** "BBB@ HHHH **** "BBB@ HHHH
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M/B[H=AIFGKI_C&ZTO9H(MICXETBQLM/\5S1Z;JU]>PVABN(Y+J%_G+_@XJ^
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MG _M/_\ JZ/%-?NIXB&?#^NCUT;5!^=E/7X8_P#!MRH7_@E_X44 #;^T!^U
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M5^RWH/['/_!9']F3X9^!_B1^TA\?_P#@HS^V_P#M9:[^S=\&]"^&7B.Y.O\
MP]_:)\#^#/!'A/Q_XDF:UN8M(ET._BO]6?PM(Q\2+?:59)&D2SO?V8!_HK?"
M_P")?@CXR_#CP)\6/AQXALO%?P_^)GA30?'/@KQ'I[$V>N>%_$^G0:QH>HV^
M[#;+FPNH)@KA9$8LDB)("@] K\_O^"6G[/7CO]E3_@G;^QU^SO\ $\2)\1OA
M7\"/ 7A[QU9_;(K^'2/%/]EQ7NM^'K:]A4QW-GH%]=SZ1;20C88+"%E;:0:_
M0&@ I,#.<#. ,XYP,X'T&3@=LGUI:* "C XX''3V^E%% !2;5R3M&3U.!D\
M<_@ /H .U+10 4F!Z#CIQTSUI:* "OXL/^#/QRT?_!4A23S^U=%)CG )'B0-
MQT!. #WXYR*_M/K^+;_@S^CVV_\ P5(; X_:T6+..?E7Q%WZX&<@>] ']I-%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4456+%"78D1@.6D
MW J!WY)&Q4QN+-D ;B6"@F@"S7Q+^VO^WY^SG^P=X!?QI\;_ !E;6VL7]K=R
M>#?AOHDUM?\ Q"\>7UNI(LO#^A/-$T=DKX^WZ]J#VFCZ7"))KJZ'ELI_+S_@
MHY_P75\#_ GQ!=?LW_L6Z/!^TC^U3J]S+X;CD\.6UQXI\"> -=G5H([9X]$,
M\_C[QE:3M&Z^$]#<V5E*ULWB/4]/M9I!7SQ^Q/\ \$2/B7\<_B$/VQ?^"LWB
MK5_BA\3O%,MMK^G_  *UC44OK6S$ODW6G0?$N[L)EL[2QL0+?[+\*?"HL_#N
MCO$D6LS7=Y%=P3@'R?;>'_\ @I%_P<'>-H=5\237G[+?_!/W2-<"V<,2W<WA
M_P 16UEJ"*9=,L)S8W7QJ\;&T0NNJ7XM?AGX<OWGMX(KZ1;*\D_J)_8X_86_
M9Q_89^','P_^ G@BWTF2[AB;Q=X[U;R=1^(7Q"U)22]_XO\ $\D,=[>GS2?L
MVG0_9](L%_=V=E"VZ1_KC1M%T?P[I>GZ)H&E:;H>BZ3:0:?I6CZ/86NF:7I>
MGVL:Q6UAI^GV44-I96=M&JQP6UM%%!$@"QHJ@"M/ ]!TQ^'I]* $"@8X''H
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M36[-M<2\2'3M+O6?VB#_ (.!/VR?L\+W/_!"C]OX3/&C.8-)C: L0"?*\S1
M^SG(+*&QC(&: /Z)?V>?B?KOQK^!OPI^+OBGX:>*_@SXB^(_@3P[XOUOX4>.
MHXX?&/P_U#6].BO+GPOXECC5$36=(:4VM[M1/GBP8XR"B^SUXM^SS\4/$'QL
M^!7PG^+WBOX:^+/@SXD^)'@/P[XPUKX4>.(XH?&'P^O]<T^*]N?#'B*-%5(]
M8TAIS;W@"1G?'AHHVR@]I_6@ HHHH **** "BBB@ HHHH *_B^_X,_QG3?\
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M2GRRZ%P1^-H_X+K671O^"9'_  5(4]_^,7[\X/<?\AL9YXSQ0!\)?M[^!/\
M@NU_P47^#?A/]GOQU_P3<_9U^"?AJR^.GP6^*^H_$#1_VV/"/CC4M+M_A?X\
MTOQ5<6]MX>?1=(2[^V06DD4C?:F>)6S;P22E5']:8.1GUYK^?;Q?_P '"7P8
M^&.C0>*_C)^Q'_P40^#?@EM:\/Z!>^-_B+^SCJ.@^$])U+Q5K5GX>T*+4M8D
MU5X;5M1U;4+6RM!DO/=7$5O&&DE0'^@@9P,]<#/?G'//&?RH 6BBB@ HHHH
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M/[/GCGQ'H<'PQ7Q_XI\37(N;)+/0+35O$R>#=.A=M$MIKJQDFM[K[+9RX/\
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M M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU?V%_P!G#]O_ .#MQ\$/VEO [^*?#*ZI%XB\-Z[I&H2Z!XX\ >*[+>-/\7^
M?%MDKZCX:\0VF\^7<P">VFB(@U"RO(UB1?C;]CK_ ((C_LB?L?\ QRC_ &FH
MO$OQ_P#VE?V@])T-O"W@;XL?M8?%K5_C3XF^&?AN1-0AGTOX?3:O:VD'A_[7
M;:C>VL^H%+N\BM[NZ@TY].AOKZ.Z_8VC ]/?\?6@ _G7\5?_  9^?-)_P5+;
M Y_:IMSCWW>*6'ZGCTZU_:I7\5__  9\_P"J_P""I![_ /#5EOSW^[XF[T ?
MVH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS]J#QCK?[0?Q!N[Q-4U2TO+W4]/\'7-^%;]WJ4US=R^*?%AMR4DM[S5]0L<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP_"JP3S+Q],5Q+%'%\/=,O%T+3/WT>UG\:ZEJFKV$Q6Z@A<*(S^[WP,_9=^
M_P"SAHBZ+\&_ACX:\$HZ,MYJEE9)<>)=2DDVB1]2\37SW6KWQE9=YMY[XV<;
M,S6T$ (4>_HC G]V<!0%'!XZ[0Q/(]><'&<DU4N,\MR&#I<$9#A<!B(Z+/\
M/?9YGG4K)I5*-.<)X+!\WQ<N'HU)QNDVVKF"X"SCB25#%<>\28W'4YR4H<,9
M#*KEO#^'E\7+B*D94\=F"CK"^*JTX22;2M)(^'?V:?\ @GC^RU^RY#97?@#X
M;Z=J?BZV59'^(7C98?%'C5[J,[DGM]3O8!;Z1(F2L;Z'9:>5C^1I)!EC]T"(
M8W8&[: #QG'7!;N <]#COWI=N>?NY )!'0]_Y>OH.E/ V@ G_/I[U\)C\PS+
M-:_US-L;5QV)YG*]6K5JN[DY>[[2<U"*;;C"FJ<(Z6@K*WZ3E>3Y9DF'^IY5
M@:.!P_+:2HTJ5/G:2C>;IP@ZC:6LJCJ2D[MR=W<"K_= SUX'7&.3W],TZBBL
M#U$DA,#K@9]<4M%% ));)+T5@HHHH&&!Z"BBB@/UW"BBB@ HHHH **** ,?Q
M#_R -<_[ ^I_^D4]?A;_ ,&W#!O^"87AK@#'[0O[4(XX_P":T^*F_/![5^Z7
MB'_D :Y_V!]3_P#2*>OPK_X-MXBG_!,/PX23B3]H?]J*1<GJI^-'BE.,=!E3
MT[@T ?O91110!_/]_P '.0)_X)"_&)1R6^,_[)J@>I/[3/PMP*_?V(8BB!ZB
M- <]>% YK\ O^#G($_\ !(;XP <,?C1^R:%/3#']IGX78.>WUK]^X6RD8](H
MR?7.T?SS^8J)_"_E^: FHHHJELO1?D@"BBBF 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% '\?G_  76_;H\1?\ !/#_ (*W
M_P#!,_\ :/U?QM\;?%WP/\-_"[XD6?Q:_9D^$Q\76%KKVF:W-XQT"U^(>L-$
MUK\/O&4EEJ^K:'-;^$]>OTU:SD\%0WMD((M2$S_3VG_\'8/_  2PN["WN;R'
M]J#2[N929M.G_9X\9W$UHV/NR7%DMQ:2$'C,$T@YSSQ7U+_P5U_X*8M^QCKO
MP(_9\^!?[,2_MD_MR?M.W>M6GP/^"HLK=K+3?#>A,/\ A(/&WB[5#87]Y8>'
M[!WN#:6T$=O%?'3]6N;W4-,TW2[^_B_*;QK_ ,% /^"X_P"Q#I?_  T+^WU_
MP2?_ &9O$'[)6A:C8W7Q3O\ ]GC6O!WB+XB?"[P1=7ENFJ>*;RST;Q3XS%S%
MH%BTLDT^J:7I>B23O'#J&KZ5&7N( #^K?X _&[P3^TG\$_A;\?/AO_;1\ _&
M#P1H'Q"\('Q#I%[H&O?V!XEL8M2TXZKHM^JWFF7P@E'GV5PHDA?"$8->Q5Y#
M\"/BY\-_CS\&?A9\:O@YJ,.K_"KXI^ _#7COX?:A:V1TV*Z\)>)M)M=4T:0:
M8T:/82I:3Q1R:>\<3V<JS6[QAHL#UZ@ HHHH **** "BBB@ HHHH *_BS_X-
M \-)_P %3\<9_:Q0@_\  _$Y'ITQQ7]IE?Q9_P#!G]R/^"I;_P![]K"/G\/$
MQZ_C4S^%^F_;?4#^TRBBBJ6P!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%?._P"TO^U-\#_V1?AIJOQ9^/7CO2_!/A/3
ME:*S2=_M/B#Q)J6PM!HGA7P] &U'Q!K5T1MAL=/@E=5/G3F&!))4 /==2U*R
MT>TN]2U2]M-,TNQMIKW4-2O[J*SL+&T@C:2>[O+NZDCM[6WA1&>2:6011JI=
MR@Z_S#?MR?\ !;_QU\4/'C_L<?\ !*7PGJWQI^-GB>>\T"[^,^A::FJZ'HV!
M);:C)\-K6Z7[!J4VG,C_ &OXB>(3;>#=""O?V@UIH)$A^6_&'Q:_X*"?\%_O
M'VH_#GX%V&L_LR_\$^=%UP6'BWQEJPFAA\8VMG>#S4\0:G9O$?B!XD:)5EM_
MAMX9O'\*:7));2>*]6N>)(_Z1OV(/^"?/[-O[ WP^3PA\$/"2#Q'J5G91>//
MBKX@2"_^('Q!O;=$\R[UK5VC#V>EK.NZP\-Z.++1-/18A';372RW<X!^8W_!
M.G_@A;X,^"6O0_M+?MM:W!^TK^U9K^H#Q;=P^)+NX\6>!O!?B6_,5S/?W<FL
MI+)\1/&]E,J1R^)M6B_LG3[B IX=TQ+>"ROU_HBP,8(!Z9XZX]OY>E  P./7
M&1R >WK]?7O2T )@9!P,C.#CD9ZX/;/>EHHH **** &$\X)(P,G!QW].>?H<
M\TP%B&SU&<<X^F?7@$_S]*D.TYY[8)]NOT_&OYV/^"J_[6G[2OP2_:5\(>"/
MA#\8_$?PZ\*7GPA3Q+=Z3H>C^%M0BO-8?Q1]@:_F?7]#U.Z)%F?)"07,4*'Y
MWC;K7U'!'!F;\?\ $.$X7R#ZG_:..HXFK2CC:WL<.UA*;JU+U4GRMI/39Z:K
M<^,X[XWR;P^X>K\39^\9_9V%Q.'PU1X&A[>JI8R?LJ3]FM6E/1RZ,_HCR",$
MG/4<DY_#IQZY%*'P, CCCD'\N"?48XK^+YO^"AG[;Y0M_P --^.)-O+;/#_P
M]YP,G.WPISGJ<9]B1BO1O@?_ ,%4_CM\)OBCH/C;X^?&#XE_$[X9V>D^+K/4
MO "Z7X#@?7O$-WHZKX319[+P]I$]GY&K9=Y7U)8K>/:\T5PC!#^SYQ]%7Q1R
M7*L=FE2&28F&!IN<\%@<?4Q&)EI>T*4J.'IR;U^*O%=7+37\6RWZ5GAGF6;8
M/*HQS?#3QTN2GC<3AHPPRULG*5#ZPX[:KEO?3EOHOZ]]Y/0MD8R"<@]3P0,
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MB@ HHHH **;N]F/N!P?I2Y/H?T_QI<R?4+BT4F>F>,_YQZ4M, HHHH ****
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M!OB+XB0Z+8ZF^F6^FKJ<R,;;5=6TZ;3%G@2:7,5U)%!*MI,47<#[)HK\8O\
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MJ^O+B3594+Z+IMEH]S/J;7$'C'_"N?\ @["8<_'W_@FHIQT_X0GQ9G\UT;%
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MW%S>F6"RBC>6\B5OF7X;?\%3O^"+'@?5?A-\)_C1_P $V_%'[-'PI\2Q^%_
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M%E3PEJ.G:;?17%L0-6LIT>PU?4+>?+_X.:_AKX"_98^%?['W_!3SX0^$M'\
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MG#/$M167PY!FLT_G_9RWT>_GL? ?[6<?BG3_ -H/Q^(_VS+#X=07L^G7VG^
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MLI1?ZP^BZ3-JD7B+Q;<V%HSW4&@:%=^(/#L=U?3PK;K;WDMR9#'9W+Q?O/\
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M:[=:[;Q*/EMX=3N+][Z%$Y 2.X"JQ8J#U/Z$?L#:GKLWQ?N_B7\0OB_J>C^
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M 0!U+$\<G.36,<K^D-CKJOQMX?96GM]2X1S3'.+V:3Q>/I+1Z*3O>U[:Z/\
MM;P.PBC['@WC[-6GOCN+,JP7,MU)K+\NG:_\NED][J[_ "OU?_@LAHRY71?@
M5XJ#'_5_VYJJ6RMUP"^CV.K#TSS_ %KG4_X*C_M$>+]T/P[_ &9(+^64?N)8
M;KQCK\A<\@?9;;PI81MQU N@,]\=?VTL?"GAG3 J:;X=T33T7[JZ?I=C: ?1
M;:&,#&!CT'; K:%K$B@1KM7@A%48'<8';'MW_.B7 7B_CH\N-\9:F$;ZY3PA
MD^'MOI'ZQ5J-+LVW)*R;;O<?&_A;A9J>"\'Z.(BMEFW&.=UT]+>]##TZ5.3V
M=VDKWLNWX:+^U9_P4^U_]YHO[/4FDQ3C]TUW\(/$\JIGG+7=YXDM(BHXP[0C
M<H!*@DBHM1\3_P#!7SQ= 'L/#L/AL2Y4MIVG^"?#L\>1PXB\2:AJ?E8SNS(&
M & 5.,#]T%23.6.1S@99CCG!ZD#KTXZ_A2./5.AZC&?;J"1QC].E9Q\%.(ZO
M_(V\9/$[-'+5J.)R;*XIZMJ"RS!4W&*O:*DVU%+WFTV7'Q9R7#J3RSP?\-<)
M_*\9@<VS!I;+F_M',Y1D]KM*"D]>5)V/P7M_@)_P5A\9SJOBCXO:AX;M)<!Q
M?>./!J1A2/O;/ VE_;0?4(RGVK>?_@GI^VQK8636OVHTB#8,BP?$+XKADR"6
MQ##!#!WSG>%R", =?W-5 3P!GCD]1[$\_IQ[5((QG)/)Z\#./3/'ZU:^CUPK
MB&ZF:Y_Q]FZENL9QQG]G+J^7!XG#*.M_=2LMK62L/QUXLI14<LR/@+)U!^[]
M1X'R!**_E7UNABFE'HU).6[DVS\)9/\ @D7\3O$K*?&W[4%Y=QMS)%)H6M>+
M?,W9)S-X@\1V>X;B2-\>6!RV.17::!_P1?\ A38NDFO_ !5\2ZM(,&1](\*Z
M#X>DE)!! <W6J8R22.N <<]:_:0(">  ![#C]?7N#[U)L4<GMSVQG\?4^_>O
M0H_1]\+;\M;AJ>8)=<YS7.\QO9+?VV:*]]'JKO6[U.*MXY^*-9WI\21P"2LH
MY1E&1Y=#?M0RF3O_ -O=DEH?EAI__!)/]FZS*&X\2?%F[4!=\3>*=&@A?  (
M=8?#!DV\<+]HP =HZ UZ5I'_  3*_8_TQ5^V_#O4O$3H<K+KOBWQ'(S^[KIF
MHZ9"1WVF,*#T  Q7Z"!6))PN"<@')_'C@]3BHRR=T8G//\*YSUSG\L\?2O;P
MG@MX6X!_[/P+PTN6W\?*XXA==$\1.O=>K>ENNIX^-\6/$S,5)8OCCB:K&2LX
MK-:N$5O)X6.&LDMN1QMTY=CXWG_87_9;3P_K&A:3\)/#FC'5;"[L(=3ADU6Z
MU&PEF@,<-_:7-_J5U+'<VCXE202!BT:\X.#^&'P9_9XU7QK^U)_PS[XB69(/
M"?BC6(O'5Q*[VUQ+X2\+,M[<3I]G21K.X\2V,FG?9)0XACEU:.)I(L*%_47]
MI#X=_P#!0W6_C!XDU3X(_$*XTOX8W,.EC0=(M=:\#:>MB8[18]0$MOKVCW6H
MR//=;WW-=&, Y5=O%?(FF_L@?\%#M)^(VK?%;3->CL/B1XBMC9:UXNMO%G@1
M;N_LC';+);3VS6LED?.2QMD,L>GQ2 VR,)/E3;_*WC3P%E'$W$_!D\M\$>(,
M3@^"N):E?&5LNRG*,-A,[R>G2DY4\/"EB<,JL*F-CAYT8SIW=.FU)17,I?T7
MX0<8YMPQPSQI]>\8^&:.*XTX2='+*>:YUG.,S/(,]=3]S5KPQ.%Q*PLH8.MC
M85ZF&JUIQJQPDX7D[Q^^/$?_  3"_9"\2I-)8^!M:\'7-QN,MYX4\7ZU#,6D
M)9BT6N7&MVP 8[@BP;%P H"@"OGOQI_P1L^$>JQ0MX+^*/C70+R(R&*?Q3I&
M@^-XQ("?+$3*OAUX"& !*2L2<\9XKWS]DKP-^W-X8^(^O:E^TEX]3Q%\/9O!
M,EAI.CS:GX9OKR+QBVNZ;<0:K!_8&DVLL5NNC)J-G()[EX-TZ'RMZ;J_1L9*
MC".3C)#$$].AY."!QCGFOZ R/PO\-.,\EHYQCO#"EPUC*Z5*G@<9E\<HS;"2
MIM13E4RW$4H-*2<H.4I)/WDTW<_$,?XE>)7!V/J9/@/%'&<0X7#P4I9A@<?4
MS;*L4JJ52<::S;+ZU:]VXU>:S<KIN6C/PIA_X)J?M9^"42'X=_M,P&SL\-I\
M,GBCXC>%]K1X")_8FEG4]'A.  J/+);+PIW(!FS:^&_^"LGPMN&%KK=U\0=,
MM"?+>XU;P)XCM9E4@$"Q:WTOQ#-D<J&E$K9^<!]U?N8R';E1M(!! &64=2.2
M, ]\9!&!48# = "!M#,N<#., #/R\<*. .,#I4UOH_<-X>I[?A[B'C[A;&<O
M(L3EW%6:UJ$;M;X?,L7CL-9-:)45%))+1)'2O'#B3&P]EQ!P_P !\1T+QDY9
MIPCDU.LTE_T%8&G@,5&5M93:G.[?=GX87'[<O[>GPJN1/\6?@%;:EH<;;6N[
MWP1XK\$Q$ X<P:Y:S>(K*\;()VI9('SD'#8K\U_B;XO\/>-OB!X@\8>'_"K^
M!;/Q;?7'B.?PY*\EQ!IVLW\IG\1"RN)[:RFGT^ZU!I-33S88;Y)[J\)M8XEA
MW_UY2#Y6E8J$4[GSEE*1J<E 2  W(=6^50"0#S7P[^U?X'^!WQK^%?BOPR?$
MGPRMO&]I:W6L^%M8.JZ#'J&G^)=*5I[:WEN+:<7+VEY(LFGZC:B5/M4$[PN#
M(,U^(>.?T>^)^*.!\=EV9^+6/XBP^55L7G&2X;B[ Y(ZU2='#2;RW!YMA(X/
M$*55P]E>,95>3V=W)WO^L>#7CKPYPKQGA<VP?A?@,HK9G2HY5FV*X3QF=?5J
M>#QF.HTYYCC<FQ/U_"RIX92=:$N:"I7JNC+54S^=#2K35/$&KZ3X?\-Z?<ZM
MX@\2ZI8:)H.DVR,]SJ6N:K<QV>G6L,>0\O\ I,PFOV&R*"SB=Y&C4M(/ZFOV
M<_@E8? #X.^&OAIH]Q;3:E96-S?>)=<@MQC6O&>KJ+G7=>>,A)983?LD&G13
ML)H]'L[&S=V\D,/QR_X)?^%/ $GCWQC\5OB!K'AS3=1\!VEIX<\$V6MZA8VT
MEOK/B""\'B36HOM5S&6O+#3[3^P(=B^6L&I7DJ$2-"R_OI8:II&O6S7.CZI8
MZG9.7@%]I=];W<6\QLKA+FTEFA::'<6*DAXMZ, IVYX/H.^$N7\'<+XOC+'8
MG+L9Q3Q)5K*,'4A]<RK)L-4J4(4'3YG/VF*Q-"=>L^2#=**EK%Z^I],KQ,S#
MBKBZAP=@XX_#\.\*TZ-6K4E2JQI9IG&*HTL1[=<U.$*D,'A,11PM%ISUJ59J
MTHRY/Q[\3_L<?\%@=7U76KC2/^"M7@70M&U#4-3FTW1$_8A\&WQTO2KVZF:R
MTQ]2E^(@GO'L+.5+8WC0PO,T(F>.,OA?IC_@F'^Q%KO_  3X_92TC]G+Q%\5
MA\9]:L?B#\2/'^I>/4\*1^#5U*[^)/BJ]\57T*Z!#J&HQ6:VM_?71 BNF78P
M1455!/R!XU_X(D:'XDUOQ7XI/_!2O_@J_HAUO4O$/B$:'H/[6YT_0-'DU*[N
M]2&E:-9Q^!G:ST;3VN/LFG6+7+R065O#")CM\P7_ /@WW\;_ !&\>?\ !/*W
MNOBC\3O'OQ:\3>&/VC/VD/ $/CCXF>(KWQ9XRU+P_P"!OBCJWAW08-7UO47D
MN+N:#3-/@1F<*B,TGE11(50?W^IQ:O==W;7].^A_%Q^WXZ#&0,#KU_'/.?K2
MT@.0#Z@'UZ^]+5 ?@)_P<UL%_P""1GQ=)Y'_  NK]DP$<'(/[37PM'>OWZ7[
MJXZ8'\J_ /\ X.;%+?\ !(OXNJ.I^-7[)?7_ +.:^%IK]_%&% ] !^0H 6BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBO%/V@OV@OA-^RS\&O''Q]^.GBN#P-\)_AMIUKJ_C+Q7=6M]J$&BZ?>:K
M8:):S2V>F07=_<>9J6IVELJVUO.Q,@8KM!( /SC_ ."DW_!*_P"(G_!0'Q[\
M._&O@[_@H1^UC^QK:^ _"=[X8N?"O[//BG6O#VA^+I[W5+C4O^$@U^#2_%OA
MU+C5K:.Z.G6\L\$[QVT,8#X1<?@=^W[_ ,$'/VX?V:/V3OC?^T5\#O\ @M9^
MWEX[\0_ WX=^)?BKK/@/XD_%GXC^']*\3^$? FDW7B3Q;9Z9XIT3XEWL^CZ^
MOA[3+^;1DGTF]M;[4(X;.>2T%QYX_<W]M7]FG]MC]O<? GXY?\$_/^"G/B#]
MD/X/:[\*M.UM=+\._#33?%EG\2H_%S'Q%X=\<&77%MK_ $UG\.W]A8PV+Q1%
M80TLL:3Y%?F[\2/^""O_  5)_:1\(ZI\(/VGO^"Z?Q=\;?!;Q8;:U\=^#_#W
MP@TG1[GQ+H@E26]T6YN--\1Z TEEJ C:">TO;B[TN>,_\3#3-0A#6C@'[G_\
M$L_B#H7Q6_X)R_L4_$'PWXG\?>,],\4?LY_#+4CXE^*GB!_%7Q+U+4CX:L8=
M8;QQXDFEEDUSQ3#JT=]:ZMJ[2RB\NH7N5D=)5<_?W^?\XKQ7]GCX%?#_ /9B
M^!?PF_9Z^%5E<:;\.O@QX!\-?#SP=;7TPO+]-!\+Z5;:99SZC>X0WVHW4=K]
MHO[PA7N+N:6:1=QKVJ@ HHHH /Z]:/Z]:** "BBB@ P!T &>M(54G)4$^I S
MUS_/GZ\TM% !7\47_!GSDZC_ ,%3V/?]I^Q_/S_&!/\ ,?I7]KM?Q2?\&?0Q
M=_\ !4LXX_X:BM!GOGS?%>!GVSGUYR* /[6Z*** "BBB@ HHHH **3\L#.?7
MVQ7F/Q(^-?P@^#NE3:W\5OB?X"^'6DVRAIK[QEXKT7P] @QG.=3O+=V&.254
MX&#WH \6_;'_ &T/@C^PS\)+SXM_&W6;V&RENVTCPCX2T&"/4O&/C[Q+);RW
M%MX>\+Z2T\ FN'5"U]J%Y-9Z3HUN#>ZI?6EJ Y_G^LO^#G+3F\7(=3_9#UN'
MX>_:099M/^)VF7?Q#@LCS)NT"?0K/PE)?PK@M;KXU^R.0?)OG!!K\H_^"U7[
M5^@?M9?ML:M=?#;XCZ!\2_@C\)_!'A'PE\,-:\)Z@FI^%KJ_\0:1;>)OB!JF
MG7<)>WOM7B\0S/H%]?VF':VT^TL"TL=JI'Y+R-M4 9 &=HZ%<^@(&"<_-T/7
M(JU3?5V[):OI_GMN8SJJ*W27?=MZZ+^OS/\ 3W_9K_:=^#G[7'PET+XU? OQ
M;#XH\$ZV;FUF,T$VGZSX>UK3R(M6\->*-&O%COO#^OZ1<'R]0L+^-7C 2> S
MVL\$\G+?'3]N7]D/]FBWCE^./[17PJ^'UU<1/+9:-J_B[27\0ZEL(4QZ7X?L
MY[G5[^8L"$AM[*21LD@ <C^#[_@FC^SQ^T7^V?\ %CQQ^R]\'OVI?'_[-7P]
MUGPG_P +,^)\O@N\\1);ZX^CWEAX:LFN++P_K'AR>?4;JQN%TN,7VIPV-]8Z
M>8)UE$,:C^BWX*?\&S7[$G@351XC^-GC?XN_M$:RTBS7MEK&JVO@'P=J3)DM
M)J&C^'GN?$4\TK<O.?&:.3N).3FLZLH4?XCLK>GWWV]=O0N#;T^[=W\EI?\
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M &T+@Y(P.BD'(Q[=/7UK\VCX?^+.;)+B+QBQ>#3;;_U/R/+LD<%*_NQGF/\
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MV#/V4_!"Q2:9\)-%U*[0YEO_ !+=:IXDDN,C.Z6WU74)]-)8\-Y-B@!X"@8
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MOM1;QQXV+WMY=WKQ_P!G^&25:[GDN'5G&G*\I#RG<[L6=LNQRQK]BRH.,!<
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M-SCO_P"">&NG.?\ C+[]KYE)YQ_Q>KQ"P(]#SG/J2:_=;5>-)U+VTZ\Z]?\
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M=X4Z=-]X*$']\8Q/1;;5FVUV;NON=T1F)6()'08YYX[#GL#SSGGIBD\F,9.
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M++LON0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M****+):) %%%%*R[+7?1:_@!GZM_R"M3/_4/O/I_Q[2U_%?^Q_XN_;#^"?\
MP20T7]IO]F7]K;]G;]F#X>_ +]K?]N7QS^T!IO[2_@G5O%/@7XL^''^*VN6^
MA>&([OPQ97?BRUO/MD4UKI>D^&6L-9UO5[^SCMK]C$EG/_:?K'_((U3_ +!U
M]_Z32U_-M_P1#_9X^!G[5G_!*/6/A)^T+\-/#7Q8^'4O[9W[3.N7W@_Q;;37
M6DRZ_P"%OCWJVO:!J.+6>VN([C3=1BM;F';,$F02P7,<UM-+$S _(?\ X-]/
MBK_P42\6?&GQ+^SWH_BO]F[]CKPUXC_:-O/^"B/QH^!/Q#\ ^.S^T5\>?@=^
MT1J.C:^\WP7?6; >&8/A4F@V5AH&FW\<\/B/1WO;34+Z2!9FC?SS_@MM^TM_
MP41^ /[67P/^'_Q1\4?LY?MG)^RS^TMJ'_!2SX8V?PP\+>.=/^)7[.'P.^'O
MB#6+'P_H_P"U)I^@:'+I-I\/H-*U_3E&J:=G7K\^%+F]DO[U;JV4?W(W_P"R
MW^SOJ'QV\$?M-77PA\'2?'OX:>!-6^&/@/XFPZ:]IXA\+> ==0Q:CX5TU[1X
M;*/3'@DF@@BDLYIM/M+J]M["2VM[RYBEYVS_ &+OV5-,^*GQW^-]O\#O '_"
MTOVF/!VG?#_X]^-+K36O=1^)O@O2M..EP>'/$<5]//8?V9+IQM[?4H+&TMUU
M>.QTXZF+J73K%X #^6?_ (*.ZS^V1\1/^"$GQ^^-G[67[4'[-W[3>C?'7XW_
M +$_CSX%:U^R[X6UOP[\-O!_@74/CY\,/M>BVUQXEMXM=U)I[\VTDO\ ;4MU
MJ>DW4-_9W\BW,;V\?]G4*!(HU (VQHHSC=A5  )!.3QSR1GN:_FK_P""]WP$
M^#O[,W_!#[Q9\#O@+\/= ^%GPG\$_&/]D^P\+>"?"]O-'H^D0WW[5'PWU&\9
M6N7N[Z::ZU"[GO;V]O[B>\O+F9_/G=Y,G^E@=/\ '.?QSS^?-*R[+[@"BBBF
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M17BWQN^!O@+]H'PM8>#_ (BR>/H=$T[6[;Q%;R?#OXJ_$_X0:TFI6$5S;0"X
M\2_"?QAX-U^]T\17EQ]HT>]U*?1[QQ%<7%E)-:V[Q^QV\*6\$-O&TC1P0QPQ
MF622:4I$@13)-*S22N54;I)&:21LN[LQ)(!-1110 4444 %%%% !1110 444
M4 %%?(_[9?[;O[-G[ WP>U#XY_M/_$:V\!^"(-1M-!T2SBLKS6O%?C/Q5?;C
MI_A3P1X5TF&ZUSQ/K]ZL;3)8Z=:RBWM8[B_OI[:P@GGB^'OV/O\ @N5^QQ^U
MY\=(/V9&TCXU_LW?'O7-+DUSP%\,/VH/AIJ/PIU[XG:(EJUZ;[P+<7MS>:7J
MUP;%)+Z'1GO[;7+NSAN;FTL)H[2Y:, _94   [3DMCGKWY'\Z_R _P!D%G$W
M[4X!P/\ AI;QH".@.9[@%>.#D#!'<5_K_ 8XSD=1GK[_ /Z^^37^7C_P2#_X
M)V?M$?MJZ5^V3XH^#-IX8O-&\'_M8^+-!UXZYXEL]%O$U"YB3487M8[BWN%E
MA-G<-NG'FH)>/*; )ZLMP?U[%4,)#$Y?@)2G%JOF%=X;!4TFI/FJ^QK6W;C:
M%VTUH[,\_,\9_9^!Q6+=#'8E1@_]FP%/VN)J.2<4H1LVT[>]=V47>Z5[>M?!
MW]A;XV?M.>'W^)?@;]G?XJ?&;PCX0\1:IX5L]4\+^);9/#VEZA;F"]U71XO#
MJ1/KEG++<W4DFK3Z:8K34[J5[DQ-<I)(WV+H'[,O[8WPYDMQX9_X)M?%;3/[
M-B$=I<>%? ?B!+^/'25-?/A+4]9D<$;OGU  -DC:.*_I?_X)*_L7?'_]B_PI
M\5/"/Q=NO!]IX7\5:QH.N>#_  QX5UZ^\02Z=K=M8S6?B#6+^ZGLH8;>368(
M-,\Q(YKF66\M[B9FRZ&OV*)9EVA>>F1P5.!R,]R,GUQZ&OI<YXBSS(<US'!<
M.<4QA0A' )YKEF P.,A6EA\+%S="OF&"Q-6$G)RC*=*G#F48OWKV=\&5.!\?
MDN Q?&W@_E&?XMRJRIX'B3..(\"\)RXR3@ZF&X>S'"89N:496G.6D[22::/X
M.[O2?VG$E6Y^(/\ P2O_ &BO&[1<2GQ/<_%A4 _B,4UKX)#1YP2V+@#!''%=
MGH7QY\/_  X6%O$G_!$4126WSS7/BGQ/\>;LECUDGLM8\,:AII)(R2L!SG'
MP#_<I@X&5)X'.23^(R#GUZ5$R9.=I[?P$\<]>>??KUKY+&9_XD8Z-I^)?$T8
MWYE%1R[#+77;+Z&"OH]5+?2Z;/UG"9UX 8?6M]%OPUE/X7.GG?&*E9-;3QF(
MS.I%NS=U+KH?QT>'_P#@K'\(?!CVYD_X)&_"?P[/:+O%S#H4$U];%> \5UJ7
MP>2\9\ ?-YY<$')ZU])Z!_P<0>%M"M8K$?L8>)-$L8@=MIX=U>*WM8 ,8V6[
M^&-.BC''\*@CIMX.?Z@)+.VE7;+:PNOI)#&R_P#CRX Z<?K6=)X<T*YR9M&T
MN7/WC+8VTF[&.#NC;(]001^-?,8BAQCBE:MQYCL0KIVQ&70Q"NG?:KB:D;WZ
M\J>[5FSZ7#<9?1[I-<WT;,OP4K_Q,I\0,_PTK62]UU,L;2MI:^UET/YSK3_@
MXR^&Y57O?V4/C3%CEC::AX>D1!T! O;JR7GV]?7.-2+_ (./?V?DXOOV:/C_
M &N!^\:.Y^'I"X)YV7'BRTZ\\YY]>E?T'S>!?!5P&2Y\(^&IU.01+H.F2JP]
MP]HP/'7C'IFN5U#X%?!352QU3X/_  NU+=RS:AX!\+7;-Z[C/I4F>IZUR?V?
MQ9>\N)L*VNLLHI:KL_WM_EINSUX\<_1QG&U7P(XGH=_[/\5,QI_^I&4U;^5T
MK'\/_P"V]^VS\&/VK?VF=/\ C5X0\'?%#PEX2\0^'/#6D_$.U\1V?A?4_%EK
M<^'(I-(AE\"Z/HFOSZ5J7F:+':RNFJZ_9237RS)Y,5LBR/BZ)XB_8&O-AU']
MH/\ :2\.7$A_>6M]^SAIES/ AZEET_X@W<1*C&2),;AD @U^Y?\ P5#_ &!O
M'?AOX@?"']M7]BKX5^'=4\9?!.YLY/&GP<\(^%=+BC\6:187EQ)%KVC^$M/L
M[>S\1ZE]@U'4- \0:7:1?VI/HGV:^TV"[N[.?9\P^)_^"T?P"U'P?-H.E?\
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M_P""W[/7P%^*]WX0_9XU75(M6^./C7Q'H7B?PO;0:FNI00:=;^(]*NM.CO\
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M\3]3UH =1110 4444 (<<9]>/K2TUNW^\/PIU !1110 4444 %%%% !1110
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M&=!Q[CP8WX8J]_Q%2_\ !$S'_)T/B7Z?\*)^->?I_P B-C]<>]=%_P $^_\
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ME)=_!3X4?;/&[>#YV\4'Q#;E="L;C4UT*=8K--3*(UL[_9A<N1M9?W"\ ?\
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M2ZM;Z3_;\\6G-X:A\5,JVCVJW4J7SEK=D5]Q(8'W*/\ @ZN_X(E9!_X:5\8
MCH?^%!?&O],>":SM;_X.C_\ @AOXETC5M UO]H[Q+J>B:YIE]I.L:;=? +XU
M_9M1TK5[2:PU*RN4;P3&TD-Q93S6UQ&")3'(QC)!)K]#7_X(Q_\ !*67[W[
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MB/\ X+U?\%*? 7Q/_84\&3_LE:+\"OA[J7P6TWQ)\*I;+X/6GBPWOPP769O
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MD5&6(N/V,/&$6XD$'YX_A-G/S$\;6R.N0:_*;]F_]L?_ ()O_#+]M+XP>+_
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M@\FOU9P/0=_U.3^9Y/J:3:O/ Y.3P.3G.3ZG/.?6@!< ]1_GK_, _A7XY?\
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MHHLNR^Y?Y %& >HZ<CV/K1119=E]R_R ****++LON7^0"8&<X&>><<\]>??
MSZXI:**8!6)K^DKK>B:WH3R/#'K6DZEIC7$:*SP+J=I-9R3 $(A:%9O,12X9
MRN">];=?S_?\%7_VV?VK9?VF?V:?^"5G_!/;5[#X?_M1_M1:-J?Q$^(G[1.M
M:':^*=)_9N^ 'AV^N;/7_&&G^'Y%OXK[QA?36%S#IHU?2I--MXGT^)9HKC6X
M-3TD ^E_^"1__!+/3?\ @E)\'OBS\)-'^,^H_&R+XJ?&C7_C#-KFJ>";/P/+
MHDFM6-AIRZ!#86OB7Q(-02V@L4EEU.2\M&FEDD*64,96$?K57\KGQ-^$W_!8
M_P#X)0^/_@I\=?A_^U5\<_\ @K-^SKXL^(GA[P!^TS^S_P",_A%977Q4\)Z'
MXGNH;>3XJ_"V7X?0Z_K\47A]TN;N:P6)]'L,PV&IVEY!J2ZGIG]3-C=+?65G
M>I#<VZ7EK;W207MO):7D"W$23+#=VDRK-:W,8<)/;RJLD,JO&ZAE( !:HP/0
M444 %%%% #&0'V/7\?7'^&* @&<@$G/..QQD?I3Z*S]E&]_>O;ETD_A>Z7EY
M;>0?YW^??U\]PI,#W_,_XTM%7RQ[+[E_D A .,@'!R,C.#ZCT/O2T44P"BBB
M@ HHKX[_ &U/VZ/V:?V ?A#<_&7]ICXBVW@W0+BYDTKPAX;MX7U7QY\2_%8B
M\ZT\$_#GPG:[M6\5^);\%1'I]A"5M86:^U&YL]/BFN8S;R_KR ^COB!X2/CO
MP'XV\$R7[Z9%XS\(>)O"DFI1P+<SZ<OB/1[S1FOH("T*S26B7AN4A9U\]XQ$
M7C#;Z_//_@DI_P $W[+_ ()7_LC6W[*6F?%Z_P#C796?Q.\=_$2'QQJ/@R'P
M3=2+XUFTR1=)FT2W\1>*(HVT[^SP);Q=4S>/,\@M;5<)7Y1?\$>_^"BG[9_[
M<?\ P5:_;LTS]H[P3XV_9Z^&'@W]G7X5>(?@S^RKXP:*WU3X?>'_ !/XO#^'
M_%_C2Q*?:K3XD^,?#S)J?B"&;R$LH=0M].M;46MM!<W/[ ?\%#_^"GW[,W_!
M-_P+I.K_ !CUG4O$_P 4_'YN-.^!_P"SQ\/["7Q'\8?C;XH\U+'3]!\'^&K)
M9[F.S?6)[+3;[Q'J*V^C:?<7EO \\M[/:V5R ?H[M4\X'(Q[8_SWI0H P  !
M[>O7\^_K7\T__!O/^VS^U_\ MMZ]_P %+?&/[8,FH^'/&7@W]IWPEX=\-_!B
M2Y5M%^!&BS^"KRY?X;:*A>62.;2C':Q^()+V:2]N]=AO9KN*SG<VEO\ TLCI
M_G_$_P S]:5EKHM7KIN^[[OUNQ65T[*Z5D[*Z79.UTO):>0W:O3:.<]AWZ_G
MWH*K@C:#QP,>G3WIU%'+&R5E9:I65D^Z5M/E8?\ 7W[B 9 R!T'&.E1M'DC:
M O.>,#YO4\<_7D\5+16#HR=WSZM^?^8# @'4 D]20.M/Z=***?LI+[:?JI-?
MB]P"@ #H /I116R271?<O\@"BBBF F 1@@8],<?E2T44 %?*_P"VM^S3:_ME
M?LG?M"_LK7WC"Z\ V/Q]^%_B;X:7/C6ST6+7[GPU#XDLFLWU:#19K_2H-5>V
M3<_V234[$39"?:(2=]>&_P#!0C_@IK^SW_P3N\)^'3\1F\1>/_C;\4YKG2/@
M!^S5\,M.E\3_ !D^-_BI)+>RM],\*>'+022VVCIJE[IMCJOB2_,&E:7)>PQ,
M\][/;65Q^6/_  ;B?MO_ +5_[=EG_P %%OB+^UIJVK67C'PY^U?9>&-'^$]U
M(3HWP,T^S\-7=I?_  OT&U>-);=-"OM/%EK)N MS=ZS;7MY.EO<3201@'[*?
M\$]_V0K7]@C]C3X#?L@V7CZX^)UI\#?"NI>&8O'5WX<3PK=^)%U'Q7K_ (G%
MV_A^WUC7(M*:/^W&L1;)J]^72V6=K@EV1?M,'.,\$C[IQGW[G\P2/>OYR?VV
M?VK/VSOVP/\ @H4/^"3_ /P3L^,&B?LW0_"KX<Z-\8OVUOVNH=$T/QMXP^&?
MAS7KZ"V\/?#+X:^%=:D.G3>--;BN=.;4);J**>WMM8M[B#4]'CL+RZK@OAM:
M_P#!6S_@F/\ MP_ #X2?%+XR?&#_ (*B?L*_M0:F_@[6OB=?_".*+XK?LK^-
M4FBCM_$GBR\\&0ZI&/ 4[:A!=7^HZM?7EC-IMIJ*6]KH>HV5L-7 /Z<\#T'Y
M"EP!T &.GM2#.!GK@9^OX$C]3]:6ERQM:RMKI96UWTM;7KW *3 ZX&>N<#KZ
MTM%,++LO^&V# &< #)R?<^I]3P**** $(!Z@''3(SBD**3DJ"<@Y(R<@$#\@
M2/QIU%*RVLK:K;H]U\^O?K</Z_&_YI/U5QI16^\ ?3(''TXX_G1M7T'T[?ET
M_2G45'LH62L]'S+5^Z^\>S\U9Z#N]KNW:[#I2  #:,=2<#CJ23P/<\^O?K2T
M5FZ+U:GOO>_XZZB"BH2?O#<XW$G!(!50 "RGJB@\Y8')SM'(S_*3I_Q;_P""
MAG_!:3]MG]JOX<_LW?M0>.OV ?\ @GY^Q;XWN_@G>^/OAOX+TZ_^,G[1?QCT
MF[N;7Q))9:SXKMK5=#\-Z+?:7J,=L^AW7V2VTHZ/=7D>LW7B6,:)T+MY ?LS
M_P %7?V A_P4X_8I^(W[';_$\_!M?'WB'X>:\WCI?"@\:?V<O@/QQHWC(6Z:
M!_;WAG[0=4?2%L6F;58OLIF:;RIMJH_VI\$OAP/@]\&?A'\(QJ[^(?\ A5GP
MQ\!?#D:_)9C3Y-<'@CPII/AG^V'L!<78L7U/^R_MK68NKD6S3F$7$P3S&_FQ
M_8^_:;_;F_87_P""OOAW_@D=^UU^T)<_MO\ PH_:#^#VL?&3]G7X]^*O#>D>
M%/BSX#_X1O1?%>J:EX5\<0Z*K6FMV-PO@C7M/>6:74;O[1=:)K-IJEM;3ZGH
M5G]Q_P#!5S_@L+X0_8>T?5_@/^SWX<NOVDO^"@'B[P;K>N_#SX >"[6;Q _P
M_P!"M-)GU"[^+OQLDTT-!X+^'OAK3XIM=*:S<6%WX@@LI4MGMM+CU#5K%679
M?<O\@/VZHK\*/^#<SX]?&?\ :7_X)8_";XW?'SXB^)OBI\3O'/Q#^,NI:]XN
M\57YO=2G ^(FJPVNGV^X1PV>E:?%&UMING6J16>FVBI:V<,5O&D:_NL#D ^H
M!['J,]1Q^7%,!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BC')Z\_I]** "BBB@#^5W
M_@H:N/\ @YD_X(L2:PS'17^"/Q^B\/";<+0>+X]!^*YNFC# Q?;&TEH57:/-
M^6(9&4KZ+_X.DX=$F_X(L?M/MK$5K)/!K'PCFT W/EAXM;_X6=X:CCDM1("?
MM2Z;)J2*(\2>4\Q!"AJ['_@MI^P]^T+\<5_92_;:_8JTK3_$7[8O_!/OXIW?
MQ1\"_#G4M1MM%A^,WPZU>.PB^(7PVAU6Y58X=:O]/TU8]"A>:WCNH-4UZQ@N
M&U*]TZ-_S:_:P\5_MD_\%_YO@)^Q'%^P3^TO^Q)^S)X:^)G@?XR?MK_%G]J/
MPT_@2:\@\$27D9^$'P@L(9Y9?&AURXOK]8-99898[F/2=2O='L;*QEDO0#^I
M']EN;5[G]FG]GF?Q!YO]N3_!3X7RZJ9=PE-\W@K16N/-WY8NTC,S[B6+9+$G
M)KWJLW1M*LM#T?2M$TV+R=.T?3;'2K"$[<Q66GVL5I:Q':JK^[@B13M55XX4
M#BM*@ HHHH **** "BBB@ HHHH **** "BBB@ K^(']J/PY^U-\8O^#H+XW_
M  !_9I^(MC\$/%'Q-_8D^&GACQ+^T/+IG]M^-O@E\ X-#\.ZS\3M2^#NDWUS
M;:6_Q"\6:U<:5X;TG5[F4+H4MW<:Q;K]NTZ.:#^WZOYZ/^"HW[(7[6OP[_;'
M^ /_  5Q_P""??@31_C+\;?@GX"UOX,?'_\ 9LN=0T_P]JOQY^ ^MWKZG.GA
M37+VUF4^,]%F,:V]NS_:Y8M.T5M(MKZ>UN+&Y /SE_;3^#_[6W_!OA<_";]N
MOX'_ +=G[4/[5/[)][\3_ _PP_:V^ G[8GQ!O/B_J#:'XNOY+2/X@_#_ ,1W
M,-O)HE];%;I1::=INEW5I>QZ:;S5=;TZ[N;.U_L8\.Z[8^*/#^A>)=+:1M,\
M1:-IFNZ<TJ[)6L=6LH-0M&D0%@DAM[B,NH9MK$C)QFOY+?VD[[]O?_@OAXB^
M#W[)6J_L&?&_]@W]A'PQ\1?!/Q5_:Q^)7[5.F6&@^/OB _@F\.IVOPK^%_A*
MTOTGU72]3ODFM'UZUNI8YX;J+4M5BT*+3X;'5OZVM'TFPT'2-+T/2K=;32]&
MTZQTG3;52S+;6&G6T5G9VZERSE8;>&.,%R6(4%B3DT :-%%% !1110 4444
M%%%% !1110 4444 %>2_$+X(?!SXK^(_AUXI^)_PT\%^/]?^$>OWGBSX9ZCX
MP\/:=X@F\">*+RQ&G3>)O#*ZI:W,6F:U]B46T.J0*EU:@;[26*7YZ]:I,#C@
M<'(X'!'0CT(]: /YBOV!=S?\'(7_  6(W$L%_9[_ &=%&[)POVK3R ,]!P2
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M2 ?MI_P2D_8F_:J_:!_;$\8?\%L/^"D?AN+X=_'/XA>!Y?A_^R5^S1;AQ/\
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MB\3:=!JFAZ;IUF%FO=6US5;6=#9:-I-OJ&HW167[/;.L;LOP%^SO_P %_/\
M@DU^U-\8=%^!/PC_ &L=(NOB5XGO!IOA/1?&G@'XH?#"Q\6:FS*EOI?AKQ'\
M1/!WA?0-7U2]F(CT[3;74GOM2<A+"WN-REORY_X*D^(/V3O@K^RQ_P $BOA)
M^U=\!_C5^VQ^U7X:MOAM>_LV?LG?#O6O[(MOB?\ $S1/!'A/3=7E^+NGW6FZ
MG:W_ (5TV[BL].%M/I&HW7VE+Z*&S&GG69!^3/\ P6A^(?[?WQ/TG]@_XB_M
M6?\ !-']G;]@?P?X:_;$^#FF_"O6]#^+7@[XD_'V:8ZWI=TN@6MSX%M-)M]
M\)VMM;07>I:7?:9:7%I?6EBT%I;E"S ']R'@?]MG]FCXE?M+_%7]CSP?\3;.
M^_:/^"VA:9XF^(OPQO-%\2:-JVD>']8-N+'6-/O]8TFRT7Q%9NEY9R2/X>U+
M41;Q74$\S11S0NUKX@_ME_LX_#']H_X0?LC>,OB3!I7[0WQTT35_$OPS^'%O
MH?B35=1U_P .Z&;Y-3UFZU#2M(O=(T#3[>33+Z)+O7M1TZ.:6VDBA::3 /\
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M6A>$]!T6]^'/B#PG_9J>'-0\-:OIME:S07.LRA-,U,Q3%=>75)Q?)<W$RRJ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?RO\ C+_@WR_:WT?]J_\ :S_:@_98_P""OWQ'_9//[6GQ6U[XG^,O!7@C
M]G?3M:%N-4U2^U'2]'O==O/C'ICZP=%-_/;V^H)H^E-<"1R;:,OMKTW]G?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !@=,<>E%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
1%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>ea028514801_img24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img24.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &T!(4# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.RW%X/,,OQ=*-;#8W UH5Z%>,K-2A4I3G"2DFG=3?FD]!:*,CUHK([PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***/\_GTH **** "BC(]1ST]Z* "BBB@ HHHR/6@ HHR/6B@ HHHR/7I
MUH **,@]#FB@ HHHR/7W_#UH **,CU'_ .OI^=)D=,C/IF@+KNOO0M%&1ZT4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4A//<<'GM_\ K[\BEKPC]ISXD>+_ (/_  "^+7Q/\!>$Y?'7C#P-X'UOQ%X=
M\)P1S3OK&I6%N7BB:"W(GG@MU+7EU#"4EDM;::..2-W#C;#X>IB\3AL)1475
MQ6)H8:ESSC3IJI7JPI4W4J3:A"FIU(<\YOEC&\I:19SXK$TL'AL1BZW.Z6&H
MU<145.+G4]G1ISJ3Y(+6<^6$N6*UD[)7;2?NC8('(R#P01G_ "?P]>U.'H3G
M'?\ S_7FOY'OV5_^#@_XD:5XJET/]K?P;I'B/PCJ-Z2OB[X<Z1)H_B'PD';+
MQ7OAN\NI4US38&?"*C6&K6D,)!34I&4'^GOX'?'WX._M$^#+7Q]\&/'_ (?\
M>^&+P1DW6C7:/=Z=.T:R/8:SISE+[2M2@+A;BRO[>WN(GRKQCBOM>,O#/C#@
M.I1_U@RR4,+B*=*KALTP7^VY5B85HJ4%#&THRA3FU)+V59TIMIJ//&R?QG"'
MB/PEQO&I_869PEB:-6O1JY?C?]BS*,L/)QJ2A@JLHU*M.-KNI",HJ+4FET]G
MHHHKX0^["BBB@ HHHH **** "BBB@ HHHH :6&..>,CT(_\ U9KY;_:L_:G\
M%?LE^ M'^('CG0O$VNZ;JWBFV\+6MGX972WO8[RZTW5-1CN9QJ>HZ=;FW\G3
M)H\+.]P;AX (#DL/J0J,<<<8'H!_^K-?-W[3'[,'PY_:I\%:5X"^)LWB6'1M
M*\26_B>T?PSJ=OI=X^H6VGZCIT<=Q/<Z=J"-;?9]3N"8UA63S_(=9P8\'U>'
MGDJSG+GQ+''3R)8^F\TAESC',)9?=^U6';]U5FO@OIO<^9XMCQ-+AK.X\'SR
MVGQ.\NJ+))YM&<LLCF5OW#Q4:?ONAS7]HH^]:UO>/SN_X?<_L\]OAQ\5L=OW
M?@S_ .:FC_A]S^SS_P!$X^*W_?OP9_\ -37:_P##F']DL?\ ,4^*_P#X5>C_
M /S+T?\ #F']DO\ Z"GQ7_\ "KT?_P"9>OWCV_T7_P#H"\2/_!]/_P"3/Y<^
MJ_3;ZYEX2WZVP^(M?K:\+VOM?7:^IQ7_  ^Y_9Y_Z)Q\5O\ OWX,_P#FIH_X
M?<_L\_\ 1./BM_W[\&?_ #4UVO\ PYA_9+_Z"GQ7_P#"KT?_ .9>C_AS#^R7
M_P!!3XK_ /A5Z/\ _,O1[?Z+_P#T!>)'_@^G_P#)A]5^FU_T,?";_P )\1_\
M@<5_P^Y_9Y_Z)Q\5O^_?@S_YJ:/^'W/[//\ T3CXK?\ ?OP9_P#-37:_\.8?
MV2_^@I\5_P#PJ]'_ /F7H_X<P_LE_P#04^*__A5Z/_\ ,O1[?Z+_ /T!>)'_
M (/I_P#R8?5?IM?]#'PF_P#"?$?_ ")Q7_#[G]GG_HG'Q6_[]^#/_FIH_P"'
MW/[//_1./BM_W[\&?_-37:_\.8?V2_\ H*?%?_PJ]'_^9>C_ (<P_LE_]!3X
MK_\ A5Z/_P#,O1[?Z+__ $!>)'_@^G_\F'U7Z;7_ $,?";_PGQ'_ ,B<5_P^
MY_9Y_P"B<?%;_OWX,_\ FIH_X?<_L\_]$X^*W_?OP9_\U-=K_P .8?V2_P#H
M*?%?_P *O1__ )EZ/^',/[)?_04^*_\ X5>C_P#S+T>W^B__ - 7B1_X/I__
M "8?5?IM?]#'PF_\)\1_\B<5_P /N?V>?^B<?%;_ +]^#/\ YJ:/^'W/[//_
M $3CXK?]^_!G_P U-=K_ ,.8?V2_^@I\5_\ PJ]'_P#F7H_X<P_LE_\ 04^*
M_P#X5>C_ /S+T>W^B_\ ] 7B1_X/I_\ R8?5?IM?]#'PF_\ "?$?_(G%?\/N
M?V>?^B<?%;_OWX,_^:FC_A]S^SS_ -$X^*W_ '[\&?\ S4UVO_#F']DO_H*?
M%?\ \*O1_P#YEZ/^',/[)?\ T%/BO_X5>C__ #+T>W^B_P#] 7B1_P"#Z?\
M\F'U7Z;7_0Q\)O\ PGQ'_P B<5_P^Y_9Y_Z)Q\5O^_?@S_YJ:/\ A]S^SS_T
M3CXK?]^_!G_S4UVO_#F']DO_ *"GQ7_\*O1__F7H_P"',/[)?_04^*__ (5>
MC_\ S+T>W^B__P! 7B1_X/I__)A]5^FU_P!#'PF_\)\1_P#(G%?\/N?V>?\
MHG'Q6_[]^#/_ )J:/^'W/[//_1./BM_W[\&?_-37:_\ #F']DO\ Z"GQ7_\
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MO^_?@S_YJ:[7_AS#^R7_ -!3XK_^%7H__P R]'_#F']DO_H*?%?_ ,*O1_\
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MX3?^$^(_^1.*_P"'W/[//_1./BM_W[\&?_-31_P^Y_9Y_P"B<?%;_OWX,_\
MFIKM?^',/[)?_04^*_\ X5>C_P#S+T?\.8?V2_\ H*?%?_PJ]'_^9>CV_P!%
M_P#Z O$C_P 'T_\ Y,/JOTVO^ACX3?\ A/B/_D3BO^'W/[//_1./BM_W[\&?
M_-31_P /N?V>?^B<?%;_ +]^#/\ YJ:[7_AS#^R7_P!!3XK_ /A5Z/\ _,O1
M_P .8?V2_P#H*?%?_P *O1__ )EZ/;_1?_Z O$C_ ,'T_P#Y,/JOTVO^ACX3
M?^$^(_\ D3BO^'W/[//_ $3CXK?]^_!G_P U-'_#[G]GG_HG'Q6_[]^#/_FI
MKM?^',/[)?\ T%/BO_X5>C__ #+T?\.8?V2_^@I\5_\ PJ]'_P#F7H]O]%__
M * O$C_P?3_^3#ZK]-K_ *&/A-_X3XC_ .1.*_X?<_L\_P#1./BM_P!^_!G_
M ,U-'_#[K]G@<M\./BOCVB\&?_-37:_\.8?V2_\ H*?%?_PJ]'_^9>D/_!&'
M]DK'.J?%?'_8V:./U_X1<_RH]O\ 1>^U@?$FW6U>E>W6UYVOZZ!]5^FW]G,O
M"2_3FP^)<;_WE&*E;TUV.+'_  6V_9ZDRD?PV^*_F'J%@\&N2,C+%/\ A*<_
M*.2 K=QCBOS>_:G_ &A/V!OVC3J7B+1OA/\ %/X:?$:1)9)?$_AK2_!$>G:M
M=MB1&\1:%'XICMKAYI%/FZC:"TU'=)YEU+>[8XA^J3?\$:/V2K=9)AJ_Q63R
MP7D=_%^C1JB)\S%G/A<!4 !W,64*O)8#D?E;^U7\,_\ @G)\"9-4\*?#W5OB
M?\6OB);&>UN;+2O'6D?\(OHE]DQF/5-=A\*RQW=[;2%MVEZ=]IG1T"WLEHK"
M0??>'+\'ZO$F%?AW@?%I9U&I2<:F K\M"G0]I#F>:2E/ZJL#R_Q5C7*G**FJ
M<7+EM^5>,$?I 4.#<2O%G,O YY!..*56GFN'<JE6K[&K[&.2P4?K;S)3_B/!
M)3]FTF[GY\?"?XV_$OX$>+%\5_"7QAJ_AO48)ES/:3.MGJ5NKDK;:IIDA?3[
MVWD!VS6UY!=1HQ+POYBQR#^A3]E+_@K_ . O'8TWPC^T1:6OP\\4R"*WA\;6
M3D^#M4NBVPMJ4+N]QX=F/RL[RO<::JG,MW;[UBK\!?@I^SK\6?VC/%7_  CG
MPD\%:KJ^Z=/M=YY30:)HUH[%1/JVN3;=/MHK?C)FD5IY L<8\R5$K^BK]E'_
M ())?"KX2KIOBKXUR6OQ6\>0"&X31GMS'X'T:=#YBA;*94EU^XC)7,NHB.U9
M=\<EA<!8Y3^D?2&K^#'U+$T^*8^VXT6$I_5/[$=%\00J>Q_=?VC6H-X)4%+E
M=58U2INGS+#04S\<^B3A/I*1S2C4X)G'#>'3QE?ZQ_K3'$_ZG5*/UJ7M5D&&
MQ"CFRJ.G[3ZL\,XS3<'B9RIO7[K_ &F?VH? W[+G[/7BS]I/Q)I^M>,O!'A>
M#PS=O9>"_P"RKK5=5M/%.OZ/X=TVXTEM4U#2]-EMS<:S;WKO+?QA[1)9(&D<
MQQ/^0*_\'&_[*@W@?!/]H(8(Y^Q?#GOUP/\ A/2".>H)Z\U^R7[17[-GPZ_:
M?^!GB?\ 9X\?C6](^'_BJ/0(+]?!EY::#JUG;^&]=TSQ#I<.E7,NFW]I9P)>
MZ/:021G3Y$:T\V")(MZRI^5:_P#!O-^PF2Y'B/\ :$.2.#\1M!QQGG_D1?7_
M .OT%?R%P/4\'89=CEX@8?BVMF3Q\WE[R&I".'CEOLJ2HQQ*C**>)]JJSDXK
MEM9;62_TGXVI^+D\RP#X$K\+T\M6"2QRS6G)U98].O[9X7GC*:PS_<\JNI6N
M<%_Q$;_LJ_\ 1%?V@O\ P"^''_S>TO\ Q$;_ +*O_1%?V@?_  "^''_S>UWW
M_$/-^PK_ -#!^T#_ .''T'_YA*/^(>;]A7_H8/V@?_#CZ#_\PE?:>W^C%_T!
M>(__ (.A_P#)GQWL?I*_]!7 G_@JK_\ (' ?\1&_[*O_ $17]H+_ , ?AS_\
MWE'_ !$;_LJ_]$5_:"_\ ?AS_P#-Y7?_ /$/-^PK_P!#!^T#_P"''T'_ .82
MC_B'F_85_P"A@_:!_P##CZ#_ /,)3]O]&+_H"\1__!T/_DP]C])7_H+X$_\
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MX)J__(G ?\1&_P"RK_T17]H+_P  OAQ_\WM+_P 1&_[*O_1%?V@?_ +X<?\
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M\.#_ "\>UWW_ !#S?L*_]#!^T#_X<?0?_F$H_P"(>;]A7_H8/V@?_#CZ#_\
M,)1]8^C%_P! 7B/_ .#H?_)!['Z2G_07P)_X)J__ ")P'_$1O^RK_P!$5_:"
M_P# 'X<__-Y1_P 1&_[*O_1%?V@O_ 'X<_\ S>5W_P#Q#S?L*_\ 0P?M _\
MAQ]!_P#F$H_XAYOV%?\ H8/V@?\ PX^@_P#S"4?6/HQ?] 7B/_X.A_\ )!['
MZ2O_ $%\"?\ @FK_ /(G ?\ $1O^RJ?^:*_M!?\ @%\.!_/Q[2_\1&_[*H_Y
MHK^T#_X!?#@_R\>UWW_$/-^PK_T,'[0/_AQ]!_\ F$H_XAYOV%?^A@_:!_\
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MPM^)/AG5?#$5IXH\!Z[XLNI+/1K_ %VS^WFU&C32Q2I<WMI=SFRDA>.ZBCF
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M5\"^"O%VD>!=,B\1^#;G3M<\?^(=>L#J6D6O@G2FG>?4X[JR/GS7-P;6WM$
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M:$I3IX=\LZE.HOGL!QIXB8#,93PU'%YKE&-XHK1C6Q'#V/6(Q665?[(IPQ.
MP>+G2PV$P2G+'5(X:E.GBDFZ_-*%&K%_V+0*R[BQ 8M@\CIC"@<9R/\ :+$_
MWC4F2.0.O\1SR<X&<9 YP,=2,XYZLB7*+O + _,%[-_%GO@'IDL0."2:?M()
M(R3U!R #W  !QC*CKT!XQG-?RV[J\8.-24+0G*3E=02=FI)7J2T_N[]T?U*K
M.TN5TXRY9QBHV?-**<N:-FJ=F]5S/6ZOW_GZU3_@XG_95TC5=;TB?X,?'V6?
M0]7U329I8+/X=F&>?3-0N-/GDMVD\=QO)#));O)&Q3+(R[E5@0*!_P"#C?\
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MM-.LK73["UMK&PL8(K6SM+.WBM+2UMH4$<-O;6L*K%!#"BK''%&B1H@4(H4
M5_!?BI4\-:G$=67AK2S"GE_-/Z\ZW.LJGB+[Y-3Q-\?##[\RQ$G![T%&ERH_
MO'PMAXC4\A@O$6KEU3'6A]25!0>9QH<JTS2IAE' SK6Y;.A%35K5VZO.W=HH
MHK\R/TT**** "BBB@ HHHH **** "BDR/4?G2T %%%% !1110 4444 %%%%
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M&F>*[)IDFT6\OX,17#-;NDXMI2GV6]6%A(]E/<(@=B$;W6D.>><#:>W0^O\
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M/&2>/LG8 GCL">E _P""L7[$9 (^)FI8)V@_\(EK^"W7 /V3DXYP.<<]*/\
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M*? +<TW!+BC*FYI7NX)8EN:5G=Q4DK.[5G;](*#[<U^;W_#V+]B/_HIFI?\
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M+Z53%Y57NZ&8X>,Z\95,)6C[T:L%*$DI6;LVOT@HK\WC_P %8OV(P%)^)FI
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MEAD7_A6?C; DB<QN!_Q*>BLN-RY#%L@G<,>1/A#BBEBZV"J<.9Y3Q]&%.=?
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M"C@>@_(5^/ _X+N_\$U^WQEU\^W_  KSQ@?QYTRG?\/W/^":[=?C'K_7&/\
MA7?C'[V<8XTSDY.,<_S-'_$/>.WHN#N(I>7]CXS7Y>RN)\><%+1\59 F]D\R
MP\;Z7ZV>VNVVNQ^PN1ZC\Q1D>H_,5^/0_P""[/\ P36;./C%KW'7/P[\9<>Q
M_P")9U]J4?\ !=?_ ()KL,CXQZ[^/P\\9#'U_P")9Z<_2G_Q#KCW?_4GB2U[
M7_L7&VNMU?V-KKKKIUL2N/>"GMQ7P\_3-<,_RN?L)D>H_,49'J/S%?CX?^"Z
M_P#P37'7XQZZ/^Z>>,O_ )6=/?I0/^"ZW_!-@D@?&/7<CD@_#SQD#S['3*/^
M(=<>WM_J5Q'?M_8V-O\ =[*_X ^/N"EH^+.'D^SS7#)]>CL^CZ='V/V#R/4?
MF*-P]?RY_E]17X^_\/U?^";'_18M=_\ #>>,?_E92C_@NG_P3:/3XPZ[_P"&
M\\8__*RA>'7'K=EP5Q*G_=R;&<WRO22]0_U^X*_Z*SAW:_\ R-L-L]GZ/OMY
MG[ [A[_D?\/<?G1N'O\ D?\ #W'YU^/_ /P_3_X)M?\ 18==_P##>^,?_E;1
M_P /T_\ @FU_T6'7?_#>^,?_ )6U7_$./$#_ *(OBSU_L7%__*Q?Z_<%?]%9
MPY_X=L-_F?L!N'O^1_P]Q^=&X>_Y'_#W'YU^/_\ P_2_X)MGI\8M<'U^'OC'
M_P"5HI?^'Z/_  3;'_-8];/T^'OC ?STVC_B''B!_P!$7Q9_X9<7_P#*P_U^
MX*_Z*WAS_P .V'_X;\3]?]P]_P C_A[C\Z,YZ<_7(_I7Y ?\/T?^";?_ $6'
M7/\ PWWB_P#^5M'_  _1_P"";>"?^%PZYQC_ )I]XP[_ /<-_G3_ .(<>('_
M $1?%G_AEQ?_ ,K$^/\ @I*[XMX<2\\VPQ^O_/H/S/\ A1D^@_,_X5^00_X+
MG_\ !-PC/_"XM<Y]?A]XQ'\],I?^'YW_  3<_P"BQ:W_ .&^\8?_ "MIKPW\
M0?\ HB>+?_#+B_\ Y G_ (B%P1_T5_#7_AWPQ^OF3_L_]]?_ %O<?G2%L=<?
MF3_(>X_.OR$_X?G?\$W/^BPZY^'P^\8G^6F4H_X+G_\ !-X9Q\8==]_^+>>,
M??\ ZA?UI_\ $-O$'9<%<67_ .Q)C/\ Y6P_XB%P-UXPX:7_ '6,+_FC]>=X
M]OS/_P 32@D] /S/_P 37Y#?\/T/^";W.?C%KGX_#SQ@/YZ7S3A_P7+_ ."<
M!^[\8M; &1D?#[Q>,]O^@9VY_IR12_XAKXB?]$5Q;Z_V)B__ )2+_B(? ?\
MT6/#7_AXPO\ \F?KQSZ#\S_A02>X'XG\?3\:_(C_ (?E?\$X?^BQZ[_X;_Q=
M[_\ 4+^OY<?PY/\ A^7_ ,$X._QCUK_@7P_\7?I_Q+/\XXXQ1_Q#7Q$_Z(KB
MW_PR8O\ ^4!_Q$3@);\8\-)=_P"V<)_\F?KM^"_G_P#6]OT]J49[;1].?;VQ
MTQ_^JOR)'_!<K_@F^>GQBU@_]T_\7?\ RL]J/^'X_P#P3A/3XP:VW^[\/_%_
M'UQIO?M^E"\-/$5_\T1Q=;_L28O_ .4?J+_B(W '_19\-?\ AXPG_P F?KMS
MZC\C_C1S['\Q_C7Y$_\ #\;_ ()Q?]%>UW_PWWC#_P"5M*/^"XW_  3CYQ\7
M]='_ '3_ ,7CZ==-_P#U=^,T_P#B&?B-_P!$1Q?_ .&/&?\ RD/^(C< ?]%G
MPU_X>,)_\FC]=>?0?F?\*.?0?F?\*_(K_A^/_P $X^_QAUT?7P!XP_\ E;[C
M^O1J4?\ !<;_ ()QGI\8M<_\(#Q?[_\ 4-_SCZY?_$,O$;_HB.+O_#'C/_E(
M?\1%X!_Z+/AG_P /&$_^6'ZZ<^@_,_X4<^@_,_X5^1?_  _%_P""<G_18=='
M_=/_ !A[_P#4,_R1CKG*_P##\3_@G+_T6'7<^G_" >,,]^W]F?YP/Q/^(9>(
MW_1$<7?^&+&?_*1?\1&X _Z+3AC_ ,/.#_\ EI^N?/H/S/\ A1SZ#\S_ (5^
M1P_X+A?\$YF_YK#K@QZ^ /%P[CUTS/''Y>O51_P7"_X)S#C_ (7#K?/KX \6
M^P_Z!GN/R].I_P 0Q\1_^B'XN_\ #%C/_F?]0_XB/X?WM_KKPQ_X>L%_\M/U
MPY]!^9_PHY]!^?\ ]C7Y(#_@N%_P3F(R/C%K0Q_U('BWN,C_ )AA[4H_X+@?
M\$Z#T^,6M'_N0/%O_P K!_G%'_$,?$C_ *(?B_\ \,6,_P#E GXD>'RWXVX7
M7KG6"7_N4_6[GT7\_P#[&CGT'Y__ %J_)+_A^!_P3H_Z+%K(Z_\ ,@^+/ZZ9
MVP?UI#_P7 _X)SYQ_P +AUHG'_0A>+1_[C@/_K52\+_$E_\ -"<82\O["QMO
M_3"%_P 1*\/5_P UOPM_X>L$_P#W*S];N?0?F?\ "CGT'YG_  K\D/\ A]__
M ,$YR<GXP:U^/@+Q;QC/_4.SV/ZT[_A]_P#\$Z/^BP:U_P"$%XN_^5W^<?3+
M_P"(7^)7_1!<8/\ [H6.?_N$/^(E^'O7C?A?R_X6L'_\F?K;SZ#\S_A1SZ#\
MS_A7Y(_\/O\ _@G1_P!%?UO_ ,(/Q;_\KZ>O_!;O_@G0X)_X7!K QQ\W@3Q8
M#^&=/I_\0N\2W_S0/&'_ (8L=_\ *1/Q,\.U_P UOPM\\[P7_P F?K7SZ#\S
M_A2\]_YY_H*_)7_A]O\ \$Z?^BP:M_X0OBS_ .5U'_#[C_@G2.!\8=7'?CP)
MXL^G7^SOP/MU[$'_ !"[Q+_Z('C#_P ,6._^4DOQ.\.DKRXYX52ZO^V\%_\
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MZ4]NJ^S<^WRMU_.MURV7P[+MY&+MY7^7>P_)]3^9JS$!G..2O)[GI5;!]/\
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MBBBOXT/[ "BBB@",@#).<*4(_P" CN>_O7YW?\%4PJ_L,?&8[<_/X&;UR?\
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MI6AVOP7C6#2=>T_4;ZXU+5L6UM 9;JUN(H[2U,;6RO&UM-(P<*!M&:_5,?\
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M1^O^-2KP!P,'L21U/8Y_3@<U_6F/^#6^ZQAOVNGZ]OA["?PYO1ZGZ'&*>O\
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M[8('.!QD@DL1EL8!QZ@$=C4E !11D=,\^E% !1110 449'KUZ49'K0 4444
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M<=W_ &3I=U?_ &61RK!$N/L_E,Y5@JN3M.,55\!>(/\ A+_ _@OQ=]D33_\
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MC2/QMX/T_46D#WD*_9+T!@SF:  "60J3AI4VO@X+9)P1DU]OD&=1S&#IU/\
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MD'(((R"",@@@C!Z$=*_(S0?B'#*RH;C<"0&!D"X4'YF!!R"@&Y<<[EXZXK]
MO@EX\3Q7H;V,\R27NE.+<ON+/+;X)A9B3C<JJ5YZX(& ,5])E>;1QEZ=1WFM
MMM[]M?OVL<&)PKHW:3LNZ=GYIM;'GW[9O_)*?"/)_P"3C?V4>_\ U<C\,/\
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M  P)UU.'3?$\8BOK L/(EO=-U6&6#4M-GEARD-_8S(\&T,Y+! OC_P#P4_\
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M(Q8V-OLCWG)W)A:X9PFDYZ7DGI?9M/IOOI_2.ZE*E42E*'+;7:UGN^B/TC^
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M>E ;@@\M:*HV#(>>1<(/ZIOV=/@OIWPG\'V-@ELD5Y]G@611$D8C*CYE4(
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M=3L-)T:TL+6_62V!MW^V6]O%<[[<+!)Y@,.4*T =?2-T/T/8'MZ'@_0\4M%
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M9XR">_ &3FO1Z#R#1IU5UU7==5\U=?,-5JMUJO5;?B?Q8_M\_P#!,OQ#X?\
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M;N].O78\8_8O_9FT[X-^$M->6P\BX2VA\I9E!G0LH+_O" TC%LN\KY.3L4C
M)^_UQ@8! ' SZ5'%%%"B0QHJ)&H5$50 JC@ #L!T J6OJZ=.%*$:5))4(KW(
M]EI;\CQ).4YN<W>3Z^7H%>6?&_P)J/Q.^$GQ ^'^D7EK8:GXM\-7^BV5[>B4
MVEM/=*H26X$'[[RUP=WE_-Z5ZG7E'QT\+>)O&WP?^(?A+P;<):^*=?\ #&H:
M;H5Q)=O8)#J,ZJ(':\C5WM@"#F558KZ&M0/5!MW<'J3D$=SR#TR.!QV.,=17
M+>,?">G>,=%NM)U")72>-E4D X+*5Y# @X!X!^AKICC>IZA\$#:2>@(8D\KM
MP.#@=, MTFH^5_+OY?/;YA^'FNGG\C^>_P#:Y_X)L:+XXNY[B[\)6>O6:&1[
M*X5)8-1LT!9R+2^MPES;)DY\MWE4]5(!P/R2\2_\$LK.TDN1:OX_TAA(WEVW
M^@7EC&HX 5Y;(7+(..&F+8 &>:_MUGMK>Y79<0QS*>-LD:N"/0[E/'L>*Y>Z
M\"^%KUF^T:/9R%\DL;>(GDYZE2<]OH?IC@Q.5Y;B[SKX6$IORV;TOMTT_P S
MJH8[%4%:EB)QZ==O7\];L_A@;_@F/K\4KB'Q3XACCW?<D\/1R2*H)S\ZR1!B
M!QT(_/A1_P $T/$BGCQ=X@ ]_#D8X&3R1.<?@.IS7]Q+?"KP0Y);1+,^@,$1
M XQW3G\:9_PJCP,.?["L3CTMH?Z(#_GGBN+_ %=RI:O#II=O^&ZG0\TQVO\
MM4_N>I_$)9_\$S]>$R^;XG\2RQEEW^5H4<3E1R0K-)(H8GNRL.GR]*].TO\
MX)BV\XC#77Q(N6(4.'&EP0R=]B;;!Y%&?]M6Q@9S7]F"?"[P0A!&A6@(.?\
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MRT.D7OPGT;P#'8@R_;5U+3O&&O>(9;HY'D&U>VU6&%,'S?.CDR FVO5I 2C
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MGL_)B>SUMYKIYGX?_M>_\$\=$^(4=XY\+Z?XETN0SW*6%Q:+OL'N<AY],FB
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MM/4YZV*KUU&-2M.?*]G=)]+=>A%;016L,=O"H2.) JJHP !]./PSFIZ**[S
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MMHOB3Q C:]K.O6&GZ9J<^GW:ZB+SP]#+9Z9:11VNB2V5M $+PHLCN6[#Q_\
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M_$34M.\'7L6H^$-/LO'&K:M<>(M%LO"]_$EWHEKI%Y9P64X><(9))&;.UO\
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MEEC:X-]/,9R7!)_%W]GKPC\4/ .G?\$Q_&GQ5\,^ M"_9KB^-EZGP1U7P3-
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M$%L?[,46O_"8W'C37]-O576?LPD:?^Q+33F?2OM1CC1EN_LX:8RL >R4444
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M$]LSM>^:1*%:%9OEV$HI.2">@XYK2,4FN=V\OZ];?\,-6NK[=3KFO@I+'C/
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M?@AX<\!Z_J(U.V\+^.M%TG0[S3_$UDDD-QJL.E^,-$:^BNI?,\B^ET^YOEU
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M%2J30W(4W"H 0S0R#'W1\W(Y"[>XKZPTO4[36+*UU"S<2P7,?F1D8RF1AE<
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MKNOO7^8!129'J/S%+D'H<T77=?>O\P"BBC('4XHNNZ^]?Y@%>/?'3_DGE_\
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MC68<8Y6WBS[<! ??V^F:XGEV$?\ RX@_N_R_R.Z.88I*RFU;9;]#\&OV4_\
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MY;*.EEJUVLQU%(&4XPRG(!!!!!!Z$$$@@]01D$<@TM;;[:^FH@HHHH ****
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M Q*K@'YL#!R=N!-40;+'!W L 1\O!^7N<$ 9SM +<[LC(!EH **** "BBB@
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M]_AUOV"BDR/4?G2T[KNOO0!5:]_X\[O_ *]I_P#T4]6:JWA!L[O!!_T:?O\
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MX7YJ/A"92/!<'P>T7Q1"[6GR?\)5=^-M?TBY U(+Y;.NC6=D&M%<NB%)2N)
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M\@YH_P T?O7^8M%)D>_Y'_"C(]_R/^%'++^67W/_ "#FC_-'[U_F+129'O\
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M8]:SGU/3HT,K7UH(U95+_:H"JLS;5#,'P"6RH!P<@CM5B=ML,F3C]W)MYQ_
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M+2 !F+%_6*&GN/7:S;O;=+?:VI2J0NGRW2:;V\OT.;/B>P!(^T0$@$X%S%G
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M8?L^:0VD_#W1XGC"%K:/;M)(*I&BJ>?8<$]:]UK'T/2HM%TVSTV!=L5K D0
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M9?\ ] E#_P %K_,\0_X9_P# G_/37_\ P9Q__(7U_P G@_X9_P# G_/37_\
MP9Q__(7U_P GCV^BC^U\T_Z#L5_X/G_\B']F9?\ ] E#_P %K_,\0_X9_P#
MG_/37_\ P9Q__(7U_P G@_X9_P# G_/37_\ P9Q__(7U_P GCV^BG_;&:?\
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MS,O_ .@2A_X+7^9XA_PS_P"!/^>FO_\ @SC]_P#IR^GZ^G)_PS_X$_YZ:_\
M^#./W_Z<OI^OIS[?11_:^9_]!V*_\'S_ /D _LS+_P#H$H?^"U_F>(?\,_\
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M&<U)48)#<X&X@+G.3C<3ZC[N",'UR<U)0 4444 %(QP">F :6D89!''0]>E
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M^0\KM(L<318<O_.[^TU_P2:^*_Q%_:E^/OQVT?Q'HBZ#\4OB)8^.]&T*_O\
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M_:@.=%\'XY_XGUUT]]-EQ_+M[>M?,<7Z\-9KUOA8I>;]I3T6NKTVU/KN ?\
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M\?\ V:M"L^YYW$>A/X?-_C6&(^!>K_)B>S]#\ ?V\Y-O[6$P!&/^$<\"@\C
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M1+GH1ST^N?I1]DB/_+-1_G\:M8R7=_\ DWZ2_0?UF7=_^ K_ #/*O^$;M_\
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M6#=W=F 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX\*_%[X6'_C.P8Y#?%#6L_4:==$?IS[XQ7[2:V1D'(QN)SVQN4U^,GPL4?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC.3CJI*)\F_%[_@FW\!_C]X[\'>/_B_IZ>(=<\/6&DP:G%86<.FV'B*YTQ4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*G:V-B?-@]L=P-H'7W_ UZI9$[!Z8 'OG)Q^9%?'FF?M8_LGZ>JH/VA/A_,
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MX;+\!9/(_P"*7^)_/?C_ (H7TY^E/_5CB5)-\.Y[9[/^Q\RL_1_4K/[QK/\
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M\/O?^"5F,_\ #8O@3'_8L?$W_P"8?]:/]5>*$F_]6\_LMW_8N:66O+J_J/\
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M>TJ5JSQ6&PM2K@\VHX3!JICL+"C6UHF\ 5!Y,/#$\Q)@$\' VYXQC^E?H?\
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M)X:$XT*K3GS248Q;/YZR-HR>_P O(Z$XQ^?8],X SD4X,N/FSN(&#@C()XY
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MWZ7,)I<ST73HNWH&%]!^0_SWI:3N/H?Z?X4M7W,:B6FBZ]%_D%6(/X_^ _\
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MZ4;6..*W9(X46)$C^=D1"(RG"2_\$3/VAU0)!X^^&J>:P$@^V:\RA3ZJ=%
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M9)XP\0,+S4PUO !'%>6=F8K:X(7(%X^?G8FOFW]F_P#X*#_&W]F_P?HWPO\
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M\O-4%R(XH8R)22N2>N[  YQR<X[=:_:(_P#!$W]H4,-OCCX:X_V;[7U[>O\
M8V1^)/4X]*5O^")G[0CKM/COX;IP<,+[7F(/4<'1/7'/7 Q[5^B1\??!^FTJ
M7%N C2?LI1C.&85(TW1P\<-#GI+"I22C!-P37,NI^0U/HI_2%Q'OU>!,RGB(
M>WC.<)9=1J5HXC'U,PJ>RQ,JLI4INI6FH5))NG=Q7NNSYC_@C$DR?M2ZB)-J
MJ?AKXD*+P6*C5=!+'@DX.Y<-PIS@$GI^5O\ P=(Y/_!0[X;=/^34/ X4L2 '
M/Q,^+!0G;\RX.3N )';D5_2O^P)_P3E^+G[*OQJO/B)XS\3>#=8T:Z\)ZOH
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M$=.E@<1B\%;ZI4KX.E%JM&,H1DX3J\DFDFMC[[#8CC7!9?1R_#Y+C%.E"O\
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MQV\&EV&O7,:"VFO=7\J[N]2AAA:WM&O?LD;W"VYN)_Z9_ '_  <%?L&Z/)\
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M\"^*OB)I'C=;37]3L_%%_>V'B2&&WO[4Z?::7>VXE2V_XF6V1G3[ D_X+D_
M_P +_M%_L$_%GP3X#^*&O>"/@/\ LM:G^SE\?=!\0Z+HFB:KJ!US3_!=L^L^
M E@U_5K?7(M&N_#5U=1)J,^A-J,<D5LZP>:[P_G1_P .+?\ @JX !_PR1K'
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MM*EM%=07EE*7CD_,M/\ @AG_ ,%50#G]DK6<_P .?B?\%AVQ_P!%%./KGI^
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MK]3/^'(__!4?_HU/5Q]?B7\'/Z?$$U*/^")7_!48 #_AE/5^ /\ FI7P<_\
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M49!;2S6]J!$OYW?\.6_^"G&T*/V6]6&#_P!%&^$'KP<#Q_T'Y^U/_P"'+?\
MP4X 9/\ AE[5P"OWE^(WP@SC@L%;_A/B%8@8 (S_ +0XS]7Q#1\'N)<SGFN,
MXTR;#3JX?!83,*&5\94\MPF>4<MK/%8..;86C4<L5&E.T86J4&I<L93<+Q/F
MLFEXH\/Y7++L%PEF]>C"5:K@9X_A^>/Q65X_-*%:AB99=5Q.'DZ%)TE[.I4G
M"48<ZFU&=I'[B?\ !&'Q/\6?V?/V%OCY\:_VB/#.GZ-\!K2]U7]HOX+>(M;O
M=%%CJ=YJECJ%QKC>'](M+JZN=%L-4\2)'#IL]U!IMT+F_P#L]G#Y&)*_+?\
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M[J__ (<7X1'_ -WT5Z\/$GP]3C?C?A567_0]R_M_U^/._P!1N-/^B2XDW?\
MS)LP_P#E!^8J \GUZ?K4E?IVO_!&3_@ID !_PR[JW_AQ?A%Z_P#8^&E_X<R_
M\%,O^C7=6_\ #B_"/_YO*V_XB5X>?]%QPI_X?LN_^7&<N!.-FV_]4>(__#-C
M_P#Y0?F _5?K_A3Z_3IO^",?_!3)L?\ &+NK<?\ 51?A%[?]3Z*=_P .9?\
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M "7G".S_ .9_EW9_]/A_\0_XZ_Z([B;_ ,,N/_\ E)^:-%?IM_PYM_X*5_\
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M;_\ +C*7ASQ^W=<%<4[+_F1YA_\ *3\R:LGM[#^IK]+?^'-__!2?_HV75/\
MPX7PG_\ FYJ;_ASC_P %)?\ HV;5/_#@_"C_ .;FM(^*7AJD[\?<'[K_ )J'
M+>W_ %^%_P 0YX_Y7_QA7%.Z?_(CS#T_Y\GYET5^F9_X(Y?\%)NW[,VJ?C\0
MOA0/_=X-*/\ @CC_ ,%)>_[,^IC_ +J#\*3_ .[Q6D?%3PS3N_$#@Y:/_FH<
MM_\ EQRU/#CQ!=[<$\5/5?\ ,BS'_P"4'YETY/O#\?Y&OTS_ .'./_!27_HV
MC4__  X/PI_^;BG+_P $<?\ @I)N'_&-&I]_^:@_"GT/_4\5K_Q%7PR_Z.!P
M=_XD.6__ "XQ_P"(;>(7_1$<5?\ ABS'_P"4'YH45^FG_#G+_@I'_P!&TZE_
MX<+X4_\ S<4?\.<O^"D?_1M.I?\ APOA3_\ -Q6E'Q6\,E5@WX@\'))ZM\0Y
M:DM'_P!/A2\-?$-Q:7 _%=[K_F0YCTE%_P#/GR/S/A_X^HO:XC/X"2(FO]0/
MPE_R*WAS_L!:1_Z;K:OX+X_^".?_  4B6X1S^S3J6T2!B?\ A8/PJX 9/^IW
MZX!./;GMG^]CP[:SV6@:)9W2&*YM=)TVVGC)5C'-!9012H64E24D1ERI*G&5
M)!!/\5?2XXIX9XFQ' LN',_R?/5@\/G<<6\IS##8]8:5:K@G25=X><_9.HH2
M<%.W,HRML?UM]%+AGB/AREQJN(,BS;)7B\7ETL*LTP&(P3Q$*<<0IRH^WA'V
MBCS+F<;VNKVN;-%%%?QL?U\%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>ea028514801_img25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img25.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #< G # 2(  A$! Q$!_\0
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MMT3(F<_(V/2J/L*LGSRSAO*\K!P5SN_PJBGGX8-Y6?X=N?UK>)E(E]AUI.G
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M %'_  MU?^@.?^_U']GXG^3\O\P^O8?^8],HKS/_ (6ZO_0'/_?ZC_A;J_\
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M]ZL:(<V#?]=&K2(!&".*YJ>L$:0M97/,M1L+O4-0CU!]0@@NA,LC 12E(L
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M@\+^(%6US?B)DD9Y-MR[<D@AAGL!QBE[.'\P>TG_ "G;B2,R-$'4R* 64'D
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M6;(<9(7J0N<D"H8].O)8WD2VDV)]YF& .">_L#6A:^)9[.UL+>)%5+<MYI
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M4E!1110 5#:F,VR&($1\X!^M35%;.)+9&"! <_*.W- $M%%% !1110 4444
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M6"BBBD,**** "H[=I'@1I5VN<Y&.G-25';B18$$QS(,[C^- $E%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !2-]T_2EI&^Z?I0!#HYS9'_?-7ZS=#.;!C_P!-&K2KGI_ BX[!
M7->+/$\WAUK-8;1+@SK*YW,XP$4-@!58DG/TKI:S]3T6QU<PF\B9S#NV%792
M PPPX/0BK*.;O_&=_IYGN)-/M&L8K>&Y+I<,SF.1POW0F"1G/!YJ>W\7WEZ+
M5K'2A<?:1YJ1B;#K#Y@0NV1@$9)*YR.GK6Z^B::Z[3:1[?+CC ' "HP9!^!
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M.N:LP<2J!T%+H,MMR0OKU^E.X'6FKSEO7^5#<D+^)K,L=1110 4444 %%%%
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D' HY@Y60\(O^>:10>K=?Y5+&BLH<]32%%:38>F,T<R#E9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>ea028514801_img26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img26.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #: G # 2(  A$! Q$!_\0
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MH4N)VOK"6TMH)KJ(Y4L\OE.BC9CC)+@8/?%6I_BAHMM"LEQ:ZA"?M)M94DA
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MY]OY0;SLCY?F_AQ3LC;GEW)1IUDK!A:P@JY<'8.&/4T@TRQ4*!:0@*I4?(.
M>HKC_$^IZU87>J1PWH2(BS,+%?+2%6>0/E\'&0H^;!QD<5:'B74(=,T3>(DG
MO+8N\EU$XWR#: @"]&.XGZ#IZ%D/GEW.F.EV!4J;2'!01D;!]T=!5I5"J%4
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MW7%:.FZ='I\&T$-(W+N>]-7J-:61+ES;%TGU/Y55G_UIP,?6K6?]H?A52?\
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M;;0HV#"CMQTISDK&Q R0.![TD6[R8RXPY4%A[]Z0%V X@S[FG@8'/7O4<'*
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M7IGWJ)XJE!7O<J%"I)VL=3\-]*ETOP? )E*RW#&8@]@>GZ5UM(JA5"J  !@
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MH?>.@QU%4KOP? ]M*EK=3JY79&)&RD2EPY P,]137LKZB;K6T+Q\2Z.!&YO
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M1YB^_P"56L#THP/2B\@Y2KYB^_Y4>8OO^56L#THP/2B\@Y2KYB^_Y4>8/?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW<&K-5+\_NU^M)B>P^JEQ_K35NJEQ_K371'<R9%1115D!1110 4444 %%%%
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MHAZLT[O6M,L9EANKZ"&1EWA7< D=C5>]\3Z/8B427L3RQ EH8V!?@X( ]?\
M U7O_#:W$DL\,[YDMUAD@<CRYMH8)N.,@?.<XJA:> X+?38[1K^YVO"B704C
M]^ZY.\DC.<D_7B@1LKXCTJ1U6"[CGS.L#F)@PC=LA=WL2,9]:U:Y*S\#6NFK
M'%9S.(?M$4C[\9"1L750>^6/)/:NMH *SM6.%M_^N@K1K+UIL"U'K**SJ?"3
M+8N54N/]::MU4G_UIKJCN9LBHHQ1BM" HHQ1B@ HHP:,4 %%&*,4 %%&*,4
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M=NN/K6MIFGQ6%OL0[G;EW/>FKU&M+(ERYMB<6L2PM$ ^QNN9&)_/.:JW%K&
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@+A8B YR>O\J:?GX'W>Y]:FE VC@=13]J^@_*BX6/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>ea028514801_img27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img27.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #7 G # 2(  A$! Q$!_\0
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M'6C%D@OY8VWF12NTLH,/E#GZ<YKFSX?UNYT74XK/2CI_VEOGM6D #1JIV*K
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M4/8:W+(&,DG)--<G.!U_E3V..!U/2F8P/?N:S+):*** "BBB@ HHHH ****
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M_<;Z51JXDR*>K6;ZAH]Y9QL%>>(HI;H":R#X2MQ<6;C=+L;?<&9RQD(3:OX
M]JV=16X?3;E;0D7!0A"#@Y]O>N>NK:=@QM8[^.RRI"2%V)?#9R-V['W>AZBM
M8SE%63,I4XR=V0Q^#IRT1N9(I"C1;N3RJAMP_'(_*F'PEJAFM&^TP8@A$6[<
M=V-I!'N.1766/F_8+?SD9)?+&Y6;<0?<]ZL5I]8F9^P@<A#X>>WUC3+:%'2T
MBA5[P@'9(Z'*X/<DDYJ[/HM[_P )+-J40B>*4Q\&=T*[1@\#@_C7145+K292
MHQ1QH\'W4<2B.2%OE4RQLS;9F$A;#>V#BJUMX4U&._BA(A5841OM +?(?-9B
M$]\''/K7=T57UB9/U>!R$?A2_29G-S$/WBL64MF;$F_<^>X'%,/@V<6P16@9
MML98,3AW60MD_@<5V5%'MYA["!7LH6@@*-%%$2[-MB)(Y.<\]ZL445@]6;)6
M"D7G)]:&Z8'4\4O2@8C=,#J:6D'+$^G%!.!F@ ZMGL.*4G )I ,#%!Y8#MU-
M $<>SSY<9\S"E_3OC^M68>90OJ#^55U=3<2KMP5"DMZYS5BUYEW>HI/8?4MF
MH^I+?@*<YXP.II",# Z5F624444 %>4_&+_CXTK_ '7_ *5ZM7E'QDXGTD]M
MK_TKLP7\>)S8K^$SS&C-,S1FOI+GB6'T4S-&:+A8?2<4W-&:+A8]"\)>'=%U
M;0[![M$%\]U*1N)Q-&@&Y#SUP<CZ&H+;PQHLBP>5XA6%IF GC:X10$ZLOZ8&
M:X=9Y4V[)'7:25PQ&">N*CZ]17(Z-1R;YWJ;^TC9+E/6G\(:+G6Q]BCPK8MV
M64L(E\G=R0<+SW/7I7.^.M"T[2+33WT^W2)&)C+_ #;I<*IW<G!'/45QGVF?
M#CSI<2##C>?F'OZTCS2R!1)([A!A0S$[1Z#TJ:="I&:DYW7_  "IU(2BTHV"
MBF9HS7;<YK#^*.*9FC-%PL/S13,T9HN%CUWX/?\ (/U/_KJO\J]+KS/X._\
M(.U,_P#39?Y5Z97S.,_CR/<PW\)!1117*= 4444 %%%% !1110 4444 16[.
M\6YUVMN88QCC)Q4M10"41?OOO[F_+)Q^F*EH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** &O]QOI5&KS_<;Z51JXDR"BH[B>*UMY
M+B=PD4:EG8]A44%_:W,TL4,ZN\0!?'1<C(R>F?:KL[7(NMBS11D>HJDNKV#Z
M@;!;E#= D&/!Z@9(STS[4)-[ VEN7:*3(QG<,>N:7(SC(X]Z0PHJ.>XBMK=Y
MYI%2)%+,Q/  IRR(Z!U8%2 P.>QZ46"XZB@$'H0?QJC#K%A<7C6D5QNG5BC*
M$; (ZC.,4TF]A-I;EZBF22QQ1/*[JL: LS9Z #)HAFCGB26)PR.H92.X/>E8
M=QW5_H*"< FHC<11O&C. TS$(/7 S_*B6XACEAC>5 TK$("?O$=A185T2@8&
M*.K>PI<\9SQ2+TSW/- Q>E(O3/<\T-S@>M+0!%N=II$(P@"[3Z]<_P!*M6_^
MM_"JJ!S-*S'Y"%"?KFK,)_>8'4C I/8:W+(Y8M^ IKG"\=3P*?C QVIAY8GL
M.*S+):*** "N"^*NBRZEX?BO($+R6;EB!U*'K7>TUT61"C@%6&"#WK2G4=.:
MFNA$X*<7%GRKNHW5[#XB^$]O>W#W.DS"V9CDQ,,KGV]*Y=OA-KX8@26Y'KDU
M[D<;1DKMV/*EAJB>USAMU&ZNX_X5/X@_OV_YFC_A4_B#^_;_ )FK^MT?YB?8
M5.QP^ZC=7<?\*G\0?W[?\S1_PJ?Q!_?M_P S1]:H_P P>PJ=CA]U&ZNX_P"%
M3^(/[]O^9H_X5/X@_OV_YFCZU1_F#V%3L</NHW5W'_"I_$']^W_,T?\ "I_$
M']^W_,T?6J/\P>PJ=CA]U&ZNX_X5/X@_OV_YFC_A4_B#^_;_ )FCZU1_F#V%
M3L</NHW5W'_"I_$']^W_ #-'_"I_$']^W_,T?6Z/\P>PJ=CA]U&:[I?A-KY;
M!DMP/7)KK?#/PLM=,N$N]3E%U,ARL>/D!_K43QM&*NG<J.&J-[6-3X:Z)+H_
MA=6N%*3W3^<RGJ!V'Y5V-(    , =!2UX4YN<G)]3UH148J*"BBBH*"BBB@
MHHHH **** "BBB@"*W0I#M9]YW,<Y]SQ4M0VJHD&(WWKN8Y]\G/ZU-0 4444
M %%%)0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U_N-]*HU>?
M[C?2J-7$F13U:T?4-'O+.-@KSQ,BL>@)KF)_!]ZMB;"TN4-F)5F5)&.2VW#
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M^]=ANV@9R,#U]*Z"^T?3M2</>6<4S@!0S#D#.<9JO_PB^A[64:9;@,JK@+C
M7ICTZ#D4 85G\0K>9Y?-L+E5>?R;0A1F8XC.T@GY6S(!SQQUJ36/&CVNGV,]
MC9LSW+3;Q,I/E"'/F9VGU'7V[UH7^D^'-)LKF^N-.@2(JJR%(BQ.2JC '?(4
M<<\#TK*_M[P=>6D5B(?.CAD"16ZVSD[CNS@8R>5<'Z'- $,/C>_NYX8;>VLP
MU[N:U=W;:B*T@._W/E\8]?:M*;QI#!::=,VG7<SWEM%<;8 IV>8RJH))'\3
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M*HU:FN((\(\R*S#*J6P3]*I>=%YOE>8OF?W,\_E75$SD/HJ-9X79E25&*_>
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M,4SJ2W;H*S+):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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/C@#J::Q"@ #V HHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>ea028514801_img28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img28.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #L G # 2(  A$! Q$!_\0
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M J=06.]A]!Z5E+<<=A54C);[QZ^WM2@DOM'0?>/]*1F(P%^\>G^-.10HP/\
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M -E3^9K*6XX["J#RS?>/Z#TI<DOM'89/^%#-M7/7T'J:$7:.>2>2?>D,2/\
MU:_04ZFQ_P"K7Z"G4(&%%%% 'S]X[;'CK6/^NP_]!6LS1+>*^U[3[.<,T,]P
MD;A3@E2><&K_ (]/_%>:Q_UV'_H*UST<LD,JRQ.R2(=RNIP5/J#7KP5X+T/G
MZDK5'?O^IZ#-X%M)H8);6^V6TC3S"X)W;H04"#:2 &!8@\]JJ1> I)K5KA=5
M@,*YRZKD$(S"4CGHN ??<*Y"+4K^W\OR;VYC\LL4V2D;2WWL>F>]-%_>*A07
M<X0[\J)#@[OO?GW]:GDG_,7[6F_L_B=7J/A:W2">]M;HQVMM;H\ZNN2C-$CI
MWYWEB!Z8I^E:'I][H^G^;97)GO(;F1KU)3L@,>=N5QC''/-<PVL7K:;+8-(&
MBF='E8C+OL&$4M_='85H6^G>)Y=,6"V%V;"4)B))\1L),E>,XYP<_K0XR2U8
M*<6](FQ/X+=X+B>&<Q;(XWC1HSL?(CS\Y.>K^A'%)+X-MX1)(^JRB"(3>8QL
MR&!C=$.%+<@EN#[4U/#GB*2%4_M=O)FW_NI)C\Q2(2892<8(P.>. 3@8J"YD
M\2:_JDFDW+&"ZM;:606\*D^8,!RHP3NW87';@5";_F-'RK>+);CP6]KYT<NH
M*)H_,D&(6,?E))Y;$L.C=]N/YU9_X0,F29AJBK:JBF.X>-0LC,6''S?=&WD]
M>>E%KX0URYB:*YUF[@,AAGD@,,SD229(+@="-O+'VK-L[#7M0.MSQ:Q,]SIP
M$4@69F,XW$;5;/3@FB[?V@LEO!_>2:AX=@TSPQ=7DDSRWT9MF^5"(T$H9L!N
MC\ <\8K1OO#^A%+6PM96CU298'"1N\KE6CWR%D( &.V#4-YX3O+9&TW4/$Z1
MVT<L,,2.LCQ-(ZEE&!G:!@\U0O?#NJ:;I9UN;5,74+%-J;RR;6V;?,' 88^Z
M<<4T[_:!IJ_N?UU->'P;91-+#-<2S3K.%0["J%#;M*,X/!X^G'O52?P6MFZK
M<ZL@"6\D\_EQ;F38BN< -R"&QDXY'3FN7_MC4]SM_:-WNDP'/G-EL# SSSQQ
M3&U*^=$1[VX9$C,2J920J'JH]CZ52A/N9NK3_E.RE\&V47D6\FIO'<-/.C2M
M%\CA%0J!DX#'>.IQU].>3U"VDT_4;FRD#!X)"AW+@\>HR<?G34UG5(B3'J5V
MA+;B5F89.,9Z]<<54>1Y)&DD=G=CEF8Y)/J35QC);LB=2+7NJQT7@AL^.-&_
MZ^!_(U[EK]A+JFAW-E#M\R7:!NZ8# GK[ UX'X0CEG\7Z7%!<-;RM-A954,4
M.#S@\&O?4L=072WMFUB5KIFRMV8$#*,]-N,?_KKDQ'NS33/2P45.DTWN[?@8
M-KHFOZ=);PVD\:6Z7+R2LCA1*K-UV 87Y>,#N/>B?1O$DVF26LEZ9A)'M=3<
M %F,6T_-C[N_G'>MY+#4%TM[9M8E:Z9LK=^0@91GIMQC_P#70MAJ TMK8ZQ*
M;HMD7?D)N STVXQ[5G[9WOI]QU?5H6MS?F8ZZ7XC#",WQ2$.H;9-C*!A]T8^
M7"Y!]347]E^)DA1FN%N)XXVVEY\$.T0!PP&0-^3Q6ZMAJ TIK8ZQ*;HMD7?D
M)N STVXQ[4?8-0_LHVW]L2_:MV?M?D)NQGIMQCVI>V?E]P?5H?S?G]YC#3?%
M"LP34F""U"(9) S%]H!S@8R3D[NV1Z4C^&[VYT=+25DCD.IM=,SLLVU#NQG(
MPQY'!%;/V#4/[*-M_;,OVK=G[7Y";L9Z;<8]J#8:A_90MO[9E%UNS]K\A-Q&
M>FW&/:CVTNEON#ZM#K+\SG1H7B);&&PBG2&U6S>!E2X."Y5OFZ9'S%3QT'':
MKD6E^((IE\JY6*(S%]OF@[1N7)?CY\J&&/4YK7-AJ']E"V_MB476[/VOR$W$
M9Z;<8]J&L-0.E+;#6)5N@V3=^0FXC/3;C'M0ZS?;[@6&@OM?G_5B"ZTR8Z[+
MJ, 8A[)H.)BK;MX(QG(7@'FI=-TUK'4]5G_Y97<J2)ERQR$PV<].:<UAJ!TM
M;8:Q*+H-DW?D)N(STVXQ0]AJ#:6ELNL2K=*V6NQ A9AGIMQC_P#54<SM:_D:
M>RA>]^OG]X[3[Z2[O-3A>)46TN!$A&?G&Q6R?Q-7ZI:5)NLS&U\;Z6&1HI9B
M@0EP>00...E7:S>Y<_BT"BBBD0%%%% !1110 4444 %%%% !1110 444E "T
ME%% !1^/Y449_P B@ _2CCZT?A^='X@4 5;G_6C)P,5#]!4MS_K1@9X[U$?<
MUHMC-[F/_P ([:R:S=ZC<HL\DI1H02<1E5QDC.#SSG'%9Z^#Q&NGHTD!CMHH
M8Y$\KB0I)O)Q[^]/O=*OIM4GEBMMTSW,4MM?>;M^SQ*%W1XSGG#< $'?D]*?
MX7TVZTTW2SVIA1@FW<ZL[,,[LE3AAR/F(#'N.*U5:HNIBZ%-]"H/!TL5KY<5
MS:IF-$<&#(;:SG/UPX&?:FR>%[FUTJ;[.5FU$_9Q;S(H4Q-&H7<2>W4X]ZZ\
M#G)Z_P J6K^L5.K(^KT^B,'5?#OVO2].LK22*-+)PRB4-A@%*_PD'OGK5?\
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M5I1W$=Q );>19$<D*R]"<X/\C2<9+=#4XO9CE^9RW8<#^M.9MJD]3V'K0 %
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M'R\CKUYJ.3PG;2* +F5=OF%"%'REI%D!]\%0/>GW/BS3[<859GD9"\:E=H<
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M]>!]*0PC_P!6OT%.IL?^K7Z"G4(&%%%% !1110 4444 %%%% !1110 4444
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#8__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>ea028514801_img29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img29.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #K FH# 2(  A$! Q$!_\0
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M?) .,#O6;_;8_P"?<_\ ?7_UJL:U_P >A_WQ6!7=1I1E&[/+Q-><)\L6:_\
M;@_Y]S_WW_\ 6H_MP?\ /N?^^_\ ZU<9K&O7%CJMKI6G:=]NO[B)Y]AF$2I&
MI )+$'G)  IA\7Z=:0VO]K+-IMU.F]K:9"S0C=MRY48"YZ,< UI[.E>QC[:N
MU=/\CMO[<'_/N?\ OO\ ^M1_;@_Y]S_WW_\ 6KA[CQOX?MKN6UEO)/.B=HV5
M8';+KR5! Y..<"G2>-O#T30!K_B>))D81,5V.<*Q(&%&>.>E'LZ0>VQ']([;
M^W!_S[G_ +[_ /K4?VX/^?<_]]__ %JY >*M%.H36(O09X0Y;Y&VDH-S@-C!
M(') YJ.7QAH4$(EDO2$,,,X(B8Y24D1GIWQTH]G2#V^(_I'9_P!N#_GW/_??
M_P!:C^W!_P ^Y_[[_P#K5PEYXYT.UTD7Z7#2^8LIBB6)M[&/[P(QE0#P2>F:
MV].N_P"T-,M+W9L^T0K+LSG;N&<9H5*DW9"=>NE=G1Q:RDDJH\14$XSNSBIK
MS4DM)!'L+MC)YQBL&/\ UJ?[PJYJ_P#R$#_N+4NC#G2+6)J>S;OK=%G^W!_S
M[G_OO_ZU']N#_GW/_??_ -:LBBM/80[&7UJKW-?^W!_S[G_OO_ZU']N#_GW/
M_??_ -:N"O\ Q-?V/B>/2FTJ(V[Q-<?:C<XQ"A&]MN.HST[U,OC;P^UL)Q>/
MM,P@VF!]^\C<!MQGD<BH]G2-/;8@[?\ MP?\^Y_[[_\ K4?VX/\ GW/_ 'W_
M /6KAG\;Z"ES+$;I]L*.\DOE,$4*P4\]SN.W SS2)XWT:>_TVTMGGG-^\D:.
MD38C9.H<8R#_ "Z]*?LZ0O:XC^D=U_;@_P"?<_\ ??\ ]:C^W!_S[G_OO_ZU
M9%%5["'8CZU5[F[;:LD\RQ-&4+< YS2W6JI;S&(1ERO4YQ619?\ '[#_ +U.
MU#_D(3_[U9^QASV\C7ZS4]E>^MR]_;@_Y]S_ -]__6H_MP?\^Y_[[_\ K5D4
M5I["'8R^M5>YK_VX/^?<_P#??_UJ/[<'_/N?^^__ *U9%%'L(=@^M5>YK_VX
M/^?<_P#??_UJ/[<'_/N?^^__ *U8[':C-Z FN6L_B!HTFEV%U?2-:2W< G\K
M8T@1"Y0$L!@#(ZFI=*FMRHUZ\MF>@_VX/^?<_P#??_UJ/[<'_/N?^^__ *U<
M)?>--.MM8@TRWS<3O,T,I (2,A"Y^;&">!D#IFGV?C+2;A=/26X$=S>Q1R+&
MBLZIO^[N;&!GMG%'LZ17M<1:YW']N#_GW/\ WW_]:C^W!_S[G_OO_P"M7 WO
MCW0K.UO9EEFF>S ,D20L&8;MN5R.1GO4W_"8Z9$]T;ES%'"\21@(S22&1-P&
MS&<X[<TO9T@]KB/Z1W']N#_GW/\ WW_]:C^W!_S[G_OO_P"M7$3^-_#MOY!?
M4,K/$LR,L3,-A;:&) X&>#GI7052I4WL2\176[_ U_[<'_/N?^^__K4?VX/^
M?<_]]_\ UJR**?L(=B?K57N:_P#;@_Y]S_WW_P#6H_MP?\^Y_P"^_P#ZU9%%
M'L(=@^M5>YNVNJI<3K$T90MP#G-%SJJ6\QB6,N5ZG.*RK#_C_@_WZ+[_ (_I
MO]ZL_8PY[>1K]9J>RO?6Y8O/%%KI]I)=W@6"WC&7D=\!>WI3;#Q99:I;?:+!
MH[F')7?')D CJ#QP:YOQ+I<VM>'[G3[>2..6785:3.W*L&YQ]*YV^\&:E?K<
MW,MU9"[N[KSYK= ZV^!'Y:]#DD?>SW-.5**>B".(DUK*S/4/[;_Z=S_WW_\
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MB!H-M93W,<L\_D.BO&D+!L,VT,,CD9SS2Y*0_:XB]OT._P#[<'_/N?\ OO\
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M\:YBN?M<C+N5H_N@+C:!UXQWJ(> M/%E-:_:KG9+9R6;'C.UY/,)^N37I/\
M9=O_ ,\E_P"^VH_LNW_YY+_WVU3[6GV-/85_YOZ^X\ZF\%6K7#75O?WEK=_:
M&G2>(KN3<@1E ((P0/PJ*;P'8SZM;Z@]]>,T+P.$=@^3$,#+$9Y[XZGFO2O[
M+M_^>2_]]M1_9=O_ ,\E_P"^VI>UI]@]A7_F_K[CSYO!]D_AZ/1))YI+..Z6
MY0.%)&'W[.G*YJSJGAJTU!;)K:233KBQ=FMIK0*ICW###&,$'TKN/[+M_P#G
MDO\ WVU']EV__/)?^^VI^VI]A?5JU[W/.!X'LHK6V%O?7D%_;SR7"WZL#*TC
M\.6R,$$=L=JVM(TN/2+ 6L<\\YWM(\L[[G=F.22?Z5UO]EV__/)?^^VH_LNW
M_P">2_\ ?;4*M36R!X:M)6;7]?(P*T;'_D'WOT%7O[+M_P#GDO\ WVU/2TCA
M1HDC4++PPW&B=>+5@IX6<97=NIQNMZ/!KNEM87+,L3.CDKC/RL& Y[<5B7O@
M#2[MYGCEEM]]P;F-(T4I$Q3:P52,8(Y^M>E?V7;_ //)?^^VH_LNW_YY+_WV
MU#K4WN@CAJT=F>0S^!M2@\3V=]IL]L+6VC@C0SX8J$SN)7;RQR<$$8S6E_PK
M_3P^FE;RZ"V!!C VY.'+_>QD<G!QU%>F?V7;_P#/)?\ OMJ/[+M_^>2_]]M2
M52GV+=&N^J//[;PA:VUW#,EW=%8+F>YBC)&$,JD. <9QR36=:_#C3;6UNH!?
M7C_:(4B\P[0R;'WJW Y.>YSFO4?[+M_^>2_]]M1_9=O_ ,\E_P"^VH]K3[$^
MPK_S?U]QYU-X+MY+B6[34;R&^DN3<?:8]NX,T8C88(Q@@?G2'P+I@M9;:.:X
MCBDMH+; (.%B?>#]23S7HW]EV_\ SR7_ +[:C^R[?_GDO_?;4_:T^P>PK_S?
MU]QYFOP^TW[?=74EW=2_:$G1D8KP)?O?-C)QVSTK5N/#T-WHMCIL]U,ZV<D,
MBRG 9S&<KGM7;_V7;_\ /)?^^VH_LNW_ .>2_P#?;4*M3703P]9[O^ON.";P
MI:/&Z&>;#ZG_ &F<$?ZS^[]*RH/AMIL,=ROVZ\<S0B$.=NY )!(&SCDY'4YS
M7J7]EV__ #R7_OMJ/[+M_P#GDO\ WVU)U:3Z#5"NMI?U]Q@VP*O"K,7(*@L>
MI]ZZT]35%=,@5@PB7(.1\S5-]H;NHS6=:HIVL=&&HRII\W434O\ CV?ZBL>M
MC4O^/9_J*QZVP_P&>(^,***RKGQ#I]IXCLM"ED87MXA>, ?*,9P">Q.#CZ5L
MVEN8)-[&K17+0>/]&DDD$RW=K$J32)-/%A)1"<2;2#S@UJ:/KT6LRRQ+8W]I
M)&JN%NX#'O1NC*>A^G44E-,IPDMT:M%8</BS3)-1N[*07-LUM%),9;B$HCHA
MVNRD]0"<>_;-1Q^--'DLM'NA)(%U>7RK5"GS'D@L1V QU]Z.9"Y)=CH**QM#
M\3Z=X@EGBL_/5XE63$T>SS(V)"NOJI(/Y5LTTT]A--:,*Z#L/I7/]ZZ#T^E<
MV(Z'5A^H445B^*[2ZOO#L]M9!C/))$ %ST\Q=V<$'&,YYZ5RG4;6*,5PVJZ5
MK]O)81Z3 C1Z6INV\N1XTN)"WW%!+%OD##!.,L#FH+>T\10W=Y<7$%W-'<M<
M)IZKD&S+OPT@S\P*G(/\.W&.:!V/0,48KSFXL?$T+:G<I:7+6U["]O%#',S2
M0B+'E,5Z+D!\D$YW+FK>LQZUJVI0WMC:WZ:;':H+JTD1H9;G;)DHO/RG'/\
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MDG*<9CRQVY7CYMWJ*U8;+R]4N[UGW-.L<:KC[BKGC\2Q/Y4"+=%%% !1110
M4444 %%%% !1110 4444 '4'Z5Y'<_%/6;:[FMTLK K$[("5?) ./[U>N=C7
MS3J1_P")K>?]=W_]"->GE]*%24N=7/.Q]6=.,>1V.U_X6UKG_/CI_P#WR_\
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M/Q*U8D'[)9<'/W6_QKBA3J/J=#^5?U\Q?7L3_._Z^1VG_"R]6_Y\[+_OEO\
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MP%X?\QA]@' '_+>3_&NIIB_ZU_H*/K%7^9_>'U:C_(ON.<_X0+P__P! \?\
M?^3_ !I?^$#T#_GP'_?^3_&NEHH^L5?YG]X?5J'\B^XYK_A!- _Y\!_W_?\
MQI?^$%T'_GP'_?\ D_QKI**/K%7^9_>+ZK0_D7W'-_\ "#Z%_P ^(_[_ +_X
MTO\ P@^A?\^ _P"_S_XUT=%'UBK_ #/[P^JT/Y%]R.<_X0?0_P#GQ'_?Y_\
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M*:_WD^M.IK_>3ZU)8ZBBB@ HHHH **** "BBB@ HHHH **** "J9ZU<JF>M
MT1>(O^05-_O+_.N/KLM>"'390Y8+N7E1SUKE?+M/^>DW_?(_QK6$)25TCS\3
M;GW*]4UTVW74GOMN9&(< ]%<+MW#W*X'X5J>7:?\])O^^1_C1Y=I_P ])O\
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MV#[H[^BN%T[5?$\M_HZW272VTB*+]OLH&R3+  =\' W<<?C7=5<9<QE.#AN
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M=AJ$L13?YBHFW&P2'JW93G\,=:GE\:V,3?+:7LHD<Q6S(J_Z0PD6-@N3QAF
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MGW06+8_$\T")N^>]&3ZT44 &3ZT9/K110 9-+D^M)10 9/K1D^M%% !1110
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MJWINL6NJ/(ENMPCH Q6:%HR5/0C/45E0>#+!--NK>7#W%P)0;E<Y4.V[ !)
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M^'Q#ITVG37V^5(H)%BE62(JZ,Q4 %3SSN4_0U4BT+4;66=;/63!:R2RW"1"
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M 'Y_^O1YEC_S\2_]^?\ Z];&'*QE%/\ ,L?^?B7_ +\__7H\RQ_Y^)?^_/\
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MU_H* 'T444 %%%% !1110 4444 %%%% !37^\GUIU-?[R?6@!U%%% !1110
M4444 %%%% !1110 4444 %4SUJY5,]:!HS_&O_(MW'_72/\ ]"KS*O3?&O\
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M!P<_>J2B@!N7_P">8_[ZHR__ #S'_?5.HH ;E_\ GF/^^J,O_P \Q_WU3J*
M&Y?_ )YC_OJC+_\ /,?]]4ZB@!N7_P">8_[ZHR__ #S'_?5.HH ;E_\ GF/^
M^J,O_P \Q_WU3J* &Y?_ )YC_OJC+_\ /,?]]4ZB@!NY_P#GF/\ OJH?)?V_
'.K%% S__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>ea028514801_img30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img30.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $= A0# 2(  A$! Q$!_\0
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M7S1S+]Z*0;7'X=Q[CBE8+E^BBB@84444 %%%% !1110 4444 %%%% !1110
M445%)(D2%W8*H&2Q. !0!(3BLZ;4 )3;VT9GN.Z*<!/=CV_G[5%YESJ0Q"SV
M]J1_KNCR?[H/W1[GGT]:O6]K%;1B.*-44<X'<^I]3[T>HBI%I[2NL][)Y\H.
M53&(T^B^ON>?I6@[K&I+$ >I-// KB_',DE[]@T&!L27\N7/]U%YS_GTJH1<
MI)$3ER1;.QWKC=D;<=<\4Q9XFP%D1B>P85Q>@WS3>!=1L)_^/G3XY;=P>N #
M@_E_*N-M$\-)X369KAH]<"DH(G;?NS\O XZ8K94;WN]G8PEB+6LMU<]I+JJY
M)P!W--CE2491U<>JD&O.+M[[6;GP[HNHR2(D]OYUTH.UI",X!_ ?K5S2X-#T
M[Q9''H^K"!CNAGL,,P=AGH3P",?I4.G9:O4I5[O1:'?9QUJ/[1$#@RIGT+"L
MZU\1:1?79M+34()K@ _ND;)XZUYG!:65M'<7>O:#?,)+IR]P245 3P,9YI0I
MN5[Z#J5>6UM3UYY$C7<SJJ^I( IX<$9!R*\XULV%SXLM;75IMNCBS#VP9RL;
M-CJ3]/Z59\(&?4='U;3;.^EBAAN-EK<#EE0\\9]A^M4Z-H\U_P"F)5[RY;'?
M;QG'>HS/&K!6=58] 6&37%^"H7MO$/B"WDN);@PR(@DF;<QZUR>K-:"\UW^T
M5FN=1$O^BW$;DI$,\ D'"XJHT+R:OV_$4J]HJ5N_X'LH.14<V?*;;][:<8JC
MH8F71+-;B42S>2N^0'(8XZY[UHN=J%CV&:YI*UT=,7=)F7'GRUW=<<YIU(K;
ME##H>:6A;#"BBBF 5AW+>=KTF[I!$ H]"W)-;E<_<SP)XA94FC8S1#*JX)5A
MV/I4S6ATX9KF?H8VJZS?6FL&V1[2VB"QF'[6C!;MB?F42 [4(Z<YY-2G6KG^
MS6N?+C#C5/L6W!QL\W9GKUQ4^HZ#_:33JU_=16URJK<6Z[2D@'ID$K[X_GS3
M?^$=C%SN%Y<"T^T_:_L?R[/-SG.<;L9YQGK4&]I7*]M>:T^OSV7G65U!;1%I
MF2%H]LA^Y'NW'G')XX&/6GVFH:M?Z7)(%LH+F.\E@FD)9HHHT)RP!P6/'MZU
M-I6ARZ2V$U6ZFA+O(\4J1_.S'))8+N)S[]J2Z\.Q7.F3V"W4\44]RUQ(5VG<
M6;<5((P5SVH"S)M&NI=5T.*>[1 TP8$H"%D7) < \@,,'\:N:9'<W6GQ^9>R
MJJ$QA8\#A3CDTR-7L+%C<73W!C!/F.JJ<=AA0!5[2K=X--A5U(=@78>A8YK2
ME\1EB/X6O<3^RX3]Z6Y8^IF- TU%.8[BZ0^HE)_G5[!'8TE=5V>:4]NH0',=
MPEPH_AE7:?S%30:C'+*(9D:"?LC_ ,7T/0U-45Q;QW,1CE4$=CW!]0>U)I/<
M:DT6Z*H6,\JRO9W#%I(QN1S_ !K_ (BK]825G8U3N%6K$L83NSPYQGTJI5VT
M8/",?PD@_6H>Z*Z%FBBBJ$%%%% !1110 4444 %%%% !1110 4444 %5+JTA
MO% E4Y7E'4X9#Z@CD5;HH R3+=Z><7.ZYM_^>R+\Z#_:4=1[C\JT(9HYXQ)$
MZNC#(93D$5*0#69+820R-/8L(I#R\1_U<GU'8^X_'-/<1J450MK^.X+1L&BG
M3[\+_>7W]Q[BK^:0PHHHH **** "BBB@ HHHH ***JW-S':0F60\#@ <EB>@
M [DT %U=16L#2RMM4>V23V '<^U4TMIK]UFO5VQ*<QVV> ?5_4^W0>].@MI9
MIA>7@'G#_51 Y6$?U;U/X"M,#%&P@"@4M%% QI^Z:XF\\)7&M^)KJ]U(LEFD
M8CM1#+AN/7'3O^==O28JHS<-8D3A&:M(X2V\)7NE:E?I8XDL+RT9"9I<N),'
M&?7GO[UK>%?#XTO1+6"^M+?[9'NW.%#'J<?-CTKIL4M.564E9D1HPB[HY;Q+
MH%Y?7=EJFERQQZA9D[!)]UU/8UGVFAZWJ'B*SU75(K.T6T! CMR6+Y]:[>EP
M!0JC2L@=*+E<I)IUI"YDAMH(I""-Z1J&&??%<;>Z+XJO+*;1IY[:XLYI.;QS
MB0)G.-OK7?9Q5"35;&.X\EKJ/S!U .<?7TI0E).ZU'.,6K-V,O6-,OAI=E9Z
M9:65TT0";[T9$8 P& [FI_#6A?V'8-$\OG7$TAEGD P&8^@]*TX+RUN6*PS1
M2$=E;)JT*;G+EY04(\W,CF="T>\L/$.MWDX00WDJM$5;)(&>H[5AOX;\0V$6
MIZ=8)8SV6H2,YFE8AX]W7([UZ#FD.#0JLD[_ -:"=.+5OZU,_1=/_LK1K6P,
MAD,$80OZFM!U#H5/0C%+3)<^4^,YVG&*SD[W;-8JR21G*NU0HZ#BEIL8/EKG
M.<#.:=0MAA6#?>)X(I&@T^,WLZG#%3B-#[MW^@IGBUIULX #(MDSD731YSMQ
MQG'.W/6L>'RO)7R0ACQ\NSI^E=5*DI*[/.Q>*E3?+%#KB:_U#/VZ\<QG_EA;
M_(GX]S^)J)+6&) L$:Q8.04&"#ZU/173RQM:QYGUBHIJ=]47[74U<"*Y(CEZ
M!C]U_H:T!TSVKGB PPPW#T-(BM&/W4TL?LK\5Q3PLK^Z>]1S>E)?O59^6QT5
M1S3Q6Z;II%0>]8ADN2,&\FQ[$"K^BK:^>RS('N>J22')(]L]ZS^KU.IUPS&A
M)VB[LL6]O+J,R33H8[1#N2-NLA[$CL*YCP[IUK=:MJ5W=V6GR;=5NQ]IENF$
MR@,0!LZ8'UZ5W]43HNE-<&X.F69G8EC*8%W$GJ<XZUI&'*C*K6=1ZG#PZ;I<
MFFZWK^G116MO]@GAL(XI3ETVG=,PS_$1\OHHSWJ_(VJS:UX<AU VUK!);7($
MMI<,6'[@?,=R@# YSS@UU$.AZ3;L6ATNRC8J5)2!1\I&".G3%6I+:WEV^9#&
M^Q2J[E!P",$#V(XJK&5SF?"=K9B^NKW2AY6F20I#"OF%C<LI.Z<@GC.< ]6Q
MGTKJZJ6NE:?8R&2SL+:W<C:6BB521Z<#I5HD*"2< <DTTM"2I<_+J5@P^\79
M3],5I5FV>;V]-YC]Q&"D.?XCW;Z=JTC6=3>QK'8*MV:!(>">6)-5*M6.[R6W
M9^^<9]*Q=KHOH6Z***H04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %&ZLTN@K F.5,F.5?O(?ZCVZ&HK2]D$XM+P*EQ_ R_<E [K[^H[5I55NK:
M*ZB,<JD@G((."I[$'L:+B+0.:6LJVN9HYQ9WI!D.?*EQ@2C^C#N/Q%:M PHH
MHH **** "BBD)P* (IYX[>!Y97"(@RS'L*H6T4EU.+ZX0J?^6$1_Y9KZG_:/
MZ=/6FC_B97Q;_ETMWX])9!W^BG]?I6L.*>PMP Q2T44AA1110 4444 )14<L
MJ0QM)(P5%&68] *Q+CQCHENI+7FXC^%4)/\ *@5S>SQ5.^U"WTZTENKEPD4:
MY+>OL/4UR=MKX\2ZG*$#QV</"*<@L?4_X4V2:QB26&<-(O(52Q.#ZUHJ<FM#
MG>*IQE[VQ3E\17OB&]B\BV>"RSB,,V"Q]3_A2_8Q;NX((8GYL=S7.K<?V;>%
MYKE8XQG8#Z5M17QF@68,61^AS730I3A'W^IPYCB:%::]@G9+<T]/MC"KW(D=
M&C^9=M=M"V^)'_O*#7!)?2/;M&K[01V[U;TSQ%+8;;>]R]N!@2CED^H[BHJT
MI-W0L+BJ<(J#^\[>BJ-EJ5IJ"EK:=)0OWMIY'U%7NU<K5CUE)25T+4<C;$+8
MX )K,;5+Q791HUX0"0"'CY]_O4U]4O'4J=$O,$8/SQ__ !5#B[:!S(>K;@&
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MXEOSJ7>ZL%RU1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV=(0+I0BA ZW#!M@4KLS_=*G!'IBM"QT+3]-N1<6L3)((WC'SD@*S[R,?[U
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MH_?7UTV^9_;/\*_[*X% &:+77O$QSJ#R:-IC=+2!_P#2IE_Z:2#B,'^ZO/\
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MKC?"^CWMAK6ISW)F2U7;%9PLY*KD!I2N3RN_H3S@5V5 !1110 4444 %%%%
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M(S\N<X^3/4CG%?0ZX\L8QMQQCIBO";K4WUY/[)LK..2[N@L4:QD,0, 9/HH
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M[CZ***T, HHHH ***1B I)H HWUPUM9_NEW3R,(XE]6/3\!U^@J2SMEM+6.
M$D(.2>K'J2?J<FJMH/M]T;\_ZE04MP>X[O\ CV]OK6I3\A(6BBBD,*,444 9
ME];R)*M[;KF:,89!_P M4_N_4=1[_6K=O<1W4"31-N1QD'_/>IR,C%94\4EC
M</=VZDP/\T\2CG/]]??U'?ZT]Q;&M14,,R3Q++&ZNC#*LIR"*FI#$-<[XKN_
M(TP0J?FF;:?H.M=%7'>,]WVBU)SLVMSVS6M%7FCDQ<W"C)HY?( YX KE]:U
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MK2IJD2MLNE>TDSC$PPI^C#@_G3L%S3HIH<$ @\'H:=2&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %)@>E+10 FT>E&!Z4M% "8'I1M'I
M2T4 )M7.<#- 51T %+10 FT>E&!Z4M% ";1Z48%+10 4444 %%%% !112$^]
M "TF!52YO;>UP)9E5S]U.K'Z <FJ_P!IOKI?]&MQ;H?^6EQ]['J$']2*=A7+
M\DT<49>1U11U9C@"J OYKL :?%YBG_EO+E8Q].[?AQ[TZ+2XO,$MRSW,PZ-+
MR%^B]!6B% Z4M U,Z+3 THFO)&NI5.5+C"I_NKT'UY/O6B ,YQ2T4#"BBB@
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M'*,2(CC_ &E!JL^D6#M\UG;Y/<1@&C0-2[FEQ6?_ &18J<B$K_NR,/Y&@:7
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=10 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>ea028514801_img31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img31.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !B FL# 2(  A$! Q$!_\0
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M_.O$S.G&+CRJVY[F53E)2YG?8U**X/\ X6QH7_/M??\ ?M?_ (JC_A;&A?\
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M0R0:?]HM#:-(=^YY"!,F/[S<!B>@':IAX;LHC,TI23%\L86.;<50E@%(')/
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M?A]XI_Z \_YC_&FGX>>*O^@/-^8_QJ'7I?S+[RU0J_RO[CEC3#75'X=^*_\
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40 4444 %%%% !1110 M%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>ea028514801_img32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img32.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !C FL# 2(  A$! Q$!_\0
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M_P#09N/_ !W_  K S[49]J/J]'^5?<'UFK_,_O.FL_'?B6&]A=]4DE4.,QR
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M-IA!P?M*<CZU])J?E'TKY[,:,:53W%9,^BRVM.K3?,[V/GKQQ_R.VK?]=O\
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M2=VC;;1;*UC\J\E2.1I'02&0YX("D+C!'-0W>D)]GE-O"T;0S>43++C=[D'
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MNJ_,T]DNYSQ&"0>"."#33R:W[-K>?6;B2XNH;D);$^?/%\A<8&<=_K6C%?\
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MW-M7D#)Y[9XZ'KZ54N();6=H9T*2+C(SGKS5*<7LR7"2W1[1\*?^13_[;/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC/KBHJV@I)>\[F4W%_"K!1116AF:?AS_ )&73/\ KX3^=?2B?<'TKYK\.?\
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MPT?;KS_G[G_[^&J]% %C[=>?\_<__?P_XT?;KS_G[G_[^'_&J]% %C[=>?\
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M86JP'>LNXXYR,KDK@'WYK.^R77_/";_ODT?9+O\ YX3<^QH NOID$2!FF=L
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MT_NBCRT_NBBB@ \M/[HH"J.@%%% #J*** "BBB@ HHHH :R*>H%'EI_=%%%
M!Y:?W11Y:?W1110 >6G]T4>6G]T444 'EI_=%'EI_=%%% #J*** "BBB@ II
M13U -%% !Y:?W11Y:?W1110 >6G]T4>6G]T444 'EI_=%'EI_=%%% !Y:?W1
M1Y:?W1110 >6G]T4>6G]T444 'EI_=%'EI_=%%% !Y:?W11Y:?W1110 >6G]
MT4>6G]T444 'EI_=%'EI_=%%% !Y:?W11Y:?W1110 >6G]T4H4+T&*** %HH
MHH **** $('I2>6G]T444 'EI_=%'EI_=%%% !Y:?W11Y:?W1110 >6G]T4>
G6G]T444 'EI_=%'EI_=%%% !Y:?W11Y:?W1110 H '04M%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>ea028514801_img33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img33.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #] 3@# 2(  A$! Q$!_\0
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M_P"%-*O'M+W7;.*XC.'3<6*GT.,X--1<MD%SI**Y'_A:'@G_ *&*T_\ 'O\
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MF/\ A8GA'_H.VW_CW^%'_"P_"7_0<MO_ ![_  I^QJ?RO[F+VD.Z.GHKF?\
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M&\2[=_GKMZ8XV_K[52]JHZ[_ / $[7,:]\.ZCI6L6FFZG ;:6Y,>P[@X*NV
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MS7H8*K"":D[&52+>QY317IG_  HOQ7_S]:7_ -_G_P#B*/\ A1?BO_GZTO\
M[_/_ /$5Z'UFE_,9\LNQYG17IG_"B_%?_/UI?_?Y_P#XBC_A1?BO_GZTO_O\
M_P#\11]9I?S!RR['F=%>F?\ "B_%?_/UI?\ W^?_ .(H_P"%%^*_^?K2_P#O
M\_\ \11]9I?S!RR['F=%>F?\*+\5_P#/UI?_ '^?_P"(H_X47XK_ .?K2_\
MO\__ ,11]9I?S!RR['F=%>F?\*+\5_\ /UI?_?Y__B*/^%%^*_\ GZTO_O\
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M ,14)TD]*A+4G]D\[6I!7H0^"OB<?\O.F?\ ?Y__ (FG#X+^)O\ GXTW_O\
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M/+D_Y[O^0_PJ2B@"/RY/^>[_ )#_  H\N3_GN_Y#_"I** (_+D_Y[O\ D/\
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M&R F)P.N#67Y$W_/-ORK6HIIB,GR9?\ GFWY4>3+_P \V_*M:BBX6,GR9?\
MGFWY4>3+_P \V_*M:BBX6,GR9?\ GFWY4>3+_P \V_*M:BBX6,GR9?\ GFWY
M4>3+_P \V_*M:BBX6,GR9?\ GFWY4>3+_P \V_*M:BBX6,GR9?\ GFWY4>3+
M_P \V_*M:BBX6,GR9?\ GFWY4>3+_P \V_*M:BBX6,GR9?\ GFWY4>3+_P \
MV_*M:BBX6,GR9?\ GFWY4>3+_P \V_*M:BBX6,GR9?\ GFWY4>3+_P \V_*M
M:BBX6,GR9?\ GFWY4>3+_P \V_*M:BBX6,GR9?\ GFWY4>3+_P \V_*M:BBX
M6,GR9?\ GFWY4>3+_P \V_*M:BBX6,GR9?\ GFWY4>3+_P \V_*M:BBX6,GR
M9?\ GFWY4>3+_P \V_*M:BBX6,GR9?\ GFWY4>3+_P \V_*M:BBX6,GR9?\
MGFWY4>3+_P \V_*M:BBX6,GR9?\ GFWY5)!%(LZ$HP&>N*TJ*+A8****0S__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>ea028514801_img34.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img34.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %S @P# 2(  A$! Q$!_\0
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M&NT#K5:1LD_6I0X X'-02#Y3NH>AE!7>I$%9V"J,NQ^7_&M:ULX[6,32Y?\
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MCII045S,AED:5^!A1P!Z4J#;CUJ98MHZ<TB(#+D]!^M8%\UR91A1Z]ZLPX4
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M./,EH9:6D\V=D+MCK@5 8RI(S@C@@UU9E9"J;'5R  6&:CGTN.XC=_)5)&.
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M$[?(XQ[ UE:I:B*02@=\-]:TA+H:2CL5[Q2BI@@D'-46W;ONUH-'O7/6D:,
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M4'BM4<LR8&JB9&J,F0/,'!/N,58!XJG>JOVJ$GHRD9_$&N;$KW+FF&?OE^:
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M[LC-1BW:Q!:M?74I215B\GY<^M5]3D?R1;N%RC\L.]:L5Y;H@9FQ(YVD>AK
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MD\#%/!# G@']/PJHJS,9R4DK#<Y!]*3I4FT=1Q4; BKN"$+<U&S4K&HFI&J
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M[K>Y%/>^L+/=Y+87;D.H(V\]..<T]$<M24Y.W*TRM9ZK/;7\\BH\P93N4-O
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MHF5YE3-N&XV1DX_' _.L#3=21PEO!$X5F*LH?)0>OTKIK&X^RB1I#&?W952
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M)7. V>/I]:K'![J/I3FD+%@PX/..RG'6F.0N0"IS^GTKHA%HY:TU(&&'(R&
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M5'?0>(SS@C\Z:01UIH)%+YAS_2NM7.!I-!FDI<@_6FGBF39B,:;F@FFEJ=A
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1RR W$X[TLO\ K#114BZG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>ea028514801_img35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_img35.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %9 G # 2(  A$! Q$!_\0
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M ,_6I?\ @PF_^*HT#4Z:BN9_LB'_ )^M2_\ !A-_\51_9$/_ #]:E_X,)O\
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M?4( B':S;N%.XK@_B"/PITVMV$-DMX)Q) THB#1\_-GI1<+%C[?KW_/#3O\
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M_B?SD)CLF0+\RJQ&[)7/7H0-V/PH U)=-L9QB6TA?Y0OS(#P.@_4U+;V\-I
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M_H'ZA_X#FC^VE_Z!^H?^ YHLPYD:=%9G]M+_ - _4/\ P'-']M+_ - _4/\
MP'-%F',C3HK,_MI?^@?J'_@.:/[:7_H'ZA_X#FBS#F1IT5F?VTO_ $#]0_\
M <T?VTO_ $#]0_\  <T68<R-.BLS^VE_Z!^H?^ YH_MI?^@?J'_@.:+,.9&G
M169_;2_] _4/_ <T?VTO_0/U#_P'-%F',C3K*UC_ (^-)_Z_A_Z+>G?VTO\
MT#]0_P# <U0U'46N9M/:/3M0(ANA(_[@\+L8?S(II.XI25CHJ*S/[:7_ *!^
MH?\ @.:/[:7_ *!^H?\ @.:5F/F1IT5F?VTO_0/U#_P'-']M+_T#]0_\!S19
MAS(TZ*S/[:7_ *!^H?\ @.:/[:7_ *!^H?\ @.:+,.9&G169_;2_] _4/_ <
MTU]=CCC9VL-0"J"2?LYX HLPYD:M%5X;^UGACE2XCVNH9<L.AI_VJW_Y[Q?]
M]BD.Z):*B^U6_P#SWB_[[%'VJW_Y[Q?]]B@+DM%1?:K?_GO%_P!]BC[5;_\
M/>+_ +[% 7):*B^U6_\ SWB_[[%'VJW_ .>\7_?8H"Y+147VJW_Y[Q?]]BC[
M5;_\]XO^^Q0%R6BHOM5O_P ]XO\ OL4?:K?_ )[Q?]]B@+DM%1?:K?\ Y[Q?
M]]BC[5;_ //>+_OL4!<EHI 0P!!!!Z$4M PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*S/$/_("N?HO_H0K3K,\0?\ ("N?HO\ Z$*:W)ELS3HHHI%!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5;4/^0;=
M?]<7_D:LU6U#_D&W7_7%_P"1H6XGL9VEZ+I3Z39LVF618P(23;KDG:/:K?\
M8>D?] JQ_P# =/\ "GZ5_P @>Q_Z]X__ $$5<JFW<2BK;%#^P](_Z!=C_P"
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MR"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT'_(U6__ %YO_P"AK70T,$%%%%(84444 %%%% !1110 4444 %%%% !1110
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M +X%&@:E?^VM,_Z"%M_W\%']M:9_T$+;_OX*L?9;?_GWB_[X%'V2W_Y]XO\
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M9![>]7M/1KO3[:XOK***Z(W,A4?NVY _2JDUOKRZA=2VUW;M;R.OE)*#^Z4
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MVSC&=Z].M-#Z>%VA[3&<XW+C/K4NCZ-ICZ-9,VGVI8PJ23$,GBKO]B:5_P!
MVT_[\K_A0["3;,])K*/.R:V7/7:ZC-.^UVW_ #\P?]_!_C5[^Q-*_P"@;:?]
M^5_PH_L32O\ H&VG_?E?\*-!ZF/+/#)KVB".:-SY\O"N#_RQ>NGJI!I>GVTP
ME@LK>*0='2, C\:MT,$%%%%(85S<\T47BN]\R6-,V=OC<P&?FE]:Z2JMQIUE
M=R"2YM()G VAI(PQQZ<TT)F9]KMO^?F#_OX/\:/M=M_S\P?]_!_C5[^Q-*_Z
M!MI_WY7_  H_L32O^@;:?]^5_P *- U*/VNV_P"?F#_OX/\ &C[7;?\ /S!_
MW\'^-7O[$TK_ *!MI_WY7_"C^Q-*_P"@;:?]^5_PHT#4H_:[;_GY@_[^#_&C
M[7;?\_,'_?P?XU%X=T?39?#U@\EA;,S1 EFB!)K3_L32O^@;:?\ ?E?\*;23
ML)-M7*/VNV_Y^8/^_@_QH^UVW_/S!_W\'^-7O[$TK_H&VG_?E?\ "C^Q-*_Z
M!MI_WY7_  I:#U,/4KB"272U2:)F_M"'A7!/\5=75.+2--AE66*PMDD4Y5EB
M (/M5RA@@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K+\1?\@*Y_X#_P"A"M2LOQ%_R KG_@/_ *$*
M:W)ELS4HHHI%!1110 4444 %%%% !1110 4444 %%%% !1110!F:#_R#6_Z^
M)O\ T8U:=9F@_P#(-;_KXF_]&-6G3EN3'9!1112*"BBB@ HHK)N?$-I;7LUI
MY%[-+#M$GD6KR*I(R!D#&<$46$W8UJ*Q?^$EMO\ GQU3_P  9/\ "C_A);;_
M )\=4_\  &3_  IV8<R-JJFISI;Z;<NSJI$3XW'&3@U0_P"$EMO^?'5/_ &3
M_"L7Q9/9^(_#MU8&QU02E=\+?89/ED'3M^'XTXQU5R92T=CI-$=&T2R"2*^(
M$!*G/.T5H5Q7A*>T\-^';:P^PZH9@-\["QD^:0]>WX?A6W_PDMM_SXZI_P"
M,G^%.2U=@A+W5<VJ*Q?^$EMO^?'5/_ &3_"C_A);;_GQU3_P!D_PJ;,KF1M4
M5DVWB&TN;V&U\B]ADF)$9GM7C5B 6(R1CH#6M2L"=PHHHH&%%%% !1110 44
M44 97AG_ )%K3_\ KB*U:RO#7_(M:?\ ]<16K52W9,?A04445)04444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@:9:3
MZA9M<RZG?*[32C:D@"@"1E  QZ 5<_L=O^@IJ/\ W]7_ .)I/#W_ ""!_P!=
MY_\ T:]:E4V[D12L9G]CM_T%-1_[^K_\31_8[?\ 04U'_OZO_P 36G12NQ\J
M,S^QV_Z"FH_]_5_^)H_L=O\ H*:C_P!_5_\ B:TZ*+L.5&9_8[?]!34?^_J_
M_$U%<>'UNH'@FU+46C;J/-'U_NUL44<S#E1S>J:9-968FBUC4]WF(OS3 C!8
M _P^]:/]CM_T%-1_[^K_ /$TFO\ _(+_ .VT7_H8K4IW=A**N9G]CM_T%-1_
M[^K_ /$T?V.W_04U'_OZO_Q-:=%*['RHS/[';_H*:C_W]7_XFC^QV_Z"FH_]
M_5_^)K3HHNPY49G]CM_T%-1_[^K_ /$T?V.W_04U'_OZO_Q-:=%%V'*C,_L=
MO^@IJ/\ W]7_ .)IFD^;'?ZE:R7,TZ0R)L,I!(R@)&0!WK6K*T__ )#>L?\
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M Z+:WH?RI*P8?"EM"^X7^H,O&$:<D#&>GY_RK7LK1+&SCM8V9DC!"ENN,YH
MAN/^0[HG_7Q+_P"B7KI*YNX_Y#NB?]=Y?_1+UTE-]!+=A1112&%%%% !1110
M 4444 97AK_D6M/_ .N(K5K*\-?\BUI__7$5JU4MV3'X4%%%%24%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !161J^HWUK>VEK8Q
MVS/.KL6N&8 !<=-H/K57[;XA_P">>D_]]R__ !-.PKG0U5U&^CTS3Y[V9)&B
M@0NXC7<V!UP*R/MOB'_GGI/_ 'W+_P#$TCW6OR(R/%I#*PP07EP1_P!\T6$W
MV*_@?Q%9:WI\T5FLQ\B61G9TPOSR,P /K@BNJKB]!TW5/#NGFRL8=*$9D:0D
MO+DDG/IV&!^%:?VWQ#_SSTG_ +[E_P#B:J=G)\NQ-/F44I;G0T5SWVWQ#_SS
MTG_ON7_XFD&JZQ!>6B7<.GF&>81$PN^X9!YY&.U38NYT5%%<VNK:S=7%W]EA
MT]88;AX%\YY-QVXY.!BBP-V.DHKGOMOB'_GGI/\ WW+_ /$T?;?$/_//2?\
MON7_ .)HL%RKXW\1V6AV,$5XLP\^161D3*_*P)!/KBNBT^^CU+3X+V%9%BG0
M.@D7:V#TR*Y/7M-U3Q%8+9WT.E&-95D!#RY!!_W>XR/QK36[U]$"K%I 51@
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MXK!;S)(%&K>';=VDV!?*7GYF*X/'!  )YI#-A]<TX:==7T=P)H+8 R^4,D9
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M!Z8R,TD8UHWT*RK +554LZ/\Q?)W C^[C&/>K'GZM_T +C_P)A_^*H\_5O\
MH 7'_@3#_P#%46"Z+M4=0_X^M+_Z_4_D:7S]6_Z %Q_X$P__ !51M%JEY>V
M?2);>.*Y65Y'GC8  'L"3WII";.HKF-*ZZE_V$)_YBNGKEH8M5L;B^1='EG2
M2[DF21)XP"K8QP2"*2![C=6BU5S&=,D52 <AF &??(_S@^M)MUPPJ6:U\T$9
M"CY6&[IST^7O5CS]6_Z %Q_X$P__ !5'GZM_T +C_P "8?\ XJBP[HKV']NM
M=YU%;5(!$PVP-G+Y&.OMFJUNGB:&"-7:UG<LH8R$#"Y.XY&,G&W%:/GZM_T
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MR[1O>YBPOS DG#9[5UU#V$MPHHHI%&9H/_(-;_KXF_\ 1C5IUF:#_P @UO\
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MI"HZD 9Q4\OF%R7Y_P#9H^?_ &:\R'QIT\@'^Q;WG_IHG^-'_"Z;#_H"WO\
MW\3_ !K7ZM4[,P^LTOYCTWY_]FCY_P#9KS+_ (73I_\ T!;W_OXG^-'_  NG
M3_\ H"WO_?Q/\:/JU3LP^LTOYCTWY_\ 9H^?_9KS+_A=-A_T!;W_ +^)_C1_
MPNG3_P#H"WO_ '\3_&CZM4[,/K-+^8]-^?\ V:/G_P!FO,O^%TV'_0%O?^_B
M?XT?\+IT_P#Z M[_ -_$_P :/JU3LP^LTOYCTWY_]FCY_P#9KS+_ (73I_\
MT!;W_OXG^-=MX8\0Q>)]$34X;>2!'=T\N0@D%3CM4RHRBKRN7"M";M%W-?Y_
M]FCY_P#9IU%9\OFS0;\_^S1\_P#LTZBCE\V WY_]FCY_]FG44<OFP&_/_LT?
M/_LTZBCE\V WY_\ 9H^?_9IU%'+YL!OS_P"S1\_^S3J*.7S8#?G_ -FCY_\
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M +"C[9K7_0(@_P# W_["N6QV<R-6BLK[9K7_ $"(/_ W_P"PH^V:U_T"(/\
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MX,AMK^UEMIQ-*QCE&& +DBN7%2BX:,[<'"49MM=#KZ***\\]4**** "BBB@
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M^+_^@9'_ .!4?^-'_"L?%_\ T#(__ J/_&A5*:^T)T:K^R<C177?\*Q\7_\
M0,C_ / J/_&C_A6/B_\ Z!D?_@5'_C3]K3[B]A5_E8?##_DH.G_]<YO_ $ U
M]!5X_P"!? OB+1?&%IJ&H6*16T:2!G$Z,02I X!SUKV"O/Q,E*=T>KA(RC3M
M)6"BBBN<ZPHHHH **** "BBB@ HHHH 3 SG SZU\\_$C_DH.J_6+_P!%+7T/
M7BGCGP=XAU/QIJ%[9:9)-;2F/9(K* <(H/4^H-=.&DHSNSCQD7*G:*ZGG5%=
M+_PK_P 5_P#0&F_[[7_&C_A7_BO_ * TW_?:_P"->A[6'<\KV-3^5G-5KV'B
M._TV*&.U9%$;!CD9WXSC/YU>_P"%?^*_^@--_P!]K_C4=QX&\36MO)<3:1*D
M4:EW8LO '4]:3G3>C:&J=6.J3,_4-8GU&/9+'&IRI++GG P.IK.KHU\ ^*74
M,NC3$$9!WK_C3O\ A7_BO_H#3?\ ?:_XT*I36B:!TJKU:9S5%=+_ ,*_\5_]
M :;_ +[7_&C_ (5_XK_Z TW_ 'VO^-/VL.XO8U/Y6:'PI_Y'V#_KUF_]EKWN
MO'?AWX2U[2/&$5YJ&G206ZV\BEV8'DXP.#[5[%7G8AISNCU\)%QIV:"BBBN<
MZ@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *R_$O_(L:I_UZR?\ H)K4K+\2_P#(L:I_UZR?^@FG'=$R^%EZU_X\X/\
MKFO\JFJ*U_X\X?\ KFO\JEI,:V"BBB@84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!%<W,-G;27%Q((X8QN=CT JA_PD.F?\]W_P"_
M3_X4GB7_ )%V]_W!_,5JT]+$ZWLC+_X2'3/^>[_]^G_PH_X2'3/^>[?]^G_P
MK4HHT#4R_P#A(=,_Y[O_ -^7_P */^$ATS_GNW_?I_\ "M2BC0-3+_X2'3/^
M>[_]^G_PH_X2'3/^>[_]^G_PK4HHT#4R_P#A(=,_Y[M_WZ?_  IDOB?288S(
M]PX4$#_4OWX]*UZS/$!QH\F/[\?_ *&*:L)\R0G_  D.F?\ /=O^_3_X4?\
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M#2?_ !-;-%*Z[#M+N8W_  E&E_\ /2?_ ,!I/_B:/^$HTO\ YZ3_ /@-)_\
M$ULT4778+2[F-_PE&E_\])__  &D_P#B:/\ A*-+_P">D_\ X#2?_$ULT477
M8+2[F-_PE&E_\])__ :3_P")H_X2C2_^>D__ (#2?_$ULT4778+2[F-_PE&E
M_P#/2?\ \!I/_B:RM;\5:9>Z)J-K;?:Y97ADB4):2$%L8QG;775DZ%]S4/\
MK^F_G5)K>Q,E)Z7&V^M0I;1*;34,A #_ *(_I]*E_MR#_GUU#_P$D_PK3HJ;
MHJS[F9_;D'_/KJ'_ ("2?X4?VY!_SZZA_P" DG^%:=%%T%GW,S^W(/\ GUU#
M_P !)/\ "C^W(/\ GUU#_P !)/\ "M.BBZ"S[F9_;D'_ #ZZA_X"2?X4#7;7
MS(T>&\C\QPBM);.JY/09(K3K+UW_ (];;_K[B_\ 0A35F)W2O<U****DL***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBJ\U_9V\GES7<$;XSM>0*?R)H L453_M;3?^
M@A:_]_E_QH_M;3?^@A:_]_E_QIV8KHJ^)?\ D7;W_<'\Q6M7"?$6:2\\.&32
M-7C6:)AOACG7]ZA.".O8X/YUOZ'=06.C6L%]K,%S=J@,TKSJ2S'D]^G:J<?=
M3,U+WVC<HJG_ &MIO_00M?\ O\O^-']K:;_T$+7_ +_+_C469I=%RBH8+JWN
M@QMYXI@O7RW#8_*IJ!A152]U73].*"]O8+<O]WS9 N?IFJO_  D^A?\ 08L?
M^_Z_XT[,5T:M9GB!!)H-X-Q4K'O4CJ"O(_44W_A)]"_Z#%C_ -_U_P :YGQU
M/HWB'PW+#:ZQ9B\B/F08N%&XCJO7N/Z548^\KD3E[KL=Q"Q>%&)R2H)_*GUR
M?AF^T'0?#]I8'6K-Y$3,KFX4EG/)[UK_ /"3Z%_T&+'_ +_K_C2<7?0<9)K4
MU:*RO^$GT+_H,6/_ '_7_&K-GJ^G:C(T=E?6]PZC<RQ2!B!Z\4K,JZ+E%%%(
M845#=7=O90-/=3QPQ+U>1@H'XFJ'_"3Z%_T&+'_O^O\ C19BND:M%97_  D^
MA?\ 08L?^_Z_XTV3Q'H,D;(=9LP&!!*W"@_GFG9BYEW'Z7_Q_P"J_P#7R/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA0[@Y]OS.TM;&^EDCG36+:.X5!(%>,9X.!WZ?.:PM>2Y6XB-S<&=MI4%DVD
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ME0-MSZ53_P"$.\-_] 2R_P"_0K;HHNP<4^AB?\(=X;_Z EE_WZ%'_"'>'/\
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*1=A9!1112&?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>ea028514801_ex4-15img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_ex4-15img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !& 2H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MJ-YDC7<[*H]2<4 245@WGC/P_8L4FU.#>.JHVX_I5'_A86C2';;+=W#>D=NW
M^%:JC4:NHLQ=>DM')'645S"^,D;IHVJ$>OV<U,OC"Q S/;7T'_72V?\ PH]C
M4[ J]-]3H:*QK7Q3HUVP2+4(?,/\#G:?R-:ZN'4,K @]"#42BX[HTC.,MF.H
MHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *JW^H6NFVS7%Y.D,2]68XI-2U"WTNPFO+EPD42[F->%WVH
MZGX\\1B$2%8-Q*(3A8D'<_A77AL,ZS;;M%;LXL5BE1225Y/9'8:G\2;[4KPV
M'AFS,K'CSW'Z@=A]:QGLKG4&VZOJMYJ-TQ_X\[,_*/8D<?I6YH'A]+X&TT]6
M@TF,[99QP]RPZ\^E>@:?I=GID(BM($C4>@Y/U-=DZM+#^[".OX_-_HOO//IT
MZ^*]Z4M/P^2_5_<>?Z=X2U!D M]*L-.3^_,OFR'\\_RK6G\.26-FT^H>)9H8
M5'S% (U'Y5V4TT5O"\LKJD:#<S,< "O"/'7C&3Q%?&VMF9=/B;Y%'\9_O&EA
MY5L3.RT75VO^=RL11H8:%Y7D^FMOP5CT:V\)6U_;I<6^O7L\3C*R+*2#^M$G
M@>Z09MM>O%;L&8X_G7GO@/QB_A^^%I=NQT^4X8'_ )9GU%>YQ31S1++&ZLC#
M*L#P14XF6(P\[-W731?Y#PU#"XB%U&SZZO\ S/-K_P .>)[<Y)AU",=G17/Z
MC-5]-\3OHU^B7UC-;A.&2-V"_P#?#9_3%>FS7EK;@F6>-/\ >8"L'4M;\.3$
M+<B*Y8=,1[_UKF>944N6NE\M&;K**]^;"R=_/5?U\S9TS4[;5K-;JT<M$QQD
MC'/I5VN5@\30)$(M-TFX=1]U4C"BIAJ/B&YYATJ.$>LLG]*\MXNDV^2[7HW^
MA[4,)645[2R?JE^ITE%<Z(_%$I^::RB'^Z34J66N'_6:I&O^Y%G^=-5V]H/^
MOF-T4MYK\?\ (W:*RET_4?XM6<_2$?XT\65\/^8FQ^L0_P :M3E_*_P(<(K[
M2_'_ "-*BJEO#=1R9FNEE3'3R]I_/-6\UHG=;&;5NH4449%,0449%&10 449
MJAK&K6^BZ;-?W6[R8L;MHR>3BFDV[(4I**N]B_17(Z1\0]&UG4X;"V$_FRDA
M=R8'3-=<*J=.=-VFK,BG5A45X.X4449J#0**,T4 %%%&: "BC-% !11FC(H
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,4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>ea028514801_ex15-2img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_ex15-2img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  R (\# 2(  A$! Q$!_\0
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MA=C)-<%R=LKJ"<!3P,>GX=9\/8[8)>/I/BR76](;;Y,5P_F36[=P6.#@\8!
M_P 9O$%SXSTW77N=-TRTUO1I(0OV+S5@EB<=3N;A@?\ ('4T/!7AS4X_%VI^
M)]0TFVT1;JW6WCT^WE63H02[E?ESP!QZG\0#T&BBB@ I@C4-D*H/J!3Z* &>
M6F[=M7=ZXYH,,;-N**6]2.:?10*R"BBB@84444 %%%% !1110 4444 %%%%
K!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>ea028514801_ex15-4img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028514801_ex15-4img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $O QD# 2(  A$! Q$!_\0
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M]Q* A QM.<$<YSDY]\EL\<5!(/F*;0_S(QR"1P\08C'/RQD$^\?'2O*/V?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'R=\-/$WA[Q_^T0OB#PGJ?\ ;6F^'OV=?"6F:I?P%WLXK[Q)XFO=:TVQ$C
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M:M2I:RG)R2ZJ]M/E:R+I0=.E"#U<5;\0HHHK(T"BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/LD)! Y'&WG/8'Z5_.Y_P<8M&OP*^ $:%/,;XGZVV. WEV_A_!V)R=H).0.
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MA*%?-$NZ"\MHYVD=]_S.H#$HQ\QFQU)!KY1_:U_X)5_M#_L7_#6?XR?%74M
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M,2Y2CB%S)R3UG=M._I;3KYZG3T445\>?9A1110 4444 %%%% !1110 4444
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MR^;_ .&L?09E!4<9&DF^2CG&%@FWJXP]FHR?JMWU9_H<^$ 1X3\+@\,OAO1
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M5R>@QN&<D\ 8ZD]L\BDU=-+1M6TWU#1:O9;^G4IMQA48;61""4)</(,(Q/\
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M8FA)TU%J\VK>N[]'9?)]M6?;KGH"2 "KJ ",LV0%/9LY!P!G@]^EM 0J@X)
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M65/JM7%PG)++^(G6<5%VFG4LXNSTM=._E;9G>_\ !QW!:7G[6_PQ=Y98TA^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\IF>P;QSH.I>#M3M9FBSON+2378PDB?(S1J!G(%?=5E\'? .G_#S0_A3;Z'
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MY]JKA<%*$JEJ;:G3C&4K7Y&X0WO[S4?+?56NV>?'$8F'-"TK**E;Y-_+7?\
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M=U?:K>2UUDFH176S:,HU\16JN-I)<T;=M)0TUU2W>OKU/W@7H/H.O7I2T@X
M^@I:^;/<6R]%^2"BBB@84444 %%%% !1110 4444 ,.T9+<!06)/;)R3^&/U
MI$((+ @ANA'?K_/K5>^$CVMRL7^L,1"CU)!P/7J14.E1W$=C;I<C$P'SCK@X
M/?\ 3\* -*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5>M01>'?#\,>H06^@Z+#!JLK7&K6\&FV<46IS2*!)+J,*1+'>S-%C+W(D<G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!_#/ABYT^Y (MKS4K=(M1N]@#0RLZ-RQ%?I86 7/J!QZYIJ#.<\CC&>G?/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^5P  .KCTK\\?V3/BW\:OBG\0M7\4^*=0\.ZY\)_&WA._P#$WA2WTB6&35/
MMW#XDN;'3-%UU$9I//U#0U%ZN[;A9PI!(S7E_P 5/BW\=_$_Q5^(O@+X.:]%
MHUUJOQ.3X>:5JU[:2WMAX5TWX<?#D>+_ !/?7*QJRI+X@UB^TW2HF.",,IX7
M!VCEM65:6'O;DH0>MTNJUZWZ+[]$9_6U[%5EM=I][KL_GMN?K!N8J>1NQA>.
MI.0I(ZXSU_NX(/2G%WVDJRX;E0W7: P( ZGG:=PXP*_*#X1_MJ?$OXD?%+]E
M/X77/A&;18_B+X(\1^(OB!XMFMVETG5+[0]&U&%]'T*=5\J*[_M&S:_F(8E8
M) A (-?0G@/XP^)M/_9?^+?C+7KR'4O%_P (KGXT:!<:JP+6\NJ>#=0U<:5O
MC^\T:6KZ>)..0C =ZB6!K4735^:[IQ[KWZGLXZKO)-6O>]T.EB56C)V:M&5K
MW6T6W:_W]OQ/MAI)%4$J&;C:@!7<6)P@;IN55YZ]1[4\2ONVJH"KDLS$# VC
MGG^'+!\]P-O>OSP_98^)/QITOX+^//BM^T+X\\&^,K"Q\-:?XOT=?")C_P")
M4L6@OJ5[I=ZT;,#=33M;6L49.XRR%>IX^<M#_:_^/'Q@^#'P?\0_#J+3=%\;
M:[X5^,WQ?\766KVC.EQX1^%NMRVVG>$XLKBVNM:N#;6/VA\(%5LG@UI_9M=5
MZL6](-1;L^5-QYK:M=&OG)=]$L5'V5)MKWEM=-Z+MYO^MC]GED<J2< %<JQ4
M@ Y*X/Z-T^[G@U&279OE#$!&.2-D8R%90>A)!D+'/& ",BOR/^)WQ2_:WU'Q
M9^S_ /$7X6^*_",/PG^.'B/X3Z5;^%]0M/M.KJGB*PCU3Q:ULZ@Y%A9VEZIE
M7*Q@!VQG(]H_;#^)_P :="^)/P&^%7P:\2>&?!]WXY;Q;X@\1:_XJ:,V#Z5X
M7;2E&E*DC FZUB34'6T/>8!1D@BLW@?WD(*2YI.4;+56BM4^MT[I[:HI8A6;
MMHDFV]-^OI^9^A;R_P 6"IC5F;(.1D8^7^_@!F(')"@=33!/)NP5."47(&0I
M9G4'(^\&(0<<(20W2OS#N_VC/B_IW[0.M6?G:;/\-['XW^!OV?X_#LNU==?4
MK[PI+KOB#Q?;,V"UB;O;#;QC)=6(7@$UP%Q^TO\ M+?#/P_\7K_XE1:(/$/B
M7PKI7B/X0Z!"BV\WA&_\6_$*\\">']%U\N%\YG'D:P9=NSRF*YR#6[RRM*W)
M))-*R3WO9W5]79.[[+OI?)8RE9\]G9M72NNO77JFO,_8$.2[#." N!@@9()V
MGG[PZ^V<<]:D7) 8@@D<J3P/\_\ ZZ^3OV2/$'QBUGP)KMI\:;[0]=\0:)XI
MN+/3?%7AIXY-(\2:2;6UE%]:M$67=%>M=VDR@ED>%@V#7UBGW1EMV1G<.A!Y
M!_+%<=6E*C4G2F[R@[-_)/\ 4ZJ<XSA&<?ADKKTU_P AU%%%9EA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYX-<K8^*=#U*PN-:T_7M-OM&L#,EWJ$%]:O9PR0LRS+<7"2F*+[+E_M D=2
MD9[T3^,O"EOINGZO<>(M'@TO5I4ATK47O[9+/4)I9"L45G*TNRXDF("HD;.2
M,<=#0Z4G.SA-6T;L]=&^U[K>W;[PYX+>2MZKTZZ?B=62&! /;Z?SI 0@P<YZ
MX_SQV]:P)O$6D6NIVVB3:KI\.MWL)NK+29+VV6^O(  LDEO:M()I(XVX+*A'
MRD^M+J6MZ7H_V4:KJ-IIYOKN&QM&N[F&V6XNIQ((K:'SI$\V>1D;;&A9L^7\
MI!J%AU[2*Y)MRBW%V>UGVWOJ]--/*P.<.64U)6C)1>JO=_U_5S=96*, >21@
MYYQD?3L#3AA0,\>OUQW]>E<]<>)M"M=4@T2;6]-BUFZC9[72Y;R!;Z4#G<MJ
M9!.Z*I!++&1CD'I3%\1Z-)'JC1:M8SQZ'N&LR1WEM(VEL(6O#'>[9#]G<V^Q
ME68H51OF'2G'#R4(Q<9VWOJKWE9>NMDO/83FDG:4;*U_NT_JQTH]0<Y__5Q^
M5+6+I>KZ?K6GP:GH^H6FI:?=*);6_L)XKBUN(WPH:*6)G0JI8;@&R&!R!6R,
MXYZ\_H2*MQY7RM6MI9Z6^\J+ND]'?JMOD+1112&%%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^.@ST'%*OF=7$TE2DXVMRZ)WMS*=M;WU6_4='!0HS4UNO^#Y?UJ.484<8_\
1UTZBBN [@HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>57
<FILENAME>aapg-20251231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Wed Apr 29 21:00:58 UTC 2026 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2025" targetNamespace="http://www.ascentage.cn.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr1="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:aapg="http://www.ascentage.cn.com/20251231" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="aapg-20251231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="aapg-20251231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="aapg-20251231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="aapg-20251231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement" id="aapg_r_ConsolidatedIncomeStatement">
        <link:definition>995301 - Statement - Consolidated Statements of Profit or Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatementAlt0" id="aapg_r_ConsolidatedIncomeStatementAlt0">
        <link:definition>995301 - Statement - Consolidated Statements of Profit or Loss Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome" id="aapg_r_ConsolidatedComprehensiveIncome">
        <link:definition>995302 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncomeAlt0" id="aapg_r_ConsolidatedComprehensiveIncomeAlt0">
        <link:definition>995302 - Statement - Consolidated Statements of Comprehensive Loss Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet" id="aapg_r_ConsolidatedBalanceSheet">
        <link:definition>995303 - Statement - Consolidated Statements of Financial Position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals" id="aapg_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>995304 - Statement - Consolidated Statements of Financial Position (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ShareholdersEquityType2or3" id="aapg_r_ShareholdersEquityType2or3">
        <link:definition>995305 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ConsolidatedCashFlow" id="aapg_r_ConsolidatedCashFlow">
        <link:definition>995306 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/CorporateandGroupInformation" id="aapg_r_CorporateandGroupInformation">
        <link:definition>995307 - Disclosure - Corporate and Group Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/AccountingPolicies" id="aapg_r_AccountingPolicies">
        <link:definition>995308 - Disclosure - Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimates" id="aapg_r_SignificantAccountingJudgementsandEstimates">
        <link:definition>995309 - Disclosure - Significant Accounting Judgements and Estimates</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OperatingSegmentInformation" id="aapg_r_OperatingSegmentInformation">
        <link:definition>995310 - Disclosure - Operating Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGains" id="aapg_r_RevenueOtherIncomeandGains">
        <link:definition>995311 - Disclosure - Revenue, Other Income and Gains</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/LossBeforeTax" id="aapg_r_LossBeforeTax">
        <link:definition>995312 - Disclosure - Loss Before Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OtherExpenses" id="aapg_r_OtherExpenses">
        <link:definition>995313 - Disclosure - Other Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FinanceCosts" id="aapg_r_FinanceCosts">
        <link:definition>995314 - Disclosure - Finance Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/IncomeTax" id="aapg_r_IncomeTax">
        <link:definition>995315 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/Dividends" id="aapg_r_Dividends">
        <link:definition>995316 - Disclosure - Dividends</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany" id="aapg_r_LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany">
        <link:definition>995317 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/PropertyPlantandEquipment" id="aapg_r_PropertyPlantandEquipment">
        <link:definition>995318 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/Leases" id="aapg_r_Leases">
        <link:definition>995319 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/Goodwill" id="aapg_r_Goodwill">
        <link:definition>995320 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OtherIntangibleAsset" id="aapg_r_OtherIntangibleAsset">
        <link:definition>995321 - Disclosure - Other Intangible Asset</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/InvestmentinaJointVenture" id="aapg_r_InvestmentinaJointVenture">
        <link:definition>995322 - Disclosure - Investment in a Joint Venture</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLoss" id="aapg_r_FinancialAssetsatFairValuethroughProfitorLoss">
        <link:definition>995323 - Disclosure - Financial Assets at Fair Value through Profit or Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/DeferredTax" id="aapg_r_DeferredTax">
        <link:definition>995324 - Disclosure - Deferred Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OtherNonCurrentAssets" id="aapg_r_OtherNonCurrentAssets">
        <link:definition>995325 - Disclosure - Other Non-Current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/Inventories" id="aapg_r_Inventories">
        <link:definition>995326 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/TradeReceivablesNet" id="aapg_r_TradeReceivablesNet">
        <link:definition>995327 - Disclosure - Trade Receivables, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssets" id="aapg_r_PrepaymentsOtherReceivablesandOtherAssets">
        <link:definition>995328 - Disclosure - Prepayments, Other Receivables and Other Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/CashandBankBalances" id="aapg_r_CashandBankBalances">
        <link:definition>995329 - Disclosure - Cash and Bank Balances</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/TradePayables" id="aapg_r_TradePayables">
        <link:definition>995330 - Disclosure - Trade Payables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OtherPayablesandAccruals" id="aapg_r_OtherPayablesandAccruals">
        <link:definition>995331 - Disclosure - Other Payables and Accruals</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ContractLiabilities" id="aapg_r_ContractLiabilities">
        <link:definition>995332 - Disclosure - Contract Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowings" id="aapg_r_InterestBearingBankandOtherBorrowings">
        <link:definition>995333 - Disclosure - Interest-Bearing Bank and Other Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/DeferredIncome" id="aapg_r_DeferredIncome">
        <link:definition>995334 - Disclosure - Deferred Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ShareCapitalandTreasuryShares" id="aapg_r_ShareCapitalandTreasuryShares">
        <link:definition>995335 - Disclosure - Share Capital and Treasury Shares</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/Reserves" id="aapg_r_Reserves">
        <link:definition>995336 - Disclosure - Reserves</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ShareBasedPayments" id="aapg_r_ShareBasedPayments">
        <link:definition>995337 - Disclosure - Share-Based Payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlows" id="aapg_r_NotestotheConsolidatedStatementsofCashFlows">
        <link:definition>995338 - Disclosure - Notes to the Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/Commitments" id="aapg_r_Commitments">
        <link:definition>995339 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ContingentLiabilities" id="aapg_r_ContingentLiabilities">
        <link:definition>995340 - Disclosure - Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/PledgeofAssets" id="aapg_r_PledgeofAssets">
        <link:definition>995341 - Disclosure - Pledge of Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/RelatedPartyTransactions" id="aapg_r_RelatedPartyTransactions">
        <link:definition>995342 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategory" id="aapg_r_FinancialInstrumentsbyCategory">
        <link:definition>995343 - Disclosure - Financial Instruments by Category</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstruments" id="aapg_r_FairValueandFairValueHierarchyofFinancialInstruments">
        <link:definition>995344 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPolicies" id="aapg_r_FinancialRiskManagementObjectivesandPolicies">
        <link:definition>995345 - Disclosure - Financial Risk Management Objectives and Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/EventAftertheReportingPeriod" id="aapg_r_EventAftertheReportingPeriod">
        <link:definition>995346 - Disclosure - Event After the Reporting Period</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompany" id="aapg_r_CondensedFinancialInformationoftheCompany">
        <link:definition>995347 - Disclosure - Condensed Financial Information of the Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ApprovaloftheFinancialStatements" id="aapg_r_ApprovaloftheFinancialStatements">
        <link:definition>995348 - Disclosure - Approval of the Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy" id="aapg_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/CorporateandGroupInformationTables" id="aapg_r_CorporateandGroupInformationTables">
        <link:definition>996001 - Disclosure - Corporate and Group Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/AccountingPoliciesTables" id="aapg_r_AccountingPoliciesTables">
        <link:definition>996002 - Disclosure - Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OperatingSegmentInformationTables" id="aapg_r_OperatingSegmentInformationTables">
        <link:definition>996003 - Disclosure - Operating Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables" id="aapg_r_RevenueOtherIncomeandGainsTables">
        <link:definition>996004 - Disclosure - Revenue, Other Income and Gains (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/LossBeforeTaxTables" id="aapg_r_LossBeforeTaxTables">
        <link:definition>996005 - Disclosure - Loss Before Tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OtherExpensesTables" id="aapg_r_OtherExpensesTables">
        <link:definition>996006 - Disclosure - Other Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FinanceCostsTables" id="aapg_r_FinanceCostsTables">
        <link:definition>996007 - Disclosure - Finance Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/IncomeTaxTables" id="aapg_r_IncomeTaxTables">
        <link:definition>996008 - Disclosure - Income Tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables" id="aapg_r_LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables">
        <link:definition>996009 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/PropertyPlantandEquipmentTables" id="aapg_r_PropertyPlantandEquipmentTables">
        <link:definition>996010 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/LeasesTables" id="aapg_r_LeasesTables">
        <link:definition>996011 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/GoodwillTables" id="aapg_r_GoodwillTables">
        <link:definition>996012 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OtherIntangibleAssetTables" id="aapg_r_OtherIntangibleAssetTables">
        <link:definition>996013 - Disclosure - Other Intangible Asset (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables" id="aapg_r_InvestmentinaJointVentureTables">
        <link:definition>996014 - Disclosure - Investment in a Joint Venture (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLossTables" id="aapg_r_FinancialAssetsatFairValuethroughProfitorLossTables">
        <link:definition>996015 - Disclosure - Financial Assets at Fair Value through Profit or Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/DeferredTaxTables" id="aapg_r_DeferredTaxTables">
        <link:definition>996016 - Disclosure - Deferred Tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OtherNonCurrentAssetsTables" id="aapg_r_OtherNonCurrentAssetsTables">
        <link:definition>996017 - Disclosure - Other Non-Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/InventoriesTables" id="aapg_r_InventoriesTables">
        <link:definition>996018 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/TradeReceivablesNetTables" id="aapg_r_TradeReceivablesNetTables">
        <link:definition>996019 - Disclosure - Trade Receivables, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssetsTables" id="aapg_r_PrepaymentsOtherReceivablesandOtherAssetsTables">
        <link:definition>996020 - Disclosure - Prepayments, Other Receivables and Other Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/CashandBankBalancesTables" id="aapg_r_CashandBankBalancesTables">
        <link:definition>996021 - Disclosure - Cash and Bank Balances (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/TradePayablesTables" id="aapg_r_TradePayablesTables">
        <link:definition>996022 - Disclosure - Trade Payables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OtherPayablesandAccrualsTables" id="aapg_r_OtherPayablesandAccrualsTables">
        <link:definition>996023 - Disclosure - Other Payables and Accruals (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ContractLiabilitiesTables" id="aapg_r_ContractLiabilitiesTables">
        <link:definition>996024 - Disclosure - Contract Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables" id="aapg_r_InterestBearingBankandOtherBorrowingsTables">
        <link:definition>996025 - Disclosure - Interest-Bearing Bank and Other Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/DeferredIncomeTables" id="aapg_r_DeferredIncomeTables">
        <link:definition>996026 - Disclosure - Deferred Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables" id="aapg_r_ShareCapitalandTreasurySharesTables">
        <link:definition>996027 - Disclosure - Share Capital and Treasury Shares (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ShareBasedPaymentsTables" id="aapg_r_ShareBasedPaymentsTables">
        <link:definition>996028 - Disclosure - Share-Based Payments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables" id="aapg_r_NotestotheConsolidatedStatementsofCashFlowsTables">
        <link:definition>996029 - Disclosure - Notes to the Consolidated Statements of Cash Flows (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables" id="aapg_r_RelatedPartyTransactionsTables">
        <link:definition>996030 - Disclosure - Related Party Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategoryTables" id="aapg_r_FinancialInstrumentsbyCategoryTables">
        <link:definition>996031 - Disclosure - Financial Instruments by Category (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstrumentsTables" id="aapg_r_FairValueandFairValueHierarchyofFinancialInstrumentsTables">
        <link:definition>996032 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables" id="aapg_r_FinancialRiskManagementObjectivesandPoliciesTables">
        <link:definition>996033 - Disclosure - Financial Risk Management Objectives and Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables" id="aapg_r_CondensedFinancialInformationoftheCompanyTables">
        <link:definition>996034 - Disclosure - Condensed Financial Information of the Company (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable" id="aapg_r_ScheduleofPrincipalSubsidiariesTable">
        <link:definition>996035 - Disclosure - Corporate and Group Information - Schedule of Principal Subsidiaries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/AccountingPoliciesDetails" id="aapg_r_AccountingPoliciesDetails">
        <link:definition>996036 - Disclosure - Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable" id="aapg_r_ScheduleofNewandRevisedIFRSsTable">
        <link:definition>996037 - Disclosure - Accounting Policies - Schedule of New and Revised IFRSs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable" id="aapg_r_ScheduleofPropertyPlantandEquipmentofAnnualRatesTable">
        <link:definition>996038 - Disclosure - Accounting Policies - Schedule of Property, Plant and Equipment of Annual Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable" id="aapg_r_ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable">
        <link:definition>996039 - Disclosure - Accounting Policies - Schedule of Intangible Assets are Amortized on the Straight-Line Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable" id="aapg_r_ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable">
        <link:definition>996040 - Disclosure - Accounting Policies - Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails" id="aapg_r_SignificantAccountingJudgementsandEstimatesDetails">
        <link:definition>996041 - Disclosure - Significant Accounting Judgements and Estimates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/OperatingSegmentInformationDetails" id="aapg_r_OperatingSegmentInformationDetails">
        <link:definition>996042 - Disclosure - Operating Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofRevenueTable" id="aapg_r_ScheduleofRevenueTable">
        <link:definition>996043 - Disclosure - Operating Segment Information - &#8203;Schedule of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable" id="aapg_r_ScheduleofNonCurrentAssetsTable">
        <link:definition>996044 - Disclosure - Operating Segment Information - &#8203;Schedule of Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable" id="aapg_r_ScheduleofRevenuefromCustomersTable">
        <link:definition>996045 - Disclosure - Operating Segment Information - Schedule of Revenue from Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable" id="aapg_r_ScheduleofDisaggregatedRevenueTable">
        <link:definition>996046 - Disclosure - Revenue, Other Income and Gains - &#8203;Schedule of Disaggregated Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable" id="aapg_r_ScheduleofContractLiabilitiesTable">
        <link:definition>996047 - Disclosure - Revenue, Other Income and Gains - &#8203;Schedule of Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable" id="aapg_r_ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable">
        <link:definition>996048 - Disclosure - Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable" id="aapg_r_ScheduleofOtherIncomeandGainsTable">
        <link:definition>996049 - Disclosure - Revenue, Other Income and Gains - Schedule of Other Income and Gains (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable" id="aapg_r_ScheduleofLossBeforeTaxTable">
        <link:definition>996050 - Disclosure - Loss Before Tax - Schedule of Loss Before Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable" id="aapg_r_ScheduleofOtherExpensesTable">
        <link:definition>996051 - Disclosure - Other Expenses - Schedule of Other Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable" id="aapg_r_ScheduleofFinanceCostsTable">
        <link:definition>996052 - Disclosure - Finance Costs - Schedule of Finance Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/IncomeTaxDetails" id="aapg_r_IncomeTaxDetails">
        <link:definition>996053 - Disclosure - Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable" id="aapg_r_ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable">
        <link:definition>996054 - Disclosure - Income Tax  - Schedule of Current and Deferred Components of the Income Tax (Credit)/Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable" id="aapg_r_ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable">
        <link:definition>996055 - Disclosure - Income Tax  - Schedule of Reconciliation between the Income Tax Expense/(Credit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails" id="aapg_r_LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails">
        <link:definition>996056 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofBasicLossPerShareTable" id="aapg_r_ScheduleofBasicLossPerShareTable">
        <link:definition>996057 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company - Schedule of Basic Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable" id="aapg_r_ScheduleofPropertyPlantandEquipmentTable">
        <link:definition>996058 - Disclosure - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/LeasesDetails" id="aapg_r_LeasesDetails">
        <link:definition>996059 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable" id="aapg_r_ScheduleofRightofUseAssetsTable">
        <link:definition>996060 - Disclosure - Leases - Schedule of Right-of-Use Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable" id="aapg_r_ScheduleofLeaseLiabilitiesTable">
        <link:definition>996061 - Disclosure - Leases - Schedule of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable" id="aapg_r_ScheduleofRecognizedinProfitorLossTable">
        <link:definition>996062 - Disclosure - Leases - Schedule of Recognized in Profit or Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/GoodwillDetails" id="aapg_r_GoodwillDetails">
        <link:definition>996063 - Disclosure - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofGoodwillTable" id="aapg_r_ScheduleofGoodwillTable">
        <link:definition>996064 - Disclosure - Goodwill - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable" id="aapg_r_ScheduleofOtherIntangibleAssetTable">
        <link:definition>996065 - Disclosure - Other Intangible Asset - Schedule of Other Intangible Asset (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofInvestmentinaJointVentureTable" id="aapg_r_ScheduleofInvestmentinaJointVentureTable">
        <link:definition>996066 - Disclosure - Investment in a Joint Venture - Schedule of Investment in a Joint Venture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable" id="aapg_r_ScheduleofGroupsPrincipalJointVentureTable">
        <link:definition>996067 - Disclosure - Investment in a Joint Venture - Schedule of Group&#8217;s Principal Joint Venture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable" id="aapg_r_ScheduleofInformationoftheGroupsJointVentureTable">
        <link:definition>996068 - Disclosure - Investment in a Joint Venture - Schedule of Information of the Group&#8217;s Joint Venture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable" id="aapg_r_ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable">
        <link:definition>996069 - Disclosure - Financial Assets at Fair Value through Profit or Loss - Schedule of Financial Assets at Fair Value through Profit or Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/DeferredTaxDetails" id="aapg_r_DeferredTaxDetails">
        <link:definition>996070 - Disclosure - Deferred Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable" id="aapg_r_ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable">
        <link:definition>996071 - Disclosure - Deferred Tax - Schedule of Movements in Deferred Tax Liabilities and Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable" id="aapg_r_ScheduleofMovementsinDeferredTaxAssetsTable">
        <link:definition>996072 - Disclosure - Deferred Tax - Schedule of Movements in Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" id="aapg_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable">
        <link:definition>996073 - Disclosure - Deferred Tax - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable" id="aapg_r_ScheduleofOtherNonCurrentAssetsTable">
        <link:definition>996074 - Disclosure - Other Non-Current Assets - Schedule of Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofInventoriesTable" id="aapg_r_ScheduleofInventoriesTable">
        <link:definition>996075 - Disclosure - Inventories - Schedule of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofTradeReceivablesNetTable" id="aapg_r_ScheduleofTradeReceivablesNetTable">
        <link:definition>996076 - Disclosure - Trade Receivables, Net - Schedule of Trade Receivables, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable" id="aapg_r_ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable">
        <link:definition>996077 - Disclosure - Trade Receivables, Net - Schedule of Based on the Invoice Date and Net of Loss Allowance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable" id="aapg_r_ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable">
        <link:definition>996078 - Disclosure - Prepayments, Other Receivables and Other Assets - Schedule of Prepayments, Other Receivables and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/CashandBankBalancesDetails" id="aapg_r_CashandBankBalancesDetails">
        <link:definition>996079 - Disclosure - Cash and Bank Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable" id="aapg_r_ScheduleofCashandBankBalancesTable">
        <link:definition>996080 - Disclosure - Cash and Bank Balances - Schedule of Cash and Bank Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable" id="aapg_r_ScheduleoftheTradePayablesTable">
        <link:definition>996081 - Disclosure - Trade Payables - Schedule of the Trade Payables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable" id="aapg_r_ScheduleofOtherPayablesandAccrualsTable">
        <link:definition>996082 - Disclosure - Other Payables and Accruals - Schedule of Other Payables and Accruals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ContractLiabilitiesDetails" id="aapg_r_ContractLiabilitiesDetails">
        <link:definition>996083 - Disclosure - Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0" id="aapg_r_ScheduleofContractLiabilitiesTable0">
        <link:definition>996084 - Disclosure - Contract Liabilities - Schedule of Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails" id="aapg_r_InterestBearingBankandOtherBorrowingsDetails">
        <link:definition>996085 - Disclosure - Interest-Bearing Bank and Other Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable" id="aapg_r_ScheduleofInterestBearingBankandOtherBorrowingsTable">
        <link:definition>996086 - Disclosure - Interest-Bearing Bank and Other Borrowings - Schedule of Interest-Bearing Bank and Other Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable" id="aapg_r_ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable">
        <link:definition>996087 - Disclosure - Interest-Bearing Bank and Other Borrowings - Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofDeferredIncomeTable" id="aapg_r_ScheduleofDeferredIncomeTable">
        <link:definition>996088 - Disclosure - Deferred Income - Schedule of Deferred Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable" id="aapg_r_ScheduleofMovementsinGovernmentGrantsTable">
        <link:definition>996089 - Disclosure - Deferred Income - Schedule of Movements in Government Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails" id="aapg_r_ShareCapitalandTreasurySharesDetails">
        <link:definition>996090 - Disclosure - Share Capital and Treasury Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable" id="aapg_r_ScheduleofIssuedandFullyPaidTable">
        <link:definition>996091 - Disclosure - Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals" id="aapg_r_ScheduleofIssuedandFullyPaidTable_Parentheticals">
        <link:definition>996092 - Disclosure - Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Parentheticals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable" id="aapg_r_ScheduleofShareCapitalandTreasurySharesTable">
        <link:definition>996093 - Disclosure - Share Capital and Treasury Shares - Schedule of Share Capital and Treasury Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ReservesDetails" id="aapg_r_ReservesDetails">
        <link:definition>996094 - Disclosure - Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails" id="aapg_r_ShareBasedPaymentsDetails">
        <link:definition>996095 - Disclosure - Share-Based Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable" id="aapg_r_ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable">
        <link:definition>996096 - Disclosure - Share-Based Payments - Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable" id="aapg_r_ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable">
        <link:definition>996097 - Disclosure - Share-Based Payments - Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable" id="aapg_r_ScheduleoffairvaluesofshareoptionsgrantedTable">
        <link:definition>996098 - Disclosure - Share-Based Payments - Schedule of fair values of share options granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable" id="aapg_r_ScheduleofUnlockingDateTable">
        <link:definition>996099 - Disclosure - Share-Based Payments - Schedule of Unlocking Date (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable" id="aapg_r_ScheduleofRestrictedSharesOutstandingTable">
        <link:definition>996100 - Disclosure - Share-Based Payments - Schedule of Restricted Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails" id="aapg_r_NotestotheConsolidatedStatementsofCashFlowsDetails">
        <link:definition>996101 - Disclosure - Notes to the Consolidated Statements of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" id="aapg_r_ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable">
        <link:definition>996102 - Disclosure - Notes to the Consolidated Statements of Cash Flows - Schedule of Changes in Liabilities Arising from Financing Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable" id="aapg_r_ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable">
        <link:definition>996103 - Disclosure - Notes to the Consolidated Statements of Cash Flows - Schedule of Cash Outflow for Leases Included In the Statement of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/CommitmentsDetails" id="aapg_r_CommitmentsDetails">
        <link:definition>996104 - Disclosure - Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ContingentLiabilitiesDetails" id="aapg_r_ContingentLiabilitiesDetails">
        <link:definition>996105 - Disclosure - Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails" id="aapg_r_RelatedPartyTransactionsDetails">
        <link:definition>996106 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable" id="aapg_r_ScheduleofTransactionwithRelatedPartyTable">
        <link:definition>996107 - Disclosure - Related Party Transactions - Schedule of Transaction with Related Party (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable" id="aapg_r_ScheduleofOutstandingBalancewithRelatedPartyTable">
        <link:definition>996108 - Disclosure - Related Party Transactions - Schedule of Outstanding Balance with Related Party (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable" id="aapg_r_ScheduleofCompensationofkeyManagementPersonnelTable">
        <link:definition>996109 - Disclosure - Related Party Transactions - Schedule of Compensation of key Management Personnel (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable" id="aapg_r_ScheduleofCategoriesofFinancialInstrumentsTable">
        <link:definition>996110 - Disclosure - Financial Instruments by Category - Schedule of Categories of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable" id="aapg_r_ScheduleofFinancialInstrumentsTable">
        <link:definition>996111 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable" id="aapg_r_ScheduleofAssetsMeasuredatFairValueTable">
        <link:definition>996112 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Assets Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails" id="aapg_r_FinancialRiskManagementObjectivesandPoliciesDetails">
        <link:definition>996113 - Disclosure - Financial Risk Management Objectives and Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable" id="aapg_r_ScheduleofInterestRateRiskTable">
        <link:definition>996114 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Interest Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable" id="aapg_r_ScheduleofForeignCurrencyRiskTable">
        <link:definition>996115 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Foreign Currency Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable" id="aapg_r_ScheduleofCreditQualityandMaximumExposureToCreditRiskTable">
        <link:definition>996116 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Credit Quality and Maximum Exposure To Credit Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable" id="aapg_r_ScheduleofLiquidityRiskTable">
        <link:definition>996117 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Liquidity Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable" id="aapg_r_ScheduleofEquityPriceRiskTable">
        <link:definition>996118 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Equity Price Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable" id="aapg_r_ScheduleofFairValuesoftheEquityInvestmentsTable">
        <link:definition>996119 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Fair Values of the Equity Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable" id="aapg_r_ScheduleofCapitalManagementTable">
        <link:definition>996120 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Capital Management (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyDetails" id="aapg_r_CondensedFinancialInformationoftheCompanyDetails">
        <link:definition>996121 - Disclosure - Condensed Financial Information of the Company (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable" id="aapg_r_ScheduleofStatementsofFinancialPositionTable">
        <link:definition>996122 - Disclosure - Condensed Financial Information of the Company - Schedule of Statements of Financial Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable" id="aapg_r_ScheduleofCondensedStatementsofComprehensiveIncomeTable">
        <link:definition>996123 - Disclosure - Condensed Financial Information of the Company - Schedule of Condensed Statements of Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable" id="aapg_r_ScheduleofCondensedStatementsofCashFlowsTable">
        <link:definition>996124 - Disclosure - Condensed Financial Information of the Company - Schedule of Condensed Statements of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable" id="aapg_r_ScheduleofCompanysReservesTable">
        <link:definition>996125 - Disclosure - Condensed Financial Information of the Company - Schedule of Company&#8217;s Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ascentage.cn.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:element name="ConsolidatedStatementsOfComprehensiveLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract"/>
  <xs:element name="ConsolidatedStatementsOfChangesInEquityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ConsolidatedStatementsOfChangesInEquityAbstract"/>
  <xs:element name="ScheduleOfPrincipalSubsidiariesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfPrincipalSubsidiariesAbstract"/>
  <xs:element name="ScheduleOfNewAndRevisedIfrssAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfNewAndRevisedIfrssAbstract"/>
  <xs:element name="ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract"/>
  <xs:element name="ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract"/>
  <xs:element name="ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
  <xs:element name="ScheduleOfRevenueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfRevenueAbstract"/>
  <xs:element name="ScheduleOfNonCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfNonCurrentAssetsAbstract"/>
  <xs:element name="ScheduleOfRevenueFromCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfRevenueFromCustomersAbstract"/>
  <xs:element name="ScheduleOfDisaggregatedRevenueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfDisaggregatedRevenueAbstract"/>
  <xs:element name="ScheduleOfContractLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfContractLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract"/>
  <xs:element name="ScheduleOfOtherExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfOtherExpensesAbstract"/>
  <xs:element name="ScheduleOfPropertyPlantAndEquipmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfPropertyPlantAndEquipmentAbstract"/>
  <xs:element name="ScheduleOfRightOfUseAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfRightOfUseAssetsAbstract"/>
  <xs:element name="ScheduleOfOtherIntangibleAssetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfOtherIntangibleAssetAbstract"/>
  <xs:element name="ScheduleOfGroupSPrincipalJointVentureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract"/>
  <xs:element name="ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract"/>
  <xs:element name="ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract"/>
  <xs:element name="ScheduleOfMovementsInDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfMovementsInDeferredTaxAssetsAbstract"/>
  <xs:element name="ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract"/>
  <xs:element name="ScheduleOfCashAndBankBalancesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCashAndBankBalancesAbstract"/>
  <xs:element name="ScheduleOfTheTradePayablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfTheTradePayablesAbstract"/>
  <xs:element name="ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract"/>
  <xs:element name="ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract"/>
  <xs:element name="ScheduleOfIssuedAndFullyPaidAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfIssuedAndFullyPaidAbstract"/>
  <xs:element name="ScheduleOfShareCapitalAndTreasurySharesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfShareCapitalAndTreasurySharesAbstract"/>
  <xs:element name="ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract"/>
  <xs:element name="ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract"/>
  <xs:element name="ScheduleOfFairValuesOfShareOptionsGrantedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract"/>
  <xs:element name="ScheduleOfUnlockingDateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfUnlockingDateAbstract"/>
  <xs:element name="ScheduleOfRestrictedSharesOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfRestrictedSharesOutstandingAbstract"/>
  <xs:element name="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract"/>
  <xs:element name="ScheduleOfTransactionWithRelatedPartyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfTransactionWithRelatedPartyAbstract"/>
  <xs:element name="ScheduleOfCategoriesOfFinancialInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCategoriesOfFinancialInstrumentsAbstract"/>
  <xs:element name="ScheduleOfFinancialInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfFinancialInstrumentsAbstract"/>
  <xs:element name="ScheduleOfAssetsMeasuredAtFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfAssetsMeasuredAtFairValueAbstract"/>
  <xs:element name="ScheduleOfInterestRateRiskAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfInterestRateRiskAbstract"/>
  <xs:element name="ScheduleOfForeignCurrencyRiskAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfForeignCurrencyRiskAbstract"/>
  <xs:element name="ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract"/>
  <xs:element name="ScheduleOfLiquidityRiskAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfLiquidityRiskAbstract"/>
  <xs:element name="ScheduleOfEquityPriceRiskAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfEquityPriceRiskAbstract"/>
  <xs:element name="ScheduleOfFairValuesOfTheEquityInvestmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfFairValuesOfTheEquityInvestmentsAbstract"/>
  <xs:element name="ScheduleOfCapitalManagementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCapitalManagementAbstract"/>
  <xs:element name="ScheduleOfStatementsOfFinancialPositionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfStatementsOfFinancialPositionAbstract"/>
  <xs:element name="ScheduleOfCondensedStatementsOfCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCondensedStatementsOfCashFlowsAbstract"/>
  <xs:element name="ScheduleOfCompanySReservesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCompanySReservesAbstract"/>
  <xs:element name="CostOfSalesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CostOfSalesAbstract"/>
  <xs:element name="EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract"/>
  <xs:element name="OtherComprehensiveIncomeForTheYearAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherComprehensiveIncomeForTheYearAbstract"/>
  <xs:element name="EquitySettledShareBasedPaymentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_EquitySettledShareBasedPaymentsAbstract"/>
  <xs:element name="OtherComprehensiveIncomeForTheYearAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherComprehensiveIncomeForTheYearAbstract0"/>
  <xs:element name="EquitySettledShareBasedPaymentsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_EquitySettledShareBasedPaymentsAbstract0"/>
  <xs:element name="OtherComprehensiveIncomeForTheYearAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherComprehensiveIncomeForTheYearAbstract1"/>
  <xs:element name="EquitySettledShareBasedPaymentsAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_EquitySettledShareBasedPaymentsAbstract1"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_UnlabeledAbstract"/>
  <xs:element name="TypesOfGoodsOrServicesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypesOfGoodsOrServicesAbstract"/>
  <xs:element name="TimingOfRevenueRecognitionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TimingOfRevenueRecognitionAbstract"/>
  <xs:element name="AtAPointInTimeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AtAPointInTimeAbstract"/>
  <xs:element name="OverTimeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OverTimeAbstract"/>
  <xs:element name="LossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LossAbstract"/>
  <xs:element name="SharesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SharesAbstract"/>
  <xs:element name="AtDecember312024Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AtDecember312024Abstract"/>
  <xs:element name="AtDecember312025Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AtDecember312025Abstract"/>
  <xs:element name="AnalyzedIntoAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AnalyzedIntoAbstract"/>
  <xs:element name="December312025Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_December312025Abstract"/>
  <xs:element name="DenominatedInAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DenominatedInAbstract"/>
  <xs:element name="ShortTermAdvancesRecognizedFromCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ShortTermAdvancesRecognizedFromCustomersAbstract"/>
  <xs:element name="LongTermAdvancesRecognizedFromCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LongTermAdvancesRecognizedFromCustomersAbstract"/>
  <xs:element name="CurrentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CurrentAbstract"/>
  <xs:element name="NonCurrentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_NonCurrentAbstract"/>
  <xs:element name="CurrentAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CurrentAbstract0"/>
  <xs:element name="NonCurrentAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_NonCurrentAbstract0"/>
  <xs:element name="AnalyzedIntoAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AnalyzedIntoAbstract0"/>
  <xs:element name="a2024Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_a2024Abstract"/>
  <xs:element name="a2025Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_a2025Abstract"/>
  <xs:element name="InvestmentsListedInAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_InvestmentsListedInAbstract"/>
  <xs:element name="InvestmentsListedInAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_InvestmentsListedInAbstract0"/>
  <xs:element name="OtherComprehensiveIncomeForTheYearAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherComprehensiveIncomeForTheYearAbstract2"/>
  <xs:element name="EmployeesShareBasedCompensationSchemeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_EmployeesShareBasedCompensationSchemeAbstract"/>
  <xs:element name="OtherComprehensiveIncomeForTheYearAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherComprehensiveIncomeForTheYearAbstract3"/>
  <xs:element name="EmployeesShareBasedCompensationSchemeAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_EmployeesShareBasedCompensationSchemeAbstract0"/>
  <xs:element name="OtherComprehensiveIncomeForTheYearAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherComprehensiveIncomeForTheYearAbstract4"/>
  <xs:element name="EmployeesShareBasedCompensationSchemeAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_EmployeesShareBasedCompensationSchemeAbstract1"/>
  <xs:element name="Interestbearingbankandotherborrowingscurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_Interestbearingbankandotherborrowingscurrent"/>
  <xs:element name="InterestbearingBankAndOtherBorrowingsNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent"/>
  <xs:element name="DeferredIncomeNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_DeferredIncomeNonCurrent"/>
  <xs:element name="CommitmentAndContingencies" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_CommitmentAndContingencies"/>
  <xs:element name="CapitalAndReserves" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_CapitalAndReserves"/>
  <xs:element name="StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary"/>
  <xs:element name="RepurchaseOfOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_RepurchaseOfOrdinaryShares"/>
  <xs:element name="StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses"/>
  <xs:element name="StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses"/>
  <xs:element name="StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits"/>
  <xs:element name="StockIssuedDuringPeriodValueEquitysettledBonus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockIssuedDuringPeriodValueEquitysettledBonus"/>
  <xs:element name="StockIssuedDuringPeriodValueShareOptionExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockIssuedDuringPeriodValueShareOptionExpenses"/>
  <xs:element name="AdjustmentsForDepreciationOfRightofuseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_AdjustmentsForDepreciationOfRightofuseAssets"/>
  <xs:element name="AdjustmentsForGainOnDisposalOfLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_AdjustmentsForGainOnDisposalOfLeases"/>
  <xs:element name="AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances"/>
  <xs:element name="IncreaseDecreaseInTimeDepositsWithOriginalMaturity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity"/>
  <xs:element name="InvestmentInOtherFinancialAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_InvestmentInOtherFinancialAssets"/>
  <xs:element name="InvestmentInJointVenturesClassifiedAsInvestingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities"/>
  <xs:element name="ListingExpensePaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_ListingExpensePaid"/>
  <xs:element name="TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths"/>
  <xs:element name="DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock"/>
  <xs:element name="DisclosureOfLossBeforeTaxExplanatoryTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock"/>
  <xs:element name="DisclosureOfOtherPayablesAndAccrualsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock"/>
  <xs:element name="DisclosureOfContractLiabilitiesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfContractLiabilitiesTextBlock"/>
  <xs:element name="DisclosureOfPledgeOfAssetsExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfPledgeOfAssetsExplanatory"/>
  <xs:element name="DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" type="dtr1:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards"/>
  <xs:element name="DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory"/>
  <xs:element name="DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock"/>
  <xs:element name="DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory"/>
  <xs:element name="DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory"/>
  <xs:element name="DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock"/>
  <xs:element name="ScheduleOfOtherExpensesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfOtherExpensesTableTextBlock"/>
  <xs:element name="DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory"/>
  <xs:element name="DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory"/>
  <xs:element name="DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock"/>
  <xs:element name="DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock"/>
  <xs:element name="ScheduleOfInvestmentInAJointVentureTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock"/>
  <xs:element name="ScheduleOfGroupsPrincipalJointVentureTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock"/>
  <xs:element name="ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock"/>
  <xs:element name="DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory"/>
  <xs:element name="ScheduleOfDeferredTaxLiabilitiesExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory"/>
  <xs:element name="DisclosureOfDeferredTaxAssetsExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfDeferredTaxAssetsExplanatory"/>
  <xs:element name="DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory"/>
  <xs:element name="ScheduleOfOtherNonCurrentAssetsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock"/>
  <xs:element name="DisclosureOfDetailedInformationOfInventoriesExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory"/>
  <xs:element name="ScheduleOfTradeReceivablesNetTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfTradeReceivablesNetTableTextBlock"/>
  <xs:element name="ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock"/>
  <xs:element name="ScheduleOfCashAndBankBalancesExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCashAndBankBalancesExplanatory"/>
  <xs:element name="DisclosureOfTradePayablesExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfTradePayablesExplanatory"/>
  <xs:element name="DisclosureofOtherPayablesAndAccrualsExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory"/>
  <xs:element name="DisclosureOfContractsLiabilitiesExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfContractsLiabilitiesExplanatory"/>
  <xs:element name="ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock"/>
  <xs:element name="ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock"/>
  <xs:element name="ScheduleOfDeferredIncomeTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfDeferredIncomeTableTextBlock"/>
  <xs:element name="DisclosureOfShareCapitalAndTreasurySharesExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory"/>
  <xs:element name="ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock"/>
  <xs:element name="DisclosureOfUnlockingDatetextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfUnlockingDatetextBlock"/>
  <xs:element name="DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory"/>
  <xs:element name="DisclosureofTransactionWithRelatedPartyExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureofTransactionWithRelatedPartyExplanatory"/>
  <xs:element name="DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory"/>
  <xs:element name="DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory"/>
  <xs:element name="DisclosureOfInterestRateRiskExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfInterestRateRiskExplanatory"/>
  <xs:element name="DisclosureOfForeignCurrencyRiskExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfForeignCurrencyRiskExplanatory"/>
  <xs:element name="DisclosureOfEquityPriceRiskExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfEquityPriceRiskExplanatory"/>
  <xs:element name="DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory"/>
  <xs:element name="DisclosureOfCapitalManagementExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisclosureOfCapitalManagementExplanatory"/>
  <xs:element name="ScheduleOfCondensedCashFlowStatementsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock"/>
  <xs:element name="ScheduleOfReservesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfReservesTableTextBlock"/>
  <xs:element name="CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable"/>
  <xs:element name="PercentageOfEquityInterestsAttributableToTheCompanyDirect" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect"/>
  <xs:element name="AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable"/>
  <xs:element name="AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable"/>
  <xs:element name="AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable"/>
  <xs:element name="AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable"/>
  <xs:element name="RightofuseAssetsOfEstimatedUsefulLives" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_RightofuseAssetsOfEstimatedUsefulLives"/>
  <xs:element name="OperatingSegmentInformationScheduleofRevenueDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable"/>
  <xs:element name="OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable"/>
  <xs:element name="OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems"/>
  <xs:element name="OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable"/>
  <xs:element name="OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems"/>
  <xs:element name="RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable"/>
  <xs:element name="RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable"/>
  <xs:element name="RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable"/>
  <xs:element name="RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems"/>
  <xs:element name="LossBeforeTaxArrivedCharingOrCrediting" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_LossBeforeTaxArrivedCharingOrCrediting"/>
  <xs:element name="FinancialAssetsAtFVTPL" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialAssetsAtFVTPL"/>
  <xs:element name="FinancialLiabilitiesAtFVTPL" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialLiabilitiesAtFVTPL"/>
  <xs:element name="PenaltyExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_PenaltyExpense"/>
  <xs:element name="Penaltys" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_Penaltys"/>
  <xs:element name="Penalty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_Penalty"/>
  <xs:element name="OthersExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_OthersExpenses"/>
  <xs:element name="IncomeTaxComputedAtTheStatutoryTaxRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncomeTaxComputedAtTheStatutoryTaxRate"/>
  <xs:element name="LowerTaxRateForASpecificEntity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_LowerTaxRateForASpecificEntity"/>
  <xs:element name="StatutoryIncomeAndExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StatutoryIncomeAndExpense"/>
  <xs:element name="IncomeNotSubjectToTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncomeNotSubjectToTax"/>
  <xs:element name="ResearchAndDevelopmentSuperdeduction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_ResearchAndDevelopmentSuperdeduction"/>
  <xs:element name="GainlossAttributableToJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_GainlossAttributableToJointVentures"/>
  <xs:element name="NewProvisionsReturn" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_NewProvisionsReturn"/>
  <xs:element name="UncertainTaxPosition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_UncertainTaxPosition"/>
  <xs:element name="EffectOfWithholdingTaxOnTheInterestIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_EffectOfWithholdingTaxOnTheInterestIncome"/>
  <xs:element name="NetOperatingLossExpired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_NetOperatingLossExpired"/>
  <xs:element name="DeductibleTemporaryDifferencesNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_DeductibleTemporaryDifferencesNotRecognized"/>
  <xs:element name="PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable"/>
  <xs:element name="PropertyAndEquipmentCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_PropertyAndEquipmentCost"/>
  <xs:element name="AccumulatedDepreciationsCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_AccumulatedDepreciationsCost"/>
  <xs:element name="PropertyAndEquipmentNetOfAccumulatedDepreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation"/>
  <xs:element name="LeasesScheduleofRightofUseAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_LeasesScheduleofRightofUseAssetsDetailsTable"/>
  <xs:element name="ExchangeRealignmentRightofuseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_ExchangeRealignmentRightofuseAssets"/>
  <xs:element name="PaymentsofLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_PaymentsofLeaseLiabilities"/>
  <xs:element name="ExchangeRealignments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_ExchangeRealignments"/>
  <xs:element name="DisposalsLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_DisposalsLeaseLiabilities"/>
  <xs:element name="DepreciationChargeofRightofuseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_DepreciationChargeofRightofuseAssets"/>
  <xs:element name="TotalAmountofRecognizedInProfitOrLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_TotalAmountofRecognizedInProfitOrLoss"/>
  <xs:element name="CostGoodwill" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_CostGoodwill"/>
  <xs:element name="AccumulatedImpairmentGoodwill" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_AccumulatedImpairmentGoodwill"/>
  <xs:element name="OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable"/>
  <xs:element name="IntangibleAssetsGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IntangibleAssetsGross"/>
  <xs:element name="AccumulatedAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_AccumulatedAmortization"/>
  <xs:element name="RegisteredShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_RegisteredShareCapital"/>
  <xs:element name="PrincipalActivities" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PrincipalActivities"/>
  <xs:element name="AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture"/>
  <xs:element name="ListedEquityInvestmentsAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_ListedEquityInvestmentsAtFairValue"/>
  <xs:element name="OtherUnlistedInvestmentsAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherUnlistedInvestmentsAtFairValue"/>
  <xs:element name="DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable"/>
  <xs:element name="DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable"/>
  <xs:element name="DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition"/>
  <xs:element name="ContractAcquisitionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_ContractAcquisitionCosts"/>
  <xs:element name="FinancialAssetsAgingDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialAssetsAgingDomainDomain"/>
  <xs:element name="TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable"/>
  <xs:element name="PrepaymentsForClinicalTrialExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_PrepaymentsForClinicalTrialExpenses"/>
  <xs:element name="PrepaidListingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_PrepaidListingExpense"/>
  <xs:element name="DepositsAssetsPrepayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_DepositsAssetsPrepayments"/>
  <xs:element name="PrepaymentForTreasurySharePurchaseFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_PrepaymentForTreasurySharePurchaseFees"/>
  <xs:element name="CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable"/>
  <xs:element name="TradePayablesScheduleoftheTradePayablesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_TradePayablesScheduleoftheTradePayablesDetailsTable"/>
  <xs:element name="CurretPayablesForConstructionCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_CurretPayablesForConstructionCost"/>
  <xs:element name="GovernmentSubsidy" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_GovernmentSubsidy"/>
  <xs:element name="ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable"/>
  <xs:element name="ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems"/>
  <xs:element name="InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable"/>
  <xs:element name="InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable"/>
  <xs:element name="RecognizedAsIncomeDuringTheYear" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_RecognizedAsIncomeDuringTheYear"/>
  <xs:element name="PortionClassifiedAsCurrentLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_PortionClassifiedAsCurrentLiabilities"/>
  <xs:element name="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable"/>
  <xs:element name="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable"/>
  <xs:element name="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable"/>
  <xs:element name="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems"/>
  <xs:element name="IssuedShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IssuedShareCapital"/>
  <xs:element name="IssueOfOrdinaryShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IssueOfOrdinaryShare"/>
  <xs:element name="IssueOfOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IssueOfOrdinaryShares"/>
  <xs:element name="IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares"/>
  <xs:element name="IssueOfSharesUnderThePreIPOShareOptionScheme" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme"/>
  <xs:element name="IssueOfSharesUnderThe2021RSUSchemeInshares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares"/>
  <xs:element name="IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme"/>
  <xs:element name="IncreaseDecreaseInNumberOfSharesEquitysettledBonus" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus"/>
  <xs:element name="StockIssuedDuringPeriodValuesEquitysettledBonus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus"/>
  <xs:element name="RepurchaseOfOrdinaryShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_RepurchaseOfOrdinaryShare"/>
  <xs:element name="IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares"/>
  <xs:element name="VestingOfRestrictedShareUnit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_VestingOfRestrictedShareUnit"/>
  <xs:element name="VestingOfRestrictedShareUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_VestingOfRestrictedShareUnits"/>
  <xs:element name="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable"/>
  <xs:element name="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems"/>
  <xs:element name="ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable"/>
  <xs:element name="ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable"/>
  <xs:element name="PercentageOfConditionalShares" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PercentageOfConditionalShares"/>
  <xs:element name="PercentageOfVestedConditionalShares" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PercentageOfVestedConditionalShares"/>
  <xs:element name="ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable"/>
  <xs:element name="NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable"/>
  <xs:element name="CashInflowOutflowForLease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_CashInflowOutflowForLease"/>
  <xs:element name="RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable"/>
  <xs:element name="OtherPayablesAndAccruals" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherPayablesAndAccruals"/>
  <xs:element name="OutstandingBalanceOtherNoncurrentLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_OutstandingBalanceOtherNoncurrentLiabilities"/>
  <xs:element name="OutstandingBalanceWithRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_OutstandingBalanceWithRelatedParty"/>
  <xs:element name="FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable"/>
  <xs:element name="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable"/>
  <xs:element name="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems"/>
  <xs:element name="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable"/>
  <xs:element name="IncreasedecreaseInLossBeforeTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncreasedecreaseInLossBeforeTax"/>
  <xs:element name="ChangeInForeignExchangeRatesDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ChangeInForeignExchangeRatesDomainDomain"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable"/>
  <xs:element name="IncreasedecreaseWeakensAgainst" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncreasedecreaseWeakensAgainst"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable"/>
  <xs:element name="CashAndBankBalancesNotYetPastDue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_CashAndBankBalancesNotYetPastDue"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems"/>
  <xs:element name="MarketEquityIndex" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_MarketEquityIndex"/>
  <xs:element name="StockExchangeIndexShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockExchangeIndexShare"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems"/>
  <xs:element name="AdjustedCapitals" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_AdjustedCapitals"/>
  <xs:element name="ExchangeFluctuationReserve" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_ExchangeFluctuationReserve"/>
  <xs:element name="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable"/>
  <xs:element name="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems"/>
  <xs:element name="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable"/>
  <xs:element name="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems"/>
  <xs:element name="ComprehensiveIncomeLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_ComprehensiveIncomeLoss"/>
  <xs:element name="PreIPOShareOptionExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_PreIPOShareOptionExpenses"/>
  <xs:element name="RestrictedShareUnitExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_RestrictedShareUnitExpenses"/>
  <xs:element name="StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions"/>
  <xs:element name="StockIssuedDuringPeriodValueVestingOfRSUs" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockIssuedDuringPeriodValueVestingOfRSUs"/>
  <xs:element name="AccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_AccountingPoliciesDetailsTable"/>
  <xs:element name="OtherEmployeeBenefitContributionPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherEmployeeBenefitContributionPercentage"/>
  <xs:element name="AnnualBaseSalaryPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AnnualBaseSalaryPercentage"/>
  <xs:element name="IncomeTaxesDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncomeTaxesDomainDomain"/>
  <xs:element name="SignificantAccountingJudgementsandEstimatesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_SignificantAccountingJudgementsandEstimatesDetailsTable"/>
  <xs:element name="IncomeTaxDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_IncomeTaxDetailsTable"/>
  <xs:element name="PreferentialRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PreferentialRate"/>
  <xs:element name="WithholdingTax" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_WithholdingTax"/>
  <xs:element name="LeasesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_LeasesDetailsTable"/>
  <xs:element name="TermsOfLandLease" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TermsOfLandLease"/>
  <xs:element name="LeaseTerms" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LeaseTerms"/>
  <xs:element name="DeferredTaxDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_DeferredTaxDetailsTable"/>
  <xs:element name="FutureTaxableProfitsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_FutureTaxableProfitsPercentage"/>
  <xs:element name="TaxCredits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_TaxCredits"/>
  <xs:element name="UnrecognizedTaxBenefit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_UnrecognizedTaxBenefit"/>
  <xs:element name="DeferredTaxAssetsTaxLossCarryforwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_DeferredTaxAssetsTaxLossCarryforwards"/>
  <xs:element name="UnrecognizedTaxBenefitsRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_UnrecognizedTaxBenefitsRecognized"/>
  <xs:element name="CashandBankBalancesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_CashandBankBalancesDetailsTable"/>
  <xs:element name="ContractLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ContractLiabilitiesDetailsTable"/>
  <xs:element name="InterestBearingBankandOtherBorrowingsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_InterestBearingBankandOtherBorrowingsDetailsTable"/>
  <xs:element name="ShareCapitalandTreasurySharesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ShareCapitalandTreasurySharesDetailsTable"/>
  <xs:element name="WeightedAverageExercisePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_WeightedAverageExercisePrice"/>
  <xs:element name="NumberOfTreasuryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_NumberOfTreasuryShares"/>
  <xs:element name="BonusDueToEmployeesAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_BonusDueToEmployeesAmount"/>
  <xs:element name="SharesConsiderationAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_SharesConsiderationAmount"/>
  <xs:element name="SubscriptionOfShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SubscriptionOfShares"/>
  <xs:element name="AllottedSharesPricePerShares" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_AllottedSharesPricePerShares"/>
  <xs:element name="StockPurchasedDuringPeriodShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_StockPurchasedDuringPeriodShares"/>
  <xs:element name="ReservesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ReservesDetailsTable"/>
  <xs:element name="TransferredOutFromCapitalAndReserves" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_TransferredOutFromCapitalAndReserves"/>
  <xs:element name="CapitalAndReserveFunds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_CapitalAndReserveFunds"/>
  <xs:element name="BonusAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_BonusAmount"/>
  <xs:element name="GrantAnniversariesDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_GrantAnniversariesDomainDomain"/>
  <xs:element name="ShareBasedPaymentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_ShareBasedPaymentsDetailsTable"/>
  <xs:element name="ShareGrantExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_ShareGrantExpense"/>
  <xs:element name="AdditionalOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_AdditionalOrdinaryShares"/>
  <xs:element name="PercentageOfExceedShareCapital" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PercentageOfExceedShareCapital"/>
  <xs:element name="AggregateShareIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AggregateShareIssued"/>
  <xs:element name="SharesGranted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_SharesGranted"/>
  <xs:element name="PercentageOfVestingRequirementsForSharebasedPaymentArrangement" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement"/>
  <xs:element name="NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement"/>
  <xs:element name="SharebasedPaymentVestingPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SharebasedPaymentVestingPeriod"/>
  <xs:element name="RSUsGrantedFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_RSUsGrantedFairValue"/>
  <xs:element name="NotestotheConsolidatedStatementsofCashFlowsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable"/>
  <xs:element name="NumberOfGrantees" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_NumberOfGrantees"/>
  <xs:element name="NumberOfNewlyIssuedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_NumberOfNewlyIssuedShares"/>
  <xs:element name="NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities"/>
  <xs:element name="NonCashDisposals" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="aapg_NonCashDisposals"/>
  <xs:element name="NoncashAdditionsToIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_NoncashAdditionsToIntangibleAssets"/>
  <xs:element name="NonCashAdditionsToPropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_NonCashAdditionsToPropertyPlantAndEquipment"/>
  <xs:element name="CommitmentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_CommitmentsDetailsTable"/>
  <xs:element name="CommitmentsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CommitmentsDetailsLineItems"/>
  <xs:element name="RelatedPartyTransactionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_RelatedPartyTransactionsDetailsTable"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable"/>
  <xs:element name="FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems"/>
  <xs:element name="InterestBearingBankBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="aapg_InterestBearingBankBorrowings"/>
  <xs:element name="ConcentrationsOfCreditRisk" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_ConcentrationsOfCreditRisk"/>
  <xs:element name="LiquidityRiskPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="aapg_LiquidityRiskPercentage"/>
  <xs:element name="ChangeInForeignExchangeRatesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="aapg_ChangeInForeignExchangeRatesAxis"/>
  <xs:element name="FinancialAssetsAgingAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="aapg_FinancialAssetsAgingAxis"/>
  <xs:element name="GrantAnniversariesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="aapg_GrantAnniversariesAxis"/>
  <xs:element name="IncomeTaxesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="aapg_IncomeTaxesAxis"/>
  <xs:element name="AccountingStandardsVolume11Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AccountingStandardsVolume11Member"/>
  <xs:element name="AccruedInterestInOtherPayablesAndAccrualsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AccruedInterestInOtherPayablesAndAccrualsMember"/>
  <xs:element name="AmendmentsToIASTwentyOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AmendmentsToIASTwentyOneMember"/>
  <xs:element name="AmendmentsToIFRSNineAndIFRSSevenMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AmendmentsToIFRSNineAndIFRSSevenMember"/>
  <xs:element name="AmendmentsToIFRSNineAndIFRSSevenOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember"/>
  <xs:element name="AmendmentsToIFRSTenAndIFRSTwentyEightMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember"/>
  <xs:element name="AscentagePharmaGroupIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AscentagePharmaGroupIncMember"/>
  <xs:element name="AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember"/>
  <xs:element name="BankAndOtherLoansMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_BankAndOtherLoansMember"/>
  <xs:element name="BankLoansSecuredMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_BankLoansSecuredMember"/>
  <xs:element name="BankLoansUnsecuredMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_BankLoansUnsecuredMember"/>
  <xs:element name="BankLoansUnsecuredOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_BankLoansUnsecuredOneMember"/>
  <xs:element name="CapitalAndReservesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CapitalAndReservesMember"/>
  <xs:element name="CapitalManagementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CapitalManagementMember"/>
  <xs:element name="CarryingAmountOfEquityInvestmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CarryingAmountOfEquityInvestmentsMember"/>
  <xs:element name="ChiefCommercialOfficerMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ChiefCommercialOfficerMember"/>
  <xs:element name="ChineseMainlandMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ChineseMainlandMember"/>
  <xs:element name="CommercializationRightsIncomeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CommercializationRightsIncomeMember"/>
  <xs:element name="ConstructionInProcessMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ConstructionInProcessMember"/>
  <xs:element name="ContractLiabilitiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ContractLiabilitiesMember"/>
  <xs:element name="CurrentPortionOfLongTermBankLoansSecuredMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CurrentPortionOfLongTermBankLoansSecuredMember"/>
  <xs:element name="CurrentPortionOfLongTermBankLoansUnsecuredMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember"/>
  <xs:element name="CurrentPortionOfLongTermBankLoansUnsecuredOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember"/>
  <xs:element name="CustomerAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CustomerAMember"/>
  <xs:element name="CustomerBMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CustomerBMember"/>
  <xs:element name="CustomerCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CustomerCMember"/>
  <xs:element name="CustomerDMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CustomerDMember"/>
  <xs:element name="DecreaseincreaseInLossBeforeTaxMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DecreaseincreaseInLossBeforeTaxMember"/>
  <xs:element name="DerivativeFinancialInstrumentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DerivativeFinancialInstrumentsMember"/>
  <xs:element name="DonationExpensesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DonationExpensesMember"/>
  <xs:element name="DrYangDajunMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DrYangDajunMember"/>
  <xs:element name="DrYangMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DrYangMember"/>
  <xs:element name="DrZhaiYifanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DrZhaiYifanMember"/>
  <xs:element name="EmployeeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_EmployeeMember"/>
  <xs:element name="FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember"/>
  <xs:element name="FinancialAssetsAtAmortizedCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialAssetsAtAmortizedCostMember"/>
  <xs:element name="FinancialAssetsAtFairValueThroughProfitOrLossMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember"/>
  <xs:element name="FinancialAssetsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialAssetsMember"/>
  <xs:element name="FinancialLiabilitiesAtAmortizedCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialLiabilitiesAtAmortizedCostMember"/>
  <xs:element name="FinancialLiabilitiesAtFairValueThroughProfitOrLossMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember"/>
  <xs:element name="FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember"/>
  <xs:element name="FinancialLiabilitiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FinancialLiabilitiesMember"/>
  <xs:element name="FirstAnniversariesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FirstAnniversariesMember"/>
  <xs:element name="ForecastMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ForecastMember"/>
  <xs:element name="FourthAnniversaryMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FourthAnniversaryMember"/>
  <xs:element name="FurnitureAndEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FurnitureAndEquipmentMember"/>
  <xs:element name="GuangzhouHealthquestPharmaCoLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_GuangzhouHealthquestPharmaCoLtdMember"/>
  <xs:element name="HealthquestPharmaAcquisitionAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_HealthquestPharmaAcquisitionAgreementMember"/>
  <xs:element name="HighAndNewTechnologyEnterpriseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_HighAndNewTechnologyEnterpriseMember"/>
  <xs:element name="HongKongStockExchangeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_HongKongStockExchangeMember"/>
  <xs:element name="IFRSEighteenMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IFRSEighteenMember"/>
  <xs:element name="IFRSNineteenMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IFRSNineteenMember"/>
  <xs:element name="IfRMBStrengthensAgainstUSDollarsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IfRMBStrengthensAgainstUSDollarsMember"/>
  <xs:element name="IfRMBWeakensAgainstUSDollarsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IfRMBWeakensAgainstUSDollarsMember"/>
  <xs:element name="IncreasedecreaseInBasisPointsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncreasedecreaseInBasisPointsMember"/>
  <xs:element name="IncreasedecreaseInLossBeforeTaxMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IncreasedecreaseInLossBeforeTaxMember"/>
  <xs:element name="InnoventBiologicsSuzhouCoLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_InnoventBiologicsSuzhouCoLtdMember"/>
  <xs:element name="IntellectualPropertyIncomeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IntellectualPropertyIncomeMember"/>
  <xs:element name="IntellectuallPropertyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_IntellectuallPropertyMember"/>
  <xs:element name="InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember"/>
  <xs:element name="LeaseLiabilitiesCurrentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LeaseLiabilitiesCurrentMember"/>
  <xs:element name="LeaseLiabilitiesNonCurrentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LeaseLiabilitiesNonCurrentMember"/>
  <xs:element name="LeaseLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LeaseLiabilityMember"/>
  <xs:element name="LeaseholdLandMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LeaseholdLandMember"/>
  <xs:element name="LloanPrimeRateMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LloanPrimeRateMember"/>
  <xs:element name="LongtermAdvancesRecognizedFromCustomersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LongtermAdvancesRecognizedFromCustomersMember"/>
  <xs:element name="LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember"/>
  <xs:element name="MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember"/>
  <xs:element name="MonetaryAssetsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_MonetaryAssetsMember"/>
  <xs:element name="NonExecutiveDirectorMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_NonExecutiveDirectorMember"/>
  <xs:element name="OneToThreeMonthsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OneToThreeMonthsMember"/>
  <xs:element name="OtherNonCurrentLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherNonCurrentLiabilityMember"/>
  <xs:element name="OthersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OthersMember"/>
  <xs:element name="OverTimeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OverTimeMember"/>
  <xs:element name="PatentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PatentMember"/>
  <xs:element name="PostIPOOptionSchemeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PostIPOOptionSchemeMember"/>
  <xs:element name="PreIPOShareOptionSchemeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PreIPOShareOptionSchemeMember"/>
  <xs:element name="PreIPOShareOptionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PreIPOShareOptionsMember"/>
  <xs:element name="ProductsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ProductsMember"/>
  <xs:element name="RSUMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_RSUMember"/>
  <xs:element name="ReservesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ReservesMember"/>
  <xs:element name="RestrictedShareUnitMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_RestrictedShareUnitMember"/>
  <xs:element name="SecondAnniversaryMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SecondAnniversaryMember"/>
  <xs:element name="SecuredBankBorrowingsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SecuredBankBorrowingsMember"/>
  <xs:element name="SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember"/>
  <xs:element name="ShareCapitalMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ShareCapitalMember"/>
  <xs:element name="ShareOptionSchemeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ShareOptionSchemeMember"/>
  <xs:element name="ShortTermBorrowingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ShortTermBorrowingMember"/>
  <xs:element name="ShorttermAdvancesRecognizedFromCustomersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ShorttermAdvancesRecognizedFromCustomersMember"/>
  <xs:element name="SimplifiedApproachMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SimplifiedApproachMember"/>
  <xs:element name="SpecialOptionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SpecialOptionsMember"/>
  <xs:element name="Stage1Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_Stage1Member"/>
  <xs:element name="StageThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_StageThreeMember"/>
  <xs:element name="StageTwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_StageTwoMember"/>
  <xs:element name="SuzhouAscentagePharmaCoLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SuzhouAscentagePharmaCoLtdMember"/>
  <xs:element name="SuzhouShengheInnovationWorksBiotechCoLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember"/>
  <xs:element name="SuzhouYashengMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_SuzhouYashengMember"/>
  <xs:element name="TaxesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TaxesMember"/>
  <xs:element name="ThirdAnniversaryMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ThirdAnniversaryMember"/>
  <xs:element name="ThreeToSixMonthsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ThreeToSixMonthsMember"/>
  <xs:element name="TradePayablesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TradePayablesMember"/>
  <xs:element name="TradeReceivables45To120DaysMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TradeReceivables45To120DaysMember"/>
  <xs:element name="TradeReceivablesWithin45DaysMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TradeReceivablesWithin45DaysMember"/>
  <xs:element name="TreasurySharesOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TreasurySharesOneMember"/>
  <xs:element name="TwentySixNov202526Nov2035Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TwentySixNov202526Nov2035Member"/>
  <xs:element name="TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember"/>
  <xs:element name="TwoThousandEighteenRSUSchemeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TwoThousandEighteenRSUSchemeMember"/>
  <xs:element name="TwoThousandTwentyOneRSUSchemeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TwoThousandTwentyOneRSUSchemeMember"/>
  <xs:element name="TwoThousandTwentyOnesRSUSchemeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TwoThousandTwentyOnesRSUSchemeMember"/>
  <xs:element name="TwoThousandTwentyTwoFurtherGrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TwoThousandTwentyTwoFurtherGrantMember"/>
  <xs:element name="TwoThousandTwentyTwoRSUSchemeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TwoThousandTwentyTwoRSUSchemeMember"/>
  <xs:element name="TwoThousandTwentyTwoRSUchemeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TwoThousandTwentyTwoRSUchemeMember"/>
  <xs:element name="TypeOfEligibleParticipants10Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants10Member"/>
  <xs:element name="TypeOfEligibleParticipants1OneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants1OneMember"/>
  <xs:element name="TypeOfEligibleParticipants1ThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants1ThreeMember"/>
  <xs:element name="TypeOfEligibleParticipants1TwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants1TwoMember"/>
  <xs:element name="TypeOfEligibleParticipants2FourMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants2FourMember"/>
  <xs:element name="TypeOfEligibleParticipants2OneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants2OneMember"/>
  <xs:element name="TypeOfEligibleParticipants2ThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants2ThreeMember"/>
  <xs:element name="TypeOfEligibleParticipants7Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants7Member"/>
  <xs:element name="TypeOfEligibleParticipants8Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants8Member"/>
  <xs:element name="TypeOfEligibleParticipants9Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipants9Member"/>
  <xs:element name="TypeOfEligibleParticipantsFiveMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipantsFiveMember"/>
  <xs:element name="TypeOfEligibleParticipantsFourMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipantsFourMember"/>
  <xs:element name="TypeOfEligibleParticipantsOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipantsOneMember"/>
  <xs:element name="TypeOfEligibleParticipantsSixMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipantsSixMember"/>
  <xs:element name="TypeOfEligibleParticipantsThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipantsThreeMember"/>
  <xs:element name="TypeOfEligibleParticipantsTwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypeOfEligibleParticipantsTwoMember"/>
  <xs:element name="TypesOfGoodsOrServicesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_TypesOfGoodsOrServicesMember"/>
  <xs:element name="WithinOneMonthMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_WithinOneMonthMember"/>
  <xs:element name="ApprovalOfTheFinancialStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ApprovalOfTheFinancialStatementsAbstract"/>
  <xs:element name="CashAndBankBalancesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CashAndBankBalancesAbstract"/>
  <xs:element name="CashAndBankBalancesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_CashAndBankBalancesLineItems"/>
  <xs:element name="ContractLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ContractLiabilitiesLineItems"/>
  <xs:element name="DeferredTaxLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DeferredTaxLineItems"/>
  <xs:element name="DividendAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DividendAbstract"/>
  <xs:element name="FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract"/>
  <xs:element name="LeasesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_LeasesLineItems"/>
  <xs:element name="MovementsInGovernmentGrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_MovementsInGovernmentGrantsAbstract"/>
  <xs:element name="NetOfLossAllowanceLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_NetOfLossAllowanceLineItems"/>
  <xs:element name="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems"/>
  <xs:element name="OtherIntangibleAssetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_OtherIntangibleAssetAbstract"/>
  <xs:element name="PledgeOfAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_PledgeOfAssetsAbstract"/>
  <xs:element name="ScheduleOfCashAndBankBalancesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCashAndBankBalancesLineItems"/>
  <xs:element name="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems"/>
  <xs:element name="ScheduleOfDeferredIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfDeferredIncomeAbstract"/>
  <xs:element name="ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems"/>
  <xs:element name="ScheduleOfFinanceCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfFinanceCostsAbstract"/>
  <xs:element name="ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems"/>
  <xs:element name="ScheduleOfInventoriesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfInventoriesAbstract"/>
  <xs:element name="ScheduleOfInvestmentInAJointVentureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfInvestmentInAJointVentureAbstract"/>
  <xs:element name="ScheduleOfLossBeforeTaxAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfLossBeforeTaxAbstract"/>
  <xs:element name="ScheduleOfOtherIntangibleAssetLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfOtherIntangibleAssetLineItems"/>
  <xs:element name="ScheduleOfOtherNonCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfOtherNonCurrentAssetsAbstract"/>
  <xs:element name="ScheduleOfTheTradePayablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_ScheduleOfTheTradePayablesLineItems"/>
<!-- [WMV7][r4m7E4LM4InJcXt/yIMLsURghhzAuFOZJ9AoAgICqvB0ljzDyQBT28qpZUVOwnuQwQXrnDGxwsZYW18vag9aT2Cb6ryNHgB7reaTqHSnkvrl1/BPAWbEsYJtxswY6qMSDJPxp0pdusPl5VYGpJJCeIyI4Dpv8ucwOoAsrR7cKovwZSechS0gj67abOUTsREqmaKMpGkVeE2u6jV3fZeVBjeYtPhM+arB2AuBoTt6G0gimVX7CboH4wk9jW8vhrW5IQc++Z6TbkArdZd2DoLOFDvacJE2fB9ZdiP3zJxxL+CzGAwI5UaRlKXloGsQyXTRb4caCRY+iRY7+z3o6XVBYyFN7VEwr1ExS0PbNUshCjZNAu0uEJlQDR0Ag1qqknjEy0V+T5L5pKHz] CSR-->
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="aapg_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>58
<FILENAME>aapg-20251231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Wed Apr 29 21:00:58 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedIncomeStatement" roleURI="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedIncomeStatementAlt0" roleURI="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatementAlt0"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedComprehensiveIncome" roleURI="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedComprehensiveIncomeAlt0" roleURI="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncomeAlt0"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedBalanceSheet" roleURI="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedCashFlow" roleURI="http://www.ascentage.cn.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherIncomeandGainsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherExpensesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFinanceCostsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRecognizedinProfitorLossTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofGoodwillTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherNonCurrentAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInventoriesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInterestBearingBankandOtherBorrowingsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOutstandingBalancewithRelatedPartyTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCompensationofkeyManagementPersonnelTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCategoriesofFinancialInstrumentsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFinancialInstrumentsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCreditQualityandMaximumExposureToCreditRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCapitalManagementTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofStatementsofFinancialPositionTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCondensedStatementsofComprehensiveIncomeTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCondensedStatementsofCashFlowsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"/>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_Revenue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_CostOfSales" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_GrossProfit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_OtherIncome" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_SellingExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdministrativeExpense" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_OtherExpenseByNature" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_FinanceCosts" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossBeforeTax" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatementAlt0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncomeAlt0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_RightofuseAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_Goodwill" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_OtherIntangibleAssets" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_DeferredTaxAssets" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_Inventories" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentTradeReceivables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_OtherCurrentPayables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentContractLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_Interestbearingbankandotherborrowingscurrent" xlink:href="aapg-20251231.xsd#aapg_Interestbearingbankandotherborrowingscurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="aapg_Interestbearingbankandotherborrowingscurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentAssets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentLiabilities" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_NoncurrentAssets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_CurrentAssets" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentContractLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent" xlink:href="aapg-20251231.xsd#aapg_InterestbearingBankAndOtherBorrowingsNonCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredIncomeNonCurrent" xlink:href="aapg-20251231.xsd#aapg_DeferredIncomeNonCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="aapg_DeferredIncomeNonCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_CurrentLiabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_NoncurrentLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_SharePremium" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_CapitalAndReserves" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="aapg_CapitalAndReserves" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_TreasuryShares" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_NoncontrollingInterests" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForGainOnDisposalOfLeases" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForGainOnDisposalOfLeases"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="aapg_AdjustmentsForGainOnDisposalOfLeases" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForDepreciationOfRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForDepreciationOfRightofuseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="aapg_AdjustmentsForDepreciationOfRightofuseAssets" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForFinanceCosts" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForProvisions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForProvisions" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" order="10" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_InvestmentInOtherFinancialAssets" xlink:href="aapg-20251231.xsd#aapg_InvestmentInOtherFinancialAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="aapg_InvestmentInOtherFinancialAssets" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities" xlink:href="aapg-20251231.xsd#aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromIssuingShares" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_ListingExpensePaid" xlink:href="aapg-20251231.xsd#aapg_ListingExpensePaid"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="aapg_ListingExpensePaid" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:to="ifrs-full_CashAndCashEquivalents" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" xlink:href="aapg-20251231.xsd#aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:to="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetForeignExchangeGain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetForeignExchangeGain"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_NetForeignExchangeGain" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RentalIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RentalIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_RentalIncome" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherGainsLosses" order="7" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DonationsAndSubsidiesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DonationsAndSubsidiesExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_DonationsAndSubsidiesExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ForeignExchangeLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ForeignExchangeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_ForeignExchangeLoss" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_Penalty" xlink:href="aapg-20251231.xsd#aapg_Penalty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="aapg_Penalty" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_OthersExpenses" xlink:href="aapg-20251231.xsd#aapg_OthersExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="aapg_OthersExpenses" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" order="7" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBankLoansAndOverdrafts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsCapitalised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_InterestCostsCapitalised" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_InterestExpenseOnBorrowings" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_CurrentTaxExpenseIncome" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_DeferredTaxExpenseIncome" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <loc xlink:type="locator" xlink:label="aapg_LowerTaxRateForASpecificEntity" xlink:href="aapg-20251231.xsd#aapg_LowerTaxRateForASpecificEntity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_LowerTaxRateForASpecificEntity" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectFromChangeInTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxEffectFromChangeInTaxRate" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_UncertainTaxPosition" xlink:href="aapg-20251231.xsd#aapg_UncertainTaxPosition"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_UncertainTaxPosition" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_EffectOfWithholdingTaxOnTheInterestIncome" xlink:href="aapg-20251231.xsd#aapg_EffectOfWithholdingTaxOnTheInterestIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_EffectOfWithholdingTaxOnTheInterestIncome" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_NetOperatingLossExpired" xlink:href="aapg-20251231.xsd#aapg_NetOperatingLossExpired"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_NetOperatingLossExpired" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_DeductibleTemporaryDifferencesNotRecognized" xlink:href="aapg-20251231.xsd#aapg_DeductibleTemporaryDifferencesNotRecognized"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_DeductibleTemporaryDifferencesNotRecognized" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxComputedAtTheStatutoryTaxRate" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxComputedAtTheStatutoryTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_IncomeTaxComputedAtTheStatutoryTaxRate" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_StatutoryIncomeAndExpense" xlink:href="aapg-20251231.xsd#aapg_StatutoryIncomeAndExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_StatutoryIncomeAndExpense" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeNotSubjectToTax" xlink:href="aapg-20251231.xsd#aapg_IncomeNotSubjectToTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_IncomeNotSubjectToTax" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_ResearchAndDevelopmentSuperdeduction" xlink:href="aapg-20251231.xsd#aapg_ResearchAndDevelopmentSuperdeduction"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_ResearchAndDevelopmentSuperdeduction" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_GainlossAttributableToJointVentures" xlink:href="aapg-20251231.xsd#aapg_GainlossAttributableToJointVentures"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_GainlossAttributableToJointVentures" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="aapg_NewProvisionsReturn" xlink:href="aapg-20251231.xsd#aapg_NewProvisionsReturn"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aapg_NewProvisionsReturn" order="14" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_TotalAmountofRecognizedInProfitOrLoss" xlink:href="aapg-20251231.xsd#aapg_TotalAmountofRecognizedInProfitOrLoss"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aapg_TotalAmountofRecognizedInProfitOrLoss" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_DepreciationChargeofRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_DepreciationChargeofRightofuseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aapg_TotalAmountofRecognizedInProfitOrLoss" xlink:to="aapg_DepreciationChargeofRightofuseAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aapg_TotalAmountofRecognizedInProfitOrLoss" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofGoodwillTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <loc xlink:type="locator" xlink:label="aapg_CostGoodwill" xlink:href="aapg-20251231.xsd#aapg_CostGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Goodwill" xlink:to="aapg_CostGoodwill" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_AccumulatedImpairmentGoodwill" xlink:href="aapg-20251231.xsd#aapg_AccumulatedImpairmentGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Goodwill" xlink:to="aapg_AccumulatedImpairmentGoodwill" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractAcquisitionCosts" xlink:href="aapg-20251231.xsd#aapg_ContractAcquisitionCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="aapg_ContractAcquisitionCosts" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentValueAddedTaxReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_NoncurrentValueAddedTaxReceivables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermDeposits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_LongtermDeposits" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPrepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPrepayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_NoncurrentPrepayments" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInventoriesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WorkInProgress" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WorkInProgress"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_WorkInProgress" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinishedGoods"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_FinishedGoods" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_CurrentProvisions" order="3" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <loc xlink:type="locator" xlink:label="aapg_PrepaymentsForClinicalTrialExpenses" xlink:href="aapg-20251231.xsd#aapg_PrepaymentsForClinicalTrialExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="aapg_PrepaymentsForClinicalTrialExpenses" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_PrepaidListingExpense" xlink:href="aapg-20251231.xsd#aapg_PrepaidListingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="aapg_PrepaidListingExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ValueAddedTaxReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="ifrs-full_ValueAddedTaxReceivables" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="ifrs-full_OtherReceivables" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_DepositsAssetsPrepayments" xlink:href="aapg-20251231.xsd#aapg_DepositsAssetsPrepayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="aapg_DepositsAssetsPrepayments" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_PrepaymentForTreasurySharePurchaseFees" xlink:href="aapg-20251231.xsd#aapg_PrepaymentForTreasurySharePurchaseFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="aapg_PrepaymentForTreasurySharePurchaseFees" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Prepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Prepayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="ifrs-full_Prepayments" order="7" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_ShorttermBorrowings" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_LongtermBorrowings" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_CashInflowOutflowForLease" xlink:href="aapg-20251231.xsd#aapg_CashInflowOutflowForLease"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aapg_CashInflowOutflowForLease" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aapg_CashInflowOutflowForLease" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_OutstandingBalanceWithRelatedParty" xlink:href="aapg-20251231.xsd#aapg_OutstandingBalanceWithRelatedParty"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherPayablesAndAccruals" xlink:href="aapg-20251231.xsd#aapg_OtherPayablesAndAccruals"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aapg_OutstandingBalanceWithRelatedParty" xlink:to="aapg_OtherPayablesAndAccruals" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_OutstandingBalanceOtherNoncurrentLiabilities" xlink:href="aapg-20251231.xsd#aapg_OutstandingBalanceOtherNoncurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aapg_OutstandingBalanceWithRelatedParty" xlink:to="aapg_OutstandingBalanceOtherNoncurrentLiabilities" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_NoncurrentReceivables" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_LongtermBorrowings" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_CashAndBankBalancesNotYetPastDue" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesNotYetPastDue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="aapg_CashAndBankBalancesNotYetPastDue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_TradeReceivables" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDebt" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDebt"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetDebt" xlink:to="ifrs-full_OtherBorrowings" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetDebt" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetDebt" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetDebt" xlink:to="ifrs-full_OtherPayables" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetDebt" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_NetDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustedCapitals" xlink:href="aapg-20251231.xsd#aapg_AdjustedCapitals"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="aapg_AdjustedCapitals" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiaries"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_InvestmentsInSubsidiaries" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReceivablesDueFromAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesDueFromAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_ReceivablesDueFromAssociates" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_OtherCurrentPayables" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentAssets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentLiabilities" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_NoncurrentAssets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_CurrentAssetsLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetAssetsLiabilities" xlink:to="ifrs-full_AssetsLessCurrentLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_IssuedCapital" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReserves" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_OtherReserves" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="aapg_ExchangeFluctuationReserve" xlink:href="aapg-20251231.xsd#aapg_ExchangeFluctuationReserve"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="aapg_ExchangeFluctuationReserve" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_RetainedEarnings" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_TreasuryShares" order="5" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_OtherGainsLosses" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_OperatingExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_OtherExpenseByNature" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
<!-- [WMV7][yp5VMC6p/FRPELsDG9mq914vLykc/h0zaeF3riPQ1RzlpARILYTz6a8JRBHIomlma4jxNIwVdxeTYTcBc8NuywJTIHFAoZEP7oXTzA1BHP0WJ3NDNl59k2xIyKzMwxVCXCBYmEWum/WYXhU+uLKjL/YXHud3GXe9gYh/MTCc8RTV63PgXiKR71Akmmoe/CcqK7RZ9ELNLMbAaqUfdvjKBM1bYr7H97wT1BdBN5UYL4hVZTxX+SP4WXBMDxxi9itjs5SXrtccU+PFzGFDtQAjcpfKUrKevK6g74Q7uNXbZylJ7JWoaco6uZCyLARuIX/wkwZ13g28O2TxH6eRSoECTNSwsyPMY4IAMXOeG8goLgx5aepr/IHlnjdJZCA9gN7zBYt3UnoNdRtT6rYk] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="4" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>59
<FILENAME>aapg-20251231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Wed Apr 29 21:00:58 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedIncomeStatement" roleURI="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedComprehensiveIncome" roleURI="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedBalanceSheet" roleURI="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareholdersEquityType2or3" roleURI="http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedCashFlow" roleURI="http://www.ascentage.cn.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CorporateandGroupInformation" roleURI="http://www.ascentage.cn.com/role/CorporateandGroupInformation"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_AccountingPolicies" roleURI="http://www.ascentage.cn.com/role/AccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_SignificantAccountingJudgementsandEstimates" roleURI="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimates"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OperatingSegmentInformation" roleURI="http://www.ascentage.cn.com/role/OperatingSegmentInformation"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RevenueOtherIncomeandGains" roleURI="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGains"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossBeforeTax" roleURI="http://www.ascentage.cn.com/role/LossBeforeTax"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherExpenses" roleURI="http://www.ascentage.cn.com/role/OtherExpenses"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinanceCosts" roleURI="http://www.ascentage.cn.com/role/FinanceCosts"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_IncomeTax" roleURI="http://www.ascentage.cn.com/role/IncomeTax"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Dividends" roleURI="http://www.ascentage.cn.com/role/Dividends"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany" roleURI="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PropertyPlantandEquipment" roleURI="http://www.ascentage.cn.com/role/PropertyPlantandEquipment"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Leases" roleURI="http://www.ascentage.cn.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Goodwill" roleURI="http://www.ascentage.cn.com/role/Goodwill"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherIntangibleAsset" roleURI="http://www.ascentage.cn.com/role/OtherIntangibleAsset"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InvestmentinaJointVenture" roleURI="http://www.ascentage.cn.com/role/InvestmentinaJointVenture"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialAssetsatFairValuethroughProfitorLoss" roleURI="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLoss"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredTax" roleURI="http://www.ascentage.cn.com/role/DeferredTax"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherNonCurrentAssets" roleURI="http://www.ascentage.cn.com/role/OtherNonCurrentAssets"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Inventories" roleURI="http://www.ascentage.cn.com/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_TradeReceivablesNet" roleURI="http://www.ascentage.cn.com/role/TradeReceivablesNet"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PrepaymentsOtherReceivablesandOtherAssets" roleURI="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssets"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CashandBankBalances" roleURI="http://www.ascentage.cn.com/role/CashandBankBalances"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_TradePayables" roleURI="http://www.ascentage.cn.com/role/TradePayables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherPayablesandAccruals" roleURI="http://www.ascentage.cn.com/role/OtherPayablesandAccruals"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContractLiabilities" roleURI="http://www.ascentage.cn.com/role/ContractLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InterestBearingBankandOtherBorrowings" roleURI="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowings"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredIncome" roleURI="http://www.ascentage.cn.com/role/DeferredIncome"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareCapitalandTreasuryShares" roleURI="http://www.ascentage.cn.com/role/ShareCapitalandTreasuryShares"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Reserves" roleURI="http://www.ascentage.cn.com/role/Reserves"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareBasedPayments" roleURI="http://www.ascentage.cn.com/role/ShareBasedPayments"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_NotestotheConsolidatedStatementsofCashFlows" roleURI="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Commitments" roleURI="http://www.ascentage.cn.com/role/Commitments"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContingentLiabilities" roleURI="http://www.ascentage.cn.com/role/ContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PledgeofAssets" roleURI="http://www.ascentage.cn.com/role/PledgeofAssets"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RelatedPartyTransactions" roleURI="http://www.ascentage.cn.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialInstrumentsbyCategory" roleURI="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategory"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FairValueandFairValueHierarchyofFinancialInstruments" roleURI="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstruments"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialRiskManagementObjectivesandPolicies" roleURI="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPolicies"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_EventAftertheReportingPeriod" roleURI="http://www.ascentage.cn.com/role/EventAftertheReportingPeriod"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CondensedFinancialInformationoftheCompany" roleURI="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompany"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ApprovaloftheFinancialStatements" roleURI="http://www.ascentage.cn.com/role/ApprovaloftheFinancialStatements"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_AccountingPoliciesByPolicy" roleURI="http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CorporateandGroupInformationTables" roleURI="http://www.ascentage.cn.com/role/CorporateandGroupInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_AccountingPoliciesTables" roleURI="http://www.ascentage.cn.com/role/AccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OperatingSegmentInformationTables" roleURI="http://www.ascentage.cn.com/role/OperatingSegmentInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RevenueOtherIncomeandGainsTables" roleURI="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossBeforeTaxTables" roleURI="http://www.ascentage.cn.com/role/LossBeforeTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherExpensesTables" roleURI="http://www.ascentage.cn.com/role/OtherExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinanceCostsTables" roleURI="http://www.ascentage.cn.com/role/FinanceCostsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_IncomeTaxTables" roleURI="http://www.ascentage.cn.com/role/IncomeTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables" roleURI="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PropertyPlantandEquipmentTables" roleURI="http://www.ascentage.cn.com/role/PropertyPlantandEquipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LeasesTables" roleURI="http://www.ascentage.cn.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_GoodwillTables" roleURI="http://www.ascentage.cn.com/role/GoodwillTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherIntangibleAssetTables" roleURI="http://www.ascentage.cn.com/role/OtherIntangibleAssetTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InvestmentinaJointVentureTables" roleURI="http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialAssetsatFairValuethroughProfitorLossTables" roleURI="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLossTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredTaxTables" roleURI="http://www.ascentage.cn.com/role/DeferredTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherNonCurrentAssetsTables" roleURI="http://www.ascentage.cn.com/role/OtherNonCurrentAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InventoriesTables" roleURI="http://www.ascentage.cn.com/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_TradeReceivablesNetTables" roleURI="http://www.ascentage.cn.com/role/TradeReceivablesNetTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PrepaymentsOtherReceivablesandOtherAssetsTables" roleURI="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CashandBankBalancesTables" roleURI="http://www.ascentage.cn.com/role/CashandBankBalancesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_TradePayablesTables" roleURI="http://www.ascentage.cn.com/role/TradePayablesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherPayablesandAccrualsTables" roleURI="http://www.ascentage.cn.com/role/OtherPayablesandAccrualsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContractLiabilitiesTables" roleURI="http://www.ascentage.cn.com/role/ContractLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InterestBearingBankandOtherBorrowingsTables" roleURI="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredIncomeTables" roleURI="http://www.ascentage.cn.com/role/DeferredIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareCapitalandTreasurySharesTables" roleURI="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareBasedPaymentsTables" roleURI="http://www.ascentage.cn.com/role/ShareBasedPaymentsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_NotestotheConsolidatedStatementsofCashFlowsTables" roleURI="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RelatedPartyTransactionsTables" roleURI="http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialInstrumentsbyCategoryTables" roleURI="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategoryTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FairValueandFairValueHierarchyofFinancialInstrumentsTables" roleURI="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstrumentsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialRiskManagementObjectivesandPoliciesTables" roleURI="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CondensedFinancialInformationoftheCompanyTables" roleURI="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofPrincipalSubsidiariesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofNewandRevisedIFRSsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofPropertyPlantandEquipmentofAnnualRatesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRevenueTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRevenueTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofNonCurrentAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRevenuefromCustomersTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofDisaggregatedRevenueTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofContractLiabilitiesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherIncomeandGainsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofLossBeforeTaxTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherExpensesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFinanceCostsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofBasicLossPerShareTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofBasicLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofPropertyPlantandEquipmentTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRightofUseAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofLeaseLiabilitiesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRecognizedinProfitorLossTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofGoodwillTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherIntangibleAssetTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInvestmentinaJointVentureTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInvestmentinaJointVentureTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofGroupsPrincipalJointVentureTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInformationoftheGroupsJointVentureTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofMovementsinDeferredTaxAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherNonCurrentAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInventoriesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofTradeReceivablesNetTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofTradeReceivablesNetTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCashandBankBalancesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleoftheTradePayablesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherPayablesandAccrualsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofContractLiabilitiesTable0" roleURI="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInterestBearingBankandOtherBorrowingsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofDeferredIncomeTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofDeferredIncomeTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofMovementsinGovernmentGrantsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofIssuedandFullyPaidTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofIssuedandFullyPaidTable_Parentheticals" roleURI="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofShareCapitalandTreasurySharesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleoffairvaluesofshareoptionsgrantedTable" roleURI="http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofUnlockingDateTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRestrictedSharesOutstandingTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofTransactionwithRelatedPartyTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOutstandingBalancewithRelatedPartyTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCompensationofkeyManagementPersonnelTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCategoriesofFinancialInstrumentsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFinancialInstrumentsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofAssetsMeasuredatFairValueTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInterestRateRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofForeignCurrencyRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCreditQualityandMaximumExposureToCreditRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofLiquidityRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofEquityPriceRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFairValuesoftheEquityInvestmentsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCapitalManagementTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofStatementsofFinancialPositionTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCondensedStatementsofComprehensiveIncomeTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCondensedStatementsofCashFlowsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCompanysReservesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_AccountingPoliciesDetails" roleURI="http://www.ascentage.cn.com/role/AccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_SignificantAccountingJudgementsandEstimatesDetails" roleURI="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OperatingSegmentInformationDetails" roleURI="http://www.ascentage.cn.com/role/OperatingSegmentInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_IncomeTaxDetails" roleURI="http://www.ascentage.cn.com/role/IncomeTaxDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails" roleURI="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LeasesDetails" roleURI="http://www.ascentage.cn.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_GoodwillDetails" roleURI="http://www.ascentage.cn.com/role/GoodwillDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredTaxDetails" roleURI="http://www.ascentage.cn.com/role/DeferredTaxDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CashandBankBalancesDetails" roleURI="http://www.ascentage.cn.com/role/CashandBankBalancesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContractLiabilitiesDetails" roleURI="http://www.ascentage.cn.com/role/ContractLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InterestBearingBankandOtherBorrowingsDetails" roleURI="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareCapitalandTreasurySharesDetails" roleURI="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ReservesDetails" roleURI="http://www.ascentage.cn.com/role/ReservesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareBasedPaymentsDetails" roleURI="http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_NotestotheConsolidatedStatementsofCashFlowsDetails" roleURI="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CommitmentsDetails" roleURI="http://www.ascentage.cn.com/role/CommitmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContingentLiabilitiesDetails" roleURI="http://www.ascentage.cn.com/role/ContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RelatedPartyTransactionsDetails" roleURI="http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialRiskManagementObjectivesandPoliciesDetails" roleURI="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CondensedFinancialInformationoftheCompanyDetails" roleURI="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#DocumentAndEntityInformation" roleURI="http://www.ascentage.cn.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="ifrs-full_ProductsAndServicesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IntellectuallPropertyMember" xlink:href="aapg-20251231.xsd#aapg_IntellectuallPropertyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="aapg_IntellectuallPropertyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ProductsMember" xlink:href="aapg-20251231.xsd#aapg_ProductsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="aapg_ProductsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OthersMember" xlink:href="aapg-20251231.xsd#aapg_OthersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="aapg_OthersMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_Revenue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_CostOfSales" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_OtherIncome" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_SellingExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_AdministrativeExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_OtherExpenseByNature" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_FinanceCosts" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ProfitLossBeforeTax" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ProfitLoss" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:href="aapg-20251231.xsd#aapg_ConsolidatedStatementsOfComprehensiveLossAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_OtherComprehensiveIncome" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_RightofuseAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Goodwill" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_OtherIntangibleAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_OtherNoncurrentAssets" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Inventories" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentTradeReceivables" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssets" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_OtherCurrentPayables" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentContractLiabilities" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_Interestbearingbankandotherborrowingscurrent" xlink:href="aapg-20251231.xsd#aapg_Interestbearingbankandotherborrowingscurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="aapg_Interestbearingbankandotherborrowingscurrent" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsLiabilities" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_AssetsLessCurrentLiabilities" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentContractLiabilities" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent" xlink:href="aapg-20251231.xsd#aapg_InterestbearingBankAndOtherBorrowingsNonCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredIncomeNonCurrent" xlink:href="aapg-20251231.xsd#aapg_DeferredIncomeNonCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="aapg_DeferredIncomeNonCurrent" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_OtherNoncurrentLiabilities" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentLiabilities" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CommitmentAndContingencies" xlink:href="aapg-20251231.xsd#aapg_CommitmentAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="aapg_CommitmentAndContingencies" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Liabilities" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_TreasuryShares" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_SharePremium" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CapitalAndReserves" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="aapg_CapitalAndReserves" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncontrollingInterests" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Equity" order="37" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_ParValuePerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesAuthorised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesAuthorised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NumberOfSharesAuthorised" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NumberOfSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NumberOfSharesOutstanding" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_IssuedCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasurySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_TreasurySharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_SharePremiumMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CapitalAndReservesMember" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReservesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="aapg_CapitalAndReservesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_RetainedEarningsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_ParentMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterestsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_NoncontrollingInterestsMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ProfitLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ComprehensiveIncome" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IssueOfEquity" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_RepurchaseOfOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_RepurchaseOfOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aapg_RepurchaseOfOrdinaryShares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueEquitysettledBonus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aapg_StockIssuedDuringPeriodValueEquitysettledBonus" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueShareOptionExpenses" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueShareOptionExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aapg_StockIssuedDuringPeriodValueShareOptionExpenses" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForDepreciationOfRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForDepreciationOfRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="aapg_AdjustmentsForDepreciationOfRightofuseAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForGainOnDisposalOfLeases" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForGainOnDisposalOfLeases"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="aapg_AdjustmentsForGainOnDisposalOfLeases" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForFinanceCosts" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForProvisions" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_InvestmentInOtherFinancialAssets" xlink:href="aapg-20251231.xsd#aapg_InvestmentInOtherFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="aapg_InvestmentInOtherFinancialAssets" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities" xlink:href="aapg-20251231.xsd#aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromIssuingShares" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ListingExpensePaid" xlink:href="aapg-20251231.xsd#aapg_ListingExpensePaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="aapg_ListingExpensePaid" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="44" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="45" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="46" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="47" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="48" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" xlink:href="aapg-20251231.xsd#aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" order="49" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="50" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/CorporateandGroupInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/AccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimates" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OperatingSegmentInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGains" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/LossBeforeTax" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OtherExpenses" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseByNatureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ExpenseByNatureAbstract" xlink:to="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FinanceCosts" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_InterestCostsAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/IncomeTax" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/Dividends" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_DividendAbstract" xlink:href="aapg-20251231.xsd#aapg_DividendAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDividendsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDividendsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DividendAbstract" xlink:to="ifrs-full_DisclosureOfDividendsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/PropertyPlantandEquipment" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/Leases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/Goodwill" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfGoodwillExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OtherIntangibleAsset" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_OtherIntangibleAssetAbstract" xlink:href="aapg-20251231.xsd#aapg_OtherIntangibleAssetAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_OtherIntangibleAssetAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/InvestmentinaJointVenture" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLoss" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/DeferredTax" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OtherNonCurrentAssets" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/Inventories" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/TradeReceivablesNet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssets" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:to="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/CashandBankBalances" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_CashAndBankBalancesAbstract" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CashAndBankBalancesAbstract" xlink:to="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/TradePayables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OtherPayablesandAccruals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ContractLiabilities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfContractLiabilitiesTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfContractLiabilitiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ContractLiabilitiesAbstract" xlink:to="aapg_DisclosureOfContractLiabilitiesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowings" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsAbstract" xlink:to="ifrs-full_DisclosureOfBorrowingsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/DeferredIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDeferredIncomeExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfDeferredIncomeExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ShareCapitalandTreasuryShares" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/Reserves" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:to="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ShareBasedPayments" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlows" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowHedgesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowHedgesAbstract" xlink:to="ifrs-full_DisclosureOfCashFlowStatementExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/Commitments" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CapitalCommitmentsAbstract" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ContingentLiabilities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/PledgeofAssets" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_PledgeOfAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_PledgeOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfPledgeOfAssetsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfPledgeOfAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_PledgeOfAssetsAbstract" xlink:to="aapg_DisclosureOfPledgeOfAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/RelatedPartyTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategory" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstruments" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:href="aapg-20251231.xsd#aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/EventAftertheReportingPeriod" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompany" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ApprovaloftheFinancialStatements" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ApprovalOfTheFinancialStatementsAbstract" xlink:href="aapg-20251231.xsd#aapg_ApprovalOfTheFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ApprovalOfTheFinancialStatementsAbstract" xlink:to="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" order="33" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/CorporateandGroupInformationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/AccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OperatingSegmentInformationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfProductsAndServicesExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPerformanceObligationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPerformanceObligationsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfPerformanceObligationsExplanatory" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/LossBeforeTaxTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OtherExpensesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseByNatureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherExpensesTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherExpensesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ExpenseByNatureAbstract" xlink:to="aapg_ScheduleOfOtherExpensesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FinanceCostsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceCostExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_InterestCostsAbstract" xlink:to="ifrs-full_DisclosureOfFinanceCostExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/IncomeTaxTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/LeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/GoodwillTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OtherIntangibleAssetTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_OtherIntangibleAssetAbstract" xlink:href="aapg-20251231.xsd#aapg_OtherIntangibleAssetAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_OtherIntangibleAssetAbstract" xlink:to="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLossTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:to="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/DeferredTaxTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDeferredTaxAssetsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDeferredTaxAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="aapg_DisclosureOfDeferredTaxAssetsExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OtherNonCurrentAssetsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/InventoriesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/TradeReceivablesNetTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfTradeReceivablesNetTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTradeReceivablesNetTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="aapg_ScheduleOfTradeReceivablesNetTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssetsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:to="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/CashandBankBalancesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_CashAndBankBalancesAbstract" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCashAndBankBalancesExplanatory" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCashAndBankBalancesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CashAndBankBalancesAbstract" xlink:to="aapg_ScheduleOfCashAndBankBalancesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/TradePayablesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfTradePayablesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfTradePayablesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="aapg_DisclosureOfTradePayablesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OtherPayablesandAccrualsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureofOtherPayablesAndAccrualsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ContractLiabilitiesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfContractsLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfContractsLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ContractLiabilitiesAbstract" xlink:to="aapg_DisclosureOfContractsLiabilitiesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsAbstract" xlink:to="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsAbstract" xlink:to="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/DeferredIncomeTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfDeferredIncomeTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDeferredIncomeTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:to="aapg_ScheduleOfDeferredIncomeTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ShareBasedPaymentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfUnlockingDatetextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfUnlockingDatetextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="aapg_DisclosureOfUnlockingDatetextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowHedgesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowHedgesAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowHedgesAbstract" xlink:to="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureofTransactionWithRelatedPartyExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureofTransactionWithRelatedPartyExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="aapg_DisclosureofTransactionWithRelatedPartyExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategoryTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstrumentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:href="aapg-20251231.xsd#aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:to="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfInterestRateRiskExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfInterestRateRiskExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="aapg_DisclosureOfInterestRateRiskExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfForeignCurrencyRiskExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfForeignCurrencyRiskExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="aapg_DisclosureOfForeignCurrencyRiskExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="ifrs-full_DisclosureOfCreditRiskExposureExplanatory" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfLiquidityRiskExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLiquidityRiskExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="ifrs-full_DisclosureOfLiquidityRiskExplanatory" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfEquityPriceRiskExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfEquityPriceRiskExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="aapg_DisclosureOfEquityPriceRiskExplanatory" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfCapitalManagementExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCapitalManagementExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="aapg_DisclosureOfCapitalManagementExplanatory" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfReservesTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfReservesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="aapg_ScheduleOfReservesTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SuzhouAscentagePharmaCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_SuzhouAscentagePharmaCoLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="aapg_SuzhouAscentagePharmaCoLtdMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_GuangzhouHealthquestPharmaCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_GuangzhouHealthquestPharmaCoLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="aapg_GuangzhouHealthquestPharmaCoLtdMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AscentagePharmaGroupIncMember" xlink:href="aapg-20251231.xsd#aapg_AscentagePharmaGroupIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="aapg_AscentagePharmaGroupIncMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect" xlink:href="aapg-20251231.xsd#aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NewIFRSsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NewIFRSsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" xlink:to="ifrs-full_NewIFRSsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NewIFRSsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NewIFRSsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="ifrs-full_NewIFRSsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NewIFRSsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NewIFRSsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="ifrs-full_NewIFRSsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IFRSEighteenMember" xlink:href="aapg-20251231.xsd#aapg_IFRSEighteenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NewIFRSsDomain" xlink:to="aapg_IFRSEighteenMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IFRSNineteenMember" xlink:href="aapg-20251231.xsd#aapg_IFRSNineteenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NewIFRSsDomain" xlink:to="aapg_IFRSNineteenMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AmendmentsToIFRSNineAndIFRSSevenMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIFRSNineAndIFRSSevenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NewIFRSsDomain" xlink:to="aapg_AmendmentsToIFRSNineAndIFRSSevenMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NewIFRSsDomain" xlink:to="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NewIFRSsDomain" xlink:to="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AmendmentsToIASTwentyOneMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIASTwentyOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NewIFRSsDomain" xlink:to="aapg_AmendmentsToIASTwentyOneMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingStandardsVolume11Member" xlink:href="aapg-20251231.xsd#aapg_AccountingStandardsVolume11Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NewIFRSsDomain" xlink:to="aapg_AccountingStandardsVolume11Member" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TitleOfNewIFRS" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TitleOfNewIFRS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="ifrs-full_TitleOfNewIFRS" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_BuildingsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseholdImprovementsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_LeaseholdImprovementsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FurnitureAndEquipmentMember" xlink:href="aapg-20251231.xsd#aapg_FurnitureAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="aapg_FurnitureAndEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MotorVehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MotorVehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_MotorVehiclesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRatePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRatePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DepreciationRatePropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" xlink:to="ifrs-full_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_ComputerSoftwareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_LicencesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems" xlink:to="aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="ifrs-full_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseholdLandMember" xlink:href="aapg-20251231.xsd#aapg_LeaseholdLandMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:to="aapg_LeaseholdLandMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:to="ifrs-full_BuildingsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_RightofuseAssetsOfEstimatedUsefulLives" xlink:href="aapg-20251231.xsd#aapg_RightofuseAssetsOfEstimatedUsefulLives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems" xlink:to="aapg_RightofuseAssetsOfEstimatedUsefulLives" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRevenueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems" xlink:to="aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ChineseMainlandMember" xlink:href="aapg-20251231.xsd#aapg_ChineseMainlandMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="aapg_ChineseMainlandMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_CH" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CH" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems" xlink:to="ifrs-full_Revenue" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems" xlink:to="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ChineseMainlandMember" xlink:href="aapg-20251231.xsd#aapg_ChineseMainlandMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="aapg_ChineseMainlandMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OthersMember" xlink:href="aapg-20251231.xsd#aapg_OthersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="aapg_OthersMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems" xlink:to="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorCustomersAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" xlink:to="ifrs-full_MajorCustomersAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorCustomersDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="ifrs-full_MajorCustomersDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorCustomersDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="ifrs-full_MajorCustomersDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CustomerAMember" xlink:href="aapg-20251231.xsd#aapg_CustomerAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorCustomersDomain" xlink:to="aapg_CustomerAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CustomerBMember" xlink:href="aapg-20251231.xsd#aapg_CustomerBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorCustomersDomain" xlink:to="aapg_CustomerBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CustomerCMember" xlink:href="aapg-20251231.xsd#aapg_CustomerCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorCustomersDomain" xlink:to="aapg_CustomerCMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CustomerDMember" xlink:href="aapg-20251231.xsd#aapg_CustomerDMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorCustomersDomain" xlink:to="aapg_CustomerDMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" xlink:to="ifrs-full_ProductsAndServicesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IntellectualPropertyIncomeMember" xlink:href="aapg-20251231.xsd#aapg_IntellectualPropertyIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="aapg_IntellectualPropertyIncomeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ProductsMember" xlink:href="aapg-20251231.xsd#aapg_ProductsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="aapg_ProductsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CommercializationRightsIncomeMember" xlink:href="aapg-20251231.xsd#aapg_CommercializationRightsIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="aapg_CommercializationRightsIncomeMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OthersMember" xlink:href="aapg-20251231.xsd#aapg_OthersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="aapg_OthersMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypesOfGoodsOrServicesMember" xlink:href="aapg-20251231.xsd#aapg_TypesOfGoodsOrServicesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="aapg_TypesOfGoodsOrServicesMember" order="4" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:to="aapg_TypesOfGoodsOrServicesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:to="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodsOrServicesTransferredOverTimeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_Revenue" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" xlink:to="ifrs-full_SegmentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems" xlink:to="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_NotLaterThanOneYearMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanOneYearMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetForeignExchangeGain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetForeignExchangeGain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_NetForeignExchangeGain" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RentalIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RentalIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_RentalIncome" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_OtherGainsLosses" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_OtherIncome" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfLossBeforeTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSalesRoomOccupancyServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesRoomOccupancyServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_CostOfSalesRoomOccupancyServices" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoryWritedown2011" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoryWritedown2011"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_InventoryWritedown2011" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_DepreciationExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WagesAndSalaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WagesAndSalaries"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_WagesAndSalaries" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LossBeforeTaxArrivedCharingOrCrediting" xlink:href="aapg-20251231.xsd#aapg_LossBeforeTaxArrivedCharingOrCrediting"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="aapg_LossBeforeTaxArrivedCharingOrCrediting" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAtFVTPL" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAtFVTPL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="aapg_FinancialAssetsAtFVTPL" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesAtFVTPL" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtFVTPL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="aapg_FinancialLiabilitiesAtFVTPL" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForGainOnDisposalOfLeases" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForGainOnDisposalOfLeases"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="aapg_AdjustmentsForGainOnDisposalOfLeases" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PenaltyExpense" xlink:href="aapg-20251231.xsd#aapg_PenaltyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="aapg_PenaltyExpense" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AuditorsRemuneration" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AuditorsRemuneration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AuditorsRemuneration" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DonationsAndSubsidiesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DonationsAndSubsidiesExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_DonationsAndSubsidiesExpense" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_Penaltys" xlink:href="aapg-20251231.xsd#aapg_Penaltys"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="aapg_Penaltys" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherExpensesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DonationsAndSubsidiesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DonationsAndSubsidiesExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_DonationsAndSubsidiesExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ForeignExchangeLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ForeignExchangeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_ForeignExchangeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_Penalty" xlink:href="aapg-20251231.xsd#aapg_Penalty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherExpensesAbstract" xlink:to="aapg_Penalty" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OthersExpenses" xlink:href="aapg-20251231.xsd#aapg_OthersExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherExpensesAbstract" xlink:to="aapg_OthersExpenses" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_OtherExpenseByNature" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFinanceCostsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFinanceCostsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBankLoansAndOverdrafts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFinanceCostsAbstract" xlink:to="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsCapitalised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFinanceCostsAbstract" xlink:to="ifrs-full_InterestCostsCapitalised" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFinanceCostsAbstract" xlink:to="ifrs-full_InterestExpenseOnBorrowings" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFinanceCostsAbstract" xlink:to="ifrs-full_FinanceCosts" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:to="ifrs-full_CurrentTaxExpenseIncome" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:to="ifrs-full_DeferredTaxExpenseIncome" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxComputedAtTheStatutoryTaxRate" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxComputedAtTheStatutoryTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_IncomeTaxComputedAtTheStatutoryTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LowerTaxRateForASpecificEntity" xlink:href="aapg-20251231.xsd#aapg_LowerTaxRateForASpecificEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_LowerTaxRateForASpecificEntity" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StatutoryIncomeAndExpense" xlink:href="aapg-20251231.xsd#aapg_StatutoryIncomeAndExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_StatutoryIncomeAndExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeNotSubjectToTax" xlink:href="aapg-20251231.xsd#aapg_IncomeNotSubjectToTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_IncomeNotSubjectToTax" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ResearchAndDevelopmentSuperdeduction" xlink:href="aapg-20251231.xsd#aapg_ResearchAndDevelopmentSuperdeduction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_ResearchAndDevelopmentSuperdeduction" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_GainlossAttributableToJointVentures" xlink:href="aapg-20251231.xsd#aapg_GainlossAttributableToJointVentures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_GainlossAttributableToJointVentures" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NewProvisionsReturn" xlink:href="aapg-20251231.xsd#aapg_NewProvisionsReturn"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_NewProvisionsReturn" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectFromChangeInTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxEffectFromChangeInTaxRate" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_UncertainTaxPosition" xlink:href="aapg-20251231.xsd#aapg_UncertainTaxPosition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_UncertainTaxPosition" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_EffectOfWithholdingTaxOnTheInterestIncome" xlink:href="aapg-20251231.xsd#aapg_EffectOfWithholdingTaxOnTheInterestIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_EffectOfWithholdingTaxOnTheInterestIncome" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NetOperatingLossExpired" xlink:href="aapg-20251231.xsd#aapg_NetOperatingLossExpired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_NetOperatingLossExpired" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DeductibleTemporaryDifferencesNotRecognized" xlink:href="aapg-20251231.xsd#aapg_DeductibleTemporaryDifferencesNotRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aapg_DeductibleTemporaryDifferencesNotRecognized" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="15" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofBasicLossPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BasicEarningsPerShareAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BasicEarningsPerShareAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" xlink:href="aapg-20251231.xsd#aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_BuildingsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseholdImprovementsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_LeaseholdImprovementsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OfficeEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_OfficeEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MotorVehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MotorVehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_MotorVehiclesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConstructionInProgressMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_ConstructionInProgressMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PropertyAndEquipmentCost" xlink:href="aapg-20251231.xsd#aapg_PropertyAndEquipmentCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="aapg_PropertyAndEquipmentCost" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AccumulatedDepreciationsCost" xlink:href="aapg-20251231.xsd#aapg_AccumulatedDepreciationsCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="aapg_AccumulatedDepreciationsCost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation" xlink:href="aapg-20251231.xsd#aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_LeasesScheduleofRightofUseAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_LeasesScheduleofRightofUseAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="aapg_LeasesScheduleofRightofUseAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_LeasesScheduleofRightofUseAssetsDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_BuildingsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseholdLandMember" xlink:href="aapg-20251231.xsd#aapg_LeaseholdLandMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="aapg_LeaseholdLandMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_RightofuseAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_AdditionsToRightofuseAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DepreciationRightofuseAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisposalsRightofuseAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ExchangeRealignmentRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_ExchangeRealignmentRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="aapg_ExchangeRealignmentRightofuseAssets" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_LeaseLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PaymentsofLeaseLiabilities" xlink:href="aapg-20251231.xsd#aapg_PaymentsofLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="aapg_PaymentsofLeaseLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ExchangeRealignments" xlink:href="aapg-20251231.xsd#aapg_ExchangeRealignments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="aapg_ExchangeRealignments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DisposalsLeaseLiabilities" xlink:href="aapg-20251231.xsd#aapg_DisposalsLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="aapg_DisposalsLeaseLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DepreciationChargeofRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_DepreciationChargeofRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="aapg_DepreciationChargeofRightofuseAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TotalAmountofRecognizedInProfitOrLoss" xlink:href="aapg-20251231.xsd#aapg_TotalAmountofRecognizedInProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="aapg_TotalAmountofRecognizedInProfitOrLoss" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofGoodwillTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ChangesInGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_CostGoodwill" xlink:href="aapg-20251231.xsd#aapg_CostGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="aapg_CostGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AccumulatedImpairmentGoodwill" xlink:href="aapg-20251231.xsd#aapg_AccumulatedImpairmentGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="aapg_AccumulatedImpairmentGoodwill" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="ifrs-full_Goodwill" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherIntangibleAssetLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherIntangibleAssetLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ScheduleOfOtherIntangibleAssetLineItems" xlink:to="aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_ComputerSoftwareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PatentMember" xlink:href="aapg-20251231.xsd#aapg_PatentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="aapg_PatentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicencesAndFranchisesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesAndFranchisesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_LicencesAndFranchisesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ConstructionInProcessMember" xlink:href="aapg-20251231.xsd#aapg_ConstructionInProcessMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="aapg_ConstructionInProcessMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherIntangibleAssetLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherIntangibleAssetLineItems" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherIntangibleAssetLineItems" xlink:to="ifrs-full_AmortisationExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IntangibleAssetsGross" xlink:href="aapg-20251231.xsd#aapg_IntangibleAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherIntangibleAssetLineItems" xlink:to="aapg_IntangibleAssetsGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AccumulatedAmortization" xlink:href="aapg-20251231.xsd#aapg_AccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherIntangibleAssetLineItems" xlink:to="aapg_AccumulatedAmortization" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInvestmentinaJointVentureTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInvestmentInAJointVentureAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInvestmentInAJointVentureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInvestmentInAJointVentureAbstract" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfGroupSPrincipalJointVentureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_RegisteredShareCapital" xlink:href="aapg-20251231.xsd#aapg_RegisteredShareCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:to="aapg_RegisteredShareCapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:to="ifrs-full_ProportionOfOwnershipInterestInJointVenture" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PrincipalActivities" xlink:href="aapg-20251231.xsd#aapg_PrincipalActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:to="aapg_PrincipalActivities" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" xlink:href="aapg-20251231.xsd#aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ListedEquityInvestmentsAtFairValue" xlink:href="aapg-20251231.xsd#aapg_ListedEquityInvestmentsAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:to="aapg_ListedEquityInvestmentsAtFairValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherUnlistedInvestmentsAtFairValue" xlink:href="aapg-20251231.xsd#aapg_OtherUnlistedInvestmentsAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:to="aapg_OtherUnlistedInvestmentsAtFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxLineItems" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_DeferredTaxLineItems" xlink:to="aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember" xlink:href="aapg-20251231.xsd#aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="ifrs-full_RightofuseAssetsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="ifrs-full_NetDeferredTaxLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" xlink:to="srt_RestatementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesMember" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="aapg_ContractLiabilitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="ifrs-full_LeaseLiabilitiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DonationExpensesMember" xlink:href="aapg-20251231.xsd#aapg_DonationExpensesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="aapg_DonationExpensesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember" xlink:href="aapg-20251231.xsd#aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestatedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="ifrs-full_RestatedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherNonCurrentAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherNonCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractAcquisitionCosts" xlink:href="aapg-20251231.xsd#aapg_ContractAcquisitionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="aapg_ContractAcquisitionCosts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentValueAddedTaxReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentValueAddedTaxReceivables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="ifrs-full_LongtermDeposits" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPrepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPrepayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentPrepayments" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="ifrs-full_OtherNoncurrentAssets" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInventoriesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInventoriesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WorkInProgress" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WorkInProgress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_WorkInProgress" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinishedGoods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_FinishedGoods" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_CurrentProvisions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_Inventories" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofTradeReceivablesNetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_NetOfLossAllowanceLineItems" xlink:href="aapg-20251231.xsd#aapg_NetOfLossAllowanceLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" xlink:href="aapg-20251231.xsd#aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_NetOfLossAllowanceLineItems" xlink:to="aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAgingAxis" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAgingAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" xlink:to="aapg_FinancialAssetsAgingAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAgingDomainDomain" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAgingDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="aapg_FinancialAssetsAgingAxis" xlink:to="aapg_FinancialAssetsAgingDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAgingDomainDomain_0" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAgingDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="aapg_FinancialAssetsAgingAxis" xlink:to="aapg_FinancialAssetsAgingDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TradeReceivablesWithin45DaysMember" xlink:href="aapg-20251231.xsd#aapg_TradeReceivablesWithin45DaysMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialAssetsAgingDomainDomain" xlink:to="aapg_TradeReceivablesWithin45DaysMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TradeReceivables45To120DaysMember" xlink:href="aapg-20251231.xsd#aapg_TradeReceivables45To120DaysMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialAssetsAgingDomainDomain" xlink:to="aapg_TradeReceivables45To120DaysMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NetOfLossAllowanceLineItems" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_PrepaymentsForClinicalTrialExpenses" xlink:href="aapg-20251231.xsd#aapg_PrepaymentsForClinicalTrialExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="aapg_PrepaymentsForClinicalTrialExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PrepaidListingExpense" xlink:href="aapg-20251231.xsd#aapg_PrepaidListingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="aapg_PrepaidListingExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ValueAddedTaxReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="ifrs-full_ValueAddedTaxReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="ifrs-full_OtherReceivables" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DepositsAssetsPrepayments" xlink:href="aapg-20251231.xsd#aapg_DepositsAssetsPrepayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="aapg_DepositsAssetsPrepayments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PrepaymentForTreasurySharePurchaseFees" xlink:href="aapg-20251231.xsd#aapg_PrepaymentForTreasurySharePurchaseFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="aapg_PrepaymentForTreasurySharePurchaseFees" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Prepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Prepayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="ifrs-full_Prepayments" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCashAndBankBalancesLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCashAndBankBalancesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ScheduleOfCashAndBankBalancesLineItems" xlink:to="aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_CN" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CN"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="country_CN" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_HK"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="country_HK" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OthersMember" xlink:href="aapg-20251231.xsd#aapg_OthersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="aapg_OthersMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_CashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepositsFromBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepositsFromBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_DepositsFromBanks" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BalancesWithBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BalancesWithBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_BalancesWithBanks" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfTheTradePayablesLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTheTradePayablesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_TradePayablesScheduleoftheTradePayablesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_TradePayablesScheduleoftheTradePayablesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ScheduleOfTheTradePayablesLineItems" xlink:to="aapg_TradePayablesScheduleoftheTradePayablesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_TradePayablesScheduleoftheTradePayablesDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_WithinOneMonthMember" xlink:href="aapg-20251231.xsd#aapg_WithinOneMonthMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="aapg_WithinOneMonthMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OneToThreeMonthsMember" xlink:href="aapg-20251231.xsd#aapg_OneToThreeMonthsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="aapg_OneToThreeMonthsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ThreeToSixMonthsMember" xlink:href="aapg-20251231.xsd#aapg_ThreeToSixMonthsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="aapg_ThreeToSixMonthsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfTheTradePayablesLineItems" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccrualsClassifiedAsCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccrualsClassifiedAsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_AccrualsClassifiedAsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CurretPayablesForConstructionCost" xlink:href="aapg-20251231.xsd#aapg_CurretPayablesForConstructionCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="aapg_CurretPayablesForConstructionCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_OtherPayables" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_GovernmentSubsidy" xlink:href="aapg-20251231.xsd#aapg_GovernmentSubsidy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="aapg_GovernmentSubsidy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentExciseTaxPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentExciseTaxPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_CurrentExciseTaxPayables" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_OtherCurrentPayables" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems" xlink:to="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfCustomersAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" xlink:to="ifrs-full_TypesOfCustomersAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfCustomersDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfCustomersAxis" xlink:to="ifrs-full_TypesOfCustomersDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfCustomersDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfCustomersAxis" xlink:to="ifrs-full_TypesOfCustomersDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ShorttermAdvancesRecognizedFromCustomersMember" xlink:href="aapg-20251231.xsd#aapg_ShorttermAdvancesRecognizedFromCustomersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfCustomersDomain" xlink:to="aapg_ShorttermAdvancesRecognizedFromCustomersMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LongtermAdvancesRecognizedFromCustomersMember" xlink:href="aapg-20251231.xsd#aapg_LongtermAdvancesRecognizedFromCustomersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfCustomersDomain" xlink:to="aapg_LongtermAdvancesRecognizedFromCustomersMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems" xlink:to="ifrs-full_ContractLiabilities" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ShortTermBorrowingMember" xlink:href="aapg-20251231.xsd#aapg_ShortTermBorrowingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_ShortTermBorrowingMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember" xlink:href="aapg-20251231.xsd#aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember" xlink:href="aapg-20251231.xsd#aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CurrentPortionOfLongTermBankLoansSecuredMember" xlink:href="aapg-20251231.xsd#aapg_CurrentPortionOfLongTermBankLoansSecuredMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_CurrentPortionOfLongTermBankLoansSecuredMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseLiabilitiesCurrentMember" xlink:href="aapg-20251231.xsd#aapg_LeaseLiabilitiesCurrentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_LeaseLiabilitiesCurrentMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_BankLoansUnsecuredMember" xlink:href="aapg-20251231.xsd#aapg_BankLoansUnsecuredMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_BankLoansUnsecuredMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_BankLoansUnsecuredOneMember" xlink:href="aapg-20251231.xsd#aapg_BankLoansUnsecuredOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_BankLoansUnsecuredOneMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_BankLoansSecuredMember" xlink:href="aapg-20251231.xsd#aapg_BankLoansSecuredMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_BankLoansSecuredMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseLiabilitiesNonCurrentMember" xlink:href="aapg-20251231.xsd#aapg_LeaseLiabilitiesNonCurrentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_LeaseLiabilitiesNonCurrentMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRateBasis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_BorrowingsInterestRateBasis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsMaturity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsMaturity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_BorrowingsMaturity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_ShorttermBorrowings" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_LongtermBorrowings" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_Borrowings" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems" xlink:to="aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_NotLaterThanOneYearMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanFiveYearsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems" xlink:to="ifrs-full_Borrowings" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofDeferredIncomeTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfDeferredIncomeAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDeferredIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfDeferredIncomeAbstract" xlink:to="ifrs-full_CurrentGovernmentGrants" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_MovementsInGovernmentGrantsAbstract" xlink:href="aapg-20251231.xsd#aapg_MovementsInGovernmentGrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_MovementsInGovernmentGrantsAbstract" xlink:to="ifrs-full_GovernmentGrants" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_RecognizedAsIncomeDuringTheYear" xlink:href="aapg-20251231.xsd#aapg_RecognizedAsIncomeDuringTheYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_MovementsInGovernmentGrantsAbstract" xlink:to="aapg_RecognizedAsIncomeDuringTheYear" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PortionClassifiedAsCurrentLiabilities" xlink:href="aapg-20251231.xsd#aapg_PortionClassifiedAsCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_MovementsInGovernmentGrantsAbstract" xlink:to="aapg_PortionClassifiedAsCurrentLiabilities" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalMember" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="aapg_ShareCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_Equity" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalMember" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="aapg_ShareCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ParValuePerShare" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_OrdinarySharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_IssuedCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasurySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_TreasurySharesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IssuedShareCapital" xlink:href="aapg-20251231.xsd#aapg_IssuedShareCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_IssuedShareCapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfOrdinaryShare" xlink:href="aapg-20251231.xsd#aapg_IssueOfOrdinaryShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_IssueOfOrdinaryShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_IssueOfOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_IssueOfOrdinaryShares" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" xlink:href="aapg-20251231.xsd#aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme" xlink:href="aapg-20251231.xsd#aapg_IssueOfSharesUnderThePreIPOShareOptionScheme"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares" xlink:href="aapg-20251231.xsd#aapg_IssueOfSharesUnderThe2021RSUSchemeInshares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValuesEquitysettledBonus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_RepurchaseOfOrdinaryShare" xlink:href="aapg-20251231.xsd#aapg_RepurchaseOfOrdinaryShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_RepurchaseOfOrdinaryShare" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_VestingOfRestrictedShareUnit" xlink:href="aapg-20251231.xsd#aapg_VestingOfRestrictedShareUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_VestingOfRestrictedShareUnit" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_VestingOfRestrictedShareUnits" xlink:href="aapg-20251231.xsd#aapg_VestingOfRestrictedShareUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_VestingOfRestrictedShareUnits" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PostIPOOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PostIPOOptionSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_PostIPOOptionSchemeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember" xlink:href="aapg-20251231.xsd#aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember" xlink:href="aapg-20251231.xsd#aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember" xlink:href="aapg-20251231.xsd#aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwentySixNov202526Nov2035Member" xlink:href="aapg-20251231.xsd#aapg_TwentySixNov202526Nov2035Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TwentySixNov202526Nov2035Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyOneRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOneRSUSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_TwoThousandTwentyOneRSUSchemeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_TwoThousandTwentyTwoRSUSchemeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoFurtherGrantMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoFurtherGrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_TwoThousandTwentyTwoFurtherGrantMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsOneMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipantsOneMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsTwoMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipantsTwoMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsThreeMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipantsThreeMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsFourMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsFourMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipantsFourMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsFiveMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsFiveMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipantsFiveMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsSixMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsSixMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipantsSixMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants1OneMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants1OneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants1OneMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants1ThreeMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants1ThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants1ThreeMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants2FourMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants2FourMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants2FourMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants2ThreeMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants2ThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants2ThreeMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants7Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants7Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants7Member" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants8Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants8Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants8Member" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants9Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants9Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants9Member" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants10Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants10Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants10Member" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants1TwoMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants1TwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants1TwoMember" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants2OneMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants2OneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="aapg_TypeOfEligibleParticipants2OneMember" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfConditionalShares" xlink:href="aapg-20251231.xsd#aapg_PercentageOfConditionalShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_PercentageOfConditionalShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfVestedConditionalShares" xlink:href="aapg-20251231.xsd#aapg_PercentageOfVestedConditionalShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_PercentageOfVestedConditionalShares" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyOnesRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOnesRSUSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_TwoThousandTwentyOnesRSUSchemeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoRSUchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_TwoThousandTwentyTwoRSUchemeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AccruedInterestInOtherPayablesAndAccrualsMember" xlink:href="aapg-20251231.xsd#aapg_AccruedInterestInOtherPayablesAndAccrualsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:to="aapg_AccruedInterestInOtherPayablesAndAccrualsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_BankAndOtherLoansMember" xlink:href="aapg-20251231.xsd#aapg_BankAndOtherLoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:to="aapg_BankAndOtherLoansMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseLiabilityMember" xlink:href="aapg-20251231.xsd#aapg_LeaseLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:to="aapg_LeaseLiabilityMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_InterestExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CashInflowOutflowForLease" xlink:href="aapg-20251231.xsd#aapg_CashInflowOutflowForLease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="aapg_CashInflowOutflowForLease" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DrZhaiYifanMember" xlink:href="aapg-20251231.xsd#aapg_DrZhaiYifanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_DrZhaiYifanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DrYangDajunMember" xlink:href="aapg-20251231.xsd#aapg_DrYangDajunMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_DrYangDajunMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherPayablesAndAccruals" xlink:href="aapg-20251231.xsd#aapg_OtherPayablesAndAccruals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="aapg_OtherPayablesAndAccruals" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OutstandingBalanceOtherNoncurrentLiabilities" xlink:href="aapg-20251231.xsd#aapg_OutstandingBalanceOtherNoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="aapg_OutstandingBalanceOtherNoncurrentLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OutstandingBalanceWithRelatedParty" xlink:href="aapg-20251231.xsd#aapg_OutstandingBalanceWithRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="aapg_OutstandingBalanceWithRelatedParty" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAtAmortizedCostMember" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAtAmortizedCostMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="aapg_FinancialAssetsAtAmortizedCostMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsMember" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="aapg_FinancialAssetsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesAtAmortizedCostMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtAmortizedCostMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="aapg_FinancialLiabilitiesAtAmortizedCostMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="aapg_FinancialLiabilitiesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember" order="5" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_NoncurrentReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_FinancialAssets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" xlink:to="ifrs-full_MeasurementAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MeasurementDomain" xlink:to="ifrs-full_AtFairValueMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="ifrs-full_FinancialAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="ifrs-full_LongtermBorrowings" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="ifrs-full_Level1OfFairValueHierarchyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreasedecreaseInBasisPointsMember" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseInBasisPointsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_IncreasedecreaseInBasisPointsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreasedecreaseInLossBeforeTaxMember" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseInLossBeforeTaxMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_IncreasedecreaseInLossBeforeTaxMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRateBasis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:to="ifrs-full_BorrowingsInterestRateBasis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreasedecreaseInLossBeforeTax" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseInLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:to="aapg_IncreasedecreaseInLossBeforeTax" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ChangeInForeignExchangeRatesAxis" xlink:href="aapg-20251231.xsd#aapg_ChangeInForeignExchangeRatesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" xlink:to="aapg_ChangeInForeignExchangeRatesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ChangeInForeignExchangeRatesDomainDomain" xlink:href="aapg-20251231.xsd#aapg_ChangeInForeignExchangeRatesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="aapg_ChangeInForeignExchangeRatesAxis" xlink:to="aapg_ChangeInForeignExchangeRatesDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ChangeInForeignExchangeRatesDomainDomain_0" xlink:href="aapg-20251231.xsd#aapg_ChangeInForeignExchangeRatesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="aapg_ChangeInForeignExchangeRatesAxis" xlink:to="aapg_ChangeInForeignExchangeRatesDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsAndLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" xlink:to="ifrs-full_AssetsAndLiabilitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsAndLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_AssetsAndLiabilitiesAxis" xlink:to="ifrs-full_AssetsAndLiabilitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsAndLiabilitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_AssetsAndLiabilitiesAxis" xlink:to="ifrs-full_AssetsAndLiabilitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_MonetaryAssetsMember" xlink:href="aapg-20251231.xsd#aapg_MonetaryAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AssetsAndLiabilitiesDomain" xlink:to="aapg_MonetaryAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IfRMBWeakensAgainstUSDollarsMember" xlink:href="aapg-20251231.xsd#aapg_IfRMBWeakensAgainstUSDollarsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ChangeInForeignExchangeRatesDomainDomain" xlink:to="aapg_IfRMBWeakensAgainstUSDollarsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IfRMBStrengthensAgainstUSDollarsMember" xlink:href="aapg-20251231.xsd#aapg_IfRMBStrengthensAgainstUSDollarsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ChangeInForeignExchangeRatesDomainDomain" xlink:to="aapg_IfRMBStrengthensAgainstUSDollarsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreasedecreaseWeakensAgainst" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseWeakensAgainst"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:to="aapg_IncreasedecreaseWeakensAgainst" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:to="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_Stage1Member" xlink:href="aapg-20251231.xsd#aapg_Stage1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="aapg_Stage1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StageTwoMember" xlink:href="aapg-20251231.xsd#aapg_StageTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="aapg_StageTwoMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StageThreeMember" xlink:href="aapg-20251231.xsd#aapg_StageThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="aapg_StageThreeMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SimplifiedApproachMember" xlink:href="aapg-20251231.xsd#aapg_SimplifiedApproachMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="aapg_SimplifiedApproachMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CashAndBankBalancesNotYetPastDue" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesNotYetPastDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="aapg_CashAndBankBalancesNotYetPastDue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="ifrs-full_TradeReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="ifrs-full_FinancialAssets" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OnDemandMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OnDemandMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_OnDemandMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_NotLaterThanOneYearMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanFiveYearsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TradePayablesMember" xlink:href="aapg-20251231.xsd#aapg_TradePayablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="aapg_TradePayablesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="ifrs-full_LeaseLiabilitiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember" xlink:href="aapg-20251231.xsd#aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherNonCurrentLiabilityMember" xlink:href="aapg-20251231.xsd#aapg_OtherNonCurrentLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="aapg_OtherNonCurrentLiabilityMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DerivativeFinancialInstrumentsMember" xlink:href="aapg-20251231.xsd#aapg_DerivativeFinancialInstrumentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="aapg_DerivativeFinancialInstrumentsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_LeaseLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_OtherBorrowings" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_OtherPayables" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DerivativeFinancialAssetsHeldForHedging" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DerivativeFinancialAssetsHeldForHedging"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_DerivativeFinancialAssetsHeldForHedging" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" xlink:to="ifrs-full_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_MarketEquityIndex" xlink:href="aapg-20251231.xsd#aapg_MarketEquityIndex"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" xlink:to="aapg_MarketEquityIndex" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockExchangeIndexShare" xlink:href="aapg-20251231.xsd#aapg_StockExchangeIndexShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" xlink:to="aapg_StockExchangeIndexShare" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CarryingAmountOfEquityInvestmentsMember" xlink:href="aapg-20251231.xsd#aapg_CarryingAmountOfEquityInvestmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="aapg_CarryingAmountOfEquityInvestmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DecreaseincreaseInLossBeforeTaxMember" xlink:href="aapg-20251231.xsd#aapg_DecreaseincreaseInLossBeforeTaxMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="aapg_DecreaseincreaseInLossBeforeTaxMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" xlink:to="ifrs-full_FinancialAssets" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" xlink:to="ifrs-full_CategoriesOfFinancialAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="ifrs-full_CategoriesOfFinancialAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="ifrs-full_CategoriesOfFinancialAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CapitalManagementMember" xlink:href="aapg-20251231.xsd#aapg_CapitalManagementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:to="aapg_CapitalManagementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_OtherBorrowings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_OtherPayables" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDebt" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_NetDebt" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustedCapitals" xlink:href="aapg-20251231.xsd#aapg_AdjustedCapitals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="aapg_AdjustedCapitals" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="srt_CondensedBalanceSheetStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="ifrs-full_ParentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiaries"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_InvestmentsInSubsidiaries" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherNoncurrentAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NoncurrentAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReceivablesDueFromAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesDueFromAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_ReceivablesDueFromAssociates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_CurrentAssets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherCurrentPayables" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_CurrentLiabilities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_CurrentAssetsLiabilities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_AssetsLessCurrentLiabilities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NetAssetsLiabilities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_IssuedCapital" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_TreasuryShares" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReserves" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherReserves" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ExchangeFluctuationReserve" xlink:href="aapg-20251231.xsd#aapg_ExchangeFluctuationReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="aapg_ExchangeFluctuationReserve" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_RetainedEarnings" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_Equity" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedStatementOfComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="srt_CondensedStatementOfComprehensiveIncomeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedStatementOfComprehensiveIncomeTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="ifrs-full_ParentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OtherGainsLosses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OperatingExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OtherExpenseByNature" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_ProfitLossBeforeTax" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_ProfitLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OtherComprehensiveIncome" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="ifrs-full_ParentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="ifrs-full_ParentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserveMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalReserveMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_CapitalReserveMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_NoncontrollingInterests" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_ProfitLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ComprehensiveIncomeLoss" xlink:href="aapg-20251231.xsd#aapg_ComprehensiveIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="aapg_ComprehensiveIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PreIPOShareOptionExpenses" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="aapg_PreIPOShareOptionExpenses" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_RestrictedShareUnitExpenses" xlink:href="aapg-20251231.xsd#aapg_RestrictedShareUnitExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="aapg_RestrictedShareUnitExpenses" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRSUs" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueVestingOfRSUs"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="aapg_StockIssuedDuringPeriodValueVestingOfRSUs" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueEquitysettledBonus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="aapg_StockIssuedDuringPeriodValueEquitysettledBonus" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/AccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="aapg_AccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_AccountingPoliciesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherEmployeeBenefitContributionPercentage" xlink:href="aapg-20251231.xsd#aapg_OtherEmployeeBenefitContributionPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="aapg_OtherEmployeeBenefitContributionPercentage" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AnnualBaseSalaryPercentage" xlink:href="aapg-20251231.xsd#aapg_AnnualBaseSalaryPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="aapg_AnnualBaseSalaryPercentage" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_SignificantAccountingJudgementsandEstimatesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_SignificantAccountingJudgementsandEstimatesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="aapg_SignificantAccountingJudgementsandEstimatesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxesAxis" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_SignificantAccountingJudgementsandEstimatesDetailsTable" xlink:to="aapg_IncomeTaxesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxesDomainDomain" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="aapg_IncomeTaxesAxis" xlink:to="aapg_IncomeTaxesDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxesDomainDomain_0" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="aapg_IncomeTaxesAxis" xlink:to="aapg_IncomeTaxesDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_SignificantAccountingJudgementsandEstimatesDetailsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnusedTaxLossesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="ifrs-full_UnusedTaxLossesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TaxesMember" xlink:href="aapg-20251231.xsd#aapg_TaxesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_IncomeTaxesDomainDomain" xlink:to="aapg_TaxesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxAssets" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/OperatingSegmentInformationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/IncomeTaxDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxDetailsTable" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="aapg_IncomeTaxDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_IncomeTaxDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_IncomeTaxDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_HK"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_HK" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ChineseMainlandMember" xlink:href="aapg-20251231.xsd#aapg_ChineseMainlandMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="aapg_ChineseMainlandMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SuzhouYashengMember" xlink:href="aapg-20251231.xsd#aapg_SuzhouYashengMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="aapg_SuzhouYashengMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_HighAndNewTechnologyEnterpriseMember" xlink:href="aapg-20251231.xsd#aapg_HighAndNewTechnologyEnterpriseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_HighAndNewTechnologyEnterpriseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_ApplicableTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PreferentialRate" xlink:href="aapg-20251231.xsd#aapg_PreferentialRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="aapg_PreferentialRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_WithholdingTax" xlink:href="aapg-20251231.xsd#aapg_WithholdingTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="aapg_WithholdingTax" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/LeasesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_LeasesLineItems" xlink:href="aapg-20251231.xsd#aapg_LeasesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_LeasesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_LeasesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_LeasesLineItems" xlink:to="aapg_LeasesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_LeasesDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_LeasesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_LandAndBuildingsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TermsOfLandLease" xlink:href="aapg-20251231.xsd#aapg_TermsOfLandLease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_LeasesLineItems" xlink:to="aapg_TermsOfLandLease" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseTerms" xlink:href="aapg-20251231.xsd#aapg_LeaseTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_LeasesLineItems" xlink:to="aapg_LeaseTerms" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/GoodwillDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/DeferredTaxDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxLineItems" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxDetailsTable" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_DeferredTaxLineItems" xlink:to="aapg_DeferredTaxDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_DeferredTaxDetailsTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ChineseMainlandMember" xlink:href="aapg-20251231.xsd#aapg_ChineseMainlandMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="aapg_ChineseMainlandMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FutureTaxableProfitsPercentage" xlink:href="aapg-20251231.xsd#aapg_FutureTaxableProfitsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="aapg_FutureTaxableProfitsPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TaxCredits" xlink:href="aapg-20251231.xsd#aapg_TaxCredits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="aapg_TaxCredits" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_UnrecognizedTaxBenefit" xlink:href="aapg-20251231.xsd#aapg_UnrecognizedTaxBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="aapg_UnrecognizedTaxBenefit" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxAssetsTaxLossCarryforwards" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxAssetsTaxLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="aapg_DeferredTaxAssetsTaxLossCarryforwards" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_UnrecognizedTaxBenefitsRecognized" xlink:href="aapg-20251231.xsd#aapg_UnrecognizedTaxBenefitsRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_DeferredTaxLineItems" xlink:to="aapg_UnrecognizedTaxBenefitsRecognized" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/CashandBankBalancesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_CashAndBankBalancesLineItems" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_CashandBankBalancesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CashandBankBalancesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_CashAndBankBalancesLineItems" xlink:to="aapg_CashandBankBalancesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_CashandBankBalancesDetailsTable" xlink:to="srt_CurrencyAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CurrencyAxis" xlink:to="currency_AllCurrenciesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="currency_AllCurrenciesDomain_0" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CurrencyAxis" xlink:to="currency_AllCurrenciesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_CNY"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_CNY" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="currency_USD" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_USD"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_USD" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CashAndBankBalancesLineItems" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ContractLiabilitiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesLineItems" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_ContractLiabilitiesLineItems" xlink:to="aapg_ContractLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ContractLiabilitiesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_InnoventBiologicsSuzhouCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_InnoventBiologicsSuzhouCoLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_InnoventBiologicsSuzhouCoLtdMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ContractLiabilitiesLineItems" xlink:to="ifrs-full_ContractLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_ContractLiabilitiesLineItems" xlink:to="ifrs-full_Revenue" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestBearingBankandOtherBorrowingsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankandOtherBorrowingsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="aapg_InterestBearingBankandOtherBorrowingsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LloanPrimeRateMember" xlink:href="aapg-20251231.xsd#aapg_LloanPrimeRateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="aapg_LloanPrimeRateMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConstructionInProgressMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_ConstructionInProgressMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_RightofuseAssetsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_BuildingsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SecuredBankBorrowingsMember" xlink:href="aapg-20251231.xsd#aapg_SecuredBankBorrowingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_SecuredBankBorrowingsMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:to="ifrs-full_RightofuseAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_ShorttermBorrowings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_Borrowings" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnsecuredBankLoansReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnsecuredBankLoansReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_UnsecuredBankLoansReceived" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_ShareCapitalandTreasurySharesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareCapitalandTreasurySharesDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareCapitalandTreasurySharesDetailsTable" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareCapitalandTreasurySharesDetailsTable" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalMember" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:to="aapg_ShareCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_HongKongStockExchangeMember" xlink:href="aapg-20251231.xsd#aapg_HongKongStockExchangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:to="aapg_HongKongStockExchangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TreasurySharesOneMember" xlink:href="aapg-20251231.xsd#aapg_TreasurySharesOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:to="aapg_TreasurySharesOneMember" order="2" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="aapg_TreasurySharesOneMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoRSUchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="aapg_TwoThousandTwentyTwoRSUchemeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PreIPOShareOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="aapg_PreIPOShareOptionSchemeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyOneRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOneRSUSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="aapg_TwoThousandTwentyOneRSUSchemeMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_RestrictedShareUnitMember" xlink:href="aapg-20251231.xsd#aapg_RestrictedShareUnitMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:to="aapg_RestrictedShareUnitMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfOrdinaryShare" xlink:href="aapg-20251231.xsd#aapg_IssueOfOrdinaryShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_IssueOfOrdinaryShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_WeightedAverageExercisePrice" xlink:href="aapg-20251231.xsd#aapg_WeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_WeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IssuedCapital" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NumberOfTreasuryShares" xlink:href="aapg-20251231.xsd#aapg_NumberOfTreasuryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_NumberOfTreasuryShares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_BonusDueToEmployeesAmount" xlink:href="aapg-20251231.xsd#aapg_BonusDueToEmployeesAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_BonusDueToEmployeesAmount" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SharesConsiderationAmount" xlink:href="aapg-20251231.xsd#aapg_SharesConsiderationAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_SharesConsiderationAmount" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SubscriptionOfShares" xlink:href="aapg-20251231.xsd#aapg_SubscriptionOfShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_SubscriptionOfShares" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AllottedSharesPricePerShares" xlink:href="aapg-20251231.xsd#aapg_AllottedSharesPricePerShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_AllottedSharesPricePerShares" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_StockPurchasedDuringPeriodShares" xlink:href="aapg-20251231.xsd#aapg_StockPurchasedDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aapg_StockPurchasedDuringPeriodShares" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ReservesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ReservesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ReservesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="aapg_ReservesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ReservesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ReservesDetailsTable" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ReservesMember" xlink:href="aapg-20251231.xsd#aapg_ReservesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_ReservesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedShareUnitsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedShareUnitsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:to="ifrs-full_RestrictedShareUnitsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserve" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="ifrs-full_CapitalReserve" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="ifrs-full_SharePremium" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TransferredOutFromCapitalAndReserves" xlink:href="aapg-20251231.xsd#aapg_TransferredOutFromCapitalAndReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="aapg_TransferredOutFromCapitalAndReserves" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_CapitalAndReserveFunds" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReserveFunds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="aapg_CapitalAndReserveFunds" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_BonusAmount" xlink:href="aapg-20251231.xsd#aapg_BonusAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="aapg_BonusAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="ifrs-full_ParValuePerShare" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_ShareBasedPaymentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_GrantAnniversariesAxis" xlink:href="aapg-20251231.xsd#aapg_GrantAnniversariesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsDetailsTable" xlink:to="aapg_GrantAnniversariesAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_GrantAnniversariesDomainDomain" xlink:href="aapg-20251231.xsd#aapg_GrantAnniversariesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="aapg_GrantAnniversariesAxis" xlink:to="aapg_GrantAnniversariesDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_GrantAnniversariesDomainDomain_0" xlink:href="aapg-20251231.xsd#aapg_GrantAnniversariesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="aapg_GrantAnniversariesAxis" xlink:to="aapg_GrantAnniversariesDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_ShareBasedPaymentsDetailsTable" xlink:to="ifrs-full_CategoriesOfFinancialAssetsAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="ifrs-full_CategoriesOfFinancialAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="ifrs-full_CategoriesOfFinancialAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NonExecutiveDirectorMember" xlink:href="aapg-20251231.xsd#aapg_NonExecutiveDirectorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_NonExecutiveDirectorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ChiefCommercialOfficerMember" xlink:href="aapg-20251231.xsd#aapg_ChiefCommercialOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_ChiefCommercialOfficerMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DrZhaiYifanMember" xlink:href="aapg-20251231.xsd#aapg_DrZhaiYifanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_DrZhaiYifanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DrYangDajunMember" xlink:href="aapg-20251231.xsd#aapg_DrYangDajunMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_DrYangDajunMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PreIPOShareOptionsMember" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_PreIPOShareOptionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_ShareOptionSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_ShareOptionSchemeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SpecialOptionsMember" xlink:href="aapg-20251231.xsd#aapg_SpecialOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_SpecialOptionsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PreIPOShareOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_PreIPOShareOptionSchemeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PostIPOOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PostIPOOptionSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_PostIPOOptionSchemeMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedShareUnitsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedShareUnitsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="ifrs-full_RestrictedShareUnitsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandEighteenRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandEighteenRSUSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_TwoThousandEighteenRSUSchemeMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyOnesRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOnesRSUSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_TwoThousandTwentyOnesRSUSchemeMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoRSUchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_TwoThousandTwentyTwoRSUchemeMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoFurtherGrantMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoFurtherGrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_TwoThousandTwentyTwoFurtherGrantMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FirstAnniversariesMember" xlink:href="aapg-20251231.xsd#aapg_FirstAnniversariesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_GrantAnniversariesDomainDomain" xlink:to="aapg_FirstAnniversariesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SecondAnniversaryMember" xlink:href="aapg-20251231.xsd#aapg_SecondAnniversaryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_GrantAnniversariesDomainDomain" xlink:to="aapg_SecondAnniversaryMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ThirdAnniversaryMember" xlink:href="aapg-20251231.xsd#aapg_ThirdAnniversaryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_GrantAnniversariesDomainDomain" xlink:to="aapg_ThirdAnniversaryMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_FourthAnniversaryMember" xlink:href="aapg-20251231.xsd#aapg_FourthAnniversaryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_GrantAnniversariesDomainDomain" xlink:to="aapg_FourthAnniversaryMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_RSUMember" xlink:href="aapg-20251231.xsd#aapg_RSUMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:to="aapg_RSUMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ForecastMember" xlink:href="aapg-20251231.xsd#aapg_ForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="aapg_ForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareGrantExpense" xlink:href="aapg-20251231.xsd#aapg_ShareGrantExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_ShareGrantExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AdditionalOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_AdditionalOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_AdditionalOrdinaryShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_SharePremium" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserve" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_CapitalReserve" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfExceedShareCapital" xlink:href="aapg-20251231.xsd#aapg_PercentageOfExceedShareCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_PercentageOfExceedShareCapital" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_AggregateShareIssued" xlink:href="aapg-20251231.xsd#aapg_AggregateShareIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_AggregateShareIssued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SharesGranted" xlink:href="aapg-20251231.xsd#aapg_SharesGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_SharesGranted" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfVestedConditionalShares" xlink:href="aapg-20251231.xsd#aapg_PercentageOfVestedConditionalShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_PercentageOfVestedConditionalShares" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement" xlink:href="aapg-20251231.xsd#aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" xlink:href="aapg-20251231.xsd#aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_SharebasedPaymentVestingPeriod" xlink:href="aapg-20251231.xsd#aapg_SharebasedPaymentVestingPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_SharebasedPaymentVestingPeriod" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_RSUsGrantedFairValue" xlink:href="aapg-20251231.xsd#aapg_RSUsGrantedFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aapg_RSUsGrantedFairValue" order="20" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:href="aapg-20251231.xsd#aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_RangeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_EmployeeMember" xlink:href="aapg-20251231.xsd#aapg_EmployeeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="aapg_EmployeeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_PostIPOOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PostIPOOptionSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="aapg_PostIPOOptionSchemeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyOneRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOneRSUSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="aapg_TwoThousandTwentyOneRSUSchemeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUSchemeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="aapg_TwoThousandTwentyTwoRSUSchemeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NumberOfGrantees" xlink:href="aapg-20251231.xsd#aapg_NumberOfGrantees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="aapg_NumberOfGrantees" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NumberOfNewlyIssuedShares" xlink:href="aapg-20251231.xsd#aapg_NumberOfNewlyIssuedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="aapg_NumberOfNewlyIssuedShares" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_BonusAmount" xlink:href="aapg-20251231.xsd#aapg_BonusAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="aapg_BonusAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" xlink:href="aapg-20251231.xsd#aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NonCashDisposals" xlink:href="aapg-20251231.xsd#aapg_NonCashDisposals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="aapg_NonCashDisposals" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NoncashAdditionsToIntangibleAssets" xlink:href="aapg-20251231.xsd#aapg_NoncashAdditionsToIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="aapg_NoncashAdditionsToIntangibleAssets" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_NonCashAdditionsToPropertyPlantAndEquipment" xlink:href="aapg-20251231.xsd#aapg_NonCashAdditionsToPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="aapg_NonCashAdditionsToPropertyPlantAndEquipment" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/CommitmentsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_CommitmentsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_CommitmentsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_CommitmentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CommitmentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_CommitmentsDetailsLineItems" xlink:to="aapg_CommitmentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_CommitmentsDetailsLineItems" xlink:to="ifrs-full_CapitalCommitments" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/ContingentLiabilitiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_RelatedPartyTransactionsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RelatedPartyTransactionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="aapg_RelatedPartyTransactionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_RelatedPartyTransactionsDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfContractsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_RelatedPartyTransactionsDetailsTable" xlink:to="ifrs-full_TypesOfContractsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfContractsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfContractsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_HealthquestPharmaAcquisitionAgreementMember" xlink:href="aapg-20251231.xsd#aapg_HealthquestPharmaAcquisitionAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfContractsDomain" xlink:to="aapg_HealthquestPharmaAcquisitionAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_DrYangMember" xlink:href="aapg-20251231.xsd#aapg_DrYangMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="aapg_DrYangMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingCostsIncurred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_BorrowingCostsIncurred" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksDomain" xlink:to="ifrs-full_InterestRateRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreditRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CreditRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksDomain" xlink:to="ifrs-full_CreditRiskMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiquidityRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiquidityRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksDomain" xlink:to="ifrs-full_LiquidityRiskMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestBearingBankBorrowings" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="aapg_InterestBearingBankBorrowings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_ConcentrationsOfCreditRisk" xlink:href="aapg-20251231.xsd#aapg_ConcentrationsOfCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="aapg_ConcentrationsOfCreditRisk" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="aapg_LiquidityRiskPercentage" xlink:href="aapg-20251231.xsd#aapg_LiquidityRiskPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="aapg_LiquidityRiskPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="ifrs-full_InvestmentIncome" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.ascentage.cn.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ContactPersonnelEmailAddress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorOpinionTextBlock" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
<!-- [WMV7][zSHu2slo2UrwGRKOGzgiHbMC2pk6+DHh9XOzExt2RCyql8OhuyJ66ZEPFOTy1Wx9GLJv999o4qJziCYHhTsv4OwtQ81shnliGJhl88OmoQD9SOzOzSS0/LSvyjALU0X29aLNsdvCtA2GF4qQkuGfG3KO2JqCyBjQFpckADDYQQnH0aCwBR+ruw8Nz/rAfdosoEk2SbzXZHgWYnEdObfl8Iu+0bxdd0B+sNPgYAA2i1uYRve4n1u6JkilCyfYGlXvp16Iad3HWao+rHvQLrcvZJgiBwDN2G7dsX1F8WBIJGxJ0YxANrCh067J1ZSRclx5WnQQX2uP1QOO4nz8O8iKbWjVuMAYz+jQP92jEe2Nw422cGRs1QSSCt6MZXCYf5u8THIwzVrFtZniwcg=] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="42" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>60
<FILENAME>aapg-20251231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Wed Apr 29 21:00:58 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesAxis_lbl" xml:lang="en-US">Products and services [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_GrossProfit_lbl" xml:lang="en-US">Gross profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US">LOSS BEFORE TAX</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl0" xml:lang="en-US">Loss before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US">LOSS FOR THE YEAR</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLoss_lbl0" xml:lang="en-US">LOSS FOR THE YEAR</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLoss_lbl1" xml:lang="en-US">Loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:href="aapg-20251231.xsd#aapg_ConsolidatedStatementsOfComprehensiveLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract_lbl" xml:lang="en-US">Consolidated Statements of Comprehensive Loss [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="aapg_ConsolidatedStatementsOfComprehensiveLossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US">OTHER COMPREHENSIVE INCOME/(LOSS) FOR THE YEAR, NET OF TAX</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl0" xml:lang="en-US">TOTAL COMPREHENSIVE INCOME FOR THE YEAR</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US">TOTAL COMPREHENSIVE LOSS FOR THE YEAR</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl0" xml:lang="en-US">Total comprehensive loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of financial position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssetsLiabilities_lbl" xml:lang="en-US">NET CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentAssetsLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_AssetsLessCurrentLiabilities_lbl" xml:lang="en-US">TOTAL ASSETS LESS CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_AssetsLessCurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US">Total non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_lbl" xml:lang="en-US">Equity attributable to ordinary equity holders of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_lbl0" xml:lang="en-US">Equity attributable to owners of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US">Total equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Equity_lbl2" xml:lang="en-US">Balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Equity_lbl3" xml:lang="en-US">Share capital, Ordinary shares of US$0.0001 each</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl3"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US">Components of equity [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash flows used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0" xml:lang="en-US">Net cash generated from(used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash flows generated from/ (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash flows generated from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0" xml:lang="en-US">Net cash (used in)/generated from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US">NET (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl0" xml:lang="en-US">Net decrease in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl0" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT END OF YEAR</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl1" xml:lang="en-US">Cash and cash equivalents at end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl2" xml:lang="en-US">Cash and cash equivalents as stated in the consolidated statements of cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl2"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks_lbl" xml:lang="en-US">Cash and bank balances at end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks_lbl0" xml:lang="en-US">Cash and bank balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_lbl" xml:lang="en-US">Corporate and Group Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xml:lang="en-US">Subsidiaries [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NewIFRSsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NewIFRSsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NewIFRSsAxis_lbl" xml:lang="en-US">New IFRSs [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="ifrs-full_NewIFRSsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US">Range [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_lbl" xml:lang="en-US">Property, plant and equipment including right-of-use assets [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl" xml:lang="en-US">Significant Accounting Judgements and Estimates [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xml:lang="en-US">Operating Segment Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorCustomersAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorCustomersAxis_lbl" xml:lang="en-US">Major customers [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="ifrs-full_MajorCustomersAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl" xml:lang="en-US">Revenue, Other Income and Gains [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_lbl" xml:lang="en-US">Timing of transfer of goods or services [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract_lbl" xml:lang="en-US">Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract" xlink:to="aapg_ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US">Maturity [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AnalysisOfIncomeAndExpenseAbstract_lbl" xml:lang="en-US">Schedule of Other Income and Gains [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_AnalysisOfIncomeAndExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherIncome_lbl" xml:lang="en-US">Total other income and gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherIncome_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherIncome_lbl0" xml:lang="en-US">Other income and gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherIncome_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl" xml:lang="en-US">Loss Before Tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfLossBeforeTaxAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfLossBeforeTaxAbstract_lbl" xml:lang="en-US">Schedule of Loss Before Tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfLossBeforeTaxAbstract" xlink:to="aapg_ScheduleOfLossBeforeTaxAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseByNatureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseByNatureAbstract_lbl" xml:lang="en-US">Other Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNatureAbstract" xlink:to="ifrs-full_ExpenseByNatureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherExpensesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfOtherExpensesAbstract_lbl" xml:lang="en-US">Schedule of Other Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherExpensesAbstract" xlink:to="aapg_ScheduleOfOtherExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherExpenseByNature_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_OtherExpenseByNature_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherExpenseByNature_lbl0" xml:lang="en-US">Other expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_OtherExpenseByNature_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_OtherExpenseByNature_lbl1" xml:lang="en-US">Other expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_OtherExpenseByNature_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestCostsAbstract_lbl" xml:lang="en-US">Finance Costs [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestCostsAbstract" xlink:to="ifrs-full_InterestCostsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFinanceCostsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFinanceCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfFinanceCostsAbstract_lbl" xml:lang="en-US">Schedule of Finance Costs [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfFinanceCostsAbstract" xlink:to="aapg_ScheduleOfFinanceCostsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceCosts_lbl0" xml:lang="en-US">Finance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xml:lang="en-US">Income Tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_lbl" xml:lang="en-US">Schedule of Current and Deferred Components of the Income Tax Expense/(Credit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:to="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US">Income tax credit/(expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl0" xml:lang="en-US">Income tax credit/(expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl" xml:lang="en-US">Schedule of Reconciliation between the Income Tax Expense/(Credit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DividendAbstract" xlink:href="aapg-20251231.xsd#aapg_DividendAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DividendAbstract_lbl" xml:lang="en-US">Dividends [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DividendAbstract" xlink:to="aapg_DividendAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl" xml:lang="en-US">Loss Per Share Attributable to Ordinary Equity Holders of the Company [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl0" xml:lang="en-US">LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsPerShareAbstract_lbl" xml:lang="en-US">Schedule of Basic Loss Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsPerShareAbstract" xlink:to="ifrs-full_BasicEarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation" xlink:href="aapg-20251231.xsd#aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation" xlink:to="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation" xlink:to="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US">Carrying amount of beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RightofuseAssets_lbl0" xml:lang="en-US">Carrying amount of end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssets_lbl1" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Lease Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_LeaseLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US">Carrying amount at January 1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl0" xml:lang="en-US">Carrying amount at December 31</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl1" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US">Schedule of Recognized in Profit or Loss [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TotalAmountofRecognizedInProfitOrLoss" xlink:href="aapg-20251231.xsd#aapg_TotalAmountofRecognizedInProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="aapg_TotalAmountofRecognizedInProfitOrLoss_lbl" xml:lang="en-US">Total amount recognized in profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TotalAmountofRecognizedInProfitOrLoss" xlink:to="aapg_TotalAmountofRecognizedInProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract_lbl" xml:lang="en-US">Goodwill [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_IntangibleAssetsAndGoodwillAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ChangesInGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ChangesInGoodwillAbstract_lbl" xml:lang="en-US">Schedule of Goodwill [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="ifrs-full_ChangesInGoodwillAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Goodwill_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Goodwill_lbl0" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherIntangibleAssetAbstract" xlink:href="aapg-20251231.xsd#aapg_OtherIntangibleAssetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherIntangibleAssetAbstract_lbl" xml:lang="en-US">Other Intangible Asset [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherIntangibleAssetAbstract" xlink:to="aapg_OtherIntangibleAssetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Cost Beginning Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Cost Ending Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl1" xml:lang="en-US">Net carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl2" xml:lang="en-US">Net carrying amount in US$ (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl2"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract_lbl" xml:lang="en-US">Investment in a Joint Venture [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ifrs-full_DisclosureOfJointVenturesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInvestmentInAJointVentureAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInvestmentInAJointVentureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfInvestmentInAJointVentureAbstract_lbl" xml:lang="en-US">Schedule of Investment in a Joint Venture [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInvestmentInAJointVentureAbstract" xlink:to="aapg_ScheduleOfInvestmentInAJointVentureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfGroupSPrincipalJointVentureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract_lbl" xml:lang="en-US">Schedule of Group&#8217;s Principal Joint Venture [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:to="aapg_ScheduleOfGroupSPrincipalJointVentureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_lbl" xml:lang="en-US">Schedule of Information of the Group&#8217;s Joint Venture [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract_lbl" xml:lang="en-US">Financial Assets at Fair Value through Profit or Loss [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract_lbl" xml:lang="en-US">Schedule of Financial Assets at Fair Value through Profit or Loss [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:to="aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred Tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl" xml:lang="en-US">Balance at beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl0" xml:lang="en-US">Balance at ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl1" xml:lang="en-US">Balance at ending (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl" xml:lang="en-US">Balance at beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl0" xml:lang="en-US">Balance at ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl1" xml:lang="en-US">Balance at ending (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl2" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl2"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xml:lang="en-US">Liabilities arising from financing activities [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Analysis of the Deferred Tax Balances of the Group for Financial Reporting Purposes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US">Other Non-Current Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl0" xml:lang="en-US">NON-CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherNonCurrentAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherNonCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfOtherNonCurrentAssetsAbstract_lbl" xml:lang="en-US">Schedule of Other Non-Current Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="aapg_ScheduleOfOtherNonCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl0" xml:lang="en-US">Other non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl1" xml:lang="en-US">Other non-current Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfInventoriesAbstract_lbl" xml:lang="en-US">Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_ClassesOfInventoriesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInventoriesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInventoriesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfInventoriesAbstract_lbl" xml:lang="en-US">Schedule of Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInventoriesAbstract" xlink:to="aapg_ScheduleOfInventoriesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Inventories_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Inventories_lbl0" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xml:lang="en-US">Trade Receivables, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherReceivablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_lbl" xml:lang="en-US">Schedule of Trade Receivables, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAgingAxis" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAgingAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialAssetsAgingAxis_lbl" xml:lang="en-US">Financial Assets, Aging [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAgingAxis" xlink:to="aapg_FinancialAssetsAgingAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract_lbl" xml:lang="en-US">Prepayments, Other Receivables and Other Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:to="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaymentsAbstract_lbl" xml:lang="en-US">Schedule of Prepayments, Other Receivables and Other Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl0" xml:lang="en-US">Prepayments, other receivables and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_CashAndBankBalancesAbstract" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CashAndBankBalancesAbstract_lbl" xml:lang="en-US">Cash and Bank Balances [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashAndBankBalancesAbstract" xlink:to="aapg_CashAndBankBalancesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasAxis_lbl" xml:lang="en-US">Geographical areas [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract_lbl" xml:lang="en-US">Trade Payables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherPayablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl" xml:lang="en-US">Other Payables and Accruals [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xml:lang="en-US">Other accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContractLiabilitiesAbstract_lbl" xml:lang="en-US">Contract Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractLiabilitiesAbstract" xlink:to="ifrs-full_ContractLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfCustomersAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfCustomersAxis_lbl" xml:lang="en-US">Types of customers [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfCustomersAxis" xlink:to="ifrs-full_TypesOfCustomersAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsAbstract_lbl" xml:lang="en-US">Interest-Bearing Bank and Other Borrowings [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsAbstract" xlink:to="ifrs-full_BorrowingsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameAxis_lbl" xml:lang="en-US">Borrowings by name [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Borrowings_lbl" xml:lang="en-US">Total borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Borrowings_lbl0" xml:lang="en-US">Interest-Bearing Bank and Other Borrowings Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Borrowings_lbl1" xml:lang="en-US">Net carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:to="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfDeferredIncomeAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDeferredIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfDeferredIncomeAbstract_lbl" xml:lang="en-US">Schedule of Deferred Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfDeferredIncomeAbstract" xlink:to="aapg_ScheduleOfDeferredIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_MovementsInGovernmentGrantsAbstract" xlink:href="aapg-20251231.xsd#aapg_MovementsInGovernmentGrantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_MovementsInGovernmentGrantsAbstract_lbl" xml:lang="en-US">Schedule of Movements in Government Grants [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_MovementsInGovernmentGrantsAbstract" xlink:to="aapg_MovementsInGovernmentGrantsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_GovernmentGrants_lbl" xml:lang="en-US">At beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_GovernmentGrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_GovernmentGrants_lbl0" xml:lang="en-US">At end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_GovernmentGrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_lbl" xml:lang="en-US">Share Capital and Treasury Shares [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_lbl" xml:lang="en-US">Classes of share capital [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl1" xml:lang="en-US">Ordinary shares, shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl2" xml:lang="en-US">Number of shares in issue, Ordinary shares of US$0.0001 each</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl3" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_lbl4" xml:lang="en-US">Shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl5" xml:lang="en-US">Newly issued shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl5"/>
    <loc xlink:type="locator" xlink:label="aapg_IssuedShareCapital" xlink:href="aapg-20251231.xsd#aapg_IssuedShareCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="aapg_IssuedShareCapital_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssuedShareCapital" xlink:to="aapg_IssuedShareCapital_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="aapg_IssuedShareCapital_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssuedShareCapital" xlink:to="aapg_IssuedShareCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IssuedShareCapital_lbl1" xml:lang="en-US">Balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssuedShareCapital" xlink:to="aapg_IssuedShareCapital_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReservesWithinEquityAbstract_lbl" xml:lang="en-US">Reserves [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:to="ifrs-full_DisclosureOfReservesWithinEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract_lbl" xml:lang="en-US">Share-Based Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Exercise price, Outstanding as of beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Exercise price, Outstanding as of ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl1" xml:lang="en-US">Exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl2" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl2"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US">Number of options, Outstanding as of beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl0" xml:lang="en-US">Number of options, Outstanding as of ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl1" xml:lang="en-US">Number of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract_lbl" xml:lang="en-US">Schedule of fair values of share options granted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:to="aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of RSUs, Outstanding, beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of RSUs, Outstanding, ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowHedgesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowHedgesAbstract_lbl" xml:lang="en-US">Notes to the Consolidated Statements of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowHedgesAbstract" xlink:to="ifrs-full_CashFlowHedgesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl0" xml:lang="en-US">Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl1" xml:lang="en-US">Ending balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl" xml:lang="en-US">Classes of contingent liabilities [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Schedule of Cash Outflow for Leases Included in the Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CashInflowOutflowForLease" xlink:href="aapg-20251231.xsd#aapg_CashInflowOutflowForLease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="aapg_CashInflowOutflowForLease_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashInflowOutflowForLease" xlink:to="aapg_CashInflowOutflowForLease_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CapitalCommitmentsAbstract_lbl" xml:lang="en-US">Commitments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalCommitmentsAbstract" xlink:to="ifrs-full_CapitalCommitmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract_lbl" xml:lang="en-US">Contingent Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PledgeOfAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_PledgeOfAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PledgeOfAssetsAbstract_lbl" xml:lang="en-US">Pledge of Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PledgeOfAssetsAbstract" xlink:to="aapg_PledgeOfAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_RelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US">Categories of related parties [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OutstandingBalanceWithRelatedParty" xlink:href="aapg-20251231.xsd#aapg_OutstandingBalanceWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="aapg_OutstandingBalanceWithRelatedParty_lbl" xml:lang="en-US">Outstanding balance with related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OutstandingBalanceWithRelatedParty" xlink:to="aapg_OutstandingBalanceWithRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_lbl" xml:lang="en-US">Schedule of Compensation of Key Management Personnel [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Financial Instruments by Category [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinancialAssets_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialAssets_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis_lbl" xml:lang="en-US">Classes of financial instruments [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xml:lang="en-US">Classes of financial assets [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:href="aapg-20251231.xsd#aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Fair Value and Fair Value Hierarchy of Financial Instruments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:to="aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_LongtermBorrowings_lbl" xml:lang="en-US">Non-current portion of interest-bearing bank and other borrowings (other than lease liabilities)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LongtermBorrowings_lbl0" xml:lang="en-US">Non-current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MeasurementAxis_lbl" xml:lang="en-US">Measurement [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xml:lang="en-US">Levels of fair value hierarchy [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureAbstract_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="ifrs-full_DisclosureOfCreditRiskExposureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ChangeInForeignExchangeRatesAxis" xlink:href="aapg-20251231.xsd#aapg_ChangeInForeignExchangeRatesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ChangeInForeignExchangeRatesAxis_lbl" xml:lang="en-US">Change in foreign exchange rates [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ChangeInForeignExchangeRatesAxis" xlink:to="aapg_ChangeInForeignExchangeRatesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsAndLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAndLiabilitiesAxis_lbl" xml:lang="en-US">Assets and liabilities [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAndLiabilitiesAxis" xlink:to="ifrs-full_AssetsAndLiabilitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xml:lang="en-US">Classes of financial liabilities [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDebt" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NetDebt_lbl" xml:lang="en-US">Net debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDebt" xlink:to="ifrs-full_NetDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl" xml:lang="en-US">Capital and net debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl0" xml:lang="en-US">Deferred tax liability (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAxis_lbl" xml:lang="en-US">Categories of financial assets [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="ifrs-full_CategoriesOfFinancialAssetsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl" xml:lang="en-US">Event After the Reporting Period [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_lbl" xml:lang="en-US">Condensed Financial Information of the Company [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NetAssetsLiabilities_lbl" xml:lang="en-US">Net assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetAssetsLiabilities" xlink:to="ifrs-full_NetAssetsLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Schedule of Condensed Statements of Comprehensive Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_StatementOfComprehensiveIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NoncontrollingInterests_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NoncontrollingInterests_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncontrollingInterests_lbl1" xml:lang="en-US">Non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncontrollingInterests_lbl2" xml:lang="en-US">Balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl2"/>
    <loc xlink:type="locator" xlink:label="aapg_ApprovalOfTheFinancialStatementsAbstract" xlink:href="aapg-20251231.xsd#aapg_ApprovalOfTheFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ApprovalOfTheFinancialStatementsAbstract_lbl" xml:lang="en-US">Approval of the Financial Statements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ApprovalOfTheFinancialStatementsAbstract" xlink:to="aapg_ApprovalOfTheFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueAbstract_lbl" xml:lang="en-US">REVENUE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueAbstract" xlink:to="ifrs-full_RevenueAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RevenueAbstract_lbl0" xml:lang="en-US">Amounts expected to be recognized as revenue:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueAbstract" xlink:to="ifrs-full_RevenueAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US">Total revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Revenue_lbl0" xml:lang="en-US">Disaggregated revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_Revenue_lbl1" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_CostOfSalesAbstract" xlink:href="aapg-20251231.xsd#aapg_CostOfSalesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CostOfSalesAbstract_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CostOfSalesAbstract" xlink:to="aapg_CostOfSalesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Share of profit/(loss) of a joint venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_lbl" xml:lang="en-US">Attributable to:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl" xml:lang="en-US">Ordinary equity holders of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl0" xml:lang="en-US">Loss attributable to ordinary equity holders of the parent, used in the basic loss per share calculation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xml:lang="en-US">Non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US">Basic (in Dollars per share and Yuan Renminbi per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US">Diluted (in Dollars per share and Yuan Renminbi per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract_lbl" xml:lang="en-US">OTHER COMPREHENSIVE INCOME/ (LOSS)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xml:lang="en-US">Other comprehensive income/ (loss) that may be reclassified to profit or loss in subsequent periods, net of tax:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation_lbl" xml:lang="en-US">Exchange differences on translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xml:lang="en-US">Other comprehensive income/ (loss) that will not be reclassified to profit or loss in subsequent periods, net of tax:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations_lbl" xml:lang="en-US">Exchange differences on translation of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToAbstract_lbl" xml:lang="en-US">Attributable to:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl" xml:lang="en-US">Ordinary equity holders of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl" xml:lang="en-US">Non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl0" xml:lang="en-US">Net carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl1" xml:lang="en-US">Net carrying amount in US$ (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherIntangibleAssets_lbl" xml:lang="en-US">Other intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIntangibleAssets" xlink:to="ifrs-full_OtherIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Investment in a joint venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl0" xml:lang="en-US">Share of net assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Financial assets at fair value through profit or loss (&#8220;FVTPL&#8221;)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl1" xml:lang="en-US">Financial assets at FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DeferredTaxAssets_lbl0" xml:lang="en-US">Net deferred tax assets recognized in the consolidated statements of financial position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_DeferredTaxAssets_lbl1" xml:lang="en-US">Unrecognised deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US">CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentTradeReceivables_lbl" xml:lang="en-US">Trade receivables, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentPayables_lbl" xml:lang="en-US">Other payables and accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentPayables" xlink:to="ifrs-full_OtherCurrentPayables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherCurrentPayables_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentPayables" xlink:to="ifrs-full_OtherCurrentPayables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentContractLiabilities_lbl" xml:lang="en-US">Contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentContractLiabilities" xlink:to="ifrs-full_CurrentContractLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_Interestbearingbankandotherborrowingscurrent" xlink:href="aapg-20251231.xsd#aapg_Interestbearingbankandotherborrowingscurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_Interestbearingbankandotherborrowingscurrent_lbl" xml:lang="en-US">Interest-bearing bank and other borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Interestbearingbankandotherborrowingscurrent" xlink:to="aapg_Interestbearingbankandotherborrowingscurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US">NON-CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentContractLiabilities_lbl" xml:lang="en-US">Contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentContractLiabilities" xlink:to="ifrs-full_NoncurrentContractLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent" xlink:href="aapg-20251231.xsd#aapg_InterestbearingBankAndOtherBorrowingsNonCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent_lbl" xml:lang="en-US">Interest-bearing bank and other borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent" xlink:to="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl0" xml:lang="en-US">Net deferred tax liability recognized in the consolidated statements of financial position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredIncomeNonCurrent" xlink:href="aapg-20251231.xsd#aapg_DeferredIncomeNonCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DeferredIncomeNonCurrent_lbl" xml:lang="en-US">Deferred income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredIncomeNonCurrent" xlink:to="aapg_DeferredIncomeNonCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CommitmentAndContingencies" xlink:href="aapg-20251231.xsd#aapg_CommitmentAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CommitmentAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CommitmentAndContingencies" xlink:to="aapg_CommitmentAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US">EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract" xlink:href="aapg-20251231.xsd#aapg_EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract_lbl" xml:lang="en-US">Equity attributable to ordinary equity holders of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract" xlink:to="aapg_EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares_lbl" xml:lang="en-US">Ordinary shares (par value of US$0.0001 per share as of December 31, 2024 and 2025; 315,224,993 and 373,321,692 shares authorized, issued and outstanding as of December 31, 2024 and 2025, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalOrdinaryShares" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares_lbl0" xml:lang="en-US">Nominal value of issued/&#8203;registered share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalOrdinaryShares" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares_lbl1" xml:lang="en-US">Share capital (in Yuan Renminbi)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalOrdinaryShares" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl0" xml:lang="en-US">Share capital, Ordinary shares, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_ParValuePerShare_lbl1" xml:lang="en-US">Price per shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesAuthorised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesAuthorised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesAuthorised_lbl" xml:lang="en-US">Ordinary shares, shares authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesAuthorised" xlink:to="ifrs-full_NumberOfSharesAuthorised_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares, shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremium_lbl" xml:lang="en-US">Share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CapitalAndReserves" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CapitalAndReserves_lbl" xml:lang="en-US">Capital and reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalAndReserves" xlink:to="aapg_CapitalAndReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xml:lang="en-US">Exchange fluctuation reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl" xml:lang="en-US">Accumulated losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract" xlink:href="aapg-20251231.xsd#aapg_OtherComprehensiveIncomeForTheYearAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract_lbl" xml:lang="en-US">Other comprehensive income for the year:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl" xml:lang="en-US">Exchange differences on translation of operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl0" xml:lang="en-US">Exchange differences on translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl1" xml:lang="en-US">Exchange differences on translation of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary_lbl" xml:lang="en-US">Capital contribution from a non-controlling shareholder of a subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" xlink:to="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssueOfEquity_lbl" xml:lang="en-US">Issue of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RepurchaseOfOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_RepurchaseOfOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_RepurchaseOfOrdinaryShares_lbl" xml:lang="en-US">Repurchase of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RepurchaseOfOrdinaryShares" xlink:to="aapg_RepurchaseOfOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_EquitySettledShareBasedPaymentsAbstract" xlink:href="aapg-20251231.xsd#aapg_EquitySettledShareBasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_EquitySettledShareBasedPaymentsAbstract_lbl" xml:lang="en-US">Equity-settled share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EquitySettledShareBasedPaymentsAbstract" xlink:to="aapg_EquitySettledShareBasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses_lbl" xml:lang="en-US">Pre-IPO share option expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" xlink:to="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses_lbl" xml:lang="en-US">RSU expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" xlink:to="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xml:lang="en-US">Exercise of Pre-IPO share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits_lbl" xml:lang="en-US">Vesting of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" xlink:to="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueEquitysettledBonus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockIssuedDuringPeriodValueEquitysettledBonus_lbl" xml:lang="en-US">Equity-settled bonus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueEquitysettledBonus" xlink:to="aapg_StockIssuedDuringPeriodValueEquitysettledBonus_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract0" xlink:href="aapg-20251231.xsd#aapg_OtherComprehensiveIncomeForTheYearAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract0_lbl" xml:lang="en-US">Other comprehensive income for the year:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract0" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_EquitySettledShareBasedPaymentsAbstract0" xlink:href="aapg-20251231.xsd#aapg_EquitySettledShareBasedPaymentsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_EquitySettledShareBasedPaymentsAbstract0_lbl" xml:lang="en-US">Equity-settled share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EquitySettledShareBasedPaymentsAbstract0" xlink:to="aapg_EquitySettledShareBasedPaymentsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract1" xlink:href="aapg-20251231.xsd#aapg_OtherComprehensiveIncomeForTheYearAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract1_lbl" xml:lang="en-US">Other comprehensive income for the year:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract1" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_EquitySettledShareBasedPaymentsAbstract1" xlink:href="aapg-20251231.xsd#aapg_EquitySettledShareBasedPaymentsAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_EquitySettledShareBasedPaymentsAbstract1_lbl" xml:lang="en-US">Equity-settled share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EquitySettledShareBasedPaymentsAbstract1" xlink:to="aapg_EquitySettledShareBasedPaymentsAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueShareOptionExpenses" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueShareOptionExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockIssuedDuringPeriodValueShareOptionExpenses_lbl" xml:lang="en-US">Post-IPO share option expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueShareOptionExpenses" xlink:to="aapg_StockIssuedDuringPeriodValueShareOptionExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US">Adjustments for:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl" xml:lang="en-US">Depreciation of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForDepreciationOfRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForDepreciationOfRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AdjustmentsForDepreciationOfRightofuseAssets_lbl" xml:lang="en-US">Depreciation of right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForDepreciationOfRightofuseAssets" xlink:to="aapg_AdjustmentsForDepreciationOfRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense_lbl" xml:lang="en-US">Amortization of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US">Equity-settled share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl0" xml:lang="en-US">Post-IPO share option expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Fair value loss on financial assets measured at FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">Fair value loss on financial assets at FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl" xml:lang="en-US">Fair value gain on derivative financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForFinanceCosts_lbl" xml:lang="en-US">Finance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFinanceCosts" xlink:to="ifrs-full_AdjustmentsForFinanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForProvisions_lbl" xml:lang="en-US">Provision for inventory write-down</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForProvisions" xlink:to="ifrs-full_AdjustmentsForProvisions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl" xml:lang="en-US">Foreign exchange (gain)/loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl0" xml:lang="en-US">Foreign exchange (gain)/loss, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances_lbl" xml:lang="en-US">(Increase)/ Decrease in restricted cash balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" xlink:to="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xml:lang="en-US">(Increase)/Decrease in inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xml:lang="en-US">(Increase)/Decrease in trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl" xml:lang="en-US">Increase in prepayments, other receivables and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xml:lang="en-US">(Increase) /Decrease in other non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl" xml:lang="en-US">(Decrease) /Increase in trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets_lbl" xml:lang="en-US">Increase in other payables and accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities_lbl" xml:lang="en-US">Increase /(Decrease) in contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities_lbl" xml:lang="en-US">Increase in deferred income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl" xml:lang="en-US">Income tax paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Proceeds from disposal of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromIssuingShares_lbl" xml:lang="en-US">Proceeds from issue of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingShares" xlink:to="ifrs-full_ProceedsFromIssuingShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xml:lang="en-US">Proceeds from exercise of share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Proceeds from bank loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests_lbl" xml:lang="en-US">Capital contribution from non-controlling shareholders of a subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:to="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of foreign exchange rate changes, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0" xml:lang="en-US">Effect of change in foreign exchange rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_UnlabeledAbstract" xlink:href="aapg-20251231.xsd#aapg_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UnlabeledAbstract" xlink:to="aapg_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashEquivalentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashEquivalentsAbstract_lbl" xml:lang="en-US">ANALYSIS OF BALANCES OF CASH AND BANK BALANCES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashEquivalentsAbstract" xlink:to="ifrs-full_CashEquivalentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Restricted bank balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_lbl0" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_lbl1" xml:lang="en-US">Less: Cash and bank balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" xlink:href="aapg-20251231.xsd#aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths_lbl" xml:lang="en-US">Time deposits with original maturity of more than three months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" xlink:to="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CostOfSales_lbl" xml:lang="en-US">Total cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SellingExpense_lbl" xml:lang="en-US">Selling and distribution expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingExpense" xlink:to="ifrs-full_SellingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdministrativeExpense_lbl" xml:lang="en-US">Administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and development costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TreasuryShares_lbl" xml:lang="en-US">Treasury shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_TreasuryShares_lbl0" xml:lang="en-US">Treasury shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl" xml:lang="en-US">Depreciation of investment property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl0" xml:lang="en-US">Depreciation of investment property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US">(Gain)/loss on disposal of items of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustmentsForGainOnDisposalOfLeases" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForGainOnDisposalOfLeases"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_AdjustmentsForGainOnDisposalOfLeases_lbl" xml:lang="en-US">Gain on disposal of leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForGainOnDisposalOfLeases" xlink:to="aapg_AdjustmentsForGainOnDisposalOfLeases_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="aapg_AdjustmentsForGainOnDisposalOfLeases_lbl0" xml:lang="en-US">Gain on disposal of items of lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForGainOnDisposalOfLeases" xlink:to="aapg_AdjustmentsForGainOnDisposalOfLeases_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_lbl" xml:lang="en-US">Fair value loss on financial liabilities measured at FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Share of (profit)/loss of a joint venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Purchases of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Purchase of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Payment of contingent consideration related to acquisition of a subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:to="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity_lbl" xml:lang="en-US">Maturity/(Placement) in time deposits with original maturity of more than three months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity" xlink:to="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InvestmentInOtherFinancialAssets" xlink:href="aapg-20251231.xsd#aapg_InvestmentInOtherFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_InvestmentInOtherFinancialAssets_lbl" xml:lang="en-US">Investment in other financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentInOtherFinancialAssets" xlink:to="aapg_InvestmentInOtherFinancialAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities" xlink:href="aapg-20251231.xsd#aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Investment in a joint venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities" xlink:to="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_lbl" xml:lang="en-US">Treasury share purchases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:to="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Interest paid classified as financing cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Repayment of bank loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Principal portion of lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ListingExpensePaid" xlink:href="aapg-20251231.xsd#aapg_ListingExpensePaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_ListingExpensePaid_lbl" xml:lang="en-US">Listing expense paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ListingExpensePaid" xlink:to="aapg_ListingExpensePaid_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IntellectuallPropertyMember" xlink:href="aapg-20251231.xsd#aapg_IntellectuallPropertyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IntellectuallPropertyMember_lbl" xml:lang="en-US">Intellectual Property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IntellectuallPropertyMember" xlink:to="aapg_IntellectuallPropertyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ProductsMember" xlink:href="aapg-20251231.xsd#aapg_ProductsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ProductsMember_lbl" xml:lang="en-US">Products</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ProductsMember" xlink:to="aapg_ProductsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_ProductsMember_lbl0" xml:lang="en-US">Sales of products [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ProductsMember" xlink:to="aapg_ProductsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_OthersMember" xlink:href="aapg-20251231.xsd#aapg_OthersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OthersMember_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OthersMember" xlink:to="aapg_OthersMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_OthersMember_lbl0" xml:lang="en-US">Others [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OthersMember" xlink:to="aapg_OthersMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US">Share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IssuedCapitalMember_lbl0" xml:lang="en-US">Share capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasurySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TreasurySharesMember_lbl" xml:lang="en-US">Treasury shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasurySharesMember" xlink:to="ifrs-full_TreasurySharesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TreasurySharesMember_lbl0" xml:lang="en-US">Treasury shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasurySharesMember" xlink:to="ifrs-full_TreasurySharesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremiumMember_lbl" xml:lang="en-US">Share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CapitalAndReservesMember" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReservesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CapitalAndReservesMember_lbl" xml:lang="en-US">Capital and reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalAndReservesMember" xlink:to="aapg_CapitalAndReservesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xml:lang="en-US">Exchange fluctuation reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl0" xml:lang="en-US">Exchange fluctuation reserve [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RetainedEarningsMember_lbl0" xml:lang="en-US">Accumulated losses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ParentMember_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParentMember" xlink:to="ifrs-full_ParentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ParentMember_lbl0" xml:lang="en-US">Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParentMember" xlink:to="ifrs-full_ParentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_ParentMember_lbl1" xml:lang="en-US">Parent [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParentMember" xlink:to="ifrs-full_ParentMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterestsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncontrollingInterestsMember_lbl" xml:lang="en-US">Non- controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterestsMember" xlink:to="ifrs-full_NoncontrollingInterestsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl" xml:lang="en-US">CORPORATE AND GROUP INFORMATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl" xml:lang="en-US">Schedule of Principal Subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl" xml:lang="en-US">Place and date of incorporation/&#8203; registration and place of business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect" xlink:href="aapg-20251231.xsd#aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect_lbl" xml:lang="en-US">Percentage of equity interests attributable to the Company Direct</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect" xlink:to="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xml:lang="en-US">Percentage of equity interests attributable to the Company Indirect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl0" xml:lang="en-US">Gearing ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl" xml:lang="en-US">Principal business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl0" xml:lang="en-US">Place of registration and business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_lbl" xml:lang="en-US">ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_lbl" xml:lang="en-US">Schedule of New and Revised IFRSs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:to="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TitleOfNewIFRS" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TitleOfNewIFRS"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TitleOfNewIFRS_lbl" xml:lang="en-US">New and revised IFRS codification, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TitleOfNewIFRS" xlink:to="ifrs-full_TitleOfNewIFRS_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory_lbl" xml:lang="en-US">Schedule of Property, Plant and Equipment of Annual Rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" xlink:to="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRatePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRatePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepreciationRatePropertyPlantAndEquipment_lbl" xml:lang="en-US">Property, plant and equipment, rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRatePropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationRatePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Intangible Assets are Amortized on the Straight-Line Basis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets are amortized useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" xlink:to="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RightofuseAssetsOfEstimatedUsefulLives" xlink:href="aapg-20251231.xsd#aapg_RightofuseAssetsOfEstimatedUsefulLives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_RightofuseAssetsOfEstimatedUsefulLives_lbl" xml:lang="en-US">Right-of-use assets of estimated useful lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RightofuseAssetsOfEstimatedUsefulLives" xlink:to="aapg_RightofuseAssetsOfEstimatedUsefulLives_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING JUDGEMENTS AND ESTIMATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xml:lang="en-US">OPERATING SEGMENT INFORMATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl" xml:lang="en-US">&#8203;Schedule of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:to="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_lbl" xml:lang="en-US">&#8203;Schedule of Non-Current Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:to="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl0" xml:lang="en-US">Financial assets included in other non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_lbl" xml:lang="en-US">Schedule of Revenue from Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US">Revenue from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock_lbl" xml:lang="en-US">REVENUE, OTHER INCOME AND GAINS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" xlink:to="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US">&#8203;Schedule of Disaggregated Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypesOfGoodsOrServicesAbstract" xlink:href="aapg-20251231.xsd#aapg_TypesOfGoodsOrServicesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypesOfGoodsOrServicesAbstract_lbl" xml:lang="en-US">Types of goods or services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypesOfGoodsOrServicesAbstract" xlink:to="aapg_TypesOfGoodsOrServicesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TimingOfRevenueRecognitionAbstract" xlink:href="aapg-20251231.xsd#aapg_TimingOfRevenueRecognitionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TimingOfRevenueRecognitionAbstract_lbl" xml:lang="en-US">Timing of revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TimingOfRevenueRecognitionAbstract" xlink:to="aapg_TimingOfRevenueRecognitionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AtAPointInTimeAbstract" xlink:href="aapg-20251231.xsd#aapg_AtAPointInTimeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AtAPointInTimeAbstract_lbl" xml:lang="en-US">At a point in time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AtAPointInTimeAbstract" xlink:to="aapg_AtAPointInTimeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OverTimeAbstract" xlink:href="aapg-20251231.xsd#aapg_OverTimeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OverTimeAbstract_lbl" xml:lang="en-US">Over time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OverTimeAbstract" xlink:to="aapg_OverTimeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory_lbl" xml:lang="en-US">&#8203;Schedule of Contract Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl" xml:lang="en-US">Commercialization rights income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPerformanceObligationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPerformanceObligationsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfPerformanceObligationsExplanatory_lbl" xml:lang="en-US">Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPerformanceObligationsExplanatory" xlink:to="ifrs-full_DisclosureOfPerformanceObligationsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US">Recognized as revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl" xml:lang="en-US">Schedule of Other Income and Gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks_lbl" xml:lang="en-US">Bank interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" xlink:to="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks_lbl0" xml:lang="en-US">Bank interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" xlink:to="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromGovernmentGrants_lbl" xml:lang="en-US">Government grants related to income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromGovernmentGrants" xlink:to="ifrs-full_RevenueFromGovernmentGrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RevenueFromGovernmentGrants_lbl0" xml:lang="en-US">Government grants related to income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromGovernmentGrants" xlink:to="ifrs-full_RevenueFromGovernmentGrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetForeignExchangeGain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetForeignExchangeGain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetForeignExchangeGain_lbl" xml:lang="en-US">Foreign exchange gain, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeGain" xlink:to="ifrs-full_NetForeignExchangeGain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RentalIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RentalIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RentalIncome_lbl" xml:lang="en-US">Rental income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RentalIncome" xlink:to="ifrs-full_RentalIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_lbl" xml:lang="en-US">Fair value gain on derivative financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_lbl0" xml:lang="en-US">Derivative financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Gain on disposal of items of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:to="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherGainsLosses_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherGainsLosses" xlink:to="ifrs-full_OtherGainsLosses_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherGainsLosses_lbl0" xml:lang="en-US">Other income and gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherGainsLosses" xlink:to="ifrs-full_OtherGainsLosses_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock_lbl" xml:lang="en-US">LOSS BEFORE TAX</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock" xlink:to="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock_lbl" xml:lang="en-US">Schedule of Loss Before Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" xlink:to="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_lbl" xml:lang="en-US">Cost of inventories sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:to="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSalesRoomOccupancyServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesRoomOccupancyServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CostOfSalesRoomOccupancyServices_lbl" xml:lang="en-US">Cost of services provided</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSalesRoomOccupancyServices" xlink:to="ifrs-full_CostOfSalesRoomOccupancyServices_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoryWritedown2011" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoryWritedown2011"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InventoryWritedown2011_lbl" xml:lang="en-US">Write-down of inventories to net realizable value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoryWritedown2011" xlink:to="ifrs-full_InventoryWritedown2011_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepreciationExpense_lbl" xml:lang="en-US">Depreciation of right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Amortization of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlansAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlansAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlansAbstract_lbl" xml:lang="en-US">Employee benefit expense (including directors&#8217; remuneration):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlansAbstract" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlansAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WagesAndSalaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WagesAndSalaries"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WagesAndSalaries_lbl" xml:lang="en-US">Wages and salaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WagesAndSalaries" xlink:to="ifrs-full_WagesAndSalaries_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US">Equity-settled share-based payment expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_lbl" xml:lang="en-US">Pension scheme contributions (defined contribution scheme)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LossBeforeTaxArrivedCharingOrCrediting" xlink:href="aapg-20251231.xsd#aapg_LossBeforeTaxArrivedCharingOrCrediting"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LossBeforeTaxArrivedCharingOrCrediting_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LossBeforeTaxArrivedCharingOrCrediting" xlink:to="aapg_LossBeforeTaxArrivedCharingOrCrediting_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivativesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivativesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivativesAbstract_lbl" xml:lang="en-US">Fair value (gain)/loss, net:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnChangeInFairValueOfDerivativesAbstract" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivativesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAtFVTPL" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAtFVTPL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialAssetsAtFVTPL_lbl" xml:lang="en-US">Financial assets at FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAtFVTPL" xlink:to="aapg_FinancialAssetsAtFVTPL_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesAtFVTPL" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtFVTPL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialLiabilitiesAtFVTPL_lbl" xml:lang="en-US">Financial liabilities at FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesAtFVTPL" xlink:to="aapg_FinancialLiabilitiesAtFVTPL_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PenaltyExpense" xlink:href="aapg-20251231.xsd#aapg_PenaltyExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PenaltyExpense_lbl" xml:lang="en-US">Lease payments not included in the measurement of lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PenaltyExpense" xlink:to="aapg_PenaltyExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AuditorsRemuneration" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AuditorsRemuneration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AuditorsRemuneration_lbl" xml:lang="en-US">Auditors&#8217; remuneration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AuditorsRemuneration" xlink:to="ifrs-full_AuditorsRemuneration_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DonationsAndSubsidiesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DonationsAndSubsidiesExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DonationsAndSubsidiesExpense_lbl" xml:lang="en-US">Donations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DonationsAndSubsidiesExpense" xlink:to="ifrs-full_DonationsAndSubsidiesExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_Penaltys" xlink:href="aapg-20251231.xsd#aapg_Penaltys"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_Penaltys_lbl" xml:lang="en-US">Penalty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Penaltys" xlink:to="aapg_Penaltys_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_lbl" xml:lang="en-US">OTHER EXPENSES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherExpensesTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherExpensesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfOtherExpensesTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherExpensesTableTextBlock" xlink:to="aapg_ScheduleOfOtherExpensesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ForeignExchangeLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ForeignExchangeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ForeignExchangeLoss_lbl" xml:lang="en-US">Foreign exchange loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ForeignExchangeLoss" xlink:to="ifrs-full_ForeignExchangeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_Penalty" xlink:href="aapg-20251231.xsd#aapg_Penalty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_Penalty_lbl" xml:lang="en-US">Penalty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Penalty" xlink:to="aapg_Penalty_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Loss on disposal of items of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:to="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OthersExpenses" xlink:href="aapg-20251231.xsd#aapg_OthersExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OthersExpenses_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OthersExpenses" xlink:to="aapg_OthersExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US">FINANCE COSTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceCostExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinanceCostExplanatory_lbl" xml:lang="en-US">Schedule of Finance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceCostExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBankLoansAndOverdrafts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_lbl" xml:lang="en-US">Interest on bank loans and other borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:to="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsCapitalised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestCostsCapitalised_lbl" xml:lang="en-US">Interest on lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestCostsCapitalised" xlink:to="ifrs-full_InterestCostsCapitalised_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpenseOnBorrowings_lbl" xml:lang="en-US">Interest on long-term payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnBorrowings" xlink:to="ifrs-full_InterestExpenseOnBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US">INCOME TAX</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory_lbl" xml:lang="en-US">Schedule of Current and Deferred Components of the Income Tax (Credit)/Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" xlink:to="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl" xml:lang="en-US">Deferred (note 18)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory_lbl" xml:lang="en-US">Schedule of Reconciliation between the Income Tax Expense/(Credit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" xlink:to="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LowerTaxRateForASpecificEntity" xlink:href="aapg-20251231.xsd#aapg_LowerTaxRateForASpecificEntity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LowerTaxRateForASpecificEntity_lbl" xml:lang="en-US">Lower tax rate for a specific entity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LowerTaxRateForASpecificEntity" xlink:to="aapg_LowerTaxRateForASpecificEntity_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xml:lang="en-US">Items not deductible for tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectFromChangeInTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate_lbl" xml:lang="en-US">Effect of tax rate changes on deferred taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:to="ifrs-full_TaxEffectFromChangeInTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_UncertainTaxPosition" xlink:href="aapg-20251231.xsd#aapg_UncertainTaxPosition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_UncertainTaxPosition_lbl" xml:lang="en-US">Uncertain tax position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UncertainTaxPosition" xlink:to="aapg_UncertainTaxPosition_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_EffectOfWithholdingTaxOnTheInterestIncome" xlink:href="aapg-20251231.xsd#aapg_EffectOfWithholdingTaxOnTheInterestIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_EffectOfWithholdingTaxOnTheInterestIncome_lbl" xml:lang="en-US">Effect of withholding tax on the interest income of the Group&#8217;s HK subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EffectOfWithholdingTaxOnTheInterestIncome" xlink:to="aapg_EffectOfWithholdingTaxOnTheInterestIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NetOperatingLossExpired" xlink:href="aapg-20251231.xsd#aapg_NetOperatingLossExpired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NetOperatingLossExpired_lbl" xml:lang="en-US">Tax loss expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NetOperatingLossExpired" xlink:to="aapg_NetOperatingLossExpired_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DeductibleTemporaryDifferencesNotRecognized" xlink:href="aapg-20251231.xsd#aapg_DeductibleTemporaryDifferencesNotRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DeductibleTemporaryDifferencesNotRecognized_lbl" xml:lang="en-US">Deductible temporary differences not recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeductibleTemporaryDifferencesNotRecognized" xlink:to="aapg_DeductibleTemporaryDifferencesNotRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl" xml:lang="en-US">Tax losses not recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfTaxLosses" xlink:to="ifrs-full_TaxEffectOfTaxLosses_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl0" xml:lang="en-US">Tax losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfTaxLosses" xlink:to="ifrs-full_TaxEffectOfTaxLosses_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDividendsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDividendsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDividendsExplanatory_lbl" xml:lang="en-US">DIVIDENDS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDividendsExplanatory" xlink:to="ifrs-full_DisclosureOfDividendsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US">LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl" xml:lang="en-US">Schedule of Basic Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareExplanatory" xlink:to="ifrs-full_EarningsPerShareExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LossAbstract" xlink:href="aapg-20251231.xsd#aapg_LossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LossAbstract_lbl" xml:lang="en-US">Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LossAbstract" xlink:to="aapg_LossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SharesAbstract" xlink:href="aapg-20251231.xsd#aapg_SharesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SharesAbstract_lbl" xml:lang="en-US">Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharesAbstract" xlink:to="aapg_SharesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US">Weighted average number of ordinary shares outstanding during the year used in the basic loss per share calculation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageShares_lbl0" xml:lang="en-US">Issuable shares on weighted average number of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Schedule of Property, Plant and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PropertyAndEquipmentCost" xlink:href="aapg-20251231.xsd#aapg_PropertyAndEquipmentCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PropertyAndEquipmentCost_lbl" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PropertyAndEquipmentCost" xlink:to="aapg_PropertyAndEquipmentCost_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccumulatedDepreciationsCost" xlink:href="aapg-20251231.xsd#aapg_AccumulatedDepreciationsCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AccumulatedDepreciationsCost_lbl" xml:lang="en-US">Accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccumulatedDepreciationsCost" xlink:to="aapg_AccumulatedDepreciationsCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_lbl" xml:lang="en-US">Transfers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Exchange realignment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AtDecember312024Abstract" xlink:href="aapg-20251231.xsd#aapg_AtDecember312024Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AtDecember312024Abstract_lbl" xml:lang="en-US">At December 31, 2024:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AtDecember312024Abstract" xlink:to="aapg_AtDecember312024Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US">Deficit on adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl0" xml:lang="en-US">Accretion of interest recognized during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl1" xml:lang="en-US">Interest on lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_AtDecember312025Abstract" xlink:href="aapg-20251231.xsd#aapg_AtDecember312025Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AtDecember312025Abstract_lbl" xml:lang="en-US">At December 31, 2025:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AtDecember312025Abstract" xlink:to="aapg_AtDecember312025Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xml:lang="en-US">LEASES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Right-of-Use Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ExchangeRealignmentRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_ExchangeRealignmentRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ExchangeRealignmentRightofuseAssets_lbl" xml:lang="en-US">Exchange realignment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ExchangeRealignmentRightofuseAssets" xlink:to="aapg_ExchangeRealignmentRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock_lbl" xml:lang="en-US">Schedule of Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" xlink:to="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">New leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ExchangeRealignments" xlink:href="aapg-20251231.xsd#aapg_ExchangeRealignments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ExchangeRealignments_lbl" xml:lang="en-US">Exchange realignment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ExchangeRealignments" xlink:to="aapg_ExchangeRealignments_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AnalyzedIntoAbstract" xlink:href="aapg-20251231.xsd#aapg_AnalyzedIntoAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AnalyzedIntoAbstract_lbl" xml:lang="en-US">Analyzed into:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AnalyzedIntoAbstract" xlink:to="aapg_AnalyzedIntoAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US">Current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US">Non-current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl0" xml:lang="en-US">Financial liabilities included in other payables and accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory_lbl" xml:lang="en-US">Schedule of Recognized in Profit or Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:to="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DepreciationChargeofRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_DepreciationChargeofRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DepreciationChargeofRightofuseAssets_lbl" xml:lang="en-US">Depreciation charge of right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DepreciationChargeofRightofuseAssets" xlink:to="aapg_DepreciationChargeofRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US">Expense relating to short-term leases (included in administrative expenses) (note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory_lbl" xml:lang="en-US">GOODWILL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:to="ifrs-full_DisclosureOfGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_lbl" xml:lang="en-US">Schedule of Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CostGoodwill" xlink:href="aapg-20251231.xsd#aapg_CostGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CostGoodwill_lbl" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CostGoodwill" xlink:to="aapg_CostGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccumulatedImpairmentGoodwill" xlink:href="aapg-20251231.xsd#aapg_AccumulatedImpairmentGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AccumulatedImpairmentGoodwill_lbl" xml:lang="en-US">Accumulated impairment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccumulatedImpairmentGoodwill" xlink:to="aapg_AccumulatedImpairmentGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US">OTHER INTANGIBLE ASSET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Intangible Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" xlink:to="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IntangibleAssetsGross" xlink:href="aapg-20251231.xsd#aapg_IntangibleAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IntangibleAssetsGross_lbl" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IntangibleAssetsGross" xlink:to="aapg_IntangibleAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccumulatedAmortization" xlink:href="aapg-20251231.xsd#aapg_AccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccumulatedAmortization" xlink:to="aapg_AccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_December312025Abstract" xlink:href="aapg-20251231.xsd#aapg_December312025Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_December312025Abstract_lbl" xml:lang="en-US">December 31, 2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_December312025Abstract" xlink:to="aapg_December312025Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl" xml:lang="en-US">INVESTMENT IN A JOINT VENTURE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock_lbl" xml:lang="en-US">Schedule of Investment in a Joint Venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock" xlink:to="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock_lbl" xml:lang="en-US">Schedule of Group&#8217;s Principal Joint Venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock" xlink:to="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RegisteredShareCapital" xlink:href="aapg-20251231.xsd#aapg_RegisteredShareCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_RegisteredShareCapital_lbl" xml:lang="en-US">Registered share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RegisteredShareCapital" xlink:to="aapg_RegisteredShareCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestInJointVenture_lbl" xml:lang="en-US">Percentage of ownership interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:to="ifrs-full_ProportionOfOwnershipInterestInJointVenture_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PrincipalActivities" xlink:href="aapg-20251231.xsd#aapg_PrincipalActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PrincipalActivities_lbl" xml:lang="en-US">Principal activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrincipalActivities" xlink:to="aapg_PrincipalActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock_lbl" xml:lang="en-US">Schedule of Information of the Group&#8217;s Joint Venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" xlink:to="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Share of the joint venture&#8217;s (loss)/gain for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Share of the joint venture&#8217;s total comprehensive (loss)/gain for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" xlink:href="aapg-20251231.xsd#aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture_lbl" xml:lang="en-US">Aggregate carrying amount of the Group&#8217;s investment in the joint venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" xlink:to="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_lbl" xml:lang="en-US">FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory_lbl" xml:lang="en-US">Schedule of Financial Assets at Fair Value through Profit or Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" xlink:to="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ListedEquityInvestmentsAtFairValue" xlink:href="aapg-20251231.xsd#aapg_ListedEquityInvestmentsAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ListedEquityInvestmentsAtFairValue_lbl" xml:lang="en-US">Listed equity investments, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ListedEquityInvestmentsAtFairValue" xlink:to="aapg_ListedEquityInvestmentsAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherUnlistedInvestmentsAtFairValue" xlink:href="aapg-20251231.xsd#aapg_OtherUnlistedInvestmentsAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherUnlistedInvestmentsAtFairValue_lbl" xml:lang="en-US">Other unlisted investments, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherUnlistedInvestmentsAtFairValue" xlink:to="aapg_OtherUnlistedInvestmentsAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl" xml:lang="en-US">DEFERRED TAX</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of Movements in Deferred Tax Liabilities and Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory" xlink:to="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl" xml:lang="en-US">Deferred tax charged/(credited) to the statement of profit or loss during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDeferredTaxAssetsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDeferredTaxAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfDeferredTaxAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Movements in Deferred Tax Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDeferredTaxAssetsExplanatory" xlink:to="aapg_DisclosureOfDeferredTaxAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:to="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition_lbl" xml:lang="en-US">Deferred tax offset in the consolidated statements of financial position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" xlink:to="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_lbl" xml:lang="en-US">OTHER NON-CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Non-Current Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock" xlink:to="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractAcquisitionCosts" xlink:href="aapg-20251231.xsd#aapg_ContractAcquisitionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ContractAcquisitionCosts_lbl" xml:lang="en-US">Contract acquisition costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ContractAcquisitionCosts" xlink:to="aapg_ContractAcquisitionCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentValueAddedTaxReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentValueAddedTaxReceivables_lbl" xml:lang="en-US">Value added tax recoverable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:to="ifrs-full_NoncurrentValueAddedTaxReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LongtermDeposits_lbl" xml:lang="en-US">Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermDeposits" xlink:to="ifrs-full_LongtermDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPrepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPrepayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentPrepayments_lbl" xml:lang="en-US">Prepayment for property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPrepayments" xlink:to="ifrs-full_NoncurrentPrepayments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory_lbl" xml:lang="en-US">INVENTORIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory_lbl" xml:lang="en-US">Schedule of Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory" xlink:to="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WorkInProgress" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WorkInProgress"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WorkInProgress_lbl" xml:lang="en-US">Work in progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WorkInProgress" xlink:to="ifrs-full_WorkInProgress_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinishedGoods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinishedGoods_lbl" xml:lang="en-US">Finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinishedGoods" xlink:to="ifrs-full_FinishedGoods_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US">TRADE RECEIVABLES, NET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfTradeReceivablesNetTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTradeReceivablesNetTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfTradeReceivablesNetTableTextBlock_lbl" xml:lang="en-US">Schedule of Trade Receivables, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfTradeReceivablesNetTableTextBlock" xlink:to="aapg_ScheduleOfTradeReceivablesNetTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl" xml:lang="en-US">Trade receivables, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock_lbl" xml:lang="en-US">Schedule of Based on the Invoice Date and Net of Loss Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" xlink:to="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory_lbl" xml:lang="en-US">PREPAYMENTS, OTHER RECEIVABLES AND OTHER ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Prepayments, Other Receivables and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PrepaymentsForClinicalTrialExpenses" xlink:href="aapg-20251231.xsd#aapg_PrepaymentsForClinicalTrialExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PrepaymentsForClinicalTrialExpenses_lbl" xml:lang="en-US">Prepayments for clinical trial expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrepaymentsForClinicalTrialExpenses" xlink:to="aapg_PrepaymentsForClinicalTrialExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PrepaidListingExpense" xlink:href="aapg-20251231.xsd#aapg_PrepaidListingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PrepaidListingExpense_lbl" xml:lang="en-US">Prepaid listing expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrepaidListingExpense" xlink:to="aapg_PrepaidListingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ValueAddedTaxReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ValueAddedTaxReceivables_lbl" xml:lang="en-US">Value added tax recoverable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ValueAddedTaxReceivables" xlink:to="ifrs-full_ValueAddedTaxReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherReceivables_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DepositsAssetsPrepayments" xlink:href="aapg-20251231.xsd#aapg_DepositsAssetsPrepayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DepositsAssetsPrepayments_lbl" xml:lang="en-US">Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DepositsAssetsPrepayments" xlink:to="aapg_DepositsAssetsPrepayments_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PrepaymentForTreasurySharePurchaseFees" xlink:href="aapg-20251231.xsd#aapg_PrepaymentForTreasurySharePurchaseFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PrepaymentForTreasurySharePurchaseFees_lbl" xml:lang="en-US">Prepayment for treasury share purchase fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrepaymentForTreasurySharePurchaseFees" xlink:to="aapg_PrepaymentForTreasurySharePurchaseFees_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Prepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Prepayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Prepayments_lbl" xml:lang="en-US">Other prepayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Prepayments" xlink:to="ifrs-full_Prepayments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory_lbl" xml:lang="en-US">CASH AND BANK BALANCES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCashAndBankBalancesExplanatory" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCashAndBankBalancesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfCashAndBankBalancesExplanatory_lbl" xml:lang="en-US">Schedule of Cash and Bank Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCashAndBankBalancesExplanatory" xlink:to="aapg_ScheduleOfCashAndBankBalancesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepositsFromBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepositsFromBanks"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepositsFromBanks_lbl" xml:lang="en-US">Time deposits with original maturity of more than three months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepositsFromBanks" xlink:to="ifrs-full_DepositsFromBanks_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BalancesWithBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BalancesWithBanks"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BalancesWithBanks_lbl" xml:lang="en-US">Cash and bank balances as stated in the consolidated statements of financial position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BalancesWithBanks" xlink:to="ifrs-full_BalancesWithBanks_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DenominatedInAbstract" xlink:href="aapg-20251231.xsd#aapg_DenominatedInAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DenominatedInAbstract_lbl" xml:lang="en-US">Denominated in:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DenominatedInAbstract" xlink:to="aapg_DenominatedInAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_lbl" xml:lang="en-US">TRADE PAYABLES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfTradePayablesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfTradePayablesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfTradePayablesExplanatory_lbl" xml:lang="en-US">Schedule of the Trade Payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfTradePayablesExplanatory" xlink:to="aapg_DisclosureOfTradePayablesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock_lbl" xml:lang="en-US">OTHER PAYABLES AND ACCRUALS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock" xlink:to="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureofOtherPayablesAndAccrualsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory_lbl" xml:lang="en-US">Schedule of Other Payables and Accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory" xlink:to="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccrualsClassifiedAsCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccrualsClassifiedAsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccrualsClassifiedAsCurrent_lbl" xml:lang="en-US">Accrued promotion expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccrualsClassifiedAsCurrent" xlink:to="ifrs-full_AccrualsClassifiedAsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl" xml:lang="en-US">Payroll payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CurretPayablesForConstructionCost" xlink:href="aapg-20251231.xsd#aapg_CurretPayablesForConstructionCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CurretPayablesForConstructionCost_lbl" xml:lang="en-US">Payables for construction cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurretPayablesForConstructionCost" xlink:to="aapg_CurretPayablesForConstructionCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl" xml:lang="en-US">Long-term payables &#8211; current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl0" xml:lang="en-US">Interest-bearing bank and other borrowings (current and non-current portions)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_lbl" xml:lang="en-US">Other non-current liabilities - current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:to="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherPayables_lbl" xml:lang="en-US">Other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPayables" xlink:to="ifrs-full_OtherPayables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherPayables_lbl0" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPayables" xlink:to="ifrs-full_OtherPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_OtherPayables_lbl1" xml:lang="en-US">Long-term payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPayables" xlink:to="ifrs-full_OtherPayables_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_GovernmentSubsidy" xlink:href="aapg-20251231.xsd#aapg_GovernmentSubsidy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_GovernmentSubsidy_lbl" xml:lang="en-US">Government subsidy</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GovernmentSubsidy" xlink:to="aapg_GovernmentSubsidy_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentExciseTaxPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentExciseTaxPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentExciseTaxPayables_lbl" xml:lang="en-US">Tax payables other than income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentExciseTaxPayables" xlink:to="ifrs-full_CurrentExciseTaxPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfContractLiabilitiesTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfContractLiabilitiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfContractLiabilitiesTextBlock_lbl" xml:lang="en-US">CONTRACT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfContractLiabilitiesTextBlock" xlink:to="aapg_DisclosureOfContractLiabilitiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfContractsLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfContractsLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfContractsLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of Contract Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfContractsLiabilitiesExplanatory" xlink:to="aapg_DisclosureOfContractsLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShortTermAdvancesRecognizedFromCustomersAbstract" xlink:href="aapg-20251231.xsd#aapg_ShortTermAdvancesRecognizedFromCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ShortTermAdvancesRecognizedFromCustomersAbstract_lbl" xml:lang="en-US">Short-term advances recognized from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShortTermAdvancesRecognizedFromCustomersAbstract" xlink:to="aapg_ShortTermAdvancesRecognizedFromCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContractLiabilities_lbl" xml:lang="en-US">Total contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractLiabilities" xlink:to="ifrs-full_ContractLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ContractLiabilities_lbl0" xml:lang="en-US">Contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractLiabilities" xlink:to="ifrs-full_ContractLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_LongTermAdvancesRecognizedFromCustomersAbstract" xlink:href="aapg-20251231.xsd#aapg_LongTermAdvancesRecognizedFromCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LongTermAdvancesRecognizedFromCustomersAbstract_lbl" xml:lang="en-US">Long-term advances recognized from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LongTermAdvancesRecognizedFromCustomersAbstract" xlink:to="aapg_LongTermAdvancesRecognizedFromCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBorrowingsExplanatory_lbl" xml:lang="en-US">INTEREST-BEARING BANK AND OTHER BORROWINGS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:to="ifrs-full_DisclosureOfBorrowingsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock_lbl" xml:lang="en-US">Schedule of Interest-Bearing Bank and Other Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" xlink:to="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CurrentAbstract" xlink:href="aapg-20251231.xsd#aapg_CurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CurrentAbstract_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentAbstract" xlink:to="aapg_CurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRateBasis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingsInterestRateBasis_lbl" xml:lang="en-US">Effective interest rate per annum (%)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRateBasis" xlink:to="ifrs-full_BorrowingsInterestRateBasis_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BorrowingsInterestRateBasis_lbl0" xml:lang="en-US">Increase/(decrease) in basis points</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRateBasis" xlink:to="ifrs-full_BorrowingsInterestRateBasis_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsMaturity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsMaturity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingsMaturity_lbl" xml:lang="en-US">Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsMaturity" xlink:to="ifrs-full_BorrowingsMaturity_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermBorrowings_lbl" xml:lang="en-US">Current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NonCurrentAbstract" xlink:href="aapg-20251231.xsd#aapg_NonCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NonCurrentAbstract_lbl" xml:lang="en-US">Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCurrentAbstract" xlink:to="aapg_NonCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CurrentAbstract0" xlink:href="aapg-20251231.xsd#aapg_CurrentAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CurrentAbstract0_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentAbstract0" xlink:to="aapg_CurrentAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NonCurrentAbstract0" xlink:href="aapg-20251231.xsd#aapg_NonCurrentAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NonCurrentAbstract0_lbl" xml:lang="en-US">Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCurrentAbstract0" xlink:to="aapg_NonCurrentAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" xlink:to="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AnalyzedIntoAbstract0" xlink:href="aapg-20251231.xsd#aapg_AnalyzedIntoAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AnalyzedIntoAbstract0_lbl" xml:lang="en-US">Analyzed into:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AnalyzedIntoAbstract0" xlink:to="aapg_AnalyzedIntoAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDeferredIncomeExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDeferredIncomeExplanatory_lbl" xml:lang="en-US">DEFERRED INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredIncomeExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredIncomeExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfDeferredIncomeTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDeferredIncomeTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfDeferredIncomeTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfDeferredIncomeTableTextBlock" xlink:to="aapg_ScheduleOfDeferredIncomeTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentGovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentGovernmentGrants_lbl" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentGovernmentGrants" xlink:to="ifrs-full_CurrentGovernmentGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory_lbl" xml:lang="en-US">Schedule of Movements in Government Grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:to="ifrs-full_DisclosureOfGovernmentGrantsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PortionClassifiedAsCurrentLiabilities" xlink:href="aapg-20251231.xsd#aapg_PortionClassifiedAsCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PortionClassifiedAsCurrentLiabilities_lbl" xml:lang="en-US">Portion classified as current liabilities (note 26)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PortionClassifiedAsCurrentLiabilities" xlink:to="aapg_PortionClassifiedAsCurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US">SHARE CAPITAL AND TREASURY SHARES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xml:lang="en-US">Schedule of Issued and Fully Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory_lbl" xml:lang="en-US">Schedule of Share Capital and Treasury Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory" xlink:to="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfOrdinaryShare" xlink:href="aapg-20251231.xsd#aapg_IssueOfOrdinaryShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IssueOfOrdinaryShare_lbl" xml:lang="en-US">Issue of ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfOrdinaryShare" xlink:to="aapg_IssueOfOrdinaryShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_IssueOfOrdinaryShare_lbl0" xml:lang="en-US">Subscription of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfOrdinaryShare" xlink:to="aapg_IssueOfOrdinaryShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_IssueOfOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IssueOfOrdinaryShares_lbl" xml:lang="en-US">Issue of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfOrdinaryShares" xlink:to="aapg_IssueOfOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" xlink:href="aapg-20251231.xsd#aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares_lbl" xml:lang="en-US">Issue of shares under the pre-IPO share option scheme (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" xlink:to="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme" xlink:href="aapg-20251231.xsd#aapg_IssueOfSharesUnderThePreIPOShareOptionScheme"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme_lbl" xml:lang="en-US">Issue of shares under the pre-IPO share option scheme</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme" xlink:to="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares" xlink:href="aapg-20251231.xsd#aapg_IssueOfSharesUnderThe2021RSUSchemeInshares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares_lbl" xml:lang="en-US">Issue of shares under the 2021 RSU scheme (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares" xlink:to="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme_lbl" xml:lang="en-US">Issue of shares under the 2021 RSU scheme</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" xlink:to="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus_lbl" xml:lang="en-US">Equity-settled bonus (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus" xlink:to="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValuesEquitysettledBonus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus_lbl" xml:lang="en-US">Equity-settled bonus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus" xlink:to="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RepurchaseOfOrdinaryShare" xlink:href="aapg-20251231.xsd#aapg_RepurchaseOfOrdinaryShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_RepurchaseOfOrdinaryShare_lbl" xml:lang="en-US">Repurchase of ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RepurchaseOfOrdinaryShare" xlink:to="aapg_RepurchaseOfOrdinaryShare_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares_lbl" xml:lang="en-US">Repurchase of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" xlink:to="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_VestingOfRestrictedShareUnit" xlink:href="aapg-20251231.xsd#aapg_VestingOfRestrictedShareUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_VestingOfRestrictedShareUnit_lbl" xml:lang="en-US">Vesting of RSUs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_VestingOfRestrictedShareUnit" xlink:to="aapg_VestingOfRestrictedShareUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_VestingOfRestrictedShareUnits" xlink:href="aapg-20251231.xsd#aapg_VestingOfRestrictedShareUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_VestingOfRestrictedShareUnits_lbl" xml:lang="en-US">Vesting of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_VestingOfRestrictedShareUnits" xlink:to="aapg_VestingOfRestrictedShareUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US">RESERVES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US">SHARE-BASED PAYMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US">Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Exercise price, Forfeited during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Exercise price, Exercised during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average share price exercised (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Exercise price, Granted during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of options, Granted during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Granted options shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_lbl" xml:lang="en-US">Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock_lbl" xml:lang="en-US">Schedule of fair values of share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" xlink:to="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US">Risk-free interest rate%</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xml:lang="en-US">Expected life of options (year)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Weighted average share price (HKD per share) (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfUnlockingDatetextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfUnlockingDatetextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfUnlockingDatetextBlock_lbl" xml:lang="en-US">Schedule of Unlocking Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfUnlockingDatetextBlock" xlink:to="aapg_DisclosureOfUnlockingDatetextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Grant fair value per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfConditionalShares" xlink:href="aapg-20251231.xsd#aapg_PercentageOfConditionalShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PercentageOfConditionalShares_lbl" xml:lang="en-US">% of conditional shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfConditionalShares" xlink:to="aapg_PercentageOfConditionalShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_lbl" xml:lang="en-US">Vesting date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:to="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfVestedConditionalShares" xlink:href="aapg-20251231.xsd#aapg_PercentageOfVestedConditionalShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PercentageOfVestedConditionalShares_lbl" xml:lang="en-US">% of vested conditional shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfVestedConditionalShares" xlink:to="aapg_PercentageOfVestedConditionalShares_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_PercentageOfVestedConditionalShares_lbl0" xml:lang="en-US">percentage of vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfVestedConditionalShares" xlink:to="aapg_PercentageOfVestedConditionalShares_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl" xml:lang="en-US">Schedule of Restricted Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US">Number of RSUs, Granted during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl0" xml:lang="en-US">RSU granted shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl1" xml:lang="en-US">Number of RSU</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl" xml:lang="en-US">NOTES TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:to="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl" xml:lang="en-US">Schedule of Changes in Liabilities Arising from Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Changes from financing cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpense_lbl" xml:lang="en-US">Interest expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets_lbl" xml:lang="en-US">Disposal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory_lbl" xml:lang="en-US">Schedule of Cash Outflow for Leases Included In the Statement of Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" xlink:to="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_lbl" xml:lang="en-US">Within operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Within financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xml:lang="en-US">COMMITMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_lbl" xml:lang="en-US">CONTINGENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfPledgeOfAssetsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfPledgeOfAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfPledgeOfAssetsExplanatory_lbl" xml:lang="en-US">PLEDGE OF ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfPledgeOfAssetsExplanatory" xlink:to="aapg_DisclosureOfPledgeOfAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureofTransactionWithRelatedPartyExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureofTransactionWithRelatedPartyExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureofTransactionWithRelatedPartyExplanatory_lbl" xml:lang="en-US">Schedule of Transaction with Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureofTransactionWithRelatedPartyExplanatory" xlink:to="aapg_DisclosureofTransactionWithRelatedPartyExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xml:lang="en-US">Transaction with related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory_lbl" xml:lang="en-US">Schedule of Outstanding Balance with Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" xlink:to="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherPayablesAndAccruals" xlink:href="aapg-20251231.xsd#aapg_OtherPayablesAndAccruals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherPayablesAndAccruals_lbl" xml:lang="en-US">Other payables and accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherPayablesAndAccruals" xlink:to="aapg_OtherPayablesAndAccruals_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OutstandingBalanceOtherNoncurrentLiabilities" xlink:href="aapg-20251231.xsd#aapg_OutstandingBalanceOtherNoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OutstandingBalanceOtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OutstandingBalanceOtherNoncurrentLiabilities" xlink:to="aapg_OutstandingBalanceOtherNoncurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xml:lang="en-US">Schedule of Compensation of key Management Personnel</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US">Short term employee benefits and fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xml:lang="en-US">Equity-settled share-based payment expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xml:lang="en-US">Post-employment benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">FINANCIAL INSTRUMENTS BY CATEGORY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Schedule of Categories of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Financial assets included in prepayments, other receivables and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">Financial assets included in prepayments, other receivables and other assets - Normal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentReceivables_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentReceivables" xlink:to="ifrs-full_NoncurrentReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets_lbl" xml:lang="en-US">Financial assets included in other non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialAssets" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets_lbl0" xml:lang="en-US">Financial assets included in other non-current assets - Normal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialAssets" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_lbl" xml:lang="en-US">Financial liabilities included in other payables and accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_lbl" xml:lang="en-US">Long-term payables (current and non-current portion)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:to="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Schedule of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" xlink:to="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAbstract_lbl" xml:lang="en-US">Financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:to="ifrs-full_CategoriesOfFinancialAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Financial assets at FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">NASDAQ - Financial assets at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_lbl" xml:lang="en-US">Financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Assets Measured at Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Financial liabilities included in other payables and accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xml:lang="en-US">FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfInterestRateRiskExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfInterestRateRiskExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfInterestRateRiskExplanatory_lbl" xml:lang="en-US">Schedule of Interest Rate Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfInterestRateRiskExplanatory" xlink:to="aapg_DisclosureOfInterestRateRiskExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_a2024Abstract" xlink:href="aapg-20251231.xsd#aapg_a2024Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_a2024Abstract_lbl" xml:lang="en-US">2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_a2024Abstract" xlink:to="aapg_a2024Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreasedecreaseInLossBeforeTax" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseInLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IncreasedecreaseInLossBeforeTax_lbl" xml:lang="en-US">Increase/(decrease) in loss before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseInLossBeforeTax" xlink:to="aapg_IncreasedecreaseInLossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_a2025Abstract" xlink:href="aapg-20251231.xsd#aapg_a2025Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_a2025Abstract_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_a2025Abstract" xlink:to="aapg_a2025Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfForeignCurrencyRiskExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfForeignCurrencyRiskExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfForeignCurrencyRiskExplanatory_lbl" xml:lang="en-US">Schedule of Foreign Currency Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfForeignCurrencyRiskExplanatory" xlink:to="aapg_DisclosureOfForeignCurrencyRiskExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreasedecreaseWeakensAgainst" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseWeakensAgainst"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IncreasedecreaseWeakensAgainst_lbl" xml:lang="en-US">Increase/(decrease) in foreign currency rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseWeakensAgainst" xlink:to="aapg_IncreasedecreaseWeakensAgainst_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl" xml:lang="en-US">Increase/(decrease) in loss before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_lbl" xml:lang="en-US">Increase/(decrease) in other comprehensive income (without tax)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureExplanatory_lbl" xml:lang="en-US">Schedule of Maximum Exposure and Year-end Staging</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:to="ifrs-full_DisclosureOfCreditRiskExposureExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CashAndBankBalancesNotYetPastDue" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesNotYetPastDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CashAndBankBalancesNotYetPastDue_lbl" xml:lang="en-US">Cash and bank balances - Not yet past due</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashAndBankBalancesNotYetPastDue" xlink:to="aapg_CashAndBankBalancesNotYetPastDue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeReceivables_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfLiquidityRiskExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLiquidityRiskExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfLiquidityRiskExplanatory_lbl" xml:lang="en-US">Schedule of Liquidity Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLiquidityRiskExplanatory" xlink:to="ifrs-full_DisclosureOfLiquidityRiskExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherBorrowings_lbl" xml:lang="en-US">Interest-bearing bank and other borrowings (excluding lease liabilities)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherBorrowings" xlink:to="ifrs-full_OtherBorrowings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherBorrowings_lbl0" xml:lang="en-US">Interest-bearing bank and other borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherBorrowings" xlink:to="ifrs-full_OtherBorrowings_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Financial liabilities included in other payables and accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DerivativeFinancialAssetsHeldForHedging" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DerivativeFinancialAssetsHeldForHedging"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DerivativeFinancialAssetsHeldForHedging_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DerivativeFinancialAssetsHeldForHedging" xlink:to="ifrs-full_DerivativeFinancialAssetsHeldForHedging_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfEquityPriceRiskExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfEquityPriceRiskExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfEquityPriceRiskExplanatory_lbl" xml:lang="en-US">Schedule of Equity Price Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfEquityPriceRiskExplanatory" xlink:to="aapg_DisclosureOfEquityPriceRiskExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_MarketEquityIndex" xlink:href="aapg-20251231.xsd#aapg_MarketEquityIndex"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_MarketEquityIndex_lbl" xml:lang="en-US">Market equity index</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_MarketEquityIndex" xlink:to="aapg_MarketEquityIndex_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockExchangeIndexShare" xlink:href="aapg-20251231.xsd#aapg_StockExchangeIndexShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockExchangeIndexShare_lbl" xml:lang="en-US">stock exchange index</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockExchangeIndexShare" xlink:to="aapg_StockExchangeIndexShare_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory_lbl" xml:lang="en-US">Schedule of Carrying Amounts at the End of the Reporting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" xlink:to="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InvestmentsListedInAbstract" xlink:href="aapg-20251231.xsd#aapg_InvestmentsListedInAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_InvestmentsListedInAbstract_lbl" xml:lang="en-US">Investments listed in:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentsListedInAbstract" xlink:to="aapg_InvestmentsListedInAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InvestmentsListedInAbstract0" xlink:href="aapg-20251231.xsd#aapg_InvestmentsListedInAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_InvestmentsListedInAbstract0_lbl" xml:lang="en-US">Investments listed in:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentsListedInAbstract0" xlink:to="aapg_InvestmentsListedInAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfCapitalManagementExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCapitalManagementExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfCapitalManagementExplanatory_lbl" xml:lang="en-US">Schedule of Capital Management</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCapitalManagementExplanatory" xlink:to="aapg_DisclosureOfCapitalManagementExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AdjustedCapitals" xlink:href="aapg-20251231.xsd#aapg_AdjustedCapitals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AdjustedCapitals_lbl" xml:lang="en-US">Adjusted capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustedCapitals" xlink:to="aapg_AdjustedCapitals_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod_lbl" xml:lang="en-US">EVENT AFTER THE REPORTING PERIOD</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod" xlink:to="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory_lbl" xml:lang="en-US">CONDENSED FINANCIAL INFORMATION OF THE COMPANY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl" xml:lang="en-US">Schedule of Statements of Financial Position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiaries"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InvestmentsInSubsidiaries_lbl" xml:lang="en-US">Investments in subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiaries" xlink:to="ifrs-full_InvestmentsInSubsidiaries_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReceivablesDueFromAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesDueFromAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReceivablesDueFromAssociates_lbl" xml:lang="en-US">Prepayments, other receivables and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReceivablesDueFromAssociates" xlink:to="ifrs-full_ReceivablesDueFromAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US">Share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IssuedCapital_lbl0" xml:lang="en-US">Share capital (in Yuan Renminbi)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReserves" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherReserves_lbl" xml:lang="en-US">Capital and reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReserves" xlink:to="ifrs-full_OtherReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ExchangeFluctuationReserve" xlink:href="aapg-20251231.xsd#aapg_ExchangeFluctuationReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ExchangeFluctuationReserve_lbl" xml:lang="en-US">Exchange fluctuation reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ExchangeFluctuationReserve" xlink:to="aapg_ExchangeFluctuationReserve_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US">Accumulated losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_lbl" xml:lang="en-US">Schedule of Condensed Statements of Comprehensive Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:to="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock_lbl" xml:lang="en-US">Schedule of Condensed Statements of Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock" xlink:to="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfReservesTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfReservesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ScheduleOfReservesTableTextBlock_lbl" xml:lang="en-US">Schedule of Company&#8217;s Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfReservesTableTextBlock" xlink:to="aapg_ScheduleOfReservesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract2" xlink:href="aapg-20251231.xsd#aapg_OtherComprehensiveIncomeForTheYearAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract2_lbl" xml:lang="en-US">Other comprehensive income for the year:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract2" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ComprehensiveIncomeLoss" xlink:href="aapg-20251231.xsd#aapg_ComprehensiveIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ComprehensiveIncomeLoss_lbl" xml:lang="en-US">Total comprehensive income for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ComprehensiveIncomeLoss" xlink:to="aapg_ComprehensiveIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl" xml:lang="en-US">Issue of ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl0" xml:lang="en-US">New shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl1" xml:lang="en-US">Ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_EmployeesShareBasedCompensationSchemeAbstract" xlink:href="aapg-20251231.xsd#aapg_EmployeesShareBasedCompensationSchemeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_EmployeesShareBasedCompensationSchemeAbstract_lbl" xml:lang="en-US">Employees share-based compensation scheme</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EmployeesShareBasedCompensationSchemeAbstract" xlink:to="aapg_EmployeesShareBasedCompensationSchemeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PreIPOShareOptionExpenses" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PreIPOShareOptionExpenses_lbl" xml:lang="en-US">Pre-IPO share option expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreIPOShareOptionExpenses" xlink:to="aapg_PreIPOShareOptionExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RestrictedShareUnitExpenses" xlink:href="aapg-20251231.xsd#aapg_RestrictedShareUnitExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_RestrictedShareUnitExpenses_lbl" xml:lang="en-US">RSU expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RestrictedShareUnitExpenses" xlink:to="aapg_RestrictedShareUnitExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions_lbl" xml:lang="en-US">Exercise of Pre-IPO share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" xlink:to="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRSUs" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueVestingOfRSUs"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRSUs_lbl" xml:lang="en-US">Vesting of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueVestingOfRSUs" xlink:to="aapg_StockIssuedDuringPeriodValueVestingOfRSUs_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract3" xlink:href="aapg-20251231.xsd#aapg_OtherComprehensiveIncomeForTheYearAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract3_lbl" xml:lang="en-US">Other comprehensive income for the year:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract3" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_EmployeesShareBasedCompensationSchemeAbstract0" xlink:href="aapg-20251231.xsd#aapg_EmployeesShareBasedCompensationSchemeAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_EmployeesShareBasedCompensationSchemeAbstract0_lbl" xml:lang="en-US">Employees share-based compensation scheme</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EmployeesShareBasedCompensationSchemeAbstract0" xlink:to="aapg_EmployeesShareBasedCompensationSchemeAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract4" xlink:href="aapg-20251231.xsd#aapg_OtherComprehensiveIncomeForTheYearAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract4_lbl" xml:lang="en-US">Other comprehensive income for the year:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract4" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_EmployeesShareBasedCompensationSchemeAbstract1" xlink:href="aapg-20251231.xsd#aapg_EmployeesShareBasedCompensationSchemeAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_EmployeesShareBasedCompensationSchemeAbstract1_lbl" xml:lang="en-US">Employees share-based compensation scheme</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EmployeesShareBasedCompensationSchemeAbstract1" xlink:to="aapg_EmployeesShareBasedCompensationSchemeAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory_lbl" xml:lang="en-US">APPROVAL OF THE FINANCIAL STATEMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">(Gain)/Loss on disposal of items of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:to="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Fair value loss on financial liabilities at FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxComputedAtTheStatutoryTaxRate" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxComputedAtTheStatutoryTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_IncomeTaxComputedAtTheStatutoryTaxRate_lbl" xml:lang="en-US">Income tax computed at the statutory tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeTaxComputedAtTheStatutoryTaxRate" xlink:to="aapg_IncomeTaxComputedAtTheStatutoryTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StatutoryIncomeAndExpense" xlink:href="aapg-20251231.xsd#aapg_StatutoryIncomeAndExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_StatutoryIncomeAndExpense_lbl" xml:lang="en-US">Statutory income and expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StatutoryIncomeAndExpense" xlink:to="aapg_StatutoryIncomeAndExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeNotSubjectToTax" xlink:href="aapg-20251231.xsd#aapg_IncomeNotSubjectToTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_IncomeNotSubjectToTax_lbl" xml:lang="en-US">Items not subject to tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeNotSubjectToTax" xlink:to="aapg_IncomeNotSubjectToTax_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ResearchAndDevelopmentSuperdeduction" xlink:href="aapg-20251231.xsd#aapg_ResearchAndDevelopmentSuperdeduction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_ResearchAndDevelopmentSuperdeduction_lbl" xml:lang="en-US">Research and development super-deduction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ResearchAndDevelopmentSuperdeduction" xlink:to="aapg_ResearchAndDevelopmentSuperdeduction_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_GainlossAttributableToJointVentures" xlink:href="aapg-20251231.xsd#aapg_GainlossAttributableToJointVentures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_GainlossAttributableToJointVentures_lbl" xml:lang="en-US">(Gain)/loss attributable to joint ventures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GainlossAttributableToJointVentures" xlink:to="aapg_GainlossAttributableToJointVentures_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NewProvisionsReturn" xlink:href="aapg-20251231.xsd#aapg_NewProvisionsReturn"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_NewProvisionsReturn_lbl" xml:lang="en-US">Provision to return</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NewProvisionsReturn" xlink:to="aapg_NewProvisionsReturn_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciation provided during the year (note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US">Depreciation charge</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DisposalsRightofuseAssets_lbl" xml:lang="en-US">Disposal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsRightofuseAssets" xlink:to="ifrs-full_DisposalsRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PaymentsofLeaseLiabilities" xlink:href="aapg-20251231.xsd#aapg_PaymentsofLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_PaymentsofLeaseLiabilities_lbl" xml:lang="en-US">Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PaymentsofLeaseLiabilities" xlink:to="aapg_PaymentsofLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisposalsLeaseLiabilities" xlink:href="aapg-20251231.xsd#aapg_DisposalsLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_DisposalsLeaseLiabilities_lbl" xml:lang="en-US">Disposal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisposalsLeaseLiabilities" xlink:to="aapg_DisposalsLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AmortisationExpense_lbl" xml:lang="en-US">Amortization provided during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationExpense" xlink:to="ifrs-full_AmortisationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_lbl" xml:lang="en-US">Deferred tax (credited)/charged to the statement of profit or loss during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CurrentProvisions_lbl" xml:lang="en-US">Less: Provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisions" xlink:to="ifrs-full_CurrentProvisions_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RecognizedAsIncomeDuringTheYear" xlink:href="aapg-20251231.xsd#aapg_RecognizedAsIncomeDuringTheYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aapg_RecognizedAsIncomeDuringTheYear_lbl" xml:lang="en-US">Received during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RecognizedAsIncomeDuringTheYear" xlink:to="aapg_RecognizedAsIncomeDuringTheYear_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of options, Forfeited during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of options, Exercised during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of RSUs, Forfeited during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of RSUs, Vested during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OperatingExpense_lbl" xml:lang="en-US">Operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OperatingExpense" xlink:to="ifrs-full_OperatingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SuzhouAscentagePharmaCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_SuzhouAscentagePharmaCoLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SuzhouAscentagePharmaCoLtdMember_lbl" xml:lang="en-US">Suzhou Ascentage Pharma Co., Ltd. (&#8220;Suzhou Yasheng&#8221;) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SuzhouAscentagePharmaCoLtdMember" xlink:to="aapg_SuzhouAscentagePharmaCoLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_GuangzhouHealthquestPharmaCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_GuangzhouHealthquestPharmaCoLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_GuangzhouHealthquestPharmaCoLtdMember_lbl" xml:lang="en-US">Guangzhou Healthquest Pharma Co., Ltd. (&#8220;Healthquest Pharma&#8221;) [Member ]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GuangzhouHealthquestPharmaCoLtdMember" xlink:to="aapg_GuangzhouHealthquestPharmaCoLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AscentagePharmaGroupIncMember" xlink:href="aapg-20251231.xsd#aapg_AscentagePharmaGroupIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AscentagePharmaGroupIncMember_lbl" xml:lang="en-US">Ascentage Pharma Group Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AscentagePharmaGroupIncMember" xlink:to="aapg_AscentagePharmaGroupIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember_lbl" xml:lang="en-US">Suzhou Shenghe Innovation Works Biotech Co., Ltd. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember" xlink:to="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IFRSEighteenMember" xlink:href="aapg-20251231.xsd#aapg_IFRSEighteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IFRSEighteenMember_lbl" xml:lang="en-US">IFRS 18 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IFRSEighteenMember" xlink:to="aapg_IFRSEighteenMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IFRSNineteenMember" xlink:href="aapg-20251231.xsd#aapg_IFRSNineteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IFRSNineteenMember_lbl" xml:lang="en-US">IFRS 19 and its amendments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IFRSNineteenMember" xlink:to="aapg_IFRSNineteenMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AmendmentsToIFRSNineAndIFRSSevenMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIFRSNineAndIFRSSevenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AmendmentsToIFRSNineAndIFRSSevenMember_lbl" xml:lang="en-US">Amendments to IFRS 9 and IFRS 7 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AmendmentsToIFRSNineAndIFRSSevenMember" xlink:to="aapg_AmendmentsToIFRSNineAndIFRSSevenMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember_lbl" xml:lang="en-US">Amendments to IFRS 9 and IFRS 7 One [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember" xlink:to="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember_lbl" xml:lang="en-US">Amendments to IFRS 10 and IAS 28 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember" xlink:to="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AmendmentsToIASTwentyOneMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIASTwentyOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AmendmentsToIASTwentyOneMember_lbl" xml:lang="en-US">Amendments to IAS 21 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AmendmentsToIASTwentyOneMember" xlink:to="aapg_AmendmentsToIASTwentyOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingStandardsVolume11Member" xlink:href="aapg-20251231.xsd#aapg_AccountingStandardsVolume11Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AccountingStandardsVolume11Member_lbl" xml:lang="en-US">Annual Improvements to IFRS Accounting Standards &#8211; Volume 11 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccountingStandardsVolume11Member" xlink:to="aapg_AccountingStandardsVolume11Member_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US">Buildings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseholdImprovementsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseholdImprovementsMember" xlink:to="ifrs-full_LeaseholdImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FurnitureAndEquipmentMember" xlink:href="aapg-20251231.xsd#aapg_FurnitureAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FurnitureAndEquipmentMember_lbl" xml:lang="en-US">Furniture and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FurnitureAndEquipmentMember" xlink:to="aapg_FurnitureAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MotorVehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MotorVehiclesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MotorVehiclesMember_lbl" xml:lang="en-US">Motor vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MotorVehiclesMember" xlink:to="ifrs-full_MotorVehiclesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl0" xml:lang="en-US">Bottom of Range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl0" xml:lang="en-US">Top of Range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComputerSoftwareMember_lbl" xml:lang="en-US">Software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftwareMember" xlink:to="ifrs-full_ComputerSoftwareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_lbl" xml:lang="en-US">Patent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:to="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LicencesMember_lbl" xml:lang="en-US">License [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesMember" xlink:to="ifrs-full_LicencesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseholdLandMember" xlink:href="aapg-20251231.xsd#aapg_LeaseholdLandMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LeaseholdLandMember_lbl" xml:lang="en-US">Leasehold land [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseholdLandMember" xlink:to="aapg_LeaseholdLandMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ChineseMainlandMember" xlink:href="aapg-20251231.xsd#aapg_ChineseMainlandMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ChineseMainlandMember_lbl" xml:lang="en-US">Chinese mainland [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ChineseMainlandMember" xlink:to="aapg_ChineseMainlandMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_ChineseMainlandMember_lbl0" xml:lang="en-US">Chinese Mainland [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ChineseMainlandMember" xlink:to="aapg_ChineseMainlandMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="country_CH" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_CH_lbl" xml:lang="en-US">Switzerland [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_US_lbl" xml:lang="en-US">United States [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="country_US_lbl0" xml:lang="en-US">US [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="country_US_lbl1" xml:lang="en-US">UNITED STATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_CustomerAMember" xlink:href="aapg-20251231.xsd#aapg_CustomerAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CustomerAMember_lbl" xml:lang="en-US">Customer A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CustomerAMember" xlink:to="aapg_CustomerAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CustomerBMember" xlink:href="aapg-20251231.xsd#aapg_CustomerBMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CustomerBMember_lbl" xml:lang="en-US">Customer B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CustomerBMember" xlink:to="aapg_CustomerBMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CustomerCMember" xlink:href="aapg-20251231.xsd#aapg_CustomerCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CustomerCMember_lbl" xml:lang="en-US">Customer C [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CustomerCMember" xlink:to="aapg_CustomerCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CustomerDMember" xlink:href="aapg-20251231.xsd#aapg_CustomerDMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CustomerDMember_lbl" xml:lang="en-US">Customer D [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CustomerDMember" xlink:to="aapg_CustomerDMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IntellectualPropertyIncomeMember" xlink:href="aapg-20251231.xsd#aapg_IntellectualPropertyIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IntellectualPropertyIncomeMember_lbl" xml:lang="en-US">Intellectual Property Income [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IntellectualPropertyIncomeMember" xlink:to="aapg_IntellectualPropertyIncomeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_IntellectualPropertyIncomeMember_lbl0" xml:lang="en-US">Intellectual property income [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IntellectualPropertyIncomeMember" xlink:to="aapg_IntellectualPropertyIncomeMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_TypesOfGoodsOrServicesMember" xlink:href="aapg-20251231.xsd#aapg_TypesOfGoodsOrServicesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypesOfGoodsOrServicesMember_lbl" xml:lang="en-US">Types of goods or services [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypesOfGoodsOrServicesMember" xlink:to="aapg_TypesOfGoodsOrServicesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CommercializationRightsIncomeMember" xlink:href="aapg-20251231.xsd#aapg_CommercializationRightsIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CommercializationRightsIncomeMember_lbl" xml:lang="en-US">Commercialization rights income [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CommercializationRightsIncomeMember" xlink:to="aapg_CommercializationRightsIncomeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_CommercializationRightsIncomeMember_lbl0" xml:lang="en-US">Commercialization rights income (commercial milestone) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CommercializationRightsIncomeMember" xlink:to="aapg_CommercializationRightsIncomeMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_lbl" xml:lang="en-US">At a point in time [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:to="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OverTimeMember" xlink:href="aapg-20251231.xsd#aapg_OverTimeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OverTimeMember_lbl" xml:lang="en-US">Over time [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OverTimeMember" xlink:to="aapg_OverTimeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodsOrServicesTransferredOverTimeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember_lbl" xml:lang="en-US">Over time [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember_lbl0" xml:lang="en-US">Timing of revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl" xml:lang="en-US">Within one year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanOneYearMember" xlink:to="ifrs-full_NotLaterThanOneYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl0" xml:lang="en-US">Less than 1 year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanOneYearMember" xlink:to="ifrs-full_NotLaterThanOneYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LaterThanOneYearMember_lbl" xml:lang="en-US">After one year	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearMember" xlink:to="ifrs-full_LaterThanOneYearMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US">Gross carrying amount [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl0" xml:lang="en-US">Carrying Amounts [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US">Accumulated depreciation and amortisation [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OfficeEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OfficeEquipmentMember_lbl" xml:lang="en-US">Furniture and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OfficeEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConstructionInProgressMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ConstructionInProgressMember_lbl" xml:lang="en-US">Construction in progress [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ConstructionInProgressMember_lbl0" xml:lang="en-US">Construction in progress [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_ConstructionInProgressMember_lbl1" xml:lang="en-US">Construction in Progress [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConstructionInProgressMember_lbl2" xml:lang="en-US">Investment Property [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="aapg_PatentMember" xlink:href="aapg-20251231.xsd#aapg_PatentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PatentMember_lbl" xml:lang="en-US">Patent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PatentMember" xlink:to="aapg_PatentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicencesAndFranchisesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesAndFranchisesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LicencesAndFranchisesMember_lbl" xml:lang="en-US">License [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesAndFranchisesMember" xlink:to="ifrs-full_LicencesAndFranchisesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ConstructionInProcessMember" xlink:href="aapg-20251231.xsd#aapg_ConstructionInProcessMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ConstructionInProcessMember_lbl" xml:lang="en-US">Construction In process [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ConstructionInProcessMember" xlink:to="aapg_ConstructionInProcessMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember" xlink:href="aapg-20251231.xsd#aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember_lbl" xml:lang="en-US">Fair Value Adjustments Arising From Acquisition of a Subsidiary [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember" xlink:to="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssetsMember_lbl" xml:lang="en-US">Right-of-use assets [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsMember" xlink:to="ifrs-full_RightofuseAssetsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RightofuseAssetsMember_lbl0" xml:lang="en-US">Right of Use Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsMember" xlink:to="ifrs-full_RightofuseAssetsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestatedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestatedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RestatedMember_lbl" xml:lang="en-US">Restated [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestatedMember" xlink:to="ifrs-full_RestatedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesMember" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ContractLiabilitiesMember_lbl" xml:lang="en-US">Contract Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ContractLiabilitiesMember" xlink:to="aapg_ContractLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LeaseLiabilitiesMember_lbl" xml:lang="en-US">Lease liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DonationExpensesMember" xlink:href="aapg-20251231.xsd#aapg_DonationExpensesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DonationExpensesMember_lbl" xml:lang="en-US">Donation expenses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DonationExpensesMember" xlink:to="aapg_DonationExpensesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember" xlink:href="aapg-20251231.xsd#aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember_lbl" xml:lang="en-US">Losses Available for Offsetting Against Future Taxable Profits [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember" xlink:to="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TradeReceivablesWithin45DaysMember" xlink:href="aapg-20251231.xsd#aapg_TradeReceivablesWithin45DaysMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TradeReceivablesWithin45DaysMember_lbl" xml:lang="en-US">Within 45 days [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TradeReceivablesWithin45DaysMember" xlink:to="aapg_TradeReceivablesWithin45DaysMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TradeReceivables45To120DaysMember" xlink:href="aapg-20251231.xsd#aapg_TradeReceivables45To120DaysMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TradeReceivables45To120DaysMember_lbl" xml:lang="en-US">45 to 120 days [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TradeReceivables45To120DaysMember" xlink:to="aapg_TradeReceivables45To120DaysMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_CN" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CN"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_CN_lbl" xml:lang="en-US">RMB [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CN" xlink:to="country_CN_lbl"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_HK"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_HK_lbl" xml:lang="en-US">HK [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="country_HK_lbl0" xml:lang="en-US">Hong Kong [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_WithinOneMonthMember" xlink:href="aapg-20251231.xsd#aapg_WithinOneMonthMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_WithinOneMonthMember_lbl" xml:lang="en-US">Within 1 month [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_WithinOneMonthMember" xlink:to="aapg_WithinOneMonthMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OneToThreeMonthsMember" xlink:href="aapg-20251231.xsd#aapg_OneToThreeMonthsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OneToThreeMonthsMember_lbl" xml:lang="en-US">1 to 3 months [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OneToThreeMonthsMember" xlink:to="aapg_OneToThreeMonthsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ThreeToSixMonthsMember" xlink:href="aapg-20251231.xsd#aapg_ThreeToSixMonthsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ThreeToSixMonthsMember_lbl" xml:lang="en-US">3 to 6 months [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ThreeToSixMonthsMember" xlink:to="aapg_ThreeToSixMonthsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShorttermAdvancesRecognizedFromCustomersMember" xlink:href="aapg-20251231.xsd#aapg_ShorttermAdvancesRecognizedFromCustomersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ShorttermAdvancesRecognizedFromCustomersMember_lbl" xml:lang="en-US">Short-term advances recognized from customers [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShorttermAdvancesRecognizedFromCustomersMember" xlink:to="aapg_ShorttermAdvancesRecognizedFromCustomersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LongtermAdvancesRecognizedFromCustomersMember" xlink:href="aapg-20251231.xsd#aapg_LongtermAdvancesRecognizedFromCustomersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LongtermAdvancesRecognizedFromCustomersMember_lbl" xml:lang="en-US">Long-term advances recognized from customers [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LongtermAdvancesRecognizedFromCustomersMember" xlink:to="aapg_LongtermAdvancesRecognizedFromCustomersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShortTermBorrowingMember" xlink:href="aapg-20251231.xsd#aapg_ShortTermBorrowingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ShortTermBorrowingMember_lbl" xml:lang="en-US">Short-Term Borrowing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShortTermBorrowingMember" xlink:to="aapg_ShortTermBorrowingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember" xlink:href="aapg-20251231.xsd#aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember_lbl" xml:lang="en-US">Current Portion of Long-Term Bank Loans &#8211; Unsecured [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember" xlink:to="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember" xlink:href="aapg-20251231.xsd#aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember_lbl" xml:lang="en-US">Current Portion of Long-Term Bank Loans &#8211; Unsecured [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember" xlink:to="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CurrentPortionOfLongTermBankLoansSecuredMember" xlink:href="aapg-20251231.xsd#aapg_CurrentPortionOfLongTermBankLoansSecuredMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CurrentPortionOfLongTermBankLoansSecuredMember_lbl" xml:lang="en-US">Current Portion of Long-Term Bank Loans &#8211; Secured [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentPortionOfLongTermBankLoansSecuredMember" xlink:to="aapg_CurrentPortionOfLongTermBankLoansSecuredMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseLiabilitiesCurrentMember" xlink:href="aapg-20251231.xsd#aapg_LeaseLiabilitiesCurrentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LeaseLiabilitiesCurrentMember_lbl" xml:lang="en-US">Lease Liabilities, Current [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseLiabilitiesCurrentMember" xlink:to="aapg_LeaseLiabilitiesCurrentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_BankLoansUnsecuredMember" xlink:href="aapg-20251231.xsd#aapg_BankLoansUnsecuredMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_BankLoansUnsecuredMember_lbl" xml:lang="en-US">Bank Loans &#8211; Unsecured [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BankLoansUnsecuredMember" xlink:to="aapg_BankLoansUnsecuredMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_BankLoansUnsecuredOneMember" xlink:href="aapg-20251231.xsd#aapg_BankLoansUnsecuredOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_BankLoansUnsecuredOneMember_lbl" xml:lang="en-US">Bank Loans &#8211; Unsecured [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BankLoansUnsecuredOneMember" xlink:to="aapg_BankLoansUnsecuredOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_BankLoansSecuredMember" xlink:href="aapg-20251231.xsd#aapg_BankLoansSecuredMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_BankLoansSecuredMember_lbl" xml:lang="en-US">Bank Loans &#8211; Secured [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BankLoansSecuredMember" xlink:to="aapg_BankLoansSecuredMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseLiabilitiesNonCurrentMember" xlink:href="aapg-20251231.xsd#aapg_LeaseLiabilitiesNonCurrentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LeaseLiabilitiesNonCurrentMember_lbl" xml:lang="en-US">Lease Liabilities, Non-current [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseLiabilitiesNonCurrentMember" xlink:to="aapg_LeaseLiabilitiesNonCurrentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_lbl" xml:lang="en-US">In the second year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_lbl" xml:lang="en-US">In the third to fifth years, inclusive [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LaterThanFiveYearsMember_lbl" xml:lang="en-US">Beyond five years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LaterThanFiveYearsMember_lbl0" xml:lang="en-US">Over 5 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalMember" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ShareCapitalMember_lbl" xml:lang="en-US">Share Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareCapitalMember" xlink:to="aapg_ShareCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US">Number of shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PostIPOOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PostIPOOptionSchemeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PostIPOOptionSchemeMember_lbl" xml:lang="en-US">Post-IPO Option Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PostIPOOptionSchemeMember" xlink:to="aapg_PostIPOOptionSchemeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember" xlink:href="aapg-20251231.xsd#aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember_lbl" xml:lang="en-US">15 Aug 2018&#8211;15 Aug 2028 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember" xlink:to="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember" xlink:href="aapg-20251231.xsd#aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember_lbl" xml:lang="en-US">15 May 2019&#8211;15 May 2029 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember" xlink:to="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember" xlink:href="aapg-20251231.xsd#aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember_lbl" xml:lang="en-US">16 Sept 2019-16 Sept 2029 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember" xlink:to="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TwentySixNov202526Nov2035Member" xlink:href="aapg-20251231.xsd#aapg_TwentySixNov202526Nov2035Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TwentySixNov202526Nov2035Member_lbl" xml:lang="en-US">26 Nov 2025&#8211;26 Nov 2035 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwentySixNov202526Nov2035Member" xlink:to="aapg_TwentySixNov202526Nov2035Member_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsOneMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipantsOneMember_lbl" xml:lang="en-US">Type of Eligible Participants 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsOneMember" xlink:to="aapg_TypeOfEligibleParticipantsOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyOneRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOneRSUSchemeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TwoThousandTwentyOneRSUSchemeMember_lbl" xml:lang="en-US">2021 RSU Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyOneRSUSchemeMember" xlink:to="aapg_TwoThousandTwentyOneRSUSchemeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_TwoThousandTwentyOneRSUSchemeMember_lbl0" xml:lang="en-US">Two Thousand Twenty One RSU Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyOneRSUSchemeMember" xlink:to="aapg_TwoThousandTwentyOneRSUSchemeMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsTwoMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsTwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipantsTwoMember_lbl" xml:lang="en-US">Type of Eligible Participants 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsTwoMember" xlink:to="aapg_TypeOfEligibleParticipantsTwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsThreeMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipantsThreeMember_lbl" xml:lang="en-US">Type of Eligible Participants 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsThreeMember" xlink:to="aapg_TypeOfEligibleParticipantsThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsFourMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsFourMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipantsFourMember_lbl" xml:lang="en-US">Type of Eligible Participants 4 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsFourMember" xlink:to="aapg_TypeOfEligibleParticipantsFourMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsFiveMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsFiveMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipantsFiveMember_lbl" xml:lang="en-US">Type of Eligible Participants 5 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsFiveMember" xlink:to="aapg_TypeOfEligibleParticipantsFiveMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipantsSixMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsSixMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipantsSixMember_lbl" xml:lang="en-US">Type of Eligible Participants 6 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsSixMember" xlink:to="aapg_TypeOfEligibleParticipantsSixMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants1OneMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants1OneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants1OneMember_lbl" xml:lang="en-US">Type of Eligible Participants 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants1OneMember" xlink:to="aapg_TypeOfEligibleParticipants1OneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUSchemeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TwoThousandTwentyTwoRSUSchemeMember_lbl" xml:lang="en-US">2022 RSU Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyTwoRSUSchemeMember" xlink:to="aapg_TwoThousandTwentyTwoRSUSchemeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_TwoThousandTwentyTwoRSUSchemeMember_lbl0" xml:lang="en-US">Two Thousand Twenty Two RSU Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyTwoRSUSchemeMember" xlink:to="aapg_TwoThousandTwentyTwoRSUSchemeMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants1ThreeMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants1ThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants1ThreeMember_lbl" xml:lang="en-US">Type of Eligible Participants 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants1ThreeMember" xlink:to="aapg_TypeOfEligibleParticipants1ThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants2FourMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants2FourMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants2FourMember_lbl" xml:lang="en-US">Type of Eligible Participants 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants2FourMember" xlink:to="aapg_TypeOfEligibleParticipants2FourMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoFurtherGrantMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoFurtherGrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TwoThousandTwentyTwoFurtherGrantMember_lbl" xml:lang="en-US">2022 Further Grant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyTwoFurtherGrantMember" xlink:to="aapg_TwoThousandTwentyTwoFurtherGrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants2ThreeMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants2ThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants2ThreeMember_lbl" xml:lang="en-US">Type of Eligible Participants 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants2ThreeMember" xlink:to="aapg_TypeOfEligibleParticipants2ThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants7Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants7Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants7Member_lbl" xml:lang="en-US">Type of Eligible Participants 7 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants7Member" xlink:to="aapg_TypeOfEligibleParticipants7Member_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants8Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants8Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants8Member_lbl" xml:lang="en-US">Type of Eligible Participants 8 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants8Member" xlink:to="aapg_TypeOfEligibleParticipants8Member_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants9Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants9Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants9Member_lbl" xml:lang="en-US">Type of Eligible Participants 9 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants9Member" xlink:to="aapg_TypeOfEligibleParticipants9Member_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants10Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants10Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants10Member_lbl" xml:lang="en-US">Type of Eligible Participants 10 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants10Member" xlink:to="aapg_TypeOfEligibleParticipants10Member_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants1TwoMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants1TwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants1TwoMember_lbl" xml:lang="en-US">Type of Eligible Participants 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants1TwoMember" xlink:to="aapg_TypeOfEligibleParticipants1TwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TypeOfEligibleParticipants2OneMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants2OneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TypeOfEligibleParticipants2OneMember_lbl" xml:lang="en-US">Type of Eligible Participants 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants2OneMember" xlink:to="aapg_TypeOfEligibleParticipants2OneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyOnesRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOnesRSUSchemeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TwoThousandTwentyOnesRSUSchemeMember_lbl" xml:lang="en-US">2021 RSU Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyOnesRSUSchemeMember" xlink:to="aapg_TwoThousandTwentyOnesRSUSchemeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandTwentyTwoRSUchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUchemeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TwoThousandTwentyTwoRSUchemeMember_lbl" xml:lang="en-US">2022 RSU Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyTwoRSUchemeMember" xlink:to="aapg_TwoThousandTwentyTwoRSUchemeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccruedInterestInOtherPayablesAndAccrualsMember" xlink:href="aapg-20251231.xsd#aapg_AccruedInterestInOtherPayablesAndAccrualsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AccruedInterestInOtherPayablesAndAccrualsMember_lbl" xml:lang="en-US">Accrued interest in other payables and accruals [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccruedInterestInOtherPayablesAndAccrualsMember" xlink:to="aapg_AccruedInterestInOtherPayablesAndAccrualsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_BankAndOtherLoansMember" xlink:href="aapg-20251231.xsd#aapg_BankAndOtherLoansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_BankAndOtherLoansMember_lbl" xml:lang="en-US">Bank and other loans [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BankAndOtherLoansMember" xlink:to="aapg_BankAndOtherLoansMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseLiabilityMember" xlink:href="aapg-20251231.xsd#aapg_LeaseLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LeaseLiabilityMember_lbl" xml:lang="en-US">Lease liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseLiabilityMember" xlink:to="aapg_LeaseLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DrZhaiYifanMember" xlink:href="aapg-20251231.xsd#aapg_DrZhaiYifanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DrZhaiYifanMember_lbl" xml:lang="en-US">Dr. Zhai Yifan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DrZhaiYifanMember" xlink:to="aapg_DrZhaiYifanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DrYangDajunMember" xlink:href="aapg-20251231.xsd#aapg_DrYangDajunMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DrYangDajunMember_lbl" xml:lang="en-US">Dr. Yang Dajun [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DrYangDajunMember" xlink:to="aapg_DrYangDajunMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember_lbl" xml:lang="en-US">Financial assets at fair value through profit or loss [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember" xlink:to="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAtAmortizedCostMember" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAtAmortizedCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialAssetsAtAmortizedCostMember_lbl" xml:lang="en-US">Financial assets at amortized cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAtAmortizedCostMember" xlink:to="aapg_FinancialAssetsAtAmortizedCostMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsMember" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialAssetsMember_lbl" xml:lang="en-US">Financial Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsMember" xlink:to="aapg_FinancialAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember_lbl" xml:lang="en-US">Financial liabilities at fair value through profit or loss [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember" xlink:to="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesAtAmortizedCostMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtAmortizedCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialLiabilitiesAtAmortizedCostMember_lbl" xml:lang="en-US">Financial liabilities at amortized cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesAtAmortizedCostMember" xlink:to="aapg_FinancialLiabilitiesAtAmortizedCostMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialLiabilitiesMember_lbl" xml:lang="en-US">Financial Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesMember" xlink:to="aapg_FinancialLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AtFairValueMember_lbl" xml:lang="en-US">Fair Values [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AtFairValueMember" xlink:to="ifrs-full_AtFairValueMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level1OfFairValueHierarchyMember" xlink:to="ifrs-full_Level1OfFairValueHierarchyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreasedecreaseInBasisPointsMember" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseInBasisPointsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IncreasedecreaseInBasisPointsMember_lbl" xml:lang="en-US">Increase/(decrease) in basis points [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseInBasisPointsMember" xlink:to="aapg_IncreasedecreaseInBasisPointsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncreasedecreaseInLossBeforeTaxMember" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseInLossBeforeTaxMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IncreasedecreaseInLossBeforeTaxMember_lbl" xml:lang="en-US">Increase/(decrease) in loss before tax [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseInLossBeforeTaxMember" xlink:to="aapg_IncreasedecreaseInLossBeforeTaxMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IfRMBWeakensAgainstUSDollarsMember" xlink:href="aapg-20251231.xsd#aapg_IfRMBWeakensAgainstUSDollarsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IfRMBWeakensAgainstUSDollarsMember_lbl" xml:lang="en-US">If RMB weakens against US$ [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IfRMBWeakensAgainstUSDollarsMember" xlink:to="aapg_IfRMBWeakensAgainstUSDollarsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IfRMBStrengthensAgainstUSDollarsMember" xlink:href="aapg-20251231.xsd#aapg_IfRMBStrengthensAgainstUSDollarsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IfRMBStrengthensAgainstUSDollarsMember_lbl" xml:lang="en-US">If RMB strengthens against US$ [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IfRMBStrengthensAgainstUSDollarsMember" xlink:to="aapg_IfRMBStrengthensAgainstUSDollarsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_MonetaryAssetsMember" xlink:href="aapg-20251231.xsd#aapg_MonetaryAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_MonetaryAssetsMember_lbl" xml:lang="en-US">Monetary Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_MonetaryAssetsMember" xlink:to="aapg_MonetaryAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_Stage1Member" xlink:href="aapg-20251231.xsd#aapg_Stage1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_Stage1Member_lbl" xml:lang="en-US">Stage 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Stage1Member" xlink:to="aapg_Stage1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StageTwoMember" xlink:href="aapg-20251231.xsd#aapg_StageTwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StageTwoMember_lbl" xml:lang="en-US">Stage 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StageTwoMember" xlink:to="aapg_StageTwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StageThreeMember" xlink:href="aapg-20251231.xsd#aapg_StageThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StageThreeMember_lbl" xml:lang="en-US">Stage 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StageThreeMember" xlink:to="aapg_StageThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SimplifiedApproachMember" xlink:href="aapg-20251231.xsd#aapg_SimplifiedApproachMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SimplifiedApproachMember_lbl" xml:lang="en-US">Simplified approach [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SimplifiedApproachMember" xlink:to="aapg_SimplifiedApproachMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TradePayablesMember" xlink:href="aapg-20251231.xsd#aapg_TradePayablesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TradePayablesMember_lbl" xml:lang="en-US">Trade Payables [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TradePayablesMember" xlink:to="aapg_TradePayablesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember" xlink:href="aapg-20251231.xsd#aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember_lbl" xml:lang="en-US">Interest-bearing bank and other borrowings excluding lease liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember" xlink:to="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember_lbl" xml:lang="en-US">Financial liabilities included in other payables and accruals [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember" xlink:to="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherNonCurrentLiabilityMember" xlink:href="aapg-20251231.xsd#aapg_OtherNonCurrentLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherNonCurrentLiabilityMember_lbl" xml:lang="en-US">Other non-current liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherNonCurrentLiabilityMember" xlink:to="aapg_OtherNonCurrentLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DerivativeFinancialInstrumentsMember" xlink:href="aapg-20251231.xsd#aapg_DerivativeFinancialInstrumentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DerivativeFinancialInstrumentsMember_lbl" xml:lang="en-US">Derivative financial instruments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DerivativeFinancialInstrumentsMember" xlink:to="aapg_DerivativeFinancialInstrumentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OnDemandMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OnDemandMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OnDemandMember_lbl" xml:lang="en-US">On demand</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OnDemandMember" xlink:to="ifrs-full_OnDemandMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_lbl" xml:lang="en-US">1 to 5 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CarryingAmountOfEquityInvestmentsMember" xlink:href="aapg-20251231.xsd#aapg_CarryingAmountOfEquityInvestmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CarryingAmountOfEquityInvestmentsMember_lbl" xml:lang="en-US">Carrying amount of equity investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CarryingAmountOfEquityInvestmentsMember" xlink:to="aapg_CarryingAmountOfEquityInvestmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DecreaseincreaseInLossBeforeTaxMember" xlink:href="aapg-20251231.xsd#aapg_DecreaseincreaseInLossBeforeTaxMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DecreaseincreaseInLossBeforeTaxMember_lbl" xml:lang="en-US">Decrease/ (increase) in loss before tax [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DecreaseincreaseInLossBeforeTaxMember" xlink:to="aapg_DecreaseincreaseInLossBeforeTaxMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CapitalManagementMember" xlink:href="aapg-20251231.xsd#aapg_CapitalManagementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CapitalManagementMember_lbl" xml:lang="en-US">Capital Management [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalManagementMember" xlink:to="aapg_CapitalManagementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserveMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalReserveMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CapitalReserveMember_lbl" xml:lang="en-US">Capital and reserves [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalReserveMember" xlink:to="ifrs-full_CapitalReserveMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxesAxis" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_IncomeTaxesAxis_lbl" xml:lang="en-US">Income Taxes [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeTaxesAxis" xlink:to="aapg_IncomeTaxesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis_lbl" xml:lang="en-US">Classes of ordinary shares [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_lbl" xml:lang="en-US">Types of antidilutive instruments [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_GrantAnniversariesAxis" xlink:href="aapg-20251231.xsd#aapg_GrantAnniversariesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_GrantAnniversariesAxis_lbl" xml:lang="en-US">Grant anniversaries [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GrantAnniversariesAxis" xlink:to="aapg_GrantAnniversariesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfContractsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfContractsAxis_lbl" xml:lang="en-US">Types of contracts [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksAxis_lbl" xml:lang="en-US">Types of risks [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherEmployeeBenefitContributionPercentage" xlink:href="aapg-20251231.xsd#aapg_OtherEmployeeBenefitContributionPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_OtherEmployeeBenefitContributionPercentage_lbl" xml:lang="en-US">Employee contribution percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherEmployeeBenefitContributionPercentage" xlink:to="aapg_OtherEmployeeBenefitContributionPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AnnualBaseSalaryPercentage" xlink:href="aapg-20251231.xsd#aapg_AnnualBaseSalaryPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AnnualBaseSalaryPercentage_lbl" xml:lang="en-US">Annual base salary rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AnnualBaseSalaryPercentage" xlink:to="aapg_AnnualBaseSalaryPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments_lbl" xml:lang="en-US">Number of reportable operating segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments" xlink:to="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US">Income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PreferentialRate" xlink:href="aapg-20251231.xsd#aapg_PreferentialRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PreferentialRate_lbl" xml:lang="en-US">Preferential tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreferentialRate" xlink:to="aapg_PreferentialRate_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_WithholdingTax" xlink:href="aapg-20251231.xsd#aapg_WithholdingTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_WithholdingTax_lbl" xml:lang="en-US">Withholding tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_WithholdingTax" xlink:to="aapg_WithholdingTax_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TermsOfLandLease" xlink:href="aapg-20251231.xsd#aapg_TermsOfLandLease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TermsOfLandLease_lbl" xml:lang="en-US">Terms of land lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TermsOfLandLease" xlink:to="aapg_TermsOfLandLease_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LeaseTerms" xlink:href="aapg-20251231.xsd#aapg_LeaseTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LeaseTerms_lbl" xml:lang="en-US">Lease terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseTerms" xlink:to="aapg_LeaseTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl" xml:lang="en-US">Discount rate of cash flow projections</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FutureTaxableProfitsPercentage" xlink:href="aapg-20251231.xsd#aapg_FutureTaxableProfitsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FutureTaxableProfitsPercentage_lbl" xml:lang="en-US">Future taxable profits percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FutureTaxableProfitsPercentage" xlink:to="aapg_FutureTaxableProfitsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl" xml:lang="en-US">Deductible temporary differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TaxCredits" xlink:href="aapg-20251231.xsd#aapg_TaxCredits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TaxCredits_lbl" xml:lang="en-US">Tax credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TaxCredits" xlink:to="aapg_TaxCredits_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_UnrecognizedTaxBenefit" xlink:href="aapg-20251231.xsd#aapg_UnrecognizedTaxBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_UnrecognizedTaxBenefit_lbl" xml:lang="en-US">Unrecognized tax benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UnrecognizedTaxBenefit" xlink:to="aapg_UnrecognizedTaxBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxAssetsTaxLossCarryforwards" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxAssetsTaxLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DeferredTaxAssetsTaxLossCarryforwards_lbl" xml:lang="en-US">Deferred tax assets related to tax loss carry forwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxAssetsTaxLossCarryforwards" xlink:to="aapg_DeferredTaxAssetsTaxLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_UnrecognizedTaxBenefitsRecognized" xlink:href="aapg-20251231.xsd#aapg_UnrecognizedTaxBenefitsRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_UnrecognizedTaxBenefitsRecognized_lbl" xml:lang="en-US">Unrecognized tax benefits recognized amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UnrecognizedTaxBenefitsRecognized" xlink:to="aapg_UnrecognizedTaxBenefitsRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnsecuredBankLoansReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnsecuredBankLoansReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UnsecuredBankLoansReceived_lbl" xml:lang="en-US">Bank loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnsecuredBankLoansReceived" xlink:to="ifrs-full_UnsecuredBankLoansReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingsInterestRate_lbl" xml:lang="en-US">Bank loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl" xml:lang="en-US">Shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:to="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_WeightedAverageExercisePrice" xlink:href="aapg-20251231.xsd#aapg_WeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_WeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_WeightedAverageExercisePrice" xlink:to="aapg_WeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NumberOfTreasuryShares" xlink:href="aapg-20251231.xsd#aapg_NumberOfTreasuryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NumberOfTreasuryShares_lbl" xml:lang="en-US">Treasury shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfTreasuryShares" xlink:to="aapg_NumberOfTreasuryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_BonusDueToEmployeesAmount" xlink:href="aapg-20251231.xsd#aapg_BonusDueToEmployeesAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_BonusDueToEmployeesAmount_lbl" xml:lang="en-US">Bonus due to employees amount (in Yuan Renminbi)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BonusDueToEmployeesAmount" xlink:to="aapg_BonusDueToEmployeesAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SharesConsiderationAmount" xlink:href="aapg-20251231.xsd#aapg_SharesConsiderationAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SharesConsiderationAmount_lbl" xml:lang="en-US">Total consideration shares (in Yuan Renminbi)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharesConsiderationAmount" xlink:to="aapg_SharesConsiderationAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SubscriptionOfShares" xlink:href="aapg-20251231.xsd#aapg_SubscriptionOfShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SubscriptionOfShares_lbl" xml:lang="en-US">Subscription of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SubscriptionOfShares" xlink:to="aapg_SubscriptionOfShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AllottedSharesPricePerShares" xlink:href="aapg-20251231.xsd#aapg_AllottedSharesPricePerShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AllottedSharesPricePerShares_lbl" xml:lang="en-US">Allotted shares price per shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AllottedSharesPricePerShares" xlink:to="aapg_AllottedSharesPricePerShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_StockPurchasedDuringPeriodShares" xlink:href="aapg-20251231.xsd#aapg_StockPurchasedDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_StockPurchasedDuringPeriodShares_lbl" xml:lang="en-US">Stock purchased during period, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockPurchasedDuringPeriodShares" xlink:to="aapg_StockPurchasedDuringPeriodShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xml:lang="en-US">Total consideration (in Yuan Renminbi)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserve" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CapitalReserve_lbl" xml:lang="en-US">Capital reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalReserve" xlink:to="ifrs-full_CapitalReserve_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TransferredOutFromCapitalAndReserves" xlink:href="aapg-20251231.xsd#aapg_TransferredOutFromCapitalAndReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TransferredOutFromCapitalAndReserves_lbl" xml:lang="en-US">Transferred out from capital and reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TransferredOutFromCapitalAndReserves" xlink:to="aapg_TransferredOutFromCapitalAndReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CapitalAndReserveFunds" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReserveFunds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_CapitalAndReserveFunds_lbl" xml:lang="en-US">Capital and Reserve Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalAndReserveFunds" xlink:to="aapg_CapitalAndReserveFunds_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_BonusAmount" xlink:href="aapg-20251231.xsd#aapg_BonusAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_BonusAmount_lbl" xml:lang="en-US">Bonus amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BonusAmount" xlink:to="aapg_BonusAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aapg_BonusAmount_lbl0" xml:lang="en-US">Settlement of bonus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BonusAmount" xlink:to="aapg_BonusAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Exercised shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareGrantExpense" xlink:href="aapg-20251231.xsd#aapg_ShareGrantExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ShareGrantExpense_lbl" xml:lang="en-US">Share grant expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareGrantExpense" xlink:to="aapg_ShareGrantExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AdditionalOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_AdditionalOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AdditionalOrdinaryShares_lbl" xml:lang="en-US">Additional ordinary shares. (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdditionalOrdinaryShares" xlink:to="aapg_AdditionalOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfExceedShareCapital" xlink:href="aapg-20251231.xsd#aapg_PercentageOfExceedShareCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PercentageOfExceedShareCapital_lbl" xml:lang="en-US">Exceed share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfExceedShareCapital" xlink:to="aapg_PercentageOfExceedShareCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AggregateShareIssued" xlink:href="aapg-20251231.xsd#aapg_AggregateShareIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_AggregateShareIssued_lbl" xml:lang="en-US">Aggregate shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AggregateShareIssued" xlink:to="aapg_AggregateShareIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SharesGranted" xlink:href="aapg-20251231.xsd#aapg_SharesGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SharesGranted_lbl" xml:lang="en-US">Shares granted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharesGranted" xlink:to="aapg_SharesGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement" xlink:href="aapg-20251231.xsd#aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement_lbl" xml:lang="en-US">Percentage of vesting percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement" xlink:to="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Exercise price, share options granted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" xlink:href="aapg-20251231.xsd#aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Share option expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" xlink:to="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xml:lang="en-US">Date of adoption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SharebasedPaymentVestingPeriod" xlink:href="aapg-20251231.xsd#aapg_SharebasedPaymentVestingPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SharebasedPaymentVestingPeriod_lbl" xml:lang="en-US">Share-based payment vesting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharebasedPaymentVestingPeriod" xlink:to="aapg_SharebasedPaymentVestingPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">RSUs exercised weighted average price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RSUsGrantedFairValue" xlink:href="aapg-20251231.xsd#aapg_RSUsGrantedFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_RSUsGrantedFairValue_lbl" xml:lang="en-US">RSUs granted fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RSUsGrantedFairValue" xlink:to="aapg_RSUsGrantedFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NumberOfGrantees" xlink:href="aapg-20251231.xsd#aapg_NumberOfGrantees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NumberOfGrantees_lbl" xml:lang="en-US">Number of grantees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfGrantees" xlink:to="aapg_NumberOfGrantees_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NumberOfNewlyIssuedShares" xlink:href="aapg-20251231.xsd#aapg_NumberOfNewlyIssuedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NumberOfNewlyIssuedShares_lbl" xml:lang="en-US">Number of newly issued shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfNewlyIssuedShares" xlink:to="aapg_NumberOfNewlyIssuedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" xlink:href="aapg-20251231.xsd#aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities_lbl" xml:lang="en-US">Non cash addition for right of use assets and lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" xlink:to="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NonCashDisposals" xlink:href="aapg-20251231.xsd#aapg_NonCashDisposals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NonCashDisposals_lbl" xml:lang="en-US">Non-cash disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCashDisposals" xlink:to="aapg_NonCashDisposals_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NoncashAdditionsToIntangibleAssets" xlink:href="aapg-20251231.xsd#aapg_NoncashAdditionsToIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NoncashAdditionsToIntangibleAssets_lbl" xml:lang="en-US">Non-cash additions to intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NoncashAdditionsToIntangibleAssets" xlink:to="aapg_NoncashAdditionsToIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NonCashAdditionsToPropertyPlantAndEquipment" xlink:href="aapg-20251231.xsd#aapg_NonCashAdditionsToPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NonCashAdditionsToPropertyPlantAndEquipment_lbl" xml:lang="en-US">Non-cash additions to property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCashAdditionsToPropertyPlantAndEquipment" xlink:to="aapg_NonCashAdditionsToPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CapitalCommitments_lbl" xml:lang="en-US">Capital commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalCommitments" xlink:to="ifrs-full_CapitalCommitments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_lbl" xml:lang="en-US">Contingent liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Contingent consideration amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingCostsIncurred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingCostsIncurred_lbl" xml:lang="en-US">Borrowing cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingCostsIncurred" xlink:to="ifrs-full_BorrowingCostsIncurred_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestBearingBankBorrowings" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_InterestBearingBankBorrowings_lbl" xml:lang="en-US">Interest-bearing bank borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestBearingBankBorrowings" xlink:to="aapg_InterestBearingBankBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ConcentrationsOfCreditRisk" xlink:href="aapg-20251231.xsd#aapg_ConcentrationsOfCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ConcentrationsOfCreditRisk_lbl" xml:lang="en-US">Concentrations of credit risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ConcentrationsOfCreditRisk" xlink:to="aapg_ConcentrationsOfCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LiquidityRiskPercentage" xlink:href="aapg-20251231.xsd#aapg_LiquidityRiskPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LiquidityRiskPercentage_lbl" xml:lang="en-US">Liquidity risk percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LiquidityRiskPercentage" xlink:to="aapg_LiquidityRiskPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xml:lang="en-US">Equity investment percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InvestmentIncome_lbl" xml:lang="en-US">Impairment associated with investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentIncome" xlink:to="ifrs-full_InvestmentIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xml:lang="en-US">BASIS OF PREPARATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl" xml:lang="en-US">Basis of consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock_lbl" xml:lang="en-US">CHANGES IN ACCOUNTING POLICIES AND DISCLOSURES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" xlink:to="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards_lbl" xml:lang="en-US">ISSUED BUT NOT YET EFFECTIVE IFRS ACCOUNTING STANDARDS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" xlink:to="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures_lbl" xml:lang="en-US">Investments in joint venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_lbl" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xml:lang="en-US">Fair value measurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_lbl" xml:lang="en-US">Impairment of non-financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory_lbl" xml:lang="en-US">Related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property, plant and equipment and depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl" xml:lang="en-US">Intangible assets (other than goodwill)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US">Research and development costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_lbl" xml:lang="en-US">Investments and other financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Derecognition of financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_lbl" xml:lang="en-US">Impairment of financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl" xml:lang="en-US">Financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock_lbl" xml:lang="en-US">Derecognition of financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" xlink:to="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Offsetting of financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Derivative financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl" xml:lang="en-US">Treasury shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US">Provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US">Income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_lbl" xml:lang="en-US">Other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory_lbl" xml:lang="en-US">Contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" xlink:to="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US">Share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xml:lang="en-US">Other employee benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_lbl" xml:lang="en-US">Borrowing costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock_lbl" xml:lang="en-US">Events after the reporting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" xlink:to="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xml:lang="en-US">Foreign currencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TaxesMember" xlink:href="aapg-20251231.xsd#aapg_TaxesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TaxesMember_lbl" xml:lang="en-US">Taxes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TaxesMember" xlink:to="aapg_TaxesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnusedTaxLossesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UnusedTaxLossesMember_lbl" xml:lang="en-US">Unused tax losses [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesMember" xlink:to="ifrs-full_UnusedTaxLossesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_HighAndNewTechnologyEnterpriseMember" xlink:href="aapg-20251231.xsd#aapg_HighAndNewTechnologyEnterpriseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_HighAndNewTechnologyEnterpriseMember_lbl" xml:lang="en-US">High and New Technology Enterprise [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_HighAndNewTechnologyEnterpriseMember" xlink:to="aapg_HighAndNewTechnologyEnterpriseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SuzhouYashengMember" xlink:href="aapg-20251231.xsd#aapg_SuzhouYashengMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SuzhouYashengMember_lbl" xml:lang="en-US">Suzhou Yasheng [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SuzhouYashengMember" xlink:to="aapg_SuzhouYashengMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LandAndBuildingsMember_lbl" xml:lang="en-US">Land and Buildings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LandAndBuildingsMember" xlink:to="ifrs-full_LandAndBuildingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_CNY"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_CNY_lbl" xml:lang="en-US">RMB [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_CNY" xlink:to="currency_CNY_lbl"/>
    <loc xlink:type="locator" xlink:label="currency_USD" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_USD"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_USD_lbl" xml:lang="en-US">US [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_USD" xlink:to="currency_USD_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InnoventBiologicsSuzhouCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_InnoventBiologicsSuzhouCoLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_InnoventBiologicsSuzhouCoLtdMember_lbl" xml:lang="en-US">Innovent Biologics Suzhou) Co Ltd [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InnoventBiologicsSuzhouCoLtdMember" xlink:to="aapg_InnoventBiologicsSuzhouCoLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SecuredBankBorrowingsMember" xlink:href="aapg-20251231.xsd#aapg_SecuredBankBorrowingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SecuredBankBorrowingsMember_lbl" xml:lang="en-US">Secured Bank Borrowings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SecuredBankBorrowingsMember" xlink:to="aapg_SecuredBankBorrowingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LloanPrimeRateMember" xlink:href="aapg-20251231.xsd#aapg_LloanPrimeRateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_LloanPrimeRateMember_lbl" xml:lang="en-US">Lioan Prime Rate [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LloanPrimeRateMember" xlink:to="aapg_LloanPrimeRateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TreasurySharesOneMember" xlink:href="aapg-20251231.xsd#aapg_TreasurySharesOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TreasurySharesOneMember_lbl" xml:lang="en-US">Treasury shares one [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TreasurySharesOneMember" xlink:to="aapg_TreasurySharesOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_HongKongStockExchangeMember" xlink:href="aapg-20251231.xsd#aapg_HongKongStockExchangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_HongKongStockExchangeMember_lbl" xml:lang="en-US">Hong Kong Stock Exchange [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_HongKongStockExchangeMember" xlink:to="aapg_HongKongStockExchangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember_lbl" xml:lang="en-US">2018 and 2022 RSU Schemes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember" xlink:to="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PreIPOShareOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionSchemeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PreIPOShareOptionSchemeMember_lbl" xml:lang="en-US">Pre-IPO Share Option Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreIPOShareOptionSchemeMember" xlink:to="aapg_PreIPOShareOptionSchemeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RestrictedShareUnitMember" xlink:href="aapg-20251231.xsd#aapg_RestrictedShareUnitMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_RestrictedShareUnitMember_lbl" xml:lang="en-US">Restricted Share Unit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RestrictedShareUnitMember" xlink:to="aapg_RestrictedShareUnitMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedShareUnitsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedShareUnitsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RestrictedShareUnitsMember_lbl" xml:lang="en-US">RSU Schemes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedShareUnitsMember" xlink:to="ifrs-full_RestrictedShareUnitsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RestrictedShareUnitsMember_lbl0" xml:lang="en-US">Restricted share units [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedShareUnitsMember" xlink:to="ifrs-full_RestrictedShareUnitsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ReservesMember" xlink:href="aapg-20251231.xsd#aapg_ReservesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ReservesMember_lbl" xml:lang="en-US">Reserves [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ReservesMember" xlink:to="aapg_ReservesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PreIPOShareOptionsMember" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_PreIPOShareOptionsMember_lbl" xml:lang="en-US">Pre-IPO Share Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreIPOShareOptionsMember" xlink:to="aapg_PreIPOShareOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_ShareOptionSchemeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ShareOptionSchemeMember_lbl" xml:lang="en-US">Share Option Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareOptionSchemeMember" xlink:to="aapg_ShareOptionSchemeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SpecialOptionsMember" xlink:href="aapg-20251231.xsd#aapg_SpecialOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SpecialOptionsMember_lbl" xml:lang="en-US">Special Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SpecialOptionsMember" xlink:to="aapg_SpecialOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FirstAnniversariesMember" xlink:href="aapg-20251231.xsd#aapg_FirstAnniversariesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FirstAnniversariesMember_lbl" xml:lang="en-US">First anniversaries [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FirstAnniversariesMember" xlink:to="aapg_FirstAnniversariesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SecondAnniversaryMember" xlink:href="aapg-20251231.xsd#aapg_SecondAnniversaryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_SecondAnniversaryMember_lbl" xml:lang="en-US">Second Anniversary [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SecondAnniversaryMember" xlink:to="aapg_SecondAnniversaryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ThirdAnniversaryMember" xlink:href="aapg-20251231.xsd#aapg_ThirdAnniversaryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ThirdAnniversaryMember_lbl" xml:lang="en-US">Third Anniversary [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ThirdAnniversaryMember" xlink:to="aapg_ThirdAnniversaryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FourthAnniversaryMember" xlink:href="aapg-20251231.xsd#aapg_FourthAnniversaryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_FourthAnniversaryMember_lbl" xml:lang="en-US">Fourth Anniversary [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FourthAnniversaryMember" xlink:to="aapg_FourthAnniversaryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ForecastMember" xlink:href="aapg-20251231.xsd#aapg_ForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ForecastMember" xlink:to="aapg_ForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TwoThousandEighteenRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandEighteenRSUSchemeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_TwoThousandEighteenRSUSchemeMember_lbl" xml:lang="en-US">2018 RSU Scheme [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandEighteenRSUSchemeMember" xlink:to="aapg_TwoThousandEighteenRSUSchemeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RSUMember" xlink:href="aapg-20251231.xsd#aapg_RSUMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_RSUMember_lbl" xml:lang="en-US">RSU [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RSUMember" xlink:to="aapg_RSUMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NonExecutiveDirectorMember" xlink:href="aapg-20251231.xsd#aapg_NonExecutiveDirectorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_NonExecutiveDirectorMember_lbl" xml:lang="en-US">Non-Executive Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonExecutiveDirectorMember" xlink:to="aapg_NonExecutiveDirectorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ChiefCommercialOfficerMember" xlink:href="aapg-20251231.xsd#aapg_ChiefCommercialOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_ChiefCommercialOfficerMember_lbl" xml:lang="en-US">Chief Commercial Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ChiefCommercialOfficerMember" xlink:to="aapg_ChiefCommercialOfficerMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_EmployeeMember" xlink:href="aapg-20251231.xsd#aapg_EmployeeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_EmployeeMember_lbl" xml:lang="en-US">Employee [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EmployeeMember" xlink:to="aapg_EmployeeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_HealthquestPharmaAcquisitionAgreementMember" xlink:href="aapg-20251231.xsd#aapg_HealthquestPharmaAcquisitionAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_HealthquestPharmaAcquisitionAgreementMember_lbl" xml:lang="en-US">Healthquest Pharma Acquisition Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_HealthquestPharmaAcquisitionAgreementMember" xlink:to="aapg_HealthquestPharmaAcquisitionAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DrYangMember" xlink:href="aapg-20251231.xsd#aapg_DrYangMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aapg_DrYangMember_lbl" xml:lang="en-US">Dr. Yang [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DrYangMember" xlink:to="aapg_DrYangMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US">Floating Interest Rates [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreditRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CreditRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CreditRiskMember_lbl" xml:lang="en-US">Credit Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CreditRiskMember" xlink:to="ifrs-full_CreditRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiquidityRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiquidityRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US">Liquidity Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesDomain_lbl" xml:lang="en-US">Products and services [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="ifrs-full_ProductsAndServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityDomain_lbl" xml:lang="en-US">Components of equity [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_ComponentsOfEquityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US">Statement of changes in equity [table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_lbl" xml:lang="en-US">Subsidiaries [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable_lbl" xml:lang="en-US">Corporate and Group Information - Schedule of Principal Subsidiaries (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" xlink:to="aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl" xml:lang="en-US">Schedule of Principal Subsidiaries [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NewIFRSsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NewIFRSsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NewIFRSsDomain_lbl" xml:lang="en-US">New IFRSs [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NewIFRSsDomain" xlink:to="ifrs-full_NewIFRSsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable_lbl" xml:lang="en-US">Accounting Policies - Schedule of New and Revised IFRSs (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" xlink:to="aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_lbl" xml:lang="en-US">Schedule of New and Revised IFRSs [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_lbl" xml:lang="en-US">Classes of property, plant and equipment [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeDomain_lbl" xml:lang="en-US">Range [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_RangeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable_lbl" xml:lang="en-US">Accounting Policies - Schedule of Property, Plant and Equipment of Annual Rates (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" xlink:to="aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Schedule of Property, Plant and Equipment of Annual Rates [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_lbl" xml:lang="en-US">Classes of intangible assets other than goodwill [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable_lbl" xml:lang="en-US">Accounting Policies - Schedule of Intangible Assets are Amortized on the Straight-Line Basis (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" xlink:to="aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems_lbl" xml:lang="en-US">Schedule of Intangible Assets are Amortized on the Straight-Line Basis [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_lbl" xml:lang="en-US">Property, plant and equipment including right-of-use assets [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable_lbl" xml:lang="en-US">Accounting Policies - Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems_lbl" xml:lang="en-US">Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable_lbl" xml:lang="en-US">Operating Segment Information - &#8203;Schedule of Revenue (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable" xlink:to="aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems_lbl" xml:lang="en-US">&#8203;Schedule of Revenue [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems" xlink:to="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable_lbl" xml:lang="en-US">Operating Segment Information - &#8203;Schedule of Non-Current Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" xlink:to="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems_lbl" xml:lang="en-US">&#8203;Schedule of Non-Current Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems" xlink:to="aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorCustomersDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorCustomersDomain_lbl" xml:lang="en-US">Major customers [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorCustomersDomain" xlink:to="ifrs-full_MajorCustomersDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable_lbl" xml:lang="en-US">Operating Segment Information - Schedule of Revenue from Customers (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" xlink:to="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems_lbl" xml:lang="en-US">Schedule of Revenue from Customers [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems" xlink:to="aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_lbl" xml:lang="en-US">Timing of transfer of goods or services [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable_lbl" xml:lang="en-US">Revenue, Other Income and Gains - &#8203;Schedule of Disaggregated Revenue (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" xlink:to="aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_lbl" xml:lang="en-US">&#8203;Schedule of Disaggregated Revenue [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable_lbl" xml:lang="en-US">Revenue, Other Income and Gains - &#8203;Schedule of Contract Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" xlink:to="aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_lbl0" xml:lang="en-US">&#8203;Schedule of Contract Liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityDomain_lbl" xml:lang="en-US">Maturity [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_MaturityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable_lbl" xml:lang="en-US">Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" xlink:to="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems_lbl" xml:lang="en-US">Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems" xlink:to="aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountMember_lbl" xml:lang="en-US">Carrying amount [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_CarryingAmountMember_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" xlink:href="aapg-20251231.xsd#aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable_lbl" xml:lang="en-US">Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl0" xml:lang="en-US">Schedule of Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_LeasesScheduleofRightofUseAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_LeasesScheduleofRightofUseAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LeasesScheduleofRightofUseAssetsDetailsTable_lbl" xml:lang="en-US">Leases - Schedule of Right-of-Use Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeasesScheduleofRightofUseAssetsDetailsTable" xlink:to="aapg_LeasesScheduleofRightofUseAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_lbl" xml:lang="en-US">Schedule of Right-of-Use Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable_lbl" xml:lang="en-US">Other Intangible Asset - Schedule of Other Intangible Asset (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" xlink:to="aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherIntangibleAssetLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherIntangibleAssetLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfOtherIntangibleAssetLineItems_lbl" xml:lang="en-US">Schedule of Other Intangible Asset [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherIntangibleAssetLineItems" xlink:to="aapg_ScheduleOfOtherIntangibleAssetLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_lbl" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable_lbl" xml:lang="en-US">Deferred Tax - Schedule of Movements in Deferred Tax Liabilities and Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" xlink:to="aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxLineItems" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DeferredTaxLineItems_lbl" xml:lang="en-US">Deferred Tax [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxLineItems" xlink:to="aapg_DeferredTaxLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementDomain_lbl" xml:lang="en-US">Revision of Prior Period [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_lbl" xml:lang="en-US">Liabilities arising from financing activities [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable_lbl" xml:lang="en-US">Deferred Tax - Schedule of Movements in Deferred Tax Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" xlink:to="aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl" xml:lang="en-US">Schedule of Movements in Deferred Tax Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialAssetsAgingDomainDomain" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAgingDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialAssetsAgingDomainDomain_lbl" xml:lang="en-US">FinancialAssetsAgingDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAgingDomainDomain" xlink:to="aapg_FinancialAssetsAgingDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" xlink:href="aapg-20251231.xsd#aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable_lbl" xml:lang="en-US">Trade Receivables, Net - Schedule of Based on the Invoice Date and Net of Loss Allowance (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" xlink:to="aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NetOfLossAllowanceLineItems" xlink:href="aapg-20251231.xsd#aapg_NetOfLossAllowanceLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NetOfLossAllowanceLineItems_lbl" xml:lang="en-US">Schedule of Based on the Invoice Date and Net of Loss Allowance [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NetOfLossAllowanceLineItems" xlink:to="aapg_NetOfLossAllowanceLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasDomain_lbl" xml:lang="en-US">Geographical areas [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="ifrs-full_GeographicalAreasDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable_lbl" xml:lang="en-US">Cash and Bank Balances - Schedule of Cash and Bank Balances (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" xlink:to="aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCashAndBankBalancesLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCashAndBankBalancesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCashAndBankBalancesLineItems_lbl" xml:lang="en-US">Schedule of Cash and Bank Balances [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCashAndBankBalancesLineItems" xlink:to="aapg_ScheduleOfCashAndBankBalancesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_TradePayablesScheduleoftheTradePayablesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_TradePayablesScheduleoftheTradePayablesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TradePayablesScheduleoftheTradePayablesDetailsTable_lbl" xml:lang="en-US">Trade Payables - Schedule of the Trade Payables (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TradePayablesScheduleoftheTradePayablesDetailsTable" xlink:to="aapg_TradePayablesScheduleoftheTradePayablesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfTheTradePayablesLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTheTradePayablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfTheTradePayablesLineItems_lbl" xml:lang="en-US">Schedule of the Trade Payables [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfTheTradePayablesLineItems" xlink:to="aapg_ScheduleOfTheTradePayablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfCustomersDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfCustomersDomain_lbl" xml:lang="en-US">Types of customers [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfCustomersDomain" xlink:to="ifrs-full_TypesOfCustomersDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable_lbl" xml:lang="en-US">Contract Liabilities - Schedule of Contract Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" xlink:to="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems_lbl" xml:lang="en-US">Schedule of Contract Liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems" xlink:to="aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameDomain_lbl" xml:lang="en-US">Borrowings by name [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="ifrs-full_BorrowingsByNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable_lbl" xml:lang="en-US">Interest-Bearing Bank and Other Borrowings - Schedule of Interest-Bearing Bank and Other Borrowings (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems_lbl" xml:lang="en-US">Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable_lbl" xml:lang="en-US">Interest-Bearing Bank and Other Borrowings - Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" xlink:to="aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems_lbl" xml:lang="en-US">Schedule of Estimated Interest-Bearing of Borrowings [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems" xlink:to="aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_lbl" xml:lang="en-US">Classes of share capital [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable_lbl" xml:lang="en-US">Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" xlink:to="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl" xml:lang="en-US">Schedule of Issued and Fully Paid [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable_lbl" xml:lang="en-US">Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Parentheticals) (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" xlink:to="aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable_lbl" xml:lang="en-US">Share Capital and Treasury Shares - Schedule of Share Capital and Treasury Shares (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" xlink:to="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems_lbl" xml:lang="en-US">Schedule of Share Capital and Treasury Shares [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_lbl" xml:lang="en-US">Types of share-based payment arrangements [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable_lbl" xml:lang="en-US">Share-Based Payments - Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" xlink:to="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems_lbl" xml:lang="en-US">Schedule of Share Options Outstanding [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_lbl" xml:lang="en-US">Ranges of exercise prices for outstanding share options [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable_lbl" xml:lang="en-US">Share-Based Payments - Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" xlink:to="aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_lbl" xml:lang="en-US">Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding [Line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable_lbl" xml:lang="en-US">Share-Based Payments - Schedule of Unlocking Date (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" xlink:to="aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xml:lang="en-US">Schedule of Unlocking Date [Line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable_lbl" xml:lang="en-US">Share-Based Payments - Schedule of Restricted Shares Outstanding (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" xlink:to="aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl0" xml:lang="en-US">Schedule of Restricted Shares Outstanding [Line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesDomain_lbl" xml:lang="en-US">Classes of contingent liabilities [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable_lbl" xml:lang="en-US">Notes to the Consolidated Statements of Cash Flows - Schedule of Changes in Liabilities Arising from Financing Activities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:to="aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_lbl" xml:lang="en-US">Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_lbl" xml:lang="en-US">Categories of related parties [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable_lbl" xml:lang="en-US">Related Party Transactions - Schedule of Transaction with Related Party (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" xlink:to="aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_lbl" xml:lang="en-US">Related Party [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain_lbl" xml:lang="en-US">Classes of financial assets [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US">Classes of financial instruments [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable_lbl" xml:lang="en-US">Financial Instruments by Category - Schedule of Categories of Financial Instruments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" xlink:to="aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems_lbl" xml:lang="en-US">Schedule of Categories of Financial Instruments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MeasurementDomain_lbl" xml:lang="en-US">Measurement [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MeasurementDomain" xlink:to="ifrs-full_MeasurementDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable_lbl" xml:lang="en-US">Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" xlink:to="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems_lbl" xml:lang="en-US">Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LevelsOfFairValueHierarchyDomain_lbl" xml:lang="en-US">Levels of fair value hierarchy [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="ifrs-full_LevelsOfFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable_lbl" xml:lang="en-US">Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Assets Measured at Fair Value (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" xlink:to="aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems_lbl" xml:lang="en-US">Schedule of Assets Measured at Fair Value [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_DisclosureOfFinancialAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies - Schedule of Interest Rate Risk (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_lbl" xml:lang="en-US">Schedule of Interest Rate Risk [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ChangeInForeignExchangeRatesDomainDomain" xlink:href="aapg-20251231.xsd#aapg_ChangeInForeignExchangeRatesDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ChangeInForeignExchangeRatesDomainDomain_lbl" xml:lang="en-US">ChangeInForeignExchangeRatesDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ChangeInForeignExchangeRatesDomainDomain" xlink:to="aapg_ChangeInForeignExchangeRatesDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsAndLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAndLiabilitiesDomain_lbl" xml:lang="en-US">Assets and liabilities [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAndLiabilitiesDomain" xlink:to="ifrs-full_AssetsAndLiabilitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies - Schedule of Foreign Currency Risk (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems_lbl" xml:lang="en-US">Schedule of Foreign Currency Risk [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:to="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies - Schedule of Credit Quality and Maximum Exposure To Credit Risk (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureLineItems_lbl" xml:lang="en-US">Schedule of Credit Quality and Maximum Exposure To Credit Risk [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="ifrs-full_DisclosureOfCreditRiskExposureLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain_lbl" xml:lang="en-US">Classes of financial liabilities [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies - Schedule of Liquidity Risk (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_lbl" xml:lang="en-US">Schedule of Liquidity Risk [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies - Schedule of Equity Price Risk (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems_lbl" xml:lang="en-US">Schedule of Market Equity Index [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies - Schedule of Fair Values of the Equity Investments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems_lbl" xml:lang="en-US">Schedule of Fair Values of the Equity Investments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfFinancialAssetsDomain_lbl" xml:lang="en-US">Categories of financial assets [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:to="ifrs-full_CategoriesOfFinancialAssetsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies - Schedule of Capital Management (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems_lbl" xml:lang="en-US">Schedule of Capital Management [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedBalanceSheetStatementTable_lbl" xml:lang="en-US">Condensed Balance Sheet Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="srt_CondensedBalanceSheetStatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems_lbl" xml:lang="en-US">Condensed Balance Sheet Statements, Captions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="srt_CondensedBalanceSheetStatementsCaptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedStatementOfComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedStatementOfComprehensiveIncomeTable_lbl" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedStatementOfComprehensiveIncomeTable" xlink:to="srt_CondensedStatementOfComprehensiveIncomeTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedStatementOfIncomeCaptionsLineItems_lbl" xml:lang="en-US">Condensed Statement of Income Captions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="srt_CondensedStatementOfIncomeCaptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable_lbl" xml:lang="en-US">Condensed Financial Information of the Company - Schedule of Condensed Statements of Cash Flows (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" xlink:to="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems_lbl" xml:lang="en-US">Schedule of Condensed Statements of Cash Flows [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable_lbl" xml:lang="en-US">Condensed Financial Information of the Company - Schedule of Company&#8217;s Reserves (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" xlink:to="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems_lbl" xml:lang="en-US">Schedule of Company&#8217;s Reserves [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_AccountingPoliciesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccountingPoliciesDetailsTable" xlink:to="aapg_AccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_lbl" xml:lang="en-US">Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxesDomainDomain" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxesDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncomeTaxesDomainDomain_lbl" xml:lang="en-US">IncomeTaxesDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeTaxesDomainDomain" xlink:to="aapg_IncomeTaxesDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_SignificantAccountingJudgementsandEstimatesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_SignificantAccountingJudgementsandEstimatesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SignificantAccountingJudgementsandEstimatesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Judgements and Estimates (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SignificantAccountingJudgementsandEstimatesDetailsTable" xlink:to="aapg_SignificantAccountingJudgementsandEstimatesDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl0" xml:lang="en-US">Significant Accounting Judgements and Estimates [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_IncomeTaxDetailsTable" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncomeTaxDetailsTable_lbl" xml:lang="en-US">Income Tax (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeTaxDetailsTable" xlink:to="aapg_IncomeTaxDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl1" xml:lang="en-US">Income Tax [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_LeasesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_LeasesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LeasesDetailsTable_lbl" xml:lang="en-US">Leases (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeasesDetailsTable" xlink:to="aapg_LeasesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_LeasesLineItems" xlink:href="aapg-20251231.xsd#aapg_LeasesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LeasesLineItems_lbl" xml:lang="en-US">Leases [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeasesLineItems" xlink:to="aapg_LeasesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_DeferredTaxDetailsTable" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DeferredTaxDetailsTable_lbl" xml:lang="en-US">Deferred Tax (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxDetailsTable" xlink:to="aapg_DeferredTaxDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_AllCurrenciesDomain_lbl" xml:lang="en-US">All Currencies [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_AllCurrenciesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CashandBankBalancesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CashandBankBalancesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CashandBankBalancesDetailsTable_lbl" xml:lang="en-US">Cash and Bank Balances (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashandBankBalancesDetailsTable" xlink:to="aapg_CashandBankBalancesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CashAndBankBalancesLineItems" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CashAndBankBalancesLineItems_lbl" xml:lang="en-US">Cash and Bank Balances [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashAndBankBalancesLineItems" xlink:to="aapg_CashAndBankBalancesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ContractLiabilitiesDetailsTable_lbl" xml:lang="en-US">Contract Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ContractLiabilitiesDetailsTable" xlink:to="aapg_ContractLiabilitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ContractLiabilitiesLineItems" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ContractLiabilitiesLineItems_lbl" xml:lang="en-US">Contract Liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ContractLiabilitiesLineItems" xlink:to="aapg_ContractLiabilitiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_InterestBearingBankandOtherBorrowingsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankandOtherBorrowingsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InterestBearingBankandOtherBorrowingsDetailsTable_lbl" xml:lang="en-US">Interest-Bearing Bank and Other Borrowings (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="aapg_InterestBearingBankandOtherBorrowingsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xml:lang="en-US">Interest-Bearing Bank and Other Borrowings [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsDomain_lbl" xml:lang="en-US">Types of antidilutive instruments [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain_lbl" xml:lang="en-US">Classes of ordinary shares [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:to="ifrs-full_ClassesOfOrdinarySharesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareCapitalandTreasurySharesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareCapitalandTreasurySharesDetailsTable_lbl" xml:lang="en-US">Share Capital and Treasury Shares (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareCapitalandTreasurySharesDetailsTable" xlink:to="aapg_ShareCapitalandTreasurySharesDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl0" xml:lang="en-US">Share Capital and Treasury Shares [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ReservesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ReservesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ReservesDetailsTable_lbl" xml:lang="en-US">Reserves (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ReservesDetailsTable" xlink:to="aapg_ReservesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReservesWithinEquityLineItems_lbl" xml:lang="en-US">Reserves [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="ifrs-full_DisclosureOfReservesWithinEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_GrantAnniversariesDomainDomain" xlink:href="aapg-20251231.xsd#aapg_GrantAnniversariesDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_GrantAnniversariesDomainDomain_lbl" xml:lang="en-US">GrantAnniversariesDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GrantAnniversariesDomainDomain" xlink:to="aapg_GrantAnniversariesDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_lbl" xml:lang="en-US">Non-adjusting events after reporting period [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ShareBasedPaymentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareBasedPaymentsDetailsTable_lbl" xml:lang="en-US">Share-Based Payments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareBasedPaymentsDetailsTable" xlink:to="aapg_ShareBasedPaymentsDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl1" xml:lang="en-US">Share-Based Payments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable_lbl" xml:lang="en-US">Notes to the Consolidated Statements of Cash Flows (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:href="aapg-20251231.xsd#aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems_lbl" xml:lang="en-US">Notes to the Consolidated Statements of Cash Flows [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CommitmentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CommitmentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CommitmentsDetailsTable_lbl" xml:lang="en-US">Commitments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CommitmentsDetailsTable" xlink:to="aapg_CommitmentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_CommitmentsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_CommitmentsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CommitmentsDetailsLineItems_lbl" xml:lang="en-US">Commitments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CommitmentsDetailsLineItems" xlink:to="aapg_CommitmentsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfContractsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfContractsDomain_lbl" xml:lang="en-US">Types of contracts [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfContractsDomain" xlink:to="ifrs-full_TypesOfContractsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_RelatedPartyTransactionsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RelatedPartyTransactionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RelatedPartyTransactionsDetailsTable_lbl" xml:lang="en-US">Related Party Transactions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RelatedPartyTransactionsDetailsTable" xlink:to="aapg_RelatedPartyTransactionsDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_lbl0" xml:lang="en-US">Related Party Transactions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksDomain_lbl" xml:lang="en-US">Types of risks [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksDomain" xlink:to="ifrs-full_TypesOfRisksDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems_lbl" xml:lang="en-US">Financial Risk Management Objectives and Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AccumulatedAmortization_lbl0" xml:lang="en-US">The amount of accumulated amortization.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccumulatedAmortization" xlink:to="aapg_AccumulatedAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AccumulatedDepreciationsCost_lbl0" xml:lang="en-US">Accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccumulatedDepreciationsCost" xlink:to="aapg_AccumulatedDepreciationsCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AccumulatedImpairmentGoodwill_lbl0" xml:lang="en-US">The amount of accumulated impairment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccumulatedImpairmentGoodwill" xlink:to="aapg_AccumulatedImpairmentGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AdditionalOrdinaryShares_lbl0" xml:lang="en-US">Additional ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdditionalOrdinaryShares" xlink:to="aapg_AdditionalOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AdjustedCapitals_lbl0" xml:lang="en-US">The amount of adjusted capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustedCapitals" xlink:to="aapg_AdjustedCapitals_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in restricted cash balances to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" xlink:to="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AdjustmentsForDepreciationOfRightofuseAssets_lbl0" xml:lang="en-US">Adjustments for depreciation of right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForDepreciationOfRightofuseAssets" xlink:to="aapg_AdjustmentsForDepreciationOfRightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AdjustmentsForGainOnDisposalOfLeases_lbl1" xml:lang="en-US">Adjustments for gains (losses) on disposals of leases in the scope of IFRS 9 to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForGainOnDisposalOfLeases" xlink:to="aapg_AdjustmentsForGainOnDisposalOfLeases_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture_lbl0" xml:lang="en-US">Aggregate carrying amount of the Group&#8217;s investment in the joint venture.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" xlink:to="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AggregateShareIssued_lbl0" xml:lang="en-US">Number of aggregate share issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AggregateShareIssued" xlink:to="aapg_AggregateShareIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AllottedSharesPricePerShares_lbl0" xml:lang="en-US">Allotted shares price per shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AllottedSharesPricePerShares" xlink:to="aapg_AllottedSharesPricePerShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_AnnualBaseSalaryPercentage_lbl0" xml:lang="en-US">Percentage of annual base salary .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AnnualBaseSalaryPercentage" xlink:to="aapg_AnnualBaseSalaryPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_BonusAmount_lbl1" xml:lang="en-US">The amount of bonus paid to employee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BonusAmount" xlink:to="aapg_BonusAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_BonusDueToEmployeesAmount_lbl0" xml:lang="en-US">Bonus due to employees, amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BonusDueToEmployeesAmount" xlink:to="aapg_BonusDueToEmployeesAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_CapitalAndReserveFunds_lbl0" xml:lang="en-US">Capital and Reserve Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalAndReserveFunds" xlink:to="aapg_CapitalAndReserveFunds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_CapitalAndReserves_lbl0" xml:lang="en-US">The amount represent the vaue of capital and reseve.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalAndReserves" xlink:to="aapg_CapitalAndReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_CashAndBankBalancesNotYetPastDue_lbl0" xml:lang="en-US">The amount of cash and bank balances.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashAndBankBalancesNotYetPastDue" xlink:to="aapg_CashAndBankBalancesNotYetPastDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_CashInflowOutflowForLease_lbl0" xml:lang="en-US">The amount of cash inflow outflow for lease.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashInflowOutflowForLease" xlink:to="aapg_CashInflowOutflowForLease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_CommitmentAndContingencies_lbl0" xml:lang="en-US">Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company&apos;s resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CommitmentAndContingencies" xlink:to="aapg_CommitmentAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ComprehensiveIncomeLoss_lbl0" xml:lang="en-US">Total comprehensive income for the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ComprehensiveIncomeLoss" xlink:to="aapg_ComprehensiveIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ConcentrationsOfCreditRisk_lbl0" xml:lang="en-US">Concentrations of credit risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ConcentrationsOfCreditRisk" xlink:to="aapg_ConcentrationsOfCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ContractAcquisitionCosts_lbl0" xml:lang="en-US">Amount of contract acquisition costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ContractAcquisitionCosts" xlink:to="aapg_ContractAcquisitionCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_CostGoodwill_lbl0" xml:lang="en-US">Cost of goodwill.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CostGoodwill" xlink:to="aapg_CostGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_CurretPayablesForConstructionCost_lbl0" xml:lang="en-US">Amount of payables for construction cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurretPayablesForConstructionCost" xlink:to="aapg_CurretPayablesForConstructionCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DeductibleTemporaryDifferencesNotRecognized_lbl0" xml:lang="en-US">Deductible temporary differences not recognized.&#xd;
.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeductibleTemporaryDifferencesNotRecognized" xlink:to="aapg_DeductibleTemporaryDifferencesNotRecognized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DeferredIncomeNonCurrent_lbl0" xml:lang="en-US">Represent the amount of deferred income.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredIncomeNonCurrent" xlink:to="aapg_DeferredIncomeNonCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DeferredTaxAssetsTaxLossCarryforwards_lbl0" xml:lang="en-US">Amount, before allocation of valuation allowance, of deferred tax asset attributable to tax loss carryforwards.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxAssetsTaxLossCarryforwards" xlink:to="aapg_DeferredTaxAssetsTaxLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition_lbl0" xml:lang="en-US">Represent the amount of deferred tax offset in the consolidated statements of financial position.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" xlink:to="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DepositsAssetsPrepayments_lbl0" xml:lang="en-US">Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DepositsAssetsPrepayments" xlink:to="aapg_DepositsAssetsPrepayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DepreciationChargeofRightofuseAssets_lbl0" xml:lang="en-US">Amount of depreciation charge of right-of-use assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DepreciationChargeofRightofuseAssets" xlink:to="aapg_DepreciationChargeofRightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory_lbl0" xml:lang="en-US">The description of contract liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" xlink:to="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s material accounting policy information for the derecognition of financial liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" xlink:to="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock_lbl0" xml:lang="en-US">The description of events after the reporting period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" xlink:to="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards_lbl0" xml:lang="en-US">Description of accounting policy for issued but not yet effective ifrs accountingstandards.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" xlink:to="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">the disclosure of detailed information about fair value and fair value hierarchy of financial instruments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" xlink:to="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory_lbl0" xml:lang="en-US">The disclosure of information about right-of-use assets of lease terms and estimated useful lives of assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" xlink:to="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfCapitalManagementExplanatory_lbl0" xml:lang="en-US">The detailed information of capital management.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCapitalManagementExplanatory" xlink:to="aapg_DisclosureOfCapitalManagementExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory_lbl0" xml:lang="en-US">The carrying amounts at the end of the reporting period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" xlink:to="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory_lbl0" xml:lang="en-US">The detailed information of cash outflows of lease included in cashflows.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" xlink:to="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock_lbl0" xml:lang="en-US">The disclosure of changes made to accounting policies by the entity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" xlink:to="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfContractLiabilitiesTextBlock_lbl0" xml:lang="en-US">The disclosyre of contract liabuilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfContractLiabilitiesTextBlock" xlink:to="aapg_DisclosureOfContractLiabilitiesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfContractsLiabilitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of contracts liabilities explanatory.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfContractsLiabilitiesExplanatory" xlink:to="aapg_DisclosureOfContractsLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory_lbl0" xml:lang="en-US">The entire disclosure for current and deferred components of the income tax expense/(credit).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" xlink:to="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory_lbl0" xml:lang="en-US">The disclosure deferred tax assets and liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:to="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfDeferredTaxAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of deferred tax assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDeferredTaxAssetsExplanatory" xlink:to="aapg_DisclosureOfDeferredTaxAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory_lbl0" xml:lang="en-US">The disclosure of detailed information about financial assets at fair value through profit or loss.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" xlink:to="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory_lbl0" xml:lang="en-US">The disclosure of detailed information about property, plant and equipment of annual rates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" xlink:to="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory_lbl0" xml:lang="en-US">The detailed information of inventories/.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory" xlink:to="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfEquityPriceRiskExplanatory_lbl0" xml:lang="en-US">The detailed information of equity price risk.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfEquityPriceRiskExplanatory" xlink:to="aapg_DisclosureOfEquityPriceRiskExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfForeignCurrencyRiskExplanatory_lbl0" xml:lang="en-US">The detailed information of foreign currency risk.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfForeignCurrencyRiskExplanatory" xlink:to="aapg_DisclosureOfForeignCurrencyRiskExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfInterestRateRiskExplanatory_lbl0" xml:lang="en-US">The detailed information of interest rate risk.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfInterestRateRiskExplanatory" xlink:to="aapg_DisclosureOfInterestRateRiskExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure for lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" xlink:to="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock_lbl0" xml:lang="en-US">Disclosure of loss before tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" xlink:to="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock_lbl0" xml:lang="en-US">Disclosure of detailed information about loss before tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock" xlink:to="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock_lbl0" xml:lang="en-US">The disclosure of other intangible assets explanatory.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" xlink:to="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock_lbl0" xml:lang="en-US">Disclosure of other payables and accruals.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock" xlink:to="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfPledgeOfAssetsExplanatory_lbl0" xml:lang="en-US">The disclosure of pledge of assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfPledgeOfAssetsExplanatory" xlink:to="aapg_DisclosureOfPledgeOfAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory_lbl0" xml:lang="en-US">The disclosure of reconciliation between the income tax expense/(credit).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" xlink:to="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock_lbl0" xml:lang="en-US">Disclosure of explanatory information about revenue other income and other gains.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" xlink:to="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory_lbl0" xml:lang="en-US">The disclosure of share capital and treasury shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory" xlink:to="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfTradePayablesExplanatory_lbl0" xml:lang="en-US">The disclosure of trade payables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfTradePayablesExplanatory" xlink:to="aapg_DisclosureOfTradePayablesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureOfUnlockingDatetextBlock_lbl0" xml:lang="en-US">The disclosure of unlocking date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfUnlockingDatetextBlock" xlink:to="aapg_DisclosureOfUnlockingDatetextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory_lbl0" xml:lang="en-US">The disclosure of other payables and accruals.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory" xlink:to="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory_lbl0" xml:lang="en-US">The disclosure of  outstanding balance with related party explanatory.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" xlink:to="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisclosureofTransactionWithRelatedPartyExplanatory_lbl0" xml:lang="en-US">The disclosure of transaction with related party explanatory.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureofTransactionWithRelatedPartyExplanatory" xlink:to="aapg_DisclosureofTransactionWithRelatedPartyExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_DisposalsLeaseLiabilities_lbl0" xml:lang="en-US">Amount of disposal lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisposalsLeaseLiabilities" xlink:to="aapg_DisposalsLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_EffectOfWithholdingTaxOnTheInterestIncome_lbl0" xml:lang="en-US">The amount of effect of withholding tax on the interest income &#8212; of the group&#8217;s HK subsidiary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EffectOfWithholdingTaxOnTheInterestIncome" xlink:to="aapg_EffectOfWithholdingTaxOnTheInterestIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ExchangeFluctuationReserve_lbl0" xml:lang="en-US">Represent the amount of exchange fluctuation reserve.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ExchangeFluctuationReserve" xlink:to="aapg_ExchangeFluctuationReserve_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ExchangeRealignmentRightofuseAssets_lbl0" xml:lang="en-US">Exchange realignment, right-of-use assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ExchangeRealignmentRightofuseAssets" xlink:to="aapg_ExchangeRealignmentRightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ExchangeRealignments_lbl0" xml:lang="en-US">Exchange realignment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ExchangeRealignments" xlink:to="aapg_ExchangeRealignments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_FinancialAssetsAtFVTPL_lbl0" xml:lang="en-US">The amount of financial assets at FVTPL.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAtFVTPL" xlink:to="aapg_FinancialAssetsAtFVTPL_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_FinancialLiabilitiesAtFVTPL_lbl0" xml:lang="en-US">The amount of financial liabilities at FVTPL .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesAtFVTPL" xlink:to="aapg_FinancialLiabilitiesAtFVTPL_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_FutureTaxableProfitsPercentage_lbl0" xml:lang="en-US">Future taxable profits percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FutureTaxableProfitsPercentage" xlink:to="aapg_FutureTaxableProfitsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_GainlossAttributableToJointVentures_lbl0" xml:lang="en-US">The amount of gain/(loss) attributable to joint ventures.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GainlossAttributableToJointVentures" xlink:to="aapg_GainlossAttributableToJointVentures_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_GovernmentSubsidy_lbl0" xml:lang="en-US">The amount of government subsidy.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GovernmentSubsidy" xlink:to="aapg_GovernmentSubsidy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IncomeNotSubjectToTax_lbl0" xml:lang="en-US">Income not subject to tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeNotSubjectToTax" xlink:to="aapg_IncomeNotSubjectToTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IncomeTaxComputedAtTheStatutoryTaxRate_lbl0" xml:lang="en-US">Represent the amount of income tax computed at the statutory tax rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeTaxComputedAtTheStatutoryTaxRate" xlink:to="aapg_IncomeTaxComputedAtTheStatutoryTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus_lbl0" xml:lang="en-US">Represent the number of shares, equity-settled bonus.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus" xlink:to="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity_lbl0" xml:lang="en-US">(Increase)/Decrease in time deposits with original maturity of more than three months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity" xlink:to="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme_lbl0" xml:lang="en-US">Issue of shares under the 2021 RSU.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" xlink:to="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares_lbl0" xml:lang="en-US">Represent the amount of share capital, repurchase of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" xlink:to="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IncreasedecreaseInLossBeforeTax_lbl0" xml:lang="en-US">Increase/(decrease) in loss before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseInLossBeforeTax" xlink:to="aapg_IncreasedecreaseInLossBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IncreasedecreaseWeakensAgainst_lbl0" xml:lang="en-US">Increase/(decrease) in foreign currency rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseWeakensAgainst" xlink:to="aapg_IncreasedecreaseWeakensAgainst_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IntangibleAssetsGross_lbl0" xml:lang="en-US">Intangible assets gross amount before charging accumulated amortization.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IntangibleAssetsGross" xlink:to="aapg_IntangibleAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_InterestBearingBankBorrowings_lbl0" xml:lang="en-US">Interest-bearing bank borrowings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestBearingBankBorrowings" xlink:to="aapg_InterestBearingBankBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent_lbl0" xml:lang="en-US">Represent the amount of interest-bearing bank and other borrowings non-current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent" xlink:to="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_Interestbearingbankandotherborrowingscurrent_lbl0" xml:lang="en-US">Amount of interest-bearing bank and other borrowings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Interestbearingbankandotherborrowingscurrent" xlink:to="aapg_Interestbearingbankandotherborrowingscurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Represent the amount of investment in joint ventures classified as investing activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities" xlink:to="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_InvestmentInOtherFinancialAssets_lbl0" xml:lang="en-US">The amount of investment in other financial assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentInOtherFinancialAssets" xlink:to="aapg_InvestmentInOtherFinancialAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IssueOfOrdinaryShare_lbl1" xml:lang="en-US">Issue of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfOrdinaryShare" xlink:to="aapg_IssueOfOrdinaryShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IssueOfOrdinaryShares_lbl0" xml:lang="en-US">Issue of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfOrdinaryShares" xlink:to="aapg_IssueOfOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares_lbl0" xml:lang="en-US">Issue of shares under the 2021 RSU scheme.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares" xlink:to="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme_lbl0" xml:lang="en-US">Issue of shares under the pre-IPO share option scheme.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme" xlink:to="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares_lbl0" xml:lang="en-US">Issue of shares under the pre-IPO share option scheme.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" xlink:to="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IssuedShareCapital_lbl2" xml:lang="en-US">The nominal value of capital issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssuedShareCapital" xlink:to="aapg_IssuedShareCapital_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_LeaseTerms_lbl0" xml:lang="en-US">Lease terms.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseTerms" xlink:to="aapg_LeaseTerms_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_LiquidityRiskPercentage_lbl0" xml:lang="en-US">Liquidity risk percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LiquidityRiskPercentage" xlink:to="aapg_LiquidityRiskPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ListedEquityInvestmentsAtFairValue_lbl0" xml:lang="en-US">Listed equity investments, at fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ListedEquityInvestmentsAtFairValue" xlink:to="aapg_ListedEquityInvestmentsAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ListingExpensePaid_lbl0" xml:lang="en-US">Listing expense paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ListingExpensePaid" xlink:to="aapg_ListingExpensePaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_LossBeforeTaxArrivedCharingOrCrediting_lbl0" xml:lang="en-US">It represents total amount of expenses before tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LossBeforeTaxArrivedCharingOrCrediting" xlink:to="aapg_LossBeforeTaxArrivedCharingOrCrediting_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_LowerTaxRateForASpecificEntity_lbl0" xml:lang="en-US">Lower tax rate for a specific entity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LowerTaxRateForASpecificEntity" xlink:to="aapg_LowerTaxRateForASpecificEntity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_MarketEquityIndex_lbl0" xml:lang="en-US">Market equity index.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_MarketEquityIndex" xlink:to="aapg_MarketEquityIndex_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NetOperatingLossExpired_lbl0" xml:lang="en-US">The amount of net operating loss (NOL) expired .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NetOperatingLossExpired" xlink:to="aapg_NetOperatingLossExpired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NewProvisionsReturn_lbl0" xml:lang="en-US">The amount of provision to return.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NewProvisionsReturn" xlink:to="aapg_NewProvisionsReturn_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities_lbl0" xml:lang="en-US">Non cash addition for right of use assets and lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" xlink:to="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NonCashAdditionsToPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Non-cash additions to property, plant and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCashAdditionsToPropertyPlantAndEquipment" xlink:to="aapg_NonCashAdditionsToPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NonCashDisposals_lbl0" xml:lang="en-US">Non-cash disposals.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCashDisposals" xlink:to="aapg_NonCashDisposals_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NoncashAdditionsToIntangibleAssets_lbl0" xml:lang="en-US">Non-cash additions to intangible assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NoncashAdditionsToIntangibleAssets" xlink:to="aapg_NoncashAdditionsToIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NumberOfGrantees_lbl0" xml:lang="en-US">Number of grantees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfGrantees" xlink:to="aapg_NumberOfGrantees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NumberOfNewlyIssuedShares_lbl0" xml:lang="en-US">Number of newly issued shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfNewlyIssuedShares" xlink:to="aapg_NumberOfNewlyIssuedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of share options expense in share-based payment arrangement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" xlink:to="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_NumberOfTreasuryShares_lbl0" xml:lang="en-US">Number of treasury shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfTreasuryShares" xlink:to="aapg_NumberOfTreasuryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_OtherEmployeeBenefitContributionPercentage_lbl0" xml:lang="en-US">Percentage of Other Employee Benefit Contribution.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherEmployeeBenefitContributionPercentage" xlink:to="aapg_OtherEmployeeBenefitContributionPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_OtherPayablesAndAccruals_lbl0" xml:lang="en-US">The amount of other payables and accruals.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherPayablesAndAccruals" xlink:to="aapg_OtherPayablesAndAccruals_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_OtherUnlistedInvestmentsAtFairValue_lbl0" xml:lang="en-US">Other unlisted investments, at fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherUnlistedInvestmentsAtFairValue" xlink:to="aapg_OtherUnlistedInvestmentsAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_OthersExpenses_lbl0" xml:lang="en-US">Represents the amount of others expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OthersExpenses" xlink:to="aapg_OthersExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_OutstandingBalanceOtherNoncurrentLiabilities_lbl0" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OutstandingBalanceOtherNoncurrentLiabilities" xlink:to="aapg_OutstandingBalanceOtherNoncurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_OutstandingBalanceWithRelatedParty_lbl0" xml:lang="en-US">Outstanding balance with related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OutstandingBalanceWithRelatedParty" xlink:to="aapg_OutstandingBalanceWithRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PaymentsofLeaseLiabilities_lbl0" xml:lang="en-US">Amount of payment of lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PaymentsofLeaseLiabilities" xlink:to="aapg_PaymentsofLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_Penalty_lbl0" xml:lang="en-US">Represents the amount of penalty.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Penalty" xlink:to="aapg_Penalty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PenaltyExpense_lbl0" xml:lang="en-US">Represent the amount of penalty.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PenaltyExpense" xlink:to="aapg_PenaltyExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_Penaltys_lbl0" xml:lang="en-US">It represents amount of penalty to expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Penaltys" xlink:to="aapg_Penaltys_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PercentageOfConditionalShares_lbl0" xml:lang="en-US">Represent the percentage of conditional shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfConditionalShares" xlink:to="aapg_PercentageOfConditionalShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect_lbl0" xml:lang="en-US">Percentage of equity interests attributable to the company direct.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect" xlink:to="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PercentageOfExceedShareCapital_lbl0" xml:lang="en-US">Percentage of exceed share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfExceedShareCapital" xlink:to="aapg_PercentageOfExceedShareCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PercentageOfVestedConditionalShares_lbl1" xml:lang="en-US">Represent the percentage of vested conditional shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfVestedConditionalShares" xlink:to="aapg_PercentageOfVestedConditionalShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Percentage of vesting requirements for share-based payment arrangement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement" xlink:to="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PortionClassifiedAsCurrentLiabilities_lbl0" xml:lang="en-US">The amunt of portion classified as current liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PortionClassifiedAsCurrentLiabilities" xlink:to="aapg_PortionClassifiedAsCurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PreIPOShareOptionExpenses_lbl0" xml:lang="en-US">Represent the amount of pre-ipo share option expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreIPOShareOptionExpenses" xlink:to="aapg_PreIPOShareOptionExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PreferentialRate_lbl0" xml:lang="en-US">Preferential rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreferentialRate" xlink:to="aapg_PreferentialRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PrepaidListingExpense_lbl0" xml:lang="en-US">Prepaid listing expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrepaidListingExpense" xlink:to="aapg_PrepaidListingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PrepaymentForTreasurySharePurchaseFees_lbl0" xml:lang="en-US">The amount of prepayment for treasury share purchase fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrepaymentForTreasurySharePurchaseFees" xlink:to="aapg_PrepaymentForTreasurySharePurchaseFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PrepaymentsForClinicalTrialExpenses_lbl0" xml:lang="en-US">The amount of prepayments for clinical trial expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrepaymentsForClinicalTrialExpenses" xlink:to="aapg_PrepaymentsForClinicalTrialExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PrincipalActivities_lbl0" xml:lang="en-US">Principal activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrincipalActivities" xlink:to="aapg_PrincipalActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PropertyAndEquipmentCost_lbl0" xml:lang="en-US">Amount of property and equipment cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PropertyAndEquipmentCost" xlink:to="aapg_PropertyAndEquipmentCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation_lbl1" xml:lang="en-US">Amount net of accumulated depreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation" xlink:to="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_RSUsGrantedFairValue_lbl0" xml:lang="en-US">RSUs granted fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RSUsGrantedFairValue" xlink:to="aapg_RSUsGrantedFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_RecognizedAsIncomeDuringTheYear_lbl0" xml:lang="en-US">Represent the amount of recognized as income during the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RecognizedAsIncomeDuringTheYear" xlink:to="aapg_RecognizedAsIncomeDuringTheYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_RegisteredShareCapital_lbl0" xml:lang="en-US">Registered share capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RegisteredShareCapital" xlink:to="aapg_RegisteredShareCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_RepurchaseOfOrdinaryShare_lbl0" xml:lang="en-US">Repurchase of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RepurchaseOfOrdinaryShare" xlink:to="aapg_RepurchaseOfOrdinaryShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_RepurchaseOfOrdinaryShares_lbl0" xml:lang="en-US">Represent the amount of repurchase of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RepurchaseOfOrdinaryShares" xlink:to="aapg_RepurchaseOfOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ResearchAndDevelopmentSuperdeduction_lbl0" xml:lang="en-US">The amount of research and development super-deduction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ResearchAndDevelopmentSuperdeduction" xlink:to="aapg_ResearchAndDevelopmentSuperdeduction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_RestrictedShareUnitExpenses_lbl0" xml:lang="en-US">Represent the amount of restricted share unit expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RestrictedShareUnitExpenses" xlink:to="aapg_RestrictedShareUnitExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_RightofuseAssetsOfEstimatedUsefulLives_lbl0" xml:lang="en-US">Right-of-use assets of estimated useful lives.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RightofuseAssetsOfEstimatedUsefulLives" xlink:to="aapg_RightofuseAssetsOfEstimatedUsefulLives_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure for based on the invoice date and net of loss allowance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" xlink:to="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock_lbl0" xml:lang="en-US">Disclosure of  carrying amounts of borrowings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" xlink:to="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfCashAndBankBalancesExplanatory_lbl0" xml:lang="en-US">Schedule of cash and bank balances explanatory.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCashAndBankBalancesExplanatory" xlink:to="aapg_ScheduleOfCashAndBankBalancesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock" xlink:to="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfDeferredIncomeTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of schedule of deferred income.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfDeferredIncomeTableTextBlock" xlink:to="aapg_ScheduleOfDeferredIncomeTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory_lbl0" xml:lang="en-US">The entire disclosure for deferred tax liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory" xlink:to="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock_lbl0" xml:lang="en-US">Schedule of fair values of share options granted [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" xlink:to="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock_lbl0" xml:lang="en-US">Schedule of Group&#8217;s Principal Joint Venture.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock" xlink:to="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock_lbl0" xml:lang="en-US">Schedule of Information of the Group&#8217;s Joint Venture.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" xlink:to="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Interest-Bearing Bank and Other Borrowings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" xlink:to="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock_lbl0" xml:lang="en-US">Schedule of Investment in a Joint Venture.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock" xlink:to="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfOtherExpensesTableTextBlock_lbl0" xml:lang="en-US">The disclosure of the other expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherExpensesTableTextBlock" xlink:to="aapg_ScheduleOfOtherExpensesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of other non-current assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock" xlink:to="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfReservesTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of reserves.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfReservesTableTextBlock" xlink:to="aapg_ScheduleOfReservesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ScheduleOfTradeReceivablesNetTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of trade receivables, net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfTradeReceivablesNetTableTextBlock" xlink:to="aapg_ScheduleOfTradeReceivablesNetTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ShareGrantExpense_lbl0" xml:lang="en-US">Share grant expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareGrantExpense" xlink:to="aapg_ShareGrantExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_SharebasedPaymentVestingPeriod_lbl0" xml:lang="en-US">Share-based payment  vesting period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharebasedPaymentVestingPeriod" xlink:to="aapg_SharebasedPaymentVestingPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_SharesConsiderationAmount_lbl0" xml:lang="en-US">Shares consideration amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharesConsiderationAmount" xlink:to="aapg_SharesConsiderationAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_SharesGranted_lbl0" xml:lang="en-US">Shares Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharesGranted" xlink:to="aapg_SharesGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StatutoryIncomeAndExpense_lbl0" xml:lang="en-US">Statutory income and expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StatutoryIncomeAndExpense" xlink:to="aapg_StatutoryIncomeAndExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockExchangeIndexShare_lbl0" xml:lang="en-US">The shares stock exchange index.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockExchangeIndexShare" xlink:to="aapg_StockExchangeIndexShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary_lbl0" xml:lang="en-US">Represent the amount of capital contribution from a non-controlling shareholder of a subsidiary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" xlink:to="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockIssuedDuringPeriodValueEquitysettledBonus_lbl0" xml:lang="en-US">Represent the amount of equity-settled bonus.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueEquitysettledBonus" xlink:to="aapg_StockIssuedDuringPeriodValueEquitysettledBonus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions_lbl0" xml:lang="en-US">Represent the amount of exercise of pre-ipo share options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" xlink:to="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses_lbl0" xml:lang="en-US">Represent the amount of pre-IPO share option expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" xlink:to="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses_lbl0" xml:lang="en-US">Represent the amount of restricted share unit (&#8220;RSU&#8221;) expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" xlink:to="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockIssuedDuringPeriodValueShareOptionExpenses_lbl0" xml:lang="en-US">Amount of post-IPO share option expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueShareOptionExpenses" xlink:to="aapg_StockIssuedDuringPeriodValueShareOptionExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRSUs_lbl0" xml:lang="en-US">Represent the amount of vesting of restricted share units (RSUs).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueVestingOfRSUs" xlink:to="aapg_StockIssuedDuringPeriodValueVestingOfRSUs_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits_lbl0" xml:lang="en-US">Represent the amount of vesting of restricted share units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" xlink:to="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus_lbl0" xml:lang="en-US">Equity-settled bonus.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus" xlink:to="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_StockPurchasedDuringPeriodShares_lbl0" xml:lang="en-US">Number of shares that have been purchased during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockPurchasedDuringPeriodShares" xlink:to="aapg_StockPurchasedDuringPeriodShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_SubscriptionOfShares_lbl0" xml:lang="en-US">Number of subscription of shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SubscriptionOfShares" xlink:to="aapg_SubscriptionOfShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_TaxCredits_lbl0" xml:lang="en-US">Tax credits.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TaxCredits" xlink:to="aapg_TaxCredits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_TermsOfLandLease_lbl0" xml:lang="en-US">Terms of land lease.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TermsOfLandLease" xlink:to="aapg_TermsOfLandLease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths_lbl0" xml:lang="en-US">Time deposits with original maturity of more than three months.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" xlink:to="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_TotalAmountofRecognizedInProfitOrLoss_lbl0" xml:lang="en-US">Amount of recognized in profit or loss.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TotalAmountofRecognizedInProfitOrLoss" xlink:to="aapg_TotalAmountofRecognizedInProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_TransferredOutFromCapitalAndReserves_lbl0" xml:lang="en-US">The amounrt represents the value of transferred out from capital and reserves.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TransferredOutFromCapitalAndReserves" xlink:to="aapg_TransferredOutFromCapitalAndReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_UncertainTaxPosition_lbl0" xml:lang="en-US">The amount of uncertain tax position.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UncertainTaxPosition" xlink:to="aapg_UncertainTaxPosition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_UnrecognizedTaxBenefit_lbl0" xml:lang="en-US">The amount of unrecognized tax benefit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UnrecognizedTaxBenefit" xlink:to="aapg_UnrecognizedTaxBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_UnrecognizedTaxBenefitsRecognized_lbl0" xml:lang="en-US">The amount of unrecognized tax benefits recognized amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UnrecognizedTaxBenefitsRecognized" xlink:to="aapg_UnrecognizedTaxBenefitsRecognized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_VestingOfRestrictedShareUnit_lbl0" xml:lang="en-US">Vesting of restricted share units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_VestingOfRestrictedShareUnit" xlink:to="aapg_VestingOfRestrictedShareUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_VestingOfRestrictedShareUnits_lbl0" xml:lang="en-US">Vesting of restricted share units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_VestingOfRestrictedShareUnits" xlink:to="aapg_VestingOfRestrictedShareUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_WeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted average exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_WeightedAverageExercisePrice" xlink:to="aapg_WeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_WithholdingTax_lbl0" xml:lang="en-US">Withholding tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_WithholdingTax" xlink:to="aapg_WithholdingTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_ChangeInForeignExchangeRatesAxis_lbl0" xml:lang="en-US">Change in foreign exchange rates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ChangeInForeignExchangeRatesAxis" xlink:to="aapg_ChangeInForeignExchangeRatesAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aapg_IfRMBStrengthensAgainstUSDollarsMember_lbl0" xml:lang="en-US">If RMB strengthens against US Dollars.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IfRMBStrengthensAgainstUSDollarsMember" xlink:to="aapg_IfRMBStrengthensAgainstUSDollarsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremium_lbl0" xml:lang="en-US">Share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl0" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_lbl" xml:lang="en-US">Schedule Of Changes In Liabilities Arising From Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="aapg_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipantsTwoMember_lbl0" xml:lang="en-US">Type Of Eligible Participants Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsTwoMember" xlink:to="aapg_TypeOfEligibleParticipantsTwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfInterestRateRiskExplanatory_lbl1" xml:lang="en-US">Disclosure Of Interest Rate Risk Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfInterestRateRiskExplanatory" xlink:to="aapg_DisclosureOfInterestRateRiskExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_lbl0" xml:lang="en-US">Disclosure of reserves within equity [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LiquidityRiskPercentage_lbl1" xml:lang="en-US">Liquidity Risk Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LiquidityRiskPercentage" xlink:to="aapg_LiquidityRiskPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl2" xml:lang="en-US">Liabilities arising from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_lbl1" xml:lang="en-US">Comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants1OneMember_lbl0" xml:lang="en-US">Type Of Eligible Participants1 One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants1OneMember" xlink:to="aapg_TypeOfEligibleParticipants1OneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Other inflows (outflows) of cash, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl0" xml:lang="en-US">Accumulated depreciation and amortisation [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl2" xml:lang="en-US">Interest expense on lease liabilities, financing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_lbl0" xml:lang="en-US">Share of profit (loss) of joint ventures accounted for using equity method, investing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LeaseholdLandMember_lbl0" xml:lang="en-US">Leasehold Land Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseholdLandMember" xlink:to="aapg_LeaseholdLandMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfCapitalManagementExplanatory_lbl1" xml:lang="en-US">Disclosure Of Capital Management Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCapitalManagementExplanatory" xlink:to="aapg_DisclosureOfCapitalManagementExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingExpense_lbl0" xml:lang="en-US">Selling expenses, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingExpense" xlink:to="ifrs-full_SellingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Interest Bearing Bank And Other Borrowings Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" xlink:to="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PatentMember_lbl0" xml:lang="en-US">Patent Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PatentMember" xlink:to="aapg_PatentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfShareCapitalAndTreasurySharesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfShareCapitalAndTreasurySharesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfShareCapitalAndTreasurySharesAbstract_lbl" xml:lang="en-US">Schedule Of Share Capital And Treasury Shares Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfShareCapitalAndTreasurySharesAbstract" xlink:to="aapg_ScheduleOfShareCapitalAndTreasurySharesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetForeignExchangeGain_lbl0" xml:lang="en-US">Net foreign exchange gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeGain" xlink:to="ifrs-full_NetForeignExchangeGain_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory_lbl1" xml:lang="en-US">Description Of Accounting Policy For Contract Liabilities Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" xlink:to="aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherIntangibleAssets_lbl0" xml:lang="en-US">Other intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIntangibleAssets" xlink:to="ifrs-full_OtherIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl0" xml:lang="en-US">Expense from equity-settled share-based payment transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_HK_lbl1" xml:lang="en-US">HONG KONG</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks_lbl1" xml:lang="en-US">Interest income on loans and advances to banks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" xlink:to="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfNonCurrentAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfNonCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfNonCurrentAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Non Current Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfNonCurrentAssetsAbstract" xlink:to="aapg_ScheduleOfNonCurrentAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_lbl0" xml:lang="en-US">Disclosure of major customers [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasuryShares_lbl1" xml:lang="en-US">Treasury shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl0" xml:lang="en-US">Adjustments for depreciation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl0" xml:lang="en-US">Retained earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestatedMember_lbl0" xml:lang="en-US">Currently stated [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestatedMember" xlink:to="ifrs-full_RestatedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory_lbl1" xml:lang="en-US">Disclosure Of Reconciliation Between The Income Tax Expense Credit Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" xlink:to="aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss_lbl1" xml:lang="en-US">Adjustments for decrease (increase) in financial assets measured at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TwoThousandTwentyTwoFurtherGrantMember_lbl0" xml:lang="en-US">Two Thousand Twenty Two Further Grant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyTwoFurtherGrantMember" xlink:to="aapg_TwoThousandTwentyTwoFurtherGrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_lbl0" xml:lang="en-US">Goods or services transferred at point in time [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:to="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfRevenueFromCustomersAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRevenueFromCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfRevenueFromCustomersAbstract_lbl" xml:lang="en-US">Schedule Of Revenue From Customers Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfRevenueFromCustomersAbstract" xlink:to="aapg_ScheduleOfRevenueFromCustomersAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory_lbl1" xml:lang="en-US">Detailed Information About Rightof Use Assets Of Lease Terms And Estimated Useful Lives Of Assets Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" xlink:to="aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IntellectuallPropertyMember_lbl0" xml:lang="en-US">Intellectuall Property Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IntellectuallPropertyMember" xlink:to="aapg_IntellectuallPropertyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl1" xml:lang="en-US">Current prepayments and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfPrincipalSubsidiariesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfPrincipalSubsidiariesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfPrincipalSubsidiariesAbstract_lbl" xml:lang="en-US">Schedule Of Principal Subsidiaries Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfPrincipalSubsidiariesAbstract" xlink:to="aapg_ScheduleOfPrincipalSubsidiariesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants10Member_lbl0" xml:lang="en-US">Type Of Eligible Participants10 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants10Member" xlink:to="aapg_TypeOfEligibleParticipants10Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of other non-current assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl2" xml:lang="en-US">Net deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember_lbl0" xml:lang="en-US">Fair Value Adjustments Arising From Acquisition Of ASubsidiary Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember" xlink:to="aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl0" xml:lang="en-US">Adjustments to reconcile operating profit (loss) [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TimingOfRevenueRecognitionAbstract_lbl0" xml:lang="en-US">Timing Of Revenue Recognition Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TimingOfRevenueRecognitionAbstract" xlink:to="aapg_TimingOfRevenueRecognitionAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AuditorsRemuneration_lbl0" xml:lang="en-US">Auditor&apos;s remuneration, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AuditorsRemuneration" xlink:to="ifrs-full_AuditorsRemuneration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl0" xml:lang="en-US">Disclosure of subsidiaries [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfContractLiabilitiesTextBlock_lbl1" xml:lang="en-US">Disclosure Of Contract Liabilities Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfContractLiabilitiesTextBlock" xlink:to="aapg_DisclosureOfContractLiabilitiesTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_lbl0" xml:lang="en-US">Interest expense on bank loans and overdrafts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:to="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OutstandingBalanceWithRelatedParty_lbl1" xml:lang="en-US">Outstanding Balance With Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OutstandingBalanceWithRelatedParty" xlink:to="aapg_OutstandingBalanceWithRelatedParty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AscentagePharmaGroupIncMember_lbl0" xml:lang="en-US">Ascentage Pharma Group Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AscentagePharmaGroupIncMember" xlink:to="aapg_AscentagePharmaGroupIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract_lbl0" xml:lang="en-US">Other Comprehensive Income For The Year Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Other cash payments to acquire interests in joint ventures, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:to="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_lbl0" xml:lang="en-US">Other current borrowings and current portion of other non-current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:to="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl0" xml:lang="en-US">Deductible temporary differences for which no deferred tax asset is recognised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl3" xml:lang="en-US">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TitleOfNewIFRS_lbl0" xml:lang="en-US">Title of new IFRS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TitleOfNewIFRS" xlink:to="ifrs-full_TitleOfNewIFRS_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCashAndBankBalancesExplanatory_lbl1" xml:lang="en-US">Schedule Of Cash And Bank Balances Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCashAndBankBalancesExplanatory" xlink:to="aapg_ScheduleOfCashAndBankBalancesExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherPayablesAndAccruals_lbl1" xml:lang="en-US">Other Payables And Accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherPayablesAndAccruals" xlink:to="aapg_OtherPayablesAndAccruals_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SimplifiedApproachMember_lbl0" xml:lang="en-US">Simplified Approach Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SimplifiedApproachMember" xlink:to="aapg_SimplifiedApproachMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfDeferredIncomeTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Deferred Income Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfDeferredIncomeTableTextBlock" xlink:to="aapg_ScheduleOfDeferredIncomeTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl1" xml:lang="en-US">Gross carrying amount [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Increase (decrease) through transfers, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl0" xml:lang="en-US">Weighted average share price, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCashAndBankBalancesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCashAndBankBalancesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCashAndBankBalancesAbstract_lbl" xml:lang="en-US">Schedule Of Cash And Bank Balances Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCashAndBankBalancesAbstract" xlink:to="aapg_ScheduleOfCashAndBankBalancesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentContractLiabilities_lbl0" xml:lang="en-US">Non-current contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentContractLiabilities" xlink:to="ifrs-full_NoncurrentContractLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TradeReceivablesWithin45DaysMember_lbl0" xml:lang="en-US">Trade Receivables Within45 Days Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TradeReceivablesWithin45DaysMember" xlink:to="aapg_TradeReceivablesWithin45DaysMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PreIPOShareOptionExpenses_lbl1" xml:lang="en-US">Pre IPOShare Option Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreIPOShareOptionExpenses" xlink:to="aapg_PreIPOShareOptionExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSalesRoomOccupancyServices_lbl0" xml:lang="en-US">Cost of sales, room occupancy services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSalesRoomOccupancyServices" xlink:to="ifrs-full_CostOfSalesRoomOccupancyServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ContractAcquisitionCosts_lbl1" xml:lang="en-US">Contract Acquisition Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ContractAcquisitionCosts" xlink:to="aapg_ContractAcquisitionCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for leases [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CurrentAbstract0_lbl0" xml:lang="en-US">Current Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentAbstract0" xlink:to="aapg_CurrentAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl0" xml:lang="en-US">Disclosure of classes of share capital [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipantsSixMember_lbl0" xml:lang="en-US">Type Of Eligible Participants Six Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsSixMember" xlink:to="aapg_TypeOfEligibleParticipantsSixMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AtFairValueMember_lbl0" xml:lang="en-US">At fair value [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AtFairValueMember" xlink:to="ifrs-full_AtFairValueMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCompanySReservesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCompanySReservesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCompanySReservesAbstract_lbl" xml:lang="en-US">Schedule Of Company SReserves Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCompanySReservesAbstract" xlink:to="aapg_ScheduleOfCompanySReservesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueAbstract_lbl1" xml:lang="en-US">Revenue [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueAbstract" xlink:to="ifrs-full_RevenueAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Other Intangible Asset Explanatory Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" xlink:to="aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl1" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IFRSNineteenMember_lbl0" xml:lang="en-US">IFRSNineteen Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IFRSNineteenMember" xlink:to="aapg_IFRSNineteenMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture_lbl1" xml:lang="en-US">Aggregate Carrying Amount Of The Groups Investment In The Joint Venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" xlink:to="aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl0" xml:lang="en-US">Key management personnel compensation, short-term employee benefits, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RecognizedAsIncomeDuringTheYear_lbl1" xml:lang="en-US">Recognized As Income During The Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RecognizedAsIncomeDuringTheYear" xlink:to="aapg_RecognizedAsIncomeDuringTheYear_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of profit (loss) from operating activities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:to="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory_lbl0" xml:lang="en-US">Disclosure of government grants [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:to="ifrs-full_DisclosureOfGovernmentGrantsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherIncome_lbl1" xml:lang="en-US">Other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_lbl0" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicencesAndFranchisesMember_lbl0" xml:lang="en-US">Licences and franchises [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesAndFranchisesMember" xlink:to="ifrs-full_LicencesAndFranchisesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate_lbl0" xml:lang="en-US">Tax effect from change in tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:to="ifrs-full_TaxEffectFromChangeInTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OnDemandMember_lbl0" xml:lang="en-US">On demand [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OnDemandMember" xlink:to="ifrs-full_OnDemandMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NonExecutiveDirectorMember_lbl0" xml:lang="en-US">Non Executive Director Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonExecutiveDirectorMember" xlink:to="aapg_NonExecutiveDirectorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_HighAndNewTechnologyEnterpriseMember_lbl0" xml:lang="en-US">High And New Technology Enterprise Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_HighAndNewTechnologyEnterpriseMember" xlink:to="aapg_HighAndNewTechnologyEnterpriseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FutureTaxableProfitsPercentage_lbl1" xml:lang="en-US">Future Taxable Profits Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FutureTaxableProfitsPercentage" xlink:to="aapg_FutureTaxableProfitsPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CapitalAndReservesMember_lbl0" xml:lang="en-US">Capital And Reserves Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalAndReservesMember" xlink:to="aapg_CapitalAndReservesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfContractLiabilitiesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfContractLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfContractLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Contract Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfContractLiabilitiesAbstract" xlink:to="aapg_ScheduleOfContractLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_BankLoansSecuredMember_lbl0" xml:lang="en-US">Bank Loans Secured Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BankLoansSecuredMember" xlink:to="aapg_BankLoansSecuredMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Goodwill_lbl1" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReserves_lbl0" xml:lang="en-US">Other reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReserves" xlink:to="ifrs-full_OtherReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl1" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl1" xml:lang="en-US">Profit (loss), attributable to owners of parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfMovementsInDeferredTaxAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfMovementsInDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfMovementsInDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Movements In Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfMovementsInDeferredTaxAssetsAbstract" xlink:to="aapg_ScheduleOfMovementsInDeferredTaxAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl0" xml:lang="en-US">Deferred tax expense (income) recognised in profit or loss, income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember_lbl0" xml:lang="en-US">Interestbearing Bank And Other Borrowings Excluding Lease Liabilities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember" xlink:to="aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfLiquidityRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfLiquidityRiskAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfLiquidityRiskAbstract_lbl" xml:lang="en-US">Schedule Of Liquidity Risk Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfLiquidityRiskAbstract" xlink:to="aapg_ScheduleOfLiquidityRiskAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl2" xml:lang="en-US">Par value per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl1" xml:lang="en-US">Current financial assets at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory_lbl1" xml:lang="en-US">Disclosure Of Detailed Information About Property Plant And Equipment Of Annual Rate Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" xlink:to="aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for impairment of assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember_lbl0" xml:lang="en-US">Amendments To IFRSNine And IFRSSeven One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember" xlink:to="aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ListedEquityInvestmentsAtFairValue_lbl1" xml:lang="en-US">Listed Equity Investments At Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ListedEquityInvestmentsAtFairValue" xlink:to="aapg_ListedEquityInvestmentsAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl2" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DeferredIncomeNonCurrent_lbl1" xml:lang="en-US">Deferred Income Non Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredIncomeNonCurrent" xlink:to="aapg_DeferredIncomeNonCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LongTermAdvancesRecognizedFromCustomersAbstract_lbl0" xml:lang="en-US">Long Term Advances Recognized From Customers Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LongTermAdvancesRecognizedFromCustomersAbstract" xlink:to="aapg_LongTermAdvancesRecognizedFromCustomersAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_lbl0" xml:lang="en-US">Adjustments for gains (losses) on change in fair value of derivatives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfForeignCurrencyRiskExplanatory_lbl1" xml:lang="en-US">Disclosure Of Foreign Currency Risk Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfForeignCurrencyRiskExplanatory" xlink:to="aapg_DisclosureOfForeignCurrencyRiskExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl0" xml:lang="en-US">Disclosure of revenue from contracts with customers [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AtAPointInTimeAbstract_lbl0" xml:lang="en-US">At APoint In Time Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AtAPointInTimeAbstract" xlink:to="aapg_AtAPointInTimeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense_lbl0" xml:lang="en-US">Adjustments for amortisation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl0" xml:lang="en-US">Key management personnel compensation, post-employment benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for finance income and costs [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfUnlockingDateAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfUnlockingDateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfUnlockingDateAbstract_lbl" xml:lang="en-US">Schedule Of Unlocking Date Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfUnlockingDateAbstract" xlink:to="aapg_ScheduleOfUnlockingDateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OfficeEquipmentMember_lbl0" xml:lang="en-US">Office equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OfficeEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_lbl0" xml:lang="en-US">Disclosure of financial instruments at fair value through profit or loss [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Current liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl0" xml:lang="en-US">Disclosure of earnings per share [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl0" xml:lang="en-US">Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DrYangMember_lbl0" xml:lang="en-US">Dr Yang Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DrYangMember" xlink:to="aapg_DrYangMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract_lbl" xml:lang="en-US">Schedule Of Credit Quality And Maximum Exposure To Credit Risk Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract" xlink:to="aapg_ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_lbl0" xml:lang="en-US">Later than one year and not later than two years [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashEquivalentsAbstract_lbl0" xml:lang="en-US">Cash equivalents [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashEquivalentsAbstract" xlink:to="ifrs-full_CashEquivalentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl0" xml:lang="en-US">Discount rate applied to cash flow projections</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl0" xml:lang="en-US">Disclosure of entity&apos;s operating segments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_EquitySettledShareBasedPaymentsAbstract_lbl0" xml:lang="en-US">Equity Settled Share Based Payments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EquitySettledShareBasedPaymentsAbstract" xlink:to="aapg_EquitySettledShareBasedPaymentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock_lbl1" xml:lang="en-US">Disclosure Of Other Payables And Accruals Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock" xlink:to="aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets_lbl1" xml:lang="en-US">Other non-current financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialAssets" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SharesConsiderationAmount_lbl1" xml:lang="en-US">Shares Consideration Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharesConsiderationAmount" xlink:to="aapg_SharesConsiderationAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Inventories_lbl1" xml:lang="en-US">Current inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LloanPrimeRateMember_lbl0" xml:lang="en-US">Lloan Prime Rate Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LloanPrimeRateMember" xlink:to="aapg_LloanPrimeRateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentValueAddedTaxReceivables_lbl0" xml:lang="en-US">Non-current value added tax receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:to="ifrs-full_NoncurrentValueAddedTaxReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AdditionalOrdinaryShares_lbl1" xml:lang="en-US">Additional Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdditionalOrdinaryShares" xlink:to="aapg_AdditionalOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_a2025Abstract_lbl0" xml:lang="en-US">a2025 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_a2025Abstract" xlink:to="aapg_a2025Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl0" xml:lang="en-US">Proceeds from exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory_lbl0" xml:lang="en-US">Disclosure of inventories [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfPledgeOfAssetsExplanatory_lbl1" xml:lang="en-US">Disclosure Of Pledge Of Assets Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfPledgeOfAssetsExplanatory" xlink:to="aapg_DisclosureOfPledgeOfAssetsExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl0" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfTransactionWithRelatedPartyAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTransactionWithRelatedPartyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfTransactionWithRelatedPartyAbstract_lbl" xml:lang="en-US">Schedule Of Transaction With Related Party Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfTransactionWithRelatedPartyAbstract" xlink:to="aapg_ScheduleOfTransactionWithRelatedPartyAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfDeferredTaxAssetsExplanatory_lbl1" xml:lang="en-US">Disclosure Of Deferred Tax Assets Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDeferredTaxAssetsExplanatory" xlink:to="aapg_DisclosureOfDeferredTaxAssetsExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForFinanceCosts_lbl0" xml:lang="en-US">Adjustments for finance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFinanceCosts" xlink:to="ifrs-full_AdjustmentsForFinanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilities_lbl2" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Losses on disposals of property, plant and equipment, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:to="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_WeightedAverageExercisePrice_lbl1" xml:lang="en-US">Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_WeightedAverageExercisePrice" xlink:to="aapg_WeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember_lbl0" xml:lang="en-US">Two Thousand Eighteen And Two Thousand Twenty Two RSUScheme Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember" xlink:to="aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ExchangeRealignments_lbl1" xml:lang="en-US">Exchange Realignments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ExchangeRealignments" xlink:to="aapg_ExchangeRealignments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">Financial liabilities at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl0" xml:lang="en-US">Key management personnel compensation, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCondensedStatementsOfCashFlowsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCondensedStatementsOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCondensedStatementsOfCashFlowsAbstract_lbl" xml:lang="en-US">Schedule Of Condensed Statements Of Cash Flows Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCondensedStatementsOfCashFlowsAbstract" xlink:to="aapg_ScheduleOfCondensedStatementsOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl0" xml:lang="en-US">Increase (decrease) through exercise of options, equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureExplanatory_lbl0" xml:lang="en-US">Disclosure of credit risk exposure [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:to="ifrs-full_DisclosureOfCreditRiskExposureExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for borrowing costs [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InvestmentInOtherFinancialAssets_lbl1" xml:lang="en-US">Investment In Other Financial Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentInOtherFinancialAssets" xlink:to="aapg_InvestmentInOtherFinancialAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl0" xml:lang="en-US">Share of total comprehensive income of associates and joint ventures accounted for using equity method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of fair value measurement of assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_lbl2" xml:lang="en-US">Restricted cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember_lbl0" xml:lang="en-US">Level 1 of fair value hierarchy [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level1OfFairValueHierarchyMember" xlink:to="ifrs-full_Level1OfFairValueHierarchyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_HealthquestPharmaAcquisitionAgreementMember_lbl0" xml:lang="en-US">Healthquest Pharma Acquisition Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_HealthquestPharmaAcquisitionAgreementMember" xlink:to="aapg_HealthquestPharmaAcquisitionAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl1" xml:lang="en-US">Trade and other current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod_lbl0" xml:lang="en-US">Explanation of financial effect of non-adjusting event after reporting period [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod" xlink:to="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccruedInterestInOtherPayablesAndAccrualsMember_lbl0" xml:lang="en-US">Accrued Interest In Other Payables And Accruals Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccruedInterestInOtherPayablesAndAccrualsMember" xlink:to="aapg_AccruedInterestInOtherPayablesAndAccrualsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember_lbl0" xml:lang="en-US">Current Portion Of Long Term Bank Loans Unsecured One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember" xlink:to="aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock_lbl1" xml:lang="en-US">Schedule Of Fair Values Of Share Options Granted Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" xlink:to="aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SecondAnniversaryMember_lbl0" xml:lang="en-US">Second Anniversary Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SecondAnniversaryMember" xlink:to="aapg_SecondAnniversaryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DepreciationChargeofRightofuseAssets_lbl1" xml:lang="en-US">Depreciation Chargeof Rightofuse Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DepreciationChargeofRightofuseAssets" xlink:to="aapg_DepreciationChargeofRightofuseAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfEquityPriceRiskExplanatory_lbl1" xml:lang="en-US">Disclosure Of Equity Price Risk Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfEquityPriceRiskExplanatory" xlink:to="aapg_DisclosureOfEquityPriceRiskExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl0" xml:lang="en-US">Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl0" xml:lang="en-US">Equity [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl1" xml:lang="en-US">Issued capital [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_VestingOfRestrictedShareUnits_lbl1" xml:lang="en-US">Vesting Of Restricted Share Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_VestingOfRestrictedShareUnits" xlink:to="aapg_VestingOfRestrictedShareUnits_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfOtherIntangibleAssetAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherIntangibleAssetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfOtherIntangibleAssetAbstract_lbl" xml:lang="en-US">Schedule Of Other Intangible Asset Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherIntangibleAssetAbstract" xlink:to="aapg_ScheduleOfOtherIntangibleAssetAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IssueOfOrdinaryShares_lbl1" xml:lang="en-US">Issue Of Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfOrdinaryShares" xlink:to="aapg_IssueOfOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits_lbl1" xml:lang="en-US">Stock Issued During Period Value Vesting Of Restricted Share Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" xlink:to="aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfNewAndRevisedIfrssAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfNewAndRevisedIfrssAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfNewAndRevisedIfrssAbstract_lbl" xml:lang="en-US">Schedule Of New And Revised Ifrss Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfNewAndRevisedIfrssAbstract" xlink:to="aapg_ScheduleOfNewAndRevisedIfrssAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Contingent consideration recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccumulatedImpairmentGoodwill_lbl1" xml:lang="en-US">Accumulated Impairment Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccumulatedImpairmentGoodwill" xlink:to="aapg_AccumulatedImpairmentGoodwill_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfAssetsMeasuredAtFairValueAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfAssetsMeasuredAtFairValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfAssetsMeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Schedule Of Assets Measured At Fair Value Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfAssetsMeasuredAtFairValueAbstract" xlink:to="aapg_ScheduleOfAssetsMeasuredAtFairValueAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl0" xml:lang="en-US">Gains (losses) on exchange differences on translation of foreign operations, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PercentageOfExceedShareCapital_lbl1" xml:lang="en-US">Percentage Of Exceed Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfExceedShareCapital" xlink:to="aapg_PercentageOfExceedShareCapital_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract_lbl" xml:lang="en-US">Schedule Of Weighted Average Interest Rate For The Outstanding Short Term Bank Loans Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract" xlink:to="aapg_ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfRightOfUseAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRightOfUseAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfRightOfUseAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Right Of Use Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfRightOfUseAssetsAbstract" xlink:to="aapg_ScheduleOfRightOfUseAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OrdinarySharesMember_lbl0" xml:lang="en-US">Ordinary shares [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LowerTaxRateForASpecificEntity_lbl1" xml:lang="en-US">Lower Tax Rate For ASpecific Entity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LowerTaxRateForASpecificEntity" xlink:to="aapg_LowerTaxRateForASpecificEntity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl0" xml:lang="en-US">Tax effect of expense not deductible in determining taxable profit (tax loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnBorrowings_lbl0" xml:lang="en-US">Interest expense on borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnBorrowings" xlink:to="ifrs-full_InterestExpenseOnBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl1" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Lease Liabilities Explanatory Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" xlink:to="aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl1" xml:lang="en-US">Profit (loss) before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ResearchAndDevelopmentSuperdeduction_lbl1" xml:lang="en-US">Research And Development Superdeduction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ResearchAndDevelopmentSuperdeduction" xlink:to="aapg_ResearchAndDevelopmentSuperdeduction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AdjustmentsForDepreciationOfRightofuseAssets_lbl1" xml:lang="en-US">Adjustments For Depreciation Of Rightofuse Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForDepreciationOfRightofuseAssets" xlink:to="aapg_AdjustmentsForDepreciationOfRightofuseAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TwoThousandTwentyTwoRSUchemeMember_lbl0" xml:lang="en-US">Two Thousand Twenty Two RSUcheme Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyTwoRSUchemeMember" xlink:to="aapg_TwoThousandTwentyTwoRSUchemeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InvestmentsListedInAbstract0_lbl0" xml:lang="en-US">Investments Listed In Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentsListedInAbstract0" xlink:to="aapg_InvestmentsListedInAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_lbl1" xml:lang="en-US">Gains (losses) on change in fair value of derivatives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfForeignCurrencyRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfForeignCurrencyRiskAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfForeignCurrencyRiskAbstract_lbl" xml:lang="en-US">Schedule Of Foreign Currency Risk Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfForeignCurrencyRiskAbstract" xlink:to="aapg_ScheduleOfForeignCurrencyRiskAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ListingExpensePaid_lbl1" xml:lang="en-US">Listing Expense Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ListingExpensePaid" xlink:to="aapg_ListingExpensePaid_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_EmployeesShareBasedCompensationSchemeAbstract1_lbl0" xml:lang="en-US">Employees Share Based Compensation Scheme Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EmployeesShareBasedCompensationSchemeAbstract1" xlink:to="aapg_EmployeesShareBasedCompensationSchemeAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_EmployeesShareBasedCompensationSchemeAbstract0_lbl0" xml:lang="en-US">Employees Share Based Compensation Scheme Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EmployeesShareBasedCompensationSchemeAbstract0" xlink:to="aapg_EmployeesShareBasedCompensationSchemeAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IssuedShareCapital_lbl3" xml:lang="en-US">Issued Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssuedShareCapital" xlink:to="aapg_IssuedShareCapital_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReceivables_lbl0" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicencesMember_lbl0" xml:lang="en-US">Licences [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesMember" xlink:to="ifrs-full_LicencesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_lbl0" xml:lang="en-US">Disclosure of range of exercise prices of outstanding share options [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherExpenseByNature_lbl2" xml:lang="en-US">Other expenses, by nature</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_OtherExpenseByNature_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LeaseTerms_lbl1" xml:lang="en-US">Lease Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseTerms" xlink:to="aapg_LeaseTerms_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_Penalty_lbl1" xml:lang="en-US">Penalty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Penalty" xlink:to="aapg_Penalty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NonCurrentAbstract0_lbl0" xml:lang="en-US">Non Current Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCurrentAbstract0" xlink:to="aapg_NonCurrentAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember_lbl0" xml:lang="en-US">Level 2 of fair value hierarchy [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypesOfGoodsOrServicesMember_lbl0" xml:lang="en-US">Types Of Goods Or Services Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypesOfGoodsOrServicesMember" xlink:to="aapg_TypesOfGoodsOrServicesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockPurchasedDuringPeriodShares_lbl1" xml:lang="en-US">Stock Purchased During Period Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockPurchasedDuringPeriodShares" xlink:to="aapg_StockPurchasedDuringPeriodShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TwoThousandEighteenRSUSchemeMember_lbl0" xml:lang="en-US">Two Thousand Eighteen RSUScheme Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandEighteenRSUSchemeMember" xlink:to="aapg_TwoThousandEighteenRSUSchemeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_WithinOneMonthMember_lbl0" xml:lang="en-US">Within One Month Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_WithinOneMonthMember" xlink:to="aapg_WithinOneMonthMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory_lbl0" xml:lang="en-US">Disclosure of cash and bank balances at central banks [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl0" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of other equity instruments granted in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_EquitySettledShareBasedPaymentsAbstract1_lbl0" xml:lang="en-US">Equity Settled Share Based Payments Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EquitySettledShareBasedPaymentsAbstract1" xlink:to="aapg_EquitySettledShareBasedPaymentsAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants9Member_lbl0" xml:lang="en-US">Type Of Eligible Participants9 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants9Member" xlink:to="aapg_TypeOfEligibleParticipants9Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncomeTaxComputedAtTheStatutoryTaxRate_lbl1" xml:lang="en-US">Income Tax Computed At The Statutory Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeTaxComputedAtTheStatutoryTaxRate" xlink:to="aapg_IncomeTaxComputedAtTheStatutoryTaxRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl1" xml:lang="en-US">Current portion of non-current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_EquitySettledShareBasedPaymentsAbstract0_lbl0" xml:lang="en-US">Equity Settled Share Based Payments Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EquitySettledShareBasedPaymentsAbstract0" xlink:to="aapg_EquitySettledShareBasedPaymentsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PostIPOOptionSchemeMember_lbl0" xml:lang="en-US">Post IPOOption Scheme Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PostIPOOptionSchemeMember" xlink:to="aapg_PostIPOOptionSchemeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncreasedecreaseWeakensAgainst_lbl1" xml:lang="en-US">Increasedecrease Weakens Against</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseWeakensAgainst" xlink:to="aapg_IncreasedecreaseWeakensAgainst_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement_lbl1" xml:lang="en-US">Percentage Of Vesting Requirements For Sharebased Payment Arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement" xlink:to="aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl1" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates reported in separate financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfPropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Schedule Of Property Plant And Equipment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:to="aapg_ScheduleOfPropertyPlantAndEquipmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TermsOfLandLease_lbl1" xml:lang="en-US">Terms Of Land Lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TermsOfLandLease" xlink:to="aapg_TermsOfLandLease_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipantsThreeMember_lbl0" xml:lang="en-US">Type Of Eligible Participants Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsThreeMember" xlink:to="aapg_TypeOfEligibleParticipantsThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSales_lbl0" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_BankLoansUnsecuredOneMember_lbl0" xml:lang="en-US">Bank Loans Unsecured One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BankLoansUnsecuredOneMember" xlink:to="aapg_BankLoansUnsecuredOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl0" xml:lang="en-US">Share of profit (loss) of associates and joint ventures accounted for using equity method, investing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl1" xml:lang="en-US">Research and development expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_MonetaryAssetsMember_lbl0" xml:lang="en-US">Monetary Assets Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_MonetaryAssetsMember" xlink:to="aapg_MonetaryAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for derivative financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_lbl2" xml:lang="en-US">Profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants2ThreeMember_lbl0" xml:lang="en-US">Type Of Eligible Participants2 Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants2ThreeMember" xlink:to="aapg_TypeOfEligibleParticipants2ThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Adjustments for gain (loss) on disposals, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl0" xml:lang="en-US">Current provisions for employee benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestrictedShareUnitsMember_lbl1" xml:lang="en-US">Restricted share units [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedShareUnitsMember" xlink:to="ifrs-full_RestrictedShareUnitsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfUnlockingDatetextBlock_lbl1" xml:lang="en-US">Disclosure Of Unlocking Datetext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfUnlockingDatetextBlock" xlink:to="aapg_DisclosureOfUnlockingDatetextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NonCurrentAbstract_lbl0" xml:lang="en-US">Non Current Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCurrentAbstract" xlink:to="aapg_NonCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_lbl4" xml:lang="en-US">Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl1" xml:lang="en-US">Other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialLiabilitiesAtFVTPL_lbl1" xml:lang="en-US">Financial Liabilities At FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesAtFVTPL" xlink:to="aapg_FinancialLiabilitiesAtFVTPL_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity_lbl1" xml:lang="en-US">Increase Decrease In Time Deposits With Original Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity" xlink:to="aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ForeignExchangeLoss_lbl0" xml:lang="en-US">Foreign exchange loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ForeignExchangeLoss" xlink:to="ifrs-full_ForeignExchangeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract_lbl" xml:lang="en-US">Schedule Of Intangible Assets Are Amortized On The Straight Line Basis Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract" xlink:to="aapg_ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FurnitureAndEquipmentMember_lbl0" xml:lang="en-US">Furniture And Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FurnitureAndEquipmentMember" xlink:to="aapg_FurnitureAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl0" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RentalIncome_lbl0" xml:lang="en-US">Rental income, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RentalIncome" xlink:to="ifrs-full_RentalIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory_lbl1" xml:lang="en-US">Disclosureof Other Payables And Accruals Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory" xlink:to="aapg_DisclosureofOtherPayablesAndAccrualsExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TradePayablesMember_lbl0" xml:lang="en-US">Trade Payables Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TradePayablesMember" xlink:to="aapg_TradePayablesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl3" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl0" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromGovernmentGrants_lbl1" xml:lang="en-US">Income from government grants, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromGovernmentGrants" xlink:to="ifrs-full_RevenueFromGovernmentGrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests_lbl0" xml:lang="en-US">Proceeds from contributions of non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:to="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssetsMember_lbl1" xml:lang="en-US">Right-of-use assets [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsMember" xlink:to="ifrs-full_RightofuseAssetsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherGainsLosses_lbl1" xml:lang="en-US">Other gains (losses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherGainsLosses" xlink:to="ifrs-full_OtherGainsLosses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Gains on disposals of property, plant and equipment, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:to="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_CNY_lbl0" xml:lang="en-US">China, Yuan Renminbi</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_CNY" xlink:to="currency_CNY_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl0" xml:lang="en-US">Country of incorporation of subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl0" xml:lang="en-US">Other non-current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ConsolidatedStatementsOfChangesInEquityAbstract" xlink:href="aapg-20251231.xsd#aapg_ConsolidatedStatementsOfChangesInEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ConsolidatedStatementsOfChangesInEquityAbstract_lbl" xml:lang="en-US">Consolidated Statements Of Changes In Equity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ConsolidatedStatementsOfChangesInEquityAbstract" xlink:to="aapg_ConsolidatedStatementsOfChangesInEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Proceeds from borrowings, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract_lbl" xml:lang="en-US">Schedule Of Exercise Prices And Exercise Periods Of Share Options Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract" xlink:to="aapg_ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_lbl0" xml:lang="en-US">Reclassification adjustments on exchange differences on translation of foreign operations, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation_lbl0" xml:lang="en-US">Other comprehensive income, before tax, exchange differences on translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisposalsLeaseLiabilities_lbl1" xml:lang="en-US">Disposals Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisposalsLeaseLiabilities" xlink:to="aapg_DisposalsLeaseLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants7Member_lbl0" xml:lang="en-US">Type Of Eligible Participants7 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants7Member" xlink:to="aapg_TypeOfEligibleParticipants7Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Acquisitions through business combinations, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract_lbl" xml:lang="en-US">Schedule Of Share Options Outstanding Under Pre Ipo Share Option Scheme Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract" xlink:to="aapg_ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl3" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">Non-current financial liabilities at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AllottedSharesPricePerShares_lbl1" xml:lang="en-US">Allotted Shares Price Per Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AllottedSharesPricePerShares" xlink:to="aapg_AllottedSharesPricePerShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TaxCredits_lbl1" xml:lang="en-US">Tax Credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TaxCredits" xlink:to="aapg_TaxCredits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SharesGranted_lbl1" xml:lang="en-US">Shares Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharesGranted" xlink:to="aapg_SharesGranted_lbl1"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OthersExpenses_lbl1" xml:lang="en-US">Others Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OthersExpenses" xlink:to="aapg_OthersExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PercentageOfVestedConditionalShares_lbl2" xml:lang="en-US">Percentage Of Vested Conditional Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfVestedConditionalShares" xlink:to="aapg_PercentageOfVestedConditionalShares_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember_lbl0" xml:lang="en-US">Financial Liabilities Included In Other Payables And Accruals Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember" xlink:to="aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPrepayments_lbl0" xml:lang="en-US">Non-current prepayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPrepayments" xlink:to="ifrs-full_NoncurrentPrepayments_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfStatementsOfFinancialPositionAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfStatementsOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfStatementsOfFinancialPositionAbstract_lbl" xml:lang="en-US">Schedule Of Statements Of Financial Position Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfStatementsOfFinancialPositionAbstract" xlink:to="aapg_ScheduleOfStatementsOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl1" xml:lang="en-US">Issued capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl0" xml:lang="en-US">Description of accounting policy for government grants [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseholdImprovementsMember_lbl0" xml:lang="en-US">Leasehold improvements [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseholdImprovementsMember" xlink:to="ifrs-full_LeaseholdImprovementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceCostExplanatory_lbl0" xml:lang="en-US">Disclosure of finance cost [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceCostExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory_lbl1" xml:lang="en-US">Disclosureof Outstanding Balance With Related Party Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" xlink:to="aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CurrentAbstract_lbl0" xml:lang="en-US">Current Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentAbstract" xlink:to="aapg_CurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl0" xml:lang="en-US">Disclosure of cash flow statement [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:to="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_UnrecognizedTaxBenefitsRecognized_lbl1" xml:lang="en-US">Unrecognized Tax Benefits Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UnrecognizedTaxBenefitsRecognized" xlink:to="aapg_UnrecognizedTaxBenefitsRecognized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_a2024Abstract_lbl0" xml:lang="en-US">a2024 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_a2024Abstract" xlink:to="aapg_a2024Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PropertyAndEquipmentCost_lbl1" xml:lang="en-US">Property And Equipment Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PropertyAndEquipmentCost" xlink:to="aapg_PropertyAndEquipmentCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl0" xml:lang="en-US">Disclosure of joint ventures [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Based On The Invoice Date And Net Of Loss Allowance Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" xlink:to="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments_lbl0" xml:lang="en-US">Description of factors used to identify entity&apos;s reportable segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments" xlink:to="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_lbl0" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AdjustmentsForGainOnDisposalOfLeases_lbl2" xml:lang="en-US">Adjustments For Gain On Disposal Of Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForGainOnDisposalOfLeases" xlink:to="aapg_AdjustmentsForGainOnDisposalOfLeases_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of contingent liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory_lbl1" xml:lang="en-US">Disclosure Of Cash Outflow For Leases Included In The Statement Of Cash Flows Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" xlink:to="aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReceivablesDueFromAssociates_lbl0" xml:lang="en-US">Receivables due from associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReceivablesDueFromAssociates" xlink:to="ifrs-full_ReceivablesDueFromAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRate_lbl0" xml:lang="en-US">Borrowings, interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MotorVehiclesMember_lbl0" xml:lang="en-US">Motor vehicles [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MotorVehiclesMember" xlink:to="ifrs-full_MotorVehiclesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpense_lbl0" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl2" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PreferentialRate_lbl1" xml:lang="en-US">Preferential Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreferentialRate" xlink:to="aapg_PreferentialRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl0" xml:lang="en-US">Transaction price allocated to remaining performance obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivativesAbstract_lbl0" xml:lang="en-US">Gains (losses) on change in fair value of derivatives [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnChangeInFairValueOfDerivativesAbstract" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivativesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentGovernmentGrants_lbl0" xml:lang="en-US">Current government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentGovernmentGrants" xlink:to="ifrs-full_CurrentGovernmentGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OthersMember_lbl1" xml:lang="en-US">Others Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OthersMember" xlink:to="aapg_OthersMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for transactions with related parties [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_Penaltys_lbl1" xml:lang="en-US">Penaltys</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Penaltys" xlink:to="aapg_Penaltys_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFairValuesOfTheEquityInvestmentsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFairValuesOfTheEquityInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfFairValuesOfTheEquityInvestmentsAbstract_lbl" xml:lang="en-US">Schedule Of Fair Values Of The Equity Investments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfFairValuesOfTheEquityInvestmentsAbstract" xlink:to="aapg_ScheduleOfFairValuesOfTheEquityInvestmentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NonCashAdditionsToPropertyPlantAndEquipment_lbl1" xml:lang="en-US">Non Cash Additions To Property Plant And Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCashAdditionsToPropertyPlantAndEquipment" xlink:to="aapg_NonCashAdditionsToPropertyPlantAndEquipment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremiumMember_lbl0" xml:lang="en-US">Share premium [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl0" xml:lang="en-US">Disclosure of basis of consolidation [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Movements In Deferred Tax Liabilities And Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract" xlink:to="aapg_ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IfRMBStrengthensAgainstUSDollarsMember_lbl1" xml:lang="en-US">If RMBStrengthens Against USDollars Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IfRMBStrengthensAgainstUSDollarsMember" xlink:to="aapg_IfRMBStrengthensAgainstUSDollarsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl2" xml:lang="en-US">Non-current financial assets at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesMember_lbl0" xml:lang="en-US">Lease liabilities [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TotalAmountofRecognizedInProfitOrLoss_lbl1" xml:lang="en-US">Total Amountof Recognized In Profit Or Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TotalAmountofRecognizedInProfitOrLoss" xlink:to="aapg_TotalAmountofRecognizedInProfitOrLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncreasedecreaseInLossBeforeTax_lbl1" xml:lang="en-US">Increasedecrease In Loss Before Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseInLossBeforeTax" xlink:to="aapg_IncreasedecreaseInLossBeforeTax_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RepurchaseOfOrdinaryShares_lbl1" xml:lang="en-US">Repurchase Of Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RepurchaseOfOrdinaryShares" xlink:to="aapg_RepurchaseOfOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ThreeToSixMonthsMember_lbl0" xml:lang="en-US">Three To Six Months Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ThreeToSixMonthsMember" xlink:to="aapg_ThreeToSixMonthsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BuildingsMember_lbl0" xml:lang="en-US">Buildings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NumberOfGrantees_lbl1" xml:lang="en-US">Number Of Grantees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfGrantees" xlink:to="aapg_NumberOfGrantees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRateBasis_lbl1" xml:lang="en-US">Borrowings, interest rate basis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRateBasis" xlink:to="ifrs-full_BorrowingsInterestRateBasis_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockIssuedDuringPeriodValueShareOptionExpenses_lbl1" xml:lang="en-US">Stock Issued During Period Value Share Option Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueShareOptionExpenses" xlink:to="aapg_StockIssuedDuringPeriodValueShareOptionExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_BonusDueToEmployeesAmount_lbl1" xml:lang="en-US">Bonus Due To Employees Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BonusDueToEmployeesAmount" xlink:to="aapg_BonusDueToEmployeesAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl2" xml:lang="en-US">Increase (decrease) in number of ordinary shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_GuangzhouHealthquestPharmaCoLtdMember_lbl0" xml:lang="en-US">Guangzhou Healthquest Pharma Co Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GuangzhouHealthquestPharmaCoLtdMember" xlink:to="aapg_GuangzhouHealthquestPharmaCoLtdMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ChangeInForeignExchangeRatesAxis_lbl1" xml:lang="en-US">Change In Foreign Exchange Rates Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ChangeInForeignExchangeRatesAxis" xlink:to="aapg_ChangeInForeignExchangeRatesAxis_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfOtherExpensesTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Other Expenses Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherExpensesTableTextBlock" xlink:to="aapg_ScheduleOfOtherExpensesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareOptionSchemeMember_lbl0" xml:lang="en-US">Share Option Scheme Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareOptionSchemeMember" xlink:to="aapg_ShareOptionSchemeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DrYangDajunMember_lbl0" xml:lang="en-US">Dr Yang Dajun Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DrYangDajunMember" xlink:to="aapg_DrYangDajunMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AtDecember312024Abstract_lbl0" xml:lang="en-US">At December312024 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AtDecember312024Abstract" xlink:to="aapg_AtDecember312024Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTradeReceivables_lbl0" xml:lang="en-US">Current trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares_lbl2" xml:lang="en-US">Issued capital, ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalOrdinaryShares" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PrepaymentsForClinicalTrialExpenses_lbl1" xml:lang="en-US">Prepayments For Clinical Trial Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrepaymentsForClinicalTrialExpenses" xlink:to="aapg_PrepaymentsForClinicalTrialExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NumberOfNewlyIssuedShares_lbl1" xml:lang="en-US">Number Of Newly Issued Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfNewlyIssuedShares" xlink:to="aapg_NumberOfNewlyIssuedShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember_lbl0" xml:lang="en-US">Suzhou Shenghe Innovation Works Biotech Co Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember" xlink:to="aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SuzhouAscentagePharmaCoLtdMember_lbl0" xml:lang="en-US">Suzhou Ascentage Pharma Co Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SuzhouAscentagePharmaCoLtdMember" xlink:to="aapg_SuzhouAscentagePharmaCoLtdMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl0" xml:lang="en-US">Comprehensive income, attributable to owners of parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Condensed Cash Flow Statements Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock" xlink:to="aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationRatePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Depreciation rate, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRatePropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationRatePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PortionClassifiedAsCurrentLiabilities_lbl1" xml:lang="en-US">Portion Classified As Current Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PortionClassifiedAsCurrentLiabilities" xlink:to="aapg_PortionClassifiedAsCurrentLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PenaltyExpense_lbl1" xml:lang="en-US">Penalty Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PenaltyExpense" xlink:to="aapg_PenaltyExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockExchangeIndexShare_lbl1" xml:lang="en-US">Stock Exchange Index Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockExchangeIndexShare" xlink:to="aapg_StockExchangeIndexShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Other Non Current Assets Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock" xlink:to="aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl2" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl0" xml:lang="en-US">Current accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CurretPayablesForConstructionCost_lbl1" xml:lang="en-US">Curret Payables For Construction Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurretPayablesForConstructionCost" xlink:to="aapg_CurretPayablesForConstructionCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossProfit_lbl0" xml:lang="en-US">Gross profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme_lbl1" xml:lang="en-US">Issue Of Shares Under The Pre IPOShare Option Scheme</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme" xlink:to="aapg_IssueOfSharesUnderThePreIPOShareOptionScheme_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LeaseLiabilitiesCurrentMember_lbl0" xml:lang="en-US">Lease Liabilities Current Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseLiabilitiesCurrentMember" xlink:to="aapg_LeaseLiabilitiesCurrentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsMaturity_lbl0" xml:lang="en-US">Borrowings, maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsMaturity" xlink:to="ifrs-full_BorrowingsMaturity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasurySharesMember_lbl1" xml:lang="en-US">Treasury shares [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasurySharesMember" xlink:to="ifrs-full_TreasurySharesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ApplicableTaxRate_lbl0" xml:lang="en-US">Applicable tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl0" xml:lang="en-US">Disclosure of products and services [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:to="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TwentySixNov202526Nov2035Member_lbl0" xml:lang="en-US">Twenty Six Nov202526 Nov2035 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwentySixNov202526Nov2035Member" xlink:to="aapg_TwentySixNov202526Nov2035Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RSUMember_lbl0" xml:lang="en-US">RSUMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RSUMember" xlink:to="aapg_RSUMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialLiabilitiesAtAmortizedCostMember_lbl0" xml:lang="en-US">Financial Liabilities At Amortized Cost Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesAtAmortizedCostMember" xlink:to="aapg_FinancialLiabilitiesAtAmortizedCostMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Prepayments_lbl0" xml:lang="en-US">Prepayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Prepayments" xlink:to="ifrs-full_Prepayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl1" xml:lang="en-US">Non-current lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for income tax [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SecuredBankBorrowingsMember_lbl0" xml:lang="en-US">Secured Bank Borrowings Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SecuredBankBorrowingsMember" xlink:to="aapg_SecuredBankBorrowingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearMember_lbl0" xml:lang="en-US">Later than one year [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearMember" xlink:to="ifrs-full_LaterThanOneYearMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl0" xml:lang="en-US">Disclosure of leases [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl1" xml:lang="en-US">Adjustments for share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NetOperatingLossExpired_lbl1" xml:lang="en-US">Net Operating Loss Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NetOperatingLossExpired" xlink:to="aapg_NetOperatingLossExpired_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_GovernmentSubsidy_lbl1" xml:lang="en-US">Government Subsidy</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GovernmentSubsidy" xlink:to="aapg_GovernmentSubsidy_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of fair value of financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_lbl0" xml:lang="en-US">Non-current portion of other non-current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:to="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RestrictedShareUnitExpenses_lbl1" xml:lang="en-US">Restricted Share Unit Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RestrictedShareUnitExpenses" xlink:to="aapg_RestrictedShareUnitExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl1" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareCapitalMember_lbl0" xml:lang="en-US">Share Capital Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareCapitalMember" xlink:to="aapg_ShareCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestCostsCapitalised_lbl0" xml:lang="en-US">Interest costs capitalised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestCostsCapitalised" xlink:to="ifrs-full_InterestCostsCapitalised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialAssetsAtFVTPL_lbl1" xml:lang="en-US">Financial Assets At FVTPL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAtFVTPL" xlink:to="aapg_FinancialAssetsAtFVTPL_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory_lbl1" xml:lang="en-US">Disclosure Of Current And Deferred Components Of The Income Tax Expense Credit Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" xlink:to="aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AnnualBaseSalaryPercentage_lbl1" xml:lang="en-US">Annual Base Salary Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AnnualBaseSalaryPercentage" xlink:to="aapg_AnnualBaseSalaryPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PercentageOfConditionalShares_lbl1" xml:lang="en-US">Percentage Of Conditional Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfConditionalShares" xlink:to="aapg_PercentageOfConditionalShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of prepayments and other assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LossBeforeTaxArrivedCharingOrCrediting_lbl1" xml:lang="en-US">Loss Before Tax Arrived Charing Or Crediting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LossBeforeTaxArrivedCharingOrCrediting" xlink:to="aapg_LossBeforeTaxArrivedCharingOrCrediting_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_lbl0" xml:lang="en-US">Disclosure of changes in accounting policies [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember_lbl0" xml:lang="en-US">Amendments To IFRSTen And IFRSTwenty Eight Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember" xlink:to="aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation_lbl2" xml:lang="en-US">Property And Equipment Net Of Accumulated Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation" xlink:to="aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_lbl0" xml:lang="en-US">Deferred tax expense (income) relating to tax rate changes or imposition of new taxes, income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_GainlossAttributableToJointVentures_lbl1" xml:lang="en-US">Gainloss Attributable To Joint Ventures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GainlossAttributableToJointVentures" xlink:to="aapg_GainlossAttributableToJointVentures_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SubscriptionOfShares_lbl1" xml:lang="en-US">Subscription Of Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SubscriptionOfShares" xlink:to="aapg_SubscriptionOfShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_December312025Abstract_lbl0" xml:lang="en-US">December312025 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_December312025Abstract" xlink:to="aapg_December312025Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_lbl1" xml:lang="en-US">Financial assets at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards_lbl1" xml:lang="en-US">Description Of Accounting Policy For Issued But Not Yet Effective Ifrs Accounting Standards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" xlink:to="aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AggregateShareIssued_lbl1" xml:lang="en-US">Aggregate Share Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AggregateShareIssued" xlink:to="aapg_AggregateShareIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCosts_lbl1" xml:lang="en-US">Finance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PrepaidListingExpense_lbl1" xml:lang="en-US">Prepaid Listing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrepaidListingExpense" xlink:to="aapg_PrepaidListingExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl0" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl0" xml:lang="en-US">Basic earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LongtermAdvancesRecognizedFromCustomersMember_lbl0" xml:lang="en-US">Longterm Advances Recognized From Customers Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LongtermAdvancesRecognizedFromCustomersMember" xlink:to="aapg_LongtermAdvancesRecognizedFromCustomersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AtDecember312025Abstract_lbl0" xml:lang="en-US">At December312025 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AtDecember312025Abstract" xlink:to="aapg_AtDecember312025Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentContractLiabilities_lbl0" xml:lang="en-US">Current contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentContractLiabilities" xlink:to="ifrs-full_CurrentContractLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures_lbl0" xml:lang="en-US">Description of accounting policy for investments in joint ventures [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock_lbl1" xml:lang="en-US">Disclosure Of Revenue Other Income And Other Gains Explanatory Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" xlink:to="aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_lbl0" xml:lang="en-US">Later than one year and not later than five years [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl1" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermDeposits_lbl0" xml:lang="en-US">Long-term deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermDeposits" xlink:to="ifrs-full_LongtermDeposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OneToThreeMonthsMember_lbl0" xml:lang="en-US">One To Three Months Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OneToThreeMonthsMember" xlink:to="aapg_OneToThreeMonthsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LeaseLiabilitiesNonCurrentMember_lbl0" xml:lang="en-US">Lease Liabilities Non Current Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseLiabilitiesNonCurrentMember" xlink:to="aapg_LeaseLiabilitiesNonCurrentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses_lbl1" xml:lang="en-US">Stock Issued During Period Value Pre IPOShare Option Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" xlink:to="aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ConcentrationsOfCreditRisk_lbl1" xml:lang="en-US">Concentrations Of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ConcentrationsOfCreditRisk" xlink:to="aapg_ConcentrationsOfCreditRisk_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl1" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl1" xml:lang="en-US">Retained earnings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfContractsLiabilitiesExplanatory_lbl1" xml:lang="en-US">Disclosure Of Contracts Liabilities Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfContractsLiabilitiesExplanatory" xlink:to="aapg_DisclosureOfContractsLiabilitiesExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in deferred income other than contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants1ThreeMember_lbl0" xml:lang="en-US">Type Of Eligible Participants1 Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants1ThreeMember" xlink:to="aapg_TypeOfEligibleParticipants1ThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_lbl0" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AmendmentsToIASTwentyOneMember_lbl0" xml:lang="en-US">Amendments To IASTwenty One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AmendmentsToIASTwentyOneMember" xlink:to="aapg_AmendmentsToIASTwentyOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl1" xml:lang="en-US">Principal place of business of subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus_lbl1" xml:lang="en-US">Stock Issued During Period Values Equitysettled Bonus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus" xlink:to="aapg_StockIssuedDuringPeriodValuesEquitysettledBonus_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl1" xml:lang="en-US">Number of other equity instruments outstanding in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl0" xml:lang="en-US">Disclosure of commitments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses_lbl1" xml:lang="en-US">Stock Issued During Period Value Restricted Share Unit RSUExpenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" xlink:to="aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncreasedecreaseInBasisPointsMember_lbl0" xml:lang="en-US">Increasedecrease In Basis Points Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseInBasisPointsMember" xlink:to="aapg_IncreasedecreaseInBasisPointsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember_lbl0" xml:lang="en-US">Financial Liabilities At Fair Value Through Profit Or Loss Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember" xlink:to="aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl0" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccrualsClassifiedAsCurrent_lbl0" xml:lang="en-US">Accruals classified as current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccrualsClassifiedAsCurrent" xlink:to="ifrs-full_AccrualsClassifiedAsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IssueOfOrdinaryShare_lbl2" xml:lang="en-US">Issue Of Ordinary Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfOrdinaryShare" xlink:to="aapg_IssueOfOrdinaryShare_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FirstAnniversariesMember_lbl0" xml:lang="en-US">First Anniversaries Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FirstAnniversariesMember" xlink:to="aapg_FirstAnniversariesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl0" xml:lang="en-US">Increase (decrease) through financing cash flows, liabilities arising from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_Interestbearingbankandotherborrowingscurrent_lbl1" xml:lang="en-US">Interestbearingbankandotherborrowingscurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Interestbearingbankandotherborrowingscurrent" xlink:to="aapg_Interestbearingbankandotherborrowingscurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DonationExpensesMember_lbl0" xml:lang="en-US">Donation Expenses Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DonationExpensesMember" xlink:to="aapg_DonationExpensesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_lbl0" xml:lang="en-US">Estimated financial effect of contingent liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_lbl0" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:to="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of other operating expense [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShareGrantExpense_lbl1" xml:lang="en-US">Share Grant Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShareGrantExpense" xlink:to="aapg_ShareGrantExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Events After The Reporting Period Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" xlink:to="aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CostGoodwill_lbl1" xml:lang="en-US">Cost Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CostGoodwill" xlink:to="aapg_CostGoodwill_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfReservesTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Reserves Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfReservesTableTextBlock" xlink:to="aapg_ScheduleOfReservesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory_lbl0" xml:lang="en-US">Disclosure of authorisation of financial statements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl1" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherNonCurrentLiabilityMember_lbl0" xml:lang="en-US">Other Non Current Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherNonCurrentLiabilityMember" xlink:to="aapg_OtherNonCurrentLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccumulatedAmortization_lbl1" xml:lang="en-US">Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccumulatedAmortization" xlink:to="aapg_AccumulatedAmortization_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_EmployeesShareBasedCompensationSchemeAbstract_lbl0" xml:lang="en-US">Employees Share Based Compensation Scheme Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EmployeesShareBasedCompensationSchemeAbstract" xlink:to="aapg_EmployeesShareBasedCompensationSchemeAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCategoriesOfFinancialInstrumentsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCategoriesOfFinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCategoriesOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Categories Of Financial Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCategoriesOfFinancialInstrumentsAbstract" xlink:to="aapg_ScheduleOfCategoriesOfFinancialInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect_lbl1" xml:lang="en-US">Percentage Of Equity Interests Attributable To The Company Direct</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect" xlink:to="aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CustomerDMember_lbl0" xml:lang="en-US">Customer DMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CustomerDMember" xlink:to="aapg_CustomerDMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DrZhaiYifanMember_lbl0" xml:lang="en-US">Dr Zhai Yifan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DrZhaiYifanMember" xlink:to="aapg_DrZhaiYifanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RightofuseAssetsOfEstimatedUsefulLives_lbl1" xml:lang="en-US">Rightofuse Assets Of Estimated Useful Lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RightofuseAssetsOfEstimatedUsefulLives" xlink:to="aapg_RightofuseAssetsOfEstimatedUsefulLives_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares_lbl1" xml:lang="en-US">Increase Decrease Through Share Capital Repurchase Of Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" xlink:to="aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of other equity instruments forfeited in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentExciseTaxPayables_lbl0" xml:lang="en-US">Current excise tax payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentExciseTaxPayables" xlink:to="ifrs-full_CurrentExciseTaxPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterests_lbl3" xml:lang="en-US">Non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationExpense_lbl0" xml:lang="en-US">Amortisation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationExpense" xlink:to="ifrs-full_AmortisationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateRiskMember_lbl0" xml:lang="en-US">Interest rate risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants8Member_lbl0" xml:lang="en-US">Type Of Eligible Participants8 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants8Member" xlink:to="aapg_TypeOfEligibleParticipants8Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl0" xml:lang="en-US">Option life, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory_lbl1" xml:lang="en-US">Disclosure Of Carrying Amounts At The End Of The Reporting Period Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" xlink:to="aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Depreciation, property, plant and equipment, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl1" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_lbl0" xml:lang="en-US">Later than four years and not later than five years [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent_lbl1" xml:lang="en-US">Interestbearing Bank And Other Borrowings Non Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent" xlink:to="aapg_InterestbearingBankAndOtherBorrowingsNonCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl2" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock_lbl1" xml:lang="en-US">Disclosure Of Loss Before Tax Explanatory Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock" xlink:to="aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl0" xml:lang="en-US">Expected volatility, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToAbstract_lbl0" xml:lang="en-US">Comprehensive income attributable to [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialAssetsAtAmortizedCostMember_lbl0" xml:lang="en-US">Financial Assets At Amortized Cost Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAtAmortizedCostMember" xlink:to="aapg_FinancialAssetsAtAmortizedCostMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationExpense_lbl0" xml:lang="en-US">Depreciation expense, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentPayables_lbl1" xml:lang="en-US">Other current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentPayables" xlink:to="ifrs-full_OtherCurrentPayables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances_lbl1" xml:lang="en-US">Adjustments For Decrease Increase In Restricted Cash Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" xlink:to="aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of other equity instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities_lbl1" xml:lang="en-US">Non Cash Addition For Increase Decreasein Right Of Use Assets And Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" xlink:to="aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Proceeds from sales of property, plant and equipment, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for treasury shares [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_lbl0" xml:lang="en-US">Disclosure of trade and other payables [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl0" xml:lang="en-US">Revenue from contracts with customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WorkInProgress_lbl0" xml:lang="en-US">Current work in progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WorkInProgress" xlink:to="ifrs-full_WorkInProgress_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths_lbl1" xml:lang="en-US">Time Deposits With Original Maturity Of More Than Three Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" xlink:to="aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of other operating income (expense) [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl2" xml:lang="en-US">UNITED STATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CarryingAmountOfEquityInvestmentsMember_lbl0" xml:lang="en-US">Carrying Amount Of Equity Investments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CarryingAmountOfEquityInvestmentsMember" xlink:to="aapg_CarryingAmountOfEquityInvestmentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl0" xml:lang="en-US">Profit (loss), attributable to non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl0" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_lbl0" xml:lang="en-US">Cost of inventories recognised as expense during period, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:to="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of finance income (cost) [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfTheTradePayablesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTheTradePayablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfTheTradePayablesAbstract_lbl" xml:lang="en-US">Schedule Of The Trade Payables Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfTheTradePayablesAbstract" xlink:to="aapg_ScheduleOfTheTradePayablesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory_lbl1" xml:lang="en-US">Disclosure Of Deferred Tax Assets And Liabilities Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:to="aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DecreaseincreaseInLossBeforeTaxMember_lbl0" xml:lang="en-US">Decreaseincrease In Loss Before Tax Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DecreaseincreaseInLossBeforeTaxMember" xlink:to="aapg_DecreaseincreaseInLossBeforeTaxMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SuzhouYashengMember_lbl0" xml:lang="en-US">Suzhou Yasheng Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SuzhouYashengMember" xlink:to="aapg_SuzhouYashengMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnsecuredBankLoansReceived_lbl0" xml:lang="en-US">Unsecured bank loans received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnsecuredBankLoansReceived" xlink:to="ifrs-full_UnsecuredBankLoansReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingCostsIncurred_lbl0" xml:lang="en-US">Borrowing costs incurred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingCostsIncurred" xlink:to="ifrs-full_BorrowingCostsIncurred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember_lbl1" xml:lang="en-US">Goods or services transferred over time [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlansAbstract_lbl0" xml:lang="en-US">Post-employment benefit expense in profit or loss, defined benefit plans [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlansAbstract" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlansAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl2" xml:lang="en-US">Other non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_lbl0" xml:lang="en-US">Payments to acquire or redeem entity&apos;s shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:to="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory_lbl1" xml:lang="en-US">Disclosure Of Detailed Information Of Inventories Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory" xlink:to="aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ThirdAnniversaryMember_lbl0" xml:lang="en-US">Third Anniversary Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ThirdAnniversaryMember" xlink:to="aapg_ThirdAnniversaryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Non-current liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ProductsMember_lbl1" xml:lang="en-US">Products Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ProductsMember" xlink:to="aapg_ProductsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentProvisions_lbl0" xml:lang="en-US">Current provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisions" xlink:to="ifrs-full_CurrentProvisions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IntangibleAssetsGross_lbl1" xml:lang="en-US">Intangible Assets Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IntangibleAssetsGross" xlink:to="aapg_IntangibleAssetsGross_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PaymentsofLeaseLiabilities_lbl1" xml:lang="en-US">Paymentsof Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PaymentsofLeaseLiabilities" xlink:to="aapg_PaymentsofLeaseLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Right Of Use Assets Of The Lease Terms And The Estimated Useful Lives Of The Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:to="aapg_ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_lbl0" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl0" xml:lang="en-US">Earnings per share [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareExplanatory" xlink:to="ifrs-full_EarningsPerShareExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Repayments of borrowings, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants2FourMember_lbl0" xml:lang="en-US">Type Of Eligible Participants2 Four Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants2FourMember" xlink:to="aapg_TypeOfEligibleParticipants2FourMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermBorrowings_lbl1" xml:lang="en-US">Non-current portion of non-current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TwoThousandTwentyOnesRSUSchemeMember_lbl0" xml:lang="en-US">Two Thousand Twenty Ones RSUScheme Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyOnesRSUSchemeMember" xlink:to="aapg_TwoThousandTwentyOnesRSUSchemeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl0" xml:lang="en-US">Number of shares reserved for issue under options and contracts for sale of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:to="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares_lbl1" xml:lang="en-US">Issue Of Shares Under The Pre IPOShare Option Schemein Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" xlink:to="aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfTradeReceivablesNetTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Trade Receivables Net Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfTradeReceivablesNetTableTextBlock" xlink:to="aapg_ScheduleOfTradeReceivablesNetTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory_lbl0" xml:lang="en-US">Disclosure of goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:to="ifrs-full_DisclosureOfGoodwillExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DenominatedInAbstract_lbl0" xml:lang="en-US">Denominated In Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DenominatedInAbstract" xlink:to="aapg_DenominatedInAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipantsFiveMember_lbl0" xml:lang="en-US">Type Of Eligible Participants Five Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsFiveMember" xlink:to="aapg_TypeOfEligibleParticipantsFiveMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl1" xml:lang="en-US">Interest paid, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IfRMBWeakensAgainstUSDollarsMember_lbl0" xml:lang="en-US">If RMBWeakens Against USDollars Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IfRMBWeakensAgainstUSDollarsMember" xlink:to="aapg_IfRMBWeakensAgainstUSDollarsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">Gains (losses) on financial liabilities at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for derecognition of financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypesOfGoodsOrServicesAbstract_lbl0" xml:lang="en-US">Types Of Goods Or Services Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypesOfGoodsOrServicesAbstract" xlink:to="aapg_TypesOfGoodsOrServicesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl0" xml:lang="en-US">Current trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForProvisions_lbl0" xml:lang="en-US">Adjustments for provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForProvisions" xlink:to="ifrs-full_AdjustmentsForProvisions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterestsMember_lbl0" xml:lang="en-US">Non-controlling interests [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterestsMember" xlink:to="ifrs-full_NoncontrollingInterestsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DeferredTaxAssetsTaxLossCarryforwards_lbl1" xml:lang="en-US">Deferred Tax Assets Tax Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxAssetsTaxLossCarryforwards" xlink:to="aapg_DeferredTaxAssetsTaxLossCarryforwards_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory_lbl0" xml:lang="en-US">Disclosure of information about separate financial statements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract_lbl0" xml:lang="en-US">Other comprehensive income [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AdjustedCapitals_lbl1" xml:lang="en-US">Adjusted Capitals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AdjustedCapitals" xlink:to="aapg_AdjustedCapitals_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory_lbl1" xml:lang="en-US">Disclosure Of Detailed Information About Financial Assets At Fair Value Through Profit Or Loss Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" xlink:to="aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncreasedecreaseInLossBeforeTaxMember_lbl0" xml:lang="en-US">Increasedecrease In Loss Before Tax Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreasedecreaseInLossBeforeTaxMember" xlink:to="aapg_IncreasedecreaseInLossBeforeTaxMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InventoryWritedown2011_lbl0" xml:lang="en-US">Inventory write-down</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoryWritedown2011" xlink:to="ifrs-full_InventoryWritedown2011_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CapitalManagementMember_lbl0" xml:lang="en-US">Capital Management Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalManagementMember" xlink:to="aapg_CapitalManagementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ContractLiabilitiesMember_lbl0" xml:lang="en-US">Contract Liabilities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ContractLiabilitiesMember" xlink:to="aapg_ContractLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DepositsAssetsPrepayments_lbl1" xml:lang="en-US">Deposits Assets Prepayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DepositsAssetsPrepayments" xlink:to="aapg_DepositsAssetsPrepayments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DonationsAndSubsidiesExpense_lbl0" xml:lang="en-US">Donations and subsidies expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DonationsAndSubsidiesExpense" xlink:to="ifrs-full_DonationsAndSubsidiesExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks_lbl1" xml:lang="en-US">Cash and bank balances at central banks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Increase (decrease) through net exchange differences, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for impairment of financial assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_GrantAnniversariesAxis_lbl0" xml:lang="en-US">Grant Anniversaries Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_GrantAnniversariesAxis" xlink:to="aapg_GrantAnniversariesAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock_lbl1" xml:lang="en-US">Disclosure Of Changes In Accounting Policies Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" xlink:to="aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember_lbl0" xml:lang="en-US">Current Portion Of Long Term Bank Loans Unsecured Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember" xlink:to="aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TreasurySharesOneMember_lbl0" xml:lang="en-US">Treasury Shares One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TreasurySharesOneMember" xlink:to="aapg_TreasurySharesOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_lbl0" xml:lang="en-US">Categories of financial liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CostOfSalesAbstract_lbl0" xml:lang="en-US">Cost Of Sales Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CostOfSalesAbstract" xlink:to="aapg_CostOfSalesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DerivativeFinancialAssetsHeldForHedging_lbl0" xml:lang="en-US">Derivative financial assets held for hedging</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DerivativeFinancialAssetsHeldForHedging" xlink:to="ifrs-full_DerivativeFinancialAssetsHeldForHedging_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Information Of The Groups Joint Venture Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" xlink:to="aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl0" xml:lang="en-US">Number of shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInJointVenture_lbl0" xml:lang="en-US">Proportion of ownership interest in joint venture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:to="ifrs-full_ProportionOfOwnershipInterestInJointVenture_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsLiabilities_lbl0" xml:lang="en-US">Current assets (liabilities)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentAssetsLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl0" xml:lang="en-US">Expense relating to leases of low-value assets for which recognition exemption has been used, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl0" xml:lang="en-US">Increase through new leases, liabilities arising from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Carrying Amounts Of Borrowings Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" xlink:to="aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Derecognition Financial Liabilities Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" xlink:to="aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IFRSEighteenMember_lbl0" xml:lang="en-US">IFRSEighteen Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IFRSEighteenMember" xlink:to="aapg_IFRSEighteenMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for financial liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl1" xml:lang="en-US">Reserve of exchange differences on translation [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Borrowings_lbl2" xml:lang="en-US">Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract0_lbl0" xml:lang="en-US">Other Comprehensive Income For The Year Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract0" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract1_lbl0" xml:lang="en-US">Other Comprehensive Income For The Year Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract1" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract2_lbl0" xml:lang="en-US">Other Comprehensive Income For The Year Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract2" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ComprehensiveIncomeLoss_lbl1" xml:lang="en-US">Comprehensive Income Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ComprehensiveIncomeLoss" xlink:to="aapg_ComprehensiveIncomeLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract3_lbl0" xml:lang="en-US">Other Comprehensive Income For The Year Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract3" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember_lbl0" xml:lang="en-US">September Sixteen Two Thousand Ninteen September Sixteen Two Thousand Twenty Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember" xlink:to="aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl0" xml:lang="en-US">Adjustments to reconcile profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherComprehensiveIncomeForTheYearAbstract4_lbl0" xml:lang="en-US">Other Comprehensive Income For The Year Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherComprehensiveIncomeForTheYearAbstract4" xlink:to="aapg_OtherComprehensiveIncomeForTheYearAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl0" xml:lang="en-US">Depreciation, right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BalancesWithBanks_lbl0" xml:lang="en-US">Balances with banks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BalancesWithBanks" xlink:to="ifrs-full_BalancesWithBanks_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UnlabeledAbstract" xlink:to="aapg_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DerivativeFinancialInstrumentsMember_lbl0" xml:lang="en-US">Derivative Financial Instruments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DerivativeFinancialInstrumentsMember" xlink:to="aapg_DerivativeFinancialInstrumentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl0" xml:lang="en-US">Current lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for offsetting of financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl1" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_EffectOfWithholdingTaxOnTheInterestIncome_lbl1" xml:lang="en-US">Effect Of Withholding Tax On The Interest Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EffectOfWithholdingTaxOnTheInterestIncome" xlink:to="aapg_EffectOfWithholdingTaxOnTheInterestIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of other equity instruments exercisable in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CashAndBankBalancesNotYetPastDue_lbl1" xml:lang="en-US">Cash And Bank Balances Not Yet Past Due</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashAndBankBalancesNotYetPastDue" xlink:to="aapg_CashAndBankBalancesNotYetPastDue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CreditRiskMember_lbl0" xml:lang="en-US">Credit risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CreditRiskMember" xlink:to="ifrs-full_CreditRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember_lbl0" xml:lang="en-US">August Fifteen Two Thousand Eighteen To August Fifteen Two Thousand Twenty Eight Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember" xlink:to="aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CashInflowOutflowForLease_lbl1" xml:lang="en-US">Cash Inflow Outflow For Lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CashInflowOutflowForLease" xlink:to="aapg_CashInflowOutflowForLease_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract_lbl" xml:lang="en-US">Schedule Of Based On The Invoice Date And Net Of Loss Allowance Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract" xlink:to="aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialAssetsMember_lbl0" xml:lang="en-US">Financial Assets Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsMember" xlink:to="aapg_FinancialAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockIssuedDuringPeriodValueVestingOfRSUs_lbl1" xml:lang="en-US">Stock Issued During Period Value Vesting Of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueVestingOfRSUs" xlink:to="aapg_StockIssuedDuringPeriodValueVestingOfRSUs_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl0" xml:lang="en-US">Current assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContractLiabilities_lbl1" xml:lang="en-US">Contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractLiabilities" xlink:to="ifrs-full_ContractLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CommercializationRightsIncomeMember_lbl1" xml:lang="en-US">Commercialization Rights Income Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CommercializationRightsIncomeMember" xlink:to="aapg_CommercializationRightsIncomeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl0" xml:lang="en-US">Disclosure of trade and other receivables [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_lbl0" xml:lang="en-US">Post-employment benefit expense, defined contribution plans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CapitalReserve_lbl0" xml:lang="en-US">Capital reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalReserve" xlink:to="ifrs-full_CapitalReserve_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of investment contracts liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentReceivables_lbl0" xml:lang="en-US">Trade and other non-current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentReceivables" xlink:to="ifrs-full_NoncurrentReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StageTwoMember_lbl0" xml:lang="en-US">Stage Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StageTwoMember" xlink:to="aapg_StageTwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement_lbl1" xml:lang="en-US">Number Of Share Options Expense In Sharebased Payment Arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" xlink:to="aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PrepaymentForTreasurySharePurchaseFees_lbl1" xml:lang="en-US">Prepayment For Treasury Share Purchase Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrepaymentForTreasurySharePurchaseFees" xlink:to="aapg_PrepaymentForTreasurySharePurchaseFees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DeductibleTemporaryDifferencesNotRecognized_lbl1" xml:lang="en-US">Deductible Temporary Differences Not Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeductibleTemporaryDifferencesNotRecognized" xlink:to="aapg_DeductibleTemporaryDifferencesNotRecognized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl1" xml:lang="en-US">Tax effect of tax losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfTaxLosses" xlink:to="ifrs-full_TaxEffectOfTaxLosses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccountingStandardsVolume11Member_lbl0" xml:lang="en-US">Accounting Standards Volume11 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccountingStandardsVolume11Member" xlink:to="aapg_AccountingStandardsVolume11Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ConstructionInProcessMember_lbl0" xml:lang="en-US">Construction In Process Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ConstructionInProcessMember" xlink:to="aapg_ConstructionInProcessMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OverTimeMember_lbl0" xml:lang="en-US">Over Time Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OverTimeMember" xlink:to="aapg_OverTimeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LandAndBuildingsMember_lbl0" xml:lang="en-US">Land and buildings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LandAndBuildingsMember" xlink:to="ifrs-full_LandAndBuildingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdministrativeExpense_lbl0" xml:lang="en-US">Administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus_lbl1" xml:lang="en-US">Increase Decrease In Number Of Shares Equitysettled Bonus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus" xlink:to="aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_UnrecognizedTaxBenefit_lbl1" xml:lang="en-US">Unrecognized Tax Benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UnrecognizedTaxBenefit" xlink:to="aapg_UnrecognizedTaxBenefit_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfRevenueAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRevenueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfRevenueAbstract_lbl" xml:lang="en-US">Schedule Of Revenue Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfRevenueAbstract" xlink:to="aapg_ScheduleOfRevenueAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherPayables_lbl2" xml:lang="en-US">Other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPayables" xlink:to="ifrs-full_OtherPayables_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TwoThousandTwentyOneRSUSchemeMember_lbl1" xml:lang="en-US">Two Thousand Twenty One RSUScheme Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyOneRSUSchemeMember" xlink:to="aapg_TwoThousandTwentyOneRSUSchemeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl0" xml:lang="en-US">Percentage of voting equity interests acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StageThreeMember_lbl0" xml:lang="en-US">Stage Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StageThreeMember" xlink:to="aapg_StageThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Investment In AJoint Venture Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock" xlink:to="aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_VestingOfRestrictedShareUnit_lbl1" xml:lang="en-US">Vesting Of Restricted Share Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_VestingOfRestrictedShareUnit" xlink:to="aapg_VestingOfRestrictedShareUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl0" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_lbl0" xml:lang="en-US">Other inflows (outflows) of cash, classified as operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfDisaggregatedRevenueAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDisaggregatedRevenueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfDisaggregatedRevenueAbstract_lbl" xml:lang="en-US">Schedule Of Disaggregated Revenue Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfDisaggregatedRevenueAbstract" xlink:to="aapg_ScheduleOfDisaggregatedRevenueAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ExchangeFluctuationReserve_lbl1" xml:lang="en-US">Exchange Fluctuation Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ExchangeFluctuationReserve" xlink:to="aapg_ExchangeFluctuationReserve_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl0" xml:lang="en-US">Adjustments for fair value losses (gains)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TwoThousandTwentyTwoRSUSchemeMember_lbl1" xml:lang="en-US">Two Thousand Twenty Two RSUScheme Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TwoThousandTwentyTwoRSUSchemeMember" xlink:to="aapg_TwoThousandTwentyTwoRSUSchemeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for employee benefits [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl1" xml:lang="en-US">Deferred tax liability (asset)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl0" xml:lang="en-US">Exercise price, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LossAbstract_lbl0" xml:lang="en-US">Loss Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LossAbstract" xlink:to="aapg_LossAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IntellectualPropertyIncomeMember_lbl1" xml:lang="en-US">Intellectual Property Income Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IntellectualPropertyIncomeMember" xlink:to="aapg_IntellectualPropertyIncomeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsRightofuseAssets_lbl0" xml:lang="en-US">Disposals, right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsRightofuseAssets" xlink:to="ifrs-full_DisposalsRightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ForecastMember_lbl0" xml:lang="en-US">Forecast Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ForecastMember" xlink:to="aapg_ForecastMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfIssuedAndFullyPaidAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfIssuedAndFullyPaidAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfIssuedAndFullyPaidAbstract_lbl" xml:lang="en-US">Schedule Of Issued And Fully Paid Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfIssuedAndFullyPaidAbstract" xlink:to="aapg_ScheduleOfIssuedAndFullyPaidAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares_lbl1" xml:lang="en-US">Issue Of Shares Under The2021 RSUScheme Inshares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares" xlink:to="aapg_IssueOfSharesUnderThe2021RSUSchemeInshares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InnoventBiologicsSuzhouCoLtdMember_lbl0" xml:lang="en-US">Innovent Biologics Suzhou Co Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InnoventBiologicsSuzhouCoLtdMember" xlink:to="aapg_InnoventBiologicsSuzhouCoLtdMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory_lbl1" xml:lang="en-US">Disclosure Of Share Capital And Treasury Shares Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory" xlink:to="aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl0" xml:lang="en-US">Disclosure of information about key management personnel [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for financial assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncomeTaxesAxis_lbl0" xml:lang="en-US">Income Taxes Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeTaxesAxis" xlink:to="aapg_IncomeTaxesAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl1" xml:lang="en-US">Non-current financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PreIPOShareOptionsMember_lbl0" xml:lang="en-US">Pre IPOShare Options Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreIPOShareOptionsMember" xlink:to="aapg_PreIPOShareOptionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SharesAbstract_lbl0" xml:lang="en-US">Shares Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharesAbstract" xlink:to="aapg_SharesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl1" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAbstract_lbl0" xml:lang="en-US">Categories of financial assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:to="ifrs-full_CategoriesOfFinancialAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl0" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AccumulatedDepreciationsCost_lbl1" xml:lang="en-US">Accumulated Depreciations Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AccumulatedDepreciationsCost" xlink:to="aapg_AccumulatedDepreciationsCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDebt_lbl0" xml:lang="en-US">Net debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDebt" xlink:to="ifrs-full_NetDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AnalyzedIntoAbstract0_lbl0" xml:lang="en-US">Analyzed Into Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AnalyzedIntoAbstract0" xlink:to="aapg_AnalyzedIntoAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for provisions [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetAssetsLiabilities_lbl0" xml:lang="en-US">Assets (liabilities)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetAssetsLiabilities" xlink:to="ifrs-full_NetAssetsLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_lbl1" xml:lang="en-US">Equity attributable to owners of parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CapitalReserveMember_lbl0" xml:lang="en-US">Capital reserve [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalReserveMember" xlink:to="ifrs-full_CapitalReserveMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for intangible assets and goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract_lbl" xml:lang="en-US">Schedule Of Interest Bearing Bank And Other Borrowings Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract" xlink:to="aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfCapitalManagementAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCapitalManagementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfCapitalManagementAbstract_lbl" xml:lang="en-US">Schedule Of Capital Management Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfCapitalManagementAbstract" xlink:to="aapg_ScheduleOfCapitalManagementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Disposals, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SpecialOptionsMember_lbl0" xml:lang="en-US">Special Options Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SpecialOptionsMember" xlink:to="aapg_SpecialOptionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember_lbl0" xml:lang="en-US">Level 3 of fair value hierarchy [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions_lbl1" xml:lang="en-US">Stock Issued During Period Value Exercise Of Pre IPOShare Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" xlink:to="aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanFiveYearsMember_lbl1" xml:lang="en-US">Later than five years [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember_lbl0" xml:lang="en-US">May Fifteen Two Thousand Ninteen May Fifteen Two Thousand Twenty Nine Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember" xlink:to="aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OperatingExpense_lbl0" xml:lang="en-US">Operating expense, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OperatingExpense" xlink:to="ifrs-full_OperatingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermBorrowings_lbl0" xml:lang="en-US">Current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl0" xml:lang="en-US">Disclosure of deferred taxes [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ValueAddedTaxReceivables_lbl0" xml:lang="en-US">Value added tax receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ValueAddedTaxReceivables" xlink:to="ifrs-full_ValueAddedTaxReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipantsOneMember_lbl0" xml:lang="en-US">Type Of Eligible Participants One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsOneMember" xlink:to="aapg_TypeOfEligibleParticipantsOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherEmployeeBenefitContributionPercentage_lbl1" xml:lang="en-US">Other Employee Benefit Contribution Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherEmployeeBenefitContributionPercentage" xlink:to="aapg_OtherEmployeeBenefitContributionPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities_lbl1" xml:lang="en-US">Investment In Joint Ventures Classified As Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities" xlink:to="aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl0" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssueOfEquity_lbl0" xml:lang="en-US">Issue of equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CustomerCMember_lbl0" xml:lang="en-US">Customer CMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CustomerCMember" xlink:to="aapg_CustomerCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesAuthorised_lbl0" xml:lang="en-US">Number of shares authorised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesAuthorised" xlink:to="ifrs-full_NumberOfSharesAuthorised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Gains (losses) on disposals of property, plant and equipment, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:to="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl1" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl0" xml:lang="en-US">Additions to right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in accrued income other than contract assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CN_lbl0" xml:lang="en-US">CHINA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CN" xlink:to="country_CN_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_UncertainTaxPosition_lbl1" xml:lang="en-US">Uncertain Tax Position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_UncertainTaxPosition" xlink:to="aapg_UncertainTaxPosition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShortTermAdvancesRecognizedFromCustomersAbstract_lbl0" xml:lang="en-US">Short Term Advances Recognized From Customers Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShortTermAdvancesRecognizedFromCustomersAbstract" xlink:to="aapg_ShortTermAdvancesRecognizedFromCustomersAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_lbl0" xml:lang="en-US">Financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TradeReceivables45To120DaysMember_lbl0" xml:lang="en-US">Trade Receivables45 To120 Days Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TradeReceivables45To120DaysMember" xlink:to="aapg_TradeReceivables45To120DaysMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl0" xml:lang="en-US">SWITZERLAND</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl0" xml:lang="en-US">Deferred tax expense (income)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Description of vesting requirements for share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:to="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl0" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OutstandingBalanceOtherNoncurrentLiabilities_lbl1" xml:lang="en-US">Outstanding Balance Other Noncurrent Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OutstandingBalanceOtherNoncurrentLiabilities" xlink:to="aapg_OutstandingBalanceOtherNoncurrentLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl0" xml:lang="en-US">Key management personnel compensation, share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LeaseLiabilityMember_lbl0" xml:lang="en-US">Lease Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LeaseLiabilityMember" xlink:to="aapg_LeaseLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssuingShares_lbl0" xml:lang="en-US">Proceeds from issuing shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingShares" xlink:to="ifrs-full_ProceedsFromIssuingShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinishedGoods_lbl0" xml:lang="en-US">Current finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinishedGoods" xlink:to="ifrs-full_FinishedGoods_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition_lbl1" xml:lang="en-US">Deferred Tax Offset In The Consolidated Statements Of Financial Position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" xlink:to="aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBorrowingsExplanatory_lbl0" xml:lang="en-US">Disclosure of borrowings [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:to="ifrs-full_DisclosureOfBorrowingsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NumberOfTreasuryShares_lbl1" xml:lang="en-US">Number Of Treasury Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NumberOfTreasuryShares" xlink:to="aapg_NumberOfTreasuryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl3" xml:lang="en-US">Intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShorttermAdvancesRecognizedFromCustomersMember_lbl0" xml:lang="en-US">Shortterm Advances Recognized From Customers Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShorttermAdvancesRecognizedFromCustomersMember" xlink:to="aapg_ShorttermAdvancesRecognizedFromCustomersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract_lbl0" xml:lang="en-US">Equity Attributable To Ordinary Equity Holders Of The Company Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract" xlink:to="aapg_EquityAttributableToOrdinaryEquityHoldersOfTheCompanyAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of intangible assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StatutoryIncomeAndExpense_lbl1" xml:lang="en-US">Statutory Income And Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StatutoryIncomeAndExpense" xlink:to="aapg_StatutoryIncomeAndExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedTaxLossesMember_lbl0" xml:lang="en-US">Unused tax losses [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesMember" xlink:to="ifrs-full_UnusedTaxLossesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_WithholdingTax_lbl1" xml:lang="en-US">Withholding Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_WithholdingTax" xlink:to="aapg_WithholdingTax_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InterestBearingBankBorrowings_lbl1" xml:lang="en-US">Interest Bearing Bank Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InterestBearingBankBorrowings" xlink:to="aapg_InterestBearingBankBorrowings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfLiquidityRiskExplanatory_lbl0" xml:lang="en-US">Disclosure of liquidity risk [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLiquidityRiskExplanatory" xlink:to="ifrs-full_DisclosureOfLiquidityRiskExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl0" xml:lang="en-US">Disclosure of share-based payment arrangements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_lbl0" xml:lang="en-US">Profit (loss), attributable to [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OverTimeAbstract_lbl0" xml:lang="en-US">Over Time Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OverTimeAbstract" xlink:to="aapg_OverTimeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RegisteredShareCapital_lbl1" xml:lang="en-US">Registered Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RegisteredShareCapital" xlink:to="aapg_RegisteredShareCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl1" xml:lang="en-US">Proportion of ownership interest in subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl0" xml:lang="en-US">Reserve of exchange differences on translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RSUsGrantedFairValue_lbl1" xml:lang="en-US">RSUs Granted Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RSUsGrantedFairValue" xlink:to="aapg_RSUsGrantedFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TaxesMember_lbl0" xml:lang="en-US">Taxes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TaxesMember" xlink:to="aapg_TaxesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_USD_lbl0" xml:lang="en-US">United States of America, Dollars</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_USD" xlink:to="currency_USD_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NonCashDisposals_lbl1" xml:lang="en-US">Non Cash Disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NonCashDisposals" xlink:to="aapg_NonCashDisposals_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInSubsidiaries_lbl0" xml:lang="en-US">Investments in subsidiaries reported in separate financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiaries" xlink:to="ifrs-full_InvestmentsInSubsidiaries_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl2" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants1TwoMember_lbl0" xml:lang="en-US">Type Of Eligible Participants1 Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants1TwoMember" xlink:to="aapg_TypeOfEligibleParticipants1TwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember_lbl0" xml:lang="en-US">Financial Assets At Fair Value Through Profit Or Loss Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember" xlink:to="aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureofTransactionWithRelatedPartyExplanatory_lbl1" xml:lang="en-US">Disclosureof Transaction With Related Party Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureofTransactionWithRelatedPartyExplanatory" xlink:to="aapg_DisclosureofTransactionWithRelatedPartyExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl2" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PreIPOShareOptionSchemeMember_lbl0" xml:lang="en-US">Pre IPOShare Option Scheme Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PreIPOShareOptionSchemeMember" xlink:to="aapg_PreIPOShareOptionSchemeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfTradePayablesExplanatory_lbl1" xml:lang="en-US">Disclosure Of Trade Payables Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfTradePayablesExplanatory" xlink:to="aapg_DisclosureOfTradePayablesExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl0" xml:lang="en-US">Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">Current financial liabilities at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory_lbl1" xml:lang="en-US">Detailed Information About Fair Value And Fair Value Hierarchy Of Financial Instruments Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" xlink:to="aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialAssetsAgingAxis_lbl0" xml:lang="en-US">Financial Assets Aging Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialAssetsAgingAxis" xlink:to="aapg_FinancialAssetsAgingAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl0" xml:lang="en-US">Risk free interest rate, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiquidityRiskMember_lbl0" xml:lang="en-US">Liquidity risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl2" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory_lbl1" xml:lang="en-US">Schedule Of Deferred Tax Liabilities Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory" xlink:to="aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPerformanceObligationsExplanatory_lbl0" xml:lang="en-US">Disclosure of performance obligations [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPerformanceObligationsExplanatory" xlink:to="ifrs-full_DisclosureOfPerformanceObligationsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDividendsExplanatory_lbl0" xml:lang="en-US">Disclosure of dividends [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDividendsExplanatory" xlink:to="ifrs-full_DisclosureOfDividendsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_lbl0" xml:lang="en-US">Copyrights, patents and other industrial property rights, service and operating rights [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:to="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_lbl0" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme_lbl1" xml:lang="en-US">Increase Decrease Through Issue Of Shares Under The RSUScheme</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" xlink:to="aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipants2OneMember_lbl0" xml:lang="en-US">Type Of Eligible Participants2 One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipants2OneMember" xlink:to="aapg_TypeOfEligibleParticipants2OneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl0" xml:lang="en-US">Comprehensive income, attributable to non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfInterestRateRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestRateRiskAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfInterestRateRiskAbstract_lbl" xml:lang="en-US">Schedule Of Interest Rate Risk Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfInterestRateRiskAbstract" xlink:to="aapg_ScheduleOfInterestRateRiskAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CurrentPortionOfLongTermBankLoansSecuredMember_lbl0" xml:lang="en-US">Current Portion Of Long Term Bank Loans Secured Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CurrentPortionOfLongTermBankLoansSecuredMember" xlink:to="aapg_CurrentPortionOfLongTermBankLoansSecuredMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl0" xml:lang="en-US">Trade and other current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TransferredOutFromCapitalAndReserves_lbl1" xml:lang="en-US">Transferred Out From Capital And Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TransferredOutFromCapitalAndReserves" xlink:to="aapg_TransferredOutFromCapitalAndReserves_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for fair value measurement [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl0" xml:lang="en-US">Revenue that was included in contract liability balance at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations_lbl0" xml:lang="en-US">Other comprehensive income, before tax, exchange differences on translation, other than translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract_lbl" xml:lang="en-US">Schedule Of Property Plant And Equipment Of Annual Rates Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract" xlink:to="aapg_ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Loss Before Tax Explanatory Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" xlink:to="aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_lbl0" xml:lang="en-US">Non-derivative financial liabilities, undiscounted cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_BankLoansUnsecuredMember_lbl0" xml:lang="en-US">Bank Loans Unsecured Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BankLoansUnsecuredMember" xlink:to="aapg_BankLoansUnsecuredMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherBorrowings_lbl1" xml:lang="en-US">Other borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherBorrowings" xlink:to="ifrs-full_OtherBorrowings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CommitmentAndContingencies_lbl1" xml:lang="en-US">Commitment And Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CommitmentAndContingencies" xlink:to="aapg_CommitmentAndContingencies_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_InvestmentsListedInAbstract_lbl0" xml:lang="en-US">Investments Listed In Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_InvestmentsListedInAbstract" xlink:to="aapg_InvestmentsListedInAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RepurchaseOfOrdinaryShare_lbl1" xml:lang="en-US">Repurchase Of Ordinary Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RepurchaseOfOrdinaryShare" xlink:to="aapg_RepurchaseOfOrdinaryShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CapitalCommitments_lbl0" xml:lang="en-US">Capital commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalCommitments" xlink:to="ifrs-full_CapitalCommitments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_lbl0" xml:lang="en-US">Disclosure of initial application of standards or interpretations [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:to="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NewProvisionsReturn_lbl1" xml:lang="en-US">New Provisions Return</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NewProvisionsReturn" xlink:to="aapg_NewProvisionsReturn_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ReservesMember_lbl0" xml:lang="en-US">Reserves Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ReservesMember" xlink:to="aapg_ReservesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GovernmentGrants_lbl1" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_GovernmentGrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl0" xml:lang="en-US">Disclosure of related party [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParentMember_lbl2" xml:lang="en-US">Parent [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParentMember" xlink:to="ifrs-full_ParentMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfEquityPriceRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfEquityPriceRiskAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfEquityPriceRiskAbstract_lbl" xml:lang="en-US">Schedule Of Equity Price Risk Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfEquityPriceRiskAbstract" xlink:to="aapg_ScheduleOfEquityPriceRiskAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_Stage1Member_lbl0" xml:lang="en-US">Stage1 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_Stage1Member" xlink:to="aapg_Stage1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl1" xml:lang="en-US">Adjustments for gains (losses) on fair value adjustment, investment property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_BankAndOtherLoansMember_lbl0" xml:lang="en-US">Bank And Other Loans Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BankAndOtherLoansMember" xlink:to="aapg_BankAndOtherLoansMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_HongKongStockExchangeMember_lbl0" xml:lang="en-US">Hong Kong Stock Exchange Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_HongKongStockExchangeMember" xlink:to="aapg_HongKongStockExchangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDeferredIncomeExplanatory_lbl0" xml:lang="en-US">Disclosure of deferred income [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredIncomeExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredIncomeExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfRestrictedSharesOutstandingAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRestrictedSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfRestrictedSharesOutstandingAbstract_lbl" xml:lang="en-US">Schedule Of Restricted Shares Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfRestrictedSharesOutstandingAbstract" xlink:to="aapg_ScheduleOfRestrictedSharesOutstandingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssets_lbl1" xml:lang="en-US">Financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember_lbl0" xml:lang="en-US">Losses Available For Offsetting Against Future Taxable Profits Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember" xlink:to="aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_RestrictedShareUnitMember_lbl0" xml:lang="en-US">Restricted Share Unit Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_RestrictedShareUnitMember" xlink:to="aapg_RestrictedShareUnitMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_EmployeeMember_lbl0" xml:lang="en-US">Employee Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_EmployeeMember" xlink:to="aapg_EmployeeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsLessCurrentLiabilities_lbl0" xml:lang="en-US">Assets less current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_AssetsLessCurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepositsFromBanks_lbl0" xml:lang="en-US">Deposits from banks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepositsFromBanks" xlink:to="ifrs-full_DepositsFromBanks_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl0" xml:lang="en-US">Accumulated other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_NoncashAdditionsToIntangibleAssets_lbl1" xml:lang="en-US">Noncash Additions To Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_NoncashAdditionsToIntangibleAssets" xlink:to="aapg_NoncashAdditionsToIntangibleAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockIssuedDuringPeriodValueEquitysettledBonus_lbl1" xml:lang="en-US">Stock Issued During Period Value Equitysettled Bonus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueEquitysettledBonus" xlink:to="aapg_StockIssuedDuringPeriodValueEquitysettledBonus_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ShortTermBorrowingMember_lbl0" xml:lang="en-US">Short Term Borrowing Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ShortTermBorrowingMember" xlink:to="aapg_ShortTermBorrowingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CustomerBMember_lbl0" xml:lang="en-US">Customer BMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CustomerBMember" xlink:to="aapg_CustomerBMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary_lbl1" xml:lang="en-US">Stock Issued During Period Value Capital Contribution From ANoncontrolling Shareholder Of ASubsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" xlink:to="aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentIncome_lbl0" xml:lang="en-US">Investment income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentIncome" xlink:to="ifrs-full_InvestmentIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerSoftwareMember_lbl0" xml:lang="en-US">Computer software [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftwareMember" xlink:to="ifrs-full_ComputerSoftwareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_PrincipalActivities_lbl1" xml:lang="en-US">Principal Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_PrincipalActivities" xlink:to="aapg_PrincipalActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AmendmentsToIFRSNineAndIFRSSevenMember_lbl0" xml:lang="en-US">Amendments To IFRSNine And IFRSSeven Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AmendmentsToIFRSNineAndIFRSSevenMember" xlink:to="aapg_AmendmentsToIFRSNineAndIFRSSevenMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl0" xml:lang="en-US">Disclosure of financial risk management [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CapitalAndReserves_lbl1" xml:lang="en-US">Capital And Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalAndReserves" xlink:to="aapg_CapitalAndReserves_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl1" xml:lang="en-US">Adjustments for unrealised foreign exchange losses (gains)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl0" xml:lang="en-US">Amounts payable, related party transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of other current assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_lbl0" xml:lang="en-US">Disclosure of non-current assets held for sale and discontinued operations [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:to="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_IncomeNotSubjectToTax_lbl1" xml:lang="en-US">Income Not Subject To Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_IncomeNotSubjectToTax" xlink:to="aapg_IncomeNotSubjectToTax_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_AnalyzedIntoAbstract_lbl0" xml:lang="en-US">Analyzed Into Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_AnalyzedIntoAbstract" xlink:to="aapg_AnalyzedIntoAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets_lbl0" xml:lang="en-US">Adjustments for gains (losses) on disposal of financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_SharebasedPaymentVestingPeriod_lbl1" xml:lang="en-US">Sharebased Payment Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_SharebasedPaymentVestingPeriod" xlink:to="aapg_SharebasedPaymentVestingPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CustomerAMember_lbl0" xml:lang="en-US">Customer AMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CustomerAMember" xlink:to="aapg_CustomerAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_OtherUnlistedInvestmentsAtFairValue_lbl1" xml:lang="en-US">Other Unlisted Investments At Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_OtherUnlistedInvestmentsAtFairValue" xlink:to="aapg_OtherUnlistedInvestmentsAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ChiefCommercialOfficerMember_lbl0" xml:lang="en-US">Chief Commercial Officer Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ChiefCommercialOfficerMember" xlink:to="aapg_ChiefCommercialOfficerMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_TypeOfEligibleParticipantsFourMember_lbl0" xml:lang="en-US">Type Of Eligible Participants Four Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_TypeOfEligibleParticipantsFourMember" xlink:to="aapg_TypeOfEligibleParticipantsFourMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_BonusAmount_lbl2" xml:lang="en-US">Bonus Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_BonusAmount" xlink:to="aapg_BonusAmount_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_MarketEquityIndex_lbl1" xml:lang="en-US">Market Equity Index</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_MarketEquityIndex" xlink:to="aapg_MarketEquityIndex_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WagesAndSalaries_lbl0" xml:lang="en-US">Wages and salaries, operating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WagesAndSalaries" xlink:to="ifrs-full_WagesAndSalaries_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FourthAnniversaryMember_lbl0" xml:lang="en-US">Fourth Anniversary Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FourthAnniversaryMember" xlink:to="aapg_FourthAnniversaryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_FinancialLiabilitiesMember_lbl0" xml:lang="en-US">Financial Liabilities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_FinancialLiabilitiesMember" xlink:to="aapg_FinancialLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl1" xml:lang="en-US">Income tax expense (income), income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Groups Principal Joint Venture Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock" xlink:to="aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl0" xml:lang="en-US">Current tax expense (income), income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl1" xml:lang="en-US">Not later than one year [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanOneYearMember" xlink:to="ifrs-full_NotLaterThanOneYearMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="aapg_ScheduleOfFinancialInstrumentsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ScheduleOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Financial Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ScheduleOfFinancialInstrumentsAbstract" xlink:to="aapg_ScheduleOfFinancialInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_CapitalAndReserveFunds_lbl1" xml:lang="en-US">Capital And Reserve Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_CapitalAndReserveFunds" xlink:to="aapg_CapitalAndReserveFunds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ChineseMainlandMember_lbl1" xml:lang="en-US">Chinese Mainland Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ChineseMainlandMember" xlink:to="aapg_ChineseMainlandMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl0" xml:lang="en-US">Disclosure of general information about financial statements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aapg_ExchangeRealignmentRightofuseAssets_lbl1" xml:lang="en-US">Exchange Realignment Rightofuse Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aapg_ExchangeRealignmentRightofuseAssets" xlink:to="aapg_ExchangeRealignmentRightofuseAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl1" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivables_lbl0" xml:lang="en-US">Trade receivables</label>
<!-- [WMV7][VgrNzxhC6qPg/UlJB7h7YJDEl8qXWSeruLd3bkRGj1ydJppbPGQnQenxVCQXj8720HBmnTV2RSDMJCK7yV+yglYA2KwRPnndXlbSI19TL/QgEKrrR9+m2sJpYVPd6s+82n4d4ExmKoqxa618x5xWWvfth9hGxQsECjzNB6ntYbHsB2oIUzoI12cbyf5A5Bn7eqc5c+W0ddxTCdvDBfm2s5iZZa/Xb6XS5C593FKRdNPp6vx9utKe1tEocsIaroCWNRcOvUFqc3k87SbJ9PCZtqzIlvHbMKP0mA7mMqIEFD77PHv3vGndMNkrwPso5cca6fZ9WSsRuwObKmV7MZiAXMMKOmKVM+oJJtihtMOU1OlLsa9H/Jgykre6d52wtX8tla1469lvat7pwP8j] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>61
<FILENAME>aapg-20251231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Wed Apr 29 21:00:58 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedIncomeStatement" roleURI="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedComprehensiveIncome" roleURI="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedBalanceSheet" roleURI="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareholdersEquityType2or3" roleURI="http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ConsolidatedCashFlow" roleURI="http://www.ascentage.cn.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CorporateandGroupInformation" roleURI="http://www.ascentage.cn.com/role/CorporateandGroupInformation"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_AccountingPolicies" roleURI="http://www.ascentage.cn.com/role/AccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_SignificantAccountingJudgementsandEstimates" roleURI="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimates"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OperatingSegmentInformation" roleURI="http://www.ascentage.cn.com/role/OperatingSegmentInformation"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RevenueOtherIncomeandGains" roleURI="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGains"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossBeforeTax" roleURI="http://www.ascentage.cn.com/role/LossBeforeTax"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherExpenses" roleURI="http://www.ascentage.cn.com/role/OtherExpenses"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinanceCosts" roleURI="http://www.ascentage.cn.com/role/FinanceCosts"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_IncomeTax" roleURI="http://www.ascentage.cn.com/role/IncomeTax"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Dividends" roleURI="http://www.ascentage.cn.com/role/Dividends"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany" roleURI="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PropertyPlantandEquipment" roleURI="http://www.ascentage.cn.com/role/PropertyPlantandEquipment"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Leases" roleURI="http://www.ascentage.cn.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Goodwill" roleURI="http://www.ascentage.cn.com/role/Goodwill"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherIntangibleAsset" roleURI="http://www.ascentage.cn.com/role/OtherIntangibleAsset"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InvestmentinaJointVenture" roleURI="http://www.ascentage.cn.com/role/InvestmentinaJointVenture"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialAssetsatFairValuethroughProfitorLoss" roleURI="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLoss"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredTax" roleURI="http://www.ascentage.cn.com/role/DeferredTax"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherNonCurrentAssets" roleURI="http://www.ascentage.cn.com/role/OtherNonCurrentAssets"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Inventories" roleURI="http://www.ascentage.cn.com/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_TradeReceivablesNet" roleURI="http://www.ascentage.cn.com/role/TradeReceivablesNet"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PrepaymentsOtherReceivablesandOtherAssets" roleURI="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssets"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CashandBankBalances" roleURI="http://www.ascentage.cn.com/role/CashandBankBalances"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_TradePayables" roleURI="http://www.ascentage.cn.com/role/TradePayables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherPayablesandAccruals" roleURI="http://www.ascentage.cn.com/role/OtherPayablesandAccruals"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContractLiabilities" roleURI="http://www.ascentage.cn.com/role/ContractLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InterestBearingBankandOtherBorrowings" roleURI="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowings"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredIncome" roleURI="http://www.ascentage.cn.com/role/DeferredIncome"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareCapitalandTreasuryShares" roleURI="http://www.ascentage.cn.com/role/ShareCapitalandTreasuryShares"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Reserves" roleURI="http://www.ascentage.cn.com/role/Reserves"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareBasedPayments" roleURI="http://www.ascentage.cn.com/role/ShareBasedPayments"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_NotestotheConsolidatedStatementsofCashFlows" roleURI="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_Commitments" roleURI="http://www.ascentage.cn.com/role/Commitments"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContingentLiabilities" roleURI="http://www.ascentage.cn.com/role/ContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PledgeofAssets" roleURI="http://www.ascentage.cn.com/role/PledgeofAssets"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RelatedPartyTransactions" roleURI="http://www.ascentage.cn.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialInstrumentsbyCategory" roleURI="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategory"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FairValueandFairValueHierarchyofFinancialInstruments" roleURI="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstruments"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialRiskManagementObjectivesandPolicies" roleURI="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPolicies"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_EventAftertheReportingPeriod" roleURI="http://www.ascentage.cn.com/role/EventAftertheReportingPeriod"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CondensedFinancialInformationoftheCompany" roleURI="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompany"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ApprovaloftheFinancialStatements" roleURI="http://www.ascentage.cn.com/role/ApprovaloftheFinancialStatements"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_AccountingPoliciesByPolicy" roleURI="http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CorporateandGroupInformationTables" roleURI="http://www.ascentage.cn.com/role/CorporateandGroupInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_AccountingPoliciesTables" roleURI="http://www.ascentage.cn.com/role/AccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OperatingSegmentInformationTables" roleURI="http://www.ascentage.cn.com/role/OperatingSegmentInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RevenueOtherIncomeandGainsTables" roleURI="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossBeforeTaxTables" roleURI="http://www.ascentage.cn.com/role/LossBeforeTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherExpensesTables" roleURI="http://www.ascentage.cn.com/role/OtherExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinanceCostsTables" roleURI="http://www.ascentage.cn.com/role/FinanceCostsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_IncomeTaxTables" roleURI="http://www.ascentage.cn.com/role/IncomeTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables" roleURI="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PropertyPlantandEquipmentTables" roleURI="http://www.ascentage.cn.com/role/PropertyPlantandEquipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LeasesTables" roleURI="http://www.ascentage.cn.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_GoodwillTables" roleURI="http://www.ascentage.cn.com/role/GoodwillTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherIntangibleAssetTables" roleURI="http://www.ascentage.cn.com/role/OtherIntangibleAssetTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InvestmentinaJointVentureTables" roleURI="http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialAssetsatFairValuethroughProfitorLossTables" roleURI="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLossTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredTaxTables" roleURI="http://www.ascentage.cn.com/role/DeferredTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherNonCurrentAssetsTables" roleURI="http://www.ascentage.cn.com/role/OtherNonCurrentAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InventoriesTables" roleURI="http://www.ascentage.cn.com/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_TradeReceivablesNetTables" roleURI="http://www.ascentage.cn.com/role/TradeReceivablesNetTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_PrepaymentsOtherReceivablesandOtherAssetsTables" roleURI="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CashandBankBalancesTables" roleURI="http://www.ascentage.cn.com/role/CashandBankBalancesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_TradePayablesTables" roleURI="http://www.ascentage.cn.com/role/TradePayablesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OtherPayablesandAccrualsTables" roleURI="http://www.ascentage.cn.com/role/OtherPayablesandAccrualsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContractLiabilitiesTables" roleURI="http://www.ascentage.cn.com/role/ContractLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InterestBearingBankandOtherBorrowingsTables" roleURI="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredIncomeTables" roleURI="http://www.ascentage.cn.com/role/DeferredIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareCapitalandTreasurySharesTables" roleURI="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareBasedPaymentsTables" roleURI="http://www.ascentage.cn.com/role/ShareBasedPaymentsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_NotestotheConsolidatedStatementsofCashFlowsTables" roleURI="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RelatedPartyTransactionsTables" roleURI="http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialInstrumentsbyCategoryTables" roleURI="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategoryTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FairValueandFairValueHierarchyofFinancialInstrumentsTables" roleURI="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstrumentsTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialRiskManagementObjectivesandPoliciesTables" roleURI="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CondensedFinancialInformationoftheCompanyTables" roleURI="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofPrincipalSubsidiariesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofNewandRevisedIFRSsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofPropertyPlantandEquipmentofAnnualRatesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRevenueTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRevenueTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofNonCurrentAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRevenuefromCustomersTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofDisaggregatedRevenueTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofContractLiabilitiesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherIncomeandGainsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofLossBeforeTaxTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherExpensesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFinanceCostsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofBasicLossPerShareTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofBasicLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofPropertyPlantandEquipmentTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRightofUseAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofLeaseLiabilitiesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRecognizedinProfitorLossTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofGoodwillTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherIntangibleAssetTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInvestmentinaJointVentureTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInvestmentinaJointVentureTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofGroupsPrincipalJointVentureTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInformationoftheGroupsJointVentureTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofMovementsinDeferredTaxAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherNonCurrentAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInventoriesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofTradeReceivablesNetTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofTradeReceivablesNetTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCashandBankBalancesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleoftheTradePayablesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOtherPayablesandAccrualsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofContractLiabilitiesTable0" roleURI="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInterestBearingBankandOtherBorrowingsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofDeferredIncomeTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofDeferredIncomeTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofMovementsinGovernmentGrantsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofIssuedandFullyPaidTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofIssuedandFullyPaidTable_Parentheticals" roleURI="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofShareCapitalandTreasurySharesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleoffairvaluesofshareoptionsgrantedTable" roleURI="http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofUnlockingDateTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofRestrictedSharesOutstandingTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofTransactionwithRelatedPartyTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofOutstandingBalancewithRelatedPartyTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCompensationofkeyManagementPersonnelTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCategoriesofFinancialInstrumentsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFinancialInstrumentsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofAssetsMeasuredatFairValueTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofInterestRateRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofForeignCurrencyRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCreditQualityandMaximumExposureToCreditRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofLiquidityRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofEquityPriceRiskTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofFairValuesoftheEquityInvestmentsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCapitalManagementTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofStatementsofFinancialPositionTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCondensedStatementsofComprehensiveIncomeTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCondensedStatementsofCashFlowsTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ScheduleofCompanysReservesTable" roleURI="http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_AccountingPoliciesDetails" roleURI="http://www.ascentage.cn.com/role/AccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_SignificantAccountingJudgementsandEstimatesDetails" roleURI="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_OperatingSegmentInformationDetails" roleURI="http://www.ascentage.cn.com/role/OperatingSegmentInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_IncomeTaxDetails" roleURI="http://www.ascentage.cn.com/role/IncomeTaxDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails" roleURI="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_LeasesDetails" roleURI="http://www.ascentage.cn.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_GoodwillDetails" roleURI="http://www.ascentage.cn.com/role/GoodwillDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_DeferredTaxDetails" roleURI="http://www.ascentage.cn.com/role/DeferredTaxDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CashandBankBalancesDetails" roleURI="http://www.ascentage.cn.com/role/CashandBankBalancesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContractLiabilitiesDetails" roleURI="http://www.ascentage.cn.com/role/ContractLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_InterestBearingBankandOtherBorrowingsDetails" roleURI="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareCapitalandTreasurySharesDetails" roleURI="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ReservesDetails" roleURI="http://www.ascentage.cn.com/role/ReservesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ShareBasedPaymentsDetails" roleURI="http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_NotestotheConsolidatedStatementsofCashFlowsDetails" roleURI="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CommitmentsDetails" roleURI="http://www.ascentage.cn.com/role/CommitmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_ContingentLiabilitiesDetails" roleURI="http://www.ascentage.cn.com/role/ContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_RelatedPartyTransactionsDetails" roleURI="http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_FinancialRiskManagementObjectivesandPoliciesDetails" roleURI="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="aapg-20251231.xsd#aapg_r_CondensedFinancialInformationoftheCompanyDetails" roleURI="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#cover" roleURI="http://xbrl.sec.gov/dei/role/document/Cover"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#ai" roleURI="http://xbrl.sec.gov/dei/role/document/AuditInformation"/>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="ifrs-full_ProductsAndServicesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="IntellectuallPropertyMember" xlink:href="aapg-20251231.xsd#aapg_IntellectuallPropertyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="IntellectuallPropertyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProductsMember" xlink:href="aapg-20251231.xsd#aapg_ProductsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ProductsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersMember" xlink:href="aapg-20251231.xsd#aapg_OthersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="OthersMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_RevenueAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RevenueAbstract" xlink:to="ifrs-full_Revenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CostOfSalesAbstract" xlink:href="aapg-20251231.xsd#aapg_CostOfSalesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CostOfSalesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostOfSalesAbstract" xlink:to="ifrs-full_CostOfSales" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_OtherIncome" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_SellingExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_AdministrativeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_OtherExpenseByNature" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_FinanceCosts" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ProfitLossBeforeTax" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ProfitLoss" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_ProfitLossAttributableToAbstract" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLoss_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_EarningsPerShareAbstract" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:href="aapg-20251231.xsd#aapg_ConsolidatedStatementsOfComprehensiveLossAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_OtherComprehensiveIncome" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfComprehensiveLossAbstract" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:to="ifrs-full_ComprehensiveIncome_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_Goodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_OtherIntangibleAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_OtherNoncurrentAssets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_Inventories" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentTradeReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentPayables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentContractLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Interestbearingbankandotherborrowingscurrent" xlink:href="aapg-20251231.xsd#aapg_Interestbearingbankandotherborrowingscurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="Interestbearingbankandotherborrowingscurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_AssetsLessCurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentContractLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestbearingBankAndOtherBorrowingsNonCurrent" xlink:href="aapg-20251231.xsd#aapg_InterestbearingBankAndOtherBorrowingsNonCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="InterestbearingBankAndOtherBorrowingsNonCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredIncomeNonCurrent" xlink:href="aapg-20251231.xsd#aapg_DeferredIncomeNonCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="DeferredIncomeNonCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherNoncurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CommitmentAndContingencies" xlink:href="aapg-20251231.xsd#aapg_CommitmentAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="CommitmentAndContingencies" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Liabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_TreasuryShares" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_SharePremium" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalAndReserves" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="CapitalAndReserves" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncontrollingInterests" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Equity" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_ParValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesAuthorised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesAuthorised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NumberOfSharesAuthorised" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NumberOfSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NumberOfSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfChangesInEquityAbstract" xlink:href="aapg-20251231.xsd#aapg_ConsolidatedStatementsOfChangesInEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfChangesInEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_IssuedCapitalMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasurySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_TreasurySharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_SharePremiumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalAndReservesMember" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReservesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="CapitalAndReservesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_RetainedEarningsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ParentMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterestsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_NoncontrollingInterestsMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain" order="8.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ProfitLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ComprehensiveIncome" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IssueOfEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RepurchaseOfOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_RepurchaseOfOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="RepurchaseOfOrdinaryShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueShareOptionExpenses" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueShareOptionExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="StockIssuedDuringPeriodValueShareOptionExpenses" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="StockIssuedDuringPeriodValuePreIPOShareOptionExpenses" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueEquitysettledBonus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="StockIssuedDuringPeriodValueEquitysettledBonus" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity_0" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity_1" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsForDepreciationOfRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForDepreciationOfRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="AdjustmentsForDepreciationOfRightofuseAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsForGainOnDisposalOfLeases" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForGainOnDisposalOfLeases"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="AdjustmentsForGainOnDisposalOfLeases" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForFinanceCosts" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForProvisions" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss" order="14.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="AdjustmentsForDecreaseIncreaseInRestrictedCashBalances" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInTimeDepositsWithOriginalMaturity" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="IncreaseDecreaseInTimeDepositsWithOriginalMaturity" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentInOtherFinancialAssets" xlink:href="aapg-20251231.xsd#aapg_InvestmentInOtherFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="InvestmentInOtherFinancialAssets" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentInJointVenturesClassifiedAsInvestingActivities" xlink:href="aapg-20251231.xsd#aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="InvestmentInJointVenturesClassifiedAsInvestingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromIssuingShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ListingExpensePaid" xlink:href="aapg-20251231.xsd#aapg_ListingExpensePaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ListingExpensePaid" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents_1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" xlink:href="aapg-20251231.xsd#aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/CorporateandGroupInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/AccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimates" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OperatingSegmentInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGains" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/LossBeforeTax" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfLossBeforeTaxExplanatoryTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="DisclosureOfLossBeforeTaxExplanatoryTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OtherExpenses" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseByNatureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseByNatureAbstract" xlink:to="ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FinanceCosts" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_InterestCostsAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/IncomeTax" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/Dividends" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DividendAbstract" xlink:href="aapg-20251231.xsd#aapg_DividendAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDividendsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDividendsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DividendAbstract" xlink:to="ifrs-full_DisclosureOfDividendsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/PropertyPlantandEquipment" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/Leases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/Goodwill" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfGoodwillExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OtherIntangibleAsset" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="OtherIntangibleAssetAbstract" xlink:href="aapg-20251231.xsd#aapg_OtherIntangibleAssetAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIntangibleAssetAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/InvestmentinaJointVenture" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLoss" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/DeferredTax" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OtherNonCurrentAssets" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/Inventories" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/TradeReceivablesNet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssets" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:to="ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/CashandBankBalances" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="CashAndBankBalancesAbstract" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndBankBalancesAbstract" xlink:to="ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/TradePayables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OtherPayablesandAccruals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfOtherPayablesAndAccrualsTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="DisclosureOfOtherPayablesAndAccrualsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ContractLiabilities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfContractLiabilitiesTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfContractLiabilitiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ContractLiabilitiesAbstract" xlink:to="DisclosureOfContractLiabilitiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowings" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsAbstract" xlink:to="ifrs-full_DisclosureOfBorrowingsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/DeferredIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDeferredIncomeExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfDeferredIncomeExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ShareCapitalandTreasuryShares" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/Reserves" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:to="ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ShareBasedPayments" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlows" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowHedgesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowHedgesAbstract" xlink:to="ifrs-full_DisclosureOfCashFlowStatementExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/Commitments" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CapitalCommitmentsAbstract" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ContingentLiabilities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/PledgeofAssets" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="PledgeOfAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_PledgeOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfPledgeOfAssetsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfPledgeOfAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PledgeOfAssetsAbstract" xlink:to="DisclosureOfPledgeOfAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/RelatedPartyTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategory" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstruments" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:href="aapg-20251231.xsd#aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/EventAftertheReportingPeriod" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompany" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ApprovaloftheFinancialStatements" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ApprovalOfTheFinancialStatementsAbstract" xlink:href="aapg-20251231.xsd#aapg_ApprovalOfTheFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ApprovalOfTheFinancialStatementsAbstract" xlink:to="ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DisclosureOfChangesInAccountingPoliciesPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" xlink:href="aapg-20251231.xsd#aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/CorporateandGroupInformationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/AccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OperatingSegmentInformationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfProductsAndServicesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPerformanceObligationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPerformanceObligationsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfPerformanceObligationsExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/LossBeforeTaxTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="DisclosureOfLossBeforeTaxExplanatoryTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OtherExpensesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseByNatureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseByNatureAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherExpensesTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherExpensesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseByNatureAbstract" xlink:to="ScheduleOfOtherExpensesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FinanceCostsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceCostExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_InterestCostsAbstract" xlink:to="ifrs-full_DisclosureOfFinanceCostExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/IncomeTaxTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/LeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/GoodwillTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OtherIntangibleAssetTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="OtherIntangibleAssetAbstract" xlink:href="aapg-20251231.xsd#aapg_OtherIntangibleAssetAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIntangibleAssetAbstract" xlink:to="DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfInvestmentInAJointVentureTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ScheduleOfInvestmentInAJointVentureTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfGroupsPrincipalJointVentureTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ScheduleOfGroupsPrincipalJointVentureTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLossTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract" xlink:to="DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/DeferredTaxTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredTaxLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ScheduleOfDeferredTaxLiabilitiesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfDeferredTaxAssetsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDeferredTaxAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DisclosureOfDeferredTaxAssetsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OtherNonCurrentAssetsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherNonCurrentAssetsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ScheduleOfOtherNonCurrentAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/InventoriesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfDetailedInformationOfInventoriesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="DisclosureOfDetailedInformationOfInventoriesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/TradeReceivablesNetTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfTradeReceivablesNetTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTradeReceivablesNetTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ScheduleOfTradeReceivablesNetTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssetsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract" xlink:to="ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/CashandBankBalancesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="CashAndBankBalancesAbstract" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCashAndBankBalancesExplanatory" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCashAndBankBalancesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndBankBalancesAbstract" xlink:to="ScheduleOfCashAndBankBalancesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/TradePayablesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfTradePayablesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfTradePayablesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="DisclosureOfTradePayablesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OtherPayablesandAccrualsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureofOtherPayablesAndAccrualsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureofOtherPayablesAndAccrualsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="DisclosureofOtherPayablesAndAccrualsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ContractLiabilitiesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfContractsLiabilitiesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfContractsLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ContractLiabilitiesAbstract" xlink:to="DisclosureOfContractsLiabilitiesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsAbstract" xlink:to="ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsAbstract" xlink:to="ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/DeferredIncomeTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredIncomeTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDeferredIncomeTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:to="ScheduleOfDeferredIncomeTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfShareCapitalAndTreasurySharesExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="DisclosureOfShareCapitalAndTreasurySharesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ShareBasedPaymentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ScheduleOfFairValuesOfShareOptionsGrantedTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfUnlockingDatetextBlock" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfUnlockingDatetextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="DisclosureOfUnlockingDatetextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowHedgesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowHedgesAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowHedgesAbstract" xlink:to="DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureofTransactionWithRelatedPartyExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureofTransactionWithRelatedPartyExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="DisclosureofTransactionWithRelatedPartyExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="DisclosureofOutstandingBalanceWithRelatedPartyExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategoryTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstrumentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:href="aapg-20251231.xsd#aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" xlink:href="aapg-20251231.xsd#aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:to="DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfInterestRateRiskExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfInterestRateRiskExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="DisclosureOfInterestRateRiskExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfForeignCurrencyRiskExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfForeignCurrencyRiskExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="DisclosureOfForeignCurrencyRiskExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="ifrs-full_DisclosureOfCreditRiskExposureExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfLiquidityRiskExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLiquidityRiskExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="ifrs-full_DisclosureOfLiquidityRiskExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfEquityPriceRiskExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfEquityPriceRiskExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="DisclosureOfEquityPriceRiskExplanatory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfCapitalManagementExplanatory" xlink:href="aapg-20251231.xsd#aapg_DisclosureOfCapitalManagementExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="DisclosureOfCapitalManagementExplanatory" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCondensedCashFlowStatementsTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="ScheduleOfCondensedCashFlowStatementsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfReservesTableTextBlock" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfReservesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="ScheduleOfReservesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPrincipalSubsidiariesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfPrincipalSubsidiariesAbstract"/>
    <loc xlink:type="locator" xlink:label="CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrincipalSubsidiariesAbstract" xlink:to="CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SuzhouAscentagePharmaCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_SuzhouAscentagePharmaCoLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="SuzhouAscentagePharmaCoLtdMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GuangzhouHealthquestPharmaCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_GuangzhouHealthquestPharmaCoLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="GuangzhouHealthquestPharmaCoLtdMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AscentagePharmaGroupIncMember" xlink:href="aapg-20251231.xsd#aapg_AscentagePharmaGroupIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="AscentagePharmaGroupIncMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SuzhouShengheInnovationWorksBiotechCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="SuzhouShengheInnovationWorksBiotechCoLtdMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfEquityInterestsAttributableToTheCompanyDirect" xlink:href="aapg-20251231.xsd#aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="PercentageOfEquityInterestsAttributableToTheCompanyDirect" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <loc xlink:type="locator" xlink:label="PercentageOfEquityInterestsAttributableToTheCompanyDirect_0" xlink:href="aapg-20251231.xsd#aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfNewAndRevisedIfrssAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfNewAndRevisedIfrssAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNewAndRevisedIfrssAbstract" xlink:to="AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NewIFRSsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NewIFRSsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" xlink:to="ifrs-full_NewIFRSsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IFRSEighteenMember" xlink:href="aapg-20251231.xsd#aapg_IFRSEighteenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="IFRSEighteenMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IFRSNineteenMember" xlink:href="aapg-20251231.xsd#aapg_IFRSNineteenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="IFRSNineteenMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmendmentsToIFRSNineAndIFRSSevenMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIFRSNineAndIFRSSevenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="AmendmentsToIFRSNineAndIFRSSevenMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmendmentsToIFRSNineAndIFRSSevenOneMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="AmendmentsToIFRSNineAndIFRSSevenOneMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmendmentsToIFRSTenAndIFRSTwentyEightMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="AmendmentsToIFRSTenAndIFRSTwentyEightMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmendmentsToIASTwentyOneMember" xlink:href="aapg-20251231.xsd#aapg_AmendmentsToIASTwentyOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="AmendmentsToIASTwentyOneMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccountingStandardsVolume11Member" xlink:href="aapg-20251231.xsd#aapg_AccountingStandardsVolume11Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NewIFRSsAxis" xlink:to="AccountingStandardsVolume11Member" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable" xlink:to="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TitleOfNewIFRS" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TitleOfNewIFRS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="ifrs-full_TitleOfNewIFRS" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract" xlink:to="AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_BuildingsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseholdImprovementsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_LeaseholdImprovementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FurnitureAndEquipmentMember" xlink:href="aapg-20251231.xsd#aapg_FurnitureAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="FurnitureAndEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MotorVehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MotorVehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_MotorVehiclesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRatePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRatePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DepreciationRatePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract" xlink:to="AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ComputerSoftwareMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_LicencesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:to="AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="LeaseholdLandMember" xlink:href="aapg-20251231.xsd#aapg_LeaseholdLandMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="LeaseholdLandMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="ifrs-full_BuildingsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RightofuseAssetsOfEstimatedUsefulLives" xlink:href="aapg-20251231.xsd#aapg_RightofuseAssetsOfEstimatedUsefulLives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems" xlink:to="RightofuseAssetsOfEstimatedUsefulLives" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRevenueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenueAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="OperatingSegmentInformationScheduleofRevenueDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenueAbstract" xlink:to="OperatingSegmentInformationScheduleofRevenueDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingSegmentInformationScheduleofRevenueDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ChineseMainlandMember" xlink:href="aapg-20251231.xsd#aapg_ChineseMainlandMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="ChineseMainlandMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_CH" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_CH" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingSegmentInformationScheduleofRevenueDetailsTable" xlink:to="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems" xlink:to="ifrs-full_Revenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfNonCurrentAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfNonCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNonCurrentAssetsAbstract" xlink:to="OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ChineseMainlandMember" xlink:href="aapg-20251231.xsd#aapg_ChineseMainlandMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="ChineseMainlandMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersMember" xlink:href="aapg-20251231.xsd#aapg_OthersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="OthersMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable" xlink:to="OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenueFromCustomersAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRevenueFromCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable"/>
    <loc xlink:type="locator" xlink:label="OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenueFromCustomersAbstract" xlink:to="OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorCustomersAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" xlink:to="ifrs-full_MajorCustomersAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorCustomersDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="ifrs-full_MajorCustomersDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CustomerAMember" xlink:href="aapg-20251231.xsd#aapg_CustomerAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="CustomerAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerBMember" xlink:href="aapg-20251231.xsd#aapg_CustomerBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="CustomerBMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerCMember" xlink:href="aapg-20251231.xsd#aapg_CustomerCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="CustomerCMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerDMember" xlink:href="aapg-20251231.xsd#aapg_CustomerDMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorCustomersAxis" xlink:to="CustomerDMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable" xlink:to="OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfDisaggregatedRevenueAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDisaggregatedRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDisaggregatedRevenueAbstract" xlink:to="RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TypesOfGoodsOrServicesMember" xlink:href="aapg-20251231.xsd#aapg_TypesOfGoodsOrServicesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="TypesOfGoodsOrServicesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GoodsOrServicesTransferredOverTimeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodsOrServicesTransferredOverTimeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="ifrs-full_GoodsOrServicesTransferredOverTimeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" xlink:to="ifrs-full_ProductsAndServicesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="IntellectualPropertyIncomeMember" xlink:href="aapg-20251231.xsd#aapg_IntellectualPropertyIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="IntellectualPropertyIncomeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ProductsMember" xlink:href="aapg-20251231.xsd#aapg_ProductsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ProductsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="CommercializationRightsIncomeMember" xlink:href="aapg-20251231.xsd#aapg_CommercializationRightsIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="CommercializationRightsIncomeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersMember" xlink:href="aapg-20251231.xsd#aapg_OthersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="OthersMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TypesOfGoodsOrServicesMember_0" xlink:href="aapg-20251231.xsd#aapg_TypesOfGoodsOrServicesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="TypesOfGoodsOrServicesMember_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_Revenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfContractLiabilitiesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfContractLiabilitiesAbstract" xlink:to="RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract"/>
    <loc xlink:type="locator" xlink:label="RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract" xlink:to="RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_NotLaterThanOneYearMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanOneYearMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable" xlink:to="RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems" xlink:to="ifrs-full_RevenueAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RevenueAbstract" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetForeignExchangeGain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetForeignExchangeGain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_NetForeignExchangeGain" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RentalIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RentalIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_RentalIncome" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_OtherGainsLosses" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="ifrs-full_OtherIncome" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfLossBeforeTaxAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfLossBeforeTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSalesRoomOccupancyServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesRoomOccupancyServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_CostOfSalesRoomOccupancyServices" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoryWritedown2011" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoryWritedown2011"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_InventoryWritedown2011" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_DepreciationExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WagesAndSalaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WagesAndSalaries"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_WagesAndSalaries" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossBeforeTaxArrivedCharingOrCrediting" xlink:href="aapg-20251231.xsd#aapg_LossBeforeTaxArrivedCharingOrCrediting"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="LossBeforeTaxArrivedCharingOrCrediting" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialAssetsAtFVTPL" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAtFVTPL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="FinancialAssetsAtFVTPL" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialLiabilitiesAtFVTPL" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtFVTPL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="FinancialLiabilitiesAtFVTPL" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" order="15.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsForGainOnDisposalOfLeases" xlink:href="aapg-20251231.xsd#aapg_AdjustmentsForGainOnDisposalOfLeases"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="AdjustmentsForGainOnDisposalOfLeases" order="16.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="PenaltyExpense" xlink:href="aapg-20251231.xsd#aapg_PenaltyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="PenaltyExpense" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="18.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks" order="19.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AuditorsRemuneration" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AuditorsRemuneration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AuditorsRemuneration" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DonationsAndSubsidiesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DonationsAndSubsidiesExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_DonationsAndSubsidiesExpense" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Penaltys" xlink:href="aapg-20251231.xsd#aapg_Penaltys"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="Penaltys" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossBeforeTaxAbstract" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherExpensesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DonationsAndSubsidiesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DonationsAndSubsidiesExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_DonationsAndSubsidiesExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ForeignExchangeLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ForeignExchangeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_ForeignExchangeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Penalty" xlink:href="aapg-20251231.xsd#aapg_Penalty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherExpensesAbstract" xlink:to="Penalty" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersExpenses" xlink:href="aapg-20251231.xsd#aapg_OthersExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherExpensesAbstract" xlink:to="OthersExpenses" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherExpensesAbstract" xlink:to="ifrs-full_OtherExpenseByNature" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinanceCostsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFinanceCostsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBankLoansAndOverdrafts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinanceCostsAbstract" xlink:to="ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsCapitalised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinanceCostsAbstract" xlink:to="ifrs-full_InterestCostsCapitalised" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinanceCostsAbstract" xlink:to="ifrs-full_InterestExpenseOnBorrowings" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinanceCostsAbstract" xlink:to="ifrs-full_FinanceCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:to="ifrs-full_CurrentTaxExpenseIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:to="ifrs-full_DeferredTaxExpenseIncome" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxComputedAtTheStatutoryTaxRate" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxComputedAtTheStatutoryTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="IncomeTaxComputedAtTheStatutoryTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="LowerTaxRateForASpecificEntity" xlink:href="aapg-20251231.xsd#aapg_LowerTaxRateForASpecificEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="LowerTaxRateForASpecificEntity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StatutoryIncomeAndExpense" xlink:href="aapg-20251231.xsd#aapg_StatutoryIncomeAndExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="StatutoryIncomeAndExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeNotSubjectToTax" xlink:href="aapg-20251231.xsd#aapg_IncomeNotSubjectToTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="IncomeNotSubjectToTax" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ResearchAndDevelopmentSuperdeduction" xlink:href="aapg-20251231.xsd#aapg_ResearchAndDevelopmentSuperdeduction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ResearchAndDevelopmentSuperdeduction" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="GainlossAttributableToJointVentures" xlink:href="aapg-20251231.xsd#aapg_GainlossAttributableToJointVentures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="GainlossAttributableToJointVentures" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NewProvisionsReturn" xlink:href="aapg-20251231.xsd#aapg_NewProvisionsReturn"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="NewProvisionsReturn" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectFromChangeInTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxEffectFromChangeInTaxRate" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UncertainTaxPosition" xlink:href="aapg-20251231.xsd#aapg_UncertainTaxPosition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="UncertainTaxPosition" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EffectOfWithholdingTaxOnTheInterestIncome" xlink:href="aapg-20251231.xsd#aapg_EffectOfWithholdingTaxOnTheInterestIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="EffectOfWithholdingTaxOnTheInterestIncome" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetOperatingLossExpired" xlink:href="aapg-20251231.xsd#aapg_NetOperatingLossExpired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="NetOperatingLossExpired" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeductibleTemporaryDifferencesNotRecognized" xlink:href="aapg-20251231.xsd#aapg_DeductibleTemporaryDifferencesNotRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="DeductibleTemporaryDifferencesNotRecognized" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofBasicLossPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BasicEarningsPerShareAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BasicEarningsPerShareAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfPropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" xlink:href="aapg-20251231.xsd#aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_GrossCarryingAmountMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_BuildingsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseholdImprovementsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OfficeEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_OfficeEquipmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MotorVehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MotorVehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_MotorVehiclesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConstructionInProgressMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ConstructionInProgressMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PropertyAndEquipmentCost" xlink:href="aapg-20251231.xsd#aapg_PropertyAndEquipmentCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="PropertyAndEquipmentCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccumulatedDepreciationsCost" xlink:href="aapg-20251231.xsd#aapg_AccumulatedDepreciationsCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyAndEquipmentCost" xlink:to="AccumulatedDepreciationsCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyAndEquipmentCost" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyAndEquipmentCost" xlink:to="ifrs-full_PropertyPlantAndEquipment_0" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="PropertyAndEquipmentNetOfAccumulatedDepreciation" xlink:href="aapg-20251231.xsd#aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyAndEquipmentCost" xlink:to="PropertyAndEquipmentNetOfAccumulatedDepreciation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PropertyAndEquipmentNetOfAccumulatedDepreciation_0" xlink:href="aapg-20251231.xsd#aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="PropertyAndEquipmentNetOfAccumulatedDepreciation_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="AtDecember312024Abstract" xlink:href="aapg-20251231.xsd#aapg_AtDecember312024Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="AtDecember312024Abstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRightOfUseAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRightOfUseAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesScheduleofRightofUseAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_LeasesScheduleofRightofUseAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRightOfUseAssetsAbstract" xlink:to="LeasesScheduleofRightofUseAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseAssetsDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_BuildingsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseholdLandMember" xlink:href="aapg-20251231.xsd#aapg_LeaseholdLandMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="LeaseholdLandMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseAssetsDetailsTable" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_RightofuseAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_AdditionsToRightofuseAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DepreciationRightofuseAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisposalsRightofuseAssets" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ExchangeRealignmentRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_ExchangeRealignmentRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ExchangeRealignmentRightofuseAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_RightofuseAssets_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_LeaseLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentsofLeaseLiabilities" xlink:href="aapg-20251231.xsd#aapg_PaymentsofLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="PaymentsofLeaseLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ExchangeRealignments" xlink:href="aapg-20251231.xsd#aapg_ExchangeRealignments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ExchangeRealignments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisposalsLeaseLiabilities" xlink:href="aapg-20251231.xsd#aapg_DisposalsLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="DisposalsLeaseLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_LeaseLiabilities_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="AnalyzedIntoAbstract" xlink:href="aapg-20251231.xsd#aapg_AnalyzedIntoAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="AnalyzedIntoAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AnalyzedIntoAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AnalyzedIntoAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="DepreciationChargeofRightofuseAssets" xlink:href="aapg-20251231.xsd#aapg_DepreciationChargeofRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="DepreciationChargeofRightofuseAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalAmountofRecognizedInProfitOrLoss" xlink:href="aapg-20251231.xsd#aapg_TotalAmountofRecognizedInProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="TotalAmountofRecognizedInProfitOrLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofGoodwillTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ChangesInGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="CostGoodwill" xlink:href="aapg-20251231.xsd#aapg_CostGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="CostGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccumulatedImpairmentGoodwill" xlink:href="aapg-20251231.xsd#aapg_AccumulatedImpairmentGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="AccumulatedImpairmentGoodwill" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="ifrs-full_Goodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherIntangibleAssetAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherIntangibleAssetAbstract"/>
    <loc xlink:type="locator" xlink:label="OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" xlink:href="aapg-20251231.xsd#aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherIntangibleAssetLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherIntangibleAssetLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIntangibleAssetAbstract" xlink:to="OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ComputerSoftwareMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PatentMember" xlink:href="aapg-20251231.xsd#aapg_PatentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="PatentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicencesAndFranchisesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesAndFranchisesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_LicencesAndFranchisesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConstructionInProcessMember" xlink:href="aapg-20251231.xsd#aapg_ConstructionInProcessMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ConstructionInProcessMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable" xlink:to="ScheduleOfOtherIntangibleAssetLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIntangibleAssetLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIntangibleAssetLineItems" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIntangibleAssetLineItems" xlink:to="ifrs-full_AmortisationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIntangibleAssetLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsGross" xlink:href="aapg-20251231.xsd#aapg_IntangibleAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIntangibleAssetLineItems" xlink:to="IntangibleAssetsGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccumulatedAmortization" xlink:href="aapg-20251231.xsd#aapg_AccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIntangibleAssetLineItems" xlink:to="AccumulatedAmortization" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIntangibleAssetLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIntangibleAssetLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_2" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInvestmentinaJointVentureTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfInvestmentInAJointVentureAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInvestmentInAJointVentureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInvestmentInAJointVentureAbstract" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfGroupSPrincipalJointVentureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RegisteredShareCapital" xlink:href="aapg-20251231.xsd#aapg_RegisteredShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:to="RegisteredShareCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:to="ifrs-full_ProportionOfOwnershipInterestInJointVenture" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrincipalActivities" xlink:href="aapg-20251231.xsd#aapg_PrincipalActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGroupSPrincipalJointVentureAbstract" xlink:to="PrincipalActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" xlink:href="aapg-20251231.xsd#aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract"/>
    <loc xlink:type="locator" xlink:label="ListedEquityInvestmentsAtFairValue" xlink:href="aapg-20251231.xsd#aapg_ListedEquityInvestmentsAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:to="ListedEquityInvestmentsAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherUnlistedInvestmentsAtFairValue" xlink:href="aapg-20251231.xsd#aapg_OtherUnlistedInvestmentsAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:to="OtherUnlistedInvestmentsAtFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxLineItems" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract" xlink:to="DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember" xlink:href="aapg-20251231.xsd#aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_RightofuseAssetsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable" xlink:to="DeferredTaxLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="ifrs-full_NetDeferredTaxLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="ifrs-full_NetDeferredTaxLiabilities_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="ifrs-full_NetDeferredTaxLiabilities_1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfMovementsInDeferredTaxAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfMovementsInDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMovementsInDeferredTaxAssetsAbstract" xlink:to="DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestatedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="ifrs-full_RestatedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ContractLiabilitiesMember" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ContractLiabilitiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LeaseLiabilitiesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DonationExpensesMember" xlink:href="aapg-20251231.xsd#aapg_DonationExpensesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="DonationExpensesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember" xlink:href="aapg-20251231.xsd#aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets_1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherNonCurrentAssetsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfOtherNonCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ContractAcquisitionCosts" xlink:href="aapg-20251231.xsd#aapg_ContractAcquisitionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="ContractAcquisitionCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentValueAddedTaxReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentValueAddedTaxReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="ifrs-full_LongtermDeposits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPrepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPrepayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentPrepayments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherNonCurrentAssetsAbstract" xlink:to="ifrs-full_OtherNoncurrentAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInventoriesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfInventoriesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WorkInProgress" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WorkInProgress"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_WorkInProgress" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinishedGoods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_FinishedGoods" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_CurrentProvisions" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_Inventories" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofTradeReceivablesNetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract"/>
    <loc xlink:type="locator" xlink:label="TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" xlink:href="aapg-20251231.xsd#aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable"/>
    <loc xlink:type="locator" xlink:label="NetOfLossAllowanceLineItems" xlink:href="aapg-20251231.xsd#aapg_NetOfLossAllowanceLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract" xlink:to="TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FinancialAssetsAgingAxis" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAgingAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" xlink:to="FinancialAssetsAgingAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialAssetsAgingDomainDomain" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAgingDomainDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialAssetsAgingAxis" xlink:to="FinancialAssetsAgingDomainDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TradeReceivablesWithin45DaysMember" xlink:href="aapg-20251231.xsd#aapg_TradeReceivablesWithin45DaysMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialAssetsAgingAxis" xlink:to="TradeReceivablesWithin45DaysMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradeReceivables45To120DaysMember" xlink:href="aapg-20251231.xsd#aapg_TradeReceivables45To120DaysMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialAssetsAgingAxis" xlink:to="TradeReceivables45To120DaysMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable" xlink:to="NetOfLossAllowanceLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetOfLossAllowanceLineItems" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="PrepaymentsForClinicalTrialExpenses" xlink:href="aapg-20251231.xsd#aapg_PrepaymentsForClinicalTrialExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="PrepaymentsForClinicalTrialExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaidListingExpense" xlink:href="aapg-20251231.xsd#aapg_PrepaidListingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="PrepaidListingExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ValueAddedTaxReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="ifrs-full_ValueAddedTaxReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="ifrs-full_OtherReceivables" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DepositsAssetsPrepayments" xlink:href="aapg-20251231.xsd#aapg_DepositsAssetsPrepayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="DepositsAssetsPrepayments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaymentForTreasurySharePurchaseFees" xlink:href="aapg-20251231.xsd#aapg_PrepaymentForTreasurySharePurchaseFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="PrepaymentForTreasurySharePurchaseFees" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Prepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Prepayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="ifrs-full_Prepayments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPrepaymentsAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCashAndBankBalancesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCashAndBankBalancesAbstract"/>
    <loc xlink:type="locator" xlink:label="CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCashAndBankBalancesLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCashAndBankBalancesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCashAndBankBalancesAbstract" xlink:to="CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_CN" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CN"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_CN" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_HK"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_HK" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersMember" xlink:href="aapg-20251231.xsd#aapg_OthersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="OthersMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandBankBalancesScheduleofCashandBankBalancesDetailsTable" xlink:to="ScheduleOfCashAndBankBalancesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_CashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepositsFromBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepositsFromBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_DepositsFromBanks" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BalancesWithBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BalancesWithBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_BalancesWithBanks" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCashAndBankBalancesLineItems" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheTradePayablesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTheTradePayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="TradePayablesScheduleoftheTradePayablesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_TradePayablesScheduleoftheTradePayablesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfTheTradePayablesLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTheTradePayablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheTradePayablesAbstract" xlink:to="TradePayablesScheduleoftheTradePayablesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TradePayablesScheduleoftheTradePayablesDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="WithinOneMonthMember" xlink:href="aapg-20251231.xsd#aapg_WithinOneMonthMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="WithinOneMonthMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OneToThreeMonthsMember" xlink:href="aapg-20251231.xsd#aapg_OneToThreeMonthsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="OneToThreeMonthsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThreeToSixMonthsMember" xlink:href="aapg-20251231.xsd#aapg_ThreeToSixMonthsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ThreeToSixMonthsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TradePayablesScheduleoftheTradePayablesDetailsTable" xlink:to="ScheduleOfTheTradePayablesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheTradePayablesLineItems" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccrualsClassifiedAsCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccrualsClassifiedAsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_AccrualsClassifiedAsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurretPayablesForConstructionCost" xlink:href="aapg-20251231.xsd#aapg_CurretPayablesForConstructionCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="CurretPayablesForConstructionCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_OtherPayables" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GovernmentSubsidy" xlink:href="aapg-20251231.xsd#aapg_GovernmentSubsidy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="GovernmentSubsidy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentExciseTaxPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentExciseTaxPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_CurrentExciseTaxPayables" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_OtherCurrentPayables" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfContractLiabilitiesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfContractLiabilitiesAbstract" xlink:to="ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfCustomersAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" xlink:to="ifrs-full_TypesOfCustomersAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfCustomersDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfCustomersAxis" xlink:to="ifrs-full_TypesOfCustomersDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ShorttermAdvancesRecognizedFromCustomersMember" xlink:href="aapg-20251231.xsd#aapg_ShorttermAdvancesRecognizedFromCustomersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfCustomersAxis" xlink:to="ShorttermAdvancesRecognizedFromCustomersMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LongtermAdvancesRecognizedFromCustomersMember" xlink:href="aapg-20251231.xsd#aapg_LongtermAdvancesRecognizedFromCustomersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfCustomersAxis" xlink:to="LongtermAdvancesRecognizedFromCustomersMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable" xlink:to="ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems" xlink:to="ifrs-full_ContractLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract"/>
    <loc xlink:type="locator" xlink:label="InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract" xlink:to="InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ShortTermBorrowingMember" xlink:href="aapg-20251231.xsd#aapg_ShortTermBorrowingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ShortTermBorrowingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentPortionOfLongTermBankLoansUnsecuredMember" xlink:href="aapg-20251231.xsd#aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="CurrentPortionOfLongTermBankLoansUnsecuredMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentPortionOfLongTermBankLoansUnsecuredOneMember" xlink:href="aapg-20251231.xsd#aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="CurrentPortionOfLongTermBankLoansUnsecuredOneMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentPortionOfLongTermBankLoansSecuredMember" xlink:href="aapg-20251231.xsd#aapg_CurrentPortionOfLongTermBankLoansSecuredMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="CurrentPortionOfLongTermBankLoansSecuredMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseLiabilitiesCurrentMember" xlink:href="aapg-20251231.xsd#aapg_LeaseLiabilitiesCurrentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="LeaseLiabilitiesCurrentMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BankLoansUnsecuredMember" xlink:href="aapg-20251231.xsd#aapg_BankLoansUnsecuredMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BankLoansUnsecuredMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BankLoansUnsecuredOneMember" xlink:href="aapg-20251231.xsd#aapg_BankLoansUnsecuredOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BankLoansUnsecuredOneMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BankLoansSecuredMember" xlink:href="aapg-20251231.xsd#aapg_BankLoansSecuredMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BankLoansSecuredMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseLiabilitiesNonCurrentMember" xlink:href="aapg-20251231.xsd#aapg_LeaseLiabilitiesNonCurrentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="LeaseLiabilitiesNonCurrentMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRateBasis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_BorrowingsInterestRateBasis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsMaturity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsMaturity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_BorrowingsMaturity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_ShorttermBorrowings" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRateBasis_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsMaturity_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsMaturity"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_LongtermBorrowings" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems" xlink:to="ifrs-full_Borrowings" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRateBasis_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsMaturity_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsMaturity"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRateBasis_2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsMaturity_2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsMaturity"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract"/>
    <loc xlink:type="locator" xlink:label="InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract" xlink:to="InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_NotLaterThanOneYearMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanFiveYearsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable" xlink:to="ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AnalyzedIntoAbstract0" xlink:href="aapg-20251231.xsd#aapg_AnalyzedIntoAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems" xlink:to="AnalyzedIntoAbstract0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AnalyzedIntoAbstract0" xlink:to="ifrs-full_Borrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofDeferredIncomeTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredIncomeAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfDeferredIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredIncomeAbstract" xlink:to="ifrs-full_CurrentGovernmentGrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="MovementsInGovernmentGrantsAbstract" xlink:href="aapg-20251231.xsd#aapg_MovementsInGovernmentGrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementsInGovernmentGrantsAbstract" xlink:to="ifrs-full_GovernmentGrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="RecognizedAsIncomeDuringTheYear" xlink:href="aapg-20251231.xsd#aapg_RecognizedAsIncomeDuringTheYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementsInGovernmentGrantsAbstract" xlink:to="RecognizedAsIncomeDuringTheYear" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PortionClassifiedAsCurrentLiabilities" xlink:href="aapg-20251231.xsd#aapg_PortionClassifiedAsCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementsInGovernmentGrantsAbstract" xlink:to="PortionClassifiedAsCurrentLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementsInGovernmentGrantsAbstract" xlink:to="ifrs-full_GovernmentGrants_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfIssuedAndFullyPaidAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfIssuedAndFullyPaidAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIssuedAndFullyPaidAbstract" xlink:to="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalMember" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ShareCapitalMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_Equity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfIssuedAndFullyPaidAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfIssuedAndFullyPaidAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIssuedAndFullyPaidAbstract" xlink:to="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalMember" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ShareCapitalMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ParValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareCapitalAndTreasurySharesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfShareCapitalAndTreasurySharesAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareCapitalAndTreasurySharesAbstract" xlink:to="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_OrdinarySharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_IssuedCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasurySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_TreasurySharesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable" xlink:to="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedShareCapital" xlink:href="aapg-20251231.xsd#aapg_IssuedShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IssuedShareCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfOrdinaryShare" xlink:href="aapg-20251231.xsd#aapg_IssueOfOrdinaryShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IssueOfOrdinaryShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_IssueOfOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IssueOfOrdinaryShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" xlink:href="aapg-20251231.xsd#aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IssueOfSharesUnderThePreIPOShareOptionSchemeinShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfSharesUnderThePreIPOShareOptionScheme" xlink:href="aapg-20251231.xsd#aapg_IssueOfSharesUnderThePreIPOShareOptionScheme"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IssueOfSharesUnderThePreIPOShareOptionScheme" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfSharesUnderThe2021RSUSchemeInshares" xlink:href="aapg-20251231.xsd#aapg_IssueOfSharesUnderThe2021RSUSchemeInshares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IssueOfSharesUnderThe2021RSUSchemeInshares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInNumberOfSharesEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IncreaseDecreaseInNumberOfSharesEquitysettledBonus" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValuesEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValuesEquitysettledBonus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="StockIssuedDuringPeriodValuesEquitysettledBonus" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RepurchaseOfOrdinaryShare" xlink:href="aapg-20251231.xsd#aapg_RepurchaseOfOrdinaryShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="RepurchaseOfOrdinaryShare" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VestingOfRestrictedShareUnit" xlink:href="aapg-20251231.xsd#aapg_VestingOfRestrictedShareUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="VestingOfRestrictedShareUnit" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VestingOfRestrictedShareUnits" xlink:href="aapg-20251231.xsd#aapg_VestingOfRestrictedShareUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="VestingOfRestrictedShareUnits" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued_0" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedShareCapital_0" xlink:href="aapg-20251231.xsd#aapg_IssuedShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IssuedShareCapital_0" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued_1" order="16.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedShareCapital_1" xlink:href="aapg-20251231.xsd#aapg_IssuedShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems" xlink:to="IssuedShareCapital_1" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract" xlink:to="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PostIPOOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PostIPOOptionSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="PostIPOOptionSchemeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable" xlink:to="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract" xlink:to="ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember" xlink:href="aapg-20251231.xsd#aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember" xlink:href="aapg-20251231.xsd#aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember" xlink:href="aapg-20251231.xsd#aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwentySixNov202526Nov2035Member" xlink:href="aapg-20251231.xsd#aapg_TwentySixNov202526Nov2035Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TwentySixNov202526Nov2035Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValuesOfShareOptionsGrantedAbstract" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfUnlockingDateAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfUnlockingDateAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUnlockingDateAbstract" xlink:to="ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyOneRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOneRSUSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="TwoThousandTwentyOneRSUSchemeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyTwoRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="TwoThousandTwentyTwoRSUSchemeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyTwoFurtherGrantMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoFurtherGrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="TwoThousandTwentyTwoFurtherGrantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipantsOneMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipantsOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipantsTwoMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipantsTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipantsThreeMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipantsThreeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipantsFourMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsFourMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipantsFourMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipantsFiveMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsFiveMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipantsFiveMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipantsSixMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipantsSixMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipantsSixMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants1OneMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants1OneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants1OneMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants1ThreeMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants1ThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants1ThreeMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants2FourMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants2FourMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants2FourMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants2ThreeMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants2ThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants2ThreeMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants7Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants7Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants7Member" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants8Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants8Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants8Member" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants9Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants9Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants9Member" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants10Member" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants10Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants10Member" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants1TwoMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants1TwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants1TwoMember" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TypeOfEligibleParticipants2OneMember" xlink:href="aapg-20251231.xsd#aapg_TypeOfEligibleParticipants2OneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TypeOfEligibleParticipants2OneMember" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofUnlockingDateDetailsTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfConditionalShares" xlink:href="aapg-20251231.xsd#aapg_PercentageOfConditionalShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="PercentageOfConditionalShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfVestedConditionalShares" xlink:href="aapg-20251231.xsd#aapg_PercentageOfVestedConditionalShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="PercentageOfVestedConditionalShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRestrictedSharesOutstandingAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfRestrictedSharesOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestrictedSharesOutstandingAbstract" xlink:to="ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyOnesRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOnesRSUSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="TwoThousandTwentyOnesRSUSchemeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyTwoRSUchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="TwoThousandTwentyTwoRSUchemeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccruedInterestInOtherPayablesAndAccrualsMember" xlink:href="aapg-20251231.xsd#aapg_AccruedInterestInOtherPayablesAndAccrualsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="AccruedInterestInOtherPayablesAndAccrualsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BankAndOtherLoansMember" xlink:href="aapg-20251231.xsd#aapg_BankAndOtherLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="BankAndOtherLoansMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseLiabilityMember" xlink:href="aapg-20251231.xsd#aapg_LeaseLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="LeaseLiabilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_InterestExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashInflowOutflowForLease" xlink:href="aapg-20251231.xsd#aapg_CashInflowOutflowForLease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="CashInflowOutflowForLease" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfTransactionWithRelatedPartyAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfTransactionWithRelatedPartyAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionWithRelatedPartyAbstract" xlink:to="RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="DrZhaiYifanMember" xlink:href="aapg-20251231.xsd#aapg_DrZhaiYifanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="DrZhaiYifanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DrYangDajunMember" xlink:href="aapg-20251231.xsd#aapg_DrYangDajunMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="DrYangDajunMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="OtherPayablesAndAccruals" xlink:href="aapg-20251231.xsd#aapg_OtherPayablesAndAccruals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="OtherPayablesAndAccruals" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OutstandingBalanceOtherNoncurrentLiabilities" xlink:href="aapg-20251231.xsd#aapg_OutstandingBalanceOtherNoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="OutstandingBalanceOtherNoncurrentLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OutstandingBalanceWithRelatedParty" xlink:href="aapg-20251231.xsd#aapg_OutstandingBalanceWithRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="OutstandingBalanceWithRelatedParty" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCategoriesOfFinancialInstrumentsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCategoriesOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsAbstract" xlink:to="FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FinancialLiabilitiesAtFairValueThroughProfitOrLossMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="FinancialLiabilitiesAtFairValueThroughProfitOrLossMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FinancialAssetsAtFairValueThroughProfitOrLossMember" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="FinancialAssetsAtFairValueThroughProfitOrLossMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialAssetsAtAmortizedCostMember" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsAtAmortizedCostMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="FinancialAssetsAtAmortizedCostMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialAssetsMember" xlink:href="aapg-20251231.xsd#aapg_FinancialAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="FinancialAssetsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialLiabilitiesAtAmortizedCostMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtAmortizedCostMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="FinancialLiabilitiesAtAmortizedCostMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialLiabilitiesMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="FinancialLiabilitiesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialLiabilitiesAtFairValueThroughProfitOrLossMember_0" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="FinancialLiabilitiesAtFairValueThroughProfitOrLossMember_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable" xlink:to="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_NoncurrentReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_FinancialAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCategoriesOfFinancialInstrumentsLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialInstrumentsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialInstrumentsAbstract" xlink:to="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_GrossCarryingAmountMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" xlink:to="ifrs-full_MeasurementAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_AtFairValueMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable" xlink:to="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="ifrs-full_CategoriesOfFinancialAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:to="ifrs-full_FinancialAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems" xlink:to="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_LongtermBorrowings" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:to="ifrs-full_FinancialLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfAssetsMeasuredAtFairValueAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfAssetsMeasuredAtFairValueAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAssetsMeasuredAtFairValueAbstract" xlink:to="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_Level1OfFairValueHierarchyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable" xlink:to="ifrs-full_DisclosureOfFinancialAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfInterestRateRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfInterestRateRiskAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInterestRateRiskAbstract" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IncreasedecreaseInBasisPointsMember" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseInBasisPointsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="IncreasedecreaseInBasisPointsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreasedecreaseInLossBeforeTaxMember" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseInLossBeforeTaxMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="IncreasedecreaseInLossBeforeTaxMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="a2024Abstract" xlink:href="aapg-20251231.xsd#aapg_a2024Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems" xlink:to="a2024Abstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRateBasis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="a2024Abstract" xlink:to="ifrs-full_BorrowingsInterestRateBasis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreasedecreaseInLossBeforeTax" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseInLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="a2024Abstract" xlink:to="IncreasedecreaseInLossBeforeTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfForeignCurrencyRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfForeignCurrencyRiskAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfForeignCurrencyRiskAbstract" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ChangeInForeignExchangeRatesAxis" xlink:href="aapg-20251231.xsd#aapg_ChangeInForeignExchangeRatesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" xlink:to="ChangeInForeignExchangeRatesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IfRMBWeakensAgainstUSDollarsMember" xlink:href="aapg-20251231.xsd#aapg_IfRMBWeakensAgainstUSDollarsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeInForeignExchangeRatesAxis" xlink:to="IfRMBWeakensAgainstUSDollarsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IfRMBStrengthensAgainstUSDollarsMember" xlink:href="aapg-20251231.xsd#aapg_IfRMBStrengthensAgainstUSDollarsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeInForeignExchangeRatesAxis" xlink:to="IfRMBStrengthensAgainstUSDollarsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsAndLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" xlink:to="ifrs-full_AssetsAndLiabilitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MonetaryAssetsMember" xlink:href="aapg-20251231.xsd#aapg_MonetaryAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAndLiabilitiesAxis" xlink:to="MonetaryAssetsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable" xlink:to="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IncreasedecreaseWeakensAgainst" xlink:href="aapg-20251231.xsd#aapg_IncreasedecreaseWeakensAgainst"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:to="IncreasedecreaseWeakensAgainst" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems" xlink:to="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="Stage1Member" xlink:href="aapg-20251231.xsd#aapg_Stage1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="Stage1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StageTwoMember" xlink:href="aapg-20251231.xsd#aapg_StageTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="StageTwoMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StageThreeMember" xlink:href="aapg-20251231.xsd#aapg_StageThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="StageThreeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SimplifiedApproachMember" xlink:href="aapg-20251231.xsd#aapg_SimplifiedApproachMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="SimplifiedApproachMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable" xlink:to="ifrs-full_DisclosureOfCreditRiskExposureLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="CashAndBankBalancesNotYetPastDue" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesNotYetPastDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="CashAndBankBalancesNotYetPastDue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="ifrs-full_TradeReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:to="ifrs-full_FinancialAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfLiquidityRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfLiquidityRiskAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLiquidityRiskAbstract" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OnDemandMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OnDemandMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_OnDemandMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_NotLaterThanOneYearMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanFiveYearsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TradePayablesMember" xlink:href="aapg-20251231.xsd#aapg_TradePayablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="TradePayablesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_LeaseLiabilitiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember" xlink:href="aapg-20251231.xsd#aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember" xlink:href="aapg-20251231.xsd#aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherNonCurrentLiabilityMember" xlink:href="aapg-20251231.xsd#aapg_OtherNonCurrentLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="OtherNonCurrentLiabilityMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DerivativeFinancialInstrumentsMember" xlink:href="aapg-20251231.xsd#aapg_DerivativeFinancialInstrumentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="DerivativeFinancialInstrumentsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_LeaseLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_OtherBorrowings" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_OtherPayables" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DerivativeFinancialAssetsHeldForHedging" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DerivativeFinancialAssetsHeldForHedging"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_DerivativeFinancialAssetsHeldForHedging" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfEquityPriceRiskAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfEquityPriceRiskAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityPriceRiskAbstract" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" xlink:to="ifrs-full_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MarketEquityIndex" xlink:href="aapg-20251231.xsd#aapg_MarketEquityIndex"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" xlink:to="MarketEquityIndex" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockExchangeIndexShare" xlink:href="aapg-20251231.xsd#aapg_StockExchangeIndexShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems" xlink:to="StockExchangeIndexShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValuesOfTheEquityInvestmentsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfFairValuesOfTheEquityInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValuesOfTheEquityInvestmentsAbstract" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CarryingAmountOfEquityInvestmentsMember" xlink:href="aapg-20251231.xsd#aapg_CarryingAmountOfEquityInvestmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="CarryingAmountOfEquityInvestmentsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseincreaseInLossBeforeTaxMember" xlink:href="aapg-20251231.xsd#aapg_DecreaseincreaseInLossBeforeTaxMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="DecreaseincreaseInLossBeforeTaxMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InvestmentsListedInAbstract" xlink:href="aapg-20251231.xsd#aapg_InvestmentsListedInAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems" xlink:to="InvestmentsListedInAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsListedInAbstract" xlink:to="ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsListedInAbstract" xlink:to="ifrs-full_FinancialAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCapitalManagementAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCapitalManagementAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCapitalManagementAbstract" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" xlink:to="ifrs-full_CategoriesOfFinancialAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CapitalManagementMember" xlink:href="aapg-20251231.xsd#aapg_CapitalManagementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="CapitalManagementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable" xlink:to="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_OtherBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_OtherPayables" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDebt" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_NetDebt" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustedCapitals" xlink:href="aapg-20251231.xsd#aapg_AdjustedCapitals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="AdjustedCapitals" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfStatementsOfFinancialPositionAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfStatementsOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStatementsOfFinancialPositionAbstract" xlink:to="srt_CondensedBalanceSheetStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_ParentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="srt_CondensedBalanceSheetStatementsCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NoncurrentAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiaries"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_InvestmentsInSubsidiaries" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_OtherNoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_CurrentAssetsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReceivablesDueFromAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesDueFromAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_ReceivablesDueFromAssociates" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_CurrentLiabilitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentPayables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_CurrentAssetsLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_AssetsLessCurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetAssetsLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_NetAssetsLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_EquityAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_IssuedCapital" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_TreasuryShares" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReserves" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_OtherReserves" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExchangeFluctuationReserve" xlink:href="aapg-20251231.xsd#aapg_ExchangeFluctuationReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ExchangeFluctuationReserve" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_RetainedEarnings" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_Equity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedStatementOfComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="srt_CondensedStatementOfComprehensiveIncomeTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedStatementOfComprehensiveIncomeTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_ParentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedStatementOfComprehensiveIncomeTable" xlink:to="srt_CondensedStatementOfIncomeCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OtherGainsLosses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OperatingExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByNature"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OtherExpenseByNature" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_ProfitLossBeforeTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_ProfitLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="ifrs-full_OtherComprehensiveIncome" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCondensedStatementsOfCashFlowsAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCondensedStatementsOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCondensedStatementsOfCashFlowsAbstract" xlink:to="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_ParentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable" xlink:to="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompanySReservesAbstract" xlink:href="aapg-20251231.xsd#aapg_ScheduleOfCompanySReservesAbstract"/>
    <loc xlink:type="locator" xlink:label="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanySReservesAbstract" xlink:to="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserveMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalReserveMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_CapitalReserveMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_RetainedEarningsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_ParentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable" xlink:to="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_NoncontrollingInterests" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_ProfitLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherComprehensiveIncomeForTheYearAbstract2" xlink:href="aapg-20251231.xsd#aapg_OtherComprehensiveIncomeForTheYearAbstract2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="OtherComprehensiveIncomeForTheYearAbstract2" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherComprehensiveIncomeForTheYearAbstract2" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ComprehensiveIncomeLoss" xlink:href="aapg-20251231.xsd#aapg_ComprehensiveIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ComprehensiveIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmployeesShareBasedCompensationSchemeAbstract" xlink:href="aapg-20251231.xsd#aapg_EmployeesShareBasedCompensationSchemeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="EmployeesShareBasedCompensationSchemeAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreIPOShareOptionExpenses" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeesShareBasedCompensationSchemeAbstract" xlink:to="PreIPOShareOptionExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeesShareBasedCompensationSchemeAbstract" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RestrictedShareUnitExpenses" xlink:href="aapg-20251231.xsd#aapg_RestrictedShareUnitExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeesShareBasedCompensationSchemeAbstract" xlink:to="RestrictedShareUnitExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeesShareBasedCompensationSchemeAbstract" xlink:to="StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueVestingOfRSUs" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueVestingOfRSUs"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeesShareBasedCompensationSchemeAbstract" xlink:to="StockIssuedDuringPeriodValueVestingOfRSUs" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueEquitysettledBonus" xlink:href="aapg-20251231.xsd#aapg_StockIssuedDuringPeriodValueEquitysettledBonus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeesShareBasedCompensationSchemeAbstract" xlink:to="StockIssuedDuringPeriodValueEquitysettledBonus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_NoncontrollingInterests_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems" xlink:to="ifrs-full_NoncontrollingInterests_1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/AccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_AccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="AccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesDetailsTable" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OtherEmployeeBenefitContributionPercentage" xlink:href="aapg-20251231.xsd#aapg_OtherEmployeeBenefitContributionPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="OtherEmployeeBenefitContributionPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AnnualBaseSalaryPercentage" xlink:href="aapg-20251231.xsd#aapg_AnnualBaseSalaryPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="AnnualBaseSalaryPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingJudgementsandEstimatesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_SignificantAccountingJudgementsandEstimatesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="SignificantAccountingJudgementsandEstimatesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesAxis" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingJudgementsandEstimatesDetailsTable" xlink:to="IncomeTaxesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDomainDomain" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxesDomainDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesAxis" xlink:to="IncomeTaxesDomainDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TaxesMember" xlink:href="aapg-20251231.xsd#aapg_TaxesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesAxis" xlink:to="TaxesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingJudgementsandEstimatesDetailsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnusedTaxLossesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_UnusedTaxLossesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingJudgementsandEstimatesDetailsTable" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/OperatingSegmentInformationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/IncomeTaxDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxDetailsTable" xlink:href="aapg-20251231.xsd#aapg_IncomeTaxDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="IncomeTaxDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_HK"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_HK" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChineseMainlandMember" xlink:href="aapg-20251231.xsd#aapg_ChineseMainlandMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="ChineseMainlandMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="SuzhouYashengMember" xlink:href="aapg-20251231.xsd#aapg_SuzhouYashengMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="SuzhouYashengMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="HighAndNewTechnologyEnterpriseMember" xlink:href="aapg-20251231.xsd#aapg_HighAndNewTechnologyEnterpriseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="HighAndNewTechnologyEnterpriseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDetailsTable" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_ApplicableTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreferentialRate" xlink:href="aapg-20251231.xsd#aapg_PreferentialRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="PreferentialRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WithholdingTax" xlink:href="aapg-20251231.xsd#aapg_WithholdingTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="WithholdingTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/LeasesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_LeasesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LeasesLineItems" xlink:href="aapg-20251231.xsd#aapg_LeasesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="LeasesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_LandAndBuildingsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsTable" xlink:to="LeasesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TermsOfLandLease" xlink:href="aapg-20251231.xsd#aapg_TermsOfLandLease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesLineItems" xlink:to="TermsOfLandLease" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseTerms" xlink:href="aapg-20251231.xsd#aapg_LeaseTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesLineItems" xlink:to="LeaseTerms" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/GoodwillDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/DeferredTaxDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxDetailsTable" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxDetailsTable"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxLineItems" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxDetailsTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ChineseMainlandMember" xlink:href="aapg-20251231.xsd#aapg_ChineseMainlandMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ChineseMainlandMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxDetailsTable" xlink:to="DeferredTaxLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="FutureTaxableProfitsPercentage" xlink:href="aapg-20251231.xsd#aapg_FutureTaxableProfitsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="FutureTaxableProfitsPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TaxCredits" xlink:href="aapg-20251231.xsd#aapg_TaxCredits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="TaxCredits" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrecognizedTaxBenefit" xlink:href="aapg-20251231.xsd#aapg_UnrecognizedTaxBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="UnrecognizedTaxBenefit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsTaxLossCarryforwards" xlink:href="aapg-20251231.xsd#aapg_DeferredTaxAssetsTaxLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="DeferredTaxAssetsTaxLossCarryforwards" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrecognizedTaxBenefitsRecognized" xlink:href="aapg-20251231.xsd#aapg_UnrecognizedTaxBenefitsRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLineItems" xlink:to="UnrecognizedTaxBenefitsRecognized" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/CashandBankBalancesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="CashAndBankBalancesAbstract" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesAbstract"/>
    <loc xlink:type="locator" xlink:label="CashandBankBalancesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CashandBankBalancesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CashAndBankBalancesLineItems" xlink:href="aapg-20251231.xsd#aapg_CashAndBankBalancesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndBankBalancesAbstract" xlink:to="CashandBankBalancesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandBankBalancesDetailsTable" xlink:to="srt_CurrencyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_CNY"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CurrencyAxis" xlink:to="currency_CNY" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="currency_USD" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_USD"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CurrencyAxis" xlink:to="currency_USD" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandBankBalancesDetailsTable" xlink:to="CashAndBankBalancesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndBankBalancesAtCentralBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndBankBalancesAtCentralBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndBankBalancesLineItems" xlink:to="ifrs-full_CashAndBankBalancesAtCentralBanks" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ContractLiabilitiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ContractLiabilitiesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ContractLiabilitiesLineItems" xlink:href="aapg-20251231.xsd#aapg_ContractLiabilitiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ContractLiabilitiesAbstract" xlink:to="ContractLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractLiabilitiesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InnoventBiologicsSuzhouCoLtdMember" xlink:href="aapg-20251231.xsd#aapg_InnoventBiologicsSuzhouCoLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="InnoventBiologicsSuzhouCoLtdMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractLiabilitiesDetailsTable" xlink:to="ContractLiabilitiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractLiabilitiesLineItems" xlink:to="ifrs-full_ContractLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractLiabilitiesLineItems" xlink:to="ifrs-full_Revenue" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAbstract"/>
    <loc xlink:type="locator" xlink:label="InterestBearingBankandOtherBorrowingsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankandOtherBorrowingsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsAbstract" xlink:to="InterestBearingBankandOtherBorrowingsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis" xlink:to="ifrs-full_RightofuseAssetsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LloanPrimeRateMember" xlink:href="aapg-20251231.xsd#aapg_LloanPrimeRateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="LloanPrimeRateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConstructionInProgressMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ConstructionInProgressMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_RightofuseAssetsMember_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_BuildingsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SecuredBankBorrowingsMember" xlink:href="aapg-20251231.xsd#aapg_SecuredBankBorrowingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="SecuredBankBorrowingsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestBearingBankandOtherBorrowingsDetailsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_ShorttermBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_Borrowings" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnsecuredBankLoansReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnsecuredBankLoansReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_UnsecuredBankLoansReceived" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalandTreasurySharesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalandTreasurySharesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ShareCapitalandTreasurySharesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TreasurySharesOneMember" xlink:href="aapg-20251231.xsd#aapg_TreasurySharesOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="TreasurySharesOneMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyTwoRSUchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="TwoThousandTwentyTwoRSUchemeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreIPOShareOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="PreIPOShareOptionSchemeMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyOneRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOneRSUSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="TwoThousandTwentyOneRSUSchemeMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesDetailsTable" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RestrictedShareUnitMember" xlink:href="aapg-20251231.xsd#aapg_RestrictedShareUnitMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="RestrictedShareUnitMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesDetailsTable" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalMember" xlink:href="aapg-20251231.xsd#aapg_ShareCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ShareCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="HongKongStockExchangeMember" xlink:href="aapg-20251231.xsd#aapg_HongKongStockExchangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="HongKongStockExchangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TreasurySharesOneMember_0" xlink:href="aapg-20251231.xsd#aapg_TreasurySharesOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="TreasurySharesOneMember_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandTreasurySharesDetailsTable" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfOrdinaryShare" xlink:href="aapg-20251231.xsd#aapg_IssueOfOrdinaryShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="IssueOfOrdinaryShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageExercisePrice" xlink:href="aapg-20251231.xsd#aapg_WeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="WeightedAverageExercisePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IssuedCapital" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfTreasuryShares" xlink:href="aapg-20251231.xsd#aapg_NumberOfTreasuryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="NumberOfTreasuryShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BonusDueToEmployeesAmount" xlink:href="aapg-20251231.xsd#aapg_BonusDueToEmployeesAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="BonusDueToEmployeesAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharesConsiderationAmount" xlink:href="aapg-20251231.xsd#aapg_SharesConsiderationAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="SharesConsiderationAmount" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubscriptionOfShares" xlink:href="aapg-20251231.xsd#aapg_SubscriptionOfShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="SubscriptionOfShares" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllottedSharesPricePerShares" xlink:href="aapg-20251231.xsd#aapg_AllottedSharesPricePerShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="AllottedSharesPricePerShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockPurchasedDuringPeriodShares" xlink:href="aapg-20251231.xsd#aapg_StockPurchasedDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="StockPurchasedDuringPeriodShares" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ReservesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ReservesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ReservesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:to="ReservesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReservesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ReservesMember" xlink:href="aapg-20251231.xsd#aapg_ReservesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ReservesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReservesDetailsTable" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedShareUnitsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedShareUnitsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_RestrictedShareUnitsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReservesDetailsTable" xlink:to="ifrs-full_DisclosureOfReservesWithinEquityLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserve" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="ifrs-full_CapitalReserve" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="ifrs-full_SharePremium" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransferredOutFromCapitalAndReserves" xlink:href="aapg-20251231.xsd#aapg_TransferredOutFromCapitalAndReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="TransferredOutFromCapitalAndReserves" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalAndReserveFunds" xlink:href="aapg-20251231.xsd#aapg_CapitalAndReserveFunds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="CapitalAndReserveFunds" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BonusAmount" xlink:href="aapg-20251231.xsd#aapg_BonusAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="BonusAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReservesWithinEquityLineItems" xlink:to="ifrs-full_ParValuePerShare" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_ShareBasedPaymentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract" xlink:to="ShareBasedPaymentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ForecastMember" xlink:href="aapg-20251231.xsd#aapg_ForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PreIPOShareOptionsMember" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="PreIPOShareOptionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_ShareOptionSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ShareOptionSchemeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SpecialOptionsMember" xlink:href="aapg-20251231.xsd#aapg_SpecialOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="SpecialOptionsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreIPOShareOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PreIPOShareOptionSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="PreIPOShareOptionSchemeMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PostIPOOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PostIPOOptionSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="PostIPOOptionSchemeMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedShareUnitsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestrictedShareUnitsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_RestrictedShareUnitsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandEighteenRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandEighteenRSUSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="TwoThousandEighteenRSUSchemeMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyOnesRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOnesRSUSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="TwoThousandTwentyOnesRSUSchemeMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyTwoRSUchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="TwoThousandTwentyTwoRSUchemeMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyTwoFurtherGrantMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoFurtherGrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="TwoThousandTwentyTwoFurtherGrantMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NonExecutiveDirectorMember" xlink:href="aapg-20251231.xsd#aapg_NonExecutiveDirectorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="NonExecutiveDirectorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChiefCommercialOfficerMember" xlink:href="aapg-20251231.xsd#aapg_ChiefCommercialOfficerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ChiefCommercialOfficerMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DrZhaiYifanMember" xlink:href="aapg-20251231.xsd#aapg_DrZhaiYifanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="DrZhaiYifanMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DrYangDajunMember" xlink:href="aapg-20251231.xsd#aapg_DrYangDajunMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="DrYangDajunMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantAnniversariesAxis" xlink:href="aapg-20251231.xsd#aapg_GrantAnniversariesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsDetailsTable" xlink:to="GrantAnniversariesAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantAnniversariesDomainDomain" xlink:href="aapg-20251231.xsd#aapg_GrantAnniversariesDomainDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GrantAnniversariesAxis" xlink:to="GrantAnniversariesDomainDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FirstAnniversariesMember" xlink:href="aapg-20251231.xsd#aapg_FirstAnniversariesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GrantAnniversariesAxis" xlink:to="FirstAnniversariesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecondAnniversaryMember" xlink:href="aapg-20251231.xsd#aapg_SecondAnniversaryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GrantAnniversariesAxis" xlink:to="SecondAnniversaryMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThirdAnniversaryMember" xlink:href="aapg-20251231.xsd#aapg_ThirdAnniversaryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GrantAnniversariesAxis" xlink:to="ThirdAnniversaryMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FourthAnniversaryMember" xlink:href="aapg-20251231.xsd#aapg_FourthAnniversaryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GrantAnniversariesAxis" xlink:to="FourthAnniversaryMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsDetailsTable" xlink:to="ifrs-full_CategoriesOfFinancialAssetsAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="ifrs-full_CategoriesOfFinancialAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RSUMember" xlink:href="aapg-20251231.xsd#aapg_RSUMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="RSUMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentsDetailsTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareGrantExpense" xlink:href="aapg-20251231.xsd#aapg_ShareGrantExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ShareGrantExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalOrdinaryShares" xlink:href="aapg-20251231.xsd#aapg_AdditionalOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="AdditionalOrdinaryShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_SharePremium" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserve" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_CapitalReserve" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfExceedShareCapital" xlink:href="aapg-20251231.xsd#aapg_PercentageOfExceedShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="PercentageOfExceedShareCapital" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateShareIssued" xlink:href="aapg-20251231.xsd#aapg_AggregateShareIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="AggregateShareIssued" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesGranted" xlink:href="aapg-20251231.xsd#aapg_SharesGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="SharesGranted" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfVestedConditionalShares" xlink:href="aapg-20251231.xsd#aapg_PercentageOfVestedConditionalShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="PercentageOfVestedConditionalShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfVestingRequirementsForSharebasedPaymentArrangement" xlink:href="aapg-20251231.xsd#aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="PercentageOfVestingRequirementsForSharebasedPaymentArrangement" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" xlink:href="aapg-20251231.xsd#aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="NumberOfShareOptionsExpenseInSharebasedPaymentArrangement" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="SharebasedPaymentVestingPeriod" xlink:href="aapg-20251231.xsd#aapg_SharebasedPaymentVestingPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="SharebasedPaymentVestingPeriod" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RSUsGrantedFairValue" xlink:href="aapg-20251231.xsd#aapg_RSUsGrantedFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="RSUsGrantedFairValue" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowHedgesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesAbstract"/>
    <loc xlink:type="locator" xlink:label="NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:href="aapg-20251231.xsd#aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowHedgesAbstract" xlink:to="NotestotheConsolidatedStatementsofCashFlowsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyOneRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyOneRSUSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="TwoThousandTwentyOneRSUSchemeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyTwoRSUSchemeMember" xlink:href="aapg-20251231.xsd#aapg_TwoThousandTwentyTwoRSUSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="TwoThousandTwentyTwoRSUSchemeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PostIPOOptionSchemeMember" xlink:href="aapg-20251231.xsd#aapg_PostIPOOptionSchemeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="PostIPOOptionSchemeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EmployeeMember" xlink:href="aapg-20251231.xsd#aapg_EmployeeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="EmployeeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="ifrs-full_RangeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotestotheConsolidatedStatementsofCashFlowsDetailsTable" xlink:to="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfGrantees" xlink:href="aapg-20251231.xsd#aapg_NumberOfGrantees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="NumberOfGrantees" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfNewlyIssuedShares" xlink:href="aapg-20251231.xsd#aapg_NumberOfNewlyIssuedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="NumberOfNewlyIssuedShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BonusAmount" xlink:href="aapg-20251231.xsd#aapg_BonusAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="BonusAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" xlink:href="aapg-20251231.xsd#aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonCashDisposals" xlink:href="aapg-20251231.xsd#aapg_NonCashDisposals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="NonCashDisposals" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NoncashAdditionsToIntangibleAssets" xlink:href="aapg-20251231.xsd#aapg_NoncashAdditionsToIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="NoncashAdditionsToIntangibleAssets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonCashAdditionsToPropertyPlantAndEquipment" xlink:href="aapg-20251231.xsd#aapg_NonCashAdditionsToPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToTheConsolidatedStatementsOfCashFlowsLineItems" xlink:to="NonCashAdditionsToPropertyPlantAndEquipment" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/CommitmentsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_CommitmentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CommitmentsDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_CommitmentsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CapitalCommitmentsAbstract" xlink:to="CommitmentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsTable" xlink:to="CommitmentsDetailsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDetailsLineItems" xlink:to="ifrs-full_CapitalCommitments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/ContingentLiabilitiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsTable" xlink:href="aapg-20251231.xsd#aapg_RelatedPartyTransactionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="DrYangMember" xlink:href="aapg-20251231.xsd#aapg_DrYangMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="DrYangMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfContractsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="ifrs-full_TypesOfContractsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfContractsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="HealthquestPharmaAcquisitionAgreementMember" xlink:href="aapg-20251231.xsd#aapg_HealthquestPharmaAcquisitionAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="HealthquestPharmaAcquisitionAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingCostsIncurred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_BorrowingCostsIncurred" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesDetailsTable" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:href="aapg-20251231.xsd#aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfCreditRiskExposureAbstract" xlink:to="FinancialRiskManagementObjectivesandPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesDetailsTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_InterestRateRiskMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreditRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CreditRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_CreditRiskMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiquidityRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiquidityRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_LiquidityRiskMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesDetailsTable" xlink:to="FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InterestBearingBankBorrowings" xlink:href="aapg-20251231.xsd#aapg_InterestBearingBankBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="InterestBearingBankBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConcentrationsOfCreditRisk" xlink:href="aapg-20251231.xsd#aapg_ConcentrationsOfCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="ConcentrationsOfCreditRisk" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LiquidityRiskPercentage" xlink:href="aapg-20251231.xsd#aapg_LiquidityRiskPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="LiquidityRiskPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementObjectivesandPoliciesDetailsLineItems" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="ifrs-full_InvestmentIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/Cover" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/AuditInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
<!-- [WMV7][v0fsRBkGvKcyhxzFoeSGXznYE+bP6w81HgqZ1yo+homRgblJ3HD23N13x1zHxErq1/Z40UGF/YVYjT/VU5IqZKP6rFEBPY0Ayje1hWbGFzkvseIakZGCbxExyDtDnWXW3HsXIANZJ6DwSEsTH2a9TOWhRNXXr8ExrrT5BWD9Z37esh4Ur4Lsi3bWf1cVrkMCtpM+4dkLDZTb1F8AtpkkTPbiDxFWIJU8DmZwNeEMQi+GChNpeRs7/BGeVPCIs1OhuG+oqUbZB6/ZinCVRUE7wzev+gNzNDO8sGKaNAu9XtPs13mOHWZm4t7S0XxUfIfRxMHQTxVLZX2l5ctU3eT40WTEdOhVs5n9qZq5hdyiFglelTGVBIi+6wgyEjhDlHo3h9iXL9JE19SPsyQ=] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Apr. 01, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ASCENTAGE
PHARMA GROUP INTERNATIONAL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0002023311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">333-284064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">68 Xinqing Road Suzhou Industrial Park<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suzhou<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Jiangsu<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">00000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American depositary shares  (each representing four ordinary shares, no par value per share)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AAPG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,322,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Thomas
J. Knapp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">thomas.knapp@ascentage.com<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">700
King Farm Blvd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rockville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPhoneFaxNumbersLineItems', window );"><strong>Entity Phone Fax Numbers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-1026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityContactPersonnelLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityContactPersonnelLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPhoneFaxNumbersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPhoneFaxNumbersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorTable', window );"><strong>Auditor [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young Hua Ming LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">China<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">We
have audited the accompanying consolidated statements of financial position of Ascentage Pharma Group International (the
Company) as of December 31, 2025 and 2024, the related consolidated statements of
profit or loss, comprehensive loss, changes in equity and cash flows for each of the three years in the period ended December 31,
2025, and the related notes (collectively referred to as &#8220;the consolidated financial statements&#8221;). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31,
2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31,
2025, in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Profit or Loss<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>&#165; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;) </div>
<div>&#165; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;) </div>
<div>&#165; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">&#165; 574,120<span></span>
</td>
<td class="nump">$ 82,098<span></span>
</td>
<td class="nump">&#165; 980,650<span></span>
</td>
<td class="nump">&#165; 221,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CostOfSalesAbstract', window );"><strong>Cost of sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Total cost of sales</a></td>
<td class="num">(48,938)<span></span>
</td>
<td class="num">(6,998)<span></span>
</td>
<td class="num">(29,085)<span></span>
</td>
<td class="num">(30,543)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">525,182<span></span>
</td>
<td class="nump">75,100<span></span>
</td>
<td class="nump">951,565<span></span>
</td>
<td class="nump">191,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income and gains</a></td>
<td class="nump">103,495<span></span>
</td>
<td class="nump">14,800<span></span>
</td>
<td class="nump">57,359<span></span>
</td>
<td class="nump">59,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingExpense', window );">Selling and distribution expenses</a></td>
<td class="num">(353,640)<span></span>
</td>
<td class="num">(50,570)<span></span>
</td>
<td class="num">(195,998)<span></span>
</td>
<td class="num">(195,387)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">Administrative expenses</a></td>
<td class="num">(246,281)<span></span>
</td>
<td class="num">(35,218)<span></span>
</td>
<td class="num">(187,125)<span></span>
</td>
<td class="num">(181,076)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(1,137,448)<span></span>
</td>
<td class="num">(162,653)<span></span>
</td>
<td class="num">(947,245)<span></span>
</td>
<td class="num">(706,972)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByNature', window );">Other expenses</a></td>
<td class="num">(73,599)<span></span>
</td>
<td class="num">(10,525)<span></span>
</td>
<td class="num">(9,075)<span></span>
</td>
<td class="num">(5,203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance costs</a></td>
<td class="num">(54,070)<span></span>
</td>
<td class="num">(7,732)<span></span>
</td>
<td class="num">(64,455)<span></span>
</td>
<td class="num">(96,057)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) of a joint venture</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">LOSS BEFORE TAX</a></td>
<td class="num">(1,236,047)<span></span>
</td>
<td class="num">(176,753)<span></span>
</td>
<td class="num">(395,255)<span></span>
</td>
<td class="num">(932,862)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax credit/(expense)</a></td>
<td class="num">(6,940)<span></span>
</td>
<td class="num">(992)<span></span>
</td>
<td class="num">(10,425)<span></span>
</td>
<td class="nump">7,150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">LOSS FOR THE YEAR</a></td>
<td class="num">(1,242,987)<span></span>
</td>
<td class="num">(177,745)<span></span>
</td>
<td class="num">(405,680)<span></span>
</td>
<td class="num">(925,712)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToAbstract', window );"><strong>Attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Ordinary equity holders of the Company</a></td>
<td class="num">(1,242,769)<span></span>
</td>
<td class="num">(177,714)<span></span>
</td>
<td class="num">(405,433)<span></span>
</td>
<td class="num">(925,637)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="num">(218)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">LOSS FOR THE YEAR</a></td>
<td class="num">&#165; (1,242,987)<span></span>
</td>
<td class="num">$ (177,745)<span></span>
</td>
<td class="num">&#165; (405,680)<span></span>
</td>
<td class="num">&#165; (925,712)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic (in Dollars per share and Yuan Renminbi per share) | (per share)</a></td>
<td class="num">&#165; (3.49)<span></span>
</td>
<td class="num">$ (0.5)<span></span>
</td>
<td class="num">&#165; (1.34)<span></span>
</td>
<td class="num">&#165; (3.28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted (in Dollars per share and Yuan Renminbi per share) | (per share)</a></td>
<td class="num">&#165; (3.49)<span></span>
</td>
<td class="num">$ (0.5)<span></span>
</td>
<td class="num">&#165; (1.34)<span></span>
</td>
<td class="num">&#165; (3.28)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aapg_IntellectuallPropertyMember', window );">Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">&#165; 678,415<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aapg_ProductsMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">499,272<span></span>
</td>
<td class="nump">71,395<span></span>
</td>
<td class="nump">260,835<span></span>
</td>
<td class="nump">193,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CostOfSalesAbstract', window );"><strong>Cost of sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Total cost of sales</a></td>
<td class="num">(46,661)<span></span>
</td>
<td class="num">(6,672)<span></span>
</td>
<td class="num">(27,031)<span></span>
</td>
<td class="num">(29,342)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aapg_OthersMember', window );">Others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">74,848<span></span>
</td>
<td class="nump">10,703<span></span>
</td>
<td class="nump">41,400<span></span>
</td>
<td class="nump">28,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CostOfSalesAbstract', window );"><strong>Cost of sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Total cost of sales</a></td>
<td class="num">&#165; (2,277)<span></span>
</td>
<td class="num">$ (326)<span></span>
</td>
<td class="num">&#165; (2,054)<span></span>
</td>
<td class="num">&#165; (1,201)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CostOfSalesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CostOfSalesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aapg_IntellectuallPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aapg_IntellectuallPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aapg_ProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aapg_ProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aapg_OthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aapg_OthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ConsolidatedStatementsOfComprehensiveLossAbstract', window );"><strong>Consolidated Statements of Comprehensive Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">LOSS FOR THE YEAR</a></td>
<td class="num">&#165; (1,242,987)<span></span>
</td>
<td class="num">$ (177,745)<span></span>
</td>
<td class="num">&#165; (405,680)<span></span>
</td>
<td class="num">&#165; (925,712)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Other comprehensive income/ (loss) that may be reclassified to profit or loss in subsequent periods, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation of foreign operations</a></td>
<td class="num">(41,574)<span></span>
</td>
<td class="num">(5,945)<span></span>
</td>
<td class="nump">2,829<span></span>
</td>
<td class="nump">20,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Other comprehensive income/ (loss) that will not be reclassified to profit or loss in subsequent periods, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations', window );">Exchange differences on translation of the Company</a></td>
<td class="num">(11,441)<span></span>
</td>
<td class="num">(1,636)<span></span>
</td>
<td class="nump">4,120<span></span>
</td>
<td class="nump">5,666<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">OTHER COMPREHENSIVE INCOME/(LOSS) FOR THE YEAR, NET OF TAX</a></td>
<td class="num">(53,015)<span></span>
</td>
<td class="num">(7,581)<span></span>
</td>
<td class="nump">6,949<span></span>
</td>
<td class="nump">26,259<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">TOTAL COMPREHENSIVE LOSS FOR THE YEAR</a></td>
<td class="num">(1,296,002)<span></span>
</td>
<td class="num">(185,326)<span></span>
</td>
<td class="num">(398,731)<span></span>
</td>
<td class="num">(899,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract', window );"><strong>Attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Ordinary equity holders of the Company</a></td>
<td class="num">(1,295,784)<span></span>
</td>
<td class="num">(185,295)<span></span>
</td>
<td class="num">(398,484)<span></span>
</td>
<td class="num">(899,378)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="num">(218)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">TOTAL COMPREHENSIVE LOSS FOR THE YEAR</a></td>
<td class="num">&#165; (1,296,002)<span></span>
</td>
<td class="num">$ (185,326)<span></span>
</td>
<td class="num">&#165; (398,731)<span></span>
</td>
<td class="num">&#165; (899,453)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ConsolidatedStatementsOfComprehensiveLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ConsolidatedStatementsOfComprehensiveLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, before tax, after reclassification adjustments, related to exchange differences on translation of financial statements of foreign operations. [Refer: Other comprehensive income, before tax]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, before tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income, before tax]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Financial Position<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>NON-CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">&#165; 781,235<span></span>
</td>
<td class="nump">$ 111,715<span></span>
</td>
<td class="nump">&#165; 849,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">47,827<span></span>
</td>
<td class="nump">6,839<span></span>
</td>
<td class="nump">56,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">24,694<span></span>
</td>
<td class="nump">3,531<span></span>
</td>
<td class="nump">24,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets</a></td>
<td class="nump">65,936<span></span>
</td>
<td class="nump">9,429<span></span>
</td>
<td class="nump">75,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Investment in a joint venture</a></td>
<td class="nump">33,030<span></span>
</td>
<td class="nump">4,723<span></span>
</td>
<td class="nump">32,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at fair value through profit or loss (&#8220;FVTPL&#8221;)</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">31,957<span></span>
</td>
<td class="nump">4,570<span></span>
</td>
<td class="nump">44,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">30,725<span></span>
</td>
<td class="nump">4,394<span></span>
</td>
<td class="nump">59,303<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">1,019,404<span></span>
</td>
<td class="nump">145,773<span></span>
</td>
<td class="nump">1,143,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">28,618<span></span>
</td>
<td class="nump">4,092<span></span>
</td>
<td class="nump">6,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables, net</a></td>
<td class="nump">252,938<span></span>
</td>
<td class="nump">36,170<span></span>
</td>
<td class="nump">83,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets', window );">Prepayments, other receivables and other assets</a></td>
<td class="nump">192,532<span></span>
</td>
<td class="nump">27,532<span></span>
</td>
<td class="nump">123,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances</a></td>
<td class="nump">2,470,085<span></span>
</td>
<td class="nump">353,217<span></span>
</td>
<td class="nump">1,261,211<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">2,944,173<span></span>
</td>
<td class="nump">421,011<span></span>
</td>
<td class="nump">1,474,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">106,740<span></span>
</td>
<td class="nump">15,264<span></span>
</td>
<td class="nump">91,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Other payables and accruals</a></td>
<td class="nump">276,666<span></span>
</td>
<td class="nump">39,563<span></span>
</td>
<td class="nump">258,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentContractLiabilities', window );">Contract liabilities</a></td>
<td class="nump">37,485<span></span>
</td>
<td class="nump">5,360<span></span>
</td>
<td class="nump">37,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_Interestbearingbankandotherborrowingscurrent', window );">Interest-bearing bank and other borrowings</a></td>
<td class="nump">1,222,481<span></span>
</td>
<td class="nump">174,812<span></span>
</td>
<td class="nump">779,062<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">1,643,372<span></span>
</td>
<td class="nump">234,999<span></span>
</td>
<td class="nump">1,166,611<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsLiabilities', window );">NET CURRENT ASSETS</a></td>
<td class="nump">1,300,801<span></span>
</td>
<td class="nump">186,012<span></span>
</td>
<td class="nump">307,551<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AssetsLessCurrentLiabilities', window );">TOTAL ASSETS LESS CURRENT LIABILITIES</a></td>
<td class="nump">2,320,205<span></span>
</td>
<td class="nump">331,785<span></span>
</td>
<td class="nump">1,451,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>NON-CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentContractLiabilities', window );">Contract liabilities</a></td>
<td class="nump">210,224<span></span>
</td>
<td class="nump">30,062<span></span>
</td>
<td class="nump">248,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_InterestbearingBankAndOtherBorrowingsNonCurrent', window );">Interest-bearing bank and other borrowings</a></td>
<td class="nump">757,238<span></span>
</td>
<td class="nump">108,284<span></span>
</td>
<td class="nump">889,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeferredIncomeNonCurrent', window );">Deferred income</a></td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="nump">27,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">12,031<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
<td class="nump">6,274<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">985,993<span></span>
</td>
<td class="nump">140,995<span></span>
</td>
<td class="nump">1,177,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CommitmentAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">2,629,365<span></span>
</td>
<td class="nump">375,994<span></span>
</td>
<td class="nump">2,343,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapitalOrdinaryShares', window );">Ordinary shares (par value of US$0.0001 per share as of December 31, 2024 and 2025; 315,224,993 and 373,321,692 shares authorized, issued and outstanding as of December 31, 2024 and 2025, respectively)</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares</a></td>
<td class="num">(2,961)<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">8,916,853<span></span>
</td>
<td class="nump">1,275,093<span></span>
</td>
<td class="nump">6,545,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CapitalAndReserves', window );">Capital and reserves</a></td>
<td class="num">(397,276)<span></span>
</td>
<td class="num">(56,810)<span></span>
</td>
<td class="num">(384,515)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Exchange fluctuation reserve</a></td>
<td class="num">(179,086)<span></span>
</td>
<td class="num">(25,609)<span></span>
</td>
<td class="num">(126,071)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccumulatedOtherComprehensiveIncome', window );">Accumulated losses</a></td>
<td class="num">(7,013,324)<span></span>
</td>
<td class="num">(1,002,892)<span></span>
</td>
<td class="num">(5,770,555)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Equity attributable to ordinary equity holders of the Company</a></td>
<td class="nump">1,324,462<span></span>
</td>
<td class="nump">189,396<span></span>
</td>
<td class="nump">264,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="nump">9,750<span></span>
</td>
<td class="nump">1,394<span></span>
</td>
<td class="nump">9,968<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">&#165; 1,334,212<span></span>
</td>
<td class="nump">$ 190,790<span></span>
</td>
<td class="nump">&#165; 274,162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CapitalAndReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represent the vaue of capital and reseve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CapitalAndReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CommitmentAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CommitmentAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DeferredIncomeNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DeferredIncomeNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_InterestbearingBankAndOtherBorrowingsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of interest-bearing bank and other borrowings non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_InterestbearingBankAndOtherBorrowingsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_Interestbearingbankandotherborrowingscurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest-bearing bank and other borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_Interestbearingbankandotherborrowingscurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccumulatedOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccumulatedOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsLessCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsLessCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndBankBalancesAtCentralBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and bank balances held at central banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndBankBalancesAtCentralBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets less the amount of current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapitalOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapitalOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2025-01-01<br> -Paragraph 22<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 119<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_119&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2025-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Financial Position (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfFinancialPositionAbstract', window );"><strong>Statement of financial position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Ordinary shares, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesAuthorised', window );">Ordinary shares, shares authorized (in Shares)</a></td>
<td class="nump">373,321,692<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares, shares issued (in Shares)</a></td>
<td class="nump">373,321,692<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ordinary shares, shares outstanding (in Shares)</a></td>
<td class="nump">373,321,692<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Share capital </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Share capital </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Treasury shares </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Treasury shares </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Share premium </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Share premium </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Capital and reserves </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Capital and reserves </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Exchange fluctuation reserve </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Exchange fluctuation reserve </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Accumulated losses </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Accumulated losses </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Total </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Total </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Non- controlling interests </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Non- controlling interests </div>
<div>USD ($)</div>
</th>
<th class="th"><div>CNY (&#165;)</div></th>
<th class="th"><div>USD ($)</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance (in Dollars)</a></td>
<td class="nump">&#165; 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (26,552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 5,393,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (359,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (159,279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (4,439,485)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 408,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 408,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,393,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(359,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,439,485)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(925,637)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(925,637)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(925,712)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation of operations</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(925,637)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(899,378)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(899,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary', window );">Capital contribution from a non-controlling shareholder of a subsidiary</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issue of ordinary shares</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses', window );">Pre-IPO share option expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses', window );">RSU expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of Pre-IPO share options</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,347)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits', window );">Vesting of RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,951,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(371,441)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(133,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,365,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance (in Dollars)</a></td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,951,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(371,441)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(133,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,365,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(405,433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(405,433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(405,680)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation of operations</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(405,433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(398,484)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(398,731)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issue of ordinary shares</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses', window );">RSU expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of Pre-IPO share options</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,373)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits', window );">Vesting of RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,625)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2024</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,545,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(384,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126,071)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,770,555)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance (in Dollars)</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,545,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(384,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126,071)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,770,555)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,242,769)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,242,769)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,242,987)<span></span>
</td>
<td class="num">$ (177,745)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation of operations</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,242,769)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,295,784)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,296,002)<span></span>
</td>
<td class="num">(185,326)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issue of ordinary shares</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,279,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,279,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,279,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,590)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,590)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,590)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueShareOptionExpenses', window );">Post-IPO share option expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses', window );">RSU expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of Pre-IPO share options</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,623)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits', window );">Vesting of RSUs</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,012)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2025</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="num">(2,961)<span></span>
</td>
<td class="num">$ (423)<span></span>
</td>
<td class="nump">8,916,853<span></span>
</td>
<td class="nump">$ 1,275,093<span></span>
</td>
<td class="num">(397,276)<span></span>
</td>
<td class="num">$ (56,810)<span></span>
</td>
<td class="num">(179,086)<span></span>
</td>
<td class="num">$ (25,609)<span></span>
</td>
<td class="num">(7,013,324)<span></span>
</td>
<td class="num">$ (1,002,892)<span></span>
</td>
<td class="nump">1,324,462<span></span>
</td>
<td class="nump">$ 189,396<span></span>
</td>
<td class="nump">9,750<span></span>
</td>
<td class="nump">$ 1,394<span></span>
</td>
<td class="nump">1,334,212<span></span>
</td>
<td class="nump">190,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance (in Dollars)</a></td>
<td class="nump">&#165; 256<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="num">&#165; (2,961)<span></span>
</td>
<td class="num">$ (423)<span></span>
</td>
<td class="nump">&#165; 8,916,853<span></span>
</td>
<td class="nump">$ 1,275,093<span></span>
</td>
<td class="num">&#165; (397,276)<span></span>
</td>
<td class="num">$ (56,810)<span></span>
</td>
<td class="num">&#165; (179,086)<span></span>
</td>
<td class="num">$ (25,609)<span></span>
</td>
<td class="num">&#165; (7,013,324)<span></span>
</td>
<td class="num">$ (1,002,892)<span></span>
</td>
<td class="nump">&#165; 1,324,462<span></span>
</td>
<td class="nump">$ 189,396<span></span>
</td>
<td class="nump">&#165; 9,750<span></span>
</td>
<td class="nump">$ 1,394<span></span>
</td>
<td class="nump">&#165; 1,334,212<span></span>
</td>
<td class="nump">$ 190,790<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_RepurchaseOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of repurchase of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_RepurchaseOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of capital contribution from a non-controlling shareholder of a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValueEquitysettledBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of equity-settled bonus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValueEquitysettledBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of pre-IPO share option expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of restricted share unit (&#8220;RSU&#8221;) expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValueShareOptionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of post-IPO share option expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValueShareOptionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of vesting of restricted share units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#165; (1,236,047)<span></span>
</td>
<td class="num">$ (176,753)<span></span>
</td>
<td class="num">&#165; (395,255)<span></span>
</td>
<td class="num">&#165; (932,862)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments for:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">65,761<span></span>
</td>
<td class="nump">9,404<span></span>
</td>
<td class="nump">71,184<span></span>
</td>
<td class="nump">55,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty', window );">Depreciation of investment property</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AdjustmentsForDepreciationOfRightofuseAssets', window );">Depreciation of right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,657<span></span>
</td>
<td class="nump">1,524<span></span>
</td>
<td class="nump">11,134<span></span>
</td>
<td class="nump">11,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForAmortisationExpense', window );">Amortization of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,062<span></span>
</td>
<td class="nump">1,439<span></span>
</td>
<td class="nump">10,851<span></span>
</td>
<td class="nump">10,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Equity-settled share-based payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,874<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
<td class="nump">20,924<span></span>
</td>
<td class="nump">31,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment', window );">(Gain)/loss on disposal of items of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AdjustmentsForGainOnDisposalOfLeases', window );">Gain on disposal of leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(685)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss', window );">Fair value loss on financial assets measured at FVTPL</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">832<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives', window );">Fair value loss on financial liabilities measured at FVTPL</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,533<span></span>
</td>
<td class="nump">4,223<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFairValueGainsLosses', window );">Fair value gain on derivative financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,822)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceCosts', window );">Finance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,070<span></span>
</td>
<td class="nump">7,732<span></span>
</td>
<td class="nump">64,455<span></span>
</td>
<td class="nump">96,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of (profit)/loss of a joint venture</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(314)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="num">(1,076)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForProvisions', window );">Provision for inventory write-down</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,180<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains', window );">Foreign exchange (gain)/loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,161<span></span>
</td>
<td class="nump">1,453<span></span>
</td>
<td class="num">(6,694)<span></span>
</td>
<td class="num">(1,621)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLoss', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,030,596)<span></span>
</td>
<td class="num">(147,374)<span></span>
</td>
<td class="num">(222,323)<span></span>
</td>
<td class="num">(716,931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances', window );">(Increase)/ Decrease in restricted cash balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,948<span></span>
</td>
<td class="nump">2,710<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="num">(7,936)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">(Increase)/Decrease in inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(26,201)<span></span>
</td>
<td class="num">(3,747)<span></span>
</td>
<td class="nump">9,570<span></span>
</td>
<td class="num">(6,719)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">(Increase)/Decrease in trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(169,795)<span></span>
</td>
<td class="num">(24,281)<span></span>
</td>
<td class="nump">62,750<span></span>
</td>
<td class="num">(91,537)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses', window );">Increase in prepayments, other receivables and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(86,337)<span></span>
</td>
<td class="num">(12,346)<span></span>
</td>
<td class="num">(14,421)<span></span>
</td>
<td class="num">(7,841)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">(Increase) /Decrease in other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,784<span></span>
</td>
<td class="nump">3,974<span></span>
</td>
<td class="num">(48,950)<span></span>
</td>
<td class="num">(3,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">(Decrease) /Increase in trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,774<span></span>
</td>
<td class="nump">2,113<span></span>
</td>
<td class="nump">19,521<span></span>
</td>
<td class="num">(23,114)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets', window );">Increase in other payables and accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">113,809<span></span>
</td>
<td class="nump">16,274<span></span>
</td>
<td class="nump">78,506<span></span>
</td>
<td class="nump">48,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities', window );">Increase /(Decrease) in contract liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(37,485)<span></span>
</td>
<td class="num">(5,360)<span></span>
</td>
<td class="num">(3,654)<span></span>
</td>
<td class="nump">81,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities', window );">Increase in deferred income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">7,740<span></span>
</td>
<td class="nump">1,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income tax paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash flows used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,174,128)<span></span>
</td>
<td class="num">(167,898)<span></span>
</td>
<td class="num">(111,357)<span></span>
</td>
<td class="num">(726,077)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchases of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(27,571)<span></span>
</td>
<td class="num">(3,942)<span></span>
</td>
<td class="num">(24,289)<span></span>
</td>
<td class="num">(46,108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds from disposal of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Purchase of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(10,736)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities', window );">Payment of contingent consideration related to acquisition of a subsidiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(43,342)<span></span>
</td>
<td class="num">(6,198)<span></span>
</td>
<td class="num">(9,516)<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity', window );">Maturity/(Placement) in time deposits with original maturity of more than three months</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(925,139)<span></span>
</td>
<td class="num">(132,294)<span></span>
</td>
<td class="num">(312,230)<span></span>
</td>
<td class="nump">98,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_InvestmentInOtherFinancialAssets', window );">Investment in other financial assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,000)<span></span>
</td>
<td class="num">(572)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities', window );">Investment in a joint venture</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flows generated from/ (used in) investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,000,052)<span></span>
</td>
<td class="num">(143,006)<span></span>
</td>
<td class="num">(362,035)<span></span>
</td>
<td class="nump">21,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issue of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,304,905<span></span>
</td>
<td class="nump">329,597<span></span>
</td>
<td class="nump">533,940<span></span>
</td>
<td class="nump">470,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares', window );">Treasury share purchases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,036)<span></span>
</td>
<td class="num">(1,292)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,923)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of share options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(51,308)<span></span>
</td>
<td class="num">(7,337)<span></span>
</td>
<td class="num">(60,556)<span></span>
</td>
<td class="num">(92,348)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from bank loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,240,970<span></span>
</td>
<td class="nump">177,456<span></span>
</td>
<td class="nump">535,923<span></span>
</td>
<td class="nump">953,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Repayment of bank loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(923,990)<span></span>
</td>
<td class="num">(132,129)<span></span>
</td>
<td class="num">(672,850)<span></span>
</td>
<td class="num">(956,091)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Principal portion of lease payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,717)<span></span>
</td>
<td class="num">(1,390)<span></span>
</td>
<td class="num">(8,413)<span></span>
</td>
<td class="num">(10,766)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests', window );">Capital contribution from non-controlling shareholders of a subsidiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ListingExpensePaid', window );">Listing expense paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11,728)<span></span>
</td>
<td class="num">(1,677)<span></span>
</td>
<td class="num">(13,283)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flows generated from financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,540,100<span></span>
</td>
<td class="nump">363,229<span></span>
</td>
<td class="nump">314,767<span></span>
</td>
<td class="nump">368,751<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">NET (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">365,920<span></span>
</td>
<td class="nump">52,325<span></span>
</td>
<td class="num">(158,625)<span></span>
</td>
<td class="num">(335,404)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">893,100<span></span>
</td>
<td class="nump">127,712<span></span>
</td>
<td class="nump">1,038,048<span></span>
</td>
<td class="nump">1,345,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of foreign exchange rate changes, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(63,236)<span></span>
</td>
<td class="num">(9,042)<span></span>
</td>
<td class="nump">13,677<span></span>
</td>
<td class="nump">27,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">CASH AND CASH EQUIVALENTS AT END OF YEAR</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,195,784<span></span>
</td>
<td class="nump">$ 170,995<span></span>
</td>
<td class="nump">893,100<span></span>
</td>
<td class="nump">1,038,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,195,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">893,100<span></span>
</td>
<td class="nump">1,038,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Restricted bank balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,633<span></span>
</td>
<td class="nump">24,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths', window );">Time deposits with original maturity of more than three months</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,268,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,478<span></span>
</td>
<td class="nump">31,248<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances at end of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 2,470,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1,261,211<span></span>
</td>
<td class="nump">&#165; 1,093,833<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The depreciation of property, plant and equipment, the depreciation of investment property, the depreciation of right-of-use assets, the amortization of intangible assets and the equity-settled share-based payment expenses for the years are included in &#8220;Cost of Sales&#8221;, &#8220;Research and development expenses&#8221;, &#8220;Selling and distribution expenses&#8221; and &#8220;Administrative expenses&#8221; in the consolidated statements of profit or loss.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in restricted cash balances to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AdjustmentsForDepreciationOfRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation of right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AdjustmentsForDepreciationOfRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AdjustmentsForGainOnDisposalOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on disposals of leases in the scope of IFRS 9 to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AdjustmentsForGainOnDisposalOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>(Increase)/Decrease in time deposits with original maturity of more than three months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of investment in joint ventures classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_InvestmentInOtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investment in other financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_InvestmentInOtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ListingExpensePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Listing expense paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ListingExpensePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Time deposits with original maturity of more than three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the decrease (increase) in accrued income other than contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Accrued income other than contract assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in financial assets measured at fair value through profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Financial assets; Financial assets at fair value through profit or loss; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFairValueGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFairValueGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the increase (decrease) in contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Contract liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the increase (decrease) in deferred income other than contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income other than contract liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndBankBalancesAtCentralBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and bank balances held at central banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndBankBalancesAtCentralBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire interests in joint ventures (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities. [Refer: Total for all joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire or redeem entity's shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToAcquireOrRedeemEntitysShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from proceeds from contributions of non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate and Group Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate and Group Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">CORPORATE AND GROUP INFORMATION</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORPORATE
                                            AND GROUP INFORMATION</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a limited liability company incorporated in the Cayman Islands on November 17, 2017. The registered office of the Company
is located at the office of Walkers Corporate Limited, with the registered address of 190 Elgin Avenue, George Town, Grand Cayman KY1-9008,
Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an investment holding company. The Company became the holding company of the subsidiaries upon completion of the reorganization
in July 2018. The Company is a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address
global medical needs primarily in hematological malignancies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2019, the Company completed its Hong Kong initial public offering with the Stock Exchange of Hong Kong Limited (the &#8220;Hong
Kong Stock Exchange&#8221;). In January 2025, the Company completed its U.S. initial public offering with the NASDAQ.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars
of the Company&#8217;s principal subsidiaries are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place and date of incorporation/ registration and</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="4" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominal value of issued/registered</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentage of equity interests attributable to the Company</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company name</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">place of business</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">share capital</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indirect</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">business</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 35%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suzhou Ascentage Pharma Co., Ltd.*@ <br/> (&#8220;Suzhou Yasheng&#8221;)</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC/Chinese<br/> mainland</span><span style="font-family: Times New Roman, Times, Serif"><br/> June 1, 2016</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-191; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 12%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical research and development</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guangzhou Healthquest Pharma Co., Ltd.*@ <br/> (&#8220;Healthquest Pharma&#8221;)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC/Chinese<br/> mainland<br/> July 3, 2012</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-192; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical development and sale of products</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage Pharma Group Inc.</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States of America <br/> (&#8220;United States&#8221;) <br/> November 4, 2015</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-193; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical trials</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suzhou Shenghe Innovation Works Biotech Co., Ltd.*@</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC/Chinese<br/> mainland <br/>September 21, 2022</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-194; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental of buildings to group companies</span></td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English names of the companies registered in the PRC represent the best efforts made by the management of the Company in directly translating the Chinese names of these companies as no English names have been registered.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">@</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These entities are limited liability companies established in the PRC.</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 128<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_128&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 51<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory', window );">ACCOUNTING POLICIES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTING
                                            POLICIES</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BASIS OF PREPARATION</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements have been prepared in accordance with IFRS Accounting Standards (which include all International Financial Reporting
Standards, International Accounting Standards (&#8220;IASs&#8221;) and interpretations) approved by the International Accounting Standards
Board (the &#8220;IASB&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
have been prepared under the historical cost convention, except for financial assets at FVTPL and derivative financial instruments which
have been measured at fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Basis
of consolidation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements of the Company and its subsidiaries (collectively referred to as the
&#8220;Group&#8221;) for each of the three years ended December 31, 2025. A subsidiary is an entity (including a structured entity),
directly or indirectly, controlled by the Company. Control is achieved when the Group is exposed, or has rights, to variable returns
from its involvement with the investee and has the ability to affect those returns through its power over the investee (i.e., existing
rights that give the Group the current ability to direct the relevant activities of the investee).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
there is a presumption that a majority of voting rights results in control. When the Company has less than a majority of the voting or
similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee,
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            contractual arrangement with the other vote holders of the investee;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rights
                                            arising from other contractual arrangements; and</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Group&#8217;s voting rights and potential voting rights.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies.
The results of subsidiaries are consolidated from the date on which the Group obtains control and continues to be consolidated until the
date that such control ceases.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Profit
or loss and each component of other comprehensive income are attributed to the owners of the parent of the Group and to the non-controlling
interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity,
income, expenses and cash flows relating to transactions between members of the Group are eliminated in full on consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group reassesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of
the three elements of control described above. A change in the ownership interest of a subsidiary, without a loss of control, is accounted
for as an equity transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Group loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, any non-controlling
interest and the exchange fluctuation reserve; and recognizes the fair value of any investment retained and any resulting surplus or
deficit in profit or loss. The Group&#8217;s share of components previously recognized in other comprehensive income is reclassified
to profit or loss or retained profits, as appropriate, on the same basis as would be required if the Group had directly disposed of the
related assets or liabilities.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGES IN ACCOUNTING POLICIES AND DISCLOSURES</span></p></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has adopted amendments to IAS 21 Lack of Exchangeability for the first time for the current year&#8217;s financial statements. The Group
has not early adopted any other standard or amendment that has been issued but is not yet effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no new IFRS Accounting Standards, amendments or interpretations that became effective in 2025 that have any impact on the Group&#8217;s
financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED BUT NOT YET EFFECTIVE IFRS ACCOUNTING STANDARDS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has not applied the following new and amended IFRS Accounting Standards, that have been issued but are not yet effective, in these
financial statements. The Group intends to apply these new and amended IFRS Accounting Standards, if applicable, when they become effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="padding-left: 0.25in; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 18</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 59%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Presentation and Disclosure in Financial Statements<sup>2</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 19 and its amendments</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsidiaries without Public Accountability: Disclosures<sup>2</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 9 and IFRS 7</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendments to the Classification and Measurement of Financial Instruments<sup>1</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 9 and IFRS 7</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contracts Referencing Nature-dependent Electricity<sup>1</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 10 and IAS 28</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sale or Contribution of Assets between an Investor and its Associate or Joint Venture<sup>3</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IAS 21</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation to a Hyperinflationary Presentation Currency<sup>2</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Annual Improvements to IFRS Accounting Standards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8211; Volume 11</i></span></p></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 7<sup>1</sup></span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Effective for annual periods beginning on or after January 1, 2026</span></p></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2</sup></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Effective for annual/reporting periods beginning on or after January 1, 2027</span></td></tr> </table>


<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>3</sup></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No mandatory effective date yet determined but available for adoption</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group is in the process of making an assessment of the impact of these new and revised IFRS Accounting Standards upon initial application.
So far, the Group considers that these new and revised IFRS Accounting Standards, except for IFRS 18, are unlikely to have a significant
impact on the Group&#8217;s results of operations and financial position. IFRS 18 is expected to be applicable to the Group. IFRS 18
introduces new requirements on presentation within the statement of profit or loss, including specific totals and subtotals. It also
requires disclosure of management-defined performance measures in a note and introduces new requirements for aggregation and disaggregation
of financial information. The new requirements are expected to impact the Group&#8217;s presentation of the statement of profit or loss
and disclosures of the Group&#8217;s financial performance.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL
                                            ACCOUNTING POLICIES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Investments
in joint venture</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
joint venture is a type of joint arrangement whereby the parties that have joint control of the arrangement have rights to the net
assets of the joint venture. Joint control is the contractually agreed upon sharing of control of an arrangement, which exists only
when decisions about the relevant activities require the unanimous consent of the parties sharing control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.3pt; text-indent: -20.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s investments in joint ventures are stated in the consolidated statement of financial position at the Group&#8217;s share
of net assets under the equity method of accounting, less any impairment losses. Adjustments are made to bring into line any dissimilar
accounting policies that may exist. The Group&#8217;s share of the post-acquisition results and other comprehensive income of joint ventures
is included in the consolidated statement of profit or loss and consolidated other comprehensive income, respectively. In addition, when
there has been a change recognized directly in the equity of the joint venture, the Group recognizes its share of any changes, when applicable,
in the consolidated statement of changes in equity. Unrealized gains and losses resulting from transactions between the Group and its
joint ventures are eliminated to the extent of the Group&#8217;s investments in the joint ventures, except where unrealized losses provide
evidence of an impairment of the assets transferred. Goodwill arising from the acquisition of joint ventures is included as part of the
Group&#8217;s investments in joint ventures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Goodwill&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
is initially measured at cost, being the excess of the aggregate of the consideration transferred, the amount recognized for non-controlling
interests and any fair value of the Group&#8217;s previously held equity interests in the acquiree over the identifiable assets acquired
and liabilities assumed. If the sum of this consideration and other items is lower than the fair value of the net assets acquired, the
difference is, after reassessment, recognized in profit or loss as a gain on bargain purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is tested for impairment annually
or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. The Group performs its
annual impairment test of goodwill as at December 31. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Group&#8217;s cash-generating units, or groups of
cash-generating units, that are expected to benefit from the synergies of the combination, irrespective of whether other assets or
liabilities of the Group are assigned to those units or groups of units.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment
is determined by assessing the recoverable amount of the cash-generating unit (group of cash-generating units) to which the goodwill
relates. Where the recoverable amount of the cash-generating unit (group of cash-generating units) is less than the carrying amount,
an impairment loss is recognized. An impairment loss recognized for goodwill is not reversed in a subsequent period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 61.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
goodwill has been allocated to a cash-generating unit (or group of cash-generating units) and part of the operation within that unit
is disposed of, the goodwill associated with the operation disposed of is included in the carrying amount of the operation when determining
the gain or loss on the disposal. Goodwill disposed of in these circumstances is measured based on the relative value of the operation
disposed of and the portion of the cash-generating unit retained.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Fair
value measurement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group measures its financial assets at FVTPL and derivative financial instruments at fair value at the end of each reporting period. Fair
value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the
liability takes place either in the principal market for the asset or liability, or in the absence of a principal market, in the most
advantageous market for the asset or liability. The principal or the most advantageous market must be accessible by the Group. The fair
value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
fair value measurement of a non-financial asset takes into account a market participant&#8217;s ability to generate economic benefits
by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest
and best use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair
value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value
hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.75pt; text-indent: -30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8211; based on quoted prices (unadjusted) in active markets for identical assets or liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8211; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is observable,
either directly or indirectly</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8211; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
assets and liabilities that are recognized in the financial statements on a recurring basis, the Group determines whether transfers have
occurred between levels in the hierarchy by reassessing categorization (based on the lowest level input that is significant to the fair
value measurement as a whole) at the end of each reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Impairment
of non-financial assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
an indication of impairment exists, or when annual impairment testing for an asset is required (other than inventories, deferred tax
assets and non-current assets), the asset&#8217;s recoverable amount is estimated. An asset&#8217;s recoverable amount is the higher of the asset&#8217;s
or cash-generating unit&#8217;s value in use and its fair value less costs of disposal, and is determined for an individual asset, unless the
asset does not generate cash inflows that are largely independent of those from other assets or groups of assets, in which case the recoverable
amount is determined for the cash-generating unit to which the asset belongs.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
testing a cash-generating unit for impairment, a portion of the carrying amount of a corporate asset (e.g., a headquarters building)
is allocated to an individual cash-generating unit if it can be allocated on a reasonable and consistent basis or, otherwise, to the
smallest group of cash-generating units.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
impairment loss is recognized only if the carrying amount of an asset exceeds its recoverable amount. In assessing value in use, the
estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments
of the time value of money and the risks specific to the asset. An impairment loss is charged to the statement of profit or loss in the
period in which it arises in those expense categories consistent with the function of the impaired asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
assessment is made at the end of each reporting period as to whether there is an indication that previously recognized impairment losses
may no longer exist or may have decreased. If such an indication exists, the recoverable amount is estimated. A previously recognized
impairment loss of an asset other than goodwill is reversed only if there has been a change in the estimates used to determine the recoverable
amount of that asset, but not to an amount higher than the carrying amount that would have been determined (net of any depreciation/amortization)
had no impairment loss been recognized for the asset in prior years. A reversal of such an impairment loss is credited to the statement
of profit or loss in the period in which it arises.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Related
parties</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
party is considered to be related to the Group if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            party is a person or a close member of that person&#8217;s family and that person:</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                            control or joint control over the Group;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                            significant influence over the Group; or</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                            a member of the key management personnel of the Group or of a parent of the Group;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            party is an entity where any of the following conditions applies:</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity and the Group are members of the same group;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            entity is an associate or joint venture of the other entity (or of a parent, subsidiary or
                                            fellow subsidiary of the other entity);</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity and the Group are joint ventures of the same third party;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            entity is a joint venture of a third entity and the other entity is an associate of the third
                                            entity;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-indent: -76.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity is a post-employment benefit plan for the benefit of employees of either the Group
                                            or an entity related to the Group;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity is controlled or jointly controlled by a person identified in (a);</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            person identified in (a)(i) has significant influence over the entity or is a member of the
                                            key management personnel of the entity (or of a parent of the entity); and</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity, or any member of a group of which it is a part, provides key management personnel
                                            services to the Group or to the parent of the Group.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Property,
plant and equipment and depreciation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
plant and equipment, other than construction in progress, are stated at cost less accumulated depreciation and any impairment losses.
The cost of an item of property, plant and equipment comprises its purchase price and any directly attributable costs of bringing the
asset to its working condition and location for its intended use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditure
incurred after items of property, plant and equipment have been put into operation, such as repairs and maintenance, is normally charged
to the statement of profit or loss in the period in which it is incurred. In situations where the recognition criteria are satisfied,
the expenditure for a major inspection is capitalized in the carrying amount of the asset as a replacement. Where significant parts of
property, plant and equipment are required to be replaced at intervals, the Group recognizes such parts as individual assets with specific
useful lives and depreciates them accordingly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is calculated on the straight-line basis to write off the cost of each item of property, plant and equipment to its residual value over
its estimated useful life. The principal annual rates used for this purpose are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 86%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.75</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20% to 33.33</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    and equipment</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5% to 31.67</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicles</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.75</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
parts of an item of property, plant and equipment have different useful lives, the cost of that item is allocated on a reasonable basis
among the parts and each part is depreciated separately. Residual values, useful lives and the depreciation method are reviewed, and
adjusted if appropriate, at least at each financial year end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
asset&#8217;s carrying amount is written down immediately to its recoverable amount if the asset&#8217;s carrying amount is greater than
its estimated recoverable amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
item of property, plant and equipment including any significant part initially recognized is derecognized upon disposal or when no future
economic benefits are expected from its use or disposal. Any gain or loss on disposal or retirement recognized in the statement of profit
or loss in the year the asset is derecognized is the difference between the net sales proceeds and the carrying amount of the relevant
asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
in progress is stated at cost less any impairment losses and is not depreciated. It is reclassified to the appropriate category of property,
plant and equipment when completed and ready for use.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Intangible
assets (other than goodwill)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination
is the fair value at the date of acquisition. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible
assets with finite lives are subsequently amortized over the useful economic life and assessed for impairment whenever there is an indication
that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at each financial year end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are amortized on the straight-line basis over the following useful economic lives:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 87%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 10 years</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14 years</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20 years</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
useful lives of software are assessed by the Group considering different purpose and usage of the software, and the authorized period
for use. The useful life of patent is assessed by the Group based on the remaining and foreseeable patent protection period after acquisition.
The useful life of a purchased license is assessed by considering the expected usage of the license by the Group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Research
and development costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
research costs are charged to the statement of profit or loss as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditure
incurred on projects to develop new products is capitalized and deferred only when the Group can demonstrate the technical feasibility
of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or
sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the project and the ability
to measure reliably the expenditure during the development. Product development expenditure which does not meet these criteria is expensed
when incurred. During the reporting period, all expenses incurred for research and development activities were regarded as research expenses
and therefore were expensed when incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group assesses at contract inception whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract
conveys the right to control the use of an identified asset for a period of time in exchange for consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Group
as a lessee</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets.
The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
                                            assets</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
assets are recognized at the commencement date of the lease (that is the date the underlying asset is available for use). Right-of-use
assets are measured at cost, less accumulated depreciation and any impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis
over the shorter of the lease terms and the estimated useful lives of the assets as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 87%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold land</span></td>
    <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 years</span></td>
    <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 to 7 years</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
ownership of the leased asset transfers to the Group by the end of the lease term or the cost reflects the exercise of a purchase option,
depreciation is calculated using the estimated useful life of the asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
                                            liabilities</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are recognized at the commencement date of the lease at the present value of lease payments to be made over the lease term.
The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease
payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also
include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for termination
of a lease, if the lease term reflects the Group exercising the option to terminate the lease. The variable lease payments that do not
depend on an index or a rate are recognized as an expense in the period in which the event or condition that triggers the payment occurs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
calculating the present value of lease payments, the Group uses its incremental borrowing rate at the lease commencement date because
the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is
increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities
is remeasured if there is a modification, a change in the lease term, a change in lease payments (e.g., a change to future lease payments
resulting from a change in an index or rate) or a change in assessment of an option to purchase the underlying asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s lease liabilities are included in interest-bearing bank and other borrowings.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
                                            leases and leases of low-value assets</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (that is those leases that
have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the recognition
exemption for leases of low-value assets to leases of office equipment that are considered to be of low value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
payments on short-term leases and leases of low-value assets are recognized as an expense on a straight-line basis over the lease term.</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Investments
and other financial assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets are classified, at initial recognition, as subsequently measured at amortized cost and fair value through profit and loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics
and the Group&#8217;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Group has applied the practical expedient of not adjusting the effect of a significant financing component,
the Group initially measures a financial asset at its fair value plus in the case of a financial asset not at FVTPL, transaction costs.
Trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are
measured at the transaction price determined under IFRS 15 in accordance with the policies set out for &#8220;Revenue recognition&#8221;
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order for a financial asset to be classified and measured at amortized cost, it needs to give rise to cash flows that are solely payments
of principal and interest (&#8220;SPPI&#8221;) on the principal amount outstanding. Financial assets with cash flows that are not SPPI
are classified and measured at fair value through profit or loss, irrespective of the business model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash flows.
The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or
both. Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial
assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through other comprehensive
income are held within a business model with the objective of both holding to collect contractual cash flows and selling. Financial assets
which are not held within the aforementioned business models are classified and measured at fair value through profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
or sales of financial assets that require delivery of assets within the period generally established by regulation or convention in the
marketplace are recognized on the trade date, that is, the date that the Group commits to purchase or sell the asset.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent
measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsequent measurement of financial assets depends on their classification as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
assets at amortized cost (debt instruments)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment. Gains and losses
are recognized in the statement of profit or loss when the asset is derecognized, modified or impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
assets at FVTPL</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets at FVTPL are carried in the statement of financial position at fair value with net changes in fair value recognized in the statement
of profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
on the equity investments are also recognized as other income in the statement of profit or loss when the right of payment has been established.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derecognition
of financial assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized
(i.e., removed from the Group&#8217;s consolidated statement of financial position) when:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            rights to receive cash flows from the asset have expired; or</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Group has transferred its rights to receive cash flows from the asset or has assumed an obligation
                                            to pay the received cash flows in full without material delay to a third party under a &#8220;pass-through&#8221;
                                            arrangement; and either (a) the Group has transferred substantially all the risks and rewards
                                            of the asset, or (b) the Group has neither transferred nor retained substantially all the
                                            risks and rewards of the asset, but has transferred control of the asset.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Group has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risk and rewards of ownership of the asset. When it has neither transferred nor retained
substantially all the risks and rewards of the asset nor transferred control of the asset, the Group continues to recognize the transferred
asset to the extent of the Group&#8217;s continuing involvement. In that case, the Group also recognizes an associated liability. The
transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Group has retained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Group could be required to repay.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Impairment
of financial assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group recognizes an allowance for expected credit losses (&#8220;ECLs&#8221;) for all debt instruments not held at fair value through
profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash
flows that the Group expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows
will include cash flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
approach</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ECLs
are recognized in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition,
ECLs are provided for credit losses that result from default events that are possible within the next 12 months (a 12-month ECL). For
those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is
required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each reporting date, the Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition.
When making the assessment, the Group compares the risk of a default occurring on the financial instrument as at the reporting date with
the risk of a default occurring on the financial instrument as at the date of initial recognition and considers reasonable and supportable
information that is available without undue cost or effort, including historical and forward-looking information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group considers a financial asset in default when contractual payments are 120 days past due. However, in certain cases, the Group may
also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive
the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets at amortized cost are subject to impairment under the general approach, and they are classified within the following stages for
measurement of ECLs except for trade receivables which apply the simplified approach as detailed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.65in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
                               1 &#8211; </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            instruments for which credit risk has not increased significantly since initial recognition
                                            and for which the loss allowance is measured at an amount equal to 12-month ECLs</span></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.65in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
                                            2 &#8211; </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            instruments for which credit risk has increased significantly since initial recognition but
                                            that are not credit-impaired financial assets and for which the loss allowance is measured
                                            at an amount equal to lifetime ECLs</span></td>
</tr></table>

<p style="text-align: left; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.65in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
                                            3 &#8211; </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            assets that are credit-impaired at the reporting date (but that are not purchased or originated
                                            credit-impaired) and for which the loss allowance is measured at an amount equal to lifetime
                                            ECLs</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Simplified
approach</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
trade receivables that do not contain a significant financing component or when the Group applies the practical expedient of not adjusting
the effect of a significant financing component, the Group applies the simplified approach in calculating ECLs. Under the simplified
approach, the Group does not track changes in credit risk but instead recognizes a loss allowance based on lifetime ECLs at each reporting
date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking
factors specific to the debtors and the economic environment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Financial
liabilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
liabilities are classified, at initial recognition, as financial liabilities at FVTPL, loans and borrowings, or payables, as appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s financial liabilities include trade payables, financial liabilities included in other payables and accruals, interest-bearing
bank and other borrowings, long-term payables and other current and non-current liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent
measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsequent measurement of financial liabilities depends on their classification as follows:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
liabilities at fair value through profit or loss</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
liabilities at fair value through profit or loss include financial liabilities designated upon initial recognition as at fair value through
profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
liabilities designated upon initial recognition as at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied. Gains or losses on liabilities designated at fair value through profit or loss are
recognized in the statement of profit or loss, except for the gains or losses arising from the Group&#8217;s own credit risk which are
presented in other comprehensive income with no subsequent reclassification to the statement of profit or loss. The net fair value gain
or loss recognized in the statement of profit or loss does not include any interest charged on these financial liabilities.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
liabilities at amortized cost (trade and other payables, and borrowings)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
initial recognition, trade and other payables, and interest-bearing borrowings are subsequently measured at amortized cost, using the
effective interest rate method unless the effect of discounting would be immaterial, in which case they are stated at cost. Gains and
losses are recognized in the statement of profit or loss when the liabilities are derecognized as well as through the effective interest
rate amortization process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the effective
interest rate. The effective interest rate amortization is included in finance costs in the statement of profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derecognition
of financial liabilities </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial liability is derecognized when the obligation under the liability is discharged or cancelled or expires.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing
liability are substantially modified, such an exchange or modification is treated as a derecognition of the original liability and a
recognition of a new liability, and the difference between the respective carrying amounts is recognized in the statement of profit or
loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Offsetting
of financial instruments </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, or to realize the assets
and settle the liabilities simultaneously.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derivative
financial instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and subsequent measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently
remeasured at fair value. Derivatives are carried as assets when the fair value is positive, and as liabilities when the fair value is
negative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
gains or losses arising from changes in fair value of derivatives are taken directly to profit or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Treasury
shares </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Own
equity instruments which are reacquired and held by the Company or the Group (treasury shares) are recognized directly in equity at cost.
No gain or loss is recognized in the statement of profit or loss on the purchase, sale, issue or cancellation of the Group&#8217;s own
equity instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Inventories</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are stated at the lower of cost and net realizable value. Cost is determined on the first-in, first-out basis, in the case of work in
progress and finished goods, comprises direct materials, direct labor, contract manufacturing fee and an appropriate proportion of overheads.
Net realizable value is based on estimated selling prices less any estimated costs to be incurred to completion and disposal.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Cash
and cash equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents in the statements of cash flows comprise cash on hand and at banks, and short-term highly liquid deposits with a
maturity of generally within three months that are readily convertible into known amounts of cash, subject to an insignificant risk of
changes in value and held for the purpose of meeting short-term cash commitments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of the consolidated statements of financial positions, cash and bank balances comprise cash and cash equivalents as defined
above, restricted bank balances and time deposits with original maturity of more than three months as defined above.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Provisions
</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
provision is recognized when a present obligation (legal or constructive) has arisen as a result of a past event and it is probable that
a future outflow of resources will be required to settle the obligation, provided that a reliable estimate can be made of the amount
of the obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Group expects some or all of a provision to be reimbursed, the reimbursement is recognized as a separate asset, but only when the
reimbursement is virtually certain. The expense relating to a provision is presented in the statement of profit or loss net of any reimbursement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the effect of discounting is material, the amount recognized for a provision is the present value at the end of the reporting date of
the future expenditures expected to be required to settle the obligation. The increase in the discounted present value amount arising
from the passage of time is included in finance costs in the statement of profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Income
tax</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax comprises current and deferred tax. Income tax relating to items recognized outside profit or loss is recognized outside profit or
loss, either in other comprehensive income or directly in equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, based on tax
rates (and tax laws) that have been enacted or substantively enacted by the end of each of the reporting period, taking into consideration
interpretations and practices prevailing in the countries in which the Group operates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax is provided, using the liability method, on all temporary differences at the end of reporting date between the tax bases of assets
and liabilities and their carrying amounts for financial reporting purposes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax liabilities are recognized for all taxable temporary differences, except:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                            the deferred tax liability arises from the initial recognition of goodwill or an asset or
                                            liability in a transaction that is not a business combination and, at the time of the transaction,
                                            affects neither the accounting profit nor taxable profit or loss and does not give rise to
                                            equal taxable and deductible temporary differences; and</span></td>
</tr></table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            respect of taxable temporary differences associated with investments in subsidiaries, when
                                            the timing of the reversal of the temporary differences can be controlled and it is probable
                                            that the temporary differences will not reverse in the foreseeable future.</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognized for all deductible temporary differences, and the carryforward of unused tax credits and any unused tax losses.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which the deductible
temporary differences, and the carryforward of unused tax credits and unused tax losses can be utilized, except:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                            the deferred tax asset relating to the deductible temporary differences arises from the initial
                                            recognition of an asset or liability in a transaction that is not a business combination
                                            and, at the time of the transaction, affects neither the accounting profit nor taxable profit
                                            or loss and does not give rise to equal taxable and deductible temporary differences; and</span></td>
</tr></table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            respect of deductible temporary differences associated with investments in subsidiaries,
                                            deferred tax assets are only recognized to the extent that it is probable that the temporary
                                            differences will reverse in the foreseeable future and taxable profit will be available against
                                            which the temporary differences can be utilized.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer
probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized
deferred tax assets are reassessed at the end of each reporting period and are recognized to the extent that it has become probable that
sufficient taxable profit will be available to allow all or part of the deferred tax asset to be recovered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realized or the liability
is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and deferred tax liabilities are offset if and only if the Group has a legally enforceable right to set off current tax assets
and current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation
authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets
on a net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts
of deferred tax liabilities or assets are expected to be settled or recovered.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Government
grants</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
grants are recognized at their fair value where there is reasonable assurance that the grant will be received and all attaching conditions
will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the periods that
the costs, for which it is intended to compensate, are expensed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
government grants whose primary condition is to compensate for research and development projects or other than purchase, construct or
otherwise acquire long-term assets are designated as grants related to income. Some of the grants related to income have future related
costs expected to be incurred and require the Group to comply with conditions attached to the grants and the government to acknowledge
the compliance of these conditions. These grants related to income are recognized as deferred income in the consolidated statement of
financial position and transferred to profit or loss when related costs are subsequently incurred, and the Group received government acknowledge
of compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
government grants related to income that are receivable as compensation for expenses or losses already incurred or for the purpose of
giving immediate financial support to the Group with no future related costs are recognized in profit or loss in the period in which
they become receivable.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Revenue
recognition </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from contracts with customers is recognized when control of goods or services is transferred to the customers at an amount that reflects
the consideration to which the Group expects to be entitled in exchange for those goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the consideration in a contract includes a variable amount, the amount of consideration is estimated to which the Group will be entitled
in exchange for transferring the goods or services to the customer. The variable consideration is estimated at contract inception and
constrained until it is highly probable that a significant revenue reversal in the amount of cumulative revenue recognized will not occur
when the associated uncertainty with the variable consideration is subsequently resolved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the contract contains a financing component which provides the customer with a significant benefit of financing the transfer of goods
or services to the customer for more than one year, revenue is measured at the present value of the amount receivable, discounted using
the discount rate that would be reflected in a separate financing transaction between the Group and the customer at contract inception.
When the contract contains a financing component which provides the Group with a significant financial benefit for more than one year,
revenue recognized under the contract includes the interest expense accreted on the contract liability under the effective interest method.
For a contract where the period between the payment by the customer and the transfer of the promised goods or services is one year or
less, the transaction price is not adjusted for the effects of a significant financing component, using the practical expedient in IFRS
15.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
                                            of products</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from the sale of products is recognized at the point in time when control of the asset is transferred to the customer, generally on acceptance
of the products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
                                            rights</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group provides commercialization, development and branding rights (collectively, &#8220;Commercialization Rights&#8221;) to customers
for an agreed upon commercialization period ending ten years from the date of the first sale of the product as stipulated in the relevant
agreement. The consideration for Commercialization Rights includes upfront payment, development and regulatory milestones payments and
commercialization milestones payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
and regulatory milestones payments are fully constrained until the period in which those regulatory approvals are achieved due to the
inherent uncertainty with the approval process and included in the transaction price in the period regulatory approval is obtained. Upfront
payment and development and regulatory milestones payments are recorded under contract liabilities and recognized as revenue over time
during the commercialization period on a straight-line basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
milestone payments based on the level of sales are recognized at a point in time when the later of the following events occurs: (i) the
related sale occurs, or (ii) the performance obligation to which commercialization milestones payments have been allocated has been satisfied.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
                                            property income</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
property income is recognized at the point in time at which the non-patented intellectual property is granted to the customer because
the Company will not undertake activities that affect such intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consideration for intellectual property income comprises a fixed element and a variable element. Variable element is recognized as the
transaction price when the Company can conclude that it is highly probable that a significant reversal in the amount of cumulative revenue
recognized will not occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -42.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group provides consulting services to its customers through contracts. Depending on the contract, revenue is recognized over time as
the service is rendered, or at the point in time as the service is completed and accepted.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
income</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income is recognized on an accrual basis using the effective interest method by applying the rate that exactly discounts the estimated
future cash receipts over the expected life of the financial instrument or a shorter period, when appropriate, to the net carrying amount
of the financial asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Contract
liabilities </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
contract liability is recognized when a payment is received or a payment is due (whichever is earlier) from a customer before the Group
transfers the related goods or services. Contract liabilities are recognized as revenue when the Group performs under the contract (i.e.,
transfers control of the related goods or services to the customer).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Share-based
payments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates share incentive plans which include the pre-IPO share option scheme, the post-IPO share option scheme, 2018 restricted
share unit scheme (the &#8220;2018 RSU Scheme&#8221;), 2021 restricted share unit scheme (the &#8220;2021 RSU Scheme&#8221;) and 2022
restricted share unit scheme (the &#8220;2022 RSU Scheme&#8221;). Employees (including directors) of the Group receive remuneration in
the form of share-based payments, whereby employees render services in exchange for equity instruments (&#8220;equity-settled transactions&#8221;).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of equity-settled transactions with employees is measured by reference to the fair value at the date at which they are granted,
further details of which are given in note 31 to the financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of equity-settled transactions is recognized in employee benefit expense, together with a corresponding increase in equity, over
the period in which the performance and/or service conditions are fulfilled. The cumulative expense recognized for equity-settled transactions
at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group&#8217;s
best estimate of the number of equity instruments that will ultimately vest. The charge or credit to the statement of profit or loss
for a period represents the movement in the cumulative expense recognized as at the beginning and end of that period.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service
and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood
of the conditions being met is assessed as part of the Group&#8217;s best estimate of the number of equity instruments that will ultimately
vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without
an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value
of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
awards that do not ultimately vest because non-market performance and/or service conditions have not been met, no expense is recognized.
Where awards include a market or non-vesting condition, the transactions are treated as vesting irrespective of whether the market or
non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
the terms of an equity-settled award are modified, as a minimum an expense is recognized as if the terms had not been modified, if the
original terms of the award are met. In addition, an expense is recognized for any modification that increases the total fair value of
the share-based payments or is otherwise beneficial to the employee as measured at the date of modification. Where an equity-settled
award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognized for the award is
recognized immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dilutive effect of outstanding options is reflected as additional share dilution in the computation of loss per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Other
employee benefits</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pension
scheme</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
employees of the Group&#8217;s subsidiaries which operate in the Chinese mainland are required to participate in a central pension scheme
operated by the local municipal government. The subsidiaries operating in Chinese mainland are required to contribute a certain percentage
of their payroll costs to the central pension scheme. The contributions are charged to profit or loss as they become payable in accordance
with the rules of the central pension scheme.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group implemented a safe harbor defined contribution 401(k) savings plan (the &#8220;401(k) Plan&#8221;) for U.S. employees. The 401(k)
Plan covers all U.S. employees and allows participants to defer a portion of their annual compensation on a pre-tax basis. In addition,
the Company implemented a matching contribution to the 401(k) Plan, matching 100% of an employee&#8217;s contribution up to a maximum
of 6% of the participant&#8217;s annual base salary. Such matching contribution vests when made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Borrowing
costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
costs directly attributable to the acquisition, construction or production of qualifying assets, i.e., assets that necessarily take a
substantial period of time to get ready for their intended use or sale, are capitalized as part of the cost of those assets. The capitalization
of such borrowing costs ceases when the assets are substantially ready for their intended use or sale. All other borrowing costs are
expensed in the period in which they are incurred. Borrowing costs consist of interest and other costs that an entity incurs in connection
with the borrowing of funds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Events
after the reporting period </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Group receives information after the reporting period, but prior to the date of authorization for issue, about conditions that existed
at the end of the reporting period, it will assess whether the information affects the amounts that it recognizes in its financial statements.
The Group will adjust the amounts recognized in its financial statements to reflect any adjusting events after the reporting period and
update the disclosures that relate to those conditions in light of the new information. For non-adjusting events after the reporting
period, the Group will not change the amounts recognized in its financial statements but will disclose the nature of the non-adjusting
events and an estimate of their financial effects, or a statement that such an estimate cannot be made, if applicable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Foreign
currencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are presented in RMB. Each entity in the Group determines its own functional currency and items included in the
financial statements of each entity are measured using that functional currency. Foreign currency transactions recorded by the entities
in the Group are initially recorded using their respective functional currency rates prevailing at the dates of the transactions. Monetary
assets and liabilities denominated in foreign currencies are translated at the functional currency rates of exchange ruling at the end
of the reporting period. Differences arising on settlement or translation of monetary items are recognized in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">Non-monetary
items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the
initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the
date when the fair value was measured. The gain or loss arising on translation of a non-monetary item measured at fair value is treated
in line with the recognition of the gain or loss on change in fair value of the item (i.e., translation difference on the item whose
fair value gain or loss is recognized in other comprehensive income or profit or loss is also recognized in other comprehensive income
or profit or loss, respectively).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the exchange rate on initial recognition of the related asset, expense or income on the derecognition of a non-monetary asset
or non-monetary liability relating to an advance consideration, the date of initial transaction is the date on which the Group initially
recognizes the non-monetary asset or non-monetary liability arising from the advance consideration. If there are multiple payments or
receipts in advance, the Group determines the transaction date for each payment or receipt of the advance consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currencies of certain overseas subsidiaries are currencies other than the RMB. As at the end of the reporting period, the
assets and liabilities of these entities are translated into RMB at the exchange rates prevailing at the end of the reporting period
and their statements of profit or loss are translated into RMB at the exchange rates that approximate to those prevailing at the dates
of the transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
resulting exchange differences are recognized in other comprehensive income and accumulated in the exchange fluctuation reserve, except
to the extent that the differences are attributable to non-controlling interests. On disposal of a foreign operation, the cumulative
amount in the reserve relating to that particular foreign operation is recognized in the statement of profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
goodwill arising on the acquisition of a foreign operation and any fair value adjustments to the carrying amounts of assets and liabilities
arising on acquisition are treated as assets and liabilities of the foreign operation and translated at the closing rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of the consolidated statements of cash flows, the cash flows of overseas subsidiaries are translated into RMB at the exchange
rates ruling at the dates of the cash flows. Frequently recurring cash flows of overseas subsidiaries which arise throughout the year
are translated into RMB at the exchange rates that approximate to those prevailing at the dates of the transactions.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of changes made to accounting policies by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Judgements and Estimates<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Significant Accounting Judgements and Estimates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">SIGNIFICANT ACCOUNTING JUDGEMENTS AND ESTIMATES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNIFICANT
                                            ACCOUNTING JUDGEMENTS AND ESTIMATES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the Group&#8217;s financial statements requires management to make judgements, estimates and assumptions that affect the
reported amounts of expenses, assets and liabilities, and their accompanying disclosures, and the disclosure of contingent liabilities.
Uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amounts
of the assets or liabilities affected in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Judgements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the process of applying the Group&#8217;s accounting policies, management has made the following judgements, apart from those involving
estimations, which have the most significant effect on the amounts recognized in the financial statements:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group applied the following judgements that significantly affect the determination of the amount and timing of revenue from contracts
with customers:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
rights contracts include variable consideration based on future events. In estimating the variable consideration, the Group is required
to use either the expected value method or the most likely amount method based on which method better predicts the amount of consideration
to which it will be entitled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.2pt; text-indent: -1.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
that the payments of certain variable consideration are not within the control of the Group, such as regulatory approvals, relevant consideration
is not considered until relevant approvals are obtained. The Group determines that the most likely amount method is the appropriate method
to estimate the variable consideration. When the Group can conclude that it is highly probable that there will not be a subsequent reversal
of a significant amount of revenue, the variable consideration will be included in the transaction price.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Estimation
uncertainty</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key assumptions concerning the future and other key sources of estimation uncertainty at the end of the reporting period, that have a
significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are
described below.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: left; text-indent: -1.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax assets are recognized for unused tax losses to the extent that it is probable that taxable profit will be available against which
the losses can be utilized. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized,
based upon the likely timing and the level of future taxable profits, together with future tax planning strategies. The Group has carried
forward tax losses of RMB 4,425,237 and RMB5,347,045 (US$764,617) as of December 31, 2024 and 2025, respectively, of which related deferred
tax assets of RMB3,523 and RMB12,373 (US$1,769) have been recognized as of December 31, 2024 and 2025, respectively. Deferred tax assets
have not been recognized in respect of losses that have arisen in subsidiaries that have been loss-making for some time, and it is not
considered probable that taxable profits will be available against which the tax losses can be utilized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">If
the Group was able to recognize all unrecognized deferred tax assets, net loss would have decreased and equity would have increased by
RMB1,119,913, RMB1,321,638 and RMB1,572,664 (US$224,889) during the years ended December 31, 2023, 2024 and 2025, respectively. Further
details on taxes are disclosed in Note 9.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Operating Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">OPERATING SEGMENT INFORMATION</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPERATING
                                            SEGMENT INFORMATION</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">For
management purposes, the Group has only one reportable operating segment, which is discovering, developing and commercializing
therapies to address global medical needs primarily in hematological malignancies Management monitors the operating results of the
Group&#8217;s operating segment as a whole for the purpose of making decisions about resource allocation and performance assessment.
Therefore, no analysis by operating segment is presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Geographical
information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from external customers</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0; text-indent: 369.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese
    mainland</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221,984</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">302,235</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">574,120</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,098</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Switzerland</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-195; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">678,415</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-196; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-197; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221,984</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">980,650</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">574,120</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,098</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0; text-indent: 369.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
revenue information above is based on the locations of the customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current assets</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese
    mainland</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,088,733</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,090,914</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">978,233</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">139,885</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,474</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,489</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">642</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">444</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    non-current assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,091,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,095,832</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">982,757</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,532</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
non-current assets information above is based on the locations of the assets and excludes financial instruments and deferred tax assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Information
about major customers</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from customers amounting to over 10% of the total revenue of the Group in the reporting period is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the years ended December 31,</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer A</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,323</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,895</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">436,644</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,439</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 11pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    B</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-198; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">678,415</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-199; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-200; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 11pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    C</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-201; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-202; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-203; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 11pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    D</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,623</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-204; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-205; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-206; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">172,967</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">908,310</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">436,644</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,439</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These customers generated less than 10% of the total revenue of the Group during the years ended December 31, 2023, 2024 and 2025.</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Other Income and Gains<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Revenue, Other Income and Gains [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock', window );">REVENUE, OTHER INCOME AND GAINS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUE,
                                            OTHER INCOME AND GAINS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
analysis of revenue is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Revenue
from contracts with customers</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated revenue information</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Types of goods
    or services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intellectual
    property income</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-207; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">678,415</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-208; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-209; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif">Sales
    of products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">193,535</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">260,835</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">499,272</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,395</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif">Commercialization
    rights income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,049</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,485</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72,629</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,386</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,400</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,915</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,219</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">317</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221,984</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">980,650</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">574,120</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">82,098</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Timing
    of revenue recognition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">At
    a point in time</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intellectual
    property income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-210; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">678,415</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-211; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-212; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Sales of products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">193,535</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">260,835</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">499,272</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,395</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commercialization
rights income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-213; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,144</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,026</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Over
    time</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commercialization
    rights income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,049</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,485</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,485</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,360</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,400</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,915</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,219</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">317</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221,984</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">980,650</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">574,120</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">82,098</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the amounts of revenue recognized in the current reporting period that were included in the contract liabilities
at the beginning of the reporting period:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
    rights income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,049</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,360</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-indent: 37.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
                                            obligations</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about the Group&#8217;s performance obligations is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -22pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intellectual
property income</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
intellectual property income is recognized at the point of time upon the customer obtains the right to use the non-patented intellectual
property as there are no ongoing activities that significantly affect the intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
of products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
performance obligation is satisfied upon acceptance of the products and payment is generally due within 45 to 120 days from the date
of billing.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Commercialization
rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
performance obligation is satisfied over time as commercialization rights are granted for an agreed upon commercialization period ending
ten years from the date of the first sale of the product as stipulated in the relevant agreement. Among these, revenue from sales-based
commercialization milestone payments is recognized at a point in time when the related sale occurs. Upfront payment in advance is required,
and the development and regulatory milestones payments and commercialization milestones payments are generally due within 120 days from
the date of billing.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of transaction prices allocated to the remaining performance obligations (unsatisfied or partially unsatisfied) as at December
31, 2024 and 2025 are as follows:&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts expected to be recognized as revenue:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    one year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,360</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
    one year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248,460</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">210,224</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,062</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">285,945</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,709</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of transaction prices allocated to the remaining performance obligations which are expected to be recognized mainly related to
commercialization rights, which have been partially recognized during the reporting period (note 26). The amounts disclosed above do
not include variable consideration which is constrained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Other
income and gains</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    interest income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,409</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,840</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,125</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,744</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants related
    to income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange gain, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,694</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,324</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,989</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value gain on derivative
    financial instruments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    on disposal of items of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,702</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,428</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,885</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other income and gains</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,316</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,359</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,495</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,800</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of explanatory information about revenue other income and other gains.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Before Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Loss Before Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock', window );">LOSS BEFORE TAX</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
                                            BEFORE TAX</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s loss before tax is arrived at after charging/(crediting):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 40%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    of inventories sold</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,342</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,031</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,481</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,074</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    of services provided</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,201</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,054</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,277</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">326</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Write-down
    of inventories to net realizable value</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right">-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,180</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">598</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of property, plant and equipment**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,281</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,184</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,761</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,404</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of investment property**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,883</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of right-of-use assets**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13(a)</span></td><td style="text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,632</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,657</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of intangible assets**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,399</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,851</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">706,972</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">947,245</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,137,448</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162,653</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    benefit expense (including directors&#8217; remuneration):</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wages
    and salaries</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">337,381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">367,008</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">404,195</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,799</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    share-based payment expenses**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,503</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,924</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,874</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,985</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pension
    scheme contributions (defined contribution scheme)*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,705</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,404</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,234</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,038</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">399,589</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">422,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">460,303</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value (gain)/loss, net:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    financial instruments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at FVTPL</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">832</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities at FVTPL</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-231">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,533</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,223</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Gain)/Loss
    on disposal of items of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    on disposal of items of lease</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(685</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(99</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    payments not included in the measurement of lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13(c)</span></td><td style="text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">329</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
    grants related to income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    interest income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(32,409</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(37,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(82,125</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,744</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditors&#8217;
    remuneration</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,550</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">729</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,988</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,322</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,395</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,345</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,777</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">826</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    exchange (gain)/loss, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,694</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,161</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no forfeited contributions that may be used by the Group as the employer to reduce the existing level of contributions.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The depreciation of property, plant and equipment, the depreciation of investment property, the depreciation of right-of-use assets, the amortization of intangible assets and the equity-settled share-based payment expenses for the years are included in &#8220;Cost of Sales&#8221;, &#8220;Research and development expenses&#8221;, &#8220;Selling and distribution expenses&#8221; and &#8220;Administrative expenses&#8221; in the consolidated statements of profit or loss.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about loss before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Other Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory', window );">OTHER EXPENSES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
                                            EXPENSES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value loss
    on financial liabilities at FVTPL</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,533</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,223</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,988</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,322</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,395</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,345</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange loss</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,161</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-style: normal; text-decoration: none; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-237"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none">2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,777</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">827</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value loss on financial assets at FVTPL</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">832</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on disposal of items of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">492</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,581</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">512</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,203</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,075</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,599</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,525</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance Costs<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestCostsAbstract', window );"><strong>Finance Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">FINANCE COSTS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8<i>.</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCE
                                            COSTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
analysis of finance costs is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on bank loans and other borrowings</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,690</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,555</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,812</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,409</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on lease liabilities (note 13(b))</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,321</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on long-term payables</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,046</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,402</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,140</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,057</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,455</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,070</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">INCOME TAX</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCOME
                                            TAX</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group is subject to income tax on an entity basis on profits arising in or derived from the jurisdictions in which members of the Group
are domiciled and operate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cayman
Islands</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the current laws of the Cayman Islands, the Company and Ascentage Pharma Group International are not subject to tax on income or capital
gain arising in the Cayman Islands. Additionally, upon payments of dividends by these companies to its shareholders, no Cayman Islands
withholding tax will be imposed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong
Kong</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsidiaries incorporated in Hong Kong are subject to income tax at the rate of 16.5% on the estimated assessable profits arising in
Hong Kong. For the years ended December 31, 2023, 2024 and 2025, the Company did not make any provisions for Hong Kong profits tax as
there were no assessable profits derived from or earned in Hong Kong for any of the periods presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United
States</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsidiary operating in the United States is subject to tax at a maximum of 21.36% and 21.61%, respectively, for the years ended December
31, 2024 and 2025. No provision for income tax has been made as the Group had no assessable profits earned in the United States during
the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
requirement to capitalize and amortize previously deductible research and experimental expenses resulting from a change in Section 174
made by the Tax Cuts and Jobs Act of 2017 (the &#8220;TCJA&#8221;) became effective on January 1, 2022. Under the TCJA, the Company is
required to capitalize and subsequently amortize R&amp;D expenses over five years for research activities conducted within the U.S. and
fifteen years for research activities conducted outside of the U.S.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2025, the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;) was enacted, which reinstated current deductibility of domestic research
and experimental expenditures and provided an election to accelerate the recovery of previously capitalized costs. The Company did not
elect to accelerate the deduction of previously capitalized domestic research and experimental expenditures and will continue to amortize
such costs over the remaining statutory periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chinese
mainland</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s subsidiaries domiciled in the PRC are subject to the statutory rate of 25%, in accordance with the Enterprise Income
Tax law (the &#8220;EIT Law&#8221;), which was effective since January 1, 2008, except for the following entities which are eligible
for a preferential tax rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthquest
Pharma was qualified as a High and New Technology Enterprise (&#8220;HNTE&#8221;) and was subject to a preferential rate of 15% for three
years from 2022 to 2024. In 2025, Healthquest Pharma was no longer qualified as a HNTE and thus subject to the statutory tax rate of
25%.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">Suzhou
Yasheng was recognized as a qualified HNTE under the EIT Law by the relevant government authorities and is subject to a preferential
rate of 15% for three years from 2023 to 2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends,
interest, rent or royalties payable by the Company&#8217;s PRC subsidiaries, to non-PRC resident enterprises, and proceeds from any such
non-resident enterprise investor&#8217;s disposition of assets (after deducting the net value of such assets) shall be subject to 10%
withholding tax, unless the respective non-PRC resident enterprise&#8217;s jurisdiction of incorporation has a tax treaty or arrangements
with China that provides for a reduced withholding tax rate or an exemption from withholding tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current and deferred components of the income tax (credit)/expense are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    (note 18)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,150</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,425</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,911</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">988</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            income tax (credit)/expense for the year</span></p></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,150</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,425</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,940</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">992</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation
between the income tax expense/(credit) computed by applying the statutory tax rate to loss before income tax and the actual provision
for income tax is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss
    before tax</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(932,862</span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(395,255</span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,236,047</span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(176,753</span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    tax computed at the statutory tax rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(244,549</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(70,114</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(287,881</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(41,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lower
    tax rate for a specific entity</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,396</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,112</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,759</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,545</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statutory
    income and expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,824</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,534</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(12,900</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,845</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Items
    not subject to tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,093</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,236</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,533</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,076</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Items
    not deductible for tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,192</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,045</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">49,582</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,091</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Research
    and development super-deduction</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(67,525</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(75,135</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(48,919</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(Gain)/loss
    attributable to joint ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(269</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(78</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Provision
    to return</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,311</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(35,342</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">68,391</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,779</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect
    of tax rate changes on deferred taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(56,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,822</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(71,206</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,183</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Uncertain
    tax position</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,665</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,236</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,036</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Effect
    of withholding tax on the interest income of the Group&#8217;s HK subsidiary</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-243; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Tax
    loss expired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-244; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31,670</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,237</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Deductible
    temporary differences not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,235</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,465</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">49,919</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,138</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Tax
    losses not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">237,432</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">68,580</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">163,913</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,438</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax (credit)/expense at the Group&#8217;s effective rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,150</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,425</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,940</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">992</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</span></td><td style="text-align: justify"><p style="margin: 0pt 0">The disclosure <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">presentation of previous
periods has been adjusted to be in line with the 2025 disclosure presentation of &#8220;Tax loss expired&#8221; to ensure consistency.</span></p></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dividends<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DividendAbstract', window );"><strong>Dividends [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDividendsExplanatory', window );">DIVIDENDS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDENDS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
board of directors resolved not to declare any final dividend for the years ended December 31, 2023, 2024 and 2025.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DividendAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DividendAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDividendsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of dividends. Dividends are distributions of profits to holders of equity investments in proportion to their holdings of a particular class of capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDividendsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share Attributable to Ordinary Equity Holders of the Company<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Loss Per Share Attributable to Ordinary Equity Holders of the Company [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
                                            PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The calculation of the basic loss per share amount is based on the loss for the year attributable to ordinary equity holders of the parent, and the weighted average number of ordinary shares of 356,130,452 (2024: 302,062,104, 2023: 282,299,269) outstanding during the year, as adjusted to reflect the rights issued during the year.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
adjustment has been made to the basic loss per share amounts presented for the years ended December 31, 2023, 2024 and 2025 in respect
of a dilution as the impact of the options and RSUs outstanding had an anti-dilutive effect on the basic loss per share amounts presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of basic loss per share is based on:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Loss</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    attributable to ordinary equity holders of the parent, used in the basic loss per share calculation</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(925,637</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(405,433</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,242,769</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(177,714</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Shares</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average number of ordinary shares outstanding during the year used in the basic loss per share calculation#</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">282,299,269</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">302,062,104</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">356,130,452</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average number of shares was after taking into account the effect of treasury shares held.</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">PROPERTY, PLANT AND EQUIPMENT</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPERTY,
                                            PLANT AND EQUIPMENT</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Buildings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Leasehold<br/> improvements</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Furniture&#160;and<br/> equipment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Motor<br/> vehicles</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Construction<br/> in progress</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">December 31, 2024</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>At January 1, 2024:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in">Cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">834,913</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">29,218</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">179,256</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">609</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">12,650</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">1,056,646</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(65,137</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,517</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(73,771</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(406</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(150,831</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">769,776</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">17,701</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">105,485</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">12,650</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">905,815</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">At January 1, 2024, net of accumulated depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">769,776</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,701</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,485</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">203</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">905,815</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,059</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,807</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,866</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Depreciation provided during the year (note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39,599</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,896</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,569</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(120</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(71,184</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Transfers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,105</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,010</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,049</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-254">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,164</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-255">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exchange realignment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">At December 31, 2024, net of accumulated depreciation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">731,282</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">25,815</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">84,977</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">83</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,293</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">849,450</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">At December 31, 2024:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">836,018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,239</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,734</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">609</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,293</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,070,893</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(104,736</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,424</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(97,757</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(526</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(221,443</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">731,282</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">25,815</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">84,977</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">83</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,293</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">849,450</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Buildings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Leasehold improvements</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Furniture and equipment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Motor vehicles</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Construction in progress</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">December 31, 2025</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>At January 1, 2025:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in">Cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">836,018</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">44,239</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">182,734</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">609</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">7,293</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">1,070,893</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(104,736</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,424</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(97,757</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(526</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(221,443</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">731,282</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">25,815</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">84,977</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">83</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,293</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">849,450</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">At January 1, 2025, net of accumulated depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">731,282</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,815</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,977</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,293</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">849,450</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,270</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,635</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">427</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,561</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Depreciation provided during the year (note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,117</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,374</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,157</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(65,761</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Transfers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,802</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">368</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16,412</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Deficit on adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,982</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,982</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exchange realignment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">At December 31, 2025, net of accumulated depreciation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">676,985</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">31,953</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">69,790</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">397</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,110</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">781,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">At December 31, 2025:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">818,838</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,734</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">185,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,036</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,110</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,068,264</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(141,853</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,781</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(115,756</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(639</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(287,029</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">676,985</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">31,953</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">69,790</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">397</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,110</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">781,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount in US$</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">96,808</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,569</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">9,980</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">302</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">111,715</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">LEASES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEASES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">The
Group as a lessee</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has lease contracts for land and buildings. Lump sum payments were made upfront to acquire the leased land from the owners with
lease periods of 30 years, and no ongoing payments will be made under the terms of these land leases. Leases of buildings generally have
lease terms between 2 and 7 years. Other leases generally have lease terms of 12 months or less and/or are individually of low value.
Generally, the Group is restricted from assigning and subleasing the leased assets outside the Group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
                                            assets</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Group&#8217;s right-of-use assets and the movements during the year are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    land</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at January 1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,654</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,598</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,252</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,329</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,108</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-279; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,108</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,446</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation charge (note
    6)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,130</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,592</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,067</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-280; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,067</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(153</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange realignment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-281; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2024 and January 1, 2025</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,641</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,468</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,109</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,023</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-282; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">722</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation charge (note
    6)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,130</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,657</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,675</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,675</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(382</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange realignment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,489</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,338</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,827</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,839</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
                                            liabilities</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 35.4pt 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of lease liabilities (included under interest-bearing bank and other borrowings) and the movements during the year are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying amount
    at January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,681</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,232</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,323</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New leases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,108</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">722</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion of interest recognized
    during the year (note 8)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,911</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,835</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,549</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange realignment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,152</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,360</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(481</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying
    amount at December 31</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,232</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,196</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,174</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analyzed into:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,283</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,041</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current
    portion</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,793</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,913</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,133</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maturity analysis of lease liabilities is disclosed in note 39 to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts recognized in profit or loss in relation to leases are as follows:</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest on lease
    liabilities (note 8)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,498</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation charge of right-of-use
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,657</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense
    relating to short-term leases (included in administrative expenses) (note 6)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">329</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total amount recognized in
    profit or loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,870</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,104</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,731</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            total cash outflow for leases and future cash outflows relating to leases that have not yet
                                            commenced are disclosed in notes 32(c) and 33(b), respectively, to the consolidated financial
                                            statements.</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGoodwillExplanatory', window );">GOODWILL</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GOODWILL</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -11pt; padding-left: 11pt">Cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">24,694</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">24,694</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,531</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated impairment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">24,694</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">24,694</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,531</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of goodwill as at December 31, 2024 and 2025 was allocated to the cash-generating unit (&#8220;CGU&#8221;) of Healthquest
Pharma.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Impairment
testing of goodwill</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverable amount of the cash-generating unit has been determined based on a value in use calculation using cash flow projections
approved by senior management. The cash flows of the unit are projected based on the forecasted sales of the new drug after the
approval of the new drug application (&#8220;NDA&#8221;) and within the patent protection period. No revenue nor cash flow has been
forecasted after the expiration of the patent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
were used in the value in use calculation of the cash-generating unit for the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following describes each key assumption on which management has based its cash flow projections to undertake impairment testing of goodwill:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
rate - The discount rate applied to the cash flow projections was 19.40% as at December 31, 2025 (2024: 24.20%). The discount rate used
is before tax and reflects specific risks relating to the relevant unit.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
revenue &#8211; The revenue is based on the business strategy and management&#8217;s expectation for the market development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
values assigned to the key assumptions are consistent with external information sources. The management believes that any reasonably
possible change in any of the key assumptions on which the recoverable amount is based would not cause the cash-generating unit&#8217;s
recoverable amount to drop lower than its carrying amount.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Intangible Asset<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OtherIntangibleAssetAbstract', window );"><strong>Other Intangible Asset [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">OTHER INTANGIBLE ASSET</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
                                            INTANGIBLE ASSET</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    at January 1, 2024, net of accumulated amortization</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,232</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,089</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,125</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,446</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,403</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,403</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    provided during the year (note 6)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,100</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,251</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,500</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,851</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,535</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,838</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,625</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,728</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,050</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,778</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,193</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(52,212</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,375</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(65,780</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    carrying amount</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,535</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,838</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,625</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    at January 1, 2025, net of accumulated amortization</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,535</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,838</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,625</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,998</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    provided during the year (note 6)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,262</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,300</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,500</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,062</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,273</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,538</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,125</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,936</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,728</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,050</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,778</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,455</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(59,512</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,875</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(75,842</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    carrying amount</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,273</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,538</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,125</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,936</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    carrying amount in US$</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,183</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,796</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,450</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,429</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OtherIntangibleAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OtherIntangibleAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in a Joint Venture<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesAbstract', window );"><strong>Investment in a Joint Venture [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesExplanatory', window );">INVESTMENT IN A JOINT VENTURE</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INVESTMENT
                                            IN A JOINT VENTURE</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 64%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share of
    net assets</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,717</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,030</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,723</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars
of the Group&#8217;s principal joint venture are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-indent: -22.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of registration and business</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registered share capital</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of ownership interest</b></span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal activities</b></span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suzhou Ascentage Harvest Venture Capital LLP* (&#8220;Ascentage Harvest&#8221;)</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">360,000</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.42</span></td> <td style="white-space: nowrap; vertical-align: top; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%**</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in Biotechnology companies</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-indent: -22.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above investment is indirectly held by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.25pt; text-indent: -0.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English name of the company registered in the PRC represents the best efforts made by the management of the Company in directly translating the Chinese name of this Company as no English name has been registered.</span></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group holds two of three representatives in the committee that directs the relevant activities of Ascentage Harvest. As a result, the Group has significant influence over the financial and operating policy decisions of Ascentage Harvest.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table illustrates the summarized financial information of the Group&#8217;s joint venture:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            of the joint venture&#8217;s (loss)/gain for the year</span></p></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(281</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                 of the joint venture&#8217;s total comprehensive (loss)/gain for the year</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(281</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate carrying amount
    of the Group&#8217;s investment in the joint venture</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,717</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,030</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,723</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of joint ventures. [Refer: Total for all joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B4<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B4_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Assets at Fair Value through Profit or Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract', window );"><strong>Financial Assets at Fair Value through Profit or Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory', window );">FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
                                            ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listed
    equity investments, at fair value</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    unlisted investments, at fair value</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;4,000</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above listed equity investments were classified as financial assets at fair value through profit or loss as they were held for trading.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above unlisted investments were classified as financial assets at fair value through profit or loss as they represent investments in
non-trading equity instruments and have not been designated as financial assets at fair value through other comprehensive income.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial instruments measured at fair value through profit or loss. [Refer: At fair value [member]; Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">DEFERRED TAX</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFERRED
                                            TAX</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
movements in deferred tax liabilities and assets during the reporting period are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Deferred
tax liabilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value adjustments arising from acquisition of a subsidiary</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
    assets</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,549</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,413</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,962</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 9)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,181</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,300</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,881</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities at December 31, 2024 and January 1, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,368</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,081</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax charged/(credited) to the statement of profit or loss during the year (note 9)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,975</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,241</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">734</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities at December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,343</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,472</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,815</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities at December 31, 2025 in US$</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,051</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">782</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,833</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Deferred
tax assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
    liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donation
    expenses</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Losses
    Available<br/>
    for Offsetting<br/>
    Against<br/>
    Future<br/>
    Taxable<br/>
    profits</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,440</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,413</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,402</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,255</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,623</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,300</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,896</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,879</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,306</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets at December 31, 2024 and January 1, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,817</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,896</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,523</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,949</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,582</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,241</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,204</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,177</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets at December 31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,235</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,472</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,692</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,373</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,772</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets at December 31, 2025 in US$</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,609</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">782</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">242</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,769</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,402</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
presentation purposes, certain deferred tax assets and liabilities have been offset in the statements of financial position. The following
is an analysis of the deferred tax balances of the Group for financial reporting purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax offset in the consolidated statements of financial position</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,713</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,815</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,833</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    deferred tax assets recognized in the consolidated statements of financial position</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,236</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,957</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,570</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    deferred tax liability recognized in the consolidated statements of financial position</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,368</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2024 and 2025, the Group has tax losses arising in Chinese mainland of RMB2,963,587 and RMB3,047,076 (US$435,726), respectively,
that will expire from 2026 to 2035 for offsetting against future taxable profits. The Group has tax losses arising in other jurisdictions
of RMB1,438,160 and RMB2,250,477 (US$321,814), mainly from the United States that are available indefinitely for offsetting against up
to&#160;80% of future taxable profits of the company in which the losses arose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2024 and 2025, the Group has deductible temporary differences of RMB828,668 and RMB1,000,310 (US$143,042), respectively.
The Group has the tax credits of RMB120,606 and RMB158,931 (US$22,727), mainly from the United States that will expire between 2039 and
2045 if not utilized.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
deferred tax assets have not been recognized in respect of above tax losses, deductible temporary differences and tax credits as they
have arisen in entities that have been loss-making and it is not anticipated there will be sufficient taxable income in the foreseeable
future to utilize these items.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024 and 2025, there was <span style="-sec-ix-hidden: hidden-fact-301"><span style="-sec-ix-hidden: hidden-fact-302">no</span></span> unrecognized deferred tax liability for taxes that would be payable on the unremitted earnings
of the Group&#8217;s subsidiaries or joint ventures in the Chinese mainland as these enterprises are still in accumulative losses status.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024 and 2025, the Company has uncertain tax position amounts of RMB23,665 and RMB37,901 (US$5,420), respectively, of
which <span style="-sec-ix-hidden: hidden-fact-297">nil</span> and <span style="-sec-ix-hidden: hidden-fact-298">nil</span> are presented on a net basis against the deferred tax assets related to tax loss carry forwards on the consolidated
balance sheets. As of December 31, 2024 and 2025, the uncertain tax position amounts of RMB23,665 and <span style="-sec-ix-hidden: hidden-fact-299">nil</span> (US <span style="-sec-ix-hidden: hidden-fact-300">nil</span>), respectively, if
ultimately recognized, will impact the effective tax rate.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023, 2024 and 2025, the Company did not record any interest expense and penalty accrued in relation to
the uncertain tax position in income tax expenses.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Other Non-Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory', window );">OTHER NON-CURRENT ASSETS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
                                            NON-CURRENT ASSETS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Contract acquisition costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">30,529</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">29,851</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,269</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Value added tax recoverable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,034</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">Deposit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,439</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">690</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Prepayment for property, plant and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">301</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">184</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">59,303</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">30,725</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,394</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other non-current assets. [Refer: Other non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">INVENTORIES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INVENTORIES</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work in progress</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,736</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,371</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,628</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,861</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,427</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    Provision</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,180</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(598</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,597</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,618</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,092</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade Receivables, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">TRADE RECEIVABLES, NET</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRADE
                                            RECEIVABLES, NET</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade receivables, net</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,143</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252,938</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,170</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s trading terms with its customers are mainly on credit. The credit period is generally 45 to 120 days. Each customer has
a maximum credit limit. The Group seeks to maintain strict control over its outstanding receivables and has a credit control department
to minimize credit risk. Overdue balances are reviewed regularly by senior management. The Group does not hold any collateral or other
credit enhancements over its trade receivable balances. Trade receivables are non-interest-bearing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
aging analysis of the trade receivables as at the end of the reporting period, based on the invoice date and net of loss allowance, is
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Within 45 days</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">54,484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">252,938</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">36,170</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">45 to 120 days</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,659</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">83,143</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">252,938</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">36,170</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">An
impairment analysis is performed at each reporting date. The Group has applied the simplified approach to provide for ECLs prescribed
by IFRS 9, which permits the use of the lifetime expected loss provision for all trade receivables. The directors of the Company are
of the opinion that the ECL in respect of the balance of trade receivables is minimal. No loss allowance for impairment of trade receivables
is provided as at December 31, 2025 (2024: nil).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepayments, Other Receivables and Other Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract', window );"><strong>Prepayments, Other Receivables and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory', window );">PREPAYMENTS, OTHER RECEIVABLES AND OTHER ASSETS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PREPAYMENTS,
                                            OTHER RECEIVABLES AND OTHER ASSETS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Prepayments for clinical trial expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">71,050</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100,769</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14,410</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Prepaid listing expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Value added tax recoverable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,748</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,685</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,455</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">208</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,367</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">309</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Prepayment for treasury share purchase fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,754</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,798</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,258</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other prepayments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,644</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,603</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,662</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">123,211</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">192,532</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">27,532</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of financial assets included in prepayments, other receivables and other assets approximate to their fair values.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial assets included in the above balances relate to receivables for which there was no recent history of default or past due amounts.
As at December 31, 2024 and 2025, the loss allowance was assessed to be minimal.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of prepayments and other assets. [Refer: Other assets; Prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Bank Balances<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashAndBankBalancesAbstract', window );"><strong>Cash and Bank Balances [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory', window );">CASH AND BANK BALANCES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
                                            AND BANK BALANCES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents as stated in the consolidated statements of cash flows</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">893,100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,195,784</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,995</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    cash</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,633</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,685</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">812</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time
    deposits with original maturity of more than three months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">343,478</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,268,616</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,410</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances as stated in the consolidated statements of financial position</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,261,211</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,470,085</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,217</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominated
    in:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">298,922</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">205,783</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,426</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">947,012</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,257,307</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">322,791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HK$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,812</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,827</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">547</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,465</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,168</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">453</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,261,211</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,470,085</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,217</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the end of the reporting period, the cash and bank balances of the Group denominated in RMB amounted to RMB205,783 (US$29,426) (2024:
RMB298,922). The RMB is not freely convertible into other currencies, however, under Chinese mainland&#8217;s Foreign Exchange Control Regulations
and Administration of Settlement, and Sale and Payment of Foreign Exchange Regulations, the Group is permitted to exchange RMB for other
currencies through banks authorized to conduct foreign exchange business.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
at banks earn interest at floating rates based on daily bank deposit rates. Time deposits with original maturity of more than three
months earn interest at fixed interest rates for varying periods of between two years and three years. The bank balances are deposited
with creditworthy banks with no recent history of default.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CashAndBankBalancesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CashAndBankBalancesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and bank balances at central banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Payables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesAbstract', window );"><strong>Trade Payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory', window );">TRADE PAYABLES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRADE
                                            PAYABLES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
aging analysis of the trade payables as at the end of each reporting period, based on the invoice date, is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within 1 month</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,506</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,119</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 to 3 months</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,288</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,648</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">522</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 6 months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,172</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,973</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,712</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,740</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,264</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trade payables are non-interest-bearing and are normally settled in less than six months.&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Payables and Accruals<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Other Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock', window );">OTHER PAYABLES AND ACCRUALS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
                                            PAYABLES AND ACCRUALS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    promotion expenses</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,009</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121,545</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,381</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payroll
    payables</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,848</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,423</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,214</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payables
    for construction cost</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,888</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">842</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    payables-current portion (note 36)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,344</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,194</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities-current portion (note 36)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,968</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">281</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    payables</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,442</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,493</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
    subsidy</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,232</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    payables other than income tax</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,627</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,700</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,959</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    accrued expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,847</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,709</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">387</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">258,098</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">276,666</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,563</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
payables are non-interest-bearing.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other payables and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilitiesAbstract', window );"><strong>Contract Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfContractLiabilitiesTextBlock', window );">CONTRACT LIABILITIES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTRACT
                                            LIABILITIES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of contract liabilities as at December 31, 2024 and 2025 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term advances recognized
    from customers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
    rights income</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,360</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    advances recognized from customers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
    rights income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248,460</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">210,224</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,062</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">285,945</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,709</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
liabilities include long-term and short-term advances related to commercialization rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2021, the Group entered into an agreement with Innovent Biologics (Suzhou) Co., Ltd (&#8220;Innovent&#8221;). Under the agreement,
the Group owns all intellectual property generated in connection with the development and commercialization of HQP1351. Innovent was
granted the commercialization rights of HQP1351 in China and should make a non-refundable payment and milestone payments for such rights
to the Group, which are recorded under contract liabilities and recognized as revenue over time during the commercialization period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the agreement, the Group recognized RMB349,523 (US$49,981) in aggregate as contract liabilities from contract inception
through December 31, 2025 (2024: RMB349,523). The Group recognized RMB37,485 (US$5,360) as revenue during the year ended December 31,
2025 (2024: RMB37,485; 2023: RMB26,049). Milestone payments are recognized as the transaction price when the Group can conclude that
it is highly probable that there will not be a subsequent reversal of a significant amount of revenue.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfContractLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosyre of contract liabuilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfContractLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest-Bearing Bank and Other Borrowings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAbstract', window );"><strong>Interest-Bearing Bank and Other Borrowings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBorrowingsExplanatory', window );">INTEREST-BEARING BANK AND OTHER BORROWINGS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTEREST-BEARING
                                            BANK AND OTHER BORROWINGS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective interest rate<br/> per annum (%)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term borrowing</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.60-2.70 or 1 year LPR-0.30 to 0.75</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.15 to 0.65 or 1 year LPR+0.65 to 0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,170</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80 - 4.55</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,439</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">779,062</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.45 to 0.65 or 1 year LPR+0.70 to 0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026 - 2028</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">203,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80-4.50</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026 - 2027</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026 - 2038</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">588,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026 - 2028</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,793</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; non-current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">889,435</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,668,497</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective interest rate<br/> per annum (%)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term borrowing</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11-2.50 or 1 year LPR-0.60 to 0.89</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,040,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,718</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.45 to 0.75</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156,200</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,359</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,283</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,041</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,222,481</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,812</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; font-weight: bold; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.45 to 0.75</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027 &#8211; 2028</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,431</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,750</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,256</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027 &#8211; 2038</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">583,675</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,464</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027 &#8211; 2028</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,913</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,133</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; non-current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,238</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,284</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,979,719</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,096</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:
LPR represents the Loan Prime Rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The bank loans amounting to RMB600,173 (US$85,823) as at December 31, 2025 were secured by the pledge of the Group&#8217;s buildings with a net carrying amount of RMB676,985 (US$96,808) and right-of-use assets with a net carrying amount of RMB25,338 (US$3,623) as at December 31, 2025. Such loans were also guaranteed by two of the Group&#8217;s subsidiaries.</span></p></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
bank loans amounting to RMB599,745 as at December 31, 2024 were secured by the pledge of the Group&#8217;s buildings with a net carrying
amount of RMB731,282 and right-of-use assets with a net carrying amount of RMB26,468 as at December 31, 2024. Such loans were also guaranteed
by two of the Group&#8217;s subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unsecured bank loans amounting to RMB140,000 (US$20,020) (2024: RMB278,070) were guaranteed by the Group&#8217;s subsidiaries as at December
31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of borrowings are all denominated in RMB. The weighted average interest rate for the outstanding short-term bank loans
as of December 31, 2024 and 2025, was 2.63% and 2.18%, respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analyzed into:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    one year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">779,062</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,222,481</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,812</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the second year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">242,473</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,201</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,908</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the third to fifth years, inclusive</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159,355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,034</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
    five years</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">487,607</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">456,937</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,668,497</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,979,719</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,096</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract', window );"><strong>Deferred Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredIncomeExplanatory', window );">DEFERRED INCOME</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFERRED
                                            INCOME</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">929</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
movements in government grants during the reporting period are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At beginning of
    the year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,360</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,932</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Received during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,740</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">143</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portion
    classified as current liabilities (note 25)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16,600</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,146</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At end
    of the year</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">929</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred income. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Treasury Shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Share Capital and Treasury Shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">SHARE CAPITAL AND TREASURY SHARES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE
                                            CAPITAL AND TREASURY SHARES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
and fully paid</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
    shares in <br/>
    issue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB
    equivalent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares of US$0.0001 each</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,196,560</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
    shares in <br/>
    issue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB
    equivalent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares of US$0.0001 each</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,224,993</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">214</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31, 2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
    shares in <br/>
    issue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB
    equivalent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares of US$0.0001 each</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">373,321,692</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">Movements
in the issued share capital and treasury shares from January 1, 2023 to December 31, 2025 were as follows:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury
    shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2023</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,185,950</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,552</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,372</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ordinary shares
    (a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the Pre-IPO share option scheme (b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">911,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the 2021 RSU scheme (c)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,034</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus (d)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,528,514</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase of ordinary
    shares (e)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,923</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,923</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs (f)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,123</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,123</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023 and January 1, 2024</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,196,560</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,351</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ordinary shares
    (g)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,307,322</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the Pre-IPO share option scheme (h)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">656,077</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the 2021 RSU scheme (i)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,034</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus (j)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase of ordinary
    shares (k)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,959</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,959</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs (l)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,671</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,671</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2024 and
    January 1, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,224,993</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">214</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">206</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ordinary shares
    (m)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,040,576</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the Pre-IPO share option scheme (n)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">455,263</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-335; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-336; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the 2021 RSU scheme and 2022 RSU scheme (o)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,008,253</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-337; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus (p)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,592,607</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-338; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-339; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-340; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase of ordinary
    shares (q)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-341; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-342; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,590</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,590</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs (r)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-343; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-344; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">637</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">637</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2025</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">373,321,692</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,961</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,705</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">373,321,692</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(423</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(386</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the share placement, 22,500,000 placing shares of the Company were issued and allotted at a price of HK$24.45 per share on February 1, 2023, and an amount of RMB15 was credited as share capital.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company before December 31, 2023 to those grantees. In connection with the exercised share options, 911,062 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB1 was credited as share capital.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2023 to those selected persons. In connection with the exercised RSUs, 71,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, 1,528,514 ordinary shares and 1,237,884 treasury shares, being underlying shares of the RSUs granted under the 2021 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB1 and RMB1 were credited as share capital and treasury shares, respectively.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the Company instructed the trustee to purchase 250,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB5,923 for the purpose of the 2022 RSU scheme.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the exercise of RSUs granted under the 2018 and 2022 RSU Scheme, 1,069,461 treasury shares were allotted to the employees during the year ended December 31,2023.</span></td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, 24,307,322 placing shares of the Company were issued and allotted at a price of HK$24.10 per share on June 20, 2024, and an amount of RMB17 was credited as share capital.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 656,077 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.5 was credited as share capital.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2024, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2024 to those selected persons. In connection with the exercised RSUs, 65,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2024, 397,949 treasury shares and 2,081,399 treasury shares, being underlying shares of the RSUs granted under the 2022 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB8,630 and RMB1.4 were both credited as treasury shares.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2024, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB1,959 for the purpose of the 2022 RSU Scheme.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of RSUs granted under the 2018 and 2022 RSU Schemes, 939,687 treasury shares were allotted to the employees during the year ended December 31, 2024.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="font-size: 10pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, 7,325,000 ADS (represents 29,300,000 of the Company&#8217;s ordinary shares) were offered at a price of US$17.25 per ADS on January 23, 2025, followed by an additional 935,144 ADS (represents 3,740,576 of the Company&#8217;s ordinary shares) were offered at the same price on February 13, 2025, and 22,000,000 placing shares of the Company were issued and allotted at a price of HK$68.6 per share on July 17, 2025, amounts of RMB40 (US$6) was credited as share capital.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2025, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 455,263 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.3 (US$0.04) was credited as share capital.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During June to September 2025, the Company issued ordinary shares with respect to the restricted share units under the 2021 and 2022 RSU Scheme exercised by certain selected persons of the Company before December 31, 2025 to those selected persons. In connection with the exercised restricted share units, 1,008,253 new shares of the Company were issued, and an amount of RMB0.7 (US$0.1) was credited as share capital.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2025, 775,685 ordinary shares and 816,922 ordinary shares, being underlying shares of the restricted share units granted under the 2021 RSU scheme and the 2022 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB0.5 (US$0.07) and RMB0.6 (US$0.09) credited as share capital.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2025, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB3,590 (US$513) for the purpose of the 2022 RSU scheme.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of restricted share units granted under the 2022 RSU Scheme, 17,925 treasury shares were allotted to the employees during the year ended December 31, 2025.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reserves<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract', window );"><strong>Reserves [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory', window );">RESERVES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESERVES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of the Group&#8217;s reserves and the movements therein for the current and prior years are presented in the consolidated statements
of changes in equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the post-IPO share option scheme, the 2021 RSU Scheme, and 2022 RSU
Scheme, expenses amounting to RMB20,874 (US$2,985) (2024: RMB20,924; 2023: RMB31,503) were recognized and contributed to capital and
reserves during the year ended December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the exercise of the Pre-IPO share option scheme and vesting of restricted share units granted under the 2021 RSU Scheme,
and 2022 RSU Scheme, RMB33,000 (US$4,719) (2024: RMB19,333; 2023: RMB32,593) was credited to share premium, and RMB33,635 (US$4,810)(2024:
RMB33,998; 2023: RMB43,709) was transferred out from capital and reserves during the year ended December 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
PRC laws and regulations, there are restrictions on the Company&#8217;s PRC subsidiaries with respect to transferring certain of their
net assets to the Company either in the form of dividends, loans, or advances. Amounts of net assets restricted include paid in capital
and reserve funds of the Company&#8217;s PRC subsidiaries, totaling RMB3,033,545 (US$433,791) and RMB2,702,519 as at December 31, 2025
and 2024, respectively. See note 41 for the statement of financial position of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
connection with the equity-settled bonus, the Company settled the bonus of RMB58,869 (US$8,418) (2024: RMB49,350) by issuing 1,592,607
ordinary shares (2024: 2,479,348 treasury shares) at a price of HK$40.05 (2024: HK$21.95) to employees, among which, RMB58,868 (US$8,418)
(2024: RMB40,719) was credited to share premium.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of reserves within equity. [Refer: Other reserves [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReservesWithinEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract', window );"><strong>Share-Based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">SHARE-BASED PAYMENTS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARE-BASED
                                            PAYMENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            option scheme</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
pre-IPO share option scheme</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
July 2018, the Company adopted the pre-IPO share option scheme for the purpose of providing incentives and rewards to eligible participants
who have contributed or will contribute to the Group. Eligible participants of the pre-IPO share option scheme may include any substantial
shareholder, existing or incoming employees, directors (including executive directors, non-executive directors and independent non-executive
directors) and officers, or any other service providers of any member of the Group who the board of directors consider, in its sole discretion,
have contributed or will contribute to the Group. The pre-IPO share option scheme was terminated but continues to govern the terms and
conditions of the outstanding awards previously granted under the Company&#8217;s pre-IPO share option scheme.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
maximum number of shares which may be issued upon the exercise of all pre-IPO share options is 12,307,533. The exercise price for each
share under the pre-IPO share options was HK$0.01.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following share options were outstanding under the Pre-IPO share option scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise<br/>

price&#160;HK$ </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>per share</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number
of<br/>
 options</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise<br/>
price&#160;HK$ </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>per share</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/>
 options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Outstanding as of January 1</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,263,648</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,607,571</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Forfeited during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(81</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Exercised during the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.01</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(656,077</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.01</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(455,263</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">Outstanding as of December 31</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,607,571</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,152,227</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of share options exercisable was 2,152,227 as at December 31, 2025 (2024: 2,607,571).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average share price at the date of exercise for share options exercised during the year ended December 31, 2025 was HK$58.54
per share (2024: HK$34.03 per share, 2023: HK$22.98 per share).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices and exercise periods of the share options outstanding as at the end of the reporting period are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
    <br/>
Number of<br/>
 options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price<br/>
 HK$<br/>
 per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    period</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,360,420</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 68%; text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aug
    15, 2018-Aug 15, 2028</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">232,719</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    15, 2019-May 15, 2029</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,432</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept
    16, 2019-Sept 16, 2029</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,607,571</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025<br/>

    Number of<br/>
 options</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price<br/>
 HK$<br/>
 per share</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    period</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,983,383</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 68%; text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">Aug 15, 2018&#8211;Aug 15, 2028</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159,712</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">May 15, 2019&#8211;May 15, 2029</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,132</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">Sept
    16, 2019-Sept 16, 2029</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,152,227</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Group did not grant any new share options under the Pre-IPO share option scheme during the year ended December 31, 2025 (2024: <span style="-sec-ix-hidden: hidden-fact-352">Nil</span>).
As the share options have been fully unlocked in 2023, the Group has not recognized any share option expense during the year ended December
31, 2025 (2024:<span style="-sec-ix-hidden: hidden-fact-353">Nil</span>, 2023: RMB3,750).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
exercise in full of the outstanding share options would, under the present capital structure of the Company, result in the issue of 2,152,227 additional ordinary shares of the Company and additional share capital and share premium of US$4,957, equivalent to RMB34,662 (before
issue expenses), transferred from capital and other reserves.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
post-IPO share option scheme&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 21pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
September 2019, the Company adopted the post-IPO share option scheme for the purpose of providing incentives and rewards to eligible
participants who have contributed or will contribute to the Group.  Eligible participants of the post-IPO share option scheme
include (a) any executive director of, manager of, or other employee holding an executive, managerial, supervisory or similar
position in any member of the Group, any full-time or part-time employee, or a person for the time being seconded to work full-time
or part-time for any member of the Group; (b) a director or proposed director (including an independent non-executive director) of
any member of the Group; (c) any substantial shareholder of any member of the Group; (d) a customer, consultant, business or joint
venture partner, franchisee, contractor, agent or representative of, a supplier of goods or services to, a person or entity that
provides design, research, development or other support or any advisory, consultancy, professional or other services to any member
of the Group; and (e) an associate of any of the persons referred to in paragraphs (a) to (c) above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 21pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
April 2025, the Company amended the post-IPO share option scheme. Under the amendments, eligible participants were restricted to (i)
Employee Participants (as defined under former paragraphs (a) and (b)) and (ii) Service Providers, and the categories previously set
out in former paragraphs (c), (d) and (e) were eliminated. In addition, the maximum number of shares which may be issued upon the exercise
of all Post-IPO share options was reduced from 20,707,462 to 14,907,462.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 21.7pt; text-align: justify; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">Under the post-IPO share option scheme, the maximum number of shares
issuable upon the exercise of all options granted under this and other Group plans shall not exceed 10% of the Company&#8217;s issued
share capital as of the listing date (including any outstanding, cancelled, lapsed, or unexercised options). The Company may, with separate
shareholder approval, grant options exceeding this limit, provided that any excess is granted only to eligible participants. The aggregate
number of shares subject to options granted under the Post-IPO Share Option Scheme and other Group plans shall not exceed 30% of the Group&#8217;s
issued share capital at the time of grant.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to any restriction contained in the post-IPO share option scheme, an option may be exercised in accordance with the terms of the post-IPO
share option scheme.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
November 26, 2025, the Company granted options to 33 grantees to subscribe for an aggregate of 633,243 shares under the post-IPO share
option scheme. Subject to the terms and conditions as set out in the Post-IPO share option scheme, 486,868 shares granted to 25 grantees
are vested in the portions of 25%, 25%, 25% and 25% on the first, second, third and fourth anniversaries of the grant date of the options,
and the remaining options granted to eight grantees in respect of 146,375 shares are vested in the portion of 8.33% monthly on the 26th
of each month over an 11-month period starting from November 26, 2025, with the remaining 8.37% to be vested on October 26, 2026. The
exercise price for each share under the post-IPO share options is HK$63.35.&#160;&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no cash settlement alternatives. The Group does not have a past practice of cash settlement for these share options. The Group accounts
for the scheme as an equity-settled plan. Share options do not confer rights on the holders to dividends or to vote at shareholders&#8217;
meetings.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following share options were outstanding under the post-IPO share option scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 12pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 12pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-347; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">633,243</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised
    during the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-348; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December
    31</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">633,243</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices and exercise periods of the share options outstanding as at the end of the reporting period are as follows:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025
    Number of options</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    period</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 31%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">633,243</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 31%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 30%; font-size: 10pt; text-align: center"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov
                                            26, 2025&#8211;Nov 26, 2035</span></p></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group granted 633,243 new shares options under the Post-IPO Scheme during the year ended December 31, 2025 (2024: <span style="-sec-ix-hidden: hidden-fact-354">Nil</span>), and recognized
share option expense of RMB2,420 (US$346) during the year ended December 31, 2025.</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise in full of the outstanding share options would, under the present capital structure of the Company, result in the issue of 633,243
additional Ordinary Shares of the Company and additional share capital and share premium of US$2,902 equivalent to RMB20,294 (before
issue expenses) transferred from capital and other reserves.</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the share options granted was estimated as at the grant date by using the binary tree option pricing model. The following
table lists the key inputs to the fair value model used:</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">At grant dates</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Expected volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">49.65</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.09</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life of options (year)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Weighted average share price (HKD per share)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34.98</td><td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs
                                            granted to employees</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2018 RSU Scheme</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 6, 2018, the Company approved and adopted the 2018 RSU Scheme. The purpose of the 2018 RSU scheme is to incentivize the existing
and incoming directors, senior management and employees for their contribution to the Company, and to attract, motivate and retain skilled
and experienced personnel to strive for the future development and expansion of the Company. Unless otherwise cancelled or amended, the
2018 RSU Scheme will remain in force for 10 years from the date of adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of RSUs that may be granted under the 2018 RSU Scheme in aggregate (excluding RSUs that have lapsed or been cancelled
in accordance with the rules of the 2018 RSU Scheme) shall be 5,274,657 ordinary shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 14, 2020, pursuant to the 2018 RSU Scheme, 2,590,592 RSUs were granted to 50 selected persons, who are employees of the Company.
The RSUs granted would vest on the third month from the grant date, and in equal tranches over the remaining years of the total vesting
period as three years, on condition that employees remain in service without any performance requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each RSU under the 2018 RSU Scheme at the grant date was determined by reference to the fair value of the ordinary shares
of the Company issued to its shareholders, using the market approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.4pt; text-align: justify; text-indent: -1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group did not recognize share-base payment expense during the year ended December 31, 2025 (2024: <span style="-sec-ix-hidden: hidden-fact-355">Nil</span>; 2023: RMB3,169).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2023, all RSUs under the 2018 RSU Scheme had been exercised.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 RSU Scheme</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">On
February 2, 2021, the Company approved and adopted the 2021 RSU Scheme The purpose of the 2021 RSU scheme is to (i) incentivize the existing
and incoming directors , senior management, and employees for their contribution to the Group; and (ii) attract, motivate, and retain
skilled and experienced personnel to strive for the future development and expansion of the Group by providing them with the opportunity
to own equity interests in the Company. Unless otherwise cancelled or amended, the 2021 RSU Scheme will remain in force for 10 years
from the date of adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
maximum number of RSUs that may be granted under the 2021 RSU Scheme in aggregate (excluding RSUs that have lapsed or been cancelled
in accordance with the 2021 Scheme Rules) shall be 3,133,526 shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
April 30, 2025, the Company amended the 2021 RSU Scheme, thereby expanding the eligible participants by adding a service provider as
a new category of eligible participants.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
May 17, 2021, pursuant to the 2021 RSU Scheme, 440,490 RSUs were granted to 34 selected persons, which include employees, senior management
of the Group, and a director of the Company. Among the awards, 10,641 RSUs were granted to an independent non-executive director and 55,157
RSUs were granted to the Chief Commercial Officer. On July 23, 2021, 26,892 RSUs were granted to three independent non-executive directors
of the Company. The RSUs granted were categorized in six types based on the vesting period and the proportion of shares that can be unlocked
upon each of the vesting dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant fair<br/> value HK$ <br/> per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of <br/> conditional <br/> shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested <br/>
conditional shares</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2021-2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2021-2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2022&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2022&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2022&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2022&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2025, 48,439 RSUs were granted to 34 selected persons of the Commercialization Department.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant fair <br/>
value HK$ <br/>
per share</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of <br/>
conditional shares</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested<br/> conditional shares</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77.45</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 27, 2025</span></p></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
for the restricted shares granted to employees and senior management, the conditions for releasing the restrictions comprised two parts,
namely the participants have not been terminated with or without cause on or before each relevant vesting date and the participants have
obtained a score of B or above in the annual performance review prior to the applicable vesting date. The percentage of shares in respect
of which the restrictions may be released depends on the achievement of those conditions. For the independent non-executive directors,
the restricted shares would vest on condition that independent non-executive directors remain in service without any performance requirements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following restricted shares were outstanding under the 2021 RSU Scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024<br/>
    Number of<br/>
    RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025<br/>
    Number of<br/>
    RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,998</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,552</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,412</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-350; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    during the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(65,034</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(89,991</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December
    31</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,552</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-351; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each RSUs under the 2021 RSU Scheme at the grant date was determined by reference to the fair value of the ordinary shares
of the Company issued to its shareholders, using the market approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average share price at the date of exercise for RSUs exercised during the year was HK$70.48 per share (2024 HK$20.80 per share,
2023 HK$19.96 per share).</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized a share-base payment expense of RMB3,604 (US$515) during the year ended December 31, 2025 (2024: RMB856; 2023: RMB1,589).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise in full of the outstanding RSUs would, under the present capital structure of the Company, result in additional share capital
and share premium of HK$1,894, equivalent to RMB1,712 (US$245), transferred from capital and other reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 RSU Scheme</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
June 23, 2022, the Company approved and adopted the 2022 RSU Scheme. The purpose of the 2022 RSU scheme is to (i) incentivize the
existing and incoming directors, senior management, and employees for their contribution to the Group; and (ii) attract,
motivate, and retain skilled and experienced personnel to strive for the future development and expansion of the Group by providing
them with the opportunity to own equity interests in the Company. Unless otherwise cancelled or amended, the 2022 RSU Scheme will
remain in force for 10 years from the date of adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
maximum number of RSUs that may be granted under the 2022 RSU Scheme in aggregate (excluding RSUs that have lapsed or been cancelled
in accordance with the 2022 Scheme Rules) shall be 11,072,695 shares. &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt"><span style="font-family: Times New Roman, Times, Serif">On
April 30, 2025, the Company amended the 2022 RSU Scheme, thereby expanding the eligible participants by adding a service provider as
a new category of eligible participants.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
for the restricted shares granted to employees and senior management under the 2022 RSU Scheme, the conditions for releasing the restrictions
comprised two parts, namely the participants having not been terminated with or without cause on or before each relevant vesting date
and the participants having obtained a score of B or above in the annual performance review prior to the applicable vesting date. The
percentage of shares in respect of which the restrictions may be released depends on the achievement of those conditions.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the 2022 RSU Scheme, on June 23, 2022, the Company initially granted an aggregate of 1,634,426 RSUs under the 2022 RSU Scheme (the
&#8220;2022 Awards&#8221;), representing 1,634,426 shares to a total of 80 selected persons, who are employees of the Group, among which
100,000 RSUs, representing 100,000 shares, were granted to Dr. Zhai Yifan (&#8220;Dr. Zhai&#8221;), who is the chief medical officer
and a substantial shareholder of the Company. The RSUs granted were categorized in six types based on the vesting period and the proportion
of shares that can be unlocked upon each vesting date.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type of eligible participants</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant fair value HK$ per share</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>% of conditional shares</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting date</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>% of vested conditional shares</b></span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2021-2024</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="width: 31%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 9%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 9%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 23%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2023&#8211;2026</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2023&#8211;2026</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2023&#8211;2024</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%, 60%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2023&#8211;2025</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%, 30%, 40%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2023&#8211;2026</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23%, 69%, 6%, 2%</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the 2022 RSU Scheme, on May 4, 2023, the Company granted 1,379,094 RSUs under the 2022 RSU Scheme, representing 1,379,094 shares to
172 selected persons (the &#8220;2022 Further Grant&#8221;), who are employees of the Group. The RSUs granted were categorized in two
types based on the vesting period and the proportion of shares that can be unlocked upon each vesting date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant <br/> fair value<br/> HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of<br/> conditional<br/> shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested conditional shares</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.8</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 1, 2023&#8211;2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%, 60%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 1, 2023&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%, 30%, 40%</span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the 2022 RSU Scheme, on September 2, 2024, the Company granted 777,006 RSUs under the 2022 RSU Scheme, representing 777,006 shares
to 59 selected persons (the &#8220;2022 Further Grant&#8221;), who are employees of the Group. The RSUs granted were categorized in ten
types based on the vesting period and the proportion of shares that can be unlocked upon each vesting date.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Type of eligible participants</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Grant fair value HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">% of conditional shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Vesting date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">% of vested conditional shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 20%; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">100%</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75%, 25%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%, 50%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%, 30%, 40%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.5%, 22.5%, 55%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%, 25%, 25</span><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">7</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 37%, 38</span><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">8</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">100%</span></td><td style="text-align: left"></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">9</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2025-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%, 60</span><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2025-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%, 50</span><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the 2022 RSU Scheme, on November 26, 2025, the Company granted 1,177,256 RSUs under the 2022 RSU Scheme, representing 1,177,256 shares
to 145 selected persons, who are employees of the Group, among which 143,363 RSUs, representing 143,363 shares, were granted to Dr. Yang
Dajun (&#8220;Dr. Yang&#8221;), who is the chief executive officer of the Company. The RSUs granted were categorized in six types based
on the vesting period and the proportion of shares that can be unlocked upon each vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td> <td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant
fair<br/> value HK$<br/>
per&#160;share</span></td> <td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of <br/> conditional <br/> shares</span></td> <td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested<br/> conditional shares</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 26, 2026-2028</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; width: 19%; font-size: 10pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.33%, 33.33%, 33.34%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 26, 2026-2029</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following restricted shares were outstanding under the 2022 RSU Scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024&#160;Number of&#160;RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025&#160;Number of&#160;RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,641,974</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,436,525</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">777,006</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,177,256</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(42,768</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(132,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    during the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(939,687</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(936,187</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December
    31</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,436,525</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,545,292</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each RSU under the 2022 RSU Scheme at the grant date was determined by reference to the fair value of the ordinary shares
of the Company issued to its shareholders, using the market approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2022 RSU Scheme, the fair value of the RSUs granted during the year ended December 31, 2025 amounted to RMB68,327 (US$9,771)
(2024: RMB24,078, 2023: RMB27,063).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average share price at the date of exercise for RSUs exercised during the year through the treasury was HK$20.14 per share (2024:
HK$19.24 per share, 2023: HK$18.15 per share) and through the issuance was HK$79.35 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized a share-base payment expense of RMB14,850 (US$2,124) for the year ended December 31, 2025 (2024: RMB20,068, 2023:
RMB22,995).</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise in full of the outstanding RSUs would, under the present capital structure of the Company, result in additional share capital
and share premium of HK$85,945, equivalent to RMB78,740 (US$11,260), transferred from capital and other reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no cash settlement alternatives. The Group does not have a past practice of cash settlement for these RSUs. The Group accounts for
the scheme as an equity-settled plan.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes to the Consolidated Statements of Cash Flows<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowHedgesAbstract', window );"><strong>Notes to the Consolidated Statements of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory', window );">NOTES TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
                                            TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
                                            non-cash transactions</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">During the year ended December <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,
2025, the Company granted 633,243 options (2024: <span style="-sec-ix-hidden: hidden-fact-377">Nil</span>, 2023: <span style="-sec-ix-hidden: hidden-fact-378">Nil</span>) under the Post-IPO option scheme to 33 grantees. </span></p></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">During the year ended December <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,
2025, the Company issued 48,439 RSUs under the 2021 RSU scheme to 34 grantees and 1,177,256 RSUs under the 2022 RSU scheme to 145 grantees.
During the year ended December 31, 2024, the Company granted <span style="-sec-ix-hidden: hidden-fact-379">nil</span> RSUs under 2021RSU and granted 777,006 RSUs under the 2022 RSU scheme
to 59 grantees. During the year ended December 31, 2023, the Company granted <span style="-sec-ix-hidden: hidden-fact-380">nil</span> RSUs under 2021RSU and granted 1,379,094 RSUs under the
2022 RSU scheme to 172 grantees.</span></p></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">During the year ended December <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,
2025, the Company issued 1,592,607 newly issued shares to employees including 176,278 newly issued shares to Dr. Zhai as settlement of
bonus of RMB58,869 (US$8,418) (2024: RMB49,350, 2023: RMB55,468).</span></p></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td><td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year ended December 31, 2025, the Group had non-cash additions
to right-of-use assets and lease liabilities of RMB5,047 (US$722) (2024: RMB17,108,2023: RMB16,194), and non-cash disposals of RMB2,675
(US$382) and RMB3,360 (US$480) (2024: RMB1,067 and RMB1,152,2023:<span style="-sec-ix-hidden: hidden-fact-381">Nil</span> and <span style="-sec-ix-hidden: hidden-fact-382">Nil</span>), respectively, in respect of lease arrangements for buildings.</p>
</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td><td style="text-align: left"><p style="margin: 0pt 0">As at December 31, 2025, 2024 and 2023, the Group had non-cash additions to intangible assets of <span style="-sec-ix-hidden: hidden-fact-383">nil</span>, RMB1,403,
and RMB805, respectively, and non-cash additions to property, plant and equipment of RMB 10,011(US$1,432), RMB9,424 and RMB26,823, respectively,
included in other payables and accruals.</p></td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in liabilities arising from financing activities</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other payables</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accruals</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other loans</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2023</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">383</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,775,505</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,222</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    from financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(91,027</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,591</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,766</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    leases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-356; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-357; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,194</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,690</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-358; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,321</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid classified as financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-359; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-360; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,321</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of change in foreign exchange rates</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-361; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-362; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,046</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,772,914</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,681</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other payables<br/> and accruals</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other loans</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,046</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,772,914</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,681</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    from financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(59,057</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(136,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,413</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    leases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-363; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-364; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,108</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,152</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,279</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid classified as financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-365; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-366; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of change in foreign exchange rates</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-367; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-368; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,265</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,638,265</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,232</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other payables</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accruals</span></p></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other loans</span></p></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities</span></p></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2025</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,265</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,638,265</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,232</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    from financing cash flows</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50,190</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,980</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,717</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    leases</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-369; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-370; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,047</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-371; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-372; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,360</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,534</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,278</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid classified as financing cash flows</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-373; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-374; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,118</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of change in foreign exchange rates</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-375; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-376; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">609</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,957,523</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,196</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">279,922</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,174</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            cash outflow for leases</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total cash outflow for leases included in the statements of cash flows is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within operating
    activities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">329</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    financing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,087</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,911</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,835</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,549</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,268</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,149</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,164</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,596</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowHedgesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowHedgesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section Presentation of a statement of cash flows<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS07_g10-17_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashFlowStatementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalCommitmentsAbstract', window );"><strong>Commitments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsExplanatory', window );">COMMITMENTS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMITMENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2025, the Group had capital commitments of RMB307 (US$44) relating to furniture and equipment (2024: RMB4,366).</span></p></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group has no lease contracts that have not yet commenced as at December 31, 2025.</span></p></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group enters into business agreements with institutions to license intellectual property.
                                            The Group may be obligated to make future research and developmental milestone payments,
                                            regulatory and commercial milestone payments and royalty payments on future sales of specified
                                            products associated with the agreements. Payments under these agreements generally become
                                            due and payable upon achievement of such milestones or sales. These commitments are not recorded
                                            on the consolidated financial statements because the achievement and timing of these milestones
                                            are not fixed and determinable. When the achievement of these milestones or sales has occurred,
                                            the corresponding amounts are recognized in the consolidated financial statements.</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract', window );"><strong>Contingent Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory', window );">CONTINGENT LIABILITIES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTINGENT
                                            LIABILITIES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group had <span style="-sec-ix-hidden: hidden-fact-384">no</span> significant contingent liabilities as at the end of the reporting date.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of contingent liabilities. [Refer: Classes of contingent liabilities [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 86<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_86&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 259<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_259&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 259<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_259&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pledge of Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PledgeOfAssetsAbstract', window );"><strong>Pledge of Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfPledgeOfAssetsExplanatory', window );">PLEDGE OF ASSETS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLEDGE
                                            OF ASSETS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the Group&#8217;s assets pledged for the Group&#8217;s bank loans are included in note 27 to the consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfPledgeOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of pledge of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfPledgeOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PledgeOfAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PledgeOfAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">36.</span></td><td style="text-align: justify"><span style="font-size: 10pt">RELATED PARTY TRANSACTIONS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">a)</span></td><td style="text-align: left"><span style="font-size: 10pt">Apart
                                            from the transactions detailed elsewhere in this financial information, the Group had no
                                            transactions with related parties during the years ended December 31, 2023, 2024 and 2025.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">b)</td><td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">T</span>ransaction
with a related party</p>
</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Dr. Zhai Yifan</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">29,533</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,223</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Dr. Yang Dajun</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,933</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">562</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">33,466</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,785</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in">&#160;</td> <td style="text-align: left"><span style="font-size: 10pt">According to the HealthQuest Pharma Acquisition Agreement, a contingent consideration of RMB29,533 (US$4,223) due to Dr. Zhai was recognized during the year ended December 31, 2025.</span></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left"><span style="font-size: 10pt">On 17 July 2025, the Company borrowed 22,000,000 ordinary shares of the Company from Dr. Yang to fulfil a placement to designated subscribers within the required timeline. The borrowed shares were returned to Dr. Yang on 29 July 2025 through the issuance of new shares, accompanied by a contractual borrowing cost payment of RMB 3,933, which was recorded as a reduction in equity in connection with such issuance.</span></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td><span style="font-size: 10pt">c)</span></td> <td style="text-align: left">Outstanding balance with a related party</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Other payables and accruals</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">29,344</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,308</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,474</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,374</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">911</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total for Dr. Zhai Yifan</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">29,344</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">16,682</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,385</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: left">In accordance with the acquisition agreement, payable to Dr. Zhai Yifan represented the contingent consideration
related to the acquisition of Guangzhou HealthQuest Pharma Co., Ltd.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">d)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Compensation of key management
personnel of the Group:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td colspan="16" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For
                                            the years ended December 31,</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>RMB</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>RMB</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>RMB</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>US$</b></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Short term employee benefits and fees &#160; </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20,118</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">19,059</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">59,283</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,477</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Equity-settled share-based payment expenses &#160; </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,763</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">449</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Post-employment benefits &#160; </td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">986</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">977</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">711</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">102</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total &#160; </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,867</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">20,661</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">63,135</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">9,028</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments by Category<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Financial Instruments by Category [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">FINANCIAL INSTRUMENTS BY CATEGORY</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">37.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">FINANCIAL INSTRUMENTS BY CATEGORY</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The carrying amounts of each of the categories of financial
instruments as at the end of each reporting period are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>assets at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>fair value </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>through </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>profit or </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>loss</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>assets at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>amortized </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>cost</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Financial assets included in prepayments, other receivables and other assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,846</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,846</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Cash and bank balances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,261,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,261,211</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,143</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Financial assets at FVTPL</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,141</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Financial assets included in other non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-393">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,141</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,356,639</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,357,780</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>fair value </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>through </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>profit or </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>loss</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>amortized </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>cost</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Interest-bearing bank and other borrowings (current and non-current portions)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,668,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,668,497</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">&#160;&#160;&#160;&#160;-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,966</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Financial liabilities included in other payables and accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,014</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,014</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Other non-current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,274</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,869,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,869,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/>
 assets at<br/>
 fair value<br/>
 through<br/>
 profit or<br/>
 loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial assets at amortized cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt">Financial assets included in prepayments, other receivables and other assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,609</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,609</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">516</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Cash and bank balances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,470,085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,470,085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">353,217</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">252,938</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">252,938</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,170</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Financial assets at FVTPL</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">572</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Financial assets included in other non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">690</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">690</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">99</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,727,322</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,731,322</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">390,574</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>fair value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>through</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>profit or</b></p>

<p style="margin: 0pt 0"><b>loss</b></p>

</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at amortized</b></p>

<p style="margin: 0pt 0"><b>cost</b></p>

</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt">Interest-bearing bank and other borrowings (current and non-current portions)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,979,719</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,979,719</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">283,096</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,264</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Financial liabilities included in other payables and accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,968</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">138,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">140,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">20<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,084</span></div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,374</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,657</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,720</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">8,342</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,230,598</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,238,940</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">320,164</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value and Fair Value Hierarchy of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract', window );"><strong>Fair Value and Fair Value Hierarchy of Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory', window );">FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-size: 10pt">38.</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Group&#8217;s financial instruments, other than those with carrying amounts that reasonably approximate to fair
values, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="22" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Carrying
    amounts</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Fair
    values</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Financial assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial
    assets at FVTPL</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,141</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">572</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,141</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">572</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial
    assets included in other non-current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,439</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">99</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,311</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">624</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">89</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,580</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,690</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">671</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,624</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">661</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial liabilities
    included in other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-407; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,968</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">282</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-408; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,968</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">281</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Other non-current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,274</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,031</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,720</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,742</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,706</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Non-current
    portion of interest-bearing bank and other borrowings (other than lease liabilities)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">868,642</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">742,325</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">106,151</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">859,707</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">709,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">101,435</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">874,916</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">756,324</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">108,153</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">865,449</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">723,016</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">103,390</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has assessed that the fair values of cash and bank balances, trade receivables, financial assets included in prepayments, deposits and
other receivables, trade payables, the current portion of long-term payables, the current portion of interest-bearing bank and other
borrowings, financial liabilities included in other payables, and accruals approximate to their carrying amounts largely due to the short-term
maturities of these instruments, or the interest rate being approximate to the discount rate of current market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s finance department is responsible for determining the policies and procedures for the fair value measurement of financial
instruments. The finance manager reports directly to the chief financial officer and the audit committee. At each reporting date, the
finance department analyses the movements in the values of financial instruments and determines the major inputs applied in the valuation.
The directors review the results of the fair value measurement of financial instruments periodically for annual financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current
transaction between willing parties, other than in a forced or liquidation sale. The following methods and assumptions were used to estimate
the fair values:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of the financial assets and liabilities included in other non-current assets, and the non-current portion of interest-bearing
bank and other borrowings have been calculated by discounting the expected future cash flows using rates currently available for instruments
with similar terms, credit risk and remaining maturities. The Group&#8217;s own non-performance risk for other non-current assets, and
interest-bearing bank and other borrowings as at December 31, 2025 was assessed to be insignificant.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of listed equity investments are based on quoted market prices. The fair value of the unlisted equity investments designated
at fair value through profit or loss have been estimated using an asset-based valuation technique based on assumptions that are not supported
by observable market prices or rates. The fair value measurement of these financial instruments may involve unobservable inputs. Fair
value change resulting from changes in the unobservable inputs was not significant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Level 3 financial liabilities, the Group adopts the valuation techniques to determine the fair value. Valuation techniques include a
discounted cash flow analysis. The fair value measurement of the financial instruments may involve unobservable inputs such as discount
rate and possibility of payment. The Group periodically reviews all significant unobservable inputs and valuation adjustments used to
measure the fair values of financial assets in Level 3.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Fair
value hierarchy</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables illustrate the fair value measurement hierarchy of the Group&#8217;s financial instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Assets
measured at fair value</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">active</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">markets</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unobservable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at FVTPL</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-409; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-410; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2025</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 12pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">active</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">markets</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unobservable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at FVTPL</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-411; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;-</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-412; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liabilities
measured at fair value</i></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2025</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">active</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">markets</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities included in other payables and accruals</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-414; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,968</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,968</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">281</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-415; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-416; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,374</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,374</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">911</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2023, 2024 and 2025, there were no transfers of fair value measurements between Level 1 and Level 2 and
no transfers into or out of Level 3 for both financial assets and financial liabilities.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value of financial instruments. [Refer: Classes of financial instruments [domain]; At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureAbstract', window );"><strong>Financial Risk Management Objectives and Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory', window );">FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
                                            RISK MANAGEMENT OBJECTIVES AND POLICIES</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 61.8pt 0pt 70.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s principal financial instruments comprise cash and bank balances and interest-bearing bank and other borrowings. The main
purpose of these financial instruments is to raise finance for the Group&#8217;s operations. The Group has various other financial assets
and liabilities such as trade receivables and trade payables, which arise directly from its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
main risks arising from the Group&#8217;s financial instruments are interest rate risk, foreign currency risk, credit risk,
liquidity risk, and equity price risk. The Directors review and agree on policies for managing each of these risks, and they are
summarized below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
rate risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s exposure to the risk of changes in market interest rates relates primarily to the Group&#8217;s long-term debt obligations
with floating interest rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s policy is to manage its interest cost using a mix of fixed and floating rate debts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2025, the total interest-bearing bank borrowings of RMB1,911,273 (US$273,308) (2024: RMB1,116,015) of the Group were
with floating interest rates denominated in RMB.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table demonstrates the sensitivity to a reasonably possible change in the RMB interest rate, with all other variables held
constant, of the Group&#8217;s loss before tax through the impact on floating rate borrowings. This analysis does not include the effect
of interest capitalized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease)</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in basis points</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease)</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in loss before tax</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,160</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,113</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,113</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
currency risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has transactional currency exposures. Such exposures arise from sales or purchases by operating units and investing and financing
activities in currencies other than the units&#8217; functional currencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table demonstrates the sensitivity as at the end of each reporting period to a reasonably possible change in the US$ and HK$
exchange rates, with all other variables held constant, of the Group&#8217;s loss before tax and in other comprehensive income (without
tax) due to changes in the fair values of monetary assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease) in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rate</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease)</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in loss</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">before</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease) in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">comprehensive</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">income</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(without tax)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB weakens
    against US$</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(44</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,796</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB strengthens against
    US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56,796</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB weakens against US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(65</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124,210</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB strengthens against
    US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(124,210</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Credit
risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group trades only with recognized and creditworthy third parties. Concentrations of credit risk are managed by the customer. At the
end of the reporting period, the Group had certain concentrations of credit risk as 68% (2024: 73%) and 91% (2024: 96%) of the
Group&#8217;s trade receivables were due from the Group&#8217;s largest customer, respectively. It is the Group&#8217;s policy that
all customers who wish to trade on credit terms are subject to credit verification procedures. In addition, receivable balances are
monitored on an ongoing basis, and the Group&#8217;s exposure to bad debts is not significant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
credit risk of the Group&#8217;s other financial assets, which comprise cash and bank balances, trade receivables, financial assets included
in prepayments, deposits and other receivables and other non-current assets, arises from default of the counterparty, with a maximum
exposure equal to the carrying amounts of these instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Maximum
exposure and year-end staging</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tables below show the credit quality and the maximum exposure to credit risk based on the Group&#8217;s credit policy, which is mainly
based on past due information unless other information is available without undue cost or effort, and year-end staging classification.
The amounts presented are gross carrying amounts for financial assets.</span></p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12-month ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lifetime ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage 1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage 2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage 3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simplified approach</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets included in prepayments, other receivables and other assets - Normal**</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,846</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-417; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: hidden-fact-418; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-419; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,846</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and bank balances - Not yet past due</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,261,211</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-420; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-421; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-422; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,261,211</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade receivables*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-423; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-424; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,143</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,143</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets included in other non-current assets - Normal**</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,439</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,439</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,273,496</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-429; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-430; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,143</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,356,639</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12-month
    ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lifetime
    ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
    1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
    2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
    3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simplified
    approach</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets included in prepayments, other receivables and other assets - Normal**</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,609</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-431; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-432; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-433; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,609</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">516</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances - Not yet past due</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,470,085</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-434; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-435; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-436; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,470,085</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,217</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    receivables*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-437; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-438; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-439; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252,938</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252,938</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,170</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets included in other non-current assets - Normal**</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-440; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-441; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-442; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,474,384</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: hidden-fact-443; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: hidden-fact-444; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252,938</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,727,322</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">390,002</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For trade receivables to which the Group applies the simplified approach for impairment, information based on provision matrix is disclosed in note 21 to the financial statements.</span></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit quality of the financial assets included in prepayments, other receivables and other assets and financial assets included in other non- current assets is considered to be &#8220;normal&#8221; when they are not past due and there is no information indicating that the financial assets had a significant increase in credit risk since initial recognition. Otherwise, the credit quality of the financial assets is considered to be &#8220;doubtful&#8221;.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidity
risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Group&#8217;s objective is to maintain a balance between continuity of funding and flexibility through the use of bank loans, lease liabilities
and other interest-bearing loans. As at December 31, 2025, 62% (2024: 47%) of the Group&#8217;s borrowings would mature in less than
one year based on the carrying values of the borrowings.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maturity profile of the Group&#8217;s financial liabilities as at the end of the reporting period, based on the contractual undiscounted
payments, is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As at December 31, 2024</b></span></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    demand</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than<br/>
    1 year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    to 5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
    <br/>
    5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    payables</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-445; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,966</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-446; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-447; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,966</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-448; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,592</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-449; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,266</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest-bearing
    bank and other borrowings (excluding lease liabilities)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-450; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">813,610</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,765</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,079</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,831,454</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities included in other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,670</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,344</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-451; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-452; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,014</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-453; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-454; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,274</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-455; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,274</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,670</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">945,594</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">467,631</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,079</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,051,974</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As at December 31, 2025</b></span></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    demand</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1&#160;year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    to 5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
    <br/>
    5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    payables</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-456; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,740</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-457; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-458; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,740</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,264</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-459; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,262</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,226</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-460; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,502</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest-bearing
    bank and other borrowings (excluding lease liabilities)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-461; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,255,814</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365,732</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">546,806</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,168,352</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">310,070</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities included in other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,142</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,308</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-462; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-463; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,450</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,084</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-464; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-465; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,031</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-466; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,031</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,720</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,142</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,381,124</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">393,989</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">546,806</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-467; font-family: Times New Roman, Times, Serif">2,<span style="font-size: 10pt">452,061</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,640</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
price risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
price risk is the risk that the fair values of equity securities decrease as a result of changes in the levels of equity indices and
the value of individual securities. The Group is exposed to equity price risk arising from individual equity investments included in
financial assets at FVTPL (note 17) as at December 31, 2025. The Group&#8217;s listed investments held in the prior year were listed
on NASDAQ and were valued at the quoted market price at the end of the reporting period, whereas the investments in the current year
don&#8217;t involve publicly traded market quotations.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market equity index for the following stock exchange, at the close of business of the nearest trading day in the year to the end of the
reporting period, and its respective highest and lowest points during the year were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High/low</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High/low</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States&#8211;NASDAQ
    index</span></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,311</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,205/14,478</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-468; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-470"><span style="-sec-ix-hidden: hidden-fact-469; font-family: Times New Roman, Times, Serif; font-size: 10pt">-/-</span></div></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table demonstrates the sensitivity to every 5% change in the fair values of the equity investments, with all other variables
held constant and before any impact on tax, based on their carrying amounts at the end of the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying<br/> amount of<br/> equity<br/> investments</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Decrease/<br/> (increase)<br/> in loss<br/> before tax</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments listed in:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ - Financial assets at fair value through profit or loss</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments listed in:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ - Financial assets at fair value through profit or loss</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-471; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-472; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ - Financial assets at fair value through profit or loss in USD</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-473; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-474; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capital
management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary objectives of the Group&#8217;s capital management are to safeguard the Group&#8217;s ability to continue as a going concern
and to maintain healthy capital ratios in order to support its business and maximize shareholders&#8217; value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group manages its capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics
of the underlying assets. To maintain or adjust the capital structure, the Group may adjust the dividend payment to shareholders, return
capital to shareholders or issue new shares. No changes were made in the objectives, policies or processes for managing capital during
the reporting year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group monitors capital using a gearing ratio, which is net debt divided by the adjusted capital plus net debt. Net debt includes interest-bearing
bank and other borrowings, trade payables, financial liabilities included in other payables and accruals and long-term payables, less
cash and bank balances. Capital includes equity attributable to owners of the parent. The gearing ratios as at the end of the reporting
periods were as follows:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2025</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2025</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">RMB</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">RMB</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Interest-bearing bank and other borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,668,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,979,719</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">283,096</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,264</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financial liabilities included in other payables and accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,014</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">140,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,084</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other non-current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,031</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,720</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Cash and bank balances</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,261,211</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,470,085</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(353,217</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Net debt</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">608,540</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(231,145</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(33,053</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Equity attributable to owners of the parent</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">264,194</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,324,462</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">189,396</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Adjusted capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">264,194</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,324,462</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">189,396</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Capital and net debt</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">872,734</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,093,317</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">156,343</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Gearing ratio</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">70</td><td style="padding-bottom: 4pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-475; font-size: 10pt">NA&#160;</span></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-476; font-size: 10pt">NA&#160;</span></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExposureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExposureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's financial risk management practices and policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialRiskManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Event After the Reporting Period<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Event After the Reporting Period [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod', window );">EVENT AFTER THE REPORTING PERIOD</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVENT
                                            AFTER THE REPORTING PERIOD</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at the date of approval of these financial statements, there have been no significant events after the end of the reporting period.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The explanation of either an estimate of the financial effect of a non-adjusting event after the reporting period or a statement that such an estimate cannot be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2025-01-01<br> -Paragraph 21<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_21_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 190<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_190_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 190<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_190_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of the Company<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information of the Company [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory', window );">CONDENSED FINANCIAL INFORMATION OF THE COMPANY</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDENSED
                                            FINANCIAL INFORMATION OF THE COMPANY</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
of financial position of the Company</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in
    subsidiaries</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">380,339</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">448,431</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,125</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current Asset</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,529</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,851</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,269</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    non-current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">410,868</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">478,282</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,394</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments, other receivables
    and other assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,986,172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,806,759</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">687,358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470,170</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,841,572</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">263,341</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,456,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,648,331</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">950,699</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT LIABILITIES</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,187</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,382</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">341</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,187</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,382</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">341</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    CURRENT ASSETS</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,432,155</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,645,949</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">950,358</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    ASSETS LESS CURRENT LIABILITIES</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,843,023</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,124,231</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,018,752</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,843,023</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,124,231</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,018,752</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share capital</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">214</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,961</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(423</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital and reserves</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,652,916</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,011,879</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,145,683</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange fluctuation reserve</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,598</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(40,959</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,857</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    losses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(918,697</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(843,984</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,688</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    equity</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,843,023</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,124,231</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,018,752</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
statements of comprehensive income</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income and
    gains</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,597</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,925</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,560</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,666</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,118</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,983</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,975</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24,741</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,585</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    BEFORE TAX</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,684</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    FOR THE YEAR</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,684</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,629</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,715</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(149,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,386</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    COMPREHENSIVE INCOME FOR THE YEAR</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,367</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,072</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(74,844</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,702</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
statements of cash flows</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            cash generated from(used in) operating activities</span></p></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,727</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41,686</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,427</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,650</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash used in investing
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(535,395</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(589,153</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,850,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(264,604</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                 cash generated from financing activities</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">464,166</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">531,922</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,229,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of foreign exchange rate changes, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,581</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,311</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56,093</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,021</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            (decrease)/increase in cash and cash equivalents</span></p></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(59,921</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(89,606</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446,265</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,815</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the Company&#8217;s reserves is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    and<br/> reserves</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange<br/>
    Fluctuation<br/> reserve</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated<br/>
    losses</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 52%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2023</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,526,096</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43,746</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(890,792</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,591,558</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-477; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-478; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-479; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,629</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-480; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,629</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive income for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-481; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,629</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,367</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470,066</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-482; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-483; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470,066</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Employees
    share-based compensation scheme</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Pre-IPO
    share option expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,750</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-484; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-485; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,750</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,753</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-486; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-487; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,753</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-488; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-489; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,123</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-490; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-491; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,123</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,466</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-492; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-493; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,466</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023 and January 1, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,072,015</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,883</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(905,054</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,207,844</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-494; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-495; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-496; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,715</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-497; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,715</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive income for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-498; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,715</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,072</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">533,923</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-499; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-500; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">533,923</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
    share-based compensation scheme</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,924</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-501; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-502; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,924</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-503; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-504; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,671</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-505; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-506; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,671</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,719</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-507; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-508; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,719</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024 and January 1, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,652,916</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,598</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(918,697</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,842,817</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-509; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-510; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-511; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(149,557</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-512; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(149,557</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive income for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-513; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(149,557</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(74,844</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,279,855</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-514; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-515; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,279,855</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Employees
    share-based compensation scheme</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Post-IPO
    share option expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,420</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-516; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-517; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,420</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,454</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-518; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-519; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,454</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-520; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-521; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(638</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-522; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-523; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(638</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,868</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-524; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-525; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,868</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,011,879</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(40,959</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(843,984</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,126,936</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,145,683</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,857</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,688</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,019,138</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
                                            of presentation</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
separate condensed financial statements above have been presented on a &#8220;parent company only&#8221; basis. Under a &#8220;parent
company only&#8221; presentation, the Company&#8217;s investment in its subsidiaries is presented at cost. Such investment is presented
on the separate condensed statements of financial position of the Company as &#8220;Investment in subsidiaries&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 68.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsidiaries did not pay any dividends to the Company for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span style="-sec-ix-hidden: hidden-fact-526"><span style="-sec-ix-hidden: hidden-fact-527">no</span></span> indicators of impairment associated with the investment in subsidiaries as of December 31, 2024 and 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 68.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
information and note disclosures normally included in financial statements prepared in accordance with IFRS Accounting Standards have
been condensed or omitted in this parent company only condensed financial information by reference to the Group&#8217;s consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 57.2pt 0pt 68.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have any significant commitments or long-term obligations as of December 31, 2024 and 2025.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about separate financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS27_g15-17_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Section Objective<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS12_g1-4_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Approval of the Financial Statements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ApprovalOfTheFinancialStatementsAbstract', window );"><strong>Approval of the Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory', window );">APPROVAL OF THE FINANCIAL STATEMENTS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPROVAL
                                            OF THE FINANCIAL STATEMENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements were approved and authorized for issue by the board of directors on April 29, 2026.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ApprovalOfTheFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ApprovalOfTheFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the authorisation of financial statements for issue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk
Management and Strategy</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cybersecurity risk management program is designed to protect the confidentiality, integrity, and availability of our critical systems,
information and data. The policies, standards, processes and practices of our cybersecurity risk management program are part of our information
security management system, or ISMS, program, which is integrated into our enterprise risk management process. Our cybersecurity risk
management program includes a comprehensive set of policies and procedures to prevent accidental or intentional unauthorized modification,
destruction or disclosure of confidential, proprietary, personal or otherwise critical information, including an appropriate level of
security over the equipment, processes and software used to process, store and transmit information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
elements of our cybersecurity risk management program include, but are not limited to the following:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a cybersecurity
    threat defense system that addresses both internal and external threats;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a cybersecurity incident response
    plan that includes procedures for responding to cybersecurity incidents and risk assessments designed to help identify material cybersecurity
    risks to our critical systems, information, products, services, and our broader enterprise information technology environment;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a security
    team principally responsible for managing our cybersecurity risk assessment processes, our security controls, and our response to
    cybersecurity incidents;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">network,
    host and application security;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sensitive
                                            information protection methods, including technical safeguards, procedural requirements,
                                            and monitoring program on our corporate network;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">continuous
                                            testing of our security posture both internally and with outside vendors;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">security
                                            system effectiveness reviews with reference to applicable security standards; and</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regular
                                            cybersecurity training for employees and contractors.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
further improve the effectiveness of our cybersecurity risk management program, we engage third-party service providers, where appropriate,
to assess and test the adequacy of our security controls and processes, consult best practices to address new challenges and evolving
risks, or otherwise assist with aspects of our security processes. Additionally, our risk monitoring systems are regularly audited by
our internal auditors as well as cybersecurity audit companies. We consider the results of external and internal audits of our risk detection
and monitoring systems and implement modifications as necessary.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also implement third-party risk management processes to identify, assess and monitor material risks from cybersecurity threats associated
with key services providers that have access to our information technology systems or our confidential, proprietary, personal or otherwise
critical information based on our assessment of the potential impact to our operations and respective risk profile.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established and seek to continuously improve effective information security governance. We apply a risk-based approach in line with
our overall risk management framework to address potential gaps in security controls. The processes of our cybersecurity risk management
program are aligned to ISO 27001:2022, an international standard for information security management.</span></p>As of the date of this Annual Report on Form 20-F, we have not experienced
any cybersecurity incidents or risks from cybersecurity threats that have materially affected or are currently viewed as reasonably likely
to materially affect, us, our business strategy, results of operations, or financial condition. However, the scope and impact of any future
cybersecurity threats cannot be predicted, and there can be no assurance that our cybersecurity risk management program will be effective
in preventing material cybersecurity threats in the future. For a description of the risks from cybersecurity threats that may materially
affect us, including our results of operations and financial condition, see &#8220;Item 1. Key Information&#8212;D. Risk Factors&#8212;Risks
related to our industry, business and operations&#8212;We or our CROs, contractors, consultants, or other third parties may suffer system
failures, security breaches, or other incidents which may have a material adverse impact to our operations and financial position, which
could result in material disruption of our product development programs and adversely impact our business, financial condition or results
of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">Our
cybersecurity risk management program is designed to protect the confidentiality, integrity, and availability of our critical systems,
information and data. The policies, standards, processes and practices of our cybersecurity risk management program are part of our information
security management system, or ISMS, program, which is integrated into our enterprise risk management process.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
elements of our cybersecurity risk management program include, but are not limited to the following:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a cybersecurity
    threat defense system that addresses both internal and external threats;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a cybersecurity incident response
    plan that includes procedures for responding to cybersecurity incidents and risk assessments designed to help identify material cybersecurity
    risks to our critical systems, information, products, services, and our broader enterprise information technology environment;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a security
    team principally responsible for managing our cybersecurity risk assessment processes, our security controls, and our response to
    cybersecurity incidents;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">network,
    host and application security;</span></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sensitive
                                            information protection methods, including technical safeguards, procedural requirements,
                                            and monitoring program on our corporate network;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">continuous
                                            testing of our security posture both internally and with outside vendors;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">security
                                            system effectiveness reviews with reference to applicable security standards; and</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regular
                                            cybersecurity training for employees and contractors.</span></td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">Additionally, our risk monitoring systems are regularly audited by
our internal auditors as well as cybersecurity audit companies. We consider the results of external and internal audits of our risk detection
and monitoring systems and implement modifications as necessary.<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also implement third-party risk management processes to identify, assess and monitor material risks from cybersecurity threats associated
with key services providers that have access to our information technology systems or our confidential, proprietary, personal or otherwise
critical information based on our assessment of the potential impact to our operations and respective risk profile.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established and seek to continuously improve effective information security governance. We apply a risk-based approach in line with
our overall risk management framework to address potential gaps in security controls. The processes of our cybersecurity risk management
program are aligned to ISO 27001:2022, an international standard for information security management.</span></p>As of the date of this Annual Report on Form 20-F, we have not experienced
any cybersecurity incidents or risks from cybersecurity threats that have materially affected or are currently viewed as reasonably likely
to materially affect, us, our business strategy, results of operations, or financial condition. However, the scope and impact of any future
cybersecurity threats cannot be predicted, and there can be no assurance that our cybersecurity risk management program will be effective
in preventing material cybersecurity threats in the future. For a description of the risks from cybersecurity threats that may materially
affect us, including our results of operations and financial condition, see &#8220;Item 1. Key Information&#8212;D. Risk Factors&#8212;Risks
related to our industry, business and operations&#8212;We or our CROs, contractors, consultants, or other third parties may suffer system
failures, security breaches, or other incidents which may have a material adverse impact to our operations and financial position, which
could result in material disruption of our product development programs and adversely impact our business, financial condition or results
of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">As of the date of this Annual Report on Form 20-F, we have not experienced
any cybersecurity incidents or risks from cybersecurity threats that have materially affected or are currently viewed as reasonably likely
to materially affect, us, our business strategy, results of operations, or financial condition.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Governance</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is responsible for overseeing cybersecurity risk as part of its enterprise risk oversight function and has delegated
to the Audit Committee oversight of cybersecurity and other information technology risks. The Audit Committee oversees management&#8217;s
implementation of our cybersecurity risk management program. Our board of directors receives periodic reports regarding operational,
financial, strategic, regulatory and other risks to the Company, including risks and exposures associated with cybersecurity, information
security and privacy matters and the steps management has taken to monitor and control such exposures. The Audit Committee and our board
of directors receive biannual reports from our Chief Executive Officer regarding management&#8217;s plans to monitor and address cybersecurity
risks and results from our internal audit function and third-party service-providers on their evaluation of the effectiveness of our
cybersecurity risk management program.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cybersecurity management team, led by our head of information technology, is responsible for the day-to-day activities of our information
technology systems and implementing our cybersecurity risk management program, assessing and managing our material risks from cybersecurity
threats and supervising both our internal cybersecurity personnel and our external cybersecurity consultants. Our cybersecurity management
team is informed about and monitors cybersecurity risks and incidents through various means, which may include briefings from internal
security personnel, threat intelligence and other information obtained from governmental, public or private sources, including external
consultants engaged by us, and alerts and reports produced by security tools deployed in the information technology environment. Our
head of information technology has more than 10 years of experience in cybersecurity leadership, directing enterprise security strategies,
managing cross-functional teams, and overseeing compliance with frameworks such as ISO27001. In addition, she performs risk assessments,
security related policy development, and incident response coordination, ensuring alignment with business objectives. She has also implemented
advanced security architectures including endpoint/virtual desktop infrastructure security, network security, data security, email security,
and others and led audits for information technology security compliance as well as fostering a security-first culture through staff
training and threat simulations. Based on ongoing communications with our cybersecurity management team and internal and external cybersecurity
personnel, our head of information technology provides updates to our Chief Executive Officer as to our overall security controls, policies
and operations and our Chief Executive Officer informs the Audit Committee and the board of directors regarding the effectiveness of
our cybersecurity risk management program, associated risks and steps taken to reduce our vulnerability and mitigate impacts associated
with cybersecurity threats.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The Audit Committee oversees management&#8217;s
implementation of our cybersecurity risk management program.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">Our cybersecurity management
team is informed about and monitors cybersecurity risks and incidents through various means, which may include briefings from internal
security personnel, threat intelligence and other information obtained from governmental, public or private sources, including external
consultants engaged by us, and alerts and reports produced by security tools deployed in the information technology environment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">BASIS OF PREPARATION</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BASIS OF PREPARATION</span><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements have been prepared in accordance with IFRS Accounting Standards (which include all International Financial Reporting
Standards, International Accounting Standards (&#8220;IASs&#8221;) and interpretations) approved by the International Accounting Standards
Board (the &#8220;IASB&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
have been prepared under the historical cost convention, except for financial assets at FVTPL and derivative financial instruments which
have been measured at fair value.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory', window );">Basis of consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Basis
of consolidation</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements of the Company and its subsidiaries (collectively referred to as the
&#8220;Group&#8221;) for each of the three years ended December 31, 2025. A subsidiary is an entity (including a structured entity),
directly or indirectly, controlled by the Company. Control is achieved when the Group is exposed, or has rights, to variable returns
from its involvement with the investee and has the ability to affect those returns through its power over the investee (i.e., existing
rights that give the Group the current ability to direct the relevant activities of the investee).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
there is a presumption that a majority of voting rights results in control. When the Company has less than a majority of the voting or
similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee,
including:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            contractual arrangement with the other vote holders of the investee;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rights
                                            arising from other contractual arrangements; and</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Group&#8217;s voting rights and potential voting rights.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies.
The results of subsidiaries are consolidated from the date on which the Group obtains control and continues to be consolidated until the
date that such control ceases.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Profit
or loss and each component of other comprehensive income are attributed to the owners of the parent of the Group and to the non-controlling
interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity,
income, expenses and cash flows relating to transactions between members of the Group are eliminated in full on consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group reassesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of
the three elements of control described above. A change in the ownership interest of a subsidiary, without a loss of control, is accounted
for as an equity transaction.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Group loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, any non-controlling
interest and the exchange fluctuation reserve; and recognizes the fair value of any investment retained and any resulting surplus or
deficit in profit or loss. The Group&#8217;s share of components previously recognized in other comprehensive income is reclassified
to profit or loss or retained profits, as appropriate, on the same basis as would be required if the Group had directly disposed of the
related assets or liabilities.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock', window );">CHANGES IN ACCOUNTING POLICIES AND DISCLOSURES</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGES IN ACCOUNTING POLICIES AND DISCLOSURES</span><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has adopted amendments to IAS 21 Lack of Exchangeability for the first time for the current year&#8217;s financial statements. The Group
has not early adopted any other standard or amendment that has been issued but is not yet effective.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no new IFRS Accounting Standards, amendments or interpretations that became effective in 2025 that have any impact on the Group&#8217;s
financial statements.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards', window );">ISSUED BUT NOT YET EFFECTIVE IFRS ACCOUNTING STANDARDS</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED BUT NOT YET EFFECTIVE IFRS ACCOUNTING STANDARDS</span><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group has not applied the following new and amended IFRS Accounting Standards, that have been issued but are not yet effective, in these
financial statements. The Group intends to apply these new and amended IFRS Accounting Standards, if applicable, when they become effective.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="padding-left: 0.25in; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 18</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 59%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Presentation and Disclosure in Financial Statements<sup>2</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 19 and its amendments</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsidiaries without Public Accountability: Disclosures<sup>2</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 9 and IFRS 7</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendments to the Classification and Measurement of Financial Instruments<sup>1</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 9 and IFRS 7</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contracts Referencing Nature-dependent Electricity<sup>1</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 10 and IAS 28</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sale or Contribution of Assets between an Investor and its Associate or Joint Venture<sup>3</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IAS 21</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation to a Hyperinflationary Presentation Currency<sup>2</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Annual Improvements to IFRS Accounting Standards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8211; Volume 11</i></span></p></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 7<sup>1</sup></span></td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Effective for annual periods beginning on or after January 1, 2026</span></p></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2</sup></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Effective for annual/reporting periods beginning on or after January 1, 2027</span></td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>3</sup></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No mandatory effective date yet determined but available for adoption</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group is in the process of making an assessment of the impact of these new and revised IFRS Accounting Standards upon initial application.
So far, the Group considers that these new and revised IFRS Accounting Standards, except for IFRS 18, are unlikely to have a significant
impact on the Group&#8217;s results of operations and financial position. IFRS 18 is expected to be applicable to the Group. IFRS 18
introduces new requirements on presentation within the statement of profit or loss, including specific totals and subtotals. It also
requires disclosure of management-defined performance measures in a note and introduces new requirements for aggregation and disaggregation
of financial information. The new requirements are expected to impact the Group&#8217;s presentation of the statement of profit or loss
and disclosures of the Group&#8217;s financial performance.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures', window );">Investments in joint venture</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Investments
in joint venture</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
joint venture is a type of joint arrangement whereby the parties that have joint control of the arrangement have rights to the net
assets of the joint venture. Joint control is the contractually agreed upon sharing of control of an arrangement, which exists only
when decisions about the relevant activities require the unanimous consent of the parties sharing control.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s investments in joint ventures are stated in the consolidated statement of financial position at the Group&#8217;s share
of net assets under the equity method of accounting, less any impairment losses. Adjustments are made to bring into line any dissimilar
accounting policies that may exist. The Group&#8217;s share of the post-acquisition results and other comprehensive income of joint ventures
is included in the consolidated statement of profit or loss and consolidated other comprehensive income, respectively. In addition, when
there has been a change recognized directly in the equity of the joint venture, the Group recognizes its share of any changes, when applicable,
in the consolidated statement of changes in equity. Unrealized gains and losses resulting from transactions between the Group and its
joint ventures are eliminated to the extent of the Group&#8217;s investments in the joint ventures, except where unrealized losses provide
evidence of an impairment of the assets transferred. Goodwill arising from the acquisition of joint ventures is included as part of the
Group&#8217;s investments in joint ventures.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory', window );">Goodwill</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Goodwill&#160;</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
is initially measured at cost, being the excess of the aggregate of the consideration transferred, the amount recognized for non-controlling
interests and any fair value of the Group&#8217;s previously held equity interests in the acquiree over the identifiable assets acquired
and liabilities assumed. If the sum of this consideration and other items is lower than the fair value of the net assets acquired, the
difference is, after reassessment, recognized in profit or loss as a gain on bargain purchase.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is tested for impairment annually
or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. The Group performs its
annual impairment test of goodwill as at December 31. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Group&#8217;s cash-generating units, or groups of
cash-generating units, that are expected to benefit from the synergies of the combination, irrespective of whether other assets or
liabilities of the Group are assigned to those units or groups of units.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment
is determined by assessing the recoverable amount of the cash-generating unit (group of cash-generating units) to which the goodwill
relates. Where the recoverable amount of the cash-generating unit (group of cash-generating units) is less than the carrying amount,
an impairment loss is recognized. An impairment loss recognized for goodwill is not reversed in a subsequent period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
goodwill has been allocated to a cash-generating unit (or group of cash-generating units) and part of the operation within that unit
is disposed of, the goodwill associated with the operation disposed of is included in the carrying amount of the operation when determining
the gain or loss on the disposal. Goodwill disposed of in these circumstances is measured based on the relative value of the operation
disposed of and the portion of the cash-generating unit retained.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory', window );">Fair value measurement</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Fair
value measurement</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group measures its financial assets at FVTPL and derivative financial instruments at fair value at the end of each reporting period. Fair
value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the
liability takes place either in the principal market for the asset or liability, or in the absence of a principal market, in the most
advantageous market for the asset or liability. The principal or the most advantageous market must be accessible by the Group. The fair
value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
fair value measurement of a non-financial asset takes into account a market participant&#8217;s ability to generate economic benefits
by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest
and best use.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair
value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value
hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8211; based on quoted prices (unadjusted) in active markets for identical assets or liabilities</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8211; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is observable,
either directly or indirectly</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8211; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
assets and liabilities that are recognized in the financial statements on a recurring basis, the Group determines whether transfers have
occurred between levels in the hierarchy by reassessing categorization (based on the lowest level input that is significant to the fair
value measurement as a whole) at the end of each reporting period.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory', window );">Impairment of non-financial assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Impairment
of non-financial assets</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
an indication of impairment exists, or when annual impairment testing for an asset is required (other than inventories, deferred tax
assets and non-current assets), the asset&#8217;s recoverable amount is estimated. An asset&#8217;s recoverable amount is the higher of the asset&#8217;s
or cash-generating unit&#8217;s value in use and its fair value less costs of disposal, and is determined for an individual asset, unless the
asset does not generate cash inflows that are largely independent of those from other assets or groups of assets, in which case the recoverable
amount is determined for the cash-generating unit to which the asset belongs.&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
testing a cash-generating unit for impairment, a portion of the carrying amount of a corporate asset (e.g., a headquarters building)
is allocated to an individual cash-generating unit if it can be allocated on a reasonable and consistent basis or, otherwise, to the
smallest group of cash-generating units.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
impairment loss is recognized only if the carrying amount of an asset exceeds its recoverable amount. In assessing value in use, the
estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments
of the time value of money and the risks specific to the asset. An impairment loss is charged to the statement of profit or loss in the
period in which it arises in those expense categories consistent with the function of the impaired asset.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
assessment is made at the end of each reporting period as to whether there is an indication that previously recognized impairment losses
may no longer exist or may have decreased. If such an indication exists, the recoverable amount is estimated. A previously recognized
impairment loss of an asset other than goodwill is reversed only if there has been a change in the estimates used to determine the recoverable
amount of that asset, but not to an amount higher than the carrying amount that would have been determined (net of any depreciation/amortization)
had no impairment loss been recognized for the asset in prior years. A reversal of such an impairment loss is credited to the statement
of profit or loss in the period in which it arises.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory', window );">Related parties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Related
parties</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
party is considered to be related to the Group if:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            party is a person or a close member of that person&#8217;s family and that person:</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                            control or joint control over the Group;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                            significant influence over the Group; or</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                            a member of the key management personnel of the Group or of a parent of the Group;</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            party is an entity where any of the following conditions applies:</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity and the Group are members of the same group;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            entity is an associate or joint venture of the other entity (or of a parent, subsidiary or
                                            fellow subsidiary of the other entity);</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity and the Group are joint ventures of the same third party;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            entity is a joint venture of a third entity and the other entity is an associate of the third
                                            entity;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity is a post-employment benefit plan for the benefit of employees of either the Group
                                            or an entity related to the Group;</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity is controlled or jointly controlled by a person identified in (a);</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            person identified in (a)(i) has significant influence over the entity or is a member of the
                                            key management personnel of the entity (or of a parent of the entity); and</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            entity, or any member of a group of which it is a part, provides key management personnel
                                            services to the Group or to the parent of the Group.</span></td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment and depreciation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Property,
plant and equipment and depreciation</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
plant and equipment, other than construction in progress, are stated at cost less accumulated depreciation and any impairment losses.
The cost of an item of property, plant and equipment comprises its purchase price and any directly attributable costs of bringing the
asset to its working condition and location for its intended use.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditure
incurred after items of property, plant and equipment have been put into operation, such as repairs and maintenance, is normally charged
to the statement of profit or loss in the period in which it is incurred. In situations where the recognition criteria are satisfied,
the expenditure for a major inspection is capitalized in the carrying amount of the asset as a replacement. Where significant parts of
property, plant and equipment are required to be replaced at intervals, the Group recognizes such parts as individual assets with specific
useful lives and depreciates them accordingly.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is calculated on the straight-line basis to write off the cost of each item of property, plant and equipment to its residual value over
its estimated useful life. The principal annual rates used for this purpose are as follows:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 86%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.75</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20% to 33.33</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    and equipment</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5% to 31.67</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicles</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.75</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
parts of an item of property, plant and equipment have different useful lives, the cost of that item is allocated on a reasonable basis
among the parts and each part is depreciated separately. Residual values, useful lives and the depreciation method are reviewed, and
adjusted if appropriate, at least at each financial year end.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
asset&#8217;s carrying amount is written down immediately to its recoverable amount if the asset&#8217;s carrying amount is greater than
its estimated recoverable amount.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
item of property, plant and equipment including any significant part initially recognized is derecognized upon disposal or when no future
economic benefits are expected from its use or disposal. Any gain or loss on disposal or retirement recognized in the statement of profit
or loss in the year the asset is derecognized is the difference between the net sales proceeds and the carrying amount of the relevant
asset.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
in progress is stated at cost less any impairment losses and is not depreciated. It is reclassified to the appropriate category of property,
plant and equipment when completed and ready for use.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory', window );">Intangible assets (other than goodwill)</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Intangible
assets (other than goodwill)</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination
is the fair value at the date of acquisition. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible
assets with finite lives are subsequently amortized over the useful economic life and assessed for impairment whenever there is an indication
that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at each financial year end.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are amortized on the straight-line basis over the following useful economic lives:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 87%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 10 years</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14 years</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20 years</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
useful lives of software are assessed by the Group considering different purpose and usage of the software, and the authorized period
for use. The useful life of patent is assessed by the Group based on the remaining and foreseeable patent protection period after acquisition.
The useful life of a purchased license is assessed by considering the expected usage of the license by the Group.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Research
and development costs</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
research costs are charged to the statement of profit or loss as incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditure
incurred on projects to develop new products is capitalized and deferred only when the Group can demonstrate the technical feasibility
of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or
sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the project and the ability
to measure reliably the expenditure during the development. Product development expenditure which does not meet these criteria is expensed
when incurred. During the reporting period, all expenses incurred for research and development activities were regarded as research expenses
and therefore were expensed when incurred.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Leases</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group assesses at contract inception whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract
conveys the right to control the use of an identified asset for a period of time in exchange for consideration.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Group
as a lessee</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets.
The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
                                            assets</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
assets are recognized at the commencement date of the lease (that is the date the underlying asset is available for use). Right-of-use
assets are measured at cost, less accumulated depreciation and any impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis
over the shorter of the lease terms and the estimated useful lives of the assets as follows:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 87%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold land</span></td>
    <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 years</span></td>
    <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 to 7 years</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
ownership of the leased asset transfers to the Group by the end of the lease term or the cost reflects the exercise of a purchase option,
depreciation is calculated using the estimated useful life of the asset.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
                                            liabilities</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are recognized at the commencement date of the lease at the present value of lease payments to be made over the lease term.
The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease
payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also
include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for termination
of a lease, if the lease term reflects the Group exercising the option to terminate the lease. The variable lease payments that do not
depend on an index or a rate are recognized as an expense in the period in which the event or condition that triggers the payment occurs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
calculating the present value of lease payments, the Group uses its incremental borrowing rate at the lease commencement date because
the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is
increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities
is remeasured if there is a modification, a change in the lease term, a change in lease payments (e.g., a change to future lease payments
resulting from a change in an index or rate) or a change in assessment of an option to purchase the underlying asset.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s lease liabilities are included in interest-bearing bank and other borrowings.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
                                            leases and leases of low-value assets</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (that is those leases that
have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the recognition
exemption for leases of low-value assets to leases of office equipment that are considered to be of low value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
payments on short-term leases and leases of low-value assets are recognized as an expense on a straight-line basis over the lease term.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory', window );">Investments and other financial assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Investments
and other financial assets</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and measurement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets are classified, at initial recognition, as subsequently measured at amortized cost and fair value through profit and loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics
and the Group&#8217;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Group has applied the practical expedient of not adjusting the effect of a significant financing component,
the Group initially measures a financial asset at its fair value plus in the case of a financial asset not at FVTPL, transaction costs.
Trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are
measured at the transaction price determined under IFRS 15 in accordance with the policies set out for &#8220;Revenue recognition&#8221;
below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order for a financial asset to be classified and measured at amortized cost, it needs to give rise to cash flows that are solely payments
of principal and interest (&#8220;SPPI&#8221;) on the principal amount outstanding. Financial assets with cash flows that are not SPPI
are classified and measured at fair value through profit or loss, irrespective of the business model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash flows.
The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or
both. Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial
assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through other comprehensive
income are held within a business model with the objective of both holding to collect contractual cash flows and selling. Financial assets
which are not held within the aforementioned business models are classified and measured at fair value through profit or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
or sales of financial assets that require delivery of assets within the period generally established by regulation or convention in the
marketplace are recognized on the trade date, that is, the date that the Group commits to purchase or sell the asset.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent
measurement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsequent measurement of financial assets depends on their classification as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
assets at amortized cost (debt instruments)</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment. Gains and losses
are recognized in the statement of profit or loss when the asset is derecognized, modified or impaired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
assets at FVTPL</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets at FVTPL are carried in the statement of financial position at fair value with net changes in fair value recognized in the statement
of profit or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
on the equity investments are also recognized as other income in the statement of profit or loss when the right of payment has been established.&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory', window );">Derecognition of financial assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derecognition
of financial assets</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized
(i.e., removed from the Group&#8217;s consolidated statement of financial position) when:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            rights to receive cash flows from the asset have expired; or</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Group has transferred its rights to receive cash flows from the asset or has assumed an obligation
                                            to pay the received cash flows in full without material delay to a third party under a &#8220;pass-through&#8221;
                                            arrangement; and either (a) the Group has transferred substantially all the risks and rewards
                                            of the asset, or (b) the Group has neither transferred nor retained substantially all the
                                            risks and rewards of the asset, but has transferred control of the asset.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Group has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risk and rewards of ownership of the asset. When it has neither transferred nor retained
substantially all the risks and rewards of the asset nor transferred control of the asset, the Group continues to recognize the transferred
asset to the extent of the Group&#8217;s continuing involvement. In that case, the Group also recognizes an associated liability. The
transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Group has retained.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Group could be required to repay.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory', window );">Impairment of financial assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Impairment
of financial assets</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group recognizes an allowance for expected credit losses (&#8220;ECLs&#8221;) for all debt instruments not held at fair value through
profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash
flows that the Group expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows
will include cash flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
approach</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ECLs
are recognized in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition,
ECLs are provided for credit losses that result from default events that are possible within the next 12 months (a 12-month ECL). For
those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is
required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each reporting date, the Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition.
When making the assessment, the Group compares the risk of a default occurring on the financial instrument as at the reporting date with
the risk of a default occurring on the financial instrument as at the date of initial recognition and considers reasonable and supportable
information that is available without undue cost or effort, including historical and forward-looking information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group considers a financial asset in default when contractual payments are 120 days past due. However, in certain cases, the Group may
also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive
the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets at amortized cost are subject to impairment under the general approach, and they are classified within the following stages for
measurement of ECLs except for trade receivables which apply the simplified approach as detailed below.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.65in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
                               1 &#8211; </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            instruments for which credit risk has not increased significantly since initial recognition
                                            and for which the loss allowance is measured at an amount equal to 12-month ECLs</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.65in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
                                            2 &#8211; </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            instruments for which credit risk has increased significantly since initial recognition but
                                            that are not credit-impaired financial assets and for which the loss allowance is measured
                                            at an amount equal to lifetime ECLs</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.65in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
                                            3 &#8211; </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                            assets that are credit-impaired at the reporting date (but that are not purchased or originated
                                            credit-impaired) and for which the loss allowance is measured at an amount equal to lifetime
                                            ECLs</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Simplified
approach</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
trade receivables that do not contain a significant financing component or when the Group applies the practical expedient of not adjusting
the effect of a significant financing component, the Group applies the simplified approach in calculating ECLs. Under the simplified
approach, the Group does not track changes in credit risk but instead recognizes a loss allowance based on lifetime ECLs at each reporting
date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking
factors specific to the debtors and the economic environment.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory', window );">Financial liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Financial
liabilities</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and measurement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
liabilities are classified, at initial recognition, as financial liabilities at FVTPL, loans and borrowings, or payables, as appropriate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s financial liabilities include trade payables, financial liabilities included in other payables and accruals, interest-bearing
bank and other borrowings, long-term payables and other current and non-current liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent
measurement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
subsequent measurement of financial liabilities depends on their classification as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
liabilities at fair value through profit or loss</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
liabilities at fair value through profit or loss include financial liabilities designated upon initial recognition as at fair value through
profit or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
liabilities designated upon initial recognition as at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied. Gains or losses on liabilities designated at fair value through profit or loss are
recognized in the statement of profit or loss, except for the gains or losses arising from the Group&#8217;s own credit risk which are
presented in other comprehensive income with no subsequent reclassification to the statement of profit or loss. The net fair value gain
or loss recognized in the statement of profit or loss does not include any interest charged on these financial liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
liabilities at amortized cost (trade and other payables, and borrowings)</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
initial recognition, trade and other payables, and interest-bearing borrowings are subsequently measured at amortized cost, using the
effective interest rate method unless the effect of discounting would be immaterial, in which case they are stated at cost. Gains and
losses are recognized in the statement of profit or loss when the liabilities are derecognized as well as through the effective interest
rate amortization process.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the effective
interest rate. The effective interest rate amortization is included in finance costs in the statement of profit or loss.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock', window );">Derecognition of financial liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derecognition
of financial liabilities </span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial liability is derecognized when the obligation under the liability is discharged or cancelled or expires.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing
liability are substantially modified, such an exchange or modification is treated as a derecognition of the original liability and a
recognition of a new liability, and the difference between the respective carrying amounts is recognized in the statement of profit or
loss.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory', window );">Offsetting of financial instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Offsetting
of financial instruments </span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, or to realize the assets
and settle the liabilities simultaneously.&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory', window );">Derivative financial instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Derivative
financial instruments</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
recognition and subsequent measurement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently
remeasured at fair value. Derivatives are carried as assets when the fair value is positive, and as liabilities when the fair value is
negative.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
gains or losses arising from changes in fair value of derivatives are taken directly to profit or loss.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory', window );">Treasury shares</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Treasury
shares </span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Own
equity instruments which are reacquired and held by the Company or the Group (treasury shares) are recognized directly in equity at cost.
No gain or loss is recognized in the statement of profit or loss on the purchase, sale, issue or cancellation of the Group&#8217;s own
equity instruments.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Inventories</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are stated at the lower of cost and net realizable value. Cost is determined on the first-in, first-out basis, in the case of work in
progress and finished goods, comprises direct materials, direct labor, contract manufacturing fee and an appropriate proportion of overheads.
Net realizable value is based on estimated selling prices less any estimated costs to be incurred to completion and disposal.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Cash
and cash equivalents</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents in the statements of cash flows comprise cash on hand and at banks, and short-term highly liquid deposits with a
maturity of generally within three months that are readily convertible into known amounts of cash, subject to an insignificant risk of
changes in value and held for the purpose of meeting short-term cash commitments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of the consolidated statements of financial positions, cash and bank balances comprise cash and cash equivalents as defined
above, restricted bank balances and time deposits with original maturity of more than three months as defined above.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Provisions
</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
provision is recognized when a present obligation (legal or constructive) has arisen as a result of a past event and it is probable that
a future outflow of resources will be required to settle the obligation, provided that a reliable estimate can be made of the amount
of the obligation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Group expects some or all of a provision to be reimbursed, the reimbursement is recognized as a separate asset, but only when the
reimbursement is virtually certain. The expense relating to a provision is presented in the statement of profit or loss net of any reimbursement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the effect of discounting is material, the amount recognized for a provision is the present value at the end of the reporting date of
the future expenditures expected to be required to settle the obligation. The increase in the discounted present value amount arising
from the passage of time is included in finance costs in the statement of profit or loss.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income tax</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Income
tax</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax comprises current and deferred tax. Income tax relating to items recognized outside profit or loss is recognized outside profit or
loss, either in other comprehensive income or directly in equity.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, based on tax
rates (and tax laws) that have been enacted or substantively enacted by the end of each of the reporting period, taking into consideration
interpretations and practices prevailing in the countries in which the Group operates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax is provided, using the liability method, on all temporary differences at the end of reporting date between the tax bases of assets
and liabilities and their carrying amounts for financial reporting purposes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax liabilities are recognized for all taxable temporary differences, except:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                            the deferred tax liability arises from the initial recognition of goodwill or an asset or
                                            liability in a transaction that is not a business combination and, at the time of the transaction,
                                            affects neither the accounting profit nor taxable profit or loss and does not give rise to
                                            equal taxable and deductible temporary differences; and</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            respect of taxable temporary differences associated with investments in subsidiaries, when
                                            the timing of the reversal of the temporary differences can be controlled and it is probable
                                            that the temporary differences will not reverse in the foreseeable future.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are recognized for all deductible temporary differences, and the carryforward of unused tax credits and any unused tax losses.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which the deductible
temporary differences, and the carryforward of unused tax credits and unused tax losses can be utilized, except:</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">when
                                            the deferred tax asset relating to the deductible temporary differences arises from the initial
                                            recognition of an asset or liability in a transaction that is not a business combination
                                            and, at the time of the transaction, affects neither the accounting profit nor taxable profit
                                            or loss and does not give rise to equal taxable and deductible temporary differences; and</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            respect of deductible temporary differences associated with investments in subsidiaries,
                                            deferred tax assets are only recognized to the extent that it is probable that the temporary
                                            differences will reverse in the foreseeable future and taxable profit will be available against
                                            which the temporary differences can be utilized.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer
probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized
deferred tax assets are reassessed at the end of each reporting period and are recognized to the extent that it has become probable that
sufficient taxable profit will be available to allow all or part of the deferred tax asset to be recovered.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realized or the liability
is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and deferred tax liabilities are offset if and only if the Group has a legally enforceable right to set off current tax assets
and current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation
authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets
on a net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts
of deferred tax liabilities or assets are expected to be settled or recovered.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants', window );">Government grants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Government
grants</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
grants are recognized at their fair value where there is reasonable assurance that the grant will be received and all attaching conditions
will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the periods that
the costs, for which it is intended to compensate, are expensed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
government grants whose primary condition is to compensate for research and development projects or other than purchase, construct or
otherwise acquire long-term assets are designated as grants related to income. Some of the grants related to income have future related
costs expected to be incurred and require the Group to comply with conditions attached to the grants and the government to acknowledge
the compliance of these conditions. These grants related to income are recognized as deferred income in the consolidated statement of
financial position and transferred to profit or loss when related costs are subsequently incurred, and the Group received government acknowledge
of compliance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
government grants related to income that are receivable as compensation for expenses or losses already incurred or for the purpose of
giving immediate financial support to the Group with no future related costs are recognized in profit or loss in the period in which
they become receivable.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory', window );">Revenue recognition</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Revenue
recognition </span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue
from contracts with customers</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from contracts with customers is recognized when control of goods or services is transferred to the customers at an amount that reflects
the consideration to which the Group expects to be entitled in exchange for those goods or services.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the consideration in a contract includes a variable amount, the amount of consideration is estimated to which the Group will be entitled
in exchange for transferring the goods or services to the customer. The variable consideration is estimated at contract inception and
constrained until it is highly probable that a significant revenue reversal in the amount of cumulative revenue recognized will not occur
when the associated uncertainty with the variable consideration is subsequently resolved.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the contract contains a financing component which provides the customer with a significant benefit of financing the transfer of goods
or services to the customer for more than one year, revenue is measured at the present value of the amount receivable, discounted using
the discount rate that would be reflected in a separate financing transaction between the Group and the customer at contract inception.
When the contract contains a financing component which provides the Group with a significant financial benefit for more than one year,
revenue recognized under the contract includes the interest expense accreted on the contract liability under the effective interest method.
For a contract where the period between the payment by the customer and the transfer of the promised goods or services is one year or
less, the transaction price is not adjusted for the effects of a significant financing component, using the practical expedient in IFRS
15.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
                                            of products</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from the sale of products is recognized at the point in time when control of the asset is transferred to the customer, generally on acceptance
of the products.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
                                            rights</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group provides commercialization, development and branding rights (collectively, &#8220;Commercialization Rights&#8221;) to customers
for an agreed upon commercialization period ending ten years from the date of the first sale of the product as stipulated in the relevant
agreement. The consideration for Commercialization Rights includes upfront payment, development and regulatory milestones payments and
commercialization milestones payments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
and regulatory milestones payments are fully constrained until the period in which those regulatory approvals are achieved due to the
inherent uncertainty with the approval process and included in the transaction price in the period regulatory approval is obtained. Upfront
payment and development and regulatory milestones payments are recorded under contract liabilities and recognized as revenue over time
during the commercialization period on a straight-line basis.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
milestone payments based on the level of sales are recognized at a point in time when the later of the following events occurs: (i) the
related sale occurs, or (ii) the performance obligation to which commercialization milestones payments have been allocated has been satisfied.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
                                            property income</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
property income is recognized at the point in time at which the non-patented intellectual property is granted to the customer because
the Company will not undertake activities that affect such intellectual property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consideration for intellectual property income comprises a fixed element and a variable element. Variable element is recognized as the
transaction price when the Company can conclude that it is highly probable that a significant reversal in the amount of cumulative revenue
recognized will not occur.</span></p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group provides consulting services to its customers through contracts. Depending on the contract, revenue is recognized over time as
the service is rendered, or at the point in time as the service is completed and accepted.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory', window );">Other income</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
income</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income is recognized on an accrual basis using the effective interest method by applying the rate that exactly discounts the estimated
future cash receipts over the expected life of the financial instrument or a shorter period, when appropriate, to the net carrying amount
of the financial asset.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory', window );">Contract liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Contract
liabilities </span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
contract liability is recognized when a payment is received or a payment is due (whichever is earlier) from a customer before the Group
transfers the related goods or services. Contract liabilities are recognized as revenue when the Group performs under the contract (i.e.,
transfers control of the related goods or services to the customer).</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Share-based
payments</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates share incentive plans which include the pre-IPO share option scheme, the post-IPO share option scheme, 2018 restricted
share unit scheme (the &#8220;2018 RSU Scheme&#8221;), 2021 restricted share unit scheme (the &#8220;2021 RSU Scheme&#8221;) and 2022
restricted share unit scheme (the &#8220;2022 RSU Scheme&#8221;). Employees (including directors) of the Group receive remuneration in
the form of share-based payments, whereby employees render services in exchange for equity instruments (&#8220;equity-settled transactions&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of equity-settled transactions with employees is measured by reference to the fair value at the date at which they are granted,
further details of which are given in note 31 to the financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of equity-settled transactions is recognized in employee benefit expense, together with a corresponding increase in equity, over
the period in which the performance and/or service conditions are fulfilled. The cumulative expense recognized for equity-settled transactions
at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group&#8217;s
best estimate of the number of equity instruments that will ultimately vest. The charge or credit to the statement of profit or loss
for a period represents the movement in the cumulative expense recognized as at the beginning and end of that period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service
and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood
of the conditions being met is assessed as part of the Group&#8217;s best estimate of the number of equity instruments that will ultimately
vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without
an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value
of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
awards that do not ultimately vest because non-market performance and/or service conditions have not been met, no expense is recognized.
Where awards include a market or non-vesting condition, the transactions are treated as vesting irrespective of whether the market or
non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
the terms of an equity-settled award are modified, as a minimum an expense is recognized as if the terms had not been modified, if the
original terms of the award are met. In addition, an expense is recognized for any modification that increases the total fair value of
the share-based payments or is otherwise beneficial to the employee as measured at the date of modification. Where an equity-settled
award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognized for the award is
recognized immediately.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dilutive effect of outstanding options is reflected as additional share dilution in the computation of loss per share.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Other employee benefits</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Other
employee benefits</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pension
scheme</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
employees of the Group&#8217;s subsidiaries which operate in the Chinese mainland are required to participate in a central pension scheme
operated by the local municipal government. The subsidiaries operating in Chinese mainland are required to contribute a certain percentage
of their payroll costs to the central pension scheme. The contributions are charged to profit or loss as they become payable in accordance
with the rules of the central pension scheme.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group implemented a safe harbor defined contribution 401(k) savings plan (the &#8220;401(k) Plan&#8221;) for U.S. employees. The 401(k)
Plan covers all U.S. employees and allows participants to defer a portion of their annual compensation on a pre-tax basis. In addition,
the Company implemented a matching contribution to the 401(k) Plan, matching 100% of an employee&#8217;s contribution up to a maximum
of 6% of the participant&#8217;s annual base salary. Such matching contribution vests when made.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory', window );">Borrowing costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Borrowing
costs</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
costs directly attributable to the acquisition, construction or production of qualifying assets, i.e., assets that necessarily take a
substantial period of time to get ready for their intended use or sale, are capitalized as part of the cost of those assets. The capitalization
of such borrowing costs ceases when the assets are substantially ready for their intended use or sale. All other borrowing costs are
expensed in the period in which they are incurred. Borrowing costs consist of interest and other costs that an entity incurs in connection
with the borrowing of funds.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock', window );">Events after the reporting period</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Events
after the reporting period </span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Group receives information after the reporting period, but prior to the date of authorization for issue, about conditions that existed
at the end of the reporting period, it will assess whether the information affects the amounts that it recognizes in its financial statements.
The Group will adjust the amounts recognized in its financial statements to reflect any adjusting events after the reporting period and
update the disclosures that relate to those conditions in light of the new information. For non-adjusting events after the reporting
period, the Group will not change the amounts recognized in its financial statements but will disclose the nature of the non-adjusting
events and an estimate of their financial effects, or a statement that such an estimate cannot be made, if applicable.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign currencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Foreign
currencies</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are presented in RMB. Each entity in the Group determines its own functional currency and items included in the
financial statements of each entity are measured using that functional currency. Foreign currency transactions recorded by the entities
in the Group are initially recorded using their respective functional currency rates prevailing at the dates of the transactions. Monetary
assets and liabilities denominated in foreign currencies are translated at the functional currency rates of exchange ruling at the end
of the reporting period. Differences arising on settlement or translation of monetary items are recognized in profit or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif">Non-monetary
items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the
initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the
date when the fair value was measured. The gain or loss arising on translation of a non-monetary item measured at fair value is treated
in line with the recognition of the gain or loss on change in fair value of the item (i.e., translation difference on the item whose
fair value gain or loss is recognized in other comprehensive income or profit or loss is also recognized in other comprehensive income
or profit or loss, respectively).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the exchange rate on initial recognition of the related asset, expense or income on the derecognition of a non-monetary asset
or non-monetary liability relating to an advance consideration, the date of initial transaction is the date on which the Group initially
recognizes the non-monetary asset or non-monetary liability arising from the advance consideration. If there are multiple payments or
receipts in advance, the Group determines the transaction date for each payment or receipt of the advance consideration.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currencies of certain overseas subsidiaries are currencies other than the RMB. As at the end of the reporting period, the
assets and liabilities of these entities are translated into RMB at the exchange rates prevailing at the end of the reporting period
and their statements of profit or loss are translated into RMB at the exchange rates that approximate to those prevailing at the dates
of the transactions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
resulting exchange differences are recognized in other comprehensive income and accumulated in the exchange fluctuation reserve, except
to the extent that the differences are attributable to non-controlling interests. On disposal of a foreign operation, the cumulative
amount in the reserve relating to that particular foreign operation is recognized in the statement of profit or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
goodwill arising on the acquisition of a foreign operation and any fair value adjustments to the carrying amounts of assets and liabilities
arising on acquisition are treated as assets and liabilities of the foreign operation and translated at the closing rate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of the consolidated statements of cash flows, the cash flows of overseas subsidiaries are translated into RMB at the exchange
rates ruling at the dates of the cash flows. Frequently recurring cash flows of overseas subsidiaries which arise throughout the year
are translated into RMB at the exchange rates that approximate to those prevailing at the dates of the transactions.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of contract liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the derecognition of financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for issued but not yet effective ifrs accountingstandards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of changes made to accounting policies by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for interest and other costs that the entity incurs in connection with the borrowing of funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the derecognition of financial instruments. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for derivative financial instruments. [Refer: Classes of financial instruments [domain]; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 216<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_216_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 216<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_216_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the impairment of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the impairment of financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for investments in joint ventures. [Refer: Total for all joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the offsetting of financial instruments. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for transactions with related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 170<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_170&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 170<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_170&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfConsolidationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue from contracts with customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g105-109_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g110-129_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate and Group Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate and Group Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">Schedule of Principal Subsidiaries</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars
of the Company&#8217;s principal subsidiaries are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place and date of incorporation/ registration and</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="4" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominal value of issued/registered</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentage of equity interests attributable to the Company</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company name</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">place of business</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">share capital</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indirect</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">business</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 35%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suzhou Ascentage Pharma Co., Ltd.*@ <br/> (&#8220;Suzhou Yasheng&#8221;)</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC/Chinese<br/> mainland</span><span style="font-family: Times New Roman, Times, Serif"><br/> June 1, 2016</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-191; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 12%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical research and development</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guangzhou Healthquest Pharma Co., Ltd.*@ <br/> (&#8220;Healthquest Pharma&#8221;)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC/Chinese<br/> mainland<br/> July 3, 2012</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-192; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical development and sale of products</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ascentage Pharma Group Inc.</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States of America <br/> (&#8220;United States&#8221;) <br/> November 4, 2015</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-193; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical trials</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suzhou Shenghe Innovation Works Biotech Co., Ltd.*@</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC/Chinese<br/> mainland <br/>September 21, 2022</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-194; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental of buildings to group companies</span></td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English names of the companies registered in the PRC represent the best efforts made by the management of the Company in directly translating the Chinese names of these companies as no English names have been registered.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">@</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These entities are limited liability companies established in the PRC.</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B4<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations', window );">Schedule of New and Revised IFRSs</a></td>
<td class="text">The Group intends to apply these new and amended IFRS Accounting Standards, if applicable, when they become effective.<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="padding-left: 0.25in; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 18</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 59%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Presentation and Disclosure in Financial Statements<sup>2</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 19 and its amendments</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsidiaries without Public Accountability: Disclosures<sup>2</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 9 and IFRS 7</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendments to the Classification and Measurement of Financial Instruments<sup>1</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 9 and IFRS 7</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contracts Referencing Nature-dependent Electricity<sup>1</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 10 and IAS 28</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sale or Contribution of Assets between an Investor and its Associate or Joint Venture<sup>3</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IAS 21</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation to a Hyperinflationary Presentation Currency<sup>2</sup></i></span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 0.25in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Annual Improvements to IFRS Accounting Standards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8211; Volume 11</i></span></p></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 7<sup>1</sup></span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Effective for annual periods beginning on or after January 1, 2026</span></p></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2</sup></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Effective for annual/reporting periods beginning on or after January 1, 2027</span></td></tr> </table>


<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>3</sup></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No mandatory effective date yet determined but available for adoption</span></td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory', window );">Schedule of Property, Plant and Equipment of Annual Rates</a></td>
<td class="text">The principal annual rates used for this purpose are as follows:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 86%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.75</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20% to 33.33</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    and equipment</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5% to 31.67</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicles</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.75</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of Intangible Assets are Amortized on the Straight-Line Basis</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are amortized on the straight-line basis over the following useful economic lives:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 87%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 10 years</span></td>
    <td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14 years</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20 years</span></td>
    <td style="background-color: #CCEEFF; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory', window );">Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets</a></td>
<td class="text">Right-of-use assets are depreciated on a straight-line basis
over the shorter of the lease terms and the estimated useful lives of the assets as follows:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 87%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold land</span></td>
    <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 11%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 years</span></td>
    <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 to 7 years</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about right-of-use assets of lease terms and estimated useful lives of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment of annual rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 178<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_178&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 178<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_178&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Operating Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesExplanatory', window );">&#8203;Schedule of Revenue</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from external customers</span><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese
    mainland</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221,984</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">302,235</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">574,120</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,098</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Switzerland</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-195; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">678,415</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-196; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-197; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221,984</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">980,650</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">574,120</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,098</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory', window );">&#8203;Schedule of Non-Current Assets</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current assets</span><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese
    mainland</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,088,733</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,090,914</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">978,233</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">139,885</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,474</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,489</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">642</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">444</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    non-current assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,091,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,095,832</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">982,757</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,532</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory', window );">Schedule of Revenue from Customers</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from customers amounting to over 10% of the total revenue of the Group in the reporting period is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the years ended December 31,</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer A</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,323</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,895</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">436,644</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,439</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 11pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    B</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-198; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">678,415</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-199; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-200; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 11pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    C</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,021</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-201; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-202; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-203; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 11pt; text-indent: -11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    D</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,623</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-204; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-205; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-206; font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">172,967</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">908,310</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">436,644</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,439</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These customers generated less than 10% of the total revenue of the Group during the years ended December 31, 2023, 2024 and 2025.</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for non-current assets held for sale and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Section Presentation and disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS05_g30-42_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProductsAndServicesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's products and services. [Refer: Products and services [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProductsAndServicesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of major customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Other Income and Gains (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Revenue, Other Income and Gains [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory', window );">&#8203;Schedule of Disaggregated Revenue</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated revenue information</span><table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Types of goods
    or services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intellectual
    property income</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-207; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">678,415</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-208; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-209; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif">Sales
    of products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">193,535</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">260,835</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">499,272</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,395</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif">Commercialization
    rights income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,049</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,485</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72,629</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,386</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,400</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,915</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,219</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">317</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221,984</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">980,650</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">574,120</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">82,098</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Timing
    of revenue recognition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">At
    a point in time</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intellectual
    property income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-210; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">678,415</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-211; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-212; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Sales of products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">193,535</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">260,835</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">499,272</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,395</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commercialization
rights income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-213; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,144</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,026</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Over
    time</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commercialization
    rights income</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,049</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,485</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,485</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,360</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,400</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,915</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,219</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">317</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221,984</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">980,650</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">574,120</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">82,098</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory', window );">&#8203;Schedule of Contract Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the amounts of revenue recognized in the current reporting period that were included in the contract liabilities
at the beginning of the reporting period:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
    rights income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,049</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,360</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPerformanceObligationsExplanatory', window );">Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of transaction prices allocated to the remaining performance obligations (unsatisfied or partially unsatisfied) as at December
31, 2024 and 2025 are as follows:&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts expected to be recognized as revenue:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    one year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,360</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
    one year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248,460</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">210,224</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,062</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">285,945</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,709</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory', window );">Schedule of Other Income and Gains</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Other
income and gains</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    interest income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,409</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,840</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,125</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,744</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants related
    to income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange gain, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,694</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,324</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,989</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value gain on derivative
    financial instruments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    on disposal of items of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,702</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,428</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,885</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other income and gains</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,316</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,359</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,495</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,800</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investment contracts liabilities. [Refer: Investment contracts liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPerformanceObligationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of performance obligations in contracts with customers. [Refer: Performance obligations [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 119<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_119&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 107<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_107&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 107<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_107&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPerformanceObligationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Before Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Loss Before Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock', window );">Schedule of Loss Before Tax</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Group&#8217;s loss before tax is arrived at after charging/(crediting):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 40%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    of inventories sold</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,342</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,031</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,481</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,074</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    of services provided</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,201</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,054</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,277</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">326</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Write-down
    of inventories to net realizable value</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right">-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,180</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">598</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of property, plant and equipment**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,281</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,184</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,761</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,404</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of investment property**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,883</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    of right-of-use assets**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13(a)</span></td><td style="text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,632</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,657</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of intangible assets**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,399</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,851</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">706,972</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">947,245</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,137,448</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162,653</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    benefit expense (including directors&#8217; remuneration):</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wages
    and salaries</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">337,381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">367,008</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">404,195</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,799</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    share-based payment expenses**</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,503</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,924</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,874</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,985</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pension
    scheme contributions (defined contribution scheme)*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,705</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,404</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,234</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,038</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">399,589</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">422,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">460,303</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value (gain)/loss, net:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    financial instruments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at FVTPL</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">832</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities at FVTPL</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36(b)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-231">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,533</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,223</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Gain)/Loss
    on disposal of items of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    on disposal of items of lease</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(685</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(99</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    payments not included in the measurement of lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13(c)</span></td><td style="text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">329</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
    grants related to income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    interest income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(32,409</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(37,840</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(82,125</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,744</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditors&#8217;
    remuneration</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,550</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">729</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,988</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,322</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,395</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,345</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,777</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">826</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    exchange (gain)/loss, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,694</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,161</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no forfeited contributions that may be used by the Group as the employer to reduce the existing level of contributions.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The depreciation of property, plant and equipment, the depreciation of investment property, the depreciation of right-of-use assets, the amortization of intangible assets and the equity-settled share-based payment expenses for the years are included in &#8220;Cost of Sales&#8221;, &#8220;Research and development expenses&#8221;, &#8220;Selling and distribution expenses&#8221; and &#8220;Administrative expenses&#8221; in the consolidated statements of profit or loss.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of loss before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Other Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfOtherExpensesTableTextBlock', window );">Schedule of Other Expenses</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value loss
    on financial liabilities at FVTPL</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,533</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,223</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,988</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,322</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,395</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,345</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange loss</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,161</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-style: normal; text-decoration: none; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-237"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none">2</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,777</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">827</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value loss on financial assets at FVTPL</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">832</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on disposal of items of property, plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">492</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,581</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">512</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,203</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,075</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,599</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,525</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfOtherExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfOtherExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestCostsAbstract', window );"><strong>Finance Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceCostExplanatory', window );">Schedule of Finance Costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
analysis of finance costs is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on bank loans and other borrowings</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,690</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,555</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,812</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,409</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on lease liabilities (note 13(b))</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,321</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    on long-term payables</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,046</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,402</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,140</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,057</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,455</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,070</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceCostExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceCostExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory', window );">Schedule of Current and Deferred Components of the Income Tax (Credit)/Expense</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current and deferred components of the income tax (credit)/expense are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    (note 18)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,150</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,425</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,911</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">988</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            income tax (credit)/expense for the year</span></p></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,150</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,425</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,940</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">992</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory', window );">Schedule of Reconciliation between the Income Tax Expense/(Credit)</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation
between the income tax expense/(credit) computed by applying the statutory tax rate to loss before income tax and the actual provision
for income tax is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss
    before tax</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(932,862</span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(395,255</span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,236,047</span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(176,753</span></td><td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    tax computed at the statutory tax rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(244,549</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(70,114</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(287,881</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(41,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lower
    tax rate for a specific entity</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,396</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,112</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,759</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,545</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statutory
    income and expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,824</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,534</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(12,900</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,845</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Items
    not subject to tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,093</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,236</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,533</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,076</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Items
    not deductible for tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,192</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,045</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">49,582</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,091</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Research
    and development super-deduction</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(67,525</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(75,135</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(48,919</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(Gain)/loss
    attributable to joint ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(269</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(78</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Provision
    to return</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,311</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(35,342</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">68,391</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,779</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect
    of tax rate changes on deferred taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(56,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,822</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(71,206</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,183</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Uncertain
    tax position</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,665</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,236</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,036</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Effect
    of withholding tax on the interest income of the Group&#8217;s HK subsidiary</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-243; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Tax
    loss expired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-244; font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31,670</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,237</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Deductible
    temporary differences not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,235</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,465</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">49,919</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,138</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Tax
    losses not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">237,432</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">68,580</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">163,913</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,438</span></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax (credit)/expense at the Group&#8217;s effective rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,150</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,425</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,940</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">992</span></td><td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for current and deferred components of the income tax expense/(credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of reconciliation between the income tax expense/(credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share Attributable to Ordinary Equity Holders of the Company (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Loss Per Share Attributable to Ordinary Equity Holders of the Company [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Schedule of Basic Loss Per Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of basic loss per share is based on:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Loss</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    attributable to ordinary equity holders of the parent, used in the basic loss per share calculation</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(925,637</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(405,433</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,242,769</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(177,714</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Shares</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average number of ordinary shares outstanding during the year used in the basic loss per share calculation#</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">282,299,269</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">302,062,104</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">356,130,452</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average number of shares was after taking into account the effect of treasury shares held.</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Buildings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Leasehold<br/> improvements</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Furniture&#160;and<br/> equipment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Motor<br/> vehicles</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Construction<br/> in progress</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">December 31, 2024</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>At January 1, 2024:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in">Cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">834,913</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">29,218</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">179,256</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">609</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">12,650</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">1,056,646</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(65,137</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,517</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(73,771</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(406</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(150,831</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">769,776</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">17,701</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">105,485</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">12,650</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">905,815</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">At January 1, 2024, net of accumulated depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">769,776</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,701</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,485</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">203</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,650</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">905,815</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,059</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,807</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,866</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Depreciation provided during the year (note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39,599</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,896</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,569</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(120</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(71,184</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Transfers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,105</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,010</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,049</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-254">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,164</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-255">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exchange realignment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">At December 31, 2024, net of accumulated depreciation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">731,282</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">25,815</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">84,977</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">83</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,293</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">849,450</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">At December 31, 2024:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">836,018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,239</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,734</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">609</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,293</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,070,893</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(104,736</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,424</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(97,757</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(526</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(221,443</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">731,282</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">25,815</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">84,977</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">83</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,293</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">849,450</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Buildings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Leasehold improvements</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Furniture and equipment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Motor vehicles</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Construction in progress</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">December 31, 2025</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>At January 1, 2025:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in">Cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">836,018</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">44,239</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">182,734</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">609</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">7,293</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td style="width: 8%; text-align: right">1,070,893</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(104,736</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,424</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(97,757</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(526</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(221,443</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">731,282</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">25,815</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">84,977</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">83</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,293</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">849,450</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">At January 1, 2025, net of accumulated depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">731,282</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,815</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,977</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,293</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">849,450</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,270</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,635</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">427</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,561</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Depreciation provided during the year (note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,117</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,374</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,157</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(65,761</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Transfers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,802</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">368</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16,412</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Deficit on adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,982</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,982</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exchange realignment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">At December 31, 2025, net of accumulated depreciation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">676,985</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">31,953</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">69,790</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">397</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,110</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">781,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">At December 31, 2025:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">818,838</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,734</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">185,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,036</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,110</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,068,264</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(141,853</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,781</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(115,756</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(639</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(287,029</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">676,985</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">31,953</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">69,790</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">397</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,110</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">781,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net carrying amount in US$</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">96,808</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,569</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">9,980</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">302</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">111,715</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Schedule of Right-of-Use Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Group&#8217;s right-of-use assets and the movements during the year are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    land</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at January 1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,654</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,598</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,252</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,329</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,108</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-279; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,108</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,446</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation charge (note
    6)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,130</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,592</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,067</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-280; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,067</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(153</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange realignment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-281; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2024 and January 1, 2025</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,641</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,468</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,109</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,023</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-282; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">722</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation charge (note
    6)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,130</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,657</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,675</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,675</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(382</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange realignment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,489</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,338</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,827</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,839</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock', window );">Schedule of Lease Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of lease liabilities (included under interest-bearing bank and other borrowings) and the movements during the year are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying amount
    at January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,681</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,232</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,323</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New leases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,108</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">722</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion of interest recognized
    during the year (note 8)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,911</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,835</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,549</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange realignment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,152</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,360</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(481</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying
    amount at December 31</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,232</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,196</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,174</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analyzed into:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,283</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,041</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current
    portion</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,793</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,913</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,133</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory', window );">Schedule of Recognized in Profit or Loss</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts recognized in profit or loss in relation to leases are as follows:</span><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest on lease
    liabilities (note 8)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,498</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation charge of right-of-use
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,657</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,524</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense
    relating to short-term leases (included in administrative expenses) (note 6)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">329</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total amount recognized in
    profit or loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,870</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,104</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,731</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory', window );">Schedule of Goodwill</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -11pt; padding-left: 11pt">Cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">24,694</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">24,694</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,531</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated impairment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">24,694</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">24,694</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,531</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Intangible Asset (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OtherIntangibleAssetAbstract', window );"><strong>Other Intangible Asset [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock', window );">Schedule of Other Intangible Asset</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    at January 1, 2024, net of accumulated amortization</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,232</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,089</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,125</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,446</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,403</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,403</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    provided during the year (note 6)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,100</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,251</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,500</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,851</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,535</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,838</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,625</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,728</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,050</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,778</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,193</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(52,212</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,375</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(65,780</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    carrying amount</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,535</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,838</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,625</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    at January 1, 2025, net of accumulated amortization</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,535</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,838</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,625</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,998</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    provided during the year (note 6)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,262</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,300</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,500</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,062</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,273</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,538</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,125</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,936</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,728</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,050</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,778</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,455</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(59,512</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,875</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(75,842</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    carrying amount</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,273</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,538</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,125</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,936</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    carrying amount in US$</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,183</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,796</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,450</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,429</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other intangible assets explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OtherIntangibleAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OtherIntangibleAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in a Joint Venture (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesAbstract', window );"><strong>Investment in a Joint Venture [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock', window );">Schedule of Investment in a Joint Venture</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 64%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share of
    net assets</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,717</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,030</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,723</span></td>
    <td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock', window );">Schedule of Group&#8217;s Principal Joint Venture</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars
of the Group&#8217;s principal joint venture are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-indent: -22.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of registration and business</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registered share capital</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of ownership interest</b></span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal activities</b></span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suzhou Ascentage Harvest Venture Capital LLP* (&#8220;Ascentage Harvest&#8221;)</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">360,000</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.42</span></td> <td style="white-space: nowrap; vertical-align: top; width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%**</span></td> <td style="text-align: left; vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left; vertical-align: top; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in Biotechnology companies</span></td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English name of the company registered in the PRC represents the best efforts made by the management of the Company in directly translating the Chinese name of this Company as no English name has been registered.</span></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group holds two of three representatives in the committee that directs the relevant activities of Ascentage Harvest. As a result, the Group has significant influence over the financial and operating policy decisions of Ascentage Harvest.</span></td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock', window );">Schedule of Information of the Group&#8217;s Joint Venture</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table illustrates the summarized financial information of the Group&#8217;s joint venture:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            of the joint venture&#8217;s (loss)/gain for the year</span></p></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(281</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                 of the joint venture&#8217;s total comprehensive (loss)/gain for the year</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(281</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate carrying amount
    of the Group&#8217;s investment in the joint venture</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,717</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,030</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,723</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Group&#8217;s Principal Joint Venture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Information of the Group&#8217;s Joint Venture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Investment in a Joint Venture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Assets at Fair Value through Profit or Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract', window );"><strong>Financial Assets at Fair Value through Profit or Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory', window );">Schedule of Financial Assets at Fair Value through Profit or Loss</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listed
    equity investments, at fair value</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    unlisted investments, at fair value</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;4,000</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial assets at fair value through profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory', window );">Schedule of Movements in Deferred Tax Liabilities and Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
movements in deferred tax liabilities and assets during the reporting period are as follows:</span></p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value adjustments arising from acquisition of a subsidiary</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
    assets</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,549</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,413</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,962</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 9)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,181</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,300</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,881</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities at December 31, 2024 and January 1, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,368</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,081</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax charged/(credited) to the statement of profit or loss during the year (note 9)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,975</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,241</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">734</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities at December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,343</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,472</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,815</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liabilities at December 31, 2025 in US$</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,051</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">782</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,833</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfDeferredTaxAssetsExplanatory', window );">Schedule of Movements in Deferred Tax Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Deferred
tax assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
    liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donation
    expenses</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Losses
    Available<br/>
    for Offsetting<br/>
    Against<br/>
    Future<br/>
    Taxable<br/>
    profits</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,440</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,413</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,402</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,255</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,623</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,300</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,896</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,879</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,306</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets at December 31, 2024 and January 1, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,817</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,896</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,523</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,949</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,582</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,241</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,204</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,177</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets at December 31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,235</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,472</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,692</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,373</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,772</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax assets at December 31, 2025 in US$</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,609</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">782</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">242</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,769</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,402</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">The following
is an analysis of the deferred tax balances of the Group for financial reporting purposes:<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax offset in the consolidated statements of financial position</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,713</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,815</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,833</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    deferred tax assets recognized in the consolidated statements of financial position</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,236</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,957</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,570</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    deferred tax liability recognized in the consolidated statements of financial position</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,368</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure deferred tax assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfDeferredTaxAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfDeferredTaxAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for deferred tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Other Non-Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock', window );">Schedule of Other Non-Current Assets</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Contract acquisition costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">30,529</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">29,851</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,269</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Value added tax recoverable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,034</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">Deposit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,439</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">690</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Prepayment for property, plant and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">301</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">184</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">59,303</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">30,725</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,394</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of other non-current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory', window );">Schedule of Inventories</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work in progress</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,736</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,371</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,628</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,861</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,427</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    Provision</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,180</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(598</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,597</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,618</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,092</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The detailed information of inventories/.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade Receivables, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfTradeReceivablesNetTableTextBlock', window );">Schedule of Trade Receivables, Net</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade receivables, net</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,143</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252,938</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,170</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock', window );">Schedule of Based on the Invoice Date and Net of Loss Allowance</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
aging analysis of the trade receivables as at the end of the reporting period, based on the invoice date and net of loss allowance, is
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Within 45 days</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">54,484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">252,938</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">36,170</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">45 to 120 days</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,659</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">83,143</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">252,938</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">36,170</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for based on the invoice date and net of loss allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfTradeReceivablesNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of trade receivables, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfTradeReceivablesNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepayments, Other Receivables and Other Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract', window );"><strong>Prepayments, Other Receivables and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory', window );">Schedule of Prepayments, Other Receivables and Other Assets</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Prepayments for clinical trial expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">71,050</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100,769</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14,410</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Prepaid listing expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Value added tax recoverable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,794</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,748</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,685</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,455</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">208</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,367</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">309</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Prepayment for treasury share purchase fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,754</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,798</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,258</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other prepayments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,644</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,603</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,662</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">123,211</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">192,532</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">27,532</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other current assets. [Refer: Other current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Bank Balances (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashAndBankBalancesAbstract', window );"><strong>Cash and Bank Balances [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCashAndBankBalancesExplanatory', window );">Schedule of Cash and Bank Balances</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents as stated in the consolidated statements of cash flows</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">893,100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,195,784</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,995</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    cash</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,633</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,685</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">812</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time
    deposits with original maturity of more than three months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">343,478</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,268,616</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,410</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances as stated in the consolidated statements of financial position</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,261,211</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,470,085</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,217</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominated
    in:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">298,922</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">205,783</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,426</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">947,012</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,257,307</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">322,791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HK$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,812</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,827</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">547</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,465</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,168</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">453</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,261,211</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,470,085</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,217</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CashAndBankBalancesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CashAndBankBalancesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfCashAndBankBalancesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of cash and bank balances explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfCashAndBankBalancesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Payables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesAbstract', window );"><strong>Trade Payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfTradePayablesExplanatory', window );">Schedule of the Trade Payables</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
aging analysis of the trade payables as at the end of each reporting period, based on the invoice date, is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within 1 month</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,506</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,119</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,030</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 to 3 months</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,288</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,648</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">522</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 6 months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,172</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,973</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,712</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,740</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,264</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfTradePayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfTradePayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Payables and Accruals (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Other Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureofOtherPayablesAndAccrualsExplanatory', window );">Schedule of Other Payables and Accruals</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    promotion expenses</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,009</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121,545</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,381</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payroll
    payables</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,848</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,423</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,214</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payables
    for construction cost</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,888</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">842</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    payables-current portion (note 36)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,344</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,194</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities-current portion (note 36)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,968</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">281</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    payables</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,442</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,493</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
    subsidy</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,232</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    payables other than income tax</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,627</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,700</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,959</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    accrued expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,847</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,709</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">387</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">258,098</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">276,666</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,563</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureofOtherPayablesAndAccrualsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other payables and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureofOtherPayablesAndAccrualsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilitiesAbstract', window );"><strong>Contract Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfContractsLiabilitiesExplanatory', window );">Schedule of Contract Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of contract liabilities as at December 31, 2024 and 2025 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    at December 31,</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RMB</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term advances recognized
    from customers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
    rights income</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,485</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,360</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    advances recognized from customers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization
    rights income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248,460</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">210,224</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,062</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">285,945</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,709</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfContractsLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of contracts liabilities explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfContractsLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest-Bearing Bank and Other Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAbstract', window );"><strong>Interest-Bearing Bank and Other Borrowings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock', window );">Schedule of Interest-Bearing Bank and Other Borrowings</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective interest rate<br/> per annum (%)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term borrowing</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.60-2.70 or 1 year LPR-0.30 to 0.75</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.15 to 0.65 or 1 year LPR+0.65 to 0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,170</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80 - 4.55</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,453</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,439</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">779,062</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.45 to 0.65 or 1 year LPR+0.70 to 0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026 - 2028</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">203,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80-4.50</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026 - 2027</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026 - 2038</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">588,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026 - 2028</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,793</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; non-current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">889,435</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,668,497</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective interest rate<br/> per annum (%)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term borrowing</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11-2.50 or 1 year LPR-0.60 to 0.89</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,040,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,718</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long term bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.45 to 0.75</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156,200</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of long-term bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,359</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,283</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,041</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,222,481</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,812</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; font-weight: bold; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 year LPR-0.45 to 0.75</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027 &#8211; 2028</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,431</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; unsecured</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.80</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,750</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,256</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank loans &#8211; secured*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year LPR-0.85</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027 &#8211; 2038</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">583,675</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,464</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities (note 13(b))</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00 - 4.35</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027 &#8211; 2028</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,913</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,133</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total &#8211; non-current</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">757,238</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,284</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,979,719</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,096</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The bank loans amounting to RMB600,173 (US$85,823) as at December 31, 2025 were secured by the pledge of the Group&#8217;s buildings with a net carrying amount of RMB676,985 (US$96,808) and right-of-use assets with a net carrying amount of RMB25,338 (US$3,623) as at December 31, 2025. Such loans were also guaranteed by two of the Group&#8217;s subsidiaries.</span></p></td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock', window );">Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans</a></td>
<td class="text">The weighted average interest rate for the outstanding short-term bank loans
as of December 31, 2024 and 2025, was 2.63% and 2.18%, respectively.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analyzed into:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    one year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">779,062</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,222,481</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,812</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the second year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">242,473</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,201</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,908</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the third to fifth years, inclusive</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159,355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,034</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
    five years</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">487,607</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">456,937</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,668,497</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,979,719</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,096</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of  carrying amounts of borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Interest-Bearing Bank and Other Borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract', window );"><strong>Deferred Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfDeferredIncomeTableTextBlock', window );">Schedule of Deferred Income</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">929</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGovernmentGrantsExplanatory', window );">Schedule of Movements in Government Grants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
movements in government grants during the reporting period are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At beginning of
    the year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,360</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,932</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Received during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,740</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">143</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portion
    classified as current liabilities (note 25)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16,600</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,146</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At end
    of the year</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">929</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfDeferredIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of schedule of deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfDeferredIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGovernmentGrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for government grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS20_g39-39_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGovernmentGrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Treasury Shares (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Share Capital and Treasury Shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Schedule of Issued and Fully Paid</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
and fully paid</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
    shares in <br/>
    issue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB
    equivalent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares of US$0.0001 each</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,196,560</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
    shares in <br/>
    issue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB
    equivalent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares of US$0.0001 each</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,224,993</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">214</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31, 2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <br/>
    shares in <br/>
    issue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB
    equivalent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares of US$0.0001 each</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">373,321,692</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory', window );">Schedule of Share Capital and Treasury Shares</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif">Movements
in the issued share capital and treasury shares from January 1, 2023 to December 31, 2025 were as follows:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury
    shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2023</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,185,950</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,552</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,372</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ordinary shares
    (a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the Pre-IPO share option scheme (b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">911,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the 2021 RSU scheme (c)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,034</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus (d)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,528,514</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase of ordinary
    shares (e)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,923</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,923</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs (f)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,123</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,123</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023 and January 1, 2024</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,196,560</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,351</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ordinary shares
    (g)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,307,322</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the Pre-IPO share option scheme (h)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">656,077</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the 2021 RSU scheme (i)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,034</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus (j)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase of ordinary
    shares (k)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,959</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,959</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs (l)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,671</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,671</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2024 and
    January 1, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,224,993</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">214</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">206</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of ordinary shares
    (m)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,040,576</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the Pre-IPO share option scheme (n)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">455,263</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-335; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-336; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of shares under the 2021 RSU scheme and 2022 RSU scheme (o)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,008,253</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-337; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus (p)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,592,607</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-338; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-339; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-340; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase of ordinary
    shares (q)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-341; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-342; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,590</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,590</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs (r)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-343; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-344; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">637</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">637</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2025</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">373,321,692</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,961</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,705</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">373,321,692</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(423</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(386</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the share placement, 22,500,000 placing shares of the Company were issued and allotted at a price of HK$24.45 per share on February 1, 2023, and an amount of RMB15 was credited as share capital.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company before December 31, 2023 to those grantees. In connection with the exercised share options, 911,062 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB1 was credited as share capital.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2023 to those selected persons. In connection with the exercised RSUs, 71,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, 1,528,514 ordinary shares and 1,237,884 treasury shares, being underlying shares of the RSUs granted under the 2021 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB1 and RMB1 were credited as share capital and treasury shares, respectively.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the Company instructed the trustee to purchase 250,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB5,923 for the purpose of the 2022 RSU scheme.</span></td></tr> </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the exercise of RSUs granted under the 2018 and 2022 RSU Scheme, 1,069,461 treasury shares were allotted to the employees during the year ended December 31,2023.</span></td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, 24,307,322 placing shares of the Company were issued and allotted at a price of HK$24.10 per share on June 20, 2024, and an amount of RMB17 was credited as share capital.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2024, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 656,077 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.5 was credited as share capital.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2024, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2024 to those selected persons. In connection with the exercised RSUs, 65,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2024, 397,949 treasury shares and 2,081,399 treasury shares, being underlying shares of the RSUs granted under the 2022 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB8,630 and RMB1.4 were both credited as treasury shares.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2024, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB1,959 for the purpose of the 2022 RSU Scheme.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></td> <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of RSUs granted under the 2018 and 2022 RSU Schemes, 939,687 treasury shares were allotted to the employees during the year ended December 31, 2024.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="font-size: 10pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, 7,325,000 ADS (represents 29,300,000 of the Company&#8217;s ordinary shares) were offered at a price of US$17.25 per ADS on January 23, 2025, followed by an additional 935,144 ADS (represents 3,740,576 of the Company&#8217;s ordinary shares) were offered at the same price on February 13, 2025, and 22,000,000 placing shares of the Company were issued and allotted at a price of HK$68.6 per share on July 17, 2025, amounts of RMB40 (US$6) was credited as share capital.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2025, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 455,263 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.3 (US$0.04) was credited as share capital.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During June to September 2025, the Company issued ordinary shares with respect to the restricted share units under the 2021 and 2022 RSU Scheme exercised by certain selected persons of the Company before December 31, 2025 to those selected persons. In connection with the exercised restricted share units, 1,008,253 new shares of the Company were issued, and an amount of RMB0.7 (US$0.1) was credited as share capital.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2025, 775,685 ordinary shares and 816,922 ordinary shares, being underlying shares of the restricted share units granted under the 2021 RSU scheme and the 2022 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB0.5 (US$0.07) and RMB0.6 (US$0.09) credited as share capital.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2025, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB3,590 (US$513) for the purpose of the 2022 RSU scheme.</span></td></tr> <tr style="font-size: 8pt; vertical-align: top"> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td> <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of restricted share units granted under the 2022 RSU Scheme, 17,925 treasury shares were allotted to the employees during the year ended December 31, 2025.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of share capital and treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Classes of share capital [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract', window );"><strong>Share-Based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following share options were outstanding under the Pre-IPO share option scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise<br/>

price&#160;HK$ </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>per share</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number
of<br/>
 options</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise<br/>
price&#160;HK$ </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>per share</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/>
 options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Outstanding as of January 1</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,263,648</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,607,571</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Forfeited during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(81</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Exercised during the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.01</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(656,077</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.01</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(455,263</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">Outstanding as of December 31</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,607,571</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,152,227</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following share options were outstanding under the post-IPO share option scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 12pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 12pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-347; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">633,243</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised
    during the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-348; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December
    31</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">633,243</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory', window );">Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise prices and exercise periods of the share options outstanding as at the end of the reporting period are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
    <br/>
Number of<br/>
 options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price<br/>
 HK$<br/>
 per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    period</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,360,420</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 68%; text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aug
    15, 2018-Aug 15, 2028</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">232,719</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    15, 2019-May 15, 2029</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,432</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept
    16, 2019-Sept 16, 2029</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,607,571</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025<br/>

    Number of<br/>
 options</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price<br/>
 HK$<br/>
 per share</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    period</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,983,383</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 68%; text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">Aug 15, 2018&#8211;Aug 15, 2028</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159,712</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">May 15, 2019&#8211;May 15, 2029</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,132</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">Sept
    16, 2019-Sept 16, 2029</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,152,227</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025
    Number of options</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    period</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 31%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">633,243</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 31%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 30%; font-size: 10pt; text-align: center"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov
                                            26, 2025&#8211;Nov 26, 2035</span></p></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock', window );">Schedule of fair values of share options granted</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the share options granted was estimated as at the grant date by using the binary tree option pricing model. The following
table lists the key inputs to the fair value model used:</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">At grant dates</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Expected volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">49.65</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.09</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life of options (year)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Weighted average share price (HKD per share)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34.98</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfUnlockingDatetextBlock', window );">Schedule of Unlocking Date</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant fair<br/> value HK$ <br/> per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of <br/> conditional <br/> shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested <br/>
conditional shares</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2021-2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2021-2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2022&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2022&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2022&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2022&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant fair <br/>
value HK$ <br/>
per share</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of <br/>
conditional shares</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested<br/> conditional shares</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77.45</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 27, 2025</span></p></td><td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 17%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type of eligible participants</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant fair value HK$ per share</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>% of conditional shares</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting date</b></span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>% of vested conditional shares</b></span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2021-2024</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35%, 15%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="width: 31%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 9%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 9%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 23%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2023&#8211;2026</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2023&#8211;2026</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2023&#8211;2024</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%, 60%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 8, 2023&#8211;2025</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%, 30%, 40%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.15</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2023&#8211;2026</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23%, 69%, 6%, 2%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the unlocking date are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant <br/> fair value<br/> HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of<br/> conditional<br/> shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested conditional shares</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.8</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 1, 2023&#8211;2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%, 60%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 1, 2023&#8211;2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%, 30%, 40%</span></td></tr> </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Type of eligible participants</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Grant fair value HK$ per share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">% of conditional shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Vesting date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">% of vested conditional shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 20%; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">100%</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75%, 25%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%, 50%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%, 30%, 40%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.5%, 22.5%, 55%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%, 25%, 25</span><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">7</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2024-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 37%, 38</span><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">8</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">100%</span></td><td style="text-align: left"></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">9</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2025-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40%, 60</span><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.95</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">September 16, 2025-2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%, 50</span><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type of eligible participants</span></td> <td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant
fair<br/> value HK$<br/>
per&#160;share</span></td> <td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of <br/> conditional <br/> shares</span></td> <td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting date</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of vested<br/> conditional shares</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 17%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 26, 2026-2028</span></td> <td style="width: 1%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="white-space: nowrap; width: 19%; font-size: 10pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.33%, 33.33%, 33.34%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.35</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 26, 2026-2029</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%, 25%, 25%, 25%</span></td></tr> </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory', window );">Schedule of Restricted Shares Outstanding</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following restricted shares were outstanding under the 2021 RSU Scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024<br/>
    Number of<br/>
    RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025<br/>
    Number of<br/>
    RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,998</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,552</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">-</div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,412</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-350; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    during the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(65,034</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(89,991</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December
    31</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,552</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-351; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following restricted shares were outstanding under the 2022 RSU Scheme during the year:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024&#160;Number of&#160;RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025&#160;Number of&#160;RSUs</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of January 1</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,641,974</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,436,525</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">777,006</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,177,256</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited during the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(42,768</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(132,302</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    during the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(939,687</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(936,187</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December
    31</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,436,525</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,545,292</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfUnlockingDatetextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of unlocking date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfUnlockingDatetextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of fair values of share options granted [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the range of exercise prices for outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes to the Consolidated Statements of Cash Flows (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowHedgesAbstract', window );"><strong>Notes to the Consolidated Statements of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory', window );">Schedule of Changes in Liabilities Arising from Financing Activities</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in liabilities arising from financing activities</span><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other payables</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accruals</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other loans</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2023</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">383</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,775,505</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,222</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    from financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(91,027</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,591</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,766</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    leases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-356; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-357; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,194</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,690</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-358; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,321</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid classified as financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-359; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-360; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,321</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of change in foreign exchange rates</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-361; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-362; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,046</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,772,914</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,681</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other payables<br/> and accruals</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other loans</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,046</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,772,914</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,681</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    from financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(59,057</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(136,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,413</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    leases</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-363; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-364; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,108</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,152</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,279</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid classified as financing cash flows</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-365; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-366; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of change in foreign exchange rates</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-367; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-368; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,265</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,638,265</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,232</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other payables</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accruals</span></p></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other loans</span></p></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities</span></p></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January
    1, 2025</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,265</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,638,265</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,232</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    from financing cash flows</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50,190</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,980</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,717</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    leases</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-369; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-370; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,047</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-371; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-372; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,360</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,534</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,278</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    paid classified as financing cash flows</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-373; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-374; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,118</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of change in foreign exchange rates</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-375; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-376; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">609</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,957,523</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,196</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">279,922</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,174</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory', window );">Schedule of Cash Outflow for Leases Included In the Statement of Cash Flows</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total cash outflow for leases included in the statements of cash flows is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within operating
    activities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">329</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
    financing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,087</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,911</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,835</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,549</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,268</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,149</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,164</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,596</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The detailed information of cash outflows of lease included in cashflows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowHedgesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowHedgesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureofTransactionWithRelatedPartyExplanatory', window );">Schedule of Transaction with Related Party</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">T</span>ransaction
with a related party</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Dr. Zhai Yifan</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">29,533</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,223</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Dr. Yang Dajun</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,933</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">562</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">33,466</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,785</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory', window );">Schedule of Outstanding Balance with Related Party</a></td>
<td class="text">Outstanding balance with a related party<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Other payables and accruals</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">29,344</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,308</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,474</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,374</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">911</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total for Dr. Zhai Yifan</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">29,344</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">16,682</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,385</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">Schedule of Compensation of key Management Personnel</a></td>
<td class="text"><span style="font-size: 10pt">Compensation of key management
personnel of the Group:</span><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td colspan="16" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For
                                            the years ended December 31,</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>RMB</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>RMB</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>RMB</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: center"><b>US$</b></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Short term employee benefits and fees &#160; </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20,118</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">19,059</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">59,283</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,477</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Equity-settled share-based payment expenses &#160; </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,763</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">449</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Post-employment benefits &#160; </td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">986</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">977</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">711</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">102</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total &#160; </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,867</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">20,661</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">63,135</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">9,028</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of  outstanding balance with related party explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureofTransactionWithRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transaction with related party explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureofTransactionWithRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments by Category (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Financial Instruments by Category [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory', window );">Schedule of Categories of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The carrying amounts of each of the categories of financial
instruments as at the end of each reporting period are as follows:</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>assets at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>fair value </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>through </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>profit or </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>loss</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>assets at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>amortized </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>cost</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Financial assets included in prepayments, other receivables and other assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,846</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,846</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Cash and bank balances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,261,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,261,211</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,143</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Financial assets at FVTPL</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,141</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Financial assets included in other non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-393">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,141</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,356,639</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,357,780</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>fair value </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>through </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>profit or </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>loss</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>amortized </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>cost</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Interest-bearing bank and other borrowings (current and non-current portions)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,668,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,668,497</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">&#160;&#160;&#160;&#160;-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,966</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Financial liabilities included in other payables and accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,014</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,014</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Other non-current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,274</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,869,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,869,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/>
 assets at<br/>
 fair value<br/>
 through<br/>
 profit or<br/>
 loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial assets at amortized cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt">Financial assets included in prepayments, other receivables and other assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,609</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,609</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">516</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Cash and bank balances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,470,085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,470,085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">353,217</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">252,938</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">252,938</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,170</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Financial assets at FVTPL</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">572</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Financial assets included in other non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">690</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">690</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">99</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,727,322</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,731,322</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">390,574</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Financial liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>fair value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>through</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>profit or</b></p>

<p style="margin: 0pt 0"><b>loss</b></p>

</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>liabilities at amortized</b></p>

<p style="margin: 0pt 0"><b>cost</b></p>

</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">RMB</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">US$</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt">Interest-bearing bank and other borrowings (current and non-current portions)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,979,719</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,979,719</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">283,096</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,264</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Financial liabilities included in other payables and accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,968</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">138,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">140,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">20<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,084</span></div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,374</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,657</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,720</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">8,342</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,230,598</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,238,940</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">320,164</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35K<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35K&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value and Fair Value Hierarchy of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract', window );"><strong>Fair Value and Fair Value Hierarchy of Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory', window );">Schedule of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Group&#8217;s financial instruments, other than those with carrying amounts that reasonably approximate to fair
values, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="22" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Carrying
    amounts</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Fair
    values</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Financial assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial
    assets at FVTPL</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,141</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">572</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,141</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">572</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial
    assets included in other non-current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,439</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">99</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,311</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">624</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">89</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,580</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,690</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">671</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,624</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">661</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Financial liabilities
    included in other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-407; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,968</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">282</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-408; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,968</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">281</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Other non-current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,274</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,031</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,720</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,742</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,706</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Non-current
    portion of interest-bearing bank and other borrowings (other than lease liabilities)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">868,642</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">742,325</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">106,151</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">859,707</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">709,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">101,435</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">874,916</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">756,324</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">108,153</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">865,449</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">723,016</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">103,390</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory', window );">Schedule of Assets Measured at Fair Value</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">active</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">markets</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unobservable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at FVTPL</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-409; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-410; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2025</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 12pt Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">active</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">markets</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unobservable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets at FVTPL</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-411; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;-</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-412; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">572</span></td><td style="padding-bottom: 2.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2025</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prices in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">active</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">markets</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">observable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inputs</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities included in other payables and accruals</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-414; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,968</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,968</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">281</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-415; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-416; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,374</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,374</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">911</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>the disclosure of detailed information about fair value and fair value hierarchy of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value measurement of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureAbstract', window );"><strong>Financial Risk Management Objectives and Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfInterestRateRiskExplanatory', window );">Schedule of Interest Rate Risk</a></td>
<td class="text">This analysis does not include the effect
of interest capitalized.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease)</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in basis points</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease)</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in loss before tax</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,160</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,113</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,113</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfForeignCurrencyRiskExplanatory', window );">Schedule of Foreign Currency Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table demonstrates the sensitivity as at the end of each reporting period to a reasonably possible change in the US$ and HK$
exchange rates, with all other variables held constant, of the Group&#8217;s loss before tax and in other comprehensive income (without
tax) due to changes in the fair values of monetary assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease) in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rate</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease)</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in loss</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">before</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase/</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(decrease) in</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">comprehensive</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">income</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(without tax)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB weakens
    against US$</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(44</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,796</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB strengthens against
    US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56,796</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB weakens against US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(65</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124,210</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If RMB strengthens against
    US$</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(124,210</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureExplanatory', window );">Schedule of Maximum Exposure and Year-end Staging</a></td>
<td class="text">The amounts presented are gross carrying amounts for financial assets.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12-month ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lifetime ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage 1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage 2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage 3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simplified approach</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets included in prepayments, other receivables and other assets - Normal**</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,846</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-417; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: hidden-fact-418; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-419; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,846</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and bank balances - Not yet past due</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,261,211</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-420; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-421; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-422; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,261,211</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade receivables*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-423; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-424; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,143</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,143</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets included in other non-current assets - Normal**</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,439</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,439</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,273,496</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-429; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-430; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,143</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,356,639</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12-month
    ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lifetime
    ECLs</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
    1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
    2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stage
    3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simplified
    approach</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets included in prepayments, other receivables and other assets - Normal**</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,609</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-431; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-432; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-433; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,609</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">516</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances - Not yet past due</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,470,085</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-434; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-435; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-436; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,470,085</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">353,217</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    receivables*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-437; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-438; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-439; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252,938</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252,938</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,170</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets included in other non-current assets - Normal**</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-440; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-441; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-442; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">690</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,474,384</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: hidden-fact-443; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: hidden-fact-444; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252,938</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,727,322</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">390,002</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For trade receivables to which the Group applies the simplified approach for impairment, information based on provision matrix is disclosed in note 21 to the financial statements.</span></td>
</tr></table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit quality of the financial assets included in prepayments, other receivables and other assets and financial assets included in other non- current assets is considered to be &#8220;normal&#8221; when they are not past due and there is no information indicating that the financial assets had a significant increase in credit risk since initial recognition. Otherwise, the credit quality of the financial assets is considered to be &#8220;doubtful&#8221;.</span></td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfLiquidityRiskExplanatory', window );">Schedule of Liquidity Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maturity profile of the Group&#8217;s financial liabilities as at the end of the reporting period, based on the contractual undiscounted
payments, is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As at December 31, 2024</b></span></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    demand</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than<br/>
    1 year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    to 5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
    <br/>
    5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    payables</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-445; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,966</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-446; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-447; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,966</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-448; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,592</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-449; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,266</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest-bearing
    bank and other borrowings (excluding lease liabilities)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-450; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">813,610</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,765</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,079</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,831,454</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities included in other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,670</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,344</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-451; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-452; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,014</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-453; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-454; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,274</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-455; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,274</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,670</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">945,594</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">467,631</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,079</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,051,974</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As at December 31, 2025</b></span></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    demand</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1&#160;year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    to 5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
    <br/>
    5 years</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    payables</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-456; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,740</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-457; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-458; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,740</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,264</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-459; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,262</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,226</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-460; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,502</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest-bearing
    bank and other borrowings (excluding lease liabilities)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-461; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,255,814</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365,732</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">546,806</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,168,352</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">310,070</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    liabilities included in other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,142</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,308</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-462; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-463; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,450</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,084</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-464; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-465; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,031</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-466; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,031</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,720</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,142</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,381,124</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">393,989</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">546,806</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-467; font-family: Times New Roman, Times, Serif">2,<span style="font-size: 10pt">452,061</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,640</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfEquityPriceRiskExplanatory', window );">Schedule of Equity Price Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market equity index for the following stock exchange, at the close of business of the nearest trading day in the year to the end of the
reporting period, and its respective highest and lowest points during the year were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High/low</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High/low</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States&#8211;NASDAQ
    index</span></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,311</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,205/14,478</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-468; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-470"><span style="-sec-ix-hidden: hidden-fact-469; font-family: Times New Roman, Times, Serif; font-size: 10pt">-/-</span></div></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory', window );">Schedule of Carrying Amounts at the End of the Reporting Period</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table demonstrates the sensitivity to every 5% change in the fair values of the equity investments, with all other variables
held constant and before any impact on tax, based on their carrying amounts at the end of the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying<br/> amount of<br/> equity<br/> investments</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Decrease/<br/> (increase)<br/> in loss<br/> before tax</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments listed in:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ - Financial assets at fair value through profit or loss</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,141</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments listed in:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ - Financial assets at fair value through profit or loss</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-471; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-472; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ - Financial assets at fair value through profit or loss in USD</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-473; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-474; font-family: Times New Roman, Times, Serif">-<span style="font-size: 10pt">&#160;</span></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisclosureOfCapitalManagementExplanatory', window );">Schedule of Capital Management</a></td>
<td class="text">The gearing ratios as at the end of the reporting
periods were as follows:<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As at December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2025</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2025</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">RMB</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">RMB</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Interest-bearing bank and other borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,668,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,979,719</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">283,096</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,264</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financial liabilities included in other payables and accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,014</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">140,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,084</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other non-current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,031</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,720</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Cash and bank balances</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,261,211</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,470,085</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(353,217</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Net debt</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">608,540</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(231,145</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(33,053</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Equity attributable to owners of the parent</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">264,194</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,324,462</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">189,396</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Adjusted capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">264,194</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,324,462</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">189,396</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Capital and net debt</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">872,734</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,093,317</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">156,343</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Gearing ratio</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">70</td><td style="padding-bottom: 4pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-475; font-size: 10pt">NA&#160;</span></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-476; font-size: 10pt">NA&#160;</span></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfCapitalManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The detailed information of capital management.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfCapitalManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amounts at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfEquityPriceRiskExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The detailed information of equity price risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfEquityPriceRiskExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfForeignCurrencyRiskExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The detailed information of foreign currency risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfForeignCurrencyRiskExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisclosureOfInterestRateRiskExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The detailed information of interest rate risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisclosureOfInterestRateRiskExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExposureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExposureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExposureExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the credit risk exposure. Credit risk exposure is the credit risk inherent in an entity&#8217;s financial assets and commitments to extend credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExposureExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLiquidityRiskExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of liquidity risk. [Refer: Liquidity risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLiquidityRiskExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of the Company (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information of the Company [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Schedule of Statements of Financial Position</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
of financial position of the Company</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    at December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in
    subsidiaries</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">380,339</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">448,431</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,125</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    non-current Asset</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,529</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,851</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,269</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    non-current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">410,868</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">478,282</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,394</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments, other receivables
    and other assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,986,172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,806,759</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">687,358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and bank balances</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470,170</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,841,572</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">263,341</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,456,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,648,331</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">950,699</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT LIABILITIES</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other payables and accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,187</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,382</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">341</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,187</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,382</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">341</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    CURRENT ASSETS</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,432,155</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,645,949</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">950,358</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    ASSETS LESS CURRENT LIABILITIES</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,843,023</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,124,231</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,018,752</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,843,023</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,124,231</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,018,752</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share capital</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">214</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,961</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(423</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital and reserves</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,652,916</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,011,879</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,145,683</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange fluctuation reserve</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,598</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(40,959</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,857</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    losses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(918,697</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(843,984</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,688</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    equity</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,843,023</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,124,231</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,018,752</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock', window );">Schedule of Condensed Statements of Comprehensive Income</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
statements of comprehensive income</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income and
    gains</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,597</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,925</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,560</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,666</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,118</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,983</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,975</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24,741</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,585</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    BEFORE TAX</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,684</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS
    FOR THE YEAR</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,684</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,629</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,715</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(149,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,386</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -11pt; padding-left: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    COMPREHENSIVE INCOME FOR THE YEAR</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,367</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,072</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(74,844</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,702</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock', window );">Schedule of Condensed Statements of Cash Flows</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
statements of cash flows</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            cash generated from(used in) operating activities</span></p></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,727</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41,686</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,427</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,650</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash used in investing
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(535,395</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(589,153</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,850,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(264,604</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                 cash generated from financing activities</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">464,166</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">531,922</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,229,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of foreign exchange rate changes, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,581</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,311</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56,093</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,021</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            (decrease)/increase in cash and cash equivalents</span></p></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(59,921</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(89,606</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446,265</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,815</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfReservesTableTextBlock', window );">Schedule of Company&#8217;s Reserves</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the Company&#8217;s reserves is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    and<br/> reserves</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange<br/>
    Fluctuation<br/> reserve</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated<br/>
    losses</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RMB</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 52%; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    January 1, 2023</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,526,096</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43,746</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(890,792</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,591,558</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-477; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-478; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-479; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,629</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-480; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,629</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive income for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-481; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,629</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,262</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,367</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470,066</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-482; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-483; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470,066</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Employees
    share-based compensation scheme</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Pre-IPO
    share option expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,750</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-484; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-485; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,750</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,753</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-486; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-487; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,753</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-488; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-489; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,123</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-490; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-491; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,123</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,466</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-492; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-493; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,466</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023 and January 1, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,072,015</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,883</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(905,054</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,207,844</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-494; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-495; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-496; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,715</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-497; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,715</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive income for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-498; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,715</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,643</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,072</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">533,923</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-499; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-500; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">533,923</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
    share-based compensation scheme</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,924</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-501; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-502; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,924</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-503; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-504; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,671</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-505; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-506; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,671</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,719</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-507; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-508; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,719</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024 and January 1, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,652,916</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,598</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(918,697</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,842,817</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-509; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-510; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive income for the year:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
    differences on translation of the Company</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-511; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(149,557</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-512; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(149,557</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    comprehensive income for the year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-513; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(149,557</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,713</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(74,844</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    of ordinary shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,279,855</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-514; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-515; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,279,855</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Employees
    share-based compensation scheme</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Post-IPO
    share option expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,420</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-516; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-517; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,420</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,454</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-518; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-519; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,454</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-IPO share options</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-520; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-521; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of RSUs</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(638</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-522; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-523; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(638</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity-settled
    bonus</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,868</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-524; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-525; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,868</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,011,879</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(40,959</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(843,984</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,126,936</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2025 in US$</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,145,683</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,857</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,688</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,019,138</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfReservesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfReservesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedStatementOfComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Corporate and Group Information - Schedule of Principal Subsidiaries (Details) - 12 months ended Dec. 31, 2025<br> &#165; in Thousands</strong></div></th>
<th class="th"><div>CNY (&#165;)</div></th>
<th class="th"><div>USD ($)</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_SuzhouAscentagePharmaCoLtdMember', window );">Suzhou Ascentage Pharma Co., Ltd. (&#8220;Suzhou Yasheng&#8221;) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Principal Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Place and date of incorporation/&#8203; registration and place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">PRC/Chinese mainland June 1, 2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapitalOrdinaryShares', window );">Nominal value of issued/&#8203;registered share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">&#165; 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect', window );">Percentage of equity interests attributable to the Company Direct</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage of equity interests attributable to the Company Indirect</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">Medical research and development<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_GuangzhouHealthquestPharmaCoLtdMember', window );">Guangzhou Healthquest Pharma Co., Ltd. (&#8220;Healthquest Pharma&#8221;) [Member ]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Principal Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Place and date of incorporation/&#8203; registration and place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">PRC/Chinese mainland July 3, 2012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapitalOrdinaryShares', window );">Nominal value of issued/&#8203;registered share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">&#165; 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect', window );">Percentage of equity interests attributable to the Company Direct</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage of equity interests attributable to the Company Indirect</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">Clinical development and sale of products<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_AscentagePharmaGroupIncMember', window );">Ascentage Pharma Group Inc. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Principal Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Place and date of incorporation/&#8203; registration and place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United States of America  (&#8220;United States&#8221;)  November 4, 2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapitalOrdinaryShares', window );">Nominal value of issued/&#8203;registered share capital | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect', window );">Percentage of equity interests attributable to the Company Direct</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage of equity interests attributable to the Company Indirect</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Clinical trials<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember', window );">Suzhou Shenghe Innovation Works Biotech Co., Ltd. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Principal Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Place and date of incorporation/&#8203; registration and place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">PRC/Chinese mainland September 21, 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapitalOrdinaryShares', window );">Nominal value of issued/&#8203;registered share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">&#165; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect', window );">Percentage of equity interests attributable to the Company Direct</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage of equity interests attributable to the Company Indirect</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">Rental of buildings to group companies<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English names of the companies registered in the PRC represent the best efforts made by the management of the Company in directly translating the Chinese names of these companies as no English names have been registered.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These entities are limited liability companies established in the PRC.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity interests attributable to the company direct.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The country in which a subsidiary of the entity is incorporated. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapitalOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapitalOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The principal place of business of a subsidiary. [Refer: Principal place of business; Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_SuzhouAscentagePharmaCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_SuzhouAscentagePharmaCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_GuangzhouHealthquestPharmaCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_GuangzhouHealthquestPharmaCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_AscentagePharmaGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_AscentagePharmaGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OtherEmployeeBenefitContributionPercentage', window );">Employee contribution percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AnnualBaseSalaryPercentage', window );">Annual base salary rate</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AnnualBaseSalaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of annual base salary .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AnnualBaseSalaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OtherEmployeeBenefitContributionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Other Employee Benefit Contribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OtherEmployeeBenefitContributionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies - Schedule of New and Revised IFRSs (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=aapg_IFRSEighteenMember', window );">IFRS 18 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Schedule of New and Revised IFRSs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">New and revised IFRS codification, description</a></td>
<td class="text">Presentation and Disclosure in Financial Statements2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=aapg_IFRSNineteenMember', window );">IFRS 19 and its amendments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Schedule of New and Revised IFRSs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">New and revised IFRS codification, description</a></td>
<td class="text">Subsidiaries without Public Accountability: Disclosures2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIFRSNineAndIFRSSevenMember', window );">Amendments to IFRS 9 and IFRS 7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Schedule of New and Revised IFRSs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">New and revised IFRS codification, description</a></td>
<td class="text">Amendments to the Classification and Measurement of Financial Instruments1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember', window );">Amendments to IFRS 9 and IFRS 7 One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Schedule of New and Revised IFRSs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">New and revised IFRS codification, description</a></td>
<td class="text">Contracts Referencing Nature-dependent Electricity1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember', window );">Amendments to IFRS 10 and IAS 28 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Schedule of New and Revised IFRSs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">New and revised IFRS codification, description</a></td>
<td class="text">Sale or Contribution of Assets between an Investor and its Associate or Joint Venture3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIASTwentyOneMember', window );">Amendments to IAS 21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Schedule of New and Revised IFRSs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">New and revised IFRS codification, description</a></td>
<td class="text">Translation to a Hyperinflationary Presentation Currency2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=aapg_AccountingStandardsVolume11Member', window );">Annual Improvements to IFRS Accounting Standards &#8211; Volume 11 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Schedule of New and Revised IFRSs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">New and revised IFRS codification, description</a></td>
<td class="text">Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 71<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">Effective for annual/reporting periods beginning on or after January 1, 2027</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">Effective for annual periods beginning on or after January 1, 2026</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No mandatory effective date yet determined but available for adoption</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TitleOfNewIFRS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 181<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_181_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 181<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_181_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TitleOfNewIFRS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=aapg_IFRSEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=aapg_IFRSEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=aapg_IFRSNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=aapg_IFRSNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIFRSNineAndIFRSSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIFRSNineAndIFRSSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIASTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=aapg_AmendmentsToIASTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=aapg_AccountingStandardsVolume11Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=aapg_AccountingStandardsVolume11Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies - Schedule of Property, Plant and Equipment of Annual Rates (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment of Annual Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Property, plant and equipment, rates</a></td>
<td class="nump">4.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment of Annual Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Property, plant and equipment, rates</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment of Annual Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Property, plant and equipment, rates</a></td>
<td class="nump">33.33%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aapg_FurnitureAndEquipmentMember', window );">Furniture and equipment [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment of Annual Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Property, plant and equipment, rates</a></td>
<td class="nump">9.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aapg_FurnitureAndEquipmentMember', window );">Furniture and equipment [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment of Annual Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Property, plant and equipment, rates</a></td>
<td class="nump">31.67%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment of Annual Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Property, plant and equipment, rates</a></td>
<td class="nump">23.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The depreciation rate used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRatePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aapg_FurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aapg_FurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies - Schedule of Intangible Assets are Amortized on the Straight-Line Basis (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets are Amortized on the Straight-Line Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Intangible assets are amortized useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets are Amortized on the Straight-Line Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Intangible assets are amortized useful life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember', window );">Patent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets are Amortized on the Straight-Line Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Intangible assets are amortized useful life</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">License [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets are Amortized on the Straight-Line Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Intangible assets are amortized useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies - Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=aapg_LeaseholdLandMember', window );">Leasehold land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems', window );"><strong>Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RightofuseAssetsOfEstimatedUsefulLives', window );">Right-of-use assets of estimated useful lives</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_BuildingsMember', window );">Buildings [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems', window );"><strong>Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RightofuseAssetsOfEstimatedUsefulLives', window );">Right-of-use assets of estimated useful lives</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_BuildingsMember', window );">Buildings [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems', window );"><strong>Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RightofuseAssetsOfEstimatedUsefulLives', window );">Right-of-use assets of estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_RightofuseAssetsOfEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets of estimated useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_RightofuseAssetsOfEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=aapg_LeaseholdLandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=aapg_LeaseholdLandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Judgements and Estimates (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Significant Accounting Judgements and Estimates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax losses</a></td>
<td class="nump">&#165; 163,913<span></span>
</td>
<td class="nump">$ 23,438<span></span>
</td>
<td class="nump">&#165; 68,580<span></span>
</td>
<td class="nump">&#165; 237,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">44,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Unrecognised deferred tax assets</a></td>
<td class="nump">31,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember', window );">Unused tax losses [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Significant Accounting Judgements and Estimates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">12,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,769<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncomeTaxesAxis=aapg_TaxesMember', window );">Taxes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Significant Accounting Judgements and Estimates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax losses</a></td>
<td class="nump">5,347,045<span></span>
</td>
<td class="nump">$ 764,617<span></span>
</td>
<td class="nump">4,425,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Unrecognised deferred tax assets</a></td>
<td class="nump">&#165; 1,572,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1,321,638<span></span>
</td>
<td class="nump">&#165; 1,119,913<span></span>
</td>
<td class="nump">$ 224,889<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IncomeTaxesAxis=aapg_TaxesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IncomeTaxesAxis=aapg_TaxesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Segment Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Operating Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments', window );">Number of reportable operating segment</a></td>
<td class="text">one<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the factors used to identify the entity's reportable segments, including the basis of organisation (for example, whether management has chosen to organise the entity around differences in products and services, geographical areas, regulatory environments or a combination of factors and whether operating segments have been aggregated). [Refer: Geographical areas [domain]; Operating segments [member]; Products and services [domain]; Reportable segments [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 22<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_22_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Segment Information - &#8203;Schedule of Revenue (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems', window );"><strong>&#8203;Schedule of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">&#165; 574,120<span></span>
</td>
<td class="nump">$ 82,098<span></span>
</td>
<td class="nump">&#165; 980,650<span></span>
</td>
<td class="nump">&#165; 221,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=aapg_ChineseMainlandMember', window );">Chinese mainland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems', window );"><strong>&#8203;Schedule of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">574,120<span></span>
</td>
<td class="nump">82,098<span></span>
</td>
<td class="nump">302,235<span></span>
</td>
<td class="nump">221,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">Switzerland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems', window );"><strong>&#8203;Schedule of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">&#165; 678,415<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=aapg_ChineseMainlandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=aapg_ChineseMainlandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Segment Information - &#8203;Schedule of Non-Current Assets (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems', window );"><strong>&#8203;Schedule of Non-Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Total non-current assets</a></td>
<td class="nump">&#165; 982,757<span></span>
</td>
<td class="nump">$ 140,532<span></span>
</td>
<td class="nump">&#165; 1,095,832<span></span>
</td>
<td class="nump">&#165; 1,091,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=aapg_ChineseMainlandMember', window );">Chinese mainland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems', window );"><strong>&#8203;Schedule of Non-Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Total non-current assets</a></td>
<td class="nump">978,233<span></span>
</td>
<td class="nump">139,885<span></span>
</td>
<td class="nump">1,090,914<span></span>
</td>
<td class="nump">1,088,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems', window );"><strong>&#8203;Schedule of Non-Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Total non-current assets</a></td>
<td class="nump">4,489<span></span>
</td>
<td class="nump">642<span></span>
</td>
<td class="nump">4,474<span></span>
</td>
<td class="nump">2,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=aapg_OthersMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems', window );"><strong>&#8203;Schedule of Non-Current Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Total non-current assets</a></td>
<td class="nump">&#165; 35<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">&#165; 444<span></span>
</td>
<td class="nump">&#165; 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=aapg_ChineseMainlandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=aapg_ChineseMainlandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=aapg_OthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=aapg_OthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Segment Information - Schedule of Revenue from Customers (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems', window );"><strong>Schedule of Revenue from Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from customers</a></td>
<td class="nump">&#165; 436,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 62,439<span></span>
</td>
<td class="nump">&#165; 908,310<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#165; 172,967<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=aapg_CustomerAMember', window );">Customer A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems', window );"><strong>Schedule of Revenue from Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from customers</a></td>
<td class="nump">436,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">62,439<span></span>
</td>
<td class="nump">229,895<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">107,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=aapg_CustomerBMember', window );">Customer B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems', window );"><strong>Schedule of Revenue from Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">678,415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=aapg_CustomerCMember', window );">Customer C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems', window );"><strong>Schedule of Revenue from Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=aapg_CustomerDMember', window );">Customer D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems', window );"><strong>Schedule of Revenue from Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#165; 30,623<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These customers generated less than 10% of the total revenue of the Group during the years ended December 31, 2023, 2024 and 2025.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=aapg_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=aapg_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=aapg_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=aapg_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=aapg_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=aapg_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=aapg_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=aapg_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Other Income and Gains - &#8203;Schedule of Disaggregated Revenue (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">&#165; 574,120<span></span>
</td>
<td class="nump">$ 82,098<span></span>
</td>
<td class="nump">&#165; 980,650<span></span>
</td>
<td class="nump">&#165; 221,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aapg_ProductsMember', window );">Sales of products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">499,272<span></span>
</td>
<td class="nump">71,395<span></span>
</td>
<td class="nump">260,835<span></span>
</td>
<td class="nump">193,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aapg_OthersMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">74,848<span></span>
</td>
<td class="nump">10,703<span></span>
</td>
<td class="nump">41,400<span></span>
</td>
<td class="nump">28,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aapg_TypesOfGoodsOrServicesMember', window );">Types of goods or services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">574,120<span></span>
</td>
<td class="nump">82,098<span></span>
</td>
<td class="nump">980,650<span></span>
</td>
<td class="nump">221,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=aapg_TypesOfGoodsOrServicesMember', window );">Types of goods or services [Member] | Intellectual property income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">678,415<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=aapg_TypesOfGoodsOrServicesMember', window );">Types of goods or services [Member] | Sales of products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">499,272<span></span>
</td>
<td class="nump">71,395<span></span>
</td>
<td class="nump">260,835<span></span>
</td>
<td class="nump">193,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=aapg_TypesOfGoodsOrServicesMember', window );">Types of goods or services [Member] | Commercialization rights income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">72,629<span></span>
</td>
<td class="nump">10,386<span></span>
</td>
<td class="nump">37,485<span></span>
</td>
<td class="nump">26,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=aapg_TypesOfGoodsOrServicesMember', window );">Types of goods or services [Member] | Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">2,219<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">3,915<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember', window );">At a point in time [Member] | Intellectual property income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">678,415<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember', window );">At a point in time [Member] | Sales of products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">499,272<span></span>
</td>
<td class="nump">71,395<span></span>
</td>
<td class="nump">260,835<span></span>
</td>
<td class="nump">193,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember', window );">At a point in time [Member] | Commercialization rights income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">35,144<span></span>
</td>
<td class="nump">5,026<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember', window );">Timing of revenue recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">574,120<span></span>
</td>
<td class="nump">82,098<span></span>
</td>
<td class="nump">980,650<span></span>
</td>
<td class="nump">221,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember', window );">Timing of revenue recognition | Commercialization rights income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">37,485<span></span>
</td>
<td class="nump">5,360<span></span>
</td>
<td class="nump">37,485<span></span>
</td>
<td class="nump">26,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember', window );">Timing of revenue recognition | Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Disaggregated Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Disaggregated revenue</a></td>
<td class="nump">&#165; 2,219<span></span>
</td>
<td class="nump">$ 317<span></span>
</td>
<td class="nump">&#165; 3,915<span></span>
</td>
<td class="nump">&#165; 2,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aapg_ProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aapg_ProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aapg_OthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aapg_OthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aapg_TypesOfGoodsOrServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aapg_TypesOfGoodsOrServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=aapg_TypesOfGoodsOrServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=aapg_TypesOfGoodsOrServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aapg_IntellectualPropertyIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aapg_IntellectualPropertyIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aapg_CommercializationRightsIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aapg_CommercializationRightsIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Other Income and Gains - &#8203;Schedule of Contract Liabilities (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>&#8203;Schedule of Contract Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod', window );">Commercialization rights income</a></td>
<td class="nump">&#165; 37,485<span></span>
</td>
<td class="nump">$ 5,360<span></span>
</td>
<td class="nump">&#165; 37,485<span></span>
</td>
<td class="nump">&#165; 26,049<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 116<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_116_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Amounts expected to be recognized as revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Recognized as revenue</a></td>
<td class="nump">&#165; 247,709<span></span>
</td>
<td class="nump">$ 35,422<span></span>
</td>
<td class="nump">&#165; 285,945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Within one year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Amounts expected to be recognized as revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Recognized as revenue</a></td>
<td class="nump">37,485<span></span>
</td>
<td class="nump">5,360<span></span>
</td>
<td class="nump">37,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember', window );">After one year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Amounts expected to be recognized as revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Recognized as revenue</a></td>
<td class="nump">&#165; 210,224<span></span>
</td>
<td class="nump">$ 30,062<span></span>
</td>
<td class="nump">&#165; 248,460<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 108<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_108_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 108<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_108_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Other Income and Gains - Schedule of Other Income and Gains (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Schedule of Other Income and Gains [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks', window );">Bank interest income</a></td>
<td class="nump">&#165; 82,125<span></span>
</td>
<td class="nump">$ 11,744<span></span>
</td>
<td class="nump">&#165; 37,840<span></span>
</td>
<td class="nump">&#165; 32,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants related to income</a></td>
<td class="nump">14,496<span></span>
</td>
<td class="nump">2,073<span></span>
</td>
<td class="nump">9,073<span></span>
</td>
<td class="nump">19,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain, net</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,694<span></span>
</td>
<td class="nump">1,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RentalIncome', window );">Rental income</a></td>
<td class="nump">4,989<span></span>
</td>
<td class="nump">713<span></span>
</td>
<td class="nump">2,324<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives', window );">Fair value gain on derivative financial instruments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment', window );">Gain on disposal of items of property, plant and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Others</a></td>
<td class="nump">1,885<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
<td class="nump">2,702<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Total other income and gains</a></td>
<td class="nump">&#165; 103,495<span></span>
</td>
<td class="nump">$ 14,800<span></span>
</td>
<td class="nump">&#165; 57,359<span></span>
</td>
<td class="nump">&#165; 59,316<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2025-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RentalIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RentalIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Loss Before Tax - Schedule of Loss Before Tax (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfLossBeforeTaxAbstract', window );"><strong>Schedule of Loss Before Tax [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod', window );">Cost of inventories sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 42,481<span></span>
</td>
<td class="nump">$ 6,074<span></span>
</td>
<td class="nump">&#165; 27,031<span></span>
</td>
<td class="nump">&#165; 29,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSalesRoomOccupancyServices', window );">Cost of services provided</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,277<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">2,054<span></span>
</td>
<td class="nump">1,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryWritedown2011', window );">Write-down of inventories to net realizable value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,180<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">65,761<span></span>
</td>
<td class="nump">9,404<span></span>
</td>
<td class="nump">71,184<span></span>
</td>
<td class="nump">55,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty', window );">Depreciation of investment property</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation of right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">10,657<span></span>
</td>
<td class="nump">1,524<span></span>
</td>
<td class="nump">11,134<span></span>
</td>
<td class="nump">11,632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">10,062<span></span>
</td>
<td class="nump">1,439<span></span>
</td>
<td class="nump">10,851<span></span>
</td>
<td class="nump">10,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,137,448<span></span>
</td>
<td class="nump">162,653<span></span>
</td>
<td class="nump">947,245<span></span>
</td>
<td class="nump">706,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Wages and salaries</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">404,195<span></span>
</td>
<td class="nump">57,799<span></span>
</td>
<td class="nump">367,008<span></span>
</td>
<td class="nump">337,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Equity-settled share-based payment expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">20,874<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
<td class="nump">20,924<span></span>
</td>
<td class="nump">31,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans', window );">Pension scheme contributions (defined contribution scheme)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">35,234<span></span>
</td>
<td class="nump">5,038<span></span>
</td>
<td class="nump">34,404<span></span>
</td>
<td class="nump">30,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_LossBeforeTaxArrivedCharingOrCrediting', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">460,303<span></span>
</td>
<td class="nump">65,822<span></span>
</td>
<td class="nump">422,336<span></span>
</td>
<td class="nump">399,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives', window );">Derivative financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,822)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialAssetsAtFVTPL', window );">Financial assets at FVTPL</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">832<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialLiabilitiesAtFVTPL', window );">Financial liabilities at FVTPL</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,533<span></span>
</td>
<td class="nump">4,223<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment', window );">(Gain)/Loss on disposal of items of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AdjustmentsForGainOnDisposalOfLeases', window );">Gain on disposal of items of lease</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(685)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PenaltyExpense', window );">Lease payments not included in the measurement of lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">329<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants related to income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,496)<span></span>
</td>
<td class="num">(2,073)<span></span>
</td>
<td class="num">(9,073)<span></span>
</td>
<td class="num">(19,358)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks', window );">Bank interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(82,125)<span></span>
</td>
<td class="num">(11,744)<span></span>
</td>
<td class="num">(37,840)<span></span>
</td>
<td class="num">(32,409)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemuneration', window );">Auditors&#8217; remuneration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,100<span></span>
</td>
<td class="nump">729<span></span>
</td>
<td class="nump">7,900<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DonationsAndSubsidiesExpense', window );">Donations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,395<span></span>
</td>
<td class="nump">3,345<span></span>
</td>
<td class="nump">6,322<span></span>
</td>
<td class="nump">3,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_Penaltys', window );">Penalty</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,777<span></span>
</td>
<td class="nump">826<span></span>
</td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains', window );">Foreign exchange (gain)/loss, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 10,161<span></span>
</td>
<td class="nump">$ 1,453<span></span>
</td>
<td class="num">&#165; (6,694)<span></span>
</td>
<td class="num">&#165; (1,621)<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The depreciation of property, plant and equipment, the depreciation of investment property, the depreciation of right-of-use assets, the amortization of intangible assets and the equity-settled share-based payment expenses for the years are included in &#8220;Cost of Sales&#8221;, &#8220;Research and development expenses&#8221;, &#8220;Selling and distribution expenses&#8221; and &#8220;Administrative expenses&#8221; in the consolidated statements of profit or loss.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no forfeited contributions that may be used by the Group as the employer to reduce the existing level of contributions.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AdjustmentsForGainOnDisposalOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on disposals of leases in the scope of IFRS 9 to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AdjustmentsForGainOnDisposalOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FinancialAssetsAtFVTPL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets at FVTPL.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FinancialAssetsAtFVTPL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FinancialLiabilitiesAtFVTPL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities at FVTPL .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FinancialLiabilitiesAtFVTPL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_LossBeforeTaxArrivedCharingOrCrediting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents total amount of expenses before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_LossBeforeTaxArrivedCharingOrCrediting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PenaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of penalty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PenaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_Penaltys">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents amount of penalty to expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_Penaltys</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfLossBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfLossBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemuneration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemuneration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSalesRoomOccupancyServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSalesRoomOccupancyServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DonationsAndSubsidiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DonationsAndSubsidiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryWritedown2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryWritedown2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 203<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_203&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 203<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_203&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 9<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expenses - Schedule of Other Expenses (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfOtherExpensesAbstract', window );"><strong>Schedule of Other Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Fair value loss on financial liabilities at FVTPL</a></td>
<td class="nump">&#165; 29,533<span></span>
</td>
<td class="nump">$ 4,223<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DonationsAndSubsidiesExpense', window );">Donations</a></td>
<td class="nump">23,395<span></span>
</td>
<td class="nump">3,345<span></span>
</td>
<td class="nump">6,322<span></span>
</td>
<td class="nump">3,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ForeignExchangeLoss', window );">Foreign exchange loss</a></td>
<td class="nump">10,161<span></span>
</td>
<td class="nump">1,453<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_Penalty', window );">Penalty</a></td>
<td class="nump">5,777<span></span>
</td>
<td class="nump">827<span></span>
</td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss', window );">Fair value loss on financial assets at FVTPL</a></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">832<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment', window );">Loss on disposal of items of property, plant and equipment</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OthersExpenses', window );">Others</a></td>
<td class="nump">3,581<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByNature', window );">Total</a></td>
<td class="nump">&#165; 73,599<span></span>
</td>
<td class="nump">$ 10,525<span></span>
</td>
<td class="nump">&#165; 9,075<span></span>
</td>
<td class="nump">&#165; 5,203<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OthersExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of others expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OthersExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_Penalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of penalty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_Penalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfOtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfOtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in financial assets measured at fair value through profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Financial assets; Financial assets at fair value through profit or loss; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DonationsAndSubsidiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DonationsAndSubsidiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2025-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on financial liabilities at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_56_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_56_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance Costs - Schedule of Finance Costs (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfFinanceCostsAbstract', window );"><strong>Schedule of Finance Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts', window );">Interest on bank loans and other borrowings</a></td>
<td class="nump">&#165; 51,812<span></span>
</td>
<td class="nump">$ 7,409<span></span>
</td>
<td class="nump">&#165; 61,555<span></span>
</td>
<td class="nump">&#165; 91,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestCostsCapitalised', window );">Interest on lease liabilities</a></td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">1,498<span></span>
</td>
<td class="nump">1,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBorrowings', window );">Interest on long-term payables</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">3,046<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Total</a></td>
<td class="nump">&#165; 54,070<span></span>
</td>
<td class="nump">$ 7,732<span></span>
</td>
<td class="nump">&#165; 64,455<span></span>
</td>
<td class="nump">&#165; 96,057<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfFinanceCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfFinanceCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestCostsCapitalised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestCostsCapitalised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBankLoansAndOverdrafts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Income tax rate</a></td>
<td class="nump">16.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_WithholdingTax', window );">Withholding tax</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_HighAndNewTechnologyEnterpriseMember', window );">High and New Technology Enterprise [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Income tax rate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PreferentialRate', window );">Preferential tax rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_HK', window );">Hong Kong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Income tax rate</a></td>
<td class="nump">21.61%<span></span>
</td>
<td class="nump">21.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=aapg_ChineseMainlandMember', window );">Chinese Mainland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Income tax rate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=aapg_SuzhouYashengMember', window );">Suzhou Yasheng [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PreferentialRate', window );">Preferential tax rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PreferentialRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferential rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PreferentialRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_WithholdingTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Withholding tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_WithholdingTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_HighAndNewTechnologyEnterpriseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_HighAndNewTechnologyEnterpriseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=aapg_ChineseMainlandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=aapg_ChineseMainlandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=aapg_SuzhouYashengMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=aapg_SuzhouYashengMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax  - Schedule of Current and Deferred Components of the Income Tax (Credit)/Expense (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract', window );"><strong>Schedule of Current and Deferred Components of the Income Tax Expense/(Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current</a></td>
<td class="nump">&#165; 29<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred (note 18)</a></td>
<td class="nump">6,911<span></span>
</td>
<td class="nump">988<span></span>
</td>
<td class="nump">10,425<span></span>
</td>
<td class="num">(7,150)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax credit/(expense)</a></td>
<td class="nump">&#165; 6,940<span></span>
</td>
<td class="nump">$ 992<span></span>
</td>
<td class="nump">&#165; 10,425<span></span>
</td>
<td class="num">&#165; (7,150)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax  - Schedule of Reconciliation between the Income Tax Expense/(Credit) (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract', window );"><strong>Schedule of Reconciliation between the Income Tax Expense/(Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before tax</a></td>
<td class="num">&#165; (1,236,047)<span></span>
</td>
<td class="num">$ (176,753)<span></span>
</td>
<td class="num">&#165; (395,255)<span></span>
</td>
<td class="num">&#165; (932,862)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncomeTaxComputedAtTheStatutoryTaxRate', window );">Income tax computed at the statutory tax rate</a></td>
<td class="num">(287,881)<span></span>
</td>
<td class="num">(41,166)<span></span>
</td>
<td class="num">(70,114)<span></span>
</td>
<td class="num">(244,549)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_LowerTaxRateForASpecificEntity', window );">Lower tax rate for a specific entity</a></td>
<td class="nump">59,759<span></span>
</td>
<td class="nump">8,545<span></span>
</td>
<td class="nump">7,112<span></span>
</td>
<td class="nump">59,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StatutoryIncomeAndExpense', window );">Statutory income and expense</a></td>
<td class="num">(12,900)<span></span>
</td>
<td class="num">(1,845)<span></span>
</td>
<td class="num">(17,534)<span></span>
</td>
<td class="nump">2,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncomeNotSubjectToTax', window );">Items not subject to tax</a></td>
<td class="num">(7,533)<span></span>
</td>
<td class="num">(1,076)<span></span>
</td>
<td class="num">(7,236)<span></span>
</td>
<td class="num">(4,093)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Items not deductible for tax</a></td>
<td class="nump">49,582<span></span>
</td>
<td class="nump">7,091<span></span>
</td>
<td class="nump">24,045<span></span>
</td>
<td class="nump">9,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ResearchAndDevelopmentSuperdeduction', window );">Research and development super-deduction</a></td>
<td class="num">(48,919)<span></span>
</td>
<td class="num">(6,995)<span></span>
</td>
<td class="num">(75,135)<span></span>
</td>
<td class="num">(67,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_GainlossAttributableToJointVentures', window );">(Gain)/loss attributable to joint ventures</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="num">(269)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NewProvisionsReturn', window );">Provision to return</a></td>
<td class="nump">68,391<span></span>
</td>
<td class="nump">9,779<span></span>
</td>
<td class="num">(35,342)<span></span>
</td>
<td class="nump">23,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectFromChangeInTaxRate', window );">Effect of tax rate changes on deferred taxes</a></td>
<td class="num">(71,206)<span></span>
</td>
<td class="num">(10,183)<span></span>
</td>
<td class="num">(10,822)<span></span>
</td>
<td class="num">(56,104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_UncertainTaxPosition', window );">Uncertain tax position</a></td>
<td class="nump">14,236<span></span>
</td>
<td class="nump">2,036<span></span>
</td>
<td class="nump">23,665<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_EffectOfWithholdingTaxOnTheInterestIncome', window );">Effect of withholding tax on the interest income of the Group&#8217;s HK subsidiary</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NetOperatingLossExpired', window );">Tax loss expired</a></td>
<td class="nump">29,628<span></span>
</td>
<td class="nump">4,237<span></span>
</td>
<td class="nump">31,670<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeductibleTemporaryDifferencesNotRecognized', window );">Deductible temporary differences not recognized</a></td>
<td class="nump">49,919<span></span>
</td>
<td class="nump">7,138<span></span>
</td>
<td class="nump">71,465<span></span>
</td>
<td class="nump">33,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax losses not recognized</a></td>
<td class="nump">163,913<span></span>
</td>
<td class="nump">23,438<span></span>
</td>
<td class="nump">68,580<span></span>
</td>
<td class="nump">237,432<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax credit/(expense)</a></td>
<td class="nump">&#165; 6,940<span></span>
</td>
<td class="nump">$ 992<span></span>
</td>
<td class="nump">&#165; 10,425<span></span>
</td>
<td class="num">&#165; (7,150)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DeductibleTemporaryDifferencesNotRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deductible temporary differences not recognized.
.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DeductibleTemporaryDifferencesNotRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_EffectOfWithholdingTaxOnTheInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of effect of withholding tax on the interest income &#8212; of the group&#8217;s HK subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_EffectOfWithholdingTaxOnTheInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_GainlossAttributableToJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gain/(loss) attributable to joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_GainlossAttributableToJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IncomeNotSubjectToTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income not subject to tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IncomeNotSubjectToTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IncomeTaxComputedAtTheStatutoryTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of income tax computed at the statutory tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IncomeTaxComputedAtTheStatutoryTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_LowerTaxRateForASpecificEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lower tax rate for a specific entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_LowerTaxRateForASpecificEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NetOperatingLossExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net operating loss (NOL) expired .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NetOperatingLossExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NewProvisionsReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provision to return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NewProvisionsReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ResearchAndDevelopmentSuperdeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of research and development super-deduction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ResearchAndDevelopmentSuperdeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StatutoryIncomeAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Statutory income and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StatutoryIncomeAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_UncertainTaxPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of uncertain tax position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_UncertainTaxPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectFromChangeInTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectFromChangeInTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share Attributable to Ordinary Equity Holders of the Company (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Loss Per Share Attributable to Ordinary Equity Holders of the Company [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Issuable shares on weighted average number of ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">356,130,452<span></span>
</td>
<td class="nump">302,062,104<span></span>
</td>
<td class="nump">282,299,269<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average number of shares was after taking into account the effect of treasury shares held.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share Attributable to Ordinary Equity Holders of the Company - Schedule of Basic Loss Per Share (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsPerShareAbstract', window );"><strong>Schedule of Basic Loss Per Share [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss attributable to ordinary equity holders of the parent, used in the basic loss per share calculation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#165; (1,242,769)<span></span>
</td>
<td class="num">$ (177,714)<span></span>
</td>
<td class="num">&#165; (405,433)<span></span>
</td>
<td class="num">&#165; (925,637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of ordinary shares outstanding during the year used in the basic loss per share calculation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">356,130,452<span></span>
</td>
<td class="nump">356,130,452<span></span>
</td>
<td class="nump">302,062,104<span></span>
</td>
<td class="nump">282,299,269<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average number of shares was after taking into account the effect of treasury shares held.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">&#165; 1,068,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1,070,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(287,029)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(221,443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">781,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">849,450<span></span>
</td>
<td class="nump">$ 111,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">781,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">849,450<span></span>
</td>
<td class="nump">111,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Deficit on adjustment</a></td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">1,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">818,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">836,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(141,853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104,736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">676,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,282<span></span>
</td>
<td class="nump">96,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">676,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,282<span></span>
</td>
<td class="nump">96,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">60,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(28,781)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">31,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,815<span></span>
</td>
<td class="nump">4,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">31,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,815<span></span>
</td>
<td class="nump">4,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">185,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(115,756)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97,757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">69,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,977<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">69,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,977<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">1,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Construction in progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">2,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">2,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,293<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">2,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,293<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">1,070,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,056,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(221,443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,831)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">849,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">905,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">849,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">905,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">836,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">834,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(104,736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65,137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">731,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">769,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">731,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">769,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">44,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(18,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,517)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">25,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">25,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">182,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(97,757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,771)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">84,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">84,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="num">(526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Construction in progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentCost', window );">Cost</a></td>
<td class="nump">7,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedDepreciationsCost', window );">Accumulated depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount</a></td>
<td class="nump">7,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">7,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">849,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">905,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">17,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation provided during the year (note 6)</a></td>
<td class="num">(65,761)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Deficit on adjustment</a></td>
<td class="num">(19,982)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange realignment</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">781,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">849,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">731,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">769,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation provided during the year (note 6)</a></td>
<td class="num">(37,117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,599)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">2,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Deficit on adjustment</a></td>
<td class="num">(19,982)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange realignment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">676,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">25,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">3,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation provided during the year (note 6)</a></td>
<td class="num">(10,374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,896)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">13,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Deficit on adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange realignment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">31,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">84,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">2,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation provided during the year (note 6)</a></td>
<td class="num">(18,157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Deficit on adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange realignment</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">69,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation provided during the year (note 6)</a></td>
<td class="num">(113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Deficit on adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange realignment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Construction in progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">7,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">11,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation provided during the year (note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="num">(16,412)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,164)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Deficit on adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange realignment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation', window );">Balance</a></td>
<td class="nump">&#165; 2,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 7,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AccumulatedDepreciationsCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated depreciation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AccumulatedDepreciationsCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PropertyAndEquipmentCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of property and equipment cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PropertyAndEquipmentCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount net of accumulated depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_LeasesLineItems', window );"><strong>Leases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_TermsOfLandLease', window );">Terms of land lease</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember', window );">Land and Buildings [Member] | Bottom of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_LeasesLineItems', window );"><strong>Leases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_LeaseTerms', window );">Lease terms</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember', window );">Land and Buildings [Member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_LeasesLineItems', window );"><strong>Leases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_LeaseTerms', window );">Lease terms</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_LeaseTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_LeaseTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_LeasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_LeasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_TermsOfLandLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Terms of land lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_TermsOfLandLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Right-of-Use Assets (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Schedule of Right-of-Use Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Carrying amount of beginning of year</a></td>
<td class="nump">&#165; 56,109<span></span>
</td>
<td class="nump">$ 8,023<span></span>
</td>
<td class="nump">&#165; 51,252<span></span>
</td>
<td class="nump">$ 7,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions</a></td>
<td class="nump">5,047<span></span>
</td>
<td class="nump">722<span></span>
</td>
<td class="nump">17,108<span></span>
</td>
<td class="nump">2,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charge</a></td>
<td class="num">(10,657)<span></span>
</td>
<td class="num">(1,524)<span></span>
</td>
<td class="num">(11,134)<span></span>
</td>
<td class="num">(1,592)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsRightofuseAssets', window );">Disposal</a></td>
<td class="num">(2,675)<span></span>
</td>
<td class="num">(382)<span></span>
</td>
<td class="num">(1,067)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ExchangeRealignmentRightofuseAssets', window );">Exchange realignment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Carrying amount of end of year</a></td>
<td class="nump">47,827<span></span>
</td>
<td class="nump">$ 6,839<span></span>
</td>
<td class="nump">56,109<span></span>
</td>
<td class="nump">$ 8,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Schedule of Right-of-Use Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Carrying amount of beginning of year</a></td>
<td class="nump">29,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions</a></td>
<td class="nump">5,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charge</a></td>
<td class="num">(9,527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,004)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsRightofuseAssets', window );">Disposal</a></td>
<td class="num">(2,675)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ExchangeRealignmentRightofuseAssets', window );">Exchange realignment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Carrying amount of end of year</a></td>
<td class="nump">22,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aapg_LeaseholdLandMember', window );">Leasehold land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Schedule of Right-of-Use Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Carrying amount of beginning of year</a></td>
<td class="nump">26,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charge</a></td>
<td class="num">(1,130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsRightofuseAssets', window );">Disposal</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ExchangeRealignmentRightofuseAssets', window );">Exchange realignment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Carrying amount of end of year</a></td>
<td class="nump">&#165; 25,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 26,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ExchangeRealignmentRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exchange realignment, right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ExchangeRealignmentRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in right-of-use assets resulting from disposals. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aapg_LeaseholdLandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aapg_LeaseholdLandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Liabilities (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Schedule of Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Carrying amount at January 1</a></td>
<td class="nump">&#165; 30,232<span></span>
</td>
<td class="nump">$ 4,323<span></span>
</td>
<td class="nump">&#165; 22,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">New leases</a></td>
<td class="nump">5,047<span></span>
</td>
<td class="nump">722<span></span>
</td>
<td class="nump">17,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Accretion of interest recognized during the year</a></td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">1,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PaymentsofLeaseLiabilities', window );">Payments</a></td>
<td class="num">(10,835)<span></span>
</td>
<td class="num">(1,549)<span></span>
</td>
<td class="num">(9,911)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ExchangeRealignments', window );">Exchange realignment</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DisposalsLeaseLiabilities', window );">Disposal</a></td>
<td class="num">(3,360)<span></span>
</td>
<td class="num">(481)<span></span>
</td>
<td class="num">(1,152)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Carrying amount at December 31</a></td>
<td class="nump">22,196<span></span>
</td>
<td class="nump">$ 3,174<span></span>
</td>
<td class="nump">30,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AnalyzedIntoAbstract', window );"><strong>Analyzed into:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current portion</a></td>
<td class="nump">7,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,439<span></span>
</td>
<td class="nump">$ 1,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current portion</a></td>
<td class="nump">&#165; 14,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 20,793<span></span>
</td>
<td class="nump">$ 2,133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AnalyzedIntoAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AnalyzedIntoAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DisposalsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of disposal lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DisposalsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ExchangeRealignments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exchange realignment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ExchangeRealignments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PaymentsofLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PaymentsofLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 44B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44B&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Recognized in Profit or Loss (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Schedule of Recognized in Profit or Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest on lease liabilities</a></td>
<td class="nump">&#165; 1,118<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">&#165; 1,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DepreciationChargeofRightofuseAssets', window );">Depreciation charge of right-of-use assets</a></td>
<td class="nump">10,657<span></span>
</td>
<td class="nump">1,524<span></span>
</td>
<td class="nump">11,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed', window );">Expense relating to short-term leases (included in administrative expenses) (note 6)</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_TotalAmountofRecognizedInProfitOrLoss', window );">Total amount recognized in profit or loss</a></td>
<td class="nump">&#165; 12,104<span></span>
</td>
<td class="nump">$ 1,731<span></span>
</td>
<td class="nump">&#165; 12,870<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DepreciationChargeofRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of depreciation charge of right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DepreciationChargeofRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_TotalAmountofRecognizedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recognized in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_TotalAmountofRecognizedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate of cash flow projections</a></td>
<td class="nump">19.40%<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_d_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_e_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill - Schedule of Goodwill (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInGoodwillAbstract', window );"><strong>Schedule of Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CostGoodwill', window );">Cost</a></td>
<td class="nump">&#165; 24,694<span></span>
</td>
<td class="nump">$ 3,531<span></span>
</td>
<td class="nump">&#165; 24,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedImpairmentGoodwill', window );">Accumulated impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Total</a></td>
<td class="nump">&#165; 24,694<span></span>
</td>
<td class="nump">$ 3,531<span></span>
</td>
<td class="nump">&#165; 24,694<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AccumulatedImpairmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accumulated impairment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AccumulatedImpairmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CostGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CostGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Intangible Asset - Schedule of Other Intangible Asset (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Jan. 01, 2025 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfOtherIntangibleAssetLineItems', window );"><strong>Schedule of Other Intangible Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Cost Beginning Balance</a></td>
<td class="nump">&#165; 9,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 10,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization provided during the year</a></td>
<td class="num">(1,262)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Cost Ending Balance</a></td>
<td class="nump">8,273<span></span>
</td>
<td class="nump">$ 1,183<span></span>
</td>
<td class="nump">9,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">18,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 18,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(10,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="nump">8,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,535<span></span>
</td>
<td class="nump">9,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">8,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,535<span></span>
</td>
<td class="nump">9,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aapg_PatentMember', window );">Patent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfOtherIntangibleAssetLineItems', window );"><strong>Schedule of Other Intangible Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Cost Beginning Balance</a></td>
<td class="nump">40,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization provided during the year</a></td>
<td class="num">(7,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,251)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Cost Ending Balance</a></td>
<td class="nump">33,538<span></span>
</td>
<td class="nump">4,796<span></span>
</td>
<td class="nump">40,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">93,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(59,512)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="nump">33,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,838<span></span>
</td>
<td class="nump">40,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">33,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,838<span></span>
</td>
<td class="nump">40,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember', window );">License [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfOtherIntangibleAssetLineItems', window );"><strong>Schedule of Other Intangible Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Cost Beginning Balance</a></td>
<td class="nump">25,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization provided during the year</a></td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Cost Ending Balance</a></td>
<td class="nump">24,125<span></span>
</td>
<td class="nump">3,450<span></span>
</td>
<td class="nump">25,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(5,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,375)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="nump">24,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,625<span></span>
</td>
<td class="nump">25,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">24,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,625<span></span>
</td>
<td class="nump">25,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aapg_ConstructionInProcessMember', window );">Construction In process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfOtherIntangibleAssetLineItems', window );"><strong>Schedule of Other Intangible Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Cost Beginning Balance</a></td>
<td class="nump">75,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization provided during the year</a></td>
<td class="num">(10,062)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,851)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Cost Ending Balance</a></td>
<td class="nump">65,936<span></span>
</td>
<td class="nump">$ 9,429<span></span>
</td>
<td class="nump">75,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">141,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(75,842)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="nump">65,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,998<span></span>
</td>
<td class="nump">75,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount in US$ (in Dollars)</a></td>
<td class="nump">&#165; 65,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 75,998<span></span>
</td>
<td class="nump">&#165; 75,998<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accumulated amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets gross amount before charging accumulated amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfOtherIntangibleAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfOtherIntangibleAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aapg_PatentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aapg_PatentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aapg_ConstructionInProcessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aapg_ConstructionInProcessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investment in a Joint Venture - Schedule of Investment in a Joint Venture (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInvestmentInAJointVentureAbstract', window );"><strong>Schedule of Investment in a Joint Venture [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of net assets</a></td>
<td class="nump">&#165; 33,030<span></span>
</td>
<td class="nump">$ 4,723<span></span>
</td>
<td class="nump">&#165; 32,717<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfInvestmentInAJointVentureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfInvestmentInAJointVentureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in a Joint Venture - Schedule of Group&#8217;s Principal Joint Venture (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfGroupSPrincipalJointVentureAbstract', window );"><strong>Schedule of Group&#8217;s Principal Joint Venture [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Place of registration and business</a></td>
<td class="text">PRC<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RegisteredShareCapital', window );">Registered share capital</a></td>
<td class="nump">$ 360,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Percentage of ownership interest</a></td>
<td class="nump">33.42%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Investment in Biotechnology companies<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English name of the company registered in the PRC represents the best efforts made by the management of the Company in directly translating the Chinese name of this Company as no English name has been registered.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group holds two of three representatives in the committee that directs the relevant activities of Ascentage Harvest. As a result, the Group has significant influence over the financial and operating policy decisions of Ascentage Harvest.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PrincipalActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PrincipalActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_RegisteredShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Registered share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_RegisteredShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfGroupSPrincipalJointVentureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfGroupSPrincipalJointVentureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The principal place of business of a subsidiary. [Refer: Principal place of business; Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Total for all joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in a Joint Venture - Schedule of Information of the Group&#8217;s Joint Venture (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract', window );"><strong>Schedule of Information of the Group&#8217;s Joint Venture [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of the joint venture&#8217;s (loss)/gain for the year</a></td>
<td class="nump">&#165; 314<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="num">&#165; (281)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of the joint venture&#8217;s total comprehensive (loss)/gain for the year</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="num">(281)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture', window );">Aggregate carrying amount of the Group&#8217;s investment in the joint venture</a></td>
<td class="nump">&#165; 33,030<span></span>
</td>
<td class="nump">$ 4,723<span></span>
</td>
<td class="nump">&#165; 32,717<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the Group&#8217;s investment in the joint venture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the total comprehensive income of associates and joint ventures accounted for using the equity method. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B16<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B16_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Assets at Fair Value through Profit or Loss - Schedule of Financial Assets at Fair Value through Profit or Loss (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract', window );"><strong>Schedule of Financial Assets at Fair Value through Profit or Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ListedEquityInvestmentsAtFairValue', window );">Listed equity investments, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">&#165; 1,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OtherUnlistedInvestmentsAtFairValue', window );">Other unlisted investments, at fair value</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Total</a></td>
<td class="nump">&#165; 4,000<span></span>
</td>
<td class="nump">$ 572<span></span>
</td>
<td class="nump">&#165; 1,141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ListedEquityInvestmentsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Listed equity investments, at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ListedEquityInvestmentsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OtherUnlistedInvestmentsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other unlisted investments, at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OtherUnlistedInvestmentsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeferredTaxLineItems', window );"><strong>Deferred Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax losses</a></td>
<td class="nump">&#165; 163,913<span></span>
</td>
<td class="nump">$ 23,438<span></span>
</td>
<td class="nump">&#165; 68,580<span></span>
</td>
<td class="nump">&#165; 237,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FutureTaxableProfitsPercentage', window );">Future taxable profits percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences</a></td>
<td class="nump">&#165; 1,000,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">828,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_TaxCredits', window );">Tax credits</a></td>
<td class="nump">158,931<span></span>
</td>
<td class="nump">22,727<span></span>
</td>
<td class="nump">120,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_UnrecognizedTaxBenefit', window );">Unrecognized tax benefit</a></td>
<td class="nump">37,901<span></span>
</td>
<td class="nump">5,420<span></span>
</td>
<td class="nump">23,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeferredTaxAssetsTaxLossCarryforwards', window );">Deferred tax assets related to tax loss carry forwards | &#165;</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_UnrecognizedTaxBenefitsRecognized', window );">Unrecognized tax benefits recognized amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">23,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=aapg_ChineseMainlandMember', window );">Chinese Mainland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeferredTaxLineItems', window );"><strong>Deferred Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax losses</a></td>
<td class="nump">3,047,076<span></span>
</td>
<td class="nump">435,726<span></span>
</td>
<td class="nump">2,963,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeferredTaxLineItems', window );"><strong>Deferred Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax losses</a></td>
<td class="nump">&#165; 2,250,477<span></span>
</td>
<td class="nump">$ 321,814<span></span>
</td>
<td class="nump">&#165; 1,438,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DeferredTaxAssetsTaxLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to tax loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DeferredTaxAssetsTaxLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DeferredTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DeferredTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FutureTaxableProfitsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future taxable profits percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FutureTaxableProfitsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_TaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_TaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_UnrecognizedTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_UnrecognizedTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_UnrecognizedTaxBenefitsRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of unrecognized tax benefits recognized amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_UnrecognizedTaxBenefitsRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=aapg_ChineseMainlandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=aapg_ChineseMainlandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax - Schedule of Movements in Deferred Tax Liabilities and Assets (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeferredTaxLineItems', window );"><strong>Deferred Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Balance at beginning</a></td>
<td class="nump">&#165; 12,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 15,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax charged/(credited) to the statement of profit or loss during the year</a></td>
<td class="nump">734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,881)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Balance at ending</a></td>
<td class="nump">12,815<span></span>
</td>
<td class="nump">$ 1,833<span></span>
</td>
<td class="nump">12,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Balance at ending (in Dollars)</a></td>
<td class="nump">12,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember', window );">Fair Value Adjustments Arising From Acquisition of a Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeferredTaxLineItems', window );"><strong>Deferred Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Balance at beginning</a></td>
<td class="nump">5,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax charged/(credited) to the statement of profit or loss during the year</a></td>
<td class="nump">1,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,181)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Balance at ending</a></td>
<td class="nump">7,343<span></span>
</td>
<td class="nump">1,051<span></span>
</td>
<td class="nump">5,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Balance at ending (in Dollars)</a></td>
<td class="nump">7,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember', window );">Right-of-use assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeferredTaxLineItems', window );"><strong>Deferred Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Balance at beginning</a></td>
<td class="nump">6,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax charged/(credited) to the statement of profit or loss during the year</a></td>
<td class="num">(1,241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Balance at ending</a></td>
<td class="nump">5,472<span></span>
</td>
<td class="nump">$ 782<span></span>
</td>
<td class="nump">6,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Balance at ending (in Dollars)</a></td>
<td class="nump">&#165; 5,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 6,713<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DeferredTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DeferredTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>187
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax - Schedule of Movements in Deferred Tax Assets (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes', window );">Deferred tax (credited)/charged to the statement of profit or loss during the year</a></td>
<td class="num">&#165; (6,177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (14,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="nump">44,772<span></span>
</td>
<td class="nump">$ 6,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="nump">44,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=aapg_ContractLiabilitiesMember', window );">Contract Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes', window );">Deferred tax (credited)/charged to the statement of profit or loss during the year</a></td>
<td class="num">(12,582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="nump">25,235<span></span>
</td>
<td class="nump">3,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="nump">25,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes', window );">Deferred tax (credited)/charged to the statement of profit or loss during the year</a></td>
<td class="num">(1,241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="nump">5,472<span></span>
</td>
<td class="nump">782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="nump">5,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=aapg_DonationExpensesMember', window );">Donation expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes', window );">Deferred tax (credited)/charged to the statement of profit or loss during the year</a></td>
<td class="num">(1,204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="nump">1,692<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="nump">1,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember', window );">Losses Available for Offsetting Against Future Taxable Profits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes', window );">Deferred tax (credited)/charged to the statement of profit or loss during the year</a></td>
<td class="nump">8,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,879)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="nump">12,373<span></span>
</td>
<td class="nump">$ 1,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="nump">12,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=ifrs-full_RestatedMember', window );">Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at beginning</a></td>
<td class="nump">50,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=ifrs-full_RestatedMember', window );">Restated [Member] | Contract Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at beginning</a></td>
<td class="nump">37,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=ifrs-full_RestatedMember', window );">Restated [Member] | Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at beginning</a></td>
<td class="nump">6,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=ifrs-full_RestatedMember', window );">Restated [Member] | Donation expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at beginning</a></td>
<td class="nump">2,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=ifrs-full_RestatedMember', window );">Restated [Member] | Losses Available for Offsetting Against Future Taxable Profits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Schedule of Movements in Deferred Tax Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at beginning</a></td>
<td class="nump">&#165; 3,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance at ending (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 3,523<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=aapg_ContractLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=aapg_ContractLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=aapg_DonationExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=aapg_DonationExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=ifrs-full_RestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=ifrs-full_RestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Tax - Schedule of Deferred Tax Assets and Liabilities (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Schedule of Analysis of the Deferred Tax Balances of the Group for Financial Reporting Purposes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition', window );">Deferred tax offset in the consolidated statements of financial position</a></td>
<td class="nump">&#165; 12,815<span></span>
</td>
<td class="nump">$ 1,833<span></span>
</td>
<td class="nump">&#165; 6,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Net deferred tax assets recognized in the consolidated statements of financial position</a></td>
<td class="nump">31,957<span></span>
</td>
<td class="nump">4,570<span></span>
</td>
<td class="nump">44,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Net deferred tax liability recognized in the consolidated statements of financial position</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">&#165; 5,368<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of deferred tax offset in the consolidated statements of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Non-Current Assets - Schedule of Other Non-Current Assets (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfOtherNonCurrentAssetsAbstract', window );"><strong>Schedule of Other Non-Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ContractAcquisitionCosts', window );">Contract acquisition costs</a></td>
<td class="nump">&#165; 29,851<span></span>
</td>
<td class="nump">$ 4,269<span></span>
</td>
<td class="nump">&#165; 30,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentValueAddedTaxReceivables', window );">Value added tax recoverable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermDeposits', window );">Deposit</a></td>
<td class="nump">690<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPrepayments', window );">Prepayment for property, plant and equipment</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Total</a></td>
<td class="nump">&#165; 30,725<span></span>
</td>
<td class="nump">$ 4,394<span></span>
</td>
<td class="nump">&#165; 59,303<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contract acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfOtherNonCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfOtherNonCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of long-term deposits held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current prepayments. [Refer: Prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>190
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Schedule of Inventories (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInventoriesAbstract', window );"><strong>Schedule of Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work in progress</a></td>
<td class="nump">&#165; 25,371<span></span>
</td>
<td class="nump">$ 3,628<span></span>
</td>
<td class="nump">&#165; 2,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished goods</a></td>
<td class="nump">7,427<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">3,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisions', window );">Less: Provision</a></td>
<td class="num">(4,180)<span></span>
</td>
<td class="num">(598)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total</a></td>
<td class="nump">&#165; 28,618<span></span>
</td>
<td class="nump">$ 4,092<span></span>
</td>
<td class="nump">&#165; 6,597<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WorkInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WorkInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>191
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade Receivables, Net - Schedule of Trade Receivables, Net (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Schedule of Trade Receivables, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade receivables, net</a></td>
<td class="nump">&#165; 252,938<span></span>
</td>
<td class="nump">$ 36,170<span></span>
</td>
<td class="nump">&#165; 83,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>192
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade Receivables, Net - Schedule of Based on the Invoice Date and Net of Loss Allowance (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NetOfLossAllowanceLineItems', window );"><strong>Schedule of Based on the Invoice Date and Net of Loss Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Total</a></td>
<td class="nump">&#165; 252,938<span></span>
</td>
<td class="nump">$ 36,170<span></span>
</td>
<td class="nump">&#165; 83,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialAssetsAgingAxis=aapg_TradeReceivablesWithin45DaysMember', window );">Within 45 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NetOfLossAllowanceLineItems', window );"><strong>Schedule of Based on the Invoice Date and Net of Loss Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Total</a></td>
<td class="nump">252,938<span></span>
</td>
<td class="nump">36,170<span></span>
</td>
<td class="nump">54,484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialAssetsAgingAxis=aapg_TradeReceivables45To120DaysMember', window );">45 to 120 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NetOfLossAllowanceLineItems', window );"><strong>Schedule of Based on the Invoice Date and Net of Loss Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">&#165; 28,659<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NetOfLossAllowanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NetOfLossAllowanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FinancialAssetsAgingAxis=aapg_TradeReceivablesWithin45DaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FinancialAssetsAgingAxis=aapg_TradeReceivablesWithin45DaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FinancialAssetsAgingAxis=aapg_TradeReceivables45To120DaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FinancialAssetsAgingAxis=aapg_TradeReceivables45To120DaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>193
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepayments, Other Receivables and Other Assets - Schedule of Prepayments, Other Receivables and Other Assets (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAbstract', window );"><strong>Schedule of Prepayments, Other Receivables and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PrepaymentsForClinicalTrialExpenses', window );">Prepayments for clinical trial expenses</a></td>
<td class="nump">&#165; 100,769<span></span>
</td>
<td class="nump">$ 14,410<span></span>
</td>
<td class="nump">&#165; 71,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PrepaidListingExpense', window );">Prepaid listing expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">22,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ValueAddedTaxReceivables', window );">Value added tax recoverable</a></td>
<td class="nump">46,748<span></span>
</td>
<td class="nump">6,685<span></span>
</td>
<td class="nump">9,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">1,455<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">6,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_DepositsAssetsPrepayments', window );">Deposits</a></td>
<td class="nump">2,159<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="nump">5,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PrepaymentForTreasurySharePurchaseFees', window );">Prepayment for treasury share purchase fees</a></td>
<td class="nump">8,798<span></span>
</td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">4,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Prepayments', window );">Other prepayments</a></td>
<td class="nump">32,603<span></span>
</td>
<td class="nump">4,662<span></span>
</td>
<td class="nump">3,644<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets', window );">Total</a></td>
<td class="nump">&#165; 192,532<span></span>
</td>
<td class="nump">$ 27,532<span></span>
</td>
<td class="nump">&#165; 123,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_DepositsAssetsPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_DepositsAssetsPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PrepaidListingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid listing expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PrepaidListingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PrepaymentForTreasurySharePurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of prepayment for treasury share purchase fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PrepaymentForTreasurySharePurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PrepaymentsForClinicalTrialExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of prepayments for clinical trial expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PrepaymentsForClinicalTrialExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Prepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables that represent amounts paid for goods and services before they have been delivered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Prepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables related to a value added tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>194
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and Bank Balances (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CNY', window );">RMB [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashAndBankBalancesLineItems', window );"><strong>Cash and Bank Balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances | &#165;</a></td>
<td class="nump">&#165; 298,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 205,783<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashAndBankBalancesLineItems', window );"><strong>Cash and Bank Balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CashAndBankBalancesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CashAndBankBalancesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndBankBalancesAtCentralBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and bank balances held at central banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndBankBalancesAtCentralBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>195
<FILENAME>R133.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and Bank Balances - Schedule of Cash and Bank Balances (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCashAndBankBalancesLineItems', window );"><strong>Schedule of Cash and Bank Balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents as stated in the consolidated statements of cash flows</a></td>
<td class="nump">&#165; 1,195,784<span></span>
</td>
<td class="nump">$ 170,995<span></span>
</td>
<td class="nump">&#165; 893,100<span></span>
</td>
<td class="nump">$ 127,712<span></span>
</td>
<td class="nump">&#165; 1,038,048<span></span>
</td>
<td class="nump">&#165; 1,345,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">5,685<span></span>
</td>
<td class="nump">812<span></span>
</td>
<td class="nump">24,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepositsFromBanks', window );">Time deposits with original maturity of more than three months</a></td>
<td class="nump">1,268,616<span></span>
</td>
<td class="nump">181,410<span></span>
</td>
<td class="nump">343,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BalancesWithBanks', window );">Cash and bank balances as stated in the consolidated statements of financial position</a></td>
<td class="nump">2,470,085<span></span>
</td>
<td class="nump">353,217<span></span>
</td>
<td class="nump">1,261,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances at end of year</a></td>
<td class="nump">2,470,085<span></span>
</td>
<td class="nump">353,217<span></span>
</td>
<td class="nump">1,261,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1,093,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_CN', window );">RMB [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCashAndBankBalancesLineItems', window );"><strong>Schedule of Cash and Bank Balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances at end of year</a></td>
<td class="nump">205,783<span></span>
</td>
<td class="nump">29,426<span></span>
</td>
<td class="nump">298,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCashAndBankBalancesLineItems', window );"><strong>Schedule of Cash and Bank Balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances at end of year</a></td>
<td class="nump">2,257,307<span></span>
</td>
<td class="nump">322,791<span></span>
</td>
<td class="nump">947,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_HK', window );">HK [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCashAndBankBalancesLineItems', window );"><strong>Schedule of Cash and Bank Balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances at end of year</a></td>
<td class="nump">3,827<span></span>
</td>
<td class="nump">547<span></span>
</td>
<td class="nump">13,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=aapg_OthersMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCashAndBankBalancesLineItems', window );"><strong>Schedule of Cash and Bank Balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances at end of year</a></td>
<td class="nump">&#165; 3,168<span></span>
</td>
<td class="nump">$ 453<span></span>
</td>
<td class="nump">&#165; 1,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfCashAndBankBalancesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfCashAndBankBalancesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BalancesWithBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash balances held at banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BalancesWithBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndBankBalancesAtCentralBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and bank balances held at central banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndBankBalancesAtCentralBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepositsFromBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deposit liabilities from banks held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepositsFromBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=aapg_OthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=aapg_OthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>196
<FILENAME>R134.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade Payables - Schedule of the Trade Payables (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfTheTradePayablesLineItems', window );"><strong>Schedule of the Trade Payables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Total</a></td>
<td class="nump">&#165; 106,740<span></span>
</td>
<td class="nump">$ 15,264<span></span>
</td>
<td class="nump">&#165; 91,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aapg_WithinOneMonthMember', window );">Within 1 month [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfTheTradePayablesLineItems', window );"><strong>Schedule of the Trade Payables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Total</a></td>
<td class="nump">91,119<span></span>
</td>
<td class="nump">13,030<span></span>
</td>
<td class="nump">72,506<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aapg_OneToThreeMonthsMember', window );">1 to 3 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfTheTradePayablesLineItems', window );"><strong>Schedule of the Trade Payables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Total</a></td>
<td class="nump">3,648<span></span>
</td>
<td class="nump">522<span></span>
</td>
<td class="nump">6,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aapg_ThreeToSixMonthsMember', window );">3 to 6 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfTheTradePayablesLineItems', window );"><strong>Schedule of the Trade Payables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Total</a></td>
<td class="nump">&#165; 11,973<span></span>
</td>
<td class="nump">$ 1,712<span></span>
</td>
<td class="nump">&#165; 13,172<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfTheTradePayablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfTheTradePayablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aapg_WithinOneMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aapg_WithinOneMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aapg_OneToThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aapg_OneToThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aapg_ThreeToSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aapg_ThreeToSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>197
<FILENAME>R135.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Payables and Accruals - Schedule of Other Payables and Accruals (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Other Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccrualsClassifiedAsCurrent', window );">Accrued promotion expenses</a></td>
<td class="nump">&#165; 121,545<span></span>
</td>
<td class="nump">$ 17,381<span></span>
</td>
<td class="nump">&#165; 67,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisionsForEmployeeBenefits', window );">Payroll payables</a></td>
<td class="nump">78,423<span></span>
</td>
<td class="nump">11,214<span></span>
</td>
<td class="nump">61,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CurretPayablesForConstructionCost', window );">Payables for construction cost</a></td>
<td class="nump">5,888<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="nump">35,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Long-term payables &#8211; current portion</a></td>
<td class="nump">8,340<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
<td class="nump">29,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings', window );">Other non-current liabilities - current portion</a></td>
<td class="nump">1,968<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other payables</a></td>
<td class="nump">21,493<span></span>
</td>
<td class="nump">3,073<span></span>
</td>
<td class="nump">23,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_GovernmentSubsidy', window );">Government subsidy</a></td>
<td class="nump">22,600<span></span>
</td>
<td class="nump">3,232<span></span>
</td>
<td class="nump">16,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentExciseTaxPayables', window );">Tax payables other than income tax</a></td>
<td class="nump">13,700<span></span>
</td>
<td class="nump">1,959<span></span>
</td>
<td class="nump">9,627<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities', window );">Other accrued expenses</a></td>
<td class="nump">2,709<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="nump">14,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Total</a></td>
<td class="nump">&#165; 276,666<span></span>
</td>
<td class="nump">$ 39,563<span></span>
</td>
<td class="nump">&#165; 258,098<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CurretPayablesForConstructionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payables for construction cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CurretPayablesForConstructionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_GovernmentSubsidy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of government subsidy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_GovernmentSubsidy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccrualsClassifiedAsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals classified as current. [Refer: Accruals]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccrualsClassifiedAsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentExciseTaxPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current excise tax payables. [Refer: Excise tax payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentExciseTaxPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPortionOfLongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPortionOfLongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other borrowings and the current portion of non-current other borrowings. [Refer: Other borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts payable that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>198
<FILENAME>R136.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Liabilities (Details) - Innovent Biologics Suzhou) Co Ltd [Member]<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ContractLiabilitiesLineItems', window );"><strong>Contract Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract liabilities</a></td>
<td class="nump">&#165; 349,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 349,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">&#165; 37,485<span></span>
</td>
<td class="nump">$ 5,360<span></span>
</td>
<td class="nump">&#165; 37,485<span></span>
</td>
<td class="nump">&#165; 26,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ContractLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ContractLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_InnoventBiologicsSuzhouCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_InnoventBiologicsSuzhouCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>199
<FILENAME>R137.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contract Liabilities - Schedule of Contract Liabilities (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems', window );"><strong>Schedule of Contract Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Total contract liabilities</a></td>
<td class="nump">&#165; 247,709<span></span>
</td>
<td class="nump">$ 35,422<span></span>
</td>
<td class="nump">&#165; 285,945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfCustomersAxis=aapg_ShorttermAdvancesRecognizedFromCustomersMember', window );">Short-term advances recognized from customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems', window );"><strong>Schedule of Contract Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Total contract liabilities</a></td>
<td class="nump">37,485<span></span>
</td>
<td class="nump">5,360<span></span>
</td>
<td class="nump">37,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfCustomersAxis=aapg_LongtermAdvancesRecognizedFromCustomersMember', window );">Long-term advances recognized from customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems', window );"><strong>Schedule of Contract Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Total contract liabilities</a></td>
<td class="nump">&#165; 210,224<span></span>
</td>
<td class="nump">$ 30,062<span></span>
</td>
<td class="nump">&#165; 248,460<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfCustomersAxis=aapg_ShorttermAdvancesRecognizedFromCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfCustomersAxis=aapg_ShorttermAdvancesRecognizedFromCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfCustomersAxis=aapg_LongtermAdvancesRecognizedFromCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfCustomersAxis=aapg_LongtermAdvancesRecognizedFromCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>200
<FILENAME>R138.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Interest-Bearing Bank and Other Borrowings (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowings</a></td>
<td class="nump">&#165; 1,222,481<span></span>
</td>
<td class="nump">$ 174,812<span></span>
</td>
<td class="nump">&#165; 779,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Net carrying amount</a></td>
<td class="nump">1,979,719<span></span>
</td>
<td class="nump">283,096<span></span>
</td>
<td class="nump">1,668,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnsecuredBankLoansReceived', window );">Bank loans</a></td>
<td class="nump">&#165; 20,020<span></span>
</td>
<td class="nump">$ 140,000<span></span>
</td>
<td class="nump">&#165; 278,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Bank loans</a></td>
<td class="nump">2.18%<span></span>
</td>
<td class="nump">2.18%<span></span>
</td>
<td class="nump">2.63%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_LloanPrimeRateMember', window );">Lioan Prime Rate [Member] | Secured Bank Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 599,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_LloanPrimeRateMember', window );">Lioan Prime Rate [Member] | Investment Property [Member] | Secured Bank Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowings</a></td>
<td class="nump">&#165; 600,173<span></span>
</td>
<td class="nump">$ 85,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Net carrying amount</a></td>
<td class="nump">676,985<span></span>
</td>
<td class="nump">96,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_LloanPrimeRateMember', window );">Lioan Prime Rate [Member] | Right of Use Assets [Member] | Secured Bank Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Net carrying amount</a></td>
<td class="nump">&#165; 25,338<span></span>
</td>
<td class="nump">$ 3,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_LloanPrimeRateMember', window );">Lioan Prime Rate [Member] | Buildings [Member] | Secured Bank Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_RightofuseAssetsMember', window );">Right of Use Assets [Member] | Lioan Prime Rate [Member] | Secured Bank Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 26,468<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnsecuredBankLoansReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loans received from banks that have not been secured by collateral. [Refer: Loans received]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnsecuredBankLoansReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_LloanPrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_LloanPrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_SecuredBankBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_SecuredBankBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>201
<FILENAME>R139.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Interest-Bearing Bank and Other Borrowings - Schedule of Interest-Bearing Bank and Other Borrowings (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 1,222,481<span></span>
</td>
<td class="nump">&#165; 779,062<span></span>
</td>
<td class="nump">$ 174,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non-current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">757,238<span></span>
</td>
<td class="nump">889,435<span></span>
</td>
<td class="nump">108,284<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 1,979,719<span></span>
</td>
<td class="nump">&#165; 1,668,497<span></span>
</td>
<td class="nump">283,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_ShortTermBorrowingMember', window );">Short-Term Borrowing [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Effective interest rate per annum (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2.11-2.50 or 1 year LPR-0.60 to 0.89<span></span>
</td>
<td class="text">2.60-2.70 or 1 year LPR-0.30 to 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2026<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 1,040,000<span></span>
</td>
<td class="nump">&#165; 290,000<span></span>
</td>
<td class="nump">148,718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_ShortTermBorrowingMember', window );">Short-Term Borrowing [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_ShortTermBorrowingMember', window );">Short-Term Borrowing [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember', window );">Current Portion of Long-Term Bank Loans &#8211; Unsecured [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Effective interest rate per annum (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2.80<span></span>
</td>
<td class="text">1 year LPR-0.15 to 0.65 or 1 year LPR+0.65 to 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2026<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 2,500<span></span>
</td>
<td class="nump">&#165; 213,170<span></span>
</td>
<td class="nump">358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember', window );">Current Portion of Long-Term Bank Loans &#8211; Unsecured [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember', window );">Current Portion of Long-Term Bank Loans &#8211; Unsecured [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember', window );">Current Portion of Long-Term Bank Loans &#8211; Unsecured [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Effective interest rate per annum (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1 year LPR-0.45 to 0.75<span></span>
</td>
<td class="text">2.80 - 4.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2026<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 156,200<span></span>
</td>
<td class="nump">&#165; 255,000<span></span>
</td>
<td class="nump">22,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember', window );">Current Portion of Long-Term Bank Loans &#8211; Unsecured [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember', window );">Current Portion of Long-Term Bank Loans &#8211; Unsecured [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansSecuredMember', window );">Current Portion of Long-Term Bank Loans &#8211; Secured [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Effective interest rate per annum (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">5 year LPR-0.85<span></span>
</td>
<td class="text">5 year LPR-0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">2026<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#165; 16,498<span></span>
</td>
<td class="nump">&#165; 11,453<span></span>
</td>
<td class="nump">2,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansSecuredMember', window );">Current Portion of Long-Term Bank Loans &#8211; Secured [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansSecuredMember', window );">Current Portion of Long-Term Bank Loans &#8211; Secured [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesCurrentMember', window );">Lease Liabilities, Current [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Effective interest rate per annum (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">4.00 - 4.35<span></span>
</td>
<td class="text">4.00 - 4.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2026<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 7,283<span></span>
</td>
<td class="nump">&#165; 9,439<span></span>
</td>
<td class="nump">1,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesCurrentMember', window );">Lease Liabilities, Current [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesCurrentMember', window );">Lease Liabilities, Current [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredMember', window );">Bank Loans &#8211; Unsecured [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Effective interest rate per annum (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1 year LPR-0.45 to 0.75<span></span>
</td>
<td class="text">1 year LPR-0.45 to 0.65 or 1 year LPR+0.70 to 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non-current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 114,900<span></span>
</td>
<td class="nump">&#165; 203,100<span></span>
</td>
<td class="nump">16,431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredMember', window );">Bank Loans &#8211; Unsecured [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2027<span></span>
</td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredMember', window );">Bank Loans &#8211; Unsecured [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2028<span></span>
</td>
<td class="text">2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredOneMember', window );">Bank Loans &#8211; Unsecured [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Effective interest rate per annum (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2.80<span></span>
</td>
<td class="text">2.80-4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non-current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 43,750<span></span>
</td>
<td class="nump">&#165; 77,250<span></span>
</td>
<td class="nump">6,256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredOneMember', window );">Bank Loans &#8211; Unsecured [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredOneMember', window );">Bank Loans &#8211; Unsecured [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansSecuredMember', window );">Bank Loans &#8211; Secured [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Effective interest rate per annum (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">5 year LPR-0.85<span></span>
</td>
<td class="text">5 year LPR-0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non-current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#165; 583,675<span></span>
</td>
<td class="nump">&#165; 588,292<span></span>
</td>
<td class="nump">83,464<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansSecuredMember', window );">Bank Loans &#8211; Secured [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">2027<span></span>
</td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansSecuredMember', window );">Bank Loans &#8211; Secured [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">2038<span></span>
</td>
<td class="text">2038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesNonCurrentMember', window );">Lease Liabilities, Non-current [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Effective interest rate per annum (%)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">4.00 - 4.35<span></span>
</td>
<td class="text">4.00 - 4.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non-current borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 14,913<span></span>
</td>
<td class="nump">&#165; 20,793<span></span>
</td>
<td class="nump">$ 2,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesNonCurrentMember', window );">Lease Liabilities, Non-current [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2027<span></span>
</td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesNonCurrentMember', window );">Lease Liabilities, Non-current [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems', window );"><strong>Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">2028<span></span>
</td>
<td class="text">2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The bank loans amounting to RMB600,173 (US$85,823) as at December 31, 2025 were secured by the pledge of the Group&#8217;s buildings with a net carrying amount of RMB676,985 (US$96,808) and right-of-use assets with a net carrying amount of RMB25,338 (US$3,623) as at December 31, 2025. Such loans were also guaranteed by two of the Group&#8217;s subsidiaries.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_ShortTermBorrowingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_ShortTermBorrowingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansSecuredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_CurrentPortionOfLongTermBankLoansSecuredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_BankLoansUnsecuredOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_BankLoansSecuredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_BankLoansSecuredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesNonCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_LeaseLiabilitiesNonCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>202
<FILENAME>R140.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Interest-Bearing Bank and Other Borrowings - Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AnalyzedIntoAbstract0', window );"><strong>Analyzed into:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Interest-Bearing Bank and Other Borrowings Total</a></td>
<td class="nump">&#165; 1,979,719<span></span>
</td>
<td class="nump">$ 283,096<span></span>
</td>
<td class="nump">&#165; 1,668,497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Within one year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AnalyzedIntoAbstract0', window );"><strong>Analyzed into:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Interest-Bearing Bank and Other Borrowings Total</a></td>
<td class="nump">1,222,481<span></span>
</td>
<td class="nump">174,812<span></span>
</td>
<td class="nump">779,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">In the second year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AnalyzedIntoAbstract0', window );"><strong>Analyzed into:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Interest-Bearing Bank and Other Borrowings Total</a></td>
<td class="nump">160,201<span></span>
</td>
<td class="nump">22,908<span></span>
</td>
<td class="nump">242,473<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">In the third to fifth years, inclusive [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AnalyzedIntoAbstract0', window );"><strong>Analyzed into:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Interest-Bearing Bank and Other Borrowings Total</a></td>
<td class="nump">140,100<span></span>
</td>
<td class="nump">20,034<span></span>
</td>
<td class="nump">159,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Beyond five years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AnalyzedIntoAbstract0', window );"><strong>Analyzed into:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Interest-Bearing Bank and Other Borrowings Total</a></td>
<td class="nump">&#165; 456,937<span></span>
</td>
<td class="nump">$ 65,342<span></span>
</td>
<td class="nump">&#165; 487,607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AnalyzedIntoAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AnalyzedIntoAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>203
<FILENAME>R141.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Income - Schedule of Deferred Income (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfDeferredIncomeAbstract', window );"><strong>Schedule of Deferred Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentGovernmentGrants', window );">Government grants</a></td>
<td class="nump">&#165; 6,500<span></span>
</td>
<td class="nump">$ 929<span></span>
</td>
<td class="nump">&#165; 27,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfDeferredIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfDeferredIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>204
<FILENAME>R142.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Income - Schedule of Movements in Government Grants (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_MovementsInGovernmentGrantsAbstract', window );"><strong>Schedule of Movements in Government Grants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GovernmentGrants', window );">At beginning of the year</a></td>
<td class="nump">&#165; 27,500<span></span>
</td>
<td class="nump">$ 3,932<span></span>
</td>
<td class="nump">&#165; 36,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RecognizedAsIncomeDuringTheYear', window );">Received during the year</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">7,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PortionClassifiedAsCurrentLiabilities', window );">Portion classified as current liabilities (note 26)</a></td>
<td class="num">(22,000)<span></span>
</td>
<td class="num">(3,146)<span></span>
</td>
<td class="num">(16,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GovernmentGrants', window );">At end of the year</a></td>
<td class="nump">&#165; 6,500<span></span>
</td>
<td class="nump">$ 929<span></span>
</td>
<td class="nump">&#165; 27,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_MovementsInGovernmentGrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_MovementsInGovernmentGrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PortionClassifiedAsCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amunt of portion classified as current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PortionClassifiedAsCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_RecognizedAsIncomeDuringTheYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of recognized as income during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_RecognizedAsIncomeDuringTheYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>205
<FILENAME>R143.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Treasury Shares (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2023 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 29, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 01, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 20, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Jun. 20, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfOrdinaryShare', window );">Subscription of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,528,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapitalOrdinaryShares', window );">Share capital (in Yuan Renminbi)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 256,000<span></span>
</td>
<td class="nump">&#165; 214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">&#165; 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">New shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">911,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_WeightedAverageExercisePrice', window );">Weighted average exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital (in Yuan Renminbi) | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 50.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfTreasuryShares', window );">Treasury shares</a></td>
<td class="nump">2,081,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,237,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_SharesConsiderationAmount', window );">Total consideration shares (in Yuan Renminbi) | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 5,923,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_SubscriptionOfShares', window );">Subscription of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,307,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=aapg_ShareCapitalMember', window );">Share Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_BonusDueToEmployeesAmount', window );">Bonus due to employees amount (in Yuan Renminbi) | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=aapg_HongKongStockExchangeMember', window );">Hong Kong Stock Exchange [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockPurchasedDuringPeriodShares', window );">Stock purchased during period, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration (in Yuan Renminbi) | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1,959,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=aapg_TreasurySharesOneMember', window );">Treasury shares one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfTreasuryShares', window );">Treasury shares</a></td>
<td class="nump">397,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">939,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">939,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AllottedSharesPricePerShares', window );">Allotted shares price per shares (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=aapg_RestrictedShareUnitMember', window );">Restricted Share Unit [Member] | Share Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_BonusDueToEmployeesAmount', window );">Bonus due to employees amount (in Yuan Renminbi) | &#165;</a></td>
<td class="nump">&#165; 8,630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=aapg_RestrictedShareUnitMember', window );">Restricted Share Unit [Member] | Treasury shares one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_BonusDueToEmployeesAmount', window );">Bonus due to employees amount (in Yuan Renminbi) | &#165;</a></td>
<td class="nump">&#165; 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TreasurySharesOneMember', window );">Treasury shares one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfTreasuryShares', window );">Treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyTwoRSUchemeMember', window );">2022 RSU Scheme [Member] | Hong Kong Stock Exchange [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember', window );">2018 and 2022 RSU Schemes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfTreasuryShares', window );">Treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,069,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_PreIPOShareOptionSchemeMember', window );">Pre-IPO Share Option Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">New shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_WeightedAverageExercisePrice', window );">Weighted average exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital (in Yuan Renminbi) | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">Two Thousand Twenty One RSU Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">New shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">48,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">Two Thousand Twenty One RSU Scheme [Member] | Share Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital (in Yuan Renminbi) | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 50.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AllottedSharesPricePerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allotted shares price per shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AllottedSharesPricePerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_BonusDueToEmployeesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bonus due to employees, amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_BonusDueToEmployeesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IssueOfOrdinaryShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IssueOfOrdinaryShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NumberOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NumberOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_SharesConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares consideration amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_SharesConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockPurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been purchased during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockPurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_SubscriptionOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of subscription of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_SubscriptionOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_WeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_WeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapitalOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapitalOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issue under options and contracts for the sale of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=aapg_ShareCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=aapg_ShareCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=aapg_HongKongStockExchangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=aapg_HongKongStockExchangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=aapg_TreasurySharesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=aapg_TreasurySharesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=aapg_RestrictedShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=aapg_RestrictedShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TreasurySharesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aapg_TreasurySharesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyTwoRSUchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyTwoRSUchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_PreIPOShareOptionSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aapg_PreIPOShareOptionSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyOneRSUSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyOneRSUSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>206
<FILENAME>R144.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Details) - Share Capital [Member]<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Schedule of Issued and Fully Paid [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares in issue, Ordinary shares of US$0.0001 each</a></td>
<td class="nump">373,321,692<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
<td class="nump">290,196,560<span></span>
</td>
<td class="nump">290,196,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Share capital, Ordinary shares of US$0.0001 each</a></td>
<td class="nump">&#165; 256<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">&#165; 214<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">&#165; 197<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_ShareCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aapg_ShareCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>207
<FILENAME>R145.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Parentheticals) (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_ShareCapitalMember', window );">Share Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Schedule of Issued and Fully Paid [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Share capital, Ordinary shares, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_ShareCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aapg_ShareCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>208
<FILENAME>R146.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Treasury Shares - Schedule of Share Capital and Treasury Shares (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems', window );"><strong>Schedule of Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">315,224,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssuedShareCapital', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 206<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#165; (21,154)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#165; (26,372)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfOrdinaryShare', window );">Issue of ordinary shares (in Shares) | shares</a></td>
<td class="nump">1,528,514<span></span>
</td>
<td class="nump">24.45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24.45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfOrdinaryShares', window );">Issue of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfSharesUnderThePreIPOShareOptionScheme', window );">Issue of shares under the pre-IPO share option scheme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme', window );">Issue of shares under the 2021 RSU scheme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValuesEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,590)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,959)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="num">(5,923)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_VestingOfRestrictedShareUnits', window );">Vesting of RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#165; 14,671<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
<td class="nump">11,123<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">373,321,692<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">315,224,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssuedShareCapital', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (2,705)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (386)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#165; 206<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21,154)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">315,224,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssuedShareCapital', window );">Balance (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (2,705)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#165; 206<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#165; (21,154)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_OrdinarySharesMember', window );">Number of shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems', window );"><strong>Schedule of Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">315,224,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">290,196,560<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">265,185,950<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfOrdinaryShare', window );">Issue of ordinary shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,040,576<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">55,040,576<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">24,307,322<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">22,500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares', window );">Issue of shares under the pre-IPO share option scheme (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">455,263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">455,263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">656,077<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">911,062<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfSharesUnderThe2021RSUSchemeInshares', window );">Issue of shares under the 2021 RSU scheme (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,008,253<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">1,008,253<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">65,034<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">71,034<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus', window );">Equity-settled bonus (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,592,607<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">1,592,607<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="nump">1,528,514<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RepurchaseOfOrdinaryShare', window );">Repurchase of ordinary shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_VestingOfRestrictedShareUnit', window );">Vesting of RSUs (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">373,321,692<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">315,224,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">290,196,560<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">315,224,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">290,196,560<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember', window );">Share capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems', window );"><strong>Schedule of Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssuedShareCapital', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#165; 197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#165; 180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfOrdinaryShares', window );">Issue of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfSharesUnderThePreIPOShareOptionScheme', window );">Issue of shares under the pre-IPO share option scheme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme', window );">Issue of shares under the 2021 RSU scheme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValuesEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_VestingOfRestrictedShareUnits', window );">Vesting of RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssuedShareCapital', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssuedShareCapital', window );">Balance (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember', window );">Treasury shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems', window );"><strong>Schedule of Share Capital and Treasury Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssuedShareCapital', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21,351)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(26,552)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfOrdinaryShares', window );">Issue of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssueOfSharesUnderThePreIPOShareOptionScheme', window );">Issue of shares under the pre-IPO share option scheme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme', window );">Issue of shares under the 2021 RSU scheme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValuesEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,631<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,590)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,959)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="num">(5,923)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_VestingOfRestrictedShareUnits', window );">Vesting of RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,671<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
<td class="nump">11,123<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssuedShareCapital', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,961)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21,351)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IssuedShareCapital', window );">Balance (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (2,961)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#165; (8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#165; (21,351)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, 7,325,000 ADS (represents 29,300,000 of the Company&#8217;s ordinary shares) were offered at a price of US$17.25 per ADS on January 23, 2025, followed by an additional 935,144 ADS (represents 3,740,576 of the Company&#8217;s ordinary shares) were offered at the same price on February 13, 2025, and 22,000,000 placing shares of the Company were issued and allotted at a price of HK$68.6 per share on July 17, 2025, amounts of RMB40 (US$6) was credited as share capital.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, 24,307,322 placing shares of the Company were issued and allotted at a price of HK$24.10 per share on June 20, 2024, and an amount of RMB17 was credited as share capital.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the share placement, 22,500,000 placing shares of the Company were issued and allotted at a price of HK$24.45 per share on February 1, 2023, and an amount of RMB15 was credited as share capital.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">During the year ended December 31, 2025, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 455,263 new shares of the Company were issued with a weighted average exercise price of HK$ 0.01, and an amount of RMB0.3 (US$0.04) was credited as share capital.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">During the year ended December 31, 2024, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 656,077 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.5 was credited as share capital.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company before December 31, 2023 to those grantees. In connection with the exercised share options, 911,062 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB1 was credited as share capital.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During June to September 2025, the Company issued ordinary shares with respect to the restricted share units under the 2021 and 2022 RSU Scheme exercised by certain selected persons of the Company before December 31, 2025 to those selected persons. In connection with the exercised restricted share units, 1,008,253 new shares of the Company were issued, and an amount of RMB0.7 (US$0.1) was credited as share capital.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2024, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2024 to those selected persons. In connection with the exercised RSUs, 65,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2023 to those selected persons. In connection with the exercised RSUs, 71,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2025, 775,685 ordinary shares and 816,922 ordinary shares, being underlying shares of the restricted share units granted under the 2021 RSU scheme and the 2022 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB0.5 (US$0.07) and RMB0.6 (US$0.09) credited as share capital.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2024, 397,949 treasury shares and 2,081,399 treasury shares, being underlying shares of the RSUs granted under the 2022 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB8,630 and RMB1.4 were both credited as treasury shares.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, 1,528,514 ordinary shares and 1,237,884 treasury shares, being underlying shares of the RSUs granted under the 2021 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB1 and RMB1 were credited as share capital and treasury shares, respectively.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2025, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB3,590 (US$513) for the purpose of the 2022 RSU scheme.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[14]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2024, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB1,959 for the purpose of the 2022 RSU Scheme.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[15]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the Company instructed the trustee to purchase 250,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB5,923 for the purpose of the 2022 RSU scheme.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[16]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of restricted share units granted under the 2022 RSU Scheme, 17,925 treasury shares were allotted to the employees during the year ended December 31, 2025.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[17]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of RSUs granted under the 2018 and 2022 RSU Schemes, 939,687 treasury shares were allotted to the employees during the year ended December 31, 2024.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[18]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the exercise of RSUs granted under the 2018 and 2022 RSU Scheme, 1,069,461 treasury shares were allotted to the employees during the year ended December 31,2023.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of shares, equity-settled bonus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of shares under the 2021 RSU.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of share capital, repurchase of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IssueOfOrdinaryShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IssueOfOrdinaryShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IssueOfSharesUnderThe2021RSUSchemeInshares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of shares under the 2021 RSU scheme.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IssueOfSharesUnderThe2021RSUSchemeInshares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IssueOfSharesUnderThePreIPOShareOptionScheme">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of shares under the pre-IPO share option scheme.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IssueOfSharesUnderThePreIPOShareOptionScheme</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of shares under the pre-IPO share option scheme.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IssuedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IssuedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_RepurchaseOfOrdinaryShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_RepurchaseOfOrdinaryShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValuesEquitysettledBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity-settled bonus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValuesEquitysettledBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_VestingOfRestrictedShareUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting of restricted share units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_VestingOfRestrictedShareUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_VestingOfRestrictedShareUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting of restricted share units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_VestingOfRestrictedShareUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>209
<FILENAME>R147.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reserves (Details)<br> $ / shares in Units, &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesWithinEquityLineItems', window );"><strong>Reserves [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">&#165; 8,916,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 6,545,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,275,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_TransferredOutFromCapitalAndReserves', window );">Transferred out from capital and reserves | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 43,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CapitalAndReserveFunds', window );">Capital and Reserve Funds</a></td>
<td class="nump">3,033,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,702,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 433,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_BonusAmount', window );">Bonus amount</a></td>
<td class="nump">&#165; 58,869<span></span>
</td>
<td class="nump">$ 8,418<span></span>
</td>
<td class="nump">&#165; 49,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Newly issued shares (in Shares) | shares</a></td>
<td class="nump">373,321,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Price per shares (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember', window );">RSU Schemes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesWithinEquityLineItems', window );"><strong>Reserves [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalReserve', window );">Capital reserve</a></td>
<td class="nump">&#165; 20,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 20,924<span></span>
</td>
<td class="nump">31,503<span></span>
</td>
<td class="nump">$ 2,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,333<span></span>
</td>
<td class="nump">&#165; 32,593<span></span>
</td>
<td class="nump">4,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_TransferredOutFromCapitalAndReserves', window );">Transferred out from capital and reserves</a></td>
<td class="nump">33,635<span></span>
</td>
<td class="nump">$ 4,810<span></span>
</td>
<td class="nump">33,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_ReservesMember', window );">Reserves [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesWithinEquityLineItems', window );"><strong>Reserves [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">&#165; 58,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 40,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Newly issued shares (in Shares) | shares</a></td>
<td class="nump">1,592,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,479,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,592,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Price per shares (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.95<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_BonusAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of bonus paid to employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_BonusAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CapitalAndReserveFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital and Reserve Funds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CapitalAndReserveFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_TransferredOutFromCapitalAndReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounrt represents the value of transferred out from capital and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_TransferredOutFromCapitalAndReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the capital reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReservesWithinEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReservesWithinEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_ReservesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_ReservesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>210
<FILENAME>R148.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments (Details)<br> $ / shares in Units, $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="9">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3"></th>
</tr>
<tr>
<th class="th"><div>Oct. 26, 2026</div></th>
<th class="th">
<div>Nov. 26, 2025 </div>
<div>shares</div>
</th>
<th class="th"><div>Jun. 27, 2025</div></th>
<th class="th"><div>Sep. 02, 2024</div></th>
<th class="th"><div>May 04, 2023</div></th>
<th class="th"><div>Jun. 23, 2022</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>May 17, 2021</div></th>
<th class="th"><div>Feb. 02, 2021</div></th>
<th class="th"><div>Sep. 14, 2020</div></th>
<th class="th"><div>Jul. 06, 2018</div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>HKD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Apr. 30, 2025</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>HKD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Exercised shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,707,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of share options exercised in share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">455,263<span></span>
</td>
<td class="nump">455,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656,077<span></span>
</td>
<td class="nump">656,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average share price exercised (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareGrantExpense', window );">Share grant expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 3,169<span></span>
</td>
<td class="nump">$ 1,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AdditionalOrdinaryShares', window );">Additional ordinary shares. (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,152,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,152,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,152,227<span></span>
</td>
<td class="nump">2,152,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 8,916,853,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,916,853,000<span></span>
</td>
<td class="nump">&#165; 6,545,129,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,545,129,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,275,093,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfExceedShareCapital', window );">Exceed share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AggregateShareIssued', window );">Aggregate shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_SharesGranted', window );">Shares granted (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted options shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price, share options granted (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement', window );">Share option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 2,420,000<span></span>
</td>
<td class="nump">$ 346,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,177,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019', window );">RSUs exercised weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_GrantAnniversariesAxis=aapg_FirstAnniversariesMember', window );">First anniversaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">percentage of vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25%<span></span>
</td>
<td class="text">25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_GrantAnniversariesAxis=aapg_SecondAnniversaryMember', window );">Second Anniversary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">percentage of vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25%<span></span>
</td>
<td class="text">25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_GrantAnniversariesAxis=aapg_ThirdAnniversaryMember', window );">Third Anniversary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">percentage of vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25%<span></span>
</td>
<td class="text">25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_GrantAnniversariesAxis=aapg_FourthAnniversaryMember', window );">Fourth Anniversary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">percentage of vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25%<span></span>
</td>
<td class="text">25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PreIPOShareOptionsMember', window );">Pre-IPO Share Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Exercised shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,307,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,307,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,307,533<span></span>
</td>
<td class="nump">12,307,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_ShareOptionSchemeMember', window );">Share Option Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of share options exercised in share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,152,227<span></span>
</td>
<td class="nump">2,152,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,607,571<span></span>
</td>
<td class="nump">2,607,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,957,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalReserve', window );">Capital reserve | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 34,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfExceedShareCapital', window );">Exceed share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_SpecialOptionsMember', window );">Special Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average share price exercised (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PreIPOShareOptionSchemeMember', window );">Pre-IPO Share Option Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareGrantExpense', window );">Share grant expense | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PostIPOOptionSchemeMember', window );">Post-IPO Option Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Exercised shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,907,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of share options exercised in share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average share price exercised (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted options shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement', window );">Percentage of vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember', window );">Restricted share units [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AdditionalOrdinaryShares', window );">Additional ordinary shares. (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,902,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalReserve', window );">Capital reserve | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 20,294,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,294,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember', window );">Restricted share units [member] | Dr. Yang Dajun [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandEighteenRSUSchemeMember', window );">2018 RSU Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Date of adoption.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,590,592<span></span>
</td>
<td class="nump">5,274,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_SharebasedPaymentVestingPeriod', window );">Share-based payment vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOnesRSUSchemeMember', window );">2021 RSU Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareGrantExpense', window );">Share grant expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,604,000<span></span>
</td>
<td class="nump">$ 515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 856,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalReserve', window );">Capital reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1,712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Date of adoption.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,439<span></span>
</td>
<td class="nump">48,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019', window );">RSUs exercised weighted average price | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOnesRSUSchemeMember', window );">2021 RSU Scheme [Member] | RSU [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,490<span></span>
</td>
<td class="nump">3,133,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOnesRSUSchemeMember', window );">2021 RSU Scheme [Member] | Non-Executive Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,892<span></span>
</td>
<td class="nump">10,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOnesRSUSchemeMember', window );">2021 RSU Scheme [Member] | Chief Commercial Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUchemeMember', window );">2022 RSU Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareGrantExpense', window );">Share grant expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 14,850,000<span></span>
</td>
<td class="nump">$ 2,124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 20,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,995,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalReserve', window );">Capital reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 78,740,000<span></span>
</td>
<td class="nump">$ 11,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Date of adoption.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,177,256<span></span>
</td>
<td class="nump">1,177,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777,006<span></span>
</td>
<td class="nump">777,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019', window );">RSUs exercised weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RSUsGrantedFairValue', window );">RSUs granted fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 68,327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,327,000<span></span>
</td>
<td class="nump">&#165; 24,078,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,078,000<span></span>
</td>
<td class="nump">&#165; 27,063,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,063,000<span></span>
</td>
<td class="nump">$ 9,771,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUchemeMember', window );">2022 RSU Scheme [Member] | RSU [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,177,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777,006<span></span>
</td>
<td class="nump">1,379,094<span></span>
</td>
<td class="nump">1,634,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,072,695<span></span>
</td>
<td class="nump">11,072,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUchemeMember', window );">2022 RSU Scheme [Member] | Dr. Zhai Yifan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | RSU [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=aapg_ForecastMember', window );">Forecast [Member] | Post-IPO Option Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement', window );">Percentage of vesting percentage</a></td>
<td class="nump">8.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AdditionalOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AdditionalOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AggregateShareIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of aggregate share issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AggregateShareIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options expense in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PercentageOfExceedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of exceed share capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PercentageOfExceedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PercentageOfVestedConditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the percentage of vested conditional shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PercentageOfVestedConditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting requirements for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_RSUsGrantedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>RSUs granted fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_RSUsGrantedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ShareGrantExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share grant expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ShareGrantExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_SharebasedPaymentVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based payment  vesting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_SharebasedPaymentVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_SharesGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_SharesGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the capital reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_GrantAnniversariesAxis=aapg_FirstAnniversariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_GrantAnniversariesAxis=aapg_FirstAnniversariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_GrantAnniversariesAxis=aapg_SecondAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_GrantAnniversariesAxis=aapg_SecondAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_GrantAnniversariesAxis=aapg_ThirdAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_GrantAnniversariesAxis=aapg_ThirdAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_GrantAnniversariesAxis=aapg_FourthAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_GrantAnniversariesAxis=aapg_FourthAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PreIPOShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PreIPOShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_ShareOptionSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_ShareOptionSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_SpecialOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_SpecialOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PreIPOShareOptionSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PreIPOShareOptionSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PostIPOOptionSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PostIPOOptionSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrYangDajunMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrYangDajunMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandEighteenRSUSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandEighteenRSUSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOnesRSUSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOnesRSUSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=aapg_RSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=aapg_RSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_NonExecutiveDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_NonExecutiveDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_ChiefCommercialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_ChiefCommercialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrZhaiYifanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrZhaiYifanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=aapg_ForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=aapg_ForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>211
<FILENAME>R149.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 26, 2025</div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems', window );"><strong>Schedule of Share Options Outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price, Outstanding as of beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options, Outstanding as of beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,607,571<span></span>
</td>
<td class="nump">3,263,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options, Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Exercise price, Forfeited during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Number of options, Forfeited during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercise price, Exercised during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of options, Exercised during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(455,263)<span></span>
</td>
<td class="num">(656,077)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price, Outstanding as of ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options, Outstanding as of ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,152,227<span></span>
</td>
<td class="nump">2,607,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PostIPOOptionSchemeMember', window );">Post-IPO Option Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems', window );"><strong>Schedule of Share Options Outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price, Outstanding as of beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options, Outstanding as of beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Exercise price, Granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options, Granted during the year</a></td>
<td class="nump">146,375<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercise price, Exercised during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of options, Exercised during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price, Outstanding as of ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.35<span></span>
</td>
<td class="nump">$ 63.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options, Outstanding as of ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PostIPOOptionSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PostIPOOptionSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>212
<FILENAME>R150.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-Based Payments - Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems', window );"><strong>Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">2,152,227<span></span>
</td>
<td class="nump">2,607,571<span></span>
</td>
<td class="nump">3,263,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price per share (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember', window );">15 Aug 2018&#8211;15 Aug 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems', window );"><strong>Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">1,983,383<span></span>
</td>
<td class="nump">2,360,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price per share (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember', window );">15 May 2019&#8211;15 May 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems', window );"><strong>Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">159,712<span></span>
</td>
<td class="nump">232,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price per share (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember', window );">16 Sept 2019-16 Sept 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems', window );"><strong>Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">9,132<span></span>
</td>
<td class="nump">14,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price per share (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TwentySixNov202526Nov2035Member', window );">26 Nov 2025&#8211;26 Nov 2035 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems', window );"><strong>Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price per share (in Dollars per share)</a></td>
<td class="nump">$ 63.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TwentySixNov202526Nov2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TwentySixNov202526Nov2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>213
<FILENAME>R151.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Schedule of fair values of share options granted (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract', window );"><strong>Schedule of fair values of share options granted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">49.65%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate%</a></td>
<td class="nump">3.09%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of options (year)</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average share price (HKD per share) (in Dollars per share)</a></td>
<td class="nump">$ 34.98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>214
<FILENAME>R152.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Schedule of Unlocking Date (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">2021 RSU Scheme [Member] | Type of Eligible Participants 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 43.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 8, 2021-2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">35%, 15%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">2021 RSU Scheme [Member] | Type of Eligible Participants 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 43.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 8, 2021-2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">25%, 25%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">2021 RSU Scheme [Member] | Type of Eligible Participants 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 43.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 8, 2022&#8211;2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">35%, 15%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">2021 RSU Scheme [Member] | Type of Eligible Participants 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 43.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">April 30, 2022&#8211;2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">35%, 15%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">2021 RSU Scheme [Member] | Type of Eligible Participants 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 43.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 8, 2022&#8211;2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">25%, 25%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">2021 RSU Scheme [Member] | Type of Eligible Participants 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 8, 2022&#8211;2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">25%, 25%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">2021 RSU Scheme [Member] | Type of Eligible Participants 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 77.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 27, 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">100%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember', window );">2022 RSU Scheme [Member] | Type of Eligible Participants 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 20.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 8, 2021-2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">35%, 15%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember', window );">2022 RSU Scheme [Member] | Type of Eligible Participants 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 20.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">April 30, 2023&#8211;2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">25%, 25%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember', window );">2022 RSU Scheme [Member] | Type of Eligible Participants 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 20.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 8, 2023&#8211;2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">25%, 25%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember', window );">2022 RSU Scheme [Member] | Type of Eligible Participants 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 20.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 8, 2023&#8211;2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">40%, 60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember', window );">2022 RSU Scheme [Member] | Type of Eligible Participants 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 20.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">June 8, 2023&#8211;2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">30%, 30%, 40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember', window );">2022 RSU Scheme [Member] | Type of Eligible Participants 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 20.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">April 30, 2023&#8211;2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">23%, 69%, 6%, 2%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember', window );">2022 RSU Scheme [Member] | Type of Eligible Participants 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 21.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">August 1, 2023&#8211;2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">40%, 60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember', window );">2022 RSU Scheme [Member] | Type of Eligible Participants 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 21.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">August 1, 2023&#8211;2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">30%, 30%, 40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">100%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2024-2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">50%, 50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2024-2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">30%, 30%, 40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2024-2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">22.5%, 22.5%, 55%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2024-2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">50%, 25%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2024-2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">75%, 25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2024-2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">25%, 37%, 38%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">100%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2025-2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">40%, 60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 10 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 33.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">September 16, 2025-2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">50%, 50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 63.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">November 26, 2026-2028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">33.33%, 33.33%, 33.34%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember', window );">2022 Further Grant [Member] | Type of Eligible Participants 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Unlocking Date [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Grant fair value per share</a></td>
<td class="nump">$ 63.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfConditionalShares', window );">% of conditional shares</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting date</a></td>
<td class="text">November 26, 2026-2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PercentageOfVestedConditionalShares', window );">% of vested conditional shares</a></td>
<td class="text">25%, 25%, 25%, 25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PercentageOfConditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the percentage of conditional shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PercentageOfConditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PercentageOfVestedConditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the percentage of vested conditional shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PercentageOfVestedConditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Types of share-based payment arrangements [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOneRSUSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOneRSUSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipantsSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants1OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants1OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants1ThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants1ThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants2FourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants2FourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoFurtherGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants2ThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants2ThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants1TwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants1TwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants2OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aapg_TypeOfEligibleParticipants2OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>215
<FILENAME>R153.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Schedule of Restricted Shares Outstanding (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOnesRSUSchemeMember', window );">2021 RSU Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Restricted Shares Outstanding [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of RSUs, Outstanding, beginning balance</a></td>
<td class="nump">41,552<span></span>
</td>
<td class="nump">108,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of RSUs, Granted during the year</a></td>
<td class="nump">48,439<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement', window );">Number of RSUs, Forfeited during the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,412)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of RSUs, Vested during the year</a></td>
<td class="num">(89,991)<span></span>
</td>
<td class="num">(65,034)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of RSUs, Outstanding, ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">41,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUchemeMember', window );">2022 RSU Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Restricted Shares Outstanding [Line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of RSUs, Outstanding, beginning balance</a></td>
<td class="nump">1,436,525<span></span>
</td>
<td class="nump">1,641,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of RSUs, Granted during the year</a></td>
<td class="nump">1,177,256<span></span>
</td>
<td class="nump">777,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement', window );">Number of RSUs, Forfeited during the year</a></td>
<td class="num">(132,302)<span></span>
</td>
<td class="num">(42,768)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of RSUs, Vested during the year</a></td>
<td class="num">(936,187)<span></span>
</td>
<td class="num">(939,687)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of RSUs, Outstanding, ending balance</a></td>
<td class="nump">1,545,292<span></span>
</td>
<td class="nump">1,436,525<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOnesRSUSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyOnesRSUSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_TwoThousandTwentyTwoRSUchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>216
<FILENAME>R154.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes to the Consolidated Statements of Cash Flows (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 26, 2025</div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems', window );"><strong>Notes to the Consolidated Statements of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of RSU</a></td>
<td class="nump">1,177,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfGrantees', window );">Number of grantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares, shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,224,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,321,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfNewlyIssuedShares', window );">Number of newly issued shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,278<span></span>
</td>
<td class="nump">176,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_BonusAmount', window );">Settlement of bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 58,869<span></span>
</td>
<td class="nump">$ 8,418<span></span>
</td>
<td class="nump">&#165; 49,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities', window );">Non cash addition for right of use assets and lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,108<span></span>
</td>
<td class="nump">&#165; 16,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NonCashDisposals', window );">Non-cash disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NoncashAdditionsToIntangibleAssets', window );">Non-cash additions to intangible assets | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
<td class="nump">805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NonCashAdditionsToPropertyPlantAndEquipment', window );">Non-cash additions to property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,011<span></span>
</td>
<td class="nump">1,432<span></span>
</td>
<td class="nump">9,424<span></span>
</td>
<td class="nump">&#165; 26,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems', window );"><strong>Notes to the Consolidated Statements of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NonCashDisposals', window );">Non-cash disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,675<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems', window );"><strong>Notes to the Consolidated Statements of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NonCashDisposals', window );">Non-cash disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 3,360<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="nump">1,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_EmployeeMember', window );">Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems', window );"><strong>Notes to the Consolidated Statements of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares, shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,592,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,592,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_BonusAmount', window );">Settlement of bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 58,869<span></span>
</td>
<td class="nump">$ 8,418<span></span>
</td>
<td class="nump">&#165; 49,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PostIPOOptionSchemeMember', window );">Post-IPO Option Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems', window );"><strong>Notes to the Consolidated Statements of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of RSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="nump">633,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfGrantees', window );">Number of grantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyOneRSUSchemeMember', window );">Two Thousand Twenty One RSU Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems', window );"><strong>Notes to the Consolidated Statements of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfGrantees', window );">Number of grantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares, shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember', window );">Two Thousand Twenty Two RSU Scheme [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems', window );"><strong>Notes to the Consolidated Statements of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_NumberOfGrantees', window );">Number of grantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777,006<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares, shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,177,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,177,256<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_BonusAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of bonus paid to employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_BonusAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash addition for right of use assets and lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NonCashAdditionsToPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash additions to property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NonCashAdditionsToPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NonCashDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash disposals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NonCashDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NoncashAdditionsToIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash additions to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NoncashAdditionsToIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NumberOfGrantees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of grantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NumberOfGrantees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_NumberOfNewlyIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of newly issued shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_NumberOfNewlyIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PostIPOOptionSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aapg_PostIPOOptionSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyOneRSUSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyOneRSUSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aapg_TwoThousandTwentyTwoRSUSchemeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>217
<FILENAME>R155.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes to the Consolidated Statements of Cash Flows - Schedule of Changes in Liabilities Arising from Financing Activities (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Jan. 01, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Jan. 01, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=aapg_AccruedInterestInOtherPayablesAndAccrualsMember', window );">Accrued interest in other payables and accruals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning balance</a></td>
<td class="nump">&#165; 1,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 1,046<span></span>
</td>
<td class="nump">&#165; 383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes from financing cash flows</a></td>
<td class="num">(50,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,057)<span></span>
</td>
<td class="num">(91,027)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">New leases</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets', window );">Disposal</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expenses</a></td>
<td class="nump">49,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,276<span></span>
</td>
<td class="nump">91,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid classified as financing cash flows</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of change in foreign exchange rates</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance</a></td>
<td class="nump">609<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance (in Dollars)</a></td>
<td class="nump">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">&#165; 1,265<span></span>
</td>
<td class="nump">&#165; 1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=aapg_BankAndOtherLoansMember', window );">Bank and other loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning balance</a></td>
<td class="nump">1,638,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,772,914<span></span>
</td>
<td class="nump">1,775,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes from financing cash flows</a></td>
<td class="nump">316,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136,928)<span></span>
</td>
<td class="num">(2,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">New leases</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets', window );">Disposal</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expenses</a></td>
<td class="nump">2,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,279<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid classified as financing cash flows</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of change in foreign exchange rates</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance</a></td>
<td class="nump">1,957,523<span></span>
</td>
<td class="nump">279,922<span></span>
</td>
<td class="nump">1,638,265<span></span>
</td>
<td class="nump">1,772,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance (in Dollars)</a></td>
<td class="nump">1,957,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,638,265<span></span>
</td>
<td class="nump">1,772,914<span></span>
</td>
<td class="nump">1,638,265<span></span>
</td>
<td class="nump">1,772,914<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=aapg_LeaseLiabilityMember', window );">Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning balance</a></td>
<td class="nump">30,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,681<span></span>
</td>
<td class="nump">17,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Changes from financing cash flows</a></td>
<td class="num">(9,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,413)<span></span>
</td>
<td class="num">(10,766)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">New leases</a></td>
<td class="nump">5,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,108<span></span>
</td>
<td class="nump">16,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets', window );">Disposal</a></td>
<td class="num">(3,360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,152)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expenses</a></td>
<td class="nump">1,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,498<span></span>
</td>
<td class="nump">1,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid classified as financing cash flows</a></td>
<td class="num">(1,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,498)<span></span>
</td>
<td class="num">(1,321)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of change in foreign exchange rates</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance</a></td>
<td class="nump">22,196<span></span>
</td>
<td class="nump">$ 3,174<span></span>
</td>
<td class="nump">30,232<span></span>
</td>
<td class="nump">22,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance (in Dollars)</a></td>
<td class="nump">&#165; 22,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 30,232<span></span>
</td>
<td class="nump">&#165; 22,681<span></span>
</td>
<td class="nump">&#165; 30,232<span></span>
</td>
<td class="nump">&#165; 22,681<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on disposals of financial assets in the scope of IFRS 9 to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 44B<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44B_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 44B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44B&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=aapg_AccruedInterestInOtherPayablesAndAccrualsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=aapg_AccruedInterestInOtherPayablesAndAccrualsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=aapg_BankAndOtherLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=aapg_BankAndOtherLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=aapg_LeaseLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=aapg_LeaseLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>218
<FILENAME>R156.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes to the Consolidated Statements of Cash Flows - Schedule of Cash Outflow for Leases Included In the Statement of Cash Flows (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfCashFlowsAbstract', window );"><strong>Schedule of Cash Outflow for Leases Included in the Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities', window );">Within operating activities</a></td>
<td class="nump">&#165; 329<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">&#165; 238<span></span>
</td>
<td class="nump">&#165; 181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities', window );">Within financing activities</a></td>
<td class="nump">10,835<span></span>
</td>
<td class="nump">1,549<span></span>
</td>
<td class="nump">9,911<span></span>
</td>
<td class="nump">12,087<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashInflowOutflowForLease', window );">Total</a></td>
<td class="nump">&#165; 11,164<span></span>
</td>
<td class="nump">$ 1,596<span></span>
</td>
<td class="nump">&#165; 10,149<span></span>
</td>
<td class="nump">&#165; 12,268<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CashInflowOutflowForLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash inflow outflow for lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CashInflowOutflowForLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 21<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inflows (outflows) of cash, classified as operating activities, that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 14<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_14&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>219
<FILENAME>R157.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CommitmentsDetailsLineItems', window );"><strong>Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalCommitments', window );">Capital commitments</a></td>
<td class="nump">&#165; 307<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">&#165; 4,366<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CommitmentsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CommitmentsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of future capital expenditures that the entity is committed to make.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>220
<FILENAME>R158.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingent Liabilities (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract', window );"><strong>Contingent Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities', window );">Contingent liabilities</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the estimated financial effect of contingent liabilities. [Refer: Classes of contingent liabilities [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 86<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_86_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 259<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_259_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 259<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_259_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimatedFinancialEffectOfContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>221
<FILENAME>R159.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 29, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Jul. 17, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,034<span></span>
</td>
<td class="nump">911,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aapg_HealthquestPharmaAcquisitionAgreementMember', window );">Healthquest Pharma Acquisition Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 29,533<span></span>
</td>
<td class="nump">$ 4,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_DrYangMember', window );">Dr. Yang [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Borrowing cost | &#165;</a></td>
<td class="nump">&#165; 3,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest and other costs that an entity incurs in connection with the borrowing of funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aapg_HealthquestPharmaAcquisitionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aapg_HealthquestPharmaAcquisitionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_DrYangMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_DrYangMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>222
<FILENAME>R160.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Transactions - Schedule of Transaction with Related Party (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related Party [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Transaction with related party</a></td>
<td class="nump">&#165; 33,466<span></span>
</td>
<td class="nump">$ 4,785<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrZhaiYifanMember', window );">Dr. Zhai Yifan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related Party [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Transaction with related party</a></td>
<td class="nump">29,533<span></span>
</td>
<td class="nump">4,223<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrYangDajunMember', window );">Dr. Yang Dajun [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Related Party [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Transaction with related party</a></td>
<td class="nump">&#165; 3,933<span></span>
</td>
<td class="nump">$ 562<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrZhaiYifanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrZhaiYifanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrYangDajunMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aapg_DrYangDajunMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>223
<FILENAME>R161.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Transactions - Schedule of Outstanding Balance with Related Party (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OtherPayablesAndAccruals', window );">Other payables and accruals</a></td>
<td class="nump">&#165; 10,308<span></span>
</td>
<td class="nump">$ 1,474<span></span>
</td>
<td class="nump">&#165; 29,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OutstandingBalanceOtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">6,374<span></span>
</td>
<td class="nump">911<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OutstandingBalanceWithRelatedParty', window );">Outstanding balance with related party</a></td>
<td class="nump">&#165; 16,682<span></span>
</td>
<td class="nump">$ 2,385<span></span>
</td>
<td class="nump">&#165; 29,344<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OtherPayablesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other payables and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OtherPayablesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OutstandingBalanceOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other non-current liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OutstandingBalanceOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OutstandingBalanceWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Outstanding balance with related party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OutstandingBalanceWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>224
<FILENAME>R162.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Schedule of Compensation of key Management Personnel (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract', window );"><strong>Schedule of Compensation of Key Management Personnel [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short term employee benefits and fees</a></td>
<td class="nump">&#165; 59,283<span></span>
</td>
<td class="nump">$ 8,477<span></span>
</td>
<td class="nump">&#165; 19,059<span></span>
</td>
<td class="nump">&#165; 20,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Equity-settled share-based payment expenses</a></td>
<td class="nump">3,141<span></span>
</td>
<td class="nump">449<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="nump">1,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Post-employment benefits</a></td>
<td class="nump">711<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">977<span></span>
</td>
<td class="nump">986<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">&#165; 63,135<span></span>
</td>
<td class="nump">$ 9,028<span></span>
</td>
<td class="nump">&#165; 20,661<span></span>
</td>
<td class="nump">&#165; 22,867<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 227<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_227&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 227<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_227&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>225
<FILENAME>R163.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments by Category - Schedule of Categories of Financial Instruments (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems', window );"><strong>Schedule of Categories of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets included in prepayments, other receivables and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#165; 3,609<span></span>
</td>
<td class="nump">$ 516<span></span>
</td>
<td class="nump">&#165; 9,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,470,085<span></span>
</td>
<td class="nump">353,217<span></span>
</td>
<td class="nump">1,261,211<span></span>
</td>
<td class="nump">&#165; 1,093,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Financial assets included in other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">690<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,727,322<span></span>
</td>
<td class="nump">390,002<span></span>
</td>
<td class="nump">1,356,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Interest-bearing bank and other borrowings (current and non-current portions)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,340<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
<td class="nump">29,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember', window );">Financial assets at fair value through profit or loss [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems', window );"><strong>Schedule of Categories of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets included in prepayments, other receivables and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Financial assets included in other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialAssetsAtAmortizedCostMember', window );">Financial assets at amortized cost [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems', window );"><strong>Schedule of Categories of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets included in prepayments, other receivables and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,470,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">252,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Financial assets included in other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,727,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,356,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialAssetsMember', window );">Financial Assets [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems', window );"><strong>Schedule of Categories of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets included in prepayments, other receivables and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,609<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="nump">9,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,470,085<span></span>
</td>
<td class="nump">353,217<span></span>
</td>
<td class="nump">1,261,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">252,938<span></span>
</td>
<td class="nump">36,170<span></span>
</td>
<td class="nump">83,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Financial assets included in other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">690<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,731,322<span></span>
</td>
<td class="nump">390,574<span></span>
</td>
<td class="nump">1,357,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialLiabilitiesAtAmortizedCostMember', window );">Financial liabilities at amortized cost [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems', window );"><strong>Schedule of Categories of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Interest-bearing bank and other borrowings (current and non-current portions)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,979,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,668,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">106,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">138,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Long-term payables (current and non-current portion)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,230,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,869,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialLiabilitiesMember', window );">Financial Liabilities [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems', window );"><strong>Schedule of Categories of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Interest-bearing bank and other borrowings (current and non-current portions)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,979,719<span></span>
</td>
<td class="nump">283,096<span></span>
</td>
<td class="nump">1,668,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,031<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">106,740<span></span>
</td>
<td class="nump">15,264<span></span>
</td>
<td class="nump">91,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">140,450<span></span>
</td>
<td class="nump">20,084<span></span>
</td>
<td class="nump">103,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Long-term payables (current and non-current portion)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,238,940<span></span>
</td>
<td class="nump">$ 320,164<span></span>
</td>
<td class="nump">1,869,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember', window );">Financial liabilities at fair value through profit or loss [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems', window );"><strong>Schedule of Categories of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Interest-bearing bank and other borrowings (current and non-current portions)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 8,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember', window );">Financial liabilities at fair value through profit or loss [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems', window );"><strong>Schedule of Categories of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Interest-bearing bank and other borrowings (current and non-current portions)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Long-term payables (current and non-current portion)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit quality of the financial assets included in prepayments, other receivables and other assets and financial assets included in other non- current assets is considered to be &#8220;normal&#8221; when they are not past due and there is no information indicating that the financial assets had a significant increase in credit risk since initial recognition. Otherwise, the credit quality of the financial assets is considered to be &#8220;doubtful&#8221;.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndBankBalancesAtCentralBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and bank balances held at central banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndBankBalancesAtCentralBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPortionOfLongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPortionOfLongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current other borrowings. [Refer: Other borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 72<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_72_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 72<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_72_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialAssetsAtAmortizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialAssetsAtAmortizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialLiabilitiesAtAmortizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialLiabilitiesAtAmortizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>226
<FILENAME>R164.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 572<span></span>
</td>
<td class="nump">&#165; 1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Financial assets included in other non-current assets</a></td>
<td class="nump">982,757<span></span>
</td>
<td class="nump">140,532<span></span>
</td>
<td class="nump">1,095,832<span></span>
</td>
<td class="nump">&#165; 1,091,422<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="nump">2,727,322<span></span>
</td>
<td class="nump">390,002<span></span>
</td>
<td class="nump">1,356,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="nump">14,913<span></span>
</td>
<td class="nump">2,133<span></span>
</td>
<td class="nump">20,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non-current portion of interest-bearing bank and other borrowings (other than lease liabilities)</a></td>
<td class="nump">757,238<span></span>
</td>
<td class="nump">108,284<span></span>
</td>
<td class="nump">889,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair Values [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Financial assets included in other non-current assets</a></td>
<td class="nump">624<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">2,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="nump">4,624<span></span>
</td>
<td class="nump">661<span></span>
</td>
<td class="nump">3,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="nump">1,968<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">11,706<span></span>
</td>
<td class="nump">1,674<span></span>
</td>
<td class="nump">5,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non-current portion of interest-bearing bank and other borrowings (other than lease liabilities)</a></td>
<td class="nump">709,342<span></span>
</td>
<td class="nump">101,435<span></span>
</td>
<td class="nump">859,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">723,016<span></span>
</td>
<td class="nump">103,390<span></span>
</td>
<td class="nump">865,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Carrying Amounts [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAbstract', window );"><strong>Financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Financial assets included in other non-current assets</a></td>
<td class="nump">690<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="nump">4,690<span></span>
</td>
<td class="nump">671<span></span>
</td>
<td class="nump">3,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="nump">1,968<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">12,031<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
<td class="nump">6,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non-current portion of interest-bearing bank and other borrowings (other than lease liabilities)</a></td>
<td class="nump">742,325<span></span>
</td>
<td class="nump">106,151<span></span>
</td>
<td class="nump">868,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">&#165; 756,324<span></span>
</td>
<td class="nump">$ 108,153<span></span>
</td>
<td class="nump">&#165; 874,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>227
<FILENAME>R165.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Assets Measured at Fair Value (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Assets Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 572<span></span>
</td>
<td class="nump">&#165; 1,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="nump">1,968<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Other non-current liabilities</a></td>
<td class="nump">6,374<span></span>
</td>
<td class="nump">$ 911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Assets Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Other non-current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Assets Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Other non-current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Assets Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at FVTPL</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="nump">1,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Other non-current liabilities</a></td>
<td class="nump">&#165; 6,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities that meet either of the following conditions: (a) they meet the definition of held for trading; or (b) upon initial recognition they are designated by the entity as at fair value through profit or loss. An entity may use this designation only when permitted by paragraph 4.3.5 of IFRS 9 (embedded derivatives) or when doing so results in more relevant information, because either: (a) it eliminates or significantly reduces a measurement or recognition inconsistency (sometimes referred to as &#8216;an accounting mismatch&#8217;) that would otherwise arise from measuring assets or liabilities or recognising the gains and losses on them on different bases; or (b) a group of financial liabilities or financial assets and financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the group is provided internally on that basis to the entity&#8217;s key management personnel (as defined in IAS 24). [Refer: At fair value [member]; Key management personnel of entity or parent [member]; Derivatives [member]; Financial assets; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities measured at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>228
<FILENAME>R166.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems', window );"><strong>Financial Risk Management Objectives and Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Equity investment percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Floating Interest Rates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems', window );"><strong>Financial Risk Management Objectives and Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_InterestBearingBankBorrowings', window );">Interest-bearing bank borrowings</a></td>
<td class="nump">&#165; 1,911,273<span></span>
</td>
<td class="nump">$ 273,308<span></span>
</td>
<td class="nump">&#165; 1,116,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember', window );">Credit Risk [Member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems', window );"><strong>Financial Risk Management Objectives and Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ConcentrationsOfCreditRisk', window );">Concentrations of credit risk</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember', window );">Credit Risk [Member] | Bottom of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems', window );"><strong>Financial Risk Management Objectives and Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ConcentrationsOfCreditRisk', window );">Concentrations of credit risk</a></td>
<td class="nump">91.00%<span></span>
</td>
<td class="nump">91.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems', window );"><strong>Financial Risk Management Objectives and Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_LiquidityRiskPercentage', window );">Liquidity risk percentage</a></td>
<td class="nump">62.00%<span></span>
</td>
<td class="nump">62.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ConcentrationsOfCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concentrations of credit risk</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ConcentrationsOfCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_InterestBearingBankBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest-bearing bank borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_InterestBearingBankBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_LiquidityRiskPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidity risk percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_LiquidityRiskPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>229
<FILENAME>R167.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Schedule of Interest Rate Risk (Details) - CNY (&#165;)<br> &#165; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_IncreasedecreaseInBasisPointsMember', window );">Increase/(decrease) in basis points [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_a2024Abstract', window );"><strong>2024</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Increase/(decrease) in basis points</a></td>
<td class="text">100<span></span>
</td>
<td class="text">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreasedecreaseInLossBeforeTax', window );">Increase/(decrease) in loss before tax</a></td>
<td class="num">&#165; (100)<span></span>
</td>
<td class="num">&#165; (100)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=aapg_IncreasedecreaseInLossBeforeTaxMember', window );">Increase/(decrease) in loss before tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_a2024Abstract', window );"><strong>2024</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Increase/(decrease) in basis points</a></td>
<td class="text">19,113<span></span>
</td>
<td class="text">11,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreasedecreaseInLossBeforeTax', window );">Increase/(decrease) in loss before tax</a></td>
<td class="num">&#165; (19,113)<span></span>
</td>
<td class="num">&#165; (11,160)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IncreasedecreaseInLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase/(decrease) in loss before tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IncreasedecreaseInLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_a2024Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_a2024Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_IncreasedecreaseInBasisPointsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_IncreasedecreaseInBasisPointsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=aapg_IncreasedecreaseInLossBeforeTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=aapg_IncreasedecreaseInLossBeforeTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>230
<FILENAME>R168.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Schedule of Foreign Currency Risk (Details) - Monetary Assets [Member] - CNY (&#165;)<br> &#165; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ChangeInForeignExchangeRatesAxis=aapg_IfRMBWeakensAgainstUSDollarsMember', window );">If RMB weakens against US$ [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems', window );"><strong>Schedule of Foreign Currency Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreasedecreaseWeakensAgainst', window );">Increase/(decrease) in foreign currency rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Increase/(decrease) in loss before tax</a></td>
<td class="num">&#165; (65)<span></span>
</td>
<td class="num">&#165; (44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax', window );">Increase/(decrease) in other comprehensive income (without tax)</a></td>
<td class="nump">&#165; 124,210<span></span>
</td>
<td class="nump">&#165; 56,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ChangeInForeignExchangeRatesAxis=aapg_IfRMBStrengthensAgainstUSDollarsMember', window );">If RMB strengthens against US$ [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems', window );"><strong>Schedule of Foreign Currency Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_IncreasedecreaseWeakensAgainst', window );">Increase/(decrease) in foreign currency rate</a></td>
<td class="num">(5.00%)<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Increase/(decrease) in loss before tax</a></td>
<td class="nump">&#165; 65<span></span>
</td>
<td class="nump">&#165; 44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax', window );">Increase/(decrease) in other comprehensive income (without tax)</a></td>
<td class="num">&#165; (124,210)<span></span>
</td>
<td class="num">&#165; (56,796)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_IncreasedecreaseWeakensAgainst">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase/(decrease) in foreign currency rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_IncreasedecreaseWeakensAgainst</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reclassification adjustments related to exchange differences when the financial statements of foreign operations are translated, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2025-01-01<br> -Paragraph 48<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_48&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 92<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_92&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ChangeInForeignExchangeRatesAxis=aapg_IfRMBWeakensAgainstUSDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ChangeInForeignExchangeRatesAxis=aapg_IfRMBWeakensAgainstUSDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=aapg_MonetaryAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=aapg_MonetaryAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ChangeInForeignExchangeRatesAxis=aapg_IfRMBStrengthensAgainstUSDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ChangeInForeignExchangeRatesAxis=aapg_IfRMBStrengthensAgainstUSDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>231
<FILENAME>R169.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Schedule of Credit Quality and Maximum Exposure To Credit Risk (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Schedule of Credit Quality and Maximum Exposure To Credit Risk [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets included in prepayments, other receivables and other assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#165; 3,609<span></span>
</td>
<td class="nump">$ 516<span></span>
</td>
<td class="nump">&#165; 9,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashAndBankBalancesNotYetPastDue', window );">Cash and bank balances - Not yet past due</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,470,085<span></span>
</td>
<td class="nump">353,217<span></span>
</td>
<td class="nump">1,261,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">252,938<span></span>
</td>
<td class="nump">36,170<span></span>
</td>
<td class="nump">83,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Financial assets included in other non-current assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">690<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,727,322<span></span>
</td>
<td class="nump">$ 390,002<span></span>
</td>
<td class="nump">1,356,639<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_Stage1Member', window );">Stage 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Schedule of Credit Quality and Maximum Exposure To Credit Risk [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets included in prepayments, other receivables and other assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashAndBankBalancesNotYetPastDue', window );">Cash and bank balances - Not yet past due</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,470,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Financial assets included in other non-current assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,474,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,273,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_StageTwoMember', window );">Stage 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Schedule of Credit Quality and Maximum Exposure To Credit Risk [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets included in prepayments, other receivables and other assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashAndBankBalancesNotYetPastDue', window );">Cash and bank balances - Not yet past due</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Financial assets included in other non-current assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_StageThreeMember', window );">Stage 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Schedule of Credit Quality and Maximum Exposure To Credit Risk [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets included in prepayments, other receivables and other assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashAndBankBalancesNotYetPastDue', window );">Cash and bank balances - Not yet past due</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Financial assets included in other non-current assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_SimplifiedApproachMember', window );">Simplified approach [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Schedule of Credit Quality and Maximum Exposure To Credit Risk [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets included in prepayments, other receivables and other assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CashAndBankBalancesNotYetPastDue', window );">Cash and bank balances - Not yet past due</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">252,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Financial assets included in other non-current assets - Normal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#165; 252,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 83,143<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit quality of the financial assets included in prepayments, other receivables and other assets and financial assets included in other non- current assets is considered to be &#8220;normal&#8221; when they are not past due and there is no information indicating that the financial assets had a significant increase in credit risk since initial recognition. Otherwise, the credit quality of the financial assets is considered to be &#8220;doubtful&#8221;.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For trade receivables to which the Group applies the simplified approach for impairment, information based on provision matrix is disclosed in note 21 to the financial statements.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CashAndBankBalancesNotYetPastDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and bank balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CashAndBankBalancesNotYetPastDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExposureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_Stage1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aapg_Stage1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_StageTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aapg_StageTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_StageThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aapg_StageThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aapg_SimplifiedApproachMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aapg_SimplifiedApproachMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>232
<FILENAME>R170.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Schedule of Liquidity Risk (Details)<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_TradePayablesMember', window );">Trade Payables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">&#165; 106,740<span></span>
</td>
<td class="nump">$ 15,264<span></span>
</td>
<td class="nump">&#165; 91,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">24,488<span></span>
</td>
<td class="nump">3,502<span></span>
</td>
<td class="nump">19,266<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember', window );">Interest-bearing bank and other borrowings excluding lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Interest-bearing bank and other borrowings (excluding lease liabilities)</a></td>
<td class="nump">2,168,352<span></span>
</td>
<td class="nump">310,070<span></span>
</td>
<td class="nump">1,831,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember', window );">Financial liabilities included in other payables and accruals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="nump">140,450<span></span>
</td>
<td class="nump">20,084<span></span>
</td>
<td class="nump">103,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_OtherNonCurrentLiabilityMember', window );">Other non-current liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other non-current liabilities</a></td>
<td class="nump">12,031<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
<td class="nump">6,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_DerivativeFinancialInstrumentsMember', window );">Derivative financial instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssetsHeldForHedging', window );">Total</a></td>
<td class="nump">2,452,061<span></span>
</td>
<td class="nump">$ 350,640<span></span>
</td>
<td class="nump">2,051,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_OnDemandMember', window );">On demand | Trade Payables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_OnDemandMember', window );">On demand | Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_OnDemandMember', window );">On demand | Interest-bearing bank and other borrowings excluding lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Interest-bearing bank and other borrowings (excluding lease liabilities)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_OnDemandMember', window );">On demand | Financial liabilities included in other payables and accruals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="nump">130,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_OnDemandMember', window );">On demand | Other non-current liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other non-current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_OnDemandMember', window );">On demand | Derivative financial instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssetsHeldForHedging', window );">Total</a></td>
<td class="nump">130,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than 1 year | Trade Payables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">106,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than 1 year | Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">8,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than 1 year | Interest-bearing bank and other borrowings excluding lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Interest-bearing bank and other borrowings (excluding lease liabilities)</a></td>
<td class="nump">1,255,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">813,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than 1 year | Financial liabilities included in other payables and accruals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="nump">10,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than 1 year | Other non-current liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other non-current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than 1 year | Derivative financial instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssetsHeldForHedging', window );">Total</a></td>
<td class="nump">1,381,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">945,594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">1 to 5 years | Trade Payables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">1 to 5 years | Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">16,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,592<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">1 to 5 years | Interest-bearing bank and other borrowings excluding lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Interest-bearing bank and other borrowings (excluding lease liabilities)</a></td>
<td class="nump">365,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">1 to 5 years | Financial liabilities included in other payables and accruals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">1 to 5 years | Other non-current liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other non-current liabilities</a></td>
<td class="nump">12,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">1 to 5 years | Derivative financial instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssetsHeldForHedging', window );">Total</a></td>
<td class="nump">393,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">467,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Over 5 years | Trade Payables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Over 5 years | Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Over 5 years | Interest-bearing bank and other borrowings excluding lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Interest-bearing bank and other borrowings (excluding lease liabilities)</a></td>
<td class="nump">546,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Over 5 years | Financial liabilities included in other payables and accruals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Over 5 years | Other non-current liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Other non-current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Over 5 years | Derivative financial instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssetsHeldForHedging', window );">Total</a></td>
<td class="nump">&#165; 546,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 565,079<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities measured at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialAssetsHeldForHedging">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of derivative financial assets held for hedging. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialAssetsHeldForHedging</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts payable that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_TradePayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_TradePayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_OtherNonCurrentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_OtherNonCurrentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_DerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aapg_DerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_OnDemandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_OnDemandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>233
<FILENAME>R171.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Schedule of Equity Price Risk (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems', window );"><strong>Schedule of Market Equity Index [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_MarketEquityIndex', window );">Market equity index</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">19,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems', window );"><strong>Schedule of Market Equity Index [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockExchangeIndexShare', window );">stock exchange index</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">20,205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems', window );"><strong>Schedule of Market Equity Index [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockExchangeIndexShare', window );">stock exchange index</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,478<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_MarketEquityIndex">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market equity index.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_MarketEquityIndex</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockExchangeIndexShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The shares stock exchange index.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockExchangeIndexShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>234
<FILENAME>R172.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Schedule of Fair Values of the Equity Investments (Details) - CNY (&#165;)<br> &#165; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_CarryingAmountOfEquityInvestmentsMember', window );">Carrying amount of equity investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_InvestmentsListedInAbstract', window );"><strong>Investments listed in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">NASDAQ - Financial assets at fair value through profit or loss</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">&#165; 1,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_DecreaseincreaseInLossBeforeTaxMember', window );">Decrease/ (increase) in loss before tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_InvestmentsListedInAbstract', window );"><strong>Investments listed in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">NASDAQ - Financial assets at fair value through profit or loss</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="num">&#165; (57)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_InvestmentsListedInAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_InvestmentsListedInAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_CarryingAmountOfEquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_CarryingAmountOfEquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_DecreaseincreaseInLossBeforeTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=aapg_DecreaseincreaseInLossBeforeTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>235
<FILENAME>R173.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Schedule of Capital Management (Details) - Capital Management [Member]<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems', window );"><strong>Schedule of Capital Management [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Interest-bearing bank and other borrowings</a></td>
<td class="nump">&#165; 1,979,719<span></span>
</td>
<td class="nump">&#165; 1,668,497<span></span>
</td>
<td class="nump">$ 283,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">106,740<span></span>
</td>
<td class="nump">91,966<span></span>
</td>
<td class="nump">15,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Financial liabilities included in other payables and accruals</a></td>
<td class="nump">140,450<span></span>
</td>
<td class="nump">103,014<span></span>
</td>
<td class="nump">20,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Long-term payables</a></td>
<td class="nump">12,031<span></span>
</td>
<td class="nump">6,274<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Less: Cash and bank balances</a></td>
<td class="num">(2,470,085)<span></span>
</td>
<td class="num">(1,261,211)<span></span>
</td>
<td class="num">(353,217)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDebt', window );">Net debt</a></td>
<td class="num">(231,145)<span></span>
</td>
<td class="nump">608,540<span></span>
</td>
<td class="num">(33,053)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Equity attributable to owners of the Company</a></td>
<td class="nump">1,324,462<span></span>
</td>
<td class="nump">264,194<span></span>
</td>
<td class="nump">189,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_AdjustedCapitals', window );">Adjusted capital</a></td>
<td class="nump">1,324,462<span></span>
</td>
<td class="nump">264,194<span></span>
</td>
<td class="nump">189,396<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Capital and net debt</a></td>
<td class="nump">&#165; 1,093,317<span></span>
</td>
<td class="nump">&#165; 872,734<span></span>
</td>
<td class="nump">$ 156,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Gearing ratio</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_AdjustedCapitals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of adjusted capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_AdjustedCapitals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net debt of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 72<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_72_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 72<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_72_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts payable that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=aapg_CapitalManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=aapg_CapitalManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>236
<FILENAME>R174.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of the Company (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information of the Company [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentIncome', window );">Impairment associated with investment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investment income, such as interest and dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>237
<FILENAME>R175.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Financial Information of the Company - Schedule of Statements of Financial Position (Details) - Parent [Member]<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>NON-CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiaries', window );">Investments in subsidiaries</a></td>
<td class="nump">&#165; 448,431<span></span>
</td>
<td class="nump">$ 64,125<span></span>
</td>
<td class="nump">&#165; 380,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current Asset</a></td>
<td class="nump">29,851<span></span>
</td>
<td class="nump">4,269<span></span>
</td>
<td class="nump">30,529<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">478,282<span></span>
</td>
<td class="nump">68,394<span></span>
</td>
<td class="nump">410,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesDueFromAssociates', window );">Prepayments, other receivables and other assets</a></td>
<td class="nump">4,806,759<span></span>
</td>
<td class="nump">687,358<span></span>
</td>
<td class="nump">3,986,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndBankBalancesAtCentralBanks', window );">Cash and bank balances</a></td>
<td class="nump">1,841,572<span></span>
</td>
<td class="nump">263,341<span></span>
</td>
<td class="nump">470,170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">6,648,331<span></span>
</td>
<td class="nump">950,699<span></span>
</td>
<td class="nump">4,456,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Other payables and accruals</a></td>
<td class="nump">2,382<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">24,187<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">2,382<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">24,187<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsLiabilities', window );">NET CURRENT ASSETS</a></td>
<td class="nump">6,645,949<span></span>
</td>
<td class="nump">950,358<span></span>
</td>
<td class="nump">4,432,155<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AssetsLessCurrentLiabilities', window );">TOTAL ASSETS LESS CURRENT LIABILITIES</a></td>
<td class="nump">7,124,231<span></span>
</td>
<td class="nump">1,018,752<span></span>
</td>
<td class="nump">4,843,023<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets</a></td>
<td class="nump">7,124,231<span></span>
</td>
<td class="nump">1,018,752<span></span>
</td>
<td class="nump">4,843,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares</a></td>
<td class="num">(2,961)<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReserves', window );">Capital and reserves</a></td>
<td class="nump">8,011,879<span></span>
</td>
<td class="nump">1,145,683<span></span>
</td>
<td class="nump">5,652,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ExchangeFluctuationReserve', window );">Exchange fluctuation reserve</a></td>
<td class="num">(40,959)<span></span>
</td>
<td class="num">(5,857)<span></span>
</td>
<td class="nump">108,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated losses</a></td>
<td class="num">(843,984)<span></span>
</td>
<td class="num">(120,688)<span></span>
</td>
<td class="num">(918,697)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">&#165; 7,124,231<span></span>
</td>
<td class="nump">$ 1,018,752<span></span>
</td>
<td class="nump">&#165; 4,843,023<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ExchangeFluctuationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of exchange fluctuation reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ExchangeFluctuationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsLessCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsLessCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndBankBalancesAtCentralBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and bank balances held at central banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndBankBalancesAtCentralBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets less the amount of current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries in an entity's separate financial statements. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG63<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IG63&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceivablesDueFromAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables due from associates. [Refer: Total for all associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceivablesDueFromAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>238
<FILENAME>R176.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of the Company - Schedule of Condensed Statements of Comprehensive Income (Details) - Parent [Member]<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedStatementOfIncomeCaptionsLineItems', window );"><strong>Condensed Statement of Income Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Other income and gains</a></td>
<td class="nump">&#165; 102,560<span></span>
</td>
<td class="nump">$ 14,666<span></span>
</td>
<td class="nump">&#165; 17,925<span></span>
</td>
<td class="nump">&#165; 18,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="num">(27,800)<span></span>
</td>
<td class="num">(3,975)<span></span>
</td>
<td class="num">(9,983)<span></span>
</td>
<td class="num">(8,118)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByNature', window );">Other expenses</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(21,585)<span></span>
</td>
<td class="num">(24,741)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">LOSS BEFORE TAX</a></td>
<td class="nump">74,713<span></span>
</td>
<td class="nump">10,684<span></span>
</td>
<td class="num">(13,643)<span></span>
</td>
<td class="num">(14,262)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">LOSS FOR THE YEAR</a></td>
<td class="nump">74,713<span></span>
</td>
<td class="nump">10,684<span></span>
</td>
<td class="num">(13,643)<span></span>
</td>
<td class="num">(14,262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation</a></td>
<td class="num">(149,557)<span></span>
</td>
<td class="num">(21,386)<span></span>
</td>
<td class="nump">67,715<span></span>
</td>
<td class="nump">84,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">TOTAL COMPREHENSIVE INCOME FOR THE YEAR</a></td>
<td class="num">&#165; (74,844)<span></span>
</td>
<td class="num">$ (10,702)<span></span>
</td>
<td class="nump">&#165; 54,072<span></span>
</td>
<td class="nump">&#165; 70,367<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedStatementOfIncomeCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedStatementOfIncomeCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>239
<FILENAME>R177.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of the Company - Schedule of Condensed Statements of Cash Flows (Details) - Parent [Member]<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems', window );"><strong>Schedule of Condensed Statements of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash generated from(used in) operating activities</a></td>
<td class="nump">&#165; 123,427<span></span>
</td>
<td class="nump">$ 17,650<span></span>
</td>
<td class="num">&#165; (41,686)<span></span>
</td>
<td class="nump">&#165; 9,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,850,400)<span></span>
</td>
<td class="num">(264,604)<span></span>
</td>
<td class="num">(589,153)<span></span>
</td>
<td class="num">(535,395)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash (used in)/generated from financing activities</a></td>
<td class="nump">2,229,331<span></span>
</td>
<td class="nump">318,790<span></span>
</td>
<td class="nump">531,922<span></span>
</td>
<td class="nump">464,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of foreign exchange rate changes, net</a></td>
<td class="num">(56,093)<span></span>
</td>
<td class="num">(8,021)<span></span>
</td>
<td class="nump">9,311<span></span>
</td>
<td class="nump">1,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net decrease in cash and cash equivalents</a></td>
<td class="nump">&#165; 446,265<span></span>
</td>
<td class="nump">$ 63,815<span></span>
</td>
<td class="num">&#165; (89,606)<span></span>
</td>
<td class="num">&#165; (59,921)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>240
<FILENAME>R178.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Financial Information of the Company - Schedule of Company&#8217;s Reserves (Details) - Parent [Member]<br> &#165; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CNY (&#165;) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems', window );"><strong>Schedule of Company&#8217;s Reserves [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance</a></td>
<td class="nump">&#165; 4,842,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 4,207,844<span></span>
</td>
<td class="nump">&#165; 3,591,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="nump">74,713<span></span>
</td>
<td class="nump">$ 10,684<span></span>
</td>
<td class="num">(13,643)<span></span>
</td>
<td class="num">(14,262)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OtherComprehensiveIncomeForTheYearAbstract2', window );"><strong>Other comprehensive income for the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation of the Company</a></td>
<td class="num">(149,557)<span></span>
</td>
<td class="num">$ (21,386)<span></span>
</td>
<td class="nump">67,715<span></span>
</td>
<td class="nump">84,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ComprehensiveIncomeLoss', window );">Total comprehensive income for the year</a></td>
<td class="num">&#165; (74,844)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 54,072<span></span>
</td>
<td class="nump">&#165; 70,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Issue of ordinary shares (in Shares) | shares</a></td>
<td class="nump">2,279,855<span></span>
</td>
<td class="nump">2,279,855<span></span>
</td>
<td class="nump">533,923<span></span>
</td>
<td class="nump">470,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_EmployeesShareBasedCompensationSchemeAbstract', window );"><strong>Employees share-based compensation scheme</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PreIPOShareOptionExpenses', window );">Pre-IPO share option expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Post-IPO share option expenses</a></td>
<td class="nump">&#165; 2,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RestrictedShareUnitExpenses', window );">RSU expenses</a></td>
<td class="nump">18,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,924<span></span>
</td>
<td class="nump">&#165; 27,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions', window );">Exercise of Pre-IPO share options</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueVestingOfRSUs', window );">Vesting of RSUs</a></td>
<td class="num">(638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,671)<span></span>
</td>
<td class="num">(11,123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="nump">58,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,719<span></span>
</td>
<td class="nump">55,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance</a></td>
<td class="nump">7,126,936<span></span>
</td>
<td class="nump">$ 1,019,138<span></span>
</td>
<td class="nump">4,842,817<span></span>
</td>
<td class="nump">4,207,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance (in Dollars)</a></td>
<td class="nump">7,126,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,842,817<span></span>
</td>
<td class="nump">4,207,844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_CapitalReserveMember', window );">Capital and reserves [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems', window );"><strong>Schedule of Company&#8217;s Reserves [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance</a></td>
<td class="nump">5,652,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,072,015<span></span>
</td>
<td class="nump">4,526,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OtherComprehensiveIncomeForTheYearAbstract2', window );"><strong>Other comprehensive income for the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation of the Company</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ComprehensiveIncomeLoss', window );">Total comprehensive income for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Issue of ordinary shares (in Shares) | shares</a></td>
<td class="nump">2,279,855<span></span>
</td>
<td class="nump">2,279,855<span></span>
</td>
<td class="nump">533,923<span></span>
</td>
<td class="nump">470,066<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_EmployeesShareBasedCompensationSchemeAbstract', window );"><strong>Employees share-based compensation scheme</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PreIPOShareOptionExpenses', window );">Pre-IPO share option expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Post-IPO share option expenses</a></td>
<td class="nump">&#165; 2,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RestrictedShareUnitExpenses', window );">RSU expenses</a></td>
<td class="nump">18,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,924<span></span>
</td>
<td class="nump">&#165; 27,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions', window );">Exercise of Pre-IPO share options</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueVestingOfRSUs', window );">Vesting of RSUs</a></td>
<td class="num">(638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,671)<span></span>
</td>
<td class="num">(11,123)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="nump">58,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,719<span></span>
</td>
<td class="nump">55,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance</a></td>
<td class="nump">8,011,879<span></span>
</td>
<td class="nump">$ 1,145,683<span></span>
</td>
<td class="nump">5,652,916<span></span>
</td>
<td class="nump">5,072,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance (in Dollars)</a></td>
<td class="nump">8,011,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,652,916<span></span>
</td>
<td class="nump">5,072,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember', window );">Exchange fluctuation reserve [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems', window );"><strong>Schedule of Company&#8217;s Reserves [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance</a></td>
<td class="nump">108,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,883<span></span>
</td>
<td class="num">(43,746)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OtherComprehensiveIncomeForTheYearAbstract2', window );"><strong>Other comprehensive income for the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation of the Company</a></td>
<td class="num">(149,557)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,715<span></span>
</td>
<td class="nump">84,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ComprehensiveIncomeLoss', window );">Total comprehensive income for the year</a></td>
<td class="num">&#165; (149,557)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 67,715<span></span>
</td>
<td class="nump">&#165; 84,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Issue of ordinary shares (in Shares) | shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_EmployeesShareBasedCompensationSchemeAbstract', window );"><strong>Employees share-based compensation scheme</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PreIPOShareOptionExpenses', window );">Pre-IPO share option expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Post-IPO share option expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RestrictedShareUnitExpenses', window );">RSU expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions', window );">Exercise of Pre-IPO share options</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueVestingOfRSUs', window );">Vesting of RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance</a></td>
<td class="num">(40,959)<span></span>
</td>
<td class="num">$ (5,857)<span></span>
</td>
<td class="nump">108,598<span></span>
</td>
<td class="nump">40,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance (in Dollars)</a></td>
<td class="num">(40,959)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,598<span></span>
</td>
<td class="nump">40,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_RetainedEarningsMember', window );">Accumulated losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems', window );"><strong>Schedule of Company&#8217;s Reserves [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance</a></td>
<td class="num">(918,697)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(905,054)<span></span>
</td>
<td class="num">(890,792)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="nump">74,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,643)<span></span>
</td>
<td class="num">(14,262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_OtherComprehensiveIncomeForTheYearAbstract2', window );"><strong>Other comprehensive income for the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation of the Company</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_ComprehensiveIncomeLoss', window );">Total comprehensive income for the year</a></td>
<td class="nump">&#165; 74,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (13,643)<span></span>
</td>
<td class="num">&#165; (14,262)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Issue of ordinary shares (in Shares) | shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_EmployeesShareBasedCompensationSchemeAbstract', window );"><strong>Employees share-based compensation scheme</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_PreIPOShareOptionExpenses', window );">Pre-IPO share option expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Post-IPO share option expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_RestrictedShareUnitExpenses', window );">RSU expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions', window );">Exercise of Pre-IPO share options</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueVestingOfRSUs', window );">Vesting of RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aapg_StockIssuedDuringPeriodValueEquitysettledBonus', window );">Equity-settled bonus</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance</a></td>
<td class="num">(843,984)<span></span>
</td>
<td class="num">$ (120,688)<span></span>
</td>
<td class="num">(918,697)<span></span>
</td>
<td class="num">(905,054)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Balance (in Dollars)</a></td>
<td class="num">&#165; (843,984)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#165; (918,697)<span></span>
</td>
<td class="num">&#165; (905,054)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_ComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total comprehensive income for the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_ComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_EmployeesShareBasedCompensationSchemeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_EmployeesShareBasedCompensationSchemeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_OtherComprehensiveIncomeForTheYearAbstract2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_OtherComprehensiveIncomeForTheYearAbstract2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_PreIPOShareOptionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of pre-ipo share option expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_PreIPOShareOptionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_RestrictedShareUnitExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of restricted share unit expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_RestrictedShareUnitExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValueEquitysettledBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of equity-settled bonus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValueEquitysettledBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of exercise of pre-ipo share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aapg_StockIssuedDuringPeriodValueVestingOfRSUs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of vesting of restricted share units (RSUs).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aapg_StockIssuedDuringPeriodValueVestingOfRSUs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aapg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2025-01-01<br> -Paragraph 22<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_CapitalReserveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_CapitalReserveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>241
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>242
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>244
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>734</ContextCount>
  <ElementCount>612</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>200</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995300 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995301 - Statement - Consolidated Statements of Profit or Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Profit or Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995302 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995303 - Statement - Consolidated Statements of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Statements of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995304 - Statement - Consolidated Statements of Financial Position (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Statements of Financial Position (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995305 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995306 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995307 - Disclosure - Corporate and Group Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/CorporateandGroupInformation</Role>
      <ShortName>Corporate and Group Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995308 - Disclosure - Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/AccountingPolicies</Role>
      <ShortName>Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995309 - Disclosure - Significant Accounting Judgements and Estimates</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimates</Role>
      <ShortName>Significant Accounting Judgements and Estimates</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995310 - Disclosure - Operating Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OperatingSegmentInformation</Role>
      <ShortName>Operating Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995311 - Disclosure - Revenue, Other Income and Gains</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/RevenueOtherIncomeandGains</Role>
      <ShortName>Revenue, Other Income and Gains</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995312 - Disclosure - Loss Before Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/LossBeforeTax</Role>
      <ShortName>Loss Before Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995313 - Disclosure - Other Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OtherExpenses</Role>
      <ShortName>Other Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995314 - Disclosure - Finance Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FinanceCosts</Role>
      <ShortName>Finance Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995315 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995316 - Disclosure - Dividends</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/Dividends</Role>
      <ShortName>Dividends</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995317 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany</Role>
      <ShortName>Loss Per Share Attributable to Ordinary Equity Holders of the Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995318 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/PropertyPlantandEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995319 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995320 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995321 - Disclosure - Other Intangible Asset</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OtherIntangibleAsset</Role>
      <ShortName>Other Intangible Asset</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995322 - Disclosure - Investment in a Joint Venture</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/InvestmentinaJointVenture</Role>
      <ShortName>Investment in a Joint Venture</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995323 - Disclosure - Financial Assets at Fair Value through Profit or Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLoss</Role>
      <ShortName>Financial Assets at Fair Value through Profit or Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995324 - Disclosure - Deferred Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/DeferredTax</Role>
      <ShortName>Deferred Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995325 - Disclosure - Other Non-Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OtherNonCurrentAssets</Role>
      <ShortName>Other Non-Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995326 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995327 - Disclosure - Trade Receivables, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/TradeReceivablesNet</Role>
      <ShortName>Trade Receivables, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995328 - Disclosure - Prepayments, Other Receivables and Other Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssets</Role>
      <ShortName>Prepayments, Other Receivables and Other Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995329 - Disclosure - Cash and Bank Balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/CashandBankBalances</Role>
      <ShortName>Cash and Bank Balances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995330 - Disclosure - Trade Payables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/TradePayables</Role>
      <ShortName>Trade Payables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995331 - Disclosure - Other Payables and Accruals</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OtherPayablesandAccruals</Role>
      <ShortName>Other Payables and Accruals</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995332 - Disclosure - Contract Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ContractLiabilities</Role>
      <ShortName>Contract Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995333 - Disclosure - Interest-Bearing Bank and Other Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowings</Role>
      <ShortName>Interest-Bearing Bank and Other Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995334 - Disclosure - Deferred Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/DeferredIncome</Role>
      <ShortName>Deferred Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995335 - Disclosure - Share Capital and Treasury Shares</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ShareCapitalandTreasuryShares</Role>
      <ShortName>Share Capital and Treasury Shares</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995336 - Disclosure - Reserves</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/Reserves</Role>
      <ShortName>Reserves</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995337 - Disclosure - Share-Based Payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ShareBasedPayments</Role>
      <ShortName>Share-Based Payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995338 - Disclosure - Notes to the Consolidated Statements of Cash Flows</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlows</Role>
      <ShortName>Notes to the Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995339 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995340 - Disclosure - Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ContingentLiabilities</Role>
      <ShortName>Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995341 - Disclosure - Pledge of Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/PledgeofAssets</Role>
      <ShortName>Pledge of Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995342 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995343 - Disclosure - Financial Instruments by Category</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategory</Role>
      <ShortName>Financial Instruments by Category</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995344 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstruments</Role>
      <ShortName>Fair Value and Fair Value Hierarchy of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995345 - Disclosure - Financial Risk Management Objectives and Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPolicies</Role>
      <ShortName>Financial Risk Management Objectives and Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995346 - Disclosure - Event After the Reporting Period</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/EventAftertheReportingPeriod</Role>
      <ShortName>Event After the Reporting Period</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995347 - Disclosure - Condensed Financial Information of the Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompany</Role>
      <ShortName>Condensed Financial Information of the Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995348 - Disclosure - Approval of the Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ApprovaloftheFinancialStatements</Role>
      <ShortName>Approval of the Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/AccountingPolicies</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Corporate and Group Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/CorporateandGroupInformationTables</Role>
      <ShortName>Corporate and Group Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/CorporateandGroupInformation</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/AccountingPoliciesTables</Role>
      <ShortName>Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/AccountingPolicies</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Operating Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OperatingSegmentInformationTables</Role>
      <ShortName>Operating Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/OperatingSegmentInformation</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Revenue, Other Income and Gains (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables</Role>
      <ShortName>Revenue, Other Income and Gains (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/RevenueOtherIncomeandGains</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Loss Before Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/LossBeforeTaxTables</Role>
      <ShortName>Loss Before Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/LossBeforeTax</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>996006 - Disclosure - Other Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OtherExpensesTables</Role>
      <ShortName>Other Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/OtherExpenses</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Finance Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FinanceCostsTables</Role>
      <ShortName>Finance Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/FinanceCosts</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Income Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/IncomeTaxTables</Role>
      <ShortName>Income Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/IncomeTax</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>996009 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables</Role>
      <ShortName>Loss Per Share Attributable to Ordinary Equity Holders of the Company (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996010 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/PropertyPlantandEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/PropertyPlantandEquipment</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/Leases</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996012 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/Goodwill</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996013 - Disclosure - Other Intangible Asset (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OtherIntangibleAssetTables</Role>
      <ShortName>Other Intangible Asset (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/OtherIntangibleAsset</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996014 - Disclosure - Investment in a Joint Venture (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables</Role>
      <ShortName>Investment in a Joint Venture (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/InvestmentinaJointVenture</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Financial Assets at Fair Value through Profit or Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLossTables</Role>
      <ShortName>Financial Assets at Fair Value through Profit or Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLoss</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996016 - Disclosure - Deferred Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/DeferredTaxTables</Role>
      <ShortName>Deferred Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/DeferredTax</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Other Non-Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OtherNonCurrentAssetsTables</Role>
      <ShortName>Other Non-Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/OtherNonCurrentAssets</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996018 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/Inventories</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996019 - Disclosure - Trade Receivables, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/TradeReceivablesNetTables</Role>
      <ShortName>Trade Receivables, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/TradeReceivablesNet</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996020 - Disclosure - Prepayments, Other Receivables and Other Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssetsTables</Role>
      <ShortName>Prepayments, Other Receivables and Other Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssets</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996021 - Disclosure - Cash and Bank Balances (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/CashandBankBalancesTables</Role>
      <ShortName>Cash and Bank Balances (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/CashandBankBalances</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996022 - Disclosure - Trade Payables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/TradePayablesTables</Role>
      <ShortName>Trade Payables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/TradePayables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996023 - Disclosure - Other Payables and Accruals (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OtherPayablesandAccrualsTables</Role>
      <ShortName>Other Payables and Accruals (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/OtherPayablesandAccruals</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>996024 - Disclosure - Contract Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ContractLiabilitiesTables</Role>
      <ShortName>Contract Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/ContractLiabilities</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Interest-Bearing Bank and Other Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables</Role>
      <ShortName>Interest-Bearing Bank and Other Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowings</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>996026 - Disclosure - Deferred Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/DeferredIncomeTables</Role>
      <ShortName>Deferred Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/DeferredIncome</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Share Capital and Treasury Shares (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables</Role>
      <ShortName>Share Capital and Treasury Shares (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/ShareCapitalandTreasuryShares</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>996028 - Disclosure - Share-Based Payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ShareBasedPaymentsTables</Role>
      <ShortName>Share-Based Payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/ShareBasedPayments</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>996029 - Disclosure - Notes to the Consolidated Statements of Cash Flows (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables</Role>
      <ShortName>Notes to the Consolidated Statements of Cash Flows (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlows</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>996030 - Disclosure - Related Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/RelatedPartyTransactions</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>996031 - Disclosure - Financial Instruments by Category (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategoryTables</Role>
      <ShortName>Financial Instruments by Category (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategory</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>996032 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value and Fair Value Hierarchy of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstruments</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>996033 - Disclosure - Financial Risk Management Objectives and Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables</Role>
      <ShortName>Financial Risk Management Objectives and Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPolicies</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>996034 - Disclosure - Condensed Financial Information of the Company (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables</Role>
      <ShortName>Condensed Financial Information of the Company (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompany</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Corporate and Group Information - Schedule of Principal Subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable</Role>
      <ShortName>Corporate and Group Information - Schedule of Principal Subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>996036 - Disclosure - Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/AccountingPoliciesDetails</Role>
      <ShortName>Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/AccountingPoliciesTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>996037 - Disclosure - Accounting Policies - Schedule of New and Revised IFRSs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable</Role>
      <ShortName>Accounting Policies - Schedule of New and Revised IFRSs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>996038 - Disclosure - Accounting Policies - Schedule of Property, Plant and Equipment of Annual Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable</Role>
      <ShortName>Accounting Policies - Schedule of Property, Plant and Equipment of Annual Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>996039 - Disclosure - Accounting Policies - Schedule of Intangible Assets are Amortized on the Straight-Line Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable</Role>
      <ShortName>Accounting Policies - Schedule of Intangible Assets are Amortized on the Straight-Line Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>996040 - Disclosure - Accounting Policies - Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable</Role>
      <ShortName>Accounting Policies - Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>996041 - Disclosure - Significant Accounting Judgements and Estimates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails</Role>
      <ShortName>Significant Accounting Judgements and Estimates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimates</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>996042 - Disclosure - Operating Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/OperatingSegmentInformationDetails</Role>
      <ShortName>Operating Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/OperatingSegmentInformationTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>996043 - Disclosure - Operating Segment Information - ???Schedule of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofRevenueTable</Role>
      <ShortName>Operating Segment Information - ???Schedule of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>996044 - Disclosure - Operating Segment Information - ???Schedule of Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable</Role>
      <ShortName>Operating Segment Information - ???Schedule of Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Operating Segment Information - Schedule of Revenue from Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable</Role>
      <ShortName>Operating Segment Information - Schedule of Revenue from Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>996046 - Disclosure - Revenue, Other Income and Gains - ???Schedule of Disaggregated Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable</Role>
      <ShortName>Revenue, Other Income and Gains - ???Schedule of Disaggregated Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>996047 - Disclosure - Revenue, Other Income and Gains - ???Schedule of Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable</Role>
      <ShortName>Revenue, Other Income and Gains - ???Schedule of Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>996048 - Disclosure - Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable</Role>
      <ShortName>Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>996049 - Disclosure - Revenue, Other Income and Gains - Schedule of Other Income and Gains (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable</Role>
      <ShortName>Revenue, Other Income and Gains - Schedule of Other Income and Gains (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>996050 - Disclosure - Loss Before Tax - Schedule of Loss Before Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable</Role>
      <ShortName>Loss Before Tax - Schedule of Loss Before Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>996051 - Disclosure - Other Expenses - Schedule of Other Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable</Role>
      <ShortName>Other Expenses - Schedule of Other Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>996052 - Disclosure - Finance Costs - Schedule of Finance Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable</Role>
      <ShortName>Finance Costs - Schedule of Finance Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>996053 - Disclosure - Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/IncomeTaxDetails</Role>
      <ShortName>Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/IncomeTaxTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>996054 - Disclosure - Income Tax  - Schedule of Current and Deferred Components of the Income Tax (Credit)/Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable</Role>
      <ShortName>Income Tax  - Schedule of Current and Deferred Components of the Income Tax (Credit)/Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>996055 - Disclosure - Income Tax  - Schedule of Reconciliation between the Income Tax Expense/(Credit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable</Role>
      <ShortName>Income Tax  - Schedule of Reconciliation between the Income Tax Expense/(Credit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>996056 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails</Role>
      <ShortName>Loss Per Share Attributable to Ordinary Equity Holders of the Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>996057 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company - Schedule of Basic Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofBasicLossPerShareTable</Role>
      <ShortName>Loss Per Share Attributable to Ordinary Equity Holders of the Company - Schedule of Basic Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>996058 - Disclosure - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable</Role>
      <ShortName>Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>996059 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/LeasesTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>996060 - Disclosure - Leases - Schedule of Right-of-Use Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable</Role>
      <ShortName>Leases - Schedule of Right-of-Use Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>996061 - Disclosure - Leases - Schedule of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable</Role>
      <ShortName>Leases - Schedule of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>996062 - Disclosure - Leases - Schedule of Recognized in Profit or Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable</Role>
      <ShortName>Leases - Schedule of Recognized in Profit or Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>996063 - Disclosure - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/GoodwillDetails</Role>
      <ShortName>Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/GoodwillTables</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>996064 - Disclosure - Goodwill - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofGoodwillTable</Role>
      <ShortName>Goodwill - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>996065 - Disclosure - Other Intangible Asset - Schedule of Other Intangible Asset (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable</Role>
      <ShortName>Other Intangible Asset - Schedule of Other Intangible Asset (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>996066 - Disclosure - Investment in a Joint Venture - Schedule of Investment in a Joint Venture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofInvestmentinaJointVentureTable</Role>
      <ShortName>Investment in a Joint Venture - Schedule of Investment in a Joint Venture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>996067 - Disclosure - Investment in a Joint Venture - Schedule of Group???s Principal Joint Venture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable</Role>
      <ShortName>Investment in a Joint Venture - Schedule of Group???s Principal Joint Venture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>996068 - Disclosure - Investment in a Joint Venture - Schedule of Information of the Group???s Joint Venture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable</Role>
      <ShortName>Investment in a Joint Venture - Schedule of Information of the Group???s Joint Venture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>996069 - Disclosure - Financial Assets at Fair Value through Profit or Loss - Schedule of Financial Assets at Fair Value through Profit or Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable</Role>
      <ShortName>Financial Assets at Fair Value through Profit or Loss - Schedule of Financial Assets at Fair Value through Profit or Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>996070 - Disclosure - Deferred Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/DeferredTaxDetails</Role>
      <ShortName>Deferred Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/DeferredTaxTables</ParentRole>
      <Position>123</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>996071 - Disclosure - Deferred Tax - Schedule of Movements in Deferred Tax Liabilities and Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable</Role>
      <ShortName>Deferred Tax - Schedule of Movements in Deferred Tax Liabilities and Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>996072 - Disclosure - Deferred Tax - Schedule of Movements in Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable</Role>
      <ShortName>Deferred Tax - Schedule of Movements in Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>996073 - Disclosure - Deferred Tax - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable</Role>
      <ShortName>Deferred Tax - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>996074 - Disclosure - Other Non-Current Assets - Schedule of Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable</Role>
      <ShortName>Other Non-Current Assets - Schedule of Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>127</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>996075 - Disclosure - Inventories - Schedule of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofInventoriesTable</Role>
      <ShortName>Inventories - Schedule of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>128</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>996076 - Disclosure - Trade Receivables, Net - Schedule of Trade Receivables, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofTradeReceivablesNetTable</Role>
      <ShortName>Trade Receivables, Net - Schedule of Trade Receivables, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>129</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>996077 - Disclosure - Trade Receivables, Net - Schedule of Based on the Invoice Date and Net of Loss Allowance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable</Role>
      <ShortName>Trade Receivables, Net - Schedule of Based on the Invoice Date and Net of Loss Allowance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>130</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>996078 - Disclosure - Prepayments, Other Receivables and Other Assets - Schedule of Prepayments, Other Receivables and Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable</Role>
      <ShortName>Prepayments, Other Receivables and Other Assets - Schedule of Prepayments, Other Receivables and Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>131</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>996079 - Disclosure - Cash and Bank Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/CashandBankBalancesDetails</Role>
      <ShortName>Cash and Bank Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/CashandBankBalancesTables</ParentRole>
      <Position>132</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R133.htm</HtmlFileName>
      <LongName>996080 - Disclosure - Cash and Bank Balances - Schedule of Cash and Bank Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable</Role>
      <ShortName>Cash and Bank Balances - Schedule of Cash and Bank Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>133</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R134.htm</HtmlFileName>
      <LongName>996081 - Disclosure - Trade Payables - Schedule of the Trade Payables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable</Role>
      <ShortName>Trade Payables - Schedule of the Trade Payables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>134</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R135.htm</HtmlFileName>
      <LongName>996082 - Disclosure - Other Payables and Accruals - Schedule of Other Payables and Accruals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable</Role>
      <ShortName>Other Payables and Accruals - Schedule of Other Payables and Accruals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>135</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R136.htm</HtmlFileName>
      <LongName>996083 - Disclosure - Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ContractLiabilitiesDetails</Role>
      <ShortName>Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/ContractLiabilitiesTables</ParentRole>
      <Position>136</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R137.htm</HtmlFileName>
      <LongName>996084 - Disclosure - Contract Liabilities - Schedule of Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0</Role>
      <ShortName>Contract Liabilities - Schedule of Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>137</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R138.htm</HtmlFileName>
      <LongName>996085 - Disclosure - Interest-Bearing Bank and Other Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails</Role>
      <ShortName>Interest-Bearing Bank and Other Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables</ParentRole>
      <Position>138</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R139.htm</HtmlFileName>
      <LongName>996086 - Disclosure - Interest-Bearing Bank and Other Borrowings - Schedule of Interest-Bearing Bank and Other Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable</Role>
      <ShortName>Interest-Bearing Bank and Other Borrowings - Schedule of Interest-Bearing Bank and Other Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>139</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R140.htm</HtmlFileName>
      <LongName>996087 - Disclosure - Interest-Bearing Bank and Other Borrowings - Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable</Role>
      <ShortName>Interest-Bearing Bank and Other Borrowings - Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>140</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R141.htm</HtmlFileName>
      <LongName>996088 - Disclosure - Deferred Income - Schedule of Deferred Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofDeferredIncomeTable</Role>
      <ShortName>Deferred Income - Schedule of Deferred Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>141</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R142.htm</HtmlFileName>
      <LongName>996089 - Disclosure - Deferred Income - Schedule of Movements in Government Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable</Role>
      <ShortName>Deferred Income - Schedule of Movements in Government Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>142</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R143.htm</HtmlFileName>
      <LongName>996090 - Disclosure - Share Capital and Treasury Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails</Role>
      <ShortName>Share Capital and Treasury Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables</ParentRole>
      <Position>143</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R144.htm</HtmlFileName>
      <LongName>996091 - Disclosure - Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable</Role>
      <ShortName>Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>144</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R145.htm</HtmlFileName>
      <LongName>996092 - Disclosure - Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Parentheticals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals</Role>
      <ShortName>Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Parentheticals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>145</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R146.htm</HtmlFileName>
      <LongName>996093 - Disclosure - Share Capital and Treasury Shares - Schedule of Share Capital and Treasury Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable</Role>
      <ShortName>Share Capital and Treasury Shares - Schedule of Share Capital and Treasury Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>146</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R147.htm</HtmlFileName>
      <LongName>996094 - Disclosure - Reserves (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ReservesDetails</Role>
      <ShortName>Reserves (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/Reserves</ParentRole>
      <Position>147</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R148.htm</HtmlFileName>
      <LongName>996095 - Disclosure - Share-Based Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails</Role>
      <ShortName>Share-Based Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/ShareBasedPaymentsTables</ParentRole>
      <Position>148</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R149.htm</HtmlFileName>
      <LongName>996096 - Disclosure - Share-Based Payments - Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable</Role>
      <ShortName>Share-Based Payments - Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>149</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R150.htm</HtmlFileName>
      <LongName>996097 - Disclosure - Share-Based Payments - Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable</Role>
      <ShortName>Share-Based Payments - Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>150</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R151.htm</HtmlFileName>
      <LongName>996098 - Disclosure - Share-Based Payments - Schedule of fair values of share options granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable</Role>
      <ShortName>Share-Based Payments - Schedule of fair values of share options granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>151</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R152.htm</HtmlFileName>
      <LongName>996099 - Disclosure - Share-Based Payments - Schedule of Unlocking Date (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable</Role>
      <ShortName>Share-Based Payments - Schedule of Unlocking Date (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>152</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R153.htm</HtmlFileName>
      <LongName>996100 - Disclosure - Share-Based Payments - Schedule of Restricted Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable</Role>
      <ShortName>Share-Based Payments - Schedule of Restricted Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>153</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R154.htm</HtmlFileName>
      <LongName>996101 - Disclosure - Notes to the Consolidated Statements of Cash Flows (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails</Role>
      <ShortName>Notes to the Consolidated Statements of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables</ParentRole>
      <Position>154</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R155.htm</HtmlFileName>
      <LongName>996102 - Disclosure - Notes to the Consolidated Statements of Cash Flows - Schedule of Changes in Liabilities Arising from Financing Activities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable</Role>
      <ShortName>Notes to the Consolidated Statements of Cash Flows - Schedule of Changes in Liabilities Arising from Financing Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>155</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R156.htm</HtmlFileName>
      <LongName>996103 - Disclosure - Notes to the Consolidated Statements of Cash Flows - Schedule of Cash Outflow for Leases Included In the Statement of Cash Flows (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable</Role>
      <ShortName>Notes to the Consolidated Statements of Cash Flows - Schedule of Cash Outflow for Leases Included In the Statement of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>156</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R157.htm</HtmlFileName>
      <LongName>996104 - Disclosure - Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/CommitmentsDetails</Role>
      <ShortName>Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/Commitments</ParentRole>
      <Position>157</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R158.htm</HtmlFileName>
      <LongName>996105 - Disclosure - Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ContingentLiabilitiesDetails</Role>
      <ShortName>Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/ContingentLiabilities</ParentRole>
      <Position>158</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R159.htm</HtmlFileName>
      <LongName>996106 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>159</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R160.htm</HtmlFileName>
      <LongName>996107 - Disclosure - Related Party Transactions - Schedule of Transaction with Related Party (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable</Role>
      <ShortName>Related Party Transactions - Schedule of Transaction with Related Party (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>160</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R161.htm</HtmlFileName>
      <LongName>996108 - Disclosure - Related Party Transactions - Schedule of Outstanding Balance with Related Party (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable</Role>
      <ShortName>Related Party Transactions - Schedule of Outstanding Balance with Related Party (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>161</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R162.htm</HtmlFileName>
      <LongName>996109 - Disclosure - Related Party Transactions - Schedule of Compensation of key Management Personnel (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable</Role>
      <ShortName>Related Party Transactions - Schedule of Compensation of key Management Personnel (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>162</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R163.htm</HtmlFileName>
      <LongName>996110 - Disclosure - Financial Instruments by Category - Schedule of Categories of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable</Role>
      <ShortName>Financial Instruments by Category - Schedule of Categories of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>163</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R164.htm</HtmlFileName>
      <LongName>996111 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable</Role>
      <ShortName>Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>164</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R165.htm</HtmlFileName>
      <LongName>996112 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Assets Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable</Role>
      <ShortName>Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Assets Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>165</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R166.htm</HtmlFileName>
      <LongName>996113 - Disclosure - Financial Risk Management Objectives and Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails</Role>
      <ShortName>Financial Risk Management Objectives and Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables</ParentRole>
      <Position>166</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R167.htm</HtmlFileName>
      <LongName>996114 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Interest Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Schedule of Interest Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>167</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R168.htm</HtmlFileName>
      <LongName>996115 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Foreign Currency Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Schedule of Foreign Currency Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>168</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R169.htm</HtmlFileName>
      <LongName>996116 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Credit Quality and Maximum Exposure To Credit Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Schedule of Credit Quality and Maximum Exposure To Credit Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>169</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R170.htm</HtmlFileName>
      <LongName>996117 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Liquidity Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Schedule of Liquidity Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>170</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R171.htm</HtmlFileName>
      <LongName>996118 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Equity Price Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Schedule of Equity Price Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>171</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R172.htm</HtmlFileName>
      <LongName>996119 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Fair Values of the Equity Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Schedule of Fair Values of the Equity Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>172</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R173.htm</HtmlFileName>
      <LongName>996120 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Capital Management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Schedule of Capital Management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>173</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R174.htm</HtmlFileName>
      <LongName>996121 - Disclosure - Condensed Financial Information of the Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyDetails</Role>
      <ShortName>Condensed Financial Information of the Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables</ParentRole>
      <Position>174</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R175.htm</HtmlFileName>
      <LongName>996122 - Disclosure - Condensed Financial Information of the Company - Schedule of Statements of Financial Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable</Role>
      <ShortName>Condensed Financial Information of the Company - Schedule of Statements of Financial Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>175</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R176.htm</HtmlFileName>
      <LongName>996123 - Disclosure - Condensed Financial Information of the Company - Schedule of Condensed Statements of Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable</Role>
      <ShortName>Condensed Financial Information of the Company - Schedule of Condensed Statements of Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>176</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R177.htm</HtmlFileName>
      <LongName>996124 - Disclosure - Condensed Financial Information of the Company - Schedule of Condensed Statements of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable</Role>
      <ShortName>Condensed Financial Information of the Company - Schedule of Condensed Statements of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>177</Position>
    </Report>
    <Report instance="ea0285148-20f_ascentage.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R178.htm</HtmlFileName>
      <LongName>996125 - Disclosure - Condensed Financial Information of the Company - Schedule of Company???s Reserves (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable</Role>
      <ShortName>Condensed Financial Information of the Company - Schedule of Company???s Reserves (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>178</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>aapg-20251231.xsd</File>
    <File>aapg-20251231_cal.xml</File>
    <File>aapg-20251231_def.xml</File>
    <File>aapg-20251231_lab.xml</File>
    <File>aapg-20251231_pre.xml</File>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" isUsgaap="true" original="ea0285148-20f_ascentage.htm">ea0285148-20f_ascentage.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ea028514801_img1.jpg</File>
    <File>ea028514801_img10.jpg</File>
    <File>ea028514801_img11.jpg</File>
    <File>ea028514801_img12.jpg</File>
    <File>ea028514801_img13.jpg</File>
    <File>ea028514801_img14.jpg</File>
    <File>ea028514801_img15.jpg</File>
    <File>ea028514801_img16.jpg</File>
    <File>ea028514801_img17.jpg</File>
    <File>ea028514801_img18.jpg</File>
    <File>ea028514801_img19.jpg</File>
    <File>ea028514801_img2.jpg</File>
    <File>ea028514801_img20.jpg</File>
    <File>ea028514801_img21.jpg</File>
    <File>ea028514801_img22.jpg</File>
    <File>ea028514801_img23.jpg</File>
    <File>ea028514801_img24.jpg</File>
    <File>ea028514801_img25.jpg</File>
    <File>ea028514801_img26.jpg</File>
    <File>ea028514801_img27.jpg</File>
    <File>ea028514801_img28.jpg</File>
    <File>ea028514801_img29.jpg</File>
    <File>ea028514801_img3.jpg</File>
    <File>ea028514801_img30.jpg</File>
    <File>ea028514801_img31.jpg</File>
    <File>ea028514801_img32.jpg</File>
    <File>ea028514801_img33.jpg</File>
    <File>ea028514801_img34.jpg</File>
    <File>ea028514801_img35.jpg</File>
    <File>ea028514801_img4.jpg</File>
    <File>ea028514801_img5.jpg</File>
    <File>ea028514801_img6.jpg</File>
    <File>ea028514801_img7.jpg</File>
    <File>ea028514801_img8.jpg</File>
    <File>ea028514801_img9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/srt/2025</BaseTaxonomy>
    <BaseTaxonomy items="12">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
    <BaseTaxonomy items="2397">https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>247
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0285148-20f_ascentage.htm": {
   "nsprefix": "aapg",
   "nsuri": "http://www.ascentage.cn.com/20251231",
   "dts": {
    "schema": {
     "local": [
      "aapg-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_def.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_pre.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "aapg-20251231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aapg-20251231_def.xml"
     ],
     "remote": [
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml"
     ]
    },
    "labelLink": {
     "local": [
      "aapg-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aapg-20251231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0285148-20f_ascentage.htm"
     ]
    }
   },
   "keyStandard": 424,
   "keyCustom": 188,
   "axisStandard": 38,
   "axisCustom": 4,
   "memberStandard": 51,
   "memberCustom": 129,
   "hidden": {
    "total": 532,
    "http://www.ascentage.cn.com/20251231": 199,
    "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 328,
    "http://xbrl.sec.gov/dei/2025": 5
   },
   "contextCount": 734,
   "entityCount": 1,
   "segmentCount": 200,
   "elementCount": 1341,
   "unitCount": 8,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 2397,
    "http://xbrl.sec.gov/dei/2025": 47,
    "http://xbrl.sec.gov/cyd/2025": 12,
    "http://fasb.org/srt/2025": 2,
    "http://xbrl.sec.gov/ecd/2025": 1
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation",
     "longName": "995300 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
     "longName": "995301 - Statement - Consolidated Statements of Profit or Loss",
     "shortName": "Consolidated Statements of Profit or Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:Revenue",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:CostOfSales",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome",
     "longName": "995302 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
     "longName": "995303 - Statement - Consolidated Statements of Financial Position",
     "shortName": "Consolidated Statements of Financial Position",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:OtherIntangibleAssets",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "longName": "995304 - Statement - Consolidated Statements of Financial Position (Parentheticals)",
     "shortName": "Consolidated Statements of Financial Position (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "ifrs-full:ParValuePerShare",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:NumberOfSharesAuthorised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "ifrs-full:NumberOfSharesAuthorised",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3",
     "longName": "995305 - Statement - Consolidated Statements of Changes in Equity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c16",
      "name": "ifrs-full:Equity",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c30",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
     "longName": "995306 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:AdjustmentsForDepreciationOfRightofuseAssets",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.ascentage.cn.com/role/CorporateandGroupInformation",
     "longName": "995307 - Disclosure - Corporate and Group Information",
     "shortName": "Corporate and Group Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.ascentage.cn.com/role/AccountingPolicies",
     "longName": "995308 - Disclosure - Accounting Policies",
     "shortName": "Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimates",
     "longName": "995309 - Disclosure - Significant Accounting Judgements and Estimates",
     "shortName": "Significant Accounting Judgements and Estimates",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.ascentage.cn.com/role/OperatingSegmentInformation",
     "longName": "995310 - Disclosure - Operating Segment Information",
     "shortName": "Operating Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.ascentage.cn.com/role/RevenueOtherIncomeandGains",
     "longName": "995311 - Disclosure - Revenue, Other Income and Gains",
     "shortName": "Revenue, Other Income and Gains",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.ascentage.cn.com/role/LossBeforeTax",
     "longName": "995312 - Disclosure - Loss Before Tax",
     "shortName": "Loss Before Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.ascentage.cn.com/role/OtherExpenses",
     "longName": "995313 - Disclosure - Other Expenses",
     "shortName": "Other Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.ascentage.cn.com/role/FinanceCosts",
     "longName": "995314 - Disclosure - Finance Costs",
     "shortName": "Finance Costs",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.ascentage.cn.com/role/IncomeTax",
     "longName": "995315 - Disclosure - Income Tax",
     "shortName": "Income Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.ascentage.cn.com/role/Dividends",
     "longName": "995316 - Disclosure - Dividends",
     "shortName": "Dividends",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDividendsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDividendsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany",
     "longName": "995317 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company",
     "shortName": "Loss Per Share Attributable to Ordinary Equity Holders of the Company",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.ascentage.cn.com/role/PropertyPlantandEquipment",
     "longName": "995318 - Disclosure - Property, Plant and Equipment",
     "shortName": "Property, Plant and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.ascentage.cn.com/role/Leases",
     "longName": "995319 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.ascentage.cn.com/role/Goodwill",
     "longName": "995320 - Disclosure - Goodwill",
     "shortName": "Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.ascentage.cn.com/role/OtherIntangibleAsset",
     "longName": "995321 - Disclosure - Other Intangible Asset",
     "shortName": "Other Intangible Asset",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.ascentage.cn.com/role/InvestmentinaJointVenture",
     "longName": "995322 - Disclosure - Investment in a Joint Venture",
     "shortName": "Investment in a Joint Venture",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLoss",
     "longName": "995323 - Disclosure - Financial Assets at Fair Value through Profit or Loss",
     "shortName": "Financial Assets at Fair Value through Profit or Loss",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.ascentage.cn.com/role/DeferredTax",
     "longName": "995324 - Disclosure - Deferred Tax",
     "shortName": "Deferred Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.ascentage.cn.com/role/OtherNonCurrentAssets",
     "longName": "995325 - Disclosure - Other Non-Current Assets",
     "shortName": "Other Non-Current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.ascentage.cn.com/role/Inventories",
     "longName": "995326 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.ascentage.cn.com/role/TradeReceivablesNet",
     "longName": "995327 - Disclosure - Trade Receivables, Net",
     "shortName": "Trade Receivables, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssets",
     "longName": "995328 - Disclosure - Prepayments, Other Receivables and Other Assets",
     "shortName": "Prepayments, Other Receivables and Other Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.ascentage.cn.com/role/CashandBankBalances",
     "longName": "995329 - Disclosure - Cash and Bank Balances",
     "shortName": "Cash and Bank Balances",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.ascentage.cn.com/role/TradePayables",
     "longName": "995330 - Disclosure - Trade Payables",
     "shortName": "Trade Payables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.ascentage.cn.com/role/OtherPayablesandAccruals",
     "longName": "995331 - Disclosure - Other Payables and Accruals",
     "shortName": "Other Payables and Accruals",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfOtherPayablesAndAccrualsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfOtherPayablesAndAccrualsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.ascentage.cn.com/role/ContractLiabilities",
     "longName": "995332 - Disclosure - Contract Liabilities",
     "shortName": "Contract Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfContractLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfContractLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowings",
     "longName": "995333 - Disclosure - Interest-Bearing Bank and Other Borrowings",
     "shortName": "Interest-Bearing Bank and Other Borrowings",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.ascentage.cn.com/role/DeferredIncome",
     "longName": "995334 - Disclosure - Deferred Income",
     "shortName": "Deferred Income",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.ascentage.cn.com/role/ShareCapitalandTreasuryShares",
     "longName": "995335 - Disclosure - Share Capital and Treasury Shares",
     "shortName": "Share Capital and Treasury Shares",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.ascentage.cn.com/role/Reserves",
     "longName": "995336 - Disclosure - Reserves",
     "shortName": "Reserves",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.ascentage.cn.com/role/ShareBasedPayments",
     "longName": "995337 - Disclosure - Share-Based Payments",
     "shortName": "Share-Based Payments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlows",
     "longName": "995338 - Disclosure - Notes to the Consolidated Statements of Cash Flows",
     "shortName": "Notes to the Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.ascentage.cn.com/role/Commitments",
     "longName": "995339 - Disclosure - Commitments",
     "shortName": "Commitments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.ascentage.cn.com/role/ContingentLiabilities",
     "longName": "995340 - Disclosure - Contingent Liabilities",
     "shortName": "Contingent Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.ascentage.cn.com/role/PledgeofAssets",
     "longName": "995341 - Disclosure - Pledge of Assets",
     "shortName": "Pledge of Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfPledgeOfAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfPledgeOfAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.ascentage.cn.com/role/RelatedPartyTransactions",
     "longName": "995342 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategory",
     "longName": "995343 - Disclosure - Financial Instruments by Category",
     "shortName": "Financial Instruments by Category",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstruments",
     "longName": "995344 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments",
     "shortName": "Fair Value and Fair Value Hierarchy of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPolicies",
     "longName": "995345 - Disclosure - Financial Risk Management Objectives and Policies",
     "shortName": "Financial Risk Management Objectives and Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.ascentage.cn.com/role/EventAftertheReportingPeriod",
     "longName": "995346 - Disclosure - Event After the Reporting Period",
     "shortName": "Event After the Reporting Period",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompany",
     "longName": "995347 - Disclosure - Condensed Financial Information of the Company",
     "shortName": "Condensed Financial Information of the Company",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.ascentage.cn.com/role/ApprovaloftheFinancialStatements",
     "longName": "995348 - Disclosure - Approval of the Financial Statements",
     "shortName": "Approval of the Financial Statements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.ascentage.cn.com/role/CorporateandGroupInformationTables",
     "longName": "996001 - Disclosure - Corporate and Group Information (Tables)",
     "shortName": "Corporate and Group Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.ascentage.cn.com/role/AccountingPoliciesTables",
     "longName": "996002 - Disclosure - Accounting Policies (Tables)",
     "shortName": "Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.ascentage.cn.com/role/OperatingSegmentInformationTables",
     "longName": "996003 - Disclosure - Operating Segment Information (Tables)",
     "shortName": "Operating Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables",
     "longName": "996004 - Disclosure - Revenue, Other Income and Gains (Tables)",
     "shortName": "Revenue, Other Income and Gains (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.ascentage.cn.com/role/LossBeforeTaxTables",
     "longName": "996005 - Disclosure - Loss Before Tax (Tables)",
     "shortName": "Loss Before Tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfLossBeforeTaxExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfLossBeforeTaxExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.ascentage.cn.com/role/OtherExpensesTables",
     "longName": "996006 - Disclosure - Other Expenses (Tables)",
     "shortName": "Other Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfOtherExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfOtherExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.ascentage.cn.com/role/FinanceCostsTables",
     "longName": "996007 - Disclosure - Finance Costs (Tables)",
     "shortName": "Finance Costs (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinanceCostExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinanceCostExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.ascentage.cn.com/role/IncomeTaxTables",
     "longName": "996008 - Disclosure - Income Tax (Tables)",
     "shortName": "Income Tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables",
     "longName": "996009 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company (Tables)",
     "shortName": "Loss Per Share Attributable to Ordinary Equity Holders of the Company (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.ascentage.cn.com/role/PropertyPlantandEquipmentTables",
     "longName": "996010 - Disclosure - Property, Plant and Equipment (Tables)",
     "shortName": "Property, Plant and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.ascentage.cn.com/role/LeasesTables",
     "longName": "996011 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.ascentage.cn.com/role/GoodwillTables",
     "longName": "996012 - Disclosure - Goodwill (Tables)",
     "shortName": "Goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.ascentage.cn.com/role/OtherIntangibleAssetTables",
     "longName": "996013 - Disclosure - Other Intangible Asset (Tables)",
     "shortName": "Other Intangible Asset (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables",
     "longName": "996014 - Disclosure - Investment in a Joint Venture (Tables)",
     "shortName": "Investment in a Joint Venture (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfInvestmentInAJointVentureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfInvestmentInAJointVentureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLossTables",
     "longName": "996015 - Disclosure - Financial Assets at Fair Value through Profit or Loss (Tables)",
     "shortName": "Financial Assets at Fair Value through Profit or Loss (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.ascentage.cn.com/role/DeferredTaxTables",
     "longName": "996016 - Disclosure - Deferred Tax (Tables)",
     "shortName": "Deferred Tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfDeferredTaxLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfDeferredTaxLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.ascentage.cn.com/role/OtherNonCurrentAssetsTables",
     "longName": "996017 - Disclosure - Other Non-Current Assets (Tables)",
     "shortName": "Other Non-Current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfOtherNonCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfOtherNonCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.ascentage.cn.com/role/InventoriesTables",
     "longName": "996018 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfDetailedInformationOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfDetailedInformationOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.ascentage.cn.com/role/TradeReceivablesNetTables",
     "longName": "996019 - Disclosure - Trade Receivables, Net (Tables)",
     "shortName": "Trade Receivables, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfTradeReceivablesNetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfTradeReceivablesNetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssetsTables",
     "longName": "996020 - Disclosure - Prepayments, Other Receivables and Other Assets (Tables)",
     "shortName": "Prepayments, Other Receivables and Other Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.ascentage.cn.com/role/CashandBankBalancesTables",
     "longName": "996021 - Disclosure - Cash and Bank Balances (Tables)",
     "shortName": "Cash and Bank Balances (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfCashAndBankBalancesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfCashAndBankBalancesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.ascentage.cn.com/role/TradePayablesTables",
     "longName": "996022 - Disclosure - Trade Payables (Tables)",
     "shortName": "Trade Payables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfTradePayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfTradePayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.ascentage.cn.com/role/OtherPayablesandAccrualsTables",
     "longName": "996023 - Disclosure - Other Payables and Accruals (Tables)",
     "shortName": "Other Payables and Accruals (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureofOtherPayablesAndAccrualsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aapg:DisclosureOfOtherPayablesAndAccrualsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureofOtherPayablesAndAccrualsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aapg:DisclosureOfOtherPayablesAndAccrualsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.ascentage.cn.com/role/ContractLiabilitiesTables",
     "longName": "996024 - Disclosure - Contract Liabilities (Tables)",
     "shortName": "Contract Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfContractsLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aapg:DisclosureOfContractLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfContractsLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aapg:DisclosureOfContractLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables",
     "longName": "996025 - Disclosure - Interest-Bearing Bank and Other Borrowings (Tables)",
     "shortName": "Interest-Bearing Bank and Other Borrowings (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.ascentage.cn.com/role/DeferredIncomeTables",
     "longName": "996026 - Disclosure - Deferred Income (Tables)",
     "shortName": "Deferred Income (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfDeferredIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:ScheduleOfDeferredIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables",
     "longName": "996027 - Disclosure - Share Capital and Treasury Shares (Tables)",
     "shortName": "Share Capital and Treasury Shares (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.ascentage.cn.com/role/ShareBasedPaymentsTables",
     "longName": "996028 - Disclosure - Share-Based Payments (Tables)",
     "shortName": "Share-Based Payments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables",
     "longName": "996029 - Disclosure - Notes to the Consolidated Statements of Cash Flows (Tables)",
     "shortName": "Notes to the Consolidated Statements of Cash Flows (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables",
     "longName": "996030 - Disclosure - Related Party Transactions (Tables)",
     "shortName": "Related Party Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureofTransactionWithRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureofTransactionWithRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategoryTables",
     "longName": "996031 - Disclosure - Financial Instruments by Category (Tables)",
     "shortName": "Financial Instruments by Category (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstrumentsTables",
     "longName": "996032 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments (Tables)",
     "shortName": "Fair Value and Fair Value Hierarchy of Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables",
     "longName": "996033 - Disclosure - Financial Risk Management Objectives and Policies (Tables)",
     "shortName": "Financial Risk Management Objectives and Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfInterestRateRiskExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DisclosureOfInterestRateRiskExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables",
     "longName": "996034 - Disclosure - Condensed Financial Information of the Company (Tables)",
     "shortName": "Condensed Financial Information of the Company (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable",
     "longName": "996035 - Disclosure - Corporate and Group Information - Schedule of Principal Subsidiaries (Details)",
     "shortName": "Corporate and Group Information - Schedule of Principal Subsidiaries (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c74",
      "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c74",
      "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.ascentage.cn.com/role/AccountingPoliciesDetails",
     "longName": "996036 - Disclosure - Accounting Policies (Details)",
     "shortName": "Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:OtherEmployeeBenefitContributionPercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:OtherEmployeeBenefitContributionPercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable",
     "longName": "996037 - Disclosure - Accounting Policies - Schedule of New and Revised IFRSs (Details)",
     "shortName": "Accounting Policies - Schedule of New and Revised IFRSs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c83",
      "name": "ifrs-full:TitleOfNewIFRS",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c83",
      "name": "ifrs-full:TitleOfNewIFRS",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable",
     "longName": "996038 - Disclosure - Accounting Policies - Schedule of Property, Plant and Equipment of Annual Rates (Details)",
     "shortName": "Accounting Policies - Schedule of Property, Plant and Equipment of Annual Rates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c90",
      "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c90",
      "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable",
     "longName": "996039 - Disclosure - Accounting Policies - Schedule of Intangible Assets are Amortized on the Straight-Line Basis (Details)",
     "shortName": "Accounting Policies - Schedule of Intangible Assets are Amortized on the Straight-Line Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c96",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c96",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable",
     "longName": "996040 - Disclosure - Accounting Policies - Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets (Details)",
     "shortName": "Accounting Policies - Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c100",
      "name": "aapg:RightofuseAssetsOfEstimatedUsefulLives",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c100",
      "name": "aapg:RightofuseAssetsOfEstimatedUsefulLives",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails",
     "longName": "996041 - Disclosure - Significant Accounting Judgements and Estimates (Details)",
     "shortName": "Significant Accounting Judgements and Estimates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:TaxEffectOfTaxLosses",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c106",
      "name": "ifrs-full:NetDeferredTaxAssets",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.ascentage.cn.com/role/OperatingSegmentInformationDetails",
     "longName": "996042 - Disclosure - Operating Segment Information (Details)",
     "shortName": "Operating Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:FactorsUsedToIdentifyEntitysReportableSegments",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:FactorsUsedToIdentifyEntitysReportableSegments",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofRevenueTable",
     "longName": "996043 - Disclosure - Operating Segment Information - \u200bSchedule of Revenue (Details)",
     "shortName": "Operating Segment Information - \u200bSchedule of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:Revenue",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c112",
      "name": "ifrs-full:Revenue",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable",
     "longName": "996044 - Disclosure - Operating Segment Information - \u200bSchedule of Non-Current Assets (Details)",
     "shortName": "Operating Segment Information - \u200bSchedule of Non-Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:NoncurrentFinancialAssets",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c118",
      "name": "ifrs-full:NoncurrentFinancialAssets",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable",
     "longName": "996045 - Disclosure - Operating Segment Information - Schedule of Revenue from Customers (Details)",
     "shortName": "Operating Segment Information - Schedule of Revenue from Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable",
     "longName": "996046 - Disclosure - Revenue, Other Income and Gains - \u200bSchedule of Disaggregated Revenue (Details)",
     "shortName": "Revenue, Other Income and Gains - \u200bSchedule of Disaggregated Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:Revenue",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c151",
      "name": "ifrs-full:Revenue",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "aapg:DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable",
     "longName": "996047 - Disclosure - Revenue, Other Income and Gains - \u200bSchedule of Contract Liabilities (Details)",
     "shortName": "Revenue, Other Income and Gains - \u200bSchedule of Contract Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInvestmentContractsLiabilitiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInvestmentContractsLiabilitiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable",
     "longName": "996048 - Disclosure - Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details)",
     "shortName": "Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfPerformanceObligationsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfPerformanceObligationsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable",
     "longName": "996049 - Disclosure - Revenue, Other Income and Gains - Schedule of Other Income and Gains (Details)",
     "shortName": "Revenue, Other Income and Gains - Schedule of Other Income and Gains (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfLossBeforeTaxExplanatoryTableTextBlock",
       "aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c13",
      "name": "ifrs-full:NetForeignExchangeGain",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable",
     "longName": "996050 - Disclosure - Loss Before Tax - Schedule of Loss Before Tax (Details)",
     "shortName": "Loss Before Tax - Schedule of Loss Before Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfLossBeforeTaxExplanatoryTableTextBlock",
       "aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfLossBeforeTaxExplanatoryTableTextBlock",
       "aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable",
     "longName": "996051 - Disclosure - Other Expenses - Schedule of Other Expenses (Details)",
     "shortName": "Other Expenses - Schedule of Other Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfOtherExpensesTableTextBlock",
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfOtherExpensesTableTextBlock",
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable",
     "longName": "996052 - Disclosure - Finance Costs - Schedule of Finance Costs (Details)",
     "shortName": "Finance Costs - Schedule of Finance Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:InterestExpenseOnBankLoansAndOverdrafts",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceCostExplanatory",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:InterestExpenseOnBankLoansAndOverdrafts",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceCostExplanatory",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.ascentage.cn.com/role/IncomeTaxDetails",
     "longName": "996053 - Disclosure - Income Tax (Details)",
     "shortName": "Income Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "ifrs-full:ApplicableTaxRate",
       "ifrs-full:ApplicableTaxRate",
       "ifrs-full:ApplicableTaxRate",
       "span",
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "ifrs-full:ApplicableTaxRate",
       "ifrs-full:ApplicableTaxRate",
       "ifrs-full:ApplicableTaxRate",
       "span",
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable",
     "longName": "996054 - Disclosure - Income Tax  - Schedule of Current and Deferred Components of the Income Tax (Credit)/Expense (Details)",
     "shortName": "Income Tax  - Schedule of Current and Deferred Components of the Income Tax (Credit)/Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable",
     "longName": "996055 - Disclosure - Income Tax  - Schedule of Reconciliation between the Income Tax Expense/(Credit) (Details)",
     "shortName": "Income Tax  - Schedule of Reconciliation between the Income Tax Expense/(Credit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:IncomeTaxComputedAtTheStatutoryTaxRate",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails",
     "longName": "996056 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company (Details)",
     "shortName": "Loss Per Share Attributable to Ordinary Equity Holders of the Company (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:WeightedAverageShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R110": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofBasicLossPerShareTable",
     "longName": "996057 - Disclosure - Loss Per Share Attributable to Ordinary Equity Holders of the Company - Schedule of Basic Loss Per Share (Details)",
     "shortName": "Loss Per Share Attributable to Ordinary Equity Holders of the Company - Schedule of Basic Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R111": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable",
     "longName": "996058 - Disclosure - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details)",
     "shortName": "Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "aapg:PropertyAndEquipmentCost",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "aapg:PropertyAndEquipmentCost",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.ascentage.cn.com/role/LeasesDetails",
     "longName": "996059 - Disclosure - Leases (Details)",
     "shortName": "Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "aapg:TermsOfLandLease",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:TermsOfLandLease",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R113": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable",
     "longName": "996060 - Disclosure - Leases - Schedule of Right-of-Use Assets (Details)",
     "shortName": "Leases - Schedule of Right-of-Use Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c14",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c41",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable",
     "longName": "996061 - Disclosure - Leases - Schedule of Lease Liabilities (Details)",
     "shortName": "Leases - Schedule of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c14",
      "name": "ifrs-full:LeaseLiabilities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c14",
      "name": "ifrs-full:LeaseLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable",
     "longName": "996062 - Disclosure - Leases - Schedule of Recognized in Profit or Loss (Details)",
     "shortName": "Leases - Schedule of Recognized in Profit or Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:InterestExpenseOnLeaseLiabilities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "aapg:DepreciationChargeofRightofuseAssets",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.ascentage.cn.com/role/GoodwillDetails",
     "longName": "996063 - Disclosure - Goodwill (Details)",
     "shortName": "Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R117": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofGoodwillTable",
     "longName": "996064 - Disclosure - Goodwill - Schedule of Goodwill (Details)",
     "shortName": "Goodwill - Schedule of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "aapg:CostGoodwill",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "aapg:CostGoodwill",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R118": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable",
     "longName": "996065 - Disclosure - Other Intangible Asset - Schedule of Other Intangible Asset (Details)",
     "shortName": "Other Intangible Asset - Schedule of Other Intangible Asset (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "c250",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c242",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R119": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofInvestmentinaJointVentureTable",
     "longName": "996066 - Disclosure - Investment in a Joint Venture - Schedule of Investment in a Joint Venture (Details)",
     "shortName": "Investment in a Joint Venture - Schedule of Investment in a Joint Venture (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfInvestmentInAJointVentureTableTextBlock",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R120": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable",
     "longName": "996067 - Disclosure - Investment in a Joint Venture - Schedule of Group\u2019s Principal Joint Venture (Details)",
     "shortName": "Investment in a Joint Venture - Schedule of Group\u2019s Principal Joint Venture (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfGroupsPrincipalJointVentureTableTextBlock",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfGroupsPrincipalJointVentureTableTextBlock",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R121": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable",
     "longName": "996068 - Disclosure - Investment in a Joint Venture - Schedule of Information of the Group\u2019s Joint Venture (Details)",
     "shortName": "Investment in a Joint Venture - Schedule of Information of the Group\u2019s Joint Venture (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R122": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable",
     "longName": "996069 - Disclosure - Financial Assets at Fair Value through Profit or Loss - Schedule of Financial Assets at Fair Value through Profit or Loss (Details)",
     "shortName": "Financial Assets at Fair Value through Profit or Loss - Schedule of Financial Assets at Fair Value through Profit or Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "c14",
      "name": "aapg:ListedEquityInvestmentsAtFairValue",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c14",
      "name": "aapg:ListedEquityInvestmentsAtFairValue",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R123": {
     "role": "http://www.ascentage.cn.com/role/DeferredTaxDetails",
     "longName": "996070 - Disclosure - Deferred Tax (Details)",
     "shortName": "Deferred Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:TaxEffectOfTaxLosses",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R124": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable",
     "longName": "996071 - Disclosure - Deferred Tax - Schedule of Movements in Deferred Tax Liabilities and Assets (Details)",
     "shortName": "Deferred Tax - Schedule of Movements in Deferred Tax Liabilities and Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "c14",
      "name": "ifrs-full:NetDeferredTaxLiabilities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c41",
      "name": "ifrs-full:NetDeferredTaxLiabilities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R125": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable",
     "longName": "996072 - Disclosure - Deferred Tax - Schedule of Movements in Deferred Tax Assets (Details)",
     "shortName": "Deferred Tax - Schedule of Movements in Deferred Tax Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "125",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfDeferredTaxAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfDeferredTaxAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R126": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
     "longName": "996073 - Disclosure - Deferred Tax - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Deferred Tax - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "126",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R127": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable",
     "longName": "996074 - Disclosure - Other Non-Current Assets - Schedule of Other Non-Current Assets (Details)",
     "shortName": "Other Non-Current Assets - Schedule of Other Non-Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "127",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "aapg:ContractAcquisitionCosts",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfOtherNonCurrentAssetsTableTextBlock",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "aapg:ContractAcquisitionCosts",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfOtherNonCurrentAssetsTableTextBlock",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R128": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofInventoriesTable",
     "longName": "996075 - Disclosure - Inventories - Schedule of Inventories (Details)",
     "shortName": "Inventories - Schedule of Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "128",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:WorkInProgress",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfDetailedInformationOfInventoriesExplanatory",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:WorkInProgress",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfDetailedInformationOfInventoriesExplanatory",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R129": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofTradeReceivablesNetTable",
     "longName": "996076 - Disclosure - Trade Receivables, Net - Schedule of Trade Receivables, Net (Details)",
     "shortName": "Trade Receivables, Net - Schedule of Trade Receivables, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "129",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:TradeAndOtherCurrentReceivables",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R130": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable",
     "longName": "996077 - Disclosure - Trade Receivables, Net - Schedule of Based on the Invoice Date and Net of Loss Allowance (Details)",
     "shortName": "Trade Receivables, Net - Schedule of Based on the Invoice Date and Net of Loss Allowance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "130",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:TradeAndOtherCurrentReceivables",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c303",
      "name": "ifrs-full:TradeAndOtherCurrentReceivables",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R131": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable",
     "longName": "996078 - Disclosure - Prepayments, Other Receivables and Other Assets - Schedule of Prepayments, Other Receivables and Other Assets (Details)",
     "shortName": "Prepayments, Other Receivables and Other Assets - Schedule of Prepayments, Other Receivables and Other Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "131",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "aapg:PrepaymentsForClinicalTrialExpenses",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory",
       "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "aapg:PrepaymentsForClinicalTrialExpenses",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory",
       "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R132": {
     "role": "http://www.ascentage.cn.com/role/CashandBankBalancesDetails",
     "longName": "996079 - Disclosure - Cash and Bank Balances (Details)",
     "shortName": "Cash and Bank Balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "132",
     "firstAnchor": {
      "contextRef": "c308",
      "name": "ifrs-full:CashAndBankBalancesAtCentralBanks",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c308",
      "name": "ifrs-full:CashAndBankBalancesAtCentralBanks",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R133": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable",
     "longName": "996080 - Disclosure - Cash and Bank Balances - Schedule of Cash and Bank Balances (Details)",
     "shortName": "Cash and Bank Balances - Schedule of Cash and Bank Balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "133",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfCashAndBankBalancesExplanatory",
       "ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:DepositsFromBanks",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfCashAndBankBalancesExplanatory",
       "ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R134": {
     "role": "http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable",
     "longName": "996081 - Disclosure - Trade Payables - Schedule of the Trade Payables (Details)",
     "shortName": "Trade Payables - Schedule of the Trade Payables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "134",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:TradeAndOtherCurrentPayables",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfTradePayablesExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:TradeAndOtherCurrentPayables",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfTradePayablesExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R135": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable",
     "longName": "996082 - Disclosure - Other Payables and Accruals - Schedule of Other Payables and Accruals (Details)",
     "shortName": "Other Payables and Accruals - Schedule of Other Payables and Accruals (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "135",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:AccrualsClassifiedAsCurrent",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureofOtherPayablesAndAccrualsExplanatory",
       "aapg:DisclosureOfOtherPayablesAndAccrualsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:AccrualsClassifiedAsCurrent",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureofOtherPayablesAndAccrualsExplanatory",
       "aapg:DisclosureOfOtherPayablesAndAccrualsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R136": {
     "role": "http://www.ascentage.cn.com/role/ContractLiabilitiesDetails",
     "longName": "996083 - Disclosure - Contract Liabilities (Details)",
     "shortName": "Contract Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "136",
     "firstAnchor": {
      "contextRef": "c323",
      "name": "ifrs-full:ContractLiabilities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "aapg:DisclosureOfContractLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c323",
      "name": "ifrs-full:ContractLiabilities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "aapg:DisclosureOfContractLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R137": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0",
     "longName": "996084 - Disclosure - Contract Liabilities - Schedule of Contract Liabilities (Details)",
     "shortName": "Contract Liabilities - Schedule of Contract Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "137",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:ContractLiabilities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfContractsLiabilitiesExplanatory",
       "aapg:DisclosureOfContractLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:ContractLiabilities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfContractsLiabilitiesExplanatory",
       "aapg:DisclosureOfContractLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R138": {
     "role": "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
     "longName": "996085 - Disclosure - Interest-Bearing Bank and Other Borrowings (Details)",
     "shortName": "Interest-Bearing Bank and Other Borrowings (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "138",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:ShorttermBorrowings",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:UnsecuredBankLoansReceived",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R139": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable",
     "longName": "996086 - Disclosure - Interest-Bearing Bank and Other Borrowings - Schedule of Interest-Bearing Bank and Other Borrowings (Details)",
     "shortName": "Interest-Bearing Bank and Other Borrowings - Schedule of Interest-Bearing Bank and Other Borrowings (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "139",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:ShorttermBorrowings",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c373",
      "name": "ifrs-full:BorrowingsInterestRateBasis",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R140": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable",
     "longName": "996087 - Disclosure - Interest-Bearing Bank and Other Borrowings - Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans (Details)",
     "shortName": "Interest-Bearing Bank and Other Borrowings - Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "140",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:Borrowings",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c171",
      "name": "ifrs-full:Borrowings",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R141": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofDeferredIncomeTable",
     "longName": "996088 - Disclosure - Deferred Income - Schedule of Deferred Income (Details)",
     "shortName": "Deferred Income - Schedule of Deferred Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "141",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:CurrentGovernmentGrants",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfDeferredIncomeTableTextBlock",
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:CurrentGovernmentGrants",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfDeferredIncomeTableTextBlock",
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R142": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable",
     "longName": "996089 - Disclosure - Deferred Income - Schedule of Movements in Government Grants (Details)",
     "shortName": "Deferred Income - Schedule of Movements in Government Grants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "142",
     "firstAnchor": {
      "contextRef": "c14",
      "name": "ifrs-full:GovernmentGrants",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c14",
      "name": "ifrs-full:GovernmentGrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R143": {
     "role": "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails",
     "longName": "996090 - Disclosure - Share Capital and Treasury Shares (Details)",
     "shortName": "Share Capital and Treasury Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "143",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "aapg:DisclosureOfShareCapitalAndTreasurySharesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c415",
      "name": "ifrs-full:IssuedCapitalOrdinaryShares",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "aapg:DisclosureOfShareCapitalAndTreasurySharesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R144": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable",
     "longName": "996091 - Disclosure - Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Details)",
     "shortName": "Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "144",
     "firstAnchor": {
      "contextRef": "c438",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c438",
      "name": "ifrs-full:Equity",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R145": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals",
     "longName": "996092 - Disclosure - Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Parentheticals) (Details)",
     "shortName": "Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Parentheticals) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "145",
     "firstAnchor": {
      "contextRef": "c438",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c438",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R146": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable",
     "longName": "996093 - Disclosure - Share Capital and Treasury Shares - Schedule of Share Capital and Treasury Shares (Details)",
     "shortName": "Share Capital and Treasury Shares - Schedule of Share Capital and Treasury Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "146",
     "firstAnchor": {
      "contextRef": "c14",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "ifrs-full:NumberOfSharesAuthorised",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c24",
      "name": "aapg:IssuedShareCapital",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "aapg:DisclosureOfShareCapitalAndTreasurySharesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R147": {
     "role": "http://www.ascentage.cn.com/role/ReservesDetails",
     "longName": "996094 - Disclosure - Reserves (Details)",
     "shortName": "Reserves (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "147",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:SharePremium",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c12",
      "name": "aapg:TransferredOutFromCapitalAndReserves",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R148": {
     "role": "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails",
     "longName": "996095 - Disclosure - Share-Based Payments (Details)",
     "shortName": "Share-Based Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "148",
     "firstAnchor": {
      "contextRef": "c461",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c461",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R149": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable",
     "longName": "996096 - Disclosure - Share-Based Payments - Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme (Details)",
     "shortName": "Share-Based Payments - Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "149",
     "firstAnchor": {
      "contextRef": "c14",
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
      "unitRef": "hkdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
      "unitRef": "hkdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R150": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable",
     "longName": "996097 - Disclosure - Share-Based Payments - Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding (Details)",
     "shortName": "Share-Based Payments - Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "150",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c510",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R151": {
     "role": "http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable",
     "longName": "996098 - Disclosure - Share-Based Payments - Schedule of fair values of share options granted (Details)",
     "shortName": "Share-Based Payments - Schedule of fair values of share options granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "151",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfFairValuesOfShareOptionsGrantedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfFairValuesOfShareOptionsGrantedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R152": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable",
     "longName": "996099 - Disclosure - Share-Based Payments - Schedule of Unlocking Date (Details)",
     "shortName": "Share-Based Payments - Schedule of Unlocking Date (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "152",
     "firstAnchor": {
      "contextRef": "c514",
      "name": "ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019",
      "unitRef": "hkdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfUnlockingDatetextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c514",
      "name": "ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019",
      "unitRef": "hkdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfUnlockingDatetextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R153": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable",
     "longName": "996100 - Disclosure - Share-Based Payments - Schedule of Restricted Shares Outstanding (Details)",
     "shortName": "Share-Based Payments - Schedule of Restricted Shares Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "153",
     "firstAnchor": {
      "contextRef": "c542",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c541",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R154": {
     "role": "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
     "longName": "996101 - Disclosure - Notes to the Consolidated Statements of Cash Flows (Details)",
     "shortName": "Notes to the Consolidated Statements of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "154",
     "firstAnchor": {
      "contextRef": "c463",
      "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c14",
      "name": "aapg:NumberOfGrantees",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R155": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable",
     "longName": "996102 - Disclosure - Notes to the Consolidated Statements of Cash Flows - Schedule of Changes in Liabilities Arising from Financing Activities (Details)",
     "shortName": "Notes to the Consolidated Statements of Cash Flows - Schedule of Changes in Liabilities Arising from Financing Activities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "155",
     "firstAnchor": {
      "contextRef": "c571",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c556",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R156": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable",
     "longName": "996103 - Disclosure - Notes to the Consolidated Statements of Cash Flows - Schedule of Cash Outflow for Leases Included In the Statement of Cash Flows (Details)",
     "shortName": "Notes to the Consolidated Statements of Cash Flows - Schedule of Cash Outflow for Leases Included In the Statement of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "156",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R157": {
     "role": "http://www.ascentage.cn.com/role/CommitmentsDetails",
     "longName": "996104 - Disclosure - Commitments (Details)",
     "shortName": "Commitments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "157",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:CapitalCommitments",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:CapitalCommitments",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R158": {
     "role": "http://www.ascentage.cn.com/role/ContingentLiabilitiesDetails",
     "longName": "996105 - Disclosure - Contingent Liabilities (Details)",
     "shortName": "Contingent Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "158",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R159": {
     "role": "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails",
     "longName": "996106 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "159",
     "firstAnchor": {
      "contextRef": "c416",
      "name": "ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "aapg:DisclosureOfShareCapitalAndTreasurySharesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c583",
      "name": "ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R160": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable",
     "longName": "996107 - Disclosure - Related Party Transactions - Schedule of Transaction with Related Party (Details)",
     "shortName": "Related Party Transactions - Schedule of Transaction with Related Party (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "160",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:AmountsPayableRelatedPartyTransactions",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:AmountsPayableRelatedPartyTransactions",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R161": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable",
     "longName": "996108 - Disclosure - Related Party Transactions - Schedule of Outstanding Balance with Related Party (Details)",
     "shortName": "Related Party Transactions - Schedule of Outstanding Balance with Related Party (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "161",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "aapg:OtherPayablesAndAccruals",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "aapg:OtherPayablesAndAccruals",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R162": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable",
     "longName": "996109 - Disclosure - Related Party Transactions - Schedule of Compensation of key Management Personnel (Details)",
     "shortName": "Related Party Transactions - Schedule of Compensation of key Management Personnel (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "162",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R163": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
     "longName": "996110 - Disclosure - Financial Instruments by Category - Schedule of Categories of Financial Instruments (Details)",
     "shortName": "Financial Instruments by Category - Schedule of Categories of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "163",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c596",
      "name": "ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R164": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable",
     "longName": "996111 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details)",
     "shortName": "Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "164",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c603",
      "name": "ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory",
       "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R165": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable",
     "longName": "996112 - Disclosure - Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Assets Measured at Fair Value (Details)",
     "shortName": "Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Assets Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "165",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R166": {
     "role": "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails",
     "longName": "996113 - Disclosure - Financial Risk Management Objectives and Policies (Details)",
     "shortName": "Financial Risk Management Objectives and Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "166",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "aapg:DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c610",
      "name": "aapg:InterestBearingBankBorrowings",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R167": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable",
     "longName": "996114 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Interest Rate Risk (Details)",
     "shortName": "Financial Risk Management Objectives and Policies - Schedule of Interest Rate Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "167",
     "firstAnchor": {
      "contextRef": "c620",
      "name": "ifrs-full:BorrowingsInterestRateBasis",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c620",
      "name": "ifrs-full:BorrowingsInterestRateBasis",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R168": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable",
     "longName": "996115 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Foreign Currency Risk (Details)",
     "shortName": "Financial Risk Management Objectives and Policies - Schedule of Foreign Currency Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "168",
     "firstAnchor": {
      "contextRef": "c626",
      "name": "aapg:IncreasedecreaseWeakensAgainst",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfForeignCurrencyRiskExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c626",
      "name": "aapg:IncreasedecreaseWeakensAgainst",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfForeignCurrencyRiskExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R169": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable",
     "longName": "996116 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Credit Quality and Maximum Exposure To Credit Risk (Details)",
     "shortName": "Financial Risk Management Objectives and Policies - Schedule of Credit Quality and Maximum Exposure To Credit Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "169",
     "firstAnchor": {
      "contextRef": "c15",
      "name": "ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c15",
      "name": "aapg:CashAndBankBalancesNotYetPastDue",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    },
    "R170": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable",
     "longName": "996117 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Liquidity Risk (Details)",
     "shortName": "Financial Risk Management Objectives and Policies - Schedule of Liquidity Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "170",
     "firstAnchor": {
      "contextRef": "c672",
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfLiquidityRiskExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c672",
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfLiquidityRiskExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R171": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable",
     "longName": "996118 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Equity Price Risk (Details)",
     "shortName": "Financial Risk Management Objectives and Policies - Schedule of Equity Price Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "171",
     "firstAnchor": {
      "contextRef": "c13",
      "name": "aapg:MarketEquityIndex",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfEquityPriceRiskExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c13",
      "name": "aapg:MarketEquityIndex",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfEquityPriceRiskExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R172": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable",
     "longName": "996119 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Fair Values of the Equity Investments (Details)",
     "shortName": "Financial Risk Management Objectives and Policies - Schedule of Fair Values of the Equity Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "172",
     "firstAnchor": {
      "contextRef": "c698",
      "name": "ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c698",
      "name": "ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R173": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable",
     "longName": "996120 - Disclosure - Financial Risk Management Objectives and Policies - Schedule of Capital Management (Details)",
     "shortName": "Financial Risk Management Objectives and Policies - Schedule of Capital Management (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "173",
     "firstAnchor": {
      "contextRef": "c703",
      "name": "ifrs-full:OtherBorrowings",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c703",
      "name": "ifrs-full:OtherBorrowings",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R174": {
     "role": "http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyDetails",
     "longName": "996121 - Disclosure - Condensed Financial Information of the Company (Details)",
     "shortName": "Condensed Financial Information of the Company (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "174",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R175": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable",
     "longName": "996122 - Disclosure - Condensed Financial Information of the Company - Schedule of Statements of Financial Position (Details)",
     "shortName": "Condensed Financial Information of the Company - Schedule of Statements of Financial Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "175",
     "firstAnchor": {
      "contextRef": "c707",
      "name": "ifrs-full:InvestmentsInSubsidiaries",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c707",
      "name": "ifrs-full:InvestmentsInSubsidiaries",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R176": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable",
     "longName": "996123 - Disclosure - Condensed Financial Information of the Company - Schedule of Condensed Statements of Comprehensive Income (Details)",
     "shortName": "Condensed Financial Information of the Company - Schedule of Condensed Statements of Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "176",
     "firstAnchor": {
      "contextRef": "c710",
      "name": "ifrs-full:OtherGainsLosses",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock",
       "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c710",
      "name": "ifrs-full:OtherGainsLosses",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock",
       "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R177": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable",
     "longName": "996124 - Disclosure - Condensed Financial Information of the Company - Schedule of Condensed Statements of Cash Flows (Details)",
     "shortName": "Condensed Financial Information of the Company - Schedule of Condensed Statements of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "177",
     "firstAnchor": {
      "contextRef": "c710",
      "name": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfCondensedCashFlowStatementsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c710",
      "name": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfCondensedCashFlowStatementsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true,
      "unique": true
     }
    },
    "R178": {
     "role": "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
     "longName": "996125 - Disclosure - Condensed Financial Information of the Company - Schedule of Company\u2019s Reserves (Details)",
     "shortName": "Condensed Financial Information of the Company - Schedule of Company\u2019s Reserves (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "178",
     "firstAnchor": {
      "contextRef": "c706",
      "name": "ifrs-full:NoncontrollingInterests",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfReservesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c714",
      "name": "ifrs-full:NoncontrollingInterests",
      "unitRef": "cny",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "aapg:ScheduleOfReservesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0285148-20f_ascentage.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccountingPoliciesScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies - Schedule of Intangible Assets are Amortized on the Straight-Line Basis (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccountingPoliciesScheduleofNewandRevisedIFRSsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies - Schedule of New and Revised IFRSs (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccountingPoliciesScheduleofPropertyPlantandEquipmentofAnnualRatesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies - Schedule of Property, Plant and Equipment of Annual Rates (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccountingPoliciesScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies - Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AccountingStandardsVolume11Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccountingStandardsVolume11Member",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual Improvements to IFRS Accounting Standards \u2013 Volume 11 [Member]",
        "label": "Accounting Standards Volume11 Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccrualsClassifiedAsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccrualsClassifiedAsCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued promotion expenses",
        "label": "Accruals classified as current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of accruals classified as current. [Refer: Accruals]"
       }
      }
     },
     "auth_ref": [
      "r683"
     ]
    },
    "aapg_AccruedInterestInOtherPayablesAndAccrualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccruedInterestInOtherPayablesAndAccrualsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest in other payables and accruals [Member]",
        "label": "Accrued Interest In Other Payables And Accruals Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccumulatedAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated amortization",
        "documentation": "The amount of accumulated amortization.",
        "label": "Accumulated Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated depreciation and amortisation [member]",
        "label": "Accumulated depreciation and amortisation [member]"
       }
      }
     },
     "auth_ref": [
      "r19",
      "r651",
      "r658",
      "r660",
      "r661"
     ]
    },
    "aapg_AccumulatedDepreciationsCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccumulatedDepreciationsCost",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated depreciation",
        "documentation": "Accumulated depreciation",
        "label": "Accumulated Depreciations Cost"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AccumulatedImpairmentGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AccumulatedImpairmentGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofGoodwillTable": {
       "parentTag": "ifrs-full_Goodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated impairment",
        "documentation": "The amount of accumulated impairment.",
        "label": "Accumulated Impairment Goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccumulatedOtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "Accumulated other comprehensive income"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total consideration (in Yuan Renminbi)",
        "label": "Consideration transferred, acquisition-date fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r352"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Acquisitions through business combinations, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r331"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "aapg_AdditionalOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AdditionalOrdinaryShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional ordinary shares. (in Shares)",
        "documentation": "Additional ordinary shares.",
        "label": "Additional Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Additions other than through business combinations, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r305"
     ]
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsToRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Additions to right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r153",
      "r260"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "aapg_AdjustedCapitals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AdjustedCapitals",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable": {
       "parentTag": "ifrs-full_DeferredTaxLiabilityAsset",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjusted capital",
        "documentation": "The amount of adjusted capital.",
        "label": "Adjusted Capitals"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForAmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Adjustments for amortisation expense"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in other payables and accruals",
        "label": "Adjustments for decrease (increase) in accrued income other than contract assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the decrease (increase) in accrued income other than contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Accrued income other than contract assets; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable": {
       "parentTag": "ifrs-full_OtherExpenseByNature",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value loss on financial assets measured at FVTPL",
        "verboseLabel": "Fair value loss on financial assets at FVTPL",
        "label": "Adjustments for decrease (increase) in financial assets measured at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in financial assets measured at fair value through profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Financial assets; Financial assets at fair value through profit or loss; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Increase)/Decrease in inventories",
        "label": "Adjustments for decrease (increase) in inventories"
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Increase) /Decrease in other non-current assets",
        "label": "Adjustments for decrease (increase) in other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in prepayments, other receivables and other assets",
        "label": "Adjustments for decrease (increase) in prepaid expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "aapg_AdjustmentsForDecreaseIncreaseInRestrictedCashBalances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AdjustmentsForDecreaseIncreaseInRestrictedCashBalances",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Increase)/ Decrease in restricted cash balances",
        "documentation": "Adjustments for decrease (increase) in restricted cash balances to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Adjustments For Decrease Increase In Restricted Cash Balances"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Increase)/Decrease in trade receivables",
        "label": "Adjustments for decrease (increase) in trade accounts receivable"
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDepreciationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of property, plant and equipment",
        "label": "Adjustments for depreciation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "aapg_AdjustmentsForDepreciationOfRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AdjustmentsForDepreciationOfRightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of right-of-use assets",
        "documentation": "Adjustments for depreciation of right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Adjustments For Depreciation Of Rightofuse Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForFairValueGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForFairValueGainsLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value gain on derivative financial instruments",
        "label": "Adjustments for fair value losses (gains)"
       }
      }
     },
     "auth_ref": [
      "r664"
     ]
    },
    "ifrs-full_AdjustmentsForFinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForFinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance costs",
        "label": "Adjustments for finance costs"
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share of (profit)/loss of a joint venture",
        "label": "Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Gain)/loss on disposal of items of property, plant and equipment",
        "label": "Adjustments for gain (loss) on disposals, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "aapg_AdjustmentsForGainOnDisposalOfLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AdjustmentsForGainOnDisposalOfLeases",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on disposal of leases",
        "negatedTerseLabel": "Gain on disposal of items of lease",
        "documentation": "Adjustments for gains (losses) on disposals of leases in the scope of IFRS 9 to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Adjustments For Gain On Disposal Of Leases"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fair value loss on financial liabilities measured at FVTPL",
        "label": "Adjustments for gains (losses) on change in fair value of derivatives"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "ifrs-full_AdjustmentsForGainsLossesOnDisposalOfFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForGainsLossesOnDisposalOfFinancialAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal",
        "label": "Adjustments for gains (losses) on disposal of financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gains (losses) on disposals of financial assets in the scope of IFRS 9 to reconcile profit (loss) to net cash flow from (used in) operating activities."
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation of investment property",
        "negatedTerseLabel": "Depreciation of investment property",
        "label": "Adjustments for gains (losses) on fair value adjustment, investment property"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInContractLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase /(Decrease) in contract liabilities",
        "label": "Adjustments for increase (decrease) in contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the increase (decrease) in contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Contract liabilities; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in deferred income",
        "label": "Adjustments for increase (decrease) in deferred income other than contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the increase (decrease) in deferred income other than contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income other than contract liabilities; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Decrease) /Increase in trade payables",
        "label": "Adjustments for increase (decrease) in trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "ifrs-full_AdjustmentsForProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForProvisions",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for inventory write-down",
        "label": "Adjustments for provisions"
       }
      }
     },
     "auth_ref": [
      "r664"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total",
        "label": "Adjustments to reconcile profit (loss)"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments for:",
        "label": "Adjustments to reconcile operating profit (loss) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-settled share-based payments",
        "verboseLabel": "Post-IPO share option expenses",
        "label": "Adjustments for share-based payments"
       }
      }
     },
     "auth_ref": [
      "r664"
     ]
    },
    "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange (gain)/loss",
        "verboseLabel": "Foreign exchange (gain)/loss, net",
        "label": "Adjustments for unrealised foreign exchange losses (gains)"
       }
      }
     },
     "auth_ref": [
      "r463",
      "r664"
     ]
    },
    "ifrs-full_AdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Administrative expenses",
        "label": "Administrative expenses"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r439",
      "r500"
     ]
    },
    "aapg_AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate carrying amount of the Group\u2019s investment in the joint venture",
        "documentation": "Aggregate carrying amount of the Group\u2019s investment in the joint venture.",
        "label": "Aggregate Carrying Amount Of The Groups Investment In The Joint Venture"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AggregateShareIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AggregateShareIssued",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate shares (in Shares)",
        "documentation": "Number of aggregate share issued.",
        "label": "Aggregate Share Issued"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r538",
      "r549",
      "r565",
      "r600"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r541",
      "r552",
      "r568",
      "r603"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r542",
      "r553",
      "r569",
      "r595",
      "r604",
      "r608",
      "r616"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "aapg_AllottedSharesPricePerShares": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AllottedSharesPricePerShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allotted shares price per shares (in Dollars per share)",
        "documentation": "Allotted shares price per shares.",
        "label": "Allotted Shares Price Per Shares"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AmendmentsToIASTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AmendmentsToIASTwentyOneMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendments to IAS 21 [Member]",
        "label": "Amendments To IASTwenty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AmendmentsToIFRSNineAndIFRSSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AmendmentsToIFRSNineAndIFRSSevenMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendments to IFRS 9 and IFRS 7 [Member]",
        "label": "Amendments To IFRSNine And IFRSSeven Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AmendmentsToIFRSNineAndIFRSSevenOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AmendmentsToIFRSNineAndIFRSSevenOneMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendments to IFRS 9 and IFRS 7 One [Member]",
        "label": "Amendments To IFRSNine And IFRSSeven One Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AmendmentsToIFRSTenAndIFRSTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AmendmentsToIFRSTenAndIFRSTwentyEightMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendments to IFRS 10 and IAS 28 [Member]",
        "label": "Amendments To IFRSTen And IFRSTwenty Eight Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmortisationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization provided during the year",
        "label": "Amortisation expense"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Amortisation, intangible assets other than goodwill"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r332"
     ]
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmountsPayableRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction with related party",
        "label": "Amounts payable, related party transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r39",
      "r42",
      "r317"
     ]
    },
    "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AnalysisOfIncomeAndExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Income and Gains [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AnalyzedIntoAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AnalyzedIntoAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Analyzed into:",
        "label": "Analyzed Into Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AnalyzedIntoAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AnalyzedIntoAbstract0",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Analyzed into:",
        "label": "Analyzed Into Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AnnualBaseSalaryPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AnnualBaseSalaryPercentage",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual base salary rate",
        "documentation": "Percentage of annual base salary .",
        "label": "Annual Base Salary Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax rate",
        "label": "Applicable tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r298"
     ]
    },
    "aapg_ApprovalOfTheFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ApprovalOfTheFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Approval of the Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_AscentagePharmaGroupIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AscentagePharmaGroupIncMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ascentage Pharma Group Inc. [Member]",
        "label": "Ascentage Pharma Group Inc Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AssetsAndLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AssetsAndLiabilitiesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r292",
      "r314",
      "r378",
      "r390"
     ]
    },
    "ifrs-full_AssetsLessCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AssetsLessCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_NetAssetsLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS LESS CURRENT LIABILITIES",
        "label": "Assets less current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of current liabilities."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_AtDecember312024Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AtDecember312024Abstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At December 31, 2024:",
        "label": "At December312024 Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AtFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AtFairValueMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Values [member]",
        "label": "At fair value [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r83",
      "r115",
      "r131",
      "r339",
      "r367",
      "r368"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r520",
      "r523",
      "r545"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r520",
      "r523",
      "r545"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r520",
      "r523",
      "r545"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AuditorsRemuneration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AuditorsRemuneration",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditors\u2019 remuneration",
        "label": "Auditor's remuneration, operating"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "aapg_AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "15 Aug 2018\u201315 Aug 2028 [Member]",
        "label": "August Fifteen Two Thousand Eighteen To August Fifteen Two Thousand Twenty Eight Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ifrs-full_BalancesWithBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BalancesWithBanks",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and bank balances as stated in the consolidated statements of financial position",
        "label": "Balances with banks"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash balances held at banks."
       }
      }
     },
     "auth_ref": [
      "r667"
     ]
    },
    "aapg_BankAndOtherLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "BankAndOtherLoansMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank and other loans [Member]",
        "label": "Bank And Other Loans Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_BankLoansSecuredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "BankLoansSecuredMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Loans \u2013 Secured [Member]",
        "label": "Bank Loans Secured Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_BankLoansUnsecuredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "BankLoansUnsecuredMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Loans \u2013 Unsecured [Member]",
        "label": "Bank Loans Unsecured Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_BankLoansUnsecuredOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "BankLoansUnsecuredOneMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Loans \u2013 Unsecured [Member]",
        "label": "Bank Loans Unsecured One Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in Dollars per share and Yuan Renminbi per share)",
        "label": "Basic earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58"
     ]
    },
    "ifrs-full_BasicEarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BasicEarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Basic Loss Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_BonusAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "BonusAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ReservesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bonus amount",
        "verboseLabel": "Settlement of bonus",
        "documentation": "The amount of bonus paid to employee.",
        "label": "Bonus Amount"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_BonusDueToEmployeesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "BonusDueToEmployeesAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bonus due to employees amount (in Yuan Renminbi)",
        "documentation": "Bonus due to employees, amount.",
        "label": "Bonus Due To Employees Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingCostsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingCostsIncurred",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowing cost",
        "label": "Borrowing costs incurred"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_Borrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Borrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable",
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total borrowings",
        "terseLabel": "Interest-Bearing Bank and Other Borrowings Total",
        "verboseLabel": "Net carrying amount",
        "label": "Borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_BorrowingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest-Bearing Bank and Other Borrowings [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable",
      "http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "ifrs-full_BorrowingsByNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsByNameDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "ifrs-full_BorrowingsInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsInterestRate",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank loans",
        "label": "Borrowings, interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "ifrs-full_BorrowingsInterestRateBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsInterestRateBasis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable",
      "http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate per annum (%)",
        "verboseLabel": "Increase/(decrease) in basis points",
        "label": "Borrowings, interest rate basis"
       }
      },
      "en": {
       "role": {
        "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "ifrs-full_BorrowingsMaturity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsMaturity",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity",
        "label": "Borrowings, maturity"
       }
      },
      "en": {
       "role": {
        "documentation": "The maturity of borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails",
      "http://www.ascentage.cn.com/role/LeasesDetails",
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable",
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bottom of range [member]",
        "verboseLabel": "Bottom of Range [Member]",
        "label": "Bottom of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r135",
      "r163",
      "r179",
      "r285",
      "r468",
      "r469",
      "r669"
     ]
    },
    "ifrs-full_BuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BuildingsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings [Member]",
        "label": "Buildings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r523",
      "r545"
     ]
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "CH",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Switzerland [Member]",
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "country_CN": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "CN",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RMB [Member]",
        "label": "CHINA"
       }
      }
     },
     "auth_ref": []
    },
    "currency_CNY": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2025",
     "localname": "CNY",
     "presentation": [
      "http://www.ascentage.cn.com/role/CashandBankBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RMB [Member]",
        "label": "China, Yuan Renminbi"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CapitalAndReserveFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CapitalAndReserveFunds",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ReservesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital and Reserve Funds",
        "documentation": "Capital and Reserve Funds",
        "label": "Capital And Reserve Funds"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CapitalAndReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CapitalAndReserves",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital and reserves",
        "documentation": "The amount represent the vaue of capital and reseve.",
        "label": "Capital And Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CapitalAndReservesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CapitalAndReservesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital and reserves",
        "label": "Capital And Reserves Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CapitalCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CapitalCommitments",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital commitments",
        "label": "Capital commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of future capital expenditures that the entity is committed to make."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_CapitalCommitmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CapitalCommitmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CapitalManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CapitalManagementMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Management [Member]",
        "label": "Capital Management Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CapitalReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CapitalReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ReservesDetails",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital reserve",
        "label": "Capital reserve"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the capital reserves."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_CapitalReserveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CapitalReserveMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital and reserves [Member]",
        "label": "Capital reserve [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing capital reserves."
       }
      }
     },
     "auth_ref": [
      "r675"
     ]
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r16",
      "r72",
      "r75",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r188",
      "r198",
      "r199",
      "r304",
      "r308",
      "r330",
      "r333",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r354",
      "r361",
      "r362"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount [member]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r75",
      "r80",
      "r82",
      "r83",
      "r188",
      "r198",
      "r199",
      "r308",
      "r333",
      "r336",
      "r338",
      "r339",
      "r354",
      "r361",
      "r362"
     ]
    },
    "aapg_CarryingAmountOfEquityInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CarryingAmountOfEquityInvestmentsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying amount of equity investments [Member]",
        "label": "Carrying Amount Of Equity Investments Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CashAndBankBalancesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CashAndBankBalancesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Bank Balances [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndBankBalancesAtCentralBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndBankBalancesAtCentralBanks",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/CashandBankBalancesDetails",
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable",
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash and bank balances at end of year",
        "terseLabel": "Cash and bank balances",
        "label": "Cash and bank balances at central banks"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and bank balances held at central banks."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_CashAndBankBalancesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CashAndBankBalancesLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/CashandBankBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Bank Balances [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CashAndBankBalancesNotYetPastDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CashAndBankBalancesNotYetPastDue",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and bank balances - Not yet past due",
        "documentation": "The amount of cash and bank balances.",
        "label": "Cash And Bank Balances Not Yet Past Due"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashAndBankBalancesAtCentralBanks",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of year",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF YEAR",
        "terseLabel": "Cash and cash equivalents at end of year",
        "verboseLabel": "Cash and cash equivalents as stated in the consolidated statements of cash flows",
        "label": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r123",
      "r286",
      "r398"
     ]
    },
    "ifrs-full_CashFlowHedgesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowHedgesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes to the Consolidated Statements of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows generated from financing activities",
        "terseLabel": "Net cash (used in)/generated from financing activities",
        "label": "Cash flows from (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r97"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES",
        "label": "Cash flows from (used in) financing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows generated from/ (used in) investing activities",
        "terseLabel": "Net cash used in investing activities",
        "label": "Cash flows from (used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r97"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES",
        "label": "Cash flows from (used in) investing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows used in operating activities",
        "terseLabel": "Net cash generated from(used in) operating activities",
        "label": "Cash flows from (used in) operating activities"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r97"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES",
        "label": "Cash flows from (used in) operating activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CashInflowOutflowForLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CashInflowOutflowForLease",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "documentation": "The amount of cash inflow outflow for lease.",
        "label": "Cash Inflow Outflow For Lease"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CashandBankBalancesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CashandBankBalancesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/CashandBankBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Bank Balances (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CashandBankBalancesScheduleofCashandBankBalancesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CashandBankBalancesScheduleofCashandBankBalancesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Bank Balances - Schedule of Cash and Bank Balances (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CategoriesOfFinancialAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialAssetsAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets",
        "label": "Categories of financial assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CategoriesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialAssetsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r358"
     ]
    },
    "ifrs-full_CategoriesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialAssetsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of financial assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r210",
      "r358"
     ]
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialLiabilitiesAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities",
        "label": "Categories of financial liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ContractLiabilitiesDetails",
      "http://www.ascentage.cn.com/role/IncomeTaxDetails",
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ReservesDetails",
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable",
      "http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r319"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails",
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ReservesDetails",
      "http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r319"
     ]
    },
    "aapg_ChangeInForeignExchangeRatesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ChangeInForeignExchangeRatesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in foreign exchange rates [Axis]",
        "documentation": "Change in foreign exchange rates.",
        "label": "Change In Foreign Exchange Rates Axis"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "ifrs-full_ChangesInGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ChangesInGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ChiefCommercialOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ChiefCommercialOfficerMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Commercial Officer [Member]",
        "label": "Chief Commercial Officer Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ChineseMainlandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ChineseMainlandMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails",
      "http://www.ascentage.cn.com/role/IncomeTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable",
      "http://www.ascentage.cn.com/role/ScheduleofRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chinese mainland [Member]",
        "verboseLabel": "Chinese Mainland [Member]",
        "label": "Chinese Mainland Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfContingentLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfContingentLiabilitiesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r187",
      "r328"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r205",
      "r206",
      "r229",
      "r230",
      "r382"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r170",
      "r205",
      "r206",
      "r229",
      "r230",
      "r382"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r200",
      "r201",
      "r202",
      "r361",
      "r363"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r200",
      "r201",
      "r202",
      "r361",
      "r363"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r206",
      "r229",
      "r230"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r334"
     ]
    },
    "ifrs-full_ClassesOfInventoriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfInventoriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfOrdinarySharesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfOrdinarySharesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ifrs-full_ClassesOfOrdinarySharesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfOrdinarySharesDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/LeasesDetails",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r309"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/LeasesDetails",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r309"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable",
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r375",
      "r420"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r375",
      "r420"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "aapg_CommercializationRightsIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CommercializationRightsIncomeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercialization rights income [Member]",
        "verboseLabel": "Commercialization rights income (commercial milestone) [Member]",
        "label": "Commercialization Rights Income Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CommitmentAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CommitmentAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitment And Contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CommitmentsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CommitmentsDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CommitmentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CommitmentsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "ifrs-full_ComponentsOfEquityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income/ (loss) that may be reclassified to profit or loss in subsequent periods, net of tax:",
        "label": "Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income/ (loss) that will not be reclassified to profit or loss in subsequent periods, net of tax:",
        "label": "Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncomeAlt0": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL COMPREHENSIVE LOSS FOR THE YEAR",
        "terseLabel": "Total comprehensive loss for the year",
        "label": "Comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r107",
      "r120",
      "r321",
      "r342",
      "r384",
      "r425",
      "r467"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Attributable to:",
        "label": "Comprehensive income attributable to [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncomeAlt0": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interests",
        "label": "Comprehensive income, attributable to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r384",
      "r428"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncomeAlt0": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary equity holders of the Company",
        "label": "Comprehensive income, attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r384",
      "r429"
     ]
    },
    "aapg_ComprehensiveIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ComprehensiveIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total comprehensive income for the year",
        "documentation": "Total comprehensive income for the year.",
        "label": "Comprehensive Income Loss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComputerSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComputerSoftwareMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software [Member]",
        "label": "Computer software [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "aapg_ConcentrationsOfCreditRisk": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ConcentrationsOfCreditRisk",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentrations of credit risk",
        "documentation": "Concentrations of credit risk",
        "label": "Concentrations Of Credit Risk"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CondensedBalanceSheetStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedBalanceSheetStatementTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Balance Sheet Statement [Table]",
        "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "srt_CondensedBalanceSheetStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedBalanceSheetStatementsCaptionsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Balance Sheet Statements, Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information of the Company [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Company\u2019s Reserves [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CondensedFinancialInformationoftheCompanyScheduleofCompanysReservesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information of the Company - Schedule of Company\u2019s Reserves (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Condensed Statements of Cash Flows [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CondensedFinancialInformationoftheCompanyScheduleofCondensedStatementsofCashFlowsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information of the Company - Schedule of Condensed Statements of Cash Flows (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CondensedStatementOfComprehensiveIncomeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedStatementOfComprehensiveIncomeTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Statement of Comprehensive Income [Table]",
        "documentation": "Disclosure of information about condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "srt_CondensedStatementOfComprehensiveIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedStatementOfComprehensiveIncomeTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Condensed Statements of Comprehensive Income",
        "label": "Condensed Statement of Comprehensive Income [Table Text Block]",
        "documentation": "Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r670"
     ]
    },
    "srt_CondensedStatementOfIncomeCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedStatementOfIncomeCaptionsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Statement of Income Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "aapg_ConsolidatedStatementsOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ConsolidatedStatementsOfChangesInEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements Of Changes In Equity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ConsolidatedStatementsOfComprehensiveLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ConsolidatedStatementsOfComprehensiveLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements of Comprehensive Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ConstructionInProcessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ConstructionInProcessMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction In process [Member]",
        "label": "Construction In Process Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress [Member]",
        "verboseLabel": "Construction in progress [member]",
        "netLabel": "Construction in Progress [Member]",
        "label": "Investment Property [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContingentConsiderationRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration amount",
        "label": "Contingent consideration recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r186",
      "r353"
     ]
    },
    "aapg_ContractAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ContractAcquisitionCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract acquisition costs",
        "documentation": "Amount of contract acquisition costs.",
        "label": "Contract Acquisition Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContractLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ContractLiabilitiesDetails",
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total contract liabilities",
        "verboseLabel": "Contract liabilities",
        "label": "Contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r140",
      "r252"
     ]
    },
    "ifrs-full_ContractLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContractLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ContractLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ContractLiabilitiesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ContractLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ContractLiabilitiesLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ContractLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ContractLiabilitiesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract Liabilities [Member]",
        "label": "Contract Liabilities Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ContractLiabilitiesScheduleofContractLiabilitiesDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Contract Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ContractLiabilitiesScheduleofContractLiabilitiesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Liabilities - Schedule of Contract Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patent [Member]",
        "label": "Copyrights, patents and other industrial property rights, service and operating rights [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CorporateInformationAndStatementOfIFRSComplianceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate and Group Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CorporateandGroupInformationScheduleofPrincipalSubsidiariesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate and Group Information - Schedule of Principal Subsidiaries (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CostGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CostGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofGoodwillTable": {
       "parentTag": "ifrs-full_Goodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost",
        "documentation": "Cost of goodwill.",
        "label": "Cost Goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CostOfInventoriesRecognisedAsExpenseDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of inventories sold",
        "label": "Cost of inventories recognised as expense during period, operating"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r281"
     ]
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total cost of sales",
        "label": "Cost of sales"
       }
      }
     },
     "auth_ref": [
      "r383",
      "r439"
     ]
    },
    "aapg_CostOfSalesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CostOfSalesAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost Of Sales Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfSalesRoomOccupancyServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CostOfSalesRoomOccupancyServices",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of services provided",
        "label": "Cost of sales, room occupancy services"
       }
      }
     },
     "auth_ref": [
      "r685"
     ]
    },
    "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CountryOfIncorporationOrResidenceOfSubsidiary",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Place and date of incorporation/\u200b registration and place of business",
        "label": "Country of incorporation of subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r52",
      "r109",
      "r112"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CreditRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CreditRiskMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Risk [Member]",
        "label": "Credit risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r479"
     ]
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/CashandBankBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "documentation": "Information by currency."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other accrued expenses",
        "label": "Current accrued expenses and other current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_AssetsLessCurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_CurrentAssetsLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r116",
      "r410",
      "r467"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT ASSETS",
        "label": "Current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssetsLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_AssetsLessCurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CURRENT ASSETS",
        "label": "Current assets (liabilities)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets less the amount of current liabilities."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_CurrentContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Current contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ifrs-full_CurrentExciseTaxPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentExciseTaxPayables",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax payables other than income tax",
        "label": "Current excise tax payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current excise tax payables. [Refer: Excise tax payables]"
       }
      }
     },
     "auth_ref": [
      "r683"
     ]
    },
    "ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets included in prepayments, other receivables and other assets",
        "verboseLabel": "Financial assets included in prepayments, other receivables and other assets - Normal",
        "label": "Current financial assets at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r208",
      "r356"
     ]
    },
    "ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities included in other payables and accruals",
        "label": "Current financial liabilities at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities measured at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r209",
      "r357"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentGovernmentGrants",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDeferredIncomeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "label": "Current government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion",
        "label": "Current lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_AssetsLessCurrentLiabilities",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_CurrentAssetsLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r411",
      "r467"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT LIABILITIES",
        "label": "Current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CurrentPortionOfLongTermBankLoansSecuredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CurrentPortionOfLongTermBankLoansSecuredMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Portion of Long-Term Bank Loans \u2013 Secured [Member]",
        "label": "Current Portion Of Long Term Bank Loans Secured Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CurrentPortionOfLongTermBankLoansUnsecuredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CurrentPortionOfLongTermBankLoansUnsecuredMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Portion of Long-Term Bank Loans \u2013 Unsecured [Member]",
        "label": "Current Portion Of Long Term Bank Loans Unsecured Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CurrentPortionOfLongTermBankLoansUnsecuredOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CurrentPortionOfLongTermBankLoansUnsecuredOneMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Portion of Long-Term Bank Loans \u2013 Unsecured [Member]",
        "label": "Current Portion Of Long Term Bank Loans Unsecured One Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPortionOfLongtermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentPortionOfLongtermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term payables \u2013 current portion",
        "verboseLabel": "Interest-bearing bank and other borrowings (current and non-current portions)",
        "label": "Current portion of non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_CurrentPrepaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentPrepaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Prepayments, Other Receivables and Other Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentPrepaymentsAndOtherCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Prepayments, other receivables and other assets",
        "label": "Current prepayments and other current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_CurrentProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentProvisions",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofInventoriesTable": {
       "parentTag": "ifrs-full_Inventories",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Provision",
        "label": "Current provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "ifrs-full_CurrentProvisionsForEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentProvisionsForEmployeeBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll payables",
        "label": "Current provisions for employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      }
     },
     "auth_ref": [
      "r380",
      "r414"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current",
        "label": "Current tax expense (income), income taxes"
       }
      }
     },
     "auth_ref": [
      "r440",
      "r494"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Current and Deferred Components of the Income Tax Expense/(Credit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables, net",
        "label": "Current trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r496",
      "r502",
      "r504"
     ]
    },
    "aapg_CurretPayablesForConstructionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CurretPayablesForConstructionCost",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables for construction cost",
        "documentation": "Amount of payables for construction cost.",
        "label": "Curret Payables For Construction Cost"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CustomerAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CustomerAMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer A [Member]",
        "label": "Customer AMember"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CustomerBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CustomerBMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer B [Member]",
        "label": "Customer BMember"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CustomerCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CustomerCMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer C [Member]",
        "label": "Customer CMember"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_CustomerDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "CustomerDMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer D [Member]",
        "label": "Customer DMember"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]",
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r530",
      "r626"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Board of Directors Oversight [Text Block]",
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r530",
      "r626"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]",
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r534",
      "r630"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]",
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r532",
      "r628"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]",
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r526",
      "r622"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes Integrated [Flag]",
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r527",
      "r623"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes Integrated [Text Block]",
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r527",
      "r623"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r525",
      "r621"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r525",
      "r621"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r525",
      "r621"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Third Party Engaged [Flag]",
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r528",
      "r624"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r529",
      "r625"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r529",
      "r625"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]",
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r533",
      "r629"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Role of Management [Text Block]",
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r531",
      "r627"
     ]
    },
    "aapg_DecreaseincreaseInLossBeforeTaxMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DecreaseincreaseInLossBeforeTaxMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease/ (increase) in loss before tax [Member]",
        "label": "Decreaseincrease In Loss Before Tax Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deductible temporary differences",
        "label": "Deductible temporary differences for which no deferred tax asset is recognised"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r299"
     ]
    },
    "aapg_DeductibleTemporaryDifferencesNotRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DeductibleTemporaryDifferencesNotRecognized",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deductible temporary differences not recognized",
        "documentation": "Deductible temporary differences not recognized.\r\n.",
        "label": "Deductible Temporary Differences Not Recognized"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredIncomeIncludingContractLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredIncomeIncludingContractLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DeferredIncomeNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DeferredIncomeNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income",
        "documentation": "Represent the amount of deferred income.",
        "label": "Deferred Income Non Current"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "verboseLabel": "Net deferred tax assets recognized in the consolidated statements of financial position",
        "netLabel": "Unrecognised deferred tax assets",
        "label": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r300",
      "r402",
      "r406"
     ]
    },
    "ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DeferredTaxAssetsTaxLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DeferredTaxAssetsTaxLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets related to tax loss carry forwards",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to tax loss carryforwards.",
        "label": "Deferred Tax Assets Tax Loss Carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DeferredTaxDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DeferredTaxDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred (note 18)",
        "label": "Deferred tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r301"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax charged/(credited) to the statement of profit or loss during the year",
        "label": "Deferred tax expense (income) recognised in profit or loss, income taxes"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r301"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax (credited)/charged to the statement of profit or loss during the year",
        "label": "Deferred tax expense (income) relating to tax rate changes or imposition of new taxes, income taxes"
       }
      }
     },
     "auth_ref": [
      "r441",
      "r495"
     ]
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "verboseLabel": "Net deferred tax liability recognized in the consolidated statements of financial position",
        "label": "Deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r300",
      "r402",
      "r406"
     ]
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilityAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Capital and net debt",
        "terseLabel": "Deferred tax liability (in Dollars)",
        "label": "Deferred tax liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r300"
     ]
    },
    "aapg_DeferredTaxLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DeferredTaxLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax offset in the consolidated statements of financial position",
        "documentation": "Represent the amount of deferred tax offset in the consolidated statements of financial position.",
        "label": "Deferred Tax Offset In The Consolidated Statements Of Financial Position"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DeferredTaxScheduleofMovementsinDeferredTaxAssetsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax - Schedule of Movements in Deferred Tax Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DeferredTaxScheduleofMovementsinDeferredTaxLiabilitiesandAssetsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax - Schedule of Movements in Deferred Tax Liabilities and Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r557",
      "r558",
      "r572"
     ]
    },
    "aapg_DepositsAssetsPrepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DepositsAssetsPrepayments",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits",
        "documentation": "Deposits",
        "label": "Deposits Assets Prepayments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepositsFromBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DepositsFromBanks",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time deposits with original maturity of more than three months",
        "label": "Deposits from banks"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deposit liabilities from banks held by the entity."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_DepreciationChargeofRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DepreciationChargeofRightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable": {
       "parentTag": "aapg_TotalAmountofRecognizedInProfitOrLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation charge of right-of-use assets",
        "documentation": "Amount of depreciation charge of right-of-use assets.",
        "label": "Depreciation Chargeof Rightofuse Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DepreciationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of right-of-use assets",
        "label": "Depreciation expense, operating"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DepreciationPropertyPlantAndEquipment",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation provided during the year (note 6)",
        "label": "Depreciation, property, plant and equipment, operating"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r18",
      "r307"
     ]
    },
    "ifrs-full_DepreciationRatePropertyPlantAndEquipment": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DepreciationRatePropertyPlantAndEquipment",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, rates",
        "label": "Depreciation rate, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The depreciation rate used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r303"
     ]
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DepreciationRightofuseAssets",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation charge",
        "label": "Depreciation, right-of-use assets"
       }
      }
     },
     "auth_ref": [
      "r150",
      "r257"
     ]
    },
    "ifrs-full_DerivativeFinancialAssetsHeldForHedging": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DerivativeFinancialAssetsHeldForHedging",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Derivative financial assets held for hedging"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of derivative financial assets held for hedging. [Refer: Derivative financial assets]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_DerivativeFinancialInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DerivativeFinancialInstrumentsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative financial instruments [Member]",
        "label": "Derivative Financial Instruments Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBorrowingCostsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowing costs",
        "label": "Description of accounting policy for borrowing costs [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for interest and other costs that the entity incurs in connection with the borrowing of funds."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "aapg_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "documentation": "The description of contract liabilities.",
        "label": "Description Of Accounting Policy For Contract Liabilities Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derecognition of financial liabilities",
        "documentation": "The description of the entity's material accounting policy information for the derecognition of financial liabilities.",
        "label": "Description Of Accounting Policy For Derecognition Financial Liabilities Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derecognition of financial assets",
        "label": "Description of accounting policy for derecognition of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the derecognition of financial instruments. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative financial instruments",
        "label": "Description of accounting policy for derivative financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for derivative financial instruments. [Refer: Classes of financial instruments [domain]; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other employee benefits",
        "label": "Description of accounting policy for employee benefits [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "aapg_DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Events after the reporting period",
        "documentation": "The description of events after the reporting period.",
        "label": "Description Of Accounting Policy For Events After The Reporting Period Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value measurement",
        "label": "Description of accounting policy for fair value measurement [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income",
        "label": "Description of accounting policy for finance income and costs [text block]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments and other financial assets",
        "label": "Description of accounting policy for financial assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities",
        "label": "Description of accounting policy for financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currencies",
        "label": "Description of accounting policy for foreign currency translation [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForGoodwillExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Description of accounting policy for goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "label": "Description of accounting policy for government grants [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r28",
      "r311"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of non-financial assets",
        "label": "Description of accounting policy for impairment of assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the impairment of assets."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of financial assets",
        "label": "Description of accounting policy for impairment of financial assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the impairment of financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax",
        "label": "Description of accounting policy for income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for income tax."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets (other than goodwill)",
        "label": "Description of accounting policy for intangible assets and goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForInvestmentsInJointVentures",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in joint venture",
        "label": "Description of accounting policy for investments in joint ventures [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for investments in joint ventures. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "aapg_DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ISSUED BUT NOT YET EFFECTIVE IFRS ACCOUNTING STANDARDS",
        "documentation": "Description of accounting policy for issued but not yet effective ifrs accountingstandards.",
        "label": "Description Of Accounting Policy For Issued But Not Yet Effective Ifrs Accounting Standards"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Description of accounting policy for leases [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Description of accounting policy for measuring inventories [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r23",
      "r279"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting of financial instruments",
        "label": "Description of accounting policy for offsetting of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the offsetting of financial instruments. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment and depreciation",
        "label": "Description of accounting policy for property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provisions",
        "label": "Description of accounting policy for provisions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development costs",
        "label": "Description of accounting policy for research and development expense [text block]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments",
        "label": "Description of accounting policy for share-based payment transactions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related parties",
        "label": "Description of accounting policy for transactions with related parties [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for transactions with related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury shares",
        "label": "Description of accounting policy for treasury shares [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for treasury shares. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r287"
     ]
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "presentation": [
      "http://www.ascentage.cn.com/role/GoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate of cash flow projections",
        "label": "Discount rate applied to cash flow projections"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r67",
      "r323",
      "r325"
     ]
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Expected volatility, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ifrs-full_DescriptionOfInitialApplicationOfStandardsOrInterpretations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfInitialApplicationOfStandardsOrInterpretations",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of New and Revised IFRSs",
        "label": "Disclosure of initial application of standards or interpretations [text block]"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r289"
     ]
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life of options (year)",
        "label": "Option life, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate%",
        "label": "Risk free interest rate, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfVestingRequirementsForSharebasedPaymentArrangement",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting date",
        "label": "Description of vesting requirements for share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Types of share-based payment arrangements [domain]]"
       }
      }
     },
     "auth_ref": [
      "r172",
      "r343"
     ]
    },
    "aapg_DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Instruments",
        "documentation": "the disclosure of detailed information about fair value and fair value hierarchy of financial instruments.",
        "label": "Detailed Information About Fair Value And Fair Value Hierarchy Of Financial Instruments Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets",
        "documentation": "The disclosure of information about right-of-use assets of lease terms and estimated useful lives of assets.",
        "label": "Detailed Information About Rightof Use Assets Of Lease Terms And Estimated Useful Lives Of Assets Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in Dollars per share and Yuan Renminbi per share)",
        "label": "Diluted earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58"
     ]
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimates"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SIGNIFICANT ACCOUNTING JUDGEMENTS AND ESTIMATES",
        "label": "Disclosure of accounting judgements and estimates [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Compensation of Key Management Personnel [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAnalysisOfInsuranceRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAnalysisOfInsuranceRevenueLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "\u200bSchedule of Revenue [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAuthorisationOfFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAuthorisationOfFinancialStatementsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ApprovaloftheFinancialStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "APPROVAL OF THE FINANCIAL STATEMENTS",
        "label": "Disclosure of authorisation of financial statements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the authorisation of financial statements for issue."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBasisOfConsolidationExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of consolidation",
        "label": "Disclosure of basis of consolidation [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for consolidation."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BASIS OF PREPARATION",
        "label": "Disclosure of basis of preparation of financial statements [text block]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBorrowingsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INTEREST-BEARING BANK AND OTHER BORROWINGS",
        "label": "Disclosure of borrowings [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "aapg_DisclosureOfCapitalManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfCapitalManagementExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Capital Management",
        "documentation": "The detailed information of capital management.",
        "label": "Disclosure Of Capital Management Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Carrying Amounts at the End of the Reporting Period",
        "documentation": "The carrying amounts at the end of the reporting period.",
        "label": "Disclosure Of Carrying Amounts At The End Of The Reporting Period Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/CashandBankBalances"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH AND BANK BALANCES",
        "label": "Disclosure of cash and bank balances at central banks [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of cash and bank balances at central banks."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfCashFlowStatementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCashFlowStatementExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOTES TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS",
        "label": "Disclosure of cash flow statement [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for a statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "aapg_DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash Outflow for Leases Included In the Statement of Cash Flows",
        "documentation": "The detailed information of cash outflows of lease included in cashflows.",
        "label": "Disclosure Of Cash Outflow For Leases Included In The Statement Of Cash Flows Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingEstimatesLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingPoliciesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCOUNTING POLICIES",
        "label": "Disclosure of changes in accounting policies [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of changes made to accounting policies by the entity."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "aapg_DisclosureOfChangesInAccountingPoliciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfChangesInAccountingPoliciesPolicyTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CHANGES IN ACCOUNTING POLICIES AND DISCLOSURES",
        "documentation": "The disclosure of changes made to accounting policies by the entity.",
        "label": "Disclosure Of Changes In Accounting Policies Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital and Treasury Shares [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Issued and Fully Paid",
        "label": "Disclosure of classes of share capital [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Classes of share capital [domain]]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r375",
      "r420"
     ]
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable",
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Issued and Fully Paid [Line Items]",
        "terseLabel": "Share Capital and Treasury Shares [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCommitmentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/Commitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS",
        "label": "Disclosure of commitments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompany"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CONDENSED FINANCIAL INFORMATION OF THE COMPANY",
        "label": "Disclosure of information about separate financial statements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about separate financial statements."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r130"
     ]
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ContingentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CONTINGENT LIABILITIES",
        "label": "Disclosure of contingent liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of contingent liabilities. [Refer: Classes of contingent liabilities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r328"
     ]
    },
    "aapg_DisclosureOfContractLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfContractLiabilitiesTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/ContractLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CONTRACT LIABILITIES",
        "documentation": "The disclosyre of contract liabuilities.",
        "label": "Disclosure Of Contract Liabilities Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfContractsLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfContractsLiabilitiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ContractLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Contract Liabilities",
        "documentation": "Disclosure of contracts liabilities explanatory.",
        "label": "Disclosure Of Contracts Liabilities Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCreditRiskExposureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCreditRiskExposureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCreditRiskExposureExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCreditRiskExposureExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maximum Exposure and Year-end Staging",
        "label": "Disclosure of credit risk exposure [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the credit risk exposure. Credit risk exposure is the credit risk inherent in an entity\u2019s financial assets and commitments to extend credit."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r363"
     ]
    },
    "ifrs-full_DisclosureOfCreditRiskExposureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCreditRiskExposureLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Credit Quality and Maximum Exposure To Credit Risk [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Current and Deferred Components of the Income Tax (Credit)/Expense",
        "documentation": "The entire disclosure for current and deferred components of the income tax expense/(credit).",
        "label": "Disclosure Of Current And Deferred Components Of The Income Tax Expense Credit Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDeferredIncomeExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDeferredIncomeExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DEFERRED INCOME",
        "label": "Disclosure of deferred income [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of deferred income. [Refer: Deferred income including contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "aapg_DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "documentation": "The disclosure deferred tax assets and liabilities.",
        "label": "Disclosure Of Deferred Tax Assets And Liabilities Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfDeferredTaxAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfDeferredTaxAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Movements in Deferred Tax Assets",
        "documentation": "Disclosure of deferred tax assets.",
        "label": "Disclosure Of Deferred Tax Assets Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDeferredTaxesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDeferredTaxesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DEFERRED TAX",
        "label": "Disclosure of deferred taxes [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest-Bearing Bank and Other Borrowings [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Assets at Fair Value through Profit or Loss",
        "documentation": "The disclosure of detailed information about financial assets at fair value through profit or loss.",
        "label": "Disclosure Of Detailed Information About Financial Assets At Fair Value Through Profit Or Loss Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategoryTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Categories of Financial Instruments",
        "label": "Disclosure of detailed information about financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r195",
      "r200",
      "r207",
      "r355"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Intangible Assets are Amortized on the Straight-Line Basis",
        "label": "Disclosure of detailed information about intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r334"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/PropertyPlantandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "label": "Disclosure of detailed information about property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r309"
     ]
    },
    "aapg_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment of Annual Rates",
        "documentation": "The disclosure of detailed information about property, plant and equipment of annual rates.",
        "label": "Disclosure Of Detailed Information About Property Plant And Equipment Of Annual Rate Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfDetailedInformationOfInventoriesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfDetailedInformationOfInventoriesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventories",
        "documentation": "The detailed information of inventories/.",
        "label": "Disclosure Of Detailed Information Of Inventories Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Other Income and Gains [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u200bSchedule of Disaggregated Revenue",
        "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]"
       }
      }
     },
     "auth_ref": [
      "r138",
      "r250"
     ]
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable",
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "\u200bSchedule of Disaggregated Revenue [Line Items]",
        "terseLabel": "\u200bSchedule of Contract Liabilities [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDividendsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDividendsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/Dividends"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DIVIDENDS",
        "label": "Disclosure of dividends [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of dividends. Dividends are distributions of profits to holders of equity investments in proportion to their holdings of a particular class of capital."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompany"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY",
        "label": "Disclosure of earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/OperatingSegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPERATING SEGMENT INFORMATION",
        "label": "Disclosure of entity's operating segments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "aapg_DisclosureOfEquityPriceRiskExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfEquityPriceRiskExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Equity Price Risk",
        "documentation": "The detailed information of equity price risk.",
        "label": "Disclosure Of Equity Price Risk Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Assets at Fair Value through Profit or Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets Measured at Fair Value",
        "label": "Disclosure of fair value measurement of assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r370"
     ]
    },
    "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FairValueandFairValueHierarchyofFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS",
        "label": "Disclosure of fair value of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value of financial instruments. [Refer: Classes of financial instruments [domain]; At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfFinanceCostExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinanceCostExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinanceCostsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finance Costs",
        "label": "Disclosure of finance cost [text block]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinanceCosts"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCE COSTS",
        "label": "Disclosure of finance income (cost) [text block]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Assets Measured at Fair Value [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments by Category [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialAssetsatFairValuethroughProfitorLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS",
        "label": "Disclosure of financial instruments at fair value through profit or loss [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial instruments measured at fair value through profit or loss. [Refer: At fair value [member]; Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Interest Rate Risk [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialInstrumentsbyCategory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCIAL INSTRUMENTS BY CATEGORY",
        "label": "Disclosure of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES",
        "label": "Disclosure of financial risk management [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "aapg_DisclosureOfForeignCurrencyRiskExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfForeignCurrencyRiskExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Foreign Currency Risk",
        "documentation": "The detailed information of foreign currency risk.",
        "label": "Disclosure Of Foreign Currency Risk Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/CorporateandGroupInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CORPORATE AND GROUP INFORMATION",
        "label": "Disclosure of general information about financial statements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r392"
     ]
    },
    "ifrs-full_DisclosureOfGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGoodwillExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/Goodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GOODWILL",
        "label": "Disclosure of goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGovernmentGrantsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Movements in Government Grants",
        "label": "Disclosure of government grants [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for government grants."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAX",
        "label": "Disclosure of income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Compensation of key Management Personnel",
        "label": "Disclosure of information about key management personnel [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of New and Revised IFRSs [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/OtherIntangibleAsset"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER INTANGIBLE ASSET",
        "label": "Disclosure of intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets are Amortized on the Straight-Line Basis [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfInterestRateRiskExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfInterestRateRiskExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Interest Rate Risk",
        "documentation": "The detailed information of interest rate risk.",
        "label": "Disclosure Of Interest Rate Risk Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInventoriesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVENTORIES",
        "label": "Disclosure of inventories [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "ifrs-full_DisclosureOfInvestmentContractsLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInvestmentContractsLiabilitiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u200bSchedule of Contract Liabilities",
        "label": "Disclosure of investment contracts liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of investment contracts liabilities. [Refer: Investment contracts liabilities]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in a Joint Venture [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfJointVenturesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfJointVenturesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/InvestmentinaJointVenture"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENT IN A JOINT VENTURE",
        "label": "Disclosure of joint ventures [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of joint ventures. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r54",
      "r129",
      "r366"
     ]
    },
    "aapg_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease Liabilities",
        "documentation": "Tabular disclosure for lease liabilities.",
        "label": "Disclosure Of Lease Liabilities Explanatory Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfLeasesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Disclosure of leases [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159"
     ]
    },
    "ifrs-full_DisclosureOfLiquidityRiskExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfLiquidityRiskExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Liquidity Risk",
        "label": "Disclosure of liquidity risk [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of liquidity risk. [Refer: Liquidity risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "aapg_DisclosureOfLossBeforeTaxExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfLossBeforeTaxExplanatoryTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/LossBeforeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Loss Before Tax",
        "documentation": "Disclosure of loss before tax.",
        "label": "Disclosure Of Loss Before Tax Explanatory Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfLossBeforeTaxExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfLossBeforeTaxExplanatoryTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/LossBeforeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LOSS BEFORE TAX",
        "documentation": "Disclosure of detailed information about loss before tax.",
        "label": "Disclosure Of Loss Before Tax Explanatory Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Liquidity Risk [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Event After the Reporting Period [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/OperatingSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u200bSchedule of Non-Current Assets",
        "label": "Disclosure of non-current assets held for sale and discontinued operations [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for non-current assets held for sale and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Shares Outstanding",
        "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme",
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r178",
      "r349"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segment Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherCurrentAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepayments, Other Receivables and Other Assets",
        "label": "Disclosure of other current assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other current assets. [Refer: Other current assets]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "aapg_DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/OtherIntangibleAssetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Intangible Asset",
        "documentation": "The disclosure of other intangible assets explanatory.",
        "label": "Disclosure Of Other Intangible Asset Explanatory Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherNoncurrentAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/OtherNonCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER NON-CURRENT ASSETS",
        "label": "Disclosure of other non-current assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other non-current assets. [Refer: Other non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingExpenseExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/OtherExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER EXPENSES",
        "label": "Disclosure of other operating expense [text block]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Income and Gains",
        "label": "Disclosure of other operating income (expense) [text block]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "aapg_DisclosureOfOtherPayablesAndAccrualsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfOtherPayablesAndAccrualsTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/OtherPayablesandAccruals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER PAYABLES AND ACCRUALS",
        "documentation": "Disclosure of other payables and accruals.",
        "label": "Disclosure Of Other Payables And Accruals Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPerformanceObligationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPerformanceObligationsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/RevenueOtherIncomeandGainsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations",
        "label": "Disclosure of performance obligations [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of performance obligations in contracts with customers. [Refer: Performance obligations [domain]]"
       }
      }
     },
     "auth_ref": [
      "r142",
      "r254"
     ]
    },
    "aapg_DisclosureOfPledgeOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfPledgeOfAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/PledgeofAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PLEDGE OF ASSETS",
        "documentation": "The disclosure of pledge of assets.",
        "label": "Disclosure Of Pledge Of Assets Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/PrepaymentsOtherReceivablesandOtherAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PREPAYMENTS, OTHER RECEIVABLES AND OTHER ASSETS",
        "label": "Disclosure of prepayments and other assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of prepayments and other assets. [Refer: Other assets; Prepayments]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfProductsAndServicesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfProductsAndServicesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/OperatingSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "\u200bSchedule of Revenue",
        "label": "Disclosure of products and services [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's products and services. [Refer: Products and services [domain]]"
       }
      }
     },
     "auth_ref": [
      "r224"
     ]
    },
    "ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfProfitLossFromOperatingActivitiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Recognized in Profit or Loss",
        "label": "Disclosure of profit (loss) from operating activities [text block]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/PropertyPlantandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PROPERTY, PLANT AND EQUIPMENT",
        "label": "Disclosure of property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property, Plant and Equipment of Annual Rates [Line Items]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Right-of-Use Assets",
        "label": "Disclosure of quantitative information about right-of-use assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r155",
      "r262"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Right-of-Use Assets [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding",
        "label": "Disclosure of range of exercise prices of outstanding share options [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the range of exercise prices for outstanding share options."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding [Line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation between the Income Tax Expense/(Credit)",
        "documentation": "The disclosure of reconciliation between the income tax expense/(credit).",
        "label": "Disclosure Of Reconciliation Between The Income Tax Expense Credit Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/GoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Disclosure of reconciliation of changes in goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r354"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInPropertyPlantAndEquipmentIncludingRightofuseAssetsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Right-of-Use assets of the Lease Terms and the Estimated Useful Lives of the Assets [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Liabilities Arising from Financing Activities",
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r284",
      "r462"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RELATED PARTY TRANSACTIONS",
        "label": "Disclosure of related party [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/Reserves"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RESERVES",
        "label": "Disclosure of reserves within equity [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of reserves within equity. [Refer: Other reserves [member]]"
       }
      }
     },
     "auth_ref": [
      "r277",
      "r376",
      "r421"
     ]
    },
    "ifrs-full_DisclosureOfReservesWithinEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReservesWithinEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserves [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReservesWithinEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReservesWithinEquityLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ReservesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserves [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition",
        "label": "Disclosure of revenue from contracts with customers [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146"
     ]
    },
    "aapg_DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/RevenueOtherIncomeandGains"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUE, OTHER INCOME AND GAINS",
        "documentation": "Disclosure of explanatory information about revenue other income and other gains.",
        "label": "Disclosure Of Revenue Other Income And Other Gains Explanatory Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSegmentsMajorCustomersExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/OperatingSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue from Customers",
        "label": "Disclosure of major customers [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of major customers."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "aapg_DisclosureOfShareCapitalAndTreasurySharesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfShareCapitalAndTreasurySharesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Capital and Treasury Shares",
        "documentation": "The disclosure of share capital and treasury shares.",
        "label": "Disclosure Of Share Capital And Treasury Shares Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasuryShares"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHARE CAPITAL AND TREASURY SHARES",
        "label": "Disclosure of share capital, reserves and other equity interest [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r377",
      "r422"
     ]
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPayments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHARE-BASED PAYMENTS",
        "label": "Disclosure of share-based payment arrangements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Information of the Group\u2019s Joint Venture [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/CorporateandGroupInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Principal Subsidiaries",
        "label": "Disclosure of subsidiaries [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r54",
      "r128",
      "r365"
     ]
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Principal Subsidiaries [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSummarisedFinancialInformationAboutForeignOperationLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Foreign Currency Risk [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Before Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable",
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Movements in Deferred Tax Assets [Line Items]",
        "terseLabel": "Significant Accounting Judgements and Estimates [Line Items]",
        "verboseLabel": "Income Tax [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable",
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unlocking Date [Line items]",
        "terseLabel": "Schedule of Restricted Shares Outstanding [Line items]",
        "verboseLabel": "Share-Based Payments [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/TradePayables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TRADE PAYABLES",
        "label": "Disclosure of trade and other payables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/TradeReceivablesNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TRADE RECEIVABLES, NET",
        "label": "Disclosure of trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "aapg_DisclosureOfTradePayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfTradePayablesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/TradePayablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of the Trade Payables",
        "documentation": "The disclosure of trade payables.",
        "label": "Disclosure Of Trade Payables Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Line Items]",
        "terseLabel": "Related Party Transactions [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureOfUnlockingDatetextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureOfUnlockingDatetextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unlocking Date",
        "documentation": "The disclosure of unlocking date.",
        "label": "Disclosure Of Unlocking Datetext Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureofOtherPayablesAndAccrualsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureofOtherPayablesAndAccrualsExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/OtherPayablesandAccrualsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Payables and Accruals",
        "documentation": "The disclosure of other payables and accruals.",
        "label": "Disclosureof Other Payables And Accruals Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureofOutstandingBalanceWithRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureofOutstandingBalanceWithRelatedPartyExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Outstanding Balance with Related Party",
        "documentation": "The disclosure of  outstanding balance with related party explanatory.",
        "label": "Disclosureof Outstanding Balance With Related Party Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisclosureofTransactionWithRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisclosureofTransactionWithRelatedPartyExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Transaction with Related Party",
        "documentation": "The disclosure of transaction with related party explanatory.",
        "label": "Disclosureof Transaction With Related Party Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DisposalsLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DisposalsLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Disposal",
        "documentation": "Amount of disposal lease liabilities.",
        "label": "Disposals Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisposalsPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposals",
        "label": "Disposals, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r306"
     ]
    },
    "ifrs-full_DisposalsRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisposalsRightofuseAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Disposal",
        "label": "Disposals, right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in right-of-use assets resulting from disposals. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "aapg_DividendAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DividendAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r557",
      "r558",
      "r572"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r523",
      "r545"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r523",
      "r545",
      "r596"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r523",
      "r545",
      "r596"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "aapg_DonationExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DonationExpensesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Donation expenses [Member]",
        "label": "Donation Expenses Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DonationsAndSubsidiesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DonationsAndSubsidiesExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable": {
       "parentTag": "ifrs-full_OtherExpenseByNature",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Donations",
        "label": "Donations and subsidies expense"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "aapg_DrYangDajunMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DrYangDajunMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dr. Yang Dajun [Member]",
        "label": "Dr Yang Dajun Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DrYangMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DrYangMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dr. Yang [Member]",
        "label": "Dr Yang Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_DrZhaiYifanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "DrZhaiYifanMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dr. Zhai Yifan [Member]",
        "label": "Dr Zhai Yifan Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Per Share Attributable to Ordinary Equity Holders of the Company [Abstract]",
        "terseLabel": "LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic Loss Per Share",
        "label": "Earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of foreign exchange rate changes, net",
        "verboseLabel": "Effect of change in foreign exchange rates",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90"
     ]
    },
    "aapg_EffectOfWithholdingTaxOnTheInterestIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "EffectOfWithholdingTaxOnTheInterestIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of withholding tax on the interest income of the Group\u2019s HK subsidiary",
        "documentation": "The amount of effect of withholding tax on the interest income \u2014 of the group\u2019s HK subsidiary.",
        "label": "Effect Of Withholding Tax On The Interest Income"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "aapg_EmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "EmployeeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee [Member]",
        "label": "Employee Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_EmployeesShareBasedCompensationSchemeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "EmployeesShareBasedCompensationSchemeAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees share-based compensation scheme",
        "label": "Employees Share Based Compensation Scheme Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r515"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r647"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "terseLabel": "Balance (in Dollars)",
        "verboseLabel": "Share capital, Ordinary shares of US$0.0001 each",
        "label": "Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r106",
      "r131",
      "r132",
      "r133",
      "r320",
      "r341",
      "r368",
      "r369",
      "r381",
      "r405",
      "r415"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EQUITY",
        "label": "Equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Equity attributable to ordinary equity holders of the Company",
        "terseLabel": "Equity attributable to owners of the Company",
        "label": "Equity attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r538",
      "r549",
      "r565",
      "r600"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r535",
      "r546",
      "r562",
      "r597"
     ]
    },
    "ifrs-full_EstimatedFinancialEffectOfContingentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EstimatedFinancialEffectOfContingentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent liabilities",
        "label": "Estimated financial effect of contingent liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the estimated financial effect of contingent liabilities. [Refer: Classes of contingent liabilities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r327"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ExchangeFluctuationReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ExchangeFluctuationReserve",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange fluctuation reserve",
        "documentation": "Represent the amount of exchange fluctuation reserve.",
        "label": "Exchange Fluctuation Reserve"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ExchangeRealignmentRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ExchangeRealignmentRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange realignment",
        "documentation": "Exchange realignment, right-of-use assets.",
        "label": "Exchange Realignment Rightofuse Assets"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ExchangeRealignments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ExchangeRealignments",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange realignment",
        "documentation": "Exchange realignment.",
        "label": "Exchange Realignments"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExercisePriceShareOptionsGranted2019",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, share options granted (in Dollars per share)",
        "label": "Exercise price, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "ifrs-full_ExpenseByNatureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseByNatureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-settled share-based payment expenses",
        "label": "Expense from equity-settled share-based payment transactions"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsAlternativeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable": {
       "parentTag": "aapg_TotalAmountofRecognizedInProfitOrLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense relating to short-term leases (included in administrative expenses) (note 6)",
        "label": "Expense relating to leases of low-value assets for which recognition exemption has been used, operating"
       }
      }
     },
     "auth_ref": [
      "r152",
      "r259"
     ]
    },
    "ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod",
     "presentation": [
      "http://www.ascentage.cn.com/role/EventAftertheReportingPeriod"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EVENT AFTER THE REPORTING PERIOD",
        "label": "Explanation of financial effect of non-adjusting event after reporting period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The explanation of either an estimate of the financial effect of a non-adjusting event after the reporting period or a statement that such an estimate cannot be made."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r294"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FactorsUsedToIdentifyEntitysReportableSegments": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FactorsUsedToIdentifyEntitysReportableSegments",
     "presentation": [
      "http://www.ascentage.cn.com/role/OperatingSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable operating segment",
        "label": "Description of factors used to identify entity's reportable segments"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the factors used to identify the entity's reportable segments, including the basis of organisation (for example, whether management has chosen to organise the entity around differences in products and services, geographical areas, regulatory environments or a combination of factors and whether operating segments have been aggregated). [Refer: Geographical areas [domain]; Operating segments [member]; Products and services [domain]; Reportable segments [member]]"
       }
      }
     },
     "auth_ref": [
      "r213"
     ]
    },
    "aapg_FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Adjustments Arising From Acquisition of a Subsidiary [Member]",
        "label": "Fair Value Adjustments Arising From Acquisition Of ASubsidiary Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FairValueAndFairValueHierarchyOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value and Fair Value Hierarchy of Financial Instruments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofAssetsMeasuredatFairValueDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Assets Measured at Fair Value (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FairValueandFairValueHierarchyofFinancialInstrumentsScheduleofFinancialInstrumentsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value and Fair Value Hierarchy of Financial Instruments - Schedule of Financial Instruments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 8.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "negatedLabel": "Finance costs",
        "label": "Finance costs"
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "ifrs-full_FinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Total",
        "label": "Financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r194",
      "r198",
      "r199",
      "r201",
      "r361",
      "r362",
      "r363",
      "r480"
     ]
    },
    "aapg_FinancialAssetsAgingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialAssetsAgingAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Assets, Aging [Axis]",
        "label": "Financial Assets Aging Axis"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialAssetsAgingDomainDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialAssetsAgingDomainDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FinancialAssetsAgingDomain [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialAssetsAtAmortizedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialAssetsAtAmortizedCostMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at amortized cost [Member]",
        "label": "Financial Assets At Amortized Cost Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialAssetsAtFVTPL": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialAssetsAtFVTPL",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at FVTPL",
        "documentation": "The amount of financial assets at FVTPL.",
        "label": "Financial Assets At FVTPL"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialAssetsAtFairValueThroughProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable",
      "http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at FVTPL",
        "negatedLabel": "NASDAQ - Financial assets at fair value through profit or loss",
        "label": "Financial assets at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r208",
      "r356"
     ]
    },
    "aapg_FinancialAssetsAtFairValueThroughProfitOrLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialAssetsAtFairValueThroughProfitOrLossMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at fair value through profit or loss [Member]",
        "label": "Financial Assets At Fair Value Through Profit Or Loss Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialAssetsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Assets [Member]",
        "label": "Financial Assets Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialInstrumentsbyCategoryScheduleofCategoriesofFinancialInstrumentsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments by Category - Schedule of Categories of Financial Instruments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "aapg_FinancialLiabilitiesAtAmortizedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialLiabilitiesAtAmortizedCostMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities at amortized cost [Member]",
        "label": "Financial Liabilities At Amortized Cost Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialLiabilitiesAtFVTPL": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialLiabilitiesAtFVTPL",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities at FVTPL",
        "documentation": "The amount of financial liabilities at FVTPL .",
        "label": "Financial Liabilities At FVTPL"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities included in other payables and accruals",
        "label": "Financial liabilities at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities that meet either of the following conditions: (a) they meet the definition of held for trading; or (b) upon initial recognition they are designated by the entity as at fair value through profit or loss. An entity may use this designation only when permitted by paragraph 4.3.5 of IFRS 9 (embedded derivatives) or when doing so results in more relevant information, because either: (a) it eliminates or significantly reduces a measurement or recognition inconsistency (sometimes referred to as \u2018an accounting mismatch\u2019) that would otherwise arise from measuring assets or liabilities or recognising the gains and losses on them on different bases; or (b) a group of financial liabilities or financial assets and financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the group is provided internally on that basis to the entity\u2019s key management personnel (as defined in IAS 24). [Refer: At fair value [member]; Key management personnel of entity or parent [member]; Derivatives [member]; Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r209",
      "r357"
     ]
    },
    "aapg_FinancialLiabilitiesAtFairValueThroughProfitOrLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLossMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities at fair value through profit or loss [Member]",
        "label": "Financial Liabilities At Fair Value Through Profit Or Loss Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities included in other payables and accruals [Member]",
        "label": "Financial Liabilities Included In Other Payables And Accruals Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialLiabilitiesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Liabilities [Member]",
        "label": "Financial Liabilities Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Capital Management [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofCapitalManagementDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies - Schedule of Capital Management (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofCreditQualityandMaximumExposureToCreditRiskDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies - Schedule of Credit Quality and Maximum Exposure To Credit Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Market Equity Index [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofEquityPriceRiskDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies - Schedule of Equity Price Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Values of the Equity Investments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofFairValuesoftheEquityInvestmentsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies - Schedule of Fair Values of the Equity Investments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofForeignCurrencyRiskDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies - Schedule of Foreign Currency Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofInterestRateRiskDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies - Schedule of Interest Rate Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FinancialRiskManagementObjectivesandPoliciesScheduleofLiquidityRiskDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management Objectives and Policies - Schedule of Liquidity Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofInventoriesTable": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Current finished goods"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r497",
      "r505",
      "r654"
     ]
    },
    "aapg_FirstAnniversariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FirstAnniversariesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First anniversaries [Member]",
        "label": "First Anniversaries Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ForecastMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast [Member]",
        "label": "Forecast Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ForeignExchangeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ForeignExchangeLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable": {
       "parentTag": "ifrs-full_OtherExpenseByNature",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange loss",
        "label": "Foreign exchange loss"
       }
      }
     },
     "auth_ref": [
      "r31",
      "r312",
      "r391"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r542",
      "r553",
      "r569",
      "r604"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r542",
      "r553",
      "r569",
      "r604"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r542",
      "r553",
      "r569",
      "r604"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r542",
      "r553",
      "r569",
      "r604"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r542",
      "r553",
      "r569",
      "r604"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r522",
      "r556"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FourthAnniversaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FourthAnniversaryMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fourth Anniversary [Member]",
        "label": "Fourth Anniversary Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "aapg_FurnitureAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FurnitureAndEquipmentMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and equipment [Member]",
        "label": "Furniture And Equipment Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_FutureTaxableProfitsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "FutureTaxableProfitsPercentage",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future taxable profits percentage",
        "documentation": "Future taxable profits percentage.",
        "label": "Future Taxable Profits Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_GainlossAttributableToJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "GainlossAttributableToJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Gain)/loss attributable to joint ventures",
        "documentation": "The amount of gain/(loss) attributable to joint ventures.",
        "label": "Gainloss Attributable To Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnChangeInFairValueOfDerivatives",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value gain on derivative financial instruments",
        "negatedLabel": "Derivative financial instruments",
        "label": "Gains (losses) on change in fair value of derivatives"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r685"
     ]
    },
    "ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnDisposalsOfPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Gain)/Loss on disposal of items of property, plant and equipment",
        "label": "Gains (losses) on disposals of property, plant and equipment, operating"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase/(decrease) in loss before tax",
        "label": "Gains (losses) on exchange differences on translation of foreign operations, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable": {
       "parentTag": "ifrs-full_OtherExpenseByNature",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fair value loss on financial liabilities at FVTPL",
        "label": "Gains (losses) on financial liabilities at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) on financial liabilities at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r191",
      "r359"
     ]
    },
    "ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsOnDisposalsOfPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on disposal of items of property, plant and equipment",
        "label": "Gains on disposals of property, plant and equipment, operating"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r445",
      "r471",
      "r477",
      "r489"
     ]
    },
    "ifrs-full_GeographicalAreasDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r445",
      "r471",
      "r477",
      "r489"
     ]
    },
    "ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GoodsOrServicesTransferredAtPointInTimeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At a point in time [Member]",
        "label": "Goods or services transferred at point in time [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for goods or services transferred to customers at a point in time. [Refer: Performance obligations satisfied at point in time [member]]"
       }
      }
     },
     "auth_ref": [
      "r474",
      "r492"
     ]
    },
    "ifrs-full_GoodsOrServicesTransferredOverTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GoodsOrServicesTransferredOverTimeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over time [Member]",
        "verboseLabel": "Timing of revenue recognition",
        "label": "Goods or services transferred over time [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for goods or services transferred to customers over time. [Refer: Performance obligations satisfied over time [member]]"
       }
      }
     },
     "auth_ref": [
      "r474",
      "r492"
     ]
    },
    "ifrs-full_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofGoodwillTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Goodwill",
        "label": "Goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r64",
      "r68",
      "r188",
      "r322",
      "r326",
      "r354",
      "r394"
     ]
    },
    "ifrs-full_GovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GovernmentGrants",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "At beginning of the year",
        "periodEndLabel": "At end of the year",
        "label": "Government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_GovernmentSubsidy": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "GovernmentSubsidy",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government subsidy",
        "documentation": "The amount of government subsidy.",
        "label": "Government Subsidy"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_GrantAnniversariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "GrantAnniversariesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant anniversaries [Axis]",
        "label": "Grant Anniversaries Axis"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_GrantAnniversariesDomainDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "GrantAnniversariesDomainDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GrantAnniversariesDomain [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross carrying amount [member]",
        "verboseLabel": "Carrying Amounts [member]",
        "label": "Gross carrying amount [member]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r72",
      "r81",
      "r84",
      "r188",
      "r199",
      "r201",
      "r304",
      "r330",
      "r337",
      "r340",
      "r362",
      "r363",
      "r480"
     ]
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross profit"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "aapg_GuangzhouHealthquestPharmaCoLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "GuangzhouHealthquestPharmaCoLtdMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guangzhou Healthquest Pharma Co., Ltd. (\u201cHealthquest Pharma\u201d) [Member ]",
        "label": "Guangzhou Healthquest Pharma Co Ltd Member"
       }
      }
     },
     "auth_ref": []
    },
    "country_HK": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "HK",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HK [Member]",
        "verboseLabel": "Hong Kong [Member]",
        "label": "HONG KONG"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_HealthquestPharmaAcquisitionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "HealthquestPharmaAcquisitionAgreementMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Healthquest Pharma Acquisition Agreement [Member]",
        "label": "Healthquest Pharma Acquisition Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_HighAndNewTechnologyEnterpriseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "HighAndNewTechnologyEnterpriseMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "High and New Technology Enterprise [Member]",
        "label": "High And New Technology Enterprise Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_HongKongStockExchangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "HongKongStockExchangeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hong Kong Stock Exchange [Member]",
        "label": "Hong Kong Stock Exchange Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IFRSEighteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IFRSEighteenMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IFRS 18 [Member]",
        "label": "IFRSEighteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IFRSNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IFRSNineteenMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IFRS 19 and its amendments [Member]",
        "label": "IFRSNineteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r520",
      "r523",
      "r545"
     ]
    },
    "aapg_IfRMBStrengthensAgainstUSDollarsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IfRMBStrengthensAgainstUSDollarsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "If RMB strengthens against US$ [Member]",
        "documentation": "If RMB strengthens against US Dollars.",
        "label": "If RMBStrengthens Against USDollars Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IfRMBWeakensAgainstUSDollarsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IfRMBWeakensAgainstUSDollarsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "If RMB weakens against US$ [Member]",
        "label": "If RMBWeakens Against USDollars Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IncomeNotSubjectToTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncomeNotSubjectToTax",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Items not subject to tax",
        "documentation": "Income not subject to tax",
        "label": "Income Not Subject To Tax"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Recognized in Profit or Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IncomeTaxComputedAtTheStatutoryTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncomeTaxComputedAtTheStatutoryTaxRate",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax computed at the statutory tax rate",
        "documentation": "Represent the amount of income tax computed at the statutory tax rate.",
        "label": "Income Tax Computed At The Statutory Tax Rate"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IncomeTaxDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncomeTaxDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofCurrentandDeferredComponentsoftheIncomeTaxCreditExpenseTable",
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income tax credit/(expense)",
        "negatedLabel": "Income tax credit/(expense)",
        "label": "Income tax expense (income), income taxes"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r47",
      "r126",
      "r217",
      "r296",
      "r297",
      "r298",
      "r433"
     ]
    },
    "aapg_IncomeTaxesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncomeTaxesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Axis]",
        "label": "Income Taxes Axis"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IncomeTaxesDomainDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncomeTaxesDomainDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IncomeTaxesDomain [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax paid",
        "label": "Income taxes paid (refund), classified as operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      }
     },
     "auth_ref": [
      "r92",
      "r451"
     ]
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS",
        "terseLabel": "Net decrease in cash and cash equivalents",
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r286"
     ]
    },
    "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of ordinary shares (in Shares)",
        "verboseLabel": "New shares issued",
        "netLabel": "Ordinary shares (in Shares)",
        "label": "Increase (decrease) in number of ordinary shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "aapg_IncreaseDecreaseInNumberOfSharesEquitysettledBonus": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncreaseDecreaseInNumberOfSharesEquitysettledBonus",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-settled bonus (in Shares)",
        "documentation": "Represent the number of shares, equity-settled bonus.",
        "label": "Increase Decrease In Number Of Shares Equitysettled Bonus"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IncreaseDecreaseInTimeDepositsWithOriginalMaturity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncreaseDecreaseInTimeDepositsWithOriginalMaturity",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Maturity/(Placement) in time deposits with original maturity of more than three months",
        "documentation": "(Increase)/Decrease in time deposits with original maturity of more than three months",
        "label": "Increase Decrease In Time Deposits With Original Maturity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of Pre-IPO share options",
        "label": "Increase (decrease) through exercise of options, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes from financing cash flows",
        "label": "Increase (decrease) through financing cash flows, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r283"
     ]
    },
    "aapg_IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares under the 2021 RSU scheme",
        "documentation": "Issue of shares under the 2021 RSU.",
        "label": "Increase Decrease Through Issue Of Shares Under The RSUScheme"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange realignment",
        "label": "Increase (decrease) through net exchange differences, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "aapg_IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase of ordinary shares",
        "documentation": "Represent the amount of share capital, repurchase of ordinary shares.",
        "label": "Increase Decrease Through Share Capital Repurchase Of Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfers",
        "label": "Increase (decrease) through transfers, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable",
      "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New leases",
        "label": "Increase through new leases, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r460",
      "r463"
     ]
    },
    "aapg_IncreasedecreaseInBasisPointsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncreasedecreaseInBasisPointsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase/(decrease) in basis points [Member]",
        "label": "Increasedecrease In Basis Points Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IncreasedecreaseInLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncreasedecreaseInLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase/(decrease) in loss before tax",
        "documentation": "Increase/(decrease) in loss before tax",
        "label": "Increasedecrease In Loss Before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IncreasedecreaseInLossBeforeTaxMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncreasedecreaseInLossBeforeTaxMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase/(decrease) in loss before tax [Member]",
        "label": "Increasedecrease In Loss Before Tax Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IncreasedecreaseWeakensAgainst": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IncreasedecreaseWeakensAgainst",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase/(decrease) in foreign currency rate",
        "documentation": "Increase/(decrease) in foreign currency rate",
        "label": "Increasedecrease Weakens Against"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r542",
      "r553",
      "r569",
      "r595",
      "r604",
      "r608",
      "r616"
     ]
    },
    "aapg_InnoventBiologicsSuzhouCoLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InnoventBiologicsSuzhouCoLtdMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Innovent Biologics Suzhou) Co Ltd [Member]",
        "label": "Innovent Biologics Suzhou Co Ltd Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r524",
      "r620"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r524",
      "r620"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r524",
      "r620"
     ]
    },
    "ifrs-full_IntangibleAssetsAndGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost",
        "documentation": "Intangible assets gross amount before charging accumulated amortization.",
        "label": "Intangible Assets Gross"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cost Beginning Balance",
        "periodEndLabel": "Cost Ending Balance",
        "terseLabel": "Net carrying amount",
        "verboseLabel": "Net carrying amount in US$ (in Dollars)",
        "label": "Intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r75",
      "r333",
      "r394"
     ]
    },
    "aapg_IntellectualPropertyIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IntellectualPropertyIncomeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual Property Income [Member]",
        "verboseLabel": "Intellectual property income [Member]",
        "label": "Intellectual Property Income Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IntellectuallPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IntellectuallPropertyMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual Property",
        "label": "Intellectuall Property Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_InterestBearingBankBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InterestBearingBankBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest-bearing bank borrowings",
        "documentation": "Interest-bearing bank borrowings.",
        "label": "Interest Bearing Bank Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_InterestBearingBankandOtherBorrowingsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InterestBearingBankandOtherBorrowingsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest-Bearing Bank and Other Borrowings (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InterestBearingBankandOtherBorrowingsScheduleofInterestBearingBankandOtherBorrowingsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest-Bearing Bank and Other Borrowings - Schedule of Interest-Bearing Bank and Other Borrowings (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InterestBearingBankandOtherBorrowingsScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest-Bearing Bank and Other Borrowings - Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestCostsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Costs [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestCostsCapitalised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestCostsCapitalised",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on lease liabilities",
        "label": "Interest costs capitalised"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expenses",
        "label": "Interest expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r215",
      "r222"
     ]
    },
    "ifrs-full_InterestExpenseOnBankLoansAndOverdrafts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseOnBankLoansAndOverdrafts",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on bank loans and other borrowings",
        "label": "Interest expense on bank loans and overdrafts"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_InterestExpenseOnBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseOnBorrowings",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable": {
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinanceCostsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on long-term payables",
        "label": "Interest expense on borrowings"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable": {
       "parentTag": "aapg_TotalAmountofRecognizedInProfitOrLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deficit on adjustment",
        "verboseLabel": "Accretion of interest recognized during the year",
        "netLabel": "Interest on lease liabilities",
        "label": "Interest expense on lease liabilities, financing"
       }
      }
     },
     "auth_ref": [
      "r151",
      "r258"
     ]
    },
    "ifrs-full_InterestIncomeOnLoansAndAdvancesToBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestIncomeOnLoansAndAdvancesToBanks",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank interest income",
        "negatedLabel": "Bank interest income",
        "label": "Interest income on loans and advances to banks"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest paid",
        "negatedTerseLabel": "Interest paid classified as financing cash flows",
        "label": "Interest paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ifrs-full_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Floating Interest Rates [Member]",
        "label": "Interest rate risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r167",
      "r211"
     ]
    },
    "aapg_InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest-bearing bank and other borrowings excluding lease liabilities [Member]",
        "label": "Interestbearing Bank And Other Borrowings Excluding Lease Liabilities Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_InterestbearingBankAndOtherBorrowingsNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InterestbearingBankAndOtherBorrowingsNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest-bearing bank and other borrowings",
        "documentation": "Represent the amount of interest-bearing bank and other borrowings non-current.",
        "label": "Interestbearing Bank And Other Borrowings Non Current"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_Interestbearingbankandotherborrowingscurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "Interestbearingbankandotherborrowingscurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest-bearing bank and other borrowings",
        "documentation": "Amount of interest-bearing bank and other borrowings.",
        "label": "Interestbearingbankandotherborrowingscurrent"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Inventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Inventories",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofInventoriesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Inventories",
        "label": "Current inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r280",
      "r396",
      "r502"
     ]
    },
    "ifrs-full_InventoryWritedown2011": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InventoryWritedown2011",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Write-down of inventories to net realizable value",
        "label": "Inventory write-down"
       }
      }
     },
     "auth_ref": [
      "r26",
      "r282",
      "r437"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r558",
      "r559",
      "r560",
      "r561"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "aapg_InvestmentInJointVenturesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InvestmentInJointVenturesClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in a joint venture",
        "documentation": "Represent the amount of investment in joint ventures classified as investing activities.",
        "label": "Investment In Joint Ventures Classified As Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_InvestmentInOtherFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InvestmentInOtherFinancialAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in other financial assets",
        "documentation": "The amount of investment in other financial assets.",
        "label": "Investment In Other Financial Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InvestmentIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InvestmentIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment associated with investment",
        "label": "Investment income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investment income, such as interest and dividends."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r685"
     ]
    },
    "ifrs-full_InvestmentsInSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InvestmentsInSubsidiaries",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in subsidiaries",
        "label": "Investments in subsidiaries reported in separate financial statements"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments in subsidiaries in an entity's separate financial statements. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofInvestmentinaJointVentureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in a joint venture",
        "verboseLabel": "Share of net assets",
        "label": "Investments in subsidiaries, joint ventures and associates reported in separate financial statements"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "aapg_InvestmentsListedInAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "InvestmentsListedInAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFairValuesoftheEquityInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments listed in:",
        "label": "Investments Listed In Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssueOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssueOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of ordinary shares",
        "label": "Issue of equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "aapg_IssueOfOrdinaryShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IssueOfOrdinaryShare",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of ordinary shares (in Shares)",
        "verboseLabel": "Subscription of shares",
        "documentation": "Issue of ordinary shares.",
        "label": "Issue Of Ordinary Share"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IssueOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IssueOfOrdinaryShares",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of ordinary shares",
        "documentation": "Issue of ordinary shares.",
        "label": "Issue Of Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IssueOfSharesUnderThe2021RSUSchemeInshares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IssueOfSharesUnderThe2021RSUSchemeInshares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares under the 2021 RSU scheme (in Shares)",
        "documentation": "Issue of shares under the 2021 RSU scheme.",
        "label": "Issue Of Shares Under The2021 RSUScheme Inshares"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IssueOfSharesUnderThePreIPOShareOptionScheme": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IssueOfSharesUnderThePreIPOShareOptionScheme",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares under the pre-IPO share option scheme",
        "documentation": "Issue of shares under the pre-IPO share option scheme.",
        "label": "Issue Of Shares Under The Pre IPOShare Option Scheme"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_IssueOfSharesUnderThePreIPOShareOptionSchemeinShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IssueOfSharesUnderThePreIPOShareOptionSchemeinShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares under the pre-IPO share option scheme (in Shares)",
        "documentation": "Issue of shares under the pre-IPO share option scheme.",
        "label": "Issue Of Shares Under The Pre IPOShare Option Schemein Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital",
        "verboseLabel": "Share capital (in Yuan Renminbi)",
        "label": "Issued capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r506"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital",
        "verboseLabel": "Share capital [Member]",
        "label": "Issued capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "ifrs-full_IssuedCapitalOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalOrdinaryShares",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares (par value of US$0.0001 per share as of December 31, 2024 and 2025; 315,224,993 and 373,321,692 shares authorized, issued and outstanding as of December 31, 2024 and 2025, respectively)",
        "verboseLabel": "Nominal value of issued/\u200bregistered share capital",
        "netLabel": "Share capital (in Yuan Renminbi)",
        "label": "Issued capital, ordinary shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "aapg_IssuedShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "IssuedShareCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "terseLabel": "Balance (in Dollars)",
        "documentation": "The nominal value of capital issued.",
        "label": "Issued Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Key management personnel compensation, operating"
       }
      }
     },
     "auth_ref": [
      "r38",
      "r316"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Post-employment benefits",
        "label": "Key management personnel compensation, post-employment benefits"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-settled share-based payment expenses",
        "label": "Key management personnel compensation, share-based payment"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompensationofkeyManagementPersonnelTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term employee benefits and fees",
        "label": "Key management personnel compensation, short-term employee benefits, operating"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ifrs-full_LandAndBuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LandAndBuildingsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land and Buildings [Member]",
        "label": "Land and buildings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanFiveYearsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Beyond five years [Member]",
        "verboseLabel": "Over 5 years",
        "label": "Later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r169",
      "r265",
      "r269",
      "r482",
      "r483",
      "r485"
     ]
    },
    "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In the third to fifth years, inclusive [Member]",
        "label": "Later than four years and not later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than four years and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r169",
      "r482",
      "r485",
      "r676"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1 to 5 years",
        "label": "Later than one year and not later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r268",
      "r481",
      "r485"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In the second year [Member]",
        "label": "Later than one year and not later than two years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than two years."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r169",
      "r482",
      "r485",
      "r676"
     ]
    },
    "ifrs-full_LaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanOneYearMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "After one year\t[Member]",
        "label": "Later than one year [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable",
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Carrying amount at January 1",
        "periodEndLabel": "Carrying amount at December 31",
        "terseLabel": "Lease liabilities",
        "label": "Lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ifrs-full_LeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Lease Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_LeaseLiabilitiesCurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LeaseLiabilitiesCurrentMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Liabilities, Current [Member]",
        "label": "Lease Liabilities Current Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities [Member]",
        "label": "Lease liabilities [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r461",
      "r464"
     ]
    },
    "aapg_LeaseLiabilitiesNonCurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LeaseLiabilitiesNonCurrentMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Liabilities, Non-current [Member]",
        "label": "Lease Liabilities Non Current Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_LeaseLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LeaseLiabilityMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities [Member]",
        "label": "Lease Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_LeaseTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LeaseTerms",
     "presentation": [
      "http://www.ascentage.cn.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease terms",
        "documentation": "Lease terms.",
        "label": "Lease Terms"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements [Member]",
        "label": "Leasehold improvements [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "aapg_LeaseholdLandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LeaseholdLandMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold land [Member]",
        "label": "Leasehold Land Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_LeasesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LeasesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_LeasesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LeasesLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_LeasesScheduleofRightofUseAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LeasesScheduleofRightofUseAssetsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases - Schedule of Right-of-Use Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "ifrs-full_Level1OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Level1OfFairValueHierarchyMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1 [Member]",
        "label": "Level 1 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r63",
      "r66",
      "r132",
      "r324",
      "r369"
     ]
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Level2OfFairValueHierarchyMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2 [Member]",
        "label": "Level 2 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r66",
      "r132",
      "r324",
      "r369"
     ]
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Level3OfFairValueHierarchyMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3 [Member]",
        "label": "Level 3 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r66",
      "r132",
      "r324",
      "r369"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r132",
      "r369"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r132",
      "r369"
     ]
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES",
        "label": "Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r218",
      "r221",
      "r368",
      "r369",
      "r405"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Ending balance (in Dollars)",
        "label": "Liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r284",
      "r462"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r462"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r284",
      "r462"
     ]
    },
    "ifrs-full_LicencesAndFranchisesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LicencesAndFranchisesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License [Member]",
        "label": "Licences and franchises [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity and the right to operate a business using the name, merchandise, services, methodologies, promotional support, marketing and supplies granted by another entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "ifrs-full_LicencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LicencesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License [Member]",
        "label": "Licences [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "ifrs-full_LiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiquidityRiskMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquidity Risk [Member]",
        "label": "Liquidity risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r479"
     ]
    },
    "aapg_LiquidityRiskPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LiquidityRiskPercentage",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquidity risk percentage",
        "documentation": "Liquidity risk percentage.",
        "label": "Liquidity Risk Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ListedEquityInvestmentsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ListedEquityInvestmentsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Listed equity investments, at fair value",
        "documentation": "Listed equity investments, at fair value.",
        "label": "Listed Equity Investments At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ListingExpensePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ListingExpensePaid",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Listing expense paid",
        "documentation": "Listing expense paid.",
        "label": "Listing Expense Paid"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_LloanPrimeRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LloanPrimeRateMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lioan Prime Rate [Member]",
        "label": "Lloan Prime Rate Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_LongtermAdvancesRecognizedFromCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LongtermAdvancesRecognizedFromCustomersMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term advances recognized from customers [Member]",
        "label": "Longterm Advances Recognized From Customers Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LongtermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LongtermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Non-current portion of interest-bearing bank and other borrowings (other than lease liabilities)",
        "terseLabel": "Non-current borrowings",
        "label": "Non-current portion of non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_LongtermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LongtermDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposit",
        "label": "Long-term deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of long-term deposits held by the entity."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_LossBeforeTaxArrivedCharingOrCrediting": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LossBeforeTaxArrivedCharingOrCrediting",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "documentation": "It represents total amount of expenses before tax.",
        "label": "Loss Before Tax Arrived Charing Or Crediting"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Losses Available for Offsetting Against Future Taxable Profits [Member]",
        "label": "Losses Available For Offsetting Against Future Taxable Profits Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LossesOnDisposalsOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable": {
       "parentTag": "ifrs-full_OtherExpenseByNature",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on disposal of items of property, plant and equipment",
        "label": "Losses on disposals of property, plant and equipment, operating"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "aapg_LowerTaxRateForASpecificEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "LowerTaxRateForASpecificEntity",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lower tax rate for a specific entity",
        "documentation": "Lower tax rate for a specific entity",
        "label": "Lower Tax Rate For ASpecific Entity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorComponentsOfTaxExpenseIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major customers [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_MajorCustomersDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorCustomersDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major customers [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "aapg_MarketEquityIndex": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "MarketEquityIndex",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market equity index",
        "documentation": "Market equity index.",
        "label": "Market Equity Index"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable",
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable",
      "http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r156",
      "r157",
      "r160",
      "r161",
      "r163",
      "r169",
      "r193",
      "r204",
      "r249",
      "r256",
      "r266",
      "r270",
      "r360",
      "r409",
      "r447",
      "r482"
     ]
    },
    "ifrs-full_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable",
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable",
      "http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r156",
      "r157",
      "r160",
      "r161",
      "r163",
      "r169",
      "r193",
      "r249",
      "r256",
      "r266",
      "r270",
      "r360",
      "r409",
      "r447",
      "r482",
      "r484"
     ]
    },
    "aapg_MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "15 May 2019\u201315 May 2029 [Member]",
        "label": "May Fifteen Two Thousand Ninteen May Fifteen Two Thousand Twenty Nine Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ifrs-full_MeasurementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MeasurementAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r83",
      "r131",
      "r339",
      "r368"
     ]
    },
    "ifrs-full_MeasurementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MeasurementDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r83",
      "r131",
      "r339",
      "r368"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "aapg_MonetaryAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "MonetaryAssetsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monetary Assets [Member]",
        "label": "Monetary Assets Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MotorVehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MotorVehiclesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Motor vehicles [Member]",
        "label": "Motor vehicles [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing self-propelled ground vehicles used in the entity's operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "aapg_MovementsInGovernmentGrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "MovementsInGovernmentGrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Movements in Government Grants [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "ifrs-full_NetAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetAssetsLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net assets",
        "label": "Assets (liabilities)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of liabilities."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r676"
     ]
    },
    "ifrs-full_NetDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable": {
       "parentTag": "ifrs-full_DeferredTaxLiabilityAsset",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net debt",
        "label": "Net debt"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of net debt of the entity."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_NetDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable",
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning",
        "periodEndLabel": "Balance at ending",
        "terseLabel": "Balance at ending (in Dollars)",
        "verboseLabel": "Deferred tax assets",
        "label": "Net deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDeferredTaxAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Analysis of the Deferred Tax Balances of the Group for Financial Reporting Purposes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning",
        "periodEndLabel": "Balance at ending",
        "terseLabel": "Balance at ending (in Dollars)",
        "label": "Net deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_NetForeignExchangeGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetForeignExchangeGain",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange gain, net",
        "label": "Net foreign exchange gain"
       }
      }
     },
     "auth_ref": [
      "r656",
      "r679"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NetOfLossAllowanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NetOfLossAllowanceLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Based on the Invoice Date and Net of Loss Allowance [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NetOperatingLossExpired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NetOperatingLossExpired",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax loss expired",
        "documentation": "The amount of net operating loss (NOL) expired .",
        "label": "Net Operating Loss Expired"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r558",
      "r559",
      "r560",
      "r561"
     ]
    },
    "ifrs-full_NewIFRSsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NewIFRSsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New IFRSs [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r291"
     ]
    },
    "aapg_NewProvisionsReturn": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NewProvisionsReturn",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision to return",
        "documentation": "The amount of provision to return.",
        "label": "New Provisions Return"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non cash addition for right of use assets and lease liabilities",
        "documentation": "Non cash addition for right of use assets and lease liabilities.",
        "label": "Non Cash Addition For Increase Decreasein Right Of Use Assets And Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NonCashAdditionsToPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NonCashAdditionsToPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash additions to property, plant and equipment",
        "documentation": "Non-cash additions to property, plant and equipment.",
        "label": "Non Cash Additions To Property Plant And Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NonCashDisposals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NonCashDisposals",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash disposals",
        "documentation": "Non-cash disposals.",
        "label": "Non Cash Disposals"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NonExecutiveDirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NonExecutiveDirectorMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Executive Director [Member]",
        "label": "Non Executive Director Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r542",
      "r553",
      "r569",
      "r595",
      "r604"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r295"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r295"
     ]
    },
    "aapg_NoncashAdditionsToIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NoncashAdditionsToIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash additions to intangible assets",
        "documentation": "Non-cash additions to intangible assets.",
        "label": "Noncash Additions To Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "terseLabel": "Non-controlling interests",
        "verboseLabel": "Balance (in Dollars)",
        "label": "Non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r108",
      "r111",
      "r403"
     ]
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncontrollingInterestsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non- controlling interests",
        "label": "Non-controlling interests [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_AssetsLessCurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_AssetsLessCurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "label": "Non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r117",
      "r410",
      "r467"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Non-Current Assets [Abstract]",
        "terseLabel": "NON-CURRENT ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Non-current contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current contract liabilities. [Refer: Contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ifrs-full_NoncurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total non-current assets",
        "verboseLabel": "Financial assets included in other non-current assets",
        "label": "Non-current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at fair value through profit or loss (\u201cFVTPL\u201d)",
        "verboseLabel": "Total",
        "netLabel": "Financial assets at FVTPL",
        "label": "Non-current financial assets at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r208",
      "r356"
     ]
    },
    "ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAssetsMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Non-current financial liabilities at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities measured at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r209",
      "r357"
     ]
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current portion",
        "verboseLabel": "Financial liabilities included in other payables and accruals",
        "label": "Non-current lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "label": "Non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r119",
      "r411",
      "r467"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NON-CURRENT LIABILITIES",
        "label": "Non-current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentPortionOfOtherNoncurrentBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term payables (current and non-current portion)",
        "label": "Non-current portion of other non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current other borrowings. [Refer: Other borrowings]"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_NoncurrentPrepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentPrepayments",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment for property, plant and equipment",
        "label": "Non-current prepayments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current prepayments. [Refer: Prepayments]"
       }
      }
     },
     "auth_ref": [
      "r496",
      "r504"
     ]
    },
    "ifrs-full_NoncurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "label": "Trade and other non-current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]"
       }
      }
     },
     "auth_ref": [
      "r379",
      "r397",
      "r413"
     ]
    },
    "ifrs-full_NoncurrentValueAddedTaxReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentValueAddedTaxReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value added tax recoverable",
        "label": "Non-current value added tax receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current value added tax receivables. [Refer: Value added tax receivables]"
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonderivativeFinancialLiabilitiesUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable": {
       "parentTag": "ifrs-full_NetDebt",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable",
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities included in other payables and accruals",
        "label": "Non-derivative financial liabilities, undiscounted cash flows"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r364"
     ]
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotLaterThanOneYearMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable",
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Within one year [Member]",
        "verboseLabel": "Less than 1 year",
        "label": "Not later than one year [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r169",
      "r263",
      "r267",
      "r407",
      "r482",
      "r485"
     ]
    },
    "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotesAndOtherExplanatoryInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Judgements and Estimates [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NotesToTheConsolidatedStatementsOfCashFlowsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NotesToTheConsolidatedStatementsOfCashFlowsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes to the Consolidated Statements of Cash Flows [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NotestotheConsolidatedStatementsofCashFlowsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NotestotheConsolidatedStatementsofCashFlowsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes to the Consolidated Statements of Cash Flows (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NotestotheConsolidatedStatementsofCashFlowsScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes to the Consolidated Statements of Cash Flows - Schedule of Changes in Liabilities Arising from Financing Activities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_NumberOfGrantees": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NumberOfGrantees",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of grantees",
        "documentation": "Number of grantees.",
        "label": "Number Of Grantees"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of RSUs, Granted during the year",
        "verboseLabel": "RSU granted shares",
        "netLabel": "Number of RSU",
        "label": "Number of other equity instruments granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r668"
     ]
    },
    "aapg_NumberOfNewlyIssuedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NumberOfNewlyIssuedShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of newly issued shares (in Shares)",
        "documentation": "Number of newly issued shares.",
        "label": "Number Of Newly Issued Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised shares",
        "label": "Number of other equity instruments exercisable in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of RSUs, Vested during the year",
        "label": "Number of other equity instruments exercised or vested in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of RSUs, Forfeited during the year",
        "label": "Number of other equity instruments forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of RSUs, Outstanding, beginning balance",
        "periodEndLabel": "Number of RSUs, Outstanding, ending balance",
        "label": "Number of other equity instruments outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable",
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of options, Outstanding as of beginning",
        "periodEndLabel": "Number of options, Outstanding as of ending",
        "terseLabel": "Number of options",
        "label": "Number of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r177",
      "r179",
      "r344",
      "r348"
     ]
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of options, Exercised during the year",
        "terseLabel": "Number of share options exercised in share-based payment arrangement",
        "label": "Number of share options exercised in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r347"
     ]
    },
    "aapg_NumberOfShareOptionsExpenseInSharebasedPaymentArrangement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NumberOfShareOptionsExpenseInSharebasedPaymentArrangement",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share option expense",
        "documentation": "Number of share options expense in share-based payment arrangement.",
        "label": "Number Of Share Options Expense In Sharebased Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of options, Forfeited during the year",
        "label": "Number of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r346"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, Granted during the year",
        "verboseLabel": "Granted options shares",
        "label": "Number of share options granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r345"
     ]
    },
    "ifrs-full_NumberOfSharesAuthorised": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfSharesAuthorised",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares authorized (in Shares)",
        "label": "Number of shares authorised"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares authorised."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r371",
      "r416"
     ]
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ReservesDetails",
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable",
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in Shares)",
        "periodEndLabel": "Balance (in Shares)",
        "terseLabel": "Ordinary shares, shares issued (in Shares)",
        "verboseLabel": "Number of shares in issue, Ordinary shares of US$0.0001 each",
        "netLabel": "Balance (in Shares)",
        "label": "Shares issued",
        "totalLabel": "Newly issued shares (in Shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares outstanding (in Shares)",
        "label": "Number of shares outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r274",
      "r373",
      "r418"
     ]
    },
    "aapg_NumberOfTreasuryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "NumberOfTreasuryShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury shares",
        "documentation": "Number of treasury shares.",
        "label": "Number Of Treasury Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and equipment [Member]",
        "label": "Office equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "ifrs-full_OnDemandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OnDemandMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "On demand",
        "label": "On demand [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an on demand time band."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "aapg_OneToThreeMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OneToThreeMonthsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1 to 3 months [Member]",
        "label": "One To Three Months Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Operating expenses",
        "label": "Operating expense, operating"
       }
      }
     },
     "auth_ref": [
      "r685"
     ]
    },
    "aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "\u200bSchedule of Non-Current Assets [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OperatingSegmentInformationScheduleofNonCurrentAssetsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segment Information - \u200bSchedule of Non-Current Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_OperatingSegmentInformationScheduleofRevenueDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OperatingSegmentInformationScheduleofRevenueDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segment Information - \u200bSchedule of Revenue (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue from Customers [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OperatingSegmentInformationScheduleofRevenuefromCustomersDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segment Information - Schedule of Revenue from Customers (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares [Member]",
        "label": "Ordinary shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable": {
       "parentTag": "ifrs-full_NetDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable",
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest-bearing bank and other borrowings (excluding lease liabilities)",
        "verboseLabel": "Interest-bearing bank and other borrowings",
        "label": "Other borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of contingent consideration related to acquisition of a subsidiary",
        "label": "Other cash payments to acquire interests in joint ventures, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to acquire interests in joint ventures (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r454"
     ]
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "OTHER COMPREHENSIVE INCOME/(LOSS) FOR THE YEAR, NET OF TAX",
        "terseLabel": "TOTAL COMPREHENSIVE INCOME FOR THE YEAR",
        "label": "Other comprehensive income"
       }
      }
     },
     "auth_ref": [
      "r122",
      "r387",
      "r424",
      "r434"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange differences on translation of foreign operations",
        "label": "Other comprehensive income, before tax, exchange differences on translation of foreign operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, before tax, after reclassification adjustments, related to exchange differences on translation of financial statements of foreign operations. [Refer: Other comprehensive income, before tax]"
       }
      }
     },
     "auth_ref": [
      "r412",
      "r435"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange differences on translation of the Company",
        "label": "Other comprehensive income, before tax, exchange differences on translation, other than translation of foreign operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, before tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income, before tax]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "aapg_OtherComprehensiveIncomeForTheYearAbstract2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OtherComprehensiveIncomeForTheYearAbstract2",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income for the year:",
        "label": "Other Comprehensive Income For The Year Abstract2"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange differences on translation of operations",
        "verboseLabel": "Exchange differences on translation",
        "netLabel": "Exchange differences on translation of the Company",
        "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r412",
      "r434"
     ]
    },
    "ifrs-full_OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities - current portion",
        "label": "Other current borrowings and current portion of other non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current other borrowings and the current portion of non-current other borrowings. [Refer: Other borrowings]"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_OtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other payables and accruals",
        "verboseLabel": "Total",
        "label": "Other current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_OtherEmployeeBenefitContributionPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OtherEmployeeBenefitContributionPercentage",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee contribution percentage",
        "documentation": "Percentage of Other Employee Benefit Contribution.",
        "label": "Other Employee Benefit Contribution Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherExpenseByNature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherExpenseByNature",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 7.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "negatedLabel": "Other expenses",
        "negatedTerseLabel": "Other expenses",
        "label": "Other expenses, by nature"
       }
      }
     },
     "auth_ref": [
      "r439",
      "r499"
     ]
    },
    "ifrs-full_OtherGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others",
        "verboseLabel": "Other income and gains",
        "label": "Other gains (losses)"
       }
      }
     },
     "auth_ref": [
      "r672",
      "r673"
     ]
    },
    "ifrs-full_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income and gains",
        "terseLabel": "Other income and gains",
        "label": "Other income"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r499",
      "r500"
     ]
    },
    "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable": {
       "parentTag": "aapg_CashInflowOutflowForLease",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Within financing activities",
        "label": "Other inflows (outflows) of cash, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable": {
       "parentTag": "aapg_CashInflowOutflowForLease",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCashOutflowforLeasesIncludedIntheStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Within operating activities",
        "label": "Other inflows (outflows) of cash, classified as operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "Inflows (outflows) of cash, classified as operating activities, that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "aapg_OtherIntangibleAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OtherIntangibleAssetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Intangible Asset [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OtherIntangibleAssetScheduleofOtherIntangibleAssetDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Intangible Asset - Schedule of Other Intangible Asset (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangible assets",
        "label": "Other intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "aapg_OtherNonCurrentLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OtherNonCurrentLiabilityMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities [Member]",
        "label": "Other Non Current Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 8.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofOtherNonCurrentAssetsTable",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Other non-current assets",
        "verboseLabel": "Other non-current Asset",
        "label": "Other non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_OtherNoncurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets included in other non-current assets",
        "verboseLabel": "Financial assets included in other non-current assets - Normal",
        "label": "Other non-current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]"
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "ifrs-full_OtherNoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other non-current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r124",
      "r401"
     ]
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ifrs-full_OtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable": {
       "parentTag": "ifrs-full_NetDebt",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable",
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherPayablesandAccrualsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other payables",
        "verboseLabel": "Other non-current liabilities",
        "netLabel": "Long-term payables",
        "label": "Other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_OtherPayablesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OtherPayablesAndAccruals",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable": {
       "parentTag": "aapg_OutstandingBalanceWithRelatedParty",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other payables and accruals",
        "documentation": "The amount of other payables and accruals.",
        "label": "Other Payables And Accruals"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ifrs-full_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r504"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "ifrs-full_OtherReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherReserves",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital and reserves",
        "label": "Other reserves"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r498",
      "r506"
     ]
    },
    "aapg_OtherUnlistedInvestmentsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OtherUnlistedInvestmentsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofFinancialAssetsatFairValuethroughProfitorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other unlisted investments, at fair value",
        "documentation": "Other unlisted investments, at fair value.",
        "label": "Other Unlisted Investments At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_OthersExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OthersExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable": {
       "parentTag": "ifrs-full_OtherExpenseByNature",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others",
        "documentation": "Represents the amount of others expenses.",
        "label": "Others Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_OthersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OthersMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable",
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable",
      "http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others",
        "verboseLabel": "Others [Member]",
        "label": "Others Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r540",
      "r551",
      "r567",
      "r602"
     ]
    },
    "aapg_OutstandingBalanceOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OutstandingBalanceOtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable": {
       "parentTag": "aapg_OutstandingBalanceWithRelatedParty",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "documentation": "Other non-current liabilities",
        "label": "Outstanding Balance Other Noncurrent Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_OutstandingBalanceWithRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "OutstandingBalanceWithRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOutstandingBalancewithRelatedPartyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Outstanding balance with related party",
        "documentation": "Outstanding balance with related party",
        "label": "Outstanding Balance With Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r543",
      "r554",
      "r570",
      "r605"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r543",
      "r554",
      "r570",
      "r605"
     ]
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.ascentage.cn.com/role/ReservesDetails",
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value (in Dollars per share)",
        "verboseLabel": "Share capital, Ordinary shares, par value",
        "netLabel": "Price per shares (in Dollars per share)",
        "label": "Par value per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r372",
      "r417"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ParentMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofCashFlowsTable",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "verboseLabel": "Parent [Member]",
        "netLabel": "Parent [member]",
        "label": "Parent [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an entity that controls one or more entities."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r318"
     ]
    },
    "aapg_PatentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PatentMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patent [Member]",
        "label": "Patent Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal portion of lease payments",
        "label": "Payments of lease liabilities, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsToAcquireOrRedeemEntitysShares",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury share purchases",
        "label": "Payments to acquire or redeem entity's shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to acquire or redeem entity's shares."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "aapg_PaymentsofLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PaymentsofLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments",
        "documentation": "Amount of payment of lease liabilities.",
        "label": "Paymentsof Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "aapg_Penalty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "Penalty",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable": {
       "parentTag": "ifrs-full_OtherExpenseByNature",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Penalty",
        "documentation": "Represents the amount of penalty.",
        "label": "Penalty"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PenaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PenaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease payments not included in the measurement of lease liabilities",
        "documentation": "Represent the amount of penalty.",
        "label": "Penalty Expense"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_Penaltys": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "Penaltys",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Penalty",
        "documentation": "It represents amount of penalty to expenses.",
        "label": "Penaltys"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "aapg_PercentageOfConditionalShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PercentageOfConditionalShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "% of conditional shares",
        "documentation": "Represent the percentage of conditional shares.",
        "label": "Percentage Of Conditional Shares"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PercentageOfEquityInterestsAttributableToTheCompanyDirect": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PercentageOfEquityInterestsAttributableToTheCompanyDirect",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of equity interests attributable to the Company Direct",
        "documentation": "Percentage of equity interests attributable to the company direct.",
        "label": "Percentage Of Equity Interests Attributable To The Company Direct"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PercentageOfExceedShareCapital": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PercentageOfExceedShareCapital",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exceed share capital",
        "documentation": "Percentage of exceed share capital",
        "label": "Percentage Of Exceed Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PercentageOfVestedConditionalShares": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PercentageOfVestedConditionalShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "% of vested conditional shares",
        "verboseLabel": "percentage of vested",
        "documentation": "Represent the percentage of vested conditional shares.",
        "label": "Percentage Of Vested Conditional Shares"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PercentageOfVestingRequirementsForSharebasedPaymentArrangement": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PercentageOfVestingRequirementsForSharebasedPaymentArrangement",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of vesting percentage",
        "documentation": "Percentage of vesting requirements for share-based payment arrangement.",
        "label": "Percentage Of Vesting Requirements For Sharebased Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity investment percentage",
        "label": "Percentage of voting equity interests acquired"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r351"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PledgeOfAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PledgeOfAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pledge of Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "aapg_PortionClassifiedAsCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PortionClassifiedAsCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion classified as current liabilities (note 26)",
        "documentation": "The amunt of portion classified as current liabilities.",
        "label": "Portion Classified As Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "aapg_PostIPOOptionSchemeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PostIPOOptionSchemeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Post-IPO Option Scheme [Member]",
        "label": "Post IPOOption Scheme Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PostemploymentBenefitExpenseDefinedContributionPlans",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension scheme contributions (defined contribution scheme)",
        "label": "Post-employment benefit expense, defined contribution plans"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r310"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "aapg_PreIPOShareOptionExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PreIPOShareOptionExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-IPO share option expenses",
        "documentation": "Represent the amount of pre-ipo share option expenses.",
        "label": "Pre IPOShare Option Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PreIPOShareOptionSchemeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PreIPOShareOptionSchemeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-IPO Share Option Scheme [Member]",
        "label": "Pre IPOShare Option Scheme Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PreIPOShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PreIPOShareOptionsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-IPO Share Options [Member]",
        "label": "Pre IPOShare Options Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PreferentialRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PreferentialRate",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferential tax rate",
        "documentation": "Preferential rate.",
        "label": "Preferential Rate"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PrepaidListingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PrepaidListingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid listing expense",
        "documentation": "Prepaid listing expense.",
        "label": "Prepaid Listing Expense"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PrepaymentForTreasurySharePurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PrepaymentForTreasurySharePurchaseFees",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment for treasury share purchase fees",
        "documentation": "The amount of prepayment for treasury share purchase fees.",
        "label": "Prepayment For Treasury Share Purchase Fees"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Prepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Prepayments",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other prepayments",
        "label": "Prepayments"
       }
      },
      "en": {
       "role": {
        "documentation": "Receivables that represent amounts paid for goods and services before they have been delivered."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r504"
     ]
    },
    "ifrs-full_PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PrepaymentsAndAccruedIncomeOtherThanContractAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments, Other Receivables and Other Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PrepaymentsForClinicalTrialExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PrepaymentsForClinicalTrialExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments for clinical trial expenses",
        "documentation": "The amount of prepayments for clinical trial expenses.",
        "label": "Prepayments For Clinical Trial Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PresentationOfLeasesForLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PresentationOfLeasesForLesseeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PrincipalActivities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PrincipalActivities",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal activities",
        "documentation": "Principal activities.",
        "label": "Principal Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PrincipalPlaceOfBusinessOfSubsidiary",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable",
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal business",
        "verboseLabel": "Place of registration and business",
        "label": "Principal place of business of subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The principal place of business of a subsidiary. [Refer: Principal place of business; Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r52",
      "r109",
      "r112"
     ]
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from bank loans",
        "label": "Proceeds from borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromContributionsOfNoncontrollingInterests",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital contribution from non-controlling shareholders of a subsidiary",
        "label": "Proceeds from contributions of non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from proceeds from contributions of non-controlling interests. [Refer: Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r662"
     ]
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromExerciseOfOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of share options",
        "label": "Proceeds from exercise of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r662"
     ]
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issue of shares",
        "label": "Proceeds from issuing shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from disposal of property, plant and equipment",
        "label": "Proceeds from sales of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProductsAndServicesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r470",
      "r488"
     ]
    },
    "ifrs-full_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r470",
      "r488"
     ]
    },
    "aapg_ProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ProductsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Products",
        "verboseLabel": "Sales of products [Member]",
        "label": "Products Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatementAlt0": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedComprehensiveIncome",
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "LOSS FOR THE YEAR",
        "terseLabel": "LOSS FOR THE YEAR",
        "verboseLabel": "Loss for the year",
        "label": "Profit (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r107",
      "r218",
      "r220",
      "r321",
      "r342",
      "r386",
      "r423",
      "r467",
      "r475"
     ]
    },
    "ifrs-full_ProfitLossAttributableToAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Attributable to:",
        "label": "Profit (loss), attributable to [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatementAlt0": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interests",
        "label": "Profit (loss), attributable to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r110",
      "r426"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatementAlt0": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofBasicLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary equity holders of the Company",
        "verboseLabel": "Loss attributable to ordinary equity holders of the parent, used in the basic loss per share calculation",
        "label": "Profit (loss), attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofCondensedStatementsofComprehensiveIncomeTable",
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "LOSS BEFORE TAX",
        "terseLabel": "Loss before tax",
        "label": "Profit (loss) before tax"
       }
      }
     },
     "auth_ref": [
      "r189",
      "r486",
      "r487",
      "r499",
      "r500"
     ]
    },
    "aapg_PropertyAndEquipmentCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PropertyAndEquipmentCost",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost",
        "documentation": "Amount of property and equipment cost.",
        "label": "Property And Equipment Cost"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_PropertyAndEquipmentNetOfAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PropertyAndEquipmentNetOfAccumulatedDepreciation",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "documentation": "Amount net of accumulated depreciation.",
        "label": "Property And Equipment Net Of Accumulated Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "verboseLabel": "Net carrying amount",
        "netLabel": "Net carrying amount in US$ (in Dollars)",
        "label": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r308",
      "r393"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment including right-of-use assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment including right-of-use assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of asset representing property, plant and equipment including right-of-use assets whose underlying assets would be presented as property, plant and equipment if they were owned. [Refer: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "aapg_PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProportionOfOwnershipInterestInJointVenture": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInJointVenture",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of ownership interest",
        "label": "Proportion of ownership interest in joint venture"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r53",
      "r114"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable",
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of equity interests attributable to the Company Indirect",
        "verboseLabel": "Gearing ratio",
        "label": "Proportion of ownership interest in subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r53",
      "r113"
     ]
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of intangible assets",
        "label": "Purchase of intangible assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property, plant and equipment",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "aapg_RSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RSUMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU [Member]",
        "label": "RSUMember"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_RSUsGrantedFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RSUsGrantedFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs granted fair value",
        "documentation": "RSUs granted fair value.",
        "label": "RSUs Granted Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesDetails",
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails",
      "http://www.ascentage.cn.com/role/LeasesDetails",
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable",
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r135",
      "r163",
      "r179",
      "r285",
      "r468",
      "r469",
      "r669"
     ]
    },
    "ifrs-full_RangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesDetails",
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails",
      "http://www.ascentage.cn.com/role/LeasesDetails",
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable",
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r135",
      "r163",
      "r179",
      "r285",
      "r468",
      "r469",
      "r669"
     ]
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable",
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Range [domain]]"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ifrs-full_ReceivablesDueFromAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReceivablesDueFromAssociates",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments, other receivables and other assets",
        "label": "Receivables due from associates"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of receivables due from associates. [Refer: Total for all associates [member]]"
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofForeignCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase/(decrease) in other comprehensive income (without tax)",
        "label": "Reclassification adjustments on exchange differences on translation of foreign operations, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of reclassification adjustments related to exchange differences when the financial statements of foreign operations are translated, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r30",
      "r436"
     ]
    },
    "aapg_RecognizedAsIncomeDuringTheYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RecognizedAsIncomeDuringTheYear",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinGovernmentGrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Received during the year",
        "documentation": "Represent the amount of recognized as income during the year.",
        "label": "Recognized As Income During The Year"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation between the Income Tax Expense/(Credit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r535",
      "r546",
      "r562",
      "r597"
     ]
    },
    "aapg_RegisteredShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RegisteredShareCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofGroupsPrincipalJointVentureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registered share capital",
        "documentation": "Registered share capital.",
        "label": "Registered Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "ifrs-full_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_RelatedPartyTransactionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RelatedPartyTransactionsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RelatedPartyTransactionsScheduleofTransactionwithRelatedPartyDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofTransactionwithRelatedPartyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions - Schedule of Transaction with Related Party (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RentalIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RentalIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rental income",
        "label": "Rental income, operating"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of bank loans",
        "label": "Repayments of borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "aapg_RepurchaseOfOrdinaryShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RepurchaseOfOrdinaryShare",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase of ordinary shares (in Shares)",
        "documentation": "Repurchase of ordinary shares.",
        "label": "Repurchase Of Ordinary Share"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_RepurchaseOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RepurchaseOfOrdinaryShares",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase of ordinary shares",
        "documentation": "Represent the amount of repurchase of ordinary shares.",
        "label": "Repurchase Of Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development expenses",
        "terseLabel": "Research and development costs",
        "label": "Research and development expense"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r335"
     ]
    },
    "aapg_ResearchAndDevelopmentSuperdeduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ResearchAndDevelopmentSuperdeduction",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development super-deduction",
        "documentation": "The amount of research and development super-deduction.",
        "label": "Research And Development Superdeduction"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange fluctuation reserve",
        "label": "Reserve of exchange differences on translation"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r32",
      "r313"
     ]
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange fluctuation reserve",
        "verboseLabel": "Exchange fluctuation reserve [Member]",
        "label": "Reserve of exchange differences on translation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r32",
      "r313",
      "r501"
     ]
    },
    "aapg_ReservesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ReservesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ReservesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserves (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ReservesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ReservesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ReservesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reserves [Member]",
        "label": "Reserves Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RestatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RestatedMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restated [Member]",
        "label": "Currently stated [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the information currently stated in the financial statements. It also represents the standard value for the 'Retrospective application and retrospective restatement' and 'Departure from requirement of IFRS' axes if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r101",
      "r103",
      "r162",
      "r288",
      "r290",
      "r293",
      "r385",
      "r678"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r248"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r536",
      "r547",
      "r563",
      "r598"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r537",
      "r548",
      "r564",
      "r599"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r544",
      "r555",
      "r571",
      "r606"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r248"
     ]
    },
    "ifrs-full_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashAndBankBalancesAtCentralBanks",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable": {
       "parentTag": "ifrs-full_NetDebt",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow",
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable",
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted bank balances",
        "verboseLabel": "Restricted cash",
        "negatedLabel": "Less: Cash and bank balances",
        "label": "Restricted cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_RestrictedShareUnitExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RestrictedShareUnitExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU expenses",
        "documentation": "Represent the amount of restricted share unit expenses.",
        "label": "Restricted Share Unit Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_RestrictedShareUnitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RestrictedShareUnitMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Share Unit [Member]",
        "label": "Restricted Share Unit Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RestrictedShareUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RestrictedShareUnitsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ReservesDetails",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU Schemes [Member]",
        "verboseLabel": "Restricted share units [member]",
        "label": "Restricted share units [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for restricted share units."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "Retained earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r506",
      "r507"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "verboseLabel": "Accumulated losses [Member]",
        "label": "Retained earnings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r501"
     ]
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ContractLiabilitiesDetails",
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable",
      "http://www.ascentage.cn.com/role/ScheduleofRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total revenue",
        "verboseLabel": "Disaggregated revenue",
        "netLabel": "Revenue",
        "label": "Revenue"
       }
      }
     },
     "auth_ref": [
      "r121",
      "r189",
      "r214",
      "r219",
      "r224",
      "r225",
      "r227",
      "r430",
      "r467",
      "r499",
      "r500"
     ]
    },
    "ifrs-full_RevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueAbstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement",
      "http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUE",
        "verboseLabel": "Amounts expected to be recognized as revenue:",
        "label": "Revenue [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromContractsWithCustomers",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRevenuefromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from customers",
        "label": "Revenue from contracts with customers"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138",
      "r250"
     ]
    },
    "ifrs-full_RevenueFromGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromGovernmentGrants",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable": {
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable",
      "http://www.ascentage.cn.com/role/ScheduleofOtherIncomeandGainsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants related to income",
        "negatedLabel": "Government grants related to income",
        "label": "Income from government grants, operating"
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RevenueOtherIncomeandGainsScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Other Income and Gains - Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RevenueOtherIncomeandGainsScheduleofContractLiabilitiesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Other Income and Gains - \u200bSchedule of Contract Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RevenueOtherIncomeandGainsScheduleofDisaggregatedRevenueDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Other Income and Gains - \u200bSchedule of Disaggregated Revenue (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercialization rights income",
        "label": "Revenue that was included in contract liability balance at beginning of period"
       }
      }
     },
     "auth_ref": [
      "r141",
      "r253"
     ]
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Carrying amount of beginning of year",
        "periodEndLabel": "Carrying amount of end of year",
        "terseLabel": "Right-of-use assets",
        "label": "Right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r154",
      "r261"
     ]
    },
    "ifrs-full_RightofuseAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RightofuseAssetsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets [member]",
        "verboseLabel": "Right of Use Assets [Member]",
        "label": "Right-of-use assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "aapg_RightofuseAssetsOfEstimatedUsefulLives": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "RightofuseAssetsOfEstimatedUsefulLives",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets of estimated useful lives",
        "documentation": "Right-of-use assets of estimated useful lives.",
        "label": "Rightofuse Assets Of Estimated Useful Lives"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "aapg_ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfAmountsOfTransactionPricesAllocatedToTheRemainingPerformanceObligationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Amounts of Transaction Prices Allocated to the Remaining Performance Obligations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfAssetsMeasuredAtFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfAssetsMeasuredAtFairValueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Assets Measured At Fair Value Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Based On The Invoice Date And Net Of Loss Allowance Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/TradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Based on the Invoice Date and Net of Loss Allowance",
        "documentation": "The entire disclosure for based on the invoice date and net of loss allowance.",
        "label": "Schedule Of Based On The Invoice Date And Net Of Loss Allowance Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCapitalManagementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCapitalManagementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Capital Management Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted Average Interest Rate for the Outstanding Short-Term Bank Loans",
        "documentation": "Disclosure of  carrying amounts of borrowings.",
        "label": "Schedule Of Carrying Amounts Of Borrowings Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCashAndBankBalancesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCashAndBankBalancesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Cash And Bank Balances Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCashAndBankBalancesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCashAndBankBalancesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/CashandBankBalancesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Bank Balances",
        "documentation": "Schedule of cash and bank balances explanatory.",
        "label": "Schedule Of Cash And Bank Balances Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCashAndBankBalancesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCashAndBankBalancesLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cash and Bank Balances [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCategoriesOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCategoriesOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Categories Of Financial Instruments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCategoriesOfFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCategoriesOfFinancialInstrumentsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Categories of Financial Instruments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In Liabilities Arising From Financing Activities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCompanySReservesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCompanySReservesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Company SReserves Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Statements of Financial Position",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r670"
     ]
    },
    "aapg_ScheduleOfCondensedCashFlowStatementsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCondensedCashFlowStatementsTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Condensed Statements of Cash Flows",
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.",
        "label": "Schedule Of Condensed Cash Flow Statements Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCondensedStatementsOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCondensedStatementsOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Condensed Statements Of Cash Flows Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfContractLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfContractLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Contract Liabilities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfCreditQualityAndMaximumExposureToCreditRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Credit Quality And Maximum Exposure To Credit Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfDeferredIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfDeferredIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfDeferredIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfDeferredIncomeTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Income",
        "documentation": "Tabular disclosure of schedule of deferred income.",
        "label": "Schedule Of Deferred Income Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfDeferredTaxLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfDeferredTaxLiabilitiesExplanatory",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Movements in Deferred Tax Liabilities and Assets",
        "documentation": "The entire disclosure for deferred tax liabilities.",
        "label": "Schedule Of Deferred Tax Liabilities Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfDisaggregatedRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfDisaggregatedRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Disaggregated Revenue Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfEquityPriceRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfEquityPriceRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Equity Price Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfEstimatedInterestBearingOfBorrowingsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofWeightedAverageInterestRatefortheOutstandingShortTermBankLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Estimated Interest-Bearing of Borrowings [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfExercisePricesAndExercisePeriodsOfShareOptionsOutstandingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Exercise Prices And Exercise Periods Of Share Options Outstanding Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfFairValuesOfShareOptionsGrantedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfFairValuesOfShareOptionsGrantedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values of share options granted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfFairValuesOfShareOptionsGrantedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfFairValuesOfShareOptionsGrantedTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of fair values of share options granted",
        "documentation": "Schedule of fair values of share options granted [Text Block]",
        "label": "Schedule Of Fair Values Of Share Options Granted Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfFairValuesOfTheEquityInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfFairValuesOfTheEquityInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Values Of The Equity Investments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfFinanceCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfFinanceCostsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finance Costs [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfFinancialAssetsAtFairValueThroughProfitOrLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Financial Assets at Fair Value through Profit or Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Instruments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfForeignCurrencyRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfForeignCurrencyRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Foreign Currency Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfGroupSPrincipalJointVentureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfGroupSPrincipalJointVentureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Group\u2019s Principal Joint Venture [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfGroupsPrincipalJointVentureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfGroupsPrincipalJointVentureTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Group\u2019s Principal Joint Venture",
        "documentation": "Schedule of Group\u2019s Principal Joint Venture.",
        "label": "Schedule Of Groups Principal Joint Venture Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Information of the Group\u2019s Joint Venture",
        "documentation": "Schedule of Information of the Group\u2019s Joint Venture.",
        "label": "Schedule Of Information Of The Groups Joint Venture Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfIntangibleAssetsAreAmortizedOnTheStraightLineBasisAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Intangible Assets Are Amortized On The Straight Line Basis Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfInterestBearingBankAndOtherBorrowingsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Interest Bearing Bank And Other Borrowings Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfInterestBearingBankAndOtherBorrowingsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Interest-Bearing Bank and Other Borrowings [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Interest-Bearing Bank and Other Borrowings",
        "documentation": "Schedule of Interest-Bearing Bank and Other Borrowings.",
        "label": "Schedule Of Interest Bearing Bank And Other Borrowings Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfInterestRateRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfInterestRateRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Interest Rate Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfInventoriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfInventoriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventories [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfInvestmentInAJointVentureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfInvestmentInAJointVentureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Investment in a Joint Venture [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfInvestmentInAJointVentureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfInvestmentInAJointVentureTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/InvestmentinaJointVentureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investment in a Joint Venture",
        "documentation": "Schedule of Investment in a Joint Venture.",
        "label": "Schedule Of Investment In AJoint Venture Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfIssuedAndFullyPaidAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfIssuedAndFullyPaidAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Issued And Fully Paid Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfLiquidityRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfLiquidityRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Liquidity Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfLossBeforeTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfLossBeforeTaxAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Loss Before Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfMovementsInDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfMovementsInDeferredTaxAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Movements In Deferred Tax Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfMovementsInDeferredTaxLiabilitiesAndAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Movements In Deferred Tax Liabilities And Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfNewAndRevisedIfrssAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfNewAndRevisedIfrssAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of New And Revised Ifrss Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfNonCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfNonCurrentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Non Current Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfOtherExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfOtherExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfOtherExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfOtherExpensesTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/OtherExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Expenses",
        "documentation": "The disclosure of the other expenses.",
        "label": "Schedule Of Other Expenses Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfOtherIntangibleAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfOtherIntangibleAssetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Intangible Asset Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfOtherIntangibleAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfOtherIntangibleAssetLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofOtherIntangibleAssetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Intangible Asset [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfOtherNonCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfOtherNonCurrentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Non-Current Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfOtherNonCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfOtherNonCurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/OtherNonCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Non-Current Assets",
        "documentation": "The entire disclosure of other non-current assets.",
        "label": "Schedule Of Other Non Current Assets Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfPrincipalSubsidiariesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfPrincipalSubsidiariesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Principal Subsidiaries Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfPropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property Plant And Equipment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfPropertyPlantAndEquipmentOfAnnualRatesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property Plant And Equipment Of Annual Rates Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfReservesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfReservesTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/CondensedFinancialInformationoftheCompanyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Company\u2019s Reserves",
        "documentation": "Tabular disclosure of reserves.",
        "label": "Schedule Of Reserves Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfRestrictedSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfRestrictedSharesOutstandingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Restricted Shares Outstanding Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Revenue Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfRevenueFromCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfRevenueFromCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Revenue From Customers Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfRightOfUseAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfRightOfUseAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Right Of Use Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfRightOfUseAssetsOfTheLeaseTermsAndTheEstimatedUsefulLivesOfTheAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Right Of Use Assets Of The Lease Terms And The Estimated Useful Lives Of The Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfShareCapitalAndTreasurySharesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfShareCapitalAndTreasurySharesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Capital And Treasury Shares Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfShareOptionsOutstandingUnderPreIpoShareOptionSchemeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Options Outstanding Under Pre Ipo Share Option Scheme Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfStatementsOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfStatementsOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Statements Of Financial Position Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfTheTradePayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfTheTradePayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Trade Payables Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfTheTradePayablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfTheTradePayablesLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of the Trade Payables [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfTradeReceivablesNetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfTradeReceivablesNetTableTextBlock",
     "presentation": [
      "http://www.ascentage.cn.com/role/TradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Trade Receivables, Net",
        "documentation": "The entire disclosure of trade receivables, net.",
        "label": "Schedule Of Trade Receivables Net Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfTransactionWithRelatedPartyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfTransactionWithRelatedPartyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Transaction With Related Party Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfUnlockingDateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfUnlockingDateAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Unlocking Date Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ScheduleOfWeightedAverageInterestRateForTheOutstandingShortTermBankLoansAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Weighted Average Interest Rate For The Outstanding Short Term Bank Loans Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_SecondAnniversaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SecondAnniversaryMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second Anniversary [Member]",
        "label": "Second Anniversary Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_SecuredBankBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SecuredBankBorrowingsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Bank Borrowings [Member]",
        "label": "Secured Bank Borrowings Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r510"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable",
      "http://www.ascentage.cn.com/role/ScheduleofRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247"
     ]
    },
    "ifrs-full_SegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r139",
      "r218",
      "r251",
      "r446",
      "r478"
     ]
    },
    "ifrs-full_SegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r139",
      "r223",
      "r251",
      "r446",
      "r478"
     ]
    },
    "ifrs-full_SellingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SellingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Selling and distribution expenses",
        "label": "Selling expenses, operating"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "aapg_SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "16 Sept 2019-16 Sept 2029 [Member]",
        "label": "September Sixteen Two Thousand Ninteen September Sixteen Two Thousand Twenty Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareBasedPaymentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareBasedPaymentsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareBasedPaymentsScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments - Schedule of Exercise Prices and Exercise Periods of Share Options Outstanding (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareBasedPaymentsScheduleofRestrictedSharesOutstandingDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments - Schedule of Restricted Shares Outstanding (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Options Outstanding [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareBasedPaymentsScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments - Schedule of Share Options Outstanding under Pre-IPO Share Option Scheme (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareBasedPaymentsScheduleofUnlockingDateDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareBasedPaymentsScheduleofUnlockingDateDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments - Schedule of Unlocking Date (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareCapitalMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable",
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Capital [Member]",
        "label": "Share Capital Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareCapitalandTreasurySharesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareCapitalandTreasurySharesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital and Treasury Shares (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareCapitalandTreasurySharesScheduleofIssuedandFullyPaidParentheticalsDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIssuedandFullyPaidTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital and Treasury Shares - Schedule of Issued and Fully Paid (Parentheticals) (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Capital and Treasury Shares [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareCapitalandTreasurySharesScheduleofShareCapitalandTreasurySharesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital and Treasury Shares - Schedule of Share Capital and Treasury Shares (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShareGrantExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareGrantExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share grant expense",
        "documentation": "Share grant expense.",
        "label": "Share Grant Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of profit/(loss) of a joint venture",
        "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method, investing"
       }
      }
     },
     "auth_ref": [
      "r216",
      "r222",
      "r432"
     ]
    },
    "ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of the joint venture\u2019s (loss)/gain for the year",
        "label": "Share of profit (loss) of joint ventures accounted for using equity method, investing"
       }
      }
     },
     "auth_ref": [
      "r685"
     ]
    },
    "ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInformationoftheGroupsJointVentureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of the joint venture\u2019s total comprehensive (loss)/gain for the year",
        "label": "Share of total comprehensive income of associates and joint ventures accounted for using equity method"
       }
      },
      "en": {
       "role": {
        "documentation": "The entity's share of the total comprehensive income of associates and joint ventures accounted for using the equity method. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Investments accounted for using equity method]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "aapg_ShareOptionSchemeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShareOptionSchemeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Option Scheme [Member]",
        "label": "Share Option Scheme Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SharePremium",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ReservesDetails",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share premium",
        "label": "Share premium"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r506"
     ]
    },
    "ifrs-full_SharePremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SharePremiumMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share premium",
        "label": "Share premium [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "aapg_SharebasedPaymentVestingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SharebasedPaymentVestingPeriod",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment vesting period",
        "documentation": "Share-based payment  vesting period.",
        "label": "Sharebased Payment Vesting Period"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_SharesConsiderationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SharesConsiderationAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total consideration shares (in Yuan Renminbi)",
        "documentation": "Shares consideration amount.",
        "label": "Shares Consideration Amount"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_SharesGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SharesGranted",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares granted (in Shares)",
        "documentation": "Shares Granted",
        "label": "Shares Granted"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued",
        "label": "Number of shares reserved for issue under options and contracts for sale of shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares reserved for issue under options and contracts for the sale of shares."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r374",
      "r419"
     ]
    },
    "aapg_ShortTermBorrowingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShortTermBorrowingMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Borrowing [Member]",
        "label": "Short Term Borrowing Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ShorttermAdvancesRecognizedFromCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ShorttermAdvancesRecognizedFromCustomersMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term advances recognized from customers [Member]",
        "label": "Shortterm Advances Recognized From Customers Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShorttermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current borrowings",
        "label": "Current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "aapg_SignificantAccountingJudgementsandEstimatesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SignificantAccountingJudgementsandEstimatesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Judgements and Estimates (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r54",
      "r128",
      "r365"
     ]
    },
    "aapg_SimplifiedApproachMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SimplifiedApproachMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Simplified approach [Member]",
        "label": "Simplified Approach Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "aapg_SpecialOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SpecialOptionsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Special Options [Member]",
        "label": "Special Options Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_Stage1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "Stage1Member",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stage 1 [Member]",
        "label": "Stage1 Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StageThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StageThreeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stage 3 [Member]",
        "label": "Stage Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StageTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StageTwoMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stage 2 [Member]",
        "label": "Stage Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable",
      "http://www.ascentage.cn.com/role/ScheduleofRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cash Outflow for Leases Included in the Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Condensed Statements of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StatutoryIncomeAndExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StatutoryIncomeAndExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Statutory income and expense",
        "documentation": "Statutory income and expense.",
        "label": "Statutory Income And Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r539",
      "r550",
      "r566",
      "r601"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockExchangeIndexShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockExchangeIndexShare",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "stock exchange index",
        "documentation": "The shares stock exchange index.",
        "label": "Stock Exchange Index Share"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital contribution from a non-controlling shareholder of a subsidiary",
        "documentation": "Represent the amount of capital contribution from a non-controlling shareholder of a subsidiary.",
        "label": "Stock Issued During Period Value Capital Contribution From ANoncontrolling Shareholder Of ASubsidiary"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockIssuedDuringPeriodValueEquitysettledBonus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockIssuedDuringPeriodValueEquitysettledBonus",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-settled bonus",
        "documentation": "Represent the amount of equity-settled bonus.",
        "label": "Stock Issued During Period Value Equitysettled Bonus"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of Pre-IPO share options",
        "documentation": "Represent the amount of exercise of pre-ipo share options.",
        "label": "Stock Issued During Period Value Exercise Of Pre IPOShare Options"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockIssuedDuringPeriodValuePreIPOShareOptionExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockIssuedDuringPeriodValuePreIPOShareOptionExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-IPO share option expenses",
        "documentation": "Represent the amount of pre-IPO share option expenses.",
        "label": "Stock Issued During Period Value Pre IPOShare Option Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU expenses",
        "documentation": "Represent the amount of restricted share unit (\u201cRSU\u201d) expenses.",
        "label": "Stock Issued During Period Value Restricted Share Unit RSUExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockIssuedDuringPeriodValueShareOptionExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockIssuedDuringPeriodValueShareOptionExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Post-IPO share option expenses",
        "documentation": "Amount of post-IPO share option expenses.",
        "label": "Stock Issued During Period Value Share Option Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockIssuedDuringPeriodValueVestingOfRSUs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockIssuedDuringPeriodValueVestingOfRSUs",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCompanysReservesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting of RSUs",
        "documentation": "Represent the amount of vesting of restricted share units (RSUs).",
        "label": "Stock Issued During Period Value Vesting Of RSUs"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting of RSUs",
        "documentation": "Represent the amount of vesting of restricted share units.",
        "label": "Stock Issued During Period Value Vesting Of Restricted Share Units"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockIssuedDuringPeriodValuesEquitysettledBonus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockIssuedDuringPeriodValuesEquitysettledBonus",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-settled bonus",
        "documentation": "Equity-settled bonus.",
        "label": "Stock Issued During Period Values Equitysettled Bonus"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_StockPurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "StockPurchasedDuringPeriodShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock purchased during period, shares",
        "documentation": "Number of shares that have been purchased during the period.",
        "label": "Stock Purchased During Period Shares"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_SubscriptionOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SubscriptionOfShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subscription of shares",
        "documentation": "Number of subscription of shares.",
        "label": "Subscription Of Shares"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_SuzhouAscentagePharmaCoLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SuzhouAscentagePharmaCoLtdMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Suzhou Ascentage Pharma Co., Ltd. (\u201cSuzhou Yasheng\u201d) [Member]",
        "label": "Suzhou Ascentage Pharma Co Ltd Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_SuzhouShengheInnovationWorksBiotechCoLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SuzhouShengheInnovationWorksBiotechCoLtdMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrincipalSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Suzhou Shenghe Innovation Works Biotech Co., Ltd. [Member]",
        "label": "Suzhou Shenghe Innovation Works Biotech Co Ltd Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_SuzhouYashengMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "SuzhouYashengMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Suzhou Yasheng [Member]",
        "label": "Suzhou Yasheng Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "aapg_TaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TaxCredits",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credits",
        "documentation": "Tax credits.",
        "label": "Tax Credits"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxEffectFromChangeInTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxEffectFromChangeInTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of tax rate changes on deferred taxes",
        "label": "Tax effect from change in tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r297"
     ]
    },
    "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Items not deductible for tax",
        "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r297"
     ]
    },
    "ifrs-full_TaxEffectOfTaxLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxEffectOfTaxLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable",
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax losses not recognized",
        "verboseLabel": "Tax losses",
        "label": "Tax effect of tax losses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r297"
     ]
    },
    "aapg_TaxesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TaxesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes [Member]",
        "label": "Taxes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable",
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r302"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofMovementsinDeferredTaxLiabilitiesandAssetsTable",
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r302"
     ]
    },
    "aapg_TermsOfLandLease": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TermsOfLandLease",
     "presentation": [
      "http://www.ascentage.cn.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Terms of land lease",
        "documentation": "Terms of land lease.",
        "label": "Terms Of Land Lease"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ThirdAnniversaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ThirdAnniversaryMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Anniversary [Member]",
        "label": "Third Anniversary Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_ThreeToSixMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "ThreeToSixMonthsMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "3 to 6 months [Member]",
        "label": "Three To Six Months Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashAndBankBalancesAtCentralBanks",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time deposits with original maturity of more than three months",
        "documentation": "Time deposits with original maturity of more than three months.",
        "label": "Time Deposits With Original Maturity Of More Than Three Months"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TimingOfTransferOfGoodsOrServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TimingOfTransferOfGoodsOrServicesAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of transfer of goods or services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r492"
     ]
    },
    "ifrs-full_TimingOfTransferOfGoodsOrServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TimingOfTransferOfGoodsOrServicesDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of transfer of goods or services [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all timings of the transfer of goods or services in contracts with customers. It also represents the standard value for the 'Timing of transfer of goods or services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r492"
     ]
    },
    "ifrs-full_TitleOfNewIFRS": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TitleOfNewIFRS",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofNewandRevisedIFRSsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New and revised IFRS codification, description",
        "label": "Title of new IFRS"
       }
      }
     },
     "auth_ref": [
      "r465",
      "r493"
     ]
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/AccountingPoliciesDetails",
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails",
      "http://www.ascentage.cn.com/role/LeasesDetails",
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofEquityPriceRiskTable",
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable",
      "http://www.ascentage.cn.com/role/ScheduleofInterestBearingBankandOtherBorrowingsTable",
      "http://www.ascentage.cn.com/role/ScheduleofPropertyPlantandEquipmentofAnnualRatesTable",
      "http://www.ascentage.cn.com/role/ScheduleofRightofUseassetsoftheLeaseTermsandtheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Top of range [member]",
        "verboseLabel": "Top of Range [Member]",
        "label": "Top of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r135",
      "r163",
      "r179",
      "r285",
      "r468",
      "r469",
      "r669"
     ]
    },
    "aapg_TotalAmountofRecognizedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TotalAmountofRecognizedInProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRecognizedinProfitorLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total amount recognized in profit or loss",
        "documentation": "Amount of recognized in profit or loss.",
        "label": "Total Amountof Recognized In Profit Or Loss"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Trade and other current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables",
        "label": "Current trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      }
     },
     "auth_ref": [
      "r503",
      "r683"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable",
      "http://www.ascentage.cn.com/role/ScheduleofTradeReceivablesNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables, net",
        "verboseLabel": "Total",
        "label": "Trade and other current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      }
     },
     "auth_ref": [
      "r379",
      "r397",
      "r413"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Trade Receivables, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherPayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Payables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable": {
       "parentTag": "ifrs-full_NetDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCapitalManagementTable",
      "http://www.ascentage.cn.com/role/ScheduleofCategoriesofFinancialInstrumentsTable",
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables",
        "label": "Trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business."
       }
      }
     },
     "auth_ref": [
      "r683"
     ]
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Receivables, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TradePayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TradePayablesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Payables [Member]",
        "label": "Trade Payables Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TradePayablesScheduleoftheTradePayablesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TradePayablesScheduleoftheTradePayablesDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Payables - Schedule of the Trade Payables (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable": {
       "parentTag": "ifrs-full_FinancialAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofCreditQualityandMaximumExposureToCreditRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "label": "Trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r504"
     ]
    },
    "aapg_TradeReceivables45To120DaysMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TradeReceivables45To120DaysMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "45 to 120 days [Member]",
        "label": "Trade Receivables45 To120 Days Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TradeReceivablesNetScheduleofBasedontheInvoiceDateandNetofLossAllowanceDetailsTable",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Receivables, Net - Schedule of Based on the Invoice Date and Net of Loss Allowance (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TradeReceivablesWithin45DaysMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TradeReceivablesWithin45DaysMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofBasedontheInvoiceDateandNetofLossAllowanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Within 45 days [Member]",
        "label": "Trade Receivables Within45 Days Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofAmountsofTransactionPricesAllocatedtotheRemainingPerformanceObligationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recognized as revenue",
        "label": "Transaction price allocated to remaining performance obligations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [domain]]"
       }
      }
     },
     "auth_ref": [
      "r143",
      "r255"
     ]
    },
    "aapg_TransferredOutFromCapitalAndReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TransferredOutFromCapitalAndReserves",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ReservesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transferred out from capital and reserves",
        "documentation": "The amounrt represents the value of transferred out from capital and reserves.",
        "label": "Transferred Out From Capital And Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r617"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r617"
     ]
    },
    "ifrs-full_TreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TreasuryShares",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable": {
       "parentTag": "ifrs-full_Equity",
       "weight": -1.0,
       "order": 5.0
      },
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ConsolidatedBalanceSheet",
      "http://www.ascentage.cn.com/role/ScheduleofStatementsofFinancialPositionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury shares",
        "negatedTerseLabel": "Treasury shares",
        "label": "Treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r498",
      "r506"
     ]
    },
    "ifrs-full_TreasurySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TreasurySharesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable",
      "http://www.ascentage.cn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury shares",
        "verboseLabel": "Treasury shares [Member]",
        "label": "Treasury shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "aapg_TreasurySharesOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TreasurySharesOneMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury shares one [Member]",
        "label": "Treasury Shares One Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TwentySixNov202526Nov2035Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TwentySixNov202526Nov2035Member",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "26 Nov 2025\u201326 Nov 2035 [Member]",
        "label": "Twenty Six Nov202526 Nov2035 Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018 and 2022 RSU Schemes [Member]",
        "label": "Two Thousand Eighteen And Two Thousand Twenty Two RSUScheme Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TwoThousandEighteenRSUSchemeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TwoThousandEighteenRSUSchemeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018 RSU Scheme [Member]",
        "label": "Two Thousand Eighteen RSUScheme Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TwoThousandTwentyOneRSUSchemeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TwoThousandTwentyOneRSUSchemeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 RSU Scheme [Member]",
        "verboseLabel": "Two Thousand Twenty One RSU Scheme [Member]",
        "label": "Two Thousand Twenty One RSUScheme Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TwoThousandTwentyOnesRSUSchemeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TwoThousandTwentyOnesRSUSchemeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 RSU Scheme [Member]",
        "label": "Two Thousand Twenty Ones RSUScheme Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TwoThousandTwentyTwoFurtherGrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TwoThousandTwentyTwoFurtherGrantMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Further Grant [Member]",
        "label": "Two Thousand Twenty Two Further Grant Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TwoThousandTwentyTwoRSUSchemeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TwoThousandTwentyTwoRSUSchemeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 RSU Scheme [Member]",
        "verboseLabel": "Two Thousand Twenty Two RSU Scheme [Member]",
        "label": "Two Thousand Twenty Two RSUScheme Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TwoThousandTwentyTwoRSUchemeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TwoThousandTwentyTwoRSUchemeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 RSU Scheme [Member]",
        "label": "Two Thousand Twenty Two RSUcheme Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants10Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants10Member",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 10 [Member]",
        "label": "Type Of Eligible Participants10 Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants1OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants1OneMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 1 [Member]",
        "label": "Type Of Eligible Participants1 One Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants1ThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants1ThreeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 1 [Member]",
        "label": "Type Of Eligible Participants1 Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants1TwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants1TwoMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 1 [Member]",
        "label": "Type Of Eligible Participants1 Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants2FourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants2FourMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 2 [Member]",
        "label": "Type Of Eligible Participants2 Four Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants2OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants2OneMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 2 [Member]",
        "label": "Type Of Eligible Participants2 One Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants2ThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants2ThreeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 2 [Member]",
        "label": "Type Of Eligible Participants2 Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants7Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants7Member",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 7 [Member]",
        "label": "Type Of Eligible Participants7 Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants8Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants8Member",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 8 [Member]",
        "label": "Type Of Eligible Participants8 Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipants9Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipants9Member",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 9 [Member]",
        "label": "Type Of Eligible Participants9 Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipantsFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipantsFiveMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 5 [Member]",
        "label": "Type Of Eligible Participants Five Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipantsFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipantsFourMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 4 [Member]",
        "label": "Type Of Eligible Participants Four Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipantsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipantsOneMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 1 [Member]",
        "label": "Type Of Eligible Participants One Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipantsSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipantsSixMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 6 [Member]",
        "label": "Type Of Eligible Participants Six Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipantsThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipantsThreeMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 3 [Member]",
        "label": "Type Of Eligible Participants Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_TypeOfEligibleParticipantsTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypeOfEligibleParticipantsTwoMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Eligible Participants 2 [Member]",
        "label": "Type Of Eligible Participants Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfAntidilutiveInstrumentsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ReservesDetails",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of antidilutive instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ifrs-full_TypesOfAntidilutiveInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfAntidilutiveInstrumentsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ReservesDetails",
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of antidilutive instruments [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ifrs-full_TypesOfContractsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfContractsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of contracts [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r476",
      "r491"
     ]
    },
    "ifrs-full_TypesOfContractsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfContractsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of contracts [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r476",
      "r491"
     ]
    },
    "ifrs-full_TypesOfCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfCustomersAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of customers [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r490"
     ]
    },
    "ifrs-full_TypesOfCustomersDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfCustomersDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofContractLiabilitiesTable0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of customers [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of customers. It also represents the standard value for the 'Types of customers' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r490"
     ]
    },
    "aapg_TypesOfGoodsOrServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "TypesOfGoodsOrServicesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofDisaggregatedRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of goods or services [Member]",
        "label": "Types Of Goods Or Services Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r164",
      "r165",
      "r166",
      "r168",
      "r192",
      "r196",
      "r197",
      "r315"
     ]
    },
    "ifrs-full_TypesOfRisksDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfRisksDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/FinancialRiskManagementObjectivesandPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r164",
      "r165",
      "r166",
      "r168",
      "r192",
      "r196",
      "r197",
      "r315"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofRestrictedSharesOutstandingTable",
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable",
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r350"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsDomain",
     "presentation": [
      "http://www.ascentage.cn.com/role/NotestotheConsolidatedStatementsofCashFlowsDetails",
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r350"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails",
      "http://www.ascentage.cn.com/role/IncomeTaxDetails",
      "http://www.ascentage.cn.com/role/ScheduleofCashandBankBalancesTable",
      "http://www.ascentage.cn.com/role/ScheduleofNonCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States [Member]",
        "verboseLabel": "US [Member]",
        "netLabel": "UNITED STATES",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "currency_USD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2025",
     "localname": "USD",
     "presentation": [
      "http://www.ascentage.cn.com/role/CashandBankBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US [Member]",
        "label": "United States of America, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_UncertainTaxPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "UncertainTaxPosition",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofReconciliationbetweentheIncomeTaxExpenseCreditTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax position",
        "documentation": "The amount of uncertain tax position.",
        "label": "Uncertain Tax Position"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "aapg_UnrecognizedTaxBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "UnrecognizedTaxBenefit",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefit",
        "documentation": "The amount of unrecognized tax benefit.",
        "label": "Unrecognized Tax Benefit"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_UnrecognizedTaxBenefitsRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "UnrecognizedTaxBenefitsRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/DeferredTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits recognized amount",
        "documentation": "The amount of unrecognized tax benefits recognized amount.",
        "label": "Unrecognized Tax Benefits Recognized"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UnsecuredBankLoansReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UnsecuredBankLoansReceived",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/InterestBearingBankandOtherBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank loans",
        "label": "Unsecured bank loans received"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of loans received from banks that have not been secured by collateral. [Refer: Loans received]"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UnusedTaxLossesMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/SignificantAccountingJudgementsandEstimatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused tax losses [member]",
        "label": "Unused tax losses [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r302"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofIntangibleAssetsareAmortizedontheStraightLineBasisTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets are amortized useful life",
        "label": "Useful life measured as period of time, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r329"
     ]
    },
    "ifrs-full_ValueAddedTaxReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ValueAddedTaxReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofPrepaymentsOtherReceivablesandOtherAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value added tax recoverable",
        "label": "Value added tax receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of receivables related to a value added tax."
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "aapg_VestingOfRestrictedShareUnit": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "VestingOfRestrictedShareUnit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting of RSUs (in Shares)",
        "documentation": "Vesting of restricted share units.",
        "label": "Vesting Of Restricted Share Unit"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_VestingOfRestrictedShareUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "VestingOfRestrictedShareUnits",
     "crdr": "credit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareCapitalandTreasurySharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting of RSUs",
        "documentation": "Vesting of restricted share units.",
        "label": "Vesting Of Restricted Share Units"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "ifrs-full_WagesAndSalaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WagesAndSalaries",
     "crdr": "debit",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofLossBeforeTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Wages and salaries",
        "label": "Wages and salaries, operating"
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "aapg_WeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "WeightedAverageExercisePrice",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareCapitalandTreasurySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price (in Dollars per share)",
        "documentation": "Weighted average exercise price.",
        "label": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs exercised weighted average price",
        "label": "Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofUnlockingDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant fair value per share",
        "label": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, Exercised during the year",
        "verboseLabel": "Weighted average share price exercised (in Dollars per share)",
        "label": "Weighted average exercise price of share options exercised in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r176",
      "r347"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, Forfeited during the year",
        "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r175",
      "r346"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, Granted during the year",
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r174",
      "r345"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofExercisePricesandExercisePeriodsofShareOptionsOutstandingTable",
      "http://www.ascentage.cn.com/role/ScheduleofShareOptionsOutstandingunderPreIPOShareOptionSchemeTable",
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Exercise price, Outstanding as of beginning",
        "periodEndLabel": "Exercise price, Outstanding as of ending",
        "terseLabel": "Exercise price per share (in Dollars per share)",
        "verboseLabel": "Exercise price (in Dollars per share)",
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r173",
      "r177",
      "r344",
      "r348"
     ]
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "presentation": [
      "http://www.ascentage.cn.com/role/ShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Date of adoption.",
        "label": "Weighted average remaining contractual life of outstanding share options"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoffairvaluesofshareoptionsgrantedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average share price (HKD per share) (in Dollars per share)",
        "label": "Weighted average share price, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://www.ascentage.cn.com/role/LossPerShareAttributabletoOrdinaryEquityHoldersoftheCompanyDetails",
      "http://www.ascentage.cn.com/role/ScheduleofBasicLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of ordinary shares outstanding during the year used in the basic loss per share calculation",
        "verboseLabel": "Issuable shares on weighted average number of ordinary shares",
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "aapg_WithholdingTax": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "WithholdingTax",
     "presentation": [
      "http://www.ascentage.cn.com/role/IncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Withholding tax",
        "documentation": "Withholding tax.",
        "label": "Withholding Tax"
       }
      }
     },
     "auth_ref": []
    },
    "aapg_WithinOneMonthMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "WithinOneMonthMember",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleoftheTradePayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Within 1 month [Member]",
        "label": "Within One Month Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WorkInProgress": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WorkInProgress",
     "crdr": "debit",
     "calculation": {
      "http://www.ascentage.cn.com/role/ScheduleofInventoriesTable": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work in progress",
        "label": "Current work in progress"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]"
       }
      }
     },
     "auth_ref": [
      "r497",
      "r505",
      "r654"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "aapg_a2024Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ascentage.cn.com/20251231",
     "localname": "a2024Abstract",
     "presentation": [
      "http://www.ascentage.cn.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "a2024 Abstract"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_21_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2025-03-27"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_viii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2025-03-27"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI",
   "URIDate": "2025-03-27"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2025-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS20_g39-39_TI",
   "URIDate": "2025-03-27"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "48",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_48&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "A19",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_A19_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "A19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_A19_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2025-03-27"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS27_g15-17_TI",
   "URIDate": "2025-03-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2025-03-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "130",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "iiA",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_e_iiA&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "86",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_86_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "86",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2025-03-27"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "32A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "14",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44B_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44H_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "Presentation of a statement of cash flows",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI",
   "URIDate": "2025-03-27"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "29",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_29_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "30",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_30_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "49",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_49_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "19B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_a_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B16",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B16_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B4",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Section": "Objective",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS12_g1-4_TI",
   "URIDate": "2025-03-27"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "105",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "116",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_116_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "116",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_116_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_120_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI",
   "URIDate": "2025-03-27"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI",
   "URIDate": "2025-03-27"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2025-03-27"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2025-03-27"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2025-03-27"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Section": "Presentation and disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS05_g30-42_TI",
   "URIDate": "2025-03-27"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2025-03-27"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2025-03-27"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "22",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_22_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2025-03-27"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "M",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2026-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "30A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_30A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "105",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_105_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "105",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_105_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "107",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_107&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_108_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_108_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_128&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "166",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_166_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "166",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_166&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "168",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_168_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "169",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "170",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_170&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "178",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "178",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "179",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_179_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "180",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_180_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "182",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_182&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "186",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_186_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "190",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_190_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "190",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_190&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "192",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "203",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_203&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "216",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_216_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "218",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "218",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "223",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_223_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "223",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_223_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "227",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_227&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "230",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_d_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_e_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "f",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_f_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "255",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_255_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "259",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_259_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "259",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_259&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "266",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "269",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_269&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "271",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "271",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "273",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "274",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_274_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "43",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "56",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_56_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "64A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_64A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "71",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "72",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_72_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "88",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_88_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iv&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_vii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B15",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B15&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_e&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2026-01-01",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.49",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.49&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_125&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_51&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_k&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_l&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_m&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_o&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_q&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_r&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_56&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "92",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_92&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "98",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "98",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44B&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2025-03-27"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI",
   "URIDate": "2025-03-27"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_31_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_IG63&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "181",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_181_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "193",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "193",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_68&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_70&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "9",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2025-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_20_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard",
   "URIDate": "2025-03-27"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>248
<FILENAME>0001213900-26-049412-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-049412-xbrl.zip
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MJH:KS&I)4Z,0#LC.&SE7%9>714;6GL V=@AOZ9\D9/]X2]S0V@Q!_IJ)6N$
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MO;(>9IQ#FQES9HB9.^R0X"E=^@0?W(3VQ@3TRK:#-,:#]:N0[WL; <9@:\&
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M%[#.8(W58AP85U-F 9/3"J=1QDAYTPM67#O(+:ZGX_V8V$UPMY/)#?*PUD4
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M#1[QTW<[.ASY>,X\Z[(3 ,L8=1RK:=C)U\E3%G(<F&Q*C-:7)= D4B T.Z-
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M" JGR:S,5WUW>Q[13Q,@:P)+E#H9Z_FX(<JG1ZBV$:^E';\*3]T8QZ,(@SG
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M),L+#47=:F J29II;D%)HP5G*Q&0OJO$I90C\E,/RJS<0*..$0H#;@G$D/(
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MJEIT*J^I /E3NNC/(_N"D46!2V6SY\V0GP8HXQ+NZLD2IX64"9I&+"JH?,8
M*K(M:*/\Q4HGBU,$I]4:$1HENZ#?F;,!J@CF<YH%\QE.2K\DD.RV V[40]9
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MG[V41?@4S*0T*U(+CP9U!\B'1*F88]0SB:%BL#G2>^DDSB2TQ6KD(^^N-37
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MC%FMJ#6[N'#H8W-JN. "E)["<YOJ)A.B>I)9)4A',*G3?29#=7H*H$8I(Z?
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MO_2V;YBWYCF]3'9[#+<P3M$3+.CI<LL;R@+'%R"BVO2PA5!;L(TQ+//X^QW
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MY0C&SFY)*WTMUP^ 5?]U)/LZS<G+OR$@DZO'B<1'3 .JK(:&,PSJ-">/04-
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M&2N++CR6&HL/:3*W-_U$%A(>;S/6#$GA&^U3+L]+LXUW1TVGJ!\*+)^5VJA
M9:D'>T%Z!;[!](X<@>_A.H_#RPBD*5HC&"[2Y1YB0-^9+8(,/;G5&RWF9J4A
M>N*WU,G]R#,M;/$EI7KI$WU)=F:%MZR(C39]/Y&_.]9B$"8:UI6O"$CZ0=\
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M"QVC,="N4!$.>^\FNEXG7P\HACDY^^50 @Q+CREZ*7N/:$[M>86TT2C ZSK
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M;&.ZQ"WTA)(:&" KT["G+5DT=YPKW'9Z0H$4).!59ZY1&&'7CI"3J'A+ &H
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MG5A34T!1?MQ+*MK1-:Z)]OLY^!0Q#7X+240F=Z33YP?DAPT2@Q2^VB<6><"
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MU']J<@" E_H@(NP<^T3E"S\B%U_WWEMS+8MZ73/]YJ$6)/"D0*5Y281.</"
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M,F-=R8ONA&6E,I#YU&BQJ.0DZ;>F:&5'RI+2F)Y#2HMNKW6,G!8J>#KDM!#
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MW2=[_K__^=MP>OWKKUV?%8)1F\T0T>6_FL#H7[_1]N^M$/W??_T_4$L#!!0
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M&?7N#Q:0A3V!#NP14')P=-,D1/M;3$F0-W%'&KO&Q+/!*_^K36-RUK=U4G!
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M_>B7(FX@];(1:3?Q0_I+ZQ.H! G(1H$44M>$^D >(O_)7W706'2KG<O #H%
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MI:H*Q/CV:%Z%^*SM:-,L.G-ZCMY@#N)DSI(ZVG=#!P-L]<;I0* 5/)RB"78
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MV,J/T9G7XN7IR>E50+<%?@K28CN-93)'>2ISXJT"$4FB TH,T:<-XVU:S@S
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M12[0I5.;+<=:^KW6MP"E<'@[@>4+B!"Q,NW/[N02&5(=?1*4G6YA@!ZJ=N"
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M>3\8*3N:=X69<IBBB71Y[S0;U52K1$D%^9B7WUHGF%C?&YS_OZ@R,/Z*DW7
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M!3?2#LL5)4@R+)& W<E6"QMO+N6IIS(73$_?I)HNLG;( ^<FI^EXMKVIBNQ
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M]+_Y"__OQ<C5*(<I.]C0&0Z-%VP.AGK'@J&0/P*E,)XH*W6=H;<["-K=\X9
M_@PX[[7$:+Z'0XNFT!1R+!=\IQ<X\&XQIV_[%2[/04ACHM?YD[!;A&*EM;8"
M!1\'D$E3 (4["=4%#3D0AY/X4.E$+(]0;N?6AR@/Q8M++R(CC? # <:I"(M"
MKA$WAFI_L9L/5M;2/,'[X+BW/%0Y75L?J.<8I%/I(7\2-MN@4&.MC(/\3S-8
M:A1S@Q=M:!*JY(EOU 7+#N'+-I<@(A =A8;HS9:D> '*J^X2?N5A2[^Q3YY
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M"+G/W>J\;VD9S@O?J^8C +E3S84BRQ>!(D+=XC47RH]W:O3\)K7XFP$B2Z6
M>.&DU6/EZCZ(UN%Q0U;V55'5;UA%P\22EB[F)_^O<3(ZIEF\)\,%>NKL1@5[
M3[<+GLI&;.X((DH15+7AS-RGS O)75PE*9GG(F/RNR7?0.N>)/XZKU9==62-
MN-U( #*4=4 25H>KD7+M!"F5]=S.G:4B@9[A=T4G[*R-WL#=4[>-_>N#'S1<
MM17^FEV35G_1CK0SZ0,JJ,X JXB(X\_CZ?WX-9JM/HX7:#(=S3X5.3Z\R11B
M5W-(Y7,#XDR%-T@@49#ZNUU":Z:Q6.?.T0/M(/0"#!M:U .Y^JJZU@O>.+?I
M- 3=).%$?25L,"NLR /I;$N#+=)94NZ$>0\IZT[)Z'<T8=.FRZ&(UL3T)<J]
M'7T-Q0E*BQ>AK+6:4BICK/#5)LP(]D&TJUBXP.MX1V^7T.@!'79T-V.5(9UP
M1"QA+^9W0'-?,SF]"T8491V=R*(F  /">)DWCP.:OXC&=6F11/"J36+P(8@N
M4V;(1P?Z.-VQR<@+4 R0"[W2NN3K3&K*/>%$6\=G+UFM+=?J7'1H2QX#5:=(
MLJ?Z:+P/&<*3/F4=JWR-6A%F:+=9'1VHCZP,4]TA+AM"M8:<\8>U22-V?O5$
MUW/S;?7H9S_YZ:38=I]$99]EE\_7/NEOC;WL&N^"*&)39AZV;'M[KA=6J V\
M/J!%&5/C/5GST*.$X.]%40P:2\@.3V(0BWT16G%W WN+<Y# &YRP &*:G>\A
M#'9N!"MTHX(-O^F"IW#BXNUIS"!;HK*Z*$3OE/[SA"[SD!<R)>)-F8EL@?=^
M0!F :IVC6N_.3!_*C)*$\2C)U[Q$925N)NU*UJNXDC(?@;6QT ,B0+E+4ZS"
M8Q^V>J77J/RT7)@#UVCLRYAV)<=>(AO"[K.M_"*.AV:NI[,M&6 X2L69&"P9
M?T5HH#. &D:%:8 UA/(&V#TG=KSBC#'7HXG8HFO(R[@T>)4?D38^B^YB,LB\
M:.-MGN@@2E?QM1_]8L^&J^*Q7T)<#9B O/1O5=94%]QT3;VWZE]KR&+H4CSL
M-&PP5?%"TGZUNNI35+ ZGOL0/^$DHIL7'\A\;3$4588!,GBG#49@(4Z/H1U[
MCOAP8;F6<8"$"BH61N]P10!@&#H@<;,C_\K48FX#ICB[C1,<[**RC"EURJP-
M?T'W]L/0N3@$@[YX$N&RT.V.//L:11@V9[I<E:WX9O'WFL\F448+(M'!97'Z
MJ'4*,%^<>A<N\.DC;MB<<_VTC4SK<TRIP-9U=ZSVZRS*<]I.HEL_2#[[X9&E
M'4J")[(Z.LN/<$&FZ&"R3B0-<"*;1!Y&3_1I9HUH1JM-]1+:5O<U2#]9<F31
MX:!L-*!(DZRZ(@-P7#0A\AR9FW_HL"Z@7@9I%MT$Z2%._3!EMV>!\TWJ8((Q
M2&K@1"NCT@H53;!B81G>LU.@@RPA)3RG]9C"X;2&Y$PI?8I/SP>0-=Z>=6R=
MG&T$HE@H^ABLA10IJ4D9[O< 7 /EX>!-2OD^?G#:Q]^![^.;"UIW4CF[/4*;
MNL9;LII:^5\'N7C4W2+4-:-.9(*A>#=;+M'U^':V&*.5]S\N7")25AOWRI":
M("[%+%:=;WAZ-9MUCF,-> K'C;0AE+>$2%-.DXZK43WFG8O'O+QNFN7QC!%Y
M+,!I$:60TM2GQ4GFS3')#^YM!A1J P,HLJN'4!@JF&9Y==VJ(93&X0:X:JX9
M+=J%<PTDU(_)-*M+NHCC_6R]/A[((OJYO&)DF;D2($!,%2/J8&9YPXPNY9Z"
M#7:!FMUZYE&Q0P3F(1HYPY]_2LBR=Q-_B=Z_???.8D0&MWN   P>#@&YV#-7
M]*&V\<MB>KR"$LR"IVDJ<K;7"7S +]-P^SQ?*(8A*J@4=M->"!NG;]"J* 4(
M :_J3[(+D.?YB9TI?])2I;C02?V333F45\!(67ONU%[00V6==UKP1/<O\^H)
M%2.#=HT%4#X:T:+)5'TA&5=V)K,XWA_"^)GNJ5[C"&^#K'0DR<\1WA2_I!NP
M@LP ERSV;(C/?OUG,Z "AH]92QBCA_P=A/.6T*L\5QR]WI$7FH^3E%X;?/?O
M?R#S^_X8%?D6O_L];$GB?K1J52GN(5K3<?&3O\,L.:P?^M2'LD;XLXZM,[F-
M0.1NTL?8!G9:/ C*.)'"FE3B?ILI1PH*TK R>BJ5/1/SG(5XLWST$_S@DS7Y
MW&>4K=WB2"?13X_!^K&5K8,LXW'PA#<WP68:9W\^$D=]^WP;)_7\#*GE/*=
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MR!MO3\]%!V_*:=J%Z;DW8[BS<C]9&]T?_((3TN["S_!MG'C+ UX'VV ]CK)
M,1"@HPF[]P5E4(2GO%]HH7K"LX2\AK9Q@GR4%F\BS%Z%NT:HHI[:]<'.[S>N
MWDJXM]WB=3;;%AR<QMD-&<CKC&;3F40WF&Y(L!J:Y%FZ*3%/XFU IWZK@4>]
M@=JOY-H3L6CISB(5Z*613=468W<&DH!V>"JUBKL.(<7>HX.F32CO.18#T3[S
M>2#@6,U!(TK7P9YGZ_/2&N<Q;7D43NF\DC\";WBJJ%O 3I$T#.;N>X(TR?R
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MXP6;;G"]8P>3)O $63FL9]C[)4>8[ ]^D-!C!2W5R5L 2H]PCD0A/T)0O>1
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M-W5U/&2F=/%2)Y7%I!>K#IY9]_MU\Q)U]+%T=?/V^HGX3U"TARZ$39:PIYH
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M*IG "*.2,CRY(WXWNH;MXX;^6--'K ,?5I]I*.&N3!-$;!2-](S+.\CW45Y
MBA.M.$59>[MQ2$(^A,=(=0NR]8,FQ.;]'W?A1J-Z:,4:R<<Z+PS>3,7!&U^
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M;*0LP[ H^LZ KM7(/'W^ID 47@S3TJ#.XOG,]=S$^AG*;!(L*X]N$@8%1-P
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M[NW\%NZMOQ;N[7^$A7L[S<*]G>T-[^)8[-(LROLOBOUYNZO'H=,WNUJLBN)
M[^\?EC\MWE>/<IL7NX^KQ8H6.?:GFK$1>L0O<_7E-TL9,L+"(<V#.(<]=WK
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MHZ3XB71"]M!J-[@J=.RB2($C^1:2NL9!JS58F5^A/7HN";B"D8;6:A2IRL,
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M==$R/FI3,U)E)V@_OKM)LPV.:%4Z^FL:@%SN.199!A;-ZK'J%!X=F*8)[ H
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MJM>AQ)(P:+"&1)$B"AB&%_KCWYSC1$]UC2^B+I,SX&F9X!DAU5#S"54U5X;
M(NV]!]= C\KXZDIG!HBM<%+27WTFOSW1]6\"R&3T7,),PI<ZT-Z^84A;/*)W
M[CT: U4*<38FGJE(6Y1T)UBP(0EG>!JPH@8A@,U;OV CU L?*?R!FX!CO4Z/
M"9Q7/Q9D2@59F/^4QL<]?OM6!Q^C5*Q"9(P;$4J2Y!C$Z'8/;RMPU^(T-%%-
M%-&2IF^_1XPZ>NL!IE35V<!*25BFUUP7QR@.H5HY#TQGO.7J]VL]W*C'@ !Q
M]5<N@3.JK>X%%V]DIO"@;\EV:1RVYYQEJ,AXL X;"3/"YP5E"Q2U[987>%)0
M;Q=;8\,W6.!NCED201*7=AH%C:5-UM[FHB;A0Y3,LFK13>/J?(U2T$B].HV-
MVM3P?$C)7W_"NV@=8]L&A]>W=4/#84( (_HE>BX_]<.P2-37-2BB81K[,VE1
MI/OEY@&"@&S[-)R^[?LU0R9$O@W]$B+.:,04^F7O 7 D^NMY.8)Q.JA6+&"%
M%Y'>R/R!R=R'R3I5YN91X:OTX&:J#CJV/D_[' @F*?G,LQDJTED7*MSA.9B;
M/#YX$[.4LT>STES.YO.Q3/&</::;XG.0V9Z5@NZMSTT^'Z)@C_(C/U CUV#O
M%;EXF.8 .IPR.!'/[X,"]H9D6T!CN6^3\ C59H.X2IU'LU'ECSA[CM:P>ZCC
M<MD?K$-O9L8=@';>$0AS8!6.]ZCG1UM_FIQ!L,8'<H0PD8SU,[ANM_:/W3K]
MBT[:X*/<$T/,5U3O-&TX*H,#M/I,[GV0Z$1A\MK9/##C]#]ZA!K#29GK\S&)
MP.MS,='@#/1[N8L2G.,/D 5;3\/\EC9US.5 H.7R6[0O/W:N9ZG@:TV+AVAM
MNR/G@[?=J63]X7<B:]TM#[U2S4[_NOQ1LH3F>/W--GW^MOR8+J#5/^ALHS.M
M1<K2S&IZ%&U)/D?%;SASK=BAD$&1/>[-]$9&.9?>""G+>OOX*-#;QX0^IZ<5
M'IT>Y _%W-9<R;\U\];MEV?./C[Z+JW9RJC7SWB+<5&]Y8GJ[G9U?<7JI[JH
MG:HBK+=&;A+9BZ5[G"UT'*1>&ZNN4;=OD5-4?H46[I=HOH";Q9DSH EZO##0
MXX5#/5ZHZ?'"&SU>C.CQ8AX]7AKH\=*A'B_5]'CIC1XO1_1X.8\>KPST>.50
MCU=J>KSR1H]7(WJ\FJ;'VZ3 <8S7Q;$YKV2I0C44.TK$ZBN\$6:$Q5J;9JAJ
MA\H2KJ[!H*JE5FU&!2'8/8E088GGQ7<44U4ZKRJD_BX5HWML00FOR ?Y<O-#
MFH;Y,BLO&[@7 H))+"5@<P++&!'%0T 3N*G?0B/(*I^7S9PC1$4O-3I&AVZR
M4J?[/23("N*R!@6[==(V\BITK*[HX_R(5OE^2\0N\GPQ*AH::]P!16E8/GU6
MXXI[%CVBI*_6]0=H'\68>$,)=I\UZHRZ,P_@Z=F3518D.:M#L2CNH6#J;;**
M^,;@C+?'>EQ9OUS68D_T-*U  3K0$KM1@HK(K7&9"(CN+;6^> S6KB4Q,")D
M"I:I7A.;*U*W:U%V1/*1<R1(A%M;)<YHYK<_,@4[,3UNX*//F<_H,E>\JHF1
M8?/<CHT9?]SHXF@/#Y,AD!MR4QPQ^2\MV%*X+CAD3V\3<L>GQ?N S*C5+H"T
M'E#0QK(5$7-@OTR"B!6!G?AG5.R(1T)<9E:%VPMK,:K17E9HZ9@=V ,I0SP#
M #7&4$&^1F\]R.,]H_3-9[7C*>W+?-::S(M- 3GBR[G\_WDQEW6@I#*+=3W.
M+,WSRR#+3F2%7>PACL"VBRGDP+Y/*6)%E%@9OD?KL@$*: L_GIF-ZK7GB4A'
M[L)EE#'$/0:KM, ^SG]_:C!?*Q;K]7%_C*%PP14^$-\YHJ=GBR1LURFV/.^U
MF+)N"G2X$ZTV#0D4MFC0=!5!BXH?4#4!2:_HM:[,C(N+;#9DOR3-=G+."B/<
MWJTCE,O&RTF5HJC-7O$1X9C-7US2^CAK0.9M<I^E6Z(N^Z\G)4PX> DIYD9X
M4=@T@0/\0]G(#X"IZ+C_9G%$! X\HC&>^'>#(KWXL.+,KQ=+8>+J#/%"R/M*
MN?^=3Y:W,\^6>))&WG$T<IL\X[R@*V(=T/8[5<8[D]M%]G!;XVZQT\#FS6*[
M8V]?X ME6E\I#H8Q];T[\<%OLB!9[Z+<V>-W'@_.7L)SF'E)S^(E^N2_D1>-
MURA.KF=BU@*/61@?)VYO-RY.R(>*FWM+W:FUXX5;52.M&"KYJ$U2D 91]E,0
M'_$B_/7(UM%\D45YE&QO").+-=FOY?2N=KE9/!Z?\BB,@NRD 9EI/5A-8SJ%
M4]'NG=!$E"AJ444E601T48LPW),'J*'M')ZSX*-)F3I9PJ:+*8TV3#?''"_R
M'%O/L23HWOH2RN=#@%WZ\>MT\YI\C@+ZO1^;3[DRNXNH9,0.#@+$W/". .C7
M8!(^$@4L2@7XX,K,HP#S2Y$'LN6#HVK;L[C;K?W9V^E?-&O+CSQ!"E=3/80,
MAV7FVA99L"[>1\%3%)-%1.MAD+BU9;>6SX78J:7?HU8#YR[#J"+:_JQDN),*
M-XR@X-PU&YS!:(P/69HQ%/N!(E55<NHSS($D"LVK-*$WGM=?#G""H&-*!$UM
MVA$^"P+=5Q\C7'[MW(+(A5^;#\DH37()IL0]R1?/041^&^.;-%MN-L1A@1R6
MBVT0D:WWS1'N85?!%_B ;+\W$7\C(<HZ.*D'J_D)IW J,C&4)JJ)HDV:H88L
M*NDB1AB5E%%)VCDF9X%'DR-QLH!-7D]G08@?\!I'ST S9_'1?_[+57#2>D,]
M3L;J2^I1=N3AX7_^"PK)I\X!IJZ=YB6UVM!G@,J?_[)*W[Y[,Q$I0RHN@3+@
M1H 3 I B1>1+/W$B5(T0)OR!&V:1O),XUII9).^L9Y&\$^VA/SC-5344;B=[
MY-T$??WXC]GT14A9UM>/_Q#HZ\=_^*"N1K9M=95,6T\9R?KE'2O^F!)WZQ_P
M?YX+S2A'#%L$H?ALFA0[C=6*V]#F L5C0.Z[O$5[^-3YFB23>;T,"8=G\F8^
MP:MT1=3)B.DX)8*F5M_0<UD0J/HM>!]_8HIV[WW(!=^\JQ>/T,0;!4*K]#'Z
MHJUM05.K?B>7!8&V_P3:_JLOVI8+OG$PQ2,TT/;C+LT*(M+](GP.(/[E@3T8
M_PV'<$E<Y03408$F29OHT&--E/4<B+P&*B@HR53/[ D=!!I%ZXJ2<U29*;A&
MFX'$C(X#D^V\(-2C:/>X3X,SX?%>LGTQ"#12;NOP3E=<IE9P17JY2+,L_1PE
M6UU[QVMLW;)QF)#:,/@>U0V< V5,"UVC)!JL4>KA+,-)<0]O[R :"C!'R0?)
MI_=ID.0?$[);/V;\& AA;F)-HG:3%^LQ)\QN3,F@D@Y$SU#3Q(!%:"%*#/WQ
M#]^]>_OV>U13=8XU4Y6WLB4;2/"LV(3-WCG@V=#U$Z$U?__!(!WHW@"G73F>
M ZJ/\QO11W]-Z.,9#.CC2T$F5]7JH!S*SK1@82M(I>Q59Q<AI6"]B*&($VF<
M4:O1*U3AS35^E%33+7(H';P!.B8Y=UXX<9K.FM=+G;+?-;=_-=6/\L5?TO>+
M7A@>Q"[.&5R9"2Z+!ZZ)E@OBL9>AZ$V<UVNX2Y/ICL. B$O?H<^,NOM 6KY>
M>^I"B/0D]"*X8I@KR^0B"=OY+%>?4_BM]?!X+:Z<YZ24LB>LLH2*'4;$\*=)
MZ%'J62- R+-8CHMG,GIOB)HIT5Y?-]$S=@I@5<;<85B10SF,BUV4A7 KO8DV
MQ8["F9C=*%G'QYS0\0S:FF@1H%M'<-,![AS(_@!6"9@7^ 2&=0/HHW#T#8-Z
M6)-AZMS!@FK\\(((:1&&OS#Y_T[$;A1N^+@+,GP9'*(BB+5N: ?-[-[-]KL7
MWLJ2#U'YI7,'6RSLUD4L=V3&Z4JS,$J"[$3)VK;0W,[M)ROE<"% R]T1_@A7
M!CG]V _#+--A+T>I:*@FB=?2O+B]7RX/<)_PN-YAK0I/XM964[*)N!#E9R/?
MOR8-$&N!6!/G9F-4%4WR-NF #5"P.&Z/>7%#7&>,87NTVJ7'/$C":\B* ;]*
M15^L/N.D.-'O-' S9W\VD38CWZ(XZK\@0@*]>_/VN_)0L?[-N^^<0_0,.*E!
M/;=L#:;!A^ TI'X7)? ;[M]8S^0+':,YO1>;D)_,K1CHI#D _>\-T-EOWOW=
M.=!G0T(-[WGD:.+ZDW%2 H_1%W[WDB\8$SH[AMEZL[K1F(MK$=C_BH  1?OK
MYA\> 'UV=#1;G%EE:O(>A](@M._29P#JN[_2'_[T%PTXC]&P^D)'SHL >N_^
MBLAG +:_E':V_LV?_N(<?HHZ:M[P*,C !"KD@^7F.HZV$:2Q"+(B6D>'("ER
MO9@&%3I6(3/.CP VT!)VR%5;U&Z,WKH'CKK&&O H2L/(UO1,%Z'X\/A1>T.M
M0L>NS1GE1V1WWKQ[B\BGONRN-334LC9JH[=V$*[#%;?,[><456T1:XQ(Z_\0
M/1F=G(N-!NEUEJ6AH>/'TE#S8[0TO'./('6-*2P-76G,"R#Z\GP6"+4H>0*B
MAB,C&/W)9Q@-]:8"I)Y$9H42A +,@J06(3^ U#!DA*,_>XRCH=(48-23Q[PH
MBI[GL4<M0IZ@J&;("$4>;)0UE*:"HJX\9D41)-B8 T0-'3\P5/-C!*&_>@RA
M@<84$-25QJP >CO7H<M;WTY=WOY^CUV&2E, T=OY#U[(+V8Y>.'0<7KP,N1'
M?/#RSNL-O5A#X@V]8/2.#U[X7*D>O,#O_C/T-//!R]OY-LYO_=LYOYVZ=?9Z
ME3#;.P]D,BN>WLVV>W[GW?;YW<3]L\_'>1R]*6"I+Y&9G(Z;8U;L</9#%FB]
M=U0DY=KU&+(D\S[*KQ']W#V M+0E7=L$8IC7&LVWNKWS;W5[-W5U\]H@F:UN
M YG,BJ>_S0*EOWF%HK]- -#?/ ;0W[2Q\[=SP>:[66#SG5>P^6X";-P'7ROK
M2@$VWYT+-G^?!39_]PHV?Y\ &_<1GLJZ4H#-W\\%F[=OYMG.O_$*.!4[9MOX
M-QY#IZ\OE3W\F[.!9ZY(G!8A3P T+1;'[Y,@@V"<GCSFW7?-=>OTSK=;IW?3
M;IV\WG&9W#J].TNX;SY7O.^ D.N WSY#+SCB5Z0D:2@I=_SSW57.=%7I#6(&
M[+SLBTJ#^Z\Y7F2OU]D1A[<)$3[.B]MD"0>/]\&)UD9<)"']((AU2GOHTK3Z
MLEJ/-P&D2BHH*LF0'U!*CZ(/)24$%[!!2<LYY RUW+R9-I":85)/0HP2I_DB
M-4 G:FL[K2>'!UE>3X )0TY,,WRZ1LJ("CHI/45#G9K34^<=,+>AL]R=\M>Y
M+%]GW"2X=*YMF=CY:3DGOI6]RO[_71#]'&V"1$/)PU8V-3SH7:#>J^P;!%\B
M^JESW0I%72N6/S CK?Y,!'$5_'K4TVJ_E5VM]GJ7:!6^1/13#[0J$'5+J[R!
M&6CU)DJ"9!T%\2+/<9$OBIL@RGX*XB->[;+TN-W=9^DF*I;$_N<Z*[4)79O(
M,.!/@)V:$@HH*104:$.(H6>@A@I&#ATH/92"#Y"[7Q0FZ+T&H:D,YX#I8@]5
M2W[#X66:ZX3(*!%R"D0.0QK("ZK6:$V:^P<SB=[$N!*)9#J0S)'C'BJ*V& ?
M^X8$-=7/I.M6NOGY%SA=XDX0H\GD**C:^YN7M=X98F&(4!.1S@;BR<O?*#7W
M,#59"'NX]'4U5-7E".K.L2ZV.IB(*T^ I(B<]QZ=V(PK0PH,8R0T68%;%HV'
M@C,F@![V;#W[\X %$7A@U:.?$<CLG4%&06O=E,_\\1D7=<#/.'Z[W-0T?XQP
M1MC><4]XSUG<88P1^T4>1C@2'B&39F[C;?35VZLYH#+R28A[YPOB9(RX09R$
M(RGBG,;FZ*N7@[BQD4]"W)]\09R,$3>(DW D19S3Q$SZZN4@;FSD!J[X;;+.
MX#8NQ.R_M\E%D$?Y?1HE6@=6*G1L.N<*_ C+<K$6WWY5M?T:@C&>H#DZT/;.
M?78-K=7.NZI$9@$1'$5<X$V:X56@DU-'C9);('$XTH,2/:-ZHA00,=0>HDFB
M/@F>1((Q0=3FX</%/W'P"2?Y8AM$25Y\?+Q*XUA0QDT$IW$R5K$TRHX(2!M$
M6J+/K"D*6%OT\?%_NP>/LJ8:Y*B)P10VCT6&DVVQFP$ZXZ2LPV>4)3F$\J:Y
M?S!2UEP72FHB,:FJDB:X"+*3]O4=MZ'5VB<<!@3 J#[UY>Y.)O2F)HEH?"9E
M1HI@B]]J:+?3P&JQCU;'HGJ"\(D'SZ=X0FT*;/3'8:HUO>=SO2;6-3?V)([I
MSOVC);YHN]J;_)R-4=%,&#)H9%^'HTE F!;=9X$6";BGQ^D)/!ZC_2&.-A$.
M%X=#E@;KG8Y&18VM:E; A$C#]><H*+]WK^T1)31:EXW5Y&E8%H2X>K>AH7A>
M.ZN/OX;]B]Z8PI>H^M2YIB4";UYW"09G=+;#7N@\X2"+DFW[E<9%FF7I9_++
M_/K+.CZ&Y*=.9+_>K?XL'=D]&9K.L/#@B)%^7=)&3]V7/4\U?82K#E#LW6.0
M.;'3.G>:2>PS!:[<)M 5/&6;X:'CI Y<![^H,JH56!651'U_$#D'-*2!-EK2
M-< VI7J7)I?'+,-)8?)T;H2$37S*61$@D#9"29J\7K-F7EE3-075&%*0@,G#
M+)Q%ST$1/>,:H[=)7F3'/=:[,%0B9/7YE@)#HA===5.TJ8U8U#1V#AT=K37/
MOE0%8AKHL$RN\)X8<<MA#;UNK0<Q=/L7F:($A?0KI[$*? UU(Q,XPS&.? F(
M^%:[(%DF^&?BWI&U[2XMZM]"Z1?X-=?,G#,.1H\M^U$Q6OR)"CVC(D5_02?X
MT&U\C!$(>M$R^A(Q6 LO@RP[D3W&8I\>DV*YN?[WD:ROM\DSV9WH+H>JM&RN
MB(H\"0!5M89W$:0Y9.G"E !9&6L*SE=&31W6BZ..;(S<+!94$253(VK4*-EU
MM!0X$GI:940-^JIJ[F5(C9;^6AZ7JF2,K-4A*H+X0Y $6PP0U;)._+9VK1&7
M!Z'UH5^CYG/GF!A10,NTB =JZEF5-!]PCC-^I<0S^D_<SJU[23PN1L #!TP9
M^][I2J6FQZX+)!RN67QGN@<+A//%ERA7/,[OMK$<L]GN6QR=2;Y"]#/T"WSH
M,@*3)^!VK.5@0'IZS+/B7^PD:'T:ZK S^3=!_D2'0-K0>?\MCHL<_D753%4\
M(#>O>F..9OM=BN9N^8D[C8I$#=KD#L+8J,>0BB-?;I99&"5!=GK<!1EOBI[3
MMDMX.#\FE/@0 86U@'U)6K9!.6V$?@D<04=+MSU[/R( 4Y!!,F)"=9$441C%
M1S@.;)T"6L6: BLV(3?.CB1I-<5=T&K:/2]V#T!UO7=QJ"@5 R^$UJY:) FA
MF.5!%FDX(X*F-GT2/@L"A+#R8T'[:\<>BESXM:,B&:6I ;I+DR#\]9@74;*]
M?J8@VA!1/^ #Y*-(MO<XB]+0JB'28,FF05)G2P [0N!U30%A2@(%0(-L@THB
MZ$"I^&"B])'1-56:\IJX@EZF29$%:S=K9K=S!ZMDAX&Q=7%=?>P#RF3JXRY]
MPZ%.1,Y#E']R@IJF8P>(J3L?0TL&'WJ$E(&ZN"CI#D\/(>M3^*_+TQ/X&^MC
M%A4G(-:<%]YGZ1K#9N FS>"!3)X38W8;DK]$&WIGD83T8_(CA'\'1;["7XH+
MTM<G"<)(7]]LT^=O2>?L5(#\T!P(G)$E2U[:^48@VH"V.T/06_NTNNX/;=(,
MU3V^0JT^7]$3RJI;5/:+?H&>$>W:Q80X/SIA0IU97>>9D!"[NLV" H<W<; ]
M^V3K=>?91.IR-W&2-,30+T#.9^#S4: #:H[HS@U8>TL$KT]OH3N7D6_C]V68
M;PDTS* \NP%^("-=;IH^SP1A<3<N42OD2AVH0 (<[/8=NH?8'%6S$(YR&<UJ
M45>[* NAE-_I.MF2WYW5 >!WYH<-Y?)F9#PI)5KP\81*6MZN_5+U*YA+L=3F
M7??3/"JB-,F7V66ZWT=%@7'^@/,#^174HCR_$Z#,@!]H5N;7S#VHJ$-F\X8^
M:G7@I46> "@5UT%+YK/,#P*/*(CCTV*SP6OBJBRS!QSD:1(\Q:?WT2<<GU9I
M_ZL'O(WR NY#SC9KYF++[5R::10Z,ZPBAJH^88(UO2+6+43$#[Y%3=>>SKV9
MP2J9D7-JSH-Y>@Z7; :.7O+LU'7NYIJ8GKF!\^'R;+-Q3H?R(@VR<+FYBC+2
M19KE2X@&B+:[<ZV$"OVYG$3C[*E/$4H+-N4U-523\W(]4L>"$-J*\IL+N+53
MN<P>CT_KZE\M#_,FS:Q VI03YV W9%QW&M3=P"K1[JBS0X+[LQ<P1R;"3CY[
MIBC$Z@D#"[Y9I93KLUZ2:3/R,DX<!GR?[>2!]02^&)N-OCE=DR$WPUD$7QLS
MS*CR_H3,VMN$&+A]E&P;KNR>WDUCQ>6LFL2Y^KPJNZ$+4=U1>[:]K-.]6: G
MG%O3=6*:^^AZ?XC3$\87.,&;J*!A?-'3$:;W/28X3"!?IE*XN08YZSF1E-@2
M8+MJRP(TRU80$%PV<YH924M]W2Q)ZC(QP-8B28Y!?!'D^#&(@^RDB25)<YO8
M$;,AP IK &53,,II$P2W_*X@,JZ%&A(C0S4-YKT)Z.;U8X[#55I%HEV3_R].
M.7,3()_;(][2AS+60GTUV;+^;%N//]'#AB,\?Z;!PG43E!+#%= G#3EK[31X
MV P>W=!B UD9U^P\'.)H#>16P9<',K&M 7;8L_V:G7T6Y"_,(2&)(]NGH+!>
MN4[NT R6O7N" PR)!Z,@'N)#L-@-&ME<XOJ="Y3:_LRE:J52KA<S[J ,U/G/
MJ-CMTAA2ZA)@*"FSU\2F*KM="Q39^@CTZ$J%?,G6"N0,Q21+.\[V^7+S/DA"
MFA%928&#1E;SL_<Z%[T"@L]@88_A*01-@>TL,;M QDU6=MZ0#)1)&U-B2FIL
M?6Y3@4VWPJJ<L#<HX M7*AM*LE96CWU3/^D*Y^LL.L!6$FZP\C6DBP-#G-.5
M%ARURR#?W<3IY_LL_16OZ6FB-6?*D#WK'I<9GZ(D<F5[NG+3]Z:D*=J0MNC0
M-';JK4V#3=>EFR [DQ3YQ^)(L]6!#TGH;:(BUSSR&"%A-<V]E!51(GO:"'P*
MNL\\L&8>G).IZ:;)0C\^>'.S&!X)SNC9[9YL3(/L=!5MJ*>ZIF_V_KF+UKN[
M] J\UXQ -/A"2[W=DGWL.MTF$=GB6C22,S#KP&1.YUJ8A;,B39;ODC8*&^*.
M3>=\T.H;TIDD:N+ !U\N"<FH?S(H<MV;SZTZ[76W(G>=[)?7[ MG;OI DHV#
MWF7?0$T?DXRI^C>J_O)"04EE@J8VU<=G0:#*]L?T'.2)?>Y*KW+1USJ6C-$H
M3W-WJN?D!\C92]-#;]+L<Y"%:C-6C9+=/,T*' E7"-:6 B-@A64S'-/WK45*
M?TM3-J^!%JJ(N<O6K*'%5K9F5?G,9DBJA>2WOO>C95/:5-R;EQ8WFI8&(%7_
MGF69]\OX<-0U8H?ZPC#UKS\F-*8"AU >[7T:)$ 81\\6O68)"]9]83$O LC!
M=\1"!8Z/ <;5V/501\9IBJ:FKEY5?,_JC9^@>^LHXO/A-X+DJNNB1S(^4^2P
M)+1E$O(0@KKR_(@_)B'.EO1$"NK7U0G3R-\? WB2SYI9 ]@T+JWC<!*[HIK&
M+/-Q!)3<UIR:!3)=8$\7F,F-*890>APNGG$6;/'U%YRMHQS?9]%:[1A42L#J
M;:J$$='=:MD$!:P-PF4C=(!64+T%7:5Q'&3T7)0EWO[:V16L@JJ:"]DQ:1A@
MA<4G+3<K*/MRK')W*Z%$T-0F/O@L"*MILX_*7.NN5"Z7>*ULR= ,U'R1)L?\
MZHA7:15QFK/Z44J:%K>VJ6PA%R(_"+Y'X1'#OA]73:JB8& '?CX&"7K R3Y*
MGB)G-F!4-S4FY!(P@ 4#U24$LX<T)#%--& A;FT3%D(N1&8@A0([Z_;W5?4%
M?S QJI@:$_+AFV#B^-2ZM=58#[@-K2*!PX#(Z6Q]"O?P;I<$F<@;18M&9_(R
M(([3@G@2C IU(.YQIJ%K*0&KKP,DC(C>!Y1-JEG/_,+:%\P]<Q%5=-6\(!@3
MAXE!*-+UIWNBMEV0X_#JF-4)ZG6,PQ@1JX9BA!F1T8!FZ%"U(ZY%UI0E>.7:
MABAJJ;$G*D(P#M)?__L8L0>J85#@FR#*?@KB(]G:TN6WLURMLB#)V86&M7,7
M4_[L!_R;,:KA^WCA],R&G-Z;@@G2FZ?@I35$][IU7.1RI+QEQK[RJ* E'S^<
M09E$T#3(6AZ+&\)'27>1A"5IQ=@:%4)6HVX4&!*>QM1-47HL$*@'K3GE3YU%
MZVAHK8GC416(>1GEAM+-,5$,\1 T=5!$N<>"0AG<\G-$OW=<05D@^WX!9=X@
M30_M=(_I7!W,*1S%N0V4X$BS>[#&.S:917K/.'M*U>7WAK?UP$41ERD[-N@)
M&KP .;XQ+[U7GGZS) G$B2M.K5J.Y<T'!(??)G2W H_]P_O@!']>9,0(LZP=
MUKRON?BU[K;-Q+@H;4=Y116ZVQR?#5.]BGXSRM'T()^6P+S^<L")XC/+82OK
M!_?MWF4! FA+TZMB]J738WF>F+O'\8-!F1S1AB'=MP9QMZRRVO&LJ+'5HUD!
M$Z)CV?KS?E7L;^@9!6OL[AAV1!_-$:QLV";I#.IW3\O-]9<U+@]W2U=3"0XC
M)*RF.I"R(EQ&X$.&AFJ/Z"SO@9(ZFBP(X^,U,0[;;8:W08$I,1I3I!:6S6UH
MU2AP&! 9A.K3]KV,:RL@$7QC 41C-+ZAIPN*HHJ[+>S?Q)<]RZ/]MNPC'U3*
ME7#O>KT]IHDF_"=,JSX_8.(C9M3GHV%_RIL8!1-OT(6K)4"?55%NG)HH;)"?
M&5D/'C[/HWKN<F(H.],M>2?<D/921K"6D^/=F[=_M[;?5F+&^F9:A:N1G3*+
M1B@ODU'*FG?,I1>1"6:PZ&Z9E:4U(:RU3;;<D.F<&(U$ONI3=Q$<J\VE=!_.
M(.EZ(SY9OX,X6S,IF1K37BCW ]X'44*,>?44X!C$[Z,-,?++8Y$700))N-H<
M6C6VLS!KW1C/P;7HC7&9O2<(V6SXQJD%GA-+70L]FPA--S[MJ5>Z.RQ$27TG
M)"9A?6LD9$5F<%_35NC FK4]6]+0Z9YI5#G=391\]#,9THY/,7(:#W6J@!$<
MR@V]2UM[MO&X-L?G&IA@*CT\?LSKEV A^MQ_)$:];I^L^+F!+#7T9U6.P5H
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MW":/QZ><[!%I.*GEA5>#):L@569+F*RP^="/15E?^3UPZHG$Y#H\S0YI1J8
MV2+_D*7'PVVR2;-]4+UG"(\Q3C?W692LHT,0=SK&11#%.6=M%]V<S]37^4$Y
M)[M"3[*D3@\G*'W4Z@"]1E4?8'GK7E 'Y%^5'7WM<!][#A@U5_TSZF".<J J
M$]*^NV'.H4W[;LRER-R/SP_'^_L9,22N%*HO2M.)<(<_W]X\/-IV5WK=VH1L
MMVM1E!W^C.A7?O@<?"UU\<,9EX'OT*O50'#6F&32 S'9#_@YRG'(^M)U%R:0
MM^0AF',H@%)#$%44>XX @ T<AI)P"3QO_(#ID*B7_HG"G6.UOX42TT&\.!P(
M P$K4$+VBTD89&&^S&Y9&GG2,WT2ZG;=-^75E0=@R*^"+\"?(EZZ A,!)G8*
MIDC7^$(A#J VQY*XX^D!9\7IGJBH6"0A'*<<P"NQ?<&@RI#5"P=%ID3;1M8<
M<'XH";Q"4 6IH)C'%1$_?!%=2/0N*71$99P."\[\+ .SW:=-[+7Z%;T#8CD_
M?< .1S&]O$F]T<SLP79 %[1 EVX627(,8AK].*M7:]"E!YZN/M?&WN]];?+N
M:Y-7=P<?L [+P-07X16;PTS)4S94SAS>L]!JNW64%=ARY1./LZ9T%*8S1[QT
MB]61(_: %64YV=F]A6FUC<C$69!?%#DM5K[:!<D/:1I^CN+8E=.KRI@3YU>1
MN7$G.*H)H8!20BFM%E\06FA;$O/#H3&%C, IUA'AS*Y1O^L@PXL]U##^#8=I
M0OAX++( 'MG#7+L(\FA>-VEB]QZX3--&8.P^-=TBUB^"O'MUSRA-:'7NJO/7
M=&V@W;\,7VH>7"KY53-H<)X3RBX;KL\@1=RX.V44<*3@2$V8+5YZ5:-8D1TG
MRL0XX5D+WT6[3=;Q$8HN/H!@T\TQ+_NU_^K%C$'+CV*,F!2_F9&<*D853911
MS*>;UX1LY7IYX69-1=7@X8VY=&=VN\J>/N:8R3O=$/OSGOP#KW"VA\Q&Y-_7
M>1'MR=8N))^1$;R/GC'[L.1N3D=L=H8\<,WF'I.QL_903;"/S00COX8EA[*#
M*#]T?L+O:I80XPE1IJH6Y0+V(KRX<\%<R:\[B_KG\/0>(!?I.HJC\C:O#E;6
MMU!NG<2S#,25?WF.P2BXIN>P#5[ZK.=$O=C=/9M6]0Q!GA7_>L1;H/\#3K=9
M<-A%ZV#\0+%^N4D(M%YMDG\U+S;EM,\_G:3]"V9 ^T/TRY4S7U-)+X"N\4$:
M>(A+@D":AZ6DS(V(?L#/.#EB;6_/F+@ES\V4/P&B:G*HI-<+P?_C'[Y[]^9/
MWW=,+R/NCRLU%0^U6S1)MG.X.(LDB$]Y1,^VR6\",NZR.[<>BPI?KAP0!=X$
MV)=@VTM70 ,=XI5=55SGLLMW:7)YS#+R9\/M^/1>?++4,D;G,]F0!K?LQKN-
M\&RHT3/CHX*W/ $$!OX,D\"FR9Z/674;S@&[8W,^/SAFP?H\=Q@?@E_3[/*8
M%^D>9[;O)[B=V_1$> P(H$H_1>OJ6S_N"F3:ZSH1PI&>>0<''#?=GG,[)^[)
M)T,YQJRAU\#S@J$/5'?RPEP&5?@8[?[DTG<P(\[@/BCU]D)FAM;1,A_]+\:'
MT$');."?QY=817O"PG*S(OO2?(.SY09"^?)EYBCIIRH_-CT.19Y$9>EH:WKQ
M4;:'GR%,-$?$._$K1:@F'+K^BHZ<C J,T[E 8TYODS69"Y"@@Q!L7:5>17FP
MW69X"S=/I@?2LW1DR4S/P:NP^CG]\A6BQ!&CSC+' 'W^N4>G+_\.KN?$4*O\
M^DPZF.- N]41O4<L^[J!%21-B E:%_D_HV)7+R=NS[DGL.OJ^-N<9?43%?XT
M\O*,?#K@Q$?G$T5]ID6FZOI]%#Q%<528Y"6;HQ^/EI@15N=<8:JN4*NOE[7
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M+](L2S]'R3:_.-T%>VQYQ1=T;W/%Y[,@0&CS,7HZH81\[L>*+U=C=\67#-C
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M-(02M@>VBV4I&1[(KG9N$![*3E\AH,N\%%QUW$IBD9&^_0:?KOB,0&>F([_
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MR^C::"X3LP"\ZIX)+VN[I14JQ3 !7:-!]IRHVSNP@P!MB;":Y,F\#3JCEKL
MO=9%O##)A;+0U1,*A+'3ZV2L\?I&$I/].9->8:7$;^M?TC%T8I\D!4,L=K8\
M Q0'7=,FR7+0%C9EM4]X@[7RV!A1Y):;15$<DQSR!!R@>?MU0_)M1'D=P?<1
M^4*";\0;O7TG-IS$MQ)X;0Q@OB\AP\%)_'(+%1-,R,W^P':&F+)S6V 7R)"L
MI8S/Q-8I^!RYF*R"LT7MJ\*'32(5?3UDL1'[>N''>RB;71:V2OV6 %F51)+
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MXLG8][1I<IJBE?E>R?2S'JXB.5V,)[Q].E(@DD1P1<B1Q8'*,TDTH?J5L=G
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M[?XX^@0'/6@'GN >A$6BL/$T=)(Z"2%<A]^S6OE&W*YW1E_>D UX?\V:758
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MC"EO\(BHT R+[-;-5;\)!LSX*A #%_MRPWWLWY@F4:UV !%Q<[L<9!H8J\6
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MB^*KFP CN=Q\S+-M]I#3VZ1JLG5V2!@7;[DY-MY4@(V&,T".)ST"T@X-VUS
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M RK5*OG.Y@3:KQ7+@N( K#0XB"$Q %L,^- OUCC77K<N8PXP9\H\Q^IA88G
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M7^FHV9[I\(>RSO@B+ZMLFQ5)_B5I\#A>;KY ;&J7%+RA)_L@=D9+"H@128T
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M?!V6QW_MRN-O2;VCQ79\4?BC1#P;6/Z:>0]//Q-O/G6>;P7&SF@*U4"?RZ0
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M7KSFUXV4 RTW:N&Z(V+NNQ_>_LVT*7X=K^""J$L?(^!/@V/\(F+4[\,77+$
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M5B_6[-^5N6%$1P <((](HJN\$D1((JB$#2&[\FJ(&T\3E=?@"KO-+ :C"*_
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M0OLWCC+ GK#X/-A@(D:3'O""($Z,#PAD!GA%X!ON;.$,MN6%Q.T5Z$HB+%F
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M2#QX:.\LD0S6_@("#M=HK7_HS&BI=GH<1ZF5C/!IUTVL0O(&D90T1W@K#T!
M)F$'5*''0!(#9 =[P',48\+!&QF8&!ZIX^QZK1(HCC6:&CR[<_S2XP]CV(MG
MQ<:!3*3E0?_QC[#KZ5/_-6MV.W9H,H. 3</T?2M/@5D<ZI/N3W;P'>MX\58A
M.  V[4-6Z,L =5"P[T-B=-B9&4C=@?50E^[GC"D%*5,+[K+ZC\DW;BY'DXH-
MC_.Z-7%HOVO'91-JQ<;"O--U)DL@/5(5RE4&]C6>)DW/08E-UL"MU]?F;=80
M'\>K8%Y?#3HP1-+(S,:=,5[A(!-?P?1'6D%QH&U!X#D"#P8W-4]G/ Q[:UGR
M),\[NLUJN"A3M3&X23/HGNYW3P\E6_WL!Q(>8]+SZ7(H*YY.Q'N7[+*#U%-N
MBOOC0\VNOL3<P+XC@%!\D@08X5QC \"]EDKHL\:-5^.A,T54/E=1]$#IRKZN
ML\V&S0N<?LMBQ6ZR.D]DB$EW-@D"O<JYM*,!A7--1R7H*CKSJE_%B:+R=>;=
M?Y.]5%OD:^.)QYXEXF$"3W/PZ& 'GF;JP^/.R%],E6Z HU(TV!WUS(*VK*,4
M=<F:PK%^NTP6F:_B!8!%L90I('I,X&J$;IJ#/3%@P4.% >;-K)___NW^VNPJ
MS-J<#2R77^QIE:V3*W)=YGE2A?B@U7FK<ASRXRLP7V(Q=5M0;PS)LXL3'B3M
MD\%B\2<S'D;AM2SYC;]+K*M:4:=&8:+: 3TU$YIW5Q24-0'XS+L;4VVSY\!Q
M>0/+IGC\J(1"@*4H&=*G#1O>Z39$'S.%E*)G3*EDDT<.T6WA7+]R3N(*#G[Y
M=O54GH%^^18[)L0*?]DQ-[R*G27B:8G:W$#1K;!IM>;5KBJ/VQWW@"TK\(&-
MKUB7;BG:X"X:Q6H@@AX1[L)E18!DX$6<P?Y@36>+T%=.;NM]+C=H=@* 85E
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M&24I)O$_OG_[AS???X?B%0EQO/G']Y\??Y@]7M_=??^__N?_^*__ZX<?OON
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MLG@6_IZGO$QL>DN2![0B\0I'Z 34N?ZK(YJ8ZFN0&O2%11/G#:( 5CBH.=:
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M>M%[:QE\\U%DA. N2&+$Q*\$QD\7^ ?RC)*8F?\?DL";TTL$[(($Y9SHE9
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M*;)=L/TX7VT>5B.SJ@,V7]_=/CRRD$Z$V;W5?3])4X!6FC!3B<)KO KBK%'
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MT X9&%,E(>NF])SH:JXO:F/ZHSH]#&YJD"+!/%<F0>OZ<7I1GDT#T&Y2CF%
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M]<QWO]RBHV[/3ZH]*%5FZ(2>RXI=XGKN/'M $=O_%T&2'>JGZ!A[OVPNYZ=
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M1+K=O:7IF57GA%M9><S_LR7YK#IV%MN KOB:W&?A1\0>UJGM]7V#@#IO=)6
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MS*\[_QK3 ;=X7T&OK=O=.:*.:/I28\0'T.I.1RMK$07L8+O*4[JP- 4Q.93
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M4"](B/28!?I<^3H*>(V=#@O0J5VC!N?RK!1%-IC+RD";HQ??#=D%V%W1=&5
ML-N.EG;IBD1%<@O6QU6.>80\=7R"M.>=++?." AJ+?!V-2SI@9YA"7E&_%&F
M8]9V89@LFSL)"WJ0S]=KO$+')3AFMGCVR;)90DS00J@?"?W77] 6KR+D6I=%
M<T^6N4)"FM<4M6&$DSC-DB)7_RZF2]I0FKKF<2>(R3*[F[16'[M<S&5$-YX"
ML"U6L.J(6"4IK8#5V<>@4FX6Q:K'8\Z) ?"D7N+[2)6YTSD H*[)1(TWC^Q<
M-&BI(_C2U%[5H5;AIA+QS.]W5C)>I,A^>_/*V &,9>0SN,<=GVQEMDXSEOR^
MENPKQJ=<YZ">,DV?..;VR)[7J'K,@L2(C[4(0!CR%T0I+[V]W 9QV<G@*D_I
M$9[2DV'WA,MF-/!;M"6X$[6?[+,-U/EW[)8 +U<*4$!EQJZ:GMVB>MD 7 3S
MM&EZ("I*:"Y76M28 5)'ZX2R:MU3M?(IU[],@CBE6#S8<<P17JQH#6 ::$3C
MK,8[#[[4VC8Z%*H^)!<L/+U, (V*2(2;7A"JCH"UIZ7>;D^Z<"]8W.RP$R"<
MHWM/;3MJ)GR-'U,V3,AJ'M8I' #O8R,[:991L>61I3^^I8S\D]9C(.G'$[U4
MRXEASZ@8NWHW>Q!'UI]35/2G'.$A&9]B?IK"\/V8=!C-@KELRTWE!-!^&J8U
MH(WG7_^=!ZQ6+67],[J+UR39%?KR1/*LG#RO)C\36Z<OPLR0@CX2ZQ-67D)8
M2X3 GM"\9CVK,=]D1QB4V>RA*+QF-MO.R7G-;)X0MWS(;#ZFW=X'<2AB9)?]
MT?IN8HP0+MVJ7VY2QXD%8P_J#4T;DK.MZ&QB;ZZ4@\SUIF"<4]<\N&8_#6!)
MP+C?A>$2!:&3YK"!^9J;"DP<.D%<HCQT4WU(KI>%@.HQ20!.'J0(+E(8Y/0&
MZ9-3134>4!#A3<P,P&Y)D%5Y5ACG<OBI1#70%SUM. ZS<B^8[]WTM1OU&3FV
MT ZCCU#]LSV%\\*?4@"#GC5#)(#XE>_1QUC!DV51P@;DQ:B*\Q_C^U\+UT!]
M50E.<;QAS3-N<1S$*U9X947W#M>Y/T.13DA6++ %N)?W:\K8*&*AF@1FX%0;
M\!QJ$1QX 8;SXU0MM4;^N??,Z5JZ+S<9XZO+!.@O7B[ G>-XHS52 ?G7WG.@
M8^$&-P&;3ITV((>7O^FQL9ML!GTKK63RQ4%T^ \*Z<%']++X1!]ZSP/Q<@W:
M2UHLB9(G;&U@]IML?@!>=@EC*[%"1C30=V:?2+P"YF8'!*\9VD6ZR31F.'7S
MPG'13X0DK*/(""ZOHDG0(\6,Y-T8QG46".=_O<^.?,KU,-[T.JNS80XK 5&/
M4EYO@V1SRH[1BP0I#>0[K]2H >IJ*H7G 44!:W"V)(6G;+Z^)U^?@R@O4=Z2
MY-<M7FW+39 MZ/TWM-NS/_P<I%<(Q9_3=LO($?78,FS?!6D\?@$\C5VR#G5%
M[?'ZJ7I7GJIS?JHJ;1)J(_G.7$5Z#'B?ZK8EX ="PJ\XBD8PC(KVX^E=7,WA
MW#22(]!3 E8>J!I"2=8;'\ F__8Q@0EU<WVP!?Q.'1"T*-X]@O\LZ*$ J-DA
M9L2(>CLAOHFH-."8=KOY\P?3=ZQ4ZX9UQN;6R @/3D73&#XZ[1Q*3[Y%0W63
M1OLIZL I]-;33:1[\<-3(X+?^_$T5$6LF(H.933X*\$6NE.=@^/&!/)P5 T6
M@(C8T6S)^T%%9H )#=GM<WKF/Y)U]I52R'E!=^'T?KQ_T]*C=DEW,5D!;.4%
MM1'%O3:D*2>U#R;*B>:B8?O<X!6O!#2+P]LDB.F"4^>],;HP3)3#B@0&<(&=
MM7-821IE2)T!\N\GRJQ.DEBMS39)LT'9%(=Z%MS+<)<QOAXDWMTQSJY29Y&^
M/MIZD P_6_T[QVGY:%5>+LT?0;$&>&KR9(]3L,V$:UUHR[B8.]D1S#TY,1#1
M#_@E<:_,.<Q"O3S%5Z+NT+X3ALFJ;6R\5;62-2S^<AJ\D:P:( ._%BXJ-H;_
MJ#=ID7T[#1Y(5VZUKY[]G?#MZTXXXD[X=DC:OA/^OWOE_XC\?S?DZ<#Y:\"1
MXZYW\3-*,Q;AI];[/PF.LU_HG_,$C1!\/<UU%\_J<QE&8/O',]>A:F1ZF7G,
MGU(<XB#!**W/PKR"5 @(2]1TFHJLCPU4RY39WM8T QZ8NS.<:QZUV/)]NDAP
MO,+[(!I9]_ALC\+9#+5/943S]H[EJ(LH6-&Y*B_#?'T4A(,SA5," ZIA&LQM
M]X%4H;--I5(6A@>TP2E[J! ^;BD)KH,]S@*U!#S)IU-BD6SUH'XS5K2577-(
M3$VGKS$=<(OWU6N2N[B^)H?*J8YI2@)@2'6 F.1Q2;+J--+.+N??38E#PG7;
M"SB.;O<?"Y"1-;W#%-;(*$;(293KU= >\2;&:[P*F%E8L_1.UISS''U#>*;;
M*=_9>2GL-<[86XWYNFG:KE;L;0<*;TGRF14=8D6RL\-'E&V)NQ=3PU!Z4WQ/
M7]R:N_! 9H&^0"^Q\_="+'LL05L4I[P*(7MD-%_7B!"'_LJ@_05<FGB.P&(
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M$O(5QQOW2ML!95*LUR,R?!7D$N4)%(O"MI"W2OT"2(D%J!.5(AM, GBIUEJ
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MKTU6@ Z-#VB?)ZLME4V3^[3\ZPMD9P>I*D^(RTH^DB.FOCPI8K,]7&^&"Y2
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M)"3&9%_Q.-IX!IH-;KTW 97D/VD9FLTO_+NTZ!IHC'DM*H"Z1TY:6H?-MTL
M6^$< P#'A4(J.^T%5 /)3NW936T<*E[QHG>]]LZ-L2M44<1X$Q=%05>'D6[[
M@EE,ZU-UC.3BSB^8W]&UOV]F&S?_QWRW"Q),!;MVQ%"AWA7:]D3RK(0QWZ.D
M$CY )\ @P+!EJOI5PMPET"NE;J^&U]L@WM!-LH3U_MN*_X"=6H(&O!*MZ1UD
M,F:VXA["V-]/.8! Q=WZX>/5KRCX@N)TM@DP-4(_/]Z0* H2K8M^_S  +%65
M56X&*! "XJ+/8#UF=(6;;&N!1_U#38%/"@0!#?J5T>PXK$>47#I-I0 N<6-5
MH;M;[\1'$E.LR4&[8:[P0U!?19\H,P:(EVMUM[Q,>;5GK[LMCM.^,S?/32,7
M06L(;_QS-JY1(C=#FV2@OKL/# 1S>Z!T?CQ^;_":HD"L5^ \7B9!G$9\>9]0
M-E^?>8+&+.UHA.[B)&@PNT!-H@>T8JV%\1JOBG6'O^=IQMW='HJ<';07+(*6
MV#F9-*IKB@MG_YT'U (Z4 /@8_ -[_+=^V][3N(E*7YA))]K8_99Y^R&OEB3
M&5SX:#7H[LAW:XK(AD_W-'0U':S+M@L/;*\2<X4Q]]0:RRI8+7:VA8M*<#EM
M$= %8C+7OX'[5*MB52=??),6QX^$>V# 5C914"@U5@]^'OS(C)FW&JZGQ@>3
MH&)SB0"W&PY@^97H4OGTR73H7%LFP,/7 @*EK+"">2>M:Q]-B-KUI5I];JI(
M;[S;1_1RA\+9?I^08+75H;OLXVG07[ITJVW/7Y9%HWR)@7H#?"TL%NS)\SPC
M<-XXGQ0NK<(NY<[>!@](EF0];>GU\BJ(OUP%4< \79](]B^4+8(TN\G5_!"]
M@TR-E?U4 75%\Z;6#VB%\#-O<^U,C\\FGAICNV@(6@Y%5MW5<8WU'AC397<?
M?<U-U->:^EXP6,91$V/7;4'5>_SO'-/%CI7OWAC?,+HB'L-%_*0QLZ,(B7Q.
M&S&0CT&6)]RK'T2'%*>W)&D)[\\H"NE/.5X<;QIP8.,EMK"#QE8Z%<(\>M(A
MJ5 >[R.[G':LK$\Z&6]![S[3:G38H"PT?UUWIFQ."]L242#B8E99+%@ZCV_0
MCKF4W)8J;$WK.=W;1 *N8I7=!W2<Y3:(YS'Z%PH2Q\R3(_"<CQVD,[\R6[DU
MM6'-XK .]I9N]NS'POSU,2N*ZL'RG/VZ1 8(]@C @O-^JER6\=/@'FU%Q\^C
M7E!/DOJ17*JQJ\ #MV$O[KQ=! ?NN=4([(J^\RRFV_%*2;AJT&<7[7YTSDMW
M"Z>?#D?[*0GQHKJLX_)$3P$<;U@0C)[YW(%^*O;R_MLJRD/FX%$0 >D+*@L3
M38?9=N@*$*42+>XN9CA1>!?S!52[$EW0;+5*\B#2$81!$TQ' (;1$<"NKH)F
M93Y#!5O8H4'"VIXAIL.\/EI8S:U28\\-2O!SP*P\40TV#28I#30=5JG1I638
MGU]&,IRFQ3]*O,KM$^]6JD=UU%8[[)+P'S_F^WV$*4/=YM#THO$F$&\Y6BE(
MPNGGC%=W'+#;S0N1"6F/<YC 0<L^=YN)Y4L[:V?,/Z,V:%)>.X_7O[XGY@A?
MACP-X"!H'*-Q(+K=<XZSO@P):5$:.-HAN+HT5O@S"MD"W>5^*>)Y&;*BS!U[
M=\N1<T_?T\5GAT6"5V/U5FK-8)A_*AO%109J:VY'.:A=L\*M^DQ!G*W\WH_<
MT1YQ-L\>[90RJ/S"!U8$R6F0_33C9%QK"OM#J_34B:J@C'6<-5J?$]1>.)-J
M 7LL)HLNR7Z^YH,Z#H^?3>PSU<^I9*X;5DSQ*Y)E9 ?#.='</C-/2"O+R:&7
M<@Z,9(XYK@\=)%]05H"ZH]<#M:XZYU]-G+G"^Z* -@ !C,>,K+Y4=2PYC,<M
MI8G:O4OR[25R2TJGZ71-JMR8*5EG6U0)'J5-4<YTC!9*QRGGZZ5@2M-^2JK#
M.FFNU$-65YV6=&!X1!<7G@)M*+!-EC259D#')2W1]:<<8RU+!SBSOXUD,B>?
MR:[5E^Q_QA;'#;N")#G@>#/;D9RN?WVV)HU,-]6Q/$MVDRA&4:I(D3H -NA-
MV2H"QT.;/*N--!VN*5+F975\-MV[7-DQ;J_8-2CW.,U8BKB66=WU_:6)A/!F
MUTE T)1"/XLT>E^=44$C.FM"C5" \:=")F*T";+R=U]K@+GG[(2\-=?!'F=!
M=-H!Q^BVTI[#M*>*=!PGG5/:L[OJC](Y+^3*7?A4^N>&[8O2)]H#NI]TRQN8
MFX2>+!N28/ V)STX)F-3*NTK+9]('P]<>T1:*]#R@(B_A;T[J\EXX>^0K/UE
M=6M5%N+13B"H0O<O^$'.R-:$VE,<M_7I7U]Q^BPC>N\WH2K_T:O46=Y^[2'0
MYSC$Z8IYSU'X?]J[MN:V<2S]OK]B]CG5F[C3EZ1J=JMT==3M6!I9CA-/3:5H
M"9(84Z3"BVWEUR\ DA)% B0 DCBDHH>9)&X3Y^ [![=S)87_AY;SK$^1%-D[
M=<U2E1I\$?^?+VM+_[&4R=>2R=+;V^S\<M*>(OSR-.>1_N%=D/Q!+-1/AD4L
M6?H"JXL8.76=*):$0EI?E:;=:X1G\N#K.U0B>J<N^#VN)1+N4LT>%*0;>J4Z
M/M;!A\ G&]/,&3_;^#P9+R<4*&V"%V#EU'5"1!J1NORA\980]I<G.Q2=E9@)
M-_/1:0HOBTTDH#]!KG']B-[,>-F7^:+&*&W+F,_!:2J $/:13KP#V>,GKK-U
M7(+V>!GN)FMS&U=T'-DWP8-G+DS#W6G3$7&.3EUG)&03Z=#[*FQ8-3N*;_ 0
M% 3/.=C$)XYGDH%K<!H?Z(VS]!0=R&)CRJU)S_6_]HAUP/;0(NK.>+-&R-\3
M8SB(C];ATO >J'3Q4'0)OD:6[Y%_T<G0B8A2J9IW#Z\! @[/UUO#1!@D05V\
M4HI(=@)AC6B""W>*+/*>Q#=1_07L\]D $+KD6N8[95FH0DD[?&1HSA@^(MH8
M7RY?V5,G^!%D%3N:FJW/:D<"E//UT$$U\LXS[P7UNDO8##12VOS3/./MX, *
M&J><",M,7*-UUD#E<P"ZQQ4M@V/IYL (*MY43V385M--:$ L)U8.?,!E2\#D
MV691<J6HXD<N;VSJ@1ZQ;.JM/E\Y@(+&I4S1')E/U(W=#] 0SQBSY^"WKJ_Q
M?,UE O89(;YZ\Y$$/6(C?S3I]1,IL-?Q>WA>KF&1'^I\_!=QTA9Q"V *NK![
M(,=OKSEGKXPLFW?J)DN$ QV]+!9.X?QE0@L?L1=Q!Q.XER;>A)6;LP083Z ,
M?+ G;F8*@*NW7=)D05?B)*WX'00HT2P#I[ ;,V MT?.BO+0C?I#G :[A7"9:
M+?5\>$NT+RPO^6L$N,:9Q$'W;9&%D(F#Y:]FE7.XLJ!8W3?H%-E6K]@TA)5V
MK)3V!7E>L(_0U.?_.:(*NBK9"IWR]!R#!'H1GI'"8H&[H^5L=29&'I%MO,C2
M,"E<>(\S1685O4JG&##W2?=S=$^U\8)+@01@1HBK1@^M8.X'%*&('Z$PR9S/
M&PI^WH1!V^5-29RPC18#P[6U%@7($&ZHY/*@ NA<GF99\_6P^5**8:DNKZWN
MLF;QC3<9MMYS-GC\-?ZY^81&-OX,51:X?L!J3W',(JC]!2+(3HG \7P*E4>_
MBY"K9C;AB+5&P M0 ]T<Y)0Y$T JI!KG,/@FA\%+K.YS//PY'KX]\?"2BBU]
M2( 6)+O$EVJ/E!'6_6!/$FZ0A N.<L93_@A!X%ICXRUR,7KV:O"R)3/3)](T
MX=:*-(-@:<-:!3:UB)GN[IJT"=<H5A;QUHJ6B:3"[ENYW30LYW[424/?A8-!
MNZT29N((&AMPX A H"<@1V K7Q@GEKWT72,\):Q=L6&Y;RXQ8XB$]([MF6O8
MGD7!UAR25X+1MJI*>0FIFRJKN;)Q)@"N.B>G$E66SP*Q2L?50NOHO)$E.#X0
M5&W#(3:H9 WY>-!$NS)\UF\HYK39$A&]8>]$T93NSE$O!\U @V/#UHP(J&U;
M=7'08O_U*NG9$-XP0[B63>EL-3];S1MM-=>V"C2<>E!&^3U+)!WXUB,=Y?8F
MR0XI0:@YD42,G1-2MH+'A:A\P+.W4TR&M5P:HT0L=GYJ)6+*!S8=/,MDA%)3
ME(C%SD^M1$SY@.8I#Y9+-"?=W2,SW!1/MT?_YHUMX/83*KS]/.JE)#G08.I1
MU),^[E$_@E8P889^'JT2EU%U?I_:;;44)R].Z:C%.AN*(B:A;(_E#*/!YGB,
MD1Z;:PY-J!EKL*L6T 6VI.8KLO+C/D^]P*REF"O'#JW%4>Z$5BLIFWQ;SIKB
M#2-U'>:@W1SI]YV-8>H+"> R &L?S5T412*-(4Q85]2?MS39.5(PS?9J)O'V
MR(4)'7!12LK+X;G"B_?0+&A9OEJC ]* JYLA*@FS2:>/:M<#)OD6B9L-G_J#
MOQ*IGAW2H%<N,1>T=A_:V05]=D%7K_>U& '4]\]R2X04CG=L'X^$__LJ[CFG
MM^@^BWZK5:; ]LG%7'VY;9%K.L0>ZY;L"?[3Y2EHDSHCET%OBPU>./30<6=K
M] 49;FR%^U7(*"DSWND)5@K-!I2(/N>NU*)E"HNJIKP5F5-CG[BH=%HPN,T>
M&%Q/!OO;T]L@N"@US#=^'9"[_G@Y=A<8A[B.8%@($M!#GLO6Z6F+NH0 \B('
MFZWE[!#R*"==S.2"S!7#0]$@"/#J5O%*"4J->'KBET04H)#NQ$6CR9BR-Z;9
M=U$"O=BVS_\:0)9*ZDNDE(,!:)AO9_$MB/HSXGL'Y>^!S&IB[#9: YT*&6F3
MM&7P!7G0X8W%=\VYCQ:4I5O;]*469=[W;1)4+@X 3Z\;WYD_AL=S/W!->S6A
MUIE/AA6@P0MRYZ:'QLO,9B(F-.7!VR11=00!+M=YS'X*8_G'R^G-;7GY'H]V
M*@)-801PG\U5-^H0]9#O6VC1=>R@@F6:'?)49,E""[3K \?6_O7-V<.AW\-!
M4%<OO1'Z. 9VR3IJ/-XNSAH!H!$7>XWXLXJ[<XD0?SJ^A^;_LW*>7L]WBY!$
M;_= -J$YWNC\W=3T'C\:MK&B20\=>W&#-T<?K79]TYM;CI>HR%<FWA\3_YI#
M-R:*Z5\Z& (B.)$JX<FYT4K3^"^'(M.EB,JM1152147!JY^<2GZ "IW,PM$R
MNRO(/( J%)QL+R44J:IH\(:CE@E>*:FA>H/H"YB=N,X<D7*[0\<EW>,\CQPM
M^#SSS>6.)+_:"_K+^*\SO*@,WYOA#;F+:3W6M=;*L-02E6(>]'5*"L"T*CH=
M<H]9$8P60\M8U:Y4*7(_@\*D$09(+I!G5=\VPZ+Y<ZE%=J/0:>IE\CMU2(KC
M@>N:U(%/YN0T( =1 (-OP5QG:].E@=:[@;W"/ZOU;& 3.SD%*$07P&I<M%<Y
MGDF=$F,2WK4Q?1\A8C39XA^9^%9>_R$AS, )JXN$% #LU!SF\7BF85F[#BV]
M@A9C=XH,S['Q8VYW93XB:S=STK\U12N3O)!K.VZJ8^L$U:TRB557F1I6">LX
M\RK@Z*QZ3#FIF^"KU;JN8[B+\;)ONIA)Q_7&&!#/7*WKVM,$Z)V<QHA@'.G#
MNT;HP_[<'KLWP<,\_E?B$!\ZKA9-4>7D-'5(62Z1=KV'UB[Q6^(4;1W7GSET
MWK6:^J09.3G=*B65V#P(;BR.+%5X!80.==->'2:F]T58CI63TZ^2DHDUK (+
M="WU"#OSN1/8)*!NXECFW-P':%01F1!XOZP,8_LU2T0@_F#?ZCH:Y?6AW77T
MDX,B"Q"26Z1<6,1+#Q8,H1J/=(@=&2^CNJHC^T!KX/GF!NN[4#?Q:N.4Y#D#
MV"S$59+L"$5J %4D;DK0U5JJYD 10&ABJS%5>>@ $:B4-%?O2]($K2:345&&
M>"HLRS=SMN,E'51S_9X,X2:CGD6I4@=YP[<$A:-3;RFJL--P%&C?139:FGZ/
MA,&:#P'!=(+<Z XG= .1& Y4:96O-/O"&H*8 80&=6P[,"R2+G%C6(:[DQ1A
MSN?M%5D>)M7M1_64;S=7MKDTYX;M'V;[5[ (GX.>82_V4Z_P'96,B\<CXY=L
MW)/<PD]1_/N[1!B^P-.JZOP$<9XD$ZVDT19_GJF.7<6[;88V6\?%FG^HTG)K
M!QY:S(P74O2#PKG_20^O -,'?M"59!ETLU)8-#1Q357[]+XWPEHQ&'16\5*.
M\J>_@2CN7VYM$P%E9@X0[9G@(7S-L-Y[Q5(X^A9 &APE2J%\/$/E5QL=B_5,
MX^"4_/UF87,T$]!"YDK[LU8+DCJ'[=R=*I$-5"ED)98UF[K*\ AZ'RF]5BM0
MKPI-;REBFNUO;.JG)%\.OFVUW%6ZM5;YJ@(MM$A*=T:=$_?LZMM)6<0;8U^J
MYK6<VC.9<%=<OU[:N(/\?D04,T42'W565F<1/VD=8,,-4IHM,6DP!?C)I,\7
MO<QEFUD9N1;+\[Y;_ U:D8,R8;RJQ=*<Q#]-6R1\ISY3))\;U44W-&AH,VF&
M/7/B//,!_G^?U*TA48/D!A*3TS9I2;8:LUP+U>5X)<JB7YT7KY:%NC<7U;(L
M/QK?'#?9@8O6?*?5*T/"VI>F.$>*EE5IUP[[R[/CIG6.&VEE/[)70SIE/-?_
MNF]W?HF<E6MLU_C-:Q687/=!KWB 1, K_M<AV#5_;$@#.>^]7H &@&C"PR3)
M2J'Q4E@TW+$!1".DAWL1\5%1-A-2 X^[^_KA[QQH]UD*X2]'F0KA/Q+9"H>A
MFHQD<L8@C\F8@=N;RB#'0[4!<C)C@*HNO34^+CWT$:\4R[ 7$IY-]I=-AIHS
M5Y!^KC?!C[43?#&\-;)7$JBSOFLRYLQY E0P.5S,SOUS5:]"XAA"N7[Y?&GV
M[Q8RTKINN<70*M^S/IBK-7[(7:/G&9JO;<=R5L2&@MRM:WK,G C.YB@T4$N0
M%P.EK8Y4B;VF&6[22APDG>W6PH<DR;(U7J98^-KVHRSEQEA<ZW"0,( &R)^8
M4#+$)FQ866GSVX<=?W2"@LH" Q!_>&?ZZ[5C+4@A7N-%2#:I3TY0,FE0JGN1
MUN*O().;H+!-6<</\Z;(JO>=N(%DV*7E YX2YB?9Y:$6#\? <&T,W8$GW0X-
M+@.J1]8=(A5MT**##T",?MB/4]MTV-1!UUV1B(\/(@Y\50;KU+.P2#O6>M+
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M)=9DN*9B3:?:UJ1_B76<?YC E1?)G@A^#\_6)2WA[$>=U6.*.&G&@5GP"A8
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MEW4JLRS+JE2%=1+20VO.MN>0/QG9\N %KJZP+WHS-&W#GIN&-;+Q,1F$[<%
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MYY+*\))I7H7EB>/YF"55\7"_;I]H^$"4,,N7O]&?(Y=JNJX)Q"\I9.*7J(W
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M$%,%UMY:6G=<.S[6. >K)9Z\YUCF@F04W^#A0C.#L^P9WGIH.<_U]/2(1_^
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M3>_QHV$;83KT^.$;PE@\(5*F8N)8YER+WP5#8_J$D\'+EOX,UNG"9T=N$2J
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M>_IJEUZBPM9;OEK8\I.ST0?GE_#SSW$2G^8+^-QGE? Y&XGIWQ_Y^X_<V%O
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MD #IN!&L,T*^=CR43&$&NPD2A<(J:!XAY(H_1[HSZ$H38<=$.$J"VZ%C6:7
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M>BW+//7GGA0\,"_BF1#_@E70X)= ^'I8"])NGL:J>L_X,TWAN+ )#@Z ,/%
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MC\2_KPRVPP>>CX[J+NNZ%];+N6LOA^^61/!ZKCI</G 'IZ"8MU8 I_36U%Z
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M#[E%=/A46+[#_C B9>0+J@,AF NK-D'%R?'9:[U?11*0,X!-?6'5!E:W+7H
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MP"@>.TOH[RA1LLPS+FNK^E4=/26"_$%C2S<6'4;'/T1QT!KD/YQ4: I!E6&
M/(DY F475V>IAZ7>:4CQ\V42A:K<1OV !00I?KQ@)I+B&JK^;J;&*: %"MM+
M::15=B5$W7 I?*H:JDB%YY8A@BCR$<+J"5536H(/;A:86P!)9K>1-[2@FF[0
M'U>:['S,)DCL9@6=MSH?';5QFE8M[*I:^#(H )ROH5)$U(14()AT0.A%&J]4
MI[T+3!3"\BD,2YKI2"!#S5&"(N^*I>RI)P/O+[ ;)4.PY-C_[^&(,[H]#2;Q
M54Y]U3')\$GI3:9Y2HO],I0@]<Y%MY7]RF1-@YAP9S@7(,8/02/8@(TTQC&.
M55DM7<_I\(:Y*T+_WTL]5LT%%O<#A-9NA= #$D(CX3<M0Y_A #'@-&0IR1-N
M&-7J:#6!3^!T1&4\K#5V&_CTJ'_4H1\S/*J20:NOL$VG&@\-"W>HQ(8FLR4D
MF##![AF,-/&9!QMUE%];CII1"U?3DAN=)(7?S]%"2$L5[RA@6#JXZ])!2433
M74TS1;[(/*Z9Q,&)6CB72T3VP#-8<>X+D]HTR/LFV;2#PND.EMH(..7@QP5.
M.6R!4QX:I6^9:H>SNUZ[/U+'NTF??SFT267S44!>]R0^/J;/FVY]KV9#=97?
M8UDJ 4TN.GL 1^P!N'V?1N5089>Q'MXF7AJ097!^U#][VW%#:37;A3'%@AEG
M3)=C"5OIDK;%"8)8J48XZ5P+1A8'K60B?$^CF:I)\5AUYWT2,=HNA76@/8.5
MT9WCP9&>,4:U>6CFJ)<A/P?^L0@E1M_VAOJRP!U*F8,=D),UH.MG?TTB*BP[
M40\[,A:+VA9ZY;[/,UZS*_+QT#K"Y#;3XTIXJ:JOZQ^/BUD/@4!+!QY,R)[*
M*]/A>6 MFBQ)BY!S\"/9-"C= 5RO>3@)S3TPU$A^%1I/)@!9^(O&D.*#H8U!
MFVX/_K*GYR$Q&(0928\N(6V)(8];;TG7O9CKUZ1E3<TF=/1 ^VR.AFF!B\_S
M>?76L/?IF1?5 ^[MM^U4AV"6[#%M8Y5,*GN#U>:6S"JRJE".;973MVL^WHV*
MH-;-NUXUZ!VX6;1_8\^ONIKUQP\^ZX"+R0YRT)LGMD>(TAQ130SY&A@3!QZ$
M39\7C&BB]D3S..<T#94#8<-'X738U(OE5+DUDCJ=T&-B[\V;I(F']38;:?V[
M$_NW-:V^@B=UY-M5D6]'52M6Y(L1["C]:L/%6[CC.QG?;NW/G;0_=;XUR*GU
MJ60QU/$2&4*U@TU16D;A7WD8:)NPI/CIA\2-W\,"X/^[A_34@[,.6C;=9C;5
MK@:W,I=XBPH;)UAVH"?,1^$GY$\>W7.9H)435:8Q<%& 2\,G3'L'.(8T4!!^
MN$KRED%;!FT9])9QG"MA&LH,>A'"3.J605>NP,%>(..J<J6(>]82A"C /$]1
MC),*0HY 5[L8[U($>SS?SU.:GDE/YJMU!?-ZI4^'N^!462+?V$TF$8:(=$_U
MDL!L,_#SO5P% 3B.E*@Q)@%%K76\1X4L2!;!PV@91ARI]=X0(*BT']R;>/D:
M3V-B&&.R(X-!)O6=7 5IF;@>GDDL,)"%F"5%$[Q*P^W2*U>\IFU<N%[G'\(A
M;4WSZQ"0P2X#C(&EE )6P<"E)[,*4(U=U<*17V33RO@+-4)=YSB[;A^CL"P=
M4*8X-?VFGC\/00@0PD(N&7TM3:9 #$6.ML!!P"8G(!11&:YA8'UOFFX!=W,H
ML-+=WD.KI[8=$PE <8;8/$-B>$"C#V][G8.GA]U]%VX=X;$]_CC^6^_%B^X+
M_<E/';SLZ?ZSXB,Z2?CPU8']X52%ERGV[N+LE< ]%CZ</VBVPU['.=@_>-9Q
MX;]/Z0;PET.J3%WJCGHB4EB6_2N7?W6%"$4!Z;U%SH)-\0F_QHO.?N^P>UA^
MC<[^_D'WE7D1;+_7*7T':1MK]3U?Y%SXJV&(K,X?S+#,P]D<.[AAE;F*%>HT
M29@AC BH?%FRH//E-$VPIE>5,]"@,Y"NN?:C+8YWL-R82WZ]*DX5I1RT13';
M-.PZP0 ^L)_-@[#>RQ"YNNO^(=@Y@+=*LHJT,3K!*2'A&H 6QFVT^J"*IG^4
M+7$2&VP%>],J91L5_ 5:4EE\X2!/>T]*-S,U>FI>G(GZ:<V6Q#.J>BW,G>Y.
ML.6V0A(^>M./LCE.-W2N%/&4H ."F^6Z+F+2OY=PH"G2*AUDS; &0R/<UB+J
MZ*KK# L\=;HWHSK4TE ]M>@A&?4#8%& W:RR+$-)8;C;?+%6]=]UQR6]#/\Q
M(38F6/B5$F6T5ZRB=7H1I]W*PE8H56$Z5(5IMRU6.19EVBSU%K!$L+M-S6N
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M>-J7\SC0YDZ%4#]D [C>O2QB:T[38#%;QRI,J*L=4+,HK6&YP["7H;CJE$(
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ME-HC570:8U?J O9][\29Y)D=O;=&?B%W6N][319$&W0UK*M5.0^%QIHW55A
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M+LDUF5I,IGHK]?*T%O:Y;5#>LIG13(19+V)DLX2SBKSR7A=B#<RRA>2#Q%B
M?=$#E%_?>NC'TQ^W!^)9VP/1:NI64W^_2!=6\=/(NP[-2:;Q$/B/0$Q%7%1Q
M(F*"KTM*L4H&ZYPB+US8/H%=K=PT<\:5S5P?_0!52LMH#XC1E&O9>!!Y4:"T
MH;NYWM0K&@K*'JZ.5#?SHXU-7J[,+O> L[?O>TMV9=O(<\N36\Z37Z+\[,YK
M'3\N P>8.2<&8,"X1*6JQM?X<<LA+8<\( [!VJ.B5*)4?XS-<0DC[&;"G\=)
ME,P,+J$J$[:2I@]Q:O$V+?5CG(61PW7G!=:79_>5V+7F%+@WO>!<R&K0BJG
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M:@.G83LPB:N#^R%"/*_?@[#:T;1L>EZ^F<:\F 42?SLJ0A(P =\/(AX@W[Q
ML[E*7U8N4,@"J%@W'*2X8@5@1M9N%)"'C; 'VBG<&N#! DU  @Y&0<N;S9-Z
M^V2-G)0[?BVFBO:V#4MFF/S=+&W?" LRUEZ+>OG(2WWKL9H&^,)67ADR5=1!
MNZ\;.B?\I@0:WT)1>$1*:;1GE"HW;,H=^!%KP!GX"!2"2?.1 6-\5 6BK$-
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M:#<E/#M_'"2+3V8)=88#(IL3O?$V#2 HY4@ \$L/"=1[X'2[0W25_I 792_
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ML6=J(BT6>HB#FC\=[H,_0!F7/(JNJ;W;7>8K#&##7>YL\TC0CA@Y(,GH;EK
MLKWJXZ;#'[A[*X?%RR8[G855Q?.O>+V-_DU<*X-4:GZ+;6:B,NF27DB;82Y,
M5A+&O97PW6R000L?-9 HET1%,HJ]-WD4?].T/;6=.?#%>^3E#,8J$IT0)'N6
M(AEUE;X8/-I$-@DW0]LDSQ,Z+CK@C1FG:J8>"R&CLWO.Z*48HR 52Q<XDFZT
M?9FVZ92#?3)HN_U9XZZM5>/WAC3;UGH=0TU\AC0GB=;F\#;TZ<((. B"9 ,"
M5/:MGNG27$.7#DQU#B,#M.'VS#"%H:-6GR"ZSMI[C3X,PB1'$6ANS4G65=1\
M>RR.QO6=J1.^:^J;;A\"IEJDV1LI"2L\LG:O=<9&C1Y^O#+PAU!('+7CA((6
M2&. L!R2N8VG/:;!3A9S\=&)W/(N3^0]6 ;B>[9<:=M B]I0H4C:Y.F>),\;
M)5=&!%26LT/Z?0:D'XGGS7I&[CF(P$BQM+$81[Q=R#624T,R]<XA?H2U"$VC
M:&G'-<$X$0T!?B17@N0[Z!!B,BI/TP,OW\Z.C?9%'%,.2)C7;&!THA8*KXXD
M'1<L1718\(=$VGZVO=:,:),*Q7V.GK -!',[=KE<_O(<8LD?MJ'-X]8TCLIJ
M2;LF03!@_?E!!C0+<O@433CO'Y@,_A-IDWO2'S/G0@R""W>.0H]% Z2DK->\
M\E'E\H\:F&J(MN:ZQ1G@)ILH93AJWEN)-S=F7?#0P^ID$<C#4\+$K'RQ)+B8
MWU_LGK*#M#KYMD)MY!U2X,+J&C1OH1HFS2LNP:ST']MSYL45NG2RQ6P>A6J\
MK8OCZ6?<Q?'ETL6Q6&Q9ZJ\@*W2$,G0,D#\PGID2H%7CY@#%,Y7"B13RN8S"
MO689_@=:98(DPI5_2+%W?<P>)#C"4WZ!U'/40J)VP.!4N#!;I(G?:;\;[O7#
MBV=:X[)05CBV)&EG2B-7R?/!$C0)QULR>F2,66D$<S &"<#-L2ZXM9#KD4C7
M&9D\&M-:3.?19.\3O3*GSWQ']X*'O "J/"Q %7 OS %4F2N0KE3)907'V"-4
MS-R] =?R("7FF2B8TV-P"[37(G&+Q*G$N?[,J6AYUC(<SB1L-H2UE2("^-87
MD5M$[B&+G-8V9YUW-._6M-<5VR:77'"MRQOR(0L6"BZ12UIH$81%$!ZR(&AP
M,E,.IJC'>?QQX'HMIW\Y_0_Y]'-?)*II<\X_NU*2;JU"$F-D$;1#SM;-8 B>
MOWDU52*1?@\=<>9?UMM9R_# /JMH0M./<U1F5W=%[GHMD>6^YLF^:"11>F+\
M /2<1=SZ<(OT+]+_D*7?$9_..O(OWWPG65#;I/?]\P!/4FN2$^*P2,,B#0]9
M&CR;]CQKB'XM\R_@6 2MARU=B0]'2,SM^BQY G!<B1AQ:"\BLXC,0Q:9N8F[
M,6^\9Z>8[,68AD_5R1MM*$8?X#S'$<U:5A 7$5M$["&+F#1]SLM+6R8+CV$S
M44YN3-<W%8O=N<ZC1386V7C(LN$FM^9(1SALLC'7A;3O3>!!^:D:1K.HCT=!
M".(NLR71MXC*)8F*/<NS1$7%0^L[55T]88M2\' ^Y_G^7M>;U/47O4:7:P'V
M/_KZWY^_SJ+.V<Q-I<Q;! ;'T>JZ T6?;SKB>1I![NXMEH6M##LH\*EB,*<(
M&6]E_CI8380;T:DF8="-:TS8[!2'P#=U*_?#WH[V=A[Z_%C?8+QLG@+3SBR&
M9;'=68O^6?3/0]8_'U!F<T!_#""%/'M16>A1"P,.M*Q_\U!4'H D"GR'=7\5
M+V7IB5H$YH($1EMEYUJ&<&P/:*&5878%F"WA$<@7ANQ%#BY(#N@-,L/*A^5
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M57-$EN7?)K% *9O!/59Y1[?&UI&FI.?'E_6L"HNG +RB"$I^NZ)_<_)$P18
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MR-&5X&N!- _P*742,G=(/).AOTN"Z'L?C2K^R5K%)#99 A40K(D1 WD0DU0
M1%]#4ONN<\$N;$-@2'Z5PSU!7B#2/ [5D,-%.P3M0\;+T >7YSV)YRRI7\9\
M&P*]12/.YY +A/@@-13Z%38I!4C2]T<Z'CAKF)CE!E=.4N?='KBEI".>TZ]W
MD*>G8Z"R3NABC![LMI-4W[IO;L]?6)8C.;<1>(,=+>0#&MZ;IZ%L)K]+;!P@
M<D<>2;K-V\XT<08)H\VTT4'1QF9O%I__T_O\?##7\@[I(T"*'XQ,$I11A1PZ
MK**WPSJ>#VX *-+&IS##&[PN@$LK3AJ^O@?-%[-.2ZV/_)KRE* ! "BR=*Q[
MQ:=3@U:7]8[M#$9^3*,8/W33O&'R(FN&@# NIQMW$#!]8_'7,#]=G20*4+U-
MYJ;<7"4OPN?4 VF&,+_CI_;(BWDG]EH:%@(QT%QR,0*Q"38,2>/D^2_/Q*K]
M+&#P;C?)-NR+4BG*#K#!(E78C-C:<_Q5V:![BQ_155L_H<CO]]@4=>.Q?02>
M5C+J"<,>VV .4<LI&MH'L).G,V=0#_^DZY*"#$Y<*@:@>]F\20=HF[)X!^A+
M;%@+]3#8KC\SO,S/ 1I^>NP;H2%2IK8,H1?BC"K=%T DE$+@"M&9K8'<<Y-X
M61ZU"L$$[PT% _\6)_K$X#VT6\A+E(.^D@8$<1[G($OWG"O38-0"._$&J*\C
MGALMGO^(,9U>:4KL)S+&/:G9*9X1*&*!N1)'HDT-8*SH9A1115>/KA$)IP,6
MP"'AC/W*>+27)-]"*>=>3"TR!ZQ/]&H"1!X!M7R.[@H^ 'PV7L<;_UKY<+A$
M)!1X6,,_;5W)FYTD $P(\2 H6+Q*GYTQ,C8OP6?<&AMZ,GN[VXEI;(7)6B@$
M_&/[-$",N<58I3_1NQ(HA?S<@L,2E?B#7&F!B!3[NMXD'HII"@_GEIG^  9'
M@F$!CH(FQ*]BV"G22EW!.BTX&_0Y4*E'M3CO$8@SH90.UE<.58I-Q8BB9%4*
MQU8 S(JUNK$<^*#:Y32'XJ6O3:F.:J+!PQ %S&[U#[;,&C4/M,:D:#+[DFPP
M>6.=.:1?(Q?DX;VT(OF<%8(TI'WY[7=7Z7?J0">OZ/WA#>M'?\?[K [!]M%5
M]+/7;YX'?X2K<L4W?WH9D>P%!=T#H&=371=-+6_%G5ZHK0@+62,GSC&K! @R
MH05)4RBZK8C- -2DJ&*L0S $M%<)"K#Z#8\6B+R,#TN59B;XG&4Z" !@K)EI
M=,!OY:'Q1M#ZFHME39+8,/,&["LM0!,CJC[3TB6LK 5T!A/,*5/5WZBA@A_B
MY!Z/MZUFCO?D7,-"T,0)##I;&.?/.(6E.@+>Q*ZI^V/0P9!QJT_>JU&O%7(K
MC]H=5&W[)# 4=U!'Y\8"]YBR<U#BR O2::/[JCS[^OH2%G]2;DK8(VDY(6>+
M.R9NA*F422?ZINT#+,,0FV8>&9(E)^$R?ROL;]:F#(+G1%TL(= [%[2+(^)[
MRAP?D9NJ#EAPS_2KG9_8460YY?9C):&-QX9LHVQ30-H:>0Q("53RB(Z*(/.9
M:4T"D;-P[)CIR7>]C&L72@N9Q+%]N'-G<(,*2]A;;0L86+P/?33EI;K&N3CY
M!]<A6\L\!;(G^2)[N">.6I)!QUG<!R,I\$+8C>,V+8M2A8MLFOQF\A$N*Z5P
M039:A-S"DTU*>/ Z0@=;)K9W N:N=.!TKO>8P>[)RG=<MN%TJ7O-P*:=.J J
MUHGDJP-^U#/&[K^Y%UG0^:<NARQ&&_;A_6#H!_3)#^2L9^D+NIZ(W?.ZI946
MZ_29Y&Z??O/57S-8ZA]>/'_F.0#HK+HI"-?O-<AAQZ=:N^NF5L<9M4%7G+@(
M.D.!?'Z:)Y:N#D%ML35/2$\BT5]9>O+"(I-V-FU#EM[D^!Q]<%U UJX"G,(M
M#IG5'4T?@S?3J@R%40=/PY9WR1B95#)"E18,4OYA2]Y3O<.'Y-8<Z\)A+QH0
M6\!X>&WBOF';2@65C%9TLED'G#[-K;MJJCZ#1.%XC_QV\"K35X>J6-%.O3'<
M;XEW><@WY&@ W@Z)!._F#=]FQ!S">*?MF4*':W'.$D%OUN2+7!OY4-S<W>2V
M<^YC9=&2-@.!PX/R]=&L6?^ZRCA[8!,.4MQM*)A_7:>ID&XO@=>F;[04%-S#
M:UO/?EO%66M?.*_JZ@FK^H(KFIRDBE:37)Y7]L#8#_[R&;>R_75I9;OPH_ZQ
M!U.$?&^#\;Y\Y(9JN2V'"BHXP1^:.F-)[\2VV!^C*.)MHWH%[+2_%SC?=%>@
M4K:AX)R\]2RQ&KIH,'_2"'HK.26K8L/MQ^RA=,P+*'DM;IFW*?!!#!/0\$R9
M2FZ 8=>Y\::!>^3K1M*LM';ZG='*6[XI,+5RI#"#W!$F^CGN3ZV#D<I\HY?^
MT.T'6;L>.8P)"^OV=]6[:0\RAZ;$[NAU(A((9Y&?57>9^B)ZD;$'H*U/>H=-
MB@)38:%W(S\C?!?)]+NXGU-Q]JIGWG#0.#=\^.27.XR]#3X=#3TWN-$_)$ID
M7R&LTTBMC5VN27?M%*;,T0[2<"XE$ %_.7V3>2@&4L" =TK_0EJ+O7D!0W;0
M]]RBWJ]*NMK>Y"7L/>V0MO9Q\*W)^BQ\=H_Q#\Z1UO($# =+6G(VV[KQ/I@#
MX?!Q.4-0X^G(".&3 S)K2-$'X7KD#X7A;&*C=[J>QK(28PLVLZOVC(&EW)%^
MJ7T<8Z=+6*T%K%=O>OZ"B0N=P^# .5_:=^<R>_8ZBPOUD9?Z&M5":0TU[WCZ
MAK7LI(J^46QLCEBW%,.NX#I%^2WN$<1W?$+7,68/N$$U[G7UM^3LG>]N!>5Z
M'ZX?U'+L7)%=IV_\5@H>]SQ^&%(B^Z16_(O.U@NY\#:ERFQ!3JZK,VT^4KBC
M+^0J?5O0:T/?@*URN6=,)I\1%0%V SO>;O=P]E%$I_3!P^C]RM.'/D1RQT-D
MS'VBZ2\IQ$D'@MW4#;WKVI7SD+[(;++,?<=O=\CJ,EAQ$JZXYTR'K?1'+44V
M1@T+E7\P5[NK+&6/.,BKLMD(OO?'T7L8GC5&6@KY=IIHR:Z9@EMZA0/%M2O?
M^V"XR]C*+^<2T/6$4C?"3^ZWP&7+4@/_%[.[V*&PH[[.J'JC:6!;3K(:WK5>
M6$\4!586[9B.AU<>-_]N>1- /(42N((BAJ6<WRAAR<1&3G>FC9JIR:>LR10W
MTEEV1()I,R0P=FK%=X4$,Y-Q4CL1+[KM!!,DJ+Y/_EQ[V7 %-RR'=\A4SM=&
M'7KNCF:E)MGD(X6N%T*/?.',O,^2'T!,\DL#73O1L,'E ZL&[]>MD:7WZ2:,
MNS6F#KBV$&BQY(YVC/3#VS$N[:T]Y,KB?_PM)DY)D#CFUA9[=LX<M\C7FF3?
M>?[3CU 2,?V.+5&#TP=QD$34&"92.A[H8ID0PIQ27?ET^\%?Q?6G@P^(Z^JC
MKO'LW,*+-LKD*X11KA/4 S; Q*IW+?O)F=\&67D\NJT"!,E@131#6Y=66FR[
MCE1<7@NFA3[/F:5*5,K!B<P'<5^G7+M1WPMFH:]<.YIK3F0]X,C(4FW%<UU6
MCCDY\(+5\4F;NBS57$;^STCZK\XM/!= )LX"U9;/86QF)-!$(AU)$D_UAIM)
MY"W49BO#X0";_0W'?:+,DBGU837'.379=[XRZCU4A_M-T2?/^/,BIJ]A:ZP1
M"T4PYJ949T@3<0N)NEY:M<$'J!3T'&N[J'9?D\7=R&+Z"L>.!\"8$KI54C^N
M,RE(K$B3*X7S8 F3-['Z]$-/<G(=!/,$/7;XE YJ)7*1SVRE4_':7A.-V241
M5-#9@U*BE.@NM.MSUCHF_5>?!SUL06'$A>_#$^WK*)?AAUQ09*[#RW4B_1$=
M8[%:DCDZDT=D 5D.(REI( Q'SC<V).":MK7C/.=D2UM!;/),VT8.F%Z2NR7C
MOFD 9-QZS,71];=IS\V)!+V>X7.9]^NR;\$Q[U)[B04]^DWCNVQ".*_'HB)U
M8_:V*X\-LW@\GW;%;\:]TMHRP5UO PK@F"UYS*J'OW[?8[""ED<?XU +LH\<
M/SOL("95)OO(JBO,BWA+B><UY?F/X"Q&K16OY.]<87^V'J0P_0VUET%Z L)S
M76S5Q.HW[(2V<[J27,38"J_T#=H>1C72;2H4C9)LD:$3KH[87RF@T 1I*R!B
M&-R)*PE??O%%]L477[ O<%UL>EA4B3.3@7/G<ADZ$<FM*'=<8^)=>4_#C3E7
MM:]+2#?8N@MZ+7C $,LF0T/N&/*$U6885W.=24OVUG8%_HUF=,A HWH@S?MM
M7IIV^-NI=2_6[;?%.W^W1S5#6UYN9VIP0,_:LB#9Z6E"98I"V$HGF0#'+SYR
M;*6M>KU/(O/G7&5,HY!_VI5&0W)-!3$=MNW@"^R2E4;ND.PWQ@UY0%;8- WL
MC$U81O3/Y=#E:O.#+BCZ2_!0 >^Z7V*P,$D*!E/T^BV047&B0GK'H[.>!#+Z
M](OX&[%NE:O'?XO,M=[-R1SPZGA'V^*]O; [!R3\FGU#0- FHXC@W &1B"!\
M>1YALV0J=O)+!!VO%LVE %;A4D7[Z +^V;<8_Z& )WEUBR="SU0BN1>SQO/[
MMIUB1N%!)81E?#S!GPO6?Y.W(;H9:7&%"'$/EH20OEP\=#V]G)<VP1/#?<?9
M/84%LRC,0A3,ZBY.#_ 2S]F;3Z/Y?@^M]S_6LO37S[AEZ9NE9>FR3?Q+) ^!
M,$VFE>*Q <,S-):K29W1RJM3<EMZ$HT1/;G'AQ,Y;\4F+4W_SAR*G-W+9_[S
M\G0X[NOU"0G+^#L__BC9[AT%LPW:93#W7'$7 AE;-!+WY)ERM_+?7[[]1;Z<
M<^S[1&+?%V%.]6.G4=,HC9K<D48-^;+OL[N3R^6]W)S:8YEC!#QM3]6F013U
M=AB".PP#QT0IAK(S"M<QR!@*SI4M1>'MR@RS!VK2P$I-O>-1CQP7WY6ML5KB
M/)SI7^;!]?V/D4;D;J%ZNWTB0*FNR"+;%7A(FM*0?(G"/>A@L'4Y$^LVV'O[
M4 Z+BOS/ 6ZK[:;R?0ZW^&W^"0*'@?XH+F/B_ 0,R33.EPE:D]J>'2H=ZL.=
M^>;MOKZIM.L/>+\DKQR2>991GBU[9UHWILSS9Q:5!TT"&AVNR?Y?>7URP9IO
M""0OE_I072B"W!K;O;ZN^Z;CQH56Z['_5?SM>=[EY:GM$AX7;Z^R]&6UODJO
MK]+O*&IIFARII"Q]^G7ZP]77I *>?OG--^D?GCZE?SXOFBN*GK]\^D=N[/K_
MR-W#5!/]Y:LL?5X#^ZAMI>>+_H_D?6/[P28R$18\ZSG:R$H6X$WZS,VI<5Y#
MYSGH!O^)T_'\V;,,L <->[U:'SSC^08%AF%>F(^YE:*D%Q\R%$;2?%QF#_U,
M)"LY&.(4 J<YR7]M;G-&.>[0S'>^DG;1C=:0IE])_!+$%.!PM#9SWO4RZ(5^
MU["0XYX-H0%GV*&T8Q(LK >2*@L223/O$7,5TL.9G-O+55FOWXU[W+P"852#
M2(LX!3G:WHPU.JO"LL3'K=UPJ%K:IGQC?.1A-G9O-4ATIXK;0.0MHSF"K&FN
M)N(J?=E)^,$X)RDI'CLW#"J2G2ZCQ$BB@[?:@>HHL2]&2]3YY@  +YY;Y+$\
M6T*CE2M4%#_QFD)+NRMG-O$J?77&2%:FD*:5/> D*@DIPW01MWE,(B'()T%L
MVG #=#M=3CL%*?$Q?)HKUR?#<CWNK8F&R2MS2VY4:KEZ0/F<"TH]34+>D30D
M+N@=UTJB6AE#4L=%K^N:O"HI5J2OW_R_S!;PN(E=6GA3I0;1G%5>Q1FJ/(*A
MEZK=N=7 B9'"G+;PV?M'3>*-V:!56)U/J4$.USUTK!R WB^^]YC]0Q+.JMT*
M^']KM,SC[EJ[));^YDI:/V\8Z//,4] ^"6^9_$22N=-?M048\8OP':?Y!('#
M=!XC5=-$\@QT$_LNV)=&L0@] NQ!.7Q53!J01>]LDFIUTB2>X)2YTKSM2_4;
MCFM:'@264 70"U_VYCZGBF[Y@K[.2/1??I'!&G]]E?ZCOC$"M\+;\X-9->P,
M?,5?^,],*H$5J<@PY4T67 8/RY)^O[&I;-X$B41Z!4NCB$&1 4T;U^5Z4D4E
M"<RQDS5])6OZAK:U3C=VPIUC'/N8R3T>DP\<-SBA$:XZ-[;*?CWC*X?$(@-T
MQ//RFMBGA2A8M,&XUYB>'.#ZDCONR]+7+&VJS*_ZZH)4V04MU8[D3TPQV\++
MO?M)0NB"$<@!ASQ:MSY3GDZFNC#"(_!1VIC2N]J8DM^IC2F]7QM3\ONT,:6W
MMS$E4VU,HQ/R43J9[CA\9WL^/TTS4WIK,U/R.S4SI7<U,R6_6S-3>I]FIF1I
M9GIP2[6]2V&'QP#F/4:VTN,> MBMC ?M.X<N^P??%#)(4T,[A(E5173'D":C
M:_T1PG>F,<B.0820ZAHM!M-S.;AX-(<@3%N*3D4';GVNY_NR6HH^_O$:I^8^
MV>)?;I./_'X1L=_^>J,V.G:6*9X*VNGLF,N&5L"Y]5YR2C)GX@FE/+A1VYEC
MK >#A#<G>\X!P;P>0S8E$26E6IL0^6EC#N0&,'K-S(/-1HMW,:85$%@GSO-P
M,61G8!*DE]!BD$@W@'4)@[VXHAB)]$*;GL-S9K>"@4J9;64;8X0.O(XALT74
M\B!Y?P @^OEP[A2(V++8C3I@\W6",&A+^S^?3*0_-2GK)[4ADXM_3&2[TC!R
M6OAVPSL',PMS>&ZU3:8=,IKD%5+Y B6$$7WZA["D5"BA#7#I)I3<[\51_S\J
MJ;<UI'SS^3:D?/G%(VQ("?>!+%[WY*W9(>M@'S]XRY_D:,M;^_B'^_%RLD^:
MB;$[O!B.#S(<;#84K%<QOP>%6G8/F35-$N'"/FJ32.9@FIU1FCB S 0HW#,M
MF+W]&7QV\2UMX6"V8?J(O0V_FV%:I/:Q2ZT;QYPC*LA6RD@)MQL"J"A,9.(C
MEI4@A*M7+MBST S5FH6ML9E8--3/644^1.1WXP-!<OMV3F1=AQE=:]9"BI!C
M4>N)DJ>(0)L7E;&HC,>@,A3\99:(2!T7PN!@T>**53P*ZL0U] J"UB+;$(61
M]CG+F*C9+$*Y".4C$$HA@9TE"XV#<4+EW2+W#Q@H8R/I[&QD8P/ _* 4/L^$
M'@ QJJ1,DX2[=^F!D0E?!'L1[$<@V&2R9CJC@62:"CT=W#7G)@VKGMO$HDG"
M?= "P661UO9/:LONS%C:M5%PW_@BEXM<+G(96TSEZ1F&L(*D2._0<Q)$W5<Q
M_4R$IS1G,8[!KJO7]>(#+R+Y*$3R@T2A+2QL0E%=(Q6]D[@3))&YL(X(BG@L
M,QD[SZX#1,199CM%CN>ELNXG\YQRVS3U\2AI:@7Y7\SJ(L./188_)+FD?4W=
MOF@V3Y"1/J7/W[R2D142X7;+0*^%)7!<=SU(8/M.J?#.&]A9JV 'VG7N;DR^
M*8$DLLCE(I>/0"Y_:WY)C@47: <N+QO@14H6*7D$4I(?5L6NK_MYR4^0T1F,
M85\;:7TH#K;-(1,#)2T/;J:RJ!C O^U<'<72"^E7%W%:Q.D1B%-?;?/KFB%A
MYPH4BXB@#1@G0"'/EYW8 KUD?T1K*KXYT94:-(K/6D2P>+< 7\1P,"\5(PIL
M1PU'"A*X5"L7P7Y\@FVYCV8)5$SXC88!#)JG+]]\EZ4OWOY$___[YP.2=H;I
M*$QL1MU$;<'4./ENMG*!:ND;Q6$8TZM/M+%G"F%9@*;0=@<=ZHT?<NSJ>1E<
MF:SE7-2B%!:E\ B40E\)\=9L<]\4+;K\95Z>@6-+(S1C:/QOP<VBXW Z/<TC
M*C)9C=%2-<:+<5WDZ#'(D07MFB5#(1G6?-,JM',*>!!QM\QK&Q@ZYT*]U]'S
M"FW04(K=0*UV#0*%?I'B18H?@11_8)=M. >>QR R% NCO6\0:2[BLHC+(Q"7
MW]2.8\$='$X#Q(6,7RO63VS<]\\C;M4)6\5%QIDS9Y9^?"F#+,+X:(31$U_,
M39J*:Q=21I%(TG&Q@&G1E=G1+)A7V;>O:Y:H:#8RG&9"8I&9DZFY^K@!IFR
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M<1^/FQ4'3BAO+GKM(R_5TWNY<Y$)= _R0'Q6\9>M +M:1!_'U3.-2A0X'!%
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M!QPPS\[K*KICV]$V;I'A8Y!GR1J[W](ZU,MT16![KKE1$,QJL=TU"2?^%5+
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M"/-U/FP=*=48&P_?:##O261/(GLL(OM0JQLA0F9W#TW^T1D.I]&G[Y8L@,0
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M(=B=0'78#Z>FL'7%198MD\KJS(<43)FU9?4A-374" &^8-Z>]-S,>BI)P!7
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MS2_Y[AL9?"ZT[_7TVN75R)O9=3A\J9*.J3W/+)E;V,#,>8U,F.ZB\L*1@R>
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MVRU2"H.O]!19P+9;-Q50M?+>[&##]YDQ;%</N%7XO:);F/&MY_G\-D5:12\
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M4&UBT0X^^I'3 +R'2WT2F7;1^3;)!9$D#FDE[K"&/T%F01R7A;K]BZ$"EO!
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M $5PD,UUHAM75J?C7<&3ADDP?^KOX,YB<7+9-@_]Z63,7')8;*IJ'3D$^)T
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M->M:/>UCS1R&LC'LPN102V9-2C]5Y\?D"$6"^=?"=1%IFW/G6RHUG#98^KO
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M$_B:HSB'1R0R4V,O;NGK-S;MU+1J'4G<J\IN&-UV+>/CM\+4FEH3TF')H=I
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MUYQ9A3WDU\-M79GX(!/!-N6C(,WP?$]F(XZ"W\@O'.5SGEP?JPB^A 1L'S<
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MZ"_=F(@0DW$8W,#5^UTG=%EP2E,FFF.R9BU=1]/02L;B=5(QT0*Y!Y>F//
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M,3AO(I^1?,ZDLARA.^\CA&&,)_/3 8ZVM^:(Q/0'(=V082QC)$FO UB,NU
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M27@@@L^P%?J>R;VNYT5T'LO577E2K"?X>:M] _XW7ZZ<89GCG"2!"*$FV35
M3H1<^$3WB<LOI"!Q%V"4,-H&R @0[BN@T>8C !LC;N@[WZKS"1S-0#F0_U+Z
M0^(=Y[\%;JTCPEFBOD5P*00B):@FXTO[]J8\XKDISO#&U&=X8\J<<,=\,0IS
MNPEA;J"3U_)%9/M^%E?#,[K%YF0?*;89<XOOQJ$W=1]-^RW%*E$PF4"'B.R=
M#D.8)X.9HH Z5^%C&12./7^&,[>:=N;<K^+,K::<.?>LG;E[DFT/Z;+]]"/N
MLGVY=-DN5GJR#&'Y_=@/M+R.D6Z "#LQ2$$E9_R/!^E]G\E +!G_]SOB5WMH
MU;N^<:QSCFD>99>&/'.X/NL-U81.#]L 8T6N?#_,E:>\FY3-32/+R2V)]R%<
M>F$C^<-QWYP\O';:J#Q#@2Q@%BO*?E[,Y9ZL66DX;,EA>:'_G:G4<[H7AY#,
M8KB>CP-(^I8M1&+,QE?O]A4)T#7K/=_/'8F7U1"CE'9TX/4T$O5J%='P-$^Z
MTO^<+[$X3)YCXCMJK?O.FT,\L4'L:XG<U(XU7Z*$7E2"QR=0=I93M>@EEB>D
MA6YJ+) XEH'1&=Q'/\V$DX*QMSN06%81;(Q@?E],E[?HA<YGR%W,D%,($O.?
M*9EM#*QC6E3#E5T;XDU0?&FXV.Z+24)0W#B1,U22LZ!6Y\Z0A:YFR$(K2"0T
MDKSD6.SQ&$2=\E4EI*'CA,X\%ZX=QL.(1167DJGUN?.#F&9RS19LQ,?+1ZDX
M3\Q[V4@FFJ?')9VIZEGD^9VD^<TH2U$-X7+*TC/Z5C/LI!D9Z8AQU#T:X^B$
M:MVHS7TZ;U [R:C$-,%J(DV0H!R-*)CH-_ =&F$3F8ECFYF8N1AGN8>5QM8D
M6=^A>" ;1U,ABZ98K\$/(H![FB,F?2A==V@):=IW.KKW@6\3EX5YM'/N<X=1
M?@>>VQ@7D*B_L48-U+'W*&5.A\_Z!F-&Z"EW87'/W^N(OQU:9[I]V+*LB.FC
MDUM;+%)YVU2L1_PPT;Y$1C?GFAY[N",ZX7Q?8GI:\E33";&DN )>J:W!GH\%
MI6;-X<"Z:K*K-%//JNKMT+&8JDHMSY<25FDI 3^W"V]3$^K#%B=,;<+EM07+
M;*\3C9<<48@G!8?_J&Z9+.D6TN'U<%B#SQGU9-GMV$&B Z=;W[A@4 EE4YVR
M(K6KZZ&$-_%>43A<OU<XEW\;[H\X\8Q HL\J_8-^>JKFAW.5%_VNW'])N2KC
M#J0,_WS!72I:K8]0B<SBX9CU]V ^.O)@X8ML@:/]<J.K_E5WZ:Z!\!<U/H#W
MN&G-Z1"=I2TIH&%&-NRPX.9TWD M8 S.N'8P=]<0CF!(%X-7K*%8Z%OBW8ZA
M8'D$">,!\4MO=TXZCTY!7# X='!04J[:X-XT*G0'$$1%PJ"##YXH[CI(<]M
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MWPQ7W_AS]]XZE.S@R<!:>9R,I+U;9R9[HAL_$7P?NLALO0J]6_$)QI>WENL
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M%PKQ2;?(N,,K90*04AX]D.AOH,FJP30.R4VKR'P,<J(?N$OGS;*#2IZ.,IC
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M:%GW^2\L(=9[!\Z/8:WJ'&>YW2SPL=H&V*P.%2U&>GX3-F/8LC4UI//Q,U4
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M=EU7A:-6PO4%9M+ 7:OPG.T$W)7>8=WB0<%,(V-*F-(_A/*^W+('JXH/]6X
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MWI]/FT#1K2/]Y_KT4=QQRZ'^T ^UL++]3/\Y*Q'ZMPCNRZ2;-5NW#5^TJ@G
M+]CA<EXFY\4>,1]B[O,_4N$083?+(5T.Z0=P2"\6Z2*4DC(N3I_7$-]"/P<D
MFY!<8EOHG[;^ML'"F%:)M*1]V;T[C6X6C!/\5#BW4*W7'M?1D!&?*V6O';6B
M7#:(ZI#BA[!\<4JO^AY*\ 2Y2)D%Q=\HPDHV'!1C#T:U#A;NLISD1QHI+P;J
M0S=0[U A@+/?W-5I!Q^</: :*LX@Y2->#O+FU0%SZ$)4N[UL(-SL,!^IL%F:
M+NGO&+2_G.GE3']X9_KQPGW&JB";%3$N&X;4RE"14J9]^-45+$PN[\G6X+\,
MD^FTE]HJT'5O9,J9M"D2.9&+!<4""X>:<H($$T&TJK;-*T_)K$_N74NHA8%5
MW@2SCM_I"*D9@:/ +[WI)UBF9MK,78((!GHPZ.B918J)&RQ<Z ":Q.H+M=A2
MZU@]^>K:IQ,FND*6$^Q+[JDEVBEM+CU$NT)LA+K:-C4CS*%;+3RWU \BSB3,
M7J'/-,CFH8=*.9*A0'$H[))FZ! -EE2UW85+(@1FV(=D"U$ "V^E;<'PWQ)=
M2E_MH=\9@X6-4,U#2+ZM_'8!H+X'D8 D4[K#K8G0!B$'HMX0#'JZ9"&QL-E7
M;#0VY;'JD2#B-BPP=5U$T%9&[("68'L+V*=MZA,Y9*BK_GO(0&'<H99R/V1G
M$(W^W4USH-9)#0##OMQW#3F&U,0:MMY-=>1OZ(:6]*QG&&/AI-&:VB60L\^*
M7 P+)/JQA_J-O? =[\>P!+VOP[HP^7I$X3%PT>(0DX8:,,/A0H(M.!RI-S;L
MRW 7@>&5C1F_G6( H3L2]R1<*6Q$J=GD+$#WM^FV+]<=*5<B]4E?HL<2?NMW
M&0U69?Y>LY47UBMDN\)F04DY3%^A33L=:$289R'TG#,H4(RHI"<(*":0  1Q
MRC7)3@,9"B :FBU. ^1$ #B QQYH*#Q;C&"R3YJ*T;>V!)PXOWYU:@9"G")1
M1Z]<DD1/:;LMPN=][$,7$M7,@$W-"U[<&"AN-D-&OWNU>J746-" DJ::)<]E
M4!RIO4JVXG;P!/:F'!<VDP<K5-7LBB#M&'DJ8:38UVZD,Z"!IZ-XZ-C >FS0
M&-U6;5,?B!SEZ]W$^(#7AOI?Y'PD]#AVA$5*]2+(;+3U)VUXQXYB,I\0,1M-
MDB+ON1(\N,RZBVAXX\(@5UOF'-Z)!_)OWX0SNPU&8$MM+NIM8A=9.QRE=Y7H
MX>0 I ^,6&*BE:6'C/W4;!A%U&F)U'AA8S:;"CLR&+)#.!ABVDM^%2EZRP.+
M2Q'K!ED;HFHW1P5'5"@\AZ"[:W\-+4;!/N;S P<BZEH)#6X2]>1?X3<-WN#S
MN)>>1Y?(N?[M^5AUZFBE5I?]YGBL8E^6-&-AI_ $K]Y=3BW@M"GNN<WC4VZD
MF!CQWTF;):49IT;?Z\JJ#SW@6BKF"BM$ :7,7B; JFILQ:/8";8?TFG/WO41
M=&>Q"MVIZSW097TQJ" =>_O&N8G?';H'@?4*AV3N"I:>.QL3N&YLK,8:20GI
M4+_U;;F'0@E8.;D(R(' TS$Y'\CB @;\1>R[9%(7A3B"(T.&E\EXIM5?IEGG
MOE:&T*E%VS94#(,WP'5Q=G DJ/..R0T.D65GQ2L0AV@ZK;BE=./50IB #<6M
MPA7$<'6"BFHSJH6*QFL'[\-Q(,?W\];754SK1&IRPV4PE]O.DBOXUUFG5)B%
MJGH@5CYS..(DC^<X)K/NGV1'$#YR_'<89,"89%,PL2"@[ZU%W_S'-]_E3#33
M^P,%63[[7-Q:+#ML;E!_+H':8JR1S@0LZ39X2+3%-YNPE4N%$QM^(?-F%LE0
M2!XNK")T4% LDOY$<+,:4G6(/<K0+L4.7/CJOP<@?92]%D,A(:&3OW1A1GOB
MSY-_:GWP42@="$/>MN4=>EZXCSKI$$1?/\9RF,8"!YLXXS$K5N!^Q,:%=JA-
M9!"^$R8@5<OD3!;VO;6Y"@ 03LT;J,E$ E!C1I/UP&M=%$0A_Y#RLNY@) 4\
M,3:$T5.I)8P=/DQMPO3A\?;5_X0!SM!BGEN=ONE)99!;]( /&GO7F/XH1L#<
M4F(IQYB/R)H!V \U_S/)%;05.*7X&YOJMDH8S5#9HO/"PQ#FH>0O\UH9I;1)
MHL0Y;N'8M.YBT_KS\'W?<T[F$8M)O_F;S5.XS0WH+=Y3T6S:"-"R^Z9<T=?E
MV_N&KPEB[C+9&$A!FD.Y9093^G98[_GC&ZT8!5J47 =*U_!^/^,>3KNM\-YS
M\S.@R<NM&+;<<O,X8 0P$KX@.FM B #/C"M:=>:8H=<2R@DPC_O3!,^,(:"8
MK.7LRW"<;_ FEP4@.1J(3/DF/I%3,6'+PI->R*P8KR>[%Y66#<H<!\J,]"R9
M:!<>BN\K_K?DY\/KP@2$'\%A-[/?(G99IU\$5KZ;4Q>AN#?^@/]Q\&%UM\J'
M0WY&,H4KG<+P-K@I\?W5DNGHS^XH-[.C;+M.#.;IXJ-LT5VI:18?WWYS4@J?
MC%0D]]T(9@1+/F$6'\\NOL="YR6=+&$,'V\GRZ=+)\LODZRX)&7QF) <YBJA
MRH#E]]7"0(626U*V#4Z3U"O8)#F)/K@-$+]@ZLZ&:EM<LDZ:%XY-31K+.R%'
M8 79GBD[\(.WS7XX4$A#_""V",ZW(M7)X2($9P)\Z_!+ -ONDC[N)D3JQ=A!
M''OS,>7U'LS/9(KREUCNUT(?441G/\;W845???>U1M>I#Q()?%T963:(:'0%
MU*K@@E.%0G9!Y,TP4G<,DLT3#C;+D(0_N)E8*2*R7XCN.4O#*!)X4P+TBD6^
MI64&N+CJ;?!N_M'<>919"]'B_&;$U-0Y3S2K!R*UC8/W4@8\'%8M7/T\+4T\
M4!',# E7$(;#[6F0Q^@,5;W\L]G#E&[R4A=2ABYVZ_ E'-"[;\BA&VO38%TP
MTJ206B051>C-N>>_)D4Z];/32A-,S]^__O:'+U__Z_LO5Z\V\-B>?8=XM-Q$
MH/P5(FC4I]CZ/DP *=7BN4"Q6B2QLJ1JVR8!6T=J&9:E_1'5<BG\1,RV2>\1
MPUX!4X#KJ)4P^0+Q8&+1!CYP[9OX&00M96N^]OV=]W.,FJ]O@ID$W<HN298Y
M9;?D+4V,A1F4*.55FZ=0FXA?H]9N]5X,UR-Z9/=W&S^^D,U8034A K=-/Q.0
M#N%Y7%=-(FXNPAN<._!ENP'1J'#W]$-\+"PUW% .4R[^C;KSR0#@CQC!7%<;
M(!K!M W^LVB\0HHO'AWB;<;#V;8E,T7JV:!:M!*'Q:8&Y-YVQ$)>^UU%^XLT
M*>V/3C]^*0<]*J\6D[ FFV-B$P2O!37/5O\.=K!?090M2(9T$Q47;Q?.'!C8
MDY,;E^]9BM*IGG-@T<URN*;_F<INGA?='/'&GV?>(B9Y.BI3TJ-P47$_4?YG
M>0.86QZ>);SL<MB6#9NIFA/N@Z%%#>76@^<!B6.3_0\7V[6WM7X8:AV./XX,
M6%!?0%6=DJYA"6"U"L*; !WHP.$ZCG,;/&CN2/1O*PK5L=?@IMEOT?\F4 =<
MT4BK<XBJ*BB^8J5HR>."C()RK6(:^.>:.O2S$]DA9ZQ?VPP<(MPU[7Z;)>@2
MP06<GUS*GG[YZ[IN;G472?8B^WJJ/^]>P6GY_X(AVX0[]YNP[=[@M[_;!2O0
M%JE=ILQ%W*QG7G[2ED>YZR_""KSXJFR!5NTUG-#6?<T?#";WF_+4K%[C^,-_
M?!$VWA8U?/BCJ]=X0(L0<//1Y'_71VC %;P+Y%2B(NHWP<&LKLOZ*E@/D<%B
MN9VJ!]9M]IX 2=#[@_LCY,N,+!I=#*\)&LN.T]^O5G\7KPI8?"'YQW_Z)ZU2
M,;& <17@.F#'@\5ZT:/47T5]*89G70\A-@NO;A!:C$).4)>_54^Z#8XLL<@@
M.KHC+Q9<<L(^)1+COXN@K!S&G[Q H886? !*_S+%UXXKU_;3"LS,4%UA2/]G
MJ/WJY2<O_\CJ9.1;(*R-M#+"H3ZFNU8%)=PU3L5V]6/YQF_+R6]!0C+\-?V;
MG)W?HCY%V5%8JQ2#Y0XT6, (_F["PK)O\&/P]X$V^S2].K@R/*[I.1V_U\2<
MWF3S.GX'3*0[ZLH.%T8G]6!Z>@&"-PB%"+-[9G3\Y71@2-6V%&X>6XK(0PX\
MA=\+"SN'7K +N&0OO03&HQ&Z]YA3JOUU(X*E4NH()WVRVH"(DG#-17UUZMPI
M$>$/F ^;;B"0:7Z<903!YA>R$4WAU_A&M+LH+U:LB+B>/A1L47T-M=80<)/<
M#<!:.BNG9$V3*<2(CCPJ"@G<O3!GA5Z40[K.0&=08^'<R[CS+R/S/?$H,T(F
M A2Q6$,=2E:WD\HK_R=Z3G39X_ES6P][8X7U,0U>1Q!)K!!5;X)_>=,0EE%K
M8+&>MJ+2F(H=L4S%'*8%7TY9]9F-/R:<J+8DQ1WU%0N+THR;3%F'LSP8U3XJ
M5EDB+:C\D1:GBG)9!L+$&LFI\)"N#;I_@J>(2K]CP24,VNYXY7&3J*>F*H%X
M:X 2)A(P:R)(TQ#<3GYC'@0_TPS@&%V7[58*8L&9K_IX.^KW*6U"ZIT<YHH"
M@FQ?5.B ^_)J]4U8/L!9%"[E[D^5"9M(P)_H!2"S79O@9@G#E 8_YCQT]YSN
MSLT B2R_YTF@95LP*8)A)TFDE<=D$!Z3#@ J!,F-[N4NC<YN/;\9+[>-N&0^
ML*(\*86&PKAR/V*H$KQ"N[.R(FB(HCPS"GE(D):;$R<)E6I9OLIJ:5MWQ\H*
M<= ""4K B7*F[H_[<&[25XD^--881A=#6#F7! .%J(*#N13X8K G, ,W+%S8
M(B^K6EXC/14S(;+1Z&,0=J54Z[S9S8LNWL,C#_5U>EK=S&F-T:D(MB0)"ZJI
MQU:RS%,(ZR@N!5-B-)L!OCFIQP+ALEM#,C<EMXSWGN&U/ZRYYZ1C;V /68!Y
M-5[<9MPD!G<AY]?#?P%MA^7ECO>6$J28R&;9B(\\5(8?%>Z!]\<].[*J;YO]
M[0SY*L7+*?XZ++QOH2F6J@LN=@,:5RH2L"_4ZT^0EN%C)V%(+-1%= Q4MC7&
M%IH26R\!I$BYB;,C[B"G\CB DNR18,B@GGPI 506&R[L*,_P&"[L*(]W,)5^
M;6BA3O$@_WZF:1@[7($@"1YXZ;GDS@Q/601 ;":=_NW$2+1K$F7D(-6=M55R
M-J*X:"PI,KFR\<HN>)7:GHM=V1N*R:0K5+)BMU2=@HP703T00'6I8L1NH"Y0
MC62A<[J%VH$D8KB4!*?()II@MK!TV"6)AXK3)K^>S</__[._7'WRI^-"!KW8
MOZ=B_PC,/DI82E=Z51N\F1Q*SC,GWT%2QJ/YY\N,(#VB7 >CBE).>1*E]<=P
MJ,D6UIA^G.KX1OLIV@V(?&_: [<"7&J!\C%0>BN#F"\NU&)"/FH30N#BJE8T
M]5X!* 3CH/\]@;HIF"B)&PZ)%&@;CNX&GM%<QG@7!B#?)$:BA0MR.:H?Y%$M
M+SR>\6 +UEQ[S"U],GCQD<X5B/ $VT*G5$(EB$2JWH#0+QJ.26<T*Z%>F!O/
M1W%@?W7IHC]_^A$W?+U<&KX6Z:+E_GH>KJ9FZY!^'!6*"!Q1"-<"AJV])R87
M: IBC.!9]O(+/4T8Q<#XY^GG4N?^L:U\7R+!3D2D8C44&Y+!Z;VN;CV6Q""G
M=M$@A%8.ZOV8[*H]@(Q[)IFS)!Z1&XYH@)BY\<P+7!8HS[\LR3M#5Q AS"-T
M0]DU/HHK?K%I'[I-$P+*BPU)B8=?VNL8U5RF7CN=915@5O()P2=S_IU@4@3B
MORSI?V^M88XL1P87N1.8^B%:HDMM2=FNJ[XU1DP2_+8%I$<[$@EL**18;,EB
M2SX 6Y(B="XZ/QC?"_4V7K_;@6@#D%7<]&A64[V\C/PD7JLM:%!I"\1E8LH)
M06[.1D5-]!XXI<M^U'W,'<K=?,OQ97Y2;$^.D*,UX([+C6_7)8^F]1MJC^I+
M:"4!I'7P9JK=3MO=?G4=C,7"+!;F241@S5U-7L(+^%_3$1 RKL_! XW+T)&"
M^J7R-L9$AM\0)K!#P0!] EQO2J3^ \T1C(,@<B3RK*0S"X- IB-4M^<RY2K\
MN<F)N+K48#Q]\_"4AOJJ<T+14:S2)@OAO^'N_Y7I_D>P"E&K('%FCC\F8&S:
M=UY, _=%GT<ZD83'U?+JL1K(#@8(J-A(@)E(&\+^N:9&!M-CT\5JEG9*9\08
M(OP"]/3 ?\#8VH2I#G35PE3N ==]_G8>DWPFOYVW5;?>^ A$^2+.@YM>$*!/
M!2,M\&)A?4F,$M7QL=$M;9@^_R5(KN![G@ 554&$4CO+AT3-F:TT2\+KC58E
M8K%&[383BS$:=OHP>5OW+B^D>UHX_\*N[9$3?4(*9@(P 9A[2H3!)JCZSMDO
M,8 ,MX.I]G"LQR0$X\\+Z2QV9,6,SD30V,H0L!UM$[8M'P_7E7L!S6GM1_F6
M,HH!RR< 7T'A;P*@&)X^5LZ!)!-!^78$>+\WMF79+MMV-P'N&Z"?'3N3[XV5
MXXO +L.IO*N%BE9VG##;1]X*EY\L[..(EU8&PNDXN<;J0= 1K4.D'E,A(;L?
MTVBF?N;,9I,Y!X%<MXQ@/A!3$_;&P6]24UP?F29I R!YYN!3'D9H+7'6""$+
M+C1"A9UQ/XGMZD,EL7V2H81R#8FB&]I,OEN1M8DN5[DRA<$;$.QAK]3"\FK4
M4%CN."\4/PB;JV)3*;L>T<BF+:O<@MJ8JU DS)/-5Y)NEC\<B9F+.S:-#V"H
M(7@G"Y5LO!D7#J''YA#B#>?NV7 B,9VO:\+'WT W._0-PXU<L.XTHPR+B/@C
M0Z.MV&9#%D8!CH$,OY]+I(JTX0-W*0U&P)@E-73"D9#V9Q*D>A,.5.<H_(D%
M&"$%$EV%!IOVB9'.ORVAHS!R"@L]AW+29#$2DUP:--= +:TIXX:+3'74:?X/
MZ!O\3_C_?@ BRS"1K[;0[((.-3S]^^!5<W_BZIMR4P[G/X@S]6-9W94UDPJ,
MAYG&<F-*$%F$3:6J=^][V"X.^UYBE??/E.+N9TIA'ICHXAE_ZUB>N#45SD1S
M*ED9:SWTW+P\PWZ3<:RX]\:QLKJ,8\5=PK'"3AR?*AMA)E>%DLU)CB,Q5-3<
M[;=I!Z9+C=1%_H[D-C.BUT7S\^=>-U_7A@V3^"VRVML]MQ!F"EA2PXK)" ?F
M@[D%[(WASO@UAEMS1A&+!RBN=78GZ!UP4W946)0L67I@DZ#%31.=A9T;S"TV
M-^;L=Z17"!$[\LOC)0>?^_0OGZRVY4G=13K1=\$N@89E.'35ALF-/Y>K$8H5
M<(2K&M>':/DYMD>AQ"@Z$F\&9F7!$<>Y9$,H=P/&)LF$3-PX\1KEJ\7QG]#V
M1O&_Y2C^O*.87)P.8U[.$LSSC\$M1I:]$ L_VM:P1:A[+]X;>:98GHQ*O74\
M";CAXN\!&6]8^*[9>]OGBVJ&Z19.*9;H\1WK-Q+Y(=_T>'DG-$WZ2IB$H*8]
M\+SH'Y7<2+9TEK70Z(:3FL1PDIW.32:+P+^GEB^Y5>/["]><>-8'SU0_>FL3
M'<KHCE>>R4@83$, V<T#"703"J*,+-!;#^ZY5R(=OE0=IQ9H,H6Q';B[,5&:
MYW[93EL%<N3_B>=V%;=:1NX-3X1L%7@61MPG_;K#?$APU\(F]UT/^39UH5!1
MZ&2]*$S%;:/N.;(=)?=-.H5*\4Y4F'%V.+F[(C$WQ_%YO!$,C?QBF-X!.?WR
M(T9._V%!3C_SK?Z8'(G$OTM\57?*G\R%%"*PPOQ@EOVX)W-#PK^0?-F?- <R
M<!G&)CJ"#SKT> ^#WN5 [:O!/'9='BZ-)(+3I$Y4[(QT&RR=B.IN]76QZL)-
MWC4M-Z=CO4'+T,Q8Y_C2YI>)SB50%J/H(<]#9(<TF7<TX]3.9C,^-YYNH?T)
M?BXX^R71)./GP*\=:A4)0:9@0@3N_6V)V!9^R<4'?>RA?AU"'V79@F5'G7LD
M-;PW(RYA(5,E$5#:LE":K LK,Z1*H@MGTE,&'WWL4*-+D3UZ+,Y1)A%9)]I<
MXL6E*!L4$,%F,]#!%(./>U!WN0S#&*NB"Z[X&1Z\!?67__+=9: VSN$+MRA<
M-?\]@- N<ZR&8)15T+CQ0.AW3'54U"B:R#::5,TN&D^>#RW.=3)'05X14LW2
MI,NA7@[U!W"HW_E^E5A#"KIZ6@2KLUT-G2!XNT.(P%X<FKW?# BCBR(IG>;<
MEA.UG*@/X$2]4RM?UL W<0=F/7L^;=>['Z9XR6C&D,8'H$S.]/!E?7F7\7I-
M]_!IA6+IY5N,R8=K3"[TN:-DX<9#Q7&B6J18$J,KTW.AD@$E6$]7D#NHGUYF
M/:SQ8HQ+N;E!73Q.7NFXT')P:T-N]X(AQ0H5)6<E5+\L!C<S "5;I*U'&/WB
M;BP6XL.P$)"HO^1,&$V<<US^TPHP7,9.A9M+;@&XS%:U#8-')QT>+F'L=MP&
M>*QJ47R-5+Q8Z>:ZAZ\WS0 URTOIBD5A.#@NU+*U]8#Y"P[%H7R#]9K8^'N)
M&W9IP_,D7NLR-VPQ:8M)^P!,VL_*2> 1-<0#%)H@]>\E7+]8.;ML%"-1LRFZ
MWT*HWB-1\>B+RS%>CO%'>(PGM(7'>1!,!"1U/8Q66+0-NW0(&=)AKR-\Z+)6
M_+[<[5B:3_F">E\>[CV4#SB5R68=;]5?XO2]W[[ Y90OI_R^:](>YW6B\65@
M5%U9;PB(9'"\(ZJ!GU4/5/G42WWO=RL'+I?V<IP_].,\R:UJF%052WB.3E4\
MY O9^W>0)Z!P_#Q9ZRX7$6"'7"A9D9#%?( K#9?& G/LK82\1PI7ZJ^LZEN0
MI;V,>_7RA.P[4*S*@)9X9#%M'[MI$YC#6(J<=''+(XK9DE<!]07JO#=-]LLI
M6D[1!W"*I/7O4NR="D';IG1(\$-7M-"-VKC>* F6<A:UZO].H]!F1<R_C8.)
M<.OFOV-Y9J B&FEF3'/*95:%$,4)=<=T1+'PA2XVX\.P&3^#GO.<QOATA5(X
M:ZAC3%IZI8?L,L>Y7HV8F(K5F@$$:!"@=\9OJ>G[6+4>PXE1VC+GL;L4C96U
M#2MAZ4(/^G[I0>N3RZ@-J6.J]=<-^(#24+43$I?MPSJII:_KP40M[@,FIGL"
M0R4:NJ]WSE K:OX"&))PU5"8V#8)@(M2^ST6^J;U#1(FN+"<Q%M(6V0]16V^
M$+T]-M$;GD1HJ/1;!TT?")W8E[7I*BZ2ALF$>U>6NZ&&8OUO/\%^Q3SQL;U2
M2%_H1_]9=>6N;S;[\BTRW=SY?!P/_>F<.A.@*T.P1=N*D^;-T'?0ZAS>1@:U
MXX1WV&*K;P=U95VZT[>KZ[:Y2_<M]F*3.J?8+>,'7W!,\&8.5S<RL2*C1X54
MN]NP.&$N3VY:)N1J]8]PQX8/1(X<*A7>>D09'Y#;7_J,@#B<GF+G+T)XY'B;
MZ9SX32&A.\#($6-DF+F0O^O8 H<0_ZKQ141<O!O675]B*FV?. "TM;OQ&($3
MIEGC7/8W;3-<2P,V&(TYX?CP)C=-A^2U8=<?/#:[IU(-:'>&]0O[8P5UIL.$
M)%"FJDW*L-0&/H0E^#&\FU]5X6EXZ>%:XJ["&DS6.34UT*K#O&P+K#1P36*-
M%JWA;;,?#LP[->9L56/I)HWE4S,YLY>+V,GW;]TO8B#YPT?,0/+'A8'D@]KX
M[^HDC$B(D_J/X7+EK(U74%?7AXN>35>&+J,['\"I Q##-NV;>#V*QG3*_1[9
M4=WD+?@U1*- /T6Z%),.9_0]<JJ\U $ID)2$AK\EPKKH>?!;%<[04=6W@%^[
MAI&^" _L*^SPHU?%^S#< TAX9F>.P?^)3,$F!.L@*-#S=8,W**L1;@=)!!Z\
M[R,9U]:76Y0>P.A:;W /Z<("V-8V Q#6BYC!'G3 T=L)ES1<;,C43+Z&K-B<
M(MDT?SE=R\X %!0]@+Y_F]$"3EV  G/6*TZC@-154,K-IWI@GE\<,$TYQ+N3
MN57VIRCN8MS;5)=>[$!VUJ]6:9Q!7'TVT!A1&>$GS*%SK[__%DW H:F!/==
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M]CW$7>V)CQ36!L*$[)M.E;335]/7HF%C@30;.&9!=SX?' I8Q6D]7:V^!+0
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M^-$'A?EO_!803$O"]3VU^\>UL:W $WP>][.J_O:A79R_LSSV<&,X,([%!,>
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M;< N%#<,<%#(I&IT16_E"DSQO#(.'('TSTU*>$I Z9'&B2S<7!5<!DQ;S+F
M?L"/KL3I1W'XC\A.(1 ,B=A;TIJ62GQ;EKLDGW#>-&\U:4@*Q@HAM9@/R[QU
M2,X\08@JQWJ$Z)(X/ PYG^-1N:RVI>DH9-EB]RR&))$/,$_'OQ1U>7!^#XY=
MC:+@\-Q]D*%8S!\\?^@6PT/'&@7N]=(II-59OO<Q/(K=]VM(H[_]'0-M_O0
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ME+H;+D,@36&9@Q@81>L-ISY<%O\LVC4-53>M0%V*#I?YRPSXO_ ZVR*OG9Z
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M4PZJ_8;;!+-F6ND,EC_;<,4+7Y_RSON:C ORPFONFA]N*D_=!:61!.XEE[4
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M9.9$@.>,>($H^6&M^#&\UIVN7,?2\Q[]BCB1E5 2@C:P)UYA(7_GOQ,:<#@
M6;NTG1A,679:-,D3^N)M::+T2Y;YU7&E3P]HKN+8KKJ3!3V[OT3.%QY#3W2!
M!$;3C!3<0%4)@_Z+<L=IFJRC-0VLYD4_(S* ;* /CL5''NH;ZL\/%>G"B_<*
M"C?J&0=IA0CHEA=51VM^K3I\1CG(.U0DS37L<UR 5T1EVSK&[.)=87Q^0CX,
MWJY@]&O"O" 2]"0TC6.2Z>F>'SCX25J_A0X6) ;%&L)I/?-E+A?/FOJBA9A%
M@[.(E*D[*<J\$?**(5\BRM&5WR*T,9L8\6E/"S8Q,W1"2A#:5P\;]F-K8GA3
M>1[W95T+.\J31T^>\'7P)J[,L[W$*']ISKO%&?,%/WGT^)M%N063//8G:5=Q
M6(I>#"2!9YD)F7H1V0;:,)#C.<2/2I@D&GV4S"1-!KE&L.-WQ8'.  A.D%U5
M51X*JY3&GO+&,?3_9RG,WO[;$%YNZ/C1%^8,BHXM0UDV^/(:U\6Q1>E1C[^>
M>-!B\D'*?#]Z&NL\O*S+Q=/J(CPMXW&JB+?B*;'AG)':5WSVRZ=/GYX1'39-
MBV@C3LSY.MZCI(UP[\E?C"9_R66'FBX?5KBG \IOF?9)L2%FGN_+54DB#8LO
M'R]IWWP%-APX#?<;0%M><>G*/!<:S^.O3S D6^2"V4S(L/':LNESG)XRB31+
M0G[*9:!.!4Z<TV+.1\8+1&^YVO?, MF9);IJUHZRM6]8/(HEGZ3017^Y:6,H
M1BFN 5$[??KYJ[AR<>#D^RCS)D@498P4_]?QX#[^^M_CV.7)A*B(EO=J?\4&
MDE>J6%.YO5R'Y&UC.TB%#6X4U;LD@1+]G M*3+2[1I7.-FRW1PO*!__+23),
MUEN3"TKX%E49-BC+; W6L9ZEX^6SP]AA4O1P6M\T#RG4<7FX!C[R4)_7P?OF
MO,>H%K0Z<+MI\LQ!X$,)MHZ-S[9Z&Z^ RZ99 \,G'*M"@2.N<$[>O1G'EPN0
MA9M+O0[BD, T+LXR[X.^YHVX/3"*K\_>R E3";97C*BEUR4-$7SJ^:O7RT%4
MX3R6&,]PR0O?*@\,\6\<W_4@&I Y<*5NB5QR*K8BVA7)1<9[MF)SD6B0!BQ'
MQ!S=KFDF6HW%DVZ$F\M; _%I!5%1?!X?LH?3]$DR"*1^<K%MS@D#D1NT) F:
M,\*;U@DMJQPDW$>DR\TYO./+I1Q?*<Z7KYAEC0[7>"E578N\SFI=D>"1DHQ3
M'*963M#,L*#Q>E4LQ8#8C72F()QT#F 1%6"GM0K86R.^_D%")CH<2?QK.4X1
M<)HA?O2RVG%JQOE;HF?)>80-V.J0=P@^2M0H4 $2TX'?Y N>+LZB.[8TRZ^Y
M&R-U5MERT=A%ADB<'6''8R0)T?!%;Y1*<[EV'1M?!\L9?JRJN90GGXQ/[YI-
M3S)Y"T'BZ.IIJ6PFO_)% +V?Y7V06G+N5KZR\0<YYF5B347C33G_I"&$Z[;C
M.:9K@]0L"3#"KKF_1P4_4[PEZDS=R4LM7NDMKRO:J;-MVO-2.^NH]@E)=;F<
M4H*.AI54 /J^K<[W !=2>KG;E2ORE$>[4^5!;.AP5DTDA"JS2\M<Z0OQ[YFJ
ML&-U/%% EFWC[TX ANPV#N*M8!G+3B0&RO@;UJOPY.&N3%>7)]P3#</+U_ 2
MHD5QQ9/^&OVVY8QI2S$7B0P4W>5BLVUN>!O%_R!QX&LLP"+7HQ\I#_,&F-I,
M*X(*M7*T;".MF[2-' 6EYC=K!F'16L Y1U3:MTW!@X\FINH<0;_WZ_EIF:R%
MYV64N.&VB16T08OJD;&SMU?A_?U]<UXF7)3/\?(X.A^%- *=DO">56#H%J%J
M/#2$21=<"5+CXI-((E]19CV=S;TJ5I<$6-[&L)(BB2]$JQ'/@E3(8A>M*TO=
M9@7RX+1):+< SN*K]+R1$C?MK1[P@Y>$;QKC[P?O</;\)%],GPH1<4RR&+3J
M5;=(6V5+D8ML&<N.G5?-CM:N6)5[%GVGU1?'Z;*,!N)R55!^/'I572]H#($[
M7@$BRPDBA* JR@:;,AHGX78Z5)R$@;I>9S5,%RGQ[J 8;$*"8AF*=2/2J5(B
M&5JP7"0DHWDNMA=T*5]>F=SU)MKO<OT=BW;@(IV N"S!X=W$)\4(&R@6E@1D
MS-!Y5?"<)H4ZBT$A<MF) @@'Z&)S<:DDS5Q!=])B@=J7F(?IBOXN3B445\%,
M31)A->NW0:,H;.(U@OH8X;N>//J.9G2_(G>A:0_XV6.HZ!*1\DHA,7T\N!T>
M3'*@LC"+LK_$%JBZ;E\FBOD\XJ%\%PETEO%^C;$/T?60R- RI)+(TIYDLY 6
M^COEC'-J*#*5A'-K.U.'VI&8545CCHXKKP[6@C5H5?%8KJ_H@)[$G=!V0:[#
MZ 16K14A"&E%IG*\*ZMZ$(@K^+^(U^.ATYT9ITJ\6G7#.E(N9?3?>K]B4WI@
ML1/5 N1%)S\)>FO>?\DG%>)D?86#RW)E3D03&DX./D4#/&_A=WF>2E$Z,_5'
MB&8#12UWQ/C=:< JGRS]7B:F3:YMT96W2M2GS>OR@ZYE+%H>)/IA:>)>B?Z4
M*A'P+56R-I,"*)7K6C!Y#(U+,+.6MES'\IA)G"MM,E.2D?V$NIB.DLY;7,3H
M).\Y-2/9G#UCXPZ<)".7+%%=^V8*#ASA=U?-UM): R+P9:8$-?F2I,=372--
MI\ST_&)+.P>%=$28\TB+52!6/) 6&>O$,78MGM]SD]Q=FVS<PA:=R?G+^I)Q
MC%F(V@XT3G/PV_3GY!:A[47>M:P-(_TV3#U_^GE?WI\9[.W)[QCV]N4#[.W(
MM_K'+&BDZEO*88D1BZYL6^RJ]99DAP4NGC)PT3M2A(;*_"9VS05?\\X/WC2K
M/:?LI.RUH\B?2K?E54FO=Q&\,RNAOOL)JT5L#S0*\@S(H^DAV#Y*TQ5.5UVN
M""]I<ML%L0SB!R45"O*920U>Y>J64V(5R^1/J)-,?B=E0BG+N:]5AD@2"F3(
MW^TXE]</A>5,DM'E%?%GY ARZJ/%?V?N$?4'*&J1/A0=L,MJ6[*/3HLIN)7M
M@1O*KJ(/>DG5VWCC;\HU96 2Y@:8>2Z_G[X^Y9J*#$;*Z9E\HKO[EK)UT%(H
M[T0.2'W1,$3ENHHCC^ZE9D !G4EB\R8GFP1&17F>T3K9GW4.8C /P^.[/,[5
M 4Q+"FR+OXD;N95&1ODE=X!H^$T5[5+A//DN8 WNP6;!XL05C%,P\2V2:!3W
MTJK@G"\Z>SZAY.HK\99MXF;': .J4JI=(HFMM6L!F21WA)>R2NX%2M-=VFB+
MUS\\2_K?=$BCYWI3=)>8G Y-L/&3V&/DC*X$1_##G@Y048>_UWA];Q"TE9*&
M\L/?XWUDZ9+G+EUBH W]V'/^"?MA94?.3=61]&V1[]DE8EIQKWG[H-?5IE5F
M5?=Q?#8W=+)I<5_E0!=J(-KX/4X"UITS[8#Y\_<_OV()&N0/N889[[J"L_,K
M8";"5?&6=U5S46)_(HIW7W:QK]9*W_(_J<M"_M+@)DEW/ [7:;#'D<CF8[O%
MO:@IQY,6WQO1H*EC%S&('[O4MJ>A.DXY@B"P*(PKZ:(N4K'@O2@F:Z[!@Z6=
MX\M*MLVJY/[+5'5=<)^22=+:@U,#2(K3](.8K55U76VU#<:+N[%TUU0]>)!L
M_: ,ZV=XK;^?!U)3;+G]D!'_,MG<3@T[1/[84S/<#<>DW:ZI->3MRC!R*Y(M
MS#N(2[X>17_86GWP-4#W\+XB@5GT\-$VF*XO\:F%Y0W.\HJ?0D:Z0_!:K%IJ
M#QS49;+X_KQDQ;#\0$9GI-QNZ.:C,@C*HEPLQ-[F%P[IY$.N/7Z8)F\7O[&2
MV8N&A[X6G66-&[3;G4(68\>:LCZ<WQOP#PPATVP30KQI?DO[][]UJ*^X#+J-
M_L!,_G[D";N,L%#\[*D'L:<3U.S[6?5!.%UQ66'O)C_4EH$UWOC1/4D"GBY>
M9^.R!-]L-EKRSH=,;P\G-<-ACT#Y*)#1%J-QT+8NMC>D&+^B,@<;86@49JAO
M/%#T&NNF=O8>-V565T]I'[E/9O+-2C<;-->4K0S=276YU1S@E62L ./3PF4M
MRF6)I($.7*.0!?*&2'^O7">U[&M6++\LA5LDJ4UW0<JVYH@7_,I*<L%2[!78
M#ZZ:&"E(&RTFXR \!^GELZ^4(0$(D&#A<''DNRB]QE](>4!%(BZR/"E9(+I<
ML?_V4O5/<^;#IQ65UZ./<N4 ^Y/*<F_@O.#O&1['3PRZ#TN!G,:O@T!>]&$Y
M/BBV)R@M<WIZR]AA&B L_%6Q+@=?_4S0!\W$*%YFND)6$0_<S0I\ADT)MU*3
M5T3?QK'JS*&V+.'$_4>#!P4)E@GY52D\<."+=6,L7]":/GJ^O::D[H>9/>#.
MA:OT#S*H2Y8'-?[8ZS*+JE9*[1'X[SB 0E5Q>+Z.PA0?T:UA5!98H&0/*<TA
M=H^C"EF(;:D\2I2MJ![P;?\"?!N78L@<N7EG4Y5S)L0(+(ZC0HZK57]4KUB0
M6Z4"%S_4D=B 9PAD4VH>1FL=A .HYVID2S$V@\NXX4!:$5,&98"_3>B?:.SH
MD]OB!L4YLC&*I^5G^B$,J7:" :\NFSUP$+[=B7P#]ZUI3M199K&1BPR?7 R_
M*?6OK!IS=^,C^AMZ<\(:DZ:H7(_TGV6IX0(F2?1YZ5[E#[+[U1]VY-G$T>QK
MJLR(PX*$(D' !,F=O<WYOEV70C#@1KV&.X2^AFT,;DQJ&L">0W1$6%DW@07[
MZ5>?F.+H\,-KXAA>T&;56I!04[LG2-KDO&(H8"GA__2G^2+58A?X460'9U6H
MO5:;/&CLNH"#:H\=V*(C.-%'=#L8DQZTK].&6D<?F_Z_Y*B1$B42<];8*=D*
M9=AY%*<$C7J[N6!P/7%4LAN;^>24M4&K\/A7"8+(?UZ)>0+;V 6YU,0(4G'[
M WE(RVE:M TY'&C1[)+!FAYK: O"(XC(^:L73Q\O'SUZ1 ^A_WZ$?P"(!QBP
MU,!'AR+E3V^UL&;\YL=S&LZ,'P=K@?^.+OA97>_1;L%XYYJBE:O%DT<G/RZU
MT(R##WR ,#P[1RV^0IX=7RG9 *>ZX,E[H;/ YQ?E^*L=PW2%7<^!?[ 7,NZ?
MQB<.L<3CL[YXT;0EC09#CP^OI7R!VC0YFO'A2%8'I]Q.L69)?C/,*9D5]=W5
M3,->LLF7T&\O"M^\%NGS$U?3XHZK*60M+#\U-Z6^@"A\H[9?+@[-GO<##7WF
M@)B=YCTJ&Q8-77(Y""&.'5M]A>#(C(:OL?2@)(E'\A:PJ63DXLQ2L 2FH,W>
M25/;I-?([3K-34U]H;;GF8ZO7!N;HW@Y(%M:EPN/&MI46T1APWADVP#'EN;)
M^OEC2!:?3D7;'4&JQ>6A<?A==99W [$;$@W,B<\L<U/WC.$P,1J.[(2CH=MW
M.VY01'18=4H(-<(6+T-&&"6_SR%*BEZC^H?X3?3B-"\T8=9#KK/MP4>^G;N>
MZ4RR-0X/_4C_74&9.' !+ )O$Y\L.TZ$X9?>UD3WJ>19 K>"59QTO'TVBXLL
M%MNC<#C,KE%["P,:\16P12F!-\8)&KS\(3S\M"-^9N77Q+V0F(S;8<-%:P41
MU_CC[A>JCL1;L%S/[*4L_R;E#4E,)>;5H'??)L8UOB1^$UW$.*:3:)D)6T07
M/F\EES#4(IEL\5(K!KR5J]KH91G40+>UC".^/T&6R.12;:$KMNCP\D,^;^J]
MM@U% ]C<T'B[I=I8(S5<['>,WK@JWJ&76WB7I5DF^:]\V[@)Y*@<_2B<?PL4
M 3:*C+A!,I3R:^)@>-/.9(ISG@#S[^B1P^4/N&F\MA6X(>5XG[9&/'DN%))Q
M".4Z3*ZL;\KG:8[/+Y#Z&2:U=;YETLB<9!UUT:D#/9^#0E[NK_ 56C13'(79
MMN$>P@KY;30P>M[!8#R!K9V#@W-5R^$E4UN\&UW0T; C D^#DJ TPSPX]-MD
MWX]@@GB%E)I;<ZU7E-)O!_UAX&<:-(1I[5KL9<&8<BF%K 1[BVZ?^&?]IH!D
MEU(MBD_SGK-FC,W(Q)^7: X;1CR!$QH$"^GB,_EUQ9T$Q7%R)S]XY;*S%D<U
MR#.22X:,R*ZHQH9HMA7;LAP^P]$M>9ATH"^'5Z?X?UV9+LIHHK;291?7)&SA
M4I6EE>'+3F'* Z17^F33:NQ86P^GU3UO>ZT9YSK,.EXZ"T,7KEP/E]J/U 5T
M UGJ9*GM_M;N?X8J3][^-!%#,Y2AI+-S,.5>G,[Y9I_CC?N9X8>__!WCA[]Z
MP \?^5;_F)[[*P*>!,>]M@;,T]$P:\KQ:+S[XUH L**/TJC2PZ<IG:5D;E+C
M3N9YPFG-,YMY.H>=W.AD,<P5GU?9!>:=.FF+BKP/1PQV^K#B'W^H+^OPEWWT
M.?X(#K''G.;ZLP"+7Z+PJ$EHI@5Z%F.H565@LKC*0SAJ4>N62.  6?K#<O&/
M>)X),TZ2M/OMA:*+P\M=54N6(GX3 0SBAYY%_X00KXOOJ67R^99=VM>,F:9]
M=);8WN*6.EL1CT\>-_VUN+',&?G?S ?*K53K <5B8#J['1$8*1\X&AK+HCO9
M5@!Q("@7F+#!II?*]2@5C^O*2I3&+F'(>SX4ROBDST?+IE9%%EL!WE/FG)6F
MSI4R('TG8FRA4^WDZQ#[5\8<P/H[NQ)81".H,TB6[["HU^ZX9BGNH]C(1W3F
MJ/__V>N,[O>6$AJ+7]&>BO$8)_%9:J?D!HX,TT:+J!#P%"6X7>8VEFZ'4#)"
MO4+NXD<$L$1\"^Z!>O%C>=[N*1/^Y"O8B"_91@Q>P#;ZS%L,COOB9^,!E ,/
MXMVR1N,./=XUK%8"[#MK5Y?5-9WZ$3792WT_9QN>RX%2N46\=SQ&W^LQ^"&]
MM[4,V+A"?/!@$$M'11)_^P(4B\*^^.7IXN=]2U]H3(KVJ,74HSB)5*1#F59!
M(?0 4S&*;'M0!&#\Z;I9[8WXV2H!7H4#?2R+KERUI7R*X,GXC?R,#$O/C=L7
M2 DV;@UGOF 9Y,WL@UV:;6>7W$\[YH+#CJKZO03SMALGK@BE<Y),-<DNZ8\(
MEA#G98^A-*V?IL7$--WU.M817 F8(3L@XOUT %9W5.=4N*9,@MG5L"XI!<7,
M.GKM.-HY;?E@:3.["G$1V8\I_31Q>VWI]A*2U:O*OANKN#H,KR\W$+F>NQAM
M+;:$$L?7L=?&AWQ=]D6UQ7*5RCSP']7_?MZ75XNOB-C*,2&PTRW 2*C0//GN
MZ>GBJ7KE=/RH#TM^]>=TCR3K)+_+"Q>3/V3 :-I$BL=?9#>C4+K&%\65C!J%
MDB6<"5>S>V;PV.+A:G/^(UK3W+XJQI:94KM,0"1'V7&R"?T)E^5AOI\^D%N+
MS&0\"VB&X?2Z#4CRYD: -LE;E8KF13>%P.C,G';)QZ &]926;[9@24I?/#'?
MG781:1<<9YJ$[S3SA, W0<54:RD<%I\&>33]WF KH N9/Q%3Z9'CW"EO=XDP
M<-N-*/$A!Q.^#)Z7MKI5&Q>@/HA=B:\>ION/T"9T6T;_IK0TOB)V?2%NN VS
M/#-7;J4@R$EGLFLJQ<CIYTD+*1LL(08R.BB(+67E:(<=A-+9J&D+[&9D3;$;
M^6P%71+_1ZE"1:UB%<'6_=/7<8T/@@"#%R\7QJX@42*]KO-8;R&QGN=NCN>J
MX6<"E4;97[X1%&?LR&;N4PO_0 JLI::3@YPT8VSK1?65+ZM<%I9QXC[)7I:]
M;@47)PN/2&K*W!YTIEO+A,>?75:@OB,B$+=F.*9*.*''@W_H#C/Z?^G8JI.?
M\)/V+JR'Y?\D'Y,JXK+N8G0E^LOM X[[4]2!:V-27X9J RLCE3@32B56Q'66
M>\F.3>J74U0L6B,K[CAQ0IW<IKHE[:OHCM(W,2!0\$K64A)F_L9Z%=!Q,*#>
MEOXX! DN1S1IRRA :9U1YZAFORV%OY?*.G:'*]A+;:_5BZ3D03V@:S2,PM^Y
MR\[X,M1( K98W!05+LG-^/!B?>!94X^.^U[TXEN?\=H]3Z@8^:&GB]>"[_$#
MYD]J;D"^7HC:H\=!K4^LI9:Y'X$E68M!VTEJ:QF;GGO-SH?8UZ 4B-.$R$O?
M/J,P]OL9U:,XPD=D;1B@]*JD$D^X0"]=ZUQ% 4<\.WO&2&\A5U/2BL1Z*YT*
M%@!".UH<;?+NF!E3?<CR'7=Q+Z=NOW#[[;=(^H^W[5H?Y=UGSX[V83@POY5Z
MN[\I_-/G69!]60<3M'CRK4]&TP9$!%R"U?7NA-E,AGGQS/-M$%L]$8>\$'X!
M"15"WS1OK?'!);\>?XTQ/9'K5!(/ANZU7 .[E.1K<<X 3" IGI\<0TJST[M"
M1#PG!U&6$V9 -I+:JEWMKSA3Y[2)"&:U;^,A8_1)7?9@KTB:Y)A+I&6059;0
M7P>.E#&:,HMM\$QQ\;_;PDC4EQIJQ[]X]OSYRZ5"PO5Q-3Q&(SZQ>=&_DR@4
M5206]QPPT\5Q  0>YYB2<23)$3\-9#3%A1S9D:GIS-!4WM!$CW?UULQ-O&Y_
M=9HCS*8Y[LIHS*<Y)M?94<& C</G-CZP*R!O2>!Y%EGW>MP505BJ@_E8X,O<
M'%AC 8L=I$MJU[ <P]P";EFOH@#%<[Z 1H(P.3RTA[.X/+49^$ER.L8.]Q*W
M:B6*]/[BXCUYJ\G@"\(&T$8K5%V7ZUN^^(9I=NGIBJX"9##<W@QC1R1^#9UW
MH S-<'@+1IY:*7J1L@8;HEX2J-/DII$>;=K]RZ!T]MR!058#2G:2^.^=Z-@<
MF@>!;[PU*^F;49 @MF66']G'F&6[^,N^_JE<_/6O/UL/2KQ&<:?2AM:WH)_O
M:XB7',8\55S?FCP0+5_RW$B0472,PU>X&T+G%$U ,!/P2:%)_H+]A"BBS^G.
M_LQ 5%_]CD%47S^ J(Y\JW_84,EQ7ISM+_9='YX\\F[S:S7XT9V),55?6H#]
MMT+2W#^738RQX)M\\UV7RTN^?O:WGY\MQV5;O>B]W_1S(JS[:W$3/#)$JZK/
M?_ZK)N.I@_O*D:.P4?\;H=O)^7_L7X+^;A&]ACU*7 )R("&%E;^#)%=$?FOT
M1T[XV 8354$_]=@_.5W$J0/VY9NEZ"Z2RX"Z@RA2Z2UT!B\'][G&"[B+OZ?+
M\!F^]"F^=/%&OM3BB>FW?5WN>O^Z3S"85&E_HI7VP8BR;[=5+MHU+1[ZL/&;
M9VX>;$BT+I/+I]'O>SQK,?,L6_#7SY[-K7? #$1_H5Q8Z?RE5M/ES;]*H9\*
MIXY! _%?5TVO=<%7XKO0CO<K@C7ZD01"\#4O5WT3YST\9C##U_9%0Q03WN+L
MQ:OE[/P_*YF"T+S=R9TP/U6W;9"_%#6'G1CE'SEZ^0\) AY]]W&+M).!REV5
MVXGH912V:*Q'X8M'1Z"79=;U7"3T)[.G^F-M6DGP,Y70#=T!<<\I+#'5S]':
MP\/<$3E*7C'G2)Y3E%PEMQSLI,T(CIMSE2U_TAH]1^9A$V>\DC]/T >*+IJ+
M.EXL^)R$^W!@)U\21BV^$8BT>A"C*RY!S'98ER>,*T%'T[2A^Q4AH^;AF.8Q
M3?%#-O8C#U7;R$/5&][ DOR*+$B,O*Z68A296H<VQE$1D)HOCTO]HK\482UW
MQ..3K:<JDVI5<XG&%)+QL)K_,@\@<2WC1F"H2>DJ]>GF&="C.N0W?9.^VS*D
M2KZ(H)I4@!&86=8./3AW%3>,28O9)^YZAWSH86+H++V)PC4/!:=H0,ET$*B(
MSCJ3,R#('6*IUU;K%H4 00W8D5PZL,!1[/$C.HY_)HZ1P!R$:?%\N5 Q\;Y[
MC?D!U@/$07>Y)Q#:#6_,Q/I&)3C:'8-NK;E&_W /<,-[29 ND\+3OPZ#D+_=
M!!CAMAK@")H0,F@">B&/#)[ 53@]&<=59J(\.F?Y?GYV]O(I=>JF(GJ\P)C)
MVO/)E'Y+H:)'0KU4+F'FBW7J>U>F+^;-5&E"EEBDM+4E^BV1&RR2^2%&3>H4
M==XMEAPVA<3PSTZ>)]_I.1!GBR0S^9/H6*JLNK7IH]%@7T,HA5H0.!R[:5@S
M=K5'F .1[V7:SJG96SH)E#M[N,<!=?9_$=W)R^H<JO7<F:X $$ITFA*Z.V^:
M\60R1H, GL3_.,' H;0#,,D'O"T#T_@U7$:9AFSQ7W])]61K[!8*(7UU$2VP
M%],$NKX9.Q=WE7!'$*8Q8."XCM.1L59H1*>H\/L?E[A>,:I]9+OEIQ^?G9T9
M:(A.KRJF:HW5&/G@1L)H"!R[D_@\P"8XKBW&P0!5O:^Q43<5<9%JR99-%LD6
MV)<)UQ\S:;^/)4NV*A3.(.4%2<\!#E0YSK?8*6(6OMLXP6>]98Y89&KR"4',
MVX2I6CA310_&N/1LWFZB<&KY<-/9Y:+3[4;),22,C)):-C%.*AE2P_:A_TRP
ME7)M+!<_M$3+_S^*J]UWB_\;GW*Q^&E?+%[00U",JB V0;X+.6:2[) M$F:V
MB "0"7!7U5MZ5T:84_XH@12R9"O)75 L5#**="LY20L:-'*2G<XN$ =591@!
ML^8V@9XL64KJCI5N!Q_O#Z,UF2O+\]:%R DKHPGS>"7F%==U)K:=P=@+HOI"
MXB+KZ\QZ-#2NF?Y$E8M+<TES=#C"D+/6O04.;)&A!Y+/:^*X4P_@=U@2"PQ=
M6C1*II4FYK0XT+6TB!#7@N'W@L/G9<=CTQ#S#$@3Y0"#M$= ZP(2X<M-SH9T
M'VE$KQ]U%S#MC>-P6H\HD'M>!ZZ/2([?3/^@C0WI74X-@E;O1^PJBTA D"-4
M^-H+JXTV5/]H5LUV6F5&M;DY?',W8:XLDZXD=!!P!XC</(90'U!]T'?3GYSP
M:2O70U/6C:T8AO$3'8'_;*@5R-LT!3FY65I0U\,>O;)Z-][0"92K$?;=H7#C
M]P/RD2[-?-CRU),[C7!'TK7K_]H7+=_FH_=89._A+^/X42ZIO+&7>-I078-9
M9UGG2QLJ8<1S@?8P<!'H?=_'&;C3![G7NP6W1HEBTN?J>'!DC ;],;8X\76Z
M3;&*9I.HDV5M?(>1WU^VF4;C#[]R;08D.X/.*4#*=]QW M]AC[U(72(8.MI1
MR+-"N*AZ0X,[3>X#O^8Z*=B-Z_+*)!#</KUKY%<-R\DT[0UM(%J6'7F]I>F/
M39#O*!().<7A[SO4+(C;YTWF@^+:H0;'E=1:Y:S1\E(I3J0/>@;.!)4!PT[0
M*@BN%'QKMI^[5 [!%4-^M@Y"W$D>AW,HYUS@P6D.[[?M1S$^&3ZJ .*YY^6A
MJ24V;*"S<)<O7]DC.<R-<Y8[V=F5/?*TI9CF?*UJZ' ;S)$&M=]1 F+*=Q:Y
MD9-TGL+@7K\M$< %\*);%__U$9("U_*UXE.?AMM[UT3!PHP&I;,1MKQW*#5L
M@YNVE&[+G,:;9R*)(&,"+>KB,@:59=MEO\>]$[\+J07^$6<@2?B8?GK%6?BI
MG ".'3F=.+YA6L=K)(*,IDTI)4CC1IZ]X"'C$+LF4:'<C8,\#)Z(\:-MF9&Z
M(;T\M9/0"MU$!\)HNA/E/_IRL!NSF@(8W'JEF$[)&1Z8E$RL1T1[4]D=W[4,
M/TZ#D+[/T>2EQM-D39),^F:#>-PI3C(,+U,)4?^ 8WB/%W49X:#IXNPM$1H)
M-UKJ.$W!CHJSH7#$$:2^6MH\*]OP$WQK;RY+OZS!+VN6(;_'/L'L@J6:7GK7
MZ['8"Q 4=1MU&;-E&E:V0EJN7]'*^!!9? "F\.O?,:;PCP^8PB/?ZA^YUA.M
M8T@>ZV5%!EJ$4 #;GPB2DJL^0:19R2]!3F*6.UHNL:C-YLZH6$@,W-?$6*(%
M24QJX6J2_Z \G=;2Z9[U4"_XQ"U>5#K6O"VO]%16]E9O$[=^EQ*"RLDBJ=3U
MHMQV)5/K("*80SD%1CF)%+%L'2'+XIH%O@YJ/YS7-H*9J:2TU+,PSDE!)4XX
M55U.-GO3A<FG[1Q6COV#WH>UW,?%7E6;Q? ]>)(1V?;=-(UT2KUZE%KH!/R9
MY]==A.75I[(H2YB,YO(E]TQE\341# O[6\A)62+*\C<?8-\VJ41N8;-LFEW1
M]<QT'6< O7+KBEH)2?4"&IO1<U$1GY$6)9O'^QW 0&]ON18^>"XQ'O<)6L3Z
M@XDL^GYXX882B(R]S9# 9Y&D<W";N)-BLQ3<U.1 $C'[ ZX++^VL/Y?)X[!Q
MYE80.(/_LHPZXXIJGJB[K(37"QQ7Z2+*)@#X&[(^Y3HK5HPAV#J-LC[IPYWF
MFX\'U7)DMY-I*!HI.?/7N/P*(+DF'=2M*DX6K1CT7)RW3;%^<"(^>9\X=PH\
M1M?&XV_OSU@Z[&49-5.\*$A82*LZK]/Z4@]!:FVPGP?T%@PZR%-S>+' CHBF
M:8.4,#<)C+8-K(.RA*)JK..YRL8S^,-383L%86(S&-EB,#+'\)AND2LJBE$#
M]8"F5RGI^$IFB.Q@T(EIL,BX!O7PV&&ADA3/ O//:+E71,)<$S #8;N2%I=U
M!>DN9*@S_Q14:?3 'E)4@ ?0<ZSA]Y+2(EYI*U3= )X)$KU$7SAX+:AGIDF7
MYZ)Z?4B^F)"IV% )8K A5#QW'_.LL6@S/31.23@76A80PDA3L\'75O$&OXI#
M^$>T*C7E%X$]91A5&1U*/\$J\0XF&# S$?T7J^CA$FD$)@["5\ZBR^Q1\4+T
MXG5+#16_-8,[N'KG]A5[O4!0GPMOD31TY%I%2%N.^4%#UAL]KY[&OU'Y;^G.
M2'W3266,^K%+;GH;KNP?/#V"3YO%F&37EB?69-'U\?IFGR9OO.A<BX<H$>(8
M?9%O<%S;;I-#&TT_ZU4GAFQ#H2[)3:5L:WJEL2A)ECL<KN_BCO65T\E07MHU
M"53_?C#C&3CQ'/K8*(&LX'077:S6MY"2AC61$HWU>P\6>%JT@K_*H6M256;>
M6([TX(()229BTH&\JY/:2%J3K!0YH^YX%+?MT:6HG@%BAK"ZC'NHB79U&:.
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M#S;1E"[30='Y?LCD'G,F-]-"'7P%M2#T_'C7GBT(J%]*5Z3MRKJ"QIMV4S?
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M58RO/C3=BN:FVR3:;$4V;YMHO\,&/0^B+0<C3X$PS213H&5]DDB=3RZS,_$
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M=&$%<8B<GOP=_/P?R_-V3U[*8TX!?#UV]/W.4QF!U\0_4VT.NC6>7R&:F=J
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MW<*U-V:M55,E@-^T O?QI3VY#A#CRF&5:K84X!FO9DT;!S+Q,<VA=+ -\KV
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MXO;-8[1N*?&%3F'-[0(DB+B5NY*8'R9!N.C?)[SH GP9]L/J:IJWNB;MZE6
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MJ:_AP,36 S%'6A%(#F(P+$ R$IOL(][S(/5U0\'JS CR5>G!887!50MV-4?
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M\GID;U/!O<2Q5YW4(] PA\SI]/PC]R72X^5M-L?NO6X4'>,1NZHK3 W"S4_
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M#E#!)TU)V!%%<I&%Q8P-D=F6<N!,NYC-I)A!@/LT%((S=M_52F)WMH5;U.T
MVC9#X&T0^ L/WUV^>*IKQ,H8GXK2;$;-G8DWF)TH3R)$#/?)\9AED&[W:?B?
MQ@>/Y2>:RN(1BTD7ENN0)D14[Z091#W [WH1%%+B]!BE)9PH%+UGLOU05E<@
MP\^E/\@NACP7(Q#%98NN:\=C)';!H)JCQ>I+?-[. $[V2MF_"GD0!TJP@LG
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MP5XMCS1$\P^_4B3 %TA#.)>/[=UE.0GO&N=<=<:<,@%S++C%)0U#\GH7@_Y
M)7D!1FXQO\@34C*SJH'%[\XK;%4$CB1S"4\*]$]+>8+3B__#O^4.3CQXNN$W
MQY9&0E*,5I/B/AVU\>FXU.%!MWS$893A_)&D'5 C@T0-MS7! \.)+!<+,/N
M#O'A.V?/?WD0[Z;9%,=J@4XX!]NPKM"+P50JIT- ?@&5=#.Q WY^=?;^WM6
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M3J7D]B#4=3;YC.K,!8"L*B<8)4-W>K,UU;<W 4*\JVPVKZX('D]$"_$Q,5S
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MKMMJ,=\<<A>(K$J=:D"$4_ 0*B1CB93A,PGDO&-&0(FYL,W$OV<J9IK*^#V
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MC1&?@+T*N2K*F8SK!)XUQY0X6EH@;$I;"N9\(/U&*&<\.\*N>@Q/PJ$I2Y8
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MT1T.OT9<1Z6="7T4(DW8+L%16K3)][^^B@/%R? !K+\;0G D?'[)70.-"*R
ME'316K"3"Z%D"BQ%0#DA"MEWDP>#UUC.(.B3 1['"KB052O-:!6\6HL$NP:(
M2!C8=D/JG8^ *QQG"X19$!R 4.;+5*[;#(%<2TI]-I]MQ=)6+-WYLIYGV9S6
M059V"]Z!X&PV6"OAUVR0O[W<8<<=3I,+^$-6GO-D;<Q&-;8C96@^_8:PX);Y
MMLQWA\M21R O06<F5 >C$^BEWEJTL>N2NF[Z1*^'+X2&N0XMCL%A:"DA(HP
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M7::=!#D*?T_!(-/9'D$W2-<A1L=&YCY1]$EAIX'LDI3'*,4N]F3_B!CJC-:
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M KUVB\9@;ES]='56@NW65NG:#2+\$TG=+/(X\:8LW:#3)CO7F,A+HD%;OHJ
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MMT)A/KF9SL;T([_#P7<VVQJ^W!BF.GS]+$:<!Y:@\#BK BT<,%5M8QBN8\Z
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MH+LH#V'D"5.RP/T4E1FF@ZM,'&R!@MIUSQRKTL$EP24MAYAHAR 3*)3.Y2R
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M&TCLKT2?33?]_>C3Z9XFT@:EX82.;U$N__Z OJQ0X@5]A;X',R,6%Z:9%TW
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MC??0>4[:00)J(@I>B!!:0[GY  VX)Z:G5S8]_1J9+L^B\#94 I;COV(U"D>
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M7T^QTZ,/2D;N@S3'YO_J_-E0!K"^E@@4?T/.#X=I9/$6"TOF,$HK868BDKY
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M<]NE/!#*\H#53\\K:V><AB9KYOG;9R^>:5D*1/)OJ7:L?2X(E%=%C?P9\L=
MSCQ_-7 I9_]-_Q7.P/QBTWPQE6^_^N4X>=-4=8.8DK*ZZ0L9OIE]S&KM Z2O
M\VR2/.P7H1,L/>[%^^<O!C)\),D-XT)*A\FF!3G#MQZL9$GIQ:YC6FS6#S87
M*XE+3A_/RZ88UVO*@\52%W)CX,/19Z^L9/23AKO^'2?_LDRE.>(U",04]&J$
MSD$=*DNW:> ==1F3U[2B]46[E)C11;1K=":7@K;5*\Q]P?P+1V7%[)TX./[&
M XTR*4>(1!:80,XM=*7M;R:4?R&GVA['P*2UY'G3NK6T$4V>@I5Y>5M1$ ?Q
M<4GD9W4$PE_(?(X2W7U&0X>N=]@#?0ROH:&33H_CR^)0REB.BXS&!LK1IJX]
M\6!$X\=MEF4KN=%"='_:,]U?.OAVR;C=B/N__X91PV<G!]3P+3_L5Y<*9SYL
M>#T/SIX^C?L177O_N]L;[;G2J*%N!=+>T"4,NF1%D9<H"^N#\T7=,J$_?WK_
M3](7S)==.<5!OVP669[]"07ZK(:0P35ZP_QT__U?3\].G_P D&\Y1QH=L"7&
M[Y7YDHR?(P]:-:,I4H(IB/]_?__L^7W:P=&T$$M]3OJ;1,+L./FCR+,/;*R#
MA5P4&T85HW?=1(&2B9&':-_CL88\"U'<9*](BB(M3( ?(K-/U@1F!33N>. 1
MCKI"46-27B4Z9&F&5\7/)HU*<FH*I3P^6I#TY-'B^S/U7_@#!>M&4&*C['F^
M[R\LID_T'QA0>\;'R?,J8V\S7\+ZS$+WWF28EZ,/ NG^Z?G;(_P0"T)?Y99#
MG_#=19+1JVLZ$R.!4E9V2%8/N;!DPV!KVJ-HOUS[$2N_,N/*RH^9M(36UEUL
MI6>3B:WX2P'BS.F@1-H-G0ODF!Y^%(#0SAQ%!9CIZ08\8"LKK61_Q3B*SR@G
MCB(#)SH;K4Y'W+E83WSX?2K'0#GAW7:CQ[7A#<2/NHVNY_#[G84Y=:7#,F/&
MPH8;X=;L^!;*DELX9"_^ "/( (]\]=L+\DO(D^23[4WP/X[?'3.8F,[._Z9%
M Y%%7NECI4V)?DRW+'>-Q7L>)'%!T*31DWSO,CSJJP$M(W/H2E_;%Y!ZT;!/
MA?FRCT)"O! O4;RT-#G/RR%=9@VHFA6>TV \Z)UY\T]'<SI0E*WK1>^=1J7'
MZ*2+^UA(?V(6TA97>X3F@KO))\'#BX^O9]GVM45[J00;\K5Z]/WITUO7:O"6
MBC"LM>'R"V>.E-*!?)B5Z<<TRZ5/"O<OZ-@IR<\_OXA[FO-_,HRC&39%)N[_
MV^=G=%NG&=D.=&&7^'-5<CMUND3G3:X9#A)UZ%TP=P5@J--!JX,%GJB]&,:B
M!;DJ*%1+C9! QG@X9D6O4[F*ACE,'YSE5MH1T&,_V*4\VE=3"=X= 0Q@:YT!
MHD:+20&(EO"+!-VXX$2DM!6-_9\F&WU #RBWFNT1BYG8S$FD8WTDW\)+QH_%
M@+TXFMG%=)GS6I!Q R'F8D;'YE\VM*1P+UKI"!_Z4G $#N8.)M[A/2B$Z3AT
MA!^2'7U$:YN3N8B_B8SZYXLCMEBY<R,^/A2T?/W&V?OH+GZBW<6O7%,<>HS?
M["L2U?ZHL:1-PP.)2^PDS<JQ%;)=D0="D:'EMI 2(M+(0'N0/'OW2X>=)))4
MSA;S0LS++8/4^(SK2%L""/6AL.ZR@M,;OPPAONH&1AJ:;BT1O">QZU+H#G-O
MQ5,E8XX)Y#5KSJ\E>?S+4'(/)/UR?B0_^>7 _#W[D10'R=VJ3!!B0I530PM*
MMO>#A_^C?7SF96;%W;0S3AE+YN67=\^1 ,'ZR6]&936&VUQ*1]RT1["21AS#
M5>0%/DC9/0^97'\<"MDHKDU_^]LS:>FV4GN-,T)ZLA*B(R[?0 .XH[&=VT+V
M+"T*6VE2,$YWN9-V[,X9'2U?:BHM-CG)U'X>"D?F:ABAX;,RU506@2D^+2/$
MES0JQ2>9R6'&=(U1=U]Q3;O4N-,[.5;$E+^2:^_VH4*?S)3,#EO5 ^-,(ET*
MF@.>)D>7#[A.8^"NZ)AC/ZA>3WGD&]8GCJM(-JN@VY4?)S_QRI8\S=HZ 30P
M2$*UVDIU_#BQM( =3'Y[_>;9D5^S :T/L(2TX_3O<=F0_7HT)!F&B%N>CNRP
M/-*WY_B&ID0]]MB%THYD)K8FT<>FIN$T67+OM^?O3QX]>?+@T=/']V4$O"NN
M307G,)VIQL$SI4"0^&@[<1G@/BQ5VQ9UDI+ /*??:.VTV&_2/-NZ%E^WZNK=
M0FGQ+[VF#K %F8UH3CAP>ES$HB =0"?_B+PFQ+[=V8I/SL/31R??/[W?4D;]
MV>O!2E,6L]*,);X)?4V-H)*DT<DLC<,1G-/^I1R?TZ.]_^&^.-!P(XJ>(SI?
MG$C07A02*BD61M@;@M@3_\+Q0 3>"?HE'!)Q ]FWXB<59>))-<*7O=<I&7D$
MQ@1/@'O$"PF)1]>-BYK'1B4*(FPD1EZGRP0!(K)"SM0JZ%ZYN$IO(10D+!C"
M973I[U:-^.&J[7G($N S/L#'P ,]U:(T/-%@&V,0WP*/QF)C2\PK5_'?#;_=
MHK6YONW<C=3LP<FW#$\X/< 3[MCIOSIAEBY2\X:,3TWH[+^:^SH6_.8#I5=$
MPN<AIU<>LP%*O?F[^V6\V0R9WB@?]T"^LPMT^H4=66Z8O$HHS/T(H\"3BTJ1
M>>=5/5CJW_VB/VZ%EG:D1L6#W$.12U"< EF#LUE3E#-RO<C,1X*/J:?NO7J=
MO;@? RFZ]1>)XCEWJ\.H$_M)H"+@YUF2SWR>,<5P'RG/U#H4KHM38%1L9X^0
MN,B1;7B0T#[3>N[6:=I-MT[N/?_YU]?EBYJ=W'@[7K_64.#G8=E;!_(2_NY#
M[<=!I-T>D;:&'[U7E$U:HNSG7Y[UB3(-C.]8T;4B+QA.%HL4+TA<*0.YR0L
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M$@)=N#?R]+?\=!2>TOG[8#7D.4O'EFG4RXI6H2$#7$,>:!D]L4R7;&"0N#*
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M5=G,Z0'5G'XSR[CVVK^/M0.]\/S/:=DDO]@T7TQ%?NFO\;MC]\.XR^ .(QM
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M;-%AY,@R3F0?6@1R080$?5,K>9_UZ?!!0'NIB1;A!\(CXM8"W<I##OE -2$
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M%-:P_R<B""M+5T*%71JI?>/FZ<X'JSC\%!_8@B8^LM'3@JP[:+P]#_EE4\$
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MP=TS2_]=NE#EQ90,9209\-20TZ!S,Z%/!)8//B"R!C40-J4#M^"XY%%9C"1
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M)-3FY4+:=NUT@;@7?#/.?&?[;B9PZ0*//<%&K8J2E+JG/ )@><? A18ENC'
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MXU=?=99>382%C@ET.C^B(P]EUQ7Z/5;M(H[S"#4-23[)2'"4H^<V1#(1_G>
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MER?D>K(^J\(%>&7(ET8\NZ.+:,"CO 7Y(5E42$1G@YYO$2NIRQ&3F<D38_-
MU2)\7W;_=#W)C_;&)%9(,%H]J:22E:@M5JG;#+9UWD[ZLEG*(W7-6!1)T\W^
MR-&*@CVI>*-J"D4-;88E&G!R/U,MO,)!S>14S8T/@;9#]A-.$PC8*@TL<?3@
MCVR*<5?/=*&N,2_=:&I''^9EAI66QITE;Q8'5DIO'+<#[Y+0/>!$]AMJ+ NM
M-)"V "L&/#OJ!0S;II9F?TX2QCZ3 S+*$7.F,%N<,-;9V%<$1?RS.$Z4#LMF
MP0Y0&T@IF : I>BBD;E)$R$!,:KCF%JKGREXZ=&7/&";)BQI8T1@'/W(BKC
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M?+E3E'@$E14\A\'5Y0',=[U$8P\HDWS?!1%ZY%[2A7-Y)%IQ\+XL=V/"E!&
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MCIXPDCKPEA29 C,?T1-QE _D;(5#/7@$% B#N%M:=L<'K_;K\LBT#T>S"_(
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MRT>TU?E%?U.*XC-UI7PBY^ CTBP?Y4'<[#ZD$RI"?\&GN/$<33V,__P_^SV
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MY+UPU!KS6 AE^J9H!R_+S)5:XUZ6BF2N:*5@6LZ;EM,R*78I'R.7N,NSVEF
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M/&;&*;!XA(' V4IU79D +40"ZZHE&?9DP(^]TS$:@6\.'NM781 6^O5&()&
MJ_37S!SM/ML?#8^:_/J+8-<6<3F'P#<<=H1Q; MKFZ5R/+&12E)X>5%N.0:W
MH'-6[_,(/%?A0;?Y=,*305&;<'I1L#/QH/[)=KX2U.=EF:7?S36 6Z'*,/Y0
M=;]F1HWSH(NGU(T#G'G$[*91SDN2)D.=^<:^V4P5(A>/(DE0_'*FW>IXPL?N
M$>_]8?&I\U()(O'8]=/\&%_=FS$4]P6EK-Z.]WEP.C:%A606XJBQ^^\A&(MG
M'(,_D=Q#&G1GFM00@"!YG*0V*KD5Q@DM1DT_)F&R;PV&:'(GY(O&;_P;O\NZ
M"_#>D#$4[(JV.HW-S'_%23MAU*N6^FX<F(B=7K)^ _#3QNQ7U->0$LF$D.*J
M:3>K']Q]_(V2;?@;=V7I$G>=6XPXBR-.1VL="]0LA :Q>[]'_^S4_DMM7,FT
M<>4S^G(C]_3@R>&3;^[0N_G\P[=LOR:87 :Y WX=FLS$ZB84G;'Q2 @QO?OG
M42XAA@OQ8 CHN%-@"6JVE><%F>EA L4CFI-8YBX2K-4])P-2ICOK23FD/JRT
M^M"#?6QZ$U5XYB9'1BR><WNJ^I!9XI/LBN5[NAL9C74O7:S)-QP=3<6)3UR7
M87*8)0F9CU^\%,K.,/+!L>N\@ZE^T2P'/J-.U-/(I*7T;TV+3.4;HIY96:;Z
M+5^>SD JCRHW][MH(#MI.WMT0A7>:OM868MG(OIX_(6#[3LY_>B@A)P8F]45
M]UV.^T>U2SCWSI@P+;>IY5=!07FU$%YAPKM+$R>GU<)KCMSB3;4N<9J%P5(.
M*I-NL9$BN@BSD'2W::3&++E<7Y.G45"+.58[@5UR&VHW4'\AZ!]+DD2$"G@#
MJ5X)1B"PPW*F9Y?04K I<?UW+,:JX4GYH>H8.C6^>;XH^^5A'F,G7J9 7(IF
MKGN]_ORC@:@MA1;-!;71/<4S\K^?3=F AFY@ :!&Q#--!ZKKB6N:N$?PVZ_&
MO[WW!^8GA:VO,S,6Q)E2:S5DUG"-@FM-T(-T>\-70&_(N@6V0G92A<!RR7VP
MEML'F24$T:B%A"MIP!O?;-^M_T0U*\HNF&((O_/2I!(LFT?^\8@QZV'U?);#
MFXHJ.TIQ@ 6SMA,V4A/,Z<X:O3LC57?8\'M[_B$'4IN*N5W:LB7TI</%&]]N
MEON$2\U"$W5I/+U,5E8S'22M*O2J2;"=,J_Q<B.'9-4@CU-Y@!HS4Y=EGPWU
MMG3D!G0S_B(=(0?N"%F$W4/<1!%!YZ_%YT_3[L S7:_4L3@,![. )LUM(O2U
MAU86V>PK4!,=[\3LO?[\#3MP,8I=3*1WGA/PY= VNS(,\M=:#[;_+FB!L8AF
MQMT:71^6#+M4]WX'_MD9[.,DF]A-TXE8'@\)[4\[T%]W5"\ #YN6,CV.28P+
M8:1%7]>1J;#1<"9J+U=*[(-A[&QA_JUHG @)<9>9ZB5')E67I*$U5P4[.ZFD
MIQ*,>Y/HH\9CTO.*R@HDN J"8.--+L7!7;)_R0LQMA-S0,@A(!TOCL7#,7.O
M?!,#_:2LP\66"11\5(4<=5/_OPC]039=MXL57JT=ZLW;8P,(_.7XC0B.@#8=
M\T8AXCG!LGDB1E\'((D%QS9IM38; W1&$*M1=S$1(_.T;TM.L^&)%Z-\X+^!
MG;T1ROS-?88R?_L 99XL2S>$.YR>!-HA>SB5/U_$,CY,Y9#UV7E@8^4@3<^Z
MW= 297V$_II[7+ \@5PJN-!C,;?DMIF'-L*I=Q1+7^=&()-KF_:T2WN$E0)L
ME"NVS.Y$Y68I+!7U^-MO!^F_Q<'&X#P@=G646(>$NI(',A4]CL%=B_A)?)*<
MYL< KTB+Y1/G9>FOJ:#-47-1 ORDH*VAWN&S,GU9"BJ,+^'LFI-CT_;+\65%
M-]/2J;KCR"7 )481J-PK_]CK\P)95YM2.K4U##.8P)YK6+L<9SOQ!CN/O1QQ
MS@6G,AQ<<V'5E[?][HZVVB]UII"_KYX TO=-W)03(/O/#2/TZL5)>%W:](9\
MM_6SOAXV?74@7?>C;?:7H5J5&^1$!.ZF3F?V<3]3M,F40\:C$L,C%!50::PO
M1GGEQ7FX")H#%8/IZ&6:M8\2\BQMXYM*S_)/JN2YMW@ <8JFB>!PTY/7Q\?O
M\LB8F*#FL7G.W8/BVYE+4Y-YZ"JZ35&7S="1<RT<\#-QTZH*L]-"1PDC(MUU
M?6$=>=33?=\WRV9C]1V]Y3:$-]G0.?AX" &HA9'LD K/S\[%_%1H$&0Q&5&%
MTF*+P1'GT<(*_YG:*F"Z&.1,I =9%*%WX5O4=8R+Y=\@,OAR!AH,A9[<3Y]8
M=\D^0_&B7!IN]FCU]X&+,2?4N4]'V])I*4RAT"?:S31AQXKG;A;/W4J4IVF_
ML$B%$M]./9[<?17?6C5A%@AMH=E2[^J04)>P;"+^+"L4+PLIV9R<D#X2 29&
M>XF8ZBU_*RH.E/!?ECNF$;DLEDHH(-Z.WQ!&-.*R5WQ8_E,3$6E=-;.^\GC.
MIRD9>^K#Q=^X) '0MO+*SC>3N?KB#+IL'AIB72FJ@SK_!))C584+R>XP?['0
M!.G\3:@RZ<U24TR/8M]F(V 9$_6X]]O^7Z)L--H"/IAX".X^!SNP]].L7X\9
M[,*_A^U96VXVQ8B<>K/AZE/POV(:%NBUQVPZ+1I,WR<$UOJR *-PQ;Y?%+/B
M@M:95+:8B5I/Z7";$@Y:O'(19<PH!:J"/<)0"Z@I%'&%8S>!]U+3P="SA>V(
MLXJ4D6,I]1]#.92))S%*UM;-E2%M"J527C=3+\6-N%.K)'%=47.5E4SD.A>;
M^^V3S%0X5L5U-Z[(\<U-2)65^AH E=GRJB<%Y(IPITM*.#P?S9D<F%$PDK<:
M-7!U-/O0^X.2.%UK4EN$>E7:D+A3C(LHGM,(9SX-/N%R"0J@\Z2)^*;3)LT*
MY)G\MYX3<O(U'RK[4P2^.^+VR3J<UCF%0]TUR,EEK"@ %_/%2^0!$FHM'Q#[
M.L3,G7D=T55PYDCOX>0Y-=KU H/"]U45M0C 4\4^&Y_Z/!_27!EY_!MU1_9-
MB10@PP+$NG-N.EQV4D/=]<K0-KHI=3HOY<KJL8E@@&+:29?1$!"\/-A12E^$
M \QH4Z$Q@X<Y*Z"I2JV3N 8/1F]).'-)X,BS (T;C.""5(W[?.(A372W%MU%
MP4-<E>66>3^C!3BI#0TW64 #$6KOM"O#L[3M6X%:AY*XAP*PPJ_\N7=$K%^,
M/%*D>UJ#X3CW)%XL>Q-"4R9N?S&T-XQG8FB0CQEV>/])2L\/540U.8H4MBE^
M*/<MY>!MAIXX5V]ZOF&'BZH1,!4W&=.>[FCR"0E4LY2ZU)ZK9W[DDW[6G4W4
M+YYBF<F3OW*')!D(5-+Z"2RP_JW7L=#7D6<SF3\?I!L]0=F7%EJ7!Q/.0)(.
MK4%-1OQP,*2L1&<:<^D,>S/%7X0%P8=6?AOJ*IR Z6N7XR+E3BC'B\/A5M;-
M9M-<'0R[9,5P#84]<V*AURX;O7=6UFWXH7)AVMC"[ELG8;WZ]N<-:T"/YB8N
M1EVV?&[R,T<309-'.(OQW&4WS-WL5I'C(QSJX9@-V]2E?"K36M13DL>B4^CL
M%8%* ?O /<;>L$N*LI4**[^AB64'C/Y0U\-F\Q"\_.G!RT\D0YE1%U4/K1V%
MV3U4ICY?PAD4)3[9_!$-SDX^Y)09V3C3A\-DA'SXJTIO3C-.+S\4VMB8BHK0
MG4F3'<RXQ\&2L=Y?>![J%*1_O/R@8NI8,Q!(H37S5M<,DKSOF.?BE-*Y]@D(
M<R*CO6:Q)34M>&^BE0@?'E3U9=FA$X !,X*4ZZ 8+^4W#$\D5*=KMZHGX8SY
M1X:/(3P%56T,BL\QQYYG6[R.%!BB"*,N'THV]2:2<^(DMC+?MSY9^-LO.G,O
MVK/(_+(+#F$D$QV]<?=:%^/7NO=M\4OH*-DO7JVOC]&ZZF1%^%FG_]PW\>K8
M2/44IZK3O&?D$F<G:UT,["NE#)!Q#C+/'B$>SS1C>M."I%_\])>WB;# S?0V
MJBB!IR8TC_!#4"<><5DR\.9K'GAZZ9$.FDX9,K<4E[67,H*A(VP$@$P?4#D0
MBAOEH\%B-+\FF>_,YGL2EU:=J^KD*A(V_[:T.T,40[H]+]5%D7 )HDMTF/WT
M6[] (QT\-@H7R3?@,F<>G*W-QBL%Z47B;T5@/EENP0OGCE_WTVSRT\/%GH%Y
M?\XU"\:_1K9M%A]#<['B9O<M^GA?"%5\E"W_"'+3?;>39DVK-4' Q"72$\/@
M&-H1&7=N0'T<4*P>.9XEUOV(Z,#?/>0L#)E9G##60Y!ZD<H%&@JX*UW^0@CH
M<"0,NMSP.O1K"?B94ES+GIM+:*F0\\TFHRU)W:7E)M*"?'E8^TQ/#6*GYKU8
MWK3-W)2[=NS?L9#]Q)!T!WV7OO681\+5V;UO&\VCL%@;1!_\:.%G%]494GY(
M=G%M\^.>9J@W94=G;GF]D+8B"2T*A[87<7?)*=&[B>O!4?V&1\ UZ"A=:;N'
M_&CV!ZBP^&)I>"^1; H7* S?@C=_/6MHL6<W2)8F6:RD*KJC;%\MTGZ6%Z.%
MP(0K.%7.ROZJ+.M,;PH&;O%%FBN:%UV 4YXW2I$2'8QR("?Y0\FN/J("_8[.
MPY@WHKZMI1LU_E$L+[(P2<'KQ*HFX OU>3\&B3$G??&'V7SM;59 X9#&"0*'
MIC^X:EEPP9K-I?H:)1R_FVQ2^$U'JSAJ._PBM,_?>J:X6[FY62J-!,Z=WP3Z
MTA&^UQF(!ST6MP/1?J4N@2HER;9<9:9":J>SN2$W'.Y]M=%*W_XC?N]DFI]\
M[X/A6_,>?WN?P<+?/8"%[^I"_]>@C\L/Y787"XMIJ41=,O*$'Y) GZFADNIW
M;4GREU.&J/$)#SHLA"4L=PUW-*KF6 1@O=_<)YF4?\_; OJ'5T5%[269%L7)
M$Y5V;'<W^D771Y*82BIAO% 8"1=#)!'"?D3-[USKZNVBX7N;YDSZH:X?YXOH
M4:,G-.,2.C^>-5EVPF$:)P:.!0YN3JM\GU#06N(D<AC^15&/(I2V82K (SP!
MW?Z5P&P XA@50%Y@.$W$U8VNE+-PK%6&$@D)9@G40&DJ:CI35-9;9/X6ACE4
MSF+:E..U@4P^3=FDKI1;MKZ&1FIX=T-;+*^%FB"XD^$X06-4V@Y6!]\'] -T
M:P7!6Z2PI$ P>+?H#A><\SQ#:PPMQWU2"LM*D)/'30W8)J-L?RI::OOZIY7C
MXHN=$"V]'95SWJ328/@.NX:_=MSK=7+\T^'B5).,!O3OZ;'(2R3P;-.S. V)
MB9<%92/60S"</8W",*:2<P2T5+C7=LU.?-(')^YS&$["L31H+.0N.^Y)UV["
MA%Z&>[HI?X!(E;_:<P&U6"R#W3DXNSY8 L)3=)6]REU!I7$3)!-()$<ZF<E[
MCR"3D?@)%W?]V7QMB; D>)0V32H"3MK<(Y89H97$5:<2C]!3YY20M#SS5Q.#
M:)TD/YT<>^LXR^RB65Z?.39S^"LI8A&^\N<PY'"57^CP* N\N>P%L[%P )7T
MIULKNLPY#J78^S[3>^[P#V@F#[M/"'IN[DK/N"L]/ TWI?.CAWL\>OHX[;%7
M0I=\\>C98Z."(2LM3# M*%9NZ.(?,\&$M\K V*QN7(S)^-!K23<I(4P$XH:_
M/_KJ]XU 7ZQF*6SZ0-%R!98V3.YR0Q7B&;J8!.6N15E?&K'W&-YB6W7O%^']
M5><"0=@42@M^/?Z='C:9K5[9#Q$KI>AD)4N[]P;RSW;^4Z( 94S!&STG)NK(
M[2Z=T0\LN)]XH&.*=$83CF$;XF1U1I+4+4[RQ0G^_PE>U\G_>$6^@G#HM!>#
M^68>*0:@_*CT*\A:!;<HO-4PL Z<7<TZ2S#M#H7(X,S+"(73]"E1I"G61P7G
MQX( G,Z+LAH$+E&.ZS&B3+AU\>$$.E*O/%L+L]_R15UL8Q3;1F89^W\$\#O!
MS#GC)*#41?#K:$ZH9DDN0ADAOEP 35571@ZM&X[ Z'!X[Q3A"M'WCG;:G#>,
MBU>%ID1ADY?TGQNF3'H'-0228:WJ%>C(2>$%NHE<BKCW9O23^IG0-I^3C9E%
M'\[V $WBG2GC0U2PT<2SDR* ?DO&?IUPPT8J".G]&W-!+-X95<7-X[;M+FI
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M58Z_D7(CVLX&VM_B^VYTK.<1:<GS'?VN+!IQQ\(0O-J!QN)QU5XVC/M?1H?
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MQS7P&>+NF-VUWLUF4.'%3NV9J?H/RVLFS0FPYC53K-TK]:":EB??BK/S;0^
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M&?>868\Q*9U53_U'\%F&4:BM?:";X!33ZVD-4I.T<_?DEX1#VE@588H-8M/
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M_&$PXRHUF%C\5<Q;>;/S%@D%='7II/NDP?'5EY_-?7AGWX=7FOIK@)%5FNR
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MI3:AD:6)?E'J*65W1] "'T2\_\R=@Z&",RJ!0N.#'=&I?H[C_C,.<-L)'-'
MBO%:";!(9:ZPS(!I$"MVGDZ?$8>[_1OU2@HP9G1 D;_B#;$Q,!7 IK)Y*845
M,T/!Q$L=A:Y;\LIC&@Q=9%9^5C$UN(1A1]TG*@.PVL47%S1CL^JI"$@J&&0>
M:<-8G;VSF&"EL8DW57-A(B#_ZYE6&@O9LZQZX& D25 QXH^X<0;N#DX,=NBD
MM$-,K*A>K/Q_XI.J(L[&/DH<*ZF1RF!8S]V >$KG27XAB1\!GYFQ$VX<MVD
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M11B(2\$)D$@0=J4W 4H*(/B,.U,1S><)>>?L[F $=TEDQE8:2S,_TW@\ ?D
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MN3P^P6Q0@F<N$3)U3<G<D9D[E-PD.4[JZM:!.JV0&MN0W5='\-QP#PNF$9]
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M,H**N1"12$ %IZTK')O>:">+W2":)<)/A>NG[I5PESY\KSZ;TT!+X<]G8(_
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M#W.T-_GB\I5$LXT$MPC%I0_VYP6&=R(.Z.39,D[XDI$W=$M2<)I(82!)8?3
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M$-4@0+%+,WF]960[!&V,=2*4J;_]X\TWCJ+VSCB*BI_:1H"CC0#0W4E'9&,
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M$TL AIC)N K3GH)P"%)@3U%.X69,JL(;\C9.5DZ_>_+6<Z=Y9D?OTAQ,N5E
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M4WB>EBN3L;!2E]*Q',9[)T!\:;38T^ZXKPN$0K1I3 6?U7?#"F%<O&QQ9.?
M\2POX_!2V%EM-!\Y>V>&\/L$+QNB^TAJ&;@_2<"^!#)2)%=&'XS_%0X%[@;>
M+E?&4CV9.J?0^<@'878.3PFG\Y4-V8KQF6+(;BY $Z9? K,+YO!=JA0%)A3.
M$]37SB*;FY,:<5'U:8W*!0[TZDAZ+23YL? /@PB+GI=4VTE[+,].RNA,S)91
M',87]'-Y/13?@?D(?\49=\S<@ E=)/XJ92913NO#W4"5"V%_5:".W4M$F=K,
ME!:QE?L88QFIW+2B M60=:EVT]RN$H-RZI(?I]I=0!J"S'HD O(:-:4:K9>2
M#14K*4MUL0#EAC,_:2<<L^-R"-DT KV?-;NHV<P5V=QT+Z\""LOAW6P8!V8*
MM_2R322LS<4K6(P[[/ATNXS%X6/.6!P]P(Q%>R/6(&A.SL4%\@>U_K'Y26/[
M@Z.Y5[N=*G8L\=.ELPCCJWU6Z3SF#09C_G>1.>1XSU-V6QN;QQ@F[+T[DB/0
MI5*'W=;"+F9L;L. SHP;CT>WN?!ZDS+.5V\\,7UJGM7WFV#L+G+TAL7NSZK7
M##9IKE0=CPLM-+C5(M6&&'R1&6C^%R:KN#LJ-W0X,T66SRP+T9EC(@*Z%I53
MR%]A5;KQBS"PB<9%6.L'/Y__48P):;-(?TKF<@EOK#:CF"N#*F? 88=4^8>L
M(Y%H*QAL#-BT"/3J>\,R+E/?QF6J TFY;RJ]6P:WW\LTO.UEZO5L/+WF>^/6
MWQNLKA^<C>QJ_BVN2&_2-]?5M7TFWW4CG)W?"/=[;H33<"-Z5@7V?LR2'Z"I
M_9?<_MCD6'C3.3CJ'-B-?8?"^Z'N[W90 Y5[4+?_CI;.W6ZYIJ9G@WEHZ6PX
M#,'5<9X=XOW@^VS<.]62T:,H#\=PT7UA(KJQ;)Z5P?U$OZ(C1904R).21!H4
M= 6JFF8W:@E2KPBC5T+R)+]: 4JO)A_=J<#FR3Y9%JP=SFA<KCFJM+-#/WFQ
M""=. B  /\2*471L4O8$%9Q2WE:V3(20R1Z.[+W9'YF3H8,96/V6:F3SXY+,
MNY[J%I!7=>*Z[G8I<3T8]\U-NM5%<K[K(KG%BS0LR/FH"'ZY)94ZC50JWS+H
M]>U*.PH.83Y<*G>&)DN%!$5@,"EMQ_L6MH^8HDO&-.9)!7-.)35I/<=N4-]Y
MU^>[$M]!1%XF5H/U>3D6EY$9,7^C]&1.53&]7;W1L%(L.[:+94TJ7A"5F5$A
MWU55WPZZPU)WV0&8RB9EW^0H8HW(NT\?M6BDI&^9:/N\MA^S#HQ2JHVT!*@8
MBB=96MVH9UB;['.[23 >) 4?$2.YI6B\B=%H\6@W/+U!/!:*:&7W](&E&=8G
MR,I<<15W(S-0%]HN*CGELF.XMS6)L@TI9/D9%Y0K6.DSRS=E*:VRT#PM9G!(
M:6CIF<<M#;>*+(T><V1I_  C2\= F0<X58PJP6>)CY ^H1-/@0AED@_QE]C?
M:S/O>U7,OG_&A[,+MP XV1XX1$<YSB9G%AHJN>A/!W;/:7B012<+(LNE20V;
M$RHL0@W.,M2D8Z5?<JQ0]S!O/#ZU0B+-P[N%X=U!MQ%RQ<$BJD4<AK0VE]..
MR53%K).E52T7F-Q=UY_&5(TB$;9FYHZXM7<$C4[K&-S*,>S397(XY'A[9LCG
M,0.[?<WA@+_^U/U)"QH6JI3VM4YA2/77<_<JF&=+?$?WR6T,*CDB3 850USN
MM^<_H:CY)4O46RGG<.:'2B*S"/M)"J1LWFS8E9L(]_JC($*K@U9V@@]AXTCY
M<?D](#OWN/'9_%=K[O3TE<!$*UQ@.#>SU!(;E9?]3DCO*)PK?OK7GWJ#GS9,
ML4Y/VD+QVMD*7J0TX[J+?F3[?':<VSPL;///6?*=5[?FZMWV]I9O_V.]NIMV
M] !IZPTE96/36EQ L14;UH+[492OCF/G]67N'_)E_B"]^0U[6KN!-93S6*_7
M<1PRZ.#M^3[@\P6+K3W?'Q&/-QU6U1K@1[>4H:V$/.++U4K(1W#(!R\A6V/J
M &CYR(RIIT^>W8:H[X\A[%=B;J2P>]B)0SN'<=FANT$-VN])_3+]]6D0T0RQ
MT4WJ1_/T62%:=._;=R"'MU$&[/N8#G976M9RL*+S.-1 X#Z\!IO]/$RU\$?#
M8S6GM^>(V2L$3XJRTH'<*;^MH\_[B!/>^9T]Z@6U&W9@X[<;UO*AEDK:#=N9
M>O.<JI01C3V:8SY2G/S%32ZF3_O=H=<?G'K]T>C97CQC*L]I_&2_7K)S[.!U
M@D!.M B=#-B@G:II/3D,<U1-I_=DWZ9IO]/KG?0[HRZGJ"1NCTL3WG_Z#&<Y
M[F*52+=S>M:P;W5\5>]E4Q#HL/9X[UN\T>J\879G^R> ;G_\?7.[YYUK2>_8
M2:_G=8?4]J*EOY;^[H/^AJ?>I'?:4M_#56[&75!N)O7*S4 J-Y.F9.<'L,>/
M_(9OR&1OV*$[C=;?D]5Q0$LODP!!Y>Z4 LXV:1CWMQ/;&^I'EZ BPPXT:VR+
M)"O?0FR-32VUJ5"/RLQ.\HC R<7\/IV#]Q,49EE$<V%Y-!Q]ASPZ9"%T@)+G
MX&SI U,A6W(ZH-/KC<9>_];6<4M1+44U,JB^-QBT+.I(":JB,?2DQC >%8W;
M_X\^8L]]JTP<ZUUMMEWOW&J[MUC]G=JD^S5$>P.O-VD2Y@=K?=Y3F+BU3^^?
M_W2:/..MZ#A\T=$J>2TY[8R<O%%KA;;TM+,I#4:WC;FVU/1=&:V[GQ<H!=V3
M86?46I5'>O=:J_)A696CT8;PYL%:E0_)9CPIVXP'8#'>#QL>E?V3K?/QB,5$
M:T&VY+2SR,78&YZU2G]+4+MS20Q&334I![A)ATI/K9[0WL/6G&S-22VG>]YP
M-#B, WW4,<KWU+D0YVPUB3@4>K\[3CSL=-'=.&CEP_'*A]:.;,EI5U.:>/W3
M)O%T@)O4TM.!TQ-6(/<.:D9'24^M<M#>OM9X?.S&XYDW'&R#$W-0MN-#P'G\
M$F<P]NPXT![O@N,>X)1:(?! IM02U(&?7L_K]_O>\+35ZUN:VAE-38;>::]_
M4',Z2HHZE'D=X)3:R_>CI]<:BL=A*$XF9UYWW,1-#]94_)XPX_$9D[_'46M*
MMH+BP0F* YQ22U#'?'H'.*66H([Y] YP2H=*4(<RKP.<4GOW6C/R<9B1AW2@
M#[CT\:4??>5,U,>.B-,BMCXXH=#O]B>T.=O^WXD+/VDKV5H*W!E3Z0V]LQ9>
MIZ6HW5'4V!L.VNCWD1)4HY)1 _(ZZ;8@K\=]5[$^YF2#1M':I<=GE_:[ Z]W
M?)@\#["*LC5=-4VV8*Y'+"(F!S6A5ID[9G(:#KS)J#4W6X+:U93&H!NT-=Y'
M&M)4>*[;:*N'M%L'2%CW:T VJ0BM 7E\!N1D BSUZ.S'8[<.I6WXOP^%GEL\
MME8<W$T\<]#&,UL*W!DS.1UXX\:$B /<II:B#IRB@*"&X^%!3>DH":I5+MJ+
MN M;LU%=:&W-X[,U1Z>G7O_L4=1B'K@YVD*^<GRB174[>BG1IM2V%'B/4\*,
MVEX+$]L2U,Y8FM<;M/34*A3M[6MS9%NS<S=GZDW.CJ[1R$/ ]V&PV*A%^6G%
MP7&*@V.;4DM0!WYZD]$$O88'-:>6HHZ9HGK=4Z]_VH8L6_V@O7R'-:765CP^
M6_'T%#N+'$BGF!8NML:</!2:;T5$*R(>XI1:@CKPT^MY9Y,S;])K6]*W-+4S
M%_GIP.N>M965K8;07K[#FE)K1!Z?$=GSQN-3;WAV('6RRHS\.?.GH?CUEWEP
M^:L#__?+S_C7+VO[O3S,36]=^<E% )/'1[M[G/U:3?8 I_I[G(F_..\_?783
ML4Y$"FPA=;.E<-_'\(9/"?S:_>QGHK.WU?!_.P.PQN_P#(B(@ N&H?0+_/6G
M[D^W7\E5,,^6^&CWR7/@L\E<)"?PQAD,B,O[]ORG&UP?Y%LH\Q,Y:K=CN2CL
MM>UNE_[W)K:VQ_>^2-UXX;X6,[&:BL0=]#S,:!UY[K108>SZJSB/,MA-1.W[
M_.'EN N;XL([PR".W*=_G/_GZ:ASJCYXYEZ)1+BR+-F=7A,EKT,QOQ#XOCA/
MW&D>A'C>*9Q=MG1]-Q*9._.3Y!K?PN_#9_%EDTFG6WC9V=A^F1_-F>N>Q(N3
M/!6NGZ8BVV+@_J@S*(P[Z(SUL!U:_GD^6\H]H#7Y81J[%[F?^""WY=JN8K6H
M-)^FP3SPDT"D';=^<X>\N0T;.SH[ZTSTG/"5-(U=;:4[&?3,FKW;;!W-H[A]
MX\Y(#=7YD9VZ6;X<(,=N8FQJKO_KY,1]&XAP_A?WDW\AGL- _\I%-,,!)N/G
M[G_[88Y_NR<G\J=T[?G'\!\U25[ "3 H>+B_SM223EB=_(L[QL\DSU.?O0S]
MV5>WUQG!JM,X#.8_E3;/6DJ=0JI?0J_MUKR5&9&U2+6\Y^Z7ZS4,_2+QI\'L
MN?N[OQ*\!;_'N-;>>&+_[&?U.]H'W$:] TT[,DV$__5D*A9Q B.O:7/MZ8YK
MIHL[9^^!11;F*!M?;L\75V+.[)@H\P"G^F4I'(UMN(DO]H;=H@SH6_]F$8 <
M:7+:Z16X9XD#E5D/\#N;1SM* -* S*Q!&5N+619<BO!Z?]K7?9Q_-61S )-'
MBEC$81A?T>&3>D@B"6X[R"24?BL_RY,@NX9#\L/K-$B54 F0=8DT ]X IPL_
M)X+"HXSA=PDRR83&+9^[6SGWOSR$D]ZH7$N),8.]]M<I#*G^*FG3VR_S>_1N
MY2JZV?-U9\9\3212Q2RU-$'!>D?^+3@6_/2O/_6*AE%IBG4R? NE8(>6!,VX
M=*D:MKAV/VMBP <2$6_)<POR[!\R=2)O/VQ:; ^X/>#V@#<><%-6ZH$<\,.0
M)@=.=+N<'AB,A[$K[7G0]/XX_\_#V)7V/ [L?K2L]2X,QEW.[VD0T82R99RG
M?C1/GQW&+NV(E'8=9W^!GJQ_BSFZL.*_E+;JWCC.7M,:[CY=I-W*HQG_,6WE
M?NLRI"]W/'RR7PRX/X-L&41N' E"S6S@]LJS_.1NDP/U:_>[!QO5 3F'L](<
M]I NUN_WO>%I4QO- ]J+E@SV2 :3H7?::T+'/*"=:(E@G^TXSKSN^/"(8)>X
M-;N<ZKN( LRIF,71O$Z.M>G,/\Z8QEVOWVV23FV"^O&=**@;9]T6XNP!'>@0
M%,C)T6&<[:)L?0_2!.RB9(YI;(M@D2U)JJ0>S2.(9F&>!I>B)>&=2YEA]W Z
M6;<GNI, L-<=-(6 VP,]O@/MC<Z\P>CHP%&V@3[9>SK'2W$-%@I-9 'R@X7*
M;=(C[M;FOBE1Y!Y-\=M-;>>78#@:>V>#IM+.ALR6>]NLEI0.F)3&(V\P;/+U
MM)344M+V3.ETXHV[A\V4]FL6[IT\Z\#'VKMQ!'?C)KRDP[@=+3$=!3%M!DIJ
M2:DEI9VAQ!P&,36!QQQA<>4A3?67Z:^O.LYGD0H_F2VIB/6UN!1AO%Z)*//<
M3WY&@#+XQ?M@)J(41Q/9K//+S]-?CV6)ZD".9,9OX\3QW7F0SO(TQ7IT6:6<
MV,<T-\?D^EAE3KTS/3<5POVO_SCM]V'!P:_O,K%RAQWW7;2(DY6?T6@<77@5
MKV#"U_ALK__\9<=]F:=!)-+4_0@*\64@KG[Y.?B5ANH]=_"59ECYHQ<=]^-:
M)#Z5VP,1Y6&&F!SZ5T>QV\=U6U]WG"^)@,.P3_1H*/MAW,4,#Z!RU3;<"7D=
M7+P:M1<);M_[X%]Y,&=P@KG[RE\'8.?A '#S9]@4-_BU<TS7BA;'1QT<QU%_
M1*@')UO"<'Y*1Q[&J9B[(DS%U1(A00+DG$'JOHBBG YG'2<9\E.@DI7;[YZ\
M]=PKX?KP:!0#6[["OX!@@,UJHLFCF4@R/XB87<_%RJ?/9_%J%60KDK9 <\#=
M(\:N(&:-;GH7!A#S&N@)F')&+TV$G\81*$C7;AA\%? _6>PN_4N8$F)?P+IA
MUDA>_AQ8?"I<L5B(&:V Y0N\-,=9!1%,1WC..HD70(?4F?G:@T$5C<*T9I)$
M$T6BGDN3A;E<Q7DXAP<0%PIGOP@B/YKARP.+:U$0>TZE"S=MJP/KF/*F1K#\
M-/43.&+XX3R8^8BP@KN\R+.<-H'N' E-OHAQA%MJS0*3M +\_&'!LAS 5('!
MO^DXKY* '&J@F,P4&H](LP!I,#T:UG]<VX[*'MU:)_._,<\]DGWFR=O"XD@F
M;O;;!>X%?Z^3  4&<![99U!JZ@N1($H5/(B:./X(_P9.%?H*J2H 13V%3V;Q
M111@/5><9VDP%RZS8.1?((U2?%'C0XY\" RT@&"+L*R"_J"YB268;\@KF;OC
MD/, !LN(D[H">'OVP("J#F"JKY@2B$HD1B(211BP5"4H,9!:*Q#=!&4&XA-%
MIL1+%-\00DQ0%MA4T-&#Y(9_+Y)XA2>X]@/ZDO+%_&\L6?T\6\:)- BG/M%D
MA%\["7)@]RG. "<4^E?I,Y;9I"9,A0!"B'QZ9<R(9YD?,8:9_D)B2:(5 J0N
M?+!(42M>XOQ0="-)@^0-XKD';_F*_\3J1!2[2*TLDAW"W *JS*2$QCFM$S1E
M0<##7^+2APVBW]+8)$D(>@T^N%H&\-8\E2)^C^BV=T&V6R$_3AXS\N-IB_S8
M,E2>ZFLI3I7<!=EW"5P%> WZKRZ(5RCN>@U\%5@A?(=<,0R!;%? H?SD&D0?
MV#X)4E&J>*YD:(:)S8&S $_,KI M2@Y+_)2L"^;F3H6;(V]=BB I(^FR-6>L
M$(M9YLD:3,VTX[ZV=(6*C+ $/XY$ZP&6/PU!!ZE;%^@!WV9BG3T(2,)#FNK3
MX)ESM90T,:\[LFLXL #IA.0T/A9$<)!TZG2(F?0E7<3Q_"J D\0#C9BF2-G3
M X&T\]TL\:,492,Y;X%>@?#!&G9\=ZJ\MJ#338&V6 &(@.0E58/9)91\MH:!
M[\GXAW&DMDAJAS'8I.(9H5'/5%;614FYC47JH%U^@9HEKAFU$>#/OB9.J03/
M<W@O_K.65I_C4T=Q^$=%IT"H0#\2B9:H0)Y) R-,TQAX$RIY!.0=1)=@M[-3
M"L:Q 7 ]5]\ H# D&*T#HF\)CE_1G'J38[]I!DN<HE('.ET<AJCX I4$F>3H
M4Y[D4M%P[6SIWB#M\2N%TA11R*="T!#L%#IN]?  IUH0PLJLJ1=1-]U\3TE,
MEI?PLRL_(4&<1WDJ^>H,WA5(TPF]J=97R(I =#H%T5D_)6DG@>J*MCGST3J*
M*[([(C.@51\-$F9H%WX0I9FT0E@(J$4VB>);+K*R0'5C\@S$PK]1W6F%^QT+
M=Q;.MM>F>/1-3'4[3:!6^CN;I+][I]+?:9#^;BO]#W.J-=+_9EJ]C0)0O1S,
M<>,HO"ZR76<KMKM9T-\HY%WIU=K(NYTJ[ZY_9XG=MAK$'N#Z:UK-U-$4^;PQ
M(<6X1VW?8]GIR+UID-(WB?PH!C8678C$*5)AFB\6P2R@IV_2 V!P'QL.D)Y#
MSM@D4\RV1G*P#U=3E/M'9"Z)TW29,*8+XB.]Q=JWTGJ6?@JSH4! 80.<O6^
M=F*W=^HNM/(M@@T4C*+(@$XEL ,/_GK-J03408KI3&M(?+)T1?V0@U))T0?G
MP)?P3!:BTFI'(]P]1"/JHA MG=T1G=6ZPA31Q8L%4<J"^ZJ@C@!_YZE*4 G%
M!7 1/%<0[3,6[)3LC)1'>O'"Q%6++W;LCVM\L?6:RJ8)DY)/_"W0\5KX.$0Q
MI$DN]5<U0;=K!_YA*=7Z*5P03%*FSRA=(RM^AR]GU03C8S!%-5(L[Y"[::UR
M:3@;!UNPP6T+9%Y.K"ZHN;7\&SFL?65QN#18Y2'<-A'G:7CM4808)8[4M20;
MT*&X- !I W+#QZ"W='?'"Z=Q@]$Y8(1<*<PIN04^U J+_:9=?.:<+\<R1H\J
M!^.(-EQM-3D"R/'ISU3'Q%F>9L!FDG*"!XE9Z215X0*Z/"FF:*.= L^37:_N
M&4MI,Q[*\T@IV"1;$[$(T?1W.*INQ>3QUWR=K]2=E#>2>%/(N7KBVVSI@^8L
MDQ-CL,DJTVIOZXZG^B<00LV!D7M(T9+*J(1#=R_!1F?W"YV\9R>58'Y2<914
MI^?-#0WDJ=;XK>-WBL>O2$]%7JL$6J+(C@N6GYG>AHD J=HK$VOEW*(?P>=!
M!"H(^JM":=,M05T #:)HT/D%V21S7$V40KH3K*W)0?#YE%1J'C874L4<XAD(
M8JT&.Y;CQ&3X7O/ESC8N&+5:RF?(R&N2QN%E*^WV>G^8I/ /= 4!@<B8/) P
M)LK%$:I7? =D<D%:(&'5Y-:FJZF(!'E'%]9HVND*-T1S;V?#Y: [M8H3(EV#
MB>QI2@1Z*1MOLNDW4%B8:U>O)&<@7!%<(MUYE-".'R*%8J($[8;ZD$PQ.WF;
M['22$\ST8;4"K'M\REJ?Y9=6:1*YT;KUJFIO<L?]T3/)T[J3, D6ZDQNVE3+
M"Y-'<ZFV5YDJ^^ZY421)QR@EEWDB,FG2VC\S 7PS)J?;<PJF'(?S4SJ8ZFYQ
M<H?K#2Q[V\Y"6?O75/8ES1"SS7+?;9)C"HE7E)A:JSVH_2#'OL#LT5*LP%DG
M\*R..<S_">^3\3VS*,Z(J3L(^P3M'!V9ZP?GA'LY)X<3$-J[MY_/W=ZH98 P
MU6*:'>Y[L+C>:8C ?^:<^R&Q#: 2# ZD[<;O4>UGAT!QPTLJOV+K<< 7@B)X
M93N@X'G;H/][[@4PP80<*Z@\S9#YPJT4CN$--(GVONTZ^C9]YKR*5W &*(N"
M?[.^1PZM!WG%>O#^UR*Z^/\#/RK,:J=:G%#2WYF5]]8KED2#+)S"O4#H KGK
M[E-L5*PZ<GNJ"K-Z2)_I<5EL^0ROE#&G%S)/[R(1J"Z 6',K,U$R6_#;,[BZ
M!+-G4@ HL53>P$60@!Z@F()U)[$*$3C^&JT1526'RDHH+D&\.C0%7"M;5$6[
M J?9M#"ET;CY&B8$>R7UB>H&)N("7QXGU]@:'=05$.*I>IPS7ZN+KWFRAKD<
M$\5OE9Y_^IC3\\_:]/Q'QXLMG!#G9F9!;OY%CGJ(Y;UQV7OS_]C[UJ:VD;31
M[_H5JM3.*3@E&&SN,[NI(L!,,A.2O"&SLWF_G&K;;:R)+'EU@7A^_7DNW:W6
MQ6"##19H:VL"1FX]W?W<KY:=8P(*[%BT%A439/TBX*5$?^0#  -WD$FE]#A^
M..*(2JT'1G\?V2N6$'/"::$&N6#VN,KL"6WP:N A&ZJ7TGZVW3^8ISK:1JNT
MZICOI% ?C =T0 .JWRM9E3K@8^N-B3%H,6)">J,SR(QG;J:8BLBZQQL!Z; 5
MP#XX;C2_2O@H^+:.-% 1L8ZYT/P^\Y WAM@0%U#0H\"O)*B2N[)&\Z=O8@&_
M41HB3+N@NFIN%$#NR.0G=\/?)%K@ .9 Z17T1XH#8E*81F@JQ4<^'?5 4I0B
M ',)=BM.CWD@?7HE9Y; 1PE\+QGZK3?SD8SY_J;S#D0]Z;@9,SJX92HAP1CV
MRG;&_]WN[OMA@^YCN97@^;$[I6.?Q[P7=CYB&(5;$^J[Q6,]ZRXT<:] 4J55
M@Q]SNK#OAG,C\U@%"9%4?)-6IR@5'.$&($FF$@XJKVI)=Q5YCQ5;;<8U,P+I
MS@+L%O].+6FDT2:L6)_Z>!LLD>(G91Q,:OR[)&AN)"6^ H!L(EH)DW,&U^X;
M5'-,4*U%N4>1%H--ASH>K<X;U<J%/ZEJ OU59/5D 64E<J>#:!PA]0&UV-%
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MP_- H[D&E!R_X $EASOM@)*G9'!+;JJU_)["A18N4:%]RXJVM/S2B09V6F7
MN8%'I7F'J[>" U:H]>;6,.)Y**@8X)B)1,;7W,\<'YC54"'!F:-N=V?GF%L6
M)ZYNQ* :J(^U^N'@,KU(Q%2#D_>6TRMT#K?=3S&V#<2A8 H>ZL6<T;PM.)>I
MYY[%V]2*)(=XX)XDR.4$CNJ*Q40"@'TXEW=A'W;+PSY!\;D1V.+]DAH3.O_&
M?LN?0!?R28(!/)]MO0C^T@_\D*K0K5$\9E H;'>/'H0?CBRHL2VH!2*_<B+B
M="N%N\*^U$.9)!&?<9)-L/$S_(KS @<1G@8U*,T&W .66T:?8JD2' #Q<?SP
M,@MA>;AK .2/T,=&JC@)E7J_ CS4 !7^/>#S#^%TU/1D@%._'U[XQH_Z(SGV
MDQ3G[80#YR(*X'(#$>.?@N@*#GOVMS^&?7J&7L*'"@=^C:UDKW#ZCH;^?33N
MP8W[U6W\*J/X2J;1C;T+'N38.3[>5[OH;.?'":@J@B2B4:X&6U&MO8E<-N?A
M^,;B2OSMXQP5+!_$^JY\&-T(/Y>FO\"E.FDUC(ZVHA[]A6C..:-+2;;U$P84
MGOV+\U@ J#<"#C*(8GRJ<_@SO9G>@=-^B)K@H0N1P,;M1\P1TIYGW*H?.K0)
MLPY3+WP=2T01T?GK%WY_!"<?PJ;PKO(5FM&;MN%,EKNL5#JL&"8[BYV6.ETH
M5OA;%DR1'^XR[N.RQ$J0G@H\B]B#0FJ@V<E( -_M$_\3@:,I%^ABZX_+$\,@
MCIFT.CO;[B_JHT/]D9>_,8>78;WLXQ1A;(ILP 403L&N$H,(2"V*)Q&[)X!O
MN#T_2F5_%!*&XSQ)Y-XX3OO:C[($]A?XB9KL_$$D _%?5\^:QR'<P!C4(/!S
M'W^L;$ZQ]S+G350W?8:[:I,@HST)!2C7\KN[<8D!<]CJYN?_(\:3G\]@#W!S
M[]/!MCDK=3 [1]ZM!P'L#*EY++Z[)_W_9CZWZ:,SR=?2+.W0PV$!A8M\*T60
MCOXGPZ'5M*\R,]^G]^MMZ+L_PZGAZ5@M\HE/2+'E%+<?^-]]?50;?,X_N>?_
M.7^_26]PD,&J-^S2&[2 S,6AVBT !DN^$5/8[:?B5=C;!,Y]K#FWIQ4"45SD
M;8;* ; O'+]"?^G+Q&$8!9X>CMKM3=U?+W]W)T%_TS-+'^#2^(H280CW4Y2D
M1H+^(K$9KI9 28;8-*6!I; ?=70?M+Q0<NE=")(KS5)I)-"N>MF!];*<[<-7
M*(_Q=M[M6KR;#D[Q[N)5P5^_1-]]2QHX+3M?"/ &' ;U[[%[]QCAD,]TRP5#
MN35+231T]PDIU9&Z]RZ()W@<?/\86"(R4=1MU4!=H!1KQ !UD$;]CA5A$7X#
MU=QBP']%H"^#9J1T<;"I&<F]7/>^P&[@^(SA8VJ4$;._OHBE\RY_QQM^AXNY
M5Q.D9B!5_-(O?OKW%7;'&.3*?1\'L>#X!?BY5Q86(!+P;=ON&W(Q*%F!8$7Q
MMWP\9> /@5MH?E3=+ -">OG;* M\/*SWT3?)%/SYS2D ./%3>-^%@'5QKL1'
M&@]#\&4X[@".%'4XO2#N&&<Z('^AJ\"Y"+X::#B 0TD<O%DZ5PF,,065G/_%
M29+?<+3,0/923_ER>S@D"M3YK)_29$KBZ#? #/'?7C;=0H'S8P(?T$_N!8F]
M$Y='#;/XAA-(\1_4_B>Q#T2!>O PZF>)-1:G(-W-\>;; /S! :0BYW@UQ@7)
M=^'2VGKAR.C$Z)WQ\H$6EHD A_@EPCF@D;9P+MZ<X#M46P>7M@6<D_>1KW'9
M'\&UD4P;13SJ_0UN"^>5PM?5HE4.N[8\I;'ZLNK"I#LP>>YOMVO+2BDI6NV5
M+CF*1UZ0W@+:+*@);YGW6'KGS.40K][+*UCN9#@4OIZF NL<(7^S5_W%_L,O
MLA=G(B:-_9C82@Z[T).I<( ;FN[G[]^?7+KOD=-HS<?]%=E*24ES+M]?;GIJ
M;J%1BGX5@01UPFC#ZDL^SICE\7!2*<\5S5CO12FA'5!H+V)U_,:X*)TG31X^
M-8SA4O9CF>).T7JO!45I_B7V.X?VGY_IC@)P7PL.)U?CR_?/LI(OS6[P60<S
MW.YEU@?.$)7UUWE UU?@@%YZ(0+@OOUO<31(RVOE)M5Q;E(9 6@A _SQ XYG
M^%.B6R!TS^'D@5=95A3@PM?+\Y_<#W^>;]*N/@[SBR'M?CQ!?OI>W+B?P R
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M?  E^H.?Y0G]F$YE'OCP[@_X^V]^^!W+9M&T"? F."E,N?3=C;>_G_^'LYA
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MVKU(::JZD;4* #N8<I[Y!9VX23%5L!X=\CZ/CAC66W.OG3R;NM+91%F?6'X
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M5*T\,E?:D)2[1\R"3'B$@)V.WY#Q60W*N[XSUU%<7<7R"IM\S)OUB+]_]8<
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M$98>F'PA6H$ J& )Y."31K "N#$NY,<LL=0,9'P5PJ!,.%H=#<R49)KGCB.
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MS#F?VT+=N!E)U,] CNDNS_"=, JWS >;93/6<I@2OX-_QJSS%46@0P@A";B
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MV<RZ+[TQBG7F#_Z83<BH0G<1/$-XK"T8LHG#/F,8G@>S5GK<'T_P!6"KX7:
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MA (V[: FUK"!IEOA[P0"J,E,Q?1^XG]DK1-/):[+^0(1A?P57U7/.M5G\60
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M(DL[)HM)'>3G9N>3". ,\03A>/3#$^$/C*9ID8#G]K*T_*'Y%J8*4@FGE28
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MO."W6.;VA8K[:P\$N[#B><QH6>^'N<^86A7D;N.TO&B2QED?.TO9HAR[ F
M2U7ZYH][JMT KA215+YKKFEU'\X]*M+:4K1UT:M?NA;-_3H6TQDE8CRP &5M
MJL!Q#>%B$J!J4E?V1Q>(ECO'+JS'&UKGSF]!4$.OZH7%]Y&[@+MCF]X%NI4U
MI2L&"\/"T\I$K+I.V_$N*TQ6L^N%O7D/%V4MUVBM\?6QQHTP]U17>^P1RDT;
M\RPNH6J (AJ> 02>V!XPQ8'LMM3W\>OQ#*9SPT/,#":[O!;G.0F>S9)Q"Y_9
MWS1S;1<!ICC.Q VHZ66AGZ;NF$0]CI#/FB[YJFRAF'1ML=\% _TE1:O0]CM
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M"RG2D1+1QE3-C46"!V?I[M/KTUFV30U#N'=X;/+,]N];-7_Q(CIX\3@Z?/)
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ML)?"(BV7;YT6/[9'$SM\'#T^.(R>/MYP8CR-%7%X?V*_)C-PF9F6I/.OIQU
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M5]^.X29YS'^U=NJRG-=JIAMF:$\V?5"N_FNZ<6S]/%Z/PMITEFJ][N!8MO_
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ML":+F)1 $C8'D\=_$QUF'J<DV>!",F\0M8OVF0RKBCNI5BG)2/%AJZ[GS3:
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M-##39&*S2U@3"[^_6WWDX+7U.CATI-7RT9B_PO>D%4QO1LGZUTP>"68F#H]
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MQ7]^=_#=]M._3F?U)1X]^)N5:?3&*0V(-7W^_COPY3_JT@Q]A0@XF55&?)$
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MF%98&_>8\RKEI&->!UL<04U2P"L^D#WB8*5_MLPPQ(&6C6'!-D)^63:XG9/
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MY%!IK*F!00:45Q5]"T*EQ^>];>1&TD.:4!_ J/M;?':=9!G7>[@,F\XDR.K
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MFKR@'<PRI,#M_7;V'\=/)T?F T&%I\?"Y\>30_-I9-)W&-%]<A^^T5UTMS[
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M6%I59]Y1),4^(@@$#%-WV84J'Y.[U>;=;+,;TP$U.(%ESFI?E4+CXAQ"#8*
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MK;7B0BD1ZA86QYOK.L>-K-#+RVH*LG2]SDG*4)*H.1W\9>DM7R'G+],[KWC
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M:X05,X%E+"_\=N4B2JLHQ3OVT8U@6J='1H0JAH^$M3ZE"UN3"L&IRN]9C,&
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M3%BMP:2[/>P-E5SM7+6'TAPH6#? P4O<@RAJFT1UFDER<QD" ^,G86V,HNN
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MMIM93M3^"9X(<19,)UX("+K&A*5?9U5Q>(F@J,2.RTOLH.":=_+A5J"+;TU
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M$(O[#=*ZH>4:_7PPN\Y>8[(D(G*!V\_?)B"++\ *CXK%KRR<4Z U9L+B=\7
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M@B)!129H[@N9K+^;B084(-D;JYE@MOOAKH@V]<S7(<).5NMUN9ZWI'<$?0%
MG\FMP,:@UP'T]5I5KC:PC@^"OI"@7W+30.!:M2:W6JU\01Z]-^B]0=L0"8H$
M18(>,4%WZ[W1LM8>;RYY<9.PT(G4Z78O>XOU3=8I&IG/9G.WS1ZF(-8&K-28
M:U1?-MUIWR:BZ?+K9I9'IPTO4;BQ%0O9 $I#UO5W.VXTP6Q8A'U.8)]A9<Z-
M8=\$YTU54>2F@L!'X!<6^$L.'*@^WJS+2OHX&S%@CPX<=."@>8@$18(B08^8
MH#ESX/1N>YUO;![<=2-]N^QV8W?.^IJU JFXZ--!'7_O/IU0N2>^_\[HA(;"
MN@SIJJR^_ZH6#5P$_P$,W.W!KT++H:JFR)KR[H;1"'X$?Q[ O^CA:6CE=K6J
MRHWW]TH_K(?G-(!B1NTOIO78+I6^G,*_7R;)4?E+WAIS;'@/%ITZ/*KL<.Z3
M:*K17/^K4I&N+&*;GZ4[XX&"L4O^FA)G0%^@:8TSZ0_#GL++I$HE_"H[=_S+
M]'_1)/D"*H$[H0]K0)'PDXA.=?CLK2"U\L+F)98R3V+N,HH'8<,J*T9E>W!5
M22XS6N"9U'N9T)=W/(K9P9ET0\'--^'&A=7JR2^=1M]B^P#;&._ NAWI>\3X
M6>D3>J+H>R=L<Y/3K:^8+NQ<<@\2L)B1<NW@R?G".F8TRQ,R%Z>ZBNR;3O\-
M@&3(;?OMC@^SI-M?NAL9E)E*OWKN="*Q+%3' -9FV%].^^WBK?S<==@I-@)B
MEOR _C.FL_8E=R@-+<=P!I9A2Q/7MY@@^@B2R'*FQ/R4]^U@J__8&;M3NMR2
MY4C!R)WZAF.RM=\39VPY?4OZ^(^_-35-.;O__I7]I)Y]8E5%?IQT3Z@R8-N&
MY\</_>C^/7I(ELCS@- E4E8B4:'<)QZ\UZ?P(KS4[81^PGZ5Z.8;*?=3?![
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M3>AI21R6Z^B<I#-1]7*[);?JV$,349\ONW@KU-<!]0T]=>@THAY1GSO4+[F
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M5)0BH)Y8Z=6.EKKT*@E5PNI!BJ=VJJF+IQ)6":L'*7_:J6U1_I30>AIHE:2
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M.P4>4KZ?/YR#&F!9NNM%#WU_^%OXD*JP7P,&:P;1HL!QC.$+\%[>#</C;YC
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M)*[H9E$<)\-><5R%ZPA5")!CB8?'<;;%'?<(8RPG0-4$9%DB 3DID)=N074
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MW:6P&M+\BH9:$D.21Z3$6R)? W."F'C@K)DL"*53[M9;%;72UF2H34  / 0
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M\;/7_(WEA<V++675S3,:A ];63$JWX.KL_@RPP5^5!Y?)O#RGJOWS<%'Y08
M+C;AQL'5@DX2^];[\&M\(W ?HRU8MR5]E^D_SOH,V I>/.&[&Y]O<\5\<>OB
MFQ##Q8R6:P>/SQ<7,B/:"G(_3"S3/WM@3V/8RW#YG=E7,@+SGBT&DX4%\__H
M7.0,_UVIM&#H]WKW*-86O!T$JNVA:/Z@3"<3Y@YTC\$@_6[/PQ&!S*6[D0Z2
M6_G==:83Y1IG8>LH0G7KT_M^=^W>R+W\5TDK]_1?H]Z-XS.OY#O*X]\O\6#F
M\D_WF:$,31N.4U.W8!;P ;*G=]1TA-6^[8V=*:RC9&)PO#/U=-OPT"I[S^RQ
M:?=-Y>W__+5=K58^WG_[S'_2/K[CYMSO#Z K69;N>M$CWQ_^%CYR[/O"?@W8
MQ"\!0!30N/K,Q3WQ@)W1= VK!\2(7Q7 AI[O<O?(ND+3NYF.X>N#>;6T4E88
M*(X3=**X4[:L>'XQO8'E>%.7W0Y_9S8#??/:%JHKB+Q>WYGZ5R$'/40,=/EK
M DJJ[CMN[ I6:[<P!>P3U^& P)85*)>_E6$:6^[F1F7DH_+3-/P1OJ_R)M*'
M8)<&,"H^\>LCSF>M&P?>O4K5+<7TXV" RGG^Q0*T\P.XORYN[^]N[WN/EUSS
M2?H_[,_P^_WM]SOE^N;J]OY;[_'Z]F;N3LE5^E"?+^W,3?R_K<IY,]?+\ 1Y
M*I.I"KQDFCHU8J4+9PRO>U%,$&>*98Y-/. L$S1N"Y.F!N&?[8'C3AR7GW_\
MB&#*A?X"HRC7GB7."ENY<9X9EY%:2U6J%:UUKL 8BLN>3 ]$,T,WW] $%1UD
M*'^#>'L)!K>< 7^W[O._S)[[IV[]8'"V7(3C*U_%+%61Z.7/#P#B 40S/[FT
M3D6YM& 7E=XSLZ=,57YGC@M*]Z/S$S;G=Q?E=["(__V7=M:I5-IJ:7Y5YT=!
MR"/&G UH>F:>CV> ,G(L%.XAZ@1ZPJ?[;  '#:?WPG,AG+QIWS,-4W=-F-)T
MPNTIXXG%N&DE>,9%".BV^5]^&*&V\X^I]8)@;<\/QQGBR7+ZH.;U36?"-?@!
MFW)I'XW,["?0[SE+&'#L ?Y=F)BJ&.R96<X$)\E+3CIC.$GQP#/_BY_!3%Q]
M@M,$_3* ;"D8;,P,/H3-&'#5Q#6!++#5.,2(P1GJ6,X3?V#,Y3>>HXQPFO54
MK^W2[<!W4)@!-CIJ7%Z%L$*Z^Y[R=P<H^K_X'],V?;P63*9]"]0F$&(<#C-!
M]> [@Q_*Y:_!2+>?N'B;?3D0:\I;?#!0I/&O)?[7^6^&VO4Y7":5?^CV5'<1
MP]7&IGE^/W\X?WV*-[V'+[W_-X<G66FT"DY9*:X/P%HFG$&Z[5]' LJ[MA]B
M,F:=RMII+9K)Y-FS.QWUU2E>UTKSIS!B2FM]Y"('9,H$K[=Q@8IW'-V#-UJ6
M\]/[D"T7YPV+C1>(0,D?X"UVXL%[PI\6+@/)U[;ZVO!Z^!=_QIC;A9\,G0[X
M@&7D:S*7=>B\;_EW%ISK_)A&\PX*Y9FV"SK"^T"]%+_A<S)M&D 5/_FM7"\?
M; -OG#$OM?",K@B^?YXW9<;[F5HN^8Z]GF6U?U""NBB,Q[BA6*W<1Q40=]/C
M)<M]U^Q/A5@#'3(FQV7::PF'SIUPX>FYY(U,*_ZW0&6F9IQ B40M24+"2LBS
M$WZ0 +OVIYYIPY5.IFT[#K$G3.F@I)O^/ <=>OODW;(OILL&ODQ[%4&M*C/4
MKFU#NIT[_- 2$FJ5-$UXH"9+IXFO?Z4_)[@%UAIO5F7/S*?9=":QA!J1D-/)
MUL/P,/WOR)DJ472!$D077#CGJO+5-\[_S_]5/O7=]]W('QM\XU^Z-V+VT\PU
MNQH"X9WWS?Y0%PY9?[,&3!O,.JUZ:'SY=^7?0WW@KPB%0]>V^W([O(Y?[&[=
M>^:9!L8,W0XCN\Y+ILK@_<7[BQ&BEPF*C'73MF)7R.U&0L\TONT?4YLI&G>U
M-*.MG=LJF:A;SW3(^V^?)03P"@&Q]TFTWQPR:K65+FHUX%QM#>=><TO"A= '
M;UT0JL"A#SS\8FT =[>J5BH5_/_&B%5)$%-)0*TSCPW.S%]G(], <?5!$?^>
MX9:=:1TM&'O;>9Y)N"O$1ZVY#*!J,C:JKF&C.]>!4X\?>L/;GS9SO9$YN0ZL
M23&GQDO$5&?5&%=-IBXK=U_K:W0 .KZ1"+J;-$>MNGHCDJDUM;54#4Q-W()]
M._P<*,IY:3/? L\T@(;I[F D;.;"TXWNL4TJ2&*%?5X=WT[;_JBL($;^2-@;
MU/:=XDV+RV-Q^SW4]EQJXV"[6N2U%1XQAUOT8=6$ ^3&[<UX=GB#V>]3W7[B
M%K"_,]WR1W].0>M]W6JV_/ ZR]EAS\9-2F0S4B+KQV,;"VQ;UHM2X[:MZFNV
MK6.2#BOL5@46JWLY2S;?HUO;V*,:6=JCM$8R:Y0TU-AL;ZIF;6\B_.>)_^86
M=J2F+':DO1J/I-,!DYWL+4G,0Q>6:7/[4,PDQ$U$'B !PV(FKF-,![Y'=B(R
MI=#B3O&DDFA7B[RVPB.&[$1D)\K>3K044176:QF<2\'6B2P^[5U-/+%,MDZG
MG>7^?K=Y@B.O^< SM'M\ ?J"W6WNL:C4B'@FRC"O<\M0HTB6H>\/?Y,"9@4Z
M/3;?C#OQFW$E97F]M):@Q<)ZG4JY6SGG$"Z&6:A&9J%C G\[C5DH#SO0'#-H
M9!;*QBRTXOA/9 >:G?J=2K65BUG(=TT &QE_R#Y"BSO%\TBB72WRV@J/&#+^
MD/$GMZRZ!\R0&S'EVK:=9VXG4?[IN#\\Y;/I^&PPBL<+2<'N28Q"[4KD+&P?
M31B0L/@\L(DO+#Y5GNA6I6"@HQ6?A[_UMM,UE@IXII-E,%"C.(% =;+X'!/V
M*UL$ FGK4JHI$D@6DT_L<-?6I='N.Q3H'OUHEBB%8_):K;S2Z1/WIXG:J29+
M8@H*JST?>XG!M',^H1KE_V?NUK&1X0$G0\?Q;=#$8R4?@D_*RJ^Q]0$T1]AX
M.*.^/V1<MEBYM)\LTQMQYO+">L(1F.-%J(,"V:#:PJ<33)>T15GK/N82L"%(
M7M\#PAKPR0O_ \Q!?^*%\!=J8XO*PEBGQH(GL5>%!9JY*"&L!'KSW(R\^)QT
M3[&=A8F/]&><"+-C,SZ/LV*XH8(B"V77B0]SY,/_3#W?'+ZL9D73+K_O'H9%
M_V\"%HWFOHI+M;UQ*< ?F,CTPXJUZTK:X]^!&0$KP!ES+)N8%Y;/K87?CZWE
M6)*.8_63[CA6+6#'L<DJ;@XW,U-YN4<,R]U9B!J'%9EZU#B,&H=1X[!E0P5H
MX?B[:4^9T?-_*_\[WF_A@O>U\*[MWF" > (-^@[X9C#?9N%L4/DWON/?6II>
M#LG>'0^!T1J-,G4=VQ8BU4-T'>M=7-Q^OWF\OOD]5=NQN]NOUQ?7EP_Q&:^_
M\LZ1<IF0=+65%9!:*B/35A+LL^Z9WNWPSF43/?">#C?W.=Q.FJ4?9TZR-3M9
M[NSGWL/U@W)[!1?GR[O>_7S3OA5FW5R:^.VMLU! ?#URKF2.A*J@57; DK81
M$;?5E%9IQ#$+Y82O69AG=#B\70/[V(MF5==7]P_*[$3'?!';T%U0/M_^')F#
M$79QL:8&4W3+FK\Z*='N@9+*O5CV4RGZNKKP\.HA H7UNO?@S2FUO$4'3-OG
M7_?@P\G$=9YA"8&E]_67ESX[\,]<'S 8)M*=XZVY.(_%42EQ1[4D/)4E]JNR
M8W\%S*<V'+.BQ:'IP6J"7H.>C]+F&0V;#KQ=7"W0?QN[4>J>QWAC&.7JC\>[
MKT%M1M?$("889_:@:7MPR A.XXP2F\B8Z;COO WG4#==T=*G8(C;Y72_B*[S
ML/2LCO)U+YT[M]LU>?$\]R:N4AEL$(20?>"8MDR;@;: Z\6V<X/XBB,"S8,L
MICID"[&%V$))M8=7D;9!54B 4FFQA UB7S6:16<[BLJ5#RQX4?G1#!_/=31\
MBWW^V #EH_6BN&S(7)1]V)+5PV^7@M.76U^C4Q[%+M-!OPB&\$<N8\H+0SL6
M TP9RA<V$"&+-1&RV#A7>K.1P[ZWW$WUHKP52^&=8A64S .?2V#QYW=J*?+^
MPKBF'?ZF<@2YN(!(M;@(V^9>B#_Q@08CDZ'Z\7/$A(M+V)+A3^S7Q/&PCS*\
M> 0KYN%(0!E8_S-L$+]K@B(S=6VO-'2=,=] TWYVK&?AJ8YZAHH6ODPTT1N)
MS5-"?QMNYW (DT;SH!>]$O?-F3Z-^%LGSD\TD#T'AU_TOK?F.3O' P].0U32
MQ!3A&3B?GO!8FRV(.^.G0$ L.C,;6NQ7T/K78L\Z_AE)+ER$ 0W# 0NM7.TN
M<FH[B!R)U;'?F<U<N"6\J"5LS,Q$[V>,VYB.)WSK..!TF,Q_0"?S></I9X=K
M[0$B\5F+LT?(E^?*/T.."X40<H:%S<GA=?;"Z_"YX)6.6_),6(GNAF^'O^MV
M!%(UAGJ4E*:!_='QEA,A'*/ A)EY8+J#Z1@$(]R;^/103_0\WO)WQ'"YP(!\
M9C$>C ]6BN33ASWR1D'.Z/H.#%,KK 6Z<<!0EK?ZNP,8IU&92&.5YC($>'B*
M%SO71??%_(GK<,Y]QA";D6-Q ;!PE'U<;]&F@VV1UQH[\&F=^#0//NT?@D_%
M>9N*54%3YJ<IUY %6Z[A7N_C8O-H8LO-K-7<@2V+Z\ ]*%L.CN'XC"[L6NNC
MMZ"I\]@+.#<!F]BR//ZW<^+-Y/S5VH$WFY+<!86U:9/]:,Y>A,$ZD:D>S4#\
M"7V,IH7 C81A/:9C! :D\.:G*E-^1O#;FN=S$\7,\3,)8E'.2X_<2B%NDA@M
MM#CXO%T,#QP<!']5@*;"ZS6[&SI]7S=M+[R0BNM@0'>>CM-?>"/.Q^*&+_Y*
M?NGUIO#.\ T#IL/E\14;B124/1A;M'=@BY8D;+$J2]MUAJ9? LS#HH00Y390
M#*9W["!M)=1^QL D(P90?\;K"/S..'IUWW?-_M07)E9^B^&)@R&O(5_-\E\$
MAG&@X&';L<]"FR?: LT@V1!FS9Z9K9CX/7/.%+/B:TKT-70S"ZNKP8; @+[2
MURTTDYPK/0O=9*##G8F,M="W9L_R"$S<+?;GU/1?N(D$%HEVR@DL.PCP&^C>
M2!E:SD^<4IBTXX@<'I'KZ $'^C^%WPWMQ=["VF'/&.8OV)P[83WH0%($3&=(
M(I/E)I[J[,"/;7GY$<\M@1*7"8L>\R*#'H:<.C[:]0+@>W&+'C+*>OL@=O@+
M9;\PAO*#1T10(GZ!VW& L>-B3??2S /"K-G1&1X8!O,&P//H4.X[S\A9P:M"
M[G3"U.&(+[FQ,^8M4;G1PYFB_97+GMGK5>'@X <I,WBHK2Y<*YPOXZQ69";9
M&M\=>?%]+9 E( [K8C,U1EBHYQ "2(?K%ALX3S:\PPN]/5QL!K([YF9[<ASC
MIVE9[]1Y:8XF^G6'C#B(X+7L5P#@H86>.D$!S/!TGQF_WRL+\YB%40@S_DO
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MTQ7,/(HJXJ:['+?4%XL^(.C_L8YAS."WB3#0U?H53OWA55JI\P>6N+S[.HM
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MZSG3W[N+)299BT0G[GJ^"L1R"!/V=;8V( K/@1L@WAS6%6A?7"H_B\MF=ZU
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M+H>U3BM'M%H+A*\?;)UPRN?%KH;V_8L*N1TJN]VRE(#$'&]))< % O^"-6(
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MG*_$< ^O"OG$G2T,!S2*'#W[IA8[4R,0_6J-OB,'Q(IIM+-T^68BTP>EZ4U
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MVU\&K5;C[???W]'?FF]?Z_ A_8];L(-LV_3\Z"-_W/Y/^)&ZKPM[G+!EH %
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MV![G#J9ZSZCY3>K95]$B)=9 *$X2@0C_!PM (P9_M1N?$>;E$<8NI1!O"_C
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M0-C\EDIDN+8GPW)0%2&!IWB!&!\=^,823I7IY>.-!&A*@$<#&8FN8NZL+/=
M$@DX*BRY<T[/''/GY?P>+MJ^;FX_+?LM\>.YM*7S62ZF[RB',I^[8#ZO^F[
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M$67IE$3YIY)FGR\VL.24B!O/?; "Q.1'"L=DIZU4&1#==K/?:RMB5T\=")@
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MQB 6E?EZ>QS?'-^I\+UR*J!-':3ZP;OHFX_LZRHXV63QYN/%"L9CU\;AZ1D
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M(BJ]GJCHJWFA[P5W&L!1U:'EIT=3CU:ACA ,6/07',,>>;#!N* /T,LO'\3
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M9R]+??H2Z=E.9V^Q2<M"(W/RTU)-;0JQ2<Y"XW#RDU-+;Z4498YD<<KM:9[
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M288>,?YL#0D(!PP\H=1-SE=?,U\D79(("5S,>;GQY<GYXD+F3*L3- N:ZCK
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M"AWVS%[._0B/WD'Q+-=%$F<F>V8<W[9SSG/^FDM V]8&2XPDDG@__5W5DD"
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MTGP[E)?9"M]](E<KTQ%%D[M#0]3-S&[4S.F=#9W).<Y;@O/C#BFY<:YTA\I
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MGU_O) ]M/ RXE6L[G;,V2Y&CG)DGQ,SZ<DDJ-Y76RR@X.Q-)&+'=>"D%!EP
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MPX$4\'BYMT8'G$V6UN@HV+K.?1^-&IUQD];;SDM<@0 4YVB=>PL28QC?^[;
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M[<ISXE63&JZ:=%P,T_N%YP&/5]S^E3([6Y0'5C[HBWKVS%>&N,8!V\[PC*,
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MUGDH337MEK&JA]VB45XM5*K:<=B-(=!/*(9 TW51,=0J+M_Q7CO]AD6Z5*E
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M>N,6<<!(E8\I)79$&S=9#IN7FHIH2-L)LYW-T-Z(_@=64Z Q4TFKZ:,>UOK
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M8]!V:JB@[I3+E.+U*VJL*SU6%4F:SBN:''"'!/W\N!F6O\-X.SHMH/!PR80
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M,STKYF%P-E$(NR;2\&6N7$IV[W'G"[D[E$5SH(KJ("V'E\%+^9T3.9.@A%:
MN96N-5W)X%IC'@>G'*- 0Q*6X0BTEZ9\=0)!"?M&KUN.FZ\UJ6.32MT4^_+^
MVR V>';",0K,PK*=VXM68'LY,TQ7M&NL A)D,]HU>(Q""=60ZE8"2O-[D]X=
MFJ)\($Z!R9OY3)-B8 I,TH4AW+=S\S,*;'[M@0=[-U-5!#"<;;S"4=.K.6BA
M^0I">G]_!2'&K^DS5A-L? I,TJ7V&(;VDHJ]/8.9:(;MBF"M"6\HNRI2^+_C
M:F6$I3%^A:/J7)C:4\%Q ^$)C+E L)Q7P8&'UDMA%.J+N;/^45RP*SGWO?T3
MT ]_8\\B&KZY[(S\E'H=S]8W(HP)<03<N5YATC-W\A5F8#NTL(Y(GPD7_6SY
M=-$>F;A/#O!L2E>^MBKR8TX<_]"R.AO+RK$J-;FJN/C/W1_O#A3_60M9[JF9
M-G3+FC^]I1OWK\CFZW!IR]U;3>S>$^=U??,>8*.?OKZ=F%QF6;)RA;'\6F3E
M2=VR^(P= C6N)I,L-[/1IM9=S*9B0@CG<)@"C2U,K+D=6#.8B;>8! N/Q.]Z
M[[[ #%]%P+>_F 4X%'YL^_Z"?J=T@Y'B:P2[!+[.FGWV8!F6]WH?G?M2C,2T
M(^&!^G_+UPMN]/Z04/[&LFF-G\2W0VK&Q,)?QI7>R(N]>,&GO]P?*+EE2 6D
M;F5&4T+<AN.E2MW"GZ[1 L8;:J*I;]-!%,A?"_L;O $0$+B'%<:14W\?TNT.
M(.=]RZ8R#!F+G8F&L>T4$R[&!(8GG1"+D8[UWX!R!L7D/Q+/ ^7ZZ+DO:PQS
M@;T>HAGGX"?U#ATAV2^\O,;H9<A\_O;G%;9B7A_H;[V>\-$FL^E;X=9Z@C/J
M/0"+.!.8J#+0KX1_6K,%3EKH]:(GJ049/IQH?12.W@O<.7Q907LQ^B2V(@W\
M+&\_SP3)TN^1D\-**:-26G_L)9<9+_!*>'B=P\M'GC6V)U?"#4 ^),*-BZLU
MU.13/\>/44)0R,4DV$62L4>LK[T0Z6_!?$;J)N=KI,P729<D0H*IR3JU.P9/
MSA<7LF):U;AJIUR4'4H7O3U48J!>WPJ+^1PV>@NL+&SI.O)Q1&!,YQ:V@A<K
MLD,_X2P<*]RHPFZOK5S^SL-.FQ9QB(<W;D#\#FRY#[]=XQY+]9:%%60?P1IQ
M)C8UQ> #](C[K>8FK/9B].(N8!T=:CRZ"Q_V86IIW1'GQ7;&MG"!-Z>*= 46
M"/V7?/6&;M9?[H4IQN5[_O(K8%_%7VD[7<B/"?J\L1#P1E7NL+CDJK@M8,-J
M]W(/B//>7(V\2]J[DV_D=Z1G;>RY6(!W[]B_.MNA:Q+8>S^G5/L)3<%J78>J
M?+GF!TOWUU6P^][_-KJ[[KT;W5]_H'9%UO]N1__^X_KFX5ZX6!:V?;/F=J2N
MO*4?KRS;G 6+Y%3A'YYXFI* "^M-0Q* 2CL7]M?=G_4+ /U3ERZUK1N-^H5A
MXQ2^I\SUOCB"U*K6:NA<..XERN8!LS$'X-SU@UT^]&JN#."K!LP<(0/_K\AE
MHX55=^LGIX/1".'U P8GB.MNPBG0'JQWZE+=PQ3TEX5?6GCP/>I!G7ON-YOZ
M:FT'[2[[6V3^>>2[Y8&A#,<$ M2U0>@[<PO5L0V#!K[P_=D-KRH0EIX]7N 4
M8(#O]FR6^ Q?L+RON!2$Z^AEPMK+(L?GOMF#_3Z9+::@GZPW])*#_""3!4Y8
MF-H>F8"4P&M$H+T#Q]/PW_@1];B1E_G,?25$>'9G82%T9_7\\ADX^(B"OP#+
M]YOM@]#A\[X-++(\1#OUPZ(/&D=_(;'-O%R=2'^!SL9> /S#IW&1X0_Q#.BD
M++2N?7A9S!'ZE3&A/G,"Q,.;&2#<=]?[NGIA9^V%^.B.B5P)%V.@48(N'C(:
M>3Y=?7@1$C2BA@UCSO%*R D$QW5ZV]1] V-T=H\X";GB+\;H_@_LV&&-% ^_
MO?O9*<YV M+KOA!/I&?2Q0S?(@KCA6\[Q/=Q#?_CVD[0^093Q#L")(6#7W\$
MC3EYMGTD+@6>A=,%;CSA8ESTMT8W#19=$"+#0C[/9W8XER>75L\';B/KL;Q^
MX(HK+KEX61;8P2M,V@HZH<S E^#_0>_0VPEB>9-G$3[Y1F;N_"4:. 0?CN1Z
M](-07$-T)=8Y@1_@K8^PSOAB('YV-:$$_3KK]$-YO2!(?\'R?1<.\&&W%WP@
MEBRZ$A^F&KFFX7V 9*"A]>19\V>?BA5\2/DX=K^1<GOUG*O>'LT]>T;O53=T
M]DMX_7I(ZUT*7Y;79?09:AB(2YV\KD:_$P_;.?B@>R=!R.0+^TWG.M9^M\DO
M7UB(X$>0KFET)X?.(N)M@H*B:_PF^H=MO\'E(2B%VU 0/%^DO\,Y3@!Z3ZYG
M UE YK[9[L*?@5(@0<==T/N[E#$F;\10!40PIJN !;[8#GJE+H5/SO(:+*3B
MB_7#?EF\;#LNOC_;DV?X]2LHT_":$-8V=\-KP_C&$J7'@DWJ-HWN/FUK!!*R
MF,07. >NI<K)*T)IO_YK 4KFDX/WH)$!N&R+5D9W+D/!Z@EB7^J+6MJ=%L#E
MP%K+B5.O9:TJ+;QG[EAKA=KMLK]#OT4?VG23?2OT)/QF54IO\VB;IYA(R6IP
MI<'V:;K]DDWO6:F?8DN<A4B<8_FE 4!+G1: 89"X>@VO*_!8Y>.;X3$,GT%?
M*#Q1=J-R&DUP"[,,KTRP1Q&.0\$=74<OP=Q3]J)9 S1O1Z[\M!$Q0%. ^E=^
MI/HZ&Q$#2SM[9ONTWP]M"[=F![XFXS? 0@';A,QF9"H*M#[-E)JO"V?5+"ZB
M^IO+_\?>MS6WC23IOO-78+CC#3L"E'$G:?4R0K:E:<W:DH\D]T;ORP1$0A;&
M%, &0,G:7W\RJP 2)$ 2 '$ID-6[XXM, E5YKZS,+X6[F'L#"RS"22!X!-./
MICZP.O%@T)QA#(71-JW66LZ@0_K0*B5@&[J 0 S/*,19FD$8^H\Q)+27S'8=
M<#.QL\J*7Z1K,W_\\*P?N)2$VX"@]=\0X^(#-DF1M707A'\"K1P6;NG1J@P)
M6YMK6;N,Z=V1ND7&R,8B">N$SG5-PH+E:0;#:J1A>>//ZJIC8"!V3$OK41GM
MA >!*,J+I,@D<5Q8(+7=SL*"PI^$@=)2F_%P.QZ[W@3UGBHP8:CE/24.Z9VT
M<)5Y,K+([>[HVNE<P9F+)GAHS\G:@6%AZ$+[!&*@JN%/Z?$03]YCS[Z/4@-+
M@[>S5$Z#:*E@K5ST#F)P+HE1R%HG9QC=D:&JHJ*E3),,+?-\0^S063LEW2XM
M^%)@T2AC,L6F) /_!P<1(3R(K)CT5#W90;("()K+\E7_'Y2?F6G5[XZT@2$.
MC)19DR&M(A$!&BCZ0C0ZN+-GL!9Q\^"%HP$7<I$ZY5$#E[#)S?Q!GO@IHJXY
MO4U9-$[<UM^L%[V+.UYJ[/?28:&7]O=Z:5]*?2F1P.WO'>SW7CG]O6&(_&![
M/@10-*6(]L3V)F1-#^[< ]MN.H[]#.=WDQS80_M.0[)H8C IZ:4V1^Q$IWS/
M>@)_@W':>KB$(1CVQBPM$\@<K'J&RKG;#)4"V!YO[ K5K(P395_!$Z4AJGU]
MHPINU+6\>]>*!7\H,\"6&RRM]>@ETH7K9=K[]N"P#\?IP8F:--1OA"?8QB-$
MWZ',*4;PB!D6R\1,#/Z; )Z-."19[M$?A'-&X9Q!YXZ2-$N* UP$($N!VT[$
MOL0T$35"Q&0M]!O4F_N%Z,"VKL>!&Z.%08XP:T-@B9\G9*;N:Y.O7"BIO7M>
M]UY@5RL=V"E:F+^[NJ]CB'"B)C7N9.,58_/Q7$O"SO1)PQ!;H<PX+ISJ?#R_
M!\&4"+E@3L,B3RQ=)T?JL//*M6@7$KD.-.'H[0<@H<BH,?$AZP\*;[W\M<ZG
M^#/Q%$*J]J(;LO *$P<8.Z1S('CMT4=.R&'[)#R61[(^<<F20+@?L.(>?9(?
MF2B:A2!!\\3&U()#;W_@[\\NN#TXQL:R%7YXYNT\61;:!;^%)]I$64.B$($Z
MSS-GL@U5P5^?JYXVNKOY^H0-([3I/.N4OB2\;XBW+>TPI!OZ!$N>DUWCH/<V
M8E6GM%@HE7?SKKUW%>&V2?R,!5BST=VRPK3VDPS]+*5M@"!WLSQO.3.T!Q?$
M[*CA# IB$C4< ^/V32GGS"^P 1KID$5#;)HR+H ]CK?4+"W?RZ9<-D"7;0+%
MV<395/O0@KY1'%>[.XK!:87E!?\TX8CIO0HRDQ/'61BV/FP6SUXJ4&3 &.9B
MW]B4%=PE=,USGPO^5L'?BC2D]<,W%UUECSGY8!7*/\S8K^>X6)D ?C1C[/5Z
MC'6F:]("AKJ?TU ?SPS[XY1@UJ[T!YLKD-B0T&K/ ,DB\<K/?Y$1FI"U;'<O
M6T]C#  C-SC>H"V3#>IR8 NQ*MV%#7.Z,":PW;GRU*8\VT\L@XI.+&Q(V3ZG
ME\KE,IF;6F#=XE+431DJKC#M]39&ZW-; XG[&ZX^+*A/(R,V!G+N$QD;"I &
M]+\*Y[L!X+<L$*4Z,)(R0>X:1PVYJW'(W49$LQ5(E!Q=EZ/K<G1=CJ[;)+HN
MQQ?E\+H<7G<E+FIF;L6AJ@6'W<WX7].PNSD5HT)D7*T,9%QUS\ZS$,"+@'AI
MY::LDKV[- I8_HPT1"]:\%?[T]S51'8(LF,AXM!#V!U-NLSAG\/&:OPV?)(V
MO/FKC6DEM*951*4*X(+7EDJ?N;,7\@;E#)&45EL?-R2V-G5!EME5I]3459=2
M@KT[8YDX()$?[&KZ*+NQC.SA:A%K%^_KV+H3EBK0FUAAVR6E@LXO+B]'(R_$
MN[:+ ?5TD<AO-N7)&JPW5W>NJH+4S]8+-KD S%K9%VQ*[@LVEGF<LJC&^BN8
M(P[K"M#. @VU>/,1<Q+2&O6I?"9<N@))F=>5=OE:[LWGE?N<*[T4P:@1^"+Y
M%+X>_DC5XZEZ=J5U9TG%T60R*@1%HC?,$7QC=FPXQCHY!MH6+%D'*!)-6 ]S
M:FFPWJFH3@*=TQ&5CH)/I5HE0&"L:!^$[+7 .BSQRIZ&4O%.#,<LC=T?#O!D
ML@JG' X4)S>I.P:C%QF+3C /TUAR3M^;D27;AJ</].Y($34EB2@NO-TUIIZ1
M+:T/LQ\8. _>2&SH75:AV8X<ER')MVH1%)G,G:C_?I==<[;(J..H&; ["PC;
M6 Y]#?W-G4\G8ASSC<Z*6H#:XX22,9DXM3IL@<Q]FD\78-($$7\WSFN_P+P8
M"K4]B8" KSW8A^F]1H# V2"D!_W-)K)C+AXN1$^G@(K^VJZ)U8I]>FT @!.-
M!  J/MGS)_SV+FU?(TE&?5^Z%K+.;_1]V?08<:G%H90R @>1)9_A 0Z!$M]E
M>O==>3B@X08$SGNVLIG5(9GAHPRU%+M*RP;I;(;(A?CO!%JK1.=^$:C=.+OH
MU J/+F$'MF5N"Y5VXUN3@=J"N@V*8@&I9W@I[,VM571VB (F\RF<)R],VR.%
MK'YJU'('C_LX=<<_E^S1!T,X3;*+?PD;$IYQ1^GWC%$0B .P$ +YB52M+6\<
M8\#@]Z\"SN6C'N^>FHO LQ;A"V;6\9^?W(DUI;BN"_3-#KT8PQDT/OG^3^L5
M;.AL'O@1?']LI>0)\#)KLG:-V:;8O^T FZL9]]WUV&=!3%C\C!TB$>$VW!K$
M_SW7P^K)@ \&J> A&'R247S/[A0.K5,[>-T"#)-&@N2Y//F6=-+L@%W)'(!G
M@U%?>K7/%LXA(88 +]$I ?Y8[#_%EF;$3Q]*W9$V/#'24F\Y %W>5 &]<F/[
M/WL/: )MS B!_11P[-6;!=#$%MYF96AS7,3=7<#F+L.]W4037XKQ489SU(DT
MW,G&$GA7!BQ"3(VG]H,5*R\0WN)Q[QTS3,Z;45]A,N7E%]CA-M9N3<,,<4:&
M="(E#_V[65O,9"^Y-XJN!P23W@\L3B)XR__V]__^O+SF;R_'UNY PK-/SGD+
M<"!*O]P8JICA.!DFAPP5XU\\=1N;3W,XP1NOTRU:IWO?4)WNS>UW/]<]2GRT
M43A(V=]<H=LJT6;TH IV:R  G\*4?&5S%7CB-$3*<#K_G$]?!7([* _6)I63
M6:W6)$S\0> 3CBU?XQ(]Y4-$,'/]18)A\9FPR-WVZ>!YO#:UGV$)X21?.H^6
MS!>#?W2?R'!:VX.8R\7IXK[EV*X'='#,'^$L&JR>CK11"(?$V!YQM)Y]/R=>
M-\PF+/*U9'R9*YA!@%Y-%)Y<6 2F,^A-#,[0%/R?-LZ[[=#R;*SXPOY=TK#E
MNXYC3<FH17C'LQ6]5GB8D_3PQ'JVINYLN;Y?\%H_'/X56PC.=)_B_%J2>GO!
M;/5BSBZ.H0EGPQ,VK.L">(CI-!R'%8Y3#P=!;1TSUU\-,_">ZL-D[F'PNC/$
MN(EF;WU"V@+AYN84@\2-A4@T[(A'%5I\>O%B2!V^W:<)2:1.-'&.R!@\I]P1
MW5SOTVUM<N V.D@Z:CD<#YL<A;PNE'9\V.A;ZU<T3WKY*#(:BHZ01A&_MRQG
M*?2=#6-GO?ET>?^P]LYWX7!E6-^.%'TI,^MC@^K3Q]?G.R;IW9$N*GU--/3D
M-#@@4'@#0R-TK@AU#$8")WAK@7,C:B!KY,)6$M&A^7/364R671/#75-B^Z54
M?)8L?09>?^E#"?Z7<@5&E);,Q(I%OKH$3GA*<R#4%0(I7QY=TFJT=,1KCJZ#
M(0%YWN)N 6];R9S#:!@;'4I*YT(N?,$R>TR]MDUFOIE3<I4%A/?I3,G5T9#4
MGX1+"%R\X'JFHQP[45^4O\--JJEN\@44$D*0Y!3?>#%!.#7R&WG3*KW[W5'P
MB*E!LL+D9%HJ-?1*E9K+)467KAXOZ.S0/.(,8PS.8%]DO6@VO=B\RNI,QI%:
MA^3]&1F\B89@LUM,WIOAU=K$PNG49%S[/<YQ?P!50_XE[[ZBVH55=]!9NY G
MM[U$2>W 7QE<*,8NZ8!(/ZV 1O.P\BH$1.Z?:!NJ4<(?VD J?'Y//AFR?;JM
M6)3"P9GVA RI7!2!4>[UT*P(,VI6%I5@U=6EZ?&ZM%-\BOIA9^F#7""L6AI.
MXJ_"PJQ4I[5>]C <=$>J*!O).X-W/#RJ0VK/_ Z8LW5Q4\$]0Q!.7/QF._AH
M3FC$'U5G34Y6*I#3@=':CGZ2"2RM?]1@:3H'2^-@:1PLC8.E<; T#I;&P=(.
M&16*@Z5E_X\]L#0N_KS8HK%BBR-4@PJQUO0RL-:T$K#6ZDRTT*H21>95)7G7
MOY<I(K=J%]:]-\?TM4)21G+F\I(5=J57EX0?6:DN>6N_RUMA(J24F(BY:DS(
MV?.4?.6M#0M(U)B(L2*33EAD(E119$)/P?>O M+5GH0YXZ?EK;H[0[1 S+2^
MXLG+?2%W:_"W1>6Z'[4T%BA82?"M8,&*UFC!RG!SP4JG]04K[.:=]RI)616[
MBDI2R&O"5]Q@>4KV.I12!F&66@F@2!*Y55%545>2;>V5EY\<I 2#QSN;>?94
M4"5Z([?F[ZBM3)-9\D&(PUZI48],MV"!VMMX+)J9> 2QX=_ 1,/'Z E),!>E
M =3D@T:8?L<DL!=C$/\?$+F1&^NTYZQREV&KU:+K,R($7\%2R?THY$F6$:VQ
M?H?Q*&4R4\G&0^Z.-$T2M6$*Q$=J$9&JI181V>-'C,G 0,=*B5(BLDX\PJ'Q
ME+F(X1(UMF=/;J@_YHOI3?R=).XS2&+23B4:FIR1PB;&6!-K9I%""P&^T+-^
M66,(5<'7+4B%E-M!C &#Q%"[(UT7Y92*R4XJ,8@X/-K6 PK%$]X\([K%PP-8
M2N]$N'8$4O2.=]A41W>09,@@2> <KACB(',9'RU#VRTBZT5&M+A_M9+/(K@?
MQ+T@?A$I4;-_"<'K#"PC229$)7YA%=X"G=R9A$ K+L$MIV>7,-]/0C,(PS"@
MFCN(KP#!V'R&D$A8<!4N*WHBZ2]G,$ I!:-B)>F#M3,K.9OOA#A A,] @R "
MHX@AD&_&N-C]F!BFQ5#J*RW+]GS&4_9T(</S:(OTQ(;W2/[\"59'Q'833C[;
M%_FL@$ID@938/G$^(PIT58C)6*&R,3@N /7,'/AW?0O:$^>[3EAOXF5)J>UO
M]][[45AOBTCP]._[X,%S"6B#!+PA2&V$V8O:>P@/Z4]H+,(TJ9E;4+X!S+7S
M^X]8Q,CIN*?>8/B-:+&H+)VX^J0H#M[1E@74D@:(E(Z[5-Z&Y=T(VLVC>-<G
MDBQMN[\!V:J\VK3M8/9:=6#V6Y,#)4/:*Y+>'6GJR2 -M8?+/IO;;J'LD]P#
M2&!8MGW]\&GI.=:@;+?BARF2@6E1UJ3U#7."JDAO-H0#6Q)/A+5;<<+"4.HF
MUF]ZX7K;T;67Z2195<HDQ#_GCB4,: JWAZUO"YJL7MZSPQ5Y'9 Q)U<2:O0'
MB<92E"E.]'ZI%;7Z&U&0\1<E_&4KU;.&@-M31:4.#,Q0#EF+6:]-^!IS6$TZ
M*?U0 K1^S@"-R_&QRW%YP=8@5[!59X35B-!E\]9ZM3&4H3890[6![H6B)&-0
M:I 1#Y#*BY+R)LHJ;:WB_N<8_(]Q*''4D,=17(Z;B:-DB<=1^?VY46T<A<BD
ME<112CAU$PO VQM-&7M%4]A%PW-.BPUHW,<<@X_I'TBL),L\5N)RW%"LI/!8
M*;^W[E<:*RF*7BJ>8+Q'[C"BI?X^T9*BEEHP7E&TQ%+N2>=^Z!C\T.!0XBF5
MQU-<CAN*IS0>3^7WYX-JXRG=X+FG+-0O%$T9<@MN\NJ+E0SN8X[!QPP/)5;"
M^4A*^AA9+L=<CBN-E?(5E_-8*>)8E;'2H-3RY8.+E89[Q4K#4@OR"\5*F^9$
M[X_"T'80JLK73X:_@CXH_0BN;#L.SD!B#P='QOKH@:BIR?% F9&H8@!2(5:0
M_7\FV?]G"S$A<%4E(\TT(IM;H87SHLPHE WYP6GV Y2)S4,]$C"91D2E3(09
MI2Z$F8P]\_$9)>0';0&8J6WA6T\'NY=R*J3NHAD DBS+389=F:9IE;:;)29-
M"*RP!DK3V0>4ADO-@4K-$L=F%Q '%Y123VEM$(X,H#<L4[K-*DDA<I( 4ZU4
MS#HP?!*;;!C4I];U9$,Z24NDUF3MF"9,?]>J:LY?*]*AW,,,NJ-^_T33"T"M
ML"<F7'\.6'_*N_\9%@47JI6Q.]&&FA=V1=I%E"@ZB^(>)-('03_1R&K31C03
M6.5M=R$H.Q7>1*E&^>A%4>9]XSW)C&4NM]2D9;I84U)1V#/<K_7PNPL@]N)W
M<ZI1:@\=L6M;+SD+,G?]4F%Q*9"75I58R+75;;QY7/E0&<-PVG[Y6&K#A]^)
M1MGAC#D0.KQ\"Z<^I([]Q#D1*6/Y\ F+$S6=R^=94\OTHWE)T>/)/X_=IYEG
MXS"*X,4EN7=?[*!"3E_I$(KX3"4R$LQQ SH,#.S#D^V0:>1D_A>\"']WYSB@
M8HYC"!TZ. R68-'Q%+B09TSCQ@=4+ =>K+^KX][C/$"\.(+@!)_B/@@?R4B]
M>_?9BL;PF0X(Y10O*DD@A /)/.O9!M+#UI"F=-:).9M-X52.=PSQU]/9';.%
M(L:&;<#SX;>9-2:S=>@DG@0%PY%KE,:P5#H[Q(^&>\"V;>N9\(9>H>* QB5_
M3H2+D.L9IHZ(G73Q>''GTPG9E$"#1?IP.BPDPW-C\P?]<%16Q$F<R;5*V&5<
M$+_N3;$B^\X=3\Y"V#2VV*.9'BEMCG&EYH2=/286\[=>3[BPK>GD@_ -I/H4
MWOC7',=H0N Y&)P*?^#M"2Q2Z/7";^)\X?#+\,MJ<$G7@[>4B?<;LPQ3*M8O
MM'>&O!DF5'='%[WX-J,-G@IXI_A!.//,>WM\*ER!-:-$N')QMX81_];[Z&N$
M$$22(Q)L(LF]9YD_>]2N?0"KA=2-K]=(62^2;D/,OI2KC2^/KQ<WLF1:"KMO
MP<P%O5OK!RIIM'TYQNAU<5VLA6U=V1(ZE(WC'CX] +?KH^G[(,QGZ"' P,-+
M[L%9A\ZB\PTL\),93I6]Q%4X)HW>?GM_/VKI]B/N'30/K]S \G'"[]WOY^@S
MB9TBT<P#1#4.F8;F!_ #XNM:S4W8[=NS)W<.^^B0F,F=^R:)41Z$&\N!*.[>
M%MYBJ:<BG=Y\_4C^))^^(Y'9]UMA@J4K$"9$'_E^^_?H(VVGB_5K;,T"$GHO
MY^F&817N?E%4@+&B6>=VZS@.K:Y_:SU3WCUM==UK-5#IE4U;+M3@V1N(U4D>
MTB4XJ+U/.;R7/LX]K<]</MF0B:F8U;>_G]V<]SZ>W9Y_)H%$UO^^G?WY]?SJ
M[E9XNTCLO(OOH$/R HNT0&H\45#\N:3O+>DT*]&4L+^]?]>,L&,-<RXI3\VG
M'+3$;RUK7JE-WI;J]\]_S:8F1+BN][JH5C9H1G:_A^C;4\WKB>:5E]&B^3-G
MLNUJV-]T-YRVF@W306-7)E6\/I[9UK1]B\ KS%7>/5H=6L>-2;24?!2V$[CS
M ,)G.J9][N#4]93!WL)D[D5YR5?+]'A9N%#.X%$PAQD*PVF.H>+>K?5JNL:+
MYZ)=;RR@8ZM>CB".DPI67/=5=$I9_@C=7X&*N>8J5[D$Y)8 O>42@#%4%IN4
MK4ARP;_5(+=OE#JNZ#KFP4R2+/FG"?&3]RKLK(^L27R3M]%-5Q:L#V^JN30*
MHJ82NB_3([68.&PO),S6E*D0P.N!.!P.&)O4QL)<02[B&T5<:8^((T:N+.JZ
MPKZ$9W=02?=3Y5+#TN7U@U*=T!=U;C<WYDKL7K;G6^.>_:OW:$\F%GR$_@Y+
M&0<]51MV1[TP&7+0Z#A,<ZL>&ZD-2@D#R@5A4)2-( QLH#95&Z)7N9D+UWNP
M;&XE:]"[MSL4K\+@9,'E4D(3%8[5HB9GCDRJ9.?ZM0F7TYWN7)?"UQ5=6J]M
M1G>W2:TAE49KU,E"MIO:K>FG>H^.NQ%/&E.!?$L[)&,>78Y-KCTJ4Z48=:T[
M,G114K6L5GU#=K1.8\\UY0 TI<*T8S6:HG='@Z$X',JMT91JCR?KVU/*UK[D
M9<)G:VPAX\E2U$U7"I4OK*!9T$#S)N[\?FJQ9A4VK8SG:3=: R-OGC95*AL4
M!*XE56K)]I.87-%)C T9B]P.A^"MK;(,(?XHN!_B0F+?* &IW5Q$9@;DQZ2J
MD[:4OH"+G5BT0]6:"/>O@F<]6![I\PK;05=?@S\!-;$=O-ZG96R=)>+M#-L@
M;=^?TYI1._#I9Q[=*:P)]C-?=-<"E7Y: 3:;>BXLO61(W#J1CULF-B]A]:5@
MTO++L&UCAM67D800V4"A"F-JTAU-A"OZ22*%3$3I]__^>YX#0!V01CF/!?G!
MC91^=]273K1D=4*L*>8M%J=E((]R>.098%U6VKRR)7G$#I!'S4 >M:WDF?N;
MR(,P0<.3H;&%/.]6C&/"MF2 1$Y#O&;9!%:T3#1_D9?RK+'[P['_CX(F()E[
MR%1A1ID*AFYF.3ZQ@C=?/^:Q:CTU.](4$29R/7I.W[>0'C4F/6/G=45H<,:G
M*AI2,GTGO/U^F\L$E[]8$/75Q<K=D2XGH=_>)3P(@B],%L=]..I3/"-J/#]D
M8(-2,QN4[FB@)S7W%)>M[EZP7.#DNV.YTC9&J&!J1'V0O%??86 8T-P6&9A%
MS&0[ OJ=1=0<2VS181*(1B+&PO49. <T/6-S9@>DJ]J;CX.Y9PFK$;:(K23S
M*4*6"'CVBT/"1E_N$-2;,+*SGNSY$SYDMX?5"JC0TL42P?Q&WY>J0A FK,JD
MAC(Y&"8MF2@@@@J<.Y B<);8K?W[+?T3I=N-A<@N&?5?Q\7W4^[&LYCARI>;
MT'\#(K$4#,YWHD";_RW/PZY^SWU:B"!*D8N1$8H<OLDO\:!6Y_B-"@U(Y6M'
MJX(SIF)'^79NI $FL',<CXU(4NG,,'$E;4(R(<\8CH+.F1-W1AIO:18GSOH0
MAVONS5Q_X1D6G_%IIL?VT6:^M=^!C\!.'/L9V("?!/=D4TPO? W\H_M$ +X6
MT%EI4&GXT67_;PB_9GO$HGGV_9R":-%T$4%X.25?>6O#^\T@0$,C=IY<6(49
M6/1Q'H[# 2K^M*?3<,\8<7LVIIZB84J.-<7'8MODLQ6]%YPJ\8D3Z]F:NC,2
MK(=?!R.&*PEI0K%F[E\%I*N-?A=AP9XH"!OQR+.9ZP5H+U_Q->Z+0WP._,W&
MWB4X[_D1=%K(I!/ANS.U?)_:Q!?T\F.$^R)[0+BU)Q+#BFE\@_=.IYTE@AAL
M9TPWM:VA5QOH*YX!4\P?('#&@'GG$?>&O PV_@D9!5R8F],O]@.>=I?!"/'9
MUP35U*?GU[C/Z&/SQ7HREX3K/O44\701D5IX3EN2>>SF[JC1?S)_V4\0N2T1
M5TC@2.#J0CB]J$-_)>F[(G88)/[XX5D_D$EOK5_CZ7P9@Y)'$;A"TEP[H4"$
MEK,4:P3",<=CUYL07+N%\I#7A*^XF8-2O,-P$\)=6-2.R,=@K^A8'8"<RZ+4
M5T1CF R1PDSWB5"9O,C#$VV?J[@*17G_I8'C.YMY]E10I6@XX(KGHU8S37K)
M!ST+C#@Q[Y,H7Y Z!0MM/;T+PY1."-!(C3_HANEW3,&!)8Y!$7ZXWNO&:5J9
M\!K+P+9H-/9:V\=6',3A4>,@]@\0![%,R] T'E<=>VD99AL'9N3 C!R8D0,S
M<F#&0X"KX\",V?_CP(QMEG0.S)CM/P[,6"(P8[\,8$:C!!C"Z'^L#DW9G&7,
M.4ZEDS9.1=@R3@4?4OI E<ZF@2KX@=I&JG1VC%01*ANILI(K+#E;V+J[Q JK
M;K_-/7\.LM4)I2&A.\"O+1>#M@/\,J>@&9&FFO&4/L[MWIYO[S.8;\>R1]%0
M-5%34DH?DW7L*U<:;_$B,SS*D7\[>S&]B1\=Z; ^)JRE04UK'W4T:2MU0A,!
MTF3"+UBF 3(PD,!>3RUBV.GM*4CDRR-\!FW@PJ['[T9%P7QR@4#$NG1VD&G
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MQ G2NA0?[SG@T A^SIKZULNC18Y]\#';CWD^VZ'5,_"-]4HIQ\UWN1%_-[D
M\ZBY$7 _F(:;S#U2 K1ER U>Z:OD5XT8X-4;_J3\<P6H4P&P1B6+G=ONKQ:3
M%L\"FG",C2)T'^Z68H1X-QM<UF(HH9PICYGUL7%/*,O*^I&YSD-==W07ROUR
MY1VB5N:*8KVFI6$ZS>A*VIS)_1F\(QQA<]Y:FH)$(6Q$LZ)#4&+?3QET)N6#
M:L^2.+H(4XJ;1Y,5G3\2)T5^>/7&B%S!8!@ZD*D,.K9DMSK?;5,Z$G:P921C
MN?0*!VSD>2=?7+@X,@HCU^(JE)>L>]MMG%O^X%I YPTM%1[SLW<B_.^C:0M_
MV@^FLP6C-6WKZY]*>T&ZI.] 0(U=U&POY-"[HUZ8X\H#"KIU4;7O=ENSBC[H
M[]6M$N9MO]&JSGBL' NC,W:PP'%&&8JZJJ:T]'+BETO\1&.4BNU#BE(B[6L!
MKT7[\J?I_! ^F_^>)^Q+CO!J];"6"\ L72Z*X8UEMDS&1LN4&7\K?=WMH]EV
M%1LR8]^T[D@5AQG,&^<@&QQ,&$D(!W1#J89_]0+6:;/,XK/^T1)04W+(SBZ0
MD\P&LY_98&K[*!O;U*JP([M,2VD@]H2HI30S<]XQQKN$C>QC(-D?I*'H[LVZ
M-/2<%;2<3J<]-VZQY']WM,WN!^Z,?&##%5F<0OD_E?OR=XS]=B%2 N;<?[?,
M:?#X_^:6'PAA$=K9^*^Y[=M$3,^B_D%1,./M#UCH9$_(^ [X5 : "WVP'ZCZ
MLK_J4_S5-[2IS2?C1!YB*_\,.I#-6@TVGEMWPV PLZN$'@\W'0C?D5Y.X/XB
MM_-B^O'FP+5K] VWZ&N= ZC:F91@79"S"_:Z):GX==OUZ-H1Y+[PS_GT-88"
M\\E]@N^\8L;><U^ :#MD9P5I1,HI.I?.V$-X V ,^?T2;V>!0=</UZC@IO=Z
M2PK-+GU_;DT60B/%A(96HJW(C2*!-BBB)$GXOZ1&N.&SHRJVL&,@VCFI%%D<
MZ@D8R_3!GH+MF(&3I,VO\-.)A5U5Y([9G]_[8\^^QY[S%SJ8DG9/@<Q[%FG3
MM::V8Y$FXB5EP]>_6*2Q-9A[#NT/7[P;J*T,EPR"AT+(_8-V3=M $A/KP6'U
M#MAW^C"P<& <<1\V/.O^-31XN'7L9J>O1LT8NV KPT;OT/3MXO1^_OUC].I/
M\&8?&$]Z@S-9-^PT33^UBL++HSU^7&@_=F&33C;X&S:<DPMVA^#G!*_X)]B2
M8]&?DSH!TNX=D;*EUF"[DJ^B-NPP%_L4I5S/ S\P2<OV1W.*]"RS-B77TU>E
M1P%+M_PV'%W)UX7T.I%U+,0E:THK$9'68KE,%2%%J<L+0YHN#$EBKK%TS<U+
M05JR6UX*TA8=.:IR"Z875T<M2,[ZB?VJ+ZK[=I,%&F1X4(3*1)N*X!3CP8'%
M;\,5>B&P31+@DHV'&4__S)F<A;O.=BI22<Y'3<$2/=!:A4(9YA((K9%!'JJ4
M-KJ&$[HXH=?S?0K."!*U?HD"74L!"+5?L-X>26JL NNT_V8\\_7F@->#5*Q=
MB20 $;TKUPD%+P;;ELVT&=V1(:H9-(YSD T.)FQFOSM*GZ/+;#U(EJ@U4\JT
M0.'^K@?RQ33A1TG1PYV+H+<(,["]8/N *B:*'QQV9H.SF?]!YB,$+W(IW?(7
M8]D08F1#- ;Y2P YR^IAV;J+5O$Z6E1;7(ZT?F/%^_WSN%WZN4N'7,U[D^7E
M(T747M8IF<LZI0BB/%[B0KPA0K(B9KQ#L.0I%&%J/5,GNM@,:Z3B+W(?A'_,
M3>?'_SVZ\[3BJ4_NB2A\"28G5-5_*[=%GDM34?B421;XE$(0$_^*0R!=+O%.
MSN[=>?#?UNM7TS%_$-G\9GD^%E%,<]SFIR,MY7Y-''E"5?N[J(7U/);C+ZK[
M?EJO(!/1"SJSZ U"'#'TPX+"*94 56M"6B5 :9QI=25 T?3#\F;?6-]IQGS
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MRVPXPN0O+-NSDJV":K*J/0K2=$G2?-'<L#L:#O)CH#!0'L@>GZMV<GOP69.
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MPN!C# ZHV>1 8=JC?L;*-"(!TU['&V/]-36\+6K>J>%5R\Z@E)>M0Q"L#BG
M7L.\(LWEOX(Q!8M>IFP\C$\!V).'1]'X<V3;Y7U.?'',+H[W.1W9@UO1YW3,
M<R(T23OT1B=#VF^6:4FS"@8$/VW8'XI]^6@::@QIO_&D)=%^*'':UT7[]5S>
M4.Z.E($J2L/VMR\Q.:1#D_1654?N:X_+FR$Q5!#ZW1#[6CNK(??5\!(IJ7)*
M%J-DPEQ"/";KHF*T )U\WSI^!D>;;+\)&[(ZQ +G-.$PG';VQ.SK$:HDK &$
M!2W0!OL6=K?3L%5)VCZ05I-$36?79V0.P; 41$IB4#Z83_;T]<.N>X,$7J4H
M#;3%)6W^P*[T\'BO%H%,,VH*W"MMJWA@ILQV/Y>QJ<PV+W@[3D,P1+5 .<51
M5TGOZYA*8]^P.])%0]_=T<[95Z+S*XE].N**R(HHJ?GG)G#^-<"_M3.9+I$Q
MLWVEHAX39D]JS-;)\\6T8C&5AZ&\6:',8+.X?U.ZHX&H:KRNNL;8LCBW"&"7
MHDJB/MR=+^(<*RT<*<XQC7)L( XSY-<YQ^KG6")B1! R11+E#&G\"D>EK?ZD
M[)%FI66[HHU5- @J]_2U_E%/7]/Y]+4V2WN&$61[+#]\>MNFOI7-O8/F(0LS
MZ&KB9FQN72?/W#HAZ]RZ]M*%#L+KY!N$M[[=%MK?E0FSJ^$D'-@64^+.@O6)
M;!%^6)[A;((%P>0,TQW>W$K&G\6>OXQ$#57%T]YA3 U,$]/M8P0'6\<(;@VT
MLLX5/+N\$?XX^_+]7#B[^BS$_OK[Y?G-V<VGW_\4KB^$U/&#R;6M=R57,&%O
MBVBGB:)ISGY\V#AW+Y+(,V>R^//OMN69WOCQ-9^8RJ4/*BS/8-P]6IVQZ7FO
MV!M@AE-.P1@&CQ8-;]#DR_U3/^8?[>66H_$HP:-)/(QO@2(%CT+BD?"!0(#@
MV8<@Z7[Z*IBSF>?^@I-I8(%ZD"%Q'=+$"H]$NVO""T'GW!?_0]D-W15:VW+6
M=QBMYHN<M70B4Q.WFK<.?UR8'PGRKV8>LC=$EOC^E.ZB"CHJ"R_XS"<+!$W\
M;(TM$O>HLKB!@-E;-,MDX)X]<5SH4.ADB2&A^Q2Z BIZU!TP)7*<?=L6C,$/
M62+USDQQCAN+,CP40\*F2(K&E(1Q;FWGELZYQ;G%N<4MX=%SB^L6YQ:/8\LG
M3@G(/(570_"&&M@S)RXG[G[$)6!4G+A<<CEQ.7$9, OMC'"J9CO#R^6[Y[OG
MN^>[/[+=U^.GRDTHK$^IY.SDN^>[Y[OGNS_2W=> N9!T=&'9H3)(P3<M_[BV
M\'FTJHA.9S8#X>*/NV]?-AQQ8SBV50C'^EO2NARKR5?LP-$M^LZMW:?RH-3A
M@?L/?]<1IDP692T-AV:[/-3.*2Z"98B@(NNLB6!_\W1++H)<!"L0P41S_J [
MTOMI8"5<  ]0  U)8<T&#KD;;GIC-8N@RI@(RA)WPTUO[,A$<-T-8\LGBVYX
M;]2ZY,%_\V%_K8BNEAQ $FH_CLV<FB"/WEUC663XM"+XI-5H;3%\4R8S"RF8
MJ-E'J>NR@G!DFIHV22F[U-3'."ZT3 CMO@?!/856[8Z,8>9PAXLL%]FZ1381
M(&G=T9 ;62ZQ-28[]C2R.D8&JIPYL<&%E@OM_F?3/876@,A 2<-IY2++198)
MD4U$!OWN:,!V9-!(@<4&*.6RLRKA)(%,Q%::T<_M\-LUJN<N^&XF\R.%W,B@
M.U)%?5#XB+D1][L>1\(%M0%!+?ER/)N@#O'J9X]<"!=4+JA5".IZE*-($)CW
M"Y\EN9@>GYB67.N1R9XJ,CI^3<]\D\D%E0MJR=?QV015(8Z_>*J#"RH7U%H<
M/][5&6P[_@JJ1'8@&]31);(RF'N%V%6J75U:5:;29'Y1%1OBS.#,X,S@S.#,
MX,S@S&@=,QJY&ZLQE(R'D61UR8KCF?F*LUOH*#%S//;F<+PX0HGM^=:X9__J
M/=H38-@'@?X.KQX'/4WJAX>"C"OI<=/"A&FIJ:;PBV7Z5MY9THJ&O6=#(VWR
M-Q<>+CS;$S-8WS?(G.CFHE.U@QAP!\$*HYC)N.[K( SN(+CP%'40?700F3/W
MK!RS&#I$72<:,GE.GHF:0,*8E++=W/9UT!T9HM+/? O+[2M#4K1O %Z:%"&$
MB")**B.VEHM1*\1HW5^K$@9[?25S+2B7(H:D:-]JM[*,D8I('F)?XXF!=DK1
M?D>&TJ1( 5L$QD@RN!AQ,2KNTE1T:08K\35C=WT5XPU=+<^M9*DSUR.2XCX(
M-L[EL?R@=V^9'KP3]NO\)-=_]$;PWO4\]P7^P1?>TI\$C["(*:8AXF?@=[PQ
MEN7&V'V/V5]<YP<(RM/'A3AD<QY:=S0P!J*1/0CAC=Q<7O<_B1655[T[@H!9
M5'',*I=7+J^,R6LBJL);(<D099UCNW!YK3%'4=2^(D*&/H339)_+*Y?7^HZQ
M1>5U /& -!15'K]R>6507A/Q -X_2;*HJ6S'KQ74 '"0(=X96RK(4-Y$N29!
M;-/7Q*&<.5/..[FYO)8&X9);7F6(;71#5#GR )=7!N5U/;;1\")2&HBRKG)Y
MY?):._90;ONJXMV'+FI:84A0+J_'**\E(;ODEE<-X@%%%24>OW)Y95!>$_&
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MGA!<!K@,<!G@,L!EX.ADH(:A>%NGW^V'WY=6RK- "<*U1 @5@7#QQ]VW+[6
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MT/3U@W 3"DX ?&_F39T1$6,K/"/5SI+OXQ$G'E8=P804(HOH(>L9"66(_*>
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M^XD-%OY!-[]1D(#LAVD9_SB,$^^85P(XZ7C"D)S6DTC09E0A_E@4OTJ""4Z
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M%SY,T)5K#\;XW[OD)O$MO4B\Y6(VGC';%[.7EZ\CVV"C)^PD87<*NTWTGG.
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M('H1JVFLF-D'QP'W@ZL%*^.HS).\NV^?65P:SAG&.%.M#*]?/RY73:304,J
MS1FD64M7K0S<I%+4%YGT%TRP%HH<EE"VN-GRTN1%+?BN=[P!;QO 38[U L_2
MAW;.^Y"X6@4Y#M\LG[$,V AAU)E8F-'6Q(+G1^Y]ELI0E16D*O=>S!9"JKV7
M:G3,HVI*K562RMZJ.L"3Q>/MJB!(.S7)VNZ;W:RSE\.[6GAWF(5WI]75V_7
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M^B3TL:V(%J'OD=F:2OI;'Y.OT84@Z[A8@FU+,O21]>,\ZIM^@3?69'73]!H
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MRAG*,D.+V<[G2//]Q/*1,+)F3FA-.19KM8.^"8(YLB\CWF7;1*BMKB)G[MO
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MR<=0Z]A0=\3.X0J)ERKFLE#V5:R"9,' MKDC&E+FPT<N"UP6*@[G'R(*VR6
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M3?[T7L ?$K[?8U]G.K7\8/&1[_>_)!])(%+OU4$O(S0+ST@+.9=6RB8K$Y7
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M%I;.+\XXCD\& _>!W!*;4JM> FH-YJF&L-YFGFI(0DS6J58!;U0&=#IC5"N
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M(2=7!?0W"[2"&- J-7\@J_5*20(Y:E1*$G!$K*G;RJL6:!1!  &*OF@Z0-0
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MU#7+II)M8=K3V5^'KCZNO?9XD_IU2Y71 ;PW97\]M#I(9W50E;*TLU2?'<#
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M&2 K?&U<**>2,T!6N-FXR X;9X"LL+=Q(:'JS@ +*M%K-"XR5.$98%$\:EQ
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M6GTYG<5:Z/F/C4$N(A/'!T;$HSCO&DS OW^DJ^5 _1S>5UY1Z,4(EC;8KM?
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MC.I@K-A%&-PKZ-ILJ38I%D!&;F"D_00+^&2TWQ.?LS)9@//;8WX#P]I0":6
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MG5Q'4B3R[JEB;]QC32LT+@,8(4FV'$TTW$,XIM(4&(W]4(W"--5%HT" <;N
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M5E3YE@$OA<[+!E5('N07*D-5>I&J,LGMF%-D&E>$1?GL&W>KI?7+SJ/^P>I
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M*Z2OQC%MI3(F1$?KWET9S0J 6S)VNV3E;&OU+=TLXD V4O-?[4QL?/:>'.)
M;BS#'$>/8<X4H).F-NJHJHC]9VFN>.BU"9FA$/<[B'W?QHU+G($,7V'QPLW5
M9Q.?OKIZ."\(O!W=/%5_)U3@_,<)5SU2J@ 'TGH2X0V/WT;$,XVGP,X;7>X(
MA-!87-;(/>. HPN H\'B)J O&!YU]"ZR]-&19IXR#[0I*ILLL+@-%H-=W;[P
MQ)^K0AT4HT(WZ!Y2W(W**UEP2T"? ]D]#4C1M:G]S&-(GJ_,\\-Z[MSMTW2U
M-#3)8;#92-F,+8%&4@R(U/*\.XOM"=2:RD4//OJIF,"2+REWX%"#HCVCI=+)
M:3V"8L2V3V)6!.W]5ZR2BZ3]7G11IW?JE8DVN9&O;9OU,Z8:T](>6Q8/FM=+
MS[PH<DU/;2 N7B0B?.(J,J>'A\@FAW,*7'".-H69IO%%]F6W@F[3>G)&43<Q
MRF!UJL:H ]T4!!2@M8O7Q^DA*#C117%LW)2^!940JV=,SV :#8>XZE0]/T1A
M$<F[/Z[J>1WHJ.MH/#1WT[U+,OO4QQX;UX?VK ,@J0M0_(/J5F%8!6P_3^ S
MX!4"LFA+PC,UCPPP@U5Z!@ CNXS%%@\"U21U8L:ZT%W3,4K5M?2"X1G76#Q#
M\>TD'4GXU#:@MV?G.!"Q$3WRDP,1Q_;G:]<"A*=HU7-C+;_-38HQ54^E$X'+
M9\ACKF])_+?A$L92[+PB=$C(ZB'4%E9EN+:W9.FGY8U%RS?U]_1E?P6Z6?^]
M?%7@%H$/SHQ@3$!_&U_8SLCAQWL_1XLK:4K]QH&<9]Q(XHY6+T3%Y5^M]RX@
MB/N/Y3B0J(UZ9VE.587WD535>-F(L.,%[:+.UJ3MFO:?"VT$M6DDS.7X]F#Q
MFPJ%4NJB2:ZG:[[(;/#-9+?YMAMW%LE!'W1%'^.J]%QCGNI^L'OJJM+VX=G;
MGN?LJOCD\JGC0U6Z#=Z\KS9N%BU+&5O5N5A'XTH=2'0[1$RH^&&V[&O&9)LZ
MEU5],U!P18;AOH9V=7R=/O6JD0KGQUQH&-*4NC73[SQR74^C'&U+/MZ-(SJ[
M?4&U%_>%%+\9WI\ZPI0':RD2,*5%GNIU^VAPE"EN !N%,P\4HWW(NIWU/A26
M2*<+GDS@_80>:LTR@+X9K5.%+^\LH]JW,XNZ/JG+B(S6J\MG]M6&"NA"^US[
M 7G"VV73SGPQ1FH1=3(E/(88Q72GXH2O8?<WCS5KPV,T=R;%T#5='IJCM>^\
M0.5Y.B1>[<;/_H1\U=!,+>NRKY^_S@N'BB=_G,M!>US% ?*;2U_"2CX!TCM4
MTXZ(?M&S4P?X#$=NSXXU[X(EZAG1'<WHL+L&O-_FQ%-31.Z.2AS@(KM VU;W
MS(<34IB(XKF)XR_';K]N9"*H>=(TN^'+.01>RK,1P.?(-#)3V2M((],Y%+GH
M0(P,\^VPNI.4CKM\L6%33.EUT)C0FN:LHN3K73H?HR;4(\W,RQ.G@RNTS3/<
M:*(=:RH/6-=&$%-@AN%?[^/JG)"/ZR3LPYAZTF<O#FCB)%P 6?NXSNW-N!"2
M() %WPO@#(?U]"E)RTCG:-=1C+T2G4THZKY6'[SPX)M+/#DKU! >D+Z1QWAN
MQ2#%8=0JDZV[/J]8B?$X['[^7?*@R5G91=0?!B!GHL*8A^C<"7K*U#[IU:Y/
M].+71?Y5A=\FYE2? @0[^FHG- DAV:P[<<P5=< %Y0_[A!!@'UL8K[@; 7AW
MQ3"EI-ZG]Q6C+$LC26,5X4Y6![L5BAF->QW-*NWW72Q-?)Y?<RL]M]JWR,>*
MEQ]QV$=SRV=?5U<7.H[\,5,KBW$G(B%I-L3O<LG4\1])K*^>5IKS4S["*V7#
MP3;U\N9V7\/FAW/92Z/8TVZ?,%H?,?Z^3S^_(E9-(HM-/74[-B0L'@OG!?J$
M><7XY.S__4#MI<XE[]],?SNE_AUD':@7.A$4:7H5F\O="[&YW4@0P'7S &%@
M#7-,0*R?Z6&(T[IU+.+\/G;VO'(T;'Z:>W7XJ,H0V>IB06QGA/CA9Z,RPBFZ
MV(6FC/P?N?G$<K!X!:7L]W"6/!61V-96=8"^<N+Y\6%Z1H&M4$JOL**0AR]%
MI5ZW[LVLCZAQQ OBOKE(U;_,C?"_.IK;?[9&G\#6Z$_=,CN[,<DJP/C0QS;N
M-M+A"0B_R- -.&!9R.X=PM@#]K0*;@HRKD6ACS%)VP;6G#_^Q,>&B@?&-Y^D
M6N#%\+O1?NUMX_=ANS$\VK'L(TP3@U-IM/-CE_&6![BC !*;]Q!CDX**9\/=
M)XU#&# 'P(M&^,+/'J*,5A2Y8_0&"6TXJ,%>;'^+#F!:@":VOVH1'<%X%OOJ
M3E334*)^6.F\.O+H=9[AZU4W,';C@9\K-*JRZ0[BKV12W&(3M]\X#^92RRS7
M;._[67GTZ&QZ: 2EWW:;[UH4N#]KFB-PRS'F0[-%)X4^0F?:)V6/EMB0;8B*
M5CE!%3:W2SLN^WEKM-KEY-H%J62&/3^\8%N0M!%RM92TP,46C^O$K<,!5PYD
MUPH)^*GX7]V^VS^Z_34D;1)0VES>0^= 4 P^ $\QC:MJ-J9G36Z\H%<E,O6G
M D([^N@19-WL=L1!=O<=]G[@CPK+Y^@3:UVC$Z+TKCBL_J+X9M(-S9T=TQ=#
M>O+4UTGJ"+O$F?%(:"@90;>'"0/!G1Q(S6KT=3U5NBGU/DZ0^6N4"46_)D_R
MA9 2LJ6%&7OQ5,*X N[N=F RF]=?^O@ \R3K];/YC5=CTO!103ZX]-D .54?
MA=) RNMO9SK&2J<:^$]D^*0/$)5Z!/R<,"ZA>7[HVSG;TUN9S@T?-#9RRW*_
M9+U('N_#V&=XJF",$LO%ADJMS?-/J@=-%\65)J;/LON^U[2WVA&5S;-K-VII
MO#=&_*S9J1S(/X='.+KT(@FU%3#Q9Y,)HHC^!XJXDRVRK"*<7[\XNPLD"#+2
MGS*9S)9=A$D8Z& _8K4!)",Q,":+ ^'&J#-$')OH^/NX:P<,5]OF@QE)[=FX
M_7I\)=?&.9![>L=#:%6^X1&/]4_,7HBR&ZX[OW_"EG%RHY)5SQ;23FD^R7A-
M8Q/ @'X.G*47;-@U 5([N@ 7A1B#,9T*_/*8&DC>5P%N.= DV[%%<!AC3-N'
M3[C2# 1%>-*);O28^K:=/(7%KNS$\6-%WO4J#59\1=*A[0%#&T[F+2.V):4H
M$4.GAP,A\OB+3O&#]].>%2F//L_DU0CQMCHYGNI+-?:-T&$4V+=4I[:SW$?O
M5PN_]7J:;4?>$0_36V"9.^4\".YH,$P]M'\ZI:-'U"^DS)I=^:M#]_G7V=M_
MF/GFK4;#:OO)"!'L\&;^8>"/'6O_"1Z@$N$/3>9 ]LVRHHX \$+TX]^K >ZI
M+U)WD''YNNEDE\"X)2:.$L\THWPY($&U90^$SR;_A,?F9'ZH J_:4Q5G^;W:
M5&3).[R!7XJBUI9GGG%+34W6ZGFIUFG+'L8MCW5?KYEYY%?,L+^2 Q$=W!K<
MR9;VZ?0XXFU_;8 <9.5YVK&]74#$2I/&[UR"$5*=MBM((.Z\^W'Y166EX)LR
M72'BTFQ@DX$X)JB%$06DZ0>;#BU-?]3T_3F=?B%&7/7QF<"LB#N)\W)7&O9?
M[)!YY^5]=7^9G?"/>80?7+@Y]2/:OUWC[7L7T9E$JK/-B5OE<O&,@@;1B6YQ
MY=-M]]SJ6^$_)P5P2WF+L.T3*LQ'8#&)8QH"8_0="G>;)K"G%.B]P)@D(\:S
MIQ!M27_0MP,A3NA^6WI5:EV 2S]97#NNKC\Q7#$>"T/[6 ]??E6?"A5$5YD_
M-AM\=*[^0G7-WC41_INCAR3(]O[>AQ<I=,T?.1DW!S+#(A#/*=ZZ/?<-JF'A
M%3Y6R!Q[M8P,0626QS*(PX4;MJW#-YE&CGQ)[Q>#]JA9G;)N&PK!%CTTS)=&
M-Y7SJ+;%B@O1T+9%?8H\=C<L\A'5?QDK_6WH0 ![:^%_#!UZ094-*&\N'WB&
M6'I-+Z=JM[^!4:')&,] _FQ&8"?V>$,-$$AE670XHFKQ9%14T^I=S-'"^3XB
MVLL-2*&?,:87_U&*0;;0Q^)"WG!U#$VZ^H_KQ\5@X!7.BP$B[56 BD_G:O(A
M-+(K)S#60,R7+0Y6"2)9V $!Q2C3)'H=2=D6K&R#DTSWIFJ@OGQ!%Y>$,0ND
M6*!$T4;M$\*#3-="M$]KCD)]!'&A18'^<Z7*,R#DR;-4B;N%3[(L+>T(*K?S
M88>+]LY_+-52_#DB/%_&2-XZ_3@GXW+.YF IGN'QN&R:'/)-'+-\63:E]YMN
MJ0-YH)@BE-7TA_UT3*FNQ]CG(K/.(C,3=@]J./NOL]?_HHOZ/^B2K2["YB7L
M&"^.A[9S( F64_BH;>UH$0ITN:\<W=MJZPPL]Z>V',>^;^&FX\E0;C2"TH5?
M7@GY!KW(GAS4ZHWV@<>" EQPWD-N2),D.OG%O9CXK.O9_!F4(&F*2*KMC*-^
MBYBJCS,0QD@T C7PMR1A(+%GL;V< 7>-:^- A(ZPTK1(X^GM-JU/@2B^ ZZ=
M!@([^I5Y4ZY.%<V:XS=>4[MR!*AU3?4D>EWY=M6N'\$<R.7.O@[#3VZN(9)3
M1,NS:L&CH4')5YY]+="^<;XQ:<>H ^>_1!K5+?.ULH<_]"[3M%>IS/.Q0:I8
M3Q>L#)<JF0==++547%9<<ER?_1,/Q+_@@?_',-,CG ,I^ 8N]D?Y5G0@H%S?
MB=HWO]DT6@1K987#!=!>&V'#7>15D44V?(!T%<F[D*_ 2F/Z,KK(XW<2@BF3
MO##A^:8Q<I48V@46YR$X^#/2Q^%5>E=VO?# FZ>UU?2)@GEPS3UZ0)=795\5
MD+T12I^]SS[DZF;T9,'E1GDDX]@BS3$.@PS;V>O,'C\:\HW+C%ZW@E=(?[)0
MO$.YVNA;^/D;.G7FNU&89W%[F2NR^&N#IPX_;DVA2+A1,KV=!I-3?#\\J^0E
M:2=3T*>0FV'K5EE13,E=0PH5E%$E+U"W,EPZIU^$*/+;S0_%N+T2DK?NL3H>
MG:RH*-*_'Z$E.L9._I=B]09'FUBLJMI>^'-$.L066.7S&OIS1$K*17[V9_-*
M,% ;>&"-SF7$,'A,(<1-'!AE.N\@F7"&<?U]BX7\O0"!.LG+/,S*QQ[#*#<-
MU"V;1V(7+4<JU-E'@$UDW:#FZN&OQ<T3$B-5"L8Y@[/G!U%3\!1"76![%1X,
M+B87!\)GBV(].3I*FGJ2+\I*P7 5,='5],DX/;$I6-PX:6G2<\=H$2$XO@KV
MY>U(?G0265JU>EB]CK#7UR("TR+6,+2ROF,Q-S6\/#V24Y!-MS>_O3A( >R>
MVM3.[9QO>YDAJ61=]7[>0FKY2F%YY\&+EHV= =J6RHVE>>ALPTK9 _'4GG4-
M)XR\GM=3W4^^)K=G$SH\BT2IGIEZFCX6"YFJ=ALIH!(>]!CWZ,"9_$W7_IFK
M2'\?@7O]SBK&&(56^&:%D^)J84L[O5]<SR2HR60>H[B6INW2\PC+43Q>>^_]
MA>CPV(L+9'&VDQX4C(\+0)WZV-(.O1:0&2/GRP+$)^U$=+;K6&5( E9IWN H
M8S.> [F6=[)-6F; L_YCLP:EZJ"OM"@J9D+4M:%V<I_?J[17M9HIH7;TC5+A
M+*W5,>2G0*I5/2-IPXN5SE9&$SWP9#8<["/Q,=)'&*^:LD9'D3C:XSRX!;ZS
M>!%94U_[:BB$+_"P4;GS0KC;J:RDX@7AS5,*XWOO=C9Y_L#RO2](*(CIGNLL
M/!Y2;GZ';'M[\J6EDB7U2\B1A<$\&K?HCSK-6MM<1P$@,]VN];(&TR@Q4[PQ
M"P;EO5',V^S?,9;AK9)1<!>OSIL$]2"HFS_(':92%*I4<&4X0;:!OP>4X3X;
MNQYPZ'R3^ZDSGJ%AI>="+8."?G-;CE+U/)@J6I"E]4WV3/?16[\IN=%A_\3\
M[_7A3=]-A"3B>RFZG-TTSX%L^]=4*54F9]]ON-6"S!RKRO#T=ZC*IJC:EUN/
M!9<Z5.RSRRT<5>!SMOQLHI%LDVSS<NQQ0@,'DOSBJRG!\^;7LZGMGB\:6[QB
MVBES:G+*UD_C.NR?FN<>:K7+?FV5&ZALEUNDJ&SNF$4P__,I?O^_##T+_EWB
M84_B6L^RY=B#./YUQ.?$L0WGX=MS!K+ YD8AO>M^%1-1X;LAXB)"AO,Z,?6!
M%%JD+:6XKA0U[@Z/><X,#:*HPOG;J;T^+QL^:O'MJ-(BI)IM"PF/PV>9AVD;
M]:S'&,6=<PL$J6:I*?QAIMT@&""D!&XPU_+6V0VKZ>G3QRB$& [D*C(&)>4)
M2%$(8L!E*=4+C.SDV@"+K@% %WEXP:6EM!2=[A9-UB7%Z&E3'UL<+?P4['5K
M@K>7(73M\JU]G9J7B+8"XJ()E$$T[GF)\O-0S;*&G;*TN#/9S570L/7IQMF$
ML%>"L8I<'9DJPV2[3%TG9:_C=M4O@SJ?[R_3M>W9\CQKAQV@RMM^-N'[H\[Y
M!WQA[1=**! EQWS2W*8;!_+=[\]GRQS(KX?+3.Y?\^019A\3S,E12>PA[,&&
M%T *)?#^MGY_.VDO=@0FAMV/:^.BG*6ZHSI( AAU^N9&\"CVJ#OZ-37EV\8]
M\+I]8U'-RI5^+3"&1P6\737 EERO"XUNMLF)S"^(""9>>_EC4H@#F2J#U>9N
MX.IPL08"& W U(<*BYJ$LF4!0FN^5OXF65HY[4<O!>P/#]SP!O*TVS]5KH94
M>%'P'7@HNMV)P=W&,IPU'[R^7'M-4[4\Q:LCN+]"(269WLQM.9+\\OR:;;!U
M8AO-M>RI^1M'%8O%/RQU*&4E:^;J=<+#7G*CZ\$P(?\R02*Y+LS_5ND'YUAG
M44INM<X%;?50UF.%(C':B\&<^XK7/IB9@[(%-ASXJ\AS(',>]'HVUZ__#D'\
M^^-IQS5CZBJ@"N_ \:&_;$311PAO$;O075: ]A0*YA^NOAK7[%TIOYFH0$=&
M8270!4B@AI567HZ.FMV(8#3GGQZNJL4=_(2^Q5>.Y+MV<^(3$$W>;AY_]:B
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M^\'T&2FR+L,YQXJ_$K,/*M(=_K]8>^^HIK:O;316%$2D(PA149&NTA20'$5
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M),C!+MG .2Y Q;+VBEXI)O/*0YK9R673X59L^P>[8H>7;;+._IY.GA]WO;U
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M,+[ B6-12#:%.<-@%MV5:Q!O+"93R"3MY>F 21S'SZ*XXA%0N^5;6AF)L^C
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M89O\D""F$=>$7*;9\..$P2HYEE%%:B*'H\0!+W*4TI&^HW54?G;5JTJ&L,]
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M:K.X@.&]^-_.VA/TF 3M%" V#M#KME(%B&/':S9_;J*@.)^-KF9R>>H<GR5
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MW96@#V$;=ACPA./\VFGRD ?+NQ7UBQQ5%ZK'_KV$C"W"GSNV- E7D3=YYV>
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M''X- @%UDL51BV,1<%W<*H(2 285]2=J\QPZTF*Z *1L3M].A11FUW;#KKX
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MCCB]ITTZ(I+AR Z. $C'<K#(+EDY 3">;0"K2\!2PP) 'V2!\'X= P' L*!
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M8V,UX?LL-;+(1&/<-&I#M&?K6&E)Y:<P!:M6Q0"IH[P"1*:*MS4JM4"^ID4
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ME_CIG%KZ7K.KE([2VUG5)R/5HD<B[/<^>E]GP,1L@_= A*%DEYJRAD 8NS,
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MP>F&[=-'4)!Z(]63P!M?:27@YE3XB]CZR'_I@1J^9A?R-5D V*?V>*/^Z1A
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MHF@A1@1$0(F*2F]40*6-BH" $.D[(:6H"(B(@$0(B0722&-*6@4A*D+HHT
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M#V( _%O=G9E/Y:!O@;OT!DKU<MWHC7EQY/R2HN)"5\Z<'<_?"R _PFWG,>[
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M2EJ\Q*LKKC=7^&"JP[\>;-U<H#I@"$\>)B<9IB';<K\,N]WCZW 0+?G:F'6
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MNI8?CYA48*1.D ],3;>:*<X*C]AUKS_KXJ[,/X]7J8*;$0C"AW@N4:0NLI;
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M][9]^;&[=<R$)N0/ME 1W!UM?-CB9* 5&%DK14.0,IAIQ.FA::O%SV_!/47
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MC#E*7X<O&LFTJ@L/XU1TH%US^L^0NXLQ]>]2,UY339%_V9 G]8D),=+5>^\
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M5I'1/=1C_X8L(Y^C<OM=>3/J3J^E]O[XL3=VO@?.EV4:E+4>E"G5+)5PM=Y
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M]Y1NE=EX7+J];?>\V]8ZBWZQVK$E:.(FON=HF7XHB?46;>XL%(X./GPJ12?
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M93ULV%6H2E,>MNBZ/JQ9*/KK9-C+@@!U@Q('YTM>'@J?_-K9D/NUN-H5QM%
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M,PQ3]@T+V[_\4N&YIO0CFM9;Y9^??-?N7<NWJA06K+QYU?U+&$+MT.7ME&I
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M(;P*72@9_DLQA=*_NLCS_$[Z3S+G]2DA=U\U%&8)[28H"N1JE^?0X@-7%7I
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MI%C: XD+TI96![ XK127>WXZ;ZQK:AJ;8J_6'^C>OAL8>JIOR=/!WC.<R_(
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M-'$?D_.E*;[7?09K>!K5P<NM7227=57_3-TZ7\/U4Z&AH%08\LB#,0 FWT,
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M:\G=,8]?*ESFLG=\OR^0I%.\#7J+$V;TP7L@/#0^,F*/DYZH# 9Z!ZQ,VR;
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M+7^>' %O"1V=I1F.:O$P9A U$TFU4TG%;V /AT#@D+(9EUQ32N9[V)4R7*"
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MD6HHI,>*9<Q:P]L!#D- 98B/1%!_^XEOC] [5=H5-V5#E\K<:#,FC12BC9B
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M=#JDXS>#;QF'%8C(/']$\J:@K9"-4$HG XO"U!N@2O,S35@!H_%PA*S(101
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MOE'IM^G]EZ%K&Q2L5M?8QS] 3YG&2U X=!Q.35PA?12?Q7<.!+6RZZ6;_\=
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M[[DF?[TW*'+AP[EEZ< VG"(Y!%3)1^!/Q'LS[ZAJ38QF@.&\YGOPFI'!K8+
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M) !'<!DXP(6I3GZGI01D)D'6(@OH!$45.O)<H(>$B/3G@/P#(/TEZUG7(\_
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M1( 4+!O#PU\G2./.A<3Z[GPJP*<VX@'F"6"@A)>9E/^HH,3VX:>@=T5@F.=
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M1K-=K<'<4'HI7NTAK&X&O<_-TR^3@AYC^X3=<X \W1X8'2\@*>[;%?BJ6K[
M+PIU\_=C'D5]X2[AF!_[KER[&^<X\Q- /X%\OAQ74C.#7_C_ O#%SFKN(].4
MU[RUA>I6O8#)U9_8_9F B;WKP:^R]!%Q6?I6JH:5Y=?S04SJ@A"R[09]0O:E
MIO:XU:$IP0^'G:)F5_E;B5]S>_0/BX2*LC>?OVJ;G\6US1V:DG>_+"EY_,MD
M_6PHX_UKPEMWQ]X8J_FBX'\,04W</5=/\@CA4[5X2=#>R?:9RZJ4"EFOT [+
M)U%<WUKG7Z@MS0MWDTOY76>UM1E$T_R-%31-YC0Q/)_\X#7J]K? "\-O]K]X
M.MR?.8GN^&;$D^]@:$_E,@D*Z"$7(:0:VHS=C-K9:WJ0>P+N1U69"7_CKGX6
MN<18/0*6[F*;/[QK3;U4><_/\*J'"X7FE3MX/X"/_"QC9?K$-R,]BF_V.2H<
M]QX M;*FG-EPCAG;:!KW'.789ZI00D%%\W,-99/P4G#)25^W;+)% YX=]*X-
M5]:\JK+W@6'92>[^J^<_VJ^)ZU3AWY!?U?!G]*H<(:33U!=[+8J<V()0VI^_
MD8V\<&E?&^--G89QE,&.#XM3B)?WXJ5.2X?G3K'E4[WNE>[NN9\-SP=?5EEU
M+,^NO'Y,9NPO='P_ CW4YGWPPLI YS<5R=HG[(>4L$I#K;A/&MXW$VN*7OG3
M_+_$C]''3CM_B\)\<I+_+5)=-N1\/08@\?R'$DO,WZ9B"Z.?B&=_F?@_&M?P
M-B42BGUS3$WA:TR(P.!U8D5,XNZ?!/=@S=.9!?*SFN_<%K;@5/XOHN,@.H40
MW$_X.%>[-)+M1$09MY&= !O^'#K=&[["#V13!1LP7$5>")] N'25CR7XEB&D
MO'B60DC\.,N!H1:"'&K-?]=X\(NI).-J7RU'0 [<P")C?:YXV$;4Z5X_DUQX
M)D!U$336;EAA\OPC9"]R9>S4/HQ7X,\\V& P6Q^&226(M.YL"U '3!UE6W%,
MP'ATXTE,Z^PM%R_)K-;#[_5$:A1>X$\)[TALL@I6;"7+^>5H][Q ^"3KJ\('
M=WTYQ5:YCQD5'QI:J<Q3)G&>\.^;2HG\^P6X[,/="VIS E^:2X/1[&C.9U9Q
M:YIO*U0>KXV2 H'G&])T;%^"X2%78SO;HMZDI^6>+/FP?TN"_XOIM(5QA.Y"
M%I;\TQ,+96M& T,F8++N1URP?:+Y>E^TT%VVT >-$V_=![6(;?P0(>1W D5;
M(-55PC-GU4_;B3I 3^]L@6YH,F2?"DP[V@Q5-I>QRZ4@$7#0F^%YN?60W]Q7
M2N'P@BM1\E[/A$E*07]]PL<9<A?,%S.0*)!6%1^]:O7S2,L3HM!BKB@B*Z/C
M_ Q3J0ID(,>;_QB_$:0Z@DGR(+FM?XGC+KXL>@N8'9:^-E/'8W(L**@@;33K
M4P\S0=6OID67NO#[[@]CDF0AA&R1L3U=]N4W@5KWQ]IYK=#%^O+^X2BH^"X'
M6X00$B!2=-Z89+P2/PFE#$L10OQFDUU6(M[!)"8"2P?]MU WZ9KO&"Y.Y(G4
MGLN;IH9Z'6\:5&8X(*KW:D=7;Y:;X%-VCU2J@PJOFE].H-T50N306P7OQ-=N
MP1*!E[C$IH-,:@J698=+A\O@S?SQ$NS,>MF$:X#?)J=W1V;,]6Q+D'?IR"#3
M0,9TP-R\Y\L^/>=K61F?\RZ,;OD&6!T5BX*TD:YE8'$L, (PJR6M3)TGAR_E
MLR4$4D'<0X+^3&RM]O2X*"S+\2OQ*F H!\T60J:?AK "WZ%E^#D+T"V#2*HC
M2Z^%$&NR5I"6%R#09^]^M-']&GX?N:AWU"-%5=/ L>5RO5= .:6=T&#PA9;#
MG,2P"[^:A4X=,;A_3Y29_UF98@]O@D&_!9C]TAE7>825A6616#AXU#"P/&SX
M+[&3W1IDBB&./).1FC%O$'&U9PO9O"7CIZN=CK5?B@K\XOX'GPX*(9I_"Q?1
M1M]%!OJI6?8.EGD&%OV-]--BUZ_QK5@U*8 QS[?$1F,J8.U/MFY\DFYVI".7
MQ\8&!(3@R]L P_*@Q=<NI$^)ZS)"T'.N<&ER4563*[^I_*N3\63U=VWD=B;D
M>^/F&RN_CQ9'"9#FD !RJ,CL;80Z]!U*[;?^3)%820C6[%$]FV-[-&9$ Y0V
M[\D.M>_O/C@/(Q?(O1>!X<:N1Q>Q8]<?7'<V'BF,T%C]37!,X@/Q]ZBK!"V\
MDF!@FQ"2+,IC*N UOE/11N]F$TQ\$_&JJ*W=O$ ?MJUMSQF88OADV1L=>@R5
M8__F^;*%;S=3"+E5A62D?/:5&U\)4'16B%_^Q#'P<4TH=%4P-<B,B \KR("[
ME[QL^"ZM'W"ZN^15!>5!C5WT.*ZO2;_TD5,GZD*ZA/:[JS7[0.='SI]":N>E
M+YQ^=54:9?=NIB+P>'R 4LZA-]LJ6R[EWFKIW.3^XF!?P+LFO^X'V[ 5'G\2
M8>]XWT+FLLE_%4B)6]Z;RC5/_&;BPH--Y DA%?Y"R+/DI1\SO"P&\2/CGGO@
M#YN3BN<4O2=@D\Z"5QB^U/,W%WI7Z>]>%[)56XV&"'8H=CPOWN.CXX?2&5U^
M1"PF+FSY=7;ESX)XZA07]DH(N2M)BAOBY<!,0)) 6I^ETR&6DDK<W]&?@0T9
M5ED,6#MA<(D!:X&OM6*8V84%K>79,+"RP^,4MS[#\_6OMFQ)^,$,[Z/5/[B<
MYF2Q80O%O#,OH2(,^IBZ&G9Y0QD1U%)NP8#:N&FH>MJ;F5SNCG%J-:8-"UK6
M(J8#58]VSJZ%)1A.8C=.IOG[<GI?9KKD?)RQ/6IYG?/QA*-^,L\=].;^!C2W
M8JN J;=BQ\7<7)&=<F!KOC57)H53$V'K8,&RFY$D9Q:Y30^"TN\MWEL8H)RS
MZA5I5A?;AE:HZ3V@R?I:OV6EJ:YRB/+6?7DJ2#MQI>OO.Y>*L[H>S1.^\X20
M]X(_1(0#![4<IL/9DIQ0\5EQJ%TD_"$/00]4@> -#$'IA(Y9BA%3N6U6J2[N
M.;+Z9$^YJ95V<H6IKJI_1 ]UD\:H6XH5*^<F[,$?*[L?_XY8U$0N*2LMD'F*
MEAQED,VU0U.IK--0D1R_9;XQBXZ="F=CV\V/@A_T;O/LPV+0FV0]Z[OSJA'2
MXYIV30)J$^+EUT?E=GV8S"^M.9?DE3&<P+^O(1\!<),KBS(1/ )V&8H!H,!E
M>#I,CD"K^KG%HIM>8KI=9 !?A"B1AZ)6L34\1"I5%::B?1NO"<(O]*!,#*";
M -]/AM$.=2-N&R83>X/6%FPRH%E_*7!"A; \!%(.W$#0L@7+<C?3.0'2):>Z
MV1(<*C]W@9 *K2*TPVZ-&#82R$U'E1.#%@<70-X?F=D^:9PX[W*'D$L%DROA
MJ4M&:84C$Z=Z9HZ4Y]Y#C.O]O><7[_[5ZP[9:05Q[5<TT<.BX"+8P-O+3Q="
MKE%C@9=Z-U%F=%E%WJ$&,(T;YH?7[6T*9$^VF1BU#)9?;>A''2PNOQ71C<QH
M^VUP/>]L4= ^JO.]"9\[;F5V:MA":JT0,C4D8MVKX$FN+<H$%)'N&I"]=!/F
M)^)+#G5U#2(6I@!<$D(HB1U&*\HMKY-XVL4MEPI1-JRN;S?F/!P89NXZMCIO
M'"D>T7=++%&^V])RRK1>0/$J?]N*X?S=!7@8^A=NS@LA5ZG@+LGI])4LGI(>
MIPQDTQ&#^;2.:05NA* +K<G'"J#H+GAUWT(=?+VILGK[TV)B( .F!+;Z,Z06
M^=[.W35C,[/3"T/%M6F+.J4Y](K<^H39VP!-1%^UWD#S$1&+9:TXO,.IHXQ!
M$0NLW2F:LTL%Z#U@1$F T1R808>FAA\Q?(HXVX_7",!O3WZG<JG'L#.R)DG5
MW7/?!4;.T;*]TP4)SM>QO2-_VTZ@^&KSW_I_2; =W0)EG8>#^WS;'0:?#PFD
MO44#*.;\SL^ 7<4DW8"JU +QA.H.3#@AR?PW<):M^6[N)IW]/,"]9H-L FK7
M+JL+-&6G3YFN1E6&35F$WQL3IW&#H9RMX"(+(]@@*:Y/\>MXWK)QWJ ZUY:G
M#=K0B D*XSE[N4 *U8UUOOUQR(LB KV/M%W06GNN_M6<UK;XV1P7^6/^'$NN
MWDFUE!4A)-$ M@WPP0QX,,4WGX(Z0@A/T8$SR'Y B-,$H=PS/%W0DBZ;<&@<
MO==(H)OARKK8KQ\(9]U%1H:]ETFZEK>W]="!W.C1Z5/;54ZW+<&GAU@1[80:
MO2DX]RQ*&KR>?08/ VM9SNV"M:P_)BE8SJEDP79RC?]43??SB7?]4P.#AIW/
M.R,XMG';-BYO2H6^^,?FR>\](]B;V*,".)&':1%"Q$=S&J(/(1,%ZP_F LV_
MH7P90H@,SQQDAG!W4U"*?3S;O !E+TW6C;M,G4W'[=P'K_1.[R#-U$)E S9M
MW!9<JM4D9YKIF@71C-QNL^R1+W@+L"Y2U<2'L\\ M(>!XOT,T]S=* ,,?6W'
M.\Q60?>()-NEE %3X9UCC=PMLC&KN.E-#U(^79UXH@E,C%GWM B9W[;T>7[
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M[^(_%$"0]Q 4<EN/%_H33,%\-3+0A40!9)"C#NR(^!?X?1YCE/JDVIB#'L>
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MM^XP(62S:9YM-%^K(GP]H1QVBZJ(TF+CZ/ 6AU2\1-/CLRR]-MQJI#/#*.[
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M+9ED2EHA[15IU/8QW7"64][K'F WO(*J6Y2M5E^"/UI9RXH3R*SG/\'K\GQ
M;_H%@82@VVLC/UM@AO+O!7SU!F<Y VR]1(/;^#6\W\&6P@GE* -S]>ZFQ_WD
ML*='/?K"N*]E92>7DG3K<@U"K0P.ER.>BZ(&^A;O.O\5#\I*X;2*@^%E=86W
M.3O!I^QBSOTJ=G$J;LK4Z+G;A7'".G,Y4/J+;3GO/!BG]=5(5R,QNA0KTIK^
MW5HO*#_*@R+\@\(RWI4((9^((H5#>P)CG27$"R&K85=P \Z<+%;Q6R"!RG+
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MW./+DR_F[*X&#XI46CD8SBX^BVTC;#3L!=7+>>Y9;]':T'5- -<IP$BW1 1
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M%Q]6ZZOY/'I(^]TG25NB?G?J$Z4/%'OK#\V:N9I%)V,4TE:&!+*6<\& KAE
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M(:(QF]9A0KNQ/ZGEBO/B )(NQ)6TY&]??<5OS]W,>WVPLA* MQ!@;K,'^LF
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MPN9 O4CJ7/65BG3RLAE7C,,7CF%V4V:AG+]2:.X9QP7;584H%YKOY6B&6K9
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M#AQ'AGDR.[%D)W]XNT=P1*'UP_>Z?6U'LRG4Y5J^B->'*A1X2(\K&>&PZ_:
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MX+&NHNI+!'H,W/$[?0OC1DQ9R#.TCB6:PJT4TN_O=>ST72+0%^D,:[8LD_3
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M@UHDH>6WNGQ$R3QE6?CK2D<>B8^03_\3TS4"AI!UX/RZ,FZ6@)T)@+J>^4Q
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M@XP-=AV54RA',DZ#EMP>"J>+BYRLH?P3]K<B#?)/ A\1)<B-'VY?0;]R[@P
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MC;!.7TH]/KE8(?W\0(5I@O+DQ9<AY_L4ZSY_IVZ(%PGXEJ3M;V(*7R-NQKK
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M4$Z#:[GZS,PG@> ]O"AD-:A?V8T9;1>NW5[ZZG33]X!O 0H9)[9=_#Q=PD<
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M$9"7K>)9L_06GC2\@5327L4]A)A$B F@&&^@C6N9N)&G#$) #._4AN43=O0
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M.MWZO4[;5 ?5DY_ _H4;ONK8,&F<._U!9)?*LD/P</@4[RVG5!"RF.W!^"C
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MCOVD&V(U@&@LC]"!G6"?K)"9W <&T;FV2WVA]<1.@\2]%/O>/")?"Y1(QQP
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M'[G;;7!<*:I QN_CA_/$/>N[B4WO#0ZWUE^PNOELVMGTUZS-Z)13JJ;*15*
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M9<N1XVM^._']QWG-!\R5+2:>_G1T%^S[.8?1,"R)[P])CCW_[8&!W#DS$D)
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M]&Q#97A/#3'E-'#1S.=D!V9G$3IXAGF.?3&./BN!M"GP'SN>QM\^V34=!UW
M"2'KAGDJ_%L"6=Y6_G/SG=@Z4KE1(R%Q1)Q=_Z+;U(<%HY,CRX20U>@T:D4,
M3RL/G>;(&NX1Q$L6X0R')D,#AGOOC&A%M?>2FX[[7GJ;<NMEU&;8SI7W7=1?
MAOG!!N+>X*2%$"\RH#/&DQ%"&"+,##:TH5:7K3("9>O=,5<%]#UZ+F[I85)C
M*6\64]6VL9X#3F,-YN'$GID8.F7MD>5;O9E/&SE#@J8U7>&BH+HD; NTS#R)
M3>!,\8F&E!O+%=/UW'V"#G,I-CG"7 RCVGOB9-=6(\_M[,:1[1V/68(,@C6J
M:!A]@A852Z"VZ2&Z?XTG*BZX9%=(F]4T$,P,_=-W8O2"D69!%WN_DAYT>.3;
M<#NJ+A/30WH"BO,GHWD;3PC$&K@6N/KC*SNL#^+H%2VD#3P#U@R)A0 G7:M
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MH2WHUU+T$M!5;:J@<TDMP,TG.V1GHSOK/N+\M3="/BK@Z.&O=X"#GG>'+LF
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M@C>:V%6^*<(RU66M3A8E.=*F!-G4UBIK4 NVRE-X=,^0>5RF3(2TT"D];(<
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ME)Q.NU>S@T'FSO/YTL*7DG/[L[37SGG;7=BRJ<GF[=T=VK8V-VXXO;?_-!Y
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MW O7Z!$3IM-<*#CI6<ZG(SR(&RX*6JK$%E\8@];R(%L0K%OL35]K()BOJ=+
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MO7-=.N/+V3\6$[XCU .AW_?*^\Q[ CT66Y1.&&PQD65Y<ZLN%KS<@(-$,&8
M4"XM2<U%WX>;)^(54R4>6HL5Y;;F-%V/EGADOMU$1W9:OVD:IF$Y?,[A<UF
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M=',/,A"A-8J8GC7$\Q*84%DV?_#.+,:=2@INZVC#_HG1^/2ATYY>Z&95*WB
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MYNV&-TR0]_AE?]7.;]% 1F#Y#070=CTP2AFR%-9B@*0NA"WQ(,$URL"&MT!
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M&H2N>K-L100 U]%-<BEB1,KSI:F' S8>J=&V16V<Z-\I/%=7MZ=%)JKT2.I
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MI%E=<5"^_-9R6>N<(H4):QWLJ5!C!VD2UN@E/$B/(%+GR(95SXCC\]@AG>E
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M6.$8,>-!SSOT?M60?9EK@K#*H+T)5%JE_>M?G6\"-<-)(1T/]U=WR"MD$Y1
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MCKA6O1*?M[B/7[ (I%P<#L3H6,S(WW^++\*^E>:(WT=O;1-'<(X!=S=!.U.
M&\0CS-0&?3@K&OC(/LL;I^Q98:QYB#:?I8U!>?LW05%DKT]4J5 ^+-S$EM[^
MZN2W)#;B_B/(:K9FL4SI0E?3D%W]$F+,BX!0*?CKL&^_#>G<8H=*'@'!,M^
M4Y9B20C\4\Q.;K[!?EZ[\U&F11>^O2<!(\4,C./)H1P4CK'F+8;*P=MGI3<H
M4<A3_N7@D0TT*]@Y&LUL]UW^%77T>"'[!E<#I1PHH$(4_-ANM#:[!/].:2.
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MX9XU5C$ >:2B)* J2(RX ZAB\QVET9?D B8O3V@OA#(Q,ZPKW#S,(=X8YN#
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M(QLH(E@/+%F)5;)UX C'A]&U"8K7$\OA.'(3]$2IV#TH) T9[M<C_=5@- ]
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M^BXM1/6!HGOVIS3Y>1-PNUPVH!5J[6XU3)?>3I;;+7SRMK.14ANN$=,.9=B
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MT4CMQ:@C:=!9A9N'=8>%@V6P$^])C)L_^=-&1I'*8-%8!"026T9:,&,+<T#
M*\47>>CK0#W;Q&+'^,$29D0.U4+*SEP$W"0M;E#K$?0Q*/=2KI$;2HKLHU="
M5XPO_] 7N&K)"G'OZP\,%?-,@M%>]?/HQ6G]B'EB9N1*&4.750F<81NC3;CO
M>3*<HP/^%#%/?.DF"%=D<!!MRU1..U[!N 86.UK"#LBA0D10V4X6@C'^H7M&
M)KR"U-75W_=GTK3$N^6T5H9,\CGSS%J>4".-]!/+.L00;(8#*CO %;!&TG[,
MSTH$ED9)<)9$'N3['R,#F)E<2_B-W<^Y6CN@Z*%<53N<#,^<MRAG3*5E;]##
M,U[*>MI_<(R:9RDG[=M].$Q#\OS>/8\FB@-%ZIZ9-MRYL?S"(2^4CBG8X&7.
MF\MHKN<LUAY;]9B?*7$Y-)GYI9TZE(BNC9Z<5F&<W]*68R1"?Y5S>7F+Q9=0
M;,8I_D#G]ES+;,!UYF$B^_ZI1_]3L]WICS<V03J/[FA<VO$T\>P?X^#'CS2"
M WH\"9=3!)]<T@M8O*C?@V0L7:ZR^U;3^:KSE3_ZTZ+M^%B H(PF_81U0%^V
MWRMMSFRUA8J<D[;049+JS_*K+\*6O;\VW,L)N_M([MG!J9T==V ''T[P[G+.
M D*,SJV3I_)X/Z#EBAGLBRB;%K!$'9R!,&4026R#D9&#=?83=%EU%>I;,13>
MJD9<$Y;G9/+.H\KJ<N6?#L7:^T27("]\__7'OP02NC*!.0W+W8?$W@;+QW N
M ZH3,%G[35"C_R8( 8V2SA1B.N&>:6%'>II9LG8)WGJ0(@= UVY NIFR@Y9L
MV:]W4SW.09(^Y>7B+]-?A'SP);[0.[$MM\\+?Z'%]VJ5".1C'1J\WSJ)<+ Z
MU!ELW=I_\[=$^?.36E)D\\P?7N>2N;%-4;23KD2U&UD9:CA1R)YES?>B^8,I
M6&/Y2TG=Q; 3#\1852TW;S#[-UZZQ.,&W0Y:],9](#T2WKY;4#DL@?AJI9@/
ME8><5'B-0]@-F +Z>_9V/N3IV?7+BG*>:N+8NT:PLWK^\S1BSVI?^Q0*&P.G
MXN805D:2;?Z*"DQ5GF$E;^,&* 1?X82;;L!H-=B%,"$\0U88B75;D"%=-KS3
M.6<']Z5:>G]5^OFYBIX"\YGI;[*E9>XUO]P+_YJ]G_=I^R23G62F65N>H'7S
M]YNQ5Y(WI.Y=SE<SPNKRO1@YO/#;-Y]O3A6>$J9G$U3>TR0J_B=8N@67 "ZW
MC9R$1% D]!2* 1>;(;0X;<1OU.Y%.41\ELRW/BN46V!*#LBN;+R?H53]C)JI
M/,J56+I+60%3K<U]-!<5@Q3O52MUN;FIZ7V7?%E[L/%7.FU'ZTO%6Q=/DNOK
M",";JF/$8_4RG'.\1LIG&#V4+89M1/-S!OBIHEX?\3CG&C>1"$*%L-*KN>F\
MLU7/*^@VC08*P"5F"!7>TF5CSDBIFIQWE%G1E[/[S!2J[O6NT__DR2K./%K-
M#ZC/517,8W@O%3*I=*VM)PK.N((C"[*F@)UL,TPGO'RX91,TPIY<HBM,PLB!
M+&]@DGT6?720>,8C;0HKMMA"CN0+> F/C9L+\)\.71_:L]Q9UI[:MFLF-GVK
M]N!K7_H7Z<C#O,_$_D>'DT9<WWA-'7IM:Z;W0=L-TT25>FS,/&ZH?$K*Z%[W
MQ(=?MT^^;DEZO29TQ=CN+^<G[SZ6E;TLY*/Z_L*"[A7WZJ)3:<D(<_+LL1HG
M^Z-C]HAQ7HDT"6+D[3_.K1JV6;_-?0EUHY#A-%(D=*("SK FQ(,%.$X,^&UN
M'48,%=M$VL;;A@AVXK:W7F$(/L6 ?P%NUP;US*B."-^/'C5KT:E&C 79@!CU
M49LO)">GOE[U=)@VU(;')Q;$(P"2)_*#$=FL'M*@J/G#0'ETJ^!&0?,"3\&3
M)S&\0@$;%CD#.-KM2AU[AO\T7CI*VFK :,':\9;!VU-+!Z;)YNZN9E0W[OK9
M;WUU2VH1MLV+!ZK2%D3EIAL>60Z<DIC2>&\O<6BG;) S3,?,U:,J6O;Q][ZR
M0W[&1W\NN<8%H8[>*E!5BVGPRME10S&NJ+*=HM X15Z"=.6-4QD;JH$<V/3D
M/\KT89CO?&V+Y!Q(Y@DU4_&C91/XEC=Z/@P5J@JN/%Z\B9P:0U1&RS#!SZ%4
M-2"+%FIB5\84C?3K+!*TR43\7!G38 VS[WV_[>B@9^VP#1G0C2;P]LSS20"#
M(;K =_D=3&XZR0W\,Y;?;Y=YHTX@1T*<"F]5,&^2%4!?!'J*9TOG L]9 5DM
M:1E=?:@PY[!FYJB'[?;?B[<\ @Z\WYGX?0I[0]Q"JR5>N;0NSCXJQ4;IV[F%
MYJ3NVW6QB=GGQ30]3[MXE2=VZ7]TV5%ZI?UXE[AF2*H/VMMV[W[Q\(;1I\MM
M+=,X5W;MXWE7N5&G5,L-B"KO#'UC7'I\>'DI=)73PR=MP/E8U@D@G2_$OY.$
M]%P86&H\H1TKP>N$@\L)\;*;H(;19UW0UJ6(9MB77C2<JJ\LW'E7ZWN -IY<
M==I0N:HJX+2YUUW)UE\OFK 26I0]O&9\N4HT1HBS]5*('\N-@AQ7P7:X%-#9
M[,4,N<DE& BB+P,>C) );/B-40O:!62=C714H>.M@?(O]FFJE3HNOSP^=P3E
MSMK9]2EH0;^\3+Z[T_R4C.DAB1.'UI]'2;Y*=4F2'!Q&H_:]O8'S/QMM;NK8
M)3>M_,7C;3YL' V\>F4L8/;EI4NGZM>/K[2.C<XC_J3WKSN.C%J25#YF>XZ&
MZO4'K!-:>"&\(YQCP"N739"@*.8[\3PC[PGZ^B9(%+VU'X<&Y$PXPJ("QL68
M,H!=%JH&(@Q$M#<[*Y"8C@Y.[L$/^YU:7>0=C/,*S?(KTEOBY9,T=#&BG&T,
M7*.Z=!NI?.L4]0)LHQX4N31JP]MCAF7VM_>A5(R3&_!B!H<P/9ASO03O!3I/
M?I9\+.O8%X\)$?'&RK3L5D(%]VJ/=:_?)FB?V?T7/2(51:UOP918"^A+%N\A
M86^<=DLWSQ%7]SOQ])YF8=D:WNIS#W:KM=$%;X)$05#?KEO?/0TON%/EU<Z<
M=W4UGGB];BT]\^"\YMBQT>"YT2%MA^S*8*>C6<.A-9H%K5@(K+)&EY?'$)H@
M1>(E, >PC75@ABTL@B)#W &TLX*8E?%L>WM4!)9/?AF8,JJ7L%D_QXHF<L0+
M F,<>Q_HNB^:AA7^\WC6SL$B-XL:RW4T-4<@C,Q)IT("DI=P<6"&%26>4AG)
M$0]K@C,LP>'@SUBZ2Q9F!%L.;<1&P,O:8W.8D4T9YL: P 1%P!F%;*[!$)C>
MHG'6MPUB\P$W1\;0*S>"QP']BK=26&1*)SW90D)J&-JKPI% LJ[@69L@;@)&
MC=?1,\ED_$1;A#7W&DTB,A2Q!W+#N6%%CHAM=E?X?!Z&J/86J7[>DII"3RK5
MC+S3,\!789RST&9\!%QDZZ@%3[-""#\C1XSO - ;I6VL^(+6";SPK**\=.[@
MU$M'$_2&/<E1.LGO:=Z9R >*=W$NZB\I$ C$O"+0OS)-?WALY%O!G^3 <8OL
MI%%86_NR(1L-6$-&["YS(TD/D.0RGM!L-N87B6&!!V%Z@L'-%.FM5QZ,SA:L
M.,D='$:1UP3O45!Q9BI&LYRLQRT$F]*&<DL]@XVZBHJBZ_J.U5;5#*FO[E9[
ME]H$G7@!+QW/*^8-D2IC>5^QPE@$?"2+)V3'A++N#!(E/<:%N44TIC$.2X/'
M8=1[3ZT4B.Y'@9LSCPY"M$:]Y"ZS;]<4.KQ\3-'Y\S$P%_:IX^AWJ4?8N]%J
M4;=V84\DFAR9\DHZ=D?FG%>CM<;]YYP$S /E)\<]\M([#UPXHE=HNM C<?4Q
M6\E2*4&?:BQY[OBO UJ"6LZMRU5N5:XA(P6^]AZ_"47E*O-B]>5\N7R@DNBT
M"2H -X@N+#/ +"UN./$ :HW%#[=GB=A&.:(NVIM;A)$"<*U#X+V\DYRC@ JM
M)]I@&S>[7'7$VYLCP"<.32Y4^MV'?D(9?<<)?<I#$'&C+T_'O_7<J$QK@\W9
M\7;7,]S:P;NQ+NJGYFG:"Q\9Z:S33&P+17:>IXM\2MIS>/B=DW"SML^H/>"P
MMG7'!+%$S5FWOO]N(L6Q4;VD[',D3/N188@>B^])A9T^)]<1T]5BNF:[=ZP_
M^C:CYG*Y_8Z^?7O/6Z^&7!F9QE.73@DE:D0+EVE_+[8<^].\UZSE:?6^X-X]
MGG*>A7V]<+O!18I15=K#HS='1L<<JPK3,1G2'21-7),HH"[8C <#2Y,$CM@0
MN]%Y.Q,77[XDP!LOHD'DG0''IK29Z(=U2N]$][HS</M1I3.FG^NK&(M11[DC
M ZN1I25V,88SHNHE^*UCF0%_IBB?7C <1($CJ0EZ9R8@LJC4!MXN)KCM ;,G
MWD]4"(AT9&##=JYH7_XVT\I3Z5^9SY!NF@\NMNY=+6!O>S05M+-#AKML]B#<
MZ4C2C82+'<=-7(->?'%-S#I\N"S17.R+\>_S76J^,/G'EY.N)GZ3[L+Y2KP^
M(8=NV2ME;)6H'=]^ 9)&>K X7E-=;YLY5_7GJ+T]0KH^H\^;+P&NME-%6TD1
MX^<'L!/4I1$!F@KGD+/6 $9J%OJYIQVZ%Y7>GN(L/?R 89S\<8XY?V84P%HQ
M_6Q%WGF0N[AU<6I^\UW&<IT126)[8=/'EIYO@NX1R(8T"$=,U8&;3W*!DLM8
MYMQ/!LIH_4$#*&H3- E?:&?B6:Z ;@':F='>*KH/;4I,M88+>R)SX$> D!:P
M>T*WJAOIE7=1FN[/Q16XNCKR%*FPHCK9Y<J#%W<@U8Z%"4?D)VIV'E+Z>JY$
MURP.EQC1*9FPZ">GE';IH(^>67WR_86K2^"@*S$7/ +6<<E?.CIR%GCD@%>C
M?\@U,9YD)Z=@0A?;P_%6T0'B_,V9WOF9-7R;T\P"@7T+-<D3JN*OV ]N!1'"
MV<W7O9N@.#C#:C1#MQ4O3'K U34>X)@Q#8V!T/? 9+.&AZ$3(_>51V"A RK2
M)N'\HE+OA\I4FXBFOKD-'OF'V![L%6<Q()"V"=J/;3SNAP\/4%0<**K#%O$:
M[0SVEC RL_)Z<A"&;=I\[%KR&X6)_/((?AZ0/+NV/)=DE"=L/E69-,ZZDWI9
MZI?)GV<]/M/<[)[SU:?,$L\LWR)\*]5<Z#J2E%.]L^K^?IMMEP]TJ;PY;(O^
M>&ITZL%]Y3<*([&N;=MN?7.-8'4<S/WHF%5[NVHT8#1P&=GK?L+.MIY6N)1E
MC73U7EIV8W"ST->X)7J!FZ!=ZQ;LPV@0%T]Z*!H.!6/OCYE0EYYM@CST%7CR
M0'I#YBGF3".")('ZA)0GH_</JT3HDB3-?E>^S53JTPPQ\[^EEJ(:BPBIU7VR
MC#9G>Z+W<9/YJ;[%SEEDJ\8#VW@4ZQ5O,FD0,;Z3B6\'DU4FVYN0BF:3L,B-
M4V$^2,$HM/Y$ETV;;&4] 9AOP:@QM3@!&SFXI^6</QM:V:GPNTZZCRHV0<:[
M:JL#[1VF;=^ @[_V?2LUWN6BZ!A!AM^Y'1&WRXK=EOCDQ,<@WX-QRM_#79=?
M41]$ISS8H??BI$;4_<:3KO#,.PNW)W\78HKRVGLAGUGDX>"@4;LQ/U*AH=-1
MD@>!M-%[FX>"H&4F*6)\%N2U"9IXN0F2\EN*).V/;(Z7XPD1\MTSE9DYPT_K
M8'>I/7N I-D'@LV*)X>\5_(U-T$B0)R>=Z3AT,SGP6T_,1V5IF]X*MQ7T <D
M'&;KD!-O?I]-FZ ]68 14]2<.=P&(6,G PH8!<W.RHR 6FKL)BA*QQ?E9E);
M-:@GMXODF@N)5H-D]2T6^<W3U1<?$KR?.3ITJ?6URN.'27A=M9(W;F>^T\PD
MIQX?._%$]E'KRQ+0D8<W_>*#DJ='S937- Y^+^M4O2AVST/AM;)[^YI/ZGBO
MPJB3/38P7/TWLB@T?3C4$2L\E\355AIU)C<-F9N,K*S5\;BPZ1 6DA&0SH^%
M<_Q1[P;R6)I,E49<'-]'^-1:BHO7N\!(<P0G0/=I8;?=)K51(H@R!F<85;$8
M!5*4K9 65J2S<+:36AOOB3 _43XTJ*7J&&OZRM!\"LKP5@QC)K-RF*GMA*W3
M173=%'I:'&$"G'/<2)[DW &EW2Z,]D;1?;-D<$(%70K=(19I/^#'5@<[F(+O
MIU7$MXRXO<K!_A(%CD<N]+"M><-@84W12&B9"?U%"%MQ;-Q3\6@_[R0J;;2!
M,.EDV(X715N]+X[/1\$MW2M"-6::-N*4?SF1$5)KXM_:6-/:(Z1@-F3A*5N=
MH\6-YFO-I7!X&;CI($&N$2^\<GSEYZK^]39_G/C\<)_6)BB: R_6O/K9K  5
MZY V<_W+WRRCN*LO(!NE76EY[);5 -OZPO0_@_@''+P1>>S62$Y7("9=U1]I
MX3=:68._-A4L.LQQ[_FL.'E!D>MYAJ2D?[;'\N5D ]30<82%]3W#BN;RO?LI
M9%DZ5R>3PO4U,JROQU[B27B[;"EHT_OKBF&KFR#9LPN",UP+8^TIM]R@V;ZW
M*,$_'OSFC^H_8+V@["#LZ_HS WQHG$\[J4"?WQ!E9/DJ;H+>\5W.4.7K"I@
M_# ]Q!"L[L9F_&_T<*Q;=W)X=CV.*P2V@H>1*NSH=+8'I@%<U48@<#SX0AP^
MV<X1/TM+;1Z3 D?H+"V,,F)AS/86T:=8"<UY766F?EY\:C-K"*,R[)=AS>IQ
M&.#0$58);:H*-B95/Y;V#@7:VO"6<*?W!T^L?)7A//)9;6S/,9/'R5L;U4[=
MC19[V:'0*'/AU3&W\$IFB;.2S'ER%.9.CHSCE?Z:H>'YHOXQK-WN0:N1-K/R
MM)J5WG%N+4_E;SU; RT*9/$]^3S?DU-Y0UC&=07X!*D-.2+(LF42%CQHA)^=
M#1M+.$UQ1L]D>^L8K,U+"E_ N:8H,9 2M#**VS?[8<[<O/Z!;N?]<T11J<"-
M[)2U"$HK]B$>T"XSYZ:2)C(V0>6V>+8NADQB7.]1\.!M!^"3(HA&4IE"0A4U
MPX:Z"4KP1]1^657EL]@QC@$#^?S>0$4UVB2_2WW\O4>N\?#?;EC7H1/PG^8]
MRNGF7_OV/[W1F=IP.^J#ZX/C)9?W34B<AL1Y"6B^@&EJM#&N]BX\[OTJK%Q2
M\R)B;^1CZ=L1B6>#(B,OU@W4>.1FI <.#6%8K#)GAR!5BC6W< GK?]1+:R2(
MI#J'$>>+&QX81> )I?(A)X%!:G/RQI*;6>^9?-PN6VJ"Q]60%MB3NQ\,8)0X
MT"$"1A9EV\?/@) FW&XCZA*=LL]=4;;F[(@]"FO7M\@/)W/[>[574E2N+..!
MDZG-E 1*)7+!G"W*&\>6X1JA"I>8HRP'H(OAQAKB=_.@1W+6PI5Y<JV9M5W=
MI)6OEI;*8SOU#18 TB5[/^[E>7->3\S?:?63O*;^J^G7,\=[21^TTER3N^V5
MQ0^ NW_-0UX?/*W;J1=S,>CI:U/7Y,?K<:9J-EW5&M'?B_NE[&7-<M1&![SM
MU$ /6\Q?[BB34;[WUV#@SAC4-ZE+.<E!7W806G_X9 $^_8T3:=I1UV,#WZ%-
MO\O<!+7#&4ZB49N@$NA"'I_TWN#F\0Z@#P&![$N $BN!^YEX#-,+WJ,%"Z^!
M/.7C ,ON,C;206&H2*V#YF2]7F%A.?[-\8+:8B[)23 @)<7:^9<]GU7!*PAT
M%2J%[V.>0 ?;!)4V?'-P!1=.W%,_N("&9C7Z!!8"!2U'I2T9D<\U.Q&W'H3$
MF[0J'DN_VJ^&'G3?V?I37.>B\@N#R)"/;^]TJHHL+-71E\'J[,FX@J^-2K>O
MRKFWM=ETW4@9)_\50X;LS*%7WAOS"/782:\M=W56"0G)SWV:'<VJ<3UGJ':2
M24BOO&Y\#O9F67N(_V5K7LE#^G2;D2E[/#9&*"L5XZ,_>;J;('?*3\/)X:UC
M0>(4CP DYMD&XG&@@&W*Z\=6P)H@H[$L-L,DHKR #F_%* &^/I.Z"H$\R:.9
MSYY9.*PUDP0YXJ=213E'?.I*9K6E'%9LF:^MCL!*L!.IJ111#+__1CL2XA]G
M;4,!*QHRG%*B2& K<Y0 0]_0? YD@"B*0M+ =*%L5&:_0ZA;,^] ?6G?9'TU
M@Q"F1J@[\W'NNCV^U/S()>4B5K[%\,K'E#]"5H>.7+]T]]B._(\G'A;L$HVX
M%^XLU?P^44J+^DSUEO5X'WFH>^A(EV11]OY10SF-(UTJKW98752T=5KL.*A1
M4Y@PLEN"Y3T[,NN-_Y8SS!OW*C(<-2H(J:'0U2$C4L$N'^F;H&'-&[JCP_SL
M:SRMOPFZQ).\(O[/+*X7=T?4Y^TFZ*Q5_+K,;&:P7Y[BM@W9@%#\+X@[?A3&
M&X=/0Z[YZY,VII^V_O<T'N()>_$'"F>^^WOFB7Z;+Z?K_SD/"TKN8ZUR!0&K
M+SCL#VSX8?I' Y-W7&Q;7L6+K)K*%TK+LA>H_O&/S4M-"_,-UM0N@B8F)EB?
MPC#&P6Z9&2=YF:/(A5L&3:?H"8S&W2U?+0\R-+;)Z&_3UWEFEM\QZMXQET&4
M)B5^F527_Y+LH25C5/GV0]I5V*NJ7G/CM;Z9:3!'O(#E _BPH?/PBJZUYB4<
M40SX#6G%)0P;:#-=\\+#8TC-X/V=0;0W^";9^9$YV2?)-L8#I[(4'X]\)8VL
M*7W334?.OI&??!OLT[&J\.@\9U?H(ZPP="+6>2_3[;G>UM%8LOB6\?U,Z?![
MPYL@A(*)5>_]X3K=C^YB" =T6BIN7-_PJM?E[C[]J]^#>B&CZG5_OKZ0<1T]
MDLKM.M4NH)=Y82HA&-QN +1?71\7R\])O'Z#L0FRO7GRGLK55Z8Z_B?Z$W0E
MZ=9Q24FLI'K3L9#>),]Y&SZ2*KR/:49EM(C*9!"/$N2A(A8/^K-2K2+4#>0Z
MWB_,F9R,:?YRQZ,[1>KEY^%XLSNC+6TW;YJU7<-=XHNF>,$7<=L6S^*G_QN,
MPTW<1KCM4XJ]T$H\MX[TW?GU7 AVM4L@)C(DF!?&.?ZKG?0'VI3(&L K_<"0
M)B]-W=D;$C>S>BQ+[N_9?A)LUO+>165LYC]\X$L_VV,3--K):<W*^9?_O'^=
M24H$<ST-,2$'%",)AC\.8 \/D;;7R3!F:)(DCCR>646+;W^"]A!M5C#D"<TS
MUIK3L"U!G!,$$P9O$]02\,B#[OO. =51SJ1V%GG^>G:LKVCU!(1V_X7#3M0O
MR%+TODM?OS9.)IC*"##/*Q K3J?X[!DM[PO:8S^DL#2UW71/@+>PW+/6UY_.
M7FWVU<@4GGKL.3?D:1>L6K!(R:__%'<_.;;&0W5LK$@=^8+##XW&!DI%(/W2
M)XX3X,K>B3X%F+/O.& Z'7C)[X "5@/0Q0?F@\RJ!+3=I*@PHE-KE=2$!:&R
M+/NS?UB4SC(NHF](VU8FS@7.NQ2T^B)R]?DT_!:_U]-0;])(<E,@=!?T#F4D
ME2=4P?;%?(>*$J;J/O=S[C+=6,'#',A$RR!=,[;(W(89V J)DGXD@]1:VJ^?
M;!1$4[AW;TTG?+ BR7QWRO@9[MYV;!!2+$&N-JK_%/5.==K>"WK;/U$=+D@?
MN?C(#%3BNRR88<F[Z1A$6,I]6IDJXG-J2!EDWO;75,#XW//[AQ)KJ^^<254>
M^/5EL=;QPU 'Q9S8:<L*EKW FU5%(*#!HX@0QZ*431 6&VZP%S.,.0DL,\M8
M7<"V+,XV((N!N\5]K25,V@.HTM9:XZ5OE@ V3))]O4XQ_CT0UD .^[-Q/S@O
M8L$_UCQDS-9)^\;@XBZ<GF^[AOKWHZ2T"U@$9)<[B5%.@")$@<-K47I;%6<O
M?J"=)A4$J*1XHB3F:]@-P'RR1_+7+RT<7W7$2)'$TT(-+4HK&4OD%3K,?HC<
M;N>87QAX*B=7OY5\"^NN<1MVI%5.KZ]U3VFV]9<S38XGFT1/?_T6]VZ7\N*]
M$E)G.4@X.G&7Z&%WVNFVW[^^)2I>L2(:'G^@THT+&'E<V$(7OGG2VZ?,U@DI
MQPO1H@RMP8SVE%04$[S$4YW)!H2\CK-_V;S=5+8<,,F2XSXSD.#( )_4!-N\
M0NR8D:T]L>=8!XP9L\X7@#>$+IHY96_V4"DW80KU0+7:#U]!IAN[OS7N_G)W
M&=)<(.+"VW.4/UU?IG;;DMB()Y3Q#<PP-R/P)#D23M[=LYKP:'"E8"S=!<X'
M]@.%Z@1.]6H\E%H<4\F3ZX/0$F8L2'^]%HMR8V:S>Q9S;T1T!QXH).!?9_Y^
M*?)ISL#H/OGTXTOG\[TF*JJVZSKJ.EX)VINDGE%4$14D'''VJ[I+7)?/,6%S
MY3<O\>ONHU%9+\ZW2?4Z6BPA 1T<V3P@:X:802?06- G(M*-LH\ @0DDH+)*
M6NAE:H !U12^QMMYKPIHIL&BD]$*0SD#-HVV%*E5N%@/\]/\I.,M.<>>'9<F
M@LH[I:N];H_.J7JPRU\<J4+@5W;'NR8<G\R\F39]_O"SZ6F-*[ZWC>0] M50
MAS0#M0__OMR9T9IP)NSZNM5Z5X#7A#9]]W.*',(WX-Z5$?E==#'(COV,DJ:R
MJ!'[*I'WMME'2[O>!G9<M_\KL:WZ4;385].FY23[Z+E)045V0&7,TO3J(.FR
MJ[U^FEU?1^YH,-;6N3#I7WGLA.&9\X(K$JTAB(H*TKV'_TR(AZ=<#J[)],Q9
MG$9^[;'D0G,N1(->\(+R^!FQ:09FZ;>4UT+Z[O O19&SMV4"_,-:@5X\-,2-
M+M47G.=I/@IQ^>6VD<PUJ#A(>9&9L8&]ZC.!/;4)RL,N]Q=96\[[%V\4!(VI
M()V?RL;,+=L2:RB,H4V0[XK+KT<WHQKW'DS<O1XA*B-S7D5F*8Z32SJ&D> -
M0.706]=?AG"SH:[QB%;20T!Z OQT0SL6?8(JD.W1:Y!.$XX'4V\NU,2E#3R*
M-Y[J@$:OYCD^R* /C&?:'ZD2WFC^TKV/GHVOVW=P,E^A-.CZF82+^L98+:*\
M]D(P="*/I#C<= :U"!T]CS[4)]KR14NP;A/T?%O=3NXKQL];Q2]VI);:%W]Z
M*/A<VTSR^5EIG-6R\M&WI"X?"57CJGV6*1H'=9"ZN7/]F<=0=M$Y"SYG4F3%
MGKNMOAGXV&EOG833NS=%EZO8R NO> RXCA\S.4W]91ED6Q6QGO:-^?+T/%@^
M66KY;7*J9LO5HJL:G7_ZG[58H[XVV<25/'KW;M*I8L.>NPWZ9&JXWT%41_'%
M)NC.*(2KDD"\L]?L@IZ7=S,[;W2(F/%C-Z^I]^]%OK9UQ3E#?Y-U5IEPMXU%
MC(LA+15P62^[%W.\^&S^.IN6P7U5%:U^I/I+@K27HO2>=1EXY>VW,P?_Q%,J
M@KX,^35I(.G 'VW_'N=G]6=ISWV@45YO:/&_/$X?/_5I$Z1Z>YSEJI3W<)4S
MWTWLN(_]/0YN.Q^YG%!_4G[\FW:PG[-9+=:ILJ3C)F95-[M\S&EQ= 7F71\B
M2:KT(ZWSPG@;4*H)JYLO6J _L!03SLGVD2+H3!Q\;18*Q!AT\9%2[]XFB&3&
M1SG;1E10*(6QAP^>.G .G[-M@D+!C"RVF_DF"/\'NI3%DW198(7XL&[Y\C&J
M ">S"2+Z]J4N#$&7Z:)<-HQWY!E2]'<JGQX@_S>>?OTF]?<:MH$O\Q[.8I>Y
M@MP5;!..G@'A8?GZF8@#;N+*1NCM(W>[?7G%>FZ\]9ZK\#(^J/640]?H_,Z$
MZJ I\&%NG2UOI&]K[YHH^\\F*!S\7V=2 'Y0O@G*/(.E9&^":,?96GD<9BR/
MJ[()$KMD%YDZM@D"$;AE.?P^5\!KO7S1#JWT(ZQS_S$)6X,>MRJP:^2%GHUJ
M)IX]HW\"T^6R"3+XL0FBE&_U=HS!L^-B1UN1_V7(5O^MMQ(6 K8^*<W=X!L*
M5^: [3E(6NK#,B4D_XW5K_*M_O/_K=6Q_S^<.K9GX=_-'%?U\BT[M'OEW\W]
MOWG<_6W_!WOO =1DOZV+QXJ*@%)$:E1 1)J%(@A$/SZD"2@H* A1$1$C1 0D
M0$@$1*09 8%/4$)'17H)/?2H?/02"4)((DI)(*&$5])N=.^SS][WWKWGG'/O
M_\[\9P[#P"0S[WK?WUK/>IZUDE]A7T$L<.J8)XE@'9^_WAS#N8WE6FR= G\2
M@,I>NOW=)=+H>W/0%<XO +T/SQCF(X3],BI% 'J:1Q_#KG2K,&;4S<@!S=L\
ME*'!W,WXOX/GD7_PX!6.Z4M0>)JR,7_19/<:H2?CKX!3X8\7_72<8<PR?N';
M_^)U%^[/ Y/_B=.?<D*L^W%?EOZIU_\M:X1>OWU&Z/5G^$;,%E/_Y6]_B?@.
M :C6YV>VV%&X91L_4O\3>68VY1C 6#\]\!_(L^<BXS=H98NTUOYKR/H"CCX&
M=N<L'5E-$X 4LS,[?D#75C31__3J?T?V+^=WAC?E?Y]8#,XN[NA9%( >N?PK
ME'I7'9"H["! )PD1674_ FS9,.6Q@:C//WP(?*-_YN]_C?+_(X>;EN2(5"P/
M8[@/_I)C?Y;\\ZO_@<PN_D+\7O9R"A9>/Q59)J';R-\$_9] ^F_^>Q^>]><C
MLQX))72P\O90VDRO[OC[,+??)#QGBL# S#^#^+]?_7\9XNS:Q\J$'GL(ZY.0
M4U,%(.@)W+^X_N^8Q/(7YBPG/MF'MWP/W=5DTK($;$/_"SX,.P'B:)D$\;X@
MY!8PZ7KXVQ4,WQVFF+17:-H+*01:D]_B]1^CTRC?OR"\6U6(M'\B))I\]/7_
MVP!7^$N4CPN=_>!_$V29VSW.0VI--;%+OI^L W;[B59&8@[E+1L\?Y@2N7]/
MV-#_'/>KU;4XCCMNG%&"&M Y<"RD0@/3*YF#0>S]?OVZZ*:/<DJSS36,4O:X
M6;-I*#*V22E==9+DG%C_>D;FSB1IR2M<9W2U_H=PW%M;>64_%Z&%+C&*O%AE
M70TZC3 FG/VT!0ACC@<*0+OO*"O*0Q]+KG156'H'Z<1XW2'U$E/RKWA>&$FC
MKIKXQJ[;'5X:)3->'Y'B8_U";WW-^N*Y9>1A][%C <,KZOR=C;X<<&D-YV81
MO4JW4Z'9BHMJAB?2J*I[WUFP=DP"57T.NW8LJI_-+NF B>TX?G"3KYG?#G 1
MUKNF#>R-Z]Y)534RFEO?(<<]CNUN@3\VPRG&2R@Z'WUBD%^4F-PYW&4K*V?.
M,9>>3KW:KKB8H&VQ<J3!,:I(1DT!/]ITC_\Q/58N]7S1 <+]%JB6P44M X?8
MG+5===*5NW.S#D&<<K3.JVCY:3@3;"Z_>\ QN>6]/4LE30;]#S0I!#6D_*\T
M2?^PA5[.(J[[3WN7FET;XF40:JH/L,U<_06@9RY#X!?_J>S+GO@E;A6Q1FS.
MB_^0MGG?,2B?]H8T8E;;0S=^W;WIP,9?Z2Z:+\M#?B+_B[+@9Z[K<E:%0@CV
MJC8)V6M8$;L=S>J;O*-1%Q+>]<]3K]R7'@N>+9_>': 8?CK0YGYUE8JF[XYU
M(=/U'K%N3C(9(9YKFB*;HO\L_J=%06+!FZ\=PNS#"(==R$L;8'W]?:I;55B<
M$$X'Y4S"BTJCOA4.DZ:L_CG?BC4GJ?#V*6YZYHDI\HNUYVBG[=PWD!#\DVX#
MIA*A6*IFAYWR AI KQS]%ZG\C\E(D0K;_]Q;F,6,L9_Y6/<?O;M0:'3&F%$+
M,^I_$_86_']":@R$D6C?)R0""/"=]E-JOOPKF=L^]2&)'R\.(APG#.-^%])/
M.@QQ=FWY%X)^L0\9^A_G'XIHV/X4+#> ]4M@_X'U7L",7<(6[I^>P9S_7BX
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M I!G?Q2V\G8$YQXP3%-^@JW")E0W&UYB2B2LQH=;7FH&(@)*7KK8#B#ELBU
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M1X=Z11P]G61S,RGDUO7CKY):E6)-0>H1K[PB+B;O ,>1F1?0XT0VG5<I ,'
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M0H '/J\ XZJD/-H.V99VLX48FA;C69?BVNR=2D2_)4?>H^JM7-506RF\^P>
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M8+S#T(G^^]V@5T-I'.E,\LBEZ!'MAE_]VL"8+DLMV6B"<@RSAD[)^;@KWQ^
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M1P%K5K:-Z-VYM_ "SRTUR862XD&O,-K]OJCV]V6S]9FL*J8-+[F*?5H^M:2
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MDY>.J<41-\P?<CT4_#/[/U!+ P04    " !TBIU<[+"K$A0= @ $(0( %0
M &5A,#(X-3$T.# Q7VEM9S$Q+FIP9Z2W:3R4<?LW? XR9!<R&4L9B2S9MV%(
M6;.D1!&*LF4/DVT&$1K[FFW(3E'9]WU+62*RQ# 8NQGKR.!V7?_[<S]OGA?/
MY[G/>3,SY^]W',?W6+_'V9\S',"JIZ6K!8! (,#F_ .<30.:__GU?_7\1\C_
MK0S061O 1@=RH3*G!ET#J-A U&R@LRZ 'P! %_[G /"_'Q 5-<T%6C =_46&
M\P/5K  5B)J:BH;ZP@4:FO.W@>?O 1JV"^Q7I31H+]U_!K[FP2$=')]+)WC[
M:SNGR0@1)O/<,X3^(M=E;L@5H>O"-T1$9>7D%125E#7OW-72UM'5>_#0])&9
M^>,GMG8O7MH[.#IYO?;V\46^\0M]&Q;^+B(R*B$Q*3DE->U#^L>\_(+"HN*2
MTF^55=4UM77U#1V=7=T]O7W]WW^-COT>G_@S.36_@%]<6B:LK*Z1=G;W]@\.
MR4?__H,+!%#_'^C_K[C8SG%1T=!0TX#_@PM$Y?N? VPT%ZY*T;)KW <_\[AT
M33J8CN-V?.[7=GI!&1,BYW//D8M<,-EY(=)_H/T7V?\W8"'_OY#]'V#_#ZXI
M@)$:=!X\:C8  9R>WBB=<S+2/$5=?%,782M&ZV>_'KN[^1,PN*MY$-':PC**
MW=U>-7!.:^<UU*9YO4B]/7@KL!Z<#GR]JW$0@08K@K%6%MAEQZ 1+FDHGTPM
M0F%)_=)]TY\_+&VV^GO 7V")JVBE?U$:GF]Q(;= $.AB"N\Q46-O>\SX0KJH
MI)J874-L23>M0Z\6&,[H"[?E-_'8SZ%W*/VXRF(;HJBH&L/B-K#BN HW%_3#
ML-]"KGD"0Y94RAZ_T,*%B1BOX.VYZ0G%?DX>(SK^0!UA*'3_GZE9X]V.#?MI
M-#-HZ/BI']33HU<6U4[AG,/QRV+U)R4I'PH.*S4A%*6/E=U[SS[<3J"5J85*
M";"" ^PS[4C;)I](C.Q=;VQ*!AFDC$V_*<*BF\.ED7F?&];)3\Z ]/4)SP>M
M^$"A@JQ&WQ&KB;\.3_I65&S/@,]ZS*BB5NKTLH/B=KBM@$)>X*RG5#]@8PMG
M]'^0,L^L<>2.2/':;*,N@ASD.+NMNV)SGT=%&+%!9O/6U'.+(OV^G $LNU/!
M"2.F+6/9[UHK;$.GQQZ&(/N/_^ RL]-X/0._(92!E*BW0W0$OVP5KS8!V]C;
MG;$H/]NG6E(3.0*9P8-:NGN\0Z_^#9^[]:JL'=Y][<WFYFF@(YS\36L#/SJ#
M"PIL=J!R$JVOQ[#*C-G#W15$%_^]R !\93\N2-,+NTJ_V:-&5#@!V5'OAR*8
M+:E7X['?XX:X'[G,W.@_^<_%NGI,)A3C2I.-KC V,FQB[B)DB\PYO%?1KU#W
MPJ;.87?'T=<_?MS%GQX$2O4AC)X\JS\/F#M5UM]Z&-L^=__!,EKLOO&'!6C*
M)K832\R9T43[AL9G,NOPX6N+)F*J0'*<H'J,+5CI#%A'Q1*Z!>HB%A,Q[EXK
MM/[X& / _&/N\9T[]N[KL4'H,^ :0DIG@@T/H<EDA'HE8H($94&JG.:673KK
MPYEXM#;W4 E-?$Q[,Y..<,2B*Q "&H)FAZ"%SJU;&*0.'<VE\=19)S]$.6*^
M/H@##?H_<_=:;8?^"WH->AD5NLE*X$&K2KM+Q6>W:B3N%4$6@(3UWM91BC9!
MG7WD/*]MJ96&U+*"3[7_>1=8I$7 LNJ&K&UC5/M7E$]?GUMQ.8L-PER$V2?P
M*@<B_XT:=*G;^Y8C&%$1E!4J/]'6*4&E076($AP3&CL4>G0%F2V(S63TBU."
MQXXBXL\3OYBI2Q.A0%VWZ-U+&S?30[^F7>%V!IBUZOVWWM*T2?Z_/BRTJ;3O
M 8N86*->[.?S.C53D(K1%L MVH(%I]6RCEGTN);E!Y&BR*&Z]7_QZEPWBIO(
MC7WG>5:8$1&R!?;Q9S8"@V-_D+)!__7:4RU#9NT)RG'L(/8@HNX(#:[O0<"'
M:<8>7E\0\&CBRU*"[A7R1$S$>/0/322@I!VH?G*R8"_S*UB?MI*-[=]#9ED\
M0?V\@]JU?D!Z%'I&2SX[9T^PMH)7FUOM*/^R5.8B'LR?QF_XW_ ?D1:CVUC-
M69$]M)[^.!+&;]3@AV:+(7W;'AA"J>^U-+X0)?IM1NL/#BVMI245'"--JRA,
M+.*)V$5[NC-+@Y1PH#5=/'_VC7-/4GO1#?W,1/EB!Z#85]YRD,;8X7U>[5:K
M3%N:8]MTH/:N)J$+\3XV9\U(F"2\^V]$G;4A4WZ&L1S4AH>%^/E!0_\4PZ @
MXS=WOLP6N<&W9Z61/?(A]##6244"YC5J*O?T#%AQ+%Q5G-S-^M,;E$_=)@CI
M,8*RJB]>--M)/:66/+T#REWR*960J6M(X5XLH6$;0DBU*QYI>1C%W H.;A?Z
M1A6=ZWD+,#'D1NOS:?GO<7370Z[=E<)1*=C8KR8.*L+M#GH\#(\?(F9/$$,%
MJOX**QF4.,:=Q3WADC[W/.XC]T8+&I=%^S+O?-8EW:NTM"!7Z=EW-'88%P%;
MCZ%?^><7YTX0__ (/<P,N_3S(X7 !3-7T-(WEA)N =Y> 6J]4Y,SH,VN8O5U
M.?5;L4_Y1W<8<6(O=&&A8U+K@[YVML(0;LEX\R^BR-Z_-,(_N*ETI[K?4S5J
M<T/@A+?_E<U$N\:_[34ML$^)N=%Z^.(,0 ]0T!H06(J51W "%*-@N6EY8TB0
M)DX#'"/(M0&T8W"86+%P1;<F\Z^B/K%)F'FTZINBC#@=MO)3Z3\KS>I[B]FT
M'NW];067[]MPJ5A RY7 N?Q9"D7:J_:HA@D*X,/C<#'XF_I%'6[J<ETP=6AC
MZ$1P%&6&6$3A. ,.?$CO-@=(S@=,U<-!8BLHMJ"+ 4*_3V\A\0L*&#B;Y-L@
M5E2'0HZ5XT'#*-*^*UN@Z>L8Y8%;P1G@\"ZCZXEA)"*L:=U :YS7:2%0>4&Q
M55LHY3+H_5=C]]N8@.@J1>$8J7X"#>];UC9^POI"[X;;<5" U1D0\A59=A ^
M00$?P_\$];;<.HD/NAK4Z1?36$@Q)T%;N??FPM7@6#,2[T0W@^3%H?G<'"S'
M8W+H@UA#M2M7$J9^%N3=D^.H][@&VQXY^1EXJ,-<.7\&4*"0X\ODULY995)O
M5!#?Z2\$?1"_XQE "W<[UJ2PDE*[*L)KKI@6;3XF^LX3WE]NF[U&DFQS$9WN
M,O,;_%R"9==_V> ;#K]KF^/L>T6^)-]Y],G4GS76^/W4C;PSX(+F24;KN32Z
M@/NDRY&?FFR/A<FA./NH/4GZ $MRX/%CR? 6-G)LN]FIV.C5<<I5#^]B2W+"
M8:>9,BI*]GV:Z]Z':^--ATD#CF)L]S(LCO91Y*L("H<@7K+=FHK"2SY>P$X6
M=<B<=EA_Q7953+H=2)',0N#W%_X^8HD^%2&A8N&(3ZM!"/) WE^'E"'B<2?7
M+#41$1Z@.,6<[%WFA"7&SZXU-!U>,G_O;'=B?_(>@<L(DB/)8JMCNUK)(F=
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M4MG0U&I&]QBS\^>]9M"F7C%ZB^YOKN!AW+^SU =8'S(_Q/&]F1Y\B"\/E [
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M2=GOV"-]"+S7^4Y*3M2L<XF%2:RF:B:P]L!5[E%96(&IL,AW),0D&V)JHE?
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MLA+Q^*!\5&*3\/LE.1*9,BOX>Z^5Q:K_19Z3A+C@C_[PTQEXX#$+Y2*YZ-@
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M/X<77_<P6PCF'M7:[/A%'5V3_-.*PZ"J>\]YYJND;R0JBB[9Y5C)*N@'BC&
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M"/_#<F1TLZH6)YDZ0_26@=^[;;'?=F%TG5;HO>K[M\UO^W*>:+?@X)"10VY
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M#&PC)*OC!$D8$ZB9 9?5@0%GEWO^=P_#\AEFL9AX"BBBBQ#DSLZ@A.BJ_;B
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M=#/@(G9D4";5_H6 T]*)H9@&:@['8?&=@=V3A9-QJ1WR=2A=FEVW+)B /7(
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M)NOM)./((7E4HF18;R(.3RE$#@AW8F6RSP!F=K2U^L8'IBY][JSZ&D5&?GG
MBP^N@0^)-FOL.H&Z(N\_;4'SM6*;5K?B*[FYMAM:4VZU_+I^_Y(\4D:,D[IT
M<RGU.N\BJ"_W,S*Q!\U'OU,P(Z="@R6B'-6?@ 6R!M-1%UX#*3'''AZC-!;>
M^-!6L$ T/Y9^\7?RI_O/NW$<L,_O#;O@YJ5\LG:: ^,#Y O/3#QZ8X.3I5J-
M1FM]7<#&,5><=7UQ6NUA3]RC-<<[U*G7RN*!(MD<"E02UX_2+Z;]BNUU6[!(
M'%UZ[-.@)BYTZZ[CDW=1R29Z*JX\$WVW: W(>JMT5%Z%A%GIQE+.+ =CE_4"
M%I2EL=;%!?Q2C^Q?D*45IIA8T/G^]UFPJ1=;W9%R9YH2+!\8L\S7!WH';[1.
M-"E_G+SSL<%19NS>KI!:F($HH_QFV0F/R 52 F]C8#FM^Z9<HH1D\%+T <B
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M_]6_)I]T)>2Q0*WYC01Y[8*NVFE&'7/Z$$2Y]E]/43(V&N*/.N[;4A/#/,V
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M)K2D)9 .G/J:6H)-UL%Q_@@;HKW@9=*,1D=^E>Z4D-4*AG)]>S:X_Q DC?+
MSX8381N3E'2W.BS*'8^;9''Y.Z0D(.B2=Y6R$K^[S<L<,=/[TC#3IJA71>L2
M?;L,%_WK.*TZ:)ZQ=Z.^H:GI1]TFA)LY#J58X%.+&CPW870;!!R((T$X&&<H
MJ+[_&K2?8O)[[4'9$((U?51>TDP<5;4RO2<1Y04#KIE857A-S"%,;?7M7<TG
MNUYY\]:8V&W)J?76?"+-UWQ;_+2-&[-5[G ]"XU<V[$]JU#K])$<P#-\N[3!
MS_GU1L'V.<SL8NHZJKZAU6)+<.,&W7T6.8?BWC;3AH<3T@=&8V2$BN[4QW:Q
MHMB^L\WQ>[^F5YU_S>AJ1UT9,-JC9\9+1:>\;QRO48&9Y-111?J3JYWOL8G0
M<MBC5@9,+K+VT8#B]I;N!_30A"FHC5FZ$\,%2*;,=;,$$[0W78:A04GO.; @
M6D37LX+I[1Q?3IR:UGT63E*+(]T]UY9NE[UXTX.8][%OZ4OYJY+'61#=0]#]
MFI_VM(V#*!.+,AO*GQXB_T@RE4Y+ #PKF#-F)RF0!-UA*<)VC_IL'6&T:VB;
M8ZZ+8M&%E*6:TCX@]1F>U,#)7;SD>N,>9%8OH[>&)JAZ96P_?9.U5@XZ,$>W
M02X>@G@PWC\9II0FHD+/=MPB! BG'D6>19A2]%^$V,^!^[/-CM1^M3+[;UJE
M7N'Y]&XC?,^!DT->V-""GF?3I(R+Q[\WQY\YB0W+EP_90/=^(KV5O;8J#!9I
M>^XG<;6.MHO9^NSH[7)GJP4#*Z\&9Q-(:W6[[E]]ACLK7&2*>FQ(.JZ)[DN3
M.6@PX287_9PCKD0CM1%W*4[]![R=4/X/>01\<L?I53/.J;9P8H%3#U,+B JU
MP0NN.N<7ZGZF'(SD/ @EG>+IWGSB[_<XS>KTP<1X0[)JN-5$P[ , ^^UOY7U
MP3?"['V:M=MJ1%^I<VK<Q/&[\B[)+E]GWR9K?O]NY91H\?<+U8G)O4VW6$ .
M@"F.KL+V$^]9HM(3U67ICW!ZX$OB-U_$=Q<>HV"B0GN\B6 N0$)7BMXZ5*!O
M#P03;%*M]R%*W,7MV--QJH3+YR,.JH#;X>&42:)GCV!\("!&.O>Y2,!,"BY,
MI$RG-F:UWF11.J3'44;&%ZL.OS<<LO\HPWKN>=Q;ER?^1RK2Q$3"(X+\\7]I
ML8C!!>C>N -4M&(APGD?YYG:=;[5J<SS,29LK\4.O[$U,:W@\<RAUFYE;%-N
M]X2UL/C-D;$VMDZ_V0VV+ME'*9^[C46OZ61H[2H$B\P?XZJ1)8AT*O#P!FD6
MZ8*/PUYO@?F1I_]8JJC6IX"&XQ[S!X^EW-_%!;\$C52GDM8+G)<WEBB>R3IG
M;VGI_FK@C[F;S07+J'4>E4^63V*[&"TSF<HX#OOY4"[\O-FM91IE]>P"KC5C
M#Q9YKG+'"ATJ;2?T-<BN8"$C*:5Z/O<0A);"W]H4&W[V9+KU;(K1\KB5(<Z2
M@W#>CE?3T,W*'UU.^(5.=.)BN_3%@$>#[5X-1C5>KE!S(/AVS_#@]T+K+%G"
M_5#WR5=3TD?L[([Q',WP^ =*\>O73M/7)M[^DB$F=4&<(*/=V66E\^_6[7IO
M%UODP>;C^L@"VXZVF?!:OUD7URIJ>&MSR,[ SK>=U<W\M#?]$2GB?++"KRU&
M#.4D<,>D1E G @?[S8]J_V@^=>5^N*&)X,V!BU.3X2.=9KL2H$_NL6D7N.2,
MOXX$1P5:V@39*UZ.N6VN&<4Y\4Y3.5Y"VC-0.5XY6\XGRMK=QBC&,O66C%%^
M&'O<#B% NW/MPEF=_$;;.8M'B^T)WF$YWP]![SJ@;I'@&_NQKW9+?Y9X+\F
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ML:W1*/T%:6+BV$Y3@<I6C9S+J7'KC).O#7[.%^$]^$J#X_K'WH5]^Q?^*#_
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MZ,'4C&A+Y ZRZT-UU2??#_M5[9>9O.&L1 =JZX'U<F^F$3!)6K>?G2.Q(]2
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M/!&,^<4W2IP[8Z-NDD+@/"MB=])=_,#FA:$"D2O^NM/S\L"BI#O>K1:9B_?
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M&]'8GCA)"$8559^#0TX-"4JQS9/12BU+K?U2GNB)>L5\J$K"UHA1\?5SH^;
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M2P"/#D;FYB_+O.*=LY-4KX[%Z7<]D1*BLSZW(_CL40H+5#\PB![;A5:#L$M
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M\OSYL488WV(U7W\5#<)OU,;K49H735$%T@]/@<#60*[M#.VE!W9V2$X+7HA
MW/,4<UJD<V"?Z:,;1VE,MMSV2HRH]!^!^Z'.,0+424IF$T]4C"P]C)J$;\X5
M; =EY?5D\S2F'!Q^4)B>'UV!='?X(UP>VJLN5IS?/:^QF< I'HK,U_8@-V/$
M:?=CT]\(I3Y*HH2.L2.RK42\3_=VO(;O1]XT'>!YI]_1NXCP]FI].A-*@@4+
MB@H6_!FZE_[W541T\##8'DA]M)WR;V^%$8/#FHK]V6S5W.'B7&M5L'%S!O#5
M 2[L$B"LV%P3]D2Q]4E',\Y31>6I7S+2CW^[[B_[?@#\>)D$W!PVRP(D;5R
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M*K<J/W#TY#7K&V#&8WF.[/Q;+^,)]3\CR39#>NGFZ=/ES7HU?_@T[Q;GL/I
M\KVFNHS^MCT%,5/?-WH$ZNQ#.2;P))=DMV1X[)Z)OF7K2270%,ZG!OZ%)SO@
MM4M90SS)]%IQR>MX"^-E/G]:.81=B^D#+ W5WVT@3>:YV$,7R#!-5%O=DY&
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M(=YI)97N%6&=E3P1%/-M%^9$!61<B<SWVZP$?+KM;SQAY23JIYZ>M.&BWE7
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M[O]S1!O%5('([_J+3'?IWZ;;X3W5&)GD-[_1@>X>^L_/J1C\>L1V&?NVV:=
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M+9.K 4T>%YZ/^&3BC-RESH1TB"=N:5QUG(6@EK%?CK*PN[_>"W & *'+GNH
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M31\*%B>#M&KBC?_.L)\6QU1OE[?M['_S&](96ZO#I91C^W\'G0K)GI%VQ,]
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M:#WG]WS#"F*W@D]D8[)=J/[/#=\GW[CJ*90\](NZ"HSMVK\]RW4"ZVR=R]F
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M1^?6.P"!I P/KH.^XXV\LY1T"(3LT?='6A":JU3B-202%A9 04O6T]DW$6A
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M1)S?L$F^("/YV*CU%W;<#QLJ7)@3/XUA\20J$@X!^S&&+)9YXM7V#,-Z7R-
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MI>O3Z(/9EIW'; M&I=2\SG 6VPOM8/T_+'UG5%-;U_6A]]"EA:)$@_0F$%I
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MD/N2>/G]Q]QBTDBU!6+ZD#HO*FK-TQXVEL"RFOJA< TY(#M&3TTR*)UD$Z7
M>5,/,APID![Y[,K(8 ]_1^@?3.G 'QM*RT)-11LA#^-XGK?L:RXDBLD X+$[
M_9%-<6W/#^GHS3I'\=RC^R@%2:P34"P5W0G;1M)Z>&8SZ<CS$&UYJ/ ]K^Z4
MH^6&]5OPG?3#]'_;QSC  PZ6<O\]%*4!9'G/'3L[H'S,R%M*'C1VJ6/);*Q'
MVQT;<B/N64"V&)_CQ!I==K0D\/!0DX);'NGAI4KQQRH?%ZT_6"*7XI>*HD9B
M/O50*LB@F9-2O,.##+WYJV\)@'LJ)+Z?Y=O;,Q'ULU-  !F)WF= &\3$8%:0
M!8V2&*=H\Z+D(YG8" ?=+Q?T[9\C7U6# >28/Z0'G:0\LAY^DR[#GU+^=6GD
MVS-H5"16 G;RW76\=%G&OM(O&T.A[RRR;9(UT9%J[&>&P[)>1#X-<QHCD$1Q
MK6R>;K0-;4HVXI:&&Z.%73MW'(5RA(Z7!IK)RRP-0MP]>2O0FGI=HGUPH5G;
M#1(NDYTL;DX_4<H'@.X/W*40Z),L '^<$U?GJX!!VX'7!C"#E\3S&E&P\W#%
ME)C> \\%.T4T8ST8R<#0S[.0*T_\D>3(/J0XDHH[@L@,DQIE[+$A;"GU>X7(
MPH:!Q2YF3CQX[?[IQ_,!F;+;I S 7$M$,XR4*%&%.X"$/=]&6,J.3)-,_QWO
M.V1;!QM7/$GX0'[);2.F G0)JZ65,.MS"T*S:66:E'IZKXJ11V-''VET%ZN6
MR=Z5^_&+B>UAE&?TU\434_\J2T[V#@FX/'/T[8>8=R^$$A=B[L_L4DM%O+T+
MH1P9JLG&**@L)G+$*GG_!4H.Q!2ACV;"WN]OZK?\.XCJQ0_]8?[OE-VH3JB2
M), Q4LIE:>V*X)>;N]@MY7M'TO.'2T<5<B)GX3CNI!3',017B)?P2?H3^BG\
M!5<&>W^? U>$U7L;70OJ(G_YJ.^6) XR-W(0#Z5 $HUS@#>X7YEUA_.FF0I3
MFG (:X"#,.!(;Y0*S[NYA!K_T%3K]6]K^<X]IO[/E,PM+=/**ZTR]RR27O/#
M.E9ZA1\QR?)<AD,._5!!QI9;"VXV&ESF@8+!=%WL1$GLF]/@Y^^BD/NIGOT*
M4HGA8)"'I+'G;]G*>V6"XJ#X;[G^@)H&/PG LQYAX:6)_\BHI=AT%!(-,L=/
MUVO?(G0\-2KI>,%7Q\Y$-&SZ"5U'+I^:2*?)/H?96))!9X>.B)4,2^&GA/=T
M#8HKO(U2S -LV:W8W> ^-O\]@>%] RV6$O=2PR!)HA^JNOYJA)*0KFALI"PG
M4HXUK>\NGQR#WQG66$[6FUX:W,W!XCJYU+Q;2N:'O<2]O)&^Z$SW3+]P"JB@
MK/@ 1<?::<\C8@H*_J6R0:Y]""N,3-7O/(\$ F@,2ZH )]Q))FG/A]Z_\1+G
M"$IGYQX)PW'WP/Z4"CRUFMXNU4=RFCJ9!R];<M6?G.U9>-9#)"5,3"B)@+0?
MR0K@;-C5@<61IL3Y /VC3@@Q^#[Z6,YA01T&&PFR63*J'"B< 1\[K 2!5.4Z
M(<R1@6N&$&3:E@Y'G&@O>X]WLE0?D/M>3B7,MLG =-K5M;SM&M@.9N2RMDYM
M;?._5+PZ8WN43),&8$=RO<-5Y>0PN<7"1.4B8A1&8V>L[)/2J_),NO.WP?4N
M2$>D_45F[\Q:]L?D9*TT")*N\QOB]=Y<MPU#$";;>I30/>GSJ?9ACN&300E2
MVTJ;OU3#&OQN,+K^7JW2N_V00K]\H7(1-]-YHVF,MQFD$/145C2@S%OAL%1F
MO"IL_\S7?&Z^LO>_=R#V>?X[V!8%S(P06&-/VRPW/D>MTL _9$62VGZ(VP'
MN<ZGY$+F<4:*>EI;LT:=2 [(^8>4>O'^97Y!0H&XL</Z=^LD.%9#.(?DBEKC
M8[@N@15QVFG@H=)[>EDB."-WGO86R>2U'9%&W+I]FGLS$P)G=_H9E^-PH&!U
M^:G=23?:_]2*<9QP)Y<%IXTY)TBLF-:/513G+ENDZNC]D_EST*)IT<)>.@[\
MRFQW3I%@Q<\1\^-A "V+%.=I]+<DUMB.IDSIS)_/7;48$[_H+3W36KR*Y^O
M7CEFZ=)U+SPVC3F<?%UN(G?!<4_AC= @%[WC28BPQ]/@Z)=C910&OLZE)9V&
MF;FHHI':%@7,-4",&_S)(XV%OVZQ_A@0WP,'[;E^)2!6<@2O:,K-.\^"7M,\
M*"QJ?,7^(+N>X1N*05.XV$_]3C.%YD?!U/L)<28]1,*%,;\U^E:\Y.3X.;B=
M#V3_ZS'X0IA^/ZAD#$A2N2Q%.%_2=R^)YPKEW7*^L.Y.JYD,T?5TB10*K&WN
MN_.TLC#F 6//F=CM!!42U@M9O/C5<)#N3BUV:GLE-^% 8;7^I[E0)?-6FZ#R
M75SKJJ:B_NJ;HLF60M=[\WHICT13';^%HA:8US)<3D=N&<>O4N.2'++L:\19
M%K8>F,2X1O4\5FW 0S8?"M;\09T5W]J$.3W!CZI/'-33!YBGH>]:AQ,>#344
MLU&BGU=E+X=[5_"<ID%CH_\-M=X-4;M3 6)_99;G!*:3A<:51J=!W]1J&*N-
M[-[&&X:-7 -5]%W-\+>(&O_N<MF5WM>^(D$C/YIH4Y\N.RO?/G!_6_FN-B.F
MY?9*Z#V:<L?N9[]*F36F@AR^_DK)U^@0U<3JTB$Z==J?)W'AS$\1!QGA;:+:
M&&OZL+&\FK8D_!T<M267ZN2G21]$XL5P1HGSK25Z7-S'5[=.YWHC]_C':P;C
M*M3*7*GB?72^_#"N3&]'E_*270,OA:Z!.9(KJG+\RQ F'&-EV&23[([V@>-J
MS/>#1Z<>V+K"E6UZ#N<+WNX1ROI8'\2;*YK: \NKO)5+PVYED@GZN?+=O;W;
MC4E^>-.X["&V/SH1>/*PN79F9840F<ORD"=XT>UK@+RF/:D=:\$;>0W4BL4C
M'(L/>%_O*S[&\IXZ8N$=^\PAX@=B-S(ZSO!EYCO.>WD5N-P-0^<A@^DNV6>)
MA4[>_F!\KK\A6R5LF*Z@\3BM<.!R&Q8\0&\<NCN>5E3QX?Q'<2PJ_H_';(E6
M@>&3V9H3I[E]QZKX9U(7DXO@HCL9F<%Q&+R1+MUETNR>R^H1;5-T]F>$Z)]^
M/;?T/0KG@ F)E%'3!S0+9N5-RXA7?TN+^]I<3,><,[4VC^:%WR:>3O?L[YR1
M06PI#R%>J>+_NM_5/3!$W+2."S>0K5LF\%]^#F-[^M<*]MMG9,9QI3@)\>(:
MF'GXA&N5N.M+V#B<X@H2$I#1RYG^U;%AFDE$V^IW&$-A953-X*+[3I$FIZL,
M;+?;Y7N0Z4[MS9C-N!.,;OPU\,TDX:!^!;'KAG 0HR*8X'H/A%:7(Y7%<,6/
ML:P970E6XSK8JT(L1K5I5)$*\^3AF1&6]2S^^+2Y?GSI<+.2YW[8*)CQ7U6E
MRN9?F-&7[[+"3BH=G<L4BI:F%F>4$EB+E8['CI(&+JRMFOTM=7=46N[\V>M;
M<AH,+9I[NL59'O6JCE]O[!C?7^ALJ6LXWC9Z.B3_XU##3;D_T)]6IH(_TS?C
MI4<I6-_B"5V-?.Z;D0<[05ZD4]+]LLLZ)=C9BL%ZQTRSI_;U]2KCFK>FC&"+
MUC_;4O%$UT"GILB5S-74W#*RA16O\PK.L\]\13WB7TPPP:9_6G%2I@X;NP9
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MW>E(^NN<ID#Y[GX(76MZQFQMHR=Q^"-P2#[D:(0$.!J64VKB?,3C3W9>U=S
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M+'ZQ0;%>+^AWZ!?\[)3UA4J#,*6)4$I-I8D<J>?A,9?:%#6[8#@+N5G6NNA
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MZ/[+M#+@X:R5#0,@,V8CY!G3-[S>#SE" 1?Q1:_^RA3E^*@J,KNM$;Y\661
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M_L9MF0L)O@"=G@%(=/GY"9O^;.L:/Q_?(.7JF6^@;8O5!_!._ N&R X]!D
M',X.C_6WKOUEGG*7X:INDH'(S6!1@7FDBIX*-DU5H^#>2ORXL27V2<XX1LL2
M^^G'D8Y:IKB'T1<Q#-P4Z;T1$#&,@=[6]%[)R@87 N=L* PAQ#G\[E8N<6
M6">]G?27'4E%IP])'KT8\=T>Z<018L+X&=FD:IY4H_MYJFI\F/SSY[-DZ2NV
MOW,R!@)@GL%/LZ)-U :8(L5+8-VBE:7C@4F-)G-K%$9NKXIGKIC[K56E9*DZ
MK8%*HQ*,204&(!G\:YQBF.RBZV)EQ041UQ&LV9K!$IZ8S)8:G-5I $]928D]
MYX &WG@M<:@N,:J<< [ E_:-L4/%IO\@8H3!I*0BMV]E6-*]'GMV;V&)2'NS
M)M3=*LUVVF[OJRH/-\5J:;>B+CJ\^_XYX.4Y .-R6'-6<F%S3>*BQ&?:GQ)=
M#HU_X*>T;FZN05Z3U2?%ZXAB=E>(/!DX-"?31Z^ 1X3$-U)7XFL>' 9GC7S2
M+;/&/+,W?.XO,G($';<;__9@/G5X[#[2N@FK&QGDUI#\P$U7X==4KOM&VP)F
MR-;&.6O34.+G\1Q%B+=X!T01_BMO=*HK5,3/R$H]?>#+]9;G!7F.2#D34J!%
M1C.LOPN->R_2=$&LR3_]4&4^I(/EF),K/\<V/=VIZ_[AF^^*I0*<_:A-Y4]8
M]7[F%!TZ[V?!S$Y08DZ9?]6O=X56^[!G>3)BS=MJMAAC+8&1-D?+65>?G?Z1
M]P[Q&G4_V=N[ERFV4Q3\3U7KSA^D6P5XL/X<0/-F_(K?_WO%X%4![1;4:^RN
M#.N)C.H@#3$Z5.&_AN)C_S^2I!J1O>B8><:ZF$E@?>#"1!Y@610^LYEQ[VK,
M:8/&YW49O2O*#OZ RV\/ ,),#C-T1/6!'.4>1.*B,BE[B074=[*8A#-A?>9Q
MDI6"B[RT^45+;EH4%>J(>$! )WA2VVVV[I0$:%@<AD.I<IP]D;6Q]]7\IFY,
M;;LTG2Z@@F:#UD]XM\6+'AS^$&^U#@K7G,[ZX=59^,H.?#&T%U'?U>RWTT_O
MD#4(X.V7?V<T?0YP&N,C2Y\5*?I@P$MYA0*/(+C"UW9"XW] )/ZBL]8G3Q6.
M9J37INY:S3Y=A%1MLW\EZ#.-L$X._7=9'MST^<]:B>1!OZ(%0H> *F.S.L\$
M8^D'1<L'N/_4D"016UZ1!,128=\W_9[_]GH@OR3D+J/CT,YH#LI(YW62XJ>G
ME,FK-?V%KZ\ZEU2&2G=W<I%<?((46A=+EX0$=&>"J 0M]3PD)%D?-T]FS9I2
M2R^@Z\:V[Q&2#P=(\D7D0!(HHLHV5.T<8#/3+OEIPT[J^XZ&XK+]95)O#ZKF
M(RF[.TJ)L$I4;E5^_4>=M#A^\KV]$AEMGF_LH7)7^M_;>2=;&&BY^E.[;Q*[
MI89'4F8YD+W&'[MK'U'>TUH"%T2CZSH )GZ6)MV\2WXE#TPI<E6ANM#X(L=5
M<<AVHPDHW0A(,.@0Y3L'))S_9]$S"A*7'9WRW^%8Z_9CYP,U90>[S@+>J!"4
M]4I]3:D>9M)]O!>I#9::'A37%RM^[/!\BO_MSFGQ<FQ7P@N;53'/A2SV-$/.
MYNE/[(;Z-88#,R<_^\TRPI6YIYY"E!?V):>GC8+#-6&BEA0&SI)+.O_'D<94
M7>"KQXOZ.A2X/U6_OLK)D^E"@D$DAV%;:#7XOQ@3%+/ZZL$Y@-!&;J!W>K2G
MGFSQ,E6C5K(AO2%3'[!\T-!?8I7Y2+L_.+Z;JE46%^_IHMY"!X"[+&'GP(=+
M),=3IE"0_M\'7A)@#;Q]572/Q\EF2[;!)M$PID;@ZPW"4;<PPQLF! =9FY01
MXB59@GA%%B^^YUNXD9UMYXDO#<6]3/EYZV99T^I(T:E:T/11X]2INNL3)\QC
M(\C'A95CF[G[6?GMV/1C\U.1B_G(G -<[5]?>')\Q*EYU R8\!B8$'6=L+:M
M24SL1M,K#&G);@1++IT#9K%W6VJ3\3Z(JHR'%^C8P_99U-L^0(6PN,%$$)%3
MF77[]M:L)#&]S +8?U>A<MF1BHCRC]=6I=M:M6);\/>7,WGP9Y<-UFV&=@XE
MAQ#T\:6]]BQ1W]$-A7"**E2"Y$<<,QFG ,AB4^V^:"8*,]FZ8'BN"\U&D?NV
M-HNXM&Y=;\_PRI]?\7(CJL#1V6OI#K;XB&?,1R,M74#!3,,.>E>4*_YNK$Z7
M:(6P]K)JK^1-/5:*W5#QXKB11T4R>DA\?'K*76DE/T^LH0/9F6\[8;C:V?H[
M2J^0)&:<$7<.$/B/<N(*+Q(>4[VFCB?K'Q]M5N%>C;W^OX'!=9F.(OS7FC-0
M(XZK_E4%W,8Q>>[Y=6W/7/!->/^W*4[79<9/76?S1#C<WY^!#G!+[&K:@/#W
M^QY90_U3"W" 4BS]O I37CDSWQ_%9VFV3A< $8C<_,-9H661L>K]FUB/W/B
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MSY1MFM*V (0^==#*J?"I\&/"J7^'.7>+3-[@"!@1SA?WF_CNE#YXL.5V_SY
M[HGP&]LQ8_"KF(U46EHZ=ZH*S+C=&U;[O@"F1,!+2_[5\&4W@!]*P-] =;F
M)12VK4J(]<%P'KJ?O3\'N*PK-A!69_K'XH!LG5?=*"+_&LZY8E!O B5RA=0?
M=:;*U77D62+8.G2O]5T>! $LF_D8!//.K!]&V;2N=<@^-_97'1HU#H?[S,\C
MK^C3E2_ST6:\0;IM35B@]-&VV^< @(WUA&7'Q$I(ZP914GV'HH_7)W.:'-XZ
MJ^L4HDRXG1I29J-82&:$ZDW<$9ES#,]+YLS%K25H\4(-"Y<,2)GX"R](:@)R
MA!8N2[^N7ID(/"#T67\9S2V:(T5HY]BTY5I5[^+_^<)=CEP[\N7O M^D"[CD
MKT,7D=63EQ8BS]QD0A.SR98"N"Q ?=L2=)MAL8B_2Z.63T6$>04.H*?3MKI,
MY==Q<JMKS/,R8R\*)' /\.3Y5?<?7C8=<S.VNUX'J/DGQ6L23<C&JF',#VQK
M<$A(F\^'.D'1MWX=V7S=(-_U#C1'A%]#ZA\<B@')IX6'%US"K8G&#8W*;W2/
MZO%=H\O?CH&SBRX+Z4\@0[=);S32QT:[</!L:.J_W1HG@9M?-,.5&IIJT3Z[
MU/4S.1+C+-(MFO:Y447Y'Q]]R83\#'>D\C=P_%''QU%,W1#W76B$="'JER//
M$BEW*#,UIQQD",F$L-R+%I(&OV1-*9 C)J; 7,X!;%#;Z4YJ8%(G'2D1SZ_
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MSE=#EW*[7/]51R.TZ^5_K=+>%;1X,\+9M!_#:4?U# !KHL%,,G>+D-^0^JH
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M-?K0S<__;%\S)K+ O33CUS*DA\-,+&2>.4G)9]V\VV#<?9A?AE/G6[UI^\:
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M(AP+:CM+Q;*I+6,_WD:S#ALS#(AD@OA7<.$@Y*OGAC5?Z57G^>)ZV>9E!:P
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MDUI5E6^0)DB%?U!0MHNZ*6SI4XPZ\RKCV5(PV\\AA[M-?,+&BS(V!99OM"M
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MV'A4%]&QD(O6]? (*)W3.PM:^(WJR-@L-2F,*/SJ\\6>)'$AJ&I'!D30%Q_
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MI<TA%D!I]*H"F0E1W@8K+"UBW.3LA;-PZ>M8C)D0(4R(]&?'.%(]#O'@\<U
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M0W!=^C!S<Q#J!D"]"L<%CQQ:0(#F\Z+UA.'[:0_?&NE,D/0PE77,O=BL+"J
M7UF%D07Y]GRU^0EZ\;L[IS[[7T[=#(\^7,NQ"J[QIFHG6",U1LV>^:-CJ0LS
M7$UZ><K'Z^&_#+#7OT2O ,^1]=T=J1DOI7YN+9$$D\OW_O#Z@B]@A>&XU%IP
M_J0$?/?2OPTU3;U[QEYX3Y<_"6$<_?+7P=S+.)94RU5%E'?KCR^MG^\;QF]"
MEV!GJ.O,&\ [MW26I?!)6RX\'S;@)8:T.^<PZ03-C;"8E;:6U9NO=&E>"19]
M9MLX!_/ RWX9J_!%^_^@\-UK#EQ]_-%:Y_++%SN96-ZXD2"B$:2GI-S/9Y$9
MM'3R561L&J-9C#K>Y1MLWLVKR5;E,/$ O975G<_E%2P=^C(']?5G"+=.81>8
M6[?84);V9M;.=K3^Q\,ZR,FU1OF,DK+X66IJZO!\AU_:9\?9<FLM_=GPI4#?
M5#'<,CCXE0YG?EA14T**9#EL,E*V>9;MX_CK3L9FB1$B?GM^.X )DXF)B>K]
M%T4U156LK'S%0<29(^0;G_A^S38FH!Z5$6>4>D49&#_:_=\M5WGY^QNL-4L"
M86B'7M&<P_,#]?<%^ITM37MATFNFL[IG.\M>1?&8-WK,?S/3NVZ%YC^9E=ZA
MSG;EM\>>DS.DIF_Y!4KDR2;?EC(>%0]%M?-G! T[K]DL[9@&Q]5]786#.U12
M*W8MMSJK=Y^-0JIV%,12'<4J:G87%U\V#KN]J3*W>FV] A(6\5)+&SHE6T]>
MPSVVW:=Y@^%X<?W%\?H+'G #( K5W[#V0&W'A4+?@.M=P>LP#ER %Y8L3NE9
MZ<X9"_M9D\]G1!5"FJU.A#]J=8)%G[?-T5]_1.RG[EEW!\*ZHZTEI_ZP*MO0
MVT#'YB>B;NT"FGFNNRSAE*GY5Y%E@J2HUBRJ-++!IXU8*-S OU5M3##O2[)R
M(]U<Y+%_'U_[F+)./1UJ>DB<"&^%H8LB"(<*8\/C-P[CH/>:K3SH<>(CQ9P=
M+);B"2>*N2Y\78W91(OV(YC7B!^)TBU#WNJ2(@GKG2OMB"C-62H[OY_AQ:F+
M#<I8D)Y@:SAT\70YM]"Z.%V?G%O#GW2#(W*03B+'L[20Z764*JO\3[D+;?FJ
MQ()'$?B]AV,(.1J*54HT[QUM!TJO"%UQ#DEV4^:5%.=#B7]E7MM*M.4I:9*E
M:<TR"[Y\_%](M7D>$0D:$NW3J2FX"Z=IE]HNCGUT>H\DOP90Z[Q5?6*.C,R0
M^/Y-7H[K^=.+'_OJ#Y8]JXF>$+$*1-L+'\6,*B'1O%FTL@EX]<^!9L\70\W6
MPYPF!E=9,#_30V"!V;8+3GKZSS1FI,:<NN:E%??R'KQI;6U)W,Q,7S49V(P3
M7D>'$"C=;@ DUYB2_I([A%\]?-<U!+8=6U*"X)Y";BSF?%12IDX9EM3"1;F]
MG__GVQSD7;VT1-4."X=F5?4TA"NV\%9D_%3S^>?M_6>#K^%BQ1#7;JJHKIQ9
MM[J#/.O:MKE;WU;9T3FK]T<;?C)^<'%^,#;QE/^O]X\ :B:EK.<?],76<OZ+
M3&Y=]SIJ>FHH$:7R4J$0U9"98LJ<7/.OAV_F)/W>/_;6HGJ<QY""7UQ;Z5Z^
MR8 -N.-G:HVE5E#5;D?8_(M1'\<0R!-]#\E"UA_$<=1WEP/_ $:(Y  \>24=
M"L44%V'?5.4V$7HUATN(PY8VA%6SWMKV#8 8TY*QH52VY?(<X"S$BCR]6DG?
M.[@K?%UZ\(.41I U:W_073-0B#Z-U@)D74J=:5KX^"4YAX&><V3:=Y6+4:5C
M^->G-D\CA!FHZ#YV$'T/X<P"C&W,53#WC/?N'1P\]%#D[ZCGH]S[QMB20!K/
M>8<21G.4U<<XD)2-UE\R<P$4<GKJ HA^DHDW<VN:]':X_?5@)"S? !K6HJ N
M^G1G^MAX-"ERC39\1D6PNV'V!!C74<L^)!N0_[O"XZSNF2IA10:(21N%K<&S
M12N3X.F(^K*!6@L_LAF1&P"8+J*C#<VU#ENBTL/!4&%:9\48K0A>'&R#)YK9
M1P>8B'^&%"ZK[#U;_3S.UM#F=;>W=!7JV#)Z%B,3O%KDI=RA%43OLIV*#GNU
M&=Y)4.:>_AZ:GJ/G +?V[01#PJ06NINM09Z2CSUUQ=3I+ES-<MZJN"Q24F;(
MQ-_JI!=?!E:IUM">WV$LXO$/)$ 6&S=MJ/*/CXSU+HG)RO>!>_?EW(GLC'/X
M..^^*UJ]&!^7?L-'(6@<6BXA>C"J%(R-G'XN5]TT-V4=5/?N!G!'&4A/\.UR
MXNOGHJ6B#AV4O_!^=DRKR@J(&TO2^?BM/J5:^R?KPP.1JLTWQ]OVD'><]"4?
M,N.^K<@!BI=._])-5VWLO :EX2'(&T#<*AT6-"2>T,,_A^=!VA+_R^OAPT*3
MI%^)G_G'?[9(/RE8&J*?\%RU\&+7H'ZIIY32,)#R][&499N;^^FU4GV)OM^W
M64AY6PB79SM]K'?-MT<FK_%CSP%1?_;;28Y_I'E.1DXHBNT_ROCKV-\WR)F2
M]BQVW\",YB<Y$\8IY]8CI6\ 4>%[)41X\)7^#K0%%"&(X\$<C\"!@^F<N)'U
M:=N6;LQH>JAZ,RYDP+(D1DQJ'NN@\+N;,_8D@4/7Z.O#<27^ND)$>#%.%9N-
MDD638;8';P#,/62X&\#@&F,X&ZY."$H7.#AP3J=2!#TSDUCN?_*C8<HY",S[
MV,?1CS/@7N_$P]F43Z)%!P6F5FX0C_H"Q:4:=,NN\2:3?RT,LG!J=I5N^HSY
MY10K5>IW >U!FNI:*V^)Y1]6GL)M\F9F3]Y8F'DY\MYA^]/$O,R9E\DLJ5MY
M@##_UC<N8L7P\&M*371*@S?(5*V\\ 80P*%]2I865_H0^"&6Q([S4NLAWU=>
M/Q*NT;G,M,<9NFW4YG*;(/(JG@> Z%P.$V^%>@J^3V1W2\YR><1SJ]A8Y9'U
MJ+20C%BS18"?O$@26?M'T4^)'S=S&*2-"A6I4WQY?&6TGE>/YN.N;L?A_(H!
M[X\KP#(B1P?$X3XH6$K/([S0;,L-@#Y4#9-O8^-R]*^' Y,ZU-HCBB7M*:M%
M6( O6Y-18#X7O.K7G3Q9YGROU'RP\3VPO(9405/8:6=3L-5<7=;NJ:C:2S,]
MD$W)[Y[$$ENIB*PMWC[TFZN5CXB)NR87MJ3A+Y?X&]W%#)YX*.C_*(US])[4
M7-:.N/-<-'=5AZ0-D.>U2S?)TU2%CKQZ&K[X>"/Q!N#4FWPI.XP Q<N>L3NG
MG-(0ZRR^\T50G%H(Z2MLW4*:Y=S^NU.TL&'N;Y?]%GT&*\3C%XI9;RD;+IVD
MQ_BI[TUR'N?R>_<LT<22^&[SN52C?^_N^76CJ\8O@K*=>LZK*EI.]BV.MVX
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M,]M:W)%#!NVV9OK9V]U@]TK8&JZP9M*8I]D,@1S4.9G0ADY+1ZMX3^0X+<7
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MO6J/HM%8J(>VW  2H P$3CPG1CPY_'&H);8W+IP=+X4QR);IWN#A#)PPCM;
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M;H^:9C<?K;&:<A3=CCU5-B"O3(U)BW (,VRLOMY2C'[G1"S'YT,FI^@91)I
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M+I#/VE>P+-73G*U0?T/@-]VZ"23DM:QM E800X5=$A\1%RM)IA-_D(=R,YE
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MG%>$*0@5?K9]WKTW@G-T:%JZS,AHN+L+]<+,'&URYCC :43DBGBWZ\6(P"?
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M;H%$W!9(K-L5+(P= 9SA5O'Y.QWL85@$FPJ3DQ/%-ILN&XJM">0!=%*E&15
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M*MI,[#@H@UW%[B#ME\CU[B)R@L5C=B!NR6"U+\J!B'D.X0;9F#R@+J;40D&
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MPZR/_+ O9!(?,]B+;?LZ0UWJ732V;7B(F<UOU-:?/G]!RTYG_:G?UF:H):@
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M+8:^&)W#((\GRFDNSK1!G(2=S%ET%_:V4Y<KJC;;-17:R6",GJ67''WN26S
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M/QVC*?:YR*&M@R)F6/6^/7=6]BY&F L6Y9J6I=<>L&.(4SL43J.;21P[#0^
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M,_,O$ 4T;6-K+DI-/I'LP&V&R$;H"*AW#L* MB+#H=/WX%M)KL"/K"?SQ;N
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M:K*R;_!N@#,]Q69@'_MZ#"65JKN "BIQ#*TXP0_W9#$V#%HCM=NY[2*YD&^
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M-J<Q]"!^)T:Y)>D)[MR<L%ZW)*^"BS. L)UDG9$#BP=X]Y1=71K=9XY_Z3N
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M<S20'?V&L[Z%?B8/JR!"MQN'IG'BQ5R"^=<UEL6]CW-PO'E?79148Q[Q>K.
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M 55#%9@#%26S''6 HA?U9E[$C[E",C,1,1DRGJ-X[8'^\X7,21AMDL*-';E
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ME"0Y0]E&O8U>CV[$#^5:W$*5T9+PA%4?3]N,%+^THH*7W-W@E(RD)]3<-;[
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M=R,[8VD3HR,8%4R?@]L"6:VHO#?X@\^[3K<((YOD&S(JNL:T(S^SA)1[EO9
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M%K0^,G/:,3VPU+>[\+/<^DS&^@*^\CSL:DMTMI2AG-R,8@S>?;WO25]P?MC
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M)Y;C4.IVAI ;\$"Y?>SFF9Y8U6'5V^>.:FZ=/6;0<*C"PDFEYUVL=;!]+O9
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M3L^C<K>IZ::!6SO;ZR8NVX&MN?M?,"]J2TV_+"<=W2TYHU36%'+%Y NT].!
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M8:YC6Y&A8H 2<6E*(H_"_VC$SO(,Y3 ;].: DNC-JE[0N2!+)4P)>1K'/K;
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MX@Z?(1_;KDC+,(WM:%*7>[]Z*6! L>N$]K*%/2=/$J4?>KWU^R!#+EKX=;4
M]8_G'V]3,\4<]@>NBCAN:X1M5=T#>:TG/2DPI^$37UV>?N0!-6([GA?HEG*2
MXI7B.7_U+6K7#B0<_:2_']>8+C7CJQS3JGC&+L#*!!=+.RM<TO9K6;'+\;LJ
M W^(X96::7CKK=DM.3^OLG"#GJ.J1O4HLN3I]U#7P,=-A=GK^H/*<^8Y$0J
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MA!^'ZH+7TY.HLL$Q%D#@.W'6G?7P'A5F0S0E!7;47?U>EK8L\G9\QU#OFYB
M"O-C,9WN]RL,UCI;X););VE69FKG+!0GO3;'?J#9)Z9*PM)NZTG<#U^)Q9I7
M%KZ]_.I>KJR2808VR>'!:%%JOZO6I^:.I/P5:5=1^VEVP2_9%X4_6)]1;2=1
M=U$30YNA;!R$?)?U@*E P0*82AP1^,IE8\41/T/=3=6J11%X^%+=]R;7FJC'
M]S[IYJA+]"!2)GNN5<,YV$DF>E=#R.@)B;$X%\E)&_@;*W>. %X0#%^,SG?+
M#[@XFYYS*'RNBLDJ1A9\ 8JS<6TLI1C2U\+;9MR2S[IM,-HMN@XUF#:'S<;$
M'T]?9_&'S)<'IO+[&.B[;CVN88X-WIF7W@]W2XC(/R\>H]NJ(UPBG%,UC3A+
M-U07&,0XG):_4BM4X2X6C/"#2-3HH.K*R[\Y;FJ<?]=H]_1+J>&_CTBH=8FR
MA8/[HA:R<]A^8\-\;<[&5 Q@^^[K@_"!,.Q63.;0D *XN,1L6S1-:EF6QO7]
M282@":3D.JX$_Y*/C65H?K[#D53L<3]D&$A4%#@[Q^4:I$\;BMV";E-8CYD.
MU"EISBBLH;J6C!=J*2W59(E=V/Q3JW?DG;>N-VT2 6>8Y^O"%G2#P:G%SG$)
M=R<^W;?;5]UO.N&"[PXI01%I03# 6BQA*,VD%4>^W"6LSOD!:<C>/L"]GP1
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M?/F>0<C"W9(GI8>&"@?1]5CMFY:0"_OQ/$416C[ .(QN=F* 8L'*T6M?DQ.
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MTO+(BZ :I]\+ZCX?DR(#A;,OKE5].'VHE71)7/#J?:/Y7N(NH4%Z&J"5_Q@
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MX0+I^ .@9T?OFB#L!A%ZI"A!.4B'C%5+0ZGSG?G"/<#%'WY+]]8^3V9I8O8
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MB[4-*2MQ.)[9^-P";,2ES$J^.F #_0C1@)08?]3E1RBK0<N :Z8ZQP1BC$Q
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MDIJI&[+WG&^PO9DB=A*[AGN"NBHP.<^E>;2V<C)!NUJV+#/PC-KYN1GX$M(
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MSM@'UH;XAX;*Y >:_AM2(2XZ*XKUR6LV6<HMC3>_8"@!6]IJY[@53ID)VQ^
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M%+C2Z2I.:$=+82\PZSHH^WG?'V:0Q<SW>5-$7<X"><VE"Q3YED,VC&;3MJS
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M<]/P4HW3*\UU'/P;?]'ZKM5)VS0?;</RU*WKQ4J^AF;0+:=W,]3@("%.F['
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M/5SP*T.MG[O/K.7P=4]@-(9%YZM7?_B]N(%8E9NP@+A6"8:,WT=,_[5FW%@
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M]X?O29;F@U7-!V4)*SSZFW4JPTWU6AY16#_W:I"]BG+]Y$M(Z^Y%!_K?Q.6
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M!A?A3/H3RI\N@HV3D?[3?2-G_6EW:,/,ZD(><=CI"&Q?A9C!^6)!JL:4 "%
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MERL0;3C_&?4 9)DL\]%1L$!R#C5!>1CV%\DZGH_9J!Y8@V@Y'I,RAS5"7)I
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M?@?9.0Z!VN*%I%IT=F.,)LGNXW;0NH:OU(J)PU8G!OIX'",X2*T%I[,HI1W
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M%<J)^.1H"X+B,10S,RWK#@ELZ7%DI#>R9@; ;U(65Z!GDU3K9FKV6I 9I3&
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MY?[1O?6%D&NK.!:#3O'[+,,]A.[1V=F]\-\:<OYW0Y-6<U&IML.=+T9#UG+
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MQWZ%7 G6K_GS-HZ65&Q_SWR?MN+G&L1@(E_*$1 &KUT_RUMH)"4+[20"&AO
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MR/O"X'KL]^0B>$(TS[5K4F[P.D9;@\+5&1JR="SY2<@<8UQH2/99\N;OL>)
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MW<LO"5G8TU^YYJFL_,PIQ1&:LN=C"*3P'43Y"\178K)&JM%?40"J>FI]7ED
M\JS,IVEHI6>%V+A$EAT^67:Q=_;ET=6A)K6ZAH\SN;\@W'7ZF^$8RI,*RRAR
MZR!ED]]PI?4)]]#A%^D@;;>;J9,U4 @P5VQEP<CDJ);IF'[^,.MPSFI4:G K
M$__=_VF^(_:H)C*(Z[C%>7;(\L$=N84$BOGRYMHLN 4KA6>Z0)/'['%$JC!K
M,,^I%+GZXAV4 TLX6MXD5>6CH=4W-Y#O-A*G V-SW0>]IKY>^"6M_KYG^^\A
M[6S$W_U!*H[HMKW.-NU7[N#9D<NS4KL(TU'LQ[PJ> AXE,C?(Z2MG3J#F.U"
MCXQG]" 4PO"UDQ5T!VX4D\*7V1CX6T\9=>UH+(A6CA: KM7Q*8[O Q_^;CJO
MZW3PS92V5L1TJWE_:2ISQ+04:8D^KI#Y]6I=4O[ -_Y+QA.7G @Q;YG$,C>/
MG LNJ-0O#C47O_I4\ENH,7"UU\##7-+L.'U&!%!@['C[M&FKEAZ;2DAD=,1)
M[LP?BEO7Z_:)?GUCIO[;BDE&SPU'-8>>A2?IB%W\=R_POX-YSYKU["'&0WUF
M^U%GR)EXCN+'6/@KPBR%OPO+R(*WW89E"47IF>117]_KZW!Y;B16E1(G]=@8
MK)]/PHOB=S?=O]+0$G>L+&>>T2G6>5C11URF]%6FGQ/S7]>]$J&>G3*D+(XS
MQ1/&V;&-9GUB.\+^N[IRP^QS+T:8%]MAQ&"*,O_[E#C:M89[DSG5@=N.OC;8
M'$>7U$(P\8F6&J6 @B^>UI"71.WY%![JM UV??U3D0%R;^CMQX5CW7;/]'O?
MR/^GQXZ#?N-+!F3GIWZ0O/:IZW5<T1F8G(?,HRMF'CL3/,M%C:$C1[=094_I
M.@.$M H=G4>O;#R<[[<4_9J'ON=I,*'UDQ!5:L5:$>_YE!U%%:U9T?U+P]68
M.4,B /G?D+(SYF\BE<AL_;.RJ.V*US5+;,52BW5J=&628MZN57[$>I6XR&F_
MQ[P@N#A\T:$6@H[*M9A]L4XLZ8[*=?'??W7-G.*?R,4AK_^Z$'I3Z43/]@]D
MYZSNF_'VE\ NA@5/HJ&#%33DQ(I/==F[6UZ'!CP:\QR"V4W36'G3V#N3[-B6
MK=A/GQJS)B868J--K.D"T$?BYW,>\)&[6+SM,E]$,H/GQ8=_&VP7,S-O;]_*
M'JYLI'P/4;&Q+-Q^(_Y=Y-+RWVU+KB>/O+R]%ZYQ_JSZ_L3OS-#36Z:<*8[.
M$(6V^2)P60$+^Y;S8,U<J X"4)*^7%J:/X(\?JU=2!S.]7TG&!O]F=E*)Q2U
M%,WG$I$S#4Q']I4/P%,:6!K5CE'DGF>=#,6K$$--^*/,O_CJUB08.V+)A!7K
M+.W9&T#[Q DYE.JU:;I=M]+SNO]#36D+8W_>[N@.>+T>TYX;/QXCDNDDO^M0
M0N'J%S+<4.0A=R^F#UN_O+3)9-"Z"=3ENT)WOUXII%/,0]8@^W4^B;_/-ZH]
M+S*D;A[>H-!MY>%5,#GE,5"S_$/-UK=E*$8TY*7.Z@1"SRRM- N^<\M.KQPM
M]YAL2I<@)[^=6H#(V4(?#_3,>Q1A7P7>3)9W-.RZ_.IU#&.IS#7O>M5CY5!C
M7M$?S <J#V+=R8(80-3BCYG%SAXHMM=YQ;(^PK*7G>9J)U)N%J *+:M0V.1>
M(W2=%6FXNH"N86^4+'=9W=?UB^[KT(R*U$=\-B\52\TE[H('X_:B.&>!'AH%
M-R6QB#:E+>E>Z->L;TD\D>M*;!Z>_#H_Z8B30^UAC_TQ6RH]^L8]5#.+]$6]
M_J(<[R1Z.P 35M5!Z@QI^1Y$M&4D@JO.G++_T!^M0I'Q]42B[M$'&!>'8E+"
M79:=!^NKM"N\L\[0%<>FG!M.-9Q6#XBUBX,_AB;AY8G4)CSD^GK\<9H660"2
M1]NT,'EE-:55[64 GO9?D/.[3Q^.-6ZX6%>4C_[78])VN+9SX/CAP( ]VR*&
M*8!61+( 1'VC#">'NS#8DR/-GE5H*!3<;"/UI&#R$W.2/P0,+QL']4^'P7;7
M#MVO'<LZ:W\<-CJH]\Y<ZBYZY)YYL4W>[P\FJG@-.D:K,]"DUDSY%];5@*1W
M3$O<6ZZ/EM%Y*5*Q4.+&:'SHA1(-![O(FRZ/R]3@U<VGJ# ELV=M%C^79;&A
MT'M8QU^$>_ &,X)>NPOKN$BGJGVG9YGYN1Y?"+3G9JO*E[>*F3^R50SSQ,![
M8@90%Z_$55ZH=#X*OS9B=5OBIE6<Y=8M]ESFE9?EV2_9,XW'<1%7P(-6<\.\
M$QM\(A4_$R4$NXT%'O;!X+#]R*8K'8J"/*O;S(L@)8,8;ZV^&),V\EE\MT-6
M*CS&5H[]["DOP!K[6A\+WN)?/;V=4!Y/V>0*0%*%KI47$@H3OU F*(I^ E "
M-#ND]*[UO3HCA?TQ9B^,GKZ8X[^SC)TV4U<44[+<MZU-J=U,=ONV+SLRI=LH
MEM)D:HBK*.KSYH4>Z9G?BE*O[3$?U,OC/B_<^X&+;I[L&0D_/E]$N%P1=(OP
M^^KRZP&*?7S#8&L^G *E8]MYT&[A7AE9^D*8AZB_'S 06V)Q/"]VA464>(?J
MG*KHM#\P71Q^I7=TXBHE[Y+'":+1IZNP(_^.] C"*<Y/ LS'Q:@E 4A=VEQ,
M220SEM""5N>$8W[@ZP2@;N@XH0TJPM^'UF91$H4<C&"31@)^-(<QD] 1KVNJ
M*[FV&4N-#M4MO/PM/<T=1\8.'0\G2;]/V=.:+Y3J?TT7LOSAS%Y\'8W1M/@[
M++=0 !J*,#=?$A*[EP!T'/W?5^9CU$;&O #4Z9YWIBKH_:BPX+1*MS$P)1'^
M8DG9!G$-%D\*;H2Z'7"/#C&_$_O72QL_!TY1A(]-N-Y%G<1(\ <0+RJ2)N6:
M4[:_%R=-&I#CE2NZ5*&DL/$W4J>*!:!J<_3[!']FC'I&E&>#UY._/J?@$3":
M R^> _OW^G"-,HICHP%7YAYX@@QJV%H!Y<LU*]9%IANB+J]_'G<=BHEH-$UQ
MI6VD*9S9'XH,"+M<$RH60RP<4<?F0I=-%UM8 _ Q)!5YCV_210MD7L <P7<9
MPI*?^4#4P\W1AG1>1,>=<4]EZT0V7HAM5X26O<C_TB3?,>WU]_V19T^Q^X3A
M)P U$)=Z."?Y_5@I[@$A,/H!,<^Y$BR#IXR,K"BRE^EB;RR-IWF\!4SR^OWC
MH2S$Y(/"EESCLO1/[Y!<D4,=?YB]98>]RU?&MW0'%Z-YFGU6<,?!1>,>,R_;
MG=E%_B&7_:4+@HHC-']T'P[W/]JCVZ-[2GEW8.P3[H \?*!XS^7W](9=@7%-
MJ8_-2I." XBCGH$(9.);KKF7R=Q@3UGBMSG_ ^X-UZ[O4=QC4 QY4>2%>ISV
MV-.]L$262(G8U[Q[RP$%H[/#O87)!8H^QBH]PD!7J)#E:B&*-)2I2HY;[WL"
MO/N/7)U7\ZGV]8J$BU\?AP3&+/R6/3Q &D@.N%]YIDC'L&2W7RKZ)=0%C#BE
MBD'B7!=7K"^/FU.H1^ ZIUF)]44E;TUCNK?-5%A2_1LMJ"[W%$O4=AW"[(?$
M68XL\Y OB>K)V/;!ZV[76]R6L,?YWH<,IC _YT8RHQ;(",1MH^S6NYAM;E%K
MAS#-&Z1*\/6C(MOO,,%F&V6W^AP;K2VO4C>@/4W473/9J.EM+L7XGH7Q\=57
MPPEF2F(AYNJJT[?8E-5*,&(%2R$VJ#F/(7?$0_\(>5;>>#)&177=-*_E@TI0
MZDI\.Z3(0G6$92@ [5@6QKV2/<>'WSTE)ESR6%ZE0ILD2^4\T'/+<C]Q>TJ&
MBKVR*7DJO5AU99JU%R#2"$M:'RQLFE=%TR[_UIO;EHW0ZLOE! \2IS7\"T78
M/3[4PL)>R/=;#VZHE&/\CHSN&&'&<78)X_<LEOJ<N$VX9:!) M!NS&Y I&UL
M@P03$^XGQ26T4>4"7*+!-^I<@;XMHZF3%[A!&2X96;S<>G%=[>1?XP*5JZ=.
M2>\[^U_3'^O##$!]VZ/?P^\7P![2>1>^^3ON5G8+.N,(80(IB.+SW9<B.+@W
MKIEJ[L6X')?SC[ UK2E*%=F>'JF%MFE,F2X8V/(0O9)9K)D7UHG1B#3=QJQQ
MR/Y<')X_5/V(%LG%)I #3(QTWL_2#(V9/T,-R<,E)ULN7K@0,IS!3Q#6%^$6
M8-I]%H NP\=V8BS(''NM+JM6,9;'/0&()B_D$CU+22WNA;DKQ+'S0 I?OB+C
MV\F>1<\PN7[*&.GN]><K[?#&]SJVZ%_35ZD25U4OR30]B$]A01JXN%DLTXT
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M1',KC-=*A=,\L2<.XMM%/(D'6S^ 0/YX)L.-/Z,XDHQ6Q[RK*&Z@YUU/#/Q
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M>?Z[?]S7Z][/_=QSWN_W.9]SCAXIF7-"CV"MO#ORD96$%-]W.]SV&W_#MB%
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MRLK*&LZ/+1E.+GWIN7BD')J*,-3@$KT /287/_N4&Q3"[I603Q:<U9;<[S\
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MZJ5G^92F&HI]?,NG?_*ZY&IT'"L6>9^8>[F1_.H %!V&\\&^AM4%]KRY H(
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M7Q!<;:%5;%MW>LF^RR+T9\6(Y3J"]RDJD:W@K9L<OQ21"[S(1_C$MT/Q2GC
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M_65G3A<M^D*%"/D]GG"&)8KU2._W(QZH48:]P_)*'.N:/IG=/ZV[MZ6N7!>
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M/L?'OJ#O]=;P'P?/D>K5@,,WIQ,L0E4T;4:M&[YZ 7+C>\SEH.._!AFN98[
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MLI7^=K6 .9U4#*0.J9=5;'RK[3,RN9%L4?](AGK;;LKR5D0B[SSJ(#J)*R!
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M#]NK:I]EP,^U[2D7Z!VWT/A=$%3N[O,>T:[:I]#?3WJ-LOCF]'F#>9(*=6Y
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M!R5UONT#<_BP!X+*:U[67!:[O@^1LWZ,>PDR?UG.S;T@1*%%+F"N')85=OU
M[DKRP!<>,*HY%]^G,DZX#Q!W7+ #J'T^7%4[S$W6#ZYL*Z#"-+S*R>4J3EZF
MX<2\K'[O@OAT9R07G7F&6TS=FF'). XQS)^>!'Z0@6,KVA\9Q5P6>W0Y!/9.
MOFRLI3I<ISU%]ESCS;^6)L<$3;ROW&VT\<X#785ESH+[*R9FN/RQ_\J%L:>
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MA"04(29[R+X-QDP2LA<A&3-)$F+*7F&L8XNQRQ*SD&R9L=Z8&:^>YWW>=_Z
M>Z[[<W^_YSKG<UW?<^35+R0^"WQ,CJ^%M]6Z:2"OQVIIJA3%D=SK(N(S[\R/
M-CN5:YLW4JT4!8N+D7JC0@O72L\<V@.]4QG+V:0 UJ4<,H8[V'<<3"<WUXO1
M??(H];!%&CHCN&A>Y_BF[(7,B"]A7K#DAT2G09>$PU5'QG]><([[F7VROITC
MI;YI?#1JUX!UYC1#!'7/*\WL\Y56YO=9B2[F)&1?^%+W=8PB/SRY0>V%-'8/
MY(.\_H,L_NL<PS/SW@,0]&TC^$D>A'6L9-/9P9HT+;&606)'-#]6DWX1Q@AP
M$2H\5-LKM0(*7'U]@3ZO_JR9>C$#*=:2Y'I+60P25Y)02KH_-MIZ.X/W4H'#
M)^>X] S/-<N,FVT-QND>G?D \3ER=-X<QQ0(SG5$R3),SN1CYR0^>)O(==5N
MP0HR7=:9VYGJ$M(E"BW=9WTR;3(M"/Q$E1BCL@=GCSQ-3T[M(QS@]$T?;#BW
M2*#BXQ"B+ @=<^R&:V 1+)ZZ[*UQ]&K0[E7![]\OGCJHM,SZ,^*A%B)AZ==R
M4+_ #IY5\]B%7AVX@.$%=#=]]@$UDB7+SN*<M$<9,2#Q#:<\O_5,17U$ABWI
MF7W\(_;&=FS!EZM'I_T#,N)6G=VK1^"T&]3XT-HT;=@=(O)CXS([@@Z/U178
M_DU\2&&9B=-6[]FEE&/Q9\D.BL*'GW:L\7[-!"\<PZ(+[&D*S:*M5H6]BX,)
MGD))]Z:2V.I/F75>J1UYS^DL_(E.K=C[=4Z9?+%KMF,DZPT1*T4N6YQ:O8)0
ML,* 1?#Y7:UO@19)94-VD/\]47/2GL2,M\]F<#*XA+A/ADIC0?XO4\RN#^[L
M\&?GS6B*S_C_N=D)S=;8\ )\1S<,1_= W37LR/>W#NASBVO-R>/T8?FLA ,=
MX"&WE @A769*+2E<=M)\H$*=7\COH@#/W,^HB:).<2CGW4=NW,G5N9[4].:9
M<OYCN*M=*=S:O=R4@< A(<C']3W0"7/96\R UFRG0S/,[&.89T6='1.5L;VJ
MM4E'")&:\X,.N6=\':Q]R&YT(B+=@X6U3(O$6F:Y_'K)^@_PW9S<)[TDQ$0A
ME<E.:#B"[G/FR)[<?>C5THX7K%1R-F?R'RUF_6<HJ6CFZJ%WL,5,=&'3Z_<1
MZ*.L'U*M^_SO+0$X8[9<5,H9PO$ N?E *@7?0ARC7P%,B@#$;49J#$M"N>C#
MO-@QH-E,:&&\*:7=;E?/JBU84?/K>:<\AX7-3;O4-_\I OZ,P49XQ6@\YQQG
M<E]5"/\SNHN;KBB,I^_71RIZ3!4:-W6Z7^]Z1+'IAQ:FJ+!'662^T<B2=ZO.
M%X^Z9Y<G:(*?0[)CAW?IU!J64$L+IA(<O0R38UU@5^NI,E6:Q++&,[.<::;R
MC3I_BSX8??2P?"^9@15V +JF')6P;<Y8[I"X/W.'K)G+M^;:EO+;'N^!1%HF
M_TU@6_.3+YFW4(#HZ/(Z,C2C>XPDXJ^6(I#I"W5-P+INH'S.?BK0N>1NWFF6
MB9\"LFE6D2U3 GH5,437$,AY\I?*6HQB=T-6:JHZ*K;FN8:'DW,J(7>@^3=+
M.Y:Z,$A+.BM9;6/'QS\A=HYMC,1*:U/-6W94.(.# 7":5T%2Z@ZWC;10F/9:
M4^\1"*QNU>-VP8<YSK4=F_ET=KYK.^?6YB(B"LSAQI2FI^^:/,K+*8.)+V1/
M[M/O(LI&$_D63JL SKB^[(_< \5F#821P"Q%I9O!\C)Z?E+IDX(Z @"A#T.3
M0TZ[=E/X"X+V11JB_&9I9C4RU*M$5ZD,(XEI-=NY&K1SN3(S,:<-)EF?.5HE
M5EJSV!,ZQ ;L+8WO7/>2O/WWJTY&RLW&P]DH%B5"VO_GLDCXU",?$;<:G-3S
MYPKE$]TRK?\5M1Q&VO=]?APWWLY_L5%6<9N5RN&.*GN6 5Z6ST\_VU3'4AO6
M/'DH<P(OC?61L+#SF^%W(]K#75+'.'.;3@#T+0KZG6E:F/3WDKU7Z[<*Y%/R
MS:QK";/!;%O[:UKPB@]#&N>M[.[G.J8%AC13WOI+N] :OC\%:EJQ:YHX2"+J
MXA[(,J JBF#OAE\TX-+$V!5:8?U^BCQKOO;J/3-HUJJ$X(DM@8@;GQ\C?*4X
MJ#%-G@<:U\(N,Y(9LI;21TY524^S [N044ZJ0R46R=)\C92B:WXY^18%KHF6
M:?X./6V7QG=<G+EDX,U9?0(SD!]T_?K B<6;]?!_QY"RDP\M OPGQ.&=4:SO
M(?(_K1=\0] ?;STI,VKJZ&C4IM<4]2)EOVX4XC#D0OC@!BO_UM^9M(MAL*\/
M,(A5A6MJ%\/]\6N<P(&4PO^=+,I:L!F$L&Y]JNC4S&S(_>^/#CWI(=8?&]1Y
M"',4_QG,$C6A;RT1=Z&L"X 4A3S6W22KQR"W]%C2E3[DT'HL]D"D+XB%:"M@
MF6G2:LGWL?*ETCO]TJDBI;>"0L5?#'][3SH0O^KOUW/Y@N&$-[=,W I=2PXL
MSA65]+)##C3**-@]C+K$S@Y>&9.C^E31R<"YN!;?IS E_!V@(Q@3:SL21<OI
ML6XY*M9NEJ!XW#I]_MMRQOMRQ-@GG7>5%UO?*;[FK)U_291BEFC0'Q>>Z/ZB
M=U3!_,>"&S,_87.[VOJ5RM)<=.MN^.>2-[VYO!6%]HZ3%YEI199319"0H\1!
MEA*-18X._-2BWH6.>TWX4!J^C6)4,$8/M]89-0\C,1!+"8-/M23DE$3WFK3I
MC9@@47/C6.4DOWL.3B5=E0I42@&[E*7,9,%T &<&O5VR<EPTO1@Y2-T#1:/L
MBCRLQE^=.JINSI2/JUQV6VW^Y7MFU[;)W3^<\9_/TTEQ^M6+:R*OMZ*M!L"L
MMO5@LFYL@9. %@F.TM<&K;UL6F9M/L(S;MB11?[LF"54FHT36G:J$VG>ZK='
M*Y,=R%0<X4Q9:8&7:,A.;&Y1T^D&32-9W5W=US[.'G=N6IC7G>^]M$\&2)P3
MO8;+FN^%(-J ?1&="X;3@6WKMZ$:Q%H1TL.2O.C#;,?BNW=+#%-7Y:5O94@:
MWQN,D6A6/';N&_.9VY#(O4/L0:!"C7F]?=O-)JDH4JS8]6[AZ]]"A1GPXUH^
M*A<*]4(NW^FV+7I68 4?8_@U<G9>>2$.L8N#90SVD5RX9%ZI?9/THB7)W7)P
M9T/B2(#_3P9&X&90>-D+:"["@ L'KUP"S<AJO=Z0%NZ8>8KLX& @+$%Z*YCC
MXV4(AJ^;;.B%+.^!>$@1X7UP2BSNA',JX-$C-QK*4EBVC.X\(4Q_X0>+*P,[
MVELPH>V'Q7Q!!8,(X+G$F2HOS&8P $]?;-L#'8//'TFOZ2_WY:QF\>^!_@W-
M0 @OV8=RW0UZ,=65_J.IRW9<BRE9X$('I$RJ5M%)XI=O@3*E[.2A[[>294HW
MJEJCQ+C0/UW"#AYM]'$=_]3H?D%Q>PW*N X1C'JY:^HA^Q7.%VR>Y'R4G *Y
MQ22/:FRJ+-W8 QWZ-8QQ@29*CK9V3R?I(%K%@S&'%AJ$=/0)3WU1NOIU.[B"
M=]-E[X+Y4H46^4XUOS&YTI=X_\UU/_&.@S)3^']9#=F9H9F4P&DP%#*K]>G6
M(_I: 2G;0'^V-E0R!4DLZBO@!>),2:I)Y];,MNI&RMTK6F GD/UOF$<L,YG@
MJ'M:[J=)3G03=?(L35[ +?5<<\"]P/;K%_*N:7T**NH]7E1\/ZS9PRDLQU,)
M6EP<1D+7QSDV+D"NDL'8 P-X\Z3DVD89^"D#B..H^,:ZQAET7V7:-+J&2">4
MDJ<V!A9ZN^;+K/!WAV?=JCTTW8-#O1+^SQ.$D3I><?1_XI:VV%B.3A(6TZ_(
M?-2KVAMP&R(!3N)R^$M$N??1%_= "T<Y_T*<[/" *W[<CW^&TXN7,5 ?@L0X
M*-'E?O,;7#3@%M<^_7!A?*'2AVQG8W]YI:Q3L\)GY*92I#8[ESW]*,T'KT%?
M%O(^2^WI30^ITUCC.!,I&7"&]1XH972*]Y\?,:?3&E,Q'56*AIHP5C:= 4GT
MZ3V0![)QP8CJ9788L&SVH(69Y^Q**MU8W_5',7],CRT&D$ZX/#D)'_DZ<LFQ
M%O/XT=RAV%_%][DR.@[1*+@KTE^TM4_,/,&DX %YS:5[C(K-7'8NW(W(@])C
MU]=)1#!EZ9MV )Q&$&&='&3)T+S-;!C_J;+@C&>V?U.+= &"67EVG7:1I]6.
MZ=IUWK8SO;S7OM1:[D#W0 (71B>B]^M)?)^ Q=@7\S-9"*:=9A]V-<!KV_D$
M/57FLT;@G^X65]+K\^YAS]1^-$O[MOP,#[IX5U5K_.[%WN-6)YOS\S:,AXON
M?5RD%IM2%YK5$I-0ON_%DG#GW23V0'RS++E=^"RE<!/"^Y AD<N+N] YS.0-
M]E3(#GT>["=M]ZP@I>LSRR33O#"U^:&?7UA 7K;Q?>.,HH$8F_T/RW6__TOO
MEWU*#V6J?V8!.2\$#" .:F!C,9O^JQ;!R5))6!D[LWN]NA"]P,$OY$(-UNX>
MJ"6Q:DF:,_A&:P/** F&16)^(^<(: ]#EN#W5KT#NZ9_ -!+?,RWUXLK^TW>
M!(91-G=2"]"G@/$]T.\639_4U%7-N<)='1;'G8)G"G->I/KF/Z9M[8'2"UM$
MT;:.N:,;0YRGL57O@B1'$INDB#3_#XSPM9R738UZ:^0:,=H;";J-]^]8FIB$
MD?>L49[KY!753JEOGWOO+I\^8D%$7822=?<%+!_JOZYC1(]<'OKXV!I,;"&?
M/\SZ ,JKLGPF*KV)2TX"O)FXSQC4@W?U4;Q ),-GJ]5JZL(WAGY*J;O*\\?K
MG4%>D3<78">&-0I>!HT15&9J'J5;V(7QV7?/Z2E=Y"Z_X+6).M;F<,K]*TZ>
MKVU*$E,4%GQ!N#3V!V;D 5%[IU=-XU$;152,3[SKE>NUDM9=Y+QV/]8M?=9P
MR@\B!N2T2GQ0 9,XQS$?M8.E#[8Z5L WVL_3-)+;O_7%#7&*GA08(\,B'2P^
M?3G?)>)\V^]C'LQN]]=Q<\1'Z*>CVF"Y/&U?"[_C!S;HJUL?W4^ C+@4&F75
M^]8ZN;C@V7-?BFX'&#KCK@L:&( ??Z2LJ@7V'KY^\F2 B<LJ:-M.7NXI-Y=N
MN _%&9_SJ(GSB3\G?2BPN6B"-.D"S:J5=JZ=<4[BG0GFS_#YJO+T*BBZDHO#
M()\(?V(P:._=._BU_(APH=/!&4V)3MZ;)(/P&6G)F94HU2\2SL2G%\.<G\"<
MKIQ($L9G/=%RLLHC]J!K5I=W3OQ+?[+L/"$0DA1P>?8UP><(:.;%%;#/C;"V
M_M:>E^DQ?W;#SSD\"Z;#4W02UI/OIV*%4Y(*L2"3-+.W/#^]Y:*>>/4J?ZZX
M^+B(KD6"U'8X=Y(M.SOS7V[91VRY81<K]!5>\9>GA,_0^\-8%:F]:<^T'OK_
MA.S^:4_MT*2G#(_[9YY[EP!2:,OY+RNS5/N@2#;_LR+'&C\R2+B#K/50YT7X
MO7#5VBBL"\YPMW!['98O5R]+C*7DYNYZ8B[)2C%\62(MF_< )8K*.)@&;TTV
M;)/['S$:QGK(#(WGR'A9O? <\$0<TY/9M>:0B4($-(AE._*W01GEDDZ'MZ4F
MX2NF8V!*R.N-4*@>E(+A78 +"/U5.MLY>F>X8%!%W[UY6FP/1/DB.=U.X&)I
M#K@T,,6>KT.?X;]8MTTGAE_^RABDR._O;F[[O?X W3>('D2?!:89N[30%!4J
M8Y^GM0^A)?XT' ?<&;O4G\")-W\+X,_K5(J]X,=Z\9!X)WNSG:.&:4>,'$,3
M[E]QR=26/2_R2E!&5K]<#O(J#7J:WX4:\O5]1K]3F'W^M:676=XOZVJGF'FG
MY8S*X9?*^'&V1YP.+J7<'LB:9J-V,W\7>#6K1*Z,3-AP?'9#X!",VSXI.IS!
M]$*!*X$-VB^S1L%?J.M,6 5S8&&-BEFJ<2Z:EU2.8O 9C%22XUIL&'_S:&Q%
M6\"53AA7()LS1M+IT". F"F03B4<7!C'Y<!*2NNK$^F+&('T1CSC/D+8 24/
M;!QN)Q&.HONA_!A7:'*X6<HEJ/@?Q!<]A #+BSG1N@<2@SOC!>U1$(9*G-Y)
MFKZS01T;OY&LV *5*&N08=UAVOZ9EKZP#N'O<2Q!;MW\-GKA[;[*SI>&F*TM
M;FPMWKS2SK6ZO,^>M20N;6/J57+V0%%L):[<H 3[78XAI2:)=6;_)1\"+:4
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M3\FN/6"W>8&QTK:L2?M=RE2A3>(%@Z?!"Y(BF]DZ4\E"^GRW1DI]2Y7-$JN
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M_N;,<L'V2S@N,H4.N"S"H/7STW-":R@&G!<X37\%?%M<RX:_:XHDR7PC=)0
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MOFI*$YG48F$1QE9]<^.++V*N.IJR;E7ZG)A>38AA";(IMF"DLHMN\DV11T:
M^H(?:8+NT5P?X'AV(0GUIWLYVAP0"U"IT^C BR"*:U^8'>?[J@JZ&%CV72H1
M=<&]^B_0.&8F]_W&JS*<^PTG\:&0/E6F2>DWTV>"\].+,"%QI$[$BKN&=KDM
MU/)R _AM\.4',&FBQGVN^]SJ 6G]TRGFRA[Y@:>37)?!ZK1+@]UG>\N^LGIJ
MO"W<7WGEV9ZH:J3/_S-V[_KV=YO[JC++*GJ=G1IK?YS*JJNF/GU\<8TC*Z#7
M_>B@1U"]]5S/F.+ZC]\Y]X_>58E:&K45[;/G'I5('7XM2BQ^."5SD\.WF"E7
MOYT27]+9'?61<UD .]*^#0N<@D,6?A^H1-;P4\JD0#F 5$L2Z.S""FW5@^T6
M,M*+:9GH$!$=VLA*09\18GDA')^-"GJ?<LTBK)VY'=B>*<+"2>N&Y2@6R.#^
M/8>+R4F(]3KV4;D6)V3Q3'QR3P.#]:J9U/;'+">:.@MIAGX- ],WVL.N1/1$
M95ZE7LSEJX8+] Y2S!0/*K"$#($F/5GU08.;ZJ(V,?"=;%O55S0@05]5KC=;
MNZ?'W]#=<%[/N_'E9\]/!QQ2!SM+#ID7G@IJ+W4,#+\UF#VK9.G^S<T:RFFL
M)FIYC7UV+[W*:RZOOT\5%- !G*[Q?U0B?;CLG^FW]^F\;$%$QX\[",=;8+U[
MZ*K"S+.9JY[?O?=0M6A?L,#QBMTRBI(CR+_+"J#??>DL_B'F&NU]VTT)[G E
M7Z<;J.(K&0,'E:]E%P*0*G6]F@=WAXH+_!=A58>?C/T-Q!H3XF>ED%$DBF-U
M2I5X?U3T9[<;%%0&N?>)S1(8Y /071$+[A?Q#T8;]+B+FFOV&3K4_!%%D(5X
MJT3]@F05.0@*ENT)7+"=+BXB4Z#F)U/,K9 _$(%/8*VJ0(>+D9HDXI'!N1D"
MIX&2YB_,?61%=@@L@ (Y'A^G(IXW4!Z5I&F>2SA2SVKHE:R/)X;R@BNGNEA"
M19B?P^-30[P0_V*+R(EFNE.!0[>0T$&,89FB;8/%J+M\0XJ1_"H05O0Z6#C%
M,B1O <?CE!M(5X<X>VYY4@HCGYZ?&M,=L(G:;G6ISW5@-E>6M\?K>7-TY^F^
MBN=U9Z\+;LV^X$J>V4UL(U2L8)>\W8M>=7GMC<^8:[J_'64891\=<):,3+7A
MJX=2F$N5O52-4.IR$D.:KB+J>K#(U-)[8,Y[#RJ5;SP[8R*LB$.R49K^S+7)
M,B^ D;8!LMJ<(<B%Q^7@DIM0)0$^NN #'J;X9NC,=2]B+S^!B06<VHG+H=TB
M:MLBS. [!@M1Q5UP%Q!_5^XO]#YHZL%F;@&DC)7G)W(Z[KTX:+8O=]^;Y,K[
M)=OT+%M#5MON=%UU7<MV83.]J#RLRL?KWCO"2SK*XWU?G\?SL,J?]S.<?U9/
M#P$FH(G@-%4'ZR<9+>#@*@)S?+MD9.5@A%UM'WFCHG[)$<SZO>?,@*D(S]NT
M;ZMW;MIZ:L?+M>O_8CU#QM"!,\,8?;D9Y W44*\2UTQQA<5WFN# #X<@<J0V
M3?N-<C6@B(\.\ZMF0!X\^C#BE'&@3QJ:/U;S;UZ0<I3D*_LGSW9:IJ*M%ZHD
M=R2'#U+]\4FZSH"3]#M(36,%H%*1>IAUI"DV7M?&](#2*)"E/S<$7L8OGUM#
M62T_W=!;0&NCA U)?0I+V;ZE4Z_.NX;;5 <:C3:"Q4H-%6 MW0XY(./EYF"@
MD#C= R#:D6L(_4T(()^8B#61XX6F(9S\;8WIHT?K_O1W<@8)[9UPR'DNRL)]
M</: 0=ZS3MV!,"O#-M&1ZV%>?W]1WN) )T7N^BE[<Y,@KW8T0KM/M,T[@+;$
M(_;&H]*G\7E^0P6Q>>2K6R+/]E2\/"/]M_AHV!G'Y4+CDV?VRL^"FA-W1<5:
M #W!CM;KLKU-I7]EDWW 4#1!,*3N4=+V<&M]T+;:O?Z@H<&%W4U@;]O6>P5X
M.T9BB?85\.9[MW]5 .@7E(0%D_+WK-7/@K(2:)<PB,>/=8=A1\0UE)?*_Q9A
M""+6'QY-T8:ZB0)O?&LPJ0&O?SC?J*DIVZ>^+R%>[E$&G:UN>!Z!2<_>_'O6
M@[G?>A@=^^:LYK&+O[[(HQ2Y5,&_+."PAC4*(I#DNX&-TA)((;.#0MC*58HG
MZ$/J[3@];/MA,.Q.MA,+=&K'PD@HT0P$;*YC!'I2"I87%#;M')G@S11*T\TL
MIUQ2+%4K4%TLU^4J-6Q*H*-<:00P1V?31M3$X1UO;4QHT6/FO9BMI/_D1QMK
MH8LOOJO@3/GW9[D=%"E&I7J&%:?,;&N"%P748NP;JNO\R#N%$AWOJ:%Y79OJ
M@[@FP=A:$&7Q7^DEB,VYAD!<"6GI+SAD];1M>.W]T.",TH3,;;[MPJU'"QV/
MIEKV2+7^=AUTB^A+QNX57#< 739]V+FFP@YTT^0:G3F_S',-F:'9<HZPZC3[
MFS[C8"$ZDGL!?)B3^?1X[$YK']WV@_BS:3[7 XZBYID.MJ?4\NQE&6.]8O2R
M+\KI_& NBW%"6!1@6:UE+UNY<Q%FEK&PA(<F#*V-B/ 06[3AH,TTN2Y.&@VT
MCZ<KU>0;(".0WNJ>HU+^>"+: RB5WH4*Q1+M88AV//K]CWGV?$YW''/GI+OA
M0G--5F'Q)-QWV^OS>_)>^"^D[FA.FWO>*Y>!=*5&KBJX3[V![A9.@)!80&Q)
M682-H-KWL!"+L !<PCWE1S/S+&\O8=AX')%LYR_ IM&!^_)KM<V0KS"WB\H=
M4P.O>18DVCRJ^5MN6ER8P2,]&YKA%_H457R< 3$LR[ ?E 8QG-!Y>S2;<J:K
M66DRIG2:Q2KH+^;[&"Q 3_QS$>8!4:JIA(!#RHM#' $2FJ67G,PG,SGTXJ/R
M)  GUR,J-31!R]8Q,Y5E')=&0.?$DH0QJ]Z"(?).,6.Y/!!J%V'523&.]PI3
M Q:PB;.,E#I/1V4^;=6$PT#-IW]'NY;U[ZIT(>ZRX&3C7X7+=3R)R!%EWVMY
ML.+A-A8!#B==ETG)H#K[D S'A\<B5/7>L<R?B?G3;]D&GMA'#DMQJX)B? 56
M^T[US?)7;JORC\B.)J+(Y_O2]N%DWB6WI0ECB[#_QD\4C>*;W#T@-TE#[]#1
M!7KO,_^%>&?[**!E';P2]W83M0]+_-6^QV_[.LWQT6Z-:P_T'3=Y274;K\]Y
M<RX3KM_Z&NY[HUM<EXH59/&!P[0$#^:2/LPZLAYD)0C"B>I2K+O_(EOUD;W
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M-#^V&C2(R_N0%@E:3+-58=H(]0&^4AJT!?05(=(Q,%*Q*^3,\*/KS^&2E-J
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M2Y?;/B>]7(2=[%,.*]*P5XD(95<#M:.<*/+@8-7EQR"Z;#_9ZZ-R&TGB!H4
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M'B3_;7-J8I4\!",\/IOZ:U:6F<O_=K4_GYZ?(]\*"[I1W#.X%'E,,!O2BE(
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M#+.D !)MH@-E/7*!^KMIIDA; =BG"^6;F4G4,4J6,DS62#C>!38E;WCX+RL
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M:M(>6/GZ[W_?_H/_E&H25YK4.>FD>WB__SG+TX&ZA+V$S\IZ[(ED1?&#.A3
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M=1&2@F[!7YK90&;(7J<$3LD0R66+,&I>T>IJEN^C^^4[S.2=FU?1W^AB:#;
M8?^W^B"5<G3)Z11^6SJ)L..#5V_;XF260;)(-O1>#G3BF6J31B9"YQ11F SL
MA(EH'[\B,P+EU?(4"3>OQ ]O4[^X_YKK?!E.2WJ^T+71514.FU%HWD \+6#E
M_[&KJ?ZJCZLN9P/O("'%-&4#L0&0HN[_U<8&8-__/=C:R49!I1Z#7&W9DFG"
MAE';'\ @5!ST'TK587PA?E!="6Y&P8[K-,NS#O5'BXKVR\+%9J@A@+3Z0B3S
M]/50^!>KB'G44:/=]/2"@GMA*]BKZ"FLKN7J4+\!_C].GD5!=QJ$[H1?0[UX
MP@:NEX^/[BO(]8U<*[&2,9.!:D<P]<M*HDC !RN*]^ I6VT.DQ;?],^%R3]X
MM^I<)G!P4]'K'/^I/(+I?XT8=N?X)"5/Z8CU:9<OH)R!N^-%P"V/L>?:B/75
MXYY"-C^"NK>W=%96!E-).15F8UT3[W<[SFXNOG/QG94G-YT?QTV==IG^*!2"
MONU;/&7.#/J+5_]/THUB0-1143%Y**QJ.=+<V-M0-/4D [LM02CJZP2PXM-,
M  &T1(H*Z,>!_;5Z!X$N^5SBD-P(Y.<\3S80B#M/@%R [U_&LX2/LX$Z9@P;
M.$ YR@8(GV-8<(AV?-UE],]ZL41%MAKZ+%L6SJY!J&_+\=/%?$G8)5U_\$T;
MUTRL(L$0L-NR&UW)2%%:=Y=\IRE @7%==R_S0[T]^80YP@::C$#K%?3?Y"]6
M_X+K8?<5B:DE]@LTS:[,(V@"IQ$[].=XTJX^ZJ\SZ\X=YB.B%^9FR!W00$G6
MT]4(HM!SY&QO((&$;[U;R/M4X/?/F2#M\@#F2Q0I%ZDU@E/\.<$:FN+R#D)$
MJ<WK+IGYOL<0VVKLBJ?UKO$+D$\R$!2QS>CT*U.=)5?&.^4>Y,#43K-6ETQ1
MG\IK$8N6-YA_()^-9C0[!1])(E%DR@1TDWX@']6T4'/1CSJN= P6)03YC>@7
M:%HWR//6]IPT5<KQR?*M6.YK@.V9V7F@SI_TVEYRZ8;7I4;MO@8I+>U+^6[?
M1 <31][W,!^,U;0AJ,NK/YQ8B5.M1%";1EAB \*JFAV>:*I)\@^1*V 1%451
M #G?.H)S6QA:^'9RDXCK3PRQJ_J!KE9"N?>R]Z%V\:1,D2<=A;$JE5].N(7+
MC5US:E0971E?<^+-?ER=.K6!A0C+V)NF=_1S;^(4.,_:L8&G06/T>#:0=[#2
MZW\<WMUSII-,6'5; R)V<O6_;)63Z!3G!()XD_K[4[9L(*J%9N9S[@NL*_>H
M?B>&DF1*2SI7OKK'_*>$O>P!O&2"^Z-S.R%';H7:3R?'$4DO\!]JGC383I<?
M6IR2QAUU\F0=IVG%-AB]GQAGG >]I$JKB\J]M.JJ7_OZ\G>U[<S%34KT=K]^
M)/8VPR'O8I+)K2"5*<O6%U&2W/(22I7^MK:F&J0,"7[[ Y1>.VOGQ1PG*X\J
M$>HDK2X8R9NT=N)!R.-FZ^:K;:T8K*UGE;3,(3X-9_GSITQ/9Z1EGA[5LNC9
M)?3#6Z-_TRZ0/6Z:P>,0_$DA.T8,N5V%/ICD#6/)6Q%#:>A!RY67K^?MT97N
M\;XL)%:3680\CCV;N?4 #!-9CH$O#Y%7$T/_EK["#8J[)S6I3V*OIQG18"W@
M]'?D0:S;Z$9Q_\].!)0A!W%:7CA!ZO&,Q'RO5 ]IE>\;_"(43I-NT(W%$T[G
M7W"5I_:5OF$\ )/#2Q:DCU.W2O-^:"6S)"PRQYO22JYYBKND34R W&)_K6=W
MQWE#CD0[%&;I7/8W%TKX)+_<OS495Q<UFH8L+^@HN;;@[Y59Y^1YYLF[\;N9
M(EIV Y[;=J[W?U\H, MR"_<^G*<A.-Y[LF#XV)VL<;_TCFM1DFV"D>GBF"Q<
M9Y2QR4V_S5-K/K8A0X^*17NLS'[?-^TQ;26=B$&DW @0QRS<*#AA(9=HZ@N/
MC3YJ]O-[SFV=6@\Q$U.> *2[Z-*M%,;D3XS,5E/RM 8*+DOM7U$APE=0I/=G
MB-5KF$\TG*SS3]5'>@:0IH#7,W-]B>[#6<J*D,+RCHF8<F46_ZTL]FHA-9XE
MKWM,*AL?:LZJ3@M"0 6]1:Z)D^$'PJ>)D9$4D9B@<IXVVB$6SSHUIMVNL*6)
M"_Q.)O!C:J:=,Z;@JLB3'FR@ZC'^$$Z.819SCEF,%%X,\+!K.MA A[7%$V-S
M)<%$&FZ.+F_72+U4^HJAQVP9PLEAU48:#+W)_/+3\A%5EH==%\Z,;Q*B*MF
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M-MA JM0[_/H?9NCF9OG7-'HHZ^=/-I"6!F;!1-F ^:!N<&<@+KP._Q#OBYY
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MPQ!W(Z3B!^3N$/]*0W0GDS N]\K_1JCQ$5ZS5),NQ&?\!9MF@[AC^V1ZD]G
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M)61,1*@M--7.ABTOMUP==7QL6? BERX!G1YKF*A\HGCL(]LJ>6[\UJ4\'ZO
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MXI6+#@D^7</BDSX_Z?UGGS@/?QL-V_[8A% V<MV@)=V[OBF8C'((%E_':$E
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M/!JQ.%%]G+TIC7E1WH57O/B1.#.I=XT]TQW3\I"F3: 'B8?R2OY\?#"HQ.B
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M,C(IJN]VLP4C$"TIRD$C<&8N#3"Y8=I5->0[M6.DK5#/L)X!="^\S=N&[+;
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MAZ2+>#([I5K$"+7UYT]Y"#>WMFCNY$K2:))\3H&3.W@OY*N?($<2Q73IF#M
M!HI"WDA9_ G]S,V0T-2DTZ:KA2?FB*PCX!F:.8:7YA7VV[;;ZKX=YS9NN=YP
M!MHI1CS%-[L1=&:'<D%I.(*B&Z,%I!VOR.5]CH_+PC&>4J"R"W,=<DX7[XU9
M6LL+$",^-]Z,B@F=&,\E,E\Q$(^1_,/@1<V,7,-X*:Q7LQ5R8+&38$/Z&BAX
M:$U8#3JIB1$ESDM6\LL_HC.B,QV0%7TSNXF_[N#/S0ZW#>?Y64R*Q(AV*_I?
M.!%9:"P0TDF<JUZY#U RO+_Z'F,\WOZZ>69VDO".!.RFM&R%T?9W/RM0$6<$
MBTMORQ"Z]O+S$&!W;8L.#=S"4%LK=_H98$+\C;921Y)K].8PD+J?X*$8\4R9
MCR&M/ AI(NJ ;V<<Q8A$=U%1/?*V&*&4S+R,NS0MF5%\']%'M> \^?2_O$(6
MT?EF8L07U4G,(B4#\]OC?-2/!]>@*3'"G?QZ"<L[+W?[K(?G82ME?LQ)G@-"
MYQ@O3'E?1_=Z*=HKM-<8Z6.QI$2LJ=&_J)-$[.29=2G62F)&"!NVS"#\()O7
M:1QS=&/*W^B%"!Y(=\")]@+AK$O>\%W^]O,""5V>N>3]ZU*Z9Y!P</_1)0.G
M8%.[K8U9@96_)7K_B&QU?49)L*%3.?;<G$LA<U6&*Y+L<O-HWTJJ7Y8SM@@6
MX]RI>_^!?*]3+&3(K8-+@)2CD0NDV%0XMS3U:=??@97X55MBF=@TK0/ER<Q>
MC#SG*3:3S.M!5E%#8K%*:Z.1TN/<#(LMF9]EE[O6H/[6/GT&TZ9S6TRC7G0+
M:#O;*K)FP"FO1/S<#$>NHU:,>/$93CV+B>P!:H&]FV$KMJ__*J$.CEUQBPX<
M.TR7Q&)_HQ9((CE-&L4L%Y.!W=1_@VK6.;_0CU<A+D51NEN%>Z OWZ7@FG0P
M"KG!FSM_YKB%8!:P(O1@J]YJPGYZ?FO22C\\WZ8AC#0UTP8CA[2BVD,78A3%
MB _#OTP[\=<7;@6=$R.F80NHM1^X4\HP8I3-F-N_/_C^"J?'7FGZU/BY5$NQ
ME;91]UHL7!?N+.+.C#U<ZQD[<+[S7Z^L[O'YFVX5CKA^*]5NE.3/$&U>V+WK
MMZSK)98UQ8@*[@Q*S2\+]L3V=(DK8:SH%]*OUE_9HG =T4?8Y[BWA_2W8%P@
M :>12CB=+%9T8;>Y^>9WGI(9A9G=O?ZPP:EB1'>S/30Q\AC.IV L'0N@5H9I
MR 5]<K15-I4<:#T<3EB$^K U2>W849O.J.$[>-4GN"G; 1-#V=KD8"[?.?_)
MJ.O[R_7Y&8]^>O0\QY'<'_VYL\0WLM-GWSU:\>9A_2NS$9TGM"+":@(-4T&F
MO4=OPSV<\MXA>D;T38W@G4M53<.O9\TF#-4G):-BPD[HM U7@)< %[[/D4"3
MHT'NF.E\U(DAF:$G^U]<RXZVH-IB6%F$/>3E;N(,I8 C-!.@.!BGD3YEP:,=
M*/74EK,4THN)2[X'WN:;G3CGZ:->)/7>Y#E%9;&Z*+!,?@6SD1,F0SAKHYA[
M)GQO5NG=M DK*UZO4<+1DO&TL7]"5+Z/+=6ZZ\Q$Z<W?IPG4 %J@T '4 (1$
MN$"JBRI !Y9A@K8&OR;A-5Z6+P4:BTBWH=V>N'JX;JC>G.6,86&&Q=M!>OE[
MQ>3 QH\W6:"Q6<;K/[,^C]N(FQJ1%R)$>AUB1.$)HR?70X?5NZ(7=:'+9/?%
M/MS'_[)7J-M_V;%C5P31<&!5RLX7_^XQ>K-,C-@R15E2%2..;_<?^J\O/TO8
MMACMCI(G]6$^U!G"7Y=IW,I/;5D9;J=H>TRY$)3YZ]YZ.3/:QPWY2;<7;ZDZ
M#@29>IP.8%,D L?5^=[9SH(/WW\><*Z]'/S4;<^?CP(7514Z_BZ&^8A:L06!
ME .#I)[09A*$ESBQ(\2V%4XL?6S\-GHR>W+T@X=K.2I1E5H7Z&'^*U_!HZ&H
MMJYQ_U!F0_"[.@]+CX87M4GA/8&!H>;'4]8_0M\"BH1G "D6MH,JC=_6R*-U
M]FW&"3N;U7.ZLD<Q;8P$]#X@03:9M9FH,%&@F-7AO7, Q!0[O< 1':'1P8NU
MIXFWM ;N>3#&;:X):LP4BC]@Y:G,#,8;<J<;M+F'@Y$"KPQN!=SXL#)0:]SK
M>TOH @V,%CWB4^*G31N<9+W&CY6#EP8?;:4'FWZM-A^SR[*GWI_K'1J/7@Y_
M5.U@?&I%A\9X"X>4FH*L6FJ'%:\+>TUB*GOF""NRW0U49V+EIC04^@P3&\\P
MY$%+OLHP6S:]G/;29GMV24 $JV'#Z@J-P%4\#\:&EDO[[R/<@4QA,/01LZ&J
MR<-UF&"(<_*LY'%3FK?@-G>&XM%-V&1W4GRC+Z^!2>O$DB!S'BVMBKHJ/_HT
MKZ"I$#0 ]/BJ[@?0U*"++ST9OX=6UKQ6#'2O>>03,>G,0#:O]1K'-3A4 _V\
M[*G3 +$TT%V.M">(H(M#LY=:#W"33*(9\@#)AA_T_$!CCK8&[$?6C-GIX<4F
MC'O&AUG;?A/A=Y=3B>-M7]ALS(=U1&:F^WCQLX"HM>_XP^U#V>.K@/.8EI"D
MVN;-P%G3IC]EO/$>0:2H%BWUVWL[\'K)VR*,34I5\":,CE)30+OR@!L!46A*
M)--R(BA<=$#(#J:$LDJC_I[JV0YM\Q\B* +Q_)#VC2SB.E><#HL8#^L -< ^
MT(^-5(5Z!9 )4!G!)[=2-T?H8SNC'M2FXV_QQY@,FF$R=BWHP=FXO]V6?FTQ
M1!%'9;-_NR=6<[X[M>7NE(*[(+@'LVJZX#3':;U:$-ZI&-@Q>9ZO<K]_#-?G
M GV$NGEWYE+;E;QW#5)K%LZ^ **.>UT"KZY<K*IXB!U=;NQ*Y4\Q2<E67@&\
MOT%7:U8"XFFYB8]"RR:@=9^A;8"-"S\!2KXBT3!TK='T8NFW*9>H\Q7WAC7N
M['<(7'7OR@,IIU@K"S%B]?=!*RF>5$O!^L_-YD!2!V,SI(WCMI 5] E;<3V0
M0A7@P2$KXZU$STP8&?4QW#1(RA\R=Y(>"\SM37\^ J(:@*3"=_Q?F2S+(+2'
ME_WIBB_#[9'C-L(]L#@Q@_: .D"/3P0'JP7HG &">*7LI79J&F$S_W@R;WRX
MG;&)H(_CMC,J4:GH39,N\M[M?+G.,SA%5IX[K7-V<R<R/J+'RZ7C9@7@?92.
M/_+R][CUH.'K%LPUB6ZI <D^[X  1(OD9XEE K$W^_\9:/??#;73F 439JGC
M<*/]8GE5+[_)6]A,:IB3_/+R6<IO"03B/N+]9#2YA+(9F.$WM(D1E=SVLA!V
M3GHX4?TJ08[75%[Z"B@7MC9O)G?, Q[M[G))U63%P''#X=<SQ8GVAC+^N<Y)
MMW84E2A )V?]KMWK,?VV1:B/<YF1XWD1T'C,&R DC'+LB;\B>!(PXSBI%OYN
M]\ J V=9(9VDM>"I(4C;<VQ_\8LCLEE\C;%6,8)W!TB9G!*>^(XW+0]4F?-?
M$B/\70=-(T*<6HM7)";ATKB1DHK?RZ(JN[E.K@21DZOTD1W.N9%W%P)GY0(%
M*KF?$IH+@WS+_36>G[H:I5(=L.8#[,.5M$V,B=H2ZP<_]GJV[T;-ZPC5X5A=
M"9]-Q+R=G<[G?8-Z<\MK8'DA1EPAQZ*E@RX9INS7"(\JQ?FP0A*J; 9\WA(E
MOV_>.>O>T5N3'G%CJ&=G0OF.R_.;5U(D@\<C"?S*/+\]]I?O(9BL)$E-GS<4
MMJK@ DP+@J%1[_VP</3#J@-8YKM!O#%[%B:0Z_!.K!DG2 75UF-,?#;%D&NT
M+@TPHUX>L H-(%X-?EW^Y.&8M_N8UZ%?:G^V9D3X)WWF"51W=9[OH.TO<7RP
M\VSJL\E+VMK['N?]DV/*^3C@TCXZZ^7&Q_N2V#*RJE(&R*=GJJ,>IF1V"/<H
M=)U0*CSFF,\<^.?6B]$SXY/C-M.*Q-:PA0K9V:^IKJ?G2B[RHQV[O[<M L2J
M@N@Y*<<7S>5_+RJ_)&[D5O$.3"$W@D$O M&FO-K;5DZB_&(O_Y4:<A&%!%H6
M!JY$W!O\8[#@TKS?*' _[_OW=(./)IG=_1Y!&QKX,L16?6KPS </IOV:[CU2
M';/Q'3\=7>(Y0[J7HWS>2M6.U4>"BD+!T^R0A!PZSO(PG<K2X$FU.DBYOQVP
M<GMNO9A1S*2NQIT]RM_X+DA_T0']PQT[8?9F[)O;I,O-VHN7"M1S=^VC?B Z
M9&SG*]X&;&)#QR5?]RGF7[$Z_>A"7>QUZ#C05;4OUTUIKZL=^PWYS$?N[1?S
MJB9O35Z>BO 3WAWZ)S=.*"<9TN'V*SJ)O_M&3\6TP1$K1S<751NAAFG8L;1S
M',=\UZZ1C&M[_BFT?V17?R-8_\.>%<II.*AEK@&Y+XJ+,2WYQ]U,9@Z+$8ZW
M7-C6]_?T70PU+73\>]M;X+[7B?O#76X<W)+WPYB.X3GGFQ,_K1TTUR*R+G\5
MP'5PG]\UCAA!R07$" ]1/#'07A3B1:T!CLZ$Q)1-+M5,XR-YD_OOC\]!@7<]
MGS?O<=L6L"W3+N6HG:)YN)O9-BZQ78(P?*2X3;%@F3_;GA&ZP,<M0MZ-,05N
M>?QJSUK#TM3V2]D[RK&W2^]R>_R/$UU+XUH'.\+:E_!9@D6]7?3K\<7HJ\'R
MUT-)/]32ECK6L??*%\9W'#A-<3=A"(SOA[/<JRX,_'3*O7HJ3?<YYTKN_?X7
MT.<L2/K]"SO-3$Q+C)WS.1RLD-K>5^CNN=L]HM/J$!]?$-I[@*.$ I5S3B:J
M7<+>'DU=5YBQMY)M???#LZ#5$LR6X\S;,UL/6B'J6H$*IQ%505VZ.H.U5EFI
MX>]L9DW$RW=7+CFEF4M+H,H/6D4\PXPH"NHSG0_Q;C^(D"V&8)Z>9)/XTP,Z
MOFCNNX63D7<[*I)XE1\IDF3K#T.*+\'FKSFPJKC;$'.\N8GX-C][M&AZYN=;
MP2LXS=W#(0R[_>J1+<1/]I6S\;U6:NNF"AYV&?<I(0&]X^0\8EO"P/L]AV@=
MI6@P39'9&W6SUS(7J(34I 3U+5*L=31=/QI5]M9[+H;ORER<%=TZ*T1 P]@%
MV[<9[30Q0G;O_5L(.;4?FEEYVEQ88#D:BA%/KAUG+.@7UD)KKD/?^8K0[5*P
MP@EFG_5@I@"F>W%5$RT<2&E_4<%#C$*9<8%4R!IY1F4X%Z&!!:*/YQ%F6X).
M<M\ 60&?KX>2U\Q#MR@I< N^30TL3V+)<3F,)'40?FW4-W6"> $Y.D4!=^\E
M'X(!E:2["&OG1QW<8<I5E<#.66SII2"&\$#.Q(ZR); >.=:\C?A9.9(K2EE8
M:-)WJBR&+7D[,==N8LA3/+_!Y,Q!6R#+)\]>_4@:L.?V0<*^S5GYQ6K[Y  ]
MQ^Q7"&#CRWN%_E)LZWOFGHAU:!FM=ULV/DU2G\(J4Z?7"SVW5;[GI4JG>#T$
MEEC#TE1C.&#*]WH_%U,0!!/67W]M[ :.KCU^2(Q(B.4QN=9R8,;JA2X+237D
M$:%+ZF/G=C82NZS27QO"79P(>;A'V(%=D2@7(_ZD#39/VF$F;B&OPL%R?'Q?
MJB7(_L4-]/:O'"ES%'HCS6=JY0NQ?;2*3P-WII]3O"T!9/FOC;KA%-<B.2#@
M?FG6AW6[A C^I=_WD$[+2(*6&.&DQN%IGD&.2 K>7; !=RMI^I"0>#,N9LD\
M<QFJVC.<^EV,^/I6[I-OE0NK=Y9XCQ@,I A:76)@ERN"$\@ ,HR:_"ZTY-6'
M6[0)NF[QO5'QS(\0L4>I&)+N?\$D=B8."/T@ X>G5O-CK4G\%K7_1(\8V$SE
M_;TSXAWL(6)QFLV$/4S\)86>><3.9Z??]X$N#-G8B31-H&5QBO$MSA8EH*C:
M'TOLL"0.U)!8LW!/APU)IJ_!PM^"UY.N1_!.&E5%\IP=]N,NQS:OFKQX)<7V
MT3#[6.;NBJWICZ5:$^QW!K7O/*ACWM(:"5H7.GKN!#:\O/=D9PC@YHR_M[?+
M2HVPA(_XH\=^A+F '1TWN:4+'+6JX]R\A"?RF#/IA_RN(=4O7#S.:6&&:]+_
M@[]G:]'R:9LPOXC =5D,[RW-^D"X3K/#!A/VU-ADW6,Q8J3F_MS$?IJHB;VY
M5JBR38P0;+^Y[)U?4$]L1\*RM7W4!$:IR>9SO0<E(16'XBUI7/(:".D9Q<Z"
MM.G%$MF 7 GI%'J[6PVZCN>F3IO7KN:'@$9R,Y'=,&Z.9!:,6P/7;28XVDT-
MVM]WM0M6B<HKXWEW)6.'_^:A#2>>H]@]U?UG(W+T&[:B_5*,MI<=<891U"EJ
M8!OTK+E+P(Y0"XM"IDK^GMZ!<_"C+$%R4C_C$W];WU0:>4WL@E1S6-J9OS@K
MD$-*5,L7V&*3;^(L9N=P1C_F)RUO;FO6^P^:*C-Y=[):I2#%V224-@W2DZ-3
MB@S_VAG!8*T2>= 8LF%3C"ZOOF+U0AC<E)#22X:#1+\SRZ+2%7_,S*R\?LA+
M-H;W$>X40F6MF/#?2WY?7; \9ZU]@M%?7Z'55V-1<:YN.>QCJ0_<3M][L)'Y
M0DJB,NYY5,;5]__:79C)VWQ6:G4>WJY2"ID4[U0B4)O"*MD+):%A%?Y[*^KZ
M530%JPI;?#2/^>KXDX;*('[2P7TC6RN!<V1>"Z::?IE\QWJ?(_SQ;YF")XH<
M>9K6FZ8HQ"XQXBH_HFSQVC$AT0_N<S\HE)P?AK"UBK4#H=(BXMOO55Y-9(/Q
M$W_&*F>VPD([@%[9!V>C!<(/QARJX.]3-,H-:7\0?K&]!Y!TPUBL(IUCTT99
MBS]-.IK3G@G0'.H&"OM]!Q3/QZ#-(_2:K+<%';:T7UT?<"QGU$S_0=VQAT<_
M?$RT@0A.TQ)"+Y@^=3[?[7C<AH36>"<EE4E6W;_.?&>'UFL)E'K?1&2;'("R
MF9ZGX(UYQ\2(F8V\#6TKM5W*G_6KQ @UQE7W,M%WSJ?GC?4WLT+TAY.LCJYL
M_S "$.AVE2GL7CN9S,/IH3K?U=\OX8BJ!>Q0\[N_JJ[2"S6,'JA:F1B)$8W<
MP;!#XU&!?M4%W$%>@4^GVL<K!@4QAZOW6%U_D[_^7,_3>%*-8.CZ6>=\N]T$
M8=J39UGUP;2)QUI/[FWP>?.#'#(?.QFH8\.736"K!1N$:_G9#\T$F7IA#S?6
M?0F9,54+,NV3FS1S/][T[+N]WY[^L:NCVF6^T453&M>F<T:O% :$^42O5MT_
M?YRLC $5+04*TJ%",]R6K"Z-I<[MMIRM28+E;IV76^(_IVG,$'VQ(WX"+U'*
M,/N]*!=2":#*[@"X?)0'4,EWG!L[SU];&<VFJ$^YK.1/>?9A[IHZ.$UK>-^K
M+^O-?_([]T# J&-.,>MB5>"C\O)R0I60/NGU?]Z(\R"GC-B]>PFJ(XO6!Y[)
M<9D3'?S_>M)&:6AUVN6TS+R(KEM(SDQ!TX;2]P0#4(6'Z1(IVO.62)?Y'Z.\
MTRD>N/NMX!J^#YO:MM'-U-[#<FR=0]]=]": WC(*/;VPA9I/MAE8M/^D$DBN
M].XIMOZ9_J"S3HIE!LJK0AOL^=&0-)E/%S" TWP]9E\[*:&>.%U4"KB<Y F*
MF4%^G0>*9E,PK"W\G ZJK">Z&GD7=7_\VY@'3J47!W7*[+";#:Y]=5PG'7,-
M,H/H#"FBWV.&5 !6,0*C45[-7X51ZF,AY4 T@.&G<FR23:,Q:]PF1I-23258
MU'CM57RHP:?(?W]N5\Z.PE>343$%CS=<5;F7^J+@<IH8@2+R C'33L)ST'MB
MU2RH+.DI>D+UPZ9A5UOI\%'N0#AY0S4YQ5N%KYT:R+'7VLQ&=DV5)GY>),LO
MUWIONT\_.10>V- PW-147Z!U?$CPZ]?-!K?G4 $F !G/T&H\S0]DFG7UW78G
MMYWGV[2*)#DNB89X##^FT2^0)7+O8?_*9]J6+=H['&EU7AJ-&\<1A"TU,_L?
MAUY^<[7&/>^]2M&+;QXVND^01P$S-K4=>]<;R:.EX.7^;H]7V Z9\)P?\9%M
M4=FD\H#A4U,08I!50W;D%SS6C$3Z/VZ//.WM_F#PSN$O9H^VYMH6?_1)XJ-F
MC@FM<4><^TVLB6QNW+5%)_E1X*H8<:2Z=I ]*/NT"*!V)?.X[:,#9P.VK8Q:
MRPJ[^N#B]ZW^Q_RQHH#A]X:"HI_YC<8.2'9!$:S/+P"4)X$Y+MH;@'8F44F-
ML Y':G=736G>YCJY426'OZ$#6>&4 2LUZ\BV$-Y#P*D33A\>J3.7VR&GB#^7
MP>C$;+(ZRYQ=]9[M$-E>+(@!DMFK^Z%M(Y'DC41F)F1$-Z5N\,+#G3@QAF^8
M]),ORLFP<GGN[3^:E!ZRX+7!1O02K05]J<'(+'RR<>$A$Q;ZM +<?[TMPO7C
M3U-JDYJ5<5$AJNDZ7?7$ML>^?.V2)[AKDDN)7^:&3]7&S7WQ+R\SN&2?ZO'2
M:T=M?>VC(^UA05:^[()QW*/M<;C\PER4F\Z5XS+7;DL=E*)G/)C/F7[ PYP7
MP<W3;Q:!5QJL%EEVA#"5^<<?O\ &J*@>\";YLA[/;L;E>/"(B0M!^R;9$PM-
MR%9(<= $NVXBRE-!/S'_XM.QKQ/7W2?>C(ZV+T3\[WOL_N^_6R\:)09G*R26
MRX1$>GZ34OU_/3-0'3DI1NR7*CI]3/FS!%:+,(JM48W'^,@E0JI\;NITU:<3
M7!IQDPNK]LXU\ A?LI4JW:AG>'<K3XH$[;[JQ ZYZVTYL >/8<4<&&ZA;FCT
M"_.Q>CNIZDZ]N[4?;QUR);VT6I0T4CW/F%DCQ(SB\5\:-ZP"#_*Y;405T(B_
M($;(-VN!ML#U@C4-?*<[H-U+O!40R\OQK*OZ FT'4&QDK*FK*261J@3&L)++
M0'OF]ZN;58<O#8=75PV'I^N=JOG[N-XZ7)RA*LZE':U7^Z:1OH6/25H(D3_R
M8O+,A)E&XF/9ZF+WR=" I24-E9*RWSFJ-:'?4J-+%H+\7+X4U=GITJLMI_8G
M3F*[&"-'!$_YI$3J1<I(Y<$J'B/ACWX5Z:NJ(.!-8L"/P>Q;EVH!/6:"W177
M\CL7OQ.NG),XE[=+1UT4!6!YL^T8*4@#?P"P898&/L:LQ1ORS.XT:P&'>^?^
M! I[L!L Y"%ZH^D3#R]&[\GA8><5QT<!6IW?:)_J'V@$H /646C$$1N!#Q#+
M-AR)%A@.7S/%2FW/H AU")]<!,EA)8&[;M0,(]> "OWZ;:BD'^E7I _>LS%^
M 6L+0%.$DK'9]N#:I3ZO-4Y?Z3B_NP]<.^T&LG))%>ZUJRD?%YPK&OQR'O5H
MEGQ927GYL\_0OZ1K8_6'=Q[<KZB8[-D!H?$1T2O0KW3*W?D1)A'4D]%(F-Y?
MT:-X=69/Z#O+<<P^WI/KDFLV;MYE_GY5.?ZFZ 7HQZ.P2,E68<_]T1J#IOK:
M,=([KYD:EVQ8G^,\="W\77J/N_>AL(?/&@(N[?U ;3PF6Z;-O+Z ^1K&1F>6
M!43EC>;$%]?29R_69^I7.[C]>9YB+!R(VP5:AP1_D<^/\ZC3H<G^V-06 N=Z
M);:#E$+<@+=AALAZ N[MSD,&)KN"_BS.G!'0[6RKFJ)HYQZ4H^@F3<&+6C-!
M6EOE74^673_<?<DIE]HK1KR0O;B0W2I"-9/,G0JGS3]X;V!??Q0)'GO$:\9F
ML^NBS(N['K["/>0^S.M-\/3=S/MV?>X?W@/_LXG:GN^M#MLT9;TZRY+=F6U]
M5HQP];%1J-A^MVJO]U?F6-%N>4>38NC+8--SC0!WE\_ !6*K,\'T)A# JPNW
MZF.W1&G><ZQ9K\FE2UE8P)4MJ0Q_M17)*R.HD):*^1>7K#;Z<^>G:'0)##.;
M6N6G RD0XSX>\(,4R!IOS6D62%D/R1=2/33)/[\*&#Q[IU&3"\0V!]Y9+1OP
MO/9^[NTHF''535J3=$:IQ<O =UWJV()==-6;FU]6BM0.OU\^%C3T[0NH\[@#
MUC,LQS^?BNU7S<0(GM=$UCZHKGGQD<H[CTW?UZD;PJ.S NQT[N\[.KZGZ^NF
M0A\(93^2EZ!3(/$-%X[EG0])W]N526D/2:A+5C!:#>GW#DA(M Z]ETQ3H*&+
MZO-48$KJ2>A?KWG?++E9.B%=^[@8D5+8-7WPF!\*7NH ^8$3@FO%4<J$E;@!
MQO^]3L8QOEGKJ8IMMN_X-NFUK'[78!3K[6K675W%^_MD-TH7:V+//_SJP2Z.
MKUQVPW@IVE9C%#6P<\;.D2$C3*\5(LJO9L7S-Y$UA=&H[(.M2J* -?P+7;=@
M:IS\]3?.0O)EJ_JV?^"#.1-,?'18M6T,H8A=V77PQ\9 ZY6"F'>=,+%L+R/Z
MSZZH-TMK-^&=.!?[*& 6R3OJ A/YC-A>AO'_;,['M)X>)@-V8% !YD]>A@2F
M6^%6\8PY RH<SJEH!1G.LH0=X1"=$)R]!MMCZS$<9/*N08R0<P,&^T /3 (M
M+8N+HY"6*LO2;D1G."*L?OT# Z/9) [#'@4-N'6/.^,E2\2(A\/%Z(=_]TQ?
M72TJO$YDOP3VV(2)$>N=,J2TWR%EU:[C?FAR:T_UP_]0(RH,HZ6@-_@4HW?Q
MNZ(OBQ'OS=47U36UBZT2^KI$E5*_2BYB)Y["9DT09_2)$T-28D3F[)+HUP_J
MWPCN>_Z&G$C=\$@W^3,$\^IWH[_/)\/^^MS2BMK"U?P1483DG2>EGUB+5@?U
M3Y7&)H,N]Y0NK%I;VRTIN:5&EJ@)_UJ<!]0?:J-;@7O,K.GN_W'#RHES[=6V
MRK<<5K/=[LT6DZ&SCC# W0G]"3>:=P"[6VX3?_CSZWIM-.62U%?'+]DX?EU%
M"J!)0W^LR_\4*..SX:0F=\.QO?:G$B5&7+^N]Z=*>99;TDQDEF(V2X%TIX0?
M!?&?^,'7#UHO-J9EV)R,H"F1>8N4=,R" T&%6S??Z%;P"#.O,;,LE&Y#\NQ#
M1LT524J@TBP-W(ZVH)V.S>0Q:Y_\^"$*< (5A@49,#Y2R,PWTT1V"9^&0L-Z
M40)<M[!E<?5Y<T:T#Q3^)A?"#B:?MW(@+AC3H?P+T1%TXL2M/\3VH6:3OZU@
M@UW?(<-4XX*1OWZ#U?APY]^KX67X !IF(T'ULN:F*WRW+9'FT.AJY.FQ=YP\
MR?]$[19\V&)F"6JX$VVNJPWKSOO7Y8+EM(LU6>W0^@"AC2:QTX'G8OW766_[
M0F%Q_$UQ3#-/9G'*P2E=Z"-&\)P5L<W#0H@'6Q8"77$GTE]OJ%YH\*3,F?[X
M]U)]0,&N2YB-:)69; N=2]OYU\TSU5UOUW^^= LEW=HTO&6 \==G)XP(&J"!
M6HMD+S\X-':BK"!?#O7TO?7R!)&9@ZFZ;-1C#)"9=:ZGBRXTH_COMNJ<F;OH
MU)YW>8VYIE^Q$O\_*WFS'RADULC:P@LJI6G&V4E!=GWJF@6VOW*J.(149/-X
MS_J5K>^ QV,F#"CF@KX8\?SQO\>VD8*4*6WT G(S_Z+UW]U8QK2H92C0.I#C
MR@1- ,\G:20&KC(S+9XT\^9ZS*W5?E81K9B_\;2T0.\$=EN34JQ"/TO\':IX
M0\YJ90XC?0-.;GVJ/UV,,,:T>D<A@1/X,!J3H)D6UN<9.95K7;QYT56,R-^C
MWRQ4[&,'S8@1TBYSA;%@S&#QXJ]:&U#9C^-H#+])9_EO(2\'L<N__?#QZ)/,
M2A/,.OZ;!]@%![2*Z"BTFY.V*:PL(^QWU.6;[[EP$1TB5P7H0+M#XI)JT;"?
M.!9]8%8<48(VO(,$1!3/;&9T4-<XB3ZAS<0([O48D;\@+WAZ('34>RIK7=:,
M*""X:![W**A2G\H=6D_5+VD@.IO^(3)?$34,@KBU.2Q*VV &>]?6L%_ FWO;
MS]Q)"XRI[%V'BAU_@>&=IZ2[]8%ZF(2'J/M^?#>!E(ZKY!;%%@L:(KS/ D;-
MZ@;1L[*+V;]"%/%J\H>4[G>[=$!F>YQ-#<8. =>?/KQ]<#EI7"<OS?'?/G/=
M'(T"]HRH6?"=,M8Z:>;AS;3S+2-:/LE2-(/>DYRGIGGI45,AW8[%R?5%FO3A
M$::%<XH8X6O_03!<G<X HOJZDKYMA@OK-[E9>W:;'.2<L7<853R05@Q:^W".
MK\?"N7)()\^.W6)Y0<&TZ+V.VNSP^)O_)"%RWAA45EN$#RQ'44/*2IFK=[=R
MU#HEH?6!0AOBYW[>N8P[Q+:SG PY3;C"67#IJY>F.K7IZ>-31K,AOO$_ZY<Q
M_2O7# /8P4,?06I$;#7#PQUR C,;,<Q2K,9\/(_!\D/<@QO9#!W)M[) ?_/+
MN[<QYJP021BC*A#]&:F1!9)\3#Q^\]/? N_U0^"IT:0DW^$?S4+'_->X$*?:
MN-,OKYK=# PP&O(+T.RHO)7I\3Q8LKZ6AOHW5^5IR="&J,M ,4U]JL 6"+V]
M;K4?>:@IDAD)*K""&F\LD:M5XYO7@!> 6[*QKXZ\P%V=6:2H;D J>XX'K&WW
M2#W)5XT/#]SYO)I>5NVAVFR_^.XH5=XFZ(#MC!3!!;WG5J+B5(_*&\*@R*<@
M6S6S]4MN:EZAH?^3XJ"+*G\&IZNM/;.+D<3 "SJY-GM7[I1V7LJ;N,!Q-!FX
M^NG=APWD3&%FCD'C4,5@K="PE*9;'_0CM-!.Y^CA;;NN^-1=V/U2]_[:ZQ+H
M0<T5*#GH]5?@)L?U"XN_MK"8<764D* O>A[U"<IYX> 75#+I[.[ST;!\VF0J
MW<8I#IH;7Z\__8M:D?'+MF!2 M7A3@(5702(VK<-=20!!EA[.0.EU\#ZD[9V
M>D;WETSM'L<H;2F=\C7%H$(JM'Z^"+P)[!4>!XB"2T ,*R056;E0@&H SI<#
M)ZS/MF5K(P=!UWJK P4-MY[@HL_2PXD*@<XUN28W<_49R=<B<%6V(=5G7[0&
MA<9L;Q/-#.7.OEUYM[)MG36F#R%&;-L5@)",!>='9$%!T?_?71<'=:3N165T
M1'_I/[AQW>TXI<LR<A=G)J"870.G#Z[9@I"1?2@YIP8=///?SUSXW[,7 B@R
MD_\^C7X#\_=I]'[[_S*+X=V82U09X_SWY=B)<Z>/A2-<NHDU?C/*?$E!$!#(
MHJK@30#+UZ ?'Y6,CPEA<O^.&^,8-#W'V=LZK<4QND;)Z5;80)X<LY8&MYHW
MOXT\@.V->WW1R;P>UT2B*D!NUPA:''H<@E\*%=WR-N97,EWB(&L@S);'38MP
MNCN*X"W=I7<2D'RY-DH*59X@B^L[-BR7U'B$I9>:*J<&[N4;)C0>?H/%^706
MZ/0'3QL8_MFCH>\TPQMM+PL811<7HZ(#OA,"(#L1:_#F\!R=?Z OD;#W#9#.
MFVU!;EK(MV^O[\KA4%8#+EWNP65,D3NW0UM^< _^]-.1P)NC20G54Y^,CS8,
M@9;1(3'*7<FEW_U''7H+B^V";J$?7=Q#"4"R:=/&PL/@Z<_$2\B1GF/T""\#
MRXV& GM1[O1K=HQLFTO&.#(.6N]Z^N>N^L,OC3QO?SQT15T7.49:@[-L1\J"
M6UF&")S.\;<\;CQ>CE4FUPHI\ 2Y)&WR$\"G_8!O3?J3WT/RW7/UHP&Y7@_*
MTNO?Z]Y?=\%KSMB7],-E6E6HYPUD"91%R=4 &!G@7T^;3A(:3VX;=9+Y9#DF
M*F36QGV_.)_8I)I[3JLY(%$?^"8?)?><]6I92Z..EM]V9^)$'KILYO>Y\@?'
MSK^K*NER1+-_!@]%>\Y5'G"=?//LS;Y_?#7N"\I-E2T[6V^4!YB6+=H/K(2Q
MEFC$Y +=P=DR4Z\KK3,S"R4&A?8Q<DZU(>9>HP?-;%]&[LSP.Y.W*]C1=C4N
M<B9:Z((/ JQ5VVD\U-WP4F/V+KQS?;& E!A>=L[6)('W_NVFF&>&"Y%IDY&Q
M'RZ<U SIRTX@O.*1I_M+ /LS#<VD+HV;+X.O:72WA%N661U^\6N<^0$%T9M=
M?(W6^#<^L;W!:O8J^XFM,IL^4HZ/)K5)DQ7"J>OEI)L;Q\;:A@NV.ARK'NSO
MO^VZ.+/Q=2=%X'C+C!"9O_1TKN\1%(Q[VXZUPQ/IW"2 '+M7\Z+3;YK]G1L?
MT8%')#K,K:CQ105TEN/6I^D1YL$U%^V5SRK,YRZ?Y+HQM0[4D4N'(BQ*=FDW
M&^9Z:UXQWV/U5-8H>]N9U@^*<5VO-F@EDM]EY/Y(\]8Z?^=L;GU84D,A\;$D
M)+U7Z%J+Y#W">6040IODY#+O6Q/B%U9.PW1;5?0Z$<.NX-5M+"#++<BD15^S
MXD5Q!_R>K-A#6OIEJS!LR!]<P/!>4VRM#_C1FCEI633O@$]PNWPXU(<EY>Y<
MP1LU:A'_X 6F(M]%69,)%_7M_8W!FXN&:H?#E["Q0*W +]E2B"?,?+V",POR
MREJJK5GY3?<RP \Q>*>QHZTY/CA:VVLM-TVSVXWH2#V]M8C5-)VX]19:!_OV
M8(&=Q3/>=U\6&/$J7NW>1@)<5M:/OFHXS#P>%=1W70*A_6#A-9EGUW1%K?A!
ML[4_[4.B'>;'0X;,FC,T$N#TCF4[P4@+^\<)T!VOUCWU 6W]NUM;-TN*E2ZP
MO2=UALANU)1AIEW>A+C8.[E"TKC:]$+/2XP8,\H1+D U?Y!?"W1G%].(Q8("
M.3$B"\HNAA?-XQ-'NV-)ZC@7->2\4Y4F\N2/E^HSL06-TG*@DH>@ CEO@3LG
M1GQ'?Y;"/O6)9R!B;$XOY( 'L![6!/1O;BU&)B1JA=B]/$0"PIMK^T#L)T4M
MV&(L3 ]SEK#\"?M)S4 Q K,7"W@DB!'QRW$]5C!7) -B!&C!'(;&\5__$[(D
M).\AX*K)<V%!\6D^F1\4!V3KIM=&_QMI-]GFO;Q6&F9NRV^M ^'R7*I/GZ,Q
MU@Y6;$6+U!7#7$,6KVU)<V&*TSYI#HIVPH+#/M"5RQE/9V3QNH0ZG_F<?I'U
M2BZF$J!#!':M&/'DFY[<=)^"UXR'-D.4QL,^9[#QPRA0Z:R XIMMS(99X+[Z
MAWW@*0U9VRU)JZ]!6QS-5A4_;='93>6=)HZV\*PNLD[5M<&228(%F6O*/0AK
MZ?HF:V1MNV(A1C"SW#_*V^T%E@K?_SBFVT!DN6$1X^XJT@?Y?RS&XO9VM[XW
M7Q4"A/=6;G%!:B]<VU<J@S>B:LIGD@%*99[\B/:[+D2A$)..X?XQ%",V&-4*
MQV9^-ZSW+=AN&NFA33Y::;79>980A)YI<LJE@4I80:4.21WPD]1$)HVNW9O1
M*$$O:(BIL$"!5CZ""@2QTX=U+?,S'O,Y6C-<(B-*NX[F=&B!#![P\: AD>$^
M65UH-6^9@A9Y3C,8NE"$!73+Z]MU.$,I+9=EP'U-B-#>=7S^ZKQY@'DCP$I*
M(Z(TQ46,>/EM=VUD]!/H(W^K7C2^'=9,.,L%: 5[ WT-=GTJ-&13G 8:X'HD
MF!NE)(N)>TAGA_G=G5M@79)*&,(NF .N/S3),/#7KI4[^X^WM<5[%,:I2 I4
M\,!*87C-51>GQ B5KB4I!F2SJ,-'I:A"Z_7+%8ALD3_5"7 V8[RP(H2EH N[
MR/-+RC^AL3M8X75J)?XOJ)9)D.8;>S'B!G7J%_[O8&&GT;9C_C_XI#OC9LYV
M2B#Z<TW5->F*MV.UJ_?+F;?0/MH5RP$[*3,^+=I[>12$!'Q<8;OPNE+X[[VQ
M-/,^R3>4Y[ (C7.8RN;U6>)O]0M:92KR\/L:)Q2,F<3.J'6]1C>^SX\^1_+L
M8FZ]:>?TIMUX$@MCIVT):;0:UN)M!"=M,>*PE!JZ"#96J#PF$JZ'^:N<T+*#
MM SK?'REE=S$>:B@^%,\)*TO=!,C/G-9IZ?12'\M2X[,+7 O(];A/PX]ROD[
M9T33!\,/64"$_MY7O+S$U9+Z0N5->$5CYKS#+\1(M>M]BX$I__H_?_*-VG(@
M+4,*L?]6OZT \,$3G0"GOM"1C/SHTXO:QHRQ2\VX:12W#[HP-ZM Y$(780TC
MC=LQ#)U'7X4/ET88L@KBDQ*6ITA)HU*:F?&?N2.2&7(6+9O_347B9P[KFKP8
M<11>F?F/N>-#E.=]H((+E@,9]J9$P\O;VRRE0P'[N&K=/Z_;E%E0F?='^7!9
M*%/S@4K2Y[5C,&RJ#ND$]C3'DKA9F0M]OR-&_"A;BNOY>^:=_#7UCQA1]<9^
MKE04CK[R&)+>+G3V/+)G'ZZA;5:IO_&,'' 0C[E?-O=&_4C^!UMAQKY]ZW1R
MD,!.VHPO#73V5NU#H5B"."E=F3@?32ZE/*:"D%$/1] I,+MF_KL9+48]>WS]
ME7",#.5<77KD@]6 4-)<TA(W-3+ A=;KE<])T?(U+RPB90Q)CI;@P8N+?^0X
MYQ<-C'_6UG2LQ(2M)S;U,G@'4H5F'>F84>,-Q)$^6,[W_,\\?/,]GH/< ,M!
MZF<Y3H</R1T+X&@SEZY+I34:YLUA6-C?5O%T23^8:7+(/EB[6MAIGELD^1P;
MN(SYXM:O<&G/"0C)WP>[_R;*B<!V24BU-TW)CPPXNSR?I^L"0C7M#]:(3N2_
MCE,8@]/P(Y+;2UW=+L1TE(Z-<KZ%#_[";5X>6\J9&:)]2OJW0ZZRY><D))G3
M0#V19.B25? /P:AE6(;_?Z)L>4A['^^-9":,>C'B8'>KQ9:9%O/NU8:.A2C3
MA4?_&M%Q 1_=;]=G#OA$K0,;8U;"%Y3(O D'W 4RZ<!^&\S<2<KM7N+T$[G/
M<HZ_$F(Y)M3TE.8&CE'ZU\5?W"G@IMPT0P$# ZQ8=)+G,"M&8 WP@W"5=1&4
MY5IL>]R%5KUGFU;D=-O*ZONAL;DJXM[5EW_XZ-&L2 UBQ&7#L5>T#@W5#+@(
M7@U)%R/6@1NL:ZA%KKA=H"\%0+)N7,TNM,^=\G2P-HUQLM>@N_48%"R=\7C]
MZ8K!%I>]96W<[F J,VOT9_7KI8U\SO&0'3MN2+5;SCZ\?7C.BF#W?NMU6;OM
M-M;H;M%#XJ5\.>;Q!^SOR*Z5I#L$ \.[U3%ZY^D_!_&2?B':<8+]9T:\;()D
MWY;@<L)S;^.>YP9&5FYQ?]:]P_)$U".#S<D[?RD5/QHHYY6<_W5^+^[JFU_A
M>1?RS1T^3!8ZF"(MQR>BOYG%<4Y85&L\&O2\]D9:>=!VL(M52@\+1VE$)ARX
M__AGR<ZJZ7\(>@O>%#%B8Y%0"ZY#*%^AR75+,!+P6(&[S/GS5HK"0*B;*@\9
MMO.D6&+$C!D/14.JE^.UY$@+LXF0/$!FR6T"2EUY^)SZ/V1T[;. 4<<27$1/
MS'YN>VZMX-L!J]KA^C55^VM'OY?G^Y1,1)J-PUZ6CF:A1 J,) QP%.<G1CQX
M$/^,T"M&2#2:\O=ATR!M8"^O]C!0:W9'WPI65HHF1 D<]B1_%-!N/SMH6HI=
M?X1=JF^P\2JC/;DTT+VFR( 4<DLY_=//A<IO[<;/=V#>8>RM[Z?L?"(SXP$=
M&L;^,8323O2__C]?_+=[?/VW^WZ9#"=&I([;+I>M:!)[_M^K5$W>3=CSW_^7
MM.+Z@4IC@F]T,>(B]6M.)W;3=$1?4JY9)U)^PMN\G[ 1F5(_$"75S@ <\(:\
ML2Z,@H&IH1JCZ?L_%;]7G)) ]5+[8O_]D<ZY.21\8"AS-C'JV&)B)2<&/3>V
MX/AN5@GP:&_>SQN^"VYFS^@X\E7O@%Y/)R%UOE-21+0_)3P_NGT4(H<6!489
ME/H:^8>8S)QU:*Q[VUC]Z&28>Y^NH_0[I?R9XH@E+RRO3BK!ZE A4-FNO9GO
MDE3ML3'R(!^=\!R7=&1HH>%E2-4G/]NA*F&,O<-@^%B/<W1@S\;#O9-Z/98-
MD3@#_1<9KOG/,AV(<-&I#)FI%GKA/ 1A(C)HRNH;564;I+-F9<%-P.EG_@<<
MTD8UODY$'<]B6J]J/TDO.Q.D$N \^N'#.OVR(;OG$2FF"B<\#(@-G:=27CY?
M3;KZ<JI%XG#>_8[Y],[D/OTL[*>0Z?,P/0X#CO"-!<:B3$@'"UX$REY@ :'@
M K">8R\ZT-;>JN Z,HXK9KG<6>PIM52IYTT/[_@R'CV<,O+-R;3]<&;5O/U6
M/\RA]I%OE9(NRE:]:7J'B\R/W\_6-L]PZRH,>OG>=#,]:']VJ4,4'JOV\QWD
MF]AZ9$N'DYQ[]K8JOJS:<&Q8T>[=1H[/'#[M3@'3@P?*R_Q^$==B@K&C]89W
MHL2(NQ1H'Q#?D3N%=Z7C,6N64L)%<J[WZ;8AJQU*[7Q]U>GZS%H[RENK<IU;
M/T9*?]TZX1/,[<)6P[ED$2T75QU(3&O6^[)C"%1>6_+2PS_@V<1*-,.&354-
MP/K;ATR_N[]+]RW]VK:'6]?-K+O>\'U^19T9 NA26RE2.)LS/-_A#L-D;QUZ
MA)RR!_ NV% N<:&AQQXPL3/1"=',=4Y>?<.])Q"5^X&_W.:+;!I5VO'G'>S0
M.L"C-%]C)UH7?_3+ZW M%7WIMB_K&BUP74/6'BY#[AZII3/;W"X7V'^Z,G$]
M;N>VA"T9.T]M10';")N!84Q1CG;H3^FOU4CIL!./.N9VA[&7;?0$N+2L)*.1
MW>%U[NK_9*^G;8[_F(<<V/7J1M:K!ZC3Y\CC5[X48EL=-5EYFI[X0VU7SDU=
M6?[G7,D@)<XUK2TXK3+BO/VF?W:S@@O5HH_^X_7 C/C!6.A-&+C @52Y'8HT
M;-5OPO,"S)LN6:.HRV&??79C BFC]_PB:7UW#VIN<AA/F&WI3:)/]#G:J(O0
M<)=QPAO"9&Z#'YOXV1UWB)B=:$Q/6]",-.D#(N3:!C!SSLVHM+PP/Y;$</.$
MB95V7<MR\F_C%"@EVZ8S-/4?_N"VVG_&?4\?\UIZX'N9$IP:Z&$/:=?Y98R3
M1Y7_K! #!X+<Q8AQ!R*SMZD*^S!$Z 4-X-K *. V,]'YTU!2VJ9#2(.[L@>W
MQ_8A_/*NHV8BA:=CX_E3;.F7:F>"J_:M-3(R?F:D$P\>JY__1LA[#T?D&>#Y
MMF<;Z 8\WI6@>T_"CR59]TQE9-WG.3.9\K5R'VV.."9!ZP_QZFTO_8-W!?(T
M7 LS*WV93$;CP0ZM^G5;TN:*,F0M=*_\<\-Q5U[,MPB['?DO*C7*3&]672VO
M"0UT,*BEGQ4Y<YK&+V)KP8S=.^IG>AGY[^@+[LB'Z?_Z60&-QA\*N1CYE-\%
M0_K2#6.:3LDG24&#J&2]%*3*Z-A2AS$;K3*0E5W?F]1WJ*4K*D_&;P$DMJ((
MJDM +=\RC=A3?.<0YWNX\1^Y\JB"5KB+.X(&,_Q -B$:60' I,U:#A39O8):
MV55EBZ/U#.R,=!/QC\[5[[-S:]HU(X.,I2'RF"*5LPM3'R!XNWR;4<V=.;[/
M!@ZP?O=$Y-/0*9I@RX(UL-!B$B]H%)68ZW 8'7L488'G+M]"TQ4C.K*>Z*"6
MAR<1?UD7WK /H]*,ROR[$1;N:$0?<1HM-\=I_BO08*M@K91:R;<L!E?^M4MF
M?JPX;/I@A?8>.TKYT#!%D.X1%-14"-5^4Y4)':?RGF++8<M@-5N$^OD\YT%!
M\2])PC"Y6G8]!DG88C1Z",;F9;,/-L?ZE>9_/]<VSCWTUZ%^\7PNV\#F(CIE
M'<<JJ3]O/C/#1DW+UG0E$@,JI++N&#D9 6_YUN#+R_\<OP9NLW_XN:8U74:S
M>7^:_'"<G.DV,>*O:Y6E()7A#IBQKZ6-@%KJZNJCY_QW&T]:M$[>^KDG/F6(
M[%7Z Z:M@;?$"#JC$XP7N7!J***G'M'>;IW'N,_"<IB#5,./&""P;_1.&)P/
M2^SU J%SXEIK_C/):=FHS/M.IBLY/&-(^J)0'8AF&<:&.V4P:FC32\_P%[XL
MV$Y#6R?0YD KTT&U<R4DF5GWSGX,LVE"U;TL?XC\ZF"I9MC7;V,>GV0_WS^D
MOF8W"3P0R4J"+69T?#EN'FBX3G.A#VQY&T^"^1>Q'WN'(3O=K( WY?FU>QF>
M'8PHP[1&Z=<D^[VZRI:;T1N+]MF:8?\V2&E_SPY=^81$W72=H^<1^C%2<C^_
M#FV0OYOMEUSB_N#$W@3S'OD#$^>X#E5Y1>__>.V?:>X[WDRY4U&PK2<4]^K1
MT.ZB*&6C_@2U@:Z!3O=7KXH^%N[JRQ2B?:/UBH/Z'IR%I&%&MYKYX,M.8G#?
M5ZOW.L]#9X$9WH3BQ\PA$SF=*9:.LY^T5\JSRPJ'X[T3_CU/7RDU,\7K7>)(
M31?S/8X#E4QKO8Y12MSB)QM'^F*3ZBG>4FK5$?D!$%/^NT"7'I[NX]288L%L
MK,A_33XY%%[:H!]XE#I0%3VU6?@_>GOS>*C^N&]X_"A*F42V,)5*):ED'S/U
MZV>KF*(H8I(*V9)D8LP4V9=)DD*FDB:)2;:R#09#VUBRQVS*GG/$.,QV3[_K
M]7I>SW6_[N=ZKC_N^_[C_''F+//]?M;W^YSS^7[(Q6<S&T<M%YS17@-OC-;C
M?.F$=5V!2#,.0FFB81/P,TO[[:07 N@C>3_SR[EDS-SQ'?1?<<H."O"YDCGR
MQ?I;1XA<P(Z6[L]3ES(>-U0:&))'E@UHOU'STRL889KA26)+]2FI-3#26!2A
MH&/6E7?J!P7V)*4#QD<<HQ0]M+SY]*\#.S_.[(+==ZC.E(6%Z]_ISZE(;=J@
M&CASJMU"0Y:JC?"QJ68QHPB6T?TJ 4RO?FQ64NA$Z,P!L:K/=W&^>%0"&\\)
MYGT]4S:S1OP@> &^,)P:WCA)!K2[+D?G?^KQ^BB!"4*XUH82&)S8T(^ QN?%
MMT]*;7/Z]XGOQ/=$+% 0^JL$^HM8J%;M2"NA7JB9D[+1C,>E).C^5-W\(4%Y
M9UCB>39;R9RA47(^BMPC1'\-,'#_OF+[ZMG9ASV_&C=C7&0%OL_XD\-Y_K_&
MTBC:_*FPV.65I8(YH;#*47RDL$1,_+&2/G2 Q(2%+;))OX>RM8E>:#JBT#AT
M)D$H5JVE#89\?%(S*$:/KZR=ZNL'::P \3:>COD2;)WX@4RZ,/*"SX)J[I^S
MTE@SU3]LZLB\9:\FG 3F1AOME0)18W>-;FJ-S%@^:W;WN(5<9.JZW]T5S;<=
MY(LZ9.],#P,2V*+6Y[X(TVS<J_3/WEMV.3LL9[^5KR+NBPXXCA1U*X7F70J?
MSE>R$*+7.O7U34::0(7A2P.'1OL7610/+Q;Z?;1JH_ .P]HR7::)/39V(8^@
MK16MOM@C1ORLDTHW?NVNYX_^JVYP_\5;@O^B6W-:A/CO)=:<AP0VJ5.YZ>M2
M9#T+^_]\> 4GC(JM0.+MAK6*<PDTG0KF'?(&$\, ;!5P*'N%UHQ9\UUX6@H=
M@0*N;_H-VMT5NQ9XNNX&* 7HYRQ^I>C?S6V+9"8CCP""UJ>056/^3D#TY&%V
M1 F#&P3_I=4,ZL<C37CK=T;+MN8C.NLPST8^!1E^3>%:ZV/Z%G*+ L?3?_4Y
M+,PZC4Y]]0\*OI \-3@6EZ.8Z)-S\)WM&Y7ZBE\T$V(S^]92(UK'$^\":0(>
MW*"9[N]>>!L( XPSLK-5<-?GFGK.>^)HS5I&B:7ZN<U:\86E6)RK@R\M8Y@>
MD=-'#7^N)OY,/D-[.##R2;A9S)3 -C7L&<2OAO1\*$(7J.#EP(!0&[KL[^OM
M ^JU/;SIZBHE\YWLZHJR\JJ^YU65E55Q&T<5_;;97TC>D7XH[;0A\9D"PP:Q
M;R8V(UV!'98:=ML*%CH ;T(/8,5K$@2:N"6^GBA-&,H-68][B-T(,?@NHB="
M%Z[F!>@9-U?A<E^X!':7H-P;[G#A;<)I^[W<A_RI6QO[%+CQJT+774U^ZM9Y
M37PYYE/ 14H:G:F\MI.B</UDG.^:OZ]G!CF:EUXVI=;^.!Y0P#-GZ'T)^XQ:
M_= ML3#AR3J;JY7UI=NJ=)Q4GA:UVIZ.GC3_$N9@;<(* YX0]@N]9\$H;O\Z
M:9)0/\JX5"2O(8'= V8.*HQ_NT%!I"(T2&B@FF X/LS-3J^-L.A/MR:<#Q\;
MSQ&3B9P>Q-M77UEKH8(?[$PPH+71Z+P$]OGLN+9V!NOM)B\,M ,QH[XYD'P8
M7*>DJD,"8UO AIZ\C25OGC71O=]>MPO-BY)&",I:041<FB5FD]QWX'6^.WCR
M?%$'<UV9<XOMGGT'ZP#0P>E@W>EGN_'J*W%MR#KFP>;YP-S/9:\-1R:)5YY-
MSEGG]HZ0/]M#3>!M7<(^H;N./%JU[B:&@!ZSFG![B9M.7DG@1T(LL/@84-WJ
MZ,S@SK5TO;(I%AYXFSX_SO#:T:L?_Y6/3GPWTA0B*BFZNCNP^OK@.0?T8+>*
M1>7=8YXG900OT.PLQ-LM8Q,U?+BVT ?<9Y5*@O*51! 2L'+SY6#_?/Y]AET<
M%,SXIZLTYU.+BE_/U,,52NOZ*.?T@#1Y 4:PS\\].M QD$\_]VU3R\%MY[=S
M]-W.%@Q#I&XWHU8HETW>?,U.]B0E@?OF5SI&^W6IGO+Q'2\*8YGS>71ES9\W
MMK]F?WB+.W':QUGM9V::19%MP?%?^ ,=82A5WJ@65U>OE0,.ZKJE%F,/-G:U
M8321CFO890_T'+U#';RGS=PK-<U[G7;;=$1UG1!&@-166O+*7&S#IFE+<@L3
M<7XJ>\@MK:"A+J5U:/%!?\8@CG>FZET ]2UVB'&M[V%KD+?Q]M0J,#$V<)5=
M+K6%E/3Z=3%HP+5\?5O5B"3T2(T,+59IYST]60"[  I^%(OIZ'>NA2\G;[H,
MGM]!23 TV74CP J>N%+XPG3Z%>O[U?[<Y"FJ(?T\RZG;^/MQ@UW>6JO^.75N
M [$)3?1YO#79MJ(7V;$M[3NQN:?/5J?K'*1%@:DT-BX?;H3)8)-QQIQLW6LA
M\>=WT\\[/N(4YO\X>\)3N^T:,]3B?GC E0\O#^:>_75NSR_S0"]=I5!\46N3
M64<$06_LD7@7+WT'<WZO%T+^P94/L2WL_?=;F?)[48@IR/UJ9C,GYYG=PQM7
M&]Q/G;R?)=YM+Y1BRK@,\) $]N48) 4-"?)M6T2X/GDO,67G/:$]E&.!WBC>
MGC^ 3=3=%UR@L]E5Y" ,6+HKQ6THHL]U-*_?E2'U@^9O?:$+3'Z1-6["8OI.
M3HC0:IQOUD;X]'H<*0NZG6.'L00G4L-Z\LGD2=H48X.^!*:WUO4W@VLR+]81
M!W1"Y$7UI"#ICR?,BK^$8C/+!8\A%&J'T%%?GFO7\CP:0Q)B6=\DL, X=@2#
MT_3Q3PT<E,L0GJ<EG9\?A.YPN1AK8U')?$QD>*.&I@XZ0@+CL-!EC8V"G<7Y
M>?C3?5%@C^#$NHSO^_X\FL.+VWAB3Y._;TV"+N>^WII^<A+>R>>25\K(U1'I
M!>'#^UN'Q_W\2SMH=<?OX'*/_WSD)H&%GW#&AC.;?H-ZW( QLQ9RDMQ^V#A#
M;-0VBM,37-B]ZJW]<'M[VT%[FC)AY]:/PN/0O:?Y?T,26-M:*Q]%4?'M ]]\
MY%\>UJ".%$E@;#*Y[/LUS';7R.+CV@?K+@A/]]D?W![85808>F01KLG+#\MP
M,1*J_.9;7'8-<#R]4?4M8I-)_II3>>39 WD^Z5$78.:%XC>^<VZD%S7$=OH&
M443"0AU#_!PTZ!&XK!]E'FJ9ZXE@E?;_1BO(2T?Z04ZJQOO7(LF)NH:S,R:A
M_1H=JVJB_J)P,2TS>?@3T+V#,!Y7/A7.M>^]98WY1BXDS)$A?>;,-6-QRNO4
M!2F)*"I1NC69=L(7U*?T98MU%@6;B<R71?WH^3,FI9'SH:_#I7 L#1Y7WA&P
M-UK'J,I,W2IH7+4AHG;V@@1VZGWNRX!XK\>E^RSY0D$]IJD'U.>&\L1J=BV9
M^4YS4JM:;&_2ZKX7M?$67SN&!KPC[$SE<=U:[K!("%R+BI3='BCHE\#>.%E0
M1^%0!',F1 )#13Z5P&J*2L*6K^8M2M%<^@,$I-__[Y&:5Q,*:*FT!GGBORFL
MMU*S[DU=-(B.C*-6]Y<1//?2%$DB6VX0K?*:!(;L5U^:FFGPHK"7H0SPP+UB
M_#$H]4RVORNXE+K_XU$# _AL[">#35;VW^$GQN[A[: <!03P3JSG;:LJ'5NK
MARQ%[^R6T&\7?L]](<QBI'A;*$KGQ7#MWU2:9FUYS,5"[N[TX R?FX?17-^\
M;-G\P8[)Y ?$)A3-YV)!>/[K-;)Z8K7\,H8L:7GMG?1!V#5+I3W$WL#Y7UCL
M\P_5$EA0J_7#OAI_CX6I'8W?'4.6M3@T8#*Y4@+S&G'[+-PJ==O,?]WV!'1_
MOR6QF<C[R_@[3W!6&_%J<I0$G4.H.$A@][- #9\\$@)B; F]!^<SO'#HEP%+
M..(?YR4N+_2B*-R7E<N^ A>D+^U/+975--]4 B,[NJ!8JHND$$^W_H$%BKC8
MM_C,HY/56'[=\5ZA!+::+A7AE5E128(7=NA]%>T0C;V"B)V5ZO4F#GH,;A&0
M$;A&D@@90\B3S5^_"\H$S1>A/P/18)"$%^I6I)#,.T&GC$0(P]9*8, <=8!5
M^?+5M=48H:%C0'7/:9X."1&'^/,[>YUBT&FX8$].%]/K[M1CC94+X\-W@+9H
MWT^D9X3IS4FU$PM+#T=,*H6_X'?>Y_P:+-6\V>"?4DVQ@7X1X.1$UL:/LR%)
MV(T:&Q5E>1*8VKM[QO3=O;;L:S)R&3&VQK%VPKVDI$=2+;BU$ \3.6@PD9<Z
M1@S(KUM@(-ENOPJ7_I1*(Y.__CJ[=]$LQ^#6BT1$<B1]=99>F%:6N,=B<_OR
MM8,#[,P<Z2R45D1I"8A+O0H3<*&A]:4#LJF9HM<'X?H/D;_O#-K%E7_Y02J,
MJAW63*IZ,E/0TQ-E?;)?%C1EFM+-@H@<%Q4JCSC]6:B+WDC0YT/9H/8X:1DA
M]&Y<(08J6?FP"F6E49#7+W78"TY*1(XUF(#%!_B2"9;CW]SFY/^-M>-J.476
MMH0] 8@3/H)3\98^6\0Z=*E)+HO2P%C?UV*TZF*>]@TIPZ8L;#H>]_M;!:/S
MW?3B=T^117!?"O,4\57="98P3>H44'BKQ\],;)H(WBPKU:B?!D(:_L,GD-&\
M=7"\C@_EL 63=HT%G4.KM!&Y8T([E%2#^1 -R:OFLZTC 7/M)>JH\G_\<1.7
M>;I#;AW>I2^2H/6TG??]]H'T"L2_H<72_>H')@(,#W_6H>TKWOED>6K-])UN
MTJ*/=8T$%DRGF:6UV@$8,:)7?B6EA;5@0J>>Z%</$#YI<%PFQTJ#1,-.'6D2
M4!9OJW&8?^? HZF](Y\\&K!7Z9K\E_=*[S54"[CHEK=*J.U"6WFY]:,H\ YL
M4Z,5L0HC>UM&/PZU**!*V9J<6$1Z5I%_-G#1[K'>3J30I<\C3.<I$([4W;_?
MSJ61N7/\CSN8RY'?33V:E,!V8,XAE= I+OJ=/A9+VL[9BK[=V+F!J-%I4:UZ
MD,XH?[*KWC4'>U1DQY7"6N- PR7'*X^*1P63!I,-#QLZ*-4&0!B_YT]OA>:0
M>*T=$MA,K2 (URVPAX@<'=/?K6($I&>6N&"D.G+.SU7M-Y1B V[J3W$>]^HV
M*?*)/N[81_DG^TS9^VI:EC+%P"M7?;;GIX,V$6"@JV]$#;K@R>4#9WM"9<.J
MA3OEK^Z[SI"'J7R)]F5'P15P:#I* ]"/H\XXI7'25(X#HW<NAC]:M)I8*%%J
MWJR#&AE_^#.@MB-H9M;'+=_UOO]-S<*+GV>LZI2BI8Y*;J;9/U/7.O1\Z,&S
M8P_TMP\[9UE>NYL3/%OJ]_'+X%"_.[F,\W22,^'RH-?!I< V;UPS;/=7U:+F
MZ\&SU;MMG68_6(VZ5^$S!2J$;RL)LR0 3L=J5R(&>;RE&899HO[[2L1ZM#0E
M*[CC]!DOW.V"9[DZQG:Q+M^,C)#*;^KI#ARC#5?[\A'?PD4HE5<=G)&#FM[G
M4%4O8$KYW_,QLK+;YXD;;VU?*BQ)^_R_Y0U(N8@:'8-:I 5*8)^>T-X_S_[/
M2WJ$518O$G/_8PD/&/4K&MK-;*&M%>Z'9#DBEY;1+1"S8#1  E-=P,KCC!VA
M(Z LM[K9"JZ"&_<"?$ENAZN@'C""79@B/ 'Y WI-Q4%1H <C?RM *'LV[9[%
MI-?+-ZW<0&PP@:NZX[="*2L6CEOMK->8L^\YF"_HA38NF<M7^049>I%[;_]&
MQ/@7,8  SK8 +ZM<;GX9@HZ6813CG=YW)23L0^E-^7/2=H?#=9D<-H:O.GJ@
M9B.4[*B1-QGRJC(6UJF,92[-^,H9"C:+VR_1U>QFB@06M\\=V2*US3S Z^PU
M!?,I!_.1GK]H+SIOL1\Z8P1GEZL 6UR[4%Y?8SOAA!3[H1>P@S$A V;\K;DM
M$:.K/",Q P+^Y6C/X#JWT%6=WS:S*3'K&_-'3!(?:N+I@O86A\J.9?4[V%/-
MC^NN)T,?[S=QR]+K]YQ,O591_V)R_EMN<"@_?&/JKX)W2P^"!N;+D=O!:R^*
M^B@V/7DC4Q]/I>;&'/M>'ELS8C#;4^T(Q&CTG.@_UE)<>Z9RBTS9P:HMF?-9
MS+V?CS".Q-AK"KM$[V>#MD-3,YW#QWB-8N6_')ZE#8<\?J,35[C1^,+X3^O^
M?#MTK>4E6CDJ01OT:]@*K+_K=O!%3UO#[G-RY7:::=M#*J;NO]V3<$'AHPX.
M>8>$!*5>,)#"W2G-R6OTTTK$FW&QYTU=<T+X<?VIBPH[U$Q1(8.&PEH=0A\K
M$(6GF67^1#\:'GDO*QRE+!P&=:(M\)B5DQB3CMT 1OM"Z/L3Y0D%<5ST8LJJ
MO:XVS8\OXEJUUQU,.'8V+V53(OE=B6MA<=<-CN:>7]%"ASVW6 D?B JG6IKC
MK=:D-%_<<W'JJ]'Z79QBG]?'UOQ-K:Y-WZ.<8%S)7L[/J/[M'K@WLC+KL;GF
M9S6A]L9(ZOG889V5ZKUJE@0TKYL18US3QR0?MKMGKF<^HR"$+YPF^AI!^D_U
M=+4A=TLIDYTKU7T_89>\6AY+U8']D)_A_>F"+(U["N/-3'K;T$3[TI]/ZLDO
MG0)6!G$1Y',F.RNJ!?G> 42.578F\1DT+CSZAG'<5S.D."O*KZ3<47HIUA*?
M_;N<;P!GEY<QS5OKWR[H::2DZL929>6?*@0>FG]OZGJ.>20HJ,V"MW360N>Z
M,>GO5<1_R@E?L0 F=%V)>KQ8_=!SBW47<,/G.S)] L=PK[0?-K)C.^BR7RSA
M@^5\6-39X.T M1EXL=W9"L?R.*UN*_?0WJPZ.48SRXF?=+SFF:N>G,H/7VTC
ME&[CZ2^X6,N/[[2I<,N3+5=N]?K_L(A>TY\9IW"&<>7,?@W+@R7.^Y[L<%%>
M<SHG].7K8_L,KJ*TQC627A\*0ZZ/?$?;H76RM;?8(.K+WZJ][NE=CH**'\][
MW6>)5@CO=TVM6=G:[.%A7>-.65W8RH)LNLQ+40JFZ:_NQCQ?W\$@D@5B1IE!
M>;IE73[QJ:</1UVH8D"O3J) MX7*7=0=5<<A0Q-T4F1<:L]9YE[@Z*VUYW'U
MZ_K>80+"UIZW+5'\)-=>4J^]C@9)>0AP;'2(UH@(%)[]H$>A"'>BJ8MOWIY;
MOXZQYJA.-KC3@=3(G7P]<#Y8'F&G?K?E5.;]M!,H WA*RZD6EY]WNXMMZ^W-
M-'=UO*]X6]RH,6-][('!^*TS:[]1]H3[G2EV?^(>EO:@Z%O<.>=BIZN3QXP+
M-8\,@?W81@GL[=E+\+<#O)Z9/O:-L>C//K&I8]>-OZXZ-# IH/$^MH1V>KB#
M/=K+7B-K-*S[J^=(0@,IDM@1.B[ LE=?.R"!J;N/W1D I?Z3K=>92C#?2?J/
MN0!PH1/:]Q=&B@1*8<SW$MC=]O&\!0:662!R*9&F444+GV$QMG)IM%(\]_F3
MR*;%:/G5P?"1Z&!WT6PUH2I "D;E5CW,-TXQV"A-Z-E17@Y3US9<R%,BGU@J
MF''5S[Q\"8YO"FDWGYXG!X=!;G-G&+>)[(=KUGW.J6Y<G>&=57 *]!H+OI9Z
M"@=FWVSDY>/&52'AGPJ2MWL4KTI@Y< .VQ^(3:5*2JL/Z[?9_<I?,YVW]+-8
M=/I-Q;FO;E(D3D+GB ^*4*ZK&M]G56^XU-70<?'EW.^@%PU^0F6!TI,\4?KG
ML;R?BF&W[2?G-\+&LK371?NSO'MHR6TM-YI,^[[_SNP^P)+/2Q=7"D8DL+42
MF'@-MMV2-B,5'M[M?0=, AOX079Z/%Y]Q)-VA^@KI67$ED_3(C-.7RQ0S-"*
MSP[8Q*?X<K"Z 5JBWKB\GLVXX.#G/75GKO<!#J$U<O=/OIZ/27:05T+J)>8]
M\/^Y'/AB[I-6^!XGIX[J2Z\_.G589W8%E-V Y#6=CZF6?W\>EEGAL[;WZE='
M_9T%&IC<?W+]=_OE=ND3QP,'_(6DMY/"?/[#@K?3B1^L(S<<2#>^[S*CIGVE
MK06F!!]D,SK7Y\G&$&(IH2(+"8PN3^CPQ#21X*328FZGI0]%N!T'2PU=8!ZB
M\)5$F59X-6#IV]3H7F:U\+,FXO%*WZ<88_B*AC<-T#[^>VY\2HI46\R^9/8<
M:MPG_FFVF/E[=L7HIY$ [:2'N/@ND+TQ:+91+Y6X^D";Y:6%G[$^WAVFKD>W
MSP>5Y&I:H"--73H8(VQMDKLXAXKVQ@RB%*T^]+"K$Y;H <A73E1NMRQ#T7(!
MU*HRVR4?L%MOR_ZO5S^*FQ'O/+:508:<^=8CTJ1?G7*@G2E:MSTOZF=<DV:"
M2)[C,I^N_XL5_%P"2PS*]9H^U*C/RM2L7QRI%PRBCRZGB)D][^ #@1ZLF:JG
MOB\)9QO9D4989YE"P?KD/,7-6^K;JZL;%\T57HC_$:P0G8A DP3V+D2D3(03
MV<.M[X4TSE;&,N,8FA,K@5UBKFP;U1G7E,"2J"F6T6C.EBF+%5"*CO4.L 1'
M%8D -VB9)-[:$%PI_M:(I>TT_E4YN[1COA;]J,>;PJ\HG\Y(B2)8WEBVNA=V
M_T"ZQ=>3 V<O$9\.1A.8(1FSS;&+TWD9[9M$EH@!*_YQ]&\;(8KXRY#;B3:"
M[#$+X@HB75[<01'[T1)$9<50!0$'RA\B%FF21.OVTR"EK83_$( UL7*_^B].
M&N;WP_J%W^A'3=XOR<O7R\P7JF*I&GIC[4);XIZCWA=@PSX7#PS/]#%D95_Z
M-$ZF6\MS1,97R6^K9YX%4+">-@"6_M)^[Z_+:>E%W._RZ?KA[;K;Y%+O=,:V
M68UYH=]&S&1)8/^XT:%9"4R%J$9XWR_-*D6:Z1+8D,85P3S7<#E!>#20E2/=
M?P1WT[Y2;SHO@>DM)PM6W6$/G46$O!M>%S:KA@EE+DCUD'Y6%/_E'0[A6_UU
MM1.F8T%SNO_I%Z)3 A\NRE1@"'<3X3+#XIVCAD@X)?'T.,5": V'+DA@@\:4
M/\<R4N%0+E2-3I(&J01]ZS:B2E_V"NF1!-9)7TN;_8Y9%M\6FGT9I0T]CA;,
M^[B]S.L3PG\:S6@1S<O+Y+5E@N01B=C^8<HA\B!?3H5OH'T/_6-HW0)L?'?Z
M"+K1;4$ZKW4(P4X?!%!89RV!Q8:HR2S#-T0N%8@UK/@GVN!-(7"?'H%':X$$
M=E/6$;"5#NRG=[P$UAAJ=<M@&! P)+ -+--Z":QR__JEL;8;P[,[*#F+-,S/
MO?[\\XBRP77W#_ # L%TNU_S8:ELE=1Y]4-IE $89N -X53J9H_KT6WGC/.T
M8ZX?:5-H9"YT%1&::>_"2])Z6["KA$A=\Y1]X2'J/A8PWY#$SB6FW,;0_,?%
MK']M&(N!G,6(+?D)KN"52+X4(MQ-MQ2LK,5.H=#B6"![XOL!+6SEFQ7LXM!'
MK\U7YEDFC5Y?O[BT>H9 RZQOPM6BK$6L*G24GP"Y4?$6D#MY4YWGY6+<[4F"
MPEO0* Z_)J)XKW@U>+E^MH6@#[K0GP^69E[Y?=4HQ"HES<9PZ&,'H>O0=L(8
M:4B=_XF! #!$90*B@M480@G""!>H;H#=3)+ "F\.7LG@A<CAC;HJX*I^!\]_
M>C%M.D1.''__[N%\\^_C-0>:HMZ,G*M^0IE2OSEV/&3+Z<>/89F7,D2[L3[W
M?F2]R],&>E_WE.R^N*?/)?9-=YK3/\\$D\?<S4WOOSOF.<+L-,?NH&9<[MV/
MRUD 3:Y>++YH76BR_<$>VYPTL\^9P=JD3Z/=C)^85 DL@#A<3<^WA!"<$6/Q
MFC@>307GPS5JN<-!)([N["+Z8^_\/@Y0FL:/?C/Q("7VW]L\45%BA^DNW:LV
M.F[[+;SDKVE7E4)20FDE6OF[?^3JXI6K%%1#7:JV-B^]@'(-7BGWUQ&]C!ZA
M^*_LPBC?[O\=+]!\J0^U6G^I*M>P[@](,ZP5T<?&ZG\B1?6L8B'KD6Z6C:K;
MX57X*$&DT!B,:*4.&O%"8H5K(L#U2%^SF,62X\TY=G2TZE74!A">C+<K'/CN
MZ:>K]KZW(NJ+L4ONX=[*\'?BT4Y.;^!>H8./7,[JAOY1S6_A3]2=!6OOW8[L
M[)7 J(_6.6\VUUX=+$T.I=>O63M\-QZ6$Q!-R66Y>\1M4EO4VGN;!%W&#+:N
M7;Z]@<[NCZE>E]DQH81QLD#")PT;#MO_LG.Y,W AWPE3JI$G4A R( ^!NKB'
M+(_2Q%M!1]B8(2P_G-Q(6XM<ST''YZ_);:.]760F"GWU8^ODGP[@W)IGN:P-
M4E>ME$\X-!O5(DW/EJ[Y-?QJ;PY-:6!JZ/D(=@A'M*E^3W*L6M'58OI?.@.&
M[^'X)JVTFKN<BK-W&;N6^VHXZUB8\\\:!QN#J[G([Y^,;MW=?73HM=?7ZUG?
MK9_C/_95'PKLMRO)ZO<@H^>\4J?@@LF,!;W4R!67$TGI.D[H(1WYZT?D\P3)
M*W-BS6%^NP16<%^4R>SGR_6B5_8QYBFD01Z_?4R:@AW$'V4^P$@#F\]H2,\J
MK[%8&L]_1*5*P_>=V$CDRX+ID#?><T2LC^A&V=B^S=GG/7?61GOY"UE6V-!Y
M#2GXRK\=^E5#.;W>*2J2/&G?O5O;_B#&N=$7!AQ()6,8W0VUZ'+&;&:/6 O#
MQ^CUB#74S[01R$!_[*)PTFX&%%PBJL_N$.P*3:.!MVM>,;S(8+;C;(]&8Z&8
MQC$5MQ=-E*D:+=6@'Q&+0\0QDY'17EBR-2D#V7BGNOVI[-=+SFN^KD8%.T6&
M\]#NR['\BK,>30TR2D5;=?>"VS@2&$Y5 O/VF]^%U'G:H<95ZKIW'6XA<D67
M,V<3SSP0=V/?W5)Z<Y=(_^MJ@85\F:@TGM.O=\].+O7G0_C@;WY[DNLN"<R?
M/'C&-$[.1K!J>O_J<,<[R4T"KSUC^\Y<5^J]^'06*8&AH_5Q(2J\_KN:<_&/
M30+UE7S*D?T)87LL2OVU!K[K[!I[G/MYCW,^PNAEF7'X0JKV+9\U36&CQCG9
M@Q Q,4$.=/5H"?<_>I"2+;H"[=J1D'4FD?XUYEB)C>N&L?$L>]J5,<J5'/1?
M=:>V*T^0%=LFN%C(S4W#L4L?FXQ5-=M/NMF[G?U6%DI:?E06C)[=GR&N6]4A
M@3U,JB#R&-H\#4VF2[+XK@E\T)?_NF\?:K 8?TM$,HEZMO'OZC^-=$:G3WW8
MH-<.-F>KDROKNA7T_"_AN$IZMO?M#FO9[DP491#]K]^"/@DVI9OKB]=TFPMI
M 1L#?F.4D#H,P.ZO:]4*W-^?U;R3V@_FW"+H;8YOXG*.JCB;YQ&VG=E]5-G9
MI*B5H8GYGK7L?C_EQZE4(I*'@A>UXMU:M!TP.@E-SDSC\ZZ7M56!Q6*,4MG!
MU">:_6G'KE8\Y87X?_R056M 1+=Q67*:/7Y3$<_:F:6'&[?S4+P&/_63_$<^
M0_;\Q3$12,++B )69-#OC&:-R,M[R67GI/PSX882"SO4KB4_DR(X/DY.)9=A
MO6C KRPI#QB;<9# K-='/V>?_]OU[(JB^$< ^FLM,>DW E0L4PSDK:VL?ZBH
M$K!47BJ!69T5$].^:4CQ>YP46!ANVWXI;Z-9C)UV?L'\H9B?^PZ_/_*P0S1S
M5/_9]*XMXQ;+D6/Y/VE/Y449-'^ODT)?4?*[TZE2*&Y[.OCC/'SV@O&$6_%U
M*VZV6!/!?]". &J(%TM&/,0FG0X^3"2A]_O&%^NN.TRFSLJOI'A:'UC8).!<
MI3T9">EY*X%QU?NG\[S%9RVGYTN66672::3DAFMC$$6BF6/FVO?_N9TQ%;DT
MC;TLIJ\LS3J^$-J#[\2?$$I$7U;BT /QZBK= [$\1ALID2@_>Z-X%]XN2$32
MCP]&(83*4+\I;<=8]Q1ZZ.W430*"A+$W1#'#\4LN'D=6KA$O88;.\]!2@'GQ
M>>1?1/83.?8B4_@D/I1!=?$0ZXKR:('H-9BP< YFR(Q_ JC_,F80$A[*F1N0
M=^[RK:EVT+I479/K)"HMR<?==[YT]D>8UL?6YOC ?LJ#:P_F/T=K!Y95O([:
M=Z.( 3?_>'[AA]JW'\[XO&I:[KL9$E:/O><QRO_NY\+'ITK?=A?IVYJ[WPL[
ML^MK5H'S&?=8IZL8V[S@G/J<5BG,FA:OY4E@ME)H(R>ECBU#(BGT7)'=C5+$
MC8O7%KP6?W/&1?!C160)S(>ZBO"Q@!,4_PR=CE(A=))5&K9"XG[N@QQ&DK.C
M@4TYZ-9$3-#']@P?JP;&^5^S2W#'FRVOI*T">BN,$AOV?'.7P)J&?%](8,VE
M(IH580!;_GZ%T-*P1P*;:'V!4"2&O V3P-;'":S&%B6PU.V@VY_*UNBRE2-\
MUT+R3*UP4;"J+S)<@,R_#6_WZ4G^@%B1DEEIKI5S:[DO-!35_TRWOR22*MSW
M^CL]QA8)+'X'Z#82OF>X7'!Q@\SZK[;P8_?P1J*&.VO1@9A!=FCCOV=@G 88
ML_$R[)L:;+ 5%EUI@\=(22*-+S63@F;1$S$-:/FS,MY$*V-2:OMK:_\]0!?E
MH\$U^#,26%?2841@%U:%V$P5T6!H\!&V7 K8:G> KL1UA ':5Q)TAE4]+M)%
MS$BEF^C I8I3C\$$*N=Y-KV)TZ(G4D+]8MZU!&\="E#Y_ \Q ?[$0/3@CX+W
MR?;GX0.9K=L#L\YI_!9XW[-=,Y[S2'A U!!%&""7-VK(BT]DMOI21:,:PIKT
MA!R8(#@9RA5OBIA=EL#L$@1(A. ==A,1,[SAU'\Y:*DBT!. 5&121G3S.)<Z
M*;BXUA;R%D2_VOMG(-]E^L7[LUO/$W]R50XC? +^4UM#:L)+Z)P@ZKO-=B.!
MM_CKU_O[^N3YVT"7(KG4&#2GS&+[AM4*%^SU\DZS@#>TD(?26Q.^LB_)2& :
MQ[EU&T/3,;-)'1:(1ULN)%N*&J.K;?"._\NA'B.HBUGD!1RQ_/V_@G5;%)4Y
MPJ++_K_.MV>M0X=4:J*K$#._Y*G" _K)4H,^ %^>/(RX?/7I$]284N%)>%$&
MK&0M%(^)8U5_3FQG5:G/S#3R$D2)0N=VPF6]>%$9++CE G M*FPK=%F 7Y!:
M"EWTA.%$*S-*AMJ_KI'NMPSG78^6^0K;=ALU]+QAYY^:F1!Z^[_F1Q+^+97]
MPL4S7] <\NS(Z@(*YC6A'P$+7[]O_=]M0<[-3/X!$/4DXI5_AB=]YS,?_U<=
M@O-7E2?[W1X&6%=6/=M)?K4C=9YQLT^]>$WE ]F9H=VO-LN&CN_%6,#4VA'A
M87?N]/R>=OKO/&HG"1WGWNO_K)9.@&Q%=-Y5^/]N.WY^+F)*L$2X$'E&]93G
MOVMHX5L%E_#'_O2F'^QG$ X!IN4O(-]612(;OL8_W[#_T'"TSS'@,$0"#9K^
M=.*JB[Y5B#WO[I]S'U)T!#WG4O7*^H*].TLI7=L2/#-NW*PW>2+0$MJ"U!9J
M[$KO.&GQ!YB06*<(CO.E@5T_[6OV"[]^+]-NL2RABZB*4O)#[>R[P5(:]"=H
M5X*7^2GL7 5\J 2F\#/C&>XZKZTJ?UM-)]*"4[*-^XF^XML]N@7@QW*_*)X#
M:,DW//5;\K5 W<PB/]16@%]/.3>MI5;_+,#49;*F(:7$7RO5S/)F\8NIFO O
M7^(+7[*&SY_#GOON&! N]_;CQ*!8$;"+16V&L'\#:#IK#132V+ 6:'@<\!SR
M;1I5ZJR@K<.YT7.L[S\H[ZZ *TW<K+)$I;T<UMM47=836%+B+9?(.9]W._S?
MA<B<-ZX^>+BCL4-6/UV>IO=;=6/]&EF]U'O&PZF+XL>Z%3(037"8T,6JH,8V
M6 LQG2@U?&!WG0OP&P/:-6/CR!N#GT,^[-R05>*.2"9C+HWUCM0T%_\P1SXI
M?'/*; 07.RO/8<D+G:!R<)Q+2. 6CT1Q&'?QFUX)=>K ZEBQ]B NH<F4IBG\
MS:'.%@D< A!J-^H1+E!&(11+)ZY#^V'BL.4V<PD7 &Q,T'91845($K9B;M8#
MD'>%9E&%OKY!4<^NBC6 ZL99!,/5%;VN]%"(K(Y'(U93W/\\P-*64N#W[SKB
MKAY\6U'F<%N#*72/56XWLT#8AC_6A7?D4)-TK8FQB'7#;;0-2"N>Q]D2I.]3
M'*\5PXFEXLIMP/#4#4-0P?'^2D6!(:%;@]/[M#;9Y%2_/PTF7N4WQ*23-_HC
M5C>H^GMM@<PXQ=35PFW]%:R$_ UE?015R%3@Z*FUU$Q<'^[AJ6LP]Q?NXF_;
MM!O%]?+-U5I.F6$4>-D7/WY+RV'KH#6["FNRG.V>Z6WW1?(HTTXO2SO?.YN^
M8IR_<R<?TQG;,1EK^T,\O[*H8SY.?2]DE*@=MGRLIVKGG5EYE@USV'()MD:V
MRF)+V/W#FI3@4[T)/W>;[=8YHL'T&@F;'KJ-7BW>36RR(1R8(E92&?#;8@5:
M7X,:9&>3S0^!'-FY3#6\ MB0P;56\0"79K^P,8,A//BL3!!7F@!&U\9R:(D+
MN2GH1+@WH'*L@MQ*6-\7C+0H$/[3MQ7T31">B>+4KR;>(5919]5YZ.11^7?]
M#3O]"'I=2$/!B0GL.U0AV]&H*7]]ST_1<[S1K5N"TQ-S G=_-_[-?JW1--/R
M(,#G'U"<]A+274'$JS5H05CPIV(TNN5A9&DL58@4D4%L,S->%UT%KB*G$Q X
M1!N?L!=X(Z7_9R@I=;N?XO*'6QH4:M_GS$\WY6^)=>^9X_4A=X1%A(:&F\57
M[OC0]>)]SKDO25F#Q7HG(!T \P^(B*G#%N!W0-XO<+4<VIT>#HE.V^1/D '2
MR5RL#-XTW=PGA3,74SELK:OCTMRP.GDS;BNIV7U3'YFS&*]1X&EUR4]5MC?;
M7'/Z#KG48IHY?MQ^+6]+VM-PN0LRO\P;"Z['QARV8&Q7NJ:$W@;G[I+Q3[>7
ME==.OP;7'LM;D"VR+LO/._537S^2'6X5;_[UUE=S!NK)I$;!.C6OIR(.%-HY
MY@N+@5-492!YH]D/ B<<B6?Z@7T.'UTDW-^-,A+BH + AT.W8Y-C45MB.=7Q
M*'EBTQ&4&J'=RP!DW*66ZO<A;9Y!="^@FH0WK;F9"_ZIB34'EM((6_ >G?CC
M'$=$LZX.Y(N@L])TT#.U@F!Q%TNM8;MP8PWHEEYGC4IZC?<!?&=ZN"'Q*YA8
MI(FO/ZB/Z?WS"#(9H3M'] ^R.GU["K6W:]'0HQ6UMMQ3SZXK_ @P^JEQ!9N\
MM[!K;M$@!:L^02YU'Y^9%J!Q#XE)2X0=$ *(:%'';IY!6A7B_6KZ49J0WIGW
M$*T0LATI0>ZFX$_EGNS\M1V*]>;DN@40X>>@RLJH(#4UOXKV$A\KV]),P([=
M$,<E*^'F_H8<@4_2,!TKE/4%*,VZ![N1:SB.5JVH39 GY?.25@0]9#WN/M,A
MX6QGG8PWDF1(BKU1.XU5<K=O+5D8&$P_;'W$Z33B%&N15P67"Y=S*4JI/.W=
MX/7TR5/8+=@%F#QRW8W&R63G*=B.>*4#[>/6!Z;S4GU*8)8YC5D7#MQ_(V,M
MT[8:AR3(4XYY?NK1>SMEF1\[%=J=D7SOB-[Z#[?:C&/LQV-OK[%^NQY&M*Y1
MGVT2G(&8O)^U0/XT5Y6FA%<$J_GQ8 @=&TO;N+D9K1#N"R3<)J@3>K%J!#B4
MV8I8MS 96)DK4N+/'0.RZ48Q[C\29MTXGT8\G$7/4-MI26+52=VM@%=6*+MX
MWS3_F.@#S8^:2MLHS>3U/JUB$Z!D*4Z\$W^QBWC%,XSS,I9CN/K3D=Z%/YV1
M@LZ+A],$KE#(>7@H+RH"9+1X6N,W<480@BAGR!=.MXYRO'.C Q^J@HO']J5A
M^+ZBW$H:Y'[\C5 6TB\FI2,& \"2<'1<OEP#0H-8YF[7Y<*E#E5HVK4<>?%I
M^_W) )[,FY0UCPLKE1WB=?8]D=KIZ@Q>"B*IQJYY+L$2VU)OW.@J!4$+S,2<
MD!BDX67>%RM.=&F!$M4?X-);^X9.1XK(MX/"/?S"-X?(>[ 8G':C"\E3AB;!
M6]-M8 N-UV4687QQ'N&\<T_$-K:Z)N.FYI:(I8GKT6G[?NB<O3'R+9J%I=".
MP=P;06?H29TQ=Q5PJE.];7W!U>,<7]#YZD;<%?0&DQ<%]MDMROY&ND6HM$W+
M,8['UEL&1 W.JIT-"@YZ>2/?>K:1)Z>]T/0U*I3D)'[0W,[)QO$TAQKW3]@=
MS<AH1UZ[#H_<)_^;4_"G)*!R!Y7.C$-L"D=OAH@M[M5WB5?F!M09J!W0&0JT
MF>YN0YU%\^:&I*0NHHT<1U,.N<&^=W74"'A A >A="8;3(#5<8# -7WSYC2S
M-E.O0RB+GA_EL78_@M'!S*'R(UT-VR<H/&:"T"$:\.5?!!FS&12\?2:GGQ[@
M04S+8=Z5ZIPVJ,_329AIVI?U8J A@0(=]>P5HW#WSYJ@Y3>'I'1"BLZ09T
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M6LPU6H>;8P(LDE#Y.21EM:RU[ZD;"<.T2G1,)34Q_Z\JT=,Z,U"&YLN*1QE
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M'/!@*0!F^6JV8'1NQGH>HM88XC6-B3D_&N9QZV5(^,Z.6MA!+VUL2&,E[(
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M61NZF^ W?#WSE:\,C23<9PB;X-0H$2L!!_S4YX-GD%%T:_AA7BK==FT=>0Y
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MDH).'B(I!6C%10F&U@G9>[YE/C2;V5C*8MXY!MT&YYOU3$H+'H,>1S"GL3S
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MP53VG?!-JQZG&OFUU[?5M6MTGAOYC>]-D]Z]:R309NA0!@RH)^YSGB@G;;/
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M9$]YM^?:?V-B;OV[Q&'H)S>C_\UB]-G3>I68<5?P^R31HU34[7VVE6_"OF*
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MXR?ZY>Z9*VXTX0K2:ZXWEE^O4^,JN[_:Z*F@SBZ'1/G4Y4LVO1L)VTE0Q(Q
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M1,FP>"]>HDT,H6-%W?B32LFWF?V.M&N$EVMDZ[Y1WOP,,6V^?+:KO?C3)X<
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M"%^@/(&)UISAGDT9#NR) 0?V$KXK#;3 !RH']DGX?@%FY#)B=8-KAV6-JGB
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MXNHOLGF[NW.XOK!UHDH6H'C<8VRPNUMG=T%A.\HXZ?.^[)3=W=&[ZRG6$1N
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M^J1O<2#-Y4=51=+KZIBTR_Y?"S]WW'"L=WAVU\'\1K?*T6LP[ZS@=A8+:KQ
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M=U.APS4M@E$=IDPFV+;^,!(:U=D63.#)5VENNX(EG4!OZN%;D=OG24])6[V
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M<F>#$,5=0RT]"5E9E_'*/9^",,-MHY-XUC$\TY'Q&75,\XS_$#HV1&&G1AU
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MM;,6&ZW)+E]7(X&R<8L]Q;.-(@QD,S("Q:<I9[6 JN!ZCG(V#"BN=W>GVJS
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MSX\-*"H%6T\8^29TW%\_OK;PZH&4%>E'E/1H\X(*JTQ.BBU*"SDRIXG\HBF
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M\V&$]$S=^^UH2ZF;Z%!1_I&X1=6SMUJ&R/H/HP?,;P2I5LP<\GT[1/B<M[A
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MTN].X64>.DF(9LL8O28T;M"#(YUXR&ZR+KNND7?^7#Z"&>+4FB*!5><LGNN
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MPMVJO.%RJG\8'ZLG'HQ!46*:E@0H^$>4VG>^FWAH"W* BS<4P@!T;[#=N1?
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MU;]J%]^GAO5<KW(K32HUC(H(<:X]VB<OKZTR_M"]>CBS<'XSSP9_?VD+ GC
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M&.XN])4@3[]M8#Q'A+9O(/9PGY&Y\<WZP=MZPX(R=A2]Q==.$'V_6FZG*9A
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MY5/EBJ'PPJZE59T%G'ASTJP%Q>N-[&S7/WQYZ)M#3$5G E9A",VEP.DL"L?
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MTMPK!DQ_[,P<,,K[8V^F3.AW6Z9>>3UX81H63RE+'J+/<"$1"-=TWR8G15#
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M/]::'YE:$;?'K#2C3J)6YT.4*C24O$N4LVB$ -M:M^[GNEU1V\)9!8[S\<S
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M0->F1WM2<[&J0%5HG5C^!.:AY!?4\ )MPB#8B;EL)V+5\)SP,U[:;HAZ&&A
M0(V3%ES+/C%PYJT] M'6N4\X Z\!90)F,$XX+<-2\#+!^+[O]:@QBY>#'GU]
MAD<927E?4V!C>N.-9D<;!D8[QU%*%VIM?&;<B0&!J 5TL+G^@T=5\74"KR8[
M\Q8;U(",Z(*F9R;J$02:+LRL/N)"*O:LB6=@H" CIT"O9>6PG>CR94-UQK.P
M6?I>LWLC%<?D:P,J3FAZV516%CN:3XZC*A.^NX=X2;F(]9C05OCU;HR73,H"
M:RC4PH%YI4(3@GO9J'*A8N$NE*>3^H<JB;!$HZ.J8\_A_:L?GI6XC%T:>COH
MQS:2235K*!\\7E7SKNQ=0L>"0,X39K>>T)>7/3L_E#FB.O(4H@,4% _^E/#Z
MS?'(?;D!^W+27]Q/L+6IJ<7;VJ*<M@CJMLJ5-61/XG=E<W-3-8W>+A\?-1LF
MDV&D]KWKN+[@F98(HSMI=OPY/@;XGI-Q'4_Q=D\A:1V)+1E2$0.F@S(C:]=+
MU&/)8^)O/2KEW8M62"GKB/)[*!\AYN)YF5KTV[I:PLV4J3MR7YK,DQH.?UST
M.B%+>$G(<:HKK/6^_:7DA7[_E]R%D7Q?#WQC+\N:&B]": 8]6QY!GUKTME4A
MLQ8E0DHJN\[<>>J@'M[Z/JRC8%;UF 7U>NGEE][F<AU";3Y)MZMBLN4^^@^?
MC;E=,6)5,7(S+Z,PKS8O;7O DX'0&>!8N#),.)]4IKPY%>CV1_]6H[.]D N1
M/P?F\KR,.*#)A:!4INN#P_ZJ K'@@_Y1'GC)-(D+68#+;;)L&46XD0[*%DKG
M'VMF8EBL_ZR$:781JC,X9_'0H>7C[P;5@NV1E<G/G]VJ;A@H]5*:<46F'Y+/
M,W2]6G,ZY>+U'0[()M@^3Z<=?T#1C).#QX;J]*>(/UXDY-4737QV^#*Q\*@G
M<DU22L6"_&1YW88YJU#;Z>X:1Z/;S+K\9G3^X#E;+]YPN)Q%B>#:$EN)B/AB
M=V9_F<OU4N^UQ1<F@7:)&_@RT[-7NF#=1;F)LS^](X;!#PR'P%@R('I*Y0"E
MN0B,;$3\.&I -\"J*FUVEF(QK(-X-3K_*)E=WSIGW_GTWC(]-^-"Z= ]%[N=
MW:\-/,9,V&G7F,]&1/9M*Z.#)X0LI(>0.2=P+G+^+Z<1;Q^I%M_-($$)UQS&
MVB3(@^F2-->/2<YR[(?G,\LC<GO6+U ;)F5(.H:L6OAO_[=+:(J:VUS\\?;@
MOWCM8-BV/4#2>>GO+OI'6<XI6*7;UV^/@1YJ[\XY/LA#L2UM]$O$$1[P9B&F
MTBG,?>QR\CH*JTWL6WBY EZ09>,7>";U34,WIA:TQBVN\G"Y*'*VD\-_HH#3
MCQ/&>5'&#6F92_->#-EF:?4Z=O2/.AZ1#1)@XA0ETA(SL.1.0T_,3E\!P_/G
MS3V<I$>PFD4+6MZ_^A-,+(=+9"MK7ESI.^EU:UE;6U\\.G)Z95R/PV\"\#7"
M).J"J.EZTY%T<:]M-<YGM"3N3KU"8QJEB0W!5$W+-N%BR/NP"M"E38;,*EH(
M%+]4Q=@=WX@8W]DB\8M6*IZE<O-FKD?(3V2&Z"/JR[F0N[ !4[&E:[2M_4TS
MH ,2ZH(!;Q3<>#,DBZ\HHA503YPV>UFLJ-!B'HL2.]UO'.M7H!5'D-NVRDMZ
M<]"W^/RM8DM_60OW2V.7K6%G/718;WT28HAR0</FJ;59K!YPA+;"$C.DHNGY
M@.244'L+0@P3KP=417(ASND'*;;O0"0!C.<90L7@Y$E2#7I"I*WA])".&!!J
M!63$8#5Q[@67I#C9#$VJ($R@HJ!.NW0^!,9(9=8/>M-XL$(2,?6*!_9V<R&[
ME4"%$JP^NY"',#J@8\7,WQBXYG@82P[TQ '-S4Y"#,-0'6_%C!U@X$TJ\1!K
M'R#>$A_)"\=&5*%)L0$_V![,XK1P+(.O>;CF&WXM?C\FR/:%$1DV["A&4%9K
MMHS= Z)/,M?<;KQ>M,PRB"Z,;KKC5RX;G1#'GXTGGO;-M82*+WU6Z'[QHMFR
MF>J6G]KUG5AZZX++Z?CD#HN*T^;)TJ8>)S<M34V"6K5]J[O1'8=2&9W,U\ O
MN/W++*%IE5@4HC$=W<H##T8KN\!OS"3T8RTL17J-_)BC!"K1UL")::53))4P
M<TP\33Q&;>7H*":H<6NFFSA%D5B$"57$7EZ>-@-:R]7B. +37,C$-H=?M9#3
M^;"FJ@F'QU7 R=.QFC05EJ@Q%]+(A8@10G:/+32WIU(@<"5[T',JLA$FAH$V
M(G;5V0>Z3G^Q;#9'3Q(C_9_#)3&WO#0&'#);QEGCE:F'$L77.QF14ZE-WN,[
M&Q-^G-@P!1-F&0!WT_*>ERJ'TTP0)'O4XB/%V6^&PQ6;V9A[:UW.)N^4E"(*
M\S^C**ASY&?W'W_62&U:"4<(<?:!L%] =R"U$2X%!DVI")_JGVL0 RI?[$G-
M&26Q9]IR"QP4]\N=<UI Q7X9SBY$?ZX;J8EE#[72Z2T;EIT*6Z+O*#+A6OZ+
M]RL%Q.(BSL;:FM6=26@:;.[-H78YU38B16SJ[;>UDIP-XO:9>QE")9[EVAS1
MJ=W_=?JHUQ4+OZ]$<7-3,PNS/GS!ZU<$O\^YEFF3V]%)Z._RQ2Q+]EO63@:1
MV<TP2V9H,HO>O@43&>*<?=,TF)@'DPL1(L&DKV.EV,\XQUFG 6;6MA[+CIVA
M(^L/+-KVV3N  =-?#"V J^/2J>ZT>N_&+:G),IJN;Z/TS\-KEB6:E=B]8.YV
M",L#W-P^SM)DB//4/B[>A"AGUD^K3.1?BZ3UL$XC!#':[9E2\-TL:0:L>1_N
M3OQ!EAWR(%;5"T$=KIJ^[H\0<5\\CG%^G]83SY)WU2!Z9KD'C&>.TQ'96PI=
MA#:KTWU)XL(SGOL!LDT^/EE'UZ@OZ<%0JD6+9=C;P72/ V&GD./&N:?$3LXC
M1:=_-W2;.IF3.;SXP/?[.UFY0EF[H21)ZQ<SB5[:*%M23M8CY":-AQ1?8C2I
M!SD3DSO T.T@3C?Y$!?BCAO%<CK2-IYPQ.;@$-">(3 =$(;=O8UT9%U.XT):
M)2+Q'&G6^;@-JP$=EVE$)&P4A6RF2"\\<DC1NCUND^]\L]@M8-9D8!79#A5F
M>?,D=X&CP6F?E&:7D.], ]J<O<E9F&BJ;"C6=NHF0X3FR*RE0L<1EB-8%0!*
MJ^^)75O!ISZ:K)))*897376=:SF+6?:261X(R761^KV2N&B&/W/4TW)W1.>;
MU<X4F<."1]^(-(]\4A7I8!P.-(M^27Y[^J;GC8);96I9J!2$&-3=\@C=V<)8
M)/?(+\6I18G%*AY3"U;,(I]\,92(L9'*O7R)A+"3@X6-8Y>[9 ;<N1"MFA&Z
M^C;6D3,J$1+O68!U[J^S#-XVXW2'B(.^V^JC6)$XW-A$&^7-1@QV)U7)>1K7
MCCC$<DQMU S00L>RE$H6X%H9LZNX*(E3*Z%U^E0OOD95$'8]&H5#S*I$4"KX
MZ-E47 2Z?/;9M,KAD#YT>6KS=@^$,R M!SB1 #[F^5YL( W-F^"SB=LNF*I+
M@&N3BA3KQV[F/<EY;EJ1C0->1+<:G4BJ2U4+@FZ*;-6*;+&N'8C]1![6%;6<
M%A33\IM7/MR1=-,X]L+Y=_*^YKDV2:Z[+7>@DD<JDK(4;6 PE(I(_"S1?+C)
M1!FYP[Q*I=2F-BD]G>YN9)3O49;Z2UK8O/ZJ185%K+[]Y@S[!<[-&Y3GBR%/
MY4O+@\&,RXN.O2&BUUF6(.4U&$D5S@;*6XVFZ'S,8& E;&V1^ 1V8,W[:"/0
M/]*X94"B?7FXW($AO>-<P"QOM(YL-)P <D>>U)W/@%761[_AV5\2AS=),MN(
M$_F<?2/3F8=#.J7YP"Q?AN:T:SQ+9?LRAG@-?#!Y*KK%:0= 7/H^;0C 4QG:
M-A'=03>I!%B+1MJE7O$6$?T;:?7U88=:O_D(DNNM;&6WQFPBW",^K7[:+9CA
M=_91]=6Y&?_%J62<U^.6J1E\L:WPG'72M$6]CM4)\\'$PLN9%00+GW /K6!]
MXYBYX6*M!?]I1^,*9_-6@Y+3<J?@MQ.OW?>R0YGU&3-2&43 =\JP324<47$H
M=OLRRP=T)V!-V:'P'U6W;!$\^]D-NC+OO0&=I\7JP5.TGJ=.2J0^^"'.1$WW
M8R_7<RP;H#U<QT0L-:QBGVR?NM).:OL3?Q*C)_).JM63U>4!)H*S;V(*%[>%
M7DK?ONT&$Y89@(NP7(:Y$&_H1*@MZ$.#17-V,*1)5!,[]<PX%&DYFD9 -JDN
M-$"'=<RI//SJKNRW&*O@.$!?OR+S9+G3/&%'*OOYZQK?.(T6U\.!%L6I5'?3
M3N5RR_2KVODIM(8J?9M&,]4LI\KC.8LE(3)FZCX+.:>B_4_WYI^]OXD]\]TB
MUHZT_:W(V)8@;-BI'FAP!A]?_L1,;6E0Z8A:B"F/:?F0 YP))V%VFH[Y%&5B
MHH4CP4@:WX@.D;''N#:)9TB,'&<T/*-VN=(0+88CSHP5O'JF%*:_I[5&/.8N
M24G3!MCSPEDZ!7ML2KM>I6D\<N+>W?17K(>@TK86%C?(,F+X,JT8*\WQ4I<
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M9S8V*($O>'+937%GS$?M90@_IVG;^>_-[_]:A2.H=P5,M_ZH^@Q="(&!SL"
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MZ^0I&Q[2'28I.M\+B:K(0X5L%,_2;1?6R\1<Z?>K7VQ]]=PVNPH_-S8[& B
M3O[KUZF<?!OICM2JEEMTA.?7$-7A!@WW+<V(4CB,I?YC3]5^)U0J(R*1EHD?
M)X;Z$:&3T==/VGOM1+T%^*+N,)3*ZCV++?U]\]SBE*:>+%U$40DT'==BUMVW
M_3J:*LWD2(H0UI F,&&($[<#FVEWJJA>DLVVE-N5?I&_-/2SA(B3F+<C])Z
M>]]-W*F;(5U>WGYEFZE>N\FE?\]J_)M)+J0G?82SLY,+:3$_:GKJX_;+D]6G
M+L"]W=BOT^G\E6T&0#[N2T&0O/+U[]UY=:TZJ/SU.ZL.;XE#"[33/1,W?>5+
M;A%[/AH>SDKKMY:[>6%DZ*;>@O^)I?D2?2S*DMF@25L)UT"+$.'2:);>($E^
MK6</+\8ZZE$SHD.<P4":RM-#*JY!.9X9)]R]?A[1,<T#-2TC/(D"<VEAS''%
M#;++L'_ZZ65.=Y\7V^=Y^O/1E#NW/K4GV,49R0XF&!7_4^ 5D.+?6M6'"J8
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M&5V^KW+OUV#)HM=V_-N^G#_O3__1]OI7P1]__I_[_];W".[8_P)02P,$%
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M,(BV3Y6))@1RIRT8C[;LT$&2UYR<4ZAABZEQ>M*P#");4KO<(H0G,2]"<,K
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M#5H'QEFX"+'C>ZD\JZ,S:Z[/%RC<Y:W"^7 =M'QUCJ>D"+'"[E6)HG@0D!3
MJ600X)U8'EGH=BB,>/2C,B'9E0Z"X+X[.$FQI0R%;< */9+=M?C@T@6CWU2A
MJ@+D:;]&NSY+-DLV9WXWYAN$BTFU<18U%X]=,\D566PO:YT<$9^2NI<[QY:'
M"ST?!$P>'8T.U-9>^OA9*.><ZTDK;=E]]J>KXI_"EO9FWB_W&^/@8_(Z_UQT
M$^+%PK>DMU'O1 9P#]*ZF7>8^H->JE,W ?Y%H:U(HB$;(0+N!@0=.\.:+ 'M
M8Q\J)Y", 1+[.L7>-P%M)"EN.JA'@B$]<!,*UTJD:1\=) Y#]GB(DQ&=*G&:
M7'8J[%2;EA_MSH%5L)J=;AKWC^J JY_&_S"XL:>#NO^%RY!5#KSK/D4?H*80
MZE(<C["&0!WQN#-ERD,)VP!@A/K [/U$"-.&AW [$%\(.%N1VR%G-+9,MOM^
M;X/%5O4:&K;+W_O21)HHAB>3U6&YBYPL\Z+)RII?O!+*$WL)?NW_%!IS\'A;
MPQ(T21ZZO;X]21\3,C<JR <?\??E"&4O[I>(_RN[9XQ7'+C9$9[/@^?@L>&(
MQ8\ERT,Q23E-U38<=J\^CGWU-8%Z)6;=LG"0;U7O\:P@*;SPR"3_J3WAJ$VF
M"L_,Q<5.]6)% WG]%F87?N:R^^?:^^LEPNY6>U'TIM?NK]4JI\9Y8S^EWCUW
M<\4L_<^D/H$I]\+<F< Y96>PCIT6%8?.8;ZPN#N12D*!\RM5?J8>K $OB($)
M>I N.HB="B%7[P(X&KLIT5"[5V\'C^;R$Q5ZK8Q0@?\+W"5V1N5.13:\\,<?
M3?R.)DKQ 4P& 1A?U^Q:C*]<,=S4MP%\ON<FEV.;%]GT8(\2FXIYE/ND]O@^
MW @PA9)&9O3OD*^F$9&IHGZT[S11\F-DG79<(1!:3'6G3,4:^-<,E/?7(,:U
M)&4F:!*^8'(F#&W[':Y>YN+JGUN2G?$L9!8*B51K_N-4U-<B_G0T648FWKGW
MIJ;O\.>\'D]U^;%D<_N$+$[Y<M=J%V->NPXXMD0T#*%<%D0+,O)SA(D9P2H=
M;&,ES#WSBYP*E!T3>Y?W/JR-H0V"=.*L\^4<4*("UZ:/'/U(Y$[L478YYE'K
M<TS5AFA,2D;1FI-V;G9UQ7KH;1??W"=YG@%*6R<G^R??TEQG[OQT[=?LG9@8
M3[L1P/+,1KTXJ(Z;N0\I@N %^(V_PV^0 A,@W.T2[V&%?$B.#80L!1-;+Z&
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MU-<+?#FD#C0>S3,[[[HV<Y!*H(/8@+<#@87KK<]646*?)RD$)3TB<8B/V]N
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MI>*D"']_ORDS:I'H[K?0A2BDJINWU>>WN+GIWC(WL?+_NBRB,_>G>6Y.Y]:
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M%=,> G^4"Y\/6,J%^I)^>?E<_9AC:[VFZZ;I)U=/;*D._1"P6ON3V'A0OWT
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M^@Z4_,%!)L,YCK2M_8S@"D>ZT5[20?\#1__E^&S02AGO?P2M'3H>^4FBG1W
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MG&G*($(<&;G37]8O_9>1/Z,>,+K<=W]G!D.LR3C6IXUZ<)*=7V$OPGHX&H
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M<.<Q9(!-+.TR1;+HV!$FYM'T_0E<V6G*9%)#%ROBC]4CY\10W2J0/G?645Q
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M['G,DE>$ZO K_>Y60.]&:UOOV141/C4Q$O=!7R6-84'D#?.'R9=%+F-Z;\D
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M8\QHR&XAENJA,IY^+EU(/+'K:E[I+^LNSQ'K$K?\O321,"#S=MZU3-MYZ;'
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M(UBQ8A-T+E9>3E.\-6<2,I'L=[AK^6Q1T7%+Z<\=?:)?J@R47[U<3I2_'-:
M]1MYPA4'UAEYB 2NQM(X0C)X4%[N<J>#FV+=!\"<X<G2)3)6C?^N<K3I#R73
M]3)>?.^AVU!+7(^N%8[,9U\/[$E8Y&K16LW+L)>[PTPB.=?^5Z.22]/28QM5
M@D#S M*PC1+=,&5IF=-GSE9OOIG^W<<_UW6@N:#A6<[1-4T_]QA'C[ALTI^5
MEV8O+4P-0WX&E$@5J=]XY%ORH=WI4II98/"J8&5BZ56RCG/?#@5RE!9S)T_9
M,+!O9,ZN5US<P!*2E(;M3%9M0-YDU,C3CDX=-A>.+3/#OJ=9E]EC%-GD9S"5
MN4&P&Q;%!$?!$',(P1G+8TTY$#:!N(*9.NM<1L@<9JQ@S$-7A__,A.LT_&<J
M-U5WXFN_]"P X5QT6'D>:++RF649&0KG&X[M$5"<O_@T[$=R;Z'O_![_UB$@
M;U9H3PL50ZD?[8W9H AB#9<9O9'O]D'/?5%U8P]Q_+H5\C6%Z.:>FD*@9&QK
MEQI6UU[AA_$[Y-%U NUDGU#1M*7QL^)D^R!C<&)F*V4(9O?.E]Z[&L%$R*##
M$%W]"EVW?\G,$-?J5^$H(AWGQ)'DBHQI!/>[7&.Z.CO&;%\UU9&=>!@\*=NO
MM6:=//S#12EVHRU-590\NKZ$*X4/7RPRUZ>&F[VTTSA\5 FI8X"V2BRR*C,<
M^IEVPZR T^X5G"7W(;,E386N:Y]A3&NI=6HWR7?)PV_N@]Q1$](G]%YMN0'J
M)>>G9/6>:E<G'EPHNVY\\[--8NT+DT,Z>ERIJJTKI_=!/5JXDX=4E+GGC13X
M2]8@H&,7#0P^_XB@KX<2/!&QZ<V%;1$\!G;RC_37@8IRKK'E9I)@",;:\3L<
M"R !FJB)\RT#W*C,[;@*SA6YJMC@?5#,=KL*+1@!GJ0[?K $8P,_UW^NO]$X
MO"$'EU/8"MXKW%@-HNYDS32DYT44+>:<!^Y5^<BX;I+B,4+A_9<[:__B+[*8
MDX.5SE1"ON^.@=^)SG';[)]ME)NMGLR65>3>FC::*:YJIA?ZG:$D"3=+NQ2B
MZ1DBY9982EM(>SD5"'=[\K- W-JJV0S6=Z/?)TQ#D_[DB<.3I965],3-<WMQ
MB/N81#/" W#DHFQ*K3%+)%WAD0 ?(2/FTZ%B*7OZDW3! !EN-ZI6K+:<4 ?I
M,'Z@9&?R-/A=UP(H0-Z1!/(P,.CYYSN,=F<O%:YHRFP+Z<D1!1@>LX.RTTLR
MO_/)8O4S1]W \M@&G$T$8SV( 8ZK<5Y^_(N^\)1S)F]1)KKIJ;;SZ2-QI2BT
M87;\KWW0A$R^F^*'?&[?C,2/K^V*0% OI;XWD7O:FZL#!+&)C-\9OF6NOF/+
M'M"NUQRC(T3FU"UT6')Z7RDVB$J'YQ7(:NC:B%?TM!5/_Y(,"VA)$UT?V7ID
M;E@VD.5G_+?YS<]L_;YTLZI:7$K6PMK(\PKD[0 [I4.#&.T/8O9M^Z G#?-A
MBAE:EFG&6V$MC<Q)MTB$.V'BN$$"5YHX6_6ORXUJ+-C4?F;;[(6'Q_OC5^3^
M#>K5-M\5XWYZ\>%_3^!#(H?>"WV ?#2\"7L:>O@"^'3B0F)D4'P'<&77D/,/
MR[BEE!2[#Y*N@JMP#/WY@5<=AI#.W3U#+D1 ,[MT*4 IIJ3R5\A.]%9<X%>L
M[O1XITGGDT8$*QY]@2[4=G#ZVY)>B5O(6WPO#S4YAXL _JO O=UKW[%\G=/'
MACDZA81.44:%X#[H"NM6K3?^Q)#VU#7[*"K=E15CVFK*7(:*88E=NEI2(O4Y
ME]IRUNQ<O4QHT'\*].QM]T&-2X'GNSO;U@F>EWORZLS*J@1ZT[/D%LU>IJ&8
M.LA WZE:7&93Z=Z76C.5SWL9$=;SZ-W*SRIJX0)[\83[%W+?;-T#U&,9K8WP
M \,?@Z3I\Y89#5LU@I.F]#M'%HH1[J2) Y/W"762'7H/].U0H$7U.^+*3\\J
M)5P0U$UD'>6/_[M,G:FAK,H6=1=_]R4T.B1J8O;<!@8L;.X,GV./QK:-;K1I
MN8*O.U8HLV]5)\E>IYUM./]"HV&Z@1!0[.9[CKFH\6B %(^XCZ K=W-EV>W/
M*KD3<)T/_B>_8;=OQ=R4[,J\\8+8$\[#9O56HPKO<9E_:/6TO5=HC[RE$R;O
M_%P]KGRH&U%^[8NWS1_?^2QYV#^"X.\XPYQ'?O\BN$/QPDY.)?BGVRRO.#7,
MJ 7+ES2TK8;X50[_K MSW:W>XT7TOHW@?P1/GKR>MG)_9PG\$YPK#9*W^^^.
MV@MC!U6PM$V_ K=K'U2K>,^<^Q_J\'&M'Q(LD33BX6292_.<Q310VJ#18_U*
MH5Y(;6\RIL)K+J0+>A3G7LNB]$#CM]I%AK3!$-)A9V<4P-^Y(S?V?&?@5?ZR
MC/98NT;RG$W-4']2?:/37GL"1CIYP8VUN3?9I_.X77XOA>)- >OFR36M^@>=
MA$/9NL]XJM\I)HV1%'1U#(/6-A*D76].N/ZR%^7LJDD0<YJ\)E$3WB!#E[MD
M\7),!>KV9Y%)UE[\T(=(4PFRB2^R6D#Z9QY/<RQ"VI#J"E3,LG1LJO0O6Q=(
M7[7XG+\JXU<5VK2;_\I)":T]^1*_-'I#)]0\W33\/T*-\DK")3_B%@K0N"CT
MX3G^P+#+LR'S>P(NR=F!@4?N/+O%@\=S>RDB<_N@8Q26[7._\MZ/,K<%KYQ6
MX"[_N'OEKTM4)/:3P;KOX 1?EYL1"YDP:YF,D,:0XIL?O6%[H=A3JV,51<X^
MDF'$&(PE<8<<Z<<Q\)",?;AY64YP;34LGWO^B;D%<O+JJ%(6\"!<B%3GXOR7
MV[0KRQV6*8K#^.&I6]31>LM:"Z8?@C%:'X9*U"$!_\ T2B< MW$+FH:-"]LM
MUZ_$9ZE=O#%FM\N!/>5#]YWQ"2,3U_RJH)7O4@O_+EAK#<Z;7C$M^>QE'>V,
MO%"T\EW5[%U@:X&.=:)1ELJO9=M4E61[,UWB)3]7-U)SYFC]\+#>_+:G6GM*
M8BCYZ]S6^;T7WRY:3B3,OHFV_J]O5N.23^75I&Z/,\8WI1E7X+,.5QC^$\Y;
M#WCP<8]).(H?)//CC)@:9QF:&Q5!EBR)F.:<C'!Y>=DV.#/<,?/+E@3]J^OD
MPP]/LUF?947PF'%>>I)(]/]D@N>V&MFO?,*":4OV94&EV(&C#W6P'$0YX'_]
M XU'R?:CG#:()5ND-H/P<-@+=>([#]"6,AO>C];WJ4WZ-^.4BGR=$-$XM7PL
MR2FAJUUQ&*;!F%+N<E-JJG]E&=45QGV3[SBQ##]-M/S0,J*I?F8,<_21SOF5
MW]"U2HVQ'R8Z\UVE?QJE2@:RSI;\K.M13<[WL2FRT2XLZ= XQ6VP%BU!ECXZ
M58,TM],/U.VXO$>4-9JI"UD,9H3[A[>$%06%-NEN3;76J'<EUCR,=*F!I=_5
MLK0..?4B:(ZK"%IN)EGM?D,:$OK*^;*"89#E1;?NSW-57T)[X,2<-GWXGN%X
M,O J*<1J'X0_MH?O%R$X:8VTM:93.GSVVG;\"W?*@FFU^D%*N_^&VCF%=:)G
MQEOJ-A$\.^R+FE#NFJGW3^:*8ZG4:8,AG#3X6;L,+A2XPKP_4M%0LM:P1MP'
MU>-FA.LMXW9TWVB^4K=RZB_%"G70*]]X%KN(Z:8QA;+%;!I=&[>/M,M#6*:4
MN*19.5D&AR+%A11&OUL.LR25!X=;*'>_F+C#L25OW1W=!WGZ2V(KOPYD'-_+
MG&-\S[0@$K67*^!,8=AW(/G/;Y6BYJ9X2N"=IQ=N'II=C^K,_AX9*BV'V O^
M>O(\WR%<GB+FDQHY\!_07OBZ6RIKQ,=TP.J1-;JI7ZFV=K*66QE:W>U0=+13
MK-Y]3;Q/TBM$;:IL>I4""%E&!4,G)'O@HD!H!<Z(M= 5[EQ<14 O4Y*)W9E)
MX[&M%RNQ,YTO.=JC]4;@#O();<KS5=;N/XWO63.)@U'WWC<"?CS:%\$.=DP?
M'M[,#D%:GEK"GQ[1L<S,W7N*\'&H#5_>!]'MWK)=-PN;WB[)-$6U*_ :=,IR
M$_67P_)T%_<PJ^<-,V'F(-"C)J?'^-W"EECO-B1,P!2;VWKRWDZ@CR\'F&".
MU'CLBNB&4'6_@A7T/YY*G#T6GAB\H)WG?WKN]!\CO;O!&SW\[_F,0-+E<H?O
MIP['FZG13?-30^VJU-1,D,GC$XT=3%\#,XON+X&!J5FG)P-#?!E#>A4O&U8G
MG-?GYJI6:M@MS)G>-^!8";(8[A*X,UO6#KA6<8VUM.P*1+USP;[SCW'3!KSF
M/,#Q1]+]-Y8CC"V".O"*;;1-UP/U;;+^L0\K-A&"4S/"_O;M##P"W[D/$H/#
MEV?J-X?83=29YR]PCK1@B@@@A&*=2Z?W+7.%:3K=[(@U(AR.A3JPQLB:'RJQ
M+<S#340.FFDIYYUC]*%MN!S'SX 0Y8\/U1..^$".5W!\=Y[J5H;.&9S>FCUN
MR'X*XLM!7 ,]#1I94/QCH"A^>A/2:>+O$]0Q5(+'Z(6J(/#FT\X^O_=&&YLU
MFT9/LG70@7_T->\$&G]-CN/U*TAWN"6D[668*^(9',;MH]1[\=@J8:&'($+Q
M60UA()YN@OD7923J&$E&N!M;OSB6RC&;%@I=7*TA]>!EH%Y-K2S)@0HYLDD&
M.Y8F1)R?Q-F0//J9W[RJ#HX3[D+H#EU<L3963L&N W;!DM901<3KLU*?O,19
MOV=[%CUKJ!);,ES]XCOVQ(G8(:Q@"<0=VW:*26!6R%X;T^! W^(0;&A,\*<;
M1<G!@* +ON7N@<A_#KT: &UW*)XXJA1X\JYH3Q!27^'E!1#U_N/0C@&L<COR
MTD=U$72KAK0_CY@:V^KI/DZ.E?XQDTYTQVFVO577:*09O#^P.'\O37>#OI;2
MR)GTJY@< ;9GP1]GDA#'N,K >/<^Z#C^/!T[V#E]CB5)A.G(Q^/,YRQ/WL+=
M8^QFZXK-^9U#B%_Q4X[2P*SJ]EJ/PAP9":LHY@D+YN!Q-S? Q)F5$Y.93BS9
MB\V;EY::/6$PN[DVZ'2O0TH*=/SF'(T/-BO_)H@V#WMZ W:![Z71W\5/<Y/2
M?)/Q]..VX^JA%4_&M;-RFNFK37[E%/D)LT?(/PTKZ?$7W98:AVHI(7XA,YC3
MF'T0 H4T"OA8_&D;%JAE')0&6T@\>,7(4'0DRGK$+TLW(%G+R$&!U/5(:LET
MQX[@N@\2:<_X^^KK.B7!04:\J-,R0;)=;5B3<XWAC(B>.?Z;8\.8%'KM!^5]
M4>8OX'MBF2X<_1U\:JN)WO-OQA.)C,>?3WUU^=ZK:"%[MGJ#=.Q?)]0QG58+
MX9;"IUM?+UV"Z5;Y^8QM_;ETHE_Q^+^,$'?'":$3YB="$3*0D_N@3LFY:[,&
MJQJM3V!R3 )PI1(C?8]HV<2NVM+8YIRE+8FYE#EW>XBTJGNVIL\[T=4>_W%Y
M=./AEN&!]WJ9 LVJC_ZC&[3>/YW;]F=6KSSZ<<PES,]:<7E':^E_#MF0=UO'
MR')>C[S"89=,=R\'%A2T%?S]0<L??FY+#O;D]EX]M?SZ08-J.*+<SD_E;O4+
M.WEAFJV'M/ZN3I*=JT]M0L= *MHJVC'\Z](,ZM?Y1\1?A#0^RO_;SE;[O]O9
M1?_?V]G-(7T,RK&L TG@ZP-X%^B$!@O487 H,:KG0#>.EU6'10 +]CYHSO)C
M!?0CI6Z4_%0'(>J&N\;BF=1$;7)LDYM\[==-P@%';[?SNX^RQ0?C.'QLB(7I
M//MZN_A+'D1N.(QS3Y%<:.68""WFZH.JDOIO38 7U2_JV=M?73\(H+I&Q3^A
M0@UAQT 3*P(;07$*UK)138<"WW?<I2X5O33<&CSR(? [3?3E3X,'?L^+B%5Q
M?6QSR:LYFJEE#"]KLF'1ZN+51GF;^*WD)TEA6DEFP:7& :D>^)5)5>I"Z /T
M*V:I>S&C#J;0.5X255H-%-L4,P9^V:6=NH[NWU62F+]:[BE@FUCR14<1-\H"
M=^J1CU&\4(>P#K: ;Q[GS'M6EV1*/VN2"H>/X,\!X9TU$!D?F>>Z< @[IJS0
M>SPD3*.[G+5DB$QN=DTB/B^'^G$4"B8+,W*=^+AV,RRKP:<(401/9T\2ME(
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M"T<7$T\<N?)I'W1MC0\_.,/BH0 ))U<);-_8RR&X^_%UYL@Z_\58F# M.Y4
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M[P?" H\JC+4)(LQRI LH @'JV3G?5J)](S9+:'4KC36LO\0A8NS%IGEF>:3
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M?A7PBYZ,0*^06-9\3B<<K0"8=!3* WF13/FUCO$L;.<D^BHSK9P*EG)F:S1
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M .->6R0V\,VURC=Z-/C/&W?_*45EUH=UR+.B/U-@EI=A6UP^(?S]=H=[BEO
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MZ)RR* ITTX\/2/M@9U<HL_O[ZSEY9\=\ER2*"[)<@?R0XOB '#3, ]EG\:V
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M&)W+Z8$)LKA)_44-/K8.IS>*-<*7=-)GHC-?WBQC*S(GN^4,6/I7!_OHB ,
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M+D^VA29EO2]L$E\Z_K:$> /\0T7QA*[B4_6733&[E!-!H)3TV?E#3ZT#%'A
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M:;+"]T8S9K,,$D/:;8%G'"ES)LD<*>CM/!934VH[K?1Q4%NZ.<QZ&-L[!^]
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M,P/;\4+XA_T?O.#'_' RP!>T^/),=0=.%3@PVR]'RU\.Y'QU.X@^X0)HP"4
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MDM+8VO@VP7V0!UR2';17P>9E8;TRTZCMT/&9FS #%CQAOO)C_.465D%B_@
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M<#_YMG40D<]E1;^XINYC'^#)1:D_X,ZZ :!IL.. ,@O9/2.RV:=#OUHZ.W/
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M:"/]A9)SY7+DYHOV].,X+*]7R6(&0^ X8N"6R848$GW@@G/V]LR@:-" O)Q
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MX*])T*XY,/T2^41.',*^>L,V2K]I2I]G[6"N\U#29I)N5DRM[<ZU7@O-N>\
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MU<I(J @8/%CUL@P+5_L<IQW.@!T(C!@YM(FR_'S< $:9"4K#=>/WP)/0W85
M(R%;'K=5O#Q?Z#H+[B.9W_X+4$L#!!0    ( '2*G5RC7^A>O\   &3%   5
M    96$P,C@U,30X,#%?:6UG,38N:G!GY+MW4%/MVRX:!06D24>J(DH'Z1!*
M7D"Z@'0! 1$1 M*DA1JE=Z0K5:1$2HCT%D"Z@(B0 $I/$)">4 .$Y/!^Y^S?
M=\[,V3-[SO[SK$QF[LRZUY-UW>6ZU_5D0OY%7@;<--#1UP%<N7(%\.SR!2#/
M ;3^_?2_=?R[R/_N&E?(7P%,U #$E5Z**P* JTQ7*)BND/L!_ # E6O_IP/@
M_SJN7*6@O':=BIKF!NVE0]--P-4K%!17*2FN7:.DO#P;?GD>0,ETC?F.M,9U
M%E,G*@%?5IFWZ274=S7K>MC,)G""LL]?1]+<8.?@O,5U[[Z0L(BHG+R"HI(R
M4.NAMHZNGKZ!N86EE?43&UOG%RXO7=W [G[^ 8%!D."0J.B8V+CXA,2,S*SL
MG-SW'_(^E9:55\ ^5U;5-S0V-;>TMK7W]O4/# Y]&QZ91*&GIF=^_9[%8%?^
MK*ZM_]W8Q.\?'!X=GQ!.S_[%=05 \1_H_Z^XF"YQ7:6DI*"D^A?7E:M!_SHP
M45Z[(WV=6<.4RLF714#F+36K9GI)70_-75DS'-OSUQ,WV 7E,/?P_T+[+V3_
M:\ B_S\A^P^P_\8U"Z"CN'*9/ HF  A .E85(@,$NN- VU3ET TZMM9MC1O7
M(8+,H9C60;6.]()SKCY<,3&1Q$,&?.'+)@/*'EBM1!6<)8<2J^^L;!6$RZA,
M7$0(&_U6Z)!-P\_$2R*E,"F&M@TML6MK8S4CVJ^?/EP"(Q.O,SB[^-:Y"+*!
M@C6.$5?(@)@=K.,9Q5\8B0I*!@RS;3MRD %_-&8@JLVY12'0_A\HBJBC#4>N
M-]3#@/W@(0>C\&XZE_=T7HY6S5(T!IU/L.M&QEXPF<A2'0/:G!JVS*R\R;,]
MC[L'DM(_&IYVR)?J7DN%QY:KLHFF%BH::8]-(V[I'YA6WI]W9L.7NU7K6HV[
M_><6ND\6R  R0-"4#*"=Z^\^I)J [G60 20]!.?70_YWI10_(S2[TLZI[I,!
M)0&,72UD@)2ZR048RWC&_1R*$P41OX>"B%+>S&3 3WYM,J!KCPP@7+AZ\#=Z
M[L4UIMCU<Q$=6"?D)&@?=4T'C'E;=;9^F6P,%WK4' K7,D/OU7HQTZJHJ+@5
M>20E%)K)&1OK48TP4'E_9>@\"W5.,S@83RQF:$Q+@M(3/7!#_1S6TURZJ7*T
M*7PKIBBSJ;W#RFGLTF-4@)V2U*=BDX[6R2,/,0F-5_*<DG([&L\4%''ZKJK?
M DKZ3NFJ'Z>$71.%!%N5<QV)#,(-LOZVHZ="LC:0FI:BYI\V+6(4)@M*.5O@
MY2D1HM@G/Q&BMW($*@3DJI!JP&SAWFR#D:P%T0!1<3$?&+#J9L'VJ?/]PT7U
MTN7QN0;,4#^W&+U6C[H2P04K)F&*M,W)5<B#'S6Z$*^!2Y8@$Y(Z%>+<QM[T
M8)((;I54(W^O?O^5_(+HL:P$?%N&KW?TN ;5Q&O='W(O!X$CK=C@LIL+@['A
MT@%_I_>T&J;\1\,]C-"(#$.T)4I*+K]:39/>5C'31*'EL=Z)_MK]O3'NXE\(
MBYFP0L>AI4:IU A!2"^(%]*-9=E2E\05)7V&N!Q!F8=Q5:$@.JUENY3GV%Y0
M;+,,40C5W:Q**UFI%A>OTU%EFW 8*F8D.;F4V$P&1+Z&A(S=;T&1I+8"TZ&N
MU,^0:9B9:&M[>R.BTB)G]^1NTQ&:^=@Q1K%9,2\YD R@$9\>>CBQ[,G'*V;1
ME-O7'HX*9SPKQFP5/D'V6JQPSF:1 ?721]A-\8?F8?LY?'!WJ-7K+$$<0=^B
M<N0BFXTK"W; OS64\"Z&'>=;+?ER<^!E*Q>]UF_#;&'AYR*HRIV=[T5W6:C-
M//TLLDJ!4+@"&= D7SXUW0GV_ QAMDNCM7/+712D>/*B94*<:/AB%A:'". ^
ME<PUCD79HH;FY.:RD6Z2)3TVBL!J-\-SW3'>S@%T X1=S%"D9@=1NXJ_5F/5
M',25;/H4/-W28E(IT5D^=H'$C3M?^UYG&$19-^:5H2W0&>$"T3T6P W%J-,3
MEI;[BX!H>3C5X+$CS6%'TF6ST+BMT:L8$LRQ'=[,&[.O0GAF"U<+=S]4#;S*
M$Y_.-7^_+7<1R590DH*T&^S^XE MCTA;^GK,Q38-PY(!/ 1$OQ4_+L^C_7II
MZ>S?(IEF0KEW (P0IX4^A!L^Q#]=O)6++2H/6C:,JH"\/N]]MP&T"'QMOZFP
M)S\NV.K\]JXM7 3K>X.A3 3CR[JOZA)B6;J-6YR$N] 95KZ-JK1F&:GJ;;S+
M(W=[P69Z+0T6@RUF]O5OVT"-8LQ8[UDSZ=X:4%:W$3::&M#)X:?#MX;XXP]2
M@! 7JR<AZ7F0!$OW;& @](OGN:T;?B.OJT&]!;>+TOO)/:!EBT8<':)V_ E$
MAF32@]8\P_..EQY2]#IIDO!*N[)I]@F1K/G&9](_460 ^#S<1EP0)2\5%[11
MJ>M\O_C8A.77]YD^RP;2!$H;Z5&YEV&XHYJ_]20P8;5IK+?_N4X \542B>9(
MI*FE&8E>]VZ$2*TH1JIJ^'I6$2R]Y>$L*^Q16'N^$X.,RP :H"7N3B"E@K'Y
M8\Z&\7\/W&<X<DR#0PJ3S>?[?!'!YS2+2[\)USG:4#N2Q#MXOG-L($(]D_&M
MW.<P<_C\&*[=4QK66(\R"Q?=ZFM>HON15/JTT/Q)?<M$F#W63JM"? *LF&48
MAU0^?I?L:_,))E(.'(_QLQ&UN,@1:=F^J*JV/+?EA%1J6IR6ID3YKVR+/MJ,
M]<4VQ*GI^[07UYG\EKI),#6P+'P$-+54AAD76(HVM:%+%:J<7(9%JM#8B'J"
M]S'RIZKSJYDN5CQC7S$3>,NWS+:VM,(#&ZX0VAGN]>?GCG@3>X>=A,Z>)5?
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M8S7J E/^"^S8-7DWB0#:UI+V'!Z]T5,5J6U%G'<OGS0N9B^)) VN#BJ]_TD
M-Y-P6,BHW3I=@G]! DRD-@DJ=(FB).WZ%1>E<2GE"7BUG>92]DJG6D9J^SF3
M^\6NE=8:ET.]!X24Q<!E-5%I S:1!+?Y[!PH!<3A^B12T1<OA)GIA_-K__2N
M;>I(\="<E&CBCQVM*%^LA'M,;K)SK55[>_IY@YV=7/AUSPHQFUGWQ -%S"K9
M1+ULV"5S@6'X;#VK !C71*F9W*J9W,<_4Y )F.4T3#2C^.B@/UAD4.FI8F.Y
M$%>B\MIU6,/3GUG.9FE?HC>,RY6-'V3;#(A,%-J@_%VII:;UR "P_OTG#K2(
M*]];./S QW#&>$\ANT+-19#ZBDF#6X (^][CV.LV@J@=Y!8Z);UK/($C@/[N
M<7G33*,]1;^M]LE;;W]^5MO.O=@ IQKYSJ).5V9#N88-HW _CWO[6G1F8TJ1
MBI#G*>7O!9\I$S,<"4(F49ZYO4P;_.R[<N%2O<"3GG"O.8-&G$GT'=1+O&-/
M!RC&JGEVJC$P9"H!A;1;$4/$!J[W!U6=6,O,$A#6S7I"Z&NQ55T#-1'?^'BG
M,!=Y'\F Z+7CR97CURW=]753SW"+*0$UA):^LQ\-3I7NL^*7 -'KDX>>8K;Y
M>DDFZ.@\XTZ>=)V7=< (F'N+V+@ZT[(@;I-S-N,X[>96VXO65D-Z+HCME+!N
M[E;8^X29@=Y4+K_R>SRBB)TV40U]^ :^.S[S;$B=2VY!^/$Q4ZQ?9#7/H\WG
M(JA:= X;\&9I;$!UK[S36+Q_H;SP: X9\#$$M.-22HC3KY_Q!]T,>S#5:*\S
M;H+>#K!C9-LX^#6_,5LP>CTW+)>V,OCYC%EK0,N7#\WWMG^DVS5\&XD#0]W.
M<[HR'^F',=[_G,OR>[1<LMMKMB H9V)48BQ_8^OS1;M*]1//W7MM31!*G+:W
MK^#$ISXQH3^%W426[I[ )09YDZM#*W;\.Q*:![V)18*9&,4H2<_Q.*0(SLS[
M;8[M]4J,1_[OQAT7IY^[B##74H>%I8==_(0D%4C%D''&LNIKMQXR@/(4=R^V
MS1=K)#24-Y7:M2@>-6!5).)-17A^,MB,ZL&:\&[9U2+M@V4W0YKAH<XK<A/R
M\$"BOA_<[N^74:BGJC7*YF$Q#8Y?WN/YYH#(#SG6^L0&/WW]WG(;K5LF&<Q/
MO[AG*UMGKA?<,=+*J7_JB04>BV#N2+I0V?<I]VEE&(WFL6)4Z>:KM$.'?WPJ
M?_EQT]C,N'B#V-U4D4Z_L%.0-],WT(I"\ONM[&C$M@LVUN.TBTHETX*P'9V:
M8FURO_Q5C,P6P]4WCVJ;[1:T1!_5;=^OG8M LY_DV=?6>52%J>1J(QL-YXQL
M5/5?M@<,E'V9>YJPW)EI:N?'GQ[N(JNP/*$=ZGKW(\>#X.(\$'6W$QE 3Q3]
MJ7X;$H ,#L>*,<8[TB*#<!V/FRZK$*0_<7BA,(ZEBK?KMRVJ=H:IU]7TB1_/
MH SPOQST[\'1*/T@\:J=Q)7+DHT,)D08N6JT374)Z5=!@O[!#Q;BK_)3\\=$
ML#9/2LFC^'OJL!XJ8[.=:!8W(+'XVJ&-1.,'<0<)-OEPG3L*L#]S\A:MNF\N
M.FT?#^IC-D9XWK>Y0/*Q(N%FR+62F(#@O]-GV+Z?T>[3%FRWIN"B&3Z)?I)*
M> $YL,59@9##IQI8K$T7,[]57K]Y#%_(DJ4/W.")JU63OEED-5<5*UKB_LP6
MD/0S\X>$BP[.OC\H),^MN5Z[MD?&P7VW6M!6HJ;RLVI02-^NS=W)CS*+7_S]
MFVY8_M F W;D*S:.K=IC2*7+*N'J)XZ-N/+:CP$E\LFD^^A9/W")Q%CG-JZB
M4F;.?EBM(*.LR*AS8/ C?G;ND?E^B_Z_(P@BI8-;?(NQ<TP HH$1:;Z?:-,:
M"%)]5OUSOR&RF*#HHT[7/M_RC:3+LF0.L(E@ [=/?\#K&K(0XOJ"@#^:V&JL
M!_6\=*O=H?6I[[IOD.B(PI.2<EL+5)?S;0 >-$B2\G/Q6#Y/XR2$8JFBNV0)
MLH/U@[/RG8?ZV OU/NQA7DO<GO>C"M)YW_&$@^-<(QX)L<"HTR1OB'(F8%GK
MI*/1]9N_3%QCCCDWZVLWT8,_^"8L2Z+[4*5L\F9/QL'C!BFW'LZJ>F-I89;H
MDFUW+?IQVI>0,(/*Q( O6:4Z#\K?FOLO</U"/MR4OZ7):6FD4VZ;4&R^ <(]
M-GF[>*>N#7WHG;A$(T^O@+)LGZSU_C2S5]*4]AA%E*TF=&V$G;_?Z7L8)O)Q
M"[A3A&#R%%W7F]R[-['G=97^M_42SA3QFS1NC"NJ#L([8OR!0:FN4Z^0_ ]R
M^S.U:Y<(?F:Y^FC_)!453TF[>"FBVN>O^,6_05]L%_O$!4B;Z#G/]V&7E4TG
M&UXIR(_[0)I8NAGFY4\&U&^<74M%+(]?3[OAQL<Y06* ():GDTK!$==:<\UP
M8XUCI9#2<[O^W)M/YOZ2;J/E=NH(?KK E*/5$&A?\>_4=<Q:&JYV>AT;V[UB
M9(TQ&>2/AW+)':,/0^W%]*<"I'C"U/!2;Y[CU I+-]M7]^)4[Y7W81EW]%S;
MIL-,*I,:"^G2-S)ZG)Q^VT43@>5&P #?]^U%$U*N!BEA0/]U7=:9^W=9(FU1
M_5I4-[)%G?[V933?Z4V3N&:#GUPQ8745XJKK<_I4V5QE7,O/(@E!]SD</O@5
M.UNICRTWSA(SKBKD$BU_,M)=KWXRV:7RU&/6.!?N]@42:CD14 A$/9Z4MU??
M/,:.FTXV*67LG6O^V%76RSVWI=()[4D@9MQ-UHVR"^SF0FIX32)#[B=TA><7
M*R:R"VL8>OA?U:BG9GJOS<FMI5I_D\]58E_JZQ+ '4JKSA F3PBH<;!SW.)C
MPL&+<JL7-E!&"GEGC;D<(:FE#)GR_58'AN6_[1V-G"M&Y3L[U%+@'>_OS-\Q
M>3(21*%&V#NU_F&-V4YDP]\LC2RQ30$>E6@V'(_.F<:XUY5;YVXQYLZ:I0!S
MZAU(.4;:X3K\24HYM7PQ!K]3[\>$- JC$;HG4K^F"KG\J@T_.-5>%-H8%\&[
M@ZS]YXZ;"5M8[S,*-^3!NYF%D  6QAE0KDYQZN(]0/%V.$>1^M'I.B49,.X7
M-53"V[%,:#9O<>@\]YOW4?.=*Z?B5.)-P\P),H2'X]^%)HZ>4_S[X[<7/QD@
MAE#K;*O'%MVQ59UCVRQDFR.5%"\A3L_%';F. M$27K5RA<#?E%_*=P:2[!OW
M;4I3,,O!R(XZUE=[S*W,GY=XF!_^\%B">WEZ;8_UWX0/?O!E#5+,>Z5=P=3C
M0UGG?B8[U#36D;X>W4(CT-[1_\51$]?2QRE8^SKXZRU>R/"/?RAY7LMFT-QV
MI?CK'7F6 P]WA7X2]VQX2!-<MFG&,_>;N_F^/=<Z'>]V[0<N"#;)-XH%^,:*
M)XP,8/JC9,NIG=)C"HL]ZS!D,I;)2+&UO,>I T97*NZ QX86DM(:RQ6RE#&(
M:9\TEI4ZI9/<EY:;SZ<EE)VJ#:3]2FT+7$3,(WX4@/RL\C+7LFS+K:2]#-AX
M.[^$?S2BRI8Q"?O2F.>R$7#3(P]R97%D9^6J0I&\M[3@( 5;1]+)RUU@ EO@
M++P24IIC<W^B/.NF_]8A@Z2_79$?'8OH,*O/ ==.SK6>V)] "I:/"=G;.Y)>
M@1\Y9?YR;2H_*Q:YT=S"["6MU^'D"A7&<D_=6%<^*%JEE!X3L/60'O0]EOB'
MS4[M)?H=8Z;T?I(ZQ36/X"=4L7^M>XMA[]1FHNT7]L27$W<^Y&V*2)2![[8]
M?X3_-E)N,VFVN:IO]O6=W@!;F=01X4T"4O7$DW]W#!UT]LIW/NO4J%?WWL@P
MUR/=]Y4"U55?K!]_312^ZDU#!GQ#8,;/KVPXGFDQKA(N@--;AWS]F61 F)I/
M!/>,<PON^.V5YAR=-.W)P55_P%NGZWJ4D52J+UZL<^[9@7#I@Q;I'L*4/,SX
MMP7I&<:Z3WU1""&!YK/.P$R+/RA]N',56&ZFL\%(?L9A77; :0J[.:!F;I6-
MLC:RRRTU"JF%B>#]90FT#D^FRCQGG_U*?/'<VKQ9:/7QDV6Z=U2 "[&5*)Z/
MQ?/S)/89H2.:M)&N/?4[\9GY-F\WTF2D"Y;?Z*T7?716%GP6HV1"T+M-!A0Q
M0Y<F'+4SUUH+8+2J,J,7[=E@JW5(C%&MNS]F=*3$[/A/Y][T].3>'[]=WC[7
M]R.0\1V3JE8G3-RQ!_V.U+!9V>EI9[D"8D=B=&0ZMPO6R_>T^V!PG0RX4MM-
MR%-M@ZZGC),H[*%X^1,H4? F=)P&M/>WE,1,#5J/+CXYM*XF-3[O_FO6C8.3
M ?N9_62 Z8.E0U4R8%3Q\CT>]=TO,'8%W]1&JFOI+A=.U'K[9]Z5)\K;1^:!
M+EY'1UFM;F<@?(D,H*'D/^@U.3\3)BVUD '%P:"]31098.OK>"CB2+C4ZJ<F
MWT%H5:D+QLM5/TN1=D[G"2K#6<F<7B$\T-*GO@6N:>(411!5_Z^\(H_,;_K2
M#]WM1!+F&8*85E^PO--16N%YFWC>]S]N^LB-M!1%@EP.=:A5VA&,C0S0?+]'
M!FAX[Y(8EGR@GR$.']9)-E+C<\%"S7G$+@8FO>MT'(+[_1=%*X*ID.NW'R@I
M#<[39:^\T7JPOCVCAB>E*1@K;36T4KH*[@.4Q\)7+KJIB+A,$@DN111\<!DQ
MI1^@$*5QV.G6N"UHNL#<*O@A%(<@ UK!$<TMXTZUE'T2#=.UT[_N-]JSU4G/
MK>^KT^^_5'O6JGQ+N3D?\$Y7Q=0G)!(BM#J\$?W@N_*#IW_X=']7 %S3L,D*
MKZ\XGQZ/+SKBWFF0 :HOCBYC!CR;3+O9"]00NKAPF )MJ0N18J2GH#_-PKLW
M^4?.O3]#/[="S_CUH?,%"*]$,L!NH_9D\<S.,>H1R[.(M96"RZPU?O<)>7%J
MPR\9LJ*F/'X[\;G,[58JU9>S3S._F:>S_R.4&7F=\<[K:^&KEWFC UWF#9'7
MMD<\&(?SX][U+=)0#SYPX4?QG$_\5V68<ML[7E1?@H4Z?B"5/KXDX,-+Z,]>
M[U04/VU9ZY;%.QZ77>3(.\[>-[FVR<787\Q$%)XA<H"Q[(W3_D8R^T>(@/<Q
MN0E='.Z*7^X-5(UZXK:PM6DE$-PO_34-1)]+P,>EZU^Z6A.0(?P$H=7F!%59
M@OE NV7-@V%L-=SUG\NEJMPCN @Y 2 ^HA2^)=8?E)1SR6*%,TE(B4_:RQ+>
MNAU?%*7'92#M^Z'LS<D.=DM0#:'^FRR97G^25V0JMXJ&U)&ART<59("W'4^4
M%\&+F_GSMXU4M6[1$QQ)"*_ <<50O _C3$?/9FG>IXR!459;(&P-7N?06%9E
M/]761QTWP8Z"]57%>D=8-R=/B8Y1!?(I@Y;?I95.S&\Y9L[./!XTS_3?0)45
MW*$+A1F8P72R1 T*;F\)DP&-X@]=@ $@!J+&.;="6QEI7$&&<&[6/=7MVAT[
MO4CUD^B(E6(PJ2;DG-O$#2W1JKY8?-#8'MHM^PB9V(=9V(N5\'Q1M/MP,J!5
M8E?*RZFIS6Y<%J=+9%D\[XMZR'>;T %W;R5$>6(=XT&_@-<KR[3QW+VF8!+W
MM#=2*@ V_GEAHXNCV(;0N<P85\Q:NX(KK$C!7$C[P_UZ0B33P9B=E]A;T!(*
MQ%P!BQ?1_P)+!D@6QIV.43BV\$K,!Y$!3SJ#;UVXEV#36,U+S1GIY"Q%&RJ5
MA_*I_RP\-9:])<^51B%B'C>-)Q0\ D^F !_#@99WC-D>' K15"[/T%DB>+0?
M>:OI#1:P^ Z^;C*DC^DUSUJNPZ?H#]%']OT\SLRJ,BBX=^N':;69#)&R]2(%
M:8]Q_(VP(DAC[*T-\7OQ1WNI4"K270]%DDKQ8%YQ3%,*1T^1#,YE*,$+J5]"
M2.L'QF<8.?=U\;1VXZ5B586$X@[3F#9EAUD5S-PY%+FRU^B7B"R7#_BT2W\S
MB/IHQ%&X[I #/9[^1_LKI >FS8LHAH%&.; 3[#FB&"HQ_*QN)$E4XPZMS82\
M%#>$2<Z;"9SRZ>DF>\Z,-6.H6X#Y!5UAR*](^H;E([[GRY?\9@MJ@7>O+YQ#
M1RVW'X ,FK M;-H_'O=.QAB\KR+,-I6*WH"_TA&0<Q(R1<I&PJ@?5U1.EAMD
ML9RL;1JSAL?ZX:QCJI1"'X5M:N8PI%Y/$=%EV?[K]-<8KC>8ERHJ$W!/%+5>
M;17P<F57PSRZ.M2[!\I$ZM5]4CQD!NYF4[7\-(0MYB9J3Q_2F!MVMB)Q)F_#
MG):]V?\"A?KLU2%[<-LM[0FB_0KB%B3_27N.'D)^3*J?@XO+!'P<JO+^@<M%
M5)B6VKS>I<AI[/!FV%R\,Z%J@QVGVHA@PA<EE(!GNOA,4F]N\-$1GI\Q)LO!
M'7N@#)X[$8KN[*/.[)_D.[1Q:P6S 4<EK7.N%Q2\$?,%^4$_J/\M%\9_@])*
M!NA$ "/P'E*$1)Y'"ZLQ,(5L26O%Z/SDS_M V22(TKY%N9(H>E-#TQ<10IRL
M!%8U&?9$<&1"=U")7K9:6U^2S#/]DC_539HE8Q>4!XTJ3=W3.JA1V5+K+-87
M;Y#A,(+'UW:=%/R-+8>9[=@$W.ZE]F+/LTR+?H&+ZRGTP KUAT.Q.7D.LXO3
MZX..<\6T70(>( 9QJ9=UF8/M<0F2KX@>-9LPTZ;,QW'S),6(P0.B Z$Z:.5"
M;' =\Z,X&#=N0/#S#,!TT[H;XJ5ZCT,X8B)$"<][I:@A _*&'D:*_TS=(>32
M0HKUVE"[DO)B)O1SMG.+=D^?WEM [.K-[ P9!FVD'26A)M-VSL.BCH.^<?(C
M'8KC+FF=:Q*66&!BULQ_$^?O'-^GRW8CH.1(K^N12YB"0%6V5"52)5DHINRS
MQL]"4?T9KQCKQ/ZJ!OYKA)=R'I?RLM%])%:@@AEN^_I)Q2G.'\]:.6SYI'6F
M4P];=1ZT4P),,6NR=8_A=R7N%A.$C(:.PU.04!;Y))UF@A;6.^[FK'95F$/G
MI*H48BN'!+J<S]&EO0JY)-4\PQ39)XY\^D*)JB)8L#POQ8^)5]Q:D]M?6]CY
MVA"DH9ONCM08@EWYEJU.X?4D/*H?>@O)+[$>N5M[Z$UG"XDRG/&/Q@WFE@\$
M9CY12&?O#@AW^OS$R)O+_?&0<(MEAB;4%]H")Y !NO]6!.0L)(*5-^37&_7O
M!%X0I'N]:*5D5]273\376+3\1O9?D7%Z,[;/I -&ZD&X?.*?K%)#6AUYWKK6
MSRURJ\+3&06K+Q;,<(XQGWL[@4]^/,&Z6?1-GT@;C:0X5IWKZ9@/H'TZ>C#E
M8Y0%+@:2-SA6XPXPP60 Y1$3O9D4/5&K=>)9)T$$-X.1+^P^]D[JKJ]QQD6D
M+]/S#P9VXU)L()%+?3*7LOU%!!WZJ%/7 CF)0(9CBED)EU.CO^L6GCV_=JZV
M\K[5A\LEU_)ZR8#>DR 0\UI7E&X^9O[LNT(SGQINB@R(KU5E6K;G_^J[F=LE
M@%M*W%8U#:C:"'3@0S5)41L%PT<E4J9+$;;N08J/%[3%H ^+YZ:7#G8OI$EU
M(2'APJ3%YJW+BE'^MY=T*?9W[,SP'DD;YC'"Y@8W$R,],4*F@W(NFJ*6KI'9
M-JVH@BP7LW*=B@5';.@HL(C&)]NF/7.@1<3 '!P>R(HNMY(O6S'@_#L9F85%
M</9*^SK\&,E+=B988DQ^=9WWY8%VJ"I&5T)E*\.>$[R7QRDAT %;J:@ >ME^
M(%5"!.^E9H/U@ZC#GN"ST6>%APX/\$2'>X24"I/J<:\\SZ)2\/*<F,TSM]H7
M"/%)T'+^>-D3L,()/^LNT<FOA)!!'V2DKHQ+.>X 2\2F8[MCBI1P)S%'U"[H
M%SGAHN/]BXSXHZ.QKWZ!&W@!P]#@NU$ZB;>@G]XB[.C2O98S,\^G_ISE,71[
MA<QU/X+6.#Z"GFV)JHOZ6O')EVI&@VNT#=@\A$=O=);A?KE&E@>K\E1KYO6!
M7(%R=7)NZ CB1N5@[I?V15H?>("VU:!RC9JJMJA^C?MJK!B3.9L5L?7O8%EG
MI[YQP>9DM5G**=C"="T 1(>D..<HOA(F3FC!#1GBD<>^1$M<[=LR>_=9H5B$
M?UD#GB$33LBWF5+5@CKSXCSU('#Y.0F._L?E _#5XP27 />3]ZW1/>N7"J1'
M77+O3BJ48"O[E^\VDRK[[% 44:1J0ZLG3QWFC5\-V*,(4[">AK7C9MX@EY+;
M W+2/^D'J/240B1I#2O+0JME85!-_KGC7V+'03V<=[\[Z$@?G4U<=+Z23@J^
M/A%SL9E!50$=Y_'_7(J%LORL-FL2EW.V@MM:5EGX]:&S-LUB1'U?'_\RF)_P
M_VN:O#$^:UZ]C:VJ>K=6JO+O4)Z&Z60_\LL&LKIJ9K%*^Z0H6<"MD*>6JIX*
MY3L>5EFBVJA"12OW_(I35_Z>#3+ Z;RRBX4@A1EH&8#R@8<Q^JK.OO??R(.8
M(9D8Z^.T9+F]A&D_2-Q#W'B2ZU284P4D;]$Q/G$T,,Q-3LP(I ^TCB-*E]B8
M>++R7&^[[)N_K>C#\ZU0[X03A4SWYI^,3!H>GR"E#^OQ\],.DDD.*(DPUU#,
M3N"0?2O*OU-P82,DZ#C\J&FW.-!3\E5%)&O>W8N;EX]P<RO\KF$^NGL<R<S0
M8M!3,ZCWW $IE7AT@3TX@KL1J@<@P<J3GTH5$^#)?ETWC+!BZ,O@@%>'Y;;N
MF4EGN0[?NZ6#:(P1;7R.B$2*V0M/#?II.VTXM07[UCD,I@CI%%@VT%94@E[.
M^IA%9;F89 2(3!$U"27GW&Y+S$B/94>F1<>-3# ?)\$(MX2YWU$!*>Z=+4Z2
MMP_5([C@98T)"16/BFY/RW,OZ&!Y U5"QU@<X_JM;<=V_F@9=Q8_1K;&;M2J
M5O=!<2;W4=[^YVFL889HHA\K.ZAA++:<H=M[)33)R%R/\( ,H.6PP45W<5U2
M]0<D/R@::>Z-&Q&:F#']N7>T<'6KGRO+]7'&V%ZN&2DZM?-5R)SRV;?N7-1L
M[GG(_%&+WR#5'D>+TMDS%H)KDXO6 (-PWV.(NYRR\#D-)BL<3J-T.7:/[G$:
M0\ _\E_W6WI9V-/(;Z\("?_\5+D O=[JR!2?(]HL;8"LUD%65&*?P<Q8_Z*2
MLIR2HN^Q<;%># _6F ?P!-O;=J%.&Z;)@.6B)2;),+-Q;SQ%GX/ 1)@WEC&Q
M'98<@+@)T;)*!%$-8Y>N$O+[U'GQ5E'+<T;NX[HFO!O['F?0XVOC43MR](Q]
MMK!8_PL'CUMK'9U=WI<J]*7)VR(!@EZ$A'N$,+!I;"\)^;I=\8VGO)K6>> E
M]19?#>.X*/'%'?1Q!#6+^I\V<2^Q$3JPH)0C,)/MH6*B_X[LX[:LO\<XNX@1
MWL"EINHZRINJ UMO--1D 'U\$7L:&2(@S.WXS/>""]^$QC3C-6Y17F6DJ#4.
M;9#T85?I)]WY_J"^UUGFC$WX1PYS\KR0<=8J'9NWI_Z(Q=_R'U.JZGPU&"XS
M>%S?),QZSL#2_?M7@DI?6Z ,Y[:DIP,;!GAT9YRK"<.14 J4YY"PW=D?F$(X
M9&15B4(2#PIXE0:SA8E\ N]?A!?Y9B[.!O(>O!%0^G9K_8T=!?B;U+[+RH.G
MD=022> A3:KO=&$ W8\]RIO:X>@P+88)4HJ2\=Y:2?KPX 3?4CM_T3^4RV\
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MQ$C0<3+@WAYT5853U;6R+B5CQGA?0B,635VKEV/>^;+SN=?P\^]\2N]SYAW
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MT2M O#.%>V=:VA _NHC^-R=37JPK%>>-AD-(H[#PXV/15(Y9V1A-092[&-C
M\5R72LA>)H><I3]KDVPZ DO55GWJ>.!)5LEU9L2S=;&'G)UW=Q96<JV'[T>I
M)I=89$#YX'V4=%*3A.5S3)OQ>/EM+:N4U# ^6Z"<MC+N@S'V1*=4KZ!77Z9G
MO%16U<*W^%>+DH'N5@E^%/1I(>=/F#Y9KKC ] A(0B_U4H$D$I::A%Y<H0K(
MO@51*HO_WRV@LY:JRK-:"$-27W^F <B^W\]<WW,[;RP;U?$+D.S>$U[[B%K\
M;1_XG@;@4_M?7U0[!(X&  J 5J>IEQ$X+#F2!NCK _V?VL;F16B CYH@JH /
MD/(!44.1HP'ND9$4)0+H2.$X>64L7)_B\C^?[D=G-2.6 O>A 8K=R6IGO]GP
M;#2 Y.W_O];_"9GX/R$C=IY16XB]IXQX$'$R\2P1A]8U_J?__\=1^)\^_^^C
M4'QJC <=TYUA#J[WW%E!BCW>Q@+W@&]I *R# @V0"OJT%:9_ADI39DYMK_=[
M:0#HS-B^P&7WHU?_3X0>9#4R18<<@0#_&^I':;&JRY)EAWJ&Y!YA:J$=*XDJ
M@U_@]\F1_,WEO!;OZ[*XF.BC _4?/[QI<@>\K_)V LT8NT<=_KYQMB\$A/%L
M[RHT0'@7Z*248-D6MG+J/K*RS]6TVZ-VG"_7HSJ$9GPSYE]*GSK:&#Y?D/5C
M+5\!&@>M+:!<.SD()Y>B7</9R0LX0=N#H FEA \>4JWVG]P;VF7)I@<SY0\"
MWVTXW&KX.JJ$9.S0K'F79PL=CHEV&10=JT_@H7N(J?\\Q#K&/FMK=\_//9C>
M.C#3JK;;SS/ W8\GF[G2]H-H"G^E*]X_FVDQY>'+M[')^DEIDPE)_5^./)\,
M]^(DGU48&SX^B)?)>]+39U8,R5TWK>1I^):GGFSJ*3X:JQC<]@NCV%\+,:O,
MQ*_B"R];6IHO)T$X4[PDVH6J7"=+_J;Z^)7A% MNVDP5C5_M'A)^%TQXGW_J
MNY88I,;B]T>[*7FQ*/XVX/]G.:<V9 (:.CKH;?HTR_)TA\UC_]S#'C9& 1^8
M)L,BGU\*(R.OQ#F!0_H#57IGT8BKK+TBJHDI)B$ARLR^N1Y(^J4O^28&6LD7
M 1<5$DE-K["J3"D&BT^59^^(>CF^0UTR^=MQ,@406-8Q\<OEXEE$/CI?G-*:
M._IE. 3 &R\#_G6G-_2\"0^PV6_,4?1%W8LO///6/((BYCT&SPX_D%[?T]RC
M^TAG=%O@\X,>(_] '%B ^^:06?C+7CJO80<#@B!FYE5$Z>/I/U%Q@#F1BZI6
MEAT=FND>D4V\EW8=&H+G]43#W]0V*+)BST7FODGQS1!)T4E$BI*\;*%Y:7\3
M-+1&[P D/CQACT3Q\ ?BM.UJV1_6_,.<KDRD@S&'GN&W\;] <Z,;F\\.7_U:
MYJ&2Y.D&]<R4U)ZD^66(++S^[M1CI1G1\T'>2(*30<5NMN&<F?:>;^X[X(4F
M.@_71"]G,PLNX71O&;K^P5]T#\/N<QP&SRP# $=6UU-<HR(J?D4_DZ*_ ^A8
M"EBU#Q83HQ?9G&8*3M9C;/147*,!V$Z]%W0#80GV(/3&\1B=S(^?=Q^S2S_]
M+JOX3>KK9P]'1DY)9666(5DM #K#[$_>&'_+F]Y4H&7\C>#$?R_EB.<97&=C
M/+O!'P02&9I][MS5MJ_RN!/J<P_+@07?TJ-W9 9N3:O<O5=KO*F8Z'>0!9MG
M4$M7\;2Y2 - <)ZCK\HON(9-HASR9,.I#8%;H/Y*:@-[TWFU!\&6YZ6U6;M5
M?OS0S_5+J1A.Z;3F+WKSXOWG08OY"*"TB6UHK7?PG>\M^262 A5OHI(N!_;(
M]> ?R14K\"Z=+/F\5V:;PCWE]_I]>>J%0-^]I\I1]%7!Y8<" "8!.<$I'XL:
M 'UNQJ7O*\(!&[HT %I[THH&B'1NR)0^14"E0U*=UT:U0AQYA<C[% T^2*QJ
M[R,A)C7)Q"\@E;)7\L&#!CT791\MQ1CTJ%-%?@<)'+/K/W:=.886[$^&!4F?
MA@,_'-\N>A>Y?\;I^Q"\+_U+JPMOKW-PWUS*UF.Z*O=I*5_OIN_O"_+:'$PV
M4Y]5-\;\5U;!O#V^&Y&O?=R56>Q^R=I\N11KRQ&)E$U+V7"EC\F%OU-@.<UE
M>6%R!,B89TAR<(UO^U7Z:)"MKR*ZM>G&#W[/PI^76D44C,Z*G$(&>X_QW\^#
ML/KXT,"&^T/3T"'DJ5+F1P<_CZ2(NR>F@#J8/W;3K+XH]>]'\Y ^\ #F<H;N
M=_X767=#WZ'D(%_++50 <2_3">ZPZH.PBN#%:[CTUJ;.GT(;<8_A/?P!3[L9
M%SS?T<6JNCN?L2+/#]!BN,MA/RHT#E6;E"5BG;HY6G;_1FV&K8L=O!/_+%(T
M@080.CC2B/K:&X'+>A08&&UFE2@@@9/:-,U0N'WI#H_R]?J$JI37)X;W):N^
M\BB2G:9%WS&5\-Q\=&C^4U)B*=U"J;L+%5%H(2<JT2UT[7;OE' V'H?],8/Z
MENZ;^/'2E_LM,?%<-YB=!&J?#4(,))>L^H?#'QYG>9U"E[4\I1PM$R$S[_FB
M+A"2/D3SWWOI)/7+MU].-#?%H*@B>L+.V[;2* "1]3345/([_WMFPY?F(GJ7
M>]Y5;$O8TJD6?8AU*=BY,(SYQU1* ZRQ<%7,^E&U"8TF3_R7O]:!C\ZO+AS0
M_X_'NC2&>-9T'+A/?P)O.B:LOLQKRP,1SP3( /EJA6)  TSV%209H#<&NUX9
MT,O]E![KG!^95Y/QJGDAK._NZ<T_:S?;!WZX&*$FFOI^I]B1\3U%@#JWT "-
MPW@,(>>OD]\$?7I4P J7"RLGZR^BHI\%(8U^PYD=$;[>#*T3)UEB).ODF]8D
MAK:J/M;^CJ"RU=]'ZEZIG@#J&>V[:YGMZIVF@=P\O<'IF_NL(F>F9JW\SR"*
MS3O8B=C?E7I/7F!1T83K7?+]VVH$.LIFE4RZE(<I3X6^D\?[<V].FC8)ND?Z
M@ N "T-TPH3"4S#6[FO&C> R1U7Q<:RF]J7(%,S7)_&6E7B)^Z$FI:KFQ;_R
MQI54R]I*CC"\)'?UZD@;96NF9G_?.UW+/&G9AG6?K$NCL3J0D]^EXI8U10L2
MU;>-RW#&V*:30 :Z5UIW-!SS6^*PONG"R09:5S8WWR2F+FB8:"$QDU^@Y7^I
MTR'>X7=>\2?Z[],)_/4=$CQ7O-DKH$': E#4U-:F,3;'59E3D!"J5L,,^#[)
M*>L@-U3K65M;^$F>\\Q?&D 8$0V<Y@P)3[#+G,DYV5X@MX&&"-.9FP.G!S1
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MDYR3X&UG*HU=("*[&:.K13&1AO'4Z6<JTP7T[;<,2(ZX@TB"9(X]0^=9 H_
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M'T,0<52!U88%H@DS%@4;@IQ6U.696TU0//%M\JR79*>&L.%\OS4U$#[M0'(
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M2(/6K#VFM"WC7#)K1L-$G0?>^>Z&I<RUIO'P9./].N[%>>5)X=][$A[V-<]
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MGRC#?&'2>:-BNYOS2'E8).3*:J/OS/14=VCQ+]FH;-V_@2%A2=D.KFAWGXQ
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M)DEJX^\C+*3_\*&/0NL#0D"Q4,^RAO"DPH#LQCX1(/EJ6I=B>URE"C+<B3M
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M+)5WM(VKBS"B[Q"A,)801835R)Q:%":8(1%(>B!TU6)PWMN):=6(ER[S0J!
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MY;4M\;QIF>%Y4B#8%9S!#2*\=L?5(EGEWUH/O6E_!_JH9I13^^V*,_L--BI
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M;RK%:*R)Y(]H@)J]@=[0B<-/X;S-(')X+?3TW ;R1,\'%K,+Q!QK_[?_LWB
MT!#@RJ$R3;E R>SD%'^*&/3DV)(*,+LO:$#_D0K0H*U[G"59)GP7J'ML'KX.
MN6:B#Q"G_TB.XA%ZO7>UUCQHX>S/A8X#T-N"\S_#;F?$_1=K_-^_DC]M;Z4"
MWC/^.]K@WZ%R5_^+!'+\VR&!-K/%J#&-0?[ZMXLT3/+CO_SY_]88/AC)_1+P
M'PG]N);2)W!R\0+KY'G6$MG6^W3#C/R_OK)H*M)K1:RM"+,QE+^+TKUPF4%;
MEQ>4N76X5@&PMGE %][+_# :D'"1J2"QD"-\[]4MW@V+"-T+$71R;V]$T&M(
ME/;Z75)_5/OPX80/.Z_P"D<J(V3;51;Z[/.ARR*;T6_VZZ\^7J)/B&#0^MH?
MGI<0KLMRZ\*EX;%;PESO$P(D<A*>GW^2DJ1S=&=C'X36>63!!KAP '!=AU0R
MDH'Y99LS3$I-X4R%2;KJ DL".%WG\ ;ORX*8F-+S@"?G:U(9A.NAZMJ* -U.
MED91 "O 5%\<3G_AN?JZ8;5@LL_=0^$G41_/H>-[4'L"V9166<A!KN>TYW>T
M76^3VEGP+Q#FSS)9ID6!"H C#S=+UN[B?D#"02>GH#-Q5^7!E,[.Y=\\WSN'
ME38F0AF+U#N_?S_0AH!\8'3T-!V3MT2Y7[<M)$5G&;6TA&@\?]',O_4..%GW
MEV\_;PG D+"2:L2S# H!.3YGTY"^^@IP'29)]PJQ<(E.0KU/!WTX;#1,YZ@[
M;%0RJ@_@-/KN^>N2P17&!RRNXH9)BG=$ZH&X%O5UKU1#,]^Y^0.!I=#@$;-)
M8W!_4  5(/\KTGK S[?)9NB]J\3.AP*S5ZM,EPMX /]<W-F9=_[K[N-&B[^0
M*_.09[C$+F\PRZO@N8BYVSP/AG_<-PW2XE;'JT<^=]58DKW'D3;QO4/@_#]7
MWFQ7[MKS\]EG)P3=^#C'LY50ZRL/&)%(;@UG>?-X;.P2WNAAW$(C9$O>5@15
MEOE"1.#A6XUGKW1F'['&+PPHCAG*%US/8]C/,JF+!S\I?/8V*>J.^2N&HMM>
M 03;I[:X?5#&<641RYZ?/TIUTYG',7A6XT)6*#[ZCARGX>Z.\)LD1;GMOP_N
M^KT\+]C<]9Q1JS[E59-)QKYK;>3>)[T027I>DWN?&)H%?-I2Z;7J(^IWT]ZJ
M 5CX!KJOOW5E2-'MW?[K?^5S-ZCU])CYVTJ.U.-@W':\C%NDS.]:@UDM>/_Y
M$=1(XD/KQS?!_?/@BGXK=Z 68['Z?N62F9W7O84[=*??3)IEG#(GRAY\Y_#E
M85^C01_HY@D#Y>"%J9=R@?J/?:-O%[X+9R;= *_MI&,Y@JY.C8Q2F&S8RJ<@
M)_>A'XO/=<V,,C9FJ,&7G3$.#J:*0LYLK^87&M[_ZF>R]:]]^]Z$7S?UR65A
M>0/=O!>B&J+>8CO> FL1E_9N/F>]<EXG_WK*:?:EE/V_Z;OB\F4=CZ*]O&:Z
MDM\=-X@UWGAM).[:S$X%##(K-G <BIO$B,[VY;"??AY<,&JAP%2*C<3JR=_^
MXU$UB[]A5?M*5  .%.&#?6#TW%OL;&55OE)$3XD\EO[/V^M2?CWFMZQXF #G
MXA98Y>D!IZ\40RFDK0.0KOXYI=K_SW>3Q]% 3O)3'.#_I4GS.EOSBJ1\%_E\
MV.><D@>DS]-Y[.$A>2X\SBU;9E_\SA*YX\HO'@#.2!V<<TEB=9;GAKS>0XVY
MZP<6#,+AXT)-]-%@WWW!#E8!?]0^EAQ\V'%0MF??I_CH^KF7ET RKXS6,?3\
M=T2%"K]NO )<A=SB>7B5_D+*JVX!-8WM88.EQ3C?AY=?!O&2@<8#(?:-MMGN
M7%;>B-+G'YWE7@TFL'@[YDAU[)KKEEY["VM6:1T,>$,A0D4CDK+?2O%VA!8"
M+IUW%>:7O</[1P.B.PQASX."[DZ_A:,YIXL64%G#W:_N #Y'_S/RT&_]OBL
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M3R<S^XLDZLC='I5;BA8)K.>=J/C<A7$'T6C2'2:N( M O9W(2/:-)SH-T50
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MK:RQYIISS?G,YQFP?K*F@5/Z.GHZP($#!X#[X _ &@.T?L_^GSZ_#_E_/>,
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M[O,BF?[V6JKBXN*KZF\#1=;UQ/Y:#IKF4QLNC4/-21=P/#'24U9I[E*:^G?
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M'I8LH*4,#,-7[E'Z55H>59A8TPYA0\XW3ZI0C2/4K8EHSH6]LNA2-[5?&$2
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M3#EW',77Q#W$"!0XQ:Q+B)OF2SW>UN%PF3*>*3: V)3C74S.)NA3L*_\Y3A
MAJS)/;0)8Z??[*?+D\<,UOY %MO20K%3/Y$U!A1"K$PN90X;F*>-*-#X+&]_
M8ZMJ;55N__RRC6PLAE:\;3%(MPAU"28=*)SZ*AX><C1ENX[0'LQP]:@>1AWS
M4C^(L:95PR+K.@NS1L:T\MN(QB=H[Q9]W%(=LK)<ZP(2]D+!HNAG]EM_9>0W
M'1-ZW_52W4^-,X8)(W: >I%GE9,%Z,I3#%C ,2]!%A ;5@Y_56O+:6)1F*9G
M*-&A9OK=M>S>QHBH >1<B.=VU2;"5Z1OREO=L?E=45$5J,*2LV,>9/"_[Q3Z
M)C0P:M*J96N>HI1J^C0Q(=$</?N&MKK/[K!LZA&TMA)//K=8ICCU^L'Z)+[S
MP7<'9$)[T.@$[8Q-,HG0.?STU"C-2OO>XXOXRCX(J <$9]-KV"&Q3@197(7D
M!'-PZD NA05$-PBQ@$]K+QNTB&MG0VP8.4SQ-"SG/=<@XU=^TJA75\]:X0"Z
MS =WA^/U_54:"@8T,U+W(R&Q\FI"SH\JZ!&#P*P%-;Y0AU49G"6*Q"\W*LR,
M<YI.89Z>O,8"^&'_L=*W'_!B;V[+V=- TJH'+IT_,ST])%'[5?7J:$!2SO?4
M&).4/7RS,8DDA=?#>YMUN S<]<LS]9N%C-]H-4G2%1<92XC5]%<RXH2GP2A5
M+& ZPVL:<FYY-&!E*B /N5HEN:(N3]EI5W90):29#HA2F%E>Q+%]X[.V(5JA
MT+9B(NJ,>Y#H3E256%V\+2TZGW;&/'->=\ S[()N%@V5-ARFRFS./R:CKKK/
MM>P=74 OK(*="KE!%4FM>ON*SHEY[?=B($PL_SWB::H#FKQ?D[J-OQLUWY%Y
M\4?5!N*0VL/1A[!"^'^3 /]=4NCWJ5A<G0R(2IKM<7G=8VJC+9''+]\@W(TL
MM,=(N@^]?4<U/B@V1HIYN&:6(>GD.YC]^7Z2TM>7X8D7B3W<RI+BD@YF\9>L
M-NYIE7X\K;E[2.7-GM>3$K[G<4?("3'>;_Z\QL2C6EQ@,R"7.\0$VX8WLX\%
M[-F3ONV!"G]Z%#HJ^N9'&!YVJ'/V_!LB7' ^:ZO/J&I';K4%W&]+(^_;+D$K
MDK;?4,.)QL\BF_M&$HA]S>=H6PA81UT_52QGVFWKO:>ZR?UA2TMA(_S6A2(=
MF<KNI-KZZLN?4^<,E[@?('/.9[HD6L4Y&PZT7>JW3,V+JH*5W*<,%DRHJR7,
M%QJ9V!595OC,&BIG*L?23,L"VF@%+HJBD:!Y3\:CHJRXV;RMAOK#NI#OF2?T
M]O4KBV[XZ#SU]K0KS =#=_GZDJ[9U/C 3%#\=ZO--W_7HCAV59YR>Q]D0#)D
M'#6'>2&;D0U;F-,\AB+^7L!J>P><M&7J)%;#U^=YQI@MQH[(9RW5<$ICQ CJ
MNZ;C&+/9>&Y*>##,B>ZQ:/P,RAUVA,;>%G;I1Y@"_81Q3)L=E="&XW+=7\-]
MRAFHC#^^ ./T,S[M^FE)S;.*V'?ZXO(ZLD]G<'5E12DZ]**];MM9GJ")QK&?
M;E]@B/\L@O]<Z:WAHO0@U7Q['F2/.P=Y=PVD/@GIGRTTAO!UV:\,#>'[WUN1
M,X^WX_V*7#8'!;+$%KH4LTS4?.:C8VU45,PC&W&74JXT.,30.[U&%;:A7FRN
M#ASP$9YV^9^++L8-J4NAGM]8P-W01U .9+CQH%Q5A@-,P,U!E$JW"I,8+%&B
ME59!.&G7C&NJ8GYJY8QIY5BWE!!J&%DHQQZYMBO( #U&?,A-,/)M36?*"54&
M:]RC]L@$JZ$51<BK.IZ89'S'CJ;H((C*;I,B<"Z:T9:2S!^M[&.@O&'7S-&,
MQ2Q)YHW;,L&FV:X(K]1E"'2UR-%%&P*8BJC_LJ#46=%[QA(^QAOQ.7UTKQ=1
M,H93Q/D6-Q7MB254N$ZS &O:<9#H6,M;;L<5QQ,J]O5S4A02<2-KXCV/$D(*
M<W=M]:>B<7Q-8LSNL$N4C%^Q%-2V[Z F'S*KJ@_BGARFU$#5*0]6'QY.'JW"
M1BM^K91&GZ/EZ _XP4XICFKFY2##AOS=Z/*A;@$>/%%*[#Q_6GU;NL[[A?Y$
M82WN3R<!COOS4<RWN/_!<Z[D=*@KW!3JY:NY,N?3Z!R/O5;%31UJ^V9I5]1?
M%U7_R<KE*31.1?J$\8@9Z6BO>J_=S_A5.T.#K]I*JQ[3\YH6WTK9"[H<S!/<
M6,#57:&<#:Z'_TSUL'[HIB_T$(Z23)VB]?_'RC!N.> DZL= "O-8!PO8D,31
M;YT\ 5+J[7,@\FQ F(Z:)UG \XM4%G!8C?'>MZN'&@Q21Y?V;_0VJA&,*$Z%
MH6B%_O3I=1@)$<A4WQ<@; WMLZ%:()IJS"Y4E5<K;E39AM9/2>D:A;=54]]\
MIN3'YB-Q-P>W;I"P !+38A*:9H&KP%76['-,7HPV^<O00PY](C?Y2[_>E3MH
M2?<I"@*U>J;0?;0Z%U>);;EM93*X=>+& R]VVN(H=V-#\H).[Q]'7-NSV _?
M[= ZS-<16$G+N1"'B&E7_Y927I@R+=$:UL7M9IX7]5W*_#G<:J[A@F5ZFK=)
MR*+8Z%L'#2$5XNWYW0A9ZY[#$:4)LRKN%J$1:OC2R"X7;H\;<H6?)<TBQ%Z,
M)7+9%'QV%LO-H97O"[NBN,+.TU)(XJW82!; Q12EJ_;3=2EC=E1XS&;?RR;N
MH9!0DIS 3]JCN;;6[2;H)XIF-!;I9#J,/8%NMW]HX.U<:C/IQN1#=UQX4%==
M7U>)7O:8 HDLY:ZT=8-ND1NN2C:\M"UO47E2EA\$U!H'?MVHS?C(O:;X'&OW
M(*'/L,@L2F]CKE)-; Y!M,GPT5KKY7$#LJ!TQUY1R'6P04=M&L!JN^CG#/=U
M"B>@J]<H-F*C7QSD.&A[8NL3UH+LM[YTB%A*+/X5EUO\QV>S4R U=6$!KG\^
M%V7D:QY[U9!?PPEA1VY\.Z6>'5##^<>IZSO010@ ERR#9'YYN!N-;;<^;#-0
M:*S2K'/&'/_R<5'9A0UMGV]&N1]_I/E:VGP6R7Y;]0:9>9FH/[1DB6D/O'5!
M9< H4_AB:73(#R.%M&*SP\??^H*-2#$_AS?W[6PLD^L'S@4W.M:Z'F)$24=5
MQE7DTJ:FO;K@+\-X*=OQTY;#ZM;$$>;%L,&]JWDDZZ8+AN0&UTEARLGGA[LA
M@AZ%1,-'<X(N=_?]]FQT/82*;8?A%5YTKJ?#^-O5>)AKQ/,!)MY^\#&*M(!<
M,ZI,I+-1N7^EY(ZW%+IK<E25#UNH:Q-9@%Q;F,C 6E6HK"2,*(#NY.^,/5M#
MQ =N9[. EBI8Y=O #IB[7'CQ=I*TCUG;U*G$\4(RHD6/;?3(U?BIP'<' 1]?
MSQWFB5I&@;_$YCM_N5$<43/K9'BN6'B6=G!.B&Y=O/:/MW-+NW[VHN*IVOC*
MI,;&Q@;^T'?/\:O* 6=X0T8>/OIFS=2?&/9/JJ^<F7\[F#:W[8?W9@$NEM'%
M?(-NWPQ]\[Z/<_;)7B)BI,O$O\Q^7U.VBE@VGMPV)XWS#'%G+[?F>5KW(J32
M&W8PY^@2N ,PKQ.FACHLP(Q1N(*M;+RX83BPMI4A3,*^DBU#;$&.VX48)MR*
M&O2H@[V4D5E55R:CCR'CM0?]^91B-1"R_J_HVJY*$U>";=/00K0UBM<VC@)M
M0PO0L*2:+GOI]M3#Y+&%3!E*'JX==G:)?^?59BRT0Y,G-C>A;13WTN^6\0G7
M,!E:?WYW_KTE7[>#=_%TK6 2[-BB#?;Y+T25 1K?Q@*.@"#T^'C-JC+%.C'I
M$J9-4U-J)?KB\Z6.9U()XQ).&Q*9CU&E*8%_M^I $28>?=CVR;EPI%-7NZKY
MK9LCOAF% A*?>T]+O'GRIO/L(O6D]K%6T]Y/!-Y>F4X^)7V?V9C$=">5'YXG
MJG+))0@>;N3$HD%TK4V&C6_*Z9FR4^DB1.-(#].T%RY\*JVY3VKR5&V6<H61
M>CHF\5<0((:.',2)Q"1,9:(X_%;C.W%N=#D6('&8EL8"W$X-X+9LZ6K8 K#$
M=/>U4?T](:?[&%%-:H(?55;CJ6SA<%\W& 54G7$V7O0S%1WPC_MT.,WD:CT)
M-FJ))P_".9/;.@JS;1:'F\Y2")'Q$0\INQ\1-^UOY/_@I_J+#":/??U\S_ C
MTGK6&G-F1HF<4J2:)%FGVFG[NMC]7M[7FR_MM(I--AQS_ ^K5.<$*LD]E<E/
MG+=#M+Y+2F3 5;.LEN@WWI*6177Y&S//L;_J-&ITZ0F/\L;P_^43$Y@_F'))
M!&] Z_\B>!L:&X Z3C<AQA^B&])09#E^FAJ!)/="78:T>L:>*O=,[E%-!*$C
M]6I&L&#/7*R"PXV ^ZTDQ6^V2Y8I088S!<FI57F]&1J#<HPCO_LTJM(8->HT
MG:S+T&^Z!HUT %:NF?Q'JR'DTBHB9MF./4I<E:C]-EC^YFFBG7V>P!6WD7I]
M&<4M0\7W*P;QR"NYXL=<?H99M]Y-D1'HO%))(LI:ZQ[FTQXU&H@VC:X =^TB
MIRIW5MI"B6F-TIWPBMY2JG&[1^GXTFL2]C3-EZC;QAMB*T6#&/>O*$'YD%[3
MZIG 1[QH?.>V<+N5@P"EBK#]<-23[%_B'M2$*4GK%.^"_Q1;:P_2S"H+^Z*I
MVO!#<>W4PFI 7A<Y(E37C&(431DSH&1@(L4'$0V!V:,ED>W)RJFKVX\?#BE9
M8^]310DQ">8?$0=-&&#%O7+%N<;OJ<8_A],,D&MTU_]8\7CIDBX.C50I%5SM
MABN^+'L;4J3(Y91M.1M5864K"E53-VDVH2&C&I1I\M8SI^>BHF=C+A>=ZA=+
MO,"5VF!::8ZZM&D\BI^6>[D6\O 2S-GX&*VM+>PJV)U7UDK@2'C7<":O:R4J
M$GV\Z>Q"YDE:/%&0[5[_RLP0PG\*2JO71IU='*6;C8PT]F("BI%M=X;]G91*
M9R&OX97S+1!>)'O')"]EIS745H?ZM/X#ZI$[G-.%YK&O[):*Z2BUW;\XT':;
MRA9?&7NP%3Z"._1+$SIAVRT7>9Z1UAD)BR5[H\B-VDJ[CP;[EJ;H6MK[MU#]
MWT-.@PS;M@M%UOV/E9M]*CH*L=JI>OJRIW&:CW8SE QU,_1C<JY)W36BVO6H
M?M7'R-QC?TV'F;W4SFQ"JOD8#O?.?E^4DCKIG2EDDI%TW US*'=-57)XIM1X
MM_H0<$5W#M8WV[QJ64F"5?E5$)AB:B@CU.RZG#XSG@7\!^?*)#!/%#"R$;]*
M/6'$O*9CEZOKJC]+LX"C-7$MWEY7##Z>^8L=T?Q8X/3)$T'09=1OCI3<Q[0C
M[6% :MSD4L@". ^&^Z/&?KK@Z&US0JBM/T*<09+4=SYLRJ8<MJG%/+)%9C[<
M8@&POH.I-(_M)[1N2@Y1,XWJ84#+H\2-D5)#="F_T,18L24#"/ND/5)V:E^Z
M,[FNNB*GFV1@@*D83C,=;I K6%Q??.NV_CY$8ZZ[8$RCL<27!1BS@)H=.J<6
M&;N:L7_+(<3K!U.>+D8+=?2=A@)(I1#5DD6F+/7PIB]-69OYK;8)H=/99E3C
MZC4CY'>J]--7#I?',3WU,.Z_"_<&"TA[1Q-E 2^P<2R@LR&F_E6M_\.?'&?E
MKL2JXEL="X=?",=B3+DENM%)YCDW%SN]7XZ+#2:1QK-GT,\2O"./ZD9>*:D7
MS##+L4R&A^>]RCLZIU@T4'K3""-5&ME:P\/7F9: ,=4WF/"\ZQ.#4_<,DT:U
M7)4)@9#B3R.-IR&O_;S.ND^*$Q2E81&ILU,Q=#V21!C4'0Z9[E=<CI7N'(UL
M!Q_E^$*I!ZE[K,?*;A"!+6VP+[F1^U4S12[BEW^:AX9R4AUM$=2ANW5#=,WX
M?2%:-O3HPJ34D!"I\T2 262[51-[PR#=GG1T]9=2,"SF[(EBCRON:M@7= WN
M?)P&Y4<(-S%M64.A/<7*IEW/<<_[?\*:RWMIUK[*F0_FQA"J#WQOD=+-S<WB
M!.%)XMV2DGJJ>M5KF%M(]+,',U-<Y/Q923W]>RL;J9(M-[15B!=GLKAV194D
MRP+M&_GIGX;#5,/:@CI30O,-]J5IGP;80\]9U% J;31K4Z47;=Y0=IZK7\MS
M<*_+B(Q/,"5LU6-I.DJ&+J;4Y'+98H13P7+ I3 A9-SVKQU+CWAJS?:!UPV!
MJ&SF-R%ERJ^*,L-B&R3O&"V9W![$\VPSUN &(42)BP6,."C0T%A9;*&N<[&M
M1\#5NG>#*%)1><UPI8;OS6!V";8ER/^@?BT8]:W5!OL>I[-3G^[U>KBX^2H2
M/KIM**TYT+\MUBL'V9DUO_8I$^NP638NFZ\.6T\S5)<V-,2&[?@:=IK.)B;0
MD_M1KMB1=9!EH4]40EY/_2%*A;Y2EZ,LZ]!"23@N)/PVQ25\2]!H],2UKJ=,
MD:8!')$'W5IMDUQ%.M=H2]PW(/7QNHVFQ,C(A$!]4G4^9]LM61'XL8G,_DQ-
M&ANYU*RU>%\S1)J@>9IFU5;-E/Y4VZ^T^QB[IB1*"+DU*?JQ$6T-/X5,LVE\
MVXHPL.PO+:GJ@9N'GKGYJ5]Q F955V[Q^W]Z7O\-=/RG@!M GZ)42165* 3F
MIX^&)SM)*1?,?V?$?/S%'ZPG@;H8MF2;-D!B'LZQ?R!)Y4C,7JK2MU!X34PH
M6E+%%1L<6;0/=H_*3,[-<Q7]O(ZCG^IB&@60(QGO"5U0!A\QBFY1<=YF;":>
MMA.)V^=FI(<UPRG:4W&P\I0.E!!=FQ F1Y>D,C Q3<=I.\1;_):QCJ35(\N&
M==0$-YT3GK89-SN9TFF&L'VEAGT)<E0@?4B^-XU7N?TO,/ 5,,&<"-ZT[2+:
MS3LF(LZ1;6M\$@^BCEQ'^)'5TQ^^60H:5E3).1_A\IZ0[&1HBM6]%"M9I)*/
MD5(L?U/R]EYPF9[Y\YT<KMU&@DB:7:VG*E$_<-(W*M-;VY%Z[W%<QO%B2)QW
MH;H85#[BHGQ4RX:<B]1FPER,F:]=F=Y57.HG'8APUB_I7[ #S"$HFR(\0N@$
MS8P,IF=\JY 27A'&0?/2IHK'/EZM-(21=*/$^IM@>M2@O4[[())8E2;/H+KZ
M,E$W(EB$:C_B$7MQOP-*B5!JBG?;6P7+M8?NQP)R"FD@$8L 40U*;\AA7DC[
M#1-@2X]F :#$C8'M!MI;T- OJ?(OW.>LS.=7SQ,Y6A-S-!TL1*7,':7S/GGJ
M7=.T'*CQE(ZM/<?'[XW-Z"BRT"A5-DKVNOFD(.=;/D8+HF\513-/)Z$;O\QD
MDW>?H"O!3FR;$:P+^]@8$W:\#FS,D0V.Q!XA"/^9$C?^1VFER%2R]0__C$=S
MZQX3@?ZHDQXVRI&E%06C]WY:TRPG?UJ7#_L;7A]H8.3!'DS8?",1+!D1?M4>
M2'58+@U1V<=CD%L6^6$![#T-+B3;=V5PX\%5V0;CHB6A4X1-C>-@9Z+>V>N8
MJ]T31GI8#N*(_-$&334,<Y"&/&*JH?H'Z1=90!N*#&$ZF/PC2/ZK^^;_7+-2
MWIX_MMGC+;F('5:(GORJ&@+C&C1-F[0<)KA1RR2FN3V\C\C8]"A%DZYA7#N^
M:EKNYF<)!7I="QZNQVW,4[%=0H*T%*I+5Z8&)?X%B0*-4#<KU2IP=3CY7%!J
M4N[DSQMY;G7N;M26[#9$[O5\VV.>[?Q^G&/MGC:7'SH'HKLW!C.7VJA]+ #^
MIF7I-G;Q":JE BVH"Z,,P8XR<11L@],OV()R9J@/3+X5[%T*.,$Z\.;@_879
ML&UKO/&,GK>WST,=T/$(S4O$ ATN\ONNMZ=BA'MTSXGE'"W(G;UTS>>IS3?#
MZE]CB.H@<]K^\T6S/'V^"5G]NYBCOHX;?'HZZ8Y'-XSN21H9)[.GFB;X!"0@
M:E YL.D1N5WQJ2H"(QY]'+=UCHI F23M\H$-)Y,%//>FD9G'B$1L;!!/;)@X
MS9AD-\45HCN]ZF5<2ZE^5N)JLBB/]- ;5EQ^)6=FV=@0_-H3;:IW <EW6NGE
MT&"R7=AGPHR=072;4\7W-IX71<6.RT;1&!,=;U.35B)1[FFNHY);J\E.-M:C
MN%B9OM_Y.0*B2(H9@_Y95LY[1_N.0HZ-?.%A$[/FZ86>@J&7:E%#DD::FQ?7
MS@X-I4ED1U'ZDH][% B+UPC3-^BU&(O@A,M16H"8L:SAN]%[3?B/P(SDM3\[
M;POZ>*=>DUV5"6$!V.]J6(M=[ ;]\ $]LH@+W^)@.O/#TZVMK(_*3N+'C\XG
M?%F-(;_I"9.DRU>!SN>%7*+PM*'/(3^XH_@:# N0NNV:,"JJU=[7@L+8+L8L
M"7%1,.%R6Y"(G4FI.-@AM]& V# Y^W@>-X<#'VNJJ)#G3?S(.L&KMGVGEM4.
MSWWH_HG$D"+I8(MBGM[LYR&6O<<L\%^MH;";477JI]&1HV?+N;M>SE/AS=+H
MUV>9IW!42(<RR%R:]MNO:HHQ/JA?(^' RG9:X(]O8[ 1G[[$NCD(?_Y,=8A%
MD2 .U@K;<9>_7ZG[:)IN?X^4<QCY36^4^V*1RJ3FRL"3M$1S4=F'?;GH$X:6
M26JJO5H.Z2ZF0I.J,1(=WQ(QQVR27'4J8HFNYB9^2]_\R$8^\S'QA-6<0_/Q
M6*.,ZT*[T_M!J:X >0&5(%3;Y;C59T-_1O,EXVB2D/83;&3/&O):9*88S;^H
M95\Q)*R2II?K5F<57JDGQY3IAH3[PU]8F2U::8I3;]HBR49-@PWV1 \W\2$8
M\71C-653><?0GWNH"5MD,)T!81ZWI]1WPMA.EI(N4%U:=X(0>7WM7I!E;U?F
M!?QFO1P?W82F31S#GAP/T7I*0Y$42'V131 TR:O=DOJ,8EF1'ZLZUO(7+>">
MH9SQ(!;_==?B7A\T6:=4T[RPY,ZCHIH;!'?N^QC="4N,N*2.YJA=E&&GI1FQ
MRWBL-;!7EW_3SMRU),1=IR'O13+8"5)-"B/<,W)NFJ43C9<5S!/38DKWMHN.
MKM4#;_!H[!VAP>FHP$,L -V*TT"Y+/>-B>UOHVE9@=3BFP1U98KG6MOD^5I*
MQ(NZJ9<A>M.KY^R]*:Z+J4^?81>W^95?5;U"=(?HVAIJ6?179CTI+JCJ2"KG
M]T'_J.KMSSRI6L9AQ.=8)!4V\-)C(,<J\T7B=(:->P[F>]GGQ:FWV3:2^?'0
M<R_VDI _]CK/<4U"3]@/M0Y:N&F37(MZHU,1:I6!C4D/*V-O5U:>Z8:C\'1)
M_8-Q#1R0/+4F%T:!+6D=:=6"(9I#.<4_>@EFA]PU#N^CD&#13LTN+9F*S#Y4
MY!KU 6FJ>;E KAU'LT*/S9NB8,Q3>!*L_.!EWOE/*W%:B_;A@TPT4:=E"65,
MP?:B3X3H,BH5^13#2?#GZ#,A5KYY;JC*1QE%MHV$YJ.5V%,TM"D5_<(?-E*W
MO6S2WR3L9L6)?-K6<G92LK_!I,B-WP$M4U;X%%59R3.!F6AK1PJM,8\?GD:_
M;FWK3#5NAT=!3UIU\C/C@TE?8$1T9>'6.>D^=N1<=^O>1$WX:H,9(A"#--8G
M/*!8Y@1B1SPL4SN+N1F)-O&M?9"I>\@ZZV[9[E_7P_)7A#";(-N^"C';0[T,
M6=U7-Z8FV%(BPT.,J<\A7$BG]D\A4A2>B ;G:3GN,22OPUB(V8\+@^>Z,A6K
M&R@GBTDRIVTAW/:38]INW)DXS<SDT3NG1]SJO- 2M7M7HG^;4+B_!</03#X&
MH<&8;YHXCX1^.?+X7XUJ1EVJE_L,]/Q+]##]VBG..^<O2GQXJY#NOS=]\OK:
MXO)B%-T11* _42UNS,-A[0Y*=33M#TAE"]H&-4T_:F"^G<G=KZ[G1H2R(^6]
M5D=_X8VIQK'Y_71C$:'SF2.K7K"/?N@32X2SR5;)&^Z^BWV7+G?O:_Z<(-1.
M9*I\Z:I6\UY>4D.E0U]9M>S)T;F@Y(MAHV<5IER?A+C0IM&G[Q,\0SPX8LOL
MEYI$-86:4N$'%NL(4>*5S_="Y4SQ,H\?/\1OL4N4^.UWERH8U":85NS].OWU
MHW5I".*.GQ0AYUF;3EW+CX18NSOSJC?E#6U"RDW"5D1Y5'O3[<CG"L.>$5G
M2>>17W(*Q:DWFZ0A2=-94=9/SWIF"I\S+=7#QYB%QUH=#^O93YP]9E%LF2AJ
MRHDPWL8R+R()*B"MX>^/!S4BGP9J<6U?+8B:?G)*7XL%L%U;;C1>4<KQ!VE1
M)DYUFLQ$$/!LT+[2L.LT.+&+?J:B*U/\!UT#0?4@02/E_ 5U>AX-^8_ET>RG
M+^2,(CUG_>4+W36O4' QN92DE;H!V9*:=61"!_X.I8T8?.+B_OZ-K9\J6 &:
M"_/8VE7,-)(N2+4EG\W@F-0<4/1Z=?K&=*B6]8^5D /YKD&R:47(% -[?;S!
MD&$OKMAF*8A>5PUF;JSI\([)T"4_=(1,UACM::#FMOJUUE]A??OL_+G9L](#
MWQ&\90'GJEX'Z>$3'PR765H:F7AMO:*@#AD5Y3&+'^F'Q/DT<I"3):7*9*KB
MW(HR.[W#8]=D[]5VC6IW;^.9%P,(L(5.OSLQJ)X^^,Y,_*[RG8=.31!'/9!-
MJ7ND@RR18V'R/<@7T;BO0F0F'Z%:;88\BKO8<(.2QCQ6GHN\H6Z!H.Z3.M:1
M$="HRS3EVWA1O#^<)U979]BKE,[/O$JQJ&GK'%(_EE^=FNJS&*!YL;8*)6AX
MB1#TPN%P!>>=J:OTX I&8HD?A$U[7\6="1OVQ])NTQTFK]92&9VY.WI$<BY-
M'\JFA;G%Y*#DQUX4M,%W\K^<[2GG+V$S_S3P:\7ETZ>J(:D"RA2'5;HC1P*?
MD)M*L'[E!K\Y4:+3;GPC4]1GI"UI_U.5SH>\>CE(2SKGZ\*C9L20$'.,A%K2
MPCQOT-TG,;-R;FKOEK7%V8QO]P[9.08$".\=A5%\F^H46 "O?#;(6*TT4'06
M0,R0^HZB^(;5S4!HCCW<@9TH(L8K'@-;]VP;1,6BI,92!%6[[$Y6Y7A:/>FZ
M/LX1C+D3"L$]]BM;VU( *?>"%90NT2G'^*G!3>PZ F?>,K'QI ;&3S&W4>:O
MP72\LMSW)^K!"5X7Z(:OU8QOW#%8Q9<9%XR&JC#W4QA-U=?.^2"3-T7'Y&L7
M7;&1N@"*<AV:)L[(&]Y]2\03OG/W_DX+'(OS:A.KRCY_8#F"R3E1,27@]&QW
MW[)\NHD/)">?LA:W8KS0C_7J*&//=TO65<2&T:N!\<LQ+.#9.#/'B06$)RI]
MA<U]\_.?B4.Y&;" 9A;P%7?@Z_(B812K"U[QPG)\#+-C5*4/LRH:XKT>/C5]
M="\X4V4>VKU:SJ<Z/V^R<X.\I*&RY]>R6G^ UVZ+7*"A_A$F,T6VZ7JN8E_<
MD _RPTW.V(TI!F:/\ 7/O( ]M,P"CCZI843,P2/W'TT1WC!4?QL2\/!Q8E[N
MONUP@ 4DQ#5JW #+^.UQ#7D60""5=8$;SGKXR*[1G!#G3ZJ"^1G=)%R-F@L/
M_E/#*' 5_KVQ^HJ*@$3?(:=9Q_#TF>VND)T.A.V3AO00#%8C9R54OHNXFB'<
M/'X)E$7'%"?W&"Z"6*8="[#7^GVA*>:M)QLL /&=!>Q^9";CF2<O#*.9CY=O
M.WCWK9X)TF5/Z*-+O,F\W74G)MWB)PN8)B+<FF&4KKW;;+"-)RE=?];C%B).
M-K(UHJY>INBP497)Z^@VK&=C7]!P32^7P-9\3/C^1S7R8! SJ?_D'T3E)F,H
MO,2IR9@Q0V!>0!]D 3^BKLGMQGXGS,? <D&WIZ<;W;;GM[4&$H5 $#MQ&(GL
M_(4B=9T<$7#ZS-?A8$R3^U5-ZUN)SXU)(C-Y&,3E/BCUH5I,@$" $IUL&UZE
MLIC^E 4DA^X%K-'VA^D'WS0?G%E175Y;HR]K-ZN+$\3CF=Q.*1./[Z+:KTRC
M]DZUL0!V7Z.I;;YU9AGJ5C$+.+PU/#/#_)IZ5T4<'9^2$7<91OH*V4BMA])Y
MT+8)3(26O@-NP\$+<F>>Z5JPB9U_?K!YV[)7C_=:!!M&D\%6[5OE%;/5YW!U
M&H3@Y;C=S4V-EQY02*V.49]8))-[3BB(!33"Z3U.Q,B#&NN\<./=N)Y@N;W8
M<L8Q<3J/KW6(R[;%0.=3]*XL =6.9 &I\HO+^/6>+V!DZM2^HS<\^&WB4'.?
M)X72<$LQ6.=-$@[][O:NC^_.M8.K4VPU?/0;7TN#?9O5-]*]F;1F\1HCA8['
M#>K3RUC:K6C[23EY\*T+*A%@4^3&[HI/3Z(WH*E3?<;8(#2N']7B[1\(YAQO
M?3['7VQT^+DFXV\0>'@X[\2:E3#8:B?<U]*9W_GOMPC'QQ)<_E((9P%G@^..
M;J_!GR>W:9)5%HX$WLD,G.?M#519C"*\#'[VG*_\UV7O9X/^Y*ETO](<8M\1
MC?7;"!9PXWT\"[@*9QZ.!#5HQ3-9%D"&6C;BIBH\6< V;]_D4=#9JKV&%Q#:
M(\1E%P#5L52O&<Y\?>J7\6Q\4'\XDUVC=/PKUV7F]^$K!NI_M7'<I3LU9EKG
M9PRK9$5),$_SO+5^Z!RG\L9&3\3YENG*X3"N,<8O%H"\[QAOF+ZWU3>8Z6M/
M>/Y;K4AW" E1(]Z<B-G#12@9&'KIVEM^G[JG57Q/P3 ?;OCPX6M9^)VF4^Y7
MWWSO@XPA9":19>>M(O31D0("6<K&%S!J4:>?O"@?B1%6+?C:*HNR#7F3..@D
MZ=.=+&NJ;R0E.TMT^:/(0M0XTFVP*$?9Z,QW7W>3]$&1Q5:SO9G/PI(%.F8S
M*2)V>=WBW'QA_:"0G:M22II.V/8>F$Y51CZ*@L>DZ%TR$TY$/GS-Y)+NDOIX
M@?S&HC\IZ4_G\[;Q3'9AU'EQ)M_\[0.ZJK2O3ZX+\WUE 2\MY0FUR\\ZD?1U
M:%5-=%ZE*XH(IU^V_>JW4/H0AX+T/?D$[RFS]\@\/Y2/G_V\+L*_-=%N6I8T
M)YN6ZW!]M$3>P=UTK,_Q1\@U&I%JT*$I]L-/ ZI+T]/\6/VC*JDK2EW4$S&7
M<"/:9/!1ZMQ6YNR*K-(]3-J^S?;(XTM.&:)4[O&]6^1[A+1G%.A)?)[:$$V+
M79\K>U994[BC0*)3'8]6,S-Y81.\_]7#Z5M*I(",4:S-$$V838?+47(PR4BZ
ML\C[A6./6IF[@@GFW+7/XJ)<:;$)N 4!%,4JUG&5.<0".&8?R%Q_$TN@RT3C
M/:HELVN27C;3S"^T6_&<W5Y'*W#VJ,NKGC;@K\Z%4RR-.0TQ+,!=;F40-_(L
M3W>(A_2H8,]=G;.DAC.-2,&L.*Z2_)+]W38X'JIG63R#271@POHCK08>VLM-
MKR;G$>&0*:23$1YQ/NU;G ;\497\P&:P<V8ON5W8AO)X#Y&!B\P^;5PV9K?T
MQ(V0'%2BQI@/=X5#Z=[9.=$G8&U7UZ\AX\!:.MUC="TX5*%#;:Z4)&A[W9!?
MQD<0<,LQ(6S=^^"V^=K_GN+8BP&1P7Q\Z>HJZ?(X9^N]+^9(38%N^3.8E7&R
M\:L*R8+.G-)O>1(^>>*\9MYO34%5E@>9:'I,:8(^<5#C%F)_Z9-^9U'-\PFF
M@R]/^ZBY_RI?[_&K";%JGDJGD\3F323"EN$#"2"L/1K,R?B GCZ"/M1?)_*7
M =5R2;7_W1^<)%2$Q,)*KEJ$R5\WH))\^VW;"$:9IB"SO]]A<<^BE/"2[I+7
M[+E&%RZV:_%53S[>WR66D[MTJLU+J-"98Z"+NRTT>6!I(H/?XU9L>Q+MA/(J
M&UE&I\T<+^<'B:QH*7*M:PIOH!G>V@O-_.R9/!J^Z(-R)4W.?K\[WB7R^LG'
M*9M1>Q$'_\H[F<7[[-IE>OMW0^3X.=,-N.?*-7/[4]8)6O$W!PG6'CT8E[^V
M3R@>QT,N3?:XOV;^M;W;!J-,15K>2",MS'I_H7X..]YT[<2KK%22?&5QJ"W$
MC%/-?Y$$%7$SWW:/^%;B8IFA[R_#<[PA78\(YY ]UTM-]$$^V8;)-#\HI]TQ
MY""?>6=2NG5'R>[.X@.W!Z@ ?@N-MVVK_/V%-ADV%C(\1M@U6UJD5>9.^ZB=
M6NDO3&#6Q,2EX51IM^2ZW&#L_=KRRF.A_AZ.KOUN5L.KPI,&LQ,W#H[G[.(#
M/3[G]16-+?9/&HC5Q3_AMXJV;GJ^AP22VAU=\)Y8Q>HX/_9+.J-N_=E(DW<&
M#1#NH5)U::H0/*:)OU^I?N+IZ/+=875AD@<<XF!CLU2G'*WH]V/-'W'RW(1%
MB<SJ&KFRKK],-&I]9J3+"RDT.9M=OVX%O4,SH>P3E=I"=(;5G<ABFD(#LW'S
MIM2=]A,>EI3MU\Y*G]R^6QD.*4FOGC,X^\-.(ZFQ,[-<1-YHFU+1_,"$/CG?
MS7,VBVLVS$4B?R5AU@1QM3I(;/.391TLR5YD22K>RLN%=Q]W)J!N)_$S6EG*
MKO3J9D,E_.'/>@.$ '9GYER<_/C;G#]5CU_7H,VGUEC;7,I&R'8Z7OR6T/JI
MXU)(UZ4KSA^2E0\G#=Q[>CN.-U+G9&[$H:4!/&:+@=([RV6B#7!%+J)9@ D+
MV I3K$(7M!0:<WGD+YU:'"A)RWT;?"#LDVYY9+*PLF63]:0%O6>U-6ELXR%@
M=Y[#?[]T2O#U(@%GW-<HS)&BV8;'H,)T4"?'"1J,#%+\'M]C%"4#SK0U 6=Q
M*%+>QWDLW:RXC\ 4&TQE-E'O+9AXU^,//?&-_\"VZ[^'?Q_(MJ!"%@P$[^&W
M;#>_'1#%9GSZ)V0_Q0HD%X,H%V0.,\(62A?_QW3E>9=.<5P#1=<N[BAYEZ'&
M'^H+&YF48 %9R2!Y.P;BUFP5=&12\M\6#JJYRZ,W?D$VRUSVKW7 -J^ Y(JH
MAJ-7Y^S#.J#_G'XXF9IPL(9W<Y.O><_7C@#>!+7@7,X"6OU1NPC=?Y]>%Y3G
MHV_LHK8HKO]YZK]-P5.CYE 5#68L0$LFGGD&)#[=[K#_,@<6"\!C_NTV_W?'
M\/I<\_NZ-7/?N]=W*B:(,%.S2F8!AX(8J3A/XS/HUW69.23C%S ^A]YO;6:T
ME]/2B(MST+.CBS_2$!KJOL18HY\CRSM/SSZ_=LWPT<"^-N'ERZKD-/^B";?J
MJT^303Z#'F%*@-TO*KE+F _\Y8^"[$:;V1I3599)(!*@3V*RP$VU,Y"-'O_[
MU)_?ZQJ\502T[R@A,=QJIGJUWP@O<D0EC$Y_\E1X05K)*$M,";--?<2G*:7R
MO8+'EBTJQOFP9<Q;'\PU7[/"8SI^2_BDA"2URJ4;M1TC*H5R<]=90,NG,+:6
MOM5G9.'FWK"3KKQT7;KX.+F@5S]=*)P+PSR12($QA-AB]E#] C]\XXUWH15]
M63N=JMC%BA4A,96NUY? 1O& E!E)V'=:--B&G$']^ JJDQ<DU/ID(VZKZS5J
MP04,Z#$*BMXY] OW90].>Y7NYK4K2-C<R[?%=.]K3CVMF4+ WD-H$<;-(S#J
M.Z$K?2A:1= QS1$8!?V07*VW%E<)\MVP(["- *8"J ,4O6Z"H^].C1)#F1'>
M/LX".G2=^N TS)G?^1S1U=[&?&0+:-!5T'W[\#U3%F"'?(]XW\,"QIL@6RW/
MJ3RQ3YEC6 SCIC-.;O?/4$W[DDK8>^AO\U.;2"%02+8I?V !&Z&6#T"5]8@.
MX2-O-U+?S*O3!7]$9BVIA[!Y]>+RO3XBTY@1U\ J^H?5T,CVJ4WYWYFE@J;7
M8)BU5&4&QSP8!YHQ\\%ADCB_3$6#+O.T,X[>C%($$^L('BD*"E>"YF65+GH_
M U(NE*FY7>P&?O&3=@$VMQIR?_(S[4;VR5U0<QTCMJRB2U%Z^=WM#5":WF,8
M)=UL,3.U4Z4O+%12LXOD!>(#A-%MP/!_IKNWV+[\N!?#/#,]-?_\'/5<K!<+
M$/ZNV\T&IMI& _,)2(7#O=1YH,:CW1U=?QF%<2[DB 2P@#>4@'D*-/:W1!J/
M/Z(;$S;$E 'U3)%!]LGHF@_4*?*>'W:A:R5,#$2!M[]1 )2HLUU<H?&@UU?N
M@5Y?Q=$_8YCUWC?'?GOWXJ<<\P&4?BON*KC_%VCSZ'H?,P#="TIR3W1XCC#S
M2D4'XD\V^EL$K]\A?Z%KY,*^Q:@Z- 6DT.%.]CG;&*HU&;JNKXCR,A;(;(:T
MC1,V%;9A_SNU1E'K<_'E-##\!E"Z&($%I"@9Q-(*$:E#8+ NU\J6K3'O:S$O
MZIY#_=CA!/<'NK" :WWS';#I2>P1#(PRZ" MKMI'ERH]+P#>_(G[#(KB51-.
M[J(_!.LO30C'KI@U)MC@#?_!\Y-^!S7W\#= (737AUWWH:]Q"W]/8;N^YK7+
MT6='JBQ8@$^M'-,1=+=,Y;>[HF"B95JS@-X-BBAL^D]-R!U4IR$MEPS;,*@L
MI__>,E4^OUE<"(+(2<K;34:^NG$G;.Z=FQ.&T#F'"VKZ^T%AE%0XT\[TGQ%6
M1--K,<Q&JCL+>%\%IXLUXQC]TLR++@*H'_N_O;2&@U[&MW*!6H<=J<U&3\>\
M3L/"(VRL?-%[@MY,)6_8] O-,UIO]F_3$AEA?(NZ!";&V"R5,7164^P\F%:7
M0'%>"/KEU84)<]WG >O6^>-O9 97+)@X[Z  ZPXP/BL\  M0/P@ZVZNVB'Z@
M>4\=+"1\?)LY:/;L_\?8>T<UT7;OPK&B(B @(#4J($V(2I,:A4<0$1 0D)K'
MPD.)&!&0 "$1D5ZBU$<0(B!$FI$20H\0BH+44!2$D$1%0"!1R@@I)[S?.N>L
ML][?']]:A,5,)O?LO>^]K^O:F;D'P$Z !;+R#,NT-G.Y@%B\?:'NYM)$M2!?
M]IYGO4+V+DLQ'#@&4_XKF,4'S'+"-!_T%L@E)9TV<^ X)PG -M*\@X%B\B0\
MQ? <97_HYMEN-\Y?HH(QBP9@')5^02'OLNU:,8']AG9!O)0$@1^<0)_:&?T2
MJ\J/9R_?=37DA<#D1BI&J?!,[_E*P9A['5A5=S ]%X G3(%_*6'XD.Q>1Z98
M[]H"C*ALSS82>--I<_/]$"<EZ0_FO>?K55MN/@.S)7M:4&0"PG7!=%UDJL+]
MPJ1R<#^;HOB@F5U\4)<#<VA+79#F="4!@PY2V?%0X.1\_)&O* Q[U\YW/8=6
M*+(* MFJ'+-H%5VQB.F0Y9SY5W#V3<:>-/)OA[M",PM\D*[@P"6WG]@-A,#,
M'W=V8AW\'U+\?[<%7HJ+I1G[96-8N8)><U[053/4V:O<HX(W6"F:@CTW 3:8
M(][;R18T[9V;D^E&L@#F;[%K44@27F'K3JA9>"@&4'F#>^G-)5MRBUM]BVDI
M42DPDG_[4=[[]FWM+Z>$6QPC\,C!V:^>WN\&]HTI(;*#]]3K5O9T.RRY":P9
MXGS, 0/V!#Y(^S5O@ WE'M[9A @VR\GBYP=M>MR_N5^J/"^ F"O:#X-SO-6)
M7QF3H1U 26^&_3F&7&UJ=JGLWP^2K&Q^C)6<?N,84$U-<:CP^_81QKJJZ'$L
M8P832$Z^)15\\J_3Z\$2[T\KCUHF3O9.2^7:)"NJ2X'2#-1_[M>6.N$E4"1S
M&6CY5)"Y ?P."-3[Z.>C8Z [>Q@EDXJ]5T6_\ 1E^0^ $V""J#&F^SP9QXEK
MWA[Y?R;3$7P$Z)/9B!@K_XWR^E>A0J8N"):I%3<S'4ESY5X2DP06"_[H+E"_
M VV%WAG4[WR0S"E'X:6'A&B:ZS2G LL[>)%>KPR5TZ\M 3!TH5KG#K7'J&L1
M7S>4V\7T-V5^_M[6XISC%MQ=]>P,#I3K35SWSU!TZV[>]K"K'+I;JL(;K/6T
MA<.C=:_\+G8?>'7@UX"FM>KR#+-;&-_TOTT7XZC)[+")B&'W'GS2:2%N_W\T
M".,C0$T.>:'",LH)2>JZJ7F^N5Y9P5Q)*LLCZ[;G8N-=TXK.<XX9>*<'^(%C
M)'M[S2^R)"4V.N)Q>>X_$2L0R<<5C*6;)8=/R17<<]>PTF_'/Z'8$_75>]!]
MK[[9#)[-*A_H,6V-+V(QIG8N3$>2'TO:LB:(C)2499A;F_<YK90HG.1,P)9]
MUNR)L;M.GKYCB#*J7M"YP8#2S*C2N)<OA@[#Y5 S%>@/T",H/TRY%\>"*T@6
M__[J4UN+#'^4&HOIS++N&!#M['.7+1GE@XBF0G/38G*TBPCQ7W(,Q-'>X%!0
MAMN7_;2WT#J40#Q;JB8@_N3*D!S^I#Q\USN*_3DDH-CA#S<'0_B@HXQ-/JB1
MB$(KB[(/G0UC7R^1)QTVT&P7MVN3JSRM5>KQ*BCJ(D.CPW;V6TA][L=K71.4
MAA\?+!PB*D)]'1]^+7=*<Z<NL,X;CL\.&':82U!1!^EF0IUR9H.DJ#)DE$.*
M76T+&Y(81I9:VCS3>2.)B)! 9O!!SI-AE0NR*0ZO YOC9I8IBE3[Y8$P_>=E
MTXNN2YJ+QD]DOF:=^3>4_??):\?._*VS\J3E_1?1:R_?'<^P"YA@)3^Y?6QV
M)/460<-N2D,UPM[Y14%&*]ZHS_Y75JF:AJFOFL85IWM.F0^R\EL>9 8U;#5,
M!VW>O'34Y8#&P3VRJX7H?SE1&_MS7C;:J"3_9>,A,7+Y\?5#/J=\-54NS!7Y
M?Q MBO%Z_;[7F63G1$9 <[;@93&_&RH]?69F<IK1A;&<P>!:>]%S;GO2_ZCA
MVP0 \N^;7F8[+8LK&D&@X.)A;PV7 UA8#U9N4BL4^G.R<A$FUHI@Q78[=4#3
MT2K(P&UF/'D.>@@5P<*FH350SNP";$<UPIO*"6+O!B=[""4B].SL^QE5#R.Y
MA20$@GFCU<R/7JTS@A+HCKWCP"I;S(/]=*S5EA5+<6""Y8#>KD)CH+($B>V1
MF^\BIRG) K';%AP(4'>;M<V )7"L65.P_07"<^ 8E$8U($GWBGS",QI&V2C%
MSO6;X ZAS%@-;<RTW<S/O,%^;DG*X-L*W&F/<CGG%V^^CV655]I>5E5Y^>W4
MHI5.7XXJ=0OSTZO ]3[NZ-]2HC>NZ!=9E-JH:::?<RZ2DMVNSRB7LG=1TW!Y
M(G<EW2 4$QS^:_^D[) J\MBZ48_&.M#+:MDXR*TPET=.;P2P5;'=JW'XO[BY
M^ACQ '/P\.%"$_]V9224*=9-DX7CP/HS3D-V5(X9'9;@T9MH+A?8?LA\+Q!4
MBG3K51)BB26W*L+IB'U+/F*LVS91(=MZNQ0DG_68-:XN4#G?&VO^C3P6X7P#
M%:1PUT^VZ4J6YD5J<.5Y"PD7B5:\C7,ULJ%X7M.>6JH&T=+MN'G&N41!*2!A
MX(2KE*_1<*E'2I'Z+4TJWOZ5EI5AMI>I_RWGV*R_%\>*3E70YP<7U8L;A_2T
MWO-T4-ZU@&/0W _G3G-M((9!2"P\C>OPV<<R?"S?^11(Z,I;SXUM]63O<8H7
MYH,4 'R'SQ%JT!I-""G?+3?>/=O"B-:132^0?GYK,J^GI&QA$]T$.X7^+!C+
MC Z.FQ*PO[RY%)#)6(T+@TAS"ZF40HG1T_K14?9CH;!] +4G,B'Q[NWF28X1
M1O(3TK)S5H-X%AFYA3D"M[PFD"X^%+NQDLDWVG= "QRM;0?.>;;[R/,@4Y>7
MGH%;X%[,D?XHAMTIJGW#\-K0Y^D>M#Q+K<LFC"I:'J&?65;'B#(*C4N6QQ$_
M>02>FU4T_GZ@^IYI/[UW>9(US8"DR;S;\PXGQ9%G1)2-NT[;L-M3Z'9:;G!%
MY4[CS53?<<*:,$1VT>?$2'V;!862E^HA6E01(-W@<R+#VYQIW=A:T]C87,OY
MXS!%Y1T<U_+40O>CM49?M42EM$%ML0Z ;]%"N#"#J]6]U9MZUU0_ -P]8'*1
M3%VO1,37>HH= B)4,<F1WWKC0H>$@9"NS=R'0T(.Y>@)\MNO)(^A=+&?N6RY
MQ24+]@- (,^[&^3$*/*69<C)[ED%]F;JV@]H_0F@#AY=%JATBDJF0S%@Y*T#
M)S,[T?KC^C@QE,MP/>988'A.+0B=%8@CYKX;$D%"Z> T4S_&=Y9]/KONW2;X
M"$K8CZ$(<33.'DJH%\CP@/;S$_F.6"O2Q.FU[0&Q"^-596-!L^MC0\J4F]J;
M.2M&GS!!JY^K]6E)D=)-;%%:QSP]OJ1JH;FPAFEF+FB,T(ILT]ECPZBSU4 -
M&KP4^43#EPFG';)E#$ LV-(Q16V]R:$S83FS=@>KUD4D^"!7@/*.#Y+#W(*E
M\$&'5UNA=,CGP>_,=YC]IK=9U X?Q1&T)M+/X2WKWC,_]G3W4XY)D*<=L66B
MU4;G69%_PY3W[.L)X\)\O/(/ R79"9260IX/L20P&" \XH/@?-!G<&>>9"6O
M5QRI[,'^MH&?@R:B99M'30WI^2GDQX5Z(ZL<.];O+G%!7R5%,-TC**5)@5P4
MF6-)U[&=-B8O.0BAS)KM;LTS$-@3+%QL*$QF\1VXQ/S$SJ5Y]$<?\)T8CC=A
MT?A9VT3HY[46A]W(GI[?]F.F^O0/'$?&DH@/XLB/*:6"$A\ [)#>)P:>"LS=
MR%7:-;9>+>S SO)0[,'O'ON-Z;B N?,^=,#6-9>!^_QSK7_H<,#O]J*Y547_
M8CA9+L%<4CH#WBY'/=Y4/YGUV2:@HO?LZ''21"LT_#7L\Q2\V6L3MBN )@.]
M23B$A%]EY[1MJR*Q3FRQ'LB>'] C1*CH0K-A/,JV]!F<KJAF036%LB@N[*&4
MUK-%',N:\2J4&9Z0CO)DQ<,DD <"9308N!0TY.WH>I3=/42MN20 V?#BXI>)
M40/.&P&LH"<^A_([;E^N9</B.49AE9\\9@ 32N?TE7'ET;*Q^GY%!TJN.5A0
ML0_FKU+UTT(LFT<%F#?@07%JJVFMD9Z3!$IXAQ19)10?-<%!YN $F@SJ$N$#
M*\$6^.#G6_(9I4\,LK08XRD!"0SLA@B9HT*6;#5E 87]'3Y')]=-:EZKYL;;
M#19.N1"2WH09+2_[+K3NV0Y#J0 Q[)-+=,7"&.:R$&-_0O1<M'+/E$RB=JM$
M[+O(WBZ:\&<DF;Z26[V8!TD/:P-[M+%=4W2J]2N0A[9[' .<D"'781(?BE4W
MXU788J09]!!L+R+L?:M-.*NWT]"X2TDNI5/<VZZTA]U+?V]J6 D8B)R]^V\^
M*(<GSM[?0O?7,1_8:#0UJ5IL/NUV$ ^;\;0M$[!;N[@-0W%/-Y;%[%AF( XM
M1L;7T=M"?SR$346>JJQ8\)$?7M=:-OCYERJQ<-N&A8D[K9-WRM%426'DKYA\
M>Z+_(S.K9/67^W5%K<W. H6/PN8SUS>9X'X8YRB&)SS"Q#XA'T/=9,EO6+)6
M'[_Y!H15>0.W>Z$RIF%E,T#Z['QW\_71J:5FM1B4F5]E0%Y$_3"AQ-AW/I'X
M65]]E6@2;35+^<O3),K;9W,K\Y:AJ*C5N8CU8POKRFS";SN@:6[F]H8U]RU:
M"]!EYG9BQ3B.8Z8R3$BB:UY"+ H3PB@PN< .RTV^-2'?Z6.:O$F)S$T@YK_6
M6=8/,NPQUO]H" \(4];L/]9X>27(?/KQ@X_DL]U,O[02!:^W_P:&W0<T^L[&
M10Q6%1E=T7VAK&]C)7[EP49PMJ]F4JGDVM#AVJMXP][O8;JG]4VCK^X7S;Y[
MRM/UE;*#N#$1;U_J;A&F84&H<<0?Z*EJ>Z*6F';E0^E>WA0&."_&.P01#U;K
M@CSQOW7HC@1*@S6J=W/CR3F-9J?\#YTKH+/*0GNOQ_*$N7S0/GE3 K9=TG!F
MFWR08TR+;CC^YYZ]<*/Z\^V/A[#_BL/T4'K<^E9YUCQ=YN?ZG+Q#[+,99,O<
M9-H]CB4#*F?%DP>S\OP-?W-",YU8:^2I!N./ORD5'6SG3NE<94=B\@UKBIDF
MO,W91\BJ8?BL/G2JGTY(-+5DA7M-\'8'I 6QMNFDU'8E8-6"JJ.G96?"V"AA
MBCW.4Z.DT))F3P7HE>L4 \]"&"G1M[W(8\MXK!V6<A]I/'2!N@:16)#K(57S
MGOQ"$:_ N2X=YZU<QGS[G]P+S,@L5172]TVJCX!H41_XC*M7XMZ:*WXXNFC-
MM>I7/&][M,31N7^L0E.SI$C5;N!\E=]I*:V^M1?4-R5[OT;_(^@584. ^N)^
M;2;MR5+=O67:P5;CEO#=;@_OH:^]4Y#NN7^9F=<2)(C<;P'VI7_\AJ$; ZZ7
MO;)A3]J5OIRKH&CJR,9;[M9]].#,@>.XPC6'::V-X!$"!Q(N]A-!3[ELJEHY
M#6_V;L^,+G:/<-MT=;1D3)\*J-\N;6=-)B*6];@W3<]6I=E>?ML>S[BLS4S?
M^"X;B%]VW];Q6H"QL /;"C]& ^XO;?FT^<\[L>:GO9>9[ =+K"-Z9&7KMVQ4
M^XEDQOS%X=8T(8H,268*GU 57_02</*\7EM5W4=;S)%]M5Y_1C[$)@!EX?;-
M,9L0_G%\6;Z^]G#F<\*ZD)!Z&?%Z;0IQ0#\,7*T=X6+T@+;<2)OYGCM^#=,1
M 9TK'MW3TD,[+"IC!#ZX!HHPQ?3?_A3\+!U?=&PB@2=,%(1$Y'A]NP%PZ_7+
MG(> RTO-BG+5Y_F#NURN*[P(=0J>):OP3B#S*4IGV UU!$#KW58X!7/ J[MD
MZH?YH=&OAF=^Y'CXI. 7-G<O.3UM&ZPK7_3()FX07@=.IMY;O:>_V^]SC;)]
MM/+OXHPC%O4UK3<_";E ONNXBTI-!LMGQ31*G)<E>.2*?M6]_NTT5CLVP_X:
MTL/^&@)YQ3$3J^>3$7S/T'[01@T2B#UPO_HR-0NXK58VOT_#N5!83,,YZ!1=
MPZ(D-@OQS]PW85KV!Y5OW#STP%0"1YJV\01PHV-22#AI0>OI\&1**&VM#=IE
M?F2X-9C5(^A\N[=P\43X9<A:093SZ)KB.3A4;&IQ(_R(3\"$3&36U@?B,]6Q
MJM F=^VAIFF4F2!E.KVN'D_9:..FWO,[-^/Y1S#L(?WR4X;2%@8MCZQR4GE!
M+_,DPZ1'6:=KGEM$).6B^S L-\0G,D.MPP$TP[$ VNC06)AX*$88&?47FQQC
M&J:R)1PPJSQ:7VFB[8H0A9DZ!TQMQA$@?Q?.7R#7M1A:VV7,A,$5(4Z>:>9B
M@_F0&##KJMCA:0XX@8[A'#6DNU%F8'3K>/T63P3XAK_YT0FT)GYG*4XBENTT
MS8#%H,(K%L4$\._8SK;P\&\W&ZZ7%VZ#]&)$E,E A.Z/*?N:Z/M\4 93[<5H
M-R.@-^[7XEF\1]6)*Z;G*CN/I'XOZG>G5BRI[3NHV?K+Y6@3T_^#%73H<YK/
MB2)LCV/"7M_S_D[=;OA#9^8^,4[8O] <2]-7L"WU7#I(33/2['N5;8\)4+HQ
M>"9AX319A#Q'V'@X%!6]?8/W_HA[5\II4@CJU,1+8OHIT$&EB-/2*E:WSORD
MVU\0>JJY!A7!S+T94GB H5Q'O__5JQ*D:0/NC+[_ZIG&M3MI$[WPGE+FX:7L
M?5F2.;* %;.#QG+(W)8)A+W5QG*.FM"M\*P]5FQ$YZHL1UWIS&B]Y^I1P *1
MP >!;P-+$7-D<2AEP(WN$T= [E]9M1XV/4M?AG9ZN%&J0RC-UR-?)%73[">L
MIN<'PC=V!)(GT \#AEXC8WF'W'R#Z+2I/0YLJP2V6*>2F* )\LDN Q"]L*,<
M<79EKP\8>&#J5@(L3G<^--<!4EAD^FQ)Y8?*!9YV2S2$ ON;5"B\](>8R+J1
MNKQ,<8\BW9.,RR5L0]>_?+OQ1IG$>?8'QCL^3&;&\T$Q(1N[S(]A.KSX(.S&
M"V[6H)B)N03R4>3ZX(O[D>%,6K4[6!#1JF -.'8*ON'J<F/66IM%\$K5M-J5
M8=GBX&65G]62(75Q7^)AK6^(U'8C0(J]U$G>IX>5Y(,ZO*M1P@SHDV8_[%IT
M>#=L/\*9SA$H1SZ(KL5:*Q0;X5@RM> 0B0%3I>.C]1HZD%5ZS1B80E+2:LF$
MC>AA1(=NEVKGOC"DB'TR=)Y ZPIDNR!..6"YSZCK %B0=%/ZI%33J^V:[2QP
M7-BJ!$>/;?8F%HYA!-WVJ&7+/-++Q\;EV67Q]HW7AYJ?IG+LF-,P!61"UU,@
M?EPOZD;J)F8=I@/G?3A YK[33V' MI0?5&(^"PMS:2X\,K29S@KG2.VWO1DN
M4+B.VZ=LX1O"T==G+K%6'0T$2CG7?RB@/*)SI'A[7U])6]OWU;K!BH&CJ17P
M6S0Z'\214KIQHA$V9;OADW=P0NTQ QR?1Z$8VV%5&=EW39NDO3]\.WI:Y8N!
MY#-<'S014POC2$XR<O#52W*KRW26F'W;1#TNP2>,_+A=!"E&W\C5(<V)A'?*
MU0$/?HGM!F(IS4\!X0K\DY?/S85_-/?$FN4FS_8R]@UAUQ''%JXMUG&A;,1%
M+K8=X@[ KD)9CFG*=%XF'1M/WM\J7R(0[Z*$^=%EE#P#]WA6D\B&)?".H[3K
M)E#.A #TX7$$XN?/>WZY;E24'R/*S/8BJVT](95.HNHK0CT)5?.5]Z3[\_F@
M6G,Q/BBL;VM>T)6,R&;Q00PA,9ZO^2"6/LF1.J!@LVW)&[A[+@(6+S?ZXF^F
M$;6&0U;*]D6#,1UV1^,R-YYP\_O#-,WEX:#LOM08;D'FX\NFMU4>:/WVNPJ<
MW3:YI%-&$G"L.S@U+RV-UAFM1I]][HM@6WJ^S;S WA_'RF6X40J4&?IIOY$5
MOU8=V?NS&> D78Y%#;8+4M4ZA8_CG'BU9!Q?$T"?.<GH_4'[_ #Z&;SQ &AA
M8%.:<9RCNR%IQD.):%&4&6!RSUP%*.2#;HR'MFEU[)=O6I'L,NY-U%_J3]'B
M>GG3%IH]/#V\ OK+??B@>W E[;&O<IW$9(8PYH-&3CN-'7^1#UIIC$8DC?-!
M3.$^#'MW["IU<6<IRKV(U66I;6=!'5A"?5>/!J 5@<PW*+WV.K84\1LMCN-.
MQQUP]P;"NXXL# 4VIQXAKA>D<>,KR[@- T21<UN?Y<ZOS#75-[;5/_6"[#S:
M9I\IM^K..\01P*1\+Q_4*?5*='$_"+;1,NDF>$^+6\4[AHIJ :(%8LG\5;O&
M2*M(^9+2B4E3/Y&JB2V[E?+7GRBEG_QY2CDKYW40<T02?*G A^-9^B2S_;E(
M7/=J]L-A]#\>Z^!5S,^1R14O".6YZ\UG?Y^-H!W\VFC:5Z_9O(:I7:!//X%?
MT=.R%3-.OZ[J@]5VNU0_-Q5XQD7Y !]D>3_AT-?/.%'?3RO'YZIB]^1-QEDG
M%G&Q#H>_*/O<ITSF2(=YL:A=]#&MOEB2<D9&W/GQM//HIX+P[3O#K;@SY2D0
M+A]W@=E6 <JR)S!-JTNT-\;K>6*<HRT;V77MI*:Q4I9YFY\\%GJUE57[F1)\
M+%1"O6D4$KK]WE?Y?KI+-C,M,>)XH_ WTO=JTF7R#(Q[4.S7]V:X#VBH<N/G
M'1C,$6:G)$R7?>-^_[M=P*4>UP[GU*J)ABS-GN#(!?7&#_Y4^X];^'<H23VZ
MCM3[B#NE,G?;LWS_>57_0LOBE7=U@(5CQL/@@,^X\?"?O]E,"JP>3&EQ4$"B
MIZ(-&/)-H9@C/\+/O9HTUFE"[&O[.-'^X(EGI4WU2O5*%4'JB,/>%I7+;_YN
M>GR:G$JK-WC&BO(<T;/%B<W G;X@X>YL/BA9_Z!^FS#%P^$)3P'IUV4NR>HA
M,[0*'&!-#0WM8]I$F+P_[LZH5/7IM*S(ZA4BX8>CYR<1YZ^(G96ZCXE<23HV
MK156<3$DX!4PU!7Y !DIG_@UU<<#0 ^N" ^XSGA;M&5WSQ9/W/_2VT62"UM$
M]1^]QXO;A@%+3B,H# M!<6")46#'6L]4&J82VZ*ZV@\G=!N@=T4ADL#"K>)<
MO"IG:P('B:^B7F$W5%;-!D9"$SB8\MB7GOJ33ZA_Q3I-K U]FSW5]U;63^J?
M/SX^W#?"PJGE]JG1];Z:MI^&*TU-"&K;'V["72KC6_%#:E?.YH=IC#GQSK+W
M['KT_GPFM+\V;_+=7-T^Z\/3.1JCSO%*I5=/X\$!QKCKU1YOI%W >LL7MZV7
ME9ULBW>68 [%A(<@I70P]+/4ZE;?_2W!X15>@)M;KC6KE)0 B8^I"C3^7@F'
MFV7WQ)4B.W1,I=X@4ZSR'4=,S1C_RMM-(NZ:OB]]Z(.>X8.$UR'[X6A=(.S5
M$L^,NH:3 2#OGOY\C! 3'I($6KI\5%D?\T*?!CYT@C_LM2"SB)O3ST.U2B)S
MC4.;+6C37\RZH.J>O D,:+V%<'@QF-=%#>"ILH42@XAP,[4NI=T RC0\K-S?
MPX=TV'@VZ65S1S!R2RQNS<RS8_8$6WCQ80!KNU<7*^SCN1AYU<V8NF8NS7W+
M$:)##P%XCV','764R1P?='A!20R(?>6!A%F1J$1%BZ7KHQRMD-)W>1;(0QW@
M;N5N<Q5V>P&]VF,JH#YE.WJ?_KY)O3\HJP96A(/PT<P;5[Y,VEC=2#ZD;43L
M#U,]-16<')R=9^]&IK!H/IE!T5%B_?U:?>>O6F9A'K8MG6^<.I<ZKZI.NV'M
M&Q&M782F07>OU+>9+_4$(P6D_9#X&CDZ^0Y.ARH ,CX)7>+PYH24,,*>@/)O
M_@^;!PIFVH:2UX0%[#)CA_?Q20/#+$O@NWN "!=B">\+'U37F[R&D_4!M+KE
ML,EA#OM0I]FP[FH'RL2LTJ1>@4T]6"C@[:+'1-8]_2417=L:MGZ5X90;[N6B
MVT1>7.WB1*:7I8(&<H.F@:$X O)=HRH\;6YJ,1N<K,UQ>(T5N]%+UQ9==-<?
ML.T*)^6AMM"5#.W=LU']U;I=A@X,2.H4Z5/]I_9CB^W*HX1.Y""#$XAO!RS9
M=?3-]':M?E;X.UJ=*(ZU\AVS]U(Q4 *;;-T3H!2#* 9B.Y4TV8(JBX4X46Q&
MCX]5:[=ZETU?JECX-6M; M19CU>O)ZZ^;&^-'S7*D3NDBW&KECG01%I/EGAR
MW4L^*LI:/D1E]$%0:7-XXVW-OOLP#TK?N>#'L.O=%E6EJBH9Y)4L0M\4>M$Q
M>_EC]?I\!SB=!P86\ #^VK">-]PJI;,98*W_C*0&I&X:BOB)S.."N,^CT847
M;++/FEPR8&'"28>C!\FG3<T$M9Q)=WNDPA9+@?HMV=H^#ZI?=O/$Q/'$QE$:
M)4O&&^20RND%N:N187UPC](7#7(/T\0V<$EA=:JE@Z45 <VFTCF.)HOBW%66
M,T/@;3<L00Z"#1,3FT7>L@MW8D=.^4?&$0<*\0$E 4KGV/N3Z'_"M#S)LYZ+
M;EO2^?A N2?JHQZ]46'&GX;,GI+R[ /7U.R:DQ6RO/Z<V'X_MMGD23H7'FEE
MOR(^H^9W9XO5^.^X8]EBR,3U/_/;Y:,C?1^(JGVXMF.?[3UZ[/S?1'8?Q>#X
M(!>IP8?[CCI>^+\O5W1)64>YM8+SP&N+&IOO6@%3A26E[P=J,N]F+$P:C-HJ
M*> T79&4N,Q[:ZX@&9;8-:CF&3,AO/UL]D>L\,)7YO*L:L]E(9X$33($NYT\
M"CX<,/=L8U6"3=O9A?DUF8[<&B6O+_WFU2L^I\Z)/A)[ARGLS&F*H4>;,KDF
M725&?-!S4M=,#1_D"(MTI >99IC/,'Q,=E; ,Q#]/ OR_-'NS>@ESF!>\G<R
M74H 5O-\4!<9<-UY5DQ./:93"\\'#?%!21A6-=N0#]+VWU/Z\E'P4U%1JRBP
MXX\(_8'_X1 ^Z(F; Q\D"(A :=$%)^)Y#.\3C'<8"+_>.*)#U!:^W-[$FB@1
M)= 75M:VW;\-K]M&Z[J,5*^+:'Q-RNOY1;.9#"LP%DZYK?#T\R*)]5>_XEC?
MUO<#AQ$'XY4/%R*>BZ<=?A#]LL6A[= RPNC5L](O8O_>>;"=8A#!!P&70OF@
M/WP0&\*3:A>([V_58%;R A_T6R#W8!PME!T?U.\!&AG7LY/WK&VDAJ5I.8SK
M;7]8UKE7M5I]O+FAL>EMX<1BSW?_?ZQMU.J::FH;B<]C,F:C; -NW4&>]!U!
M%C^-50EN<@G;-W(C[NFNDX\OGO "*8@> QT[HE7P/S@^P@<=>"/8 >4)<K23
MU$7C$%^*)O2E;&):L)M7G"#/, ]3=V=CL<^N5#RN?'0!E+KK>E5] <2N<5QG
MC6O<-[CDU6[GX-[40$H^N.YM92*LJ&FR;'%CV&QF+/*??/P">\@H0GJP9^+S
M#<N]@4V8_W85^M^3NFMTQ&N2<[)Y9Y$,D"MHTW<R:0+[WY$#A=:[Z?^W_24\
M<6\H#\.QY8/B$$GD/_ +BK(*\[(**YL]9X3^S+>ALK<=T)T"O8U;3A'-@/IC
M8K?4TM>U#WW^60^5O%B.3.CT.3=ZM]#]GD@<+H4C7X7$=,$^PT/T)BTO-X[Y
MC:*I>E1BIHU>%<T&?&@!@"[,_I\SEX&%%^:P:X+P"GQT1B35GG_/W'8KGZ?B
M87;^;H3X2CD@<-W?)>Y/X$BY<4C:2@'>WC'#SG]\*L"]+(W5V.IZJ/7L>5,[
MU*F3!=P"E+Y'EF;GXH#FSNI86YM37^X4E$IC/PC4W5Y!)_CXG\,0C@9!#H<!
M?&"R&'S:(Z%ID-]2'I3>269='=I25A)$AO*-C</B.:Y?,%M<^'HE3SS-<,<Z
M2874%\B6KJ[=D=@_PNB"<@S]&+6%ALQGL1%)-0"F:[HT4@LZR ?]0/Q+WBZH
MWK)3ZF/,JF-^._I!@0==H6O/_V@(*&GG-IY_E'#[48'0E2:4KR*ZW:!<DG?@
MK,"^8>P*1Y[]>@D+M,-DSP_!_A2T;!(F@NEI)H)IN6K>KOV?.GPM2,?;]H)T
M7)7$T-T9,)ZG0-G?T!W:4OA'BS>OR0?]LN2#/)%X7K+I_+?GMZ!_='\E0>>>
MT%AVR-^DN=6T_2%\D'X+4W8QA-936%:MQCG2SSO86F!^!/D1,Q,(M&-PJ=WH
MBIT'4.(QPY9=., -F;MSZT)"Y]9]/DCPIT0A[K<!D-NT+ C)O;%)<;_R&3^C
M;#[HIP'I3UHP1N#@B'4!AMXO"/<'Y5^?H7,)@@;*_CH=+8Y\?_LE5):GPR0K
M .\?&2DOK$D%0><$".-P@#??B3AV^([@(WY ;4AFYE/4WQ>'J.??K\+P9%9J
M ,#8[NI]#66[ O^&;LH1R',!.WL%1<%E(#A:'(>=FB"LYR8:N,\&MN88'B$[
M\D%O3&^T*ZD.3I;YII#H)M&S^.^!F YI\ESAPB;Z*+*%#72SO9BO5QE,/FAI
MOMK3 5 VY$CR3(, 9\:LL1]#P#W.2SOYV(;.PG2>W4'#38&I;_X/&/KM8,+J
M_X&$<1UUAFI#=#YD&]>E#66IN&TM=)/7G/UH0&@/YI??_"%,AP(?]#>2M]HY
M))5>@-;F.)KI+C$(D0TXEC4?],GHC P]/!FY#M2P3=>&0AB$$.PH^2_!Z+([
ME;[]?PL=)_"<BY[9<;S5@4,F!ML%PR2T&V//^SQ/5\4L4_@@;R29EXS:%F3;
MOT.\JQS  5#Q^WE6>C?G'/O"'A4QP(,F,;TTV;T7U\4-',5TG"+?VMM#BR]4
M.[: 2X9).."Y5V<[VWD"%V]1>!C4_P:$ &N.LC&&P_L/N*SN@$MYL)^D=F."
MT<Z)T4[[>K[<Y(,NV6-^#9Q-83F;'X8!JH8_'<#"K.FN]E:. Y Z<W&O!.H*
MTFCAIYA'+9EE"_W4=I9$'TK:I0AE?$?]Q2SB@XJP8WO690G-.\7U'[=I@!N
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M5NN"2G/469M=T/UPF*2IL._-UT#_.P^_Q/J6(6G@5J]S^A3<I!IN\7AA7?Z
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MA"<0UW&>+-+#8;\#JZ4#<X_:OF]AJZT,QVI>HF_&(>JU':Z.50GDM 3-W7N
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MGK=POR9O9BHLRV5%2R=?V=?-PXILWN '3B5,OYAB5NM"']4+0!_T&4*^QA2
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M]GH;VF]LTD4R"-/8*6851(E['%J3RZ"AY)G-[=#]_$, 9!":A-ZG4[$(3Q2
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MQ86FW8N1<,WDBV^_=[3RG K1A2L35H\A29(FWS/Y]_RJ#]-$ZBWSH%=W'Q6
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M^=>%2WI_0CZV?\:59!YDYNO,0E2^.,0]+[G;\:C$6['B\N'5+/*5CO-9:+'
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M"]1RSD:EY(F@?6MJXQ?&.I\)2+#SX]X$L.8VZ--PUE_08=PGBF3=HC\00-K
MWN625PT@M'80? "!!<1'[" ,=V[ P47_D< 886IR&_3Z/;0)E_T# 5P;,@5?
M =K+W\J.RDF._\7SZZS)$XX"N5H 6;'/:8=U@":+3AJBU(*W4O$QFPO=;6VF
M3$484?A%4>@2/?+/U3<V_++Z^D#.^OD*E3\T8O&_:*01QP9JX8)7@(.@JZ8+
M>*!#VED@+. #9I_3WVM6SNW9<NMA\RX#0<C5"%<=TH 5 'B,?2L7R08!^R"_
MLH^"I/07#C)[\'H;]+5%J5];"N'E"HJ"[C(H]&N7C_+@9PTYNZ-G[;9Y](BW
MBLW7WPQEM\M1=MI*_PNE&_."_&:L6>=P1&-59LZ%9GM'XLM?3MYJ,%"GE3XX
MN6>OQP&_\'U*1SS234'EZ:9[MM_\!U!+ P04    " !TBIU<8=\V2"JX   ?
MP0  %0   &5A,#(X-3$T.# Q7VEM9S$X+FIP9Z2[>5@32=LWV@XJ[E$1<26/
M*Z,(Z(C@ NEQ?)01!C)NH&Q1$1$B1&6')*VBH")D%)61K55$1(2(+)$ULF84
M(4J$"!%"0 @A( F0T$DZG=,^[W?>]WS7=?XXU_E8_H"NKJZ[ZKY_2W7%\,70
M"RQT/G#P #!MVC3@)/X-&$3 OA]__1]]_>CD_[2/:8:WP*)9@'J:I]&TM<!/
MBZ89+9IF: "( #!MQG\U /[7U[2?C*;/F&D\:_:<N7B#TH7 3].,C'Z:;C1C
MQO3I^%4&?AV8OFC&XC7;]LXT.73*>.W%);]<N?-XUKK?BFI-#W]2K-]^^M+5
MV7.6FBU;OF+#1HN?-VVVW6%GOW/7[GW_WG_ Z?>#SD>.'G/W.'["T^^,_]F
M<X%!H6'A$9%1T3%QUZ[')]RX>>MNRKW[#U+_?ICV)/MISK/<YWDO7A>7E)9Q
MWI17U-4W-#;Q_GGWODWPN;U#^*6S2]+7_VU@4#HD&U:.3TRJU%.(1OLCKFF
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M.;</RQF/83)+WR(T]1K]7U66NBT(47U7GTVR0O]4N')O5QU\<4ZL/#A4?U@
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MI,O%Z:V)1FP-*.!"(64.L/84!HU53$#SD;N$R:A_P1,H/@OL\4(QMMB%<,0
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M?0;Q5R;4/S#?K'!4)_:1"?(*)W4K*S+']UQ7<EAUY%].S]%:;1SK&LD*JG6
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MT$$98\5];<1Y\9;&JJ7;'YX3N%*#CZ75=!\F748\E'.:J'.A!4'%^O0_VPS
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ME_>3.M58*5O/ZN5KIP6*$6,#("PTVFM^H8\9HQY%.J:^0S*YJA!2N=..;3(
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M3U,N1=X7=6ESV[=/96.+R?$4Q2OZ*46S,^RJ#&'EX!0TF'(.Z@MX-)R!#X_
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M9_4>](!_+7@,\GIODU^=%B,78=-T&\T:1\P6GB+E-+X+7?\D[59%V_M1R_S
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M]<GU<_BDK_,B#("C7#;?V.FU(N+!%JA?>KS" +":N>.Q6N;#EU \-@NK+34
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M6P4O^9S='#YVH*.ZXT6',"QU'Z]>:7[Q>N-.CL72C,@4+]N.45)N%[&,QPI
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MBI9/?CSLWL5HE[Q^W5XX8@#Z3D#:DU/LZN:=D3.N#Y0\^7IW()+%+:XZ_UU
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M8IL$_'*M1X?Y5@-PM3#*Z+#"M*9<TF+96)&:;,TM!8O01?E4HG*+@J5/V&T
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MW[0WX<_9E%'P)LCAI!!7P#''+(5KOE2K*X2OG3&K]CO:#!&:OS7C'.9 G]1
M905_=8B;%1:@_NK\G6TXJ[#7\/?Q0 ,(K[=2W9:;?HBFLI$HN$<=HX\VAIZ@
M+06IM$F!VP;MNY&,#0[ [EMBQ5?G3[XHO*YYU&=S2[3V36[+7-*^_8SQOZJV
M'5D5]8/K+5E5X(%#OLVE&%Z_/!<?TN"H6"G^\:\,ZMV  Y0,[W]&6+VIFHK4
M);X>[9]('M.NKC;^K$AN3<WH/^ CK?;MVT+"5 MBQEW\QQ=]9K*:*E2W?MX/
M;@;2R9!JE!QZY<#^'[[?,/K[O?T#JG)OI^(/\,ROD6];^_-F,N.Z)@PU.OY!
M&B8I-LG'S;AK,<P&/KFK_.PP*_^L&<>BMD#V&>QY'W;'QE@A-?UV$I2;J!\]
MU*#H,>7]!VS?*@PQX\8(G_US1F+":NA%QXUDTQ838.A\$AJ/@A[0#)KLPOS?
M:BE;0<+[D68 TUGPZH6D0)\^!;5+4B#)ZZ7?D1M))I9FY@#*0>0K$%.2 3VF
M!\/^-F R!\6H+]"AO?(;2^6&_0I:I'92A'Z1TLGEX^$OYHG @C_PHE&61N?2
MX>N:MHQ+&.DGOC+<-8 &):OL&BT*Z]:,3J<3[C08H@,7HH83D"5#S0\P=,LS
M-+W]">S6U2MN;15YP3-$UKKIY=^EO$T58KU^@H*D*?=8NSD=7,<<N*7>P+D5
M.8'Y^G;=[1^-C:S?,=#N:,907ZFR)(&6Q0:VS-]](MF[HX0./(XIBNC"E.7&
M%QB** YA=SMV4V-\RR_/U9AQ"G&!0JP;9;9511\+DY\[7[>]>-V&=ZT.X0XV
MB>[%:[LJC6WC7Q*+;] *'%K>R28RCX8W]2K+0OL)BX%PX8(UCHVK_!O^=N&/
M)QT"0HQDY,H,I@@7J="88*G:3]B80+W"+W6NZ/="'22CO+4U-5C;F&:<X8LP
MG@*!R&EF'"4%90"8@5I"IM$7P-!@$J&N6H!LI"ZC@.H_:<%"(KX=+,50="W1
MR8Q[I4!:S+CT(;*0GB2]=7X\=>R3^_V"_3$''[%7[C\A\O.__RFK([<FD?4(
MBDLY]EYH[?;HFZK?9_+7UW;U1?D&?TPS!B44$OY+D2SSB(;P,OQ-XLJ(O,^?
M:&Y"C(^N$">/JG*G@$H,BQ[&K=GRZ-:\FY\](HUN<%SCGW!.\W(;=*V(2S;=
MH5(]=CT;4+J=23^9^VB>,BG^]6?=8(+_&\EBXK<1O.V0'5-6[*_"4'5;+<'G
M99EQG67Q#047]'O&3 )A9ESJ.9C<:&=5"C5S\F!RTW+P%+0^#7.F6\;!;'#5
MU O&TC,/SVS=T$9C_/KVQ'W7P(?U?J"56]KY^Y.3[/C:\9/UO,7RZ'B>?V9H
M?.;;#AKEF/?.YH.I/<W[?3+\UH0D^:=YV$W1MB46__0UT,YHB6=:'.N,@"$1
M[A@]@?3^I?%1M&&V>Y+UC@GT:;&(Z:*+XH%7BBJ=%G$';X/_W=N];^VGJ*=I
M7=_O//^L__Z]FIH^']:'[A,.'>KH/[A_'3QP]*+WVK0#%??;23]SNIV!I$W
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M-:]W5J!8PSS=0MD\BO:.=:.[>['[!:6$]!I>X/+DBB%K,I&2P]^K$_,?&@]
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M(#X:B+[3^0\G('U\A2DL(1J;!/4_!]4JU]\OFOQ=_W),+"G]1-O=O$IQ"3F
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MU0W_\N Q*S]0N@W*NSR^1;4J#EDL'BP'EC-VT']DR5R;"-?1;]0.-X@V/31
MFM[@%#(XD F!V#W6T+=\H&,FS]HCC/$-](U:T(B'?\;F"""UP?H;* 6&+F?
M# *\(;\Y*^0X?#=:SK2B+X'O#H(W[6S5#G],$A?0REZ#4)C'.BEX=24&8(>>
MPH37*$&(V%N6GN-TDV*KT@[^8"ZX%#DBZ]_=3 1@)Z,SS8S[M:I&O9SS+ !.
MD1Y#6]7I3.+2L)S_?J"'/YD_B]!M]QWV_7$_8\]0EJZH.WUAGDJ>C6PB;(\
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M35]LT^W47&3AH*M__!.!D[AI#+O['7B%%I^Y6O.,:GX%LP'6A]LSUVO2U9@
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ME':&#KGY:%%W$:_,R*/&%5%?D&=4'A9KQ3*@85&(P"7:[$Q7>TF!%H485$
M?0"8V:)>X$SSNF)H;Q+,DMQCWE>]MLQD\?J\=CH-GU#YV) "V6(M*FLJUAB3
MYA=R->BJ,+,PUC6WRFON-VZXIQO?C7'Z%>)_6J?67<G<!ZXYIT41Q"E4),JF
M+N36M-^&@1;0UG(J!K:&Y'+/,QVSA[>@?T166Z;,5XO*@9*/L96YP*@-'E"?
MEWM4R1C\MB:E%4<GTD_$S(BR T"2#-3\H<%]R\:[Q3"WD7\=\V+'J?U&HD.\
M*V3@/00K5C#,[9 %O]=D84[M9E_*0483ODP^27I[YIW?M;*<G3MM;+:;O3_W
MD?WK7)#;*! 6C+YQ;J<P(=8M_?(#OCK#^H5EV]+)-R^><[9+_2<&E)P&L!]&
MKU)OE[LFSL47%U._]R%?]1U;*"F%/W0?W'+ZB!;UEX5F)4*%[X>.!+/J")1%
M,DP#&'NH&C=8Z\0'X['6U7+JB["$UCJ,RN5G62H--[%LWQ?1/XB3C-CP6O4B
M 6**]9H"W%T[JSS(=\:EKL^.I"DIA)*;*GG]ND*O9H7-W*3M=4;F0<PF!RN:
M)0UR?%I1)6/FZ^0QU_F(X!V '(O<".?$H]FS]*1:[_0+ONN4@9711=<'*]@N
M=9ECPGK-$FNG[]L.[-S=*7HX;;DQAW3]I/,A#C^U.O5L!/TW"J"IL,0OZ0]8
MP,24^QSB"O&U\A]J>W4*VZ::?%X68AL R)$Q+#0/8!MB"M6J4\'6)R<-JDPD
MJM-'Y:8#MGAQY!26-[U3BU+,)*&;30YU$."!'M,8]^X@:L^)<D*!$1N2=2F&
MB*_& ;:7!-:'2!Z=4VH'355P6'[ L&FGPF6K)IF@<Y^_8.9O:"+A1_.QX?$M
M2#26DC]P/<'&-@MO[W1J.J;SH\';)QB=I.[H7W9YVV,RKQ5%G(YYZ.51?2WW
M8YAG9U$QM5M]73Z!6ZD& H46>F.VHJ913BT&\?U^'\D[NL_TS';FC/UXCYAS
M]F'2K?/"/%2RKVNVKO^O%".C-<T9\AI(J]16<FE17_JER JF$=S6:U&[WQD(
ME'*^^@3%&<U=JA:B%/CVOYB[H49E=*J3H>F]L&QL:F%T_,Q/MLRP SFT^9M"
M]:RQ')^M1:&IIE? -9>Z%3[7@.5C,3ZO$1[92WTW#P2%=,L9F1^"5ZRXY>%Y
M;8X41"@H[^[S39JS+TR.,8UIV+/MWFB/89ISH(TS.OU1B\7]%H^R!XG59\TL
M)W%?[5:0XD!97'VT)B<DF$A0FN%42X4Z7S:OCMY%[1S>UC>!W4UD.<<<?6.8
M>1\9.O+SVQ:KTZ^ZEWD:[JA>SKX3DKG:R?%>DFV=BV\OP'>_LB;@%Q\BL&8/
MP])U8_MDUPQ\@7!V4Q\H0,+=_3^ !V:MY5K40*, GTB@MW1#+P=/555VSK::
M>_]45B-X>X] SU<HFLF]<%6L2XJTQI)P/=EKK+CO@<_JCS%[WX?LV9FZ5FZJ
M_K;KER>[>_-['GC<5L9<>WBQ$#8]6.?91%^'W3$DINK5E<AI=\T#%=X'+FF2
MG].@Q[R,%?T$.OY4U!.AI,U >:,RV:GKM^C#GN@=C\]/KCS_9QMQ_5[3#Z('
M$5/X[\F,([*\1N&(&=JD7E#153B%'1@AW3'9@./BY ?-,JX>NK/_R)_'V_M&
M*I=\.HUI DJ'$1R=D"=?/&4ECZ)?2;.4O_%_4]$=R?4NKG%N\U4-N@>^8UUZ
M;+"&_^K,7S)>V:VM9W<]O+:M!XSX7G+JR?/GLS6N0\<KNJK4JQW7&%,Q]/E/
M,,J#?M]@SO\9V&VTIW42)_)<O_-:G2][&O@4^V]QAJ/ZL]:_U@T9G$A0,9T^
M.)_B#*?Z,M@?_F$)X,H?@B$J($J&%AW5G[A030$=;[SWC*SC>0[-I__>W_@D
M9"$<HR'-])5?%6RQM]8I(O[%FGT6/XNV6F_Z?FC!"L)-'V/_DRXZ>ZA ,L4;
MBX 1G-A[5'_L@H!!#--XSI>^)7F.ZVJBZ[^^%SRKL8VVL9=<W/2'4(9 8K:I
M[*MXL[&]0UA\U@?__QG6K7V+6'P$%62ZC2S=@# *\;0&C5DW7,VLP\\EO@C,
MBGN6##O-%G0TZ6'B1' $[H\-)WU;C/):M:A .XI+Y/@"G-OT/Z<(VQB\.O,)
M%0D+'_P63AZ-U*/=)?G@\3V[A<N\J8 F6E=]A2\*V^IZ<[<P\X"8E2?6#0"9
M#V5'E0?173$W-6NL12$P;;RPR+D%LXN7A!"0K</Q9F*NV]++R,+K(C*.I:G1
MCBML"MV%IAN32Q,""O:(LW.ZRQ0ER2[5MP3$C=T6YC1KCUF[L/;#?O'C:H_J
MV*KP(G(VOLXVMK2(K<DO&EH;$T4!/F<M66G!H?L=U1=>$#=*P)5A7>J2NKH(
M$I1V<=]?.;&_NX^_<"TFY[?MY.(#=N:8\YIR:B:G!.O/Z)[6=8P&F.FKD8@5
MKE[LQC\E'-9)$R,974F]^^</KSNTJ+&-5:QW,/++R@WN&J\XCOE$5M#' O;?
M<P=6^FX_?_%1Y-TH+#X)C]XU1[6(4X'H^S1-NE[& HP10K-"2Y^ROT_?8?JJ
M-9'&85-']2>G6?,7-7X&\\UTM*+0N=K]Y?:77=>X4VX))//:^/4!KR+JYN''
M;,S[E]&/$;3#/[JAY]MGGVX7EWU*K)2^1V^.[U5%5I9RN"=4V-HY;)/F$79+
MH]!-7[S_2G@KZ:G8%ART/.SM_9MA;$Z@%F7W8V&#)3#WEX7J&!A(L>23UC86
MGCL([^WU/-K%H-UC'*PAWMV #Z#W\Z:7[GZ/V@QOO:U%78DW4]<MG+M(O&BM
MN*1X:3,B8!BNVG.FQG?\G27C,DW!&;.(RXZ3@38?OF],WNSUW-U9_*X]H&U'
M^K6H7/8[3"*XF4(0XHV@V.6*PZW1N!_>].XH*S/8$YP-=)C^"_-GI,Q>(C;S
MD)UXG-66?<7+HS0L%XK_$!'I6KZP(X.0L4'3<]W3;J9!$W)47_VH(J-,@U8D
M6&<YK6BTV[G;WKHK^69@_;;!3R>DS],Y/M[64W=,5LIHMU*$C:V!^1\'HPO<
MY)YJJA^\P[8]4=4BTEO!H^427T.NLO ?Y,9,#+,KJ[)[]D(A$=ZT<>Z;+CPR
MVC,SN43LE66T4$Q+S5S8VRO?,[X%F Q\CV*,4%5FO2,[Z=#+E,H'GT>OCPZ?
MJV5?JB%T>[$F,F2\$;4MF*@^#KR 7DXOZ9XMF$(W/O?O@,*; @H#<(/[#V5M
MJ-G>7?%NFEZR[5/FD] 9>CRX:()BSV?$#9O+ B=L?4L8 U?2I!\K3];&AS[1
MHOXVFKO"(N"B)E6=1Z\+HC^>/MGI'91^?5"&LWYW8()G\MG8U[;\4H"92^K1
M*?/=J8Y\MR2#Z?%,LRX[B]6I68,?/_IJ"GG-!.4/Z*V;XCY<A9=$+6B\599#
M9_V+ D;J3FQ6N$8H[L#U+U/=7[V&6Y)5E^U?/=AQ^/F\TSM.\HT'SF8)^OH*
M'X:$087O:!IW!='T/@^W#M5>P1=-+6<6*0@?>8:S9JN.\>JYU_!$+Q\I&#M;
M%T *C>*] II//P&N\JVV\":$V%X"/ZA2F(AK2E%6,^Y9;KDF\JGKFIB8O-2<
MVK\'* D6W5BMSCWQ^R+<1.?1*+MO8[/NMJ]CN/YZG'7<IZAK,*B.5D]Q80ED
MS T7MWS3E3ONG&?W+/O#U,[H@A"+ARFM)6,\8X4J^BO<ZK%?O(>&3.^4U>T1
MF^\I;@VH"'\SZGYOU6=@9+-27^Z;(^M\VD,:,<Q>NTK:\X/4[H[HOAX)>;3E
M[?OM7N:2DD+J3P:>V-C)>%V](W6$ZL1'B.]J@\8/Z?V7W[R(^KG1*H0R><+5
M,[$\/;G[65VJGW;@_P%02P,$%     @ =(J=7&@1FZUY( $ ,RL! !4   !E
M83 R.#4Q-#@P,5]I;6<Q.2YJ<&>DNGD\5/__-SPB0DRRKU.I9,^6-5,)19JR
MAI@DA(20B6E.V7>?LI4PE:REJ:P5!F.I5+)OQ<PHLG8FV\',F?M\OK_O?=W_
MW']<C^L:?\U9WN_SVI[+'-P1+AVUR\;JM!6*AX<'=0GY0W''41;_?ON_^OR[
MR/_M&CS<%I38#M3"MA!>GGVH;6(\O&(\W'84!H7BV?X_%Z#^^^'9QLNWG5]@
MAZ"0,')![2[4-AY>WFU\O-NW\_$A9V\CYU%\8MMW[]4YSB]^WDM@7ZB$[MU[
M3W8HGWC=*FG?"^[7NWPC1E!(2EI&5N[ 095#JFKZ!D<,C8Q-+$Y:6EF?.FWC
MX.CD['+!U<W[BH^OWU7_@+#PB)N1A%M1L7'Q"8E)R2GWL[)S<O,>/,Q_6ORL
MI+2LO*+R375-;5U]P]MW;;3VCLZN#Q\_]?4/# X-CXR.,9A3/W]-S_R>G6/]
M75Y975N'-C;_C8L'Q?N_0O__C4L,B6L;'Q\OG\"_<?%LB_SW C&^[7MU^'<?
M/R_@%2J^3_?N#HD3]YZ\;A54UK,')2_?Z!62VJ_/.,#Z-[3_1/:_%UC,_U%D
M_RNP_R^N,=1.7AZD>+QB*"P*_DXZ!'5Y0I%;&NR3+"XJOK2NGJ4=8[X#JN\H
MPA2M#09?8PX1C])_6#CW7WG_QL_R?9UM]RFW0-]PUV(161^1?%@]B(NB4ZF@
M_:PF_5YC$!A>39-O-A>9I4V'[R3 WU$W;F&J !^@QAK[VK!+=)*53MV-7?68
MQ_X<WB@;&\6\'KL$=-<H4F?O1](SSP^GA4U0JYK3"H3;V-XQ4W(%EO_\>COP
ME^UKNW/_:^B6<\Z.RX<?; REJ[L4=\O=+Q&T/>W1<=2$B]*ZO;>!EF2$UV$$
MW-**>/!+G]6PLZ]TGXR" ZVS\?=42,WLUV>.!TL.G;B1YIFN:C# 2<:">"JD
M&ADLQU;@HFC&I5-(\,G3@)L7%Q4# ZVV6X1A^N04&(R#\_^L4KKZ?;O2HB]I
MES4+;G)1;E[57B-^I::LU?-]U+(2>E["N]H6]M&_K0/]G^9E@*-='2]-YCLV
M.(VL?LZAZC5!ZK_Y<=!0(/33)VZ@L&!I#3R#65$J-61+<U&PT%7L=#BD1P9B
MCV RV5U=L__<?LY:&-/9[RW3<\DD^B?Z,\E)MG;AN IHA+T'Y\0UBH._-(W4
M]^#751RHD:E',E,O!@^GZG7-<)XXU ?[>*_MY*):6_"@ Q**7F9K%A<5'M#%
M1>5]OZV&;!=[%RE7Z2=AC Q;6NCQ:TWP1LLET=,J6P!*]&<!ST>CV0V>M4LF
MX.W#6!JVY#9N2V2<K8 ;%UB+S%J[([>?+-#///M@0H^+BGNLPMZ7BAD-!EZ1
M.P(/[C67Q8D#E^OJJJ>_C6A,(CUQ?.L415L?3*2]J-?\'";=\M!*U0?:Z6LZ
MUW"1;^[R:ZQ#VW [!R^R/95\-&J"-MJ7&D<Q[OIQ_ZSNZHT_X@W]A[LNO=).
MT[MH.!SZX*+*4*ALR:ES3U9?6"I@ZRG:?I)RCK?K:\LWBJ^><,XF'>*0N2@Q
M 23L,U]=B8'@N<K*UUQ4JO&EL\,JWBP*9[A5Z);(X.ER'%M!A8O:KK\GAU76
MBLV)*6#+OS;2T.7I2K(2%CVF?._;.J6_)RYAW@Z*!>7/<=[_XCSDHAC +!=5
MD]@59,W0*.+%H/QRL+ZIV-%AIF;'0OX":<</NK^93+-!ZC$@[DB1*7[1H?)
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MW:SH?\13ZRWXI8]H7IW:$0:/X:6(KN"/(**EE\E)XF3\OK:CI*%^Y[N3Q]\
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M4[?Z:C RO_.YJ(2]D&M$U?&G-):I,P24G'WG-/]]PO_TM&7YWEF2+-(4UC1
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M\[2*BT&\65WV81L17TD6WMWI27Q'&+9RT+',IC(\OV#PM E6 0,91<)")'Z
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M_5X!I#AM$@TL=XI?)M&D*:;,]XS ^&;(06:A>9\R!;"D%B)!XW]6+NBG7!\
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M)WA-][=K_^M]1TYPJ>Z_?/M?O<[Z[=L_G':[]I5_<!^ZOKY@]&0FRBWY>!4
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M8ED[ZC_^2^=O%7%ZXR'@F5V;/#GE1UNH;X._<\3ONN WH#Y#_7^\T@#Z,;F
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MVBZAE-XFO+.2IR=4$)&:B2:NVS5]#%,_H(KJYKN'L^>:=#2,[WPV.D=Q'V5
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M &^CHO]QM-B%"_B">GVX_\Y_GV<&;AQ9_=-65O[7AHM_G5OF$$.N&NKH_./
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MP8P$K]TS-&X>@QPB0^V.H[GY.OK")Y)Y)7)AU'OSW)$7$,!]+II;GDH>4C4
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M*+FWA?-U8492TZ:_%%(V!AX) JYH??U^;9N"-(,H,P'^C(?E<B^TQ*S@'>]
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MK<5[8]1V3; 8VL-/''8)$P0$>(+/R#. GB&NHI1EZ3BE8"[[&ZI>U.W8%4H
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MW\PJ66T\+(72"C[MK]\H_ N,1)7H'8_HCS%E GH,%QJ62J@#&<&(W=VS*TQ
M9<HWF'<B&G<&^CX?0HQ>M6M'K\[QL*3P982"^]MSG#(70\[<>Z3T7.(3&[:D
M_?A;0._;HU<YW $IMTT[:7)[P(7)](5?'9Q0_GG[-GHF$[ H113H,3^I-M"&
MT,CD+R!L=5L1N6:_ER_-)W I?LB3(LKKY!8/\W8SV$?S$[H#_M@]IR:WI;JZ
MWDB=8$Q3 A=YIE3[Q+72+"AZ@80A,T)'\U6* XZ@%%_9<=';E8-@EZF7\G-/
M046I3NFD"\V:^'0RI%&C0S15)F@H/"G\!L;W%O7I%J)M7F!>(.O^VB-*R\2S
M/TOT3,5+*LGZ5>P"T9U=T>SR]3(VO1,]@VJB)7:G[H75O,WC5V(%BX&O!+9[
MHIG*E<@%_SW5T&4SE+[PLPP'\ZM?E@)(*H+IHE.61?+'12]+OT[T_%$J&?_1
M,D>_76FC"7:\6?L ^_*$YNG?B9&D"R]5$Y.-O<E1C)/%URBCQ.S+/)1ZJA7D
M4/@C*B>($Q4)YH<?:\^H0W/I<]$L,2 >W,E+$V/S-YJ:L)MMFJ6>4QV580U'
M@@:"DJQZPWZ]'#)YZ4E*X37,1\5=(M#\BH;<?7A&@00C8P5BYI(<GVS_XO-D
M,_$RJ[C-7VG)1::=6GA,/&7D7&!L-M2G?T]V^>>W1MZ,NP71*!,^/AF[A&_^
M5XOBNG"EF&21L[$5I8T"QI4.&(IWV=U]R%H'A__.5YHW(?NLB?H7#\%;JV?C
M^Q]4"PH]LTS,,,\V;N 5>E7I>*]-2NI569^J[9_;);:.Q>*VI1U/6'IB<5R\
M_R<!?-M3D_LW7 @\5A9W9 ,Q4MTK?G\$P 0H$8&5"+8=EEVSV(<J_=%RY@X3
M  GUR0GN>L%^[1E"_A3)[Y38E"1+3W@AZ,*,CG;O_L0H=L#JW^0'#%L\XZSV
MCTJK\AG$G]4*%8XR;_-P_$[$M([_0*G9^A2\HV)L$OW[;"D"FS["B/<B^J^'
M?EU-Y YX&:%?OT&=%];_A%CKPS,!1NI0?_\3 %!J.$.L:8\E8A^D+^DI8NP.
MD5ERYZJ6W$,&F8"](GCYUY9'7_N'7GYT^L?\PW>^OIF:I.%7#VU\[Y_@*)PK
M@5_7)]8WENUP/Q-YECMH.G!WASB&UM:_3'M '$;W60E#P[N8 #X0I(BBU-TR
M$EV7$I<ZL%!^#73V ]YQ^]7#"76_:&54C+I(Y6VHP/7F\2V:]]+F0[P]9DNQ
MS8@OX_U'LSGAEN:Z(2Q#CC'J>N8'7 QFQ%(895[ZXD3V;A\V6Z)?U)[/T7E+
MHD:"=SZTP*P1"X($BJV\%\_^N*ZO5(O^L2GL75YOH3'?,U5;'.65)ZIY=ANU
M,^WT=-X)@J" )?C,+&"WI\A8"[V0/_ TUR:-1FW0.\F1RRS8#NF])\\>D%(5
M2N59==XL+LO"QFZ07E<J;KA-JCE9V,H'GW2<9 SJ&??I]M9V-#Y]IZ1@]^#X
MN&[V4):F<XY=I[\RX.O:/(UGQ7.G%28'WVXX9* O:;M[.\"L,-XA"MO' !IT
MTTZ]L$2$(Q$X]0#+$&HEO^H<H=W;3A"?W[V(GPV<:D^#[JGC('6U6_1L)N")
M02*B-YE2/< $5/.ZBGTA5=&*E0[M9??M:4E7OZ,8,0Z(][]7WR!^AJ[$_3=F
M6@:;_L8X^4&PL8$)0$%35EY,E/S11__ 3H)KL!OS13!_PD@O2V9X=TC483"+
M^]U@OO4\/L(F,@ZD4@1-@! ;WB]RN?50@S<W,]"E#G_WMF?[,/4D< CG8F+9
MV)1AWCJL:>$@OY2ZM3,_#7,_!$(OC>!0G8@33S[3C$;;=''(UWF*E C<8?MC
M;Q>3V\03F0O=BXB-[3AQWB9A?J1/_A,D[W;P/F$[QF<+-U&']WGD:/2@W&O'
M7+*)"3 @.CND+JJ*&CLXUKO'=UXONF6EP*$3=*"L'LA^7-LRLR[[H]GM^()3
M/VQS/+]7JM$+$5]ST)%-"2)IB[OQ@HY*Q]^;)8D"-:1.U9N (DZ7VJ3+=*&J
M"ZOOO;88;#=3A;KK[/V9N&-3<M"5RX.EGCKT9G#4!!P&,88]&"4#8!<V![XM
M!C_]#?P(I8N*./U+LP?) S-!=L]SZTNCND?.XH&/T[KA8L215QO;E7 A/%P:
MV=6@X^QZ>1QD+SD;[]62M99WH7HLNFA&G!_]4L%L97X0<1_)B=<_P02\? WC
M)GC$52[4$06BX;)>.MR-WMZ!8IMUPDDQ296&_@W[ ?"M=4"W\HSBJ-JM&I_K
M9CR\&CA0H\YBATKW _WJT\; F$ SDLS#3W37PL^DG9FG5W R#'*=]^+LS4'D
MY!5+FYQQ&W>M\2)MNB8/(3F@>\9M\;LT4%2>T)2G_O5S'5$+9-9[)UF.*V<Y
MK?)5U83PN>Z'2V9!ZQ4*7@%5I0.'-ZUS9?=*$9[3F=(K[)?SM$53PZTSC_&T
MJ,R#D-UB$67%!&4 B=POG?PJJ&CWA YPEQ$!/L4X'A "7P]K#]Y>1U34)+36
MM+32YM\_T>KLXXZP5-G[JA;Y14)KI,1O!(@LLCW'_1>>JV1V3["@G@JO:X;L
MH-J9@'?-[C0T=LY)436/_0,[^.NIOVF-7DYYA61Y;+Q?O%)W,#47JJ]*\15X
MHW%N5(RGY_37&_%?KDRI?@%QAZ*P:?\OZ"\A:?RT5?)-0F2_]))]S L65U8&
MGV&C/NY8[9:6@49U\28MRJQ"/82,ZB]/R+MG><ZJMT\TS-!:^Z8"D*_@%[L*
M+\I8Q:A4O_7@DQG0^14\7J#X"!N$L?!-6:Z'N>!4^\F%[:J,*C8FH.Z/GP T
MR8H6+:D-W/W.L[R\5!\8-TX'?_I(32DAJ3->T?WX1OPJ'_KX'3 !]DQ !O"W
M/?DY9.,\$U!+ ,UL:5+S1'PGR?PT[O0V!YPR!V,\,X7J 6#<P6Y;T<Y$.8V3
M(&)P3,"Z9DJ@&#J2(0R2Q9\Y6TO)[,DW%CG+[6##UI0'^#*P>K"':$'PK,CM
MCS!.7C*A2:/K3Y((2MWB\ XIHH:Q?A3*BS;22S.^A(J9L1).QULJQIP@YGJE
M)IBK#[E6OYT*VRS:;BC91)M4<)^*38*=E14$*0B9G,TR4RV*+; ,\(O=+=S4
MLDZ<F$RZXE I7$V78W>.ZB2#V"@+8P)"VE_(HBG+MC>B,  6*UU?N/U(Z L[
MC7$,7D_C92%(>L0V;83D\1][:PB^$/'CB-"%WWDF3[DC:EU[/_PSI9]G\%4#
M'T6IA[X)2#;8I-&;Z7)3;;I,P 4+349[/R.&-/+:XKJFW3YR>?U[A:SG]_4I
MI9$)LA#N;A+/;:WO$J^7L/1+LCML2MH<_=6B\*@]/GR'C-:/8%XFX!:.)8%?
M>_=-&C0;3%WMWM80^(3OMW+E.?\@?5&!=W_>*<@EZV%/\3+G9?H<PV\8?OS+
MHXN E\[_.-QTWK(=>-C^U?GWFR_;%N=N?E")MT!K</NW^?\6SV&+V1M1/XC
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M#'##=V]$2'<K&U24>^K88.VO%+I*SK87"A<QBBX/)_P*H@L=NVO.T40%WIM
MN(>+A; Z7KU=X@Z!4;\@I[M&,_(@ N]HN@HTC_K)5W'U50/)$YTM6)KSOK1%
MYJUD$1^(56-CJ_>A5N6K0*5=;I<1A\MZB.4"!KCW8,P7GOT;G\,!+-WN#L:/
MN':0#O-4NYXLR5I:XW+FWDK&?5-1+C+D>56T491<$AVM<Z?4V,9=1RB\L^N>
ML+J$C(%EFVS9&Y3MR$$@^UY:>52)Y9F%6WF5-Q>O;EPNPPZKU.<^69!]N*SS
M/=>+K^"TL9NH^TTW/"8U9U;G7/[:"(^1(3D<9_N[0Y"X&J^F(($S0L6I#2E8
M&]=.PM1Q<A\_SA@]CX,J["W2RZ''A$.;=*"<(<_*?&[R?GTV065G HZM32K6
MB_@E2&W;-D_ $I"<QS2%7S6N'"5ZW8CVE,H>G*\[=\1E^MH%'#J=>#DJ\O('
M!-:$"<"5[P\Q3F;\7D/7.3Q_W/>1P 2(S&8S7-2[^W !J;HA?+OB\OYU5U.X
M LUJ>@V%()RG,Q+Q('X@EW7;))C]>G#1ADMI2Y)VDT&3HJ]M4,1^I/X5&QQ2
M\*IHBS9HAZIU0#P.-7A,J7BD/%J2[D8,^M.GOM9G6\#S/,?=MO37%7,G8)O4
MK9S-_H:_K_'EN/G!5L$E9I4K1\;=B/^F#&+[X?'WP)YHA-Q!H?^F*!B%V_^*
M8%'W5/DXY<!&_5^L7ZW_SPN H073#.J_]2+'CU"8 -*GY?_C..Z_(I@ @KGQ
MK:7EOA,ZI/TUD_>=(F%+.7MTW0D_Y>!^\>;_:8_MWWJU#-N_[MTY>*C4CGA_
MW_3K0>"_Y5>?P9WA8+I7Y4J*WR'^;\;!1VR?V-995_]7HB.8@*>BJ)J_:S%/
MOQ?L4^;1)FUC&B?;7UK"M)4Z$J313E(T?&_B^[N1/_?_WE6=]DA,(9AT[!\F
MX'="!+@H$,=7P'5N/V_DL'PX]Y[->$E0QIOIB8-:79: V)'X@R0K3B'63F'_
M*9 QVMQ)@>QBU?%S DM?J%?^[CV!90)NVK4]T9IJ_<P]BM'3"R<5G*HJ@SGU
M+[8S!'Y"LS4YYSU]UM&H2[B89Q]M?]8^O?VIIS8RM?S%LR^!=8') <9 D9?Z
M/Y8UG\+8KYE+!22M'Y$,>\%QP;X7(J0/A%WO8/5#/,B@R(@([)T[@E4#1HU2
M"KJ$@?%))>3DN,61.,?H^138Q04Q106G:SYR-A-MTI+UC'*UD$F!C@MQ*YB8
M%LY.3X%4_#PGB\;S</]!\(#\"D>6_ 0I4]C%QMB];7'*T4.'K"635$R7J\S8
M]EX*E^FG>_A)^Q;T:[_-54PQ\7C[*X+%IRF*1Z^*YNM5QJ]DSN3L4*MVTM:C
M4H/"@UQDA-BAG_NN/8UGS"GCKD] 5$ZGDAL3 )J>*N$N89D.9"V^L[8-W?;C
M*2K8FV^L/GQ8> QO.Y81W&*A:MU<G>Q$U_9U.ZH;7=.2ZNW^7M_AV(/QG-_K
ML<ZGQ955.DM\,Y 1N=0S2R).<S5^3F'\(?^.BK<9DK/>X^C9X">>#P)%JV&<
ME/K+SQ0-32[#CV+?BSU3:;YW5/5'/#EB"$]%D/XN^^@#$H;!=78\M!_(A/=+
MC;0+.DS IRI:D9/Z(!)=[)E1'S36\NT9N8IN#4IDJ# Z1WP+,5]WZ\M&2](>
MKS&XD)W'&^-!AN0G1R:5!G8DCAV4'=%EOW!L(>PT0UV9:/6Z=7V_>TW#:N4V
MEJ79%PUI%J-P22\5:']WGBAR,;.;RPTG[RA5H52,!3UM$7:J_QZUV.IT\W*C
MZ6*,6PBB=-W>[GE81$M^=$M3GI;WSPY]QJ ]I+8D 2Y.\>AWU1:PFU/,8#$*
M(C_J[\9[+NMH0@)^ZGS+4^&MS*)?4UXLM.MR"O'0J/80]B3._)E:JHEI'0VB
M^%9(M3$!AEX!)TYE@ \5H=1RY=1RF44)T4=EP]9=;4%TI#R?]C37=N_UPK=%
MA^^&IJ7-P$OIW+S#<LN0:9MG93Q77GVZFZ=AI1@M:-:A[?XVW4.GME1D2<'L
M6;DE]UGOLUIMNK9%NR8T2?%+[$FN^T@'](?;NN'V,V""!>(,WA[1:+_QRR>P
M=,[*3S/YM\/'U&L#EQ#W\>S>BIW(=R?806?D[*Q^'M7=O-LO+!T-UZ%X]SJ.
M=*/._?SC*D^@9T8K+1"-D:+BO!B0*6XV3]3%%V_;,4'31)261-_'J.'#RRV\
M>^R$JY#\U>YZ]6TASO,T7OC@H3D=C?9PT;6I;L.HBVGBU&>3&+D(/X4B>M)R
M1T)E=X!GA*>6@X_OYF_CY/#0:]!".V,A9^R(A[/AB^]:D/BU!162W& L]^-
ME)FWP/7"*[AG.;?^F-D$W"ZPOEUN62C)T<<;E9A_0#*E9W+Z9WAWSX1^45=]
M6I4LG">7N",+]1J?8^,U"_8/)9_*DSI/%!1^%V^S&EMNYI\CZ<AGLRAS*-,T
M.#]-OK9  NWKF3(,X_^;XOF@E!H2D/QNQ,QB"(_LI@%0"Y:0*QL-%I49_53<
MDDB[Y([]#AU\M8_T=_;H3OO?:1\^R#,J0Y 5RCQ(!:RC6)K,,DMF(P,%Y!'M
M^_S__2U:A46.JF+!U0T?MXF0Q?>B3,#S52<A6C:I%_[.[[]I([@S$]#Y@.1M
M 23+C?NALN[XHOD9@KWO+JJ:=CCE^MW_>?*RV"M^T)&43X<(+M$'.)X3@Y9W
MXG'R]<UFZU>NX-1]_J1O[B/?0R<L1KJ4SA58JKY=[GP_EFCCY',H+V$J64[Q
MVP&_\RDSE320+OTR0!U]H0-0P40RPK-P/#U@KA3<^&>6S/+H ._Y7*%$+U8C
MLZV_?I$XU-M1Q6C_XZ973A>G3@(9+Z\@%GK7YI=+2MXPE.GF?$S M0F690<K
M3'5T;-N@4$81Z5B?%V&1X^*Y_88DL7*R&^-D/1,@F;VD1$_CDF,"K-]Y$_H9
M_ (QQ-RI3&OP;W&ZB1_IW4B#-[F6<3(!%Z'D1/E%+!-A"W(%1H?9U' FV+UX
MJB_7:%"?H+$R )1995<_:$R@Q/,2L D/3HTO2V>.FBEGI?D=FBOZ7,[=+OA!
M+_^#C^[!$%'=+#9A=W[2)_Y96LGEBAWG->F0\Y4A!>VMJM0[<__7K-X6Q!D.
MQ'&)8+%[X$7(*E*)#CM\S_BRTW\X'Z#M?B'Q[W:TPF3(R3-!(K>"9EGBIF#&
M/HY5B0%<.!YN'V4) S^.<$30@9*!.-M25,(2Y%P$,K#D=&I:/1E?,N.)1^^<
MF #CNUA(>:,=:GP[.<(*!0^/, IO: O(7R_!6+4P :-*KNQ-]T\3=/R-H4",
M6(REA:#MUO#A=/^B56,P=J^)R+^2S HWT^,-BB>/W*@XZO]!%= >YE8B1(]8
M.S9M>NDZAV[<P("OL>E6J(1TGA7K*O156.WQP\ L"GT^(K-W3KZ: @G_  /F
M4?%=\//Q3MNQ8<?W>RH-C2CIE4\<HQMR*^:]Q241/"9^X2$ADDF_L[C?R#35
MC!DT:EX-U7P-"CF\"34WH(02.1TF07<J/5OZNWW8;A.1D4'M@FOPBV/R-# N
MXHJZU;DYLZ!&S)Y/2"_9OD6L'O]Z^DYUS62;V4"^4^\'^<^^8]BE-<J!7PF$
M<D(V?<QSNS(;NP)_X_+6.SQFX'+WE1'MRP7/X"6EV\.WS'A'G+F- S#3R&\>
MDY\W@M4G]CC%G'_-KL7:CE:JJQ:OGPW5I :,R[NU:@C\>'G#/N.Q7^U,C^"K
M+,W;T,K[2XEY,X0PS";-(K=#;N]GKD+;?L2ATA?DE<T#( %UGE[TG"55-!D_
MLJW A((.N564!..,2XA$%IGE]Q068E8B)]OLR>FLSCZ]=&APGT2Y2'06UP4>
M]9X-=(VQ1B\ZR3*DFHL=PO\?MMXSJJFMZ_O.L2$BH"!%0*)2!0&5)D5B.8*
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M* U#J*DXJ<CG>NH(M\>SH!P>HNC53?(PX6'=OZ\*$"0ATW6\F!&5UK,2Q<
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M/[X YJ\.N\)_$L%/<I08V(#$2LH-/T"84XAX"1R#YK"@G3A<K/)*R;]98,N
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M1G\#\UW3Q% GH3]/KN+1^[+HVB;Y)$6%)14.5D6$*-:K<:,JUIG*44<^1.L
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MW_&ETQ)OF?:M^YR8;$&I:?9X'M0.LL2EXN,-"..4(KL_DO3 >VLA2AF;E("
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M*E(ITY)8FI)QRRBT57&X88"NX3>W,]&X*)(I<K01PY*J4/J5B7%URT^#$O=
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M/X S:"J)+*%I3W )9JP:%D+&ZQWJU]&9&<4)M1]/1;"Y-U$L'J%F*3A3:S^
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M@)#9/(XE/,FMF&D=!\#VAE3K_U<\8BHC&WV< _CQHA--,4E#_[R")@XC53@
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MUVM>C1>*>,(XOTU@Q;09TH,N,N(1M+V#78(,1^+$H]C8$" 0)44SK9+!D*N
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MRX4[E1I $%0>"_!Q1KJAA773>$C[GOI/IWM(MR]]MYUH"!>Z?$K-U:&FJ86
MV3[+:CA%ERF:;UY9#^&[(4N')*ZM:F&29L7'5@)1QO/KPI;D=1&2<1@6V?4=
MAF>DOF3@KIYK;7PJCQ:<G#/V"PT^Y=C0?%LFX!GEC=MDH'!S*(^%4*P];:MB
M(;B,4GJ]PB;:WUZ>KEUF'\*N2.@:QR801XH<[!8L!&D_0WP<I$%3XK>$I/L2
M:-@XNOV;YEAC 2CP^6A9%-&K="S_:#U92ENY/@M813YKY^]Y=TQE.-G)@= K
M<, J7WPG)9E+8\/T SC""V <!\ ?<=J"7!HR&(7F[SBQ:"0XW %"9KC0O?'Q
M!N+S(#Z492WM=<5UCYGL_FNTV/B3;:,A;Y',564$(LDOU,&:U;+#L\Z00R>#
MF9X/BQAH"C2VODH#';^#?U(_M\I2(.Y4NH3&;')3N_.]:W-,&W+<3_] ;$P#
MY'@O16WOV@Z5//!<!)\(ZK*Y2&FNI]]<O5-PTF=7G#TM\>E7M-;R>4MCZ[=C
MFX9!SD->J52=6/6!1"^Q:*82)?Q&KXT='57+\++#TW*($%[_C!^.0U-+.COJ
MK;]TSB5CI_W325_=(_KP#7MH:R\H0.!@-4)?[E?L9F#\66-P\DJ]RBY7Q/T[
M!%]T>YQ([7(Y6$C!K8(D&#E=1D#3<:9]!?+^\/*U-[31Q%*/JH;BTE38V4_>
M#L6%%"R?<M:27;+RO?XS67>;?0=>G[WVNJQ?2!0KLO*RG.+?0BEY4KYNFENF
MG\9ZGM&3I0TYPG@^3!C&*C?(/;^Q>*/&-EJ5!V<_H"6;=Y-5/V.@)L>K>C8S
M1^U1+=8J1:P;-Y5QE:%-6W>G%[103>FZ$R&X* ?X@1!#X-6W0UH82=^.\PRX
M%_U)=^Y:53$R9M@P% 8_S/ BSAX<>ET7/T3ADKJU=^ZWX9F*K_J_4E-!^R(T
M40?'ZL&\3,_&!-*W#;YP+:TW],98:K[\$0,%"L_@?B3&C.LE":T##:\729C8
MAG6@9:$_R=@B,/3FMFB-!>!QP!7:(Y;0B;QE[WJZYH"O3[^(38F_7HJH<!G9
M_YI;IM^E*$7VJF+/D_R')AN#8HY"NI>RE*R+8#^M3D?KB^=?5=4P9T)4Y?2#
M$=Z39?8%ROD/]28J]']6[?:&NML2RA04/17)A7IC%1)CV-U]7&0J<04V#27#
M;=D@"IZKQ&(3'S TZ_7?$!")RA[81\&P7[NTASO^JRLC0KG196P1(=M^NCX<
M@*O!#Q:(.YTI[A+0VT@DE@-PRDMBO$Y0Q$VD]O0-CR\Y4;//NSX_E3M/,E9]
M\-/ UCU*4-*IV$Y)[?TEJ>DBK<[#-UY<D9-M:HZF)B >DK/M$IR*LL6]TIVP
M>UZFRX8XI.N-QL1<YDTO.ZCQ[AO>H4.*_05TE"E''IQ:#=0.3,X-2>T*!\]C
M8U%0&@^A]1#A=P=PJ;6)@(X;I R*,#V;QK82%[<L4D49>(MTB\:Z^L_,\Q0_
MIK76M@0NY3O-7_[%/5MG5CG^YODJ^7XH.LK12+$]D;#-EFFG-\4;''G51V%0
M:;V=.#Y&8&=HA^@8EFZX5D(^&4!W->N@V\^\?OZH3.9Y\ F'7"6?FL HE#7Q
M&I<LY_/&J\"(^,B*F"K+^STIR@T2]\M4;4O,49M*P]U*GGD_)E+DA=_4?2N)
MRX-<Y #L&/Y(Y!BVU]E2OSI%HKB,HFB'&JF*+O$H5NH]6CX>*_<HZTS5#7O]
M>KF8,D>18^;-2-A&JV])4[:3^JGL(^30!%^%9'*NN->-6JB6C7*?<%IM;=M]
MY=8SRN_X38S.NY;E[H\97_)IN>5Z,V;6SV4ADYP]Y66*B+$EJ)[\4'!\'[R<
M-+>JO<N/S.@>GY4=-1)8^DSZ@K)G9%$M'PSLDJ&1*/LJA"UB5I511P'R(%^X
MT1M;J/+CVN[2FQAAYCG:&HY6'F[D?NH]0^?:6)5V_+I\I"OK'*L>?0L-1#UD
MO6"?8NK10$DH)=K/>0@QD'3>#;[?R=?%]!DT)D+-+SZ,#&= Y6KILNE^30XR
MLJVC:NOUW2UQ/T3C#Q85^M>VQ)!(<-%[^U\663S6G)QPDO*0ASM51,6 EK7.
M(!.:4;S^-A4VV(8>+R4;@BU&M<P6&Q=MGN5&5>RA=G[1DTBQ;[OP/J*:/GE5
M2T8F6_WU27(%Y8<MT<O;JD3YKMV;9^8-B %UZPJ'JB,CT7*6/;;,G',Y"7?&
M*M?&ZNGY%UW&[X[O^[@1WV%[_-QU\\N7O\3]D?$+C4Y(?IE_*B8T,KBIV<]A
MEDQ..]'L>]AY_,CSR[9:O!_J5*V^R7L+'I#=M\.:AS&4@-$-*@AW-"4BBPH\
MP$B\1,]8[CA-0W<E:_029419KU$\WK2@"PQ',BYZ3AIE2QT4[J-\LO/3_.'X
MJ*""LBX(25&8.$E/C=\Z-U+%M$04NX,P'( OG!3[#BW"/K8X*T3KC8M0]YV]
MDT5SO/J&L2_H%5)Y;A[6%8:)GN7-(1C)C[>)585C;>F66X/)VJ=V%K#;#B_F
MIZ=*QAM&J&_GA >/92-N@_CIAFY=,3R2G5LT.Y]XK+% 2LPYY$>UX\W5#R^5
M2/ G^_;IQ&'CK5,.9AVW.)18QCLV@K55#>2EE4BU=NCLZVE&A2 ]_2<(\PI/
M8H!"+M9E<H>M\OTWLI14E(4('DY+#3Z\MP3S:O%^-ICOJ\+6\#NH/;L*7,J1
MY%).(E.'2SF:E!SV2Y<%E- N@@/H([/'0-OW(!+HK9O([(YM#B"2CP/X8,+F
MKI]\3K?@ *ZIW>\XPFK@ +[2. #_U%U=3#)DI];  IZQP %LH) 5[$^AA]#+
M]D2?Y=\YS&=W!+FC ZX'L_.>-O13HD+S@(G/+5U[>]6/L OE+[,57@($80";
M5H,[]/>I4G'='GH"16G'0QRA1S\03I#_T#U!/=@^O>W&R"#CGN#K SLA";,:
M#>WM-"QA+HXM2?>)4]U<UL6MKP6WRVS=N>-95UN 0%:K2]L=ICXD?__F;!WY
MAL5#/[1Z;U><>;.!?@Q/#R5+KV'IQD0.@*]#&FDT:#.QN0HEZJ.C U$ZA<C^
M+E(,!LN885H&4O7D7[B.&JC0E9<I5BU&913GVYYMM(#.]KK/];ONT.6@2@[@
MW(<@">$S7]2>?]<+ICVM< 5ECQ%:,\_:GTV()!AH/[2UC3;0*$O".=NUG3QN
M$ZTW6IH9 3E%_H+1[4=0SKHY9M]\GGDVJ,08_+'LAH@^PP6IYXC$5%U+AAX9
M([8B]87=(1'W\YVMA!>;P+WS*>\WHH($]4TW#GA)F)VJ@THV2]K/6$\)Q/G8
M/;AVJ89WO^"%$VFC^]YS7ZMI@X85OQ!4G1[8)(@\D=BF/;^J<)'A3 >1[W*'
MLS9+F60:M8N^- MZ8C*LVG%^46R$>:%Q*$1:S&*LS=*0 T@RV(,FG]-$5M@V
MTJH?>X91PJRK^BI])6(CD4^V"UF)#;"C?AW2L?-;F>,R8CF]'J*TK (L#=$%
MKO(SXJ?[K.J]9EZ$"ZG7>5)<$:X<@-!%FOXOHA'_<#W+"7;L"<4"22+1JT*.
MKZDRW<2D;DTNZ=XVD=E/@7LF-%P9".0QZ8I:L.'_SJ63HQ4"XB-WVL4_%QV]
MZ]=592:[M/ML;4_?QLYDI78$A(RK]-0K^Y"O2T$H9RWVY)MMV!%&<6;D!:M7
M=OY=[7ZCN?6+MHF9OFSK5P:UAU]!LQUX^X7]AZ]\^*/N3?*>^Z4OZYZ>*><Y
M"Q"RQ$VYP[9;67'!+2%5*N0Y@KB!PDL8>IX#$ PO,F.8O5J4:*RCJ(!BX#)&
M(.13OYV2G/A38P;2/FK?DR+$$'M'K#)VP4Z-PVVV!V:2''5J&WZ)!^R:HCN-
M-AV&</6XJ8DK8^MJ3 @Y\7@P=TL4N+9YN-Y0%_E]/HI+1^/M O3VSXQ8ZGG8
M048@]?;VG.B:$+1U]#5]/)X[>GMUC5N$8I=A274MW0,>(+K!P[$?P]_[LV#D
MG@=$\Y BTR<!S21UG(+:UP4;N",VR^/P>T_U*XQX@N"U!U6.4]^.8>@^EBP7
MX46KAN!,NXSTDH$%WU+;U''E"-B!6P-CM]ZI/HB\6Y3>"R!?6(B?YTV_(*+B
M^D46H3+]11;6=!.WOTQH??_K/O&]YV@\ZN/G,P5; +DLER$N#09.6A! QU0W
M04=01O1S3Z@ST"ZT>)M8!7(8$MMJ[/] 0H>(B8&+&&CZ!)2Y]U+"V6KU=72/
M!AK[VP!E-<-Q.-C=Z)N%7V%+0V[/^J#!V=WK2,6(C^S]#$.Z:+\C([829<#P
MH_\THPU$4]7$#2SG+54H"HDH6]I"!R\C4L5L"^'=P@%$'>IT"24:GC=_V]J4
M97 VJ)(0Z.45<F!E6K^(^'OAYM*U^2^S_-CGPYU6V>=*5,\I5PL&T]U^I\AH
ML3I DR,X"^ 1J( #GPU.>=BR*P\19"3T7DD;)M#SVZ#<[D,YM=#QD'FU I^%
M^-%GCKQ-_-]7SLJ07LM4/>P)5AQ0;S@\[&!;I@S)^\3;=_H2[4.&DO+G^CMU
M*N!9A[C2$._.+R47C^OM$Y&.&/4#-4RL\!4Q^NT8T0C:1 ^0>IX#2"DX0:_&
M4,(P>_P<(Q2&#"0IEK!N">VOX*H99#D"P^_<.1\>:ID.YO/_>?X<[O4L5/I3
M/0?@.7J+Z9*MZYGM%/ =\0)9G*X2EATUW4 4>"NKPW=G\+1K_5!TVDN-*YZJ
M7AIZ[KW#[S4_$G2SY75GI3]I'"<O>KK)/5>V6+;W+Z8+$,IMR_R1?KJ]N<5%
M-@&6&_=-S'Z[F3SUGE(]4_N.+N^(Z1=R%9%XVN]N2LOTT]GRFPCQM/I)[-'(
M4=-M#5[?OS"H(+(+Y^K(?JZ.//$%;5M$R'$ B]7#>%W\[<'?YS&D)^P!(!7,
MKH0+.OY89_(#V39\+]%3:HP<#N#U6W,FA54'^;J&]P?NZD*2\#LU*#,X7Q:Z
M;Y,*V3V'$N  JH#\F) 7Z+ZH><RN/NHA!U YQP?2MC81V5ED+)8<3*YT2Q0*
M*/9O.FV[>WV$K^-%F.YH2L';ACW89R_OA6T?.(#KZ/_&2C-=3E4-<J[X6?L*
MM3904ZXP\.GT4P$11[G\OCW">S]>.7KD%-Z& _!!,Q3K07LCI-F#>-Z1SK/+
M^CJ$B_3N-N=J=]]':AQ 8OWS"#4+W,7[<T>T*ZK,9S;EZ/*/R_QFI>FT4:IQ
MR.O%>=]9DR$=FQQXH]A*U2NF.BTTEKEOUPCM@S*GX0GAD$XZ@PIGA-,P-KE\
MUSQ0QUI'0^R:B7,DESQ!I JEC:23J!Z<"!%P[J<N:\2(YUQ["XLI(Z+LH>)P
MH-&AGAMGUL4=@9$]UW]>%2X;!/*::F09/-#7IEHAE>V5K+O&MK6HB;C^N$PJ
M<E?99XX0@S1M/!@C+Q4661COI*R;]X!'/,O+RZ% 'HF2=GG&RUNJ_[3' >O2
MJ)Q>9>-TU9!&C\K%-+Q@-C<GN)I]:WB;X.I:\="#)]'UV>SLMR-4N9N12'F[
M;/&BZPY7BDW2CHMX[Q>P;GK?#5*DGBB*K#[*FK=^\RYE_G'*UNX^ZN!TQ?9E
M>DP1'4]\&M&_5'"2\1P[-_@2Q,^P>-<AQWY/WS_,-,[^1EEW;QE7:YBK9]01
M"^1HO<35P&XABRJ$"S0NV)DIYHDH0YXC&/-/TB&KB[MRC \<0$_!*3INI1.8
M@H)200E& O3QBJ!J))@\^SRH[(?+;=!1A^4N@A.-772##4KLZIM?EUQ\=+4U
M(@.-H'XZWQ.@DWB[OC^V(^GG"&56\5Z)<H'4]YH[PB*^4(V^_"L3919 FV*_
M,L?M^T67@H@V62Y914IV);!L@XPR&XR)%9"LK5^#I3A<E"UWW!;*=LW;U;M6
MXBI@E5G^01>-D!@C\QKZ#F,O62?K-^A]*[^4KXQ)K7-UFZYZZ^;JYEHRT^I.
M,J!9')TA7=F 2L]47$EH$JTU$ZXI(<IQ!XC+CFJ2CP^$(W8]F:&TT-XY293>
M. KH6>WT8W8O0X^,BP'+MY/A^QD2 >:_+M$AR0U]VBK 0RB#YF9::JQ67U4;
MS&^_Q*VG-Q+T5JN]?9NNWLSX6KXK52&2V+,P>=7C_#Z#.C&//"Q\CTW$\&M1
MCSFAP[9YJS)^^EIOMC!O)0V@*@EW_5 .@5&=\T$&MX3 'T_FSI?:19WY':T?
M\:% 63U&HGCIDEB.JI=+]:F$^F+,V)?,XM<O5':2.( GW GT*X)5C5YQ9^AQ
M %A(W!BS96)+G ,X.,@!O)_8=4=/OJ4%<0!6:(&*C<!B*/-YAS8'\.9V!0?@
M^%MOY]?06S;,9R_75#H$<GO[6S#:.=/:!)UU:&=>V-H$@"YH8HK40<?6T/.O
M\ VRVR0'[+W]!?HC5X,N>H9JV1R@!<98)YA)J::(C&5FW=BG9/O^%%X/_T9[
M?6<O L10Z>  J"+L(K'9_313;*@ANV1^[NB2V(25;$M[!VT[+33T+ME^WV#0
M/1_9X683>[[3-4?+6][M+4=W-3!".(!+P$@\+>LS_O=>?,T&L*3J:NJI/@V3
M=\%T%84/&ERO!A<8+::#IB9YU7FF6RT42\O" BO"8+?*+8TQ&05N;8,,7%Q$
M;'W="@=@. @'C76U+>M]"@J-<=.QJB48#((2>L,.V'\7GK&'+AOUD_3O;N?E
M,=.^+< 7%EB/<>C/0DX<0*?[+P[@>-'N/@\.X*5\S9]_R+3./@M?XIKPHQ/D
M"=9AHZ,<0)?C)6X-CD+(+DQ]#J#P4"><8?X#SGSLT<2TLH3MZ'#U@BY?Q@$,
MV/9R /&*7#,!E6ABG]K$_]Y&Y^1L'VSG "Y8>G$ !T+GF#=25_C"V'_D]K*/
MKN,9W>C20*8*/!:^>8*AP@$<<>?A )XJ<@!<^5IF1X$.H,DJA>B- R"ZGC;D
MQ^P(!T#,Q7( >L9LV5>I+"G_.4;B, ?P?8KM 9^4^,7:HYW*%)E#TQ,@?ZE/
M(9Y6%2&-_OQD'L>4"P:S+Q2Q17 $W X_2H0K[=717!P)HXE?1SF HC 8USGY
M8Y@+0$9Z F3S7@6: N;.(AB?WP_1UQ%SF_O'(33'<"Y/*++?3>!_'*E$SU?O
M<HVLXT[,GQ^(_V-54QD.^&/X'Q=ICFS!5C$.X(0UUZ-FV+*35R%,LW+TSTP(
MQ9P;[5!/%0<0UPYFAV/>BS$E"WE).JNN] CW&TI:STH8!RJ*;?SC2(_,J91#
MA&&O^#6BBNKCB!MIV7<?YU6/W8 <CCCU(W>T T*OK_'=J:PQH[2'4],-]>G4
M-)!=Z\W@D*B*(B7>RN**O8=E)3@ 2P9;F@F)RHY]UW$L/H[D N']D9;>?M=\
M,M+T@J[!/6M,S-RQ>%G&H<[+!69&HI]K8=RZ7L"E]4=D;&FPM2C58 [ 9G$,
M99EUM\=I@P-87>R\CA]K?9BE[7P#7?MUF16T>VGM19'%9)B*DOWWMHA^S1WE
MX8_-IZ.:M>GMYBK1=7>4/HE>KST:A)P@CFE\2$DDH/V[/<>!NWIRU@X5JZR&
M+W[W7?YM (6[_R7?C+G_3ZKZ[XH'^I=^N_:_V^U_EL+LP].@+!UK;D[GBS!U
M(M\*L;.3S@0*7.QY]7J50GU#G$X7!R!]ZF&3F$ O;]A7[V2=9O#I8K^<$-L%
M#H!F8ZAIBV>UH1$\_=+Z[.UA=(H1!*E>I5I])^ U;'6YLT.<'$])NW_X2PKA
M1-)7QQT)+ $36Z.+9!Z9GYQYZ CC^1&W].BFQF2D[J86=R0G4VM":: GTL_2
M/\Z*?9YZ5E!<4R.;\24C][=3N.*2<<I9 Q]V\4B@0)>3ARA[@#U7FBDJ9DCT
M0;OO3&S;?_U&!SGLX-^8*\M,D)K43;;J=A2',7L]FQ58R/)L4-)9E#.KA(T;
MN1,H\M2S%ES*<MQU&+KFA*YD>4TW*4"\5VQ2Z]$+Y+\D'G>?X4Z?V$YBJ)#7
M^9&NY- X%)3,)TDD556WET%]R);*VSM\$?U71NMY(/R^+CVXE_X2O=$-R^Z2
M3F-:T^&!!!V2:1E?%>OCO1G<,TMT\=R_@//P8YJ+#V,_*AJ<@Q!4177XE$;*
M5(W $*=<P7REG\,O2EQ/E5E^R&/]T!&EJC0$+XBCUGA^!,#5JFN<T0E.S&/R
M9\JL=)- P#;M$*O*A\J=]D48V](B&YD52G%FNF-=DC?P9]PPWA].&C&)[13=
M0:<:7$]#Z3\^07O63&M,1FV_FH,^(9""=RJ;9J5:7A!_[<@_#@@H9(3:T"_G
M]A21/YV:E=:YU#JRRF_B9"3+>@GQPQWW[9#Z;&!+A4@B2*%13&>Q%"VA,M_Q
MGTL.$8J-$]HPP:DE#01ZDNJ"3[2::/CD8S^B-0.]]G:X?KK=YO?*[>MBQQK8
MZ?_OS2E" )4X6!ZMJ0(>KKWB$+5@H^V5ZUGDH)E7(YA'M;Y+R?/6NT&WR;!Q
M&Q1P?0[Q'0U;V+08^&YEYT.5"5>V3?+4M_E0HYY7>)A,/?P!&/?[9J&4O.C9
MUCLJ0&@6[M8++J&$S9%ZMRM&&S "RSFS)]IT/'1RQ1A/#N;0)CK9$K6,6.'[
MRYIF =07,%ZDL6DBD?[E"_*)4T>!NY/;S+FJ$-'F)IXJ/Y)'H?<4LFA[A57'
M-*'B1)!+_3V/N!$LT"W'L6=IWV,,3I:0D'"3IE&F207RE6L R.+M9]S^4$0%
M(C=OF)&R9H$368+X9S4$/&!]X4[XQH%_PQ[_U/G?T69K4IE4/:3>TP_7"K=\
M?][*5!"YM.F"7?G^U.J%M=,C_JB2(U;YREH_;,O,H^SWO8:81,@FR1UFC!#/
M)BVS;EGIV2,M)UA;2V%7?&BE>25Q.)M[R5>Z2ES&5$:Q#FT+7,'*,XK?M6:/
M&TF-JS:P)'L]SM2-:ZV::2=*4LG)\DL6EBY@'H9%YU/_NW+?8ZM/)EZKI\W]
MP01AG=V+;X1IOG2:F38(?85X_BIQNX!563C4  )BB2#I?+#]\(H6HK1D2'5-
MO?#-R(K\\*7%1YD[4KD%\2&EOC\_O5HFI20^]"Q%9IBDU2='+-N,=$WC=HS^
M!9)U6%^T3C=WVZ#%GLK$AZY;:':U@+VU]1\$QDIZ#/A9'='*S%J99=)WY'W2
M4F51-P>IP-FPF@]T<TC'$ZS#XKU3,-+%9LOZZ90<%U?F0,0IY"X5W)V8>!X7
ME\.6IYOT8,H8O<YUZ;],^!]*8(A X3G&1(].7*-^P"MQ[77AI9R=[L_>OM3F
MEN#&*VIC)^&Z_RTZX5@2NW-]I,LZ!L1#;A3CNY3KG\\+$=#7NO[B[;42B]-1
MIUZ,;72[+VT9M$$_]SBUCA!O,"U[;M2(J"XY$N]2<"X!*NJ/&H*F!APL2SXI
M>+_ZS!;'S\>*.N8Z,H41\ZS9,I^0UR[@V [E(G=_T1%GUUAT]"SX<$Q89L*)
M-:2)6DLJ0 BNRB5"$ZUVJ]WM159E]4K]S*6-82IUO5OI1&M];4M+8\$Y>@HN
M-@9Y UEL/)4V&3:Q<Q)*^TY>N2H#WHL\IR.^ATKKB4O:<_P$E^0U= TVE"3)
MO83>6_]!\Y/_%\V7/)M,-ULSZ\/E%&UB\F4,/NK.L2RP"JEDU;IH?!VZZ766
M7(Z/[I>Y9;P+^\.=.TT3AK%CK"@[$8C?ZLV%/E %;M.^Q)7 ;'J,GGB4E@+O
M$<>*J@[N[GV1Y?C\ZS.I_'D/H5U[1665 UO1<=L;02&&.36I8 -\/^$OH@K]
MBT?!C^K\C4'X:]4ZWK(5Y+$L21*:D6''M2%*=#Q=3AC]@^K ]2D>.1R T>#&
MQC]6W_JO(K/%]\]FYY_H\!].4403,[E$4)3LR@$(/((S=R']_?^6<%(9>;F8
MS4 _#H!B:<OM^D*N$;*&LE.T YDFB^B?W)D.#/X'[P;Z!\_% 5R;^U<("T*Y
M[X\>:N?:N'AM&/M^+-/,!+2C.X:GBY5P (-US+9_G&6%_]%UJ;",T?_L=?Y&
M6>/[N+;'=!O#EAV#_/X ^FMAR%3V87OOAR7H3F.VY,Q2=HZ+=RD-361\&B@,
MU,YJ3H?M62X\_;/:1O%7"UGHP;?.=[K:M-C5PF+_"73#^BHTR*]D2<=AA/UY
M3D(V\ANI9XDRBYRF0.+-^WAI1+J%Y#&'*S-IL<I$J8D=@U[:,GG3ZC^Z0D&<
MT$M.%I#R>1+CRF\*=9- H'08#U8^LO?27#4%/WXB!_ ]?Y:73N0VA4&ZE=DR
M7"%VQ]JNL%<<)\X!E-E]_6DDUL= [)[?C7AEYV";^TT/,V'4P,J<@<)WC2=W
M@9XBL*DP&,(HPHD5H?"CQ$+@W4/8?C1.Y$1MA\I <_XM^!)+3W]=]X/&E[+Y
MC@I6>99V+'M@FSTW_6ETNV-PRCBC +Y _3<-.LY_<;J__]9/XS?W_:_BI_^7
M&73HW(EZOU!=VS ^D+5WV;Z^940-2@#&GV5AK2-=CQOT#J\^,)5OO5*D<6Y<
M^7'B&8<3_)70[XZKR45+OR -V%6=>X$E_K:=D-4]] 0GGYB>):=;";"X@M.^
M"S%.%-^%A,LGJ>GG;J8=;=54V8L>/@B)A0,+ ^A(L<X:W?V'4@D2I\X!]]]Q
MY;\+W>]3L*7 /&&T_RNW+")DU0(S;@A!T*\[F$W]W[PZPY'5DBE!!5JI!X9?
M?&+XR)(G<BR,*D1BG<]Y/J..J]THRFJRILA IO2/18G(6>3;O<"H1O2+;-H5
M)LRKYD3*]6P52F$2@F;EG#.1$9DE<0]GW;,7U@_2:C_9%+_I5[>W#_&X4U$^
MOWC1.!>^,,9Z7,T!?!;C\D=GR'<.0)R+(JXQ>JG.Q5GD\B!;$[[$+>IAX&/(
M#W-:#ELH%\(!G!SZIRL3X]S<4] _9LEXNCR1 _CY[,^N2 *SI&[#V*<8:'8X
MZ-]UU-"?C1'_9YFY;41\(<2%[/4_(=OU9W=PCZ: 8[EX&F*[<_&TSMH3$L@4
M\T#3<[EXFMO9NS3'4&_CXDF;_0I/^X,AQ(["'4&3];APWY &_=,%NIXN9D>G
M.9!I5@-A?OL?+"#V2_P\*=^(W=L-;ZAIKVFK$T2&SJ]GWZG"-@D&C+)/K1WV
MOLSK>/ID4%+2Q);"/YTZ7IU#7MUG[#=W^?-FN/3:9<1]DL=S;VQ#%]&-6-=0
MS/_\LJD9[XU+G3PM;G=N,WWBX&;ES+#.J8DCL">*WO<&E,A^;2A-$J//DUV1
MVDFM?C/2?X9>,4 K^#!0KV=O%=8DX[@]*\42?<,&W7L-[>&G^O^NK'5I;JT
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M2>RK_(R33F*O',5_A>@N"DY=U<9'#A-$FL+976VU&&&>V 36DL8Z$?T&[+8
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M/U+$O?+&%A_EYI6"W=3,U?;#3W6S+K'O?1!YO?A&ZXI_J<^9$Y<3BD4M BF
M:.T2).^O$#_".1H&&#[LZRJEO"0 ^1B;J.-? J9>0>9J!ON6?,?Q8>>H@V\
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M,KR#N&-@WXXK3I2;5XT?%626/6>F1*'W\XZ"9B*"%H G-7O"WQG Q[<<PYT
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MG"&QU"APK"^5 (^0G,!F,^_$OL4>\YT&>CIF$H#=G;7"++]#XW99F,5NP'*
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MU$V@\?NO -]KKMTLU2.1 TMY P ZPQ)MMM)QL_A;VG$3,>-JV?(4=7%_<<N
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M?ZOU\$IVP$G>,1G*;T"_NTIRPLD<>:L=2UU.'_V)@A8?IH@R4"1LH&3+*>P
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M4KVL(C^\/G-A[BJH75-3FUI)/F/^$/3VD"BW2_OK<E4OWIQ?39/C:8,7"0?
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M#_ ^9._+QVK8:+WUM. "Y#_\6+K?.4UN/;^&)H'_#=Q5$U&,"^R=/=R>WZ/
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M%>*6%X(<"R]/J8PXH'&SP8.>Z9'&FSR97+9?-_G7*<BZDZR(=RF#[@ZQ!0\
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M&O--$=?_FV<2K=%VM2=(NX?*F3YT^8!+IS;1#[5W&J_%S\3_VOKEH2[*CW0
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M<<?F6V?!Z$L_^]MQ7I\IK)];$XER$*M.K;8=#&.B&B<2?Q'"QKQ2"E&L9PC
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MMIWW(4UT9E+&Y [)3[YQ=C'5[,MZ\5_U09[Q5 KBE2><7#7.5>7UMG#(#))
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M0<0A;&]%5EUB##;GK:W-IWW7^6[CU:GT;Z\+G)JE&9:)T,SJB#YG<SK(=*1
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M?&XIL(_#WLTMQWS4%Z3QG58(S]B*8Y\G*/LAR'^7_2P$R.J0XH-&S5@XGHQ
M7OT:]=/;8^H7%Z\*M$=AIEP:! 7T>'C0%MP]@.F\)PBKM&\=P0<=-MF+ YQC
MHV'<PSQG.T&^!36?F#I7Y-H^QI/U,<P;]9UJ[.N</14>$',LS$)QMC9GN2WC
M'V9)X"@JW:9V2%/HH/+>W7K,[678QB$J'\02F>:#LD;^=U>AOZ'""*!2$T
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MQQ>.9XD&15FR RZW<T/+58H<EP[,VMS+L.ZOM#D3I!5CJ''J94M_N=3$-<Z
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MFB4I'1UUPD%2^LZ)BRKW8:/XU5]\T/YEM#6;#Z+ #@/#"P%]7K"D!'6V[M.
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M9?]'>U?^U53:I*.MH@+B!@@(:=E4,"#(HFSY7!%B0$!9A8B(&")$1"1 3%I
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MC_'WEBU,#TEH)'R.\%,W"R$2E$A!?^$OC%/,PY2IB^FRE%_T*']B*H#-95/
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M+?^+6HD0M;:LKO6U>P:LSD.!)LKF<UNONL3]3I^DV<Y)O1/#YN7N)G\T\B1
M.ZC""-Q7GWW! 7YY"MI!%[;+ =-_XO?Y;,+0,=#=>A)*P_96A/Q_ /*7IM\#
MOGG1X%4<?3@! Q;_E]S,W#2Q*8AZ/S#]["EET.J(/GO99)",955W$GF1>FN-
M%=A1\=T)IX62/Q[8X,D*>JR_&5N/\0+S+UR]CG>3JEH)J1/(?3Y61/DW=5-F
M^&,$J'XHMZ8#OR^3]7MV94RV)PU.)MHQT$O;C_^SY1)^,9$N29!E5'W4^;!8
ME#"P."RA ;%N@ O[D$.3X,(X0 )O_D?++611[=-_@+35E>GAU58HN-]&KZBU
MRZV],B%MF,JU.* ="+S>=2ER)X+QN:Q-]U[\3^:MC9RL9&Z[!_3<9H$1FVNG
M]K_T-KL92ELH-5XP/)0PI8Y?*MEU-E'^[,@UW[:1GT$![!"L2AZKZR6U"W7E
M P<XFS0R_GL#);%<#^16YAA!"BD'A;QC0RX](:YF.$5.O9?7+Z# [9_J@D*'
M-S?>WZX6:>PQ #P^H?^?!?6OJ;>'>-YM#QV8)D*[83NGE1U)6(*R6<AW@?R>
MH[XSHF*?IF3Q!R3'@]*1E/WCA%\^"4[E)T"-:&QL;#VAK!A3>"4?G44:[9J=
M??M?!;5QF@M3AOI*6CVDPR%LM/\%<C8:FGEIB!*]ZJ,LI W1@^V;0KXW!]+P
M8:0O)YN&=% =#_3XT5:MK6.:U:[&45];R0&/2.Z 5%6]#?WED0H7ID385W("
M^%03T_ ]US &J9)"ZBA*7#7^._(A?ZT17++9VEF;V;:7!]RUF=AF?C^AX0%G
M(<(AUN-C-I]DY-T[B?AH%M6S JU=#?]EN]],*US8&>NH@=^*! UV&1BN@G)O
M[O_P* /U.ZCH/-O45RZLNNQO!B^A,?3-!+WI& C:/E#R7WH$!>![D+Z2H@8R
MS3KR<)R-%'5KYKOW_^X5OV.MPJU_>05TF=]>D<C1QJ]V5OQGI]CY9OPH>.$_
MI B%8K?\)45>_C__%E<((O]#<O99#H6B\^>5=BAT)4&.W#)'(7QI_X(80;-^
MWG-EL^A]O]WB<>X_<?8=M,1!V?:S #,^>CK-%$W--T^;["/0//^_BG'3_TN"
MAC<]B7?3+* 9SP7= U] GA'QKW+VY?_Z;;JT_QR<!:&%4$GQ+_-S##QI/;F.
M1C%Y_YM-_3\<'8=0G8= GWUY4V\0B6R3S0P9_(K3NCE] A-X$;/;7>/U[VN>
MV+1S-*AOT_G76GR0OODX(@]/[\GO6"XEX#+_'6V_4?#MM[!LKAV;O?OX>Q6'
MU#81@R9F+Q5#>P#4.^"10JM:DR+AB_;Z7T."_[=#FO#'$%Z!^>U_P7<6L;S)
MJ-F_&,6<?H_ 3$PG__7P<:83^?OQ TM^;,O/GP^RF9D;H80(X$L+#CTJ"Y#1
M#,+& %M;?9>BW_G^^X4ST'%P=]&'S[;U+M==]NZ>S-SE+?<\KW#("9A4I2B<
MP'6D7C"654"[:59(H$=2.E>SF$:LF^!G$H*-\AG/?D HCVQ$QF8IE76]K],-
M(&,BL_>Q%2FC=TGG2VI*2VK[9(GGC V7EN05^M;,B5[>&#OXT1/XHM<! F=V
M;-@=N>_S8SP\J^Z.7JBG*S(HJPX&PX_#08%[D,V^#M7Y",L>-*>(_L&+CB+P
M^;R MQ%^\/;/KM]&<H#X4.>6=6FU '5\BGF+EL6MIA><LIC8)_FB\E('<SW\
M[@8T3/TZL,?-7*TCWWG*^ KCO2G#H#)-IA)C/PL\-M45'I?\8:HK!&M<ZR2R
MD2W]ZRQ('W\@EI+P._>0:!T(@0AM EF'6=8*O/R#-;\"Y1\N# DP-7A ,V4R
MG*6<&$':R ZVQ=?2J*!AG2+G/I6P$I4MVHY<0E&0<PJ)X B@86&J"^AE1S\2
M,LTZRR3:G5OM(AFO]*-T/C+N#7=6/=]./&,W<@GG\>9,Z>DICW>>%N'#O-L.
M(1QN>[ ZF1AHCNL0=M2#I:"O@6Q13B'@GCC8T615H]O9A(Z4/,)\1,VO@,>F
M%W$F"90,N9WI2XZ(YM#CJ13;50F3GP>DB.6]T0?6=CK'!1,:_:>/MBW*(GY5
M\1[F"9\XO8WG!944'N?S'=F-,X9$[,8HQ-15VLD.QE M<8X+<S5HV!%\ ! ?
M=0\8JG^4/M+NFJL2T;:HZ]+SVK> _TZA]UWOH\>^7HUA][=XFAQ[>$?M!SZQ
M65_PF;*:R^I)\[8/'X9,G;[?OI/ONG#!9&3:T:F/E<#?3)[I^>9BEHJ.FOAX
M(O_F7O,XNR=E>5,'9$RXL(-V@V[5ZT>X,'Y>4,!D]!$S@'S]O$2P' N5,CN*
MOC*DGR>%&)/0#54%OZ-+,7.]+%^@T;$"_0BQK1RQ=PALWL"W?,.@?Z B/;4L
MWPY?I!&;P8/$"A5:K7OHT0BJ#8W97V&#OQIC[#Z]:GYC.?:<99#;84Y:(KF*
M+?[E.X%NP11C?]GUF8J)N7;I$_G3AVU'%B[R)%@D" 03N+ =K-#^*^SCG _@
MZ=!V-'^PU&L/]#;"K<08]-Y@+S+I@%'^C,>[6SH'F!ZX&8;3SLIN^:P#4CVG
M_ 5@T\M.J/QOPC,OK5V3?E[5>B=_CZF%BU*J=MT8M!:\N.,IKD7X1G%YOHF)
MLM*S4%>5D@$O!Y$JXZ#/7K_Z<B-;J:67CUW3"A,+UM.X\_".N)OAG8>"\1KO
M=;ZQU+\=-ZBO?COO.]W)/+GX$<.4 :"9D1'[P4_9?,CKF7?[&9ETU? Z9=$F
MC"16JA&QWY\DP!1UI+='>:[4RUGU!SO5K/3UKUF) )B>-R6]]F95?(=\1H_R
MJ6VD42/GE"'D02H2Y@%^0PAX@]K@%RC4M<D11(<&L!A;NDC&:R:UW4F'+AIU
MRH^GB!G>8C?Q/?K=-(UYLPU6=FG9+<E-I*\D\'3[P<]"3\X"X[D S0$=AR@1
MG>]X'?I%<C=3!EJ5VD+%:[L;]KA7Z9R$SED=15HITJ6LLIJO5!C)\1^8=TY$
M12C)E(_=B%L L#'WJ;\6F?(DMA"J#5J^T^8F:&.+C< >+25J .>-*WVJ6> V
M-M:V9V65UI>=%ZQ66^]E;R0BTB\ ^.^N^AKM=:?X(^6T[5-UJ8D\%+(0%7DZ
MP6;1)<,ZTQ^"VT""9\B[C*?OQ[;K[7N1(U9]PG#^_=WT-?>+QU":+3)AOE\P
M!KXN?H0!EYM/I?CO4-5QQ\_W/*G/+2PM V\W:/]"T"ZM ^.IQ<Q",J(I]0?2
M4\"\>4CG52XS"HNAHC-< 8 RG"]3F6W?^UZ6)IW42&Z+:+-=,W [H8N56) ^
M8[U,)9/XF6EMXN_N(1YJ*5,4A3W,YT^[A4IVK<J[7@GY5H+\L?+A9NKQ=#.I
M&+>F0IVM)=YR+&].[H$B+FR\?S'RIOZ-O6 G@O=KO"0IY6C_NRBUYJTY[A.W
MF^^KO+A>K\I )Y(!]KX.<&?K&[#O'J*)(]L*'*SS@ ;0+'F.;LQX=<A*@Q ;
M[$7?O\#GA]@]DR43T3=E44I#1Q[]$%]4/GO[\X2=9I0(8QZ'+N[ OGUKG48)
M>:B$G6L6;'GVHFI+6+LS+M; _$6.6U^^$(V)+9+:Z3BF\"WO,R&C_<;I=BIM
M.=^<]T'C-68 ?T([ZU3#H1%BF%>KW F+6HR]JO3[BA+V:>PP.:T%'Y%V>I"M
MQPRDHK:,CL .A[=)'NC3TO&.%?B4NNRN4GQ1ZX$>)5H*52YB.4X5;0+WT]'Q
MJVI^R!U8YQ8G^3X7M(JV5+.X2DX1Z>GW;7BOMXWGDEIK)V)L&86GF]*\X:N%
M=#C(W\L2#QTD%4\E-NP+'<GF\?=GME,T%?>[V>E'A$K<TF])/Y:1QWEB34.U
M8/BQ^):S;D^PSE:E/=L+T8-%0TXMUZHKEA7F%-[$EP#C#[FP"G@4* Q^)>P-
ME0S]0J*ALF,!">0MHWI4BZBD-'/=$]S]HT'4?>Q(_>TQ/EI5?'#@NQD5\<A(
M/R]>(Y%$G7C<Q> R Z\@OR29KY,^*\K,'+5F%YLZJ[.1SN&MU^A"M+54C7-+
M;,.\^?F^,[YQV:7=9J:& 09M^PVMZ-,_U5V"VWGU(MQ..8D*7K ,/!+VM&3F
M2GB:S.4SB:<<BA8:/.QMU59!^SH?6@!EJEG,ZWV#=+ <,W)<TR-:JS"(((:]
MZ/AC[LT3W2^E8T[#[2[/]:RDY HU'Q?P'[+F=;X6DC\V/#WD&/&JP-T:-3$X
M7>.8\CTG;U1-ZH2'BXMPZ]=WU0?K/J!O-5Z[+P#DB48&2[$N@C\@7DZUDK9#
M%JK7L(=]$ )8 EN7C(Y2Z1^#TTP*1>/9)S"OVU^..6 #;-VFP*XP8DNZ[KCH
M:8?IM0!C+W\W3)#;.7.E:$ 4.7Z?5$9JQ _6,H29H]!F)$ ''LH'F].WMDU1
MX\&D0I*M[>BLTT%F(.TT,_QR]8\ZF4!_1OZY>J.6H8CP0I6<O+:^?NOKE*&V
M\8K<O/V!SX"]/4ML[Z.5:$/LB(@F[X-71KSQ_K^<IV)C?>ZT&9[T/FFX[*XX
M:C8Q6/&+HG;&M/5:SFY[&_'RDY23/6U7J9&%#W)UU;\K/3SH;:+DIEL_9.8.
M9="VJ5A0(/@J,^2MG8>.!M.<+MHXI#MWBW&O/3I8YOVO#8<2]2^7,0I>1ZMB
M5&3TUH?.=AZ0%0YW&0<.N=^[R PWIEG'*=9I)!G?WN!$1JS&CNX1.U55L4J<
MZ>M+=&4$G1>*]Y4RE KO>&SRN>0^V-@ )>/&#G396EOG%K8K#3T_RT+:3H_M
M[_=JK0ICRXQ_.[-&$<FF GL\D%X1:\U.QRKZKE>4$RM"SA#G1/?-"BB7GS'"
M+MGS&\QUVS'@3-4<1CP31<\A+\Z'LP3<*C?JLG>RD53$(2QAO/UAL(]\!O8!
MP940VY^>E?D.:VT1UFT?:_M^)42/$A3O5:2@X/4PZ^0C$7WKL7L^6O99$Q].
M6<F>)N>1<QZT=!6=:#]P\IF^OK#9Z7RS>!M9C;(W;R<^2[]2G"KUG,AIKM91
M// P)VVJ]Z21H-X[LO$X)2-_I^$5W+&?3T/>],L_S3!<BQD #_O%B]K2A7]J
M8"+]')V=")G2Z0*J%XD*%2$F-J_,EKY)9+XQ-^DZ&=::=.G*'Z>V?-.TZ5+N
MW#/6D$81$+3XH6SS1%V:Z%]_9LV L"3#A5F?'42W"GUZ@TAI\E+[4F;-V,S.
M>SCW_3&#_8PN3AT[D,J2C8$/$EON3<U-C<=[;VS!N/IA5H^S+2D2[KVYNQXW
M<F$[0W#AKF4-L>X=.(\J3<?KJ7\ SSN9)X!Y3<5Y@.43^@-]R&M1NH;6EDNU
M)^S&;I>(L@E%8(]G[V;J4A\^.9)AVKW"K# :V#(L\W/Y\IWO;?7!9='(BK(O
MZ]Z"<+'QT]A=ED"YU+&ID\]:Q>GAB7*1]0<<QX)'U?VK)YWOG' 9=#GD&/QG
M;EPKM?":)%^AW@LW==ESPV9KA^R'TXR6G::::,,CHYT85U?!SL! +:O*VWJY
M/[-F*']&C GI6@>XR22)[DH8&9?;#ZTC%Z U/@/<*<KBLP&_(/F#E>D=XSOB
M*9A$N[2F67WF(_J>J19)E?+^=UK^%$?U"CE&65AS2^60-(:L.:][KDAF^!*_
M_/M$-YG5NJ5R"FH" >[T9QU'#-6"NP1H640;(K0"-4/)88%T2,M/4DD^HW5\
M<.XG+?,A_N@SG*-Y6YJX<,6WN.<L[V?I;RU32<J<Y.![S&;63<A'+0F#0<U(
M>.CVX&MTT;D@7+!6/_L /:!] QZQN!"\:TR6B?/'^+H5.8WE\,N6,4/\R8F\
M]6TXZ6LK'?+FK2+TRL%CHW0V\,)9)K'9Y<#-JS2SYBOY+ZS0]ECTO4S-BWN*
MU/3,WKTZ6?QZ)-/ X&)J=WE#1OB=.:UB[ LBXM'&A):NS40/X>[,N1QEXYZ)
MB90<$<IZ=[E5@7T%&("6! 68A8P YBC=?CP@_BHV&$4K;'<Z2@M]W2H=H=GU
MQOV,G>U,G\_G\&/9[]SRO?*GB33O(L74\>Q:A[6P!N%@%#/E5#%;C>E+Q4O4
M%]:8:"'((9B6?1?&>8X:JV2ZR-?Y'K/XO"_[JWF8M9@RYP3$]DXNK-2.K<-Y
M"1X ^[(DB-*QS0B)<W_25%N,:M5N/V;KTF1*%9X#ODI-L?A]3.E65U?W/7V2
M^^L^>);@I^48 "TR>@7-/#8UQ_& X-Y<S\D*UBQT"M9F D4V,\!^OQ /6QHZ
M2C:CF4'$#J'V&XP'1?F[-1Q&SV;?JNK%5/#]]#"VQ!RNLWE=&2/&.60M8<37
MO'Y,(W5_ED*EZTZRJUD1VD4O_MZ9.)\]%9?:0K_++TMS^EZ/,&+5\FZ'%65,
M/@]QL"C^$'PH-QXGUFAB'F_B;2VF*GI\IMS:A&&LBE]_BRUK##U+$\E7>$3%
M[V1F--I]B9#/999=Z#DG]VZ/ 5^>_?#GVX-2'*-/US]]5]\!J=(6*BDJ/7Q:
M<@L-&<OVRC]\\5@F&05WOS?R(^+ UAM$K\E+EU^Z:#&6)4)=+GX#KI-H#HNQ
MT'YZD27LEL7'*2",9UFK.*E6A(A<0KJCMC()36,*3!<:J^UN^KM;50V('K_*
M'JUK9 Z\E=&A\EPU,MAE1R(C/.\SOW2GFW->=A>"*8T*7YE%,:4#FN4Z!YRF
MQL%'=&)+EGA#-1T1 QYV2ZMI2$&V1FD9Y.D7Z=,-X;N->*-=/0X*LQ02G:?^
M[*NYG'Z#47)*=;_6>X($Y=9/-<]^EL(N?Y_5.[^^)ZA;=>3,)4\4T/UZ#9.L
M>D\TG5GS3K8Z+RGXREJCQ:6KK>]VX]7\ZR]$G*IG@AQ=35[('C_Q;?[-B#TQ
M?;J,O5;G1>NGH)KM?Y4O1F7#V:[CFM/$KQ&DUC'QWG+>9TCV$DBL>'3CSG-/
M?3DET\QGPH]>W])8BZZP\5/<?4NC*JJBL+30*_>6A@L#G_?]^ZSX7"F1_*'Z
MZO>9!^SBC&=;-Q\OWB70S#MC@8H*_!P?'?X144E@"U(-F+TAQR(I!T/0U/:/
MB2*_T@E-7-A6AXNBS\E<6$RZ4W2>07ZP&4WF>_0=KP4,I(!IEX&RHKKTE/FB
MT=$7CJ+L?1<9-RHYSY#CSU0(%? F5'AZ0"MIB$A%AK%-Z5O;C7L6RHOX[?IO
MA%OTK  [V.HE=/^-2PV2M'+:]!4/U3'S/_OWS_@>?)KEX7$E%CRZ+?_&<GO_
M1].$(Y2<L%<HON<% Y[&MKE@EU5-7=X%Q*$)M0ON<EE*$V47R=++EZ[F4]PU
M]C<;"5I5RL%^73_](\S;XE:WE67!EY'BF#N)YZKM@Y!D>%OV'IW#;)7:1!24
MG10/8,4W="]NKXIEJ[Z[)=,276^EVB/_RB@M:8N_15*4R>4@#]$_:""!4F0F
M@6@:0_0%&Q6-"GLX(O[HQJ]F3%V>.Y5ZST]4L-BUZ>=+QY;=X>AI>;)B!!H!
MY?A77%C)6ALJ'&HS>E"S,9M/"Y-IU]EH+2G6OT(0&S+I'U(>[8QD8\8[/DPV
M]&K)41)WSQ@(Q\\$4N>_=(G]3!V:G!Q$:B/'A_"1"/Y@>99::'<'>8 MJCCO
M1<Z.)^QE;Z=J6UM51E!;-/1BR1_T4L:W!'A'LIQ1M$RP<$=90)#'VXI2M(%@
MZ^V;M94QNL^843FI-VVJ)XJQ(Z7O19[DAK=^:1 A]+E^*E'V*8G-R-U176"4
MPK ?]5#@;T#R129<.TXN.>=BI=1ZE1S9$A3MJY>I<"/7WH*\H__L73?W;+HI
M-%.2&'APL!6@\Y*1+>AMT]T/]Z&QN"9Q1I++Q(?]TJ\9:ZBP,;5GQ?R3ACQG
MM\->[!H_Y<>Y:--013P7C[S26R$W*"*GK6I44M-3P9]_<)M,?4J<N<-7G^]'
MXROQLCSI7)@^,H8@#(R_1N\)W1%\DS8U'\3:&WR&4U4G#USS]_*0G2,4V=K>
M&B(\?.^) WO+Z>BFQ>C^M- SJ1OM?-J9BQ&>%0'Q.4_&]=U\A,N0U$ZV^#*9
M,+AFR<QG7<4^@4SMWK$D>JTN?4]"]J[@LQ3;PSULZW'\P[3DV3/N?1J[:^+X
M@QC?I"Q%=!!]JT&WBBID+_TIJNDU\428R-]N.97L>B#3H5(PR_'4N>EW>S1G
M+6[2S\1PJ :6.2;R0X4I:DNM'4FC*M6SMS/%;MHZ[5!;SYO<WW*>$[1]U8XP
M1T]VWXMZ\N9G6K6P8M"?\P' 1% +::N.&E91'[T7BFS]K4C^6RCQK^E]U>.H
MO3;3'F*>F-0%+^7#%G*19QU.)RBO9][__)[G JT_NLY2JZ]!E+88I:7K[R4^
MXC",#=)OZ%NX6OEXWG8JT20".,K'MU7]T,FSATYT"H-I3L>8\5  5V*:(MM<
MF;6L,VQQ3JG.7O3@[!TL[WE.EG\&>A=V2$#2H_!I>+,3DA;0.J][BGW3V\_V
M:"6!"WMHJ9!;6[>\7^"D1Z 8CHQG'RP,>>..I)F2F,<GN+#(4&%W]-;RH,5M
MOP*LD-LK<%G&]N2@#OI9TZ!.WAEY+1%BNT):GO:/A*XB^>ZF/AO/5_%%X]'#
MIQ0EK\M-V+YUME?(,0N\<;OW>O'S%%H%-2I_5VCG@9UZ:GG?$[5[<+P[^J62
MG[C-QI!WG?/=7;BM;%<'2\_FF6]=O:QHY,-<_[O3A,@_)S,\TD>*5-D9MY!\
M.O+8M^WV/>RS- )%A/ 6Z_F-4P_D,,^B>^3];L;7U4:M\F>$J%-B[.]>*5-P
M',>DZ@JT7J%AFA.C2'L7%=]I\8S#Q9E#:Y=CW)3E,/Q,M$W?PKG5"@&9#G3%
MHW!.ZB48Y@S?E]'W9R>N$W[PDGG9PJ74%B3-&BT.N;U:L!3-O#%+D*E++ER4
M^"4JJ=3]S V4Z0%EF4%&Y73),KQ*,FYX^%;[I3Z%Q=R*YZ10W+GB>DY/YZF(
MLYU@/T SS]X5^A%9M?B1-- YCIFCTTBH;@@A'4VA\DPNC!*BTT9J&GK$**([
M.X"-1'\)!0&1/GZ/>3?'G%YE 7N;P"'''..J*N-Y'YOW&IVR=FJZS>66]Y@'
M;EH(?I7EO_K*Q-)5_?/%-2_SQ)HGM<E&1M-WR)?Q Q:M^CKO\JZTZF^)\E",
M6XQY0374*KYC8NHO<[<OM1=MQ(5E5TP\8F0$JF3G#\R(.[URDVH,Q,U45JEH
M/"HON&VUU+W ;_],AO<-1KQLS_EKZ?/!"%H.!=<B9S1_\2-R-SN(:JQI'&.[
M*J#?K"/8[Y_!;W-$\^83CPXYU3*+Z ?P4O*8^NEWJH?@<SP@_S>6.).7:LT6
M4@3Y)EY.:RA71;(-6";8MT!$]O[5S/VC7OZ*^WXY(7H.]_QLJ,?>%W3O:Q /
M-R5Z5APPTP]3C7]A*$_E9ZFR3&8(%80YWW'T ]).Y/ASH,2ZF10]MOW'ZZ4Z
M>X\\9IDN33*2/,JKS])2^I4>\O3,H.,8$]>ZQ;6N@:[<$[ KN6IHP;E'\5B2
MW%M"U)4$09FBR(]F^7'?KJ$%HYJMV^MD=BDUJU\CJ2A2GB3'DU_7&%1\7;_T
MJI$P_SQ7X\-@5TYJS5Y<#"[<<L8*^[1BXWW/7':]3*C5>H[?>^"YUWSN0H:O
M#VXFU7K(A5-XSEHC--?%QQG@F5IPL'/4EQ@Y&[=P:2K.>_Q]J+FCS!04PZ/$
M_6H<ZQ?O!WNX^;[_>K5+_KV6+&7G1.\4GU"\9!K/8&#:A%3J <,AJ12#/^,K
M]E Y&4#C9Z 4"%LE#/:/$^8K$/?]()YF'SR7&"4)HZ%:#SH>(QE7U_?[X27L
MC$X4T_7P;T\.SZ8U\/6N3,N?XWCRX6HB:/;18(=PN6GH:Z#1F."M?1;D6V8=
M9$LS.<ZTVF:D("A7/K:'AFS"!IL+&;B1XU$M8X+1=><I4@7R=4.IV9@]:;BB
MHI_B%GU5]]*&#E<%AGZ1%5:BSO3^NF'VT46IG7I6?( M3>M5>I)S2MM=)<9B
M5M>N2+I SZG/S2C)::3#&L29YD9]S:>6++UZV/&+/-LN5'S[3M%NW>&&*I1>
M5NKDW;N&4^OMV'YR50L00;2W#]:EP>/JX/(K!C)QH8JT[_B7_+E^RU(>ZOYR
MEZYGQH K^E.&K5N.*DL@7R*8,HOL?3E0OIF_R))FW^3@&]1FLK12@I7(B3&G
M@Y68J-<##K=X[/K8BN.UHR@]NE5AD8-]1[Z'ALMDKDSMM+A>BIN0J%FC\.<>
M!\VA#E8CO9#2_A * 'DDV@5T-*(<W@J/U#@63S%*?)1UEFY<\:C8^ ^L*D6Q
M62!TIFG6@>:='[*74!S#F-7+.O[]>G7:Y8:LIDG]!#V\!;1SZ8'##2>8K5#<
MQV=01<K&O>"7>I&N\*W,YD8[IQ3<S-JR#?8M<;S_/K6A>[&"[V9I@O$91Q?Y
MHQ&,@[IU1I?+6I8T'DI:^;?9MDD=+YP[77BJ[9IO:\KU:6)KAV"H39/[WA?C
MZRFV>.<3MZ@'U/76B&6GR.]*LUR,AJ]/Q#=>/Q/P_(IODU[6DQ?Y)PSR??6?
MR&7*^&/?C%4AO^=8=_EGPV=4Q5%1Y^+1%WJ+'&+C%>V+:XF*9 .QS][+ ^A&
MC"^/]H?XI+@_+C^\]*:0QT+,F6<V>;$=D8I$YX;XLNZ"_: ,IY;@AA</[085
M:!'1X]H!;>+HARMN;,67,];WWC]W]1HGP >Q-[]C,14[O3 *QWJ.%HN:>T=;
M'7/>]>I2M_6Z4-:H[_?;(9?8OOW##7*KP<*>NIX2X@,%^YJOSUR[W3#T]&"^
MT(CH.6<%2[_,?M631+_$L#:S5_K"\;@+5<H[*>A2JS*/S*5EF:\YN1G6I=[]
M<T]-=?T.-:)SD#0#]/HE_;EU+@P=JL&%]0928MB3^"X\4QK'?B/+".+"\)V'
MN+"9.KIVX',2.WH9R=K2 DR7U<IQ84D)O&!3'A<V?9DIVY:]I,YL!MN^ 5R8
MB77*]\2:L8'V2I1R%[8?U$>) @.]%#A'P[%?0T.5S.;"-E9_70-&W8"P-##G
M#TH^VYH+\T&NS&7/J,0<+]R[^9NM?SZMVB/]7N&QB<WW^"_W=>"9L>=_V$U?
MN<2(+7+ONV?O^,:3_B[1O>JF?_R;^!M*41UYGGW:_B2X+Q?&+TC^P;N-?9%V
M&/U4!\66J5$_G+]M7[F2EA_OXS,>&F4I&LH%NK+'30N/OZ6DG<DU+:P.*K3'
MO'W4'>=J]4)Z_H %[H"J['97-5R@O'...T<!0/M ;E>(YB-WE7^SMN'4UCF^
M.9;KZGPG/B_X""TD#G&KMC+!]]"=42QC>Q*->3+787YWQQ/?+\QV4,"BN(;6
MD)_'/L2I,F]MD H[('B9J&5)ZS0JIGV;WWCE7]&SNK@;V^[80.R[L!<3;IQ)
MQ-X14O!@.(.[B! GZ$PHD6P7YV2 _,%GF)KT@Q]) JN)VYEX WI";@%VNNY*
M3<C",U#,46UP('O7@+MU]+WD2\?TLH0J=UZ"URI#6Q#-$& >ZVR!,Z4S\>V8
M6&2%[+S7>*;YQRQI6F6BBT*T<Q$V5I=I2[;X@5=8-2(=F+$>TTXVB2"UJ)[^
M-'0G5DXX*/8X;<T\2;@.>-!-&9E1X[M.Z"M8^IK?DWE27:M8J* M5ZW?YQ'R
MG=Z3";/8+EWU6SD!O@P^VJ0=77%7J;C%:<'<R,)3W\4^GPA"W\2=T+B33) R
M5M>4_3J1^P09AHD!>!ND@B68)53,@S%UVEPZIE5Q*[.!^C%],9*';Y1M['4O
M]6YE7UG$B0"/O,_*KXCOG:]-#8U>,'&H2?RE2JUB[R6.3S4C$M$T%&H0;\QY
MJ16(H?,PFI);B,%_U$*YZ-5,4C"RFZU-FV>;*?I)'':W"VQ@H:(]\>5[JP(>
MIU29*SW5,A+*$O-'\4!#-@#&ZX=$:FDSJCV@");(B/OAWR'@SN^5.M0?KK//
M[OV'L>/II.T-C>]'L=X#4@:1'ZH(56Y=(A?@LZ+S<'IYL#D7%IY!<$%LLW62
M&8NDB1HGDCE)X3O$E$-<R?B$8'-*T.'8*D&;F;19+ZVX SVXI[Q/\ZOFE^.6
MU1C/Q"U*A$^+O5/=33WK\/W%D1UY/38NJR?WF\<;R\9F&N353[QY\33092GP
M)D0R,;:NH9'@(WPV^<Y78>L3;0-NUA/XXS7>9]:>.HL>GZG/[8X?3O!:8XN7
MT3"7,J_V$C#9^Z>3/S5XJFQ$-@$[!KY>W_W%)48N.RKOZ[O!T:-OFQI+56\3
ME,$>),T3VG0BD#OK+.GZ#'].KF>#MKN3T \,VTCU ?OB> 9FA[N.5'=Y8>#[
MQ7GVD8)?D'1$K;#J[VK:2'KI#"T8J2U.QA==?SQ:7VX&%@&-UPGC\4 YFBV$
M9CQ@.M,#QM?:@$> 0)WV./!PZJ-&5B+UL];=FLS)@F#+0NS#&2LD+=9-_%%T
M*4OEE4"93$_T;=<8JX'K-]PW!!DF-+T'$"6N<,*TK*^QG$*)&ZJ)"^?XN3 A
M[+!Q A=F4U-%))^U>7=/L1D9(0Y$*_!&*1^OL!\^9=_(D,,F6_5ZWZ\*^Z)X
MFGT3$7NV!GN9L"^"DCXPUUWD?DXVJ6Z[W$FS@IQ<.[_N !06=WQYM&.4.#U#
M6T!K,..TO25SPYO,<F,+C<XEJ-0-N:>=R<"9Y1A_+LSK-&KKL,:O-Z7XN^Z_
MP%AJ6SQ47%.JM5]**'5,=TBE?+^<U"LU:U)O<_**[%PM2R'X!J<$/,MT'=?_
MB!=0C-;RIYS7)O)GY!++O7C.$[^:>4C*T$7R%1?*1Q&&$7\&NMZY^:'Z25_3
M=_5%[Z+QY&;_;WK:Z!9Q1OGC#,M>]OGW'J;#-:=5:.X;]9,YVU^4Y#R6%/K
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M8Y9F$WUS!?66S<*^#9.R\5=5Q73F1A\"@@/BNT:^FMX*\E596DP5,QNJB2C
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MKHL,:7.Z6CC;BL*1)<W,3L\NS<&]!DA!Y#0Y4P'"AV['R02?[7AT"FW$;L?
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MXB$W=$<=-;*>ZA40]F5.G(M!Y3K[2,\?8!GE65_].("L@(-JRS,JS[$BG-<
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MN?X^;M6.0:YH'RW5S7Q/*XY"??I*O<Y*X,9-7Y_7B\S#UKTWN&-QK,U0'U]
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M<KK=>@K$>OFOID\[A3TYNF?'([4ITV\[GUW>H=LP\65U@ $I]29CSA.N,FZ
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M#7RY*LVO-31!:/)S."^G4NRWI[Z9Y6!8ODQV263'X=J)Y3Q8+)</:#!&4G[
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M''(23D=9DBS? G13M2\6(X $MQ/)CSL<B*+9S0RR7.P=4_'A.(E*NE'G5]]
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MW;ON>M>]?X0%BS4[N_R>Y_<\>^_9V]6\ZNV7#TGC[M-_G#T;Z)74%U-0U3M
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M!AO7'G?_S- Q,Y<57T/Y%Q^\'S8ZO^[%WQL?':#?U(C1>H=9N)!Y&(/H 4'
M7=2MG"(,FLG9:-\%(#TLE=)Q^X3\@RL/'W^H<(?6GB1&&1K/8IH*D-UO24PH
MK3%]HH68F&4!<F,&]W0S[7'Y% !U_D?C_%:61@07>ODZK:_(W.?]%_);6<32
M1X8$Y>VP_N >M-A8JJ8R$0Y3>%/5H4[%!H@D)\M"V5I5G5BW?IKQV4Z)VQ)?
MTDQ;A18S9%&LCXF@J9:6>_G1P9D;N?G#/GOE8RY%EX:4[FAR>H<=1SWTO F(
M*R$,3B-:FC60#*QI%6#13AL4<$SF0,%@C_B2^%OW -2QOQ_!06C]?;?VPCN7
M&,9\GH@0=8G-;F9.&;FLLG!?$'/HAAE8.OZ7 #Q)A-8SQG\7($V"I01A8CI9
MRA7CHFOCXD,M!KCRIY"G'_A^I'%X%_B^JN#[\+H/%Z%D?%GN)R@^ISN_=]@T
M\'./E9V/-=]![Z?GY3+7@T3I\P0,0F ',#Z2D<5/9 1$\Z?R!6TI\H&F![+;
ML(. _*YL&A5D*R% &-[(G@OO B_BYX)7&;(B$:V.+/1<![XS,0"1U\64B/U=
M\ %QI)>85)><'=C-$0T:,0^/'/:O4UY6EA/\9S%)A*6HCH]A+YO%7&:KP_8\
MZEZ9P%-YU]X.9!^%+ET,157EH:TP$ AR]W:5U._4Z8PP^8N?PBH,='@:)QV[
MPEW".C+.-" /J%+39V4#^QQA,+&-#>['0>NX4?BE")?/32($<#\FBE'=)@/$
M!)2;K7XDDR1HKV!OPZ=%D2'-_<<WY&YX$ODB,+W]7NCO,&^2L7O@@@Q-Y="=
M^O2%PK31"7Z[!(#UHEJ\PL?)B@ 8I[P/.XN!**]JNH2P"!E@@(<G3( FM1?P
MGH0 V+4TT!<G"S5L>&>CQUI3TV=I%DEH33]RK2QC#RMN?TU?J%UV1($3Z5^Y
MTF8SSE LA2.4!6@OE+$KN/!RK,J(N[JZ((L(H+[0)MK^>)C,VCC\%,AZ**'S
M<6VT#=U33-O!H\0%%"OSRE>3?[7VE606^K">Y+7-F/+7999<Y;<9 >-M/U#E
MZ9WA?:=6HV!#S1.@8;FL\H16W L[K=CB$RN%DA*'64P^(<UR#ER#IO$Z9H1B
M-TQ2*0752ZIP^.= 7VO(2'$>2I0 49/Q/MUC1.BTC*&T<)(=9:BM652IB#"R
M6-0<'G;59,C"BA)<\^.$.AK;G+FSF$LXOHW\ H\@++#!X9!E$$,4S&XC#,YB
MQ$ K+B:9DE3YB&4% <PQVKJZ'NK)'..=)WO/C-;\*4"QQT_U,.TTB/)_!^RA
MK4>+LY_L!)#%1J C*@[ &O'!7+!"'!Y5KUY*70F-B1+-#07'P!&I)@B<7.83
MD*Z>D-BQI);V6L@,:']!"?&\??@?&<>XY0_SE&I!MQ<&B20(4X!RGG01Z(8L
M5O'C7U"5C"ARBX<U09[\#C0J)"Z##62TE_R3H\#227.;(_W!Y"J')6>^>Z31
M7(LZU/\B2Z_DS/UJOW97RIK?O.94'K&J%#8V$KOI0^X!5FZQ O H=F >96V;
MUR/OLV])))F_6-H DT3';[V56_5.*@A+#Q1F!'QZKW^T/@0I1"%TC%]I&].6
M5N@]:O,PD%\\$_G9]O(SJ]IA1[\"%_(:3U^7@/&B,%UFQP'[U/%_*EZL2,2T
M\$9J8!TZLFA*Q/VH(V*W.%B/M<WDM[D]()BP-D,,"5&*E?6T&(9Z7:V3F8GU
MX[>.I%KK+>VPO.46"UN=MY#[QU;>RTLU,KI1>\FNY.E&]6^M__M1P?\_/@:U
MG4/#C)R@M'[K'=_#J[W"IH;R,C +(O=]'^[W9(Z?[]C\NR9DS9Z,)QZA45ML
MZ2-^B.9KY0,4FP-D^45EGCU9X4.UX+$,:5V,2H$4=? 2]<3*B17 Q;?B#@9V
MZ&- O]<:@2#0]@%S9?^.[U$M_*%';X%-#UQO_.Y2<_GJK%R)XJE3'5Z9B867
M3XC)X[]!B5RE(V[ &E"13&T/U%D(W1V3/X9BP(IC798-Y(-0Y'--Z^%F45*F
M/+\DT,/=J7W:,'/J:VGDY4>I/?;6EJ\ON41Z?=^-MU4=HAM8"J&"=UP7)#2Q
M*P3C':H=C-2C*(?4$^;G#WY-%(]$7Z4>$"M#O9NU"L43!J1IFPO31)E)Z;5D
MG[-#@K,KF"V)I(#J_NVM2X"!]<OGQ(L4"J6+4]>4YDF7C/V]I9-)>,7QKGS*
ME[3#K-JJ6/&$:VI XH$M_3J=ZXO+][<:2[;DWM'T#OW_.#ZHMR7?R=*"&,6>
M0<@ZMJPJ=R@S8?2#12Q,*H4NO_,N[CZ[:%U%]U9AS:O:'66:6Q+>G=_XI'%A
M9'D9=7^KI7E@2D+YMYGL!2=./TXT>'.N.675_;N[YUT,_1O[E"#ZDZ8WB_E
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MXYHX9S_HM<0FJ2OV=!?OY.8W>^=M6W]H9%?IYV9$Z[*RP=Y S* SRE O.[^
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M_$:',YJJFFWM_K'?&QE2-#0ZXYNLV7=_G%SZ['X'>=ZC3OWOZN-Q:&G#RKO
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M?XEMNG#B=^5U?[1NGH->4#'PHYCR$?AQ.%FEX\G*!;1_U[M*9S%;BCZ@[C^
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M/NR.FW;_?^&.'/6..+0*9VQ12TE'&V*$5;X]H9K<^P^]2(;M\&BJ^9(2Z7S
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MS /2<(N>N1J4F#3OZ[_0/7YEI!:<RCZR)K;]"/UPQGB=-.?UH]V7L#/)BKT
M9S<>0_N PQ'.T^GA698\Q-B7UNAKRF@!%N)Q,"&-PR??KMI(:_;/.P-%M-B&
M]=,C(LC/1]VMMWD->$-7%4ZAU2VTD"LG7G!G2#-([1VH=1:C;@6%[.]6'2N@
M#WOGC!K>2!$'[T06[P2GF]T-VYY<FA_[3#V.7$70<,;_F>;>U4Z04QYU+TKM
MNWQF[<-U 1?F.B]J4Q8#E[C\)X"PF%'I+_5'^3] ^1*X[!,N+P=BA^>#-5*2
M8@TU\&[/B=Y*IHYSPOMVMU<]4Z0&(T_D7121?NCE$&E)K17RI. H.(NY,CA:
MTR_WDX\@B]7^W4QLAB)?JT&91D8VPFXRQAV&_"2D%*$9RXB3""J.@PFE\?9N
MHH'BW*H/\#'6VJZP_N %X67WC]9ZONSU](GV $6:U'Q%$!JZRVCJ2"^[<IQ8
M7<IA\^,DO/'=BE-#W_20E3+_5MQ =AO_X.UANYYQ\=WN;K+N*&];A5O!WOR]
MNLF"P.G:B"#M X'*0MTQKWUO?D?2)M!J-=_YG:3 (@.WWM>(!9 9C^.6R #=
MN+% F3JLZ]T,E)>V"!*(RZ@AX,&;ICV()9-]VVJ,NV@L[ZNQ(S&KPZNB=\IX
M9ZOAQ8=C-C?2"_K7I ]MF5KX0TS0 CCSJ&@:G?\W$3(EQU81/IYL0EG@2.E2
MJK%,D,3:(*!4G($$A? >AH007T^TB2\UIQ[(A7U\L,UIU3UG!U;0.G,&AC_Y
M[(!N%AN=KWGUX""2PQ8R<* +=D @Q\BP;6X)7N&M] 1<)2 U4.SA7IW%&! "
MN'Q<VRW_^_AUE ZWZG27Q.!ESJMBFX]4=J]-=WITZ'QE1%VKRYDIHXZ^ZA@/
M$59EIFL%:L7U-V6D%J#<22I1^*G8&;'_GF;(;F7<$50(6AVVMHNNLL-?&*7V
M^_=8,@\.1T@W!KF%VVKL)EM,#N&'NKEN/=(KSUUNN0.\J9DY[P!.%7L.:PT\
M!^1*!2*!#O6*,IFU*2!KHS*OQ/XBU12E%X6G3'";M13Z=:QGGLE.\%RB!RBG
M8^.8?<QQ]^:CY6G'8TD1Q__86F[#FYQLSGPRY]ZZB\)93 -'7>WU/+]>0_@\
M. WKA,N]E#& ,.U?/"8KK .(.I_1X$N@Z5!=>V$_)KR[O]+!0_X(*I,$AS3Q
MK'G#:WNJI*>9H8,3QL.M)%(>] ?_S*H>R\0SS%"I-6=5@EGXE!NT-I]#OC>+
MJ;" =8AHE-K)^G\@'>+W=T H"&_99>\IMC,FHRFNM][YA8"20%@RQL]D/0LG
MA[^ ;G0C@RXLDO<3:7;#W4/,)W_3Y_R<439& HJCJDOO,>PK@FC47S>2^1ZB
MO$29HRC\7EYE[]9Z.V;D<]/RODE>>'?8$/94>?K@"1!IR'W3TY$W9NCSI6JJ
MSG7K0+:S#^[W+12EYX&!--0OH 6A((56"<;G@S!LC7;U)K$#3JY:M$F!O@^V
MI,]B$NLI@G)!$S-PZR1V/D72CJSMFR+K#/O"SK+]2P.]K!D%00<F4WRT?O*'
M77>ZU^\$B'X>W;_>%^9+V#.1-9./&6]T1HD9[+*X<=QSVCL"CGV%S<\7J[=I
M $GL2GUIG&QK1XO71%)IY9C/8L)<V!1L>'H+:&;?'=8K#R:>T*;X<ZKS#O5_
M=ETR\XA9Y+//]Y]/<]H["7L(:-5T$0$ GE("0@MIU[_+.D\( =AH]+=9S$4W
MR-1)JEV(<&<Q&NSSWA-1MS;DYU(=(3LPS1LTC;9B0(>I-WXV%WU+_X(DB^UN
MCN,[KOXZXWP>R/_V,U#;-=>%K$R#ET(9EV3Y0EX3.9%_.7-K2CY\'+HN++VG
M5WMQW%Z)Y[4.XRIYJ\O"+YU85_, W+MASY42FD\I8Z1#8@,;#0BY\82EB$.
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M368Q!WHM%855WL8'.C\=RRVO^*GX@/N+ /Y1$PU;Y5*FD87-$A\SQ^Y*AFX
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M'WSP^"2I;O/KK58*.(U9?EM/>J$9.T4PB)/]Q&UT3K=3V=E*6"9[^,S@W8$
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MN3$ V>IB-(U]TX43?YVQ0O/_T":Y+I^9+M+6$ ,CH  I: (;Y(4:=R;!.J"
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M#,$(6A45O\))?O?Z K-T4[A]QS@F/DJ90#>&"YM2S%-6_$7@T9>!%U1+WB.
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M,4]EG#U:_-*"K.RFK[?P^.L\P?7[ND2K=_#JA?GMRVS0>4Q<HPD;M)\-BIH
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M.6NCM]%*U\A[R[%!6)X@G.(75>M&L930*O<25N8'<_!U)DSL,&Z5J3T__9!
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MX>Z4#DI*@&R"+,Z@!$P-%8;H!]$:Z; >4/43X+R"ZN]4 /R\ L:]6%JRA^;
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M:0G\&=(,$70(C_"Q\ HY9+$A&^BA"1] O8(Z9/%.D1UY%^2&_M6 X@571NH
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MFL:^HF2+ EIU8M#W.UF.IZ"DEA/-Q #22]W<C*3^3=H%[L&SN$PYT3K8W*_
M%$TD/;ZCFM4\MSC6J6WNU)$ZQPE:-,"W!;ORN.X1Z7Q\C0C P?OY-QR_Q'/F
ML,%5T)A=>_ZF]DFMMV.3SI:#UJ413B91D_5#3]X5&!ZV??75,M[R^CE+7+T[
MO :M+ L(D.C95U*]\* XC&S/)2Z!-*3G)U5AY9&OA'P 34G#Z@KQ[_MT!5DQ
MD[TR[,2*!N6:;C4A[5GE,_QS5MT+4I5MDZ[\^,R%1-MW)_5[-:L;=<>LX)5<
MSB!OK!^ -&6N)2.R/_B#M: \X$6,4<(M*I7QY*!DP<.]UGCL?:]<C3DNOU@
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MMH:31;<C4 >['7I*SA>].-:H\1/AE3.'I#<!SV%HE<8-X-1P)Q&>\RVU VX
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MY%N,MB&A]!Z3W[T;@>O6/8,WOU[6N,?/Q9QE\<?J=\@W(56)K66H3[I@ *R
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M"2J(;DF?X/PPH9A"PB#[B<1?FOF]:1W6U"\I41 /-KA^,BLIV%4<5UM FT>
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MM$#]#O8V.F)A#Z7GGKS^4*V3-V5<LK&B.O/>J)7.-89%.G51Q%6&$P@'[A0
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M9.YLOGU,BB]:<UM>1U0Z@.N(TZ[!ST^BPM \0*6#51TC/ )* L&B>[!?&S%
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M4(>Q->MY^)/^PQ[AO^SY W_/E^V*0%0M7_[]2A(T!USX#*BAT!Q%4%2"B7
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MZ+DYQMBWB]Z]/D/#1P@ZS=O?VQAOU,O29VK=%H*]0FQ&J@*N]$]2"H ?G=@
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MW\=-&N@H!. .Y6F">;ZN-C;#:D5)+U6VR?@>MC=N5:7.H@2Y/?(*M=[+&.
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M<\)Q;T$N6WT[SYS/.DLP5^##Z&O')_N@VINMX2FG4[ZK7W^F^##?R^JDV>M
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M"B7<W0=-%K?5FDW"K*F1VUJ/IOH>U(TU\P8F;%BS*^I<-1;Y@!9%][U.4_4
MOMG<0<#XZVF;;.P0?G7GG, 5SU.202L*@L>G?0(<F5X-9YU7I.V%A'X5C^5G
ML,_"!JJMF#RZ<!&CR?.UG*4K\"'F0NOOE;>+^B=S4JL*[&Z_IZI1!;5+$V/J
MY*1?SW>*\OF(!IQK" EFB.KV(3EZU!2<<Q)($&(N B]&0C<\^EG<O+O(4$ V
MH$U& Z+2!:DLPZMA;=Z/793\U,Q6V\C0A[MAY &[_U!.?R!F_6*HY2N[PD2Z
M0"^F1I?A'WP9]P?'VG/5Q]4E&]&] PJ-RM+#+A<9H]?Q1B?XSU>D\3N))T.+
M,??+YZE'NR-:3W[-!QWET*Q0C[LG.C_\V1_*"$C9) ^,P82P6O>?M"BLP(6&
MO M AT"R_D[B68NIQWF2 EM;M(LZ3FP79-]S7ZZ1EWJ455*]<JO3W&S3/1-N
MG2PJ1W#AIE&Q =S8:4R39F:'X!:OQOKR4-=/RR(9ZZ&XU;7M3 _H0"8$.)]&
MX5E9GY&"\/OC-5/;;=RAQRA!3I=XDE3TST07A+^\*);]YJN4Q-TX),$2"DA]
M?,@T_VEM(W&F*)3B.G![D5&>I*/*)##_9;N5[+XZY](J1-H'F0 JA'=+Y0(*
M%"W"IU][A'[E5.:6GO,<(,:MY52$"^?$]-=:J3EP*T)=,^B62AN&4>#=DGYJ
M]_5I\+%\96Q8\JLKN1TEA9O'TB7W0;<:C>C4AG5\K@3@L!H/2U[PP7H?7^JV
M0=O:O1Q],MM;8"+L?\NP=WG3>MS;'->7")QWH?"0!)Y=Q>U$.U%[TIVJ (?Y
MU1^VD3=/RWJ_\^117OND&\N5CY_+^%E&KYYT@5GN7V_;4VA$C+5/DM*-9%?!
MJL3>)S\J9QW6D:3&7;P29G#_C)/JW*$?W<N\9:V#ST[>2'0A(+$%S:-4S*LY
M>=8K+6%97<3E&T;WY#KO3K9\$)#T^%!#&(PZSWNWNQT.KM 5<CPY*9?IRL!_
M_KWGJ6CVT \R\1^?A%_28<<"Z>3B2SVY(;S7?Z7LYL$_*G2JUA99W,_KT&:Z
M:7(;8$LH'S9XU"V$XV!B/SJ6FN73>.[6W93UX=34NVZVE-!1U%P5@OV7C[8H
M[1NF"IEP7/^0QAL*V#M_LOY1WMK";ZQ7Z[U.PT;^)_.G@[3O(>;>0\%*QC;6
MXW!11"NDA**%8_>9G+0%BKK@4K6$A=KB":OV7\OM'1R*S&52-KSW:PC](4'"
MTL-L 9'*OXMW'D]8"7NC/[V UF.<PZ+G&2Z?#>5XRJ6GCV8>.RF?]<-M7LO/
M"73J)PPC]DQ*0+CLQN9*SIWL41J$>R0>'XCU>6/-Y?'1T*=,HF;28+EP?3DP
M##O 36\B%A&[GN[E 7G:IW"-JTHQJ36D[^V#DKFW6-2"*PKX40%/4N@MPPOA
M[@V<<^EX4>!*09 58:#AF1A=5Q@$MR&P2M 52T%HW$1_VLYDRQ- 7#A777EL
MJ/2G1DV:2ALB&GP\%4T39**QQA(SS2JL,H(QG!0IPM&2.:$@QD&>'A>.VH(I
M-[],RPY/X?OSACE7V2H:DCOA>W3ZWA_^>(KKCB^R?/+>(I/D-<L!_5F)EZJ'
M3Y04+A<51.9H&4[8?*"*25!5\08^"Z)/]M85%+IJUG&;PKJLYA75189QRV:O
MG^PX"6EX/'*9M_>,BLUMSU)J@9T3LLF4Q1[+X[%GUW8YNR PQJ/:Y5=3E2T]
M8(#R[[3&O( ?IB9 YE)RCC?7CC6:>N P<7"QT#1U3&<L"AR8Y"BSJ8F\;^0A
MJ^Z@F-]+M+>9/O?J<!(_*QG5!CU^<%<"J*_0-E"HO?DHX?G""_;.FD0$MNP9
M/M]NV0?3=7K$L;RQZKM88V7BS?C;[H=F?;Q&+KXV!'A) I\_MQR^@1[\H)S:
MK0IZ?)&C2&)^Z>)8,AEB<CA;Q50B(;QK*F*;&PZV#Q[/C>R]1)$BUQR6CYC=
M!UD4L99.J=V]E9EI2/X]4^LY0:S#1&M:=?S^.0@D:GY;>O]%G7=3>I6)69':
MRV]XY\)KMS:2;=52@1.OAZ3WT3^ZY+@>!KCA[=? >/ %!4[ARYQ3F. ]R4<<
MP]U/NZNOM[0$48MIC&<0N/+&[<,T[D2N8WM;Z$H*2G#G.7KK]X2Z5TZ>,+C<
M1IB[V[5UF>83:%ZXC&DO6IX?I[+.^.U>\TN8Z.9=5BW,RW?H<>DQ+M4?GK1>
M]GZ'=_SI:,T*;JS6*_QU1,"B0)+.&+E5)"V,M7859VOK+0AF!UQ-*I%OUH76
MB>1.I':;_^&6HLWR39 =V7]R-<C$WA/0/TB#5XCZ O=&OQ0)GKD/NCRCL0\"
M>:* &;[$WS1Y2N]>/_CO;)C"(J()#82L6_]A/^\A=!Z;Y4?GL<' ?_PEE(XQ
M1D=1OTR!J45T:8G!HK>P^R"ONZM[T?'_&+/];ZJ/%4+7CE*JQ) -%,5<6PQ,
M3BB 5">VY(UW[A2M_I.P+M(7LX5.HEZ(T(U%:+9!+M)._!LF//2?5 UR(+=R
MT9T[>;1??\9Y><#<@X'F32+A'P1[2Q%_81M==6"=<O<^R.W[8[P*\)BJ&7*^
M9'SWBM]>P+\2[/IT.BVQ*"K?M+,/BG'IN+H/\ATI(I4#)YX"S5M4V#\9:S;$
MY)3+7Q9?9>[V^G?4_?^QP?'U\"PMQ/>WT%\L@\O_B@HGTJFPP8 F-'AC'W1B
M,#J*-D^7!(X$<:#1(1B/9 ^,W@=I:?ZQ6'4@LT@X@"Q2-[C(U8T]R*'_G;W#
M%[KQRT:Z''=IZ.2*U='M'XLT3MA#P(,HTQ%0KQ_AO[QM?&70,'4/Q_(XWMR4
MQ5U.%GOI?.W8YZ[%;_Y"W+%SR7&'/)8AR_8N6 T-57^#!^$#PRS:[9<VPF?Y
M;3^DSL3PQ?.24N](^E6]2KITY*DE_Z!IG_ 32B33G.E3;+%7D#5I<S>SM8C7
M.8>LL7TRYNRG/M:S[T)9-SF%;:DOMH6H.2XD>$30^^A8S^/9VF-[A"NVAVX:
MWN-. [UF_W+H,A-ZM0<N073$G0H&(+;=-%9_J$E*"1@G;P#7NX.*W'M,1E^G
M>= [:R*2X*-51N'E(V4!?>2+@>@YID@:0R 2._[<'\D'G-P'&0*Q'X!12H@'
M%LEC WAWJ#],G:R-V@*7NZ<J\Y$RIGUM#)XB[]>._'IT%[U(E:63_0]TZJES
M\$T_8Q<U7C.(?-<]YV0Y$%6R)(AZ3CDWYQW%-TEI%C(5!(H[G^:?Y%HN*YZR
M7.%3OCOI%&'KOO<ZM3YD^J7;F +_6Z%8SKD-$E-5&DD-""!S(5HM*5H>2JF)
M!^^UE)/UX=^@5?'XYW6I'H,12+Y&)4+]L%#_7>PEA\HAO'>C>:%EU83.1R"R
M__OY7(FR)02-[=9I:AW"&Q&*^3R37-I$B"5=H:;3E!"ME_=!KD+7[V)N$;9)
ME1Y860\]X%RANSR/XJ58JCD\&^%T3OHAY6K1S&E+4KIRO/[:Y&H%RB48DH2R
M<6VVZDTB?329KAG5+C-M=]["Y"V3GOSAF$11.@Z,=T8.CC3#DS4#X9Q<EID_
M(8>2<6?*I*(6/>3!!G/YKQJ?S(K865WMR+MY"@B:5<N:TKOFL8AD)( IO+4T
M-BA1OD6;"\B=0P"GG9-Q\HS 1EL]7WSCN6)+^,@&RH8P_D+QJU+V2=KP,)19
M<L"?77E!Z,V]),FTX]+U,K[0U!PN"+$+^4)M6:X*PD-<\:95!R>V#P*R.Y03
M$225@XMO*"Q$[QC$7!SXN#S\".4"%4GC69KT[M8RQW%4>L^5<04ZWB XQQ8$
M(KH%<[]3E(IG A'7B2)9=S,2T]6KJZOXHBL,PB]J#YNFXHMUM>07,% I@%(V
MT;;>*U3]<1\45D?VIX/00I_IRS*4<%/^!51@'^2,B$54+B8B'D"F.$G!RO51
M'8.A-(TDFTW.R U_=@UC8\35,:^':RY-'B)7S3_7HH;+\+*2P2%7!LW+$U:-
M ^K!V=8("E\PC56*Z#>/P9L2@@_N6@_7G80/P\'4U&8Y]WT0"^7.O#'G_%C9
MNZ\[RM8YY1[O[-PS;)M9 A_*^_<9GR01+"?M9O698ZXI?+DI%$QC1A X29%4
M^HIY>-.+!,&6KH#,.\%,G\Y0/VB+3@*<<XEM\N%P"5/>93@WP;.YH'!B(.?B
MV">[DH'*W!_+^KI?AJK/21)%FJME\;1*CZ)+5A.%+A2AKBF(^P8@YW<XCC8U
M>2MJHEK/BW86G'ZI);YNFOF,R:->EJ+!,ZF]U%N5P5.EB=Z_&Q1(C]%/PH?D
M2B9F@FA2=;0!*,&>\[@!V0BF27U%CZ1\\.?Q3C @9=%9%C<.=0#4<!#^578<
MY!GM NK+&QL;-[_ AEOH+:M3#6/R7]%X)57/]<?%P9'A8S3<0/ ;<<126,JK
MF$LI_O>?,PNUAS,8%P&_+[,^)2=X[.;O@R)** K8=/HL*0A"Y<;#\X,=X AD
M54"K; !6KU;"J=I.R'I<4\>WR./E<@!SN"5N1+'/Y_<[2"J\1^CB)C<++8S&
MM+I7&Z-]%':"J(Q:N%H:F#8WV(;@\H"[S3R:'*@E[+37%WZJ/2Y<7L^W8\&I
M\;L_ZW=W_#E4Q79-4]7JXM2OG8I\<<7,X?$QLB< 1_EN[KR@)V;BI,QU:@-<
MB-:? 5E#XD(0)">B19LW%S#5B:GA;9P<#C1M:58>QM6%J&#[?[T6- ="-ORM
M[L5,:\V6NSVIA%[Q])3CM8N:NC^\G'['TTL@F_%]\;&X?NYEZ=#\-SWS@;N/
MF/L16A!>N SE9CD=A!3( W $"<E%<?$D(*'46+C$ZMYXNPV">V5LEG&T>BHX
MQ-!2J<2B[;L]XOZ*=4G#9,O89'QG[$R+F>8'GDOKE$_46(0S/7P::*R^Y >(
M5C.X$(7>]<)#::,(9I03)!13?;>)(WD.$8'AJC;FZYRLC:]V#"ERS3!.BRN5
MRS0CU(92E+#]&G@SP$(OY7$_]'9FR&B67**?!%FW)-EKPS1I\VD0=::'Q(6^
M6V47,%HZA?I.FY!,N"[TH$="?N+!W?@Z\A<.AEWBZZ^[4>()'O2F[KH1JT!A
MI"*;56"^-4.GB5K=;>#G]JI (E.47"G&*,H6P>3*-_G36JDKSY/W6\TK=W;7
MST9/4C>UZGN'\R]5,$_M4ND.\,!,J'EP8?@8@F". <ZX=&TD:JM2\QMER,>!
MQ38+*(OV68I)<YH%$0<$=*;MJ <-EU4'-\3V&^($2FZ-W\S0H)K>#+;3+4T:
MPE4^KDDD(6BLITPI%U3PN>-@0A]&,$KD^C[H&:?E/FC;;X^U0*/X?9]'$Y_'
MSFYN,+^,1G/&C%QQ/>10\\$!+?2B,E>*JBIJ@QZ#^0,B]!)SX0N01BCK'-M)
MLQ<BNCQ'N=HY!RHUA"@OV,@LHCT+"1(6MS0#?/J\!15U9OU_Y&=E4#T/3KXZ
MN+:(!D:T&FYA8F9YD-B >)2+]Z0^*83(7O:\&0)C "+8LO\OVMXSK*FU:Q>-
M(B)%47J/"@A(4SI2HB)]02@BG:A(%U"D"2%1JM0(""@($>DB(#7TT!$0$6G2
M24"0GE#"A(2PPUKO^^WOO->WK[//C_.'D#;',\:XQQCWG9D\,[A5&3-6:37N
M[J^<I.4^-G'W("5E(XO@8&/CGJH\&H=16A4@5AZ!5,$$W8%)+2KS=4(#E;&<
MP-P*KMBDL$W2NA]8\ZSK#5A,U NJS J6#WQSF/*7E[IVR#._I[+A(YS9P6K[
M#A,JIPIE4CGNK]8NK:  94>\3B9^8+*2RJ2&ATZ,4=G*(F8)%M[QB.M?B+I=
MR/&A#B'Z6@(TD@(F5+9-8"85)@= AAJ[\QZ?DSW\Z6Q3-ZQEI'U)@YO2BXVA
M^V4P%:/E$._@:3^,[IA#9'(.0[U^B7G\QNX*%O+M0(W*F',$8F":I,[,TEIT
M#/9+5#S$!7L.SCX,%_8F:FN" \<,@93BP'IOP14L"US'MV&:*835G+ 1?3HS
MI-A-\@K&C3[S]_[)W@.VO <)6@>KM/''=UA-N4[+R_9A/$(!,9HE\J-$W6Z6
M92=$*M"C92RH\D]8-T)V;+=/D*&=RA]V+X8_>JUY4&-G(GYDBFM,?G)YE!MS
M8;*?Y&Q.1<! 59*SXY-M#L>7T/L<>'DDARBV=KS%3 <1%HF0=/>_)V?GSHT\
MT7P5<+S]L_K7HJL)SYI"@;W_J$CR=>8C$%<+F;E0\?#XFI!^L:R3W21:KD(#
MD*TWX/S^?LA(OJYD/!80#U@_RQF>.C;*2"C&E47X2:(C[AW\U'D4_WD7=KXF
M.]]=J>!)7361,[-7W%3@TVW$*M2R"EX6+ O="K83-3BG/UGIZ18<\'/BP&\%
MD7E\T7K(W,<;F&->I?H3Z5[R#&><3/ P&6Y$SD/IE4-]O3EG@2%H*(0)QL_C
MG6PS7%7"MOP;:[&=&[T#_!P.C5;(WH85S,V#B/$YV5V+-WNQ]QA  =YI99R4
MXZMH%N>+T%RXURIPOMO[,;HJK;ODB_:KP8M0'KO])_F:%GHC*1S*O<)Q5\XH
M'B33XJ243/I,TW R0!/#FAN1%8=M'8C?\[<)R<-VSL9HB@ZI\^.0D3,<GCH2
M%!C^SVZ_.W_FE5GK,!T&@T'CG%.IHYB#3],BYOUNWLS+O&4N_"L_FU+WD.C=
MTL5G>0PR=_<?3U:,&;%3L>>B_EPJ;[)P\3#,U3;Y-G#JT\G4JY_U;VV5FU?M
M"#.H7!R^KBVU(1RIG/*+BYGMW;G3RN\OBIP2\TBZ5LJ4=8N32JMIC&7<$>@1
M;%R>%!PUK[QVO/:=PT_4XX\R;R.$I@(M.RXL9X&!(?Q #)B)>BDP>K=?L[OK
MQN,9;DS,4ELS"V$CTQ/YR?W S$/YQDQ<?_ZXF[*2UOH?(C4-V>H(\?2>$#,_
M1--:QVN'&T T47Z^;&V5S($8:F8@+'5 )U'S+FMY#XJZB:QZ8WY0^D#S#CY8
MY-R(@F<Z.LJW(6K8KX\LZ6'X*N.N]O#&)=OB3"YIS960CY6#RQ,S:4'+B_6L
M*X0A:X]IFM8;ZZL[3#+T5@?QSJ6?;>%DOT/DZFF9$+04NQAW;CYKW/=>FGGD
M-=L!N0*6P3M;,GHB,@MFS-=.A"Z)R+U_$(&4@!#TXYEUP#61T?BRX\M.<Y*0
MDPPD02)K>P.Y+!Y;L;>N1M3JR%(ZS*6(XKEB+8V8[0C.&:7+NB858498OK,+
M6] K,>6_H/C@$"WCQE2-RZY8):P;>(*A#<F&G2O"ULRV@0%)V/H2V9/:VLQ#
M0,5[4F3)%Y8A='Z;/!1Y0%ZV/7XOYPYQZ94?FD5;HS3O*3*G';=Y03_DTV\9
M/T&8#89O.F.B-)-QG;/,)7@RKYE\./LAE1=FO;R00EVM00:5QK/?,,B_HE6=
M>M,D<A]AQG/RG!6+P#.TEGFLY,\LEU\;C4T9WR)G[%\&)=EZ#<;Y/'OYXST1
MUL<==DR_)ARIC$VTSF%^6(QU@_(BQM&GL7,?&>=H-"@;T844H/#BU;"\*SY_
M-#6)I^,)>RW^LUP;&YY2.2.[4$8/FPXAJ=J?Z8L'@+6].Y\3J4#$Q'K*$'B7
M![<Y?+<[,.X,GO#NF"4\F5UGSZ?!RMA/]A0Z+G5", U%L61M!;/"#6J'T!VC
ML_2RFMS=CYJ%:BO#3/T(I((B72_?P&ISC>F:E\]=.!O9,682TH)[0=W>V T8
M\OY!(\S:'[N#E3]D<]1-2;FLDSCU^E6,]=39(Y#<!_IWY]HCZ=SF3RTX6Y=X
ME0PKD,8N2 J<)'S]T S;NY\"^GK*J_.6B'C/BCQ%ESI&Z_+@B2/0\49WH0+4
M=F357H2Z/A&,TT01(?,AZ.,+&8K+=D''E_1JZX"PN3+&0#GRO1^*V N C=J5
M&&^6SGF=+T,4;:D?#E9:;I_=N80$,0TQ_#LN.[. F .:T.UP^.4(Y(($TYR7
M0LY5(:X!.$*:5?HB9"*6I'-8BY ,[.N <31:S'V-3YZ>HB@1"J(5\H9+U/45
M&]PQHT_W;>[6!$VGOA9K;AQ"FT:@W/C7J/ZVZWE4:ML!QE(:[32T67T 'N=0
MVN,^$=_(;G?JXO50Y3<G]07>L#!\^UP@ N]M+U08B[%:N*[/$2U^D2>3]U$?
M???&5]:>^R<F0\?I1/BHM-99> 2J,JH>H' )XW5;9@$)V+H;^1&B$_:E( K!
M!5A1>X*P:SV%@3FM65Q !-[39\@@S9JH'-]HC[-5W;ABM6M-,?>$[PVN*)%\
M_O#Y524NG_\VI@S)1G_QQ'3-1B*_S%(X'$T)6 H'IA5-,&$=?Z8#N,V76)(,
M@9*/P-X](G2=D=",[VZ[D?<])Y=RF\A2L_K,,>A*ZE!/Y*;5L**:AJ-N;4-Y
MNAK_N&>)996E^T"?!V5W$/E767';9$-3,U(FT_10)99_:!'YT8[ZN\:0' U-
MG3P5KL0Q%WZU6X-.0D-;2<VPZ$V5TG8O]Z7&VBRCS]CG_ ^_L(FK/H)<VY $
MP(<IR(?(213I6#FIT=@C/2-PW TU#DNKP+'HLYJ<E#M$Y;7^N3(&N/YHE3?]
M,I4/,"SQL#05Z^3_HZAF;]DUL12K."GM\YU\;V016_^SZNY0B=:LK5=%V5^
M+5F..@4FF((!T=-8VE'O ,<36^2PH%&".-L^>X9BCL>^:#X!R..#49$T*:4
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M[V3.^ZB%)MU'&7,(N<_W">9F!#<<@6R>(YPMG!=^QL#+0[)*5_OL,<T-R]F
M(E&+Y ^L?Z)%N&.V(FI=-9\B3BS96]N=FQVGZYYA(D*[;$-$?Q.X(O#39I.6
MMN!S*S8_0E(/JML;&3ESQ-Y=JHUR_BW'<[P%#C?$!8*"G42HT_ZWI>@2,W!B
M"0@^U^/3=8^KB4MMGN9=?%K+_I#S<!$IO]5G>"2+P<;\W9\I!9C.CL XY@:_
M(Y"5-?O>^,,W[/7*GK]D6ID:!%ZT?E>9^,"YU<.B8Q6JE^/4?:IK?S6^I$:I
MY\08KTN;Y]?'\*F/"X\8=?8: [S]1D0!+\NJ8HS8G8S*/QLSAUA)]$ !A3V'
MY $<$C!49@BM410 RT1V'&L"G)?P;'YDKZT'P4+1'ZMZ+M4H2I10\-@7'1$A
MI!9^'W2/=;K -O7VQ58:?ULY$](*Z\5Z!BC ,ZPYDBT#N5OY3A?@RWB!;M)S
MH!)7QA3HHA.V;H-]U7CK<Z":Q=!.";]^S136#8MM2N>WM=*22'7+,;NKI#O"
MR![G%6D:.:7BS_/=VIKIA8T6!7:-=Z97*+DWXX7CXU"!+R]CHO@C?XLP<L9\
MN=<ZH??]3/[GE+HTPX;2F#["[+?T:H'<I*9DRYG^:<U)F4SJ//"=QD@\J+^0
M! OT+V&2#*!(%IVB)8#E".2!C.:+:NOS]!EI?'1I6%W#K;CG\ZJRS?M'XS49
MDM:=;%.?V;DSTQ@7*1\$#C-H\J/J^/2@UT L3=+<A23 "%;>DZMSWV/)5U=G
MY #3!P1E'.O:GD=Q9TD@RI P,1X8H)-A3G1JJVV(W['G;[_W]*RAA9ZL8I.6
M26/@SJH:OX<%9.A:Q!9CC,Y<J#7TR2T>R=[$UK5;PAPCD8ZA@ZIB<9PB5U^/
MGVT]]:2VI7=7H,0YFU]D(;-F1!39=01:]+A1B6TP*MW0;R@3'8("COO'>QX\
MHCFFJ"D/%%,9CS]N2#U\ W';#--4  R#R1;4820OC75]',.?CCD0F!&N;")X
MO0LAS'8'\7_[+N,K#O?+=AVC,WW9IG!OJ*.4-U,;!ES475,CNP?RMQ^!JI'K
MHN00BA(10YL5KB<(8JVP<E0+DI5R\P?,@&A(X0+T"3O+-4'-41QI[(;!+OB,
M@;5,?A-L;>"D]8COK4^<B1OW])&?B1P=I0MIS,FO2]YX7?M1V)9P^F?XFO@:
MAZ2,Z[6^N,>);[P>?E0VK;T:?I>'A_'[3RO6%,/35^O<S]?#)QT.BM4:RJ0A
M]PS*I.L4ZC?SB_O* 1IB3R]3!R "1R!G64#L+PCS\>G,"$U%6N&R4[FQ7;+G
ML:&4X-R:6#S'C^HC$%M?<*Z[3I>^ +_1[>GV2:/&SJO%-Z['%5="YO #X_*D
MS.-VG;D'.8=T"J$S)V[&P!6)J!;(!8H?(59KV'FH&AD+.]<HZX3G'&Z\E/<)
MRE%?_6/,3X.[XWP@4LH[X6V:?Z'7FB<G-C"=%V!*>O&LP?T]+2GG3[')J3PZ
M):'Z\&FG>*A#MB"4*3<GLSST)@JDN6O"T?7MTV!<P;=&BPF!FD;_ZF1[C(U;
MZ6R17*:V1?]M(X\APQ#R<G#>Y#"5%^D!9J0.0:IIHV6["UO!NL9 P^5I(FPM
M2HK*3"##[P/)1/X6\#FX&-[(4!_P^.0J)-H !! L+6WO$L?B*?;XL@M_T@-C
M!'7O9IC7_APEC<^!/9,>'(").C0MP51-8";=H>'(*K!O#KG6_HD2! @3QDB^
M )+00-HXWO\1Z,9M1!12_AJIMF=H\P_B[%R;4'ZUMFM83-90>NXMP\9OZ-;<
M6?CGAM%B#D>Z?]Z-]D,=!7-5T5$S?2^]U[B_XG"W%K*->LO7Z;D4KSY7<X/7
M!87#$T!6[WCFF<ZMW3];-UF;Q/J]H_9D3BH?>;)T%9N7FC"Z^N<SQ&L:&S#6
M,.;TBRI[!'*9_;6'%UMWH4'\Z6$BUA,V/DEEC"5R4QG-"=QSG.A7C?K$^<[9
M\YX*92!W"']UDT'?W:$2BB(.2Q>(L!B4R4;>D&9;W\F\T<OKFZEK4C\\ATF&
M?F$+X2>NXC'K.$(4*>TP#\%Q_!4;R-Q;S<LTQ[]0NZD:Q/?IZ+4\(BM.K T&
M"DRV!@+F^AU6S;(&<)UK!_%O,/5*V9Z<BVEY[M_]["5-;0^5S4:J]KU*%%.L
M(,6ZAI'.HH]$WA>GJ K<W]PW_LT$.L.Q-*+?SX1ANG:J]YK)"UZ.+E6>K19U
MH3N/YL 98HFZ(I",AJ;Y,>/17?*>Y,3W/1)4>WIG+-B.*H5TA "7&=:9B9;_
M%#H,,*>M*AQ=GA5-]J?H$68[H./*)%NB$D:I3+8E%A7>+#4*=YISI;ABN+D#
M$ )0=ACJ7*"6^;8SVA+& OC/FC3I/TPV-A@DH+IAD^TXR!HZF_HU#4+P_A08
M15HE!(1^ #1PD FVH3GN5N0%Q,#$\(Q0!:KU@+LK'FJ=T;;=_WE*BBOU@/II
M 'GXLMA!6Z._*\?[U#;/$:@RF^7E[;=OU\U."X>49*FV6#XNO+WV73 N\%*8
M^;BSD[B9V3E&>CM))2N)KR:SE]5*SS#)U]UR5[U4T.2,;1(,6AO!8(V;0P]H
M'0@=@,W8L=?0"$;WH[L&(B$$:^0XK=%MDX57CD!T5=APF"!" PXAPK/$#FN1
M3K.16$:JT!\';F!@SOO"2G'1;"![FR9X<,?P+)U%VNV?. P!%9WW8^?M)MQ@
MS ;U:NW4#YI@ZMN/G4>-N^"A% X4Z==A5+,$XAN8H+L9/4LPG*3A ,NG (G&
M5D6M*\_;\]\$;/.G_C1SCTC)%A#2PB@:N,0"FKS'RIY=FWB4^&<T?:1S*O&7
M7<<HM[+<V-X91W19FG"PX,)Y'GK<*XG$[?=<EU[<M% I4'BFI"RU!FK;G)F\
M&W>AELL'V?!":;XL"/ZE'OY]PNU;-2:S,6T^I.M3OQBY(,2O8;)DI/J0=3&8
M- ,4T))/!UP@>U!LP^8WURX4(5O-D'-OL>R-LKD#A-@VR+EF[D#N+J%K  ->
M#&489CNTN=ZH]>"Y'U?)\^?G2O-)SS][EDF5[60TJ9F&'K3AA^%AQWM+TASU
MHPX*<1,M*9Q+I$+"TMKS>>BOX#G==4.R<F #3G<-1S[OP5WV;+[O"'1!*2-W
M>B(P<K7MX<9OA2*O4H55H,I5R$)_%\R[,FJCIIMO_07R"TBXKT6?+(Q.5;[]
MCM=/QX2G8[WEGM,CB-*U9T87H W^HN=T98IEGGTW'C7CJ'7C#"VW8'/2DTQ'
M_-[T&X/Z]QY6-:>//Y_\*#;9.VJR-=@':^N>DZ6P8TC/@#T"EGJ6/(ATWGR%
M9(1[X,"HU-G*J'4ZG"4 *7/==)Q_2[F%9^6@W*S]485:LQ;9/I==VEJXC%$Z
MKR;91[_>4(M"<$%^,9">T#C0)/4L\2=ME&"%X,+$[@A-2"M9GA)$B$,S^#4)
MKE&>'8$8N5_!H?,9:-9E81T7MA(JQAOY0 E-][7"4'"]_"EO,MW>_L.4VR_I
MSG^Z:1:G]UWGM'_$B2>EYW$MMWE2%,YLG  +OU Q*]R_:9)M8?? ).Z:A8CD
M*=6'^:@ (T?"ULY:]>X/4;.<@(6G=KW0TLGB29?E;(H/D$%EE"1;4 )H>3F#
M;-5HYOJ#/2="@*[GD2\$#ID 8Q\HS  F?[G>/+!B8[8;(>OIV"(D4CG&%2SY
MW*^,=7KYH#2YP)W?TR_Z=_67!O*-&6YKJB3U!QBSMZXZQTI/'4!6H"GG;0V.
M^8T[E,T]B_,+4$>^"7<]S&RF#9BV),#:D\>:8O0I\.&2%<&NZ&G^2F'%9^ZL
MB_*P6TYBB07CL[/ZO-YKACUO"D]?L9.P.^5_Z3GHTF2X^H9G(Y<P?<P+CMQN
MB,@+3I,88>>M-I93EX9UJ^O4WGBQP??Q!:E\-O<J],F]WT?)]>NS7Y%6R?4D
M]PW2K"$EY0A4 EW2HC+1DT40@[2J+CD"S8778U]2^5=G.1HUR-?A-N4-A]F:
MERD*!.W2B#G94[$:$.TP:Z(V-3DOUE.MU8%KV'M^6-:W6%SZ(Z9J*.6A..9,
MN>881> "60'Q U*5'T]#^S0&H">$=8.Y"P +,B*0'0_I4*$P?.PK40Z%G\@_
M*[JI;EYV62]R3*=&:2MW;(-/-%% 7KRG[,]=7175K=@G-RTMI7)X6Q^$/X'V
M=E:LOWPOGGNMKRH^B3U.XE'OBYM4#A,?_0G+@#<<CT!3Z57V:_C2S1"%G[-C
MF0TGB^ZM$ 9=I[/Z5_;\*URV)6G%+$# KB/)*LA63YI8 ,3+6F5_K>('UD,(
M3ZC?FZ4 9ORTY-RP*<QCAGN$HAW\/+__66%71TV69F>P]V>W9P[=0IE(/KM6
M4J'(*RYJZLYD5/.0[_1M#\D2.8]#96AC[5!9(MNV42KI.W_:D&S.V0K)58F\
M8+5LWOLND4XFG3=+.&)N^CB^%J G5]"-AW&A%EU'*E^]335M$3D1?KYV06=A
MGL?U[1?/#Y+%URY>W6IXP@]6\5Q(OYS#GR=:'URREK9,M>$=R<@PD!CW;"X]
MT*CW'=N 2-.25C"+Z>Z$_6)NGZT$QS:#J0-<1R!!=6EB,0E%T&U!1MN0<LI6
MF@6^ /KYP!'(^D<5E"7P)5J_?/AT-K)T92)O YTS;B_:U#3]/3.Z]'SEI4/]
MVA<34] S]_N\GUWFYHFNT9:PJXB\&E#1O'?_&[]$JLGU.30?UND(% :NTFDB
M>'> >>$L<&]("^25,+Z@74/99*3:(X3A+R",/M<_R"5:T9.M*U!AD\W>U8-O
M.A#N<6]/(M>=5?IWA4B%/*99_5F#WH;@C+;4FN,3D3<+2=>4+TWY6!V!V.7O
MQ\ GL,]MJ]OWHJ6OI(_43*/M_2:A]4MSL%<TE@)&*<,(3]'ML(F@,9QN_-)A
MIB_ZEWG'[+EJ<-P@37Z=J"!V[DX8>>(DJC^0N:W]&&M&<DY#%97D3UQ"@6G#
M)P,! ?:HS#TTC,8??J3IL=AN(7& EV"+*^CL!^-G.T/ ^AYEI^'JPWZ%S9>1
M3C:!.99L4D'PL6Z3H:1QI@:#B8B:%HM<UR/0A[*KG@77RZ7RKE=HGRFK>]\U
MQWO"[/:+F_<N/6J9C.&3J'R1T+?M^<V8]T0+4R,]T\FMEM/W=7[S*$IK[UHN
M-FTN%^  U*31N,]AEGWFQI E-)\F@?1N75PP#WL?EZ5&I)[,7# Z JG/4O<5
MGK,C!Y2/0,U&,#FJT]Y':0LD9.8(](TY3D H^"GU\ENK+,9#>LC7#.IS[.%6
M]_Y)URU:FK*\CT!P%:H[O4#??MI,=..L=<B6\*FP1.-S/G*!F]T 4T"B,F4;
M25X8_"\[SV0784%71RRW#S<I+;6MK4L8,%XB(GH._<.<$HU=HNFU62GDZRNH
M*[#]Q2/07CMJ\8/I-^R[D#\9_;MILY>OZ:ERS"T)BR50D"\*_FO-0G=FM_N/
M0)O)NG\OON3_;O%>R+ESD/27_[S'6WD4!G_5^G^,C=BQG;_=C*FV*,/N8;=/
MSC,P9$TA7^5SB84B;T&WKOPK'N74F^GJ[Y!_N_+?CY_W>^]K'-LY;175KSWS
M6/"<Q,Q_K?I?43H"W:( V08;/=-8!4MIAR'R[/[+IV%A UZ0CKM.T2O(%$A/
M&O6Y/LV&,H#<+=S*HUGT"5''4)V>[O,%U8SLVA:7,"ZF;1L&>^VM-\^?$,[3
ML%M:5'<<PLY)P*,3GG)$T:F<&5=W8;K>0Q*@JIO?,7O-U"GII69YH=FZH9#_
MN3#VP52,S*;'ZF%0?%UNAH]^@[1#B:_-YF^/YC2![]>WLIXM3Q(Y>1\&H7^;
MG;FBVB%'C!_7X==?&Z?+FG))3W#R"+3!SX5DT9.WIU(P$0S%?:KQ%Y 3SLRS
M*GG(3=%5\;)#B>[-R6^UYAT6;F81[B75'$4Z>=:J&A]SC!5%%F9BU#'>=S)^
M'"_;*KEG7JC]9V-?!YJWF350D[=4W90(PW5%GZV]XM]$1$>UMR?\;.>D5'9!
M"5&TEBDP%C>#F,)6A.0N/T;S5@G>>PYO94$(#:EKX^G4[LA?;ILP3O03B/N
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M'<(^/%+Y>C?>K6\%^$NA@ G*'E/$TS<^2$JY=.;/DDTNSB#NJL7[QP/1F@P
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MBG0D;D&I M)!("(J38B*="$J(@+217JB(KU$04!J5 1$2E2:U$B-B!#IG9"
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M+S\65).LZZ'YMNQ6Z0K+W7D\U+UL"N-ZNIVPN@5=6MF %DXV+48\G&7*J42
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MV' +-!$AZ%I#A3RJVKBA:#@@TLV*4Z2^KG$(,V^(E#*B]^)3LV]X6A;LP_'
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M@^[]$DV+$>&.W/F//\/@[UEJ,]:0"_!9Z$Y ;[)!--SJ<8@#0_S/\(>LQ?H
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M0I4#R6> NRRTEVA1#Q9-1<Y*?L'\[%IE@\BH*:_BA9UO,JBO=YX-^+>2H;_
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M4"H \T^2O /2'SB5@GA+TRU;4X.*0OO2W^:<G*TBBLV\RT5IG>$??E]3)#M
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M Y_F#-P;J<'ADUD ;$8:THJ2I&(ZK0AH<E>AR,"CEB.(MPQ;W)= Z.Y%7(S
M(>!7EWS[. '5N"^J/\J8VEE00'F>U8+5&OT<(N#YQN=0#\.8.MYI \R2NMN)
M$M!6/X\@\MH^!+0S9,Q.3</!86HY3*6B( @&TUQ33O(^_)>Q[]"GM>]%H3)F
M)YX6%9AIOY;P&<,KVML/AZL$3D(-H^9RGL_=Q1#*)7S>F,.T.-1UO']<CTB1
M['+U575.RA=2?GWZPW?/.9?E1TU[GAX)DAJD+[]3'_H6=.2XMQX5DL )Q_%X
M)J<0BGR(]&8UMG #LA]TL2O2C&- "+V)]K::')ZCT<46I8DE4?0/"T0CS_%G
MGJAS7!$+R6(_QJ5.0<NT^Z1"U(OB Y0N=FG?8>YFE4!F&C!4!X&O. L@!,TP
M0[?*HPXQ]?T2#-5Q5*YVEV,H#6>@M(.M1?/H\#X19A7;I#2S#1*'N<KAGS5]
M5+$8;<D:JX2ZWIPPT_U&)%Q2?Q _-AD*:1M?;JB22"R P2.@$*9TA,"*)&7\
MZ&Q__>W[N\NJJ@7]/_"]3^7A/2]U9N'A9>\157Y*M3/S?2]?I/W+AWLRN!]\
MO6;L[L][60O <?!';@?QF>ZL1^C;Z G,[&M6+A-"'B $T&-HW:W$Z.!M4#6]
M$ MU6G2$=/H],12HIYG&,17VEQ=,L2H6FPR*%PFYL;!P@Q]UN;,??ZGN[I'$
MB (&.SWAUM F>YHGJ3#&4(WS![@%S-0$["L0Q/8&^0[H$U&\9$V2]?(']D$\
MOK:&!HZ#__[*# V1^]:@FJ,\3G,L+^BU.N%FK2#][-& \,I:A-[Z9+%KOQUQ
M&W0RE67U0W-Z*I$,B\+YFKWX-!<'VEV8RBW>=</7-73&:;E.=N,7<N+KWI^[
M._:=O793QMC_Z7ZCA;%ZVP.?-&+NO?E89MN[Y]?[ _QBW+;"74N?6FZ!GD'[
M-I@B>FR^YA)TZQG\S"MH=>;*Y"PT&L5/DU^9HT%:<T5I*9W0)^7^9#D@>Z84
M?!B19OU%;1UR@$!8RF"+-U52?]N=]DE;W(I)U]^*KG(VDNYK:A1?LGYL^WW(
MT9=H[\OJN>YW<75]^ 5N<Q,5^_NY7P6HU^*![JW0G[L#(GE)3^X;]0M7[EG;
M=W:OSOB1C[G?^<]I?+0R -EMQO5T[RE'Z'1"$W71T7A/M2<8,%OFVP^4]K"F
M0!1A&]2)W^MZ*=@7J4/NTQUH%P2RSS>8]^Z/-].$^XX0+M^M2=6+\KB_]X'I
M\4C(*4-. 6C;HL+<690B PRS>3'%3'7 PXWFQTGV/*B3"/HDJ?9YKB+XH&^0
MU3Y$R48[(:(L)B*4>;,!]=I/T'GID#%Y7_VO .G:[V:_;IP;=K$=\C/_S6XV
M>2U?/3%!L#)M:=C,V[CE.I46G?L@X-&+KS';H,#26R\3#[_$VO'FG_$A3DG=
M#8TQ.LJ3?^)9I.F!&S*($]&W^<>.WL5GXA]BJ->PP%E3^C/@#'5V=J,-"\A;
MK:B5(76 <E*"U1&$]L\-,K8C2=ZV>1![XGU=I'G".2:RZJ:SN5SZAV3Q3^^M
M'U>?#%CW8PH5LGE':5'T*%9)RPG4!S#.<Z529R6)<1<AUJ;.-!U"JKR!Q;I2
M(1V078Z%F) B1,CUQN81W[SWN.$L ^O^>6E3QZ':<.[5B3LUS>_>UPGD\O<4
M5HQ;#I3C)-^2LQ\,^K 6YA;F412^Y:AMD,HJ=X^XT$?=D/X'1@O>H*BH 2D,
M_#W%X./6M\OH')0-\PBK 76TDQ-HLJQ7Z)F<;5!-110)S ]DJ'%[;X.D.*0/
M*X6P/&@];@&T4E6='NB;Y2WG63>U/$::4"V8(1H^V@3G+Q,];R==-(/?V";J
M+/GOO96;J%XH^RR5WU[O>>*>&-N/1Q.C+'3];.$&-ML@]1,O[:KF&@9_Z4S\
MP%8D5OGY,IPM4=5F6[?B;9L;%@)_,>!95N,G2ZP%N5S7[1,&#9#9];R420)T
MS6IM'OT,31D.R5WFE&'OV&^SQJLQC08?US^O^"2OK[,$ .M(_OL1D')1<[NI
MILE*"P>=_G%6$Y%4..^D@XNHD(<XY+-.7U*<G@IH"&75]<DOI]DJ\.S!AJF)
MO0G;U'E@.XFKP4]CB)^W0<>W09-OUPS&.668&\M""^O+KSWPP"! #UQP?;H%
M_YI#\JX9_?"J<JRCS$_%^_2T!.,I\]N@@Q#UB>9&BO^YK3[YQ4@%VO04<N+]
M7X&+FKFL!S[IXJU[<M&%^D.^*@Y:&[@Z+/JXSF#_\N#O\3+,]V"VP/LLN-TE
M[SOHWPKW3SR;%,\ W?2(C\S+O9'VQ3UK?=?+@)YMT+GNNK"@V>90T\C[0:&F
M >YGZ?-.Z%_3S;>;F)=R7*17WK"#8>MZBWK=J^,MF/%IX>N7;OO\V95P3D;[
MEM9?W><8!QM1NV&8\:SUL)]6DB]AE\/YN$W9)ACF)9@I$!=B@3(YLO-P6$OI
MZK?O16_]9&)_;X,D=%*,M]!)P3][J]DMGIA>U8&MS>1_[]=_(;LI##S,])HV
M$%AD:SJZ8';N,@=G>F[L(.HE#<1O2"$P^/=7YC(]6<C.3V/E>BHHBNFN&G_V
M7C;D(QT[.TP?!KAHLO2A;5!4RKK?A"Q;0GY6OC7EX?1)5FR+&# P:_B,6MI)
MP,0&020 XS8)PX+2WID$O5)8=*RIC,)HA<JKT:#P0"=,I3(CL?^V+;LM2NI.
M9+-EQ)G5,)2^/:DSDQ-;ER;1K>TRLJQ:54-QG\.HW@;,BCQI[7$P6)2_FA10
M.(4TKAU.JIF6M-@55#TK4&-Z[NLXAKISB)I.[YSKY<+CBCJ2T.S@*6Q$>;@*
M/&*JW)>@47I0_.RG*^H^UVR%_#-;PQ4F\D>< .=4ZVG]7ALJCK3!%!KN1G%J
MC<@NI /G51L)856A.2'%R_Z T@$42!A"9O?T@6H@.D G*<A%M?<">[@:\"\$
M^F_VEY.F]*Z/K($MQ]8-CI,)OVX,WKZ\EC3:FNS%_L41=0NI.+(-FLF%4EU2
M"% V3R^UFES8*2#.[LU58+U@BC", ,]6HE"3?0293K6*6R,-!=T/?+&N<#)5
M\J_HT>ETPP))E?F"PB,FQ2K#%Z,-296LIW@OB@Z;7YR&H6!"J?CKL?0[8VBW
ME -,V>$6Q0H<*2Z0L?8D.,Q9=!PE;K'?X#Y0KW8\YX"*O_8CT9<.]W'ES^R9
M"COG#CN*,:6,:5STX5&4.)& ^ARVL&(UXQ>=9=5Y=ZQ)334;/<O2,1^"^S'/
M\3_:CY-/L",3R#RO4^=GVZF+<[/'5%^J+PAC5BFG&*N^D*:DE[=S"!ML$<^)
ML!Q+$4&,YLGZ4'>EUM(K%@YZ!7=7RT>)%E9)D)E)Z*8,QQJ5OOFJ$#_6C=#7
M/,<N89_T[I_(*6K?5XD[L=M)RFX;Q)0.]WS#<0)U??%9(^\]3#.J ,63:G\-
MN!XQESD:. 6U3NA4*3=Z^^ES=2L<[5>PF&:9T:4="K^'JQ9J0D(9)Q"R;+Y,
MCG</ :V,$">DY,Y].6/&>802/9/UEFE.0Y^GH9II[23[F$,_ED-*"5YWV]J&
MR<KV2;!B!ZC3=(_(=[L0:G6HX&3'S*-5 GYE9\,%#@N)K$5Q'+^Z.X$SA&((
MOZ$PZB.T<F-E8I;/+\XQ9(5(_=5Y'3'0B19&PCWETJ=2E^TE4#@R3.DC]DXU
M;CC(PNZ7<X+54,U[[&^*1OM/9Y\'TP4!E]I.6SL/6?:\+Q?._Y;VX#JRLG%P
M*2/37B/0IRN_1.]GN114FW(J?SS;6T5RH_$O(M4VU W8N>D!Y81@F*$P\E9U
MY"PI&/=F$2RD;^Y6FN?ZPX9YE?WY7>/E"KA\7Q/.O!A MR^]M1A2:A S3@5O
M3;R89URLNMQZAW\5T%<;J.9UW_RBY,;WX;##83&4R%?V)73K;?S,7Q*Q3&&]
M&5Q[#>! 9D"BP+56*X.S2G[QZ&J!CD.I[07>J.,U3F*&!T;SAYD3*C4'K[C(
MFN@&?=?>BOHAD?%"^F-E8[SYLAEJ=R6K$3(S*[ +L!2(RN60_<A+"%-R;'>X
MTC[J>FPWA6L6\EC94 BHFS_"[A1+\6M2SST1.1NQ$B=3'.J^'T>:/2ID*A-W
M6YZA_LVQ$!+:A1I2O>9S/5/]RL#,RW+X9)5K1K"T8EJAA^6U^S[J"9P?N);8
MYXR*I9YR&Z?I!0QR[] ]0X['M4[B:\9C#"5-,@S%@6R&V$W$,KGE4<&;FXN]
MY$D\+U-M].Z8'YSR#+Y:ZQVD5##Z*$,S52_ED&NQB@*2[85NE<-[H0%%="M6
MD"/+K QR"_W5GK1&\9@QYR0?&%D&.YMR"%%-OFK(/5JC=L18DM!*2E+MG^UT
M!2>SQ7\CRM:B.Z)NO6_XZ3AG\MWJ!P<&.%BS]P- 9"@ VZ!9(@7+"$;\N@@4
M,,)1XV%E$K$=?&L'2Z81IJ24J*0EGSVMKE(MR9((7U_5BJPC?EUITKDI[F^]
MPRRCW>"!FJ0BJWZ.5KQX=S4"C*[/X>&1D0[L(0A?+3A&!R.Q#8(+B"*M 9=]
MTSB2-!*!_Z";FPZ'NY&5=*AO<5B5ET)7942J1CV&:X^\/)W18RE3?2WM?FTF
M1)]<3Z+FKZ[U,PRDLQD*$QFS<GV(3S3_*$MUUU\^G_KD0_HD50C>ZU>9)H#M
M[-JD&IM?EE6)E*=*TIOQ )@A!DBR>7[1[*\"I30UNOV@,M-CY^@31%1[0W.\
MQ7W-;= 15ZA9>$%'1@*ISZ9#5.*S!#H67LN]EO?%4[<EN]B<-<A].TXV?N_$
M7@7IILM'*C["\RX?2TSE>5IV_,S/U!,\\ZOR9]GWT#-5:*H%FA#O1T#3[W/&
M_H9C"W6DT,E&QCTDF.::] 9Y#0AY"W/DBID%IJB=;JF$Z07;$2V*_84OV/S:
M(<>-UEPYIRDCM2"! TNZ]^J.^J"DZ[3H4(H[(XP]AMG%UMW!(;[7[#Y7X4&F
M$,,+&!H@;70[63W179$H[/"+9)^M'RROG<3L!QZ,M\GHP'4<W@_6-$(/$WW"
MOML9JE)'\\."WD78\?C"LR)N#57-6SHZ.?UZ6U%_PZDY;=3TA7S%P%683?')
M-_6+/9;7OC_W$.LO^V8[Y&OUIK&A.6T.CFHK^2D<<C20"RM^E(J6$0AC*[ E
MV5W3)SA#?8INO8>?*2/N,51B#X'!2&F&(E.%)M".%@:Z20+MD">Z"S&O:=N@
MN" 7T64SJESB^)<I"-TTM@GB@[2-*+JY6'J/\+8@_-8=-[CP4QR]QD'PP:O4
M!(5K7WL(V*2OT@CQ#\L$/ ]Z)A=?94\1H3JQ>?$<X EFO6DYA=3 4S-;_0C&
M-P"P6JN E/.RZY&6:MIW0X$:FJ;A49B%QI6QM5K*L9JQD7L9MK3]F?G9,>\3
M)UCY0O$^=H!3(WK+?(H(8VMKO-F\L9F376V_O%@/<!+N7@Y;C$0"#'H"JP[M
M1P3D!KK0DY+T[''(+>)7=_)>0UEJ2KN*$%F+GD!&BR^AA=[D=G\8<U6AU6:U
MEX,%$/9M!.G):2# LAXWY$%3Z9Y4+B\G-XZDKOT8 $YBN[%/P%0+!@106_A@
M2EM(;%%'[MC1[ZLQ38\>.,26@XD9RHYHXCCYCR;FA*/VL7YC%Z3UKD4(M8UM
MW'?4JJT1R]C*?;V[4^5W(][J#P.O,N58QHK-6\FQ3"CKC>$IY)D1?5DJC)Y*
MXVI5PD8:ZKP?:SI3Y(A8(K;5&1Y/Z-"8]':TJX^H\(9.I"YI*YU '1O6C*W7
M.>I0_L&!=U-@99!C!!+04\'^N@VBNG[$>T%C)<8?HCVAP"G5Z!EB+)&/&2%:
M2S)?U'<A31*Y &([2G&TQD+#<DS+ FK2] 4,K<S]!F2:#^6'SL65R[[G.W9U
M5#>> *F-<"5,E@[18;]U%I);?M:F;2ZBLE>1#@P.%+5*WH/,%* KB3$07^)D
M +V<5:1OP7!FCX19-M+D6W//43T[(_S:'=4^3&E<&PGB@^Z: )S:[6QR9()J
MZW#5^&R+YKJTJS61B!H7W2'NLJ8>]"7\#!%-Z)TE=OL]A-9 5Q@,*^#3+#FD
M:^"K/3V%AET9+V->:TXE+]RDC<<PM2+\/5XMZ:Y3>LWE5@L\(_)A68&.27V]
M4RZ+V@2'IE0RY4ZN7QS:(T6,HVL >N8O8G4#JE5"GBF48LJJN@6XR3]!RC-.
MLX=;^(!1$H07P=.D5>I"7"((Y^I3DVO]863SCTT&)[$O5.ZV4!_7C=4->BU'
M%$=$&EC[U7#<FU.@+%#@'+M_Y#@#@CW$5O_R&WJ /82F7B>FH$[0,BEGR"F[
M>\(/ID36;H,27>7K<)@KP(.&QF5#T=KZNJK&;.MLVS$;^R_D;/O1]<OEJBJ!
MC' SX?CT\EZYO,8:7%U\_\88O2Z>59:X],!2^T'21G0YJ@'^YL<P+MQK@K'U
MB0=4<=]DYL'[O;MM_TKFYL]/#EO8C\\6 '1-NPU/#6^#;N$CP7N:#+0^WT>-
MXNL@;> H0[ED!5?9D%=.J@6SZ.K/;G>\CS:-, W<]ZWHU5G U5)__'#$!^ ]
MT.)()(VX\HN:UTFL56N7EIS!4_C* 6\_E!)2F3JUHEL7-Y,BF-T+$"\/8\O7
M\8+=6F7!]QV=#[8<&[5UZ%]^^\&1Z<,A&G]Q#(LAZS"%8B9GN:*4U[34#K.[
M\#*&$JCA,S<=+LT[&T:18*4I @B<[0/_NN%VE#1MWWPU:O*YI)/@YH-L)Y/\
MQ96QS%_5U>A &\:$,%2QI@9)0)FW9 JQ^?>SXE!*3#O60_9>)]0GL("J?F@I
MNQ4OP19#NE,76I,4QRPN[+0F^-F2B-O+K7!2N:1IDOBZ61/D=2^\*%OR9D%+
MTW @HTAS&9;=+E*-<D:WVJ-GZE!@5C-DY@58VI"/N8?U=!OD4PI^DBM+?9M4
MQAX,2^GTB[8!K$B9*^NDG9LMWEL;B7(C^D%%/GR>%<L6^F8%"#V+Y$F+43^Y
M#"5Z=<:/@ZI6/[CH0Y":!4HWQU,6J7Z=>.#D0-?D6C1$BNG!$1(#EF&+^DB<
M;#X9[3Y;+O/+_-WX.B8ZK/\]G\%SQ^;TOODDQ6_FTO5CE*Q>Z]-1YQ)^@NG)
M46P^" <X @!;4LI7&-EJ94\^NA72(@3@.UP/XEGO\%X1,'+LXR9;3[*T4%M6
M<T9YQ!NF 77\<46FX_4*U\G09XM#+D",9!M_9C%LS.Y!4W)^33IVS=1#\NW*
M4#5#KY1HK@5/CAZB#[*(\_Y$,8B;'W JEM+#4.<$TAZD.T,92",1(P.Q$[TS
M&X\,CP+#9&A'_<S8*ZI:XNWAIG/>,WXB\H^TI U7B5U/O5R%*NL1-?599R(0
M=+NK7]JZR W81+P4>J8$3[T$3H%6+23B80*38 XIBGS$[@+7%':60V9P'7S-
M4-)HX2/] "J^2V)MHF(?QUA-I11K>C^WRJ6QRL+&I=B+C761%I+7AESG+U>D
M?,-3KUM-F-(!P&Q6X*L?/6GGB(^E+'R'M Y=DUJ13L5V;8,J[9\8'K4@07F9
M<,#^E5>=J_3@*IQ</Q(XP.>,R!V^4)EF/I+\:BN"IL%A16)#S8^&U@PM@&JJ
M!IO7@F/R(M:K;9!'CA*]BI6<SY&/8K<1.=2V66/6+Z'&Z@C3FCK008S'B+./
M_JA*N*EI( KEZ;Z=Y1'5+O'UU:AFA(9E;55CPVC&K%/]3?B;'ILLG\'4D.1F
MY?)QF..&E4OJQ7HEG2 8Q*EQ$H6K;0A9BNAE/$!]V ;A-,$X3<C.<;-"">24
M#Q@!Y"V:Z8=SD+MJ26"!;9!7 CQ8;;</6VBXL"&SW56;.H8E]3HQ>N'H\UDD
M5?*0+SRIF;5>4);F*FFD\HSI/0ZYNPWB0RJ/&'+O/,J).LKTB.K<!NW">Y1R
M^!6Z]09DI@HJ"7_E(MG6D%P=7M).QA]$*M95Q^6LW N"N_9>%<WRF!"K=E:V
MF7)LASVHHVZ#W/#2* 4H\R1@1/,DK[Z8P0@S+X_K<W%@ H&_!(3/-)]$'T)@
MNK+H:6[Z6Y"8W]*BG?O&\@**?2Q@]Y3+!^=AP?6!!^Q%@#T, W2KAN%9YGF.
M=2U04P1TUQ'*[P'@%)@IHM8V#0'R:#[+':VSF:TM1\=/Q&^03-OT)E]X9+CH
M7*7F)KC[Y?7=P9V>=')=>M]T@1!>Y7+9;**H.6=EI6EK396P?CS'O' @SS&L
M@A4\SM[?/8RI$F.**='=6"4M6DAU0,23:D5/9N5R=:O(7V]@I2.=:*6D6.;1
MG86)7KG2IM$<^AFS]=Q^XS3/]W<U_7$%W=)]3?0,6K?(7,N/8VGT^:ZSW_%5
M0IX].G65'_GW_];AK<A#?-CSE$%_*% LPHQ!#1ARL^JW0?<PR7CJ97 ,6(AC
MN)0X?)5?%'XF/:02@9E-Z<0^(61$@V/U/;$(O?:Z:8%!Y!EJ>LV+K%F'V$Z^
MPE:4[TK?7%)SQ[B0L[/RX6[];="X)57JHU3I_8N/(IO<S]WB?59?]]!X[B9>
MZ\9F^9J+T\65X6J6T.:/N.*5:9Q%054(WLE >9BQCHK]R:E(]\^'RLBS*M S
MM5!!I+_L (U3JM++T >7TUQ+M3GLA%O*4([F/.:TYGOFOHK3C=K*BX_2?!Z;
M*%_($UB$S1(?&>Y!7@%LR%A>U+#K$<!]5B#2NB#Y]:R%P*Q<2T(0=8(\K$;.
MM&RAB=,T!W_<;_<N;FYT<)GJ/2*6VG7LY:<?6.8&>QC_CN/8PO)T$<Z41S&O
M_TU1%9MX9O $OC9T#3W[#KX6NH(FYP3WMA&2L5BG;T9RW?%-ATM\LG)3WN;K
MI'41*/EU#07IT['%O6B8X0LL@<B=1R42T.UXJI,5H+SZB .T$VK=D,KY%QP4
M'F:EK!,/>V7A*/MHDET0H4"(-&*C<\LT=OUB4UJ[C$3=H&KJ3Z\#1;@,1^5I
MF=IWHW[':S-OT(0)$5E?S7G,+N2'>H1H#U5O9&JMYI3C[,9??<O3??X]/T]$
M-,NW3P^IXDO8Q&H0\#/S%$A;&)0IY$Y_,,0\#'OM@%"R9&'QGLL"/(X(+P(N
MMKS)0-CQZS#I"[YZ/D+_QQ>GO9&=]^(>7WA220*Y;XES\.8)8%Z Y!#<2%W4
MJ*O@2.!7;(4F<:+4F+866_">EU*(P'P0-92@:<54W^*!*LXK.2G],$_420_0
M+=TEJX2LYDAXO8-2R)L AX+LG6-QAG\'^S63I%U*.]BR'^D+\)W$D,RE.23-
M@IY#)9+>OBB^N91[%#^B;U_AE>7\L[17)B_"VQWA=W"46>KGKNQV@8%CB@G-
MWH-P9#,%-697!,L*NS%"; F B^X/A+]NWXL;WQKH@,3QO09"&()M_5]?^%9D
MFU?1A!].QCV[4_=8J,Y#"ZXE[@+?5V@A7#,\JO;BS?.(*?O.+:QJ]Q=.5/@E
MHHX"FQQE.SD)7@%HH+O8=(:-?X!R>Z-.C/HZ3+M8W:2.J"/"R.L).?.>%MK[
M4DU"Q4?W__R@9/^C9;_1*L3UVW@GFFII]3 L<Z62L1_UD5@]W12?*P^X495:
M)2#QVF_;V+(-P^ZCZ\W4,P?W#D[Y@#US[NR^3  KK][J@WK_JR=::I:_LO8)
M6T<?Q]H'I!;,:<\&9]G!2MYM*61WOV9!NI)FO[ QLZ;*C9#E^;]?]7:ZI8D"
M1ILV(7_ZJ9)_OI=@7LUN<?,.1H]_CA#N^_-/)K0?:"M:7H8+9OT7O\/.)\'_
M/I?U[=I_[<B*[C14VX96MD'8O_[INE)5?SY:^7/ J0'7G,7?3=I_C4!EIX\;
M73"Q#8*>^6VC\U]T2OYST7,>?S[Z^N\3>/]GHW?]%]^.[N[+N;20V!F:WV.F
M+4FIM#1;$BH"P%RI?:/KSQ)=)YQ@6[;3Z09SF)>I%WS+\QJ]7PF9GC"Y871<
M5[ P_$]W>$C,68IZ9F1FU^18VMOY B[^H+.?!*.0)==?>HA?ZH&)G/ITO8&P
M\0-VH4Z>QS59C>_ZEPZ2SW ':?E!L:XM]5=TF*VP8VI:TI73J0D)UMXGL^#@
M+C131(,N"/ P^ CLCFE^0*U@2<A'=ZU#5BT1Z4]V2F^A^27XEJV7'[Z=:5T?
M=[RFKL9D2JLNL]#)Z2:AL?&2Z#RG?KNXL^(OQW2F;@<2M@!.C<JWP4 "NQD?
M<J6'CZ6TO?V,> ,5FW)RT(F:I3*@VZ#7JJ^VRHP#II2?F=Y6 _<\+[*AQ3)%
M_>@FK#=X'P%!5 \.OQLE[@,YI,*607R:M:&5U3GB8VK>?BGS& WL_6L^%W((
MYFCLLC]RVO/&.R><XF.1?HV-3,H&0WX)6F>_$D'&/ R[BX63!L1Z_$@"@H@K
M#&LS\&7H$4!&#F-5.782Y^!HH/K36_7>JFIY1SE/X$NEC@*GG\[:1O&]RT!L
M=$_5$](/NUX%4X7HB\LDFO<UUW$N'C.<4T9IR;?OSU^.V,[!,%/GQN,<=(2_
M$R\FCB<AUB2=U%O]9>!9_A7W*C\YK%Z*Z?"W%!*S+#=S4^A'&%XU4-0Z-7S#
M;1VI7'(A1XO[)_8[5^<B ]'+L1<3. .CP<QIASGH$B*?K*EB:H0QJ:7& ZE$
M,W@P)3"[LXD[**YL F-K*)&Z-?4[K[CB;O+8].5'[''\'?0AI )-9Z6=*NL
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M(F'E6(O<C5X^/Z#8^';DLDVR#])ZY-2;#;%8,_-"R:."Y8D5V!G.*QR%!](
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M6)@/J2:TE23('<'5P#OQ?#_@!UO.LIW &2VHU'(#*;$IXM4$F&9?.4 96UW
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M"IA &G??R]?@IA.'4.-[8A]7U2>4@4[05$4>N/Y#AX&.[;^J7Q"2_;1!;:%
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M]VIY $M@"DUJR]"?SN?5Q0"(W4BQ7X@HY/XFLXK>A1\-(2]?HEVZF/IR"X2
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M#GL::;U^..GED-2O2_=\-K7U9RI?+V[IGS?<#+5VIT;H6$99TV7:)^QA:03
M&OH0?G ;X@V;FF/R[&U4'=L;0"1B^-SG#)(($^%, \ S13.\7+ S&]F*BQLZ
M7X!R,QBI"4_[[OT8O?X=\<#Q#9/9&[[3&B=H>%95FG7"*(*HW4]=\&.%#(^X
M;6HYW$Y+JOZ5:%&^-<WI7J/J;L!M:B*K[I_>2MPGE_C]Z]#.P(^7PN51X?_.
MF"JH_OOS2,?<"$=_:,_''^0E%<4054*@^;[^8QHK8:^6291_YTVA[#A1O-VO
M97-9Y7QHR8LG7RHB>@\K&S[MKESXGZ9?#]D8(8;+#]_)>V3\*LKLYOM-S0?/
MU^WDN[/_J2/JW_H"_D.[O/ZI0O#_\XT:%V8HT)0?<D78Q@Q"QYK<DF !6J<5
M*S^"0=",+*VC5R9O9PE:J\2;7_ -N$LS0'D\?NB]D.Q88A!WQWS%P7BAZ3NM
MOQT/P=P#0WE@ !/7W,NVYV%SE[;W#1H"JEU<YJVQ5!?P.:V\9GSR&#>GU&Q?
MAJ:GN?H-$5\!5N9A:F)Z<&Q'A.V5#-4O(X[HL<"KKI[[5,+-=A6\*/A-4&V<
MMW#>=$NYO(ZG7Z]GA>B^_U8F%Y.!VG_@V<0\@VCI6'+#)2"1J*_Q_/A[BXN6
MWI\8UE;@!\8XW9:* $_PTUW]WW#'8;+E?]9^Z5 WII"@76N1]344BR[F%A;@
MZ'S.8S\ ?[3!NMH?C[%&)T@\*;8<:S 4V34Y.]1'8OES>PD[>"QXW-B(VYLG
M2Z"MM>*CLV,3@)EA,FG_,$L+8W1CUZLNJ]*I:RD3+]X..KW,<2"M%[[/L.JO
MJ>Y5Q#OA@(4U4.G%-^SG^SS9"P,(&&N5=[)7[_A+IV.4/[G9*CP.>*<NOC'>
M-CL1R,2!^P"2(Z@&$*EY"=39&.R1IE'BQNPN-S>?&97!X*3<8 DCQR4+6B/'
M9V%=\-V@^,I\ ^OPI$#KLYTD#6J?%*VIJ )E)QS_T4W]S,NDIV<_V'70SLJ@
ML_$Y!XI-:II3R4,A#[TNEG2I??RI^8030^M^Y+8W((0_LFHE6GG.^=#9MF>?
M&_)D(T^,?+K'CBUR+A0(6]48[[EQ,MCF<._=OH ,]^0M\I6'[N)[=7 +5EP!
M.P;KS]' =MCN29X3I>PU-*#BIQ2ZW$X#R;U=,<7+J?B$&?F,(9<<UY"IKH-M
M(1F9^KO3'VK[>I9SLA530F-J$E(I"/R7_HE&9A= 6.G_<\T+)ZU%$?N5<+ 6
ML0>5IP=@]*TKJFE&HAWWU^*UD)7GCRWD3:[(A!!*?"Q*Y78Y?S3J73GQTV0@
M)JM^9SB'C[M/@5?'.C"><@2,+,+VR<OH=]:]:BC,RRU9QJJ,LC6\[Z?^;O=B
M:Y0NA_((0\GDNO=D3/EJSMZKB8)7D\4=%G&3DLS+G#R<#TD0'=H&A[7(+FY#
M#AH>I\JRDJW(SB<;NN,Q1JB"Z7Y/^>?6]>RC#5T)1]LS#G9[[R;E,,.]GAC&
MYT\E+GU"AR:>#DOQ)EPM3Z7^O&/#+Q25?$A._^D]MCW&<)@[0K01.(LN[=2F
M?LKO-PB<_$[H-E9'GR7<)?*#OAE_ZV[*MDLC)!:>VZ7T@HE%3DFTZ_G[LN:M
M^*,H7+GR'ENS8Y_*;/.O.#YRM3>]=YW1'FCL_GN&A[R]X)P%(Y1>RA(! VG<
MXK+SK".H%CF D'1JLB_"I.?BV(KA.=HQ_042SJ]H^D9+[7!Q957C8P)=T)JO
MS_U;PR,TJ2.<$ D7(%'>P*OE";R.[&"<RMN"):H;'BG$7*P"D32Y\QUN@B,Y
M5\8+Y)6&YAIB?UZN'_E% DT4,NU&[\C-OQVN=0EZ=M%?\TCF%OZ/G.9Q4HTR
MN5R4ZM %B^'"&/5136=1GBAJCIRI%:BE?D MYKE,</6/O,.5S77C-8LV!-_=
MN9_')E,M<&(JZMD4#T06MX\ ( @3_$P[QN[^))[*EAMLTID3+/.L]I?PD8DM
MIQG=GQQ";KSUSKQ/IV_]H+9I6&Y=#ZER-2G)5#^Z,^[S9UU)W<]G/X'=":TF
M&>Y9'K];E'6>!T"U6A&[+0DU/6]KJ+J=U.6^,Y97Y_>6Z]'ZWU 1!=UQACK4
M&0?R-F3B^M7J4Y+4 ]H4C*3 0'&&U0/P-4&4IA%\%V-+&$8M:_16_;[I;9\8
MA+*T!T:^6S9+J0SCY[ZSQ6+)3 B8SKKO+;\3C&;PS_&OO&29_1B3.=<,;D->
M=!;\@!U0#PH+(N.H.?1PEYSKPQOB+=9JLS9O&?)93,6DHSU7WJ='13/&V:+*
ME/HHK5E0U:^Z#,//X$]H46++@*+NM&3L)HV4L"JR];W#N6/2L$4.)WS=)X0)
MD$^@RQQ'M%2G1:0S^[*'I)_WGE7:Y#XC>2._H)A.G(J*(%>SN>_MN:I=,K-Q
MY7G=9@RYEORR'\9':M^&1]\-6@QV/; -0>2Q;$2JK>22-R?_CC5--9>0>+)Y
MG[\5/I%/@:^0J$Y-L@",2HSC":C0S./AI449F9);>=7_!VMO'@[U^[</3ZLL
MI;*%,I4M)"FRSU2*Y,,42@RF4 RALDV,F;)GFQ ^V:9"*LM4UBPS=D7('F*V
M[-M,&&]F^XW/]_N]G_O^/<]S/+\_GG_F.#AFKNMZ;>=YOF:N]W6AOHCZEWC7
ME'0-$3[HG&C55*RKR]2X!'&N,=]_XXB4/OA,VT-=XTZ9DV^2]B4]*O.D,5YH
M]+6[OK;&*Y\\IRC>L^9UPWU8%VUW>V[(;\+C90971=_[&,-#JO$E1!6GS;'(
M>J",$6V=K#.-[=3.UDT?)L0GHJT?/OD.*3B\T??^HF^2N,K[Q/<95-6UN-YP
MWQ0<L;':0J'O=1I-9$GRLX'H9(KLDQ6[J&_?;H@],M?E-/%!C<4/&M]@OF(K
M9<*7W[!5D^KDV:%H>!\ZS#M8,GE.JU1<' BX'!CHIYWD@W>_HLD9OJ;LZ5[E
MZJBR8_.A31YRPR[A-_[EA W<.^_WWR][TH^$$W^VQ&T3V\/#\/9R5)G+'(EI
MGJ@),V6O:..$ZA#)'0JH)[T,9()A3/&8U7BNFR#!A/@@K^4=C0^+4,U7F'9#
MUW0+HU;]8H.",]^^+YR7(>R-[+=X#6"Z"JHKJ__P07;6?6\'N:T+:\3DBM3^
M+JW4+YRK!09J'Y(DWM'E'@8,OAGP4,]P5/;N=GRLYXV_A&W$2/!T9MG!"N?Y
MH"C;5TO?)F2':>!PXOTHJTANPP',W9_N!C:#8[Q.Z*%\;N[6$\;D,EB['<,\
MEJ=(:!+_*42%M6B0=J+.CX / G'-3621U7&X;7\YHK+S2-'<#NN*ZNIHO4=]
M"W9/W7-2SJXCVG%/R2)8I%\D3Q\09[8W/0=6J- 6GS-[Y=MR]WX9#"PYJ!EL
M746L&+Q3D6K+F"C(]TZ_N/=B1\=T3_^:O,.ECY%(V4L?J\P9\]3I<(P$QXAA
MWH2(R=Q+BH$<YN@S,/$4\&[4G5-^NJ+.X":%P_VNO:LFDLY>ZW))>:%[HU_N
M/'?1V9K%H\T=XH/Z"E)N/GYYHD)5M2)S=9 T**-WZLJX3[#RB')A9JVE+\^<
MUIW'E.$)BPJ4MBOW*8$/\ED>M6S @O@@JC@)@)9Z*A@RL2WI#%NT'[!7)B;+
MH;:.X5R8Y-/ ](@)+!%WJ:L?0!MYO^F(+_[E==K)P7'"<<YR"L!QY&V9WFTA
MJIR#1R!',7VY1E]Z(0?1QD A\Z9X%/8 YJ2WHL6G/JB'H$4G9MZN)PX'SFX?
M 1"7F1>!0EAYNN5(0->Y[CXC4;64H3[]8YMC;8*^WJ^=<U"&)M2J08[''.7B
MZK3!L;K.CC[!MWX$:,FB31GM3P(%<@97'O:!WD $,UWPU,Y;S=O!L+Z% *[*
M='?V.+*_/.4ER=+X#ML0O9<YW1 6S$(PP<U^^\1'V"V871G4TB)&U?DD>I.+
M''9'C_M))<9D)$:RNE=+)_28]]]Y82I_NFG[I6AIRBI7_W:^:H-4]=90+7V&
M\)'.\AJ<J'5>:>KH*0X(KOD\YN,3MEI?"<W5 O3]6WBRPWR0!QE0A7(DA:@N
MM7GH&X 66T? [7MX:D 63::YQ+JSE2B'B%[/C(-;T7R@U_JF,CMM/O)!D5GF
MO>4(0]F?1\PV#YGNO^N^ *7\%A\E4*;C2)3445PS-(I\ *W!%&W'5K8G8(0
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M_N#5V55'(Y. "H)O;NC\ .\ZE/(1OP=R'-MX%(K4B@,SKO6,$)JJ:O +,>Q
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M[9#K)Z9!O]*PG['NNXME8W#1+O7UBU\^9?:IO9'N_<Z\6@-FG ?C[$F?5=O
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MM/-D)JKX(+,UYCJ30<3CVGDJ+T@,DF[/%MT@8J(".#PP4Y?P)D)MK)/#!8G
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MO9##*5P_8_*&9[ZN. T#$(YDKCRYG<Q1%F@IGJ,MB8J>AZ[ZX05R(+V?#]I
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M;^;"9]%%WD&NKWU5;1;>'1Z>X<ADUFR<TY-(:K]WZ,/+>T92E@IEGF29&%9
M]MR%3G%VA8T.565JH/YM76^"#305\MQ8RG(7#6)K&EWMH?CMW<-[5LT&2>:F
MD=H.T6=CSGI]&5"[<WJC&V8JO\ $KKAFV4V_H#TFOK;A]9%T+0H8,API,$]$
M%BF@1J4^?"-SQG&YG1"KI^G'6&XVY)PA(S-]L]RTY=H3C"\7P)T=?OV:/8=B
M2R56C2Y>YKW65M.&.TAND,.QE#P(I)]$20L&5P4+>G' WAEX*?6V?A<Q@CH.
MF6[.E1S0)0,6UD_?:#A:8C\XCSF:Z;F0\55.%H\JNS^5;[]6Q)E!_P74,L98
M[0P^:#&'C<#\($FA5>\PL=<9?2@]ECT@ZE]L<:ZVX-9>[)7,(Y96?;$W8I&.
M!W^-C1PXFK)R/=6>F+6XYT<]IAO;:,A191BQ1K8N6$!@6C/P!U9[Z?%68*<:
M9F[&:PNIX3BB@L4'H"UT>;?W9G2.NM(]^:(2R!5*G(6DLV-6=>?)A$-H!>?6
MQVU8O-O,Y)<DZ72A \GW;IPY+$&PY#)=BZXWT[0/9F>BYEY0#:CO(??R3E2^
M2>8JM[CL>B 4#9%BW/55IXKY&AE_19M3AVE5DC<ZRF2$[WY)=^86QG8^&JTK
M'[R?>J(0+A31ZG;"^I;C2%[[G1F:NNZ>4P365<&:8WG#*[P!,(BX$S., 0,P
M_P+>(!\DZ@KD,*IN 6[Y9$^YC&BYN9YK ^5<+6>)N9ILQSCC$.L\;U1\I:4%
MM?)+1>B[J4#<G F450N0F#B>B&48^S1Z7S5C +J-N UUN0(V"FL='CTVY+>,
M1F RU-PH)'%O;<1H<YZ+:;#ZK>]-H\'LFVD?EG:6G^<]1)%8UYEDC@3A$FPL
M@I7+S=/Q2\0H<K,@,M#&Y1%88PTX9JD\'=>2V5K 2J8 :Z&)9A-#H=_*8Y<J
M-!VGVL86O4.>N[S4RN@,-U#G?4>4#PETYLYAP#\/#6%"&TG/^*!R\<4(]F7/
MD)C%R\P5:X;ZB" VBLV&+P[.2Z<3E6L'EE(H?) [ZH[9^X?(^RM*,)W-G-X+
M05%5#1Y?AK;;G99=NI/4R8T^%VUTAI#("GP('LEM2SLLO=N.4<[4'7<*@NAW
M)!U((/V<:<O[;)4;O!\5UH"^+K8>5Z=!]3U,<]S [>N)1GEL:P;41\Y=>$:[
M^C/AGI81K5@:;-AZ^XXIUY:*6 N)/BMSL_ST_Z+MR\.A?/N^IU594LC.5)3L
M):(LTTJR3"2R3I)L,=D'8R9DWXI0Q%1():;LZTQV$K(SEC$DZS 3QL5L[_C]
M[OMY[N=]WOMXWN,]CO>?<3AGKFN^UW?Y?#[?ZSKG//NGC3L7>_T5AO+%V"#3
MDZUW$Y=J4Y[F&)Z,D52HOC1F5/Q'?X+$S]6E=Y9A1U']!G_*!@GH:3",!_%?
M&+LHA0T.)ZBK\1OVWTO&YG,D^E4T%*N*CHX*A]Y<:[>54OF1,KR=V%64<-.Y
MZN;:ZJ@'AXM\Z79((0JV#1S)!A$L6=)41=CHN.OVKULM14"(39]7WM=!=7LS
MQW1;7W^W0,$W.7V&RJOW1WUYRKSX4(KHAEZ4)M4J&C*5(0!P-6YB'37;5@E7
MIS(:0KVNN=S:%L9JQB+O4XS-,OS.N>,.]*6X=NY+T6W_]O$>VK'IONO]QUK(
M .$R;U$[$U'+IN%DS9,W+&H*E.^_#LK++)LY>/U]OF@IH'BA8\TNXD+;+\;E
M<&Q8]YF[B\ CA]WU(C>+N>L/5MTIL.3S89$7ND1.&VHH^+RV2=W.HEU@5N!=
M>R0Y&DT3I85N,$"[92LV.HCVEO?P,-R8[R N/9&9#LEZ6:H1$!?\05?Q[J^4
MRAO4I!)_G@(J.J8.MO^Y=-UV=HG;^\6>NR5?A0_;B0GC-=$/L6-9K$,WF$6H
M?4A=9BZ.#]6._D*>:^R)R[PV>9QB^G8:+6D#N%CB>G-Q-951*Y[@.]3\^MF8
MM*+.PN_/LMJ-S[4*7["P6MHD]]-/ FS0C!5#@#ZMN@RGGYT M+_E*%"AW_#1
M&!X=0<TX;-Y/AOP[A'LK]" ;!+]K@O;82]YM!SBTW>W[+.;)R*NN*5,[&B.
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M2X%_[)<?]?['W39Y7O.P; XB$0]!LLTD2S@0Q;\F=?W< ^)X*FO+:8F\C%:
MJ3@U&((V_HQM@]Q&MT*7&$WI]I@-SJ?DTE3S\)LK4$K>V9O[ SA"%JG%\HO@
MO$EB.7UX_RB+GH(F*H6&UB?/&LW^0,@?D\;9HB_Q:4-4Z]$O?3I+63BG#WE_
M\M<S6,P.EE"4_*7N4?1J-+@[G0T:Q)^9S7 !T"\7S;H-L*9-NOAB!=U4M ^4
M/IN,K?S*^!A@BA@]UL,\!\<Z]]CD?>X/J+2_W>\0^[4MD\_H^?=N6K_]L-4<
M(" T?J%;[8#B9M2ARV8Y!W_M]GUBV*"%;>\!%(@,P=H62$5E)$H*6)IB%>6Z
MPJ1Q//:3)J3+G^VD-$VIY^/]0_9_]ML[:'O6E9"87NKA4>A6N7ESJ,O7ZUBU
M7Y1^SU)TFBI8*8*UZS@#M;HE749.D>>524TZ^[6!=FPFJOO,A/=(YMHY9"%7
MMC/PN59"S#1)<53%5<_F17Y4AJY8?VJE$DG[I@ NZ:+-W-!C$7$J?U2=61H5
MQF?U])Q.[IA^:I&IQKS5V_A\)14YGIBW%TY;-0TV613>+!<K%W]1<+H@1(/1
MC[C*.DCGZ QAYE=.XX8/8X,$=GZ@7H,-U[E (=)0H:=,) PHW1_S)MUQ*JS&
M@:+R!Z65_7Z*A;T>'Q8)[S$N'Y:D909^)RF^B.WK/L"@Q814DIF<JJ<P\S70
MA+9&6&7!LN9'Q!V]LVXI(PZ(C :]DP-*95FV3 _#TLQNB,!=PP\=^[,*;=RW
M'[WO=/CI=2K.<#;N5,4MIW$((J[CVQ&CAIYQA6_/N]O,7AR/YH]Z:!;5IK[W
M!85Z01:Y?/_^Y[95W(_'<T]$CTIZ.<O>8]12-D\%A2*5'^D[Q[=:MIJW#G05
M3A-:>T2B<KE%W:DW%T+$/5N%D5VW2^=13;';MQ#1*B<[S_V0MFVZ@#))?2"&
M/3#+.)+Q"V&G>< HJK3.PKMZD@N<;EIT$ZB>$ZVV:+[O 17X72#Z/;7@_&OT
M0?0]XH@$[7,6[1N5BT/TP>XLT8CI%]N>0QDD]%Z$#:O3XL9#7&G2=V5]LE\&
M!MJO/B%B)&#KFJEN927^R42I9-*HTLD*S^HB[F.#O+ 2"#JMB&) IA>ZZ>DP
M7^D=G]\45VTD<E^?)G*[.Z]G]0B[B_##_3U(VK9\@<8]4</&,9T?)PU57XFD
M/!"1EP$/=J4\-O;J"4MQ0GX%A?T^G(L8BY3C;KXG&99IDKI/\>OW\-V[!/ER
ML?;52K:S<EKR3RR^*(5*XI^JU=6(VNF* RMW[S3?IY:C2B]\'CX:6Z#@G^-T
M4+U [(K=BYE/AAVUFKYS *8-I3I=UW:N[:&U 3=IT4G-&'NL(S=C]G ^-**D
M+OFHI*FU0>1)\:^%J1;AX7?<U^XK6@YEWTS4\P>2Z9;H!E&T,].6%@Q@"E@_
MP""&9AXRM.JG9S\IYRUZ1M?)J"S"P?ZVJ5K9)F'RT_;U=WQ2JL\?U"1<Z_.T
M$WF\\X.OJ738E_S*90^*'F&F36]_+_(L_3KP?2A4;AI7GH?(1M[V^#Q/L*P-
M#25I6^P\0M3/6#XSV2$3?^!=RGEOOJ9J!\BMW48]':>UM)ROW-#5W[-[/V)O
M6/;3L/#+/"6.[;$13J @Z"SVPC'5286@;^V.?QCCXI\A^RDT_O,-<Z*/\/Q7
M*OCW*"DK"+FVYDB?2\@_;4GS3JLOGSO=6C1&<[.W+_-YF*,+Y.=0A,\U?5Z*
M];4;.];VL&S-SMZX3<0&!SEB+L1, N^2'RA4+W$_<C./HEQ59^P4:^XO/LL(
M81;B7;")F I5\A@=@I!HR=DW[(<9::(%1:). ]$MXF$Q\WA!G,PW9;B2'X\6
MDJCV6]NP'_K%=:4H<U]<DQ7W&+P2?)A9@7^((0Q_0U<>JJ7#4#_P7$IZVJX8
M(;1+E\<4JI[TTO^#7SQQ']$=)5U!R1-_<9Z?/KI\K.QKW\;I7Y6)RGN8[X:F
M;^09.-+G>ZO;+5[LP>_+O6^1L__N,1<KL/HGT\#DM!C9GY;W#AUIZ#S<>(J7
MY[A9N!7F97B@Y&&]J?N&OULI#K#$I'N+,]YF;3-K.N?=2VT,H4>N((+OG!EX
M_"S2X#ME_?&&^_66?.G@\E,9:@;Y39.Z5 CO("GN@M?5IL$2/0D2+YQ;)^(H
M;ZCD?N?H'Z62YS756^_+13<;2$CVGVUU?*Q% %Y:&J4J-9F96Z0^Q5_$3Z5C
M2H:3\0^21V6:('PH^:P#N&,>#J>H(HD,HSRWREBT,VG!?ZPML_.:T;S1==W!
M[.<Q#EO&]T2*O&?KOB._;P6R#HDS,^ONT(W0#4JL\S8(;IY.HA2#;TA'GFZ(
ML&R"WMJL-&<H5-=G-=\'OR@U=)H*=6JY^-GLC5J/'N9HW?&\5Y>9Y6,JIB/9
MEY>_WDL([7_M=2S<T/*D!285-/TNIU=5>45I]=%,76EMN*UMH7;GG>JRVO*J
MQ+=5Y345Z9I1TY.(!XCWX1:N^8FOI*Q%(]:M4=;1WWU^Z-T)3[L>V?@S4=R]
MT/S%NZP7BZ9=+%K>G+PL1F'L&LJ^51*:2<4*N^C89W6KGIM6:A+,? BVS/M
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M[0'ZQ5 9Q?7-FG6&R>M<ET^C+.A?Z%![90<=YEC"PT0F^I?K3HGR,U[ =[[
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MO?-_[+1"?>T]$!HF)L=[U;_JO7T<!C&>\:2V'#^.;%>>/9*:$HYX6N"F4R*
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M(DI0Q=@2.R!F(9#!2YOSG/+<[^J!_4*3BZ[JG*1FC=OS]<'1)X%6<ES1[&C
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M2?8)T85M!T1/8Q0!.8+]A+-G9E2NQT<O$_'FN%L7 V>S\4S47.+"^W.5V-4
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M(HHZ;F3J)I5?PWE]&#IIQ5>501-B<]C.#,OEW_0QINONDUY4.Z9:JZW,GL=
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M'%JLK%D#>1IX3R_?=OJK&LB@KW8V\Z?\NI=CDPM@"?7I"?"G>IR>F7$75]/
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M+IH$PA@N 6^GJ#C@6[J!%M%<\( +7=N&8HE(M8_BO-#?ZW&2JRB] Q(4.X1
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M_D0$(Q+@V#1#3(P?\BAJ"3-IE5[2XF2$_C(;$,)@ZVVQZPH#1E+J:>YP:Q\
M_7>=<L#$Z,+BY Y(C7M\]S$(J0JR'$?Q7A5 ?</PH^39DO0I;+#B^W(G0,X"
M*IP=PI5IMW-=DLW#^G^$?4L^N+^@,=3]L>L%-_7V4<X'GL@5>XZN2<,0%+2F
M-U]@C?P^L(\!&;EL%[KO<Q5<T0)Q;XX!?<U&,:X(D7NERKV&<2OJK8IV:YY7
MB7+LE*74:+\N7XD;3^56/SS&$Q7%]$-=A?'PW]L3]ED\E>"-[E6CJ_@E(MW"
MDKHX<I"R W8.5FI0W[BOW6@'^6E]I<%0KU5O[SGL3T_4 +XJHX5GU@F*XTNN
M$'< )EHM%@LYR+[.Q#EG1&W,YX_[?/1<DTLPO#/@2XMW##'!%?ZLNG/;2^])
MWO>>_F]Y94])RW$L$6X/^!/VA2YV+[>'=$"'IX4NPF(WKM1@I+V>>,EFO$3>
MHG*N34E'?5UJYYX>G:L?J?$8HJ;?K[C]RZELT+'-5WFIG.<$##-1GG<W'^F"
MX(T+I*1"#7A2?ZP=%4N$0-:N-@HL[(!.I@TL=9GZVL[V"I7\5@ZJ'X?9^/#T
MQV$7@]LEQ(6%(-Q:#9Y_/OIN/.T.<T8^9US&L&XY9.P+I!JW+,&20?VH\APC
M56\N#]"QTRIUN5 KCUR@L,,5W!6[WF#E5S]*:@]Y-.J<EUY2+4-;5:V/Y>^H
M_^/=@14TY30GMQ[-6]C^3<5S^"^;X/D?O<=Y:0*.V $=P;5$_P!XLD[0!#\_
M?-4+FK_@C<W!O'M_U<IK<FA@D3254M'#[855B"U'L.2(BY]0/?@J;-MJ.$YV
M_="$-['KA<ZAG!-CQUX*B'NACN%#)YT??MHW?Z\>A\OPVOK>7>-' J:93P!!
MAA8U@Z=F2(=,#B%4.V$R7,$F EL.2*.*G(=BI=BZH0U1#0TFDDW0HO>?O$O>
M*#Z-_V3;[""2\#7O'L^F_Q7W@G1&)-V(,5+&Y*+[7B-X8=\/.= HD(C^Y5_?
M2J8'3:P<6S_VQ/3D28/WNCY'XGP.7R669T+#HB@:+ALXAY7U$*]ZVF^(&MX3
M,[Y*C:;M_F+"F?/6R' :%CUU8@!]#P:HHM)1^DN*R@P-S'B 6"*Z&A<[^@.
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M?Q[OPK:  2>8:&.@-Q(5%B+J9\J T10)GL M\AZQPGBLH3^1I%H(G\V\ZK@
M=^3QI[CTPC4H=PJ6OOS_VW"^5H'X=_]LG.S_K!B]\'8'-*\#GSDH_G:#[+<:
M 8.(2:$&0;QB#7NVN[FA@%@<!=C;Z_+4""J>:!PUQ,/]O6#;HZY!<S7-MM=(
M/3JOL8-36"Z_M(;M#([3B-<87S^R^IXIDLHNUE=<M*SK!QS[,?14'G2N7VW<
M:]S% ]X=4-XPGI[*'2 4\HIBZNJT,!6RGIF5X@*?-]EUJ,=W\Y9UR)]S.R#3
M_,DO,B>QJL^W?B_!3)*D_J5N*-#NUM!66#W/HZ*?%_ZUF<CNPM _9GFA6#F1
M@CYP=;>3)J15Q=K>^?-M#>@O9TUFO<=W:'/T#SW;M;R?H<6*<Q *S$1,@CN0
M;=F&Y>/[D21#NH^>J5/L.LKQM^810DN:O"#X 'N?+3X>_G)3'NIQ\L>&S(7<
M-T_JO._3O U)WLYC3>L_//U5R!23FQ,S;U6]58C(RI!Q8_VU_QZ2G><Z48^2
MYLV1;*-;+,OG#;N6-7[&2)B'W*EI_OG7]F_BOY:5HS@^.S<&H;^9I(?>UZAS
MVY 7"_%98UMU62_EUF _U)!2K$CY[<.OW0Q.=4J\.',FT>_Z3);7^2<^YEZ9
MGM73S-(P@<],$(M_U_ Y2TGE_]F[PC#C%7AI>%#TC>*Y9O!SE0G\)^Y-/(\%
M#Q"445+ P9S61K<0RU^U "\:0XB+YSUI#W';GK\%\XP_^+W6<C_5=SXN]/:%
MVC"!1K_.)WZ=//]\-_]?;HKG%%=0-X_;=:Z+P:BU785US#F^7;>0HWBA?#!P
M!Y3\]3>.53LS[%\6D)XU;C4Q<NK359NUKO&O#GCU,T-O4VHVXN\3*Z>8./MY
MC:Y/@C_D,;-6C9MWPG9SCLR T(YBMGB!+>^A-JVVS*V=%(/;7YU2X>1>.\=#
ML3!T7*=^GIOBZ-1TN>$(D^22G=W,@L]^#DMZF/D8KS%]ZNL:]^:'B=?5J$6;
M^?4!S*4,L!9?%"5M9DZ!;\MBWV/TP6"L+##",D+NY^3IV(HBW*9Y 0830/[%
MX_81;)=\]B5Z;=)T]GD76]OO2.\/!'^??"##]KFFSV6O^@#IL>_C?ZY=[)*:
M;7GX\U/G?H8^3?$\KWH @A>FN6IRK0O=D[X7_5NVDNPZ3O&JH#P"'NG*M\&S
M2-]R$OO)A,'<O(%BFM& UZ:-?D\5J<IA;>G]58TB*Q^=66E47.@X3GIFF9WT
M;GJ?;ORQX\?WORR:.V=^^.,?R7K!?/*G7LT2'NC>,N#7_=W?FC2NQ;S+>;NA
M%7.QOP7V#"_"%5W$RZP.W0)X1%GAL,UA6_"BFE_QI##FT"5-CYKD%!\/QY0+
MM./5S\$WFP-C_HP];$?%$ WCD6KTPV2W64;D%J2LYCC/].!AI#I=T?8.T 8D
M<51RW[A,/N*,>:]/!K$-1>PQ4.4PC=XA[WDL)R0+M@?M 7N&J5P-GP/@/+9Z
M@F[;"@--+N%R5.KI2<]T%M;+CJ#%O:SABN]+N[UY'Y.;^.RC\5<R^WN<Y+G.
MET6Q:F!F)"<-\@!+'"*$J$:@/4G/\:)<0X0;X6(K QRM WNYK9-95A"!-4[K
MS-(KR>L6Z,T>R6YGZCL>J<QS%-Y;8?WF?3(U<MJ#K0SYC^+ B\E,:2V.MJ 4
M/'MX>6:$R:+ GKWL0A]UU8?\$0%)LAW,'JFMWU(&%@"1MJLTO=EZYP)2V4IH
M>D;!CX>90=FY"WK)3IX7;2(+,@H\F32U#K?"'VVUS-IDHWZ=M0[X 76_;C^E
MU,KGOPP/B3Q,!SW>OST'WA9!;B/M6!;@K7S7/> 5H(T-'OW) &Z )5$#N2ML
M-;HBFLA(8,BP-:(AG!"#05MKW&^TJK=XMUW)FA4T?P2#M9]7F$[43DT\;\L-
M/T7J.Y>H_=N/L__?PB'P#S@;0V8>-X&WI9H- ^2YH.](7AI^)B#/T(56N^*Q
M8CCZ1"II88F8DK9].QC.!9T:7A)&3_2LD>@FX3]#06'/=PM'?V#7V"X&HMML
M6!8[H($S]$.[C*U_R6<7_B T^8L\QXOO@$([I6=0Z1S/.N6Y>7VA]3@>C';)
M>ZC*W\=P]MY8F9/I G=TK>O^GF<XTHXU\C*GA"[(4P;3(?AM*3PDVOB4"8\0
MDB)X^"S((ZQ?9I]R-.:O<=0;<#L@_@WEXC)W.>6&^J%9//G_!& )/  #!,)X
MI0.O!3!W0!>V!Y-XEB01Z+@6U;'@>+@?KZ*LZV5@\FF;Q):5W-[ZFDW+__T:
M=^7:B?.6;?CHF?7I3D<>([V,FROTLMA5<2V^@#U98@?DGT;A@9Q/-QO(RT=K
M.> U;HNGIMI9._X*V^/$!'%$_3:HJ>@BGNG8-D@6SU#Z-+D=T!_8%NMU1@*O
MY-R9L/NW>/P_UIM;ZVC25VKDB-Q1'=38 IORRJV'R1O(=SN\4KP;>.H+]V^.
M]QR%%YVFZ%]I #]F^RW<L;!\"84^(!:+?S@GLXL8%V;0'>X(]+K<$\3F]"X?
M<.>I*X*01?Y&))XVNP4'P*9'C)]!S-Z&(?)(B^<V=I] P$QXWOC7M[RDYABY
MH?O'](;1;78\?HL1-MJ+GN)E.;L";M.M!3'];)L'Y14NTA>9OK#SZ'>Y*"N9
MSG.;B1=Y $SG0?DQ_.^K;+Y^SC7]W$+6*'N#9LJPI?'\&<HK6]<N\M868FF,
MHM5U7>.$!NQR@IX&-'UO[HWM-I+N_Y?%1;?CJY_N4BE+SJH,2:R'(YL]0D/G
MU+*?=]K9U-S'/6*!*54>[<%@YH&ZF:#>CHP[SQ<F=%=:(K[,N!G0>I$^+),E
ML-0&^*B7.+#:FG.4_BLS4Z"'./4P<[:S1 <7M=;]QV&"CM]R4L\4Z_7;M&/3
M_)#[2;[9%0M<=+_S[PJ1,S'&<O$!5?,U%Q=4WJ5.*F&ZCS_\$-O^_=2'6)!:
MJXF*'NE05_R,I\,WT<<WMS;?22W+&:68?ID>;%IIY*>BV?%V2=LOB&#VF^;^
MN7B''V@JUG);9HP+YC2!>^7W,3<X@H!=4Q/:E)?!:AP2&S&0QEWE&GD/-/S3
M']= DP4AL'L>79+9*_;HL6D_^0QHV5;TLU(YZM'6L^19VLQJEU*@PJ5C#RH"
M)^_U$.I%FZC&IKX/AI"&'[R(&^L.1S:E@S?U,LWC-P>)"Z,.WVT#@XM<E/9-
M#4Z=DF]J3\8:8']I4QQIO!HN\(M3QP6S;W(J\ \(+ /4-SRH\70YXI=6!*8*
MWKD:Y7@QJ;T_3E$6\&>69#NL=N2<&GMTK8$\T72U<R^NIJZR_E,%Q@FZ% I%
MJ--.UF?W>2T.A)#^X+&4B?&0P-"]]Y@.<%:O1M@C$@:FE[1XZ8O%M<=\+3]!
MI!SIGI.GVG$'A8NO"VV][!#XL<^@Y8:TYH'P]F>YADXH>NKL7Q6!?+'OC% G
MD0([H/ >!)@JQCZLU0&CV^-?FNPSD6X"7/*!KK:IBX![X6*EE4<QTHN.3)=U
MHN.B-@RKSZND4GOM'0=]U^LT%3V7:9H%-2F_H'%NVMR@17"M%EMZ!T296WY3
ML -JM4-Z^[#. !%,E,]APK18[ [(30'2@LUCF_)@1<'UU]%W8S0V*MVC_<;B
M0FZO9W$_/+!DJM>]8')\T3>CM7"HS[=4.OA#B,HRQG&"$;KPOJ30/5BIIK8$
M:XYW'',?P8P^X/*I!Z5<_W3]YEGY^,1&1L[I.O0J&L(]TVC/DZ@T,IH83-9J
MW0$1Y2C?UJS(Z/AFON_L4,I&CGEP9=+-Z ?O"R:[#YRP#G[O15^\*+5>T7&X
M^VFAS1E3V2O)27\P+..-%,AA:JS03JX:'1^^SA]<N$":F-)BB*91PB18]K<^
MLU0R\A6@=QH_?9)-+_2/"S/Y\E,X:R+ZBL9TBEME]>A8S=C''9!Q?/FJKV,H
MD0C?Y!;:_Q.:DG X[#LZ\JD4I@OS7#8IJ:LM 3(-:V6MQB9^26:?JP8PY"S,
MR\1!RU\?M,+?C=UG' U..I]G=NU\M5GON8^'K.\!6_3#Z)<P>A$%H-"]8'$F
M;FTH:7.&9>L-MOGOW(/](/J?SA- 6KF4Y-?1I8*C@\<&K62/_;0/FH00L-^N
M6?EB*%P/[ IO$?9/=D!37#3[EO^4,L,VTDCBO9?K&08NIM& C#\P/_!F(TD2
MT> ZV*A+F3PQ@8B_LY@YA7OJ5N!T^?YQ_DD7B[SD\"=^W<@+P #=;5JYB3/7
M2HK#"',UB)XJRB.^*&F>IY.2*$.*0?<C=86,U$H72^X-7:QLPSW@UQS\LG]?
MW!8O&3NQ*H-Q/G#<7"@RZ?K4%/X=CR;KX[#S:CT;_0E@ ;8F\F;S*:"!CB.H
MMB0O#"%FD68,L399I9P#T8Z_+3*TXG*':[(\Z%^]HH2BTHGDH;$;A[X^<B9;
MC/BW@J6:)9$V]([^!)0<VP8(9DBT!CV8A3="R;9R@$>GXM%*E@)N0NO(INMW
M76,SR^I0:ZWUGL\KV!/>WG?Z+^;!=*47/ #TFSM57,?-KAU0BO'^*]!G3ZR.
MAX"N2;ZX%_0Z0Z#JZ%$!N5^=LJFAR%*Y4U9\=:!7'8_//WYR"^B^</VQZ33#
MD&G/2[*R"=003]2R)7'DK]YH :1A+NJKXG&&X/,=D(=5@);<PD722^ZY7DH"
MN'TL!)= ._YY)#^BPQGY^Z'?XA%FLWAEW=!R0&LEH_"N\M#N4PUS7G9=5>:\
M@_R%C]X!*:)];8G"Y. ([AG$&#6C$RRT0(R.,S*E#Y'+"O!Y",.NS(SH:NLP
M:<)F!E=A"&N3G__1J9KH7O;M=U\D-L\[Q?VI?5R08W,].MIRTW ']/>%;K7/
MCP996HZU,1@<:V)L'4RQ8*Z@37= HZ5-^C>&=+,O$AP'L*6Z8:JWJG'XP0V7
M\]RAZT.!UG)YEN$L:WQE#K7_>F6:4@*UOB;S2G["X)7QY-<8<4X1^N$.* I2
MJ;_,83@R7P%-17IOR. 77,EA(YN2,Q<UN%@_T1X?,"'DZKF[FCBJRSTJX?+@
M7<+Q83CY=N8%PN>2A5!#Y\TA'U8<=&VM86H2\FV;/S2[4;SAF*_<M<O2Z_QR
MCY_^]2UX/V'YGH"'&X%O\\I//T* QF^%_$]!()G/,P?9-6P<6P3 \N#YGR&_
M?R.N@HENY*YV\/@T5VB+I8/8FK@-2)!7CR*-!U$J; N&QXOO7XB6+P,Y9M!!
MW]43@S4_7DCS^+4)QKU(=Z;L[ON._/Q<2#F7AYXW(1/\E$):J\\.:&\G[]I8
MQ,D6HFH7_.B"H^QJBQ@10DF(G2>)<"\0!%Z/+1369@N4);[0JA&6,[XFK,:1
M';.,ZG(>A!L9%GE"?.L_U=5C'E;7I]CD93G8-#74H#*L&;I,:+E[8'UM"0.2
M:W:\Q8!?B5QQO0%![!@+*6>7CZA"SO9;$/-_'!8Z<,D^ZDRI68CHTZ.NVE$]
MCQZ<:D$;HW%:M#E6 ##-/7#T';I5 T_.C*&'MH*/!,!?Z)'D47KL(&"@<&*I
M'A[>J&W\[:Q*]#N$K7U5TU"-VI*W"(PPMJKU(]!JM5PW04\8MMSC+>)*9V\Q
MM)@\.AK>L3L^M/DX\B"/Q2Q0>2]@:C'+H0QOZK4$>D8'RI#'^H3!(.15P)X*
MEKICZ^==[NHT[VQ>-ZRN_J@,#J=-#V?<J!H^48,?^%9O4<A)U1;-"QRHD?;4
M*4\=LAE:Q-X?;.:D% 8&*G^L=ZC97&%7-R4MPOQ#N.%9&=S-WSL@V4C%TVY6
M;EL?DD^^,OA:/IY[N*/;V%G/4I4O*.56%MPDC(J/P^]O% P-+0"6J!B"[5ZO
MB_#HZ+@:0_!1!*NM6;IA"'G*-^<+ G.]=DS7^^@R^X+O=^(.R.>GI6*F9H1S
M35M?OHB^>Q /-A\X[X#4!CGU\.'U;-K2MA@]]ZE\ZC,#5?YW;+5^G1U0+$FH
M!LZOWR&B1HTF)%A38B]EW$!>&6('4D))H"ZOY>2X#$9:>9E^])%]*4ZY5M ;
MXF^4G"9S@\Q1_I1^F@3+& D;V1 1I$AW8<(Q4H$<%0./X6K;*+Q4H_!TV;VV
M_4IK!76-0T;GRA<STIG)!@=\\R/_>G!0_ ?VM)5)TIS[-M=Q/TYMK:,!CEOL
M=S^OYY<B*OGJDD!P?/BE/AYP"/-'+5[H%OJ/U=B/&,%L*3/"MB!;JJL-0K<-
M&FO>/[\#VC_$#!@V.0-,4#MK&&)_V/S%MOG</%K=)$&YHSWI?1T1:CK"$YI%
M/ -9U&E0LR8F6$[(.*C_;/=V/D."BFW#OI#]DV>F#GP,7K19:MY10L[;QYMJ
MFVBD2W91^35K^J"F9AAI7[S@D*%_]7V>=^C3_-<6B91KG:!?#KY]W>.TW(FZ
M?R&7W6_VGX(@_&E.E0["M+AESC0>GX;O19I]UT ZTC<[%249FY'PJ2O+1C;D
MI,,/I]3IM.5/+SQSJT?7Y3AF?]:'!J3H?X:&%O^YY\J+Y\[F@H7FG@INL7J>
M2G^]_.A4I2TO<-U W:J%/^6*Y.K,+D$<FU&STGGKC,]<]8W/"#W4?OB67SH_
MR/=&=WA0"6=4]*3'#U-!(TK#6\7;5[Z HO8J1N+.^22G">;%Y]<)U^./-@NC
MB##)'9 7%CBM1=.FD*)0.D.-!JQ]O PQ9DL4 8;31]Z[?UAP[ECM[">";P[!
M ^/FU0.[]V8039[3\9<':T)S]V4HYVU'5>3UNW]4RQ]IS/W-(JO2,GB05<S+
MK(_6C&!F#"=<=W4\E_F0D\(^.HT1!_C)Z5F,Z-8C*'T&O&L2VO8D0IW87%8\
M#K.B--C<M'V@*P+[\Z)/3C*ZJ#7_]H2K;O[D[T*=>OV22FO'GH:%#RM<QWI=
MIFWSY)C_]MOS9Z>/X8[*\_4]-CUVQ"PI+>V*;VZXD!$AA:]/CQ'Y\U9%U,V^
MM;HOJC)[_4?QBFAR#IIN7^;(Q')2=D">D)?XHXTB^6PE3B[Z7L-JC(D0)X\M
M<-<_4#72!^E)UA+QWI[*P")"?*XZ-KD(=HB\^_E43U]:VM/MJ?QW*.G.^$_H
M&:X3MXL$1I-GQ29*F"AZ!LV*#NW ?$J*-)%B6^(9\E,'!E$G 5<;U8Z8#Y[.
MO;WA+E/0'X"]?77ZJ)4XM::>%9#BHM%PA='9GB^_0!Q#?EV<K%U;*BQZJ]&8
M,J+AZ(ASQ0]!RBP\^KY;4!]+<GX/Q!#?S>HI?%V\FIJF]%?FI?[AY(0.TY^-
MKRS(YX&O\14BSS]Y'!.'Q6)JL;10UD-4*XEN;2N"= #>2+?!9+A3BLH,&,$V
M_/"BJTQ$+Z!?P'L'2PTSLQQLA'FZ<;+N*KY_-R_KWFA?^R;PKD 9\\,?VE#C
MHHS@'%07NMJ2+2E(+F1+>O *>G@0=Q(O@Y)##24P<IGN>$XN2HKM0E<E)&A1
MKN63)]T(_A^ 'LI4,86CJ.U1Y@E_,C3A&=+1HSYTYW:'D9JW^V/U#]<\#768
M-LVQFY4A4RM]$]%503Z&J_DX7-]DTA3C^(695Q:F!QY_M;![?F;?J()VXCZ+
MV6,9@@8SVTSF]+M^9W8P)QGBA4G UZ+9DF),+$.00)(Q==\==,UY[9/*#*;3
M$G*B\R>UNFR)D"=W@*4.9L[I'/$2;'3C@8JF@FS1;/4@[6_F^<2C3P27MM2B
MCE\AML*4HFRZ#GQK9!>6FYJD64WUJ@P%0;W+&J:F4']V,SU+YID#^!&7 />H
MH&4+1*?AVT2#DZG?1<\C5O\\C#-X1.LC?Q1:>!67HG_UZ3>S5Q;G_9.W"+Q,
MV!TY]A+0X@H5L[0GV5ZC;%U_AC!5.I9M[D%?(B>U99M0K7W,J.#VL+M.MXG5
MG\S] H]$YIHG6$)3^HX&'DU=KG=_?3JX&-H/_B46;:*(;NW%2".%!+LD6#:H
M+_BJS=B-206D'7D'-.ZU2K&,W)@P/M-_LP9*TVIS/<<H?__>VW_<VT(U47BH
MR 5(]#&A.M@7:W<BZUY_R/?6VZQTK!PK03E[!P](RWJ=NS,T.:Y7XT.KA*5G
MW^9H23^>N'9>5 B4=DS^2/SROEN"LU^+M@BG.R4K?AUJ/S>1>(U\,Y)/Z*\#
M:]((^SZIJ-$SWHQ0KM"NGCP'1+/@['.<#T8"NVU= _&MZ EIIC%C7QD9DL@5
M'GS?I"C=.*)>MG$E(.GP/,.E)U@ASJ;(TS%==C,Z@4-L#?9AQOV5Z4(K,@'S
M/-K *<'[:@&G!=D28LP8!HW$J^%B@#VS-(FJVM'/(Y7[FD_.P\20X+SY'/!P
MHQ)S.SJB3!=R .K)>"C-S!A+5A"\U=Q8DS*K4V;A/98"93TL/UU<Z V[21PD
MB;(F7'.:(R_"78+6=D 1N#><_>EHYFMY ?7/2F2)9V*F7^X)\3T7#!?B/PL)
M78<,8V9A63#Z5>Q$#!Z^.U( +VETJ_ V(G@ZFD +=@0,6!: Y@\-//LD["A;
MY,0/1+J3NK3VPK9CC-N1*:6!Y0*/(T14KE3UH)61(#AW'+:R YKNS%ZMA-/9
MI(V*M VOOH5Q&G[*Z;]I"TA;R>SNSV*39,_C)W= 70G28;S:?C=X=V"UDWH7
M?H$KPPUX_C>X:1N\:+M6])^3COY[Z;CF?OH.Z.R_&PKJ_THYN7](\JVU_Y<3
MC[B1UG= !]$7+WT3F^*(;:ANW?S/>?'8331CVIRT.S7'A8F.WDK_=XT)_Q",
MCUO_A[-2T]U(;*Y,_HWQF9E@^<UC(1AG[#^;'9ZF<[,RD!M/0 M)(45?KUIU
M.%M-ZC](M2(NP;Y(35A9V-[Z4 6?#0M9F.DQ?+F709*+XEOJ?/*TGW_K5_CT
M<4MU/B6?F<?[S@I[%/?M;Y&/#RPU?51T0>055(!^H>=4Z_&H?6(7NK>>'<5^
MA4Q@J99L*6F>Q)9D&Q>BVO'[=> O(0=7C,">_N5>Q*AL\L36.X;GYV3?LB.V
MA[WK;RV>PMTZ9OG(S>U9:?OO7P_>U,AC]E<$?OK\%JEL]]M2X.HM;S5_5YWW
M\)#\L?KL5,^EB66$1$0)8^Z09?3CNGZA&02^Y&;78.]GO!Z!/F5Y(T&FNR_M
MX*,YF=+[CN=CBX4,K&Y?OL*Y/YDBS7&]QN?NOO=WXBVGW]V=0J#@:8V?4E%6
M!ZT<OK[E!R@O.^61=:>C;MT[D#0;W;8#HMMA ;4+G!(C =898(BR R)P(%37
M.JJMB-;+1FEOBI:PEVS.&XI:SX1W6>B-YF$=8UO[H8":3W2@H2E[I9R:WMH8
M8>37HW2*Y,VK])?1Y'?HZD*>NO/6VH,BX"O@48T:_@RWCI"@F*))1&X',:R\
M3"BKXYRKEZQ>5N'XXORV45#ZMGE:QTK-Q\5S+G<LSZL[Q.;.0DY;MC]*+'")
M_:8:]>U4HZ)).M_WDN?Q%?X=CKA*PO4:*]67F/,.=P;RU3ISX].2QOU(YEJ'
MZ/+6A+=:MH;T)7 \5?'H-V PW2^2*GNA&?P58:L66VPT9M YE,_MLNJ\ WA5
M+PPG> 67R-Q\X7&*.PO_,F\PPU\3TTU^E9?V92L*=4_T0$3R5:<BU5G#QR#^
M7X]XZ1.Y-]U8TDUC%19)^I1!X[#L@6CF9T;TLC[+$[!O2^=%@HZ/H..H#D8:
ML.@<LT[ZOTA[\W@H^_=O>%IEG2*$F+J(RE;6K--R"4E$R#H5LDQ,$D;&3"5D
MOR(4,=E26:8P,]EF[)*0G1'#*+(,,Y9Q,HM[?'^OYW?_7O?S_=Y_/,\_\]]Y
MS&>.X_B\E_,\YW/0742+\&LL)U:-77E:^#NX;,CW,$/3HH  GP<^SON^'6&]
MYWX]'[9/7.U>Z!FUQOM']CO>N2:EQZ[0OO4QHU$T"F:5.AL>&A%3DM14\Z/X
M<CU*0_G<IJ'NF?4_!I>KY$]V7 X43XBO_)5FDV&MW//-V)PQ]MSX# VE+^;3
MJ=GF^/T!:G]8)FT%A=(VQFEU5CIU9DYKS3-_QU:T6A+-7U\N/EWW0;6-)9.@
MU]O8<>3/B(,&$J(1]"*)B@RX4WHQ)@ZL<OSSXXMO<-_UW^^=#!QYL-G6_"+C
MV/"J$W,/3\B9';$SHD&>9 1<8NUF()[. LYLPPNEU 7*4.7;/ULSQ;0<E>8-
M_7^H\W9=N+SDOFG[ZOZ0DU5)<I8W:C,F>B+&.W2>NRY 'V,8#J=(IS&-)FA#
M],"CC6=5<%@"M9*4'?D.V=-(4/:M4J5*N).P?E-)@:->GN'P_/DPV:*<[@]>
M%97G69F$4VI_Q\ $^/0G1F,Z,%[RJLUL"U+*; XE-K3E2DO;J-LAJV_-]Y><
M<KRQ"6LIZX+7NG%5#+8T@)Q4+V='>-PVR(GI4"G2'EW!\8"]G%D+<B:+.4QK
M>FHH;(-N,G0E]3,CT9)SW4(%&6_FRGVKT+T(&<I-\>#'41&[0=!SFZ%>C+P8
MV@.0L;BT(DCT^WV]6X&_"6+G&C6$ A[@OFC13Z 1,QLL/RYI&Q0H*CR-6/2$
MLRV ]@:(N*DD^N?$D2],C=A\ -&8Y1.-3XGII8[[G_F3:\W*/AP\T7$X0V_.
M!-_--OBKYNX;W9_J]_DQ@&'6:V"0Z<,3LIR"C1JQT$P'7"Q)"B7ZXP2SF&Y%
M.Z<3"776'R9>Q7HS3A#R(O?2OJTXBY8E1+XR0Q)A8QXW2M0.U2Q$3[^IE'P6
MHYPNXH)S.MO\N^K,X)D!D[H2FF^[Q&7[=-GUDZ4ZG_H<WA2H..;H2Y\S>Y>I
M@5D+GC95Z/YL$*BI]54!O*O)&7MD^ER!H(>#UCT%][09R95[39E5&4+1"/H5
M@R%9@L-1G3^-CJT7\YL'RO9^A [9?4<:'-W_9_\-]N[0Z0^.E,OW;QP\?_'F
M[LN6C2K)K_8FIBTDE23^?BXOYI=\H[(B=4_JQ4^W_KYL[B7W.KC>RT__5ZJE
M2&OEBQ:.&1 U!7Y&!=<%,\UI^TND8B<1L::'F +)QK#2JPVBFLVYTOT:(4D>
MS#U:2FF7O/WN!TQV1,1]NR!KO&(N%_FFZ$!G]OCOG)-$/Y4C YDG:(4Y;]*R
MW#X'4(O2H+OB/?JR$E]&YI<=M3[5?3859]EA5W* D)W\5Q;KXQF;\3>N5EDJ
M#]R?*+[Q K7>U\\IZ%39*R#2*/2T62EX>/]J^W=A^>9;E)N'16X2SYDU[+-*
M5SGA[)#IQQ'EIF,F"\A2ZN3)W&T07I,CB661!NRM@!,T><\VA7/<3!YH9"[+
M\478%"**LK]8\YFIC&^8Z3&K?0,A6"G.':;1Z)E!A-EX3I5L=$P>'(X0MQ+B
M!$+]=L;@M$ K6K",ZSVB?V"5E[,93;-6-@FF1[G1ZB0)*IPJJ4N.TG:+)(QL
M@YHL][TA&2(DH+%9ZH[]ERH'IH815:]EY\2I#JI%Y6X+^0%C61WP3BK&2MVU
MYL?@!6@5\?<8#K%@H[WU1:,E<O&^ZQ+QM!;T6>12K!\T3$W05M"V^VB>%SC=
M#>&V^S+-2N([\K>W@U=@V!$&G"G!XG/BT^KYG?&3DUA,)96N.@5^HJ!<PWT/
MA8_A=O,=6]@B<3K)Z.:/.@<$,[/-\6.(/+AERV3P71KNYYRIV(!#66&28O_,
M4&#Y&MQW2;ULG4\H[1XFW$+H) GS*6D;U(!(AN+13QAP5C5PB*G?+JL2A=;B
M2'"ST6+^_1Q[0$8Z+A].&-0QHN[S!=,@DJX NF_X>D22QY;))9LT=RMWO:71
M?GMB#3[0+\R_@Y 19U+.6<;C EPN+(Y7A45*XA$5PULCO+=[LZL=3]B<O#+]
M(-<AULU;2 ^\\4EK_Y6EP/V7+86TJ[Q?35WH.6\)^D=,^\V=/'$SK;*FS6CE
MN$")KMLS?W6(=Q]_(1GGG"XO\CX\^ED)7C'Q)*>?GYGDG;_W8GQZ .7EIU4&
MG$B!.-/CG$ @T^_C&$<(V,-@6PV$(.0XML/WOCM:?-:M+R74^,2^'<2IJ>%-
MS"CSG(3"E*M]NJIQXN)C%;76&EL!&U3&6G567<Y+UT>L.;+]6GO$IY_:1)49
M11F9X\@C!L>MSD"#HPV4Z-:+=1G33X#/NY!JEIT'S^U=S7V-:X4!QY;I'4PV
M3TB"+0.,32_3CX?D6T]_Q?A!XQ4$^G66P8"/#0.?&5,'R9OS  ^LV0A9^]P.
M@"OG!4]MABRP=8=T';)=ZZ+NS&?J2Q]\#::?.7#M@-N>KW<;;IDR.HX]V#5]
MW_2UL9W=M:%K72ICYD3;,+O[E3,>V!GK>J*DP5>E %O9:X:_!2YJB>E'_OS<
M8&^AI+3[B-=LL@!H,O?R3;%2VW/7?PZOMK-MT#]A#%MP"IEA9R.#:=3!3&9O
MX1JI49ED$.^('^0PV=>&(C -C79J-[>*<G4_YNP[(<D(+0HP30O>:X\L;OH1
M1^K2R LQX0[$A?E)O=:MGRW@UT%G&X1(H?2T0?!$^B6^->#;GJ>/YZ"B&E#?
MGE%BTR.?5GF5:?,F5Z5>8T&FYE0TEY7DHUP6F=<N>R%O0:J#9J)H"[W[N?].
M\I'U;*L$O]G/Q-JZ*X6N5NZN\:&]'8'U87,!"D7O+4?Q@5LE11/47SWCCCX=
M$+T;WG%V9Y>?Q(R^N3URZM[3CQ>4=.5[#([,_6.Y&3MA)Q::/BWWR>WHV]-'
MAE=UIV!C]CPA,M\%&0#M[ N8YHJ0E,>82N+B:S84N> .6.=Q[@+]D]F8YS6X
M]N4X4[GT?GO\C[\&[R'6ZE6;4[0NJ5*=F_?\J3$M*9AP^PESF[\LI]D+ 4Y(
MTV/9UWB#6"'2Z3\0@E-#CN<DCB[!-N;8U ).TQ$ 1Y4&$T49 2629%:BHX(I
M$&!*]D' 2^:(VG^VHDE%&M%!(05M<I:D"JFAK+(ZLP_O%E_6C(Z9!RPN;U(6
M'(*^95O6%GL3<CW0/O,DUEQ2,WG/L<EIWS^6BX*@#<4R_>^3DHI*[U6?U 5V
M:\4?26N[W,5^^=O*4Y*9PCDLS6KX ;W5,[(Q;4Z_7@X\P!R!Q-2<>,O8>'8\
MPU>B5>'L,,*SKTZUP,-C3*U_CA(R5*)C;CMP.^DWOBK9,5%0J((G"<1.QW*.
MND[:C.Z<&W<)93D-'IF]P5#.F4S03-Z:7?01:$:JAXQI1CU*>J.@^/2(Z5]F
M8(Z2%I %%8.-^DOXJ>(Z(P("SB#HJ@D#67I'^\:MX+6JHP&]&W_*.=&2*E*E
M+]TW@CCJF!7H1_7N:X+">/VT?R[_G#Z&VRM1M=OBU^1C,Z&>@5D9U50Q8;%:
MRZ_''O;(T%^DP9*PTE X(H5:U<,1=VW"$F<75=X3'Z-/@F.W5.B'!)KKP\SZ
MZIRD$W7 N^?#/G.< >U'(0<TQ 7(A%[\2%5.:+=5Y,639?3R%U%7KT1NL!5X
M Z:[N570N] H:!5?N4>[8D0X'HR E.=CYJM#\!01X(FV)RU%R'^?/#-R:CR4
MLF&C;*>2U:NND7/^R^%@=:GR.=T9; #&"*WD/(J7S\GM*,\9SAW']LR5_=<=
MWHA'O"C.:9(3FPPP"_[U4+G_OSR=Y(X9>VUPUX0)8)X<WG^;X[P-,OTU\/_?
MUD%B@4/G[\JO I@XW?W_XWM[_^50_V56O?\K3-'$SQ4#E@SD2ME_63]!@;?M
M"UA& 3IEQWHB:OS<$0'+Q4X#:STQYJ9_O;D%!M+=<O>?8YN].M=NT'%TRV>H
M?D$^DI^U>J1 T_+FD7+HHD3P-JC(T6%M7SB F]8\ >$JFWNK(+=!KHM-\2=+
M12_&GWR[>^=1O,)?B5MS>E';(&4$IJV>1XH$"J=09@?;52RK%+=!NQ&1)2@H
MT]1F->%L69D)- OZ>E;'T_@1DQ>,_7U],Y>*VP:YO)&_T(U1B^*4]!K\G>&K
M3LN@T6Y.Q9^<L"Q.3S_V]"3M]LSW_D4K)*M=T>H8]ZMPAO<17 <..-6SB&/?
MYXU!A*L0HKQ&*&$Y>AMT=UG0 U!LH\ 2JB!@I+^\ATW2UDQ9L'QY>J$SQX[1
M723?\U3G966LTX\0IWY%TE,:C>>L*9FK?(/[-S,S&@6=7A8 < UH%6($6008
M;GXT&XVZ )?0L>\I@K/T#4/^/)T49_PLU%?7D7CLE3PG;F9TX1*GBW.(FP"=
MK"$SKBV# "K+G!N//HYN)\M!?43-6TU5!TC[4,[<M[HP>5^R%.G "/"AJ#9U
M:/I*7QGN86VU3F=<QDRO9AY3[R6%XNX?ZN*1AGBTA;IN<J],&6_=JC,TA"]=
M7T'7B(D&%T>XL(L#G+((7'6>^2]8,EH3:=,&8_#]&-V K>V+$2CEB2!760K<
M<K0HZACW+4HW#VZ(?5Z%DP"*>5*1+93EEB.Z278195?@Y(/S+J8X+M[/I+4U
MYV76#=LY+=&3-T<I&'>,?"&#+U@:3QA'JO](!*YB&DW7FAX_=QRMR@ @^1JO
M&H^\>JV4L!B?_?+IQT1/&9=-:=8M/E6<Y$ !5SYM+'$+H)Z(9,C!7T 94YOU
M?0!E/4VE0*;_-KQT>17ER 1ES%YB@J,?UE9X^W(D2GJ"(HK]I<7-(DO&)^8S
M*R)3)^:'AOHGZ4ZLG7/!UH$QEG/?-FCR5:XV'_'EQ]#?@N984!&4)?NZ+Y%T
M%CN->\X#S1'A\N2H)91ZN!\W>2O!E\72TQH[,C40750GZT72J(L9J7K=G)N3
M%I59D_ES/(W.]&?UDH:'[!/3T^9S/Y1I9/LON#J/!FZ#)! \P9T#3PXSG#@2
MM;P#K3N'@PSQU%$0[EN2ZACJ>A]/V1GI.#;I\UBNW<G0+"9IVOW15*#N\]\#
M:TQ/>(AJ=\:8?)_?=+:7IU>2QUE^I)V!A=%("9Z0##^4!S</!6.43/FT]T1!
M&&4[?PH:M6E.:V8V-[0WR X5E,!KNLD?YK:*8Z9C[4CZA"S,J$5UKD$>W+4R
M\.*,62KY(WAT@__=T+NX)[ #VR ?7*SC+F,!!J(!#6% 8OIMB80OU;G#EQYO
M;I7]2#50M*)[VF-MAQ".NBM]R]=SSSU^XGF!@>-(6;%4@<]L-*\I]P0WB[3'
M#672RSNV )4B@8$5RG1[5M+P,\[IA]A8"G>IJ*15HR@?B7&O,4PD#*M*87?/
MI9H9Q5H&!C2,6_=G5OZVJ\]/+ROI52G;6BBJ";QRGY4<MK0TAI_(P)=5_.2%
M0"?+,8PKX%$?%A\+GCJ@1+@?H#Z1FJT3(MPRSKYIZBAA^3HW_R]F>UPAGZ7
M$BBW?M&-.'QDL).[F=!/9[B-_% ,*_=Z7]F4%?R!Y"_UG9$];N3)5^2*S$6G
M?TTWSX'"4YY,2 SK@"F5#1!9C/?R03BL:E]/0@C=G 9NT93@W#!G"B3A4V3@
M1.D*JQ(W2UP3\9%S"&SQ2V(&"T@VO\P=WCDTB=>$E=T&!6R# !6I*+821VX
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M/WC(88N$L ?KLU"&W?*HU22?C<W_=<+@ _0H]A,T)I^+U=6,@U25/V$;<OP
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M&B6B$6*=^H0LJ_@<B6EY9-TA/#-J)IF1*??3];74L.WPWOM?5Y02WV">D+W
M@$;/XMD0)FXR;-&,Z<ER!SK8YU#7^?V94!?"P-&DZ2HTR-$+S.!)]YZDD:X/
M'RFCE\+A[S5>FE4]\GJ4C4R[^J6FTFHL0-%:V^I0S^*%<OC[+Q.G]".S_#92
MZX>ZQV4*7@9R_XQ%>O<7U2P.1ZQ!H7RE\Q*ZE^P'2R&)\_GFJ>E!U'DFCF\7
M^<:S%^>7*\!$)+ZMS;0'?!AL6EBBAFX.S.53@J.E&GH8'*L3.X#2\G(>[1SK
MNK]"-9/K@O8_"N/(+3.')V&+07 :;-?.TR:R?Z0J*P,09F!=F2K-1SC2TYJ+
M*:/DBWA&=/+G:2/, 61$\WVUFD%BS+JJ5_78^\Z2]#3'+U;593$Y.JP^= RO
M!\,PP^[F[ R""."@N'&FRJAK@R@8TY5%(#$A+38I6,A:A./G00VT%CQS-_MO
MIMZ3=U4E.C7Z43BG;X08EDV5_R>8/R\\A7Y?G=CF EY\S1>*!_D.YS8?<NE%
M*%=NG$#CF*;(..?4)^ZGP!#L<VW40R)P*D2-\O?6WVB%"(.'U<86QKI!P<4?
M?XY9EB088"I_,8.O*)+$\P?L@C+U55WT"P)([K)6(<OWLB(":?8)%0F4H, Y
M7*A1_9WE8;/R&EAQ/?JKMCY'FL@[4#SEKLK*'5R'"7',AHT=W@.NCD#.Y'OU
M>_@<U6GI!LS!2RK/2.I_"(3>\DS6AU_D&'=S:\(%;R,;S*_.?2V?.R!?^=P@
MO<AD]O,$6Z>X8:PT ,MV ])8.\^/<M #$V*]Y,E<S*?!#H8UKGE<96HF8;J%
MV,NQHIE FPU#VLJ"PC_Z*LBE+W,L^8;A1OP2;<QQ)8EB<Q^:9S-BQ3(%PMA[
MT-_(0E!O:(P^,8L4Q5BX6I]V@ZG+_5(Y@/*C<?UGV5:M'IJD3]'?#1]2)@J;
M/#TE=!Q90RP"[W:Z4CKI'%]T+7Y@DJ>Q',GB5A@!2H=,G7P(?H*I\'F<#]QF
M"P$>TTY](:%,\WB.$QC+E)[^/9/NJ=/OZS1I$_(.0/DK4^V)<1GZ<?2W293?
M4E-R)5WO/R"*PSY65CP@;-4;O].%AAM11^=IE-#(5,>:U>7:>;0_2H=;7;?S
MRF0? Y("O0,9&6/),L/H<,8JGU:GY/5O<,FF1A34Q1\H22A''2=Q&IE 8WV8
MXJK<K,R=;:5P267!D6$?W2B$MX'J57,GGG[KUI& KA4Q]DS#GI#]-)]"!*&^
ML)C^B0F4,= U:2+0SA//X@W2=7<5P%E--"/UBR-8+;E.&;N9;_2;Z<['0R=>
M[\+D@BDJ+#5^5=ZB9( =DCG63[[#I[^]IF=W\/]ID94&L1PY1@,G:Z#D<.@>
MA;/,RPGZ,<;!X>__,,:,@-B+L@ZL FXB!<$J^5K1&F)2JOUWP&_N&#<!Z@/'
MC$JP++@YT+M*PYY,'>H>WF$@N$%_0M%"Y- "A9";YC:_552X[TER'XTW3SM9
M$Y[1VR("/QY09!KQI4-7,C_TD?.H:XE;32UA>6CJ>F-)<<EB#C6[_W+N\#BD
M9YESU.'W*'H RS"SCFAS7/W)4:W@?A:7][DM[ -^/LLT;ZI6*P\<'Z H">\>
M-<A",G7Q28QDRV?!DKR2D#TU6_21/,>:ZB"EP-V;-JI'1F5N7O[T/<]=\3DV
MW<$V_Y,?U!0S68CY!&GF:UV5Q68:='2:)E86/LFU]2<HG 4\F1!+@FN2YU1[
MB\DA95[;<"G-)]ZJ3"\DU]W(HU\Q5V! ISK[:Y8P.\+H/48)I<MHYXFA@.N,
M+?!CA2/ ![8@RJZ_RD0/*H2$LK*9X]2XOX"<8F38-8*[D?F@+E<+)FKSSGV!
MZ<=L<@R _\W4;>XX?)EM5W^_O]*ZZ0&J(BL]RT_EHV.ET[5NBDEZXY=O!^-#
M_3LF%J[A;O0_6B1&0*IK5.C"?%PV9Z;0#S$BIC MD%C*-J@-\\SE;J5 6\]>
M($3]-C/V&=ZUS)!KSQ.?ED^J;QUO=MOLE9E8V09Y?\V5R9+IS8>U:@*ZF5#&
M4L_SF^,OV$X<#^BIT_<U[G7LBSU=Z&4DYO# _)C3*)9AU0.<*"-R)&:GS-O<
MS=NHXG>!6;8+KY](*8[CZP3-9-GT^M;"1ZQ:=%916\Y4O0[,,N3]NZ@B?\.B
MI0*]#P]G(CUOD$CU5A$6LA--LC#&9=A( HWO#3U9ILR>)@S%O 4B>HVHT@9]
MO@V26M9-V8W,V@:Y,\K3)NG6]K;P')CCD Y4U-(OZ!W%^:>;_^<$@UMX(DPW
M4"7Q;![QU.5K&E#Y01R<\HV'#281!L23XRS):-&("NL5XH;R!%<'T4DC R?V
M>*"T^1W?C6E$D/;->=Q [QTV]F8L3*.QA7Z3&NGYR)0V:<.A#R4]>Z_OBYF8
MX<G?'>JFJ4G"%G_]#6IK(Q=]Y 7QJ2J*LO\#LY9&Y!S&\82"/LQM$$R/<JN@
MOER;9NC>UI6/<CU1U ,A98^:+0;I4J92,LMXX21QQUNF?5M'<NY'"_(2-[ 7
MKD' :2^SY@K2X%N+K;I^EAM$=^Y ]@1[8]'*[,RY'D6%S9ZUH@D2.:]$*>1P
MT_0G@XUMT'I_&/;">?'>JV+:7]M)P=Q383C<']]= _;"R0VS?-\Q;#T1N0_T
M?US_5L N*I%_;?N\(9J4+A,T<I2]#=J:V_M,(6IE[5?8-)62Y:=#F;%"3@RO
M5&O-_$;A,AQ[5TZ-SK&.YA<5#5:G+Y.>3>ZB_CG?T2%O<>RI ;OPX&CC_KK,
MZ>56.F02TJ@9CY4-*25@&<.-AM1X%^E[95WKZ1^L-48T],]5#_S")UN<OQ5
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MQE8L8AG6.5;388L^.X/8@Z>B&,D+K#)]DB$B91BZRTTO&AH-:UIQP=SI*/%
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M-'6#P(,E[=ZE<PQ_O00M\0/>,;YI6M'I7MIJ;U[V@&D]45@A8_-I.4BB@B(
MG^P*HV&CZN1I]7L:L0?Q9+&YK90$U*G\!2F;X%*_7(4AC=NID:<I6TM]W;2Y
M>R[Z$0F^7G=%#P=N@S310SQ^VSY]XD\]Q/_%C6QQOM9>?F(JCO2AR<=QRW2@
M<8XN]R:.,<.:A -@S0>3)*8^93=.J, C(^O.PFFU7GJ&L3$:CENSUK??MW_V
MT*Q!I'57#;Q]8HO_G4//(5WNLQY\D_%C=^/]]ZD_S]Z75C9)O;72'H+'K@_;
M+%PZ8F1$Y$P@PN#8;AA']A=FVH,J;;F'9Q/,BKKWU_N[;:\GS0]H.5A^.R2^
MY+#OZ]'/Y6,M5$:0YN+4%/;YQ'$ 'LY61%.E:U)BZX)*D+++-_M-=Y\8B@Z.
M*%Q81:*M[6WJ%?YR5NE7J7XV/OKSP)X.?\:7E(?9\#D;X"_JHC83RQ.<99]&
M+DQBVZUM&F3)"1Q+M@7*%JB\'<P8;G'!/J_:-94B,PHXZ#S7T)6WO\"@?_/O
M4'X1JEEVYW/6Q$CX!4T5GUO8,BO1O'\L[NG,O-1;4[&I\ GO_'7V;JQ:RZ)
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M" @( &>0/P"_"SB\\-7_ZF/AD/_M&0+\<F#-<L&OR]X)"6P!!-<("*T1X'\
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M]XMA79LG3N_Z\_#_'SX$^T_E3K$5\U (<858?J1V$^K"^%IG87R-Y,]?+6G
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M+1'9DS@'$HE[$=J/CRF8HN?LZ^(#GU+4H-#".77(F-L_870WMSAKXO$/B<+
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MH3<X\6UZ]\O#'AX>,C%DE<BZ9.VH1S'EU0C?P:"^NC(JF#S$L)*>D6@!T)/
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M?>=<(IF/;_W)M]?OZYR>-4^<3;\F%\.6=S_CQ;7;.ZG;A/\U27-PH*59F:V
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M_K(6LN;?C#(O'K)=A7P1IHTS.@E^V(1#-O[[AVP^6%"^A85^KYJGVON/B\*
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M0H#@T>ZJI$,V8M.MW:-88@DU;9XK:,#ZJ=,N(D\0W#Y-H4YV6E,%7@:%O%0
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MRM2X8)OJZG;[W#MLCZTM$^\XZE!/_A[KSSH1Q^:19QQF\^13--(X-[E, _/
MTVAZO;$=)PV,( OY VD;@EW> O21E^Z7E3"/PF F%15!,?$#D9'&53SE7ZO$
MF$\'([5'M:':J$Z-9##]'HXE]H[)[J4_M##F'C<2*#+89<N">AYM<K@'<S\3
M$@#^ZFXW+<S,X_@JB3W]$(H7[(9*_FB-S)E/;Y0U=QQ#"-#W*,/QWCM>K<UC
MN=UBK:IB4>XY4WK-#PU-DLJG%3Q,^:_LWLDL[D+WS /G-38.+:"!LUP;K_;<
MD;U@L49<O#('W,9A2R;Q'7Q=,8OD%"3XQP[SX9STGE-QNC98>'K*8ZX&#:O^
MT-34-/V?>&#(I7<G/Q@5I"D- CO:C*.WMZR5_),_WU<]RNTW_L/G@J2IIV>$
MC "J<@QCZ#V352BC2COJH!EJS\RR3ULRO*A#GPHQ:BO*G7A3YR3]),C&6]A]
MJL/WP:ZL!DN\AFI%!%0@&S$-3Z_)G:57OZ&;[QJ9'*.O7=/D5MC)OO"-]]E,
M$>RO/O03240T:EJ!S;U/IWTH/L**> ./H@UWVB6QSP)Z428=_K JC7B"?,#H
M:K.<$'D;)T *%^CI2XP\&_9[+2WZ[8SL?KM>T54[G?9DU) _S;^7F K%NW0?
M@,18 < $C6\X&2S2'A45%DTEB@5)(5]AYH*VOJXP8T+>%Y$NUXYJNQIUF(Q.
M3IRNKVV,-Y7(OOU>%8;=+T0%H:95F-<9'"PA1/0;3BM2!Z[25/*/C6YNHWB_
M?6!.U^0H2;@&[1ZO@%7\B-EH5^>O-:T*S$7YY>\P&3-#1I/[V2GME[H9XD?I
M/_]MX!<3UOY8^Y7W:63I^9<\M LO+5T-&16^DD8ZKF.+RXNA.]EQCGE&1KJ!
M=GSHGCM0O8FZZC9,H,I[M^T&%^?&QHX-6/$/K3U%A#H'9SQ!GIE'6,0Q6_??
M$@38@S'^20II=@"J M"@V)&(Z2XF)N/=OZKGFG4*<].UD]N-*<G5/ID>-\<5
MD]S?9RT/Y/4*GC8#YZ/J7=9+&([,,8[]\Y!DB/1O#4#EZ' "*G!S"MN-% .N
M4B$G6/S 54JL%215[L@HWC?3"@>8-Q*%/>&Q+O3>5Q7]X91JL^^!14JCO<TA
MZE,E;:D\Q7^80!TGO0YR?O4MRY>NLTPJ%F./SRF.(?2P@1EO841ZP@_ODW2_
M9IS;4+P%LP-%VA4H;PS=4G)@// 8U#2XXY_IVAT\ "V8YR+H(KSWBUBH4I8C
M(,L0YX 4/K;"CRSMUK"T=@WL</EJF5*X6D_A[Y S_=C YE&TYI[51,BVK,F^
M$W+&]_Q_L&7->?Z6<@GK73R#I?'"1XM?UDB,M\CFV0)#\D%@U[W="55/AKZ%
M4WC/NYJ@"QBO"DAPF3CO/2^G!NM_BN2^]%(= K>,@L?<-WW/Y*-M\NM38YH.
M0*-89BCP5]RCA9Z[82?>B9IV6=#X8)<&:>!'*DYH QQ@@^.&-UC3N3BDGW*D
M*9%J(]X313B$]F+P[V)2-62#JQK! GUE\"CA@<@H/E.82(@&;9DEHT?W8-[[
M>Z;R%DRW&W[BOM-3?)S%#>0SS*TFC;08PM39\GR?1RB*VK%'-G<!_VCJ<_2-
MT7]6Q6-^VY3#0[?<QZL4ZY[ O4=W^1QR /M(#L;C1G6Z_VPWRI/8KU0/*;LQ
MHDOTIR]3JI"G7CZ]^4I#,'X)[X)\V"[ER1^?F%X*<OGE0@5WH\$L+T91(P-,
M16<@K!A<?44*[5:#4;UR%R;#M@>C[ NUZFHT?BX7477P#J=KZS*H#;6/K[B6
M59[OO4B!\D:PFB'L;[WDC[\"'?JW^'4D[FK7";M6.2%4:]-D7?@RH$X6XUDX
MPXL.\66B$E_B'UZ4Y-3NZ"\8.\GDQNO0M1>AG^Q#3*L?VJCE$7);(2/H/B@O
M9*$97(N)9XL$%->C>XIY4)U6[8(^MW;-,Q_830M>H6-(D!0Y:?SHJ,1O9?IP
MJO:FN*MN<]GL5)ROZC1^3HE\*D^TY;W6O\Z./^?I-ZMAM@PH2ZB!5LSQ30CN
M$%R/@LO0@3[1S2LBTMGD;C$3O0:Z?V_TW 0+\@8.[CDV]\D&YMHPR7I;._X@
M^58[S)DH]+/)(Q%%,5_ L,2YV+QQ=.'.79?_$))[CO!L9WIFTMWIT*1RQ)41
MA X-.Z@T*<$0.0$CG!K9-++1%OO O5XRKI/VE?;8)W52).,B] )[_ !$OR$X
MH\#\FFL%P2_W#4LC;$9_&YA.)E$\QLH#Y 3&0A]G^VXT)R TRE<,1:8+Z_M/
M=[Z#3LT'4<^Y(:=?G46P].)E+#QT/M49)&HD7G@VT'"6MISO^]+(6]S@<PDO
M \M]L^O&;CFOGGUXQ(W23Y4VG\I"1!J+(I]D\+*>]0XYI"6-?Q\OM;%45\.H
MAYP,F7FU4595_1>>=[;Y7>:4+'W&A:<)+X%<9L-\@6;*M;P*!',:K/SE<2KK
M;UO%#53@_"$ VH=JS%TOI:K![$;:?1G2O6(H<0+8%!5Y1(-*_E+20F].??!(
M5?=(:V9V8%C9:I:K0B[,BJ3*/2S0"1[$?, !YYHW:'N:")GW^\7L(\B1HC-
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MAH-BWXR8'H $]O8"LJ4N0O#%/2<M;L2LH8<,(_8OZ%-+]G/_;B<4-W&HVAL
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M#]LY6^PP07'2CP91>!N*8#>Y5?:MT:A?Z4B+BF;JAL"1L*!D=9I1G)Z#/"
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M4R<0HA;6?L-7ZU_>//ZR1^QIP+(.U25T&*A%Q#1?(J"QR01&)0GHU#@RL*+
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M=?F-3-";1W)X&H TY.-/3GPV-8:\OK?!KA!>AKA)Z_/DJF,EEAMI7@2-"SO
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M51#@MW^AGU]3!H;XV<=,-2SSR7\EAY^^F9M*+:NZ\+^3!$GG-FI+ <[S_0_
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M#-N"Y4^7_^0&@;>">;FLAUU7_6=H%=HC66!PL^122XVH\)Z0W(=$UFE%D'(
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MOQMDG-AE/.\9"+0M!VP&,H<',D,<#5AM3-HRT5$\"6[2/3^P-._+MP0NT@5
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M+N>N_>/5S/_S^3^?_[L_KU+G3?.7?VZ8]X+G\K._;0OR^\/KYQD6/S58>'L
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MT_#?JSD"S.@? 493 ?JZ/'_-+C,89:Y!5X<N\,#M_<DK3*HJI-_9,WQA 9A
MKQ"FZ4;KG?/]O#WUG4H6'=(/6/J%/VABSLM)K@P6G[H%EN\_Y*#U!MT:D=U
M$=CG[-QS[8!=G,P9&QL_#5ZEY1II*EZ&;6\,?MWV67-$(K7;M)M.9#YB$*1<
M%5LMY#1==DYSR%\.UWH'=_<4[+5B&=*Z&03#B.1,=!L[78?6/QJ4*QP/"/*[
MXDA)[:]RJ/OY<-7Z8P'3HN[]V7WO I1'I'+D>B1(!M[%'MU#!>.R: R<<+)5
MX6FUD2!P36_$<B$2;4BS16,;V[G(.71=^)G:= 3P0)$OCVP4'8I35/*PZ1M4
M@ILY(2RU<'S$A&#S*+T;)0PMPD0HIR(2'FA=#B^!QFQ9T3JGZ];S' :,C/+@
MWVX<_]&E+YAP!+@OKJJ[%MR_V?>=8SDM?'6Q2@=(]WD6K5,#1.&))9D333<^
M+LDF:""[9!2[:1<)J(0J+9NWJZ'VPV]\99_*%M*D+">V2'/[8<8265*,;=?N
M5@GE4H,[.7D_J -!'KQ-,QJ#M56L0]6S&+; -&Z-(7*Z>D=7/#16IL<CO.%\
M>)0TSJI0,DO"L(KC8?,[<Y3H_8K9PE P(TN3 893U_6#?+ZWGMSWC^5Z@14&
MD(Q^PT"S*.E?"_%ST8PS?A0(UO\$M.'7D'15JQG.E(.<M#3,FVT4J9GJHU\S
M^4M&9L%*0<A6O#E#H."+IOX9Q6/=N:M]8MD2H^78E !]MQ'!]44BC1>-12Y^
MR-DTHCLVEZQ*D,)_0U!X(:1J<BKN(WH.C#/MI$*Z1,6)QW\FXC8E.FH[RM<.
MX@Y+7X4'*HUYM9@^%:_SU= ,YWK_(\2V>,X<_59$E<8Z2S<6DVQ<G;1.VB9?
MOS+>VW,%0PKKMK[7Q#>:_-23+E]D$OVUU#E3MA=<)<Y%J'WLT+K'?0E'DR*L
M*_9"<[J$+5X%\G&DR<:1C9(N6WWV_OZR1:[\$>9.CVO@RW=:DSO"BEV3YF;=
MDKP%&EGADH:<[*]Z0R1=B7?26.HU#:CW&OB" G.T7[CC^3;[EO9:,M/>K2*J
M9P%!)]>S@<)NA:U1$8$'50M?'F"?;^,?+Z)%3D2P[>U1GH()$$ZR6-\(Q3.]
M\U1@UA$@$=Y]._8+EGPV-AVIDW7@0<A9FNF"IT/86X6(<!Q_LM*(,$R)_+AH
M'AK?09,9P[?%WI[9]:D/;9C<_8&NKVT_U.[%,%1MNCZ+\Y#'/4/T[Z1Q+T6#
MBMA,X%WJ--VGY6;FR*0AA?Q%::NU[1U)LT*P;%=GB3[/]]7.XN6^DBO.-^D-
M;],UC:ZI"*TL]KYNZC!;SSP9ZF_T\4I>8;(N'1)30D8$UF? -XQB\\-0K)3-
MG0E3)YN%5)7ZW1;?\)*/SD85LR'5+\S&DT3S5BOK)QSFYO8^&DT]HH=](8W.
MWR(WV_O;8OO^=TPZ_]-C=3BP80 VKASRO48KE?W-OV^ML ?^A:8]FOJ_#UP3
M):[1*(A!2ROI N#A-ES>[&\@^&\>QLS'_1UJ(@$:^1%L*>/890'U[WAA;(")
M!B'B(.PU$^K'.FG^")!5",:^@)"\0'SPO?/D+,BD++*I[[? L'X9!FQ(<T;[
MHO?M\#1FW2/ O72B"PW8#3Z= +ZN$3$*W&.GL.[!J2?'S8\ QZB0(\!UI1?_
MX0;U-R\?WM5YDN2T]>=NXO9T\L3]UT!_^)8J=1?>F_KO?=AN36T NQ\!3D9_
MA=>">D"S81B:.%'B2:L8T=2H=B($P44V?KBO3%418C><L$K=W9TZVUSC=2'W
MLQIB)$977BF)1U&*LWQ5'XZ<:%J=01AN?=ZYW24^6"TX;)54\6AP^[TS2/Z3
M6YED4$5LK\L:ABN^Q\+*U3POBZ4.9W9YHEP(8VNLRJ^(-'DO8?)>3"/HR8NB
M*R%\E;4D7Z//_>NU$S?V/3\< 6+M=-B\0JWG_%[1)2\SM:WNFT;G-*N4B$[7
MTHE,3S<W+U^>@'F[.;MY^QY_7U]_OV==QUNY,#QF;\6]R][H_TC?##G4($O1
M3DK1L[/]61% L9L$>Z'FI?#I'2(^=\B)^,44E7:9F3W.,XZVJ]''FPG366X^
MI2MG_-X4>VGDJT((F4/*FX4?5*940G>N2; E4W>>!7>=,K7XRAG==ABE")&)
MGH/7SE*1:(^M=,CQAPFPR_YXTT3$24H8X0C0*7J1:)+I4^X ];<B6B=K/SD3
M:T(PBO3Q/=ZE&RS_(5O=J$LX"?;E><X!?ZS.\U;7Q*7;VB!N1:] _Q/+4,>1
M2R/;F!A<_MLZ@K#NDXH72\'0>TTZK,B$HI3^'R]-M=^8<Y,RNSV(*3^\4]$@
M[A>N^"?+G3VNZ^6])1HOP^]Z6YOD3YGHFE3ZZ;V[)!GTTRMHQ/1*$<F16J(C
M'#WSU^EQ7: Y".XT-#5:".8P=J7U!DYQB7I!299+1&?>?K+.P,%BW*UU4FQB
MF38ZOL5WZ?3VCS-?'(9KN.1N_M[P4V,J9#@;9 )D%-[)G!#?W7P$SQAY!"+<
M1I#5%$FN9$TLYR/$"3#V-;V@]+AH 9C2V"\E,'"%DX +49VH.RRPN#-]X<GB
MHM?IA6_H^3VIYK!OAK#ZEWHEV<KSR8<R\ Y=^ /3+S,TEDC\UJP0C67F, AV
M=EI'& HG1=40?^4L6>"&0!W.W,W$L$1E(3?<X4EE35\%=F/4F^J&*5$'KV">
M'LN84CG44Q^L"E"MEU@HT<5YBBR;)C?+)Z0V4K,@W$]TO)9'-)%X*@>=K$[]
M,=9W"</]TN+3W0"(G:78I7<+"R62)E*YJFS#@98ZC4^[77ZHFISNMD0:*B$O
M\&R:&Y;@PP3+5";((>VH@TVGII%)X4-WKA3WB(CO7&LLL&*"D.A7&BQPGW0P
M\Y,>/L=TPCMD P#49C"=HG)^'*<X#F(*C;@].KX] P X% R*:"!&.K.U@B-)
MW\D,SV=ASC:-ZCWI.@NQA7O[LI0;_J=F%&! #)=9?A:(W*/VQL"\3F9PX7IF
M<B:L_/.J6E7?[H6DCLN&1OPFVX:+Z+<9-A,V=F$3!_Z[F3]6Z](X-:. $LWX
MF9VR)FT.^,@'Y?UV.+8:0C#JR$ W@NB1Z">)96*P&CXEW^Y8J+O":[' P\5+
MRGN_/RW.<6-S-A6QS3KG*0SD-SC3Y,*3L7:36IK@))A(F0JRN+2Y)%P&7JH]
MH<^EFIT8Z#>AQWVR5K<NZRQ"51'[2[HOX C@, QU2-Q.$2H_ W$<JM%:OM(9
M:;<39$[:?^KTY.W:Y(^<"\IFDYDIS2[[[E-Z;<SU C8IWR=@[RK5G62^%9D;
MKU9A/IB9S"W$4Y8IX&%=(8?1(T#^$2!^OP^%J-V@+=/T<IQF%M"#OCR;J=0)
M6C -E+YTZ<_K1X"#_=WET3'/6>H()397^^\O5:[ 1XX J/V#,[=!-V9 Z<CI
MG+5Q9]^-G+R5QTJ[QJJSFNA/AI?$!$<(VW^6_;:MDI=R?!YV --.=BP_QZ#]
M[7V56WP<?$K;ZAM:4&UA-R+\2^=7V^?GHPL.' TO]6$],T<CEM4P50%PL55#
M!BT7FBUI:RTB@E1</^_D6]I"FD!ETZY](RT.S#0.=YKIE^VNZW(:BZ9M^I16
M6+?96+6P:H/T:U>HFI28_VC-R'_E>0-O75A#O(03EE>'C.^@_WZ$"?9#O\1/
M-<:UP,T^"EFI5T!0\#>P;+E)]&NZL[>^%L/CCGXQ%)[\D#Z\!(!%;)F]>FKK
M?0"7"#>>PC*6;:S?<M678:"N:W[F"K/8UQCM=T*NL1+:++)4PB_T / +E[FA
MCIV:>F>( &2O.,T$J+X\&MSKE5WYM'EX]$:,WE6SCX$"VNIX)O?G6T8>C<AO
MR,JJ(T!E9S'VM)"X//;-FOPC>FG+VV\10;:;PX;+9ZL9Q9>U B4&/F]K7#Z?
M%&IJ<W $>"F::!G"F,!S8(CH1X^,HZQ$;E"O'@&JDH\ K^OEY&NB3'_>[]\#
MORI^^XA?8I)V+P5AL9]K>(DAZ#^5$$C_7R(T\$"(;NZA>R/JF_#NV=TMX]55
M\BXE(G!]*+RQM]+M)AWF.Q#)$;\30YP<KA%^QA/02WPE53X13*>=UP^N9/G@
MG*Q]]2U'-XO.&[79]\X,-D^X2+^I\ET2PCNVO%9JU23>P"%3E#>#.^DQR',L
MB)=<U,6$2H0IXU!GH/[.1&!\TN=1N1DE)PF+CY-U&;5%UQ?G^*8//:Q3J[%E
MC3C_!!U&XF3NH#.0N!@+\Y*-E\TS(K(Y<Q&=XY;L'HH8,-M,[)7M.EW?WZWX
MX>'A8T3T5_,XBWFF"\\!?TKU[P$#6AF+*=9C=1 .,FL/B N.S3T"-&XN;B"(
MD23HU*8R*.T(4"="74Z0/8OH13?R997ZM"Q4%I-W;A N_*P$Q^4JQ2GMN]6K
MGAXD[=1$'P'@'4HP3D(P#DCA09#D1\'8PC#14\G&9!0=W:R. '&/#PWFH.#N
M90BAX2-QZ/7X%9@('IZ<[A]5X:"/K[3!J*I:'_20WCWWGN@2Z@GD#F<5JM;I
MH.,G697BB:*<>I0A?P1@SXH:UE, QG>0^M2 HP2?@^1\A(:?Z<&L)F*K'GX,
MW7"?GJ'[SR_$%*XQ-+;L!@FB(PJNWT-2)*\=ZGQCK;SJ?6_Y%NV;J/B+U3,6
MU)0OU/1#,,/S$KM716EN9U%;I?"]'?B,'7A7Y?7)[?]:%_J*SY(00PZE109=
M8RPDJZW'&N@JM^PY2+7-F+07A*XI%YFLVE4ZE_M\=#+_5M6W#4D% ]J9H\?:
M>>L)$AA4G#,+N0T[('-OI%LE6HA(BO-$K61'3*7PAY(T6OG"S%HJ*7R_&U76
M)=T[&\TOL8DD[/O31/Z$69-F"+(K?+9([!D89W?_9@9'Q#X0@8J@,@A^$GX\
MH[[^)2A"-!8U:;[-"=16[%N=7&[ZGKD8.Y/T>WM8>NEK'JL6GU%/J]%S+"ZA
MP!MZ&Z4YO#TH[F-I5-@FS<&HVG'GZ<629N\IRRWEHCQKH\NC75.(NDK3XTD?
MVY9U_1OG2C=_4S[2SD<O(@@&(U^&?Y,N4\NDVP'172 FSMYF&AMY;AX7 Q7#
MM<?Z+O42G^2Z#Q3)QOL]JN=:6X>=-J)WBP_J"?&?9"!T>.Z0G=.GL181@#C/
M#79"&,Z?PCU!2B4@NM"SH.N95\DH7*7.H>XA_^:Y8HQ_:0?2UB<FS NFZH-,
M]IE)F>L//!>YI'H\'7CX\7ALP!=U<9>=-3E],?7UYPL%/P=-V&K8OS5^&(XX
MQLC1O-XQ@C0[M&&DGM]Q/M.W3OC-'U!U8ZF!HR$X:9@ )YY6-!$?]LR^^P&F
MFHI+&@$:-KBFFL<Y<FAR0]B0RGM:L$OX%;U"*=:G*-/![N^3%=8D,NPF@?W"
M !M+JIJRX/70%Y:\6Y>D5A:EO+YI@@95GZ"Q'X\ ]3\S#XVC!]"UBYO*]$;K
M(^9LS/@?FE%,/I!#L$< 'C(&D[VS]?#C^&;]QTV-SZP2Q@9U:GMM*CX)L %/
MU_ 'C/)G0:L_?HNGO<ZP;*E2C.'!9@G2@?0QHBUSBS(,[Q@$U8*Z%X5HPW_N
MQ/%#Q:&%/,E@/"=9(FXY1>?\?2_7XF^+T,QN^^7N]%,42<+/''!\2).L2WR7
M/3)^F4ZO]>Q#0R64X.2L.+<DVT;T%P3!%$66;-PH(@))8M1LBAD10VHC7RN&
MW?M(5L1&PI.FCP!<M$O0&T;$RJWTW<HSB[>)>A5+0IIYZY$O9>L+[,=WK&>5
MN'Y*E17J[IA,[3;-/Y)S],3!F:"U..0Q_>/Q=K_".[1\NF#G;B35SKV"G+YS
M9T3!T<,SI>B5S4&A9Y=B#.E9FR2TR20S7_)2AP#,ZO9%69''W=8'7<BXHJ1.
MR_>K'9$LJ3>X35^U!/Y,M7GO/S3@^7EJ]E#-MG!9_-'5=9JZQ(1.?+W:!XFR
MK<P,C4?AZS$,0(G:R[_8HT-@UG2L>$_[!&%K%Z#<)#_W.32G,!-_C#R"<2[!
M!3JP""#,AN#T.QD&D7VZ&]GF#&8CW^L/45%M/SMS9NKAYOE9J[G(PSQH9\84
M4;;#GZR63.(G=Q#UL9"NB@(]^--JV .R41G,K)F(26N%X-AE.^&L?G6;#CT:
MYF3&I>._Y[.U97O#*G&EZ,9ZZ5(CD3"]9U57;$!YWQ>8R /=@GI>!=]I9P)#
M%:]\=DLL=$UTU,ZSL+WDL?]@Y[U/@?0];O;$;L,TV^G+ ZQQW9^1DD6ZUCV]
M:OIC-DH#;\Q3)9M:'@HE)7VO-#%05^N1Z@U*<MQ.:LU=(QDCVMX,,UBKG77Y
MSI8Y48A-T]=*"WZ<R\@W,FC *,[F[LYWO$VA*."7S?.>Z+O1HPB"+>@+/U:U
M R4*<ZJEOJ5QPIR:"3KIU')05_K3(P WA?\]&=\C2WHI@ZZE:+J)%O_\2;LA
MY:AT7>$M4XB0_A#$B38 J4OO&IE;)L')3H<W*+)M25N=(![8A2+RV\]CJ/>H
M+8IZ6)E=26\1+C4T2GMA098+&KW2_OR]706W)]P_C"F1^Y+]_N!,U[!V/S1(
MV"F?4 I_05@04X&!;Z@.UL"<CSW9>2? 8GLP&R7H)O?RMGX=]+(^+\MP1HF:
M1IVK?8BK>:I.+O0KKSV*TXC+!/JD[9?=1&969:-X24C11YOUFLG?&W_06X$.
MW5[:IBX!46E7.W;5S[I-/IX<@P@]G)HP=IYIJ5_X3%WT':J,G'>@AYI^I*9F
M'>2.DOL!8G#<91>C\\)BW:^AK67>9SX24EGY\]AW>L)8YAI<T4 7<,6TG#(D
M^.?U%W?^3\+_Z@0U>:;M"%4XR?BA'+P\F=:,VJX*KH6W+!XP5R4M4F^"]X;
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M))E1D;3SL%/4$HHR@1\WLNEV:$:VZ$)_R-DHJ(1=)=*9C@#J1;#K2)$Y>]
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MU6S\5PEZ?Y7^FC.YG1/>H0+'(NAR=SF%8DKDQB(WH@B<N,94BEN)3SN(*)M
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M,'="858%IFJU4(0<AYN7/>VEHO'53$MN+7LZ;(V@'REL;IBLT[DJI(%:=%E
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M.\P*) :GOKHU*IG_]AAS\@F%"X,;Z!7AI[&,$;NPA>58SMD*&O/C0^?HST<
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M(FX7?AK>P4WG<S W.=. 0$HL)<=W=T'X6)=D_+J,&^JG0NJK09SB#EP5$-U
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M+1<3/$7\5 1;0/CW(,[ =#-=Z>]9UW9X!0#M#.)LH .OCN,!$8# \23IPB-
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MSD=TS#DTIZ(^_S1 JG\":M?V;L(6*B4OU_BIH.%+5) ]XIE-@:@X5X<Z<;0
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MIPYKEL1SYP:1".E*36<P2N@,Z>5.1:=DICBG$VI=E8"7U(H#+X&5U==I[@P
MG^<%MK6$;]LS"%DCL$@.Z"(N<H*LN]TK8 ;N6YG[ G,,NH^MO)/"0I<]OIYA
M[3B%F=J+7'B>^0&.>B?6DP;T"ZM7$R^N*9.V80 LCJSBG8D*5P%48T!(9F0O
MGRLM0,>_^I_/2*K[+]+#&8#TUZF;=%\=T"L$P0(]MDP:)A-GS#F^4TY1#6FO
ML%_ZI7Z>(<=2M&$C"(X/,.DP8?)<[2$/2'RV#5'J^A0YIT506RQC^G'43MN7
M3-.0T:#G=X-P#\@0(\(H5;1PUE/0G'S;LWB_.!S2!<WA_OC+5[F2=DAL"+0#
ME*".C)4M3VN[%XJ5CZ/+,0")BG.W#+,_#=6\^%!@?/BBTX>;2-]F-8>%F] #
MS7*8H)SVZ?,$P[C59K&@/CR4&!\QWYB*$C\^,-N_AJQNU,/65D<M48-R3&ML
M&@8=N8WG318*;A7ZID-1KBN>%$MX:_!:F/\[U9736 8@%5ZKNJ)?L,CG.X,\
MOO]UIV:1("@6U([D'QLOS! Q!U(-AAIOOR5/S![J0+HE-)\@WJ\JF7;SG5*A
MV7[K@&C&UH'&LMN2@=_I)\AP;"5?F"[Q=9@A<>W)3#B?,3&[7:I_I5&F68VH
MG)5WH/G3[#,"Z15RC"[Z]-:P9(Z%Z?%!8[E',S(UM>D#!^Y3G0GSGW @YBXH
MJ'ER9@25$.9 0,[RQ58#%659M: .!%CEVX7E^:Z-*X[T)0&/J,OM(J&?(XRR
M9U03&KUG]X_;\U&MB?(MBF%RY">59$.]GV&^A#Y/+W0['];\F,.8H4KE3.;L
MH=/(JFWD2@XI:RK@O(V'1\*P^O&;PEM*_5O:J,(]2L@ #6[#1L7!72O'3.@'
MM6;7QXHAO[RQ*I',_>MPO_P*_"YDO&W&=365D$G*K2;>C*9(+L(/WQU1YJ(+
MN(&JPD+V[()LF59'U/STXU&XWK?>0*FA!_[3QN#/S?G!D/M(;+[C(7(1Y1Y]
M"E(E^+W)G'275KA_&"B& ?@L3^5/\?Z%PG%4$I$S7VH(.19$Z>_HX^ZVT)C*
M,&7"=L ON7FB<ERD=PG4@[MRD:#RTAO?=F;K^;=>FJ?PF?LBOS/T#=B!=VIN
M\<BF11BBA7>=W<'6'9RB[.ZGTTI=TW,D-2;.Q5T[K]WOLW'1HC$I%BWE+ #M
MH2*+D-L%<';$%SCUR";)F<F/G."M>LR=.65:DLPRBTEV/#.L?8$^^O@5_(DS
MN1QGU'C;W=.[8-H]\+'YFXZOGDDC@7S*PUT!LK5*N\2WWC4BOM[K<<MT;2_(
M<B-F3Z%L-Y0Y)&G_7#.\E1.YLN'- &QI\2+?F522=^L8@(I-^$)'\1?6_S='
MEO_ETJZ#7.>DZK*#.@?T3Y1;N9?G/LH(/Q$^:JX!J(.N?6< 8-D,0,);">?(
MPUK(1WEPH4Z:S!LJ Y!K%?! :J(\V?W,N%7L=![K!MT=(BT'RARZK_!DHC-I
MF]+?;F!..26'8M/TW&J13*>^@ W:&E(%D*3KS,G\8/+'+S8K-10V<BJI>+^\
M([8R$B;L/IY&A,=1Y5_/]\H&'#+8&/$HOZ<L?$'.:^7XSYF,#J$O/T0">R)I
MKAN_L$DA6Q!'B/FU3;,#! [2=4CL[0B0F2_:,3_O_!:4EZI?-C,/@91? '77
M5;&TAT&>S.2B)=%+][E9[.0[1EN</:X&Y2(%8]O/-6-8XIX)G.M0>&:+U$L5
MB4I1%&@J/E7$997K*C1D/Y(;\-3VTO;"SQR'8^AY-7BK)1+[%;#/@@V&%3 @
MX485/JQ!.0J^$<0D8E%%\%9_+A8D-N%KFGT2@NP@+@[#@61^QOD%B9.5:6KW
M& #\6\3.Z"@5WG= 9"IX4VI->S,0#9*1.IK+JN[RN+*"N=)5K?+Z6R&$D77]
MAZ@DYTI3F\-?FBP]O=+CAY=1UB]Q+B.EZ@+\G@\R_:*-56K=*Q;+040(Q9H)
M/#>9Z*$M2"N$.%7RASVBI5%=*?QAYW\R &Z80^2CM_M78*?=7XW&PS14GP1H
MJ0]N?IL^[7!A;6U)IMI3<0EG^>1T[,FZ#&6'UNS4U;C?5VSX3SI:WC[V^*,U
M9U'<:EG+]!L-0:1<]9S-YL!^+UIZ*P-0D[HZ1; CW1V N'CSC@5EHD!<,!6/
M9JV1 YBGU0P I_W"2*TXOX.&P<BC51/K_"D7Y*>?LTG?/'/-V5A\8J]&803H
M/1OP5C3\,[X5P4<5'D2Z@L8J<:<KXRN9(4JS1)@O^4T%&3VK_2[@:5L0::\9
M*?@]_.2%U0_&&Y<6Z"@178XCTSX"J1/DVM@@[@[( <T+L_2CLW#61B6<9KS(
M]TEEI@9LU"O;;C^_5E%[=!CU6],$JM9W%G?O1==,D>61DM3O=WVM2FP%"$.%
MT6VA!^;[*Y^TW+^UI+QX_]</Y0>7'H3[%9U^4F(&Z\X)"KE8N/*&8_Y9\+-@
MYP:;>MJC-6W$GB #<-3 &%=2V+I,CJ2'VFSN]_5@LG2@(0,PD K[!B%;D9E8
MC(!^I)9"9EY#L NX"/B=]5\0]J1XHFK";87^-3:<DQK*MW.ISHF3*D^7,/.I
M@9TDRPY.003J/(L;E+?ES,TIYKQ;0:(_I=]X #7>[I7=F (-J<J&?\H5)ZOU
M&0I)8=,Q*:'OA)87D[:Q23A0P78G[A5=!_Z@5Y7.&T3[H"TX%B;W$^Z*&!O%
M_FQ")%&5<'>82!\)$=CV/D >F87SV#N8@^*]E$.1B2$?7-M"/M7?&-E:KW*]
MGL(9/4GH'&8 7,K9Z+R!M/1FT24,[R7S"% 5OJ/,P>[[UY*G+D0;%")Q#Y4<
M!G76_G#3<.#1JN70;/X3,63\PU_'AAX-N,WV'[<XRWZ0(A1^XO//5J$D.DR=
M?))>@U(IB7[3ZD<$ C4][9L#[%US49JWA.:JSPY=1<N77KW5_<S6XGUF?4S5
M_4\6);3G+RW?K& H-WS\2,\]7\>,UGAC;%4'2:XDP;H]^ *4:BHC1:+#?^K#
M%1D P@"$\ A.$]I9D60 8B$)D-UM"E]W&GW_-M-%<T"T&,/1=KH$TQ5_:0%_
M0\48@,/2:LNSTE&D909 Q#PN*R]@+RN_Z="TJWYQ%IMRPP0MQ6Z+ <C.0R_F
MBA<XB^+%#,7CDQYO;:\;7O;O N:FX$MTC!93#-5:%GRIU52=_9;LP"O4RP10
MLN8!R$HH19!\G^]$D%6[MD!V.XR?6-%4'%321@R*-FX8A-H2IHM4.SP2/BA/
MR7GUKCT/EFM<](3S'-6TC)&9#J"H+$$)_CLK:()=*X*]&C&638*2RTN"SHG4
M>5)#B9FS]^MGUQ/&B<T-61O&87JS0MIRBPH/^">J.Z:!=IQ7[:0L[IO&Z:U8
M[6D-9^DE_"B:Q4?=V P)+CYZ('9F,2@[<[@4*EL9US[2?M]$6)2U9; DJGWP
M35S0 ^2J]=+=K%/9IT\H2\K0AV/*+BNVWJ^],3>^]VS<^/0]JL-<3J#MA9OY
MY:"1>=PB U ()U[B-[]#CH-0Y.!*H/]0!: -YO;X,6&/C&B7GA -\]B#6<_)
ML_H_+2,_P395EC=:S91-X*/@F9?HPP4U>W$>S'V=2?5_IVZX;OT 2TL<;3G(
MHHEGBPJ:PXF"KOEG\^#E4&8O<!*K:/@+ETHUS5GD\_4G&!$(%K\N0%4AQ\^4
MVY&T:4F:<D5!\2W-<@/*\OQDJPYU6NH3JD;)TBN.-_>"*X*\MJ@N7RG'D6\G
MT'*DU"#/M0,5;[R]P7&ZXD,D"%4DF]@P&XB2)Y^QB=Q.?9I_ZF>C\^PZ9Y@9
MN1S[I-%B5LOC!I'OB;))N/3W4?31Y9".3Z&A_J&!7IL][CP) QU9UR>N)/IL
MA^EB[SNWY8O.-TO,DC%M/TCYUNWU(+Z[BK CLP\%C\QSX8-DT4<-E=IO]+A=
M;YN1L:S,HED/5+RW;O^Z?B3^^IO+Y3]E.Y[;N_AX''IA97VV[X/UM?,EQV3\
MOLQ-A6<K/ALWU?>J&(0W/+/0APF%Z/[;5H__B>L7I8QE^YP/Y,2*' 0W@J'7
MH1B @H-S@N_V4O$.X274D D&8%2(R4)8KHYCNN2_1]Y-E"G^EU&,IOCZ&8!S
MM@;[R<7KP(,L["Y'Z%6U95$0A<YMT<1P]J@@"8+&'H!O+D@[/EK_],<# A;7
M_M[OBRU-[]['W&>FA8C^\U6'8D1%(\Q8 *7S2"6X%Y1\F@%H04_8?&\6('?-
M\CV%5MNL3!"'9C!Q7HTG9Z"IT"J;#BWO&?C31]X',=#DR^'\:^/&%Z@GWXWW
ME'ZV#R^[.7!!?@=Q1H,0>P1^K4FK#UB_);Y-P%,%&NS)"C/(7X*D3Z,0-SA@
M&2% YUI$<BJ_;):DJA/0B7,$^80P:*%):(G.JS.9.+4 3UYO[JG))<5?W:^&
M0_(^9)FP9*@Z4^J/0N.W:? 6MLW4JPQ -)QZ:-;3RB23](')$1+AK2;PAPAV
M=QM2;7_8:7(/Q6A)!7,H0++(7B_XKG*#.=>8V_COF:A9H3%Z;[G=A'UX5_EO
M7E_*[^)?M]UMP^.RBUN^C'MEW[E7[#ZRL&'TA73\^,>QL8GUE]-Z<W9VWSG]
M?MP[LAX8K*I /PNY"QU#T+D1A"K4>#BZ!3'N/;.S$D! S!Y/H<O2<N'8?$PM
M=/5\$6Q$6YV(B-;4.)1'KW$NA+K#Q!I&&C6P3TWYY\?WUAT)7H7^%6YGM3Z<
MF.2>SWE#*W5SM?$$&<(/E\? )#U!U[R/&!9?&EQ<K*AY!K1Q4 Q]9O?D4?6P
M]N"K4+,K&)?#PLZWN0]J(LM8-N-7D105/<I=6">H&KY2J]*L*8L1@QTEE\S\
MKDQXQ5&7JC^L'*JSYUCDRZ^NF94UGE?SLC%%:[#FT[/VE.XCR.=/Y<FJ)J1F
M,AJ+%'<(<ZNC)3, KJ $.B<M$R9,1X-8JC%C>6$VD&AF<'F9;(4[I/K]*[0#
MFCJ_WA9RU!!>JI(IEG38?1Q6[G\W@/OIP-F+-4UHTDO]BQ!>R!UYLG3EJA!"
M#.*!&*^B'S0MHO?2SQ!W5@T)KEC\RH0_06D&R*3@J3!^NS!)LNYKU-T=[3/#
M8?#BQ6S;D5)<N.ZAZ:K7QL6'+DP#HLX*':\U[T4F0:KD5_"4B_#6'A#!!,T-
MZ\6P:0N$<1)&$^#W(8GJ)&1!V&F"2B36%'1[!/<3)K'8]>&!.BS2W?7 6L&7
MXR.DLZ&^1W+')_0..XNZ0T=-'C%I]];QRGENTA #\#R/&5\\0Y+<$0*0;0ER
MNLD[T#!W !6%JR.:%FGQ4=:IBS(IG:S_SB___W!9WVL)7,P\L;,TL1?^.,)W
ML=?VO1\#\,&[;9</32C@+!&ZZZ>]Z9N>GIF;/NSBE-)^)&7["'LZ2M:WMG0%
M*.87RF,UN2;Q1:&%26]9-I)2IM2=U5I;UU" =S?H>\<M'^_& _'R5!9%X-W+
M>('\Z:_A6.LT+_G,;P?.]_,:_E!*,=-U1 ;=K7"_->6C*[HKL=6G5X?'?*2^
M?YIR#Z+RN%+J,!)>L-H"</'S,<9Y.@R:2352"E.?IZ<!'-#=V^B>Z%:M^&/<
M-N,3YP-O4G^N8\*WN%Q;VT2?\$W;'UFL!6QVXL&0[L3P5C7K'@&K#I*P-+(G
M@JHRD\$GIJ#OF >';K(->)R_);DRD+3A=1<UTXCH9#4O8,\_\&#D3 /B,RJ%
M+Q>^=6U8.<#IXKOWL(>(:9H@]6P#AM++ (2#B,4'ELZE[- WX1A#JMLT S#M
M35G8KP'F^+IT]S,\= M**%[_6W_<"'D+.KR/D^[\ST],C:5^P:%K';=8=LV9
M,7DZK23,DP*A=X5DQ] /ACF10PEP4C9Y5[L&"XK\&M]>+CG+45KL$6@+B:V!
M'".OF_8'P%G=U7.GCQ&[@^2O#:^'"5=X#+I_/995[^DAUKNHR K)J22?B:<>
MXR9%TRJ0;GSD,ZB6]:=0@C5Z;.X7^>AW<;X&)%F?\'2F=O7>'>(0*6KD0^-1
M[0SMXV'^Q,I$*M=;J@I1FA2381PPFW=UW3'\>/CC'\N'N<=FOZ3!+R,(-O()
MH"-A?'<HJK>H8":BQI,-28!1JB<.>L+-5J5\-G5,_AKM/8Z<]]Y=FWLXS#S@
M[>W6TEO0RK;=2R#>Q5?/M\9+*;+J+>8K,YH976*-R"0$P1Q!E@%291F "4E2
M*.$($[,CM(_"AN5F,6*_%I]0M!<0!.- \K'W5*O;JQ?L@VS,R5^F#PP:1JRM
M7186M%$=0?-E+)@Y9I=LDUEH+RUN!")W<NA[$)P!<\UAKE3WR)!G 2 +ZE)V
MCO0.4I<N,/7W7L;]P$T04P6KDG21-CJG?B<#D-F%7%_:$S^_%_N5"38YJ7OK
MJO2D!W1["+;I&GRF@>GS,06YD92[CHC"J<+-_,8 TG?X]4 #:(V]'Q5]%A2*
MF%;%Z_ /W*".*0SC(OL#^\ HJ^A4>]%';W_D5[9T_:X31YJ' !KTKRM>%+Z@
M@\MHYPT)7)\8K=%0=!4.PPOM?L6IH2K J!(M&=;58^9]8:Z!8DJQ:XI@E"58
M8+!/*>M.DJM4DM=B?A#ZX?:JCN"[]QJ8BGF4Z)I6QPSF*[5MV'\P>44I^TY*
MO3-*&"\]E!_J/\@TPAL_*M2_0 Z(Z7B;KZ5A+O-==0\$\*^PB$3*^M@,BVYH
M[5W?MVD\??/Q&CR!PY$!:/_P04N/5>U4JD(D!-R-S:W5S675U60-PD<%%7 /
M6YLK6J5GYL<<$!9FZW?QT:7JKIV-G-QZK(F+DT:8-86_8]T^9AC*  37"X,4
MYIQ$MQ?CK+;N+)W5,V[EF<P'2_'S7M00#Y)$7&4NA-6FB^2Z3VB$1D201,AA
M XW#H8E>3+7YZ$ 4L!^[4YIN^0%].V?WYQ (UM!3"5?T'])2RL^E@0N,)@_C
M/X%4=(&%RU%\0BMNS#<U[TU+;6H%S+'TYQ5$ 1^KL0=B_:]MBJ3F;BAJ.W?N
M!HMN:-_#E_QH?ATA/W##I(X]VXFE]70"8([G:"Y;!@<?6"+P36@4['ZGU&%C
M;!0+.^AR-Z=V@?CK/ROXV7_ST4P=FR@N,P4L\7@N96NPC\ORAQ#_P0P_SI-&
MDF!V?A:T'] 6T*1O<0$'OB^D!KY[T3=7/$@-+^;;*Q.L=O+%7%IC!A>;%&\!
MUL]0;5U'T.V]HT=ZWAC[<W:6+HLL0.1/0RFV-/7!XSZ/LYPP%UNE1-]-M@FC
MNY%*(;QF!YCP\B[.?^#%G(M39AI :GN!!;C 7':]^E8>5 90*BDR0R,ZLDL\
MM__ ^#E$SDG@/,YK)0+80UN);-E97#<Z<=F(9RXR@^6NCIBQ6,1V 7>U-4BA
M;G<B,W)3W$PI$BTM2CNK9\0W_3!I6VH+.P<RH^<M[%L@<T$;?73G &IB1A*/
MUW1G<^H9@,8IM%5_@%9HX-:^+?"OJ5?QE8&(;T*C=W*TY_9PA3NXY7W+O&_,
M"5)HE6(%"$N^8^=]TPP6F%JED=:IAK6.M(9^IL'%O\!@(#L##, )J$*\!OK:
MQAC6/U=<(25<AG5;TA4HS,3(FNM=%\#2[*YJ;$FN$A%J*+!8_:*16"I116T!
ME1ME ,:K=6X#T@=?V;B?>3Z5Z?E=7F6D--#CAJ")C4M6>5/UFB_HN/R%2\PP
M"'I4?M4SGS2/FME)]CY5I7-[;:Z6&?Q=\KF >:'Y(^KT1'8/:T': ;@FDO
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MW=01Y&*KF,1N=^C03[&=M53W.I"&>^[9PD:69)*-.8)Y-,0-$2E-LB#:Q#$
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MNIZ>4LWR.+&HOJ7+E6T>+PV2G\;3$+-;ZXG6P<$';V&QQ+IH-% BO9^X$K[
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M2M3.O'63[DT0K?,,_P1=G_ESX89E7>-=LCUX)%SKP]9O]*"LV,B6A!.?(EJ
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M0B;3@ZH3_BISH^>;^W>)I8'S:%8_,9&H296T5\!6=(K\XXENT?M^#<(V_FW
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MMC&,?Z"SA;85/4!&O9#8+')\!%O.OCCH.0[QDW<TCZ:CF442.$=5U%;2]*J
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MZ_7HV@5$7H8^NW'N[VHOTGD#E:X%L7R:#70ALF<&&:1]8-(=1#\.6J1HSR^
M(2.]&0OWG]8"4RR_@N)@S<B!M!*&R1/P&H>_G=+DC#7+&2S.N=114G^MF@O
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MY2IQ ];(6FV$O@9,=00I -]:F_,R#VSE:CL?Z382V'#+J&M1L(7V^*] 6WY
M>?#N,9%FIJ$-:CEVFNJ9US.] 2?IL6^P=21FB,]CN!&KYT7W><0D/T.^SC,
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M?LAL5M$'=\50.U@?$-TU\O('F4/#A[XW#Y%MZD'WY?TN0!VW/>'WT>0N)US
M-!Y,!R2UH!40Q@Y 72-3@[*J7NTQF-WC]DFDXP4>Q019V_ <\?LXGV>LMT.3
M(L +?69RLUOZ*A_.YA]"%<8_&RO\)VMO_JXH]X9 %->(HE:OS;,BIFI<92N:
MPB&3DBX*U30'%%\SHZ=9AS[V&^L>HZMLY=],,A.J$)4&!C#JN\ PYTP;PQ,N
M$46O'#!:%W0B(H&RA?@LCD,+2M:+T+MTE]S"5A78]M<[C<!3)X&JQBH?P2[
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M-$V8QNKN35"!WN.W)8[VI\@<=ML9C:FYYX1/D=W.0%\5GQ4*3#:-2V192PX
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MH(G-+_D^2XJY)/_*():P*/<^)Q4K-:%Q5?-)M84&4]U<<><?Q%HR"^;*STT
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M?3FS$>? ?HF>2>C?)&DWS[(_\UKIP!'V>L)[8M5L/&TMCM)*J6MOABGB2&[
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M>6WT%Z0Q_<O9 "X/V=+*/,*Q,J"CR"*9+I%#W5>7CCU8A;^OP#S,@*^7BT7
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M@NT45[HMB:S6?4D\?97>ODL!!L+"$G/^/XMV\A]$2[F^_W" PE[# XB^"1A
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M#,AB5,6U4L]R\ZIN",^?KE_5X7) "8J+1)Y4:LV]]D4G;+2CX1K^Z/REFYX
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M8'6D]]'![6XIXG9V@P%JV<-_NWX+N926!11E[C[Q?2N5RO>G% ?ZSRRTF6-
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MX<73NPD/O Y]0(EWWVDX0YIV#/6^8[OI\/EAPY=4'7%B/L>2)=%$Q8D1B\^
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M95V@VL66YJTYW=EA$?5G$E+*N#L+>ACA9H96WRA>&4G/!]PZ#.L]<R;4'Q$
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MN_2]O77S+BBV^1AOT[UV57A+[2&\;XD&3RG=,41@M:+J,6E_VO9../'+P4;
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M&;R&R!/"RL1]I7\V?AU!BS\VDZ"(I7:W[5C[KFE[T)#K.^F>T./9Q-F?S84
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M\]/;'.8G#,5;;&,@]+QYLPYGI=\D%@PT7.8K4D6$*,I]:@_/!2O9-DRJ;MJ
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M_.N>MN^.;X+$[G34H__9F!LD?-+K(Y[2TJ6J,WT[,M&D&WD<'0/\>+_Z>:$
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M%:QL.BE[YO;6WSZ AQC]>@\,50Y)=I'0#+362;JM>LVZ>ZM>M):<+#X(3T4
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M)T3>7 $J<<UZ61B_LHNR#V]/:#EC#Q/VH*K7%E-Y>F 5'=:91<HDU& R\#M
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M?EO,,-D8-0:CO^%? 3"W&A%1)>4U]U[F%C[X$(/7'C+W6TTX/";L0ZZ,Z#]
MUMG['$9H--J(X*X Y@!$>OHB1;\%/H9A?*]@I_ L\?T$%4JH&0?.A+8:1&]
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MPX5R+K#*I*PPL5T%665O#55J%[@?F8G=,K]^8C%C0<3*1%Z[EQ<Q>(2',F0
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MVX69Y\%+M"8;*K2#96TU@915;PB66SX_&%;BUR[R)9PEXVRGVMW8[.D_M=7
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M=XHU\A+GV8 #U!/F!Z_.7V4B6-58S\*PRU1,=[7DO*\F(KUGJS$OIJ1K;.7
M4$J ]R$$WIUZ:!9,N3)^^7L?:<TM7NU-]:/?N*Z&/Z<8HIQQ'&#^L%1Y4U"
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M-\L' B5^.8=-/ZK;!:*[?D-JO[>4F'N<O>O1</D$ OT&*PZ0HX +. 7B!!6
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MYGH%?+*V_[II^%:T(=JG -)%+<8S=*%=R,7%,FX 1&.)./%J]YOO(FP;:!7
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MLN0S\*F=,W8M5C]<O-^DZ:TCG,J2I;M^R4_$7U6_]3K>).=%>@+B_MY3Z8.
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M:-2!NG,)+?X3)4WLBRJ!,CN44HO7-N>$^S$"0Z$1NZ0.)4<E\Y+2/,6@4,7
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M<9B)\3]9/&%0Z_VP<XY_;-,]6?<X&/+6I^77[O34?K/6V;8"*>;"4]))8E$
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MI%9R56E+YC*H@UEM6$DE7"5P,;(WD+-T-8#/,(<4.@26ZPE5G$EHP^_:^J+
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M_4E4J;J6(/@F<9,$7H7-UY80%U,:CO'G%*%^;$U$L2BX"5W%C,/7L)-:2=O
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MAG0!;B5]J-!S]26;MT_O3WOT_V9!2GLE>XD8V4LT[S&VRE*X3%3@_H-A0O0
M Z.06F%#XLBIGIF%1<L4J1L_Y/?7UPD^RJ&T+NN#50,608FVZ16EN>*QHTKW
M3.5E06X/!A!RQ/*RLV,D>4+6";PNP;_5<+/LX3>8I=R"]*3[V$3["Q9EZ,2*
MAHVYXKB*X3'/^,11WP$;2S6WBI#7UB;B?_W"9^W AD@=Q!312RX8U8P&#E/O
M<%>0MI(^DFLS6Y<0X/;HA 9_04(_::=TF^A3=63PDY.<5;5OV1&VZ9:"[E8O
M?[< RU,U6K4<^SLVYOY_BRRRGC_S-R\^VM8(C]Y7R3%2'V6M7.\6"[@Q$]&J
MC)W$DZ G\&O"1E>!W<:,+] 4C9<7PRVGTREJX4);9]/VNL,/KAMF"D*%&Z_7
MF.:E#4<\R1YG1Y4,&UI=)5^R!'=?X3%R)O C5#Y*JF'JV<.,L$S#ZC VAG)0
MJ0UVD#X<\X7V;L"WBIZ34W5;[SE_>O!TNFLB3[@OTJS+)8<:4F=Q#W?]^HL]
M=V[I3>)!\W]S[U  ?R:XZ3/GZ[^Z$=4VAOHY_GW"']D0^^^A+6#A)4YY>FVI
MNG_ZP;[V/Y,T.M/]K.?#\"&^FJ97\DWH7?!PUF>%(\D7'APQ^W@D_.[]9^<?
M+>OXT7E(>I]86>!R4D8GV2)'.L7VLA<NCEOX_3](FM(U8)(@W=X[7=Q9BL,.
M^^KZ)LWQ_YFJ^M89,# _4X9]B*IA:7,^O_A*M)3$DCJAW;)*:!/40M(5C<'<
M5V@)=+L/$-T$\':@)]J^,[,1;OW$81]Y6X!6[[I89SO3?.'YJ<_7[1:JK<V^
M;S@5MVU"7A4%9@@M9&52,[FFY*UHDM>1P0S!WO9A*"<PMA%-P*BRT]\#S42H
M>-72H"U?ANHJ\J(OQ%XX^ZS+H*3L1<"I +>HE9K"2.WSB0&OD (ZI#0A0HN_
MRVJ$+NNZ7Y*;6^/XENV6AH3[Q[1F!R?F- GC&"VO"R6X'M>@$B^JRXMG!+^)
M(Z*K:DQQ<)*@WB&K8\>^["R=:Y3O%&A-/E &K2D6)4TP610%XG99Q7PF:#(G
MU9CA3[;D.YX&^9*SP^#$W\!X(RI#:#-<./151( ^ YG)PMG$U[5U/K="PP5>
MZ+_KW]2]:6"^]7^[T8.9G0EN6T)DDGGI3&WFV<SALL-R\$Y$]9-T2".+.6WA
M=IQN/C?N$O' ==$$:UU#OY\*2L!L52Y#UQ D)_-:W=PIS0X?<W\4/7_69RS.
M40I5_H/MQPHIL&.SD-V3*DQD)E" 0UQP![L%JT_ \;%MW2,Y?*UDQC:H)W"C
M")EBPTTJV"0R(ZWMP?\VWX$!76>-1?'5?N"H)[-7BGDU55<AU&JU(]37/++8
M?&99VA)BU1#$8=)*A5[ C/@%2):X$?<-DD,L5Y&Z*>I")U,@29P_5!ZAP&UU
MW(V/<O1LM B__)74+_#5K/4A;:\:L-V._^VO;.YM%C%WWM ;/TH9S1&_JI6E
M,"]:IJ!KXI<0*@T!HAN_FG>&B'-1+.P*/%8-[&X-W#P@G,_7<N__ZNF\C[#9
M(?TC/C8*5X+ENFE^N_TI>!OR)\RF5WTAAM0"&.$RN;HKL- TITV8.0D/YQ'B
MZEI1="LUP3?PKS3_@:MS2ELR*E_.""2L*BPG?>_O<M]FOP!Q$37T8=8Q1I^P
M1G9H[C!.$I^-F<X3'Y2]9@9S1^MY\V@#\L6Y]5X3U,0J,-,'J,,Y4)-L ]0G
M)#&LOH/TH:YG8&K?^*(-+9MP1^.AG::IL=7=U4^07XN@U1.2:^1F5W0H%[1
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M8W /W\FR&#MPV"HYMQM=SFTIV (R1=:NU[/: I=CU#W7^D :E8.;<IVOL3
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M M[=(Z5B7]DS<C!RY/^T]YYA3:UKUV@0%:D1I$B-B@(*&$6*TJ*RI(B(@(*
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ME@U >?'L=G</U^YG7P":NR4Q?RAK:.W'8,ARD[MW75/#'<GJHY4N=/(BEG.
M/\+T/\<?PE;7M_>G6AV/HPT<;-5 B1]G.1<\[]Q+"V<LI]@[5>6MGDD-/QZN
M7I.GY>/8M^?@1:/!FG,BF4 8!=I&%N'N?P-(4J&Q. FN =-\P;IUX"!?>M9<
M<E _+2&L4:VTA.-DW<Q\F%+H9M:=5?Q[=MV/\7<2]&#C&\<J(ZUX63"?*&%*
M70G'T ]>O=3>HL!&C<;G&^"B&WT[&9N(5/,R7GDH,JI,F;RI.Z!1;I#05%^?
MM]1?@ZRQ0Z@,51\]9S:=!&*FN M\P9.5I>A1<K5&-5.!>E P2JX7W><:L6V<
M-.'9FVB=H47=4-$56RW]?I':9T,OE?H=&MZ,()Z,3D&K)OOW9GU3)5G,...8
M]NN@+U?[J1L??,FV<R#\3[Y4?*>]'!S%H:Y&W\#( <X+G9Z2K*G"K+(RH/_X
M<*7^7,4R63[ ]LH5-N_6J-;2DM+[_O[<C\W7"9X.Q]6.L"#L(%X>YC!0WF9^
M#&A@FE!=NI:4N-I//;A'6+ZI:' ^*AG.W$)IC/]U@PMY,6^8K="JVFB[@(*>
MZGG"LB8&6>U'O-\9:9/>]]BVX?[K^ZTWO[V;<-=]^MKTZXQFA5X2B&4?3Z[V
M75QB^O:8FP$)S%@*O ,9QX<!Y0?Z6;">UDU,C6AJF@SZMX>AHJ$7R3U*/=F^
M6_AUS/G@B0 ;W>7,S"C3ZCTG/WV8Z@T+#,3ZAUV)0DI^2^%5?$Q9R>W0R5K-
M<KEO@PCS#]H1DS$^,=ZW=T<7I3#=>I92OOVZH'_'F+[L6X PY^BL0 4F;#RZ
MB,&*\;?YF1\@0KJF- ?Y<H"V!?-@+@TBK7QTF56Y()\'J:Z.7P<YRZ<7Y1-R
MW<*O#YS:K2*V4CZNK7IZZ*?]R/7K*[I&YVKSWJ^#[$80EQNK6FL:$I_E?5H;
M.A\9V613D'$!Y>V8-BT7ZE?UT"<)!)C8"/2:.[;=4!^LF';7#;JHSM'QGSJ2
MRC=SEHP@4HBQ6;3A"ZG?D+3/.E<1QRH65[26ZB943T\=K73[S1?1ZP=#[=E[
MNERL5VG/WJ!NE:O;'JH+J=^SDO[R>J_?LW,2VG+7MJF+VPK6'3D1ZPN_K:8'
M5%/ZTS!00)U9W0U3P:B0E"$@-)R(5GP^CY,QE?-*9CX)BVN^$AZH4?W,#<IN
MQ7-:S.?WP4@NX;U/O_XDU(@L/N1 ^9^?8!(*^4.$ZHVM/U*=S>7?9*UV!G'M
MF)ADVKL0D[(GAHW\GN81'1+=WG;TE%%0UV]&Z4OQWU0-L]:4DD"_RMO(K],6
MHYE-O1$BW>!X>!6Y#9) EC%5I_9A10#WWBD)P(.*E$01.OFRU:_3SM0P1U/P
M_L91Q<^\GW>7[/F2O/.[>C3BW/'2<U=?G.#(\'M'<:KK(&HI@^!C'\WD#Q(0
M.1=@2OE ,/4M?T]E?6A@<,G$0MW4/GF;TA,5ML43MB43\_S  *,LER-N]K\S
MLUW-\Y_?-C?\8^?'!5X,YB#7&K83H\7OA55GIV'VYYXR<$]3!7*H+G=JX=+S
M;O>@RN,>\XUQ/0_@3F^JLHY^JWHS(D]S]TGTW)ZFGL3>J-]>O=0&)RFTWX)(
MF9NAY0$O5AKU>_8+?]+W' H\44 N:#C5S,A]<'%)_Z.VT_"RF>?4=,_HJMUP
MJ#A'U7ANSXXQ5[*'6]N"Q*>'"R/GMNB:G!D.28'9#^GG&G?:#=7T*2.,[(9?
M(J[4O1J^KK/'-M+$Q-8Z_4KJD/C%@KJZNM^DW4XFO1:Z+9+"#>,]VBB$1TKK
MO.4IQ2O@BZ*A )E:83QM9V$WA-$ 8#8LC];,TO<9QY$UX:$FX=^&D'>NO9AT
MU3F[YT'6ED[MR!19H6FRJ+D46AT0IK284 EM2_'F6P$KYCK(.H,6"=Z*-F6.
M9E-A4NX3'C+#$R>*_>79=82 W)C:CQ/WDQ-WUGGOS@F+LQ(,+(<7=Q7HP?I9
M;U2W'QO$&.9>!.YRSZV#XBY0[8$S]HENS@^Y9T(ABY/TKC/ 9'E"X#LCT]:;
M,J_PQ)%S(O=0,^R;/)RY!M>2">F!W"4+"];F*FVF8S05&T^0X7I0HD0\6?6W
M?>+G:K=M//8S4+99,1.[N")O-)![,/"WI-_WVMW[F+H.ZE7;RA1PV#8@6<"2
M73@Q5'!OZV86YG'0<U1)>RMTL )]BHJ3GEU]%:X4GUGIKY2?]XECVW2ORM97
M7\]"KVGOX(/K+@)E\3M9TEP1;03H4BI$J/AV<@)_.^#.7.I(# 7'<<4I4/!<
MGA(S.^%9"Z%YY/N>07T/PVTZRV\J#;3'&6=7=*\Z!$5B?U]4_GB?^!0MQ\MJ
M!?'[U;2 ;GK:'8CD,ED$U<F.825SCP-]M,# \DDK#U9_4IZ=94C+9V2H>\Z[
M:S&C48[<,?^Z'VYSH]O)ET[Y(F0.Q"YOD15B+D7#*$\(K\(ZP221\[PRKA!'
MEZO![.V=='?X;/"8OVL. [&^L5@[&>KC$=:E)(^;SM6V(-;&!M\B9;TN&B/!
M/97'"TPS%+]-KNI9LVQ47MQT>!CS%7_@Q+=74<<HL:D1TP7/;\.DUT%>^"\6
M=)'%C8I3EKS:YBCF> ?)HW?Q&,<?%7@<J X.\ZV88[LE=.))4.N16N44N&UF
MIZ,U<;71LCD4+S=_DO\>=E ;O\,BP#N5:*\-)2O!N3O(;.E!S"$[SO$YR.O5
M148).C#3U7PW1*:"+PN<017#I)L_WIS:5S.2FC?DNE"AEYUS_I[!1+^6\L"F
MSD4Q+>%/K=K<78 =B]P>@>M$IL ET7(L7RJ_ZGVHO0CZ-^;W3!I>"FZK-I,T
M3S_S65>S_N>SJ#*):*6+6V=2ZF].:+9!QV#L*[R'-1_=+7E/^""N)J!<#"1=
MO($^)=()%Y[UE,N!YXUCQ^#NC4.(BLI:6)6HM^V%QMRNPX= 6>?  [+G1&ZC
MSPCF4HA[%:AE>M&SNY82C'WO\;7X_0J-625,WZXGM=^X910[=Y>\*1K'92BD
M]/NN(>_/$J-UP^,!8:/!4V/Z)M>_1KO&AB\QK#@@?@^NKF@==*<624IC1S+!
M/69>;9@ E-,EED;>0J5_G=.$15!HH6&YOT$+8RH!JW]XPG/6*%M!Z?Q0N4G;
MXN^8]N>W#Z%U!3P**'1&B,2:*N3[J\DQT^)" B%@5&"GI^KKNJ%E7?!O0XRA
M<;MA?9[QJ!:"L?B2<D+V%O/Y;I#(YMN=L%X<&"W,<NIP(W1NY$>*,_%=<&%4
M_ 1I@0]FY<5>H=E++)R+:T\[-Q1ZL5*W<L]UJJ/UEQ>@9[<W&WF< J$?,DW8
M(KR[ ELNYP',L#&\S%9A-(25^]7EG"V-+ BXDF@#*EEF7RT]UBRELL++7VXR
MZTF'P;BWO^GVWB9MB 2X&+7*1O!R^0>XQYF0[K3$=9"PN2SZ)/",^4K@BB7X
M>X#^=C?-N\V!3!Z]E3]LR43>K57>7RNYN;?TZF)4',4A1(DJY[U[@>27#_Z(
MC(<P[=\T[Q. =O]& 8$M\BS[1+1<.)Y[$@@NX6H _I3^S2@Q8H?1$ZN$:X:9
M0$$W3J[9,=LH&R?='%EI$RB?$UCV3NZ.FT^RK.']GI/!:S:F\JN&J_)AARQ"
M?<.0!D7?BM[KC&;?RG:H<9$W,AS:>W_B2]^.YN!V/;G'BNG1SKOZ!(,2SB3S
M1><X(EQ5(!O: XO; /L2\R>MK/7-2 472T7&Y<D-H6VO1-VZ-#$Y9QR7AU,<
MNG&#9'.M*:_CJ)K/S6LR)O)J#UE+;#?>$P'3@L\RB8Q]3'4JME<2;-F0M6KQ
M"GA,82AT:S_SN%3J7IXK$W5Z=)I^IJ%A/-&G)DOQ9'7I_9?W'B[IGQ.YCS83
M. QA]![@"JS=/HZP%:/$-0=.1)4L&)\M8?:W\V4&0\";YR/"[NIJ#*_TF3D=
M'WY9L5BK99 L7E[N<=IV]KM&:_V3B[[OK=^Y8+:CP< 1CAG*&)J $\+(<LV
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M>/EYDCN/<FT2_>S\;<.M7C$7+V<^S="S[L78#UQ[X'!R3&A][/\ 4$L#!!0
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MN&0B26;_^UT\C3>@^_G^8GLQ!/Z&F(5&8O>1#-"EC%!+2HL@'32@ 8"_31H
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ME$@*EUVC EV" W,ESB%I+BZP+GZB ^WU96 1L#@"=0-3?Q--L*(EZ++#L&9
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M[$PK0A8O[AYM)!+4&446APA"-^&,0/21T34HU/5_(.HE$/EP;M/X=./1G)X
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MO[E)%B5[90DODU#JBS-EIM4;/POU1M/J] <:G'8L'[AXM/:>7[]W+6IVU;A
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M.*30Y9;9%Q_47?)S-7.W<-'G692N3=ZO1)K6PDABF'6;<A>R1Y.S#Z''P,[
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M/<4\Z=&(:@.NA]DZ$3ZZU'JK'PF,_VL&X7,7)8/MPC',!_TAG:3*EG8K<P9
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M0H(\.;Y@S\NK"I4W! T9/[D&*?W<7R*Z>,NJBCZXZ^OU]&XBQHMEQ#_'B,(
MK<26%+F5E*^LX(4VZI2=,7I,-:CR-)*3:>@97;;>88O^H# 5P"T\>D@@Q^Q-
M/^RU+]R9&ZY;T"_*M"OO$/ 9-Q YRC<K9M;O&S;8F=%/?NKGM?^D,P@UAX3'
MK=;/)=C?T(<"[1^HOIF'<B!Y@Z9\?/DVQC'[4MA@JL2YJ6.ZN92?K.7K@UMW
M1U\-5ASOZ ""W?O"7/&!MMXH>#25N_:#%XBJC H^<[&^,EY/MG]&)*-'MT7N
M;=RQ'5#R*_4'1H-4SO5;>/:'(WQ4K3WLGPU*@Y AY*T_'U&LQ.2L?>C9!OY[
M.P>F EQ[.LQC\[_Z"M]W^)HA2^M2NK85XSOPVZ<N7XFZYJ0FM8SQ=9%V7**S
M>&;;^O?%\!(2:"<FZ(X-3D:5Q!?QP)$I "=1(E G7=K!SF2PF<=-%9D;*LF7
M*YLZ:(RP/M/5UC9.\$JUFL8A3]\#S9>JT-H.9US(H/_N1=: Y_&E-'*^P9-^
M;%W(XSCQ,;WDZ9L?Z^KO-R=$68IS ;ICJ;WMFV?- !Q<"H?*MP#.V)6EWJ=0
M+TMKW=_Q[A>TS8N?NV9^<[;>^R<WSS \3)1H2O*BFY&)#FN05-WS^!,M.DE'
M\2V84*M@U?(FB"W*@&NED/=)2GC,ZHZ.VW$MGJYO(4\]$CV*C!%;;*6@FRZ+
M^6E%GTC63HRM&L\IM:U)_[9E)60Q4\*7DI)6Q*OB^;.;@Q]'F7"X\AB),S(>
M-&VDX!X<:F*A&>"GBQ]P@EY ?[0%YEO3Q16F0YX4L&LTH+7%S^WO,MSY'O\V
MH\JW<I<YKS9@DG3,C+"KWT;ULLQ#R%O(H>.K;8R_V'.N]#ZE#I2-E\Q@V EF
M%> -VB=92WY_&#Z1M9_\CO(]N/=")V+%G.T_S)R1I;!J8V-C?89<=]-/9DOB
MRH*GHI%>;WP_M&P=+8WT<HE(O5WC8'USTSS86[;U[#=L6TGM2UF=$[#R'XYD
M&*OJPVG1E8>FAJ_FN$;JF=8;[8VYH1=T;H;#%;I1G,SSIOH#NHDR>M',$443
M]^.S<@R+1NR%P&OR$NAY9P,_[<=C?E^<CW=4(=&FL5&L\H$Q97J=&FFBOKG,
M=54G<5_B_K5'?CMW:RHAXEB0OQ,:#B1>2N*5:H#/V&:3QAK<W1Q]T_',4Z=K
MT*N9XY$!TJ"2G;:@;(8EP4U0L,UPE:=?K95R['<5L"?^?_^8K@X-!<ZQ$P.P
M^Q+=9*$*V(/H#NOB:Y #$+>E4=_5,8,09!JHYVRWF&!]0RT_HR,O#"F-=WOD
MRN*]^5^T -3"LT?.]T.R5>N$E^]2%0^+4DX>PT.JV6[YF!P*5=V5#OQ2_S_2
MB?I*A@=..0H9=D>5W0L02=?8?%Y[&6R*84VCO1&=K99&Y+;J_*6;A(6YJ[7S
M/P=V;FA,?RN%7-2A-O?8X3^VT?!:,B/U: 0?E-U"2[9FX,;J^ZI,]0<5J]1F
M _A?ZWN1B\_.K<)(8*A"A0:I7N^(7W@2;'K)NRVL8U=NU;:/5CD0[EZEZRF!
M\VGF%5RT&J2MHEYNB3.*4KMEF!9UK\L04,*U8XQ[DL&N"C0$QMV2YSBK3W-W
MG3.H;I2C/R-BR+)"E-0CZ0B9LH>G_W8&D!0_#3^;!)LX\Y& I'P3*"B_X?]*
M#ZDC_>X]GVAA?> 7 NZO<E>* )3NU[=,HD>+<Z!)VM6PD2@]PGRNHXR6O;V,
M08F9MJ%SH:T*ZU'ZC+E>I-':/]G!:G"9<5S]PDB43T,-7J3<WE)ACX]VV9+1
M\2B*+]#G'W6<WF;ZV^7/D09[JU*[;SIO%FSA545C-VE33(DKC$*<W"@D)-L=
M3N>Z2#<[B'+_R!%IZ7H1.+MK9FIIWI*UR1O;DLB5HO#G1XTMOKE' 6L(7D3T
MLM_I!,)*W?+H<(3,,BOWL[?1^3@BE>P!L]GC<.[VMJ[9/>\#YD.>ZLJ\D*5:
M;P_/E-^_%]4J!5&:)FN),*EX>T;0Z0_]SW/PD=V)1A&V5=$[[.&G\CFW -^3
M+;JC-#P8BR2/KE*,N>U 6W,T,#5D:FNI\0NAHK.@39,>;/2M;-CSDH\N+,U[
M[*?NX3!\9@*IP^C[I=PDQ_ICAZ8U#1EG:%?08+FX&PI'96U2)!UFJ3<0\C)E
M"\%@N#A9<6>]Z#AS;^Q2#Z]VE08)KL8K O9$,5QSH4KH2SCYJBJ&359+99S_
MQ@:0)CGFJJRG^S395;*_!(J^>!R!0#9&"OMLE\K V>DW(.$:1$-XW)N_!(W3
MHM'Y9>%"[V=JPF(IYOY5X,^^0Y:1$]@C>]3^$5$$2 ^$%?Y"+V3,-!QUAWUM
M#J%C$>+[RL_$QD?Z#.+_\Z$S^-W$EK6A3F2+6T88H6%JV$=D8H4BC[K+72.M
MJU&?4CM7-J#F7T-A=@ES0%D)G0IAW5BA'8'428364_7#=BKK*\>P@V1A'DC*
MSQB^0=N"A J]R@I,04SDDUFSU K#LLN@0#V=A8H_%/-WA/\PW@<1'H"8GH4X
M' ^I/>-?5G!&+/)CO/<&<?1S&.N^3NUQI&72T-JKSKJ9?7)"?.5VT*OOF'[C
M:?Q\5-^^OF#.YLNL851\MG^G1G-TSEK2M[>WX-7!5_X':FJZ!PED!+9K4)Z.
M@MEQ/00A/"Z&MS+-LOEK?X@?%DH2)HK]4*;8R)<1'V7"J]Q2;<CM.EB<JA>O
MCI#B'?-_%2,^<E09SQ8[7,_:U"A@1,D0F5T2VX_AE9*>*>+7$,WLP)RCI1L+
MXELO7"^5KD&]AN$*A$D8:>-!9-YC[%;_*CG@//!K<=%]RN6W\9E9^K+D-#(X
M7C.[=5;\=P:&6.I5K)Q N(,&*#4P- C+?YH&S%Y* -^]:?',N,:):*_JL9+3
MKB^3U07?H!$L=F;\S[S5<\/'8)Y,RVB,N_O@G>?-&A]<L04YZV>](%12!TR[
MDW=O[!UC*2/1-PO[8NB:PE27OS"*@FRX+D&'$B7MS-F_+I/PQ\)+GY43:Y+5
M^&AX2R^#"]H:HJ:2)N-0_F+HUX:OFYBU\1=H(K)U*#@"$SJ7(!U/-] :R"<N
MAM^P+R)#DM\7JBP@MA-9-2C22,MUE2G1T'!M&5.78KB4^-]6F[ZK4JY)KFF/
M4!IL&]+,+T_G(W._83M]_S!56W7"G.BB5M?K.;*)@ A.>34CD"B^#NC%=6-B
MD*L,J]!5S$3<B3 =$/UWCV;U1X6CO9?F]^T+HUS*3,?B[<\OZ6D;(Q[TP&5=
MN=(WTL[U-52>,T'0T3JP_YUAA9I^U647!?*2)KH<6/>C1,#>;J$GR*59(GUI
M1J5#HL0J*>3U<^OY#-9KI=]J'<D&E!@U>FFX9^R(KVG)&[[Y'9,_0!""1@U]
M873,,48RK7A&1%6E&^48D5+II^M_J+AO\E:H,3!PPJAPQU4XD&N FOX_"1F/
MHX,='>V6_5YN-@I>_Y9D&<4GSG[[Y^8<))FWV5T]QS6V-EY74CSOXU$;OUKP
M6//V6W:69KQ2%LXZ3$TIN/.)T>%_)\? )4[/@C:_%Y?.Z&T-^/,816XY&@ZE
M:_B=8BLH??_P%"&>MI[OF:=YQI:-?8S\GA]10FS8-Y[#DG[7S*U*2B7 *5?M
MT"#R_'?YCZL'5WD*J%+K1N$]'/I2YZ[+!2%S#7YO^Z=/UIODM:603J<SG21'
M@P@Y\(-GJ)G\NCH;,EF/8JC1P\>QF 10)V)H%>#?VG?&>3^?">4M7/D+)CNV
M-.)P#Q&.\'!*M@B1\5Q<^3<K<;G-E;="VCD^'9:TR%]HO$ WX'@G_=SK\"&C
MH]/#/'LYG9KCOSH*7UGO1[:,_]*@2;GMD->*O"VS0ZF=5]SU'R*2P&+G#]O_
MB977,A8S9']L&%[&,EL-EQN<Z2N?[-,N=+P<(E3A0J8^.&_/A+KC[$D^PRH:
M0I4F>#;RQJ7?!O#8,U>H4G+^J!&OL.,QJ-!.YCMU56*3D5ZA<N/;2[5OGQ!/
MFN!HE[3HJ)[2X [6%'4:/=RH-G,*?L(97R_ZY#)S#W>I$JIQE1G.N8#7!2R#
M'=G;[V7""G7<RQ:S_W#H3S>JT3G7SE3B?^2Y0X7LFMLC#Q)_;XZO& :>IW<(
M.IJ81%K+)(-N3><S_EF%)!RS;E7)\6 3=PSKU$'O5+G9%"ZN5(OY]YX*-!-E
M;336C2X)]V]^U19*\)FM^?*EKXI5A9UW./=^BSB6,)Y.=*=L.-'PS8EK:3U&
M+ ?)DKX9<#2:^;0B=0O@JQOEL:_Q&] =TAWJTY!P#PO7';2ML!/5:"B2#N&:
MTFII6+0V"Y\%-V4.)2_]=]0G!:-W_/4MOK?I(E)6/AL=3])005P\4Q2G.=+Z
M/6-G;5]*BM31&?0%U4NK44:H/3J4]ASEM+']1$VI9Z'Z@27&@C8U7Z^%(\_O
MWEV;SRW$&[%W[LEP3]]^5MLSP?CL7:' X0-'_AXP#PJ7UXH'+G"?+<XE5=-]
M-DW)"CA':A:L3&,"PS)8[J?+&MC&7>V_-?"IPA@ZFHX-U549653S&RUI3HW7
M[ZW%^<LX?R6XQX\_3?!P,4;$#C4;-6JTA+O1\MF)EMELQ.0QB]OK1?3K)F3!
M.UEXFB^,+Q5@O<;=;M>@]_+@^-X2TTD"!V#4M[@RK52/V^@X:TN*N=M^)^[W
MB&EC"LO0-*9).4).KO;-S_;1I'4!5ZIFW!;A_L*E"=X/NU*$^M$H3($7Q8[7
MWQTL1GBB0C3CP^QUZW,=$X_/(>J!_%9*)18O1*/_D:I5>17IMGH5V/VT_K*W
MFU):U+Z.2WJ*K#V83LJ9]3-($$L]:+^P@8D2%![BN;&;Q1Y'R%X9 =_QML$0
M4]N'BP,JX9-V^9$F41\"+756Y-_*CD]M="Z<^>"R!_E,97_ ,(^<#T?0RNAG
M"?[WTV9JZI/KH;)?FB/*$M,YM4)X6C!TWY8M<CPRO^'Y@-1J/!N0BKH&Q<DS
M:IIW/P# EHTXBL_W\FF678^L%BI_4ELKM<DX/7<.&TZZ71[SAC-)/O6JHMN;
M,A'>1)&.9N/&5)5\V'^$U2XIWUE\"K57S];Y6O);0'!/*&JTWG+YJYV(^3>J
MNUIU7OV2D_ XR]_@EH3S'XR0]TDD/R$?QD5D+C:_"="FW,Z[!H5 +F_GR2A\
MG2B[8'6^[T-PSK&!QK"DV(A^'3<ETN0?K06\3^-HIX,2B=$XGR)%$4^>LNG4
M]*6D6#CWAS5YSF$QBXD8,?PET[L?]6_+JWW34+X2'#$#L[ZNVHUF+:^4/=Q+
ML_W3W/36 8LPM&A";:B"C1@MS?SZVEP>3-^ZX!I4#\?3*9U67^7BGU)^.+XR
MUP!B4)>DC!X-EJ3(IOTPR?>>+M]93!JJS(B:9QXUJ1F.N)YQG4H><2Q!>&E]
MY[8>=WA^4B$F*D-YGNR]?7N,^=2VE5"#<M0&701,6&\GR82J]RTK##$Z9N*X
ME-Z-E_;Y(ACM>?4#MK5)T_FD/PY+9VGH3@[E:JJ'!LU/1TF7Q$IS,-9[46->
M]<>4SQ1!(%OIOU/2H;.9<AE"27P9C]--E?%B%YW?JZ<3JKQGP(FK6&/XXM*:
M0DPCG&2P'("A@V).JK KPN\JJP4;T38[M3^+D1CWLO4V3<UW#C2=C94,_BKK
M)/D&>M>@C'_:QR[:"_=^.236_U!\2F5A2S7J%42W@O.T*"\3^IKZR#@!)?E/
M%8+"+;-K0SD6OW-FONMWV7WGCYQ.RMMBXY,.BI1VC\2>U'0\3=WX*L&JKS>
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M1GY/11*AM>7PR2T+\\K4KRRCC];)SCV2VV&N"(!789_DTBA4J@$PQ8G-]?@
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M^.]KA64TL:!#9XP&?"_(6'+)M/ K]1_A.W$I3[S9S=&KBZFG6U??8!XL[9Q
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M-3<D2%;G] %^1&9\"JK_:7@X TEKOW:N@O+?Z>G%_WGMO+A\B'G$_ZQVY'O
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MU49DJ#7AY[:T$_+)R]22B/^V0A3 D:CMU%,K2O"T(HI?V_<%41D]QU0B4(V
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ME9>^.KZ!DX'-,/LT.K/HILH<BFG5XO<-XUFH]TM%%(=G:MK*.UN5(8@.J]S
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M'E.EOH*X3__FM(*-F5DWQJO9B!&M6N3GE3%1#[+=S=8K#>Y6*IJ>#QSS7;1
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MK.0MW/L38ELIWXE[O6:4NFE1GF6(UO M!\FBQRN-"W23(K5UXVTS'AC([_"
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MPU8"LD:^F/Z^!XHD\[,SS^._'O4P$#$:4 RT6_EV!'YU*_]OLN#U1,\T\($
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MD1$J#(N8D[!GW]UCOK2W'$9;.9/@M_#P#SJJ.,?0_^P7$GCDV] P4;)59FK
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M)4ZBXT2G#B6T&LXV2C$37=&$")]C(F7B@ _"K)N8(8SI+#&DS6Z;AY/@PG/
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M^/10IA2#_\%X@R+QEAJY-5^*V84;N"]$./Q8M%XW>*)N>8H-P3:'?VY),<O
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MY-Y@%/FJ23&W'POXD8E@[;R$M-0W%UFV1+PI*5I@/2#0B6W462C.P[C<P7D
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M?NI'*%8>RJYW#U:)Z!@I#W;*]YL,DE<1>3UM^Z9SF^]6CRA)XM&D]>.UD:_
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MD8?L;-EO2^)D6\.N_?'@J'JY?TQNVECW/F-<X6S(UAO7?)#E VAOLBN"[(#
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M:55/QA9W]S8\N*^:9.?/I\(J3L(N@=O=&6T5/+0^=N++,U]1V8?L$;=NA#Z
MNZ,B=-=.RWW5TWW:7[70KN5\:4? RS2DW^)Q9-.B_6'3*GM&$2/)8V#A]IQV
MJDAKUD8)%>1F9^E(DNUP_P=Q[Q[.Y!_'#T\G21J2,U-($LJQ'+9*DGRE5(18
M)3DL)&0R6Q'*L5*48I60M!8VRF'#AB0YD\F.E4.6W<7<V<$SO^OW7-=S^.>Y
MGN=ZGN>/>]?^V'5?]]Z?U_OU?KT^A_?M)Y-?\G&$8,X(662&@8/,I?H[" ZT
MO_Q)NPKXA%[4\?CUF3N7&<RNN(\C 6?\-8HUM31]-3CXKWBIXN,R=!7-OU#F
M8,@PI28O3HXC_;KZ<ZZ74AYHPFI+WH93#E-W*"[NJ']&>SV&KG.?'[.-=# C
MV$38 8]G<P:8'>IGAI2A77C0'-F.^-I(1PK.(KY26V#U)FDF8(7 6N;=3P,F
MG;*47TVB9C -P0_<Z#O+$ V*,5CAV^]D+!@_*(#>>M9 '<;\MQ297LP5&3?F
M>PV.**GUVG+5R+F\>46I@MY*\5@/-Y7VE5B.4L_-C96Z28IPEQ&W_+?7EZ/Q
MG QZ7KK^5M :&*>5J(YNJR4-+^QPTB)&U M''5RY9QG^R*Z*7OCS\LY8R!#A
ML@&E-@E?WJ0A.BGML,*UAL)ML#T(9>JEZ-7BK1)2'/XF==,"/AU!ULB>[]WH
MPLUC1'.8I17C@1%233"!JT-0'3R=@EC5JU>6-:V,6GK(?,WP^;"VN?A-D%:3
MOXSM9H>P6]!STDTKN#XBL_<I4PTLOK6@VP7\QX4R6/X"<W)S>V^&5"X"KH3R
M4@C'J\<G;VQPN1J-;'\W=?T2Q6>F#\PX^G=-S*\BJR]RDN/$#<_B(,'$"BH"
M#R>1_C_<)2+_? E7TOD/5J9V7)Z7+K,G:S[7@(6B8]AO^3(IZ=5&S&+59/ )
M99@M0-/B]8<CQ'(,!@P!8MD=>15@PI&^N,BCK&-V&:T^TV5C8&.;0\=#KI+E
M&<%(,YQ0T7L>5S%3J(KP$E2QB5E.>C()IPO^$)T6QX-I(@>T8]OUA!42]9))
MF"0!,M4I)LXIN5+L+)C+6F#ISE#LP2F,1^@S/V+6[W@E[]&C_7'):A%+43D5
M_A.:\0'I#=>B^_$Y=GAE"^E&L7\UZ.DPCCGY 0SA=>/2$[Q[UIA& ZMX;0Q2
MD%+Q;\L$?_I=,(<TIAW0/ *DL7;_>9 IW85C/T8*//#@MF5(9]Y8J2=0(7.2
MOB2 *E93_=7.M*N5O(VC,MR$MP&9+LD*4@!IY6#>R<&%/(5?\"U>.NB@F=%C
M=76DNN9^LN.3@,Z1N.[WMJCDP]P1[MKT?1H)( [Y Y23$*>6(5O@6NB,4^2^
M>>AMRII1V\;VQWQ2CDY[PZ:JRK.=T1K%CN-C?LB>^)TT%=5/TXJ[8M(OM6B]
MG3HL)Q\;\_[&D9:);%XV^QS'?:?UC=UJEIS.67O9.-%ET#/#=K-(^AE K'![
M'T5MFJ5O(UE-=[#(0:3APF#*XD/#N'<+3VSRZ&;RZ0L(&#J3X9ID=-*</3C&
M+]U5:72$[OL[\(P:RZOF8?9]AG_/UH[) H;\M4[#7<%=K<893JHQ'EO2GII3
M' ,N7E;6BF0?/N[^44GWR)78U/NQ>6?SHS(AE3'G0^* KOCPR%@CHT=!7*86
M4_6*^YT?;F%=!IM)N?NK=#2,%O=]OW+XB,F:<PMZ7?-31RKZ]ZMQ!F<)+PM0
M20%)B:'["LZ8L]/=-UWUZ-*-^.U'N63Q.?9CN[MM&9GN[>*TIT>M]/*]'FT/
MG1OMZ5-EOG=N7S+9E?$T=*]FM2O$1:E)'7CI [BN.9%3J;;GY8D7?Z[<ZWB=
M:>7>=K,+3K:50?KO'AGHT \SQ.HGI>M7KW>"Y>!TR_9^F2NDE:B[?.1%Z?[6
MG!Q=12W'(;&XNRN'OD.I;,+=?U2!'PLT@,>0X;O$V+NQJ0V(C>#IS@M[.B>G
MD8-0C 1W%I<&L7E[0,O0Z<<5*#5*\A=_6??DH2,0R)5UWS8_)>[S/N:Q.O\N
M_>?+%S>VYC+7%U[>W;GA-ZO.Z$SZ[ZM?]S<]?5HBGJS\G)GY8;SS&0]R;N,F
MARM[GO*>M7"+72%J:2[!^]C?SRU./XW;R[^[WREWOPWIN'Q7R2Z)3*2'0/6P
MP_IR$K(X4!!,TU[D.PIH;8OZFP26[0&+0ZS3?7&*-U^MJ<_X+V"^S^+M[&%"
MY3+DXDS]TNF1JI<ZHMKR(/_'C_"5<Z1?>MZ?YCR'^.9D/0<I@_M)VK;$5&QT
M_&7V_F7*S)<_(VBFXI. 1\;W%=A%]KEAQ;Q[?H&I9U_<0.A&(]BL7M#PQR*=
M USB"6%@R#)$07-4@Q[YG/8:_#G.>=I0TSWY>!)TB>:^HJCW*O:(NBY?$J1^
M_?3]L7D1101.B RD7W"DD/K6*LMLY,8XG$;X,J1VCAZMB#D#.E<D5_GTV[#6
MH/^VPI'B;44C3RK :\L0]]IB&]M,F^I!2T[CP G#0ZCMKL?A^2]N."G*7' A
M98UT%*]D##J+7,6(0<IVL=T3>A ,.,M4'R;&H\Q,XY<ABD@EKP-#^LG:RY!C
MS985K+7O<[?&&5P[GN]J=/%YY.3L!X'.<<DSC*GH)!/C-/ 3E+!QZ?54>;$E
M8# Q4UDUC5,B*QWF^30*7OAW8HK^6\(TY R-IKTE_?OM<VEC;4I6'DX6G-TK
MB\2@H9MX,THX!CZEREQ:&'X,?Q#P:C>];#"P@-<!0]NIRE@M%,5\T/R9AP<*
MIALHM@:0M_)RSM779IKM0'!V!/J<>;,MLV.?>H^ZW&^XS'2D)$H[]'=*"N/P
M7QM/2O!BE6C1[C!?K.Z0#?&6@YI_7GK3OO!7X$FZ.G-GOZUQ(6UQ*:K*HDS^
M]AOVB 59@:Q@:>OX(Y%L^I;AER"1X0M#%1V1MK-J)OE)@O)1-IYO*@AHQ6E0
M=*:K(N("-[=?L_),Y#16F1TXCZH$D72??']T/LWAL]W^@.VUSR,8V(KO/Y3Z
M-[8VZ0B=9,]V=,7R+4/.X3='4.PE!;A+>0H81X!9'6)7&,OCN_D T71+O?%P
MC>W6\:73\#U@/A>J@<XZ-&"Y\81.C[7;T.7+;S_'2%XHV%D@#H<]6Y>V>DBH
MU=KR6\XP1I[B+FPA?O8:7RU=/RXCO.^2AJ;D2,!7F"-Y2LI3QGCE?M&S$G%A
MJ1A?'CX-NP=0SU]C%JG_D#N1Q,'?<3)-YG;OF!TZTT+9FG^BZ$NW1/L3*BSE
ME<3YQ0UX-*@@ ^%G:JU\ZRE),67E;0(:-'P*/[+2?P8NUS]_Q*1??-"VZD3(
MV[/@NQE<5!,0]?RMOUPD(0)K]&'85LE'URTYUF'MZI5=,;C6U53V/7UUL/X\
M4'58<@>N2>/IF?EJ"_/+ R/TK8=D<;W><,SB7/,@124BR*01# @U+O[T4J@H
M?TO53"'X#D$59KY*VG)B/\P>@Y7<HX82&2F_V/RY3LN,@I*]'\"U@*4'2!7<
M=R?CE,-A@@S,H?[(T)J!)M=+LO)11OA6X#-JU:E4\**^*&J]Y:7V4SF]#*@P
M'-PJ.@5J=W+J.^<@TW@5\>9RL+L-K[PK3B\H^2"3,=ZAOWYH\(R \O[^=&&!
M_?9)]Z'@@-O!B46,_S3+TX^X9XL(:G) -%]&.&OF)-G4Z&++MB(O?J0 UD;5
M-!38#D^P4A?T?'@!_4X'.*-4E:RI.*(J&'"Z;T$4X$C;Z!E_L>@NJ>C(@-NM
M]]^NSZV6ME-KW6C1>0W+$/X!-C'=QU^CTVNS>(\ U]H<VWGW%]SP0P,5C&:;
MF9D[MI5H)ULL^G[H*\TX6C/XAC @U+-R/LHQY]DGY+_?A94Q*ORL1*85+Q#'
M0H5,P18JS8M1P2:FPJW1Q]IF/%U<4^DC)UW?H%'>17LV+N'3G+Q>>I6#A6V,
M;,%K%^>YC(5(!V[8"<,"M].KFN:$"!F$([ TZCMOU!_I)UAM;RI<[1?6-'6V
MQ!!XH(H*V@E(Z\_5*CXB$3PZI;;#&#>>3K.^XL. VS:)Y+K!;<4^I\BJ.\XO
M.JO)_;&\N0P)1HPMLA.RJ>&L;,0:B@HZU@UL%YV&\8G9C+>E;]'W9N&F8*'[
MX,+4_!; ?OSWPKBGSC%5,-6;]"'_8/_S(_SHW_)?H_Z[XA*$E 7^O23+ G$.
M\;6>4S'+JCJ+]IZD%]D1@=4=6/.\EH+% N::08PK8-B)-0 (K(PFC75E2I1G
M%'4!^6UM*"='/6#*H+&Q9L"PN83)\,B/UI@Z<#QQ\I5S\IY_<;K9L(.F+><@
M#G(W614?ODMMY#@P$F*V5^ B? OBH&TLQNJ6 J1*T]IH[MQZ\#=LTXSO4@<^
MHF2G8'OM)BHG,.!+OZV2U6Q76<2(8.+E.C;CVR-ZPMVS!_WMO!A>PDN@J2A0
MK LDM$ 9&JWWQ = #][[R\\ KUL5PPL]JL[>S@Y+2D>['8@9MN8F >0PR\AG
MQ=J]WO61_3?HE>>2N9F05D%O>IR7/!A-DZH(^/>GF?HR!_H2C#XP6.!^*<^K
M/\YQO4W/SD_[+/3]R@(\=,(B1_R^%R2<FMCU]GOU-\7<[X)UZX_OU91NT8OI
M_3&8&2^#LCT_7Q;1Z14H\U>[].%0T)M8+?"9= LJ0Y!WIVC23U"?YV0056S\
MP4L1E%':4D$J3V\3\R>:^[ZAYMW(\YK&(INDJL3JU#S1%MS*\L4%&&A2CN<Z
M>HV9L8_=%'2?!/+N4G8#.1T57)@V9C]PR.[+8, 8"NL,?"%P$5LFPJ^<K0UL
M+7U+T,]?V_^779WSC]@4]G_>#?C_\@6U ?NC>5745):Z.5QCQJ?!GMY-3"]Q
MK ?CJUB>D9$A9>B9:,69:M##N^E]LV]MRD@G,A(^PT6]9S)VO$@T\;ES!L;+
MERIHB11QK5NH87-C;Y<A=$1]9$;;7/;*]K!D&%<C=YXUCO"15&!M(Y0Q_PUB
M]S#0A2?(P[N>3_ DAD>',3 A*B 18\U5,K953/;O8H3;FGYZ8[<,8<"R#00]
MH[>:3D;R#E?K;WHO^%DOGZ5SZKUH^R.*=N%_#7E!#CFCCZ%C;PX7C%[ZP_N2
MU57_U^BOX?A[W!JF,3 JULGC(E30+[J%4;*L-L4.X,F%-\767#U?VGTQ$M01
M='*'%VG-"7X#<Y?JADH%POIDWL?-ITBYW.UV^9VZ'K8/[I[M5#ONN8X-G>X5
M.DID^<S.0LI1G*:IRH@+U'1JK66&K* KP6A2 ])@/#2-JA:%">16(3;-J!P(
MX6[/<EV&W/I+5T[.X18PF;__S8^@XHML_#A_#\]]+9)ZR.Z6>SU#O/F1E*'^
M#MN-%!PF,JJ$V\&')C28[E80 )):F:9]F*WA'/Z2V4R).HH0VWZ]_=U0TP$K
M1GNHMK_6=W4KE9V5EY<A_FI/ZIF%3#E7M9.0%YD[_M=K];\2V?^N<[04JR=)
MUV^2:XG.0L!:Q1A;CJOD0&<9[C];<9<,VF<#?:6*GK)L6.6S5PD(X E6.Y^=
MTH>>ZOQ@4G%=6J3W:-6IB^FK]8#6O7J]SYYYC@5*/:4;9N]G9CO:&ZQ:EZ3R
MGO?,*3LT>_0[3JR&DRK"1++RW[H'$R*H:,7KBE6 D_11I+H8P84J3R6PH'&.
MYA<8;2S:J&!ZT6?I_EDFXTB^A]&TT7;+W8D82M\!>/J)!S\?"T/2/UE=7F>X
MYW-U3-5.32>;X)W#SME;CM[+?,!^^@!FO_,AX]AH[1XZ-^S<U!#]PNN.-.VH
MG?$F218HHWGO:XUD?D4 [.T#W[\)@D[I)IPD!6XJ=@,3!+1# AA_<PA1[ &,
MWH+#PD[.(*#\_&/U(^)PKI(CK>A40\YG_Z9T9KOE@N.UAO>G8M4<6<$JJ1)8
M1E0V//I<S-/YWJC=5Z]O>G9W_QQWDSH7KD9(IP'ZGKE=OW@[AHGI93D5ZX^1
M=]INT<[/S/'/[*\R5K17'^^W>9K][G&Z(DRA5^%V19#-I*8GK>B3MZ\[<\_
MQ#7C-Y8J:#P-JSI()8M/<_44:=K'/]21'"INDU%*&L<T?.^_4:]C10Y%F1,H
M@_'6NWSZ$BD7_]1T:M?>-0O;T_JM::&E<W5=(INGM=A[OD@:B6#/=!DN0S).
M!79,Y4UB!_&UWA8+76<QKC77QGK7WK7:,[GC<_-?)+PHDA!5WS^.=+PJZ2G.
M>3G+:!S_++VO>GPJ-^VB^ZH'<>=.#]<<RCRPM=0L?:/5!G'WO=2STE*>I<*T
M]D@>I\>W/4AW0.S"76TOW'3S%<H_LJ3^;=;YAN]A#,^>H03&XQNQIM4I,<H_
M!#L1ZPSTH8)[IR!0I3"$05L:;,PG<U7V^?TGZL-:QN]ECW*A_&DN8LSZF RK
M5%RK49,]$,VNR!.'B@ZA[@ =N+%?7&(&)CG\&=J1$SO-V&7.U10'L\<(91^
M3-2)(UO?B9Q[W@^&K#I8 RUX!&OZ-/YA=?8J:/"]$N?#>R3[;6;$V\!4F>DK
M!^RH (OGUD+\&B"4DY12H\;Q8T3Z &C&ZZ4C(2C]#6"28+P-:UN3DM3LTM(
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M>,2O^#__1 W57F%R/520)]9M%$7,($B%XLW!PD.XL;\<1 =+%]O#JC.A1]]
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M_$^'+7^8[=,\>>8:516KSPSR^^H/+K;Z^M;_-28\+*[/C#/]/1=5?JY *"P
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MPIKA6O='6<"W8M0DA5+57PUO,UZ#?WE>M\;;J(*'[B_]P^^[Q["5X%_^^C0
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MFB7#6LA>.5N&0H[7N\CH#"Y>)<FA7B)F(*"(, *RA4J:XP>+W,?!SG:**0@
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MZA&C=*Y3S/VQ=UTW&PD!I<:GW__SWG#T9.F5\7%56U)C-0F4,(M+RTC47!J
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MH+38[LW\[WX3F6_D%V\])X)=0_T?73DZ1>O2RYX]>O86I=YH)0X0X9A^P:J
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M5HUG\VX\U*?-9J;2ENKYXP5;I%MC/]!?-W>I9B2JW;*O\Q92A5P=HA:=%U9
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MX-/ \>I_Z%3KXK#X><)KX0,9Q8R=9]EU4>@\[GW!<SZ6%X ?)ZI%6!FV:QJ
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MM*JX$!@JVJB4PPAX8E"%J@J";E*FB*@WICU$33P= 8Q0&M9A?/F$J27V"(?
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M?7(&Z@I! ?\)$@/=>>=P!X"0EFF"$LCBXCG$#D8&H[:LN.PG+=:J?B0W"3H
MFJ@Y##>],Z\G\T_7ZXG"WI$;:WFNGQHZB3]S* 5(<(__A@ZB#$CBG$:,F7+-
M-V3H^%<%_U1=M]8,@O;'QW5A:K\AQ/D&D26@V]+I!F\]%\Y9,C1*,V[*&2G*
M13M>@W[_F-8]\/3TY(DM H4W?^V5==0CK07OYN96*FJ')@DW-PV[SU+9;%Y\
M-(:[3XC..R:VG +#6*0L0EU6#U4:$XW@A@@*K=7FAKRB'TZ'IK-WIL9]-,8&
MG<K,F,K:''U++RUX21D<Q^1IF-H,S5Q4B^M]:6TI;*8,]!511V:G\ Y 0ARG
MB IF8VPQ*9"4H&$=%A":Y-YXX&[.V6A/)B49TO2,-AG B3#[FD[E\NR. E4S
M><VWZ"/+9/?&9SF>XY45JD<5;PL^/J?D$A(P0H T5<D W *%,'X84X-BQP.K
MW,."?$B9'P@^ =*X5T!L)!!Z"LR/YS0L,$V>-VJ6LDCI^-VCU;(.&+'H6@_[
M*T-U2SNN!(MJY=^(NE=/M4/Q%1>F%U& '=:0VY+%Q-P+06$EHUC#Q-<-^< /
M \<AY@RC_B;_9#/H*20E8IXIV0)+]1 L/-TI\W=*)W)[OG:G6ZU:"0QZ$D#Z
MSF(E"Z'6_BB^['$:-U103@@FT7O:& WNBQ,<O>G5.ZWRT%=K43*(9#*2E1"P
MD%;=SVO7'K!("=!>8&4H2+7\;K-6E47'RS$P[^LWS/&&,+C!TN6XT!N"6D(0
M@D[C/A/>VPQ0!Q(+XXG@8H8HUUHL.E"U4X(20C"2?JWO/=V_$ZX6C3K*T:PL
MO< W%?)GG@-'%2%)C\[O5(UG$^];C[TH[@HK"0HYT27(M72_A/C2H@ :"UV4
M$)&]I 2')C+(M!XXJ"W"[N/(=1 1N-"IK+O6FH(RRC4*/>XT4%]^&V?/B9K*
M*2:-@X:80>L]T2B'F @]@GJT0^<?[1)Z];U+]2-GS#]UCUI<N*Y"B0G8\O>%
ML-%UAS"@/HDOK9^YL03+NF@-E8@[+,JW(9Q>A\W^(?T@0>)C<'Z(D-<H1*9O
MXI!95>2=F5>!W.09UL+WV9_'S/H)IQ.R:"M'BM?XM___&Z[Z]].Q]XB4I>7B
M*+_@L?IX$_F2Y]5+P:7/6UDI,-E8\>,=@5;6SM$+Z?Y:"7]9U?O4-Y=H;H>;
MK<,T43N621]#P7U+?/D#?[AG@/)$O"1.?,!S&L/.YQWUMF,B[E DZ\;#7DW,
MY7H\S;AF&4D*##/Y4SQGF-V@N&JPU3SCFYQ]F%'LM8(75(2)CIR#F&WD0E_.
MP<P'=V\^G:&?2]]5_*A\;['\P]6\N5MO#2U[)!Y?6O!]\UC+*5&W^M22<^ON
MT)Q,S4=*+>;U92RGIU?RP[,;[4V:'T+BQCPOG N8P+$X+GP,P5!G[*O#T!!*
M:3$74NSIC-MWIM%]D06D?I>.3NAL'&'G_VVPWM<T^,NP['@ZV>W0A*=$I'DU
MJ50(2)ZCWI 7$X%*[GY0BYEUER"^6);3YY". 2N[8O,JHXD]DX<;,U%LHE)T
MX9S]']**V!U%;NKOMO(Q@Y:GL@?)A_O^D/ER#EP1S-<_S-$WT]24V)?\8X+*
M5A,O9#HJ )5*3VR?STM<33%6"OYKB2@..K^KP-+P&=6D_[7YB<J@W8Z.TZ+Z
M174\.6Z6H-1:#/J(V([SX_"X=SE0!L!@1MVNHPT;4Z473,54<IRKKT=X:WY0
M;!Q=$7C<,#"*EVW3::6\#?M>UA4CE[7MWM,2SML7I3YU6/%0]Z2.CQ7[[7^R
M/)P^-WE,\"S>=OZ^>8:BX%Q+#8\-*O1++6$EMCF=KNT]&(FPU.VJ>W3HL;L^
M)U)+N>^Z^<-RR1#H"Z(.WK8.&PN?6LV +/@QG,\/@ 5F:$>+YJP'QS2E_MVH
M<O%=V*1CQB-QG,#APHC.F'_)3ZY,?_P+GWZ%ECIG^UT*_.?\ P"BAP(>R659
M/^:PN/<&<(& 'B0Z#F"ZA3%J*OG]D<FEDQQW=LIT@>S,\4(3,",,:V2@<\_@
M:N)=P:.^R^5V>]8T$_77TO-:FW.LI7%R@B+*U PE8U)#\!(53(*#M5/)?%D=
MIETJQEWPA.*W,/:KCB -#=.K\RW_\>3;@X^P)1EEP*M^N<K/[^[&Q?@+0T&2
M.KT X],,M39K,U&2H%)'HU("3NU9 *0 $!.7*PWD.@K5OQB!1E5J)P<B/L@.
M=C@.+H\;I8[V]HYN/76IX:[1J8&;+K6R\=YU'C8XO9H%4O5$5NEI.CG&(MSJ
M8;##"S;BI$X"7YM)A$7[=TR* .AD(X(8>**]T28G@4F5!./0Y,%E*PF[(0-6
M_>O!Y1;K0;,JMGY5%>MDDFZQS:981?W@\N>IV_^7>6@$ !$&-T:56!NC2CU-
MW#GA.^A-_(L5PH]-P 0%VLPWOK;F+]!Z2M!W7SZ"H4;Q99Z<Q&SD]95>,HX<
M^L_XD[^580I>V</7<JV(N\R%[@5LY%-TG]]!?,+PI?L["&WVJ"FFL88(NVEJ
MB#9*F[XY]3M67FOA 5V(Z2 ?PM2]KF2^?"4DI7I<= MW' C>D<E&=G%H@B_E
M<W?-2/.J=_INE)BAG$57NPQV?;8U#R?."1$E!A)KTGT(24EMU*0,_X3?+'CT
MG"_G1.N9?8@9<OS/G.!+'9#4QGHW5I+RQ!1Q+)"FI7+.KPJK=8=X9BVS96$M
MZO^8[_ZS; 5:QJ[#D#_V!3R#?R2-([FIPB,EX#\0Y'^U'L99"YXN4K#HKY1S
M /08G@JIX'9)%.%'B-N,!0=&_4;XKLPJP[./EU'IUB(T>0T[EP%?GE):A%I^
M-+;N0:2?_F>B$8B$I##"0Z*#E90:D5V8-(8,RF])=6ZOV4H6#+^1U,'O!B6Z
MUB*HR@^O-OKEI$Q+#\Q8!AY\X&;KO+FX<J> MP=F;[8E&WW4RC%F]CXDQ]?G
M9'"&FR\"5.9J:J3.>(%=)WX'\.-=-.[UYI"FX3I>?D+]T;$__)<PY2VWX9V.
MGI#$.@Q LQ2+HJ8PH Y\<8%WFM!V'-+Z]N[-0#TZ"2593]F,VU[;&A&I9&T
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M7]3O=5H74=U8U]*J9!ZI\BDJ%_TJ,+:JM*3+FWW5-*S;UWMEK8MW _]QTEA
M:E6+#G[O(R*HI 0@QB1<OECZ8Z<_-L?S+(+63!Y,3]SJE=0Z/Z363F]>^U%0
MX=&08+3VR+SDBXVJ(U=PN+^SU:,&58!OVY KH"8R7G.+..[3>S#2>!W\%V(=
ML6?"H\<-9/.<^#='KM=34C$R[B<]_^6;/H,OCFM8G  H"<W&V$ANO%*'IL;K
MVII$USUO364[,XG%5Z<0?T"\T2:^$_X+XTU4Y]+754A"R)>WGJH![_#"\<.4
M!E=*)OXPSNOM(%-0$IDE&?1Q2F49)16X+]PT4:UCS2W'-SXF\F!CWK>28FQB
MY<F_46(;ZL;$6?Z;?L)A#."^KX'0%HB:NGV6&RKT^@BB\I(@86I9!/AS".1@
MAK#__XP)7XU-19U.EQ9A2,7=%%O1@!]YWVUE:-\4\7#9G4RZ'#Q&_[Q$?DP>
MQA^E6ID/;G=^M_72\N<C[(6$N=%GAW.VJC^#%4S>ED(/T=1722*"8E0 (9%2
MT]-&5<6%@5W3$MY;VC3%!V>:FQ]_=VT9-5:R==3KH$M6UE@75P>;YF.->&:'
M/[&U.\<-GN4%_*DT.Y=6Z196[B3SJ/2(A:WXH9LW*W3\E$NJ;OV:&7;&%A<V
M(.$GX)YR;BVJ+B^.EWK4DI!^XA$5-I]++_9Z'I=):YIHO=!UY/0A/((7C_]&
M@%,N(^]&K<-DFUW5@J'#M+*''43Q5HW 7T/!!&G+T#!E10^_QZ_4EM0<:_."
M8U;R*T_YY:C%%#>D>/SF#JC-9(%["8L.+(%:YZ2N@$*X_H'%0;$+.+\'+<:#
M'9WVY"'O(*1"=[L/-&]B-EV4L"D..AQX9532[_IQX\17T@$^$5F:Q<:T9&&G
MAUGOV9CP@+>XN+'*FW"=)/DML%!QZ.HAO-"[&'_PA_H!TWN^A?98Z]T+L8[S
M^ZUK"7H2+:J!5_X@0WR\;^&.-YY4I%0S&N#L1$"$*P]*LE!T4VXV9R3Y#J0*
M[N\OO'CUT+>%29W1<G=5NWLXC><IODT<I;3(\5+%/+<'@7UXB L%6YD,_O[-
MZ"MR_&&\S_=EN7A$R?RE.9>TYD<%Q:F5CO6A@0HX*Q.2D^*+P7R[7C^7((Z4
MN?JQ?YV?WIR70N_JXTB'G4\O?-*P.QU2'4IW'P[L/>#RPDGA>Y_'\^\TP0M*
M(.,NY@WU/4,3&D#5V674+<'X!F!4:?^+A=CZ!3WO>4/F.JRV^0BS_^"I7(_5
MU'I>1B,^[?G7Y'>45K]SW\?MC#@$)'$SP6^)K@-)[01I3/AX,A?\TFP/^$)B
M#X#Q3CMO02;JRL?9IJ%Z9.:;KPR+0(9B*_*]LV)^Q]I*:O?@F6+"?8,G=01)
M05:[0WC% @]3J[1(XIT2WG%<ZY%H+4A<3@AM=@)EE0 )$OL+\-RM]PA249>\
M;7\P?<$[ZN=M(ZAI!+4BUUK5D<Q7HWUQWQGT?9RK>ZTLG!J&^-N4'D]C%O*Z
M>X<<Z^N&(A9T]8T6)(*#-:Q[NR?U'-34+$Z=-!EMR&G@[:JO(]_1(M^=5/;-
MU!W8??+",)8;2V;$KY(7:)0//&/YZI%?&YE5@2<#V!^0M_<A<T+O])<(23WT
MEP@-V?8A^X$Z;]5>AM-@70$2?=<BSL"\O7O4S.#5JZI=*0955=BB3-'+F6;3
M)X]NPYZSV?)_N(0,1?V^L5;I%Z%-*425Q5T0!I"_AC+K,!T!,_?#'+4C__XZ
M;%DY=PXSH&AK^"#+BT-UBE_X^TFXF^Y;5,,J7ZGMMPF)S6-VO,V&R8";5_?\
M(_9>(@<6P2HE'&N5XX0F648Q6_2Z6B5H$40%$.-U[]M/:.>72#UO]U/#[,%
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MK#JFG1=/3+[VQ%NJ8F^G:EI*FK/UP;=OK5U5_^E!73GJ5??V+?'!8-?@3LU
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MKHHZJC[#QJ6!TY]C?UW+S@R&Q7U[WV5Y"FZAVZ!QI$;=]VOG40'];S)DH9[
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M8/+_EUW+63:^L%T GH[H&RUL=-5TG\!=,RX\[GI*X+9I<,R8XN.OIE97+V?
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MCX8<L 5,**"EWS9XO2]'MM,2\6.?F3R#A-C%Z</I'.XV30'.Z$IKCE^RD)(
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M]F/5*BW0(5$AICEX(' WX<C\%FS!P8J1WH\IB%.UVI!!4C>2J-QB=H _.T@
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M1'.VT-B]"K1DV0Z#QP>74_2N'"!FC2AYS%CH2SZ[__MYJRCR&:G6)0%!3=B
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M9H%WB7?0K[>DF"'[W6<1^AF]*.:Y9Y_U73@=U(&@H"*1OL+=GOA>@!TZ7AS
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MFE$X-"7"$%@4]>^[!3UE?P,GIS*KUV\Z'3'_CKDY2UG35RN<H2M8II)CMB^
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M+7X]/Q5Z63*+*XJ!J>VI[J6Y7BZQM(+0"2"J)WV%7<%<P70Y\9E,2_;S78V
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M-<?N9.T*'.\_JS$''#V)J8=,&W!R%3:)^I:!ALQL'/H!&40Q*/ 9/P2_9@K
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MO?&O&*^?X_/AB(]OZ/9$;(:(>H6#QFZ+V^"0P6X/F=KO'&+4$D9(C!+J -
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M.<ZO;-:A"9M^S215B22*'7Y-<5ZD\2=Y&Y_20<"BSRQ0S)OK:2H5E>E&W%2
M<G@X]80&)MSR^#R]VM\JT9)\8!9_I;#Y7>F>Y0D(C]S<U'H*):D%X0+[,RX=
MHGEUSV@,L/.\#%;-]%U%,[.E"_/OBLEWVEFD(5P?5>8\^:ZJ)-2@G]7[L ??
MX/K@/=ZH7%K,7L/L<>SPC%%68J&HGN'\8VKRT;W@W3TO0A!WNP\.?=:_]5S[
MLSGUR#S7>ET4$U#539!02Y8H<KD#9H5I.50XB^6U"#^Y9IU8.AI]/=V]IK64
M10M9GN5"$7"DLE06EWD*;C[$BII=W +/)!6[Q3"+?6OY$>,]5LNRXO%CC*93
M90C -%POHI/L0.%+>7E675>AJN8!UTN/2 F(V'_/TN(I6@VD87)@L7/C"2CR
M*5QP@&[MJJX4C"?5T51 D;'KTW[/Y%X[?18 24#4!G5Y1U(ODM2QR$0,X'D0
MH2VYZ#TCNLB'8-,]M\I#N4=Z($5(2?[W/=/,A'/2&,KUJ>;#=,=N0G9&]!Q'
M\1*+.']KAPHI0^V8:FAM7P=3T(WT;(U777<<7'49R3_\N*C-459X F*!R_[G
M7'=]B 0!B]:@J\K3L0_K=DKB=%>H.65H;"'DF\07NN_'E2<@%W)2%TAP$1J3
M_B.4R;*1O97\BKXEZ,A@LYA\:;W=-(5L".,?O^,Y2W2,=1![F]O+EK)'77[E
M&T]U@-U$B]44.\=8T4BV<\"]L[WNAA:E<#G3+Y_?R#;,^Z7KYUOM4M\C-Z1
M%849MURUI7(\G1C"WD'TF-QQ_W5VQ:2V\:,=+2B6%&^R:/ 5<=@42_6:J;.]
MCG)9^3J.#IL/59:* 4P1$FZ+-9S]F@9GGJIL;><\\-QH'9SR0OZ)BNG%O#[Z
M$C-&O0:[WF1^700L%NP;S84X/,LI5UA-2@=VR-F*$J3+NR >>9C%YZ&;.BP[
MV]D@XB5_QPYTS['"%!;2X2U!"231@"S3L >"2U> HOS;A0!)UGY\ JIY-I3%
M%,/PMEWWR^3;M3HK_UZO7>FL;WI7X\OK)?W-79$LVLZ+:/;@H![X&1KY?@A7
M,H*3U-MYI!C?K%,>+$>L&WT:^>BWME[1K/N1ZA['RRES6?O5@XP#B4=?1:3>
M68Q?>V(=!K^4- X(FQB,C/WR#;"<U9AH&_=V*#7-SM;.;Y>-\_-%QGTP5*GN
M!@S8+&WEO=\LKC1(393JM(R1V^H(BC$5K]1FB D^7'>82IVNK;[[Y?]M>58U
M7)5-O6>@29_YL^U76\A]S6&<8T=29CMT!HZAZF%(%PXH?,H=#*]3-AQG49TV
M-CVW3D 9[B_B$]F3;V')EF40)H@7#4]\0K3+TH2^^,8M2( >S1YP .VOE:>4
MZB/_T7\RR\OME7=27BE:?O]?T=C8GZ74C(SU39]'\]OA:9;?>7!H%EF-,DA<
MCI[^JOV2!'CGTO;4FK9!O*=GB57HZA=O\F=KL]=7^K%.6]?@+<IUY^&(T4Q?
M/!L56)9,5NK=[:T-G3K<AXD3K#:?$'8.\$SI@!7QU-U_(2731F30C>"&<9%0
MC"F;^P4S=9%P&9(Y!MI,8'Y3J;??_65N8;4VJQ:I,F8=,IE8YQ/UX=M_.FJ(
M-XZ I:C?X!=J%QIX9*_%[!>.(HX!R65]/[&9!.U;;0X@I;>A;Y6,R<::R3]P
M1Q/J5";GUSZ'9&<CV'"?ZO/&>?EB'X/H]$)7TG &+LU-L=)'4;"=%MRJ?$M7
M,K-<GSZ U*)3P()/2+Q 3"]22!$F2C.5XJL8KCU1)(][GB @E51;N#B[*0V5
MNXQ22$,YV#_N#M=)RLR%$8M]%"Y'+.C5)5O'ZV/B3H^[]:*_OX\7IX(I/M&*
M.=HQ=X'.0V<?O[4\R:?GBI[Q)':=>3N$\MKNM#Y=*&*<J(KW0'!2?SD"9K;&
MFI\S6#SWAU-.0.R!'_Y&N,X(7\B0RS7?WN1N]EI9&=[-/^?'!<ZR0E1Y;T8@
M!;=:&>HV @E/(3/B 0G>X#MDG<'2X&N4F^-4L(.]PP=*D/MOC%K2">CLCS4;
MR^(G.O--0OE-M6J7,3QGA_L(TN=\\R2"^=\_4_X,Y;9:VW=Q7/NP93.62I21
MM5BME^DV,3(W5?(UZ5>'%,'8 >\55,Z3^A()N>"^-[V+/B&!,(Q496=-<&;T
MYY@.YWJ;=/\KSU647Z2<^V[N%>R&RW^=:V<W6JZOX9[ZC^;+#;VG9_%1*9O\
M0%C;"4A$Q9LYN*G=AJN+0W6_G/DNH3NI-7?1<<.J/D,<\K!E;%/!FV>2P^%*
M*P8E]^M9-C1K8:6D][I5W19DWALN1Y(;]8)@\1J>FP&;TD2?X^][GI+0[S5C
M>^7R<!G*Y;$7U;.B&OD10T-#,_(W9A9F)B=GKI27;WZ)DJR+D$K28+[QPY"&
M;:\)'/>V5\[T"_VXAJ*QNOT0+-3#)OJ@;:]OSG>R-5YXR^7L;65<\T(9_JS_
MQ/) <4FZIN2FU-EPYYW.&?^OW>O/4CIWP6<I6GE/4O+H>X<Y?>I9\+[7VYZ4
M.,\%)>2RLY<^"C:R4()>1,GN7X@.<+(L*&X?JJQ!7G6ZT@%98-I^#@9X$!DF
M="TI?S$3>H@\:"]R1H[*=D"^'NS8F:=.PF.W9Y!M5!&"8Q>4 28-4,O#"4ZX
MJ,&:[916R;7..\#+"/..CL5[G-]+TJN-^_AL9[4N?!P1#0P+.$5.@]Q&*TA&
MA#MJ9VB^$Z_8$:3_DZ-1723$"I3C\ON_G7O\QRT?=>J=U.IR7S0A',LD4Z@7
M!,_,G( (UW3%!BB:TN*VV]1>>^V4[?/?>VZG'7'3< &Q1YGF(8>.:T\3#$@6
MR'_#8J2''6"A5F&*P[@*1C0X9'^8G83O")5(^THR>-!8C4[MM036'>P]!*RN
M>63=4,M%A'A+?8TKJPD3]ESZV/K[[0E(?H 6"3)?YSL^:$?/3##I,T $X1R:
M#&*)3*-!V'-<5Y5_ R8AB.[3EDF W7!R*&-&-OD.O!]=/=S%Q1'\= UQ;@;1
M88]/>1.:BX[Q.O\]3VO>9C1<-UQW__Y+;\A'AF<%(UN)O9(A>MJ_9F.#(_+H
M!:_615>Q!O]YLF:1K_VPW;)S=VPJXT%A;*"HFTZ3ZW UL-R^S21'R#"XD](<
M@&UV9%GT58AV,9 N[#[4][AB:93$@B74-R?7"D09!9=42UFM^SRRYWHQ:ZKT
M'H&"3(]1V<+)ZM1QB B% Q#%.7:"DVUBDK0#$;Z>GCI3T0'.(WLZNAV3'O..
MC@2.?[5-/D21RRDN#%48^]AG<E7]<9?2(\#376];K]=C3T"Z&GO8G5!"LASI
M=&/=8Q*2.'V<O>?I2(PY_H#&IL\<;$8Y$;P-J . U28+%RU 9R6)WD$P6KLK
MVWK<$(S:\]2?W'*4A?*LFMNN'17_JGNXJC\IG3S_G)?:"J'PE5+97K&0(91S
MC<M/5I?ADQ+L!CW^$:6X5::-'=.M4(D<,DPI;D@I1(V+/Z^3"WJMRSS0_6''
M:+IL0+YZZ /?]TN'>(:YF?3LU!^6+DM4R#-=$0 =+W:G4X+WZ>Y5Q-F__-\.
M7RB_&%/*SQH?5&;EN[BK;<DK>#M:XOV/U:?N/7EL!V9?<49E)5KUA<?B$9PZ
M/0A6&ZIO&I75D680&^VJ:9'$[?F[V"=1Z$T+;(,0\9 ^.)Q.C"=4[&EKU/]M
MB&I&A5"GP=7+FWID&>JHX_=FS _U;J[I%)IU86MVKG -0O"44<_/KYG!S.HG
MLPVB"L:J/75[9L ;+0JB)%3\VK]"LF%2?J*^^/$_> MF#GX]]\C6LG4+K4P<
MC:=LT)Z10L6$9E)XEW$Q$?!+;N@?4S0%+8$*D<:HYPZUI0$NPZJ)FFU.1:+]
M4$$CL8Y_^G@R77*V_(TWGY]24]XULN0<GI !)6E6]K2]$Z1PYU-9U;K AVXX
M>4T-AC,^C;#\<4[?WQ&WBI0_T9[%?MH8O9<B)I.,!N86Q#4DQ42'$]HD4!5C
MAW#ZHZ3*?VQ4#G03Z3N!BWC:5K,'/DJ%'.?!%:G#$D+'*(BK8S2$KYD1ATQH
M%4(#U%*BC@G\ZH*[S3-UP9>3DT?E"W''A?]E%4S28=\L3'OYC;V"E,[0-:WQ
M675@ %ID-UO7 0%,T=,+Z\1$ KIC.QXB&,!&H]2V?2S8&,>4XE9!^CD77++F
M8>QI)*^VL]4OH[(N^*9E+\)GI5PH27S^$6UP%/$JLKHB](\HE95UKDX.0-T!
MT;UBP2R"]/US0+X]4(U/7*&TD</>GX!BHQ#8FELW3T"I!F1)K_TYE>.PH%TP
MJ@9A%$B).5W/1;NNG(!>;)/DK"C\_L0F8+M#,=&1I54"9DUZ2%9MQ\TKXYG?
M+ -+]8K-FNJQU;FF8[\2C0OM[E7=])*,'B4NNI:[O$;U;/8>;3/D_.5.<3@4
MQA_]/C/R_]F_2]SU_SGM-P=ZJPE9UK;:/0&13:B#Z%KH!DWL&(4(+A2^.J(8
M">),?A"L3$P@&6.WH\"UX(T&<'*U=\S"C<E 9+0_FV,T1K!5:!TN]288OOUX
MI%H8@I,85Q$E?^#^W#A10[\DVI4Z?$!Y%:R=S/77#V*3TF?G*?7A&<_C5$,[
M4!?A)WWEV/E%5(;<([0 \V(OA3>!J']<= +"%:/=4T@RCIO=GTBVN.U-1K+Q
MB@0SZ2$P@%5_HWW+ R^O1831I$+B<_-(LVH9J6-2J%R59J1[K<+L@WHD39B-
MJM!C>++<8>;#=D^RR<5-\X$^YM=#UTU_0S4Z(BF.5X2ER^_QL?L9+J?Z0?$;
M&KW0GICS,M*?A'7JQ0VTX>)'%G2GB0[&B\<T=.(*F>&BLM+1HLM8TA2 [K@!
M;P*JB(])!W@H&.8YI1"XJ672! R]*UZY\1)9:&^]:E569].;>]'^,.X_B<<.
M&IV50^(0S_%G@7W#FL(7:A,CN&!^]S0V$W?@RL=5:&_OZ4@B'0"-IOB3C2BW
M(CMJJ>H$1 R,&0ME6WW X=T+UR!(H$NM5]6(><)  6\A%>51J$H)REKZ$J'%
M(0G5KV]IX!GP9,>X**ASM31=U7JKE%AY$[3%#+V3R I*;38F)A_G487A$TCZ
M5BGJ$$:XNG0P".?2C>:P"X;VS.A$Y_L7+&!6#M0%#A3Y:XM=!P*=KF1-"AI^
MNC".$C<-KXT'+<)%*3K <$=*S (+R0G;9+VA+0F0.V8$(YN5G75^9?K/N#J(
MC97OE2LL>!3'I2[=>U'^)&GIK7?Z^R:Q-/L:O@<@>'UE.L)Y^$\G%KSA+]@3
MV\H0['X"ZDP@'. -$N&Z%*,;T55AY;JE!.G>(+; 17&CB6WKK(X>M[3 VH]T
M9-5/SQ^_LNP.M] #@6GL<,AZ!"9H2HO]I<]))(L$\M'MJI63)6%\DR<@]],P
M<B9S1J(  V[F!1!=CF?V%+F[RQ;TB@R ]6Z1_<HX5?OKZ[<9_LS-UY:Z\$T>
M17ZMK[MSR=VH@7^OL6)NQU9:\P4OIIY>0XSKR62NWOU,%9N6RJDE^FO&8GCO
M3^*FP9>6ZWR3#_<JL]!NP]-@;,IF^&>8.H#IA7 ND-(,25!"6#M$C,+/F%$>
M4J";2Q#%;1Q820A,%&4,3E1L;CBWU+M=?<ZT@ _>I6NK++KR-4E* *E*R7*<
M?/T/8["B9/'ZTMN08=-0I\HG&SJK;4[:^\NKQGJN$S/>@379QDL9*4N10P-_
M4W=6T+QY!)>H/6_18,<N.">!O\J!%-:=Q52%RPWM,@(2YD4=QRI4RLW'![BM
MG78WO%"QAJ)E[S(7$H7.:,\2 X^1K8+4?@Q#JQA\&,(8H-FL#%3AH#'Y0&]$
MM<SV5HWAWN9%K=)2S&7/VX?_&IO2MRJ]GJ>&S!>\?/L72^<PH7>-:Y?J:R*7
MENK_._G&.4.P'>^[/,I^C[@>AR-5O/(G5[8N.[P/P]1*1S$]_J*K<+H!V5Z]
M!UDCG1R C*4A^<J:TD&C 2N":<)G/=R W.#UCK\? H*C,]G-3+P]R T.JN\:
M0%P%+PE3TN.OPHY\(&*!?2@SO>JZFU1TX;??2AA)\6L0J+=7^B$=V1#>!Q:%
M7T2T_X? YF)JAJ.J.:[O8F,VR( !L0!P[ :?@U;\L7'/TF\A*!J.;%+ GDZ?
M[W>0'QF3LZW-0S8MOE0G:@W]O/L4.E6\G+R@691W;Q,;(9CG$3?M5!=_92+/
M4"I]VEP#K^?R;J[DRYGN[ZD0'LII(^G3<CK:%*G2X"\X;X@K6(AR 8#$+P%6
M21!WKAA,U7(75!#^2U>(P)'\)<L2Q?29$'9_;-:HL6I458=H$UU5,.-NH\U[
MP2SL?"K]=4/Y5,L=Q[]@M99+^&5/D;'&Z?T&\HL2(:8AW]][/\4"L.1G1R[T
MB=I70$'M0R'KA\=R[T@(_#8CY1%@$*5[B:))T$_ .]*1EF^-P: X+@'2RR-Q
M@[L$KIC]A,?; 8-6)BVOLS3+*\H+#?DBQ%E<_]W[9Y 4QGJU9L2C=$1N?Z6Y
M8Z:NHFEMLZ;VS^$Z,?\XLY4+_@?#I&T,,..'(@,7$=&Z\JW 4G[YRF1H[D*2
MKV\0#GIN-4]FY)+)[>[1)?"/=1&]],X2M<N/?WFI?:\,^U$5T3$ZV?/G^NST
M;+O'F8RK QS5ANRRO^ N<F+NA1]2Y]+Z2A^9.4^'MUV^L1.RV0.YR.'B/F.2
M45>T=L/TLW#&@,78=D#3GTB^Z]-K CLV]@8M/GU+M^0J_ITOOA!SL?IKX8#X
MYN$)Z(.USO[^U"YZ ;9,EH7W(QG13S&O%\X=YR)<ACGM@@UPT-?(QVF=61R3
MJ)"RX6<SQ,JPBC7G&M&#U"UOB#FZ\8.P?3P+@\>.[.L]RY%79YDQ0M1':S+5
MN6DK6XW6!R;6U O+55O5B%?S+3]\__CX'D8Z7H>I'Z=0&6"7CS]3=>#C"TQ
MS5 Z(9^8,=;,4DAQ($BN'1R\I%ZH(ODZASW!W8TTKD_?J)[\48=NL,X;TA@<
M^K>K<9=^=48FOH]F^]"[O$)"#"E3-$KNFWLN:RXS?Q,>]H,,!:/,C,S,#54#
M"H45LKKG=;1TLW4_>SNV[.L^(962S\,X2<.$79H*%S:'X\C'#Q=[-RH5NX2I
M'.Z_UPXRLEY&0KKF109N$^SJCNZ:$$WLMP*.=4<\10B&/S*4KS(HU\)S6#\Q
M@I[H,_F:?BG9WCH.I.R+9V0I!EJ[5F006RH]UCUF\#3%6WW+J9L34"ET_!GB
M@HE"U$BW(V(15=L]PYPGH Y;H'0QCX81SBXGP=2\O55P)6ZW=Z;,[N6W?,MB
M&S"4;/U1TY#L$?)N\IX5L]<CL@F_@LQ6Y7' YLXWL?]3WI?&0_G^_XZ0))$E
M(::BY&O+GBS3)B0F+8282H4F3249C!E+"&F*;Q0QE2P1DQC",#&6^BJ3I<&(
MV2K9[RF-.[/XWW[_U^N\SCD/SO_W/P_.D_/@>C(/KKGNS_+^O-_7?5^?:SZ%
M:O(,M&B7Z@"8-#/YM#2Q 5>B1=>1SUTLF DP3RP;G8R]\"3[4&C.C-#NU8'O
M[I[U'S]TIMM^DI.]N:?&R#E6XO%Q3X;&L28_/[8?F;?QL- #%6=(GHZ01F\I
MDGN3X6ZHG1$V;JQUS]_0UTTW<9V]R8:A%XQ@] 1M)%)X$C03Z8JW]+?*XV#
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MY>7I\4WL)WG4ZH#OH-7KYX@\<%=6FN*O]$! (^6D?>,;P1K^O/(7:<>X-EC
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M.!"A-8,:)@B?0]/0PMCU#I('",Y3>"V&KG(;H>1TEJ/LV8U:3XN8'S%P%=Q
MK;ILOO"&HLT'2'=U.Z+SGPQ0S,)M1JHN'VR(O?E47L).&Q+9S0T$!58B'A X
M'%(ZZ54GL0,YHBZ,@^;/E;Y;8J<3SL,SO'AQ$8["8:"57#$90)[YR.]H$*D(
M;1]TI]F("@]U#02XBZU8+W5NY>D$"8G7KE4$_FC*FDBQ#\2C"&WV8J\GN-70
M=!]66J/4IHG54,)YD"VZBH>J+AC'FU>5#KBL$_0V5(/S7,Q;MLI(>'X-\&5/
M]!V*DHF7^5!01IPG^J-->!,^)5)2(6S:SD.9EP*!"808+2W+@%%&5*3IKGWH
M=;5?&":W4M></6#ZNL= 56TWSS<ZY&?Y,0^8.NJ?^60:IX0&^,V#QFF="):Z
M+[2:XS@+R0.\[LJM$;6,NS@OH-834D-^^_AZD;Z@@#^OM,?L=\,M&[+25/[!
M6.7,PR^?Q3#GD11*<_]7&K.*?*6TCB)]ZA3TE*0&^G7JZZI+'H)$>A,SU1SF
MT+"G^E'4F1WKJ(DPTH>W$TGTG PII&ANDX"CI!&B5!$B*D*(HB5%_$O*7B>]
M)G<A$DAUH9TDO; ]>1VCS@&C=/9&J@P?/6V2!0\"@BFAI>,'JL?>-85XR>VR
MR;[D&WTSQY_ZVNR#*BQ>)+(DM/G0(BQ&\X3G)6]<8#\(2E)5:2\-.(D<_D>(
ME!>?  D"_0D4I$7BIA5]OQOCXIYZ/#N==='$^28=R>3VS\!]J)3Z05Y-4Z8/
MK1]C\!"'6H:MS@6MA6]J)8]_SVMC\UPE#Y])'E!=(;9%[ZSZH0\?.B<IB4)E
MY4??-:V;W8]1!5/#=0\V 9HO52\Q\\T:][T(8$E29$:W]]A#&2YW&:4E_0RO
MAXLWVDO7ECP!C3J"E26Y$#'56\W@,F9FJ[!DCT;@>Y7 Q!V,*;E$]Q&T5-^_
M_LS#ICN5^6Y'2=Z=H/$ODWT]ADR_0/S395CRR>?^!$X.Z[B;X74B&,YF113?
M.+NM?OYV@_?S^X]-3!1EC1W\-?,<&V%"!NBP&L%:C00-\V8/NB@P@%XS+:FJ
MB T&]^'VUW^>PY2!=A'/I:-I7.Z 4=(:W,TH\HQLZ<=*Q1L=-=)/T>G5<G)2
M;]!$N+S2<RB5T&9-X(PA1_C"9P+O^R)K;/VB)\">2>-:C)2Y]MD0M'O4\;W!
M?P'VJ2]M>@@9-9Z5(XHN.PM=-.]^%^UM]-IJL=VJP,'_,&(>(=92VL^D(B';
MW)/0%H)D/09MJWPGA-<%A1TZ5QZ%V_X6]X73S@UBBL;_&3$LBJI_5=?8?/^<
MV[5U:F]0N;2<^=%(8;VDB!9N =IZ"B.!M+9EV.TE9*;81V1/'+: \+IK3.;8
M5,\)0.4NU?%Y>, %*?'EOGB-O\[D!L&/YB!IE&Q>[USOR,3=O153"?!J*<2;
MDZJA<#Q.N( 9J>339A<A_#HH*5J&0>"5!J7(H1= 6;N+F>1O%PW<=H'R9W97
M2QPOKY.@^N,>SA+TX<>4#$6]J7JV#+L5YX=F:Z'S LSS8IY1:M_=&,K7G5;R
M5N]& 4=1X&Z$,%)2- ,5VJ<$O=95>'KK=LFC&Q]U&#QB!U0*TMX&3&0LL%FZ
M7%I;H=],P_O*T]B>HT-DL>T+,/E 'V:6;)NIY&PGG'O/O#%HTXRJ"7Y).$QH
M>[<,>\WH(++\I&M$<:6X+4!1,]\,S2FE 9E\"(@3G;;5%F*" ?NDB)2RS*J%
M0)/=WYI:F_NH]B^"T;[U=D>14$4>21@)9%S3N(;XE2ZPAW1\\K6MDBP;1KI4
M"7PANHJ+!J?Y1.6P5KU7DEL1M$N,.W1>T 3Q=VGFX<%6?6RMQYM/YB^K;@09
MG=3:N!A[RR[_SI[.Q[[=;@-S):T9.Q,05811%>G:/(']/LD=V@4&$0$@"2.,
M#@(EM(,Q&GT""$X!'%VS>TX0V_#RQ*[8 /9I;"UOKN19MU.3RP-N3.'":#E.
M%.A8&##.,Z9X!IK$5.O^\N/3Q!K)4B4H6^7^ 4DB&VRS=*W"$WS[BK:ZN PC
M(C3$!D!F9RQF9@R>Y60DT.(2;SM%QJ'19<'&@M3&&)>&U3GJP1]-<UG.T@?E
M/1?- GT'BJ8^?_V#D*X]*SC -YI9"5!(JB6YX#^XK*']J]$%2Y*%MV '8)'"
M8C"9.[_A"^XPV ;(MK'$@FDA83V%>-O7+B!"'/#2KF@'TQ;=./.TW_P.ZTP?
M\Q#1O8C)%]"E:PN@XM5FB-<CT"U14CJ[SF)6412.\P069^4!")\WT\))Z0BM
MUJVX,R :*'X+H/LRX]5/"7Q;RL+'53XYN?*5#_=.'&T8"+%"!4[F>_6]:3ZC
MMATF>0TME.D&Q>TJB,.0H:52"C@7BT56G?%11G='A;L)\$F\11&+$41ZJY.)
M\\KA$X47OMAK->'Z"6&(6R% 6T.V@?!08XR1]1 +48\0:P9*UR8"D$W] ;Y4
ML5AD@5.2D/"[<+Z0K8VQGMU*56 N1C,L6!-0Z#1)BZ/IB0\*5I/UR_4GN'YI
M"[,&?LE(8"$W-Z#K:?G4'MM7GZ4#IC<7]3VA!=:!7( M7.%N*_LR:Y=A:,*=
M@*^MFI(BJF8%SA^C@?,@'FD9%#L_KV[AA#8,C'MF[=%-N^?>])UTLV\_T5YX
MMFAI4^G=\8C"AB0QAL-.7X8!45H)^*V@5E"_V(<SKT-HVT[C6@.$VW6-N;R>
MT\#$;;$G=W1,*[ FDB+M*9_\59?;_[<OEMK)6ON^3K9;#.6__,HGM%_"EF$4
M*"Y!PPDBX@)[)+H;U?";6<"=UQ6;@^^Y09@.%VU)OM@:N#M]J$E@E-ZZ#7>P
M'V,;[]:A4Y5+*JF_7_HC )_U8K(I91F686%NHS0:ACGVCPFC&<KX1RC@&&&T
MH!/10)CU@MPSL$(QL'!.[@/!  ?5'F3!A]"CU1@GJ]-:R%'9A+-MI0%,TC7U
M29WO+UX&2TK4.V-]GX;?K&4%'8J(FK4_WC\[,<#-YW<Z(0PQRS"%:UB>%:1-
MH8FK$C^['#=T%<=Q[@7>:;+>NJGWLV7MF6_UCU'K)E% #J%M@%2OE;JER1/=
M$BU5M"P+N_=1HUVW('20BN*86-2Y;DO-UJ[ZVMIP[>K)6X<%.3T=SU?!(0P$
MCA- $[)88[0+KH??2F@SP<F*],6V$B($$<NP3L):Z@:!H["R2>#=R$.RK+M<
ME.SZI^SUU0:HQE7A/F"@^^"6UE>-K_..UV<SF?3C_>.+OL2C<2(3Q$O">21H
M:M^!9#D*X9(F:@2??6M)JXT\FBQ5_%,J=@48W2JWAOSR7+8 .MCI=KPNDX)9
M!^;M'S2;V]8T2(7S'BTX\B*JYDOC?"D/S"B./295+DN$KV52Q0&1'11@1A"*
MD]>+<9('D!>J"3JT<-KP/%0_"J5_@2R3%D<D^$V Y/K1B>G25>%,-AUO!(8^
M!T.\"XXP*<H>=<W?U5@&K<TEC&=3OM%^'D[W1J3U4"6$2*OY)0* A(.F&"B!
MC?$?:76H-F2RBP-X5F#0-JX)T:F#N/-,J6&0M'^/6XJ3%J^1 R863P8(TTO8
M/SS#]<:H32G\X$N?+(>V]O,'C9KZ?V^_)=L"PJ%81*Q<ZD*[3!Y.90@!21$!
MJD+#E6V(M2YP4/84$^?Y#.?FLJM9T# K2P"68:+]BSS[C%:=\ W82N1KP"WU
MV>N:QAI F%<]%;W85"5)H8^@QM(R%+?_B]2.(?0@.@@'(D+3$6AR4I$>&,2!
MKP%_M7=U"QL U)WG@O6UE6%"?4WP/I>D,A40VA9_[/-E3L%1E/[(Y.*]<3"?
M_0\4J3<];^=:ES^_PBZ& X<Z&U"@O9^0D&VYMGL9MHX@:"S#"B^'RT]T&A:6
M\L_>]U_[S_GWZQZ>V[M;;"7)62@\WD$"+L)G=4NQ<4C:D*U,J*!I]K)-LS^F
M^F,I470DC-55>4VOY?%U=R;K2EYH-"%JVX[ARQ&E;PHN7VO>J;#P&8IR#SBE
M G*NBU2V8185 P0(H\%X0"!=:]]68+$AP! ECZ1#*R&G\ 1+Z)\?# 6\+TH#
ME1^?KUEH-%"U":M5K/S-I!E" 9$!IY1!!5GDNS(9(O2%5!Z[#$,**(PV1@I*
M2:HN/CI0554]0[&0P^WM<Y)_=OJ2RR9F%69K"G-NC?FVAYY7%C=&'N)R"\<N
M')1<_F^UZ/Q_.=:'=(ZO 4([E-7X]&!G@)CJA.'V-$94FU,1/(G"88%Y>J3S
MXV=Q'A/]406>HXH7*8]\T3'G&T)33_H;7+BZYI<R0A@(,96"<G(=>62(X_TH
M7E8A=1$)N@+2WCDMN5W8:C.J\^::5V<V6>W>FF!PSV2L_,EJT[#[+WW*[]J<
M=._?M2'DX-'R\HI5%14)FB?DC\)@YZANOI)'B(N2N&YE@?5I4!9 ^8,9O^)+
MD7I3-"6Q>CFV*;#&1CUS!'<@^IE7Q7O<Z]&]@O&6@:!#(2CS"]J:<S9'%7I(
M\#HX7&P%(@4]O-"9.,"-JY !\6JOD'T-@PO*!IT;ZX/7#KC\A<WQ;DE\.D"-
MYYNM93$"J:<6>@I/30[9+_;7^?UTVY2[J>S1],]BJ:*M2![/U%>3E"#02$@K
MB34N#7"9A:)S^,]7L<BWP9O!:&!<Z(RA(^3P"J U\E6:)_"@J+[U3.,@9: ,
M>U/OW(9([*16BJGYO,6.P2BEWYF+$V'O+U\_I/A;EF)_;B+:8?=[N3L):V!+
M=SW:YI.'CRH8\Y$PK"X/F3;G9"S0;2O2$,RG6AAFH!GKL0PZRRW#1O<15^Z
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M[&&8X=9O_U]?6T;^?VUPL+_!>/=PGN:TX^20A.W@Y>#DY6!_A\%A,(Y=?]\
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M 1LV4'L M68]#:?:\8#GP:<@A-@6 _QLSEVK5:"8;K=6M941<"LC^*V<H^'
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M,X/Q9OAQ\_73K3;U$^X3 E[!7&C'T8%*"Y?^X9P/^@('(VL$>X-V"5B=V7K
M6^R8XF(7HBD*=5*:6''_6%7P.:D>'_^Y>+IIZ=9&4]ALSB=$%N" (@4 =-Q@
M#E@+0CHVKUR_ )H-I+.08#OJL6\T\U5%+ Z\?I\-ZU7DI^8W0A.D<G%M6=:K
M(?HP*Y*GW$?W:DR,'"X)H;8O81.U#JFZ>.Y<9A\=G[!SN2N\T\I(X)M<D)'L
MSDEBWN;<*0,\ZYJN9,(CWY5>QKHP' 5^PIFD?9A^;V4DV.G_1!?:(#W7L[N<
M9BC.R;_Q/^328^9.[?LLYBP2W0F@D&NTIMU^?^YE;"Q^FX4FTX*^CL1F[0 4
M M(PU9Z&+M3W%#O+\]T0 Q7Z,+E6RGY>Y#E+VW=*GVM*_DY!1]?6$[EOZ_"_
MLM(?\'-VHL]]N*MA<.GT$J+^D>FBJ:.Q7DT@QW_<DVN[[<*V#4]!U+B(07WB
M.Y_>7K5=R;<WE5?WR:4_?'+L:&"6ZP*21A'D&?6YV+G#KYE(XR%M_1E3+OT!
M=$?DG>;DOB<"-N)0-ZN^G5,\/O)7[(@=W(;>&V!U_N87U, [S1=!YO2U?3<U
MM. N=UR;.?-8)T[L'Y? 38/ E("5T>Z'1@*7=DX];,G=*SW5:2I[/*;#9D09
MOW8B5<G9!5=^+5-+Q""2&;/W6_LYQR =M&!:_C3MG7?U$]>1V-,Q7@*7.(P$
MZD\5KJ2 >C9FD"ANK!ZQ8PQ,*&@8Y-"M^?;0HE2ILZM,?3D7XSV3+_R'U]H1
M68$V.:VX#"_O 722SGS/);N14OS$T:;=.C<Q6<;+*1A#6N=RW]G9"FAJB #V
MW3Z1>+*@M!9#!ZN.[#H]+'8S]\.PV$%HQ,?0UG/SM9H&(NQ]7VX ,O0G E8.
M39I]R[2W3W9.)AB=^Z6(\8,V T3AY=3XRH5N1V)I:TS54E*!88ML[UM4<NU*
M]U]\F0Q?4QOA-=2 LQY=_/)DR=L>2^?@-8]A1<41.E=W7&Q76@E_.7;Z4IJI
M068_,WZ9FDX;6$-\/S?\C"+[(H PIGJA^0[!0:2,OC:\J@<&<DPE+%Z1O7W;
M<^,+6'O+6#-XOF>%R'R0$A]A>2<]QNKE1AC:]=&U^SP_K![.(8Z9&[G?_A71
MQGQPXOA=<FQ4NKNI5O.YL-[KB1S?_IA*KQ'&J?N 9%M/8?OL329VX<*.]PAK
M9)XLDWP)LM",O6^SYJ8_OW>?04I8_Z<8!YK[5.S3.D7GLB^V#GN&+[O=03S(
M1=H,I9C>9$;36.XYCTRR[*\;:4ZOE*_GODL3$C7V9U:AG4.6YZVGO8G !@L-
M*_#S?5BGCU">MW@?(#P_%/,ZO]9M%;_1.91HX!,Z5QF*1Q[-5IU\$$K0"_CP
MCI,S<GGP[Q(8YNKTWOHC<__:K/Y]W^5%,Z(F9SP/(G?E4D*Y]G+C[CB,XZ_U
MU35:S'<E_\&)]]K2:<19@:PO_O,])'V(NC6U9P>P'9%G%BU<A^1<AS?4]T(Y
MM))W-,)/P4*EZ5TI;-@)^;VP6_V]XVWYP5[*1A$ 2BH[43>,4%B /R3-D;!=
MFQYL/$\NO#_]=P9^#J@OU12_,IT@8C3Y&>$TQ;. +OER0<#+Z?870&^-8+,X
MS\SWN[^QLE%X3 +GG89&8_/N084).)C(H2T]JW^&[AHEG;!T@:EJ577SX0"-
MA\R&&21VQ\?,1.#SCR273*;:7%@_TI1,1]6QC( O&F^@S759=[2^%^L_9=2R
MB2-_Z?FBKB\JYN;47>D;1Z'NI:]!KU(L>A!3XCG P!,<^#2FEAB)CXZ-6+ )
M@E8IU7473JH_#QF::H;;&M[3]SD8S1E$TJP'?A4FIS/CZ,+;[)8> P.A[AJ;
M(VR@/B-9Z/ @-JP;&27(3,! DO#0;@/B*B[C",)@/L2P.EL,VW $-"O_+&<Z
MJSAX\)Y)3A::NPF_:N6*?HUB&7^X2<4WM@&X7_BB*\/@@U/O_NHZN^ _4".X
M)CL];B0H^TYV$V\$K>66+,7-X?5KA9#B!;)AETTN7!!W7SE^ST[294K,[?U\
MVE?ZP6K>[D+U34Y&?8S\\/# .GS\S('T!WO']F//GMT9N#,BY+T.*FL9G;P<
M@9L.H^T2L"DOQ\TAZA^(VDH^AZNB.9D;7$Q&DY!V\ ]4[\:8_P"DKAZS9AU^
M<[7 -.CF*H$93D%M0K+8_;:4I;SH]=K*^.R<_S!Y/;U8=T>,W/L='[99Z-S?
MY%K['J*S2[O4(0KM5KWY)PUO^!",J/$XL:/.2!M-8@)QV9T<6R%P<Q 1%X]$
M;;'GUB,_WADOX"4\W%X+B4&&:W,KU 1KS>J?W9V'<1MK3(YW/MR8<&ARZ<,6
MFA@)"*K?J@V.H/Q-I^[B53S-3$0S&S9@U>ETLZWV \2EEZQLY=X3L&T0<AX<
M.^KGL<-46XU_6$J?RY)H63N34*ZUN5XPK=A-JVWJG5]=V(@H+/=DPYR?9'I'
MSP&)BF>NEN=()*9B7>_NG)V#P<%*,[GW'.\@,C2HCSFAMT3S35F;I_O/6R@L
MX^?I5]U17FP8LKOAS><-1'>*?D1H]J."@SK^<50V#$.;>+ #,^/Y,45 <#W8
M$43X]EGNXPZ8ZF<5Z7QP)8@_9,[;%W^;9\XG"GI$O,;;T8\\.?TO9OT0NYL+
M;DED 6P8*LLHDL 56TMT>-TTZK6<@U1BPZ0NU%-\^A0\!@!DPT^Y+'UR"C2H
M.9CUGZ[%>8] ,#VR"Z+@"Q<XL0VC;V;"T'B61[ETE7NY56[Y1X>(AH.FLN6T
M1EF'(,H&B!JW2.<U'W6O6L!EX]N]1V*?&M4LQ9<-,1^];;[3H=HA;[YK\1)_
M_(4__K3^.&HRCO:V;1R-G=HYE;#@_P_*0,QBUQ8O];4Z'V;=O2C5AS,B_N21
MQCK(J^B;S)X]&G@TPN.FZ,IF(*VHZ5&7T7&37&:CQXY>RU\_UA&IZK]/GX[7
M)HB'L$QJSDN_V.\]WWQT-E9?WCD8!=A<R"SU"O4<H#.>K/%KC1 Z*<P3*GZF
MFRQ=J_B1M6'FY*+%S?+%>8=ZC;Z2D<H@SSXH5:%=>X9M>]".]LN_(<[JE8U'
MYJGQ767#CAF*!2*",6V8_A*U0VG:>AQGIC@7+YSBT%=M(;@ !+-GK[$Y/F"-
M>6*-5SFM]OF4A+/MXL<-1Q#V/0%SSKVD\Q=!&!:7LIGU8P.>*M=8-C60@UIH
MZLTK7S&U]ZYFPXI>.-PLTVJV,M38S<4U_(D-@Z_-6UU)/7O1Y]W#%BYL;W"F
M8KR=N*4JMD'_A,8Q_[1F 0>&YYR[<!7Q8U\@K0KX=BBU@N!]XGC++@PL@)"#
M@]#S9-?_3M';8G==UU2XPS)"A[(R;Y4 Q==NF'P>IU1F,4QP8YW:X6>ZH9W^
M8I9FS0=K*<SKF=Y\5^59-M 'WE\>G,\Q&UTC?H+>R$5*8ZW=S<LL><2_"HR6
MYGV]S->"2;R_:9#J9Y#3_^Q6TV6(;3;6Y@?*5S]6[T_X'8\<8)(4+AC3\?%_
M('^JVU[<K\'COMDT^0\7GFF6!K%F>UL(T^NY(Y^_+3*C(>>Q9O.F1LXKK#L>
M!P?' D%#)D#(,KIP]>AO2]C*BXU)8G_<ZUV_1X1O 26B.1(@-FV7H;?#8DTU
M?OQ;30[PPQPBVD]-<6Q8CB@TD=X:407/#@6S0AS8L+FG^4P/M;4JNZZGPO"A
M(6,N2T2)%QF$=*#V;QT JQ6!]?-7-E,D"_??6,N@76")/C00 PKAK!\N+I%S
MB$1%R77X66:>YY)M6Q?Z FL/1.S7(-*" 3*(K0D9 _$WWD 7@ 9D.FB^^Z>2
MYDW9(E6B/@+>C2]4INH@6'9+-A#. '%HT4X>#P1D/+O0.6R8*ZZ.V@":.34#
MM"?0$.T@2[9[SH:MHMRP&XORT O[M04%K%!*Z#L"_W,P%H\SK=/:7(B@[^>!
M!.2J70;ATFJG7'HB>G5UM[TQ\FS\;J0+%YI'_&6 <+W>V@O^XI0,@=&65JN8
M" V_6A;/^]H=8!N$-C;,?00]V0#L0 M2JR9L<VZ+Q#,87);RV>Z^H1+A%ODA
MC^:O=0;\RN+4Z!]*R_!0@C'T:[V%[8B:T IV#D^5+WWY\?<0<U=)GWEE7G$/
M*,74B9TR_J;!JL3$W'W/6W2OBY5S[]H9KD=  7805U>IN03M$#M+2<G/P[G'
MGJ*/4I//4X6"R54.W>'\-]4<,-]]CGA6<E-KXO[@+GL$QTDAO;)DECI9Z3WG
M>R:/N,;F^[AG*8_!HX"Q:=10=T]SIS.U>1Q>5X/\%N]1%,C#[?XV.*8D]7[S
MA:1[AP>0_3[J;:GTLM>:"K^)[E^&G 1O:3Q7Y8I>EFU@ZB==OZ?2\7EP^FE3
M;DN$M<*OAC?&MCY)#DIWB,X.7D;2P-G^L8.[?J@PT\-1;V:>B[]NPIY<G;46
MZ#.+BRRFW,-6"5J?GO&S*'*7CG<;PS3!'V$%#6#4T95Q-JQ)>4?(\W'BRY.*
M!2O9G>%G7;V*#F2_CPHS'S:%>>I6V:>C-OJ33_)+[K#X;OUV-=W%WE 9)I80
M2SQWH>6/"K*B#O<G#-R73/:A[&!]P5\'!$8<F/Y4[MSP2SU,03:,&SE&\A&G
MZH+\RU+?-0YK5-:L1!U,4\8Z]&P< ,R%7.!?2:S>H#7G!:3'HU^X@J.K>,S*
M(]3GZ&53QH60FY?(R=]6'H&JU)?CA?"K"0V5V87CC*LYY3T;O9^+^^"F%6M%
M1Z_['L;F71WACXR\QW%WS>6@?[R)<K-Q%,IY!B.T<^)36<KXX93X%/>*(3,E
MQ1JUX))  ZGG7X_;&_CNKSJ&LS&HL\-0ZC.2&-H#.0+Q5KEYE@4^;H>7W:1_
M5]A4(]^82;\(*MNS6-<L%L;3^O;,XW6>K_=X=MX4(7#A/.:8M\>(_$P]LMLS
M/>[) Q)K#;5*I*C2W)"PQB,'J+P>.@;X3"=3SUSWY.<I>Y>*XB_D<#P=.KLS
MUG/.)Q+Q67GY"L,PQ!8IRA2C"DWBGQKP1=I\[;P]L"ZN<[R'>+GL@K=2X;$T
M]S''J'+32">"5^6H]J-AW8C<UM+QGH8)A3YZM9SEE6Z/2U;>GDF;E2]"$PO=
MPAQ=P[-YY)LG/PN>&@ROS?27TYB6,#5M-%YPKY-7ZZY,G'@;[_4K'WX2KO7B
M10 H!BS]!B\_S($W8',Y:3=JAB$P+#63%R?*OQ/YF$>H/B3B=P-U*G9L8\"-
MS/,X /[90R<JD2M:G5M?P:XBM;'Y5W6^ F/1,_CKHYFIO#3>DD.>^!+68\!S
MQ&2B;^!;.V),&8,S..D^9)'\-!"UV]$]EQZ%^;#0)-NSH7]__K:GHF3K1M:P
M5UB>DT-ATV_Y;^W.>A(:'Z_(7_/UM_.M=F]O+!GI=C?5#.A+\'&V^H64[/#,
M0?$\Z)A>T?%,.FCUJF?ZU8T^;:.2GDWOH0&CPEIS>2';H_R]NU>(L6'@Y8*?
MYUY7B,UB+E[S,RC=5&XB4H\'+[<P]*C>LXWXPP@WA/B<BW!QJ1 ]NR937*CI
MON7+.ZNMHI?Z2WEV+=1*E7<M7SI'=*_H3>NT/QIEGIZG=QP5Q?FTUO#'SM1O
M4]?6I7IO4HL)ET[X"E^T/9B>\Z*!<$"QU\/8JM(SS/3XAJ?KZ(Q][)77M]7[
M]@]PZN5=MBI)D171-K#%!234C"P'YMLY[H'_;"T(D7HQ^V%C3G4Y#6]V,_7]
MWIO:(E/^+7-(J6'QRH$A>/$LD[^'TL/Z6.*)Y0_?3>6:6!$*\?A9M,+GC,P(
M,6DH#QO\J!170!VP)OU)+#+GYR$V9HR,F'(QJ_??J "&="G2K +\K5O=TZQT
M],&0A/'IJ.)@%C9C45-UCKX9O<$]N"Q5[;E'SW#\W;*;J>;I.G_^B$1<9TE4
MR _-4Q<_>WQ9<I(K<")I$?*'V#!'>F9MON?0YG1YXK+G1D6/7K1.QN/0)T[Y
M6FF"S:FN<:VXI#!9URRYK'8O?.B/>)\(9))QOUB %F$==/ZH<7XG?R\]+:(*
M/M\S'-L,P>Q!^$VR>2,()W$UL&$\'BXGR-@8'\LWXRL'[W1%Y%OWJW.*#4BV
M#NU/F)&^1-"C:1U.6O(S;:'[N[!AC\+00Q(29.!1-4<!N@/!N\1T(Q_VLD;L
M#@FXL^B?YVG^GO7*,WE^5\& %+*[Y'/>U:S^XGQ3KRQ[F9\\,MU! ?<&6]='
M+JKOG8AWU]S3LMCE;)3)4!3ML21'MZR)M>W_K'6W]LHKAV@]>4O3EM([,L(E
M63)AQIM^[M)TIL?>LVN1#WOF,>^/LF%I[D?._%JM:YE/.\/T;:$TXR[:06-9
M2?22)L,!_</VK<0'AA%3C,S5,*+Z?4#SL(,2+C O!/A^1'UDZI)T4S/#KL&A
M#)=ME*NG(I(TY#CWYVK1KMHY5P$V[-<DY1 +A_=85$AUI*"IXA-LF,2<;3+_
MH,7$U>&+I,UHH^GW-L'7:J7(!AD9=[J=Z_?P#Y_-O?U\%UQ53FCC)*J,GO]M
M$EV,[^W&]I?5++<..=L$V8:]8\-NN"GP?5E9JAY>M+4!?X+M/JJE)5@=VTO>
M[:8M)DE#OVGBY2D'M;X1++$]&UJ;C4?Y)(@L=(HOUF40]TG/C;$#/0CP&"B&
MV(P%/Z_EH$Y>I.9/)N251U:?WJ]Q_SDU35]$Z59?1^3'><VAJ(<1NQ[;JOY8
M-<QKWS&\9^K:SBZU6D]R%>46E<;0]#@BD4!N'L<],Q#Q2#M>DFS=&;#"JUBM
MJ4G1Z-$O& @BU?F>#AE_<^MACNB9@'>P:]9YCYJL<ERRG';KG% TJCCG.^V5
MV>.M8>W\KH;BD/_Z18)6P]K ]^E?/Z_O];.HM-0KM-=J)5N]B/?2*L.JV#ID
ML]*:P;UXAI<'L*L0N*/+\P M7475C1A[2)88:.;U&!744*'*+KE92QQU/%U4
M6U368&EXSRLV3>D-O\)=?]2A@CC:T4F_K_N+5%2$=Q3LYI 2'GMP]MO1 -R"
MS3<VK"R8*6!) /?F?V"*=[)AU[E?FH\]P2]5C^[_0B5JY ><]$%+F(PQGLM7
MH_OG0WWV<:87E'\:$C)V_^[6]EKS+V(;,2I<=P(NY%&)B I7^+!H(#>PD?>A
M9]V"NX'N-?JYR--N"?:HV;Q';4ZVMJ8J+FBYI+1,:>1T_)F5]GO"%W7;)A^$
MS)L+/7J>/" Y1B,J]@98FK\I%2I<+^Y3_3UQ,>%DZW1<FPPXF+)V\N-JE%MB
MNU&K54Z[<&.=:;E\JWRCOK:3H[7%-#3&0EL&V>(WTLB -BG"7%PG-@ D8R)5
M/CFF1$O/) O=6JOTW+*JU''.SI$L^Z#Z=(%P]A/9*U\[]8PF7JHZEW[EY:\=
MLM#VCK\^I?[IJ[)@N"^YG.)'93 T/8/2Q*GC)&P3=K^ZOO'AK]W)C6]E1K&W
M"\Y\?*DWI)1+2E6^RI#\<7BY0%GV;?LOZWFIX*O#,67.KR]E?[2MNWEO79&L
M)VXDU!76(6JPC$O0"S<Y./M:AYOW1:MJN,2^UC7P9VHA<]3*:[Y=KB;0SD+B
MZ#V.OP)1Z-':E-GLO=I%F.\2O&2?)TU)X$E21]5X4/]ZE86_$>;[$2/*4_IH
M9(CHDD-3O'+A6%B[QJ+G2;NRVX7'CQ;<);2P5B&F.8"N\R(73R;BFX@OV; =
MF%B$6[MR?:W,5Q+J&1/I(SC[:,5 A@I\3]()L&K)4:_/S@O+-/7*E?WE4^!]
M-VF"PU>RRH3?KA2H^T;\8M=,% >[\\G8\<TZ-HQ_$<M5?8!D<C8214[#W/:!
M1S$17AE.(RVAW*_>:CRYFQ'G<F>B5%[L#$QC4N)[B(^(7KQ]:TU"#U>+0H?0
M@/!HDJE]9H*%OVZ1,QK'\^U-_+@\6?VCOTP[4H[B5V-V'[\LK_EQ.OKDI'#.
MX5>TS%=7V+!#@!MQD)]2R_H8+@M,8G^MC375D*7JWQH7*SW,\QBRS1L/DRLH
MS2R+G5^ZC7$<4&,TG+0M/_1CS^/<M2CD?9K/]UK1 :;(A'-8W:A,3Y$:AB_$
M\W)U9^GR<=*QKST;7CJVY;V*LG+V>TN3$ HG.EZV6%^.PLV9@'M8#$=P&.
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M_2;\5B('QDR9$P!5'#"]U2^HY]F<!7KDX +AX^J:*.X\F&F^/GZ6S0-(C$?
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M^_:AB"'7[VVH?IGS%&]T8?1L>&".3Z9UTNN"GV<"_1J.X7^7Y6O!%IN!-VB
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M[0^3?AJ=)^T;G/N^0#"EAVV6&+H1?@/686*HH"!/W' 5H<5@E'H]R T7GRN
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MVRH/ \V0QJ3.(ME/09N)U!P93:4_ET1S8Y1H %"AUHCH/@@/N>SDGM.*1IP
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MF[[/V245:5<MB][D5Z%REZ,!F@T!/&Z\P!-((861M]<*!=B,&Z5X46*03:/
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MW]4V%%@E/D>)$Y;5D<(NUI6=K_6;L >+WW;Z?^O]D#$4N/@Y_DU2II"([ZE
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MQ/U9;9&9IWH^AP/8%P:)6K85PY147)C7PQ<)5QAE+&S/9VU/U!2<RIKWOY8
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MT>4907V5!'TA-)W0NPQZ8]BB5[5A+VG3DQWQK<A=C_@@2<O-C<\HVD680C.
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M>\MF#A9CVL,0/TS?1A@JAJV,W0L[M\]XN75Z\1\X#GBV:!P?=*:\);\-M6+
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MK]?GNZ*XE*4.>,5\1*BK8O!6,>- >-C*455M<5QG\T=;])=]G>8R*5&Z!2'
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M.F9MM_0U#9BW?-Z0%U$?X20<<-;31OY']0]+&^ZO,[CB@$VI\VDWU54$,,#
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MJ3I0B=0VUOA6YCGKK>X[VDRB=[Q84->^7-?F"Q=:C<:#;C3(.B5^%G4C'"3
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MW;SUAQ 0WD4TJ3LPF %KZBF\0CU 7AM[,?XL:8 KS_B@7"V:X >+V:V<1*&
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M:$..C"2FCT^$/0R/AO(ETZTT]/YSSAI!8K:.%L2X0S4E4V5_U]5U:]_Z/7R
MM^74"=ODMD*--@QD1<JTIT'K0C@8:.W$^$U9!(>]0.E63CXG$,5)T\':0'"X
MY"F$E?\#190] TX&_#&R5%T-1>BPP?GFX-[B,=Y&PN*MMXL[UVP>/+'KTCR%
MU@:O$[LM#'3<[/5:99Y+GE1Q-AQ^ZKXFSU'=(FO/&3?7PQ7%S^=KKE#V \T'
MI=)) 61+5RZ[N&,'.7+#P_ZY1-7K^_G]:X6U-9?);KNSC$-7I1_>%BF^;IFU
MMNA8EOW>/<<.H>#;J;ONCZC1-60=AC,^7^.DJ8@>F9&526W_8TS.^ @V6GD
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MS!?8\'E9LEN0BC1:N;19?HID!C% ENRD]!MF!1E9&VIE(L?#%?&46["?-/I
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MXMO2Q,HG^Y[\V^\5EB6^3/5."_40O!1O=-=[9M1RZ/BI*$?5^P\>D"J.M),
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M(G:B;SIR*.KL<;?J+$N/#2^>87X&*I>?A!Y*S446;%P_5ZF>*-_I8Y/$"L9
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MAH2[K9$QLKO+<3( 9(WWSZ&6&X,.\<^^$G<>5>1=1'Z$Z'8]AE#<6L2(C^#
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MTH57H';T0%GCPN!'(<[G>L#Q*:,#/6';WN]Z<Z+ *SQW6='FDM/>I>[ZZP7
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MECGS!S/OGGCC'L#PJS!7="+R[5KI<QW>$^@EUX_7(,Q"7C,>=W"  O@8T;_
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MCE/*JV..9U&32"4)-'1DFA=T35'O/WCATD<K37A&3JG"K*WM,WZT.R<J!1D
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MD4(6C0Z>(LJ=?BZ!Y&CQ/;\<^.K,G>YRD;7VX+1^FH9MNN-'(3/H"YET660
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MGBOC?">L/&NZ0_Q+;1M0KS7KGA)."JIA*>@:XM2X5XSAGE!ED]8;^2=7U>-
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M[MX3C;,<Q\H)K[[!>=400H2T$VC$6$P "#PS4!+P@;:G\M4%%@!^<97+YTF
M5<"KGUX.K#,)Y: 2E<K8O$)6\,"@>@C2[>YEX-V/?90>,_,HR^G"+9<"']G?
MS;\"D6^8]I<M>A^3^+W*U69G4P@)1=+CD#;6E4M-LM78:+]AYSPNN#%C$TBE
M3&L.U6BKY3O4.%W*GQZS82JV/#CK]R8OW-E.>_$2B]#@QQGE:T"?J2A$/8.C
M#R3/E)*4_,=[(E$R M^RA=:DK ;U+IN?A3LJ7YX.P3GSBD/&J!\>F)1\S,:+
M=I9HCE2'-PY5LO%=/GAF 0*XL)2J),DVFCC9C6A82B&'K,.R$3))%2_=?ZS#
M%$S15I> I02L#;LMR(+MY42!-$=KK"UB%3/[7.:'>SPXY3_ROUN\6-ZX/:(M
M4@!/2#+U%=1'!ERS/\]T>:L+G^&TL-N$)9"J8"_87XK5';S=KLTBIC$VX7:7
MK1!3PA&*&+R=IZ/J"B=<N'W6WKYT^&L1QW2EXVVNPY3:^3?-,*AS 7PK<I;'
M$0-(X/+$'1B>/GAGT[\LK-UPW.<$0:L;;SM97B"A4?XTXA5([:;+SUO>*JBB
M^E6!.6>&:X<FK]3'KXT/M+1W)/FZQ;-4KO9MB7LT8W4A".1O'/[?C/LM&OJ!
M_6EGOTGS/?\\ZE<K33]H)$/ZZ['%Q7^^9EUP5]E5LEG%WE6\W+EU.&:3\,7@
M:<5C__]EXGNK\$_@!LGB>%]"$IW12\MB[#1!)A>)#VK=*K@X.BN^Y-)^94K\
MT?, 9S1Y/*)J)B78I..(5'JE5T+PU=&I8S:OW,=V?<UU._LB\^9C>U^\P9ZL
MP[GW5%Y7JN[SNZ?^ZH#T8F<8ZJ.10,$-DGI;C#W"/;4.:Y!8E"XVXLCS+RS0
M\P1[7$E:GZIO<=WBL?ILBXK<CXYZQX9_3RUQX7VNRMM.-9NY]+(&M,;,QE8.
MJQ?K,PEIY.8ESJK(J+K!1#9\8I@G"Y1W .8\Y\81MW-@ M?'[2WIT^3E3[UT
MN] (KD2?JK]XGU4;YGON),LN(<2/*[WH\F(A#["6]W1;\A/(5T&2YOR-!KE6
M G.1?WW0R.)*S625E9L2,DCF8'GW."1G-6CV_<VPM78%]3L=8TQY4)<2T.HC
M?+5L&C6"#CG?IP,3E D3R<Q$6S,P9^8'^38>/,!(-]THBJ&"M;>I2*VVW1%$
M_](ZG5?N=?37HCR[MF)S35'CVG7?($2R-\(!(?$CYV&>P[V[><X.PO,!^;<*
M2P+&+"_D5$P$>+@^]0NNF&N]51B ]JF8H\?^O1_M=\/'-TC==>-@_L=#3T_/
M7O6=)]+5SZ9L%LD%V,M=G7WBXH<.9Q^_?Y2GT.@>B1)A^V[D9GP($M3Z6<7W
MQ0UYZPN+#9!H!CV(>=MV[Y# JCP[B0RO74&!IWY7ANO#7]>,/577/#I8G"52
M[R#8FF5C><@WTB_JUA?;4PTB T8U\C6"G+FGD( +@AXYV9L_T.JQ8'MH.-S3
M2[]/]5M]P=U<^E+:[R75DVSID G5H4]4\8J74R=5&IL.O&UY4+'B<UI)C)L.
M26Y$7:6VB6 A6H "$[D>3I-&,ZL<39(5& K?"$\\B3,(5'W"2&ZW.>B]=UAP
M>ATF:?M$8S;=^L2C!<-<"8=(!_^;9N;R<;;#W\P7F3\L].+>6>AEE69)KI:(
M?;I[%Z-.0!'%ELO^:WV+C6<'6C8#C/'6;#5[B;12Z<5MM EMGOLF^C7"[GEP
MEX @!WQ#7@''V;W(]^1P[*E0EC!\S9_^5%!=0>Q> LU8+?BN0]:&]]9A.?'"
MEY;KL(E KC/4N(D_+%*O$DPW@7K8W3'&:Q0EU^4XLGD=MGCSS'#"/Y Y)O(8
M?G-[V%@]GME.FX''D:6P5OQ03!"T?2N7S+,;P4G\L!R/$\"!'!:>,H5@HY+Q
M_HQ4Q,X5@\,"4R9"'K2[%-LZL)2"-@ERE!NZ=T7^Q%#YZ(K:/=:SW""1[PX%
MI_@2@L-.2] 7?%W]KR5NR0EDQ;+F*+^#C9#"^/2.70P@'02^)[!C+2>=AU=B
M@N [?ZSAFGS150%N^Z/*YA]ZS+NN'CK]<JXEE!IQ(T8]*,PO5-4)??#NGM<P
M2(',3&&(XX,J\?[K,#&H!]]$X\1QLWG'P1*^'B:[F]QL%(__"YYLNQ6 ,H')
M&08%G>91BE)<X?CTVEK7M\741.K#=V((SH!1!E8KK!4A4WWW1V1H 4?[XM_X
M>Q&T=5BW'@L-VJ_#6&:B_1=T3/33SU?!6HD6',TS*]RH[2O07HA<72A>AZ&%
M!7Q/O@:Z]#$00 CB[VR->K/SWH>/T=O_4R%Q^M_78?1^-KZ/D(""M=_C6O%P
MH%H4_ZS ";@=K5E9*E <QIX,8L6BJ:H'P&3[]#XE;]51]%]%@P*G&RR5B!I/
M2KYO]ZN@Z(',HLSOW>/]>X1:IV%X"V^1.<4WX+MD\"%"GPNOA54FY$2$%&2+
MT1S%6KT4Z C;<(ISMM+@(V;0G]*@ ;?N-=]U6%9C5::V2_Q'P?OA_N>!PQ.T
M?8_9)KJ&6[RY,PX$T)S*FDV2R&CW@PODD2> 84^I)Z,A)HQXXYZQGONUK]T]
MKTT9']:ZXBJF?QBFI;.=G\PK%XWA#B0BB<W_)CG1LWG>H!,W[')39S-W;P=K
MY#7WP:;K2MPMW*PXPR?L@!O-*8O-+057<L>^*,EVQWTQIVA*_=_75AF0Q+A;
MCQ*JSB[>='(AII'4T,SU2\&BV0:&[S$Z<B=N#*&Q9V\;_F5WO'D:DOH7!7F4
M'-H""R7 D,PZLKB(EN,S":)W^2) W;S%P1DGNA0+\<"T1ELT,@62E;\M(H>E
MM]@ J+%"TMCOYYUV!.67%P3 TU>.5K_PQ^JSR#OF!H_?BT!,J&(>)50L-=TA
MP&W5L=:@(\O+O),LU2[%,DJVE1E2J,UC.6T!8^R!YCC?AX_>Z9(>E= G)@[6
M/SA3Q.S1:_5EZ/_;D__S!XSX#<7KWHIGSB^!>RT6UV&O5WN/&7/P7"9B!-X3
MX[;BC'J*4,(S\XMD0:+(MY@*"\C,LBBR(M:Y!"3S[H(V;/0#2Z?N?D<I^[<
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M#3U(>(5H<5M4!N2A[<I\VWED X,JK>?2,&BPXJC=BX<+;C GQT6:+E/TY<>
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M4W;]P-U&$(_^1#Z/_G_97'G.?:N;&?PHD__UY&^!B)C'/\5W78&D\%VFUC8
MG=KK#>>N]M&RR!JF_41IP39AH:UL0&HU]@R8_>IJ^LV1GR5Q+2?+P!B'Q]
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M":-2[^VNVO];QZ_E>!%!&'WE@(/F/0D+[5T087B,G%U%!/<Q.!]XW\9Y[6#
MYCHD4K!_*G;;%K_"7)=#-MEB.:#;SSR!W,P,OF<I"]^PE(IUYOJQ<[.Y,;W1
M=GUP)=!7X/ "#/S5'1FIZE64S++B:VPU65B(<0_Q&_Y88_*+L>V#L5VDMKWJ
MV7/9^"R!"GL:]FYN]M[ ^5?EVS'SNY2 7=5G]IPKWV-:2N3<N7JUM",CK^=;
MQ(OHR5F!#9?ZP/KL +GNKJ5[KWI@_^S3?=__N6:H8GDH)RV4M^N#P]W(D+$
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MS"CZB&9XS3VTV:WG'QGESJ]7#H,9AA*FU)'>[W_?^>ENXT^1=J [=__U1_T
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M(K8YX=,518],Y"KS'H#F +]W/%HY>66!((EI8YLGF1A$=]-ZZ*9%;\M-/XH
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M&YJP9TL%N'X?=Q\VV-H=D+M,,5U\[9A";1-$;T2.01,$P V?%KVTF"Q:@3;
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MF]J95E&WQQ/R7TG'#\6%H]?8^NOXNTE$:0Y]IZ42L/)8<@(>L,(EP %SE,!
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M,9MQ5L=[!#SHZ;Y*HU7:$7SG2D7>4#+WW'XM"4K2Y-C\+-HZ/6ZB;M?J^=K
M,Y<C-)="+:58]!6:1O+Q0ITHHM)IK&=OSKFAA2:>[*I&S>*@9H=:G$668'J3
M86_"&)LC[3J@;!/,D.+A6C"7PUP%61_0YE3GQTZ@)IPR'Z[C/U905_<<$MEI
M?<!*PN4@T,7H-//;@>PWB_I=UUJWYV&;>8U2Z*;&OO=I-I%:"7XE\GKF%1Z_
M@T(>&ID[JVIGVU^X)J.CE.?IJGKI^ @=Z4+*M*<=+T Y!BE"/OO>N>4BDO:T
M_BA.E7+'<$R/5>5R\O9XUKKUOLLUU5[9\P5,SF*^^ F>WWS;)LON(0FA+6E;
M5*&_,06+LLL+VV4FTJ$6OZ=%_1/$AF>LQ<"4VV&7?!\M>Q4N-)0\P7H6'TO:
M_Y$5MNOA"6\8VPZJH8^ -2% %*65U65+ $HZC/I[1R2[JLRD"=-G:/[J6EM#
MJ^ZTBOP23[JX9-,+:?ZCL&82%\R-]&P'4A,9W:39@8\TD04L#,[,>*;9F?M2
MG2W,=6.@-C2=C6G/K1X[Y[F9D%EW.2V=V@-[)4*VC^[%/O&1V">O:+ J:'UT
MXIV\^[$QR_@_/R.%T[D?G+W#<\1 ;0=B3'^:':!Z_+6%]CP?^2.:)*VAF&#>
MLZA+_/2"K#8;HV0JV=MBGM!K^^[5>\)!P9+?+;"H].[^Z.*#MKT/^0TZP9):
MRK%,B^$K8" =P9FJ('8_O/J7KCT& J(*/3$:];>2V8>#)N_1S!)<EK0^*3>,
MKM^5VKX8DU+5%N56^#KI%^+80=>M<]&N3WA6<[AZ?"?V-3_S&YS%!SM_FE_[
MM?>\@@CV]_*"@6T[$:+,W Z9Z'3=$.S7J=S\.B5GKQ S][C5L<ZS^9-^2-NP
MW_589&-G1N'^10]554SJZU__'II';6??>I[[G/"':)%P\N8_HH5>9N%^@X3\
MLA*#E-3FQX&!>RNWS@VX\-YQ326-:"^IE(G<.!;>OOP<=\=FZ!(DQ>E8J^0+
M3NV]]WR! ]I<FS__9PCOI8DPG^D,,+B6L-N7C#&[5]<U",JQ^2(H%9#>50'&
M]<2S.Y",$6H!$PBQ7TN/QO[:4X'] ;7=@0R?6 8JV4(-T85,<1%">&H,S -+
MC+W4MU0X:Q9K&^]_T':D47L/8W+7JF^#M4LJ]F+)+_$RKQX[S<)6,G*"4QE7
MF>KME:0?D4>B%3]H\QH'7=>O;-<$]3_O;K5'@NV\@AAM3-][ZZNG6048Z;OS
M#>-X#.51GNNP2M_F]R'FQK_8&*;F[W\YQS_$GDSK'\)<X3",_U8''"_M'R=1
MQUE-1I<XWPCLWAG#&;_6#L2#!>\AR:&= 1@!*]!VS('IR)&AXE#IVX[+Q(<-
M>O'^ O#H8,+%<;Q(BYM26F6IAY\3:.V"MW+\;KW/-.3!H3@;<=@($<M4X&0-
M]\?FCPV?6J+H.<-K<S8/1PI9V4;NOCJYKFM]O@\:I%(.!'T5OZ(_8&0_B@?L
MX>").$R/P7I[TN0&&;[2A:^W7NUC7)M>ML-QL?GC5)]4CZ#UWI_:@82']<QH
MC E%L'Y'1:THK GEUXI.=:/]68YS6]='M*<UV&S-+RA9SFC.P<B-.Y JX?0=
MB)  (Q3;H;P#>8@Z@.ESE,IU#:!=VX'0@\9;%*B:T3B!%M& I]X9A;$HM;\H
M"?#KG>Z<V[755B;%^8O!QU);?)9DVUX?#(F&P$JQSV!R+>(,<Z8XZ$3;H.#I
M0X!(CPBW!_1 RR&T:9[+@NP6G3?FT?W1VMF2A8:EA@PWX,6-^<D[*BG2G:)A
M+MTNIL!1ZCP!FP3CP4BA/4'](D(I\R182(8)!:U3Z.^]'OC_J&A1HB*/3]P<
MRI-UO9QT[Z2CM<1CQ+J\M?O);]ZTR#BNB?_]N'PE=8 MQ$4PYRRJ=>]!5MEU
MSO1ST?05LTYW8Q&OF0Z<Z<#]3 )/.NU 0N@?DW"$KM[*65M8Q#9J*O0<>X23
M#_D?_WOOX>R_[T!J\:M6 (Q^"424,!W S=E6S0X3\9'7'VK,2:LFAVC'\S_6
MRBI'H(TA2+,NV;$AN7M5(^378]99^I'<*3<A6\Z6-M5#JQJ;ZC;TD:O#*\B"
MUE$=5491V8H:\E!"7O;:G[6E*ZNK2,I%]Q3$ ]'+)<Y?A/%?]5;[.(/$TR:Z
M111A*QQFP9T/9)?3"F?=8^9;!C786@N.GIY-B@G/E>ISE0E>3OD,GGS==Y]W
M(%Y@#%4<29[>KTHB"B%RD@__0_5 I?#D'!P 7X=ZPH0Q^WYXP6HTF>+SER;V
M1<6AW4KYWD?UZ-8'AGVS/N#Y!"4*/J=>CK%SPD;.'&S!\B,>FR.58S>]LH\E
M;5]F1</(.%@-:D4(^&=T&##MO&)D5NPP>6EV(+;MT!5-]B'T^=:&BQL:F^7.
MN2+N^67+301"\-GJ(>V_M\.?C#BK-?@]P[C^1[)&M F"2I6F#$O,E.-/:&WE
MJD/E$E=W@P^8LC;;G<T#P&-07^VU2--]97G5Z(NTUE=?DONI2$?-E2P3ZMYL
MA1&Q&0'537;TQ],O]BQF&\Q._0N^#FF?G3@H_RPDF!4:,CRX]^X#><%X\FQR
M=J-QS4S:_PB@/>$;+ZZT]W7T8J\]W9;?N+HO^M'FP=ZSV^X3SZPW_A8+CV2'
MW,5YXZU[\%F<*,*O(A@63#%6/OHP.2D<)L,T Y8[TW'[;;L:@J]%Y8).UV,W
M;F,E0I]7SH5B34?78J3<^_CV?;W^_M^,[C+\1H?\P4R.&CA .0L_M(VC)QHD
M'B]7F?4*D3>\;>%=;CEF_J<^=<2]H-1O]NQZPA^42&,P7MQ]_2 K*Z*+ HPI
M\D0UE.3'XZKS6!EC^<;R35K;1S\?Y7ZW*9^*(Q0J?I)X#YS:/YMXGMFH/.H:
MR];,9/,?9*!>J>_V"L_&Z/Z9,H(!6^\$WZT"A?I+OKC[EU6'VG@Y^7&3;8@^
M#N;F@%.S\STB,5CQMH.3BR8:-:,MD";X,W)H2)=>L$%E^)![-4!/-L8EE[K-
MV(^FJ0;16X;N'.6&U<Q#+\$E'M\I5<BX&6D>$\F3^0ZX+1]Z]?)Q1Y?!_)-G
M@Q^CX+$M]O;J.DPG]6V[(/>W#W\8E9S^!HST6J9DZXE'QI_J=U(^<7V;D$BL
M<")=<UK 5X;^^JN>'/_BL8AM!Q?D7<#W,?D&R$07M+:7*:%)A[->EZ,.@1$T
M?L)-VB.IA !IPCKO-^EHIJM^,G2EU#@AOE(X6?)KT3WI[=;NK'"SMTKGP^!)
MTOC=3=<R'& CJ@85U)9@I;&Y/1<5BL>]*]:99[;3TI^ *?XT[?&86:@XZOF9
M/T'6UX9RJAN%4.JC0Y_E6?F,TYRIDH&Y:X;Y=5-)<>EZI%K-KH,:'T;GFFGO
MD$ARO_&-JX_-?=TI<)/?FP?C8ZE. V*DI1>@9!K2X*#,\W]-%)>#E!\]^(/S
MHU6WNR:8KO+Z9UU]QV1_>V?KZ<1E\VI,]UB\JI(\O*ZN)+ZVY(N7]C6:D7X&
M>M;)B^/UI'VUW9_U+RP,9W.IO')]\]#**4.CS&>T,'?.-\6]EUBYNLF!!G%6
M<V4=C)_=Q?F;PVGAPG--SF?FJ795$IKEM[LU)H]E;'1O_\0",1[V55.G4RP5
M3I*ZM+Y!NA,X<MN1CG\! R[B^6:"PMA2[JMO:?9=)*A1:*!.73<[ 5'F99<M
ME[[2_5:;Y=3EF-65K4KC>7OT);;F?>:%^NIDWT=7U:ZS5Q:#-3+?3SHL!A_'
MW<M=?')*J2XML\!A"D'731LJ$NU (! 2NN/ AX12B1MJ'CQ[*[RN\_RZ*YZH
M)WC7O\\HF_><\;*1>W1CF8ELFU/'Y&5XQS__W#Z;>CA[*,O5E=GX=5V:_\VW
M0*_]P- U9JMZ 5?G%YFR1WX8P^\;BOK?<M:OI2'0)N<CD)QBQS<I+'83>$6<
MRI2@B;VN5!\P ;%  V6]LU*8"-I3\&'HTV2LT!3R],*,]+!:;9Q4\JTC(6^'
MO\LXTMDW$[6SMU>^!9C\'#!*2C.)+LH13&HGS[Z;':GT)67X*/!Q'7(]RW89
MK?O'<JSSE51R;+5X76KUZ5JY8VJIG4U:]>-2&]MWF2$->M@F4LF]CT%W%%0&
M"==SH][O+QK)O?SZY$U$MZI*Y^NSMH42:3&7^32["WASYBNYWOGG+P['GE3+
MJJA$MK0*O^1 4_7*L__;A&V-[KK&R[MHF;J M:;E?\5=;ZRU<2\(&OC7FZ]^
MZG]^YW^ZQ6P'<H3>O .YB[3]OUX;36_MNE(:G=)*A:[R,JX?IL. )O3-'SN0
MWNK0OLIIS0,;%%8@NWT;QTZVAH?C 63L:PXUNN]Q!X>C)["*LLZOX(%/Z"NG
MC'G.S_X<Y%U_O>LT]PP+^%WGP MW$E@1QG9$^[!2Q-G;K((VZ2?KG^7MU[\4
MV3X['7%C]=DI")V*WX,ES]7_X>1@\@Y$\M<JM%=D\KAI8B.<Z$YY6CEB3832
M*:QL$\AR1E0G[@#Z/FB6QQZ6[26(B#$O@TZ :2_T@'82#QA'/6:@GEBP[=:6
MT?3N<\_4K;':Q=KN;.Z,.]T!QZY;U*=*.+<SCL?^YXI!]]UM4[80AKCK_KG2
M.@N-Q^B!RH E_2VKN'8]QF#]!?YAN2K5N:"<NFIJ"F*I.%F/#1>/;9<\=2-3
MGZAS0,!:L]:=Q?&2H;S(R8(8&[-?)@:<1]YG<N6R!^$?41RJ\1 FRQ[ *K9Q
M88;QLNQCS$,@C68S0@T-MV%*XMH=>>FL:8*I5\ OQ$;'O7PPPRN/=JBFX>'P
M*U-]A]=A7%MG8D&+"3:_U^XM=,T /!)SE,C^@=WC;:( ]E+9[P$N@HN1=;0C
ME'EXNZ''6>M*$KP5#$%2CS<Z*[682B4;UVV]G(B3J')V^"?VZ5,,G(J?A+$%
MS !;JG0$'H&5P$QDFX!<#(T?S$.L1K8F^S-)L") ,W8;^14KI3T0E=XDX:)(
M>Y@IG#.^I2?-/MHPH3Y_>N'EDNR5V-N_8U?R'D>WPWP\\G@/*;Z%D &S47GH
M][3_\CVWL#<#H!HL"H9 3?*R^448BMB.>VU\:&Z:V:HE@"<7=F 5,=^QM0V=
MN#U.0J94WL@V!3#7:;3EDBM-I-/@B5)R1<JZ2VOL$EL <?>91UJ&=XU.6F9I
MW#(J&>L)!\]FC] 702Z:-5V7]1QV%T_<HJ:O*C LT8:TI(XX*[U>O.#=02,H
M61U&58Y:-U*B9H5T!_HL.;Y_ZB\D?GNT4GV(&G<^ECIX9]FQ/#N+.QNU@&)*
MHMC\G!JQCPO$,CPP_;N>D^O@\23">GA&Y2H?C41)BC/1 TNI]KTRWFLMXN0=
M2!1&?DPGZX"9FSM/;KY3W&C38(!AZ7)_C([#];:X@DF/+:TEI"]O/+9S]ZZ#
MCV_\:%MLOJ)"!1B%C_80JS-4=0Y:!P.N:4ZF.K$2=H_P6]/AM&OY[F5!#61\
M!VX?".MN2LLRVG)T'H@K]Z_-[!K(ZSMCIK5XP\M>;P@Q\\!S7\J%T]VAK2[J
M#*-))O(C* =D]]-?C;4H5*"Q=8!TU&&04(8VJ?]4!=S:@71QCWR B\T$V0VO
MBBV1+F3>$&\-]_MP-KKX=,_^6_2,_^#,'U0B5*Y-"O,=RH_VHN%GW>/_#D3A
M^=D*B)?++F=HB;5NSEJF(\?QM<.4QF:/^]EV#G4"4Y97AE6R+Z?-*?%;\C-S
M.<HC+ Y/CJ<SXC _X4)Y)S/Q0RM&]KXO?7S:[%XL#; _]WW^6YF!)2^AXC*@
MSSAX\-JQ@6",[>JG.&O1TUDY;?N88N.;;U8J-IU8RIU(:@U-O-OE<.U@[6:H
MK:.56"]E^\Y X>+@SSLS;^]6Q^JE_5%"O<7(83ML\>0X1=XQC#A:&1SB)-04
MS6QE""CLJ@+A[3@AF >>:$J7 J3#V:+@M[8^]_Q%@_'W5,MI_AV(X[!:W<4$
M';EIO^X,MS!3[PF#B@K@O-!TUSGH""X)YK'^? <B8,)'8G,>*V:B#-JVD[AJ
M=R#\B!F]%C")FN4H!"4 0:C;]9'+YJ-"8Y0DW]'9IKJXJ]4WO::F8C[4OYAQ
M>BLJ1TV:A+(%.$J3>X[5B%'^B>;P.H[L1!IVP22D>D*=+ #W6/1I*B>J'"?B
M:C-O(E Z,"XBN'QAT"S^4?F1Z&^^>E'?_B@U]?D(7*P\Q.1\]L4 3@@SS&$T
M2> 1.%,\\,X+PG56!D89;4K#]>Y 8A2YAB.:@FQ[FZP[L7R>LI6$<NGK(ZL6
MB"V,:&T2(?AW _W1R4?>*SI]N3=5Y?>%H$!]+SH:2'^.OU?)PYZ&\[;HY: -
MP-W= >X-D "$4 ,[*^5 TRNUP'BE&X675A%'L8)3UJ>T;Y<=R^S8JEEVU.GW
MJ!@HZ&!E^7E)?HRDLPU?BI#P1%5Z)BC$.,94G6C3Q7#F4,)('4BE)$7&BRZ9
MG*0]^9"FFQ02-&.'RT=\/%DW5U6VE/I02,]B!%E16?&;JB(L!U7!],( >TU0
MF;0Z3V794B96!A@7/10UP>3\Q739%9SP)@O:Y;*7-D8/\_S<$#P30T')(1R%
M*\L1NIC0YI\SBT_2DYVZC<Y\[Y-XWCN;M)I:>!O;<0%/_D0"KN(FK:D1]6^I
MZY,$<L-*:CF;9'((#"PY-Q(4THL5K;.D YP54:9IO+M2/U;+DKH)I.46(AJ&
M[C@=T/$Z,;2B$WIA!HT']2LIE<_P;DD1V*HMIL0&122\%@M!A[*2L5[P\&VT
MBS*@D5X PF_1W#MQXMUE(J)!XO"V8?5R#1UCV2#__=I>AG)OE2(GS"=TILZF
MG=4Y.'M79%D#'X<%M39X1MC\\:0NK-?YQ9$OM#UL]Q'%UZPK7O@&LY4DLF66
MZD40Q[C"% %15,8.1!AT[0HT$:4E=>$%0&R7KE3;R:&R@&\Z:[7E3C9UK9&J
M_>H79JC??L=PCP_W&OR6D67;<3+P.V/9^0*)S?\\Y%Z T%I6"./Z#[B#\]25
M8PU-]<W68OW( -01L4JA+A[]HP&&+KH7^&1R1%8?_Y?W@%0'3%2#MJ<H@021
M:$X&K3\B7:\%GY+A4D$SL]=B[R%UWTM':"N8.H5P-R8[JKB /^1N%_H,Y5J4
M?3EWY-FIME/,$%"=80S>1\DQ?<%\,C;"1#SQ4O@RVX"FF$59%E>+ESP44\?W
MWBOFX)^2CV:J[K^5CW$E<.1Y)BM[!X)(D%KNPD+:M)B&8/,'AZN#+C]!D:YM
M[T:Z;>_'VL#Q\9K,?MVN:/X[3H24_LAC5/QW<7H<*Z]-#?,#+UF'3X+*,L^'
M5 9%==74S3U_;^FGQJE3OI287WH&L# CA8+:)$3NHN.M\(^7GAK7"H24+_4;
MLZM"0[6C:32HB(DJ^B8(G97#QL#VM012X9$DT7+M999)?[>+!#[JVIBWVJ;J
M4[6UVE(J,.U$6MS(*]"M'D-64.I??\!7)QHR@C3$\J6AAMNL'LS0$^8-%B>I
M.RSQY&K8/MC=92=<)%NL(6[6;!56?EY>41%TR+E3]PT7J:G#_>=OZ4!T>H9/
M4],(<]'!A=!)1+8.Q&Q^+%%?62UWL03Q'"WS$ <JZ:URZL(^&3"W$/,#"]BM
MBP>EC'2*7]&!0]C?3L.MWY/JT]4^3CL@MMMB[ADZH34 M87D6K9T0S9*P>LC
MC>KLTN]OK3D!!RY5@LK**^444AA. (8ZH5D')4K/XGJ%A*'1=*BDR=')OJ=Z
M+[SKWBI%V7X$$I.+^D-TVO!>Q4XS3DLN9\9^-].4?@T9I:5Z );J>;C!Q@2#
MEWP]^AW?@U-\OX=L;QJ-9L@7OD"+4Z!1)I*#:!&RIN "1A# 1OK_\*\4#G(G
M!+M5)+_WV'[ =7KR!^()1VB@9%.^6O0X.BC,O<[+,#^&:> :Q,#GZR![!O<D
MOI&H_4^KYT_1%&'K1_/0J]CL5U+\)O>U2,D34[!YR:Z@":KF<XSLHI87Z8"1
M.R6)QP,XG!9JV;4]%IGDD5Q\^(UYB/:>^LU_>R#"OM^Q&AAMSJ(\@MVWCDBW
M)\(C6VY4H#TFU C<=2"R0*Y<:LDE3K(P3L?L(_![I;G#S%*5D7X^JRH%8E)_
MB_"6'7K+MN]/?/]IY.18)V6I3-MQVEK<4?MC<H/+HXO()?1,8/<[/8*_F[W1
M]^JO)?UO;;JI"-9#BXF64Z^4G>1L&)7N$;@O"ZS@)][\U=NSW/,T7OP_28LM
MFYJ1NR&ME^GC/6/G-/U"?85>[==J4%?O[Q6;_^C>-\N5P?9UWW6(QW:8PSQ]
MA9,92IB^";; T&9A8^Q4[\SA892.I:6EE- O:[T8M$6;')"84(04J,'2NS^F
M&EZE7'ZT" ,LL5,U]+1&YT#Z"*NB3OUXIP?U 6 6@:I@7ODL *$W%:1[H/4!
MML!+@?VH6C# X0"38.RU?*]=XO'?4E]KJ0=HXVLS=+'L(P?G'FUZ#K:[51?S
MVS0AFL#/QYAE Y'%U,2C6JGO.UH4NN2MG"Q=5>^5^+"MY$I[;+_Z&?B7V(59
M6?QX9#1''2L_/K2-H!'8_"$,.28?\EJ_"UA3 #9WR=Y+D\,), UBK:4]7\X4
MD-.DAQ>]-++R+5432@)4ISQ2U_M.%E7.%=*G6!5,?88[\\E(FPIHWY&M"AR/
MHN"CZ.S]M=4T2\?Z_+)2KRA']F@TXL^=V_DU'UAOQXE_%DJROD[]J6.),J4X
M\VB.Z8'S?ACVKC!1Z*-9=CG>C#$ PZB)N7HQQYY.\'YUYI?YNR[8MP?]*G;9
MK.G/A*?V<'(K7A]++L)7X[LUH9@A%WX8'T8*S&**Y*-5JH=6UICB ,,.#_1D
M8:7JCOY$^%A2OADM9EB-BCYZ-VEQ&.:N^.#>2^[*(;3Z[#H/6G-6K=GDV^F#
M+#4I7I$W)2W6;_!T1[WW_0."J2<[74_;A).T4DH-JF_\MAOKQJ"H@7O 66H4
MK^OC1^J*<J_1E_54>TW#_XQ38BOY92)L;N;CYL_^E.(7=U3M.1V&F'2RI>WQ
MCOW.=I29.(14_GV4^X5,XO7$6]'<1=S/@D/3.<Q@8;#%D(J=*J4_'6ZQ_8!0
M/#JL<1Q\7:2;7K&8YMB6':"NVO%PW;I%5QJX0\QLEGLM+65_6=-@F*PV_N=8
M;L#C.,8AM/5(73^*;UE*]EMAW/K(JI2+5#,P7H>L(#GHHN,R0W6#[.A!?^)E
M/5Q/)Z8@C41J\/?6)TUGK3M14R)D6%*+*3#?.\Y6'*I+DD1L)_QJ$YA EOG_
MI;E'%@[?W7VOFAE04U-3FRSE]/98%I]9?*^XF!9#1#'T+#OAIV^GO'/GS\-4
MM9IK2E]]4$=S334_-Z9D;-./&-7ZO/:5/&,A\3&@Y%,O;EGGXP;A\HUB_<L:
M9V J9.OWN&&1L,;*<# W[NS)-/$HG\G8@9*R)ZC.307Y??J,'U_.JFD@;[D6
M7^KT2M]?)>H7GE?\Y9HYUK9^X<Q^Y])G):>WSI'W]$"XGAGZVL>^.)WX@WL[
M&.KZ\U:(;_O I\V!:W[/<8\A<V6_%,.A/?APQ'0]2>>?#?K[ZE-]9U)-8 VB
MK7"K?+_*L/FQU.;ADZK.&;'FESS*TK[T?Q 4/BOO<U9^SZ#(59NA2PBWNM=I
M7[[T4"Y)V/C%SIAC79Y)W+CB8&;#ZWU%?MN&_I+MQN%W+P4N'3>KP+S;@9Q$
MW N+WW:7Y_I[S&_U^M(% ZOF]="Q;&)!VLPYE;O78"ZGF8O70EQI W_+,LOA
MEA^55XD%;SVETQA6T^7UO,97:P3]EWS_5AC:@<T X:(@L:$+M@]!RS%,(,74
M!D4O$TZT_#0^!3'Y5 D3?><6I(-V<7]!4)XX&-<QF+ ]W2\J\FEY0R_W10_5
MK2^J\WZ56/ ?BL^/DHT&C&-0<-+\@Y:!2S/&(F0M-E;>]FH4[^EZPWGH+PY]
M_S=P@U7.J6A6A]_J:":2!)$/KF8E4:=5&GNP+PQC9,B^R\F?92HU:;L6>?2+
MP.Q]ZSBB=WW[O?1.HDL=]=$!;$QMINIKZ%N%/Y>%@FX/'#BKS(TG@C41Q>LT
MFM0-!;OMT."E\<GE]RL4T#"N"K_V3JNK3C*=\/)AC?4\ZUW#T/I\%0!==8?&
M^N] B"*]5-C4&0)E5+IF<8*(?0:W 2,DOT<@_?(<>H5J3#\0^_(O*X8XQ7W^
M5O-RV<?NG-LT+J%V79IY"=<3O!ZE R-F=LE>CBDDS"UBC-*[8:*%@SI]TE\"
MZC_6U##LBN5.I=F)N4R>:ZS-$OCS>@%6/]%#FMR:74]$PV9W(.$9/:V^5*F1
MWDCF/>$J2CF*,#[QQ.[JQD)P0FU3>5U+H+1NCV4<7_D-&_,C+99],N4EL?_V
MN(D=LM;Z<OKC5:YP8AZ/_K\PY*\7POL/\E;M0!38+TU47<_@)3>8&I;VDF_=
MA@=.S'UZ CM,XXJAO/85YH5&!GB13Q\@S-WHN'O8\L?-Q^Q^'W^:]N)E^9*R
M6=@F;_L '_"V,'+RH=;9>O@;ZN,?;F??X0W)V0<=$L\G$>QO1-Z[$%16'U06
M.'[/8E3*[9OLZ&FMXALACO[#K!>LYVHZDVR]Y:9X4MW#3%KL@!4@N?03%)[H
MRC890ZUVCQ>[[6MKU4F*/11UK:&^+C.@@3AL[MTU(7I!0C4-6G,XL2/M7^+^
M=B/W8_(^0<M]BQV+NT[1UMAX7(UR1RAO=\.,,5A%21)AGJ<E%DI^:J#MR;0*
M,P/&,RH5LPHJJ@*\TQY;%SG_VYJ@"A2_E_/_Z^[@^@-?X2(-;@+V/?>P%$FP
MDB,-NM16^!/TNC.,._09)<_NE.KQKB5,/SMFOVW_UY]Z)U.<@A)BH?3[3DVV
MG8E !Z"K:"^^TY[ZG]Z<M4N3K5?5_;KL.F]RJU_21KV[8?^?R5SP:._5,!U"
M4%)7J4C:_-EWA7NB$WGYWIJ(L7L[9Q?=:(F*]2<3H2K]I_YAJQ/L51BW54IB
M%8<?HX=0DSR^WT6NF6%X-P<HEC=7UPXW79FKRU*.B;Q%>:T4>6G3X>C/>.L;
MD;WZU/)Y+N5X^M\![W]'\!\08X4V\J/+EWTG+6@I#9<S@O\&6A6VK@QTO[OC
M9*4SK3WB4KR$MZK]./B%%U-X<%ZYN,=ZEICQH-<(HO4N>7NC0Z''SR'C5;JH
MHW._Y_E/B<0Y+Q_R&^8"V8__=;N0W-ESBZUWXE=5DY/F43:<4OD&,SX>_+VR
MX&";> \14U6\6!%%H9<>O3"N-W*[GSMA!\+W03ICQD/Q(-_%GPN!1W"O,/;4
MJ/AWTA0>:;5N6M:C $$39&QE1/_O,(*9Z,DZ  P.BCFO%/>>[NF,"B'V7]R!
MF 'SG9@S-"?I-V103R"BAWJFQ00JGAAY5,&4NWBX:[SXPKM75:(I*?.%QU:]
M'+>GX=NZ=_D$ Q]#(-#TY'<OSH@LCK]P>";P\LR9:U>.OHN/5PQWC;??R("1
M"W8@=='Q'QM!FRO'D%"1S3N_]KP+FS7:CM]K?;9R!/M#G!X)5C(N!XGW<HA$
M3K:T.!C80^C<OIHM/53I[\$L#3TY<F/T<.N+Y9MC=EZOO)9U$RAOT8WN_+-/
M*U\!I$4=BGMLRT40'G[Z7S>:*",[&;XP>^;.93G!8EO_S-2N:ZV.WH%9KVYN
M>CJJ'EUH9"QL4NTCWPHVIL;^8=;PO68]B82?;+PS+Q+3569WQ/9F3I'M>S[M
ML>,_7\_V5PS FXS.-0+TQMQ*NDD![ZP;#-M;*;EK[,8S73  'A>)N,FB,,ZQ
M1P\GZJN9Z()UYLJ?#"];CPSC_39SKD65GI@WN)932-)-H9M,;FXI%S//[D#"
M'MN[,\4MS9-JL;5)J_8R7!\B0 IU<&]B^Q.N6';DYD_F#<,\1M[FQL0F++#H
M0RP/%K8# ?R>37,80S38TJJ']F2E2A\M&EC5 IJ3%[Q,V0*E#.YE6#VLG208
MA"4'KK@#6K,#JY(T\:YL.5#I*6V>&M$6XU6&^0;=CSX?& "+8:LLIMZ966SZ
MC@^@5*FW ^PL+^-M#\>""O81Y!FZG%.<80D,\'N\>R[N(A/>>X-62+\*2^=\
M7\/F*AQ_0]!,$;.5]BRU[YC*4LA&!H1]%T9.Q )F2$LV'YYQG3V(%43[,728
M4+ 0@'>LYZ'/LU)W(*@$/VN@#*=8T$@+C3?0C&6+@KD6(9G3%GVUDE;WG?5N
M#ZEK+ZOKMO<+37<OTG3R#+"=T(8)Y@$HU7[5BV&%&=^!R&*$,'VPO=B'+ $Z
M L"'!8C\Z.\PD"R,A)]G-;6ISH!)5N!S&M0>7/9"%DTB,E#AF^J:YF,8&01&
MH;41^)EFSU:N'T<%.&6Z%A.[68VO;?:?W'\ODGOO_K^'-A5[XH6#Y#?)?N_<
M87=$/@=?YZ7P]N!_3'02"YEBLE@>1XY8486Y&X?,=J<3KF".+,*J%.-<R230
MGJW(XHR1LFPM[!5<D$ZUTITW=UK4CEZ3]6JU(#A$=07WA!68478@#99//G)4
M_)$="/D=%$"MQ\#N)A%Q]/MM8"%#E2G'*F<?8'J!"HA*S%#V:=HF/K(NRYZN
MQ2IJ.2%<2CU'$BX/B$NKIDD3< <4G*X 'B/W1W2^74!:7\"*:53*/]&5"DZB
M%];Y)N0J^#Z/3XQ2_"%Q-UCXTR))?V#"B/5T^8;^XTNMC$/[(">?#T)X!T6*
MV>Y+"(\/Q9ZI:ZF,86S1/HD;5_]+3:F_!-@"L^68X1V(*(Q<" .LH)/+;+X)
MBC&LDP1<=Y;KP(JSM4!W>OPHVE0Q+A]T)>>*B'J8G  #J9E"-CT;!)?# "KZ
M^."FL>7M^K'5=>^RS?U_,]7%OFGJD.J4ZSN 9K9PIZ7'?111E<WWZ=CSO2TU
M05K=5CYR\F\=U?<<=A^PE;CG-WB_U9HMH,?)B>7=%D;V&+9V![(2QC#'=ABW
M'4;O SDI,!EWD?8@#2[1XNY'-=:B>HPR;P3HU!>3"4H%F94@O LK&- J.NBI
M")W0/N@F^RK=UO2I=^I9[,F&W03GO4] 2:C_YTHR/>4'5@5>.!XPY^>5<^T(
M1P7ALX'9>5VQ.?/Q]Y_!/N FB2.SWCA DZ*3M'JB%(2YL'+4T7R4SVVGO* B
MY16/F*)%($M[(9>FOAY1[IUB6!HJ%GK>W8L[2W3\R*<K["6&55#ARCJ2AK<&
M)8&4?GKZF-'A<LR@[@PW\ LFLPF/HH\0@X[O0'H7"SZ :5N=] :+]%,>?DNJ
MAC^.%25627XY](^W[C_]K;R_W)D2R_1WK"B\^SJ4W=DFPVID\WRC*1.P,GB/
M-V@]((X:V4">EN[:@0AA]C'A56'FU@)!J;WI&=_?>[=!#6JW:Z6(EUAMN)+]
M(]?&ZBR;O4(49-?6H$<YN!6#1C ,./KU"HS8*9*8[B(^5H9V)3<+'27/O0[1
MS7I:RED)&<W-4.,VN3M!PCS):Q4!W_1NW2@U'H_N\6@Q1%18&BH8K[NF;HK0
M\UFOV1#,))Z':0D(T-^ R _H6^ M:F_5IU&T3KE 45[#F/\DFJ4,'ZRST@U1
MAY^C\:3J;ZC5)6C\&5Y2>?"I_JGBES7Z#/8+Z3D<\"8QQ7O)Z=V:$.:M<2=Z
M%.M])?O C-,2E,=(@6'%])]@JZ-U05.LZU/4TX(!LC7/'031[NT#_[[5<IXL
MK]*LA]^$REL&/+?L:%=SH'$DF18EF@C](KC( ?EZ]B2T[M+WTAP$3L1$! &K
M[EWEG86*'GQ8"T@GH0. )U;2!-59I,WUXL+^8E)0_\W(==N6U^JYBO)C&FZI
M_>%IK N<B<MBJWJ8<R*U>QS_$"<,_P%&S2JOEM/@Y,)V3NS.[!]!J5?JD"27
MB.E=ZKS=A3=&:I>?/FC^-*2.9!IR:RW9T:Q0^[Z7%O2L.2Z=(C7":I-6O@$P
M>A,(HY*>X6OAA%9>:F G2G:*P--,L7JL_T4NSMS&&68W7"=PHKQ.7<!AV/N&
M^T@=\LC<P/5:GPX-NQ/>]],WDNB7.5\N@>G8@52M]V1!Z6' M_2>I 2H5(MD
MH8(XQ3IV!X*PC@LF]9Q@"RZHHHS?!6MV]@LY3EA_!*:SZMZ-."*V]'2)^6P<
M2K4\@E65<J$=^HXD?S2*KKIK.0TCOX6*MQW5=CD(FM*6Z7LF8/>SY'J)FZ..
MJ"BDB6:0J4UZERY;>K3.*3VVAU/>RU>-CKH7=!M]UJPS#AXG*@R_5#5C"Y=,
M:"?%DJJE5WXS^$&]V]5C6 \HD4'O /4I25'9 M6OX,LB'Q:U/).#XKH;=*7B
MMZY[R$J2HHT,%<;^ N5-4S.6CQ^<GOS9 F_9@=3#5DP9.NP9'.]:VW[V"$EX
M%1U*[AF]/U%K^;JU98AYBSP@/N4TL"\J%BU-33@3@K0F-+%Q\PW)?H()7GXU
M7T:1J+L/HYGF#!ELAQ#LWL"/]%E[IG94N/TLO!>6],3 $,1VPJ6PGB*Q$W@9
MHUMD!9XYOG(-[74N:]_\12F#4R%RF7$2;:&ZZS?K:AN;:ZI'U=51Z[.-D+DV
M$P[&X*' U77B"-4<G&)<1DN,&R%I*'L@BD#B!S.[I+"BZ'LYDZ1+P$;[MO1S
M_\<9+@DE#I-==X>8QH53AMVRM2N1@?U:LLRKG*D_6VNLU4F' [98(0^?NOHH
MRCK1[/)@;8C-JI83(N.BR_&1E<-:5QSF/,I6*?'-4H&GUQX[1&+K!Z[2-WO\
MV# +]@D\>8!3;*]QPJ/H,!M*3!FB39D$QD7Z[D#VS":.[F&5_;^>#7=H2BLN
M6*A/63+H*;R7MPA4*+6.::JOJ!^!:3UTBOMT),;DEK*FRK^;68V\T"P<%$:N
M@ /6FI/?AVG,4 X2BMP:*WL8XH7C0Y]M3J7:QW41CKIZF @FV;747V\OSEYQ
M:B_#/'VUMYWK;UHLVPYS$MLQ !?>5/<6X<%\QE97=L,3%96;6T*\5-<EK:&1
M_I;MW7;0CXALF; >Q1,9E#<T1#$BP_#!HS.1@F9O-'N2P+,,^N_F-'@D7H"C
M@Q^(1!U''&T8U4D2]N!4!_OZEG-',N9V(-3P[1U(7(OE_:KZ33R0'EF;*Z/X
MX+(9,H]KNY>&2C(2)0N=W'"B#<0;Z5"$CEK59-[ CS*M*A:;E++*X_?$-]C^
M])36'<KCJPT[_&5-CL<IEID*<M!RW_KN;3I,T=I13#_M.S3><2S%XB4"RJ.=
M29(ENL )A,55*BA&Z@A&3_UYOJD>/*S0ON?H0[R&T0D.-DTP[X'?_$3B8=ZD
MJ8G>-B/:I<T=R%0 4KK#O<M$/W9&/_'?["#:EV9Z0]Q#O'KNL"*.;%O@!'$D
M"KT_SWH(2G( Z=3N3C^3E]W16L?":7-&J'A\\(TQ/L[D[-($7G1][==5H\>>
MCOOF?[1!G3^'>U].[8CKHWQ4X?KCW@,%? =ZUQ,,/H)8QGY,1YL)9_";7H^W
M'[2=J)] (RL7@?39FR;[0=_"F<6,B)(>P:2Y(.H7E=2WQ^YK.;C2@SB!&HDE
MY^AF?"OLA<8H'F2]-A'W(EY]Z0R:V38.M2@4!*5]_Z/%37PPPP]8I2>PE7[H
M1TRBRM&NE8AQK:X'\",7NJ#+,(+) :#PA7\(DJLC6P;8"M>6NW1[51LFL-"$
MBOH;=^M&K7I]9MZ4H\.%$I[!(Q'G9+CB[1/8HUBYXZQW>/>!6)Q<>8LV&AX
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M]1";-EUM9(H+K%=R)J5I; MT8>0",="AT+&?9^CN3?,H]G#$D[+!56^!YMP
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M7K*+PRWX#\R?2)+5%N(@7W%S7RK[(O' /(P4U[?[R>-MT\)JLOQ5&<W>1O'
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M/SM^:0?8J7NL8D_W,%Z@3+--7'%02/>,AG!:2]%%<G031W^)Y.M&^^6!%A^
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M)U>>RH$ELO.WL[ >@@ H>US6#>WKK.)B"WI1D#^>5 1AU">+H'BI#J8Z[\<
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MEV/%>-YS5ES^C^V:PL2I)S>UQ-/>I@6] &L= L=8/HYXG,9N5.-?MH=_[F.
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MFRW!CR[B5LP4J:1%<IPXGMIPST(BB6Y-8@.^7/L=7CLO0\?]<P*._H:^< 2
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M_6'W%(N$V>-[.[*:2'O7VCT;.QK7[WY^MWYBJ)MX"IM&W"L/]V*,;U /:<
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MH$7KI=KR0ZVG99+=%;]K3[1D:C>Z_AKF=S8<J2CSU_0?=H(KMOWNYE#RLKD
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M=(VX$.\>8$!7T=G[F"=?\6JT7E)I#+_PK0'V#%;E'O7) YZX?T7!C?(4^G#
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M?0,1$-<'E-0;5]+Z@;&N0,V@7P9AP=@\C],K;JP*+N%0>-:40YRQ>NJ/D>6
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MZ3WVJ!=Q<-W@R_NWEZVL?L[^=[A:P>]QLT\>IU*IB@=C\M>=4%JT&]>J%3.
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M9\C"9G1YWF.8,N+1[1O5&I,P0%648N.$],)RP1:LSYWIQ;=64OBTUMA"J[0
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MOD]\@.(AE&C^L(VW6N.NITXR:5].ZRIT,C-7J[#T-:X,P![B%7KRW@%>9.B
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MLTHH+HW!\3F:P?H[^RP%(85G?P,^!<KJ/J]$(6V%6JZ%27<J3$E+O4,:1$7
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M?+SGO<@EX@4NTV:=YRLWC4B;M0TIQ<"8F"M[0EI!\(*4]I6=A?[& L=F4K#
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MCS,S/DW6?$C6FB/\V\:NWEL6MU9>Q\@_B,J8FYG:C^KLENH62)Q)'=J14O4
M@=8T7H3G=]^Q"Y#X75K0:O9V4")J [)6+ZQ6!"7UQ)3/!?_5HO*'7'N':%FH
M>U_HD#TN'?2F;8X5NUOKO*LP"VEE/L,"AS&? MQDR61N-KIJ?IK)]]/^,C?"
M263I;P$'+^[MW!'502%M\V54"T;<QK]C][3KG-R[Y=Y[Z/)Q;],ZS5.GL&7$
M:Q(-TM\<=8>]H*_X$9@,YT$#$;-C9KG/F0E(#2SE4U>.LSFILZLLA_T%1_9>
MR7_NB![^02^Y\,!O^ZRS6&B;RVXGN';%N/XCN!+0W%O,FL3I>AK1"["1JE=
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M;E?44T3<_TBP?S,VY?9_'1G^9VVEPM%K$_]%BY__W_ZU*2P._S=02P,$%
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M>7U"_$X._U;KZ?SCBD>WB[L]Z!&Z/&B"+M2K)F@6_W?:A_%>@U9^H<(-)X?
MZ1>@-@X2\R\QX>.@&216)DT5?J>_8?^LFCUPOQ/$L-^(RG]J''^J1_RL$T&#
MSD.$;_'$_*OZ-OB-:EY"_T8._ZM(WV  >@Q@>S<%<AM+-V1-P_^+W<_8%0].
MW!GGT%4@#:G\)_W-'">5*W+#J$4KKRD8/3"8C>FG<_E27_]TZ#(NE')DU-,A
M::FO/Z-XX074YE1L^*JPJG2G<4;[X#>?7L_U-KFK6<( F-_3,G.^&)"'B?AG
M@0_#ZHK.?V[CA3R?!Y>=O%\XXA1#':/E,P!7LP&1C3BME*CRGV**ERX<K)\@
M_03! WH8D\\%WBV\.Y @TFC+BY*+'R),)YBEO1YB-S'PRW3NJ?CD%(7*UZ!R
M96\85=@<$<8WW5BINR=&163KOXY>5771%=AU$0A0=6:K2F9*V++;L:1"X'EP
M)Y@U\3(YKV'4CHAN*HY*;@ZR2U-2:+$UH$IL2V]<N*EC81]97]H2$.1YV'/(
M(6/C>>=WI<7DF/K3FV.B>)9YRA$^,""4XN9R*=^P^=5NO!*;GT[.R4PW.;/Y
M J8VJF7<G3S9_#<^=Z8JIAR.&LSM.AOFH]"4WE8[\]A4,]<JTR/R3KY5<4G!
MHM.3.H,%[V,6=,DZ:?C-+J^9F99Z=!R>F[X'61)L34YI%L9'K L>N=KAIE:8
MF>M59#3LGGKCX=K.\+U=P^JX28%+V=QD_+.2S_"79H/&=#9(A:J(Q6G4P\OU
M<HL;.G@_2U1$-O>9FH7AC+.&V=TO?JINB;P)5SCU95/8/?]KQ=V=/GDJ,RBW
MHT6UH65K6S* ?3/U9LSNE35SW4L!F1:GLUS[XIO.;;__>&)4=T@!=>QF@NV]
MW2V"J]+GBF<+-BY!?C0,E@>-*KUC:M1;/2AV+8_W>?'H!_G"0M?<OF_%\']Q
M-O3?B6J]VO8Z:LDFH$7Z8>V5*7A.R.$"4'5=T417#O.>I!>>MVZV:*!'V2,?
M!!M%N_:]&&.]:#[E;Z5NE);W]=UW"[CHMA1!]TE"NVS/Q/.6 X3N9NOMENUN
M4;/M#'-,7^Z2U>F(1MGI+]EY2[IOR=_43.J(+O+>B$H&X(8=BJP=+YU97"=V
M#)DUIJ)P))4]2 ?._:/5*0\80&D1SMZJNTF+CB&,GB 9>EI<[%H;]&QO+O,.
M7%:B.BYQVQQR$VWAH?]13!7UWI$_,!',0WL1L6]F$<$1M%X+ 7CMP<EYUH5V
M5"NJ$U'FTE \A)YPB68 +AA8G/=Y$$U\O;9/I;\N)3F5H]#%FU =<('"D<*1
MY*N<AG9SV>TPN_'84*A[4K]\]5JTQ%AIWI0M1!95X^^>*QM 6>MZ]HDFG*M<
MU"<3/:FWS@ 6UOBH#VO7M<4B[.,=#CF"[]_?H*S>"_KL?D83.57SY4FVJ-&C
MK$R9H3??3!62^^QL5-:P<?G@1^TV .3&LW>W6;$JWFEW:^U-UM&B#Q+ND>3>
MJM$ZY"N3BFXC*%SXQ0*(BJPW(*?4JD3"J&-=#*!1'_)0,8T+,<3R<W MBEX-
MLM^DGFW?@3#VO6[G#XAP6[ZCM\*SZ8>G:0_1L]=H+]!DTBR<6F\]%(3.%J#M
M0D+D'_:2 ;1BQ1913_!K?+584!ZJ"H=NP_YQ25@DG#H&88E+A/X%OZ:'=E6A
M[@)](9*:"F  %$Z-18C=S[(L,4%% 78:(CQN#!B9M@$5DY=A&Z$,H 'S B)^
M5K-AFB >JBAHJA@G_8(.ILN:_@#D80![>B$.Y&"B2VC0DM"S,?3O")"93&(
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M;)#<N&E)N:JM88CH1O*F!M=HAX=?"2W3#.J&']A1W<!>BD(S0M!/19#>C^"
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MSG-FI.:FV:KXG2/R#'Y4;QT_@/,_;RV C<NN@$=,;NE,8G?U7B0PHSM^6T]
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M!EH+Q _[A_0!XV?CY0O@X(&CX-[MGAV@[C)4@9<Z92[0QIM? 7-Y0[CX%0:
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M&M_<-8\I">:H#>W[I0EG#IG,<I$,;^(<M04JDDGV2UY4^:7?="TJO(%3D7(
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MLO[,\K"S_7R_DUWL>R:\3^IUNYY57SOZROJ*C=R^KH[RPBX'+V\'7]&.A([
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MF1:CIFFL4,E46+-MGIUW!IP[T-M?J-3A02/1E=^^:V;@-"8Y>?)F3$51,UQ
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MFQJ=OKMIG9TE)94Q/LB&%0 WDF%C2B(SJIX3?=POV3 O\*)[G[_66KZ19><
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MU.$,+RX^N*"4%E9K_PM*0W_$G[8A&A$>AI+":0AZ7E'L;;C&3VWA*Q E(!4
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ML_A*6/FS9W%92L7-Q+CW_JU"J\BA@ZE\&23H2X%%Y.L&OU[G3Z]!/Y;M6S+
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M$CK_U726X@A26SV@ H K]KW$!+?-JV@),D>&"+$R5]&^0/ #Z0I>O?3R$!7
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M7E_4 B+1Q!G\:\5A=,.3BN-B28__AIF05P4W&D-N,'Y]OCMJ35<;>9=G(1E
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MZ:2TD=6*/J"!36\MT);3QS?C<ZO7+@VP,FTEH;"PV:KP9P0HUK:CN3#?F:M
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MZ[RJC=D<^-7*%=!0UY<KON-R(&Q4+^R>;V)X(V$2S9; !>=X4<WM>W.($33
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M9OITI<=)67U8"-1V)]QA60-6?.+2A)F'M&CP#MEY)?:C[M!DW+.0.D>]_ZF
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M,+BAF+!M<1YG'>-O$5K5UCN<&KD>;T3SCHGG;E[%%D%Z)707Y;D;"?(A]LS
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M8Y8]&^,XA'*)C3ZR#I9W6 PKWU&Q?Z\D'8A$ADDHM'V4>G#?4$P*4T/E8O)
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M+"/]9R+\[YBN\XD2I. :&B4:QWTZAN)5+7G>"\+XYOG3.W^L%B&KXZYS1"I
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M ;-<@9P/PHELA&# =;V(DN"%U6Z,)PINA]*.%5?#FPW8"EF!Y+7$Y%"1&8)
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MDPC2M:6'0\S&200*=3MK62/1(>PF?>\";<N?LNOH6>PA*YBVTPIOJ=3%1_O
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MA#UCB+==]'.<*ACN^;,[:AUXLO<ZB:$PH\M;C#1S4N;0K]689)JLYPB,\!7
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MP5/B5TLA5.R[6%L,XZ:9?E3@;1_W%C]\MK2B,QEV6VW40W$0V#&IQ2/+4J(
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M>OR]V^&[V9#.EU*QY1#;(?(8.Y<<MHZ)73:['(".#-,/JL-;[%1]TQ31[00
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M_HL*@1PN3[G_'_#ZG';KG_&G7 %.J$<EKP#O1V 6H!]_L(%B<![K2[_Q\E>
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M3[)"?W9Z!2#9*W;/W_2SW"OV=\VW'^WWS=T$R<;P9;V:,KQGJ65CTXA"Z7A
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M#@R2U01FEGSKFNW,(FOQFJ(R%D^*K#J78!'&I\:8+Z(?;$&^[9*W!+UBS>4
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M5N3=<:>7&&1X%9C 7BNOQ<G6TMQ@M&Q_*=6#<VLG)TP_;;A6SJ3_"5/4,E(
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M) Z+INJ#@W):Q$XC5QH.7A9@M$[FC5'WZ-.I@E!1AK;4U>OO0MKB1\$[)_D
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MBD;68>8=&_TS:#NY'ZBVUMODB'1PS.3BJ\J R!9QR%>%I" UZ<Y!IS[YYC^
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M(%6PP9A_X7F%\\6%.LEN@#44'9SC(0I:1_"[&]X?B."F;<MRNGY6<BWCS(C
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MFMJ_02ZUDX+V8[T-=C80=W%ZHPR?<C;GL(+%/^-A$C':4"W#KI8AX'?KGP1
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M:UCS9QSEKU*2[9GM),^YV&GZ7+^:.*K3EAP%3)_@VC5R)6D 7S9!$5#*./0
M=L\,<:&UV-H.]I7H>5.H;+3YU651?GP7NCQ]Y2//JQ Y$1L R4GE,C(VO6.P
MG9.#_Q%@PS(5/GPGX'HFKZ"@*2U]2=ZX%.=CG\IE[UNXM*A3JZM$$OY(3P3
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MU$RIO ;ACGJQ3U(\H?2TAS9'SWM/&D1;]<W1BZB+0]@U)U8@7;L.DW*M&"2
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MD,! '!)_-!G0-(B;$P(4"])@K-9%G3)W]CP@M>1499%>\2!";F+R[V#I'==
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MS$+\#I1C EC[=EXM(IZZ'D'\,W>8@)/(;:T[#"$FX'O^-A;"!+3E(&A1NTR
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MNY0%J*VA(05;*!G*^.@;C$PA"&-L>\FC(?JB@T5I[WB;FXR@S5A/<"O>&/B
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M[1!:1T1(:+Y7+G3+Z^*O*4[)/*$ZS-^KH<W.%I1^*814:(#]SHTTE.F!#"9
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M0M5Z$6^?R,*-_?[F)BV*GSJD#F?B_8)']9T^FNWP/N*'0!L=0_C4R 1@'3M
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M78BU.(H^L1833BE9*89G1H@-!DA_/H23P:8>KT+-0VV%4C3ID%%#8VQNY3Q
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M6OHY!OJ)^\,2P@&'F!FY+ (=<N[U!.SYN(H.GBJZVZO)G)M3O#XN;V.%<7^
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M-,:WLRS3JZU0="A2 +VZ\&T-)0H]3?)W4+M,,)HK4 F3USD23OX=33(]+T0
MT-<-=/M1;^QJ]"K@5D.'TOL7(BB@IL.&0+7=DD8#3IB3]GF42#@KZC "E,8:
M:N$S;,^'[^R_/]T@@'JZ;23)3#B$)X<H)$YE;W]:^=._E5Y.O;I6\[)9 F\T
M':C3WI/W*L,K,1=C3YO)VH<]?8WM.P'"SP#AOV![=VP)""L,_FM?"85GUX(M
M5,P3GSP8(=<0-030AQS- E[0 U"!L?WRK6G/4O0^ %_DMN)_2$=6I^@(4M.]
M1QQDJAJT7>D02P6+"3K$W!<Y 3JTNKP7KB.U_WO?PJ]T=7V?_? MZC]V]=%
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M>H 0G,K[OU[;@(&%? C:"0-B5N&4;9;]]@^HM0+\($5M&4:90Z8.P3^OTIA
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M@Z@*9DW!]6%CQ0=!-3ESM-XZOV?B.D&#EF-H")B."+9O$ CTH;!IT&(:6C&
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M0 T1Z41L<2M!(&&%_^R4*F"/Z'_?\R&L0NV4CP(W]'&A<PZN0= ]=0:>_[L
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M+/@TJ<&!D9).]?5P4\BUL+2?@\5TF!@TMVC>TD*I?+&<VIB,&'//6C@K67_
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M.M9ZZAJ(AI76A#ZJQ[C>0?X+4_.8D3/B)++D;7!_2K#DN<O0F5JKF'J D+^
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M6,0QF,UY@PGTU&WW^ + [4JI]B-TR:\P9MFTLW[/_[WTQM^55YE&"1.=5R\
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M\0M)C?7&L2![\/1!PZ#^#].)T<XZ=O_[BVA-(WM9M38=B6PVAI18V(C\.=K
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MS(K<VJ38%-_KT92H^>7R4S]\^<2P!Q*!A+%UKEZJS-JBE@O C8?G"#(04C=
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M"\(2*$2&O7ZW:T.EP4#E-'GF=.XBZ:)[B)HXM*:8B\#F"I$'N,=^!B(/RU\
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MT6@6__OYZH>@(7V!(-+EOG;1O<L<B( 1JQ#W*V+_C2U//NZ :CH 39A%0L
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MCQFC.K\8B!FW84!C0Z(=M-:.V2?.?AC3:FYRD(]^]3%N@ <FE3 822D[2_2
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MVIV,![Q9,K \=>OSM;0D56?>'BK]J"JFO-YQ-O.& ?\5X3^%) 5EA4F+//?
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M'DIH9#K_U7OJ?% :^0V>/H<"%'?$0>IK.\;2!=+HP>Q8FN 29NM<2_@XG#Z
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M=L!?>Z:8$5 X1*_6&X6K[8X5I\13%1J@O.W!!=""&:-&(!%7U!WD-W[_K]#
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M^["Q=#:.Y7TO@@,17$:7@J2&!"::FBZ4_EFO]#1N\!_ Z/MS#N3JU/[:D'=
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MO2;*O(=#'Q*Q^/O_;_]_^W^Q03D3_PM02P,$%     @ =(J=7"1*R,9U.
MUST  !4   !E83 R.#4Q-#@P,5]I;6<R-2YJ<&?5N@54'=W2-MAXD 0/K@>W
MX*XA>'"7X*[!W0.$@TL"P8.[N[N[!@WN[GZ&O/>^]]YO_F]F_IGYUYHU?5:M
MWKVK]M-5I[MJ5^W>D%^050!-6EQ*'(""@@+T7WX 9!$0!5[!PR/ P[U"0$!
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M[^-LWV5Y1RC1 AI<; <YRRBN>GFRFV^=L[3V8VX#3A3-M1:./1NRN<6<XH1
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M.'!#H7!P"6*_O[W8AP;39/Q%F;6B1(T@;@>VBS>/TS6O"S,7R7L?QLU>'XP
MLG^_VW]".*T%P7%Z#B":33A/<C.B<J:":O^SL8]"L7$$"WP!3X,D67)ALPE3
MAW=3A$\V$N@[)UY"#H4+ F_G%:-G,YHX#M<0(+>(*D0I>+]_Q?1E" 2%E4/>
M#GR64(.)#$EK*1(40A(_E:QSY;R0NL"=*-'Q)U.%\T!-IH_E?4BZ&LD:5_3?
MY=TNG#RV\?!._PT!@//-B1^J\@LEI@O,!LS#1DW\V^I]E',"C49["JG0)DU@
MQ8+%2O'2!G,*H'?Q7!YO/@&!!P9T5J:^( !GCX//%?JS*59&,SM:I[]3=L[,
MFHX)AE95H#E#'68V3'#MG[<H@P"O(,!UWI>$][S- >;\ \069-P)/ N3P2>C
M'M<C<EY$OEC1.MZU(ZT=]#K:507$%F9,*Q:'\'(L1_*UX_Q2;U*=$:XC/];:
M!VLN#>IZAU-T89ZC'!U*$,$)OH;1_L2E'&"5\*.,@3K*N@YN6GJX@R6]D3.:
M.[=Y>,MJUZAK=9'&IGO2BM=3<G2+FE7?;"B<YF4*0*9GOAS1.-V.^&Q]Y6DC
MEE4#/IYAQ-AP6[8G?8,O.HI,U,5]()5[*Z3X@#7@:O%6:WOV@^:FQ&?,DW,P
M#FXO/-L<=0ZOW:L#9KWE96UV1^3DD'F"?J F?+ 4Q<L7(P#7>6\,J_OC"OX9
MT6B972'[/9^4.0:W$O,:4IE"WYR   ]VL1<%4S/+4YRK*[GD1<UPK%:%,%$V
M*QH@Y$H-PU&3:Z&FQ9$WSWX+BV9GP0DM/]Q'<:%. _-MSHNTL;<B;ZF\SM,-
MW>B'&5QJ/&\MU$D*FN.!2K/0:M$32 _\["TS!F9?*$3L)X#^TBNXVRLA("]W
MM3@A#&?2Z5BP[!&NEF.LG;(_Y^="GO.H^-R(3KX! 8IL^FH4-Q^0FF]_+8_2
MA=YP3&'R()1GY<'$2>BF( F$:%6*_@G=F^<OD7P@*X^Z!"#B$3"':3@0)AK3
MTOH?:C1:P;,Q@\==(_\^Y<EX%!0D@!9!B.61AC_%Y41&&)TH8+=6_L?6AEVM
M;V^Q=KATP\%*$73PZ6.>6U3@4?I9$0NA=/;D+NNB6<:^13O S*M$(R"O++GT
MF-6FE_./8,YVM4V[MBP5HFA%_1Q@M4/JAGVI]]5W4WL: AS,RC_!SHWJ/V:V
M/&:MI1?RZXSH*G+%]>"4N_G\EJIR\3=B=2^M'_9O\@ OAJPSQ$AYZ4XLF_TR
M(#:[KRRH(@SL..AAZZKU06^:,/164PVX8"38&N.3.UKV+%6K971^C9A5Y_;<
M@R=J#@&:HX\C1 57V>8([4_4M51*YZKLU,2XIZ4$G?1)"(?/%AB^9R26;$4:
M$CPY5EJ_\0DH;HO:2$"F2B6+5+7_G.OUM-MI*"BHV&M9/+6+N/[I[:THBDOI
MX4T,"$>5[!>TXU&@5N]:*55]H.+L95%RJ/6.I";S3U;Q\;%P;P1+:GRZL;B+
MDWO?Z,S]I@<(D&"8[/:,:>-K]Y2TQ02\BF!Z;\CQ,8TM/8$]*3ULO>ET9M.R
M75?WHZI1QS(L-8&_;<HW(KKF^_=+;H[RY9]D9+3#++;8,!UX7H>CV5^HBQ%7
MY,KG[#,G#W';]"7CDOEYP2+]>"_XV;Z#B,XXOW?RBUU9^E">4N;^X+Y2;9K>
MMKV'^E<<V>H:OT4\_K"KYGYK,^2(FBJ<;CSXA&N9,*[4QUG#;;WFG)O5LY3(
M0/A2!C6S'L5]7[NIH.SONI+P!O5"<77?CL8\ULJLT^73^]U+MFTRCNOB/)Y]
M:B9P)\K>>?">S.W<X'*I@6]TDYWXI)[))2B'I!N]_+VJ595I]LOJS6#R*)33
MUWD'W"8%TYG#6!J_I- ?JS$&"&_)>:A#B5E=X9,,W<9=-2Z/!H_U<.&[S:1-
M\#><Y&B^E4--"*;&!:75Y.7=GL[OT=M09L<NNZ<9C9H\'+6Y>#LNU#?22ZU9
MR*^+VY<I\;&UUMZ&$147*\O'_UP2L1#Y+)- N)''76BQ,:#P_G45.GX[]%TZ
MDY%#M_])BCJ!V/L.A6>E%;HZQ]*91Y,W>1DR.27Q64[)L5(F2PJVC+\<Y[ '
ME!2U)W.0I,=9"GA47*.KE12UED8[)TD:?>(5/$AR<)!)/IAC9KHIRZ6Y8Z/;
MQ%<UM,,0#900>!9Y]@]_G^KAA0F8X#9([VQXD,'C$ KYK/E!14H@-O/[GJ;C
MK;Q&R'#DX#ES[L;HQ8)2Y!(-X-^'"\KC*8OX_"6'OHFO:I]G"ZNXM-B5VC].
M-O)#$D<LE[KX)FM*X.T<\0K>+.P'QK7/#UKF"VOMT<>.X=>X]%.311)K A[T
M3OX<<+(5UBMQW.V+$?X>1OS'!S+S77?13]D0(/[8.(8<R=A9N)MFR3[6 [6$
M#[N/!,4R1BX*>^42$X>6LBM:A9N.9Z]73#VP\YE4M6;D-C16W)USJ<E!DBS8
M$ZJ7UI/;E]E3"@+0+H:"6-E%IOLSWBJX Y?<^4<?3>=1A+_>M0MI=9ZNA'KG
M+"^/>>P>,4@F?PG?&HS[SK.7<EERH(ZA#:*#11"B.1HQHX@O3AW17U2W[*[^
MNQP3V407PX)*_2F-<\09T=5'QGW-4:7SG&?F^'IPGY/D(.$D[R9(RFH]C!9^
M,75V,O)G"'9O=L%#Y52YN)3YR" ]US/&:_IG7Z.G%]?_$B@- =)W(8!6FY7\
M7<**'K]GDHJ:W2,%OOKC<]_]Q$N) ?\- @A5/%=[:OD.MY[N1#E*@T?^<Z#0
M&NEDV\Z]T&S47PB$9\<6BIIMI]$6>A</) <2_X(ZLH  K ]=20(C=/^-"K]>
MD 1*A+;UW!PE&G+$3%^J;)$<W[%+WQ*.9K$<NKCK;CM]1/9_Z? Q&HIB]4UN
M^64#W,CR5C]L5NO;PD^6<_A3!+*"7)+RJ&PHQFH].95:VA0L.TB\]TFD=YO9
MM7JAKR\$$/4$M1V 'L6-\A%=^W-.G#J/K'0O;_I2BG[4AO:LM"6DCT&PUU?L
MM&^X$& ]"HHH=!%@XE[F!BK_ -9ZT+32^$OV,T5AN:CUX?6NAJD?D1@6]*M^
MTBA+@"8C.HO"3T#VGVL:8B!B[GVW#,!!ZA$.=M4T'@6@Y:TKSP!0WGC<_&Q!
M\-V2D6P9*P&8N>[E1@*?=%U]!.C,?2SFQGUYOU0'. !/*Z.H#YH0 "EMR5 5
MJQ&E40[> LM50);L+IDHA"I%#E[65./E/E#)ZR1W;Z^$[J_B(( (QP4X/=Z;
M?O<$#0+TUQ5 @+GB]'O$LN3IQZP]W6O5TZ$98D&CLP_'_#P_=^=XO;.34HQ+
MNG'8I)BI;T0X"T\%$*E*=&^I)<&7VK(%$N83BQ^DU'6DNPGKESQ7G4I)+=5%
MY670R="RJDJY09^[4.X)W] UQS9WXWU**0R"B_R,(/+)I[<H+D$@TLY"5HQ)
M.RT0Q[^8Y,.4SO+B791]X_'&$1(@F_UU+L5V[S9=NB;?34*R*DS)0!\))+U'
M&A\#?%!3Y8< Z!2.M^H_3NSH!Y>\6A9KS<+O-V;S<.9 ;FR#@X?X8F84/$1<
M;Z[>H6HV/<CO;Z@6:*\RW49VON;2;:BMP_UBXZ3\2!;/*82R7GE;4/;.M*TE
MZ7BM3I;>UNA$P;3)P!DKIV&$GH<S:&-<Z4QV!*^P@9,HB>VED;EF,)^9G,0F
MUME5)6[1D,6NP\#';OI?.WBCTUY362#>R;[$,_%;HV<QFW?/+5-W*KI44]0S
MQ24VJXLQ#I%;<PY!> .@^NL"+Q8(0%Z;  %T]QZ+U%HYE>SS%XXA@/+>M$I!
M]@,ABI9>Z&I-0"=V$JX:5^3[*EHU:E=0N/_@QF1VH/R96$UF2>,(GB'W2G)=
MD )R+(].\"C/WJ<9;)_E:W&?#E=3JIP\'9EB#3V)[0HPK9(\TT>H;QOF_,9I
ME[5)7F=NX;^9$WLHP5D_C)=$@_<B Z.D%S(K=UPJRLA;VJ==CD#M$71'CBGA
M1BU2BNT4&E@?'4E'Y3<4-"FQ%#_^JP@HDL];T$D9L0WWEMPNGA#S&WWNG/+=
MF3'_Q\E*')PF>8T=?G+(R/7LK1;UCU.U>5:L0$"OZ_7;9 @@6"3QS[,6N^(
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M/3:*VM0)UJ'-@G_O5>BM[2<W[&<+\*F&XG@I;>#^$(*_&,A[ZC(#KIH@)EM
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M?]AQ+O;0IH6[)O5G?@-$;J+JL+@,]LUUO]PG"47MTD!9X!P_N?]L/19PR\F
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M3(*X4[P:ZB-EHUWV[YL>DM/O>ZUQOK^Q/#V\!Z]CCNT4-83^[O+MU,Z]EX4
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M")%>@*-/PY[=LQ4\ZO2VE'K!@X17[$'8V;\\C-A?_FDSR/S_!E!+ P04
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M>&O'<K(>V_+,5%A3$ @7R/G](5H,+"!'X]\/L]6;FXG0&QX@V4:^>HU^&A6
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M@79_^:J$M<T>607Y8+$=6ATT9 .(FGF4TJJW(B0N<.(%^-$DQ#:^A'BVU?^
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M D'E:C!W_C46]L#-4WN!^K(^I?\5(I(H,?-B%#:F=+&R\ 5RI0%:C_(R*MF
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M5(]%D)/.;D7Q]I '0?!L5#:#$4ED0GQJ#A.U'#::E,4 LN3,/*'\TLY8Y%
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M&STH6'*!JI*%SBX5,$/)3X2CU TKJH(T&Y-2GLRB?Y"P%W+Q)5ZNI%.3;-N
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MFG+Z8]$H=G1%BW:,C=^;.80A@V\-J;S-/[-[]Z/OE7[*B1%F/I=Q04]V$W%
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M!1'4\_9+*;#</IY^6DFH.MTMPVMU5;)E7*7M2]VO913N>-+'\^IUF/[6QE!
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M_ ?HQ.J88"M&1=PGU#?.Z%*U6I,F+7.R(?JMOAP[>3J/^@S1<$C0IF1+],?
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MLDAE :''4$3L=QC#I_XO4$L#!!0    ( '2*G5Q,)5<_!DP  )%7   5
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MJ-!I#$\/C9?B.L^_ZGFG-*16^EUW;;LAQ9HE;F?U98<WZE;I#")><DI^+M+
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M.1.Y,_1DOQ#L)+TS<PA9Z3-IQ/4H7(@SK+4B6?GWD EX>Y)?V)]YQEVK!QH
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M#,_.?I54,?]8R*21L"C)S$XRWD7TM]7>(*).NK>S)=>UI?!6\:T4;M=%T5]
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MQ( %<8M4RX1K"-[$%X7I17ZQ.NG/<*-QKA ZABC8*G/ZK]1=JZX+6GR<T*N
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MB6T\86-]8W[XM \::&3*ARP<^&(9M-1)AN]PZ&XH$_(ZB9ITJ.V+@W9!XM/
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M)L6SP\T0R8/\]8T*(-L>P#=F.%= &V"_SZ=XOG]9EZ"@S8,<EVZW#;"%"+1
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MR_Q'B>+=,]_X[<YS@CEIE+ORBEMQ1%Q'\W(F/HZK.'\.[M?\BHC8]Z+F2^=
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M04PLM!X9TF+K%GL@N HC&L[3O7:?EVHT2AH& Y:FI@@!&L<;FQJ]'R1>T;#
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M.$5>LHU1QJ?,PBO8VI])A,L=K<>:W66,I"8*GM4@#/J23W<5^3XS"ZSZLO#
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MH?68*\%RC"H#>)#.[9T1;CT]7\MVC&R+V9==Y69%U_3=7W-7:IQP-^1(E6"
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MT0,@J&R+H9  :1&!!8-4PITD;]HX$5EUP7>NQ^CR/QN6"]'ZA>@31!@?Q2M
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M##1SK4V]DS-?JACT7MM,*W<\^24C]<F8]*L.NW(W>J#%$-'2^L[WBO$<Q>'
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M-"YDZ@$74M,"7^PZ;O2#'@YG;\"1</H]-D\1O6P&.GA!6!7 _QCGZ61!TO3
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M1VM>(@:GU19-I#OM]&8M:T@HGB;P7G]Z$G\]?JC%+;3*=7X JP+P/6J!T\\
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M/LE;=U'D4I5<+=/^>JZV4L@);;L4=:6+M4-% D_0J5:<#^73"/ L;2F109N
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MOF1P]P7;.2*8IPI8U'G;-PAY_)K+3?,1"2[D)V_.E+3H<2$FT%@*8*_ A61
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MK+M^4^9,DKB0]\EW% Y3?C8>/T]9D?N'"YRPEWD&V[ C0!*+SXP5D*@?NJ,
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M)6<6_ZFZ?+)I>$.F%6F3>\,U17/'AMQ";KQK;AX4I)(4JE,5VWB+,:NPCWF
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M4ON<!:O=D=\<9[6UK+6(1D.5L9DUI8HVY<:!I7&EUH5V!QF_E^ITARBVNX:
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M)?W@BG4NPQ;-X;24AIE%&,>#? !#9S9UK:"9\\OSMSA+W019TA&,N"5M Y(
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M<9\K_A.2= _?Z6"N%H'\M0FY&>E,GX2.Q#/H9+=_8UW$>$69N:J8<^/?6:]
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M8'.H,#G@6<H1VM.?6C9%[!/!26KB/0CISIJ&B ^=\Q(O^T_<^G/T,Z<B)S@
M@[Q6_#<=X98>827KMK_7)MDD(4,U=)&6JUQ;;)]#*BA(T.XRO_(_7[PS(8F$
MADVR* Z;N6^V\];QNS&W%X=FF%;1).VEO.-<A4*NEIXOK=V"A8AK5>]]EL\
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MK17 L%$'IN;]"*%=4^HMLX?6/YN=$6UY",*_@FT=Q$U1! U*S>2H2P7%Z/#
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MK)-%MG2WP3Z9/VR4W<X;5@ UW5?GL_W(>B'P#O!3:F>!=GW5UECE9].X?:*
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M;_@\JRO'QC]8/+YFQ$?XUX>@7P:5+IX835[&RTR_!*_J!12Z^3GQH )H/:4
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M%E6(G?S35_L*1.3D*'FLU.:9+#VP62?]27S.F#Q_S06C96I*PF>23 '06T[
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MYV%]!GD#Z-AA9Y_[SSD5+/N-<K@K_&1C\Z.4""C- RMIE9N[X/5I_UCO,=6
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MJM D<B$?N*Q5_"G5WZ/W555X[SOI7(?")OTW-*5J?QKL>B7A@9Q64$3[9?)
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M?;'KZJ=Y28,\H1P/^P>KGV<438I>7O,Y885>S,0RN"*[LG#20@8HF2Z"K6\
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MSW:Q3GOJNR#E:3#/'JJ]=OT*CE+C?__^SX/+?S'6_R] ;[[\!U!+ P04
M" !TBIU<7=#, ><?   ,)@  %0   &5A,#(X-3$T.# Q7VEM9S,Q+FIP9[5Y
M!UA37=;N07J3CA# *+VH2),J$9$NTKL0D0XB4A2D14! $*2)%(%([[V)($&J
MTCN(%.E56F@)(;E!O_G&;V;^N3/_<^_)LY-S]E[G/6NMO=:[]C[!C>.^ [3J
MRFK*  $! 7 /_P%PWP!%@(R$A)2$F(R4E)2<G(R"BI&:BI*2BI6>@8:1 P0^
MSP%B9[_ ?87O N<E+G9V?DF!2U=%Q,7%P7S2UZ5$Y:Z(B8N>@A"0D9-345*Q
M4%.SB%YDORCZ7Q^X)H".#+A_QHF0@!,X0T= 2$> :P7  $! 3/#S /XX",X0
M$A&3D)*14U#B!:II@3,$A(1GB B)B8F(\*-^^'& B(Z8_J*( @F#CB4IIRNC
M:$!,.AG7S?)/3+H#V]QB]]T"R2F8S[&P@GAX^?@%!,4EKDE*2<LHWE)25E%5
M4]?3-S T,C8QM;*VL;6S=W!T]WC\Q-/KJ7?0\^"0T!=AX;%QK^/?)"0F)6=D
M9F7GY.;E%U145E77U+ZO^]#<TMK6WO'Y2^?@T/#(Z-CXUXG9N?F%Q:7EE=6U
MG5WDWO[!X1$*?6H7 4!(\+?C7]I%A[?K#!$1(1'IJ5T$9SQ/!>B(B"^*D- K
MZ)!:NC)PB@:0,=Z,22__1,XEIKO-=-]M@(*96WR69^?4M)^6_6>&!?ZO+/O3
ML+_;-0%0$1+@)X^0#H  &QB?^:Y4WNU5&1W]I!NBW<I/ELL.#TLA+N>.@BLZ
M3.J_[$6'RUFXSYWHEW\Y5H3)-!-*[+^_>YE?-^K#6WO4I3N\16M=TPZ\#^ L
M1R^Q0>?@AWN#8%8O_*DD_G14("=YY8 1!\3[?5XV*(")'7^MQ0'D42]PP(K8
M4QP TQ0_ZFN%[8$:<  BIUQK--'1G +6V;B@6ZR'@D_W]!W=QJC@ (7"OF.T
M TT$1NWT?.88[<2PDY,,M])"&4V&_X*MP\/FAD%6)'U^H8ZUPO?8/IZBEJWF
M9 _D8@HWE02K(4DG&Y/R$CO")R1;L*W5'#";UUML4 ("KREK#BA!';Y;6@?Z
M*;:TLX,(0ZQ(_P$WWXH#]C@:?^)IBH\^? V)]VLKJ,3:';[-[3C/AP/>_3@\
M.1%OF8<SPOJ?'&.QR2U\$XE:U;:K+17'D4QJA["G'WS=Y^#HLS.PF2$S>?!1
MX1P'[X$8S./PP'I.=?'3 ^_"QSV/<I*=I'5R1I*58PK%-Y,.F"(W0,'/S[WI
M:V3MEY',XY*PK1,.B>CY3BWDRD<7@P.B0.M.3;&+<2KUY[QR+C/JZ!I/5_<<
M#;5JS183E,S=.*27"J>=(F1/@;]C&AQ+Q4!Q0(Q_%[81=J!G-OLNUU3DS9AT
MN=YK_DZ=*:Y>WIW2%TOQ6<X6BVH;D54T37J069&=<R<D+I"MV:+;QP-P;S3"
M\M3A4;$'^S"\@V8PO/*<>,/;ED\PXK!FJSEA-)4%;*;%..DP4]SGYRR>G\A%
M0AJ^X8#G':W0/9;320Z).KKMJX2?QK=]QT=.#.*V43]!@[[IG_H2MIWX1Q1M
M#X].2^_P%*T+K@U]">KL]!1 !]W=9TWOS]I;A+J!2@T<L[ '?N#92 =?Q7=F
M:P1G9 ,K+JRP/'+]8692PC4+Q82MX@!S*&K,9;!1O4%?L%/(^NO^,/>RNJA/
M57!&GN,8@YGQN6<%GP>Y+1.MKRQ1IOA+G#O0WX3X%5K4'@?KH2@^3_9'_XA\
MV\\ O6[NU=>J9ZYQ8>0A@SLX'NP8=8_8#^#<?1!A-G60SI;UH'R^KC21IR\%
M!VR!#D0[71,D11L[PI*'4YX^-:^]!ON['S.Q#& Z6/]])!8+:NUA+74:U\,:
M''*U'HQ _JU#_Q-_OOQ7_ER?ZV,0=3'7Q90>!HDPXK-)3NF;\<]<*_+R@9K+
M:KVO>%\??R'62^NUJ'[.UK3'/K2WN"1[-K]HCMY,@7'I>Y+Q#2]S#!-PKV1:
M!-Y<-Q%A=@?^'?%YY8YNN*.S=XT-#FBVG+MD=WP?"=[O'\#G8.@+Q(K(S\QV
MJ:F>K3:95?T1P?8\G3J_!?':Z)44:MM'CR1_5O*]BI,J8\F3N:G 0"L+XWL+
M+E/C@PVPY3$\]A,X!H,Q"?V)]3>:H!;&\)[GXGC\,VA,OQEM+] K-_<2[7ZU
MUKUX23&L,B(MTZ[8L.QC_YW"0JV\!ETE\0A+'*#"3>OI)M69II(-<8=.82DQ
M03-#A_"7_#^5_N7<(953X%]./Y$H/%\\NQC38F+*LAM>5\/]@XZC8QW!%%8X
M:7)7Q.<BA1 CK_CS?.JRAQ?0#_N8="+8*G-=8CEU4PR&MY#6,W\/W8&?%/>'
M'ZCOVT:,3C>?,@O+L2.\&XMT^2T*_D@RX9])-I!\/1B"CVX:YU/R<\:K^6<,
MJ/P1&SWXV) (2Q93*3ME-(4?I]S7&][5;G$Q!$TJ4]SZ3*I3]3@^Q)O6:47*
MN(%_.;"39A5Z!1\Q'=W0K:AEJ-K4FO8*F@$Z*22N?:OH$XG:BA1FO;5[M?V*
M7,&WM"4#:36-I!DKW?#O.&#V@3T4^<,/!_B/X8#P3"QS>S .D!^;.?P!.RK8
MI;'?7'VU#A(KIR@05=L0ZM1J>YH^NF13*[8:H=SZB/X6"^LG]O/NH_5\8\42
M6Z1K1F^4M3-&;]QZH9\_#B,\T@NO5TV2Y>V3VN%K+=8].%"MJNO)3J9G?(>:
MF4R;45_&/_WJSCEG6[R+DMOXXM22T6M>CMI1@N''4:_2>(NR/?G^Y K)?^7P
MD>.?^:)2DX_IV[J&1_O3R_^0@ID_,_#"_[<$_(W0^N6LYBZX2?PKL;3\[[ 7
M1@E&.PZF]>2W<Q_H$02RE;G<18\5O(I'\D:HK[\A8J=[A.>7IF _<?F54GAW
M7G/JK;EB]Y6*"60A2=:6U;(6"^SS3 %LK L'R#07S_Q^59J=CN%'"W\!2YL=
MQ>[#$D.2'=J3G13%Q8<TI4:^<8C]V.F>.QBEX?&\FI1(WYA)X<@]:&0;HUG/
M)1\]TC'D$F\2F?7-P)-YW+6V'*TWICR<)NEJ(]E5&QG*Y]K4M-5CNWA^*9Q^
MPTY/$^K'IQL9;]$^JY%RQ4HNK4HI8\W]\XLW>I%;BX&?;TRE6$%,$Z0.!6Z:
M1PS=EG@BRU;7VL[F8$T;R\V?%=Q1NN#P)6M&)M!Y2K3^M6A,@X_KV@V,DD;L
MING+#3N0)=.CU<-&1:T#M89LMI<;4H2C^7':$S9?TW,2'982'5E5+7.277.2
M>Y*Y5OM"8+L7'&#[W7CR4/Z 7I!GQ0&? [)QP)@8#D@'K:\O"_JZC, 5M;Y;
M! XH,9$$@I!]+W' KO!7V%@?MM.IO^?I<AL.0)W;0*SC ]%&8B00!WB%YG=$
M8HE.:%@RPH76HZ(H^#.>_:U=[_N]W-Q5:4:@&(:P'Q#(DNE&60:, [IR8QO1
M%)HA5MUWM!V%;<0ST\!+4X.W);".Y[!]) TVPG2PZ&RL &+X"W85:["[@%B'
MG\Q#=54EE3MEHI5\YSUG>QRG-XW?:GR8+%(08J#U?W[6Z6OG,@MRZIM5:X^E
M@-MNX::5CBET'-1Q0B@,VVJ!!8-_._?Q'P5W-^YY^;?G[B+JDJH,$PY(RG'
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M.Y!_!QK'J'.#^%\T/%UJD^*^_A]02P,$%     @ =(J=7#<[[,7S(   +2<
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M4NJ&O<G/B=0T% (]&;*:7KR&Z7P=5]K-DYR]P*5XQ^SF9'/EZ^0G_<;K3][
MLJH"(5TS:.6W;-4$H"]);_2*QHB4YU0PA-?6W:"P+KWUD@-M2*Z?DJ?"P;P
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MB;Q;^4G?>CCZ4->WS8T 0(H(P%0FZ&/S?TRG15N*_?&ZXHK$[2GS"@* N$,
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M$;CZE9K\BT>!99+%Q5.S3WI]U2/TM<-LM@06"8!X*H0Y:$4GK?-";WF,W%=
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M,,]WT")N>[E6#$4;+^OC6FC">[@Y:+HI=+YJ$87W9MBO'$VA/,,H\M8X[57
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MM.7SRN@M(1OX#R[I7VJ_<8B\OJD&> /@CL%CQP?$@[]A\2M'MYAS3X!?[BV
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M .I%15FX1!MWBPCEN"X#9[\5QO-F-4PBIC.GH^8TI8,YS@&0LI.*<XIMYQ(
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MPOK=P5:#L 6VQ4.;AO!QF15UT4"HQ4V?,=NK/'?C;("YJ-K+!GCPS3BHYQ.
MLS(1Z6W-(:+26'#%3(=*-E$[N?Q9E!)*;-(_#?U>*8U2. :K,B)]K)6+%[4]
M^7GM#U-2?']K5XRY0R%5I?YZOO&Y)4=^]P8X!Y@?0DB;BN8NZS?DWWAU75W8
MHL,]/SIMA 2-5NS?S>-@Z7_I?)*L(]Q4PLVS [^F[EOV-Y6]G&Q#_@.\M/E@
M?8 -P"A2$TZI'0F@_'+P/]!,!5_[;K,((A#[,+Y79!SS/:@@FI]LU!_^_$;!
M*ZU$C__V-/\#?$ZPOABIBQB_Y_!LM,DID OO+?:P5%1E @1\VW_V9_YO;+VK
M1+67]P/74>(R(^.1Q+Q_ )M)A81W,>HEMOU641U0Q1>WE3^Z^0Y2[;T5.9YJ
MK^06A/WZX[DKXR$(WJR>:!X\&%F2!0IEK(V*1E];F0KZF-3N\$.@QZ=)-O-U
M]Q>M&>3,87(=WD:ZU^"6^[!5>^]@^BJ&;[TOPGU$&J*/; 6S#,ZJWSB*GW\B
M4_FYV[&J3.: $KGQS?P8X $=RI X$: T:;@OC,F)8;:2V[GAU/3\4SFUD"!!
M<.EO[II"M>-5##_J_]23 )E. FGO+:+K\2INP]]78H'UC(DH%U=A%;VD_H*L
MV!,FBZ$#A& AA1^UT.]IZ'6?!@49LYM+M1^HB@J;'2B9/B8E+6824LZ@"&<Y
M,],9G6']CAC3&,,6<._"W^]6=K<=6A0R,0S=EUK.L23,:=QS$.%-=ZA1+W&8
M(,NKQ=Q?ZT[R/0*UI)P/\L??=X, +.&ARGTY&1G[*1B1KTD& 5663P4>[<3;
ME?C;/'_BD98B=_LRU"KX2#24[S']&]5.=R)'ELT&]Z"VV?+6BZVWKQ%$K,1!
M^Z9+!^]K1]\,O3I.WJG]Z:S<>?B..?8#+.*DI]3AOH+GH<= V@'-#F39%F^6
M\?6/*(+EIGZ/^(<J6_/'Q.S*31'[I:Z1LNGJ?%-KE/=]:WH^)+OP,TY?![/]
M5D5=SD!!]C64N\.:0\<ADF+Y[7F=Z< _0$U+XZ&PW">70CI0#@)7 0[29=L[
M=C*+CJ<?][7 YZUO3F^N&IG6^^;KH7U:.I;2(8>C:R>:<IG,!8B')_FG]&9/
MCYV:,ZXI:'C%TX4_<Z(F4J;4&\>GY7]<='$>*-Z5ZS!)TA!^4^>DQ7N2KR/%
M>W2?(:A^]+I_)BVQ#@8^6NE\;'93!N5Q"?I0HC-$DW8Q&5"Y/;/40IF$]^1$
MJZ?4L$3(NJJ)8DR(!:YQ;TZZ.;51K&6]L!RW*O?H)!NL05Y:G\&/S[ 7(IKM
M5LZ%S@!6U6$\2)LJ//_\ZA_@$%YLGJB\[3NE?9/@9F\T/:AUE+2GM8GVBU#W
M#Q=(\1GP4'(N51<[OQVEN*I,KMG7'GS"D:P,"I65%S%EXLO[@A=JYZ0UY'N7
M6B-H 4_&?>;Z4QG/UM 5(]6>@C*5 =^[<&<]7$'WA(Q(R4;;C\<K=)Z838 W
MD%GEXL$Y!DVL7=PVI8K.%EQ7+A"6"68]+6J?XQELY@E"7%9 ??5*EN?8_,MF
M'G<IRJ_)+Q!5%?9!*;D_OV<UYT89!.<!I"YG<H^$++6!5A;#_[MA.IP^]+>A
M>[[:-[!1K7;&MG5V:I;/X$!8'%.NM/-6.'ZVV93"C?ARD/L-W*Y<$PNF.)\6
M>=G:\<<8O*-$63/Q";9>+@MB<Z.J+RN%]UG"0.:^6'+A4@ZX;G<I$]T0F9[I
M?)8QMUZ0 "P$[_DPA2/LPNIVVZUQKJZ%4PK.]ZUSI*[V3HV_#,CJ*_12(4!/
MP%$Y?$97(%W94Z7L@QG0"XM=WK4--2NN9=W/FP,H_P%I/HJ_'C/XQCJ0H5,9
M*$P!U%QZ?RHQ?V#5):C-6_+LY)>C:3B?P8];[VIFJ?,:J6-S.08H,T@[:LS7
MM!M6+!%R$L9\P3;W[6C/\SX_A#!'(^,&/+M_63)Q2L8\.0J?C!CU4S#7990-
MN)2]AV 2'\ZNE]F!YZ':<USFEK0%YEB-:$0?N_K&'$A?#B!,93CF>!E#T^;#
M/K1B0\:!<19*9F+((Q0IRH,%ES 7QI6>\V87?\\O:')(O*(+1SZX[7ML$KM9
MIA=9.[69R>"*'C#*>!#_[4;+Z"4;'+^Z/GX.5,]/K^L'/H'(3J!^9<[LA@A%
M1>N_T3+-EZ\E^BK;!.V7F#B5K"(S]=#%_<SK&1X[.MY<\Z'X*C+4YS__\?BU
M*+@>7&\GQ64%OSVS;WY3:EBXV+<[F.0?%*L[]S(R_YM*AW.3I<'CK&>:.;Z?
M[^V%JM&)OMU]JEO1.R_YVE(\GCMV07ZYOP7G8# M /3F3=0E!9#4JUWMVR<*
M-K8*/HD1*+X<1XU*K=CH<C"Z/<;X[Q(D]13-\L$0[\9=$Y+8WQ?4**1S:H_?
MR*?8?12U*E<NK7_\D/J+4CWG>-NI<;:>[3M9;-^U8;> 67:A)U2L,,8.M].]
M?3?E+M#'Z9@&*F<WAMN=#(YIB2_WWL>_" 3J,CN?1]C]FGMAI'VNV1XSK"JF
M.%]MF?$]*JN./[<DC*UKEER_^:VM#YG +^SW'JTK0KVIJ?_Y#-.84PP8HUM<
M7=,&9YR]U[$,3X[X?O7!;]_;K>A:D_3V"6>"3K2RHEES1OU7._&F1LV=Y^DF
M+T!]&:DO%!0'*-,21KW&^"JH%!(-X1491TT4RAA[9X'M'/<\H+T?Z3Q7SOP[
M9 N=#F;L'O^@3R[YL\)]\YIC";%RR6$YG1(7KCE0D3/R2F99>71I2/D,5O*(
M2$FDRA^Y4-M!>7WDL.T='RBNV9>^%N^L7V'@FT?D0I]OD'CE,*52E.:^.-J>
MOE2+CC#O^@=@&U),\Y.YQ(MFUS(U6E&I<W"I53<[AYR:<]+$V8OKSX]M[U]\
MFOKX; TGG*QX9H8F@1Z@>E.>F9FTFVM)F;3=HMA;4V>?>^O1_S2WVT('=ARD
MI'P!*4SWW5/P[M[>+3EXMR-YXSCSQ=&,C+\3D&.)'!R1(L.Z)I!:QYES[;8T
M";2TU7?,X*>4CB7Y24U'HUE2#R?.J_\!:"L'E'[%%]\$^69)AK=]T]Z#(__R
MM;!A'TSCG1GEAEPU5II;',HZ#D[\<C<^<4_\9;G\45?*%E1Q/%8^\BRC+"*K
M9 2GJ8298-('D(R^(2+[]*+2-D'8-75MV>%+*)4+A8'CJZP3]>-3&[F/9K7=
MF]2RK,&O7DD/$,3ZD;[HLZQK:)L&KQF]T)"+-*1-95.U= ZG17EW9#_5;WI?
M\<((BWZ7N+]NN=SG^91GQ)-Y;NWHOL_@R^#=[8:M5J*63NE#W3Q.H_G!P?CW
M5%3PZ'0?8YN6<$_?ZOVPIWVOM7R9^%@11M8LW,:/YDM5O[=$<,Z4."Y8G)^D
M <=[QI+;KFIT%W)*QR)^!<G%,J38=7Q$XF\^[;A-DK=YRL]Y9=Q!;/V,=(]D
M)AGW;=A(7KO6S <GL+&L*R?2F&V]_T4YEO_E5_;/])U$Y?EC/Y<[$Z=:B:/M
MO-XPBYK\ .R;N*NDAN0AL!_YG3>DSWT"*(Q\HH^M9"J6#5FQJ%[_)9U;D[?
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M- <?E'G9=*3(N-Y:9S6HE9O=KEB;R3J.GY8I_C&VUDM^,2A>N);2KNNN[#^
MVF?H7WJ:\?@5P+=M][Q[8+H2-6,W)I7@\A230@,YDK$I$V SD]+[:^+Q^TN>
M/N.4VB_+47U&A:2ZJRHB2BG#@Z647R5&[5@&"TD]3+],/W!J[5$@;>9!C("B
MOKRY2M:O.<^XIS7W?;UBA+L(^=8ZU<"%<*,$Y[>O6_Z;C?$UZG?%ZT4YE5 ;
ML>^]L"^5-(;/X[RKMZCCUAR47"0//MO45#Q@62?GR)LK?%;Q.9U/ARZTTNRL
MJ>$XL>G9G;BW!/]BEX;Z=_+?50OE<;YV3:P7LK4HX[R4VT"I(CNJ9.-/DJ"0
M6:X.!M\Q3\[[+#?@Z>$Z]WLYKI\I,0%WIKP)S(,3PWU1JNE/YO=+/1JR=M)+
M)9 /^UA?R6 :KW]7/JVFW "0/0E+QYNSHV0&]8^Y):0!$_\ -H7+7WOE\B+@
MLQ:U'RA^2^P)>C&C5#F>^GZ)[>(TU(%TF130(%]O^$FJ=A[JR9U\X7B(FFIJ
M&V$9:KG?ZZ/-$\@BO)S=L\6Q5U%*VW*:N,0!!P@0S8;AS:?#,"- <66E =\A
M%E6]3.!YMZ-&ZL)L<)_:/6\"M7&IJU\S[Z@K)8.#H47'C:^+6<J6/)^QPGQ"
MN&;1A,VT>VK;5*E=?4IT77D$?U0I*ZID6(=T1:G'U2]+]F%/.;69V0E!)^0:
MJ[->L]4HH1)49*=DLP<@58\!4X0(-V%*-;YG;"(#@R6#8+4 > -::S=YD,,\
MB$76]: ]&NM!GCGKCDTK+#LFS)2CP&8KP9D"RA'S.(:^,5XE4T.P'<73/.*.
MF!-,WIH=*[U"_0WS?-^WKS0_W^9\#SZW68U9?;H#4^-^-*[R>N'!5<W(EY=G
M@C_R<#62A*'_ /[>QD^,=U_J]>"G/X;E+MKJG:5,#L[^%L0C(QN;8SVT?S>U
MW YL*B0-U[TZLUE^&2>;H,!(Q?8:STK,E+I'I)*U;SW"S;(G6P+].Y7@JO_7
M/O[>?RCG8TH/2ST2K:G,^W2*<N[GX RB@$5Y/L#7LUBOV#HB;"Q\'.GB16\R
M?%M)1SJ:5;HJ8]KOUX]) @\)P_MLWE:^=L$V)C0GCT'6RVGDKG8;[GM#<-->
M+SSEWFF6L[*<FABU.LR&+IT:9)COYV 12.;\4P0>O $IR/G,S,ZE6_6XD:$6
MRL]S70%<^37]&E+&SI$S?Z&>) ?D)XNTUR'%[\\S?OU[0.)@+&%,=.#9_I"S
MBAY<Y7N?B-B']F)C9K,MYCABKEX@P0I'($?S!W"]V]&V9]@S+(>YG/QV9V:,
M/;M+C-"_)RXGXK*VNTJR4\)^,> T23N>^Q3?0?)^1RV.]9JS/3LJ4E3BE^<\
MIJ/EF5@&I3R@!)'SE]C7;%ECONHB0_Q<9[W C\:X[0_HF_HL.E<[_"\A+BZ!
M52&@V#-"J"$D-G2(KN=D--AIB <0.H#7?(B6X,_=7&%__#.4'.+ES@*I[L_@
M91 P%+X7.<"S-Y.$,"]OI,KSBM0^3\@DHX[?D\4;"$I8GBSN)<K5(R^>_#H*
M;,;69(6,"&3,\(C'4OGG_7;^L/YU(!"(96B%F 3_Z?XCFMX00]WA1FCI.ZA^
MT^G_$YL&FF!U<:X>>Y5+H&JW0%QKMITO\<;,'U27LK=06/PRE#8EX]I$K*&*
MB%^5/=PQ[_;8Q#A+X#'&A>%(@F=B\/.?B-8^%_)"[)E!"WE-ZVHKE(=K[V(7
MOU2T:M\1F1SIJC,Q2'"DK-K?:!72+V];%-$&@S7F)?TX03(JZBA5O/;C_UT*
M74F6E/I:?@C?O[FA R7L:EI"'?S66R]+=$;]1"D>??IR#ASBWE ^"#$7?/&!
M1S'*(;_'6+BB7]%TI%ST^Z.J4/\5RX*;V=WTS+1$FDH*J)>YB7VNVOL@ &^:
M?^H?U/&LR6Y(9#)Y),CJO'@R;$Y50F<M H:XZH:,F?'@BZ1P-F/V#3;3-V./
M. :I:E],TL@<D!@JIX =R[;?^P-2Z"<*)U # CL_[3:(6NJNJX"!P]7Q7:\D
M>U.4SXXQ=DTBXUR_Y14K-I$61NG:Y<%_@OG30EUB834*569Z?F;'MV_[9PYM
M8T?N-!CENL\C@TG'_P&^[%O3$/LJ^1%22G5Q=HJ&R:9M!7Y&O&&."?A? 1(I
M[=;FT[6Z,8Z87+<]B1V/I2@D*<@;@<@@_H:$V*#R2O48/\^WO37"G:%.?0XY
MS71>^YP."7P+^O48S'GY2/J<U)D%P,#MVJ,\L0S;6!Y':FCYF.,G%=<6CS*D
M97+B$#'<=/I[4H8 ?TJJI.",]:=GN3WJC*Q:#9-.W@\=15,2<\&G;B">:"DB
M5A3#3?,I"X/>G8J_8=Q2Y%1;A2%QGBCE"Y,3BE#>E0[LTX'%+E*3):0OBHR_
MO3<GUI<I:D.9L]!3"N:-^*:SDCK2Y1\XU@*9CVI2<T4[$\P#WI2><44HYQ0-
M,3'%-(J4KQ2!,GVH-+#$C:5UC09=R%4>YKJO$\R16FG:) ?W5K&'<#NV,#^I
M_&L[0+=&U(3R8V0*7Y]>U-N)#=7DMR_61L_0=JSE9R]#IC+DINV[*:PY[5,D
M&!DU.B#TI[?*!3N9*.A6,>*8  34LK8XJ#< 3FFB9(=32_.*1Y%"\')J'> *
MHR4>K)F;%02.%!-,,ASUJ*0YP<\9JDA;B%B>IXSFH7;)J4\K4!!))[4QCXCU
M-!;M0!M2H68YI@6%<**42FH,D*,TPO0,NK-CJ:>MSBJ >@/S189I"Z.,YXIC
M7.1UJF6^3K4:L6;V%%@-!9< L:BDFY-5C+W[#I4;/DT[#W+2R;CC\:F\WW%4
ME;:/K0)!CK18&KG5I:NT+I=,@=1M4@_<7O\ CTKF;W597OWMH)=MJAV8 QCW
M)YR371#9INGW%RS+<.8RR.I++_\ 7YKAYP[6R?N62-CN$C#KGKG\Z\7+Z$97
M<EY'U68XJI%**>BU_3Y"W(^TLD:L0R_>+M@ ^O/7BH9G\N8B:43J6)Q&1@X[
M_C2W:_*4>9&$:A8CZCOBH_W"8# NH; *##,.Y_PKW:27*ET/ K-J3;)_.<09
M\O:B.3Q\I8'@=N,4DJF.3=,8Y6$08.3D XP!]1_2K+E/*MX9=Q@)S@L/F;J!
M^N,U6NA#;6RNK 2@<H,L#R>A[?AWI-W@]-=26O>6NFA/:1W"VQEB*JQ3RRH7
MYF!_K4_D.EKYFS:D9P2< [OZCZ5!;2$6ZPB12%^5IERP0'G@C\JNV5E++$7N
M(@+:(#*%2K%3GYOT_2N!5$D[F[HRE)*QER1!KD(C)- .<CY221R?7%:4(FCD
M5 RL0NP;"".>F/6I9;1B;:;8LD$958Y&0QNW;!7MZUHK%*4#^5$%8LR;  1C
M^+=UQ[5#J*UF:>RE=-*_WDD=C<6VGF9H2'!7";1D*>"2.M132K9^8/-\[<Q!
M&1G@\X^A'Z4DVLSZ9Y0\PF0C*#.[L?F;U]AVK.,DDESYLK[I'.2"N ._X5Y&
M(K-2LF?2X'!\\%*:T^ZYT&@7BWIDANO*)E)*RD<_3VK3O?#TK*6C)VHGS*.2
MPSR?SKCFO'M[J-$!B#$,Y]>*]$M-2N[6QMY?++QM@.#U ]:Y:6(G"5[G?C<!
M3E!2Y5K^AR<UI)YOF-Y:H3C(;O\ XTEO$OG_ #,VP='"\UV]Y:0>0]S H4,-
MY7^$_P"%<O+J,45WL-LC*"21G/Y5O4QLU#D>YYV'RJG.LZD5IV_K0UA*B1PR
MPA5PH50W8=,X]*K7]G)*S; H:/)R5X/3@_3FK>F36EW%*NQXP$QN<?=_&D,K
M6RMYY+"20D;2,*?6N:%1Q]Y,[:U%23IM&$+::Y#2QQ_NR."!Q^&:IR12HQ4Q
ML!U4[<%JZ%4-U(1&H) .#D\_A4,T,D4Y2X0%.G)Y&>X]*ZZ>,E!W:N>=5RJ%
M1<L96:.>9RS%N!W/2FA@K$<U=U.S2SF&PDJW(SU'T]>M4&W!]IX/<&O:I34E
MS+9GRF(I2C+D:U6Y*6^7 %-\P^O2HW?MG ':HS(,]*Z(ZG'))/T+4,;3SK&A
M^9O6I+N"6S*B0@AAP15C22L-M<7LIQ'&I&3Z#DU6EN_[:\+F\B_UT#$LH]CR
M/RYKHY5R^9QNH_:>0ZTMY+QF6-E&T9.ZK7]DW&.'C_6H/#4HEDE(/\ /ZUE'
M2=??5Y)(U>*,S%E<RC &?K35K)VN)N7-*/-:Q=N(Y+>7RY1M;&?8_2K5MI4\
MZ"1F$:GD9ZFDUB:*7Q!I=EN!=F)<>B]1_(UF>,-3FCO8[*)F50@=@#C)-#Y4
MFV$7.;45I<UKC3IK9#)D.@ZD#D52\S(X-1Z;#XDL+=HUM8KB.3! EE^[].:I
M61N)2Z>4Q*,58*,X-3IT1I!O5-IV+Y?WJ6UADO)#'$1P,DGH*J.'BP7C9?3<
M,9K;T?54O+I[:.V6$(N[*GKSCTJHQ3=F*I.2C>)CN^UV7/*G!J:UM9;UV6/'
MRC))Z5BQ79?4KC<,A9FX]<-77:1JB7TTT*6ZPB,!OE/7-3%)L*CG"-T8HYDV
M#DYQ^-:/]C77]Z/\ZPM#G:ZU558\"4DY] :V=0@M;S5FBDUGR)F 6.",^W?W
M-$;-7%-RC)*_ZE>XA:UF\F0J6QGBD7M5&:RN;"_,,\GF9&5?^\*T(ESBLV=,
M-D[W)D3(J00DGI4L$1-7HX/:L&['5%71' K16K(O!DZTX0X'2K:0@=J<4 ZB
MIN:<MRFL>.U-F7BKNWBHIER*+ARF.Y.XU"Y/-7IHL#-49 >:M,FUB$GDTPMQ
MQ2N2*C[UHC.0]!FD=<H<4Y"%H9L* !UJS#6Y"WRKCN:B8<<4\G)--)VXH+0.
M<1 =Z@)]>U+))D8J#<<BJ&D6'/RBHJ5VX%-S3$**7I2"@\BF!(I+<4UB ,#I
M_.@$(N/SJ,G)XH&@+<T#+4W!8TN0O?F@H>9*820:8S9[&F\^](I(ZO7;XP0L
MK)FTD;R4@5<XP1S^7-<U+<I(AFEBW*WRQ(3R% QNQV]:U=;OBHG2)96E$V<J
MN=GT_#KZU@P0O<G"QO(250R8P5;KMQW^M>=@HIT^=_U]Q[N-G*,^1?U]Y%(K
MW"(J>6QB(&X_+@>^3CK6C;6,MO<C:L:3,BR?O,?B!G@'O]!4^G^'KF6&9[V9
M;:SC.Z=F&648Z?D<\^M=)K&CQS:2@LMF%4,N>3*2, EOQKHGB(QERQ9Q*BVN
M:2W_ #.+>S:YN%M(898YFY ED W)_#@'OSTS6A:Z1<ZQ<R0FW*$$K)<2#Y0!
MP H[="?QJWHOAHHK7=Y#+)*F3'&I()((Y'L/U[=*Z6*XE6WC:W\D[<AHI)<,
M0!ZGH<\<UC7Q<8OE@[JQK3PM247*:L[_ *%/P[HUGI8N%#K/*LAPY!SM' SV
MSUZ5K3RV,44EU-L:7 XSMW8/ ]\5D7.KSV5F"I#A69<MECC/!W9YX-<I>ZK+
M<1 ROE@Y93GMZ8KQJF)TLM3V\/ETISYY:([6/7;>XE,3;HU8_)(J9VGT/K5P
MV5NBA8G=92-H8C@#&<Y[>WO7GUM+<W,7E$B*97#$]"0.>GTKT+1\:E9.5=1,
MH^09QGVKB=2<GJ>W/!4L/!..AS]U8V]QJLMN;EWN;<DG(&P9[<?Q#U]Z=-HD
M<2^<J2W&,$[4/)%6M0F6TOF>\6WMBW)8+R2.Y]\U5_X39+&:/R2TBY]<9I+S
M%>I.2Y/^ 8XL9_[0:62W=59") ZD8'7IZ=/RK4T34+B>$Q/*0J?+CH,9X%;E
MS?2ZEX=:<S^9>HS[3M R#R!QU !Q[XKGX[=(+V::,-B0!V7& . 3CUK.2L>A
M2G[2+]HK-:?<=9IUX\H*&12R<%#TD7TQ67JFB7T1:ZLXDF#?,K!\,H]/PJ:V
M:.VG!.T2,3QGM[5>UD/<Z=$T;<*WS=ABA.ZU..SIU5R[,PK1M362.ZNE=$'#
M1OP"._M6N;$EB\+J;.=.K-C8:YYKR=4:U.7M=P*$]C_A5V'S+FT-O%(#M8L@
M_#E:2=CHK4I/5V7^7^9L1P6T5TDD-PK2 8VMQ^O:HM9+Q3?:(8R\?&X#DJ>>
M:YV%%CE2>6X) ZJ1R#[UT+M%//:S_:U3,2KA^ Q'';ZU:E>-K'+4H>RJ*5[Z
M&9K$D;K;$H3(5W8^N*RFC82;6PYVY##G [UT^J:5)=K'+$L1F1=I.<;L=AV]
M:YN?3[BU0N4'/.Y"#C]:]FA*'(HW/D\3";JN?*MRB_+X7IG )XJ)Q)D97)/
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MV7?L.QV4^JG%4KIW8YP3AR1T*L6!JEV/^FS_ /H1KJ_#28N;E@.2J_SKE+2
MQN68Y).2:N3>84(C=E/^R<5,--1U(<\>6Y'H<5M+J+Q73%8F=AD'&#GBM27P
M?.=762&11:[PP<ME@.N*Q[6U*!@>]$AOTRD=Q,(_[H<XJ;I+WD$J<G+W96-G
MQ!J,<VMPPPD-Y*D.0>Y/3\*O6L6Y5/K7/:=IS&8.]=A8P?=%9N3;<F;0IJ*4
M46+>V)' K2CMCCD59M+;('%:J6R+&6;@*,DUSRD=L(&2EH2,]J66"**/=+(B
M#U8XJ\EQ&L#,Y"CK@^E9^HP1ZII+M:,/-.<#UJH4W)ZZ(FI4C!>8@ME>-7C9
M71AD,IR#5>6U..E4/ <LD%WJ.B7OR2HPF@C;J0?OX_0_C777%F,' J:B=.?*
MS2"4X*2..N(BO&*SI8\UT]Y;8SQ6'<18S51E<SE&QCR+SBHRM6Y$YJ%AQ6Z.
M=D.<$TC-A<?Q']!2-UI&Z5:(9&#R<T7#!$"C[Y^][#TIN2'XZBH9B3GDDYR2
M:I 1,V<4P??%(QI8QEQ5%CY#R*3--E/STW-,FQ)NYXJ12 N[\J@3+,!3Y'XP
M*!6!FZBD#?-4>:5#@T%I$PX!/>HS][WH+<4W.!G/6@0'KP:*049H*3-G5[@6
M]Q*(8R5+!F=3PX(SD$=O\*;I^K)9RBY9H2ZC[[\G'IGUJ:Q5-2TV6VD+@*?D
M.>5/^!]*PI;>.&[:/>-RE0A?HQ)QD^@_PKXI2:UBS].I4H3?)-'8PZ]9W$SW
M5NC>:XQ+"JX63L"V1U%$FME$AM+FT+2RL%3( 4^A([5D6FK?9(I$3@H^TR8P
M,_Y%7Y);6_G^W:BS"10/+*G X'I^)'Y41JS74NO@</#['IJ[W,U]4OH=?(65
MUC'RF,-A0/;'%6[:]2WDDNA$'>;^-SN<+R,$GU..E8^H7$9C<VLA:-^<RKS[
M8-26#SG,,WW]@;D<%2..1W[\U-WN.5"U--Q6A6FO)VMI+/?^[Y8;N N.Q_*L
MZWA>1=JR(6_NLU6KBW>-B5A5B[G#YZ=OH1W_ !J)[9Y9I=R@.I8+L4Y&#QGZ
M]!3L:Q4;:$MI.)6%N79Y9-JL0,!1G+#/>MN/6WTBY7_6&,D*>.GI6#%:M;O'
M()E%PD@)^;&!CO[UJW2Q76XH,G8"-V",C.<?_7I-$U)W:OL;%U>6&K3V\U[%
M'L+-CR9#EF[-[>XITGAW3)W2[L+V5G' $PY_"N>G4K:D6YD[*22!N/J?0"K.
ME:G,Z"".1DV9+\< >Y]:3T15*BY+FC*QT%A8M:*;5YD"8(0R28'/7GM5NTMD
MCCC6X51/+-M"J^X!,]>G?K6?;O<RAXBRD_=R>F#U/OQ6@UM):WEL6:'RU<#S
M".5'5MW/ _QJ%J17;B[-ED0!)YW?;A7)7O@4S4+Z!M$FAFSAU(.#^E/U:\2&
MQ7R;6>3SI&!:),A.<<GMUS659Z3/+8!.D(&%+/NQSW)ZFB2ML9TK3M*;LD48
M[F$Q#83@K@;AS6II+1_=5@&8$J,=3SQ4,NAW%FJ9($;'F3&:O26[Z=;BX@V2
MQE0"X'*&I6YV5YTY1M%WN9-@T5PMVLX8,N2&8="/6M*"W%\L$,05TA;<S;L8
M]:DBO=$OF#31NCG+GR_NM[D4][ZPL]WDMA=N0Z@C;STXYS3T1RU)3D[<K3*U
MGJL]M?SR*CS!E.Y0V\ 9PI %7);Z:61//M$0/@C:.QZ9!'Z4D>NRV+LI<21L
MG ')![5:-_%J=HTGE@7$ !8'HP!YK12OLSGK4VM905NYBZ]:0L$FB7:ZKAE
M[#O6$JEH@Y&%W8<LO'M6_K)5[N)"X"^6#D<A<GJ*QY]S3(F0T62,D8#8Y_.O
M?H-^S5V?&XI1]M*RUV_I%4QB,.%S_O=B*;Y:G: >#_$>!3W3:/[I.0=V,8[5
M%N)Q@Y["NRFNMS@K2Z..@Z0$MR<G'6F]%' YY!I0V#AN@%,)[$<UT1TT.2:N
M[]Q<TAHR, 4'D5HF8-#" .U!&"/<4&FDG@4PT'4VC-%,!13@>:92[N]("9<5
M*A!/3-5M]3Q'D5+*2-*U R.*Z;3+*21/,"_*.YKG;,99:S8/B+<Z-J,EC>1(
M5BD9&['KP:PE%RT1TT^YZ?;3PQ?*Y(/TJU<S)-#Y:':G4D\9KS-?&:W-X)AC
MRB>@-='<>*K6YL?*6'#D8SFK^JM-&<\6U%IJQG:]>RM<>1&WR=,J:T-+U.+2
MM-Q@-*02,<XJA'+8SP.UP3YG8CK7.WUT4F,<98KD\'J/:O0]G%QY3RHN=2=]
MF7I-;DE\6:9J4K"..WG7>ZC^ G#9]L&O8)522/>C*Z-T93D'\:\FTUK"*Q=[
ME/WQ7@D51LKN^T._^U:7<NL6[+0%B8W'H5Z?C7'B<-[6SCI8]/"8I4[PDM#T
MV]@&#Q7.7T0!(Q4-K\1+*]NTM+ZSDLY)#M67=NCR>@/<5>U!/F-<').#M)'H
MS<9*Z.>F6J,F16C.M47&:WB<;16]Z9(<5,X"BJ@W,^#6J(:'-PI(ZFJSX"FI
MY<D$"J\H(&#UJT0BN34D/ )J/'-3;=D6.YJBV5V;+&DR:<8SC-,H&3Q# +5&
M[?-4@XCJNYH%'<&:A6J-CBF[J1ND3F04 [C@=J@#9-6XL*I_O&A$25AN:86.
M:=(V!4!/-!*5S2L9I(0;B"*4Q.^0.X(Z$^U7[A?.'VM((VDD5@FY<D>I ]>M
M4K"[V6$R2M&VYT38S8P""<_F*UEG=/D2Q=HCR KY/3MCH.M?$VL?I]2\972.
M?2!QY,1C=CYA9XF8C:N>GX^M6]1EF:<0E2RB/! ' /\ 7%:5RX73A-*H2X<!
M@2I( Q@@^I!XXK/DNDF;:D9=UQG:.<]S]*4CHHU>:2DUL4(K626(B0MLCX$>
M.1Q_6KZ+)+;L6 AB+91T.2"!R<^G0#U[=ZFCEAN;N6*>5$6155VC<]<CN*U;
M*PB\N2VN9=T.2PZ<+VZ=:29IB*JM[QS5Q%<R)&DC'RH_EW$CDGTQUZ5:73)7
MC2^"DPX(.)#N(QQQQQ]*ZI]/T6 6_F0&YM'3< N6D,F<'.#@ 57OKM(9)$MU
M^QJ\@^:0!Y"A'('H0<8JGH<JKJ44E$YW[/)%%; VD<ENCF22-QC@@9&3V_K5
MJR:2<9AE4R[20Q7I6Y+;VE]I@DL$9UD_=R!VPV<=2._2N<MK5(%'[Z/9M*.>
M593DG!]_\*5P=G'S*5[9M]F7?<(ZR$L>,LC>F/>J^GM)')%A2LA)5F<X4]P*
M=J#.IB"QE$8DA\?*W/7/KFBWM%EMEF:0,&;";@0<]Z?0ZZ5U&[.EA9IH#+Y7
MF(<$)C ([XQ6M;P"9/*B97F5,VX;C9&3C\<#\ZP--U)'"6\$3A68JRA\E!Z_
M2NFL;C[*)&D,9_=E5(!+')QGCM[]L5"5G8Y\0W:]M2CJ&JS65TRQHTB';E=V
M5) YX_AJ8:M9/#%LPI?EHGX!]AZ&JBRPSO.L+8WC,AQG@5$]C&UO)B( 2883
MLF67CG!Z8Q3C%RV%4=*E%*:U.IAU2.XA4.5D6;.&Z#KW]Z9#/]D5T>,;&RH#
M#&X5GVA9GC*%#:>6,3#DY[<>F.]:;13-IRQ($8"0$;0/F!],]#S^E=L<.K7>
MI\_6QG++D6E_ZU.=N+"!-\L*A2Q)XX ]LUGHTK221QE_,DP 2F0">QK1:22[
MO'@D)51E9 K$8QP#QZFLJ\9EGD1)62(/D;5P-P(.*Y'36K1]#0Q4G:,];K<J
MB\G64;G&\MGY><#T K3MY+BR\ORUFV.27B5 Q.3GKG %9&U2[,BX,C$C#9*\
M],X[ULZ8DXBEB9\,4^3C<R^P]<"HBO>21MBJBY.9V'7UQB8;1MQ$JD..1QDC
M'K6>SRA0JG<5&< YP#4B!9683,5''SN<G\:KRNJRRB,X/12.,U]-1ARPY3\X
MQ%3GJ\U]_P#,?Y7R,VTE<X#9X^GUJL<'NH^E.:0L6##@\X[*<=:8Y"Y *G/Z
M?2NB$6CEK34@88<C(8#OGK2%B3G.349)SSQ2[OEQQ70DSCDTV.R1CL:-W%-+
M$XS29JB!Q--I":;NQ5"L/I,@4S<:3-,+#]U*#FF9I5- $J]:MQ+R*J*>:MQ.
M 14L#8LQ@BM"?PSHVO[&U.Q2=U&%<$JP'ID5EVLHR.:Z*PG QS7)51UT64)/
MA1I#6CG2;BZM+H F,22^8A/8'/('O7#VIN7GFM95VS0.8Y!GHP.#7L%YK<6C
MZ-<:A(-PA7(7IDDX _,UY.;F$)<W+?/=W+M,S@8&XG)_"NC!3F[I[!B[65EJ
M2HDL3$,V#6YI$^BVUK+)>8:;MGGFN!U'5YK<+&K.\\APD8Y;GH /4FMJ[^''
MCVVLTNUT^"X#)N:&&<&1/8J<9/TS735KTX>[)G.L).HKHEUK5;!I=T(8#'05
MB)K9^X%.":P&U0F5H+I'BD1BKHXP5/H1UK=T.[TR)V>YB$OR_)SQFKA5A/X6
M:^QC2A9JYT)&FZWIQ4CR;J->"/XC6[I.OF[5--OP5OD3"N>DP Z_7U%</+?P
M0LTD) .<@#M4FEZI=>(?$=DJA5CL3YLDBC&%'\\GBL\2H<NIG24U+W=CN+@<
MFLZ4A,Y-6;FX SZGM65([RG _&N&*.KENA9)/,X!I(U W4WA!MQDFD)(X')/
M2MD8R5A'8I(&4XQ_*JKL68DT^5LL1@\<5$,LV!5HFR'1IELD<4Z0C<,$$>U*
MY$4>,\U 7PV/84R=6R67 C]ZIXR]2RL<88X8=!3$7@DT%+8>YZ >E5V//6G.
MQR?RJ+-)E00'I^E-P13ASD>U)_!2-4"CFG[B34?THW<G%,4D2,Q/%19IP'&>
M])BI%%'7Q:-:J'6:ZCB$1#D!?D8*>#GZXIPM[C3I'F!.YC\@;D$'D'/?^E;2
M[I%2*587@4%FXV,AS_=]..I]:LO8^4JP7#^;:IF2)DQZ$%3G)XX.<\U\HZ7N
MZ'VJQC<VI/Y',VL_]IV-S)+</#<VJ[GAE (8=F!/O^=8S3LEO)$\I.6&[RUY
M"]UXZ#VK5;3;G2[CSX2;B++918^=N"?Q^E074,'V1KN/,F6SM48VL!R#^8K"
M2:W1Z=*<8OW'=,R8+9KF_C6WXCC&[>!@^Q/OVK?C;RM"6(;5>0;2QR<<]?:J
M%C-MOO(D&U9EV*5/S*1S^56M<"-Y*P3XED.W+'&/<^W-2;5W-S4)*QF2ZO>+
M)($D=$<X( XS[GU_G4K12);B>X=WF4$J0<$#[W>F[(G;S9IE(C4E^@#,./RJ
M#4(Y+B);F>0( H*1 Y(7IDTK&T):69K6&I_V6J/*VR.1P%18]Q*#J3[_ *=:
ML7D-E-?W)B?[/&5+[I06 P./<9&161(OFW2%YMX@C\H.#C/3\_O&KC1(BR/+
ME5B 12I&&']<GFA$5H6,6ZB>%RL5O)@D%0,D<]Q4XM0$N)1+(Z1XVG(P&/KV
M]:T8]9:_DCM61)X44#S%3:1CW_QJ*:%\3;L31EQL1B %S].,TVS>%.6B'^&G
M8R.RR(A4<N>>2>,CT]JZ^[E8:!,L)V2.0H;&T,Q],^]<KH;,)9I&M_+FP,'^
M$\XSBNKU-)VTN**:$F(@Y:)]SAQR,<=3SSVHBKR./&S?,G;8P]-MIK5#,55G
ME^\I_AQV&1G.<DU=26\^T$RDQQ8&P8&3C.<>W;FD1OMWVB']ZCRHJL"^7CR.
MON?4^U2SQ*P\J"0E538CL=V0._YUW1@EML>)7KSE?F7O/KY!:F$8DM9F2,H4
M1$(,8.>H'J*NR?:6M(@'#S*Z 2=!SU)]/KVS6;;HD\ALV.);=L[Q'A<C^)>W
M6MBUB_=2R++(4DYW'KD=@/2NA*ZT/,JMQG=].YF22;9'7$F(LLS,<@C)X/?-
M8FK@RW4;2*5DD7Y@N<<>G;I6C?ZBC6MQ!&V^; W%2"<=\8ZXQS]:R-WVMA%"
MSJ(_F56ZEB/T%8RI3492/1HXBG*=.#WN-DN8;8,\<04@ $#UQ4VD7C?:?M,P
M98XUS@\G\/K6?<HJ2MO!^90<UK) L^B3RH^"%!C7ITZ\^^:X:*4JD4^Y[N,_
M=X:4DM;&2A::8DC#'+*.WZ]J0G;TSR.?<4]K?RXDD=D??PJJW*_6FY^784P&
M(*EA^&,^E?6QDGML?FLH-/71A(0W.<MCDDYS_A3><87UXXYI-R[^F #VH9LX
MY)XYS6B5CGD[W8T\C/;TIN:<>02, #WIAJT0Q=U&:;29IB'$TA.::6I"U 6
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M=9:@\/C8,E.Q0V]^,,UR1\%DI5*C(79/#T@(]<7X8IS57F\R6,1N^-U[T\!
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MY:PTF^'&<'1U,TFS<5 L\NC&NN_2#L>^?'\Q5=@9_8N.Z .GLQS9%Y\E)5_
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MD<XP-F#6 AYX&Y)56! .,(7PU #?,O/QR5PXYAG%)OH;-?C0[([%'.N=F=G
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MF3P^1O253+3^E9Y<=V4.XU13M.G9'K?U-X?\XA4<'+&//#OA^2Z(ULIM!):
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MO6GKZ,(4\"YA1(V7[,DPX2E@]D"1/9\#^21EYSB4*+[@]D$Q1&*D\%P=UJY
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M0#;U-?-9L(II7^;QNY*R&^%5XT-&^RZ?3:R_X2[SV2J]5'OV"VMB^87E?M-
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MO@7'_%$0J."&_)4&S'!K@)(^-?9F:CA&=@%Y *Q]!>Y@J] CJQ-&VY2>\KR
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MM'4-G(@]&-'[SRZ3#A[]%_,$B2/=/B^R#-\VG !FW?)]_3*<[D##_;32[.V
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MD >@<0G,_B5F$SK5[WUP!'D?1')]U4+JF(I,T#6-X2P/I=Q#)4?$R"M%1\?
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MSN;L2[)7?_G9,(\P@ ,3TB#'H:ZU:UX!4''K7B8<^.HOG!FM0$7#^ V)BNO
M9NRZN%_1^'2WX+3!Z9YR3^V-@9I18[7$%4K#RU'!FZB(L ILSE_35"%LN898
MV,>32^TN.@;J\F0UN<6MH%:+@]<B?5^=*:JL)^SH\]@NP4'&BAY:ZE)P@_3S
M:60B9?%;]Z/X]#:&@835"K,]1L74]$V;V1S>')%T#3R+-,NV-NK^_/;9HM9@
M4WW32:,KVE$CA<958HIC?DF]YME6836VA5HH*F7WV)]"&!F9B3SF1SAX^[C2
MOJXP5\_YI##<IQ>W!A@4I\_AO@_J2+W7%QRJ=C_V-G#$FL%C"P,BU-]7.->J
M33I5F*<IU.$2!1+)HERK,A'A46/.F+N9SZ["?KJ9:/X>J80WL-'ID3HE63_6
MIEX5<,?\Q0_O;?OV%QU=@_Q &0'"333LN!!6DOSBY\4@(%\(^]OXQ^9%Z/"V
M/D*9\&^>U]JJ$@5*["+OUUD_ [)OK<>8=8[PCEC3%9;<;6;)8;6!=YG7ZF6P
MXSDYJ]&$3,LRO6^X(G],UZ9BF.7Z.J(!U1$B;S9W3JF/H!3+O09E:>(-&3PE
M=LV..70BX>2B^_$2SN](XR7I)953L0X3(YOFPQLS)J^1^[9C&@.G9NM\E?FY
MR7HX[7 A3-YU45X(FW[15M+!:UQ:7X(B'U6>*3G;BUFRE=)7'^GZXM20EXF[
MXBU?=",I7@,*H"X[/S63KF"U)QA4SZ.5'VY- &5P S!?;ZO'G:#J-]BDR2CC
MO%A6-H[0X)Q^Z]9NQ _9F5:1XT-QSCB2O5LO<+S+JNSL>(<]9???!T/&3@IA
M[ TR8!^R991/XAEBQ.D_8DO^,WV+%CR9$I9^H2 QJ$(PMAR&K?;WWIFMVP2'
MXZR6) I=>G,(FJ]:P%VYH170T)665X 4<\^_.9M*&=2#WY2B/W"B?.Y]@R>1
MZS&=3''\*:@0E#D/K;=^ (I2*5!^EW/+78+4P\FGH[PS0&YWJUK7FJ($7&$V
MT( HP_,( E%VI"Z#V0,C^F1).D^3*5-H8=?\*/CP2$.7#V]OCW.).6GG[>]%
M1VIVRY:BX#,:855)W7T2MBHCM7:_Y56=^/[=W/2OW#/VH16V.2]2!,;L\O$:
MEXP7J;EPBWW>33X<S0I[V><?_%(K#'='O:LM/-$_^6W0>R3TLXVZ0X5+JQ"6
M.$[LL*0O<()1P S^^,^=3DE0C!]/-E^0<7Q.").<Z P17%O^5INR3802" >%
ML.&='4PH_3."]R]>@7<)+BV$+;# %H'J@2$AS !162*0</G)\#$XY)^?<5D(
MR_M?'*_Q3$3][D+8PQ>X1K271^?/IQ@=Q9&MHE3TQDS/ 8B.>^,%W\RM6BUB
MRGBG6ZF1YGMJ*S3EKCG=/S3WO9]K#A@^(!P7C#(;^[KHR1/J@<!F+WU_VPYV
MW7[3E@N]ZNOG7+KEG2?<\2VE62N/ EXQK#,_&>NIXP8S,BJ[^#KX<Z*EK--=
M)9M-EO!OQ23B39ZZ3B_FZ<07NTYC\VRS*>[F1YH;&.O;1FQJ$_6AOL3!DQ>3
MGMQN#P00BD:Y721QT.VX5R(0&]OX[FYH?(_O1_" N5LNZ_D'3X/C1DC7T9)L
M3@#GE)/FFS>,E'AC6=\#HX\IS@4NZZB'!S4YF%3(=/-,-S30.RDE=KS'YP[$
MZ)R/JO7)Z.: 1EC?@Y]MFP,32A,[&4_EY.P]-S3''S^U,9>MM!3"I!9%G)T6
M<?8OHIT#3_,R$0QZ*QT$A3#'YT1TJ2T=<(!#6GXH\"K^VCECP2!!"95#D(<O
M8SX.$,P)HT0E8A!*@A?)+]6F2>7_3=O+$^-GJ$(=91;P.%.U*K,:O&L[D-O7
M;GUY1&=N/+R_3@'W5C/=[[4WO,5+XK5[ CFBK/UM6<5\&350AJ!MUD> =UMV
M(G?@0G:5O)NY/)R&H5N)J_$?,L]DNSYK]T[1$<*HUP6D-FQ"6:7UH@3G,8.L
MIJWX=_(;PE>JQ7'Z^.]3I^(/-*^5?'9_>?3''!I2#^')']H Q7IW#/&5* F)
M(=NJ?Q(B;J!8I43 ]<J?RZ)%[/O0++^P37]Y 2GOLI2;3 Q9FTY@L,U+?0 K
M1C>Y*3=5K#M&K=M[)]3"9DY67<U *?$T 7C'.0E.9!]B%P9GK$G?LY S8<"4
MI9(E>6(CA$.+Z<&W=/ AY]85C[^LAF0\OM,^\NOI06AI#T(_<@?T9EL#US U
M^!T#K0%A[,UT:KI+%R&F[S[^W)RFDE=DSUWO8U10(6&C'RT>,&5.JEH@3AG7
M-K+;[1D7\C:NMS:=.;LOPKIW4#9MT4QP2"UA:&HLO.18.?6 ZKM")_Z#(1L;
MK_.VNVVO/HZ*RB;IX^ ]5/6)<MJC(DV+#W;I6(NIZ[(4!1WG\C>A"HW5K(\'
M9\Z^W1=_&9W_Z+ON_$]>4("KS(0WU,Y ?0N>5=QA2AS3JK(6>8BJR$-H!7Y>
M4/N$()W9Y4OJ8_O7C>CN_WE+.3$$(\4+8.!WLEVU3;$ Q6.,Z+MZIV].LJY3
MB;P7JQCR0'N=GIA+I+8I;'UY4+*09U!?CFN=YS#CG@ &+WV?+LH7(00=8%3C
MR- '50]T"_VZ[C2%D]M=ET24;3/<O@KYBM2&1#@YR5L#Z$L7POZD@.3. 32;
M-4[;C[>8P&/8:[MY9VVNS"S]A7O5XWZ)'!>N*^^UW)KFK3BF&R0X,OT!S5X^
M]CX/ZX51A)RSU9P@,?:SXB<4_VAQQ]"@2U-D[NY</8>P@J"!_>;V6-6Z<[HP
MZ-4^MZND$;.>2OL(5>N\9_57GSTK_I1?):A_<<?F6V?!Z$L_^]MQ7I\IK)];
M$XER$*M.K;8=#&.B&B<2?Q'"QKQ2"E&L9PC Q1E62.3,VPIAC<R$UR*'^_-5
MG1#F3;^#_\GJ*8B%/,T+@U LQ.2CB'DH9NX1&_$;KJL[E[B7=^;)4OUB,U%$
M,?O("U"_%8\:W?A=46(MWEG&/]?=U&&Q]4OV'!'.=/W8[Q-5%G"O!0V@N"O0
M-LC@IL=VY AAOQ\&$ ]7";MX#F #M,.=T>8I0(Z:NI7Z8V BZ9BH0%,##6K8
M7C(= L1[4[__JD:Y!*FF]]1TC-W8RGJZN1#FV<*H#:^X5:,*S736IU%T8:8&
M=NGZ3K.NUN5&G=:7'C7G.QVI'FFTL>R=71?5J.T@?E[Q]M85J'E>8S NBD#+
M-2Z\;#62N[=7^Q(CZV[P8D^/E6"-]9;888%BU?YD[%9X+]%O2"I-M"SH"HJK
M*3Q97\'NCQ\&VT$_&IIW1C1-BSJ^ Z*40.[8#B*\'P)*V,[MM8*1K;6X".(!
M_!4(_40P3#@F\K@8JRY;_N,V"PXY3I2UW>:8L5..K65_M8:DH]@'P+5XTZ-L
M$]+J.5UW4#?1)V]DWAE,>#9K.#S'@-K%!+MUM[$?<*2^>WT]OB60_'P'L2$Q
M5J"QB-FUUJ84R'[)LP%E'/F%O/-SA:Z6E&5OZ;$VO^C2/LZVIG*((R.<>= _
M4D6RP;IN3P PX^WNJ3>MJ_A_L?>>44UM7_MH/!Y%4$2D@Q 5D XJ31&(#1 0
M(KV3@XH08D!Z@$".2)$:!8$C"%$I$4*(=*5%".4 (D(H$DI(4! $213"%D)R
MX_O^[[CW_][[X7Z]8_P^[,%(LIE[SF?.]:QG)GNMC7+!#\ZKI6#S^KWR"\-"
MGYSX7GEOI26L4KIPY$I^V3/XAV=X"J1T26Z'P#L5T'L@W/+P"A&N@K<OO_IY
MH4?IFP->-8#PJMQ2TP4^G@F!2/!$M 0%@S"+I&>HW*H$]C#682$I)ZM)7$E;
MGLA0;^1ZQK&%\\ ^!@,+^U4!^T"^;8H4G*^^^Z)-CWV0J?9.5)_CR<YN9N+V
MP95.?=S 88],!TU"#J-A3#.)SCJ ;,MVQ=[R8T112=JF5HQA*:[BA,&0R;2;
M/'(RK2V "=UWI5*;)S(6K%*^<Y4W@6F<[*)/US,"WI$.(R8\4RF#LPH<ZWJV
M=%X :V72:;P-$<=VZ^.#)$P5V$7=OL?N&UPHON(0(KP<*Y329GMVV5>;Q7G,
M^@:%;PY+>* R;-[XF%S#9LUHG'K)_8,UJNN,]S4=/O2KLDN\*&'QBKF;JDJI
MW(^!M4I+HR@7\VQOY*"&U?*E!<DG""H%FK>@W.]9;NWDD$!-T_@9-G V+,\<
M-:4F9[_"!SWZ+8"/"*BK]D@X">UJ*M 6>UGKS;M.FG4XU@U!J_"K-Y*>_NG\
M-Y8$I8.'.Y2<D(2VV25 D/1D>>1#MMN:3#S^RBMTW&Y3Q[%EGD;[;EY$?,A:
ME& PUQ1476)!*"- 7->VQULR)I.VV5XXLV*$1(036[,@G<V>X4/'ACC%V#4B
M>Y*"V\LS0*WW@@]NM X?0YL"S2RO=Y/YS>+?8J,?),C1N+Z !PO:EW"F@*G3
MEQ(A:)AR[&3F#Y/9^K"/7'C\RZ^3VVWY\HH%T\BU8$O\J\O0WN]'TS-+Y\$I
MD9*?2Y5<+'S>6AY<8'Q='E(I)@7<IN9F^F<F9+6%.[HHZY7+9#;XVQ]]]FOE
MINKM%QID1NCUV5\W9YRLK7TJ2N4&(,D9 H@."B B/EOR 0@ =Q^+M<D'505"
MB!Y@U@TLH-FIS%/#29E@?SWG@?F@)02,**_&E<1R4D8[C-T!(:]=G"%$ :77
MBSLJK2/30S-_O  Y_ G^^P?P9!>65[<Q32BQ=)PK<:L&-=WM:4E<@,H <Y>8
M.A*4V ]XAN+Y""^D/-VKJ5C[%W:_@$O=R8$8>91$C_GI4<RMY1HR0X@%Z1%3
M^A9D" 5[=M26HA#=,&%3R'P?:S$O?'XONFX8S@X$ZGLG6H@]C=^S&/34CC->
M![V(%@G#> B0]4RO91L"!%)OH&< @_:M006ZLIUY2&1%+C3NU-.DCBSTW6D8
MV[!#W]+MU5OG<.G)>F\JHB!-'E$P9V=4.-6$?2]@RL1$@5\NI_6)7*?AW4=9
M>R=Y_8T>4$!=ABMU]7YQ"//1?#@?)*),V45M DC8:[ @\A R38*YM":QH\,U
M; 4@%5QU%@Y+TX$R%8F;Y RN4PU HK3@WD$S2DQJV04/(CL9"F+[OV(.SK.'
MD[D:SWL(*QTGH+(SB&8ARE:L:$-TAC8?5-LX!.O+/D(9$"?,"Z5P1S,*'=QC
MIC0&E'YF7UZ(8M+J$]8:V\>B*+M2W$N]O65?X[5-[SC@#>W>.O<ZM16?<]ZZ
M9:[N6)?)+ K-6&RI=WU"SFH/X8G\;E9.LAJB?@!XIDRFJ:'4]"_74> !0^^!
MP;6:VZ#<8T>#8&)KCO _"&>N3?VCKB8K5U5HQ97"<Y:I).)Z - >0K X5#6Z
M3"NX;Z[4F#?S5^+'80Y4A.9S\ARCA+8X%RFT%7ZB$SRIURN6"A/C::&-V)C[
M">IP3U_B?%;(U;&3$U37:X?DXUL\KPL:.:,M_0>[19BRO^A308\-G):WCJB^
M=RP]A>#R034WFQ*_<PY>R(T)V+<V)EV0'%74ZAZ 6JM)WW0*%2F;C@OI2=B9
M;T(R<!F TG$.[P@KRBKKWY7Y9:;&:'_8^R@AB93W<*:/\$@/5*?+K?QATNO&
M4M^DW2]"-NWR;3DYJ3_T1A''V:2O[*?WJE_CKH6(ORG28:+-_=V$7<D2 3%W
M A)[;X_?0T@<LA<I"<52W+J<LXW%3(TTE3[CY0%O"QG',Y$0$@Q0F^1*$BQV
MB6JYC&;L1M:%3K)<PZZ1G>6$HLX2[#"*V=5KMIWW(4UT9E+&Y [)3[YQ=C'5
M[,MZ\5_U09[Q5 KBE2><7#7.5>7UMG#(#)) G,2/H\_>D6_A>K%4DVZ"UE2:
M8OO2#';!+DTGS\I2XLIA<Y]F:J+:&]^/O%%?%=N"P][3K:&B=7IBY_IT"D0=
MW;5+T\ZV3!6;5CH7V\3<T1/.1AWSU]8BF.25WB=IC'3[53I7.JW\0&6:F=27
MRFL6</H^XGMK--D9E&<KQQ ^B]Y7.CT6950(N($L$\/P]^33 _GP K<^RV3-
M<S&+;ZZ-=L^SWZ0;!%;?EA:3<TTVM;M^E<#=8J[3(%T=TD!J-(O6UTF7X,94
M!TKS)-O8G%+6>N<HJM020-Y:0"S?;3,.9RZE;-.=\]9O-K=,Z$;01>#F:A,1
MN,/3D(>16484J_R)'PM%8WP04F]JT)(ED*'81NC#0K.LBJ<O9H#2&ZS9\46<
M6+8V5S^ F<K*FWP8;*JJNK(R$MBT_23,>ZC2U!:AE(.M,D@<MYT<!C>X4<A3
M^#ZR7",9!!1Q,AL )',X;1(LH@SDL;J4YP=;UR6": :3'-Q!PZR#[FRCM,H@
MV"%T7/64&3VYH3V:LIV5CR<MUWZ:6G:%5T][K*@A!*UH8@C7<-S [DI7/UN+
MZ9.:O&YJ&\V6%CTUI[=GQLZ/[;MDC:.$HCB*7@XL_^^E]_([9(IVY"'[Z7:1
M\U,>^\M#2VW1GDZ "GS^B89)'<ENX'1NX_F=0?NH9R]+"2T/\._?.@9[#^%W
M$9I327B?&]GR54E5EXT)T)G\CB'KR\%!(]9C+C'^'V:<8X[F;(=WPQKXH'=@
M42 !(PYEWWI76+VW,T&9S7M:@8KK,3G<7 /D4LREJ)M9MNZMK%[LK5?]T36#
MDO+[FX\9<815ZF?A)L4-?PWBYXAD9;8^IPT(8.%[,AC8HU_)1W2)2%.->; "
MJK1G6RWE^1A:;1XC*E!&P<1YG-"*DGHKTI7NZO0*>&!!;LZ?OC+2.$A05[8E
MO/%+L;CU8_*A0"3C<'^:^B/$L&UV['6F]K;J1#-3[ BBL'VQ=KY=^>(8[SC0
M>@/(>PY@NZ4_0AFM2#%*'6)[LL<L;*@!J3LP-[MY04_L$KXMN"7)<_A3(7YU
MB>7/4X?T8>6_FBNQQ1YRS5C?.DL.CT;"%.!*\F/5IF)E7.,)@<3)@!W]6IA"
MJ##\<)]@'<DD$(J]G--Y"JB%D8:BA[<:\D<]OA0<DCP6O[(9\:I<R<KN9XW%
M@9[& $)N+IPVTA;_Y6C>]=Z7!6^37\ =0PM,JMN+.-EE7Z14)M)%- QP9/A.
MS=4$L=_[9-SA@^0!96O@007W%A"/!^)<.^I&?I)0S12:(:^ >7#'*4Y,T-DI
MM-OYCYI>4JQJ[_F0%^6X.'>@XLWCJT?Z-3DR$'#'?H\KA!E?]$W #[[_/E,6
MK48<"E\@'>J4SF4B'D2<^-@H4^#HTC .7I6_OW/LRRD7:J1QI LU)(O<39OD
M2DS/8WLP?TRA;E'(,@G*EQA(R#MYL<Y93]C!E1+I.+TC@0E'67UI7$.$^<M!
M1E-#QZ1R SOO>RFR\GB1;?;:*%/'A"DW!4=;\4%_M@%F3&O#Z>(K?61Q9:13
MMPFO&0X/1FO!GPLZ-IT1KO]SH'=4[Q -%4NG;,G,J8ZBPZNG5V(_MX3->;=7
M/ Z/5AQC!XTBH%/SNNLP<;&8G9KTX#.+(T:_(K_4!\]&NMF=YTR1-)MDA)UF
M?;>[S_4Z?ADO>T)40A!\5E?7[L2'L(4XN< MUF"O:\(^MMF'II8USE.&CN_T
MCK'EF[&[OH.]+4L/N9 7Y&F_$'6#PM3D1E@#"7*GV0O^*>^-S29T+ZK/$D@5
ME"; !U&R(GA*@KFU#;*@N&\=63*PN1$B 3<JG,B?C J34"VGNL^]"]8I4YU_
MTF9O>X*4R#,(Q-3^0&!$3$,72-E' "-JM^\A ,X0:)K:J6\F, XXPP"\)ZCC
MY"17>UME[660FO.;L8*> EOMJ()+Z]HZR/+:1+U3BP$[MQC9R0P2" 7I@AQH
M,R-X!X6B]5A"]]&&0IR,[FU*H'QP)AK"6+-U0<0A;&]%5EUB##;GK:W-IWW7
M^6[CU:GT;Z\+G)JE&9:)T,SJB#YG<SK(=*1 *]2:AJ[-*_H2#75ZF>5));GJ
MYRN.IF-/XAV/OGKVRW^?0=GG)Y4_!W1Z3?LUM(A0BY=U!F:8JVR=C* $\/C=
MR.+S>IM(#5+$MX??B06.'QMMAR0\:L]VOT_\9CN^L;-FM'TT>GJ.!@TY[G'2
M7W[S/=73@.J%+]UY.E$(-Z!"G:EVAK,&-,PI20>+O?_SUEA]PV()"[9247@I
M*O7:Z.:LTL95/0/BG2ZJ,S6X6Z(G$O2VMB,]SJ/;^/254)DBB5_A%,G^IFLC
M*9 L4Z%Y3)K\OLDDWDF4?E>)&:MQ]=%@'(,DCXJ^QK:_'ZU3_ZOIAT\@[4LQ
MISA4M>UOZX.#=]<DLMAYP0C"RQI#S4M=-RH=C^)U8\.2K;N<E_!DX<OW[N%:
MVH%S4(OUK]6%]LME5%=X&=6G$#X;<X&D/,BU8D'FFS./?T2BO5@/&)AT9)N.
MGW0>(P,C#NSMBIU1.C8Z+_XP8G:_(M2Z!7OM=9+%D?1AJ%<<JCLT*?-/[Q"P
M0,\47:*B->?^9,%9O1DH6C:606%D'?EJ8O]\/4:+OMQROI8W_+H-'JEXV;*E
ML3D]*FZG3]=S)6PW3RI$_&%HDJ_RD05[>V?FM\G0I++/7]0M?O]=,OIRH,ON
M [+_;7]_V.6U'[UK'AWNL^6(4[^"1^OJD.7^_B^;Q:)9@XQ&8*1GB[*^=PXK
M!C=J.?RW+E?M^4R6V)7:-FJD@HZ"E80[A',G-^!5(,UBMZ;8_[/']!S<$SEV
MNHQC1#H:"#ED+@^X]9BKLOM2S)50"I020W:1%D#IE1=+:A %]YAK181J0M+0
ME_#+G.VFEO[C1[6""J(MO(7^/+V_M5 C+I9;E]I,ZC_WQEZ)UJSR?&GMF"H8
M.:AN@FL+?>(OXT0/#=^BY!M#\XWMEW_T+M,FH?G+T[85Q0WM#?J0VHB0-1QP
MC5P7,0Q<V_]/A$/-;N+DSNW WJ\P1;4=IX&=$(Y?^Q^L3S%\D+_Q1>\8WWMT
MSP@'CZ;9FNDZ!S<D39.3WAJ5WEKG:O.]WV>.S.#%=Z6KE^UQD/734TF1S<SI
M?3VP:*"G<LV[VM'(V#3H]J.J,YH55L?_6'L:^%Q$M&PY>*)Z.[ADR.]>\*I'
M]=I4]7?:J;]G:+ER1EO[A5#7/SYYU+TFA\R\%+;<$G9%JL7=0[5-5)GR!^W=
MZZX?K=9:/4<R59 JV3^N_?N\M5[_Z'OK5HL+'>OKF$4MW<'OL,\!@V7+3M76
MYD_Q[Q_9PDV%=?(:,@YMQ\F\+E1%?;+2R3TZD7/<K>GF=57A4S4/7QXU?7FN
MN^ZDE<H+R6O+<N'R%^Z_S=%7299*.W [[+GTW8YTM_A/'E&P,#[HI"R2N 8D
M'O!3\G:X*9L#F;TL0@'_2]AYD_?T)K155N4XJ! Q1;O6?%"5V)81Y3RKU2E!
M[+]Z[>/,?L=3FH]?:CPR&KOJ\/?S@Y(W+@C\M-)%B\_72W2A3S#"#Q5@0E#9
M]\O^*0$T+L6RB^RRHH[D[5CO1Y;5<$-]+"2=D.W3"43R4*UZ>9WMB.HOU=E=
MAH6DHZR#A23H]^'V4UG01%0*A) S^@HPN*"%HPUSD*Q5GA[;CI.+_\3U!A"E
M% 4@U;W@2D.&'14=PK!5%=9]BXY ('2T?#\B#Q66$2K<@TSL2EZ83;RJQ=B-
MN='NB2DNE1QC*RFDG95SR#^9I_G&VU=,2FYXW]._SAPNZOZK-A2O[GRCJ-R>
MJ#GF+P_<M=!T3]<9T,>[,;A76'S0";9>2JCWF6YQTC$SSX9:E&GPT1LI%[3?
MWUMY2;GU.H<@/!J>2'#-"Y(JU92M-@SZ%-MO>:_2BEN_.?PGJH_BF?4ABPD1
M 5(OCA,52UM'-XE*?)#M&++,J;%40&#-B8O"DEDU.=W995+^?XJ[4RZ/7:09
M$!Z=G_?L.-^+FLJ^I__M_E>M72B>NJH+>_^VKN%-+B@F=_J*UGR$0IGEW<.4
M<U)B'/-</NAB^P4^"$0D ^,8%\IRKNZU':C8S96P&DQ ]P_G&>+Z.<VG6H59
MZP,5,SDC3=_I/Z[RDI6X[05I^LZ_BA(KNT8BSP?_BIG5YAC,C-8%BSNT_W*T
M'^36\D&O&Y4P3)?P#]9\D$6"]0JT_\,]_9(WB_=?K%Q,D??YJ'SNY'BGG,HS
MQ:=R*KG993FQA7R0$W8U7HUW/S::M\<+PZZ"U&[@MO<MTX%]2#ZHMXK,#"O8
M5>CC@](@?-#]?7S040?(]GG(+X(ME9>ZVP 9U-H!N_!!SR.7>'O[^:#ND5UL
M%1_TT>0G'[3G,Q_$1.S:8?XWBZ]X?:.8KS)XS+Q4LT UE?+45#$C;1@@E\0+
MDQ"8A^IMGQ<TTN)0/D@,_*5(*:_:0B6LQ_^5A;:C2JVMI%.?MF,O8R%?0UF$
M/:A0U1:FK%5:57?ZKP.[84"\H!K+!=68B]K;Y6G\8*WCY-<.[8:/Q%NOZR9,
M8UA+UFQP^JF&^W]<4JHD"5R>_29Q15:8LWO=)\CI;_D?/Q:]_\6TB:UF_=_
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M@U2*H$*D7<RM#=*:_O](3,&.EJW@-3*5MT?@"KOE]U,:!:WEM9]=,-,$\,;
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M0O*I#Q:CLO!"[S='C8H68\V4WV_$%[?KIG_6[CB!$G)D9Y-8W^S9?4EZO.,
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MJ&K/R[&]UY)0%(^Z=<3S_5==R6T-,YF'W#"Z?_Y$B(5@(!C43YVBWRZ:\AY
M(S=F/4G":,.FPC9:CD"4(WH?>S;E3+J.NB'5MG,@\T0<"TJA+FP(-7-SA]/)
MW&[G!SR1D1V0$DZ)\3MY,6P!K_^3SAV' <9X2P<L$(3T_HG[I>HJH('H6XXD
MKL)LJ>Z9'<<@;@"IJ_4P'[1E\O&-V]?RWY2=#?EO\K@E%TJF%JP"%HS2S:'
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M0:*I!QO<S0<=:9.[9S!]'UF)ZKO4-(D66NP*'@U)BQ),L!L-:7J;ZH^7T1[
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M9"(OJ_*A3N$.M##.]CR1?)L%Z7YOG,SU,Z6>I;CUW'[:!-,N-<X^>J8RD^*
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MY2KV38G)B(0%*6C;2O!9\A*L*#=<EN?1B_AEQQ*61/$KTP,LR,@.TJ1RG,?
M,P*#>BC3N0 MULK]+WRSSDN<N*1<U]\7GR>>N(P0CD!#97E11PT@KUN!?YL
M[HLTI*"NZ$B1Q<PB)AK'D((V]8D'P7+X;VSJ7GN1QLQ?1WBK^8P8?,^O#3)0
MCCB<] (_.?'J-'YZUFQ"!FXJ3V;QRQ>)DOR'&OC9%8&J1/N>%#3CE=)T>3W
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M.\'M1"9D>MN5JIIOV'?[8V'+H_^2K_[R2_!_\PK_;UY*TN%_ U!+ P04
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M/TTD8P->C/*L^4LDD*0XM'G:N+!IKL:I]H5?H"QUTV-RT7?Q[/)4Y@K<265
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M*R1MRH>SF&VJ395)U6\?HC]AFP8VXY105,MK3&7*^^+BLFTHSCYZ,V8^Z1!
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M4^ Z/U>?R.(>2!WZ9 PD+.P,SB<WAP+?\&_I=,T!>0)9<C=Z<H5;XL5,C^Z
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M>CX3C?HY)^+K(*8;/$=0+8!^[<'7;B1>43MP#PB7H_^!%(@'FL-/""']O?<
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M+*E^<U-7P7]+^O-BPS WGE'3[=)!6D7%< )ST!5[%UR/RD*L3_:?((;5D/>
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M^K/R4;$AO+_(<C8 \U #G6L'3B*[ )WS@3:UT:9/_-BK_?"1(6@1*&*NNL3
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MOA9WH%FH9&H8&G!^*#.I@1B.1'- >"_N 40'773=3\L$[9XI'%5IIJJW#+L
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M*4H2-".'MLH)<2-I):7/1@@*66)S"Z=SR!&@TZPY*%AX@H_U407<F<HUX !
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MD,#7MZPH,'@(WAFF.U8D6F\H@")RN/,1/O<3>ZX3[&72C&GNOBB_%*7\&G*
M"B;;E"^NH9Q>*-WUP*54__"_GB[FHCW2\,>2RY#A=%R-6#_$51G1$96?(AC[
MJ2VM0OVY!T?[XT # Z!=;5T><%Y[-G(/""F26_M)<P^@ZF*Q8T:HDGV5NFA
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M=_F5LM)B>XU-_F'P=:^F_R"U@1TR=K&1_<A[+^3\U]I<8M^?4G[KH8FYJ>5
M>#QH_4"-7+.\P AV86<!7=7XHQ*6O22_1_7;GDG20"R1"^=<8<-30H<-%Y@2
MSQ.!C(B]D :QM&?.$7(T>5/Q^Z$5+897DRE=0OZLA>0-/#ZJL;)L^E[HQ-<L
ML>);9A3&6.]+O---!9>"%M\#8H JA2A=%<.83J6!9\??"_XM[C6M^-_-KE1[
M.Y6^)JEN(76T],Q5_5F1/%7ECTS@D:AE$.4L\XUW K7KBY<TS>YM^QJ)!D$Z
MM/\+%U\5%@7W?3U*22M*ETIW=XDH," @'4-W2'>.H'0,C<( (C'2@@Q#(SET
M#-TP"$C/2 W]O;^+[^9_<6[.<Z[V/FN=M?9S]A:J5L7Y5=HR_@HT0/DD6(U<
M*;06_@#7_^>M:W\7LMZ1.;/"E?HZ$U)^NJU1"=Q(;'3&,!!"$>ZUY$*]-"V.
M\%(W8U6CH!H)_&:7@ZIJ;_'S-. +!Y*WX;6;]P <%]$!<AV<S."!P CU!"AR
MY1EA:;X6!Z4,]^6^'-PHQ%-60"E72V3G!?(T3&W]K+=-ZY):I'92#,!81(<3
MK_]',9)*=:I?W=9)K<AU-I4(8)_YP1O$V.Q:_ER#3DI%=F2QI1M#\LI*=B$]
M(J.7!\RFY7^.ZVQ(1RT*C C8?O"[N@<<RG<2@IT\'P7M;*QUWQ+UY7JFU)QQ
MPT/7&/:+#6=OG-":>=Y$D&^@><7IR6&.$:W0LF7J9/=2FLFEY,DF2WE!P]B>
MC8CFN!Y-1CT-[;QRO:3OI7JK)]NMNI]R1.'YZ9-+.HRRZ!JVREQ;X6 CN^08
M$G!+,ID$+4-:2<DF>RGP[4FH=(U1KOG0/]0.P;5)1%=N;708AS^:];/QN25Y
M,X;C>H^%.LNOE:Y-&7U+$VH [YP2QY:5&"$F]@":;DYN#.K;B[N' XL^'^Y&
M+"EP3S9T:&[D;HOEA38HR=UBK;#)'<G>_M6KXVA6EB I$.J%NL2H,P[X-2;2
M6K#:TQ8>Q6=2([Y+IN4I.,?9CE@W[ANGP7WZ;47:(>PL!M+"K%G.21P_4=YP
MMS-*1%,C>W2(1!]YP)E5=-(8+G0Z,5E_J(C7F^P-\,?FNVK%<6?7;W#ZYX9S
M-ZQ8KB[6!Z?A8"2842)9S:AC0?$K+"@4S1)O1Y\-IIH?T!ZGZ"BR\\IQ_AE]
MDJO\@M_DTQ[WCW6% D$ZYXT=5<^E]_5W]N4=;A("[8>(J="P#R?\_34V*GQ=
M5=TF5T$_3.W*IZ^F=P=A1K[I.@6\@;HN#0W&?\.B[P$$/K<5XE8+H/.\*;\5
MSJ&QDQY69OG'"$NQIE^)'JTE+F:EHTT9NME.FEG-T]4T!"WIQ,I-05LBC=)V
MD,H@MPW8X1RFIPN,+Z@H%[1F@O.5BF/'&G>%4I(F*E'L%Y WHTH1=_-8]K+0
MX)1V]V"GT!_*A!"\\,:%P[ M?&0,CJ\?3*3(?P_H>MUF2!G7I@(SW_U/1=ZQ
MNXKBU'JNPJ)"JWF7!&##,!VTZ<4OERN'-I&EN+:^R!*"A/\$5\D\N$M:D?,.
M*;O3 TXLI/0;#>TJ$,7),$??2(;$W0,^P[H*N&<$JVAFCV:YJ1P045SP_*VF
MZ&=J M..]%+B"[491?D&6>:.NE]52),'LV2%AUUD3S&X7+V>KNY\G96F\L%*
MB=%1W;+E_%/P+[M_4 1ISI_+,4VKIYG>V19QYU]37DH[Q?6@F8%=AH9%EJ(7
MC.6Z6F]#%0PS-'9VP#UK3]SNZ&\188'70BY6S!+CR6"2,&JT'!A_C_5QFZD"
MM&7F/RQ6<R#2/C1TA=DX'Z=[<Z;]*"G]^H:]]R67]6W9U!W/(FB_D]*]@V 9
MEZ@R6=W!9A9DASY.N'EAW^BVOH:_L(L((4QV*C:O:X$7FG4$"S[5GQ;8S :Y
M:.AL=699I8")P/:W1!LZA\$VUZIW4U?3>C<\6,_D-EVT>X2%8'>01&;+7$V>
M00+ZNB? 1U/>[ U#YK\?,<)F"EVO&)5K5R'$_Z5%O7.]P)*MKAU'A(DW[KEC
MRS'\J44N 0&XL9"AA"1N-;#:D37#OJ$.'SCKVIN;@)L=F9?&Y()A/=M4$0PU
M?!GT9SS<!GV&Y8:3995[?[M'N0Y+AZ OIUPEVP^RTA5J7G1O[&EMBBZ.(LE5
MR/DC1-X7U@4MIB;F)?/+!]M6&/HD; %A'N[\8$4KS'M*'-=J_C7#?@0KKA#3
MBKR*[5V+ C^[L:DQ6=Q;G'X_7!LDU[O/=0ZU9,!R+ NFNNI9FN15S@OETCD4
MH'DXFV)D'/Q9"#!7&'%=NF+>=-NW]._L !^W $+C[%'$M;M"=R2,V+4[XBV2
M(.-UQ*$+^J_\:P^!#VT.E)$=CUW2+'5LT-(/IB1 UZ-N/7-B2[L,>>HGU9^E
MX@EZ,>K_1.O_S)VH;(2N/ K*T+4B18(I/X\A?A22=Y5'G.CJ4-RVZ)>\!0O=
M-+1K*0W0BOJ)T7)EI)W?\)GY<_"]AI:C<C\S-^<62E8?%;(O33D6PW,50R7Z
MT'5T)+XCF":XGO"%/>P1[ZZ%_H^IK9Q?WKIZ1MO>[84B%UQ19XX)TNL<KYZL
M0_*NBW[ZF/AF%!"QY5[D"V[+O)%Z:[?&4#;[KYCB$QN[]*M;"'O&DO3Z3?E&
M7I:IGHZ$D=)JM-YO*M]_46(IQBZZRV24GJYU,W] =HU&AMT;NN=13?2 G6AV
MZ.9'WY2@VBDV[7R3)C3/9-7B3,NS[QEWSDU=XK.M%TH2E48^O99Y!:Q:Y485
M&\5FTF-:(,N$*P[? RN2NPE6JK87^$8A4BEP[Y(WDDJQ_G(]U;B0;;%9QFHB
M$]"*HCH0C_N% 7*HXMMVJP@6MC$>O_$$=]$E>4<W+7CT60O]'X*/<L5GT?I?
M:VKE"8).G&6_L6^[A<HEO]3\=?(&:T>T7GO8<_[QJ;W'L_Z]]S*VDNF!.^RG
M,G_^[*!J\^X!$H9)">-?]=FVNH/?-E*?+DL)R^"OK\\5\D.$JF6449E/+YK+
M9\NUC<,%B+D77#P:EX^*(/TV%98^T<X+BD!=F/3B$D)/T'QV#<07"IN+$,4H
MEM\6EN,0&]N5L# ##$&J4?/<#=^SR?V0UP-2S[%6D3!]M XY[X/K%;U0OO9G
M@UF:6WKVK'1N5X5?_&5>\L]>_.SU8(\"XGL\&0"4Z(D'DTF.: <(:LB5,32&
MR6U6N_4PI._ELB!"__<SVTIQV!3E 8.WF3)G2]:++;7(-_[;#!N44Z@:,+6/
M3\WR.#I&KE%&B";K:V"3S],PM>B1H6%8T#ZPH1'501>F.KVJFK*FA8N'@=3<
M7=;)M?=\\85Q4Z^C!%YN?*F-\WL+M#1LH?9NUCDZ>:1#';.=Q#,34P\;.WQV
M>=$Q-@LO*)GU$]EM8]^,[?=I'I7CUGI]%*#K!C(5DF.EW9=*W);W-J5^O_6I
MQYMOY^(KH^;3R-^+?4"DM;=Y^!;RR[$(G/<:D9,SD@6APY-F SC]8/8&K<I/
MM:FLZSS=CZ#&&D&"-T9#WV8K(5QH"TR:4G@VJ;J"G\T><E3?Y03B"<QDPVSX
MK\*W6I$*;?T\M/($8R5<D)?:IIH?R*<?/Y(>?Y[$HBI[8J4#M*E4UH!.>10V
M;-5O ]=6[@$T!;F%0L:T1OD:J;T(K:E._I*\I,-P-G?_QIQP?V%_S1@@=7JP
MB0<'>OZAD]< (&D]=*=H)]5MU+_\NU/: I0\6@>?C&8E;6(G!>I]5H/4;=--
M9=?-](#A!0@3#XZ;!UZ==)TDZX$EEN78*-1W9&20].NG?ZZPH\%?(?SE0!Z.
M$C/M*].^A9HKD)9\\K\1[9?^WXZO$9Q7-P) Y(FJ>:KI.+VW5P)X%S:>+M*/
M>L4LDC8FL]FI$!Q\;COQEFX-P=$CS*A&/G#D)3)&N:_=G#- #FGQF3]$^H[C
MR>P?FG+N,JBR\VV1G,3\EMXIU/%$KFU[&Q;I^?R"HRS.C3KRY?P5EPCW^D]V
M4/M:GK\N_5\$1[Y(3#7Q>)[1#[RY*RL*_N.X7%4Y :"#4MSZ#M+3'V:DS) /
MFE,U,47V2__!]CE!K;/ZCPWWYPJ@<XEZ4CL0,>-M#=T6UVL-J87*E>#B99A9
MM?IU_9:+\VI+K<JW7W."X@O$J?$")6Q^<H&'>+P!"'[B&Z3TRU9NSKI9_C\I
MTNA.1*&?K\LO80$F'S)AO?7Z=6N XI$T9]LH9.@;2UNJ@I?L';P(UMR0[^&^
M]?)5PE@ \^\_Z0D]2S %Q:S=K4O$M%YQ\F?O+_1FT-T9\QG^E8S/):7/4"%K
MI8?S5^:*3D:9/-,^+J@DJKF ZL#=?S<ZXK@,3#V?IHM_\L.%U<7GAZ%N$-'0
M0&F;Z72[L5<#3'BH#L-I@?/T5N7%7A_AA2.1N>=1CP[4/I#<"M>U-W9&;^&K
MF[BWIKR25'_$^R9Q#+T,R?MYH#[>?P^@;6/I8)Q;=/,;RZ_H%_P09S#/-2PQ
M]#3R\[O#_B YKZ"''6J]@H^[D)0Z"D,_7IOP8GVJ=OF:%$$^<LY0]DO+P:;=
M4L@L3E\Q7UV%4C9YNO+85S+3P"!#,[01U9@;H386Z,5CS*]X-&OY9>BG3:O,
M^(_GE80/(MD?@_W!ZY%@C%%UX!UQ];6^B^(C7'3M\#V +/[Z=5".^F2'\*[9
MIX9S%@*LQ7HX5P^8KJ&(;5-;5F!3A3*I+=I@IDW68V5Z>5<7:!5S%27,3NW>
M\9G5=W<I*<2V.:_)+I<V(0C1][)^D&7Y5PPCR0\D/0 O,E7TU66\TDASS<.I
MC*V_I[]N[LXCL.EVF[+>&9[9NV9[NQVM[?S@EAI(Q=+>+(U9?OYA-JQLC^:G
ME<M5_N?)95,K4\LW.33&C<:/Q7I\G8+=Q<66EE\?,Z4-E(+HJBONWH#79PIQ
MO)*UUWH1XXMS!T!L(@C>@FN]YOEKIHSSK; T[VT93^EX."Z".C41M&97./I?
MOU:,$H6E!8@^[/;A\:OFEB4?Q =P3:_U$$FJ*F!SCAH[!6$O9?19:&?=.:D[
MN]#B;'0!FU%\3^!]]7^GK!'_YIIP_ 67&W;CTTRLK/S!?UAMG8O>.]IVB"*5
M<[8-WF[-=J%G2^!SM@W]6I(V0T57XOC<1YQ16GI]??T:W9E7B)-!GE^SUH%O
MGH[W60(PD#@/O_%D*_C(G!5!&)&GJ_UU0/[Z3@P?)+&##Y&[" K^4#IUP^/5
MPI$\\ 5(45FSJ EX8?]<XY!K)<+68["3#?>_>MK.?SI+[4;E/RG.<=LJ'XZ6
M$PCWO <XK46V[,1U4$>,Y3ID"A'F<47[W0)?S(4YB5,<",$]&=R,J%:!/YJ5
M)6-IOCK17LD'>0Z&*[Y\N!$L#?#G\O5Y< YH?$7?133;',Y+ATYX0I(U7U%A
M^KGMY8&1GFBI)._! /E/\M\B$J=$W4H/QS<M(AA]2EQF\SS]@:0/GADE&/!K
M!&6,?HUG)US]ADWA.Y96XRW/<S1Y1X"_O#=;=D?+,4B3V:C3<6&T]B8,_,3Q
MV4\Z,USNE$YVLDE_>KUO1GO-L;^3N^+,^ ]%HB ?+=9N1. )&U*Q6:(SM2J:
M%/2ZQ^5%NX_Z;A>^_^"Y/LEPP-Z:+.=$<=E4?\B.?,HC-NSWQS]?9V.^JWB2
M"+1#79_QZ_8F,MB5#QJ2:4IJJP*Y)(K*7H]H:D1^_7)DK>VE$+GY38$0, IV
M0/_,K&_+$1AT45O4%N=1K?=QUZ\/&Y6\T##6OOC;J/8OPC_9I&4^]U^B7J7L
M+XVC29_VZ@NAW=;3;)I*AEZ#S-VTC[[]#P;I-PMU2OW.NR7)"WY0:(L"F7'T
M[ 4^TN-X355?<AZ^)!KZEO[-'Z]\?,)ZIE;&3I5;> 3$5L[%]9%8<87(\LPT
M@N9]DAVI*:CT\"1026J459QCY,P<9;8$ G5ZOD#D ,K?_2.E6BW^2"CSA^E"
MYI2N1MOH!&23I;K>RS-V)#V@726]GP9"];'# DP\QG3>.3&'BTTX%:*^-&;7
MO9[M,]*$<3JF95ZFOO2I?C)F:KYAXM/$E;3=/M3D-%"2N[TW ]<<=L^^C7!"
M\IX]W=HV:ET1R#N9*Q_M&.<P5,8_6E:7__F<INM R\64/.X9=(L^_IP\I> 2
MUO!B74Q8+W7 \#L=P<+)% %(+D6;0IJKU#SA43=[8I2=11D_5%TLF\PWZT#[
MT5D-G^+X$?B/GX9(_O>S1-?S@*D9IK6XFC*#H SB)VG_NI1WG/N)\)V*SO]S
MN*'KX#A6Z@Z),'&<+Z;2$**&@Z A]+M&!>0S6].V*&/-N>JC[*,Y7= "/4'K
MPJ62LXZH\G;#:VX5C5>*16AA*F)OR@$'3T'5+ MHY+^[ V[V3TB\?2LNW-6.
M'JJ&;?JT\NN!/RECDV#5<14L??5H:'NA]^>XISQ_?9>W)^]QBH$-NPY4&#\!
M=R24&\.261JH#6VNX&Z$%H-CL#,NX4:=7Z^$""<KK1[OHK9@4JI^SD;>R>IO
M1\U<#4KR98YJMFMF8R^JT9V4@YN4"X<"?J,>QSV=SQ3IG&O1[L9]= U8EE]H
M3V871=I6#"+I3$L;J7MM+A6PRMT6G$W4'$FO.P_B%04HY4"B<L#T]C@"[+[%
MC"='*_@SZV.]D]?-C3.'^(O\'4*@P:-:PD_2\^=<[].I:1\OJ9'9'#WOXLFJ
MO!;ZCQL,[YX%R:WO]!Q_9FT@+,1R[O2IH-M(L4+H#DBYA6M.[EPWXY=[0&#Q
M@;MAX)Z1L<!YO-2BC'.J%HN3H]VUQ?7SB-%[0-UXOQPK)$(&9^=9$_8&PY52
M*WY+^_M*,;]BM:96,MJS=+A\?J^ KRF=?<J:,NSDK;^[?.3A+$T&K_8>MMQ.
M=-GL/,A\MK,NB6?*Q(DK(F3O68>,]/ *-#\OP+SU--CHMQ/TA=GWT?HAZ1^V
MO&-E1%)%JH_]J7G&&HH'52F$73-^:;T=D@4"W7$OK@DC5I7HE!S_>U/#5#':
MI56F;JR/PDQ#P\,W1TG^=9-KG#+;CNLVYNE-;B>I<$\=UGC8N5MI(+Z8K1 :
MB?!^*JRY!ZQ_ZV#&Y/1?*\W[:F%4X9NLA$&*4UU&9IY]HXZ: H[CVAAX=GNP
MI^^'<X:RDFH7!]]J'N>J9Q%[#Q3:")95?]_4;:XM3.DWWGYGW$!\NB%VJ]!<
MASS9+^#&<L56U:Z["[H3' MD,S.<Z$<N DN:A6ORR=.STT._RD^3LYQ8(=;@
M9!U4N+5K*=?59U-M^J$89%\NI =R,$X2)M1<WSAEW0I^""P;DY?YX38GS$^K
MNUN_U*8)QE,.)$?UT%F;_PH-4\BTA445/!7UKY@JAI336Y:JMS34AGCLKVXE
M,6?E:A^N%6UYJSW9,M6A]TKQC"Q6V9=)EC4QM\WG]3=D,)2QT+@;^^Z5M*';
M[&LJUQ<0>).-B:ZINQ:\,9SQ5+)W9T,;]X%CC1:I!,ZRZ\""WS_4<.;2251[
M"P@)?4\88_SZU/]F=JA_SKFIN_^:[YJX%6O467Q#@Z%,[A )NNBY2NFX(HJF
M[>N@:0I])"[--H.&IS@VM:0RYNVW\WB\<WI/\KPIF[@L1>P1E3$V>>,>P(+3
M-)F08 2M/>DKP260JVDU-$W2FPV;M+:W(*X)$3!3"]#/Y-/X8@3H$_O8^1S_
MNU9E.E;#N^%<(4@8Z:;+C056JO=J#7)'$#1E@5&*C>##N1EA_5I*SPLQ=\.]
MBPKELUI'Y>+I;YWL'/[,6PV6$""T7GA0EYIGRV$+\6QXUBW!&8:?8@@SRA-Z
MNBR]_8I'N7U7]=I7,D\S3MP+OSM]X5<( 2]JBA3I.DH6J59Q&0E6N8XE)-U5
MTU50Y5<'_6@H2)E5VT_\>Y73#\8)</T^CKX'$&5TK<K@U##&&SXW^K@N[W,^
MG2<X,147]V,;S %#5:[?K]T=DVFRU&45!^&F+_S>>7G^JS$=N.:I>X!=X9(O
M&ME72#FXL4+4&\!*NMK3=<>#58ML>^%2ZMK!U((2Y,C_5C]SV+#/AW5S"W8/
MP#_W6GWUG?OP4&UQQ+;NO[O]W:H1>6!S#\#OQE'+WS%,=M#@[- 0Y!H%KO U
MSLT.DZ@Q63ISEL^HB[H;#]WD&\>IO2UO0YV:>KKKOYOV9_P8MI5<]>X[)^FE
MVO6SNY6U>G#/>.+[,+^)".$@-JT6C-.! CH+BXPMQ;)4?POO1#<F!W/,Q1Q6
MBVO9HEYL*E'OOR.8+?K@D'.PF#^OSO*^;^[2I]'T"Y;=^^L*OQ$;D16EGM_/
M"N@>SY!!22:ZF/G#]ZQCUG"IT"4=%(<*9<^S?^8Y>\]$@LP#!85$J_4^.U:$
MFHDO<_!F)'HUY-4G??^&VE*_J?A/\DS=,/\78>0=B03ZEF]]IO&S/&,@IF<C
MH 'Y=GI]AD'+YT*U8,ZP94X^1LBA=H61CF-:H&:6KTMR5_"%6IAQ7P%I]*'%
MLW)BJM22BP$ 16\64CXRI2?2T@UF88'+,9N5-Z[5]/6NQ"%[&=82X'RM@V9N
MK:VCOOK-T]NAV2[LZ3+?T]=_3S2DL#UYKM_8'JC5' .P,R>';5O+V J+I?B(
M35!FSIW> Q[8^V.:/4@*7IP87L$9LI9K@T=+]?1:9Z0"%D%RA[Z7^[WR1])M
M0Z5,+_W^ZE::Y7._IDFR(=80T9Z<8:^J12W.7['V(#:H^&6C3+4)U?#MH#L3
M!2)GHZ%&A:%Y#N2<$ZJB:OBL5MJBE# NP@X#S-&/UJBV(\*II&A\:VC _M1I
MK6DS]FU-?JDJ:@3(^RQ_.)U">4S.-RH8J2UBY9+\XV>C5[VVD<M^:>V<IX6"
M3NSP3[!%Y=#4CMM*2,F2BRE[U4KU]]:]0-JKUK<</432*6II%B8VU%$U))M9
M=/L%-Q0\:@G;*9/O,KXIB4>]M;ZD>O'^$=[S%$K+8#KJD[[CY,-9H/XA>?38
M1A-!JJ1&^6YJ\1H],N+MKC_(&/6M:>IH?EPT)LV>9XM'9OF;]29=U_,0:ZRE
MOSQ*I&JZI-;^2C 7;*'SO;('E_ ^P<?\O*-<RB-AKAV-0-U>**3!&Z2$U3A^
M\S33>VD#TSG]5\:EO;[Y$$7\II2<D>!\_L-?P)].[,6#?@/FKAE$9:6P'.I-
M_WJ5#'5>.'MC@&3(1GMC$)6Z;7,R!TL8/\QC1Q4O0'F19)VB#3I'*=E)93XR
M&0>C,G]7UU;]W)>QCHTDB=:&?,Z32WZN.;JO8KDNAW^ZY/O,6_J^OG;W4;_\
M@G0SI-]XUHCH($I?WT/"%KK)ZXX*3"FW)+=0K%NH2;K:V6!-NI' DFKE;*@A
MR94[-RBG&H;SP  <]IM;+7V8P+1]&DBK$=$1[] ^VT&S;*G!VAM!WTDK[*)J
M/!VF1) Y,?(K;!RKTIW[O^:SIVLX.<LH4K=;$;UMQF&>V1.-63_01/UN!/O$
MF80 2^5&NRMAR@EP^KFB:901D(K^9;J(?@]BW":<^O>U0)4Q+W94["B=(]?X
M21]_W#$\JFP>@V0DIJ /Q#L&!L-P)ST!G61AWH'6J4BY/DPMDK;N!3BV0*RU
M*1"!Z2^O=BAC)9.W\Y>?781J0#R_N2'.&?JJW)ZZD@I2[U8UPC\X,%:(>F3$
MBN6>)_OZJAZ9UVVYF)KQ6<(XZ"9&?YYBX"[EMMP(#MU2PMU2!UHW7RF^QI4_
MQW:;S*]/&]XB959BR%*(I?%C7@\-9W3I*>-5>R,0SVN .UP%[;Y(G9,DQQ8P
ME9EK"V=M!<[7%%6&\G>G.=_K,9CR>%PR2RN9+AY(,T:]HFZ4W-9L^)4KT:'7
M0^\MU^?FUCCVS]Q$[/90C(^7SWR78LDY$W1SN,^VW%!C!EHJO=(_R+[8:FR1
M?[<O5DL<^2<O <*;5/WL*#_#Q:.Q?G)A;>R"=ZA;SR?P8;1JB._ #=&[LZZJ
MUY,UQSEDBN84(=?W *6[=HO< ^;H1XRQ"@I$7$JW'W9V33]H-IX,RCNQIDBC
M.SP0_6=@<-[BA6)!-+4V:5YU5>W2L):_"D?8BTV9#W?@?#WR7USTFZP_*L4>
MOU__% /8K#N]FGG]8'W6S!V,U)\H/5I<M%*;"ZRYIGDP0#3M6'I2$CO,PR8H
MTD\=*W.@2O$?<-:@TX^ 8Z%VK-42B2)(Z;\4TGAU8TJ6KD[UDPH7P-.3A?PZ
M#V^O[#JC@"4KPW)44(0=]=4 R><L[^>\A$<E'@ "#QTF?WD#\-.&1_!C8E<-
M&U/!AM0+R1ICOQCZ@*,WULKOD^@:(RS:"5UK"I@I,+^?O5>67C\;9[NR0X2<
M/CH)_<"6099SWC_T"M?SD-';[B.@2X:-^>?;< I3ZB]_%@K>+44LK279'Z4W
ME H:K&S.;2#T]_Z1V?^8+>4>+._630B1&-JB=E.0#$'L^YZHZ</Y^%3WX3G;
M[.?/O;XQ/4F-^,1$X09I_5A'$"+HHZ =K+A,H?2-L/U3_RR?4Y5KP+9H&6/\
M>WO1=!K@0RB+]T> PJ,=Z'9;_3'W5SRW)QE(&?D+)M^E4K"0M^!#$]ZL(HYC
M?NV7A18\4^XJFNX.'DZ= 6"@/1U"5CC)P<F?+]@*4:B&<)H^5UH@/?^!*[JF
MC)@J?-3IJO0YMV0Q,+'C&:YBV#A4PB<7'"_/PU=:F'##6M7/_'8,@E9X<%3E
M<9@7DABO%S0W:E![_ODVOT,Z3.FV5)'H1@!WB:DU:9SK8+VQP!A]VJPE=37*
M(+;+T9D]>-&<CGI%_$_(K[*_&>7/9W2[55;DX(O_4?X#$2[((M4NX ,MB3K_
M Q+C_(//CU<M5_::QLXLVM"='4(XL:D[$D#N1<\](/$>@-%>8\$E /WO ;&(
MG$YZQ8<@5XI^S4Z"_9R'E'$=3U&Y+HQ>F(LXFJ7>@!:_"',1T/[<K[Y_Q#1*
M@UAO8^BABR\PP$A'2_(>H* S[97%P=TGY3_4&G#<T0&[X*=XI5@LKJ^+>(F@
MYR4&_'FHJCY>A\XWUW3XV\G6]'_+)%'>/ ]TE?$WFKN01;M=5Y">3U9_\OY3
M1O1WJ[DYA\WW  )>W-=2YY";J\*NPH6<]^TX1LRX]O6;=)=Q\$;Y[!R:-N$0
M/8AP@SP.JF?\0C!$/NY0!GH>]O#3K0!X_8<5O ]R('']Z+^T-/0MG/BSQH+)
M)3(QR9&>_*Z6\E@]Y(;GPP6BY:IU',3P5TO3DRS_1D0FSP#^?S'2WS-NZ2^M
M< O)'^R<@8]J7QC/"MFO;5NX+F;=CIX7BUTF33G4'&W+?1U(2TI_;%HO"#78
M>TUY"%3;$:"^J9FY27(=Y?59*QN^GNS<\V]QY90Z7.I_[9ON#<7;"\:3V6&:
MVQ7J%B)7V1A_^#>U0:3OA^OLCL&T@R&AXPF3)IFJ2NR+%_9:)79>"L89EY/?
MNSUJ_(;?BYWG?;%YX"7Z3^.[(I@(W_]OJ.\5 A_H1"8Y^9UWP<1L,46T9SB>
MFE8^8-#WH\E'+T*^JXS?51W10H=,BWZ9.]E=$S"N_SB(2[NJ;*.LKHTMT/]O
M!#,Z1=; D/?9GVJK_$$KJX#W0!!*Z^:\+E@7%L;]-DF]3YDK8()6+H:">"?I
M3F+6M(2WB1O/&M#SX^Q(B24?MUG@T2_I0+F2R$)D*S8?<@^ [C +-&BH.PA\
ME!D.E"'ZM"2S>YA[^S"&ZTE*WURMI4].0Z^V=]GQH,9)0)+#+ _'5,"4$E'_
M*J_\N7: IF5'>';,TN.T?MT8:A*$>?8X'=,?ZS/VT(3!W##A88*NK5B; O7=
M*>:XG;0!B6<7 DR>G\:"QM3W(98=38<I?#(EIB_)6\EZ?0LSG::=8!_L69:-
M%[?JO/5:-5>,YD9N[@&2Q;(SN5':*)_62;-1EV)9N=#2$VJ@FL%[$PS>$=V?
M5!ES^P<K+=-2[]*&_GWIX7M.K'C2K*IL\U&=Y-'S)&CDP,.?G&TT1;9)[JS!
MT/5L+F8*V8=*YH$5HJY_Z]ILAOF@:)76;7HZRPC=98@O],3BC+<[O:TD!^;;
M:^IO-L.A_6Q+[[O&WI-,A)F?I672%,(K74L>TL[P>NC1$ ^23%C:5N$CGLQ%
MNZ</9)OF!?" NHF)(FA<__!48J"F]-SZ337#$<?DFR9\5KN/PK!TN1"&= 6+
MQ)\I00Z.AH-J='BL7@'+;0^!EQ#+[VT:EU"%7V5ET$O[9;M*7="0V2YUZ9IF
M-:N.=H$Q: $5^_,'3%M0]%/RG[S&!+D[DKX5#?$"XUS,D/MW*K6MOA@ODK3M
ME^5D&CN\0\1DHJ\,;>61F[21I9A2J*Q'G;L"(L'CT/W8GUQ:6M2YQ7VE7JL4
M9/F&NB31I 7N7'/&R)/%]2NXU_@!DVW',HYQHYH+.'6C=?TZZ%H#WH%A[?Y4
MMHBS4^U(WFS$%6'S#+/_!#%VM00N:JB4NRR^R_Z%:T6"G9PLA%Y/IL]B^-PD
MB^Y>86=&[P'QM?Y"CUT#_^V%W+56N,J.55:,M@ ER(T-6W+_76T-LEWDB(Z,
M!/(>Q*?9&23;X:%]W[T34S.+YN'A-=-"./@'H$+6BF\FSYL%&1HU&0S=#(."
M#3.@/+6)V1J2/LG?I]S%;R5"6&&=%/< >ZOH#H7_K,,KG*<)'&?H%HS-Z^V0
MQ&K7^J-!6K(\\KK@C?:G9O$U<$;-_?[/W2V**3F/55R>B@>2E/2.*"/_ZAPH
MHV_QSFUO"VXX,&)=BGRS[O[A@9;U]X#H.@QZOV>T?*^E\]/9TZU[0+<GYAY@
MB$*[Q1W['0KRN8U::9GND%,6,JC^DV,+,[[F!G>][B )([W-NA'Z[R0:EM0&
M1K,R!/D"<9_6-5EC%SU[VJ7>H]J$-JJ=M<(W1E7>S96F,X;&>_IK?BUJ;FD[
M\=P0^N42Q6ESZ;M9B..^!QP"P0[KY%R_96N2,4UAG&\@/2PO,$;)S(6)@FBG
MY@3&=E]#QZ:[R7;)G&3FX[1$,6$]6I+'/JA[@'%]FP"9 095'9]-K_<G6D**
M_RUO!XHBI%)96R1'RO@9:LJ<UX')IN_+C:,5B!5$E*;)L+?A%AK\OI+.*)9]
MVG:3ST)&V4S[=+'C7,DZ@O;&',>(M3LO!7]D_<6QTAD=(1&DB=[IU8G+A?6O
MN 'SG^,^413^T/3=."8U^4M[V2)%8WNZ,$QPXZATZI<KG35E?;UC=1L7(1D$
MVU2+N7'"0GIG67@A75?1:Y P1HS@T.H4\!=6/$>_)W"3K]K.*-T_898'WQ%K
M&SZA,5#TG9M"*55IX=-Y"@Y^S7^'DI4Z?+N1J/6TOT/QYPS\T.R.DGYIV7(W
MY&PG3B]@UN-,I_[+T=T4^U3#SY94_+P 3*N;)_KBT/3:/,P?UXKV3&(X[JME
M_1MR$5<Z3;6ZUMTA-"=NP:<\<5P<ZKVQ0C/&^">%F=UT #/XM!(HZBVYD=M#
MW+]0Y6JHWW.BBA"%ESIS'$UIMFS!S[04LI'%7W#4:M30J?),)Y_B V%Q9^/>
M[<>FN5DLZFT&W'HY+XOBH)>E*H]+EI]J&D%F(4LLF^M.O9V+R//@B3N6,%6<
MW(90;,?+.?AX@J785!AAI\N</'75;DL4SF/_-XMT"ZI'F6#DPBQL0H6"9M3]
MB*,EFG2 &&.U^.N\J1E'V(+H.08$Z71;2K#2A,GX;QRJSB%#+,9*2Y=N9&.
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M;.QO?ZJU]#8@PDJ19N2765IY=/X[8P34S,M]]$0\W764LR:[5DOPPBTIME_
M\>&KUC@]^H5(OJ3U/S^/"]H[>=?#0%C# ]O4%<M+&WV?DO3H5PE[@9AE'BY
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M'9E%0+^.]+CVIR@ E\1)8;3$X(O.Z09$:DY]<RN<[!M$?M%"RYVM ?QOY.Y
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M0[]VK0HB0X$&>O%*,VFXBY&BJ=Z><-?HU=20S]LKY:@3BZL+X<ZU&1%SW9U
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MB>V/@!,#KXX#U]+AC3RKUA!*5C4%%8;^Y&6 98TRR\^GP<KC]1_34O92$K]
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M7!Z%5R?^*)O?FX44XV;$1;2+7;O27QM'7A&<UNC2N]%DX_9_9O!- \[52:2
M;2<O,,#Y!6\;^47H<[9][^P5AJ!NX1J_]Y?A3<E\C4MQVH3:0WDQ;6"EJ'63
M6"]1%Y\GQ,H4T /]Y?#CT/K.$.X1FK *+M[HY@TJT?(^NF-:,;J]EIO<_5-2
M&#OYZ__-F^2Z),;@'PO]2]"NCX#0<*)>9-+=#";W#XM%;532_+5X[=@,BC>U
MJB,)34J'>4%B\ZRJ-47L=&678ZCK[0P+3Z>QJ71L)>P#'KXF&EI.)[!-"W@$
M4$N19.@Q?M/]:_L(>&^V\>W%EY>2(TT/!"%,/Y?QG(<<(GZ%]8L:%E!CQ>_.
M=5;+*C[%MG93HL.2&WY^]PCX? UO*:#BK%?WG;+;*%,M.5@S4*\^]5B Q7[-
M@>EH;-FVI]7.!R??/;OG<HZ3BX)J%5!.ME#Y^&=STL05>_"EO[7=MJHC"HJB
MD7[ +6-BT>46BIDUQ4JYK<_M%DK^C>N,ZKVQ663<&EFFU:6Z]$Z@O61[\<,5
MMBG 2LV@)=5X+H.T\'"N&_D'](?,,+:6WX*/@"UKXHU7M;7L(@]9?=\R',RI
M+-=U<_XC-(RJ)/];HOK^".\XFUS/++4J]5HNL^WXJ^ TY_#RGIIXB:9[7*SJ
M_8<+?2[05,E^R6G\7EM?:OO8Q[P0"7KW&1G/Z0 ;BIS*]_2KDN,5 BQMYNT$
M3R2F/9ZS)O<!=A&MU ^KEY(!5W?!><XN98:G_#BF%T1/<P]9KW[9T/PCWR5>
M?O=]:(,J$-C<W.D[OP<1Y] URBIE\G<65#]3TC#GZ_!MU HZE$/@]LLQHA60
M,S]NMAIY#MI+T> HG<X%*$T9Q ^=(-^OKBZA60"=+^/8*XE)YBU*96#_'"N(
MG#F^..6[-\<LD4&]$$FG#LC+M0&3Y4@H"3("JA@8",^B:HSK[YAD?$7547+0
M7':4S&+Q&^Z0N7-6RZLCC/><&=M*.>41T/?F.^(1$/$( &N]0,V8(@VR=O00
M>:'0X.JCLW*U>M4:9[RB+% P\5'%W\2#\^OO8[$?Q_8Y[#X.B-PEE*$H@S];
M-#T"$M&!.W(T$#Y-9' TE"D F5,#]0S,U]A>FK_../O49;<3^-XNP<65Q_MM
M0GR:@:J4QG=JOF^A\R'L?&-FB@;J--*L]'_7],W>EGU?[="H%"M!;P4&J0\2
ML?8K,P&CW(W%EI'-=7KL(54%$^;Q#U4ZJ9+)"7\28$DB:6="*\';U3W/EH($
MV$/0S[;I+$B@AJC66HOC._OTZM^XFO\HUD&S(4I3<B;:F^'%(M:3DM\F]+#
M0F!D\N5/SDNCY<FMQN P--N].!1G'@K>#HZ79>Q$;#:LGD? @Z/,WW1)-OD;
MQD(9G-RMO7-<WV>ZUCM>@=*_?#LM:7KWL4/R*74FJO1F]U]5QCGGXJ-8$(WR
M#QD82;1<UA!M:1PZ ,[C0_SDR)=OUR+\Y_'LUOO*W[2^T><DUBG]=]F&5)0"
M+,H\@VF"5>I?8T#7.FMP=C39\G8KFFQD>^:,Y5[A"$/[;_^-P[EX/_FD);;E
M<&5S:EKCH [% ZZM][K_14PM#FVWD4Z5B2 BQ6F*E9G)L*9FCK<Y=RHLR]77
MEOKOQ5N5YB 1K%F9^ZV"L2XW#8FCF-P[)E38/Y9-DNR#HRHY#L<:N\ E$>54
M.M627NM6AFMJ[EGQH.E+30Y5"0XNX8R_,<C>G>"A)%I%XK,(1&.?@22Y+&][
M?1C\64M^W2^4\M!9?I]PG#M#<Y?VFZ_6S?,3"K[VQ[?<Q6HTQ=SBQ"NW0Q@Z
MU-3.F1C\-DF6X1]"(O9O8VJ#QG;P)[+B BFO=#$+2>IMB 5.F!*/=7-\#&:%
M=?=,G=DFOH[AXBSO$?#,ZR'=%4TN37@OAJ(R067L],8%XZ,5'9!4[Y +JWGA
M71R(.+A8-#QTD^DEBDIA;DG*QKUTT%5V'D0V5MHZ(2TG1?^7WERD&Q%\:L@>
MQ>>*QD)TZJ*<$"V7MP,8A@CP'U<R5,.A3D.$EYE=$0_WW-8QJ3-?&4VF+MN/
MUDAY\CJL(RCGU!5QI4,<S5C<:$.5+)M>GV9'Y.MB&XW+^5*:;E<N6<5*)U#!
M/>X\2PP**[XMC!GN2M &(AQ8F7;7)0R!XZ9:>^+IE#X/4(.H?3U:<(X=6@HO
M,60 JB5Z%5X4]?X6ZV-"\5Z$!&]G2;:>,=U+6T!%EWK84![#--)F]T)&4($6
MQ$QD%Q-B8)B1^>?JI1P ,J+2@!D+<3*QB'%QX;T&&S,9+M2.Y-&GTV0H!G$G
MH;@LSL"[6N10&V348+LT$Y)%&W6X<Y^$#ZE@<-7H:6E!W'PNTTR9*8'8-4U4
M!GQ;ZL?)'=!*^0A<GC6&G6\8[&,M[_=$[9P9ZOLL>)-YNWM[!<UZ^TK-B"SN
MS2=<FIJJ2JD,;>K&^[6O34L9MCHRDOPC>_!OFB@Y2;(0]V%_6\_4DUR5@UZJ
M@J^Z(_8K-2!UHLO]C.7!,IWL"_-4CH5,\U6P:ODX97S:>GW"K?+5M!-!1:1^
MV!CRU[=#BCK&Z=PW/:]+EQQ,FO2<)5/9I234B ICP:U4FF.=PIB3AYI>T QU
MT*8%E30)DF5PDZ )P1B!6-X1"\.00.CZ7X+2,6_-N 9Z:)I@QN??E[TMEU<C
M;AHK--P#/6*3>2J:Y(US/WH.0RP4Z:H7TV^=^>7WZ-W>[683N$GYU #[@Q@N
M#7#T-#I]ZE??[]G:[(^4[DX%G$>5?* 4M?M4,]?EO;?M\#E7X&^ X8FI7"KW
M&S+"]STNRI#?W5N^JCP4-3#0 GI-8II%3;  IT3KU+B46E&&='/S6!TA:2:+
M#7OVCE];'^\WOSA6TDCO9;54@/59&H;L<_S>DU"YNZWR&0H7*:&]BF$)ZR?L
MGU-"GJ ED=/^3^;MQ;$=/T=J"EQ>S;3_.$D:2;R^XR7.3><3WEM,J^[F*4!=
MO-QU-@B+H/7L.KS0Q+<+= 6GULZ#OEU07P[OSGR;&-%HPRT--@_F[&MK)EE7
M.:$=C8YCMOK!%DGT[E2=@.C="-9\:^:3UB+_[>L3C/N?<_=8@5]CPG$$ AEO
MDI?>%@W?I"F)&\&U;W.27DCFRH?^HO@#,?4L+GG;>GZ<Z=,-Z^S-"R2.J0S7
M4'=Q^M34Z5IH!FP?-AWBE-?KNZ*>=/;;^0;S]Z:V^R$^_+R&73L&+A\5^@Z+
MX;U-:]AOJ929N6Z3 )J21*!C]4':@5S3&$^3Z&7WI*I3"N0*J-1@*M_B#%/U
M8ZT?H6AR'V-M>%UI2%+N).9AW(WN\/XC2O>&15?4%U?K]6IPHU;+7VO1J7TS
MIH:)F"!@RC[9U9LKDHS^;M%] _+%S9KBP/-C](;8WTABWMKK3#7A8XYAMZ!3
M-J\LD]\Y*1?-B7$:=:UIR_^I3[YMGIOL2XU->V'B:_'UTC@[MS/T"\XS?TZ4
M#RNB2S+K:3JI::39C^=[!G]#SV1B=W/S]Y9S\=4GE&9A)],M32 I$JSU 9XN
M0^V)@_#,56,2FTP: A<#1>NJL$F:Z"@Y!:V2X]61B"Z9G8O_]6ZC1;C&S+WF
MFV1$;PT7<C>P\:4+^X?QSE>7%C: ^''%X:MK8\*JW/6=$;4TNY9?JV-#PX&:
MBS;CM8&,W2Z8JYOU3B[/$NP_!^%\5%2^K#!?TTI@3<?1@5[B'7SF1\>;"))W
M?(2+^[M"3Y(X?B25?O1[T17Q*GDA=MN<AOGGQ81?T727$9G[PVI\3#U9=DXU
MS @KTF,@?\A_$D."E)EPMM%$I$=?"%\\=THV!BVW^%.6^X(*QUQ*S^:/Y_N<
MD;\$VJY8<US4!#FNGE\NKO!?7^!#PE00S=68TGQ0IDM.L$?*T6ID:?&6L=&Q
MP!36&)VQN>F[M%;0ZR$6%J#&:\$RRR%C?(\N%U)D/.AC=H7F^(N/+CJ-2QMF
MM;7EQXOC^VHI7]NSK2INA2/3>K[XG!T=0%/@BOS"$2S<=CPD+WS FZB-W!]Y
M&>U]+,A:1Y3=SHG9TUN%QOG"*Q$9"U6QCL0B6A<(Z;G$G"=KPB0'@6/%4Y*4
MM),ICSJ(^D>D?6.IL3(8DNE34KWJ!'/F<O"X*3QP\"/34B]).AW&'%/G D'B
M>P&=T:(3V#JLR:YW3S58=!#=UPN^&$;DFYB@-'NC4Y% .KUY/C+YAHQ/S N'
M35W-H?#5L7.ME81!Y,C3]60R%3RSK1SW2+LI\US:5'U-#D6ME2GE3:=-P<8-
M&1'TM:0@-RM'@/]XO%_W066 2$#/O/N&LW[N0D,%S@^[5RV2$4?+WSWG>_QM
M,L=G>7AY151M/FB]V5"U-"KPD, -R\WI=&L'N-<'>G.K$6!-<O<I/1&?V?ST
M.2F]5D9+4\@$0]M@%D''Z/Y4^:N'JL/?]W^LU@,E:N-*\,?1'6)^4HY;ZCV]
MAP>:@E4VTT=3',(87/NEUK^^K7"?3(KP %H-6)2X=%+*NNT-PY,9:?^KWTN4
MG1E,#;NR#ZBQ470' 7VND]>#.,]7H(_@RZZ(OQ-G9B-K[.7BQX&@ZOE/S'9V
MT*2O@!?9+6Z"XC0GH[LTOT%'_+.QI;:PY58@G^Z>0$J>D)K'84H3F,]?\YYW
M]W6]$.F[4<SY'*2/%4 L@=5K<NY%T3++?0U6.]%X]\7XO_P-PN-R3JL2C<$0
M/=MM!ZS\"[/>\"X6^JM<?1N!HB>O7SZW;'L6^\5SE)5DY/UG_2!91[(CQF<9
M7B<.QC7Q+XL&R.,]60K_Q+NX:;GDR8..+Z7-J.&!V=E4W,R.G2Y% 26;)]?2
MTC-/S+W<&BOQ+L<K#K[.NV]>]L+SX)#(#,0F\4LT"?)BT-TRY!<J$U]#5L67
M*FWX*7+&,_1=__J,2U_4Q@?++C+SYAT-@[7A+:(NB=HITI*-YMX;Q?M**D+O
MXF07T[1A:92.Q,*VVR\:FIK.'P@+E-0.4<XV,(F7*VY#(/>T"L^3UF)#2&5N
MRM6S@UV@B#.L]0 +V^%UNYGLB/9/-!]/"::2M];7/=#;T]WS1CV S@W&4 \<
M< 73"Q0JT)9I;=BU,BJ+W&RMDCH%S('L*IO32UKJKR =U&HHVB8&;N6E\MW2
MTZ]%D/$44.KP;;<(F#%NM!5<M#9=T-7D/7S]BCXT@-&/GJB]1LAXWJ:E/5-1
MV5S00];T*MX6W;6;OV?I@-/D-?/R&QL)QY=G[]JG?S[G6<9E:)<S=P;]/5S<
M%R@F^*5Q20+K4Y:0)AG#"DN4=*#8UZ\ZU*EJ_^<'9JEI=TZE/CZS?6_GOJ_K
M[SYOJ5[DW>*IWK>)8A+\LKZW.Y\HP\6EG<&<:&"17:8RUO>&32X _V<R[+UT
MG@Z7NF%"M4-K@G:#:1K P8F%1?QH1'N-04MM_]PNHR;:IIDM7&E ?.#MH.MO
MO(M?MOZTRW@Z:E6F=N>='"9+SO<RHB?U&Y'QV:<I<U.L+;Y IU_SC:UBHNDZ
M_+)Z'[E;KAH _Q4,C^E2[\38V4[/Z9$*?(3,][<$"<T2T";>G[V1;Q%C$6AT
M,OD<S^HI(9XF'D?^5:4ZC6??LI8BW08>-P'DVI#9CE3_H JMB\F*4W+3J[3Y
M4MDD),#R?P!30*R_8OS<BN6\+^-ET74I[2\E2YTG5V^SW[&0,D3J<V[[^ 2D
MFPGI@ \G!QZ&:47."J0=DTF^31/E6NUNJ?\ P3[G(ZE3VU2G5A*5%PU4US4W
M>+3T>FGYH_-WQ/H_]@>(-9TF97,FF:A=66[;L206\A59<*!_K8RC!>W)]JY6
MX;<I<$X1T#@=TX&#TQR"<C\,=![]\<M)6U^)'B6-<$2307N[*LLCW4(<O&ZY
M#1LJKM<'&00,GFO!;F-V;RPC%2"1@=AUY]..._-?..K*#IRA4<9*K22E&335
MZD4[/I=-KYG@U(>SQ6+<%R^SJJ5*$59-7:4(+71]EV///BEI2:GX$\3VX50U
MK:'4X&.<H8MN"1SN^48(. V03Q7YD:GP7&0VTGH-HRRLS#CWR1U]!CH/UA\0
MQB;0]>B(RLFBW@(ZG"QNK<>N>OMG&#T_*._##S=PP=SJ!C'"^8HX^@Q]:_,O
M'K"*&+RW%**C&I1G3JI)+VBIT5."FOM)2G*2OU;=[G]!^%E:I#"8Q-2]^>&G
MRMM\LZDDJD4KZ-J,5)+=-(\^U ;"[*3D!SS@\X)]/6O]&C_@RE8M^Q!^UH3U
M_P"&I;<GZGX9^%\\=J_SG[\AV*89BV1@#.[@\'N$/\;?PIECTK_2V_X,T]!.
MG?\ !,_XHZV^DR64GB/]J/QM)_:DMI+ VN0:7X4\(6,4RW#@+=QV3K-9 H2(
M98Y8FPPK^5,1I)):)MW2VVN?O=#6+;6O3RUV7:RT_ _KGHI!T_%OYFEK$V"B
MBB@ HHHH 0]/Q7^8KXL_X*)_#F?XN?L*?MC?#6UN-0M[SQA^S7\8-)LVTNW2
M[U&2[/@76;NVM[*TD^2XN+N>VCM$C;;GSSM8.1G[4KE/&N@KXH\,>(_#C 8\
M0^'->T&0&0PHT6LZ5=Z>0\B R( 9U^>/YT!9U!95! /\$F%6$HC=#&\:F)T(
M(9'C&UU8,,A@X;((^4_+SC)ZO3LNZ D\+D=.WU!_SWKL/C/\-]7^#_QB^*_P
MI\2P1V_B;X:_$[Q[X"UR*%I# FJ>%/$FJ:)=?9WN%CG>W:2P9X7E197A,;R(
MK2#/&6&1)$>PZ_Y[U=-RC.,H[Q=U\M6OFKHY*RYH5(K6\9)>KND_D]?D>Y_#
M/76T#Q=X>U4,8A9:E:&209RUO([).O&,IY;C<.3D$D]!7ZD:@HN;>X2/:T8,
M=W T8R'AGC,D;#KE2#U SG'/K^06E2J)3ER"JY4_-D$]-OH<8/'I7ZG?#+5W
M\1> _"6J.Q\V6P_LNZ5FR6>PD:V5F')/RJI;.>J\]J_JCP*QRQ&!S'))U4Z=
M=RQ48/5)N%1\K5[MWZK378_"?%3 RE'"XY1M*%'V56=NM%Q49/U3>GR;+<$<
MC*@8 98KP"3@=,>]7;^!'M+/<&'SW"@ \Y0A5Z@]=QS[XQCFIW1O-$!4JT<D
M@)'WL*<DE@>",@]>I^4]J2[28+:9&Y"S84(22&R"RCD@]V)'N?4?=3PD(59T
MG%7C4G#E=DM)R6[M9:[O;J?C.%Q_[QKGO[R7,GZ:I;Z/MKH=/\,OBAX\_9\^
M(?@_XL?#YM%A\6^&?[1ETN37=$M?$.FK_:%J]C<B;3;Y7@D9[=R$DP)$8!D8
M$8KSSX__ !Q^,/[1VM6'B+XO>+)_$M_HNER:/HD5O:6FCV-EI7FM*EHMIIL-
MNDR@LJB6Y,T[*B%Y&<%CW'B"-9TCLX@',5K$TA4+N3]VK.2Q^Z"&&"#^\8@*
M6;('GEUHBF#IN3Y@' #+PVP@.!MW9SE0=Q +8*@D85\OQ%2,H^UC3A9^[&:;
M?D[26B7D?4X'&9=5QD<=C</AZ^,H4XQIXBI23ERI^[&\TW=/6][/8^5IO"<L
M<4SM"$68(9!&A!>,,XC3S$ E14! 4JP.,\DELT)M%FGCBMIKBZDMK?<+>T=Y
MGMK8R,)&-K [-%:2LXR\MNB22Y;S&?)S]/7?A[_17949E4#+(I8;>.05SE4;
M[S?=3.6VJ=U9D'ADE68P%T!*%Q%O4M@GY77<&) )!4D$ $$#!KYZID=5.]&W
M,G=SE*_-K=Z73\M?F?0SX@IMQJ0G1A4@FH6A[D(N]E"*=XR2W:^UJEO?Y\B\
M%QW6Y6APK;F=0#&C(P"D,HP' SG;G)!/7/'?1^&-8UR"RL]2U75-5@T^".VM
M$O+NZNDAMK=(D@M_])>5GBB6)5C1RRJ 550NT#W'2O!UO(UJQ3;)(\"A.&'E
M2H98Y6^\J)(J$+*Y56PR[MP93ZGIG@\":2=XO)16DCB'EJ@D:)5=E"@??*GA
M<;V*.J[FBD"ZX3A^5.&(E3JU:%.NG4Q,*.(5-5I+9-IVY7=W33OH<N+XNG0H
MQISJ3Q"JI7E4O.I!6?O4VT^6HG\,UM=]SPOP]X!B:4VTEO(JK%'CY0G?C.5Q
M@YX  XZ'KCV)?AU%8I%Y%LRJ(T=L@$G/5B=O7TYP .03S7J5KH$3B&3R_*(E
M6-F.T$R 96([<,3@$@$8"J9,;%+5U,MC*R",1R.@B)\P X\M)!$Q+'C;YKJ@
M(R&9E"Y)&?2HY#K3E&G3C3Y$DW4@[6;^)JUWK=L^-QV>U:[;IU)OI&/++G<4
MW;G>G-+5WEU5CSW1- "0H%3&&P!@<8'7('H<<<$\<\UZ;I>F*#&H0\8W=L'@
M#'R]<$^N*-+L=WEQK&<9+%PF$51&7&Z4@(C,BDJC,KL.BG(SV%G;B%\ 8828
M=2-KH4+*0RD*ZY(!7</F7:R[E*D_18+#2A.*3C*,4TY1>BLK6LG?IW/D,=F%
M6O>HI2Y59.,DXN][:7[._P#P"1-/5%50.FUNHSD<X^[ZCD"I!:]#MZ?A_(#\
M/>MEHPP5E.<X)QQTQP<@9Z$'FE\LG^$<#/;I7O*=DE;;KW/ J\U2$VW]K3TL
MS%EC4H0%&\=0<X^8@#WS@_A6Y\/[^S\.^/? GB'4)##IVB>./"^LZG<>6\WV
M?3M(UVQOKZX^SQY:Z$=K;RNUK@_: #"HW,I%-U&3P.8PIX'+9']._3WKI_A]
MH^D:]\0/ .A^(8+J?0-<\:>%]&UF.PE2"];2]5UNRL+X6<SY2"X>WG=$F(#1
MD[D/F!*=7$1CA:\)*:4J4TY1:YHIK=:7OZ?(\^&'FZ]"I!QE*%2$E3DM)M-^
MZVW97ZW36A]61?'CX&Z/XV\<ZUH_AWP#92VO@?59/A]K8^&T<FH^(O&WC+X=
M_%+3?&T'C:]EWS^(]/UGQ%K7A*":SU,M8F00RV<<4*LAW--^+/[,-U\.T\)Z
M!KGPJ\#:OXATC2[CQ';^./A7K7B7X>/=P>-/!/BC7](M?"]G#<:;8W+:=:^)
MH_#[V\<::;>RVUO#)"K1NF%JO[)GPX.N:QK]_P"+O&^@?"NXN/B78Z3&NEZ-
M?^+[;QA\&=.\:>)/'O@NXL[JYAB63P[H_AGPU+I5TXC$R^([:Z)N$A2)J>D_
ML6?#S5]5M6O?$?Q4TO2["RT%I+VX\-Z==:=\2G\8_#VU\<Z+/\,]1TFWU)[C
M2]&6YMM'\6ZS_96L:=I=S##J]YLCO)H+7\YK5LEC"JY8W,E5]I)3C:JXJ]TN
M6VFCO?RZ'Z'A)9Q*O3]EA,OY:4(-IP@I/FT]Z6SVT.VTKXN?LLWNDZ%X0B7X
M?6O@W1OB9X;\0V?A?X@^"]0U(W&E1?#;Q#X:M1_PD4>FZEJ6CZ7HNN3:/%-!
M/::C9V0>VNI-&U&S2=:=\+_&7P8\#?&3]I34;+Q;X1T+PSK.F^&/#7PRE\2Z
M=X_T30;WPQ=^*M,\1^,I=.;X<0V'B32]1BCL8-,T:RM&TN+58T0W-I;03+'#
MS5Q^Q[X#TM?"$?B#Q9XHTKQCKFLOX TS2=+T_P .SZ;%KVF:1XY\2SZ]XTU4
M:K<Q3II]IX0TO3GL?#<=D!%K"7 :,V#I/>^+W[._@KP+\1O@EID'BBY\7V?C
M3XI:-X"\8:7=V-W86,VD)=^'C?\ B'1O$%E;V8ET#68=5N+**.)[Z[M;6W&H
MC5)IHS&.:%/*GSTEC,PE&7[[G2K+W8I2DK;Z\K2??6SU/TC*ZF/JQ]I4HX.G
M*G*"G3M#HXW2::6R[-:GLOBCXP_#SQR-1\8^%_C_ .)OAKHUKXD^*-S/X*TW
MP]K$/C+QOJ/B35[BVT/Q/$8[=_#^IQW_ (0FM=!\1#Q%=2W>F:3H4TCP76HS
MQ>=RWQQ_:&^&7BGX;>-= _X1.^UG0M1^)WA^R3PKI?B_Q'H]QXF^'W@#P(=*
M\)>(]*U'6X]8TKX?1#6(5;5M'\.:=IW]JVK0BZW3MYIV;O\ 9>^''A+1?%-W
MK'B/5]9\.>&-4N]2L?%G@Z/2[BX\=Z"OAW3]8TT^#)+N]^PW'A;^UM1CTNSU
M.[MQJ;W>E-J%VD-U:-:CLM=_8;\*)X+N=0UOQ7XUB@TKQC"+BYTW0+74K35O
M#.IZ]K.C6\^GV.EP:C/ YBTZPNKS4;BYOYM/N+A6DTR2V14?>G_J]3J4W+$9
MBY5(<U.5JB5.;^TTUK:-UIKK8^JQM/,)823P]' N52GS-25.T8;]4N9WLK+U
M/"/@S\=?V;_"DGPY^#+3:CHWAKP!\2/AE\3#\1];EO[OP+\2_B3HM_J&J^*=
M9N_!>G:'_P )%HW]GVUY8^!(M8&HO'+X=\.3_9+2%[V*5=[Q=\3OA)\1? GC
MCP6GQI\!^'O%3>#=-\,:KK:V/Q=UCX?WUUK_ ,4;SXE^,](\+ZUXJBUWQY+<
M:A9:=X<TV>WU>YB\/229@T1+.WCNUDXCX@?L;^&_ OAKQOXZU/QUK,-SX2T?
M7_&NAZ?!;V>I)IR>'KGPW:Z5X2\6G3M+\JR\3^*H]9DO+9Y;[2!#I=MI4VI:
M&]]<75O'UWP__8KT/7?@]X7^*%[K/C:/4O$<&D^/-<T72]!T75-8U_3-?\)>
M(M<T_2? MG;0JFH:M<-HZ:78Q75U>7EY<W%[>M96\VEBUE^#SV&5PS.-:AB,
M94NXJ]3G<7))W?(]==+O;[CQL%6S&IE]>A5H82*C*<6Z:A&6DDK\W9[K?0^'
M=/THBUG4R2SB&0+'.056<9YE$;KF.)A]S=Z\8P170Z)&(;M$9543)CC/5"2N
M#GN>O'3ISS7Z$6'[-?PGA\!>$YIXOB'X=N;R7QK!XJU_QAI=HE[I4EEXI\%:
M=X>L;W2+"ZCLM(\1:*OB60W]JMRYU'3X;J^DLX7B%NTY_9H^'G@FT\3:5X\O
M=>UGQ%X5T+QD/$U]X2CM)AX=\4>'O^$(NO$DEO<&]FM]4TOPI8>(;H6B)&@O
MT@NKUR(8F*30S6A[-^Y5T:^P^C\H_?V/D\1E>(YW:5-W4M.=7UOY]/QZ'S=X
M8=KNWG*Q1?Z.J1;PI)$^%Y.XE>0&XQSV[ ^DZ=HTMR8]V V %;"J 21G: .Q
MQG.>G8YSNW_PVLOA3KL?@^75/[>UJZL8=<U1BMI'!96&I3:E-X4-J\#2))/J
MOA5=)UW4K<DK;S:M''!+)Y15=#1;>2X)DC#L+=/*78C':0Q.22 H8XZ]< <U
M]AA9QEA:=:_*IKF47O9V^2\_^ ?.8C!NG6@JUN=2]I&,5SMQ3:W3:3NGOT/;
MOAY&#&FGWL #R1^1'*8AAG0$1$/Z,Q&<'W!!Z=MJ#6=Q$-/U&&&8VZ.8C+&D
MBJP;">6'#+N0C<I920>3FCP0+<6^E17BA+E(II(=WR_+#&SD,>A89SR>I&.E
M<SXKU!8FGGC=6*>9MVL.=K'@8(QP>N<'H#VK/!5IPQ-2JI:-N,5U23:O?S7D
M>MF5+#U\OP5.G3YJGM+RCI>#<7=M6Z_Y]S@-7L)A<7>H2!L*W[M&X1AM +$<
M$%N2%4@#/RX& /-M6O+>ZFDLH9F+&*)%M@<D2-PK[>3TSN.<9(K5U'QG<:@]
MQ9&-]A4)O4L0'7J,CJ0.A]#Q7FGA/4K>Z\;VT$R[6C$P.\[BQRV QR02 RXW
M'/3N*^KCC:[H.IS/]VE=)ZNZ;T?3;K?<^/JY;&$W-TVE!WLU9N_GY;:K4Q=9
MLYM'G43+*&E4LIVA1\I)D !7DA>1[G!-=1X<\2I!!-;"/<\L:QRNJACLW*R$
ML<D$$ G! P,$#%=7\0=+BO1:S)DA(9%) +$,P(R3VW,""1CIR,$5X1;3OI=W
M*A8@ 9)9R.!V+9QCTSUZ8.>>C!XF5:E*K*:7/)0<7JTY:7Z?<8/"2DW-+E@W
M?EM=I=K[7W.K\12AKQR&4I)"5WK@8;(*%<Y&>S$_@!UKS+7;Z-;565MLJM]G
MDY.59#M,F1C"[AD\X )/ XKU2!8=5LY)V,88&%1]W.3)S^8')!P1UZUXQXKM
M4CU.95D &_<H)(C(#')(P 1T)/J![5Z.!QU)RG%Z>S=KN2]ZSMIV^=SNPN"C
M%^TNGHM.6VSNM;]MSG+RZG@LKF\C;RWNF9+DG.XN%PP [)(N%.02<<$=_+]0
M6ULUAGGB$GVR;%IIZ,Q$\V!^^G3.1;J1@D%1@$DD$@>OZSI_E)8V]Q+A)HED
MP<!'QWD)XVXYSVX)X%?/7B6\9]:OHH)HL6L#6UDT1;]P[@+(X; +(0Y'RD@$
M^F,^CC,QC.BHP;44G]I.[U;6G<^AR]*-67V8N-DWM>S3_$X?XEW<VJ^))[F[
MAB@ECTZPME\DJ1(D,9&XE2RD+G:". H4'GFO&+QEMW4KU!9<-C&&SGH,_B37
M>:K,US*22[/!;QP&1F)\PHSAV!8Y'*C.<9P,#'3SK46W%\')52QSV YSSZ=<
M#GVKQJ47B)T(1T<Z]%=[6FI-V5KZ1V\SY[%WAC:\4N;EDGII=1;]=^;\#E?$
M,RV^A>(9F)"QZ)?-D8/#H['.>,9X^E?E)?LYWESG)+C'3:^]ACIVZ^IK],/B
MIJ36'@#Q3<+\I>R%LK [68SLB[0P.[[I!(Z8X.,D5^96J2%RQZ%0%..N"A].
M.!D#TYK\V\>L4JF+RNFI>["A6;IZ-MJCR-IIZ7<;ZIZ>1^^>&$9/#5I\C]^I
M2FEO;V/+)I_XEHFM%U3.)U! "^-W*2 [0&.UD97(4E0<(6)YS@' )P#_ *M?
M_!JSX(O_  9_P1F_9\N-0@O[>3QSXS^,GCR"&_MQ;E+#6/'VI6.GR69!)NK"
M\L]*BO;6[;#2+<%, (!7^49J;L1<>6"\BAY%0)YA)1"PPIX)! .1\RXWK\RB
MO]G?_@CG\+F^#?\ P2__ &&/ $VG7&E7NE?LW_#K4M2T^[-P;NTU+Q3I*>*;
MZ&X^V*EU'(L^L./)EC00J0D8* &OY7Q#O*+[ZV[75S]ZP[O!NUKZV[7=[?*]
MOD?I:.GXM_,TM%%8FX4444 %%%% !3'&>1U SR,@[2" 3V.>A'/4\XI]'6@#
M_'U_X.,_V?7_ &>_^"P'[76CI:Q6>D?$WQ+HWQV\.(BE8);+XKZ19ZSJS0GD
M;X_$<.K6[A6;$A<ML;Y*_$VQ?D''W3MQGKT.?\_G7]V7_!Z1^R=!8>)/V6_V
MV]!T^XD?7[?6_P!GGXB7L;1R6D%QI0F\8_#^XDA,&Z.YN(9O$NGR7#3-OBM;
M>*-055J_A1MBL;QJ4&68;@1RIP>2.HSQC-5%M236CO;[]'^#:,)-J[6Z4O/O
MZ_D=OIB9>-\_ZQA'CLO&,Y[_ *5^B_[.]XUS\/V1HWS8:]?PQRALH%D6*4Q@
M8R#N)(]1D]\5^<FELPDY)"K\R@]%))P1Z'D?I7Z%?LV.C>"M81%"O%XARP7J
M/,BBRQ .!O /S8Y //''[_X$R5/BE4U)14L/4?(Y:R]R5[)N[WZ)_D?D_B:I
M5,B>J5\5"$KJ*O3E&;DKM:)RC'56UMKJ>_!F$]T.,[HB"1DJ6+;S@_W@ #]*
M]3^$>@:5XJ^./P6\+ZS81ZEH&O?%3X<>'-;TIWD2+5M(UOQ;I.G:GILKPE9E
MAO[.YFMY1$ROY<C;7!YKR^4*MZR*!R!E>,MM9\''?"X_G[UJV&H7VD:I8:MI
M]]/INLZ5?6FIZ5J%F\EM=6&I6$\=U8W]M<QE7@N+.>..>&52#'*@<'BOZ S/
M"*KB,=3A"U6<ZT8ZRBU*6B>C3CJT[]-[G\E0QD<#BTYJ\:%>\X-:RC"=W&SU
M=U962ZZ>?[$R?LC_  0GUO\ :T\3'PC-I/@;XGZ3$/V,Y[F]N)XO"VCZ=XQ\
M,V7Q-\1Z>ES=QQWQ^&FJZI_PKEKO4=T-MJPGAD7SE /SEX2_9)^&%A\-_C#X
MJ^)MY\2KW4M,TG]ISP]\/--T31--LTMO%GP3\9^$?"6C>*KF*\EAN+^+6CXB
MN5^P()+6)U9TB==C+\<ZOX^^(=UHVDVP\<^*_P"Q[71]>T73K0ZY?K;6FG^)
M]=/B#Q;86D:S*L%GXA\01P:UJ<415;W48X[V7,RAQH:W\>?CEKM];:QKOQC^
M)&J:M9Z;J>CVU_?^(;N:>#2O$%G;6.OZ?$P?8UEK-K:6L.I13HR7:VT4DP,J
M"2OE*?#F>4Z=2'MW[6I)N$G54K4_L17-)KHKWU>MWJ?82XIRA*%L'%7A%R^)
M>\]_M+7RT]$?>/C3_@GU\&_!'@9_B3XK^)/Q<MO"7A?1/BLWQ(T&#1/AY?>.
MXO$OPBT;P9J4UOI5K8WEWHWAN3Q /%<MI+H?B'4M1U[PZ;$-J:K=7!LK?RO]
MJ7]F7X+_  0_9WT/4_"DGCK6/B=-\?\ XD^$;SQ)K%KIEMHNL_#W3? O@OQK
MX3T>_M;.YG-OK.G:=XDLHY4L+5UN]8DU +)]CA4GY?\ $/QY^-WB[09M!\8_
M%SXA^)M%N#<K/I&J>(;N[TV>&^LXM-U%9K4O''+)J>GP6UGJ+R!I;R&"$7+R
M-$C#(O/B)XVU_2+S0]>\:>)]6TC5=<MO$][I&K:M=76GWGB.PL(M(T_6[BUF
M=XFU.TTJWMM-CN@!)]BMH('++$FW:CPYGD**C6Q[4DYMQ3HZIN5HWMJFG:R=
M[VL]$8/BO*ZC=.EA$IQ5W)*;O=7[M*WE_P  _:70?V2?@'XC?4/@ZVD?"Z/4
M_!W@K]G/PYK>MZ5X>\>Z'\8/"/Q%^(&H>!K'Q;XJUSQQKMS%X#UR);GQ!J%D
M?!NEP2^?+-I;V4)$5R$X+X5^$/!'Q8^*MAX9\0_LO>$_AU\'?"?Q;U72%\?P
M6_BG2?[#TKX?:3XE\3Z[X"^*VMW]U?7'CD^(= T.*^UZ^%BFM:%)/>-9LEGJ
M.GQM^?UU\=_C-X_MX-)\;_%GQ[XNTBSU2TO;>PUOQ)?RP0W6E0(FE7D:Q2QL
M=1TXJ/LDKLTUF4@DA>-TC8=AX@^._P :O%^HV:>+OBKXW\1"+1=9TRW>^\0W
M4AM]!UN :;X@L8R@AA9M9TT"QU5GC>ZOK0+!=7$L2@#S8<-9W'VM.MBW&%::
MC1:J*]).^ZYM4DM7+KHV;1XDP&*Q6&A3PBBJ%.3KWC)JK&/+=*Z>LKKX+/>Q
M]??&WX4> -8\"?"#4_"T?P)\-^/-<\.?$'X@>(/$_@#7-=\!_"7Q+\/--UA]
M%\)^&O"UKXXSJ6K?$;3M:@UB#4+>QL+.2>SEMK:);AI% ]/\/?L=^%Y/A1X2
M\.Z_HNAS_&1OB-\"=>\?ZQ8^.=,U7Q7X<\,?%7QF_A*[^&6H> [/4KBZ\+KX
M:\)W&EZSXGU+4[.&4>(M4M[""6.6T9U_.>V\6:M>WNF/>ZG?W:>#M'MK/PQ'
M<2-(NBV\6HO?PKHL;DQ6"OJDSZC*L>&-P6G!W&M33OB-XY\,^(]2\0Z!XU\2
M:)XLU>\CU;7O$=CJ5S;ZUK.IPWRZE!?ZEJ,+B:^N$O4COHIKAY'6Z1)UPZJU
M=\^'\RC06&I8Z<)0TE-34DW97LW)].S,JF?9?];G6^JQ5*RC&FXM<MF]+:/S
MU5_/HOU,U/X+? '6],3Q[HW@KX<ZUX3\-?$KX[:I<7OPXT+QOX4L%^%_PS^&
MFMW^E^#?%%GXQN?M_B?7Y?$=SX5O8?$6@VXTT&&;39)UOIUMF_*1(KF-ECO;
M=X+M5C\^&19HY(]T:A$DBN0+A7"KPTJC=&8U3<$)/?1?M!?'&;Q%9^+&^+_Q
M&NO%&GZ9>Z-8ZY)XENK>^T[2=4=)=2TNT,;F*.QU"2*-[Z(P?Z8R(]SO=01S
M>I^(O$7B[6;WQ'XNUB]U_P 1:I*DFI:MJ4YNKZ\:-?+B:XN"B>:RQ@)G' &.
M*]3)<JS3+JE2..KJO!).,N>+MS+3X7J]4G>[/$SG-LIS!4H82DJ5>#?M))2C
M&:U=FM(>[Y*[L5PA*C'7'"_R&:D*HH)5]S;2&7&,'\S_ )-..0AQ]\/QC[PY
MR/>J4Q>,;DP"22V[C=QSUQSQD\CIZU]*J52IK!2LM[+_ #1\_.UN56L][.^N
MW?L5V&2?O?@N>WUJ&5FB1'5RK1M&RM&[(X:.19D=)$*O&Z/&KHZ,KHZJZL"H
MJ<7@50LB*C$' V]?H<CD^_<U0DY(=1F,L%(&2HW9YXR.F<<\>N*J%*;E&#C)
MZ\KO%M=4[WC:WX'.HOFM9VOI:ZTUV:U^:9I^(/'?B[7M&\-^']4UNYN-&\*-
MJYT2Q7%N(;C7)_M&LZC>7%MY5SJFKZJPABO]4U":XO;BVMH;5Y3;J8SS$.N^
M(;!K(VGB3Q%9R::?)T>:WUW5HYM%MIV_TFWT8_;&72HKL,QN4TY+9)=\B;1
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M3XH%\M(K#1[&&PLT,  2-U@@12$^15"Q)E8@Q_ROO^#6C]EG7_V@_P#@JO\
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MJ5K=VK(&DG>6=$. L!.\8Y[@#' R3VZ#SJVO)E6:.60N'0L2RJ>#GC=C&..
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MH3"OD<]\U_[\HOEZ+/<)N_#KY3*3L%!*>C2 *3<,L3V[727$+L:42H1/0*$
M/-H.N3@O,Q*2L.$E)"'(O9&ZH<3<^"KZ/@^93Y-_#>#I5QQ7W/%U=1R(2W7.
MW?YGO+TT\=I.+&O2:*9HJNC2EZF97>4\ C" 65Q,T5M\T3)!:SF8?7HM9>,U
M#L*A2I<=!*5IV YXE97=DM^,:V5O%86>OM#I5>A "@4Q)6Z.6C6 _4:A2*0$
M I+15-^&=*[?>]GDV605(PU3*JUSK0[M3 38-AV_84K4G_TM:S<> 3:U@.P(
MB>5&YOP2SA5,M)HSF[-$5-EOYMFKG! S1B>;/F)-,[!YB%_J1*7"Q.+N<@J1
MUHEV_G2\?O)(8/!O+%<\(X&-,Y$;,]X:%4]N=D8=U'MSJN#@TF(WYZ&4H!Y8
M6MI,HP*QCRC%(+SUGC%FQDH^=ZW(IBB,(R^3LKDNQ J/OE_J]!HA"7W[:X$\
M5%DXMS62R2XA;!>Y_(CG*Z:YSE^T1:^;\^LW[[YD"#DKE!@*E8]Z,O7E@O_U
M:[[K<C]@',=OX$A[0-438I!P.G*)Z>?80^^RI+2*43M'OPHO90_P%<V@I#+3
M=I=0D]=6D^:B(^C@#B#F\SH_@IU=JL8I>=E'OY87QR[!+I^HY5,).M1))B%.
M_N\A[Y6DQ!LHX9M.N<B5ID2JD3,]P9;66K$_2^8MV+<4VT"H*[&>B9/+%RJQ
M,Z?<-AYW^;P D1H+=7V_5&67WT5?/Q]0T.(G$,W1_&(PAH+!9W6[DU?7,;G,
MG9UE_W9 FN99@@T9%ZN&D/CA47 Q5,Q%288I& H[#'7?DQ UK8Q585=M,SGN
M5.*59#M@=Y4@8L'M28[Y9"(UEUW%GW[17AXSN)7_,H"6F7:WE"9>H\Q(<F?9
M>OZ$4%%U3^(AA3E!7,CA^(_TM3*TH&[9#O2#_6MPHYE@S:R:))@_?&6N-B@(
M3NKL6J N4^E\IJYQ 6]+GYJ\+61HO78#(M.FH\G#/_/)U*@&>?V2>.?-1#ZF
MT'F&QD\,D8&@Z/U5RE=6!U0R@",#'<GESBRJZP^C.R@&WN+'CP;C\3:>R\?)
M/^8;$8)IJZ>JN312%+P0>+QD\<[D\V#G*W/RA!)G/_?YH$YY^0_M,4%871=D
MP7K[W@P6-:6#F#JM4!-UB5Z1K*L'>^1%6)']NXK*ZV5Y-0W_3\_,?/DF5LHN
M\E<AH?D^]!(I\64_*>/$A1K7_8B[7:?3= T[S;GO"-PKZQ6E ZZVCOHX,L*]
MK?^M/![8G?U5VJ0U4]9K.22^ ;%<7BZNJUE>+<JY Q0DXD15;DG"Y7OXHY"1
MU]2)J#M N!W+(YQ[D/=ZT$+ZJGYT,E]0?XDG(O;V12$YG0^O# ^8^Z\4^0C[
M@,MCS5]-JJL?W%DO";N)HY[LUAT3>C\DU5)Q#\EVRT97:D?=W@,TWBU#X$@[
M01O#]4.<Y/?N]<2((%(9X0]K=P#BOW_@XS01>12<+:U?<\ZE$BK\SQD:2EWO
M +)]!=XR(] >XR;C8V5QJB-85EH.,C4K_C#08!DQPSJ)(Z.1:2?7)M=<5N!I
M0X"MYM[GQ_"D[I&^R@_^O_- B%B6DK#M\3W%1P5VY9'> =;RY6O:>^ +?JB=
M<=OOL%GDG X6$_/K18RF70>+[!^$)4RE[_+%B$PC?UV @NYK/ML/SXJ*1GV*
MEYQ#UU-O5G6'PJ=?2:O)NE)^).D< #Y0WWA,Q\6&RO)Z]+H$%QDXMUK#V0>?
MYS]+PZ5<"?C[3BBGH%TB+TLRP#]-"U>QB;CQKKFRUS+":!?2)=7O*_9R+R;C
M:-.='@T[W-J&#UY9_AIH>P[V5_Y#2T= L^=*23=X(SQ&!'*\L9!?:VS'*EL!
M[@"=>K=$<B5K.!%^XL"Y.\ C#[_!0))KI=;$O;.5Y_41:OR5@=2X+I3PEN9Z
MO-=&79/F<O\WU@C/"[[Z%WJ#E2]2KDO\/==<&*]?')W'!3[S_^_^AEU;C;*B
M:%$KPXGWY=+./N[]^3>0_8]S;K_AE#,"P %[S<Y'?700<;R ;FE(-F&%7C9Z
M2<]KFUJ^A!,BXU-F[ \=O1HB,[ZNW5:3LSO;3-: _%8/FI&8?!Q_+V*%H14Q
MO??2WOD]SV;O<=3\TZNNO?Y@?6[:]D#' WE"V-6[(\\Z(7--%Y>R8=+892D?
MF6K1OEN.D$'2,66-8,%0P7Z:BQ\N7B./"T+"-P)4B&3EVB+I]A-R^XVS)E!9
MC)D?TQ^[3E2KZ/E2V^"%,*UEY_G>=(=<*_9N:,73&WEBW?-:E0N+4?DKU1/M
MGGSPRF\%QUK/UVGB#*=E!\VTC./X1*;4^>H]/QW"#E8';E2O#))HT$."QRQZ
M_W'366\$H:Z%=V-V/335I^Q/%AZY?O!^SMYQ\?5PC#E2AT(XN#4\, #GCDZ,
MJINOV+?+6C0*)RTU/][R4N@T=)WG2Y D^-</DDO"YO7D4<"*)5#UORWY#5PG
M&W*@BY BGJB%@B_'=#8T9-^?T6W'!2G87&MTRRCJ2?AZ@M?=1%.+2XS4'Z?,
MU#]#MK\>MIQLQ"E[=J1QG?1^P(Q\2_9(=FU>6"X^5QL&G2&TR]%-5 07RA;.
M1AT77\+^8'ZLH><0ZF53-!^)._5\XZS;F2Y95M$@GV)'_85 %'J$.]PKDZ)K
M1V4%X?3D%5-\C$'2R0,!A16&.&]ASA3A:E:1J(&.[%SJY&XR*6LZ3"G-7Y2
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M'L9J.N&OB6I?:&"E]!>(11%^^^FO?P?X+*PQ[6'IA=&?L8,(*<^=4I*:J_P
M0KLHH_'!=I*X\A2]2)X?B;6MVRTT+KY\2+XV+4=9?WC^+#HODO[@^5CVSCK?
MJ[[9/MUSAN9S6MG*R]-VK9)U("+!I,>BJ >29J]UTN[03#BO!11LJB:OK^I
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MAXS]L.\>OIVO\]3XK2B@E XC7A5^CJ3OU]'P@%=<BZ/\(.I(9NWNK!'?M+"
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M4S"_"QVF.:M^$<7<P3[RF(O" /'< D"HI4VSMI6MTD5/;<>$%MJJ()BK[>8
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MU/9%95EU$LREO]*K?F01Z@SV?#BC^G"89>!^)Y\UJ\X7% B_%A>Q<<+\(,#
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MDV^NE&G5X5SX9IULDISR[<V^A<2N6PTDRZP=TSL/OVVZI"EZO0KI.(,X/VV
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MCPA#)(03=>IZC#JM :-U1N=$'9O6*'M72R:DJ0B<6F3D"!"@>QF^/\=179R
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M+,F/+%*'T4FOR/.]PC-S,.#8= I-2Q0K/(U=Z3#8A)(-784T$*4\IB$90&V
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M\ =O67]"\=>TU&GJ@:@N :Q6L1W*0'6.1ML^)LZ?%$9(/J+J^]/GJR*"VVX
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M3R><JS!+_%0@> R:LNS<J<DEUH#SMQ)'389D0+N8F7%U80KK"LR>>I6#1;W
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M "$5Z\ QVRYQ^./@"ZS2%79QH.<]MU;[J$_!_/4?RYZ@WI);_-Y:6*"O693
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M>M?.RY<>;(71O45J@H$5"#=&I+$JTK=&>"I$E98 I+%KTH1V$EJ !M\HL79
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M?D N^[#OK7URZF[3I(E(=U4BJE!<WAK*U2$R*B7R/-:\&DB9%1 H8 0P*."
MZUFF6RPJP>)RT+*G.29# L->:>K[PL[%;P)=3P^P!J,_G/Q<_E4CM<NSQ"FL
M\''><J+X+OP*/HU8BV[GR0CBP=-58)<GB&+Q4#TV 7*#V.!J5Q(38W>(;TR-
MKQG'P(ZTY8[T<P!"2HDDW+)S.:JVE7&-H$[.H^]KK\&5M!NJKC%X3#.PUXV[
M?$J..[^:D]=AP37"/S!%'7@-G 7VK+BV=0TW'IZ\ H%BE1+8Q"1XPR@!IX9Q
M9%ALG+[Q_)A$#?A<56G^6I E_)/L<1CQ,"J<MW3KCR#\'^(,/.M/JM2Q+](W
M@^.]<'F<,6X(YS"$C7GDBXGT(H._A8?!<:YYSJ4KE3-NS\I[D\HP)5X- U9N
MU[:=#QZJ/O7%(\RCGGI_ ZQLBY:<C,'C]C=<79QNPH%'M^)NX1YI0T3. Q(9
MT94LB;(^7XK:+;K@&A;M=E302#D)2!WES(:.8]4L>A20C"!NCR6HZG#J;3Y?
M&W/M4K55>M:WETIVK]Z9OI?RSG.@.C^/,\I;U49)YB.[8*D4"SXS5:*$&W>E
M$=7)*Q#ET-F$2JR#%"QOB\LI$!F6["@N3_\T#;N:;XIN6'=_WGAKT<,8W/CI
M0S!ZI4B7&(/GXD$32H[0 .-R[)ID!^XSOH$T)Q3:BAP D;N@&'GJ52N85@HR
M_49>O"A5BA 7L\/AG:;/9Y?ONWT-];UFW(SAYA&9%LJAI%),_)'^K_A]'B8N
M PNC=U3')WI[%;RNT_(_]VN\_3II4OB;1,/7:782,Y!DUPXB@TE3PQ0@^4MS
M2RR\+@AGK4!2YZ--8\!X5C6"8]^X%VSAJ!>DX=X$X=-M4[,J.M@AT;\M!&-@
M;,V+<-ZY'V6OT%4AD">9._ZSR?PL$+2(6U<@*/38/%>/WD5,P@,G8 Q+035P
M65OY;E4/'\6NS&Q=7X8)F#P]]&@?,R1B',PZ0QY2_>6:M\>_ON>;F\'.Y >*
MK@72HF"+9]5:PYH<'PI],04T>+UK-WH,U4ZM_<83Y/!M.'+=4K:)[-971JMB
MPJ1@W3Z!_0'N!_1\&"[O?<SR,/7(\AP-F/#A^"4<^1#H&/]GVA7I+%+%5:)(
MH0F^ T[9/H.7NX:N7A6S) 28 #%S]4('M\HWVYN3./,T/0^1Y9.939]EO5X2
M3PQX^@WMCM[T;L2WN*9X>^O)SL._8%(VJ-DEU%CE0/@&]%P5D*\%Z]%7$.>T
M!MMD1D\]*!W&7N%KGAEX,HK; 79YO6[:]SZ^&I/EF7#CIX#_D'$Y9#BS>^TC
M660BE47AGI'65S<^B9,V9R8\C-TJO@T/L<C4QG?BD_"-Z/1H](8P6SU))<?,
M*QS:4;*73^TJWB5!:H 6;&;NXA8OF )8\LV<W>+^YY6?[V@'"<L;^-",_7!Y
M3$P /SC#RMT?UA6@W1\-VS1;^&7NB1G\1']4O%:TGKMGRY^B#%3H%;35W[D*
M4&/KP!)+T;/5W6R+^+08)H!"=TT"Y1\?F!=PH&.3 K<!Q\WDO_)[S%LC$ZI
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MRK;0Q.P;IECC1BBFXC]QVMCS,"V)OJ1+?S=87XE"UE%3[*-EJXVIY1UR2>5
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M^$8%J0T*<"5,Y,F!UJHQ<C$" 8U&A=S[L$5N'M$.!W=!Y^!2++(6) F/8_>
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M0\/1\,J\G[>@^J_G6;3 *-A[F%6#$QP[CY_IWPBW-6+GC<V]Q)@+9QV1U$Q
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M<2%A^,3=R&>@Q*26V?.I)IEUWU(6];4VH@@.RFZ_<.S$&,@VX/0W!K[D7%O
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MKTH$"UGP>EG4LIIZ\2AGET==$'%<Z\L6#JDZI-+E9%L%D1>&E?%._.U+(7+
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MCN?_UQI.*_1I7S:<*OE'I=0)8%C:9NJ?VTT?X?Y*C!8 H_V6T@@=6XSE,\(
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M7^$\S5Y<5;H:ZBZ6HWCUW#^21TQ(]X:E@NAQ)",*V2K&C$36)2!&/\&IW<_
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M)SZ;?/IDC<M$M_'11C19?@=AR58#($2-K>UVB34+.ZF9@6_6M_#J <]W 2
MF/2-DL*SYQ)C^LC;S$%04Q .F,[S;6@/>!':^D@H_08SKQ&2$V"5J-I835LO
M"=+$/F4U3;R6K@7)W6OP"RH]JUNL<=ADRQ91P?TE,I2>P?RH2ZMG5@D$7\D#
M2)($F_=>LS$I9RPA")5?AVCJ'BMCR-T> V'!<--.;24E;,N!JF[909S39I<4
MNB-IO^^U_;,R)KP9K[^]8<YBLIW,)LF6'C-OHH+P)PC^MX/Q;SZ=0?#A3/P*
M+OZ((^@$N'M08;]MAT3R';;<-S/Q^N'=0>HFF\HY&]Z<ZF_<T@:"8P7G@9)2
M\DGWY-4C+]H^MZ57Y7VKONN^]RA>9'+UT#W_:D7JA;7S%FX/K;#>]IU70K8@
M>Y91.[T59C[%K(FH[9*6\#%U=;=ZE_ >%U*H:P=,9./$LL7$33ZQ2:60T191
MFYTZ\:S_,EZQL9*BSR-8P(LD D,[B+D+@KN!QVBUO\9><F (0W+D36;8ZG';
M;5_J")440]<>,^H@-1R:2!_Z?H&2LHZ<CGDK K\>[_JJWS]<R@UOI:U %R\9
M8)OB^MZ<K5BX4$8+GEBBF?I?6#NGD^4L-O!)N9[1<CAI<'2CJI_^/9NN,Q?1
M711<^OV'Q-^#1QYLSQ3-E.8D\EK^CKU(O3>XPSL_^CBUT9B]J%>ZA09PAC>V
M$#:LI?S@WJD=">X_>S+!!9YAX)L%J8#</$P5 19:9!(T=F )M.M,2S\_+\L/
M7F$80[^II-S;Z-#(Q'4SR-7,&@Y9P ^!Y6YH"AQ^R@L/?PC)+S[$/J?Q>_-^
M['^"1;SW5CJ)U.I-P1M&3EO>RAR ^QXF) .O*?@<M6'?"G_F@/[O&Z+,^#<M
M2HHGW+89*N(.^-+DQ!;PV$O'7VA:3[82@\PV_BRA:YUKWUF,@W>Y]JSPL;A-
M]9E*8SX9WP0"T+6$[O!D11<1NX2XS1Y,8P;2M( /^+$/&GW#T];KN9W\+D^"
MR Z+93[8<&OZ"'S^S^*Z:Z+K@HJQ_M-(+ %8D8>2,I4.0O:S ^N5E.0Y#OC8
MV@?QH0-C%>]G_J[!K?HSB]?/$.+YJA[T$R3MXV95WQ:EG1P"-Z8)NJ_R:C5K
M"X4.Y"-D*+>#*3"'U2#443)@Y] %GK\+-!SNV^9G@R310Y24[F.I-,6T'B:Q
MKHCZC9/(P&,?(V31K0PE96//U.YTU1 ,@,JL00"XG^&2W*-?"7 IE[QB(:=Y
MPCGF-G#C'>:S_HQ"$RTN'OC 03XG\]*^EL"XD=::O8:(D#P!(LXOM-9V_NC_
M-,85\EWP!^\\XR3YPX&6&TB/6W_A%W.CM_A*'[:G4;BDLL9&Z[BJB2B@SN8Y
M62U?.U_=) =6/U< ?X/$8X;Q)^Z3Z0R,.MJT9-.U=VNMKQT]<\PZN:^#U-JO
MI!A%)<(U$U &R<UR95X.ZS<@,VE-QM+'#Y'.C^-Y:Z:EG3Y^W*6V[_DKW%>\
M;V^6HW30@X*^X_BJ1_0=#5[4"\7-JS^\D'0VSUJ<\J2^;"24B? P!;4HXH__
M"#4NJ7JMI+Q-!/B =OTX9((/H>%G58X(+JQF;VMGJJVA&9!:H^Z,EOH*XX#!
ME73=I6XA;8R+/<KIFO '+VRN1'I&&$W>K]4CHR*F(,E5J;XR\]-(4_1)/C/X
MGI)2.2+8:\!PG^  K=>\&'X)P[&#CM5,OF#<U7.,T2+9,'R(0 ;S7%[=\?\&
M #$(H#[L';&LJC9C$WL3S$AAMR_F>8;9+6YLNN0[\RCP",7#I=I[3!4V+'ID
M)CX1>QPGL+C$'FU1A5E[U'44].W35+43[FLQ1F-%ASCK+,+HX\=RX6NNTCO4
M?7]@R7N>P:UPU-RI)Z"5^ /5?ER(:@>>W_-)-7("+EH%>3 4LU"X74^X%I?S
M2IC8[ S\WDK9"Q TN)KDW;AQ//XCL/I88-5'^KP5R-8U,^475BDITUEV51PL
M6TGIW7* *X\,V;-ZG$,==YSYRSH2)>S,Y9L <PN@20'MK/'E#MS$]V"N0FXX
M=:"7]^DD2>L/[ONQ&TC%[P7*=JF&919 \L=9[LQ!HDA8JNU7WR_\^AU$L[7\
M5)1/;M#5A&M67X';=W$Z(LGAT8 FF6#V*L48XI:!V/;=TH.L]6*O"1U@E5.S
MA^(FSK[V)?/84UDV%;^=+.N4F*>XB"H+\\AQ7TKN)XEIXYSG/R\QBW_^D3SR
MZ5'&-S=\##=/H&[EIK!O1](SNDXI_,D/,+A_?)QJEO!^-"F /89E@/6@Q?G9
M8XB;Y'C[B3$OD"'9FM@6&ZE-0LHAWR\['T86-$P+J&BIF![0;C<M4W F^1 -
MK#1#9!^X_S!94AENGL@N%:3VYP@XM6Z!7N;:*W-/TB:P)V$.HNE)P29]!^>F
MI-E_&B_(=W1Y.#[V^ .GFMKE9\SCW_4O<%H6:?IXC>X']GA@N7!C'**6Y1//
M8F"FBM'L(L%P]E3LD'T(:ZF8'\P=3#?P@_+EXS).INYTMK^'A2U'NR*2DSYX
MNWE;O^![^(RU4W^^JBGA.;=[L9+BM+WX"]NV">F:E?A!<12X<K:JFZ,FPR6L
M"]% &F_!@Y] ASFZK5<GS)N3Q@\7C)8 'Z*+.5@3+]*?YT]/#T[Z31!VYN:P
M,:.G[5"X;.E/*N1.S![)FB/US6,,QFVQZ$:)AE^9V/;B?C0ZES<"XS@_+^WC
M7F3/R,A0;*VEG>^<=S_"WW5+0,7Y;L>=4XN>/3VY>7AE1"1Z7+CH@M0B']9_
MP0QJT"S--L$ZEI7@QF)FJ#X<9':&0?/+R*/K\?&IM9H7\9T:,1ZG"SCQ8S9$
M)3$;^.Y[[19]L;%[U+ 8HZ''15ZA[(F86&22*Z#X=11 FGT#K&UH0CY]+GH]
MF(<%"C-"DLX[,414M7;Y[7!@$$$^(2FY>?,2[C'<3TAGAB?.7+",QN_OBI8&
MDL. ;]=P1;E=.Q6SV75Q\ZJ4%#=H')G'MI;NOY\LE(0Q=<V +<;-#.BS,C&+
M810PAV'LJ@+W)'P5NKHY,-\G/MQK?66*VJX=*071[KZ/'*>EJ";AXA-1#CY.
M0@ZM0FDY"+H1"HJ!\P7JF$FAX>PR^E L8W.9.71!__L;E"\\\-I7R#O/U,U:
M<+PQF3/4+_"MX^VJH,W]:YPDU'9'_[Z"* ]+9KU+;$=5M,Q5S,7' MHZF;B/
MN]_#;8B[R#[)69H>?BK>:;EKDA\B@G(%0['D=[.2ZA:<.;*H96O%B==A*2O7
M95RY=+DM\WST]@7T27,KHM;(O<C1)B.3+C "YO3&6AOG!JZ$M5?>/?CT2?B>
M_7?2PMR3[[L_;0LH=[_^=*=%3=?FO$X0,,(W[>Z6S:- H5!(G%$IFXJ;$P]@
M+T%U82ZIBYDK+-@YED\"@?4VJ_:BZI]<,7S3R!WBUR,V*C 9BEL3SY C[EU6
MJZ?W^,60Q5ND5G':)5F,)U\],N'0%+-)!_JWO+K%/[6$ .85X,SR(>ZV$(^@
MQCOP,X<"?BU$&HS- ZZ+Q4V%+](-R9*,!CW4*RB+<8I6R!CD$3=-JILGT>4$
MR])=]+*ST HRS.O,O5UUM1]8F=L?Z6ZY'; SE%A: N]#:C+RX-04I#,RD:6'
MZK,_I9,ZV>A&S,+W;MTAPZ'</,O$BGPR\;Z+NX5(:#)>L?%U9KGG$T]'IU=I
M!B%>#<=/%AP*DQTDKL 'D.J6' O!2 #B&('LX9B%4-MI9_0[Q\_1C5WS=V:_
M>F*O?C)I6Y7YL#A_^QW9H:5#YW0EE7M^=ZG\W*#EY#IN]+3=:JVU?].3K+]Q
M7YS-FFD1(VWUWC>A@QNEYP)CU@>>';;ITI$M9VWLVJHCRR/6B,WD,P?%ZJJ[
M!ARSW4A]ND0-39P]3+,,VE)@V4<[UY+M7KY1;6W+JYS/S5:!5RX=OTKI.!?A
M__+.3#4]HW8[HZNGK->TW%U<."'?,I1R<&/6S-J%P]0N->YVZZ:=+=PPRQMX
M;4'1=57?<!I_8!9"13IW88! )&3INH2Y'']"4[4-V_*"Z5/(R/_.MF'_P)X&
M* 6.M\#'H*Y_B(K11],&!JNV.")+"%?RR.^:8TK*M3/D>ZYL51:@JO$S>&))
M8@_<WC+L21A=)2JFV<?Y8DRNC9BCVA-0 ]#N=/ EX"N!IVSZT">!+PJT;5N>
M/"73\, C!L[4Y=/"OJ^X#"69$RS5AY"F(G,!?%%)T4;6>_-[=/# P-N%E7;4
MED#"8\ @"/D*(FL5X*AM\PH_$G,WL^"H&3RV_GUNC#S?&=+MC[!R;47>;]X<
MAP J,,6.N0HV+L>:.^2K )0<"CU$?K6?\;<289]-_Q6)L#/Y"70=Z<QV:G#?
M'7C2HA94UE*9J9\K7<8/8JVR/C%W%_NT?S[E.'=8M%LN/RBLS L8VQ >T2/\
M9 :O[1TN9.L^8 9QJ>/<M!J]A@WB+K_CW@B;?'[]Z!\(F-R/-#8S!V9PG[L1
MU[@A-'EPFSE^PZ&/J^I;!==M1D1"G??P-0!C0W:\IERDS"O!%H^9"%@#:S5X
M_ ?@&,2.-K!TIX (\X.5E&UK5-HTK?BTV:H1V@S)B(0>&YVYJR%Y"-)QC2M7
MVX0C "/535O90<Z"V^[!B9J=#"5EAJ_"F"O/X 3"27E=:OB/+0L+Z+GN!5O"
M@:%!4[3DL1=!)*\R6_8OJX.IVHC]^BO<!N(051MQG]J[?8F-7J-6=^CYP<OM
M?)DU-PV#NR_FJ7-VT5K^5 ''AILXW=?O1UYM&R^*WA?['-\!8-_%J='?.?W1
M U4R$&;4/X/%/I:(13K79();C'7Y7^AZ>:ETO8YR^\@D,A9*R0[F=CMY!Q-7
M7T*$\S+%?< ,0IT0YA=:Z]HZ@$$7 8-9<.'WR7(__OQR#Z//Z1\#>)DU8\FL
M;%/ @25!40K-L]SNDQA$YDJ9<EX!-T)5Z30C*13II&FK*./Q 9])\!#2YD^#
M=5TDS7+N-RHC%K^C,M;93"6E,%Q"G 8@L#6:U]N.#5-2IEDT5A%7><%<^<6#
M%>1>P&JDXC, A$9#/R;H9@^&/VACYC\&Z+:0\?KF\#A_ $^#W\)]BJ5@><_7
ME#&_&&!?O<!7GC.()1'0%*3QM1%-@SY4@>\H!\XEE^8$?73H46.6]>.ZN]T:
MDW)H7F'Z-_$L[2>JO_VX"_S,;]5P50VY"9HF!Y;TX<L[):4Z":S0<G?PN%R$
M>,.XZ\"V"LOAU@/7KPJ('7(.,>(++NC[GM1DR928L6&Y\UA%''%A"1$!'? &
M-WX\!Y+O2__'CL.8%M6. X>7@ZC#;1&5V2_^LMF02L0+.0-&STT48YII\N2W
MX)P[#5L=KK#V7;*/Q^9/Q+FZ[#%V!9:%XJYA!<?K)KM-E#L\J8K"G=;+H?.V
M_>S9K#FP0EQH:4PMWZCYZ/]<C57V+VNL]K-O7$HQ,6Z>,%Y)^3E2H'O47\2A
M@NZG*RF<9$B. UQ=>B-YA(,BW8C,D=+DG(N6\V/$\^VS?^PQ^+D2-EG62LID
M;2KY5NY&7EG./ >C+I(!'>3  G!ZYKM4X*^A$4C/<FQL%T? H,+OU58J*4__
MV&1PPW5?<[7(CRNK\F%5AUZ>L.AGA][$S<Q>DB>T+)0SQ0A^,VY>=]%S/K%C
M7W#/">XIJF(S;$*^^;T?+^E_DH#2=^*7<ENFX@^8N2!BM/0Q"-,UCLO?QK8B
M#WZ[?OD$^/?[\I3$5J3W083E!DBFI) QCQQN[#5X#/,CN87%ATB%JB_VKU54
MZ%1('LN52V%B? 71S_[$[?84#(([+_VQN1 M>G$UYT5:?]4'FT50*CL(Z385
M<Q3C]PGDS_/C5-I,A;2&Y?_OTF9:\PMMID/F9-B^?7N1SQQR&,"[L\ 1N/,5
MYJ2DK%+)-@4BSU2E!HY*"CT[&NIV.EK<03X"5NOSU6V )H!6U2\V#M%=G3\Z
M(QJ?NEOP#9[.1)U69L@*RW;X, .RA^^)NZG??^FTPJ'IMXGOJ,=JH,W&?1)2
MZQ D7F#6(R#'\0(*20>6*_/R%;"TF+Q>7D$W;V#\'NNI_<<^< OIBRR4E-$P
MQ]4?2GO6G=&?<GT%<&R2.R\VK3ZMV7S.)0&U4&5[-9#.)[@I8>41K]_=#A 3
MTKV+K@77.&/NX$?OA^P00?7 0*H><>6K.*[!<-.=]W#GJ4CP[*KF0HBP@O.2
MH( 5Z+B\(ALIV5S5[-$%A_7:*M97TI_C-X ]KM8X9?C@/'X"79>$L759:SC5
MP5)&WB)Y2[\K;0MVNOF4Y[T[^$'TC"]-FSW9A"'QBQ9^ ><;1!Q4*W_PQZZ2
MP5TYK=E^33VU1$F9K?Z?ZX&!_]("$S>]3:0YP2EI[#>N/.HB0 ?9]9YO'+ZQ
M=N1]%O0K*5=^0];"C9=W J=[F5U\2TGYR!=3B>TN9OQOBV6\3ZY?8 %Y'UD+
M-5[>Q\%F]G=FVC(Q.]4HVT?\ A_4918/J\2/9<+)K^H1-(KK)HS-N,B:5$?L
M?<]KZWMH2JB_5NQN4M4]XB%$"M*8[.C0F2)][8*9^Z).VZ3W,@W#A2F[L*"Z
M@LR3%S2JI8:WB3OITK9^2QW\6=@HJQ CQ=;D.=R39B+$.7AYW$L]GCB#U-(:
MY%7'+6C>%9X] CMR:\'FK9COT8WL[B<;=LRSF.@I83:1FX(20PO.S)8=O;9_
M_Y/P(X\Z8.?O\)VXI=+K\-NOPWL:)E[;OF=$F4D>??\&AP3G\O#5Q=L77GH<
M?Z\BLO]PS+%7<A"XJ.VHDD(8;$# @S&V5U*^V>+DD$B25B44R!>] 2%LY';@
MJ#Y>@!=/_CQD46'A*_(LM2CZ! C883BITR=H)]4&P%,*G 8#3_KN(Y;B-: :
M_(%^ *^JN;#W%#A#)RHA#!PNFK8I*5I&&_CDW5X37#<C;Q^(:B-J>,> _4TW
MM17SH.[9O1- ]'[LT'..C*PK3CSP:G9>DYZZVW'O6ST8O!:JZ$1>P*BKDC+5
M!+O)&U_JI=A"-3:N4U#5#&HL/!2^'K55;6?J5LI#,=5XZ?@OV7-8VS%W-!LZ
M:_DDV.@=K'?0<'3@SDB1X4W8\'KM]\3QMS*Z:WA!*>M+TGJV"U/&?)MUX-*Y
MB6?[B+S/C D%0QCLT_!:<I22XKIF&K,6D1T<\17.;<>..6G.L/'2:7O\RM->
M8]K%'.'6K@DNQHK7F_#+Q%'HG4-QRPW+Q9;E>Y9/UUO]RMS_<$._UUWB3.]I
MJ5H(:X6PL\-4M),Y^L)'M)IEM=5]]8JH=1KZI:&RC:&^R4N6%G59[!O8_+HU
M/E3*:?UU*U6V#O$<;KPG>);1.3)[=!IQGS2I]E,U$8S2:(K30(=P$CKB%F(A
M(H6S^3O'B+MW_8QS,]G)/.>VZPO'1X@W>:SIK%QU?5J,W9ZHL:70?F8=)',C
MTNFZ2(%)3;2H,(B<Z3>2ORGS2UK7RO5717D;T?NO74?XZF;JAIE9.VJI9$K2
M;BU\'%G;?OUZ2]%'],73O6LI\M!0_"D&G*#& P#E#^$[L3XOQ6)LJNP&"OCR
M.VN'?%UR")K8]3U$%#[UK>%2:7:4J5-['!6U>'>$89.&NH5:K=[C/3&]ITU^
MX)FQE71@$=\JT@G0EX?:\YW?=0T->U-_8_8C3O;'3R]F7CI6,[7YPWM*B7JO
M0[/O>;@QC8FNAR:R2Z;*W%%)EZGP->=BAHMY)N86WV[A:!1J!I8UW0B+=#TZ
M1X(/$G)",C*M#(=6X@[[SV1_]E_(=SSI<1%_?6I&SY&/]4;OF)AQ4N=4-$GV
M*(.(R/*6>DK68"]9RX6,(1X.XIR&69G8_D8)S:^[P9BGSJ)+D7PM_X6,(=B6
M@NPYZ9G/8E>6^(1O:!!)S0TF+KSYED)+?.'P.6X.\3![E)^%[ JV7F%TZ'1!
MPBDI(C8)S/*1:N49ZGPY<>;-3C/>8-PJHL2C88[T^MTCL5[#6WWU+Q#W@^\V
MM!\PJ_2IL8EV_?9USCEZ6,<RC5,%KX&]0,(6(HP+UF:O5T#'EX[//CE*BNY2
MH;07;7EG4NFE4:*9\ ^!G5\W:/4N9?)U\8G' ?C-0"&RN),F?\+R829@ ,L8
MV09 G7=RX;:LY0-)EVC=A_W*R'<O><225>02X+U!^(OK!&X[('3FO<&&X9WC
MR*FG=,B+"&K_&6Z,$SR? ISFU)^=6;>_ *ZXFF0P6\, +<A2,5?V>UBVBC7E
M!W-MHB;*F>V"872D[E\7O+K1N2(O;H>8'.!UB$FMN86=#!Y-_@#11GJQ"CQ@
MP8P91A7(U:IN$VWX5;F2P@,!II01+7=Z[?W=L;(C:')9)_'&5SXF\M;HK[.(
MOPA>'1_8>_I#MDS%-@%04.>6"_!1/')]@BB:N$X E+&1-\2A*X4]'<X9#AA6
M+7T67.,%SM W'-W/KJUJT<O +SWC]@$ZT38?JA2H(TVE*)6(K(:)-84J .XM
MO['=)&2(9&1'.QRVNL*VQ75QRJ/WTJ&?SSU1*VF57\8[[]\981+4D2H4G(U\
MPM? =AXGOP?OA1)/1KUG61NPU!I]2$D@;@;-'?_>@;FR7HY\_/]")MX!UYT@
MEJU [TJ ^Z_*6=F#MH0#SP]=T>GG_4%L 7A[K4KZ5L!W?O1KP0-FM.%PS4G4
MEDS(_J-?RW/)B5.R@TI*S]R;W+;^D/6%;^.F7RW=A'8'AK5S90=L'T'7MG^8
M%E=(X^.S7HAQIH1*Q,0RCY*S3BUE#P5(KMU+MW+3:_^Z:]\%<1?_+VO:,E%2
MQ 7]Y)MY\$_=:76P5@Q0#Y7P-)]897;H7\[$PW_.Q)NTAN.> )+R=AJ1MPII
MEQ'4^:IM#C- K4I4H%*'4V7A=6"& '6^P@W@JC/ZV7,.V?:@-B^@%'B^.9Z?
MAW3/"2;\'PZLPB/;[%5^9ZPJDZKJ#53)J)\)[O';#"XKF;9)2;D;XV@/][FV
M0[VFMCUP52;W<AN<]45E;"<8W\_(QO[(A@<GY? !-[U:F9W*NPH>UP;(E5,#
ML%Z% <H@;W0E=RQXKUD^''^.2,$=5Q5QY;LXLK @N"E.90CV*@C,H\S]R5MO
MXIO7RQTN!/>S9[#, #$M.+V4?6_OFX59/:*UW\NLS):(149YE6*".[[-MEL<
M0^FU_.<VYWUGZ!VR<+_<OOM_C[!2?Q#60+$H(RS+U3/M>26Y<X.&R=N?TL:L
MV4['PY)7MITZ"'<?F!UZ/^-;>\GIAA\-0D'&1-58+_FO)N!YY"71:26<)^'W
M:9^+AJO43@* PWN?HEC 9>C@X!V4&?U(AV_48 ]@OAQJZ\HRVS*H-W0XKO7[
M1Y-58LS5-3\4C4F=WQ6-TX#E;]*!]"IMY7M^D-6Y/47'ZH!]' 1TU6_Q%<V[
M,( "E;_STVU+K@SK@YO<-1V4%'_D-CNTGTN\4E(2UX"@ C=_A3M^$E;=*Q:*
MA%[U+RMZ8XDO2LJ=-)-4$Y1'S%8+2OU#3&;^+J[\V#7V&H__B]/A1=HKD"\'
MT6&TECN\GOLJ! 87+4-<)8IY=%W@62POP/'%/QJ9F"V"TA;2/D+/&:I8CWQ_
M!4*RJ:*E-081#Q5I5D@M7TM4Z@KF [0/;OAX_C?B66]YIT #'V?:=OM,P6_(
ME%%[K6"?]_@%-O 2.8>1INX7/,540\ AROHO>72/9HOAJI7@J&D4_#Y5DYQ
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M;:30J'.+5"*Z!@^E#R/KXA9^R5JHI&AE.8B.K'1X59)EDN(7F.?H\LQ7)-'
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M3!]IR/\;,=;H:/'\%<^(_O?A>S_8^#5RF;E0&MZ,@UQY7#HR&]Y8(2SN1;-
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MLNZSHJ! \L03E[_K30KF&$V!6/9_+FEVD"7:603_-%+]WTR:W5S9A9[WOH=
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M#G52["G 8?%H"JR"D2D1[:2WY0S'-8"QU%R"GTX!#DW/5JCX2!1IY-6,]IF
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M'+C!MD(62BR36B_("_);LH*DD\?AI06M N]);HJX,QN%.&V2,[AO,&CKT2:
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MIPIVT]3;);1_6'V5L]\KR1;<>*&YFU- N__^3_N?!XTFY4[KABI^PO%YI7$
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M=WF3/B5"J&LN^'2VPM$])L'HIA.KRGRL_-+I[K':>&:,\FAMVIXN8#\N9"9
M>A1\*$'(4?JC)A;(+*=P:O"UU#9:]N#@N9E!1$R_$G[+;0J1* K-&H>RES7U
MGVER%:KDK-CG2QIH='KVCGKBDBQ6.@O2^&@P-5%JTJ/9[K^T?3"7A$'&[@^
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ML20'@,DGOQ3P,AO5'E9,Z>$R+D1A>A#OS-*QLW]EF@P;1X[(>_TB@E:^RNR
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M]CCKC8P$$*72!,@E3#!CV;SU&!AV .@LF;9?6E*2>O]3Q%3<XL\679"60RM
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M!MX$60.TY"8G(+Z=KDVR!*RXC4L[G@^RK/M8:L3<@?=M(Y;IE38[L/M?#(8
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MCZ%X=WLL LT%4=45,C]SV+G;(Z@4,A<$R[TW#R6X-J6G;>3V1^0<ZS?Y@BC
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M6M<B%RRB+H.62+$C3#ZM;KSP$6P%)'3X:6NZ \Q\V3<]*$5K!W';R+8G-"/
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MAG'"\#+O] %][I:QTKB3[5JQ#^Q_>G0BP+TP6B:XF\H= I([R2_MNGF:WT@
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M6 J!'F-JB\(@HB2(L8;+T8W_!9-_D[/]BIK*_K"(G]R?-1;=5*@(QEJDJB[
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M<_TZ3>K$2U '#4TWZWYY(;?N3%)5[)[/4T=/O!#;MB ^:@P3R<JD??!'%1'
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ME$Q87*Y(#V7+:%N546L'KE5*!_E?2Q$!.NC*44KV(%BW L-,, D6,Q9J-;3
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MT"X09Y'7$?=R2G)S(>UC"0X*QSDY"M[?"+<^GC;"O?'&>LM^5;2.'VN'UPH
M2(V_G^!4C>(HL%0:DB*RY)*G*3F<L0;<RA\DN0Y]@QPG&X.2EPL'=/;-X-V=
M4:$WMJ4V![_;3Z.,;96\K?Y!:EG6^_K1#_O%*W8GD;S2#%4<XQJP\@F!&Q_7
M9!8Y-3SZ^)%Z96(?[M$[7#\UY)VW]H[]I[R/Y)>=NI"36I(MO0!/\SK#7C[I
ML#EJNA9AF>A\]*>T.U]OLF/;KE;VXZDTVKNW#E:*'_YW/VCR?S_>,C9" PV@
MK)D*>S::9-Q]_FNU.A,M#44U9^GWE*P[B<\F^-8O6\'O*3[S+WV-FM4QQSIG
M*!K;E<9V-S;)/7EZ^^8I9PXX@H9,YWDST/T@;LI(RY2_")#HZ:P&^:L%*WM3
M[+B]37C5)J[T":YD[<->N3KO%S[#VSC-N7D$;'UZ+Z^4[M.KJNI%TGW+Z2$7
M]EF4$_R^)<Z-+/_Z(?(*6&=9JP#68:F7$)EP%V.UD="R89>OLVMZI,"7J7YC
MYLN2.T<J46"^TVW20[TFJU7>P^W:?8- O[,#KJ#/C\HTUW"ZVP:-5;<QAPHH
MW]5@Z3$1(+5A&"FR>A9;!!;")^ 5C!11'VKB'\*YB(!Z'/=&*]N5D.2 T"W<
M&MS #D[M?7]OI@A8!YT\#6Z R)_#SKG9%K3XY7HYT =I2I^KRG2D>J@<)Q#2
M56FD]AW@'1(F5H=QLEG6$? V4A>Y J[DS-;AUE1KLT,6?;&1K@:Q9FXLFJRO
MQJ:NH >=BZ$&<N[CO'18NR.P6,TNR;4BV0;_C.S0+7':L8GP\GW( N,M^JNF
MDF :47D+E5F,+JN<MN7;P+TBX%74]#B'S+*N!^DIO,/\E?DEOE2I13UW>"-4
MU% Z*&UW/+K:ZL7$TO7A\75MWL0@7_<CZEHBX'C71?P4?T>QI\)-!N<X".U(
MFEZ-E&=-X1L1X)=)E2 $?%!U%B@T\/#<BX+-D/-(](+[97B3P 5Z=*F'ZU.5
M<VNHN50C'17EIS=-";I97O&5(40Y?V6JY.$P:U'#$]LWM)B'CN1Y/5T1N_T_
M]5@EH.$1-Q9;/YI>%@&++TRWKW ?^0J31VQ&0TE4H4]B+)#RF2<$E[M"LA@4
MA AG/[^M.6R.&H>-LCPKD?Z[I^#'T]5F_T0(;A_<BY8R1M$->&>$V20Q+WKR
MCRI&,R8<K4!2\\IX/-_FYY<WZ;&+<X7RW%LE?=9'-:B#V471HY9U2'IKO>';
MU7:<C5W6>H?9Z.6:'ENMCE1O:6^-+5V"S46$N/K:35\#J<H_OMN_9H79NK;/
ME V@Y<<OUXL5_# Q65W8]T?'7;[=BXB(> #,4)F*XN/AKR* 8YL$:3.F^4@F
M)4'(>9)8@OAL3.*P!3;^-"S5'9@$^+BFWP5+S7R9C9S*>"*6[6FW9\%7 \V)
M3#\?/*(GW>RA&H8[6OTJLG[_I5>Q=8O*BPS(I!)>8_(<.9R[068BE>- HULV
MJWKU]%H)GYNILY(B+%122R1(>Z#Q$<R]--ZR=E2)ZJI!^KCRS5NZ&ENY2@WF
M5(%-66;!YK>Q<Z'GM:N1YCM=H![#26F@EF.G+/V9,FZ\6D[2M)AVM-GFYW!W
MU@'N6&2U>Q$!QX)K\O,CB0=-&G#K"45L5%0>QSZ!C9.F??/56,]%WQM+.5Y3
MU7UM0<:8,F;2BRNCOE81J(7R32$TO-J?A>O#\#K"1]B8:*(#-Q9%QXVHBX &
MC KBVBI_J-+OF0>$:UBV2"D9G^N?4%FVODM$DVK1_..O^@9\G>]_?!&6N'O;
M[J=2'#?^>:(Q%,"F]EDW4"OSF['TDZS>9A$ ;3>8SN4?\R69<1GA9N9<A=^X
MVG$D1>*VE,,U[SLO<O'W%H9<YT]]-9Z5\_4;H_D6]-.U(IY;/X-"MJ@H5ZX%
MJQD#"CQE#E6@G ZO[N;+$Z)X^X2YL I=$"A,\D0H-/E>ED7GX@'T1J)Y*72/
MA20PX1A* 5)H=B20_ ZYJYTJ[3(R7_ES:&IQO]'[8H,_JK_.GJ\90GW#"I2=
M89FS'*EPTAKB;BJ"L<?@SR) P6(3\7P5%.'OQ]UZO-O"N ]G>9F)F]KO09_9
M5[L3:CW4X9#I<G1$+]]]<%@PM4%BS3$D'Y C=1S=I\!<$B@4\1PYGG6HNQ8J
MO8)-QD5VZ!:&?"!Y'>'Y9)/S5R*VEW@@QW+$4.-9<'#H6CFK0KJ-GTS6DP-]
MAUY?*[L_LO.SF"",U,4 $.8W"VE:-R312T>B6J@)62N@ <2R*XB67PED*V$Z
MK )Y,J]E!N<3?.MN244''?#%1V?M:M=' %_#/ZR@WT<5$QGXX\+70#OTT12'
M2M\0[0PZ^TSMO/ )AEF"XV#1T.:H>MH:Y+@:^\%JOY)BO3&UWY5VJ$)8"IL(
MU*  3PIQ'T>EF1:MT!(P$DI1\C4A;2W/8D]T-CFK>*@'[J:?*?TQ<K1=N_O:
MU'!WV!+OIO!QK04B[R"&6<50 ?%)=) YVXB.I)9BIS;GF=1C^O(;, IFQH60
MOYD?.T:[2^]:[8X?53<+E8H;>9/;Z)6QDO26H(L\H>^A2)W[6LE_D&,P%9@I
M!\3L'<(GL %8=PESF1')> 4VTNB^=8C+3XD =8*V$X3A\C\L\0PAL+[**:I)
M&XJ^5NUF]O6L&]U'^XN[["@-UU6MMS(%5!K-6\YZEO]Q]5/4PE;(FZM3AUX/
M:Q#0[,H&4,Z%D/T!+6]F\!QJJ!O6[-S&N/P2"O!X$^7006'^GM#PI3)KC]\?
M+EMN<(^*9^]<@O]"/4HTAOD85]H2B[0Y#"2/;(09U2&AW@6$7F;+!ZH80:%)
M87SF\BN-S>T+T9%%2M7OOZT;<'6WTWO@N#(TF+_+RSU[)W8@JI!V=AZV1J<"
MF/]QC/U_!:C_CY#_A4+*U17%M/_ZH&#>G(J#RZVM -OJ6ZI8PX'%?WIS![)=
M,;+P'VK\8XU#^V_K9C4B?VGD@ZS[)4$$3#K\BZKIA(4_U?JU[A_Z)OVUYE3@
M"8GW+<]R$ U<_XE-,FI")=I;<8'/SO_V)?S3N56+"$N.L1>3VEJ!I12@TT#9
M_;EZ\9%;+2+,/#G371I8UWDP+@L3Q\+4TV)P"F,=H[WGH2 F2@4:=5>E3^M>
MZ>ZL)Z&IO9FV<2?2#CR<RNE2P>Y]/6AF:'VML[BAR50F_^<G-.=&9:2[$Y65
M6.TH_J)2D.:.NBZQDHX2;#J\4;9FC_75*[4M]\S,1O0/1.X\JY-\^DLA\Y3&
MA1^]=:R:]+*XU+W#AALBH >7IC7\E"NJ+'1BJRU9LJL)/F>Q68ZM.A??U:27
MUU]\3114.-J<N^Z4X5#U/K4XK%_XVSDP>$%#!(QQEYD?X!^"*.I/ >DM?![#
MUL0A^-A.)B"^06G=FQ4!CNB?M%XIP>$B%F[9<%8)Z4*_?:T1 1.6(F#_\L@D
MABU&J.D,W\T;%P%K-M@/848]Z2V?P,903A(<=UP%5K@RR8%IG9UY+0M+=X3M
M/U'@/"2\?NX6:$ R7;!XLG^L!MQ%YJZCW -_T 1.(B J!1$\*IL$Q>#J1<""
MY_ .I#*W/$-H2]>=:?@&,FM<P07AZ'@0WKB'#(<DP5L9=]T)G1+4&;=]8)H'
M;7RV8I=_KSJ5_ I]7/91W1TAXSO-HWH>XI/0G[7_888(4 (1,T3 SXAL>(L3
MAR+<( )BJ9PY+U!0URX"Y*2;1,#RE@"48-]EC& >!261Y!&O>(<C/0(1J4D/
M4>.SXGQJ*X/Q;&&<9O[C;UT(%?UR890(^*R.YJZCWJ/^H%6?1 Q,LEP2 87B
M X)O#G^_4]#(\74BX-W5(=@E%)-?2CMA;VX//IJ]TSO0>4_BSIW'MSR3QJ8[
M!T-'?D:(@.A4HHX(. *R*0*S#+0(V!4(-AZK1<*4C>$ZPQIV*$1;TU]!0HK]
M87N,")#=@!4!9LBN\I/UF&5=#@ZRRP3GJ^&L5YCW JI^C7G5I8C>?6=1,R+
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MO?,K3F]F&%#/P?7T4!"FKY ]O\/^]D^^S0*;9$30DNLY.,@>2K!@Q(<$B9"
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M4TV]$WY]+2*8R%<!+NV.16="X&:A5,FI&]33_KKH%ZH)2%!)FU.)>$?Y7AH
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MO+'49-.=G0=22S_NI/F:IJOQJW:^%8:EI&2OG"_GZ6JT2-0#UYU$GGQ]'U]
MG[KY/>30@%!&O9I,;M%/TVP,A:C7D,W^U/3M]93Q/<2LN-P/GC2WR :>*&+>
M*T<O#]KUJR[W']G0*44J'!6-Q3&),YXB;QEF/I9YNWYI-C&E!^X)-_\BFO)H
MPX(\CKS:N\J<HK-Y](A*[W7+#3KVHY>GQC_&+<1?X66+6>YO$>9SK$-"R*#
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M)+"Z.]!MYH[FU'+VPZX([SD8P4O[2O033L+E&\+:D07T$%@9K4L\UH_PUG
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M&//,.<R>WQQ4CE<7=T@XR!@(!;J53]V+?!;!71'MK?AU%-PQR$N$X[4GJMR
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M%7(]+.Z@JYX[7[X5#YF2A>Z\45/W%] JT8(XO<^3MXFM:7%Z<CBG+97/2&C
M#'QYD<(U?&X6BJ0SCS%1WDKO=['#%[YST]1ECDFP4@M2"<R:J58;).N_JOEN
M>Y]I)F;<0>O/"B]DN)R^GWZ4"=&M_GQ6,2'3YW?_)DK7OH.1FR_F(C"-=7L)
MA:+I0>$\3",Z;FP#1  %3<>L&'%276Z49I]C=VAK&J^TU#BE=TAC6T-#72"S
M/\RT\&6_E>[/@/KZVMJZ^^/^+_4?VT3 ZW 'M\5U_]W;C=JD''WS-?HA-TK^
M_U+T&=^'H'SP<)>@4+K)!7&B[:!P0:KNV$H CZZI?'/)R@FJX>$V>E,LCHG\
M%564]]MI&#VZ*L"L;K=G2N"/@_3AW6^64($<\;&.E\ C*]H16C<:= 2@;8%"
M5U%T.UJ_P8[V+HN<"IM1G0965PF C=:MN&0L.OOT +9CU5]UV8? ]A8S@_T5
M%*'9U@,I[6[5*8X;S=3^3OL+_69N)EG0I0Z_9H$GYD:64%RM&:%HH9D#GB!L
ME)Z6)3280FWH$=S1S!,B<AM. 6IN1J^S0FOD5T#O*5UM&:J,F-*>]B0U1:'W
M[/@LY\ =W^!OWGOHZ"]H!!C<](YKF8.,]>^).'B0/),-3O/+9(6S5A=D3*PA
MC;T KY<]>FX722[I>#I$L7:'W(M\JV(*'CQ%U=W/C-<?R.4]PFZ)?/1'@!F<
M\8\Y9;1821;-H.*+:&^74!7AT0T:1#^+OH,)?-(UT[D-4%>+=^F=*:\?<6QF
M5"DEV[.FUWP]O28XPS-C,6K(6-CM=C.5K@6O<4;\^:]401+</2G1IJS%Q7?Q
M5_"Y6EZB">EF$51"SG37Z2>L:T_P?)UQM>1;0EY9#<C_&GMJ@].%M,J4#UP
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MLX=F0K62Y2RA+HSH6?/G6EEQ"R9\E966N7I@>]+%*K=M3+?S!*=7E4AN:HG
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MR<Z=$M*%!SLS8GAA[%7<S",]Y#M[OGFW7F4" %J)Q45,4Z;5I#)4R.?, *"
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MC.4IVL,<//@I9$/0F'9WB95;^+'R/NG7U?E%(Y/?O$^[7"6K][;TWI!R7JM
M)H$S9I(3% $!"I-@:7TX9:P)Q&I"L 6;WQY_46H%6 X.HV^LJSN@I;^U?[[(
M['%/B5FH)(?@5C&P8\RYH7>B-JS?S"R9*6J7U@*-Q^T<P72NLW23J60]]0\D
M ][_*L9ND:5JB8_W2.WSH?0VVMI^9B#XF,V_\. 1U:&*6=_/- KM/*$[&4K7
MF_;3&YA_B7;Y7J*VX,CL/T>,,F$R8EC^J</NXL/= #<?P4Z^N&%_\7EH2R&%
M(S[<NX0ZB[Z#-08#&TFZOPW8K>(Q]*$0I4"N4UQ\2;IS==^.,,(:"--&,TCU
M89O3V@N\._P?3A7P!X<MOPV@<(RN7Q#(> 7@_HE6HYD'T^7L-DB"I58#M,W3
M6=\@@M--(=6Y$")XLXUJ-:MM+B4)ZAV=HQL78UJ%8V\LT_U+W/0+KV]C'C-[
M6WO3$!J!EQ?DK9J&2))E(.H,!*(_ID0Y\\3WN:ZRP^\DXBJHB)\ATA@O!/,.
M#?PH[&?:\Z(P3KTSCV*5\+[5S%[,%[8^R<.4J/N&9^/]OC-,'OPI\9)Z@UTM
MC(\"L85H,%5D(%:&0MDLO;DPEA*M%0%>X4T5!51/",WK(+FV](Q!KP3AK3D1
MWWU$G\-K;.Y$1'R%-PQ*'2+//1\F1EQCG?NK<N.Y,CB#Q:U,EF"D5HA]?@"-
MIEAS*="-U0CBK**Z<1]8 4GP3A$KQI+DW$C;D70X=\*U-PRGVWF]X),/],Q>
M?]\/W=/F5N?KTYI6^*_]>;EYS:J2[Y,RH%%NGBP.7+;X5(1S.P$R\4S"A9!'
M5,371829$LD>XI@6O=&;T)RJ!#W#;Y*J@O1XJ>NS2>]PJ5E4KDJ5[P&.DU&R
M7&?AZ'0"\2HITK[E;F-]^^3$'1:9/"3/ZYKIXZ6.H-N6.S6W/(;?P^9)S0M^
MFM"SN<@]2:68A$LQ!<FDPI%&TIZ\;5\&^CJURUT]7E9G*-*KMBJZ5"^A,(CG
M'.J*8:UC!7=!V\.EF^S!P#,U?6' ;99NZ>]@0&=5XFO+GTRTP S/-Z(7C@4G
M%I=_:@^XKCAYHBF>9!CTN697I0%98#S3PTT==A;G0O.2Y87V3)SF#YD'$(<N
M2Q6^%='YUJVR4\,4L[#4:)IR;17;K,3@V,IJFX#._(D6ETK=CL=B=AKU!)CF
M=4,<5+-ZF8I_DUO,@U00MSD[\(.LL[PR#;:27I0]0TA;:B*GG#,S^O K=B]D
MP27$+3HG5N+B_>1Z[8X_G=H)6333U0O[I;J%-E/ZUAED92ABV.>Z55*VWF&O
M"[4I>Q=^_8R,9HGC\EE#@>+'D%X^5(QX8!58P;5NQVM)_0>H2D^DQKW/[7SV
MI#\*MIDMLXIKZC0^(3+KS&^-::OE*^J:%HT/7KIDF1U92RHM->B=>5CE0P$L
M<><(OT">;>CJ!>DF$=?-O8FF)\+'X6/M'$D!7)FKTXN!'P\">LQAP[>\BM7W
M+A,OGU_0<9I/SO^0KC7D4M5?0BJH^C9KEA<@%<I268&I0]-BA.I%7X&Q4G/(
M#:E2ZDNH&OP,2\!1HPU$?,CDC>H/<OB?%U5N6'4&5/XITI.5)!*]Q^F1".4\
M*2K(Y';L,[^TI6;07,UV[^W&NR@@"M!D79P;HG,]VU1N+Q\#UHI/BD#'8"UH
MW5I  .3"U1:&V3OZBAY%/JW\+@X*'5':[SULWW+3>PEU3+*-N74L>/# H0"3
MV;$]HMR;X$0CO$/$2;8B BJ0\VN:_B#3AU]RX8MAI)M*<X->G[E5U-7C=:H[
MTFV&@L5]9]Y^-BS87V#W8E*ZO#!?M<& L@ K*B'6/4J&M@-M2IHR.VN)(OP&
M6$-;1SEL=HXT'DM.T5FX'=AMY\SP^FY6T1I9_$GJ)3(\OCT-;FOW UDC?H-!
M?$79!9CCC'Z1*2R=Y5P5'X>64)G47QY*=XFT$?@49)<QH7?%31,)/?E$Z?(O
M%M!HC0L"$L9^@2Q O+@$ A#Z2VXIV=!B@ZB:B7G47"(K^'X$?&XSVE89IEC[
MH[*\N_3'-* 24G>O;SZ[V/7MC\C5 R7"#SG6P_3;(%NJ90LKV M4D@9Q<DQ[
M"9%JV6\'%!$[>"1SXRJ11DU,F![-AS4#A<IP?(W!9#*7.(0A[T_\X%#R5KWW
MC.,J5E;O0T(C ]K";D(/A7.-I>N=^=9"'@-^KR\/U8LB#X.!PC ^3HUH]O#T
M$JJI310>%VJ"I*(.%LH'FM+UDA[G<>2G<C=U/^RM*HXR<@\,#@XKFOJM+;*H
M-&WBYQT9@[:3@N<S9E9)L!2!HVAB1@6\CVG $B-J;N-^1P^1>;:.HF+>P202
M+NGQ #5<5,AG)Y"K&.C3K5=#ZTY\I6WJ#Y/DZ+8,9GU)*3JG5T>A*=IN?0V0
MEU!E$])-J\ \\7-$J8^D(;*DO,$&/0J!M_K&7<A83!)MRX(R3XK(0CG1[G=S
MQS);*EH!JZJ&[(<("3U*#]UA24S:7IWM4NKC]3(R_G&-S%"6S^*6$,"C74/R
M_*C"1OHP1OP,"@<%_*A^CQ.C$/;"0%BG3[,H9$5@63J2W<'4TU.:8\HIBT,G
M@@@M*F<-*U_6U!],&3MG .RF@ZXR9[$3A%M"R:^#.305*"&/N@F\4,MG00X[
M< $DW9-@2DQ(E\#>\T#YX"4<[V13=62HF^?)'H8.3,Q9[6IBI:@08'3=X'XT
MC L1G 3C_C$7\QQ,%3J+XL3[H%V"5"THCV_G9Y M[H>L2JC'1 O)4H-GE/1V
MK3W-8D(_7\D\FB]X,O;5IN"F[.XT4/S;F')MC]U72\P/1^F-)93;W!I*<S-N
MO9T9#X&Z%*V6+.,[=GK\3B.V'\A(9%H5#1.]Y>-#DX^."+VOY3\)R=C=17SZ
ML2NDC>CS=-NW@+.:ISQU5W^WO;0W4,X8];?JS'XN^MA>O54T(R2TZO5_J8.N
M+J%6/H7D>550#B#R;[(( =9;,>)H&!88?H>I9#>FP&;Z%$W9^.97QPA&=)7"
M+(OW&=5&.]8=VM;#J&15C 9MZ CX8D]CI^?^H26[]TIN9&*'-/1G K;2[#60
MO7T6MRE0]!/__=_ W.3F?Y =^#OM//#K/P'\\=<&HD;<L_3%_XT3N-9.7*6M
M3.V^_ ]6\&[O2MI>X_D3@/?_QJ&"PPUW77@W$?SVY]5^<^S7??ODM-\B!$W9
MR_!XU2&Y;O_<75T=D^VTO877R_VUYP6**9=S1T&+Z9NY]Y%1MF0Y#E2\L;MQ
M77[SCRD5@^YO)K?3KN;^X5P@=V5_^_Y#;^6BQ](24=<6&M$F\O;[]W6=^7+4
M92XM>(PH0,5PY6IN[=^WB1LJO+/B>-^?O+BU[U%7GJ_0=3!$K9&\K]T4G;97
MN!_]GB%$O'+57AFKP0IH/#"/A[:1I6K^SI!/'O4HY,/KX:L,&XOC(18Q#."E
MQF6BA\1UR;.I2F5E#=5]_CT&_:$C/MEM/7;N3XG#.3\\O,W_/&)Q1JGK(U[<
MB 18I]165H0UA]OHX/$EU,T,@EHE685J*"IL0?\"#W%62^5*VL'''=Z]5.UB
M2GISAM]VT=&<O-.4PXL=+>E#BKJ^6,$1L";^1\DI#\[)%Y'7'SR6PGTP%C*&
M%58A0:)-&T&K 1??5N'C.$A5$$YS\TJIYA O,F_:ICUFYE'#*U!<Z[\Z+ZI@
M<CBF*8E$<&*",$L<=JU;<<CUV0[-/@/V)/GU'&0>%X,CJXQX"L)GDB1;I%MK
MH5;)+HJC^#*4P"=KPH-%U_F$M9-CVNS*.3GB^.P&GKU[LYS$9_] 6'3@0^CW
MV6GWGCDKV]I+&)*PH.+V&\_"^4\J';B/NF)$M=$I+.X30 F[C4J4Y;*"&!]K
M#H"IS8P$FX7FPF[8%#IE9\W7'75VO>7VVQJS=#Q879)O]K>X1*,R/'.X.K=C
MZP/CH,TNQH2/=&ASEU1#2Y I5??G!0J5>(SAJTT-RMU8>]H[CH80JT-YU<)2
MYJ=AUE"^8%*8:HO#'USK?VOJ.M6'D=I&%AY!\/A4EU=5QLC)\M@/JEL]OVU#
M0FUY$3&.(A$CA?<6B<9>0J&70<JPO(!\"Q>$L$)M.W(!Y,F=BY.2C!Z J?R"
M>T\FG3U9X"B<7*B'A=EM-E_^KM&L\RC!EH2?N[S5Y_3; C?QC>9%I/!&>\'6
M\+NQG;)$ZBG0D8=NLM_ ]11N Z^VWFH7/P6-1ZJRZ>J4[RV7V['I3Z0>K"74
M[8PI0<OJ06&)N13W].L%QT**@6<5_4C%K6'=SRFITXMPW4U)I.0(C8,KUYHA
M,Z18D"%T%'$:6:O#&(GBX<XEU V>Z.K8B-=T1JY^VMZJ2(;0LCH=7Q7;-ALD
M_)+V+<C"\.D]S>L;@$0.DF[. =QL&_S,*)+(A@4G9,^8&H54E,CSSCPCSF^C
M*!]^P/<A=FV@L)O_:+[*@"*;8?5,9X+&5.:B4WUK_5B^4G7<]IJJ+-W,\S>9
MS9 #XHSJTIT@OHT#_6HM7<_A85I\M[:W8!5$"RE2%]Z<>I!-TH9S)5\] 0V[
MC34185]/R83)4T^KZF[>SWM9<[=QJ^65W3H<T%<%3>L"RC.%>HAQ9F3WL*IP
M!_"BO;%5I%_+G].E8,2W9/E,K<@"6B>]X@I1?WMEU:"5/8ZW$#-KB5]YJ$;G
M/M.&E4"6NA40O4G,[N#!<&]#T9FHAG[9?O@VK (TNK/.LH95N'%M^.$-W$+A
M%BY=3VH!K>+E^+32-3&/HCUZJQBK@[*B_EP@ GST.N(>#]BPK \SN+JZNO]\
MWVW/#8'^[T0[<7_C0!< PN":""/3CK(BJH.(T896:%@UA5LM=>;C-2%R4VK1
MU#7-82U$P2_-'I+C84L1/7ZPRX7YZN7 I<?$COC?>X[HA]4_B?@C_6(?_"O0
MV' -NTI4(]60@Q45N2.<>-8:5C"P&NH3_\Z^.,OTXN)C%E5N-BA3_10$Y-7M
M17Z0,\\M)E-J %+\;+.31I2PBD23BU6N 38?@PWZLSREE\"!N>8,Q*_W(L9V
MH*E3]Y:! 2RAQ4-X*"(PH6$KA>P ?GF.TSHG^RM41;7=/S)I1-=P4 #Y\^8V
M*F'QZR=CK_6$3IPVKJ],M-S]B#BZ D[@E$](-<BPPH0DB+*$<H>\))9P/PT%
MW1=IN577,X'5CK(R'F=]B#CBK-RQ5V K*\%R]%>\AM=0J\4GM["'S9&;KKU9
M4,.+PP+1#T=&HEG&BM\QJ+OR>U?></E2G?.J_.2*&[@/&/$Q)!JCL>:T$0!T
M+G'DL82!$@1 -_5"D854+ NDWUQ"^0-#-7SSFX)#/\PV?_5L, 0]A5:ET(D/
M\$>H:;LP+"F*["/*]OEHQH2W#LS-/NX-P^\A_PB[&VUP?Z7)!9.TC3.&PGVH
M=1J-J//;MSCNU$TXJ[+; 2EX;7CVKRY2EX>'N/K[WS2BS-=,1G^[<^?:Y)''
M?ZE=9\CF^*,]M(6%NJ@Y6F7O>XJAH/L/&_\;.^4W_6&R/(GV5OZ/B&]_X#N;
MKYS,=99'?A)7)C?^=-#;6=R^D2O4>[EX^<B_)R$/^;[],"Y5EO^\T^3/Y0DX
M>91H[A9PRGC^G[-AN/^<L/S__6ZA GU3C#%;?O$L[;Z&96Z$->]OP 85ICXZ
M/;V(!I^,V:M,PI:H19/L]D<R7%MFQ"(<)]V^HM\]G,'X"C2E4W[@"J%NN:\%
M9/VX'PB>\?W'90_EC[N--; >(;7;3= -TP7[51X_8$:@^Z3!_[SNAIZ3]3^&
M,K%.=5P$DE'8Q NBKP!>E/^OR_Z?2L"1_H\!8O_S_L#W_WFYSG_>?0G5]3_$
M#_J/FR\LH7"(],Q77I >Z-E"V$#=)ZIH0:^A:1/IVDR]0I<\R)4_R. "RB$X
M-2;FB:M>_XE)&EI4-4;'Q%=&V1QB,/PC;95^4[SFVI&_ZW[N_K&<_[B1W'M+
M#.*JJZ@8D6T;3M?. HSC9<8U6% /(+BA83/5N\=.A5=OP<>GA,8?_'-++Y,@
M\+&W0:^'DH[&!WEO3NGP8-75..1-GO-'GZO^)AUI LJ,9TA<<D(-3L=.56)"
M^S"F ;&B:(LY[2VI*D@BT+\GB.L?SW5-2O8VN];N6--_MO_2[(1%B+5HM&1T
M^ME;RY3/5E&[ZJ, 1U@]=C]EGP'GWD@N_H4T+M](GH>1:C#$*V7U2Z@00@)+
MH<$$?L/9B!1#4GAC[MK>DAW,,(D1[2.@'(J/1_]B%U@<'+ZPX)&[JSKN&!B>
M5/I\WM?]:']@;QAC1L23M-?TS014L6=F#<Y*/:5J=%C!3/(;_&%YX8;PE.0/
M>%1_-Z0BP*4LH2K9-RR!V\D@2QP%#K3&->(5J!9])*8QZ>K#QKQI;^4X\J83
MDPTKP=B;_H^\)W=_] GV#OO<&Z)36?=GA?$/]+ARQ+>=$5=VU<CG'MS;?N1R
M[]_GY8N,;[*-9S,"EE -KKOT8Q+TW'1NBDKO+3=_+K_T#(KPJW\43'BQ,/,H
M^!'TZD3Y -,AW_BU2FS?1V)6S!VAV9VZY/OLV&'MV)RP.LE1MY@=@=?2!OQ_
M5XH 6CE#MF(_2%((63M#7R2V4FVH-I]J]TW^!N)[\2QE.PS_%4;^R66?M@SL
MQFB?WCE!;Z4DB6AK2\PVU;@U?+ZB.O'0T+D[*I%C%CGM^XSM)HQOT9Z$V>,C
M@L+\;J3L>BUW9T+/67M"G]ESUBZ3QYGY"6[@(@-33_&[;K-6TC8@CD1(<<N4
M&L%&4!2XT#2FS):>#>7L#.: Z5-UR@_\HTIDT1^R9_Q/Y$[,-%R\I7=S9$\H
M<).PTLY>Y-X"Z(6J1-,5*W')8[OZ#'JHOJ*D0Z!Q;.5<HO[V'G[JD5A[TQ:L
M367?8Y%16:&AC5&RVA!GRN)UV:1-R$K%@$L&\WK3_QWC!?(9$([KV:@2EVLN
MFDB5RH%7>>&W[*Z+CIZ[+,*U-6Q !F;B^*QXMN*VEB9@T_2B7PZI"'IVW&R@
M_[%;R+A(VI' L<V_ NQ<6CZP[B->8'V+I@05+[^6WB?=*4O"!7!2<-IAQ"64
M"O6*B!W__U5OME%)7W$<QS ]S QK)H$*-DUF*W+.53Z!/3A'9.Q8F:E!6U-A
MS9&9VS]%4#FFU)"LE!(#>U"L"%=*Y@.:3["M3"VWIK94W(:H"2QI?Q7^CNKL
MS+W8V>N]N.?WXIYS'\[YWN_W<\\]MQG#E" ;'T/HB0%B#:N*P)<#(6T#8F?.
MX'Z54G4[/^ZA8OKL\:@/M"NET>_*I3<''S^>)HV0FS)-ITC+>(69.;SQ38%V
M,Q2;"ABV.1C]+U_5N0<O;!PFRK11*(UTA66?UGI(2U>3,&"&^\D45)Q)4>\L
M$2=6@%]2?KIAWM 3&E;.C(LI9JZ>=$F@40]QY9YK.I5!\D=F7$)/[7I71H;F
M>"CYLI[SEK&[H+;Q&9)NA.H^3KDZUC#%OQ9/3KRJQZA%P)G^<4S2Y>3 VZ(?
M-Z9&I:2GK#W5Y:Z>E.UH.(VP+WZ @!45\7B2 (2C9Z'?2Q-AVNFD2 [2X@.2
MAV,Y*(L?2#?^,2)M#TG\(7IH1)?=Y%D.4%M=?!M34],5/C2WWK5K:W='?3(^
M/J[;O:?&B1MV__<G?-K>I)E!V]9S4[FMQ*.9ZUV9I:S)L+FW-U<" U-.!E2L
M,)ODG'S+M+BKK"L]J4%9!GELJ/LHEM94*O@Z0.,3(XH.?#'A?D$SV77OM:W6
M/P@RW^V.4F58GQ++CE8Z/JCAJ.=AMZ*Z.W'.[,_KK><@^R>6@\:40E$E0-$R
MP/CAWTSJG(.7^@GB\OBQIU[0MQA)V0"VA"\;$VWX*I4HDJEOQQQ?"2O =QI^
MTKW8;BUOVGL9U(W*)CN-N%&\P!):TCL&^8-%QLNM3PDFK)CUV?-[B8SW4S(C
M6YJS@M')&UWZT99S>/ZGV_:&MX^I)K+]#R.\#AQXLR]'@C!05*EU)+]?%$L#
MTOJ.=N.?$VN54(O+&F8I37Q1W\#A7]+_&$P47-D7KR^-*:KH;Y7I;3U,W!FF
M3/_"[:JG\D*QW"N"=<B>N>3=[(*+P/7:G^\M2)<=CKT[7J=<HTUS@;!QO\:_
MM#</DZJS<1'OO0JYAP8ZO:<'7E7YLL[#\GQ-!HB+@66Y=KW*6,I+6PY?>DG\
MVI[%FI89"\-N>M?KA"68S59G6/")+VP5"4:SL/,PG:G<L=<PY*5[<AC9MRA\
M^MG"5=C]VK*2"+<LM5YL\F]>"IJ-O!&16HC8'"@J@;"@=%@ UP3O$4S@3\\*
M!-*"P E0GNZS97E(8R*Y>.<*-= -;IX+8=M9I6SO*M!IF-I*RN,ZLE'R&5F\
M4=/.@@.9;9@-#<\'PXH[!IZ5G)3MBY G),215RL[!DXDD-<&A!*ZT(.T3A6@
MFRJKII_5!7D<3GL0R6$$+)%<.7,ZB_R+9.<1*CTC_)BTC9O+=> L&GL,>8!H
MHVBDKE6*_*RA$<S?W=/L!N#;F^&]YG6<"(1O'5<&)%,?I1#,3!?[K"V 1']V
M<< IF)P*AVPW@>IV'!:XKI6VT[-;'""L9:>IIY'NSMYFI+9S$0!=#?G'SW7V
ML40=$+ZW]GK8P?VHTMS5YIX^Q53H7&T\?^-V^-Z:A0AQX)A0P'&TN('%6L,B
M=C@H,)X<D0J;CAEOZPT0&AA4TQR-.CY[GW%JEG*N&OO\+N3UP_2<:E?;']2O
M[%%4HB MV3MAJVOGUT77EU %\[":R$G#W X]AI0_#V,(<UK>@#8QFG'-P25Y
M'YLH=R4VHE#PJKZO\*E_Z% O&SJ)^.+2T K#J2K"JM6^A/,KGH6\4M2'^X\@
M?0KS[\R^^>UXI(Z<H\7"K.=(2<(\[#JA9LB)E%R=2W=N2D?FW[!XHP2ABXTM
MK9+EINU =)?WB4?M?M6,N+#"*Z&D% \7#:O"*2<1$^$2BV+ 46WTFT.3HF&<
M.SBD9>5RD^@Y'%<PST1X%/,-R!N-@H_0>=,MRP!U=\?RP :KJ$#)" 2FE)G4
M9=15(IKR3DE\5DQTHJJ0B>;/XN_;E DI+NBW5GN,HKVK[4?QPH0EL\/)%?[$
M-#!LSI/S':ZFNT!)=6,[6,\3X6RTB5:OB[P&BD9D;4('\)W]S93BWQ7K<'MZ
MCV:Z5TWW'U93WDZ,]3S_W9;['5:/8WC9KC('>%"0VB!69$ >GXB;V$^L6J?T
MF0*?W*=7EG^(K_?E>76G&29FRA[:.&_!X?'_FQFK5?\$UH6T.6'X5UK,F.N!
MZ^_Z!AU!IMXL)"UKK:I[-?HF2D[V?<=*ZK0VV^N_OLK]3QI\OO]/4$L#!!0
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MW^A)WRUPC%I3QNE5 2)GL50"YVV\/66$K8)9!:I(2L1[(&NP0WKHUR(4$VE
MMJX$DTOPT<,3>X"#?6<<1<_\7P_,O:W_W?<(^OM\4UCT!9,M24N^,)G(-,:!
M6UBB'870!S;@<B@M7%+9B]E+;;*'$:U UX+&H]Y!U>!2S>((+6RU^JU 'W:#
MI\]THPJP^D:161VS(A<R8(9@#FY/'+TFS\ E?N!\:,;NE\ Y*=,HY1';8089
M)3N4T6'E[45&$>,I&\##(6'\=P+F@+5E.*_+V!&')+%;J('IQW@#\_CUWR0Q
MHOO'<MT[VR51P2&AH>KLPR5/D9_;V#P880&O<3=)1 WL>/0,%SA-N^D"M9Y9
M<F:US-!TIK!KS-ODSYBH&SV^#1ED\U=B3=;>T>/%S4=LUO*Z7M1K6UWK,A6Z
MT''[QK <%),J6\]JFC@HOTN%8>,&O9+1KAHK.0]VPK@P)U:EWZ'ZT5.C7+L9
MG&5$L]V5[&@QF;[![,W.FS.&[4N9C_P8TW5I9?NZ0IZ/=1$V/N;X/B_A.$GE
M=@BJ.1L)C]M=/,M(9"P]0T;(86T-PR%SK@7'T6[!5UTKU4Z%%"G== 7(P)>$
MY'?*<-5UZ=.= J-TX< 6%C0P:%(Q+T>Y'PL1??FGN&_/GK^'O*Z\J:K+6T8H
M;9_!;)$_I6A1/J" X\2;K)V30K1,TU*2#MAGO!CAW#.;T 8U )I'I9C=2KQM
MU?5"OR>P;G5Q$+_KCTYLUJI/NICRS:H[VO+LH*R1 /UHX9;YF>'-_]"?'9E,
M^3E(]4-?YP+]&="HMH'"RP%L8 O0C$K(1*E'[IY#+^@K\5MC"K,_3>@!XT5_
M]P4M:7JE/S<>#\[RBJS1KDN.WO+Z=6Q4X&VEER1D4QVJA;&29,M?1B3NZ<<!
MW!NR_7DDAS\JCWB:F.'5@C+K[!^%EGVZM_')XUW*GX6YX3Y^YLIC[YK>"\=*
M9GIX=]+;G_SK!<)D-G %YKL"QI@WI!PKYC9A5>=GTMP$B\W^/=1 VLW,,_ZV
MU!(2BZ_Z*?M[4<&42]LCT\BNV":DH MYN-8U)XW@]O+F1J,KTHN0<IO4$PR0
M".2W8;+"B6WQZ/%AM78G&AC4B?T*3]GW!V+5([S/PQ[<AG0;T]1F8KN4VNM\
M7Q=;7]WC?S8O<=I,:O.WVC*"4.O8A'BNL_+.#]N .P;7%>9>I8]@#T(?N559
M;VFCMB= VE.R J!/;V&HRDZ#= 'Q#L8$^)H11>8HROX0WZTUV#%8$[(S^@L3
MD.D6C'"<+1X5.@05=6S+8C%O/%I$D(W$AR!EMI"^&8;;2]0 ++B;6=S:O?8L
MJ,C+FAT7,N*]6,WOYVW\B=HS=8R465ELB-KK8L*]<Z:IQ.(Q[)T]V[,GOBI&
M>)Q\G::2\U<V=PP.Q>?L*NU6ZEBG9",X(]TIVP.F/B7O$GNT.Z.. E*PNTW7
MO[3T6V:,IL'V/B9*?6JQUFM/#[Y37IX_,C[ULN9D;R%K]W:QT]KZD"4MA*(B
M=^SQ9R@ F!=D7L<$RC,HBHQ9EO0WLJ+\2<V;\D.G&T%C /^6K;9],,2DXG)$
M7'@K1@L8S,PIG?G=^WC?^.@49_'VMH;!BZQ[GU_%<V8=#.OO?<>B8&=_H_[)
MT(-:4>O8@4;@H("H+#L,\J4GH7ZN%C40G]RX![AC]:C/-*2>\!PMVT;1XI:W
M9[%<2 &V#B]3_Z:]/QRYH_ $8)_.?0%KF!\+A=2FS5A> :I2J9W&0;9B 4?J
MV$4>G-C84:GDL;A\N!6O25XGSV_4":98,T%/8?DU@7BA(99?FU>4^M>J>E?<
MNC._GVL*V<8Y'%#LZSVM7#QVCE9!_7,.W)9TG>I/')V4/ ?0(B6Q6RNVID.D
M*"6-@<F_=DUH5@_V!=9E)9M:VQ7!8CF M$]].ZO.XEZ^S[1E76..N>COX:O3
M]QVNB \3B00_Y'<_6-/<#\0#=@QP#RV>'?!F#C2BQ6-Y)<L(E0CZB"EOVF!]
M/S.5=M/J28?(N)",'&0Z8FL:=<^"*7L-<G1]2!3!C&/V@86C+RT6HRR 3UXC
M?U]6FJ&U[04TH#6/8&C[2UR/4K,%H_ASL]6 L6=?_4K.'4D5 4*##U]X.3\C
M79#\O.M=42KHUB,?'9Q=4#WA?<2GJ*$^<Y>6RI7G2X-X*THOOHK]EL%Y<PQ
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M<:ZJ?^YS6DW7H>.O:U_6O$FY@ISJN6OU."YHW\'/5ZY$;S8X@)&EV[11MZ$
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M5DR\-R_'?K#,SN[>F5<<S,E]$OL/M^G7GIJ'2$EL)*D T5(\M<E]&4$,\98
MXH#9;G+VXNPB4-#"7D/>#WCPE>*M+Z[J:A"QTLR)JN U"0&YGB"I2\S))UA4
MCTUE[VB97K)X:,J@EGE-U0[U+B/LYEV4)EDPNEZB<U"'?VV9DIWDE>:T,:S
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M;Z!135G/AJB94$/E*%@E4Q@@!D!D%(\31WT].OE'+E@3H34IL I5$!HBCNF
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MH(C'NK50OQM(J:*NI =RU.17?I=KL?]+\-><^$IB,SNA3H!,R(J:,@CG*O9
M.R/YV2XJ\X*#';X?!0<25I_/RAUZWE_]7!/UPH,=U5),U@4:M]"Y91RAB]M
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M\>Z\R:<@=!CFH_0-O EN1%4BIVCRH SMP'+O51<V4C4A  0D^X(X*XC.?-9
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MZ8ZT,WYWXZ'SM?,W+X>6'GTPE;_XQ*;[6[;7T.H602J$;'G*DSNO'A@K=[D
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M7_N[Y,EKXAM9-N6$?BMQ:9Y _U.O77*O!CY\-:2M5T!@4-Y',5^C0ITR7DD
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MMP/BP?W0Y<HX QQ=@VLX5C_K69(3',$-Z@J@:;743DF/A@D#F11\7%/% \8
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M>*G?T9B;*5<W7428.0YG5XV[B( >,_8%.GDN)[EU/[8#63-/T]E6X'PI,/X
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MC[:6TX53*0VM2GZY=FF$TBN^9L.5M0S^N)1#1:*?WOX9MKVN.O7QL:U6Q\U
MKF=E%@-GMYW17CT%ZH#=6_\J&SJ7 :5B13#6='R200E])16KR/U?JDPMAX!V
MZ6Y5;"CP6^L;)-X:"YT\Y'=]=,WN+&),IR@@LNCP@S4+"4%E^1.M9&L3I;N"
M,CV1H; U6>6!?=\VN#S:#*3-4.:(Z VS/-[@VA5Q 5;T^QYV:LE^](%N1:VD
MKVJY5ER,P"=AQ<8Y2H(7O;,G.*+NYA<]O_!8ZR1;7[I]"U[W[W.S.U?3N_1X
MT<;4^N@6;SJ1*I7L347Q8L[06YO)*S+H\(L/?$;6\2) )@)_?BQTNZ%(N*HW
MQ.L.]*X:J67(F#ZXUZJ-<- 7JPGHTY%='*DK5/I$8JLDQGBBQ>SQQZH.J/D[
M]%F+T9I'E'Q$O]"5[VUO3QT)EEB>"H;SXLB9]].3"QEZ+.FO*Y248'^XZ!(\
M")]<C=8:NVDCMMB3O0/:1\[K=$Z+SI3/"!#TD[$Y7F=Y.9CW [;JWR+VMXB)
MD,J)I6X*?!)/5>^:!B?GXCH40KJQTH#IG$3]*)FQ!\?KY-;8##A1TN5F_)V^
M&^Z 4EJD*7T#@$68CF?;V1+/R3]N7E/39VM7F8HY+]&HT_A+C8.AYM(6#1.H
MKV\J[(I^CQ^Z/=53>BJUUL,M4D;GY^BZ5 K_ML?J@"GHUIG"0! N_]ZSW22+
M-2A %9_(T457=V^,P^G(0'C/H8&4H* P]W0)7"?7OIK@CW(<T9&=;N'1JB,%
MLRL=+O<?&AW-=D!C P^LQ3<V11:/2EIS,G ^M(#>'5"M-$LR@3S;R'CQ(:V>
M>_C=_6$!&.@H1Z==NUTW]35VC-MG.;48B?YL?DK*-W3@(&#55B#3FK$:;%5E
MYQ8<?8Y,6&XA"G .],]9 $_T.I#Q=S'GK,2[Y^;ITG$W&:5-_(*-,(THE44;
M_=O.JQ:4?"$-L0E$"8#H,(.54.U"K+BZ.;0?U:/O/H-N=AE9B]QO;M5M;)3]
MNF,8=_![=Y#ZN'==E=K7O:,W&XS&O<D)_J9NR(D? @S][;.X=N<=D!<*T!:@
M'9\;B-F5*<WT#>:N;[W*&2 >]!ILL:+7+;HRU'(8Z4PF(SQ>+_<G(:R/)G"N
M):&#6-U?5^A;MO<9JG0'Y+>XE&PPWF-#;1S&+@-]VZ>P?9#J>I:D.D>P>0?$
M+S7,NDZQX^,(CC"JF0< _/81M,!<3ZQ?I$#["C^ZH+-GO$"#+I53]MT(?QLJ
M2?G@9#5L&5L\LW"/>='F;6?([<]E?N$JR*$N4O7\TH9!ZE$\+TSXPO*782AI
M/W3?\E_3HW]_UO#^:!;[T9Q] WOC2J;'K6(ZB5)02^$'(LM9,+I1-7D?-4V%
M#GM#7@%[ C"3:SZ^2@F=QF:8)JA_JLIK55N#*Q<(1QX/'[J&%>#ZC>,L)&5E
M>C]':( [^-TL @]84@TYW?"JKR7T52::G<618+G4Q%BW'&>X]."$UB++2(EF
MZ3$5ZFEJ#'!\J/;TM)Q,6,/EI94@==_K3_-<>4/Q=,OI/J[SX4QR0=D#+NW[
MEH$Y/@HGOYS@2 ]EJ+F,U$(>>8K2[9,+T=LN5?DR1:\9/4_F6TX^+A4>EA*6
M9A*Z82)C+:;TD![/?>S\VRT"],[N9#)>P@\O= ^X-8V@@Q]"O4O_N#B@(]U&
M,8:4WS7 _/#:AUON'F<X/=W7,I@G(UZZ2@RTH/5VT\^;T@E+D&T=%IR-#PV\
M"A"[<N^,M;@R JCGWK>X$;J1*3#CT:"P'5 BY."ZE[9Y#^8L=7_?FW<TM:R?
M(VM/UVBZIM#F:[Y\M+VF-T(*[A?HKZ3-=KXO*A;KL?2X6L\XV):RT3ZG//*@
MV_A+>A6$.X>$4_N1 _,L:;F+C712#Q$X@DLS;%<A"N^^/,GO"AR#>JLY:YNK
M>XRWF%,#]=MA*J,^4WT'ZI+#0C =KC)6*E_>!XE]VD?X+7!_:VZZP+SL!W*Z
MGGF.;D6;W-;!.+!S,8$1:H^@?D6=I6CEGO'2_K<L8P!/R?O(O80$N*A!0FJ&
M-Y&>D'S4X(/;2?3-9%H=W<-U0#T3O7@*8H6Y<!@KS[+\_NTT&27S+(9RZ0&E
M_^)#OQ.=R]EA1\_V.!W(FD2F0>A!"C/%)2Q1<:;XJ*Y/JL[1%GZ&X_+"F<]>
MUN]:C3$.QB>."^34I<G&\G#*LSHI\=KKS>2OF0SU<P"</MU)E,><IJS(85R'
M6/LIY?NIJ&2H?LGW;T! #TQGI";9'2R*3NL\/^H9F1?@<9\Y.W=)RMC1]L>G
M"-5GM^JOM"V'>H ["^2'==; X-^'C!-8<"_Y;*8G9#"T3T';LK8NUT^](6;Z
M0G5]3,?L_F<5:@6_-'0*;>8CBH+[E<6(A,6M!8'552XVB0\KLU^$Z4UO<(0"
MJ(TZ881'R#HP+80AW083&SO\R+ BF0YF1HU-M^' H0I"*U^>Y=B,IK8T%91(
M7'@\LV 6ZO2@.8FI!ZA)5&('274HEJ0QDXZJ7+BO_HAC[@NIS&FWPTJ99E)P
M2V\*#YSLKG3?"W-W7_@_N'O/N";:=E\TBHK4H'01@A61IM*4%A4%$2$"*DJ+
MBDB)$)$6("0*TL4H*"@*4:F*@'0%)$(H(BIBZ"T)49$221#"2":3$Y[G?=>[
MUM[O_NVU/IP/YWRX\R,SDV'FOJ_ROZ[[*DA%_*'R$Y4MQSWLBB;VS;>W$?U#
M9>#4<25:ABVG/?D9X'VL+OV<7K4("IIL,GDDG;6O>FFC==$4Q_U<^2/SMZVE
MWY+S7T?<'QM1=*5:*7(28ZLG>_#JS!RQEFS#Z4V9Y2;WF>RM'<=>99WN^U70
M6^-PNO2*9EU=EDOOHFI!?2]6P\#LU[1=4)F&G>>#ZP0U0D^E#K&YC<QQN*G;
MY$UHIM?:RC*:U,[U\&"EOQ,$M&^O5$\']VUV?4>I"ZKB*X#F(MY_2O@R+,)[
M> (-R;$ED:**FN=@&*0"83LN$%07;S$8L7VWQ[]231WU[OE$FKQ[LNB$DHYK
M3[G^0L.YFMK<J[KL';V!E_4$EU%/<>&_W2NXQOUQ>=T3@?N^SCG2&JV#"Z9^
M8[)]XG^_S*IU"Z_9T3!])MPU;9/@Q=?Q"?/H!+7"9,CY %D-KPLX</=YZF.3
MD=(B9'*8?/@!ZMDG%FDM+J(MW1_^^@3Z>)8GK?Q[1<:GU8<#A_5H+SIOQ66*
M_U86+?QE0,V';TQLWD9A/"-NKNF6P0V(0.PZHM_;:%ZIX*F5TD^D0GE0(1#W
M EQ7#;@\!R):QG=QT]J+U-_^QB V+(Q)$N5+QIL56[DSX1\O2FU?*X0Y(!DW
MW%Q3%TC MLE91"!KRVXTBA-$<^XI_65]5"\KKB;&U;D/KW;^]!\<DP,N1R7O
M&&Q7U!*[JKB !14,>2@NF5W"/T :PK8@Y!;*XY&R5EMPK'>;L!TE;32#2_W&
M]"'6P;XG?8UAG.YWW84H?XW$4MRTNND)SF#O:$R&_9>@L$O'-.PN2O'(\2N%
M$\1P&.JX)"<AR_\ISJ7%3>,^DR3S,QLO$5CH-[PNT5OC4?Y4;?B'/9I5U;'C
M1N*(W1I%!PX&A<W$+4P!T5&G^88/+W6 \TD$:_'%%U:7D*/$=[<(JB7ATM*5
ML,C!(I'9A62=D#F^Z]GU U'_KHU&HM8X@C1O#)*)S1[$;_,6=D+81=OKE(4^
M2^)9[:5$%IA&U*)S7!%_+$@;X<OI%F)"6.'SE23YOZO1^ EA@^3]*]5H2"Q$
MD2_XH%,(&W*]3YSJ)#\H^1*S5L_(5^I&[KJ8Q*B_RM$DK92CD;UW\T;GDWGX
MER\VMA/(!Y_TPA; @R=#/BDD6ISWS8V)U]OS?[IB)?P$+#[ $K/X/:NM<OTE
MZL0F3!T:]5[-SO-G9NG;="2*R+@S2AB*VF-)9*[A+DWE#_V@E/Q><H76@C-_
M#HH8XH@VHM8KJ15?RD A[EL]F3J#Z6#-D-R@\F0&_ 142/F(+; %<Z)(1;QU
M)\HG9_<&=/!#%F0<<.*Q#D8#"L%J_C^_9N[4UZ/GWWM&F\[&V.Q0<$)_%N?A
M_O->J N+/[.H\.&:X#OO/!%VC7B\^!_13(K(1!?H;:]HML+@S=C_*"@#V@MA
M1:G#/P9*HC-(U -0V%<<';+%*A,'QR9L0-F*Z#@HLLPOA@G])AI %>4+>5MH
M6SN)LZY9Y12)!.3'S4N0S9^W-4)8_!4BE-_W9@<L[OV3R5?=R#N+>18DXB04
M\L?U9>0J@6BID)._\RUM>\G4-40GV[\B>W:M\ENC<53!]^X<*(1])NZ&(4N-
MEQ&_1XEIVM-6^9#*MN44&U7$0>(#Y)<OVCIM!27^T E,S!P@(1!S_4F>U?[\
MD+O]=J(+9V[*_X7KI/=F4\28)K2%TKIR<N?>?/#87TTWJMB/'$Z29KY2MG+K
M((=?/D+8A8<BK5:)YL '0'C$/RK/4++X1LA/"'S/445P/S%F[3]#PU;&KAE(
MA.U*C.Z])2$$0<3EP:?Y-,?-T]UC+M^B@PK"+M=YLB_FU3>-Q"PC# G#A-U<
MK1M"V"74,+K=2JX_# ['%5$1:PA;,4T(KBSI0'5?M0/Z!&?\:=B%Y_Y9!X/J
MWE;G&F>/^ZC:W=VC W@@.$[TD8_/5O$]P#"5DQ(:1H]71_WJN*,<W#E*G6-M
MWW52?$F&'[.90!7AXR<SY*&YB;O;"F&<W,+)F>5@]*1-_GV/M"*_]Y\=HW@"
MRQ*^_<_GU,?(G.^;/7X_3MW]>8?MWJX^R8=E</BMDD,H*3>7-.V! J<VN[:0
M:S71GH7=$_0"\0V3#]>%4%7P&68?YY?//JY2F?G:W%^:.'FU[5 ;_WA(_!NO
M@8C@\)ILJSXDQZE[I#=44 :9"6%,_[W05=,%@781)'F 'T7^T]!]FPI-:E/R
MI=!*/6@1GN?"<?)04IF2$$:U00MA'XOFNY<%[92%4\$(2+T"#7Z)*1#"X&J"
MM\2?<P1S(M,'*82I%H@FA#)"H[ CN8-"V.CD_@[TLC=:R0D%;9E;3>Q1;*$#
M?N^(O_=0!L9%QL^SO"013IQ)$<)^Q+%7BEMO%KRU10W/L>H@I1#$I)@SD=J!
MQ'H+8::1W-X8"Q_3A1N8B6%M8JLE [6\];6[$":C H=\$/^]Y^H>^1(F>GES
M!/^Q2-BQC+D^"D+8A 9'2[#!0T\(2[@EPL2&4H(8%GIY]WZ2$";[F@SY68EX
M,/$V8?PM!4.Y_9;R(_1!Z/([(L(K9#R;R,@CUU4X%_$:@.G3E7N%,(G\;[MV
MG\IY!E.]?6CM&P^Y]9W=;=4;PQGADZ.RA@.D(LK /="*<:0@2(;I9U*J*A*?
MC-W7.C^8A)\]LS!'>UW4T8CIU.&Z;FS;]<:HRL/E6HKK/;W%M%/I$6>B]$@+
MXBMUKO&VW,DV\J !PY74M!.@>'$GTQ9_-H:&D16![(7I3>//>?"D)AV:;M-8
MU(>T_56T6?9+]N +=FW"+LYJ&/(PJ<QNIG,1PJFJ?-Y?WC4';#,,$MTU$/KL
M6_3+:BN7A$[Q,MPNA.E3OE).)C,CNS=S1;RN2]!8A)RY-9)G@_9.O-3;%/KS
M:TNP;+!-_&ZYM-U[BC9W*#KNB=_?OO?6%A4;(Y9*P?KBMNWI]H*3C%MGMBDW
M-^Y->>XY@&M\I%?J=OK)]Z3'XV)P_<B^C&L9(=>NW7MT+; D[5F*S@]XL>2_
M=,Y_?_S40[+&#9:(S\L(]5(H8"E50)_V6]WVG^7!/X=O '*:)83AA;"?.ZLQ
MYB(YZXK@3PIAAXQ6W5GG:'B+>^>J;=.A-=Z]&VZ_400_$YM;>J;IBH0M(D-)
M1)J7RX?ZQ^?ID.2&"=*P[4D@CZ^%6X(VVJO+MZ#7,SE*.3Y(4N,%KC**TE/S
MOM&6(;"UJ[5773BF=W-^[.QUC6"M(7UDH1E8)9KNC)6^@.640+8M0[P=&T?9
MO(@>BN-1!!F@9S0+<1VQN7I.>A#H.$Y#UCY-Z6XE;. 6W2S?6:.QC9-;<[FL
M:JB471W__<WMD&#?D&",M@CXP%M0,C\1M8A9@8B%(AU"(,ED5CD<1 L*D7X&
M@RZL\A;*($*D/]X-OFR4Y[A0L\;5.;D-$\3-@/(9SJJ>4O"0-TO@.#$<:'VB
M?UU-].7^#(>K!W/_:-*:OHH>5\EO7#D#DOD9.W+*W3[-U .(Y/M]XFXHW-"I
M_OGY<PQY(Y.;,KVF+FOO&>7PNL-3O2_:-:^N]B$\%.0@&5G$ZMP2OC<@QIM=
M:14*#1!4!"^L]H)2G" *@S)$?X>6A#8,XS6!0YSFQC-5(SAR>X39V=Y%D9K;
MB*.Z5N1&7XC>-F2-E6&W53^/D'F;5/,GHA7-.8(<,6="-_B'"1^1%1V@0G@7
M [G2722'6W<+[\)"Q6EL 7;XLU I:*E0;/*2%;$-M0Y4 ^X8SZS*\[/:D\!R
MH3$2W%5&3E0WIMO'%8]YT+MPUY<-(9F7C?U8)",-77E^8$?]P\!\H+SP)PEW
MZ3ZM)1.AV'A..6%KS>^SY(K"5)DGM<=^;QR!Z^^MDK5(A200ET6:*K:.V!P3
MEG,UD9L'Q@#*^52+&SZ-)":[*!Y_5"M6[V;Y0^_JA'[WFS5U5XZDJI#6'#2!
M$G&)O"U $6=$9$\<XACP5 3/M@GN6\E '\8-.%>(&RQVF,:*D_2M]H.:G*_^
M7Z;)\')CT[Z%AT;JJ%;RY=Y?BW#Y^@!#8ZA*;ZAZIX$>=%50C&0\1%<S!546
M_GP<L5D$N##=4BN-7%0))G@+SA(5/6S03-](D!O"HP%W[O&1YHOFZ#7 A+KZ
MHMYN3[4.#36:*EO^Y(4(Q=&KZP\?K%NNZ(4A=UJM@MJ&B>Q)+A62M15D5)>K
M>^+W]N!M^=YX!2".L]0Q')ZC47*!@25!BKG\#E,KS:PC\N[N 4XK6^5/II1R
M=U?<GAB>YY]XG6UHH8STO:O.=R9\0M?0KQ-T,60)2!^BC4L *\E.(GT3V^2G
M(2?(,C90 C<",6&<@7?H*F50OIMA0D8F(_WAR?WUQN//7XR/8LSF$K\UO%(V
M2^LG!RU_;M(%]\U$>)O;"\2(S484!CD;#LJS&%DI%JK%X.'>)A,0"W1R#=N(
M:D*8/XJ4S7NHD?$2] +J6-$##7TU/?GY2Y3!89L<6"TM-$;%RT/*';<]%Y/Z
MJ&OD^:/'@!H?#O0/\)B""F*@$#9LV]JDRBU*A0QP&#M!+M$7+@O@/;M].:X\
MER]Z(R???B'0B%@ENC)XC)O#IJ<T>G\[JM?H,GQN<'C,^'GH$W@<\@(2T$6\
M*QESX=D)'C>NXJOA+P,;^')X=.\B98C,6R]XT6C]$N<XQ^QN3PMAS&XB)Y8:
MV7 <'W>Q#-:2%$CB 14 T96[JEY#LY>9Z^^D8?_H@4BE.N\Y9FF[CI+=/10-
MK2_EGP1W<0=FO3E9(OYGZW'J.I"OLD#Y1);O[29+0I>5 J?[^F*:#HN< CI-
MJ-NV99.N+Q!3K;:][=,WVC]+4.MBR5S(_7VT\K?%D<L2V\]4I 9C!+OET^VF
M[9 Y>S;^LZO=_V20->;VAN^5O:8@OB%++UZ"\N+7]DME42'3JHYG0D=[C/QW
MESS(/N4O9U<1JWS:1_?&AZR3IQ\>.H4;3(0A/HDW?W^S4IF*V'Q-1,P7N3M:
MF[0$Z4(8(YT7CEX/K?]I>LU]#+ ](R@#7?PJ 7K'U)5;+L[]%CN\U=F%CR+-
M'/2S@B\4M12NPXVMA*[&9A.;;8C>Y&%K2-*5N5+5OYMMSS\&&/"(@A2DMUXT
M%:&"#,"@-G=-V$>3AS-8M^]&%LU0X)#8H+O?LOY3'B5Q7#(;@]@(S(YWK2VK
M,!E9;_5UFR0RE,AX@'@ETR$B6:96.T(,0]Y034Z!#($^OCW>0_#,XAPK<%M+
M7=/&!']HQXQ$\=2X1J#.R0&+0[J?F(-K^N>*[8J)1:I=>F^;WMWG$>HX:@S;
MY,4&RD8<F4%N06\ $IT:W3^A/ <(Z@#J;+^QVKU=9+_&WAJ9G=$-#Z7]5<X%
M:9Q#=QUL7=^[1OQWFL@"KH-HY*K$VT@?]"UDU0"5G*RQL;=)&Q?!(POR"7H.
MG&[KVEXV-I1XLVDO0-K%0267LG_0]$)_5NLY]E(U'@:N'<T*YT0Z=?M?D=2&
M;A+]B(F4*G0RJ%4 'A046^AQJ.<XKN\L@^@L?=)$=TIM_95Z<9'AO0%G=U1
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MY@TL5:#;(G'#(_:;OU(CU._5?M?<=WS5G[4B="L MP,Q'*EV-.<L/9:^'CR
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MXD(JPN*'J#(Q#3Y3)@Z.O.DAN@HK D3:]OR@.V51,C,]SI+<&=L7V@=_EV2
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M$>[VWF'Y!D9@Z):@;,5@W6NW31^["0GNV2_L7P^1@;M@L!KF18&;D3 V>4_
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M2V+#]S0+G?@R%^8O9O&7U6967(J<;)3Q^*VG+2%GQ%<_R/E^LK%&YQ9TT44
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M2W=D,?"(/MV(295]<(\U)OFTN$E4=^#U=N$8XXSIFC-#>F(1V@F_]9;XR>W
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M3 (?@[Y+X(PHS\GJQZ!B=&5D!(K%>!_Z/9%R@I+0YRR!T]@%$Q'Q8,C!1D4
M+#V4!L$7]Q2=(^NSUHY!0590)[RZ"L[0=G[TK^/_,<BCI'%VN%GROSH2B2TB
MX0O^;0Q _Q>%UX_\RPZX8'^_R6-$SQ;,#5>>/P9URG_7A"="<W2L*=^@2WU0
M'PN2*BH1<I2(L?N#F3HZ3YT70_S*)M:O0@EI,$Z%]  $8(#T(1.@?<AMS'L>
M\HO0SN'_=LPG_S\[YG-%_/?'?+KKF&TD-=9 4K"15+2O7KA)@1)_9T!CCTS_
M'O(=@Z+@CU%XPYT_1CR;.\>@VY$BQZ#U$4)F9+[="@_YW( HE;&7I,GR\AKT
M7!!-X[#1[Y$XFEKKY-C=C?R]<X DD+K ?^2:>JG]6HN$']7^N] I"!BZ%+-P
MB(D/1'0R&!W\_'>1_4.W^;\KL?^3@@]'U[PD?BHZ7+T2Z.TI$/^I=1X+9EEK
M=!Q^$6Z'J_2QP!_&D;6+?O6NS'M_7?E2<1OME6.;[W-6\;;+_&RG/Y.TTO>/
MQ5%LB8FK+4HX."LPTXDV2FKAP9F!>X0X"6R(T\B_$70!)]N:J1;-JC552[ZM
M>FW([;&+7T8/!!BWQH>Y)BK'JXW/S"?K\>UBF*ACT-J0-"U?.'ZL#55GU(;A
M)QN-KJ3/6.$9GE-E0SFZA%3&MEV]N)V>[C"O/3D8JO?2\N7\2+CM8"12%R@M
MJ=!T$QST_MWL4P71*0F"X$(TF/Y<.U<2#LH1&M*.%BK#P7F ^&MX1%R=$[S!
M1TB$((=T+;S_Q*9,V-E;HZ$LP,?5_83H_70<[K+3\H;N>5:N)3ASI!:-0RQ[
M57A#Z%NOA(L#?:[O+,XW-#_%E^&,GNN(.-Z?4N1F]B^?#36RG\#5Y-5H_+%C
M%<A*Z8BVGI)?1*)11!C@2I#7 Y0(HL0T0& !DE0@Z?0WL6\GE)=L@[>+UPJJ
M*/TX\RBN!C]46>FX/IKB_OFKT9&D1BYU^[N9L"1(Y_G[)DR"D#;>KB/M-)"+
MD^_:X0F%MPF=P'N\O5B+P_"%-MO4_PQ7Q0Y>DKK[;.<@Q<DRG=F4V5(&WW.Q
MZ95HF'BJLL>K$0']3AV)GUJ>V$'F;BK[Y"<M ZP_QYKMD]7X<+UB9_&5S,K?
MZ&3I -?RM<8 )8-@]S ZF<F]GFZQE!@IX9\,!O];Z\S_J> \E#V$\*%- %3&
M923TK]15D8R/02^#RRB!QZ#IG"CE^_^3)(S2=%V0=6&A&C7(+0%;2E"KJ)B>
M;RHTLO,8=*$>% 1=):^\3GMHX<Y2\L;S1/2JICDC_;.7C+VG*Z*#^M1VHH,
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M.1FU _#-[$= \BBJGWX0_K<F!CB-&1H9UHMZN8I@?>/>A\I7;C*:H$FH',+
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M(XNSH=D7I]-(1<73TC[#1L_Z969C_BPK[C@S@QR8$P$<QLLG6A@C,*MCIC(
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M#/05NVW1/[C94P3,X>L*KG37'R!J@_',N9E>[H87)>[HYVS&NC^<_"'/(V]
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M2JR@K6QF"<6L@=S[KP@N36X>*9$LVE8?Y6OA+[W3B%(-E[(FAPWCW )2<Z:
M5CG=MS/77T7T;[IR)G:[EJS6LO4[Q4G+B$WBL93J**>8N"5IR<V*BVX!'M1\
M&#H<_]\9_W_CRO]G7"#KC(JNM6=U;0"#/;F1L8NC.DUJ,D!%8CXAO+E>?0#_
M3\]M#Y&CW?YC<XY]B_[64^,5[WMF_+/N%@=<"SKQ/>3)8;U_J9[(S1A!)BBR
MBM@ 3_(#+*F'K%1&N4?=1/:)#;-CZT4OF@M5&@Z">1_1E@#J(;33=YCXI&U/
M.L!O\]S_S8 J3FCE3;VZE3LRF9;36_WTDE>9Z]EOE1_6M.C7,@4'842?OP5
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MR/BC_$L.2(:Q0E>]8ZU&D@=#\2@(^2V7,+I?C SNB6"F=W_"@8-M^@]D37!
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M"3H&%N: _L1,<P>I?!_#NE#D^B_P@LE^86![F*D?_C_0ZU!J$Q/]13#$P=:
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MX3<\MMEZVRC'9[^4_@79-U&%/K\>JSBJ!GU\Q;N,6YCLU:"^X6. $9H0ZF-
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M^.[V,ZW ^Y8Z/[=R0T#W)2R.6)20[IN'@SROS?F]7:R7;8]H_*$:YT6"BI"
MW@.7KF"MU(JO,O3BJ*$.V;&'L/M)U7:EM]*[AJL$4C2L76S4C#NZF\(E9<4R
M$,[MC6@>3[\NXH)WX($?^AVR%K>O2N22CI)C<U>.D;,&WQ@&!27!,Q=C 32U
ME#C6WJ(4 HMO%?J)U+KUK&O/X#P>>1S]5M&X@U5:)HI/*?F:AAY<?M=<V!C_
M[9<<?M+Y:ZAZML?$&4JMG77PS88K5F]=SYF8U38X[J.$!]8\(QT_%JN09PXD
MF/G-&7N2)B"[N;N$O.'(3^MB!*0==8R67WH@2"2MHQTOQ_X4MN]YVT4\29"O
M0?29\^YH?5Z< &XZ"T,=]##>R:^XDXHW^C%"T(*:FHH+1 ,JYBUDVU2/W4.M
MROY9CB9[!YEZ7E@/0&%:JL/]SKRE.[@- VZ6*'5?D')!I='KMZL8O:>\@E%*
ML+'W'Y&ZNQ[?&P]519S0/ES6 [;BCWUS\+Q:QGF-6!7S41=G=9VP,#CU.\H(
MDG-3E12,=$?V2#@65A@[(.^H5OF-R+<.%KN,J-J(NG1UKUJKBWLI[670E1_W
MGE [\\EVW]/2!JLG'@C)FU-6?;N^#'9F"50&O"([-.*1T8#^L4^U]9$A39]J
M:R.[)[SE)D?JBAJ>?KHS<3%0*=$UD_!8;=?%MA^_1?=!OJ\P#X1U8&IQ#W'3
MQ02J(WHO:@PJ)TN/ <9+_W) -2F-9+2TSX!?!#0ZH XFZIO55 .X$L?B5F97
M:R'[ /L?%T/4A75JWVNYXED%B#T?>D]\A')1C"EF1+2--^9G1*&FT%0'&+ZW
MVY"-.\,!)3.M&7I #C&^JS^!L+_Y%$,'H=MOE@E]C-H-A!)5=(0D.QP!3! I
M=(AXZWWU\.%1[Q?MIEKN?IJEB@Z5V>Y87-A:0$W::N8'7YS*VPIUR23K-.L-
MWZ\+_0N[%F:GNJ67X<OJE>I57IFN.3F,BDBU2)\W1VYG+D26'8T;%5?DS21=
M)+L]_:YEJ41)%@S<Y))ROZP<5/>8$_U!;P1$5NAY/J*+U'@;/SKE8S"=[[]E
M08OG*DLT*94I\HG-O\;09O\,8RM]8I6@IPN@XJU\J#Y\,I[5-9M#4W $I,/)
MIF2")**F\WY: PTHT(QN%8EE6JCWZ@QWN#AK6&VM&FRB\5YL?E?JN5#;"2_Z
MEW\8Y/#4Z6$38<2=42O8^/V=.I.M1Y$:5.Q2*56O+5\ZWH8:D)]$9%@]W6T]
MRM;KC_*7J-2\F=V'2X#GR\6Y]ET*K7-+8LLNLW%?P/-J0HTO*GAY$LSWZ O<
MLWK38<Y[,&W:T^$ET7RA2F(FE_HU&!YY.]AW?YJ9^DS53%5?T>G..$M1$HF_
M*.YW=R)%,Y_VTL'RQ>$V+'&E!U.?19&>7@$4($S14B*4XD6;(_.U%3)N,?UI
M#7&MQYD/ZE)A&'K\,-0+'+>)GTLP5B[V\;9*1(M.,LV AFE+IB"1 %YP-(>)
M^Z4O9(>(UG5-5814;<*8HBD$^O&=:+.'B+EV] =H)Q9/IH?6-+(PI3DD'%.L
MAMY-Q75>,3GIFR73+#(/J45W3'! B2XC&WUUTW7Y4[V=]*:;[OWZP]XR+QRK
MW6HE;9^';^S>SHZ;Q2_L"ZQ<KH*K:R@X5RTO+;]NJF^,G72X79\_97GDX].,
M43.?6_=HS"_7K\U%FY_K>;,GA"_Z--BC,Y&ISQV.+0+C 2@QSJ';S*#3KYJZ
MBT/+$7IT8Z"."$Z UN2QBR/563]2&<:HH6P=#J@3+(S4KT];<%Z!5YI(+I95
M^3AF-5S5'AT-&W5Q.^MZO;V"$3[[7E&H\."7/2)%;V_&' (]7@*)M?_)3;?L
M*"#TWU ?#N17BSYYOY)GZZ6$LJ?=CT&>N>6XB8^/TJ_LO#ZSK_QXY.6MF-P;
M-YC)K]/'9I3U#^F=][GB2[!=7-Y-3:>?&_$$OG+WFHF=:B=,RS%7"CYUJ9J*
MI@>P,MD0O)^H-&], 9#YM54%47IEH'86^E&&\J?>,2*ST,\SLC8AX)BH^;33
M-QSU2NJO8/H]5BYZ^C6&:HE+Y8"$D9 PY1Y-O!%;H*/('R/!5D/4N TC[<A0
M$=?4^.R^[ARBU1G;*\_:"@#E<Q]33A4"_E9U#76/,N2=-902E5,7JZS:=@ZM
M8IF2LY 4]2+8;Z;P/X-4&&#S+TX=&5I:P:ISL<$)*9-0U\^OF> X-34K:P5-
M]-C_(<MB0(>_J^5I7.F-&XU-3TL27%?@^%ZZ]L!.E;D$3+539YX32;)B.J?_
M5PT]O9I56.LN:T.=R6P,H.UV?$^='(MW:G?IFJ%7>&K&WU6R:M10'+FK7F>0
M0JJX<:BR(@I=^H=O+KYG4:N22Y^[T53;1?B!<T)3\43<K]WT$AJT WC7_B.3
MK66B6/=^5,=((@L]ON%S=\HA96.WS;.")]\>[MN*)Z7V? +_6F$+K'!G/Q_8
M*K44?D[D@'9Q[ZAJLH_I0;OOW'%(<@PG>>+H<"V&9VJR3?A(EMM(G>^ZJU:0
MBO_$<R.-^10)#L@5';CRBQ<\L;L3NHM]BJD/$,F:X][T4M:K.I;_=4"3<18A
MU8&'),.U*0I=DC=[N_)WT>(?&UOHU+\B]>]%)$HX8FP^MCQT<5]NN?CNEIH,
M\Q:!>N%E77\,!R1KK$<SI;^C]72#4S%U\3VIT1!Q#L@?C%?N0NW]&5)E2TKM
M@$:CE(>0ED6H?D-P]+JU+0/2AA%^!_UPHG) /?!=>V938V9;\W"<%G57P](8
M%4S7X)H0^4^^L)L8_!"=-(B4>,VT966TBB_@)&R[5@ZX+PSZL^4 ',,RJK2;
MJRVKFL6(%5$V1G!1!*%'IO0)X=*'(73UAGJ@\V15P+$&I3;H]$N<$%L?-82I
MCZ?LB(]D8)R*M6/E(XUH/43X8Y,][&_H/4QKGTS<@4#47L">"%]J/8%TKT_Z
MFB84W-TO5[E]+#6LB6P]E"CXP##B\VHDF"D^Q^:W)-D"*@V=T/&:[B8I2BH9
M/9YCQLJ::QQKWCL-%F;*4B%=J?QNR+.1=>P^&KVP"""X#:W[5SF='SC\_J=V
MI)RKV6CEB8#*V,GWT0LD^ZA/] NLYSM'#!]B#H2F2K)_XJC7P,F8>DQ,'60_
MS"<3)L@^C!0$+*D]IH.AGRHJ+"G-[L)UTT9E&ZX5DX;[--1O#,Z:#958C2OF
MPN.$BC'?P5^L5G[!Z7#6$]QT P=$M>H3FP;'<&7'55)I-/0N3)YYE3:7B+0H
M1WPBZ75B#RY$N$F)^4^=H@5B3S3@D^N?]RNUYOGNJQVB'+YYM&%MBN3<6LLU
M3I^?"/,(ZPUT.@57=RSI2!T-Q_6$Z==L(5:>I)5T5PN[:AJ.S^EHPL48.Y1,
M=5:ZV@UV;CMBPK2=^%6O3ZFW_([4<-&#O$9+<D WJZ1(_91/#!7VA![FP$:+
MH#LK WF$YMH>X=21 Q6>'VN"/,TBY>6U9(P6ER,2 VPF[ >4!APET_"#O38M
MT5LO^:<.#!'!$PIM,EF4'JYE[;C/ZJVN:3$L2U1>VHM !VKB-;NE=,/*"K[2
MI%SBH@3I 8!7"<QJ_P,GE%J._5"H+8105SM4W!H?(.[D#U>D5F2S>ID<$/8C
M>')^J#?[^M<]11\T+&PSOI#K]:=37R0?Z%95Q:IWU*805'YWU3^*M>]1NB:?
MR'_$XG:7ULY+M9H_J/_;WR_^EN?O?"SYI^D_'[L?_M=C:_ZKP[J+B&2?Y\-M
MG^FW#7_#=@>W!.^,R>$G (?B1>?2#N=P0.9FN1&WAI+#/5HBHPAOY4;$[5QX
MR.O_HS*"3M,&+%MF,@+;)_S?RGOLO%ZH3D;]DC_<C]X%\'% <@.*?%MC&\>:
M1:*TF$_1ZABJHREF@@_6 ]\%<'6>_(!;ZDP?^B)+ OIGX2H7^/^W0716WK,1
MZY!SS#)?J=?;X!DKV'PU^VA55@'SF9V9^/[_'LF3^C,*_:9TZ/HM+X(VN2A]
M#99]M.!^J7;&1))EF/=.%0\8VV;1E-L)>"<2KJIB^QEVADO-5,+88]FJZ^/3
MFD\N8!B/)S H_6[#L0VE%)Z->>"0T];3]3)K1)E. /K]:OPJ_7KIEG8_??.O
M@I+F+I]+&@MN9CGFFLUE/Q[?R0)N\VO\^#%V?B<MQ!3:^W^*-3"!;G"!H!6W
M+5)RE<P!.<L;KKBA">??86C'.:"Q;^AMM_T+BY?*.:!2'=SZR%6:6C=L51_
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MW#&^A,9OYNL_#0M;VTHU8IU/9[J*W1I:?TI8PTZOQEF%M;*XS$4O[/D[Y_)
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M!N^#HGFM<C?;+1<J=*RZ 9=8%<;18C(L<;@.\.0M8*%AQS'OLLE.,6M:(D/
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MP(TG4LY#!"KG9B"[$#) =!NA\EM_/R&<5CEU2:GO>W%/LWQ,@<P+.W)0$UY
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M_E62J1=[*7 040 >T-M +GBP00=P\3":,&5CWNL=>AZV1_Z*X%E$SL HK*R
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MM'@QRSGRS9WQ>NU8\Y5+"UTOE*DE0WI^K(4/;V[7]]!*.RU5^:BSOOO]HS*
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M@$Q:5KNS&/#5F,-/C"*OY-&*(9?=8N F45*9S-84@)B_%-T6^:%)"$F=X3E
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MFZG=]"XTI+@X)4*;C?MG?3O4E\X:^(R92 J&;H3&S##V('46Z;#(-$N@1QL
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M=8#U4;9A[EZ4:)1-:&S^8]\<<^_0II\[YZS.6-"[Z8)[HX1P;*LHP>6W;^:
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M2@Y_=4)@UJ+W<:/%OV#'ON-FJ9799*<E9,QH*O_3OX'5,C.IRXSWZ][)__:
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MRVE5E204K1#OP#WF'Y-)!)!Y<K._?*6 %1M)5X_R.\+;$Z_'VWFX++W6>:#
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MCZQEL(HA(T+SE (AF(Y\JC=+;!RWE3W[^$MP#"8%)#X-L?=D49[:6NH*T@.
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MK8 KQZL9SC<7'I KJSF3][58<$XF,L<A-*$)%*]6\=LT-A3/0*J-6N8#>$8
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MROO/PZ'7Y\->W0=_1#A"DE+PT!'XQ9!D!)/+X3_"B>*^:7%MV"L)6!>J.(0
MK4HYN,\\&P@.P[*@]/O.U[XU D1<6)=R_PEV0='[R2M4UU^1ID]LP^]&;?KX
M,2&PQ].>!'K 0I6!!?88=WU'C7>$,Z.JD0I<)):307G9!F-BG$&76+NQ]&!\
M*^$^M5+5Q03M394![=]E-U_7Y[OP<^,H$OX95_0_Y0!?T[Y\('9UCQ8RPL%M
MAI#$9Y[J;SS;%KT1WVA4?Q3K!=#930($0^L^^18<@7/I/,#R/#]KF2@14=7J
M0DRHU>6HM*=/_@[T=3+<OG$E(4QJ(OP4T3M.B5GY.6MB[F<XSQ*2S.29@K<Y
M)'#+6UEE,(HS'!=&'9/C'N[!"O%<W,#+?4N /E+Z%">3;I?KSY"5&_'N$DGR
M+[S\FW*K'SA1POIAM<"HY%W=*4!X'_2]]X-\&PUH*Z8*$)XD2CBWA4V*K=\1
M$<5P;B",M-.=F[JE(@J&AH;^(%4B5KB]_)=AGZ-EZ?9-VB8M;M[]2_ZR9WE6
M0U@GA\EYUE*V:\>NT=UMQ;_,Q?DOR;0JJABD@_N^/9-UB6<*P71!!=H ]5"F
MB/0%5<"=>Y9-3?X!D'@:MN]'3^']WX&G!\(*C;V2*OPW7;/T84B?'?2O^'6K
M8D#!)/;.8U?KU5YV)B31S#L.#9+9IQ=4P$L?";;5_,_DV[H4QV8JVR'S(^=@
MGX_3Y)XA4(\Q&D:*1TLM> WLL5K*5B&(6:*X(E5]2=[:R[:']XQ42>^)GBG
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MLG@7$M>:[*5_XS3K!VI/Y!Y3.ZV7_W" .S7DH[$.WW=YAE@,D (+OY'>@J]
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M6;'96L6:=P*:=-L!"/$\<2W$TH^OV,-NG*.?>;>12<01Y.:#II:%/EF*S2V
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MZ%]9Z(>&)>_69GW!"#.6@ 'F8=!QR1.]U+^0FG$'Z8(?F'<XG<3RRGS0PIF
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MV)<@16:#\^3B@:>!N"@!5@'/H3V?C'@>Q-S+Z1X_F$Q%A!)=-G,2N3\926A
M//#7M(LS9Y(<M?58U;:T\4QOO_/:Y=L,CC@=ZRLT4-Q9Y;+,/]5/O%S3VJ)I
M?BO-M!.RY46:&81'ID!OYL##,_6[>+OOSHA_.W0TK(WB?*R%_Z"Y_]Z0\YUB
M.:>D^'2O!H8>:]'W$[E@;,S2-.^&0)*3;AY&="H;M"RWKC$._&/7L%^+1HI/
M6RL1ZG2M/V;]^V),NY3//B?@1/8U-VX[%3FY0!Y.\,>L\?\H)EVVAG^0#0J
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MJ.)HO*4C0W2Z;N6QM.FXR&P/1\E^;0>AZ46;/90?;RJKS2NH#MK4)#5+&<3
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MZ$I?2+L0&RN#/A=[MD11!0+Y>5C,1TX>EC(UHX@>[0,!:0PMA24T8T?+:4D
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M1KR82B(=C9I< L[SD=J+!=1C>F<N$$DO#3#1 MZ]8U]CLGL'CGCBW>N463L
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MJ/*U*TXX[!NKE]0UR1=9U*3'4VK(&57.CA3*#G(XGH:$#DLU2$9&%;.< L
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MCUQC6ZD>U^C6X7H7G X:!7S*MCWU>/N=W+Z8%]\FM]^9$&_.S7Y-;)=Y3]N
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M/25Y6"M@:@+*#<S9<H:YY(S[60C7-[-UXC7)MQRJM>0Z_ 6G48 BF254QD"
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MWT>SCH(=1QB8H/UVVA/P\N%F;:\_8=ZA:71,#Q:)(@^K(I+P#C#]X&Y.TAX
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MMJ\OV\%P31WI)G"7JDXT"3 Q,*%<'C3%YHP%_@*I)'U]S8/>YC-WX B[-<_
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M1(T.HQ%)PG\R^*BP:#^XV(7G:.I?F&/!:JPK\+\?EV(6.F".D>SR_>^DR??
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M^!JXKX@@M3@7SC?M%N?U#[:!]P?^BZXBT==WPWZ+GM:EDVR6HA['L%!_G8C
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M(XA%24@<[;W$2BK(,"ILO]@V6Q-6W.$V?O' Y5U[_YG%9++B.;LN,#@YM+&
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M;U4:;2_0$K#+C:YGM#V(R"[+R/N479<X\G?"]N^&MH9"PC*O[J':C%R0+1^
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MSK:_O H@?-K OC@WBPLJ\H-5N/61)YHU5YN6)@$E,%-XF#$*!!]$,V_24@;
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M_I7Y/6!.P\LAJUR0(V4D\#SY]<?[R*0;M[=F\Q1_- QIMMJOIJ<7XB='B]B
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MH^KI8Z&!HH_=Q(OBO\S<K-^+4/(8*]"PU'Z)T830PDS9N5&0\4+L H1(.%\
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M(8(?13V [$D<0+H=$;%_XA8[:D;6YRU:VEM&&_RM7(X17T2T65P+:&SLFEA
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MO:65MHXEI]7R$8KG#O.=G+<@,WH#<;/IJ^^Y^<#-!0F@02#(-^8W$EQAQMB
M9>(-N(?7S#GJ3Y5']1YJ&P.^A5-5_:FZ(\^8[Z\5SCR?E@U[/*]<$7E28T?1
M@?CG*LK@R)TOQJORBNNS@L"BB5KEWQKVKB>5?_^^+- FW3GK871"(<#_WG.[
MYBAU\_@CX8K*$B_[&\V5OA]^E2:;H_AP1U?3E3?HP<NYZH5GM#\.'$NN*LLL
MMT?NI/SU+O,2/C;0OM,FOH/&G6D>56OYZ'@GL\; 6[K,+;N[RIR-Q#8AF3;4
MP9N^H#*U?F$/!\U]"\&,.XIYB-UN]AY\4F_(0S3A=GC6F5YPH*\\G(S3]'[/
MK'M3:%9$*9@)8>_)YI9Z\46VZ0H'2KV:2,'D;-[N<MB<9A<+26#[L<K<UY!I
MU'[0GD&,IY:F/\$J4?*BSH"/Z8#0[:&/.2K=10L+P4;J3H#UE\K:+]&GPF\X
MY"ME.[9(9LW9<-QJK'5\;MWP4-[6KL7(DEC:B;XHCHTY$)0G_>[9A^1CV..?
MQJ_L\]@G$O-0M-/0PW@WAE][6T!PS*BQKD:/A(R_@(N((UY^KX2E2JPXTD;.
MV$1ZX^\"E_'.T6DC+=MM'AV!,XS1$,^Y /F_%X=$W</O? Z[6N.L^M')TYK]
MI# ^BC#8.3TU-#7B=*B+*PTT\&-A10*B-ORQ75A-L(SE /=W2.$9YRTLV[RG
MHRAD&/DD,R^N8,0I;,VJMJ+D<^]*X;"<>F&;=YIE_ASCU43D]9M/M[II8KNQ
M/=02#&?GP&H5.#"*22+*H&X38T)Q.SGV[G0NZEK5#Q[BMB_?K2K'<DBVV[O4
M^]CIZ[KAC,?-3VLL==[?;3MTE98LR+QF+;\MZ HBC:_WL(S3UP9!>?\L#]_S
M8E^B<ZCWQDXGI"FUG]]B%;:.-K$P'F-\4O_1&:6=XXGK&W6LB%^*2I+":))H
MDH>/,9\'/-UAG=LZ?J7;O^"-C*YO:*J*:6&F.L,V?:PTX#Q&;#P\=8=NP83V
MS,J1Y/@7XZI.D0:Y8>6]#E6>=>X_(%@0TG*I7^PX$O OD[,IC 4%J)6H8"S.
M )ZR?=Z]O@8&DC($YX3IOH^N98]DKZS'7)8(<SU76UE3?=6[1,E2WNRU\-?!
M%]XH5Z@76:8\2R' 95G@F'9,ACB9$E-%:7YDNH.CW>T.>L"881;!*HW>=V?%
M4E4[:*I&TRN_KK(BY%:QR?>2J8X#VQ/GXP6\P/X-XW-'O_S]0'Y+?@%)7WDK
M7P(W8F7BK819UOHMZ<FU>Y)'9GKO2D_^2LEY^1T%QNU1[VJE9_I?\7]UXZC(
MO$R>6!A;WS!5W6$0*$8/#EW^7)$W/D<X]'4B)ZW8T>-<JF-WGK!21_'/B?6_
M%[_9&A]MZ<5;M%7(%LAW.Z[>[D@[4GS!_AT;UA?W^3<O"UZ*&T2-0A4;1IP[
MK(=)<2B/A8307;>'/!X;GRX@X4%?.J$IT\'[V;3=6D6RN?N[6XH:)7$;>G8U
MKT;+XZR3SO=JS]/N"^VI2X6;EA0>XA8/,<A#, BQ1/>7L%=N@TZLVX"8%U$"
M/^ *^C)@D=3B).,3Q.6[0[VBB.S5'FHT>ELB;/[UUM_)9W[;>W\EC&NNUIVF
MD[_E.DPX[KY?]](E*^:9^58):PW_#P+Z[Y*DQR4NB^PBO580.B 6WB:?,=4$
M^K[H9]Q!R;A\"4M05'MJ9OA3VH6N<4A=8G;<<D:KQ")?I4TMS68U7JAS+;1#
MO.75BS!G@HA51M&#_*]*"86JQK8JJH&+-KF'!M22UW9;)B^D'HK>X[KA!/5?
M<T_-R\9C>W&E5C@7_%"#NPO^)\<#?.SI[NKIM8OD[>GA+?[HDK"75]CS_?>W
M6_\5KWOYZ:G\/5Q^H*$*688A 7'$O:@[1+G-&?0>&JL3PC9(.(&_OK!"R>*/
MJ[#I'\&Z&;->8VSZE^9/X/#5^!E'W/G8^59+V=^.W[U$5NG=^FX/=Z\'TB+7
M9E'.>&XW:D?!E-Q7C[.#]_9;OK[QFB;OME/?5L%016%;9)1UHP%FE]O/FM1>
M_(MHGW.V7ZX:"R!S?'3?79MW;LS,<M?_>E"U.M!)?8AC("5Q4\;4/?:;$F9W
M4MK>]FR1Z-OMR><R\UY<GFX[&5#&5)FMNA4-JZEM9UGI#TS_@B%RBGB;*A,F
MW)2AG%"#'$7%5S7S$'$<&WKT&;+S#]U,(9<'1?/9!3\M=6&=,:^SK2]KZ:0:
MK66N5!84N)YL]I<^1LM=I:%8,@ZM^?;E$=-K'?>[TK8NBS;\E;LC_OC;@GP#
MOLLJBC0Q7.=; \UY,<&*BT>F&L@*E00;[09SK8[#X;<S"6C!!Z3K;R[Y6_3%
M2HF;BQ18R38;?GF;JY+K-NX>]NY;\PU\0LOH%^](PY<)5DJ[#PK,"=U0[R>H
MG+*K2CAHVVPT_3:S?W+5C(?8F@FC?@!+<3[$Q96B?U)6-_J"BG8Q2) \2GP9
MB009YZ$^T)^E5'_TS>=BYD+2H47?HB 3C$7/JSM:NJ+VFC6Z^9[,>KCY^%+S
MP,%R>1X'3TF!@0^4$O<B$S19RK1.//U!+ZK,FZ/^ >J1W3;9.!/^K67V5%K;
MJ&1-3GT)XEAU;<!T\VOA.][7=ED38R9L4>$GY7=MIV5YC^T,7!P+[(V\+OU;
MI=[6>:= H\]^@3-"@]EW71%SSMDE TL:I,8,)*:9<511J1,,W+@4^.$E[7!4
MZN$^]RN7LL]]/G=Q]9Q/X&W5R'CG65K1GM6?5J99G\,<#WDGCW\=6+WC(B^F
MHW#NO5KWY;?O=FA9.!?<O_]T;%S&WL#L]\*&%NR7-CC43CS$#5\I;)OI4>YC
MXDW-4]KQLA6/ERG"86<4;.JK_+NQ>Z,,F0L/@J,55[L;.RY5WN\6=6MV?S_D
M674EFY[I57M(V&.+T[E?]6F+$6C.[KC54FY:E"CL).,XNMY3XBWB?>PN, <G
M0/3\K@LI@$]&@0>EOG(*YDV*?X&9IC'N/,3V/JC0JRAS[K;PADQ0M5O);N?<
M.?Q@&L9$GH?8^5I%>D?!78FR$Q?Y9K?<-6@1XC_@8?JCQG]7YXTSSYY9OMCV
M1."7V*S/@5UG#?0/Y'PMQ#V4.7]4'BGN$GB^4=*OYJ0EJLEUNOOI;3#K@OZI
M/9)3[3\2Y!Z^&,T\9V67\B(3F)GPMM-KGDC]K"^;W.+N>Y"=I69X^99+0://
MT;R>B6 E&>KSVCFY@]+O.T\&A J$1F^T]+>%Z*O8AMP5^]M-X6L+VH"[#?;C
MI3!J P\AAJ*] XK%$Z%]((X$"3$Q#R&5D6GGOUB^\65>FORD*H5WH%)SFD7H
M1R_9K/)RV>!W3B.G?5)&?ID+?<V1CA%\H<+94)(/0;C^#%%\V6+HGR/XP4O%
MI>RN6L0'1$S2Q9,"Q%/?COZ<,' V4BM\]-!0_]=>I1TS7;?++ ?J.X0ZZ8<&
MC%)L2HHGJKQ-[%II7[R$$AL9^3W./4*/8]5V1J(\KN@JR3@X&7B7]9>'GH4R
M4;1Q2A*1'VO"N<!-(V!W1%V'T\"'3(*VL[X3'FEAY<*&23E'RG_,:ZU4VVL6
MK7A]W[%A'=L8F6^;<'QMU_O%IB*U$ZTZ&"L80D0J\PIN2Y@-_7?9ABS43]U=
M<X26+5[?+V4XT(!Z1-Q5QD61(%E@QSG:;:I(&7JG5X6?YX\1SUV6!]?B]M=E
M\(?FM07?.%A9N:%;"1GU2>B%WWY<R1F65-<SWG5Y2]B\E3GZ_)O+UVV?*Z!M
M@T6^K@R%4:0[U>EJ8=ZI5V@U>D(WOJ0>^!SL%'7(<_866>)43<'E_/$=(1'$
M6U/MQK\YQU)\?A%MQ'2_?6 I*CV^9?.Z8-1U5GT\,>"I_ 6I[2<+DKV/496/
M>NL)?O0>6"% PD>8.JO>H/6&_>TZ?6Y*W>&H?> ;9@SC;I]QL&(<LY!LJL J
MX.BP8JA-=>K,B0_B<2L*%L>*E&V(=4^<F+2TLVNY_85>NX:'I]H4L ^!AA(J
MLDX@2A!,W["F1OF U<QANBC^D?%^FI?WEH51=**Q"6W8^[:7-^9BQH2"%@-3
MU_.:F/S;8/]S1D5X]@W__6K5#=#U]I:$OV\]OR\V]Z14'O>R7-" 8C"SD''G
M^<?7A05GMXS%.=$^\!L?CZ#Y'5D[0=[SAU%Y@5&)XEYIGM2OZ@XSN]=T\V@C
M>497I:?0*BR\/?9YEK=5EOS8?*_C<&VGO&+49QFNZ3[2^%5'5$G30)&&@L;?
M^#,O"@O5_#P+6XZFC*=FGKN@[)94C:+E0=I,?!+@NS!4W>(LP%)\,KJP/2QN
M=/)1F;8X#/F([+R2UUX94<7:Z?F>AF4/UHY'/,P:TS$/]-8A*1L=%A!LF!V<
MRG+--6'FY[^Q/?7PXFN$) *!\(,?^@@_ 34U=E2UH#R1[WY]B\][O[#SIGMU
M94NR;EGG6ESXE'@.IV/Y][#EWV$O"Y::;_A+9SQ[:I@Z8UND8O;[2/!MJ]R4
MT*K2_C<GUGB(F96Y!7,D8YF',.T3NH'>FM2SM/:I?/;3C72[2&UR*Y"90 N6
M-BD9IA+HF %!CNS]X;J#T !>6JGA-Q\WV"L>.@.2G:./<+W8-)CG+PKQ$ ^S
M-YP2J<Q84!PNDH]+N='^PR;J2TE[%$ I%+"\ #/ AUYT"4V0AY!QOC)7W43@
MO#M U-EP>91P;[H&*_WV4350#4G:L8*PTL!])/L<ZH,429QISD-8F"\N\1""
MRK[>VJNFO[;@YC!/#Q:/"'T!0^_U/+][MM,O^B&@4>UWAO'LEXC$SZ &F7VL
M1'1Y^!XN$V@X"]!RV,IS4U[,6%'?9JP6LQ)T#60890;2]8.$,M9K[,7C7/S#
MN;6^IDWE3CM?7JA$9YS9'?VG'')$@GIQ#?;;L)H<3'M6@GV8L.G@]Z1<  O*
M,!9B?XG2$\U)CN8O7?-O?O51TO^@H26E1F;<:M>?_5VGEIEZV[B4,#M=-(FU
M]4Y!/:RYQ40V61UE[388/1^CUL'ZZG,\S69'V$>K\)A&NR?U-#_P6IN+UQDA
MY\OXHN&4%$#8 M!XI82G=Z+(/=0*6A9;_!OL7L"&R!+7OD_\4\1Q4H"E)+E>
MH16U1,^AOMF\6UE#C;,HF9-*>$(%MS$W*O@A1Q.45DP\]P;F7)( E?.]Q#:/
M.KWJ-KN!&0X:'L,&\Q"[OH].<H6+Q\>Y7]/5PP'A//)B<V?@O><_QB:7FI4\
MMCXS$1+,07<3/RR <7$-Q.4K==KBN3@2#^'(0U#BOC+R]/]<4.:<)M%Z!D8'
MFADKI2#6<(6'2!>?B$9?\D*!&9A-NTO>O<2QG&_8@UZHT?DJD^5MRS=9WD8\
MA(?[4.DX#R'\-:1\82,W<-UIV\G.W]&!/$0_!6]*O>:8WRDE,Q,#O^0AE%B4
M%11<Y9B@,K&9^*1^#7F#R;?"@(Q1G=C2.$B4RG298@6.0D; ZRB4,3R%E>+D
MTANN:I2\M\7$.LESQ(()W1B*[@DF1 ;7SEYCZX05IZ;9IQT,F2WY6!%:#>WJ
MFPFMG@8T#L:>'-*7EIF4IJPT<%3?K]2//9^/6!KXR5XE3,= ^ZE,#/ $D$8Q
M!>OY!Z LD^^JFY]%U4B:H_9"VFP>@KSI&]BZJ2)^/;(7;KJ[0:.>X]\KJGB(
M!R)D\YL$CM/L4!V[]L[($%L'+,;IK?HX1"]P*])&1E1JH].OYDK]5E4.=B.F
M_DHZO8[\(P;L.%V:]2PP(<CG%06?3YA^L!ED1>%+)\!:5B1RA<Z$S2?(XSXO
M40P@1Q=@5&%!X#FEF?ID+)2'. EBC39^CEVVG+*@+?(0KUJ\"THJQ">LIJYU
M@$G%Q1%R'7\&1YOZ<M/& P:'[,NM-5U+:E*'G>3ZV?. >I9;-MZT$C6Y'LSN
MD<[*$N3L^0)+NQGQ175V'HKILW9_:?/ZH F(#7N."72&S%KC!%Z QR?OMU$X
M6N()0"R.N4+$?(9SMI^,W;;\EAE\NR2AST@7+SYA>>9C?^K>IY[>-3'0P>KF
MRSS$F'6ZY97YDJQ<I]KQ]RD#GZ@?.!_'P[<>X6SG--B<N*Z/N!MYG8=@H9RC
M>0C4].;M;*MS1!5,#T==)]>]8B[GY!!O3,)JT^[VX ^ -H**38]XX>=%E3/5
MF6)'FN^/+(Q6I\\8MO(M;@:DRNG1X+:79\(5!PU0N5(Q_GTW!VOID2K,>??@
MKGR(Y5N68K&FA3RSL.=M3Z)]VLFA >AGNT%R)/X P7NA$/T-NM@KMOV*_)@+
M-FMUAC)U7DUZ;&7EC_^ ((H0 =6)<^2"-U PG\:^ ,=79%$DXA0=HEJ-3 ER
MY (W4 S(RHZ!@X3J%( E(RAPI04-AV;N8XG\(N4*3F3B>&C_*KNY8L#U+%>.
M<\DRS?Z,_<&PCO-KJM8!B3WCQ1:%&T7JGYXB6T_RWTN3GKK74W%1B.MYV 0#
M)]P.J X8E4L:Y/ 0WSNB I!KV\$0U)JS))$E2ISE(7@(<TW6YN=P*#$>8AUV
ME8'IST[,.93@,,#,S:X>]"(9/*ER0FZ<Z7@[_ 7]9W(T&PZ*;?I4!4=[W! 3
M&4*T6=]:+]TRSTT,.+$J#SA#"0TSI9-YT=6). QE&#>S>6.-<AZB9#Z<FVNJ
MCP-FD^+BELAQ/$0N3 Z^&Z8\1%?[YJ?A#;!'( ]/V/$/Q*&;X7,5%>R*ET.K
MYU;9G:L6H<7'\,M^+%.U!=7V!2S<*S?..X15A*Q<SKA0/CP>65'H,[FXX\0"
M^3-R].14(O63YVN5,3<L/\>+S?8%CP^L8GUPI03R_@7N4^:D,L1FKJ'2&6=1
MM&$4W',3YS199%97G3R %K],S!6,601+-%AL9O\-'L+8<C?;,.S]^ZR A*\.
M]!>!L_@S?=F9\<EU%+,U9"M*N@7M"$=TAH?(X7[V7\B93(QP793A&H9 =6B.
MG.>&Z3W*G"JK:>,IDOZ#PZ)/HT;ET(-+4"*:\9+]AX<01^'CGB)9QTS%Y[BY
M.4&8Q0LWCQ</ C6S55K98B^C%:+08TG'[=.<] [D1*<??S]<[5CZRR;:,3C:
M ?5,3^VPP:3!9(]@Q3HMJ(UT-/L('%\<9M'$"D5@\! "@UB*!^1CPTA'K@B"
MP53N@CB@!IM'#BY B? HM,-4'E@R@?RB2[*@%XH2;84W7Y'5'+_8T+.:*\D?
M;5F&AU:*BQ<UHQ5JK!S<7UWS@27!PV_;5N;[=.%2^X$#&%PR/^"?(,(WT)MH
MM#2<R*>?-P:$,;CCE,DDH"=Q$*I/XLBY;)CD$$OQ9"3Y+!C(-3:"T'0+F*?A
M/A*S'("3!YAHYB1,/E3"Y.P1[:F3=#G/#IW.L>[Q"W[]KNZ*[6"VU'. I04=
MFE_\55:-AXG^E\#,36)H]+&27Q *Z[R=.O#ED@7Y\[1!9R!UX$7KBF\]'R<.
MBSJ"^2D!<]\=E$<N#Y$)9QLE[SGS#Z MSK=I?=,Q^#EU%@6U*@@&A,%0BDPJ
M0G/.KSU(MS+X%"P7I<KL= U;"0&N]C@%?>8A1ITXY[TM-_0TJV"L^-"T< XH
MC^#JP7<@#_%+\!0/\<QD@U.3F!69E+M?+6+] =<\*A+I^\UN93.S=O[$4N!T
M\?1-K)Q%?8'D$['O2(,<%133.VYV;7@U%9S#;6R-,O YDA-'HEI%DXNTP5<4
M(2<BW4$_)!3#2K@I:[+P2<E\DOB2..I4<Z&VWR%MA(J9^U7'7N AM!8(3L&H
M9ULN+VTT1K>:OIPV =E)S<E[AHXZ!LX*' ZK5X1JR3Y>&WP\Q*,[@$<7#Z&G
MR1J&>TJBF#B!$!=-M)XY^:^;6FA0-U%AN_S2VRB]->0RW-,^,U->SF*^.M[O
MF64T/R#"2,$2YZ1"EBJ!IBKP5>3'$@WBF:5?1!XB]3=5!URSHRV2*JPB@L:"
M> C%;$]Z.DRF*: X-EM_@OA9!P9C'[09<:*".;<!3C.,6 8:C"6L1O 0[])
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ME;E,IY'="AR*G=\Y1H*"#'S+$NZ",OU3!/.D87B+$8N2"XOGAA*46'64/\B
MVV6.#@///8U>-#&-S05GZ!7JE@I/!M^GV;_4]8A\7_9[?LHW-'ID6E'4?\C.
M_N8>/>\K@?<=C A?YX;:AQVA4]M=DZI;CBPE'NF1][]8?CIZNY*@<>))"C:<
M/4$DP.X7^!9EA%IRK--/RDME4DR(TU*07W0Q"3[0$674"= CHOSX^TH)L>8$
M^:39NL@0=E ;!5*JB+.82FS)&]"$.R^=/7BSH 5?S:>8F*SP0[\6?VED]GWU
MT%<MGTT=]AX9/!CM_ @ZZ=_S<RQ2D4C)<$W3EV'$)-QKI9B8KW\',%26")%$
M8&L1Y2B?NTUE^(=[SLUE08(L6-D*M$7IWTEA]3">L3T!D6) ?+8FJ:<N(@'/
MP,5IK9%OC RE;** =*7HYEJUA;I>4?+ WXY12,;/#P?374;?)R?;=XJJJ@PV
MG^OLMO8,R,-II7WA -<9,O6,NR3Y2#<@1U6Z_$A#PP&1!+>LY,,1*?>CPRGG
M(+C)'Y5!QO%#7C@R&E9_.J;9L6DZU,JIA;, ;1 9M]4?7M'+-:@=]&!/HEM,
M:R+Z UD])/PM8Y)<>YTT#W'SIJ;Z@M>M3VME9=3KSN*L45]HMU];FTIY2=;>
M+^B_5_I-WLY7#2+)\W+;_ Y')#E7\A"H\VOO]]'O(;9L/R!_W34AL!YIE?WO
M^QANIO)PDH:"$]&QJ<P:),G07X8=CP%C4?3.[2@%K&&.N* EZ$09SP.>11>@
M1O7!X*(ED=#:]T2ZSM%0"ZI3L-V P\RGB<)&+:-+%\8KS=_;U/G>\VPQ,AO$
MI*K_R7E<?15NKH\\)4F3?Y^[\ Z7%3@]#;QJ!JX#+!&XD6%K86#S3'LFB>WY
ME?-U&0\KKB. :!70N 2.FO 0Q9 ,:R GZ!LV*F@%3E*)#M*+41ZBU'\@OA2S
M>M,][%-72)6SQ3M?\,$OSP'U=BB\"(D&%3"O.!%[]F7M#-=?3\=;-;G=>/9A
MA9^%F<F &HFCTDFQU&4GR!"@$>A),%^JHD:E<9M#6'BHA)Y$Y)XV8JUO7(97
M$L <IT*21ZJJB:#EM[)H:NC$?#OL,G1+&H;Y*LU>FRWK,G2.&AO'FC@C+O*:
M(?@,./D,15'\LF;*18-!4"HW%JZ=2/H''B)CDC4 *RV<,'FQQQ\'5=3!S=/.
MIBB]!=8P@PCMP$H!%PXKUF43U9+ 1%/D22U'DIQDIJ>YQK?4S.GDP=KA*TLW
MGS36Z?9 NXL70ND\Q,-KXJFS69$F=S(J?@&*Z :&?,K4L@):P9P@L_S7.\HX
M#S%#9GF Q$XQX(LR3,4N=7)'I,$E%D6:PKD'[4V8G,F[F0DO@<31@V7@) LN
M5=N0PL1U^TW)>X>Y.O<Q1&M.OX*;^>H00W-TH\7IRH>5\[ET/?D#Z:LA>SL<
MX"I11-2=<Z\I&UH;" 29,USJQI_$IJ 1LKPK5;'RL/[&.]::S,(?- &=A_H,
M%V4I.IDKE92$!)5!!UCV4P/789.CTNC8$<B8$THI?\XLG9SA(791\&-JR@Q,
MW'?U">E!!W=X 48A([7EW2U?F/BGJ3 'Z@D7C /,HGNA28LST8;#ODK@C.:B
MV_.UVG6#%O^<L,EI-8V$R9A>AJ#,9)8' 4T9(G[9E%0NIK(>24F PJ.9YV\Y
M6HIU53Y61WHW>N#8(V.)R\Z0,0]!RZ2'PGBXC1H]#D:':A,8G_YE'[G%6@-?
MK^'VU44MTSW^;VN+9X_6?1K\)(AQT 5><?P5\=+\RHG1$!'=,6,NW7" *T3&
M-@6S_2F3W*<X4'>#G@0D(14M%N#- 0]K :8]%+CR#MH?";H.0%(4,@&SOBU*
M$[F1\,%9E[GM8XE(<)$;L210_0#[8.3!<;>:..2.RN^F'ND_T%X\A-=UAPIO
MS'.._V7W,Q:_!>'(]O43B\7!ATMT/%>* BN@T^^BM/57&><5&2Q=F<W[ZM;)
MC/$0S6R0&9@#%)M*)4R&ZD/?UN!VU 5H\F1RO1.;"><KI(FK8YMW2HTU=E=>
MN'YT@H>HS;CH.]G-G0,TQ1EW[QI-3H$\Q H1=?MAPR__E'D!U.87#PN(Q1CP
MX0P=[FDS5EA4JB&J<8E"X-SG<MG8.RBF%Y%T=%.C+3#(/1M(.C"&&K6'FPSK
M2YR;-'CE.L;FD<:$O7,P\O; 2"0^F8/HZ51+'J(Q6WP)]?3;\< 8G#]NZF(=
M\ZR\2- PCL)9;@;<42QA'$F'PM'F(1(+<\AG0,SS3='AL=X9>;T4+FN? )%%
M<X[V0I+@KUM4X?JIG\!->5<6%(QBR80)VW'QCZJ[AC5:E'V&IVMB.4<8>Y/#
MY&OS9W,\3@YWZ;WA>(GDY ;FC-^;&T;1+Z0\A!1_-BA+*^%<!W"!,YA!<\ZI
M<693,+C.FDH*@=I # 6R417GR#*83:Q_]OF#PCV%E6(GL6.!K&Z8*"CU0M43
MTB-9#O8^Q[^'@)!B>__BP3#WY@([=IV0J=?B1Q^%7,U/N(._DH?L I86.+?X
M!J1E:(M\T/7NXR>4E99DH/#O@#L)$O4%K^NCD%AC.&XOM4E;(D.ACH:%=<8?
M)*A;38\4 1HYX-J*K'GCRMP4-TU,D.AX!6!)AVT[3G]YXZ_,*DNU9JV*?DKT
MN4VYWMR.F?]IB??B1HI'&T9)>76X@AV3Q2GS0L@-51["I/8\<AZY\8>'8.WA
MO@*:- $1P1'N:U.3ZSQ$+QS#1>@;;=6T<C0)?%A!3^)*\1!)*#BE,93)O!MY
MSD?]]+@B7PQO$](8OOC4.>#49J5CA7*%%Z<PX<8M]WV_%ZJ;3I-9CQPTZG.R
M G\%\>>\J^B-['H6;11$QBMPR9,XPJH/0.O'/9RU@/=KZK;2\IQ9*$B=Z-'A
MJL"KOV8*6^R*!D%LE7GC<TXI9<8";*OOCEK0:0X\EI+2<<3'2OU6^<ALU:'9
MJOTPD^F,SMC35<R,G ^3KV?M=OKZ>M@R=Y["D%@="Z4%U3.,_9.L(MC1GD3M
M#0S<CHH3UHT!#SCG!4JB-(TKR/#F[FXJI^OU;%&-I*@USI0Y1[:#6?+/D5KV
M+3CF<BN&5\EY)F(1*ZD,<?YC1+KE[L5VEB?V.N?XZ._2PP,SWQ-(!E%#3S"A
MELB6W=[+'":@I;8+,0\LX%BZW#=Z'%DRLXPX0<.:)GV*8WX@RF?K$3&LS;[J
M:MW>'&*I%)DQ!1,'ZN%IQ=IC71F/PXCUG:O?6$C0JP75VVTJR_).S;<>B'3U
M2UM7ENQ>03U9< R<(J,&%.'FXAI4 9-:KY @1U-\:,E G^EQ-P[Q67#C!HT_
M9H;*:IO<,RL(B;J ]O5(V$X7SFDWW>,K#;B))#.G,(54)@P7\  A9I,8%0^"
M9:-($<Y9,(X17J?B:2B6&BSX=#9*V6/;@PC=7^FJ!Y^ M[L'ARQ$7CYS2KMX
MI$(^AA45.HK:,9FEGN$>?E-'RF'/HS [Z=[Z496>=,U;%OGM[XKCK:M',$&$
MX.4:Y?H:LQ>3/\^3Y1Z0;-Z<.CI1\.5J1-G![S)F[1<?S 5C;6\5-JOGK:!N
M,?SO&[3JTUP_RXN!:YWB7YLE3P5([]193%,P4,*]2+E[6.#DOJPNS/<VW:"Y
M=UYF[F[+7<?+E]8UT^=5J83C[/?)U.*>"Z6S&H^^=G8E'T;G2\]PHR,G,O1I
MT:H+O=$HRF*>S<K 0(=OY;DC%\HD,T=R"^O>CFU@3W-4*Q5C%B5+;:KGH54C
MK8[Y4]<CQ%NM[QHB4#NNJ6P.[G5*_Q639,9#U-EQ5-[&:VT0:Q^FNZ_M#X@F
M[H<D?_'_Q)Y*^V<4SF#[$$R E/XR)PZ\M%.HC7]1TOKLC<WY+G69&=4M+  3
M_SY+N@J:UDU.]>1*7MJ)0"""^/FG!MA=9I+SFW-30]<^OXW?-+T&N?[S[)+2
M8QQA;2;Y8"M_+__*.T00PMI,*IKZFX?X]A^[7\GX43XH:#<.W2H^;F&F>/V?
MOWQ?OXQ\EOOV+A_Y! I>ZE=3ZC,>8L<YE6*^?]?N88I[AFR]9'U"."4AA,W/
M:9:!:[3@HN2+BWQFDA?Y(( RN?D3?JAKSGZ25L1-<NZMP^L04:F?YV,G\!"&
M*J\14:]5$'P_Q0PG<9B6=.7A123=P@PA:6V&4!"+3 0H$X!AR,0*='E(!=%F
M8G7K;3S"$6>SGG$T&CT)10O":T5HH6$5A8+>K%^R_M]>6*=, Q0>(A][^<7%
M+6/LC',JK_F5!S@\1#)@",\ !4+*2\?^.81;PK%0K][!W? ^(.XKY_M!281$
M2DI.="N7KYD?EH%.DA?WHJ/-VE90DS#3H=3T)'B(:21]%K7_'^/K/(1I8W*\
MRIZ4D7WOD),' #45?$BYB_M@=.N1%<YW>"=P0/X)^'9!PM(QA."Y?V#!+)ZM
M&X,5NP%JDK.QXU1!Q%WL:^2DI9D\I7JCL:-XXRY"GY__AS7Y->JB^)+ 9C@W
M1V.8_'\0T(E+.\6.\I'/W_5?[^[:G/XS/!F-@V C4*G_VOMG@#RPA)JL6%HY
MYLH9ZS(3K7CGG;>)Q?L)_+TWX]7N5&M7:E1K?Q4J0[MPB*F(;6/BUC,#,SCX
M[TMMMB8/'E ]L *=IG(N')2\:++&=R\+H3,+PS<4QDUSAV+'_$DSR4O57.P_
M&U6%=TH!N[NL%OY=_#-K*%P&"K(^NVE 4/$)#Q%% *W_@T_8%=O@,'&F5-X?
M^1='+V $X?!CJBIO[^Y0>9L-K__+9B+ OS^IZ/O'=8=1%#JT)>4&#Q&$Q6!8
MN@Q8\&-1G)V@^8>I(50S.@$IBI6;'BI*N1UQ,Y4!R/Q1E.W57FZ==VZ_<*I[
MX$IM>=K\B.^>UT=/%6U_?NW0LZ.RC#NH.YA!(YN:V!;2:A8H'!GH?Y0DLI>'
MV%.SRR/Y4LBC;MU^:7G<%7+=D8>A(]P%3G,'<CSI%[&5C>;_@:V#H(FTXMDR
M2]%++3TVW67""C;G:Q\Y7IV.B!ZO'8]]PW?P0?]:2/$%WV,'5%689Z?;/WYM
MVWH[D$K 9D<NMW(>_^,(..T"R.NN:]J+.]11%WMG@S+EYM"7:TM[EK]K#8VR
M>8B+M97Q_=WM[=VJ/MH^"Q[/'UQ9+0_IJNE&ZY!E_Y(*V2&FKQT'R)A*1CG%
MV%2!=BR=>N(NS5++_#G=<([H:#:RZ<?40$K3TDG?_([W3DYDUXF6A^]V%:<K
MJ%0['+>>*KTD0O/X)!!&-@%SW_.=,>(A;#A5< ;]%Y,77H=PT7=<UW=<4QU9
M<X7/J;OA#:=P$E/2&W,2 K@82N]_T+?)<I*7CQJ(WD6?%Q'AJ_Y@L-&T?*7U
M,BILF8##JF+[<27(^CG@/)/0@AD2IJTU\A"27L(2/<9&#  9YDMB][6WY[B=
MK_)YD^\P,O=*8"SMZCL+Q*&C[2=S(Q^Q_XJ!6W;RYX\C2+MNSLE<SZ&)N ]7
M9PR/$]R]\Z>NE;\*%)W/_'#5^53*$/6JLT/-,Z=K3J=F=&N;M+K:Y K5)=JZ
M7V_=ITA*NK-9SH\3\'"^HB;O6<$P"S&JOC;_^ZVW8@QK<KV;)A8C:7UNH7KG
MI8<B)UR>#PB^(2LI$4V2)%^,;S2F6!3J!@_.Y17.1]Q=J=?\L:LI\IFA^.LV
MMEN753VE<G*)AY!5L=!,K36NCS\--Q5W=X.KJ,Y,"U736PH)&L!.$O);[Q[_
M)-V5S[O'(I*^7>J+4*O%X6C;XM5J)2-1*!*T_7^-JZQB@;M[50J6K6=ALA('
M]Z&?3Z..6-K^>3>X#B&NOBWL,B]9XJ!H]TS-\SE3M_\YO5Y8TC;":Y?>]0_U
MSF*7/SDD"^T[XM)(VW-%VO^[V-X9$&C8TGEB^@3',T#\=$:!N?*NO3*TF"WW
MC?SFA4SQB-VMB!MWI0^W."H>3TO:%] \T*%\\$3#%3?DX9:K]VPZ)M<)/X0O
MV[IDB222\M70[4?M+0Y:S;+(=T2NIQ9<[ 'JA18%+PDR+)]%R/]?5G_U@-A[
M\2(9P3<"_RX<\<7,[FV2Q^3FFAKV!>^+]CPJ?DJ<<='Z_SS8<F+:W^)9Q$Y
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MOO1I,=A3JG'/9F9Q\AL$7Z>*R VPVCDDRB_ +48F8,R,)PU 8ON34'Z[<86
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M?5;OO?=Q%?\60,Z+7W(:"K:>_[ML$N22K>SDX8<^4U->;2;]900]\-$#L1E
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M+]#L*EGO+W4<,;UL5!-A]E&]]C_[6?<;\  @)I!;@F3"A,EX*:XU[Q*X@QO
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M,[O315_J0.&'7,Y^C8"MQYZU;=O3?'9]IRD;EM?H';03E\_>2.:4\O6=\=J
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MK:\>"O:[T7YDRCK?P5+UH\<'.]3O7KX!?M,:(O(ID5&!WKR(]M/2YO4T@=N
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MI#GY>OL%%/L%+Z.SD* Z:0'F#F+K%?>LB!XNHKS7X#Y8CYK#][1%<#'MS5I
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M>A%]%?D7-?)/D&; 08DQIJ!@<P>5.)I]XPGDR_@AD]9:!0IO4W!M,V1SW6^
M%G1MDHK899PW9UHPCY$?6//6]$8:=)=I/;N@B8RF*4W$6TX:DADIA[]AE;'
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M@TAHZ,H[^$/)M:#"X<C2C'R?VM\QCK03=CNM/ON#2O>@CPU\]O'S**25&:;
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M@/7[2\0MX>BBK_30ZY)TJY\BOC9%(^]\DCYT>0\&(@P@J9,X1K9'L /UIK_
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M-?QEG)]*!T\;'[M14=ZVNJ*C&ROS]E"<O=EP-O-AJ:\!W=8-7]PZP[OV^G&
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M.&+R1F W[33].0:.]!/\)J09USTT:T^,+S/50O:K');;Z_Q+A%!<&HXP@IC
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M>7_?W]_O]WW\_CMS'G/.?5WW?5_/Z_F\SCGWS6I?!NZ@S"V3CS4OQWH%'B:
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M&?Q^:;ZMG^<<6#16[6U:<N56\KOGKHQ967 0OEY$'\(J8+O&*:[(A=>3A,<
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M]Y%I[-R-N#"C&;D767Z/<0V;9QT/X6[OXV]8TM]WZEQC1%7!3-3ZL'?IH)8
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MM_@\1XZ__/F'-S((=M.5J?U&AYT'ZV1^2<)#^ ?T?;QT8W$=GJ;'0-TMQ"X
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MG$&8.""@U*4HL+AY4=F75W[H0TJMHQN;&1]5W6MY\^]_IA5J$":Z5V]15[K
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M"LG>\Q3N);.<+2I&^I-/1BU+),-.V[;7"I]K=>5&?IP[Y/T\RX2A22E@'<P
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MMY'^'R>O1<65?=7BH.P1'-T87M8E*)!_3?^;:GY(RD?<C9\Y/&JMUJ"WGSM
M.5)*B3X@*7E95_'%+"6@F8IIS1B5DZ&E=R*B4,*T(X.853:89H)I.DEF^?BJ
M\"0X#?O#[49NIKX5W+!9FVX(^R'UI&OD;E4"<PQ'('U3;229;[MOB4N: 84@
M 8J%<,54HOH=+DC)XZJ#UBV#GR97CGXQ8J73[GAC1-T>6Y?(7'I_P[<^974M
MRC$N#4VO&FY65TRT<:J+&7?3<#8M6XR)J!@XF/3Z6(;4S6J?3I4PYZ3#)?%G
MDB-M:.D044,9VVD+]Q":Z,> P+LCVLUC>%*\OA["V_-)M #"]V!#;"_WIZ#3
M9H5SM'B:Y3C=+ABS:^ 8%L>*7=DJ#F*_4ZT\&IUYBK,E[D<J?U>('* N9NPJ
M3JY%<?#%MT/P&[SZXN=J+>]$73X8G[CGB.>'(>0=,D*DNHA,$ 5\.RPO19F^
M'_3OU[1)4[3DTDI:VK(6C,UE?OXD'I*4]'K3 7UI\ $>ZSB^$2K(/_5B3>W[
M.-Y<0$6UI#[Q6'5M,ILRHUR?'O;RRH#J_L/7WU@*!@>'=A_DH,&S^T$I5_A.
MX_?5$\_P/C"J:=?9N\]'5^7$C;@TV"HA%KMQQ@V]>_CK-'ZI&Y3:H^@L[YJ8
M(_M,D%<^M8<G?NBB+T&S7LZ9HV,K=I2%T YH#YJ1AOD/#X[>E!VH9"1]A_P;
MNNZ J)([H'JW_X#8CF\YWL3X_Y,X/2#ELD(=0Q.& .A'0D,LCYREO 3M@-I,
MLC<4A2JYOEP0VK@UD7@V9<!@960I8O[]KV"I+GZYZ9^RO\YS"UU262JI*6MZ
MB*LR+7^;T3QBMI*M\3[<YZWML&5<@6E7NK:VG;4YT=0^]89FFME*QNG$!EMV
M"//>\ X(#HV$'=)$G42*._#,>T7..ZBTMQN> %0I%FX_)!QE:?N:///=L,+Z
MJD7]('.#,X/5B/D$ 6&74?A]S[?:[+'31@LZL-T5_7>P*OQ8=V<H5_==,%XW
MID411)!H.03$V<"$@@*-: Y3ZN61%$A$LM9^34' I"UDOGJ<>6ZNMWA)8KVP
MC41,_L8N7P/M"3MOR<M[]=*^HSE?[U2()>\?4CC4']Z*.'Q7X\#\DW,]SF]$
MEOOD?A_^-6-X[^AYRP,*BQ]DSYOA;1\XZITIL+UCF=.;6)AMT9>AK6*5OW3#
M</CVPFI&D?1HJLZ\]"UX/ZH@%2AY[1+L**I2UO9&^"_?^]37-T)@9WJ?)'=[
M&]X)]\F"79;"1-KY5Y LBY3LSD?9LM)?0X5-^-4<5:7XQ);,?R5/D+%,,4DZ
MJ@$[;Y@RGPDFAG?.&JBA-)$BX]J^9-)!]XS.U?<"_+<! U_O/='M&>#PZT.V
MR\0[K>[^,RKG-X6T_46RXV!1!.I-Z'/=%*;O"#.P #7L>)96F,*6('WTG+FC
M#R'SV_Y4% Y"0<,#=0^)4]>P80FM^-$R1%,OTC1/Z4N.?ES1L?TL91JF@Q1%
M$$QXS[P"8.8TH]>*BFNPX 2F,QES +]D(ARC=G1"6T!O3>WCGXM3!Q0LLWV8
M&4L;,];FX]4K!JY71S?6G$U'10<JQC8R5QPNWVA^;O.N[L.HVO&T+TM[<]HP
MGHH?G#+33WSMI-;(I6R=/=BW90:<:PJU+0[*Z"V]JCP;\=9L$W&G?\S?3=>Q
M*E$"6XW,2H5*__;XDDO35R+/GIYW'^P[ZSX013U\V/7\$=ZV<[*II:KO*IF&
MMN)FY_0'U**X=#+;708D_YIW>1;7P;8UIK:S^;BHCMLPHL1 =P-ZC6>>)%[:
M3W.F^V"M+P@]M_P48(.$.%.]OO_DP;3[ D>].FNR#7XU K507=W !'&F]]E@
MZ\X=T*05?7:\27AW?UX5Q3";EGX3P.?"?D#D((\T^9 7:9IMZP*P(#G6.X>S
M;:1]^L[D?A,3&L]S?P2?0JGD=NG35Y8  1IZ5]W.]FB:?0CNJP.TNX5K"*$\
MXH^5 \Y>'9V[+;I$K(WU,]"U#'^JVJJ8EBXY_ONC1>/WTXKF?R'KK3]?$C#/
M 49:4<<:$MLOT@HB\%/?U40&3&C'XXH<6SHUI/7@AFS[^*Z84X>C/0HRCSZ(
MR[ DWU,3._9;K7\DK\\R)3C2^H2SQ^]05]'^U3]Y=LC?R"J?=AS<[NN=+W_4
M@:DW7WQ2;XA2MT3O-DM+.3JI-)U-=W)]35W0L"$'!6C]8%P(ND[8^TI"1J?-
M1"#+3.O,>NGWN@*.AE&FS+.L#,ACTJ1]FYP4D$YMMZ4.Q'EM6$A,7)D@.&L*
M0GDB44+N$$$U=4IT.^H H&-1; _ .N4$K4V]FHQ"OG.@".:MDQ-8G%9WNCD
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MGA;\T"8[]@20;/KPU?OW)DRO#OF>/\6)Z:5+TFNO[+*BBY<:9E^?;;KE86?
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M=R3['9"3G=O+29NR@DS%WY!) O7*#HB821]H9+W=;0 #HT+[73LD"-*0QR1
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MU!_#^0?!T63P$+K&ZRH>')/SS*+$)L$P6"VA.>_;T[+4SI0/L4* ^L2:^OQ
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MD_;^FH6LJRS*6=VY_)!111+*_9Q$EE%;&:N;&Q65:.B*O @#H1HOKV74+$O
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M&ORXO@950'&2J&"3CU%7' PZR-;3MX]W=TL?_86W+Z+=4B^^A7CNS7]362=
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MX]S;[N& .B(-66/G9#= ? !T">6'Q9)8P :*K*N[;[)68)4ZX80]0@1/^X%
M&6]#:O<\P!N/J>R21T\A#!XTV&=/;1AL67+3RVW/Q-X<H-_XTDIO>/+[M2SE
MYQ_W[D8P8J%&(.*6%4+>NIX*^D.OSE%LGW"])B6<+A\[@-C($.XEG0(T\)8-
M_8NHS>#P<8]KG6=B^L#+1JTU@%5FK^71G[47;LST7[E7LFMN!7;28B\OA+@1
M=*=YRE' IYQ/5P9;Q/!NH3GF+1CKI)+5F$^_GJJX[)W97E9@[:^X G,R22W-
M*.3XKQUU&$-I^FK&;5GZ#P@QGPI%DHHI/W=\&*@0RGR4 ?=%">4LV6CN"@Q
M\=>"$4QD=--ZWOJTZ0>"$[[([4+W/%R'':#%'8]=B#<_VV,PUM-P8%FZB,^O
M>_;E BH@L=#6_WK%^\V?=L68QC. *;%D+J#+'A<JHOA&JX6S$\AM0JD<O(GH
M>=,VD,9B1"-4_,Q<'G\'(]@.EJU-*N"K5\WY/U52BBM O]$/=$Z'VZDY[>Q
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M</?;IU 3&:+[UE]>BC^+MQ_;L&9<@'+=OF//]C_UWDF]*%N;?K/XWE"[2<7
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MMH;8/+K23S:2RM4T')Y\.FSW%&[<IV.\T#7]0^ J_LB@S$;,6(0*#N%O@;>
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M<'N9E\P2Q]Z.KC:Y6-K AT;<J?S\F-OAN3,5-;X3LXR8XC!K?FDU\K-M4$!
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M8W%U.-![IFL0U3#$N&?AM[O+X#N&R?V&BR4'=\\R'MF\(^6YNYC! S=Y_@H
MF%0+NE 3*0E"Y(C8 MU-<R7\WP1:'-Z5*770[2DRO2A>:IK66[R//\7AK%XX
MTJNTY*\CL?&8$QRIFTTAK G<=A#KV*2\!CF;<1G7Y=ZI(3 &6\1R+J+[0@.!
MUR?,KC5(\BT"/Z(YL=<[MD]F$?H=MOU2:PN19Q/,;W^T*OI07.H]<2)6JSUD
M[)>O_8Z'YX[28W8.-*[:*;_*PR_AZ)_--#K@[V=!&(4)B!"@+FQ]+XX[6%J0
MKB1*E*Y9NVQ$Z&\<*2EV45J5 5RF:5T4!H*=E\DCL% ]R.W"4Z [9^=(^6#G
M+?8 V&AEC=/&6[6VUS]$OG2X=SN^YU!OM$ZN@_>1*:H2* ')YU5"C>-/[7*H
M3,!)ZVWL,X0"5LIXQX.?"OV]VYQ^7U%]??;)C\^U$+-$R1O+ =U@"3A6(I,H
M)?DJ\(=]))JD)!X'R"UE(8B6?[($-B/B[7/PH\]'L/L_HRUPVQSC4-6SC*84
M'(GI570Z+B'Z(KU+U_./:>R8HU\?]$PJ\Y?B*;[G%..3 -;'!'P60=TV*DT3
M06W:B9V"_7&)]Y?*BH7?SQ"X/G)'<*%'6=#A";_Q>>T]@P&O/D85<"-TLF7N
M42AW>O=9P-4<F@9=DA$[)<X@##B2Q#-G+?9 I3"N8#0'K3U-G3('8/>C:(I@
MP(5D@^V'S;*:*GQ]&:<^GF[8_ET7NKV:]T_MV^-B6XGW?KA" :ZU]4$_+;(H
MW9G(+ESS9%._!B&Y!#9,-@N!D913V>\/<R:_]8P3T\-0&GXA,'GRG@FOHB\C
MPN,1C1A#V%VS::7& JL=7HSQS]Y%:(HS@I6-!$[]*Q\$@F')IXQBU84A0/]Z
MRLTU"*S1=%%9N $T"^+@=X YGB"NON%S;#INAFES)'73QC.C)!<HN;1RCKY"
M_G/(M$G6N6'2S]<[U77?$(6ZI3./B5_^[9;F2F[[A< XZ%3K)'1MVA&76))1
ME>SV]L$)2-JIN!^ZRJJZ&RYL.2M1])LO?]H4EWV[Y7!@NF&T+JNX#%L[\/)?
M.-=4[]ZY#G3.;ZUW-\VL'SDZ(B_4W5KOT"V2@!_R_?I1A6-T1OB7.WN?/MIP
M1DIW23-R21ST\<K2IM%C=C3;7Z=>ZU\_],>Q/@>U74X7@VK^U/SCS??-F!>$
M5MI"OCY7;PW2S,'$@S>9Q*68[EFQ#"YB J^^$&YLC7JK?N-86'/YVWSNE?J(
MO,^6Q.-V@OAT#KT7(8V1!=UYAM/V^ CV<\"S&_\'NHJCGQ:Q)U='QQ8H28UK
M]//I?777[*LP!GFI.8%*I,?NZ-4\=_J?%.'''#:!*ZVRL!R^!I$Z:+?*!M]2
M #=G-XYL[ZN.21A)3&O+1P)9IYIG#]<R+GC[@&ET=Z"?_\ P7"^EP=MF@U'G
M*=XEBP;+/1IF\10]PG*-:^;BU[8:<9'8B.>2TBG%1LFC)_HL2(24SCUL(X4U
M2$^)+GW9P*K8TOXCL>.6,4GK##_RH1:IHO.<T^%?I/.\PM\WUR#B;1L%*B'(
M%GH*(DS6GI\)HH($Q] =?B2 EBPVIM7O1CMYTA>CI88:B'4^0R_#7IJI?B$>
M?+XA1Z>.RPC[L 8)H:3[;Q<]H;#R<-IP<PQ\Q&@9L0GC+\H0AO V4MOR\F'!
MK1:Q:5:;;]3LAU^NAO(-"_2'OW[:J=:P1R;I6-/7 99Y'W2\BH47JHL$^N@!
M?KWH[S)1/5FYK;_(: ]6":\]#Y/]&XT_"Q)J[,O0!+&"L_K4'+?(IMAY<.@]
M93S:M\BI1D%-:RZ^S#E$JZEA-9:^.GO#AQ[5L)YJ^(9ZN"BOJ7)VM:\@6G8F
MM_;3^)QWO-!8EC2:))2?])JT->C^.\*H,BWJVO3;AZJL W5%/IM8=RQR^J"Z
MB8]O*CD=6'@1("EEW^(.B1SPZ#0";/BKHO5YAR7D Z!T#6CXFDE*><W<AJYB
MQ?;?PD0J]27(O1"KO@HS23)BWXI"<-5(,C(#1HK4%'<_K.W+3OJ25T7+WF&[
MDO49_NMIP4O!6+'T0Q8NP?L><NLR$L]41@13,M5=NO!)!*DEDYU4ME:8]XB9
M0VH[/><LP7%,)YM^9@1F-UCAL+0&8<[=GBE2?+/-2;>9WAI?6L9E1I0&C8OZ
MYV[9;:K1;#2/96S],)W!MCM^]7OYG>LA!VYTP SZ-, S=G90FWXKQ2RPJ8LY
M$2:6B4,)K,1#WOH+YH+]V#<(!5P$8<+;9?L%=%,_8:M8%4R#04%/]A%"=8BR
M^N,8L3%ON2^SOE_V?4-CU965FWXA'H6!&2JKYST9I-P?-9N+?HB[D(!W)H)?
M(JHPHWS"\:M%>=@]XBY<:PRAU(6#EQ/J@3GUWNCU':84K"S#0O/SW= Z?<]F
ML3"\*SE9\4:\7)%RP8T@W*7PZ.B*T/PAKU!7;Y+[U%C6JJ#=I(3^>T$YZ,>>
MG1UG'/INO.#=W>I&NJ^SZY&V^09[LH&AK>FJ[>HN"5ZXOX=]%>Z0'+B]%WT2
MO9;86T]37#ZP[G-=S%?^[XB0[T<QLFO]P(HYB?\L 1[W2/O?N$V2@_._UG75
M_WN9HX8[Y.3DKKM 'F;<<7'[AW6EY#6=2M&DL"K6((!+TW@91Q,A389C/U$@
M<"6,8VR;$V4+NHUCG% U7[BW0XV4WY.7&8.DYJU(%^QZ,8;MW_DP<7?S6>?X
M8HZ,LT0=4DMV/0-FJN12.9:BC9[//I)FN5-S$W^-+1+GZ\)USI4,ZM[UR1U&
M74E>=5#X,?(!V*U;[?,.^76"A1 J2!I2_K^VPY"7&$\5H3*T7T*FBUPI7M,T
M,PN^"]W4NP;17H,$&R&<<KQY>HFW(MIJ2C$& #VSB83<X0U^V*C74#/G!LI'
MD&:-%_</J6TF%;?;/JI]8QY,C6WHP- ?NCK^X$ZL-HNLT"9]\!W@0W:\3)\D
MRH2>;)HV^G#OD8>AVNJ\H'MF1= =8&R/LB+J9U-4/-*I9&;@+"D^,Y4[@Q:[
M91MR:!*]!9QG@A($[H:F'<(H@\6"".S[J:T@(3Q.5%2+=D."I>PZRU<;SW43
M%A85/ENO?!):8VR>^/AYQWD5%)S5FX&L0:PI0(0]E8D7'Q4E45B54]M!I6D3
M%>&?HL=D?>%5L.()KNLH=A<H.,W3JS!/L+)L[.)P#3#A3V<MDOB$^+B*X-8<
MM!S?\1J*XXCQK)BOT?V)[(]MH0#K<W6@XJV2E[6I2G2WTQ58!\FD6O%[W$[X
M,>'QCU@=L(6CW[L(\YYMHVB3=9"A*HP<;Q= F>K=,0+7"XEM=R8RSA1OIB7.
MW'?D'#Y26N?W>S5IE.K48.AGIQ&S!DE<B1(,?/''T?\1-Q(S/4_QMN14S$_!
M1DVYL2?'%L*7G56\!YN,EHT,/8>-IQW#S8P.B3\XAC?5&W.B\AAS4XZ["H]
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MW\"X$#IP1,_9B0J7U]8 1N<ZCII;6'4X/GRL/<"7@$_BU?55&$P20:BHR+\
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ML6PM?_K9PO[S="M[CJQB;ZQ%5I'1?&MV:]O9>D;NUP7E;/]:RL!O(H)%IZ5
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M6I0\=-E3S=HQF!"(%,?YQ,R?KV4B'[[#'_$B3D@CHD@"/B+?8C_+B<5,MF_
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M5N]WP'S.FD[$9]*EGR%0/+,PS<Y*XAK_3S3[[V!G!2'R,N9]FKUS'CA3]_$
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M;1G*C<S23L4T5U_?7'M+/\-[ZU%9-W*'^7U^_8YN0U02N.*Y;'5>N,$_."W
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M/;8]KWM-*F\H=^GBK!:ZR,I9'U'RI=C;0(+76@=AN/\I8".8[VH0(Q:?^#Z
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MHI3X<FD!E?VB7P8T!T_.A)P_IQQX6558TO=3MNL:@BN=Q?$!.U,(3%-*5)T
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M%;DPQ#G+=06*:+,,\,B,SE4M]A&ZMVVO70_W?$"[6*\ETVB@8#BLMD^J^?L
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M9<X9H+D'Z!PMR\G- FN(44A:*G*7'AJ2,Q<:.P98 @54.)>P(7/((4N:UN-
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M=ATV]57'6)Y8'/E"Z)[*[C5$085KIDO9:T55H[ B2ZKYY>HM>XHCQG6MF+H
M9LF"FP\)@B%+!&YZA<J[ '/0D!%>J7*^AZ/X?G#*6EO:Y$R9>*)91OI4L@SI
M+'7!UJSVIU_\:G!TYA5; XGVKQW:J8$'?V=O]B]K*[<BGY%91]1<2]E(U$MF
M<O/O_UA!?[>V1,B3/IVLYMU$^K' ^\A?,DE+4;EF!HXW\@2L#E;FE[Q!![86
M]!6UI4*$C0[@"QNI)6V%=G__,9',!S1F,(@2N)X%0?4Q:-P\ 5- K7#(=%[E
M% GX^WGORT[KF;+I:QPR??Z'S8-L)ND_8>0FM7#DRPH39==T#79&[H*2HH*N
MJRPS8@W1+%.=$WA45U^!([>^O/A&#':[!S[C*XV4-B 5D[#X4V9V'ET.\<7H
M^-(WM"T-?F)_%,Y<=<A^T%1LC23JR!IJC9:N(>Y+;.7$?W\-);E804(T9'+9
M;Z;A,[*XE1#WV].@!]98:",<!HT?*FGH&D@+?Z;<RW?E\F<8=V;7=QE)%JSC
M$['[)"SNFBA(_76<K>$69F'9BW=I*88H< +F:<7_PV.PH.'Z%Z6=4%*$/9O9
M-C&*'#NHC349://(L7'NQR? T54AJPGU%\DP^!YR6MZC2/-OP/G:39XY)P(3
M%>18&P?0"?=[_LQST#5XC!L&B-T'T2G_C0(RLXELT@K?0"KE:R.,J/CU#?(]
M&5SP-?[M(!+20<L\64<" G=+-F&VYPN7_SAZ^0M'*]+]?X": D2!!-@:5O"3
M2%U?4=_.,P-5W'4;LWL*.''?'HZ0MVXG%&6'E!0_%UI0<D9P"$D'8=P]LH;8
M\QV9?^8G7M;&<0ZZE/4/EHAZ;T& $\YN8/EWOMD<LH:(-)]9(<,3\TS[_[2R
M329JN7T5!KU:[_4M6(+K^)45N[KS&F$V=D$M^S> 47YM7B^^'D9SG!/6)Q5&
M:8&SL#F.H\%VR'[J=+')RH^=9465.[\10;/?1BZ480Q=,RS93T6PDP\V-27O
M@!\9.LT[)1(-/G2-T?5H<?X':*//OR-^YA[X'[):/E8U#IU@=M!&[>4@$3)O
M,KJ(B9ZMAYW'%6:VIU#FIGJ:P+-JR98<G(Z^YT#R!HOM1[IA8>SU0/\.:3N.
M4!221B1\JFNBK'ZX#LP$S1]H7Z!@P<4'XU&/=P&>-#21]Y'%:)CY\]0V-;'I
M1&MW_*N<Y)M#5PN?7QB/DW]?HB89\R']W41-4:J"1>)S/V<U 4]C/?Q%CH %
M. ^(-"8?9U&G)T;824+[2P!%%^OD4);8UT[4I@ #T"_K\MFA/= WTI5PMJ)=
M?CN5*::GU)41Y55THDW'HWHG<;Z.3@;E#3E27]@6'"?636O,-)V!#-%PTLMD
MN/+?AO8%7 2O [$C5B$+7Z0#3!C88$L31K/T?A7!VU;1S5(V(.ZVSX1S]OL^
M:ZEM1K0.6B.V+WS8MXF)-&[7.\A!=P:<M'\[V5M6%.NQ-0'3/:T0K.\2;N,_
M)>&:<[VS<%.$C8ODQ7M*\=FWF9NG+Z3T780.0<TH!/X8>.PDH$#4D[PM;B<)
M5/8\AG;G=XY(BH ^BD@ETZAHWS0!FRD3@5>XF";S+M<75R;%SO46'VGFR47K
M1H2(G-YIB;-^Z:VC)]W0]037DZWS53B\2CRQ\[+E &:@ZT)BC''-*0XMR^$R
M:;.3P\*>E\/'J0(O;ET^JWKD4NZENW%_O-;&(ME?2X=LGY"=7_X\9IU)GW*X
M\A@0O;<J5&^5$I[U-%Z\C^//Y@LP@AD3CH,J[D8[D/MXZ4,A "]]*3@A,>/1
MXO[V48#VN.IX0XI</TALQ$NQBK*..1.$W H.IKCX#Q+J)2.',MY;URV5Y+@=
MWF,L];E*%S2$^-:WJ5]C^0>(<]/P2"?T#K> 0XD5A*U5*N!;VB6 !UQJ.OOB
MR\A6:#OG2ONBM#BVLGU!>\ ;:N]*Z:::]FQ#W2DN*L\+=2!T(D/7$)^:JE7"
M(9Y./2F01D]_J/&X0DV=I!!R>.'%]B<JP9+53:)B93(I:;J%2TD.:J^QURD%
M!=&N*JX.,9WT?:&CUGKRT%<8PJH.!^ATZHGA*/3DQT/\P'KO7:W&];>U_:)#
M.VV/&^XF?+=:-1G 3ASN?5I$W?']<_3@E1^Z%8S+Z=';MQ/%S4>KCNTG\VO4
M%RXZ ZMMQ:9K"(>L!O:!+H_";>Z4IS&9IHR#&9*OATA+I(?'W"R^@,LJN*]'
MFC.[_.*O).:@HK:TAXA>3TPQ87L*O?[P1[SBWH9 S(:$LI5'-;=VVNH4=G)$
MN6&$X5<DX,0:X@F<32-,@* EST"K)FA7CTI.E1#'"AQEH"5Q4W0"L9"TO=7&
M%K[NDGB4&GL-L<7%%^*M,)+/[WW7F=9=\>LFI4-E-*JK#=M#VD&H,=7CZP=#
M&O6$06\Z<G> .<LM+F/*9PW!MR4B>3= #8+5N8H4Z&%:E3^,"1[29@5GO\'I
MSQ:$)JHPE:PN=._)];=QJ4O5R_)=,E&<3=.3A;[2$%4* :JY<!(G!5LC #VB
M=!C.]US'&ZV=;<%69@.[K610W07%A97M,YO?[DK7"NB08,ZD/;JPM_EH@9TV
M-V[]NQ^>4@3N5 GB7M$30@SK!O<.]>H*&'>Z;HGVH/>I]B@Z!;Z95$>Z^Z=,
M"NWYH[#G<8?I7IT6Q;)O-0V8\,P#6%1LJY?C8O'QX2E]:J3#/F[XU][GL<;F
M31J';3PSF!/ZC:G>W,QA>9KJ)S?=VB8A,\VK3LVJ7^=1TT^O[_;#-3X>"<G@
M9H>W[#QPL?[NT-[C <4\S/S-3[XY?DGX@ VB 6?<'Y,^S4X[CA"C+.\7%;IZ
ML,_CJ78:/1PK%@_#,OJ=?BK4:J4GFT<M).RX"K61$!4F^PK?3L5C!15Z9N2Z
MU;3;+]2O-M,&;T^XV&_R\:%Y<<D07R:+"/&K#=.B5HE!BU*T?B(]A^@-U-$U
MF$?\&$B)"1+_(M/^;!@T@ 6=Z"@YVV+0GX$1NEVT3#TU-KEL4!(SYI<>9$:)
ML?$<Y;(9LWW8860D7L0Z0*2W2A+TP^^>*+(L6A6+?M>O'NU)_S+]( IV^9,]
MJF/%59UJEU.-Y5U/8TJBQK %;6/:!9^"W4,I#L0',HK@:5?@V$70X0TR.%X]
MOE?++#+]-#=!/53MQ:5PJ\Y%$XT0\\[%AKH?@M9?O2A^:?&&+]_%GVC^[A&X
M;U->G^J@?)[;N[N%9#T_];DX<1FLH]I._N-]6!&4$Z]%9(KVAU+2@T_/,[B1
M325JU@E+NI+NJLVP-NMKKRM(:2QP-D1*C!W_YIR!_ BD7>[X^JL[^8A%R^%<
M?'.K%W)@8,F/BE?' #:8WL)-"<QE&:D._,&K5YB@,8/XM%>94*0G=5M&N53)
M_CTNX5RH45F4A&E$_L<BRSE3G7N->MNYB3H\,.5[RWU!<".&V^WGOM*3<J8(
MX(]PW"M[=118O"-ZH0S8"T.&Q:.JY&A3*" 6%T1/>A*?QG@)2=8P!@)-L9=X
M3=N5LJ<7C94/+_1UKOJ78"9Z\]F*G(TLWAH0VH0-. HL<Q2U7?4$T:8=KDJ1
M<:U):AEBJV.DS $=K> $Q@[FOF&JDIM<]\TR/[>;)?,_;S3,3N<!O.=!/;V-
M;4!=73;0*JBNJT4]%=RG-%J4B-BFQ='Z=/A^7''HIM'9UDK7NVI6E*.V%5#
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MWJ"]1A>Y-Z'[EB$^:3CG5K$<'Q-NN6YT5=/1H!N 4NR#G/V=BR@1,,.Z&Z_
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MC$&S(;7.[,/,CZK^FCFCFT>@+RNS$<M-<GI-79V%&7[ZFFG[7Q6DD2L_6$S
MX>9(N96?&/X^0_[569.X P9"%AZQ9X4R=J6G;593-)ZW+9JIGS_QI:85XP[E
M*LBMLI*=3^XW\%A=0RQF/K\TN9B@Z-/SWD"I>>65U:^8XK@&]X>E9A?.C[Y^
MG7"8=BQ!^_%UT8Q;J?X4;^NOT_CY7V@L:SU!8:%"0WU%Y4QTPLIEWI54=@:<
MH/Z>ISKVP7E*^P%WO-UB)9F6;:@O9FM!4)G+E9%@FP48@JE [#"R@1@*ST25
MJ$H3,K1J(^"3RJ (<O9)=@"+M"CJZ=OD0E>D:4^$AE##QQ^W)P("T'=NM*9D
M95<EVZD4?,QD\7*$T1!_/D"!^(L!D7J42,41>BA>G&,.NC.F:)L#[$&ES,GF
M3!>9K95^KT&"A8AN85(+%,IPV?6B'VM[I;9HM:$J(]4LTC>]399K(15=T7#\
MYIY8IWU?-NUOWX#80/&1"MG<O;@+.D@8?H="ZJP?82D$1_)+T ;BI[*U<&A+
M*N4&+/S#KU0 &LPXP+-VW^'#JFV[7!A3%[K=7*_K0\V=*:Q+'-,1PI9)D>KX
M)1G%3RR#1S'6?5/1O"_G&A1N]DSWEON:<=6+6R<;]ODO%\(ABBI9/TT9#2K2
M0@C#27AY;C+$'Z 'H@GL<U /J: I/+O /82RH>(8>0UQT_D@G5U>\ZZ)86L]
MHV@S\='56RF0T5GP.$8V]I6KC46)?Z"&6?QP0 <;#X>:NYXNU(@N=*_!?F^J
MIN3ZI+'/<'S ;,"ECB"<4W%PF"139C<QM*]G3T7L50#_Q"W1F[I4(2.M?NQ=
MV4>BY)#?K=L[#.[J^< 6D,5_18NL(>ZH]$LQ2!QQSZ6^#F44P[W)U/!B%\4>
M$Z+%^.Q:)<H1?T+)6R#NO+WJW?\\-QZ#/+G]X7#F*47I?858X=.'8UU:K4;0
MX&$"\R(ISYVS&\.6ACH$ 2+#JNG(L'M?;3LIF,+WL6&6J#;_H881J'G!\).+
M?]JKZ5O7O;TVG?AR)P::.Q(L\:7*:M_,D+&B2T;+T"PY4,GU/"/6Q^7F+ S9
M//-ZBRC A@(>*CG$R]GA.S(S>JU)[TBI=D719NDU!,.\<5?2BI[-HPV[=JZV
M#<. >,"5]) R3+(F,D?87APY%GK:VXFN>^QJCXXOD%5O" DCQ7Z--5U]90@,
MO4RO#>93<W5II&[YAG,QN540/\98W27_1\D*02:$(WWLUOM=A)I]L-^\O'3X
M#6CPX\T>$_7+O^2?^:&/%AE<5D%8_7)D#@+BMK QN^"IV:-&V01J&[-XJ\E2
M^'8])(!N:-N(PS"^Q]=9 ^0PCCCC,L?P+:C1-+5IJ]=X]TQ!RG6_NZ[??$S\
MW._M&1!J,3@:XZ8F/Y@3&YG#QKYP/OBUU[*WORI^'JT;H 0'V'K^BN3@  Y:
MBN)  ?=B&FE/*9\6,LRK\EACY2-\2@$7&+8;&XW/W1\/F:9_ZK)_J<Q,85_=
MTG66>MU3-JQSAKNQ1662QA%>AOA[ !Z(GSB,D<+B>$ZR,+682!3OHFJ'WG&H
MC2)4+:,)>F<.#CJK6VJ$!O3Z\%SNF%4NJ#Q%978X]8J7V>4Y>*=.E@5^!.1,
M01Y '!)(8OL3:OZH$N>H<%_"F1L-F% BQ595JF=Y<;YTQY"J8P&R!:7%>;TZ
M^X:UI=R1O\J@-*F^23O^<J."0+U>#%-0X5)7:YZHZWO5(T.8NY&K7^ 8?0G"
M*FE3))>,5X<Z8)DTC=R??9U]EF.7_ZF0FQ:PAQ'.-3S)THLIBVMYU^$BCA),
MCS>5Z:^[TN,54D(0N]WFX9+I;)R)T2PNJ]IK%%')UM3,3G3*F')96$/H%5T_
MWJ"8PYY:)55NO+K-57:C&4+;]\B/48/M/)KV$2.:U3P;$[ZUN8^A7[ROEE.0
M?62\Z>;JS9O "4U^7OZ2W8MOB\_J"B\6KQ2O2!#GD=?0)-!B):0$U<QQUEHO
M+\R"U^2/VN=Q,7.B?B^G";N)8X>T#ORN1JAO"C[]'=E$ E*_Z59#V)%U7N^P
M3*C;L"=6FCA)>);ZK<T>_$DX G^>RLE:7<F5GT=>YQ)J8_^\_-S;<.7FF8V8
M8]*4E]"IV+_TR+FW49?AK,PA?./CB3G!;R(C&C2O*/-$2W":X//F$5_@.\]H
M#JT.)@CB'!0:L-1$#[_ZQ)%/1(5,L9QGA[=A"P9P23> !=).IFI/\I2IED>A
MK>Y"-$,X0%,TS]D4MWRT;U!U2_^UQ=4!V >%N!^]W+_[+BEP4RG.2M9CQU7T
MQ ,T>MTX*)Y=WQ(3ZFT=K.!'(1=^[7G^I,R1=2LC;=!VX,$WKV:3%8^G+XB,
MW80:K1DD1RK!@6UG Y+KC-F.9.9&"F#ABKY K%]5:PL?;B\4F+(5.CQ]IQ^<
MS,S\ 5H*BC?X2GI_S2NF=-[ZIN2QO^_8*W,G^8J%B3Z74O,PWU+N,KX=*TH=
MMJJF1- D:&=BL3#/Q@!3#9 >S';O#@D8]&*>J)8GG9D(YC[G1L_>+#[@)JEQ
MN48^<Q,_QZ,+/9R/%M:Y#CO;1] <?L7=,*.0Q)4SB&%5"@$&>< 1D&\X$'.1
MI4Q^-]&%^T#8;@>FD M<Q>8@?T6K!U<Y2T(G[^0;J#@\VA=_9@$K %'[%9@C
M\-V.LMJ8)],&3RMGC,Q^;V,H941-QXQIET>B&+[! =*>*>"X4>GM;I5D[U=.
M:AJG-ESJW@L)'^%,X3267H'<]6.'/V(_A31@^\H9I% (R3GS:NEI5X"22G@
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MC+YHYB@Z=,*Z<)=2>*A!;VO7\J;#=!;:?%G-;<8,Y= -D,'7)_6J'6%T+9]
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M"OYNA42(4_]7FEJV>&H)M0N)/#K_O0ZY/\.6S$\^#, FULA[D7\1*#]!&6/
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M)KQ'?5L3IH5ZY[%=V?D'P@2#/S!C!2*#9?\IQHL,;35)_3[0HRQ$C??^ U*
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MN8V/I^]Z0%<5V967IO1_?!M9[Y!F;'37U,-/X<WW49-FSV-QO\:##-&F)93
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MRV;R+DZ73^568*)I_D5'O"WU?O56Y-RAV-:64;^B>;B^M4.U/2"YM(O$F"
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M^,VV^M1'I4.UN\A7*%IM,XK>BZ2-DQI#:2+[I9.KTVR_SQP:155\*M9-15\
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M,#?&XV^'C$A,>@ZOK="@II_B6>?F>N%,^'0A6[<Q66<7:OO"@1$6]8F<NT:
MF #4TQ,?B)UH2:;T=B5[TP[M,(<;).)9DU=9;>&YI>]TU<5^FM7_# V%L[+J
M?"G/C.<G#1];J53,R*+QR_<Q88@F'F?M &UW2-52&PF]T@QJHP9-L'Y0] /
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M(3CV/IPE7"1*R,X9)-%Y&X,69():C"><'*G]J[ OAWZSV$?U2B8E64ZBA%G
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M88F_70OY7ZZ%]0:6P(<6&CQ1J+/11?,O&:YL,#<YXY_2" $)$ZA#SZ .D:"
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MTM=1T6@A\H-I'&(>!"/XJ2<(P4N[3236+EV:6!:;'ZQ='S\SAR/#NW%AD':
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MRB-S:WD5JRYE/T"R#7.4, M3LT%(!VM<87'>JN.S41:;*DW2PF\1?4WW+6@
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M89U&!]Y*/M3 ;$!+U;!JSK?*%).':.V13M)I)^1<3CV3CS'W]/J@N"6KY+7
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MZ5M25=X/2V<L%'1UVRV.32T:+QCQK@?BJA+Q+^E;Q==OL9YS &Z003O:5B6
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M942H7S;T98\V;A:-G0MV*^LV>8VUUP:#Z">\,PX9MIB>4@L*6"NODF2=O+
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M@S^0"M&A.\K^SKXY])<G=<E;S@!G/O\7>.0.?'X7M[_^D3_7]!PN71MXY$&
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M[^V2G]6\.;.V,=-A"*LL2$XY2;LF*TK%X[)QM[ ,%DMAO;:5K4QH+0QA2G(
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MK1@=]/3_CX/(^3VYYM"_J^VM;!9G!RPQ?GEE'U%SK6D<_#7B>G76'!="A%;
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MOA7>O (A[[+BCUC @&@7SR:8"'6@R&A42']P@C;V>Q=:/LWBN^^ZV[XQ=U(
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MDSPYBY@->#<;G4O8M>O6_3.#^Q-C^9Z:8]J.O;UAZ.AG6'#7Z,""[^I&IZ.
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M;8.$F 3SQ:LK"WUQ084T#$L81U4!A<R65=Z[M^!@7.="W& _BNJ(PA@O+F1
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MNCYEK( T0"FX<%%5)NJ[TH5'VO%Z,2#PK;(CP3OTA+2)"[D!EV*9 )KI*#Y
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MLX9B.V(RYAYV$]I=^R&-><-C.F\(3I%FHUC:#$UF;+7QL;P33$JM*PQ+SRV
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MRS*,O4%H0%H N1&X*^R< *(=5-?K[(3M;$XQZ? 10&!!>?W]'Z4GU&[1F!&
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M2/9;N*W/#&_K3^7,??I#A#-L/GRX"VT_/3<;!Y>\C8B#KZL^B)3IJK30BUS
M/2&*5>_D[NNL/)%C?N65=[D4EB5=ZTAXH+58I=4X=ZVXJK)C9]?(!SRA*H3A
MA]AE&?J'^>B!R5^1U(:X_/$%(%.G.M('6Q.U,BHDD6.SQBQ$WWG,Z]M-BT\!
MR<EC*T+I6O'ILUSB**=W&<87'>!L"3G,%^WBJ'(->4^Y6UC:CD JG11UAQ ;
MZ*.M$%)4=Y+)K\HGQ'*M0H?"4@VK-$Y65'8P& LM,75>GF[OXQWHD?I^+5;O
M>^K1S'-88&?>-%$ $9;EO>2+H[J4=P*8(9L(HCQ_\T#(39\[/7?Q4 F?M\CS
M'48[BR[Y9,CA60^K2UYYC6YOE9[&9)-]=!'&G2DNG\C.E%:VH0?T7=3'ZFVJ
MV+=$X\HE6,%:]*'5*I6I@\T/6DPDZ*0]N1^Q1LQ<$5D1:=/:L9GB9=IXZ'1W
M5]X,^<O*U,L)VGNS;!4M=_W<6?0MX\"9$"P#S=G-_P(G>-3@9)%K>;E(^;R0
M>7I/],SZ3,GWG2H=E>9TI3OK/*>-+ 9I&W]KG*JCJG00"'VX+&G%K]LT_>CO
MRYYFP4BE..YVIV'XAO%DF!AJDP!2XPI:-G@4K:1UV/DC5KQP-_Y]N+1%XC?=
M<JFH<(\ASO9C>;T42_:Y776Y*CN\)/.OWZ1U@+U"W=Z,>/M6=8:44C^6!DWU
M/RHBY&\DW?@[(%^GZC:M*O3TX;-7.])^_\U9.6 Y[6KD<N&,F=84U;9[P.ZQ
MGDU)6*S=XV!V0GQ9?@."]JTL:768)0J:H76UO*?$P>=PZ4#:>C[)0+&'NH=5
M1W9&6@-5PRZVE$M -&OSZ)^522SOE'B\_P1Y2V%GCWT02KDC<7]F17G&J$=%
M>E8BS%2RM4 QM>+*5W]_WUZW^&O-)F/JU _^@PB)NY .)@2R1@,"68E 9<<'
MT$KU_EVV=.7OH23[4=0FW@\XWJ*EVG.)(S.!L.]2H,)M\0,!^NDT_(>UROQN
MK;9\^NGQ$(U7T6SX_$]M !#IA]$L&+\:'_")MYDC@/SIO!!<B4W6(("-.?0U
M+?5G8WY5QRMI,:+:1_O'.MY@';\)(+]JBY^FC/6<^$(VX!-G=_7LO#P^IP_D
M/6T!)-X BW?$+(?]I4AS.%8X+I<,+?P,:S_VM]"06U5ZC$EI(NBM_T--_EC;
M29,[AE37M"+:\\[4&+-&/]^C DC>*S3 V)'Q]79Y&=3R#^GY^ _H?[C^7P55
MZW?)IS&=PB%^!@VM!^@;B7Q0";5YP[[-]/+\-)OFXC'?$]>5#RK,/V#9$1\0
M?\4#O2C:B4)9%0#?<Q>VFZNF,L6%\8LBXD+A+^'H\2B2>5A+1R)EWB#A5WGO
MM8Y]/Z?K[9+\ >B8VBV0>7Y%ZU]G%*G?Y9[]>$\S^H]?,>WE*J9ANH?ZT7OW
MK.:.[Z2N,BJ_41%9AYL]*O("1MUG^"^G+(#,L@20(2_<(%QB.'7]C:<USYYF
M]/O6C$A)F:,J[V=83;BC#?F/]/.-TXK82^A6; I-"3V82),D>I)6=QH >4)8
M'$AGE320&WJFFS(=Q@402;1'U%<C35B=H<MI"@<UL5@A@&RL6N[))2;#61+4
M73?WB]>%Y8RWF1^J\2BSZ<JM)DBXA_7V?OZVM.V%1T!=9FR2[9M;Q[Z<.:&O
M<NM=D3%2G)YYGZUN>S!"2U'YP#'U;;2G\<.2G1Y>.UXQM2/+PZ,?U4GFVJGX
MK%\^&+=1;J#4?UYB+,V6V!#F4K%2H5;>IQ&Z$I.2T&Z;D:(=-(! !!81>O*!
MQ2$8L M3NYU(.<_.YQ5S-W%,D<< CS".&W(7:ZP6]P0M@K>1 $Z<95KG:==#
M)<PS?5PU,+;$KLO5_)Z23CJ!%93JH956UEV^8+6Y/SP^F&0\A !V8FJ(LNB:
M ZL55'- G9==O8,<(DW'UJ="HQT1#14(44#+9MLD@9W"HST:;M?BZOF_QDB3
M^U1[8.[RYV@V-V,D; Q:1T\5<LX8@5<=OS]-#G)P/C5@S4>)WA;(!R%U%:--
MW\E$[3CO+L-U"W+,W73F=>R'M676T_F::0=WK#G'OA;O.N<3?L2+74[)3:G8
MPMCK-6MCZ63>IE.^0%R\YE^]%S >U(8BUW43/>#;8Q R2".6>6TH7SHD@SKC
MM&-E++*H<G^&[(?#E.5(X0\5[VSPGQXA'Q7)[H,ESF-(:$!UB;OY_& P=[,-
MG="@O9:[#T@>@L4X]C0((%LG,O:R]#"5/EE 6%U*#SOH7G9N,ITD1ND=UUOJ
MCCK5K@6RIO7V/BU4AW\PCJ9QLHQY#)X'!PO<0X0G3#B4Z#&/]5_G)K+C'AY9
M<%<WGWQ@[_=QW];PA_<NZX%BTO"8F$W+DZ)+]^/>U(\9>8ZD96H:]\XM$DT#
MI_RF<.'RQK(IMND9925=A83DU#FN=!.<$L7?D,F,8K_B92U@*"<&\Q@R+#?V
M;A[N#7Y\H=5M6+[&J6K?)2-_#X\\\SRO^PTIBBN1Z3*N#5X2NH254OQ<=;YO
M[D2;:Y_-D309"6)O,']##!/'AO-R_&"^" P63VA 4-#LXA@K[!DFKI[VI,=N
MHQ=-VJT*'_]I9:QV1=4Q(WOV==6;I9M>*T_F',VS3[SRWNMQ+0'>;RV E'Q7
ME=<\?.^=B:_/_B)ZM8%P<,Q_79I0(G1@UNHGI]Z)AR'K\X_V7_C]=.3D)Q-;
MZ]^VRF9WS<135ZC-C-ME1"<*JS/'+MZNLJSTPYV@*O:< <:D![M0<"/> N8=
M50UBGL/]CT*J<DVLL[OQ)&ZX(\8_8/TQ1O>9P"+X_VGU?V#"?$L+$SZJ[659
MLFS.%UM%Y55W2^2O<T*S/IG\FQW\.398];9+[!64Z\)?T@NQ*KW2!)"$2<^
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MX"0(T69/AW3;\9KFPTMQR,/"];^[@B!/JR%MK*-;GHP\+YLL*5<JEUYDY7?
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M:J!CP^3G@%GLK97K0&;C,;"YGA:\+)W]S8 E.2#OQ4^52#W/K8SW+06NE.O
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MXB37,0J2.)'.T_Q'2]H-MU&;L<[\5\UV+[!&:D<]-3"['\?YZ2JKUBYJ)YA
MSA9?N<83J2C4Y-+X7T607WO9?W B! 1B'X-G^_3J4M2FX(N-G@8%**54Y$$.
MT\57"8^YGV2_:^+D]1YG+Z,[C, GC8K+UW]]4S1=?!E0H@QAB)O'SR@SWA@+
M2 /F?YJ^*G(F"OFSU'#0&=.Y,((=R[UPJNQY67%Q16$E-5Y7!Y>#^T6AN]>I
M1<'$'G=)5>/.ZUMOFQ2"GM4K;SE_:IEC;)/L(O^ 7W^[51:DNM_Z3M B<WGJ
ME[RV=E?^.SM'FY&1K_#QK0L,[@>?_CL:OKE$+6YCQN\8WI\WEKA^]:_:>V$7
M+U9%'9XY_-GIV%H9ZO/S51>65QU?8>G$8\!4"''B^]M/H(H@YBIE^P.MYF<R
MN?'G&I-C/9V&%"K*L:V$"D,U\!7"([Q*I!(+3<""N6E"%? T!Y :B YYBH]K
M2'K-WW\@^7!*^Z&WU%S=FAE#U1:KPP&W#YA[7:#X:7L3Z/QFR(]( _#\Z9%,
MP3)BHTI6S8AY0REYI*D_Q;S:)/"V3U$SUJB6(^Q0UWDKW((;G6QZGQ=PXU.R
M(VKDS@SPC3^VZJS^1JKQJ^'/[W54@RN*M1+H0(,9PFI ^0=VR4_2;L%?_\V9
MAVWX.K'C(XVOK5CK-->Y*:OYFHO:EN*1(\8"*Z&NZ"YB$>&X*(.X"Z/U2+@;
MM.;8CBEBVM..A3PUO72#BI6PB+*+#LH#$QT3& ?>YAR^K_D.EWOJ%^7=&1FC
M8T5CV0-EDQO>///6*:.Y/V)E':I8-_)#OI$ZEB#3%/]>@J,O0R" :F_A)8$6
M!$:Z\]<=5ULA]HJ; DV,LN:O&C6.).@_%,J^)7AI!R=&$M;UIT@V(K2Y\.B
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MRO%Y]ZV*RLOO>CS]\=-TF$-%VPRP\R]MR1&+\(R:1SP.=-37Q=78&E3OLX5
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M@$J/PEF=F=Y-@,C,K^M*OS#=:SV^FX#O#,Z7TX+#J.N;@*2+FCM55CO/%*/
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MO \NUQ1\P+/,%,2PL_B]&ASF.HH+#?P[4%?<@]\/NP-[-@%^_J@?PV(3%IL
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MWD$O!9M-P-LJ07T^P?=JW\]<\'@=1+F_7R!<>)>YS<1]U!>^ES* I(@F94E
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M@270IO[<;D3@BX.QQY4NQK[:TWQ-\-7-VY8_J)^(!D<5+N><FZT2>%U5F]Z
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MYTN_#_O\V%^+CC^,>%#SP5&LOH15\MS/D)X3GG[:YI7Y;E(/:&Q';$PGAE:
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M:3B+F;3SMQQU'W/T()B),\^BK$$O8@JH6L24!N@-8"G#+Z85"Z_D0!9T&+?
M'" ^AA?L?XE23R G$@3J_:/?(3QTARKO]W8U]+N8-6+(9DA;FE6>O.LD810?
M[GRV/P<1&)H:K<?8@XKL!P+^_#_G&Q@1#:7:+]V';\-=@=\/Q#XT-V+W K+
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M8__V:?Y_VOC^=&X'?,#M@!Z;'9#_YA*Z(!$H-$P?1H/RP -3_R5T"_0?*5]
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MY0 +7O5G3]W6+OQ*+%0JIK*=4WMP)>]3[Q"<-U632V;X4]VBWU9_-STKC(!
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MLWV9Z;L;:+;NHY[P"BMW&)Z5$8U=5D?'5%8.&AB[%X^8!@C'XZV8:;DQNCM
M AY=]D\N\G^/^"26=><8[+,O2ZZ$2F,R>.(W2H7S7>'(8Q_XG@@(.P\O*D6$
MW<M02CQ5V-(=#3^49G760_K:?;2JJ/&@[[.)_?LDHO6_">Z['(>Y8*TS^*4!
MEZX"?PQ)J;QA:^%?E?/LKJF/MSHJ")X=/!4.;NH&M,/'5I/J^ M".QCC['<\
M?P(G0-#@Q\N P1DR3!HPHFQI>SB&$ BMO%SI%!\O*OK#"V^"+?)<#XX/,WA*
M<([$G'9ZX6:_MR_PAX)F?!]/7J2 12&D?.Q;XCR:CF!L ]@ZK2B\%T/R[7>[
M-G#EZKP[11AB6_>>-HX#7^NO0FP= 5 7,Q;-"_OGJ3=[-TYPSV1;0';,9A@W
M>Z08%;H8^4#RMN;(EF/\POP)Q";,VZ=D^W%T';2*H.G-*3_?1,=D[JF54%T\
M8&'FN;;)E[#$<.R!>%L),/BQP,,(B*>J>_/)D,1E*L@AU*ZE)A7).+7R>N"5
MMUVK##PSX/54R/&IDII2IUG):E6M^M:\9R\5/QJKI^VJM%(N*''\.EVJ/SJ/
MS1[H&UW1,R_?/YHT-RM1[84NJZ:6#Q(_Q\[Q(O/F15HZ:P^%L;%EH9B7(<DC
M;H'QF.;+D"UPPYFW@ X4@-)C[6@CSS6\X*J#KS_$<7HY!(?8N>!W3JT2V<)Y
MP7Z$O=LD.P1+YY&TBV#@0#V5)>;$N$ /F:]G[MLX>A)R6S2VP0 0*PD-:-$
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M@F#\WJE#.;2.KZ.:B6JHF,4BY<P;AQ\DF6V_<$])QR745'%O6]6)XM 52ZZ
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M6E5U'&%2E;ND[)-R0RFMO+*X:\@I*5\[,&1L;>5CK]/-P#9GTL=48/X-#L=
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M^HG6PH3PKV=&RP,;YQIN"CVRO_ TR:*J-'#73)QMZ4Q<55GECUVG5KPB2XI
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M(;ZT$ZA3!6X#\JX$X>H3S 9;,)G6L87EJ-5XA+*%H_@&MWSZL^;LN$M!GGN
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MRR0(.U5X.,BW@/$U[(0H;[=^T\%52Y!K1OR9F\R'N2('EUDU(":;X\A-XAW
MH6@#O^H(CG2RG1L2/6OZDW->J76CH;A;VIKO38%/'S12L]!XGO_%SFGKX-[3
M2<.T^\LDHR\+\)PE<?3>2DQ;)Z?K\#.'@ M6':2N<O"?KG>##W.CK!Y,_YN
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M[>.67U;I[XCCMCR1NR"1*=:4@'IKRQ$KIBZ'Z2"V0VRF7+(E'WD2?/;:I<=
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MK3(_V"]8$\$3?@'Z,T.H),Y.+%6#P QN</Q,*N?X,R6;$2(_-$6;O-%O(#(
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MZ7(">!-+-E<A<6+Y,(FTWW[P80I/CW3?GTKBR')W=%>_XL,2S.:+:I(7NV8
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M- *E(:>,2Q^,E\*ZUR8N_^ %[I92?[^DV62._=TX=.5Y@<5^.1OETD32O;/
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M/VSVOANF=BVXE;*/S!;LG#20/'$TLAAN=J:.)N1)'M %]::CGWA=1+0\IMV
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MN6C+RUZ*C%1#K-Y56IA&184%'!B!FR7-& BE1.[@6Y *2XT?8#MK&S4SV6+
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M;;-F&/I4#PX1/VZUD 0*)(D3-!(G4P>%;]'.8B 7^D?P[4>"#X4$7Q/"+,2
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M(;K1LGB$F_C+;K2X[7\ 4$L#!!0    ( '2*G5R)3W5+1C8  )11 @ 5
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MDP'H=;!.]:TG+SZ^B*7K"CH!S_)^)NA$[:)K6L#DX%37DZD6NDCAB.D*/"G
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MT/.YK)Y//>E")S_"/L'65CT= ;,(H)S_J"^8XX)T8:_R,LG$06KC&#%H(C/
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MYOB&W#'&5Z*M0%%2H1X*PF3V_.[U'HQWDR+7N':7@92P3*S""@HPM8<DPJI
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MY":(*!9-+^L$E_OQ4&&:%2.40DE\/UC</X2G!.Z#YFJ)>8I_9EBJ27C 60<
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MHQJHGFWV.]A8L2GK@]L:AAK=2)VXL,%Z2^VL.K5&[M:DKWBZT;WKPGE6$$@
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M;Y!Z5;TXJOKE'%3U\0^.'4W<B6X)O:&ECD2.R@H*57#JICE,"C"M0 5H>\C
M-CI&']FPH6E:V*+['>U"4']77 V8XA%6#X_AM0I%&*PXP9:VND*BH(Z)6BD9
M+#-J-^LW:U<78Y6.ZW(5@P($)17W237A/< V#+ +/*5))@?'^QEBG<V@*EPU
M%77QH5'ACNNA,#Z ,56Z>JB/-9AJ>=&X&'9AI&@_TQTW/<S9Z[-9Z[-7R^!@
MU_28 B6$&@"+#G@&HL/3@6+/MW=1?D ]ZZ9BJ&TZ9&V-EX9TL*7+@ 69!$7C
MJCI0500PDLBZ_&3%?DA 3?Z1H!-YH?4&$E(G(,$\#(GS!-,I)3EU%;K3+6HQ
M3AE'CB7B=OSE0.C>BN[MD:<KIB;FK27F@CRU&]O5(;M,(BJZ! >F"(N(NCZC
M] <B12@K_'8IC>".NZ-U/ZI7Y 6>\B"K\+$@=Z^1B@3L!-X7U.I.P!HQ\8.L
MCM+4&JO^9L]WQ@JZ'Q$>RDORRH)FIY/D*IBN,WEWYYNLPMB$;M#@AE(:'6,:
MXZ);ZH-)X=T=$UY/EN(%>"5@OE,+,(EL-&*92.$LQ7 DB&>]_\K$*8OL@%TQ
MX%$/OV\D^6=(4I[O[#7%TCO1OE9XVKK=7^9'N?D6;%2#>767PZ-,\&#@*X97
M[32:>_SHE[E4#!]&CG&;6[J#80AF(J#286D12S4@VAY*'A89Y14YZTG-H5&D
MSHG+#W_\W]T=N'<4$1XM#I&8)),JB:D[.E;&%"E^$#XU$CQ3V^Q3HO00X3!-
MQL-/!#:3KNO1%0;A(?M$V*FSI2UM'R\RV2UBS2)8AKG8QM,H1(H14$N?/EV@
M6GF:T0O^</4:9N8:9BDHR$ .,+O%!.;\(U ;.J$SY!B!SAE"W374*LT2##/E
M%O>)46QX9C+E,5B_*/]H_EY*^&4*CL(XN;H9G4IA8AHM9I[@.8JM3"?"6)I<
M-=!?I!M(P23=W!D,("[AV@B*J\$\:$5J0SF,,)O7'QA &.@9"O'3(I#%@O@X
MNUY62[D_EXV,&R081W1(5MZ25+K:U,@,Q)PI#!(@;U..,+&^B$5&J5)<4DPB
MP*,=F6?I'$:HLHD$TV4@II'>)#P(="86QX?E<KRJ<N JO[M.72X->G/AV^Z.
MKWPSE6^[.TM;^K8"]9FK=- OTK&^%"4P]J D78SG8WFHXRN])(HLUR?B1GSB
M=1F%8H&CO?.A_'$3$>,+AE)]+V!$/7@"&G6*(F'\0L24@6FEX[\U]#\A1C5[
M "_9*!&W\;V0(<??'4M=12#D)6*F,AT[OI)*F!OHS'!5)@9+ 4<6>=VF0*I)
MHUG9;#)Q3!I1:  UQ0OMPS=@:SP%D_:2 @V5$?KT'R]?/-]YY?.]7H$L?[YW
M.@42)%'(U "I0DB K]4>/&^H#QZ LL@(V04Z*$TL]+R4_^E89=OA()V;4!VU
M)%8&?X![1^1IQIU&3>,8M00'>&C\8:N(IM M7JEXI;+\.>@IE0H6YU ,*Q0*
MCG<'O3)I-9!1  +ES-T[$87S(NE%<J9K'RZ/2,(AW4\R:WDWQ#$3YBBO^P@8
M,^=4,H<O_I[ P].Y,J2KH1(6MV'HTU/7W25(E:"CVR+T0NF%<J9K+Y9'*(-$
MD=GJ*(U5HHA<>$W-DF/9EF-=A2Y%LVD6G1;I&GLVS9 W!5]!SUS$"O]"FUA;
MN#3PWOAPDMC#+[U(SURZ>LLCT@B>EBGXLCQ# &9/9!DZAM>*.)B_C:\8ZC>0
M0B0JP1I(."65XV%;:0Z/#%DQ45R %-(\R($.'0F/33^W 9U>0^RZ-(D_PWY(
M!.ZB+I($.&N>=KQ^'57T0)@=0:!1HHEYQTG!:G ,+Z >%SW-&L^#O 9[*'4C
M8^DY@S O,(%[GHN4T$YG.@CTN#LL/01B0R\,O2+C4,3$8KX[V]E1AK_L:]<Q
M63[\38D@$SE9-D0J$4MBM1A/ MH>=8@)T^:1]D;0" (E'=6;>0[A5RI?H5(S
MJE/3841P6C!&J'A/] N>A8J)'QA])/R?WFWU>YD\1F[R#IQ=P8&@V=HT=7H%
MZ6M#](T5HNV]^JW3WA9XQ9ZU5^[WK]SG07<#RATU-$;Z'*T<E.P3P_?P3B?R
MO!)?/L$F)=[CEB&CKBHUX2\]8=260_Y-@T=RLV&H,B(S*=.J8J&$=E0T<<2%
MU!4MS4I9$8>:.')]K78)T9=*XYBWV<EX1]8 K@$S @L;\=PEHD3P<*L*.#<'
MV=%\0A+T.V<JAV'!'0(DC2/6$O.-K"_RSOI:CB3"=LAPN( G 1/"#%:"0.NP
M6JFT@#FJLN=\F<]69<QL?!@H-7&2W]ZY?GL>&\XXIG,Y3&Z!*.]ZB+*%*.]Z
MB/+JZ'B]769\I!__^\/)T<G%^MK;QI&\U--:L4?T>P%'"9P6>/HF:$'E>-!@
MPXZ64](_Q?LQIBBJ.LNG>E9T(QFLKRW L[O_^=Y7L[6]Z;NMW>^$:T]U?:UF
M'8-)6,1I86L190\KR["4 2V]KA QH^\1$6@<)P6<UE1A9TU:^!6C$,1*7'Z"
M B751<%4_O#'^3&[$ETE<]&Q7WZ:*<PO@?,&%J;N)F0^0L!,^]J_Q%LBP#/E
M;\217+\1DBA3X1Z.%+'=23^&F9?ERA_!J$?=]*6(D!RS8<*3J8R 3!D7H,Y,
MR5W[VL#-I:;=##$0W\L-:WQC,+ATM&SE][;9>0XV.[ZK[)#&%H!XI^%=,*ME
MA%EL6!+Q \L9Y246;V>"'D=M7/JA-&YMN5LI$J0Q]B-R-$BNQSR6YJ+,Q6!?
M/B%?I+F!POZ? E$,L"? 5AI@.P0,'2[N@;Q\SWOAE?I%LKX6FH<MJDZ:S2X6
MDSL 77FD09.7,@0]8=#TH"N^C96K?;<[[/5CVC ^+_\@>?FG__CMY:O?WLPA
M</POW.Z.$6,V%)9E6T?/\% M3^2)[C&Q"(12F$4"D^(2@S]:YFR%APW<&4/
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M*.PI0>NUI]:@=I4T,G>;D%3IX9V/B2X+/G(5W7]ED@V 2L,TH\1.FARJ!B%
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M/9#ICTQT4AW7HBO&:)Z'F#F?V9*GM; _IG5]92ON</JJ]PM02P,$%     @
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MRR<_O?YSV_W/NGG\*GOU_.FO+U^\?O'\U3??O:0>R2//7SY_EOWZT[/G+_$
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MO.T! .^.RJ@G=5_=>TU&/#@@LU\<O\Q=D$ZO0"QR-26.^/ZJ#K<VF4%(N5B
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M'&"8\:F#ZNLIR.#W#JK-5I>T;>J$OQ%@,W*M9?;=: 5"K;0.9D4K8+UQ**2
M8#0,'<7; EW7X\2<K:YF8HAF=-Y+=$-MQ!%60L&U;;EDXL=1O.J3  ZD0*9Q
M5+%RR?RQ$L*(2-T@JA2>-T(/@O^R54(73<E:J9@GZB6*D.B#1Z+OX9FR5U9>
M12MD6["KNUJA0(AIZK9'X]KDG7H6@S'-O\Z.'AS+;PQR.>>XK;B<-W7#;8XA
M Y/7I1F[ZF+5X5LQP:ZH+UL^] &"NZ[:7[I G?JRRU*<#GQ49N'SX2,#JV'S
M'*AWOB#=C(&FYZ460)^SD?$;8-4NOW.&<S.:#?@\SSF[$WKCM@<%G"TY$;#1
M,IK%=KU\G!T]/);)'B[#E7,5A?Q#$T)&H>'?:/Z=CSG8"9T!#::BH:\@-T;6
MU^323<[PW8_1NZ-'QZFF8>\$FR&RG)W5Q3YMR8/Q93IRWQ. ,0I)";=%&^^3
M7 )"N@E"&9UGZCN/X:WI@Y_2VJ?F-F"6(#'Y7% ^*2DB>1HVM0L484M4_F-I
MX%_M-7#5P+_::^ WI8'C+O_]D+?_D'H^+X.*)[</4?LQ$R!-\S3J'=:.P2BB
M8MB%M,=%J2,R-16P04')C,Z4Z*D<:6Q6//-+GXS,MULZ;+\E(4V#D&T)WZX^
MRSW(IL6JZHL%1R91IIJ^ ,U+[JZ7H.W5@F%O\!V=PC-[3F.J>\GAE$ZO5\-8
MK6<(*22" SH'B\'X!L(R77$+MSY,-D9DQ_DT16H7( SFBI,7%C+W>A3];E$6
MP!U<-/<XY;(3+_44B9JG6FD9(AVB3#F/A'A#U=L-NR1W2V_JD$3(32G2Q5'-
MB+.7&F> >5*<"2-$WJ:+(.?ZQ+JF.5DV:[)86^@:M2 OZG&9^)%*AF:E*X.V
M[^!VF)&F O>V4M,F"M4;.2U<Z"?9DRA=V5D1FX[]M*B# "/)I86>.7ZO2[G6
MMX<EN8:O9U_L!:U)Z2">)C=<A,H4X"#D>I)=#1H)ZUP%QX Q_L&_86<%YR+K
M2/-;E.YD^%S5=<S4"U,L'^QDESF=#_?O$>)+DB2-36SYH(5D@.9N<Q^G2WR+
M8QZ)%-(?5_\=D;9*V-K7\J0_TZK5^P*EZ%/G(5I#[F%,C1L)C :R?4)[ R>*
MW?"7C#P)I>K5)VLT),1^@A++<.BW0LZA'2-%0W-#@\<25YG93=(;AYY5JC\C
MAG+KC=K0N.3*F9]%A\N-""-]EYA_BQ,7(!^]F\!U&7Q6TD&V'ZG'QXZ+0" ?
MFFC^*6DM*1--ELY;<M&> O:B5C,>!AH>=OM9%E=U X7\*^^KGKV@56^=!K1+
MPJ#'"^E"?C[2%&)CBF3,-,@<<*<^2A\XR9X+UK!(-KQ[X$\OJTW!VSB%03=2
M/4@KF#"SBH4;!X:RI.JRHFA!,S%W8D=IY*, SDX=:>+]"'U:@@>P R_B/RL7
M/DW;6?K'IHML=-^(5RMVX"A=H;TNNOC;4C\6<:!*0*VB,.5:X18UY4CFX21[
M.E"@L0&C+<62#FJIUXQU@_'GO#NM#=9& [A7'HC"ONC7G%00% 5&A!3@_GY
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MO'=*W\R!"#(22(&=*'\?5VE97-G],-2H!=L,KZ6W>-^5B_E)]D]Q8F\::Q4
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MCDK-74U->'V&="L&)0, X\=I16 GI:-(T.K! R_3EMJS-X1[,;C)#37_4H(
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MUK ZXW67&(;\_;2XI$4Z/'C1+:BO71ZY/U%U>L/9+8)RQ-Z>'YU@ILNG#N7
M%UI)WCAM;P#HV(2"MX3"F:LRG( 4<JPEI'8S3L\ZA&M&;@DM*"Q45& 8P%&@
M72(?)!**.5EJT_1NA<>.W"'T#BF%Y&DY,+>0"TR#51P>*+1T5G:DY5@&\9KD
MW//!?G$>=-IJPL#G4_%-C-)_+XK6B"BB+>^6,Y45(K+UG6"=KSG?G6D!LM-U
M@;H,98)O#&LU?J,C&C.>,7F<Y>J(9"SB%HLQK0Q-%?D^)!O2S%#@P"IF ZDD
M 5O)V :#B]G-J!_\9C:<&(Z(/B:NP'2"ZD ZW@&TUO<-R,AYJZ*(U\+=H^Z
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M%@N2%RD7FQ3U_:\;Z];'0",)MZ#$1P9N*><G$/[OP,V62P;=*/= RXG!/UG
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M"=*ZR<@M/!F\4SD\/ J2UGYKO/H5XYJA%5SXA'5/Z,>$*)-:OKD;NV,KG-R
M/'YZ*RXF[JGO&9_$RJ1(,Y0?>\T$R\.2D-!$ZIL3K+9.@7P"5[:$98NZ_O$C
M9Z"0=OFQ!<D$2%CT1"7)HG+..L+/AUX+^F2>20OL"4C?V;FE=F]\A/!=$6 G
MY%\BY>K7:Y 2>(">XXRER#S"%)4DN.E>W ^\14FQ/%B(C>G#'\0.R6H9,6)A
M"D)"4_2R.2K2]^+&:[,-I., C'U(\)F7*^.D1 XI#M)-2;GQ_2OA1PQ!L;O2
MY71R)49G'*2?H3L\./WE;J-%63R_5CVI9*_NQ3:P#DKE&\WQ2MIQ_Y1^T8?
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M<SI&G_5M</O!W>"HADQ!#F5^[*"0&QF%(\5B.J=V 9E_UF!98^:K+3;SL*P
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M$J4&*YWH<G^$KQ!Q?\$L3C1F=@7;M3O(/TXGE'UHH?CFLZJIR0S6#E@4I)2
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M@MK%EMWBW:S@,"PV"%EH-8*KA;/84?M#CHERM\R73;F03 (HI^2-&WB^N_N
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M(<)F1(5#T@&I"DM1J@*Z>866A(%L].Q+6#FHL%$P>3)I[#'/Z +8ZV:B 6D
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MUCY'\ >-RE:]>\VZ-J+]@8MIH>S/F,N>3N0%LA, ,&I5;B8 #9^M>F? 5Y\
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M5*0==/0/3V%X&D4QP NG#6 '#@4%U&Q\^;MXN'!NUTV1J?*C&\?E[$VQW=7
MG MKVWV.Z_IE*X"*XFT.G\T\OAWV]4(T[Z,=.(J88@EQ]QN@V@6($LX]41[X
M+  #2?I*JK08MM,+PDT '8H;VE7>;Z=:"Q_N)Y7MN4%XY\H8I2B?<R@A,)U
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M4C#&YFH!AW>1+^2:8($R >11 !8J'(5F \[B-)]DM#7P)FB$9B UX2"O\.C
M9[R1DW@5S.%LIRT45?P1F(!@?)) FP3I.3Y6_SL'P[:C:+Y5[71[AX!?$^2'
M&1C)HN)\PD#2PISS-2 LTZ6>A#.437,X#E,8+?P%PZ$)UZD.DLDYR8PI+.<\
M7BY(,-5+.19KS49!KJEO$VOP!4MSMR=N>%:5.:K-!IU5^!U.TYISNCG'])DJ
M"M3#9@-FY* W'&[UAJW2^83U@ZF>H%Q$%0][,68EQF=E%I?%?YNT51*FY*+!
MXL\2.%FL&6 EW&'#@PM:#NZ"NATU0 2'@RYLM4G)P6TGX-"@R!ZOVG0W/(+3
M-AQM_649XA>3>1 N:$.I):PXW9<^PKL7+(#BH6?C)*W1:G>]TO"@_[.]#1XI
M6)2O0-V<Z==PMW_G&F0+//2U.B'#*7V%3QVB"QI'K]6O:&/!UVI[6Z*=OQSV
M?S4#]H>QLULSCN?XV1AVN4[L9V_!K_ZL8'_ :XHKY*: ?V^"=C#T7T;=MZ S
M#WH?/IQV#P]!YOR_GY[^1'\/3[L'YN_"#$9QL@ Q>9.)E+%-P#T-EBF\J?G7
M:S"^IMDY+L?3O\%01@/S#-@I&<HGX_[!VQ?]P;F>X>!'A^87<J=G>".*!?SR
M9'3H7U )R=JGTV_X\B>C ?X/3L>5$_8$%JAFK<:)#CYOCS4<)7C-):V_OW[/
M:Y8/UW3MZKCM57BDM\F>X"[CG;,9(NUYK4C#T[RU1J*1'D8Y]HJL\7I9]C!$
MF7Q('DB"ZA848DC*>,6*3UZ7!F)>?0EF+8YJ$4QU&T4A#"5<+.,DPW_%LQF-
ME1RM@-4OB(3I:_P'.@7TRRB?!9,LYY>">^"(B_(4E8KBU]>+Y3Q>D4F%AA#\
M$,RJFLLW1-'629Z=S@NS3X\/C$O=;,B^5-,D/V-[2Q8<[1$5<,QQ$8<Z6_'7
MULEEAYBG_^BP2UX&+#K;D.*>DE4,_A38LVC0LE&<LAH!*?8,5Y/#LLW&D48[
M>JZ.XA@VP2&,A\._!W$*FC^<J"[L''CX5,_,=MS=40=' [6WL]_9>?KSABP>
M+M7/=JEZX-61#5@4)!0X)TM:C</Y'$W\Q$9%>-["&:V'7"7V9=W%[EZI-?3;
MZ#V+IY!@:'].OLQ<@SO15N?Q)=C9"9G(L$7@U?Z#/X&-X-SL6<6V&=*PR/"!
MYXMCDY:OQ&/8&X+C@U8?17PH2(S'>ZI1>J YTFQLH=",(W 'Q*V"#8^BD;W?
M'&QS]!MH,UZ&Z#^Q_T';QMK5'#.'ZW!J_*#-10@+" /CS5QT\JPO- 8GPKQO
MZ\?%L.5:/.5P9>=9" ;:+3\:E12Z?<W&-$PGO%-0^)([!IY0Q-ZJFN3@42YT
M0B$'6@G99:D5YKSVN(UJMP@;]K2N*$]D5_)] ]8O)"RR!%3'CYF,'[D.$A%+
M0:^C*SJ;J6F.GCINY"<2\LR"+_!!JD')@F,+$REI0K,D* )23P*D'%!,-&I=
M#"G 0J*"#B?Y/#"+1@?%K/@R"*?^88?!@*I09VAC1 N6%CDXRW^]]9FT9);4
M+-%HLC<;8&"QG"MG^FA.[8EIU\DQ^ULCHU#@GO%9H\A'N!CGF(+$U;"W0COI
M7LW\+=LV=6]"]@X8OAJ?5+& _H"I"6<K6*!IRT6@['Z&K9]3VA2#@&!04O"-
M)#W8E]'F)%I^*X:J1)&E$N7W=!P8ZZ3XP."3>)]->H#@C=* M7!;S8(PP4=]
MUAE?Y[(O='7AKK3%QYK3OV (+%U"AN0-C 0'B%%/CAN.-:8^:O3VQJS(3N>E
ML?38K6HVV*\J6GL.EY#BIT-0H&<@8PJA9IY&DAWSX-)'2N!N'F8FU9'HN;X
MC8V+!"(J$M<M%!V-\RX_M8;7QN3GOUYRL.^$]D]A1IJ-XKRB*#?SR8NPE;:,
M4I95\5PB^))M]&EX$5($>IZVR?$*HYRN2-66_C+1RZSX*0QT&\^*_%P>B;'L
M'-$&^)5=^318Z+_PREF9+[&U^SO ^S^%L-?N\_#N_P3:L5T1;-^].MB^^QAL
M_X'!=MEBWO*9A7NM1JLEC+J;!.-P\EH=H]BEQ3V.<<EV"[%O\RO\9B,"^/?Q
MM-U;><#;DDV'9N.;;0>U=;7MT+Z)\=!L% Q 8SSX> 3.2: E\9FB-9,Y9L0Q
M@S"?VR%'@8':!NBI4M( @W7+)(SQ:N/7>EG[4X*JN%<JF"PMDT  5V4:@H\B
ML:4PNL ;X-48A)K'*7^.O[/(TGX4Q1<<ID/H3 3>\'FX%+BNAR%H-J8ZG23A
M6+#4.L*$NTUQV&<AX#<6FVK=O>%., \48AFO_KKVEEC*X];UMG$J^2?&U%#X
MV=\,\S"U\:HQ1K'.DF!Y#NKJ!4'7QO&%;BN7_D+O%>[.=R0'1W\)%AC);3;,
M\Q@%0QZGV6<;Y$/N/%6#D]^['T:_J]/>H']RZ/*.)L%#;QU^V5[ L\_5$FX?
M3U,EB3Z9E7F09FJ*&!S8[80)QZ6SZ&\=P*E<Z2#9I)G;,>ZW3&"S,>H-/A:]
M;\16SB4VMPR+Q00T9R"%.(UJ/BVD2#=DNLHRP9[_Z_4QS+.#-GN K_KT.,A5
MG%_8<##OV<J#8TX)O&7R#0%<M+2PN\"[KIB)JH.)/JX)K,F>71.+3RXNQV6<
MS*=@!6^*K+S= @UPR-0[JM\[.3*[;<.J-'8[.\ZVPM@LICSI_!5QFEB@] 7T
M<8I@ 8-8=6')@CAL<[H)/R<_"V]$M_0., P3QH%YW/$?>I(9,P^6:\'V!-BU
MTU RP21SBR! ,>/\*@I;2>:P^'#7!5BV;74>(,:!L"B,0B%,2EL"VP)(<7 4
M,B8UF,"5["4#L#%_9B FU<SVAIPEW!R[ZC=8RCC/F@V"+!MK3&#$')T.,_CU
MBN:X[393 ="+"-[D0LKH[*:P<U@%'?FPW[9:TKY1> ^XO(TY ]@IZ)+X("FI
M;;">%6()C.NRS)-E3-O.[)+2UC1&HX5FR\MA'HY>-HK!MTKB69C9@>$X;"GB
MYB21=CM[WL'',P=GD)!!5;P'([LHVS\U*"YS.(M.@DGX%(%=</ZQHB4+&?==
M\\,-FM9]-4)D@\7%&#N'7KL #"1$O!.-Y #Q?DP0E)^P8PR3:6[!HI@\<@>7
MQ_4 ARB-R8_EI31U %2V(' 82=%]Z@P[7HJ?HP/H:2T1O5XM4#HX#Y89%HW^
MC$\:A1E<MO<,+62\TT%'[3Y]NKV[L^N.'-=:D0N(9TK3J)N-K;T7A/)"IUOM
M/]UIM1%S'WD54)WRAB0L2@PC8Q0)E7F@Q,GDA/-ND[*H<K$M71V #0JW7M&,
MZI3B-6$TPZ@FF9RLA.*E7_EA[^.>7B[5HD>FY9 'HRNBE5F^A2EUEL1LAI+0
M @B:#5=(*[\+SG0T6=F47W&E&+9G:\ PU8T"T09W9"/!BV6$=3) T1_OR5P=
M+]][Q*$_\-#XWF-H_/ZJI-MUEO; 63HX.1[V#WL#XBO9*$_I3_CA>U@(;]67
M*":PEVT1'FH3)_ ?+F<"1I#+C_$^NR+2;#\I8S*:C1,&EC\X*_"&D_'BQK,Q
MH.T"VX9J&2,UBA&$V>7*4(=W]B"W]_==G#<-+T)1Y^,#*K8EHHB[7FJGX7V-
M7M;X7ST43W]?H>=_(AUSM7K_R>BABDK?"2/W.J/#M=?MHQJO[)5\B:+'603V
MU[Z5@"KZJX98.Y[JPV&C_J@G8V'#VF>KTL/%.GF4/&LECY2O/"S1HXSDX447
M)U) L3I)PBQ&Q.2=*^%'8?07$T;P9'4?Y>##%8,%0_/F?I!GR?_TIL9>']39
MZ\W&-$\,SQVF,Q.MC+P<Z61!5795$H#M\6J[EB]"JFSQ>U-P.P[2,)48&OS#
M!IAD:&F>7(072+L1K2A_$D9>_OJ!ID1O8PG['B409H$X^>RV/S/[K*@R8:4"
MPQ8TY9">XU:B.BKZ[27L @8LS4T9MOF+*&!LV8Y+C$WBQ2*..,07S\NW)GZ4
M91).,"K,U9!!Y(5*$_ZR4!1$&DJJ*;BRTVU,V*84A/0=2AMWIY([C%2NL' T
M.X]3;4J_8-..X_@SAD!A2&Z*_"2[Y6F4W6WOBX'07.II\ +>KQ*IY/&;<C*<
M#9U,D'H*AAHG#RFX?QM;$JO[7$F=$RW%(M@E3)%P;<(L7D6^XZWS;<SD;;SB
MK<]WG6GG#>>:<KV=EC'PI ;=I:!=/@1+IQ'AAT%QBB5R;OFP2X??(-LP<G\!
MYX5XA[@R7FA!/>(Q#_LBI3PI<OK6:X%B[9/4-5>'=V]F\YZM[>Y7KBTQ_M%J
M8 6RK/0T3HWZ9N)!88=B2K73<RQC[O?+Q'F(3L@G# A=M_X4W*@N^M5+K6ZG
M$&,3EWOOFY;[^ZUO\4Q;1I@KU_<VI?0MKNW5:;C]QS3< T_#[3^FX1X:T4"?
MC6GDKI3\?M40Q&X%8@F*(9$23(GJM(N4)EMA1W?:RD?Q]!1E_)#)@\@=/'GE
M.)Z*;)@I,T?XO!#%QY2*REOMLA\B%>E$Q^K9N0PM\2@TK37<47T)U G;",*%
M)KI=L:/9%2,W14 6A;'#?:VS1A7N"/CS_20<$=S)0;PS"G.NF4]&WUCR&:(K
MH7L*-,<^%ST^Q/=H6(.=IRU&W[-J2M$K*HQ1[I'R5^L?;7[144<.HH.PN%EI
MQ1Q8QD!ABO<2P!6B7HC',HM!)L.'2!I*E,MH"\.H)N>X?TM!D>J,>YRL-YER
M]D&CG(H/\/$X_:D;2**7B&5BXF,I(DEB<"DQ$.WO'BP804V-TX:%/\$44]2=
M\H Q"N!Q'.!PEGF2YH3_BX6OD[$R7)K">ZT(3K6E\SQE0QKI2.[7;'@8KBR#
M;0O;@2D/,+/;71+SVA?5+?9>^.]/_='O"EN%#(]Z ]?9PG8IN%=D'W?P:*19
MJ764_4PYQS.-S/(I<V=:6UIG"7L>:5WN^6"_0,$&$BC).8A!A3%[3\U*8T%,
M:N"L&"+Q&E>$+N9B,<^I7H3;,C@N+K-(K&(-CQ.S^)TW'!Y+6CM.$@K$8()/
M93@R?L8,)XR5&Q5N1_&='YC'N(&]5LA.W&*FB$R,:Z/F51.-C6M#P%GS]2Y]
MO16VS!5OWFIX<H2""EGKGC(FTE G8M1@&B2TE:C,$K&#VD1IV:LI>2"X9>B+
M-N\18F-#GL,@F8<Z><5?OJ[:;[5GE:>H.D%_T66K73?4>;1 K)UY56 5L,_)
MGUN$30EI"KM236ZD2C5^AT"FF]6(_S5V=NLJG[)(F,+%LB!TLC HBB*20$P6
MY%+DCZ+F3XJ:FZX(__-Q\F]C\K]^]NM4<^UYX "B2=)ZCN_C@GW[@EW<RGK5
MF%(W7C<.P-_NVMVIVOMK[9BOWS )&'QIYFK\BSO#Y0D6P1]8BJYCXJ8()_AJ
M2()8WC&=.[7^?BP?3C6\_;&FQXPPTW )IYMLY.I82=L6(COUG59E_%CEG%L5
MG"%+.=PIQV)!!YCW"HSY6106P]"F0"?< LLCT6B?Y5AB6/"=U]S_QZ$2RA-\
MZX&5O<YN.2HVIC926"<8CJ75&J77S-1AE1I<1J3#;6$CQI+/B]"4TPJ'-H%4
M4BJP%L):@B0%7ZAJ.,_.F2U(N(BI6L^$UI(:"(M7!><1/+A4FAJ>Q_E\ZEZ'
M7D2J(_D7^/QY<,F<,:;VT)3=>?5SPD.!)!-VF#@ '.HY5K3"-TQ-S@06<>(S
MA%B7!Z6+?1'I+F7>@: ZPDV3+ZY&ZH31).&*6JS&]XC@(XV=<I E&WZWPDQ(
M*2)F+H1I0/47V^>%F;JDV:)*>$MP?A[@J5/F/6&A4O>N5,0XIGI$+)WOE$=J
MJB.U7TU90#@9B<I9#)=WF&.A)H5<TU1C,3X<76K0=AD91F27.3 X"B1:UM+E
MCUMUF084L,4*HWY J**K'W,34L%GC]G9!YZ=??:8G;W/AW#/HT-H-J3+1CR&
MC6 0GQ0!RT'L8Z&\0V-*>XX* "A.*J0AQ08^DG=#$Q,M*VG<,RN6:E.['5M?
M7D49%6Y(MZ">#=EE;#-[EA=Z8P3F7F?? %2M 5.@GIB2RC6D2#=M.VY(DV#^
MBJ064Q1$2=J!TRS/FB8!*#&'$@:5W&Q0O?XXB#XK)$HQ X%UT:&83AJDK:CK
M^F[IL&9CU*Z2D,5D8T=U";[,9AH_F#!)!K%(3W0(QF9C3*E<[K;JQE2<'H()
M5Q_UF_]G>4IKR"&*D%9I-$N&(K.F),; "%(S*3;%AH]GWPJ3_XPOQKL,G -0
MLF$G<8027R@6J-\G\=)8 OPP<FSH>8)=,%;$(A.3W>&@G6N76(EWL8A3OBU:
M65_ YHU TI$11"0UZ;GCF/P-1S;,P%[-U#_BG/AJ?"*^,;:T@I5N-J:!I78H
MI0BENH#3A-QMRP;8$\^0\V!JW/]2^DNP:5X<:) 6&/EQ]LFJIB8?F)-,B.AG
M@X3"LVN% IT;/W/+*';:RM3=BMJ(FD4RG*'6W8#I-V=U'XXEW-BTH$ WH(Z?
MKFW O^0<>1>;7+'G?@E%K.D5(LT3VJA@4,3#K]IT?CS"&/'&\-?$E01..AVD
MF-M@$$DDG',B/O0=<RI(T-QQ=B$5?S,U0\B. "[4UK._"4>G0?@O9&/!WM&S
M&6%"^+#\XU1]C!,0H,@5DVKU%L1-6QUWNAW3DADV*;HT*-W@.X+,X@]Q(J9X
MRRW>R_@92.)S?(T A0H2--$C493AWXG\75P4</Y:^*C_N_NLG,.#A8 ?))PM
M]R:;.[;:27/];5%^$"FM\X/(#0&O))F$Z7746-*KF8A9C/<R)[G!SZZ@56SO
M%\\1-IMC E(H]2E2K0>F$7<2)Y%>29M@)O&1+C-4B('XGF3*6!RTI+6XM687
MRI[RK)"=W:<$7-H@D? <61D>*KG 5:^UNVFO=;LT)?O;:M [/1F,AAO%3_+3
MF_W.#E@N),Z9&;&F!7W%;C*HP$(4B0P !"P604Q,V2IE$__(07LP1LJQ!I,H
M+?S(8+<$GOK*9]NF%MO4^#FZHL.WQ.VP\2D7W1 9NN.0(QIS"UVEOSA0S_)X
MRB5NA3+-)5I-##:]U'.0S%L[NRU6B1+07,Z1'-4)6Z([YU=TT,IY&EM)31-4
MA#:* B/MB?D$' ?Y;.M;XY&V8S6QIFEBBW1L0'V7.(%E\*7G(58Q;NT9B"FV
M-IR(J;LI[*XW"X@]?PR(/?" V//'@-A]/H3[G5W5)8S<>D5318F)IJFB8POU
M]!WU=L4"SF@8E,?_ '&/68^]'5/((&(/PV-,>,^@/?JE)7H7'YJ,]H*U3%*=
M3/EZKSM<+$!!<&]-%\2XML"^5=:OR+%940VL5L"I*3[TP=%]?8>V+L3XY>H!
MJ@H2Z64-W2S%.::8ZL7.Z/CW#9H64RL0W"1>H<+WUHY_:DKN[:)YW4 L84";
M2<+M&?/RB):=E(A?X0RTKUKAPK(RQS#VJ-;%Q;=- YJ-&RX]1>3<RG]WOM/[
ML?3?6-=?7&AJ?$M6I^&6)0%7M5%EO7@A_56ZZ?DL+U)]9V]OK[''XVTVL\<Z
M:FO:\K_PB'H#;T]*P);ZSH>6[==K(H[1KA]1A/.5.Z,*'[F+6AW=,J$C=+,H
MEFJCK!3J\HO".!9Z:GO^[(';6FGXD^9+PEA@1_AXDE/#:>XOZZ[!&GX,RQF^
M=J')-D5SE<K$2XX(E@K4KM !/[#"ZO[(H*U9RVLC)ID32;=01)PS"LA<%,PG
MEMU["^.R]JRUF#R&ZBD+ )F_AOC]3IKW#&VE@)XG*4.#Q\+4WFEGU#GIJ!XC
MFS"7E<.R!-Q:+4]3EGKN'.YWGK4,U*L@?,^#"S)^_?I@$([<F(<D+XE:MHXQ
M%>!'6@+;9+YH[#[(A?\QTO6\A<JHV9 ::'\-8/&CJ1# <XVIH*&=2EN[ G[G
M#-<80,0SIQN]&F;8%)3#J+!=#&TJ.Z 8U)3IM%KM0@2,QNXX.DC)F[&W36TM
M42[:/*C?ZXG^GL1+7?.E-&2!#\$KRQ.\FKL3\D,DH\'[>D;%D%BN[%.YC86?
MRG4D>%0&=?(F;#%?FJOUVN+=8C*?!%(P?SQKL9-['C"&$(S'\Q"LOVG;]C1P
M-Z(K+P-.@'KRH[1E1>7#,.R]&#.PPA_0)G/WQ*=<GFO*QL4)F0HA/\3\>H-A
MOJ7@BQC0RH.2QC.81J[>$^ *9I'-6;H(DC &A5%0ZKGTXPS@J%YH3LMB#$5.
M63G \F^LJZ=FHMR)DY&;6U$,SYO,Z;!RE])LM=2VQR:UWDB5:]Y9TE)[BLJO
M6VU7PC'ST@':9U&D="[V<T)*OG4Q=[R^(-:DB=,:M@-,6@M(^#^8A#84!3#R
M"\JC3##0.EOQGJX !:R,(?C&)$X2#P4]QH2S&V3/(5\_1_'E7$_/^/6\-B4=
M=12$<WQOC^/!/#5(RX!HCE<9I(+#0 0PA>B/(? AH8/TD-DCKV%6F2'DV2L,
MH)U?6NTTKLGJ2!>DRJ\W9FKV"U!'&[A=+!'*!ILS((23Z<^68A?7B+X"JR-&
M$R!=P4=,)2+MOU3YO*OR<>=$VXT/)FUTC,)FMN'P)+ =>U(-^_7,QF>-',-G
MIJ@.L/#$@.@K1[SFG?QN0G4D)T,&4=3\CNP4G@YJ9@2>$YQ )@BXB,%ZD3"%
M&;@(:N(5<44# I,)0*R"=92VS;VD91&:/ZD1'U/LYS1'W&<$0BAB1QJ.<F$%
M>$C<X!G<AM +F @%"D/%Y+/PSL'T5R?W7CPF]QYX<N_%8W+O?JN _8H*^*SU
MLD80JK(<Y.NR))=^9X@_X/(@Q :38,*.<Q36"[*@W(2-[!0/=+',,RD<Q+M=
MX$L844^@2&>XUG< +HEW8>S)2B]1"7BP#1P3I=!G'&O5Z867C%\I[%4.3JG0
M/9J7G!'O"U6WX4BEYM2B\\ /049D<7(,!%B=QWDBT1LP+WS\_X20EX0^:3O(
MN-\BCG7#5MIBF#724FODF4(#A:U1Q%1+\)[:L%(!%L=#G:JQP%-NE4GJ$^=\
M9=FWC.=0F/O7O#Q(;<P-!:O3D89?U-;SEC I44C81 ; C#Z3?.K&6%&C(E>8
M9W%_-6.[1T^75JHT\5X6V2G(56_KV4)<,EJE&,7;F8B3#^8I#H//CS%J!1G+
M&[ *_84G%:L<2R6.-?0PY9'RB-Q0V TL;#'\JS J=GP$E>OGTPT"ZA*N6FU3
M7&)WQZ&@#)A-#A[;7+.*[4=PKG606^_\VM?P&W$:%*WW"C+V<%-0F*@9GJEA
M+#Z0G1Z$-QL*<R3G@WU#E26GC%G'51LEP50C*$^=S&8AT[.ES)CO,3Z66DB'
M,Z^@@;MD+I9<WD%,^U2LL(Z9UXMM<IP:'@@[(M9<O(7%L>BB8RS(U (-%[@+
M.%QNRGU8J]#K" 1_'EQ6BD^:#=Q:LY5W5AU\Q,#+N=2";HBD@E-7KF[-[;CB
M][?KZ,3;+OH.;R6?6D5"=CO<>8$F&QQMAN-+?7/*60 +Q@PFL(53=@'::J&3
M,XU*Z#PDW4150IRTP1"+54G/GCZ5C]G5(91Y'=FQZ#/W5;/!X]X<'/E^YWFS
MT9W-L/0)I4.7JAG4Z3R(.M0ZF\+P"=(1[AF(*0E0JMO!63XZ[!+L$[V\*M.\
M6?26!;_RLI2]91]O1='Z^LZW4FZ&A@LL9/VXU1:EP8D+GP-M,#K4[@X7##(0
M+K2Q.MBYE^<KY.,F .^Z^TKE).S:*?>*!F<7Y&I(E(5]PY3'A@<\SSMFCL54
MDE?&Q$"I3.51\%Z>R(9)/XMCL"4#?&D/*H;M !@N1FJ ,6.&*+)/3%AS=<C/
M@)<SA)&XC4DB.2P8#:#Z"V\0Z(4S)>^54^(7;A#V.46ETO;#>>M_7U6#*)ZK
MVVW-:%DX&9[,VD<84;C0B(@NR:*AZ;0>8NK?-Z*-6&(@M2>.B9A#GX62B,&$
M(<+TTY;O#!"1YY15JT !L#^+&5[ P\.BPY;Z$%_2G3Z&TRD"K/L1* JM#DQI
M*P>39WZ?Z]_B9#ZE6B3U+HGSI=T!'V R4[/H++Q@WU_D\T@G^.2V"'!L92]Y
M# IS(4TP[&J8@V6\M.%RT\P<U$>[9A2'&K6"J3IZ#Z98QI&U]SE((Y1"V.N>
M1"L>*Y3K,-BS<V61[GB&\!XP.NSOG?H5973<O9;U5(45_H>'!NL>"WL*:35Z
MPKHM:G;Q*3'O@H6?K& KV0!TNY@FQ*1"ZFU=QF/$T8QC=3!3!CB ?@%66/IU
M5[*K"P;&!#XAXM[@(@CGAC3#Y1JQ21M)M*[/T9IJNFGMRA9Y5^WPK7G VT]Z
M?$N_FO _VK_:Q^P368H\YQC>]L#_T12[0'%FTSS^M?+;P-0<)?4-)PG._9\[
M2C1#M/^N>(?PROU(U0W^AE0WW(]$NJ5\SM]K9F7=I,"ZWYY\,?[PFO/_%<??
M60+5(HTRRXF)[<(FH6PG&U[Q+"/R&!,18 #U?%75DF07XX'#-#Y.NM^S/D'2
MGLOJ+)M2'$D QI8EO*1**6L;3VT<!A7QV1E%H@NQ!&;.\4E^< '7V1MR=DY-
M/9!34.D5!-@/TV"\20'+SX\Q[@<>X_[Y,<9]?P_A[=:3/E/;ZK#_H?^N=WS0
MV["2TF>=G4HN '$4SBRBR+V+C:& YWJ><<*@023=<]BMJO4$ERZ$5S$I=)VH
MP947#+)F T=B;! $G\7TS[:Z",_PGVP 3$-89K0P2<4%"U,./X]#VU6B$'GR
M-"!<@)F,"2([VNY.KKQ4WI=\+GQVG'-(9Q[.=%TPUZKJ<Z'@L!%=N#=1SH$1
MRF1[%"!-BX1O\9C"Z]QO0_[IT]CAI-@:69[9 BP&#:E4P]UK<^U/!"13,_$F
MV)SHN;[ ! +-24@A+0^N0B.[R^J*.SP(NV3#83V7-6D()M./D-H._9D!PT4,
M)L'$3ZP%RZLE5),><C,N$X/4Q3T8DU/@U$& NS/2'0)B72FU@\:E%0K&FG.)
M&Y A2I9$JGA.S!6PYZ9B2Q=?1 K&.<AB*OAVVFKWZ>X^>$WQF18F51N"^-C_
MT!N.3H[1ZQ%7;5QNCHF)H[OORGV7.-"=#KA@E!."N;54QOY*SG4PM6PNEKO6
MN%KH9;W[> I2-YCK[7R)HD\*8-I8^[Z-OKNX*6V^^L,I%<5;VN3X2SA!@42U
M\.<!F'63^#-H/S# T,6"YVC+F%483.HAD"GS1XWP*-V(^[-0K+Y-:<&]YS90
M%=B:4LH.XC_D&<6=1UN2O;W<<?>FBO<AD3I="UW[@7C>.WCT;@?;7#8;V-+8
M.-^?AA1K1O7GV*Y\=H4S*NU O@)3[F%C:,;E/_YXVD5)!F[><=?Q:H/E@YL,
MR8=\$*B_"<$WMKN0MA7N.=IG\3P^P]3$G]I42J/YKJG)UL^%R*>]+):ND=>?
MJ+KTQ%\9_VT+(_8Z&%^E?A'Z2FI\EY(MT6LXCG9_:_IMO2H[\GXMQAT\>K^C
MS"0W&W6$]E\WW<*P!8;X%;T-_G*3_.R;)OF;IO@O-[?8DW R#YA%&Q1QLS$4
M&8QVM VS<RMZ*=NL\)<&:1I/PH#[RAM>Z:!@";BR$;] N&2$@EC!.&[<;)1,
MT(UQ3FX24GSY&%)\X"'%EX\AQ?M\")\5*B<6.?)4<ID9ZQ#KVA9IU!BVS^U*
MV;5%]"9F5R3!5*+<IR),JBR(YYK0$(DV36&GFK&$6BJXX#R&R'A*@!'W_+$6
MODCL35J!P96A3%>TKW5->>T;&#!(H>J.+K'/;S908"]T!@K8"QW-J'(!8U;(
MEHL:P8VXIG1)P@(&15J\W@RGE)K&.J<I:H4IJ0/JLW!]V5.[N P(=S.039YH
MIVJ8^Q3QDG%-KH_QAYA"G&.2RVT6V2<<$71OX7SEU-P,:8*7,-QXBB&"#*\@
M,!FQWJT=8D$=^LQ&87G^*7=HMFUAS_!TNZTY-57_5IM;)L%SBW'VT2F)=KV1
MU[%I/,23?[O)A.=JN]#@>\/R"<]K\@D5[*3EGZ;"<5#1JUIPH6-RJE;!K^-$
MM &F$', >I)3"(SQZV9O2RGYPL:>"NVTJ8 @]5I6>Q#(/U7&[B#0MUC&KCYQ
M\0$!"M9R?Q8A@M@:;<E:HQ;3N2'G%C?C;MUFM!WJR\PUF"19X;XZX\+">:[+
M[>Y=7408E1JM&X8,;T[7L(+C*IA$DOZR)$0$.S$&?DG5CY:/W#+G;<["[*E>
M@"3<WF2=)4&4%7GN:R>PM+=G@AWRJRRH(N>:LHM>D6S#[ ^G5J^_25G14])O
MB0B<.$_G"#['"EC- D7HPLT;^:*A6(!<,$;PCG0RIZ:!4MDL]*0I89THC(O/
MW:"*[G)(TRKEZP.:SSO[%:)*4Q?&^2TJUS%+\0/S3O<G"+RUTR+CV14]NX8?
M7/4DY>&FMKAR,GY,5.K>SJS0J^RVB+*,\OHEN\.A(2>&",*@9LD+@O.._7W8
M(KD,$I25G+PC<C014%$5:S@/ X8>M'TZ/%A>U\[B):>QI2_JO9N\:TF;[F!G
M(=9>5H[27!=ARGPI'I=2Q9*<8&E>*NT447PCKV7FY^8HC4G\*G2M0XZ7N^NY
MY+@E2DE?-1M8R;L%]U^9TEQ3D]EZC6Q?\AVR)213_C$=9J]&"RY\Z=\DN(BQ
M?<1"ZKQ\[A,ZZ$D1T!+B'9J-G:=@]MM[3,$1C(@+DIH1)HNYQ9WB(B\BWQN
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MN$!2(;98^P&6(ORXS'7<;&QY&/9C\BB+1>2ND'^E-/XK<D0TIKNE*?N41_*
MZ?X=K]G.L2212]H\1_EM"U0\%: Q $0!:R.NW<N91(.S'CSP+M$=.+5"S%-!
MEFF869P^5"!YY#07MTE%^\&;&,FW8:!0&E^Z+C\52=&/HOB"%<2I7T)<C.?[
M; DIAA])P:*N(S6A91 R QWU5L.F80N-IQD+@LT<F\G4Y1WDE0K;0EBQO8A]
M@HXFFUC<:Q5F@X+M+,A K?M92JS^^",."65\QEV/O+#)A@@O/(R[)5H!!K<8
MI>,T$6S56%)MN#%,&,OL5<FF5#9LE:/U' M4"D7.[4(37 ]6[!LGA(K!]>15
M@2LN0E@:_:2TCB[KB=QJG&*-]%F<,2RQ6!H]UMFEUA[INDD)&^RZW]B/@.AE
M8A]383;1AN/(:,@UTLDK->)VO%O>\:VVQP!9)!2A&.(MW"F(@OD*CE.K[;7C
MSI=3&@0E0NG<X'#@OT5.(UX+FDK$E/"8B N62_%7Y6HC*AC"M*:IO_.'LD''
M80_,JH*A(]EBRI&("=9LF#B[QW9K,%HA]SZ?A\6NZOYMJEG'+4D[TE67H<G=
MTU[R#&Z/.*#9L.6(QA46KFO+46766J,9S[JK7#5Y%F!7]^(&':\\/19*W9F<
M]E%O,.B/3@:_.^3#4;_WX5"='*E/PUZ13!Q] 0/DI5_WCHYZ!Z/^KSUU",-P
M3HIC4:!7&:/X3R59BR(F &.)TR3(&)*9]G7-1JE_G>$\LBLB5)"!&H-B4"A*
MJ/0O-:H3>74T$K:HWA=2D@SS*U^#>^HPR<]4USE^2/\$*LL&_EN%V@CBD"@T
MI#]"H8/;A6\T!:$9TEF39WHI!*GI@2GOY1@6;ZL#F/^ *)W^$2R1?($G%)[/
M,MLBJ>N6JD68/9^2,/ J5*G($<,36C@*6:4*V[EKO#0/+ET+:G)CU!GXV1$6
M5UKMCD1K><AUEFLWG3=&BQ\O[*O"EI+DP$0C=T\)5XGB2V'ZAK2./+Q=]E1J
M3Y[QH3P[% 4H 1:H0YU&M9]566N*1T[>$@ZC@>^P[?AU[]CVP/(^@*0>.E(V
M-#=%]MX$$;^S\YCU>.A9CYW'K,>]/H9^Z +OO9V&_]'\ #20]JLU]2ZD:AQG
M&U4%>54P+D1(BY5M9"H9.W@G:ZB7['3XRMBJ7!MJ:C_S"/Y&7S[FAAAS>"-0
MF)&H;F*ZF,1G$1%B.9\9NWLON,'9/,;J,;D3M4#S;^V@T@3B1R8GSK2+=,=?
M%PI5\>VDB<YEG,^]7B-PL+-S^\KR^[K):;M>X3@"#-WBLZ<:W!PVSZ<*T6!$
MZ(21@R\(+Z=#)'=U>KO98/?U,DX^>U%A"2F5XY17K[W5OO)KM *N_D6<9]OQ
M;'L93S[K#*T58>$%>R4G7#DC+B._)K@28_""H=6:@FMZ"\( ,!!@Y]*,@$CW
M> C&0FT+N[=!-3"@3V?9O$AVYP=>1,WO/?61RHXEE(CX.)1*[IC?9YX[738;
MGXR5:PI! E,9 B<*(R-$NV:H0V 0YE60FF*"R!#?S_ G!FTT+LH0"PB=0=N#
M@@-B9$&T>><67<-U)]'QB;IP21VH#,7O66Q$0AGNZ?H_,;U&(@%D8TDV&](6
MHY("<W 3O&\!CU+"1'L"BIB($6R%Q)(I*$MY_PB#\?J,-B*?PT05Z.T=:3'9
M96SMK0\RUM2\7-/Z,@NS!,N.J&I?)V:0F!G@?S*1-9$G2%40R.HDTBO*(70V
M+C;\K%PCPUZFW4Z5>!).*1V5./'H?PBT';IPJ2.9!@]2FB."#H"9!]F)62X,
MQRA'1V3#LJ'O"]("X' 6\$Z9(VEEJ5WB32PI2%/:Q240O),$QU>[F9AP4H;J
MQW2%^]"7[G1+>/EX$4XP ZEYWTSI_*7Q:V)I='))*GW*,LGG[S1I0_SPBI 7
MQB!2F)J4^3LKLCN^C)0;HNV;X,?,O)R1C5S0TA5H=H5L<MJR=D I'%47I04I
MGZ8Y*UM3S(P&3$'/;(S_]'/GN:JD5<P^]F$#PO-8R+!XII%XVS"QJ9?<\[1P
M(<Y9<*:Y<X'?HYF[$16M/>%?-PMI$1S2GPJ#R]P*D)]<)\SQP!?L.=.=L"A'
M[4BYQ$@RY\A^!',"<X'V(9H$$WD=2LMS?)GMV;0N:BK%CE-#V%DEKBX/-Q >
M'YM0]:(F7K:BY-E[^=AESI67]"(4PH&[3L,T\&F;;.C6\I!QM#Z>7TAH2&07
MEA(::5:RD&KM<K@==@8'8Q<5=LH&<MFT\B4&&!8Q,]2ST2MCR:,2;S:&4@GO
M0)^P]H3[)3R]<J3S.0?E@XP9@TORWQ;75B!!F+["2E$PK28"[O5G:8&9L225
MU@B8E !3<($QL6*\GD0(KQU*Y'6UO=_X>'HQF 7[^!!V1$%7@,@$&4GRG@#Z
M^<0,JF(<,>,RZC[/;BV$EC"[.M'VK&GI*;F!PO!%X;QXHJ(8G&PVJD2"TV 1
M8','7!2QO=A7\>Y"K'QVDB4MS*<GN P2#SA!SAAF9,C<P((>4IBK&G7IIQ,\
M:N%J&Q-W/&9\Z,2?(&D%ZE0 ;N-@SOE5,Y9IR&)9_YN(B+$DA!-@A6))E_#=
M.A5!CM#O2ZSK;"N_,8U?XXAM<;!)X"5\G\9X+4T@R@DQY6IKOV#O%Y.\MA$1
MFKPTHROW E0LR8D.HB%I.^>(;'HO1LP9,-O;Q4^N+(.54))[A42NC(M=0CP<
M:*-T6LKC1C$MDFF'M.V*M,M+0J^.1X_S(%;&%#&#S8;!AAGOP,A_0IT5M8_I
M]E<-E@0LYG-3/>:IH_2<HA!L$&/5O^QMS%[()..]QX7TI0&]>962%?L4QQ:*
MIJ?0M.W&2-*/2USD*\(;7>@(;3%NYQCX=8)M(H>+ H;V<\V;.+"V[(WNP?5V
M\%136(BF!LP.M]>H<]8E(>'!+C$ZM>2*?Y@!NN-?BZAZ9_<QAO[08^B[CS'T
M[];:FS%\MUYO]FV00/5R^_BDV?BM.QATCT?]WO UJ.J/_1%!_Q7\?\F&&,+7
MW;?]#_W1[QL6&GKIU0&T_:8I&(@9Z#-N7373Z$Y@NRT*TV-C+$OVP-Z?7(BF
M,GHE=?5P4HP9&G>F9"$F%&OBOBF@-\]A_[+%3GE\$]F1$*R-:7BTSFVLQL,0
M#GN%.6I &*\DUK'W>=MV0&<5/$6L0#BV.94Z\K4A=?*H(8(F&AUND<)^#4,K
M\!Y2ZF"?P_IP8]3A2Z^&X)>W;V#;_/+D[9O^\<&'3ZAR5!^6<]![!XL+%M@1
MZ)Z3W^ ?)T=',(D#^%?OX^F'D]^110)K;+IRX<?N/^&3XQ/XZ>F@-X0/N1 '
MKO\7;)1#^LZ=6$SR=X]_5__L'Q_")?W1^]Z@V>C]"W\+7PY4'Y[2[\%W;F!O
M/XW@)B,^ZX@=.%'P,W-EZ>8(@7D/?\JYQUL>]4?'>/<C^'<7]B\*DT\?N@-U
M^FEP>H*( WJAX?#3QQ[L&WJ7X2F\0Y_N@3?^[3WL^E][ _4;C)B^[AV,<""'
MO6'_W7$;_OMK[\/)*2*4<4Z./QUU#T:?!G!O@C00( <>?X+OJP[[</MAGZ36
MV]^=NP$7^&P=S0:\3Y77&JZJ[FM8T XNYV9LUJ_G0V![Y&5GS_-A<%4+[">\
MQ+1Y8)WZ@QY(L>$_X6-<R=/> #;(1RP:4[7SCK=;/_'8_@T$*!KVF:EY<)#.
M/RN@QQ[1/HM"K'LW350I_)4(=;'\"\; C7WHX81IQ']S7B E&XG@F,X%4O,X
M)1*L&47SC12TH73XFC[F7]R @!V]JNJ$M?TVD>WB LG+F$ L.>@Y-@Q,3/]'
MK@UC>.!,7$P!C'%0"'X:)]*SDB"ES89C$*"@DV4,$/I.7#)T3+$)@[=B-UXG
M'#1=1Z I"H&-,8K V/TIA908 IO:-@G&)>.Y_-XJYBOY!K[CL\TQK3;H!I5<
MUY^;XRNEAF**P==M+\1GVK#!V*ZV8;R C,2CE[">%/\UFXR=[0F'[^$"LV%"
M74L0X-^2PBSNIM[&M3$/.(VE#+&$KX4 @P;BD5Y4B6$-K<6&6":W6S2T\U1M
M(W-\[^,QJ/_7\,_AI\'=50+7O\P=67A$4U&*@ANRB@)4H-DH8@6JYZYPW#S.
MBYL@#JY5=YAKJ<C1-A'HNYZ[1O6QAIM:>#9%6O%OC*]19JN-:"#X"/]A0I&H
MK$P@TF_;C;]F>KIFPXN#&1R!;49L:Q)9%WFQ;G.W5EO*(2A[#N>^OF!AJH/L
MO"WR@,H?_LB3%?IL\WE$O"',]D'<F#CX=E7C2M^!U%==29B:!S-LN8P=XI;3
MDDRW_"JOJ(%L-UHU&P4?C-RNBIOE$E>K*U1V!K(UQ1)O[??2*1@"-8;3:T5\
M02-A)R$$BI.;=;?!,DX:Z103</.I'2J%L:U76*)8*_;5'DKN?*^ES)/13%DF
MF)6<Z*M^:;9/:/OED#&UP%IV<%3C67;).9)"X<N=5OC>'T5OGWVC(.S>8Q#V
MH0=A]QZ#L _ZP/)> @O")YH(4S9?YR83AALR7%*6C<WR>&D1)Z(8E6EH9[ 0
MB'K.&/UD6]D8^I&5*5MA0YO!41.VVYT@Q5)'R=A=I_&+"I^SF+;@7I&!Q 7W
M=<@YSIFY]* _'FG0CBC)J5=_XC2RQQU@@7:5G+:%BTJ/NQ]GPI?7_O9[@"'K
MV:FI>!,?QXO;)G[W-T-05MM'0[KZU7R-ED31-BD3!.?)Y#Q(=8'M!K<;$YT7
MAB H*&])+4.;;]&*,59W&6^^)(D3L1UEHZ3>)<R08DO",QI%+>"@%&%!R.T%
MA1G\?G:%K=VY<KZOF6/N1GG%) >^-529Z8+#GI6H J]9AD)/S!^V#&X7-1N%
M-[UB4>(;KDO/-AIP0UB"23)9*6JT4"4'P*T)MT,59'A2!,=7AZFKK!=:R18'
M6&=*6]M_ZIO4;6F%CF$KC$1<:UV#NHR3MJD0F 2RA6JH/U-Y8>)A2!&YXN\0
MN _M#9P, <0[2-#-XZ>\],ZE1'9AE-A,Y$KN5XKO7$,FE41A"OH%;2[J#:ZQ
M8AYC=Z5E\[B,VYP[DC*"C0G'?%OL'3;Z/O96LU%PF5D=.A"GLI6A&-&6$':A
M,M62C+O@M0EMKP]=L\SZ'&*MJ8W%45&6YY[3-:9%!M:TS@("UU:8LS=E&6\U
MJ@9^V:@W^$A)$/Q'_YC2?!N65M_9 ?NP/_,4\D13 0$B68,$*\0CDD &O-^N
M%//4D:P;JT]*#7S2,"&D$7(#A,?.0]8B:/8R2)6@_70RA.O5(<I![IIP\,[>
MANQ<6H;=XC*XWCHFXB]]"M0TKQ/)A68_)J:W?AG6+&.0PY@"\L$1'NJM:E0L
ML1)^KXE@Z.$AT]0D>+AH3$B;A*?,+V[S"G=B;& ;%RC24'!AI,!V &5?R* X
M';HUCP@-2E!-340/$KF44I!YJ&>;M$'VN#,(3D:E 9(OW8G.R5]:WWK9\C"=
M05I<QMJJ#4N<X-N/&>Y);#ZLF18KOA#H+-P6NSB=<:F:36Q>,5X/$VQ-R)8'
MXZW0G*SMDN1W<F)**Y_T;LV1\#*S:W?J&!3&0A?/AO<T.G[@@(>&S4-*@2O]
MGRK-)29@F*6"#EH[05[3,;D-/6N#J#YO%##=?PR8/O2 Z?YCP/0^'T-0,3Y(
MX>:"5\K,N8 #)"OVG ?)^_):R>M(B?RF=E@G\]BSY:<W6T$+J_*16  M,[%_
MT/KSBG8Y\$PA&:N03(-%H[Y%FSUV<%DSS^,65:,LT,U!FK"(*XGCQ);Y4V%3
M@8K7A;OV.[OW:V;OX-%<3Y[E292R=2Y XFD\R1<&A^17W5",5'^9@'V(= ML
M]!D_[D7+QNW87"R04G.Z?:JW4XT-LJRIY/F$GA%';7#\OH1E?I%RHU",Y7%S
M$0HDFS1%T5>:8F>1>"4>CAT!!THE@,9UYN+U2%5I\7+AD"&+4D<R@11W- _0
MT[_>5IJV8)J0?VZ*M"R$*2RB-!BK0T"-69%234*_6[UAJX)5Q:COUK#UUYM/
MW3('(W7Q9('=(3HJR *:46Q*M7T>7\+>N]#S>%D*<YOX=DS,0 Z=XH+;'F.Q
MW*(F[.Z5M'(['P.%N;:.&E?>!!1*(S8A4\,X[T*@109*WW@1Q YLI(4F1I=9
MCCO,1/]UNJ99UE]914J3LUE+.F3!EO+B>!/DD#3IF$2?Y?. FJCZ;0.8J,%B
M/C]UAAT4=VBBPQ/4&08.N+Y36"_78:R]5E#^EG+@JHWQABG((S8RT:=EIJ^8
ML;_;WKE&0 $SHL$5?I_HM=9Z37QV8^8.7)AG%"5CJ^3*5I\&*;F&L\0D::B@
M.<!*=,KY<@DRY5C'<P%(VGX??J4VF3@&ZDTQ];9]&(HNKZ?H9)+D\-PU]\:_
M#4-6D JN\0<VM;P+';;3\J> Q#4X0E[K9(=337,$QPC)L!'R5!RQ<L#.0EO?
M-L\XJ@B7G,N79L$Q7F>*%;P-U,;*=;P9H=6I3KUXKJR$9'9<UVV:N.$DBL=!
M5#1NP,0T ?V0O3HR<UP$W>M\;<9T;YVY*K3F+G;);JL"-S(E_20-(]8BXSC^
M+*VWN94B'J.",V<<D?UV/06'?QQ-6T9+4X$W-*P. @F94BSD?BW1?3$F]EHL
MFR>! =],++(8T1Z^J8D?^O8&B4E!^]!?&)H//!!/3?1\5:95\LB:[^,TW34B
M\D^,\$9Q^V>/<?N''K=_]ABW?SS\E:CI?DN*/%WO9)#"HDI3U6^KEVT8*:M4
M3-_=-_?Z+DR49RWN,NEZ$+3];M.5TLWV.B] 6E7[19'6\J10(RNZD'BK4LOP
MADLG-9@(T>!8:9HG%T1_E$=9.#<,J('?WPKN)B@VT*4^<?4FN8K/N4<7;V.)
M R$$TK!+&4?0^MV%/!7FQSB\4=<P%%V/L:R8H=.24,DBGC+>4LP>:LU](61H
M:\K*ZWD];).)=!(O;7BTU'6RW K2!W R&5Y&I>?P3\<;UFP8=C'7*LRU?4PJ
M=G<YFH;3:(QBKR\DS2PW/\7KB-K6VNN$D/4G)RW-#M%V(TTOK#8VG@S2<U.)
M8;@C#:B:V)LM;QX=O$W:N2^*6#$FM4Z%4=ZR1R( /JI2#5LV[%*A=4TC6\M=
MO5*7[((6*1 #KX\-"A2/.[9M!(AEZZ/MP/E*E^IQ#.31]2'A&\>WFHTK8#Z;
ML0]N&>VZJ[:1"J<_' V86PKS*8/>P<G@<"-AK[L">RU W*JY0:Z]]E@($R/B
M:LDL#3F4(,8H1A"DW,2W5"SB?H-E!^:F)K&!I(96%V-<X0SI$Q(32R=.!DQ0
M"X^\;7A!:,A\"6+6?,!Q=4\-(!U4VQ2S2=U8F]\&87V"_N<GNOY4_#@LM\$^
MG>984=K6:]B';)).M;$Z O^>"2#K;FBGF*/_23YGNG.!L3<;! <E(O>YM*$5
M.E4_5^5#23:P/H&VZVZ%/R28IQ:CG6?5)26B;/9B.4ZU)A!NUL#L03%[C!5D
M=RRV #/J [$HV)! MC6%U (,:M,':<B=L^II[@L/-@_UTHV.3Y;K'_E9DC:R
MO891N:<%2FW;0M94MOC;PMNE2+!,^Y2Z?\1(@CWS9VA#=LTM*X@]4!#')_!7
M;[AINF /=$$763*DM:Q(C[834W:C4_B1^K%EKH*!&N'A%TC74*\7G#_%54%A
MZN&U+M'X65"+3_0P4OF!U[F(TJ1H!34;>.!#3'0;V,F4AVD5!-Z(ADYIP22.
MP@E])IDC%IV$L#%)VK$D9OF7I@>Y%&&DFF#ZU"P5.].3@L%VO=(70"X+!!LC
MS0>D^W=*EF/1%./98F0.BJ=0BJ10L76N60>N68[-/8A6GAH'&R@V.;2<7N'>
M3SJ\X#<N18'OZI"7]O W!"*_:4"%N"/&O[XF]FAC/!(XJP0A*5CBSN?H<.V5
M^\__5A?7'#G)_.K*W^_\[>K'U Y[Y(S]5RY"^>=GX<8C(8>E?N!?_S;>#^[Z
M/20(78Z8\3:K[GJ8>>Y["F-*#4% .#D'AS'B$Z"N^[^O>-:ZWN/^B;O-Y^T\
M?_I4O<\3?MYG\(=O_QEO\W!.#O>SW:=J]Y?AI],W&#3%_ZJC>1PGM__(;H3Y
MSS'"(#_VU?[/.T]??H>'9!EL)TE;G+[YLT?B:YZ<HN6#T?Y39.T*U+LDSI?J
M($Z6'?4AFW9N^+)?][[8^U>];>^\>'+4:9M.P <P$(0TOGRF_CO78/7"%FI_
ME\=C>^$DF&-@Y7V,7M0_X7^_SY-H80^#/_)(_1Y@>ZY3, <(NTNF^4'OQ"ZX
MDUZ2*[HST_&:%.7SQQ3E0T]1/G],4=Y?%^N6/=%]\$0_]H=X-+K'O9-/0\R)
M_-H?(@?WIKFF^^":8I^59J-<J3TF:&*:(2:F+4!:3725,+O+1&>&#47B9=PL
ME'#1<:DW/<50,BD:,@8;AGLL8I%B0.2,,1XO8(]+0-8RCHGCQ6*.&XGB2'K,
M-2&23J?.+Y/(D@2 *-J#I12$E6-<)5/'!K;SRX;$:&B%=Y&7T?5?15^8/?34
M ']A"O[(DS"=AA,_LBK!,I,#K*P@564++1)2-N(])QA(H'4KAP 9OS;GS!M8
MTJXYE =M[:@A-Q2RL==Q8MJX4D[)\)0Y[*7@NPR9Z3?P31/BTI"C&AI0)!NK
M#666WT/5O$8U*XJ1''H3RD(:3!HV<)+I-;/:;!Q0ASIX]@&Q$VW25MSSF/!\
M)*37";#"&Z&S5 )$C#_ LJU$PF"V\U=AYV$4?_P'2@AN@E?#2.,WOD+>5N1_
MT-5&PMSC"^M.\9C ?PTC;3');I('?J"(*O$)V>!BQ#5O'&/RP6.SV*#%WL<.
M>0%+$>)K0&9739*V(&UF(7)[&#Q]S:&3E#.<Z+FEI_<2S]C.A'<._MRLQ02>
M2B'/MB4/QD385,]1=?$Z<@,U81S[0B.+-%:=8)=&2JHM8LD1N[2W'<::%#CG
M# Q?H? P8G;;*34<2+A8!F%BZX@LZ\B&80GV.\^\Q)(3AG#QYTJQ':-1B(A8
MI&+1D+!%9JX!?>D*T>0,C@=MTH6+:QK9H-Q>2@OWQ#[08/G10G#M6,>:!LM7
MXQ;V^UW*\[ /'"V[83U.B_9&R!^4*P]9"&+IX28M^'-U'#<;EP&&Z2J)B1*0
MNIH31]G*4ALK\:@EK+3=YI-#'\>SC I<ESJ@PXS%#$J>:'-[8R$V T.#GV:[
M:$:(^Y$FMZ#)N9##4I Z38[W*HP><XY?$ '$J?20N@XH(<TAC[.MEO$EID^(
M9#R\"+'_NU^PXX^3,^'>SPJ_ZJ@J]1O+$IY9M'0U-A;GYE"B<KBSM=,H;'V#
M9^1ZTN?8AQSS/IAV<O# "[+NM&WQO$E[\D6M$$KT+$':3%+S>6IFRX-3E$G[
M:WZ!FR4*N+>H7QB^I/Z3HB2"*84[4M.]'52#0;=B57B9Q-:_5P>,V&4LAG@Z
M"='^F2&5/<B]A'CW1?(4.G3,I,\T?AHD"!/!QK-<1DM*]3(& 4R]JC'G90?;
M@<.;X0BM:945VG"VK6:[?N2^%1Q-BW.))A=[%/QH8@/SNL&72GP]5"*V]ZPO
M*<;.]%/3?,R1RB-6T/U P ;U601\UI,XD:%4(&O\<,OG:3O UM_LKL_/-5'(
M%X]1R(<>A7SQ&(6\YWKFYUH]XUN-)?/56HY2X([2FQ0_,\/#1XDG1IW3*\W,
M)LA9 $[.F4X=D,J6J:+/A:B[,&):[G@:VNK63$_.(]SYS'\0IM9IKL3OZL9H
M&C'/C0K47PRAC:"JUCP.7#!XG@_^Q1GI\:^['MX7I/C >Y[8T\61'6J<)M.2
M^8#AV9J\^[1^;E&3G8?C,*.@CU'S@<6)&5"Y>QV90>+HX6$49P[75RXQL)2I
M,_L[=9$@;S_ -H'7_U/S??7*M@5$!,)9$V3%];PS-!<78<Q/(2_=-K:N#*'4
MR:7<0ZQMC*>OZ6Q$7]V\I9'7Q\CTB"^T%"CT(Q*<9^H4M7W33;)M7W)\][J8
M)!YQ$A%$^C#5R(B#!X<)"":9-(4R?VHX1L=E3!E:2&=RVAS@J<""!)Z?<8Z=
MJS1S#I+'7L ;)I*'G >INXIL9O93V.T*TC1?D-,U231URT"(ORU@JG21 W,2
MD6<:O*998;2;M/([3SUU@Q8UFO*,)B_'T(S57O4Y3"+ =U]<]S)R#DC!^,VO
MC+24%350WC"J<,,B;D]/<EI&(V]@!4%<Q0FC\1Q?LSS',+O.7'%&6H]ZQ/MY
MV/ER,(&W8O&MZ][6A POXM SZL<:ICPBAN'CV'^.+P;K(K\($>20(9?$@8BG
M'VMM5(#GG7.I.;%VS.<^J5YJ3B,3[=?6#UA&!W.WL$A:YES(DE/7]HI[8-\X
MIZY2=R7SU3;;"D7U54M"U0*F.04'8^92-3#&IV=</"4O6V9":#8,#;BD6'B&
M;A+2QVX+'"XR4%$[ZY8Y(W!=+4MKX#$>$LS=M]Z\];GYXI@ YA+\HP*]U4;)
M'ZYQF>8VCET?P?<L6.Z+C@>7C[U/0>X?,F.'C76D9R';.2(VF(X%M+]7#4:B
MYR*>P^D+&,L/[K_]<QQ$GY-\F4WD&["%+J@>A"M7TRS,J U'06-03I!SBJYQ
M"3\X,,C?A-D#\Q34)>G'Y1*C+GCF;76BZ47H[8&;D*.[ K2ZQDIH5+EZ2:^:
M@8.%"XY\X#A,.:\CE,3S$<=$SVUK&%<F<LWI%#+*.*K)-Y1:T!E*."PZ)LX9
MYH\I/OI^M%]B#,BMEUM_,Z3DF=I6!R?'1["0(VR%W3\>]0:]X0C[FG??];#'
M^:8A2Y[5($O(/W#F0UJHA&9U@B?2<T1]NDQPM2[C;=S-2(FS"/Y@X_ B=FRT
MXD1XSJ*+RS4;/RHP]STG>1=>LNA0.6WG%<YQG19H-9E/>)"75?'CPK5]0NLI
M\=CZ8:Y^4G.^N26L.:[O0D[-Y6;!1)H\M\D#-^56:0PV _O76(B54X1#H@&F
M!90U9S9E_6Y$<//S8]SVH<=M?WZ,V][G8PAB=*]D8V&\%.TVE)U%<@JP@D1<
MFG1AN #'E2PN_, 3NB 4(^9N@Y'!?!GYNHPSX9[&$C50AJRQ"%FIT\SX%OR-
M0<XL0AOGM&.Q8;&-D8C]8_5;?^<8^^W]]AY,I).C=H7Y$MLX$7>#_J(G.9<0
MEUVO:<Y<*1@Q"L^0<3UU##;3'#U0FP5WK>ZX#M!+B&_.Q-94"/J2NRS9OWH0
MGIR^0I[?I%9P?5G@,Y#"1W%R=47?'EYE#O.55^X^O:;X[ZL?.[K&!/6JU=RM
M;E9S=UUYW>U_^/7C>KM:,T?7VQY/AD\*53X?.X>=MCH]A__<9/1_\LEODQ6H
MX]-P_I_OL#!;GJ0I2I?6#UVM[[R+OF%$9#=]ZSK>9'A_Z@&W,><C;/Q=&L&;
M@_, 2^4C]?=@ 48LE;1=_RYUM[K;E[FO8N@0U/XM3LRZH=[R8^YK\>++1_?S
MH;N?+Q_=S]NK*GQKA_?V>P=KUXZ@>WK:.S[L_TMUU>C$>*[JE[<H0;KO!CT)
M*-<-\"ZBY/=ABGK__:D_^EV-!MWCX5%O\$-7RZR(>ML;_=;K'?_(P?S/<?=C
M#U,0QD7ZWQ\Z-=C[^GT/F0%A?H8X+OSSTW'_U]Y@B L(GYAPQU]X0UMFBSM_
M\H\LX+Y!='SWZ6MULJ0<_"OU(4BSN[)1OMK(J-NG7VFMW3]M6-H=3]Z>'/Z.
MENN3]Z./'][\?U!+ P04    " !TBIU<W7#>\JM/  #-LP$ %0   &5A,#(X
M-3$T.# Q97@T+3$S+FAT;>U]:W/;2++E=T;P/V =.Q/2!$7KZ4?;UQ&T1-F<
MD25=D>Z^'3?V TB (MHDP % R9Q?OWDRZX4');E;DF59=S=Z+!($"E596?DX
M>?+MQ\&GHW?-QMN/W<X!_:^'_WL[Z V.NN_>/I?_I6^?JZ_?OC\Y^-WK#WX_
MZO[7LW$2Y[]X6YOSW!M$LS#SCL-+[RR9^7%+/FAY_3"-QL_HA_33TV_]W1MO
MYJ?G4?R+MQG%;[P\_)IO^-/HG#Y(H_-)KCZ*XB#$#>E^S]Z]??^N^W42#:/<
MVVUO[;Q]_IY>X_0>!_#W>)C-W]SN,\MON-\]&W1ZQU[O^/#D[%-GT#LY;C;H
M[\''7M_K_L_'WOO>P/O8Z7OON]UC[ZQ[T-D?= _HK_W.YW[7HR_INO<G@X_>
M6F_=.SX9>'23[EFO<^1UC@_H0_K4N3?=MS.@_W3I5A]Z_<%9YYC^/.MV!GV/
M'G)ZUON5?NZ=G'G[)\>'O8/N\8!NU6XV_O<?__C'_Z,['?3VZ8*^W,>]<66,
M[5M;,+ITDR=++\AMW'<C3^9J8=0'PR3/DUF-@(QHQ<+TV;NCWG[WF":]\^&L
MV_U$4W-K;R?_K0I)>^M>Y' PB3+O**+WS$*O<YZ&X8R^]-;^/@W^O4C>F$_^
MGO+?Z\T&71^.Q^$HCRY"S\^\9.QU%N>++/>VMEO>]N;VGK>63T)/W:%KKCWP
M\U#?IN4-P_PR#&.ODV&._?/0.YWXZ<SW/J3)8FX&H":^JW_H3?R+*#[WZ G-
MAA\$:9AE7D2W2?-H- V]K1VZ\S2Y;'E^'. J[RP\IP?P./'GYYC&DF91OL0G
MGZ+1)#K'K/G>*(FS/,H7>93$_I3^3.=)ZN,O_=LLIU=P?V:&^:FW_['WH7.L
MATG;1G]D!J)?Q?/3D.X^G<J\3)>W+$M8UC0<AVD:TH,3;Q*F(<T0+96S+*>=
MLT&OVU?C;3\6<?[M8Y<T6K]5G/#+*)O036DN_-&_%U%*HL.:GS\Z):5&FO"L
M]^$C:<* OAWE,G%1?$%WIO7/O&F4X4.:1GTN=5KTUVBZ")0TREF"G\W3Y"(*
M2%H6HPG]D+<6/RF?1&G@S7T2U3"[G5EX:%.NQ(JF,1LMLHRF+(A( :0T2<U&
MEJ>+4;Z@+>N-DY2OG_M+UC>TI])DZ4\Q,RRP"WI$VO(FR65(V]5<3WN4UB0*
MXU&H-Z6:3ZS-+/2S1:H7Y,*?+LQ59AW.4Y]4>M!LR+8H#IN42^C%X7F21SX+
M 3]R-HQBHP?&(=T$6WH>IEIST<=QF'N9/Z7OUDIBP:^U](8^*5C\+H4.43)"
MPV!MM7[GTK#3WKY-:;CF"%6?3<-Q7BLWY6,6%SY[=WSR&^R3LRZ9%EUL+U;)
M-$U&"S<;F-+9(E^P@B91\*':Z;+<CV):,+VHF&C(3$+7I]YYD@3\$43"'T[#
MXHU%!OQ9LB!)Q&798CR.1I R/B0N)Z3N66OC]L,E:9$O<7(Y#8/S,&C)F(P$
MJ2MP;D+ECDG/)Y?9+X]K?>M,I+>')Z1&U?/X@B <J0/T%X_W\Y36R,N2:10\
M>X?YVC_J-AM;WH9WT#WL'?=@3/;?/L=];L]ZY/^^WFZ_W)N7+?V-G;WVUMZ#
MWQ9;[:UF0QW;9%(<=]2A#75'1].,)'\*J=V?D)IJ>1\3TCS_HO^TO$_^R%^P
M1 _\Z-*/;^^8?_!3MFVF[+#7/3KP3@X]<IJ*,^=/I]XX"J=!]A--S(YGYN6L
M/V@V]D\^?>J>[<-K['>.S Q!IXVCE*QZLH(2.CP#/MY8J<X2.NW\=*E.6'RT
MH,.-_@=J=3&;L[8F+8B;A"1]]&T*1<H6D;+*#LCC/#GXO#_P_#'I#[+(PO/%
MU,\3NJ\_Q_E(*AZWKO_1A'3K$/Y#,E2JGXX+/(\\X+/>X.3L=Y;[2^ACL=TQ
M>C(]%M.<;06?_B#U%/!Q<-P=\-OWR;VAKT;\!6R,RRB?8#AD/O"%^(I."1SN
MY S$@4\&';V8MC1;YF"G9_KD1OGK-(PE/2^(X(60L4*V2IRWO!'I0KKGU,O3
MB/Y+[XGKR-:8^UD&!R0G(Y4^C?U9&#@_(Q\IRGDH].5D0=)#?](M8CR9;)M9
MYF43"':<Y#1!YJ"CF_@>+[E76G&>I[7ANLP0O8Q?F>UF@]4W#-C,<1)IA7'$
MTE*'],BQ.Q'X(J*)[M!!.H4ME>E/Q)"+L*Y#993!:"JY>WR>_FZ$D0SWF(_R
M9J-XQ3>_["*>PF-TA8IN128D+5)V4X&-R6[CKVXF5.V?2+WL:O7RX>RDW_?Z
MG]_+]/6./S0;9]U?N\>?C=?IJ.&4K/QX872(M?D"^I"6WRS5.$UF-,WFOO11
MQ4Z$UE#^G<@M_@Y)M[ 7PHY86'+[K-'>\H:+G 5J&LTB\01;VGT@&<F@\4),
M)P[>'!;H*)3]&\,JG=&^GBUFZAHQ*C.V_DE3Q,T&;=. O"!Q%N@F$?U/3@I5
MNT+TF1BMQA]:AQ:3C\)1&%V(KAOYV02/#<FAS9=MKSK?GIYNNTF@WO">H1D8
MJZGB?-) LL*<RS6D1[-Y.(K&4%M3VBZ0!/HK%$N;=D'HI["3:?\$M)S39#YC
MG>4J0'I_K<KJ5)[WYS0>?2&*WLI$_5XVZJ.PF3V[E^EW6/H5^_@!;F,;(]6W
M^C\;&]XAK)I?2*^=AV_H^G\OX##3;;V-#94=>'O0^U4_TU4(6]LPDTL:X04^
M&])\A*GY[/V4O"!OJTWVLS;IRV\1)^F,=L1-7J;J4)3T5,VH2H'ZM\_IE6K>
M;IB&_I>-84A"2E,PYREQ;_VBYM9;[$S9]W'F>N4CG7E_CHF7N7Y0PG)'.G_/
M*Y[>!\T&[:[];K^_UNVOEY0];7G:MR,<PC E2;$E8BR)XI5 CVMFM%A%I%'&
M<1?2)&-$>$(=-G+"+0@#I!'=!38DS(V8-"U?N-YB8RK*.&@ ^V"X;/'=H,^#
M%IT3X==YA"]&4S^:L7+RYJ0^^+[\D0TR*$NS>(*($9S56$\/46W<D22\J)4$
M3,+:"D'@LQ#+_PL;R_4B\&-(@/J0'8041YX.'-&;\@FC7I<'HE\=T4N,:N8'
M80L21$.)9O,DS?&O!+%3=<"*>9Y"V09O\ _8[/S+>#'V.:Z*EZ)[8,1%,<1>
M].3UP]E\FBS9K($Q0C\DTZ;F<GG$:-T>B:6EU>*MEU5,+;+JZ95\.I?G$UY1
M-5 .P]*M3LV7)"VRY:.LV;"+XJX)OE6KTE)K0+-:F/6?:'.]U"MPO*_=]&9#
M;28O2!?G8J@I*<6J>;YDWF9)%.9+^=HXSN)DRYP?'G38?2%)%>-3N;QL3M.2
MDB$,2U@M,?)6]/G>YIY967)6#T,8X%/O,$EHM0YH/!*&W4\RTO+1R.N0N-/#
M@W"L]]#VEK=_>.;M;.VVMS9?W7(2:F^GO5,)^6VV7_\( ;]79JF[Y'RS\5G4
MGD[ >AA-I_ M4A.ID7F/QKR>ZBJUB^LNMO?*C(?1@ENO7)0460Z$*)J-:4A^
MC,W*P#8G$:,)^0]OUZ7C_X\KYV"?A\6')#W?)&1*5T+W=/OD<<%"X"@41]"A
MTX(0*A/YN&9C#;HAB<D/4?X<S2+. S'E%^04P&%A8;Z,X+B)W\-B9PQZ'A"N
MP]2X@:2+B):=!B:;H>A=&B=LN+31B/7;"_!_)^%L[]U4/*'5X7TV&\CRB=S@
M_&&O4*77L"JC!3FVLS#ER BOBY*YS)QG(@D0JEJ!D1. 5QG:2<FHW->7(Y95
M3Y[2Z7F;SM1#7P$5K<N0?")?>#SV@@4G04F@GZMP;.Y_I0^R$,=Q'M(4,GHA
M,(L!59 YFB"38"<C!SB_BE0V<JNCQ=37R\4;1J_UW(\"=]-S;,7WSG&6QS/1
M&@ORUA^JGGWHJTS&E\RU-TY#Q+.:#;*&1&MJ^(P%E=#*F!W7JM.*YK=:XT%]
MG\M>Y0!.-!LNTDPL G,KV($_T<X*UIL-K6B,H-.>@.G#Y^:(C%$."_)10%9W
M_/-DCWXK!MG429BI.)YS2)*+PR<G69PJ4FDR.:2KX\R78[SEC?THQ6"^A+E<
M9U-*?'4Y3Y\@S,_)=;(DYC;+I$$@&"#BM1+Q'(8FX%D\^!_BBGU3)&_[C7?"
M:;;L%]RW+R;Y&^]73!]]_?@"?>YLZ'EXXPV6<WK=3NH/H]$;[]B?A3)7QPEF
M8+L0E-._PC=/ </OZ=Z\MBA$N/+-AOCR11?'0BHS?-JG7Y^3D!42.[+U^8B;
M^I<NQA,:NI_KQ&,:3L,+,DRA6.@DC560)E*F*'2%^JGQ-HQ!+__OUG H+[Z?
M__EM)GYA-IJ-XIPJ?!7/I2S 6K:NK4^U(DX,@;]<@:+D?%%T$7$*:)JU.( 1
MQ0M?D)=KX==1.,^+G]+X-Z#R$=5SA\++&J;XR@A#!J5PZW"B'V(9:6H>X$%W
M1R][ P%E85DMH6M7BV+K.EGT5HJBFUX>(Y B@OF%W=[1%!E.1*.G4_-S 9P"
MY>C#9.?@)V(@\S1*<+4V\)TL["FRF?:-"AM@W0$Q.A!GF$<&XPQO?IIDXA#@
MAP;!WHOCY$*B'X!*Q.063**Y3'(A)QR$V2B-AJ&@+<,8^5,3+3>/(G6, #</
MT-ZZV2C>NU9=_%Q._O5:-U.Q<L%%<"3/E0 [@X6X_%;[)2.3AN2INS!VV/%T
M=[DC'YOA5W^&H!CG[4.+9&#;6PO70[2F[PJ)N>F=G?S>.1K\[IUVSWHG!S:O
MI6/Q/"O1UXT9C7@"E'B4!)FG$DEJUJ9^EGL!<!:T!?ZYB 49?D#^U&Q(9DWH
MTU9=AG[Z,\WLEC8*U00W&X/NV:>B30CHW53-8"ZP#@@RYXA\MU*')YC4F&2/
M]*>%S)')H>$;R/;$6]O:S"<P8Z1&""%&C3FO1Y/5HN4,QBQ)8MBH83I#_0"4
M8F;Q@9QN$2]9JU#/5T5,.EEF$J"WG1K9;>_4P*$W?Q TM,7V.K"E^@0SK2*$
M@K8424Z^=$"' 2.0=+C:IXOF!CSF.]<5TQIU.,B?:9/NF*DW.-OBK%\FZ32X
M) F_99%]O=O>MB)[;>F!*3?8R/+EE-QX6K+1%SN_MU1C<&7,XG;+)+:]#>\#
MU^R>'&IYO.U:B0<N?]OM+6.32OW64"6<BGA%VLQDJ$\7&7+?&KEI P:%4Z E
M68]" 1_?TE$!]'(T>J05AW^$HUR;QU#LF?B?Y! $D6-T%_%+ROYU"Q%,4:B%
MJ]-=9^01M*0(3? @@@1A7$A+A4D5*,1"0M@(#Z?3*K91\IM<D:A@'M5$ZVV?
M+-OMUY6#9>=V*Q'O2+:VO=]($I)%WFPP\E<;Q J-*V$G\D%F_I*7J&7]HX(/
M!"!LBJAXJ2A4+4$5-^2B9UO>G,7.PSWH\A8\-!(T>((NSDE5#YB0"S+CVF.<
M+])YPE*KA:PDV=IN-PAG6PPK+QLGY-*FR9C>5@\,XS#5T;>8\1"I>='>_0$D
M9,=1,=C=&4Q#/Z\!.@B.BQ/;@<9L:350=.ETHJ((XR)-@_*2/!*D=<T/;V$%
M[B&G>G428^<I7U',5^S\G/F*E07LNP_?'=EN[WH#8%#*!>:R:PLH5BZAL#8$
M1UM$\Z8ATQ($*L&I;R$V"X?\;'T%U,F<='#"@3+11+IPA,OH%(Q)948_M_MM
M!Y+!\4</89TYRAVJQ6[[$W\.UWKK%9XTB'*Z;&</9@WNM-_VMC<W-[:WMNWA
M(G5[;/SDIG2_V5C;><GH/D3UO-W-K?46BC1BIYJN7=:GC!I*:&2"]^&Z()RM
MN3K+1%EJ?@5S_$J1'E_MD[M'MU[RC(89%_I'\1C[G;T[,=:2N5LJ9.YCGUXN
M^^-'9N6@JJ!AXJ5>OIGF&5'Y\!QGOH%JE!A!&)MWKDO,:U9*X)HF7@ $ HY^
MS82@!8E>+&>,F@'05BR,>V#WN).=>A]NU0ZY5?LGQ_W>0?>,V8Q^,I]J!\7E
M9ANJ#486KF7CH%UA!?<." T>?B#>1R!^/DX3+N UA"7"BP550<IJ9]/$<['_
MNH>'W?U![]>N=T [\8>/$'UCUN)L$<?056=&B(R9RYA!.7.8(259D77_86?J
MY8VGZDPQPS A#)U%@P2 R8Z4D5J,L@.,?;COHCV?9H->A-,7Q_M<F<N$%0]6
M6DLB,NB\/^IZ^]VCH_YI9[]W_.&_GFT^X[]/.P<'^N]O?H7+*,@GN'3S;\9;
M ?^7/\_(8-?_>L9V]MO!F7X '>@YG'P]9)J"9]H6'QSHJ_3-H]B^SN!@Y76[
MFW^CTZ\L8XLY=B(KM.*OW]G/Z#]GWS;$VO%4'ZY5Z7=X,HH85C[;*SW\.8O'
MNR?=](/J)J^DFACU)3#5,$VC/ $>[ X/H"?M\M"T2WF'W\&CO8>HV7X$Q58X
MRV_N%A:H"0_)5[9S L^Y$JK5U#:%NE2G<%65QP$I8ZC\4B=RBR#!LNW=X$E2
MQU3[M!%PC'5W)X-9!%6Y%6H<*P+ =3-WJZ[W UO>&K?UK,YM;38"RPH)($ :
M>OJ &X3IC(L=JSB.C>%RHY8N1%5XXWM=[#WTLRA3(;$HL_$B-;1LD5Y$%V"L
MC9<&$&+@*M> "7ZV9>TY-%+(B J4P^XNP!89W,&L3;YFF HD:F>IN+BTC7][
M29(AJ,>II@70?S$OD*F!LDGB43*;);%$\9)I^=;,F3-/HQ$"OU*HZL=.-#25
M+PL55FQIJ#H5T2I66$ET.<[HQEJ,!F"]P7H&-;WY),E"78U'@CQ,DB^(<M*0
M[!2YD!7#@ZPDWMP7L<Z%JF3"!2+#FE65QZ\K_# ;83H"4QD--4EO)?WT%V5E
M!5SIK\+UOTE<A73S)@4[NT^YKF*N:_<GRW7]";EZ4%H9U:BVT->>N,42_2(I
M\E6<9(ZJ>P#*Y,I3\ :>)VYXRV?RVM:Z,OXBQ;!A$4DVZP=BAXQV+%(_O"L$
M:G30X?-/@\61G[J@(X/IV(3W(RM2I-/%#IA2U5QEZ/I0;QP5"RL5ZT)U>'>=
M#+J#3;)J>6^V:-O?N&A,?LK3#*H#M81!DFES53A8%1N>4$R>3L"7T.N5.40!
M0EMP84>!B*.PL!R?K8$LWVPQO5LI*/J6?;GU&B0N#VZ5=]0JTRX8ZVSL]:O\
M0)?U]J!$/X9[$0NB'XRC*LE^U3FEIC!C4!R7J!?I8-:B=MAN>2X0K.NQ\03>
M$R;$<";=DH(U&P4.TTSH-IP5+G'?%^OIUUME1T$5XS/'KG,*KTZUM3W,! =$
M%3D+(&>CL.65_&KQE:1W@0 ="G2A=%_C37%Q/]"IKB.#$=&=;!E&SL%D/9\@
M_W+?5" PEKE'WU/!8YRF'IQXS<,8=1OKDGZ5C9;!;2F,4=TCDZ^N>+3^B81T
M%$ZFQ61*A3M:P(J&HQ1OI3![0)XP^6B>D*%.'X+IE2FT4^&MB4<3B/DM3[DX
MB?&"JXGP>$Q_9@8"E- <@")ALE9E8VE"3A\WIW#$AP-.I'AXWH+0#X"B:)?'
M"S?=H7? <.:+-%LPVC11'*N"5XEB/A-%U@I0:EN"+7/6YSD;Z!LZ.*H\)ZE5
MW1YP^\SKS)FJ[ZO7*38?^N_/O<'O'GI=]0^[9\V&Z=]D&O7<[WGV("W[8(5E
M[PB49C56),<6'6(:1<D7AZ%I\=3VN+>4_0)*CM11NI"0 Y>][6SJ54>Y6Z:1
MU*8QBJ(RLQ$2@];/PEFTH8?#]:0&&E6LT+,Z%]\YPY&Q9+7C9 W!3"]XJH#\
M\9DPP0AX;5"X'4=C;B%[]$TAD)T77,AU1:K)32V54T^E' \GD&XQ:<=>][5Y
MC6H228PSA%60I:CY>IN_7HO6]14<Z$?GL0WZS\M?Q#9[8[,<-L-1X];)"U2'
M_Y-.:G567]&L[NP\S>I?FE5G6@M01;S$1A;])Y0W>?;N?4@CB_6Q#*T(#5E?
M?DJ:3:6'L% [NRU1=,S-"*I7/YU&8?J+3@0RL%$Y<5<OXITJK:V]._+I_M(A
M&*[7XB"K_/RW"X+\5G5?5R?S<VPANX%$YIF"((Q36@J-R,2.D2^U9ZU-2G:W
MY:O,'S,9+CO7#(:'"V3!G"#3C3(RC('21_HF?])Y?_4D^6LK5@J(/*W9_9Q3
M3XOV@RS:1>V:K309N-:D;UHD7KLJXH-=<6=AJ+:DC2H KM!VKL#<^@+?_(<W
M2=+N/25IBTG:O1\\2?N-XG2GV %'!'\*M52OE>2(R"-4SXTF4<C-O"UPA3,A
M(V0J W)\Q/LQ4,8;'B(W<7">#I*Z%:L__.]^R=K?TQ_=;+^ZPPSCC13#IQHG
MDSFZW8"C#4+:P*3GGZ/51^Z-%R .L''9'RBG=_5C=MK;E>#TD'LNH@8Z&JJ6
MI*5>XKB*^>];BA@?9 P7D>;$4&T=&)R7,<E*IGO/+/$[IOY8Y!-A6E2T^%R(
MK!(6&JV["KOGT$39-*O7GR2+:6!S)_P>JO!;?H'G3_U+X=[39=6ZHM@I#59L
M5JCWMN.D 6"H$W!-T VD6X;08"6I2XYFA Q4C.8]5*=%_0X,450<?XO9U0A%
MVLHI<UTT&ZK^6'4=B4,T^@*/&OUNB:.Z6$ZJFSH H )7(3'/BW+ODF>+V7!,
MSXV)CRU@WI,6*K/ORO790RZU!GU.NSQ27?@=NH7B!62G-H\E-VS3N5/4H',F
M*\M"$/+XN30SO8PUK;Y-R!KP3/@UE%ZXS8:TK=2-H$C$"J-^1+MUQ]FMJN=,
M,J3S28-L.::V((D#_8 %P*IF-14 0PE(SWVL"CV\.),J>7'H3]6[:UPL@.>.
M6Z9JOXJ2*-R0;\$]2_++1.=J+6'T(UJK78T)!KNG4@D.'TW NUW3O2&O%IYK
MA@/%1P.61%9$8^]31+;!N1]K.CB:OR+338!*I#1KDWNAGA6D/NT?"\R.@8I@
M%H2A'W_Q0+2D!T+K$D9*:X?D32E-X0=!"O@U/:RCN!.W=K!F0VSLU(('VEZ'
M$>-R0LB#&3*C$7+\1(N8(T7&N7EA>+1C*DX/([.KC_K-_;,\I364&T4(I>J+
MJMH=XW1/M6[S,STI)D^*Q[-I!3B'@G072J\KV()1$L-R5,05W':7>:U,-X<H
MMB3&BQ2]8);,0I6PRK-0PI5+#.V(=YHEF=P6"OXK';?QN12O",E5-K'<P+]A
M9/V<CLK<^V>R8+XKERMUB*YVM-+-1N ;PHQ2GE<5>4BN5QKNN=:4T[>I6"3@
MJ_XH8A44!^IGA?82F'T^T+G5#1++*1.%/2*EL'>M4N!]XZ;?I7" 19E[Q7$W
M7[U(FNO96#HT_7JO[M*V1 V5ZK<""Z2.8+.EP:9LESD7UUA^BME;][I1G4 8
MP ,53[]J\?YQ:'B4(8A?,]<:F>*\D1+I^<(\OERYE4=3,RFZ!B24QL\S52D[
M)F_IPB!HO+6]ORF:95U4,5."A>C8>,P@']DL_SSU/B4I*5 P\&2A]Y[43<L[
M;G?:NG,Z"2FL*6@W^HXA?_@A)B+ +==$EO$9:>()7L.'4@'!&S\2J@Q_I^KO
MXJ*0W<E%;_]W>V^SE$BDA0#=KD >G,F6ELIFTFPO=N@/YA*W)AA;0&01I:,H
MNXY:3[549[H;;3A-66_(LROX(].[R"'9T<(Q(BV4N2S7QO@+@21*TCA<JF[=
M0HVDNB1Q[0L06VD@Z"J4TH;*HM92J&3*L4*VMH4)Y+Y5PM61S1=/D<UB9//%
M#Q[9_"Z42H^/57=WPSOKGIZ<#?KW,_I[.\AWVUMDG/&)M9*^O&(::BAKP4=G
M&P<HVR+83FBU5<'"/Q=T0 J6SW+7\VE1^)$.X"A,M=L'@AY]SJ8\MX=05'?<
MCX,.H6DRES-7!470W5G*6+A+AZ7.Y 8;!F[-?\V8-5=.G$#J)@OUP'/8A0*0
MO@RG=/:L;6VORZ&OHD7S*8BM[7'"?3CD#2T<>)HEYBSB^2G"<=41S?8!HJD8
M!WNEJYM?\GDN!^&*)JGK)L>FRY U)GH2H31V;4?#HM'*=*2,^=M@YGXH,K[M
M=0#X_C,R7L6/%FK&V][[I<RMEFV(PC])TA#-VMG2N'\UXX@]L,PT&P)!YY^6
M'!2VB JF" L4VTGU+DTTFY%L2OM.ZR%>6T0..H&*A5212I%HLAB+#[UO4-.M
M=QVX%3@8.-\L?KZZ.<'HJQE^V8M$2H-;S^/O&S1(Y@8Y$!('V/_0"R&_SU*
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MV<0%&I( 0:##'$E[FYOJ8S'B&.!;1W^JSK-"\'A^6UVN'\J>>-%L=,9C5)U
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M3J:\MOMD]10)EX,[3,I,!G71 H&3%$A T)C$FK8V([JJ,M("N[(*757-/H5
M"KK&L-X4]\U:GIR'DL!QNFE\ZAUU^X.38YC[RD<9EAO (6-RY[S8-V[5=A>]
M4K?:Y'MP,H0<*L-RZR[&-/0#PR!AV%"UCP'WXL.G4U*D_C3<(+^>-KFJGVBA
M&G4#3JNRSUMR]=$IEZD:1MWD:S2"CN'JU(E/YM H^4('6AZ-X%O0<T+#TE,8
M3.9 8 U=J^39(&*%\M$-SH?MO# 1&HE#&> J_J&>410>EBIQ<QPVV P9:H:K
M57;%#V0V?RM4]-F[[7:S@?9NZ%*K/<S/?0ZHXO2R;#IN;?,YUP*@6EC7!YA
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M5.?;PRTFQ+*1Y<LIS0 )_>B+?8OO%TWYTZ&A+6]CT#W[Q/DD_*-WS G11P9
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ML2-NTHU#?>'7$1TP*/R68T-;@B_73?A)#IP"VZMDG0+R34)T0S'*UK$JG6.
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MU"W 3($\;JCKR17:)N! V]V' []OJS91LR-?XY-&!KP)0(SKQN!#U]YEC:<
M4?P7 L>^@W.JB>TNR[PL=J]^GQGXGI._NZXY$DR//)HY)<:9UVMYKULT!!%G
M&'*WTTSPX4[(WKJT[K*\N"VW@V"EU*JUZL!5[0?=(B:CT#G,)((8,3.%BI?@
M-Z0;5<T4$GP2)\L6Z45T@8Y,<1Y--1^?[S8(H;LI6 [)NDMX^HA[X;"E]D(:
MGX@8J[@ D%V:4T+;8<8#*R0@D/@0E[BN,QM.^:%:1<VBH=SK61((C$RI*F[!
M>*&R8M?5?!9JZ@T9<J$[?8E0I-QSR\6E"0%.SG6A]$_+%M)L:$X1VW_%]M=*
MJUCE4G0%TZ@/)*<!%\^L=)G#=4R^:,Y*!OZYDY.59@?QPAA$DK3:Z/#E9Q,-
M)]>$41HKRKRBABR'-^-C2L"]+*(/A&XU4^S$AC(*N-ZX2H9I>%J]8K%D3<=
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M.[&CO#=3<.<C>/;.5#;?I?M\KV_T%L]X?R.??9N4V<F<DS2_>$=^EC]I),S
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MDH!M"1'>4-A-1VI +]HL<+P4JDY 4A $OPXL,7^\7>#;)HATPQG47XWE7Z@
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M <OYL_LBTK0_!*8CP,:<W<2V"V8OCW'X7XLAI@(I51,. NDEFVJP"<^BX(2
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MO0YND3=-S4FZ&1;E^0:+0EB4IQLLRE>CGK[S8,YB"LM@X-=ONBY(">P%AAC
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M]=?1Z0\V":,U$N:NF$YP 4-TT(UX.3:>2M.LHD!BV1"K?@^%B>CTM&0M[[,
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MDT' P%>7QX,\^.M*@CC^SD"'=IP29'S1H?#0+[6EB 1)A0P[77)^=C*M%$;
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M\O';"^FU.4ZQS\XYU*3&<;DP>/0O#(>UV@1-;L'=G4#T,BJ8Z/,<#M+"]/+
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M#2B([M:""-*S@]@6^=?%MGB#_+I5_/GW#Z__EX+H;\_?O_OM_P-02P,$%
M  @ =(J=7(!+52-M4   6D<" !0   !E83 R.#4Q-#@P,65X-"TX+FAT;>U]
M:7/;UI;M=U;Q/Z!3[Z;$:DBQ)(^Q.U6*[=RXVK'=EG*[^N,A>2@B!@%>#)*9
M7__V="8 E"@/$B7A#3<620 '9]CCVFN_^/WDC[>_# <O?G]]] K^&^'_>7'R
MYN3MZU]>_,3_A6]_DJ]?_/K^U?]%QR?_]_;U?_TPR[/JYVC_P;**3I*%+J-W
M^CSZF"]4%O,'<72LBV3V UP(EWXPUU7Z<[6KTN0T^SDJDM-Y]3Q:J.(TR7:K
M?/ES],#^.<ZK*E_ )S_\\N+77UY_GB?CI(H>[CU]\=.O,+H/%]QWHK-*%YO=
M^,=L7"Z?=]]STW=L/&E9M9^%G[6'^(-]?/_H_M']H_M']X_^PD??O"B'$7S\
M\^WKXYL<P,U/P?O?[O?['QV_?/WNY.B?KZ,/OQ]]_.,H^N?']W]^N,D1O7EW
M\OKCNZ.3-^_?';W=W'CZIH/;DL7Y^/KXY..;ER>O7T7'L#JOHS_?O3F)CE_^
M_OJ/U\/!P8.#_>V>GW&>3K_O)!U-\V6EI\-!GD6_Z7%1JV(5'<01SDVDLFFD
M%CJ;ZFD$W_^A5M'^,_KNT<V-^&*=<]>?+Y\EL";XN =)UH^H'U$_HGY$_8AN
M[XA@3/^QNQO]ENAT^G/T09WJY_#,?]<ZFVBP.:+=78G6O7CUYE]F\/YH]@\Z
MAO,8/QOGQ507]K-?4S7Y%.WO/8*W+?,TF8(E\B&\HQ@H;H0O?H*G=@Q@7&CU
M:7>L9WD!HUS2J/U!/>X8$P[TJH_TIN8GG!N>COOG;/SV_MV)_[S=,OE;\T.;
MWBC^=$M'Z<_B%@_3^+4W-\2;#:YT^[71!L[ES;MVUS"N=0+AY.C7MZ^CEZ_?
MOOUP].K5FW?__*\?'OQ ?Q]_.'II_OZ.ZN<\F59S?,T'_X QGGPTSSK3195,
M5&JF$NX2SFVJ9Q4F;UZ<O#+7R+U(8;WXZ>35+QW?[3U*LJX;[>\UKVC_YD-=
M+/-2TP\Q[W3R$1^#,W@32W<=&QC?NVD.X S^\,O)7$=+G@]PQF=1-4_*Z'@R
MUPL=P;^J/$HRW/[)&<@I^%9'^G-25DEV2FXZ?)DO\(]I4NA)E1<PR%)G25[
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MG*IQUR80S= D0S*B/2 L!$O0/'<=-5$;:">P$/OPJK,?+R'L&LUR.T@1B/(
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M^I63+^V8"'$&6)H=DMD@NL.X;I.^;_-$LF5<+S<-Y\JPN,H"#+#UT68:U<C
M-:MSC4G5G?V#$5<M&C,&6VCG0N[K*VI3E>HGY,.HQD=;D4MW\F,9!NGJ6V__
MN#S$TK;5&H]LGQ7WS'9'^;WA "VZ&;=;E9>@QG*-G)MHNO.\3J<&BQ TD5^[
MV?CES)PUAV>E/LQ':/SYJEA8,KQ,9]LKH(W !#[-="&."34-; E\2VJ%%AAN
MSMZ3;'S;7B!:&>\F]G(Q^5H3EB!J0^P'Q'?0IR-C:Y$?XZRMM0G;;V_6<-UV
M*UG;8*]L\_",K"_3F>I!)IB.R;<^P"SYC&>;T]:7KZ_)9%M#U^LA.!R8-?<K
M)\@M1 QV7MHT<KBOO6SPG/;Q6%/#D\SX8MRLEQR[RY&^P11ARWB8(_+JG$NR
MMV&(\%D?(FR%")_=D1#A+0&MWFDC\^$&T-6/.B].59;\;8O86W[%EJ!5;YS4
MQ/ID3&M"E0HT56;R2//'L)FRNC1_F [M_!>6S:!(DCH>$*6[:!>4,O4EFQ04
MYYN&I&ULR)FU:70YC3UU@#$UK+@4C@Y0FQ6%B=B[Q'@#-I;0V,J*U1?HCHKL
MC[#VQRHG6T(7&[7:AA4VH'QY78&VSTBK6LI@OE8M\MJ5]C:I%F.OQ AKN%KE
M11T&\&EM489L-QQ7.2B UY^1K>'4VF,M&Y ->-: "BP ##"9P*8?BP+["&Z/
M-85J"DOE& !-?*?0AK4#VPW"K(-6%/7)5LD$S_ULU5'7STLF=F,F 153'SE3
M22%A/&Q3B*L81P''<#,R8(T@:;3+\\&\+K94C&R%PM];,D-=6\R^)(Q1"!*[
M+#Y;;\818X;GV7$9FU]8<RNIW('#D>/&L57?F5;4)XT9$FAO2;Q856X <_)Q
M2OC/N?*>'" #[:,-!QZ_^W#@$,(=C(L["1WKD:W!&Z\Z7E<0*L0>U]4BJ^R>
MA,B? V(CQ-=%LLPR@KU2)H9CD(J:=M ;=)X2&9S84(X[8(SDF. $^.\MC#S,
MUK=F &9WT/&3&DB;_S^W]J&E/52F#7?HWL"$$L\>->3 $L,LQ_::J3G'?.)/
M$V$=A:,#,@7M!90:31^+">AAFP@(5 BA+C*5J832R32O?DT<!8QBHF>Q0$DT
M(9)2*33C*+7*7(W8L96[ HPL]:3&D]KTY%79($5%F<1\!]PX\)Y%/4$KJBF3
M.,04;VS4RS:W(.YU4[L:QD$?7I!LJFSG%\Z?<1-QU:U^6>9]6X%NW2$)Y6>S
MI%BL%^=.VGB'3S%=:"/VWV;OLKWIS3>AGVNB3E;KI;JJB!&*CJ5!>0<JT!0Y
M^P&0^[5/3SA>KB;$=FIIN;]BC^RT\Y@CNZ5?IL@,A)O:*%ZDV_Z\!#M JA5R
M,2*+<8*4L+E I]@ 8'L!/ 4GMBUY@AJ7AG<;IBR948NNHLB+F*,-*(+Q3N.$
MS:\\["UAP@KD\NM[62Q!]*[?<1-8-1N06LLE]VV^<Q:$\!6G=:O+NYL*;%&#
M33 E/>*4? M9'-9+R%-\[R-Q'6N06I#*T:Z],\?UA4:HQ/5EAUK\[J^\C3[[
M__S7_[PX_O/77QZ\^ G_,QS\B*JO?![M[$?_&8$53=P#/YLL0O!CR1TX;&C9
MO?6\R*[;J,_-+;/NVPP'9!40SI1M:TXMV.BXE]\-EM'>^'\V'9^SJMSP;AQ/
MB@&\]CFY.%I\\*"/%C>CQ0</^FCQ1B+Q9@7R1R\&>.L$\54;8[7$;F2D[@?Z
M=+_QJ9'%/U*"5#\?#G;"'_ZG7'C0N# ;W2];ZG)EA7VIOD9;!?.^1L%@$AG5
ME/0H"?+V%CZ) \% +64O&[<_N/#V77U0Q$'V#M%E^C5B]6H"POZEW)LF>.VM
MUJ4W+;M>^AF+,%9F("_UV.4P+LM<W&/QE_7BZMN*J\L.O]EYX0ZVF"BW;:G&
M-MBWP9Z]&X+BFI?_7<[B>SCP_/=&!B+W835=H-=OF5^EB,\5$ZPN;$:H=M9'
M26GS0P8MT\39F"B;^3,M<]-U"6,AU#12FGK=!B3N]J,COHC9Z]$F;5Z2<EE7
MNNPQ$)G'CF\2NJY-&AX28G66$T6@@24F4CCO@^V'=55)/G'*LVH;:#&HCRGQ
MV\W3+(N":SVR0'[RHI1D#XW)=A2;Z@D;(U;:4%2\/VC?@WMT_[%KE.'2=F%S
MN[XCQI9(/"&*?7R5CAC'#IW,B=K'AM7-U6)A:5,2@G(D:3D<"(BX1.TWDPX
M+BU:-FG?7!-.ZARU0,@#)F R5=4%Z^7..VB7-\5J&P-7Y:]$6F!:/VQ>O_]D
M[\%A5Y[5HI5\V$('VKGLJO5KP7P[8-N^Y*+,D<+#P_4$L^;[!/1P/F)9@!/,
M1*L,O;,RYY >3.%.:>-@*] X+UQ29UONFT0F$54+YL4JS%!3RKG[GN>*"NLH
M9VY;0"#3^P+3Y78RFN_B];VT"SX<8'9HAH@@?,3+N5JB$;W_I#,//O+[AVW
M,!V<T_8IO6(H>K\/1;="T?MW)!1]73:50S%?6&75ZRU/;UVA*X"GMR[03Z;&
MA9Q-AHL:&OPN+C^OZ*.-"URG";RD]D>]J#.#"'I);75LN^ZUY<_#@:U_]NOX
M+Z@G[RJRCTV]3I(E%6K4H,6.(3?G,HXUPP=E_B7CCZX^_$E>() LIQQ^NL+2
MG:3TE1+V"M;<<@'+3E967_MV 8*@I?=5T 32JR&R3*+>:GONQ@D!EC5C5#M^
M,1S0HL,M$.7;J/#V2O3;NCS8?[>Q0\(M=%6>.%?EA-Q6Y>(_V^6L;(V;C[*C
MDKG2@:'NMV_UPK3Z\S(I5@V+E:M ^3BM-04#?#2Q,"# &FY,,41LQLU'.029
M4G6!<QJZ6:5U*6U)7:-9(^&#38"MB8QT:XH"L'*DJFXX6$-E[<&^O5L_=QUB
M/;Y(.U SH.9E!B;H]6NM_') ]\L&NOX,UE?FVNMU9.&E"VUBU0[5;''FB0!4
M3>-6TQ;=+PNQE;^-P5)\=4YNX8IJ##2VMYWKU&H2<U?;\=6$3X/;._<F[F@[
M'SL\>DDW=Y0@'NR+NH@%[8! ,9!D[J- WT6T/G6B]8^DI$Y%F<[K6]L,]=:4
M!7Y1X/OI)GT.7N:V:]J-]JW89@(*R[1B)(TJ)"(F<P>R&PS A F[2)I.06:"
M[0?#H5HY3\-<1)N/=X=;+9;1M*Y6UHZVK;#59VK/:;[T>"G JRDPTA.T%2/M
M9RX.,1P=#6?I$J_2B3R90+X&2&?OTML@;>_Z4=^ %?P==?Z]D1S7_0E\?&G#
MS62#AIO(92+MFRUCW#2?U%P99SL4"G,%^.19&,(8#DQM(S9""\[^9IDY"3*
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M;G\H-J=BT1RJ9:=LV6'<_U!+ P04    " !TBIU<>D;M'64:  "-M   %0
M &5A,#(X-3$T.# Q97@Y-RTQ+FAT;>T];5/;N+K?,Y/_H-L[=P=F$DK9[I[9
MTM,96M@N<R@PE'ON]*-B*\2[MI65;"#[Z^_S(LERXH2V"VW@I!\*)+:D1WK>
MW_3ZM\L/)V_ZO=>_'1T<PD^!_UY?'E^>'+UY_9Q_PK?/W=>OWYX=?A(?+S^=
M'/WSV5B7U2OQ8G=:B<NL4%:<JAMQH0M9#OB#@?BH3#9^!B_"J^=?^MZ^**2Y
MRLI7 A_=W1>5NJV&,L^NX".374VJ9V]>_WIV>AD//!S+(LMGK^X:FIZUV5^*
M5P(CO7US=#O)1EG5[_WRCYT7KY^_A1W X>''^4. D*BR4N8^8?BA'-GI_F-;
M->S\P<=W1Z>7!^^/^KWSWPXN/AR(]Q=G_WLNCD\OCRY.#RZ/STX/3A[CB0!L
M_E >Y>+?G7TX/SK]2"?0[UT<O3O[]]'%)W%^=G+\[M-CA.EQDLB![?=DJJ>5
M2H4NQ:]J9&II9O#M0.SM[OWTL/#\7MLJ&\_<AUF9*AQT=^>GK'QL1Y.K<?70
M<!Q81 !YI8"93:0II'AO=#T5QX@5I:PR7<I<;%43)7[(TS]KO8^$IHNI+&=(
M4C\8^G!;9%8DNBBR"H^]TL)61I=7\)F9:B,K):[T-8Y8)FI''%@QE:82>BRJ
M27BS@)4,^CV<R\WP@[$XNA5OM30I/GZ8&954VMCY-=$3K15-I!4>#WF67-Z,
M9/*'F.H\2V8BD7E.W_%\JK0$K[A0":YU!EO"#\Y-Q9_&<^V(2WC"/0TS9;![
M<&*T$>/:P.M&=($UE;/A6)OA5!GX4>#FB.DDR[75T\E,R!)'Z/=@>Z;Y3-QD
MU43(Z11FD:-<"0#'BM%,3(V^SM(,=MO4.9R^43D  G_"[#BK4=+",8YR>K0
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MEC>HY2/D#V75"3$.[A)^Z"% E-: SASW8;L-4:\/'$&8?K:BP5(5<2A9$&]
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M;* #U+<=1-(&Z4A--5KTRC9ON"LH9?JYB2[P:=7ON2(9YZ+UK(3&R+C4/MQ
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M+FIP9U!+ 0(4 Q0    ( '2*G5R#ZCIZV#$# &67 P 5              "
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M2P$"% ,4    " !TBIU<BYS*6B(5 0#I0@$ %               @ '6@!L
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M.#4Q-#@P,5]I;6<R-2YJ<&=02P$"% ,4    " !TBIU<16&5N 8U   P.P
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M,30X,#%?:6UG,CDN:G!G4$L! A0#%     @ =(J=7""HJ7\>'0$ -$4! !0
M             ( !''<N &5A,#(X-3$T.# Q7VEM9S,N:G!G4$L! A0#%
M  @ =(J=7 K,<9444P  /U8  !4              ( !;)0O &5A,#(X-3$T
M.# Q7VEM9S,P+FIP9U!+ 0(4 Q0    ( '2*G5Q=T,P!YQ\   PF   5
M          "  ;/G+P!E83 R.#4Q-#@P,5]I;6<S,2YJ<&=02P$"% ,4
M" !TBIU<-SOLQ?,@   M)P  %0              @ '-!S  96$P,C@U,30X
M,#%?:6UG,S(N:G!G4$L! A0#%     @ =(J=7# G\L5P+0  ZC0  !4
M         ( !\R@P &5A,#(X-3$T.# Q7VEM9S,S+FIP9U!+ 0(4 Q0    (
M '2*G5Q#+DYK=&D  !!J   5              "  996, !E83 R.#4Q-#@P
M,5]I;6<S-"YJ<&=02P$"% ,4    " !TBIU<&'F:&8M&  #@5@  %0
M        @ $]P#  96$P,C@U,30X,#%?:6UG,S4N:G!G4$L! A0#%     @
M=(J=7(N<REHB%0$ Z4(! !0              ( !^P8Q &5A,#(X-3$T.# Q
M7VEM9S0N:G!G4$L! A0#%     @ =(J=7)#3N0K(20$ +$P! !0
M     ( !3QPR &5A,#(X-3$T.# Q7VEM9S4N:G!G4$L! A0#%     @ =(J=
M7%*72,\P+ ( 3G$" !0              ( !268S &5A,#(X-3$T.# Q7VEM
M9S8N:G!G4$L! A0#%     @ =(J=7/\S8)W>SP  W/8  !0
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M4$L! A0#%     @ =(J=7&B'9Y^%!   NQ$  !4              ( !\TI
M &5A,#(X-3$T.# Q97@Q,RTQ+FAT;5!+ 0(4 Q0    ( '2*G5S\?L!\O 0
M #T8   5              "  :M/0 !E83 R.#4Q-#@P,65X,3,M,BYH=&U0
M2P$"% ,4    " !TBIU<A%KW1>L"  #Q#0  %0              @ &:5$
M96$P,C@U,30X,#%E>#$U+3$N:'1M4$L! A0#%     @ =(J=7#5S78I !@
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M.#4Q-#@P,65X-"TQ,RYH=&U02P$"% ,4    " !TBIU<*@B1(IT2  "^70
M%0              @ %TOD$ 96$P,C@U,30X,#%E>#0M,34N:'1M4$L! A0#
M%     @ =(J=7,P<C> B7   N98" !0              ( !1-%! &5A,#(X
M-3$T.# Q97@T+34N:'1M4$L! A0#%     @ =(J=7(!+52-M4   6D<" !0
M             ( !F"U" &5A,#(X-3$T.# Q97@T+3@N:'1M4$L! A0#%
M  @ =(J=7.MZ?+, !   E1,  !0              ( !-WY" &5A,#(X-3$T
M.# Q97@X+3$N:'1M4$L! A0#%     @ =(J=7'I&[1UE&@  C;0  !4
M         ( !:8)" &5A,#(X-3$T.# Q97@Y-RTQ+FAT;5!+!08     .@ Z
+ ",/   !G4(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>249
<FILENAME>ea0285148-20f_ascentage_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aapg="http://www.ascentage.cn.com/20251231"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:currency="http://xbrl.sec.gov/currency/2025"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aapg-20251231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2026-04-01</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectuallPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectuallPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectuallPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aapg:CapitalAndReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:SuzhouAscentagePharmaCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:SuzhouAscentagePharmaCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:GuangzhouHealthquestPharmaCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:GuangzhouHealthquestPharmaCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:AscentagePharmaGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:AscentagePharmaGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:SuzhouShengheInnovationWorksBiotechCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">aapg:SuzhouShengheInnovationWorksBiotechCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:IFRSEighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:IFRSNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AmendmentsToIFRSNineAndIFRSSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AmendmentsToIFRSNineAndIFRSSevenOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AmendmentsToIFRSTenAndIFRSTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AmendmentsToIASTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">aapg:AccountingStandardsVolume11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:FurnitureAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:FurnitureAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:IncomeTaxesAxis">aapg:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">aapg:CustomerDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:TypesOfGoodsOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:IntellectualPropertyIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:ProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:CommercializationRightsIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aapg:OthersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">ifrs-full:GoodsOrServicesTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:HighAndNewTechnologyEnterpriseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aapg:SuzhouYashengMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aapg:LeaseholdLandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-01</instant>
        </period>
    </context>
    <context id="c255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-01</instant>
        </period>
    </context>
    <context id="c256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-01</instant>
        </period>
    </context>
    <context id="c257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-01</instant>
        </period>
    </context>
    <context id="c258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aapg:ConstructionInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">aapg:ChineseMainlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aapg:FairValueAdjustmentsArisingFromAcquisitionOfASubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ifrs-full:RestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:ContractLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:DonationExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">aapg:LossesAvailableForOffsettingAgainstFutureTaxableProfitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:FinancialAssetsAgingAxis">aapg:TradeReceivablesWithin45DaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:FinancialAssetsAgingAxis">aapg:TradeReceivablesWithin45DaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:FinancialAssetsAgingAxis">aapg:TradeReceivables45To120DaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:FinancialAssetsAgingAxis">aapg:TradeReceivables45To120DaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">aapg:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">aapg:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:WithinOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:WithinOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:OneToThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:OneToThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:ThreeToSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aapg:ThreeToSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:InnoventBiologicsSuzhouCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">aapg:ShorttermAdvancesRecognizedFromCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">aapg:ShorttermAdvancesRecognizedFromCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">aapg:LongtermAdvancesRecognizedFromCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">aapg:LongtermAdvancesRecognizedFromCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:SecuredBankBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:LloanPrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:ShortTermBorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansUnsecuredOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:CurrentPortionOfLongTermBankLoansSecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansUnsecuredOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:BankLoansSecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:LeaseLiabilitiesNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2025-02-01</instant>
        </period>
    </context>
    <context id="c416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:HongKongStockExchangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <startDate>2023-11-30</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandEighteenAndTwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-20</instant>
        </period>
    </context>
    <context id="c424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2024-06-20</instant>
        </period>
    </context>
    <context id="c425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:PreIPOShareOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:PreIPOShareOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-30</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">aapg:RestrictedShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">aapg:RestrictedShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:HongKongStockExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:HongKongStockExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="c435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">aapg:TreasurySharesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:ShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:ReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:ReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PreIPOShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:ShareOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:ShareOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:SpecialOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:SpecialOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:SpecialOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PreIPOShareOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:ShareOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="c462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="c463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <startDate>2025-11-26</startDate>
            <endDate>2025-11-26</endDate>
        </period>
    </context>
    <context id="c464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
        </entity>
        <period>
            <instant>2025-11-26</instant>
        </period>
    </context>
    <context id="c465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:GrantAnniversariesAxis">aapg:FirstAnniversariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:GrantAnniversariesAxis">aapg:SecondAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:GrantAnniversariesAxis">aapg:ThirdAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:GrantAnniversariesAxis">aapg:FourthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-26</startDate>
            <endDate>2025-11-26</endDate>
        </period>
    </context>
    <context id="c470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">aapg:ForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-10-26</startDate>
            <endDate>2026-10-26</endDate>
        </period>
    </context>
    <context id="c471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandEighteenRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-06</startDate>
            <endDate>2018-07-06</endDate>
        </period>
    </context>
    <context id="c473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandEighteenRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-14</startDate>
            <endDate>2020-09-14</endDate>
        </period>
    </context>
    <context id="c474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-02</startDate>
            <endDate>2021-02-02</endDate>
        </period>
    </context>
    <context id="c475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-02</startDate>
            <endDate>2021-02-02</endDate>
        </period>
    </context>
    <context id="c476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-17</startDate>
            <endDate>2021-05-17</endDate>
        </period>
    </context>
    <context id="c477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:NonExecutiveDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-17</startDate>
            <endDate>2021-05-17</endDate>
        </period>
    </context>
    <context id="c478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:ChiefCommercialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-17</startDate>
            <endDate>2021-05-17</endDate>
        </period>
    </context>
    <context id="c479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:NonExecutiveDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="c480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-27</startDate>
            <endDate>2025-06-27</endDate>
        </period>
    </context>
    <context id="c481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="c486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="c488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="c489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrZhaiYifanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="c490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-04</startDate>
            <endDate>2023-05-04</endDate>
        </period>
    </context>
    <context id="c491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-04</startDate>
            <endDate>2023-05-04</endDate>
        </period>
    </context>
    <context id="c492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-02</startDate>
            <endDate>2024-09-02</endDate>
        </period>
    </context>
    <context id="c493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-02</startDate>
            <endDate>2024-09-02</endDate>
        </period>
    </context>
    <context id="c494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:RSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-26</startDate>
            <endDate>2025-11-26</endDate>
        </period>
    </context>
    <context id="c495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-26</startDate>
            <endDate>2025-11-26</endDate>
        </period>
    </context>
    <context id="c496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrYangDajunMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-26</startDate>
            <endDate>2025-11-26</endDate>
        </period>
    </context>
    <context id="c497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:PostIPOOptionSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:AugustFifteenTwoThousandEighteenToAugustFifteenTwoThousandTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:MayFifteenTwoThousandNinteenMayFifteenTwoThousandTwentyNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:SeptemberSixteenTwoThousandNinteenSeptemberSixteenTwoThousandTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TwentySixNov202526Nov2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants1OneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants1ThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants2FourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants2ThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipantsSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants8Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants9Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants10Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants1TwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aapg:TypeOfEligibleParticipants2OneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyTwoFurtherGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aapg:TwoThousandTwentyOnesRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyOneRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aapg:TwoThousandTwentyTwoRSUSchemeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c553">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c556">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-01</instant>
        </period>
    </context>
    <context id="c566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-01</instant>
        </period>
    </context>
    <context id="c567">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-01</instant>
        </period>
    </context>
    <context id="c568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c574">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-01</instant>
        </period>
    </context>
    <context id="c575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-01</instant>
        </period>
    </context>
    <context id="c576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-01</instant>
        </period>
    </context>
    <context id="c577">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:AccruedInterestInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c581">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:BankAndOtherLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c582">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">aapg:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aapg:HealthquestPharmaAcquisitionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c584">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:DrYangMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-17</startDate>
            <endDate>2025-07-17</endDate>
        </period>
    </context>
    <context id="c585">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:DrYangMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-29</startDate>
            <endDate>2025-07-29</endDate>
        </period>
    </context>
    <context id="c586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrZhaiYifanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrZhaiYifanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c588">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrYangDajunMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aapg:DrYangDajunMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:FinancialLiabilitiesAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesAtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c596">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c597">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c598">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesAtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:FinancialLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:IncreasedecreaseInBasisPointsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:IncreasedecreaseInLossBeforeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:IncreasedecreaseInBasisPointsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aapg:IncreasedecreaseInLossBeforeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBWeakensAgainstUSDollarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBWeakensAgainstUSDollarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBStrengthensAgainstUSDollarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBStrengthensAgainstUSDollarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBWeakensAgainstUSDollarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBWeakensAgainstUSDollarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBStrengthensAgainstUSDollarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aapg:ChangeInForeignExchangeRatesAxis">aapg:IfRMBStrengthensAgainstUSDollarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">aapg:MonetaryAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:Stage1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:StageTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:StageThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c633">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:SimplifiedApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c634">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:Stage1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:StageTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:StageThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aapg:SimplifiedApproachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c638">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c639">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c641">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c642">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c646">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c655">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c657">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c662">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c663">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c664">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c666">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c670">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c672">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:TradePayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c673">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c674">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c675">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c677">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:InterestbearingBankAndOtherBorrowingsExcludingLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:FinancialLiabilitiesIncludedInOtherPayablesAndAccrualsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c689">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c690">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:OtherNonCurrentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:OnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c694">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c697">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aapg:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:CarryingAmountOfEquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:DecreaseincreaseInLossBeforeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:CarryingAmountOfEquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aapg:DecreaseincreaseInLossBeforeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:CapitalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:CapitalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c704">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:CapitalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">aapg:CapitalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c707">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c708">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c732">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c733">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023311</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="cny">
        <measure>iso4217:CNY</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="cnyPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:CNY</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="hkdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:HKD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="hkd">
        <measure>iso4217:HKD</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-70339">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0" id="ixv-70340">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-70341">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-70342">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-70343">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-70344">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-70345">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c0" id="ixv-70346">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-70347">333-284064</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-116">ASCENTAGE PHARMA GROUP INTERNATIONAL</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-131">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-70348">68 Xinqing Road Suzhou Industrial Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0" id="ixv-70349">Suzhou</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-70350">Jiangsu</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c0" id="ixv-70351">CN</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c1" id="ixv-156">Thomas J. Knapp</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c1" id="ixv-70352">700 King Farm Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c1" id="ixv-70353">Suite 510</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c1" id="ixv-70354">Rockville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c1" id="ixv-70355">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c1" id="ixv-70356">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c1" id="ixv-70357">(301)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1" id="ixv-70358">520-1026</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress contextRef="c1" id="ixv-70359">thomas.knapp@ascentage.com</dei:ContactPersonnelEmailAddress>
    <dei:Security12bTitle contextRef="c0" id="ixv-208">American depositary shares  (each representing four ordinary shares, no par value per share)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-214">AAPG</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-70360">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-70361"
      unitRef="shares">373322192</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-70362">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-70363">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-70364">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-70365">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-70366">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-70367">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-70368">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-70369">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-70370">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c0" id="ixv-70371">false</dei:EntityShellCompany>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-70372">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c0" id="ixv-25932">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Risk
Management and Strategy&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
cybersecurity risk management program is designed to protect the confidentiality, integrity, and availability of our critical systems,
information and data. The policies, standards, processes and practices of our cybersecurity risk management program are part of our information
security management system, or ISMS, program, which is integrated into our enterprise risk management process. Our cybersecurity risk
management program includes a comprehensive set of policies and procedures to prevent accidental or intentional unauthorized modification,
destruction or disclosure of confidential, proprietary, personal or otherwise critical information, including an appropriate level of
security over the equipment, processes and software used to process, store and transmit information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key
elements of our cybersecurity risk management program include, but are not limited to the following:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a cybersecurity
    threat defense system that addresses both internal and external threats;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a cybersecurity incident response
    plan that includes procedures for responding to cybersecurity incidents and risk assessments designed to help identify material cybersecurity
    risks to our critical systems, information, products, services, and our broader enterprise information technology environment;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a security
    team principally responsible for managing our cybersecurity risk assessment processes, our security controls, and our response to
    cybersecurity incidents;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;network,
    host and application security;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;sensitive
                                            information protection methods, including technical safeguards, procedural requirements,
                                            and monitoring program on our corporate network;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;continuous
                                            testing of our security posture both internally and with outside vendors;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;security
                                            system effectiveness reviews with reference to applicable security standards; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;regular
                                            cybersecurity training for employees and contractors.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
further improve the effectiveness of our cybersecurity risk management program, we engage third-party service providers, where appropriate,
to assess and test the adequacy of our security controls and processes, consult best practices to address new challenges and evolving
risks, or otherwise assist with aspects of our security processes. Additionally, our risk monitoring systems are regularly audited by
our internal auditors as well as cybersecurity audit companies. We consider the results of external and internal audits of our risk detection
and monitoring systems and implement modifications as necessary.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
also implement third-party risk management processes to identify, assess and monitor material risks from cybersecurity threats associated
with key services providers that have access to our information technology systems or our confidential, proprietary, personal or otherwise
critical information based on our assessment of the potential impact to our operations and respective risk profile.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have established and seek to continuously improve effective information security governance. We apply a risk-based approach in line with
our overall risk management framework to address potential gaps in security controls. The processes of our cybersecurity risk management
program are aligned to ISO 27001:2022, an international standard for information security management.&lt;/span&gt;&lt;/p&gt;As of the date of this Annual Report on Form 20-F, we have not experienced
any cybersecurity incidents or risks from cybersecurity threats that have materially affected or are currently viewed as reasonably likely
to materially affect, us, our business strategy, results of operations, or financial condition. However, the scope and impact of any future
cybersecurity threats cannot be predicted, and there can be no assurance that our cybersecurity risk management program will be effective
in preventing material cybersecurity threats in the future. For a description of the risks from cybersecurity threats that may materially
affect us, including our results of operations and financial condition, see &#x201c;Item 1. Key Information&#x2014;D. Risk Factors&#x2014;Risks
related to our industry, business and operations&#x2014;We or our CROs, contractors, consultants, or other third parties may suffer system
failures, security breaches, or other incidents which may have a material adverse impact to our operations and financial position, which
could result in material disruption of our product development programs and adversely impact our business, financial condition or results
of operations.</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c0" id="ixv-70373">Our
cybersecurity risk management program is designed to protect the confidentiality, integrity, and availability of our critical systems,
information and data. The policies, standards, processes and practices of our cybersecurity risk management program are part of our information
security management system, or ISMS, program, which is integrated into our enterprise risk management process.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c0" id="ixv-70374">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c0" id="ixv-25948">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key
elements of our cybersecurity risk management program include, but are not limited to the following:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a cybersecurity
    threat defense system that addresses both internal and external threats;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a cybersecurity incident response
    plan that includes procedures for responding to cybersecurity incidents and risk assessments designed to help identify material cybersecurity
    risks to our critical systems, information, products, services, and our broader enterprise information technology environment;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a security
    team principally responsible for managing our cybersecurity risk assessment processes, our security controls, and our response to
    cybersecurity incidents;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;network,
    host and application security;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;sensitive
                                            information protection methods, including technical safeguards, procedural requirements,
                                            and monitoring program on our corporate network;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;continuous
                                            testing of our security posture both internally and with outside vendors;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;security
                                            system effectiveness reviews with reference to applicable security standards; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;regular
                                            cybersecurity training for employees and contractors.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c0" id="ixv-70375">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c0" id="ixv-70376">Additionally, our risk monitoring systems are regularly audited by
our internal auditors as well as cybersecurity audit companies. We consider the results of external and internal audits of our risk detection
and monitoring systems and implement modifications as necessary.&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
also implement third-party risk management processes to identify, assess and monitor material risks from cybersecurity threats associated
with key services providers that have access to our information technology systems or our confidential, proprietary, personal or otherwise
critical information based on our assessment of the potential impact to our operations and respective risk profile.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have established and seek to continuously improve effective information security governance. We apply a risk-based approach in line with
our overall risk management framework to address potential gaps in security controls. The processes of our cybersecurity risk management
program are aligned to ISO 27001:2022, an international standard for information security management.&lt;/span&gt;&lt;/p&gt;As of the date of this Annual Report on Form 20-F, we have not experienced
any cybersecurity incidents or risks from cybersecurity threats that have materially affected or are currently viewed as reasonably likely
to materially affect, us, our business strategy, results of operations, or financial condition. However, the scope and impact of any future
cybersecurity threats cannot be predicted, and there can be no assurance that our cybersecurity risk management program will be effective
in preventing material cybersecurity threats in the future. For a description of the risks from cybersecurity threats that may materially
affect us, including our results of operations and financial condition, see &#x201c;Item 1. Key Information&#x2014;D. Risk Factors&#x2014;Risks
related to our industry, business and operations&#x2014;We or our CROs, contractors, consultants, or other third parties may suffer system
failures, security breaches, or other incidents which may have a material adverse impact to our operations and financial position, which
could result in material disruption of our product development programs and adversely impact our business, financial condition or results
of operations.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="c0" id="ixv-70379">As of the date of this Annual Report on Form 20-F, we have not experienced
any cybersecurity incidents or risks from cybersecurity threats that have materially affected or are currently viewed as reasonably likely
to materially affect, us, our business strategy, results of operations, or financial condition.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c0" id="ixv-70380">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c0" id="ixv-26103">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Governance&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
board of directors is responsible for overseeing cybersecurity risk as part of its enterprise risk oversight function and has delegated
to the Audit Committee oversight of cybersecurity and other information technology risks. The Audit Committee oversees management&#x2019;s
implementation of our cybersecurity risk management program. Our board of directors receives periodic reports regarding operational,
financial, strategic, regulatory and other risks to the Company, including risks and exposures associated with cybersecurity, information
security and privacy matters and the steps management has taken to monitor and control such exposures. The Audit Committee and our board
of directors receive biannual reports from our Chief Executive Officer regarding management&#x2019;s plans to monitor and address cybersecurity
risks and results from our internal audit function and third-party service-providers on their evaluation of the effectiveness of our
cybersecurity risk management program.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
cybersecurity management team, led by our head of information technology, is responsible for the day-to-day activities of our information
technology systems and implementing our cybersecurity risk management program, assessing and managing our material risks from cybersecurity
threats and supervising both our internal cybersecurity personnel and our external cybersecurity consultants. Our cybersecurity management
team is informed about and monitors cybersecurity risks and incidents through various means, which may include briefings from internal
security personnel, threat intelligence and other information obtained from governmental, public or private sources, including external
consultants engaged by us, and alerts and reports produced by security tools deployed in the information technology environment. Our
head of information technology has more than 10 years of experience in cybersecurity leadership, directing enterprise security strategies,
managing cross-functional teams, and overseeing compliance with frameworks such as ISO27001. In addition, she performs risk assessments,
security related policy development, and incident response coordination, ensuring alignment with business objectives. She has also implemented
advanced security architectures including endpoint/virtual desktop infrastructure security, network security, data security, email security,
and others and led audits for information technology security compliance as well as fostering a security-first culture through staff
training and threat simulations. Based on ongoing communications with our cybersecurity management team and internal and external cybersecurity
personnel, our head of information technology provides updates to our Chief Executive Officer as to our overall security controls, policies
and operations and our Chief Executive Officer informs the Audit Committee and the board of directors regarding the effectiveness of
our cybersecurity risk management program, associated risks and steps taken to reduce our vulnerability and mitigate impacts associated
with cybersecurity threats.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c0" id="ixv-70383">The Audit Committee oversees management&#x2019;s
implementation of our cybersecurity risk management program.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c0" id="ixv-70384">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c0" id="ixv-70385">Our cybersecurity management
team is informed about and monitors cybersecurity risks and incidents through various means, which may include briefings from internal
security personnel, threat intelligence and other information obtained from governmental, public or private sources, including external
consultants engaged by us, and alerts and reports produced by security tools deployed in the information technology environment.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <dei:AuditorFirmId contextRef="c0" id="ixv-70386">1408</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock contextRef="c0" id="ixv-27586">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Opinion
on the Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"&gt;We
have audited the accompanying consolidated statements of financial position of Ascentage Pharma Group International (the
Company) as of December 31, 2025 and 2024, the related consolidated statements of
profit or loss, comprehensive loss, changes in equity and cash flows for each of the three years in the period ended December 31,
2025, and the related notes (collectively referred to as &#x201c;the consolidated financial statements&#x201d;). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31,
2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31,
2025, in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="c0" id="ixv-70387">Ernst &amp; Young Hua Ming LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="ixv-70388">China</dei:AuditorLocation>
    <ifrs-full:Revenue contextRef="c4" decimals="-3" id="ixv-70389" unitRef="cny">678415000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c6" decimals="-3" id="ixv-70390" unitRef="cny">193535000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c7" decimals="-3" id="ixv-70391" unitRef="cny">260835000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c8" decimals="-3" id="ixv-70392" unitRef="cny">499272000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c8" decimals="-3" id="ixv-70393" unitRef="usd">71395000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c9" decimals="-3" id="ixv-70394" unitRef="cny">28449000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c10" decimals="-3" id="ixv-70395" unitRef="cny">41400000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c11" decimals="-3" id="ixv-70396" unitRef="cny">74848000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c11" decimals="-3" id="ixv-70397" unitRef="usd">10703000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c12" decimals="-3" id="ixv-70398" unitRef="cny">221984000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c13" decimals="-3" id="ixv-70399" unitRef="cny">980650000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c0" decimals="-3" id="ixv-70400" unitRef="cny">574120000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c0" decimals="-3" id="ixv-70401" unitRef="usd">82098000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales contextRef="c6" decimals="-3" id="ixv-70402" unitRef="cny">29342000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c7" decimals="-3" id="ixv-70403" unitRef="cny">27031000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c8" decimals="-3" id="ixv-70404" unitRef="cny">46661000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c8" decimals="-3" id="ixv-70405" unitRef="usd">6672000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c9" decimals="-3" id="ixv-70406" unitRef="cny">1201000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c10" decimals="-3" id="ixv-70407" unitRef="cny">2054000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c11" decimals="-3" id="ixv-70408" unitRef="cny">2277000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c11" decimals="-3" id="ixv-70409" unitRef="usd">326000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c12" decimals="-3" id="ixv-70410" unitRef="cny">30543000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c13" decimals="-3" id="ixv-70411" unitRef="cny">29085000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c0" decimals="-3" id="ixv-70412" unitRef="cny">48938000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c0" decimals="-3" id="ixv-70413" unitRef="usd">6998000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit contextRef="c12" decimals="-3" id="ixv-70414" unitRef="cny">191441000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c13" decimals="-3" id="ixv-70415" unitRef="cny">951565000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c0" decimals="-3" id="ixv-70416" unitRef="cny">525182000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c0" decimals="-3" id="ixv-70417" unitRef="usd">75100000</ifrs-full:GrossProfit>
    <ifrs-full:OtherIncome contextRef="c12" decimals="-3" id="ixv-70418" unitRef="cny">59316000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c13" decimals="-3" id="ixv-70419" unitRef="cny">57359000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c0" decimals="-3" id="ixv-70420" unitRef="cny">103495000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c0" decimals="-3" id="ixv-70421" unitRef="usd">14800000</ifrs-full:OtherIncome>
    <ifrs-full:SellingExpense contextRef="c12" decimals="-3" id="ixv-70422" unitRef="cny">195387000</ifrs-full:SellingExpense>
    <ifrs-full:SellingExpense contextRef="c13" decimals="-3" id="ixv-70423" unitRef="cny">195998000</ifrs-full:SellingExpense>
    <ifrs-full:SellingExpense contextRef="c0" decimals="-3" id="ixv-70424" unitRef="cny">353640000</ifrs-full:SellingExpense>
    <ifrs-full:SellingExpense contextRef="c0" decimals="-3" id="ixv-70425" unitRef="usd">50570000</ifrs-full:SellingExpense>
    <ifrs-full:AdministrativeExpense contextRef="c12" decimals="-3" id="ixv-70426" unitRef="cny">181076000</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c13" decimals="-3" id="ixv-70427" unitRef="cny">187125000</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c0" decimals="-3" id="ixv-70428" unitRef="cny">246281000</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c0" decimals="-3" id="ixv-70429" unitRef="usd">35218000</ifrs-full:AdministrativeExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c12" decimals="-3" id="ixv-70430" unitRef="cny">706972000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c13" decimals="-3" id="ixv-70431" unitRef="cny">947245000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-70432" unitRef="cny">1137448000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-70433" unitRef="usd">162653000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:OtherExpenseByNature contextRef="c12" decimals="-3" id="ixv-70434" unitRef="cny">5203000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="c13" decimals="-3" id="ixv-70435" unitRef="cny">9075000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="c0" decimals="-3" id="ixv-70436" unitRef="cny">73599000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="c0" decimals="-3" id="ixv-70437" unitRef="usd">10525000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:FinanceCosts contextRef="c12" decimals="-3" id="ixv-70438" unitRef="cny">96057000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c13" decimals="-3" id="ixv-70439" unitRef="cny">64455000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c0" decimals="-3" id="ixv-70440" unitRef="cny">54070000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c0" decimals="-3" id="ixv-70441" unitRef="usd">7732000</ifrs-full:FinanceCosts>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c12" decimals="-3" id="ixv-70442" unitRef="cny">1076000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c13" decimals="-3" id="ixv-70443" unitRef="cny">-281000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c0" decimals="-3" id="ixv-70444" unitRef="cny">314000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c0" decimals="-3" id="ixv-70445" unitRef="usd">45000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossBeforeTax contextRef="c12" decimals="-3" id="ixv-70446" unitRef="cny">-932862000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c13" decimals="-3" id="ixv-70447" unitRef="cny">-395255000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c0" decimals="-3" id="ixv-70448" unitRef="cny">-1236047000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c0" decimals="-3" id="ixv-70449" unitRef="usd">-176753000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c12" decimals="-3" id="ixv-70450" unitRef="cny">-7150000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c13" decimals="-3" id="ixv-70451" unitRef="cny">10425000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="-3" id="ixv-70452" unitRef="cny">6940000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="-3" id="ixv-70453" unitRef="usd">992000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss contextRef="c12" decimals="-3" id="ixv-70454" unitRef="cny">-925712000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c13" decimals="-3" id="ixv-70455" unitRef="cny">-405680000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="-3" id="ixv-70456" unitRef="cny">-1242987000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="-3" id="ixv-70457" unitRef="usd">-177745000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c12" decimals="-3" id="ixv-70458" unitRef="cny">-925637000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c13" decimals="-3" id="ixv-70459" unitRef="cny">-405433000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c0" decimals="-3" id="ixv-70460" unitRef="cny">-1242769000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c0" decimals="-3" id="ixv-70461" unitRef="usd">-177714000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="c12" decimals="-3" id="ixv-70462" unitRef="cny">-75000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="c13" decimals="-3" id="ixv-70463" unitRef="cny">-247000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="c0" decimals="-3" id="ixv-70464" unitRef="cny">-218000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="c0" decimals="-3" id="ixv-70465" unitRef="usd">-31000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLoss contextRef="c12" decimals="-3" id="ixv-70466" unitRef="cny">-925712000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c13" decimals="-3" id="ixv-70467" unitRef="cny">-405680000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="-3" id="ixv-70468" unitRef="cny">-1242987000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="-3" id="ixv-70469" unitRef="usd">-177745000</ifrs-full:ProfitLoss>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c12"
      decimals="2"
      id="ixv-70470"
      unitRef="cnyPershares">-3.28</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c12"
      decimals="2"
      id="ixv-70471"
      unitRef="cnyPershares">-3.28</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c13"
      decimals="2"
      id="ixv-70472"
      unitRef="cnyPershares">-1.34</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c13"
      decimals="2"
      id="ixv-70473"
      unitRef="cnyPershares">-1.34</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c0"
      decimals="2"
      id="ixv-70474"
      unitRef="cnyPershares">-3.49</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c0"
      decimals="2"
      id="ixv-70475"
      unitRef="cnyPershares">-3.49</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c0"
      decimals="2"
      id="ixv-70476"
      unitRef="usdPershares">-0.5</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c0"
      decimals="2"
      id="ixv-70477"
      unitRef="usdPershares">-0.5</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:ProfitLoss contextRef="c12" decimals="-3" id="ixv-70478" unitRef="cny">-925712000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c13" decimals="-3" id="ixv-70479" unitRef="cny">-405680000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="-3" id="ixv-70480" unitRef="cny">-1242987000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="-3" id="ixv-70481" unitRef="usd">-177745000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation contextRef="c12" decimals="-3" id="ixv-70482" unitRef="cny">20593000</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation contextRef="c13" decimals="-3" id="ixv-70483" unitRef="cny">2829000</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation contextRef="c0" decimals="-3" id="ixv-70484" unitRef="cny">-41574000</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation contextRef="c0" decimals="-3" id="ixv-70485" unitRef="usd">-5945000</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations contextRef="c12" decimals="-3" id="ixv-70486" unitRef="cny">5666000</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations contextRef="c13" decimals="-3" id="ixv-70487" unitRef="cny">4120000</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations contextRef="c0" decimals="-3" id="ixv-70488" unitRef="cny">-11441000</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations contextRef="c0" decimals="-3" id="ixv-70489" unitRef="usd">-1636000</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations>
    <ifrs-full:OtherComprehensiveIncome contextRef="c12" decimals="-3" id="ixv-70490" unitRef="cny">26259000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c13" decimals="-3" id="ixv-70491" unitRef="cny">6949000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c0" decimals="-3" id="ixv-70492" unitRef="cny">-53015000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c0" decimals="-3" id="ixv-70493" unitRef="usd">-7581000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c12" decimals="-3" id="ixv-70494" unitRef="cny">-899453000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c13" decimals="-3" id="ixv-70495" unitRef="cny">-398731000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="-3" id="ixv-70496" unitRef="cny">-1296002000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="-3" id="ixv-70497" unitRef="usd">-185326000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c12" decimals="-3" id="ixv-70498" unitRef="cny">-899378000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c13" decimals="-3" id="ixv-70499" unitRef="cny">-398484000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c0" decimals="-3" id="ixv-70500" unitRef="cny">-1295784000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c0" decimals="-3" id="ixv-70501" unitRef="usd">-185295000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="c12" decimals="-3" id="ixv-70502" unitRef="cny">-75000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="c13" decimals="-3" id="ixv-70503" unitRef="cny">-247000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="c0" decimals="-3" id="ixv-70504" unitRef="cny">-218000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="c0" decimals="-3" id="ixv-70505" unitRef="usd">-31000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncome contextRef="c12" decimals="-3" id="ixv-70506" unitRef="cny">-899453000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c13" decimals="-3" id="ixv-70507" unitRef="cny">-398731000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="-3" id="ixv-70508" unitRef="cny">-1296002000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="-3" id="ixv-70509" unitRef="usd">-185326000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c14" decimals="-3" id="ixv-70510" unitRef="cny">849450000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c15" decimals="-3" id="ixv-70511" unitRef="cny">781235000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c15" decimals="-3" id="ixv-70512" unitRef="usd">111715000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets contextRef="c14" decimals="-3" id="ixv-70513" unitRef="cny">56109000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c15" decimals="-3" id="ixv-70514" unitRef="cny">47827000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c15" decimals="-3" id="ixv-70515" unitRef="usd">6839000</ifrs-full:RightofuseAssets>
    <ifrs-full:Goodwill contextRef="c14" decimals="-3" id="ixv-70516" unitRef="cny">24694000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c15" decimals="-3" id="ixv-70517" unitRef="cny">24694000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c15" decimals="-3" id="ixv-70518" unitRef="usd">3531000</ifrs-full:Goodwill>
    <ifrs-full:OtherIntangibleAssets contextRef="c14" decimals="-3" id="ixv-70519" unitRef="cny">75998000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets contextRef="c15" decimals="-3" id="ixv-70520" unitRef="cny">65936000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets contextRef="c15" decimals="-3" id="ixv-70521" unitRef="usd">9429000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c14" decimals="-3" id="ixv-70522" unitRef="cny">32717000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c15" decimals="-3" id="ixv-70523" unitRef="cny">33030000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c15" decimals="-3" id="ixv-70524" unitRef="usd">4723000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c14" decimals="-3" id="ixv-70525" unitRef="cny">1141000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c15" decimals="-3" id="ixv-70526" unitRef="cny">4000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c15" decimals="-3" id="ixv-70527" unitRef="usd">572000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:DeferredTaxAssets contextRef="c14" decimals="-3" id="ixv-70528" unitRef="cny">44236000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c15" decimals="-3" id="ixv-70529" unitRef="cny">31957000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c15" decimals="-3" id="ixv-70530" unitRef="usd">4570000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c14" decimals="-3" id="ixv-70531" unitRef="cny">59303000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c15" decimals="-3" id="ixv-70532" unitRef="cny">30725000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c15" decimals="-3" id="ixv-70533" unitRef="usd">4394000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c14" decimals="-3" id="ixv-70534" unitRef="cny">1143648000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c15" decimals="-3" id="ixv-70535" unitRef="cny">1019404000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c15" decimals="-3" id="ixv-70536" unitRef="usd">145773000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Inventories contextRef="c14" decimals="-3" id="ixv-70537" unitRef="cny">6597000</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="c15" decimals="-3" id="ixv-70538" unitRef="cny">28618000</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="c15" decimals="-3" id="ixv-70539" unitRef="usd">4092000</ifrs-full:Inventories>
    <ifrs-full:CurrentTradeReceivables contextRef="c14" decimals="-3" id="ixv-70540" unitRef="cny">83143000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables contextRef="c15" decimals="-3" id="ixv-70541" unitRef="cny">252938000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables contextRef="c15" decimals="-3" id="ixv-70542" unitRef="usd">36170000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c14" decimals="-3" id="ixv-70543" unitRef="cny">123211000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c15" decimals="-3" id="ixv-70544" unitRef="cny">192532000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c15" decimals="-3" id="ixv-70545" unitRef="usd">27532000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c14" decimals="-3" id="ixv-70546" unitRef="cny">1261211000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c15" decimals="-3" id="ixv-70547" unitRef="cny">2470085000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c15" decimals="-3" id="ixv-70548" unitRef="usd">353217000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CurrentAssets contextRef="c14" decimals="-3" id="ixv-70549" unitRef="cny">1474162000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c15" decimals="-3" id="ixv-70550" unitRef="cny">2944173000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c15" decimals="-3" id="ixv-70551" unitRef="usd">421011000</ifrs-full:CurrentAssets>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c14" decimals="-3" id="ixv-70552" unitRef="cny">91966000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c15" decimals="-3" id="ixv-70553" unitRef="cny">106740000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c15" decimals="-3" id="ixv-70554" unitRef="usd">15264000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:OtherCurrentPayables contextRef="c14" decimals="-3" id="ixv-70555" unitRef="cny">258098000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables contextRef="c15" decimals="-3" id="ixv-70556" unitRef="cny">276666000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables contextRef="c15" decimals="-3" id="ixv-70557" unitRef="usd">39563000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:CurrentContractLiabilities contextRef="c14" decimals="-3" id="ixv-70558" unitRef="cny">37485000</ifrs-full:CurrentContractLiabilities>
    <ifrs-full:CurrentContractLiabilities contextRef="c15" decimals="-3" id="ixv-70559" unitRef="cny">37485000</ifrs-full:CurrentContractLiabilities>
    <ifrs-full:CurrentContractLiabilities contextRef="c15" decimals="-3" id="ixv-70560" unitRef="usd">5360000</ifrs-full:CurrentContractLiabilities>
    <aapg:Interestbearingbankandotherborrowingscurrent contextRef="c14" decimals="-3" id="ixv-70561" unitRef="cny">779062000</aapg:Interestbearingbankandotherborrowingscurrent>
    <aapg:Interestbearingbankandotherborrowingscurrent contextRef="c15" decimals="-3" id="ixv-70562" unitRef="cny">1222481000</aapg:Interestbearingbankandotherborrowingscurrent>
    <aapg:Interestbearingbankandotherborrowingscurrent contextRef="c15" decimals="-3" id="ixv-70563" unitRef="usd">174812000</aapg:Interestbearingbankandotherborrowingscurrent>
    <ifrs-full:CurrentLiabilities contextRef="c14" decimals="-3" id="ixv-70564" unitRef="cny">1166611000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c15" decimals="-3" id="ixv-70565" unitRef="cny">1643372000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c15" decimals="-3" id="ixv-70566" unitRef="usd">234999000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentAssetsLiabilities contextRef="c14" decimals="-3" id="ixv-70567" unitRef="cny">307551000</ifrs-full:CurrentAssetsLiabilities>
    <ifrs-full:CurrentAssetsLiabilities contextRef="c15" decimals="-3" id="ixv-70568" unitRef="cny">1300801000</ifrs-full:CurrentAssetsLiabilities>
    <ifrs-full:CurrentAssetsLiabilities contextRef="c15" decimals="-3" id="ixv-70569" unitRef="usd">186012000</ifrs-full:CurrentAssetsLiabilities>
    <ifrs-full:AssetsLessCurrentLiabilities contextRef="c14" decimals="-3" id="ixv-70570" unitRef="cny">1451199000</ifrs-full:AssetsLessCurrentLiabilities>
    <ifrs-full:AssetsLessCurrentLiabilities contextRef="c15" decimals="-3" id="ixv-70571" unitRef="cny">2320205000</ifrs-full:AssetsLessCurrentLiabilities>
    <ifrs-full:AssetsLessCurrentLiabilities contextRef="c15" decimals="-3" id="ixv-70572" unitRef="usd">331785000</ifrs-full:AssetsLessCurrentLiabilities>
    <ifrs-full:NoncurrentContractLiabilities contextRef="c14" decimals="-3" id="ixv-70573" unitRef="cny">248460000</ifrs-full:NoncurrentContractLiabilities>
    <ifrs-full:NoncurrentContractLiabilities contextRef="c15" decimals="-3" id="ixv-70574" unitRef="cny">210224000</ifrs-full:NoncurrentContractLiabilities>
    <ifrs-full:NoncurrentContractLiabilities contextRef="c15" decimals="-3" id="ixv-70575" unitRef="usd">30062000</ifrs-full:NoncurrentContractLiabilities>
    <aapg:InterestbearingBankAndOtherBorrowingsNonCurrent contextRef="c14" decimals="-3" id="ixv-70576" unitRef="cny">889435000</aapg:InterestbearingBankAndOtherBorrowingsNonCurrent>
    <aapg:InterestbearingBankAndOtherBorrowingsNonCurrent contextRef="c15" decimals="-3" id="ixv-70577" unitRef="cny">757238000</aapg:InterestbearingBankAndOtherBorrowingsNonCurrent>
    <aapg:InterestbearingBankAndOtherBorrowingsNonCurrent contextRef="c15" decimals="-3" id="ixv-70578" unitRef="usd">108284000</aapg:InterestbearingBankAndOtherBorrowingsNonCurrent>
    <ifrs-full:DeferredTaxLiabilities contextRef="c14" decimals="-3" id="ixv-70579" unitRef="cny">5368000</ifrs-full:DeferredTaxLiabilities>
    <aapg:DeferredIncomeNonCurrent contextRef="c14" decimals="-3" id="ixv-70580" unitRef="cny">27500000</aapg:DeferredIncomeNonCurrent>
    <aapg:DeferredIncomeNonCurrent contextRef="c15" decimals="-3" id="ixv-70581" unitRef="cny">6500000</aapg:DeferredIncomeNonCurrent>
    <aapg:DeferredIncomeNonCurrent contextRef="c15" decimals="-3" id="ixv-70582" unitRef="usd">929000</aapg:DeferredIncomeNonCurrent>
    <ifrs-full:OtherNoncurrentLiabilities contextRef="c14" decimals="-3" id="ixv-70583" unitRef="cny">6274000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities contextRef="c15" decimals="-3" id="ixv-70584" unitRef="cny">12031000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities contextRef="c15" decimals="-3" id="ixv-70585" unitRef="usd">1720000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c14" decimals="-3" id="ixv-70586" unitRef="cny">1177037000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c15" decimals="-3" id="ixv-70587" unitRef="cny">985993000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c15" decimals="-3" id="ixv-70588" unitRef="usd">140995000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities contextRef="c14" decimals="-3" id="ixv-70589" unitRef="cny">2343648000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c15" decimals="-3" id="ixv-70590" unitRef="cny">2629365000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c15" decimals="-3" id="ixv-70591" unitRef="usd">375994000</ifrs-full:Liabilities>
    <ifrs-full:ParValuePerShare
      contextRef="c14"
      decimals="4"
      id="ixv-70592"
      unitRef="usdPershares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="c15"
      decimals="4"
      id="ixv-70593"
      unitRef="usdPershares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="c15"
      decimals="4"
      id="ixv-70594"
      unitRef="usdPershares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="c14"
      decimals="INF"
      id="ixv-70595"
      unitRef="shares">315224993</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c14"
      decimals="INF"
      id="ixv-70596"
      unitRef="shares">315224993</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="c14"
      decimals="INF"
      id="ixv-70597"
      unitRef="shares">315224993</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="c15"
      decimals="INF"
      id="ixv-70598"
      unitRef="shares">373321692</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="c15"
      decimals="INF"
      id="ixv-70599"
      unitRef="shares">373321692</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c15"
      decimals="INF"
      id="ixv-70600"
      unitRef="shares">373321692</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c15"
      decimals="INF"
      id="ixv-70601"
      unitRef="shares">373321692</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="c15"
      decimals="INF"
      id="ixv-70602"
      unitRef="shares">373321692</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="c15"
      decimals="INF"
      id="ixv-70603"
      unitRef="shares">373321692</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:IssuedCapitalOrdinaryShares contextRef="c14" decimals="-3" id="ixv-70604" unitRef="cny">214000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:IssuedCapitalOrdinaryShares contextRef="c15" decimals="-3" id="ixv-70605" unitRef="cny">256000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:IssuedCapitalOrdinaryShares contextRef="c15" decimals="-3" id="ixv-70606" unitRef="usd">37000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:TreasuryShares contextRef="c14" decimals="-3" id="ixv-70607" unitRef="cny">8000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares contextRef="c15" decimals="-3" id="ixv-70608" unitRef="cny">2961000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares contextRef="c15" decimals="-3" id="ixv-70609" unitRef="usd">423000</ifrs-full:TreasuryShares>
    <ifrs-full:SharePremium contextRef="c14" decimals="-3" id="ixv-70610" unitRef="cny">6545129000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="c15" decimals="-3" id="ixv-70611" unitRef="cny">8916853000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="c15" decimals="-3" id="ixv-70612" unitRef="usd">1275093000</ifrs-full:SharePremium>
    <aapg:CapitalAndReserves contextRef="c14" decimals="-3" id="ixv-70613" unitRef="cny">-384515000</aapg:CapitalAndReserves>
    <aapg:CapitalAndReserves contextRef="c15" decimals="-3" id="ixv-70614" unitRef="cny">-397276000</aapg:CapitalAndReserves>
    <aapg:CapitalAndReserves contextRef="c15" decimals="-3" id="ixv-70615" unitRef="usd">-56810000</aapg:CapitalAndReserves>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c14" decimals="-3" id="ixv-70616" unitRef="cny">-126071000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c15" decimals="-3" id="ixv-70617" unitRef="cny">-179086000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c15" decimals="-3" id="ixv-70618" unitRef="usd">-25609000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:AccumulatedOtherComprehensiveIncome contextRef="c14" decimals="-3" id="ixv-70619" unitRef="cny">-5770555000</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:AccumulatedOtherComprehensiveIncome contextRef="c15" decimals="-3" id="ixv-70620" unitRef="cny">-7013324000</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:AccumulatedOtherComprehensiveIncome contextRef="c15" decimals="-3" id="ixv-70621" unitRef="usd">-1002892000</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:EquityAttributableToOwnersOfParent contextRef="c14" decimals="-3" id="ixv-70622" unitRef="cny">264194000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent contextRef="c15" decimals="-3" id="ixv-70623" unitRef="cny">1324462000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent contextRef="c15" decimals="-3" id="ixv-70624" unitRef="usd">189396000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests contextRef="c14" decimals="-3" id="ixv-70625" unitRef="cny">9968000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests contextRef="c15" decimals="-3" id="ixv-70626" unitRef="cny">9750000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests contextRef="c15" decimals="-3" id="ixv-70627" unitRef="usd">1394000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity contextRef="c14" decimals="-3" id="ixv-70628" unitRef="cny">274162000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c15" decimals="-3" id="ixv-70629" unitRef="cny">1334212000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c15" decimals="-3" id="ixv-70630" unitRef="usd">190790000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c16" decimals="-3" id="ixv-70631" unitRef="cny">180000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c17" decimals="-3" id="ixv-70632" unitRef="cny">-26552000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c18" decimals="-3" id="ixv-70633" unitRef="cny">5393029000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c19" decimals="-3" id="ixv-70634" unitRef="cny">-359235000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c20" decimals="-3" id="ixv-70635" unitRef="cny">-159279000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c21" decimals="-3" id="ixv-70636" unitRef="cny">-4439485000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c22" decimals="-3" id="ixv-70637" unitRef="cny">408658000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c24" decimals="-3" id="ixv-70638" unitRef="cny">408658000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c30" decimals="-3" id="ixv-70639" unitRef="cny">-925637000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c31" decimals="-3" id="ixv-70640" unitRef="cny">-925637000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c32" decimals="-3" id="ixv-70641" unitRef="cny">-75000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c12" decimals="-3" id="ixv-70642" unitRef="cny">-925712000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c29" decimals="-3" id="ixv-70643" unitRef="cny">26259000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c31" decimals="-3" id="ixv-70644" unitRef="cny">26259000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c12" decimals="-3" id="ixv-70645" unitRef="cny">26259000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:ComprehensiveIncome contextRef="c29" decimals="-3" id="ixv-70646" unitRef="cny">26259000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c30" decimals="-3" id="ixv-70647" unitRef="cny">-925637000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c31" decimals="-3" id="ixv-70648" unitRef="cny">-899378000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c32" decimals="-3" id="ixv-70649" unitRef="cny">-75000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c12" decimals="-3" id="ixv-70650" unitRef="cny">-899453000</ifrs-full:ComprehensiveIncome>
    <aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary contextRef="c32" decimals="-3" id="ixv-70651" unitRef="cny">10290000</aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary>
    <aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary contextRef="c12" decimals="-3" id="ixv-70652" unitRef="cny">10290000</aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary>
    <ifrs-full:IssueOfEquity contextRef="c25" decimals="-3" id="ixv-70653" unitRef="cny">15000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c27" decimals="-3" id="ixv-70654" unitRef="cny">470066000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c31" decimals="-3" id="ixv-70655" unitRef="cny">470081000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c12" decimals="-3" id="ixv-70656" unitRef="cny">470081000</ifrs-full:IssueOfEquity>
    <aapg:RepurchaseOfOrdinaryShares contextRef="c26" decimals="-3" id="ixv-70657" unitRef="cny">-5923000</aapg:RepurchaseOfOrdinaryShares>
    <aapg:RepurchaseOfOrdinaryShares contextRef="c31" decimals="-3" id="ixv-70658" unitRef="cny">-5923000</aapg:RepurchaseOfOrdinaryShares>
    <aapg:RepurchaseOfOrdinaryShares contextRef="c12" decimals="-3" id="ixv-70659" unitRef="cny">-5923000</aapg:RepurchaseOfOrdinaryShares>
    <aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses contextRef="c28" decimals="-3" id="ixv-70660" unitRef="cny">3750000</aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses>
    <aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses contextRef="c31" decimals="-3" id="ixv-70661" unitRef="cny">3750000</aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses>
    <aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses contextRef="c12" decimals="-3" id="ixv-70662" unitRef="cny">3750000</aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses contextRef="c28" decimals="-3" id="ixv-70663" unitRef="cny">27753000</aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses contextRef="c31" decimals="-3" id="ixv-70664" unitRef="cny">27753000</aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses contextRef="c12" decimals="-3" id="ixv-70665" unitRef="cny">27753000</aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c25" decimals="-3" id="ixv-70666" unitRef="cny">1000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c27" decimals="-3" id="ixv-70667" unitRef="cny">18354000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c28" decimals="-3" id="ixv-70668" unitRef="cny">-18347000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c31" decimals="-3" id="ixv-70669" unitRef="cny">8000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c12" decimals="-3" id="ixv-70670" unitRef="cny">8000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c26" decimals="-3" id="ixv-70671" unitRef="cny">11123000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c27" decimals="-3" id="ixv-70672" unitRef="cny">14239000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c28" decimals="-3" id="ixv-70673" unitRef="cny">-25362000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c25" decimals="-3" id="ixv-70674" unitRef="cny">1000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c26" decimals="-3" id="ixv-70675" unitRef="cny">1000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c27" decimals="-3" id="ixv-70676" unitRef="cny">55466000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c31" decimals="-3" id="ixv-70677" unitRef="cny">55468000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c12" decimals="-3" id="ixv-70678" unitRef="cny">55468000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <ifrs-full:Equity contextRef="c33" decimals="-3" id="ixv-70679" unitRef="cny">197000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c34" decimals="-3" id="ixv-70680" unitRef="cny">-21351000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c35" decimals="-3" id="ixv-70681" unitRef="cny">5951154000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c36" decimals="-3" id="ixv-70682" unitRef="cny">-371441000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c37" decimals="-3" id="ixv-70683" unitRef="cny">-133020000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c38" decimals="-3" id="ixv-70684" unitRef="cny">-5365122000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c39" decimals="-3" id="ixv-70685" unitRef="cny">60417000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c40" decimals="-3" id="ixv-70686" unitRef="cny">10215000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c41" decimals="-3" id="ixv-70687" unitRef="cny">70632000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c33" decimals="-3" id="ixv-70688" unitRef="cny">197000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c34" decimals="-3" id="ixv-70689" unitRef="cny">-21351000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c35" decimals="-3" id="ixv-70690" unitRef="cny">5951154000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c36" decimals="-3" id="ixv-70691" unitRef="cny">-371441000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c37" decimals="-3" id="ixv-70692" unitRef="cny">-133020000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c38" decimals="-3" id="ixv-70693" unitRef="cny">-5365122000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c39" decimals="-3" id="ixv-70694" unitRef="cny">60417000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c40" decimals="-3" id="ixv-70695" unitRef="cny">10215000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c41" decimals="-3" id="ixv-70696" unitRef="cny">70632000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c47" decimals="-3" id="ixv-70697" unitRef="cny">-405433000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c48" decimals="-3" id="ixv-70698" unitRef="cny">-405433000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c49" decimals="-3" id="ixv-70699" unitRef="cny">-247000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c13" decimals="-3" id="ixv-70700" unitRef="cny">-405680000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c46" decimals="-3" id="ixv-70701" unitRef="cny">6949000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c48" decimals="-3" id="ixv-70702" unitRef="cny">6949000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c13" decimals="-3" id="ixv-70703" unitRef="cny">6949000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:ComprehensiveIncome contextRef="c46" decimals="-3" id="ixv-70704" unitRef="cny">6949000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c47" decimals="-3" id="ixv-70705" unitRef="cny">-405433000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c48" decimals="-3" id="ixv-70706" unitRef="cny">-398484000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c49" decimals="-3" id="ixv-70707" unitRef="cny">-247000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c13" decimals="-3" id="ixv-70708" unitRef="cny">-398731000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IssueOfEquity contextRef="c42" decimals="-3" id="ixv-70709" unitRef="cny">17000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c44" decimals="-3" id="ixv-70710" unitRef="cny">533923000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c48" decimals="-3" id="ixv-70711" unitRef="cny">533940000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c13" decimals="-3" id="ixv-70712" unitRef="cny">533940000</ifrs-full:IssueOfEquity>
    <aapg:RepurchaseOfOrdinaryShares contextRef="c43" decimals="-3" id="ixv-70713" unitRef="cny">-1959000</aapg:RepurchaseOfOrdinaryShares>
    <aapg:RepurchaseOfOrdinaryShares contextRef="c48" decimals="-3" id="ixv-70714" unitRef="cny">-1959000</aapg:RepurchaseOfOrdinaryShares>
    <aapg:RepurchaseOfOrdinaryShares contextRef="c13" decimals="-3" id="ixv-70715" unitRef="cny">-1959000</aapg:RepurchaseOfOrdinaryShares>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses contextRef="c45" decimals="-3" id="ixv-70716" unitRef="cny">20924000</aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses contextRef="c48" decimals="-3" id="ixv-70717" unitRef="cny">20924000</aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses contextRef="c13" decimals="-3" id="ixv-70718" unitRef="cny">20924000</aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c44" decimals="-3" id="ixv-70719" unitRef="cny">11379000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c45" decimals="-3" id="ixv-70720" unitRef="cny">-11373000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c48" decimals="-3" id="ixv-70721" unitRef="cny">6000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c13" decimals="-3" id="ixv-70722" unitRef="cny">6000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c43" decimals="-3" id="ixv-70723" unitRef="cny">14671000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c44" decimals="-3" id="ixv-70724" unitRef="cny">7954000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c45" decimals="-3" id="ixv-70725" unitRef="cny">-22625000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c43" decimals="-3" id="ixv-70726" unitRef="cny">8631000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c44" decimals="-3" id="ixv-70727" unitRef="cny">40719000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c48" decimals="-3" id="ixv-70728" unitRef="cny">49350000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c13" decimals="-3" id="ixv-70729" unitRef="cny">49350000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <ifrs-full:Equity contextRef="c50" decimals="-3" id="ixv-70730" unitRef="cny">214000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c51" decimals="-3" id="ixv-70731" unitRef="cny">-8000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c52" decimals="-3" id="ixv-70732" unitRef="cny">6545129000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c53" decimals="-3" id="ixv-70733" unitRef="cny">-384515000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c54" decimals="-3" id="ixv-70734" unitRef="cny">-126071000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c55" decimals="-3" id="ixv-70735" unitRef="cny">-5770555000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c56" decimals="-3" id="ixv-70736" unitRef="cny">264194000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c57" decimals="-3" id="ixv-70737" unitRef="cny">9968000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c14" decimals="-3" id="ixv-70738" unitRef="cny">274162000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c50" decimals="-3" id="ixv-70739" unitRef="cny">214000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c51" decimals="-3" id="ixv-70740" unitRef="cny">-8000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c52" decimals="-3" id="ixv-70741" unitRef="cny">6545129000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c53" decimals="-3" id="ixv-70742" unitRef="cny">-384515000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c54" decimals="-3" id="ixv-70743" unitRef="cny">-126071000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c55" decimals="-3" id="ixv-70744" unitRef="cny">-5770555000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c56" decimals="-3" id="ixv-70745" unitRef="cny">264194000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c57" decimals="-3" id="ixv-70746" unitRef="cny">9968000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c14" decimals="-3" id="ixv-70747" unitRef="cny">274162000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c63" decimals="-3" id="ixv-70748" unitRef="cny">-1242769000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c64" decimals="-3" id="ixv-70749" unitRef="cny">-1242769000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c65" decimals="-3" id="ixv-70750" unitRef="cny">-218000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="-3" id="ixv-70751" unitRef="cny">-1242987000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c62" decimals="-3" id="ixv-70752" unitRef="cny">-53015000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c64" decimals="-3" id="ixv-70753" unitRef="cny">-53015000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c0" decimals="-3" id="ixv-70754" unitRef="cny">-53015000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:ComprehensiveIncome contextRef="c62" decimals="-3" id="ixv-70755" unitRef="cny">-53015000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c63" decimals="-3" id="ixv-70756" unitRef="cny">-1242769000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c64" decimals="-3" id="ixv-70757" unitRef="cny">-1295784000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c65" decimals="-3" id="ixv-70758" unitRef="cny">-218000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="-3" id="ixv-70759" unitRef="cny">-1296002000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IssueOfEquity contextRef="c58" decimals="-3" id="ixv-70760" unitRef="cny">40000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c60" decimals="-3" id="ixv-70761" unitRef="cny">2279855000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c64" decimals="-3" id="ixv-70762" unitRef="cny">2279895000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c0" decimals="-3" id="ixv-70763" unitRef="cny">2279895000</ifrs-full:IssueOfEquity>
    <aapg:RepurchaseOfOrdinaryShares contextRef="c59" decimals="-3" id="ixv-70764" unitRef="cny">-3590000</aapg:RepurchaseOfOrdinaryShares>
    <aapg:RepurchaseOfOrdinaryShares contextRef="c64" decimals="-3" id="ixv-70765" unitRef="cny">-3590000</aapg:RepurchaseOfOrdinaryShares>
    <aapg:RepurchaseOfOrdinaryShares contextRef="c0" decimals="-3" id="ixv-70766" unitRef="cny">-3590000</aapg:RepurchaseOfOrdinaryShares>
    <aapg:StockIssuedDuringPeriodValueShareOptionExpenses contextRef="c61" decimals="-3" id="ixv-70767" unitRef="cny">2420000</aapg:StockIssuedDuringPeriodValueShareOptionExpenses>
    <aapg:StockIssuedDuringPeriodValueShareOptionExpenses contextRef="c64" decimals="-3" id="ixv-70768" unitRef="cny">2420000</aapg:StockIssuedDuringPeriodValueShareOptionExpenses>
    <aapg:StockIssuedDuringPeriodValueShareOptionExpenses contextRef="c0" decimals="-3" id="ixv-70769" unitRef="cny">2420000</aapg:StockIssuedDuringPeriodValueShareOptionExpenses>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses contextRef="c61" decimals="-3" id="ixv-70770" unitRef="cny">18454000</aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses contextRef="c64" decimals="-3" id="ixv-70771" unitRef="cny">18454000</aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses contextRef="c0" decimals="-3" id="ixv-70772" unitRef="cny">18454000</aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c60" decimals="-3" id="ixv-70773" unitRef="cny">7627000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c61" decimals="-3" id="ixv-70774" unitRef="cny">-7623000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c64" decimals="-3" id="ixv-70775" unitRef="cny">4000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c0" decimals="-3" id="ixv-70776" unitRef="cny">4000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c58" decimals="-3" id="ixv-70777" unitRef="cny">1000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c59" decimals="-3" id="ixv-70778" unitRef="cny">637000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c60" decimals="-3" id="ixv-70779" unitRef="cny">25374000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits contextRef="c61" decimals="-3" id="ixv-70780" unitRef="cny">-26012000</aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c58" decimals="-3" id="ixv-70781" unitRef="cny">1000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c60" decimals="-3" id="ixv-70782" unitRef="cny">58868000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c64" decimals="-3" id="ixv-70783" unitRef="cny">58869000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus contextRef="c0" decimals="-3" id="ixv-70784" unitRef="cny">58869000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <ifrs-full:Equity contextRef="c66" decimals="-3" id="ixv-70785" unitRef="cny">256000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c67" decimals="-3" id="ixv-70786" unitRef="cny">-2961000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c68" decimals="-3" id="ixv-70787" unitRef="cny">8916853000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c69" decimals="-3" id="ixv-70788" unitRef="cny">-397276000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c70" decimals="-3" id="ixv-70789" unitRef="cny">-179086000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c71" decimals="-3" id="ixv-70790" unitRef="cny">-7013324000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c72" decimals="-3" id="ixv-70791" unitRef="cny">1324462000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c73" decimals="-3" id="ixv-70792" unitRef="cny">9750000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c15" decimals="-3" id="ixv-70793" unitRef="cny">1334212000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c66" decimals="-3" id="ixv-70794" unitRef="usd">37000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c67" decimals="-3" id="ixv-70795" unitRef="usd">-423000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c68" decimals="-3" id="ixv-70796" unitRef="usd">1275093000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c69" decimals="-3" id="ixv-70797" unitRef="usd">-56810000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c70" decimals="-3" id="ixv-70798" unitRef="usd">-25609000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c71" decimals="-3" id="ixv-70799" unitRef="usd">-1002892000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c72" decimals="-3" id="ixv-70800" unitRef="usd">189396000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c73" decimals="-3" id="ixv-70801" unitRef="usd">1394000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c15" decimals="-3" id="ixv-70802" unitRef="usd">190790000</ifrs-full:Equity>
    <ifrs-full:ProfitLossBeforeTax contextRef="c12" decimals="-3" id="ixv-70803" unitRef="cny">-932862000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c13" decimals="-3" id="ixv-70804" unitRef="cny">-395255000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c0" decimals="-3" id="ixv-70805" unitRef="cny">-1236047000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c0" decimals="-3" id="ixv-70806" unitRef="usd">-176753000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c12" decimals="-3" id="ixv-70807" unitRef="cny">55281000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c13" decimals="-3" id="ixv-70808" unitRef="cny">71184000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c0" decimals="-3" id="ixv-70809" unitRef="cny">65761000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c0" decimals="-3" id="ixv-70810" unitRef="usd">9404000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty contextRef="c12" decimals="-3" id="ixv-70811" unitRef="cny">-15883000</ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty>
    <aapg:AdjustmentsForDepreciationOfRightofuseAssets contextRef="c12" decimals="-3" id="ixv-70812" unitRef="cny">11632000</aapg:AdjustmentsForDepreciationOfRightofuseAssets>
    <aapg:AdjustmentsForDepreciationOfRightofuseAssets contextRef="c13" decimals="-3" id="ixv-70813" unitRef="cny">11134000</aapg:AdjustmentsForDepreciationOfRightofuseAssets>
    <aapg:AdjustmentsForDepreciationOfRightofuseAssets contextRef="c0" decimals="-3" id="ixv-70814" unitRef="cny">10657000</aapg:AdjustmentsForDepreciationOfRightofuseAssets>
    <aapg:AdjustmentsForDepreciationOfRightofuseAssets contextRef="c0" decimals="-3" id="ixv-70815" unitRef="usd">1524000</aapg:AdjustmentsForDepreciationOfRightofuseAssets>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c12" decimals="-3" id="ixv-70816" unitRef="cny">10399000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c13" decimals="-3" id="ixv-70817" unitRef="cny">10851000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c0" decimals="-3" id="ixv-70818" unitRef="cny">10062000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c0" decimals="-3" id="ixv-70819" unitRef="usd">1439000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c12" decimals="-3" id="ixv-70820" unitRef="cny">31503000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c13" decimals="-3" id="ixv-70821" unitRef="cny">20924000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c0" decimals="-3" id="ixv-70822" unitRef="cny">20874000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c0" decimals="-3" id="ixv-70823" unitRef="usd">2985000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="c12" decimals="-3" id="ixv-70824" unitRef="cny">4000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="c13" decimals="-3" id="ixv-70825" unitRef="cny">-50000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-70826" unitRef="cny">-18000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-70827" unitRef="usd">-3000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <aapg:AdjustmentsForGainOnDisposalOfLeases contextRef="c13" decimals="-3" id="ixv-70828" unitRef="cny">85000</aapg:AdjustmentsForGainOnDisposalOfLeases>
    <aapg:AdjustmentsForGainOnDisposalOfLeases contextRef="c0" decimals="-3" id="ixv-70829" unitRef="cny">685000</aapg:AdjustmentsForGainOnDisposalOfLeases>
    <aapg:AdjustmentsForGainOnDisposalOfLeases contextRef="c0" decimals="-3" id="ixv-70830" unitRef="usd">99000</aapg:AdjustmentsForGainOnDisposalOfLeases>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss contextRef="c12" decimals="-3" id="ixv-70831" unitRef="cny">699000</ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss contextRef="c13" decimals="-3" id="ixv-70832" unitRef="cny">832000</ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss contextRef="c0" decimals="-3" id="ixv-70833" unitRef="cny">1134000</ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss contextRef="c0" decimals="-3" id="ixv-70834" unitRef="usd">162000</ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives contextRef="c0" decimals="-3" id="ixv-70835" unitRef="cny">-29533000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives contextRef="c0" decimals="-3" id="ixv-70836" unitRef="usd">-4223000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="c12" decimals="-3" id="ixv-70837" unitRef="cny">-2822000</ifrs-full:AdjustmentsForFairValueGainsLosses>
    <ifrs-full:AdjustmentsForFinanceCosts contextRef="c12" decimals="-3" id="ixv-70838" unitRef="cny">96057000</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForFinanceCosts contextRef="c13" decimals="-3" id="ixv-70839" unitRef="cny">64455000</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForFinanceCosts contextRef="c0" decimals="-3" id="ixv-70840" unitRef="cny">54070000</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForFinanceCosts contextRef="c0" decimals="-3" id="ixv-70841" unitRef="usd">7732000</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c12" decimals="-3" id="ixv-70842" unitRef="cny">1076000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c13" decimals="-3" id="ixv-70843" unitRef="cny">-281000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c0" decimals="-3" id="ixv-70844" unitRef="cny">314000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c0" decimals="-3" id="ixv-70845" unitRef="usd">45000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:AdjustmentsForProvisions contextRef="c0" decimals="-3" id="ixv-70846" unitRef="cny">4180000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions contextRef="c0" decimals="-3" id="ixv-70847" unitRef="usd">598000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c12" decimals="-3" id="ixv-70848" unitRef="cny">-1621000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c13" decimals="-3" id="ixv-70849" unitRef="cny">-6694000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c0" decimals="-3" id="ixv-70850" unitRef="cny">10161000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c0" decimals="-3" id="ixv-70851" unitRef="usd">1453000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForReconcileProfitLoss contextRef="c12" decimals="-3" id="ixv-70852" unitRef="cny">716931000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss contextRef="c13" decimals="-3" id="ixv-70853" unitRef="cny">222323000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss contextRef="c0" decimals="-3" id="ixv-70854" unitRef="cny">1030596000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss contextRef="c0" decimals="-3" id="ixv-70855" unitRef="usd">147374000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances contextRef="c12" decimals="-3" id="ixv-70856" unitRef="cny">-7936000</aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances>
    <aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances contextRef="c13" decimals="-3" id="ixv-70857" unitRef="cny">-96000</aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances>
    <aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances contextRef="c0" decimals="-3" id="ixv-70858" unitRef="cny">18948000</aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances>
    <aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances contextRef="c0" decimals="-3" id="ixv-70859" unitRef="usd">2710000</aapg:AdjustmentsForDecreaseIncreaseInRestrictedCashBalances>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c12" decimals="-3" id="ixv-70860" unitRef="cny">-6719000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c13" decimals="-3" id="ixv-70861" unitRef="cny">9570000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c0" decimals="-3" id="ixv-70862" unitRef="cny">-26201000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c0" decimals="-3" id="ixv-70863" unitRef="usd">-3747000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c12" decimals="-3" id="ixv-70864" unitRef="cny">-91537000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c13" decimals="-3" id="ixv-70865" unitRef="cny">62750000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c0" decimals="-3" id="ixv-70866" unitRef="cny">-169795000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c0" decimals="-3" id="ixv-70867" unitRef="usd">-24281000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c12" decimals="-3" id="ixv-70868" unitRef="cny">-7841000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c13" decimals="-3" id="ixv-70869" unitRef="cny">-14421000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c0" decimals="-3" id="ixv-70870" unitRef="cny">-86337000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c0" decimals="-3" id="ixv-70871" unitRef="usd">-12346000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="c12" decimals="-3" id="ixv-70872" unitRef="cny">-3552000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="c13" decimals="-3" id="ixv-70873" unitRef="cny">-48950000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="c0" decimals="-3" id="ixv-70874" unitRef="cny">27784000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="c0" decimals="-3" id="ixv-70875" unitRef="usd">3974000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c12" decimals="-3" id="ixv-70876" unitRef="cny">-23114000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c13" decimals="-3" id="ixv-70877" unitRef="cny">19521000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c0" decimals="-3" id="ixv-70878" unitRef="cny">14774000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c0" decimals="-3" id="ixv-70879" unitRef="usd">2113000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets contextRef="c12" decimals="-3" id="ixv-70880" unitRef="cny">48573000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets contextRef="c13" decimals="-3" id="ixv-70881" unitRef="cny">78506000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets contextRef="c0" decimals="-3" id="ixv-70882" unitRef="cny">113809000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets contextRef="c0" decimals="-3" id="ixv-70883" unitRef="usd">16274000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeOtherThanContractAssets>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities contextRef="c12" decimals="-3" id="ixv-70884" unitRef="cny">81620000</ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities contextRef="c13" decimals="-3" id="ixv-70885" unitRef="cny">-3654000</ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities contextRef="c0" decimals="-3" id="ixv-70886" unitRef="cny">-37485000</ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities contextRef="c0" decimals="-3" id="ixv-70887" unitRef="usd">-5360000</ifrs-full:AdjustmentsForIncreaseDecreaseInContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities contextRef="c12" decimals="-3" id="ixv-70888" unitRef="cny">1360000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities contextRef="c13" decimals="-3" id="ixv-70889" unitRef="cny">7740000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities contextRef="c0" decimals="-3" id="ixv-70890" unitRef="cny">1000000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities contextRef="c0" decimals="-3" id="ixv-70891" unitRef="usd">143000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="c0" decimals="-3" id="ixv-70892" unitRef="cny">-29000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="c0" decimals="-3" id="ixv-70893" unitRef="usd">-4000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c12" decimals="-3" id="ixv-70894" unitRef="cny">-726077000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c13" decimals="-3" id="ixv-70895" unitRef="cny">-111357000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-70896" unitRef="cny">-1174128000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-70897" unitRef="usd">-167898000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c12" decimals="-3" id="ixv-70898" unitRef="cny">46108000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c13" decimals="-3" id="ixv-70899" unitRef="cny">24289000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c0" decimals="-3" id="ixv-70900" unitRef="cny">27571000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c0" decimals="-3" id="ixv-70901" unitRef="usd">3942000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c12" decimals="-3" id="ixv-70902" unitRef="cny">14000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c12" decimals="-3" id="ixv-70903" unitRef="cny">10736000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="c12" decimals="-3" id="ixv-70904" unitRef="cny">20000000</ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities>
    <ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="c13" decimals="-3" id="ixv-70905" unitRef="cny">9516000</ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities>
    <ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="c0" decimals="-3" id="ixv-70906" unitRef="cny">43342000</ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities>
    <ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="c0" decimals="-3" id="ixv-70907" unitRef="usd">6198000</ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities>
    <aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity contextRef="c12" decimals="-3" id="ixv-70908" unitRef="cny">-98752000</aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity>
    <aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity contextRef="c13" decimals="-3" id="ixv-70909" unitRef="cny">312230000</aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity>
    <aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity contextRef="c0" decimals="-3" id="ixv-70910" unitRef="cny">925139000</aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity>
    <aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity contextRef="c0" decimals="-3" id="ixv-70911" unitRef="usd">132294000</aapg:IncreaseDecreaseInTimeDepositsWithOriginalMaturity>
    <aapg:InvestmentInOtherFinancialAssets contextRef="c0" decimals="-3" id="ixv-70912" unitRef="cny">4000000</aapg:InvestmentInOtherFinancialAssets>
    <aapg:InvestmentInOtherFinancialAssets contextRef="c0" decimals="-3" id="ixv-70913" unitRef="usd">572000</aapg:InvestmentInOtherFinancialAssets>
    <aapg:InvestmentInJointVenturesClassifiedAsInvestingActivities contextRef="c13" decimals="-3" id="ixv-70914" unitRef="cny">16000000</aapg:InvestmentInJointVenturesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c12" decimals="-3" id="ixv-70915" unitRef="cny">21922000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c13" decimals="-3" id="ixv-70916" unitRef="cny">-362035000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c0" decimals="-3" id="ixv-70917" unitRef="cny">-1000052000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c0" decimals="-3" id="ixv-70918" unitRef="usd">-143006000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c12" decimals="-3" id="ixv-70919" unitRef="cny">470081000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c13" decimals="-3" id="ixv-70920" unitRef="cny">533940000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c0" decimals="-3" id="ixv-70921" unitRef="cny">2304905000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c0" decimals="-3" id="ixv-70922" unitRef="usd">329597000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares contextRef="c12" decimals="-3" id="ixv-70923" unitRef="cny">5923000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares contextRef="c0" decimals="-3" id="ixv-70924" unitRef="cny">9036000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares contextRef="c0" decimals="-3" id="ixv-70925" unitRef="usd">1292000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c12" decimals="-3" id="ixv-70926" unitRef="cny">8000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c13" decimals="-3" id="ixv-70927" unitRef="cny">6000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c0" decimals="-3" id="ixv-70928" unitRef="cny">4000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c0" decimals="-3" id="ixv-70929" unitRef="usd">1000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c12" decimals="-3" id="ixv-70930" unitRef="cny">92348000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c13" decimals="-3" id="ixv-70931" unitRef="cny">60556000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-70932" unitRef="cny">51308000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-70933" unitRef="usd">7337000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c12" decimals="-3" id="ixv-70934" unitRef="cny">953500000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c13" decimals="-3" id="ixv-70935" unitRef="cny">535923000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-70936" unitRef="cny">1240970000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-70937" unitRef="usd">177456000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="c12" decimals="-3" id="ixv-70938" unitRef="cny">956091000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="c13" decimals="-3" id="ixv-70939" unitRef="cny">672850000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-70940" unitRef="cny">923990000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-70941" unitRef="usd">132129000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c12" decimals="-3" id="ixv-70942" unitRef="cny">10766000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c13" decimals="-3" id="ixv-70943" unitRef="cny">8413000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-70944" unitRef="cny">9717000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-70945" unitRef="usd">1390000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests contextRef="c12" decimals="-3" id="ixv-70946" unitRef="cny">10290000</ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests>
    <aapg:ListingExpensePaid contextRef="c13" decimals="-3" id="ixv-70947" unitRef="cny">13283000</aapg:ListingExpensePaid>
    <aapg:ListingExpensePaid contextRef="c0" decimals="-3" id="ixv-70948" unitRef="cny">11728000</aapg:ListingExpensePaid>
    <aapg:ListingExpensePaid contextRef="c0" decimals="-3" id="ixv-70949" unitRef="usd">1677000</aapg:ListingExpensePaid>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c12" decimals="-3" id="ixv-70950" unitRef="cny">368751000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c13" decimals="-3" id="ixv-70951" unitRef="cny">314767000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-70952" unitRef="cny">2540100000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-70953" unitRef="usd">363229000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c12" decimals="-3" id="ixv-70954" unitRef="cny">-335404000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c13" decimals="-3" id="ixv-70955" unitRef="cny">-158625000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c0" decimals="-3" id="ixv-70956" unitRef="cny">365920000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c0" decimals="-3" id="ixv-70957" unitRef="usd">52325000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c24" decimals="-3" id="ixv-70958" unitRef="cny">1345639000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c41" decimals="-3" id="ixv-70959" unitRef="cny">1038048000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c14" decimals="-3" id="ixv-70960" unitRef="cny">893100000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c14" decimals="-3" id="ixv-70961" unitRef="usd">127712000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c12" decimals="-3" id="ixv-70962" unitRef="cny">27813000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c13" decimals="-3" id="ixv-70963" unitRef="cny">13677000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c0" decimals="-3" id="ixv-70964" unitRef="cny">-63236000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c0" decimals="-3" id="ixv-70965" unitRef="usd">-9042000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c41" decimals="-3" id="ixv-70966" unitRef="cny">1038048000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c14" decimals="-3" id="ixv-70967" unitRef="cny">893100000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-70968" unitRef="cny">1195784000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-70969" unitRef="usd">170995000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c41" decimals="-3" id="ixv-70970" unitRef="cny">1038048000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c14" decimals="-3" id="ixv-70971" unitRef="cny">893100000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-70972" unitRef="cny">1195784000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-70973" unitRef="usd">170995000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c41" decimals="-3" id="ixv-70974" unitRef="cny">24537000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c14" decimals="-3" id="ixv-70975" unitRef="cny">24633000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-70976" unitRef="cny">5685000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-70977" unitRef="usd">812000</ifrs-full:RestrictedCashAndCashEquivalents>
    <aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths contextRef="c41" decimals="-3" id="ixv-70978" unitRef="cny">31248000</aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths>
    <aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths contextRef="c14" decimals="-3" id="ixv-70979" unitRef="cny">343478000</aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths>
    <aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths contextRef="c15" decimals="-3" id="ixv-70980" unitRef="cny">1268616000</aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths>
    <aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths contextRef="c15" decimals="-3" id="ixv-70981" unitRef="usd">181410000</aapg:TimeDepositsWithOriginalMaturityOfMoreThanThreeMonths>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c41" decimals="-3" id="ixv-70982" unitRef="cny">1093833000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c14" decimals="-3" id="ixv-70983" unitRef="cny">1261211000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c15" decimals="-3" id="ixv-70984" unitRef="cny">2470085000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c15" decimals="-3" id="ixv-70985" unitRef="usd">353217000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory contextRef="c0" id="ixv-38776">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CORPORATE
                                            AND GROUP INFORMATION&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is a limited liability company incorporated in the Cayman Islands on November 17, 2017. The registered office of the Company
is located at the office of Walkers Corporate Limited, with the registered address of 190 Elgin Avenue, George Town, Grand Cayman KY1-9008,
Cayman Islands.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an investment holding company. The Company became the holding company of the subsidiaries upon completion of the reorganization
in July 2018. The Company is a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address
global medical needs primarily in hematological malignancies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2019, the Company completed its Hong Kong initial public offering with the Stock Exchange of Hong Kong Limited (the &#x201c;Hong
Kong Stock Exchange&#x201d;). In January 2025, the Company completed its U.S. initial public offering with the NASDAQ.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Particulars
of the Company&#x2019;s principal subsidiaries are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Place and date of incorporation/ registration and&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="4" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nominal value of issued/registered&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Percentage of equity interests attributable to the Company&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Company name&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;place of business&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;share capital&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Direct&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Indirect&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;business&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; width: 35%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Suzhou Ascentage Pharma Co., Ltd.*@ &lt;br/&gt; (&#x201c;Suzhou Yasheng&#x201d;)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PRC/Chinese&lt;br/&gt; mainland&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;br/&gt; June 1, 2016&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-191; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; width: 12%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Medical research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Guangzhou Healthquest Pharma Co., Ltd.*@ &lt;br/&gt; (&#x201c;Healthquest Pharma&#x201d;)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PRC/Chinese&lt;br/&gt; mainland&lt;br/&gt; July 3, 2012&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-192; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Clinical development and sale of products&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ascentage Pharma Group Inc.&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;United States of America &lt;br/&gt; (&#x201c;United States&#x201d;) &lt;br/&gt; November 4, 2015&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-193; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Clinical trials&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Suzhou Shenghe Innovation Works Biotech Co., Ltd.*@&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PRC/Chinese&lt;br/&gt; mainland &lt;br/&gt;September 21, 2022&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;500&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-194; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rental of buildings to group companies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The English names of the companies registered in the PRC represent the best efforts made by the management of the Company in directly translating the Chinese names of these companies as no English names have been registered.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;@&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These entities are limited liability companies established in the PRC.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory contextRef="c0" id="ixv-38797">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Particulars
of the Company&#x2019;s principal subsidiaries are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Place and date of incorporation/ registration and&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="4" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nominal value of issued/registered&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Percentage of equity interests attributable to the Company&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Company name&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;place of business&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;share capital&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Direct&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Indirect&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;business&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; width: 35%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Suzhou Ascentage Pharma Co., Ltd.*@ &lt;br/&gt; (&#x201c;Suzhou Yasheng&#x201d;)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PRC/Chinese&lt;br/&gt; mainland&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;br/&gt; June 1, 2016&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-191; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; width: 12%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Medical research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Guangzhou Healthquest Pharma Co., Ltd.*@ &lt;br/&gt; (&#x201c;Healthquest Pharma&#x201d;)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PRC/Chinese&lt;br/&gt; mainland&lt;br/&gt; July 3, 2012&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-192; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Clinical development and sale of products&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ascentage Pharma Group Inc.&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;United States of America &lt;br/&gt; (&#x201c;United States&#x201d;) &lt;br/&gt; November 4, 2015&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-193; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Clinical trials&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Suzhou Shenghe Innovation Works Biotech Co., Ltd.*@&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PRC/Chinese&lt;br/&gt; mainland &lt;br/&gt;September 21, 2022&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;500&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-194; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rental of buildings to group companies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The English names of the companies registered in the PRC represent the best efforts made by the management of the Company in directly translating the Chinese names of these companies as no English names have been registered.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;@&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These entities are limited liability companies established in the PRC.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c74" id="ix_0_fact">PRC/Chinese mainland June 1, 2016</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:IssuedCapitalOrdinaryShares contextRef="c75" decimals="-3" id="ix_1_fact" unitRef="cny">2000000000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c74" decimals="2" id="ix_2_fact" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="c74" id="ix_3_fact">Medical research and development</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c76" id="ix_4_fact">PRC/Chinese mainland July 3, 2012</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:IssuedCapitalOrdinaryShares contextRef="c77" decimals="-3" id="ix_5_fact" unitRef="cny">150000000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c76" decimals="2" id="ix_6_fact" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="c76" id="ix_7_fact">Clinical development and sale of products</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c78" id="ixv-38998">United States of America  (&#x201c;United States&#x201d;)  November 4, 2015</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:IssuedCapitalOrdinaryShares contextRef="c79" decimals="0" id="ixv-70990" unitRef="usd">15.000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c78" decimals="2" id="ixv-70991" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="c78" id="ixv-39027">Clinical trials</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c80" id="ix_8_fact">PRC/Chinese mainland September 21, 2022</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:IssuedCapitalOrdinaryShares contextRef="c81" decimals="-3" id="ix_9_fact" unitRef="cny">500000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c80"
      decimals="2"
      id="ix_10_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="c80" id="ix_11_fact">Rental of buildings to group companies</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory contextRef="c0" id="ixv-39155">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ACCOUNTING
                                            POLICIES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;BASIS OF PREPARATION&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements have been prepared in accordance with IFRS Accounting Standards (which include all International Financial Reporting
Standards, International Accounting Standards (&#x201c;IASs&#x201d;) and interpretations) approved by the International Accounting Standards
Board (the &#x201c;IASB&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
have been prepared under the historical cost convention, except for financial assets at FVTPL and derivative financial instruments which
have been measured at fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Basis
of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the financial statements of the Company and its subsidiaries (collectively referred to as the
&#x201c;Group&#x201d;) for each of the three years ended December 31, 2025. A subsidiary is an entity (including a structured entity),
directly or indirectly, controlled by the Company. Control is achieved when the Group is exposed, or has rights, to variable returns
from its involvement with the investee and has the ability to affect those returns through its power over the investee (i.e., existing
rights that give the Group the current ability to direct the relevant activities of the investee).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Generally,
there is a presumption that a majority of voting rights results in control. When the Company has less than a majority of the voting or
similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee,
including:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            contractual arrangement with the other vote holders of the investee;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;rights
                                            arising from other contractual arrangements; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            Group&#x2019;s voting rights and potential voting rights.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies.
The results of subsidiaries are consolidated from the date on which the Group obtains control and continues to be consolidated until the
date that such control ceases.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Profit
or loss and each component of other comprehensive income are attributed to the owners of the parent of the Group and to the non-controlling
interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity,
income, expenses and cash flows relating to transactions between members of the Group are eliminated in full on consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group reassesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of
the three elements of control described above. A change in the ownership interest of a subsidiary, without a loss of control, is accounted
for as an equity transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Group loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, any non-controlling
interest and the exchange fluctuation reserve; and recognizes the fair value of any investment retained and any resulting surplus or
deficit in profit or loss. The Group&#x2019;s share of components previously recognized in other comprehensive income is reclassified
to profit or loss or retained profits, as appropriate, on the same basis as would be required if the Group had directly disposed of the
related assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CHANGES IN ACCOUNTING POLICIES AND DISCLOSURES&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has adopted amendments to IAS 21 Lack of Exchangeability for the first time for the current year&#x2019;s financial statements. The Group
has not early adopted any other standard or amendment that has been issued but is not yet effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no new IFRS Accounting Standards, amendments or interpretations that became effective in 2025 that have any impact on the Group&#x2019;s
financial statements.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ISSUED BUT NOT YET EFFECTIVE IFRS ACCOUNTING STANDARDS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has not applied the following new and amended IFRS Accounting Standards, that have been issued but are not yet effective, in these
financial statements. The Group intends to apply these new and amended IFRS Accounting Standards, if applicable, when they become effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IFRS 18&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 59%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Presentation and Disclosure in Financial Statements&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IFRS 19 and its amendments&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subsidiaries without Public Accountability: Disclosures&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Amendments to the Classification and Measurement of Financial Instruments&lt;sup&gt;1&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contracts Referencing Nature-dependent Electricity&lt;sup&gt;1&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 10 and IAS 28&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sale or Contribution of Assets between an Investor and its Associate or Joint Venture&lt;sup&gt;3&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IAS 21&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Translation to a Hyperinflationary Presentation Currency&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Annual Improvements to IFRS Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#x2013; Volume 11&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 7&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective for annual periods beginning on or after January 1, 2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective for annual/reporting periods beginning on or after January 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No mandatory effective date yet determined but available for adoption&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group is in the process of making an assessment of the impact of these new and revised IFRS Accounting Standards upon initial application.
So far, the Group considers that these new and revised IFRS Accounting Standards, except for IFRS 18, are unlikely to have a significant
impact on the Group&#x2019;s results of operations and financial position. IFRS 18 is expected to be applicable to the Group. IFRS 18
introduces new requirements on presentation within the statement of profit or loss, including specific totals and subtotals. It also
requires disclosure of management-defined performance measures in a note and introduces new requirements for aggregation and disaggregation
of financial information. The new requirements are expected to impact the Group&#x2019;s presentation of the statement of profit or loss
and disclosures of the Group&#x2019;s financial performance.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;MATERIAL
                                            ACCOUNTING POLICIES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Investments
in joint venture&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
joint venture is a type of joint arrangement whereby the parties that have joint control of the arrangement have rights to the net
assets of the joint venture. Joint control is the contractually agreed upon sharing of control of an arrangement, which exists only
when decisions about the relevant activities require the unanimous consent of the parties sharing control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.3pt; text-indent: -20.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s investments in joint ventures are stated in the consolidated statement of financial position at the Group&#x2019;s share
of net assets under the equity method of accounting, less any impairment losses. Adjustments are made to bring into line any dissimilar
accounting policies that may exist. The Group&#x2019;s share of the post-acquisition results and other comprehensive income of joint ventures
is included in the consolidated statement of profit or loss and consolidated other comprehensive income, respectively. In addition, when
there has been a change recognized directly in the equity of the joint venture, the Group recognizes its share of any changes, when applicable,
in the consolidated statement of changes in equity. Unrealized gains and losses resulting from transactions between the Group and its
joint ventures are eliminated to the extent of the Group&#x2019;s investments in the joint ventures, except where unrealized losses provide
evidence of an impairment of the assets transferred. Goodwill arising from the acquisition of joint ventures is included as part of the
Group&#x2019;s investments in joint ventures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Goodwill&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
is initially measured at cost, being the excess of the aggregate of the consideration transferred, the amount recognized for non-controlling
interests and any fair value of the Group&#x2019;s previously held equity interests in the acquiree over the identifiable assets acquired
and liabilities assumed. If the sum of this consideration and other items is lower than the fair value of the net assets acquired, the
difference is, after reassessment, recognized in profit or loss as a gain on bargain purchase.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is tested for impairment annually
or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. The Group performs its
annual impairment test of goodwill as at December 31. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Group&#x2019;s cash-generating units, or groups of
cash-generating units, that are expected to benefit from the synergies of the combination, irrespective of whether other assets or
liabilities of the Group are assigned to those units or groups of units.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impairment
is determined by assessing the recoverable amount of the cash-generating unit (group of cash-generating units) to which the goodwill
relates. Where the recoverable amount of the cash-generating unit (group of cash-generating units) is less than the carrying amount,
an impairment loss is recognized. An impairment loss recognized for goodwill is not reversed in a subsequent period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 61.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
goodwill has been allocated to a cash-generating unit (or group of cash-generating units) and part of the operation within that unit
is disposed of, the goodwill associated with the operation disposed of is included in the carrying amount of the operation when determining
the gain or loss on the disposal. Goodwill disposed of in these circumstances is measured based on the relative value of the operation
disposed of and the portion of the cash-generating unit retained.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Fair
value measurement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group measures its financial assets at FVTPL and derivative financial instruments at fair value at the end of each reporting period. Fair
value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the
liability takes place either in the principal market for the asset or liability, or in the absence of a principal market, in the most
advantageous market for the asset or liability. The principal or the most advantageous market must be accessible by the Group. The fair
value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
fair value measurement of a non-financial asset takes into account a market participant&#x2019;s ability to generate economic benefits
by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest
and best use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair
value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value
hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.75pt; text-indent: -30.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 &#x2013; based on quoted prices (unadjusted) in active markets for identical assets or liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 &#x2013; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is observable,
either directly or indirectly&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 &#x2013; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
assets and liabilities that are recognized in the financial statements on a recurring basis, the Group determines whether transfers have
occurred between levels in the hierarchy by reassessing categorization (based on the lowest level input that is significant to the fair
value measurement as a whole) at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Impairment
of non-financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
an indication of impairment exists, or when annual impairment testing for an asset is required (other than inventories, deferred tax
assets and non-current assets), the asset&#x2019;s recoverable amount is estimated. An asset&#x2019;s recoverable amount is the higher of the asset&#x2019;s
or cash-generating unit&#x2019;s value in use and its fair value less costs of disposal, and is determined for an individual asset, unless the
asset does not generate cash inflows that are largely independent of those from other assets or groups of assets, in which case the recoverable
amount is determined for the cash-generating unit to which the asset belongs.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
testing a cash-generating unit for impairment, a portion of the carrying amount of a corporate asset (e.g., a headquarters building)
is allocated to an individual cash-generating unit if it can be allocated on a reasonable and consistent basis or, otherwise, to the
smallest group of cash-generating units.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
impairment loss is recognized only if the carrying amount of an asset exceeds its recoverable amount. In assessing value in use, the
estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments
of the time value of money and the risks specific to the asset. An impairment loss is charged to the statement of profit or loss in the
period in which it arises in those expense categories consistent with the function of the impaired asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
assessment is made at the end of each reporting period as to whether there is an indication that previously recognized impairment losses
may no longer exist or may have decreased. If such an indication exists, the recoverable amount is estimated. A previously recognized
impairment loss of an asset other than goodwill is reversed only if there has been a change in the estimates used to determine the recoverable
amount of that asset, but not to an amount higher than the carrying amount that would have been determined (net of any depreciation/amortization)
had no impairment loss been recognized for the asset in prior years. A reversal of such an impairment loss is credited to the statement
of profit or loss in the period in which it arises.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Related
parties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
party is considered to be related to the Group if:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            party is a person or a close member of that person&#x2019;s family and that person:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;has
                                            control or joint control over the Group;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;has
                                            significant influence over the Group; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;is
                                            a member of the key management personnel of the Group or of a parent of the Group;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;or&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            party is an entity where any of the following conditions applies:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity and the Group are members of the same group;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;one
                                            entity is an associate or joint venture of the other entity (or of a parent, subsidiary or
                                            fellow subsidiary of the other entity);&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity and the Group are joint ventures of the same third party;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;one
                                            entity is a joint venture of a third entity and the other entity is an associate of the third
                                            entity;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-indent: -76.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(v)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity is a post-employment benefit plan for the benefit of employees of either the Group
                                            or an entity related to the Group;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(vi)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity is controlled or jointly controlled by a person identified in (a);&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(vii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
                                            person identified in (a)(i) has significant influence over the entity or is a member of the
                                            key management personnel of the entity (or of a parent of the entity); and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(viii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity, or any member of a group of which it is a part, provides key management personnel
                                            services to the Group or to the parent of the Group.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Property,
plant and equipment and depreciation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property,
plant and equipment, other than construction in progress, are stated at cost less accumulated depreciation and any impairment losses.
The cost of an item of property, plant and equipment comprises its purchase price and any directly attributable costs of bringing the
asset to its working condition and location for its intended use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expenditure
incurred after items of property, plant and equipment have been put into operation, such as repairs and maintenance, is normally charged
to the statement of profit or loss in the period in which it is incurred. In situations where the recognition criteria are satisfied,
the expenditure for a major inspection is capitalized in the carrying amount of the asset as a replacement. Where significant parts of
property, plant and equipment are required to be replaced at intervals, the Group recognizes such parts as individual assets with specific
useful lives and depreciates them accordingly.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
is calculated on the straight-line basis to write off the cost of each item of property, plant and equipment to its residual value over
its estimated useful life. The principal annual rates used for this purpose are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 86%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Buildings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20% to 33.33&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.5% to 31.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
parts of an item of property, plant and equipment have different useful lives, the cost of that item is allocated on a reasonable basis
among the parts and each part is depreciated separately. Residual values, useful lives and the depreciation method are reviewed, and
adjusted if appropriate, at least at each financial year end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
asset&#x2019;s carrying amount is written down immediately to its recoverable amount if the asset&#x2019;s carrying amount is greater than
its estimated recoverable amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
item of property, plant and equipment including any significant part initially recognized is derecognized upon disposal or when no future
economic benefits are expected from its use or disposal. Any gain or loss on disposal or retirement recognized in the statement of profit
or loss in the year the asset is derecognized is the difference between the net sales proceeds and the carrying amount of the relevant
asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Construction
in progress is stated at cost less any impairment losses and is not depreciated. It is reclassified to the appropriate category of property,
plant and equipment when completed and ready for use.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Intangible
assets (other than goodwill)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination
is the fair value at the date of acquisition. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible
assets with finite lives are subsequently amortized over the useful economic life and assessed for impairment whenever there is an indication
that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at each financial year end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets are amortized on the straight-line basis over the following useful economic lives:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 87%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3 to 10 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;License&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
useful lives of software are assessed by the Group considering different purpose and usage of the software, and the authorized period
for use. The useful life of patent is assessed by the Group based on the remaining and foreseeable patent protection period after acquisition.
The useful life of a purchased license is assessed by considering the expected usage of the license by the Group.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Research
and development costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
research costs are charged to the statement of profit or loss as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expenditure
incurred on projects to develop new products is capitalized and deferred only when the Group can demonstrate the technical feasibility
of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or
sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the project and the ability
to measure reliably the expenditure during the development. Product development expenditure which does not meet these criteria is expensed
when incurred. During the reporting period, all expenses incurred for research and development activities were regarded as research expenses
and therefore were expensed when incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group assesses at contract inception whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract
conveys the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Group
as a lessee&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets.
The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
                                            assets&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
assets are recognized at the commencement date of the lease (that is the date the underlying asset is available for use). Right-of-use
assets are measured at cost, less accumulated depreciation and any impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis
over the shorter of the lease terms and the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 87%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold land&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Buildings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2 to 7 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
ownership of the leased asset transfers to the Group by the end of the lease term or the cost reflects the exercise of a purchase option,
depreciation is calculated using the estimated useful life of the asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
                                            liabilities&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
liabilities are recognized at the commencement date of the lease at the present value of lease payments to be made over the lease term.
The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease
payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also
include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for termination
of a lease, if the lease term reflects the Group exercising the option to terminate the lease. The variable lease payments that do not
depend on an index or a rate are recognized as an expense in the period in which the event or condition that triggers the payment occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
calculating the present value of lease payments, the Group uses its incremental borrowing rate at the lease commencement date because
the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is
increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities
is remeasured if there is a modification, a change in the lease term, a change in lease payments (e.g., a change to future lease payments
resulting from a change in an index or rate) or a change in assessment of an option to purchase the underlying asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s lease liabilities are included in interest-bearing bank and other borrowings.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
                                            leases and leases of low-value assets&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (that is those leases that
have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the recognition
exemption for leases of low-value assets to leases of office equipment that are considered to be of low value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
payments on short-term leases and leases of low-value assets are recognized as an expense on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Investments
and other financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Initial
recognition and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets are classified, at initial recognition, as subsequently measured at amortized cost and fair value through profit and loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
classification of financial assets at initial recognition depends on the financial asset&#x2019;s contractual cash flow characteristics
and the Group&#x2019;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Group has applied the practical expedient of not adjusting the effect of a significant financing component,
the Group initially measures a financial asset at its fair value plus in the case of a financial asset not at FVTPL, transaction costs.
Trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are
measured at the transaction price determined under IFRS 15 in accordance with the policies set out for &#x201c;Revenue recognition&#x201d;
below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order for a financial asset to be classified and measured at amortized cost, it needs to give rise to cash flows that are solely payments
of principal and interest (&#x201c;SPPI&#x201d;) on the principal amount outstanding. Financial assets with cash flows that are not SPPI
are classified and measured at fair value through profit or loss, irrespective of the business model.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash flows.
The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or
both. Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial
assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through other comprehensive
income are held within a business model with the objective of both holding to collect contractual cash flows and selling. Financial assets
which are not held within the aforementioned business models are classified and measured at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purchases
or sales of financial assets that require delivery of assets within the period generally established by regulation or convention in the
marketplace are recognized on the trade date, that is, the date that the Group commits to purchase or sell the asset.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
subsequent measurement of financial assets depends on their classification as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Financial
assets at amortized cost (debt instruments)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment. Gains and losses
are recognized in the statement of profit or loss when the asset is derecognized, modified or impaired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Financial
assets at FVTPL&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets at FVTPL are carried in the statement of financial position at fair value with net changes in fair value recognized in the statement
of profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividends
on the equity investments are also recognized as other income in the statement of profit or loss when the right of payment has been established.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Derecognition
of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized
(i.e., removed from the Group&#x2019;s consolidated statement of financial position) when:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            rights to receive cash flows from the asset have expired; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            Group has transferred its rights to receive cash flows from the asset or has assumed an obligation
                                            to pay the received cash flows in full without material delay to a third party under a &#x201c;pass-through&#x201d;
                                            arrangement; and either (a) the Group has transferred substantially all the risks and rewards
                                            of the asset, or (b) the Group has neither transferred nor retained substantially all the
                                            risks and rewards of the asset, but has transferred control of the asset.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the Group has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risk and rewards of ownership of the asset. When it has neither transferred nor retained
substantially all the risks and rewards of the asset nor transferred control of the asset, the Group continues to recognize the transferred
asset to the extent of the Group&#x2019;s continuing involvement. In that case, the Group also recognizes an associated liability. The
transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Group has retained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Group could be required to repay.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Impairment
of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group recognizes an allowance for expected credit losses (&#x201c;ECLs&#x201d;) for all debt instruments not held at fair value through
profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash
flows that the Group expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows
will include cash flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;General
approach&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ECLs
are recognized in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition,
ECLs are provided for credit losses that result from default events that are possible within the next 12 months (a 12-month ECL). For
those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is
required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
each reporting date, the Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition.
When making the assessment, the Group compares the risk of a default occurring on the financial instrument as at the reporting date with
the risk of a default occurring on the financial instrument as at the date of initial recognition and considers reasonable and supportable
information that is available without undue cost or effort, including historical and forward-looking information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group considers a financial asset in default when contractual payments are 120 days past due. However, in certain cases, the Group may
also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive
the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets at amortized cost are subject to impairment under the general approach, and they are classified within the following stages for
measurement of ECLs except for trade receivables which apply the simplified approach as detailed below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.65in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
                               1 &#x2013; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
                                            instruments for which credit risk has not increased significantly since initial recognition
                                            and for which the loss allowance is measured at an amount equal to 12-month ECLs&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.65in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
                                            2 &#x2013; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
                                            instruments for which credit risk has increased significantly since initial recognition but
                                            that are not credit-impaired financial assets and for which the loss allowance is measured
                                            at an amount equal to lifetime ECLs&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="text-align: left; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.65in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
                                            3 &#x2013; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
                                            assets that are credit-impaired at the reporting date (but that are not purchased or originated
                                            credit-impaired) and for which the loss allowance is measured at an amount equal to lifetime
                                            ECLs&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Simplified
approach&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
trade receivables that do not contain a significant financing component or when the Group applies the practical expedient of not adjusting
the effect of a significant financing component, the Group applies the simplified approach in calculating ECLs. Under the simplified
approach, the Group does not track changes in credit risk but instead recognizes a loss allowance based on lifetime ECLs at each reporting
date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking
factors specific to the debtors and the economic environment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Financial
liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Initial
recognition and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
liabilities are classified, at initial recognition, as financial liabilities at FVTPL, loans and borrowings, or payables, as appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s financial liabilities include trade payables, financial liabilities included in other payables and accruals, interest-bearing
bank and other borrowings, long-term payables and other current and non-current liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
subsequent measurement of financial liabilities depends on their classification as follows:&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Financial
liabilities at fair value through profit or loss&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
liabilities at fair value through profit or loss include financial liabilities designated upon initial recognition as at fair value through
profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
liabilities designated upon initial recognition as at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied. Gains or losses on liabilities designated at fair value through profit or loss are
recognized in the statement of profit or loss, except for the gains or losses arising from the Group&#x2019;s own credit risk which are
presented in other comprehensive income with no subsequent reclassification to the statement of profit or loss. The net fair value gain
or loss recognized in the statement of profit or loss does not include any interest charged on these financial liabilities.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Financial
liabilities at amortized cost (trade and other payables, and borrowings)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
initial recognition, trade and other payables, and interest-bearing borrowings are subsequently measured at amortized cost, using the
effective interest rate method unless the effect of discounting would be immaterial, in which case they are stated at cost. Gains and
losses are recognized in the statement of profit or loss when the liabilities are derecognized as well as through the effective interest
rate amortization process.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the effective
interest rate. The effective interest rate amortization is included in finance costs in the statement of profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Derecognition
of financial liabilities &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
financial liability is derecognized when the obligation under the liability is discharged or cancelled or expires.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing
liability are substantially modified, such an exchange or modification is treated as a derecognition of the original liability and a
recognition of a new liability, and the difference between the respective carrying amounts is recognized in the statement of profit or
loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Offsetting
of financial instruments &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, or to realize the assets
and settle the liabilities simultaneously.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Derivative
financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Initial
recognition and subsequent measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Derivative
financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently
remeasured at fair value. Derivatives are carried as assets when the fair value is positive, and as liabilities when the fair value is
negative.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
gains or losses arising from changes in fair value of derivatives are taken directly to profit or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Treasury
shares &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Own
equity instruments which are reacquired and held by the Company or the Group (treasury shares) are recognized directly in equity at cost.
No gain or loss is recognized in the statement of profit or loss on the purchase, sale, issue or cancellation of the Group&#x2019;s own
equity instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories
are stated at the lower of cost and net realizable value. Cost is determined on the first-in, first-out basis, in the case of work in
progress and finished goods, comprises direct materials, direct labor, contract manufacturing fee and an appropriate proportion of overheads.
Net realizable value is based on estimated selling prices less any estimated costs to be incurred to completion and disposal.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents in the statements of cash flows comprise cash on hand and at banks, and short-term highly liquid deposits with a
maturity of generally within three months that are readily convertible into known amounts of cash, subject to an insignificant risk of
changes in value and held for the purpose of meeting short-term cash commitments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the purpose of the consolidated statements of financial positions, cash and bank balances comprise cash and cash equivalents as defined
above, restricted bank balances and time deposits with original maturity of more than three months as defined above.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Provisions
&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
provision is recognized when a present obligation (legal or constructive) has arisen as a result of a past event and it is probable that
a future outflow of resources will be required to settle the obligation, provided that a reliable estimate can be made of the amount
of the obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the Group expects some or all of a provision to be reimbursed, the reimbursement is recognized as a separate asset, but only when the
reimbursement is virtually certain. The expense relating to a provision is presented in the statement of profit or loss net of any reimbursement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the effect of discounting is material, the amount recognized for a provision is the present value at the end of the reporting date of
the future expenditures expected to be required to settle the obligation. The increase in the discounted present value amount arising
from the passage of time is included in finance costs in the statement of profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Income
tax&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
tax comprises current and deferred tax. Income tax relating to items recognized outside profit or loss is recognized outside profit or
loss, either in other comprehensive income or directly in equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, based on tax
rates (and tax laws) that have been enacted or substantively enacted by the end of each of the reporting period, taking into consideration
interpretations and practices prevailing in the countries in which the Group operates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax is provided, using the liability method, on all temporary differences at the end of reporting date between the tax bases of assets
and liabilities and their carrying amounts for financial reporting purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax liabilities are recognized for all taxable temporary differences, except:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;when
                                            the deferred tax liability arises from the initial recognition of goodwill or an asset or
                                            liability in a transaction that is not a business combination and, at the time of the transaction,
                                            affects neither the accounting profit nor taxable profit or loss and does not give rise to
                                            equal taxable and deductible temporary differences; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
                                            respect of taxable temporary differences associated with investments in subsidiaries, when
                                            the timing of the reversal of the temporary differences can be controlled and it is probable
                                            that the temporary differences will not reverse in the foreseeable future.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets are recognized for all deductible temporary differences, and the carryforward of unused tax credits and any unused tax losses.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which the deductible
temporary differences, and the carryforward of unused tax credits and unused tax losses can be utilized, except:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;when
                                            the deferred tax asset relating to the deductible temporary differences arises from the initial
                                            recognition of an asset or liability in a transaction that is not a business combination
                                            and, at the time of the transaction, affects neither the accounting profit nor taxable profit
                                            or loss and does not give rise to equal taxable and deductible temporary differences; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
                                            respect of deductible temporary differences associated with investments in subsidiaries,
                                            deferred tax assets are only recognized to the extent that it is probable that the temporary
                                            differences will reverse in the foreseeable future and taxable profit will be available against
                                            which the temporary differences can be utilized.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer
probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized
deferred tax assets are reassessed at the end of each reporting period and are recognized to the extent that it has become probable that
sufficient taxable profit will be available to allow all or part of the deferred tax asset to be recovered.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realized or the liability
is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and deferred tax liabilities are offset if and only if the Group has a legally enforceable right to set off current tax assets
and current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation
authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets
on a net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts
of deferred tax liabilities or assets are expected to be settled or recovered.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Government
grants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government
grants are recognized at their fair value where there is reasonable assurance that the grant will be received and all attaching conditions
will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the periods that
the costs, for which it is intended to compensate, are expensed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
government grants whose primary condition is to compensate for research and development projects or other than purchase, construct or
otherwise acquire long-term assets are designated as grants related to income. Some of the grants related to income have future related
costs expected to be incurred and require the Group to comply with conditions attached to the grants and the government to acknowledge
the compliance of these conditions. These grants related to income are recognized as deferred income in the consolidated statement of
financial position and transferred to profit or loss when related costs are subsequently incurred, and the Group received government acknowledge
of compliance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
government grants related to income that are receivable as compensation for expenses or losses already incurred or for the purpose of
giving immediate financial support to the Group with no future related costs are recognized in profit or loss in the period in which
they become receivable.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Revenue
recognition &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Revenue
from contracts with customers&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from contracts with customers is recognized when control of goods or services is transferred to the customers at an amount that reflects
the consideration to which the Group expects to be entitled in exchange for those goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the consideration in a contract includes a variable amount, the amount of consideration is estimated to which the Group will be entitled
in exchange for transferring the goods or services to the customer. The variable consideration is estimated at contract inception and
constrained until it is highly probable that a significant revenue reversal in the amount of cumulative revenue recognized will not occur
when the associated uncertainty with the variable consideration is subsequently resolved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the contract contains a financing component which provides the customer with a significant benefit of financing the transfer of goods
or services to the customer for more than one year, revenue is measured at the present value of the amount receivable, discounted using
the discount rate that would be reflected in a separate financing transaction between the Group and the customer at contract inception.
When the contract contains a financing component which provides the Group with a significant financial benefit for more than one year,
revenue recognized under the contract includes the interest expense accreted on the contract liability under the effective interest method.
For a contract where the period between the payment by the customer and the transfer of the promised goods or services is one year or
less, the transaction price is not adjusted for the effects of a significant financing component, using the practical expedient in IFRS
15.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sale
                                            of products&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from the sale of products is recognized at the point in time when control of the asset is transferred to the customer, generally on acceptance
of the products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
                                            rights&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group provides commercialization, development and branding rights (collectively, &#x201c;Commercialization Rights&#x201d;) to customers
for an agreed upon commercialization period ending ten years from the date of the first sale of the product as stipulated in the relevant
agreement. The consideration for Commercialization Rights includes upfront payment, development and regulatory milestones payments and
commercialization milestones payments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
and regulatory milestones payments are fully constrained until the period in which those regulatory approvals are achieved due to the
inherent uncertainty with the approval process and included in the transaction price in the period regulatory approval is obtained. Upfront
payment and development and regulatory milestones payments are recorded under contract liabilities and recognized as revenue over time
during the commercialization period on a straight-line basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
milestone payments based on the level of sales are recognized at a point in time when the later of the following events occurs: (i) the
related sale occurs, or (ii) the performance obligation to which commercialization milestones payments have been allocated has been satisfied.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intellectual
                                            property income&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intellectual
property income is recognized at the point in time at which the non-patented intellectual property is granted to the customer because
the Company will not undertake activities that affect such intellectual property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consideration for intellectual property income comprises a fixed element and a variable element. Variable element is recognized as the
transaction price when the Company can conclude that it is highly probable that a significant reversal in the amount of cumulative revenue
recognized will not occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-indent: -42.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group provides consulting services to its customers through contracts. Depending on the contract, revenue is recognized over time as
the service is rendered, or at the point in time as the service is completed and accepted.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
income&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
income is recognized on an accrual basis using the effective interest method by applying the rate that exactly discounts the estimated
future cash receipts over the expected life of the financial instrument or a shorter period, when appropriate, to the net carrying amount
of the financial asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Contract
liabilities &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
contract liability is recognized when a payment is received or a payment is due (whichever is earlier) from a customer before the Group
transfers the related goods or services. Contract liabilities are recognized as revenue when the Group performs under the contract (i.e.,
transfers control of the related goods or services to the customer).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Share-based
payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates share incentive plans which include the pre-IPO share option scheme, the post-IPO share option scheme, 2018 restricted
share unit scheme (the &#x201c;2018 RSU Scheme&#x201d;), 2021 restricted share unit scheme (the &#x201c;2021 RSU Scheme&#x201d;) and 2022
restricted share unit scheme (the &#x201c;2022 RSU Scheme&#x201d;). Employees (including directors) of the Group receive remuneration in
the form of share-based payments, whereby employees render services in exchange for equity instruments (&#x201c;equity-settled transactions&#x201d;).&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cost of equity-settled transactions with employees is measured by reference to the fair value at the date at which they are granted,
further details of which are given in note 31 to the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cost of equity-settled transactions is recognized in employee benefit expense, together with a corresponding increase in equity, over
the period in which the performance and/or service conditions are fulfilled. The cumulative expense recognized for equity-settled transactions
at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group&#x2019;s
best estimate of the number of equity instruments that will ultimately vest. The charge or credit to the statement of profit or loss
for a period represents the movement in the cumulative expense recognized as at the beginning and end of that period.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Service
and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood
of the conditions being met is assessed as part of the Group&#x2019;s best estimate of the number of equity instruments that will ultimately
vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without
an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value
of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
awards that do not ultimately vest because non-market performance and/or service conditions have not been met, no expense is recognized.
Where awards include a market or non-vesting condition, the transactions are treated as vesting irrespective of whether the market or
non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
the terms of an equity-settled award are modified, as a minimum an expense is recognized as if the terms had not been modified, if the
original terms of the award are met. In addition, an expense is recognized for any modification that increases the total fair value of
the share-based payments or is otherwise beneficial to the employee as measured at the date of modification. Where an equity-settled
award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognized for the award is
recognized immediately.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
dilutive effect of outstanding options is reflected as additional share dilution in the computation of loss per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Other
employee benefits&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Pension
scheme&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
employees of the Group&#x2019;s subsidiaries which operate in the Chinese mainland are required to participate in a central pension scheme
operated by the local municipal government. The subsidiaries operating in Chinese mainland are required to contribute a certain percentage
of their payroll costs to the central pension scheme. The contributions are charged to profit or loss as they become payable in accordance
with the rules of the central pension scheme.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group implemented a safe harbor defined contribution 401(k) savings plan (the &#x201c;401(k) Plan&#x201d;) for U.S. employees. The 401(k)
Plan covers all U.S. employees and allows participants to defer a portion of their annual compensation on a pre-tax basis. In addition,
the Company implemented a matching contribution to the 401(k) Plan, matching 100% of an employee&#x2019;s contribution up to a maximum
of 6% of the participant&#x2019;s annual base salary. Such matching contribution vests when made.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Borrowing
costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
costs directly attributable to the acquisition, construction or production of qualifying assets, i.e., assets that necessarily take a
substantial period of time to get ready for their intended use or sale, are capitalized as part of the cost of those assets. The capitalization
of such borrowing costs ceases when the assets are substantially ready for their intended use or sale. All other borrowing costs are
expensed in the period in which they are incurred. Borrowing costs consist of interest and other costs that an entity incurs in connection
with the borrowing of funds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Events
after the reporting period &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Group receives information after the reporting period, but prior to the date of authorization for issue, about conditions that existed
at the end of the reporting period, it will assess whether the information affects the amounts that it recognizes in its financial statements.
The Group will adjust the amounts recognized in its financial statements to reflect any adjusting events after the reporting period and
update the disclosures that relate to those conditions in light of the new information. For non-adjusting events after the reporting
period, the Group will not change the amounts recognized in its financial statements but will disclose the nature of the non-adjusting
events and an estimate of their financial effects, or a statement that such an estimate cannot be made, if applicable.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Foreign
currencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements are presented in RMB. Each entity in the Group determines its own functional currency and items included in the
financial statements of each entity are measured using that functional currency. Foreign currency transactions recorded by the entities
in the Group are initially recorded using their respective functional currency rates prevailing at the dates of the transactions. Monetary
assets and liabilities denominated in foreign currencies are translated at the functional currency rates of exchange ruling at the end
of the reporting period. Differences arising on settlement or translation of monetary items are recognized in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-monetary
items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the
initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the
date when the fair value was measured. The gain or loss arising on translation of a non-monetary item measured at fair value is treated
in line with the recognition of the gain or loss on change in fair value of the item (i.e., translation difference on the item whose
fair value gain or loss is recognized in other comprehensive income or profit or loss is also recognized in other comprehensive income
or profit or loss, respectively).&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
determining the exchange rate on initial recognition of the related asset, expense or income on the derecognition of a non-monetary asset
or non-monetary liability relating to an advance consideration, the date of initial transaction is the date on which the Group initially
recognizes the non-monetary asset or non-monetary liability arising from the advance consideration. If there are multiple payments or
receipts in advance, the Group determines the transaction date for each payment or receipt of the advance consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currencies of certain overseas subsidiaries are currencies other than the RMB. As at the end of the reporting period, the
assets and liabilities of these entities are translated into RMB at the exchange rates prevailing at the end of the reporting period
and their statements of profit or loss are translated into RMB at the exchange rates that approximate to those prevailing at the dates
of the transactions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
resulting exchange differences are recognized in other comprehensive income and accumulated in the exchange fluctuation reserve, except
to the extent that the differences are attributable to non-controlling interests. On disposal of a foreign operation, the cumulative
amount in the reserve relating to that particular foreign operation is recognized in the statement of profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
goodwill arising on the acquisition of a foreign operation and any fair value adjustments to the carrying amounts of assets and liabilities
arising on acquisition are treated as assets and liabilities of the foreign operation and translated at the closing rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the purpose of the consolidated statements of cash flows, the cash flows of overseas subsidiaries are translated into RMB at the exchange
rates ruling at the dates of the cash flows. Frequently recurring cash flows of overseas subsidiaries which arise throughout the year
are translated into RMB at the exchange rates that approximate to those prevailing at the dates of the transactions.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="c0" id="ixv-39169">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;BASIS OF PREPARATION&lt;/span&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements have been prepared in accordance with IFRS Accounting Standards (which include all International Financial Reporting
Standards, International Accounting Standards (&#x201c;IASs&#x201d;) and interpretations) approved by the International Accounting Standards
Board (the &#x201c;IASB&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
have been prepared under the historical cost convention, except for financial assets at FVTPL and derivative financial instruments which
have been measured at fair value.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfBasisOfConsolidationExplanatory contextRef="c0" id="ixv-39183">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Basis
of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the financial statements of the Company and its subsidiaries (collectively referred to as the
&#x201c;Group&#x201d;) for each of the three years ended December 31, 2025. A subsidiary is an entity (including a structured entity),
directly or indirectly, controlled by the Company. Control is achieved when the Group is exposed, or has rights, to variable returns
from its involvement with the investee and has the ability to affect those returns through its power over the investee (i.e., existing
rights that give the Group the current ability to direct the relevant activities of the investee).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Generally,
there is a presumption that a majority of voting rights results in control. When the Company has less than a majority of the voting or
similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee,
including:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            contractual arrangement with the other vote holders of the investee;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;rights
                                            arising from other contractual arrangements; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            Group&#x2019;s voting rights and potential voting rights.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies.
The results of subsidiaries are consolidated from the date on which the Group obtains control and continues to be consolidated until the
date that such control ceases.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Profit
or loss and each component of other comprehensive income are attributed to the owners of the parent of the Group and to the non-controlling
interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity,
income, expenses and cash flows relating to transactions between members of the Group are eliminated in full on consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group reassesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of
the three elements of control described above. A change in the ownership interest of a subsidiary, without a loss of control, is accounted
for as an equity transaction.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Group loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, any non-controlling
interest and the exchange fluctuation reserve; and recognizes the fair value of any investment retained and any resulting surplus or
deficit in profit or loss. The Group&#x2019;s share of components previously recognized in other comprehensive income is reclassified
to profit or loss or retained profits, as appropriate, on the same basis as would be required if the Group had directly disposed of the
related assets or liabilities.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfConsolidationExplanatory>
    <aapg:DisclosureOfChangesInAccountingPoliciesPolicyTextBlock contextRef="c0" id="ixv-39301">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CHANGES IN ACCOUNTING POLICIES AND DISCLOSURES&lt;/span&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has adopted amendments to IAS 21 Lack of Exchangeability for the first time for the current year&#x2019;s financial statements. The Group
has not early adopted any other standard or amendment that has been issued but is not yet effective.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no new IFRS Accounting Standards, amendments or interpretations that became effective in 2025 that have any impact on the Group&#x2019;s
financial statements.&lt;/span&gt;&lt;/p&gt;</aapg:DisclosureOfChangesInAccountingPoliciesPolicyTextBlock>
    <aapg:DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards contextRef="c0" id="ixv-39321">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ISSUED BUT NOT YET EFFECTIVE IFRS ACCOUNTING STANDARDS&lt;/span&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has not applied the following new and amended IFRS Accounting Standards, that have been issued but are not yet effective, in these
financial statements. The Group intends to apply these new and amended IFRS Accounting Standards, if applicable, when they become effective.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IFRS 18&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 59%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Presentation and Disclosure in Financial Statements&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IFRS 19 and its amendments&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subsidiaries without Public Accountability: Disclosures&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Amendments to the Classification and Measurement of Financial Instruments&lt;sup&gt;1&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contracts Referencing Nature-dependent Electricity&lt;sup&gt;1&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 10 and IAS 28&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sale or Contribution of Assets between an Investor and its Associate or Joint Venture&lt;sup&gt;3&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IAS 21&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Translation to a Hyperinflationary Presentation Currency&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Annual Improvements to IFRS Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#x2013; Volume 11&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 7&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective for annual periods beginning on or after January 1, 2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective for annual/reporting periods beginning on or after January 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No mandatory effective date yet determined but available for adoption&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group is in the process of making an assessment of the impact of these new and revised IFRS Accounting Standards upon initial application.
So far, the Group considers that these new and revised IFRS Accounting Standards, except for IFRS 18, are unlikely to have a significant
impact on the Group&#x2019;s results of operations and financial position. IFRS 18 is expected to be applicable to the Group. IFRS 18
introduces new requirements on presentation within the statement of profit or loss, including specific totals and subtotals. It also
requires disclosure of management-defined performance measures in a note and introduces new requirements for aggregation and disaggregation
of financial information. The new requirements are expected to impact the Group&#x2019;s presentation of the statement of profit or loss
and disclosures of the Group&#x2019;s financial performance.&lt;/span&gt;&lt;/p&gt;</aapg:DescriptionOfAccountingPolicyForIssuedButNotYetEffectiveIfrsAccountingStandards>
    <ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations contextRef="c0" id="ixv-70994">The Group intends to apply these new and amended IFRS Accounting Standards, if applicable, when they become effective.&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IFRS 18&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 59%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Presentation and Disclosure in Financial Statements&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IFRS 19 and its amendments&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subsidiaries without Public Accountability: Disclosures&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Amendments to the Classification and Measurement of Financial Instruments&lt;sup&gt;1&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contracts Referencing Nature-dependent Electricity&lt;sup&gt;1&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 10 and IAS 28&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sale or Contribution of Assets between an Investor and its Associate or Joint Venture&lt;sup&gt;3&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IAS 21&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Translation to a Hyperinflationary Presentation Currency&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.25in"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Annual Improvements to IFRS Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#x2013; Volume 11&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 7&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective for annual periods beginning on or after January 1, 2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective for annual/reporting periods beginning on or after January 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No mandatory effective date yet determined but available for adoption&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations>
    <ifrs-full:TitleOfNewIFRS contextRef="c83" id="ix_15_fact">Presentation and Disclosure in Financial Statements2</ifrs-full:TitleOfNewIFRS>
    <ifrs-full:TitleOfNewIFRS contextRef="c84" id="ix_16_fact">Subsidiaries without Public Accountability: Disclosures2</ifrs-full:TitleOfNewIFRS>
    <ifrs-full:TitleOfNewIFRS contextRef="c85" id="ix_12_fact">Amendments to the Classification and Measurement of Financial Instruments1</ifrs-full:TitleOfNewIFRS>
    <ifrs-full:TitleOfNewIFRS contextRef="c86" id="ix_13_fact">Contracts Referencing Nature-dependent Electricity1</ifrs-full:TitleOfNewIFRS>
    <ifrs-full:TitleOfNewIFRS contextRef="c87" id="ix_18_fact">Sale or Contribution of Assets between an Investor and its Associate or Joint Venture3</ifrs-full:TitleOfNewIFRS>
    <ifrs-full:TitleOfNewIFRS contextRef="c88" id="ix_17_fact">Translation to a Hyperinflationary Presentation Currency2</ifrs-full:TitleOfNewIFRS>
    <ifrs-full:TitleOfNewIFRS contextRef="c89" id="ix_14_fact">Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 71</ifrs-full:TitleOfNewIFRS>
    <ifrs-full:DescriptionOfAccountingPolicyForInvestmentsInJointVentures contextRef="c0" id="ixv-39503">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Investments
in joint venture&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
joint venture is a type of joint arrangement whereby the parties that have joint control of the arrangement have rights to the net
assets of the joint venture. Joint control is the contractually agreed upon sharing of control of an arrangement, which exists only
when decisions about the relevant activities require the unanimous consent of the parties sharing control.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s investments in joint ventures are stated in the consolidated statement of financial position at the Group&#x2019;s share
of net assets under the equity method of accounting, less any impairment losses. Adjustments are made to bring into line any dissimilar
accounting policies that may exist. The Group&#x2019;s share of the post-acquisition results and other comprehensive income of joint ventures
is included in the consolidated statement of profit or loss and consolidated other comprehensive income, respectively. In addition, when
there has been a change recognized directly in the equity of the joint venture, the Group recognizes its share of any changes, when applicable,
in the consolidated statement of changes in equity. Unrealized gains and losses resulting from transactions between the Group and its
joint ventures are eliminated to the extent of the Group&#x2019;s investments in the joint ventures, except where unrealized losses provide
evidence of an impairment of the assets transferred. Goodwill arising from the acquisition of joint ventures is included as part of the
Group&#x2019;s investments in joint ventures.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForInvestmentsInJointVentures>
    <ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory contextRef="c0" id="ixv-39519">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Goodwill&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
is initially measured at cost, being the excess of the aggregate of the consideration transferred, the amount recognized for non-controlling
interests and any fair value of the Group&#x2019;s previously held equity interests in the acquiree over the identifiable assets acquired
and liabilities assumed. If the sum of this consideration and other items is lower than the fair value of the net assets acquired, the
difference is, after reassessment, recognized in profit or loss as a gain on bargain purchase.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is tested for impairment annually
or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. The Group performs its
annual impairment test of goodwill as at December 31. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Group&#x2019;s cash-generating units, or groups of
cash-generating units, that are expected to benefit from the synergies of the combination, irrespective of whether other assets or
liabilities of the Group are assigned to those units or groups of units.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impairment
is determined by assessing the recoverable amount of the cash-generating unit (group of cash-generating units) to which the goodwill
relates. Where the recoverable amount of the cash-generating unit (group of cash-generating units) is less than the carrying amount,
an impairment loss is recognized. An impairment loss recognized for goodwill is not reversed in a subsequent period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
goodwill has been allocated to a cash-generating unit (or group of cash-generating units) and part of the operation within that unit
is disposed of, the goodwill associated with the operation disposed of is included in the carrying amount of the operation when determining
the gain or loss on the disposal. Goodwill disposed of in these circumstances is measured based on the relative value of the operation
disposed of and the portion of the cash-generating unit retained.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory contextRef="c0" id="ixv-39603">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Fair
value measurement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group measures its financial assets at FVTPL and derivative financial instruments at fair value at the end of each reporting period. Fair
value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the
liability takes place either in the principal market for the asset or liability, or in the absence of a principal market, in the most
advantageous market for the asset or liability. The principal or the most advantageous market must be accessible by the Group. The fair
value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
fair value measurement of a non-financial asset takes into account a market participant&#x2019;s ability to generate economic benefits
by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest
and best use.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair
value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value
hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 &#x2013; based on quoted prices (unadjusted) in active markets for identical assets or liabilities&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 &#x2013; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is observable,
either directly or indirectly&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 &#x2013; based on valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
assets and liabilities that are recognized in the financial statements on a recurring basis, the Group determines whether transfers have
occurred between levels in the hierarchy by reassessing categorization (based on the lowest level input that is significant to the fair
value measurement as a whole) at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory contextRef="c0" id="ixv-39705">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Impairment
of non-financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
an indication of impairment exists, or when annual impairment testing for an asset is required (other than inventories, deferred tax
assets and non-current assets), the asset&#x2019;s recoverable amount is estimated. An asset&#x2019;s recoverable amount is the higher of the asset&#x2019;s
or cash-generating unit&#x2019;s value in use and its fair value less costs of disposal, and is determined for an individual asset, unless the
asset does not generate cash inflows that are largely independent of those from other assets or groups of assets, in which case the recoverable
amount is determined for the cash-generating unit to which the asset belongs.&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
testing a cash-generating unit for impairment, a portion of the carrying amount of a corporate asset (e.g., a headquarters building)
is allocated to an individual cash-generating unit if it can be allocated on a reasonable and consistent basis or, otherwise, to the
smallest group of cash-generating units.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
impairment loss is recognized only if the carrying amount of an asset exceeds its recoverable amount. In assessing value in use, the
estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments
of the time value of money and the risks specific to the asset. An impairment loss is charged to the statement of profit or loss in the
period in which it arises in those expense categories consistent with the function of the impaired asset.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
assessment is made at the end of each reporting period as to whether there is an indication that previously recognized impairment losses
may no longer exist or may have decreased. If such an indication exists, the recoverable amount is estimated. A previously recognized
impairment loss of an asset other than goodwill is reversed only if there has been a change in the estimates used to determine the recoverable
amount of that asset, but not to an amount higher than the carrying amount that would have been determined (net of any depreciation/amortization)
had no impairment loss been recognized for the asset in prior years. A reversal of such an impairment loss is credited to the statement
of profit or loss in the period in which it arises.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory contextRef="c0" id="ixv-39731">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Related
parties&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
party is considered to be related to the Group if:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            party is a person or a close member of that person&#x2019;s family and that person:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;has
                                            control or joint control over the Group;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;has
                                            significant influence over the Group; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;is
                                            a member of the key management personnel of the Group or of a parent of the Group;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;or&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            party is an entity where any of the following conditions applies:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity and the Group are members of the same group;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;one
                                            entity is an associate or joint venture of the other entity (or of a parent, subsidiary or
                                            fellow subsidiary of the other entity);&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity and the Group are joint ventures of the same third party;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;one
                                            entity is a joint venture of a third entity and the other entity is an associate of the third
                                            entity;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(v)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity is a post-employment benefit plan for the benefit of employees of either the Group
                                            or an entity related to the Group;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(vi)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity is controlled or jointly controlled by a person identified in (a);&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(vii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
                                            person identified in (a)(i) has significant influence over the entity or is a member of the
                                            key management personnel of the entity (or of a parent of the entity); and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.35in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(viii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            entity, or any member of a group of which it is a part, provides key management personnel
                                            services to the Group or to the parent of the Group.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="c0" id="ixv-39996">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Property,
plant and equipment and depreciation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property,
plant and equipment, other than construction in progress, are stated at cost less accumulated depreciation and any impairment losses.
The cost of an item of property, plant and equipment comprises its purchase price and any directly attributable costs of bringing the
asset to its working condition and location for its intended use.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expenditure
incurred after items of property, plant and equipment have been put into operation, such as repairs and maintenance, is normally charged
to the statement of profit or loss in the period in which it is incurred. In situations where the recognition criteria are satisfied,
the expenditure for a major inspection is capitalized in the carrying amount of the asset as a replacement. Where significant parts of
property, plant and equipment are required to be replaced at intervals, the Group recognizes such parts as individual assets with specific
useful lives and depreciates them accordingly.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
is calculated on the straight-line basis to write off the cost of each item of property, plant and equipment to its residual value over
its estimated useful life. The principal annual rates used for this purpose are as follows:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 86%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Buildings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20% to 33.33&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.5% to 31.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
parts of an item of property, plant and equipment have different useful lives, the cost of that item is allocated on a reasonable basis
among the parts and each part is depreciated separately. Residual values, useful lives and the depreciation method are reviewed, and
adjusted if appropriate, at least at each financial year end.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
asset&#x2019;s carrying amount is written down immediately to its recoverable amount if the asset&#x2019;s carrying amount is greater than
its estimated recoverable amount.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
item of property, plant and equipment including any significant part initially recognized is derecognized upon disposal or when no future
economic benefits are expected from its use or disposal. Any gain or loss on disposal or retirement recognized in the statement of profit
or loss in the year the asset is derecognized is the difference between the net sales proceeds and the carrying amount of the relevant
asset.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Construction
in progress is stated at cost less any impairment losses and is not depreciated. It is reclassified to the appropriate category of property,
plant and equipment when completed and ready for use.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <aapg:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory contextRef="c0" id="ixv-70995">The principal annual rates used for this purpose are as follows:&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 86%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Buildings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20% to 33.33&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.5% to 31.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentOfAnnualRateExplanatory>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="c90" decimals="4" id="ixv-70996" unitRef="pure">0.0475</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="c91" decimals="2" id="ixv-70997" unitRef="pure">0.20</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="c92" decimals="4" id="ixv-70998" unitRef="pure">0.3333</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="c93" decimals="3" id="ixv-70999" unitRef="pure">0.095</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="c94" decimals="4" id="ixv-71000" unitRef="pure">0.3167</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="c95" decimals="4" id="ixv-71001" unitRef="pure">0.2375</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory contextRef="c0" id="ixv-40143">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Intangible
assets (other than goodwill)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination
is the fair value at the date of acquisition. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible
assets with finite lives are subsequently amortized over the useful economic life and assessed for impairment whenever there is an indication
that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at each financial year end.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets are amortized on the straight-line basis over the following useful economic lives:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 87%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3 to 10 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;License&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
useful lives of software are assessed by the Group considering different purpose and usage of the software, and the authorized period
for use. The useful life of patent is assessed by the Group based on the remaining and foreseeable patent protection period after acquisition.
The useful life of a purchased license is assessed by considering the expected usage of the license by the Group.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="c0" id="ixv-40154">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets are amortized on the straight-line basis over the following useful economic lives:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 87%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3 to 10 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;License&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="background-color: #CCEEFF; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c96" id="ixv-71002">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c97" id="ixv-71003">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c98" id="ixv-71004">P14Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c99" id="ixv-71005">P20Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory contextRef="c0" id="ixv-40196">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Research
and development costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
research costs are charged to the statement of profit or loss as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expenditure
incurred on projects to develop new products is capitalized and deferred only when the Group can demonstrate the technical feasibility
of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or
sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the project and the ability
to measure reliably the expenditure during the development. Product development expenditure which does not meet these criteria is expensed
when incurred. During the reporting period, all expenses incurred for research and development activities were regarded as research expenses
and therefore were expensed when incurred.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="c0" id="ixv-40212">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group assesses at contract inception whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract
conveys the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Group
as a lessee&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets.
The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
                                            assets&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
assets are recognized at the commencement date of the lease (that is the date the underlying asset is available for use). Right-of-use
assets are measured at cost, less accumulated depreciation and any impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis
over the shorter of the lease terms and the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 87%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold land&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Buildings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2 to 7 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
ownership of the leased asset transfers to the Group by the end of the lease term or the cost reflects the exercise of a purchase option,
depreciation is calculated using the estimated useful life of the asset.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
                                            liabilities&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
liabilities are recognized at the commencement date of the lease at the present value of lease payments to be made over the lease term.
The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease
payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also
include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for termination
of a lease, if the lease term reflects the Group exercising the option to terminate the lease. The variable lease payments that do not
depend on an index or a rate are recognized as an expense in the period in which the event or condition that triggers the payment occurs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
calculating the present value of lease payments, the Group uses its incremental borrowing rate at the lease commencement date because
the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is
increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities
is remeasured if there is a modification, a change in the lease term, a change in lease payments (e.g., a change to future lease payments
resulting from a change in an index or rate) or a change in assessment of an option to purchase the underlying asset.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s lease liabilities are included in interest-bearing bank and other borrowings.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
                                            leases and leases of low-value assets&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (that is those leases that
have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the recognition
exemption for leases of low-value assets to leases of office equipment that are considered to be of low value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
payments on short-term leases and leases of low-value assets are recognized as an expense on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <aapg:DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory contextRef="c0" id="ixv-71006">Right-of-use assets are depreciated on a straight-line basis
over the shorter of the lease terms and the estimated useful lives of the assets as follows:&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 87%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold land&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Buildings&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2 to 7 years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DetailedInformationAboutRightofUseAssetsOfLeaseTermsAndEstimatedUsefulLivesOfAssetsExplanatory>
    <aapg:RightofuseAssetsOfEstimatedUsefulLives contextRef="c100" id="ixv-71007">P30Y</aapg:RightofuseAssetsOfEstimatedUsefulLives>
    <aapg:RightofuseAssetsOfEstimatedUsefulLives contextRef="c101" id="ixv-71008">P2Y</aapg:RightofuseAssetsOfEstimatedUsefulLives>
    <aapg:RightofuseAssetsOfEstimatedUsefulLives contextRef="c102" id="ixv-71009">P7Y</aapg:RightofuseAssetsOfEstimatedUsefulLives>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory contextRef="c0" id="ixv-40467">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Investments
and other financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Initial
recognition and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets are classified, at initial recognition, as subsequently measured at amortized cost and fair value through profit and loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
classification of financial assets at initial recognition depends on the financial asset&#x2019;s contractual cash flow characteristics
and the Group&#x2019;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Group has applied the practical expedient of not adjusting the effect of a significant financing component,
the Group initially measures a financial asset at its fair value plus in the case of a financial asset not at FVTPL, transaction costs.
Trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient are
measured at the transaction price determined under IFRS 15 in accordance with the policies set out for &#x201c;Revenue recognition&#x201d;
below.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order for a financial asset to be classified and measured at amortized cost, it needs to give rise to cash flows that are solely payments
of principal and interest (&#x201c;SPPI&#x201d;) on the principal amount outstanding. Financial assets with cash flows that are not SPPI
are classified and measured at fair value through profit or loss, irrespective of the business model.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash flows.
The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or
both. Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial
assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through other comprehensive
income are held within a business model with the objective of both holding to collect contractual cash flows and selling. Financial assets
which are not held within the aforementioned business models are classified and measured at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purchases
or sales of financial assets that require delivery of assets within the period generally established by regulation or convention in the
marketplace are recognized on the trade date, that is, the date that the Group commits to purchase or sell the asset.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
subsequent measurement of financial assets depends on their classification as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Financial
assets at amortized cost (debt instruments)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment. Gains and losses
are recognized in the statement of profit or loss when the asset is derecognized, modified or impaired.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Financial
assets at FVTPL&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets at FVTPL are carried in the statement of financial position at fair value with net changes in fair value recognized in the statement
of profit or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividends
on the equity investments are also recognized as other income in the statement of profit or loss when the right of payment has been established.&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory contextRef="c0" id="ixv-40619">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Derecognition
of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized
(i.e., removed from the Group&#x2019;s consolidated statement of financial position) when:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            rights to receive cash flows from the asset have expired; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            Group has transferred its rights to receive cash flows from the asset or has assumed an obligation
                                            to pay the received cash flows in full without material delay to a third party under a &#x201c;pass-through&#x201d;
                                            arrangement; and either (a) the Group has transferred substantially all the risks and rewards
                                            of the asset, or (b) the Group has neither transferred nor retained substantially all the
                                            risks and rewards of the asset, but has transferred control of the asset.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the Group has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risk and rewards of ownership of the asset. When it has neither transferred nor retained
substantially all the risks and rewards of the asset nor transferred control of the asset, the Group continues to recognize the transferred
asset to the extent of the Group&#x2019;s continuing involvement. In that case, the Group also recognizes an associated liability. The
transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Group has retained.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Group could be required to repay.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory contextRef="c0" id="ixv-40725">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Impairment
of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group recognizes an allowance for expected credit losses (&#x201c;ECLs&#x201d;) for all debt instruments not held at fair value through
profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash
flows that the Group expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows
will include cash flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;General
approach&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ECLs
are recognized in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition,
ECLs are provided for credit losses that result from default events that are possible within the next 12 months (a 12-month ECL). For
those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is
required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
each reporting date, the Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition.
When making the assessment, the Group compares the risk of a default occurring on the financial instrument as at the reporting date with
the risk of a default occurring on the financial instrument as at the date of initial recognition and considers reasonable and supportable
information that is available without undue cost or effort, including historical and forward-looking information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group considers a financial asset in default when contractual payments are 120 days past due. However, in certain cases, the Group may
also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive
the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets at amortized cost are subject to impairment under the general approach, and they are classified within the following stages for
measurement of ECLs except for trade receivables which apply the simplified approach as detailed below.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.65in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
                               1 &#x2013; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
                                            instruments for which credit risk has not increased significantly since initial recognition
                                            and for which the loss allowance is measured at an amount equal to 12-month ECLs&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.65in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
                                            2 &#x2013; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
                                            instruments for which credit risk has increased significantly since initial recognition but
                                            that are not credit-impaired financial assets and for which the loss allowance is measured
                                            at an amount equal to lifetime ECLs&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.65in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
                                            3 &#x2013; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
                                            assets that are credit-impaired at the reporting date (but that are not purchased or originated
                                            credit-impaired) and for which the loss allowance is measured at an amount equal to lifetime
                                            ECLs&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Simplified
approach&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
trade receivables that do not contain a significant financing component or when the Group applies the practical expedient of not adjusting
the effect of a significant financing component, the Group applies the simplified approach in calculating ECLs. Under the simplified
approach, the Group does not track changes in credit risk but instead recognizes a loss allowance based on lifetime ECLs at each reporting
date. The Group has established a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking
factors specific to the debtors and the economic environment.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory contextRef="c0" id="ixv-40880">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Financial
liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Initial
recognition and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
liabilities are classified, at initial recognition, as financial liabilities at FVTPL, loans and borrowings, or payables, as appropriate.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s financial liabilities include trade payables, financial liabilities included in other payables and accruals, interest-bearing
bank and other borrowings, long-term payables and other current and non-current liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
subsequent measurement of financial liabilities depends on their classification as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Financial
liabilities at fair value through profit or loss&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
liabilities at fair value through profit or loss include financial liabilities designated upon initial recognition as at fair value through
profit or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
liabilities designated upon initial recognition as at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied. Gains or losses on liabilities designated at fair value through profit or loss are
recognized in the statement of profit or loss, except for the gains or losses arising from the Group&#x2019;s own credit risk which are
presented in other comprehensive income with no subsequent reclassification to the statement of profit or loss. The net fair value gain
or loss recognized in the statement of profit or loss does not include any interest charged on these financial liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Financial
liabilities at amortized cost (trade and other payables, and borrowings)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
initial recognition, trade and other payables, and interest-bearing borrowings are subsequently measured at amortized cost, using the
effective interest rate method unless the effect of discounting would be immaterial, in which case they are stated at cost. Gains and
losses are recognized in the statement of profit or loss when the liabilities are derecognized as well as through the effective interest
rate amortization process.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the effective
interest rate. The effective interest rate amortization is included in finance costs in the statement of profit or loss.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory>
    <aapg:DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock contextRef="c0" id="ixv-41016">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Derecognition
of financial liabilities &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
financial liability is derecognized when the obligation under the liability is discharged or cancelled or expires.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing
liability are substantially modified, such an exchange or modification is treated as a derecognition of the original liability and a
recognition of a new liability, and the difference between the respective carrying amounts is recognized in the statement of profit or
loss.&lt;/span&gt;&lt;/p&gt;</aapg:DescriptionOfAccountingPolicyForDerecognitionFinancialLiabilitiesTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory contextRef="c0" id="ixv-41032">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Offsetting
of financial instruments &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, or to realize the assets
and settle the liabilities simultaneously.&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory contextRef="c0" id="ixv-41043">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Derivative
financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Initial
recognition and subsequent measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Derivative
financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently
remeasured at fair value. Derivatives are carried as assets when the fair value is positive, and as liabilities when the fair value is
negative.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
gains or losses arising from changes in fair value of derivatives are taken directly to profit or loss.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory contextRef="c0" id="ixv-41122">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Treasury
shares &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Own
equity instruments which are reacquired and held by the Company or the Group (treasury shares) are recognized directly in equity at cost.
No gain or loss is recognized in the statement of profit or loss on the purchase, sale, issue or cancellation of the Group&#x2019;s own
equity instruments.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories contextRef="c0" id="ixv-41133">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories
are stated at the lower of cost and net realizable value. Cost is determined on the first-in, first-out basis, in the case of work in
progress and finished goods, comprises direct materials, direct labor, contract manufacturing fee and an appropriate proportion of overheads.
Net realizable value is based on estimated selling prices less any estimated costs to be incurred to completion and disposal.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="c0" id="ixv-41144">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Cash
and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents in the statements of cash flows comprise cash on hand and at banks, and short-term highly liquid deposits with a
maturity of generally within three months that are readily convertible into known amounts of cash, subject to an insignificant risk of
changes in value and held for the purpose of meeting short-term cash commitments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the purpose of the consolidated statements of financial positions, cash and bank balances comprise cash and cash equivalents as defined
above, restricted bank balances and time deposits with original maturity of more than three months as defined above.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory contextRef="c0" id="ixv-41160">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Provisions
&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
provision is recognized when a present obligation (legal or constructive) has arisen as a result of a past event and it is probable that
a future outflow of resources will be required to settle the obligation, provided that a reliable estimate can be made of the amount
of the obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the Group expects some or all of a provision to be reimbursed, the reimbursement is recognized as a separate asset, but only when the
reimbursement is virtually certain. The expense relating to a provision is presented in the statement of profit or loss net of any reimbursement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the effect of discounting is material, the amount recognized for a provision is the present value at the end of the reporting date of
the future expenditures expected to be required to settle the obligation. The increase in the discounted present value amount arising
from the passage of time is included in finance costs in the statement of profit or loss.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="c0" id="ixv-41181">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Income
tax&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
tax comprises current and deferred tax. Income tax relating to items recognized outside profit or loss is recognized outside profit or
loss, either in other comprehensive income or directly in equity.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, based on tax
rates (and tax laws) that have been enacted or substantively enacted by the end of each of the reporting period, taking into consideration
interpretations and practices prevailing in the countries in which the Group operates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax is provided, using the liability method, on all temporary differences at the end of reporting date between the tax bases of assets
and liabilities and their carrying amounts for financial reporting purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax liabilities are recognized for all taxable temporary differences, except:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;when
                                            the deferred tax liability arises from the initial recognition of goodwill or an asset or
                                            liability in a transaction that is not a business combination and, at the time of the transaction,
                                            affects neither the accounting profit nor taxable profit or loss and does not give rise to
                                            equal taxable and deductible temporary differences; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
                                            respect of taxable temporary differences associated with investments in subsidiaries, when
                                            the timing of the reversal of the temporary differences can be controlled and it is probable
                                            that the temporary differences will not reverse in the foreseeable future.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets are recognized for all deductible temporary differences, and the carryforward of unused tax credits and any unused tax losses.
Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which the deductible
temporary differences, and the carryforward of unused tax credits and unused tax losses can be utilized, except:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;when
                                            the deferred tax asset relating to the deductible temporary differences arises from the initial
                                            recognition of an asset or liability in a transaction that is not a business combination
                                            and, at the time of the transaction, affects neither the accounting profit nor taxable profit
                                            or loss and does not give rise to equal taxable and deductible temporary differences; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
                                            respect of deductible temporary differences associated with investments in subsidiaries,
                                            deferred tax assets are only recognized to the extent that it is probable that the temporary
                                            differences will reverse in the foreseeable future and taxable profit will be available against
                                            which the temporary differences can be utilized.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer
probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized
deferred tax assets are reassessed at the end of each reporting period and are recognized to the extent that it has become probable that
sufficient taxable profit will be available to allow all or part of the deferred tax asset to be recovered.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realized or the liability
is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and deferred tax liabilities are offset if and only if the Group has a legally enforceable right to set off current tax assets
and current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation
authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets
on a net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts
of deferred tax liabilities or assets are expected to be settled or recovered.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants contextRef="c0" id="ixv-41388">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Government
grants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government
grants are recognized at their fair value where there is reasonable assurance that the grant will be received and all attaching conditions
will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the periods that
the costs, for which it is intended to compensate, are expensed.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
government grants whose primary condition is to compensate for research and development projects or other than purchase, construct or
otherwise acquire long-term assets are designated as grants related to income. Some of the grants related to income have future related
costs expected to be incurred and require the Group to comply with conditions attached to the grants and the government to acknowledge
the compliance of these conditions. These grants related to income are recognized as deferred income in the consolidated statement of
financial position and transferred to profit or loss when related costs are subsequently incurred, and the Group received government acknowledge
of compliance.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
government grants related to income that are receivable as compensation for expenses or losses already incurred or for the purpose of
giving immediate financial support to the Group with no future related costs are recognized in profit or loss in the period in which
they become receivable.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants>
    <ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory contextRef="c0" id="ixv-41409">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Revenue
recognition &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Revenue
from contracts with customers&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from contracts with customers is recognized when control of goods or services is transferred to the customers at an amount that reflects
the consideration to which the Group expects to be entitled in exchange for those goods or services.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the consideration in a contract includes a variable amount, the amount of consideration is estimated to which the Group will be entitled
in exchange for transferring the goods or services to the customer. The variable consideration is estimated at contract inception and
constrained until it is highly probable that a significant revenue reversal in the amount of cumulative revenue recognized will not occur
when the associated uncertainty with the variable consideration is subsequently resolved.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the contract contains a financing component which provides the customer with a significant benefit of financing the transfer of goods
or services to the customer for more than one year, revenue is measured at the present value of the amount receivable, discounted using
the discount rate that would be reflected in a separate financing transaction between the Group and the customer at contract inception.
When the contract contains a financing component which provides the Group with a significant financial benefit for more than one year,
revenue recognized under the contract includes the interest expense accreted on the contract liability under the effective interest method.
For a contract where the period between the payment by the customer and the transfer of the promised goods or services is one year or
less, the transaction price is not adjusted for the effects of a significant financing component, using the practical expedient in IFRS
15.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sale
                                            of products&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from the sale of products is recognized at the point in time when control of the asset is transferred to the customer, generally on acceptance
of the products.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
                                            rights&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group provides commercialization, development and branding rights (collectively, &#x201c;Commercialization Rights&#x201d;) to customers
for an agreed upon commercialization period ending ten years from the date of the first sale of the product as stipulated in the relevant
agreement. The consideration for Commercialization Rights includes upfront payment, development and regulatory milestones payments and
commercialization milestones payments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
and regulatory milestones payments are fully constrained until the period in which those regulatory approvals are achieved due to the
inherent uncertainty with the approval process and included in the transaction price in the period regulatory approval is obtained. Upfront
payment and development and regulatory milestones payments are recorded under contract liabilities and recognized as revenue over time
during the commercialization period on a straight-line basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
milestone payments based on the level of sales are recognized at a point in time when the later of the following events occurs: (i) the
related sale occurs, or (ii) the performance obligation to which commercialization milestones payments have been allocated has been satisfied.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intellectual
                                            property income&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intellectual
property income is recognized at the point in time at which the non-patented intellectual property is granted to the customer because
the Company will not undertake activities that affect such intellectual property.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consideration for intellectual property income comprises a fixed element and a variable element. Variable element is recognized as the
transaction price when the Company can conclude that it is highly probable that a significant reversal in the amount of cumulative revenue
recognized will not occur.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group provides consulting services to its customers through contracts. Depending on the contract, revenue is recognized over time as
the service is rendered, or at the point in time as the service is completed and accepted.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory contextRef="c0" id="ixv-41653">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
income&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
income is recognized on an accrual basis using the effective interest method by applying the rate that exactly discounts the estimated
future cash receipts over the expected life of the financial instrument or a shorter period, when appropriate, to the net carrying amount
of the financial asset.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory>
    <aapg:DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory contextRef="c0" id="ixv-41664">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Contract
liabilities &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
contract liability is recognized when a payment is received or a payment is due (whichever is earlier) from a customer before the Group
transfers the related goods or services. Contract liabilities are recognized as revenue when the Group performs under the contract (i.e.,
transfers control of the related goods or services to the customer).&lt;/span&gt;&lt;/p&gt;</aapg:DescriptionOfAccountingPolicyForContractLiabilitiesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="c0" id="ixv-41675">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Share-based
payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates share incentive plans which include the pre-IPO share option scheme, the post-IPO share option scheme, 2018 restricted
share unit scheme (the &#x201c;2018 RSU Scheme&#x201d;), 2021 restricted share unit scheme (the &#x201c;2021 RSU Scheme&#x201d;) and 2022
restricted share unit scheme (the &#x201c;2022 RSU Scheme&#x201d;). Employees (including directors) of the Group receive remuneration in
the form of share-based payments, whereby employees render services in exchange for equity instruments (&#x201c;equity-settled transactions&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cost of equity-settled transactions with employees is measured by reference to the fair value at the date at which they are granted,
further details of which are given in note 31 to the financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cost of equity-settled transactions is recognized in employee benefit expense, together with a corresponding increase in equity, over
the period in which the performance and/or service conditions are fulfilled. The cumulative expense recognized for equity-settled transactions
at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group&#x2019;s
best estimate of the number of equity instruments that will ultimately vest. The charge or credit to the statement of profit or loss
for a period represents the movement in the cumulative expense recognized as at the beginning and end of that period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Service
and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood
of the conditions being met is assessed as part of the Group&#x2019;s best estimate of the number of equity instruments that will ultimately
vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without
an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value
of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
awards that do not ultimately vest because non-market performance and/or service conditions have not been met, no expense is recognized.
Where awards include a market or non-vesting condition, the transactions are treated as vesting irrespective of whether the market or
non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
the terms of an equity-settled award are modified, as a minimum an expense is recognized as if the terms had not been modified, if the
original terms of the award are met. In addition, an expense is recognized for any modification that increases the total fair value of
the share-based payments or is otherwise beneficial to the employee as measured at the date of modification. Where an equity-settled
award is cancelled, it is treated as if it had vested on the date of cancellation, and any expense not yet recognized for the award is
recognized immediately.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
dilutive effect of outstanding options is reflected as additional share dilution in the computation of loss per share.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory contextRef="c0" id="ixv-41781">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Other
employee benefits&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Pension
scheme&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
employees of the Group&#x2019;s subsidiaries which operate in the Chinese mainland are required to participate in a central pension scheme
operated by the local municipal government. The subsidiaries operating in Chinese mainland are required to contribute a certain percentage
of their payroll costs to the central pension scheme. The contributions are charged to profit or loss as they become payable in accordance
with the rules of the central pension scheme.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group implemented a safe harbor defined contribution 401(k) savings plan (the &#x201c;401(k) Plan&#x201d;) for U.S. employees. The 401(k)
Plan covers all U.S. employees and allows participants to defer a portion of their annual compensation on a pre-tax basis. In addition,
the Company implemented a matching contribution to the 401(k) Plan, matching 100% of an employee&#x2019;s contribution up to a maximum
of 6% of the participant&#x2019;s annual base salary. Such matching contribution vests when made.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <aapg:OtherEmployeeBenefitContributionPercentage contextRef="c0" decimals="2" id="ixv-71010" unitRef="pure">1</aapg:OtherEmployeeBenefitContributionPercentage>
    <aapg:AnnualBaseSalaryPercentage contextRef="c82" decimals="2" id="ixv-71011" unitRef="pure">0.06</aapg:AnnualBaseSalaryPercentage>
    <ifrs-full:DescriptionOfAccountingPolicyForBorrowingCostsExplanatory contextRef="c0" id="ixv-41804">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Borrowing
costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
costs directly attributable to the acquisition, construction or production of qualifying assets, i.e., assets that necessarily take a
substantial period of time to get ready for their intended use or sale, are capitalized as part of the cost of those assets. The capitalization
of such borrowing costs ceases when the assets are substantially ready for their intended use or sale. All other borrowing costs are
expensed in the period in which they are incurred. Borrowing costs consist of interest and other costs that an entity incurs in connection
with the borrowing of funds.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForBorrowingCostsExplanatory>
    <aapg:DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock contextRef="c0" id="ixv-41815">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Events
after the reporting period &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Group receives information after the reporting period, but prior to the date of authorization for issue, about conditions that existed
at the end of the reporting period, it will assess whether the information affects the amounts that it recognizes in its financial statements.
The Group will adjust the amounts recognized in its financial statements to reflect any adjusting events after the reporting period and
update the disclosures that relate to those conditions in light of the new information. For non-adjusting events after the reporting
period, the Group will not change the amounts recognized in its financial statements but will disclose the nature of the non-adjusting
events and an estimate of their financial effects, or a statement that such an estimate cannot be made, if applicable.&lt;/span&gt;&lt;/p&gt;</aapg:DescriptionOfAccountingPolicyForEventsAfterTheReportingPeriodTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="c0" id="ixv-41884">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Foreign
currencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements are presented in RMB. Each entity in the Group determines its own functional currency and items included in the
financial statements of each entity are measured using that functional currency. Foreign currency transactions recorded by the entities
in the Group are initially recorded using their respective functional currency rates prevailing at the dates of the transactions. Monetary
assets and liabilities denominated in foreign currencies are translated at the functional currency rates of exchange ruling at the end
of the reporting period. Differences arising on settlement or translation of monetary items are recognized in profit or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-monetary
items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the
initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the
date when the fair value was measured. The gain or loss arising on translation of a non-monetary item measured at fair value is treated
in line with the recognition of the gain or loss on change in fair value of the item (i.e., translation difference on the item whose
fair value gain or loss is recognized in other comprehensive income or profit or loss is also recognized in other comprehensive income
or profit or loss, respectively).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
determining the exchange rate on initial recognition of the related asset, expense or income on the derecognition of a non-monetary asset
or non-monetary liability relating to an advance consideration, the date of initial transaction is the date on which the Group initially
recognizes the non-monetary asset or non-monetary liability arising from the advance consideration. If there are multiple payments or
receipts in advance, the Group determines the transaction date for each payment or receipt of the advance consideration.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currencies of certain overseas subsidiaries are currencies other than the RMB. As at the end of the reporting period, the
assets and liabilities of these entities are translated into RMB at the exchange rates prevailing at the end of the reporting period
and their statements of profit or loss are translated into RMB at the exchange rates that approximate to those prevailing at the dates
of the transactions.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
resulting exchange differences are recognized in other comprehensive income and accumulated in the exchange fluctuation reserve, except
to the extent that the differences are attributable to non-controlling interests. On disposal of a foreign operation, the cumulative
amount in the reserve relating to that particular foreign operation is recognized in the statement of profit or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
goodwill arising on the acquisition of a foreign operation and any fair value adjustments to the carrying amounts of assets and liabilities
arising on acquisition are treated as assets and liabilities of the foreign operation and translated at the closing rate.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the purpose of the consolidated statements of cash flows, the cash flows of overseas subsidiaries are translated into RMB at the exchange
rates ruling at the dates of the cash flows. Frequently recurring cash flows of overseas subsidiaries which arise throughout the year
are translated into RMB at the exchange rates that approximate to those prevailing at the dates of the transactions.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory contextRef="c0" id="ixv-41960">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SIGNIFICANT
                                            ACCOUNTING JUDGEMENTS AND ESTIMATES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the Group&#x2019;s financial statements requires management to make judgements, estimates and assumptions that affect the
reported amounts of expenses, assets and liabilities, and their accompanying disclosures, and the disclosure of contingent liabilities.
Uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amounts
of the assets or liabilities affected in the future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Judgements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the process of applying the Group&#x2019;s accounting policies, management has made the following judgements, apart from those involving
estimations, which have the most significant effect on the amounts recognized in the financial statements:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Revenue
from contracts with customers&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group applied the following judgements that significantly affect the determination of the amount and timing of revenue from contracts
with customers:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
rights contracts include variable consideration based on future events. In estimating the variable consideration, the Group is required
to use either the expected value method or the most likely amount method based on which method better predicts the amount of consideration
to which it will be entitled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.2pt; text-indent: -1.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Given
that the payments of certain variable consideration are not within the control of the Group, such as regulatory approvals, relevant consideration
is not considered until relevant approvals are obtained. The Group determines that the most likely amount method is the appropriate method
to estimate the variable consideration. When the Group can conclude that it is highly probable that there will not be a subsequent reversal
of a significant amount of revenue, the variable consideration will be included in the transaction price.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Estimation
uncertainty&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key assumptions concerning the future and other key sources of estimation uncertainty at the end of the reporting period, that have a
significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are
described below.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: left; text-indent: -1.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
tax assets are recognized for unused tax losses to the extent that it is probable that taxable profit will be available against which
the losses can be utilized. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized,
based upon the likely timing and the level of future taxable profits, together with future tax planning strategies. The Group has carried
forward tax losses of RMB 4,425,237 and RMB5,347,045 (US$764,617) as of December 31, 2024 and 2025, respectively, of which related deferred
tax assets of RMB3,523 and RMB12,373 (US$1,769) have been recognized as of December 31, 2024 and 2025, respectively. Deferred tax assets
have not been recognized in respect of losses that have arisen in subsidiaries that have been loss-making for some time, and it is not
considered probable that taxable profits will be available against which the tax losses can be utilized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;If
the Group was able to recognize all unrecognized deferred tax assets, net loss would have decreased and equity would have increased by
RMB1,119,913, RMB1,321,638 and RMB1,572,664 (US$224,889) during the years ended December 31, 2023, 2024 and 2025, respectively. Further
details on taxes are disclosed in Note 9.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="c103"
      decimals="-3"
      id="ixv-71012"
      unitRef="cny">4425237000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="c104"
      decimals="-3"
      id="ixv-71013"
      unitRef="cny">5347045000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="c104"
      decimals="-3"
      id="ixv-71014"
      unitRef="usd">764617000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c105"
      decimals="-3"
      id="ixv-71015"
      unitRef="cny">3523000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c106"
      decimals="-3"
      id="ixv-71016"
      unitRef="cny">12373000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c106"
      decimals="-3"
      id="ixv-71017"
      unitRef="usd">1769000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="c107"
      decimals="-3"
      id="ixv-71018"
      unitRef="cny">1119913000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="c108"
      decimals="-3"
      id="ixv-71019"
      unitRef="cny">1321638000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="c109"
      decimals="-3"
      id="ixv-71020"
      unitRef="cny">1572664000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="c109"
      decimals="-3"
      id="ixv-71021"
      unitRef="usd">224889000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="c0" id="ixv-42059">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;OPERATING
                                            SEGMENT INFORMATION&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
management purposes, the Group has only one reportable operating segment, which is discovering, developing and commercializing
therapies to address global medical needs primarily in hematological malignancies Management monitors the operating results of the
Group&#x2019;s operating segment as a whole for the purpose of making decisions about resource allocation and performance assessment.
Therefore, no analysis by operating segment is presented.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Geographical
information&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue from external customers&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0; text-indent: 369.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chinese
    mainland&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;221,984&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;302,235&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;574,120&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,098&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-195; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;678,415&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-196; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-197; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;221,984&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;980,650&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;574,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0; text-indent: 369.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
revenue information above is based on the locations of the customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chinese
    mainland&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,088,733&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,090,914&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;978,233&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;139,885&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;United
    States&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,665&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,474&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,489&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;444&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,091,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,095,832&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;982,757&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,532&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
non-current assets information above is based on the locations of the assets and excludes financial instruments and deferred tax assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Information
about major customers&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from customers amounting to over 10% of the total revenue of the Group in the reporting period is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the years ended December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;107,323&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;229,895&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;436,644&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;62,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
    B&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-198; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;p style="margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;678,415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-199; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-200; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
    C&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,021&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-201; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-202; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-203; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
    D&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-204; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-205; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-206; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;172,967&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;908,310&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;436,644&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;62,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These customers generated less than 10% of the total revenue of the Group during the years ended December 31, 2023, 2024 and 2025.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <ifrs-full:FactorsUsedToIdentifyEntitysReportableSegments contextRef="c0" id="ixv-71022">one</ifrs-full:FactorsUsedToIdentifyEntitysReportableSegments>
    <ifrs-full:DisclosureOfProductsAndServicesExplanatory contextRef="c0" id="ixv-42084">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue from external customers&lt;/span&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chinese
    mainland&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;221,984&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;302,235&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;574,120&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,098&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-195; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;678,415&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-196; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-197; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;221,984&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;980,650&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;574,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfProductsAndServicesExplanatory>
    <ifrs-full:Revenue
      contextRef="c110"
      decimals="-3"
      id="ixv-71023"
      unitRef="cny">221984000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c111"
      decimals="-3"
      id="ixv-71024"
      unitRef="cny">302235000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c112"
      decimals="-3"
      id="ixv-71025"
      unitRef="cny">574120000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c112"
      decimals="-3"
      id="ixv-71026"
      unitRef="usd">82098000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c114"
      decimals="-3"
      id="ixv-71027"
      unitRef="cny">678415000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c12" decimals="-3" id="ixv-71028" unitRef="cny">221984000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c13" decimals="-3" id="ixv-71029" unitRef="cny">980650000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c0" decimals="-3" id="ixv-71030" unitRef="cny">574120000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c0" decimals="-3" id="ixv-71031" unitRef="usd">82098000</ifrs-full:Revenue>
    <ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory contextRef="c0" id="ixv-42332">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current assets&lt;/span&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chinese
    mainland&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,088,733&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,090,914&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;978,233&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;139,885&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;United
    States&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,665&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,474&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,489&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;444&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,091,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,095,832&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;982,757&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,532&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c116"
      decimals="-3"
      id="ixv-71032"
      unitRef="cny">1088733000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c117"
      decimals="-3"
      id="ixv-71033"
      unitRef="cny">1090914000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c118"
      decimals="-3"
      id="ixv-71034"
      unitRef="cny">978233000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c118"
      decimals="-3"
      id="ixv-71035"
      unitRef="usd">139885000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c119"
      decimals="-3"
      id="ixv-71036"
      unitRef="cny">2665000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c120"
      decimals="-3"
      id="ixv-71037"
      unitRef="cny">4474000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c121"
      decimals="-3"
      id="ixv-71038"
      unitRef="cny">4489000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c121"
      decimals="-3"
      id="ixv-71039"
      unitRef="usd">642000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c122"
      decimals="-3"
      id="ixv-71040"
      unitRef="cny">24000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c123"
      decimals="-3"
      id="ixv-71041"
      unitRef="cny">444000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c124"
      decimals="-3"
      id="ixv-71042"
      unitRef="cny">35000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c124"
      decimals="-3"
      id="ixv-71043"
      unitRef="usd">5000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets contextRef="c41" decimals="-3" id="ixv-71044" unitRef="cny">1091422000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets contextRef="c14" decimals="-3" id="ixv-71045" unitRef="cny">1095832000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets contextRef="c15" decimals="-3" id="ixv-71046" unitRef="cny">982757000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets contextRef="c15" decimals="-3" id="ixv-71047" unitRef="usd">140532000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory contextRef="c0" id="ixv-42663">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from customers amounting to over 10% of the total revenue of the Group in the reporting period is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the years ended December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;107,323&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;229,895&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;436,644&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;62,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
    B&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-198; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;p style="margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;678,415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-199; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-200; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
    C&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,021&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-201; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-202; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-203; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 11pt; text-indent: -11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
    D&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-204; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-205; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-206; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;172,967&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;908,310&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;436,644&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;62,439&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These customers generated less than 10% of the total revenue of the Group during the years ended December 31, 2023, 2024 and 2025.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c125"
      decimals="-3"
      id="ixv-71048"
      unitRef="cny">107323000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c126"
      decimals="-3"
      id="ixv-71049"
      unitRef="cny">229895000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c127"
      decimals="-3"
      id="ixv-71050"
      unitRef="cny">436644000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c127"
      decimals="-3"
      id="ixv-71051"
      unitRef="usd">62439000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c129"
      decimals="-3"
      id="ix_19_fact"
      unitRef="cny">678415000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c131"
      decimals="-3"
      id="ixv-71053"
      unitRef="cny">35021000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c134"
      decimals="-3"
      id="ixv-71054"
      unitRef="cny">30623000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c12" decimals="-3" id="ixv-71055" unitRef="cny">172967000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c13" decimals="-3" id="ixv-71056" unitRef="cny">908310000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c0" decimals="-3" id="ixv-71057" unitRef="cny">436644000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c0" decimals="-3" id="ixv-71058" unitRef="usd">62439000</ifrs-full:RevenueFromContractsWithCustomers>
    <aapg:DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock contextRef="c0" id="ixv-42993">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;REVENUE,
                                            OTHER INCOME AND GAINS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
analysis of revenue is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Revenue
from contracts with customers&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disaggregated revenue information&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Types of goods
    or services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intellectual
    property income&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-207; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;678,415&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-208; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-209; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales
    of products&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;193,535&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;260,835&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;499,272&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,395&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,049&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72,629&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,386&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,400&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,915&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,219&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;221,984&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,650&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;574,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Timing
    of revenue recognition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;At
    a point in time&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intellectual
    property income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-210; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;678,415&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-211; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-212; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales of products&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;193,535&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;260,835&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;499,272&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,395&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Commercialization
rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-213; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35,144&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Over
    time&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,049&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,400&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,915&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,219&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;221,984&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,650&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;574,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the amounts of revenue recognized in the current reporting period that were included in the contract liabilities
at the beginning of the reporting period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,049&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-indent: 37.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Performance
                                            obligations&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
about the Group&#x2019;s performance obligations is summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -22pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Intellectual
property income&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -22.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
intellectual property income is recognized at the point of time upon the customer obtains the right to use the non-patented intellectual
property as there are no ongoing activities that significantly affect the intellectual property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.5pt; text-indent: -22.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sales
of products&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
performance obligation is satisfied upon acceptance of the products and payment is generally due within 45 to 120 days from the date
of billing.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Commercialization
rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
performance obligation is satisfied over time as commercialization rights are granted for an agreed upon commercialization period ending
ten years from the date of the first sale of the product as stipulated in the relevant agreement. Among these, revenue from sales-based
commercialization milestone payments is recognized at a point in time when the related sale occurs. Upfront payment in advance is required,
and the development and regulatory milestones payments and commercialization milestones payments are generally due within 120 days from
the date of billing.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amounts of transaction prices allocated to the remaining performance obligations (unsatisfied or partially unsatisfied) as at December
31, 2024 and 2025 are as follows:&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amounts expected to be recognized as revenue:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within
    one year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
    one year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;248,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;210,224&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;285,945&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;247,709&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amounts of transaction prices allocated to the remaining performance obligations which are expected to be recognized mainly related to
commercialization rights, which have been partially recognized during the reporting period (note 26). The amounts disclosed above do
not include variable consideration which is constrained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Other
income and gains&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank
    interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,409&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,840&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,744&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government grants related
    to income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,496&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign exchange gain, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,621&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,694&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rental income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,989&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value gain on derivative
    financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,822&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gain
    on disposal of items of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,702&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,428&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,885&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    other income and gains&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;59,316&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,359&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;103,495&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,800&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfRevenueOtherIncomeAndOtherGainsExplanatoryTextBlock>
    <ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory contextRef="c0" id="ixv-43016">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disaggregated revenue information&lt;/span&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Types of goods
    or services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intellectual
    property income&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-207; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;678,415&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-208; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-209; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales
    of products&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;193,535&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;260,835&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;499,272&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,395&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,049&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72,629&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,386&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,400&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,915&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,219&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;221,984&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,650&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;574,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Timing
    of revenue recognition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;At
    a point in time&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intellectual
    property income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-210; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;678,415&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-211; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-212; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales of products&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;193,535&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;260,835&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;499,272&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,395&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Commercialization
rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-213; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35,144&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Over
    time&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,049&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,400&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,915&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,219&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 12pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;221,984&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;980,650&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;574,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;82,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory>
    <ifrs-full:Revenue
      contextRef="c138"
      decimals="-3"
      id="ixv-71059"
      unitRef="cny">678415000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c140"
      decimals="-3"
      id="ixv-71060"
      unitRef="cny">193535000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c141"
      decimals="-3"
      id="ixv-71061"
      unitRef="cny">260835000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c142"
      decimals="-3"
      id="ixv-71062"
      unitRef="cny">499272000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c142"
      decimals="-3"
      id="ixv-71063"
      unitRef="usd">71395000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c143"
      decimals="-3"
      id="ixv-71064"
      unitRef="cny">26049000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c144"
      decimals="-3"
      id="ixv-71065"
      unitRef="cny">37485000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c145"
      decimals="-3"
      id="ixv-71066"
      unitRef="cny">72629000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c145"
      decimals="-3"
      id="ixv-71067"
      unitRef="usd">10386000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c146"
      decimals="-3"
      id="ixv-71068"
      unitRef="cny">2400000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c147"
      decimals="-3"
      id="ixv-71069"
      unitRef="cny">3915000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c148"
      decimals="-3"
      id="ixv-71070"
      unitRef="cny">2219000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c148"
      decimals="-3"
      id="ixv-71071"
      unitRef="usd">317000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c149"
      decimals="-3"
      id="ixv-71072"
      unitRef="cny">221984000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c150"
      decimals="-3"
      id="ixv-71073"
      unitRef="cny">980650000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c151"
      decimals="-3"
      id="ixv-71074"
      unitRef="cny">574120000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c151"
      decimals="-3"
      id="ixv-71075"
      unitRef="usd">82098000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c153"
      decimals="-3"
      id="ixv-71076"
      unitRef="cny">678415000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c155"
      decimals="-3"
      id="ixv-71077"
      unitRef="cny">193535000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c156"
      decimals="-3"
      id="ixv-71078"
      unitRef="cny">260835000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c157"
      decimals="-3"
      id="ixv-71079"
      unitRef="cny">499272000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c157"
      decimals="-3"
      id="ixv-71080"
      unitRef="usd">71395000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c160"
      decimals="-3"
      id="ixv-71081"
      unitRef="cny">35144000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c160"
      decimals="-3"
      id="ixv-71082"
      unitRef="usd">5026000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c161"
      decimals="-3"
      id="ixv-71083"
      unitRef="cny">26049000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c162"
      decimals="-3"
      id="ixv-71084"
      unitRef="cny">37485000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c163"
      decimals="-3"
      id="ixv-71085"
      unitRef="cny">37485000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c163"
      decimals="-3"
      id="ixv-71086"
      unitRef="usd">5360000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c164"
      decimals="-3"
      id="ixv-71087"
      unitRef="cny">2400000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c165"
      decimals="-3"
      id="ixv-71088"
      unitRef="cny">3915000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c166"
      decimals="-3"
      id="ixv-71089"
      unitRef="cny">2219000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c166"
      decimals="-3"
      id="ixv-71090"
      unitRef="usd">317000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c167"
      decimals="-3"
      id="ixv-71091"
      unitRef="cny">221984000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c168"
      decimals="-3"
      id="ixv-71092"
      unitRef="cny">980650000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c169"
      decimals="-3"
      id="ixv-71093"
      unitRef="cny">574120000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c169"
      decimals="-3"
      id="ixv-71094"
      unitRef="usd">82098000</ifrs-full:Revenue>
    <ifrs-full:DisclosureOfInvestmentContractsLiabilitiesExplanatory contextRef="c0" id="ixv-43777">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the amounts of revenue recognized in the current reporting period that were included in the contract liabilities
at the beginning of the reporting period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,049&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfInvestmentContractsLiabilitiesExplanatory>
    <ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod contextRef="c12" decimals="-3" id="ixv-71095" unitRef="cny">26049000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod contextRef="c13" decimals="-3" id="ixv-71096" unitRef="cny">37485000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod contextRef="c0" decimals="-3" id="ixv-71097" unitRef="cny">37485000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod contextRef="c0" decimals="-3" id="ixv-71098" unitRef="usd">5360000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <ifrs-full:DisclosureOfPerformanceObligationsExplanatory contextRef="c0" id="ixv-44019">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amounts of transaction prices allocated to the remaining performance obligations (unsatisfied or partially unsatisfied) as at December
31, 2024 and 2025 are as follows:&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amounts expected to be recognized as revenue:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within
    one year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
    one year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;248,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;210,224&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;285,945&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;247,709&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfPerformanceObligationsExplanatory>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="c170"
      decimals="-3"
      id="ixv-71099"
      unitRef="cny">37485000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="c171"
      decimals="-3"
      id="ixv-71100"
      unitRef="cny">37485000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="c171"
      decimals="-3"
      id="ixv-71101"
      unitRef="usd">5360000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="c172"
      decimals="-3"
      id="ixv-71102"
      unitRef="cny">248460000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="c173"
      decimals="-3"
      id="ixv-71103"
      unitRef="cny">210224000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="c173"
      decimals="-3"
      id="ixv-71104"
      unitRef="usd">30062000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations contextRef="c14" decimals="-3" id="ixv-71105" unitRef="cny">285945000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations contextRef="c15" decimals="-3" id="ixv-71106" unitRef="cny">247709000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations contextRef="c15" decimals="-3" id="ixv-71107" unitRef="usd">35422000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory contextRef="c0" id="ixv-44232">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Other
income and gains&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank
    interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,409&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,840&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,744&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government grants related
    to income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,496&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign exchange gain, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,621&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,694&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rental income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,989&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value gain on derivative
    financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,822&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gain
    on disposal of items of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,702&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,428&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,885&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    other income and gains&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;59,316&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,359&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;103,495&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,800&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory>
    <ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks contextRef="c12" decimals="-3" id="ixv-71108" unitRef="cny">32409000</ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks>
    <ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks contextRef="c13" decimals="-3" id="ixv-71109" unitRef="cny">37840000</ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks>
    <ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks contextRef="c0" decimals="-3" id="ixv-71110" unitRef="cny">82125000</ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks>
    <ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks contextRef="c0" decimals="-3" id="ixv-71111" unitRef="usd">11744000</ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c12" decimals="-3" id="ixv-71112" unitRef="cny">19358000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c13" decimals="-3" id="ixv-71113" unitRef="cny">9073000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c0" decimals="-3" id="ixv-71114" unitRef="cny">14496000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c0" decimals="-3" id="ixv-71115" unitRef="usd">2073000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:NetForeignExchangeGain contextRef="c12" decimals="-3" id="ixv-71116" unitRef="cny">1621000</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:NetForeignExchangeGain contextRef="c13" decimals="-3" id="ixv-71117" unitRef="cny">6694000</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:RentalIncome contextRef="c12" decimals="-3" id="ixv-71118" unitRef="cny">400000</ifrs-full:RentalIncome>
    <ifrs-full:RentalIncome contextRef="c13" decimals="-3" id="ixv-71119" unitRef="cny">2324000</ifrs-full:RentalIncome>
    <ifrs-full:RentalIncome contextRef="c0" decimals="-3" id="ixv-71120" unitRef="cny">4989000</ifrs-full:RentalIncome>
    <ifrs-full:RentalIncome contextRef="c0" decimals="-3" id="ixv-71121" unitRef="usd">713000</ifrs-full:RentalIncome>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives contextRef="c12" decimals="-3" id="ixv-71122" unitRef="cny">2822000</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment contextRef="c12" decimals="-3" id="ixv-71123" unitRef="cny">4000</ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:OtherGainsLosses contextRef="c12" decimals="-3" id="ixv-71124" unitRef="cny">2702000</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherGainsLosses contextRef="c13" decimals="-3" id="ixv-71125" unitRef="cny">1428000</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherGainsLosses contextRef="c0" decimals="-3" id="ixv-71126" unitRef="cny">1885000</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherGainsLosses contextRef="c0" decimals="-3" id="ixv-71127" unitRef="usd">270000</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherIncome contextRef="c12" decimals="-3" id="ixv-71128" unitRef="cny">59316000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c13" decimals="-3" id="ixv-71129" unitRef="cny">57359000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c0" decimals="-3" id="ixv-71130" unitRef="cny">103495000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome contextRef="c0" decimals="-3" id="ixv-71131" unitRef="usd">14800000</ifrs-full:OtherIncome>
    <aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock contextRef="c0" id="ixv-44683">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;LOSS
                                            BEFORE TAX&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s loss before tax is arrived at after charging/(crediting):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 40%; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
    of inventories sold&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,342&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,031&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;42,481&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,074&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
    of services provided&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,201&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,054&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,277&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;326&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Write-down
    of inventories to net realizable value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-223"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;598&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
    of property, plant and equipment**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,281&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,184&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,761&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,404&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
    of investment property**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,883&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-224"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-225"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-226"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
    of right-of-use assets**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,632&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,657&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
    of intangible assets**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,851&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,062&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
    and development costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;706,972&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;947,245&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,137,448&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;162,653&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employee
    benefit expense (including directors&#x2019; remuneration):&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wages
    and salaries&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;337,381&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;367,008&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;404,195&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,799&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    share-based payment expenses**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,503&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,924&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,874&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,985&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pension
    scheme contributions (defined contribution scheme)*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;34,404&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,234&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;399,589&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;422,336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;460,303&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,822&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value (gain)/loss, net:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Derivative
    financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,822&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-227"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-228"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-229"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;699&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;832&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-230"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-231"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,533&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,223&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Gain)/Loss
    on disposal of items of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gain
    on disposal of items of lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-232"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(85&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(685&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(99&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    payments not included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;181&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;329&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government
    grants related to income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(19,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,496&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank
    interest income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(32,409&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(37,840&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(82,125&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,744&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Auditors&#x2019;
    remuneration&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,550&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;729&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Donations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,988&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,322&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,395&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,345&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Penalty&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,425&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,777&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;826&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
    exchange (gain)/loss, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,621&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6,694&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,161&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There are no forfeited contributions that may be used by the Group as the employer to reduce the existing level of contributions.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The depreciation of property, plant and equipment, the depreciation of investment property, the depreciation of right-of-use assets, the amortization of intangible assets and the equity-settled share-based payment expenses for the years are included in &#x201c;Cost of Sales&#x201d;, &#x201c;Research and development expenses&#x201d;, &#x201c;Selling and distribution expenses&#x201d; and &#x201c;Administrative expenses&#x201d; in the consolidated statements of profit or loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</aapg:DisclosureOfLossBeforeTaxExplanatoryTextBlock>
    <aapg:DisclosureOfLossBeforeTaxExplanatoryTableTextBlock contextRef="c0" id="ixv-44693">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s loss before tax is arrived at after charging/(crediting):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 40%; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
    of inventories sold&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,342&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,031&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;42,481&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,074&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
    of services provided&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,201&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,054&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,277&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;326&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Write-down
    of inventories to net realizable value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-223"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,180&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;598&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
    of property, plant and equipment**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,281&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,184&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,761&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,404&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
    of investment property**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,883&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-224"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-225"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-226"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
    of right-of-use assets**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,632&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,657&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
    of intangible assets**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,851&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,062&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
    and development costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;706,972&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;947,245&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,137,448&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;162,653&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employee
    benefit expense (including directors&#x2019; remuneration):&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wages
    and salaries&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;337,381&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;367,008&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;404,195&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,799&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    share-based payment expenses**&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,503&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,924&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,874&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,985&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pension
    scheme contributions (defined contribution scheme)*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;34,404&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,234&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;399,589&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;422,336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;460,303&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,822&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value (gain)/loss, net:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Derivative
    financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,822&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-227"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-228"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-229"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;699&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;832&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-230"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-231"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,533&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,223&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Gain)/Loss
    on disposal of items of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gain
    on disposal of items of lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-232"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(85&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(685&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(99&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    payments not included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;181&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;329&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government
    grants related to income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(19,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,496&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank
    interest income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(32,409&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(37,840&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(82,125&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,744&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Auditors&#x2019;
    remuneration&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,550&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;729&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Donations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,988&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,322&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,395&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,345&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Penalty&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,425&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,777&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;826&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
    exchange (gain)/loss, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,621&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6,694&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,161&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.2pt 0pt 0.9in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There are no forfeited contributions that may be used by the Group as the employer to reduce the existing level of contributions.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: left"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The depreciation of property, plant and equipment, the depreciation of investment property, the depreciation of right-of-use assets, the amortization of intangible assets and the equity-settled share-based payment expenses for the years are included in &#x201c;Cost of Sales&#x201d;, &#x201c;Research and development expenses&#x201d;, &#x201c;Selling and distribution expenses&#x201d; and &#x201c;Administrative expenses&#x201d; in the consolidated statements of profit or loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</aapg:DisclosureOfLossBeforeTaxExplanatoryTableTextBlock>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod contextRef="c12" decimals="-3" id="ixv-71132" unitRef="cny">29342000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod contextRef="c13" decimals="-3" id="ixv-71133" unitRef="cny">27031000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod contextRef="c0" decimals="-3" id="ixv-71134" unitRef="cny">42481000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod contextRef="c0" decimals="-3" id="ixv-71135" unitRef="usd">6074000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <ifrs-full:CostOfSalesRoomOccupancyServices contextRef="c12" decimals="-3" id="ixv-71136" unitRef="cny">1201000</ifrs-full:CostOfSalesRoomOccupancyServices>
    <ifrs-full:CostOfSalesRoomOccupancyServices contextRef="c13" decimals="-3" id="ixv-71137" unitRef="cny">2054000</ifrs-full:CostOfSalesRoomOccupancyServices>
    <ifrs-full:CostOfSalesRoomOccupancyServices contextRef="c0" decimals="-3" id="ixv-71138" unitRef="cny">2277000</ifrs-full:CostOfSalesRoomOccupancyServices>
    <ifrs-full:CostOfSalesRoomOccupancyServices contextRef="c0" decimals="-3" id="ixv-71139" unitRef="usd">326000</ifrs-full:CostOfSalesRoomOccupancyServices>
    <ifrs-full:InventoryWritedown2011 contextRef="c0" decimals="-3" id="ixv-71140" unitRef="cny">4180000</ifrs-full:InventoryWritedown2011>
    <ifrs-full:InventoryWritedown2011 contextRef="c0" decimals="-3" id="ixv-71141" unitRef="usd">598000</ifrs-full:InventoryWritedown2011>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="c12"
      decimals="-3"
      id="ix_24_fact"
      unitRef="cny">55281000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="c13"
      decimals="-3"
      id="ix_25_fact"
      unitRef="cny">71184000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c0" decimals="-3" id="ix_26_fact" unitRef="cny">65761000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c0" decimals="-3" id="ix_27_fact" unitRef="usd">9404000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty
      contextRef="c12"
      decimals="-3"
      id="ix_28_fact"
      unitRef="cny">-15883000</ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty>
    <ifrs-full:DepreciationExpense
      contextRef="c12"
      decimals="-3"
      id="ix_29_fact"
      unitRef="cny">11632000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="c13"
      decimals="-3"
      id="ix_30_fact"
      unitRef="cny">11134000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c0" decimals="-3" id="ix_31_fact" unitRef="cny">10657000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c0" decimals="-3" id="ix_32_fact" unitRef="usd">1524000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c12"
      decimals="-3"
      id="ix_33_fact"
      unitRef="cny">10399000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c13"
      decimals="-3"
      id="ix_34_fact"
      unitRef="cny">10851000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="-3" id="ix_35_fact" unitRef="cny">10062000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="-3" id="ix_36_fact" unitRef="usd">1439000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c12" decimals="-3" id="ixv-71155" unitRef="cny">706972000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c13" decimals="-3" id="ixv-71156" unitRef="cny">947245000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-71157" unitRef="cny">1137448000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-71158" unitRef="usd">162653000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:WagesAndSalaries contextRef="c12" decimals="-3" id="ixv-71159" unitRef="cny">337381000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries contextRef="c13" decimals="-3" id="ixv-71160" unitRef="cny">367008000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries contextRef="c0" decimals="-3" id="ixv-71161" unitRef="cny">404195000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries contextRef="c0" decimals="-3" id="ixv-71162" unitRef="usd">57799000</ifrs-full:WagesAndSalaries>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="c12"
      decimals="-3"
      id="ix_37_fact"
      unitRef="cny">31503000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="c13"
      decimals="-3"
      id="ix_38_fact"
      unitRef="cny">20924000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c0" decimals="-3" id="ix_39_fact" unitRef="cny">20874000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c0" decimals="-3" id="ix_40_fact" unitRef="usd">2985000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="c12"
      decimals="-3"
      id="ix_20_fact"
      unitRef="cny">30705000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="c13"
      decimals="-3"
      id="ix_21_fact"
      unitRef="cny">34404000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="c0" decimals="-3" id="ix_22_fact" unitRef="cny">35234000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="c0" decimals="-3" id="ix_23_fact" unitRef="usd">5038000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <aapg:LossBeforeTaxArrivedCharingOrCrediting contextRef="c12" decimals="-3" id="ixv-71171" unitRef="cny">399589000</aapg:LossBeforeTaxArrivedCharingOrCrediting>
    <aapg:LossBeforeTaxArrivedCharingOrCrediting contextRef="c13" decimals="-3" id="ixv-71172" unitRef="cny">422336000</aapg:LossBeforeTaxArrivedCharingOrCrediting>
    <aapg:LossBeforeTaxArrivedCharingOrCrediting contextRef="c0" decimals="-3" id="ixv-71173" unitRef="cny">460303000</aapg:LossBeforeTaxArrivedCharingOrCrediting>
    <aapg:LossBeforeTaxArrivedCharingOrCrediting contextRef="c0" decimals="-3" id="ixv-71174" unitRef="usd">65822000</aapg:LossBeforeTaxArrivedCharingOrCrediting>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives contextRef="c12" decimals="-3" id="ixv-71175" unitRef="cny">2822000</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives>
    <aapg:FinancialAssetsAtFVTPL contextRef="c12" decimals="-3" id="ixv-71176" unitRef="cny">699000</aapg:FinancialAssetsAtFVTPL>
    <aapg:FinancialAssetsAtFVTPL contextRef="c13" decimals="-3" id="ixv-71177" unitRef="cny">832000</aapg:FinancialAssetsAtFVTPL>
    <aapg:FinancialAssetsAtFVTPL contextRef="c0" decimals="-3" id="ixv-71178" unitRef="cny">1134000</aapg:FinancialAssetsAtFVTPL>
    <aapg:FinancialAssetsAtFVTPL contextRef="c0" decimals="-3" id="ixv-71179" unitRef="usd">162000</aapg:FinancialAssetsAtFVTPL>
    <aapg:FinancialLiabilitiesAtFVTPL contextRef="c0" decimals="-3" id="ixv-71180" unitRef="cny">29533000</aapg:FinancialLiabilitiesAtFVTPL>
    <aapg:FinancialLiabilitiesAtFVTPL contextRef="c0" decimals="-3" id="ixv-71181" unitRef="usd">4223000</aapg:FinancialLiabilitiesAtFVTPL>
    <ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment contextRef="c12" decimals="-3" id="ixv-71182" unitRef="cny">4000</ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment contextRef="c13" decimals="-3" id="ixv-71183" unitRef="cny">-50000</ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-71184" unitRef="cny">-18000</ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-71185" unitRef="usd">-3000</ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment>
    <aapg:AdjustmentsForGainOnDisposalOfLeases contextRef="c13" decimals="-3" id="ixv-71186" unitRef="cny">85000</aapg:AdjustmentsForGainOnDisposalOfLeases>
    <aapg:AdjustmentsForGainOnDisposalOfLeases contextRef="c0" decimals="-3" id="ixv-71187" unitRef="cny">685000</aapg:AdjustmentsForGainOnDisposalOfLeases>
    <aapg:AdjustmentsForGainOnDisposalOfLeases contextRef="c0" decimals="-3" id="ixv-71188" unitRef="usd">99000</aapg:AdjustmentsForGainOnDisposalOfLeases>
    <aapg:PenaltyExpense contextRef="c12" decimals="-3" id="ixv-71189" unitRef="cny">181000</aapg:PenaltyExpense>
    <aapg:PenaltyExpense contextRef="c13" decimals="-3" id="ixv-71190" unitRef="cny">238000</aapg:PenaltyExpense>
    <aapg:PenaltyExpense contextRef="c0" decimals="-3" id="ixv-71191" unitRef="cny">329000</aapg:PenaltyExpense>
    <aapg:PenaltyExpense contextRef="c0" decimals="-3" id="ixv-71192" unitRef="usd">47000</aapg:PenaltyExpense>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c12" decimals="-3" id="ixv-71193" unitRef="cny">19358000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c13" decimals="-3" id="ixv-71194" unitRef="cny">9073000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c0" decimals="-3" id="ixv-71195" unitRef="cny">14496000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c0" decimals="-3" id="ixv-71196" unitRef="usd">2073000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks contextRef="c12" decimals="-3" id="ixv-71197" unitRef="cny">32409000</ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks>
    <ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks contextRef="c13" decimals="-3" id="ixv-71198" unitRef="cny">37840000</ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks>
    <ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks contextRef="c0" decimals="-3" id="ixv-71199" unitRef="cny">82125000</ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks>
    <ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks contextRef="c0" decimals="-3" id="ixv-71200" unitRef="usd">11744000</ifrs-full:InterestIncomeOnLoansAndAdvancesToBanks>
    <ifrs-full:AuditorsRemuneration contextRef="c12" decimals="-3" id="ixv-71201" unitRef="cny">2550000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration contextRef="c13" decimals="-3" id="ixv-71202" unitRef="cny">7900000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration contextRef="c0" decimals="-3" id="ixv-71203" unitRef="cny">5100000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:AuditorsRemuneration contextRef="c0" decimals="-3" id="ixv-71204" unitRef="usd">729000</ifrs-full:AuditorsRemuneration>
    <ifrs-full:DonationsAndSubsidiesExpense contextRef="c12" decimals="-3" id="ixv-71205" unitRef="cny">3988000</ifrs-full:DonationsAndSubsidiesExpense>
    <ifrs-full:DonationsAndSubsidiesExpense contextRef="c13" decimals="-3" id="ixv-71206" unitRef="cny">6322000</ifrs-full:DonationsAndSubsidiesExpense>
    <ifrs-full:DonationsAndSubsidiesExpense contextRef="c0" decimals="-3" id="ixv-71207" unitRef="cny">23395000</ifrs-full:DonationsAndSubsidiesExpense>
    <ifrs-full:DonationsAndSubsidiesExpense contextRef="c0" decimals="-3" id="ixv-71208" unitRef="usd">3345000</ifrs-full:DonationsAndSubsidiesExpense>
    <aapg:Penaltys contextRef="c12" decimals="-3" id="ixv-71209" unitRef="cny">24000</aapg:Penaltys>
    <aapg:Penaltys contextRef="c13" decimals="-3" id="ixv-71210" unitRef="cny">1425000</aapg:Penaltys>
    <aapg:Penaltys contextRef="c0" decimals="-3" id="ixv-71211" unitRef="cny">5777000</aapg:Penaltys>
    <aapg:Penaltys contextRef="c0" decimals="-3" id="ixv-71212" unitRef="usd">826000</aapg:Penaltys>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c12" decimals="-3" id="ixv-71213" unitRef="cny">-1621000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c13" decimals="-3" id="ixv-71214" unitRef="cny">-6694000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c0" decimals="-3" id="ixv-71215" unitRef="cny">10161000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c0" decimals="-3" id="ixv-71216" unitRef="usd">1453000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory contextRef="c0" id="ixv-45989">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;OTHER
                                            EXPENSES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value loss
    on financial liabilities at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,533&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,223&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Donations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,988&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,322&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,395&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,345&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,161&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Penalty&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; text-decoration: none; font-weight: normal; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-237"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none"&gt;2&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,425&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,777&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;827&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value loss on financial assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;699&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;832&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    on disposal of items of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;492&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;446&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;512&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,203&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,075&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;73,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,525&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory>
    <aapg:ScheduleOfOtherExpensesTableTextBlock contextRef="c0" id="ixv-46000">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value loss
    on financial liabilities at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,533&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,223&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Donations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,988&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,322&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,395&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,345&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,161&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Penalty&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; text-decoration: none; font-weight: normal; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-237"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none"&gt;2&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,425&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,777&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;827&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value loss on financial assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;699&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;832&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    on disposal of items of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;492&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;446&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;512&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,203&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,075&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;73,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,525&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfOtherExpensesTableTextBlock>
    <ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c0" decimals="-3" id="ixv-71217" unitRef="cny">-29533000</ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c0" decimals="-3" id="ixv-71218" unitRef="usd">-4223000</ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:DonationsAndSubsidiesExpense contextRef="c12" decimals="-3" id="ixv-71219" unitRef="cny">3988000</ifrs-full:DonationsAndSubsidiesExpense>
    <ifrs-full:DonationsAndSubsidiesExpense contextRef="c13" decimals="-3" id="ixv-71220" unitRef="cny">6322000</ifrs-full:DonationsAndSubsidiesExpense>
    <ifrs-full:DonationsAndSubsidiesExpense contextRef="c0" decimals="-3" id="ixv-71221" unitRef="cny">23395000</ifrs-full:DonationsAndSubsidiesExpense>
    <ifrs-full:DonationsAndSubsidiesExpense contextRef="c0" decimals="-3" id="ixv-71222" unitRef="usd">3345000</ifrs-full:DonationsAndSubsidiesExpense>
    <ifrs-full:ForeignExchangeLoss contextRef="c0" decimals="-3" id="ixv-71223" unitRef="cny">10161000</ifrs-full:ForeignExchangeLoss>
    <ifrs-full:ForeignExchangeLoss contextRef="c0" decimals="-3" id="ixv-71224" unitRef="usd">1453000</ifrs-full:ForeignExchangeLoss>
    <aapg:Penalty contextRef="c13" decimals="-3" id="ixv-71225" unitRef="cny">1425000</aapg:Penalty>
    <aapg:Penalty contextRef="c0" decimals="-3" id="ixv-71226" unitRef="cny">5777000</aapg:Penalty>
    <aapg:Penalty contextRef="c0" decimals="-3" id="ixv-71227" unitRef="usd">827000</aapg:Penalty>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss contextRef="c12" decimals="-3" id="ixv-71228" unitRef="cny">699000</ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss contextRef="c13" decimals="-3" id="ixv-71229" unitRef="cny">832000</ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss contextRef="c0" decimals="-3" id="ixv-71230" unitRef="cny">1134000</ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss contextRef="c0" decimals="-3" id="ixv-71231" unitRef="usd">162000</ifrs-full:AdjustmentsForDecreaseIncreaseInFinancialAssetsMeasuredAtFairValueThroughProfitOrLoss>
    <ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment contextRef="c13" decimals="-3" id="ixv-71232" unitRef="cny">50000</ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-71233" unitRef="cny">18000</ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-71234" unitRef="usd">3000</ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment>
    <aapg:OthersExpenses contextRef="c12" decimals="-3" id="ixv-71235" unitRef="cny">492000</aapg:OthersExpenses>
    <aapg:OthersExpenses contextRef="c13" decimals="-3" id="ixv-71236" unitRef="cny">446000</aapg:OthersExpenses>
    <aapg:OthersExpenses contextRef="c0" decimals="-3" id="ixv-71237" unitRef="cny">3581000</aapg:OthersExpenses>
    <aapg:OthersExpenses contextRef="c0" decimals="-3" id="ixv-71238" unitRef="usd">512000</aapg:OthersExpenses>
    <ifrs-full:OtherExpenseByNature contextRef="c12" decimals="-3" id="ixv-71239" unitRef="cny">5203000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="c13" decimals="-3" id="ixv-71240" unitRef="cny">9075000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="c0" decimals="-3" id="ixv-71241" unitRef="cny">73599000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="c0" decimals="-3" id="ixv-71242" unitRef="usd">10525000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory contextRef="c0" id="ixv-46413">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;i&gt;.&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FINANCE
                                            COSTS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
analysis of finance costs is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    on bank loans and other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,690&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;61,555&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;51,812&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,409&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    on lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    on long-term payables&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,046&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,402&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,140&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;163&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;96,057&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;64,455&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,070&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,732&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <ifrs-full:DisclosureOfFinanceCostExplanatory contextRef="c0" id="ixv-46424">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
analysis of finance costs is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    on bank loans and other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,690&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;61,555&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;51,812&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,409&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    on lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    on long-term payables&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,046&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,402&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,140&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;163&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;96,057&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;64,455&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,070&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,732&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinanceCostExplanatory>
    <ifrs-full:InterestExpenseOnBankLoansAndOverdrafts contextRef="c12" decimals="-3" id="ixv-71243" unitRef="cny">91690000</ifrs-full:InterestExpenseOnBankLoansAndOverdrafts>
    <ifrs-full:InterestExpenseOnBankLoansAndOverdrafts contextRef="c13" decimals="-3" id="ixv-71244" unitRef="cny">61555000</ifrs-full:InterestExpenseOnBankLoansAndOverdrafts>
    <ifrs-full:InterestExpenseOnBankLoansAndOverdrafts contextRef="c0" decimals="-3" id="ixv-71245" unitRef="cny">51812000</ifrs-full:InterestExpenseOnBankLoansAndOverdrafts>
    <ifrs-full:InterestExpenseOnBankLoansAndOverdrafts contextRef="c0" decimals="-3" id="ixv-71246" unitRef="usd">7409000</ifrs-full:InterestExpenseOnBankLoansAndOverdrafts>
    <ifrs-full:InterestCostsCapitalised contextRef="c12" decimals="-3" id="ixv-71247" unitRef="cny">1321000</ifrs-full:InterestCostsCapitalised>
    <ifrs-full:InterestCostsCapitalised contextRef="c13" decimals="-3" id="ixv-71248" unitRef="cny">1498000</ifrs-full:InterestCostsCapitalised>
    <ifrs-full:InterestCostsCapitalised contextRef="c0" decimals="-3" id="ixv-71249" unitRef="cny">1118000</ifrs-full:InterestCostsCapitalised>
    <ifrs-full:InterestCostsCapitalised contextRef="c0" decimals="-3" id="ixv-71250" unitRef="usd">160000</ifrs-full:InterestCostsCapitalised>
    <ifrs-full:InterestExpenseOnBorrowings contextRef="c12" decimals="-3" id="ixv-71251" unitRef="cny">3046000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings contextRef="c13" decimals="-3" id="ixv-71252" unitRef="cny">1402000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings contextRef="c0" decimals="-3" id="ixv-71253" unitRef="cny">1140000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings contextRef="c0" decimals="-3" id="ixv-71254" unitRef="usd">163000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:FinanceCosts contextRef="c12" decimals="-3" id="ixv-71255" unitRef="cny">96057000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c13" decimals="-3" id="ixv-71256" unitRef="cny">64455000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c0" decimals="-3" id="ixv-71257" unitRef="cny">54070000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c0" decimals="-3" id="ixv-71258" unitRef="usd">7732000</ifrs-full:FinanceCosts>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="c0" id="ixv-46734">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;INCOME
                                            TAX&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group is subject to income tax on an entity basis on profits arising in or derived from the jurisdictions in which members of the Group
are domiciled and operate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Cayman
Islands&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the current laws of the Cayman Islands, the Company and Ascentage Pharma Group International are not subject to tax on income or capital
gain arising in the Cayman Islands. Additionally, upon payments of dividends by these companies to its shareholders, no Cayman Islands
withholding tax will be imposed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Hong
Kong&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
subsidiaries incorporated in Hong Kong are subject to income tax at the rate of 16.5% on the estimated assessable profits arising in
Hong Kong. For the years ended December 31, 2023, 2024 and 2025, the Company did not make any provisions for Hong Kong profits tax as
there were no assessable profits derived from or earned in Hong Kong for any of the periods presented.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;United
States&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
subsidiary operating in the United States is subject to tax at a maximum of 21.36% and 21.61%, respectively, for the years ended December
31, 2024 and 2025. No provision for income tax has been made as the Group had no assessable profits earned in the United States during
the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
requirement to capitalize and amortize previously deductible research and experimental expenses resulting from a change in Section 174
made by the Tax Cuts and Jobs Act of 2017 (the &#x201c;TCJA&#x201d;) became effective on January 1, 2022. Under the TCJA, the Company is
required to capitalize and subsequently amortize R&amp;amp;D expenses over five years for research activities conducted within the U.S. and
fifteen years for research activities conducted outside of the U.S.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2025, the One Big Beautiful Bill Act (&#x201c;OBBBA&#x201d;) was enacted, which reinstated current deductibility of domestic research
and experimental expenditures and provided an election to accelerate the recovery of previously capitalized costs. The Company did not
elect to accelerate the deduction of previously capitalized domestic research and experimental expenditures and will continue to amortize
such costs over the remaining statutory periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Chinese
mainland&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 50.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s subsidiaries domiciled in the PRC are subject to the statutory rate of 25%, in accordance with the Enterprise Income
Tax law (the &#x201c;EIT Law&#x201d;), which was effective since January 1, 2008, except for the following entities which are eligible
for a preferential tax rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Healthquest
Pharma was qualified as a High and New Technology Enterprise (&#x201c;HNTE&#x201d;) and was subject to a preferential rate of 15% for three
years from 2022 to 2024. In 2025, Healthquest Pharma was no longer qualified as a HNTE and thus subject to the statutory tax rate of
25%.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Suzhou
Yasheng was recognized as a qualified HNTE under the EIT Law by the relevant government authorities and is subject to a preferential
rate of 15% for three years from 2023 to 2025.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividends,
interest, rent or royalties payable by the Company&#x2019;s PRC subsidiaries, to non-PRC resident enterprises, and proceeds from any such
non-resident enterprise investor&#x2019;s disposition of assets (after deducting the net value of such assets) shall be subject to 10%
withholding tax, unless the respective non-PRC resident enterprise&#x2019;s jurisdiction of incorporation has a tax treaty or arrangements
with China that provides for a reduced withholding tax rate or an exemption from withholding tax.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
current and deferred components of the income tax (credit)/expense are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    (note 18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,150&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,425&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,911&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;988&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
                                            income tax (credit)/expense for the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,150&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,425&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,940&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reconciliation
between the income tax expense/(credit) computed by applying the statutory tax rate to loss before income tax and the actual provision
for income tax is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss
    before tax&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(932,862&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(395,255&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,236,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(176,753&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax computed at the statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(244,549&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(70,114&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(287,881&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(41,166&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lower
    tax rate for a specific entity&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59,396&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,112&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59,759&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory
    income and expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,824&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,534&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(12,900&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,845&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Items
    not subject to tax&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,093&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,236&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,533&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,076&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Items
    not deductible for tax&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,192&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24,045&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,582&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,091&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research
    and development super-deduction&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(67,525&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(75,135&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(48,919&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,995&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Gain)/loss
    attributable to joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(269&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(78&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision
    to return&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,311&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(35,342&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;68,391&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,779&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effect
    of tax rate changes on deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(56,104&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,822&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(71,206&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,183&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Uncertain
    tax position&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,665&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,236&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,036&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effect
    of withholding tax on the interest income of the Group&#x2019;s HK subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-243; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tax
    loss expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-244; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,670&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,628&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,237&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deductible
    temporary differences not recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,235&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,465&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,919&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,138&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tax
    losses not recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;237,432&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;68,580&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;163,913&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,438&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax (credit)/expense at the Group&#x2019;s effective rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,150&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,425&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,940&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note:&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;p style="margin: 0pt 0"&gt;The disclosure &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;presentation of previous
periods has been adjusted to be in line with the 2025 disclosure presentation of &#x201c;Tax loss expired&#x201d; to ensure consistency.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:ApplicableTaxRate
      contextRef="c174"
      decimals="3"
      id="ixv-71259"
      unitRef="pure">0.165</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="c175"
      decimals="3"
      id="ixv-71260"
      unitRef="pure">0.165</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="c176"
      decimals="3"
      id="ixv-71261"
      unitRef="pure">0.165</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate contextRef="c0" decimals="3" id="ixv-71262" unitRef="pure">0.165</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="c175"
      decimals="3"
      id="ixv-71263"
      unitRef="pure">0.165</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="c176"
      decimals="3"
      id="ixv-71264"
      unitRef="pure">0.165</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="c177"
      decimals="4"
      id="ixv-71265"
      unitRef="pure">0.2136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="c177"
      decimals="4"
      id="ixv-71266"
      unitRef="pure">0.2136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="c178"
      decimals="4"
      id="ixv-71267"
      unitRef="pure">0.2161</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="c112"
      decimals="2"
      id="ixv-71268"
      unitRef="pure">0.25</ifrs-full:ApplicableTaxRate>
    <aapg:PreferentialRate
      contextRef="c179"
      decimals="2"
      id="ixv-71269"
      unitRef="pure">0.15</aapg:PreferentialRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="c179"
      decimals="2"
      id="ixv-71270"
      unitRef="pure">0.25</ifrs-full:ApplicableTaxRate>
    <aapg:PreferentialRate
      contextRef="c180"
      decimals="2"
      id="ixv-71271"
      unitRef="pure">0.15</aapg:PreferentialRate>
    <aapg:WithholdingTax contextRef="c0" decimals="2" id="ixv-71272" unitRef="pure">0.10</aapg:WithholdingTax>
    <aapg:DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory contextRef="c0" id="ixv-46807">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
current and deferred components of the income tax (credit)/expense are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    (note 18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,150&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,425&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,911&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;988&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
                                            income tax (credit)/expense for the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,150&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,425&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,940&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfCurrentAndDeferredComponentsOfTheIncomeTaxExpenseCreditExplanatory>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c0" decimals="-3" id="ixv-71273" unitRef="cny">29000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c0" decimals="-3" id="ixv-71274" unitRef="usd">4000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c12" decimals="-3" id="ixv-71275" unitRef="cny">-7150000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c13" decimals="-3" id="ixv-71276" unitRef="cny">10425000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c0" decimals="-3" id="ixv-71277" unitRef="cny">6911000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c0" decimals="-3" id="ixv-71278" unitRef="usd">988000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c12" decimals="-3" id="ixv-71279" unitRef="cny">-7150000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c13" decimals="-3" id="ixv-71280" unitRef="cny">10425000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="-3" id="ixv-71281" unitRef="cny">6940000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="-3" id="ixv-71282" unitRef="usd">992000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <aapg:DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory contextRef="c0" id="ixv-47069">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reconciliation
between the income tax expense/(credit) computed by applying the statutory tax rate to loss before income tax and the actual provision
for income tax is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss
    before tax&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(932,862&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(395,255&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,236,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(176,753&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax computed at the statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(244,549&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(70,114&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(287,881&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(41,166&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lower
    tax rate for a specific entity&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59,396&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,112&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59,759&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory
    income and expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,824&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,534&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(12,900&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,845&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Items
    not subject to tax&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,093&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,236&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,533&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,076&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Items
    not deductible for tax&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,192&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24,045&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,582&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,091&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research
    and development super-deduction&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(67,525&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(75,135&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(48,919&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,995&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Gain)/loss
    attributable to joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(269&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(78&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision
    to return&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,311&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(35,342&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;68,391&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,779&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effect
    of tax rate changes on deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(56,104&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,822&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(71,206&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,183&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Uncertain
    tax position&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,665&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,236&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,036&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effect
    of withholding tax on the interest income of the Group&#x2019;s HK subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-243; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tax
    loss expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-244; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,670&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,628&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,237&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deductible
    temporary differences not recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,235&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,465&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,919&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,138&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tax
    losses not recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;237,432&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;68,580&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;163,913&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,438&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax (credit)/expense at the Group&#x2019;s effective rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,150&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,425&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,940&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfReconciliationBetweenTheIncomeTaxExpenseCreditExplanatory>
    <ifrs-full:ProfitLossBeforeTax contextRef="c12" decimals="-3" id="ixv-71283" unitRef="cny">-932862000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c13" decimals="-3" id="ixv-71284" unitRef="cny">-395255000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c0" decimals="-3" id="ixv-71285" unitRef="cny">-1236047000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c0" decimals="-3" id="ixv-71286" unitRef="usd">-176753000</ifrs-full:ProfitLossBeforeTax>
    <aapg:IncomeTaxComputedAtTheStatutoryTaxRate contextRef="c12" decimals="-3" id="ixv-71287" unitRef="cny">244549000</aapg:IncomeTaxComputedAtTheStatutoryTaxRate>
    <aapg:IncomeTaxComputedAtTheStatutoryTaxRate contextRef="c13" decimals="-3" id="ixv-71288" unitRef="cny">70114000</aapg:IncomeTaxComputedAtTheStatutoryTaxRate>
    <aapg:IncomeTaxComputedAtTheStatutoryTaxRate contextRef="c0" decimals="-3" id="ixv-71289" unitRef="cny">287881000</aapg:IncomeTaxComputedAtTheStatutoryTaxRate>
    <aapg:IncomeTaxComputedAtTheStatutoryTaxRate contextRef="c0" decimals="-3" id="ixv-71290" unitRef="usd">41166000</aapg:IncomeTaxComputedAtTheStatutoryTaxRate>
    <aapg:LowerTaxRateForASpecificEntity contextRef="c12" decimals="-3" id="ixv-71291" unitRef="cny">59396000</aapg:LowerTaxRateForASpecificEntity>
    <aapg:LowerTaxRateForASpecificEntity contextRef="c13" decimals="-3" id="ixv-71292" unitRef="cny">7112000</aapg:LowerTaxRateForASpecificEntity>
    <aapg:LowerTaxRateForASpecificEntity contextRef="c0" decimals="-3" id="ixv-71293" unitRef="cny">59759000</aapg:LowerTaxRateForASpecificEntity>
    <aapg:LowerTaxRateForASpecificEntity contextRef="c0" decimals="-3" id="ixv-71294" unitRef="usd">8545000</aapg:LowerTaxRateForASpecificEntity>
    <aapg:StatutoryIncomeAndExpense contextRef="c12" decimals="-3" id="ixv-71295" unitRef="cny">-2824000</aapg:StatutoryIncomeAndExpense>
    <aapg:StatutoryIncomeAndExpense contextRef="c13" decimals="-3" id="ixv-71296" unitRef="cny">17534000</aapg:StatutoryIncomeAndExpense>
    <aapg:StatutoryIncomeAndExpense contextRef="c0" decimals="-3" id="ixv-71297" unitRef="cny">12900000</aapg:StatutoryIncomeAndExpense>
    <aapg:StatutoryIncomeAndExpense contextRef="c0" decimals="-3" id="ixv-71298" unitRef="usd">1845000</aapg:StatutoryIncomeAndExpense>
    <aapg:IncomeNotSubjectToTax contextRef="c12" decimals="-3" id="ixv-71299" unitRef="cny">4093000</aapg:IncomeNotSubjectToTax>
    <aapg:IncomeNotSubjectToTax contextRef="c13" decimals="-3" id="ixv-71300" unitRef="cny">7236000</aapg:IncomeNotSubjectToTax>
    <aapg:IncomeNotSubjectToTax contextRef="c0" decimals="-3" id="ixv-71301" unitRef="cny">7533000</aapg:IncomeNotSubjectToTax>
    <aapg:IncomeNotSubjectToTax contextRef="c0" decimals="-3" id="ixv-71302" unitRef="usd">1076000</aapg:IncomeNotSubjectToTax>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c12" decimals="-3" id="ixv-71303" unitRef="cny">9192000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c13" decimals="-3" id="ixv-71304" unitRef="cny">24045000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c0" decimals="-3" id="ixv-71305" unitRef="cny">49582000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c0" decimals="-3" id="ixv-71306" unitRef="usd">7091000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <aapg:ResearchAndDevelopmentSuperdeduction contextRef="c12" decimals="-3" id="ixv-71307" unitRef="cny">67525000</aapg:ResearchAndDevelopmentSuperdeduction>
    <aapg:ResearchAndDevelopmentSuperdeduction contextRef="c13" decimals="-3" id="ixv-71308" unitRef="cny">75135000</aapg:ResearchAndDevelopmentSuperdeduction>
    <aapg:ResearchAndDevelopmentSuperdeduction contextRef="c0" decimals="-3" id="ixv-71309" unitRef="cny">48919000</aapg:ResearchAndDevelopmentSuperdeduction>
    <aapg:ResearchAndDevelopmentSuperdeduction contextRef="c0" decimals="-3" id="ixv-71310" unitRef="usd">6995000</aapg:ResearchAndDevelopmentSuperdeduction>
    <aapg:GainlossAttributableToJointVentures contextRef="c12" decimals="-3" id="ixv-71311" unitRef="cny">269000</aapg:GainlossAttributableToJointVentures>
    <aapg:GainlossAttributableToJointVentures contextRef="c13" decimals="-3" id="ixv-71312" unitRef="cny">-71000</aapg:GainlossAttributableToJointVentures>
    <aapg:GainlossAttributableToJointVentures contextRef="c0" decimals="-3" id="ixv-71313" unitRef="cny">78000</aapg:GainlossAttributableToJointVentures>
    <aapg:GainlossAttributableToJointVentures contextRef="c0" decimals="-3" id="ixv-71314" unitRef="usd">11000</aapg:GainlossAttributableToJointVentures>
    <aapg:NewProvisionsReturn contextRef="c12" decimals="-3" id="ixv-71315" unitRef="cny">-23311000</aapg:NewProvisionsReturn>
    <aapg:NewProvisionsReturn contextRef="c13" decimals="-3" id="ixv-71316" unitRef="cny">35342000</aapg:NewProvisionsReturn>
    <aapg:NewProvisionsReturn contextRef="c0" decimals="-3" id="ixv-71317" unitRef="cny">-68391000</aapg:NewProvisionsReturn>
    <aapg:NewProvisionsReturn contextRef="c0" decimals="-3" id="ixv-71318" unitRef="usd">-9779000</aapg:NewProvisionsReturn>
    <ifrs-full:TaxEffectFromChangeInTaxRate contextRef="c12" decimals="-3" id="ixv-71319" unitRef="cny">-56104000</ifrs-full:TaxEffectFromChangeInTaxRate>
    <ifrs-full:TaxEffectFromChangeInTaxRate contextRef="c13" decimals="-3" id="ixv-71320" unitRef="cny">-10822000</ifrs-full:TaxEffectFromChangeInTaxRate>
    <ifrs-full:TaxEffectFromChangeInTaxRate contextRef="c0" decimals="-3" id="ixv-71321" unitRef="cny">-71206000</ifrs-full:TaxEffectFromChangeInTaxRate>
    <ifrs-full:TaxEffectFromChangeInTaxRate contextRef="c0" decimals="-3" id="ixv-71322" unitRef="usd">-10183000</ifrs-full:TaxEffectFromChangeInTaxRate>
    <aapg:UncertainTaxPosition contextRef="c13" decimals="-3" id="ixv-71323" unitRef="cny">23665000</aapg:UncertainTaxPosition>
    <aapg:UncertainTaxPosition contextRef="c0" decimals="-3" id="ixv-71324" unitRef="cny">14236000</aapg:UncertainTaxPosition>
    <aapg:UncertainTaxPosition contextRef="c0" decimals="-3" id="ixv-71325" unitRef="usd">2036000</aapg:UncertainTaxPosition>
    <aapg:EffectOfWithholdingTaxOnTheInterestIncome contextRef="c0" decimals="-3" id="ixv-71326" unitRef="cny">29000</aapg:EffectOfWithholdingTaxOnTheInterestIncome>
    <aapg:EffectOfWithholdingTaxOnTheInterestIncome contextRef="c0" decimals="-3" id="ixv-71327" unitRef="usd">4000</aapg:EffectOfWithholdingTaxOnTheInterestIncome>
    <aapg:NetOperatingLossExpired contextRef="c13" decimals="-3" id="ixv-71328" unitRef="cny">31670000</aapg:NetOperatingLossExpired>
    <aapg:NetOperatingLossExpired contextRef="c0" decimals="-3" id="ixv-71329" unitRef="cny">29628000</aapg:NetOperatingLossExpired>
    <aapg:NetOperatingLossExpired contextRef="c0" decimals="-3" id="ixv-71330" unitRef="usd">4237000</aapg:NetOperatingLossExpired>
    <aapg:DeductibleTemporaryDifferencesNotRecognized contextRef="c12" decimals="-3" id="ixv-71331" unitRef="cny">33235000</aapg:DeductibleTemporaryDifferencesNotRecognized>
    <aapg:DeductibleTemporaryDifferencesNotRecognized contextRef="c13" decimals="-3" id="ixv-71332" unitRef="cny">71465000</aapg:DeductibleTemporaryDifferencesNotRecognized>
    <aapg:DeductibleTemporaryDifferencesNotRecognized contextRef="c0" decimals="-3" id="ixv-71333" unitRef="cny">49919000</aapg:DeductibleTemporaryDifferencesNotRecognized>
    <aapg:DeductibleTemporaryDifferencesNotRecognized contextRef="c0" decimals="-3" id="ixv-71334" unitRef="usd">7138000</aapg:DeductibleTemporaryDifferencesNotRecognized>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c12" decimals="-3" id="ixv-71335" unitRef="cny">237432000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c13" decimals="-3" id="ixv-71336" unitRef="cny">68580000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c0" decimals="-3" id="ixv-71337" unitRef="cny">163913000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c0" decimals="-3" id="ixv-71338" unitRef="usd">23438000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c12" decimals="-3" id="ixv-71339" unitRef="cny">-7150000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c13" decimals="-3" id="ixv-71340" unitRef="cny">10425000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="-3" id="ixv-71341" unitRef="cny">6940000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="-3" id="ixv-71342" unitRef="usd">992000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:DisclosureOfDividendsExplanatory contextRef="c0" id="ixv-47749">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;DIVIDENDS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 70.6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
board of directors resolved not to declare any final dividend for the years ended December 31, 2023, 2024 and 2025.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfDividendsExplanatory>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="c0" id="ixv-47765">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;LOSS
                                            PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE COMPANY&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The calculation of the basic loss per share amount is based on the loss for the year attributable to ordinary equity holders of the parent, and the weighted average number of ordinary shares of 356,130,452 (2024: 302,062,104, 2023: 282,299,269) outstanding during the year, as adjusted to reflect the rights issued during the year.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
adjustment has been made to the basic loss per share amounts presented for the years ended December 31, 2023, 2024 and 2025 in respect
of a dilution as the impact of the options and RSUs outstanding had an anti-dilutive effect on the basic loss per share amounts presented.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of basic loss per share is based on:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    attributable to ordinary equity holders of the parent, used in the basic loss per share calculation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(925,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(405,433&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,242,769&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(177,714&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average number of ordinary shares outstanding during the year used in the basic loss per share calculation#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;282,299,269&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;302,062,104&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;356,130,452&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The weighted average number of shares was after taking into account the effect of treasury shares held.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:WeightedAverageShares
      contextRef="c0"
      decimals="0"
      id="ixv-71343"
      unitRef="shares">356130452</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="c13"
      decimals="0"
      id="ixv-71344"
      unitRef="shares">302062104</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="c12"
      decimals="0"
      id="ixv-71345"
      unitRef="shares">282299269</ifrs-full:WeightedAverageShares>
    <ifrs-full:EarningsPerShareExplanatory contextRef="c0" id="ixv-47783">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of basic loss per share is based on:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    attributable to ordinary equity holders of the parent, used in the basic loss per share calculation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(925,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(405,433&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,242,769&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(177,714&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average number of ordinary shares outstanding during the year used in the basic loss per share calculation#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;282,299,269&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;302,062,104&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;356,130,452&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The weighted average number of shares was after taking into account the effect of treasury shares held.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c12" decimals="-3" id="ixv-71346" unitRef="cny">-925637000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c13" decimals="-3" id="ixv-71347" unitRef="cny">-405433000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c0" decimals="-3" id="ixv-71348" unitRef="cny">-1242769000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c0" decimals="-3" id="ixv-71349" unitRef="usd">-177714000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:WeightedAverageShares
      contextRef="c12"
      decimals="INF"
      id="ix_41_fact"
      unitRef="shares">282299269</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="c13"
      decimals="INF"
      id="ix_42_fact"
      unitRef="shares">302062104</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="c0"
      decimals="INF"
      id="ix_43_fact"
      unitRef="shares">356130452</ifrs-full:WeightedAverageShares>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="c0" id="ixv-48043">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PROPERTY,
                                            PLANT AND EQUIPMENT&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 65.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Buildings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Leasehold&lt;br/&gt; improvements&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Furniture&#160;and&lt;br/&gt; equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Motor&lt;br/&gt; vehicles&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Construction&lt;br/&gt; in progress&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;At January 1, 2024:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in"&gt;Cost&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;834,913&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;29,218&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;179,256&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;609&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;12,650&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;1,056,646&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(65,137&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,517&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(73,771&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(406&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-245"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(150,831&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;769,776&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,701&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;105,485&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;12,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;905,815&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;At January 1, 2024, net of accumulated depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;769,776&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,701&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;105,485&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;203&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,650&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;905,815&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-246"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-247"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,059&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-248"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,807&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,866&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-249"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-250"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(50&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-251"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-252"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(50&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Depreciation provided during the year (note 6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(39,599&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,896&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,569&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(120&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-253"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(71,184&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Transfers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-254"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,164&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-255"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Exchange realignment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-256"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-257"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-258"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-259"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;At December 31, 2024, net of accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;731,282&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,815&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;84,977&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;849,450&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;At December 31, 2024:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;836,018&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,239&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182,734&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;609&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,070,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(104,736&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18,424&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(97,757&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(526&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-260"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(221,443&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;731,282&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,815&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;84,977&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;849,450&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Buildings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Furniture and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Motor vehicles&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Construction in progress&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;At January 1, 2025:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in"&gt;Cost&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;836,018&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;44,239&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;182,734&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;609&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;1,070,893&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(104,736&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18,424&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(97,757&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(526&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-261"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(221,443&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;731,282&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,815&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;84,977&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;849,450&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;At January 1, 2025, net of accumulated depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;731,282&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,815&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;84,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;849,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-262"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,270&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;427&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-263"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-264"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-265"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-266"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Depreciation provided during the year (note 6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(37,117&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,374&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,157&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-267"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(65,761&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Transfers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,802&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-268"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,412&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-269"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Deficit on adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,982&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-270"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-271"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-272"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-273"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,982&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Exchange realignment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-274"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-275"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-276"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-277"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;At December 31, 2025, net of accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;676,985&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;31,953&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;69,790&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;397&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,110&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;781,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;At December 31, 2025:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;818,838&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,734&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;185,546&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,068,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(141,853&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,781&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(115,756&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(639&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-278"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(287,029&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;676,985&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;31,953&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;69,790&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;397&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,110&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;781,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount in US$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;96,808&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,569&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,980&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;302&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;111,715&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="c0" id="ixv-48053">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Buildings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Leasehold&lt;br/&gt; improvements&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Furniture&#160;and&lt;br/&gt; equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Motor&lt;br/&gt; vehicles&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Construction&lt;br/&gt; in progress&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;At January 1, 2024:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in"&gt;Cost&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;834,913&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;29,218&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;179,256&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;609&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;12,650&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;1,056,646&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(65,137&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,517&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(73,771&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(406&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-245"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(150,831&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;769,776&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,701&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;105,485&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;12,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;905,815&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;At January 1, 2024, net of accumulated depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;769,776&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,701&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;105,485&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;203&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,650&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;905,815&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-246"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-247"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,059&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-248"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,807&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,866&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-249"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-250"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(50&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-251"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-252"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(50&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Depreciation provided during the year (note 6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(39,599&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,896&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,569&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(120&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-253"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(71,184&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Transfers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-254"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,164&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-255"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Exchange realignment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-256"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-257"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-258"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-259"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;At December 31, 2024, net of accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;731,282&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,815&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;84,977&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;849,450&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;At December 31, 2024:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;836,018&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,239&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182,734&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;609&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,070,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(104,736&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18,424&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(97,757&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(526&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-260"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(221,443&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;731,282&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,815&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;84,977&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;849,450&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Buildings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Furniture and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Motor vehicles&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Construction in progress&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;At January 1, 2025:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-indent: -0.125in; padding-left: 0.125in"&gt;Cost&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;836,018&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;44,239&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;182,734&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;609&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;1,070,893&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(104,736&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18,424&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(97,757&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(526&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-261"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(221,443&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;731,282&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;25,815&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;84,977&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;849,450&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;At January 1, 2025, net of accumulated depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;731,282&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,815&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;84,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;849,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-262"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,270&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;427&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-263"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-264"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-265"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-266"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Depreciation provided during the year (note 6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(37,117&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,374&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,157&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-267"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(65,761&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Transfers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,802&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-268"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,412&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-269"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Deficit on adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,982&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-270"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-271"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-272"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-273"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,982&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Exchange realignment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-274"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-275"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-276"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-277"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;At December 31, 2025, net of accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;676,985&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;31,953&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;69,790&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;397&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,110&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;781,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;At December 31, 2025:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;818,838&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,734&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;185,546&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,068,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(141,853&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,781&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(115,756&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(639&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-278"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(287,029&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;676,985&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;31,953&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;69,790&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;397&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,110&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;781,235&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Net carrying amount in US$&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;96,808&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,569&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,980&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;302&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;111,715&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <aapg:PropertyAndEquipmentCost
      contextRef="c181"
      decimals="-3"
      id="ixv-71353"
      unitRef="cny">834913000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c182"
      decimals="-3"
      id="ixv-71354"
      unitRef="cny">29218000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c183"
      decimals="-3"
      id="ixv-71355"
      unitRef="cny">179256000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c184"
      decimals="-3"
      id="ixv-71356"
      unitRef="cny">609000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c185"
      decimals="-3"
      id="ixv-71357"
      unitRef="cny">12650000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c186"
      decimals="-3"
      id="ixv-71358"
      unitRef="cny">1056646000</aapg:PropertyAndEquipmentCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c181"
      decimals="-3"
      id="ixv-71359"
      unitRef="cny">-65137000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c182"
      decimals="-3"
      id="ixv-71360"
      unitRef="cny">-11517000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c183"
      decimals="-3"
      id="ixv-71361"
      unitRef="cny">-73771000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c184"
      decimals="-3"
      id="ixv-71362"
      unitRef="cny">-406000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c186"
      decimals="-3"
      id="ixv-71363"
      unitRef="cny">-150831000</aapg:AccumulatedDepreciationsCost>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c181"
      decimals="-3"
      id="ixv-71364"
      unitRef="cny">769776000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c182"
      decimals="-3"
      id="ixv-71365"
      unitRef="cny">17701000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c183"
      decimals="-3"
      id="ixv-71366"
      unitRef="cny">105485000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c184"
      decimals="-3"
      id="ixv-71367"
      unitRef="cny">203000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c185"
      decimals="-3"
      id="ixv-71368"
      unitRef="cny">12650000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c186"
      decimals="-3"
      id="ixv-71369"
      unitRef="cny">905815000</ifrs-full:PropertyPlantAndEquipment>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c187"
      decimals="-3"
      id="ixv-71370"
      unitRef="cny">769776000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c188"
      decimals="-3"
      id="ixv-71371"
      unitRef="cny">17701000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c189"
      decimals="-3"
      id="ixv-71372"
      unitRef="cny">105485000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c190"
      decimals="-3"
      id="ixv-71373"
      unitRef="cny">203000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c191"
      decimals="-3"
      id="ixv-71374"
      unitRef="cny">12650000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c192"
      decimals="-3"
      id="ixv-71375"
      unitRef="cny">905815000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c195"
      decimals="-3"
      id="ixv-71376"
      unitRef="cny">2059000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c197"
      decimals="-3"
      id="ixv-71377"
      unitRef="cny">12807000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c198"
      decimals="-3"
      id="ixv-71378"
      unitRef="cny">14866000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c195"
      decimals="-3"
      id="ixv-71379"
      unitRef="cny">-50000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c198"
      decimals="-3"
      id="ixv-71380"
      unitRef="cny">-50000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c193"
      decimals="-3"
      id="ixv-71381"
      unitRef="cny">39599000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c194"
      decimals="-3"
      id="ixv-71382"
      unitRef="cny">6896000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c195"
      decimals="-3"
      id="ixv-71383"
      unitRef="cny">24569000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c196"
      decimals="-3"
      id="ixv-71384"
      unitRef="cny">120000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c198"
      decimals="-3"
      id="ixv-71385"
      unitRef="cny">71184000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c193"
      decimals="-3"
      id="ixv-71386"
      unitRef="cny">1105000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c194"
      decimals="-3"
      id="ixv-71387"
      unitRef="cny">15010000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c195"
      decimals="-3"
      id="ixv-71388"
      unitRef="cny">2049000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c197"
      decimals="-3"
      id="ixv-71389"
      unitRef="cny">-18164000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c195"
      decimals="-3"
      id="ixv-71390"
      unitRef="cny">3000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c198"
      decimals="-3"
      id="ixv-71391"
      unitRef="cny">3000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c199"
      decimals="-3"
      id="ixv-71392"
      unitRef="cny">731282000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c200"
      decimals="-3"
      id="ixv-71393"
      unitRef="cny">25815000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c201"
      decimals="-3"
      id="ixv-71394"
      unitRef="cny">84977000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c202"
      decimals="-3"
      id="ixv-71395"
      unitRef="cny">83000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c203"
      decimals="-3"
      id="ixv-71396"
      unitRef="cny">7293000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c204"
      decimals="-3"
      id="ixv-71397"
      unitRef="cny">849450000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentCost
      contextRef="c205"
      decimals="-3"
      id="ixv-71398"
      unitRef="cny">836018000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c206"
      decimals="-3"
      id="ixv-71399"
      unitRef="cny">44239000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c207"
      decimals="-3"
      id="ixv-71400"
      unitRef="cny">182734000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c208"
      decimals="-3"
      id="ixv-71401"
      unitRef="cny">609000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c209"
      decimals="-3"
      id="ixv-71402"
      unitRef="cny">7293000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost contextRef="c14" decimals="-3" id="ixv-71403" unitRef="cny">1070893000</aapg:PropertyAndEquipmentCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c205"
      decimals="-3"
      id="ixv-71404"
      unitRef="cny">-104736000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c206"
      decimals="-3"
      id="ixv-71405"
      unitRef="cny">-18424000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c207"
      decimals="-3"
      id="ixv-71406"
      unitRef="cny">-97757000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c208"
      decimals="-3"
      id="ixv-71407"
      unitRef="cny">-526000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost contextRef="c14" decimals="-3" id="ixv-71408" unitRef="cny">-221443000</aapg:AccumulatedDepreciationsCost>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c205"
      decimals="-3"
      id="ixv-71409"
      unitRef="cny">731282000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c206"
      decimals="-3"
      id="ixv-71410"
      unitRef="cny">25815000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c207"
      decimals="-3"
      id="ixv-71411"
      unitRef="cny">84977000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c208"
      decimals="-3"
      id="ixv-71412"
      unitRef="cny">83000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c209"
      decimals="-3"
      id="ixv-71413"
      unitRef="cny">7293000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c14" decimals="-3" id="ixv-71414" unitRef="cny">849450000</ifrs-full:PropertyPlantAndEquipment>
    <aapg:PropertyAndEquipmentCost
      contextRef="c210"
      decimals="-3"
      id="ixv-71415"
      unitRef="cny">836018000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c211"
      decimals="-3"
      id="ixv-71416"
      unitRef="cny">44239000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c212"
      decimals="-3"
      id="ixv-71417"
      unitRef="cny">182734000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c213"
      decimals="-3"
      id="ixv-71418"
      unitRef="cny">609000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c214"
      decimals="-3"
      id="ixv-71419"
      unitRef="cny">7293000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c215"
      decimals="-3"
      id="ixv-71420"
      unitRef="cny">1070893000</aapg:PropertyAndEquipmentCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c210"
      decimals="-3"
      id="ixv-71421"
      unitRef="cny">-104736000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c211"
      decimals="-3"
      id="ixv-71422"
      unitRef="cny">-18424000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c212"
      decimals="-3"
      id="ixv-71423"
      unitRef="cny">-97757000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c213"
      decimals="-3"
      id="ixv-71424"
      unitRef="cny">-526000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c215"
      decimals="-3"
      id="ixv-71425"
      unitRef="cny">-221443000</aapg:AccumulatedDepreciationsCost>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c210"
      decimals="-3"
      id="ixv-71426"
      unitRef="cny">731282000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c211"
      decimals="-3"
      id="ixv-71427"
      unitRef="cny">25815000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c212"
      decimals="-3"
      id="ixv-71428"
      unitRef="cny">84977000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c213"
      decimals="-3"
      id="ixv-71429"
      unitRef="cny">83000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c214"
      decimals="-3"
      id="ixv-71430"
      unitRef="cny">7293000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c215"
      decimals="-3"
      id="ixv-71431"
      unitRef="cny">849450000</ifrs-full:PropertyPlantAndEquipment>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c199"
      decimals="-3"
      id="ixv-71432"
      unitRef="cny">731282000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c200"
      decimals="-3"
      id="ixv-71433"
      unitRef="cny">25815000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c201"
      decimals="-3"
      id="ixv-71434"
      unitRef="cny">84977000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c202"
      decimals="-3"
      id="ixv-71435"
      unitRef="cny">83000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c203"
      decimals="-3"
      id="ixv-71436"
      unitRef="cny">7293000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c204"
      decimals="-3"
      id="ixv-71437"
      unitRef="cny">849450000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c217"
      decimals="-3"
      id="ixv-71438"
      unitRef="cny">3270000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c218"
      decimals="-3"
      id="ixv-71439"
      unitRef="cny">2635000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c219"
      decimals="-3"
      id="ixv-71440"
      unitRef="cny">427000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c220"
      decimals="-3"
      id="ixv-71441"
      unitRef="cny">11229000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c221"
      decimals="-3"
      id="ixv-71442"
      unitRef="cny">17561000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c218"
      decimals="-3"
      id="ixv-71443"
      unitRef="cny">-18000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c221"
      decimals="-3"
      id="ixv-71444"
      unitRef="cny">-18000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c216"
      decimals="-3"
      id="ixv-71445"
      unitRef="cny">37117000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c217"
      decimals="-3"
      id="ixv-71446"
      unitRef="cny">10374000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c218"
      decimals="-3"
      id="ixv-71447"
      unitRef="cny">18157000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c219"
      decimals="-3"
      id="ixv-71448"
      unitRef="cny">113000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c221"
      decimals="-3"
      id="ixv-71449"
      unitRef="cny">65761000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c216"
      decimals="-3"
      id="ixv-71450"
      unitRef="cny">2802000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c217"
      decimals="-3"
      id="ixv-71451"
      unitRef="cny">13242000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c218"
      decimals="-3"
      id="ixv-71452"
      unitRef="cny">368000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c220"
      decimals="-3"
      id="ixv-71453"
      unitRef="cny">-16412000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="c216"
      decimals="-3"
      id="ixv-71454"
      unitRef="cny">-19982000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="c221"
      decimals="-3"
      id="ixv-71455"
      unitRef="cny">-19982000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c218"
      decimals="-3"
      id="ixv-71456"
      unitRef="cny">-15000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c221"
      decimals="-3"
      id="ixv-71457"
      unitRef="cny">-15000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c222"
      decimals="-3"
      id="ixv-71458"
      unitRef="cny">676985000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c223"
      decimals="-3"
      id="ixv-71459"
      unitRef="cny">31953000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c224"
      decimals="-3"
      id="ixv-71460"
      unitRef="cny">69790000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c225"
      decimals="-3"
      id="ixv-71461"
      unitRef="cny">397000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c226"
      decimals="-3"
      id="ixv-71462"
      unitRef="cny">2110000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation
      contextRef="c227"
      decimals="-3"
      id="ixv-71463"
      unitRef="cny">781235000</aapg:PropertyAndEquipmentNetOfAccumulatedDepreciation>
    <aapg:PropertyAndEquipmentCost
      contextRef="c228"
      decimals="-3"
      id="ixv-71464"
      unitRef="cny">818838000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c229"
      decimals="-3"
      id="ixv-71465"
      unitRef="cny">60734000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c230"
      decimals="-3"
      id="ixv-71466"
      unitRef="cny">185546000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c231"
      decimals="-3"
      id="ixv-71467"
      unitRef="cny">1036000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost
      contextRef="c232"
      decimals="-3"
      id="ixv-71468"
      unitRef="cny">2110000</aapg:PropertyAndEquipmentCost>
    <aapg:PropertyAndEquipmentCost contextRef="c15" decimals="-3" id="ixv-71469" unitRef="cny">1068264000</aapg:PropertyAndEquipmentCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c228"
      decimals="-3"
      id="ixv-71470"
      unitRef="cny">-141853000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c229"
      decimals="-3"
      id="ixv-71471"
      unitRef="cny">-28781000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c230"
      decimals="-3"
      id="ixv-71472"
      unitRef="cny">-115756000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c231"
      decimals="-3"
      id="ixv-71473"
      unitRef="cny">-639000</aapg:AccumulatedDepreciationsCost>
    <aapg:AccumulatedDepreciationsCost contextRef="c15" decimals="-3" id="ixv-71474" unitRef="cny">-287029000</aapg:AccumulatedDepreciationsCost>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c228"
      decimals="-3"
      id="ixv-71475"
      unitRef="cny">676985000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c229"
      decimals="-3"
      id="ixv-71476"
      unitRef="cny">31953000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c230"
      decimals="-3"
      id="ixv-71477"
      unitRef="cny">69790000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c231"
      decimals="-3"
      id="ixv-71478"
      unitRef="cny">397000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c232"
      decimals="-3"
      id="ixv-71479"
      unitRef="cny">2110000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c15" decimals="-3" id="ixv-71480" unitRef="cny">781235000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c228"
      decimals="-3"
      id="ixv-71481"
      unitRef="usd">96808000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c229"
      decimals="-3"
      id="ixv-71482"
      unitRef="usd">4569000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c230"
      decimals="-3"
      id="ixv-71483"
      unitRef="usd">9980000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c231"
      decimals="-3"
      id="ixv-71484"
      unitRef="usd">56000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c232"
      decimals="-3"
      id="ixv-71485"
      unitRef="usd">302000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c15" decimals="-3" id="ixv-71486" unitRef="usd">111715000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfLeasesExplanatory contextRef="c0" id="ixv-49123">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;LEASES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;The
Group as a lessee&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 70.6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has lease contracts for land and buildings. Lump sum payments were made upfront to acquire the leased land from the owners with
lease periods of 30 years, and no ongoing payments will be made under the terms of these land leases. Leases of buildings generally have
lease terms between 2 and 7 years. Other leases generally have lease terms of 12 months or less and/or are individually of low value.
Generally, the Group is restricted from assigning and subleasing the leased assets outside the Group.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
                                            assets&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Group&#x2019;s right-of-use assets and the movements during the year are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
    land&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As at January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,654&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,598&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;51,252&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-279; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,446&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation charge (note
    6)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,130&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,592&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,067&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-280; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,067&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange realignment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-281; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As at December 31, 2024 and January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,641&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,468&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,047&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-282; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,047&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;722&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation charge (note
    6)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,527&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,130&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,657&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,675&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,675&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(382&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange realignment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,489&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,338&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;47,827&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,839&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
                                            liabilities&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 35.4pt 0pt 70.6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of lease liabilities (included under interest-bearing bank and other borrowings) and the movements during the year are
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Carrying amount
    at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,681&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,232&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,323&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,047&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;722&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion of interest recognized
    during the year (note 8)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,911&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,835&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,549&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange realignment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,152&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,360&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Carrying
    amount at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,232&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,196&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,174&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Analyzed into:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,283&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,041&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
    portion&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,913&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,133&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
maturity analysis of lease liabilities is disclosed in note 39 to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The amounts recognized in profit or loss in relation to leases are as follows:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest on lease
    liabilities (note 8)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation charge of right-of-use
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,657&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expense
    relating to short-term leases (included in administrative expenses) (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;329&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total amount recognized in
    profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,870&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,104&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,731&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            total cash outflow for leases and future cash outflows relating to leases that have not yet
                                            commenced are disclosed in notes 32(c) and 33(b), respectively, to the consolidated financial
                                            statements.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfLeasesExplanatory>
    <aapg:TermsOfLandLease contextRef="c0" id="ixv-71487">P30Y</aapg:TermsOfLandLease>
    <aapg:LeaseTerms contextRef="c233" id="ixv-71488">P2Y</aapg:LeaseTerms>
    <aapg:LeaseTerms contextRef="c234" id="ixv-71489">P7Y</aapg:LeaseTerms>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="c0" id="ixv-49151">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Group&#x2019;s right-of-use assets and the movements during the year are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
    land&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As at January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,654&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,598&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;51,252&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-279; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,446&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation charge (note
    6)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,130&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,592&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,067&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-280; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,067&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange realignment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-281; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As at December 31, 2024 and January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,641&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,468&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,047&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-282; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,047&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;722&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation charge (note
    6)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,527&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,130&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,657&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,675&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,675&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(382&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange realignment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,489&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,338&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;47,827&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,839&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="c235"
      decimals="-3"
      id="ixv-71490"
      unitRef="cny">23654000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="c236"
      decimals="-3"
      id="ixv-71491"
      unitRef="cny">27598000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c41" decimals="-3" id="ixv-71492" unitRef="cny">51252000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c41" decimals="-3" id="ixv-71493" unitRef="usd">7329000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="c237"
      decimals="-3"
      id="ixv-71494"
      unitRef="cny">17108000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c13" decimals="-3" id="ixv-71495" unitRef="cny">17108000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c13" decimals="-3" id="ixv-71496" unitRef="usd">2446000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="c237"
      decimals="-3"
      id="ixv-71497"
      unitRef="cny">10004000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="c238"
      decimals="-3"
      id="ixv-71498"
      unitRef="cny">1130000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c13" decimals="-3" id="ixv-71499" unitRef="cny">11134000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c13" decimals="-3" id="ixv-71500" unitRef="usd">1592000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DisposalsRightofuseAssets
      contextRef="c237"
      decimals="-3"
      id="ixv-71501"
      unitRef="cny">1067000</ifrs-full:DisposalsRightofuseAssets>
    <ifrs-full:DisposalsRightofuseAssets contextRef="c13" decimals="-3" id="ixv-71502" unitRef="cny">1067000</ifrs-full:DisposalsRightofuseAssets>
    <ifrs-full:DisposalsRightofuseAssets contextRef="c13" decimals="-3" id="ixv-71503" unitRef="usd">153000</ifrs-full:DisposalsRightofuseAssets>
    <aapg:ExchangeRealignmentRightofuseAssets
      contextRef="c237"
      decimals="-3"
      id="ixv-71504"
      unitRef="cny">-50000</aapg:ExchangeRealignmentRightofuseAssets>
    <aapg:ExchangeRealignmentRightofuseAssets contextRef="c13" decimals="-3" id="ixv-71505" unitRef="cny">-50000</aapg:ExchangeRealignmentRightofuseAssets>
    <aapg:ExchangeRealignmentRightofuseAssets contextRef="c13" decimals="-3" id="ixv-71506" unitRef="usd">-7000</aapg:ExchangeRealignmentRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="c205"
      decimals="-3"
      id="ixv-71507"
      unitRef="cny">29641000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="c239"
      decimals="-3"
      id="ixv-71508"
      unitRef="cny">26468000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c14" decimals="-3" id="ixv-71509" unitRef="cny">56109000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c14" decimals="-3" id="ixv-71510" unitRef="usd">8023000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c90" decimals="-3" id="ixv-71511" unitRef="cny">5047000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c0" decimals="-3" id="ixv-71512" unitRef="cny">5047000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c0" decimals="-3" id="ixv-71513" unitRef="usd">722000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c90" decimals="-3" id="ixv-71514" unitRef="cny">9527000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="c240"
      decimals="-3"
      id="ixv-71515"
      unitRef="cny">1130000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c0" decimals="-3" id="ixv-71516" unitRef="cny">10657000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c0" decimals="-3" id="ixv-71517" unitRef="usd">1524000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DisposalsRightofuseAssets contextRef="c90" decimals="-3" id="ixv-71518" unitRef="cny">2675000</ifrs-full:DisposalsRightofuseAssets>
    <ifrs-full:DisposalsRightofuseAssets contextRef="c0" decimals="-3" id="ixv-71519" unitRef="cny">2675000</ifrs-full:DisposalsRightofuseAssets>
    <ifrs-full:DisposalsRightofuseAssets contextRef="c0" decimals="-3" id="ixv-71520" unitRef="usd">382000</ifrs-full:DisposalsRightofuseAssets>
    <aapg:ExchangeRealignmentRightofuseAssets contextRef="c90" decimals="-3" id="ixv-71521" unitRef="cny">3000</aapg:ExchangeRealignmentRightofuseAssets>
    <aapg:ExchangeRealignmentRightofuseAssets contextRef="c0" decimals="-3" id="ixv-71522" unitRef="cny">3000</aapg:ExchangeRealignmentRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="c228"
      decimals="-3"
      id="ixv-71523"
      unitRef="cny">22489000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="c241"
      decimals="-3"
      id="ixv-71524"
      unitRef="cny">25338000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c15" decimals="-3" id="ixv-71525" unitRef="cny">47827000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c15" decimals="-3" id="ixv-71526" unitRef="usd">6839000</ifrs-full:RightofuseAssets>
    <aapg:DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock contextRef="c0" id="ixv-49725">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of lease liabilities (included under interest-bearing bank and other borrowings) and the movements during the year are
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Carrying amount
    at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,681&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,232&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,323&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,047&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;722&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accretion of interest recognized
    during the year (note 8)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,911&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,835&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,549&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange realignment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,152&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,360&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Carrying
    amount at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,232&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,196&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,174&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Analyzed into:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,283&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,041&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
    portion&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,913&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,133&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock>
    <ifrs-full:LeaseLiabilities contextRef="c41" decimals="-3" id="ixv-71527" unitRef="cny">22681000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c14" decimals="-3" id="ixv-71528" unitRef="cny">30232000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c14" decimals="-3" id="ixv-71529" unitRef="usd">4323000</ifrs-full:LeaseLiabilities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c13" decimals="-3" id="ixv-71530" unitRef="cny">17108000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c0" decimals="-3" id="ixv-71531" unitRef="cny">5047000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="c0" decimals="-3" id="ixv-71532" unitRef="usd">722000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c13" decimals="-3" id="ixv-71533" unitRef="cny">1498000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c0" decimals="-3" id="ixv-71534" unitRef="cny">1118000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c0" decimals="-3" id="ixv-71535" unitRef="usd">160000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <aapg:PaymentsofLeaseLiabilities contextRef="c13" decimals="-3" id="ixv-71536" unitRef="cny">9911000</aapg:PaymentsofLeaseLiabilities>
    <aapg:PaymentsofLeaseLiabilities contextRef="c0" decimals="-3" id="ixv-71537" unitRef="cny">10835000</aapg:PaymentsofLeaseLiabilities>
    <aapg:PaymentsofLeaseLiabilities contextRef="c0" decimals="-3" id="ixv-71538" unitRef="usd">1549000</aapg:PaymentsofLeaseLiabilities>
    <aapg:ExchangeRealignments contextRef="c13" decimals="-3" id="ixv-71539" unitRef="cny">8000</aapg:ExchangeRealignments>
    <aapg:ExchangeRealignments contextRef="c0" decimals="-3" id="ixv-71540" unitRef="cny">-6000</aapg:ExchangeRealignments>
    <aapg:ExchangeRealignments contextRef="c0" decimals="-3" id="ixv-71541" unitRef="usd">-1000</aapg:ExchangeRealignments>
    <aapg:DisposalsLeaseLiabilities contextRef="c13" decimals="-3" id="ixv-71542" unitRef="cny">1152000</aapg:DisposalsLeaseLiabilities>
    <aapg:DisposalsLeaseLiabilities contextRef="c0" decimals="-3" id="ixv-71543" unitRef="cny">3360000</aapg:DisposalsLeaseLiabilities>
    <aapg:DisposalsLeaseLiabilities contextRef="c0" decimals="-3" id="ixv-71544" unitRef="usd">481000</aapg:DisposalsLeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c14" decimals="-3" id="ixv-71545" unitRef="cny">30232000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c15" decimals="-3" id="ixv-71546" unitRef="cny">22196000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c15" decimals="-3" id="ixv-71547" unitRef="usd">3174000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c14" decimals="-3" id="ixv-71548" unitRef="cny">9439000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c15" decimals="-3" id="ixv-71549" unitRef="cny">7283000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c15" decimals="-3" id="ixv-71550" unitRef="usd">1041000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c14" decimals="-3" id="ixv-71551" unitRef="cny">20793000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c15" decimals="-3" id="ixv-71552" unitRef="cny">14913000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c15" decimals="-3" id="ixv-71553" unitRef="usd">2133000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory contextRef="c0" id="ixv-50139">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The amounts recognized in profit or loss in relation to leases are as follows:&lt;/span&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest on lease
    liabilities (note 8)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation charge of right-of-use
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,134&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,657&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,524&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expense
    relating to short-term leases (included in administrative expenses) (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;329&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total amount recognized in
    profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,870&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,104&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,731&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c13" decimals="-3" id="ixv-71554" unitRef="cny">1498000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c0" decimals="-3" id="ixv-71555" unitRef="cny">1118000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c0" decimals="-3" id="ixv-71556" unitRef="usd">160000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <aapg:DepreciationChargeofRightofuseAssets contextRef="c13" decimals="-3" id="ixv-71557" unitRef="cny">11134000</aapg:DepreciationChargeofRightofuseAssets>
    <aapg:DepreciationChargeofRightofuseAssets contextRef="c0" decimals="-3" id="ixv-71558" unitRef="cny">10657000</aapg:DepreciationChargeofRightofuseAssets>
    <aapg:DepreciationChargeofRightofuseAssets contextRef="c0" decimals="-3" id="ixv-71559" unitRef="usd">1524000</aapg:DepreciationChargeofRightofuseAssets>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed contextRef="c13" decimals="-3" id="ixv-71560" unitRef="cny">238000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed contextRef="c0" decimals="-3" id="ixv-71561" unitRef="cny">329000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed contextRef="c0" decimals="-3" id="ixv-71562" unitRef="usd">47000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <aapg:TotalAmountofRecognizedInProfitOrLoss contextRef="c13" decimals="-3" id="ixv-71563" unitRef="cny">12870000</aapg:TotalAmountofRecognizedInProfitOrLoss>
    <aapg:TotalAmountofRecognizedInProfitOrLoss contextRef="c0" decimals="-3" id="ixv-71564" unitRef="cny">12104000</aapg:TotalAmountofRecognizedInProfitOrLoss>
    <aapg:TotalAmountofRecognizedInProfitOrLoss contextRef="c0" decimals="-3" id="ixv-71565" unitRef="usd">1731000</aapg:TotalAmountofRecognizedInProfitOrLoss>
    <ifrs-full:DisclosureOfGoodwillExplanatory contextRef="c0" id="ixv-50398">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;GOODWILL&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-indent: -11pt; padding-left: 11pt"&gt;Cost&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;24,694&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;24,694&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accumulated impairment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-286"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-287"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-288"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;24,694&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;24,694&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,531&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amount of goodwill as at December 31, 2024 and 2025 was allocated to the cash-generating unit (&#x201c;CGU&#x201d;) of Healthquest
Pharma.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Impairment
testing of goodwill&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recoverable amount of the cash-generating unit has been determined based on a value in use calculation using cash flow projections
approved by senior management. The cash flows of the unit are projected based on the forecasted sales of the new drug after the
approval of the new drug application (&#x201c;NDA&#x201d;) and within the patent protection period. No revenue nor cash flow has been
forecasted after the expiration of the patent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assumptions
were used in the value in use calculation of the cash-generating unit for the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following describes each key assumption on which management has based its cash flow projections to undertake impairment testing of goodwill:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -22.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discount
rate - The discount rate applied to the cash flow projections was 19.40% as at December 31, 2025 (2024: 24.20%). The discount rate used
is before tax and reflects specific risks relating to the relevant unit.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
revenue &#x2013; The revenue is based on the business strategy and management&#x2019;s expectation for the market development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
values assigned to the key assumptions are consistent with external information sources. The management believes that any reasonably
possible change in any of the key assumptions on which the recoverable amount is based would not cause the cash-generating unit&#x2019;s
recoverable amount to drop lower than its carrying amount.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfGoodwillExplanatory>
    <ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory contextRef="c0" id="ixv-50409">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-indent: -11pt; padding-left: 11pt"&gt;Cost&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;24,694&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;24,694&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accumulated impairment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-286"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-287"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-288"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 11pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;24,694&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;24,694&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,531&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory>
    <aapg:CostGoodwill contextRef="c14" decimals="-3" id="ixv-71566" unitRef="cny">24694000</aapg:CostGoodwill>
    <aapg:CostGoodwill contextRef="c15" decimals="-3" id="ixv-71567" unitRef="cny">24694000</aapg:CostGoodwill>
    <aapg:CostGoodwill contextRef="c15" decimals="-3" id="ixv-71568" unitRef="usd">3531000</aapg:CostGoodwill>
    <ifrs-full:Goodwill contextRef="c14" decimals="-3" id="ixv-71569" unitRef="cny">24694000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c15" decimals="-3" id="ixv-71570" unitRef="cny">24694000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c15" decimals="-3" id="ixv-71571" unitRef="usd">3531000</ifrs-full:Goodwill>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections contextRef="c15" decimals="4" id="ixv-71572" unitRef="pure">0.194</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections contextRef="c14" decimals="4" id="ixv-71573" unitRef="pure">0.242</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="c0" id="ixv-50577">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;OTHER
                                            INTANGIBLE ASSET&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patent&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;License&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
    at January 1, 2024, net of accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,232&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,089&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;85,446&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,403&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,403&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
    provided during the year (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,251&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,851&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,535&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,838&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;75,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2024:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,728&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;93,050&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;141,778&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(52,212&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,375&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(65,780&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,535&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,838&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;75,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
    at January 1, 2025, net of accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,535&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,838&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,625&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;75,998&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
    provided during the year (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,262&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,300&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,273&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,538&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,125&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,936&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,728&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;93,050&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;141,778&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,455&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(59,512&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,875&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(75,842&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,273&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,538&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,125&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,936&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    carrying amount in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,183&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,796&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,450&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,429&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <aapg:DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock contextRef="c0" id="ixv-50587">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patent&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;License&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
    at January 1, 2024, net of accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,232&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,089&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;85,446&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,403&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,403&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
    provided during the year (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,251&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,851&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,535&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,838&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;75,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2024:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,728&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;93,050&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;141,778&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(52,212&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,375&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(65,780&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,535&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,838&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;75,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
    at January 1, 2025, net of accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,535&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,838&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,625&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;75,998&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
    provided during the year (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,262&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7,300&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,273&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,538&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,125&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,936&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,728&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;93,050&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;141,778&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,455&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(59,512&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,875&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(75,842&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,273&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,538&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,125&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,936&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    carrying amount in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,183&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,796&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,450&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,429&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfOtherIntangibleAssetExplanatoryTableTextBlock>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c242"
      decimals="-3"
      id="ixv-71574"
      unitRef="cny">10232000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c243"
      decimals="-3"
      id="ixv-71575"
      unitRef="cny">48089000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c244"
      decimals="-3"
      id="ixv-71576"
      unitRef="cny">27125000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c245"
      decimals="-3"
      id="ixv-71577"
      unitRef="cny">85446000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c246"
      decimals="-3"
      id="ixv-71578"
      unitRef="cny">1403000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c249"
      decimals="-3"
      id="ixv-71579"
      unitRef="cny">1403000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationExpense
      contextRef="c246"
      decimals="-3"
      id="ixv-71580"
      unitRef="cny">2100000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="c247"
      decimals="-3"
      id="ixv-71581"
      unitRef="cny">7251000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="c248"
      decimals="-3"
      id="ixv-71582"
      unitRef="cny">1500000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="c249"
      decimals="-3"
      id="ixv-71583"
      unitRef="cny">10851000</ifrs-full:AmortisationExpense>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c250"
      decimals="-3"
      id="ixv-71584"
      unitRef="cny">9535000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c251"
      decimals="-3"
      id="ixv-71585"
      unitRef="cny">40838000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c252"
      decimals="-3"
      id="ixv-71586"
      unitRef="cny">25625000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c253"
      decimals="-3"
      id="ixv-71587"
      unitRef="cny">75998000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <aapg:IntangibleAssetsGross
      contextRef="c254"
      decimals="-3"
      id="ixv-71588"
      unitRef="cny">18728000</aapg:IntangibleAssetsGross>
    <aapg:IntangibleAssetsGross
      contextRef="c255"
      decimals="-3"
      id="ixv-71589"
      unitRef="cny">93050000</aapg:IntangibleAssetsGross>
    <aapg:IntangibleAssetsGross
      contextRef="c256"
      decimals="-3"
      id="ixv-71590"
      unitRef="cny">30000000</aapg:IntangibleAssetsGross>
    <aapg:IntangibleAssetsGross
      contextRef="c257"
      decimals="-3"
      id="ixv-71591"
      unitRef="cny">141778000</aapg:IntangibleAssetsGross>
    <aapg:AccumulatedAmortization
      contextRef="c254"
      decimals="-3"
      id="ixv-71592"
      unitRef="cny">-9193000</aapg:AccumulatedAmortization>
    <aapg:AccumulatedAmortization
      contextRef="c255"
      decimals="-3"
      id="ixv-71593"
      unitRef="cny">-52212000</aapg:AccumulatedAmortization>
    <aapg:AccumulatedAmortization
      contextRef="c256"
      decimals="-3"
      id="ixv-71594"
      unitRef="cny">-4375000</aapg:AccumulatedAmortization>
    <aapg:AccumulatedAmortization
      contextRef="c257"
      decimals="-3"
      id="ixv-71595"
      unitRef="cny">-65780000</aapg:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c254"
      decimals="-3"
      id="ixv-71596"
      unitRef="cny">9535000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c255"
      decimals="-3"
      id="ixv-71597"
      unitRef="cny">40838000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c256"
      decimals="-3"
      id="ixv-71598"
      unitRef="cny">25625000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c257"
      decimals="-3"
      id="ixv-71599"
      unitRef="cny">75998000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c250"
      decimals="-3"
      id="ixv-71600"
      unitRef="cny">9535000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c251"
      decimals="-3"
      id="ixv-71601"
      unitRef="cny">40838000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c252"
      decimals="-3"
      id="ixv-71602"
      unitRef="cny">25625000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c253"
      decimals="-3"
      id="ixv-71603"
      unitRef="cny">75998000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationExpense
      contextRef="c258"
      decimals="-3"
      id="ixv-71604"
      unitRef="cny">1262000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="c259"
      decimals="-3"
      id="ixv-71605"
      unitRef="cny">7300000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="c260"
      decimals="-3"
      id="ixv-71606"
      unitRef="cny">1500000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="c261"
      decimals="-3"
      id="ixv-71607"
      unitRef="cny">10062000</ifrs-full:AmortisationExpense>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c262"
      decimals="-3"
      id="ixv-71608"
      unitRef="cny">8273000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c263"
      decimals="-3"
      id="ixv-71609"
      unitRef="cny">33538000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c264"
      decimals="-3"
      id="ixv-71610"
      unitRef="cny">24125000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c265"
      decimals="-3"
      id="ixv-71611"
      unitRef="cny">65936000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <aapg:IntangibleAssetsGross
      contextRef="c262"
      decimals="-3"
      id="ixv-71612"
      unitRef="cny">18728000</aapg:IntangibleAssetsGross>
    <aapg:IntangibleAssetsGross
      contextRef="c263"
      decimals="-3"
      id="ixv-71613"
      unitRef="cny">93050000</aapg:IntangibleAssetsGross>
    <aapg:IntangibleAssetsGross
      contextRef="c264"
      decimals="-3"
      id="ixv-71614"
      unitRef="cny">30000000</aapg:IntangibleAssetsGross>
    <aapg:IntangibleAssetsGross
      contextRef="c265"
      decimals="-3"
      id="ixv-71615"
      unitRef="cny">141778000</aapg:IntangibleAssetsGross>
    <aapg:AccumulatedAmortization
      contextRef="c262"
      decimals="-3"
      id="ixv-71616"
      unitRef="cny">-10455000</aapg:AccumulatedAmortization>
    <aapg:AccumulatedAmortization
      contextRef="c263"
      decimals="-3"
      id="ixv-71617"
      unitRef="cny">-59512000</aapg:AccumulatedAmortization>
    <aapg:AccumulatedAmortization
      contextRef="c264"
      decimals="-3"
      id="ixv-71618"
      unitRef="cny">-5875000</aapg:AccumulatedAmortization>
    <aapg:AccumulatedAmortization
      contextRef="c265"
      decimals="-3"
      id="ixv-71619"
      unitRef="cny">-75842000</aapg:AccumulatedAmortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c262"
      decimals="-3"
      id="ixv-71620"
      unitRef="cny">8273000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c263"
      decimals="-3"
      id="ixv-71621"
      unitRef="cny">33538000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c264"
      decimals="-3"
      id="ixv-71622"
      unitRef="cny">24125000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c265"
      decimals="-3"
      id="ixv-71623"
      unitRef="cny">65936000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c262"
      decimals="-3"
      id="ixv-71624"
      unitRef="usd">1183000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c263"
      decimals="-3"
      id="ixv-71625"
      unitRef="usd">4796000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c264"
      decimals="-3"
      id="ixv-71626"
      unitRef="usd">3450000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c265"
      decimals="-3"
      id="ixv-71627"
      unitRef="usd">9429000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfJointVenturesExplanatory contextRef="c0" id="ixv-51410">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;INVESTMENT
                                            IN A JOINT VENTURE&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 64%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share of
    net assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,717&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,723&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Particulars
of the Group&#x2019;s principal joint venture are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-indent: -22.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Place of registration and business&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Registered share capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage of ownership interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Principal activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="background-color: #CCEEFF"&gt; &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; width: 43%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Suzhou Ascentage Harvest Venture Capital LLP* (&#x201c;Ascentage Harvest&#x201d;)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PRC&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;360,000&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33.42&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; vertical-align: top; width: 3%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%**&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investment in Biotechnology companies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-indent: -22.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
above investment is indirectly held by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.25pt; text-indent: -0.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The English name of the company registered in the PRC represents the best efforts made by the management of the Company in directly translating the Chinese name of this Company as no English name has been registered.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Group holds two of three representatives in the committee that directs the relevant activities of Ascentage Harvest. As a result, the Group has significant influence over the financial and operating policy decisions of Ascentage Harvest.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table illustrates the summarized financial information of the Group&#x2019;s joint venture:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
                                            of the joint venture&#x2019;s (loss)/gain for the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(281&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
                                 of the joint venture&#x2019;s total comprehensive (loss)/gain for the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(281&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aggregate carrying amount
    of the Group&#x2019;s investment in the joint venture&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,717&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,030&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,723&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfJointVenturesExplanatory>
    <aapg:ScheduleOfInvestmentInAJointVentureTableTextBlock contextRef="c0" id="ixv-51420">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 64%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share of
    net assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,717&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,723&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfInvestmentInAJointVentureTableTextBlock>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c14" decimals="-3" id="ixv-71628" unitRef="cny">32717000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c15" decimals="-3" id="ixv-71629" unitRef="cny">33030000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c15" decimals="-3" id="ixv-71630" unitRef="usd">4723000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <aapg:ScheduleOfGroupsPrincipalJointVentureTableTextBlock contextRef="c0" id="ixv-51509">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Particulars
of the Group&#x2019;s principal joint venture are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-indent: -22.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Place of registration and business&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Registered share capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Percentage of ownership interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Principal activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="background-color: #CCEEFF"&gt; &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; vertical-align: top; width: 43%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Suzhou Ascentage Harvest Venture Capital LLP* (&#x201c;Ascentage Harvest&#x201d;)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PRC&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;360,000&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: top; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33.42&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; vertical-align: top; width: 3%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%**&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; vertical-align: top; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investment in Biotechnology companies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The English name of the company registered in the PRC represents the best efforts made by the management of the Company in directly translating the Chinese name of this Company as no English name has been registered.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Group holds two of three representatives in the committee that directs the relevant activities of Ascentage Harvest. As a result, the Group has significant influence over the financial and operating policy decisions of Ascentage Harvest.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</aapg:ScheduleOfGroupsPrincipalJointVentureTableTextBlock>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="c0" id="ix_44_fact">PRC</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <aapg:RegisteredShareCapital contextRef="c0" decimals="-3" id="ix_45_fact" unitRef="usd">360000000</aapg:RegisteredShareCapital>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture contextRef="c0" decimals="4" id="ix_46_fact" unitRef="pure">0.3342</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <aapg:PrincipalActivities contextRef="c0" id="ix_47_fact">Investment in Biotechnology companies</aapg:PrincipalActivities>
    <aapg:ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock contextRef="c0" id="ixv-51650">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table illustrates the summarized financial information of the Group&#x2019;s joint venture:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
                                            of the joint venture&#x2019;s (loss)/gain for the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(281&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;314&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
                                 of the joint venture&#x2019;s total comprehensive (loss)/gain for the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(281&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aggregate carrying amount
    of the Group&#x2019;s investment in the joint venture&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,717&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,030&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,723&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfInformationOfTheGroupsJointVentureTableTextBlock>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c13" decimals="-3" id="ixv-71633" unitRef="cny">-281000</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c0" decimals="-3" id="ixv-71634" unitRef="cny">314000</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c0" decimals="-3" id="ixv-71635" unitRef="usd">45000</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c13" decimals="-3" id="ixv-71636" unitRef="cny">-281000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c0" decimals="-3" id="ixv-71637" unitRef="cny">314000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c0" decimals="-3" id="ixv-71638" unitRef="usd">45000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <aapg:AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture contextRef="c13" decimals="-3" id="ixv-71639" unitRef="cny">32717000</aapg:AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture>
    <aapg:AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture contextRef="c0" decimals="-3" id="ixv-71640" unitRef="cny">33030000</aapg:AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture>
    <aapg:AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture contextRef="c0" decimals="-3" id="ixv-71641" unitRef="usd">4723000</aapg:AggregateCarryingAmountOfTheGroupsInvestmentInTheJointVenture>
    <ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory contextRef="c0" id="ixv-51828">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FINANCIAL
                                            ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Listed
    equity investments, at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    unlisted investments, at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;572&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;572&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
above listed equity investments were classified as financial assets at fair value through profit or loss as they were held for trading.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
above unlisted investments were classified as financial assets at fair value through profit or loss as they represent investments in
non-trading equity instruments and have not been designated as financial assets at fair value through other comprehensive income.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory>
    <aapg:DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory contextRef="c0" id="ixv-51838">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Listed
    equity investments, at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    unlisted investments, at fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;572&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;572&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfDetailedInformationAboutFinancialAssetsAtFairValueThroughProfitOrLossExplanatory>
    <aapg:ListedEquityInvestmentsAtFairValue contextRef="c14" decimals="-3" id="ixv-71642" unitRef="cny">1141000</aapg:ListedEquityInvestmentsAtFairValue>
    <aapg:OtherUnlistedInvestmentsAtFairValue contextRef="c15" decimals="-3" id="ixv-71643" unitRef="cny">4000000</aapg:OtherUnlistedInvestmentsAtFairValue>
    <aapg:OtherUnlistedInvestmentsAtFairValue contextRef="c15" decimals="-3" id="ixv-71644" unitRef="usd">572000</aapg:OtherUnlistedInvestmentsAtFairValue>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c14" decimals="-3" id="ixv-71645" unitRef="cny">1141000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c15" decimals="-3" id="ixv-71646" unitRef="cny">4000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c15" decimals="-3" id="ixv-71647" unitRef="usd">572000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:DisclosureOfDeferredTaxesExplanatory contextRef="c0" id="ixv-51991">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;DEFERRED
                                            TAX&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
movements in deferred tax liabilities and assets during the reporting period are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Deferred
tax liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value adjustments arising from acquisition of a subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,549&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,413&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,962&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,181&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,881&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax liabilities at December 31, 2024 and January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,368&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,081&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax charged/(credited) to the statement of profit or loss during the year (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,975&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,241&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;734&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax liabilities at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,343&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,472&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,815&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax liabilities at December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,051&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;782&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Deferred
tax assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contract
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Donation
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Losses
    Available&lt;br/&gt;
    for Offsetting&lt;br/&gt;
    Against&lt;br/&gt;
    Future&lt;br/&gt;
    Taxable&lt;br/&gt;
    profits&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43,440&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,413&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,402&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,255&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,623&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,896&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(12,879&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax assets at December 31, 2024 and January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,817&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,896&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,523&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,949&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(12,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,241&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,850&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6,177&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax assets at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,235&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,472&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,692&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,373&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44,772&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax assets at December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;782&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;242&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,769&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,402&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
presentation purposes, certain deferred tax assets and liabilities have been offset in the statements of financial position. The following
is an analysis of the deferred tax balances of the Group for financial reporting purposes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax offset in the consolidated statements of financial position&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,713&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,815&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,833&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    deferred tax assets recognized in the consolidated statements of financial position&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44,236&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,957&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,570&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    deferred tax liability recognized in the consolidated statements of financial position&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,368&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2024 and 2025, the Group has tax losses arising in Chinese mainland of RMB2,963,587 and RMB3,047,076 (US$435,726), respectively,
that will expire from 2026 to 2035 for offsetting against future taxable profits. The Group has tax losses arising in other jurisdictions
of RMB1,438,160 and RMB2,250,477 (US$321,814), mainly from the United States that are available indefinitely for offsetting against up
to&#160;80% of future taxable profits of the company in which the losses arose.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2024 and 2025, the Group has deductible temporary differences of RMB828,668 and RMB1,000,310 (US$143,042), respectively.
The Group has the tax credits of RMB120,606 and RMB158,931 (US$22,727), mainly from the United States that will expire between 2039 and
2045 if not utilized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
deferred tax assets have not been recognized in respect of above tax losses, deductible temporary differences and tax credits as they
have arisen in entities that have been loss-making and it is not anticipated there will be sufficient taxable income in the foreseeable
future to utilize these items.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024 and 2025, there was &lt;span style="-sec-ix-hidden: hidden-fact-301"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-302"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized deferred tax liability for taxes that would be payable on the unremitted earnings
of the Group&#x2019;s subsidiaries or joint ventures in the Chinese mainland as these enterprises are still in accumulative losses status.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2024 and 2025, the Company has uncertain tax position amounts of RMB23,665 and RMB37,901 (US$5,420), respectively, of
which &lt;span style="-sec-ix-hidden: hidden-fact-297"&gt;nil&lt;/span&gt; and &lt;span style="-sec-ix-hidden: hidden-fact-298"&gt;nil&lt;/span&gt; are presented on a net basis against the deferred tax assets related to tax loss carry forwards on the consolidated
balance sheets. As of December 31, 2024 and 2025, the uncertain tax position amounts of RMB23,665 and &lt;span style="-sec-ix-hidden: hidden-fact-299"&gt;nil&lt;/span&gt; (US &lt;span style="-sec-ix-hidden: hidden-fact-300"&gt;nil&lt;/span&gt;), respectively, if
ultimately recognized, will impact the effective tax rate.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended December 31, 2023, 2024 and 2025, the Company did not record any interest expense and penalty accrued in relation to
the uncertain tax position in income tax expenses.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfDeferredTaxesExplanatory>
    <aapg:ScheduleOfDeferredTaxLiabilitiesExplanatory contextRef="c0" id="ixv-52001">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
movements in deferred tax liabilities and assets during the reporting period are as follows:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value adjustments arising from acquisition of a subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,549&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,413&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,962&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,181&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,881&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax liabilities at December 31, 2024 and January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,368&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,081&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax charged/(credited) to the statement of profit or loss during the year (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,975&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,241&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;734&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax liabilities at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,343&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,472&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,815&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax liabilities at December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,051&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;782&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfDeferredTaxLiabilitiesExplanatory>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c270"
      decimals="-3"
      id="ixv-71648"
      unitRef="cny">10549000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c271"
      decimals="-3"
      id="ixv-71649"
      unitRef="cny">5413000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c41" decimals="-3" id="ixv-71650" unitRef="cny">15962000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="c272"
      decimals="-3"
      id="ixv-71651"
      unitRef="cny">-5181000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="c273"
      decimals="-3"
      id="ixv-71652"
      unitRef="cny">1300000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c13" decimals="-3" id="ixv-71653" unitRef="cny">-3881000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c274"
      decimals="-3"
      id="ixv-71654"
      unitRef="cny">5368000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c275"
      decimals="-3"
      id="ixv-71655"
      unitRef="cny">6713000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c14" decimals="-3" id="ixv-71656" unitRef="cny">12081000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="c276"
      decimals="-3"
      id="ixv-71657"
      unitRef="cny">1975000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="c277"
      decimals="-3"
      id="ixv-71658"
      unitRef="cny">-1241000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c0" decimals="-3" id="ixv-71659" unitRef="cny">734000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c278"
      decimals="-3"
      id="ixv-71660"
      unitRef="cny">7343000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c279"
      decimals="-3"
      id="ixv-71661"
      unitRef="cny">5472000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c15" decimals="-3" id="ixv-71662" unitRef="cny">12815000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c278"
      decimals="-3"
      id="ixv-71663"
      unitRef="usd">1051000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c279"
      decimals="-3"
      id="ixv-71664"
      unitRef="usd">782000</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c15" decimals="-3" id="ixv-71665" unitRef="usd">1833000</ifrs-full:NetDeferredTaxLiabilities>
    <aapg:DisclosureOfDeferredTaxAssetsExplanatory contextRef="c0" id="ixv-52265">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Deferred
tax assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contract
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Donation
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Losses
    Available&lt;br/&gt;
    for Offsetting&lt;br/&gt;
    Against&lt;br/&gt;
    Future&lt;br/&gt;
    Taxable&lt;br/&gt;
    profits&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43,440&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,413&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,402&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,255&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,623&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,896&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(12,879&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax assets at December 31, 2024 and January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,817&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,896&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,523&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,949&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax (credited)/charged to the statement of profit or loss during the year (note 11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(12,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,241&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,850&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6,177&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax assets at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,235&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,472&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,692&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,373&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44,772&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax assets at December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;782&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;242&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,769&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,402&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfDeferredTaxAssetsExplanatory>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c280"
      decimals="-3"
      id="ixv-71666"
      unitRef="cny">43440000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c281"
      decimals="-3"
      id="ixv-71667"
      unitRef="cny">5413000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c283"
      decimals="-3"
      id="ixv-71668"
      unitRef="cny">16402000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c284"
      decimals="-3"
      id="ixv-71669"
      unitRef="cny">65255000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="c285"
      decimals="-3"
      id="ixv-71670"
      unitRef="cny">5623000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="c286"
      decimals="-3"
      id="ixv-71671"
      unitRef="cny">-1300000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="c287"
      decimals="-3"
      id="ixv-71672"
      unitRef="cny">-2896000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="c288"
      decimals="-3"
      id="ixv-71673"
      unitRef="cny">12879000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes contextRef="c13" decimals="-3" id="ixv-71674" unitRef="cny">14306000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c289"
      decimals="-3"
      id="ixv-71675"
      unitRef="cny">37817000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c290"
      decimals="-3"
      id="ixv-71676"
      unitRef="cny">6713000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c291"
      decimals="-3"
      id="ixv-71677"
      unitRef="cny">2896000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c292"
      decimals="-3"
      id="ixv-71678"
      unitRef="cny">3523000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c293"
      decimals="-3"
      id="ixv-71679"
      unitRef="cny">50949000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="c294"
      decimals="-3"
      id="ixv-71680"
      unitRef="cny">12582000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="c295"
      decimals="-3"
      id="ixv-71681"
      unitRef="cny">1241000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="c296"
      decimals="-3"
      id="ixv-71682"
      unitRef="cny">1204000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes
      contextRef="c297"
      decimals="-3"
      id="ixv-71683"
      unitRef="cny">-8850000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes contextRef="c0" decimals="-3" id="ixv-71684" unitRef="cny">6177000</ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c298"
      decimals="-3"
      id="ixv-71685"
      unitRef="cny">25235000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c299"
      decimals="-3"
      id="ixv-71686"
      unitRef="cny">5472000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c300"
      decimals="-3"
      id="ixv-71687"
      unitRef="cny">1692000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c301"
      decimals="-3"
      id="ixv-71688"
      unitRef="cny">12373000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c15" decimals="-3" id="ixv-71689" unitRef="cny">44772000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c298"
      decimals="-3"
      id="ixv-71690"
      unitRef="usd">3609000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c299"
      decimals="-3"
      id="ixv-71691"
      unitRef="usd">782000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c300"
      decimals="-3"
      id="ixv-71692"
      unitRef="usd">242000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c301"
      decimals="-3"
      id="ixv-71693"
      unitRef="usd">1769000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c15" decimals="-3" id="ixv-71694" unitRef="usd">6402000</ifrs-full:NetDeferredTaxAssets>
    <aapg:DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory contextRef="c0" id="ixv-71695">The following
is an analysis of the deferred tax balances of the Group for financial reporting purposes:&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax offset in the consolidated statements of financial position&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,713&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,815&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,833&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    deferred tax assets recognized in the consolidated statements of financial position&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44,236&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,957&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,570&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    deferred tax liability recognized in the consolidated statements of financial position&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,368&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfDeferredTaxAssetsAndLiabilitiesExplanatory>
    <aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition contextRef="c14" decimals="-3" id="ixv-71696" unitRef="cny">6713000</aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition>
    <aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition contextRef="c15" decimals="-3" id="ixv-71697" unitRef="cny">12815000</aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition>
    <aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition contextRef="c15" decimals="-3" id="ixv-71698" unitRef="usd">1833000</aapg:DeferredTaxOffsetInTheConsolidatedStatementsOfFinancialPosition>
    <ifrs-full:DeferredTaxAssets contextRef="c14" decimals="-3" id="ixv-71699" unitRef="cny">44236000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c15" decimals="-3" id="ixv-71700" unitRef="cny">31957000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c15" decimals="-3" id="ixv-71701" unitRef="usd">4570000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities contextRef="c14" decimals="-3" id="ixv-71702" unitRef="cny">5368000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="c266"
      decimals="-3"
      id="ixv-71703"
      unitRef="cny">2963587000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="c267"
      decimals="-3"
      id="ixv-71704"
      unitRef="cny">3047076000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="c267"
      decimals="-3"
      id="ixv-71705"
      unitRef="usd">435726000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="c268"
      decimals="-3"
      id="ixv-71706"
      unitRef="cny">1438160000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="c269"
      decimals="-3"
      id="ixv-71707"
      unitRef="cny">2250477000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="c269"
      decimals="-3"
      id="ixv-71708"
      unitRef="usd">321814000</ifrs-full:TaxEffectOfTaxLosses>
    <aapg:FutureTaxableProfitsPercentage contextRef="c15" decimals="2" id="ixv-71709" unitRef="pure">0.80</aapg:FutureTaxableProfitsPercentage>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="c14" decimals="-3" id="ixv-71710" unitRef="cny">828668000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="c15" decimals="-3" id="ixv-71711" unitRef="cny">1000310000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="c15" decimals="-3" id="ixv-71712" unitRef="usd">143042000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <aapg:TaxCredits contextRef="c13" decimals="-3" id="ixv-71713" unitRef="cny">120606000</aapg:TaxCredits>
    <aapg:TaxCredits contextRef="c0" decimals="-3" id="ixv-71714" unitRef="cny">158931000</aapg:TaxCredits>
    <aapg:TaxCredits contextRef="c0" decimals="-3" id="ixv-71715" unitRef="usd">22727000</aapg:TaxCredits>
    <aapg:UnrecognizedTaxBenefit contextRef="c13" decimals="-3" id="ixv-71716" unitRef="cny">23665000</aapg:UnrecognizedTaxBenefit>
    <aapg:UnrecognizedTaxBenefit contextRef="c0" decimals="-3" id="ixv-71717" unitRef="cny">37901000</aapg:UnrecognizedTaxBenefit>
    <aapg:UnrecognizedTaxBenefit contextRef="c0" decimals="-3" id="ixv-71718" unitRef="usd">5420000</aapg:UnrecognizedTaxBenefit>
    <aapg:UnrecognizedTaxBenefitsRecognized contextRef="c13" decimals="-3" id="ixv-71719" unitRef="cny">23665000</aapg:UnrecognizedTaxBenefitsRecognized>
    <ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory contextRef="c0" id="ixv-52888">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;OTHER
                                            NON-CURRENT ASSETS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Contract acquisition costs&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;30,529&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,851&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,269&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Value added tax recoverable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,034&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-303"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-304"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;Deposit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,439&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;690&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Prepayment for property, plant and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;184&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;59,303&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;30,725&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,394&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory>
    <aapg:ScheduleOfOtherNonCurrentAssetsTableTextBlock contextRef="c0" id="ixv-52899">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Contract acquisition costs&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;30,529&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,851&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,269&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Value added tax recoverable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,034&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-303"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-304"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;Deposit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,439&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;690&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Prepayment for property, plant and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;184&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;59,303&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;30,725&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,394&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfOtherNonCurrentAssetsTableTextBlock>
    <aapg:ContractAcquisitionCosts contextRef="c14" decimals="-3" id="ixv-71720" unitRef="cny">30529000</aapg:ContractAcquisitionCosts>
    <aapg:ContractAcquisitionCosts contextRef="c15" decimals="-3" id="ixv-71721" unitRef="cny">29851000</aapg:ContractAcquisitionCosts>
    <aapg:ContractAcquisitionCosts contextRef="c15" decimals="-3" id="ixv-71722" unitRef="usd">4269000</aapg:ContractAcquisitionCosts>
    <ifrs-full:NoncurrentValueAddedTaxReceivables contextRef="c14" decimals="-3" id="ixv-71723" unitRef="cny">26034000</ifrs-full:NoncurrentValueAddedTaxReceivables>
    <ifrs-full:LongtermDeposits contextRef="c14" decimals="-3" id="ixv-71724" unitRef="cny">2439000</ifrs-full:LongtermDeposits>
    <ifrs-full:LongtermDeposits contextRef="c15" decimals="-3" id="ixv-71725" unitRef="cny">690000</ifrs-full:LongtermDeposits>
    <ifrs-full:LongtermDeposits contextRef="c15" decimals="-3" id="ixv-71726" unitRef="usd">99000</ifrs-full:LongtermDeposits>
    <ifrs-full:NoncurrentPrepayments contextRef="c14" decimals="-3" id="ixv-71727" unitRef="cny">301000</ifrs-full:NoncurrentPrepayments>
    <ifrs-full:NoncurrentPrepayments contextRef="c15" decimals="-3" id="ixv-71728" unitRef="cny">184000</ifrs-full:NoncurrentPrepayments>
    <ifrs-full:NoncurrentPrepayments contextRef="c15" decimals="-3" id="ixv-71729" unitRef="usd">26000</ifrs-full:NoncurrentPrepayments>
    <ifrs-full:OtherNoncurrentAssets contextRef="c14" decimals="-3" id="ixv-71730" unitRef="cny">59303000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c15" decimals="-3" id="ixv-71731" unitRef="cny">30725000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c15" decimals="-3" id="ixv-71732" unitRef="usd">4394000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:DisclosureOfInventoriesExplanatory contextRef="c0" id="ixv-53014">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;INVENTORIES&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,736&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,371&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,628&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,861&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,427&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,062&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:
    Provision&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,180&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(598&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,597&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,618&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,092&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfInventoriesExplanatory>
    <aapg:DisclosureOfDetailedInformationOfInventoriesExplanatory contextRef="c0" id="ixv-53023">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,736&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,371&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,628&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,861&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,427&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,062&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:
    Provision&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,180&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(598&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,597&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,618&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,092&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfDetailedInformationOfInventoriesExplanatory>
    <ifrs-full:WorkInProgress contextRef="c14" decimals="-3" id="ixv-71733" unitRef="cny">2736000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress contextRef="c15" decimals="-3" id="ixv-71734" unitRef="cny">25371000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress contextRef="c15" decimals="-3" id="ixv-71735" unitRef="usd">3628000</ifrs-full:WorkInProgress>
    <ifrs-full:FinishedGoods contextRef="c14" decimals="-3" id="ixv-71736" unitRef="cny">3861000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods contextRef="c15" decimals="-3" id="ixv-71737" unitRef="cny">7427000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods contextRef="c15" decimals="-3" id="ixv-71738" unitRef="usd">1062000</ifrs-full:FinishedGoods>
    <ifrs-full:CurrentProvisions contextRef="c15" decimals="-3" id="ixv-71739" unitRef="cny">4180000</ifrs-full:CurrentProvisions>
    <ifrs-full:CurrentProvisions contextRef="c15" decimals="-3" id="ixv-71740" unitRef="usd">598000</ifrs-full:CurrentProvisions>
    <ifrs-full:Inventories contextRef="c14" decimals="-3" id="ixv-71741" unitRef="cny">6597000</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="c15" decimals="-3" id="ixv-71742" unitRef="cny">28618000</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="c15" decimals="-3" id="ixv-71743" unitRef="usd">4092000</ifrs-full:Inventories>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="c0" id="ixv-53270">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;TRADE
                                            RECEIVABLES, NET&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,143&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252,938&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,170&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s trading terms with its customers are mainly on credit. The credit period is generally 45 to 120 days. Each customer has
a maximum credit limit. The Group seeks to maintain strict control over its outstanding receivables and has a credit control department
to minimize credit risk. Overdue balances are reviewed regularly by senior management. The Group does not hold any collateral or other
credit enhancements over its trade receivable balances. Trade receivables are non-interest-bearing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
aging analysis of the trade receivables as at the end of the reporting period, based on the invoice date and net of loss allowance, is
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Within 45 days&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;54,484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;252,938&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;36,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;45 to 120 days&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;28,659&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-306"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-307"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;83,143&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;252,938&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;36,170&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;An
impairment analysis is performed at each reporting date. The Group has applied the simplified approach to provide for ECLs prescribed
by IFRS 9, which permits the use of the lifetime expected loss provision for all trade receivables. The directors of the Company are
of the opinion that the ECL in respect of the balance of trade receivables is minimal. No loss allowance for impairment of trade receivables
is provided as at December 31, 2025 (2024: nil).&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <aapg:ScheduleOfTradeReceivablesNetTableTextBlock contextRef="c0" id="ixv-53280">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade receivables, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,143&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252,938&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,170&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfTradeReceivablesNetTableTextBlock>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c14" decimals="-3" id="ixv-71744" unitRef="cny">83143000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c15" decimals="-3" id="ixv-71745" unitRef="cny">252938000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c15" decimals="-3" id="ixv-71746" unitRef="usd">36170000</ifrs-full:TradeAndOtherCurrentReceivables>
    <aapg:ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock contextRef="c0" id="ixv-53393">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
aging analysis of the trade receivables as at the end of the reporting period, based on the invoice date and net of loss allowance, is
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Within 45 days&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;54,484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;252,938&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;36,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;45 to 120 days&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;28,659&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-306"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-307"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;83,143&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;252,938&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;36,170&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfBasedOnTheInvoiceDateAndNetOfLossAllowanceTableTextBlock>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c302"
      decimals="-3"
      id="ixv-71747"
      unitRef="cny">54484000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c303"
      decimals="-3"
      id="ixv-71748"
      unitRef="cny">252938000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c303"
      decimals="-3"
      id="ixv-71749"
      unitRef="usd">36170000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c304"
      decimals="-3"
      id="ixv-71750"
      unitRef="cny">28659000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c14" decimals="-3" id="ixv-71751" unitRef="cny">83143000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c15" decimals="-3" id="ixv-71752" unitRef="cny">252938000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c15" decimals="-3" id="ixv-71753" unitRef="usd">36170000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory contextRef="c0" id="ixv-53489">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PREPAYMENTS,
                                            OTHER RECEIVABLES AND OTHER ASSETS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Prepayments for clinical trial expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;71,050&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100,769&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Prepaid listing expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-308"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-309"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Value added tax recoverable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,748&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,685&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,455&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;Deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,367&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,159&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;309&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Prepayment for treasury share purchase fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,754&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,258&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Other prepayments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,644&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,603&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,662&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;123,211&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;192,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;27,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of financial assets included in prepayments, other receivables and other assets approximate to their fair values.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial assets included in the above balances relate to receivables for which there was no recent history of default or past due amounts.
As at December 31, 2024 and 2025, the loss allowance was assessed to be minimal.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory>
    <ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory contextRef="c0" id="ixv-53500">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Prepayments for clinical trial expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;71,050&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100,769&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,410&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Prepaid listing expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-308"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-309"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Value added tax recoverable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,748&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,685&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,455&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;Deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,367&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,159&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;309&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Prepayment for treasury share purchase fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,754&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,258&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Other prepayments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,644&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,603&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,662&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;123,211&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;192,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;27,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory>
    <aapg:PrepaymentsForClinicalTrialExpenses contextRef="c14" decimals="-3" id="ixv-71754" unitRef="cny">71050000</aapg:PrepaymentsForClinicalTrialExpenses>
    <aapg:PrepaymentsForClinicalTrialExpenses contextRef="c15" decimals="-3" id="ixv-71755" unitRef="cny">100769000</aapg:PrepaymentsForClinicalTrialExpenses>
    <aapg:PrepaymentsForClinicalTrialExpenses contextRef="c15" decimals="-3" id="ixv-71756" unitRef="usd">14410000</aapg:PrepaymentsForClinicalTrialExpenses>
    <aapg:PrepaidListingExpense contextRef="c14" decimals="-3" id="ixv-71757" unitRef="cny">22465000</aapg:PrepaidListingExpense>
    <ifrs-full:ValueAddedTaxReceivables contextRef="c14" decimals="-3" id="ixv-71758" unitRef="cny">9794000</ifrs-full:ValueAddedTaxReceivables>
    <ifrs-full:ValueAddedTaxReceivables contextRef="c15" decimals="-3" id="ixv-71759" unitRef="cny">46748000</ifrs-full:ValueAddedTaxReceivables>
    <ifrs-full:ValueAddedTaxReceivables contextRef="c15" decimals="-3" id="ixv-71760" unitRef="usd">6685000</ifrs-full:ValueAddedTaxReceivables>
    <ifrs-full:OtherReceivables contextRef="c14" decimals="-3" id="ixv-71761" unitRef="cny">6137000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables contextRef="c15" decimals="-3" id="ixv-71762" unitRef="cny">1455000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables contextRef="c15" decimals="-3" id="ixv-71763" unitRef="usd">208000</ifrs-full:OtherReceivables>
    <aapg:DepositsAssetsPrepayments contextRef="c14" decimals="-3" id="ixv-71764" unitRef="cny">5367000</aapg:DepositsAssetsPrepayments>
    <aapg:DepositsAssetsPrepayments contextRef="c15" decimals="-3" id="ixv-71765" unitRef="cny">2159000</aapg:DepositsAssetsPrepayments>
    <aapg:DepositsAssetsPrepayments contextRef="c15" decimals="-3" id="ixv-71766" unitRef="usd">309000</aapg:DepositsAssetsPrepayments>
    <aapg:PrepaymentForTreasurySharePurchaseFees contextRef="c14" decimals="-3" id="ixv-71767" unitRef="cny">4754000</aapg:PrepaymentForTreasurySharePurchaseFees>
    <aapg:PrepaymentForTreasurySharePurchaseFees contextRef="c15" decimals="-3" id="ixv-71768" unitRef="cny">8798000</aapg:PrepaymentForTreasurySharePurchaseFees>
    <aapg:PrepaymentForTreasurySharePurchaseFees contextRef="c15" decimals="-3" id="ixv-71769" unitRef="usd">1258000</aapg:PrepaymentForTreasurySharePurchaseFees>
    <ifrs-full:Prepayments contextRef="c14" decimals="-3" id="ixv-71770" unitRef="cny">3644000</ifrs-full:Prepayments>
    <ifrs-full:Prepayments contextRef="c15" decimals="-3" id="ixv-71771" unitRef="cny">32603000</ifrs-full:Prepayments>
    <ifrs-full:Prepayments contextRef="c15" decimals="-3" id="ixv-71772" unitRef="usd">4662000</ifrs-full:Prepayments>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c14" decimals="-3" id="ixv-71773" unitRef="cny">123211000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c15" decimals="-3" id="ixv-71774" unitRef="cny">192532000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c15" decimals="-3" id="ixv-71775" unitRef="usd">27532000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory contextRef="c0" id="ixv-53699">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CASH
                                            AND BANK BALANCES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    and cash equivalents as stated in the consolidated statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;893,100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,195,784&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,995&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Restricted
    cash&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,633&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,685&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;812&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Time
    deposits with original maturity of more than three months&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;343,478&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,268,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;181,410&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    and bank balances as stated in the consolidated statements of financial position&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,261,211&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,470,085&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;353,217&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominated
    in:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;298,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;205,783&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,426&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;947,012&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,257,307&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;322,791&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;HK$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,812&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,827&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;547&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,465&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,168&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;453&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,261,211&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,470,085&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;353,217&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the end of the reporting period, the cash and bank balances of the Group denominated in RMB amounted to RMB205,783 (US$29,426) (2024:
RMB298,922). The RMB is not freely convertible into other currencies, however, under Chinese mainland&#x2019;s Foreign Exchange Control Regulations
and Administration of Settlement, and Sale and Payment of Foreign Exchange Regulations, the Group is permitted to exchange RMB for other
currencies through banks authorized to conduct foreign exchange business.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
at banks earn interest at floating rates based on daily bank deposit rates. Time deposits with original maturity of more than three
months earn interest at fixed interest rates for varying periods of between two years and three years. The bank balances are deposited
with creditworthy banks with no recent history of default.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfCashAndBankBalancesAtCentralBanksExplanatory>
    <aapg:ScheduleOfCashAndBankBalancesExplanatory contextRef="c0" id="ixv-53709">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    and cash equivalents as stated in the consolidated statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;893,100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,195,784&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,995&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Restricted
    cash&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,633&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,685&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;812&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Time
    deposits with original maturity of more than three months&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;343,478&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,268,616&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;181,410&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    and bank balances as stated in the consolidated statements of financial position&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,261,211&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,470,085&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;353,217&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominated
    in:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;298,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;205,783&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,426&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;947,012&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,257,307&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;322,791&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;HK$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,812&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,827&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;547&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,465&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,168&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;453&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,261,211&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,470,085&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;353,217&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfCashAndBankBalancesExplanatory>
    <ifrs-full:CashAndCashEquivalents contextRef="c14" decimals="-3" id="ixv-71776" unitRef="cny">893100000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-71777" unitRef="cny">1195784000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-71778" unitRef="usd">170995000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c14" decimals="-3" id="ixv-71779" unitRef="cny">24633000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-71780" unitRef="cny">5685000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c15" decimals="-3" id="ixv-71781" unitRef="usd">812000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:DepositsFromBanks contextRef="c14" decimals="-3" id="ixv-71782" unitRef="cny">343478000</ifrs-full:DepositsFromBanks>
    <ifrs-full:DepositsFromBanks contextRef="c15" decimals="-3" id="ixv-71783" unitRef="cny">1268616000</ifrs-full:DepositsFromBanks>
    <ifrs-full:DepositsFromBanks contextRef="c15" decimals="-3" id="ixv-71784" unitRef="usd">181410000</ifrs-full:DepositsFromBanks>
    <ifrs-full:BalancesWithBanks contextRef="c14" decimals="-3" id="ixv-71785" unitRef="cny">1261211000</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks contextRef="c15" decimals="-3" id="ixv-71786" unitRef="cny">2470085000</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks contextRef="c15" decimals="-3" id="ixv-71787" unitRef="usd">353217000</ifrs-full:BalancesWithBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c309"
      decimals="-3"
      id="ixv-71788"
      unitRef="cny">298922000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c310"
      decimals="-3"
      id="ixv-71789"
      unitRef="cny">205783000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c310"
      decimals="-3"
      id="ixv-71790"
      unitRef="usd">29426000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c311"
      decimals="-3"
      id="ixv-71791"
      unitRef="cny">947012000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c312"
      decimals="-3"
      id="ixv-71792"
      unitRef="cny">2257307000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c312"
      decimals="-3"
      id="ixv-71793"
      unitRef="usd">322791000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c313"
      decimals="-3"
      id="ixv-71794"
      unitRef="cny">13812000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c314"
      decimals="-3"
      id="ixv-71795"
      unitRef="cny">3827000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c314"
      decimals="-3"
      id="ixv-71796"
      unitRef="usd">547000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c315"
      decimals="-3"
      id="ixv-71797"
      unitRef="cny">1465000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c316"
      decimals="-3"
      id="ixv-71798"
      unitRef="cny">3168000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c316"
      decimals="-3"
      id="ixv-71799"
      unitRef="usd">453000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c14" decimals="-3" id="ixv-71800" unitRef="cny">1261211000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c15" decimals="-3" id="ixv-71801" unitRef="cny">2470085000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks contextRef="c15" decimals="-3" id="ixv-71802" unitRef="usd">353217000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c306"
      decimals="-3"
      id="ixv-71803"
      unitRef="cny">205783000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c307"
      decimals="-3"
      id="ixv-71804"
      unitRef="usd">29426000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c308"
      decimals="-3"
      id="ixv-71805"
      unitRef="cny">298922000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory contextRef="c0" id="ixv-54065">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;TRADE
                                            PAYABLES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
aging analysis of the trade payables as at the end of each reporting period, based on the invoice date, is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within 1 month&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;72,506&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,119&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,030&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 to 3 months&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,288&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,648&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;522&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3 to 6 months&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,172&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,712&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,966&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;106,740&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,264&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
trade payables are non-interest-bearing and are normally settled in less than six months.&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <aapg:DisclosureOfTradePayablesExplanatory contextRef="c0" id="ixv-54075">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
aging analysis of the trade payables as at the end of each reporting period, based on the invoice date, is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within 1 month&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;72,506&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,119&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,030&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 to 3 months&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,288&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,648&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;522&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3 to 6 months&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,172&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,973&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,712&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,966&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;106,740&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,264&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfTradePayablesExplanatory>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c317"
      decimals="-3"
      id="ixv-71806"
      unitRef="cny">72506000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c318"
      decimals="-3"
      id="ixv-71807"
      unitRef="cny">91119000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c318"
      decimals="-3"
      id="ixv-71808"
      unitRef="usd">13030000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c319"
      decimals="-3"
      id="ixv-71809"
      unitRef="cny">6288000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c320"
      decimals="-3"
      id="ixv-71810"
      unitRef="cny">3648000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c320"
      decimals="-3"
      id="ixv-71811"
      unitRef="usd">522000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c321"
      decimals="-3"
      id="ixv-71812"
      unitRef="cny">13172000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c322"
      decimals="-3"
      id="ixv-71813"
      unitRef="cny">11973000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c322"
      decimals="-3"
      id="ixv-71814"
      unitRef="usd">1712000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c14" decimals="-3" id="ixv-71815" unitRef="cny">91966000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c15" decimals="-3" id="ixv-71816" unitRef="cny">106740000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c15" decimals="-3" id="ixv-71817" unitRef="usd">15264000</ifrs-full:TradeAndOtherCurrentPayables>
    <aapg:DisclosureOfOtherPayablesAndAccrualsTextBlock contextRef="c0" id="ixv-54303">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;OTHER
                                            PAYABLES AND ACCRUALS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    promotion expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,009&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;121,545&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,381&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payroll
    payables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;61,848&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;78,423&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payables
    for construction cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,381&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,888&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;842&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    payables-current portion (note 36)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,344&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,340&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,194&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current liabilities-current portion (note 36)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;281&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    payables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,442&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21,493&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government
    subsidy&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,232&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
    payables other than income tax&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,627&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,700&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,959&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,847&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,709&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;387&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;258,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;276,666&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;39,563&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
payables are non-interest-bearing.&lt;/span&gt;&lt;/p&gt;</aapg:DisclosureOfOtherPayablesAndAccrualsTextBlock>
    <aapg:DisclosureofOtherPayablesAndAccrualsExplanatory contextRef="c0" id="ixv-54313">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    promotion expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,009&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;121,545&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,381&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payroll
    payables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;61,848&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;78,423&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payables
    for construction cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,381&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,888&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;842&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    payables-current portion (note 36)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,344&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,340&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,194&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current liabilities-current portion (note 36)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;281&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    payables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23,442&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21,493&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,073&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government
    subsidy&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,232&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
    payables other than income tax&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,627&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,700&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,959&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,847&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,709&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;387&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;258,098&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;276,666&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;39,563&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureofOtherPayablesAndAccrualsExplanatory>
    <ifrs-full:AccrualsClassifiedAsCurrent contextRef="c14" decimals="-3" id="ixv-71818" unitRef="cny">67009000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:AccrualsClassifiedAsCurrent contextRef="c15" decimals="-3" id="ixv-71819" unitRef="cny">121545000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:AccrualsClassifiedAsCurrent contextRef="c15" decimals="-3" id="ixv-71820" unitRef="usd">17381000</ifrs-full:AccrualsClassifiedAsCurrent>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="c14" decimals="-3" id="ixv-71821" unitRef="cny">61848000</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="c15" decimals="-3" id="ixv-71822" unitRef="cny">78423000</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="c15" decimals="-3" id="ixv-71823" unitRef="usd">11214000</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <aapg:CurretPayablesForConstructionCost contextRef="c14" decimals="-3" id="ixv-71824" unitRef="cny">35381000</aapg:CurretPayablesForConstructionCost>
    <aapg:CurretPayablesForConstructionCost contextRef="c15" decimals="-3" id="ixv-71825" unitRef="cny">5888000</aapg:CurretPayablesForConstructionCost>
    <aapg:CurretPayablesForConstructionCost contextRef="c15" decimals="-3" id="ixv-71826" unitRef="usd">842000</aapg:CurretPayablesForConstructionCost>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c14" decimals="-3" id="ixv-71827" unitRef="cny">29344000</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c15" decimals="-3" id="ixv-71828" unitRef="cny">8340000</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c15" decimals="-3" id="ixv-71829" unitRef="usd">1194000</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings contextRef="c15" decimals="-3" id="ixv-71830" unitRef="cny">1968000</ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings contextRef="c15" decimals="-3" id="ixv-71831" unitRef="usd">281000</ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:OtherPayables contextRef="c14" decimals="-3" id="ixv-71832" unitRef="cny">23442000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables contextRef="c15" decimals="-3" id="ixv-71833" unitRef="cny">21493000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables contextRef="c15" decimals="-3" id="ixv-71834" unitRef="usd">3073000</ifrs-full:OtherPayables>
    <aapg:GovernmentSubsidy contextRef="c14" decimals="-3" id="ixv-71835" unitRef="cny">16600000</aapg:GovernmentSubsidy>
    <aapg:GovernmentSubsidy contextRef="c15" decimals="-3" id="ixv-71836" unitRef="cny">22600000</aapg:GovernmentSubsidy>
    <aapg:GovernmentSubsidy contextRef="c15" decimals="-3" id="ixv-71837" unitRef="usd">3232000</aapg:GovernmentSubsidy>
    <ifrs-full:CurrentExciseTaxPayables contextRef="c14" decimals="-3" id="ixv-71838" unitRef="cny">9627000</ifrs-full:CurrentExciseTaxPayables>
    <ifrs-full:CurrentExciseTaxPayables contextRef="c15" decimals="-3" id="ixv-71839" unitRef="cny">13700000</ifrs-full:CurrentExciseTaxPayables>
    <ifrs-full:CurrentExciseTaxPayables contextRef="c15" decimals="-3" id="ixv-71840" unitRef="usd">1959000</ifrs-full:CurrentExciseTaxPayables>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities contextRef="c14" decimals="-3" id="ixv-71841" unitRef="cny">14847000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities contextRef="c15" decimals="-3" id="ixv-71842" unitRef="cny">2709000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities contextRef="c15" decimals="-3" id="ixv-71843" unitRef="usd">387000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:OtherCurrentPayables contextRef="c14" decimals="-3" id="ixv-71844" unitRef="cny">258098000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables contextRef="c15" decimals="-3" id="ixv-71845" unitRef="cny">276666000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables contextRef="c15" decimals="-3" id="ixv-71846" unitRef="usd">39563000</ifrs-full:OtherCurrentPayables>
    <aapg:DisclosureOfContractLiabilitiesTextBlock contextRef="c0" id="ixv-54675">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CONTRACT
                                            LIABILITIES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of contract liabilities as at December 31, 2024 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term advances recognized
    from customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    advances recognized from customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;248,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;210,224&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;285,945&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;247,709&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contract
liabilities include long-term and short-term advances related to commercialization rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2021, the Group entered into an agreement with Innovent Biologics (Suzhou) Co., Ltd (&#x201c;Innovent&#x201d;). Under the agreement,
the Group owns all intellectual property generated in connection with the development and commercialization of HQP1351. Innovent was
granted the commercialization rights of HQP1351 in China and should make a non-refundable payment and milestone payments for such rights
to the Group, which are recorded under contract liabilities and recognized as revenue over time during the commercialization period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the agreement, the Group recognized RMB349,523 (US$49,981) in aggregate as contract liabilities from contract inception
through December 31, 2025 (2024: RMB349,523). The Group recognized RMB37,485 (US$5,360) as revenue during the year ended December 31,
2025 (2024: RMB37,485; 2023: RMB26,049). Milestone payments are recognized as the transaction price when the Group can conclude that
it is highly probable that there will not be a subsequent reversal of a significant amount of revenue.&lt;/span&gt;&lt;/p&gt;</aapg:DisclosureOfContractLiabilitiesTextBlock>
    <aapg:DisclosureOfContractsLiabilitiesExplanatory contextRef="c0" id="ixv-54685">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of contract liabilities as at December 31, 2024 and 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term advances recognized
    from customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37,485&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    advances recognized from customers&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commercialization
    rights income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;248,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;210,224&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;285,945&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;247,709&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,422&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfContractsLiabilitiesExplanatory>
    <ifrs-full:ContractLiabilities
      contextRef="c328"
      decimals="-3"
      id="ixv-71847"
      unitRef="cny">37485000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="c329"
      decimals="-3"
      id="ixv-71848"
      unitRef="cny">37485000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="c329"
      decimals="-3"
      id="ixv-71849"
      unitRef="usd">5360000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="c330"
      decimals="-3"
      id="ixv-71850"
      unitRef="cny">248460000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="c331"
      decimals="-3"
      id="ixv-71851"
      unitRef="cny">210224000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="c331"
      decimals="-3"
      id="ixv-71852"
      unitRef="usd">30062000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities contextRef="c14" decimals="-3" id="ixv-71853" unitRef="cny">285945000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities contextRef="c15" decimals="-3" id="ixv-71854" unitRef="cny">247709000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities contextRef="c15" decimals="-3" id="ixv-71855" unitRef="usd">35422000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="c323"
      decimals="-3"
      id="ixv-71856"
      unitRef="cny">349523000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="c323"
      decimals="-3"
      id="ixv-71857"
      unitRef="usd">49981000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="c324"
      decimals="-3"
      id="ixv-71858"
      unitRef="cny">349523000</ifrs-full:ContractLiabilities>
    <ifrs-full:Revenue
      contextRef="c325"
      decimals="-3"
      id="ixv-71859"
      unitRef="cny">37485000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c325"
      decimals="-3"
      id="ixv-71860"
      unitRef="usd">5360000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c326"
      decimals="-3"
      id="ixv-71861"
      unitRef="cny">37485000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="c327"
      decimals="-3"
      id="ixv-71862"
      unitRef="cny">26049000</ifrs-full:Revenue>
    <ifrs-full:DisclosureOfBorrowingsExplanatory contextRef="c0" id="ixv-55020">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;INTEREST-BEARING
                                            BANK AND OTHER BORROWINGS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective interest rate&lt;br/&gt; per annum (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 50%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term borrowing&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 25%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.60-2.70 or 1 year LPR-0.30 to 0.75&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long-term bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 year LPR-0.15 to 0.65 or 1 year LPR+0.65 to 0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;213,170&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long-term bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.80 - 4.55&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long-term bank loans &#x2013; secured*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 year LPR-0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.00 - 4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total &#x2013; current&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;779,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 year LPR-0.45 to 0.65 or 1 year LPR+0.70 to 0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026 - 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;203,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.80-4.50&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; secured*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 year LPR-0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026 - 2038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;588,292&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.00 - 4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026 - 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total &#x2013; non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;889,435&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,668,497&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective interest rate&lt;br/&gt; per annum (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 38%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term borrowing&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 25%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.11-2.50 or 1 year LPR-0.60 to 0.89&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 11%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,040,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;148,718&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long term bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.80&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long term bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 year LPR-0.45 to 0.75&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;156,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long-term bank loans &#x2013; secured*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 year LPR-0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,359&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.00 - 4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,041&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total &#x2013; current&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,222,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;174,812&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; font-weight: bold; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 year LPR-0.45 to 0.75&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027 &#x2013; 2028&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;114,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,431&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.80&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43,750&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,256&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; secured*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 year LPR-0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027 &#x2013; 2038&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;583,675&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,464&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.00 - 4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027 &#x2013; 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,913&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,133&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total &#x2013; non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;757,238&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;108,284&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,979,719&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;283,096&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note:
LPR represents the Loan Prime Rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bank loans amounting to RMB600,173 (US$85,823) as at December 31, 2025 were secured by the pledge of the Group&#x2019;s buildings with a net carrying amount of RMB676,985 (US$96,808) and right-of-use assets with a net carrying amount of RMB25,338 (US$3,623) as at December 31, 2025. Such loans were also guaranteed by two of the Group&#x2019;s subsidiaries.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
bank loans amounting to RMB599,745 as at December 31, 2024 were secured by the pledge of the Group&#x2019;s buildings with a net carrying
amount of RMB731,282 and right-of-use assets with a net carrying amount of RMB26,468 as at December 31, 2024. Such loans were also guaranteed
by two of the Group&#x2019;s subsidiaries.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
unsecured bank loans amounting to RMB140,000 (US$20,020) (2024: RMB278,070) were guaranteed by the Group&#x2019;s subsidiaries as at December
31, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of borrowings are all denominated in RMB. The weighted average interest rate for the outstanding short-term bank loans
as of December 31, 2024 and 2025, was 2.63% and 2.18%, respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Analyzed into:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within
    one year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;779,062&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,222,481&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;174,812&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    the second year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;242,473&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160,201&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    the third to fifth years, inclusive&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;159,355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,034&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beyond
    five years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;487,607&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;456,937&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,342&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,668,497&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,979,719&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;283,096&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfBorrowingsExplanatory>
    <aapg:ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock contextRef="c0" id="ixv-55030">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective interest rate&lt;br/&gt; per annum (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 50%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term borrowing&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 25%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.60-2.70 or 1 year LPR-0.30 to 0.75&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long-term bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 year LPR-0.15 to 0.65 or 1 year LPR+0.65 to 0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;213,170&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long-term bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.80 - 4.55&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;255,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long-term bank loans &#x2013; secured*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 year LPR-0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,453&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.00 - 4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total &#x2013; current&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;779,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 year LPR-0.45 to 0.65 or 1 year LPR+0.70 to 0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026 - 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;203,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.80-4.50&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; secured*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 year LPR-0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026 - 2038&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;588,292&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.00 - 4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026 - 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total &#x2013; non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;889,435&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,668,497&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective interest rate&lt;br/&gt; per annum (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 38%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term borrowing&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 25%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.11-2.50 or 1 year LPR-0.60 to 0.89&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 11%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,040,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;148,718&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long term bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.80&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long term bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 year LPR-0.45 to 0.75&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;156,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,336&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current portion of long-term bank loans &#x2013; secured*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 year LPR-0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,359&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.00 - 4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,041&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total &#x2013; current&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,222,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;174,812&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; font-weight: bold; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1 year LPR-0.45 to 0.75&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027 &#x2013; 2028&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;114,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,431&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; unsecured&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.80&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43,750&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,256&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank loans &#x2013; secured*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 year LPR-0.85&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027 &#x2013; 2038&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;583,675&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,464&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liabilities (note 13(b))&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.00 - 4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027 &#x2013; 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,913&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,133&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total &#x2013; non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;757,238&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;108,284&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,979,719&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;283,096&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The bank loans amounting to RMB600,173 (US$85,823) as at December 31, 2025 were secured by the pledge of the Group&#x2019;s buildings with a net carrying amount of RMB676,985 (US$96,808) and right-of-use assets with a net carrying amount of RMB25,338 (US$3,623) as at December 31, 2025. Such loans were also guaranteed by two of the Group&#x2019;s subsidiaries.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</aapg:ScheduleOfInterestBearingBankAndOtherBorrowingsTableTextBlock>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c337" id="ixv-55104">2.60-2.70 or 1 year LPR-0.30 to 0.75</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c338" id="ixv-71863"/>
    <ifrs-full:BorrowingsMaturity contextRef="c337" id="ixv-71864">2025</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c339" id="ixv-71865"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c340"
      decimals="-3"
      id="ixv-71866"
      unitRef="cny">290000000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c341" id="ixv-55128">1 year LPR-0.15 to 0.65 or 1 year LPR+0.65 to 0.85</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c342" id="ixv-71867"/>
    <ifrs-full:BorrowingsMaturity contextRef="c341" id="ixv-71868">2025</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c343" id="ixv-71869"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c344"
      decimals="-3"
      id="ixv-71870"
      unitRef="cny">213170000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c345" id="ixv-55152">2.80 - 4.55</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c346" id="ixv-71871"/>
    <ifrs-full:BorrowingsMaturity contextRef="c345" id="ixv-71872">2025</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c347" id="ixv-71873"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c348"
      decimals="-3"
      id="ixv-71874"
      unitRef="cny">255000000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c349" id="ix_48_fact">5 year LPR-0.85</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c350" id="ix_49_fact"/>
    <ifrs-full:BorrowingsMaturity contextRef="c349" id="ix_50_fact">2025</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c351" id="ix_51_fact"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c352"
      decimals="-3"
      id="ix_52_fact"
      unitRef="cny">11453000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c353" id="ixv-55200">4.00 - 4.35</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c354" id="ixv-71879"/>
    <ifrs-full:BorrowingsMaturity contextRef="c353" id="ixv-71880">2025</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c355" id="ixv-71881"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c356"
      decimals="-3"
      id="ixv-71882"
      unitRef="cny">9439000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c14" decimals="-3" id="ixv-71883" unitRef="cny">779062000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c357" id="ixv-55316">1 year LPR-0.45 to 0.65 or 1 year LPR+0.70 to 0.85</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c358" id="ixv-71884">2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c357" id="ixv-71885"/>
    <ifrs-full:BorrowingsMaturity contextRef="c359" id="ixv-71886">2028</ifrs-full:BorrowingsMaturity>
    <ifrs-full:LongtermBorrowings
      contextRef="c360"
      decimals="-3"
      id="ixv-71887"
      unitRef="cny">203100000</ifrs-full:LongtermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c361" id="ixv-55340">2.80-4.50</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c362" id="ixv-71888">2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c361" id="ixv-71889"/>
    <ifrs-full:BorrowingsMaturity contextRef="c363" id="ixv-71890">2027</ifrs-full:BorrowingsMaturity>
    <ifrs-full:LongtermBorrowings
      contextRef="c364"
      decimals="-3"
      id="ixv-71891"
      unitRef="cny">77250000</ifrs-full:LongtermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c365" id="ix_53_fact">5 year LPR-0.85</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c366" id="ix_54_fact">2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c365" id="ix_55_fact"/>
    <ifrs-full:BorrowingsMaturity contextRef="c367" id="ix_56_fact">2038</ifrs-full:BorrowingsMaturity>
    <ifrs-full:LongtermBorrowings
      contextRef="c368"
      decimals="-3"
      id="ix_57_fact"
      unitRef="cny">588292000</ifrs-full:LongtermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c369" id="ixv-55388">4.00 - 4.35</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c370" id="ixv-71896">2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c369" id="ixv-71897"/>
    <ifrs-full:BorrowingsMaturity contextRef="c371" id="ixv-71898">2028</ifrs-full:BorrowingsMaturity>
    <ifrs-full:LongtermBorrowings
      contextRef="c372"
      decimals="-3"
      id="ixv-71899"
      unitRef="cny">20793000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c14" decimals="-3" id="ixv-71900" unitRef="cny">889435000</ifrs-full:LongtermBorrowings>
    <ifrs-full:Borrowings contextRef="c14" decimals="-3" id="ixv-71901" unitRef="cny">1668497000</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c373" id="ixv-55585">2.11-2.50 or 1 year LPR-0.60 to 0.89</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c374" id="ixv-71902"/>
    <ifrs-full:BorrowingsMaturity contextRef="c373" id="ixv-71903">2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c375" id="ixv-71904"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c376"
      decimals="-3"
      id="ixv-71905"
      unitRef="cny">1040000000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="c376"
      decimals="-3"
      id="ixv-71906"
      unitRef="usd">148718000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c377" id="ixv-55613">2.80</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c378" id="ixv-71907"/>
    <ifrs-full:BorrowingsMaturity contextRef="c377" id="ixv-71908">2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c379" id="ixv-71909"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c380"
      decimals="-3"
      id="ixv-71910"
      unitRef="cny">2500000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="c380"
      decimals="-3"
      id="ixv-71911"
      unitRef="usd">358000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c381" id="ixv-55641">1 year LPR-0.45 to 0.75</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c382" id="ixv-71912"/>
    <ifrs-full:BorrowingsMaturity contextRef="c381" id="ixv-71913">2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c383" id="ixv-71914"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c384"
      decimals="-3"
      id="ixv-71915"
      unitRef="cny">156200000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="c384"
      decimals="-3"
      id="ixv-71916"
      unitRef="usd">22336000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c385" id="ix_58_fact">5 year LPR-0.85</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c386" id="ix_59_fact"/>
    <ifrs-full:BorrowingsMaturity contextRef="c385" id="ix_60_fact">2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c387" id="ix_61_fact"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c388"
      decimals="-3"
      id="ix_62_fact"
      unitRef="cny">16498000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="c388"
      decimals="-3"
      id="ix_63_fact"
      unitRef="usd">2359000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c389" id="ixv-55697">4.00 - 4.35</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c390" id="ixv-71922"/>
    <ifrs-full:BorrowingsMaturity contextRef="c389" id="ixv-71923">2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c391" id="ixv-71924"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c392"
      decimals="-3"
      id="ixv-71925"
      unitRef="cny">7283000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="c392"
      decimals="-3"
      id="ixv-71926"
      unitRef="usd">1041000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c15" decimals="-3" id="ixv-71927" unitRef="cny">1222481000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c15" decimals="-3" id="ixv-71928" unitRef="usd">174812000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c393" id="ixv-55833">1 year LPR-0.45 to 0.75</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c394" id="ixv-71929">2027</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c393" id="ixv-71930"/>
    <ifrs-full:BorrowingsMaturity contextRef="c395" id="ixv-71931">2028</ifrs-full:BorrowingsMaturity>
    <ifrs-full:LongtermBorrowings
      contextRef="c396"
      decimals="-3"
      id="ixv-71932"
      unitRef="cny">114900000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="c396"
      decimals="-3"
      id="ixv-71933"
      unitRef="usd">16431000</ifrs-full:LongtermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c397" id="ixv-55861">2.80</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c398" id="ixv-71934"/>
    <ifrs-full:BorrowingsMaturity contextRef="c397" id="ixv-71935">2027</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c399" id="ixv-71936"/>
    <ifrs-full:LongtermBorrowings
      contextRef="c400"
      decimals="-3"
      id="ixv-71937"
      unitRef="cny">43750000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="c400"
      decimals="-3"
      id="ixv-71938"
      unitRef="usd">6256000</ifrs-full:LongtermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c401" id="ix_64_fact">5 year LPR-0.85</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c402" id="ix_65_fact">2027</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c401" id="ix_66_fact"/>
    <ifrs-full:BorrowingsMaturity contextRef="c403" id="ix_67_fact">2038</ifrs-full:BorrowingsMaturity>
    <ifrs-full:LongtermBorrowings
      contextRef="c404"
      decimals="-3"
      id="ix_68_fact"
      unitRef="cny">583675000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="c404"
      decimals="-3"
      id="ix_69_fact"
      unitRef="usd">83464000</ifrs-full:LongtermBorrowings>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c405" id="ixv-55917">4.00 - 4.35</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity contextRef="c406" id="ixv-71944">2027</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsMaturity contextRef="c405" id="ixv-71945"/>
    <ifrs-full:BorrowingsMaturity contextRef="c407" id="ixv-71946">2028</ifrs-full:BorrowingsMaturity>
    <ifrs-full:LongtermBorrowings
      contextRef="c408"
      decimals="-3"
      id="ixv-71947"
      unitRef="cny">14913000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="c408"
      decimals="-3"
      id="ixv-71948"
      unitRef="usd">2133000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c15" decimals="-3" id="ixv-71949" unitRef="cny">757238000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c15" decimals="-3" id="ixv-71950" unitRef="usd">108284000</ifrs-full:LongtermBorrowings>
    <ifrs-full:Borrowings contextRef="c15" decimals="-3" id="ixv-71951" unitRef="cny">1979719000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c15" decimals="-3" id="ixv-71952" unitRef="usd">283096000</ifrs-full:Borrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="c332"
      decimals="-3"
      id="ixv-71953"
      unitRef="cny">600173000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="c332"
      decimals="-3"
      id="ixv-71954"
      unitRef="usd">85823000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:Borrowings
      contextRef="c332"
      decimals="-3"
      id="ixv-71955"
      unitRef="cny">676985000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c332"
      decimals="-3"
      id="ixv-71956"
      unitRef="usd">96808000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c333"
      decimals="-3"
      id="ixv-71957"
      unitRef="cny">25338000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c333"
      decimals="-3"
      id="ixv-71958"
      unitRef="usd">3623000</ifrs-full:Borrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="c334"
      decimals="-3"
      id="ixv-71959"
      unitRef="cny">599745000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:Borrowings
      contextRef="c335"
      decimals="-3"
      id="ixv-71960"
      unitRef="cny">731282000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c336"
      decimals="-3"
      id="ixv-71961"
      unitRef="cny">26468000</ifrs-full:Borrowings>
    <ifrs-full:UnsecuredBankLoansReceived contextRef="c15" decimals="-3" id="ixv-71962" unitRef="usd">140000000</ifrs-full:UnsecuredBankLoansReceived>
    <ifrs-full:UnsecuredBankLoansReceived contextRef="c15" decimals="-3" id="ixv-71963" unitRef="cny">20020000</ifrs-full:UnsecuredBankLoansReceived>
    <ifrs-full:UnsecuredBankLoansReceived contextRef="c14" decimals="-3" id="ixv-71964" unitRef="cny">278070000</ifrs-full:UnsecuredBankLoansReceived>
    <aapg:ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock contextRef="c0" id="ixv-71965">The weighted average interest rate for the outstanding short-term bank loans
as of December 31, 2024 and 2025, was 2.63% and 2.18%, respectively.&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Analyzed into:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within
    one year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;779,062&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,222,481&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;174,812&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    the second year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;242,473&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160,201&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,908&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    the third to fifth years, inclusive&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;159,355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,034&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beyond
    five years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;487,607&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;456,937&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,342&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,668,497&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,979,719&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;283,096&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfCarryingAmountsOfBorrowingsTableTextBlock>
    <ifrs-full:BorrowingsInterestRate contextRef="c14" decimals="4" id="ixv-71966" unitRef="pure">0.0263</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate contextRef="c15" decimals="4" id="ixv-71967" unitRef="pure">0.0218</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:Borrowings
      contextRef="c170"
      decimals="-3"
      id="ixv-71968"
      unitRef="cny">779062000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c171"
      decimals="-3"
      id="ixv-71969"
      unitRef="cny">1222481000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c171"
      decimals="-3"
      id="ixv-71970"
      unitRef="usd">174812000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c409"
      decimals="-3"
      id="ixv-71971"
      unitRef="cny">242473000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c410"
      decimals="-3"
      id="ixv-71972"
      unitRef="cny">160201000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c410"
      decimals="-3"
      id="ixv-71973"
      unitRef="usd">22908000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c411"
      decimals="-3"
      id="ixv-71974"
      unitRef="cny">159355000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c412"
      decimals="-3"
      id="ixv-71975"
      unitRef="cny">140100000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c412"
      decimals="-3"
      id="ixv-71976"
      unitRef="usd">20034000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c413"
      decimals="-3"
      id="ixv-71977"
      unitRef="cny">487607000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c414"
      decimals="-3"
      id="ixv-71978"
      unitRef="cny">456937000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="c414"
      decimals="-3"
      id="ixv-71979"
      unitRef="usd">65342000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c14" decimals="-3" id="ixv-71980" unitRef="cny">1668497000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c15" decimals="-3" id="ixv-71981" unitRef="cny">1979719000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c15" decimals="-3" id="ixv-71982" unitRef="usd">283096000</ifrs-full:Borrowings>
    <ifrs-full:DisclosureOfDeferredIncomeExplanatory contextRef="c0" id="ixv-56420">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;DEFERRED
                                            INCOME&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government grants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;929&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
movements in government grants during the reporting period are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At beginning of
    the year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,360&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,932&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Received during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,740&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;143&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Portion
    classified as current liabilities (note 25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(16,600&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(22,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,146&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At end
    of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;929&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDeferredIncomeExplanatory>
    <aapg:ScheduleOfDeferredIncomeTableTextBlock contextRef="c0" id="ixv-56430">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Government grants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;929&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfDeferredIncomeTableTextBlock>
    <ifrs-full:CurrentGovernmentGrants contextRef="c14" decimals="-3" id="ixv-71983" unitRef="cny">27500000</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:CurrentGovernmentGrants contextRef="c15" decimals="-3" id="ixv-71984" unitRef="cny">6500000</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:CurrentGovernmentGrants contextRef="c15" decimals="-3" id="ixv-71985" unitRef="usd">929000</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:DisclosureOfGovernmentGrantsExplanatory contextRef="c0" id="ixv-56512">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
movements in government grants during the reporting period are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At beginning of
    the year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,360&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,932&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Received during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,740&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;143&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Portion
    classified as current liabilities (note 25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(16,600&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(22,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,146&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At end
    of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;929&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfGovernmentGrantsExplanatory>
    <ifrs-full:GovernmentGrants contextRef="c41" decimals="-3" id="ixv-71986" unitRef="cny">36360000</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants contextRef="c14" decimals="-3" id="ixv-71987" unitRef="cny">27500000</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants contextRef="c14" decimals="-3" id="ixv-71988" unitRef="usd">3932000</ifrs-full:GovernmentGrants>
    <aapg:RecognizedAsIncomeDuringTheYear contextRef="c13" decimals="-3" id="ixv-71989" unitRef="cny">-7740000</aapg:RecognizedAsIncomeDuringTheYear>
    <aapg:RecognizedAsIncomeDuringTheYear contextRef="c0" decimals="-3" id="ixv-71990" unitRef="cny">-1000000</aapg:RecognizedAsIncomeDuringTheYear>
    <aapg:RecognizedAsIncomeDuringTheYear contextRef="c0" decimals="-3" id="ixv-71991" unitRef="usd">-143000</aapg:RecognizedAsIncomeDuringTheYear>
    <aapg:PortionClassifiedAsCurrentLiabilities contextRef="c13" decimals="-3" id="ixv-71992" unitRef="cny">-16600000</aapg:PortionClassifiedAsCurrentLiabilities>
    <aapg:PortionClassifiedAsCurrentLiabilities contextRef="c0" decimals="-3" id="ixv-71993" unitRef="cny">-22000000</aapg:PortionClassifiedAsCurrentLiabilities>
    <aapg:PortionClassifiedAsCurrentLiabilities contextRef="c0" decimals="-3" id="ixv-71994" unitRef="usd">-3146000</aapg:PortionClassifiedAsCurrentLiabilities>
    <ifrs-full:GovernmentGrants contextRef="c14" decimals="-3" id="ixv-71995" unitRef="cny">27500000</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants contextRef="c15" decimals="-3" id="ixv-71996" unitRef="cny">6500000</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants contextRef="c15" decimals="-3" id="ixv-71997" unitRef="usd">929000</ifrs-full:GovernmentGrants>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="c0" id="ixv-56681">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SHARE
                                            CAPITAL AND TREASURY SHARES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issued
and fully paid&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of &lt;br/&gt;
    shares in &lt;br/&gt;
    issue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB
    equivalent&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary shares of US$0.0001 each&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,196,560&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of &lt;br/&gt;
    shares in &lt;br/&gt;
    issue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB
    equivalent&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary shares of US$0.0001 each&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;315,224,993&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;214&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of &lt;br/&gt;
    shares in &lt;br/&gt;
    issue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB
    equivalent&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary shares of US$0.0001 each&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;373,321,692&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;256&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Movements
in the issued share capital and treasury shares from January 1, 2023 to December 31, 2025 were as follows:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Treasury
    shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At January
    1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;265,185,950&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;180&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(26,552&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(26,372&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of ordinary shares
    (a)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the Pre-IPO share option scheme (b)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;911,062&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the 2021 RSU scheme (c)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,034&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus (d)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,528,514&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repurchase of ordinary
    shares (e)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,923&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,923&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs (f)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2023 and January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,196,560&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,351&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,154&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of ordinary shares
    (g)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,307,322&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the Pre-IPO share option scheme (h)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;656,077&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the 2021 RSU scheme (i)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,034&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus (j)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,631&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,631&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repurchase of ordinary
    shares (k)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,959&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,959&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs (l)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At December 31, 2024 and
    January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;315,224,993&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of ordinary shares
    (m)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,040,576&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the Pre-IPO share option scheme (n)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;455,263&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-335; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-336; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the 2021 RSU scheme and 2022 RSU scheme (o)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,008,253&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-337; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus (p)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,592,607&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-338; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-339; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-340; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repurchase of ordinary
    shares (q)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-341; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-342; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,590&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,590&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs (r)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-343; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-344; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;637&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;637&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;373,321,692&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;256&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,961&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,705&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;373,321,692&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(423&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(386&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the share placement, 22,500,000 placing shares of the Company were issued and allotted at a price of HK$24.45 per share on February 1, 2023, and an amount of RMB15 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2023, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company before December 31, 2023 to those grantees. In connection with the exercised share options, 911,062 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB1 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In June 2023, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2023 to those selected persons. In connection with the exercised RSUs, 71,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In June 2023, 1,528,514 ordinary shares and 1,237,884 treasury shares, being underlying shares of the RSUs granted under the 2021 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB1 and RMB1 were credited as share capital and treasury shares, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In November 2023, the Company instructed the trustee to purchase 250,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB5,923 for the purpose of the 2022 RSU scheme.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the exercise of RSUs granted under the 2018 and 2022 RSU Scheme, 1,069,461 treasury shares were allotted to the employees during the year ended December 31,2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the subscription of shares, 24,307,322 placing shares of the Company were issued and allotted at a price of HK$24.10 per share on June 20, 2024, and an amount of RMB17 was credited as share capital.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2024, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 656,077 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.5 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In June 2024, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2024 to those selected persons. In connection with the exercised RSUs, 65,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(j)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In September 2024, 397,949 treasury shares and 2,081,399 treasury shares, being underlying shares of the RSUs granted under the 2022 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB8,630 and RMB1.4 were both credited as treasury shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(k)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In February 2024, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB1,959 for the purpose of the 2022 RSU Scheme.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(l)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the vesting of RSUs granted under the 2018 and 2022 RSU Schemes, 939,687 treasury shares were allotted to the employees during the year ended December 31, 2024.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(m)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the subscription of shares, 7,325,000 ADS (represents 29,300,000 of the Company&#x2019;s ordinary shares) were offered at a price of US$17.25 per ADS on January 23, 2025, followed by an additional 935,144 ADS (represents 3,740,576 of the Company&#x2019;s ordinary shares) were offered at the same price on February 13, 2025, and 22,000,000 placing shares of the Company were issued and allotted at a price of HK$68.6 per share on July 17, 2025, amounts of RMB40 (US$6) was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(n)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2025, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 455,263 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.3 (US$0.04) was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(o)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During June to September 2025, the Company issued ordinary shares with respect to the restricted share units under the 2021 and 2022 RSU Scheme exercised by certain selected persons of the Company before December 31, 2025 to those selected persons. In connection with the exercised restricted share units, 1,008,253 new shares of the Company were issued, and an amount of RMB0.7 (US$0.1) was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(p)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In June 2025, 775,685 ordinary shares and 816,922 ordinary shares, being underlying shares of the restricted share units granted under the 2021 RSU scheme and the 2022 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB0.5 (US$0.07) and RMB0.6 (US$0.09) credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(q)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In April 2025, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB3,590 (US$513) for the purpose of the 2022 RSU scheme.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(r)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the vesting of restricted share units granted under the 2022 RSU Scheme, 17,925 treasury shares were allotted to the employees during the year ended December 31, 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="c0" id="ixv-56691">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issued
and fully paid&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of &lt;br/&gt;
    shares in &lt;br/&gt;
    issue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB
    equivalent&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary shares of US$0.0001 each&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,196,560&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of &lt;br/&gt;
    shares in &lt;br/&gt;
    issue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB
    equivalent&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary shares of US$0.0001 each&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;315,224,993&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;214&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of &lt;br/&gt;
    shares in &lt;br/&gt;
    issue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB
    equivalent&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ordinary shares of US$0.0001 each&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;373,321,692&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;256&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:ParValuePerShare
      contextRef="c436"
      decimals="4"
      id="ixv-71998"
      unitRef="usdPershares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c436"
      decimals="INF"
      id="ixv-71999"
      unitRef="shares">290196560</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity
      contextRef="c436"
      decimals="-3"
      id="ixv-72000"
      unitRef="usd">27000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="c436"
      decimals="-3"
      id="ixv-72001"
      unitRef="cny">197000</ifrs-full:Equity>
    <ifrs-full:ParValuePerShare
      contextRef="c437"
      decimals="4"
      id="ixv-72002"
      unitRef="usdPershares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c437"
      decimals="INF"
      id="ixv-72003"
      unitRef="shares">315224993</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity
      contextRef="c437"
      decimals="-3"
      id="ixv-72004"
      unitRef="usd">29000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="c437"
      decimals="-3"
      id="ixv-72005"
      unitRef="cny">214000</ifrs-full:Equity>
    <ifrs-full:ParValuePerShare
      contextRef="c438"
      decimals="4"
      id="ixv-72006"
      unitRef="usdPershares">0.0001</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c438"
      decimals="INF"
      id="ixv-72007"
      unitRef="shares">373321692</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity
      contextRef="c438"
      decimals="-3"
      id="ixv-72008"
      unitRef="usd">37000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="c438"
      decimals="-3"
      id="ixv-72009"
      unitRef="cny">256000</ifrs-full:Equity>
    <aapg:DisclosureOfShareCapitalAndTreasurySharesExplanatory contextRef="c0" id="ixv-56993">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Movements
in the issued share capital and treasury shares from January 1, 2023 to December 31, 2025 were as follows:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    capital&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Treasury
    shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At January
    1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;265,185,950&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;180&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(26,552&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(26,372&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of ordinary shares
    (a)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,500,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the Pre-IPO share option scheme (b)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;911,062&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the 2021 RSU scheme (c)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,034&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus (d)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,528,514&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repurchase of ordinary
    shares (e)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,923&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,923&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs (f)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2023 and January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,196,560&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,351&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,154&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of ordinary shares
    (g)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,307,322&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the Pre-IPO share option scheme (h)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;656,077&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the 2021 RSU scheme (i)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65,034&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus (j)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,631&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,631&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repurchase of ordinary
    shares (k)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,959&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,959&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs (l)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At December 31, 2024 and
    January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;315,224,993&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of ordinary shares
    (m)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,040,576&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the Pre-IPO share option scheme (n)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;455,263&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-335; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-336; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of shares under the 2021 RSU scheme and 2022 RSU scheme (o)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,008,253&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-337; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus (p)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,592,607&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-338; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-339; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-340; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repurchase of ordinary
    shares (q)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-341; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-342; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,590&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,590&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs (r)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-343; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-344; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;637&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;637&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;373,321,692&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;256&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,961&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,705&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;373,321,692&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(423&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(386&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the share placement, 22,500,000 placing shares of the Company were issued and allotted at a price of HK$24.45 per share on February 1, 2023, and an amount of RMB15 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2023, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company before December 31, 2023 to those grantees. In connection with the exercised share options, 911,062 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB1 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In June 2023, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2023 to those selected persons. In connection with the exercised RSUs, 71,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In June 2023, 1,528,514 ordinary shares and 1,237,884 treasury shares, being underlying shares of the RSUs granted under the 2021 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB1 and RMB1 were credited as share capital and treasury shares, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In November 2023, the Company instructed the trustee to purchase 250,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB5,923 for the purpose of the 2022 RSU scheme.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the exercise of RSUs granted under the 2018 and 2022 RSU Scheme, 1,069,461 treasury shares were allotted to the employees during the year ended December 31,2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the subscription of shares, 24,307,322 placing shares of the Company were issued and allotted at a price of HK$24.10 per share on June 20, 2024, and an amount of RMB17 was credited as share capital.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2024, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 656,077 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.5 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In June 2024, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2024 to those selected persons. In connection with the exercised RSUs, 65,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(j)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In September 2024, 397,949 treasury shares and 2,081,399 treasury shares, being underlying shares of the RSUs granted under the 2022 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB8,630 and RMB1.4 were both credited as treasury shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(k)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In February 2024, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB1,959 for the purpose of the 2022 RSU Scheme.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 0.25in; font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(l)&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 12pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the vesting of RSUs granted under the 2018 and 2022 RSU Schemes, 939,687 treasury shares were allotted to the employees during the year ended December 31, 2024.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(m)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the subscription of shares, 7,325,000 ADS (represents 29,300,000 of the Company&#x2019;s ordinary shares) were offered at a price of US$17.25 per ADS on January 23, 2025, followed by an additional 935,144 ADS (represents 3,740,576 of the Company&#x2019;s ordinary shares) were offered at the same price on February 13, 2025, and 22,000,000 placing shares of the Company were issued and allotted at a price of HK$68.6 per share on July 17, 2025, amounts of RMB40 (US$6) was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(n)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2025, the Company issued ordinary shares with respect to the share options under the Pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 455,263 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.3 (US$0.04) was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(o)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During June to September 2025, the Company issued ordinary shares with respect to the restricted share units under the 2021 and 2022 RSU Scheme exercised by certain selected persons of the Company before December 31, 2025 to those selected persons. In connection with the exercised restricted share units, 1,008,253 new shares of the Company were issued, and an amount of RMB0.7 (US$0.1) was credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(p)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In June 2025, 775,685 ordinary shares and 816,922 ordinary shares, being underlying shares of the restricted share units granted under the 2021 RSU scheme and the 2022 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB0.5 (US$0.07) and RMB0.6 (US$0.09) credited as share capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(q)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In April 2025, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB3,590 (US$513) for the purpose of the 2022 RSU scheme.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="font-size: 8pt; vertical-align: top"&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(r)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the vesting of restricted share units granted under the 2022 RSU Scheme, 17,925 treasury shares were allotted to the employees during the year ended December 31, 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</aapg:DisclosureOfShareCapitalAndTreasurySharesExplanatory>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c439"
      decimals="INF"
      id="ixv-72010"
      unitRef="shares">265185950</ifrs-full:NumberOfSharesIssued>
    <aapg:IssuedShareCapital contextRef="c16" decimals="-3" id="ixv-72011" unitRef="cny">180000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c17" decimals="-3" id="ixv-72012" unitRef="cny">-26552000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c24" decimals="-3" id="ixv-72013" unitRef="cny">-26372000</aapg:IssuedShareCapital>
    <aapg:IssueOfOrdinaryShare
      contextRef="c440"
      decimals="INF"
      id="ix_70_fact"
      unitRef="shares">22500000</aapg:IssueOfOrdinaryShare>
    <aapg:IssueOfOrdinaryShares
      contextRef="c25"
      decimals="-3"
      id="ix_71_fact"
      unitRef="cny">15000</aapg:IssueOfOrdinaryShares>
    <aapg:IssueOfOrdinaryShares
      contextRef="c12"
      decimals="-3"
      id="ix_72_fact"
      unitRef="cny">15000</aapg:IssueOfOrdinaryShares>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionSchemeinShares
      contextRef="c440"
      decimals="INF"
      id="ix_73_fact"
      unitRef="shares">911062</aapg:IssueOfSharesUnderThePreIPOShareOptionSchemeinShares>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionScheme
      contextRef="c25"
      decimals="-3"
      id="ix_74_fact"
      unitRef="cny">1000</aapg:IssueOfSharesUnderThePreIPOShareOptionScheme>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionScheme
      contextRef="c12"
      decimals="-3"
      id="ix_75_fact"
      unitRef="cny">1000</aapg:IssueOfSharesUnderThePreIPOShareOptionScheme>
    <aapg:IssueOfSharesUnderThe2021RSUSchemeInshares
      contextRef="c440"
      decimals="INF"
      id="ix_76_fact"
      unitRef="shares">71034</aapg:IssueOfSharesUnderThe2021RSUSchemeInshares>
    <aapg:IncreaseDecreaseInNumberOfSharesEquitysettledBonus
      contextRef="c440"
      decimals="INF"
      id="ix_77_fact"
      unitRef="shares">1528514</aapg:IncreaseDecreaseInNumberOfSharesEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValuesEquitysettledBonus
      contextRef="c25"
      decimals="-3"
      id="ix_78_fact"
      unitRef="cny">1000</aapg:StockIssuedDuringPeriodValuesEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValuesEquitysettledBonus
      contextRef="c26"
      decimals="-3"
      id="ix_79_fact"
      unitRef="cny">1000</aapg:StockIssuedDuringPeriodValuesEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValuesEquitysettledBonus
      contextRef="c12"
      decimals="-3"
      id="ix_80_fact"
      unitRef="cny">2000</aapg:StockIssuedDuringPeriodValuesEquitysettledBonus>
    <aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares
      contextRef="c26"
      decimals="-3"
      id="ix_81_fact"
      unitRef="cny">-5923000</aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares>
    <aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares
      contextRef="c12"
      decimals="-3"
      id="ix_82_fact"
      unitRef="cny">-5923000</aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares>
    <aapg:VestingOfRestrictedShareUnits
      contextRef="c26"
      decimals="-3"
      id="ix_83_fact"
      unitRef="cny">11123000</aapg:VestingOfRestrictedShareUnits>
    <aapg:VestingOfRestrictedShareUnits
      contextRef="c12"
      decimals="-3"
      id="ix_84_fact"
      unitRef="cny">11123000</aapg:VestingOfRestrictedShareUnits>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c441"
      decimals="INF"
      id="ixv-72029"
      unitRef="shares">290196560</ifrs-full:NumberOfSharesIssued>
    <aapg:IssuedShareCapital contextRef="c33" decimals="-3" id="ixv-72030" unitRef="cny">197000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c34" decimals="-3" id="ixv-72031" unitRef="cny">-21351000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c41" decimals="-3" id="ixv-72032" unitRef="cny">-21154000</aapg:IssuedShareCapital>
    <aapg:IssueOfOrdinaryShare
      contextRef="c442"
      decimals="INF"
      id="ix_85_fact"
      unitRef="shares">24307322</aapg:IssueOfOrdinaryShare>
    <aapg:IssueOfOrdinaryShares
      contextRef="c42"
      decimals="-3"
      id="ix_86_fact"
      unitRef="cny">17000</aapg:IssueOfOrdinaryShares>
    <aapg:IssueOfOrdinaryShares
      contextRef="c13"
      decimals="-3"
      id="ix_87_fact"
      unitRef="cny">17000</aapg:IssueOfOrdinaryShares>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionSchemeinShares
      contextRef="c442"
      decimals="INF"
      id="ix_88_fact"
      unitRef="shares">656077</aapg:IssueOfSharesUnderThePreIPOShareOptionSchemeinShares>
    <aapg:IssueOfSharesUnderThe2021RSUSchemeInshares
      contextRef="c442"
      decimals="INF"
      id="ix_89_fact"
      unitRef="shares">65034</aapg:IssueOfSharesUnderThe2021RSUSchemeInshares>
    <aapg:StockIssuedDuringPeriodValuesEquitysettledBonus
      contextRef="c43"
      decimals="-3"
      id="ix_90_fact"
      unitRef="cny">8631000</aapg:StockIssuedDuringPeriodValuesEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValuesEquitysettledBonus
      contextRef="c13"
      decimals="-3"
      id="ix_91_fact"
      unitRef="cny">8631000</aapg:StockIssuedDuringPeriodValuesEquitysettledBonus>
    <aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares
      contextRef="c43"
      decimals="-3"
      id="ix_92_fact"
      unitRef="cny">-1959000</aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares>
    <aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares
      contextRef="c13"
      decimals="-3"
      id="ix_93_fact"
      unitRef="cny">-1959000</aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares>
    <aapg:VestingOfRestrictedShareUnits
      contextRef="c43"
      decimals="-3"
      id="ix_94_fact"
      unitRef="cny">14671000</aapg:VestingOfRestrictedShareUnits>
    <aapg:VestingOfRestrictedShareUnits
      contextRef="c13"
      decimals="-3"
      id="ix_95_fact"
      unitRef="cny">14671000</aapg:VestingOfRestrictedShareUnits>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c443"
      decimals="INF"
      id="ixv-72044"
      unitRef="shares">315224993</ifrs-full:NumberOfSharesIssued>
    <aapg:IssuedShareCapital contextRef="c50" decimals="-3" id="ixv-72045" unitRef="cny">214000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c51" decimals="-3" id="ixv-72046" unitRef="cny">-8000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c14" decimals="-3" id="ixv-72047" unitRef="cny">206000</aapg:IssuedShareCapital>
    <aapg:IssueOfOrdinaryShare
      contextRef="c444"
      decimals="INF"
      id="ix_96_fact"
      unitRef="shares">55040576</aapg:IssueOfOrdinaryShare>
    <aapg:IssueOfOrdinaryShares
      contextRef="c58"
      decimals="-3"
      id="ix_97_fact"
      unitRef="cny">40000</aapg:IssueOfOrdinaryShares>
    <aapg:IssueOfOrdinaryShares contextRef="c0" decimals="-3" id="ix_98_fact" unitRef="cny">40000</aapg:IssueOfOrdinaryShares>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionSchemeinShares
      contextRef="c444"
      decimals="INF"
      id="ix_99_fact"
      unitRef="shares">455263</aapg:IssueOfSharesUnderThePreIPOShareOptionSchemeinShares>
    <aapg:IssueOfSharesUnderThe2021RSUSchemeInshares
      contextRef="c444"
      decimals="INF"
      id="ix_100_fact"
      unitRef="shares">1008253</aapg:IssueOfSharesUnderThe2021RSUSchemeInshares>
    <aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme
      contextRef="c58"
      decimals="-3"
      id="ix_101_fact"
      unitRef="cny">2000</aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme>
    <aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme
      contextRef="c0"
      decimals="-3"
      id="ix_102_fact"
      unitRef="cny">2000</aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme>
    <aapg:IncreaseDecreaseInNumberOfSharesEquitysettledBonus
      contextRef="c444"
      decimals="INF"
      id="ix_103_fact"
      unitRef="shares">1592607</aapg:IncreaseDecreaseInNumberOfSharesEquitysettledBonus>
    <aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares
      contextRef="c59"
      decimals="-3"
      id="ix_104_fact"
      unitRef="cny">-3590000</aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares>
    <aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares
      contextRef="c0"
      decimals="-3"
      id="ix_105_fact"
      unitRef="cny">-3590000</aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares>
    <aapg:VestingOfRestrictedShareUnits
      contextRef="c59"
      decimals="-3"
      id="ix_106_fact"
      unitRef="cny">637000</aapg:VestingOfRestrictedShareUnits>
    <aapg:VestingOfRestrictedShareUnits
      contextRef="c0"
      decimals="-3"
      id="ix_107_fact"
      unitRef="cny">637000</aapg:VestingOfRestrictedShareUnits>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c445"
      decimals="INF"
      id="ixv-72060"
      unitRef="shares">373321692</ifrs-full:NumberOfSharesIssued>
    <aapg:IssuedShareCapital contextRef="c66" decimals="-3" id="ixv-72061" unitRef="cny">256000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c67" decimals="-3" id="ixv-72062" unitRef="cny">-2961000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c15" decimals="-3" id="ixv-72063" unitRef="cny">-2705000</aapg:IssuedShareCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c445"
      decimals="INF"
      id="ixv-72064"
      unitRef="shares">373321692</ifrs-full:NumberOfSharesIssued>
    <aapg:IssuedShareCapital contextRef="c66" decimals="-3" id="ixv-72065" unitRef="usd">37000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c67" decimals="-3" id="ixv-72066" unitRef="usd">-423000</aapg:IssuedShareCapital>
    <aapg:IssuedShareCapital contextRef="c15" decimals="-3" id="ixv-72067" unitRef="usd">-386000</aapg:IssuedShareCapital>
    <ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares
      contextRef="c15"
      decimals="0"
      id="ixv-72068"
      unitRef="shares">22500000</ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares>
    <aapg:IssueOfOrdinaryShare
      contextRef="c0"
      decimals="2"
      id="ixv-72069"
      unitRef="shares">24.45</aapg:IssueOfOrdinaryShare>
    <ifrs-full:IssuedCapitalOrdinaryShares
      contextRef="c415"
      decimals="-3"
      id="ixv-72070"
      unitRef="cny">15000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c12"
      decimals="0"
      id="ixv-72071"
      unitRef="shares">911062</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <aapg:WeightedAverageExercisePrice
      contextRef="c41"
      decimals="2"
      id="ixv-72072"
      unitRef="hkdPershares">0.01</aapg:WeightedAverageExercisePrice>
    <ifrs-full:IssuedCapital contextRef="c41" decimals="-3" id="ixv-72073" unitRef="cny">1000</ifrs-full:IssuedCapital>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c416"
      decimals="0"
      id="ixv-72074"
      unitRef="shares">71034</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IssuedCapital
      contextRef="c417"
      decimals="-1"
      id="ixv-72075"
      unitRef="cny">50.00</ifrs-full:IssuedCapital>
    <aapg:IssueOfOrdinaryShare
      contextRef="c416"
      decimals="0"
      id="ixv-72076"
      unitRef="shares">1528514</aapg:IssueOfOrdinaryShare>
    <aapg:NumberOfTreasuryShares
      contextRef="c417"
      decimals="0"
      id="ixv-72077"
      unitRef="shares">1237884</aapg:NumberOfTreasuryShares>
    <aapg:BonusDueToEmployeesAmount
      contextRef="c418"
      decimals="-3"
      id="ixv-72078"
      unitRef="cny">1000</aapg:BonusDueToEmployeesAmount>
    <aapg:NumberOfTreasuryShares
      contextRef="c419"
      decimals="0"
      id="ixv-72079"
      unitRef="shares">1</aapg:NumberOfTreasuryShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c420"
      decimals="0"
      id="ixv-72080"
      unitRef="shares">250000</ifrs-full:NumberOfSharesIssued>
    <aapg:SharesConsiderationAmount
      contextRef="c421"
      decimals="-3"
      id="ixv-72081"
      unitRef="cny">5923000</aapg:SharesConsiderationAmount>
    <aapg:NumberOfTreasuryShares
      contextRef="c422"
      decimals="0"
      id="ixv-72082"
      unitRef="shares">1069461</aapg:NumberOfTreasuryShares>
    <aapg:SubscriptionOfShares
      contextRef="c0"
      decimals="0"
      id="ixv-72083"
      unitRef="shares">24307322</aapg:SubscriptionOfShares>
    <aapg:AllottedSharesPricePerShares
      contextRef="c423"
      decimals="2"
      id="ixv-72084"
      unitRef="hkdPershares">24.1</aapg:AllottedSharesPricePerShares>
    <ifrs-full:IssuedCapitalOrdinaryShares
      contextRef="c424"
      decimals="-3"
      id="ixv-72085"
      unitRef="cny">17000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c425"
      decimals="0"
      id="ixv-72086"
      unitRef="shares">656077</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <aapg:WeightedAverageExercisePrice
      contextRef="c426"
      decimals="2"
      id="ixv-72087"
      unitRef="hkdPershares">0.01</aapg:WeightedAverageExercisePrice>
    <ifrs-full:IssuedCapital
      contextRef="c426"
      decimals="-2"
      id="ixv-72088"
      unitRef="cny">500</ifrs-full:IssuedCapital>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c427"
      decimals="0"
      id="ixv-72089"
      unitRef="shares">65034</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IssuedCapital
      contextRef="c428"
      decimals="-1"
      id="ixv-72090"
      unitRef="cny">50.00</ifrs-full:IssuedCapital>
    <aapg:NumberOfTreasuryShares
      contextRef="c429"
      decimals="0"
      id="ixv-72091"
      unitRef="shares">397949</aapg:NumberOfTreasuryShares>
    <aapg:NumberOfTreasuryShares
      contextRef="c430"
      decimals="0"
      id="ixv-72092"
      unitRef="shares">2081399</aapg:NumberOfTreasuryShares>
    <aapg:BonusDueToEmployeesAmount
      contextRef="c431"
      decimals="-3"
      id="ixv-72093"
      unitRef="cny">8630000</aapg:BonusDueToEmployeesAmount>
    <aapg:BonusDueToEmployeesAmount
      contextRef="c432"
      decimals="-2"
      id="ixv-72094"
      unitRef="cny">1400</aapg:BonusDueToEmployeesAmount>
    <aapg:StockPurchasedDuringPeriodShares
      contextRef="c433"
      decimals="0"
      id="ixv-72095"
      unitRef="shares">100000</aapg:StockPurchasedDuringPeriodShares>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="c434"
      decimals="-3"
      id="ixv-72096"
      unitRef="cny">1959000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <aapg:NumberOfTreasuryShares
      contextRef="c435"
      decimals="0"
      id="ixv-72097"
      unitRef="shares">939687</aapg:NumberOfTreasuryShares>
    <ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory contextRef="c0" id="ixv-58132">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RESERVES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amounts of the Group&#x2019;s reserves and the movements therein for the current and prior years are presented in the consolidated statements
of changes in equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the post-IPO share option scheme, the 2021 RSU Scheme, and 2022 RSU
Scheme, expenses amounting to RMB20,874 (US$2,985) (2024: RMB20,924; 2023: RMB31,503) were recognized and contributed to capital and
reserves during the year ended December 31, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the exercise of the Pre-IPO share option scheme and vesting of restricted share units granted under the 2021 RSU Scheme,
and 2022 RSU Scheme, RMB33,000 (US$4,719) (2024: RMB19,333; 2023: RMB32,593) was credited to share premium, and RMB33,635 (US$4,810)(2024:
RMB33,998; 2023: RMB43,709) was transferred out from capital and reserves during the year ended December 31, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
PRC laws and regulations, there are restrictions on the Company&#x2019;s PRC subsidiaries with respect to transferring certain of their
net assets to the Company either in the form of dividends, loans, or advances. Amounts of net assets restricted include paid in capital
and reserve funds of the Company&#x2019;s PRC subsidiaries, totaling RMB3,033,545 (US$433,791) and RMB2,702,519 as at December 31, 2025
and 2024, respectively. See note 41 for the statement of financial position of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
connection with the equity-settled bonus, the Company settled the bonus of RMB58,869 (US$8,418) (2024: RMB49,350) by issuing 1,592,607
ordinary shares (2024: 2,479,348 treasury shares) at a price of HK$40.05 (2024: HK$21.95) to employees, among which, RMB58,868 (US$8,418)
(2024: RMB40,719) was credited to share premium.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:CapitalReserve
      contextRef="c446"
      decimals="-3"
      id="ixv-72098"
      unitRef="cny">20874000</ifrs-full:CapitalReserve>
    <ifrs-full:CapitalReserve
      contextRef="c446"
      decimals="-3"
      id="ixv-72099"
      unitRef="usd">2985000</ifrs-full:CapitalReserve>
    <ifrs-full:CapitalReserve
      contextRef="c447"
      decimals="-3"
      id="ixv-72100"
      unitRef="cny">20924000</ifrs-full:CapitalReserve>
    <ifrs-full:CapitalReserve
      contextRef="c448"
      decimals="-3"
      id="ixv-72101"
      unitRef="cny">31503000</ifrs-full:CapitalReserve>
    <ifrs-full:SharePremium
      contextRef="c446"
      decimals="-3"
      id="ixv-72102"
      unitRef="cny">33000000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="c446"
      decimals="-3"
      id="ixv-72103"
      unitRef="usd">4719000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="c447"
      decimals="-3"
      id="ixv-72104"
      unitRef="cny">19333000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="c448"
      decimals="-3"
      id="ixv-72105"
      unitRef="cny">32593000</ifrs-full:SharePremium>
    <aapg:TransferredOutFromCapitalAndReserves
      contextRef="c449"
      decimals="-3"
      id="ixv-72106"
      unitRef="cny">33635000</aapg:TransferredOutFromCapitalAndReserves>
    <aapg:TransferredOutFromCapitalAndReserves
      contextRef="c449"
      decimals="-3"
      id="ixv-72107"
      unitRef="usd">4810000</aapg:TransferredOutFromCapitalAndReserves>
    <aapg:TransferredOutFromCapitalAndReserves
      contextRef="c450"
      decimals="-3"
      id="ixv-72108"
      unitRef="cny">33998000</aapg:TransferredOutFromCapitalAndReserves>
    <aapg:TransferredOutFromCapitalAndReserves contextRef="c12" decimals="-3" id="ixv-72109" unitRef="cny">43709000</aapg:TransferredOutFromCapitalAndReserves>
    <aapg:CapitalAndReserveFunds contextRef="c15" decimals="-3" id="ixv-72110" unitRef="cny">3033545000</aapg:CapitalAndReserveFunds>
    <aapg:CapitalAndReserveFunds contextRef="c15" decimals="-3" id="ixv-72111" unitRef="usd">433791000</aapg:CapitalAndReserveFunds>
    <aapg:CapitalAndReserveFunds contextRef="c14" decimals="-3" id="ixv-72112" unitRef="cny">2702519000</aapg:CapitalAndReserveFunds>
    <aapg:BonusAmount contextRef="c0" decimals="-3" id="ixv-72113" unitRef="cny">58869000</aapg:BonusAmount>
    <aapg:BonusAmount contextRef="c0" decimals="-3" id="ixv-72114" unitRef="usd">8418000</aapg:BonusAmount>
    <aapg:BonusAmount contextRef="c13" decimals="-3" id="ixv-72115" unitRef="cny">49350000</aapg:BonusAmount>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c451"
      decimals="0"
      id="ixv-72116"
      unitRef="shares">1592607</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c452"
      decimals="0"
      id="ixv-72117"
      unitRef="shares">2479348</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="c451"
      decimals="2"
      id="ixv-72118"
      unitRef="hkdPershares">40.05</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="c452"
      decimals="2"
      id="ixv-72119"
      unitRef="hkdPershares">21.95</ifrs-full:ParValuePerShare>
    <ifrs-full:SharePremium
      contextRef="c451"
      decimals="-3"
      id="ixv-72120"
      unitRef="cny">58868000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="c451"
      decimals="-3"
      id="ixv-72121"
      unitRef="usd">8418000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="c452"
      decimals="-3"
      id="ixv-72122"
      unitRef="cny">40719000</ifrs-full:SharePremium>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="c0" id="ixv-58164">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SHARE-BASED
                                            PAYMENTS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
                                            option scheme&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
pre-IPO share option scheme&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
July 2018, the Company adopted the pre-IPO share option scheme for the purpose of providing incentives and rewards to eligible participants
who have contributed or will contribute to the Group. Eligible participants of the pre-IPO share option scheme may include any substantial
shareholder, existing or incoming employees, directors (including executive directors, non-executive directors and independent non-executive
directors) and officers, or any other service providers of any member of the Group who the board of directors consider, in its sole discretion,
have contributed or will contribute to the Group. The pre-IPO share option scheme was terminated but continues to govern the terms and
conditions of the outstanding awards previously granted under the Company&#x2019;s pre-IPO share option scheme.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
maximum number of shares which may be issued upon the exercise of all pre-IPO share options is 12,307,533. The exercise price for each
share under the pre-IPO share options was HK$0.01.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following share options were outstanding under the Pre-IPO share option scheme during the year:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;br/&gt;

price&#160;HK$ &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;per share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Number
of&lt;br/&gt;
 options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;br/&gt;
price&#160;HK$ &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;per share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of&lt;br/&gt;
 options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Outstanding as of January 1&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,263,648&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,607,571&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Forfeited during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-345"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-346"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(81&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Exercised during the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(656,077&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(455,263&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding as of December 31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,607,571&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,152,227&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
number of share options exercisable was 2,152,227 as at December 31, 2025 (2024: 2,607,571).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
weighted average share price at the date of exercise for share options exercised during the year ended December 31, 2025 was HK$58.54
per share (2024: HK$34.03 per share, 2023: HK$22.98 per share).&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise prices and exercise periods of the share options outstanding as at the end of the reporting period are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024
    &lt;br/&gt;
Number of&lt;br/&gt;
 options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    price&lt;br/&gt;
 HK$&lt;br/&gt;
 per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,360,420&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 68%; text-align: center; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aug
    15, 2018-Aug 15, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;232,719&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    15, 2019-May 15, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,432&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sept
    16, 2019-Sept 16, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,607,571&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;br/&gt;

    Number of&lt;br/&gt;
 options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    price&lt;br/&gt;
 HK$&lt;br/&gt;
 per share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,983,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 68%; text-align: center; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aug 15, 2018&#x2013;Aug 15, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;159,712&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;May 15, 2019&#x2013;May 15, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,132&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sept
    16, 2019-Sept 16, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,152,227&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Group did not grant any new share options under the Pre-IPO share option scheme during the year ended December 31, 2025 (2024: &lt;span style="-sec-ix-hidden: hidden-fact-352"&gt;Nil&lt;/span&gt;).
As the share options have been fully unlocked in 2023, the Group has not recognized any share option expense during the year ended December
31, 2025 (2024:&lt;span style="-sec-ix-hidden: hidden-fact-353"&gt;Nil&lt;/span&gt;, 2023: RMB3,750).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
exercise in full of the outstanding share options would, under the present capital structure of the Company, result in the issue of 2,152,227 additional ordinary shares of the Company and additional share capital and share premium of US$4,957, equivalent to RMB34,662 (before
issue expenses), transferred from capital and other reserves.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
post-IPO share option scheme&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 21pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
September 2019, the Company adopted the post-IPO share option scheme for the purpose of providing incentives and rewards to eligible
participants who have contributed or will contribute to the Group.  Eligible participants of the post-IPO share option scheme
include (a) any executive director of, manager of, or other employee holding an executive, managerial, supervisory or similar
position in any member of the Group, any full-time or part-time employee, or a person for the time being seconded to work full-time
or part-time for any member of the Group; (b) a director or proposed director (including an independent non-executive director) of
any member of the Group; (c) any substantial shareholder of any member of the Group; (d) a customer, consultant, business or joint
venture partner, franchisee, contractor, agent or representative of, a supplier of goods or services to, a person or entity that
provides design, research, development or other support or any advisory, consultancy, professional or other services to any member
of the Group; and (e) an associate of any of the persons referred to in paragraphs (a) to (c) above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 21pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
April 2025, the Company amended the post-IPO share option scheme. Under the amendments, eligible participants were restricted to (i)
Employee Participants (as defined under former paragraphs (a) and (b)) and (ii) Service Providers, and the categories previously set
out in former paragraphs (c), (d) and (e) were eliminated. In addition, the maximum number of shares which may be issued upon the exercise
of all Post-IPO share options was reduced from 20,707,462 to 14,907,462.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.25pt 0pt 21.7pt; text-align: justify; text-indent: -0.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Under the post-IPO share option scheme, the maximum number of shares
issuable upon the exercise of all options granted under this and other Group plans shall not exceed 10% of the Company&#x2019;s issued
share capital as of the listing date (including any outstanding, cancelled, lapsed, or unexercised options). The Company may, with separate
shareholder approval, grant options exceeding this limit, provided that any excess is granted only to eligible participants. The aggregate
number of shares subject to options granted under the Post-IPO Share Option Scheme and other Group plans shall not exceed 30% of the Group&#x2019;s
issued share capital at the time of grant.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to any restriction contained in the post-IPO share option scheme, an option may be exercised in accordance with the terms of the post-IPO
share option scheme.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
November 26, 2025, the Company granted options to 33 grantees to subscribe for an aggregate of 633,243 shares under the post-IPO share
option scheme. Subject to the terms and conditions as set out in the Post-IPO share option scheme, 486,868 shares granted to 25 grantees
are vested in the portions of 25%, 25%, 25% and 25% on the first, second, third and fourth anniversaries of the grant date of the options,
and the remaining options granted to eight grantees in respect of 146,375 shares are vested in the portion of 8.33% monthly on the 26th
of each month over an 11-month period starting from November 26, 2025, with the remaining 8.37% to be vested on October 26, 2026. The
exercise price for each share under the post-IPO share options is HK$63.35.&#160;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
are no cash settlement alternatives. The Group does not have a past practice of cash settlement for these share options. The Group accounts
for the scheme as an equity-settled plan. Share options do not confer rights on the holders to dividends or to vote at shareholders&#x2019;
meetings.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following share options were outstanding under the post-IPO share option scheme during the year:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    price HK$ per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-347; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;633,243&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised
    during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-348; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;633,243&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise prices and exercise periods of the share options outstanding as at the end of the reporting period are as follows:&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025
    Number of options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    price HK$ per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 31%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;633,243&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 31%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 30%; font-size: 10pt; text-align: center"&gt;&lt;p style="margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nov
                                            26, 2025&#x2013;Nov 26, 2035&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group granted 633,243 new shares options under the Post-IPO Scheme during the year ended December 31, 2025 (2024: &lt;span style="-sec-ix-hidden: hidden-fact-354"&gt;Nil&lt;/span&gt;), and recognized
share option expense of RMB2,420 (US$346) during the year ended December 31, 2025.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.25pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise in full of the outstanding share options would, under the present capital structure of the Company, result in the issue of 633,243
additional Ordinary Shares of the Company and additional share capital and share premium of US$2,902 equivalent to RMB20,294 (before
issue expenses) transferred from capital and other reserves.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the share options granted was estimated as at the grant date by using the binary tree option pricing model. The following
table lists the key inputs to the fair value model used:&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;At grant dates&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;49.65&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.09&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life of options (year)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Weighted average share price (HKD per share)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34.98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSUs
                                            granted to employees&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
2018 RSU Scheme&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 6, 2018, the Company approved and adopted the 2018 RSU Scheme. The purpose of the 2018 RSU scheme is to incentivize the existing
and incoming directors, senior management and employees for their contribution to the Company, and to attract, motivate and retain skilled
and experienced personnel to strive for the future development and expansion of the Company. Unless otherwise cancelled or amended, the
2018 RSU Scheme will remain in force for 10 years from the date of adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
maximum number of RSUs that may be granted under the 2018 RSU Scheme in aggregate (excluding RSUs that have lapsed or been cancelled
in accordance with the rules of the 2018 RSU Scheme) shall be 5,274,657 ordinary shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 14, 2020, pursuant to the 2018 RSU Scheme, 2,590,592 RSUs were granted to 50 selected persons, who are employees of the Company.
The RSUs granted would vest on the third month from the grant date, and in equal tranches over the remaining years of the total vesting
period as three years, on condition that employees remain in service without any performance requirements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each RSU under the 2018 RSU Scheme at the grant date was determined by reference to the fair value of the ordinary shares
of the Company issued to its shareholders, using the market approach.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.4pt; text-align: justify; text-indent: -1.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group did not recognize share-base payment expense during the year ended December 31, 2025 (2024: &lt;span style="-sec-ix-hidden: hidden-fact-355"&gt;Nil&lt;/span&gt;; 2023: RMB3,169).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2023, all RSUs under the 2018 RSU Scheme had been exercised.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
2021 RSU Scheme&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
February 2, 2021, the Company approved and adopted the 2021 RSU Scheme The purpose of the 2021 RSU scheme is to (i) incentivize the existing
and incoming directors , senior management, and employees for their contribution to the Group; and (ii) attract, motivate, and retain
skilled and experienced personnel to strive for the future development and expansion of the Group by providing them with the opportunity
to own equity interests in the Company. Unless otherwise cancelled or amended, the 2021 RSU Scheme will remain in force for 10 years
from the date of adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
maximum number of RSUs that may be granted under the 2021 RSU Scheme in aggregate (excluding RSUs that have lapsed or been cancelled
in accordance with the 2021 Scheme Rules) shall be 3,133,526 shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
April 30, 2025, the Company amended the 2021 RSU Scheme, thereby expanding the eligible participants by adding a service provider as
a new category of eligible participants.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
May 17, 2021, pursuant to the 2021 RSU Scheme, 440,490 RSUs were granted to 34 selected persons, which include employees, senior management
of the Group, and a director of the Company. Among the awards, 10,641 RSUs were granted to an independent non-executive director and 55,157
RSUs were granted to the Chief Commercial Officer. On July 23, 2021, 26,892 RSUs were granted to three independent non-executive directors
of the Company. The RSUs granted were categorized in six types based on the vesting period and the proportion of shares that can be unlocked
upon each of the vesting dates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the unlocking date are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grant fair&lt;br/&gt; value HK$ &lt;br/&gt; per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of &lt;br/&gt; conditional &lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of vested &lt;br/&gt;
conditional shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 18%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 20%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2021-2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 19%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35%, 15%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2021-2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2022&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35%, 15%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 30, 2022&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35%, 15%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2022&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2022&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 27, 2025, 48,439 RSUs were granted to 34 selected persons of the Commercialization Department.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the unlocking date are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grant fair &lt;br/&gt;
value HK$ &lt;br/&gt;
per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of &lt;br/&gt;
conditional shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of vested&lt;br/&gt; conditional shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 18%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77.45&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;p style="margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 27, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
for the restricted shares granted to employees and senior management, the conditions for releasing the restrictions comprised two parts,
namely the participants have not been terminated with or without cause on or before each relevant vesting date and the participants have
obtained a score of B or above in the annual performance review prior to the applicable vesting date. The percentage of shares in respect
of which the restrictions may be released depends on the achievement of those conditions. For the independent non-executive directors,
the restricted shares would vest on condition that independent non-executive directors remain in service without any performance requirements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following restricted shares were outstanding under the 2021 RSU Scheme during the year:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;br/&gt;
    Number of&lt;br/&gt;
    RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;br/&gt;
    Number of&lt;br/&gt;
    RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;108,998&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;41,552&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-349"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,412&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-350; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested
    during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(65,034&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(89,991&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;41,552&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-351; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each RSUs under the 2021 RSU Scheme at the grant date was determined by reference to the fair value of the ordinary shares
of the Company issued to its shareholders, using the market approach.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
weighted average share price at the date of exercise for RSUs exercised during the year was HK$70.48 per share (2024 HK$20.80 per share,
2023 HK$19.96 per share).&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized a share-base payment expense of RMB3,604 (US$515) during the year ended December 31, 2025 (2024: RMB856; 2023: RMB1,589).&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise in full of the outstanding RSUs would, under the present capital structure of the Company, result in additional share capital
and share premium of HK$1,894, equivalent to RMB1,712 (US$245), transferred from capital and other reserves.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
2022 RSU Scheme&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
June 23, 2022, the Company approved and adopted the 2022 RSU Scheme. The purpose of the 2022 RSU scheme is to (i) incentivize the
existing and incoming directors, senior management, and employees for their contribution to the Group; and (ii) attract,
motivate, and retain skilled and experienced personnel to strive for the future development and expansion of the Group by providing
them with the opportunity to own equity interests in the Company. Unless otherwise cancelled or amended, the 2022 RSU Scheme will
remain in force for 10 years from the date of adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
maximum number of RSUs that may be granted under the 2022 RSU Scheme in aggregate (excluding RSUs that have lapsed or been cancelled
in accordance with the 2022 Scheme Rules) shall be 11,072,695 shares. &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
April 30, 2025, the Company amended the 2022 RSU Scheme, thereby expanding the eligible participants by adding a service provider as
a new category of eligible participants.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
for the restricted shares granted to employees and senior management under the 2022 RSU Scheme, the conditions for releasing the restrictions
comprised two parts, namely the participants having not been terminated with or without cause on or before each relevant vesting date
and the participants having obtained a score of B or above in the annual performance review prior to the applicable vesting date. The
percentage of shares in respect of which the restrictions may be released depends on the achievement of those conditions.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the 2022 RSU Scheme, on June 23, 2022, the Company initially granted an aggregate of 1,634,426 RSUs under the 2022 RSU Scheme (the
&#x201c;2022 Awards&#x201d;), representing 1,634,426 shares to a total of 80 selected persons, who are employees of the Group, among which
100,000 RSUs, representing 100,000 shares, were granted to Dr. Zhai Yifan (&#x201c;Dr. Zhai&#x201d;), who is the chief medical officer
and a substantial shareholder of the Company. The RSUs granted were categorized in six types based on the vesting period and the proportion
of shares that can be unlocked upon each vesting date.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the unlocking date are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: black 1.5pt solid; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Type of eligible participants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Grant fair value HK$ per share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;% of conditional shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vesting date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;% of vested conditional shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2021-2024&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35%, 15%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="width: 31%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 23%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 30, 2023&#x2013;2026&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2023&#x2013;2026&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2023&#x2013;2024&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40%, 60%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2023&#x2013;2025&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30%, 30%, 40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 30, 2023&#x2013;2026&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23%, 69%, 6%, 2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the 2022 RSU Scheme, on May 4, 2023, the Company granted 1,379,094 RSUs under the 2022 RSU Scheme, representing 1,379,094 shares to
172 selected persons (the &#x201c;2022 Further Grant&#x201d;), who are employees of the Group. The RSUs granted were categorized in two
types based on the vesting period and the proportion of shares that can be unlocked upon each vesting date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the unlocking date are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grant &lt;br/&gt; fair value&lt;br/&gt; HK$ per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of&lt;br/&gt; conditional&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of vested conditional shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 31%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 23%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August 1, 2023&#x2013;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 20%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40%, 60%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August 1, 2023&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30%, 30%, 40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the 2022 RSU Scheme, on September 2, 2024, the Company granted 777,006 RSUs under the 2022 RSU Scheme, representing 777,006 shares
to 59 selected persons (the &#x201c;2022 Further Grant&#x201d;), who are employees of the Group. The RSUs granted were categorized in ten
types based on the vesting period and the proportion of shares that can be unlocked upon each vesting date.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the unlocking date are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant fair value HK$ per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;% of conditional shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vesting date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;% of vested conditional shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 31%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 20%; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 21%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;75%, 25%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50%, 50%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30%, 30%, 40%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22.5%, 22.5%, 55%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50%, 25%, 25&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 37%, 38&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2025-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40%, 60&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2025-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50%, 50&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Pursuant
to the 2022 RSU Scheme, on November 26, 2025, the Company granted 1,177,256 RSUs under the 2022 RSU Scheme, representing 1,177,256 shares
to 145 selected persons, who are employees of the Group, among which 143,363 RSUs, representing 143,363 shares, were granted to Dr. Yang
Dajun (&#x201c;Dr. Yang&#x201d;), who is the chief executive officer of the Company. The RSUs granted were categorized in six types based
on the vesting period and the proportion of shares that can be unlocked upon each vesting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grant
fair&lt;br/&gt; value HK$&lt;br/&gt;
per&#160;share&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of &lt;br/&gt; conditional &lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting date&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of vested&lt;br/&gt; conditional shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 18%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 17%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 17%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November 26, 2026-2028&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; width: 19%; font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33.33%, 33.33%, 33.34%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November 26, 2026-2029&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following restricted shares were outstanding under the 2022 RSU Scheme during the year:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&#160;Number of&#160;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&#160;Number of&#160;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,641,974&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,436,525&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;777,006&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,177,256&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(42,768&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(132,302&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested
    during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(939,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(936,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,436,525&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,545,292&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each RSU under the 2022 RSU Scheme at the grant date was determined by reference to the fair value of the ordinary shares
of the Company issued to its shareholders, using the market approach.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2022 RSU Scheme, the fair value of the RSUs granted during the year ended December 31, 2025 amounted to RMB68,327 (US$9,771)
(2024: RMB24,078, 2023: RMB27,063).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
weighted average share price at the date of exercise for RSUs exercised during the year through the treasury was HK$20.14 per share (2024:
HK$19.24 per share, 2023: HK$18.15 per share) and through the issuance was HK$79.35 per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized a share-base payment expense of RMB14,850 (US$2,124) for the year ended December 31, 2025 (2024: RMB20,068, 2023:
RMB22,995).&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise in full of the outstanding RSUs would, under the present capital structure of the Company, result in additional share capital
and share premium of HK$85,945, equivalent to RMB78,740 (US$11,260), transferred from capital and other reserves.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
are no cash settlement alternatives. The Group does not have a past practice of cash settlement for these RSUs. The Group accounts for
the scheme as an equity-settled plan.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c453"
      decimals="0"
      id="ixv-72123"
      unitRef="pure">12307533</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c453"
      decimals="2"
      id="ixv-72124"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="c0" id="ixv-58254">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following share options were outstanding under the Pre-IPO share option scheme during the year:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;br/&gt;

price&#160;HK$ &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;per share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Number
of&lt;br/&gt;
 options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;br/&gt;
price&#160;HK$ &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;per share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of&lt;br/&gt;
 options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%"&gt;Outstanding as of January 1&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,263,648&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,607,571&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Forfeited during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-345"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-346"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(81&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Exercised during the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(656,077&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(455,263&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding as of December 31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,607,571&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,152,227&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following share options were outstanding under the post-IPO share option scheme during the year:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    price HK$ per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 12pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-347; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;633,243&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised
    during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-348; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;633,243&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c41"
      decimals="2"
      id="ixv-72125"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="c41" decimals="0" id="ixv-72126" unitRef="pure">3263648</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c14"
      decimals="2"
      id="ixv-72127"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="c14" decimals="0" id="ixv-72128" unitRef="pure">2607571</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c0"
      decimals="2"
      id="ixv-72129"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement contextRef="c0" decimals="0" id="ixv-72130" unitRef="pure">81</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c13"
      decimals="2"
      id="ixv-72131"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="c13" decimals="0" id="ixv-72132" unitRef="pure">656077</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c0"
      decimals="2"
      id="ixv-72133"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="c0" decimals="0" id="ixv-72134" unitRef="pure">455263</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c14"
      decimals="2"
      id="ixv-72135"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="c14" decimals="0" id="ixv-72136" unitRef="pure">2607571</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c15"
      decimals="2"
      id="ixv-72137"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="c15" decimals="0" id="ixv-72138" unitRef="pure">2152227</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c454"
      decimals="0"
      id="ixv-72139"
      unitRef="pure">2152227</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c455"
      decimals="0"
      id="ixv-72140"
      unitRef="pure">2607571</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c456"
      decimals="2"
      id="ixv-72141"
      unitRef="hkdPershares">58.54</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c457"
      decimals="2"
      id="ixv-72142"
      unitRef="hkdPershares">34.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c458"
      decimals="2"
      id="ixv-72143"
      unitRef="hkdPershares">22.98</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory contextRef="c0" id="ixv-58380">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise prices and exercise periods of the share options outstanding as at the end of the reporting period are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024
    &lt;br/&gt;
Number of&lt;br/&gt;
 options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    price&lt;br/&gt;
 HK$&lt;br/&gt;
 per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,360,420&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 68%; text-align: center; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aug
    15, 2018-Aug 15, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;232,719&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    15, 2019-May 15, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,432&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sept
    16, 2019-Sept 16, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,607,571&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;br/&gt;

    Number of&lt;br/&gt;
 options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    price&lt;br/&gt;
 HK$&lt;br/&gt;
 per share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,983,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 68%; text-align: center; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aug 15, 2018&#x2013;Aug 15, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;159,712&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;May 15, 2019&#x2013;May 15, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,132&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sept
    16, 2019-Sept 16, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,152,227&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025
    Number of options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    price HK$ per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 31%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;633,243&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 31%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 30%; font-size: 10pt; text-align: center"&gt;&lt;p style="margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nov
                                            26, 2025&#x2013;Nov 26, 2035&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c507"
      decimals="0"
      id="ixv-72144"
      unitRef="pure">2360420</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c507"
      decimals="2"
      id="ixv-72145"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c508"
      decimals="0"
      id="ixv-72146"
      unitRef="pure">232719</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c508"
      decimals="2"
      id="ixv-72147"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c509"
      decimals="0"
      id="ixv-72148"
      unitRef="pure">14432</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c509"
      decimals="2"
      id="ixv-72149"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="c14" decimals="0" id="ixv-72150" unitRef="pure">2607571</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c510"
      decimals="0"
      id="ixv-72151"
      unitRef="pure">1983383</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c510"
      decimals="2"
      id="ixv-72152"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c511"
      decimals="0"
      id="ixv-72153"
      unitRef="pure">159712</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c511"
      decimals="2"
      id="ixv-72154"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c512"
      decimals="0"
      id="ixv-72155"
      unitRef="pure">9132</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c512"
      decimals="2"
      id="ixv-72156"
      unitRef="hkdPershares">0.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="c15" decimals="0" id="ixv-72157" unitRef="pure">2152227</ifrs-full:NumberOfOutstandingShareOptions>
    <aapg:ShareGrantExpense
      contextRef="c459"
      decimals="-3"
      id="ixv-72158"
      unitRef="cny">3750000</aapg:ShareGrantExpense>
    <aapg:AdditionalOrdinaryShares
      contextRef="c15"
      decimals="0"
      id="ixv-72159"
      unitRef="shares">2152227</aapg:AdditionalOrdinaryShares>
    <ifrs-full:SharePremium
      contextRef="c460"
      decimals="-3"
      id="ixv-72160"
      unitRef="usd">4957000</ifrs-full:SharePremium>
    <ifrs-full:CapitalReserve
      contextRef="c460"
      decimals="-3"
      id="ixv-72161"
      unitRef="cny">34662000</ifrs-full:CapitalReserve>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c461"
      decimals="0"
      id="ixv-72162"
      unitRef="pure">20707462</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="c462"
      decimals="0"
      id="ixv-72163"
      unitRef="pure">14907462</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <aapg:PercentageOfExceedShareCapital contextRef="c0" decimals="2" id="ixv-72164" unitRef="pure">0.10</aapg:PercentageOfExceedShareCapital>
    <aapg:PercentageOfExceedShareCapital
      contextRef="c454"
      decimals="2"
      id="ixv-72165"
      unitRef="pure">0.30</aapg:PercentageOfExceedShareCapital>
    <aapg:AggregateShareIssued
      contextRef="c463"
      decimals="0"
      id="ixv-72166"
      unitRef="shares">633243</aapg:AggregateShareIssued>
    <aapg:SharesGranted
      contextRef="c464"
      decimals="0"
      id="ixv-72167"
      unitRef="shares">486868</aapg:SharesGranted>
    <aapg:PercentageOfVestedConditionalShares contextRef="c465" id="ixv-72168">25%</aapg:PercentageOfVestedConditionalShares>
    <aapg:PercentageOfVestedConditionalShares contextRef="c466" id="ixv-72169">25%</aapg:PercentageOfVestedConditionalShares>
    <aapg:PercentageOfVestedConditionalShares contextRef="c467" id="ixv-72170">25%</aapg:PercentageOfVestedConditionalShares>
    <aapg:PercentageOfVestedConditionalShares contextRef="c468" id="ixv-72171">25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c469"
      decimals="0"
      id="ixv-72172"
      unitRef="pure">146375</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <aapg:PercentageOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="c469"
      decimals="4"
      id="ixv-72173"
      unitRef="pure">0.0833</aapg:PercentageOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="c470"
      decimals="4"
      id="ixv-72174"
      unitRef="pure">0.0837</aapg:PercentageOfVestingRequirementsForSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c0"
      decimals="2"
      id="ixv-72175"
      unitRef="hkdPershares">63.35</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c504"
      decimals="2"
      id="ixv-72176"
      unitRef="hkdPershares">63.35</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="c505"
      decimals="2"
      id="ixv-72177"
      unitRef="hkdPershares">63.35</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c505"
      decimals="0"
      id="ixv-72178"
      unitRef="pure">633243</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c505"
      decimals="2"
      id="ixv-72179"
      unitRef="hkdPershares">63.35</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c506"
      decimals="2"
      id="ixv-72180"
      unitRef="hkdPershares">63.35</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c506"
      decimals="0"
      id="ixv-72181"
      unitRef="pure">633243</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c513"
      decimals="0"
      id="ixv-72182"
      unitRef="pure">633243</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c513"
      decimals="2"
      id="ixv-72183"
      unitRef="hkdPershares">63.35</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="c0" decimals="0" id="ixv-72184" unitRef="pure">633243</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <aapg:NumberOfShareOptionsExpenseInSharebasedPaymentArrangement contextRef="c0" decimals="-3" id="ixv-72185" unitRef="cny">2420000</aapg:NumberOfShareOptionsExpenseInSharebasedPaymentArrangement>
    <aapg:NumberOfShareOptionsExpenseInSharebasedPaymentArrangement contextRef="c0" decimals="-3" id="ixv-72186" unitRef="usd">346000</aapg:NumberOfShareOptionsExpenseInSharebasedPaymentArrangement>
    <aapg:AdditionalOrdinaryShares
      contextRef="c471"
      decimals="0"
      id="ixv-72187"
      unitRef="shares">633243</aapg:AdditionalOrdinaryShares>
    <ifrs-full:SharePremium
      contextRef="c471"
      decimals="-3"
      id="ixv-72188"
      unitRef="usd">2902000</ifrs-full:SharePremium>
    <ifrs-full:CapitalReserve
      contextRef="c471"
      decimals="-3"
      id="ixv-72189"
      unitRef="cny">20294000</ifrs-full:CapitalReserve>
    <aapg:ScheduleOfFairValuesOfShareOptionsGrantedTextBlock contextRef="c0" id="ixv-58919">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the share options granted was estimated as at the grant date by using the binary tree option pricing model. The following
table lists the key inputs to the fair value model used:&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;At grant dates&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;49.65&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.09&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life of options (year)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Weighted average share price (HKD per share)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34.98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfFairValuesOfShareOptionsGrantedTextBlock>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="c0" decimals="4" id="ixv-72190" unitRef="pure">0.4965</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="c0" decimals="4" id="ixv-72191" unitRef="pure">0.0309</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="c0" decimals="2" id="ixv-72192" unitRef="pure">10</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c0"
      decimals="2"
      id="ixv-72193"
      unitRef="usdPershares">34.98</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c472" id="ixv-72194">P10Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c472"
      decimals="0"
      id="ixv-72195"
      unitRef="pure">5274657</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c473"
      decimals="0"
      id="ixv-72196"
      unitRef="pure">2590592</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aapg:SharebasedPaymentVestingPeriod contextRef="c473" id="ixv-72197">P3Y</aapg:SharebasedPaymentVestingPeriod>
    <aapg:ShareGrantExpense contextRef="c12" decimals="0" id="ixv-72198" unitRef="cny">3169</aapg:ShareGrantExpense>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c474" id="ixv-72199">P10Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c475"
      decimals="0"
      id="ixv-72200"
      unitRef="pure">3133526</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c476"
      decimals="0"
      id="ixv-72201"
      unitRef="pure">440490</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c477"
      decimals="0"
      id="ixv-72202"
      unitRef="pure">10641</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c478"
      decimals="0"
      id="ixv-72203"
      unitRef="pure">55157</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c479"
      decimals="0"
      id="ixv-72204"
      unitRef="pure">26892</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aapg:DisclosureOfUnlockingDatetextBlock contextRef="c0" id="ixv-59072">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the unlocking date are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grant fair&lt;br/&gt; value HK$ &lt;br/&gt; per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of &lt;br/&gt; conditional &lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of vested &lt;br/&gt;
conditional shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 18%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 20%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2021-2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 19%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35%, 15%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2021-2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2022&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35%, 15%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 30, 2022&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35%, 15%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43.80&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2022&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2022&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the unlocking date are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grant fair &lt;br/&gt;
value HK$ &lt;br/&gt;
per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of &lt;br/&gt;
conditional shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of vested&lt;br/&gt; conditional shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 18%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77.45&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;p style="margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 27, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the unlocking date are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: black 1.5pt solid; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Type of eligible participants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Grant fair value HK$ per share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;% of conditional shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vesting date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;% of vested conditional shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2021-2024&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35%, 15%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="width: 31%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 23%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 30, 2023&#x2013;2026&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2023&#x2013;2026&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2023&#x2013;2024&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40%, 60%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June 8, 2023&#x2013;2025&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30%, 30%, 40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.15&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 30, 2023&#x2013;2026&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;23%, 69%, 6%, 2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the unlocking date are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grant &lt;br/&gt; fair value&lt;br/&gt; HK$ per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of&lt;br/&gt; conditional&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of vested conditional shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 31%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 23%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August 1, 2023&#x2013;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 20%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40%, 60%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August 1, 2023&#x2013;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30%, 30%, 40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant fair value HK$ per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;% of conditional shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vesting date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;% of vested conditional shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 31%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 20%; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 21%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;75%, 25%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50%, 50%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30%, 30%, 40%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22.5%, 22.5%, 55%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50%, 25%, 25&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2024-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 37%, 38&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2025-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40%, 60&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.95&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 16, 2025-2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50%, 50&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Type of eligible participants&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grant
fair&lt;br/&gt; value HK$&lt;br/&gt;
per&#160;share&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of &lt;br/&gt; conditional &lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting date&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;% of vested&lt;br/&gt; conditional shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 18%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 17%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 17%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; width: 20%; font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November 26, 2026-2028&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; width: 19%; font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33.33%, 33.33%, 33.34%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63.35&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November 26, 2026-2029&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%, 25%, 25%, 25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</aapg:DisclosureOfUnlockingDatetextBlock>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c514"
      decimals="2"
      id="ixv-72205"
      unitRef="hkdPershares">43.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c514"
      decimals="2"
      id="ixv-72206"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c514" id="ixv-59132">June 8, 2021-2024</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c514" id="ixv-59137">35%, 15%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c515"
      decimals="2"
      id="ixv-72207"
      unitRef="hkdPershares">43.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c515"
      decimals="2"
      id="ixv-72208"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c515" id="ixv-59163">June 8, 2021-2024</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c515" id="ixv-59168">25%, 25%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c516"
      decimals="2"
      id="ixv-72209"
      unitRef="hkdPershares">43.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c516"
      decimals="2"
      id="ixv-72210"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c516" id="ixv-59194">June 8, 2022&#x2013;2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c516" id="ixv-59199">35%, 15%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c517"
      decimals="2"
      id="ixv-72211"
      unitRef="hkdPershares">43.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c517"
      decimals="2"
      id="ixv-72212"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c517" id="ixv-59225">April 30, 2022&#x2013;2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c517" id="ixv-59230">35%, 15%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c518"
      decimals="2"
      id="ixv-72213"
      unitRef="hkdPershares">43.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c518"
      decimals="2"
      id="ixv-72214"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c518" id="ixv-59256">June 8, 2022&#x2013;2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c518" id="ixv-59261">25%, 25%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c519"
      decimals="2"
      id="ixv-72215"
      unitRef="hkdPershares">52</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c519"
      decimals="2"
      id="ixv-72216"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c519" id="ixv-59287">June 8, 2022&#x2013;2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c519" id="ixv-59292">25%, 25%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c480"
      decimals="0"
      id="ixv-72217"
      unitRef="pure">48439</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c520"
      decimals="2"
      id="ixv-72218"
      unitRef="hkdPershares">77.45</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c520"
      decimals="2"
      id="ixv-72219"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c520" id="ixv-59362">June 27, 2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c520" id="ixv-59369">100%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory contextRef="c0" id="ixv-59441">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following restricted shares were outstanding under the 2021 RSU Scheme during the year:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;br/&gt;
    Number of&lt;br/&gt;
    RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;br/&gt;
    Number of&lt;br/&gt;
    RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;108,998&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;41,552&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-349"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,412&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-350; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested
    during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(65,034&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(89,991&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;41,552&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-351; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following restricted shares were outstanding under the 2022 RSU Scheme during the year:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&#160;Number of&#160;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&#160;Number of&#160;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,641,974&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,436,525&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;777,006&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,177,256&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited during the year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(42,768&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(132,302&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested
    during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(939,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(936,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,436,525&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,545,292&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c541"
      decimals="0"
      id="ixv-72220"
      unitRef="pure">108998</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c542"
      decimals="0"
      id="ixv-72221"
      unitRef="pure">41552</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c481"
      decimals="0"
      id="ixv-72222"
      unitRef="pure">48439</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="c482"
      decimals="0"
      id="ixv-72223"
      unitRef="pure">2412</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c482"
      decimals="0"
      id="ixv-72224"
      unitRef="pure">65034</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c481"
      decimals="0"
      id="ixv-72225"
      unitRef="pure">89991</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c542"
      decimals="0"
      id="ixv-72226"
      unitRef="pure">41552</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="c481"
      decimals="2"
      id="ixv-72227"
      unitRef="hkdPershares">70.48</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="c482"
      decimals="2"
      id="ixv-72228"
      unitRef="hkdPershares">20.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="c483"
      decimals="2"
      id="ixv-72229"
      unitRef="usdPershares">19.96</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <aapg:ShareGrantExpense
      contextRef="c481"
      decimals="-3"
      id="ixv-72230"
      unitRef="cny">3604000</aapg:ShareGrantExpense>
    <aapg:ShareGrantExpense
      contextRef="c481"
      decimals="-3"
      id="ixv-72231"
      unitRef="usd">515000</aapg:ShareGrantExpense>
    <aapg:ShareGrantExpense
      contextRef="c482"
      decimals="-3"
      id="ixv-72232"
      unitRef="cny">856000</aapg:ShareGrantExpense>
    <aapg:ShareGrantExpense contextRef="c12" decimals="0" id="ixv-72233" unitRef="usd">1589</aapg:ShareGrantExpense>
    <ifrs-full:SharePremium
      contextRef="c484"
      decimals="-3"
      id="ixv-72234"
      unitRef="hkd">1894000</ifrs-full:SharePremium>
    <ifrs-full:CapitalReserve
      contextRef="c484"
      decimals="-3"
      id="ixv-72235"
      unitRef="cny">1712000</ifrs-full:CapitalReserve>
    <ifrs-full:CapitalReserve
      contextRef="c484"
      decimals="-3"
      id="ixv-72236"
      unitRef="usd">245000</ifrs-full:CapitalReserve>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c485" id="ixv-72237">P10Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c486"
      decimals="0"
      id="ixv-72238"
      unitRef="pure">11072695</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c487"
      decimals="0"
      id="ixv-72239"
      unitRef="pure">1634426</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c487"
      decimals="0"
      id="ixv-72240"
      unitRef="pure">1634426</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c488"
      decimals="0"
      id="ixv-72241"
      unitRef="pure">100000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c489"
      decimals="0"
      id="ixv-72242"
      unitRef="pure">100000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c521"
      decimals="2"
      id="ixv-72243"
      unitRef="hkdPershares">20.15</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c521"
      decimals="2"
      id="ixv-72244"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c521" id="ixv-59716">June 8, 2021-2024</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c521" id="ixv-59721">35%, 15%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c522"
      decimals="2"
      id="ixv-72245"
      unitRef="hkdPershares">20.15</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c522"
      decimals="2"
      id="ixv-72246"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c522" id="ixv-59745">April 30, 2023&#x2013;2026</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c522" id="ixv-59750">25%, 25%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c523"
      decimals="2"
      id="ixv-72247"
      unitRef="hkdPershares">20.15</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c523"
      decimals="2"
      id="ixv-72248"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c523" id="ixv-59774">June 8, 2023&#x2013;2026</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c523" id="ixv-59779">25%, 25%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c524"
      decimals="2"
      id="ixv-72249"
      unitRef="hkdPershares">20.15</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c524"
      decimals="2"
      id="ixv-72250"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c524" id="ixv-59803">June 8, 2023&#x2013;2024</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c524" id="ixv-59808">40%, 60%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c525"
      decimals="2"
      id="ixv-72251"
      unitRef="hkdPershares">20.15</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c525"
      decimals="2"
      id="ixv-72252"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c525" id="ixv-59832">June 8, 2023&#x2013;2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c525" id="ixv-59837">30%, 30%, 40%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c526"
      decimals="2"
      id="ixv-72253"
      unitRef="hkdPershares">20.15</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c526"
      decimals="2"
      id="ixv-72254"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c526" id="ixv-59861">April 30, 2023&#x2013;2026</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c526" id="ixv-59866">23%, 69%, 6%, 2%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c490"
      decimals="0"
      id="ixv-72255"
      unitRef="pure">1379094</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c491"
      decimals="0"
      id="ixv-72256"
      unitRef="pure">1379094</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c527"
      decimals="1"
      id="ixv-72257"
      unitRef="hkdPershares">21.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c527"
      decimals="2"
      id="ixv-72258"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c527" id="ixv-59987">August 1, 2023&#x2013;2024</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c527" id="ixv-59992">40%, 60%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c528"
      decimals="1"
      id="ixv-72259"
      unitRef="hkdPershares">21.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c528"
      decimals="2"
      id="ixv-72260"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c528" id="ixv-60016">August 1, 2023&#x2013;2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c528" id="ixv-60021">30%, 30%, 40%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c492"
      decimals="0"
      id="ixv-72261"
      unitRef="pure">777006</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c493"
      decimals="0"
      id="ixv-72262"
      unitRef="pure">777006</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c529"
      decimals="2"
      id="ixv-72263"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c529"
      decimals="2"
      id="ixv-72264"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c529" id="ixv-60083">September 16, 2024</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c529" id="ixv-60090">100%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c530"
      decimals="2"
      id="ixv-72265"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c530"
      decimals="2"
      id="ixv-72266"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c530" id="ixv-60116">September 16, 2024-2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c530" id="ixv-60123">75%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c531"
      decimals="2"
      id="ixv-72267"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c531"
      decimals="2"
      id="ixv-72268"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c531" id="ixv-60149">September 16, 2024-2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c531" id="ixv-60156">50%, 50%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c532"
      decimals="2"
      id="ixv-72269"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c532"
      decimals="2"
      id="ixv-72270"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c532" id="ixv-60182">September 16, 2024-2026</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c532" id="ixv-60189">30%, 30%, 40%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c533"
      decimals="2"
      id="ixv-72271"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c533"
      decimals="2"
      id="ixv-72272"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c533" id="ixv-60215">September 16, 2024-2026</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c533" id="ixv-60222">22.5%, 22.5%, 55%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c534"
      decimals="2"
      id="ixv-72273"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c534"
      decimals="2"
      id="ixv-72274"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c534" id="ixv-60248">September 16, 2024-2026</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c534" id="ixv-60255">50%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c535"
      decimals="2"
      id="ixv-72275"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c535"
      decimals="2"
      id="ixv-72276"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c535" id="ixv-60282">September 16, 2024-2026</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c535" id="ixv-60289">25%, 37%, 38%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c536"
      decimals="2"
      id="ixv-72277"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c536"
      decimals="2"
      id="ixv-72278"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c536" id="ixv-60316">September 16, 2025</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c536" id="ixv-60323">100%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c537"
      decimals="2"
      id="ixv-72279"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c537"
      decimals="2"
      id="ixv-72280"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c537" id="ixv-60348">September 16, 2025-2026</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c537" id="ixv-60355">40%, 60%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c538"
      decimals="2"
      id="ixv-72281"
      unitRef="hkdPershares">33.95</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c538"
      decimals="2"
      id="ixv-72282"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c538" id="ixv-60382">September 16, 2025-2026</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c538" id="ixv-60389">50%, 50%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c494"
      decimals="0"
      id="ixv-72283"
      unitRef="pure">1177256</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c463"
      decimals="0"
      id="ixv-72284"
      unitRef="pure">1177256</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c495"
      decimals="0"
      id="ixv-72285"
      unitRef="pure">143363</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c496"
      decimals="0"
      id="ixv-72286"
      unitRef="pure">143363</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c539"
      decimals="2"
      id="ixv-72287"
      unitRef="hkdPershares">63.35</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c539"
      decimals="2"
      id="ixv-72288"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c539" id="ixv-60457">November 26, 2026-2028</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c539" id="ixv-60462">33.33%, 33.33%, 33.34%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="c540"
      decimals="2"
      id="ixv-72289"
      unitRef="hkdPershares">63.35</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <aapg:PercentageOfConditionalShares
      contextRef="c540"
      decimals="2"
      id="ixv-72290"
      unitRef="pure">1</aapg:PercentageOfConditionalShares>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement contextRef="c540" id="ixv-60488">November 26, 2026-2029</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <aapg:PercentageOfVestedConditionalShares contextRef="c540" id="ixv-60493">25%, 25%, 25%, 25%</aapg:PercentageOfVestedConditionalShares>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c499"
      decimals="0"
      id="ixv-72291"
      unitRef="pure">1641974</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c498"
      decimals="0"
      id="ixv-72292"
      unitRef="pure">1436525</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c501"
      decimals="0"
      id="ixv-72293"
      unitRef="pure">777006</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c500"
      decimals="0"
      id="ixv-72294"
      unitRef="pure">1177256</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="c501"
      decimals="0"
      id="ixv-72295"
      unitRef="pure">42768</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="c500"
      decimals="0"
      id="ixv-72296"
      unitRef="pure">132302</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c501"
      decimals="0"
      id="ixv-72297"
      unitRef="pure">939687</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c500"
      decimals="0"
      id="ixv-72298"
      unitRef="pure">936187</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c498"
      decimals="0"
      id="ixv-72299"
      unitRef="pure">1436525</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c497"
      decimals="0"
      id="ixv-72300"
      unitRef="pure">1545292</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aapg:RSUsGrantedFairValue
      contextRef="c497"
      decimals="-3"
      id="ixv-72301"
      unitRef="cny">68327000</aapg:RSUsGrantedFairValue>
    <aapg:RSUsGrantedFairValue
      contextRef="c497"
      decimals="-3"
      id="ixv-72302"
      unitRef="usd">9771000</aapg:RSUsGrantedFairValue>
    <aapg:RSUsGrantedFairValue
      contextRef="c498"
      decimals="-3"
      id="ixv-72303"
      unitRef="cny">24078000</aapg:RSUsGrantedFairValue>
    <aapg:RSUsGrantedFairValue
      contextRef="c499"
      decimals="-3"
      id="ixv-72304"
      unitRef="cny">27063000</aapg:RSUsGrantedFairValue>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="c500"
      decimals="2"
      id="ixv-72305"
      unitRef="hkdPershares">20.14</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="c501"
      decimals="2"
      id="ixv-72306"
      unitRef="hkdPershares">19.24</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="c502"
      decimals="2"
      id="ixv-72307"
      unitRef="hkdPershares">18.15</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="c0"
      decimals="2"
      id="ixv-72308"
      unitRef="hkdPershares">79.35</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <aapg:ShareGrantExpense
      contextRef="c500"
      decimals="-3"
      id="ixv-72309"
      unitRef="cny">14850000</aapg:ShareGrantExpense>
    <aapg:ShareGrantExpense
      contextRef="c500"
      decimals="-3"
      id="ixv-72310"
      unitRef="usd">2124000</aapg:ShareGrantExpense>
    <aapg:ShareGrantExpense
      contextRef="c501"
      decimals="-3"
      id="ixv-72311"
      unitRef="cny">20068000</aapg:ShareGrantExpense>
    <aapg:ShareGrantExpense
      contextRef="c502"
      decimals="-3"
      id="ixv-72312"
      unitRef="cny">22995000</aapg:ShareGrantExpense>
    <ifrs-full:SharePremium
      contextRef="c503"
      decimals="-3"
      id="ixv-72313"
      unitRef="hkd">85945000</ifrs-full:SharePremium>
    <ifrs-full:CapitalReserve
      contextRef="c503"
      decimals="-3"
      id="ixv-72314"
      unitRef="cny">78740000</ifrs-full:CapitalReserve>
    <ifrs-full:CapitalReserve
      contextRef="c503"
      decimals="-3"
      id="ixv-72315"
      unitRef="usd">11260000</ifrs-full:CapitalReserve>
    <ifrs-full:DisclosureOfCashFlowStatementExplanatory contextRef="c0" id="ixv-60699">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NOTES
                                            TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Major
                                            non-cash transactions&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;During the year ended December &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,
2025, the Company granted 633,243 options (2024: &lt;span style="-sec-ix-hidden: hidden-fact-377"&gt;Nil&lt;/span&gt;, 2023: &lt;span style="-sec-ix-hidden: hidden-fact-378"&gt;Nil&lt;/span&gt;) under the Post-IPO option scheme to 33 grantees. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;During the year ended December &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,
2025, the Company issued 48,439 RSUs under the 2021 RSU scheme to 34 grantees and 1,177,256 RSUs under the 2022 RSU scheme to 145 grantees.
During the year ended December 31, 2024, the Company granted &lt;span style="-sec-ix-hidden: hidden-fact-379"&gt;nil&lt;/span&gt; RSUs under 2021RSU and granted 777,006 RSUs under the 2022 RSU scheme
to 59 grantees. During the year ended December 31, 2023, the Company granted &lt;span style="-sec-ix-hidden: hidden-fact-380"&gt;nil&lt;/span&gt; RSUs under 2021RSU and granted 1,379,094 RSUs under the
2022 RSU scheme to 172 grantees.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;During the year ended December &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,
2025, the Company issued 1,592,607 newly issued shares to employees including 176,278 newly issued shares to Dr. Zhai as settlement of
bonus of RMB58,869 (US$8,418) (2024: RMB49,350, 2023: RMB55,468).&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During the year ended December 31, 2025, the Group had non-cash additions
to right-of-use assets and lease liabilities of RMB5,047 (US$722) (2024: RMB17,108,2023: RMB16,194), and non-cash disposals of RMB2,675
(US$382) and RMB3,360 (US$480) (2024: RMB1,067 and RMB1,152,2023:&lt;span style="-sec-ix-hidden: hidden-fact-381"&gt;Nil&lt;/span&gt; and &lt;span style="-sec-ix-hidden: hidden-fact-382"&gt;Nil&lt;/span&gt;), respectively, in respect of lease arrangements for buildings.&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;v.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0"&gt;As at December 31, 2025, 2024 and 2023, the Group had non-cash additions to intangible assets of &lt;span style="-sec-ix-hidden: hidden-fact-383"&gt;nil&lt;/span&gt;, RMB1,403,
and RMB805, respectively, and non-cash additions to property, plant and equipment of RMB 10,011(US$1,432), RMB9,424 and RMB26,823, respectively,
included in other payables and accruals.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes in liabilities arising from financing activities&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;interest in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other payables&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank and&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At January
    1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,775,505&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,222&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes
    from financing cash flows&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(91,027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,591&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,766&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-356; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-357; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,194&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,690&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-358; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    paid classified as financing cash flows&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-359; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-360; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effect
    of change in foreign exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-361; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-362; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,046&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,772,914&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,681&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;interest in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other payables&lt;br/&gt; and accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank and&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At January
    1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,046&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,772,914&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,681&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes
    from financing cash flows&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(59,057&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(136,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,413&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-363; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-364; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,152&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;59,276&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,279&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    paid classified as financing cash flows&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-365; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-366; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effect
    of change in foreign exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-367; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-368; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,265&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,638,265&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,232&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;interest in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other payables&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank and&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At January
    1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,638,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,232&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes
    from financing cash flows&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50,190&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;316,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,717&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-369; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-370; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-371; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-372; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,360&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;49,534&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    paid classified as financing cash flows&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-373; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-374; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effect
    of change in foreign exchange rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-375; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-376; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;609&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,957,523&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;87&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;279,922&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,174&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
                                            cash outflow for leases&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total cash outflow for leases included in the statements of cash flows is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within operating
    activities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;181&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within
    financing activities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,087&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,911&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,835&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,549&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,268&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,149&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,164&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,596&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfCashFlowStatementExplanatory>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c505"
      decimals="0"
      id="ixv-72316"
      unitRef="pure">633243</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aapg:NumberOfGrantees
      contextRef="c506"
      decimals="0"
      id="ixv-72317"
      unitRef="pure">33</aapg:NumberOfGrantees>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c543"
      decimals="0"
      id="ixv-72318"
      unitRef="shares">48439</ifrs-full:NumberOfSharesIssued>
    <aapg:NumberOfGrantees
      contextRef="c543"
      decimals="0"
      id="ixv-72319"
      unitRef="pure">34</aapg:NumberOfGrantees>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c544"
      decimals="0"
      id="ixv-72320"
      unitRef="shares">1177256</ifrs-full:NumberOfSharesIssued>
    <aapg:NumberOfGrantees
      contextRef="c544"
      decimals="0"
      id="ixv-72321"
      unitRef="pure">145</aapg:NumberOfGrantees>
    <aapg:NumberOfGrantees
      contextRef="c546"
      decimals="0"
      id="ixv-72322"
      unitRef="pure">777006</aapg:NumberOfGrantees>
    <aapg:NumberOfGrantees contextRef="c14" decimals="0" id="ixv-72323" unitRef="pure">59</aapg:NumberOfGrantees>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c548"
      decimals="0"
      id="ixv-72324"
      unitRef="shares">1379094</ifrs-full:NumberOfSharesIssued>
    <aapg:NumberOfGrantees
      contextRef="c548"
      decimals="0"
      id="ixv-72325"
      unitRef="pure">172</aapg:NumberOfGrantees>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c549"
      decimals="0"
      id="ixv-72326"
      unitRef="shares">1592607</ifrs-full:NumberOfSharesIssued>
    <aapg:NumberOfNewlyIssuedShares
      contextRef="c0"
      decimals="0"
      id="ixv-72327"
      unitRef="shares">176278</aapg:NumberOfNewlyIssuedShares>
    <aapg:BonusAmount
      contextRef="c550"
      decimals="-3"
      id="ixv-72328"
      unitRef="cny">58869000</aapg:BonusAmount>
    <aapg:BonusAmount
      contextRef="c550"
      decimals="-3"
      id="ixv-72329"
      unitRef="usd">8418000</aapg:BonusAmount>
    <aapg:BonusAmount
      contextRef="c551"
      decimals="-3"
      id="ixv-72330"
      unitRef="cny">49350000</aapg:BonusAmount>
    <aapg:BonusAmount
      contextRef="c552"
      decimals="-3"
      id="ixv-72331"
      unitRef="usd">55468000</aapg:BonusAmount>
    <aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities contextRef="c15" decimals="-3" id="ixv-72332" unitRef="cny">5047000</aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities>
    <aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities contextRef="c15" decimals="-3" id="ixv-72333" unitRef="usd">722000</aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities>
    <aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities contextRef="c14" decimals="-3" id="ixv-72334" unitRef="cny">17108000</aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities>
    <aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities contextRef="c41" decimals="-3" id="ixv-72335" unitRef="cny">16194000</aapg:NonCashAdditionForIncreaseDecreaseinRightOfUseAssetsAndLeaseLiabilities>
    <aapg:NonCashDisposals
      contextRef="c553"
      decimals="-3"
      id="ixv-72336"
      unitRef="cny">2675000</aapg:NonCashDisposals>
    <aapg:NonCashDisposals
      contextRef="c553"
      decimals="-3"
      id="ixv-72337"
      unitRef="usd">382000</aapg:NonCashDisposals>
    <aapg:NonCashDisposals contextRef="c82" decimals="-3" id="ixv-72338" unitRef="cny">3360000</aapg:NonCashDisposals>
    <aapg:NonCashDisposals contextRef="c82" decimals="-3" id="ixv-72339" unitRef="usd">480000</aapg:NonCashDisposals>
    <aapg:NonCashDisposals
      contextRef="c554"
      decimals="-3"
      id="ixv-72340"
      unitRef="cny">1067000</aapg:NonCashDisposals>
    <aapg:NonCashDisposals
      contextRef="c555"
      decimals="-3"
      id="ixv-72341"
      unitRef="cny">1152000</aapg:NonCashDisposals>
    <aapg:NoncashAdditionsToIntangibleAssets contextRef="c13" decimals="-3" id="ixv-72342" unitRef="cny">1403000</aapg:NoncashAdditionsToIntangibleAssets>
    <aapg:NoncashAdditionsToIntangibleAssets contextRef="c12" decimals="-3" id="ixv-72343" unitRef="cny">805000</aapg:NoncashAdditionsToIntangibleAssets>
    <aapg:NonCashAdditionsToPropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-72344" unitRef="cny">10011000</aapg:NonCashAdditionsToPropertyPlantAndEquipment>
    <aapg:NonCashAdditionsToPropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-72345" unitRef="usd">1432000</aapg:NonCashAdditionsToPropertyPlantAndEquipment>
    <aapg:NonCashAdditionsToPropertyPlantAndEquipment contextRef="c13" decimals="-3" id="ixv-72346" unitRef="cny">9424000</aapg:NonCashAdditionsToPropertyPlantAndEquipment>
    <aapg:NonCashAdditionsToPropertyPlantAndEquipment contextRef="c12" decimals="-3" id="ixv-72347" unitRef="cny">26823000</aapg:NonCashAdditionsToPropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory contextRef="c0" id="ixv-60831">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes in liabilities arising from financing activities&lt;/span&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;interest in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other payables&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank and&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At January
    1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,775,505&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,222&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes
    from financing cash flows&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(91,027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,591&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,766&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-356; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-357; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,194&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,690&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-358; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    paid classified as financing cash flows&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-359; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-360; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,321&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effect
    of change in foreign exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-361; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-362; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,046&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,772,914&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,681&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;interest in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other payables&lt;br/&gt; and accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank and&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At January
    1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,046&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,772,914&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,681&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes
    from financing cash flows&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(59,057&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(136,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,413&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-363; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-364; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,108&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,152&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;59,276&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,279&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    paid classified as financing cash flows&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-365; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-366; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,498&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effect
    of change in foreign exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-367; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-368; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,265&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,638,265&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,232&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;interest in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other payables&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Bank and&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At January
    1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,638,265&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,232&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes
    from financing cash flows&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50,190&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;316,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,717&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-369; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-370; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-371; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-372; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,360&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;49,534&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    paid classified as financing cash flows&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-373; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-374; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effect
    of change in foreign exchange rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-375; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-376; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;609&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,957,523&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;87&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;279,922&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,174&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c556"
      decimals="-3"
      id="ixv-72348"
      unitRef="cny">383000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c557"
      decimals="-3"
      id="ixv-72349"
      unitRef="cny">1775505000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c558"
      decimals="-3"
      id="ixv-72350"
      unitRef="cny">17222000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="c559"
      decimals="-3"
      id="ixv-72351"
      unitRef="cny">-91027000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="c560"
      decimals="-3"
      id="ixv-72352"
      unitRef="cny">-2591000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="c561"
      decimals="-3"
      id="ixv-72353"
      unitRef="cny">-10766000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c561"
      decimals="-3"
      id="ixv-72354"
      unitRef="cny">16194000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestExpense
      contextRef="c559"
      decimals="-3"
      id="ixv-72355"
      unitRef="cny">91690000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="c561"
      decimals="-3"
      id="ixv-72356"
      unitRef="cny">1321000</ifrs-full:InterestExpense>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c561"
      decimals="-3"
      id="ixv-72357"
      unitRef="cny">1321000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c561"
      decimals="-3"
      id="ixv-72358"
      unitRef="cny">31000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c562"
      decimals="-3"
      id="ixv-72359"
      unitRef="cny">1046000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c563"
      decimals="-3"
      id="ixv-72360"
      unitRef="cny">1772914000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c564"
      decimals="-3"
      id="ixv-72361"
      unitRef="cny">22681000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c565"
      decimals="-3"
      id="ixv-72362"
      unitRef="cny">1046000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c566"
      decimals="-3"
      id="ixv-72363"
      unitRef="cny">1772914000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c567"
      decimals="-3"
      id="ixv-72364"
      unitRef="cny">22681000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="c568"
      decimals="-3"
      id="ixv-72365"
      unitRef="cny">-59057000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="c569"
      decimals="-3"
      id="ixv-72366"
      unitRef="cny">-136928000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="c570"
      decimals="-3"
      id="ixv-72367"
      unitRef="cny">-8413000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c570"
      decimals="-3"
      id="ixv-72368"
      unitRef="cny">17108000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets
      contextRef="c570"
      decimals="-3"
      id="ixv-72369"
      unitRef="cny">-1152000</ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets>
    <ifrs-full:InterestExpense
      contextRef="c568"
      decimals="-3"
      id="ixv-72370"
      unitRef="cny">59276000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="c569"
      decimals="-3"
      id="ixv-72371"
      unitRef="cny">2279000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="c570"
      decimals="-3"
      id="ixv-72372"
      unitRef="cny">1498000</ifrs-full:InterestExpense>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c570"
      decimals="-3"
      id="ixv-72373"
      unitRef="cny">1498000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c570"
      decimals="-3"
      id="ixv-72374"
      unitRef="cny">8000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c571"
      decimals="-3"
      id="ixv-72375"
      unitRef="cny">1265000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c572"
      decimals="-3"
      id="ixv-72376"
      unitRef="cny">1638265000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c573"
      decimals="-3"
      id="ixv-72377"
      unitRef="cny">30232000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c574"
      decimals="-3"
      id="ixv-72378"
      unitRef="cny">1265000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c575"
      decimals="-3"
      id="ixv-72379"
      unitRef="cny">1638265000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c576"
      decimals="-3"
      id="ixv-72380"
      unitRef="cny">30232000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="c577"
      decimals="-3"
      id="ixv-72381"
      unitRef="cny">-50190000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="c578"
      decimals="-3"
      id="ixv-72382"
      unitRef="cny">316980000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="c579"
      decimals="-3"
      id="ixv-72383"
      unitRef="cny">-9717000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c579"
      decimals="-3"
      id="ixv-72384"
      unitRef="cny">5047000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets
      contextRef="c579"
      decimals="-3"
      id="ixv-72385"
      unitRef="cny">-3360000</ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets>
    <ifrs-full:InterestExpense
      contextRef="c577"
      decimals="-3"
      id="ixv-72386"
      unitRef="cny">49534000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="c578"
      decimals="-3"
      id="ixv-72387"
      unitRef="cny">2278000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="c579"
      decimals="-3"
      id="ixv-72388"
      unitRef="cny">1118000</ifrs-full:InterestExpense>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c579"
      decimals="-3"
      id="ixv-72389"
      unitRef="cny">1118000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c579"
      decimals="-3"
      id="ixv-72390"
      unitRef="cny">-6000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c580"
      decimals="-3"
      id="ixv-72391"
      unitRef="cny">609000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c581"
      decimals="-3"
      id="ixv-72392"
      unitRef="cny">1957523000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c582"
      decimals="-3"
      id="ixv-72393"
      unitRef="cny">22196000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c580"
      decimals="-3"
      id="ixv-72394"
      unitRef="usd">87000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c581"
      decimals="-3"
      id="ixv-72395"
      unitRef="usd">279922000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c582"
      decimals="-3"
      id="ixv-72396"
      unitRef="usd">3174000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <aapg:DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory contextRef="c0" id="ixv-61775">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total cash outflow for leases included in the statements of cash flows is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within operating
    activities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;181&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Within
    financing activities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,087&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,911&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,835&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,549&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,268&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,149&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,164&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,596&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfCashOutflowForLeasesIncludedInTheStatementOfCashFlowsExplanatory>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities contextRef="c12" decimals="-3" id="ixv-72397" unitRef="cny">181000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities contextRef="c13" decimals="-3" id="ixv-72398" unitRef="cny">238000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities contextRef="c0" decimals="-3" id="ixv-72399" unitRef="cny">329000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities contextRef="c0" decimals="-3" id="ixv-72400" unitRef="usd">47000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="c12" decimals="-3" id="ixv-72401" unitRef="cny">12087000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="c13" decimals="-3" id="ixv-72402" unitRef="cny">9911000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-72403" unitRef="cny">10835000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="c0" decimals="-3" id="ixv-72404" unitRef="usd">1549000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
    <aapg:CashInflowOutflowForLease contextRef="c12" decimals="-3" id="ixv-72405" unitRef="cny">12268000</aapg:CashInflowOutflowForLease>
    <aapg:CashInflowOutflowForLease contextRef="c13" decimals="-3" id="ixv-72406" unitRef="cny">10149000</aapg:CashInflowOutflowForLease>
    <aapg:CashInflowOutflowForLease contextRef="c0" decimals="-3" id="ixv-72407" unitRef="cny">11164000</aapg:CashInflowOutflowForLease>
    <aapg:CashInflowOutflowForLease contextRef="c0" decimals="-3" id="ixv-72408" unitRef="usd">1596000</aapg:CashInflowOutflowForLease>
    <ifrs-full:DisclosureOfCommitmentsExplanatory contextRef="c0" id="ixv-61980">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;COMMITMENTS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As at December 31, 2025, the Group had capital commitments of RMB307 (US$44) relating to furniture and equipment (2024: RMB4,366).&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Group has no lease contracts that have not yet commenced as at December 31, 2025.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Group enters into business agreements with institutions to license intellectual property.
                                            The Group may be obligated to make future research and developmental milestone payments,
                                            regulatory and commercial milestone payments and royalty payments on future sales of specified
                                            products associated with the agreements. Payments under these agreements generally become
                                            due and payable upon achievement of such milestones or sales. These commitments are not recorded
                                            on the consolidated financial statements because the achievement and timing of these milestones
                                            are not fixed and determinable. When the achievement of these milestones or sales has occurred,
                                            the corresponding amounts are recognized in the consolidated financial statements.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <ifrs-full:CapitalCommitments contextRef="c15" decimals="-3" id="ixv-72409" unitRef="cny">307000</ifrs-full:CapitalCommitments>
    <ifrs-full:CapitalCommitments contextRef="c15" decimals="-3" id="ixv-72410" unitRef="usd">44000</ifrs-full:CapitalCommitments>
    <ifrs-full:CapitalCommitments contextRef="c14" decimals="-3" id="ixv-72411" unitRef="cny">4366000</ifrs-full:CapitalCommitments>
    <ifrs-full:DisclosureOfContingentLiabilitiesExplanatory contextRef="c0" id="ixv-62021">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;34.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CONTINGENT
                                            LIABILITIES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group had &lt;span style="-sec-ix-hidden: hidden-fact-384"&gt;no&lt;/span&gt; significant contingent liabilities as at the end of the reporting date.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfContingentLiabilitiesExplanatory>
    <aapg:DisclosureOfPledgeOfAssetsExplanatory contextRef="c0" id="ixv-62038">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;PLEDGE
                                            OF ASSETS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the Group&#x2019;s assets pledged for the Group&#x2019;s bank loans are included in note 27 to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</aapg:DisclosureOfPledgeOfAssetsExplanatory>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="c0" id="ixv-62090">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;36.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Apart
                                            from the transactions detailed elsewhere in this financial information, the Group had no
                                            transactions with related parties during the years ended December 31, 2023, 2024 and 2025.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;b)&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;T&lt;/span&gt;ransaction
with a related party&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the years ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Dr. Zhai Yifan&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-385"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,533&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,223&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Dr. Yang Dajun&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-386"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,933&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;562&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-387"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;33,466&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,785&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 69.95pt 0pt 50.5pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;According to the HealthQuest Pharma Acquisition Agreement, a contingent consideration of RMB29,533 (US$4,223) due to Dr. Zhai was recognized during the year ended December 31, 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;On 17 July 2025, the Company borrowed 22,000,000 ordinary shares of the Company from Dr. Yang to fulfil a placement to designated subscribers within the required timeline. The borrowed shares were returned to Dr. Yang on 29 July 2025 through the issuance of new shares, accompanied by a contractual borrowing cost payment of RMB 3,933, which was recorded as a reduction in equity in connection with such issuance.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;Outstanding balance with a related party&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Other payables and accruals&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,344&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,308&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,474&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other non-current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-388"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,374&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;911&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total for Dr. Zhai Yifan&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;29,344&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;16,682&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,385&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;In accordance with the acquisition agreement, payable to Dr. Zhai Yifan represented the contingent consideration
related to the acquisition of Guangzhou HealthQuest Pharma Co., Ltd.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Compensation of key management
personnel of the Group:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td colspan="16" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;For
                                            the years ended December 31,&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Short term employee benefits and fees &#160; &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20,118&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,059&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;59,283&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,477&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Equity-settled share-based payment expenses &#160; &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,763&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Post-employment benefits &#160; &lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;986&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;977&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;711&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;102&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total &#160; &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,867&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;20,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;63,135&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,028&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <aapg:DisclosureofTransactionWithRelatedPartyExplanatory contextRef="c0" id="ixv-62112">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;T&lt;/span&gt;ransaction
with a related party&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the years ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Dr. Zhai Yifan&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-385"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,533&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,223&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Dr. Yang Dajun&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-386"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,933&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;562&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-387"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;33,466&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,785&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureofTransactionWithRelatedPartyExplanatory>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="c587"
      decimals="-3"
      id="ixv-72412"
      unitRef="cny">29533000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="c587"
      decimals="-3"
      id="ixv-72413"
      unitRef="usd">4223000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="c589"
      decimals="-3"
      id="ixv-72414"
      unitRef="cny">3933000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="c589"
      decimals="-3"
      id="ixv-72415"
      unitRef="usd">562000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c15" decimals="-3" id="ixv-72416" unitRef="cny">33466000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c15" decimals="-3" id="ixv-72417" unitRef="usd">4785000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="c583"
      decimals="-3"
      id="ixv-72418"
      unitRef="cny">29533000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="c583"
      decimals="-3"
      id="ixv-72419"
      unitRef="usd">4223000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c584"
      decimals="0"
      id="ixv-72420"
      unitRef="shares">22000000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:BorrowingCostsIncurred
      contextRef="c585"
      decimals="-3"
      id="ixv-72421"
      unitRef="cny">3933000</ifrs-full:BorrowingCostsIncurred>
    <aapg:DisclosureofOutstandingBalanceWithRelatedPartyExplanatory contextRef="c0" id="ixv-72422">Outstanding balance with a related party&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Other payables and accruals&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,344&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,308&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,474&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other non-current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-388"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,374&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;911&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total for Dr. Zhai Yifan&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;29,344&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;16,682&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,385&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureofOutstandingBalanceWithRelatedPartyExplanatory>
    <aapg:OtherPayablesAndAccruals contextRef="c14" decimals="-3" id="ixv-72423" unitRef="cny">29344000</aapg:OtherPayablesAndAccruals>
    <aapg:OtherPayablesAndAccruals contextRef="c15" decimals="-3" id="ixv-72424" unitRef="cny">10308000</aapg:OtherPayablesAndAccruals>
    <aapg:OtherPayablesAndAccruals contextRef="c15" decimals="-3" id="ixv-72425" unitRef="usd">1474000</aapg:OtherPayablesAndAccruals>
    <aapg:OutstandingBalanceOtherNoncurrentLiabilities contextRef="c15" decimals="-3" id="ixv-72426" unitRef="cny">6374000</aapg:OutstandingBalanceOtherNoncurrentLiabilities>
    <aapg:OutstandingBalanceOtherNoncurrentLiabilities contextRef="c15" decimals="-3" id="ixv-72427" unitRef="usd">911000</aapg:OutstandingBalanceOtherNoncurrentLiabilities>
    <aapg:OutstandingBalanceWithRelatedParty contextRef="c14" decimals="-3" id="ixv-72428" unitRef="cny">29344000</aapg:OutstandingBalanceWithRelatedParty>
    <aapg:OutstandingBalanceWithRelatedParty contextRef="c15" decimals="-3" id="ixv-72429" unitRef="cny">16682000</aapg:OutstandingBalanceWithRelatedParty>
    <aapg:OutstandingBalanceWithRelatedParty contextRef="c15" decimals="-3" id="ixv-72430" unitRef="usd">2385000</aapg:OutstandingBalanceWithRelatedParty>
    <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory contextRef="c0" id="ixv-62337">&lt;span style="font-size: 10pt"&gt;Compensation of key management
personnel of the Group:&lt;/span&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td colspan="16" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;For
                                            the years ended December 31,&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;b&gt;RMB&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;b&gt;US$&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Short term employee benefits and fees &#160; &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20,118&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,059&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;59,283&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,477&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Equity-settled share-based payment expenses &#160; &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,763&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Post-employment benefits &#160; &lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;986&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;977&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;711&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;102&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total &#160; &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,867&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;20,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;63,135&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;9,028&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c12" decimals="-3" id="ixv-72431" unitRef="cny">20118000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c13" decimals="-3" id="ixv-72432" unitRef="cny">19059000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c0" decimals="-3" id="ixv-72433" unitRef="cny">59283000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c0" decimals="-3" id="ixv-72434" unitRef="usd">8477000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c12" decimals="-3" id="ixv-72435" unitRef="cny">1763000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c13" decimals="-3" id="ixv-72436" unitRef="cny">625000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c0" decimals="-3" id="ixv-72437" unitRef="cny">3141000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c0" decimals="-3" id="ixv-72438" unitRef="usd">449000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c12" decimals="-3" id="ixv-72439" unitRef="cny">986000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c13" decimals="-3" id="ixv-72440" unitRef="cny">977000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c0" decimals="-3" id="ixv-72441" unitRef="cny">711000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c0" decimals="-3" id="ixv-72442" unitRef="usd">102000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c12" decimals="-3" id="ixv-72443" unitRef="cny">22867000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c13" decimals="-3" id="ixv-72444" unitRef="cny">20661000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c0" decimals="-3" id="ixv-72445" unitRef="cny">63135000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c0" decimals="-3" id="ixv-72446" unitRef="usd">9028000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="c0" id="ixv-62538">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;37.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;FINANCIAL INSTRUMENTS BY CATEGORY&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;The carrying amounts of each of the categories of financial
instruments as at the end of each reporting period are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;2024&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="text-decoration:underline"&gt;Financial assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;assets at &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;fair value &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;through &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;profit or &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;assets at &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;amortized &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets included in prepayments, other receivables and other assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-389"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,846&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,846&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Cash and bank balances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-390"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,261,211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,261,211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-391"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets at FVTPL&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-392"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets included in other non-current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-393"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,141&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,356,639&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,357,780&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="text-decoration:underline"&gt;Financial liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;liabilities at &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;fair value &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;through &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;profit or &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;liabilities at &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;amortized &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Interest-bearing bank and other borrowings (current and non-current portions)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-394"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,668,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,668,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Trade payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-395"&gt;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;91,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;91,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Financial liabilities included in other payables and accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-396"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Other non-current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-397"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-398"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,869,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,869,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;2025&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="text-decoration:underline"&gt;Financial assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial&lt;br/&gt;
 assets at&lt;br/&gt;
 fair value&lt;br/&gt;
 through&lt;br/&gt;
 profit or&lt;br/&gt;
 loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial assets at amortized cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets included in prepayments, other receivables and other assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-399"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,609&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,609&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;516&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Cash and bank balances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-400"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,470,085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,470,085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;353,217&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-401"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;252,938&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;252,938&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets at FVTPL&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-402"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets included in other non-current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-403"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;690&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;690&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,727,322&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,731,322&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;390,574&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="text-decoration:underline"&gt;Financial liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;liabilities at&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;fair value&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;through&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;profit or&lt;/b&gt;&lt;/p&gt;

&lt;p style="margin: 0pt 0"&gt;&lt;b&gt;loss&lt;/b&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;liabilities at amortized&lt;/b&gt;&lt;/p&gt;

&lt;p style="margin: 0pt 0"&gt;&lt;b&gt;cost&lt;/b&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Interest-bearing bank and other borrowings (current and non-current portions)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-404"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,979,719&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,979,719&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;283,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Trade payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-405"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Financial liabilities included in other payables and accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,968&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;138,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;140,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-406"&gt;20&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,084&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Other non-current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,374&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,657&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,031&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,720&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,342&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,230,598&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,238,940&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;320,164&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory contextRef="c0" id="ixv-62546">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;The carrying amounts of each of the categories of financial
instruments as at the end of each reporting period are as follows:&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;assets at &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;fair value &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;through &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;profit or &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;assets at &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;amortized &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets included in prepayments, other receivables and other assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-389"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,846&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,846&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Cash and bank balances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-390"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,261,211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,261,211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-391"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets at FVTPL&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-392"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets included in other non-current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-393"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,141&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,356,639&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,357,780&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="text-decoration:underline"&gt;Financial liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;liabilities at &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;fair value &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;through &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;profit or &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;loss&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;liabilities at &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;amortized &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Interest-bearing bank and other borrowings (current and non-current portions)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-394"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,668,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,668,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Trade payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-395"&gt;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;91,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;91,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Financial liabilities included in other payables and accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-396"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Other non-current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-397"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-398"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,869,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,869,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="text-decoration:underline"&gt;Financial assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial&lt;br/&gt;
 assets at&lt;br/&gt;
 fair value&lt;br/&gt;
 through&lt;br/&gt;
 profit or&lt;br/&gt;
 loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial assets at amortized cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets included in prepayments, other receivables and other assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-399"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,609&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,609&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;516&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Cash and bank balances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-400"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,470,085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,470,085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;353,217&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-401"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;252,938&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;252,938&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets at FVTPL&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-402"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Financial assets included in other non-current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-403"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;690&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;690&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,727,322&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,731,322&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;390,574&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="text-decoration:underline"&gt;Financial liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;liabilities at&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;fair value&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;through&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;profit or&lt;/b&gt;&lt;/p&gt;

&lt;p style="margin: 0pt 0"&gt;&lt;b&gt;loss&lt;/b&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Financial&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;liabilities at amortized&lt;/b&gt;&lt;/p&gt;

&lt;p style="margin: 0pt 0"&gt;&lt;b&gt;cost&lt;/b&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Interest-bearing bank and other borrowings (current and non-current portions)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-404"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,979,719&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,979,719&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;283,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Trade payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-405"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Financial liabilities included in other payables and accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,968&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;138,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;140,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-406"&gt;20&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,084&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Other non-current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,374&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,657&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,031&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,720&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,342&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,230,598&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,238,940&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;320,164&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c591"
      decimals="-3"
      id="ixv-72447"
      unitRef="cny">9846000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c592"
      decimals="-3"
      id="ixv-72448"
      unitRef="cny">9846000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c591"
      decimals="-3"
      id="ixv-72449"
      unitRef="cny">1261211000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c592"
      decimals="-3"
      id="ixv-72450"
      unitRef="cny">1261211000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:NoncurrentReceivables
      contextRef="c591"
      decimals="-3"
      id="ixv-72451"
      unitRef="cny">83143000</ifrs-full:NoncurrentReceivables>
    <ifrs-full:NoncurrentReceivables
      contextRef="c592"
      decimals="-3"
      id="ixv-72452"
      unitRef="cny">83143000</ifrs-full:NoncurrentReceivables>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c590"
      decimals="-3"
      id="ixv-72453"
      unitRef="cny">1141000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c592"
      decimals="-3"
      id="ixv-72454"
      unitRef="cny">1141000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c591"
      decimals="-3"
      id="ixv-72455"
      unitRef="cny">2439000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c592"
      decimals="-3"
      id="ixv-72456"
      unitRef="cny">2439000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c590"
      decimals="-3"
      id="ixv-72457"
      unitRef="cny">1141000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c591"
      decimals="-3"
      id="ixv-72458"
      unitRef="cny">1356639000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c592"
      decimals="-3"
      id="ixv-72459"
      unitRef="cny">1357780000</ifrs-full:FinancialAssets>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="c594"
      decimals="-3"
      id="ixv-72460"
      unitRef="cny">1668497000</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="c595"
      decimals="-3"
      id="ixv-72461"
      unitRef="cny">1668497000</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c594"
      decimals="-3"
      id="ixv-72462"
      unitRef="cny">91966000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c595"
      decimals="-3"
      id="ixv-72463"
      unitRef="cny">91966000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c594"
      decimals="-3"
      id="ixv-72464"
      unitRef="cny">103014000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c595"
      decimals="-3"
      id="ixv-72465"
      unitRef="cny">103014000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="c594"
      decimals="-3"
      id="ixv-72466"
      unitRef="cny">6274000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="c595"
      decimals="-3"
      id="ixv-72467"
      unitRef="cny">6274000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:FinancialLiabilities
      contextRef="c594"
      decimals="-3"
      id="ixv-72468"
      unitRef="cny">1869751000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c595"
      decimals="-3"
      id="ixv-72469"
      unitRef="cny">1869751000</ifrs-full:FinancialLiabilities>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c597"
      decimals="-3"
      id="ixv-72470"
      unitRef="cny">3609000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c598"
      decimals="-3"
      id="ixv-72471"
      unitRef="cny">3609000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c598"
      decimals="-3"
      id="ixv-72472"
      unitRef="usd">516000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c597"
      decimals="-3"
      id="ixv-72473"
      unitRef="cny">2470085000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c598"
      decimals="-3"
      id="ixv-72474"
      unitRef="cny">2470085000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c598"
      decimals="-3"
      id="ixv-72475"
      unitRef="usd">353217000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:NoncurrentReceivables
      contextRef="c597"
      decimals="-3"
      id="ixv-72476"
      unitRef="cny">252938000</ifrs-full:NoncurrentReceivables>
    <ifrs-full:NoncurrentReceivables
      contextRef="c598"
      decimals="-3"
      id="ixv-72477"
      unitRef="cny">252938000</ifrs-full:NoncurrentReceivables>
    <ifrs-full:NoncurrentReceivables
      contextRef="c598"
      decimals="-3"
      id="ixv-72478"
      unitRef="usd">36170000</ifrs-full:NoncurrentReceivables>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c596"
      decimals="-3"
      id="ixv-72479"
      unitRef="cny">4000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c598"
      decimals="-3"
      id="ixv-72480"
      unitRef="cny">4000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c598"
      decimals="-3"
      id="ixv-72481"
      unitRef="usd">572000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c597"
      decimals="-3"
      id="ixv-72482"
      unitRef="cny">690000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c598"
      decimals="-3"
      id="ixv-72483"
      unitRef="cny">690000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c598"
      decimals="-3"
      id="ixv-72484"
      unitRef="usd">99000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c596"
      decimals="-3"
      id="ixv-72485"
      unitRef="cny">4000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c597"
      decimals="-3"
      id="ixv-72486"
      unitRef="cny">2727322000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c598"
      decimals="-3"
      id="ixv-72487"
      unitRef="cny">2731322000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c598"
      decimals="-3"
      id="ixv-72488"
      unitRef="usd">390574000</ifrs-full:FinancialAssets>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="c600"
      decimals="-3"
      id="ixv-72489"
      unitRef="cny">1979719000</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="c601"
      decimals="-3"
      id="ixv-72490"
      unitRef="cny">1979719000</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="c601"
      decimals="-3"
      id="ixv-72491"
      unitRef="usd">283096000</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c600"
      decimals="-3"
      id="ixv-72492"
      unitRef="cny">106740000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c601"
      decimals="-3"
      id="ixv-72493"
      unitRef="cny">106740000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c601"
      decimals="-3"
      id="ixv-72494"
      unitRef="usd">15264000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c599"
      decimals="-3"
      id="ixv-72495"
      unitRef="cny">1968000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c600"
      decimals="-3"
      id="ixv-72496"
      unitRef="cny">138482000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c601"
      decimals="-3"
      id="ixv-72497"
      unitRef="cny">140450000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c599"
      decimals="-3"
      id="ixv-72498"
      unitRef="cny">6374000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c600"
      decimals="-3"
      id="ixv-72499"
      unitRef="cny">5657000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c601"
      decimals="-3"
      id="ixv-72500"
      unitRef="cny">12031000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c601"
      decimals="-3"
      id="ixv-72501"
      unitRef="usd">1720000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c599"
      decimals="-3"
      id="ixv-72502"
      unitRef="cny">8342000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c600"
      decimals="-3"
      id="ixv-72503"
      unitRef="cny">2230598000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c601"
      decimals="-3"
      id="ixv-72504"
      unitRef="cny">2238940000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c601"
      decimals="-3"
      id="ixv-72505"
      unitRef="usd">320164000</ifrs-full:FinancialLiabilities>
    <ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory contextRef="c0" id="ixv-63303">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;38.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Group&#x2019;s financial instruments, other than those with carrying amounts that reasonably approximate to fair
values, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="22" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Carrying
    amounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    values&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
    assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;572&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;572&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
    assets included in other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;690&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,311&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;624&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,580&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,690&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,452&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,624&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;661&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial liabilities
    included in other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-407; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;282&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-408; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;281&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,274&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,031&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,720&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,742&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,706&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    portion of interest-bearing bank and other borrowings (other than lease liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,642&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;742,325&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;106,151&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;859,707&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;709,342&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;101,435&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;874,916&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;756,324&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;108,153&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;865,449&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;723,016&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;103,390&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
has assessed that the fair values of cash and bank balances, trade receivables, financial assets included in prepayments, deposits and
other receivables, trade payables, the current portion of long-term payables, the current portion of interest-bearing bank and other
borrowings, financial liabilities included in other payables, and accruals approximate to their carrying amounts largely due to the short-term
maturities of these instruments, or the interest rate being approximate to the discount rate of current market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s finance department is responsible for determining the policies and procedures for the fair value measurement of financial
instruments. The finance manager reports directly to the chief financial officer and the audit committee. At each reporting date, the
finance department analyses the movements in the values of financial instruments and determines the major inputs applied in the valuation.
The directors review the results of the fair value measurement of financial instruments periodically for annual financial reporting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current
transaction between willing parties, other than in a forced or liquidation sale. The following methods and assumptions were used to estimate
the fair values:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair values of the financial assets and liabilities included in other non-current assets, and the non-current portion of interest-bearing
bank and other borrowings have been calculated by discounting the expected future cash flows using rates currently available for instruments
with similar terms, credit risk and remaining maturities. The Group&#x2019;s own non-performance risk for other non-current assets, and
interest-bearing bank and other borrowings as at December 31, 2025 was assessed to be insignificant.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair values of listed equity investments are based on quoted market prices. The fair value of the unlisted equity investments designated
at fair value through profit or loss have been estimated using an asset-based valuation technique based on assumptions that are not supported
by observable market prices or rates. The fair value measurement of these financial instruments may involve unobservable inputs. Fair
value change resulting from changes in the unobservable inputs was not significant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
Level 3 financial liabilities, the Group adopts the valuation techniques to determine the fair value. Valuation techniques include a
discounted cash flow analysis. The fair value measurement of the financial instruments may involve unobservable inputs such as discount
rate and possibility of payment. The Group periodically reviews all significant unobservable inputs and valuation adjustments used to
measure the fair values of financial assets in Level 3.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration:underline"&gt;Fair
value hierarchy&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables illustrate the fair value measurement hierarchy of the Group&#x2019;s financial instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Assets
measured at fair value&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2024&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value measurement using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;prices in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;active&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;markets&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;observable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;unobservable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-409; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-410; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value measurement using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 12pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;prices in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;active&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;markets&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;observable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;unobservable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-411; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-412; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;572&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liabilities
measured at fair value&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value measurement using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;prices in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;active&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;markets&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;observable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities included in other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-414; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;281&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-415; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-416; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,374&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,374&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;911&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended December 31, 2023, 2024 and 2025, there were no transfers of fair value measurements between Level 1 and Level 2 and
no transfers into or out of Level 3 for both financial assets and financial liabilities.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory>
    <aapg:DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory contextRef="c0" id="ixv-63311">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Group&#x2019;s financial instruments, other than those with carrying amounts that reasonably approximate to fair
values, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="22" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Carrying
    amounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    values&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
    assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;572&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;572&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
    assets included in other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;690&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,311&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;624&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,580&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,690&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,452&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,624&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;661&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial liabilities
    included in other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-407; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;282&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-408; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;281&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,274&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,031&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,720&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,742&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,706&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    portion of interest-bearing bank and other borrowings (other than lease liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,642&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;742,325&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;106,151&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;859,707&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;709,342&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;101,435&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;874,916&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;756,324&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;108,153&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;865,449&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;723,016&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;103,390&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DetailedInformationAboutFairValueAndFairValueHierarchyOfFinancialInstrumentsExplanatory>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c186"
      decimals="-3"
      id="ixv-72506"
      unitRef="cny">1141000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c215"
      decimals="-3"
      id="ixv-72507"
      unitRef="cny">4000000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c215"
      decimals="-3"
      id="ixv-72508"
      unitRef="usd">572000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c602"
      decimals="-3"
      id="ixv-72509"
      unitRef="cny">1141000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c603"
      decimals="-3"
      id="ixv-72510"
      unitRef="cny">4000000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c603"
      decimals="-3"
      id="ixv-72511"
      unitRef="usd">572000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c186"
      decimals="-3"
      id="ixv-72512"
      unitRef="cny">2439000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c215"
      decimals="-3"
      id="ixv-72513"
      unitRef="cny">690000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c215"
      decimals="-3"
      id="ixv-72514"
      unitRef="usd">99000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c602"
      decimals="-3"
      id="ixv-72515"
      unitRef="cny">2311000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c603"
      decimals="-3"
      id="ixv-72516"
      unitRef="cny">624000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c603"
      decimals="-3"
      id="ixv-72517"
      unitRef="usd">89000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c186"
      decimals="-3"
      id="ixv-72518"
      unitRef="cny">3580000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c215"
      decimals="-3"
      id="ixv-72519"
      unitRef="cny">4690000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c215"
      decimals="-3"
      id="ixv-72520"
      unitRef="usd">671000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c602"
      decimals="-3"
      id="ixv-72521"
      unitRef="cny">3452000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c603"
      decimals="-3"
      id="ixv-72522"
      unitRef="cny">4624000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c603"
      decimals="-3"
      id="ixv-72523"
      unitRef="usd">661000</ifrs-full:FinancialAssets>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="c215"
      decimals="-3"
      id="ixv-72524"
      unitRef="cny">1968000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="c215"
      decimals="-3"
      id="ixv-72525"
      unitRef="usd">282000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="c603"
      decimals="-3"
      id="ixv-72526"
      unitRef="cny">1968000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="c603"
      decimals="-3"
      id="ixv-72527"
      unitRef="usd">281000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c186"
      decimals="-3"
      id="ixv-72528"
      unitRef="cny">6274000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c215"
      decimals="-3"
      id="ixv-72529"
      unitRef="cny">12031000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c215"
      decimals="-3"
      id="ixv-72530"
      unitRef="usd">1720000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c602"
      decimals="-3"
      id="ixv-72531"
      unitRef="cny">5742000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c603"
      decimals="-3"
      id="ixv-72532"
      unitRef="cny">11706000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c603"
      decimals="-3"
      id="ixv-72533"
      unitRef="usd">1674000</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:LongtermBorrowings
      contextRef="c186"
      decimals="-3"
      id="ixv-72534"
      unitRef="cny">868642000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="c215"
      decimals="-3"
      id="ixv-72535"
      unitRef="cny">742325000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="c215"
      decimals="-3"
      id="ixv-72536"
      unitRef="usd">106151000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="c602"
      decimals="-3"
      id="ixv-72537"
      unitRef="cny">859707000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="c603"
      decimals="-3"
      id="ixv-72538"
      unitRef="cny">709342000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="c603"
      decimals="-3"
      id="ixv-72539"
      unitRef="usd">101435000</ifrs-full:LongtermBorrowings>
    <ifrs-full:FinancialLiabilities
      contextRef="c186"
      decimals="-3"
      id="ixv-72540"
      unitRef="cny">874916000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c215"
      decimals="-3"
      id="ixv-72541"
      unitRef="cny">756324000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c215"
      decimals="-3"
      id="ixv-72542"
      unitRef="usd">108153000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c602"
      decimals="-3"
      id="ixv-72543"
      unitRef="cny">865449000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c603"
      decimals="-3"
      id="ixv-72544"
      unitRef="cny">723016000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="c603"
      decimals="-3"
      id="ixv-72545"
      unitRef="usd">103390000</ifrs-full:FinancialLiabilities>
    <ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory contextRef="c0" id="ixv-63993">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2024&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value measurement using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;prices in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;active&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;markets&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;observable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;unobservable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-409; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-410; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value measurement using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 12pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;prices in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;active&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;markets&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;observable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;unobservable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets at FVTPL&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-411; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-412; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;572&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    value measurement using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;prices in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;active&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;markets&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;observable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;inputs&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities included in other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-414; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,968&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;281&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-415; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-416; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,374&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,374&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;911&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c604"
      decimals="-3"
      id="ixv-72546"
      unitRef="cny">1141000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c14" decimals="-3" id="ixv-72547" unitRef="cny">1141000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c608"
      decimals="-3"
      id="ixv-72548"
      unitRef="cny">4000000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c609"
      decimals="-3"
      id="ixv-72549"
      unitRef="cny">4000000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c15" decimals="-3" id="ixv-72550" unitRef="usd">572000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c609"
      decimals="-3"
      id="ixv-72551"
      unitRef="cny">1968000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c15" decimals="-3" id="ixv-72552" unitRef="cny">1968000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c15" decimals="-3" id="ixv-72553" unitRef="usd">281000</ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c609"
      decimals="-3"
      id="ixv-72554"
      unitRef="cny">6374000</ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c15" decimals="-3" id="ixv-72555" unitRef="cny">6374000</ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss contextRef="c15" decimals="-3" id="ixv-72556" unitRef="usd">911000</ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory contextRef="c0" id="ixv-64659">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;39.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FINANCIAL
                                            RISK MANAGEMENT OBJECTIVES AND POLICIES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 61.8pt 0pt 70.6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s principal financial instruments comprise cash and bank balances and interest-bearing bank and other borrowings. The main
purpose of these financial instruments is to raise finance for the Group&#x2019;s operations. The Group has various other financial assets
and liabilities such as trade receivables and trade payables, which arise directly from its operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
main risks arising from the Group&#x2019;s financial instruments are interest rate risk, foreign currency risk, credit risk,
liquidity risk, and equity price risk. The Directors review and agree on policies for managing each of these risks, and they are
summarized below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Interest
rate risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s exposure to the risk of changes in market interest rates relates primarily to the Group&#x2019;s long-term debt obligations
with floating interest rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group&#x2019;s policy is to manage its interest cost using a mix of fixed and floating rate debts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the total interest-bearing bank borrowings of RMB1,911,273 (US$273,308) (2024: RMB1,116,015) of the Group were
with floating interest rates denominated in RMB.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table demonstrates the sensitivity to a reasonably possible change in the RMB interest rate, with all other variables held
constant, of the Group&#x2019;s loss before tax through the impact on floating rate borrowings. This analysis does not include the effect
of interest capitalized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease)&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in basis points&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease)&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in loss before tax&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,160&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,113&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(19,113&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Foreign
currency risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group has transactional currency exposures. Such exposures arise from sales or purchases by operating units and investing and financing
activities in currencies other than the units&#x2019; functional currencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table demonstrates the sensitivity as at the end of each reporting period to a reasonably possible change in the US$ and HK$
exchange rates, with all other variables held constant, of the Group&#x2019;s loss before tax and in other comprehensive income (without
tax) due to changes in the fair values of monetary assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease) in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;foreign&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;currency&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease)&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in loss&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;before&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;tax&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease) in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;comprehensive&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;income&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(without tax)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If RMB weakens
    against US$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(44&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,796&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If RMB strengthens against
    US$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(56,796&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If RMB weakens against US$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(65&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;124,210&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If RMB strengthens against
    US$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(124,210&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Credit
risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group trades only with recognized and creditworthy third parties. Concentrations of credit risk are managed by the customer. At the
end of the reporting period, the Group had certain concentrations of credit risk as 68% (2024: 73%) and 91% (2024: 96%) of the
Group&#x2019;s trade receivables were due from the Group&#x2019;s largest customer, respectively. It is the Group&#x2019;s policy that
all customers who wish to trade on credit terms are subject to credit verification procedures. In addition, receivable balances are
monitored on an ongoing basis, and the Group&#x2019;s exposure to bad debts is not significant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
credit risk of the Group&#x2019;s other financial assets, which comprise cash and bank balances, trade receivables, financial assets included
in prepayments, deposits and other receivables and other non-current assets, arises from default of the counterparty, with a maximum
exposure equal to the carrying amounts of these instruments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Maximum
exposure and year-end staging&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
tables below show the credit quality and the maximum exposure to credit risk based on the Group&#x2019;s credit policy, which is mainly
based on past due information unless other information is available without undue cost or effort, and year-end staging classification.
The amounts presented are gross carrying amounts for financial assets.&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12-month ECLs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Lifetime ECLs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage 2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage 3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simplified approach&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial assets included in prepayments, other receivables and other assets - Normal**&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,846&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-417; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: hidden-fact-418; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-419; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,846&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash and bank balances - Not yet past due&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,261,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-420; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-421; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-422; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,261,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade receivables*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-423; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-424; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,143&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,143&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial assets included in other non-current assets - Normal**&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,273,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-429; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-430; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,143&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,356,639&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12-month
    ECLs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Lifetime
    ECLs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simplified
    approach&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets included in prepayments, other receivables and other assets - Normal**&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,609&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-431; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-432; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-433; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,609&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;516&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    and bank balances - Not yet past due&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,470,085&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-434; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-435; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-436; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,470,085&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;353,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
    receivables*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-437; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-438; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-439; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252,938&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252,938&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,170&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets included in other non-current assets - Normal**&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;690&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-440; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-441; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-442; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;690&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,474,384&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: hidden-fact-443; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: hidden-fact-444; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252,938&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,727,322&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;390,002&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For trade receivables to which the Group applies the simplified approach for impairment, information based on provision matrix is disclosed in note 21 to the financial statements.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The credit quality of the financial assets included in prepayments, other receivables and other assets and financial assets included in other non- current assets is considered to be &#x201c;normal&#x201d; when they are not past due and there is no information indicating that the financial assets had a significant increase in credit risk since initial recognition. Otherwise, the credit quality of the financial assets is considered to be &#x201c;doubtful&#x201d;.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidity
risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Group&#x2019;s objective is to maintain a balance between continuity of funding and flexibility through the use of bank loans, lease liabilities
and other interest-bearing loans. As at December 31, 2025, 62% (2024: 47%) of the Group&#x2019;s borrowings would mature in less than
one year based on the carrying values of the borrowings.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
maturity profile of the Group&#x2019;s financial liabilities as at the end of the reporting period, based on the contractual undiscounted
payments, is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As at December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    demand&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    than&lt;br/&gt;
    1 year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1
    to 5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Over
    &lt;br/&gt;
    5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-445; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,966&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-446; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-447; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,966&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-448; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,592&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-449; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,266&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest-bearing
    bank and other borrowings (excluding lease liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-450; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;813,610&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;452,765&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;565,079&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,831,454&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities included in other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;73,670&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,344&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-451; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-452; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;103,014&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-453; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-454; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,274&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-455; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,274&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;73,670&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;945,594&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;467,631&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;565,079&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,051,974&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As at December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    demand&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    than 1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1
    to 5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Over
    &lt;br/&gt;
    5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-456; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;106,740&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-457; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-458; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;106,740&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,264&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-459; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,262&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,226&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-460; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,502&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest-bearing
    bank and other borrowings (excluding lease liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-461; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,255,814&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;365,732&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;546,806&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,168,352&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;310,070&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities included in other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;130,142&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,308&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-462; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-463; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,084&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-464; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-465; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,031&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-466; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,031&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,720&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;130,142&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,381,124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;393,989&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;546,806&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-467; font-family: Times New Roman, Times, Serif"&gt;2,&lt;span style="font-size: 10pt"&gt;452,061&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;350,640&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Equity
price risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
price risk is the risk that the fair values of equity securities decrease as a result of changes in the levels of equity indices and
the value of individual securities. The Group is exposed to equity price risk arising from individual equity investments included in
financial assets at FVTPL (note 17) as at December 31, 2025. The Group&#x2019;s listed investments held in the prior year were listed
on NASDAQ and were valued at the quoted market price at the end of the reporting period, whereas the investments in the current year
don&#x2019;t involve publicly traded market quotations.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
market equity index for the following stock exchange, at the close of business of the nearest trading day in the year to the end of the
reporting period, and its respective highest and lowest points during the year were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;High/low&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;High/low&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;United States&#x2013;NASDAQ
    index&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,311&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,205/14,478&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-468; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-470"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-469; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-/-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table demonstrates the sensitivity to every 5% change in the fair values of the equity investments, with all other variables
held constant and before any impact on tax, based on their carrying amounts at the end of the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Carrying&lt;br/&gt; amount of&lt;br/&gt; equity&lt;br/&gt; investments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Decrease/&lt;br/&gt; (increase)&lt;br/&gt; in loss&lt;br/&gt; before tax&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investments listed in:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NASDAQ - Financial assets at fair value through profit or loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(57&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investments listed in:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NASDAQ - Financial assets at fair value through profit or loss&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-471; font-family: Times New Roman, Times, Serif"&gt;-&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-472; font-family: Times New Roman, Times, Serif"&gt;-&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NASDAQ - Financial assets at fair value through profit or loss in USD&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-473; font-family: Times New Roman, Times, Serif"&gt;-&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-474; font-family: Times New Roman, Times, Serif"&gt;-&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Capital
management&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
primary objectives of the Group&#x2019;s capital management are to safeguard the Group&#x2019;s ability to continue as a going concern
and to maintain healthy capital ratios in order to support its business and maximize shareholders&#x2019; value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group manages its capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics
of the underlying assets. To maintain or adjust the capital structure, the Group may adjust the dividend payment to shareholders, return
capital to shareholders or issue new shares. No changes were made in the objectives, policies or processes for managing capital during
the reporting year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Group monitors capital using a gearing ratio, which is net debt divided by the adjusted capital plus net debt. Net debt includes interest-bearing
bank and other borrowings, trade payables, financial liabilities included in other payables and accruals and long-term payables, less
cash and bank balances. Capital includes equity attributable to owners of the parent. The gearing ratios as at the end of the reporting
periods were as follows:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Interest-bearing bank and other borrowings&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,668,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,979,719&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;283,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;91,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Financial liabilities included in other payables and accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;140,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Other non-current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Cash and bank balances&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,261,211&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,470,085&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(353,217&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Net debt&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;608,540&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(231,145&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(33,053&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Equity attributable to owners of the parent&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;264,194&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,324,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;189,396&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Adjusted capital&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;264,194&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,324,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;189,396&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Capital and net debt&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;872,734&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,093,317&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;156,343&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Gearing ratio&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-475; font-size: 10pt"&gt;NA&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-476; font-size: 10pt"&gt;NA&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <aapg:InterestBearingBankBorrowings
      contextRef="c610"
      decimals="-3"
      id="ixv-72557"
      unitRef="cny">1911273000</aapg:InterestBearingBankBorrowings>
    <aapg:InterestBearingBankBorrowings
      contextRef="c610"
      decimals="-3"
      id="ixv-72558"
      unitRef="usd">273308000</aapg:InterestBearingBankBorrowings>
    <aapg:InterestBearingBankBorrowings
      contextRef="c611"
      decimals="-3"
      id="ixv-72559"
      unitRef="cny">1116015000</aapg:InterestBearingBankBorrowings>
    <aapg:DisclosureOfInterestRateRiskExplanatory contextRef="c0" id="ixv-72560">This analysis does not include the effect
of interest capitalized.&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease)&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in basis points&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease)&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in loss before tax&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,160&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,113&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(19,113&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</aapg:DisclosureOfInterestRateRiskExplanatory>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c618" id="ixv-64763">100</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c619" id="ixv-64772">11,160</ifrs-full:BorrowingsInterestRateBasis>
    <aapg:IncreasedecreaseInLossBeforeTax
      contextRef="c618"
      decimals="-3"
      id="ixv-72561"
      unitRef="cny">-100000</aapg:IncreasedecreaseInLossBeforeTax>
    <aapg:IncreasedecreaseInLossBeforeTax
      contextRef="c619"
      decimals="-3"
      id="ixv-72562"
      unitRef="cny">-11160000</aapg:IncreasedecreaseInLossBeforeTax>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c620" id="ixv-64822">100</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsInterestRateBasis contextRef="c621" id="ixv-64831">19,113</ifrs-full:BorrowingsInterestRateBasis>
    <aapg:IncreasedecreaseInLossBeforeTax
      contextRef="c620"
      decimals="-3"
      id="ixv-72563"
      unitRef="cny">-100000</aapg:IncreasedecreaseInLossBeforeTax>
    <aapg:IncreasedecreaseInLossBeforeTax
      contextRef="c621"
      decimals="-3"
      id="ixv-72564"
      unitRef="cny">-19113000</aapg:IncreasedecreaseInLossBeforeTax>
    <aapg:DisclosureOfForeignCurrencyRiskExplanatory contextRef="c0" id="ixv-64912">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table demonstrates the sensitivity as at the end of each reporting period to a reasonably possible change in the US$ and HK$
exchange rates, with all other variables held constant, of the Group&#x2019;s loss before tax and in other comprehensive income (without
tax) due to changes in the fair values of monetary assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease) in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;foreign&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;currency&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease)&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in loss&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;before&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;tax&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Increase/&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(decrease) in&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;other&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;comprehensive&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;income&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(without tax)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If RMB weakens
    against US$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(44&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,796&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If RMB strengthens against
    US$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(56,796&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If RMB weakens against US$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(65&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;124,210&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If RMB strengthens against
    US$&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;65&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(124,210&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfForeignCurrencyRiskExplanatory>
    <aapg:IncreasedecreaseWeakensAgainst
      contextRef="c622"
      decimals="2"
      id="ixv-72565"
      unitRef="pure">0.05</aapg:IncreasedecreaseWeakensAgainst>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c623"
      decimals="-3"
      id="ixv-72566"
      unitRef="cny">-44000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c623"
      decimals="-3"
      id="ixv-72567"
      unitRef="cny">56796000</ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax>
    <aapg:IncreasedecreaseWeakensAgainst
      contextRef="c624"
      decimals="2"
      id="ixv-72568"
      unitRef="pure">-0.05</aapg:IncreasedecreaseWeakensAgainst>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c625"
      decimals="-3"
      id="ixv-72569"
      unitRef="cny">44000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c625"
      decimals="-3"
      id="ixv-72570"
      unitRef="cny">-56796000</ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax>
    <aapg:IncreasedecreaseWeakensAgainst
      contextRef="c626"
      decimals="2"
      id="ixv-72571"
      unitRef="pure">0.05</aapg:IncreasedecreaseWeakensAgainst>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c627"
      decimals="-3"
      id="ixv-72572"
      unitRef="cny">-65000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c627"
      decimals="-3"
      id="ixv-72573"
      unitRef="cny">124210000</ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax>
    <aapg:IncreasedecreaseWeakensAgainst
      contextRef="c628"
      decimals="2"
      id="ixv-72574"
      unitRef="pure">-0.05</aapg:IncreasedecreaseWeakensAgainst>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c629"
      decimals="-3"
      id="ixv-72575"
      unitRef="cny">65000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c629"
      decimals="-3"
      id="ixv-72576"
      unitRef="cny">-124210000</ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax>
    <aapg:ConcentrationsOfCreditRisk
      contextRef="c612"
      decimals="2"
      id="ixv-72577"
      unitRef="pure">0.68</aapg:ConcentrationsOfCreditRisk>
    <aapg:ConcentrationsOfCreditRisk
      contextRef="c613"
      decimals="2"
      id="ixv-72578"
      unitRef="pure">0.73</aapg:ConcentrationsOfCreditRisk>
    <aapg:ConcentrationsOfCreditRisk
      contextRef="c614"
      decimals="2"
      id="ixv-72579"
      unitRef="pure">0.91</aapg:ConcentrationsOfCreditRisk>
    <aapg:ConcentrationsOfCreditRisk
      contextRef="c615"
      decimals="2"
      id="ixv-72580"
      unitRef="pure">0.96</aapg:ConcentrationsOfCreditRisk>
    <ifrs-full:DisclosureOfCreditRiskExposureExplanatory contextRef="c0" id="ixv-72581">The amounts presented are gross carrying amounts for financial assets.&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12-month ECLs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Lifetime ECLs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage 2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage 3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simplified approach&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial assets included in prepayments, other receivables and other assets - Normal**&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,846&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-417; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: hidden-fact-418; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-419; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,846&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash and bank balances - Not yet past due&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,261,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-420; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-421; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-422; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,261,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade receivables*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-423; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-424; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-425; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,143&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,143&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial assets included in other non-current assets - Normal**&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-426; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-427; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-428; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,439&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,273,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-429; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-430; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;83,143&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,356,639&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12-month
    ECLs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Lifetime
    ECLs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stage
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simplified
    approach&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets included in prepayments, other receivables and other assets - Normal**&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,609&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-431; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-432; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-433; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,609&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;516&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    and bank balances - Not yet past due&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,470,085&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-434; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-435; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-436; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,470,085&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;353,217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
    receivables*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-437; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-438; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-439; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252,938&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252,938&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,170&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    assets included in other non-current assets - Normal**&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;690&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-440; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-441; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-442; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;690&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,474,384&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: hidden-fact-443; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: hidden-fact-444; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252,938&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,727,322&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;390,002&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For trade receivables to which the Group applies the simplified approach for impairment, information based on provision matrix is disclosed in note 21 to the financial statements.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="text-align: left; width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The credit quality of the financial assets included in prepayments, other receivables and other assets and financial assets included in other non- current assets is considered to be &#x201c;normal&#x201d; when they are not past due and there is no information indicating that the financial assets had a significant increase in credit risk since initial recognition. Otherwise, the credit quality of the financial assets is considered to be &#x201c;doubtful&#x201d;.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfCreditRiskExposureExplanatory>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c630"
      decimals="-3"
      id="ix_113_fact"
      unitRef="cny">9846000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c14"
      decimals="-3"
      id="ix_114_fact"
      unitRef="cny">9846000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <aapg:CashAndBankBalancesNotYetPastDue
      contextRef="c630"
      decimals="-3"
      id="ixv-72584"
      unitRef="cny">1261211000</aapg:CashAndBankBalancesNotYetPastDue>
    <aapg:CashAndBankBalancesNotYetPastDue contextRef="c14" decimals="-3" id="ixv-72585" unitRef="cny">1261211000</aapg:CashAndBankBalancesNotYetPastDue>
    <ifrs-full:TradeReceivables
      contextRef="c633"
      decimals="-3"
      id="ix_108_fact"
      unitRef="cny">83143000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="c14"
      decimals="-3"
      id="ix_109_fact"
      unitRef="cny">83143000</ifrs-full:TradeReceivables>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c630"
      decimals="-3"
      id="ix_115_fact"
      unitRef="cny">2439000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c14"
      decimals="-3"
      id="ix_116_fact"
      unitRef="cny">2439000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c630"
      decimals="-3"
      id="ixv-72590"
      unitRef="cny">1273496000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c633"
      decimals="-3"
      id="ixv-72591"
      unitRef="cny">83143000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c14" decimals="-3" id="ixv-72592" unitRef="cny">1356639000</ifrs-full:FinancialAssets>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c634"
      decimals="-3"
      id="ix_117_fact"
      unitRef="cny">3609000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c15"
      decimals="-3"
      id="ix_118_fact"
      unitRef="cny">3609000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c15"
      decimals="-3"
      id="ix_119_fact"
      unitRef="usd">516000</ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss>
    <aapg:CashAndBankBalancesNotYetPastDue
      contextRef="c634"
      decimals="-3"
      id="ixv-72596"
      unitRef="cny">2470085000</aapg:CashAndBankBalancesNotYetPastDue>
    <aapg:CashAndBankBalancesNotYetPastDue contextRef="c15" decimals="-3" id="ixv-72597" unitRef="cny">2470085000</aapg:CashAndBankBalancesNotYetPastDue>
    <aapg:CashAndBankBalancesNotYetPastDue contextRef="c15" decimals="-3" id="ixv-72598" unitRef="usd">353217000</aapg:CashAndBankBalancesNotYetPastDue>
    <ifrs-full:TradeReceivables
      contextRef="c637"
      decimals="-3"
      id="ix_110_fact"
      unitRef="cny">252938000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="c15"
      decimals="-3"
      id="ix_111_fact"
      unitRef="cny">252938000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="c15"
      decimals="-3"
      id="ix_112_fact"
      unitRef="usd">36170000</ifrs-full:TradeReceivables>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c634"
      decimals="-3"
      id="ix_120_fact"
      unitRef="cny">690000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c15"
      decimals="-3"
      id="ix_121_fact"
      unitRef="cny">690000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c15"
      decimals="-3"
      id="ix_122_fact"
      unitRef="usd">99000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c634"
      decimals="-3"
      id="ixv-72605"
      unitRef="cny">2474384000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="c637"
      decimals="-3"
      id="ixv-72606"
      unitRef="cny">252938000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c15" decimals="-3" id="ixv-72607" unitRef="cny">2727322000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c15" decimals="-3" id="ixv-72608" unitRef="usd">390002000</ifrs-full:FinancialAssets>
    <aapg:LiquidityRiskPercentage
      contextRef="c616"
      decimals="2"
      id="ixv-72609"
      unitRef="pure">0.62</aapg:LiquidityRiskPercentage>
    <aapg:LiquidityRiskPercentage
      contextRef="c617"
      decimals="2"
      id="ixv-72610"
      unitRef="pure">0.47</aapg:LiquidityRiskPercentage>
    <ifrs-full:DisclosureOfLiquidityRiskExplanatory contextRef="c0" id="ixv-66037">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
maturity profile of the Group&#x2019;s financial liabilities as at the end of the reporting period, based on the contractual undiscounted
payments, is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As at December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    demand&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    than&lt;br/&gt;
    1 year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1
    to 5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Over
    &lt;br/&gt;
    5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-445; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,966&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-446; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-447; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,966&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-448; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,592&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-449; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,266&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest-bearing
    bank and other borrowings (excluding lease liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-450; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;813,610&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;452,765&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;565,079&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,831,454&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities included in other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;73,670&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,344&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-451; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-452; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;103,014&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-453; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-454; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,274&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-455; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,274&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;73,670&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;945,594&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;467,631&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;565,079&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,051,974&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As at December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    demand&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    than 1&#160;year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1
    to 5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Over
    &lt;br/&gt;
    5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-456; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;106,740&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-457; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-458; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;106,740&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,264&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-459; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,262&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,226&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-460; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,488&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,502&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest-bearing
    bank and other borrowings (excluding lease liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-461; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,255,814&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;365,732&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;546,806&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,168,352&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;310,070&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
    liabilities included in other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;130,142&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,308&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-462; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-463; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,084&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-464; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-465; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,031&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-466; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,031&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,720&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;130,142&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,381,124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;393,989&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;546,806&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-467; font-family: Times New Roman, Times, Serif"&gt;2,&lt;span style="font-size: 10pt"&gt;452,061&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;350,640&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfLiquidityRiskExplanatory>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c639"
      decimals="-3"
      id="ixv-72611"
      unitRef="cny">91966000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c642"
      decimals="-3"
      id="ixv-72612"
      unitRef="cny">91966000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:LeaseLiabilities
      contextRef="c644"
      decimals="-3"
      id="ixv-72613"
      unitRef="cny">10674000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="c645"
      decimals="-3"
      id="ixv-72614"
      unitRef="cny">8592000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="c647"
      decimals="-3"
      id="ixv-72615"
      unitRef="cny">19266000</ifrs-full:LeaseLiabilities>
    <ifrs-full:OtherBorrowings
      contextRef="c649"
      decimals="-3"
      id="ixv-72616"
      unitRef="cny">813610000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="c650"
      decimals="-3"
      id="ixv-72617"
      unitRef="cny">452765000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="c651"
      decimals="-3"
      id="ixv-72618"
      unitRef="cny">565079000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="c652"
      decimals="-3"
      id="ixv-72619"
      unitRef="cny">1831454000</ifrs-full:OtherBorrowings>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c653"
      decimals="-3"
      id="ixv-72620"
      unitRef="cny">73670000</ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c654"
      decimals="-3"
      id="ixv-72621"
      unitRef="cny">29344000</ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c657"
      decimals="-3"
      id="ixv-72622"
      unitRef="cny">103014000</ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:OtherPayables
      contextRef="c660"
      decimals="-3"
      id="ixv-72623"
      unitRef="cny">6274000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="c662"
      decimals="-3"
      id="ixv-72624"
      unitRef="cny">6274000</ifrs-full:OtherPayables>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c663"
      decimals="-3"
      id="ixv-72625"
      unitRef="cny">73670000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c664"
      decimals="-3"
      id="ixv-72626"
      unitRef="cny">945594000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c665"
      decimals="-3"
      id="ixv-72627"
      unitRef="cny">467631000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c666"
      decimals="-3"
      id="ixv-72628"
      unitRef="cny">565079000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c667"
      decimals="-3"
      id="ixv-72629"
      unitRef="cny">2051974000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c669"
      decimals="-3"
      id="ixv-72630"
      unitRef="cny">106740000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c672"
      decimals="-3"
      id="ixv-72631"
      unitRef="cny">106740000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c672"
      decimals="-3"
      id="ixv-72632"
      unitRef="usd">15264000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:LeaseLiabilities
      contextRef="c674"
      decimals="-3"
      id="ixv-72633"
      unitRef="cny">8262000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="c675"
      decimals="-3"
      id="ixv-72634"
      unitRef="cny">16226000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="c677"
      decimals="-3"
      id="ixv-72635"
      unitRef="cny">24488000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="c677"
      decimals="-3"
      id="ixv-72636"
      unitRef="usd">3502000</ifrs-full:LeaseLiabilities>
    <ifrs-full:OtherBorrowings
      contextRef="c679"
      decimals="-3"
      id="ixv-72637"
      unitRef="cny">1255814000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="c680"
      decimals="-3"
      id="ixv-72638"
      unitRef="cny">365732000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="c681"
      decimals="-3"
      id="ixv-72639"
      unitRef="cny">546806000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="c682"
      decimals="-3"
      id="ixv-72640"
      unitRef="cny">2168352000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="c682"
      decimals="-3"
      id="ixv-72641"
      unitRef="usd">310070000</ifrs-full:OtherBorrowings>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c683"
      decimals="-3"
      id="ixv-72642"
      unitRef="cny">130142000</ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c684"
      decimals="-3"
      id="ixv-72643"
      unitRef="cny">10308000</ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c687"
      decimals="-3"
      id="ixv-72644"
      unitRef="cny">140450000</ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c687"
      decimals="-3"
      id="ixv-72645"
      unitRef="usd">20084000</ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:OtherPayables
      contextRef="c690"
      decimals="-3"
      id="ixv-72646"
      unitRef="cny">12031000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="c692"
      decimals="-3"
      id="ixv-72647"
      unitRef="cny">12031000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="c692"
      decimals="-3"
      id="ixv-72648"
      unitRef="usd">1720000</ifrs-full:OtherPayables>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c693"
      decimals="-3"
      id="ixv-72649"
      unitRef="cny">130142000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c694"
      decimals="-3"
      id="ixv-72650"
      unitRef="cny">1381124000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c695"
      decimals="-3"
      id="ixv-72651"
      unitRef="cny">393989000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c696"
      decimals="-3"
      id="ixv-72652"
      unitRef="cny">546806000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c697"
      decimals="-3"
      id="ixv-72653"
      unitRef="usd">350640000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <aapg:DisclosureOfEquityPriceRiskExplanatory contextRef="c0" id="ixv-67009">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
market equity index for the following stock exchange, at the close of business of the nearest trading day in the year to the end of the
reporting period, and its respective highest and lowest points during the year were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;High/low&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;High/low&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;United States&#x2013;NASDAQ
    index&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,311&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,205/14,478&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-468; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-470"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-469; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-/-&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfEquityPriceRiskExplanatory>
    <aapg:MarketEquityIndex
      contextRef="c13"
      decimals="INF"
      id="ixv-72654"
      unitRef="shares">19311</aapg:MarketEquityIndex>
    <aapg:StockExchangeIndexShare
      contextRef="c555"
      decimals="0"
      id="ixv-72655"
      unitRef="shares">20205</aapg:StockExchangeIndexShare>
    <aapg:StockExchangeIndexShare
      contextRef="c554"
      decimals="0"
      id="ixv-72656"
      unitRef="shares">14478</aapg:StockExchangeIndexShare>
    <aapg:DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory contextRef="c0" id="ixv-67160">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table demonstrates the sensitivity to every 5% change in the fair values of the equity investments, with all other variables
held constant and before any impact on tax, based on their carrying amounts at the end of the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Carrying&lt;br/&gt; amount of&lt;br/&gt; equity&lt;br/&gt; investments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Decrease/&lt;br/&gt; (increase)&lt;br/&gt; in loss&lt;br/&gt; before tax&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investments listed in:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NASDAQ - Financial assets at fair value through profit or loss&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(57&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investments listed in:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NASDAQ - Financial assets at fair value through profit or loss&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-471; font-family: Times New Roman, Times, Serif"&gt;-&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-472; font-family: Times New Roman, Times, Serif"&gt;-&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NASDAQ - Financial assets at fair value through profit or loss in USD&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-473; font-family: Times New Roman, Times, Serif"&gt;-&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-474; font-family: Times New Roman, Times, Serif"&gt;-&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfCarryingAmountsAtTheEndOfTheReportingPeriodExplanatory>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired contextRef="c15" decimals="2" id="ixv-72657" unitRef="pure">0.05</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c698"
      decimals="-3"
      id="ixv-72658"
      unitRef="cny">-1141000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c699"
      decimals="-3"
      id="ixv-72659"
      unitRef="cny">-57000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssets
      contextRef="c699"
      decimals="-3"
      id="ixv-72660"
      unitRef="cny">-57000</ifrs-full:FinancialAssets>
    <aapg:DisclosureOfCapitalManagementExplanatory contextRef="c0" id="ixv-72661">The gearing ratios as at the end of the reporting
periods were as follows:&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;As at December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;RMB&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;US$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Interest-bearing bank and other borrowings&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,668,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,979,719&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;283,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;91,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Financial liabilities included in other payables and accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;140,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Other non-current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Cash and bank balances&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,261,211&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,470,085&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(353,217&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Net debt&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;608,540&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(231,145&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(33,053&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Equity attributable to owners of the parent&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;264,194&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,324,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;189,396&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Adjusted capital&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;264,194&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,324,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;189,396&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Capital and net debt&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;872,734&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,093,317&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;156,343&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Gearing ratio&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-475; font-size: 10pt"&gt;NA&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-476; font-size: 10pt"&gt;NA&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:DisclosureOfCapitalManagementExplanatory>
    <ifrs-full:OtherBorrowings
      contextRef="c702"
      decimals="-3"
      id="ixv-72662"
      unitRef="cny">1668497000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="c703"
      decimals="-3"
      id="ixv-72663"
      unitRef="cny">1979719000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="c703"
      decimals="-3"
      id="ixv-72664"
      unitRef="usd">283096000</ifrs-full:OtherBorrowings>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c702"
      decimals="-3"
      id="ixv-72665"
      unitRef="cny">91966000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c703"
      decimals="-3"
      id="ixv-72666"
      unitRef="cny">106740000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c703"
      decimals="-3"
      id="ixv-72667"
      unitRef="usd">15264000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c702"
      decimals="-3"
      id="ixv-72668"
      unitRef="cny">103014000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c703"
      decimals="-3"
      id="ixv-72669"
      unitRef="cny">140450000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c703"
      decimals="-3"
      id="ixv-72670"
      unitRef="usd">20084000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:OtherPayables
      contextRef="c702"
      decimals="-3"
      id="ixv-72671"
      unitRef="cny">6274000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="c703"
      decimals="-3"
      id="ixv-72672"
      unitRef="cny">12031000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="c703"
      decimals="-3"
      id="ixv-72673"
      unitRef="usd">1720000</ifrs-full:OtherPayables>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="c702"
      decimals="-3"
      id="ixv-72674"
      unitRef="cny">1261211000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="c703"
      decimals="-3"
      id="ixv-72675"
      unitRef="cny">2470085000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="c703"
      decimals="-3"
      id="ixv-72676"
      unitRef="usd">353217000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:NetDebt
      contextRef="c702"
      decimals="-3"
      id="ixv-72677"
      unitRef="cny">608540000</ifrs-full:NetDebt>
    <ifrs-full:NetDebt
      contextRef="c703"
      decimals="-3"
      id="ixv-72678"
      unitRef="cny">-231145000</ifrs-full:NetDebt>
    <ifrs-full:NetDebt
      contextRef="c703"
      decimals="-3"
      id="ixv-72679"
      unitRef="usd">-33053000</ifrs-full:NetDebt>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="c702"
      decimals="-3"
      id="ixv-72680"
      unitRef="cny">264194000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="c703"
      decimals="-3"
      id="ixv-72681"
      unitRef="cny">1324462000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="c703"
      decimals="-3"
      id="ixv-72682"
      unitRef="usd">189396000</ifrs-full:EquityAttributableToOwnersOfParent>
    <aapg:AdjustedCapitals
      contextRef="c702"
      decimals="-3"
      id="ixv-72683"
      unitRef="cny">264194000</aapg:AdjustedCapitals>
    <aapg:AdjustedCapitals
      contextRef="c703"
      decimals="-3"
      id="ixv-72684"
      unitRef="cny">1324462000</aapg:AdjustedCapitals>
    <aapg:AdjustedCapitals
      contextRef="c703"
      decimals="-3"
      id="ixv-72685"
      unitRef="usd">189396000</aapg:AdjustedCapitals>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="c702"
      decimals="-3"
      id="ixv-72686"
      unitRef="cny">872734000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="c703"
      decimals="-3"
      id="ixv-72687"
      unitRef="cny">1093317000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="c703"
      decimals="-3"
      id="ixv-72688"
      unitRef="usd">156343000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c704"
      decimals="2"
      id="ixv-72689"
      unitRef="pure">0.70</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod contextRef="c0" id="ixv-67652">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EVENT
                                            AFTER THE REPORTING PERIOD&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at the date of approval of these financial statements, there have been no significant events after the end of the reporting period.&lt;/span&gt;&lt;/p&gt;</ifrs-full:ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod>
    <ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory contextRef="c0" id="ixv-67668">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;41.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CONDENSED
                                            FINANCIAL INFORMATION OF THE COMPANY&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Statements
of financial position of the Company&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NON-CURRENT ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investments in
    subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;380,339&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;448,431&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;64,125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,529&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,851&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,269&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;410,868&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;478,282&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;68,394&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CURRENT ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepayments, other receivables
    and other assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,986,172&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,806,759&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;687,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    and bank balances&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;470,170&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,841,572&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;263,341&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,456,342&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,648,331&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;950,699&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CURRENT LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,187&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,382&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;341&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,382&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;341&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NET
    CURRENT ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,432,155&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,645,949&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;950,358&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;TOTAL
    ASSETS LESS CURRENT LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,843,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,124,231&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,018,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,843,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,124,231&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,018,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EQUITY&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;256&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Treasury shares&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,961&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(423&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capital and reserves&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,652,916&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,011,879&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,145,683&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange fluctuation reserve&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;108,598&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(40,959&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,857&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(918,697&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(843,984&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(120,688&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    equity&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,843,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,124,231&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,018,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Condensed
statements of comprehensive income&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other income and
    gains&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,597&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,925&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;102,560&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,666&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,118&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,983&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(27,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,975&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(24,741&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,585&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(47&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;LOSS
    BEFORE TAX&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,684&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;LOSS
    FOR THE YEAR&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,684&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
    differences on translation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,629&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,715&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(149,557&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,386&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;TOTAL
    COMPREHENSIVE INCOME FOR THE YEAR&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;70,367&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,072&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(74,844&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,702&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Condensed
statements of cash flows&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
                                            cash generated from(used in) operating activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,727&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(41,686&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;123,427&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,650&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net cash used in investing
    activities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(535,395&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(589,153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,850,400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(264,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
                                 cash generated from financing activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;464,166&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;531,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,229,331&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;318,790&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effect
    of foreign exchange rate changes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,311&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(56,093&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
                                            (decrease)/increase in cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(59,921&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(89,606&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;446,265&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63,815&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the Company&#x2019;s reserves is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capital
    and&lt;br/&gt; reserves&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange&lt;br/&gt;
    Fluctuation&lt;br/&gt; reserve&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated&lt;br/&gt;
    losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 52%; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    January 1, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,526,096&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(43,746&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(890,792&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,591,558&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-477; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-478; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    comprehensive income for the year:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
    differences on translation of the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-479; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-480; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    comprehensive income for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-481; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;70,367&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;470,066&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-482; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-483; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;470,066&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Employees
    share-based compensation scheme&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; Pre-IPO
    share option expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-484; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-485; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSU
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-486; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-487; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of Pre-IPO share options&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-488; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-489; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,123&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-490; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-491; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,123&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-492; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-493; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2023 and January 1, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,072,015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,883&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(905,054&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,207,844&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-494; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-495; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    comprehensive income for the year:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
    differences on translation of the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-496; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-497; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    comprehensive income for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-498; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;533,923&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-499; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-500; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;533,923&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employees
    share-based compensation scheme&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSU
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,924&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-501; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-502; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,924&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of Pre-IPO share options&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-503; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-504; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-505; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-506; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-507; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-508; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2024 and January 1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,652,916&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;108,598&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(918,697&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,842,817&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-509; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-510; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    comprehensive income for the year:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
    differences on translation of the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-511; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(149,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-512; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(149,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    comprehensive income for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-513; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(149,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(74,844&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,279,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-514; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-515; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,279,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Employees
    share-based compensation scheme&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; Post-IPO
    share option expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,420&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-516; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-517; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,420&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSU
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,454&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-518; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-519; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,454&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of Pre-IPO share options&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-520; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-521; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-522; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-523; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;58,868&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-524; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-525; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;58,868&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,011,879&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(40,959&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(843,984&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,126,936&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,145,683&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,857&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(120,688&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,019,138&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basis
                                            of presentation&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
separate condensed financial statements above have been presented on a &#x201c;parent company only&#x201d; basis. Under a &#x201c;parent
company only&#x201d; presentation, the Company&#x2019;s investment in its subsidiaries is presented at cost. Such investment is presented
on the separate condensed statements of financial position of the Company as &#x201c;Investment in subsidiaries&#x201d;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 68.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
subsidiaries did not pay any dividends to the Company for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were &lt;span style="-sec-ix-hidden: hidden-fact-526"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-527"&gt;no&lt;/span&gt;&lt;/span&gt; indicators of impairment associated with the investment in subsidiaries as of December 31, 2024 and 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 54.2pt 0pt 68.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
information and note disclosures normally included in financial statements prepared in accordance with IFRS Accounting Standards have
been condensed or omitted in this parent company only condensed financial information by reference to the Group&#x2019;s consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 57.2pt 0pt 68.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commitments&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not have any significant commitments or long-term obligations as of December 31, 2024 and 2025.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="c0" id="ixv-67678">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Statements
of financial position of the Company&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NON-CURRENT ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investments in
    subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;380,339&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;448,431&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;64,125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    non-current Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,529&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,851&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,269&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;410,868&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;478,282&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;68,394&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CURRENT ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepayments, other receivables
    and other assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,986,172&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,806,759&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;687,358&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    and bank balances&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;470,170&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,841,572&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;263,341&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,456,342&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,648,331&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;950,699&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CURRENT LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other payables and accruals&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,187&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,382&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;341&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,187&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,382&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;341&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NET
    CURRENT ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,432,155&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,645,949&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;950,358&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;TOTAL
    ASSETS LESS CURRENT LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,843,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,124,231&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,018,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,843,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,124,231&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,018,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EQUITY&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share capital&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;256&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Treasury shares&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,961&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(423&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capital and reserves&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,652,916&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,011,879&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,145,683&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange fluctuation reserve&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;108,598&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(40,959&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,857&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(918,697&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(843,984&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(120,688&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    equity&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,843,023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,124,231&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,018,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <ifrs-full:InvestmentsInSubsidiaries
      contextRef="c706"
      decimals="-3"
      id="ixv-72690"
      unitRef="cny">380339000</ifrs-full:InvestmentsInSubsidiaries>
    <ifrs-full:InvestmentsInSubsidiaries
      contextRef="c707"
      decimals="-3"
      id="ixv-72691"
      unitRef="cny">448431000</ifrs-full:InvestmentsInSubsidiaries>
    <ifrs-full:InvestmentsInSubsidiaries
      contextRef="c707"
      decimals="-3"
      id="ixv-72692"
      unitRef="usd">64125000</ifrs-full:InvestmentsInSubsidiaries>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="c706"
      decimals="-3"
      id="ixv-72693"
      unitRef="cny">30529000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="c707"
      decimals="-3"
      id="ixv-72694"
      unitRef="cny">29851000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="c707"
      decimals="-3"
      id="ixv-72695"
      unitRef="usd">4269000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="c706"
      decimals="-3"
      id="ixv-72696"
      unitRef="cny">410868000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="c707"
      decimals="-3"
      id="ixv-72697"
      unitRef="cny">478282000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="c707"
      decimals="-3"
      id="ixv-72698"
      unitRef="usd">68394000</ifrs-full:NoncurrentAssets>
    <ifrs-full:ReceivablesDueFromAssociates
      contextRef="c706"
      decimals="-3"
      id="ixv-72699"
      unitRef="cny">3986172000</ifrs-full:ReceivablesDueFromAssociates>
    <ifrs-full:ReceivablesDueFromAssociates
      contextRef="c707"
      decimals="-3"
      id="ixv-72700"
      unitRef="cny">4806759000</ifrs-full:ReceivablesDueFromAssociates>
    <ifrs-full:ReceivablesDueFromAssociates
      contextRef="c707"
      decimals="-3"
      id="ixv-72701"
      unitRef="usd">687358000</ifrs-full:ReceivablesDueFromAssociates>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c706"
      decimals="-3"
      id="ixv-72702"
      unitRef="cny">470170000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c707"
      decimals="-3"
      id="ixv-72703"
      unitRef="cny">1841572000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c707"
      decimals="-3"
      id="ixv-72704"
      unitRef="usd">263341000</ifrs-full:CashAndBankBalancesAtCentralBanks>
    <ifrs-full:CurrentAssets
      contextRef="c706"
      decimals="-3"
      id="ixv-72705"
      unitRef="cny">4456342000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="c707"
      decimals="-3"
      id="ixv-72706"
      unitRef="cny">6648331000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="c707"
      decimals="-3"
      id="ixv-72707"
      unitRef="usd">950699000</ifrs-full:CurrentAssets>
    <ifrs-full:OtherCurrentPayables
      contextRef="c706"
      decimals="-3"
      id="ixv-72708"
      unitRef="cny">24187000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="c707"
      decimals="-3"
      id="ixv-72709"
      unitRef="cny">2382000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="c707"
      decimals="-3"
      id="ixv-72710"
      unitRef="usd">341000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:CurrentLiabilities
      contextRef="c706"
      decimals="-3"
      id="ixv-72711"
      unitRef="cny">24187000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="c707"
      decimals="-3"
      id="ixv-72712"
      unitRef="cny">2382000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="c707"
      decimals="-3"
      id="ixv-72713"
      unitRef="usd">341000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentAssetsLiabilities
      contextRef="c706"
      decimals="-3"
      id="ixv-72714"
      unitRef="cny">4432155000</ifrs-full:CurrentAssetsLiabilities>
    <ifrs-full:CurrentAssetsLiabilities
      contextRef="c707"
      decimals="-3"
      id="ixv-72715"
      unitRef="cny">6645949000</ifrs-full:CurrentAssetsLiabilities>
    <ifrs-full:CurrentAssetsLiabilities
      contextRef="c707"
      decimals="-3"
      id="ixv-72716"
      unitRef="usd">950358000</ifrs-full:CurrentAssetsLiabilities>
    <ifrs-full:AssetsLessCurrentLiabilities
      contextRef="c706"
      decimals="-3"
      id="ixv-72717"
      unitRef="cny">4843023000</ifrs-full:AssetsLessCurrentLiabilities>
    <ifrs-full:AssetsLessCurrentLiabilities
      contextRef="c707"
      decimals="-3"
      id="ixv-72718"
      unitRef="cny">7124231000</ifrs-full:AssetsLessCurrentLiabilities>
    <ifrs-full:AssetsLessCurrentLiabilities
      contextRef="c707"
      decimals="-3"
      id="ixv-72719"
      unitRef="usd">1018752000</ifrs-full:AssetsLessCurrentLiabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="c706"
      decimals="-3"
      id="ixv-72720"
      unitRef="cny">4843023000</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="c707"
      decimals="-3"
      id="ixv-72721"
      unitRef="cny">7124231000</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NetAssetsLiabilities
      contextRef="c707"
      decimals="-3"
      id="ixv-72722"
      unitRef="usd">1018752000</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:IssuedCapital
      contextRef="c706"
      decimals="-3"
      id="ixv-72723"
      unitRef="cny">214000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="c707"
      decimals="-3"
      id="ixv-72724"
      unitRef="cny">256000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="c707"
      decimals="-3"
      id="ixv-72725"
      unitRef="usd">37000</ifrs-full:IssuedCapital>
    <ifrs-full:TreasuryShares
      contextRef="c706"
      decimals="-3"
      id="ixv-72726"
      unitRef="cny">8000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="c707"
      decimals="-3"
      id="ixv-72727"
      unitRef="cny">2961000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="c707"
      decimals="-3"
      id="ixv-72728"
      unitRef="usd">423000</ifrs-full:TreasuryShares>
    <ifrs-full:OtherReserves
      contextRef="c706"
      decimals="-3"
      id="ixv-72729"
      unitRef="cny">5652916000</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves
      contextRef="c707"
      decimals="-3"
      id="ixv-72730"
      unitRef="cny">8011879000</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves
      contextRef="c707"
      decimals="-3"
      id="ixv-72731"
      unitRef="usd">1145683000</ifrs-full:OtherReserves>
    <aapg:ExchangeFluctuationReserve
      contextRef="c706"
      decimals="-3"
      id="ixv-72732"
      unitRef="cny">108598000</aapg:ExchangeFluctuationReserve>
    <aapg:ExchangeFluctuationReserve
      contextRef="c707"
      decimals="-3"
      id="ixv-72733"
      unitRef="cny">-40959000</aapg:ExchangeFluctuationReserve>
    <aapg:ExchangeFluctuationReserve
      contextRef="c707"
      decimals="-3"
      id="ixv-72734"
      unitRef="usd">-5857000</aapg:ExchangeFluctuationReserve>
    <ifrs-full:RetainedEarnings
      contextRef="c706"
      decimals="-3"
      id="ixv-72735"
      unitRef="cny">-918697000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="c707"
      decimals="-3"
      id="ixv-72736"
      unitRef="cny">-843984000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="c707"
      decimals="-3"
      id="ixv-72737"
      unitRef="usd">-120688000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="c706"
      decimals="-3"
      id="ixv-72738"
      unitRef="cny">4843023000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="c707"
      decimals="-3"
      id="ixv-72739"
      unitRef="cny">7124231000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="c707"
      decimals="-3"
      id="ixv-72740"
      unitRef="usd">1018752000</ifrs-full:Equity>
    <srt:CondensedStatementOfComprehensiveIncomeTableTextBlock contextRef="c0" id="ixv-68298">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Condensed
statements of comprehensive income&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other income and
    gains&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,597&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,925&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;102,560&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,666&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,118&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9,983&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(27,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,975&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(24,741&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,585&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(47&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;LOSS
    BEFORE TAX&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,684&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;LOSS
    FOR THE YEAR&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,684&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -5.5pt; padding-left: 5.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
    differences on translation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,629&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,715&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(149,557&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,386&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -11pt; padding-left: 11pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;TOTAL
    COMPREHENSIVE INCOME FOR THE YEAR&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;70,367&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,072&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(74,844&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,702&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:CondensedStatementOfComprehensiveIncomeTableTextBlock>
    <ifrs-full:OtherGainsLosses
      contextRef="c708"
      decimals="-3"
      id="ixv-72741"
      unitRef="cny">18597000</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherGainsLosses
      contextRef="c709"
      decimals="-3"
      id="ixv-72742"
      unitRef="cny">17925000</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherGainsLosses
      contextRef="c710"
      decimals="-3"
      id="ixv-72743"
      unitRef="cny">102560000</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherGainsLosses
      contextRef="c710"
      decimals="-3"
      id="ixv-72744"
      unitRef="usd">14666000</ifrs-full:OtherGainsLosses>
    <ifrs-full:OperatingExpense
      contextRef="c708"
      decimals="-3"
      id="ixv-72745"
      unitRef="cny">8118000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="c709"
      decimals="-3"
      id="ixv-72746"
      unitRef="cny">9983000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="c710"
      decimals="-3"
      id="ixv-72747"
      unitRef="cny">27800000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="c710"
      decimals="-3"
      id="ixv-72748"
      unitRef="usd">3975000</ifrs-full:OperatingExpense>
    <ifrs-full:OtherExpenseByNature
      contextRef="c708"
      decimals="-3"
      id="ixv-72749"
      unitRef="cny">24741000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="c709"
      decimals="-3"
      id="ixv-72750"
      unitRef="cny">21585000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="c710"
      decimals="-3"
      id="ixv-72751"
      unitRef="cny">47000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="c710"
      decimals="-3"
      id="ixv-72752"
      unitRef="usd">7000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="c708"
      decimals="-3"
      id="ixv-72753"
      unitRef="cny">-14262000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="c709"
      decimals="-3"
      id="ixv-72754"
      unitRef="cny">-13643000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="c710"
      decimals="-3"
      id="ixv-72755"
      unitRef="cny">74713000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="c710"
      decimals="-3"
      id="ixv-72756"
      unitRef="usd">10684000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLoss
      contextRef="c708"
      decimals="-3"
      id="ixv-72757"
      unitRef="cny">-14262000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="c709"
      decimals="-3"
      id="ixv-72758"
      unitRef="cny">-13643000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="c710"
      decimals="-3"
      id="ixv-72759"
      unitRef="cny">74713000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="c710"
      decimals="-3"
      id="ixv-72760"
      unitRef="usd">10684000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c708"
      decimals="-3"
      id="ixv-72761"
      unitRef="cny">84629000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c709"
      decimals="-3"
      id="ixv-72762"
      unitRef="cny">67715000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c710"
      decimals="-3"
      id="ixv-72763"
      unitRef="cny">-149557000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c710"
      decimals="-3"
      id="ixv-72764"
      unitRef="usd">-21386000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="c708"
      decimals="-3"
      id="ixv-72765"
      unitRef="cny">70367000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="c709"
      decimals="-3"
      id="ixv-72766"
      unitRef="cny">54072000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="c710"
      decimals="-3"
      id="ixv-72767"
      unitRef="cny">-74844000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="c710"
      decimals="-3"
      id="ixv-72768"
      unitRef="usd">-10702000</ifrs-full:OtherComprehensiveIncome>
    <aapg:ScheduleOfCondensedCashFlowStatementsTableTextBlock contextRef="c0" id="ixv-68652">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Condensed
statements of cash flows&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
    the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
                                            cash generated from(used in) operating activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,727&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(41,686&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;123,427&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,650&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net cash used in investing
    activities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(535,395&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(589,153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,850,400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(264,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
                                 cash generated from financing activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;464,166&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;531,922&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,229,331&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;318,790&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effect
    of foreign exchange rate changes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,581&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,311&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(56,093&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
                                            (decrease)/increase in cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(59,921&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(89,606&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;446,265&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63,815&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfCondensedCashFlowStatementsTableTextBlock>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="c708"
      decimals="-3"
      id="ixv-72769"
      unitRef="cny">9727000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="c709"
      decimals="-3"
      id="ixv-72770"
      unitRef="cny">-41686000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="c710"
      decimals="-3"
      id="ixv-72771"
      unitRef="cny">123427000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="c710"
      decimals="-3"
      id="ixv-72772"
      unitRef="usd">17650000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="c708"
      decimals="-3"
      id="ixv-72773"
      unitRef="cny">-535395000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="c709"
      decimals="-3"
      id="ixv-72774"
      unitRef="cny">-589153000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="c710"
      decimals="-3"
      id="ixv-72775"
      unitRef="cny">-1850400000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="c710"
      decimals="-3"
      id="ixv-72776"
      unitRef="usd">-264604000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="c708"
      decimals="-3"
      id="ixv-72777"
      unitRef="cny">464166000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="c709"
      decimals="-3"
      id="ixv-72778"
      unitRef="cny">531922000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="c710"
      decimals="-3"
      id="ixv-72779"
      unitRef="cny">2229331000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="c710"
      decimals="-3"
      id="ixv-72780"
      unitRef="usd">318790000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c708"
      decimals="-3"
      id="ixv-72781"
      unitRef="cny">1581000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c709"
      decimals="-3"
      id="ixv-72782"
      unitRef="cny">9311000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c710"
      decimals="-3"
      id="ixv-72783"
      unitRef="cny">-56093000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c710"
      decimals="-3"
      id="ixv-72784"
      unitRef="usd">-8021000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="c708"
      decimals="-3"
      id="ixv-72785"
      unitRef="cny">-59921000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="c709"
      decimals="-3"
      id="ixv-72786"
      unitRef="cny">-89606000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="c710"
      decimals="-3"
      id="ixv-72787"
      unitRef="cny">446265000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="c710"
      decimals="-3"
      id="ixv-72788"
      unitRef="usd">63815000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <aapg:ScheduleOfReservesTableTextBlock contextRef="c0" id="ixv-68901">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the Company&#x2019;s reserves is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capital
    and&lt;br/&gt; reserves&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange&lt;br/&gt;
    Fluctuation&lt;br/&gt; reserve&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated&lt;br/&gt;
    losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RMB&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 52%; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    January 1, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,526,096&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(43,746&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(890,792&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,591,558&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-477; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-478; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    comprehensive income for the year:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
    differences on translation of the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-479; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-480; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    comprehensive income for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-481; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;84,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;70,367&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;470,066&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-482; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-483; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;470,066&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Employees
    share-based compensation scheme&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; Pre-IPO
    share option expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-484; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-485; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSU
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-486; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-487; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of Pre-IPO share options&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-488; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-489; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,123&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-490; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-491; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,123&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-492; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-493; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,466&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2023 and January 1, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,072,015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,883&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(905,054&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,207,844&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-494; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-495; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    comprehensive income for the year:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
    differences on translation of the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-496; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-497; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    comprehensive income for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-498; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67,715&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13,643&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;533,923&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-499; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-500; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;533,923&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Employees
    share-based compensation scheme&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSU
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,924&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-501; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-502; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,924&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of Pre-IPO share options&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-503; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-504; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-505; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-506; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-507; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-508; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2024 and January 1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,652,916&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;108,598&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(918,697&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,842,817&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-509; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-510; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    comprehensive income for the year:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
    differences on translation of the Company&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-511; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(149,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-512; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(149,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    comprehensive income for the year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-513; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(149,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;74,713&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(74,844&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue
    of ordinary shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,279,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-514; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-515; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,279,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Employees
    share-based compensation scheme&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; Post-IPO
    share option expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,420&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-516; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-517; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,420&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSU
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,454&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-518; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-519; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,454&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of Pre-IPO share options&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-520; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-521; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vesting
    of RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-522; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-523; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(638&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-settled
    bonus&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;58,868&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-524; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-525; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;58,868&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,011,879&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(40,959&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(843,984&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,126,936&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
    December 31, 2025 in US$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,145,683&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,857&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(120,688&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,019,138&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</aapg:ScheduleOfReservesTableTextBlock>
    <ifrs-full:NoncontrollingInterests
      contextRef="c711"
      decimals="-3"
      id="ixv-72789"
      unitRef="cny">4526096000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c712"
      decimals="-3"
      id="ixv-72790"
      unitRef="cny">-43746000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c713"
      decimals="-3"
      id="ixv-72791"
      unitRef="cny">-890792000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c714"
      decimals="-3"
      id="ixv-72792"
      unitRef="cny">3591558000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:ProfitLoss
      contextRef="c717"
      decimals="-3"
      id="ixv-72793"
      unitRef="cny">-14262000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="c708"
      decimals="-3"
      id="ixv-72794"
      unitRef="cny">-14262000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c716"
      decimals="-3"
      id="ixv-72795"
      unitRef="cny">84629000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c708"
      decimals="-3"
      id="ixv-72796"
      unitRef="cny">84629000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c716"
      decimals="-3"
      id="ixv-72797"
      unitRef="cny">84629000</aapg:ComprehensiveIncomeLoss>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c717"
      decimals="-3"
      id="ixv-72798"
      unitRef="cny">-14262000</aapg:ComprehensiveIncomeLoss>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c708"
      decimals="-3"
      id="ixv-72799"
      unitRef="cny">70367000</aapg:ComprehensiveIncomeLoss>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c715"
      decimals="INF"
      id="ixv-72800"
      unitRef="shares">470066</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c708"
      decimals="INF"
      id="ixv-72801"
      unitRef="shares">470066</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <aapg:PreIPOShareOptionExpenses
      contextRef="c718"
      decimals="-3"
      id="ixv-72802"
      unitRef="cny">3750000</aapg:PreIPOShareOptionExpenses>
    <aapg:PreIPOShareOptionExpenses
      contextRef="c709"
      decimals="-3"
      id="ixv-72803"
      unitRef="cny">3750000</aapg:PreIPOShareOptionExpenses>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c715"
      decimals="-3"
      id="ixv-72804"
      unitRef="cny">27753000</aapg:RestrictedShareUnitExpenses>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c708"
      decimals="-3"
      id="ixv-72805"
      unitRef="cny">27753000</aapg:RestrictedShareUnitExpenses>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c715"
      decimals="-3"
      id="ixv-72806"
      unitRef="cny">7000</aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c708"
      decimals="-3"
      id="ixv-72807"
      unitRef="cny">7000</aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c715"
      decimals="-3"
      id="ixv-72808"
      unitRef="cny">-11123000</aapg:StockIssuedDuringPeriodValueVestingOfRSUs>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c708"
      decimals="-3"
      id="ixv-72809"
      unitRef="cny">-11123000</aapg:StockIssuedDuringPeriodValueVestingOfRSUs>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c715"
      decimals="-3"
      id="ixv-72810"
      unitRef="cny">55466000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c708"
      decimals="-3"
      id="ixv-72811"
      unitRef="cny">55466000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <ifrs-full:NoncontrollingInterests
      contextRef="c721"
      decimals="-3"
      id="ixv-72812"
      unitRef="cny">5072015000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c722"
      decimals="-3"
      id="ixv-72813"
      unitRef="cny">40883000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c723"
      decimals="-3"
      id="ixv-72814"
      unitRef="cny">-905054000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c724"
      decimals="-3"
      id="ixv-72815"
      unitRef="cny">4207844000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:ProfitLoss
      contextRef="c720"
      decimals="-3"
      id="ixv-72816"
      unitRef="cny">-13643000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="c709"
      decimals="-3"
      id="ixv-72817"
      unitRef="cny">-13643000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c719"
      decimals="-3"
      id="ixv-72818"
      unitRef="cny">67715000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c709"
      decimals="-3"
      id="ixv-72819"
      unitRef="cny">67715000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c719"
      decimals="-3"
      id="ixv-72820"
      unitRef="cny">67715000</aapg:ComprehensiveIncomeLoss>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c720"
      decimals="-3"
      id="ixv-72821"
      unitRef="cny">-13643000</aapg:ComprehensiveIncomeLoss>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c709"
      decimals="-3"
      id="ixv-72822"
      unitRef="cny">54072000</aapg:ComprehensiveIncomeLoss>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c718"
      decimals="INF"
      id="ixv-72823"
      unitRef="shares">533923</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c709"
      decimals="INF"
      id="ixv-72824"
      unitRef="shares">533923</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c718"
      decimals="-3"
      id="ixv-72825"
      unitRef="cny">20924000</aapg:RestrictedShareUnitExpenses>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c709"
      decimals="-3"
      id="ixv-72826"
      unitRef="cny">20924000</aapg:RestrictedShareUnitExpenses>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c718"
      decimals="-3"
      id="ixv-72827"
      unitRef="cny">6000</aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c709"
      decimals="-3"
      id="ixv-72828"
      unitRef="cny">6000</aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c718"
      decimals="-3"
      id="ixv-72829"
      unitRef="cny">-14671000</aapg:StockIssuedDuringPeriodValueVestingOfRSUs>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c709"
      decimals="-3"
      id="ixv-72830"
      unitRef="cny">-14671000</aapg:StockIssuedDuringPeriodValueVestingOfRSUs>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c718"
      decimals="-3"
      id="ixv-72831"
      unitRef="cny">40719000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c709"
      decimals="-3"
      id="ixv-72832"
      unitRef="cny">40719000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <ifrs-full:NoncontrollingInterests
      contextRef="c725"
      decimals="-3"
      id="ixv-72833"
      unitRef="cny">5652916000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c726"
      decimals="-3"
      id="ixv-72834"
      unitRef="cny">108598000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c727"
      decimals="-3"
      id="ixv-72835"
      unitRef="cny">-918697000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c706"
      decimals="-3"
      id="ixv-72836"
      unitRef="cny">4842817000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:ProfitLoss
      contextRef="c730"
      decimals="-3"
      id="ixv-72837"
      unitRef="cny">74713000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="c710"
      decimals="-3"
      id="ixv-72838"
      unitRef="cny">74713000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c729"
      decimals="-3"
      id="ixv-72839"
      unitRef="cny">-149557000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c710"
      decimals="-3"
      id="ixv-72840"
      unitRef="cny">-149557000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c729"
      decimals="-3"
      id="ixv-72841"
      unitRef="cny">-149557000</aapg:ComprehensiveIncomeLoss>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c730"
      decimals="-3"
      id="ixv-72842"
      unitRef="cny">74713000</aapg:ComprehensiveIncomeLoss>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c710"
      decimals="-3"
      id="ixv-72843"
      unitRef="cny">-74844000</aapg:ComprehensiveIncomeLoss>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c728"
      decimals="INF"
      id="ixv-72844"
      unitRef="shares">2279855</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c710"
      decimals="INF"
      id="ixv-72845"
      unitRef="shares">2279855</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="c728"
      decimals="-3"
      id="ixv-72846"
      unitRef="cny">2420000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="c710"
      decimals="-3"
      id="ixv-72847"
      unitRef="cny">2420000</ifrs-full:AdjustmentsForSharebasedPayments>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c728"
      decimals="-3"
      id="ixv-72848"
      unitRef="cny">18454000</aapg:RestrictedShareUnitExpenses>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c710"
      decimals="-3"
      id="ixv-72849"
      unitRef="cny">18454000</aapg:RestrictedShareUnitExpenses>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c728"
      decimals="-3"
      id="ixv-72850"
      unitRef="cny">4000</aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c710"
      decimals="-3"
      id="ixv-72851"
      unitRef="cny">4000</aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c728"
      decimals="-3"
      id="ixv-72852"
      unitRef="cny">-638000</aapg:StockIssuedDuringPeriodValueVestingOfRSUs>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c710"
      decimals="-3"
      id="ixv-72853"
      unitRef="cny">-638000</aapg:StockIssuedDuringPeriodValueVestingOfRSUs>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c728"
      decimals="-3"
      id="ixv-72854"
      unitRef="cny">58868000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c710"
      decimals="-3"
      id="ixv-72855"
      unitRef="cny">58868000</aapg:StockIssuedDuringPeriodValueEquitysettledBonus>
    <ifrs-full:NoncontrollingInterests
      contextRef="c731"
      decimals="-3"
      id="ixv-72856"
      unitRef="cny">8011879000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c732"
      decimals="-3"
      id="ixv-72857"
      unitRef="cny">-40959000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c733"
      decimals="-3"
      id="ixv-72858"
      unitRef="cny">-843984000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c707"
      decimals="-3"
      id="ixv-72859"
      unitRef="cny">7126936000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c731"
      decimals="-3"
      id="ixv-72860"
      unitRef="usd">1145683000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c732"
      decimals="-3"
      id="ixv-72861"
      unitRef="usd">-5857000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c733"
      decimals="-3"
      id="ixv-72862"
      unitRef="usd">-120688000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="c707"
      decimals="-3"
      id="ixv-72863"
      unitRef="usd">1019138000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory contextRef="c0" id="ixv-70317">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;42.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;APPROVAL
                                            OF THE FINANCIAL STATEMENTS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements were approved and authorized for issue by the board of directors on April 29, 2026.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory>
    <dei:DocumentAccountingStandard contextRef="c0" id="hidden-fact-0">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <ifrs-full:Revenue
      contextRef="c3"
      id="hidden-fact-1"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c5"
      id="hidden-fact-2"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c5"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c15"
      id="hidden-fact-4"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c15"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:CommitmentAndContingencies
      contextRef="c14"
      id="hidden-fact-6"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:CommitmentAndContingencies
      contextRef="c15"
      id="hidden-fact-7"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:CommitmentAndContingencies
      contextRef="c15"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c23"
      id="hidden-fact-9"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c25"
      id="hidden-fact-10"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c26"
      id="hidden-fact-11"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c27"
      id="hidden-fact-12"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c28"
      id="hidden-fact-13"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c29"
      id="hidden-fact-14"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c25"
      id="hidden-fact-15"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c26"
      id="hidden-fact-16"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c27"
      id="hidden-fact-17"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c28"
      id="hidden-fact-18"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c30"
      id="hidden-fact-19"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c32"
      id="hidden-fact-20"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c25"
      id="hidden-fact-21"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c26"
      id="hidden-fact-22"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c27"
      id="hidden-fact-23"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c28"
      id="hidden-fact-24"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary
      contextRef="c25"
      id="hidden-fact-25"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary
      contextRef="c26"
      id="hidden-fact-26"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary
      contextRef="c27"
      id="hidden-fact-27"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary
      contextRef="c28"
      id="hidden-fact-28"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary
      contextRef="c29"
      id="hidden-fact-29"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary
      contextRef="c30"
      id="hidden-fact-30"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueCapitalContributionFromANoncontrollingShareholderOfASubsidiary
      contextRef="c31"
      id="hidden-fact-31"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c26"
      id="hidden-fact-32"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c28"
      id="hidden-fact-33"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c29"
      id="hidden-fact-34"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c30"
      id="hidden-fact-35"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c32"
      id="hidden-fact-36"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c25"
      id="hidden-fact-37"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c27"
      id="hidden-fact-38"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c28"
      id="hidden-fact-39"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c29"
      id="hidden-fact-40"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c30"
      id="hidden-fact-41"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c32"
      id="hidden-fact-42"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses
      contextRef="c25"
      id="hidden-fact-43"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses
      contextRef="c26"
      id="hidden-fact-44"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses
      contextRef="c27"
      id="hidden-fact-45"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses
      contextRef="c29"
      id="hidden-fact-46"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses
      contextRef="c30"
      id="hidden-fact-47"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuePreIPOShareOptionExpenses
      contextRef="c32"
      id="hidden-fact-48"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c25"
      id="hidden-fact-49"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c26"
      id="hidden-fact-50"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c27"
      id="hidden-fact-51"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c29"
      id="hidden-fact-52"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c30"
      id="hidden-fact-53"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c32"
      id="hidden-fact-54"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c26"
      id="hidden-fact-55"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c29"
      id="hidden-fact-56"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c30"
      id="hidden-fact-57"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c32"
      id="hidden-fact-58"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c25"
      id="hidden-fact-59"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c29"
      id="hidden-fact-60"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c30"
      id="hidden-fact-61"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c31"
      id="hidden-fact-62"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c32"
      id="hidden-fact-63"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c28"
      id="hidden-fact-64"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c29"
      id="hidden-fact-65"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c30"
      id="hidden-fact-66"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c32"
      id="hidden-fact-67"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c42"
      id="hidden-fact-68"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c43"
      id="hidden-fact-69"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c44"
      id="hidden-fact-70"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c45"
      id="hidden-fact-71"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c46"
      id="hidden-fact-72"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c42"
      id="hidden-fact-73"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c43"
      id="hidden-fact-74"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c44"
      id="hidden-fact-75"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c45"
      id="hidden-fact-76"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c47"
      id="hidden-fact-77"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c49"
      id="hidden-fact-78"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c42"
      id="hidden-fact-79"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c43"
      id="hidden-fact-80"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c44"
      id="hidden-fact-81"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c45"
      id="hidden-fact-82"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c43"
      id="hidden-fact-83"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c45"
      id="hidden-fact-84"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c46"
      id="hidden-fact-85"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c47"
      id="hidden-fact-86"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c49"
      id="hidden-fact-87"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c42"
      id="hidden-fact-88"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c44"
      id="hidden-fact-89"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c45"
      id="hidden-fact-90"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c46"
      id="hidden-fact-91"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c47"
      id="hidden-fact-92"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c49"
      id="hidden-fact-93"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c42"
      id="hidden-fact-94"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c43"
      id="hidden-fact-95"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c44"
      id="hidden-fact-96"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c46"
      id="hidden-fact-97"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c47"
      id="hidden-fact-98"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c49"
      id="hidden-fact-99"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c42"
      id="hidden-fact-100"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c43"
      id="hidden-fact-101"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c46"
      id="hidden-fact-102"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c47"
      id="hidden-fact-103"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c49"
      id="hidden-fact-104"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c42"
      id="hidden-fact-105"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c46"
      id="hidden-fact-106"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c47"
      id="hidden-fact-107"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c48"
      id="hidden-fact-108"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c49"
      id="hidden-fact-109"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c13"
      id="hidden-fact-110"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c42"
      id="hidden-fact-111"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c46"
      id="hidden-fact-112"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c47"
      id="hidden-fact-113"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c49"
      id="hidden-fact-114"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c58"
      id="hidden-fact-115"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c59"
      id="hidden-fact-116"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c60"
      id="hidden-fact-117"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c61"
      id="hidden-fact-118"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c62"
      id="hidden-fact-119"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c58"
      id="hidden-fact-120"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c59"
      id="hidden-fact-121"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c60"
      id="hidden-fact-122"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c61"
      id="hidden-fact-123"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c63"
      id="hidden-fact-124"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c65"
      id="hidden-fact-125"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c58"
      id="hidden-fact-126"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c59"
      id="hidden-fact-127"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c60"
      id="hidden-fact-128"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c61"
      id="hidden-fact-129"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c59"
      id="hidden-fact-130"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c61"
      id="hidden-fact-131"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c62"
      id="hidden-fact-132"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c63"
      id="hidden-fact-133"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c65"
      id="hidden-fact-134"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c58"
      id="hidden-fact-135"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c60"
      id="hidden-fact-136"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c61"
      id="hidden-fact-137"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c62"
      id="hidden-fact-138"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c63"
      id="hidden-fact-139"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShares
      contextRef="c65"
      id="hidden-fact-140"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c58"
      id="hidden-fact-141"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c59"
      id="hidden-fact-142"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c60"
      id="hidden-fact-143"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c62"
      id="hidden-fact-144"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c63"
      id="hidden-fact-145"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueRestrictedShareUnitRSUExpenses
      contextRef="c65"
      id="hidden-fact-146"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c58"
      id="hidden-fact-147"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c59"
      id="hidden-fact-148"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c62"
      id="hidden-fact-149"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c63"
      id="hidden-fact-150"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c65"
      id="hidden-fact-151"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c62"
      id="hidden-fact-152"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c63"
      id="hidden-fact-153"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c64"
      id="hidden-fact-154"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c65"
      id="hidden-fact-155"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRestrictedShareUnits
      contextRef="c0"
      id="hidden-fact-156"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c59"
      id="hidden-fact-157"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c61"
      id="hidden-fact-158"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c62"
      id="hidden-fact-159"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c63"
      id="hidden-fact-160"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c65"
      id="hidden-fact-161"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty
      contextRef="c13"
      id="hidden-fact-162"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty
      contextRef="c0"
      id="hidden-fact-163"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty
      contextRef="c0"
      id="hidden-fact-164"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:AdjustmentsForGainOnDisposalOfLeases
      contextRef="c12"
      id="hidden-fact-165"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives
      contextRef="c12"
      id="hidden-fact-166"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives
      contextRef="c13"
      id="hidden-fact-167"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForFairValueGainsLosses
      contextRef="c13"
      id="hidden-fact-168"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForFairValueGainsLosses
      contextRef="c0"
      id="hidden-fact-169"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForFairValueGainsLosses
      contextRef="c0"
      id="hidden-fact-170"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="c12"
      id="hidden-fact-171"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="c13"
      id="hidden-fact-172"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="c12"
      id="hidden-fact-173"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="c13"
      id="hidden-fact-174"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="c13"
      id="hidden-fact-175"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="c0"
      id="hidden-fact-176"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="c0"
      id="hidden-fact-177"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="c13"
      id="hidden-fact-178"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="c0"
      id="hidden-fact-179"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="c0"
      id="hidden-fact-180"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:InvestmentInOtherFinancialAssets
      contextRef="c12"
      id="hidden-fact-181"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:InvestmentInOtherFinancialAssets
      contextRef="c13"
      id="hidden-fact-182"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:InvestmentInJointVenturesClassifiedAsInvestingActivities
      contextRef="c12"
      id="hidden-fact-183"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:InvestmentInJointVenturesClassifiedAsInvestingActivities
      contextRef="c0"
      id="hidden-fact-184"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:InvestmentInJointVenturesClassifiedAsInvestingActivities
      contextRef="c0"
      id="hidden-fact-185"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares
      contextRef="c13"
      id="hidden-fact-186"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests
      contextRef="c13"
      id="hidden-fact-187"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests
      contextRef="c0"
      id="hidden-fact-188"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromContributionsOfNoncontrollingInterests
      contextRef="c0"
      id="hidden-fact-189"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:ListingExpensePaid
      contextRef="c12"
      id="hidden-fact-190"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:PercentageOfEquityInterestsAttributableToTheCompanyDirect
      contextRef="c74"
      id="hidden-fact-191"
      unitRef="pure"
      xsi:nil="true"/>
    <aapg:PercentageOfEquityInterestsAttributableToTheCompanyDirect
      contextRef="c76"
      id="hidden-fact-192"
      unitRef="pure"
      xsi:nil="true"/>
    <aapg:PercentageOfEquityInterestsAttributableToTheCompanyDirect
      contextRef="c78"
      id="hidden-fact-193"
      unitRef="pure"
      xsi:nil="true"/>
    <aapg:PercentageOfEquityInterestsAttributableToTheCompanyDirect
      contextRef="c80"
      id="hidden-fact-194"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c113"
      id="hidden-fact-195"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c115"
      id="hidden-fact-196"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c115"
      id="hidden-fact-197"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c128"
      id="hidden-fact-198"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c130"
      id="hidden-fact-199"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c130"
      id="hidden-fact-200"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c132"
      id="hidden-fact-201"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c133"
      id="hidden-fact-202"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c133"
      id="hidden-fact-203"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c135"
      id="hidden-fact-204"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c136"
      id="hidden-fact-205"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c136"
      id="hidden-fact-206"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c137"
      id="hidden-fact-207"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c139"
      id="hidden-fact-208"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c139"
      id="hidden-fact-209"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c152"
      id="hidden-fact-210"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c154"
      id="hidden-fact-211"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c154"
      id="hidden-fact-212"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c158"
      id="hidden-fact-213"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c159"
      id="hidden-fact-214"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NetForeignExchangeGain
      contextRef="c0"
      id="hidden-fact-215"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NetForeignExchangeGain
      contextRef="c0"
      id="hidden-fact-216"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives
      contextRef="c13"
      id="hidden-fact-217"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives
      contextRef="c0"
      id="hidden-fact-218"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives
      contextRef="c0"
      id="hidden-fact-219"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment
      contextRef="c13"
      id="hidden-fact-220"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment
      contextRef="c0"
      id="hidden-fact-221"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:GainsOnDisposalsOfPropertyPlantAndEquipment
      contextRef="c0"
      id="hidden-fact-222"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InventoryWritedown2011
      contextRef="c13"
      id="hidden-fact-223"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty
      contextRef="c13"
      id="hidden-fact-224"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty
      contextRef="c0"
      id="hidden-fact-225"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty
      contextRef="c0"
      id="hidden-fact-226"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives
      contextRef="c13"
      id="hidden-fact-227"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives
      contextRef="c0"
      id="hidden-fact-228"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives
      contextRef="c0"
      id="hidden-fact-229"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:FinancialLiabilitiesAtFVTPL
      contextRef="c12"
      id="hidden-fact-230"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:FinancialLiabilitiesAtFVTPL
      contextRef="c13"
      id="hidden-fact-231"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:AdjustmentsForGainOnDisposalOfLeases
      contextRef="c12"
      id="hidden-fact-232"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c12"
      id="hidden-fact-233"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c13"
      id="hidden-fact-234"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ForeignExchangeLoss
      contextRef="c12"
      id="hidden-fact-235"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ForeignExchangeLoss
      contextRef="c13"
      id="hidden-fact-236"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:Penalty
      contextRef="c12"
      decimals="-3"
      id="hidden-fact-237"
      unitRef="cny">24000</aapg:Penalty>
    <ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment
      contextRef="c12"
      id="hidden-fact-238"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="c12"
      id="hidden-fact-239"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="c13"
      id="hidden-fact-240"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:UncertainTaxPosition
      contextRef="c12"
      id="hidden-fact-241"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:EffectOfWithholdingTaxOnTheInterestIncome
      contextRef="c12"
      id="hidden-fact-242"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:EffectOfWithholdingTaxOnTheInterestIncome
      contextRef="c13"
      id="hidden-fact-243"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:NetOperatingLossExpired
      contextRef="c12"
      id="hidden-fact-244"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c185"
      id="hidden-fact-245"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c193"
      id="hidden-fact-246"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c194"
      id="hidden-fact-247"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c196"
      id="hidden-fact-248"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c193"
      id="hidden-fact-249"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c194"
      id="hidden-fact-250"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c196"
      id="hidden-fact-251"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c197"
      id="hidden-fact-252"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c197"
      id="hidden-fact-253"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c196"
      id="hidden-fact-254"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c198"
      id="hidden-fact-255"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c193"
      id="hidden-fact-256"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c194"
      id="hidden-fact-257"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c196"
      id="hidden-fact-258"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c197"
      id="hidden-fact-259"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c209"
      id="hidden-fact-260"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c214"
      id="hidden-fact-261"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c216"
      id="hidden-fact-262"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c216"
      id="hidden-fact-263"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c217"
      id="hidden-fact-264"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c219"
      id="hidden-fact-265"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="c220"
      id="hidden-fact-266"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c220"
      id="hidden-fact-267"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c219"
      id="hidden-fact-268"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c221"
      id="hidden-fact-269"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="c217"
      id="hidden-fact-270"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="c218"
      id="hidden-fact-271"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="c219"
      id="hidden-fact-272"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="c220"
      id="hidden-fact-273"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c216"
      id="hidden-fact-274"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c217"
      id="hidden-fact-275"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c219"
      id="hidden-fact-276"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c220"
      id="hidden-fact-277"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:AccumulatedDepreciationsCost
      contextRef="c232"
      id="hidden-fact-278"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="c238"
      id="hidden-fact-279"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsRightofuseAssets
      contextRef="c238"
      id="hidden-fact-280"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:ExchangeRealignmentRightofuseAssets
      contextRef="c238"
      id="hidden-fact-281"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="c240"
      id="hidden-fact-282"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DisposalsRightofuseAssets
      contextRef="c240"
      id="hidden-fact-283"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:ExchangeRealignmentRightofuseAssets
      contextRef="c240"
      id="hidden-fact-284"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:ExchangeRealignmentRightofuseAssets
      contextRef="c0"
      id="hidden-fact-285"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:AccumulatedImpairmentGoodwill
      contextRef="c14"
      id="hidden-fact-286"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:AccumulatedImpairmentGoodwill
      contextRef="c15"
      id="hidden-fact-287"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:AccumulatedImpairmentGoodwill
      contextRef="c15"
      id="hidden-fact-288"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c247"
      id="hidden-fact-289"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c248"
      id="hidden-fact-290"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:ListedEquityInvestmentsAtFairValue
      contextRef="c15"
      id="hidden-fact-291"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:ListedEquityInvestmentsAtFairValue
      contextRef="c15"
      id="hidden-fact-292"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:OtherUnlistedInvestmentsAtFairValue
      contextRef="c14"
      id="hidden-fact-293"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c282"
      id="hidden-fact-294"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c15"
      id="hidden-fact-295"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c15"
      id="hidden-fact-296"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:DeferredTaxAssetsTaxLossCarryforwards
      contextRef="c14"
      id="hidden-fact-297"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:DeferredTaxAssetsTaxLossCarryforwards
      contextRef="c15"
      id="hidden-fact-298"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:UnrecognizedTaxBenefitsRecognized
      contextRef="c0"
      id="hidden-fact-299"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:UnrecognizedTaxBenefitsRecognized
      contextRef="c0"
      id="hidden-fact-300"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="c14"
      id="hidden-fact-301"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="c15"
      id="hidden-fact-302"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentValueAddedTaxReceivables
      contextRef="c15"
      id="hidden-fact-303"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentValueAddedTaxReceivables
      contextRef="c15"
      id="hidden-fact-304"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentProvisions
      contextRef="c14"
      id="hidden-fact-305"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c305"
      id="hidden-fact-306"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c305"
      id="hidden-fact-307"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:PrepaidListingExpense
      contextRef="c15"
      id="hidden-fact-308"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:PrepaidListingExpense
      contextRef="c15"
      id="hidden-fact-309"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentBorrowingsAndCurrentPortionOfOtherNoncurrentBorrowings
      contextRef="c14"
      id="hidden-fact-310"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfOrdinaryShares
      contextRef="c26"
      id="hidden-fact-311"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionScheme
      contextRef="c26"
      id="hidden-fact-312"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme
      contextRef="c25"
      id="hidden-fact-313"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme
      contextRef="c26"
      id="hidden-fact-314"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme
      contextRef="c12"
      id="hidden-fact-315"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShare
      contextRef="c440"
      id="hidden-fact-316"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares
      contextRef="c25"
      id="hidden-fact-317"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:VestingOfRestrictedShareUnit
      contextRef="c440"
      id="hidden-fact-318"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:VestingOfRestrictedShareUnits
      contextRef="c25"
      id="hidden-fact-319"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfOrdinaryShares
      contextRef="c43"
      id="hidden-fact-320"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionScheme
      contextRef="c42"
      id="hidden-fact-321"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionScheme
      contextRef="c43"
      id="hidden-fact-322"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionScheme
      contextRef="c13"
      id="hidden-fact-323"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme
      contextRef="c42"
      id="hidden-fact-324"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme
      contextRef="c43"
      id="hidden-fact-325"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme
      contextRef="c13"
      id="hidden-fact-326"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseInNumberOfSharesEquitysettledBonus
      contextRef="c442"
      id="hidden-fact-327"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuesEquitysettledBonus
      contextRef="c42"
      id="hidden-fact-328"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShare
      contextRef="c442"
      id="hidden-fact-329"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares
      contextRef="c42"
      id="hidden-fact-330"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:VestingOfRestrictedShareUnit
      contextRef="c442"
      id="hidden-fact-331"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:VestingOfRestrictedShareUnits
      contextRef="c42"
      id="hidden-fact-332"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfOrdinaryShares
      contextRef="c59"
      id="hidden-fact-333"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionScheme
      contextRef="c58"
      id="hidden-fact-334"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionScheme
      contextRef="c59"
      id="hidden-fact-335"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IssueOfSharesUnderThePreIPOShareOptionScheme
      contextRef="c0"
      id="hidden-fact-336"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughIssueOfSharesUnderTheRSUScheme
      contextRef="c59"
      id="hidden-fact-337"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuesEquitysettledBonus
      contextRef="c58"
      id="hidden-fact-338"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuesEquitysettledBonus
      contextRef="c59"
      id="hidden-fact-339"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValuesEquitysettledBonus
      contextRef="c0"
      id="hidden-fact-340"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RepurchaseOfOrdinaryShare
      contextRef="c444"
      id="hidden-fact-341"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:IncreaseDecreaseThroughShareCapitalRepurchaseOfOrdinaryShares
      contextRef="c58"
      id="hidden-fact-342"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:VestingOfRestrictedShareUnit
      contextRef="c444"
      id="hidden-fact-343"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:VestingOfRestrictedShareUnits
      contextRef="c58"
      id="hidden-fact-344"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c13"
      id="hidden-fact-345"
      unitRef="hkdPershares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c13"
      id="hidden-fact-346"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c504"
      id="hidden-fact-347"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c505"
      id="hidden-fact-348"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c482"
      id="hidden-fact-349"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="c481"
      id="hidden-fact-350"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c484"
      id="hidden-fact-351"
      unitRef="pure"
      xsi:nil="true"/>
    <aapg:ShareGrantExpense
      contextRef="c13"
      id="hidden-fact-352"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:ShareGrantExpense
      contextRef="c13"
      id="hidden-fact-353"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c13"
      id="hidden-fact-354"
      unitRef="pure"
      xsi:nil="true"/>
    <aapg:ShareGrantExpense
      contextRef="c13"
      id="hidden-fact-355"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c559"
      id="hidden-fact-356"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c560"
      id="hidden-fact-357"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="c560"
      id="hidden-fact-358"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c559"
      id="hidden-fact-359"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c560"
      id="hidden-fact-360"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c559"
      id="hidden-fact-361"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c560"
      id="hidden-fact-362"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c568"
      id="hidden-fact-363"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c569"
      id="hidden-fact-364"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c568"
      id="hidden-fact-365"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c569"
      id="hidden-fact-366"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c568"
      id="hidden-fact-367"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c569"
      id="hidden-fact-368"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c577"
      id="hidden-fact-369"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="c578"
      id="hidden-fact-370"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets
      contextRef="c577"
      id="hidden-fact-371"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainsLossesOnDisposalOfFinancialAssets
      contextRef="c578"
      id="hidden-fact-372"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c577"
      id="hidden-fact-373"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c578"
      id="hidden-fact-374"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c577"
      id="hidden-fact-375"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c578"
      id="hidden-fact-376"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c13"
      id="hidden-fact-377"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c12"
      id="hidden-fact-378"
      unitRef="pure"
      xsi:nil="true"/>
    <aapg:NumberOfGrantees
      contextRef="c545"
      id="hidden-fact-379"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c547"
      id="hidden-fact-380"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:NonCashDisposals
      contextRef="c12"
      id="hidden-fact-381"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:NonCashDisposals
      contextRef="c12"
      id="hidden-fact-382"
      unitRef="usd"
      xsi:nil="true"/>
    <aapg:NoncashAdditionsToIntangibleAssets
      contextRef="c0"
      id="hidden-fact-383"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="c15"
      id="hidden-fact-384"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="c586"
      id="hidden-fact-385"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="c588"
      id="hidden-fact-386"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="c14"
      id="hidden-fact-387"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:OutstandingBalanceOtherNoncurrentLiabilities
      contextRef="c14"
      id="hidden-fact-388"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c590"
      id="hidden-fact-389"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c590"
      id="hidden-fact-390"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentReceivables
      contextRef="c590"
      id="hidden-fact-391"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c591"
      id="hidden-fact-392"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c590"
      id="hidden-fact-393"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="c593"
      id="hidden-fact-394"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c593"
      id="hidden-fact-395"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c593"
      id="hidden-fact-396"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="c593"
      id="hidden-fact-397"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c593"
      id="hidden-fact-398"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c596"
      id="hidden-fact-399"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CashAndBankBalancesAtCentralBanks
      contextRef="c596"
      id="hidden-fact-400"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentReceivables
      contextRef="c596"
      id="hidden-fact-401"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c597"
      id="hidden-fact-402"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c596"
      id="hidden-fact-403"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="c599"
      id="hidden-fact-404"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c599"
      id="hidden-fact-405"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows
      contextRef="c601"
      decimals="-3"
      id="hidden-fact-406"
      unitRef="usd">20084000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="c186"
      id="hidden-fact-407"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="c602"
      id="hidden-fact-408"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c605"
      id="hidden-fact-409"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c606"
      id="hidden-fact-410"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c15"
      id="hidden-fact-411"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c607"
      id="hidden-fact-412"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c607"
      id="hidden-fact-413"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c608"
      id="hidden-fact-414"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c607"
      id="hidden-fact-415"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c608"
      id="hidden-fact-416"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c631"
      id="hidden-fact-417"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c632"
      id="hidden-fact-418"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c633"
      id="hidden-fact-419"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:CashAndBankBalancesNotYetPastDue
      contextRef="c631"
      id="hidden-fact-420"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:CashAndBankBalancesNotYetPastDue
      contextRef="c632"
      id="hidden-fact-421"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:CashAndBankBalancesNotYetPastDue
      contextRef="c633"
      id="hidden-fact-422"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="c630"
      id="hidden-fact-423"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="c631"
      id="hidden-fact-424"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="c632"
      id="hidden-fact-425"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c631"
      id="hidden-fact-426"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c632"
      id="hidden-fact-427"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c633"
      id="hidden-fact-428"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="c631"
      id="hidden-fact-429"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="c632"
      id="hidden-fact-430"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c635"
      id="hidden-fact-431"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c636"
      id="hidden-fact-432"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c637"
      id="hidden-fact-433"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:CashAndBankBalancesNotYetPastDue
      contextRef="c635"
      id="hidden-fact-434"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:CashAndBankBalancesNotYetPastDue
      contextRef="c636"
      id="hidden-fact-435"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:CashAndBankBalancesNotYetPastDue
      contextRef="c637"
      id="hidden-fact-436"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="c634"
      id="hidden-fact-437"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="c635"
      id="hidden-fact-438"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="c636"
      id="hidden-fact-439"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c635"
      id="hidden-fact-440"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c636"
      id="hidden-fact-441"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c637"
      id="hidden-fact-442"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="c635"
      id="hidden-fact-443"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="c636"
      id="hidden-fact-444"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c638"
      id="hidden-fact-445"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c640"
      id="hidden-fact-446"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c641"
      id="hidden-fact-447"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:LeaseLiabilities
      contextRef="c643"
      id="hidden-fact-448"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:LeaseLiabilities
      contextRef="c646"
      id="hidden-fact-449"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherBorrowings
      contextRef="c648"
      id="hidden-fact-450"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c655"
      id="hidden-fact-451"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c656"
      id="hidden-fact-452"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherPayables
      contextRef="c658"
      id="hidden-fact-453"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherPayables
      contextRef="c659"
      id="hidden-fact-454"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherPayables
      contextRef="c661"
      id="hidden-fact-455"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c668"
      id="hidden-fact-456"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c670"
      id="hidden-fact-457"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="c671"
      id="hidden-fact-458"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:LeaseLiabilities
      contextRef="c673"
      id="hidden-fact-459"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:LeaseLiabilities
      contextRef="c676"
      id="hidden-fact-460"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherBorrowings
      contextRef="c678"
      id="hidden-fact-461"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c685"
      id="hidden-fact-462"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="c686"
      id="hidden-fact-463"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherPayables
      contextRef="c688"
      id="hidden-fact-464"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherPayables
      contextRef="c689"
      id="hidden-fact-465"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherPayables
      contextRef="c691"
      id="hidden-fact-466"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:DerivativeFinancialAssetsHeldForHedging
      contextRef="c697"
      decimals="-3"
      id="hidden-fact-467"
      unitRef="cny">2452061000</ifrs-full:DerivativeFinancialAssetsHeldForHedging>
    <aapg:MarketEquityIndex
      contextRef="c0"
      id="hidden-fact-468"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:StockExchangeIndexShare
      contextRef="c82"
      id="hidden-fact-469"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:StockExchangeIndexShare
      contextRef="c553"
      id="hidden-fact-470"
      unitRef="shares"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c700"
      id="hidden-fact-471"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c701"
      id="hidden-fact-472"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="c700"
      id="hidden-fact-473"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="c701"
      id="hidden-fact-474"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c705"
      id="hidden-fact-475"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c705"
      id="hidden-fact-476"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c715"
      id="hidden-fact-477"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c716"
      id="hidden-fact-478"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c715"
      id="hidden-fact-479"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c717"
      id="hidden-fact-480"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c715"
      id="hidden-fact-481"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c716"
      id="hidden-fact-482"
      unitRef="shares"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c717"
      id="hidden-fact-483"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:PreIPOShareOptionExpenses
      contextRef="c719"
      id="hidden-fact-484"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:PreIPOShareOptionExpenses
      contextRef="c720"
      id="hidden-fact-485"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c716"
      id="hidden-fact-486"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c717"
      id="hidden-fact-487"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c716"
      id="hidden-fact-488"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c717"
      id="hidden-fact-489"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c716"
      id="hidden-fact-490"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c717"
      id="hidden-fact-491"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c716"
      id="hidden-fact-492"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c717"
      id="hidden-fact-493"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c718"
      id="hidden-fact-494"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c719"
      id="hidden-fact-495"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c718"
      id="hidden-fact-496"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c720"
      id="hidden-fact-497"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c718"
      id="hidden-fact-498"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c719"
      id="hidden-fact-499"
      unitRef="shares"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c720"
      id="hidden-fact-500"
      unitRef="shares"
      xsi:nil="true"/>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c719"
      id="hidden-fact-501"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c720"
      id="hidden-fact-502"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c719"
      id="hidden-fact-503"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c720"
      id="hidden-fact-504"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c719"
      id="hidden-fact-505"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c720"
      id="hidden-fact-506"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c719"
      id="hidden-fact-507"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c720"
      id="hidden-fact-508"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c728"
      id="hidden-fact-509"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c729"
      id="hidden-fact-510"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c728"
      id="hidden-fact-511"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c730"
      id="hidden-fact-512"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:ComprehensiveIncomeLoss
      contextRef="c728"
      id="hidden-fact-513"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c729"
      id="hidden-fact-514"
      unitRef="shares"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="c730"
      id="hidden-fact-515"
      unitRef="shares"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="c729"
      id="hidden-fact-516"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="c730"
      id="hidden-fact-517"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c729"
      id="hidden-fact-518"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:RestrictedShareUnitExpenses
      contextRef="c730"
      id="hidden-fact-519"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c729"
      id="hidden-fact-520"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueExerciseOfPreIPOShareOptions
      contextRef="c730"
      id="hidden-fact-521"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c729"
      id="hidden-fact-522"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueVestingOfRSUs
      contextRef="c730"
      id="hidden-fact-523"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c729"
      id="hidden-fact-524"
      unitRef="cny"
      xsi:nil="true"/>
    <aapg:StockIssuedDuringPeriodValueEquitysettledBonus
      contextRef="c730"
      id="hidden-fact-525"
      unitRef="cny"
      xsi:nil="true"/>
    <ifrs-full:InvestmentIncome
      contextRef="c13"
      id="hidden-fact-526"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentIncome
      contextRef="c0"
      id="hidden-fact-527"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-73396">0002023311</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-73397">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-73398">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-73399">00000</dei:EntityAddressPostalZipCode>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-194"
          xlink:label="hidden-fact-194"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-192"
          xlink:label="hidden-fact-192"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-191"
          xlink:label="hidden-fact-191"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English names of the companies registered in the PRC represent the best efforts made by the management of the Company in directly translating the Chinese names of these companies as no English names have been registered.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-194"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-192"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-191"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These entities are limited liability companies established in the PRC.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-194"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-192"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-191"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">Effective for annual periods beginning on or after January 1, 2026</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">Effective for annual/reporting periods beginning on or after January 1, 2027</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No mandatory effective date yet determined but available for adoption</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-199"
          xlink:label="hidden-fact-199"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These customers generated less than 10% of the total revenue of the Group during the years ended December 31, 2023, 2024 and 2025.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-199"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no forfeited contributions that may be used by the Group as the employer to reduce the existing level of contributions.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_36_fact"
          xlink:label="ix_36_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-225"
          xlink:label="hidden-fact-225"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_40_fact"
          xlink:label="ix_40_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-224"
          xlink:label="hidden-fact-224"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_39_fact"
          xlink:label="ix_39_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-226"
          xlink:label="hidden-fact-226"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_38_fact"
          xlink:label="ix_38_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_37_fact"
          xlink:label="ix_37_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_35_fact"
          xlink:label="ix_35_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The depreciation of property, plant and equipment, the depreciation of investment property, the depreciation of right-of-use assets, the amortization of intangible assets and the equity-settled share-based payment expenses for the years are included in &#x201c;Cost of Sales&#x201d;, &#x201c;Research and development expenses&#x201d;, &#x201c;Selling and distribution expenses&#x201d; and &#x201c;Administrative expenses&#x201d; in the consolidated statements of profit or loss.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_36_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-225"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_40_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-224"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-226"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_37_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_35_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_41_fact"
          xlink:label="ix_41_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_42_fact"
          xlink:label="ix_42_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_43_fact"
          xlink:label="ix_43_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_8_footnote" xlink:label="ix_8_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average number of shares was after taking into account the effect of treasury shares held.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_41_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_43_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_47_fact"
          xlink:label="ix_47_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_46_fact"
          xlink:label="ix_46_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_45_fact"
          xlink:label="ix_45_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_44_fact"
          xlink:label="ix_44_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_9_footnote" xlink:label="ix_9_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The English name of the company registered in the PRC represents the best efforts made by the management of the Company in directly translating the Chinese name of this Company as no English name has been registered.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_47_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_45_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_10_footnote" xlink:label="ix_10_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group holds two of three representatives in the committee that directs the relevant activities of Ascentage Harvest. As a result, the Group has significant influence over the financial and operating policy decisions of Ascentage Harvest.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_63_fact"
          xlink:label="ix_63_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_65_fact"
          xlink:label="ix_65_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_61_fact"
          xlink:label="ix_61_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_69_fact"
          xlink:label="ix_69_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_55_fact"
          xlink:label="ix_55_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_67_fact"
          xlink:label="ix_67_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_58_fact"
          xlink:label="ix_58_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_60_fact"
          xlink:label="ix_60_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_66_fact"
          xlink:label="ix_66_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_48_fact"
          xlink:label="ix_48_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_56_fact"
          xlink:label="ix_56_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_49_fact"
          xlink:label="ix_49_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_51_fact"
          xlink:label="ix_51_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_68_fact"
          xlink:label="ix_68_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_59_fact"
          xlink:label="ix_59_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_53_fact"
          xlink:label="ix_53_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_54_fact"
          xlink:label="ix_54_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_50_fact"
          xlink:label="ix_50_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_52_fact"
          xlink:label="ix_52_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_62_fact"
          xlink:label="ix_62_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_64_fact"
          xlink:label="ix_64_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_57_fact"
          xlink:label="ix_57_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_11_footnote" xlink:label="ix_11_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The bank loans amounting to RMB600,173 (US$85,823) as at December 31, 2025 were secured by the pledge of the Group&#x2019;s buildings with a net carrying amount of RMB676,985 (US$96,808) and right-of-use assets with a net carrying amount of RMB25,338 (US$3,623) as at December 31, 2025. Such loans were also guaranteed by two of the Group&#x2019;s subsidiaries.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_63_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_65_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_61_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_69_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_55_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_67_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_58_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_60_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_66_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_56_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_49_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_51_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_68_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_59_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_53_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_54_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_50_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_52_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_62_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_64_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_57_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_72_fact"
          xlink:label="ix_72_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-311"
          xlink:label="hidden-fact-311"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_71_fact"
          xlink:label="ix_71_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_70_fact"
          xlink:label="ix_70_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_12_footnote" xlink:label="ix_12_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the share placement, 22,500,000 placing shares of the Company were issued and allotted at a price of HK$24.45 per share on February 1, 2023, and an amount of RMB15 was credited as share capital.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_72_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-311"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_71_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_70_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_75_fact"
          xlink:label="ix_75_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_73_fact"
          xlink:label="ix_73_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_74_fact"
          xlink:label="ix_74_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-312"
          xlink:label="hidden-fact-312"
          xlink:type="locator"/>
        <link:footnote id="ix_13_footnote" xlink:label="ix_13_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company before December 31, 2023 to those grantees. In connection with the exercised share options, 911,062 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB1 was credited as share capital.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_75_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_73_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_74_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-312"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_76_fact"
          xlink:label="ix_76_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-315"
          xlink:label="hidden-fact-315"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-313"
          xlink:label="hidden-fact-313"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-314"
          xlink:label="hidden-fact-314"
          xlink:type="locator"/>
        <link:footnote id="ix_14_footnote" xlink:label="ix_14_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2023 to those selected persons. In connection with the exercised RSUs, 71,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_76_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-315"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-313"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-314"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_78_fact"
          xlink:label="ix_78_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_79_fact"
          xlink:label="ix_79_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_80_fact"
          xlink:label="ix_80_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_77_fact"
          xlink:label="ix_77_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_15_footnote" xlink:label="ix_15_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, 1,528,514 ordinary shares and 1,237,884 treasury shares, being underlying shares of the RSUs granted under the 2021 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB1 and RMB1 were credited as share capital and treasury shares, respectively.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_78_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_79_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_80_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_77_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-317"
          xlink:label="hidden-fact-317"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_82_fact"
          xlink:label="ix_82_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_81_fact"
          xlink:label="ix_81_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-316"
          xlink:label="hidden-fact-316"
          xlink:type="locator"/>
        <link:footnote id="ix_16_footnote" xlink:label="ix_16_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the Company instructed the trustee to purchase 250,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB5,923 for the purpose of the 2022 RSU scheme.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-317"
          xlink:to="ix_16_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_82_fact"
          xlink:to="ix_16_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_81_fact"
          xlink:to="ix_16_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-316"
          xlink:to="ix_16_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_84_fact"
          xlink:label="ix_84_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_83_fact"
          xlink:label="ix_83_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-319"
          xlink:label="hidden-fact-319"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-318"
          xlink:label="hidden-fact-318"
          xlink:type="locator"/>
        <link:footnote id="ix_17_footnote" xlink:label="ix_17_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the exercise of RSUs granted under the 2018 and 2022 RSU Scheme, 1,069,461 treasury shares were allotted to the employees during the year ended December 31,2023.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_84_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_83_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-319"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-318"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_85_fact"
          xlink:label="ix_85_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_87_fact"
          xlink:label="ix_87_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-320"
          xlink:label="hidden-fact-320"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_86_fact"
          xlink:label="ix_86_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_18_footnote" xlink:label="ix_18_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, 24,307,322 placing shares of the Company were issued and allotted at a price of HK$24.10 per share on June 20, 2024, and an amount of RMB17 was credited as share capital.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_85_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_87_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-320"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_86_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_88_fact"
          xlink:label="ix_88_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-322"
          xlink:label="hidden-fact-322"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-323"
          xlink:label="hidden-fact-323"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-321"
          xlink:label="hidden-fact-321"
          xlink:type="locator"/>
        <link:footnote id="ix_19_footnote" xlink:label="ix_19_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During the year ended December 31, 2024, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 656,077 new shares of the Company were issued with a weighted average exercise price of HK$0.01, and an amount of RMB0.5 was credited as share capital.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_88_fact"
          xlink:to="ix_19_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-322"
          xlink:to="ix_19_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-323"
          xlink:to="ix_19_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-321"
          xlink:to="ix_19_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-326"
          xlink:label="hidden-fact-326"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-325"
          xlink:label="hidden-fact-325"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_89_fact"
          xlink:label="ix_89_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-324"
          xlink:label="hidden-fact-324"
          xlink:type="locator"/>
        <link:footnote id="ix_20_footnote" xlink:label="ix_20_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2024, the Company issued ordinary shares with respect to the RSUs under the 2021 RSU Scheme exercised by certain selected persons of the Company before December 31, 2024 to those selected persons. In connection with the exercised RSUs, 65,034 new shares of the Company were issued, and an amount of RMB0.05 was credited as share capital.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-326"
          xlink:to="ix_20_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-325"
          xlink:to="ix_20_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_89_fact"
          xlink:to="ix_20_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-324"
          xlink:to="ix_20_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_90_fact"
          xlink:label="ix_90_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-327"
          xlink:label="hidden-fact-327"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-328"
          xlink:label="hidden-fact-328"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_91_fact"
          xlink:label="ix_91_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_21_footnote" xlink:label="ix_21_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2024, 397,949 treasury shares and 2,081,399 treasury shares, being underlying shares of the RSUs granted under the 2022 RSU scheme and the 2018 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB8,630 and RMB1.4 were both credited as treasury shares.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_90_fact"
          xlink:to="ix_21_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-327"
          xlink:to="ix_21_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-328"
          xlink:to="ix_21_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_91_fact"
          xlink:to="ix_21_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_93_fact"
          xlink:label="ix_93_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-330"
          xlink:label="hidden-fact-330"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_92_fact"
          xlink:label="ix_92_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-329"
          xlink:label="hidden-fact-329"
          xlink:type="locator"/>
        <link:footnote id="ix_22_footnote" xlink:label="ix_22_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2024, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB1,959 for the purpose of the 2022 RSU Scheme.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_93_fact"
          xlink:to="ix_22_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-330"
          xlink:to="ix_22_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_92_fact"
          xlink:to="ix_22_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-329"
          xlink:to="ix_22_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-331"
          xlink:label="hidden-fact-331"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-332"
          xlink:label="hidden-fact-332"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_94_fact"
          xlink:label="ix_94_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_95_fact"
          xlink:label="ix_95_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_23_footnote" xlink:label="ix_23_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of RSUs granted under the 2018 and 2022 RSU Schemes, 939,687 treasury shares were allotted to the employees during the year ended December 31, 2024.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-331"
          xlink:to="ix_23_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-332"
          xlink:to="ix_23_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_94_fact"
          xlink:to="ix_23_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_95_fact"
          xlink:to="ix_23_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_96_fact"
          xlink:label="ix_96_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-333"
          xlink:label="hidden-fact-333"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_98_fact"
          xlink:label="ix_98_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_97_fact"
          xlink:label="ix_97_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_24_footnote" xlink:label="ix_24_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the subscription of shares, 7,325,000 ADS (represents 29,300,000 of the Company&#x2019;s ordinary shares) were offered at a price of US$17.25 per ADS on January 23, 2025, followed by an additional 935,144 ADS (represents 3,740,576 of the Company&#x2019;s ordinary shares) were offered at the same price on February 13, 2025, and 22,000,000 placing shares of the Company were issued and allotted at a price of HK$68.6 per share on July 17, 2025, amounts of RMB40 (US$6) was credited as share capital.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_96_fact"
          xlink:to="ix_24_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-333"
          xlink:to="ix_24_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_98_fact"
          xlink:to="ix_24_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_97_fact"
          xlink:to="ix_24_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-336"
          xlink:label="hidden-fact-336"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-334"
          xlink:label="hidden-fact-334"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-335"
          xlink:label="hidden-fact-335"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_99_fact"
          xlink:label="ix_99_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_25_footnote" xlink:label="ix_25_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During the year ended December 31, 2025, the Company issued ordinary shares with respect to the share options under the pre-IPO share option scheme exercised by certain grantees of the Company. In connection with the exercised share options, 455,263 new shares of the Company were issued with a weighted average exercise price of HK$ 0.01, and an amount of RMB0.3 (US$0.04) was credited as share capital.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-336"
          xlink:to="ix_25_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-334"
          xlink:to="ix_25_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-335"
          xlink:to="ix_25_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_99_fact"
          xlink:to="ix_25_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_101_fact"
          xlink:label="ix_101_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_100_fact"
          xlink:label="ix_100_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_102_fact"
          xlink:label="ix_102_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-337"
          xlink:label="hidden-fact-337"
          xlink:type="locator"/>
        <link:footnote id="ix_26_footnote" xlink:label="ix_26_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During June to September 2025, the Company issued ordinary shares with respect to the restricted share units under the 2021 and 2022 RSU Scheme exercised by certain selected persons of the Company before December 31, 2025 to those selected persons. In connection with the exercised restricted share units, 1,008,253 new shares of the Company were issued, and an amount of RMB0.7 (US$0.1) was credited as share capital.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_101_fact"
          xlink:to="ix_26_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_100_fact"
          xlink:to="ix_26_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_102_fact"
          xlink:to="ix_26_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-337"
          xlink:to="ix_26_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-340"
          xlink:label="hidden-fact-340"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_103_fact"
          xlink:label="ix_103_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-339"
          xlink:label="hidden-fact-339"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-338"
          xlink:label="hidden-fact-338"
          xlink:type="locator"/>
        <link:footnote id="ix_27_footnote" xlink:label="ix_27_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2025, 775,685 ordinary shares and 816,922 ordinary shares, being underlying shares of the restricted share units granted under the 2021 RSU scheme and the 2022 RSU scheme, were allotted to the employees to settle the bonus due to employees, and amounts of RMB0.5 (US$0.07) and RMB0.6 (US$0.09) credited as share capital.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-340"
          xlink:to="ix_27_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_103_fact"
          xlink:to="ix_27_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-339"
          xlink:to="ix_27_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-338"
          xlink:to="ix_27_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_105_fact"
          xlink:label="ix_105_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-342"
          xlink:label="hidden-fact-342"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-341"
          xlink:label="hidden-fact-341"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_104_fact"
          xlink:label="ix_104_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_28_footnote" xlink:label="ix_28_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2025, the Company instructed the trustee to purchase 100,000 of its shares on the Hong Kong Stock Exchange at a total consideration of RMB3,590 (US$513) for the purpose of the 2022 RSU scheme.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_105_fact"
          xlink:to="ix_28_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-342"
          xlink:to="ix_28_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-341"
          xlink:to="ix_28_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_104_fact"
          xlink:to="ix_28_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-343"
          xlink:label="hidden-fact-343"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-344"
          xlink:label="hidden-fact-344"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_106_fact"
          xlink:label="ix_106_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_107_fact"
          xlink:label="ix_107_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_29_footnote" xlink:label="ix_29_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the vesting of restricted share units granted under the 2022 RSU Scheme, 17,925 treasury shares were allotted to the employees during the year ended December 31, 2025.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-343"
          xlink:to="ix_29_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-344"
          xlink:to="ix_29_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_106_fact"
          xlink:to="ix_29_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_107_fact"
          xlink:to="ix_29_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-437"
          xlink:label="hidden-fact-437"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_111_fact"
          xlink:label="ix_111_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-423"
          xlink:label="hidden-fact-423"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-438"
          xlink:label="hidden-fact-438"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_110_fact"
          xlink:label="ix_110_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_108_fact"
          xlink:label="ix_108_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_112_fact"
          xlink:label="ix_112_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-439"
          xlink:label="hidden-fact-439"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-425"
          xlink:label="hidden-fact-425"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_109_fact"
          xlink:label="ix_109_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-424"
          xlink:label="hidden-fact-424"
          xlink:type="locator"/>
        <link:footnote id="ix_30_footnote" xlink:label="ix_30_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For trade receivables to which the Group applies the simplified approach for impairment, information based on provision matrix is disclosed in note 21 to the financial statements.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-437"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_111_fact"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-423"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-438"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_110_fact"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_108_fact"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_112_fact"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-439"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-425"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_109_fact"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-424"
          xlink:to="ix_30_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-433"
          xlink:label="hidden-fact-433"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_118_fact"
          xlink:label="ix_118_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_121_fact"
          xlink:label="ix_121_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_115_fact"
          xlink:label="ix_115_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_116_fact"
          xlink:label="ix_116_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-442"
          xlink:label="hidden-fact-442"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_119_fact"
          xlink:label="ix_119_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-417"
          xlink:label="hidden-fact-417"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-418"
          xlink:label="hidden-fact-418"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-428"
          xlink:label="hidden-fact-428"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_122_fact"
          xlink:label="ix_122_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-419"
          xlink:label="hidden-fact-419"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-440"
          xlink:label="hidden-fact-440"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_114_fact"
          xlink:label="ix_114_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_120_fact"
          xlink:label="ix_120_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-426"
          xlink:label="hidden-fact-426"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-431"
          xlink:label="hidden-fact-431"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-432"
          xlink:label="hidden-fact-432"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-441"
          xlink:label="hidden-fact-441"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-427"
          xlink:label="hidden-fact-427"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_113_fact"
          xlink:label="ix_113_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_117_fact"
          xlink:label="ix_117_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_31_footnote" xlink:label="ix_31_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit quality of the financial assets included in prepayments, other receivables and other assets and financial assets included in other non- current assets is considered to be &#x201c;normal&#x201d; when they are not past due and there is no information indicating that the financial assets had a significant increase in credit risk since initial recognition. Otherwise, the credit quality of the financial assets is considered to be &#x201c;doubtful&#x201d;.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-433"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_118_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_121_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_115_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_116_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-442"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_119_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-417"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-418"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-428"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_122_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-419"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-440"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_114_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_120_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-426"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-431"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-432"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-441"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-427"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_113_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_117_fact"
          xlink:to="ix_31_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
